id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
25172038|NCT01726517|50309956|FG000|Overall Study|Withdrawal by Subject|0|||
25172039|NCT01726517|50309957|FG001|Overall Study|Withdrawal by Subject|0|||
25172040|NCT01726517|50309958|FG002|Overall Study|Withdrawal by Subject|1|||
25172041|NCT01726517|50309959|FG003|Overall Study|Withdrawal by Subject|0|||
25172042|NCT01726517|50309960|FG004|Overall Study|Withdrawal by Subject|0|||
25172043|NCT01752023|50309974|FG000|Overall Study|Physician Decision|2|||
25172044|NCT01752023|50309975|FG001|Overall Study|Physician Decision|1|||
25172045|NCT01726049|50309987|FG000|Overall Study|Death|1|||
25172046|NCT01726049|50309988|FG001|Overall Study|Death|1|||
25172047|NCT01726049|50309987|FG000|Overall Study|Adverse Event|4|||
25172048|NCT01726049|50309988|FG001|Overall Study|Adverse Event|1|||
25172049|NCT01726049|50309987|FG000|Overall Study|refused second HC|0|||
25172050|NCT01726049|50309988|FG001|Overall Study|refused second HC|2|||
24906677|NCT00419341|50000624|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
24906678|NCT00419341|50000624|FG000|Wash in/Wash Out Period|Adverse Event|2|||
24906679|NCT00419341|50000624|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
24906680|NCT00419341|50000624|FG000|Efficacy Period|Withdrawal by Subject|6|||
24906681|NCT00419341|50000624|FG000|Efficacy Period|Protocol Violation|1|||
24906682|NCT00419341|50000624|FG000|Efficacy Period|Lost to Follow-up|1|||
24906683|NCT00419341|50000624|FG000|Efficacy Period|Non-compliance|1|||
24906684|NCT00419341|50000624|FG000|Efficacy Period|Termination of study site|1|||
25083660|NCT02638623|50191821|FG000|Overall Study|Surgery timing|5|||
25172051|NCT01605617|50310009|FG000|First Intervention|Adverse Event|0|||
25172052|NCT01605617|50310010|FG001|First Intervention|Adverse Event|1|||
25172053|NCT01605617|50310009|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
25172054|NCT01605617|50310010|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
25172055|NCT01751867|50310027|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
25172056|NCT01751867|50310028|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
25172057|NCT01751867|50310027|FG000|Overall Study|Diease Progression|4|||
25172058|NCT01751867|50310028|FG001|Overall Study|Diease Progression|18|||
25172059|NCT01751867|50310027|FG000|Overall Study|Adverse Event|8|||
25172060|NCT01751867|50310028|FG001|Overall Study|Adverse Event|15|||
25172061|NCT01751867|50310027|FG000|Overall Study|Poor Compliance|0|||
25172062|NCT01751867|50310028|FG001|Overall Study|Poor Compliance|5|||
25172063|NCT01751867|50310027|FG000|Overall Study|Withdrawal by Subject|3|||
25172064|NCT01751867|50310028|FG001|Overall Study|Withdrawal by Subject|1|||
24906685|NCT00694122|50000630|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
25172065|NCT01751867|50310027|FG000|Overall Study|Physician Decision|4|||
25172066|NCT01751867|50310028|FG001|Overall Study|Physician Decision|7|||
25172067|NCT01751867|50310027|FG000|Overall Study|Protocol Violation|0|||
25172068|NCT01751867|50310028|FG001|Overall Study|Protocol Violation|2|||
25172069|NCT01751867|50310027|FG000|Overall Study|Death|0|||
25172070|NCT01751867|50310028|FG001|Overall Study|Death|5|||
25172071|NCT01751867|50310027|FG000|Overall Study|Other|11|||
25172072|NCT01751867|50310028|FG001|Overall Study|Other|37|||
25172073|NCT01751867|50310027|FG000|Overall Study|Randomized but not treated.|2|||
25172074|NCT01751867|50310028|FG001|Overall Study|Randomized but not treated.|1|||
25172075|NCT01751165|50310054|FG000|Overall Study|Adverse event, serious fatal|1|||
25172076|NCT01751165|50310055|FG001|Overall Study|Adverse event, serious fatal|0|||
25172077|NCT01751165|50310056|FG002|Overall Study|Adverse event, serious fatal|1|||
25172078|NCT01751165|50310054|FG000|Overall Study|Withdrawal by Subject|0|||
25172079|NCT01751165|50310055|FG001|Overall Study|Withdrawal by Subject|0|||
25172080|NCT01751165|50310056|FG002|Overall Study|Withdrawal by Subject|1|||
25172081|NCT01751165|50310054|FG000|Overall Study|Serious adverse event|0|||
25172082|NCT01751165|50310055|FG001|Overall Study|Serious adverse event|2|||
25172083|NCT01751165|50310056|FG002|Overall Study|Serious adverse event|0|||
25172084|NCT01751165|50310054|FG000|Overall Study|Lost to Follow-up|1|||
25172085|NCT01751165|50310055|FG001|Overall Study|Lost to Follow-up|1|||
25172086|NCT01751165|50310056|FG002|Overall Study|Lost to Follow-up|1|||
25172087|NCT01751087|50310081|FG000|Overall Study|Withdrawal by Subject|1|||
25172088|NCT01751087|50310082|FG001|Overall Study|Withdrawal by Subject|0|||
25172089|NCT01751087|50310083|FG002|Overall Study|Withdrawal by Subject|0|||
25172090|NCT01751087|50310081|FG000|Overall Study|Physician Decision|0|||
25172091|NCT01751087|50310082|FG001|Overall Study|Physician Decision|0|||
24906686|NCT00694122|50000631|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
24906687|NCT00694122|50000630|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
24906688|NCT00694122|50000631|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
24906689|NCT00694122|50000630|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
24906690|NCT00694122|50000631|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
24906691|NCT03922620|50000644|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
24906692|NCT03922620|50000645|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
24906693|NCT00419263|50000654|FG000|Overall Study|Lost to Follow-up|2|||
24906694|NCT00419263|50000655|FG001|Overall Study|Lost to Follow-up|1|||
24906695|NCT00419263|50000656|FG002|Overall Study|Lost to Follow-up|1|||
24906696|NCT00419263|50000654|FG000|Overall Study|Randomized in Error, Not Treated|1|||
24906697|NCT00419263|50000655|FG001|Overall Study|Randomized in Error, Not Treated|1|||
24906698|NCT00419263|50000656|FG002|Overall Study|Randomized in Error, Not Treated|0|||
24906699|NCT00419263|50000654|FG000|Overall Study|Adverse Event|0|||
24906700|NCT00419263|50000655|FG001|Overall Study|Adverse Event|0|||
24906701|NCT00419263|50000656|FG002|Overall Study|Adverse Event|1|||
24906702|NCT00419263|50000654|FG000|Overall Study|Withdrawal by Subject|0|||
24906703|NCT00419263|50000655|FG001|Overall Study|Withdrawal by Subject|0|||
24906704|NCT00419263|50000656|FG002|Overall Study|Withdrawal by Subject|1|||
24906705|NCT00399763|50000667|FG000|Overall Study|Lost to Follow-up|2|||
24906706|NCT00399763|50000668|FG001|Overall Study|Lost to Follow-up|3|||
24906707|NCT00699842|50000677|FG000|Overall Study|Death|0|||
24906708|NCT00699842|50000678|FG001|Overall Study|Death|1|||
24906709|NCT00699842|50000679|FG002|Overall Study|Death|0|||
24906710|NCT00399529|50000687|FG000|Overall Study|Off Study Prior to Treatment|2|||
24906711|NCT00712712|50000692|FG000|Overall Study|Protocol Violation|11|||
24906712|NCT00712712|50000692|FG000|Overall Study|Radiofrequency not done|3|||
24906713|NCT00712712|50000692|FG000|Overall Study|Death|8|||
24906714|NCT00712712|50000692|FG000|Overall Study|Withdrawal by Subject|1|||
24906715|NCT00411151|50000696|FG000|Overall Study|Death|38|||
24906716|NCT00411151|50000696|FG000|Overall Study|Withdrawal by Subject|2|||
24906717|NCT00411151|50000696|FG000|Overall Study|Lost to Follow-up|2|||
24906718|NCT00411151|50000696|FG000|Overall Study|Protocol Violation|1|||
24906719|NCT00411151|50000696|FG000|Overall Study|Trial prematurely closed|4|||
24906720|NCT00607048|50000702|FG000|Overall Study|Adverse Event|0|||
24906721|NCT00607048|50000703|FG001|Overall Study|Adverse Event|1|||
24906722|NCT00607048|50000704|FG002|Overall Study|Adverse Event|0|||
24906723|NCT00607048|50000705|FG003|Overall Study|Adverse Event|0|||
24906724|NCT00607048|50000706|FG004|Overall Study|Adverse Event|4|||
24906725|NCT00607048|50000707|FG005|Overall Study|Adverse Event|0|||
24906726|NCT00607048|50000702|FG000|Overall Study|Global deterioration of health|1|||
24906727|NCT00607048|50000703|FG001|Overall Study|Global deterioration of health|0|||
24906728|NCT00607048|50000704|FG002|Overall Study|Global deterioration of health|0|||
24906729|NCT00607048|50000705|FG003|Overall Study|Global deterioration of health|0|||
24906730|NCT00607048|50000706|FG004|Overall Study|Global deterioration of health|0|||
24906731|NCT00607048|50000707|FG005|Overall Study|Global deterioration of health|0|||
24906732|NCT00607048|50000702|FG000|Overall Study|Objective disease progression - relapse|1|||
24906733|NCT00607048|50000703|FG001|Overall Study|Objective disease progression - relapse|2|||
24906734|NCT00607048|50000704|FG002|Overall Study|Objective disease progression - relapse|4|||
24906735|NCT00607048|50000705|FG003|Overall Study|Objective disease progression - relapse|2|||
24906736|NCT00607048|50000706|FG004|Overall Study|Objective disease progression - relapse|2|||
24906737|NCT00607048|50000707|FG005|Overall Study|Objective disease progression - relapse|2|||
24906738|NCT00607048|50000702|FG000|Overall Study|Withdrawal by Subject|0|||
24906739|NCT00607048|50000703|FG001|Overall Study|Withdrawal by Subject|0|||
24906740|NCT00607048|50000704|FG002|Overall Study|Withdrawal by Subject|0|||
24906741|NCT00607048|50000705|FG003|Overall Study|Withdrawal by Subject|1|||
24906742|NCT00607048|50000706|FG004|Overall Study|Withdrawal by Subject|0|||
24906743|NCT00607048|50000707|FG005|Overall Study|Withdrawal by Subject|2|||
24906744|NCT00607048|50000702|FG000|Overall Study|Other|1|||
24906745|NCT00607048|50000703|FG001|Overall Study|Other|1|||
24906746|NCT00607048|50000704|FG002|Overall Study|Other|0|||
24906747|NCT00607048|50000705|FG003|Overall Study|Other|0|||
24906748|NCT00607048|50000706|FG004|Overall Study|Other|0|||
24906749|NCT00607048|50000707|FG005|Overall Study|Other|1|||
24906750|NCT00699608|50000723|FG000|First Intervention|Withdrawal by Subject|0|||
24906751|NCT00699608|50000724|FG001|First Intervention|Withdrawal by Subject|0|||
24906752|NCT00699608|50000725|FG002|First Intervention|Withdrawal by Subject|1|||
24906753|NCT00699608|50000726|FG003|First Intervention|Withdrawal by Subject|0|||
24906754|NCT00699608|50000727|FG004|First Intervention|Withdrawal by Subject|0|||
24906755|NCT00699608|50000728|FG005|First Intervention|Withdrawal by Subject|0|||
24906756|NCT00699608|50000723|FG000|First Intervention|Protocol Violation|0|||
24906757|NCT00699608|50000724|FG001|First Intervention|Protocol Violation|0|||
24906758|NCT00699608|50000725|FG002|First Intervention|Protocol Violation|0|||
24906759|NCT00699608|50000726|FG003|First Intervention|Protocol Violation|0|||
24906760|NCT00699608|50000727|FG004|First Intervention|Protocol Violation|1|||
24906761|NCT00699608|50000728|FG005|First Intervention|Protocol Violation|0|||
24906762|NCT00699608|50000723|FG000|Second Intervention|Adverse Event|0|||
24906763|NCT00699608|50000724|FG001|Second Intervention|Adverse Event|0|||
24906764|NCT00699608|50000725|FG002|Second Intervention|Adverse Event|1|||
24906765|NCT00699608|50000726|FG003|Second Intervention|Adverse Event|0|||
24906766|NCT00699608|50000727|FG004|Second Intervention|Adverse Event|0|||
24906767|NCT00699608|50000728|FG005|Second Intervention|Adverse Event|0|||
24906768|NCT00699608|50000723|FG000|Second Intervention|Withdrawal by Subject|0|||
24906769|NCT00699608|50000724|FG001|Second Intervention|Withdrawal by Subject|0|||
24906770|NCT00699608|50000725|FG002|Second Intervention|Withdrawal by Subject|0|||
24906771|NCT00699608|50000726|FG003|Second Intervention|Withdrawal by Subject|1|||
24906772|NCT00699608|50000727|FG004|Second Intervention|Withdrawal by Subject|0|||
24906773|NCT00699608|50000728|FG005|Second Intervention|Withdrawal by Subject|0|||
24906774|NCT03823404|50000739|FG000|Overall Study|Lost to Follow-up|1|||
24906775|NCT03823404|50000740|FG001|Overall Study|Lost to Follow-up|2|||
24906776|NCT03823404|50000741|FG002|Overall Study|Lost to Follow-up|3|||
24906777|NCT03823404|50000739|FG000|Overall Study|Protocol Violation|2|||
24906778|NCT03823404|50000740|FG001|Overall Study|Protocol Violation|0|||
24906779|NCT03823404|50000741|FG002|Overall Study|Protocol Violation|2|||
24906780|NCT03823404|50000739|FG000|Overall Study|Adverse Event|35|||
24906781|NCT03823404|50000740|FG001|Overall Study|Adverse Event|38|||
24906782|NCT03823404|50000741|FG002|Overall Study|Adverse Event|8|||
24906783|NCT03823404|50000739|FG000|Overall Study|Withdrawal by Subject|38|||
24906784|NCT03823404|50000740|FG001|Overall Study|Withdrawal by Subject|40|||
24906785|NCT03823404|50000741|FG002|Overall Study|Withdrawal by Subject|35|||
24906786|NCT03823404|50000739|FG000|Overall Study|Death|4|||
24906787|NCT03823404|50000740|FG001|Overall Study|Death|0|||
24906788|NCT03823404|50000741|FG002|Overall Study|Death|0|||
24906789|NCT03823404|50000739|FG000|Overall Study|Other: Various reasons provided|5|||
24906790|NCT03823404|50000740|FG001|Overall Study|Other: Various reasons provided|5|||
24906791|NCT03823404|50000741|FG002|Overall Study|Other: Various reasons provided|6|||
24906792|NCT00706706|50000749|FG000|Overall Study|Death|53|||
24906793|NCT00706706|50000749|FG000|Overall Study|Lost to Follow-up|7|||
24906794|NCT00706706|50000749|FG000|Overall Study|Study endpoint had reached|45|||
24906795|NCT00410761|50000755|FG000|Overall Study|Adverse Event|29|||
24906796|NCT00410761|50000756|FG001|Overall Study|Adverse Event|3|||
24906797|NCT00410761|50000755|FG000|Overall Study|objective disease progression|71|||
24906798|NCT00410761|50000756|FG001|Overall Study|objective disease progression|55|||
24906799|NCT00410761|50000755|FG000|Overall Study|Withdrawal by Subject|8|||
24906800|NCT00410761|50000756|FG001|Overall Study|Withdrawal by Subject|4|||
24906801|NCT00410761|50000755|FG000|Overall Study|Other|12|||
24906802|NCT00410761|50000756|FG001|Overall Study|Other|9|||
24906803|NCT00410761|50000755|FG000|Overall Study|Never received randomised treatment|0|||
24906804|NCT00410761|50000756|FG001|Overall Study|Never received randomised treatment|1|||
24906805|NCT00410605|50000762|FG000|Overall Study|Adverse Event|12|||
24906806|NCT00410605|50000762|FG000|Overall Study|Physician Decision|3|||
24906807|NCT00410605|50000762|FG000|Overall Study|Withdrawal by Subject|5|||
24906808|NCT00410605|50000762|FG000|Overall Study|Started Non-Protocol Therapy|3|||
24906809|NCT00410605|50000762|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
24906810|NCT00410605|50000762|FG000|Overall Study|Transferred to another Institution|1|||
24906811|NCT00418717|50000766|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
24906812|NCT00418717|50000766|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
25172092|NCT01751087|50310083|FG002|Overall Study|Physician Decision|1|||
24906813|NCT00572572|50000772|FG000|Overall Study|Withdrawal by Subject|3|||
24906814|NCT00572572|50000773|FG001|Overall Study|Withdrawal by Subject|6|||
24964542|NCT00433199|50054372|FG001|Double-Blind Period|Adverse Event|25|||
24906815|NCT00418561|50000782|FG000|Overall Study|Participant's (guardian's) decision|0|||
24906816|NCT00418561|50000783|FG001|Overall Study|Participant's (guardian's) decision|1|||
24906817|NCT00418561|50000784|FG002|Overall Study|Participant's (guardian's) decision|0|||
24906818|NCT00398047|50000792|FG000|Overall Study|all patient progressed before completion|3|||
24906819|NCT00631371|50000799|FG000|Overall Study|Lost to Follow-up|24|||
24906820|NCT00631371|50000800|FG001|Overall Study|Lost to Follow-up|19|||
24906821|NCT00631371|50000799|FG000|Overall Study|Other reason|5|||
24906822|NCT00631371|50000800|FG001|Overall Study|Other reason|12|||
24906823|NCT00631371|50000799|FG000|Overall Study|subject request|38|||
24906824|NCT00631371|50000800|FG001|Overall Study|subject request|45|||
24906825|NCT00631371|50000799|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
24906826|NCT00631371|50000800|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
24906827|NCT00631371|50000799|FG000|Overall Study|Death|263|||
24906828|NCT00631371|50000800|FG001|Overall Study|Death|239|||
24906829|NCT00409747|50000806|FG000|Overall Study|Withdrawal by Subject|1|||
24906830|NCT00630747|50000810|FG000|Overall Study|Death|1|||
24906831|NCT00630747|50000810|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
24906832|NCT00630747|50000810|FG000|Overall Study|Returned to country of origin|1|||
24906833|NCT00397891|50000819|FG000|Overall Study|Withdrawal by Subject|1|||
24906834|NCT00397891|50000820|FG001|Overall Study|Withdrawal by Subject|0|||
24906835|NCT00397891|50000821|FG002|Overall Study|Withdrawal by Subject|0|||
24906836|NCT00397891|50000822|FG003|Overall Study|Withdrawal by Subject|0|||
24906837|NCT00397891|50000823|FG004|Overall Study|Withdrawal by Subject|1|||
24906838|NCT00397189|50000837|FG000|3 Weeks Period|Lost to Follow-up|5|||
24906839|NCT00397189|50000838|FG001|3 Weeks Period|Lost to Follow-up|4|||
24906840|NCT00397189|50000837|FG000|3 Weeks Period|Adverse Event|3|||
24906841|NCT00397189|50000838|FG001|3 Weeks Period|Adverse Event|2|||
24906842|NCT00397189|50000837|FG000|3 Weeks Period|Withdrawal by Subject|13|||
24906843|NCT00397189|50000838|FG001|3 Weeks Period|Withdrawal by Subject|9|||
24906844|NCT00397189|50000837|FG000|3 Weeks Period|Physician Decision|0|||
24906845|NCT00397189|50000838|FG001|3 Weeks Period|Physician Decision|2|||
24906846|NCT00397189|50000837|FG000|3 Weeks Period|Protocol Violation|0|||
24906847|NCT00397189|50000838|FG001|3 Weeks Period|Protocol Violation|3|||
24906848|NCT00397189|50000837|FG000|3 Weeks Period|Other|0|||
24906849|NCT00397189|50000838|FG001|3 Weeks Period|Other|2|||
24906850|NCT00606034|50000846|FG000|Overall Study|incarceration|1|||
24906851|NCT00397033|50000855|FG000|Overall Study|Adverse Event|7|||
24906852|NCT00397033|50000856|FG001|Overall Study|Adverse Event|10|||
25083661|NCT02638623|50191822|FG001|Overall Study|Surgery timing|6|||
25083662|NCT02638623|50191821|FG000|Overall Study|Not given intervention|2|||
25083663|NCT02638623|50191822|FG001|Overall Study|Not given intervention|0|||
25083664|NCT02637141|50191831|FG000|Overall Study|Adverse Event|1|||
25083665|NCT02637141|50191832|FG001|Overall Study|Adverse Event|1|||
25083666|NCT02637141|50191833|FG002|Overall Study|Adverse Event|0|||
25083667|NCT02637141|50191831|FG000|Overall Study|Withdrawal by Subject|1|||
25083668|NCT02637141|50191832|FG001|Overall Study|Withdrawal by Subject|1|||
25083669|NCT02637141|50191833|FG002|Overall Study|Withdrawal by Subject|1|||
25083670|NCT02637063|50191844|FG000|Overall Study|Lost to Follow-up|3|||
25083671|NCT02637063|50191845|FG001|Overall Study|Lost to Follow-up|2|||
25083672|NCT02637063|50191846|FG002|Overall Study|Lost to Follow-up|3|||
25083673|NCT02637063|50191844|FG000|Overall Study|Withdrawal by Subject|2|||
25083674|NCT02637063|50191845|FG001|Overall Study|Withdrawal by Subject|2|||
25083675|NCT02637063|50191846|FG002|Overall Study|Withdrawal by Subject|3|||
25083676|NCT02635737|50191854|FG000|Overall Study|Protocol Violation|1|||
25083677|NCT02636907|50191858|FG000|Autoinjector Assessment Period|Adverse Event|2|||
25083678|NCT02636907|50191858|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
25083679|NCT02636907|50191858|FG000|Extension Phase|Adverse Event|2|||
25083680|NCT02636907|50191858|FG000|Extension Phase|Withdrawal by Subject|4|||
25083681|NCT02636907|50191858|FG000|Extension Phase|Physician Decision|1|||
25083682|NCT02636907|50191858|FG000|Extension Phase|Lost to Follow-up|2|||
25083683|NCT02636907|50191858|FG000|Extension Phase|Lack of Efficacy|1|||
25083684|NCT01374919|50191862|FG000|Overall Study|Withdrawal by Subject|2|||
25083685|NCT02726945|50191873|FG000|Overall Study|Withdrawal by Subject|0|||
25083686|NCT02726945|50191874|FG001|Overall Study|Withdrawal by Subject|0|||
25083687|NCT02726945|50191875|FG002|Overall Study|Withdrawal by Subject|1|||
25083688|NCT02726945|50191873|FG000|Overall Study|Elected to have total knee replacement|0|||
25083689|NCT02726945|50191874|FG001|Overall Study|Elected to have total knee replacement|1|||
25083690|NCT02726945|50191875|FG002|Overall Study|Elected to have total knee replacement|0|||
25083691|NCT02635347|50191885|FG000|Overall Study|Failed screening|20|||
24906853|NCT00397033|50000857|FG002|Overall Study|Adverse Event|4|||
25083692|NCT02635347|50191886|FG001|Overall Study|Failed screening|7|||
25083693|NCT02726399|50191906|FG000|Overall Study|Participant Non-Compliance|1|||
25083694|NCT02726399|50191906|FG000|Overall Study|Adverse Event|2|||
25083695|NCT02726399|50191906|FG000|Overall Study|Progression of disease|4|||
25083696|NCT02634801|50191913|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
24906854|NCT00397033|50000855|FG000|Overall Study|Lack of Efficacy|22|||
25083697|NCT02634801|50191914|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
25083698|NCT02634801|50191915|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
25083699|NCT02634801|50191913|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
25083700|NCT02634801|50191914|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
25083701|NCT02634801|50191915|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
25083702|NCT02634801|50191913|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
25083703|NCT02634801|50191914|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
25083704|NCT02634801|50191915|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
25083705|NCT02634801|50191913|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
25083706|NCT02634801|50191914|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
25083707|NCT02634801|50191915|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
25083708|NCT02634801|50191913|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
25083709|NCT02634801|50191914|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
25083710|NCT02634801|50191915|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
25083711|NCT02634801|50191913|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
25083712|NCT02634801|50191914|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
25083713|NCT02634801|50191915|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
25083714|NCT02634801|50191913|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
25083715|NCT02634801|50191914|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
25083716|NCT02634801|50191915|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
25083717|NCT02634801|50191913|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
25083718|NCT02634801|50191914|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
25083719|NCT02634801|50191915|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
25083720|NCT02634801|50191913|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
25083721|NCT02634801|50191914|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
25083722|NCT02634801|50191915|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
25083723|NCT02634801|50191913|FG000|Follow-up Period|Lost to Follow-up|3|||
25083724|NCT02634801|50191914|FG001|Follow-up Period|Lost to Follow-up|1|||
25083725|NCT02634801|50191915|FG002|Follow-up Period|Lost to Follow-up|2|||
25083726|NCT02634801|50191913|FG000|Follow-up Period|Physician Decision|0|||
25083727|NCT02634801|50191914|FG001|Follow-up Period|Physician Decision|0|||
25083728|NCT02634801|50191915|FG002|Follow-up Period|Physician Decision|1|||
25083729|NCT02634801|50191913|FG000|Follow-up Period|Withdrawal by Subject|1|||
25083730|NCT02634801|50191914|FG001|Follow-up Period|Withdrawal by Subject|2|||
25083731|NCT02634801|50191915|FG002|Follow-up Period|Withdrawal by Subject|5|||
25083732|NCT02634801|50191913|FG000|Follow-up Period|Adverse Event|1|||
25083733|NCT02634801|50191914|FG001|Follow-up Period|Adverse Event|5|||
25083734|NCT02634801|50191915|FG002|Follow-up Period|Adverse Event|0|||
25083735|NCT02724839|50191930|FG000|Overall Study|Withdrawal by Subject|1|||
25083736|NCT02724839|50191931|FG001|Overall Study|Withdrawal by Subject|1|||
25083737|NCT02724839|50191932|FG002|Overall Study|Withdrawal by Subject|0|||
25083738|NCT02724839|50191930|FG000|Overall Study|Lost to Follow-up|0|||
25083739|NCT02724839|50191931|FG001|Overall Study|Lost to Follow-up|3|||
25083740|NCT02724839|50191932|FG002|Overall Study|Lost to Follow-up|2|||
25083741|NCT02724839|50191930|FG000|Overall Study|Physician Decision|0|||
25083742|NCT02724839|50191931|FG001|Overall Study|Physician Decision|0|||
25083743|NCT02724839|50191932|FG002|Overall Study|Physician Decision|3|||
25083744|NCT01375751|50191950|FG000|Overall Study|Other|0|||
25083745|NCT01375751|50191951|FG001|Overall Study|Other|1|||
25083746|NCT01375751|50191952|FG002|Overall Study|Other|0|||
25083747|NCT00705575|50191962|FG000|Overall Study|Abnormal laboratory value(s)|0|||
25083748|NCT00705575|50191963|FG001|Overall Study|Abnormal laboratory value(s)|3|||
25083749|NCT00705575|50191962|FG000|Overall Study|Abnormal test procedure result(s)|2|||
25083750|NCT00705575|50191963|FG001|Overall Study|Abnormal test procedure result(s)|12|||
25083751|NCT00705575|50191962|FG000|Overall Study|Adverse Event|11|||
25083752|NCT00705575|50191963|FG001|Overall Study|Adverse Event|15|||
25083753|NCT00705575|50191962|FG000|Overall Study|Lost to Follow-up|3|||
25083754|NCT00705575|50191963|FG001|Overall Study|Lost to Follow-up|4|||
25083755|NCT00705575|50191962|FG000|Overall Study|Protocol Violation|2|||
25083756|NCT00705575|50191963|FG001|Overall Study|Protocol Violation|2|||
25083757|NCT00705575|50191962|FG000|Overall Study|Withdrawal by Subject|5|||
25083758|NCT00705575|50191963|FG001|Overall Study|Withdrawal by Subject|10|||
25083759|NCT02636595|50191969|FG000|Overall Study|Lost to Follow-up|1|||
25083760|NCT02636595|50191969|FG000|Overall Study|Other|1|||
25083761|NCT02636361|50191973|FG000|Period 4|Physician Decision|0|||
25083762|NCT02636361|50191974|FG001|Period 4|Physician Decision|0|||
25083763|NCT02636361|50191975|FG002|Period 4|Physician Decision|0|||
25083764|NCT02636361|50191976|FG003|Period 4|Physician Decision|1|||
25172093|NCT01750697|50310091|FG000|Overall Study|Transferred Back to Local Hospital|1|||
24906855|NCT00397033|50000856|FG001|Overall Study|Lack of Efficacy|12|||
25083765|NCT02636361|50191977|FG004|Period 4|Physician Decision|0|||
25083766|NCT02636283|50191993|FG000|Overall Study|Adverse Event|2|||
25083767|NCT02636283|50191994|FG001|Overall Study|Adverse Event|0|||
25083768|NCT02636283|50191993|FG000|Overall Study|Trial Terminated Prematurely|0|||
25083769|NCT02636283|50191994|FG001|Overall Study|Trial Terminated Prematurely|3|||
25083770|NCT04430855|50192002|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
25083771|NCT04430855|50192003|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
25083772|NCT04430855|50192002|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
25083773|NCT04430855|50192003|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
25083774|NCT04430855|50192002|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
25083775|NCT04430855|50192003|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
25083776|NCT04430855|50192002|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
25083777|NCT04430855|50192003|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
25083778|NCT04430855|50192002|FG000|Period 1 (Weeks 1-12)|Other|0|||
25083779|NCT04430855|50192003|FG001|Period 1 (Weeks 1-12)|Other|1|||
25083780|NCT04430855|50192002|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
25083781|NCT04430855|50192003|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
25083782|NCT04430855|50192002|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
25083783|NCT04430855|50192003|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
25083784|NCT04430855|50192002|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
25083785|NCT04430855|50192003|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
25083786|NCT01375673|50192013|FG000|Overall Study|Withdrawal by Subject|0|||
25083787|NCT01375673|50192014|FG001|Overall Study|Withdrawal by Subject|1|||
25083788|NCT03652961|50192020|FG000|Overall Study|Lost to Follow-up|3|||
25083789|NCT03652961|50192020|FG000|Overall Study|Screen Failure|1|||
25083790|NCT02723591|50192026|FG000|Overall Study|Adverse Event|48|||
25083791|NCT02723591|50192027|FG001|Overall Study|Adverse Event|40|||
25083792|NCT02723591|50192026|FG000|Overall Study|Death|2|||
25083793|NCT02723591|50192027|FG001|Overall Study|Death|2|||
25083794|NCT02723591|50192026|FG000|Overall Study|Lack of Efficacy|4|||
25083795|NCT02723591|50192027|FG001|Overall Study|Lack of Efficacy|3|||
25083796|NCT02723591|50192026|FG000|Overall Study|Lost to Follow-up|1|||
25083797|NCT02723591|50192027|FG001|Overall Study|Lost to Follow-up|7|||
25083798|NCT02723591|50192026|FG000|Overall Study|Protocol Violation|20|||
25083799|NCT02723591|50192027|FG001|Overall Study|Protocol Violation|23|||
25083800|NCT02723591|50192026|FG000|Overall Study|Withdrawal by Subject|4|||
25083801|NCT02723591|50192027|FG001|Overall Study|Withdrawal by Subject|8|||
25083802|NCT02723591|50192026|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
25083803|NCT02723591|50192027|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
25083804|NCT02723591|50192026|FG000|Overall Study|Miscellaneous|5|||
25083805|NCT02723591|50192027|FG001|Overall Study|Miscellaneous|6|||
25083806|NCT00705341|50192035|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
25083807|NCT00705341|50192036|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
25083808|NCT00705341|50192037|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
25083809|NCT00705341|50192038|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
25083810|NCT00705341|50192035|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
25083811|NCT00705341|50192036|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
25083812|NCT00705341|50192037|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
25083813|NCT00705341|50192038|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
25083814|NCT02723201|50192049|FG000|Second Intervention Period|Protocol Violation|1|||
25083815|NCT02723201|50192050|FG001|Second Intervention Period|Protocol Violation|0|||
25083816|NCT02723201|50192051|FG002|Second Intervention Period|Protocol Violation|0|||
25083817|NCT02723201|50192049|FG000|Second Intervention Period|Adverse Event|1|||
25083818|NCT02723201|50192050|FG001|Second Intervention Period|Adverse Event|0|||
25083819|NCT02723201|50192051|FG002|Second Intervention Period|Adverse Event|0|||
25083820|NCT03846479|50192065|FG000|Overall Study|Death|8|||
25083821|NCT03846479|50192065|FG000|Overall Study|Lost to Follow-up|1|||
25083822|NCT00705263|50192069|FG000|Overall Study|Withdrawal by Subject|2|||
25083823|NCT00704405|50192087|FG000|Overall Study (NC Population)|Adverse Event|1|||
25083824|NCT00704405|50192088|FG001|Overall Study (NC Population)|Adverse Event|0|||
25083825|NCT00704405|50192089|FG002|Overall Study (NC Population)|Adverse Event|0|||
25083826|NCT00704405|50192090|FG003|Overall Study (NC Population)|Adverse Event|0|||
25083827|NCT00704405|50192091|FG004|Overall Study (NC Population)|Adverse Event|0|||
25083828|NCT00704405|50192087|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
25083829|NCT00704405|50192088|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
25083830|NCT00704405|50192089|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
25083831|NCT00704405|50192090|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
25083832|NCT00704405|50192091|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
25083833|NCT00704405|50192087|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
25083834|NCT00704405|50192088|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
25083835|NCT00704405|50192089|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
25083836|NCT00704405|50192090|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
25083837|NCT00704405|50192091|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
25083838|NCT00704405|50192087|FG000|Overall Study (NC Population)|Other|0|||
25083839|NCT00704405|50192088|FG001|Overall Study (NC Population)|Other|0|||
25083840|NCT00704405|50192089|FG002|Overall Study (NC Population)|Other|0|||
25261090|NCT01311648|50575784|FG000|Main Study|Protocol Violation|0|||
25083841|NCT00704405|50192090|FG003|Overall Study (NC Population)|Other|0|||
25083842|NCT00704405|50192091|FG004|Overall Study (NC Population)|Other|1|||
25083843|NCT00704405|50192087|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
25083844|NCT00704405|50192088|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
25083845|NCT00704405|50192089|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
25083846|NCT00704405|50192090|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
25083847|NCT00704405|50192091|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
25083848|NCT00704405|50192087|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
25083849|NCT00704405|50192088|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
25083850|NCT00704405|50192089|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
25083851|NCT00704405|50192090|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
25083852|NCT00704405|50192091|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
25083853|NCT01534481|50192111|FG000|Overall Study|Lost to Follow-up|29|||
25083854|NCT01534481|50192112|FG001|Overall Study|Lost to Follow-up|24|||
25083855|NCT01534481|50192111|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
25083856|NCT01534481|50192112|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
25083857|NCT00704171|50192120|FG000|Overall Study|Withdrawal by Subject|1|||
25083858|NCT00704171|50192121|FG001|Overall Study|Withdrawal by Subject|0|||
25083859|NCT00703781|50192129|FG000|Overall Study|Withdrawal by Subject|1|||
25083860|NCT00703781|50192130|FG001|Overall Study|Withdrawal by Subject|2|||
25083861|NCT00703781|50192129|FG000|Overall Study|Cancelled surgery|1|||
25083862|NCT00703781|50192130|FG001|Overall Study|Cancelled surgery|0|||
25083863|NCT00703157|50192138|FG000|Overall Study|Lost to Follow-up|0|||
25083864|NCT00703157|50192139|FG001|Overall Study|Lost to Follow-up|1|||
25083865|NCT00703157|50192138|FG000|Overall Study|source data permanently lost/ other|4|||
25083866|NCT00703157|50192139|FG001|Overall Study|source data permanently lost/ other|1|||
25083867|NCT03307967|50192147|FG000|Overall Study|Lost to Follow-up|4|||
25083868|NCT02722967|50192154|FG000|Overall Study|Adverse Event|1|||
25083869|NCT02722967|50192155|FG001|Overall Study|Adverse Event|0|||
25083870|NCT02722967|50192156|FG002|Overall Study|Adverse Event|0|||
25083871|NCT02722967|50192154|FG000|Overall Study|Lost to Follow-up|0|||
25083872|NCT02722967|50192155|FG001|Overall Study|Lost to Follow-up|1|||
25083873|NCT02722967|50192156|FG002|Overall Study|Lost to Follow-up|0|||
25083874|NCT02722967|50192154|FG000|Overall Study|Non-compliance with patch wearing|2|||
25083875|NCT02722967|50192155|FG001|Overall Study|Non-compliance with patch wearing|1|||
25083876|NCT02722967|50192156|FG002|Overall Study|Non-compliance with patch wearing|1|||
25083877|NCT02722967|50192154|FG000|Overall Study|Withdrawal by Subject|1|||
25083878|NCT02722967|50192155|FG001|Overall Study|Withdrawal by Subject|0|||
25083879|NCT02722967|50192156|FG002|Overall Study|Withdrawal by Subject|1|||
25083880|NCT02722967|50192154|FG000|Overall Study|Physician Decision|1|||
25083881|NCT02722967|50192155|FG001|Overall Study|Physician Decision|0|||
25083882|NCT02722967|50192156|FG002|Overall Study|Physician Decision|0|||
25083883|NCT02722967|50192154|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
25083884|NCT02722967|50192155|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
25083885|NCT02722967|50192156|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
25083886|NCT02722499|50192167|FG000|Overall Study|Lost to Follow-up|2|||
25083887|NCT02722499|50192168|FG001|Overall Study|Lost to Follow-up|0|||
25083888|NCT02722499|50192169|FG002|Overall Study|Lost to Follow-up|1|||
25083889|NCT02721875|50192179|FG000|Overall Study|Progressive disease/relapse|1|||
25083890|NCT02721875|50192180|FG001|Overall Study|Progressive disease/relapse|0|||
25083891|NCT02721251|50192189|FG000|Overall Study|Withdrawal by Subject|8|||
25083892|NCT02721251|50192190|FG001|Overall Study|Withdrawal by Subject|7|||
25083893|NCT02721251|50192191|FG002|Overall Study|Withdrawal by Subject|9|||
25083894|NCT02721251|50192189|FG000|Overall Study|poor adherence|2|||
25083895|NCT02721251|50192190|FG001|Overall Study|poor adherence|2|||
25083896|NCT02721251|50192191|FG002|Overall Study|poor adherence|2|||
25083897|NCT00702221|50192202|FG000|Overall Study|Adverse Event|4|||
25083898|NCT00702221|50192203|FG001|Overall Study|Adverse Event|3|||
25083899|NCT00702143|50192212|FG000|Overall Study|Lost to Follow-up|0|||
25083900|NCT00702143|50192213|FG001|Overall Study|Lost to Follow-up|0|||
25083901|NCT00702143|50192214|FG002|Overall Study|Lost to Follow-up|1|||
25083902|NCT00702923|50192220|FG000|Overall Study|Adverse Event|1|||
25083903|NCT02633787|50192225|FG000|Overall Study|Withdrawal by Subject|1|||
25083904|NCT02719691|50192236|FG000|Overall Study|Physician Decision|0|||
25083905|NCT02719691|50192237|FG001|Overall Study|Physician Decision|0|||
25261091|NCT01311648|50575785|FG001|Main Study|Protocol Violation|1|||
25083906|NCT02719691|50192238|FG002|Overall Study|Physician Decision|1|||
25083907|NCT02719691|50192239|FG003|Overall Study|Physician Decision|0|||
25083908|NCT02719691|50192240|FG004|Overall Study|Physician Decision|0|||
25083909|NCT02719691|50192241|FG005|Overall Study|Physician Decision|0|||
25083910|NCT02719691|50192242|FG006|Overall Study|Physician Decision|0|||
25083911|NCT02719691|50192236|FG000|Overall Study|Withdrawal by Subject|0|||
25083912|NCT02719691|50192237|FG001|Overall Study|Withdrawal by Subject|0|||
25083913|NCT02719691|50192238|FG002|Overall Study|Withdrawal by Subject|0|||
25083914|NCT02719691|50192239|FG003|Overall Study|Withdrawal by Subject|0|||
25083915|NCT02719691|50192240|FG004|Overall Study|Withdrawal by Subject|0|||
25083916|NCT02719691|50192241|FG005|Overall Study|Withdrawal by Subject|1|||
25083917|NCT02719691|50192242|FG006|Overall Study|Withdrawal by Subject|0|||
25083918|NCT02720081|50192261|FG000|Overall Study|Adverse Event|0|||
25083919|NCT02720081|50192262|FG001|Overall Study|Adverse Event|3|||
25083920|NCT02720081|50192261|FG000|Overall Study|Protocol Violation|4|||
25083921|NCT02720081|50192262|FG001|Overall Study|Protocol Violation|1|||
25083922|NCT04248933|50192268|FG000|Overall Study|Lost to Follow-up|9|||
25083923|NCT04248933|50192268|FG000|Overall Study|Withdrawal by Subject|2|||
25083924|NCT02718131|50192274|FG000|Overall Study|Withdrawal by Subject|1|||
25083925|NCT02718131|50192275|FG001|Overall Study|Withdrawal by Subject|0|||
25083926|NCT02718131|50192274|FG000|Overall Study|Adverse Event|1|||
25083927|NCT02718131|50192275|FG001|Overall Study|Adverse Event|0|||
25083928|NCT02718131|50192274|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
25083929|NCT02718131|50192275|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
25083930|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
25083931|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
25083932|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
25083933|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
25083934|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
25083935|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
25083936|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
25083937|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
25083938|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
25083939|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
25083940|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
25083941|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
25083942|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
25083943|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
25083944|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
25083945|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
25083946|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
25083947|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
25083948|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
25083949|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
25083950|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
25083951|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
25083952|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
25083953|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
25083954|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
25083955|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
25083956|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
25083957|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
25083958|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
25083959|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
25083960|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
25083961|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
25083962|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
25083963|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
25083964|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
25083965|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
25083966|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
25083967|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
25083968|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
25083969|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
25083970|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
25083971|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
25083972|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
25083973|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
25083974|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
25083975|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
25083976|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
25083977|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
25083978|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
24995136|NCT03018028|50086055|FG000|Overall Study|Withdrawal by Subject|3|||
25083979|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
25083980|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
25083981|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
25083982|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
25172094|NCT01750697|50310091|FG000|Overall Study|Physician and Family Decision|1|||
25172095|NCT01750697|50310091|FG000|Overall Study|Transferred to Adult Services|5|||
25172096|NCT01750697|50310091|FG000|Overall Study|Physician Decision|1|||
25172097|NCT01750697|50310091|FG000|Overall Study|Withdrawal by Subject|1|||
25172098|NCT01750229|50310102|FG000|Randomized Crossover Phase|Adverse Event|1|||
25172099|NCT01750229|50310102|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
25172100|NCT01750229|50310102|FG000|Long-term Follow-up Phase|Adverse Event|2|||
25172101|NCT01750229|50310102|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
25172102|NCT01724489|50310114|FG000|Overall Study|Adverse Event|8|||
25172103|NCT01724489|50310115|FG001|Overall Study|Adverse Event|3|||
25172104|NCT01724489|50310114|FG000|Overall Study|Surgery, medication|1|||
25172105|NCT01724489|50310115|FG001|Overall Study|Surgery, medication|1|||
25172106|NCT01724489|50310114|FG000|Overall Study|Lost to Follow-up|1|||
25172107|NCT01724489|50310115|FG001|Overall Study|Lost to Follow-up|2|||
25172108|NCT01724489|50310114|FG000|Overall Study|Withdrawal by Subject|6|||
25172109|NCT01724489|50310115|FG001|Overall Study|Withdrawal by Subject|6|||
25172110|NCT01724177|50310130|FG000|Overall Study|Adverse Event|8|||
25172111|NCT01724177|50310130|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
25172112|NCT01724177|50310130|FG000|Overall Study|Nervous participant|1|||
25172113|NCT01724177|50310130|FG000|Overall Study|Serious Adverse Event Related|1|||
25172114|NCT04378270|50310149|FG000|Overall Study|Lack of Efficacy|1|||
25172115|NCT04378270|50310149|FG000|Overall Study|Withdrawal by Subject|1|||
25172116|NCT04378270|50310149|FG000|Overall Study|Screen Failure|1|||
25172117|NCT04378270|50310149|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
25172118|NCT01724021|50310155|FG000|Overall Study|Adverse Event|11|||
25172119|NCT01724021|50310156|FG001|Overall Study|Adverse Event|6|||
25172120|NCT01724021|50310155|FG000|Overall Study|Death|46|||
25172121|NCT01724021|50310156|FG001|Overall Study|Death|58|||
25172122|NCT01724021|50310155|FG000|Overall Study|Participant request/ Withdrew consent|18|||
25172123|NCT01724021|50310156|FG001|Overall Study|Participant request/ Withdrew consent|14|||
25172124|NCT01724021|50310155|FG000|Overall Study|Lost to Follow-up|15|||
25172125|NCT01724021|50310156|FG001|Overall Study|Lost to Follow-up|15|||
25172126|NCT01724021|50310155|FG000|Overall Study|Reason Not Specified|36|||
25172127|NCT01724021|50310156|FG001|Overall Study|Reason Not Specified|39|||
25172128|NCT01724021|50310155|FG000|Overall Study|Missing|1|||
25172129|NCT01724021|50310156|FG001|Overall Study|Missing|1|||
25172130|NCT01723397|50310170|FG000|Study Period 1|Protocol Violation|0|||
25172131|NCT01723397|50310171|FG001|Study Period 1|Protocol Violation|1|||
25172132|NCT01723397|50310170|FG000|Study Period 2|Protocol Violation|0|||
25172133|NCT01723397|50310171|FG001|Study Period 2|Protocol Violation|1|||
25172134|NCT01723163|50310179|FG000|Treatment Phase|Withdrawal by Subject|14|||
25172135|NCT01723163|50310180|FG001|Treatment Phase|Withdrawal by Subject|6|||
25172136|NCT01723163|50310179|FG000|Treatment Phase|Withdrawal by PI|5|||
25172137|NCT01723163|50310180|FG001|Treatment Phase|Withdrawal by PI|1|||
25172138|NCT01723163|50310179|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
25172139|NCT01723163|50310180|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
25172140|NCT01723163|50310179|FG000|3-Month Follow-up|Unable to Contact|12|||
25172141|NCT01723163|50310180|FG001|3-Month Follow-up|Unable to Contact|19|||
25172142|NCT01723163|50310179|FG000|6-Month Follow-up|Death|1|||
25172143|NCT01723163|50310180|FG001|6-Month Follow-up|Death|0|||
25172144|NCT01723163|50310179|FG000|6-Month Follow-up|Unable to Contact|17|||
25172145|NCT01723163|50310180|FG001|6-Month Follow-up|Unable to Contact|15|||
25172146|NCT01723163|50310179|FG000|12-Month Follow-up|Death|1|||
25172147|NCT01723163|50310180|FG001|12-Month Follow-up|Death|0|||
25172148|NCT01723163|50310179|FG000|12-Month Follow-up|Unable to Contact|23|||
25083983|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
25083984|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
25083985|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
25083986|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
25083987|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
25083988|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
25083989|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
25083990|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
25172149|NCT01723163|50310180|FG001|12-Month Follow-up|Unable to Contact|28|||
25172150|NCT01722071|50310190|FG000|Overall Study|Protocol Violation|1|||
25172151|NCT01722071|50310191|FG001|Overall Study|Protocol Violation|0|||
25172152|NCT01721759|50310197|FG000|Treatment Period|Disease Progression|85|||
25172153|NCT01721759|50310197|FG000|Treatment Period|Study drug toxicity|14|||
25172154|NCT01721759|50310197|FG000|Treatment Period|Death|1|||
25261092|NCT01311648|50575784|FG000|Main Study|Adverse Event|0|||
25172155|NCT01721759|50310197|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
25172156|NCT01721759|50310197|FG000|Treatment Period|Participant request to withdraw|3|||
25172157|NCT01721759|50310197|FG000|Treatment Period|Other Reasons|3|||
25172158|NCT01721759|50310197|FG000|End of Study Period|Participant Withdrew Consent|5|||
25172159|NCT01721759|50310197|FG000|End of Study Period|Death|101|||
25172160|NCT01721759|50310197|FG000|End of Study Period|Lost to Follow-up|1|||
25172161|NCT01721759|50310197|FG000|End of Study Period|Other Reasons|10|||
25172162|NCT01721369|50310206|FG000|Overall Study|Not initial etiological diagnosis|12|||
25172163|NCT01721057|50310268|FG000|Treatment Period|Withdrawal by Subject|11|||
25172164|NCT01721057|50310269|FG001|Treatment Period|Withdrawal by Subject|5|||
25172165|NCT01721057|50310270|FG002|Treatment Period|Withdrawal by Subject|8|||
25172166|NCT01721057|50310271|FG003|Treatment Period|Withdrawal by Subject|0|||
25172167|NCT01721057|50310272|FG004|Treatment Period|Withdrawal by Subject|0|||
25172168|NCT01721057|50310273|FG005|Treatment Period|Withdrawal by Subject|0|||
25172169|NCT01721057|50310274|FG006|Treatment Period|Withdrawal by Subject|0|||
25172170|NCT01721057|50310268|FG000|Treatment Period|Adverse Event|7|||
25172171|NCT01721057|50310269|FG001|Treatment Period|Adverse Event|10|||
25172172|NCT01721057|50310270|FG002|Treatment Period|Adverse Event|12|||
25172173|NCT01721057|50310271|FG003|Treatment Period|Adverse Event|0|||
25172174|NCT01721057|50310272|FG004|Treatment Period|Adverse Event|0|||
25172175|NCT01721057|50310273|FG005|Treatment Period|Adverse Event|0|||
25172176|NCT01721057|50310274|FG006|Treatment Period|Adverse Event|0|||
25172177|NCT01721057|50310268|FG000|Treatment Period|Lack of Efficacy|7|||
25172178|NCT01721057|50310269|FG001|Treatment Period|Lack of Efficacy|3|||
25172179|NCT01721057|50310270|FG002|Treatment Period|Lack of Efficacy|0|||
25172180|NCT01721057|50310271|FG003|Treatment Period|Lack of Efficacy|0|||
25172181|NCT01721057|50310272|FG004|Treatment Period|Lack of Efficacy|0|||
25172182|NCT01721057|50310273|FG005|Treatment Period|Lack of Efficacy|0|||
25172183|NCT01721057|50310274|FG006|Treatment Period|Lack of Efficacy|0|||
25172184|NCT01721057|50310268|FG000|Treatment Period|Lost to Follow-up|1|||
25172185|NCT01721057|50310269|FG001|Treatment Period|Lost to Follow-up|0|||
25172186|NCT01721057|50310270|FG002|Treatment Period|Lost to Follow-up|0|||
25172187|NCT01721057|50310271|FG003|Treatment Period|Lost to Follow-up|0|||
25172188|NCT01721057|50310272|FG004|Treatment Period|Lost to Follow-up|0|||
25172189|NCT01721057|50310273|FG005|Treatment Period|Lost to Follow-up|0|||
25172190|NCT01721057|50310274|FG006|Treatment Period|Lost to Follow-up|0|||
25172191|NCT01721057|50310268|FG000|Treatment Period|Physician Decision|0|||
25172192|NCT01721057|50310269|FG001|Treatment Period|Physician Decision|1|||
25172193|NCT01721057|50310270|FG002|Treatment Period|Physician Decision|3|||
25172194|NCT01721057|50310271|FG003|Treatment Period|Physician Decision|0|||
25172195|NCT01721057|50310272|FG004|Treatment Period|Physician Decision|0|||
25172196|NCT01721057|50310273|FG005|Treatment Period|Physician Decision|0|||
25172197|NCT01721057|50310274|FG006|Treatment Period|Physician Decision|0|||
25172198|NCT01721057|50310268|FG000|Treatment Period|Death|2|||
25172199|NCT01721057|50310269|FG001|Treatment Period|Death|0|||
25172200|NCT01721057|50310270|FG002|Treatment Period|Death|0|||
25172201|NCT01721057|50310271|FG003|Treatment Period|Death|0|||
25172202|NCT01721057|50310272|FG004|Treatment Period|Death|0|||
25172203|NCT01721057|50310273|FG005|Treatment Period|Death|0|||
25172204|NCT01721057|50310274|FG006|Treatment Period|Death|0|||
25172205|NCT01721057|50310268|FG000|Rescue Period|Adverse Event|0|||
25172206|NCT01721057|50310269|FG001|Rescue Period|Adverse Event|0|||
24906856|NCT00397033|50000857|FG002|Overall Study|Lack of Efficacy|9|||
25172207|NCT01721057|50310270|FG002|Rescue Period|Adverse Event|0|||
25172208|NCT01721057|50310271|FG003|Rescue Period|Adverse Event|1|||
25172209|NCT01721057|50310272|FG004|Rescue Period|Adverse Event|0|||
25172210|NCT01721057|50310273|FG005|Rescue Period|Adverse Event|0|||
25172211|NCT01721057|50310274|FG006|Rescue Period|Adverse Event|0|||
25172212|NCT01721057|50310268|FG000|Rescue Period|Lack of Efficacy|0|||
25172213|NCT01721057|50310269|FG001|Rescue Period|Lack of Efficacy|0|||
25172214|NCT01721057|50310270|FG002|Rescue Period|Lack of Efficacy|0|||
25172215|NCT01721057|50310271|FG003|Rescue Period|Lack of Efficacy|2|||
25172216|NCT01721057|50310272|FG004|Rescue Period|Lack of Efficacy|0|||
25172217|NCT01721057|50310273|FG005|Rescue Period|Lack of Efficacy|0|||
25172218|NCT01721057|50310274|FG006|Rescue Period|Lack of Efficacy|0|||
25172219|NCT04570384|50310303|FG000|Overall Study|Adverse Event|2|||
25172220|NCT04570384|50310304|FG001|Overall Study|Adverse Event|1|||
25172221|NCT04570384|50310303|FG000|Overall Study|Death|2|||
25172222|NCT04570384|50310304|FG001|Overall Study|Death|5|||
25172223|NCT04570384|50310303|FG000|Overall Study|Lost to Follow-up|1|||
25172224|NCT04570384|50310304|FG001|Overall Study|Lost to Follow-up|0|||
25172225|NCT04570384|50310303|FG000|Overall Study|Other|1|||
25172226|NCT04570384|50310304|FG001|Overall Study|Other|0|||
25172227|NCT04570384|50310303|FG000|Overall Study|Protocol Violation|0|||
25172228|NCT04570384|50310304|FG001|Overall Study|Protocol Violation|1|||
25172229|NCT04570384|50310303|FG000|Overall Study|Sponsor Decision|1|||
25172230|NCT04570384|50310304|FG001|Overall Study|Sponsor Decision|0|||
25172231|NCT04570384|50310303|FG000|Overall Study|Withdrawal by Subject|4|||
25172232|NCT04570384|50310304|FG001|Overall Study|Withdrawal by Subject|2|||
25172233|NCT02563522|50310357|FG000|Overall Study|Adverse Event|2|||
25172234|NCT02563522|50310358|FG001|Overall Study|Adverse Event|3|||
25172235|NCT02563522|50310357|FG000|Overall Study|Lost to Follow-up|1|||
25172236|NCT02563522|50310358|FG001|Overall Study|Lost to Follow-up|0|||
25172237|NCT02563522|50310357|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
25172238|NCT02563522|50310358|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
25172239|NCT02180724|50310366|FG000|Overall Study|Death|26|||
25172240|NCT02180724|50310367|FG001|Overall Study|Death|1|||
25172241|NCT02180724|50310366|FG000|Overall Study|Lost to Follow-up|3|||
25172242|NCT02180724|50310367|FG001|Overall Study|Lost to Follow-up|1|||
25172243|NCT02180724|50310366|FG000|Overall Study|Withdrawal by Subject|4|||
25172244|NCT02180724|50310367|FG001|Overall Study|Withdrawal by Subject|2|||
25172245|NCT02180724|50310366|FG000|Overall Study|PI Decision|5|||
25172246|NCT02180724|50310367|FG001|Overall Study|PI Decision|2|||
25172247|NCT02180724|50310366|FG000|Overall Study|Study terminated by sponsor|54|||
25172248|NCT02180724|50310367|FG001|Overall Study|Study terminated by sponsor|8|||
25172249|NCT03578146|50310394|FG000|Overall Study|Did Not Receive Treatment|1|||
25172250|NCT03578146|50310395|FG001|Overall Study|Did Not Receive Treatment|0|||
25172251|NCT03578146|50310396|FG002|Overall Study|Did Not Receive Treatment|0|||
25172252|NCT03578146|50310397|FG003|Overall Study|Did Not Receive Treatment|0|||
25172253|NCT03578146|50310398|FG004|Overall Study|Did Not Receive Treatment|0|||
25172254|NCT03578146|50310399|FG005|Overall Study|Did Not Receive Treatment|2|||
25172255|NCT03578146|50310394|FG000|Overall Study|Lost to Follow-up|0|||
25172256|NCT03578146|50310395|FG001|Overall Study|Lost to Follow-up|1|||
25172257|NCT03578146|50310396|FG002|Overall Study|Lost to Follow-up|1|||
25172258|NCT03578146|50310397|FG003|Overall Study|Lost to Follow-up|0|||
25172259|NCT03578146|50310398|FG004|Overall Study|Lost to Follow-up|0|||
25172260|NCT03578146|50310399|FG005|Overall Study|Lost to Follow-up|1|||
25172261|NCT02716896|50310415|FG000|Overall Study|Physician Decision|0|||
25172262|NCT02716896|50310416|FG001|Overall Study|Physician Decision|1|||
25172263|NCT02715726|50310471|FG000|Overall Study|Adverse Event|2|||
25172264|NCT02715726|50310472|FG001|Overall Study|Adverse Event|6|||
25172265|NCT02715726|50310471|FG000|Overall Study|Protocol Violation|1|||
25172266|NCT02715726|50310472|FG001|Overall Study|Protocol Violation|0|||
25172267|NCT02715726|50310471|FG000|Overall Study|Death|2|||
25172268|NCT02715726|50310472|FG001|Overall Study|Death|1|||
25172269|NCT02715726|50310471|FG000|Overall Study|Participant moved|1|||
24906857|NCT00397033|50000855|FG000|Overall Study|Lost to Follow-up|3|||
24906858|NCT00397033|50000856|FG001|Overall Study|Lost to Follow-up|3|||
24906859|NCT00397033|50000857|FG002|Overall Study|Lost to Follow-up|3|||
24906860|NCT00397033|50000855|FG000|Overall Study|Withdrawal by Subject|12|||
24906861|NCT00397033|50000856|FG001|Overall Study|Withdrawal by Subject|7|||
24906862|NCT00397033|50000857|FG002|Overall Study|Withdrawal by Subject|5|||
24906863|NCT00397033|50000855|FG000|Overall Study|Other|0|||
24906864|NCT00397033|50000856|FG001|Overall Study|Other|5|||
24906865|NCT00397033|50000857|FG002|Overall Study|Other|2|||
25172270|NCT02715726|50310472|FG001|Overall Study|Participant moved|3|||
25172271|NCT02715726|50310471|FG000|Overall Study|Other than specified above|11|||
25172272|NCT02715726|50310472|FG001|Overall Study|Other than specified above|15|||
25172273|NCT02715726|50310471|FG000|Overall Study|Randomized but not treated|1|||
25172274|NCT02715726|50310472|FG001|Overall Study|Randomized but not treated|2|||
25172275|NCT04248816|50310485|FG000|Overall Study|Ineligible post-randomization|7|||
25172276|NCT04248816|50310486|FG001|Overall Study|Ineligible post-randomization|21|||
25172277|NCT04248816|50310487|FG002|Overall Study|Ineligible post-randomization|25|||
25172278|NCT02314156|50310524|FG000|Overall Study|Adverse Event|1|||
25172279|NCT02314156|50310525|FG001|Overall Study|Adverse Event|0|||
25172280|NCT02314156|50310524|FG000|Overall Study|Withdrawal by Subject|1|||
25172281|NCT02314156|50310525|FG001|Overall Study|Withdrawal by Subject|0|||
25172282|NCT04034238|50310720|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
25172283|NCT04034238|50310721|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
25172284|NCT04034238|50310722|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
25172285|NCT04034238|50310723|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
25172286|NCT04034238|50310720|FG000|Dose Escalation Phase|Screen failures|0|||
25172287|NCT04034238|50310721|FG001|Dose Escalation Phase|Screen failures|0|||
25172288|NCT04034238|50310722|FG002|Dose Escalation Phase|Screen failures|0|||
25172289|NCT04034238|50310723|FG003|Dose Escalation Phase|Screen failures|2|||
25172290|NCT04034238|50310720|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
25172291|NCT04034238|50310721|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
25172292|NCT04034238|50310722|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
24995137|NCT03018028|50086056|FG001|Overall Study|Withdrawal by Subject|0|||
25172293|NCT04034238|50310723|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
24906866|NCT00572728|50000865|FG000|Overall Study|Withdrawal by Subject|10|||
25172294|NCT04034238|50310720|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
25172295|NCT04034238|50310721|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
25172296|NCT04034238|50310722|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
25172297|NCT04034238|50310723|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
25172298|NCT02716584|50310762|FG000|Overall Study|Lost to Follow-up|8|||
25172299|NCT02716584|50310763|FG001|Overall Study|Lost to Follow-up|5|||
25172300|NCT02716194|50310844|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
25172301|NCT02716194|50310845|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
25172302|NCT02716194|50310846|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
25172303|NCT03773484|50310916|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
25172304|NCT02715258|50311099|FG000|Overall Study|Withdrawal by Subject|6|||
25172305|NCT02715258|50311100|FG001|Overall Study|Withdrawal by Subject|1|||
25172306|NCT02715258|50311099|FG000|Overall Study|Lost to Follow-up|7|||
25172307|NCT02715258|50311100|FG001|Overall Study|Lost to Follow-up|1|||
25172308|NCT02715258|50311099|FG000|Overall Study|Terminated by Sponsor|0|||
25172309|NCT02715258|50311100|FG001|Overall Study|Terminated by Sponsor|1|||
25172310|NCT02715258|50311099|FG000|Overall Study|Death|0|||
25172311|NCT02715258|50311100|FG001|Overall Study|Death|1|||
25172312|NCT02715258|50311099|FG000|Overall Study|Subject non-compliant|1|||
25172313|NCT02715258|50311100|FG001|Overall Study|Subject non-compliant|1|||
25172314|NCT02715258|50311099|FG000|Overall Study|GCP violation|2|||
25172315|NCT02715258|50311100|FG001|Overall Study|GCP violation|1|||
25172316|NCT02714868|50311125|FG000|Overall Study|Withdrawal by Subject|3|||
25172317|NCT02714868|50311126|FG001|Overall Study|Withdrawal by Subject|0|||
25172318|NCT02714868|50311125|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
25172319|NCT02714868|50311126|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
25172320|NCT02714868|50311125|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
25172321|NCT02714868|50311126|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
25172322|NCT02713542|50311450|FG000|Overall Study|Use of prohibited medication|14|||
25172323|NCT02713542|50311451|FG001|Overall Study|Use of prohibited medication|5|||
25172324|NCT02713542|50311450|FG000|Overall Study|Withdrawal by Subject|4|||
25172325|NCT02713542|50311451|FG001|Overall Study|Withdrawal by Subject|1|||
25172326|NCT03548220|50311535|FG000|Overall Study|Lost to Follow-up|1|||
25172327|NCT03548220|50311536|FG001|Overall Study|Lost to Follow-up|0|||
25172328|NCT03548220|50311537|FG002|Overall Study|Lost to Follow-up|0|||
25172329|NCT03548220|50311538|FG003|Overall Study|Lost to Follow-up|0|||
25172330|NCT02712996|50311573|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
25172331|NCT02712996|50311574|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
25172332|NCT00701064|50311681|FG000|Overall Study|Protocol Violation|1|||
25172333|NCT00701064|50311682|FG001|Overall Study|Protocol Violation|1|||
25172334|NCT00701064|50311681|FG000|Overall Study|Withdrawal by Subject|1|||
25172335|NCT00701064|50311682|FG001|Overall Study|Withdrawal by Subject|1|||
25172336|NCT00701064|50311681|FG000|Overall Study|initiated other PTSD treatment|2|||
25172337|NCT00701064|50311682|FG001|Overall Study|initiated other PTSD treatment|2|||
25172338|NCT01748825|50311821|FG000|Dose Escalation|Refused further treatment|2|||
25172339|NCT01748825|50311822|FG001|Dose Escalation|Refused further treatment|2|||
25172340|NCT01748825|50311823|FG002|Dose Escalation|Refused further treatment|0|||
25172341|NCT01748825|50311824|FG003|Dose Escalation|Refused further treatment|0|||
25172342|NCT01748825|50311825|FG004|Dose Escalation|Refused further treatment|1|||
25172343|NCT01748825|50311826|FG005|Dose Escalation|Refused further treatment|2|||
25172344|NCT01748825|50311827|FG006|Dose Escalation|Refused further treatment|0|||
25172345|NCT01748825|50311828|FG007|Dose Escalation|Refused further treatment|0|||
25172346|NCT01748825|50311829|FG008|Dose Escalation|Refused further treatment|0|||
25172347|NCT01748825|50311830|FG009|Dose Escalation|Refused further treatment|0|||
25172348|NCT01748825|50311821|FG000|Dose Escalation|Switched to alternative treatment|0|||
25172349|NCT01748825|50311822|FG001|Dose Escalation|Switched to alternative treatment|0|||
25172350|NCT01748825|50311823|FG002|Dose Escalation|Switched to alternative treatment|0|||
25172351|NCT01748825|50311824|FG003|Dose Escalation|Switched to alternative treatment|1|||
25172352|NCT01748825|50311825|FG004|Dose Escalation|Switched to alternative treatment|0|||
25172353|NCT01748825|50311826|FG005|Dose Escalation|Switched to alternative treatment|0|||
25172354|NCT01748825|50311827|FG006|Dose Escalation|Switched to alternative treatment|0|||
25172355|NCT01748825|50311828|FG007|Dose Escalation|Switched to alternative treatment|0|||
25172356|NCT01748825|50311829|FG008|Dose Escalation|Switched to alternative treatment|0|||
25172357|NCT01748825|50311830|FG009|Dose Escalation|Switched to alternative treatment|0|||
25172358|NCT01748825|50311821|FG000|Dose Escalation|Adverse Event|0|||
25172359|NCT01748825|50311822|FG001|Dose Escalation|Adverse Event|0|||
25172360|NCT01748825|50311823|FG002|Dose Escalation|Adverse Event|0|||
25172361|NCT01748825|50311824|FG003|Dose Escalation|Adverse Event|0|||
25172362|NCT01748825|50311825|FG004|Dose Escalation|Adverse Event|0|||
25172363|NCT01748825|50311826|FG005|Dose Escalation|Adverse Event|0|||
25172364|NCT01748825|50311827|FG006|Dose Escalation|Adverse Event|1|||
25172365|NCT01748825|50311828|FG007|Dose Escalation|Adverse Event|0|||
24906867|NCT00572728|50000865|FG000|Overall Study|Ineligible|3|||
25172366|NCT01748825|50311829|FG008|Dose Escalation|Adverse Event|0|||
25172367|NCT01748825|50311830|FG009|Dose Escalation|Adverse Event|0|||
25172368|NCT01748825|50311821|FG000|Dose Expansion|Refused further treatment|0|||
25172369|NCT01748825|50311822|FG001|Dose Expansion|Refused further treatment|0|||
25172370|NCT01748825|50311823|FG002|Dose Expansion|Refused further treatment|0|||
25172371|NCT01748825|50311824|FG003|Dose Expansion|Refused further treatment|0|||
25172372|NCT01748825|50311825|FG004|Dose Expansion|Refused further treatment|0|||
24906868|NCT00572728|50000865|FG000|Overall Study|Enrolled under Amendment 4|5|||
24906869|NCT00572728|50000865|FG000|Overall Study|Offstudy due to complicating disease|1|||
24906870|NCT00572728|50000865|FG000|Overall Study|FLT1 not completed|4|||
24906871|NCT00572728|50000865|FG000|Overall Study|First Chemotherapy not initiated|2|||
24906872|NCT00572728|50000865|FG000|Overall Study|FLT2 not completed|5|||
24906873|NCT00572728|50000865|FG000|Overall Study|Second chemotherapy not initiated|1|||
24906874|NCT00572728|50000865|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
24906875|NCT00572728|50000865|FG000|Overall Study|Pathology missing|1|||
24906876|NCT00699374|50000873|FG000|Overall Study|Death|93|||
24906877|NCT00699374|50000874|FG001|Overall Study|Death|83|||
24906878|NCT00699374|50000873|FG000|Overall Study|Adverse Event|70|||
24906879|NCT00699374|50000874|FG001|Overall Study|Adverse Event|67|||
24906880|NCT00699374|50000873|FG000|Overall Study|Global deterioration of health status|7|||
24906881|NCT00699374|50000874|FG001|Overall Study|Global deterioration of health status|8|||
24906882|NCT00699374|50000873|FG000|Overall Study|Lost to Follow-up|3|||
24906883|NCT00699374|50000874|FG001|Overall Study|Lost to Follow-up|5|||
24906884|NCT00699374|50000873|FG000|Overall Study|Withdrawal by Subject|34|||
24906885|NCT00699374|50000874|FG001|Overall Study|Withdrawal by Subject|44|||
24906886|NCT00699374|50000873|FG000|Overall Study|Objective progression or relapse|281|||
24906887|NCT00699374|50000874|FG001|Overall Study|Objective progression or relapse|277|||
24906888|NCT00699374|50000873|FG000|Overall Study|Other|18|||
24906889|NCT00699374|50000874|FG001|Overall Study|Other|15|||
24906890|NCT00699374|50000873|FG000|Overall Study|Protocol Violation|2|||
24906891|NCT00699374|50000874|FG001|Overall Study|Protocol Violation|6|||
24906892|NCT00699374|50000873|FG000|Overall Study|Study terminated by sponsor|13|||
24906893|NCT00699374|50000874|FG001|Overall Study|Study terminated by sponsor|28|||
24906894|NCT00699374|50000873|FG000|Overall Study|Randomized but not treated|4|||
24906895|NCT00699374|50000874|FG001|Overall Study|Randomized but not treated|2|||
24906896|NCT00699374|50000873|FG000|Overall Study|Died 28 days after last dose|5|||
24906897|NCT00699374|50000874|FG001|Overall Study|Died 28 days after last dose|9|||
24906898|NCT00606892|50000880|FG000|First Intervention|Protocol Violation|1|||
24906899|NCT00606892|50000881|FG001|First Intervention|Protocol Violation|4|||
24906900|NCT00625443|50000916|FG000|Overall Study|Adverse Event|1|||
24906901|NCT00625443|50000917|FG001|Overall Study|Adverse Event|4|||
24906902|NCT00625443|50000918|FG002|Overall Study|Adverse Event|0|||
24906903|NCT00625443|50000916|FG000|Overall Study|Non-compliance with protocol|0|||
24906904|NCT00625443|50000917|FG001|Overall Study|Non-compliance with protocol|1|||
24906905|NCT00625443|50000918|FG002|Overall Study|Non-compliance with protocol|0|||
24906906|NCT00625443|50000916|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
24906907|NCT00625443|50000917|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
24906908|NCT00625443|50000918|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
24906909|NCT00625443|50000916|FG000|Overall Study|Withdrawal by Subject|0|||
24906910|NCT00625443|50000917|FG001|Overall Study|Withdrawal by Subject|1|||
24906911|NCT00625443|50000918|FG002|Overall Study|Withdrawal by Subject|2|||
24906912|NCT00625443|50000916|FG000|Overall Study|Physician Decision|0|||
24906913|NCT00625443|50000917|FG001|Overall Study|Physician Decision|4|||
24906914|NCT00625443|50000918|FG002|Overall Study|Physician Decision|2|||
24906915|NCT00625443|50000916|FG000|Overall Study|Other|0|||
24906916|NCT00625443|50000917|FG001|Overall Study|Other|1|||
24906917|NCT00625443|50000918|FG002|Overall Study|Other|1|||
24906918|NCT00625365|50000929|FG000|Overall Study|Withdrawal by Subject|1|||
24906919|NCT00625365|50000929|FG000|Overall Study|No IV access|5|||
24906920|NCT00625365|50000929|FG000|Overall Study|VSD|1|||
24906921|NCT00606580|50000936|FG000|Overall Study|Lost to Follow-up|1|||
24906922|NCT00606580|50000937|FG001|Overall Study|Lost to Follow-up|1|||
24906923|NCT00606580|50000938|FG002|Overall Study|Lost to Follow-up|4|||
24906924|NCT00606580|50000936|FG000|Overall Study|Clinical failures|1|||
24906925|NCT00606580|50000937|FG001|Overall Study|Clinical failures|0|||
24906926|NCT00606580|50000938|FG002|Overall Study|Clinical failures|12|||
24906927|NCT00606580|50000936|FG000|Overall Study|Withdrawal by investigator|0|||
24906928|NCT00606580|50000937|FG001|Overall Study|Withdrawal by investigator|1|||
24906929|NCT00606580|50000938|FG002|Overall Study|Withdrawal by investigator|6|||
24906930|NCT00606580|50000936|FG000|Overall Study|Withdrawal by Subject|0|||
24906931|NCT00606580|50000937|FG001|Overall Study|Withdrawal by Subject|1|||
24906932|NCT00606580|50000938|FG002|Overall Study|Withdrawal by Subject|0|||
24906933|NCT00629265|50000948|FG000|Overall Study|Lost to Follow-up|4|||
24906934|NCT00629265|50000949|FG001|Overall Study|Lost to Follow-up|5|||
24906935|NCT00629265|50000948|FG000|Overall Study|Withdrawal by Subject|11|||
24906936|NCT00629265|50000949|FG001|Overall Study|Withdrawal by Subject|8|||
25172373|NCT01748825|50311826|FG005|Dose Expansion|Refused further treatment|0|||
24906937|NCT00629265|50000948|FG000|Overall Study|Death|1|||
24906938|NCT00629265|50000949|FG001|Overall Study|Death|0|||
24906939|NCT00629265|50000948|FG000|Overall Study|Adverse Event|2|||
24906940|NCT00629265|50000949|FG001|Overall Study|Adverse Event|0|||
24906941|NCT00629265|50000948|FG000|Overall Study|HNC Recurrence|4|||
24906942|NCT00629265|50000949|FG001|Overall Study|HNC Recurrence|0|||
24906943|NCT00629265|50000948|FG000|Overall Study|Other CA Requiring Treatment|1|||
24906944|NCT00629265|50000949|FG001|Overall Study|Other CA Requiring Treatment|3|||
24906945|NCT00629265|50000948|FG000|Overall Study|Needed Esophageal Dilation|4|||
24906946|NCT00629265|50000949|FG001|Overall Study|Needed Esophageal Dilation|1|||
24906947|NCT00629265|50000948|FG000|Overall Study|Unrelated Medical Complications|3|||
24906948|NCT00629265|50000949|FG001|Overall Study|Unrelated Medical Complications|1|||
24906949|NCT00629265|50000948|FG000|Overall Study|Unknown Reason|2|||
24906950|NCT00629265|50000949|FG001|Overall Study|Unknown Reason|2|||
24906951|NCT00606502|50000957|FG000|Randomization|Randomized but not treated|3|||
24906952|NCT00606502|50000958|FG001|Randomization|Randomized but not treated|0|||
24906953|NCT00606502|50000957|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
24906954|NCT00606502|50000958|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
24906955|NCT00605722|50000964|FG000|Overall Study|Adverse Event|6|||
24906956|NCT00605722|50000964|FG000|Overall Study|Insufficient therapeutic response|44|||
24906957|NCT00605722|50000964|FG000|Overall Study|Failure to return|1|||
24906958|NCT00605566|50000968|FG000|Overall Study|Adverse Event|1|||
24906959|NCT00605566|50000968|FG000|Overall Study|Clinical deterioration|1|||
24906960|NCT00605566|50000968|FG000|Overall Study|Poor compliance in run-in period|1|||
24906961|NCT00396877|50000974|FG000|Overall Study|Lost to Follow-up|2|||
24906962|NCT00396877|50000975|FG001|Overall Study|Lost to Follow-up|1|||
24906963|NCT00396877|50000974|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
24906964|NCT00396877|50000975|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
24906965|NCT00628251|50000984|FG000|Randomised Part|Withdrawal by Subject|0|||
24906966|NCT00628251|50000985|FG001|Randomised Part|Withdrawal by Subject|0|||
24906967|NCT00628251|50000986|FG002|Randomised Part|Withdrawal by Subject|1|||
24906968|NCT00628251|50000984|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
24906969|NCT00628251|50000985|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
24906970|NCT00628251|50000986|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
24906971|NCT00628251|50000984|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
24906972|NCT00628251|50000985|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
24906973|NCT00628251|50000986|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
24906974|NCT00628251|50000984|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
24906975|NCT00628251|50000985|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
24906976|NCT00628251|50000986|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
24906977|NCT00628251|50000984|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
24906978|NCT00628251|50000985|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
24906979|NCT00628251|50000986|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
24906980|NCT00628251|50000984|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
24906981|NCT00628251|50000985|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
24906982|NCT00628251|50000986|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
24906983|NCT00625131|50000998|FG000|Overall Study|Lost to Follow-up|3|||
24906984|NCT00625131|50000999|FG001|Overall Study|Lost to Follow-up|2|||
24906985|NCT00625131|50001000|FG002|Overall Study|Lost to Follow-up|0|||
24906986|NCT00625131|50000998|FG000|Overall Study|Withdrawal by Subject|1|||
24906987|NCT00625131|50000999|FG001|Overall Study|Withdrawal by Subject|0|||
24906988|NCT00625131|50001000|FG002|Overall Study|Withdrawal by Subject|5|||
24906989|NCT00408499|50001006|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
24906990|NCT00408499|50001007|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
24906991|NCT00408499|50001008|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
24906992|NCT00408499|50001009|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
24906993|NCT00408499|50001010|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
24906994|NCT00408499|50001006|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
24906995|NCT00408499|50001007|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
24906996|NCT00408499|50001008|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
24906997|NCT00408499|50001009|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
24906998|NCT00408499|50001010|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
24906999|NCT00408499|50001006|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
24907000|NCT00408499|50001007|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
24907001|NCT00408499|50001008|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
24907002|NCT00408499|50001009|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
24907003|NCT00408499|50001010|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
24907004|NCT00408499|50001006|FG000|Phase II- MTD Expansion|Adverse Event|0|||
24907005|NCT00408499|50001007|FG001|Phase II- MTD Expansion|Adverse Event|0|||
24907006|NCT00408499|50001008|FG002|Phase II- MTD Expansion|Adverse Event|0|||
24907007|NCT00408499|50001009|FG003|Phase II- MTD Expansion|Adverse Event|0|||
24907008|NCT00408499|50001010|FG004|Phase II- MTD Expansion|Adverse Event|9|||
24907009|NCT00408499|50001006|FG000|Phase II- MTD Expansion|Death|0|||
24907010|NCT00408499|50001007|FG001|Phase II- MTD Expansion|Death|0|||
24907011|NCT00408499|50001008|FG002|Phase II- MTD Expansion|Death|0|||
24907012|NCT00408499|50001009|FG003|Phase II- MTD Expansion|Death|0|||
24907013|NCT00408499|50001010|FG004|Phase II- MTD Expansion|Death|2|||
24907014|NCT00408499|50001006|FG000|Phase II- MTD Expansion|Physician Decision|0|||
24907015|NCT00408499|50001007|FG001|Phase II- MTD Expansion|Physician Decision|0|||
24907016|NCT00408499|50001008|FG002|Phase II- MTD Expansion|Physician Decision|0|||
24907017|NCT00408499|50001009|FG003|Phase II- MTD Expansion|Physician Decision|0|||
24907018|NCT00408499|50001010|FG004|Phase II- MTD Expansion|Physician Decision|1|||
24907019|NCT00408499|50001006|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
24907020|NCT00408499|50001007|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
24907021|NCT00408499|50001008|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
24907022|NCT00408499|50001009|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
24907023|NCT00408499|50001010|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
24907024|NCT00408499|50001006|FG000|Phase II- MTD Expansion|treatment delay|0|||
24907025|NCT00408499|50001007|FG001|Phase II- MTD Expansion|treatment delay|0|||
24907026|NCT00408499|50001008|FG002|Phase II- MTD Expansion|treatment delay|0|||
24907027|NCT00408499|50001009|FG003|Phase II- MTD Expansion|treatment delay|0|||
24907028|NCT00408499|50001010|FG004|Phase II- MTD Expansion|treatment delay|3|||
24907029|NCT00621777|50001021|FG000|Open Phase|Adverse Event|20|||
24907030|NCT00621777|50001022|FG001|Open Phase|Adverse Event|0|||
24907031|NCT00621777|50001021|FG000|Open Phase|Did not abstain during open phase|56|||
24907032|NCT00621777|50001022|FG001|Open Phase|Did not abstain during open phase|0|||
24907033|NCT00621777|50001021|FG000|Open Phase|Withdrawal by Subject|17|||
24907034|NCT00621777|50001022|FG001|Open Phase|Withdrawal by Subject|0|||
24907035|NCT00621777|50001021|FG000|Open Phase|administrative|13|||
24907036|NCT00621777|50001022|FG001|Open Phase|administrative|0|||
24907037|NCT00621777|50001021|FG000|Open Phase|Lost to Follow-up|10|||
24907038|NCT00621777|50001022|FG001|Open Phase|Lost to Follow-up|0|||
24907039|NCT00621777|50001021|FG000|Randomized Phase|Adverse Event|3|||
24907040|NCT00621777|50001022|FG001|Randomized Phase|Adverse Event|3|||
24907041|NCT00621777|50001021|FG000|Randomized Phase|Lost to Follow-up|3|||
24907042|NCT00621777|50001022|FG001|Randomized Phase|Lost to Follow-up|3|||
24907043|NCT00621777|50001021|FG000|Randomized Phase|Withdrawal by Subject|1|||
24907044|NCT00621777|50001022|FG001|Randomized Phase|Withdrawal by Subject|9|||
24907045|NCT00621777|50001021|FG000|Randomized Phase|administrative|0|||
24907046|NCT00621777|50001022|FG001|Randomized Phase|administrative|3|||
24907047|NCT00621777|50001021|FG000|Randomized Phase|Death|0|||
24907048|NCT00621777|50001022|FG001|Randomized Phase|Death|1|||
24907049|NCT00408421|50001032|FG000|Treatment Initial Randomization|Adverse Event|5|||
24907050|NCT00408421|50001033|FG001|Treatment Initial Randomization|Adverse Event|9|||
24907051|NCT00408421|50001034|FG002|Treatment Initial Randomization|Adverse Event|0|||
24907052|NCT00408421|50001032|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
24907053|NCT00408421|50001033|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
24907054|NCT00408421|50001034|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
24907055|NCT00408421|50001032|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
24907056|NCT00408421|50001033|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
24907057|NCT00408421|50001034|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
24907058|NCT00408421|50001032|FG000|Treatment Initial Randomization|Physician Decision|1|||
24907059|NCT00408421|50001033|FG001|Treatment Initial Randomization|Physician Decision|0|||
24907060|NCT00408421|50001034|FG002|Treatment Initial Randomization|Physician Decision|0|||
24907061|NCT00408421|50001032|FG000|Treatment Initial Randomization|Protocol Violation|0|||
24907062|NCT00408421|50001033|FG001|Treatment Initial Randomization|Protocol Violation|1|||
24907063|NCT00408421|50001034|FG002|Treatment Initial Randomization|Protocol Violation|0|||
24907064|NCT00408421|50001032|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
24907065|NCT00408421|50001033|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
24907066|NCT00408421|50001034|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
24907067|NCT00408421|50001032|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
24907068|NCT00408421|50001033|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
24907069|NCT00408421|50001034|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
24907070|NCT00408421|50001032|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
24907071|NCT00408421|50001033|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
24907072|NCT00408421|50001034|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
24907073|NCT00408421|50001032|FG000|Treatment Re-Randomization|Adverse Event|2|||
24907074|NCT00408421|50001033|FG001|Treatment Re-Randomization|Adverse Event|2|||
24995138|NCT03018028|50086057|FG002|Overall Study|Withdrawal by Subject|1|||
24907075|NCT00408421|50001034|FG002|Treatment Re-Randomization|Adverse Event|4|||
24907076|NCT00408421|50001032|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
24907077|NCT00408421|50001033|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
24907078|NCT00408421|50001034|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
24907079|NCT00408421|50001032|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
24907080|NCT00408421|50001033|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
24907081|NCT00408421|50001034|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
24907082|NCT00408421|50001032|FG000|Treatment Re-Randomization|Physician Decision|1|||
24907083|NCT00408421|50001033|FG001|Treatment Re-Randomization|Physician Decision|3|||
24907084|NCT00408421|50001034|FG002|Treatment Re-Randomization|Physician Decision|0|||
24907085|NCT00408421|50001032|FG000|Treatment Re-Randomization|Protocol Violation|1|||
24907086|NCT00408421|50001033|FG001|Treatment Re-Randomization|Protocol Violation|1|||
24907087|NCT00408421|50001034|FG002|Treatment Re-Randomization|Protocol Violation|0|||
24907088|NCT00408421|50001032|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
24907089|NCT00408421|50001033|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
24907090|NCT00408421|50001034|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
24907091|NCT00604786|50001044|FG000|Overall Study|Lost to Follow-up|2|||
24907092|NCT00604786|50001045|FG001|Overall Study|Lost to Follow-up|0|||
24907093|NCT00604708|50001053|FG000|Overall Study|Withdrawal by Subject|9|||
24907094|NCT00604708|50001054|FG001|Overall Study|Withdrawal by Subject|10|||
24907095|NCT00604708|50001053|FG000|Overall Study|Protocol Violation|2|||
24907096|NCT00604708|50001054|FG001|Overall Study|Protocol Violation|8|||
24907097|NCT00604708|50001053|FG000|Overall Study|Lost to Follow-up|5|||
24907098|NCT00604708|50001054|FG001|Overall Study|Lost to Follow-up|5|||
24907099|NCT00604708|50001053|FG000|Overall Study|administrative reasons|9|||
24907100|NCT00604708|50001054|FG001|Overall Study|administrative reasons|11|||
24907101|NCT00604708|50001053|FG000|Overall Study|Adverse Event|6|||
24907102|NCT00604708|50001054|FG001|Overall Study|Adverse Event|6|||
24907103|NCT00407797|50001060|FG000|Overall Study|Lost to Follow-up|2|||
24907104|NCT00407797|50001060|FG000|Overall Study|Adverse Event|6|||
24907105|NCT00407797|50001060|FG000|Overall Study|Other|7|||
24907106|NCT00407797|50001060|FG000|Overall Study|Withdrawal by Subject|3|||
24907107|NCT00568126|50001066|FG000|Overall Study|Adverse Event|3|||
24907108|NCT00568126|50001067|FG001|Overall Study|Adverse Event|0|||
24907109|NCT00568126|50001066|FG000|Overall Study|Withdrawal by Subject|2|||
24907110|NCT00568126|50001067|FG001|Overall Study|Withdrawal by Subject|3|||
24907111|NCT00568126|50001066|FG000|Overall Study|Lost to Follow-up|4|||
24907112|NCT00568126|50001067|FG001|Overall Study|Lost to Follow-up|3|||
24907113|NCT00568126|50001066|FG000|Overall Study|Lack of Efficacy|0|||
24907114|NCT00568126|50001067|FG001|Overall Study|Lack of Efficacy|1|||
24907115|NCT00568126|50001066|FG000|Overall Study|Physician Decision|2|||
24907116|NCT00568126|50001067|FG001|Overall Study|Physician Decision|2|||
24907117|NCT00407563|50001073|FG000|Overall Study|Patient continues on treatment|1|||
24907118|NCT00567892|50001079|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
24907119|NCT00567892|50001080|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
24907120|NCT00567892|50001081|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
24907121|NCT00567892|50001082|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
24907122|NCT00567892|50001079|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
24907123|NCT00567892|50001080|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
24907124|NCT00567892|50001081|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
24907125|NCT00567892|50001082|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
24907126|NCT00623103|50001096|FG000|Overall Study|Adverse Event|70|||
24907127|NCT00623103|50001097|FG001|Overall Study|Adverse Event|60|||
24907128|NCT00623103|50001096|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
24907129|NCT00623103|50001097|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
24907130|NCT00623103|50001096|FG000|Overall Study|Withdrawal by Subject|18|||
24907131|NCT00623103|50001097|FG001|Overall Study|Withdrawal by Subject|24|||
24907132|NCT00623103|50001096|FG000|Overall Study|Lost to Follow-up|4|||
24907133|NCT00623103|50001097|FG001|Overall Study|Lost to Follow-up|1|||
24907134|NCT00623103|50001096|FG000|Overall Study|Administrative problems|2|||
24907135|NCT00623103|50001097|FG001|Overall Study|Administrative problems|4|||
24907136|NCT00623103|50001096|FG000|Overall Study|Death|11|||
24907137|NCT00623103|50001097|FG001|Overall Study|Death|11|||
24907138|NCT00623103|50001096|FG000|Overall Study|Protocol deviation|2|||
24907139|NCT00623103|50001097|FG001|Overall Study|Protocol deviation|1|||
24907140|NCT00396565|50001106|FG000|Overall Study|Physician Decision|3|||
24907141|NCT00396565|50001107|FG001|Overall Study|Physician Decision|1|||
24907142|NCT00396565|50001108|FG002|Overall Study|Physician Decision|2|||
24907143|NCT00396565|50001106|FG000|Overall Study|Adverse Event|5|||
24907144|NCT00396565|50001107|FG001|Overall Study|Adverse Event|13|||
24907145|NCT00396565|50001108|FG002|Overall Study|Adverse Event|3|||
24907146|NCT00396565|50001106|FG000|Overall Study|Withdrawal by Subject|8|||
24907147|NCT00396565|50001107|FG001|Overall Study|Withdrawal by Subject|13|||
24907148|NCT00396565|50001108|FG002|Overall Study|Withdrawal by Subject|1|||
24907149|NCT00396565|50001106|FG000|Overall Study|Lack of Efficacy|32|||
24907150|NCT00396565|50001107|FG001|Overall Study|Lack of Efficacy|64|||
24907151|NCT00396565|50001108|FG002|Overall Study|Lack of Efficacy|11|||
24907152|NCT00394771|50001120|FG000|Overall Study|Did not meet protocol requirements|1|||
24907153|NCT00394771|50001121|FG001|Overall Study|Did not meet protocol requirements|0|||
24907154|NCT00394771|50001122|FG002|Overall Study|Did not meet protocol requirements|2|||
24907155|NCT00394771|50001123|FG003|Overall Study|Did not meet protocol requirements|0|||
24907156|NCT00394771|50001120|FG000|Overall Study|Protocol Violation|2|||
24907157|NCT00394771|50001121|FG001|Overall Study|Protocol Violation|4|||
24907158|NCT00394771|50001122|FG002|Overall Study|Protocol Violation|9|||
24907159|NCT00394771|50001123|FG003|Overall Study|Protocol Violation|7|||
24907160|NCT00394771|50001120|FG000|Overall Study|Withdrawal by Subject|10|||
24907161|NCT00394771|50001121|FG001|Overall Study|Withdrawal by Subject|6|||
24907162|NCT00394771|50001122|FG002|Overall Study|Withdrawal by Subject|8|||
24907163|NCT00394771|50001123|FG003|Overall Study|Withdrawal by Subject|12|||
24907164|NCT00394771|50001120|FG000|Overall Study|Adverse Event|10|||
24907165|NCT00394771|50001121|FG001|Overall Study|Adverse Event|5|||
24907166|NCT00394771|50001122|FG002|Overall Study|Adverse Event|12|||
24907167|NCT00394771|50001123|FG003|Overall Study|Adverse Event|8|||
24907168|NCT00394771|50001120|FG000|Overall Study|Participant pregnant|0|||
24907169|NCT00394771|50001121|FG001|Overall Study|Participant pregnant|1|||
24907170|NCT00394771|50001122|FG002|Overall Study|Participant pregnant|2|||
24907171|NCT00394771|50001123|FG003|Overall Study|Participant pregnant|2|||
24907172|NCT00394771|50001120|FG000|Overall Study|Lost to Follow-up|15|||
24907173|NCT00394771|50001121|FG001|Overall Study|Lost to Follow-up|15|||
24907174|NCT00394771|50001122|FG002|Overall Study|Lost to Follow-up|13|||
24907175|NCT00394771|50001123|FG003|Overall Study|Lost to Follow-up|10|||
24907176|NCT00394771|50001120|FG000|Overall Study|Other|3|||
24907177|NCT00394771|50001121|FG001|Overall Study|Other|3|||
24907178|NCT00394771|50001122|FG002|Overall Study|Other|1|||
24907179|NCT00394771|50001123|FG003|Overall Study|Other|0|||
24907180|NCT00396409|50001135|FG000|Period 1 - 2007|Adverse Event|0|||
24907181|NCT00396409|50001136|FG001|Period 1 - 2007|Adverse Event|1|||
24907182|NCT00396409|50001135|FG000|Period 1 - 2007|Lack of Efficacy|0|||
24907183|NCT00396409|50001136|FG001|Period 1 - 2007|Lack of Efficacy|1|||
24907184|NCT00396409|50001135|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
24907185|NCT00396409|50001136|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
24907186|NCT00396409|50001135|FG000|Period 1 - 2007|Lost to Follow-up|2|||
24907187|NCT00396409|50001136|FG001|Period 1 - 2007|Lost to Follow-up|3|||
24907188|NCT00396409|50001135|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
24907189|NCT00396409|50001136|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
24907190|NCT00396409|50001135|FG000|Period 2 - 2008|Protocol Violation|1|||
24907191|NCT00396409|50001136|FG001|Period 2 - 2008|Protocol Violation|0|||
24907192|NCT00396409|50001135|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
24907193|NCT00396409|50001136|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
24907194|NCT00396409|50001135|FG000|Period 2 - 2008|Lost to Follow-up|3|||
24907195|NCT00396409|50001136|FG001|Period 2 - 2008|Lost to Follow-up|1|||
24907196|NCT02924376|50001148|FG000|Overall Study|Progressive Disease|4|||
24907197|NCT02924376|50001149|FG001|Overall Study|Progressive Disease|0|||
24907198|NCT02924376|50001150|FG002|Overall Study|Progressive Disease|1|||
24907199|NCT02924376|50001151|FG003|Overall Study|Progressive Disease|0|||
24907200|NCT02924376|50001148|FG000|Overall Study|Death|73|||
24907201|NCT02924376|50001149|FG001|Overall Study|Death|18|||
24907202|NCT02924376|50001150|FG002|Overall Study|Death|15|||
24907203|NCT02924376|50001151|FG003|Overall Study|Death|2|||
24907204|NCT02924376|50001148|FG000|Overall Study|Lost to Follow-up|3|||
24907205|NCT02924376|50001149|FG001|Overall Study|Lost to Follow-up|0|||
24907206|NCT02924376|50001150|FG002|Overall Study|Lost to Follow-up|0|||
24907207|NCT02924376|50001151|FG003|Overall Study|Lost to Follow-up|0|||
24907208|NCT02924376|50001148|FG000|Overall Study|Study Terminated by Sponsor|19|||
24907209|NCT02924376|50001149|FG001|Overall Study|Study Terminated by Sponsor|0|||
24907210|NCT02924376|50001150|FG002|Overall Study|Study Terminated by Sponsor|0|||
24907211|NCT02924376|50001151|FG003|Overall Study|Study Terminated by Sponsor|0|||
24907212|NCT02924376|50001148|FG000|Overall Study|Physician Decision|1|||
24907213|NCT02924376|50001149|FG001|Overall Study|Physician Decision|0|||
24907214|NCT02924376|50001150|FG002|Overall Study|Physician Decision|0|||
24907215|NCT02924376|50001151|FG003|Overall Study|Physician Decision|0|||
24907216|NCT02924376|50001148|FG000|Overall Study|Withdrawal by Subject|7|||
24907217|NCT02924376|50001149|FG001|Overall Study|Withdrawal by Subject|2|||
24907218|NCT02924376|50001150|FG002|Overall Study|Withdrawal by Subject|1|||
24907219|NCT02924376|50001151|FG003|Overall Study|Withdrawal by Subject|0|||
24907220|NCT02924376|50001148|FG000|Overall Study|Rolled Over to Another Study|1|||
24907221|NCT02924376|50001149|FG001|Overall Study|Rolled Over to Another Study|0|||
24907222|NCT02924376|50001150|FG002|Overall Study|Rolled Over to Another Study|0|||
24907223|NCT02924376|50001151|FG003|Overall Study|Rolled Over to Another Study|0|||
24907224|NCT00693420|50001166|FG000|Overall Study|Adverse Event|4|||
24907225|NCT00693420|50001167|FG001|Overall Study|Adverse Event|4|||
24907226|NCT00693420|50001166|FG000|Overall Study|Lost to Follow-up|0|||
24995139|NCT03018028|50086058|FG003|Overall Study|Withdrawal by Subject|2|||
24995140|NCT03018028|50086059|FG004|Overall Study|Withdrawal by Subject|0|||
24907227|NCT00693420|50001167|FG001|Overall Study|Lost to Follow-up|3|||
24907228|NCT00693420|50001166|FG000|Overall Study|Withdrawal by Subject|1|||
24907229|NCT00693420|50001167|FG001|Overall Study|Withdrawal by Subject|0|||
24907230|NCT00693420|50001166|FG000|Overall Study|Protocol Violation|0|||
24907231|NCT00693420|50001167|FG001|Overall Study|Protocol Violation|2|||
24907232|NCT00693420|50001166|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
24907233|NCT00693420|50001167|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
24907234|NCT00693420|50001166|FG000|Overall Study|Personal Reasons|1|||
24907235|NCT00693420|50001167|FG001|Overall Study|Personal Reasons|4|||
24907236|NCT00695136|50001173|FG000|Overall Study|Withdrawal by Subject|1|||
24907237|NCT00695136|50001173|FG000|Overall Study|unrelated adverse event|1|||
24907238|NCT00605176|50001189|FG000|Overall Study|Adverse Event|2|||
24907239|NCT00605176|50001190|FG001|Overall Study|Adverse Event|1|||
24907240|NCT00605176|50001191|FG002|Overall Study|Adverse Event|3|||
24907241|NCT00605176|50001189|FG000|Overall Study|Withdrawal by Subject|4|||
24907242|NCT00605176|50001190|FG001|Overall Study|Withdrawal by Subject|2|||
24907243|NCT00605176|50001191|FG002|Overall Study|Withdrawal by Subject|4|||
24907244|NCT00605176|50001189|FG000|Overall Study|Lost to Follow-up|2|||
24907245|NCT00605176|50001190|FG001|Overall Study|Lost to Follow-up|2|||
24907246|NCT00605176|50001191|FG002|Overall Study|Lost to Follow-up|1|||
24907247|NCT00605176|50001189|FG000|Overall Study|Non-complicance with study procedures|1|||
24907248|NCT00605176|50001190|FG001|Overall Study|Non-complicance with study procedures|0|||
24907249|NCT00605176|50001191|FG002|Overall Study|Non-complicance with study procedures|0|||
24907250|NCT00605176|50001189|FG000|Overall Study|Use of concomitant therapy|1|||
24907251|NCT00605176|50001190|FG001|Overall Study|Use of concomitant therapy|0|||
24907252|NCT00605176|50001191|FG002|Overall Study|Use of concomitant therapy|1|||
24907253|NCT00605176|50001189|FG000|Overall Study|Other (not due to AE)|1|||
24907254|NCT00605176|50001190|FG001|Overall Study|Other (not due to AE)|1|||
24907255|NCT00605176|50001191|FG002|Overall Study|Other (not due to AE)|0|||
24907256|NCT00694356|50001202|FG000|Overall Study|Adverse Event|1|||
24907257|NCT00694356|50001203|FG001|Overall Study|Adverse Event|0|||
24907258|NCT00694356|50001204|FG002|Overall Study|Adverse Event|0|||
24907259|NCT00694356|50001202|FG000|Overall Study|Progressive Disease|2|||
24907260|NCT00694356|50001203|FG001|Overall Study|Progressive Disease|6|||
24907261|NCT00694356|50001204|FG002|Overall Study|Progressive Disease|6|||
24907262|NCT00692406|50001212|FG000|Overall Study|PI dropped, bad data|57|||
24907263|NCT00567502|50001229|FG000|Overall Study|Lost to Follow-up|91|||
24907264|NCT00567502|50001230|FG001|Overall Study|Lost to Follow-up|14|||
24907265|NCT00567502|50001231|FG002|Overall Study|Lost to Follow-up|351|||
24907266|NCT00567502|50001232|FG003|Overall Study|Lost to Follow-up|2|||
24907267|NCT00567502|50001229|FG000|Overall Study|Death|65|||
24907268|NCT00567502|50001230|FG001|Overall Study|Death|16|||
24907269|NCT00567502|50001231|FG002|Overall Study|Death|360|||
24907270|NCT00567502|50001232|FG003|Overall Study|Death|5|||
24907271|NCT00567502|50001229|FG000|Overall Study|Other|64|||
24907272|NCT00567502|50001230|FG001|Overall Study|Other|2|||
24907273|NCT00567502|50001231|FG002|Overall Study|Other|134|||
24907274|NCT00567502|50001232|FG003|Overall Study|Other|6|||
24907275|NCT00567502|50001229|FG000|Overall Study|Participant request|12|||
24907276|NCT00567502|50001230|FG001|Overall Study|Participant request|1|||
24907277|NCT00567502|50001231|FG002|Overall Study|Participant request|33|||
24907278|NCT00567502|50001232|FG003|Overall Study|Participant request|1|||
24907279|NCT00567502|50001229|FG000|Overall Study|Sponsor request|9|||
24907280|NCT00567502|50001230|FG001|Overall Study|Sponsor request|0|||
24907281|NCT00567502|50001231|FG002|Overall Study|Sponsor request|30|||
24907282|NCT00567502|50001232|FG003|Overall Study|Sponsor request|1|||
24907283|NCT00567502|50001229|FG000|Overall Study|Never Initiated Treatment|0|||
24907284|NCT00567502|50001230|FG001|Overall Study|Never Initiated Treatment|0|||
24907285|NCT00567502|50001231|FG002|Overall Study|Never Initiated Treatment|0|||
24907286|NCT00567502|50001232|FG003|Overall Study|Never Initiated Treatment|72|||
24907287|NCT00396331|50001257|FG000|Overall Study|Failed to mobilize - no transplant|8|||
24907288|NCT00396331|50001257|FG000|Overall Study|Did not go on to transplant|5|||
24907289|NCT00396331|50001257|FG000|Overall Study|Lost to Follow-up|3|||
24907290|NCT00396331|50001257|FG000|Overall Study|Death|16|||
24907291|NCT00396253|50001269|FG000|Overall Study|Protocol Violation|1|||
24907292|NCT00396253|50001269|FG000|Overall Study|Withdrawal by Subject|7|||
24907293|NCT00396253|50001269|FG000|Overall Study|Death|3|||
24907294|NCT00396253|50001269|FG000|Overall Study|Physician Decision|1|||
24907295|NCT00396253|50001269|FG000|Overall Study|Change in eligibility status|1|||
24907296|NCT00604162|50001273|FG000|Overall Study|Physician Decision|3|||
24907297|NCT00604162|50001273|FG000|Overall Study|Withdrawal by Subject|1|||
24907298|NCT00396097|50001282|FG000|Overall Study|Withdrawal by Subject|17|||
24907299|NCT00396097|50001283|FG001|Overall Study|Withdrawal by Subject|17|||
24907300|NCT00396097|50001282|FG000|Overall Study|Lost to Follow-up|4|||
24907301|NCT00396097|50001283|FG001|Overall Study|Lost to Follow-up|9|||
24907302|NCT00396097|50001282|FG000|Overall Study|Other|3|||
24907303|NCT00396097|50001283|FG001|Overall Study|Other|5|||
24907304|NCT00396097|50001282|FG000|Overall Study|Protocol Violation|0|||
24907305|NCT00396097|50001283|FG001|Overall Study|Protocol Violation|6|||
24907306|NCT00396097|50001282|FG000|Overall Study|Adverse Event|1|||
24907307|NCT00396097|50001283|FG001|Overall Study|Adverse Event|5|||
24907308|NCT00396097|50001282|FG000|Overall Study|Insufficient Clinical Response|1|||
24907309|NCT00396097|50001283|FG001|Overall Study|Insufficient Clinical Response|4|||
24907310|NCT00375505|50001295|FG000|Overall Study|Adverse Event|1|||
24907311|NCT00375505|50001296|FG001|Overall Study|Adverse Event|2|||
24907312|NCT00375427|50001304|FG000|Overall Study|Adverse Event|21|||
24907313|NCT00375427|50001305|FG001|Overall Study|Adverse Event|27|||
24907314|NCT00375427|50001304|FG000|Overall Study|Abnormal test procedure result(s)|0|||
24907315|NCT00375427|50001305|FG001|Overall Study|Abnormal test procedure result(s)|1|||
24907316|NCT00375427|50001304|FG000|Overall Study|Abnormal laboratory value(s)|1|||
24907317|NCT00375427|50001305|FG001|Overall Study|Abnormal laboratory value(s)|2|||
24907318|NCT00375427|50001304|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
24907319|NCT00375427|50001305|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
24907320|NCT00375427|50001304|FG000|Overall Study|Patient no longer requires study drug|3|||
24907321|NCT00375427|50001305|FG001|Overall Study|Patient no longer requires study drug|7|||
24907322|NCT00375427|50001304|FG000|Overall Study|Protocol Violation|10|||
24907323|NCT00375427|50001305|FG001|Overall Study|Protocol Violation|8|||
24907324|NCT00375427|50001304|FG000|Overall Study|Withdrawal by Subject|9|||
24907325|NCT00375427|50001305|FG001|Overall Study|Withdrawal by Subject|13|||
24907326|NCT00375427|50001304|FG000|Overall Study|Lost to Follow-up|1|||
24907327|NCT00375427|50001305|FG001|Overall Study|Lost to Follow-up|1|||
24907328|NCT00375427|50001304|FG000|Overall Study|Administrative reasons|0|||
24907329|NCT00375427|50001305|FG001|Overall Study|Administrative reasons|1|||
24907330|NCT00375427|50001304|FG000|Overall Study|Death|11|||
24907331|NCT00375427|50001305|FG001|Overall Study|Death|10|||
24907332|NCT00393913|50001311|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
24907333|NCT00393913|50001311|FG000|Initial Assessment|Withdrawal by Subject|16|||
24907334|NCT00393913|50001311|FG000|CPAP|Withdrawal by Subject|3|||
24907335|NCT00393913|50001311|FG000|CPAP|Physician Decision|1|||
24907336|NCT00393913|50001311|FG000|CPAP|TEchnical problem with CPAP|3|||
24907337|NCT00567268|50001316|FG000|Overall Study|Protocol Violation|7|||
24907338|NCT00567268|50001316|FG000|Overall Study|Lost to Follow-up|36|||
24907339|NCT00567268|50001316|FG000|Overall Study|No Visit After First Day of Treatment|2|||
24907340|NCT00567268|50001316|FG000|Overall Study|No Drug Administration|4|||
24907341|NCT00567268|50001316|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
24907342|NCT03976648|50001357|FG000|Overall Study|Adverse Event|0|||
24907343|NCT03976648|50001358|FG001|Overall Study|Adverse Event|2|||
24907344|NCT03976648|50001357|FG000|Overall Study|Study terminated by sponsor|21|||
24907345|NCT03976648|50001358|FG001|Overall Study|Study terminated by sponsor|8|||
24907346|NCT00566254|50001366|FG000|Overall Study|Adverse Event|3|||
24907347|NCT00566254|50001367|FG001|Overall Study|Adverse Event|1|||
24907348|NCT00566254|50001366|FG000|Overall Study|Protocol Violation|1|||
24907349|NCT00566254|50001367|FG001|Overall Study|Protocol Violation|3|||
24907350|NCT00566254|50001366|FG000|Overall Study|Withdrawal by Subject|1|||
24907351|NCT00566254|50001367|FG001|Overall Study|Withdrawal by Subject|2|||
24907352|NCT00566254|50001366|FG000|Overall Study|Lack of Efficacy|5|||
24907353|NCT00566254|50001367|FG001|Overall Study|Lack of Efficacy|6|||
24907354|NCT00566254|50001366|FG000|Overall Study|Other|0|||
24907355|NCT00566254|50001367|FG001|Overall Study|Other|2|||
24907356|NCT00393523|50001378|FG000|Overall Study|Lost to Follow-up|0|||
24907357|NCT00393523|50001379|FG001|Overall Study|Lost to Follow-up|0|||
24907358|NCT00393523|50001380|FG002|Overall Study|Lost to Follow-up|0|||
24907359|NCT00393523|50001381|FG003|Overall Study|Lost to Follow-up|2|||
24907360|NCT00393523|50001382|FG004|Overall Study|Lost to Follow-up|1|||
24907361|NCT00393523|50001378|FG000|Overall Study|Protocol Violation|6|||
24907362|NCT00393523|50001379|FG001|Overall Study|Protocol Violation|2|||
24907363|NCT00393523|50001380|FG002|Overall Study|Protocol Violation|0|||
24907364|NCT00393523|50001381|FG003|Overall Study|Protocol Violation|1|||
24907365|NCT00393523|50001382|FG004|Overall Study|Protocol Violation|0|||
24907366|NCT00393523|50001378|FG000|Overall Study|Withdrawal by Subject|6|||
24907367|NCT00393523|50001379|FG001|Overall Study|Withdrawal by Subject|7|||
24907368|NCT00393523|50001380|FG002|Overall Study|Withdrawal by Subject|2|||
24907369|NCT00393523|50001381|FG003|Overall Study|Withdrawal by Subject|3|||
24907370|NCT00393523|50001382|FG004|Overall Study|Withdrawal by Subject|0|||
24907371|NCT00393523|50001378|FG000|Overall Study|Difficulties in specimen collection|0|||
24907372|NCT00393523|50001379|FG001|Overall Study|Difficulties in specimen collection|0|||
24907373|NCT00393523|50001380|FG002|Overall Study|Difficulties in specimen collection|1|||
24907374|NCT00393523|50001381|FG003|Overall Study|Difficulties in specimen collection|0|||
24907375|NCT00393523|50001382|FG004|Overall Study|Difficulties in specimen collection|0|||
24907376|NCT00393523|50001378|FG000|Overall Study|Vaccine supply issue|0|||
24907377|NCT00393523|50001379|FG001|Overall Study|Vaccine supply issue|0|||
24907378|NCT00393523|50001380|FG002|Overall Study|Vaccine supply issue|1|||
24907379|NCT00393523|50001381|FG003|Overall Study|Vaccine supply issue|0|||
24907380|NCT00393523|50001382|FG004|Overall Study|Vaccine supply issue|0|||
24907381|NCT00393367|50001395|FG000|Overall Study|Protocol Violation|2|||
24907382|NCT00393367|50001396|FG001|Overall Study|Protocol Violation|5|||
24907383|NCT00393367|50001395|FG000|Overall Study|Withdrawal by Subject|0|||
24907384|NCT00393367|50001396|FG001|Overall Study|Withdrawal by Subject|2|||
24907385|NCT00395863|50001406|FG000|Overall Study|Patients did not complete both exams|2|||
24907386|NCT00395863|50001407|FG001|Overall Study|Patients did not complete both exams|3|||
24907387|NCT00395629|50001419|FG000|Core Study|Adverse Event|0|||
24907388|NCT00395629|50001420|FG001|Core Study|Adverse Event|3|||
24907389|NCT00395629|50001421|FG002|Core Study|Adverse Event|4|||
24907390|NCT00395629|50001419|FG000|Core Study|Abnormal laboratory value(s)|0|||
24907391|NCT00395629|50001420|FG001|Core Study|Abnormal laboratory value(s)|0|||
24907392|NCT00395629|50001421|FG002|Core Study|Abnormal laboratory value(s)|1|||
24907393|NCT00395629|50001419|FG000|Core Study|Protocol Violation|1|||
24907394|NCT00395629|50001420|FG001|Core Study|Protocol Violation|0|||
24907395|NCT00395629|50001421|FG002|Core Study|Protocol Violation|0|||
24907396|NCT00395629|50001419|FG000|Core Study|Withdrawal by Subject|0|||
24907397|NCT00395629|50001420|FG001|Core Study|Withdrawal by Subject|1|||
24907398|NCT00395629|50001421|FG002|Core Study|Withdrawal by Subject|1|||
24907399|NCT00395629|50001419|FG000|Core Study|Lost to Follow-up|0|||
24907400|NCT00395629|50001420|FG001|Core Study|Lost to Follow-up|0|||
24907401|NCT00395629|50001421|FG002|Core Study|Lost to Follow-up|1|||
24907402|NCT00395629|50001419|FG000|Extension Study|Adverse Event|0|||
24907403|NCT00395629|50001420|FG001|Extension Study|Adverse Event|0|||
24907404|NCT00395629|50001421|FG002|Extension Study|Adverse Event|2|||
24907405|NCT00395629|50001419|FG000|Extension Study|Administrative problems|0|||
24907406|NCT00395629|50001420|FG001|Extension Study|Administrative problems|0|||
24907407|NCT00395629|50001421|FG002|Extension Study|Administrative problems|1|||
24907408|NCT00392665|50001434|FG000|Overall Study|Death|16|||
24907409|NCT00392665|50001435|FG001|Overall Study|Death|14|||
24907410|NCT00392665|50001434|FG000|Overall Study|Lost to Follow-up|1|||
24907411|NCT00392665|50001435|FG001|Overall Study|Lost to Follow-up|1|||
24907412|NCT00622869|50001444|FG000|Overall Study|Subject Withdrew Consent|13|||
24995141|NCT03014206|50086071|FG000|Overall Study|Registration Violation|12|||
24995142|NCT03010462|50086077|FG000|Overall Study|Withdrawal by Subject|3|||
24995143|NCT03010462|50086078|FG001|Overall Study|Withdrawal by Subject|1|||
24995144|NCT00021255|50086087|FG000|Overall Study|Death|1|||
24995145|NCT00021255|50086088|FG001|Overall Study|Death|0|||
24995146|NCT00021255|50086089|FG002|Overall Study|Death|2|||
24995147|NCT00021255|50086087|FG000|Overall Study|Breast cancer relapse|5|||
24995148|NCT00021255|50086088|FG001|Overall Study|Breast cancer relapse|18|||
24995149|NCT00021255|50086089|FG002|Overall Study|Breast cancer relapse|11|||
24995150|NCT00021255|50086087|FG000|Overall Study|Second primary malignancy|0|||
24995151|NCT00021255|50086088|FG001|Overall Study|Second primary malignancy|4|||
24995152|NCT00021255|50086089|FG002|Overall Study|Second primary malignancy|1|||
24995153|NCT00021255|50086087|FG000|Overall Study|Withdrawal by Subject|41|||
24995154|NCT00021255|50086088|FG001|Overall Study|Withdrawal by Subject|64|||
24995155|NCT00021255|50086089|FG002|Overall Study|Withdrawal by Subject|26|||
24995156|NCT00021255|50086087|FG000|Overall Study|Lost to Follow-up|0|||
24995157|NCT00021255|50086088|FG001|Overall Study|Lost to Follow-up|2|||
24995158|NCT00021255|50086089|FG002|Overall Study|Lost to Follow-up|3|||
24995159|NCT00021255|50086087|FG000|Overall Study|Cardiac toxicity|0|||
24995160|NCT00021255|50086088|FG001|Overall Study|Cardiac toxicity|61|||
24995161|NCT00021255|50086089|FG002|Overall Study|Cardiac toxicity|32|||
24995162|NCT00021255|50086087|FG000|Overall Study|Herceptin toxicity|0|||
24995163|NCT00021255|50086088|FG001|Overall Study|Herceptin toxicity|22|||
24995164|NCT00021255|50086089|FG002|Overall Study|Herceptin toxicity|6|||
24995165|NCT00021255|50086087|FG000|Overall Study|Adverse Event|46|||
24995166|NCT00021255|50086088|FG001|Overall Study|Adverse Event|30|||
24995167|NCT00021255|50086089|FG002|Overall Study|Adverse Event|18|||
24995168|NCT00021255|50086087|FG000|Overall Study|Protocol Violation|0|||
24995169|NCT00021255|50086088|FG001|Overall Study|Protocol Violation|2|||
24995170|NCT00021255|50086089|FG002|Overall Study|Protocol Violation|0|||
24995171|NCT00021255|50086087|FG000|Overall Study|Other than specified above|0|||
24995172|NCT00021255|50086088|FG001|Overall Study|Other than specified above|38|||
24995173|NCT00021255|50086089|FG002|Overall Study|Other than specified above|19|||
24995174|NCT00021255|50086087|FG000|Overall Study|Missing|0|||
24995175|NCT00021255|50086088|FG001|Overall Study|Missing|27|||
24995176|NCT00021255|50086089|FG002|Overall Study|Missing|13|||
24995177|NCT00021255|50086087|FG000|Overall Study|Randomized but not treated|28|||
24995178|NCT00021255|50086088|FG001|Overall Study|Randomized but not treated|2|||
24995179|NCT00021255|50086089|FG002|Overall Study|Randomized but not treated|18|||
24995180|NCT03012334|50086107|FG000|Period 1|Withdrawal by Subject|0|||
24995181|NCT03012334|50086108|FG001|Period 1|Withdrawal by Subject|0|||
24995182|NCT03012334|50086109|FG002|Period 1|Withdrawal by Subject|0|||
24995183|NCT03012334|50086110|FG003|Period 1|Withdrawal by Subject|0|||
24995184|NCT03012334|50086111|FG004|Period 1|Withdrawal by Subject|0|||
24995185|NCT03012334|50086112|FG005|Period 1|Withdrawal by Subject|0|||
24995186|NCT03012334|50086113|FG006|Period 1|Withdrawal by Subject|0|||
24995187|NCT03012334|50086114|FG007|Period 1|Withdrawal by Subject|0|||
24995188|NCT03012334|50086115|FG008|Period 1|Withdrawal by Subject|0|||
24995189|NCT03012334|50086116|FG009|Period 1|Withdrawal by Subject|1|||
24995190|NCT03012334|50086107|FG000|Period 2|Withdrawal by Subject|0|||
24995191|NCT03012334|50086108|FG001|Period 2|Withdrawal by Subject|1|||
24995192|NCT03012334|50086109|FG002|Period 2|Withdrawal by Subject|0|||
24907413|NCT00622869|50001445|FG001|Overall Study|Subject Withdrew Consent|17|||
24995193|NCT03012334|50086110|FG003|Period 2|Withdrawal by Subject|0|||
24995194|NCT03012334|50086111|FG004|Period 2|Withdrawal by Subject|0|||
24995195|NCT03012334|50086112|FG005|Period 2|Withdrawal by Subject|0|||
24995196|NCT03012334|50086113|FG006|Period 2|Withdrawal by Subject|0|||
24995197|NCT03012334|50086114|FG007|Period 2|Withdrawal by Subject|0|||
24995198|NCT03012334|50086115|FG008|Period 2|Withdrawal by Subject|0|||
24995199|NCT03012334|50086116|FG009|Period 2|Withdrawal by Subject|0|||
24995200|NCT03012334|50086107|FG000|Period 2|Protocol Violation|0|||
24995201|NCT03012334|50086108|FG001|Period 2|Protocol Violation|0|||
24995202|NCT03012334|50086109|FG002|Period 2|Protocol Violation|1|||
24995203|NCT03012334|50086110|FG003|Period 2|Protocol Violation|0|||
24995204|NCT03012334|50086111|FG004|Period 2|Protocol Violation|0|||
24995205|NCT03012334|50086112|FG005|Period 2|Protocol Violation|0|||
24995206|NCT03012334|50086113|FG006|Period 2|Protocol Violation|0|||
24995207|NCT03012334|50086114|FG007|Period 2|Protocol Violation|1|||
24995208|NCT03012334|50086115|FG008|Period 2|Protocol Violation|0|||
24995209|NCT03012334|50086116|FG009|Period 2|Protocol Violation|0|||
24995210|NCT03012334|50086107|FG000|Period 4|Non-Compliance|0|||
24995211|NCT03012334|50086108|FG001|Period 4|Non-Compliance|0|||
24995212|NCT03012334|50086109|FG002|Period 4|Non-Compliance|0|||
24995213|NCT03012334|50086110|FG003|Period 4|Non-Compliance|0|||
24995214|NCT03012334|50086111|FG004|Period 4|Non-Compliance|0|||
24995215|NCT03012334|50086112|FG005|Period 4|Non-Compliance|0|||
24995216|NCT03012334|50086113|FG006|Period 4|Non-Compliance|1|||
24995217|NCT03012334|50086114|FG007|Period 4|Non-Compliance|0|||
24995218|NCT03012334|50086115|FG008|Period 4|Non-Compliance|0|||
24995219|NCT03012334|50086116|FG009|Period 4|Non-Compliance|0|||
24995220|NCT03012334|50086107|FG000|Period 4|Adverse Event|0|||
24995221|NCT03012334|50086108|FG001|Period 4|Adverse Event|0|||
24995222|NCT03012334|50086109|FG002|Period 4|Adverse Event|0|||
24995223|NCT03012334|50086110|FG003|Period 4|Adverse Event|0|||
24995224|NCT03012334|50086111|FG004|Period 4|Adverse Event|0|||
24995225|NCT03012334|50086112|FG005|Period 4|Adverse Event|0|||
24995226|NCT03012334|50086113|FG006|Period 4|Adverse Event|0|||
24995227|NCT03012334|50086114|FG007|Period 4|Adverse Event|0|||
24995228|NCT03012334|50086115|FG008|Period 4|Adverse Event|1|||
24995229|NCT03012334|50086116|FG009|Period 4|Adverse Event|0|||
24995230|NCT03565068|50086138|FG000|Overall Study|Protocol Violation|0|||
24995231|NCT03565068|50086139|FG001|Overall Study|Protocol Violation|0|||
24995232|NCT03565068|50086140|FG002|Overall Study|Protocol Violation|0|||
24995233|NCT03565068|50086141|FG003|Overall Study|Protocol Violation|0|||
24995234|NCT03565068|50086142|FG004|Overall Study|Protocol Violation|1|||
24995235|NCT03565068|50086143|FG005|Overall Study|Protocol Violation|0|||
24995236|NCT03565068|50086144|FG006|Overall Study|Protocol Violation|0|||
24995237|NCT03565068|50086145|FG007|Overall Study|Protocol Violation|1|||
24995238|NCT03565068|50086146|FG008|Overall Study|Protocol Violation|0|||
24995239|NCT03565068|50086138|FG000|Overall Study|Sponsor decision|0|||
24995240|NCT03565068|50086139|FG001|Overall Study|Sponsor decision|0|||
24995241|NCT03565068|50086140|FG002|Overall Study|Sponsor decision|0|||
24995242|NCT03565068|50086141|FG003|Overall Study|Sponsor decision|0|||
24995243|NCT03565068|50086142|FG004|Overall Study|Sponsor decision|1|||
24995244|NCT03565068|50086143|FG005|Overall Study|Sponsor decision|1|||
24995245|NCT03565068|50086144|FG006|Overall Study|Sponsor decision|0|||
24995246|NCT03565068|50086145|FG007|Overall Study|Sponsor decision|0|||
24995247|NCT03565068|50086146|FG008|Overall Study|Sponsor decision|0|||
24995248|NCT03565068|50086138|FG000|Overall Study|Withdrawal by Subject|0|||
24995249|NCT03565068|50086139|FG001|Overall Study|Withdrawal by Subject|0|||
24995250|NCT03565068|50086140|FG002|Overall Study|Withdrawal by Subject|1|||
24995251|NCT03565068|50086141|FG003|Overall Study|Withdrawal by Subject|0|||
24995252|NCT03565068|50086142|FG004|Overall Study|Withdrawal by Subject|2|||
24995253|NCT03565068|50086143|FG005|Overall Study|Withdrawal by Subject|0|||
24995254|NCT03565068|50086144|FG006|Overall Study|Withdrawal by Subject|1|||
24995255|NCT03565068|50086145|FG007|Overall Study|Withdrawal by Subject|5|||
24995256|NCT03565068|50086146|FG008|Overall Study|Withdrawal by Subject|1|||
24995257|NCT03565068|50086138|FG000|Overall Study|Physician Decision|0|||
24995258|NCT03565068|50086139|FG001|Overall Study|Physician Decision|0|||
24995259|NCT03565068|50086140|FG002|Overall Study|Physician Decision|0|||
24995260|NCT03565068|50086141|FG003|Overall Study|Physician Decision|0|||
24995261|NCT03565068|50086142|FG004|Overall Study|Physician Decision|0|||
24995262|NCT03565068|50086143|FG005|Overall Study|Physician Decision|0|||
24995263|NCT03565068|50086144|FG006|Overall Study|Physician Decision|0|||
24995264|NCT03565068|50086145|FG007|Overall Study|Physician Decision|1|||
24995265|NCT03565068|50086146|FG008|Overall Study|Physician Decision|0|||
24995266|NCT03565068|50086138|FG000|Overall Study|Lost to Follow-up|0|||
24995267|NCT03565068|50086139|FG001|Overall Study|Lost to Follow-up|0|||
24995268|NCT03565068|50086140|FG002|Overall Study|Lost to Follow-up|0|||
24995269|NCT03565068|50086141|FG003|Overall Study|Lost to Follow-up|0|||
24995270|NCT03565068|50086142|FG004|Overall Study|Lost to Follow-up|0|||
24995271|NCT03565068|50086143|FG005|Overall Study|Lost to Follow-up|0|||
24995272|NCT03565068|50086144|FG006|Overall Study|Lost to Follow-up|0|||
24995273|NCT03565068|50086145|FG007|Overall Study|Lost to Follow-up|1|||
24995274|NCT03565068|50086146|FG008|Overall Study|Lost to Follow-up|0|||
24995275|NCT00010803|50086205|FG000|Overall Study|Withdrawal by Subject|97|||
24995276|NCT00010803|50086206|FG001|Overall Study|Withdrawal by Subject|98|||
24995277|NCT02914834|50086214|FG000|Overall Study|Study halted due to COVID|1|||
24995278|NCT02914834|50086215|FG001|Overall Study|Study halted due to COVID|1|||
24995279|NCT02914834|50086214|FG000|Overall Study|1 subject withdrew|0|||
24995280|NCT02914834|50086215|FG001|Overall Study|1 subject withdrew|1|||
24995281|NCT03497130|50086223|FG000|Overall Study|Lost to Follow-up|1|||
24995282|NCT03497130|50086224|FG001|Overall Study|Lost to Follow-up|1|||
24995283|NCT03006562|50086232|FG000|Overall Study|Lost to Follow-up|0|||
24995284|NCT03006562|50086233|FG001|Overall Study|Lost to Follow-up|1|||
24995285|NCT03007966|50086241|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
24995286|NCT03007966|50086242|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
24995287|NCT03007888|50086249|FG000|First Intervention (14 Days)|Adverse Event|1|||
24995288|NCT03007888|50086250|FG001|First Intervention (14 Days)|Adverse Event|0|||
24995289|NCT03541044|50086259|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
24995290|NCT03541044|50086260|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
24995291|NCT03541044|50086259|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
24995292|NCT03541044|50086260|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
24995293|NCT00009945|50086270|FG000|Overall Study|no follow up data|7|||
24995294|NCT00009945|50086271|FG001|Overall Study|no follow up data|5|||
24995295|NCT03540030|50086279|FG000|Overall Study|Withdrawal by Subject|2|||
24995296|NCT03540030|50086280|FG001|Overall Study|Withdrawal by Subject|1|||
24995297|NCT03540030|50086279|FG000|Overall Study|screen fail|7|||
24995298|NCT03540030|50086280|FG001|Overall Study|screen fail|1|||
24995299|NCT03540030|50086279|FG000|Overall Study|never had surgery after signing consent|9|||
24995300|NCT03540030|50086280|FG001|Overall Study|never had surgery after signing consent|1|||
24995301|NCT00008385|50086288|FG000|Overall Study|Off treatment reasons not reported|79|||
24995302|NCT00008385|50086289|FG001|Overall Study|Off treatment reasons not reported|70|||
24995303|NCT00008385|50086288|FG000|Overall Study|Progressive disease|52|||
24995304|NCT00008385|50086289|FG001|Overall Study|Progressive disease|117|||
24995305|NCT00008385|50086288|FG000|Overall Study|Adverse Event|8|||
24995306|NCT00008385|50086289|FG001|Overall Study|Adverse Event|20|||
24995307|NCT00008385|50086288|FG000|Overall Study|Death|12|||
24995308|NCT00008385|50086289|FG001|Overall Study|Death|18|||
24995309|NCT00008385|50086288|FG000|Overall Study|Withdrawal by Subject|67|||
24995310|NCT00008385|50086289|FG001|Overall Study|Withdrawal by Subject|157|||
24995311|NCT00008385|50086288|FG000|Overall Study|Start non-protocol therapy|3|||
24995312|NCT00008385|50086289|FG001|Overall Study|Start non-protocol therapy|1|||
24995313|NCT00008385|50086288|FG000|Overall Study|Other complicating disease|17|||
24995314|NCT00008385|50086289|FG001|Overall Study|Other complicating disease|30|||
24995315|NCT00008385|50086288|FG000|Overall Study|Maximum dose reached|0|||
24995316|NCT00008385|50086289|FG001|Overall Study|Maximum dose reached|2|||
24995317|NCT00008385|50086288|FG000|Overall Study|Other|105|||
24995318|NCT00008385|50086289|FG001|Overall Study|Other|212|||
24995319|NCT00008385|50086288|FG000|Overall Study|Not start protocol therapy|44|||
24995320|NCT00008385|50086289|FG001|Overall Study|Not start protocol therapy|175|||
24995321|NCT03003676|50086297|FG000|Overall Study|Lack of Efficacy|5|||
24995322|NCT03003676|50086298|FG001|Overall Study|Lack of Efficacy|7|||
24995323|NCT03003676|50086297|FG000|Overall Study|Withdrawal by Subject|0|||
24995324|NCT03003676|50086298|FG001|Overall Study|Withdrawal by Subject|1|||
24995325|NCT03003676|50086297|FG000|Overall Study|Hepatitis B infection|1|||
24995326|NCT03003676|50086298|FG001|Overall Study|Hepatitis B infection|0|||
24995327|NCT00047385|50086308|FG000|Overall Study|Death before any screening|2|||
24995328|NCT00047385|50086309|FG001|Overall Study|Death before any screening|5|||
24995329|NCT00047385|50086308|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
24995330|NCT00047385|50086309|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
24995331|NCT00047385|50086308|FG000|Overall Study|Eligible for screening but had no screen|260|||
24995332|NCT00047385|50086309|FG001|Overall Study|Eligible for screening but had no screen|492|||
24995333|NCT03002818|50086315|FG000|Overall Study|Decision of the investigator|1|||
24995334|NCT03002194|50086319|FG000|Overall Study|Lost to Follow-up|6|||
24995335|NCT03002194|50086319|FG000|Overall Study|Adverse Event|1|||
24995336|NCT03002194|50086319|FG000|Overall Study|Lack of Efficacy|1|||
24995337|NCT03002194|50086319|FG000|Overall Study|Withdrawal by Subject|2|||
24995338|NCT02912650|50086327|FG000|Overall Study|Withdrawal by Subject|1|||
24995339|NCT02912650|50086328|FG001|Overall Study|Withdrawal by Subject|0|||
24995340|NCT02912650|50086329|FG002|Overall Study|Withdrawal by Subject|1|||
24995341|NCT02912650|50086330|FG003|Overall Study|Withdrawal by Subject|5|||
24995342|NCT02912650|50086327|FG000|Overall Study|Adverse Event|0|||
24995343|NCT02912650|50086328|FG001|Overall Study|Adverse Event|0|||
24995344|NCT02912650|50086329|FG002|Overall Study|Adverse Event|1|||
24995345|NCT02912650|50086330|FG003|Overall Study|Adverse Event|0|||
24995346|NCT03004924|50086343|FG000|Overall Study|Adverse Event|6|||
24995347|NCT03004924|50086344|FG001|Overall Study|Adverse Event|5|||
24995348|NCT03004924|50086345|FG002|Overall Study|Adverse Event|10|||
24995349|NCT03004924|50086343|FG000|Overall Study|Protocol Violation|4|||
24995350|NCT03004924|50086344|FG001|Overall Study|Protocol Violation|0|||
24995351|NCT03004924|50086345|FG002|Overall Study|Protocol Violation|1|||
24995352|NCT03004924|50086343|FG000|Overall Study|Withdrawal by Subject|5|||
24995353|NCT03004924|50086344|FG001|Overall Study|Withdrawal by Subject|3|||
24995354|NCT03004924|50086345|FG002|Overall Study|Withdrawal by Subject|5|||
24995355|NCT03004924|50086343|FG000|Overall Study|Lost to Follow-up|6|||
24995356|NCT03004924|50086344|FG001|Overall Study|Lost to Follow-up|1|||
24995357|NCT03004924|50086345|FG002|Overall Study|Lost to Follow-up|4|||
24995358|NCT03004924|50086343|FG000|Overall Study|Lack of Efficacy|2|||
24995359|NCT03004924|50086344|FG001|Overall Study|Lack of Efficacy|4|||
24995360|NCT03004924|50086345|FG002|Overall Study|Lack of Efficacy|2|||
24995361|NCT03004924|50086343|FG000|Overall Study|Physician Decision|1|||
24995362|NCT03004924|50086344|FG001|Overall Study|Physician Decision|0|||
24995363|NCT03004924|50086345|FG002|Overall Study|Physician Decision|1|||
24995364|NCT03004924|50086343|FG000|Overall Study|Withdrawal by parent/guardian|1|||
24995365|NCT03004924|50086344|FG001|Overall Study|Withdrawal by parent/guardian|0|||
24995366|NCT03004924|50086345|FG002|Overall Study|Withdrawal by parent/guardian|2|||
24995367|NCT03004924|50086343|FG000|Overall Study|Screen Failure|1|||
24995368|NCT03004924|50086344|FG001|Overall Study|Screen Failure|0|||
24995369|NCT03004924|50086345|FG002|Overall Study|Screen Failure|0|||
24995370|NCT03004924|50086343|FG000|Overall Study|Pregnancy|0|||
24995371|NCT03004924|50086344|FG001|Overall Study|Pregnancy|1|||
24995372|NCT03004924|50086345|FG002|Overall Study|Pregnancy|0|||
24995373|NCT03004924|50086343|FG000|Overall Study|Terminated by Sponsor|0|||
24995374|NCT03004924|50086344|FG001|Overall Study|Terminated by Sponsor|0|||
24995375|NCT03004924|50086345|FG002|Overall Study|Terminated by Sponsor|1|||
24995376|NCT03004924|50086343|FG000|Overall Study|Missed Study Visit|0|||
24995377|NCT03004924|50086344|FG001|Overall Study|Missed Study Visit|0|||
24995378|NCT03004924|50086345|FG002|Overall Study|Missed Study Visit|2|||
24995379|NCT03004924|50086343|FG000|Overall Study|HSV1 Positive|1|||
24995380|NCT03004924|50086344|FG001|Overall Study|HSV1 Positive|0|||
24995381|NCT03004924|50086345|FG002|Overall Study|HSV1 Positive|0|||
24995382|NCT03002038|50086356|FG000|Overall Study|Adverse Event|3|||
24995383|NCT03002038|50086357|FG001|Overall Study|Adverse Event|1|||
24995384|NCT03002038|50086356|FG000|Overall Study|Withdrawal by Subject|8|||
24995385|NCT03002038|50086357|FG001|Overall Study|Withdrawal by Subject|4|||
24995386|NCT03002038|50086356|FG000|Overall Study|Immigration to another region|0|||
24995387|NCT03002038|50086357|FG001|Overall Study|Immigration to another region|2|||
24995388|NCT02911948|50086365|FG000|Overall Study|Protocol Violation|0|||
24995389|NCT02911948|50086366|FG001|Overall Study|Protocol Violation|1|||
24995390|NCT02911948|50086365|FG000|Overall Study|Withdrawal by Subject|0|||
24995391|NCT02911948|50086366|FG001|Overall Study|Withdrawal by Subject|2|||
24995392|NCT02911948|50086365|FG000|Overall Study|Lack of Efficacy|0|||
24995393|NCT02911948|50086366|FG001|Overall Study|Lack of Efficacy|1|||
24995394|NCT02911948|50086365|FG000|Overall Study|Unclassified|0|||
24995395|NCT02911948|50086366|FG001|Overall Study|Unclassified|3|||
24995396|NCT02996968|50086374|FG000|Overall Study|Withdrawal by Subject|1|||
24995397|NCT02996968|50086375|FG001|Overall Study|Withdrawal by Subject|0|||
24995398|NCT00027027|50086386|FG000|Overall Study|Adverse Event|0|||
24995399|NCT00027027|50086387|FG001|Overall Study|Adverse Event|0|||
24995400|NCT00027027|50086388|FG002|Overall Study|Adverse Event|1|||
24995401|NCT00027027|50086389|FG003|Overall Study|Adverse Event|0|||
24995402|NCT00027027|50086390|FG004|Overall Study|Adverse Event|1|||
24995403|NCT00027027|50086386|FG000|Overall Study|Admitted for Signs of PD|0|||
24995404|NCT00027027|50086387|FG001|Overall Study|Admitted for Signs of PD|0|||
24995405|NCT00027027|50086388|FG002|Overall Study|Admitted for Signs of PD|0|||
24995406|NCT00027027|50086389|FG003|Overall Study|Admitted for Signs of PD|0|||
24995407|NCT00027027|50086390|FG004|Overall Study|Admitted for Signs of PD|1|||
24995408|NCT00027027|50086386|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
24995409|NCT00027027|50086387|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
24995410|NCT00027027|50086388|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
24995411|NCT00027027|50086389|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
24995412|NCT00027027|50086390|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
24995413|NCT00027027|50086386|FG000|Overall Study|PD Requiring Surgery|0|||
24995414|NCT00027027|50086387|FG001|Overall Study|PD Requiring Surgery|0|||
24995415|NCT00027027|50086388|FG002|Overall Study|PD Requiring Surgery|1|||
24995416|NCT00027027|50086389|FG003|Overall Study|PD Requiring Surgery|0|||
24995417|NCT00027027|50086390|FG004|Overall Study|PD Requiring Surgery|0|||
24995418|NCT00027027|50086386|FG000|Overall Study|Physician Decision Due To PD|2|||
24995419|NCT00027027|50086387|FG001|Overall Study|Physician Decision Due To PD|3|||
24995420|NCT00027027|50086388|FG002|Overall Study|Physician Decision Due To PD|2|||
24995421|NCT00027027|50086389|FG003|Overall Study|Physician Decision Due To PD|3|||
24995422|NCT00027027|50086390|FG004|Overall Study|Physician Decision Due To PD|5|||
24995423|NCT00027027|50086386|FG000|Overall Study|Withdrawal by Subject|0|||
24995424|NCT00027027|50086387|FG001|Overall Study|Withdrawal by Subject|0|||
24995425|NCT00027027|50086388|FG002|Overall Study|Withdrawal by Subject|0|||
24995426|NCT00027027|50086389|FG003|Overall Study|Withdrawal by Subject|0|||
24995427|NCT00027027|50086390|FG004|Overall Study|Withdrawal by Subject|1|||
24995428|NCT00046839|50086408|FG000|Overall Study|Ineligible / No protocol treatment|0|||
24995429|NCT00046839|50086409|FG001|Overall Study|Ineligible / No protocol treatment|2|||
24995430|NCT00046839|50086408|FG000|Overall Study|Withdrawal of consent|1|||
24995431|NCT00046839|50086409|FG001|Overall Study|Withdrawal of consent|0|||
24995432|NCT00006903|50086418|FG000|Overall Study|Still receiving treatment|0|||
24995433|NCT00006903|50086419|FG001|Overall Study|Still receiving treatment|0|||
24995434|NCT00006903|50086420|FG002|Overall Study|Still receiving treatment|1|||
24995435|NCT00006903|50086418|FG000|Overall Study|Refused further treatment|0|||
24995436|NCT00006903|50086419|FG001|Overall Study|Refused further treatment|2|||
24995437|NCT00006903|50086420|FG002|Overall Study|Refused further treatment|1|||
24995438|NCT00006903|50086418|FG000|Overall Study|Adverse Event|0|||
24995439|NCT00006903|50086419|FG001|Overall Study|Adverse Event|0|||
24995440|NCT00006903|50086420|FG002|Overall Study|Adverse Event|1|||
24995441|NCT00006903|50086418|FG000|Overall Study|Death|0|||
24995442|NCT00006903|50086419|FG001|Overall Study|Death|1|||
24995443|NCT00006903|50086420|FG002|Overall Study|Death|0|||
24995444|NCT00006903|50086418|FG000|Overall Study|Patient never treated|0|||
24995445|NCT00006903|50086419|FG001|Overall Study|Patient never treated|0|||
24995446|NCT00006903|50086420|FG002|Overall Study|Patient never treated|1|||
24995447|NCT00006903|50086418|FG000|Overall Study|Ineligible|10|||
24995448|NCT00006903|50086419|FG001|Overall Study|Ineligible|1|||
24995449|NCT00006903|50086420|FG002|Overall Study|Ineligible|2|||
24995450|NCT00026793|50086428|FG000|Overall Study|Death on study due to underlying disease|4|||
24995451|NCT00026793|50086428|FG000|Overall Study|Physician Decision|2|||
24995452|NCT00026793|50086428|FG000|Overall Study|Off study|2|||
24995453|NCT03539484|50086439|FG000|Overall Study|Death|1|||
24995454|NCT03539484|50086440|FG001|Overall Study|Death|0|||
24995455|NCT03539484|50086441|FG002|Overall Study|Death|0|||
24995456|NCT03539484|50086442|FG003|Overall Study|Death|2|||
24995457|NCT03539484|50086443|FG004|Overall Study|Death|8|||
24995458|NCT03539484|50086444|FG005|Overall Study|Death|3|||
24995459|NCT03539484|50086445|FG006|Overall Study|Death|0|||
24995460|NCT03539484|50086439|FG000|Overall Study|Lost to Follow-up|0|||
24995461|NCT03539484|50086440|FG001|Overall Study|Lost to Follow-up|1|||
24995462|NCT03539484|50086441|FG002|Overall Study|Lost to Follow-up|0|||
24995463|NCT03539484|50086442|FG003|Overall Study|Lost to Follow-up|0|||
24995464|NCT03539484|50086443|FG004|Overall Study|Lost to Follow-up|1|||
24995465|NCT03539484|50086444|FG005|Overall Study|Lost to Follow-up|0|||
24995466|NCT03539484|50086445|FG006|Overall Study|Lost to Follow-up|0|||
24995467|NCT03539484|50086439|FG000|Overall Study|Withdrawal by Subject|0|||
24995468|NCT03539484|50086440|FG001|Overall Study|Withdrawal by Subject|0|||
24995469|NCT03539484|50086441|FG002|Overall Study|Withdrawal by Subject|0|||
24995470|NCT03539484|50086442|FG003|Overall Study|Withdrawal by Subject|0|||
24995471|NCT03539484|50086443|FG004|Overall Study|Withdrawal by Subject|2|||
24995472|NCT03539484|50086444|FG005|Overall Study|Withdrawal by Subject|0|||
24995473|NCT03539484|50086445|FG006|Overall Study|Withdrawal by Subject|1|||
24995474|NCT03539484|50086439|FG000|Overall Study|Study Terminated by Sponsor|0|||
24995475|NCT03539484|50086440|FG001|Overall Study|Study Terminated by Sponsor|0|||
24995476|NCT03539484|50086441|FG002|Overall Study|Study Terminated by Sponsor|1|||
24995477|NCT03539484|50086442|FG003|Overall Study|Study Terminated by Sponsor|1|||
24995478|NCT03539484|50086443|FG004|Overall Study|Study Terminated by Sponsor|2|||
24995479|NCT03539484|50086444|FG005|Overall Study|Study Terminated by Sponsor|2|||
24995480|NCT03539484|50086445|FG006|Overall Study|Study Terminated by Sponsor|1|||
24995481|NCT03561090|50086468|FG000|Overall Study|Adverse Event|11|||
24995482|NCT03561090|50086469|FG001|Overall Study|Adverse Event|7|||
24995483|NCT03561090|50086468|FG000|Overall Study|Non-Compliance With Study Drug|2|||
24995484|NCT03561090|50086469|FG001|Overall Study|Non-Compliance With Study Drug|0|||
24995485|NCT03561090|50086468|FG000|Overall Study|Protocol Violation|2|||
24995486|NCT03561090|50086469|FG001|Overall Study|Protocol Violation|2|||
24995487|NCT03561090|50086468|FG000|Overall Study|Withdrawal by Subject|7|||
24995488|NCT03561090|50086469|FG001|Overall Study|Withdrawal by Subject|7|||
24995489|NCT03561090|50086468|FG000|Overall Study|Lost to Follow-up|7|||
24995490|NCT03561090|50086469|FG001|Overall Study|Lost to Follow-up|2|||
24995491|NCT03561090|50086468|FG000|Overall Study|Study Terminated by Sponsor|10|||
24995492|NCT03561090|50086469|FG001|Overall Study|Study Terminated by Sponsor|15|||
24995493|NCT03561090|50086468|FG000|Overall Study|Randomized by Mistake|1|||
24995494|NCT03561090|50086469|FG001|Overall Study|Randomized by Mistake|1|||
24995495|NCT03561090|50086468|FG000|Overall Study|Other Not Specified|0|||
24995496|NCT03561090|50086469|FG001|Overall Study|Other Not Specified|2|||
24995497|NCT02996500|50086483|FG000|Overall Study|Adverse Event|1|||
24995498|NCT02996500|50086484|FG001|Overall Study|Adverse Event|1|||
24995499|NCT02996500|50086485|FG002|Overall Study|Adverse Event|4|||
24995500|NCT02996500|50086486|FG003|Overall Study|Adverse Event|3|||
24995501|NCT02996500|50086487|FG004|Overall Study|Adverse Event|1|||
24995502|NCT02996500|50086488|FG005|Overall Study|Adverse Event|2|||
24995503|NCT02996500|50086483|FG000|Overall Study|Lack of Efficacy|0|||
24995504|NCT02996500|50086484|FG001|Overall Study|Lack of Efficacy|0|||
24995505|NCT02996500|50086485|FG002|Overall Study|Lack of Efficacy|0|||
24995506|NCT02996500|50086486|FG003|Overall Study|Lack of Efficacy|0|||
24995507|NCT02996500|50086487|FG004|Overall Study|Lack of Efficacy|2|||
24995508|NCT02996500|50086488|FG005|Overall Study|Lack of Efficacy|0|||
24995509|NCT02996500|50086483|FG000|Overall Study|Lost to Follow-up|1|||
24995510|NCT02996500|50086484|FG001|Overall Study|Lost to Follow-up|0|||
24995511|NCT02996500|50086485|FG002|Overall Study|Lost to Follow-up|0|||
24995512|NCT02996500|50086486|FG003|Overall Study|Lost to Follow-up|0|||
24995513|NCT02996500|50086487|FG004|Overall Study|Lost to Follow-up|0|||
24995514|NCT02996500|50086488|FG005|Overall Study|Lost to Follow-up|1|||
24995515|NCT02996500|50086483|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
24995516|NCT02996500|50086484|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
24995517|NCT02996500|50086485|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
24995518|NCT02996500|50086486|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
24995519|NCT02996500|50086487|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
24995520|NCT02996500|50086488|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
24995521|NCT02996500|50086483|FG000|Overall Study|Non-Compliance With Study Drug|0|||
24995522|NCT02996500|50086484|FG001|Overall Study|Non-Compliance With Study Drug|0|||
24995523|NCT02996500|50086485|FG002|Overall Study|Non-Compliance With Study Drug|0|||
24995524|NCT02996500|50086486|FG003|Overall Study|Non-Compliance With Study Drug|0|||
24995525|NCT02996500|50086487|FG004|Overall Study|Non-Compliance With Study Drug|0|||
24995526|NCT02996500|50086488|FG005|Overall Study|Non-Compliance With Study Drug|1|||
24995527|NCT02996500|50086483|FG000|Overall Study|Progressive Disease|1|||
24995528|NCT02996500|50086484|FG001|Overall Study|Progressive Disease|0|||
24995529|NCT02996500|50086485|FG002|Overall Study|Progressive Disease|0|||
24995530|NCT02996500|50086486|FG003|Overall Study|Progressive Disease|0|||
24995531|NCT02996500|50086487|FG004|Overall Study|Progressive Disease|0|||
24995532|NCT02996500|50086488|FG005|Overall Study|Progressive Disease|0|||
24995533|NCT02996500|50086483|FG000|Overall Study|Other|2|||
24995534|NCT02996500|50086484|FG001|Overall Study|Other|0|||
24995535|NCT02996500|50086485|FG002|Overall Study|Other|2|||
24995536|NCT02996500|50086486|FG003|Overall Study|Other|0|||
24995537|NCT02996500|50086487|FG004|Overall Study|Other|0|||
24995538|NCT02996500|50086488|FG005|Overall Study|Other|0|||
24995539|NCT02996500|50086483|FG000|Overall Study|Protocol Violation|0|||
24995540|NCT02996500|50086484|FG001|Overall Study|Protocol Violation|0|||
24995541|NCT02996500|50086485|FG002|Overall Study|Protocol Violation|0|||
24995542|NCT02996500|50086486|FG003|Overall Study|Protocol Violation|1|||
24995543|NCT02996500|50086487|FG004|Overall Study|Protocol Violation|0|||
24995544|NCT02996500|50086488|FG005|Overall Study|Protocol Violation|0|||
24995545|NCT02996500|50086483|FG000|Overall Study|Withdrawal by Subject|3|||
24995546|NCT02996500|50086484|FG001|Overall Study|Withdrawal by Subject|0|||
24995547|NCT02996500|50086485|FG002|Overall Study|Withdrawal by Subject|3|||
24995548|NCT02996500|50086486|FG003|Overall Study|Withdrawal by Subject|0|||
24995549|NCT02996500|50086487|FG004|Overall Study|Withdrawal by Subject|2|||
24995550|NCT02996500|50086488|FG005|Overall Study|Withdrawal by Subject|0|||
24995551|NCT00006489|50086510|FG000|Overall Study|Adverse Event|3|||
24995552|NCT00006489|50086511|FG001|Overall Study|Adverse Event|2|||
24995553|NCT00006489|50086512|FG002|Overall Study|Adverse Event|4|||
24995554|NCT00006489|50086513|FG003|Overall Study|Adverse Event|3|||
24995555|NCT00006489|50086510|FG000|Overall Study|Withdrawal by Subject|10|||
24995556|NCT00006489|50086511|FG001|Overall Study|Withdrawal by Subject|9|||
24995557|NCT00006489|50086512|FG002|Overall Study|Withdrawal by Subject|9|||
24995558|NCT00006489|50086513|FG003|Overall Study|Withdrawal by Subject|6|||
24995559|NCT00006489|50086510|FG000|Overall Study|Scheduling Conflict|0|||
24995560|NCT00006489|50086511|FG001|Overall Study|Scheduling Conflict|3|||
24995561|NCT00006489|50086512|FG002|Overall Study|Scheduling Conflict|2|||
24995562|NCT00006489|50086513|FG003|Overall Study|Scheduling Conflict|1|||
24995563|NCT00006489|50086510|FG000|Overall Study|Death|0|||
24995564|NCT00006489|50086511|FG001|Overall Study|Death|0|||
24995565|NCT00006489|50086512|FG002|Overall Study|Death|0|||
24995566|NCT00006489|50086513|FG003|Overall Study|Death|1|||
24995567|NCT03535974|50086526|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
24995568|NCT03535974|50086527|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
24995569|NCT03535974|50086528|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
24995570|NCT03535974|50086526|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
24995571|NCT03535974|50086527|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
24995572|NCT03535974|50086528|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
24995573|NCT00025233|50086536|FG000|Overall Study|Ineligible: wrong cell type|1|||
24995574|NCT00025233|50086536|FG000|Overall Study|Ineligible: wrong primary|1|||
24995575|NCT00025233|50086536|FG000|Overall Study|Ineligible: improper prior treatment|1|||
24995576|NCT00025233|50086536|FG000|Overall Study|Never treated|1|||
24995577|NCT03535740|50086546|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
24995578|NCT03535740|50086546|FG000|Overall Study|Death|34|||
24995579|NCT03535740|50086546|FG000|Overall Study|Lost to Follow-up|1|||
24995580|NCT03535740|50086546|FG000|Overall Study|Withdrawal by Subject|13|||
24995581|NCT00025155|50086551|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
24995582|NCT00025155|50086551|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
24995583|NCT02998996|50086566|FG000|Overall Study|Lost to Follow-up|0|||
24995584|NCT02998996|50086567|FG001|Overall Study|Lost to Follow-up|0|||
24995585|NCT02998996|50086568|FG002|Overall Study|Lost to Follow-up|1|||
24995586|NCT02998996|50086569|FG003|Overall Study|Lost to Follow-up|0|||
24995587|NCT02998996|50086570|FG004|Overall Study|Lost to Follow-up|0|||
24995588|NCT02998996|50086571|FG005|Overall Study|Lost to Follow-up|0|||
24995589|NCT02998996|50086566|FG000|Overall Study|Pregnancy|0|||
24995590|NCT02998996|50086567|FG001|Overall Study|Pregnancy|1|||
24995591|NCT02998996|50086568|FG002|Overall Study|Pregnancy|0|||
24995592|NCT02998996|50086569|FG003|Overall Study|Pregnancy|0|||
24995593|NCT02998996|50086570|FG004|Overall Study|Pregnancy|0|||
24995594|NCT02998996|50086571|FG005|Overall Study|Pregnancy|0|||
24995595|NCT02998996|50086566|FG000|Overall Study|Family reasons|0|||
24995596|NCT02998996|50086567|FG001|Overall Study|Family reasons|0|||
24995597|NCT02998996|50086568|FG002|Overall Study|Family reasons|0|||
24995598|NCT02998996|50086569|FG003|Overall Study|Family reasons|0|||
24995599|NCT02998996|50086570|FG004|Overall Study|Family reasons|1|||
24995600|NCT02998996|50086571|FG005|Overall Study|Family reasons|0|||
24995601|NCT02994940|50086587|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
24995602|NCT02994940|50086588|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
24995603|NCT02994940|50086587|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
24995604|NCT02994940|50086588|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
24995605|NCT02994940|50086587|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
24995606|NCT02994940|50086588|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
24995607|NCT02994394|50086596|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
24995608|NCT02994394|50086597|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
24995609|NCT02994394|50086598|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
24995610|NCT02994394|50086599|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
24995611|NCT02994394|50086600|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
24995612|NCT02994394|50086601|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
24995613|NCT02994394|50086596|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
24995614|NCT02994394|50086597|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
24995615|NCT02994394|50086598|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
24995616|NCT02994394|50086599|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
24995617|NCT02994394|50086600|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
24995618|NCT02994394|50086601|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
24995619|NCT02998840|50086619|FG000|Overall Study|Lost to Follow-up|1|||
24995620|NCT02998840|50086620|FG001|Overall Study|Lost to Follow-up|1|||
24995621|NCT02998840|50086621|FG002|Overall Study|Lost to Follow-up|2|||
24995622|NCT02998840|50086622|FG003|Overall Study|Lost to Follow-up|3|||
24995623|NCT02998840|50086619|FG000|Overall Study|Withdrawal by Subject|1|||
24995624|NCT02998840|50086620|FG001|Overall Study|Withdrawal by Subject|1|||
24995625|NCT02998840|50086621|FG002|Overall Study|Withdrawal by Subject|0|||
24995626|NCT02998840|50086622|FG003|Overall Study|Withdrawal by Subject|1|||
24995627|NCT02998840|50086619|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
24995628|NCT02998840|50086620|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
24995629|NCT02998840|50086621|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
24995630|NCT02998840|50086622|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
24995631|NCT00023673|50086633|FG000|Overall Study|Ineligible / no protocol treatment|0|||
24995632|NCT00023673|50086634|FG001|Overall Study|Ineligible / no protocol treatment|0|||
24995633|NCT00023673|50086635|FG002|Overall Study|Ineligible / no protocol treatment|0|||
24995634|NCT00023673|50086636|FG003|Overall Study|Ineligible / no protocol treatment|1|||
24995635|NCT00023673|50086633|FG000|Overall Study|Patient withdrew consent|0|||
24995636|NCT00023673|50086634|FG001|Overall Study|Patient withdrew consent|0|||
24995637|NCT00023673|50086635|FG002|Overall Study|Patient withdrew consent|0|||
24995638|NCT00023673|50086636|FG003|Overall Study|Patient withdrew consent|1|||
24995639|NCT01069900|50086648|FG000|Overall Study|Technical problems|0|||
24995640|NCT01069900|50086649|FG001|Overall Study|Technical problems|1|||
24995641|NCT01069900|50086648|FG000|Overall Study|Lost to Follow-up|7|||
24995642|NCT01069900|50086649|FG001|Overall Study|Lost to Follow-up|1|||
24995643|NCT01069900|50086648|FG000|Overall Study|Withdrawal by Subject|6|||
24995644|NCT01069900|50086649|FG001|Overall Study|Withdrawal by Subject|1|||
24995645|NCT01069900|50086648|FG000|Overall Study|Protocol Violation|4|||
24995646|NCT01069900|50086649|FG001|Overall Study|Protocol Violation|1|||
24995647|NCT01069900|50086648|FG000|Overall Study|Insufficient Therapeutic effect|1|||
24995648|NCT01069900|50086649|FG001|Overall Study|Insufficient Therapeutic effect|0|||
24995649|NCT01069120|50086657|FG000|Overall Study|Study prematurely terminated|27|||
24995650|NCT00006237|50086665|FG000|Overall Study|Adverse Event|39|||
24995651|NCT00006237|50086666|FG001|Overall Study|Adverse Event|29|||
24995652|NCT00006237|50086665|FG000|Overall Study|Death|1|||
24995653|NCT00006237|50086666|FG001|Overall Study|Death|0|||
24995654|NCT00006237|50086665|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
24995655|NCT00006237|50086666|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
24995656|NCT00006237|50086665|FG000|Overall Study|Progression/relapse|54|||
24995657|NCT00006237|50086666|FG001|Overall Study|Progression/relapse|2|||
24995658|NCT00006237|50086665|FG000|Overall Study|Not eligible|9|||
24995659|NCT00006237|50086666|FG001|Overall Study|Not eligible|20|||
24995660|NCT00006237|50086665|FG000|Overall Study|Withdrawal by Subject|0|||
24995661|NCT00006237|50086666|FG001|Overall Study|Withdrawal by Subject|1|||
24995662|NCT00006237|50086665|FG000|Overall Study|Not protocol specified|14|||
24995663|NCT00006237|50086666|FG001|Overall Study|Not protocol specified|5|||
24995664|NCT02993926|50086675|FG000|Enantone Treatment Phase|Adverse Event|1|||
24995665|NCT02993926|50086676|FG001|Enantone Treatment Phase|Adverse Event|0|||
24995666|NCT02993926|50086677|FG002|Enantone Treatment Phase|Adverse Event|0|||
24995667|NCT02993926|50086675|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
24995668|NCT02993926|50086676|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
24995669|NCT02993926|50086677|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
24995670|NCT02993926|50086675|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
24995671|NCT02993926|50086676|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
24995672|NCT02993926|50086677|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
24995673|NCT02993926|50086675|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
24995674|NCT02993926|50086676|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
24995675|NCT02993926|50086677|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
24995676|NCT02993224|50086687|FG000|Core Phase - Period 1|Adverse Event|4|||
24995677|NCT02993224|50086687|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
24995678|NCT02993224|50086687|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
24995679|NCT02993224|50086687|FG000|Core Phase- Period 2|Adverse Event|1|||
24995680|NCT02993224|50086687|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
24995681|NCT02993224|50086687|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
24995682|NCT02993224|50086687|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
24995683|NCT02993224|50086687|FG000|Extension Phase|Adverse Event|3|||
24995684|NCT02993224|50086687|FG000|Extension Phase|Withdrawal by Subject|3|||
24995685|NCT02993224|50086687|FG000|Extension Phase|Lost to Follow-up|2|||
24995686|NCT02993224|50086687|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
24995687|NCT03495908|50086695|FG000|Overall Study|Withdrawal by Subject|3|||
24995688|NCT03495908|50086696|FG001|Overall Study|Withdrawal by Subject|1|||
24995689|NCT03495908|50086695|FG000|Overall Study|Lost to Follow-up|1|||
24995690|NCT03495908|50086696|FG001|Overall Study|Lost to Follow-up|4|||
24995691|NCT03495908|50086695|FG000|Overall Study|Adverse Event|0|||
24995692|NCT03495908|50086696|FG001|Overall Study|Adverse Event|2|||
24995693|NCT03495908|50086695|FG000|Overall Study|Death|1|||
24995694|NCT03495908|50086696|FG001|Overall Study|Death|0|||
24995695|NCT03495908|50086695|FG000|Overall Study|Physician Decision|5|||
24995696|NCT03495908|50086696|FG001|Overall Study|Physician Decision|4|||
24995697|NCT03495908|50086695|FG000|Overall Study|No documented reason|0|||
24995698|NCT03495908|50086696|FG001|Overall Study|No documented reason|2|||
24995699|NCT02992288|50086708|FG000|Overall Study|Adverse Event|8|||
24995700|NCT02992288|50086709|FG001|Overall Study|Adverse Event|2|||
24995701|NCT02992288|50086710|FG002|Overall Study|Adverse Event|2|||
24995702|NCT02992288|50086711|FG003|Overall Study|Adverse Event|2|||
24995703|NCT02992288|50086712|FG004|Overall Study|Adverse Event|2|||
24995704|NCT02992288|50086713|FG005|Overall Study|Adverse Event|7|||
24995705|NCT02992288|50086708|FG000|Overall Study|Non-compliance with study drug|0|||
24995706|NCT02992288|50086709|FG001|Overall Study|Non-compliance with study drug|1|||
24995707|NCT02992288|50086710|FG002|Overall Study|Non-compliance with study drug|1|||
24995708|NCT02992288|50086711|FG003|Overall Study|Non-compliance with study drug|0|||
24995709|NCT02992288|50086712|FG004|Overall Study|Non-compliance with study drug|1|||
24995710|NCT02992288|50086713|FG005|Overall Study|Non-compliance with study drug|0|||
24995711|NCT02992288|50086708|FG000|Overall Study|Physician Decision|3|||
24995712|NCT02992288|50086709|FG001|Overall Study|Physician Decision|0|||
24995713|NCT02992288|50086710|FG002|Overall Study|Physician Decision|1|||
24995714|NCT02992288|50086711|FG003|Overall Study|Physician Decision|0|||
24995715|NCT02992288|50086712|FG004|Overall Study|Physician Decision|0|||
24995716|NCT02992288|50086713|FG005|Overall Study|Physician Decision|1|||
24995717|NCT02992288|50086708|FG000|Overall Study|Death|2|||
24995718|NCT02992288|50086709|FG001|Overall Study|Death|0|||
24995719|NCT02992288|50086710|FG002|Overall Study|Death|2|||
24995720|NCT02992288|50086711|FG003|Overall Study|Death|1|||
24995721|NCT02992288|50086712|FG004|Overall Study|Death|2|||
24995722|NCT02992288|50086713|FG005|Overall Study|Death|0|||
24995723|NCT02992288|50086708|FG000|Overall Study|Lost to Follow-up|0|||
24995724|NCT02992288|50086709|FG001|Overall Study|Lost to Follow-up|0|||
24995725|NCT02992288|50086710|FG002|Overall Study|Lost to Follow-up|0|||
24995726|NCT02992288|50086711|FG003|Overall Study|Lost to Follow-up|1|||
24995727|NCT02992288|50086712|FG004|Overall Study|Lost to Follow-up|0|||
24995728|NCT02992288|50086713|FG005|Overall Study|Lost to Follow-up|0|||
24995729|NCT02992288|50086708|FG000|Overall Study|Protocol Violation|0|||
24995730|NCT02992288|50086709|FG001|Overall Study|Protocol Violation|0|||
24995731|NCT02992288|50086710|FG002|Overall Study|Protocol Violation|0|||
24995732|NCT02992288|50086711|FG003|Overall Study|Protocol Violation|0|||
24995733|NCT02992288|50086712|FG004|Overall Study|Protocol Violation|0|||
24995734|NCT02992288|50086713|FG005|Overall Study|Protocol Violation|1|||
24995735|NCT02992288|50086708|FG000|Overall Study|Withdrawal by Subject|4|||
24995736|NCT02992288|50086709|FG001|Overall Study|Withdrawal by Subject|2|||
24995737|NCT02992288|50086710|FG002|Overall Study|Withdrawal by Subject|1|||
24995738|NCT02992288|50086711|FG003|Overall Study|Withdrawal by Subject|5|||
24995739|NCT02992288|50086712|FG004|Overall Study|Withdrawal by Subject|3|||
24995740|NCT02992288|50086713|FG005|Overall Study|Withdrawal by Subject|4|||
24995741|NCT02953262|50086731|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
24995742|NCT02953262|50086732|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
24995743|NCT02953262|50086733|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
24995744|NCT02953262|50086734|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
24995745|NCT02992132|50086751|FG000|Overall Study|Adverse Event|4|||
24995746|NCT02992132|50086752|FG001|Overall Study|Adverse Event|1|||
24995747|NCT02992132|50086753|FG002|Overall Study|Adverse Event|3|||
24995748|NCT02992132|50086751|FG000|Overall Study|Lack of Efficacy|2|||
24995749|NCT02992132|50086752|FG001|Overall Study|Lack of Efficacy|0|||
24995750|NCT02992132|50086753|FG002|Overall Study|Lack of Efficacy|0|||
24995751|NCT02992132|50086751|FG000|Overall Study|Non-compliance with study drug|2|||
24995752|NCT02992132|50086752|FG001|Overall Study|Non-compliance with study drug|0|||
24995753|NCT02992132|50086753|FG002|Overall Study|Non-compliance with study drug|0|||
24995754|NCT02992132|50086751|FG000|Overall Study|Progressive disease|1|||
24995755|NCT02992132|50086752|FG001|Overall Study|Progressive disease|0|||
24995756|NCT02992132|50086753|FG002|Overall Study|Progressive disease|0|||
24995757|NCT02992132|50086751|FG000|Overall Study|Protocol Violation|2|||
24995758|NCT02992132|50086752|FG001|Overall Study|Protocol Violation|2|||
24995759|NCT02992132|50086753|FG002|Overall Study|Protocol Violation|0|||
24995760|NCT02992132|50086751|FG000|Overall Study|Caregiver withdrew consent|2|||
24995761|NCT02992132|50086752|FG001|Overall Study|Caregiver withdrew consent|3|||
24995762|NCT02992132|50086753|FG002|Overall Study|Caregiver withdrew consent|2|||
24995763|NCT02992132|50086751|FG000|Overall Study|Withdrawal by Subject|0|||
24995764|NCT02992132|50086752|FG001|Overall Study|Withdrawal by Subject|2|||
24995765|NCT02992132|50086753|FG002|Overall Study|Withdrawal by Subject|1|||
24995766|NCT02992132|50086751|FG000|Overall Study|Physician Decision|0|||
24995767|NCT02992132|50086752|FG001|Overall Study|Physician Decision|0|||
24995768|NCT02992132|50086753|FG002|Overall Study|Physician Decision|1|||
24995769|NCT03444584|50086763|FG000|Overall Study|Withdrawal by Subject|0|||
24995770|NCT03444584|50086764|FG001|Overall Study|Withdrawal by Subject|1|||
24995771|NCT03444584|50086763|FG000|Overall Study|Other|0|||
24995772|NCT03444584|50086764|FG001|Overall Study|Other|1|||
24995773|NCT02989168|50086773|FG000|Overall Study|Withdrawal by Subject|2|||
24995774|NCT02989168|50086774|FG001|Overall Study|Withdrawal by Subject|0|||
24995775|NCT02989168|50086773|FG000|Overall Study|Physician Decision|0|||
24995776|NCT02989168|50086774|FG001|Overall Study|Physician Decision|1|||
24995777|NCT02989168|50086773|FG000|Overall Study|Adverse Event|1|||
24995778|NCT02989168|50086774|FG001|Overall Study|Adverse Event|2|||
24995779|NCT02989168|50086773|FG000|Overall Study|Sponsor stopped study.|1|||
24995780|NCT02989168|50086774|FG001|Overall Study|Sponsor stopped study.|0|||
24995781|NCT02988622|50086782|FG000|Overall Study|Lost to Follow-up|17|||
24995782|NCT03412604|50086788|FG000|Overall Study|Withdrawal by Subject|1|||
24995783|NCT02991430|50086795|FG000|Treatment Period 1|Adverse Event|1|||
24995784|NCT02991430|50086796|FG001|Treatment Period 1|Adverse Event|0|||
24995785|NCT02991430|50086797|FG002|Treatment Period 1|Adverse Event|2|||
24995786|NCT02991430|50086795|FG000|Treatment Period 1|Withdrawal by Subject|0|||
24995787|NCT02991430|50086796|FG001|Treatment Period 1|Withdrawal by Subject|4|||
24995788|NCT02991430|50086797|FG002|Treatment Period 1|Withdrawal by Subject|0|||
24995789|NCT02991430|50086795|FG000|Treatment Period 2|Study Termination|6|||
24995790|NCT02991430|50086796|FG001|Treatment Period 2|Study Termination|3|||
24995791|NCT02991430|50086797|FG002|Treatment Period 2|Study Termination|3|||
24995792|NCT02991430|50086795|FG000|Treatment Period 2|Lost to Follow-up|0|||
24995793|NCT02991430|50086796|FG001|Treatment Period 2|Lost to Follow-up|0|||
24995794|NCT02991430|50086797|FG002|Treatment Period 2|Lost to Follow-up|1|||
24995795|NCT02991430|50086795|FG000|Post-treatment Observation Period|Study Termination|3|||
24995796|NCT02991430|50086796|FG001|Post-treatment Observation Period|Study Termination|6|||
24995797|NCT02991430|50086797|FG002|Post-treatment Observation Period|Study Termination|5|||
24995798|NCT03411902|50086807|FG000|Overall Study|Lost to Follow-up|3|||
24995799|NCT03411902|50086808|FG001|Overall Study|Lost to Follow-up|0|||
24995800|NCT03494816|50086814|FG000|Overall Study|Protocol Violation|2|||
24995801|NCT03494816|50086814|FG000|Overall Study|Physician Decision|2|||
24995802|NCT03494816|50086814|FG000|Overall Study|Did not start trial treatment|1|||
24995803|NCT03494816|50086814|FG000|Overall Study|Adverse Event|1|||
24995804|NCT03492554|50086824|FG000|Overall Study|Protocol Violation|0|||
24995805|NCT03492554|50086825|FG001|Overall Study|Protocol Violation|14|||
24995806|NCT03443414|50086837|FG000|Overall Study|Adverse Event|6|||
24995807|NCT03443414|50086838|FG001|Overall Study|Adverse Event|0|||
24995808|NCT03443414|50086839|FG002|Overall Study|Adverse Event|4|||
24995809|NCT03443414|50086840|FG003|Overall Study|Adverse Event|2|||
24995810|NCT03443414|50086841|FG004|Overall Study|Adverse Event|3|||
24995811|NCT03443414|50086837|FG000|Overall Study|Withdrawal by Subject|3|||
24995812|NCT03443414|50086838|FG001|Overall Study|Withdrawal by Subject|2|||
24995813|NCT03443414|50086839|FG002|Overall Study|Withdrawal by Subject|2|||
24995814|NCT03443414|50086840|FG003|Overall Study|Withdrawal by Subject|2|||
24995815|NCT03443414|50086841|FG004|Overall Study|Withdrawal by Subject|1|||
24995816|NCT03443414|50086837|FG000|Overall Study|Death|0|||
24995817|NCT03443414|50086838|FG001|Overall Study|Death|1|||
24995818|NCT03443414|50086839|FG002|Overall Study|Death|0|||
24995819|NCT03443414|50086840|FG003|Overall Study|Death|1|||
24995820|NCT03443414|50086841|FG004|Overall Study|Death|0|||
24995821|NCT03443414|50086837|FG000|Overall Study|Reason not specified|2|||
24995822|NCT03443414|50086838|FG001|Overall Study|Reason not specified|0|||
24995823|NCT03443414|50086839|FG002|Overall Study|Reason not specified|0|||
24995824|NCT03443414|50086840|FG003|Overall Study|Reason not specified|0|||
24995825|NCT03443414|50086841|FG004|Overall Study|Reason not specified|1|||
24995826|NCT02991118|50086855|FG000|Overall Study|Death|3|||
24995827|NCT02991118|50086856|FG001|Overall Study|Death|8|||
24995828|NCT02991118|50086855|FG000|Overall Study|Protocol Violation|0|||
24995829|NCT02991118|50086856|FG001|Overall Study|Protocol Violation|3|||
24995830|NCT02991118|50086855|FG000|Overall Study|Physician Decision|0|||
24995831|NCT02991118|50086856|FG001|Overall Study|Physician Decision|1|||
24995832|NCT02991118|50086855|FG000|Overall Study|Moved out of the country|0|||
24995833|NCT02991118|50086856|FG001|Overall Study|Moved out of the country|1|||
24995834|NCT02991118|50086855|FG000|Overall Study|Adverse Event|2|||
24995835|NCT02991118|50086856|FG001|Overall Study|Adverse Event|2|||
24995836|NCT02991118|50086855|FG000|Overall Study|Withdrawal by Subject|1|||
24995837|NCT02991118|50086856|FG001|Overall Study|Withdrawal by Subject|7|||
24995838|NCT02991118|50086855|FG000|Overall Study|Could not attend study visits|0|||
24995839|NCT02991118|50086856|FG001|Overall Study|Could not attend study visits|1|||
24995840|NCT02991118|50086855|FG000|Overall Study|Lost to Follow-up|1|||
24995841|NCT02991118|50086856|FG001|Overall Study|Lost to Follow-up|9|||
24995842|NCT03491150|50086864|FG000|Overall Study|Adverse Event|1|||
24995843|NCT03491150|50086865|FG001|Overall Study|Adverse Event|0|||
24995844|NCT03491150|50086864|FG000|Overall Study|Study Terminated by Sponsor|74|||
24995845|NCT03491150|50086865|FG001|Overall Study|Study Terminated by Sponsor|70|||
24995846|NCT03491150|50086864|FG000|Overall Study|Other|0|||
24995847|NCT03491150|50086865|FG001|Overall Study|Other|1|||
24995848|NCT03491150|50086864|FG000|Overall Study|Withdrawal by Subject|1|||
24995849|NCT03491150|50086865|FG001|Overall Study|Withdrawal by Subject|2|||
24995850|NCT02991040|50086871|FG000|Overall Study|Withdrawal by Subject|2|||
24995851|NCT02991040|50086871|FG000|Overall Study|Lost to Follow-up|2|||
24995852|NCT02910466|50086877|FG000|Overall Study|Adverse Event|1|||
24995853|NCT02910466|50086877|FG000|Overall Study|Withdrawal by Subject|3|||
24995854|NCT02910466|50086877|FG000|Overall Study|Lost to Follow-up|5|||
24995855|NCT02910466|50086877|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
24995856|NCT02910466|50086877|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
24995857|NCT03415178|50086883|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
24995858|NCT03415178|50086884|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
24995859|NCT03415178|50086883|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
24995860|NCT03415178|50086884|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
24995861|NCT01068730|50086894|FG000|Period 3|Personal reason|1|||
24995862|NCT01068730|50086895|FG001|Period 3|Personal reason|0|||
24995863|NCT01068730|50086896|FG002|Period 3|Personal reason|0|||
24995864|NCT01068730|50086897|FG003|Period 3|Personal reason|0|||
24995865|NCT01068730|50086894|FG000|Period 4|Family emergency|0|||
24995866|NCT01068730|50086895|FG001|Period 4|Family emergency|1|||
24995867|NCT01068730|50086896|FG002|Period 4|Family emergency|0|||
24995868|NCT01068730|50086897|FG003|Period 4|Family emergency|0|||
24995869|NCT01068652|50086916|FG000|Overall Study|Adverse Event|4|||
24995870|NCT01068652|50086917|FG001|Overall Study|Adverse Event|0|||
24995871|NCT01068652|50086916|FG000|Overall Study|Lack of Efficacy|0|||
24995872|NCT01068652|50086917|FG001|Overall Study|Lack of Efficacy|2|||
24995873|NCT01068652|50086916|FG000|Overall Study|Lost to Follow-up|2|||
24995874|NCT01068652|50086917|FG001|Overall Study|Lost to Follow-up|1|||
24995875|NCT01068652|50086916|FG000|Overall Study|Protocol Violation|3|||
24995876|NCT01068652|50086917|FG001|Overall Study|Protocol Violation|6|||
24995877|NCT01068652|50086916|FG000|Overall Study|Withdrawal criteria|1|||
24995878|NCT01068652|50086917|FG001|Overall Study|Withdrawal criteria|2|||
24995879|NCT01068652|50086916|FG000|Overall Study|Patient was not eligible|1|||
24995880|NCT01068652|50086917|FG001|Overall Study|Patient was not eligible|0|||
24995881|NCT01068652|50086916|FG000|Overall Study|Unclassified|7|||
24995882|NCT01068652|50086917|FG001|Overall Study|Unclassified|4|||
24995883|NCT02921776|50086929|FG000|Overall Study|patient deterioration, fatigue|2|||
24995884|NCT02921776|50086930|FG001|Overall Study|patient deterioration, fatigue|6|||
24995885|NCT02921776|50086931|FG002|Overall Study|patient deterioration, fatigue|0|||
24995886|NCT02921776|50086932|FG003|Overall Study|patient deterioration, fatigue|0|||
24995887|NCT02921776|50086933|FG004|Overall Study|patient deterioration, fatigue|0|||
24995888|NCT02921776|50086934|FG005|Overall Study|patient deterioration, fatigue|0|||
24995889|NCT02921776|50086935|FG006|Overall Study|patient deterioration, fatigue|0|||
24995890|NCT02921776|50086936|FG007|Overall Study|patient deterioration, fatigue|0|||
24995891|NCT02921776|50086929|FG000|Overall Study|Withdrawal by Subject|0|||
24995892|NCT02921776|50086930|FG001|Overall Study|Withdrawal by Subject|2|||
24995893|NCT02921776|50086931|FG002|Overall Study|Withdrawal by Subject|0|||
24995894|NCT02921776|50086932|FG003|Overall Study|Withdrawal by Subject|1|||
24995895|NCT02921776|50086933|FG004|Overall Study|Withdrawal by Subject|1|||
24995896|NCT02921776|50086934|FG005|Overall Study|Withdrawal by Subject|0|||
24995897|NCT02921776|50086935|FG006|Overall Study|Withdrawal by Subject|8|||
24995898|NCT02921776|50086936|FG007|Overall Study|Withdrawal by Subject|1|||
24995899|NCT02921776|50086929|FG000|Overall Study|Death|0|||
24995900|NCT02921776|50086930|FG001|Overall Study|Death|0|||
24995901|NCT02921776|50086931|FG002|Overall Study|Death|0|||
24995902|NCT02921776|50086932|FG003|Overall Study|Death|2|||
24995903|NCT02921776|50086933|FG004|Overall Study|Death|0|||
24995904|NCT02921776|50086934|FG005|Overall Study|Death|0|||
24995905|NCT02921776|50086935|FG006|Overall Study|Death|0|||
24995906|NCT02921776|50086936|FG007|Overall Study|Death|0|||
24995907|NCT02921776|50086929|FG000|Overall Study|extubation or early discharge|0|||
24995908|NCT02921776|50086930|FG001|Overall Study|extubation or early discharge|0|||
24995909|NCT02921776|50086931|FG002|Overall Study|extubation or early discharge|0|||
24995910|NCT02921776|50086932|FG003|Overall Study|extubation or early discharge|5|||
24995911|NCT02921776|50086933|FG004|Overall Study|extubation or early discharge|5|||
24995912|NCT02921776|50086934|FG005|Overall Study|extubation or early discharge|0|||
24995913|NCT02921776|50086935|FG006|Overall Study|extubation or early discharge|0|||
24995914|NCT02921776|50086936|FG007|Overall Study|extubation or early discharge|0|||
24995915|NCT02921776|50086929|FG000|Overall Study|Lost to Follow-up|0|||
24995916|NCT02921776|50086930|FG001|Overall Study|Lost to Follow-up|0|||
24995917|NCT02921776|50086931|FG002|Overall Study|Lost to Follow-up|0|||
24995918|NCT02921776|50086932|FG003|Overall Study|Lost to Follow-up|0|||
24995919|NCT02921776|50086933|FG004|Overall Study|Lost to Follow-up|0|||
24995920|NCT02921776|50086934|FG005|Overall Study|Lost to Follow-up|2|||
24995921|NCT02921776|50086935|FG006|Overall Study|Lost to Follow-up|3|||
24995922|NCT02921776|50086936|FG007|Overall Study|Lost to Follow-up|6|||
24995923|NCT02922634|50086960|FG000|Overall Study|Withdrawal by Subject|5|||
24995924|NCT02922634|50086960|FG000|Overall Study|Did not have their surgery|5|||
24995925|NCT00023595|50086976|FG000|5 Year Follow up|Lost to Follow-up|2|||
24995926|NCT00023595|50086977|FG001|5 Year Follow up|Lost to Follow-up|2|||
24995927|NCT00023595|50086978|FG002|5 Year Follow up|Lost to Follow-up|1|||
24995928|NCT00023595|50086979|FG003|5 Year Follow up|Lost to Follow-up|7|||
24995929|NCT00023595|50086980|FG004|5 Year Follow up|Lost to Follow-up|3|||
24995930|NCT00023595|50086976|FG000|10 Year Follow up|Lost to Follow-up|12|||
24995931|NCT00023595|50086977|FG001|10 Year Follow up|Lost to Follow-up|10|||
24995932|NCT00023595|50086978|FG002|10 Year Follow up|Lost to Follow-up|3|||
24995933|NCT00023595|50086979|FG003|10 Year Follow up|Lost to Follow-up|0|||
24995934|NCT00023595|50086980|FG004|10 Year Follow up|Lost to Follow-up|0|||
24995935|NCT02920528|50087006|FG000|Overall Study|Incomplete Data|1|||
24995936|NCT02920528|50087007|FG001|Overall Study|Incomplete Data|1|||
24995937|NCT02920528|50087008|FG002|Overall Study|Incomplete Data|1|||
24995938|NCT02920528|50087006|FG000|Overall Study|Adverse Event|0|||
24995939|NCT02920528|50087007|FG001|Overall Study|Adverse Event|0|||
24995940|NCT02920528|50087008|FG002|Overall Study|Adverse Event|3|||
24995941|NCT02920528|50087006|FG000|Overall Study|Did not meet inclusion criteria|2|||
24995942|NCT02920528|50087007|FG001|Overall Study|Did not meet inclusion criteria|0|||
24995943|NCT02920528|50087008|FG002|Overall Study|Did not meet inclusion criteria|1|||
24995944|NCT01068418|50087016|FG000|Overall Study|Physician Decision|12|||
24995945|NCT01068262|50087024|FG000|Overall Study|Adverse Event|2|||
24995946|NCT01068262|50087025|FG001|Overall Study|Adverse Event|0|||
24995947|NCT01068262|50087026|FG002|Overall Study|Adverse Event|1|||
24995948|NCT01068262|50087027|FG003|Overall Study|Adverse Event|0|||
24995949|NCT01068262|50087024|FG000|Overall Study|Protocol Violation|1|||
24995950|NCT01068262|50087025|FG001|Overall Study|Protocol Violation|0|||
24995951|NCT01068262|50087026|FG002|Overall Study|Protocol Violation|0|||
24995952|NCT01068262|50087027|FG003|Overall Study|Protocol Violation|0|||
24995953|NCT01068262|50087024|FG000|Overall Study|Withdrawal by Subject|0|||
24995954|NCT01068262|50087025|FG001|Overall Study|Withdrawal by Subject|1|||
24995955|NCT01068262|50087026|FG002|Overall Study|Withdrawal by Subject|0|||
24995956|NCT01068262|50087027|FG003|Overall Study|Withdrawal by Subject|0|||
24995957|NCT02920450|50087040|FG000|Overall Study|Death|1|||
24995958|NCT02920450|50087041|FG001|Overall Study|Death|0|||
24995959|NCT02920450|50087042|FG002|Overall Study|Death|0|||
24995960|NCT02920450|50087043|FG003|Overall Study|Death|0|||
24995961|NCT02920450|50087040|FG000|Overall Study|Withdrawal by Subject|1|||
24995962|NCT02920450|50087041|FG001|Overall Study|Withdrawal by Subject|0|||
24995963|NCT02920450|50087042|FG002|Overall Study|Withdrawal by Subject|0|||
24995964|NCT02920450|50087043|FG003|Overall Study|Withdrawal by Subject|0|||
24995965|NCT01066936|50087054|FG000|Overall Study|Death|2|||
24995966|NCT01066936|50087054|FG000|Overall Study|Device revised/removed|1|||
24995967|NCT01066936|50087054|FG000|Overall Study|Lost to Follow-up|3|||
24995968|NCT01066936|50087054|FG000|Overall Study|Withdrawal by Subject|4|||
24995969|NCT02919436|50087062|FG000|Overall Study|Did not undergo surgery|16|||
24995970|NCT02919436|50087063|FG001|Overall Study|Did not undergo surgery|20|||
24995971|NCT02919436|50087062|FG000|Overall Study|Enrolled before trial registration|44|||
24995972|NCT02919436|50087063|FG001|Overall Study|Enrolled before trial registration|33|||
24995973|NCT03804879|50087073|FG000|Overall Study|Adverse Event|3|||
24995974|NCT03804879|50087074|FG001|Overall Study|Adverse Event|0|||
24995975|NCT03804879|50087073|FG000|Overall Study|Study Terminated By Sponsor|10|||
24995976|NCT03804879|50087074|FG001|Overall Study|Study Terminated By Sponsor|12|||
24995977|NCT03804879|50087073|FG000|Overall Study|Withdrawal by Subject|3|||
24995978|NCT03804879|50087074|FG001|Overall Study|Withdrawal by Subject|1|||
24995979|NCT03803475|50087081|FG000|Overall Study|Physician Decision|1|||
24995980|NCT00005937|50087085|FG000|Overall Study|Lack of Efficacy|5|||
24995981|NCT03443024|50087093|FG000|Overall Study|Adverse Event|2|||
24995982|NCT03443024|50087094|FG001|Overall Study|Adverse Event|4|||
24995983|NCT03443024|50087095|FG002|Overall Study|Adverse Event|3|||
24995984|NCT03443024|50087096|FG003|Overall Study|Adverse Event|1|||
24995985|NCT03443024|50087093|FG000|Overall Study|Lost to Follow-up|9|||
24995986|NCT03443024|50087094|FG001|Overall Study|Lost to Follow-up|9|||
24995987|NCT03443024|50087095|FG002|Overall Study|Lost to Follow-up|7|||
24995988|NCT03443024|50087096|FG003|Overall Study|Lost to Follow-up|5|||
24995989|NCT03443024|50087093|FG000|Overall Study|Withdrawal by Subject|8|||
24995990|NCT03443024|50087094|FG001|Overall Study|Withdrawal by Subject|15|||
25083991|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
25083992|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
25083993|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
25083994|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
25083995|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
25083996|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
25083997|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
25083998|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
25083999|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
25084000|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
25084001|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
25084002|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
25084003|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
25084004|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
25084005|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
25084006|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
25084007|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
25084008|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
25084009|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
25084010|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
25084011|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
25084012|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
25084013|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
25084014|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
25084015|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
25084016|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
25084017|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
25084018|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
25084019|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
25084020|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
25084021|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
25084022|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
25084023|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
25084024|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
25084025|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
25084026|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
25084027|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
25084028|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
24995991|NCT03443024|50087095|FG002|Overall Study|Withdrawal by Subject|9|||
24995992|NCT03443024|50087096|FG003|Overall Study|Withdrawal by Subject|23|||
24995993|NCT03443024|50087093|FG000|Overall Study|Physician Decision|1|||
24995994|NCT03443024|50087094|FG001|Overall Study|Physician Decision|2|||
24995995|NCT03443024|50087095|FG002|Overall Study|Physician Decision|0|||
25084029|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
25084030|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
25084031|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
25084032|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
25084033|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
25084034|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
25084035|NCT02717195|50192310|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
25084036|NCT02717195|50192311|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
25084037|NCT02717195|50192312|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
25084038|NCT02717195|50192313|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
25084039|NCT02717195|50192314|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
25084040|NCT02717195|50192310|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
25084041|NCT02717195|50192311|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
25084042|NCT02717195|50192312|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
25084043|NCT02717195|50192313|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
25084044|NCT02717195|50192314|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
25084045|NCT02717195|50192310|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
25084046|NCT02717195|50192311|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
25084047|NCT02717195|50192312|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
25084048|NCT02717195|50192313|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
25084049|NCT02717195|50192314|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
25084050|NCT02717195|50192310|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
25084051|NCT02717195|50192311|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
25084052|NCT02717195|50192312|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
25084053|NCT02717195|50192313|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
25084054|NCT02717195|50192314|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
25084055|NCT02717195|50192310|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
25084056|NCT02717195|50192311|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
25084057|NCT02717195|50192312|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
25084058|NCT02717195|50192313|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
25084059|NCT02717195|50192314|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
25084060|NCT02717195|50192310|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
25084061|NCT02717195|50192311|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
25084062|NCT02717195|50192312|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
25084063|NCT02717195|50192313|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
25084064|NCT02717195|50192314|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
25084065|NCT02717195|50192310|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
25084066|NCT02717195|50192311|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
25084067|NCT02717195|50192312|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
25084068|NCT02717195|50192313|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
25084069|NCT02717195|50192314|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
25084070|NCT02717195|50192310|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
25084071|NCT02717195|50192311|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
25084072|NCT02717195|50192312|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
25084073|NCT02717195|50192313|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
25084074|NCT02717195|50192314|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
25084075|NCT02717195|50192310|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
25084076|NCT02717195|50192311|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
25084077|NCT02717195|50192312|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
25084078|NCT02717195|50192313|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
25084079|NCT02717195|50192314|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
25084080|NCT02717195|50192310|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
25084081|NCT02717195|50192311|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
25084082|NCT02717195|50192312|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
25084083|NCT02717195|50192313|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
25084084|NCT02717195|50192314|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
25084085|NCT02717195|50192310|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
25084086|NCT02717195|50192311|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
25084087|NCT02717195|50192312|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
25084088|NCT02717195|50192313|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
25084089|NCT02717195|50192314|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
25084090|NCT02717195|50192310|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
25084091|NCT02717195|50192311|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
25084092|NCT02717195|50192312|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
25261093|NCT01311648|50575785|FG001|Main Study|Adverse Event|1|||
25084093|NCT02717195|50192313|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
25084094|NCT02717195|50192314|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
25084095|NCT02717195|50192310|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
25084096|NCT02717195|50192311|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
25084097|NCT02717195|50192312|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
25084098|NCT02717195|50192313|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
25084099|NCT02717195|50192314|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
25084100|NCT02717195|50192310|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
25084101|NCT02717195|50192311|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
25084102|NCT02717195|50192312|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
25084103|NCT02717195|50192313|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
25084104|NCT02717195|50192314|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
25084105|NCT02717195|50192310|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
25084106|NCT02717195|50192311|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
25084107|NCT02717195|50192312|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
25084108|NCT02717195|50192313|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
25084109|NCT02717195|50192314|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
25084110|NCT00701441|50192329|FG000|Overall Study|failure in cpap compliance|0|||
25084111|NCT00701441|50192330|FG001|Overall Study|failure in cpap compliance|4|||
25084112|NCT02628873|50192342|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
25084113|NCT02628873|50192343|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
25084114|NCT02628873|50192342|FG000|Second Test (1 Hour)|Physician Decision|1|||
25084115|NCT02628873|50192343|FG001|Second Test (1 Hour)|Physician Decision|0|||
25084116|NCT02629965|50192353|FG000|Period 1|Adverse Event|1|||
25084117|NCT02629965|50192354|FG001|Period 1|Adverse Event|0|||
25084118|NCT02629965|50192353|FG000|Period 1|Unexpected worsening of disease|2|||
25084119|NCT02629965|50192354|FG001|Period 1|Unexpected worsening of disease|0|||
25084120|NCT02629965|50192353|FG000|Period 1|Other than listed above|1|||
25084121|NCT02629965|50192354|FG001|Period 1|Other than listed above|2|||
25084122|NCT02629965|50192353|FG000|Period 2|Adverse Event|1|||
25084123|NCT02629965|50192354|FG001|Period 2|Adverse Event|0|||
25084124|NCT01671111|50192360|FG000|Overall Study|Adverse Event|2|||
25084125|NCT01671111|50192360|FG000|Overall Study|Lack of Efficacy|1|||
25084126|NCT01671111|50192360|FG000|Overall Study|Withdrawal by Subject|2|||
25084127|NCT01671111|50192360|FG000|Overall Study|Physician Decision|1|||
25084128|NCT01671111|50192360|FG000|Overall Study|Other|24|||
25084129|NCT01671345|50192366|FG000|Overall Study|Lost to Follow-up|10|||
25084130|NCT01671345|50192367|FG001|Overall Study|Lost to Follow-up|6|||
25084131|NCT01671345|50192366|FG000|Overall Study|visit with non-participating physician|3|||
25084132|NCT01671345|50192367|FG001|Overall Study|visit with non-participating physician|3|||
25084133|NCT04338321|50192389|FG000|Overall Study|Adverse Event|4|||
25084134|NCT04338321|50192390|FG001|Overall Study|Adverse Event|10|||
25084135|NCT04338321|50192389|FG000|Overall Study|Death|1|||
25084136|NCT04338321|50192390|FG001|Overall Study|Death|1|||
25084137|NCT04338321|50192389|FG000|Overall Study|Lost to Follow-up|4|||
25084138|NCT04338321|50192390|FG001|Overall Study|Lost to Follow-up|9|||
25084139|NCT04338321|50192389|FG000|Overall Study|Withdrawal by Subject|45|||
25084140|NCT04338321|50192390|FG001|Overall Study|Withdrawal by Subject|69|||
25084141|NCT04338321|50192389|FG000|Overall Study|Physician Decision|5|||
25084142|NCT04338321|50192390|FG001|Overall Study|Physician Decision|9|||
25084143|NCT04338321|50192389|FG000|Overall Study|Other|3|||
25084144|NCT04338321|50192390|FG001|Overall Study|Other|10|||
25084145|NCT02487095|50192406|FG000|Dose Expansion|Unable to scan/restage participant|0|||
25084146|NCT02487095|50192407|FG001|Dose Expansion|Unable to scan/restage participant|0|||
25084147|NCT02487095|50192408|FG002|Dose Expansion|Unable to scan/restage participant|0|||
25084148|NCT02487095|50192409|FG003|Dose Expansion|Unable to scan/restage participant|0|||
25084149|NCT02487095|50192410|FG004|Dose Expansion|Unable to scan/restage participant|1|||
25084150|NCT03855137|50192433|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
25084151|NCT03855137|50192434|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
25084152|NCT03855137|50192435|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
25084153|NCT03855137|50192433|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
25084154|NCT03855137|50192434|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
25084155|NCT03855137|50192435|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
25084156|NCT03855137|50192433|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
25084157|NCT03855137|50192434|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
25084158|NCT03855137|50192435|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
25084159|NCT03855137|50192433|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
25084160|NCT03855137|50192434|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
25084161|NCT03855137|50192435|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
25084162|NCT03855137|50192433|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
25261094|NCT01311648|50575784|FG000|Main Study|Inhibitor management|0|||
25084163|NCT03855137|50192434|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
25084164|NCT03855137|50192435|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
25084165|NCT03855137|50192433|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
25084166|NCT03855137|50192434|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
25084167|NCT03855137|50192435|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
25084168|NCT03855137|50192433|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
25084169|NCT03855137|50192434|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
25084170|NCT03855137|50192435|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
25084171|NCT03855137|50192433|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
25084172|NCT03855137|50192434|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
25084173|NCT03855137|50192435|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
25084174|NCT03855137|50192433|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
25084175|NCT03855137|50192434|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
25084176|NCT03855137|50192435|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
25084177|NCT03855137|50192433|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
25084178|NCT03855137|50192434|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
25084179|NCT03855137|50192435|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
25084180|NCT00701363|50192457|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
25084181|NCT00701363|50192458|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
25084182|NCT00701363|50192459|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
25084183|NCT00701363|50192460|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
25084184|NCT00701363|50192457|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
25084185|NCT00701363|50192458|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
25084186|NCT00701363|50192459|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
25084187|NCT00701363|50192460|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
25084188|NCT00701363|50192457|FG000|Treatment Phase 1|Adverse Event|7|||
25084189|NCT00701363|50192458|FG001|Treatment Phase 1|Adverse Event|0|||
25084190|NCT00701363|50192459|FG002|Treatment Phase 1|Adverse Event|0|||
25084191|NCT00701363|50192460|FG003|Treatment Phase 1|Adverse Event|0|||
25084192|NCT00701363|50192457|FG000|Treatment Phase 1|Protocol Violation|1|||
25084193|NCT00701363|50192458|FG001|Treatment Phase 1|Protocol Violation|0|||
25084194|NCT00701363|50192459|FG002|Treatment Phase 1|Protocol Violation|0|||
25084195|NCT00701363|50192460|FG003|Treatment Phase 1|Protocol Violation|0|||
25084196|NCT00701363|50192457|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
25084197|NCT00701363|50192458|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
25084198|NCT00701363|50192459|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
25084199|NCT00701363|50192460|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
25084200|NCT00701363|50192457|FG000|Treatment Phase 1|Lack of Efficacy|1|||
25084201|NCT00701363|50192458|FG001|Treatment Phase 1|Lack of Efficacy|0|||
25084202|NCT00701363|50192459|FG002|Treatment Phase 1|Lack of Efficacy|0|||
25084203|NCT00701363|50192460|FG003|Treatment Phase 1|Lack of Efficacy|0|||
25084204|NCT00701363|50192457|FG000|Treatment Phase 2|Adverse Event|0|||
25084205|NCT00701363|50192458|FG001|Treatment Phase 2|Adverse Event|0|||
25084206|NCT00701363|50192459|FG002|Treatment Phase 2|Adverse Event|1|||
25084207|NCT00701363|50192460|FG003|Treatment Phase 2|Adverse Event|0|||
25084208|NCT00701363|50192457|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
25084209|NCT00701363|50192458|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
25084210|NCT00701363|50192459|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
25084211|NCT00701363|50192460|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
25084212|NCT01670877|50192484|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
25084213|NCT01670877|50192485|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
25084214|NCT01670877|50192486|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
25084215|NCT01670877|50192487|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
25084216|NCT01670877|50192488|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
25084217|NCT01670877|50192489|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
25084218|NCT01670877|50192484|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
25084219|NCT01670877|50192485|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
25084220|NCT01670877|50192486|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
25084221|NCT01670877|50192487|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
25084222|NCT01670877|50192488|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
25084223|NCT01670877|50192489|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
25084224|NCT01670877|50192484|FG000|Part I and Part 2|Grade 2 vomiting|0|||
25084225|NCT01670877|50192485|FG001|Part I and Part 2|Grade 2 vomiting|0|||
25084226|NCT01670877|50192486|FG002|Part I and Part 2|Grade 2 vomiting|0|||
25084227|NCT01670877|50192487|FG003|Part I and Part 2|Grade 2 vomiting|1|||
25084228|NCT01670877|50192488|FG004|Part I and Part 2|Grade 2 vomiting|0|||
25084229|NCT01670877|50192489|FG005|Part I and Part 2|Grade 2 vomiting|0|||
25084230|NCT01670877|50192484|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
25084231|NCT01670877|50192485|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
25084232|NCT01670877|50192486|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
25084233|NCT01670877|50192487|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
25084234|NCT01670877|50192488|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
25084235|NCT01670877|50192489|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
25084236|NCT01670877|50192484|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
25084237|NCT01670877|50192485|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
25172374|NCT01748825|50311827|FG006|Dose Expansion|Refused further treatment|0|||
25172375|NCT01748825|50311828|FG007|Dose Expansion|Refused further treatment|0|||
25172376|NCT01748825|50311829|FG008|Dose Expansion|Refused further treatment|1|||
25172377|NCT01748825|50311830|FG009|Dose Expansion|Refused further treatment|1|||
25172378|NCT01748825|50311821|FG000|Dose Expansion|Switched to alternative treatment|0|||
25172379|NCT01748825|50311822|FG001|Dose Expansion|Switched to alternative treatment|0|||
25172380|NCT01748825|50311823|FG002|Dose Expansion|Switched to alternative treatment|0|||
25172381|NCT01748825|50311824|FG003|Dose Expansion|Switched to alternative treatment|0|||
25172382|NCT01748825|50311825|FG004|Dose Expansion|Switched to alternative treatment|0|||
25172383|NCT01748825|50311826|FG005|Dose Expansion|Switched to alternative treatment|0|||
25172384|NCT01748825|50311827|FG006|Dose Expansion|Switched to alternative treatment|0|||
25172385|NCT01748825|50311828|FG007|Dose Expansion|Switched to alternative treatment|0|||
25172386|NCT01748825|50311829|FG008|Dose Expansion|Switched to alternative treatment|0|||
25172387|NCT01748825|50311830|FG009|Dose Expansion|Switched to alternative treatment|1|||
25172388|NCT01748825|50311821|FG000|Dose Expansion|Adverse Event|0|||
25172389|NCT01748825|50311822|FG001|Dose Expansion|Adverse Event|0|||
25172390|NCT01748825|50311823|FG002|Dose Expansion|Adverse Event|0|||
25172391|NCT01748825|50311824|FG003|Dose Expansion|Adverse Event|0|||
25172392|NCT01748825|50311825|FG004|Dose Expansion|Adverse Event|0|||
25172393|NCT01748825|50311826|FG005|Dose Expansion|Adverse Event|0|||
25172394|NCT01748825|50311827|FG006|Dose Expansion|Adverse Event|0|||
25172395|NCT01748825|50311828|FG007|Dose Expansion|Adverse Event|0|||
25172396|NCT01748825|50311829|FG008|Dose Expansion|Adverse Event|0|||
25172397|NCT01748825|50311830|FG009|Dose Expansion|Adverse Event|3|||
25172398|NCT01748825|50311821|FG000|Dose Expansion|Physician Decision|0|||
25172399|NCT01748825|50311822|FG001|Dose Expansion|Physician Decision|0|||
25172400|NCT01748825|50311823|FG002|Dose Expansion|Physician Decision|0|||
25172401|NCT01748825|50311824|FG003|Dose Expansion|Physician Decision|0|||
25172402|NCT01748825|50311825|FG004|Dose Expansion|Physician Decision|0|||
25172403|NCT01748825|50311826|FG005|Dose Expansion|Physician Decision|0|||
25172404|NCT01748825|50311827|FG006|Dose Expansion|Physician Decision|0|||
25172405|NCT01748825|50311828|FG007|Dose Expansion|Physician Decision|0|||
25172406|NCT01748825|50311829|FG008|Dose Expansion|Physician Decision|1|||
25172407|NCT01748825|50311830|FG009|Dose Expansion|Physician Decision|0|||
25172408|NCT01720667|50311892|FG000|Overall Study|Adverse Event|1|||
25172409|NCT01720667|50311893|FG001|Overall Study|Adverse Event|1|||
25172410|NCT01720667|50311892|FG000|Overall Study|Withdrawal by Subject|3|||
25172411|NCT01720667|50311893|FG001|Overall Study|Withdrawal by Subject|0|||
25172412|NCT01720043|50311901|FG000|Overall Study|Withdrawal by Subject|1|||
25172413|NCT00700752|50311905|FG000|First Intervention|Withdrawal by Subject|0|||
25172414|NCT00700752|50311906|FG001|First Intervention|Withdrawal by Subject|2|||
25172415|NCT01747811|50311923|FG000|Overall Study|Lack of Efficacy|2|||
25172416|NCT01747811|50311924|FG001|Overall Study|Lack of Efficacy|4|||
25172417|NCT01747655|50311932|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
25172418|NCT01747655|50311933|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
25172419|NCT01747655|50311932|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
25172420|NCT01747655|50311933|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
25172421|NCT01747655|50311932|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
25172422|NCT01747655|50311933|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
25172423|NCT01718483|50311941|FG000|Overall Study|Withdrawal by Subject|14|||
25172424|NCT01718483|50311942|FG001|Overall Study|Withdrawal by Subject|12|||
25172425|NCT01718483|50311941|FG000|Overall Study|Adverse Event|5|||
25172426|NCT01718483|50311942|FG001|Overall Study|Adverse Event|12|||
25172427|NCT01718483|50311941|FG000|Overall Study|Lost to Follow-up|8|||
25172428|NCT01718483|50311942|FG001|Overall Study|Lost to Follow-up|3|||
25172429|NCT01718483|50311941|FG000|Overall Study|Protocol Violation|4|||
25172430|NCT01718483|50311942|FG001|Overall Study|Protocol Violation|2|||
25172431|NCT01718483|50311941|FG000|Overall Study|Other|1|||
25172432|NCT01718483|50311942|FG001|Overall Study|Other|4|||
25172433|NCT01718483|50311941|FG000|Overall Study|Pregnancy|1|||
25172434|NCT01718483|50311942|FG001|Overall Study|Pregnancy|1|||
25172435|NCT01718483|50311941|FG000|Overall Study|Lack of Efficacy|1|||
25172436|NCT01718483|50311942|FG001|Overall Study|Lack of Efficacy|0|||
25172437|NCT01717859|50311948|FG000|Overall Study|Adverse Event|5|||
25261095|NCT01311648|50575785|FG001|Main Study|Inhibitor management|17|||
25084238|NCT01670877|50192486|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
25084239|NCT01670877|50192487|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
25084240|NCT01670877|50192488|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
25172438|NCT01717859|50311948|FG000|Overall Study|Moved out of state|1|||
25172439|NCT01717859|50311948|FG000|Overall Study|Patient concerned about mental health|1|||
25084241|NCT01670877|50192489|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
25084242|NCT00701129|50192503|FG000|Overall Study|Death|2|||
25084243|NCT01670721|50192507|FG000|Overall Study|Participant's decision|15|||
25084244|NCT01670721|50192507|FG000|Overall Study|Other than specified above|38|||
25084245|NCT02711137|50192526|FG000|Overall Study|Death|1|||
25084246|NCT02711137|50192527|FG001|Overall Study|Death|4|||
25084247|NCT02711137|50192528|FG002|Overall Study|Death|5|||
25084248|NCT02711137|50192529|FG003|Overall Study|Death|5|||
25084249|NCT02711137|50192530|FG004|Overall Study|Death|3|||
25084250|NCT02711137|50192531|FG005|Overall Study|Death|1|||
25084251|NCT02711137|50192532|FG006|Overall Study|Death|61|||
25084252|NCT02711137|50192533|FG007|Overall Study|Death|3|||
25084253|NCT02711137|50192534|FG008|Overall Study|Death|0|||
25084254|NCT02711137|50192535|FG009|Overall Study|Death|1|||
25084255|NCT02711137|50192536|FG010|Overall Study|Death|1|||
25084256|NCT02711137|50192537|FG011|Overall Study|Death|1|||
25084257|NCT02711137|50192538|FG012|Overall Study|Death|0|||
25084258|NCT02711137|50192539|FG013|Overall Study|Death|0|||
25084259|NCT02711137|50192540|FG014|Overall Study|Death|0|||
25084260|NCT02711137|50192526|FG000|Overall Study|Study Terminated by Sponsor|0|||
25084261|NCT02711137|50192527|FG001|Overall Study|Study Terminated by Sponsor|0|||
25084262|NCT02711137|50192528|FG002|Overall Study|Study Terminated by Sponsor|1|||
25084263|NCT02711137|50192529|FG003|Overall Study|Study Terminated by Sponsor|0|||
25084264|NCT02711137|50192530|FG004|Overall Study|Study Terminated by Sponsor|0|||
25084265|NCT02711137|50192531|FG005|Overall Study|Study Terminated by Sponsor|0|||
25084266|NCT02711137|50192532|FG006|Overall Study|Study Terminated by Sponsor|1|||
25084267|NCT02711137|50192533|FG007|Overall Study|Study Terminated by Sponsor|0|||
25084268|NCT02711137|50192534|FG008|Overall Study|Study Terminated by Sponsor|0|||
25084269|NCT02711137|50192535|FG009|Overall Study|Study Terminated by Sponsor|0|||
25084270|NCT02711137|50192536|FG010|Overall Study|Study Terminated by Sponsor|0|||
25172440|NCT01717859|50311948|FG000|Overall Study|Lost to Follow-up|1|||
25172441|NCT01717859|50311948|FG000|Overall Study|Withdrawal by Subject|2|||
25172442|NCT01747499|50312241|FG000|Overall Study|Steroid refractory aGvHD|1|||
25172443|NCT01747499|50312242|FG001|Overall Study|Steroid refractory aGvHD|0|||
25172444|NCT01747499|50312243|FG002|Overall Study|Steroid refractory aGvHD|0|||
25172445|NCT01747499|50312244|FG003|Overall Study|Steroid refractory aGvHD|1|||
25172446|NCT01747499|50312245|FG004|Overall Study|Steroid refractory aGvHD|4|||
25172447|NCT01747499|50312241|FG000|Overall Study|Physician Decision|0|||
25172448|NCT01747499|50312242|FG001|Overall Study|Physician Decision|1|||
25172449|NCT01747499|50312243|FG002|Overall Study|Physician Decision|0|||
25172450|NCT01747499|50312244|FG003|Overall Study|Physician Decision|0|||
25172451|NCT01747499|50312245|FG004|Overall Study|Physician Decision|2|||
25172452|NCT01747499|50312241|FG000|Overall Study|Death|0|||
25172453|NCT01747499|50312242|FG001|Overall Study|Death|0|||
25172454|NCT01747499|50312243|FG002|Overall Study|Death|0|||
25172455|NCT01747499|50312244|FG003|Overall Study|Death|1|||
25172456|NCT01747499|50312245|FG004|Overall Study|Death|1|||
25172457|NCT01747499|50312241|FG000|Overall Study|Withdrawal by Subject|0|||
25172458|NCT01747499|50312242|FG001|Overall Study|Withdrawal by Subject|0|||
25172459|NCT01747499|50312243|FG002|Overall Study|Withdrawal by Subject|0|||
25172460|NCT01747499|50312244|FG003|Overall Study|Withdrawal by Subject|0|||
25172461|NCT01747499|50312245|FG004|Overall Study|Withdrawal by Subject|6|||
25172462|NCT01747499|50312241|FG000|Overall Study|Developed AML and death|0|||
25172463|NCT01747499|50312242|FG001|Overall Study|Developed AML and death|0|||
25172464|NCT01747499|50312243|FG002|Overall Study|Developed AML and death|0|||
25172465|NCT01747499|50312244|FG003|Overall Study|Developed AML and death|0|||
25172466|NCT01747499|50312245|FG004|Overall Study|Developed AML and death|1|||
25172467|NCT01747499|50312241|FG000|Overall Study|Determined not to be eligible|0|||
25172468|NCT01747499|50312242|FG001|Overall Study|Determined not to be eligible|0|||
25172469|NCT01747499|50312243|FG002|Overall Study|Determined not to be eligible|0|||
25172470|NCT01747499|50312244|FG003|Overall Study|Determined not to be eligible|0|||
25172471|NCT01747499|50312245|FG004|Overall Study|Determined not to be eligible|1|||
25172472|NCT01717391|50312277|FG000|Overall Study|Withdrawal by Subject|5|||
25172473|NCT01717391|50312277|FG000|Overall Study|Physician Decision|1|||
25172474|NCT01717391|50312277|FG000|Overall Study|FLT technical failure|3|||
25172475|NCT01746017|50312420|FG000|Period 1|Withdrawal by Subject|0|||
25172476|NCT01746017|50312421|FG001|Period 1|Withdrawal by Subject|0|||
25084271|NCT02711137|50192537|FG011|Overall Study|Study Terminated by Sponsor|0|||
25172477|NCT01746017|50312422|FG002|Period 1|Withdrawal by Subject|0|||
25084272|NCT02711137|50192538|FG012|Overall Study|Study Terminated by Sponsor|0|||
25084273|NCT02711137|50192539|FG013|Overall Study|Study Terminated by Sponsor|0|||
25084274|NCT02711137|50192540|FG014|Overall Study|Study Terminated by Sponsor|0|||
25084275|NCT02711137|50192526|FG000|Overall Study|Physician Decision|1|||
25084276|NCT02711137|50192527|FG001|Overall Study|Physician Decision|0|||
25084277|NCT02711137|50192528|FG002|Overall Study|Physician Decision|2|||
25084278|NCT02711137|50192529|FG003|Overall Study|Physician Decision|1|||
25084279|NCT02711137|50192530|FG004|Overall Study|Physician Decision|1|||
25172478|NCT01746017|50312423|FG003|Period 1|Withdrawal by Subject|0|||
25172479|NCT01746017|50312424|FG004|Period 1|Withdrawal by Subject|0|||
25172480|NCT01746017|50312425|FG005|Period 1|Withdrawal by Subject|0|||
25172481|NCT01746017|50312426|FG006|Period 1|Withdrawal by Subject|1|||
25172482|NCT01746017|50312427|FG007|Period 1|Withdrawal by Subject|0|||
25172483|NCT01746017|50312428|FG008|Period 1|Withdrawal by Subject|0|||
25172484|NCT01746017|50312429|FG009|Period 1|Withdrawal by Subject|0|||
25172485|NCT01746017|50312430|FG010|Period 1|Withdrawal by Subject|0|||
25172486|NCT01746017|50312420|FG000|Period 3|Withdrawal by Subject|0|||
25172487|NCT01746017|50312421|FG001|Period 3|Withdrawal by Subject|0|||
25172488|NCT01746017|50312422|FG002|Period 3|Withdrawal by Subject|0|||
25172489|NCT01746017|50312423|FG003|Period 3|Withdrawal by Subject|0|||
25172490|NCT01746017|50312424|FG004|Period 3|Withdrawal by Subject|0|||
25172491|NCT01746017|50312425|FG005|Period 3|Withdrawal by Subject|1|||
25172492|NCT01746017|50312426|FG006|Period 3|Withdrawal by Subject|0|||
25172493|NCT01746017|50312427|FG007|Period 3|Withdrawal by Subject|0|||
25172494|NCT01746017|50312428|FG008|Period 3|Withdrawal by Subject|0|||
25172495|NCT01746017|50312429|FG009|Period 3|Withdrawal by Subject|0|||
25172496|NCT01746017|50312430|FG010|Period 3|Withdrawal by Subject|0|||
25172497|NCT01717313|50312492|FG000|Phase A (Weeks 0 to 24)|Death|0|||
25172498|NCT01717313|50312493|FG001|Phase A (Weeks 0 to 24)|Death|1|||
25172499|NCT01717313|50312492|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
25172500|NCT01717313|50312493|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
25172501|NCT01717313|50312492|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
25172502|NCT01717313|50312493|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
25172503|NCT01717313|50312492|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
25172504|NCT01717313|50312493|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
25172505|NCT01717313|50312492|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
25172506|NCT01717313|50312493|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
25172507|NCT01717313|50312492|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
25172508|NCT01717313|50312493|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
25172509|NCT01717313|50312492|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
25172510|NCT01717313|50312493|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
25172511|NCT01717313|50312492|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
25172512|NCT01717313|50312493|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
25172513|NCT01717313|50312492|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
25172514|NCT01717313|50312493|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
25172515|NCT01745393|50312505|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
25172516|NCT01745393|50312506|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
25172517|NCT01745393|50312505|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
25172518|NCT01745393|50312506|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
25172519|NCT01745393|50312505|FG000|12-month Follow-up|Lost to Follow-up|6|||
25172520|NCT01745393|50312506|FG001|12-month Follow-up|Lost to Follow-up|5|||
25172521|NCT01744691|50312537|FG000|Overall Study|Progressive Disease|18|||
25172522|NCT01744691|50312537|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
25172523|NCT01744691|50312537|FG000|Overall Study|Withdrawal of consent for treatment|3|||
25172524|NCT01744691|50312537|FG000|Overall Study|Physician Decision|4|||
25172525|NCT01716533|50312572|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
25172526|NCT01716533|50312573|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
25172527|NCT01716533|50312574|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
25172528|NCT01716533|50312575|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
25172529|NCT01716533|50312572|FG000|Overall Study|Withdrawal by Subject|0|||
25172530|NCT01716533|50312573|FG001|Overall Study|Withdrawal by Subject|0|||
25172531|NCT01716533|50312574|FG002|Overall Study|Withdrawal by Subject|0|||
25172532|NCT01716533|50312575|FG003|Overall Study|Withdrawal by Subject|5|||
25084280|NCT02711137|50192531|FG005|Overall Study|Physician Decision|0|||
25084281|NCT02711137|50192532|FG006|Overall Study|Physician Decision|12|||
25084282|NCT02711137|50192533|FG007|Overall Study|Physician Decision|2|||
25084283|NCT02711137|50192534|FG008|Overall Study|Physician Decision|1|||
25084284|NCT02711137|50192535|FG009|Overall Study|Physician Decision|1|||
25084285|NCT02711137|50192536|FG010|Overall Study|Physician Decision|3|||
25084286|NCT02711137|50192537|FG011|Overall Study|Physician Decision|2|||
25084287|NCT02711137|50192538|FG012|Overall Study|Physician Decision|1|||
25084288|NCT02711137|50192539|FG013|Overall Study|Physician Decision|1|||
25084289|NCT02711137|50192540|FG014|Overall Study|Physician Decision|2|||
25172533|NCT01716533|50312572|FG000|Overall Study|Death|0|||
25172534|NCT01716533|50312573|FG001|Overall Study|Death|0|||
25172535|NCT01716533|50312574|FG002|Overall Study|Death|0|||
25172536|NCT01716533|50312575|FG003|Overall Study|Death|2|||
25172537|NCT01716533|50312572|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
25172538|NCT01716533|50312573|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
24907414|NCT00622869|50001446|FG002|Overall Study|Subject Withdrew Consent|11|||
25084290|NCT02711137|50192526|FG000|Overall Study|Other|0|||
25084291|NCT02711137|50192527|FG001|Overall Study|Other|1|||
25084292|NCT02711137|50192528|FG002|Overall Study|Other|0|||
25084293|NCT02711137|50192529|FG003|Overall Study|Other|0|||
25172539|NCT01716533|50312574|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
25172540|NCT01716533|50312575|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
25172541|NCT01375374|50312589|FG000|Overall Study|Adverse Event|1|||
25172542|NCT01743989|50313201|FG000|Treatment Phase|Unstable MR4.0|0|||
25172543|NCT01743989|50313202|FG001|Treatment Phase|Unstable MR4.0|6|||
25172544|NCT01743989|50313203|FG002|Treatment Phase|Unstable MR4.0|263|||
25172545|NCT01743989|50313201|FG000|Treatment Phase|Adverse Event|0|||
24907415|NCT00622869|50001444|FG000|Overall Study|Administrative Problems|11|||
24907416|NCT00622869|50001445|FG001|Overall Study|Administrative Problems|17|||
24907417|NCT00622869|50001446|FG002|Overall Study|Administrative Problems|13|||
24907418|NCT00622869|50001444|FG000|Overall Study|Death|12|||
24907419|NCT00622869|50001445|FG001|Overall Study|Death|15|||
24907420|NCT00622869|50001446|FG002|Overall Study|Death|10|||
24907421|NCT00622869|50001444|FG000|Overall Study|Lost to Follow-up|2|||
24907422|NCT00622869|50001445|FG001|Overall Study|Lost to Follow-up|4|||
24907423|NCT00622869|50001446|FG002|Overall Study|Lost to Follow-up|2|||
24907424|NCT00622869|50001444|FG000|Overall Study|Graft Loss|5|||
24907425|NCT00622869|50001445|FG001|Overall Study|Graft Loss|3|||
24907426|NCT00622869|50001446|FG002|Overall Study|Graft Loss|2|||
24907427|NCT00622869|50001444|FG000|Overall Study|Missing|0|||
24907428|NCT00622869|50001445|FG001|Overall Study|Missing|1|||
24907429|NCT00622869|50001446|FG002|Overall Study|Missing|1|||
24907430|NCT00395083|50001456|FG000|Overall Study|Withdrawal by Subject|6|||
24907431|NCT00395083|50001457|FG001|Overall Study|Withdrawal by Subject|5|||
24907432|NCT00395083|50001456|FG000|Overall Study|Developed another disease|4|||
24907433|NCT00395083|50001457|FG001|Overall Study|Developed another disease|3|||
24907434|NCT00366457|50001463|FG000|Overall Study|never began study therapy|2|||
24907435|NCT00624819|50001471|FG000|Follow-up Period: Year 4|Parents decision|0|||
24907436|NCT00624819|50001472|FG001|Follow-up Period: Year 4|Parents decision|0|||
24907437|NCT00624819|50001473|FG002|Follow-up Period: Year 4|Parents decision|1|||
24907438|NCT00624819|50001474|FG003|Follow-up Period: Year 4|Parents decision|0|||
24907439|NCT00624819|50001471|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
24907440|NCT00624819|50001472|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
24907441|NCT00624819|50001473|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
24907442|NCT00624819|50001474|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
24907443|NCT03832387|50001486|FG000|Overall Study|Protocol Violation|2|||
24907444|NCT03832387|50001487|FG001|Overall Study|Protocol Violation|6|||
24907445|NCT03832387|50001486|FG000|Overall Study|EXCLUSION CRITERIA|3|||
24907446|NCT03832387|50001487|FG001|Overall Study|EXCLUSION CRITERIA|1|||
24907447|NCT00366301|50001497|FG000|Overall Study|Lost to Follow-up|4|||
24907448|NCT00366301|50001498|FG001|Overall Study|Lost to Follow-up|4|||
24907449|NCT00366301|50001499|FG002|Overall Study|Lost to Follow-up|3|||
24907450|NCT00366301|50001500|FG003|Overall Study|Lost to Follow-up|7|||
24907451|NCT00366301|50001497|FG000|Overall Study|Withdrawal by Subject|4|||
24907452|NCT00366301|50001498|FG001|Overall Study|Withdrawal by Subject|2|||
24907453|NCT00366301|50001499|FG002|Overall Study|Withdrawal by Subject|1|||
24907454|NCT00366301|50001500|FG003|Overall Study|Withdrawal by Subject|1|||
24907455|NCT00365989|50001510|FG000|Overall Study|Withdrawal by Subject|1|||
24907456|NCT00365989|50001510|FG000|Overall Study|Non-compliance|1|||
24907457|NCT00622713|50001515|FG000|Overall Study|Adverse Event|35|||
24907458|NCT00622713|50001515|FG000|Overall Study|Administrative problems|4|||
24907459|NCT00622713|50001515|FG000|Overall Study|Withdrawal by Subject|11|||
24907460|NCT00622713|50001515|FG000|Overall Study|Lost to Follow-up|5|||
24907461|NCT00622713|50001515|FG000|Overall Study|Death|2|||
24907462|NCT00622713|50001515|FG000|Overall Study|Subject no longer required study drug|1|||
24907463|NCT00622713|50001515|FG000|Overall Study|Did not meet eligibility criteria|1|||
24907464|NCT00392197|50001521|FG000|Overall Study|Adverse Event|4|||
24907465|NCT00392197|50001522|FG001|Overall Study|Adverse Event|12|||
24907466|NCT00392197|50001521|FG000|Overall Study|Lack of Efficacy|3|||
24907467|NCT00392197|50001522|FG001|Overall Study|Lack of Efficacy|4|||
24907468|NCT00392197|50001521|FG000|Overall Study|Lost to Follow-up|0|||
24907469|NCT00392197|50001522|FG001|Overall Study|Lost to Follow-up|1|||
25172546|NCT01743989|50313202|FG001|Treatment Phase|Adverse Event|4|||
25172547|NCT01743989|50313203|FG002|Treatment Phase|Adverse Event|67|||
25172548|NCT01743989|50313201|FG000|Treatment Phase|Withdrawal by Subject|1|||
25172549|NCT01743989|50313202|FG001|Treatment Phase|Withdrawal by Subject|3|||
24907470|NCT00392197|50001521|FG000|Overall Study|Physician Decision|3|||
24907471|NCT00392197|50001522|FG001|Overall Study|Physician Decision|2|||
24907472|NCT00392197|50001521|FG000|Overall Study|Protocol Violation|7|||
24907473|NCT00392197|50001522|FG001|Overall Study|Protocol Violation|5|||
24907474|NCT00392197|50001521|FG000|Overall Study|Withdrawal by Subject|4|||
24907475|NCT00392197|50001522|FG001|Overall Study|Withdrawal by Subject|6|||
24907476|NCT00391807|50001528|FG000|Overall Study|Did not receive study medication|23|||
24907477|NCT00391807|50001528|FG000|Overall Study|Adverse Event|177|||
24907478|NCT00391807|50001528|FG000|Overall Study|Pregnancy|25|||
24907479|NCT00391807|50001528|FG000|Overall Study|Lost to Follow-up|227|||
24907480|NCT00391807|50001528|FG000|Overall Study|Withdrawal by Subject|147|||
24907481|NCT00391807|50001528|FG000|Overall Study|Protocol Violation|20|||
24907482|NCT00391807|50001528|FG000|Overall Study|Various|96|||
24907483|NCT00624585|50001532|FG000|Overall Study|Death|3|||
24907484|NCT00624585|50001532|FG000|Overall Study|Disease Progression|6|||
24907485|NCT00624585|50001532|FG000|Overall Study|Adverse Event|3|||
24907486|NCT00622635|50001536|FG000|Treatment Period 1|Adverse Event|0|||
24907487|NCT00622635|50001537|FG001|Treatment Period 1|Adverse Event|0|||
24907488|NCT00622635|50001538|FG002|Treatment Period 1|Adverse Event|1|||
24907489|NCT00622635|50001539|FG003|Treatment Period 1|Adverse Event|0|||
24907490|NCT00622635|50001540|FG004|Treatment Period 1|Adverse Event|0|||
24907491|NCT00622635|50001541|FG005|Treatment Period 1|Adverse Event|0|||
24907492|NCT00622635|50001536|FG000|Treatment Period 1|Withdrawal by Subject|0|||
24907493|NCT00622635|50001537|FG001|Treatment Period 1|Withdrawal by Subject|1|||
24907494|NCT00622635|50001538|FG002|Treatment Period 1|Withdrawal by Subject|0|||
24907495|NCT00622635|50001539|FG003|Treatment Period 1|Withdrawal by Subject|0|||
24907496|NCT00622635|50001540|FG004|Treatment Period 1|Withdrawal by Subject|0|||
24907497|NCT00622635|50001541|FG005|Treatment Period 1|Withdrawal by Subject|0|||
24907498|NCT00622635|50001536|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
24907499|NCT00622635|50001537|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
24907500|NCT00622635|50001538|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
24907501|NCT00622635|50001539|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
24907502|NCT00622635|50001540|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
24907503|NCT00622635|50001541|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
24907504|NCT00622635|50001536|FG000|Treatment Period 2|Adverse Event|1|||
24907505|NCT00622635|50001537|FG001|Treatment Period 2|Adverse Event|0|||
24907506|NCT00622635|50001538|FG002|Treatment Period 2|Adverse Event|0|||
24907507|NCT00622635|50001539|FG003|Treatment Period 2|Adverse Event|0|||
24907508|NCT00622635|50001540|FG004|Treatment Period 2|Adverse Event|0|||
24907509|NCT00622635|50001541|FG005|Treatment Period 2|Adverse Event|0|||
24907510|NCT00622635|50001536|FG000|Treatment Period 3|Adverse Event|0|||
24907511|NCT00622635|50001537|FG001|Treatment Period 3|Adverse Event|0|||
24907512|NCT00622635|50001538|FG002|Treatment Period 3|Adverse Event|0|||
24907513|NCT00622635|50001539|FG003|Treatment Period 3|Adverse Event|2|||
24907514|NCT00622635|50001540|FG004|Treatment Period 3|Adverse Event|0|||
24907515|NCT00622635|50001541|FG005|Treatment Period 3|Adverse Event|0|||
24907516|NCT00622635|50001536|FG000|Treatment Period 3|Withdrawal by Subject|0|||
24907517|NCT00622635|50001537|FG001|Treatment Period 3|Withdrawal by Subject|0|||
24907518|NCT00622635|50001538|FG002|Treatment Period 3|Withdrawal by Subject|0|||
24907519|NCT00622635|50001539|FG003|Treatment Period 3|Withdrawal by Subject|1|||
24907520|NCT00622635|50001540|FG004|Treatment Period 3|Withdrawal by Subject|0|||
24907521|NCT00622635|50001541|FG005|Treatment Period 3|Withdrawal by Subject|0|||
24907522|NCT00391027|50001551|FG000|Overall Study|Adverse Event|8|||
24907523|NCT00391027|50001552|FG001|Overall Study|Adverse Event|8|||
24907524|NCT00391027|50001551|FG000|Overall Study|Lack of Efficacy|3|||
24907525|NCT00391027|50001552|FG001|Overall Study|Lack of Efficacy|0|||
24907526|NCT00391027|50001551|FG000|Overall Study|Withdrawal by Subject|10|||
24907527|NCT00391027|50001552|FG001|Overall Study|Withdrawal by Subject|1|||
24907528|NCT00391027|50001551|FG000|Overall Study|Other|4|||
24907529|NCT00391027|50001552|FG001|Overall Study|Other|3|||
24907530|NCT00622401|50001561|FG000|Overall Study|Disease progression prior to treatment|3|||
24907531|NCT00622401|50001562|FG001|Overall Study|Disease progression prior to treatment|2|||
24907532|NCT00622401|50001563|FG002|Overall Study|Disease progression prior to treatment|0|||
24907533|NCT00621621|50001573|FG000|Overall Study|Subjects were exited at EP study|30|||
24995996|NCT03443024|50087096|FG003|Overall Study|Physician Decision|1|||
24995997|NCT03443024|50087093|FG000|Overall Study|Sponsor Decision|1|||
24995998|NCT03443024|50087094|FG001|Overall Study|Sponsor Decision|1|||
24995999|NCT03443024|50087095|FG002|Overall Study|Sponsor Decision|0|||
24996000|NCT03443024|50087096|FG003|Overall Study|Sponsor Decision|0|||
24996001|NCT03443024|50087093|FG000|Overall Study|Protocol Deviation|0|||
24996002|NCT03443024|50087094|FG001|Overall Study|Protocol Deviation|0|||
24996003|NCT03443024|50087095|FG002|Overall Study|Protocol Deviation|0|||
24996004|NCT03443024|50087096|FG003|Overall Study|Protocol Deviation|2|||
24996005|NCT02908516|50087108|FG000|Overall Study|Study Terminated|3|||
24996006|NCT02908516|50087109|FG001|Overall Study|Study Terminated|3|||
24996007|NCT02907892|50087117|FG000|Overall Study|Lost to Follow-up|27|||
24996008|NCT02907892|50087118|FG001|Overall Study|Lost to Follow-up|40|||
24996009|NCT02906644|50087126|FG000|First 2 Weeks|Withdrawal by Subject|0|||
24996010|NCT02906644|50087127|FG001|First 2 Weeks|Withdrawal by Subject|2|||
24996011|NCT02906644|50087126|FG000|First 2 Weeks|Physician Decision|1|||
24996012|NCT02906644|50087127|FG001|First 2 Weeks|Physician Decision|1|||
24996013|NCT02906644|50087126|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
24996014|NCT02906644|50087127|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
24996015|NCT02906644|50087126|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
24996016|NCT02906644|50087127|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
24996017|NCT03410108|50087134|FG000|Overall Study|Ongoing|41|||
24996018|NCT03410108|50087134|FG000|Overall Study|Adverse Event|4|||
24907534|NCT00621621|50001574|FG001|Overall Study|Subjects were exited at EP study|0|||
24907535|NCT00621543|50001582|FG000|Overall Study|Lost to Follow-up|23|||
24907536|NCT00623805|50001588|FG000|Overall Study|Adverse Event|9|||
24996019|NCT03410108|50087134|FG000|Overall Study|Progressive Disease|58|||
25084294|NCT02711137|50192530|FG004|Overall Study|Other|0|||
24996020|NCT03410108|50087134|FG000|Overall Study|Withdrawal by Subject|1|||
24996021|NCT02982772|50087143|FG000|Intervention|Lost to Follow-up|19|||
24996022|NCT02982772|50087144|FG001|Intervention|Lost to Follow-up|13|||
24996023|NCT02982772|50087143|FG000|1M Follow-Up|Lost to Follow-up|21|||
24996024|NCT02982772|50087144|FG001|1M Follow-Up|Lost to Follow-up|18|||
24996025|NCT02982772|50087143|FG000|3M Follow-Up|Lost to Follow-up|17|||
24996026|NCT02982772|50087144|FG001|3M Follow-Up|Lost to Follow-up|11|||
24996027|NCT02982772|50087143|FG000|6M Follow-Up|Lost to Follow-up|11|||
24996028|NCT02982772|50087144|FG001|6M Follow-Up|Lost to Follow-up|9|||
24996029|NCT02982772|50087143|FG000|12M Follow-Up|Lost to Follow-up|11|||
24996030|NCT02982772|50087144|FG001|12M Follow-Up|Lost to Follow-up|5|||
24996031|NCT03488108|50087154|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
24996032|NCT03488108|50087155|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
24996033|NCT03488108|50087154|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
24996034|NCT03488108|50087155|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
24996035|NCT03440918|50087165|FG000|Overall Study|Protocol Violation|0|||
24996036|NCT03440918|50087166|FG001|Overall Study|Protocol Violation|16|||
24996037|NCT03486392|50087177|FG000|Overall Study|Lost to Follow-up|0|||
24996038|NCT03486392|50087178|FG001|Overall Study|Lost to Follow-up|0|||
24996039|NCT03486392|50087179|FG002|Overall Study|Lost to Follow-up|8|||
24996040|NCT03486392|50087180|FG003|Overall Study|Lost to Follow-up|5|||
24996041|NCT03486392|50087181|FG004|Overall Study|Lost to Follow-up|2|||
24996042|NCT03486392|50087177|FG000|Overall Study|Withdrawal by Subject|3|||
24996043|NCT03486392|50087178|FG001|Overall Study|Withdrawal by Subject|0|||
24996044|NCT03486392|50087179|FG002|Overall Study|Withdrawal by Subject|6|||
24996045|NCT03486392|50087180|FG003|Overall Study|Withdrawal by Subject|4|||
24996046|NCT03486392|50087181|FG004|Overall Study|Withdrawal by Subject|1|||
24996047|NCT03486392|50087177|FG000|Overall Study|Death|0|||
24996048|NCT03486392|50087178|FG001|Overall Study|Death|0|||
24996049|NCT03486392|50087179|FG002|Overall Study|Death|0|||
24996050|NCT03486392|50087180|FG003|Overall Study|Death|0|||
24996051|NCT03486392|50087181|FG004|Overall Study|Death|1|||
24996052|NCT02981602|50087198|FG000|Overall Study|Adverse Event|0|||
24996053|NCT02981602|50087199|FG001|Overall Study|Adverse Event|0|||
24996054|NCT02981602|50087200|FG002|Overall Study|Adverse Event|0|||
24996055|NCT02981602|50087201|FG003|Overall Study|Adverse Event|1|||
24996056|NCT02981602|50087202|FG004|Overall Study|Adverse Event|0|||
24996057|NCT02981524|50087215|FG000|Overall Study|Progressive Disease|14|||
24996058|NCT02981524|50087215|FG000|Overall Study|Death (unrelated)|1|||
24996059|NCT02981524|50087215|FG000|Overall Study|Treatment Related Toxicity|1|||
24996060|NCT02981524|50087215|FG000|Overall Study|Withdrawal by Subject|1|||
24996061|NCT03486314|50087219|FG000|Part A|Adverse Event|1|||
24996062|NCT03486314|50087220|FG001|Part A|Adverse Event|0|||
24996063|NCT03486314|50087221|FG002|Part A|Adverse Event|0|||
24996064|NCT03486314|50087219|FG000|Part A|Symptomatic Deterioration|2|||
24996065|NCT03486314|50087220|FG001|Part A|Symptomatic Deterioration|0|||
24996066|NCT03486314|50087221|FG002|Part A|Symptomatic Deterioration|0|||
24996067|NCT02905006|50087235|FG000|Overall Study|Adverse Event|1|||
24996068|NCT02905006|50087236|FG001|Overall Study|Adverse Event|1|||
24996069|NCT02905006|50087237|FG002|Overall Study|Adverse Event|1|||
24996070|NCT02905006|50087238|FG003|Overall Study|Adverse Event|1|||
24996071|NCT02905006|50087239|FG004|Overall Study|Adverse Event|0|||
24996072|NCT02905006|50087240|FG005|Overall Study|Adverse Event|1|||
24996073|NCT02905006|50087235|FG000|Overall Study|Lack of Efficacy|1|||
24996074|NCT02905006|50087236|FG001|Overall Study|Lack of Efficacy|0|||
24996075|NCT02905006|50087237|FG002|Overall Study|Lack of Efficacy|0|||
24996076|NCT02905006|50087238|FG003|Overall Study|Lack of Efficacy|0|||
24996077|NCT02905006|50087239|FG004|Overall Study|Lack of Efficacy|0|||
24996078|NCT02905006|50087240|FG005|Overall Study|Lack of Efficacy|0|||
24996079|NCT02905006|50087235|FG000|Overall Study|Protocol Violation|2|||
24996080|NCT02905006|50087236|FG001|Overall Study|Protocol Violation|0|||
24996081|NCT02905006|50087237|FG002|Overall Study|Protocol Violation|0|||
24996082|NCT02905006|50087238|FG003|Overall Study|Protocol Violation|0|||
24996083|NCT02905006|50087239|FG004|Overall Study|Protocol Violation|0|||
24996084|NCT02905006|50087240|FG005|Overall Study|Protocol Violation|0|||
24996085|NCT02905006|50087235|FG000|Overall Study|Lost to Follow-up|0|||
24996086|NCT02905006|50087236|FG001|Overall Study|Lost to Follow-up|0|||
24996087|NCT02905006|50087237|FG002|Overall Study|Lost to Follow-up|0|||
24996088|NCT02905006|50087238|FG003|Overall Study|Lost to Follow-up|1|||
24996089|NCT02905006|50087239|FG004|Overall Study|Lost to Follow-up|1|||
24996090|NCT02905006|50087240|FG005|Overall Study|Lost to Follow-up|0|||
24996091|NCT02905006|50087235|FG000|Overall Study|Withdrawal by Subject|0|||
24996092|NCT02905006|50087236|FG001|Overall Study|Withdrawal by Subject|0|||
24996093|NCT02905006|50087237|FG002|Overall Study|Withdrawal by Subject|1|||
24996094|NCT02905006|50087238|FG003|Overall Study|Withdrawal by Subject|1|||
24996095|NCT02905006|50087239|FG004|Overall Study|Withdrawal by Subject|0|||
24996096|NCT02905006|50087240|FG005|Overall Study|Withdrawal by Subject|1|||
24996097|NCT02905006|50087235|FG000|Overall Study|Screening exclusion criteria met|1|||
25084295|NCT02711137|50192531|FG005|Overall Study|Other|0|||
24996098|NCT02905006|50087236|FG001|Overall Study|Screening exclusion criteria met|0|||
24996099|NCT02905006|50087237|FG002|Overall Study|Screening exclusion criteria met|0|||
24996100|NCT02905006|50087238|FG003|Overall Study|Screening exclusion criteria met|0|||
24996101|NCT02905006|50087239|FG004|Overall Study|Screening exclusion criteria met|0|||
24996102|NCT02905006|50087240|FG005|Overall Study|Screening exclusion criteria met|0|||
24996103|NCT02905006|50087235|FG000|Overall Study|Lab withdrawal criterion met|0|||
24996104|NCT02905006|50087236|FG001|Overall Study|Lab withdrawal criterion met|1|||
24996105|NCT02905006|50087237|FG002|Overall Study|Lab withdrawal criterion met|2|||
24996106|NCT02905006|50087238|FG003|Overall Study|Lab withdrawal criterion met|2|||
24996107|NCT02905006|50087239|FG004|Overall Study|Lab withdrawal criterion met|2|||
24996108|NCT02905006|50087240|FG005|Overall Study|Lab withdrawal criterion met|1|||
24996109|NCT02905006|50087235|FG000|Overall Study|Positive for Tuberculosis|0|||
24996110|NCT02905006|50087236|FG001|Overall Study|Positive for Tuberculosis|1|||
24996111|NCT02905006|50087237|FG002|Overall Study|Positive for Tuberculosis|0|||
24996112|NCT02905006|50087238|FG003|Overall Study|Positive for Tuberculosis|0|||
24996113|NCT02905006|50087239|FG004|Overall Study|Positive for Tuberculosis|0|||
24996114|NCT02905006|50087240|FG005|Overall Study|Positive for Tuberculosis|0|||
24996115|NCT02905006|50087235|FG000|Overall Study|Subject positive for Hep B|0|||
24996116|NCT02905006|50087236|FG001|Overall Study|Subject positive for Hep B|0|||
24996117|NCT02905006|50087237|FG002|Overall Study|Subject positive for Hep B|1|||
24996118|NCT02905006|50087238|FG003|Overall Study|Subject positive for Hep B|0|||
24996119|NCT02905006|50087239|FG004|Overall Study|Subject positive for Hep B|0|||
24996120|NCT02905006|50087240|FG005|Overall Study|Subject positive for Hep B|0|||
24996121|NCT02905006|50087235|FG000|Overall Study|Patient moved abroad|0|||
24996122|NCT02905006|50087236|FG001|Overall Study|Patient moved abroad|0|||
24996123|NCT02905006|50087237|FG002|Overall Study|Patient moved abroad|0|||
24996124|NCT02905006|50087238|FG003|Overall Study|Patient moved abroad|1|||
24996125|NCT02905006|50087239|FG004|Overall Study|Patient moved abroad|0|||
24996126|NCT02905006|50087240|FG005|Overall Study|Patient moved abroad|0|||
24996127|NCT02905006|50087235|FG000|Overall Study|Patient randomized by mistake|0|||
24996128|NCT02905006|50087236|FG001|Overall Study|Patient randomized by mistake|0|||
24996129|NCT02905006|50087237|FG002|Overall Study|Patient randomized by mistake|0|||
24996130|NCT02905006|50087238|FG003|Overall Study|Patient randomized by mistake|0|||
24996131|NCT02905006|50087239|FG004|Overall Study|Patient randomized by mistake|0|||
24996132|NCT02905006|50087240|FG005|Overall Study|Patient randomized by mistake|1|||
24996133|NCT01066780|50087278|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
24996134|NCT01066780|50087279|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
24996135|NCT02975206|50087286|FG000|Overall Study|Withdrawal by Subject|14|||
24996136|NCT02975206|50087287|FG001|Overall Study|Withdrawal by Subject|11|||
24996137|NCT02975206|50087288|FG002|Overall Study|Withdrawal by Subject|11|||
24996138|NCT02975206|50087286|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
24996139|NCT02975206|50087287|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
24996140|NCT02975206|50087288|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
24996141|NCT01066156|50087296|FG000|Overall Study|ineligible|2|||
24996142|NCT01066156|50087296|FG000|Overall Study|Lost to Follow-up|7|||
24996143|NCT01066156|50087296|FG000|Overall Study|Withdrawal by Subject|1|||
24996144|NCT02980042|50087302|FG000|Overall Study|Lost to Follow-up|5|||
24996145|NCT02980042|50087303|FG001|Overall Study|Lost to Follow-up|0|||
24996146|NCT02980042|50087302|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
24996147|NCT02980042|50087303|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
24996148|NCT01066000|50087321|FG000|Overall Study|Protocol Violation|4|||
24996149|NCT01066000|50087321|FG000|Overall Study|Death|3|||
25084296|NCT02711137|50192532|FG006|Overall Study|Other|3|||
25084297|NCT02711137|50192533|FG007|Overall Study|Other|0|||
25084298|NCT02711137|50192534|FG008|Overall Study|Other|0|||
25084299|NCT02711137|50192535|FG009|Overall Study|Other|0|||
25084300|NCT02711137|50192536|FG010|Overall Study|Other|0|||
25084301|NCT02711137|50192537|FG011|Overall Study|Other|0|||
25084302|NCT02711137|50192538|FG012|Overall Study|Other|0|||
25084303|NCT02711137|50192539|FG013|Overall Study|Other|0|||
25084304|NCT02711137|50192540|FG014|Overall Study|Other|1|||
25084305|NCT02711137|50192526|FG000|Overall Study|Withdrawal by Subject|1|||
25084306|NCT02711137|50192527|FG001|Overall Study|Withdrawal by Subject|0|||
25084307|NCT02711137|50192528|FG002|Overall Study|Withdrawal by Subject|0|||
25084308|NCT02711137|50192529|FG003|Overall Study|Withdrawal by Subject|1|||
25084309|NCT02711137|50192530|FG004|Overall Study|Withdrawal by Subject|1|||
25084310|NCT02711137|50192531|FG005|Overall Study|Withdrawal by Subject|0|||
25084311|NCT02711137|50192532|FG006|Overall Study|Withdrawal by Subject|7|||
25084312|NCT02711137|50192533|FG007|Overall Study|Withdrawal by Subject|0|||
25084313|NCT02711137|50192534|FG008|Overall Study|Withdrawal by Subject|0|||
25084314|NCT02711137|50192535|FG009|Overall Study|Withdrawal by Subject|0|||
25084315|NCT02711137|50192536|FG010|Overall Study|Withdrawal by Subject|0|||
25084316|NCT02711137|50192537|FG011|Overall Study|Withdrawal by Subject|0|||
25084317|NCT02711137|50192538|FG012|Overall Study|Withdrawal by Subject|0|||
25084318|NCT02711137|50192539|FG013|Overall Study|Withdrawal by Subject|1|||
25084319|NCT02711137|50192540|FG014|Overall Study|Withdrawal by Subject|0|||
25084320|NCT02711137|50192526|FG000|Overall Study|Lost to Follow-up|1|||
25084321|NCT02711137|50192527|FG001|Overall Study|Lost to Follow-up|0|||
25084322|NCT02711137|50192528|FG002|Overall Study|Lost to Follow-up|0|||
25084323|NCT02711137|50192529|FG003|Overall Study|Lost to Follow-up|0|||
25084324|NCT02711137|50192530|FG004|Overall Study|Lost to Follow-up|0|||
25084325|NCT02711137|50192531|FG005|Overall Study|Lost to Follow-up|0|||
25084326|NCT02711137|50192532|FG006|Overall Study|Lost to Follow-up|2|||
25084327|NCT02711137|50192533|FG007|Overall Study|Lost to Follow-up|0|||
25084328|NCT02711137|50192534|FG008|Overall Study|Lost to Follow-up|0|||
25084329|NCT02711137|50192535|FG009|Overall Study|Lost to Follow-up|0|||
25084330|NCT02711137|50192536|FG010|Overall Study|Lost to Follow-up|0|||
25084331|NCT02711137|50192537|FG011|Overall Study|Lost to Follow-up|0|||
25084332|NCT02711137|50192538|FG012|Overall Study|Lost to Follow-up|0|||
25084333|NCT02711137|50192539|FG013|Overall Study|Lost to Follow-up|0|||
25084334|NCT02711137|50192540|FG014|Overall Study|Lost to Follow-up|0|||
25084335|NCT02710045|50192580|FG000|Overall Study|Death|1|||
25084336|NCT02710045|50192581|FG001|Overall Study|Death|2|||
25084337|NCT02710045|50192582|FG002|Overall Study|Death|0|||
25084338|NCT02710045|50192580|FG000|Overall Study|Withdrawal by Subject|6|||
25084339|NCT02710045|50192581|FG001|Overall Study|Withdrawal by Subject|6|||
25084340|NCT02710045|50192582|FG002|Overall Study|Withdrawal by Subject|2|||
25084341|NCT02710045|50192580|FG000|Overall Study|Protocol Violation|1|||
25084342|NCT02710045|50192581|FG001|Overall Study|Protocol Violation|2|||
25084343|NCT02710045|50192582|FG002|Overall Study|Protocol Violation|3|||
25084344|NCT02710045|50192580|FG000|Overall Study|Lost to Follow-up|3|||
25084345|NCT02710045|50192581|FG001|Overall Study|Lost to Follow-up|6|||
25084346|NCT02710045|50192582|FG002|Overall Study|Lost to Follow-up|7|||
25084347|NCT02710045|50192580|FG000|Overall Study|Physician Decision|0|||
25084348|NCT02710045|50192581|FG001|Overall Study|Physician Decision|0|||
25084349|NCT02710045|50192582|FG002|Overall Study|Physician Decision|1|||
25084350|NCT02710045|50192580|FG000|Overall Study|Poor Attendance|0|||
25084351|NCT02710045|50192581|FG001|Overall Study|Poor Attendance|1|||
25084352|NCT02710045|50192582|FG002|Overall Study|Poor Attendance|0|||
25084353|NCT02714153|50192590|FG000|Overall Study|Death|1|||
25084354|NCT04369469|50192596|FG000|Overall Study|Lost to Follow-up|2|||
25084355|NCT04369469|50192597|FG001|Overall Study|Lost to Follow-up|4|||
25084356|NCT04369469|50192596|FG000|Overall Study|Physician Decision|2|||
25084357|NCT04369469|50192597|FG001|Overall Study|Physician Decision|1|||
25084358|NCT04369469|50192596|FG000|Overall Study|Withdrawal by Subject|2|||
25084359|NCT04369469|50192597|FG001|Overall Study|Withdrawal by Subject|3|||
25084360|NCT04369469|50192596|FG000|Overall Study|Adverse Event|1|||
25084361|NCT04369469|50192597|FG001|Overall Study|Adverse Event|0|||
25084362|NCT04369469|50192596|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
25084363|NCT04369469|50192597|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
25084364|NCT04369469|50192596|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
25084365|NCT04369469|50192597|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
25084366|NCT04369469|50192596|FG000|Overall Study|Unable to Provide Consent|0|||
25084367|NCT04369469|50192597|FG001|Overall Study|Unable to Provide Consent|1|||
25084368|NCT01670097|50192618|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
25084369|NCT01670097|50192619|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
25084370|NCT01670097|50192618|FG000|Overall Study|Study burden|1|||
25084371|NCT01670097|50192619|FG001|Overall Study|Study burden|0|||
25084372|NCT01670097|50192618|FG000|Overall Study|COPD exacerbation|0|||
25084373|NCT01670097|50192619|FG001|Overall Study|COPD exacerbation|1|||
25084374|NCT01670097|50192618|FG000|Overall Study|Neutropenia|0|||
25084375|NCT01670097|50192619|FG001|Overall Study|Neutropenia|1|||
25084376|NCT01670097|50192618|FG000|Overall Study|Clinical deterioration|0|||
25084377|NCT01670097|50192619|FG001|Overall Study|Clinical deterioration|1|||
25084378|NCT01670097|50192618|FG000|Overall Study|Disease progression|0|||
25084379|NCT01670097|50192619|FG001|Overall Study|Disease progression|1|||
25084380|NCT01670019|50192627|FG000|Overall Study|Adverse Event|3|||
25084381|NCT01670019|50192628|FG001|Overall Study|Adverse Event|0|||
25084382|NCT01670019|50192627|FG000|Overall Study|Withdrawal by Subject|6|||
25084383|NCT01670019|50192628|FG001|Overall Study|Withdrawal by Subject|0|||
25084384|NCT01669629|50192634|FG000|Period 1|protocol deviation|1|||
25084385|NCT01669629|50192635|FG001|Period 1|protocol deviation|2|||
25084386|NCT00701051|50192643|FG000|Screening|Failed Screening|40|||
25084387|NCT00701051|50192644|FG001|Screening|Failed Screening|0|||
25084388|NCT00701051|50192645|FG002|Screening|Failed Screening|0|||
25084389|NCT00701051|50192643|FG000|Screening|Time conflicts|19|||
25084390|NCT00701051|50192644|FG001|Screening|Time conflicts|0|||
25084391|NCT00701051|50192645|FG002|Screening|Time conflicts|0|||
25084392|NCT00701051|50192643|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
25084393|NCT00701051|50192644|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
25084394|NCT00701051|50192645|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
25084395|NCT00700817|50192656|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
25084396|NCT00700817|50192657|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
25261096|NCT01311648|50575784|FG000|Main Study|Withdrawal by Subject|0|||
25084397|NCT00700817|50192658|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
25084398|NCT00700817|50192659|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
25084399|NCT00700817|50192660|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
25084400|NCT00700817|50192656|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
25084401|NCT00700817|50192657|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
25084402|NCT00700817|50192658|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
25084403|NCT00700817|50192659|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
25084404|NCT00700817|50192660|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
25084405|NCT00700817|50192656|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
25084406|NCT00700817|50192657|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
25084407|NCT00700817|50192658|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
25084408|NCT00700817|50192659|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
25084409|NCT00700817|50192660|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
25084410|NCT00700817|50192656|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
25084411|NCT00700817|50192657|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
25084412|NCT00700817|50192658|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
25084413|NCT00700817|50192659|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
25084414|NCT00700817|50192660|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
25084415|NCT00700817|50192656|FG000|Week 0-26 (Main Period)|Unclassified|14|||
25084416|NCT00700817|50192657|FG001|Week 0-26 (Main Period)|Unclassified|4|||
25084417|NCT00700817|50192658|FG002|Week 0-26 (Main Period)|Unclassified|8|||
25084418|NCT00700817|50192659|FG003|Week 0-26 (Main Period)|Unclassified|0|||
25084419|NCT00700817|50192660|FG004|Week 0-26 (Main Period)|Unclassified|0|||
25084420|NCT00700817|50192656|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
25084421|NCT00700817|50192657|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
25084422|NCT00700817|50192658|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
25084423|NCT00700817|50192659|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
25084424|NCT00700817|50192660|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
25084425|NCT00700817|50192656|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
25084426|NCT00700817|50192657|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
25084427|NCT00700817|50192658|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
25084428|NCT00700817|50192659|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
25084429|NCT00700817|50192660|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
25084430|NCT00700817|50192656|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
25084431|NCT00700817|50192657|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
25084432|NCT00700817|50192658|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
25084433|NCT00700817|50192659|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
25084434|NCT00700817|50192660|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
25084435|NCT00700817|50192656|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
25084436|NCT00700817|50192657|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
25084437|NCT00700817|50192658|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
25084438|NCT00700817|50192659|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
25084439|NCT00700817|50192660|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
25084440|NCT00700817|50192656|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
25084441|NCT00700817|50192657|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
25084442|NCT00700817|50192658|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
25084443|NCT00700817|50192659|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
25084444|NCT00700817|50192660|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
25084445|NCT00700817|50192656|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
25084446|NCT00700817|50192657|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
25084447|NCT00700817|50192658|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
25084448|NCT00700817|50192659|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
25084449|NCT00700817|50192660|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
25084450|NCT00700817|50192656|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
25084451|NCT00700817|50192657|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
25084452|NCT00700817|50192658|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
25084453|NCT00700817|50192659|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
25084454|NCT00700817|50192660|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
25084455|NCT00700817|50192656|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
25084456|NCT00700817|50192657|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
25084457|NCT00700817|50192658|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
25084458|NCT00700817|50192659|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
25084459|NCT00700817|50192660|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
25084460|NCT00700817|50192656|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
25084461|NCT00700817|50192657|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
25084462|NCT00700817|50192658|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
25084463|NCT00700817|50192659|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
25084464|NCT00700817|50192660|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
25084465|NCT00700817|50192656|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
25261097|NCT01311648|50575785|FG001|Main Study|Withdrawal by Subject|2|||
25084466|NCT00700817|50192657|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
25084467|NCT00700817|50192658|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
25084468|NCT00700817|50192659|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
25084469|NCT00700817|50192660|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
25084470|NCT02625909|50192672|FG000|Overall Study|Death|2|||
25084471|NCT02625909|50192673|FG001|Overall Study|Death|0|||
25084472|NCT02625909|50192672|FG000|Overall Study|Lost to Follow-up|3|||
25084473|NCT02625909|50192673|FG001|Overall Study|Lost to Follow-up|5|||
25084474|NCT02625909|50192672|FG000|Overall Study|Lack of Efficacy|9|||
25084475|NCT02625909|50192673|FG001|Overall Study|Lack of Efficacy|2|||
25084476|NCT02625909|50192672|FG000|Overall Study|Reinfection|3|||
25084477|NCT02625909|50192673|FG001|Overall Study|Reinfection|2|||
25084478|NCT02623959|50192681|FG000|Overall Study|Progression|0|||
25084479|NCT02623959|50192682|FG001|Overall Study|Progression|1|||
25084480|NCT00700739|50192692|FG000|Overall Study|Lost to Follow-up|4|||
25084481|NCT00700739|50192693|FG001|Overall Study|Lost to Follow-up|4|||
25084482|NCT02623335|50192702|FG000|Overall Study|Death|8|||
25084483|NCT02623335|50192703|FG001|Overall Study|Death|7|||
25084484|NCT02623335|50192702|FG000|Overall Study|Lost to Follow-up|15|||
25084485|NCT02623335|50192703|FG001|Overall Study|Lost to Follow-up|23|||
25084486|NCT02623335|50192702|FG000|Overall Study|Withdrawal by Subject|2|||
25084487|NCT02623335|50192703|FG001|Overall Study|Withdrawal by Subject|5|||
25084488|NCT02623335|50192702|FG000|Overall Study|Protocol Violation|2|||
25084489|NCT02623335|50192703|FG001|Overall Study|Protocol Violation|1|||
25084490|NCT00700427|50192713|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
25084491|NCT00700427|50192714|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
25084492|NCT00700427|50192715|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
25084493|NCT00700427|50192716|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
25084494|NCT00700427|50192717|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
25084495|NCT00700427|50192713|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
25084496|NCT00700427|50192714|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
25084497|NCT00700427|50192715|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
25084498|NCT00700427|50192716|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
25084499|NCT00700427|50192717|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
25084500|NCT00700427|50192713|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
25084501|NCT00700427|50192714|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
25084502|NCT00700427|50192715|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
25084503|NCT00700427|50192716|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
25084504|NCT00700427|50192717|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
25084505|NCT00700427|50192713|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
25084506|NCT00700427|50192714|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
25084507|NCT00700427|50192715|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
25084508|NCT00700427|50192716|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
25084509|NCT00700427|50192717|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
25084510|NCT00700427|50192713|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
25084511|NCT00700427|50192714|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
25084512|NCT00700427|50192715|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
25084513|NCT00700427|50192716|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
25084514|NCT00700427|50192717|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
25084515|NCT00700427|50192713|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
25084516|NCT00700427|50192714|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
25084517|NCT00700427|50192715|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
25084518|NCT00700427|50192716|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
25084519|NCT00700427|50192717|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
25084520|NCT00700427|50192713|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
25084521|NCT00700427|50192714|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
25084522|NCT00700427|50192715|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
25084523|NCT00700427|50192716|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
25084524|NCT00700427|50192717|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
25084525|NCT00700427|50192713|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
25084526|NCT00700427|50192714|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
25084527|NCT00700427|50192715|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
25084528|NCT00700427|50192716|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
25084529|NCT00700427|50192717|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
25084530|NCT00700427|50192713|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
25084531|NCT00700427|50192714|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
25084532|NCT00700427|50192715|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
25084533|NCT00700427|50192716|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
25084534|NCT00700427|50192717|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
25084535|NCT00700427|50192713|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
25084536|NCT00700427|50192714|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
25084537|NCT00700427|50192715|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
25084538|NCT00700427|50192716|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
25084539|NCT00700427|50192717|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
25084540|NCT00700427|50192713|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
25084541|NCT00700427|50192714|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
25084542|NCT00700427|50192715|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
25084543|NCT00700427|50192716|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
25084544|NCT00700427|50192717|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
25084545|NCT00700427|50192713|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
25084546|NCT00700427|50192714|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
25084547|NCT00700427|50192715|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
25084548|NCT00700427|50192716|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
25084549|NCT00700427|50192717|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
25084550|NCT00700427|50192713|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
25084551|NCT00700427|50192714|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
25084552|NCT00700427|50192715|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
25084553|NCT00700427|50192716|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
25084554|NCT00700427|50192717|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
25084555|NCT00700427|50192713|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
25084556|NCT00700427|50192714|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
25084557|NCT00700427|50192715|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
25084558|NCT00700427|50192716|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
25084559|NCT00700427|50192717|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
25084560|NCT00700427|50192713|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
25084561|NCT00700427|50192714|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
25084562|NCT00700427|50192715|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
25084563|NCT00700427|50192716|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
25084564|NCT00700427|50192717|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
25084565|NCT00700427|50192713|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
25084566|NCT00700427|50192714|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
25084567|NCT00700427|50192715|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
25084568|NCT00700427|50192716|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
25084569|NCT00700427|50192717|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
25084570|NCT00700427|50192713|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
25084571|NCT00700427|50192714|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
25084572|NCT00700427|50192715|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
25084573|NCT00700427|50192716|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
25084574|NCT00700427|50192717|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
25084575|NCT00700427|50192713|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
25084576|NCT00700427|50192714|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
25084577|NCT00700427|50192715|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
25084578|NCT00700427|50192716|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
25084579|NCT00700427|50192717|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
25084580|NCT00700427|50192713|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
25084581|NCT00700427|50192714|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
25084582|NCT00700427|50192715|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
25084583|NCT00700427|50192716|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
25084584|NCT00700427|50192717|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
25084585|NCT00700427|50192713|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
25084586|NCT00700427|50192714|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
25084587|NCT00700427|50192715|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
25084588|NCT00700427|50192716|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
25084589|NCT00700427|50192717|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
25084590|NCT00700427|50192713|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
25084591|NCT00700427|50192714|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
25084592|NCT00700427|50192715|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
25084593|NCT00700427|50192716|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
25084594|NCT00700427|50192717|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
25084595|NCT00700427|50192713|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
25084596|NCT00700427|50192714|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
25084597|NCT00700427|50192715|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
25084598|NCT00700427|50192716|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
25084599|NCT00700427|50192717|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
25084600|NCT00700427|50192713|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
25084601|NCT00700427|50192714|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
25084602|NCT00700427|50192715|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
25084603|NCT00700427|50192716|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
25084604|NCT00700427|50192717|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
25084605|NCT00700427|50192713|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
25084606|NCT00700427|50192714|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
25084607|NCT00700427|50192715|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
25084608|NCT00700427|50192716|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
25084609|NCT00700427|50192717|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
25084610|NCT00700427|50192713|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
25084611|NCT00700427|50192714|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
25084612|NCT00700427|50192715|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
25084613|NCT00700427|50192716|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
25084614|NCT00700427|50192717|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
25084615|NCT00700427|50192713|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
25084616|NCT00700427|50192714|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
25084617|NCT00700427|50192715|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
25084618|NCT00700427|50192716|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
25084619|NCT00700427|50192717|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
25084620|NCT00700427|50192713|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
25084621|NCT00700427|50192714|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
25084622|NCT00700427|50192715|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
25084623|NCT00700427|50192716|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
25084624|NCT00700427|50192717|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
25084625|NCT00700427|50192713|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
25084626|NCT00700427|50192714|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
25084627|NCT00700427|50192715|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
25084628|NCT00700427|50192716|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
25084629|NCT00700427|50192717|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
25084630|NCT00700427|50192713|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
25084631|NCT00700427|50192714|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
25084632|NCT00700427|50192715|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
25084633|NCT00700427|50192716|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
25084634|NCT00700427|50192717|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
25084635|NCT00700427|50192713|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
25084636|NCT00700427|50192714|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
25084637|NCT00700427|50192715|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
25084638|NCT00700427|50192716|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
25084639|NCT00700427|50192717|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
25084640|NCT00700427|50192713|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
25084641|NCT00700427|50192714|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
25084642|NCT00700427|50192715|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
25084643|NCT00700427|50192716|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
25084644|NCT00700427|50192717|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
25084645|NCT00700427|50192713|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
25084646|NCT00700427|50192714|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
25084647|NCT00700427|50192715|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
25084648|NCT00700427|50192716|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
25084649|NCT00700427|50192717|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
25084650|NCT00700427|50192713|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
25084651|NCT00700427|50192714|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
25084652|NCT00700427|50192715|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
25084653|NCT00700427|50192716|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
25084654|NCT00700427|50192717|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
25084655|NCT00700427|50192713|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
25084656|NCT00700427|50192714|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
25084657|NCT00700427|50192715|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
25084658|NCT00700427|50192716|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
25084659|NCT00700427|50192717|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
25084660|NCT00700427|50192713|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
25084661|NCT00700427|50192714|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
25084662|NCT00700427|50192715|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
25084663|NCT00700427|50192716|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
25084664|NCT00700427|50192717|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
25084665|NCT00700427|50192713|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
25084666|NCT00700427|50192714|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
25084667|NCT00700427|50192715|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
25084668|NCT00700427|50192716|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
25084669|NCT00700427|50192717|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
25084670|NCT00700427|50192713|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
25084671|NCT00700427|50192714|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
25084672|NCT00700427|50192715|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
25084673|NCT00700427|50192716|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
25084674|NCT00700427|50192717|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
25084675|NCT00700427|50192713|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
25084676|NCT00700427|50192714|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
25084677|NCT00700427|50192715|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
25084678|NCT00700427|50192716|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
25084679|NCT00700427|50192717|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
25084680|NCT02128763|50192727|FG000|Overall Study|Death|1|||
25084681|NCT02128763|50192728|FG001|Overall Study|Death|0|||
25084682|NCT02128763|50192727|FG000|Overall Study|Lost to Follow-up|19|||
25084683|NCT02128763|50192728|FG001|Overall Study|Lost to Follow-up|16|||
25084684|NCT02124772|50192750|FG000|Overall Study|Lack of Efficacy|2|||
25084685|NCT02124772|50192751|FG001|Overall Study|Lack of Efficacy|0|||
25084686|NCT02124772|50192752|FG002|Overall Study|Lack of Efficacy|0|||
25084687|NCT02124772|50192753|FG003|Overall Study|Lack of Efficacy|1|||
25084688|NCT02124772|50192754|FG004|Overall Study|Lack of Efficacy|2|||
25084689|NCT02124772|50192755|FG005|Overall Study|Lack of Efficacy|3|||
25084690|NCT02124772|50192756|FG006|Overall Study|Lack of Efficacy|0|||
25084691|NCT02124772|50192757|FG007|Overall Study|Lack of Efficacy|2|||
25084692|NCT02124772|50192758|FG008|Overall Study|Lack of Efficacy|0|||
25084693|NCT02124772|50192759|FG009|Overall Study|Lack of Efficacy|1|||
25084694|NCT02124772|50192760|FG010|Overall Study|Lack of Efficacy|0|||
25084695|NCT02124772|50192761|FG011|Overall Study|Lack of Efficacy|0|||
25084696|NCT02124772|50192762|FG012|Overall Study|Lack of Efficacy|1|||
25084697|NCT02124772|50192750|FG000|Overall Study|Adverse Event|1|||
25084698|NCT02124772|50192751|FG001|Overall Study|Adverse Event|4|||
25084699|NCT02124772|50192752|FG002|Overall Study|Adverse Event|1|||
25084700|NCT02124772|50192753|FG003|Overall Study|Adverse Event|5|||
25084701|NCT02124772|50192754|FG004|Overall Study|Adverse Event|2|||
25084702|NCT02124772|50192755|FG005|Overall Study|Adverse Event|1|||
25084703|NCT02124772|50192756|FG006|Overall Study|Adverse Event|1|||
25084704|NCT02124772|50192757|FG007|Overall Study|Adverse Event|5|||
25084705|NCT02124772|50192758|FG008|Overall Study|Adverse Event|0|||
25084706|NCT02124772|50192759|FG009|Overall Study|Adverse Event|3|||
25084707|NCT02124772|50192760|FG010|Overall Study|Adverse Event|1|||
25084708|NCT02124772|50192761|FG011|Overall Study|Adverse Event|3|||
25084709|NCT02124772|50192762|FG012|Overall Study|Adverse Event|1|||
25084710|NCT02124772|50192750|FG000|Overall Study|Withdrawal consent|0|||
25084711|NCT02124772|50192751|FG001|Overall Study|Withdrawal consent|1|||
25084712|NCT02124772|50192752|FG002|Overall Study|Withdrawal consent|1|||
25084713|NCT02124772|50192753|FG003|Overall Study|Withdrawal consent|1|||
25084714|NCT02124772|50192754|FG004|Overall Study|Withdrawal consent|0|||
25084715|NCT02124772|50192755|FG005|Overall Study|Withdrawal consent|1|||
25084716|NCT02124772|50192756|FG006|Overall Study|Withdrawal consent|1|||
25084717|NCT02124772|50192757|FG007|Overall Study|Withdrawal consent|0|||
25084718|NCT02124772|50192758|FG008|Overall Study|Withdrawal consent|0|||
25084719|NCT02124772|50192759|FG009|Overall Study|Withdrawal consent|1|||
25084720|NCT02124772|50192760|FG010|Overall Study|Withdrawal consent|0|||
25084721|NCT02124772|50192761|FG011|Overall Study|Withdrawal consent|1|||
25084722|NCT02124772|50192762|FG012|Overall Study|Withdrawal consent|0|||
25084723|NCT02124772|50192750|FG000|Overall Study|Investigator discretion|0|||
25084724|NCT02124772|50192751|FG001|Overall Study|Investigator discretion|2|||
25084725|NCT02124772|50192752|FG002|Overall Study|Investigator discretion|2|||
25084726|NCT02124772|50192753|FG003|Overall Study|Investigator discretion|1|||
25084727|NCT02124772|50192754|FG004|Overall Study|Investigator discretion|1|||
25084728|NCT02124772|50192755|FG005|Overall Study|Investigator discretion|0|||
25084729|NCT02124772|50192756|FG006|Overall Study|Investigator discretion|1|||
25084730|NCT02124772|50192757|FG007|Overall Study|Investigator discretion|0|||
25084731|NCT02124772|50192758|FG008|Overall Study|Investigator discretion|0|||
25084732|NCT02124772|50192759|FG009|Overall Study|Investigator discretion|1|||
25084733|NCT02124772|50192760|FG010|Overall Study|Investigator discretion|0|||
25084734|NCT02124772|50192761|FG011|Overall Study|Investigator discretion|1|||
25084735|NCT02124772|50192762|FG012|Overall Study|Investigator discretion|0|||
25084736|NCT02124772|50192750|FG000|Overall Study|Progressive disease|0|||
25084737|NCT02124772|50192751|FG001|Overall Study|Progressive disease|0|||
25084738|NCT02124772|50192752|FG002|Overall Study|Progressive disease|0|||
25084739|NCT02124772|50192753|FG003|Overall Study|Progressive disease|0|||
25084740|NCT02124772|50192754|FG004|Overall Study|Progressive disease|0|||
25084741|NCT02124772|50192755|FG005|Overall Study|Progressive disease|0|||
25084742|NCT02124772|50192756|FG006|Overall Study|Progressive disease|1|||
25084743|NCT02124772|50192757|FG007|Overall Study|Progressive disease|1|||
25084744|NCT02124772|50192758|FG008|Overall Study|Progressive disease|0|||
25084745|NCT02124772|50192759|FG009|Overall Study|Progressive disease|0|||
25084746|NCT02124772|50192760|FG010|Overall Study|Progressive disease|0|||
25084747|NCT02124772|50192761|FG011|Overall Study|Progressive disease|0|||
25084748|NCT02124772|50192762|FG012|Overall Study|Progressive disease|0|||
25084749|NCT02124772|50192750|FG000|Overall Study|Other|0|||
25084750|NCT02124772|50192751|FG001|Overall Study|Other|7|||
25084751|NCT02124772|50192752|FG002|Overall Study|Other|2|||
25084752|NCT02124772|50192753|FG003|Overall Study|Other|5|||
25084753|NCT02124772|50192754|FG004|Overall Study|Other|4|||
25084754|NCT02124772|50192755|FG005|Overall Study|Other|3|||
25084755|NCT02124772|50192756|FG006|Overall Study|Other|4|||
25084756|NCT02124772|50192757|FG007|Overall Study|Other|1|||
25084757|NCT02124772|50192758|FG008|Overall Study|Other|1|||
25084758|NCT02124772|50192759|FG009|Overall Study|Other|1|||
25084759|NCT02124772|50192760|FG010|Overall Study|Other|1|||
25084760|NCT02124772|50192761|FG011|Overall Study|Other|1|||
25084761|NCT02124772|50192762|FG012|Overall Study|Other|0|||
25084762|NCT02159482|50192814|FG000|Overall Study|Withdrawal by Subject|2|||
25084763|NCT02159482|50192814|FG000|Overall Study|Physician Decision|3|||
25084764|NCT02622321|50192822|FG000|Overall Study|Withdrawal by Subject|2|||
25084765|NCT02622321|50192823|FG001|Overall Study|Withdrawal by Subject|0|||
25084766|NCT02622321|50192824|FG002|Overall Study|Withdrawal by Subject|0|||
25084767|NCT02622321|50192825|FG003|Overall Study|Withdrawal by Subject|0|||
25084768|NCT02622321|50192822|FG000|Overall Study|Death|0|||
25084769|NCT02622321|50192823|FG001|Overall Study|Death|0|||
25084770|NCT02622321|50192824|FG002|Overall Study|Death|1|||
25084771|NCT02622321|50192825|FG003|Overall Study|Death|0|||
25084772|NCT02622321|50192822|FG000|Overall Study|Physician Decision|1|||
25084773|NCT02622321|50192823|FG001|Overall Study|Physician Decision|0|||
25084774|NCT02622321|50192824|FG002|Overall Study|Physician Decision|0|||
25084775|NCT02622321|50192825|FG003|Overall Study|Physician Decision|0|||
25084776|NCT02187172|50192851|FG000|Overall Study|Lost to Follow-up|1|||
25084777|NCT02187172|50192852|FG001|Overall Study|Lost to Follow-up|2|||
25084778|NCT02187172|50192851|FG000|Overall Study|Lack of Efficacy|1|||
25084779|NCT02187172|50192852|FG001|Overall Study|Lack of Efficacy|2|||
25084780|NCT02187172|50192851|FG000|Overall Study|Adverse Event|0|||
25084781|NCT02187172|50192852|FG001|Overall Study|Adverse Event|1|||
25084782|NCT02187172|50192851|FG000|Overall Study|Physician Decision|1|||
25084783|NCT02187172|50192852|FG001|Overall Study|Physician Decision|1|||
25084784|NCT02621931|50192863|FG000|Overall Study|Death|0|||
25084785|NCT02621931|50192864|FG001|Overall Study|Death|1|||
25084786|NCT02621931|50192865|FG002|Overall Study|Death|0|||
25084787|NCT02621931|50192863|FG000|Overall Study|Adverse Event|8|||
25084788|NCT02621931|50192864|FG001|Overall Study|Adverse Event|5|||
25084789|NCT02621931|50192865|FG002|Overall Study|Adverse Event|7|||
25084790|NCT02621931|50192863|FG000|Overall Study|Withdrawal by Subject|12|||
25084791|NCT02621931|50192864|FG001|Overall Study|Withdrawal by Subject|10|||
25084792|NCT02621931|50192865|FG002|Overall Study|Withdrawal by Subject|11|||
25084793|NCT02621931|50192863|FG000|Overall Study|Protocol Violation|2|||
25084794|NCT02621931|50192864|FG001|Overall Study|Protocol Violation|2|||
25084795|NCT02621931|50192865|FG002|Overall Study|Protocol Violation|2|||
25084796|NCT02621931|50192863|FG000|Overall Study|Pregnancy|2|||
25084797|NCT02621931|50192864|FG001|Overall Study|Pregnancy|0|||
25084798|NCT02621931|50192865|FG002|Overall Study|Pregnancy|0|||
25084799|NCT02621931|50192863|FG000|Overall Study|Noncompliance to study procedures|0|||
25084800|NCT02621931|50192864|FG001|Overall Study|Noncompliance to study procedures|1|||
25084801|NCT02621931|50192865|FG002|Overall Study|Noncompliance to study procedures|2|||
25084802|NCT02621931|50192863|FG000|Overall Study|Lost to Follow-up|8|||
25084803|NCT02621931|50192864|FG001|Overall Study|Lost to Follow-up|7|||
25084804|NCT02621931|50192865|FG002|Overall Study|Lost to Follow-up|10|||
25084805|NCT02621931|50192863|FG000|Overall Study|Lack of Efficacy|0|||
25084806|NCT02621931|50192864|FG001|Overall Study|Lack of Efficacy|0|||
25084807|NCT02621931|50192865|FG002|Overall Study|Lack of Efficacy|1|||
25084808|NCT02621931|50192863|FG000|Overall Study|Other|1|||
25084809|NCT02621931|50192864|FG001|Overall Study|Other|1|||
25084810|NCT02621931|50192865|FG002|Overall Study|Other|3|||
25084811|NCT02621073|50192877|FG000|Overall Study|Lost to Follow-up|0|||
25084812|NCT02621073|50192878|FG001|Overall Study|Lost to Follow-up|1|||
25084813|NCT02621073|50192877|FG000|Overall Study|Physician Decision|3|||
25084814|NCT02621073|50192878|FG001|Overall Study|Physician Decision|2|||
25084815|NCT02158936|50192886|FG000|Overall Study|Study closed/ terminated|57|||
25084816|NCT02158936|50192887|FG001|Overall Study|Study closed/ terminated|77|||
25084817|NCT02158936|50192886|FG000|Overall Study|Azacitidine tx discontinued|53|||
25084818|NCT02158936|50192887|FG001|Overall Study|Azacitidine tx discontinued|46|||
25084819|NCT02158936|50192886|FG000|Overall Study|Adverse Event|39|||
25084820|NCT02158936|50192887|FG001|Overall Study|Adverse Event|24|||
25084821|NCT02158936|50192886|FG000|Overall Study|Withdrawal by Subject|15|||
25084822|NCT02158936|50192887|FG001|Overall Study|Withdrawal by Subject|16|||
25084823|NCT02158936|50192886|FG000|Overall Study|Physician Decision|15|||
25084824|NCT02158936|50192887|FG001|Overall Study|Physician Decision|13|||
25084825|NCT02158936|50192886|FG000|Overall Study|Lost to Follow-up|0|||
25084826|NCT02158936|50192887|FG001|Overall Study|Lost to Follow-up|1|||
25084827|NCT02158546|50192897|FG000|Overall Study|Physician Decision|0|||
25084828|NCT02158546|50192898|FG001|Overall Study|Physician Decision|1|||
25084829|NCT02158546|50192899|FG002|Overall Study|Physician Decision|0|||
25084830|NCT02158546|50192900|FG003|Overall Study|Physician Decision|0|||
25084831|NCT02158546|50192897|FG000|Overall Study|Non-compliance|0|||
25084832|NCT02158546|50192898|FG001|Overall Study|Non-compliance|1|||
25084833|NCT02158546|50192899|FG002|Overall Study|Non-compliance|0|||
25084834|NCT02158546|50192900|FG003|Overall Study|Non-compliance|1|||
25084835|NCT02158546|50192897|FG000|Overall Study|Failure to meet eligibility criteria|0|||
25084836|NCT02158546|50192898|FG001|Overall Study|Failure to meet eligibility criteria|1|||
25084837|NCT02158546|50192899|FG002|Overall Study|Failure to meet eligibility criteria|0|||
25084838|NCT02158546|50192900|FG003|Overall Study|Failure to meet eligibility criteria|0|||
25084839|NCT02158546|50192897|FG000|Overall Study|Lack of Efficacy|1|||
25084840|NCT02158546|50192898|FG001|Overall Study|Lack of Efficacy|1|||
25084841|NCT02158546|50192899|FG002|Overall Study|Lack of Efficacy|0|||
25084842|NCT02158546|50192900|FG003|Overall Study|Lack of Efficacy|0|||
25084843|NCT02158546|50192897|FG000|Overall Study|Adverse Event|2|||
25084844|NCT02158546|50192898|FG001|Overall Study|Adverse Event|2|||
25084845|NCT02158546|50192899|FG002|Overall Study|Adverse Event|0|||
25084846|NCT02158546|50192900|FG003|Overall Study|Adverse Event|0|||
25084847|NCT02158546|50192897|FG000|Overall Study|Withdrawal by Subject|6|||
25084848|NCT02158546|50192898|FG001|Overall Study|Withdrawal by Subject|2|||
25084849|NCT02158546|50192899|FG002|Overall Study|Withdrawal by Subject|1|||
25084850|NCT02158546|50192900|FG003|Overall Study|Withdrawal by Subject|0|||
25084851|NCT02158546|50192897|FG000|Overall Study|Lost to Follow-up|5|||
25084852|NCT02158546|50192898|FG001|Overall Study|Lost to Follow-up|4|||
25084853|NCT02158546|50192899|FG002|Overall Study|Lost to Follow-up|0|||
25084854|NCT02158546|50192900|FG003|Overall Study|Lost to Follow-up|1|||
25084855|NCT02158546|50192897|FG000|Overall Study|Site Excluded|5|||
25084856|NCT02158546|50192898|FG001|Overall Study|Site Excluded|5|||
25084857|NCT02158546|50192899|FG002|Overall Study|Site Excluded|3|||
25084858|NCT02158546|50192900|FG003|Overall Study|Site Excluded|4|||
25084859|NCT02123446|50192910|FG000|Washout Period (1 Day)|Physician Decision|1|||
25084860|NCT02123446|50192911|FG001|Washout Period (1 Day)|Physician Decision|0|||
25084861|NCT02123134|50192919|FG000|Overall Study|Withdrawal of consent|3|||
25084862|NCT02123134|50192920|FG001|Overall Study|Withdrawal of consent|2|||
25084863|NCT02123134|50192919|FG000|Overall Study|Administrative decision|0|||
25084864|NCT02123134|50192920|FG001|Overall Study|Administrative decision|1|||
25084865|NCT02185534|50192932|FG000|First Period|Withdrawal by Subject|0|||
25084866|NCT02185534|50192933|FG001|First Period|Withdrawal by Subject|0|||
25084867|NCT02185534|50192934|FG002|First Period|Withdrawal by Subject|0|||
25084868|NCT02185534|50192935|FG003|First Period|Withdrawal by Subject|1|||
25084869|NCT02185534|50192936|FG004|First Period|Withdrawal by Subject|0|||
25084870|NCT02185534|50192937|FG005|First Period|Withdrawal by Subject|0|||
25084871|NCT02185534|50192932|FG000|First Washout Period|Withdrawal by Subject|1|||
25084872|NCT02185534|50192933|FG001|First Washout Period|Withdrawal by Subject|0|||
25084873|NCT02185534|50192934|FG002|First Washout Period|Withdrawal by Subject|0|||
25084874|NCT02185534|50192935|FG003|First Washout Period|Withdrawal by Subject|0|||
25084875|NCT02185534|50192936|FG004|First Washout Period|Withdrawal by Subject|1|||
25084876|NCT02185534|50192937|FG005|First Washout Period|Withdrawal by Subject|0|||
25084877|NCT02185534|50192932|FG000|First Washout Period|Protocol Violation|0|||
25084878|NCT02185534|50192933|FG001|First Washout Period|Protocol Violation|0|||
25084879|NCT02185534|50192934|FG002|First Washout Period|Protocol Violation|0|||
25084880|NCT02185534|50192935|FG003|First Washout Period|Protocol Violation|0|||
25084881|NCT02185534|50192936|FG004|First Washout Period|Protocol Violation|0|||
25084882|NCT02185534|50192937|FG005|First Washout Period|Protocol Violation|1|||
25084883|NCT02121808|50192946|FG000|Overall Study|Technical problem|3|||
25084884|NCT02157376|50192957|FG000|Overall Study|Death|10|||
25084885|NCT02157376|50192958|FG001|Overall Study|Death|4|||
25084886|NCT02157376|50192957|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
25084887|NCT02157376|50192958|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
25084888|NCT02157376|50192957|FG000|Overall Study|Withdrawal by Subject|3|||
25084889|NCT02157376|50192958|FG001|Overall Study|Withdrawal by Subject|8|||
25084890|NCT02157376|50192957|FG000|Overall Study|Not treated|8|||
25084891|NCT02157376|50192958|FG001|Overall Study|Not treated|3|||
25084892|NCT02157376|50192957|FG000|Overall Study|Investigator's misjudgement|1|||
25084893|NCT02157376|50192958|FG001|Overall Study|Investigator's misjudgement|2|||
25084894|NCT02157298|50192966|FG000|Overall Study|Adverse Event|1|||
25084895|NCT02157298|50192967|FG001|Overall Study|Adverse Event|0|||
25084896|NCT02157298|50192966|FG000|Overall Study|Subject no longer meets study criteria|1|||
25084897|NCT02157298|50192967|FG001|Overall Study|Subject no longer meets study criteria|2|||
25084898|NCT02157298|50192966|FG000|Overall Study|Poor/Non-compliance|1|||
25084899|NCT02157298|50192967|FG001|Overall Study|Poor/Non-compliance|0|||
25084900|NCT02157298|50192966|FG000|Overall Study|Withdrawal by Subject|1|||
25084901|NCT02157298|50192967|FG001|Overall Study|Withdrawal by Subject|0|||
25084902|NCT02184988|50192973|FG000|Overall Study|Pregnancy|2|||
25084903|NCT02184988|50192973|FG000|Overall Study|Adverse Event|2|||
25084904|NCT02184988|50192973|FG000|Overall Study|moving away/travelling/unable to complet|6|||
25084905|NCT02184988|50192973|FG000|Overall Study|work scheduling issues|4|||
25084906|NCT02184988|50192973|FG000|Overall Study|various other reasons|9|||
25084907|NCT02184988|50192973|FG000|Overall Study|Lost to Follow-up|32|||
25084908|NCT02121262|50192979|FG000|Overall Study|Adverse Event|6|||
25084909|NCT02121262|50192980|FG001|Overall Study|Adverse Event|3|||
25084910|NCT02121262|50192979|FG000|Overall Study|Lack of Efficacy|3|||
25084911|NCT02121262|50192980|FG001|Overall Study|Lack of Efficacy|0|||
25084912|NCT02121262|50192979|FG000|Overall Study|Personal Reasons|19|||
25084913|NCT02121262|50192980|FG001|Overall Study|Personal Reasons|5|||
25084914|NCT02121262|50192979|FG000|Overall Study|Protocol Violation|1|||
25084915|NCT02121262|50192980|FG001|Overall Study|Protocol Violation|1|||
25084916|NCT02121262|50192979|FG000|Overall Study|Participant Dropped-out|0|||
25084917|NCT02121262|50192980|FG001|Overall Study|Participant Dropped-out|1|||
25084918|NCT02121262|50192979|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
25084919|NCT02121262|50192980|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
25084920|NCT02121262|50192979|FG000|Overall Study|Consent Withdrawn|1|||
25084921|NCT02121262|50192980|FG001|Overall Study|Consent Withdrawn|0|||
25084922|NCT02120950|50192988|FG000|Overall Study|Adverse Event|5|||
25084923|NCT02120950|50192989|FG001|Overall Study|Adverse Event|4|||
25084924|NCT02120950|50192990|FG002|Overall Study|Adverse Event|3|||
25084925|NCT02120950|50192988|FG000|Overall Study|Death|3|||
25084926|NCT02120950|50192989|FG001|Overall Study|Death|0|||
25084927|NCT02120950|50192990|FG002|Overall Study|Death|1|||
25084928|NCT02120950|50192988|FG000|Overall Study|Withdrawal by Subject|6|||
25084929|NCT02120950|50192989|FG001|Overall Study|Withdrawal by Subject|3|||
25084930|NCT02120950|50192990|FG002|Overall Study|Withdrawal by Subject|2|||
25084931|NCT02120950|50192988|FG000|Overall Study|Protocol Violation|1|||
25084932|NCT02120950|50192989|FG001|Overall Study|Protocol Violation|1|||
25084933|NCT02120950|50192990|FG002|Overall Study|Protocol Violation|7|||
25084934|NCT02120950|50192988|FG000|Overall Study|Other reasons|5|||
25084935|NCT02120950|50192989|FG001|Overall Study|Other reasons|4|||
25084936|NCT02120950|50192990|FG002|Overall Study|Other reasons|1|||
25084937|NCT02120950|50192988|FG000|Overall Study|Lost to Follow-up|0|||
25084938|NCT02120950|50192989|FG001|Overall Study|Lost to Follow-up|2|||
25084939|NCT02120950|50192990|FG002|Overall Study|Lost to Follow-up|1|||
25084940|NCT02120794|50192997|FG000|Overall Study|Withdrawal by Subject|43|||
25084941|NCT02120794|50192997|FG000|Overall Study|Adverse Event|10|||
25084942|NCT02120794|50192997|FG000|Overall Study|Physician Decision|4|||
25084943|NCT02120794|50192997|FG000|Overall Study|Due to insurance coverage|1|||
25084944|NCT02184442|50193003|FG000|Overall Study|Death|61|||
25084945|NCT02184442|50193004|FG001|Overall Study|Death|65|||
25084946|NCT02184442|50193003|FG000|Overall Study|Withdrawal by Subject|3|||
25084947|NCT02184442|50193004|FG001|Overall Study|Withdrawal by Subject|11|||
25084948|NCT02155738|50193014|FG000|Overall Study|Missing critical information|1|||
25084949|NCT02155738|50193015|FG001|Overall Study|Missing critical information|0|||
25084950|NCT02155738|50193016|FG002|Overall Study|Missing critical information|0|||
25084951|NCT02155738|50193017|FG003|Overall Study|Missing critical information|1|||
25084952|NCT02181790|50193029|FG000|Overall Study|study terminated|2|||
25084953|NCT02181790|50193030|FG001|Overall Study|study terminated|0|||
25084954|NCT02618967|50193046|FG000|Overall Study|Lost to Follow-up|0|||
25084955|NCT02618967|50193047|FG001|Overall Study|Lost to Follow-up|0|||
25084956|NCT02618967|50193048|FG002|Overall Study|Lost to Follow-up|1|||
25084957|NCT02618967|50193049|FG003|Overall Study|Lost to Follow-up|0|||
25084958|NCT02618967|50193050|FG004|Overall Study|Lost to Follow-up|2|||
25084959|NCT02618967|50193051|FG005|Overall Study|Lost to Follow-up|0|||
25084960|NCT02618967|50193052|FG006|Overall Study|Lost to Follow-up|0|||
25084961|NCT02618967|50193053|FG007|Overall Study|Lost to Follow-up|0|||
25084962|NCT02618967|50193046|FG000|Overall Study|Withdrawal by Subject|1|||
25084963|NCT02618967|50193047|FG001|Overall Study|Withdrawal by Subject|0|||
25084964|NCT02618967|50193048|FG002|Overall Study|Withdrawal by Subject|0|||
25084965|NCT02618967|50193049|FG003|Overall Study|Withdrawal by Subject|0|||
25084966|NCT02618967|50193050|FG004|Overall Study|Withdrawal by Subject|0|||
25084967|NCT02618967|50193051|FG005|Overall Study|Withdrawal by Subject|0|||
25084968|NCT02618967|50193052|FG006|Overall Study|Withdrawal by Subject|0|||
25084969|NCT02618967|50193053|FG007|Overall Study|Withdrawal by Subject|0|||
25084970|NCT02616783|50193073|FG000|Overall Study|Randomized but Not Treated|1|||
25084971|NCT02616783|50193074|FG001|Overall Study|Randomized but Not Treated|0|||
25084972|NCT02616783|50193073|FG000|Overall Study|Adverse Event|1|||
25084973|NCT02616783|50193074|FG001|Overall Study|Adverse Event|0|||
25084974|NCT02616783|50193073|FG000|Overall Study|Death|1|||
25084975|NCT02616783|50193074|FG001|Overall Study|Death|0|||
25084976|NCT02616783|50193073|FG000|Overall Study|Non-Compliance with Study Drug|1|||
25084977|NCT02616783|50193074|FG001|Overall Study|Non-Compliance with Study Drug|0|||
25084978|NCT02616783|50193073|FG000|Overall Study|Protocol Violation|1|||
25084979|NCT02616783|50193074|FG001|Overall Study|Protocol Violation|1|||
25084980|NCT02616783|50193073|FG000|Overall Study|Withdrew Consent|1|||
25084981|NCT02616783|50193074|FG001|Overall Study|Withdrew Consent|1|||
25084982|NCT02616393|50193083|FG000|Overall Study|Death|5|||
25084983|NCT02616393|50193084|FG001|Overall Study|Death|12|||
25084984|NCT02616393|50193085|FG002|Overall Study|Death|1|||
25084985|NCT02616393|50193083|FG000|Overall Study|Termination by Sponsor|4|||
25084986|NCT02616393|50193084|FG001|Overall Study|Termination by Sponsor|5|||
25084987|NCT02616393|50193085|FG002|Overall Study|Termination by Sponsor|2|||
25084988|NCT02616393|50193083|FG000|Overall Study|Other|3|||
25084989|NCT02616393|50193084|FG001|Overall Study|Other|0|||
25084990|NCT02616393|50193085|FG002|Overall Study|Other|0|||
25084991|NCT02616393|50193083|FG000|Overall Study|Withdrawal by Subject|1|||
25084992|NCT02616393|50193084|FG001|Overall Study|Withdrawal by Subject|1|||
25084993|NCT02616393|50193085|FG002|Overall Study|Withdrawal by Subject|0|||
25084994|NCT02616393|50193083|FG000|Overall Study|Lost to Follow-up|0|||
25084995|NCT02616393|50193084|FG001|Overall Study|Lost to Follow-up|2|||
25084996|NCT02616393|50193085|FG002|Overall Study|Lost to Follow-up|0|||
25084997|NCT02155660|50193113|FG000|Overall Study|Other Reason|8|||
25084998|NCT02155660|50193114|FG001|Overall Study|Other Reason|6|||
25084999|NCT02155660|50193115|FG002|Overall Study|Other Reason|10|||
25085000|NCT02155660|50193116|FG003|Overall Study|Other Reason|10|||
25085001|NCT02155660|50193113|FG000|Overall Study|Study-specific withdrawal criteria|0|||
25085002|NCT02155660|50193114|FG001|Overall Study|Study-specific withdrawal criteria|1|||
25085003|NCT02155660|50193115|FG002|Overall Study|Study-specific withdrawal criteria|1|||
25085004|NCT02155660|50193116|FG003|Overall Study|Study-specific withdrawal criteria|1|||
25085005|NCT02155660|50193113|FG000|Overall Study|Severe non-compliance|0|||
25085006|NCT02155660|50193114|FG001|Overall Study|Severe non-compliance|4|||
25085007|NCT02155660|50193115|FG002|Overall Study|Severe non-compliance|0|||
25085008|NCT02155660|50193116|FG003|Overall Study|Severe non-compliance|1|||
25085009|NCT02155660|50193113|FG000|Overall Study|Adverse Event|2|||
25085010|NCT02155660|50193114|FG001|Overall Study|Adverse Event|6|||
25085011|NCT02155660|50193115|FG002|Overall Study|Adverse Event|3|||
25085012|NCT02155660|50193116|FG003|Overall Study|Adverse Event|1|||
25085013|NCT02155660|50193113|FG000|Overall Study|Lost to Follow-up|3|||
25085014|NCT02155660|50193114|FG001|Overall Study|Lost to Follow-up|6|||
25085015|NCT02155660|50193115|FG002|Overall Study|Lost to Follow-up|5|||
25085016|NCT02155660|50193116|FG003|Overall Study|Lost to Follow-up|8|||
25085017|NCT02155660|50193113|FG000|Overall Study|Death|17|||
25085018|NCT02155660|50193114|FG001|Overall Study|Death|19|||
25085019|NCT02155660|50193115|FG002|Overall Study|Death|17|||
25085020|NCT02155660|50193116|FG003|Overall Study|Death|19|||
25085021|NCT02155660|50193113|FG000|Overall Study|Withdrawal by Subject|28|||
25085022|NCT02155660|50193114|FG001|Overall Study|Withdrawal by Subject|31|||
25085023|NCT02155660|50193115|FG002|Overall Study|Withdrawal by Subject|24|||
25085024|NCT02155660|50193116|FG003|Overall Study|Withdrawal by Subject|21|||
25085025|NCT02119936|50193126|FG000|Overall Study|Lost to Follow-up|10|||
25085026|NCT02181634|50193130|FG000|Overall Study|Lack of Efficacy|33|||
25085027|NCT02181634|50193130|FG000|Overall Study|Adverse Event|17|||
25085028|NCT02181634|50193130|FG000|Overall Study|Physician Decision|8|||
25085029|NCT02181634|50193130|FG000|Overall Study|Withdrawal by Subject|5|||
25085030|NCT02181634|50193130|FG000|Overall Study|Death|2|||
25085031|NCT02181634|50193130|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
25085032|NCT02181634|50193130|FG000|Overall Study|Ineligible|1|||
25085033|NCT02181634|50193130|FG000|Overall Study|Max number of dose reduction|1|||
25085034|NCT02181634|50193130|FG000|Overall Study|Symptomatic progression|1|||
25085035|NCT02181634|50193130|FG000|Overall Study|Patient opted to proceed to surgery|1|||
25085036|NCT01595529|50193136|FG000|Overall Study|Adverse Event|2|||
25085037|NCT01595529|50193137|FG001|Overall Study|Adverse Event|0|||
25085038|NCT01595529|50193136|FG000|Overall Study|Subject Non-Compliant|2|||
25085039|NCT01595529|50193137|FG001|Overall Study|Subject Non-Compliant|0|||
25085040|NCT01595529|50193136|FG000|Overall Study|Lost to Follow-up|8|||
25085041|NCT01595529|50193137|FG001|Overall Study|Lost to Follow-up|14|||
25085042|NCT01595529|50193136|FG000|Overall Study|Protocol Violation|1|||
25085043|NCT01595529|50193137|FG001|Overall Study|Protocol Violation|2|||
25085044|NCT01595529|50193136|FG000|Overall Study|Physician Decision|1|||
25085045|NCT01595529|50193137|FG001|Overall Study|Physician Decision|0|||
25085046|NCT01595529|50193136|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
25085047|NCT01595529|50193137|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
25085048|NCT01595529|50193136|FG000|Overall Study|Administrative Decision|1|||
25085049|NCT01595529|50193137|FG001|Overall Study|Administrative Decision|0|||
25085050|NCT01595529|50193136|FG000|Overall Study|Entry Failure/Screening Failure|6|||
25085051|NCT01595529|50193137|FG001|Overall Study|Entry Failure/Screening Failure|1|||
25085052|NCT02615145|50193146|FG000|Overall Study|Did Not Start Treatment|0|||
25085053|NCT02615145|50193147|FG001|Overall Study|Did Not Start Treatment|0|||
25085054|NCT02615145|50193148|FG002|Overall Study|Did Not Start Treatment|1|||
25085055|NCT02615145|50193149|FG003|Overall Study|Did Not Start Treatment|1|||
25085056|NCT02615145|50193146|FG000|Overall Study|Failure to Return|20|||
25085057|NCT02615145|50193147|FG001|Overall Study|Failure to Return|10|||
25085058|NCT02615145|50193148|FG002|Overall Study|Failure to Return|7|||
25085059|NCT02615145|50193149|FG003|Overall Study|Failure to Return|0|||
25085060|NCT02615145|50193146|FG000|Overall Study|Death|2|||
25085061|NCT02615145|50193147|FG001|Overall Study|Death|3|||
25085062|NCT02615145|50193148|FG002|Overall Study|Death|0|||
25085063|NCT02615145|50193149|FG003|Overall Study|Death|0|||
25085064|NCT02615145|50193146|FG000|Overall Study|Other, Not Specified|5|||
25085065|NCT02615145|50193147|FG001|Overall Study|Other, Not Specified|2|||
25085066|NCT02615145|50193148|FG002|Overall Study|Other, Not Specified|0|||
25085067|NCT02615145|50193149|FG003|Overall Study|Other, Not Specified|0|||
25085068|NCT02119156|50193178|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
25085069|NCT02119156|50193179|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
25085070|NCT02119156|50193180|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
25085071|NCT02119156|50193178|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
25085072|NCT02119156|50193179|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
25085073|NCT02119156|50193180|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
25085074|NCT02119156|50193178|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
25085075|NCT02119156|50193179|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
25085076|NCT02119156|50193180|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
25085077|NCT02119156|50193178|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
25085078|NCT02119156|50193179|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
25085079|NCT02119156|50193180|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
25085080|NCT02119156|50193178|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
25085081|NCT02119156|50193179|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
25085082|NCT02119156|50193180|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
25085083|NCT02181556|50193195|FG000|Overall Study|Withdrawal by Subject|1|||
25085084|NCT02614131|50193206|FG000|Overall Study|Withdrawal by Subject|1|||
25085085|NCT02614131|50193207|FG001|Overall Study|Withdrawal by Subject|0|||
25085086|NCT02614131|50193208|FG002|Overall Study|Withdrawal by Subject|0|||
25085087|NCT02614131|50193209|FG003|Overall Study|Withdrawal by Subject|0|||
25085088|NCT02614131|50193210|FG004|Overall Study|Withdrawal by Subject|0|||
25085089|NCT02614131|50193211|FG005|Overall Study|Withdrawal by Subject|0|||
25085090|NCT02614131|50193212|FG006|Overall Study|Withdrawal by Subject|0|||
25085091|NCT02614131|50193206|FG000|Overall Study|Adverse Event|0|||
25085092|NCT02614131|50193207|FG001|Overall Study|Adverse Event|0|||
25085093|NCT02614131|50193208|FG002|Overall Study|Adverse Event|0|||
25085094|NCT02614131|50193209|FG003|Overall Study|Adverse Event|0|||
25085095|NCT02614131|50193210|FG004|Overall Study|Adverse Event|0|||
25085096|NCT02614131|50193211|FG005|Overall Study|Adverse Event|0|||
25085097|NCT02614131|50193212|FG006|Overall Study|Adverse Event|1|||
25085098|NCT01903733|50193238|FG000|Overall Study|Death|23|||
25085099|NCT01903733|50193239|FG001|Overall Study|Death|54|||
25085100|NCT01903733|50193240|FG002|Overall Study|Death|30|||
25085101|NCT01903733|50193241|FG003|Overall Study|Death|98|||
25085102|NCT01903733|50193238|FG000|Overall Study|Participant refused further follow-up|35|||
25085103|NCT01903733|50193239|FG001|Overall Study|Participant refused further follow-up|38|||
25085104|NCT01903733|50193240|FG002|Overall Study|Participant refused further follow-up|13|||
25085105|NCT01903733|50193241|FG003|Overall Study|Participant refused further follow-up|9|||
25085106|NCT01903733|50193238|FG000|Overall Study|Lost to Follow-up|18|||
25085107|NCT01903733|50193239|FG001|Overall Study|Lost to Follow-up|19|||
25085108|NCT01903733|50193240|FG002|Overall Study|Lost to Follow-up|6|||
25085109|NCT01903733|50193241|FG003|Overall Study|Lost to Follow-up|9|||
25085110|NCT01903733|50193238|FG000|Overall Study|Other|10|||
25085111|NCT01903733|50193239|FG001|Overall Study|Other|15|||
25085112|NCT01903733|50193240|FG002|Overall Study|Other|12|||
25085113|NCT01903733|50193241|FG003|Overall Study|Other|3|||
25085114|NCT01903733|50193238|FG000|Overall Study|Missing|2|||
25085115|NCT01903733|50193239|FG001|Overall Study|Missing|0|||
25085116|NCT01903733|50193240|FG002|Overall Study|Missing|0|||
25085117|NCT01903733|50193241|FG003|Overall Study|Missing|0|||
25085118|NCT01903733|50193238|FG000|Overall Study|Investigator request|18|||
25085119|NCT01903733|50193239|FG001|Overall Study|Investigator request|0|||
25085120|NCT01903733|50193240|FG002|Overall Study|Investigator request|0|||
25085121|NCT01903733|50193241|FG003|Overall Study|Investigator request|0|||
25085122|NCT01375205|50193263|FG000|Overall Study|Lost to Follow-up|15|||
25085123|NCT01375205|50193264|FG001|Overall Study|Lost to Follow-up|12|||
25085124|NCT01375205|50193263|FG000|Overall Study|Withdrawal by Subject|6|||
25085125|NCT01375205|50193264|FG001|Overall Study|Withdrawal by Subject|1|||
25085126|NCT00700271|50193272|FG000|Overall Study|Adverse Event|4|||
25085127|NCT00700271|50193273|FG001|Overall Study|Adverse Event|6|||
25085128|NCT00700271|50193272|FG000|Overall Study|Protocol Violation|1|||
25085129|NCT00700271|50193273|FG001|Overall Study|Protocol Violation|0|||
25085130|NCT00700271|50193272|FG000|Overall Study|Administrative Reasons|1|||
25085131|NCT00700271|50193273|FG001|Overall Study|Administrative Reasons|0|||
25085132|NCT00700271|50193272|FG000|Overall Study|Withdrawal by Subject|6|||
25085133|NCT00700271|50193273|FG001|Overall Study|Withdrawal by Subject|4|||
25085134|NCT00700271|50193272|FG000|Overall Study|Lost to Follow-up|2|||
25085135|NCT00700271|50193273|FG001|Overall Study|Lost to Follow-up|2|||
25085136|NCT02613507|50193281|FG000|Overall Study|Disease Progression|237|||
25085137|NCT02613507|50193282|FG001|Overall Study|Disease Progression|109|||
25085138|NCT02613507|50193281|FG000|Overall Study|Study Drug Toxicity|15|||
25085139|NCT02613507|50193282|FG001|Overall Study|Study Drug Toxicity|14|||
25085140|NCT02613507|50193281|FG000|Overall Study|Death|3|||
25085141|NCT02613507|50193282|FG001|Overall Study|Death|0|||
25085142|NCT02613507|50193281|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17|||
25085143|NCT02613507|50193282|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
25085144|NCT02613507|50193281|FG000|Overall Study|Request to Discontinue Study Treatment|8|||
25085145|NCT02613507|50193282|FG001|Overall Study|Request to Discontinue Study Treatment|17|||
25085146|NCT02613507|50193281|FG000|Overall Study|Participant Withdrew Consent|0|||
25085147|NCT02613507|50193282|FG001|Overall Study|Participant Withdrew Consent|2|||
25085148|NCT02613507|50193281|FG000|Overall Study|Lost to Follow-up|1|||
25085149|NCT02613507|50193282|FG001|Overall Study|Lost to Follow-up|0|||
25085150|NCT02613507|50193281|FG000|Overall Study|Maximum Clinical Benefit|4|||
25085151|NCT02613507|50193282|FG001|Overall Study|Maximum Clinical Benefit|10|||
25085152|NCT02613507|50193281|FG000|Overall Study|Brain Radiotherapy Activity Limited|1|||
25085153|NCT02613507|50193282|FG001|Overall Study|Brain Radiotherapy Activity Limited|0|||
25085154|NCT02613507|50193281|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
25085155|NCT02613507|50193282|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
25085156|NCT02613507|50193281|FG000|Overall Study|Randomized but not Treated|1|||
25085157|NCT02613507|50193282|FG001|Overall Study|Randomized but not Treated|10|||
25085158|NCT01375049|50193288|FG000|Overall Study|Adverse Event|2|||
25085159|NCT01375049|50193288|FG000|Overall Study|Lost to Follow-up|1|||
25085160|NCT01375049|50193288|FG000|Overall Study|Withdrawal by Subject|2|||
25085161|NCT01375049|50193288|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
25085162|NCT01594749|50193298|FG000|Overall Study|Adverse Event|2|||
25085163|NCT01594749|50193299|FG001|Overall Study|Adverse Event|1|||
25085164|NCT01594749|50193298|FG000|Overall Study|Withdrawal by Subject|2|||
25085165|NCT01594749|50193299|FG001|Overall Study|Withdrawal by Subject|2|||
25085166|NCT01594749|50193298|FG000|Overall Study|Protocol Violation|2|||
25085167|NCT01594749|50193299|FG001|Overall Study|Protocol Violation|0|||
25085168|NCT01594749|50193298|FG000|Overall Study|Physician Decision|1|||
25085169|NCT01594749|50193299|FG001|Overall Study|Physician Decision|1|||
25085170|NCT01594749|50193298|FG000|Overall Study|Non-compliance with Protocol|0|||
25085171|NCT01594749|50193299|FG001|Overall Study|Non-compliance with Protocol|1|||
25085172|NCT01594749|50193298|FG000|Overall Study|Lost to Follow-up|1|||
25085173|NCT01594749|50193299|FG001|Overall Study|Lost to Follow-up|0|||
25085174|NCT01594749|50193298|FG000|Overall Study|Death|9|||
25085175|NCT01594749|50193299|FG001|Overall Study|Death|3|||
25085176|NCT01594749|50193298|FG000|Overall Study|Not Treated|4|||
25085177|NCT01594749|50193299|FG001|Overall Study|Not Treated|10|||
25085178|NCT01594749|50193298|FG000|Overall Study|Lost Source Documentation|1|||
25085179|NCT01594749|50193299|FG001|Overall Study|Lost Source Documentation|0|||
25085180|NCT02179918|50193310|FG000|Overall Study|Death|0|||
25085181|NCT02179918|50193311|FG001|Overall Study|Death|0|||
25085182|NCT02179918|50193312|FG002|Overall Study|Death|0|||
25085183|NCT02179918|50193313|FG003|Overall Study|Death|1|||
25085184|NCT02179918|50193314|FG004|Overall Study|Death|0|||
25085185|NCT02179918|50193310|FG000|Overall Study|Lost to Follow-up|0|||
25085186|NCT02179918|50193311|FG001|Overall Study|Lost to Follow-up|0|||
25085187|NCT02179918|50193312|FG002|Overall Study|Lost to Follow-up|1|||
25085188|NCT02179918|50193313|FG003|Overall Study|Lost to Follow-up|0|||
25085189|NCT02179918|50193314|FG004|Overall Study|Lost to Follow-up|0|||
25085190|NCT02179918|50193310|FG000|Overall Study|Progressive Disease|4|||
25085191|NCT02179918|50193311|FG001|Overall Study|Progressive Disease|1|||
25085192|NCT02179918|50193312|FG002|Overall Study|Progressive Disease|1|||
25085193|NCT02179918|50193313|FG003|Overall Study|Progressive Disease|2|||
25085194|NCT02179918|50193314|FG004|Overall Study|Progressive Disease|6|||
25085195|NCT02179918|50193310|FG000|Overall Study|Other|0|||
25085196|NCT02179918|50193311|FG001|Overall Study|Other|1|||
25085197|NCT02179918|50193312|FG002|Overall Study|Other|0|||
25085198|NCT02179918|50193313|FG003|Overall Study|Other|0|||
25085199|NCT02179918|50193314|FG004|Overall Study|Other|1|||
25085200|NCT02179918|50193310|FG000|Overall Study|Subject refused further follow-up|0|||
25085201|NCT02179918|50193311|FG001|Overall Study|Subject refused further follow-up|1|||
25085202|NCT02179918|50193312|FG002|Overall Study|Subject refused further follow-up|0|||
25085203|NCT02179918|50193313|FG003|Overall Study|Subject refused further follow-up|0|||
25085204|NCT02179918|50193314|FG004|Overall Study|Subject refused further follow-up|1|||
25085205|NCT02611479|50193327|FG000|Baseline Enrollment|Exited study|13|||
25085206|NCT02611479|50193327|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
25085207|NCT02611479|50193327|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
25276953|NCT01040403|50590902|FG000|Overall Study|Not treated|1|||
25085208|NCT02611479|50193327|FG000|Data Cleaning|No baseline function or pain metrics|2|||
25085209|NCT02153788|50193333|FG000|Overall Study|Physician Decision|2|||
25085210|NCT02153788|50193334|FG001|Overall Study|Physician Decision|1|||
25085211|NCT02153398|50193345|FG000|Overall Study|Withdrawal by Subject|1|||
25085212|NCT02153398|50193346|FG001|Overall Study|Withdrawal by Subject|0|||
25085213|NCT02153398|50193347|FG002|Overall Study|Withdrawal by Subject|0|||
25085214|NCT02153398|50193348|FG003|Overall Study|Withdrawal by Subject|0|||
25085215|NCT02153398|50193349|FG004|Overall Study|Withdrawal by Subject|0|||
25085216|NCT02153398|50193345|FG000|Overall Study|Adverse Event|0|||
25085217|NCT02153398|50193346|FG001|Overall Study|Adverse Event|0|||
25085218|NCT02153398|50193347|FG002|Overall Study|Adverse Event|1|||
25085219|NCT02153398|50193348|FG003|Overall Study|Adverse Event|1|||
25085220|NCT02153398|50193349|FG004|Overall Study|Adverse Event|0|||
25085221|NCT02118766|50193363|FG000|Overall Study|Adverse Event|7|||
25085222|NCT02118766|50193364|FG001|Overall Study|Adverse Event|2|||
25085223|NCT02118766|50193363|FG000|Overall Study|Withdrawal by Subject|3|||
25085224|NCT02118766|50193364|FG001|Overall Study|Withdrawal by Subject|6|||
25085225|NCT02118766|50193363|FG000|Overall Study|Lost to Follow-up|5|||
25085226|NCT02118766|50193364|FG001|Overall Study|Lost to Follow-up|4|||
25085227|NCT02118766|50193363|FG000|Overall Study|Withdrawal by parent/guardian|12|||
25085228|NCT02118766|50193364|FG001|Overall Study|Withdrawal by parent/guardian|18|||
25085229|NCT02118766|50193363|FG000|Overall Study|Other|3|||
25085230|NCT02118766|50193364|FG001|Overall Study|Other|1|||
25085231|NCT02614287|50193372|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
25085232|NCT02614287|50193373|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
25085233|NCT02614287|50193372|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
25085234|NCT02614287|50193373|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
25085235|NCT02614287|50193372|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
25085236|NCT02614287|50193373|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
25085237|NCT02614287|50193372|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
25085238|NCT02614287|50193373|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
25085239|NCT02614287|50193372|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
25085240|NCT02614287|50193373|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
25085241|NCT02614287|50193372|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
25085242|NCT02614287|50193373|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
25085243|NCT02614287|50193372|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
25085244|NCT02614287|50193373|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
25085245|NCT02614287|50193372|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
25085246|NCT02614287|50193373|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
25085247|NCT01374971|50193384|FG000|Overall Study|Withdrawal by Subject|1|||
25085248|NCT02178592|50193390|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
25085249|NCT02178592|50193391|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
25085250|NCT02178592|50193390|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
25085251|NCT02178592|50193391|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
25085252|NCT02178592|50193390|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
25085253|NCT02178592|50193391|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
25085254|NCT02178592|50193390|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
25085255|NCT02178592|50193391|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
25085256|NCT02178592|50193390|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
25085257|NCT02178592|50193391|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
25085258|NCT02178592|50193390|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
25085259|NCT02178592|50193391|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
25085260|NCT02178592|50193390|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
25085261|NCT02178592|50193391|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
25085262|NCT02178592|50193390|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
25085263|NCT02178592|50193391|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
25085264|NCT02178592|50193390|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
25085265|NCT02178592|50193391|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
25085266|NCT02178592|50193390|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
25085267|NCT02178592|50193391|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
25085268|NCT02178592|50193390|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
25085269|NCT02178592|50193391|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
25085270|NCT02178592|50193390|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
25085271|NCT02178592|50193391|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
25085272|NCT02610777|50193402|FG000|Overall Study|Lost to Follow-up|1|||
25085273|NCT02610777|50193403|FG001|Overall Study|Lost to Follow-up|0|||
25085274|NCT02610777|50193402|FG000|Overall Study|Site Terminated by Sponsor|9|||
25085275|NCT02610777|50193403|FG001|Overall Study|Site Terminated by Sponsor|8|||
25085276|NCT02610777|50193402|FG000|Overall Study|Withdrawal by Subject|2|||
25085277|NCT02610777|50193403|FG001|Overall Study|Withdrawal by Subject|2|||
25085278|NCT02610777|50193402|FG000|Overall Study|Reason not Specified|0|||
25085279|NCT02610777|50193403|FG001|Overall Study|Reason not Specified|1|||
25085280|NCT02610777|50193402|FG000|Overall Study|Death|50|||
25085281|NCT02610777|50193403|FG001|Overall Study|Death|47|||
25085282|NCT01628692|50193417|FG000|Overall Study|Lack of Efficacy|4|||
25085283|NCT01628692|50193418|FG001|Overall Study|Lack of Efficacy|4|||
25085284|NCT01628692|50193419|FG002|Overall Study|Lack of Efficacy|5|||
25085285|NCT01628692|50193420|FG003|Overall Study|Lack of Efficacy|1|||
25085286|NCT01628692|50193421|FG004|Overall Study|Lack of Efficacy|4|||
25085287|NCT01628692|50193422|FG005|Overall Study|Lack of Efficacy|7|||
25085288|NCT01628692|50193417|FG000|Overall Study|Adverse Event|2|||
25085289|NCT01628692|50193418|FG001|Overall Study|Adverse Event|0|||
25085290|NCT01628692|50193419|FG002|Overall Study|Adverse Event|2|||
25085291|NCT01628692|50193420|FG003|Overall Study|Adverse Event|0|||
25085292|NCT01628692|50193421|FG004|Overall Study|Adverse Event|0|||
25085293|NCT01628692|50193422|FG005|Overall Study|Adverse Event|0|||
25085294|NCT01628692|50193417|FG000|Overall Study|Withdrawal by Subject|0|||
25085295|NCT01628692|50193418|FG001|Overall Study|Withdrawal by Subject|1|||
25085296|NCT01628692|50193419|FG002|Overall Study|Withdrawal by Subject|1|||
25085297|NCT01628692|50193420|FG003|Overall Study|Withdrawal by Subject|0|||
25085298|NCT01628692|50193421|FG004|Overall Study|Withdrawal by Subject|0|||
25085299|NCT01628692|50193422|FG005|Overall Study|Withdrawal by Subject|0|||
25085300|NCT01628692|50193417|FG000|Overall Study|Death|0|||
25085301|NCT01628692|50193418|FG001|Overall Study|Death|1|||
25085302|NCT01628692|50193419|FG002|Overall Study|Death|0|||
25085303|NCT01628692|50193420|FG003|Overall Study|Death|0|||
25085304|NCT01628692|50193421|FG004|Overall Study|Death|0|||
25085305|NCT01628692|50193422|FG005|Overall Study|Death|0|||
25085306|NCT01628692|50193417|FG000|Overall Study|Poor compliance/noncompliance|1|||
25085307|NCT01628692|50193418|FG001|Overall Study|Poor compliance/noncompliance|0|||
25085308|NCT01628692|50193419|FG002|Overall Study|Poor compliance/noncompliance|0|||
25085309|NCT01628692|50193420|FG003|Overall Study|Poor compliance/noncompliance|0|||
25085310|NCT01628692|50193421|FG004|Overall Study|Poor compliance/noncompliance|0|||
25085311|NCT01628692|50193422|FG005|Overall Study|Poor compliance/noncompliance|0|||
25085312|NCT01628692|50193417|FG000|Overall Study|Administrative reason by sponsor|0|||
25085313|NCT01628692|50193418|FG001|Overall Study|Administrative reason by sponsor|0|||
25085314|NCT01628692|50193419|FG002|Overall Study|Administrative reason by sponsor|0|||
25085315|NCT01628692|50193420|FG003|Overall Study|Administrative reason by sponsor|0|||
25085316|NCT01628692|50193421|FG004|Overall Study|Administrative reason by sponsor|0|||
25085317|NCT01628692|50193422|FG005|Overall Study|Administrative reason by sponsor|1|||
25085318|NCT01628692|50193417|FG000|Overall Study|Completed 12 Week only|0|||
25085319|NCT01628692|50193418|FG001|Overall Study|Completed 12 Week only|0|||
25085320|NCT01628692|50193419|FG002|Overall Study|Completed 12 Week only|0|||
25085321|NCT01628692|50193420|FG003|Overall Study|Completed 12 Week only|0|||
25085322|NCT01628692|50193421|FG004|Overall Study|Completed 12 Week only|0|||
25085323|NCT01628692|50193422|FG005|Overall Study|Completed 12 Week only|1|||
25085324|NCT02612727|50193441|FG000|Overall Study|Parent request|4|||
25085325|NCT02612727|50193442|FG001|Overall Study|Parent request|1|||
25085326|NCT02612727|50193441|FG000|Overall Study|Needed treatment incompatible with PT|1|||
25085327|NCT02612727|50193442|FG001|Overall Study|Needed treatment incompatible with PT|1|||
25085328|NCT02612727|50193441|FG000|Overall Study|Direct hyperbilirubinemia|0|||
25085329|NCT02612727|50193442|FG001|Overall Study|Direct hyperbilirubinemia|2|||
25085330|NCT01594827|50193450|FG000|Overall Study|Adverse Event|1|||
25085331|NCT01594827|50193451|FG001|Overall Study|Adverse Event|0|||
25085332|NCT01594827|50193450|FG000|Overall Study|Physician Decision|3|||
25085333|NCT01594827|50193451|FG001|Overall Study|Physician Decision|0|||
25085334|NCT02610231|50193459|FG000|Overall Study|Withdrawal by Subject|27|||
25085335|NCT02610231|50193459|FG000|Overall Study|Adverse Event|20|||
25085336|NCT02610231|50193459|FG000|Overall Study|Death|5|||
25085337|NCT02610231|50193459|FG000|Overall Study|Surgery|2|||
25085338|NCT02610231|50193459|FG000|Overall Study|Physician Decision|1|||
25085339|NCT02610231|50193459|FG000|Overall Study|Non Compliance|2|||
25085340|NCT02610231|50193459|FG000|Overall Study|Other|3|||
25085341|NCT02178358|50193469|FG000|Overall Study|Withdrawal by Subject|0|||
25085342|NCT02178358|50193470|FG001|Overall Study|Withdrawal by Subject|2|||
25085343|NCT02178358|50193471|FG002|Overall Study|Withdrawal by Subject|2|||
25085344|NCT02178358|50193469|FG000|Overall Study|Lost to Follow-up|1|||
25085345|NCT02178358|50193470|FG001|Overall Study|Lost to Follow-up|0|||
25085346|NCT02178358|50193471|FG002|Overall Study|Lost to Follow-up|0|||
25085347|NCT01598896|50193482|FG000|Overall Study|Withdrawal by Subject|0|||
25085348|NCT01598896|50193483|FG001|Overall Study|Withdrawal by Subject|1|||
25085349|NCT01598896|50193482|FG000|Overall Study|Lack of Efficacy|0|||
25085350|NCT01598896|50193483|FG001|Overall Study|Lack of Efficacy|1|||
25085351|NCT01598662|50193491|FG000|Overall Study|Lost to Follow-up|10|||
25085352|NCT01598662|50193492|FG001|Overall Study|Lost to Follow-up|17|||
25085353|NCT01598662|50193491|FG000|Overall Study|Physician Decision|1|||
25085354|NCT01598662|50193492|FG001|Overall Study|Physician Decision|2|||
25085355|NCT01598662|50193491|FG000|Overall Study|IUD expelled before month 6|0|||
25085356|NCT01598662|50193492|FG001|Overall Study|IUD expelled before month 6|2|||
25085357|NCT01629706|50193498|FG000|Phase 1 PureVision|Screen Failure|4|||
25085358|NCT01629706|50193498|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
25085359|NCT01629706|50193498|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
25085360|NCT01629706|50193498|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
25085361|NCT01629706|50193498|FG000|Phase 2 Habitual|Screen Failure|6|||
25085362|NCT01629706|50193498|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
25085363|NCT01629706|50193498|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
25085364|NCT01629706|50193498|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
25085365|NCT01629706|50193498|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
25085366|NCT02153086|50193506|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
25085367|NCT02153086|50193506|FG000|Overall Study|Other|2|||
25085368|NCT02117050|50193510|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
25085369|NCT02728895|50193517|FG000|Overall Study|Other|1|||
25085370|NCT02728895|50193518|FG001|Overall Study|Other|2|||
25085371|NCT02728895|50193517|FG000|Overall Study|Withdrawal by Subject|0|||
25085372|NCT02728895|50193518|FG001|Overall Study|Withdrawal by Subject|3|||
25085373|NCT02606877|50193526|FG000|Overall Study|Adverse Event|3|||
25085374|NCT02606877|50193527|FG001|Overall Study|Adverse Event|0|||
25085375|NCT02606877|50193526|FG000|Overall Study|Non-compliance with protocol|0|||
25085376|NCT02606877|50193527|FG001|Overall Study|Non-compliance with protocol|1|||
25085377|NCT02606877|50193526|FG000|Overall Study|Other than listed above|1|||
25085378|NCT02606877|50193527|FG001|Overall Study|Other than listed above|0|||
25085379|NCT02606643|50193537|FG000|Overall Study|did not meet inclusion criteria|1|||
25085380|NCT02606643|50193538|FG001|Overall Study|did not meet inclusion criteria|3|||
25085381|NCT02609607|50193569|FG000|Overall Study|Lost to Follow-up|0|||
25085382|NCT02609607|50193570|FG001|Overall Study|Lost to Follow-up|1|||
25085383|NCT02606253|50193579|FG000|Overall Study|Adverse Event|2|||
25085384|NCT02606253|50193580|FG001|Overall Study|Adverse Event|0|||
25085385|NCT02606253|50193581|FG002|Overall Study|Adverse Event|0|||
25085386|NCT02606253|50193579|FG000|Overall Study|Protocol Violation|2|||
25085387|NCT02606253|50193580|FG001|Overall Study|Protocol Violation|1|||
25085388|NCT02606253|50193581|FG002|Overall Study|Protocol Violation|0|||
25085389|NCT02606253|50193579|FG000|Overall Study|Physician Decision|1|||
25085390|NCT02606253|50193580|FG001|Overall Study|Physician Decision|1|||
25085391|NCT02606253|50193581|FG002|Overall Study|Physician Decision|0|||
25085392|NCT02607735|50193591|FG000|Primary Study|Randomized but Never Treated|1|||
25085393|NCT02607735|50193592|FG001|Primary Study|Randomized but Never Treated|0|||
25085394|NCT02607735|50193593|FG002|Primary Study|Randomized but Never Treated|0|||
25085395|NCT02607735|50193591|FG000|Primary Study|Lost to Follow-up|4|||
25085396|NCT02607735|50193592|FG001|Primary Study|Lost to Follow-up|0|||
25085397|NCT02607735|50193593|FG002|Primary Study|Lost to Follow-up|0|||
25085398|NCT02607735|50193591|FG000|Primary Study|Withdrew Consent|2|||
25085399|NCT02607735|50193592|FG001|Primary Study|Withdrew Consent|0|||
25085400|NCT02607735|50193593|FG002|Primary Study|Withdrew Consent|0|||
25085401|NCT02607735|50193591|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
25085402|NCT02607735|50193592|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
25085403|NCT02607735|50193593|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
25085404|NCT02607735|50193591|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
25085405|NCT02607735|50193592|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
25085406|NCT02607735|50193593|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
25085407|NCT01668537|50193603|FG000|Overall Study|Request to Discontinue Prematurely|1|||
25085408|NCT01668537|50193604|FG001|Overall Study|Request to Discontinue Prematurely|1|||
25085409|NCT01668537|50193603|FG000|Overall Study|Subject unwilling/unable to comply|5|||
25085410|NCT01668537|50193604|FG001|Overall Study|Subject unwilling/unable to comply|0|||
25085411|NCT01668537|50193603|FG000|Overall Study|Reason Precludes Participation|1|||
25085412|NCT01668537|50193604|FG001|Overall Study|Reason Precludes Participation|0|||
25085413|NCT01668537|50193603|FG000|Overall Study|Lost to Follow-up|13|||
25085414|NCT01668537|50193604|FG001|Overall Study|Lost to Follow-up|6|||
25085415|NCT01668537|50193603|FG000|Overall Study|Other|2|||
25085416|NCT01668537|50193604|FG001|Overall Study|Other|3|||
25085417|NCT01668147|50193610|FG000|Overall Study|Withdrawal by Subject|6|||
25085418|NCT02600559|50193627|FG000|Overall Study|Withdrawal by Subject|3|||
25085419|NCT02600559|50193627|FG000|Overall Study|Lost to Follow-up|20|||
25085420|NCT02601573|50193636|FG000|Overall Study|Lost to Follow-up|0|||
25085421|NCT02601573|50193637|FG001|Overall Study|Lost to Follow-up|3|||
25085422|NCT02601573|50193638|FG002|Overall Study|Lost to Follow-up|1|||
25085423|NCT02601573|50193639|FG003|Overall Study|Lost to Follow-up|0|||
25085424|NCT02601573|50193640|FG004|Overall Study|Lost to Follow-up|2|||
25085425|NCT02601573|50193636|FG000|Overall Study|Withdrawal by Subject|0|||
25085426|NCT02601573|50193637|FG001|Overall Study|Withdrawal by Subject|1|||
25085427|NCT02601573|50193638|FG002|Overall Study|Withdrawal by Subject|0|||
25085428|NCT02601573|50193639|FG003|Overall Study|Withdrawal by Subject|1|||
25085429|NCT02601573|50193640|FG004|Overall Study|Withdrawal by Subject|0|||
25085430|NCT02601027|50193654|FG000|Registration to Surgery|Withdrawal by Subject|20|||
25085431|NCT02601027|50193655|FG001|Registration to Surgery|Withdrawal by Subject|10|||
25085432|NCT02600871|50193663|FG000|Overall Study|Lost to Follow-up|13|||
25085433|NCT02600871|50193664|FG001|Overall Study|Lost to Follow-up|10|||
25085434|NCT02598297|50193673|FG000|Overall Study|Study terminated by Sponsor|21|||
25085435|NCT02598297|50193674|FG001|Overall Study|Study terminated by Sponsor|23|||
25085436|NCT02598297|50193673|FG000|Overall Study|Adverse Event|1|||
25085437|NCT02598297|50193674|FG001|Overall Study|Adverse Event|1|||
25085438|NCT02598297|50193673|FG000|Overall Study|Physician Decision|1|||
25085439|NCT02598297|50193674|FG001|Overall Study|Physician Decision|0|||
25085440|NCT02598297|50193673|FG000|Overall Study|Subject/guardian decision|1|||
25085441|NCT02598297|50193674|FG001|Overall Study|Subject/guardian decision|0|||
25085442|NCT02598297|50193673|FG000|Overall Study|Followed for survival|1|||
25085443|NCT02598297|50193674|FG001|Overall Study|Followed for survival|0|||
25085444|NCT02596893|50193684|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
25085445|NCT02596893|50193685|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
25085446|NCT02596893|50193686|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
25085447|NCT02596893|50193687|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
25085448|NCT02596893|50193684|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
25085449|NCT02596893|50193685|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
25085450|NCT02596893|50193686|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
25085451|NCT02596893|50193687|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
25085452|NCT02596893|50193684|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
25085453|NCT02596893|50193685|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
25085454|NCT02596893|50193686|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
25085455|NCT02596893|50193687|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
25085456|NCT02596893|50193684|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
25085457|NCT02596893|50193685|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
25085458|NCT02596893|50193686|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
25085459|NCT02596893|50193687|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
25085460|NCT02596893|50193684|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
25085461|NCT02596893|50193685|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
25085462|NCT02596893|50193686|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
25085463|NCT02596893|50193687|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
25085464|NCT02596893|50193684|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
25085465|NCT02596893|50193685|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
25085466|NCT02596893|50193686|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
25085467|NCT02596893|50193687|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
25085468|NCT02596893|50193684|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
25085469|NCT02596893|50193685|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
25085470|NCT02596893|50193686|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
25085471|NCT02596893|50193687|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
25085472|NCT02596893|50193684|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
25085473|NCT02596893|50193685|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
25085474|NCT02596893|50193686|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
25085475|NCT02596893|50193687|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
25085476|NCT02596893|50193684|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
25085477|NCT02596893|50193685|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
25085478|NCT02596893|50193686|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
25085479|NCT02596893|50193687|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
25085480|NCT02596893|50193684|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
25085481|NCT02596893|50193685|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
25085482|NCT02596893|50193686|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
25085483|NCT02596893|50193687|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
25085484|NCT02596893|50193684|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
25085485|NCT02596893|50193685|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
25085486|NCT02596893|50193686|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
25085487|NCT02596893|50193687|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
25085488|NCT02592447|50193703|FG000|Overall Study|Lost to Follow-up|1|||
25085489|NCT02592447|50193704|FG001|Overall Study|Lost to Follow-up|0|||
25085490|NCT02592447|50193703|FG000|Overall Study|Ineligible after randomization|1|||
25085491|NCT02592447|50193704|FG001|Overall Study|Ineligible after randomization|0|||
25085492|NCT02592447|50193703|FG000|Overall Study|Withdrawal by Subject|0|||
25085493|NCT02592447|50193704|FG001|Overall Study|Withdrawal by Subject|1|||
25085494|NCT02595723|50193713|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
25085495|NCT02595723|50193714|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
25085496|NCT02595723|50193715|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
25085497|NCT02595723|50193713|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
25085498|NCT02595723|50193714|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
25085499|NCT02595723|50193715|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
25085500|NCT01667679|50193725|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
25085501|NCT01667679|50193726|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
25085502|NCT01667679|50193725|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
25085503|NCT01667679|50193726|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
25085504|NCT01667679|50193725|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
25085505|NCT01667679|50193726|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
25085506|NCT01667679|50193725|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
25085507|NCT01667679|50193726|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
25085508|NCT01667679|50193725|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
25085509|NCT01667679|50193726|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
25085510|NCT01667679|50193725|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
25085511|NCT01667679|50193726|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
25085512|NCT01667679|50193725|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
25085513|NCT01667679|50193726|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
25085514|NCT01667679|50193725|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
25085515|NCT01667679|50193726|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
25085516|NCT01667679|50193725|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
25085517|NCT01667679|50193726|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
25085518|NCT01667679|50193725|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
25085519|NCT01667679|50193726|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
25085520|NCT01667679|50193725|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
25085521|NCT01667679|50193726|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
25085522|NCT01667679|50193725|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
25085523|NCT01667679|50193726|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
25085524|NCT01667679|50193725|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
25085525|NCT01667679|50193726|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
25085526|NCT01667679|50193725|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
25085527|NCT01667679|50193726|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
25085528|NCT01667679|50193725|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
25085529|NCT01667679|50193726|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
25085530|NCT01667679|50193725|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
25085531|NCT01667679|50193726|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
25085532|NCT01667679|50193725|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
25085533|NCT01667679|50193726|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
25085534|NCT01667679|50193725|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
25085535|NCT01667679|50193726|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
25085536|NCT01667679|50193725|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
25085537|NCT01667679|50193726|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
25085538|NCT01667679|50193725|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
25085539|NCT01667679|50193726|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
25085540|NCT01667679|50193725|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
25085541|NCT01667679|50193726|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
25085542|NCT02597049|50193737|FG000|Overall Study|Lost to Follow-up|0|||
25085543|NCT02597049|50193738|FG001|Overall Study|Lost to Follow-up|3|||
25085544|NCT02597049|50193739|FG002|Overall Study|Lost to Follow-up|2|||
25085545|NCT02597049|50193737|FG000|Overall Study|Withdrawal by Subject|2|||
25085546|NCT02597049|50193738|FG001|Overall Study|Withdrawal by Subject|2|||
25085547|NCT02597049|50193739|FG002|Overall Study|Withdrawal by Subject|1|||
25085548|NCT02597049|50193737|FG000|Overall Study|Adverse Event|2|||
25085549|NCT02597049|50193738|FG001|Overall Study|Adverse Event|0|||
25085550|NCT02597049|50193739|FG002|Overall Study|Adverse Event|0|||
25085551|NCT02597049|50193737|FG000|Overall Study|Death|2|||
25085552|NCT02597049|50193738|FG001|Overall Study|Death|0|||
25085553|NCT02597049|50193739|FG002|Overall Study|Death|0|||
25085554|NCT02597049|50193737|FG000|Overall Study|Noncompliant with Study Visits|1|||
25085555|NCT02597049|50193738|FG001|Overall Study|Noncompliant with Study Visits|0|||
25085556|NCT02597049|50193739|FG002|Overall Study|Noncompliant with Study Visits|0|||
25085557|NCT02594163|50193749|FG000|Treatment Period|Progressive disease|2|||
25085558|NCT02594163|50193750|FG001|Treatment Period|Progressive disease|3|||
25085559|NCT02594163|50193749|FG000|Treatment Period|Adverse Event|1|||
25085560|NCT02594163|50193750|FG001|Treatment Period|Adverse Event|5|||
25085561|NCT02594163|50193749|FG000|Treatment Period|Physician Decision|1|||
25085562|NCT02594163|50193750|FG001|Treatment Period|Physician Decision|3|||
25085563|NCT02594163|50193749|FG000|Treatment Period|Study termination by sponsor|2|||
25085564|NCT02594163|50193750|FG001|Treatment Period|Study termination by sponsor|1|||
25085565|NCT02594163|50193749|FG000|Treatment Period|Other, Non-AE|1|||
25085566|NCT02594163|50193750|FG001|Treatment Period|Other, Non-AE|0|||
25085567|NCT02594163|50193749|FG000|Follow-up Period|Withdrawal by Subject|0|||
25085568|NCT02594163|50193750|FG001|Follow-up Period|Withdrawal by Subject|1|||
25085569|NCT02594163|50193749|FG000|Follow-up Period|Study Termination by Sponsor|6|||
25085570|NCT02594163|50193750|FG001|Follow-up Period|Study Termination by Sponsor|4|||
25085571|NCT02594163|50193749|FG000|Follow-up Period|Lost to Follow-up|1|||
25085572|NCT02594163|50193750|FG001|Follow-up Period|Lost to Follow-up|0|||
25085573|NCT02594163|50193749|FG000|Follow-up Period|Death|2|||
25085574|NCT02594163|50193750|FG001|Follow-up Period|Death|5|||
25085575|NCT02594163|50193749|FG000|Follow-up Period|Adverse Event|0|||
25085576|NCT02594163|50193750|FG001|Follow-up Period|Adverse Event|1|||
25085577|NCT02594163|50193749|FG000|Follow-up Period|Progressive Disease|2|||
25085578|NCT02594163|50193750|FG001|Follow-up Period|Progressive Disease|0|||
25085579|NCT02594163|50193749|FG000|Follow-up Period|Physician Decision|0|||
25085580|NCT02594163|50193750|FG001|Follow-up Period|Physician Decision|1|||
25085581|NCT02712983|50193765|FG000|Treatment Phase|Adverse Event|3|||
25085582|NCT02712983|50193766|FG001|Treatment Phase|Adverse Event|1|||
25085583|NCT02712983|50193767|FG002|Treatment Phase|Adverse Event|1|||
25085584|NCT02712983|50193768|FG003|Treatment Phase|Adverse Event|4|||
25085585|NCT02712983|50193769|FG004|Treatment Phase|Adverse Event|3|||
25085586|NCT02712983|50193770|FG005|Treatment Phase|Adverse Event|0|||
25085587|NCT02712983|50193771|FG006|Treatment Phase|Adverse Event|6|||
25085588|NCT02712983|50193772|FG007|Treatment Phase|Adverse Event|6|||
25085589|NCT02712983|50193773|FG008|Treatment Phase|Adverse Event|1|||
25085590|NCT02712983|50193765|FG000|Treatment Phase|Protocol Deviation|0|||
25085591|NCT02712983|50193766|FG001|Treatment Phase|Protocol Deviation|0|||
25085592|NCT02712983|50193767|FG002|Treatment Phase|Protocol Deviation|0|||
25085593|NCT02712983|50193768|FG003|Treatment Phase|Protocol Deviation|2|||
25085594|NCT02712983|50193769|FG004|Treatment Phase|Protocol Deviation|0|||
25085595|NCT02712983|50193770|FG005|Treatment Phase|Protocol Deviation|0|||
25085596|NCT02712983|50193771|FG006|Treatment Phase|Protocol Deviation|1|||
25085597|NCT02712983|50193772|FG007|Treatment Phase|Protocol Deviation|0|||
25085598|NCT02712983|50193773|FG008|Treatment Phase|Protocol Deviation|0|||
25085599|NCT02712983|50193765|FG000|Treatment Phase|Technical Problems|0|||
25085600|NCT02712983|50193766|FG001|Treatment Phase|Technical Problems|0|||
25085601|NCT02712983|50193767|FG002|Treatment Phase|Technical Problems|0|||
25085602|NCT02712983|50193768|FG003|Treatment Phase|Technical Problems|0|||
25085603|NCT02712983|50193769|FG004|Treatment Phase|Technical Problems|0|||
25085604|NCT02712983|50193770|FG005|Treatment Phase|Technical Problems|0|||
25085605|NCT02712983|50193771|FG006|Treatment Phase|Technical Problems|1|||
25085606|NCT02712983|50193772|FG007|Treatment Phase|Technical Problems|0|||
25085607|NCT02712983|50193773|FG008|Treatment Phase|Technical Problems|0|||
25085608|NCT02712983|50193765|FG000|Treatment Phase|Physician Decision|0|||
25085609|NCT02712983|50193766|FG001|Treatment Phase|Physician Decision|0|||
25085610|NCT02712983|50193767|FG002|Treatment Phase|Physician Decision|0|||
25085611|NCT02712983|50193768|FG003|Treatment Phase|Physician Decision|0|||
25085612|NCT02712983|50193769|FG004|Treatment Phase|Physician Decision|0|||
25085613|NCT02712983|50193770|FG005|Treatment Phase|Physician Decision|0|||
25085614|NCT02712983|50193771|FG006|Treatment Phase|Physician Decision|0|||
25085615|NCT02712983|50193772|FG007|Treatment Phase|Physician Decision|1|||
25085616|NCT02712983|50193773|FG008|Treatment Phase|Physician Decision|1|||
25085617|NCT02712983|50193765|FG000|Treatment Phase|Subject Decision|2|||
25085618|NCT02712983|50193766|FG001|Treatment Phase|Subject Decision|0|||
25085619|NCT02712983|50193767|FG002|Treatment Phase|Subject Decision|0|||
25085620|NCT02712983|50193768|FG003|Treatment Phase|Subject Decision|2|||
25085621|NCT02712983|50193769|FG004|Treatment Phase|Subject Decision|1|||
25085622|NCT02712983|50193770|FG005|Treatment Phase|Subject Decision|0|||
25085623|NCT02712983|50193771|FG006|Treatment Phase|Subject Decision|1|||
25085624|NCT02712983|50193772|FG007|Treatment Phase|Subject Decision|2|||
25085625|NCT02712983|50193773|FG008|Treatment Phase|Subject Decision|0|||
25085626|NCT02712983|50193765|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
25085627|NCT02712983|50193766|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
25085628|NCT02712983|50193767|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
25085629|NCT02712983|50193768|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
25085630|NCT02712983|50193769|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
25085631|NCT02712983|50193770|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
25085632|NCT02712983|50193771|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
25085633|NCT02712983|50193772|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
25085634|NCT02712983|50193773|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
25085635|NCT02712983|50193765|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
25085636|NCT02712983|50193766|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
25085637|NCT02712983|50193767|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
25085638|NCT02712983|50193768|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
25085639|NCT02712983|50193769|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
25085640|NCT02712983|50193770|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
25085641|NCT02712983|50193771|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
25085642|NCT02712983|50193772|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
25085643|NCT02712983|50193773|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
25085644|NCT02712983|50193765|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
25085645|NCT02712983|50193766|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
25085646|NCT02712983|50193767|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
25085647|NCT02712983|50193768|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
25085648|NCT02712983|50193769|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
25085649|NCT02712983|50193770|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
25085650|NCT02712983|50193771|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
25085651|NCT02712983|50193772|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
25085652|NCT02712983|50193773|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
25085653|NCT02596971|50193796|FG000|Overall Study|Death|5|||
25085654|NCT02596971|50193797|FG001|Overall Study|Death|1|||
25085655|NCT02596971|50193798|FG002|Overall Study|Death|5|||
25085656|NCT02596971|50193796|FG000|Overall Study|Withdrawal by Subject|5|||
25085657|NCT02596971|50193797|FG001|Overall Study|Withdrawal by Subject|1|||
25085658|NCT02596971|50193798|FG002|Overall Study|Withdrawal by Subject|4|||
25085659|NCT02593773|50193809|FG000|Overall Study|Voluntary Withdrawal|3|||
25085660|NCT02593773|50193809|FG000|Overall Study|Study Terminated by Sponsor|31|||
25085661|NCT02593773|50193809|FG000|Overall Study|Death|1|||
25085662|NCT02593539|50193813|FG000|Overall Study|Adverse Event|1|||
25085663|NCT00919763|50193822|FG000|Overall Study|Adverse Event|7|||
25085664|NCT00919763|50193823|FG001|Overall Study|Adverse Event|1|||
25085665|NCT00919763|50193822|FG000|Overall Study|Lost to Follow-up|1|||
25085666|NCT00919763|50193823|FG001|Overall Study|Lost to Follow-up|0|||
25085667|NCT00919763|50193822|FG000|Overall Study|Protocol Violation|1|||
25085668|NCT00919763|50193823|FG001|Overall Study|Protocol Violation|1|||
25085669|NCT00919763|50193822|FG000|Overall Study|Withdrawal by Subject|3|||
25085670|NCT00919763|50193823|FG001|Overall Study|Withdrawal by Subject|1|||
25085671|NCT00919763|50193822|FG000|Overall Study|Non-compliance|0|||
25085672|NCT00919763|50193823|FG001|Overall Study|Non-compliance|1|||
25085673|NCT02593305|50193841|FG000|Post 1|Comparison only group. No intervention.|0|||
25085674|NCT02593305|50193842|FG001|Post 1|Comparison only group. No intervention.|0|||
25085675|NCT02593305|50193843|FG002|Post 1|Comparison only group. No intervention.|10|||
25085676|NCT02593149|50193854|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
25085677|NCT02593149|50193855|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
25085678|NCT02593149|50193854|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
25085679|NCT02593149|50193855|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
25085680|NCT02177812|50193870|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
25085681|NCT02177812|50193871|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
25085682|NCT02177812|50193872|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
25085683|NCT02177812|50193873|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
25085684|NCT02177812|50193874|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
25085685|NCT02177812|50193875|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
25085686|NCT02177812|50193876|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
25085687|NCT02177812|50193877|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
25085688|NCT02177812|50193878|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
25085689|NCT02177812|50193870|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
25085690|NCT02177812|50193871|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
25085691|NCT02177812|50193872|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
25085692|NCT02177812|50193873|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
25085693|NCT02177812|50193874|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
25085694|NCT02177812|50193875|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
25085695|NCT02177812|50193876|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
25085696|NCT02177812|50193877|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
25085697|NCT02177812|50193878|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
25085698|NCT02177812|50193870|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
25085699|NCT02177812|50193871|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
25085700|NCT02177812|50193872|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
25085701|NCT02177812|50193873|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
25085702|NCT02177812|50193874|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
25085703|NCT02177812|50193875|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
25085704|NCT02177812|50193876|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
25085705|NCT02177812|50193877|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
25085706|NCT02177812|50193878|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
25085707|NCT01626352|50193922|FG000|Overall Study|Disease Progression|3|||
25085708|NCT01626352|50193922|FG000|Overall Study|Intercurrent Illness|2|||
25085709|NCT01626352|50193922|FG000|Overall Study|Death|2|||
25085710|NCT01626352|50193922|FG000|Overall Study|Withdrawal by Subject|1|||
25085711|NCT01626352|50193922|FG000|Overall Study|Non-Compliance|1|||
25085712|NCT01626352|50193922|FG000|Overall Study|Never Treated|1|||
25085713|NCT01626118|50193933|FG000|Overall Study|Lack of Efficacy|1|||
25085714|NCT01626118|50193934|FG001|Overall Study|Lack of Efficacy|0|||
25085715|NCT01626118|50193935|FG002|Overall Study|Lack of Efficacy|1|||
25085716|NCT01626118|50193936|FG003|Overall Study|Lack of Efficacy|3|||
25085717|NCT01626118|50193933|FG000|Overall Study|Lost to Follow-up|1|||
25085718|NCT01626118|50193934|FG001|Overall Study|Lost to Follow-up|0|||
25085719|NCT01626118|50193935|FG002|Overall Study|Lost to Follow-up|0|||
25085720|NCT01626118|50193936|FG003|Overall Study|Lost to Follow-up|0|||
25085721|NCT01626118|50193933|FG000|Overall Study|Adverse Event|0|||
25085722|NCT01626118|50193934|FG001|Overall Study|Adverse Event|1|||
25085723|NCT01626118|50193935|FG002|Overall Study|Adverse Event|1|||
25085724|NCT01626118|50193936|FG003|Overall Study|Adverse Event|0|||
25085725|NCT01626118|50193933|FG000|Overall Study|Investigator Decision|0|||
25085726|NCT01626118|50193934|FG001|Overall Study|Investigator Decision|1|||
25085727|NCT01626118|50193935|FG002|Overall Study|Investigator Decision|0|||
25085728|NCT01626118|50193936|FG003|Overall Study|Investigator Decision|0|||
25085729|NCT02152384|50193946|FG000|Period 1|Withdrawal by Subject|0|||
25085730|NCT02152384|50193947|FG001|Period 1|Withdrawal by Subject|1|||
25085731|NCT02152384|50193946|FG000|Period 1|Adverse Event|1|||
25085732|NCT02152384|50193947|FG001|Period 1|Adverse Event|1|||
25085733|NCT02177266|50193959|FG000|Overall Study|Adverse Event|0|||
25085734|NCT02177266|50193960|FG001|Overall Study|Adverse Event|1|||
25085735|NCT02177266|50193959|FG000|Overall Study|Withdrawal by Subject|1|||
25085736|NCT02177266|50193960|FG001|Overall Study|Withdrawal by Subject|0|||
25085737|NCT02177032|50193970|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
25085738|NCT02177032|50193971|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
25085739|NCT02177032|50193972|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
25085740|NCT02177032|50193973|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
25085741|NCT02177032|50193970|FG000|Overall Study|Lost to Follow-up|0|||
25085742|NCT02177032|50193971|FG001|Overall Study|Lost to Follow-up|2|||
25085743|NCT02177032|50193972|FG002|Overall Study|Lost to Follow-up|0|||
25085744|NCT02177032|50193973|FG003|Overall Study|Lost to Follow-up|0|||
25085745|NCT02177032|50193970|FG000|Overall Study|OTHER|2|||
25085746|NCT02177032|50193971|FG001|Overall Study|OTHER|0|||
25085747|NCT02177032|50193972|FG002|Overall Study|OTHER|1|||
25085748|NCT02177032|50193973|FG003|Overall Study|OTHER|0|||
25085749|NCT02177032|50193970|FG000|Overall Study|Withdrawal by Subject|1|||
25085750|NCT02177032|50193971|FG001|Overall Study|Withdrawal by Subject|0|||
25085751|NCT02177032|50193972|FG002|Overall Study|Withdrawal by Subject|1|||
25085752|NCT02177032|50193973|FG003|Overall Study|Withdrawal by Subject|0|||
25085753|NCT02116972|50193997|FG000|Overall Study|Adverse Event|4|||
25085754|NCT02116972|50193998|FG001|Overall Study|Adverse Event|4|||
25085755|NCT02116972|50193999|FG002|Overall Study|Adverse Event|1|||
25085756|NCT02116972|50193997|FG000|Overall Study|Withdrawal by Subject|1|||
25085757|NCT02116972|50193998|FG001|Overall Study|Withdrawal by Subject|1|||
25085758|NCT02116972|50193999|FG002|Overall Study|Withdrawal by Subject|5|||
25085759|NCT02116972|50193997|FG000|Overall Study|Protocol Violation|1|||
25085760|NCT02116972|50193998|FG001|Overall Study|Protocol Violation|0|||
25085761|NCT02116972|50193999|FG002|Overall Study|Protocol Violation|1|||
25085762|NCT02116972|50193997|FG000|Overall Study|Lost to Follow-up|4|||
25085763|NCT02116972|50193998|FG001|Overall Study|Lost to Follow-up|3|||
25085764|NCT02116972|50193999|FG002|Overall Study|Lost to Follow-up|1|||
25085765|NCT02116972|50193997|FG000|Overall Study|Lack of Efficacy|6|||
25085766|NCT02116972|50193998|FG001|Overall Study|Lack of Efficacy|6|||
25085767|NCT02116972|50193999|FG002|Overall Study|Lack of Efficacy|5|||
25085768|NCT02116972|50193997|FG000|Overall Study|scheduling conflicts and relocation|3|||
25085769|NCT02116972|50193998|FG001|Overall Study|scheduling conflicts and relocation|3|||
25085770|NCT02116972|50193999|FG002|Overall Study|scheduling conflicts and relocation|6|||
25085771|NCT02176642|50194011|FG000|Overall Study|Withdrawal by Subject|0|||
25085772|NCT02176642|50194012|FG001|Overall Study|Withdrawal by Subject|1|||
25085773|NCT02116660|50194020|FG000|Overall Study|Deteriorating renal function|0|||
25085774|NCT02116660|50194021|FG001|Overall Study|Deteriorating renal function|1|||
25085775|NCT02116660|50194020|FG000|Overall Study|Adverse Event|1|||
25085776|NCT02116660|50194021|FG001|Overall Study|Adverse Event|1|||
25085777|NCT02116660|50194020|FG000|Overall Study|Withdrawal by Subject|0|||
25085778|NCT02116660|50194021|FG001|Overall Study|Withdrawal by Subject|2|||
25085779|NCT02116660|50194020|FG000|Overall Study|Organization reason|1|||
25085780|NCT02116660|50194021|FG001|Overall Study|Organization reason|0|||
25085781|NCT02589405|50194029|FG000|Overall Study|Adverse Event|3|||
25085782|NCT02589405|50194029|FG000|Overall Study|Withdrawal by Subject|1|||
25085783|NCT02176018|50194035|FG000|Overall Study|Adverse Event|0|||
25085784|NCT02176018|50194036|FG001|Overall Study|Adverse Event|2|||
25085785|NCT02176018|50194035|FG000|Overall Study|Lost to Follow-up|3|||
25085786|NCT02176018|50194036|FG001|Overall Study|Lost to Follow-up|1|||
25085787|NCT02176018|50194035|FG000|Overall Study|Protocol Violation|1|||
25085788|NCT02176018|50194036|FG001|Overall Study|Protocol Violation|1|||
25085789|NCT02176018|50194035|FG000|Overall Study|Withdrawal by Subject|1|||
25085790|NCT02176018|50194036|FG001|Overall Study|Withdrawal by Subject|2|||
25085791|NCT02116582|50194042|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
25085792|NCT02116582|50194042|FG000|Overall Study|Adverse Event|22|||
25085793|NCT02116582|50194042|FG000|Overall Study|Death|9|||
25085794|NCT02116582|50194042|FG000|Overall Study|Progressive Disease|148|||
25085795|NCT02116582|50194042|FG000|Overall Study|Protocol Violation|3|||
25085796|NCT02116582|50194042|FG000|Overall Study|Withdrawal by Subject|8|||
25085797|NCT02116582|50194042|FG000|Overall Study|Other: Miscellaneous|11|||
25085798|NCT02116582|50194042|FG000|Overall Study|Lost to Follow-up|1|||
25085799|NCT02116582|50194042|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
25085800|NCT02589639|50194049|FG000|Overall Study|Lost to Follow-up|1|||
25085801|NCT02589639|50194050|FG001|Overall Study|Lost to Follow-up|0|||
25085802|NCT02589639|50194051|FG002|Overall Study|Lost to Follow-up|0|||
25085803|NCT02589639|50194049|FG000|Overall Study|Protocol Violation|1|||
25085804|NCT02589639|50194050|FG001|Overall Study|Protocol Violation|0|||
25085805|NCT02589639|50194051|FG002|Overall Study|Protocol Violation|0|||
25085806|NCT02589639|50194049|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
25085807|NCT02589639|50194050|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
25085808|NCT02589639|50194051|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
25085809|NCT02589639|50194049|FG000|Overall Study|Adverse Event|4|||
25085810|NCT02589639|50194050|FG001|Overall Study|Adverse Event|5|||
25085811|NCT02589639|50194051|FG002|Overall Study|Adverse Event|3|||
25085812|NCT02589639|50194049|FG000|Overall Study|Other reason than specified above|1|||
25085813|NCT02589639|50194050|FG001|Overall Study|Other reason than specified above|2|||
25085814|NCT02589639|50194051|FG002|Overall Study|Other reason than specified above|1|||
25085815|NCT02589639|50194049|FG000|Overall Study|Not Treated|0|||
25085816|NCT02589639|50194050|FG001|Overall Study|Not Treated|3|||
25085817|NCT02589639|50194051|FG002|Overall Study|Not Treated|0|||
25085818|NCT02151682|50194061|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
25085819|NCT02151682|50194062|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
25085820|NCT02151682|50194063|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
25085821|NCT02151682|50194064|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
25085822|NCT02151682|50194065|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
25085823|NCT02151682|50194066|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
25085824|NCT02151682|50194061|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
25085825|NCT02151682|50194062|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
25085826|NCT02151682|50194063|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
25085827|NCT02151682|50194064|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
25085828|NCT02151682|50194065|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
25085829|NCT02151682|50194066|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
25085830|NCT02151682|50194061|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
25085831|NCT02151682|50194062|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
25085832|NCT02151682|50194063|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
25085833|NCT02151682|50194064|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
25085834|NCT02151682|50194065|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
25085835|NCT02151682|50194066|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
25085836|NCT02151682|50194061|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
25085837|NCT02151682|50194062|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
25085838|NCT02151682|50194063|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
25085839|NCT02151682|50194064|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
25085840|NCT02151682|50194065|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
25085841|NCT02151682|50194066|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
25085842|NCT02151682|50194061|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
25085843|NCT02151682|50194062|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
25085844|NCT02151682|50194063|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
25085845|NCT02151682|50194064|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
25085846|NCT02151682|50194065|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
25085847|NCT02151682|50194066|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
25085848|NCT02151682|50194061|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
25085849|NCT02151682|50194062|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
25085850|NCT02151682|50194063|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
25085851|NCT02151682|50194064|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
25085852|NCT02151682|50194065|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
25085853|NCT02151682|50194066|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
25085854|NCT02151682|50194061|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
25085855|NCT02151682|50194062|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
25085856|NCT02151682|50194063|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
25172550|NCT01743989|50313203|FG002|Treatment Phase|Withdrawal by Subject|28|||
25085857|NCT02151682|50194064|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
25085858|NCT02151682|50194065|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
25085859|NCT02151682|50194066|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
25085860|NCT02151682|50194061|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
25085861|NCT02151682|50194062|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
25085862|NCT02151682|50194063|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
25085863|NCT02151682|50194064|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
25085864|NCT02151682|50194065|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
25085865|NCT02151682|50194066|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
25085866|NCT02151682|50194061|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
25085867|NCT02151682|50194062|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
25085868|NCT02151682|50194063|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
25085869|NCT02151682|50194064|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
25085870|NCT02151682|50194065|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
25085871|NCT02151682|50194066|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
25085872|NCT02151682|50194061|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
25085873|NCT02151682|50194062|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
25085874|NCT02151682|50194063|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
25085875|NCT02151682|50194064|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
25085876|NCT02151682|50194065|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
25085877|NCT02151682|50194066|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
25085878|NCT02151682|50194061|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
25085879|NCT02151682|50194062|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
25085880|NCT02151682|50194063|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
25085881|NCT02151682|50194064|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
25085882|NCT02151682|50194065|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
25085883|NCT02151682|50194066|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
25085884|NCT02151682|50194061|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
25085885|NCT02151682|50194062|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
25085886|NCT02151682|50194063|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
25085887|NCT02151682|50194064|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
25085888|NCT02151682|50194065|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
25085889|NCT02151682|50194066|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
25085890|NCT02151682|50194061|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
25085891|NCT02151682|50194062|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
25085892|NCT02151682|50194063|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
25085893|NCT02151682|50194064|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
25085894|NCT02151682|50194065|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
25085895|NCT02151682|50194066|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
25085896|NCT02151682|50194061|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
25085897|NCT02151682|50194062|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
25085898|NCT02151682|50194063|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
25085899|NCT02151682|50194064|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
25085900|NCT02151682|50194065|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
25085901|NCT02151682|50194066|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
25085902|NCT02151682|50194061|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
25085903|NCT02151682|50194062|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
25085904|NCT02151682|50194063|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
25085905|NCT02151682|50194064|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
25085906|NCT02151682|50194065|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
25085907|NCT02151682|50194066|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
25085908|NCT02151682|50194061|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
25085909|NCT02151682|50194062|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
25085910|NCT02151682|50194063|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
25085911|NCT02151682|50194064|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
25085912|NCT02151682|50194065|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
25085913|NCT02151682|50194066|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
25085914|NCT02151682|50194061|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
25085915|NCT02151682|50194062|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
25085916|NCT02151682|50194063|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
25085917|NCT02151682|50194064|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
25085918|NCT02151682|50194065|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
25085919|NCT02151682|50194066|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
25085920|NCT02151682|50194061|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
25085921|NCT02151682|50194062|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
25085922|NCT02151682|50194063|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
25085923|NCT02151682|50194064|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
25085924|NCT02151682|50194065|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
25085925|NCT02151682|50194066|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
25085926|NCT02174848|50194086|FG000|Overall Study|Adverse Event|2|||
25085927|NCT02174848|50194087|FG001|Overall Study|Adverse Event|1|||
25085928|NCT02174848|50194086|FG000|Overall Study|Withdrawal by Subject|3|||
25085929|NCT02174848|50194087|FG001|Overall Study|Withdrawal by Subject|3|||
25085930|NCT02174848|50194086|FG000|Overall Study|Lost to Follow-up|0|||
25085931|NCT02174848|50194087|FG001|Overall Study|Lost to Follow-up|1|||
25085932|NCT02174848|50194086|FG000|Overall Study|Worsening of disease|1|||
25085933|NCT02174848|50194087|FG001|Overall Study|Worsening of disease|1|||
25085934|NCT02174848|50194086|FG000|Overall Study|Unable to comply with study requirements|1|||
25085935|NCT02174848|50194087|FG001|Overall Study|Unable to comply with study requirements|0|||
25085936|NCT02151058|50194101|FG000|Overall Study|Withdrawal by Subject|1|||
25085937|NCT02151058|50194102|FG001|Overall Study|Withdrawal by Subject|1|||
25085938|NCT02151058|50194103|FG002|Overall Study|Withdrawal by Subject|3|||
25085939|NCT02151058|50194101|FG000|Overall Study|Lost to Follow-up|1|||
25085940|NCT02151058|50194102|FG001|Overall Study|Lost to Follow-up|0|||
25085941|NCT02151058|50194103|FG002|Overall Study|Lost to Follow-up|2|||
25085942|NCT02149810|50194113|FG000|Overall Study|Physician Decision|1|||
25085943|NCT02149810|50194114|FG001|Overall Study|Physician Decision|2|||
25085944|NCT02149810|50194113|FG000|Overall Study|Lost to Follow-up|2|||
25085945|NCT02149810|50194114|FG001|Overall Study|Lost to Follow-up|1|||
25085946|NCT02149810|50194113|FG000|Overall Study|Withdrawal by Subject|5|||
25085947|NCT02149810|50194114|FG001|Overall Study|Withdrawal by Subject|1|||
25085948|NCT02149420|50194123|FG000|Core Study|Administrative problems|0|||
25085949|NCT02149420|50194124|FG001|Core Study|Administrative problems|1|||
25085950|NCT02149420|50194125|FG002|Core Study|Administrative problems|2|||
25085951|NCT02149420|50194123|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
25085952|NCT02149420|50194124|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
25085953|NCT02149420|50194125|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
25085954|NCT02149264|50194138|FG000|Overall Study|Withdrawal by Subject|9|||
25085955|NCT02149264|50194138|FG000|Overall Study|Adverse Event|7|||
25085956|NCT02149264|50194138|FG000|Overall Study|Physician Decision|3|||
25085957|NCT02149264|50194138|FG000|Overall Study|Protocol Violation|1|||
25085958|NCT02115256|50194144|FG000|Overall Study|Withdrawal by Subject|0|||
25085959|NCT02115256|50194145|FG001|Overall Study|Withdrawal by Subject|1|||
25085960|NCT02173054|50194154|FG000|Overall Study|lack of compliance|1|||
25085961|NCT02173054|50194155|FG001|Overall Study|lack of compliance|0|||
25085962|NCT02173054|50194156|FG002|Overall Study|lack of compliance|0|||
25085963|NCT02173054|50194154|FG000|Overall Study|Withdrawal by Subject|0|||
25085964|NCT02173054|50194155|FG001|Overall Study|Withdrawal by Subject|0|||
25085965|NCT02173054|50194156|FG002|Overall Study|Withdrawal by Subject|1|||
25085966|NCT02149108|50194185|FG000|Overall Study|Not treated|1|||
25085967|NCT02149108|50194186|FG001|Overall Study|Not treated|2|||
25085968|NCT02149108|50194185|FG000|Overall Study|Progressive Disease (PD)|324|||
25085969|NCT02149108|50194186|FG001|Overall Study|Progressive Disease (PD)|318|||
25085970|NCT02149108|50194185|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
25085971|NCT02149108|50194186|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
25085972|NCT02149108|50194185|FG000|Overall Study|Other Adverse Event (AE)|8|||
25085973|NCT02149108|50194186|FG001|Overall Study|Other Adverse Event (AE)|18|||
25085974|NCT02149108|50194185|FG000|Overall Study|Other not defined above|0|||
25085975|NCT02149108|50194186|FG001|Overall Study|Other not defined above|2|||
25085976|NCT02149108|50194185|FG000|Overall Study|Refusal to continue trial medication|15|||
25085977|NCT02149108|50194186|FG001|Overall Study|Refusal to continue trial medication|11|||
25085978|NCT02149108|50194185|FG000|Overall Study|Lost to Follow-up|1|||
25085979|NCT02149108|50194186|FG001|Overall Study|Lost to Follow-up|0|||
25085980|NCT02148952|50194194|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
25085981|NCT02148952|50194195|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
25085982|NCT02148952|50194194|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
25085983|NCT02148952|50194195|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
25085984|NCT02148952|50194194|FG000|Follow-Up|Lost to Follow-up|219|||
25085985|NCT02148952|50194195|FG001|Follow-Up|Lost to Follow-up|231|||
25085986|NCT02148952|50194194|FG000|Follow-Up|Withdrawal by Subject|46|||
25085987|NCT02148952|50194195|FG001|Follow-Up|Withdrawal by Subject|48|||
25085988|NCT02148718|50194219|FG000|Overall Study|Protocol Violation|26|||
25085989|NCT02148718|50194219|FG000|Overall Study|Discontinued Study Prematurely|5|||
25085990|NCT02148250|50194223|FG000|Screening|Withdrawal by Subject|5|||
25085991|NCT02148250|50194224|FG001|Screening|Withdrawal by Subject|0|||
25085992|NCT02147626|50194233|FG000|Overall Study|Lost to Follow-up|4|||
25085993|NCT02147626|50194234|FG001|Overall Study|Lost to Follow-up|4|||
25085994|NCT02147626|50194233|FG000|Overall Study|Pregnancy|1|||
25085995|NCT02147626|50194234|FG001|Overall Study|Pregnancy|2|||
25085996|NCT02147626|50194233|FG000|Overall Study|Withdrawal by Subject|0|||
25085997|NCT02147626|50194234|FG001|Overall Study|Withdrawal by Subject|1|||
25085998|NCT02172664|50194240|FG000|Overall Study|Lost to Follow-up|4|||
25085999|NCT02172664|50194241|FG001|Overall Study|Lost to Follow-up|4|||
25086000|NCT02172664|50194240|FG000|Overall Study|Death|1|||
25086001|NCT02172664|50194241|FG001|Overall Study|Death|1|||
25086002|NCT02172664|50194240|FG000|Overall Study|Moved out of area|1|||
25086003|NCT02172664|50194241|FG001|Overall Study|Moved out of area|1|||
25086004|NCT02172040|50194250|FG000|Overall Study|Adverse Event|0|||
25086005|NCT02172040|50194251|FG001|Overall Study|Adverse Event|2|||
25086006|NCT02172040|50194252|FG002|Overall Study|Adverse Event|0|||
25086007|NCT02172040|50194253|FG003|Overall Study|Adverse Event|0|||
25086008|NCT02172040|50194250|FG000|Overall Study|Protocol Violation|0|||
25086009|NCT02172040|50194251|FG001|Overall Study|Protocol Violation|1|||
25086010|NCT02172040|50194252|FG002|Overall Study|Protocol Violation|0|||
25086011|NCT02172040|50194253|FG003|Overall Study|Protocol Violation|0|||
25086012|NCT02172040|50194250|FG000|Overall Study|Withdrawal by Subject|0|||
25086013|NCT02172040|50194251|FG001|Overall Study|Withdrawal by Subject|0|||
25086014|NCT02172040|50194252|FG002|Overall Study|Withdrawal by Subject|1|||
25086015|NCT02172040|50194253|FG003|Overall Study|Withdrawal by Subject|0|||
25086016|NCT02172040|50194250|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
25086017|NCT02172040|50194251|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
25086018|NCT02172040|50194252|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
25086019|NCT02172040|50194253|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
25086020|NCT02172040|50194250|FG000|Overall Study|Family emergency abroad|0|||
25086021|NCT02172040|50194251|FG001|Overall Study|Family emergency abroad|0|||
25086022|NCT02172040|50194252|FG002|Overall Study|Family emergency abroad|0|||
25086023|NCT02172040|50194253|FG003|Overall Study|Family emergency abroad|1|||
25086024|NCT02112994|50194293|FG000|Overall Study|Progressive Disease|0|||
25086025|NCT02112994|50194294|FG001|Overall Study|Progressive Disease|0|||
25086026|NCT02112994|50194295|FG002|Overall Study|Progressive Disease|1|||
25086027|NCT02112994|50194293|FG000|Overall Study|Pregnancy|0|||
25086028|NCT02112994|50194294|FG001|Overall Study|Pregnancy|1|||
25086029|NCT02112994|50194295|FG002|Overall Study|Pregnancy|1|||
25086030|NCT02112994|50194293|FG000|Overall Study|Liver Transplant|0|||
25086031|NCT02112994|50194294|FG001|Overall Study|Liver Transplant|1|||
25086032|NCT02112994|50194295|FG002|Overall Study|Liver Transplant|0|||
25086033|NCT02112994|50194293|FG000|Overall Study|Withdrawal by Subject|0|||
25086034|NCT02112994|50194294|FG001|Overall Study|Withdrawal by Subject|0|||
25086035|NCT02112994|50194295|FG002|Overall Study|Withdrawal by Subject|1|||
25086036|NCT02147158|50194313|FG000|Treatment Course 1|Adverse Event|1|||
25086037|NCT02147158|50194314|FG001|Treatment Course 1|Adverse Event|4|||
25086038|NCT02147158|50194315|FG002|Treatment Course 1|Adverse Event|3|||
25086039|NCT02147158|50194316|FG003|Treatment Course 1|Adverse Event|4|||
25172551|NCT01743989|50313201|FG000|Treatment Phase|Death|0|||
25172552|NCT01743989|50313202|FG001|Treatment Phase|Death|1|||
25172553|NCT01743989|50313203|FG002|Treatment Phase|Death|3|||
25172554|NCT01743989|50313201|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
25086040|NCT02147158|50194317|FG004|Treatment Course 1|Adverse Event|1|||
25172555|NCT01743989|50313202|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
25172556|NCT01743989|50313203|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
25172557|NCT01743989|50313201|FG000|Treatment Phase|Protocol deviation|0|||
25172558|NCT01743989|50313202|FG001|Treatment Phase|Protocol deviation|0|||
25172559|NCT01743989|50313203|FG002|Treatment Phase|Protocol deviation|3|||
25086041|NCT02147158|50194318|FG005|Treatment Course 1|Adverse Event|2|||
25086042|NCT02147158|50194313|FG000|Treatment Course 1|Lost to Follow-up|2|||
25086043|NCT02147158|50194314|FG001|Treatment Course 1|Lost to Follow-up|4|||
25086044|NCT02147158|50194315|FG002|Treatment Course 1|Lost to Follow-up|3|||
25086045|NCT02147158|50194316|FG003|Treatment Course 1|Lost to Follow-up|3|||
25086046|NCT02147158|50194317|FG004|Treatment Course 1|Lost to Follow-up|2|||
25086047|NCT02147158|50194318|FG005|Treatment Course 1|Lost to Follow-up|4|||
25086048|NCT02147158|50194313|FG000|Treatment Course 1|Protocol Violation|0|||
25086049|NCT02147158|50194314|FG001|Treatment Course 1|Protocol Violation|0|||
25086050|NCT02147158|50194315|FG002|Treatment Course 1|Protocol Violation|1|||
25086051|NCT02147158|50194316|FG003|Treatment Course 1|Protocol Violation|1|||
25086052|NCT02147158|50194317|FG004|Treatment Course 1|Protocol Violation|0|||
25086053|NCT02147158|50194318|FG005|Treatment Course 1|Protocol Violation|0|||
25086054|NCT02147158|50194313|FG000|Treatment Course 1|Withdrawal of Consent|1|||
25086055|NCT02147158|50194314|FG001|Treatment Course 1|Withdrawal of Consent|1|||
25086056|NCT02147158|50194315|FG002|Treatment Course 1|Withdrawal of Consent|1|||
24907537|NCT00623805|50001589|FG001|Overall Study|Adverse Event|6|||
24907538|NCT00623805|50001588|FG000|Overall Study|Death|2|||
24907539|NCT00623805|50001589|FG001|Overall Study|Death|0|||
24996150|NCT01066000|50087321|FG000|Overall Study|Withdrawal by Subject|1|||
24996151|NCT01066000|50087321|FG000|Overall Study|Adverse Event|1|||
24996152|NCT01065844|50087325|FG000|Overall Study|Adverse Event|5|||
24996153|NCT00004635|50087331|FG000|Period One|refused|2|||
24996154|NCT00004635|50087332|FG001|Period One|refused|1|||
24996155|NCT00004635|50087331|FG000|Period One|Withdrawal by Subject|1|||
24996156|NCT00004635|50087332|FG001|Period One|Withdrawal by Subject|1|||
24996157|NCT00004635|50087331|FG000|Period One|Protocol Violation|1|||
24996158|NCT00004635|50087332|FG001|Period One|Protocol Violation|0|||
24996159|NCT00004635|50087331|FG000|Period One|PSA did not go <5 ng/mL|1|||
24996160|NCT00004635|50087332|FG001|Period One|PSA did not go <5 ng/mL|0|||
24996161|NCT00004635|50087331|FG000|Period One|second malignancy|1|||
24996162|NCT00004635|50087332|FG001|Period One|second malignancy|0|||
24996163|NCT00004635|50087331|FG000|Period One|progressed|0|||
24996164|NCT00004635|50087332|FG001|Period One|progressed|2|||
24996165|NCT00004635|50087331|FG000|Period One|health problem|0|||
24996166|NCT00004635|50087332|FG001|Period One|health problem|1|||
24996167|NCT00004635|50087331|FG000|Period One|discrepancy in data entry|0|||
24996168|NCT00004635|50087332|FG001|Period One|discrepancy in data entry|1|||
24996169|NCT00004635|50087331|FG000|Period Two|progression|2|||
24996170|NCT00004635|50087332|FG001|Period Two|progression|3|||
24996171|NCT00004635|50087331|FG000|Period Two|Adverse Event|1|||
24996172|NCT00004635|50087332|FG001|Period Two|Adverse Event|0|||
24996173|NCT00004635|50087331|FG000|Period Two|refused|0|||
24996174|NCT00004635|50087332|FG001|Period Two|refused|2|||
24996175|NCT00004635|50087331|FG000|Period Two|health problem|1|||
24996176|NCT00004635|50087332|FG001|Period Two|health problem|1|||
24996177|NCT00004635|50087331|FG000|Period Two|travel issues|0|||
24996178|NCT00004635|50087332|FG001|Period Two|travel issues|1|||
24996179|NCT00004635|50087331|FG000|Period Two|secondary malignancy|1|||
24996180|NCT00004635|50087332|FG001|Period Two|secondary malignancy|1|||
24996181|NCT00004635|50087331|FG000|Period Two|Lost to Follow-up|1|||
24996182|NCT00004635|50087332|FG001|Period Two|Lost to Follow-up|0|||
24996183|NCT00004635|50087331|FG000|Period Two|discrepancy in data entry|0|||
24996184|NCT00004635|50087332|FG001|Period Two|discrepancy in data entry|1|||
24996185|NCT00004563|50087343|FG000|Overall Study|Withdrawal by Subject|20|||
24996186|NCT00004563|50087344|FG001|Overall Study|Withdrawal by Subject|16|||
24996187|NCT00004563|50087343|FG000|Overall Study|Lack of Efficacy|3|||
24996188|NCT00004563|50087344|FG001|Overall Study|Lack of Efficacy|5|||
24996189|NCT00004563|50087343|FG000|Overall Study|Death|2|||
24996190|NCT00004563|50087344|FG001|Overall Study|Death|3|||
24996191|NCT00003645|50087352|FG000|Overall Study|Death|4|||
24996192|NCT00003645|50087353|FG001|Overall Study|Death|1|||
24996193|NCT00003645|50087352|FG000|Overall Study|Lost to Follow-up|7|||
24996194|NCT00003645|50087353|FG001|Overall Study|Lost to Follow-up|8|||
24996195|NCT00003645|50087352|FG000|Overall Study|Withdrawal by Subject|1|||
24996196|NCT00003645|50087353|FG001|Overall Study|Withdrawal by Subject|3|||
24996197|NCT00003537|50087361|FG000|Overall Study|Not evalauable|1|||
24996198|NCT00003531|50087365|FG000|Overall Study|Not evaluable|10|||
24996199|NCT02918968|50087371|FG000|1st Line AAT|Progressive disease|9|||
24996200|NCT02918968|50087372|FG001|1st Line AAT|Progressive disease|4|||
24996201|NCT02918968|50087371|FG000|1st Line AAT|Adverse Event|12|||
24996202|NCT02918968|50087372|FG001|1st Line AAT|Adverse Event|3|||
24996203|NCT02918968|50087371|FG000|1st Line AAT|Physician Decision|4|||
24996204|NCT02918968|50087372|FG001|1st Line AAT|Physician Decision|2|||
24996205|NCT02918968|50087371|FG000|1st Line AAT|Withdrawal by Subject|2|||
24996206|NCT02918968|50087372|FG001|1st Line AAT|Withdrawal by Subject|1|||
24996207|NCT02918968|50087371|FG000|1st Line AAT|Lost to Follow-up|0|||
24996208|NCT02918968|50087372|FG001|1st Line AAT|Lost to Follow-up|1|||
24996209|NCT02918968|50087371|FG000|1st Line AAT|Death|1|||
24996210|NCT02918968|50087372|FG001|1st Line AAT|Death|0|||
24996211|NCT02918968|50087371|FG000|1st Line AAT|Miscellaneous|1|||
24996212|NCT02918968|50087372|FG001|1st Line AAT|Miscellaneous|0|||
24996213|NCT02918968|50087371|FG000|2nd Line AAT|Progressive disease|21|||
24996214|NCT02918968|50087372|FG001|2nd Line AAT|Progressive disease|3|||
24996215|NCT02918968|50087371|FG000|2nd Line AAT|Adverse Event|2|||
24996216|NCT02918968|50087372|FG001|2nd Line AAT|Adverse Event|5|||
24996217|NCT02918968|50087371|FG000|2nd Line AAT|Physician Decision|0|||
24996218|NCT02918968|50087372|FG001|2nd Line AAT|Physician Decision|1|||
24996219|NCT02918968|50087371|FG000|2nd Line AAT|Withdrawal by Subject|2|||
24996220|NCT02918968|50087372|FG001|2nd Line AAT|Withdrawal by Subject|2|||
24996221|NCT02918968|50087371|FG000|2nd Line AAT|Death|0|||
24996222|NCT02918968|50087372|FG001|2nd Line AAT|Death|1|||
24996223|NCT01065766|50087380|FG000|Overall Study|Assessed before the contracted date|1|||
24996224|NCT01065766|50087380|FG000|Overall Study|Contraindication to administration|6|||
24996225|NCT01065766|50087380|FG000|Overall Study|Violated dosage/administration|25|||
24996226|NCT01063972|50087386|FG000|Overall Study|Death|12|||
24996227|NCT01063972|50087387|FG001|Overall Study|Death|11|||
24996228|NCT01063972|50087386|FG000|Overall Study|Incarcerated|2|||
24996229|NCT01063972|50087387|FG001|Overall Study|Incarcerated|1|||
24996230|NCT00042939|50087395|FG000|Overall Study|Adverse Event|6|||
24996231|NCT00042939|50087396|FG001|Overall Study|Adverse Event|7|||
24996232|NCT00042939|50087395|FG000|Overall Study|Death|3|||
24996233|NCT00042939|50087396|FG001|Overall Study|Death|2|||
24996234|NCT00042939|50087395|FG000|Overall Study|Withdrawal by Subject|3|||
24996235|NCT00042939|50087396|FG001|Overall Study|Withdrawal by Subject|4|||
24996236|NCT00042939|50087395|FG000|Overall Study|Other disease|1|||
24996237|NCT00042939|50087396|FG001|Overall Study|Other disease|0|||
24996238|NCT00042939|50087395|FG000|Overall Study|Ineligible|2|||
24996239|NCT00042939|50087396|FG001|Overall Study|Ineligible|2|||
24996240|NCT00042939|50087395|FG000|Overall Study|Deterioration of health|3|||
24996241|NCT00042939|50087396|FG001|Overall Study|Deterioration of health|4|||
24996242|NCT00042939|50087395|FG000|Overall Study|QOL diminished|1|||
24996243|NCT00042939|50087396|FG001|Overall Study|QOL diminished|0|||
24996244|NCT00042939|50087395|FG000|Overall Study|Rising ca 19-9|1|||
24996245|NCT00042939|50087396|FG001|Overall Study|Rising ca 19-9|0|||
24996246|NCT00042939|50087395|FG000|Overall Study|Patient non-compliance|1|||
24996247|NCT00042939|50087396|FG001|Overall Study|Patient non-compliance|0|||
24996248|NCT00042939|50087395|FG000|Overall Study|Still on treatment|1|||
24996249|NCT00042939|50087396|FG001|Overall Study|Still on treatment|0|||
24996250|NCT00042939|50087395|FG000|Overall Study|Treatment break > 4 weeks|0|||
24996251|NCT00042939|50087396|FG001|Overall Study|Treatment break > 4 weeks|1|||
24996252|NCT00042939|50087395|FG000|Overall Study|Did not start treatment|2|||
24996253|NCT00042939|50087396|FG001|Overall Study|Did not start treatment|1|||
24996254|NCT00003483|50087402|FG000|Overall Study|Not evaluable|1|||
24996255|NCT00003477|50087406|FG000|Overall Study|Not evalauable|4|||
24996256|NCT00003471|50087410|FG000|Overall Study|Not evaluable|4|||
24996257|NCT04185220|50087416|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
24996258|NCT04185220|50087417|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
24996259|NCT04185220|50087416|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
24996260|NCT04185220|50087417|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
24996261|NCT00002931|50087424|FG000|Overall Study|rapidly progressing disease during|2|||
24996262|NCT02918266|50087439|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
24996263|NCT02918266|50087440|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
24996264|NCT02918266|50087441|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
24996265|NCT02918266|50087442|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
24996266|NCT02918266|50087443|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
24996267|NCT02918266|50087444|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
24996268|NCT02918266|50087445|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
24996269|NCT02918266|50087446|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
24996270|NCT02918266|50087447|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
24996271|NCT02918266|50087448|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
24996272|NCT02918266|50087449|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
24996273|NCT00041067|50087469|FG000|Overall Study|Adverse Event|20|||
24996274|NCT00041067|50087469|FG000|Overall Study|Progression|19|||
24996275|NCT00041067|50087469|FG000|Overall Study|Patient refusal|12|||
24996276|NCT00041067|50087469|FG000|Overall Study|Other reasons|23|||
24996277|NCT00041067|50087469|FG000|Overall Study|Ineligible|2|||
24996278|NCT01063036|50087474|FG000|Participants Treated With Study Drug|Adverse Event|1|||
24996279|NCT01063036|50087474|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
24996280|NCT01063036|50087474|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
24996281|NCT01063036|50087474|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
24996282|NCT01063036|50087474|FG000|Participants Treated With Study Drug|Pregnancy|1|||
24996283|NCT01063036|50087474|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
24996284|NCT01063036|50087474|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
24996285|NCT01063036|50087474|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
24996286|NCT00040365|50087478|FG000|Overall Study|Death|1|||
24996287|NCT00040365|50087478|FG000|Overall Study|Progressive disease|7|||
24996288|NCT00040365|50087478|FG000|Overall Study|Lost to Follow-up|3|||
24996289|NCT02974114|50087485|FG000|Overall Study|Other (Not specified)|0|||
24996290|NCT02974114|50087486|FG001|Overall Study|Other (Not specified)|1|||
24996291|NCT02974114|50087487|FG002|Overall Study|Other (Not specified)|2|||
24996292|NCT00001959|50087497|FG000|Overall Study|newly diagnosed colon cancer|1|||
24996293|NCT00001959|50087497|FG000|Overall Study|disabling sedation|1|||
24996294|NCT00001959|50087497|FG000|Overall Study|non-compliance|1|||
24996295|NCT00001941|50087501|FG000|Overall Study|not treated- rapidly progressing disease|0|||
24996296|NCT00001941|50087502|FG001|Overall Study|not treated- rapidly progressing disease|0|||
24996297|NCT00001941|50087503|FG002|Overall Study|not treated- rapidly progressing disease|0|||
24996298|NCT00001941|50087504|FG003|Overall Study|not treated- rapidly progressing disease|0|||
24996299|NCT00001941|50087505|FG004|Overall Study|not treated- rapidly progressing disease|1|||
24996300|NCT02978326|50087513|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
24996301|NCT02978326|50087514|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
24996302|NCT02978326|50087515|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
24996303|NCT02978326|50087513|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
24996304|NCT02978326|50087514|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
24996305|NCT02978326|50087515|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
24996306|NCT02978326|50087513|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
24996307|NCT02978326|50087514|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
24996308|NCT02978326|50087515|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
24996309|NCT02978326|50087513|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
24996310|NCT02978326|50087514|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
24996311|NCT02978326|50087515|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
24996312|NCT01061866|50087525|FG000|Overall Study|Adverse Event|2|||
24996313|NCT01061008|50087531|FG000|Overall Study|Badiocephalic fistula failed|3|||
24996314|NCT01061008|50087532|FG001|Overall Study|Badiocephalic fistula failed|2|||
24996315|NCT01061008|50087531|FG000|Overall Study|Death|1|||
24996316|NCT01061008|50087532|FG001|Overall Study|Death|0|||
24996317|NCT01061008|50087531|FG000|Overall Study|Withdrawal by Subject|1|||
24996318|NCT01061008|50087532|FG001|Overall Study|Withdrawal by Subject|3|||
24996319|NCT01061008|50087531|FG000|Overall Study|Unable to exercise following surgery|1|||
24996320|NCT01061008|50087532|FG001|Overall Study|Unable to exercise following surgery|0|||
25086057|NCT02147158|50194316|FG003|Treatment Course 1|Withdrawal of Consent|5|||
24996321|NCT01061008|50087531|FG000|Overall Study|Adverse Event|0|||
24996322|NCT01061008|50087532|FG001|Overall Study|Adverse Event|1|||
24996323|NCT00039741|50087542|FG000|Overall Study|Death|0|||
24996324|NCT00039741|50087543|FG001|Overall Study|Death|1|||
24996325|NCT00039741|50087544|FG002|Overall Study|Death|0|||
24996326|NCT00039741|50087545|FG003|Overall Study|Death|0|||
24996327|NCT00039741|50087542|FG000|Overall Study|Lost to Follow-up|3|||
24996328|NCT00039741|50087543|FG001|Overall Study|Lost to Follow-up|1|||
24996329|NCT00039741|50087544|FG002|Overall Study|Lost to Follow-up|5|||
24996330|NCT00039741|50087545|FG003|Overall Study|Lost to Follow-up|2|||
24996331|NCT00039741|50087542|FG000|Overall Study|Confounding medical condition|1|||
24996332|NCT00039741|50087543|FG001|Overall Study|Confounding medical condition|0|||
24996333|NCT00039741|50087544|FG002|Overall Study|Confounding medical condition|0|||
24996334|NCT00039741|50087545|FG003|Overall Study|Confounding medical condition|0|||
24996335|NCT00039741|50087542|FG000|Overall Study|Not able to get to clinic|5|||
24996336|NCT00039741|50087543|FG001|Overall Study|Not able to get to clinic|2|||
24996337|NCT00039741|50087544|FG002|Overall Study|Not able to get to clinic|0|||
24996338|NCT00039741|50087545|FG003|Overall Study|Not able to get to clinic|3|||
24996339|NCT00039741|50087542|FG000|Overall Study|Moved|3|||
24996340|NCT00039741|50087543|FG001|Overall Study|Moved|2|||
24996341|NCT00039741|50087544|FG002|Overall Study|Moved|3|||
24996342|NCT00039741|50087545|FG003|Overall Study|Moved|6|||
24996343|NCT00039741|50087542|FG000|Overall Study|Non-compliance with protocol|1|||
24996344|NCT00039741|50087543|FG001|Overall Study|Non-compliance with protocol|0|||
24996345|NCT00039741|50087544|FG002|Overall Study|Non-compliance with protocol|1|||
24996346|NCT00039741|50087545|FG003|Overall Study|Non-compliance with protocol|0|||
24996347|NCT00039741|50087542|FG000|Overall Study|Withdrew consent|0|||
24996348|NCT00039741|50087543|FG001|Overall Study|Withdrew consent|5|||
24996349|NCT00039741|50087544|FG002|Overall Study|Withdrew consent|0|||
24996350|NCT00039741|50087545|FG003|Overall Study|Withdrew consent|1|||
24996351|NCT00039741|50087542|FG000|Overall Study|Missed final visit|2|||
24996352|NCT00039741|50087543|FG001|Overall Study|Missed final visit|1|||
24996353|NCT00039741|50087544|FG002|Overall Study|Missed final visit|2|||
24996354|NCT00039741|50087545|FG003|Overall Study|Missed final visit|2|||
24996355|NCT02973802|50087555|FG000|Overall Study|Lost to Follow-up|1|||
24996356|NCT02973802|50087555|FG000|Overall Study|Withdrawal by Subject|1|||
24996357|NCT02973100|50087564|FG000|Overall Study|Adverse Event|1|||
24996358|NCT02973100|50087565|FG001|Overall Study|Adverse Event|2|||
24996359|NCT02973100|50087566|FG002|Overall Study|Adverse Event|1|||
24996360|NCT02973100|50087567|FG003|Overall Study|Adverse Event|2|||
24996361|NCT02973100|50087564|FG000|Overall Study|Lost to Follow-up|3|||
24996362|NCT02973100|50087565|FG001|Overall Study|Lost to Follow-up|1|||
24996363|NCT02973100|50087566|FG002|Overall Study|Lost to Follow-up|1|||
24996364|NCT02973100|50087567|FG003|Overall Study|Lost to Follow-up|0|||
24996365|NCT02973100|50087564|FG000|Overall Study|Withdrawal by Subject|3|||
24996366|NCT02973100|50087565|FG001|Overall Study|Withdrawal by Subject|5|||
24996367|NCT02973100|50087566|FG002|Overall Study|Withdrawal by Subject|1|||
24996368|NCT02973100|50087567|FG003|Overall Study|Withdrawal by Subject|4|||
24996369|NCT02973100|50087564|FG000|Overall Study|Notification of change in address|0|||
24996370|NCT02973100|50087565|FG001|Overall Study|Notification of change in address|0|||
24996371|NCT02973100|50087566|FG002|Overall Study|Notification of change in address|0|||
24996372|NCT02973100|50087567|FG003|Overall Study|Notification of change in address|1|||
24996373|NCT02973100|50087564|FG000|Overall Study|Failed to attend Safety followup period|0|||
24996374|NCT02973100|50087565|FG001|Overall Study|Failed to attend Safety followup period|0|||
24996375|NCT02973100|50087566|FG002|Overall Study|Failed to attend Safety followup period|1|||
24996376|NCT02973100|50087567|FG003|Overall Study|Failed to attend Safety followup period|0|||
24996377|NCT01060540|50087582|FG000|Overall Study|Withdrawal by Subject|10|||
24996378|NCT01060540|50087583|FG001|Overall Study|Withdrawal by Subject|20|||
24996379|NCT01060540|50087582|FG000|Overall Study|Lost to Follow-up|52|||
24996380|NCT01060540|50087583|FG001|Overall Study|Lost to Follow-up|43|||
25086058|NCT02147158|50194317|FG004|Treatment Course 1|Withdrawal of Consent|3|||
25086059|NCT02147158|50194318|FG005|Treatment Course 1|Withdrawal of Consent|2|||
25086060|NCT02147158|50194313|FG000|Off-Treatment Interval 1|Adverse Event|1|||
24996381|NCT01060540|50087582|FG000|Overall Study|Death|2|||
24996382|NCT01060540|50087583|FG001|Overall Study|Death|1|||
24996383|NCT01060540|50087582|FG000|Overall Study|Physician Decision|0|||
24996384|NCT01060540|50087583|FG001|Overall Study|Physician Decision|1|||
24996385|NCT02972632|50087608|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
24996386|NCT02972632|50087608|FG000|Overall Study|Lost to Follow-up|4|||
24996387|NCT02972632|50087608|FG000|Overall Study|Voluntary Withdrawal|10|||
24996388|NCT01060384|50087612|FG000|Overall Study|Withdrawal by Subject|0|||
24996389|NCT01060384|50087613|FG001|Overall Study|Withdrawal by Subject|1|||
24996390|NCT01060384|50087614|FG002|Overall Study|Withdrawal by Subject|0|||
24996391|NCT01060384|50087615|FG003|Overall Study|Withdrawal by Subject|0|||
24996392|NCT01060384|50087616|FG004|Overall Study|Withdrawal by Subject|0|||
25086061|NCT02147158|50194314|FG001|Off-Treatment Interval 1|Adverse Event|0|||
24996393|NCT01060384|50087612|FG000|Overall Study|Death|0|||
24996394|NCT01060384|50087613|FG001|Overall Study|Death|0|||
24996395|NCT01060384|50087614|FG002|Overall Study|Death|0|||
24996396|NCT01060384|50087615|FG003|Overall Study|Death|0|||
24996397|NCT01060384|50087616|FG004|Overall Study|Death|1|||
24996398|NCT01060384|50087612|FG000|Overall Study|Intercurrent illness|0|||
24996399|NCT01060384|50087613|FG001|Overall Study|Intercurrent illness|0|||
24996400|NCT01060384|50087614|FG002|Overall Study|Intercurrent illness|0|||
24996401|NCT01060384|50087615|FG003|Overall Study|Intercurrent illness|0|||
24996402|NCT01060384|50087616|FG004|Overall Study|Intercurrent illness|1|||
24996403|NCT01060150|50087625|FG000|Overall Study|Adverse Event|6|||
24996404|NCT01060150|50087625|FG000|Overall Study|Lost to Follow-up|1|||
24996405|NCT01060150|50087625|FG000|Overall Study|Protocol Violation|6|||
24996406|NCT01060150|50087625|FG000|Overall Study|Withdrawal by Subject|8|||
24996407|NCT01060150|50087625|FG000|Overall Study|Enrolled, but not treated|2|||
24996408|NCT02972242|50087631|FG000|Overall Study|Withdrawal by Subject|1|||
24996409|NCT02972242|50087632|FG001|Overall Study|Withdrawal by Subject|0|||
24996410|NCT02970292|50087640|FG000|Overall Study|Physician Decision|1|||
24996411|NCT02970292|50087641|FG001|Overall Study|Physician Decision|1|||
24996412|NCT02970292|50087640|FG000|Overall Study|Withdrawal by Subject|11|||
24996413|NCT02970292|50087641|FG001|Overall Study|Withdrawal by Subject|5|||
24996414|NCT02970292|50087640|FG000|Overall Study|Noncompliance with study drug|2|||
24996415|NCT02970292|50087641|FG001|Overall Study|Noncompliance with study drug|2|||
24996416|NCT02970292|50087640|FG000|Overall Study|Adverse Event|5|||
24996417|NCT02970292|50087641|FG001|Overall Study|Adverse Event|0|||
24996418|NCT02970292|50087640|FG000|Overall Study|Lack of Efficacy|1|||
24996419|NCT02970292|50087641|FG001|Overall Study|Lack of Efficacy|0|||
24996420|NCT02970292|50087640|FG000|Overall Study|Lost to Follow-up|1|||
24996421|NCT02970292|50087641|FG001|Overall Study|Lost to Follow-up|0|||
24996422|NCT02970292|50087640|FG000|Overall Study|Protocol Violation|2|||
24996423|NCT02970292|50087641|FG001|Overall Study|Protocol Violation|0|||
24996424|NCT02970292|50087640|FG000|Overall Study|Other|1|||
24996425|NCT02970292|50087641|FG001|Overall Study|Other|0|||
24996426|NCT02971228|50087647|FG000|Overall Study|Withdrawal by Subject|1|||
24996427|NCT02971228|50087648|FG001|Overall Study|Withdrawal by Subject|1|||
24996428|NCT02971228|50087649|FG002|Overall Study|Withdrawal by Subject|0|||
24996429|NCT02971228|50087650|FG003|Overall Study|Withdrawal by Subject|0|||
24996430|NCT02971228|50087651|FG004|Overall Study|Withdrawal by Subject|0|||
24996431|NCT02971228|50087647|FG000|Overall Study|Logistical challenges|0|||
24996432|NCT02971228|50087648|FG001|Overall Study|Logistical challenges|1|||
24996433|NCT02971228|50087649|FG002|Overall Study|Logistical challenges|0|||
24996434|NCT02971228|50087650|FG003|Overall Study|Logistical challenges|0|||
24996435|NCT02971228|50087651|FG004|Overall Study|Logistical challenges|0|||
24996436|NCT01060072|50087664|FG000|Overall Study|Adverse Event|1|||
24996437|NCT01060072|50087665|FG001|Overall Study|Adverse Event|1|||
24996438|NCT01060072|50087664|FG000|Overall Study|Physician Decision|0|||
24996439|NCT01060072|50087665|FG001|Overall Study|Physician Decision|2|||
24996440|NCT01060072|50087664|FG000|Overall Study|Protocol Violation|0|||
24996441|NCT01060072|50087665|FG001|Overall Study|Protocol Violation|1|||
24996442|NCT01060072|50087664|FG000|Overall Study|Acute cholecystitis|1|||
24996443|NCT01060072|50087665|FG001|Overall Study|Acute cholecystitis|0|||
24996444|NCT01060072|50087664|FG000|Overall Study|Excluded Medications|0|||
24996445|NCT01060072|50087665|FG001|Overall Study|Excluded Medications|1|||
24996446|NCT02969590|50087673|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
24996447|NCT02969590|50087674|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
24996448|NCT02969590|50087675|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
24996449|NCT03345849|50087687|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
24996450|NCT03345849|50087688|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
24996451|NCT03345849|50087689|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
24996452|NCT03345849|50087690|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
24996453|NCT03345849|50087687|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
24996454|NCT03345849|50087688|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
24996455|NCT03345849|50087689|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
24996456|NCT03345849|50087690|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
24996457|NCT03345849|50087687|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
24996458|NCT03345849|50087688|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
24996459|NCT03345849|50087689|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
24996460|NCT03345849|50087690|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
24996461|NCT03345849|50087687|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
24996462|NCT03345849|50087688|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
25172560|NCT01743989|50313201|FG000|Treatment Phase|Pregnancy|0|||
24996463|NCT03345849|50087689|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
24996464|NCT03345849|50087690|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
25172561|NCT01743989|50313202|FG001|Treatment Phase|Pregnancy|0|||
25172562|NCT01743989|50313203|FG002|Treatment Phase|Pregnancy|2|||
25172563|NCT01743989|50313201|FG000|Treatment Phase|Lost to Follow-up|0|||
24996465|NCT03345849|50087687|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
25172564|NCT01743989|50313202|FG001|Treatment Phase|Lost to Follow-up|0|||
25172565|NCT01743989|50313203|FG002|Treatment Phase|Lost to Follow-up|2|||
25172566|NCT01743989|50313201|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
25172567|NCT01743989|50313202|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
25172568|NCT01743989|50313203|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
25172569|NCT01743989|50313201|FG000|Treatment Phase|Administrative problems|0|||
25172570|NCT01743989|50313202|FG001|Treatment Phase|Administrative problems|0|||
24996466|NCT03345849|50087688|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
24996467|NCT03345849|50087689|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
24996468|NCT03345849|50087690|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
24996469|NCT03345849|50087687|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
24996470|NCT03345849|50087688|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
24996471|NCT03345849|50087689|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
24996472|NCT03345849|50087690|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
24996473|NCT03345849|50087687|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
24996474|NCT03345849|50087688|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
24996475|NCT03345849|50087689|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
24996476|NCT03345849|50087690|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
24996477|NCT03345849|50087687|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
24996478|NCT03345849|50087688|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
24996479|NCT03345849|50087689|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
24996480|NCT03345849|50087690|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
24996481|NCT03345849|50087687|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
24996482|NCT03345849|50087688|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
24996483|NCT03345849|50087689|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
24996484|NCT03345849|50087690|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
24996485|NCT03345849|50087687|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
24996486|NCT03345849|50087688|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
24996487|NCT03345849|50087689|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
24996488|NCT03345849|50087690|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
24996489|NCT03345849|50087687|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
24996490|NCT03345849|50087688|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
24996491|NCT03345849|50087689|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
25086062|NCT02147158|50194315|FG002|Off-Treatment Interval 1|Adverse Event|0|||
25086063|NCT02147158|50194316|FG003|Off-Treatment Interval 1|Adverse Event|1|||
25086064|NCT02147158|50194317|FG004|Off-Treatment Interval 1|Adverse Event|0|||
25086065|NCT02147158|50194318|FG005|Off-Treatment Interval 1|Adverse Event|0|||
25086066|NCT02147158|50194313|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
25086067|NCT02147158|50194314|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
25086068|NCT02147158|50194315|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
25086069|NCT02147158|50194316|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
25086070|NCT02147158|50194317|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
25086071|NCT02147158|50194318|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
25086072|NCT02147158|50194313|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
25086073|NCT02147158|50194314|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
25086074|NCT02147158|50194315|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
25086075|NCT02147158|50194316|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
25086076|NCT02147158|50194317|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
25086077|NCT02147158|50194318|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
25086078|NCT02147158|50194313|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
25086079|NCT02147158|50194314|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
25086080|NCT02147158|50194315|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
25086081|NCT02147158|50194316|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
25086082|NCT02147158|50194317|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
25086083|NCT02147158|50194318|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
25086084|NCT02147158|50194313|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
25086085|NCT02147158|50194314|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
25086086|NCT02147158|50194315|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
25086087|NCT02147158|50194316|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
25086088|NCT02147158|50194317|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
25086089|NCT02147158|50194318|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
25086090|NCT02147158|50194313|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
25086091|NCT02147158|50194314|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
25086092|NCT02147158|50194315|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
25086093|NCT02147158|50194316|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
25086094|NCT02147158|50194317|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
24996492|NCT03345849|50087690|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
24996493|NCT03011307|50087700|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
24996494|NCT03011307|50087701|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
24996495|NCT03011307|50087700|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
24996496|NCT03011307|50087701|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
24996497|NCT03011307|50087700|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
24996498|NCT03011307|50087701|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
24996499|NCT03798717|50087713|FG000|Overall Study|Failed Screening|0|||
24996500|NCT03798717|50087714|FG001|Overall Study|Failed Screening|0|||
24996501|NCT03798717|50087715|FG002|Overall Study|Failed Screening|0|||
24996502|NCT03798717|50087716|FG003|Overall Study|Failed Screening|0|||
24996503|NCT03798717|50087717|FG004|Overall Study|Failed Screening|0|||
24996504|NCT03798717|50087718|FG005|Overall Study|Failed Screening|1|||
24996505|NCT03798717|50087713|FG000|Overall Study|Physician Decision|1|||
24996506|NCT03798717|50087714|FG001|Overall Study|Physician Decision|0|||
24996507|NCT03798717|50087715|FG002|Overall Study|Physician Decision|1|||
24996508|NCT03798717|50087716|FG003|Overall Study|Physician Decision|0|||
24996509|NCT03798717|50087717|FG004|Overall Study|Physician Decision|0|||
24996510|NCT03798717|50087718|FG005|Overall Study|Physician Decision|0|||
24996511|NCT03798717|50087713|FG000|Overall Study|Withdrawal by Subject|0|||
24996512|NCT03798717|50087714|FG001|Overall Study|Withdrawal by Subject|0|||
24996513|NCT03798717|50087715|FG002|Overall Study|Withdrawal by Subject|0|||
24996514|NCT03798717|50087716|FG003|Overall Study|Withdrawal by Subject|1|||
24996515|NCT03798717|50087717|FG004|Overall Study|Withdrawal by Subject|0|||
24996516|NCT03798717|50087718|FG005|Overall Study|Withdrawal by Subject|0|||
24996517|NCT03798717|50087713|FG000|Overall Study|Lost to Follow-up|1|||
24996518|NCT03798717|50087714|FG001|Overall Study|Lost to Follow-up|0|||
24996519|NCT03798717|50087715|FG002|Overall Study|Lost to Follow-up|0|||
24996520|NCT03798717|50087716|FG003|Overall Study|Lost to Follow-up|1|||
24996521|NCT03798717|50087717|FG004|Overall Study|Lost to Follow-up|0|||
24996522|NCT03798717|50087718|FG005|Overall Study|Lost to Follow-up|0|||
24996523|NCT03798717|50087713|FG000|Overall Study|Adverse Event|0|||
24996524|NCT03798717|50087714|FG001|Overall Study|Adverse Event|1|||
24996525|NCT03798717|50087715|FG002|Overall Study|Adverse Event|0|||
24996526|NCT03798717|50087716|FG003|Overall Study|Adverse Event|0|||
24996527|NCT03798717|50087717|FG004|Overall Study|Adverse Event|0|||
24996528|NCT03798717|50087718|FG005|Overall Study|Adverse Event|0|||
24996529|NCT03798717|50087713|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
24996530|NCT03798717|50087714|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
24996531|NCT03798717|50087715|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
24996532|NCT03798717|50087716|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
24996533|NCT03798717|50087717|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
24996534|NCT03798717|50087718|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
24996535|NCT03798483|50087727|FG000|Overall Study|Lost to Follow-up|2|||
24996536|NCT03792477|50087740|FG000|Overall Study|Adverse Event|0|||
24996537|NCT03792477|50087741|FG001|Overall Study|Adverse Event|0|||
24996538|NCT03792477|50087742|FG002|Overall Study|Adverse Event|0|||
24996539|NCT03792477|50087743|FG003|Overall Study|Adverse Event|1|||
24996540|NCT03792477|50087744|FG004|Overall Study|Adverse Event|0|||
24996541|NCT03792477|50087740|FG000|Overall Study|Lost to Follow-up|0|||
24996542|NCT03792477|50087741|FG001|Overall Study|Lost to Follow-up|0|||
24996543|NCT03792477|50087742|FG002|Overall Study|Lost to Follow-up|2|||
25086095|NCT02147158|50194318|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
25086096|NCT02147158|50194313|FG000|Treatment Course 2|Adverse Event|0|||
25086097|NCT02147158|50194314|FG001|Treatment Course 2|Adverse Event|4|||
25086098|NCT02147158|50194315|FG002|Treatment Course 2|Adverse Event|2|||
25086099|NCT02147158|50194316|FG003|Treatment Course 2|Adverse Event|1|||
25086100|NCT02147158|50194317|FG004|Treatment Course 2|Adverse Event|0|||
25086101|NCT02147158|50194318|FG005|Treatment Course 2|Adverse Event|1|||
25086102|NCT02147158|50194313|FG000|Treatment Course 2|Withdrawal of Consent|0|||
25086103|NCT02147158|50194314|FG001|Treatment Course 2|Withdrawal of Consent|1|||
25086104|NCT02147158|50194315|FG002|Treatment Course 2|Withdrawal of Consent|2|||
25086105|NCT02147158|50194316|FG003|Treatment Course 2|Withdrawal of Consent|3|||
25086106|NCT02147158|50194317|FG004|Treatment Course 2|Withdrawal of Consent|0|||
25086107|NCT02147158|50194318|FG005|Treatment Course 2|Withdrawal of Consent|0|||
25086108|NCT02147158|50194313|FG000|Treatment Course 2|Lost to Follow-up|1|||
25086109|NCT02147158|50194314|FG001|Treatment Course 2|Lost to Follow-up|0|||
25086110|NCT02147158|50194315|FG002|Treatment Course 2|Lost to Follow-up|1|||
25172571|NCT01743989|50313203|FG002|Treatment Phase|Administrative problems|1|||
25172572|NCT01743989|50313201|FG000|Treatment Phase|New cancer (CML) therapy|0|||
25086111|NCT02147158|50194316|FG003|Treatment Course 2|Lost to Follow-up|1|||
25086112|NCT02147158|50194317|FG004|Treatment Course 2|Lost to Follow-up|0|||
25086113|NCT02147158|50194318|FG005|Treatment Course 2|Lost to Follow-up|1|||
25086114|NCT02147158|50194313|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
24996544|NCT03792477|50087743|FG003|Overall Study|Lost to Follow-up|0|||
24996545|NCT03792477|50087744|FG004|Overall Study|Lost to Follow-up|0|||
24996546|NCT03792477|50087740|FG000|Overall Study|Other|0|||
24996547|NCT03792477|50087741|FG001|Overall Study|Other|0|||
24996548|NCT03792477|50087742|FG002|Overall Study|Other|0|||
24996549|NCT03792477|50087743|FG003|Overall Study|Other|0|||
24996550|NCT03792477|50087744|FG004|Overall Study|Other|1|||
24996551|NCT03790917|50087750|FG000|Overall Study|Death|1|||
24996552|NCT03788967|50087757|FG000|Overall Study|Lost to Follow-up|14|||
24996553|NCT03788967|50087758|FG001|Overall Study|Lost to Follow-up|10|||
24996554|NCT03788967|50087757|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
24996555|NCT03788967|50087758|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
24996556|NCT03788967|50087757|FG000|Overall Study|Participant Withdrawal of Consent|13|||
24996557|NCT03788967|50087758|FG001|Overall Study|Participant Withdrawal of Consent|5|||
24996558|NCT03788967|50087757|FG000|Overall Study|Adverse Event|1|||
24996559|NCT03788967|50087758|FG001|Overall Study|Adverse Event|1|||
24996560|NCT03788967|50087757|FG000|Overall Study|COVID-19|1|||
24996561|NCT03788967|50087758|FG001|Overall Study|COVID-19|2|||
24996562|NCT03782571|50087766|FG000|Period 1|Withdrawal by Subject|1|||
24996563|NCT03782571|50087767|FG001|Period 1|Withdrawal by Subject|0|||
24996564|NCT03782571|50087768|FG002|Period 1|Withdrawal by Subject|0|||
24996565|NCT03782571|50087769|FG003|Period 1|Withdrawal by Subject|0|||
24996566|NCT03782571|50087766|FG000|Period 3|Subject Unable to Attend V5|1|||
24996567|NCT03782571|50087767|FG001|Period 3|Subject Unable to Attend V5|0|||
24996568|NCT03782571|50087768|FG002|Period 3|Subject Unable to Attend V5|0|||
24996569|NCT03782571|50087769|FG003|Period 3|Subject Unable to Attend V5|0|||
24996570|NCT03782571|50087766|FG000|Period 3|Adverse Event|1|||
24996571|NCT03782571|50087767|FG001|Period 3|Adverse Event|0|||
24996572|NCT03782571|50087768|FG002|Period 3|Adverse Event|0|||
24996573|NCT03782571|50087769|FG003|Period 3|Adverse Event|0|||
24996574|NCT03783039|50087783|FG000|Overall Study|Death|2|||
24996575|NCT03783039|50087784|FG001|Overall Study|Death|1|||
24996576|NCT03776175|50087794|FG000|Treatment Period (42 Days)|Adverse Event|0|||
24996577|NCT03776175|50087795|FG001|Treatment Period (42 Days)|Adverse Event|1|||
24996578|NCT03776175|50087796|FG002|Treatment Period (42 Days)|Adverse Event|1|||
24996579|NCT03776175|50087797|FG003|Treatment Period (42 Days)|Adverse Event|0|||
24996580|NCT03776175|50087794|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
24996581|NCT03776175|50087795|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
24996582|NCT03776175|50087796|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
24996583|NCT03776175|50087797|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
24996584|NCT03776175|50087794|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
24996585|NCT03776175|50087795|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
24996586|NCT03776175|50087796|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
24996587|NCT03776175|50087797|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
24996588|NCT03776175|50087794|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
24996589|NCT03776175|50087795|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
24996590|NCT03776175|50087796|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
24996591|NCT03776175|50087797|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
24996592|NCT03776175|50087794|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
24996593|NCT03776175|50087795|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
24996594|NCT03776175|50087796|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
24996595|NCT03776175|50087797|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
24996596|NCT03776175|50087794|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
24996597|NCT03776175|50087795|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
24996598|NCT03776175|50087796|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
24996599|NCT03776175|50087797|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
24996600|NCT02903914|50087815|FG000|Overall Study|Adverse Event|0|||
24996601|NCT02903914|50087816|FG001|Overall Study|Adverse Event|0|||
24996602|NCT02903914|50087817|FG002|Overall Study|Adverse Event|1|||
24996603|NCT02903914|50087818|FG003|Overall Study|Adverse Event|0|||
24996604|NCT02903914|50087819|FG004|Overall Study|Adverse Event|0|||
24996605|NCT02903914|50087820|FG005|Overall Study|Adverse Event|1|||
24996606|NCT02903914|50087821|FG006|Overall Study|Adverse Event|2|||
24996607|NCT02903914|50087822|FG007|Overall Study|Adverse Event|1|||
24996608|NCT02903914|50087815|FG000|Overall Study|Withdrawal by Subject|3|||
24996609|NCT02903914|50087816|FG001|Overall Study|Withdrawal by Subject|1|||
24996610|NCT02903914|50087817|FG002|Overall Study|Withdrawal by Subject|28|||
24996611|NCT02903914|50087818|FG003|Overall Study|Withdrawal by Subject|0|||
24996612|NCT02903914|50087819|FG004|Overall Study|Withdrawal by Subject|1|||
24996613|NCT02903914|50087820|FG005|Overall Study|Withdrawal by Subject|1|||
24996614|NCT02903914|50087821|FG006|Overall Study|Withdrawal by Subject|12|||
25086115|NCT02147158|50194314|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
24996615|NCT02903914|50087822|FG007|Overall Study|Withdrawal by Subject|0|||
24996616|NCT02903914|50087815|FG000|Overall Study|Progressive Disease|1|||
24996617|NCT02903914|50087816|FG001|Overall Study|Progressive Disease|0|||
24996618|NCT02903914|50087817|FG002|Overall Study|Progressive Disease|4|||
24996619|NCT02903914|50087818|FG003|Overall Study|Progressive Disease|0|||
24996620|NCT02903914|50087819|FG004|Overall Study|Progressive Disease|0|||
24996621|NCT02903914|50087820|FG005|Overall Study|Progressive Disease|0|||
24996622|NCT02903914|50087821|FG006|Overall Study|Progressive Disease|2|||
24996623|NCT02903914|50087822|FG007|Overall Study|Progressive Disease|4|||
24996624|NCT02903914|50087815|FG000|Overall Study|Death|0|||
24996625|NCT02903914|50087816|FG001|Overall Study|Death|0|||
25086116|NCT02147158|50194315|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
24996626|NCT02903914|50087817|FG002|Overall Study|Death|9|||
24996627|NCT02903914|50087818|FG003|Overall Study|Death|0|||
24996628|NCT02903914|50087819|FG004|Overall Study|Death|1|||
24996629|NCT02903914|50087820|FG005|Overall Study|Death|3|||
24996630|NCT02903914|50087821|FG006|Overall Study|Death|24|||
24996631|NCT02903914|50087822|FG007|Overall Study|Death|0|||
24996632|NCT02903914|50087815|FG000|Overall Study|Lost to Follow-up|0|||
24996633|NCT02903914|50087816|FG001|Overall Study|Lost to Follow-up|1|||
24996634|NCT02903914|50087817|FG002|Overall Study|Lost to Follow-up|0|||
24996635|NCT02903914|50087818|FG003|Overall Study|Lost to Follow-up|0|||
24996636|NCT02903914|50087819|FG004|Overall Study|Lost to Follow-up|2|||
24996637|NCT02903914|50087820|FG005|Overall Study|Lost to Follow-up|0|||
24996638|NCT02903914|50087821|FG006|Overall Study|Lost to Follow-up|1|||
24996639|NCT02903914|50087822|FG007|Overall Study|Lost to Follow-up|0|||
24996640|NCT02903914|50087815|FG000|Overall Study|Physician Decision|0|||
24996641|NCT02903914|50087816|FG001|Overall Study|Physician Decision|0|||
24996642|NCT02903914|50087817|FG002|Overall Study|Physician Decision|1|||
24996643|NCT02903914|50087818|FG003|Overall Study|Physician Decision|0|||
24996644|NCT02903914|50087819|FG004|Overall Study|Physician Decision|0|||
24996645|NCT02903914|50087820|FG005|Overall Study|Physician Decision|0|||
24996646|NCT02903914|50087821|FG006|Overall Study|Physician Decision|1|||
24996647|NCT02903914|50087822|FG007|Overall Study|Physician Decision|0|||
24996648|NCT02903914|50087815|FG000|Overall Study|Symptomatic Deterioration|0|||
24996649|NCT02903914|50087816|FG001|Overall Study|Symptomatic Deterioration|0|||
24996650|NCT02903914|50087817|FG002|Overall Study|Symptomatic Deterioration|1|||
24996651|NCT02903914|50087818|FG003|Overall Study|Symptomatic Deterioration|0|||
24996652|NCT02903914|50087819|FG004|Overall Study|Symptomatic Deterioration|0|||
24996653|NCT02903914|50087820|FG005|Overall Study|Symptomatic Deterioration|0|||
24996654|NCT02903914|50087821|FG006|Overall Study|Symptomatic Deterioration|0|||
24996655|NCT02903914|50087822|FG007|Overall Study|Symptomatic Deterioration|0|||
24996656|NCT02903914|50087815|FG000|Overall Study|New Cancer Therapy|2|||
24996657|NCT02903914|50087816|FG001|Overall Study|New Cancer Therapy|2|||
24996658|NCT02903914|50087817|FG002|Overall Study|New Cancer Therapy|21|||
24996659|NCT02903914|50087818|FG003|Overall Study|New Cancer Therapy|4|||
24996660|NCT02903914|50087819|FG004|Overall Study|New Cancer Therapy|3|||
24996661|NCT02903914|50087820|FG005|Overall Study|New Cancer Therapy|6|||
24996662|NCT02903914|50087821|FG006|Overall Study|New Cancer Therapy|55|||
24996663|NCT02903914|50087822|FG007|Overall Study|New Cancer Therapy|0|||
24996664|NCT02903914|50087815|FG000|Overall Study|Reasoning not specified|2|||
24996665|NCT02903914|50087816|FG001|Overall Study|Reasoning not specified|3|||
24996666|NCT02903914|50087817|FG002|Overall Study|Reasoning not specified|20|||
24996667|NCT02903914|50087818|FG003|Overall Study|Reasoning not specified|3|||
24996668|NCT02903914|50087819|FG004|Overall Study|Reasoning not specified|3|||
24996669|NCT02903914|50087820|FG005|Overall Study|Reasoning not specified|3|||
24996670|NCT02903914|50087821|FG006|Overall Study|Reasoning not specified|20|||
24996671|NCT02903914|50087822|FG007|Overall Study|Reasoning not specified|0|||
24996672|NCT02969044|50087844|FG000|Overall Study|Withdrawal by Subject|2|||
24996673|NCT02969044|50087845|FG001|Overall Study|Withdrawal by Subject|6|||
24996674|NCT02969044|50087844|FG000|Overall Study|Adverse Event|3|||
24996675|NCT02969044|50087845|FG001|Overall Study|Adverse Event|0|||
24996676|NCT02967562|50087853|FG000|Overall Study|Consent not obtained|1|||
24996677|NCT02967562|50087854|FG001|Overall Study|Consent not obtained|0|||
24996678|NCT02967562|50087853|FG000|Overall Study|High leak precluding analysis|1|||
24996679|NCT02967562|50087854|FG001|Overall Study|High leak precluding analysis|1|||
24996680|NCT02968576|50087860|FG000|Overall Study|Pregnancy|0|||
24996681|NCT02968576|50087861|FG001|Overall Study|Pregnancy|1|||
24996682|NCT02966002|50087865|FG000|Overall Study|Withdrawal by Subject|2|||
24996683|NCT02966002|50087865|FG000|Overall Study|Adverse Event|1|||
24996684|NCT02966002|50087865|FG000|Overall Study|Lost to Follow-up|1|||
24996685|NCT02965846|50087872|FG000|Overall Study|Lost to Follow-up|1|||
24996686|NCT02965846|50087873|FG001|Overall Study|Lost to Follow-up|0|||
24996687|NCT02965846|50087874|FG002|Overall Study|Lost to Follow-up|0|||
24996688|NCT02965846|50087872|FG000|Overall Study|Withdrawal by Subject|0|||
24996689|NCT02965846|50087873|FG001|Overall Study|Withdrawal by Subject|1|||
24996690|NCT02965846|50087874|FG002|Overall Study|Withdrawal by Subject|0|||
24996691|NCT02965846|50087872|FG000|Overall Study|Study Terminated By Sponsor|4|||
24996692|NCT02965846|50087873|FG001|Overall Study|Study Terminated By Sponsor|4|||
24996693|NCT02965846|50087874|FG002|Overall Study|Study Terminated By Sponsor|0|||
24996694|NCT02965846|50087872|FG000|Overall Study|Participants not randomized|0|||
24996695|NCT02965846|50087873|FG001|Overall Study|Participants not randomized|0|||
24996696|NCT02965846|50087874|FG002|Overall Study|Participants not randomized|33|||
24996697|NCT02900170|50087880|FG000|Overall Study|Lost to Follow-up|8|||
24996698|NCT02900092|50087884|FG000|Overall Study|Adverse Event|1|||
24996699|NCT02902120|50087892|FG000|Overall Study|Lack of Efficacy|1|||
24996700|NCT02965456|50087898|FG000|Overall Study|Lost to Follow-up|40|||
24996701|NCT02965456|50087899|FG001|Overall Study|Lost to Follow-up|18|||
24996702|NCT02965456|50087898|FG000|Overall Study|Subject Request|22|||
24996703|NCT02965456|50087899|FG001|Overall Study|Subject Request|13|||
24996704|NCT02965456|50087898|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
24996705|NCT02965456|50087899|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
24996706|NCT02965456|50087898|FG000|Overall Study|Adverse Event|3|||
24996707|NCT02965456|50087899|FG001|Overall Study|Adverse Event|0|||
24996708|NCT02965456|50087898|FG000|Overall Study|Noncompliance with Study Drug|1|||
24996709|NCT02965456|50087899|FG001|Overall Study|Noncompliance with Study Drug|1|||
24996710|NCT02965456|50087898|FG000|Overall Study|Worsening Condition|0|||
24996711|NCT02965456|50087899|FG001|Overall Study|Worsening Condition|2|||
24996712|NCT02965456|50087898|FG000|Overall Study|Lack of Efficacy|1|||
24996713|NCT02965456|50087899|FG001|Overall Study|Lack of Efficacy|0|||
24996714|NCT02965456|50087898|FG000|Overall Study|Physician Decision|0|||
24996715|NCT02965456|50087899|FG001|Overall Study|Physician Decision|1|||
24996716|NCT02965456|50087898|FG000|Overall Study|Pregnancy|1|||
24996717|NCT02965456|50087899|FG001|Overall Study|Pregnancy|0|||
24996718|NCT02965456|50087898|FG000|Overall Study|Protocol Violation|0|||
24996719|NCT02965456|50087899|FG001|Overall Study|Protocol Violation|1|||
24996720|NCT02965456|50087898|FG000|Overall Study|Participant ran out of study drug|0|||
24996721|NCT02965456|50087899|FG001|Overall Study|Participant ran out of study drug|1|||
24996722|NCT02965378|50087907|FG000|Overall Study|Progression|16|||
24996723|NCT02965378|50087908|FG001|Overall Study|Progression|4|||
24996724|NCT02965378|50087907|FG000|Overall Study|Adverse Event|5|||
24996725|NCT02965378|50087908|FG001|Overall Study|Adverse Event|2|||
24996726|NCT02965378|50087907|FG000|Overall Study|Death|2|||
25172573|NCT01743989|50313202|FG001|Treatment Phase|New cancer (CML) therapy|1|||
24996727|NCT02965378|50087908|FG001|Overall Study|Death|0|||
24996728|NCT02965378|50087907|FG000|Overall Study|Refusal|2|||
24996729|NCT02965378|50087908|FG001|Overall Study|Refusal|1|||
24996730|NCT02965378|50087907|FG000|Overall Study|Not protocol specified|0|||
24996731|NCT02965378|50087908|FG001|Overall Study|Not protocol specified|2|||
24996732|NCT03772041|50087916|FG000|Overall Study|Adverse Event|8|||
24996733|NCT03772041|50087917|FG001|Overall Study|Adverse Event|3|||
24996734|NCT03772041|50087916|FG000|Overall Study|Withdrawal by Subject|0|||
24996735|NCT03772041|50087917|FG001|Overall Study|Withdrawal by Subject|2|||
24996736|NCT03772041|50087916|FG000|Overall Study|Protocol Violation|4|||
24996737|NCT03772041|50087917|FG001|Overall Study|Protocol Violation|2|||
24996738|NCT03772041|50087916|FG000|Overall Study|Physician Decision|2|||
24996739|NCT03772041|50087917|FG001|Overall Study|Physician Decision|3|||
24996740|NCT02899156|50087925|FG000|Overall Study|Death|1|||
24996741|NCT02899156|50087926|FG001|Overall Study|Death|0|||
24996742|NCT02899156|50087925|FG000|Overall Study|Physician Decision|0|||
24996743|NCT02899156|50087926|FG001|Overall Study|Physician Decision|1|||
24996744|NCT03773133|50087932|FG000|Overall Study|Screen Failure|8|||
24996745|NCT02969356|50087937|FG000|Overall Study|Adverse Event|7|||
24996746|NCT02969356|50087937|FG000|Overall Study|Consent withdrawn|2|||
24996747|NCT02969356|50087937|FG000|Overall Study|Lost to Follow-up|3|||
24996748|NCT02969356|50087937|FG000|Overall Study|Did not need to be reinjected|6|||
24996749|NCT02969356|50087937|FG000|Overall Study|Personal reasons|5|||
24996750|NCT02898454|50087944|FG000|Overall Study|Adverse Event|4|||
24996751|NCT02898454|50087945|FG001|Overall Study|Adverse Event|1|||
24996752|NCT02898454|50087946|FG002|Overall Study|Adverse Event|2|||
24996753|NCT02898454|50087944|FG000|Overall Study|Protocol Violation|1|||
24996754|NCT02898454|50087945|FG001|Overall Study|Protocol Violation|0|||
24996755|NCT02898454|50087946|FG002|Overall Study|Protocol Violation|1|||
24996756|NCT02898454|50087944|FG000|Overall Study|Lack of Efficacy|4|||
24996757|NCT02898454|50087945|FG001|Overall Study|Lack of Efficacy|1|||
24996758|NCT02898454|50087946|FG002|Overall Study|Lack of Efficacy|0|||
24996759|NCT02898454|50087944|FG000|Overall Study|Withdrawal by Subject|6|||
24996760|NCT02898454|50087945|FG001|Overall Study|Withdrawal by Subject|3|||
24996761|NCT02898454|50087946|FG002|Overall Study|Withdrawal by Subject|3|||
24996762|NCT02898454|50087944|FG000|Overall Study|Lost to Follow-up|1|||
24996763|NCT02898454|50087945|FG001|Overall Study|Lost to Follow-up|0|||
24996764|NCT02898454|50087946|FG002|Overall Study|Lost to Follow-up|0|||
24996765|NCT02898454|50087944|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
24996766|NCT02898454|50087945|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
24996767|NCT02898454|50087946|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
24996768|NCT03772587|50087964|FG000|Overall Study|COVID-19|0|||
24996769|NCT03772587|50087965|FG001|Overall Study|COVID-19|0|||
24996770|NCT03772587|50087966|FG002|Overall Study|COVID-19|1|||
24996771|NCT03772587|50087967|FG003|Overall Study|COVID-19|1|||
24996772|NCT03772587|50087968|FG004|Overall Study|COVID-19|0|||
24996773|NCT03772587|50087964|FG000|Overall Study|Withdrawal by Subject|1|||
24996774|NCT03772587|50087965|FG001|Overall Study|Withdrawal by Subject|0|||
24996775|NCT03772587|50087966|FG002|Overall Study|Withdrawal by Subject|0|||
24996776|NCT03772587|50087967|FG003|Overall Study|Withdrawal by Subject|0|||
24996777|NCT03772587|50087968|FG004|Overall Study|Withdrawal by Subject|0|||
24996778|NCT02963506|50087995|FG000|Double-Blind Period|Adverse Event|0|||
24996779|NCT02963506|50087996|FG001|Double-Blind Period|Adverse Event|0|||
24996780|NCT02963506|50087997|FG002|Double-Blind Period|Adverse Event|1|||
24996781|NCT02963506|50087998|FG003|Double-Blind Period|Adverse Event|0|||
24996782|NCT02963506|50087999|FG004|Double-Blind Period|Adverse Event|0|||
24996783|NCT02963506|50088000|FG005|Double-Blind Period|Adverse Event|0|||
24996784|NCT02963506|50088001|FG006|Double-Blind Period|Adverse Event|0|||
24996785|NCT02963506|50088002|FG007|Double-Blind Period|Adverse Event|0|||
24996786|NCT02963506|50088003|FG008|Double-Blind Period|Adverse Event|0|||
24996787|NCT02963506|50088004|FG009|Double-Blind Period|Adverse Event|0|||
24996788|NCT02963506|50088005|FG010|Double-Blind Period|Adverse Event|0|||
24996789|NCT02963506|50088006|FG011|Double-Blind Period|Adverse Event|0|||
24996790|NCT02963506|50088007|FG012|Double-Blind Period|Adverse Event|0|||
24996791|NCT02963506|50087995|FG000|Double-Blind Period|Death|0|||
24996792|NCT02963506|50087996|FG001|Double-Blind Period|Death|0|||
24996793|NCT02963506|50087997|FG002|Double-Blind Period|Death|0|||
24996794|NCT02963506|50087998|FG003|Double-Blind Period|Death|1|||
24996795|NCT02963506|50087999|FG004|Double-Blind Period|Death|0|||
24996796|NCT02963506|50088000|FG005|Double-Blind Period|Death|0|||
24996797|NCT02963506|50088001|FG006|Double-Blind Period|Death|0|||
24996798|NCT02963506|50088002|FG007|Double-Blind Period|Death|0|||
24996799|NCT02963506|50088003|FG008|Double-Blind Period|Death|0|||
24996800|NCT02963506|50088004|FG009|Double-Blind Period|Death|0|||
24996801|NCT02963506|50088005|FG010|Double-Blind Period|Death|0|||
24996802|NCT02963506|50088006|FG011|Double-Blind Period|Death|0|||
24996803|NCT02963506|50088007|FG012|Double-Blind Period|Death|0|||
24996804|NCT02963506|50087995|FG000|Double-Blind Period|Lost to Follow-up|0|||
24996805|NCT02963506|50087996|FG001|Double-Blind Period|Lost to Follow-up|1|||
24996806|NCT02963506|50087997|FG002|Double-Blind Period|Lost to Follow-up|0|||
24996807|NCT02963506|50087998|FG003|Double-Blind Period|Lost to Follow-up|0|||
24996808|NCT02963506|50087999|FG004|Double-Blind Period|Lost to Follow-up|0|||
24996809|NCT02963506|50088000|FG005|Double-Blind Period|Lost to Follow-up|0|||
24996810|NCT02963506|50088001|FG006|Double-Blind Period|Lost to Follow-up|0|||
24996811|NCT02963506|50088002|FG007|Double-Blind Period|Lost to Follow-up|0|||
24996812|NCT02963506|50088003|FG008|Double-Blind Period|Lost to Follow-up|0|||
24996813|NCT02963506|50088004|FG009|Double-Blind Period|Lost to Follow-up|0|||
24996814|NCT02963506|50088005|FG010|Double-Blind Period|Lost to Follow-up|0|||
24996815|NCT02963506|50088006|FG011|Double-Blind Period|Lost to Follow-up|0|||
24996816|NCT02963506|50088007|FG012|Double-Blind Period|Lost to Follow-up|0|||
24996817|NCT02963506|50087995|FG000|Double-Blind Period|Withdrawal by Subject|0|||
24996818|NCT02963506|50087996|FG001|Double-Blind Period|Withdrawal by Subject|0|||
24996819|NCT02963506|50087997|FG002|Double-Blind Period|Withdrawal by Subject|1|||
24996820|NCT02963506|50087998|FG003|Double-Blind Period|Withdrawal by Subject|1|||
24996821|NCT02963506|50087999|FG004|Double-Blind Period|Withdrawal by Subject|0|||
24996822|NCT02963506|50088000|FG005|Double-Blind Period|Withdrawal by Subject|0|||
24996823|NCT02963506|50088001|FG006|Double-Blind Period|Withdrawal by Subject|0|||
24996824|NCT02963506|50088002|FG007|Double-Blind Period|Withdrawal by Subject|0|||
24996825|NCT02963506|50088003|FG008|Double-Blind Period|Withdrawal by Subject|0|||
24996826|NCT02963506|50088004|FG009|Double-Blind Period|Withdrawal by Subject|0|||
24996827|NCT02963506|50088005|FG010|Double-Blind Period|Withdrawal by Subject|0|||
24996828|NCT02963506|50088006|FG011|Double-Blind Period|Withdrawal by Subject|0|||
24996829|NCT02963506|50088007|FG012|Double-Blind Period|Withdrawal by Subject|0|||
24996830|NCT02963506|50087995|FG000|Double-Blind Period|No compliance|0|||
24996831|NCT02963506|50087996|FG001|Double-Blind Period|No compliance|1|||
24996832|NCT02963506|50087997|FG002|Double-Blind Period|No compliance|0|||
24996833|NCT02963506|50087998|FG003|Double-Blind Period|No compliance|0|||
24996834|NCT02963506|50087999|FG004|Double-Blind Period|No compliance|0|||
25086117|NCT02147158|50194316|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
25086118|NCT02147158|50194317|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
25086119|NCT02147158|50194318|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
25086120|NCT02147158|50194313|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
25086121|NCT02147158|50194314|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
25086122|NCT02147158|50194315|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
25086123|NCT02147158|50194316|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
25086124|NCT02147158|50194317|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
25086125|NCT02147158|50194318|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
25086126|NCT02147158|50194313|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
25086127|NCT02147158|50194314|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
25086128|NCT02147158|50194315|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
25086129|NCT02147158|50194316|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
25086130|NCT02147158|50194317|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
25086131|NCT02147158|50194318|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
25172574|NCT01743989|50313203|FG002|Treatment Phase|New cancer (CML) therapy|0|||
25172575|NCT01743989|50313201|FG000|Treatment Phase|Physician Decision|0|||
25172576|NCT01743989|50313202|FG001|Treatment Phase|Physician Decision|0|||
25172577|NCT01743989|50313203|FG002|Treatment Phase|Physician Decision|3|||
25172578|NCT01743989|50313201|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
25172579|NCT01743989|50313202|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
25172580|NCT01743989|50313203|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
25172581|NCT01743989|50313201|FG000|Treatment Phase|Not randomized by mistake|0|||
25172582|NCT01743989|50313202|FG001|Treatment Phase|Not randomized by mistake|0|||
25172583|NCT01743989|50313203|FG002|Treatment Phase|Not randomized by mistake|1|||
25172584|NCT01743989|50313201|FG000|Treatment Phase|Included by mistake|0|||
25172585|NCT01743989|50313202|FG001|Treatment Phase|Included by mistake|0|||
25172586|NCT01743989|50313203|FG002|Treatment Phase|Included by mistake|1|||
25172587|NCT01743989|50313201|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
25172588|NCT01743989|50313202|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
25172589|NCT01743989|50313203|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
25172590|NCT01743989|50313201|FG000|TFR Phase|Adverse Event|0|||
25172591|NCT01743989|50313202|FG001|TFR Phase|Adverse Event|1|||
24996835|NCT02963506|50088000|FG005|Double-Blind Period|No compliance|0|||
24996836|NCT02963506|50088001|FG006|Double-Blind Period|No compliance|0|||
24996837|NCT02963506|50088002|FG007|Double-Blind Period|No compliance|0|||
25086132|NCT02147158|50194313|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
25086133|NCT02147158|50194314|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
25086134|NCT02147158|50194315|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
25086135|NCT02147158|50194316|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
25086136|NCT02147158|50194317|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
25086137|NCT02147158|50194318|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
25086138|NCT02147158|50194313|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
25086139|NCT02147158|50194314|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
25086140|NCT02147158|50194315|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
25086141|NCT02147158|50194316|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
25086142|NCT02147158|50194317|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
25086143|NCT02147158|50194318|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
25086144|NCT02112448|50194337|FG000|Overall Study|lab values precluding use of ketorolac|2|||
25086145|NCT02112448|50194338|FG001|Overall Study|lab values precluding use of ketorolac|2|||
25086146|NCT02112448|50194337|FG000|Overall Study|Protocol Violation|1|||
25086147|NCT02112448|50194338|FG001|Overall Study|Protocol Violation|2|||
25086148|NCT02112448|50194337|FG000|Overall Study|Physician Decision|4|||
25086149|NCT02112448|50194338|FG001|Overall Study|Physician Decision|6|||
25086150|NCT02112448|50194337|FG000|Overall Study|required heparin so could not use ketoro|1|||
25086151|NCT02112448|50194338|FG001|Overall Study|required heparin so could not use ketoro|0|||
25086152|NCT02171260|50194350|FG000|Overall Study|Death|0|||
25086153|NCT02171260|50194351|FG001|Overall Study|Death|0|||
24996838|NCT02963506|50088003|FG008|Double-Blind Period|No compliance|0|||
25086154|NCT02171260|50194352|FG002|Overall Study|Death|0|||
25086155|NCT02171260|50194353|FG003|Overall Study|Death|1|||
25086156|NCT02171260|50194350|FG000|Overall Study|Physician Decision|1|||
25086157|NCT02171260|50194351|FG001|Overall Study|Physician Decision|0|||
25086158|NCT02171260|50194352|FG002|Overall Study|Physician Decision|1|||
25172592|NCT01743989|50313203|FG002|TFR Phase|Adverse Event|0|||
25172593|NCT01743989|50313201|FG000|TFR Phase|Lost to Follow-up|0|||
25172594|NCT01743989|50313202|FG001|TFR Phase|Lost to Follow-up|2|||
24996839|NCT02963506|50088004|FG009|Double-Blind Period|No compliance|0|||
25086159|NCT02171260|50194353|FG003|Overall Study|Physician Decision|0|||
25086160|NCT02171260|50194350|FG000|Overall Study|Withdrawal by Subject|1|||
25086161|NCT02171260|50194351|FG001|Overall Study|Withdrawal by Subject|0|||
25086162|NCT02171260|50194352|FG002|Overall Study|Withdrawal by Subject|0|||
25086163|NCT02171260|50194353|FG003|Overall Study|Withdrawal by Subject|0|||
25086164|NCT02171260|50194350|FG000|Overall Study|Evidence of progressive disease|4|||
25086165|NCT02171260|50194351|FG001|Overall Study|Evidence of progressive disease|6|||
25086166|NCT02171260|50194352|FG002|Overall Study|Evidence of progressive disease|4|||
25086167|NCT02171260|50194353|FG003|Overall Study|Evidence of progressive disease|4|||
25086168|NCT02110732|50194371|FG000|Overall Study|Physician Decision|5|||
25086169|NCT02110732|50194372|FG001|Overall Study|Physician Decision|2|||
25086170|NCT02110732|50194371|FG000|Overall Study|Lost to Follow-up|1|||
25086171|NCT02110732|50194372|FG001|Overall Study|Lost to Follow-up|1|||
25086172|NCT02109562|50194381|FG000|Overall Study|Insufficient clinical response|2|||
25086173|NCT02109562|50194382|FG001|Overall Study|Insufficient clinical response|0|||
25086174|NCT02109562|50194383|FG002|Overall Study|Insufficient clinical response|4|||
25086175|NCT02109562|50194381|FG000|Overall Study|Adverse Event|0|||
25086176|NCT02109562|50194382|FG001|Overall Study|Adverse Event|2|||
25086177|NCT02109562|50194383|FG002|Overall Study|Adverse Event|3|||
25086178|NCT02109562|50194381|FG000|Overall Study|Lost to Follow-up|1|||
25086179|NCT02109562|50194382|FG001|Overall Study|Lost to Follow-up|0|||
25086180|NCT02109562|50194383|FG002|Overall Study|Lost to Follow-up|1|||
25086181|NCT02109562|50194381|FG000|Overall Study|Protocol Violation|0|||
25086182|NCT02109562|50194382|FG001|Overall Study|Protocol Violation|3|||
25086183|NCT02109562|50194383|FG002|Overall Study|Protocol Violation|1|||
25086184|NCT02109562|50194381|FG000|Overall Study|Withdrawal by Subject|20|||
25086185|NCT02109562|50194382|FG001|Overall Study|Withdrawal by Subject|25|||
25086186|NCT02109562|50194383|FG002|Overall Study|Withdrawal by Subject|21|||
25086187|NCT02109562|50194381|FG000|Overall Study|Physician Decision|3|||
25086188|NCT02109562|50194382|FG001|Overall Study|Physician Decision|4|||
25086189|NCT02109562|50194383|FG002|Overall Study|Physician Decision|5|||
25086190|NCT02109484|50194399|FG000|Overall Study|Lost to Follow-up|0|||
25086191|NCT02109484|50194400|FG001|Overall Study|Lost to Follow-up|0|||
25086192|NCT02109484|50194401|FG002|Overall Study|Lost to Follow-up|0|||
25086193|NCT02109484|50194402|FG003|Overall Study|Lost to Follow-up|1|||
25086194|NCT02109484|50194403|FG004|Overall Study|Lost to Follow-up|1|||
25086195|NCT02109484|50194404|FG005|Overall Study|Lost to Follow-up|0|||
25086196|NCT02109484|50194405|FG006|Overall Study|Lost to Follow-up|1|||
25086197|NCT02109484|50194406|FG007|Overall Study|Lost to Follow-up|0|||
25086198|NCT02109484|50194399|FG000|Overall Study|Withdrawal by Subject|0|||
25086199|NCT02109484|50194400|FG001|Overall Study|Withdrawal by Subject|0|||
25086200|NCT02109484|50194401|FG002|Overall Study|Withdrawal by Subject|0|||
25086201|NCT02109484|50194402|FG003|Overall Study|Withdrawal by Subject|0|||
25086202|NCT02109484|50194403|FG004|Overall Study|Withdrawal by Subject|1|||
25086203|NCT02109484|50194404|FG005|Overall Study|Withdrawal by Subject|1|||
25086204|NCT02109484|50194405|FG006|Overall Study|Withdrawal by Subject|1|||
25086205|NCT02109484|50194406|FG007|Overall Study|Withdrawal by Subject|0|||
25086206|NCT02109484|50194399|FG000|Overall Study|Physician Decision|0|||
25086207|NCT02109484|50194400|FG001|Overall Study|Physician Decision|0|||
25086208|NCT02109484|50194401|FG002|Overall Study|Physician Decision|0|||
25086209|NCT02109484|50194402|FG003|Overall Study|Physician Decision|0|||
25086210|NCT02109484|50194403|FG004|Overall Study|Physician Decision|2|||
25172595|NCT01743989|50313203|FG002|TFR Phase|Lost to Follow-up|0|||
25172596|NCT01743989|50313201|FG000|TFR Phase|Physician Decision|0|||
25172597|NCT01743989|50313202|FG001|TFR Phase|Physician Decision|1|||
25172598|NCT01743989|50313203|FG002|TFR Phase|Physician Decision|0|||
25172599|NCT01743989|50313201|FG000|TFR Phase|Logistical problems|0|||
25172600|NCT01743989|50313202|FG001|TFR Phase|Logistical problems|2|||
25172601|NCT01743989|50313203|FG002|TFR Phase|Logistical problems|0|||
25172602|NCT01743989|50313201|FG000|TFR Phase|Protocol deviation|0|||
25172603|NCT01743989|50313202|FG001|TFR Phase|Protocol deviation|1|||
25172604|NCT01743989|50313203|FG002|TFR Phase|Protocol deviation|0|||
25172605|NCT01743989|50313201|FG000|TFR Phase|Withdrawal by Subject|0|||
25172606|NCT01743989|50313202|FG001|TFR Phase|Withdrawal by Subject|2|||
25172607|NCT01743989|50313203|FG002|TFR Phase|Withdrawal by Subject|0|||
25172608|NCT01743989|50313201|FG000|Re-treatment Phase|Adverse Event|8|||
25172609|NCT01743989|50313202|FG001|Re-treatment Phase|Adverse Event|4|||
25172610|NCT01743989|50313203|FG002|Re-treatment Phase|Adverse Event|0|||
25172611|NCT01743989|50313201|FG000|Re-treatment Phase|Death|1|||
25172612|NCT01743989|50313202|FG001|Re-treatment Phase|Death|1|||
25086211|NCT02109484|50194404|FG005|Overall Study|Physician Decision|0|||
25086212|NCT02109484|50194405|FG006|Overall Study|Physician Decision|0|||
25086213|NCT02109484|50194406|FG007|Overall Study|Physician Decision|0|||
25086214|NCT02109484|50194399|FG000|Overall Study|Death|0|||
25086215|NCT02109484|50194400|FG001|Overall Study|Death|0|||
25172613|NCT01743989|50313203|FG002|Re-treatment Phase|Death|0|||
25172614|NCT01743989|50313201|FG000|Re-treatment Phase|Administrative problems|1|||
25172615|NCT01743989|50313202|FG001|Re-treatment Phase|Administrative problems|1|||
25172616|NCT01743989|50313203|FG002|Re-treatment Phase|Administrative problems|0|||
25172617|NCT01743989|50313201|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
25172618|NCT01743989|50313202|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
25172619|NCT01743989|50313203|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
25172620|NCT01743989|50313201|FG000|Re-treatment Phase|Unstable MR|1|||
25172621|NCT01743989|50313202|FG001|Re-treatment Phase|Unstable MR|0|||
25172622|NCT01743989|50313203|FG002|Re-treatment Phase|Unstable MR|0|||
25172623|NCT01743989|50313201|FG000|Re-treatment Phase|Physician Decision|0|||
25172624|NCT01743989|50313202|FG001|Re-treatment Phase|Physician Decision|1|||
25172625|NCT01743989|50313203|FG002|Re-treatment Phase|Physician Decision|0|||
25172626|NCT01743989|50313201|FG000|Re-treatment Phase|Lost to Follow-up|0|||
25172627|NCT01743989|50313202|FG001|Re-treatment Phase|Lost to Follow-up|1|||
25172628|NCT01743989|50313203|FG002|Re-treatment Phase|Lost to Follow-up|0|||
25172629|NCT01605461|50313236|FG000|Overall Study|Lost to Follow-up|3|||
25172630|NCT01605461|50313236|FG000|Overall Study|Withdrawal by Subject|1|||
25172631|NCT01742897|50313240|FG000|Overall Study|Adverse Event|3|||
25172632|NCT01742897|50313240|FG000|Overall Study|Withdrawal by Subject|1|||
25172633|NCT01742897|50313240|FG000|Overall Study|Other|1|||
25172634|NCT01715831|50313244|FG000|Overall Study|Adverse Event|1|||
25172635|NCT01741259|50313250|FG000|Overall Study|Protocol Violation|6|||
25172636|NCT01741259|50313251|FG001|Overall Study|Protocol Violation|4|||
25172637|NCT01741259|50313250|FG000|Overall Study|Withdrawal by Subject|0|||
25172638|NCT01741259|50313251|FG001|Overall Study|Withdrawal by Subject|2|||
25172639|NCT01715129|50313257|FG000|Overall Study|Adverse Event, fatal|1|||
25172640|NCT01715129|50313257|FG000|Overall Study|Lack of Efficacy|3|||
25172641|NCT01715129|50313257|FG000|Overall Study|Protocol Violation|1|||
25172642|NCT01715129|50313257|FG000|Overall Study|Consent Withdrawn|2|||
25172643|NCT01715129|50313257|FG000|Overall Study|Lost to Follow-up|1|||
25172644|NCT01715129|50313257|FG000|Overall Study|Other|1|||
25172645|NCT01740791|50313350|FG000|Overall Study|Randomized but never treated|5|||
25172646|NCT01740791|50313351|FG001|Overall Study|Randomized but never treated|3|||
25172647|NCT01740791|50313352|FG002|Overall Study|Randomized but never treated|2|||
25172648|NCT01740791|50313353|FG003|Overall Study|Randomized but never treated|2|||
25172649|NCT01740791|50313354|FG004|Overall Study|Randomized but never treated|1|||
25172650|NCT01740791|50313355|FG005|Overall Study|Randomized but never treated|3|||
25172651|NCT01740791|50313350|FG000|Overall Study|Lost to Follow-up|2|||
25172652|NCT01740791|50313351|FG001|Overall Study|Lost to Follow-up|0|||
25172653|NCT01740791|50313352|FG002|Overall Study|Lost to Follow-up|2|||
25172654|NCT01740791|50313353|FG003|Overall Study|Lost to Follow-up|3|||
25172655|NCT01740791|50313354|FG004|Overall Study|Lost to Follow-up|2|||
25172656|NCT01740791|50313355|FG005|Overall Study|Lost to Follow-up|3|||
25172657|NCT01740791|50313350|FG000|Overall Study|Withdrew Consent|4|||
25172658|NCT01740791|50313351|FG001|Overall Study|Withdrew Consent|0|||
25172659|NCT01740791|50313352|FG002|Overall Study|Withdrew Consent|1|||
25172660|NCT01740791|50313353|FG003|Overall Study|Withdrew Consent|2|||
25086216|NCT02109484|50194401|FG002|Overall Study|Death|0|||
25086217|NCT02109484|50194402|FG003|Overall Study|Death|0|||
25086218|NCT02109484|50194403|FG004|Overall Study|Death|0|||
25086219|NCT02109484|50194404|FG005|Overall Study|Death|0|||
25086220|NCT02109484|50194405|FG006|Overall Study|Death|0|||
25086221|NCT02109484|50194406|FG007|Overall Study|Death|2|||
25086222|NCT02109484|50194399|FG000|Overall Study|Moved away from study area|0|||
25086223|NCT02109484|50194400|FG001|Overall Study|Moved away from study area|0|||
25086224|NCT02109484|50194401|FG002|Overall Study|Moved away from study area|0|||
25086225|NCT02109484|50194402|FG003|Overall Study|Moved away from study area|0|||
25086226|NCT02109484|50194403|FG004|Overall Study|Moved away from study area|0|||
25086227|NCT02109484|50194404|FG005|Overall Study|Moved away from study area|0|||
25086228|NCT02109484|50194405|FG006|Overall Study|Moved away from study area|1|||
25086229|NCT02109484|50194406|FG007|Overall Study|Moved away from study area|1|||
25086230|NCT02105974|50194443|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
25086231|NCT02105974|50194444|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
25086232|NCT02105974|50194445|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
25172661|NCT01740791|50313354|FG004|Overall Study|Withdrew Consent|0|||
25172662|NCT01740791|50313355|FG005|Overall Study|Withdrew Consent|3|||
25172663|NCT01740791|50313350|FG000|Overall Study|Investigator's discretion|1|||
25172664|NCT01740791|50313351|FG001|Overall Study|Investigator's discretion|0|||
25086233|NCT02105974|50194443|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
25086234|NCT02105974|50194444|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
25086235|NCT02105974|50194445|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
25172665|NCT01740791|50313352|FG002|Overall Study|Investigator's discretion|1|||
25172666|NCT01740791|50313353|FG003|Overall Study|Investigator's discretion|0|||
25172667|NCT01740791|50313354|FG004|Overall Study|Investigator's discretion|0|||
25172668|NCT01740791|50313355|FG005|Overall Study|Investigator's discretion|1|||
25172669|NCT01740791|50313350|FG000|Overall Study|Adverse Event|0|||
25172670|NCT01740791|50313351|FG001|Overall Study|Adverse Event|0|||
25172671|NCT01740791|50313352|FG002|Overall Study|Adverse Event|0|||
25172672|NCT01740791|50313353|FG003|Overall Study|Adverse Event|0|||
25172673|NCT01740791|50313354|FG004|Overall Study|Adverse Event|0|||
25086236|NCT02105974|50194443|FG000|2 Week Run-in Period|Adverse Event|6|||
25086237|NCT02105974|50194444|FG001|2 Week Run-in Period|Adverse Event|0|||
25086238|NCT02105974|50194445|FG002|2 Week Run-in Period|Adverse Event|0|||
25086239|NCT02105974|50194443|FG000|2 Week Run-in Period|Study closed/terminated|1|||
25086240|NCT02105974|50194444|FG001|2 Week Run-in Period|Study closed/terminated|0|||
25086241|NCT02105974|50194445|FG002|2 Week Run-in Period|Study closed/terminated|0|||
25086242|NCT02105974|50194443|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
25086243|NCT02105974|50194444|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
25086244|NCT02105974|50194445|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
25086245|NCT02105974|50194443|FG000|2 Week Run-in Period|Withdrew consent|23|||
25086246|NCT02105974|50194444|FG001|2 Week Run-in Period|Withdrew consent|0|||
25086247|NCT02105974|50194445|FG002|2 Week Run-in Period|Withdrew consent|0|||
25086248|NCT02105974|50194443|FG000|2 Week Run-in Period|Investigator discretion|8|||
25086249|NCT02105974|50194444|FG001|2 Week Run-in Period|Investigator discretion|0|||
25086250|NCT02105974|50194445|FG002|2 Week Run-in Period|Investigator discretion|0|||
25086251|NCT02105974|50194443|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
25086252|NCT02105974|50194444|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
25086253|NCT02105974|50194445|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
25086254|NCT02105974|50194443|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
25086255|NCT02105974|50194444|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
25086256|NCT02105974|50194445|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
25086257|NCT02105974|50194443|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
25086258|NCT02105974|50194444|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
25086259|NCT02105974|50194445|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
25086260|NCT02105974|50194443|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
25086261|NCT02105974|50194444|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
25086262|NCT02105974|50194445|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
25086263|NCT02105974|50194443|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
25086264|NCT02105974|50194444|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
25086265|NCT02105974|50194445|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
25086266|NCT02105974|50194443|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
25086267|NCT02105974|50194444|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
25086268|NCT02105974|50194445|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
25086269|NCT02105974|50194443|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
25086270|NCT02105974|50194444|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
25086271|NCT02105974|50194445|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
25086272|NCT02105662|50194451|FG000|Overall Study|Lost to Follow-up|5|||
25086273|NCT02105662|50194451|FG000|Overall Study|Withdrawal by Subject|1|||
25086274|NCT02143102|50194457|FG000|Overall Study|Lost to Follow-up|11|||
25086275|NCT02143102|50194458|FG001|Overall Study|Lost to Follow-up|0|||
25086276|NCT02143024|50194466|FG000|Overall Study|Lost to Follow-up|1|||
25086277|NCT02143024|50194467|FG001|Overall Study|Lost to Follow-up|1|||
25086278|NCT02143024|50194466|FG000|Overall Study|Withdrawal by Subject|1|||
25086279|NCT02143024|50194467|FG001|Overall Study|Withdrawal by Subject|0|||
25086280|NCT02142712|50194476|FG000|Overall Study|Lost to Follow-up|1|||
25086281|NCT02142712|50194477|FG001|Overall Study|Lost to Follow-up|1|||
25086282|NCT02142712|50194478|FG002|Overall Study|Lost to Follow-up|1|||
25086283|NCT02142712|50194479|FG003|Overall Study|Lost to Follow-up|0|||
25086284|NCT02105272|50194490|FG000|Overall Study|Adverse Event|1|||
25086285|NCT02105272|50194491|FG001|Overall Study|Adverse Event|2|||
25086286|NCT02105272|50194490|FG000|Overall Study|Physician Decision|0|||
25086287|NCT02105272|50194491|FG001|Overall Study|Physician Decision|1|||
25086288|NCT02105272|50194490|FG000|Overall Study|Protocol Violation|2|||
25086289|NCT02105272|50194491|FG001|Overall Study|Protocol Violation|0|||
25086290|NCT02105272|50194490|FG000|Overall Study|Withdrawal by Subject|2|||
25086291|NCT02105272|50194491|FG001|Overall Study|Withdrawal by Subject|0|||
25086292|NCT02141854|50194502|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
25086293|NCT02141854|50194503|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25086294|NCT02141854|50194504|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25086295|NCT02141854|50194505|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25086296|NCT02141854|50194506|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25086297|NCT02141854|50194507|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25086298|NCT02141854|50194502|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
25086299|NCT02141854|50194503|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25086300|NCT02141854|50194504|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25086301|NCT02141854|50194505|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25086302|NCT02141854|50194506|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25086303|NCT02141854|50194507|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25086304|NCT02141854|50194502|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
25086305|NCT02141854|50194503|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25086306|NCT02141854|50194504|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25086307|NCT02141854|50194505|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25086308|NCT02141854|50194506|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25086309|NCT02141854|50194507|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25086310|NCT02141854|50194502|FG000|Run-In Period (Pre-assignment)|Other|14|||
25086311|NCT02141854|50194503|FG001|Run-In Period (Pre-assignment)|Other|0|||
25086312|NCT02141854|50194504|FG002|Run-In Period (Pre-assignment)|Other|0|||
25086313|NCT02141854|50194505|FG003|Run-In Period (Pre-assignment)|Other|0|||
25086314|NCT02141854|50194506|FG004|Run-In Period (Pre-assignment)|Other|0|||
25086315|NCT02141854|50194507|FG005|Run-In Period (Pre-assignment)|Other|0|||
25086316|NCT02141854|50194502|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
25086317|NCT02141854|50194503|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
25086318|NCT02141854|50194504|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
25086319|NCT02141854|50194505|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
25086320|NCT02141854|50194506|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
25086321|NCT02141854|50194507|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
25086322|NCT02141854|50194502|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
25086323|NCT02141854|50194503|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25086324|NCT02141854|50194504|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25086325|NCT02141854|50194505|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25086326|NCT02141854|50194506|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25086327|NCT02141854|50194507|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25086328|NCT02141854|50194502|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
25086329|NCT02141854|50194503|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25086330|NCT02141854|50194504|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25086331|NCT02141854|50194505|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25086332|NCT02141854|50194506|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25086333|NCT02141854|50194507|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25086334|NCT02141854|50194502|FG000|Treatment Period|Protocol Violation|0|||
25086335|NCT02141854|50194503|FG001|Treatment Period|Protocol Violation|1|||
25086336|NCT02141854|50194504|FG002|Treatment Period|Protocol Violation|0|||
25086337|NCT02141854|50194505|FG003|Treatment Period|Protocol Violation|2|||
25086338|NCT02141854|50194506|FG004|Treatment Period|Protocol Violation|2|||
25086339|NCT02141854|50194507|FG005|Treatment Period|Protocol Violation|1|||
25086340|NCT02141854|50194502|FG000|Treatment Period|Noncompliance|0|||
25086341|NCT02141854|50194503|FG001|Treatment Period|Noncompliance|0|||
25086342|NCT02141854|50194504|FG002|Treatment Period|Noncompliance|0|||
25086343|NCT02141854|50194505|FG003|Treatment Period|Noncompliance|1|||
25086344|NCT02141854|50194506|FG004|Treatment Period|Noncompliance|0|||
25086345|NCT02141854|50194507|FG005|Treatment Period|Noncompliance|0|||
25086346|NCT02141854|50194502|FG000|Treatment Period|Lack of Efficacy|0|||
25086347|NCT02141854|50194503|FG001|Treatment Period|Lack of Efficacy|0|||
25086348|NCT02141854|50194504|FG002|Treatment Period|Lack of Efficacy|0|||
25086349|NCT02141854|50194505|FG003|Treatment Period|Lack of Efficacy|1|||
25086350|NCT02141854|50194506|FG004|Treatment Period|Lack of Efficacy|1|||
25086351|NCT02141854|50194507|FG005|Treatment Period|Lack of Efficacy|7|||
25086352|NCT02141854|50194502|FG000|Treatment Period|Pregnancy|0|||
25086353|NCT02141854|50194503|FG001|Treatment Period|Pregnancy|1|||
25086354|NCT02141854|50194504|FG002|Treatment Period|Pregnancy|0|||
25086355|NCT02141854|50194505|FG003|Treatment Period|Pregnancy|0|||
25086356|NCT02141854|50194506|FG004|Treatment Period|Pregnancy|0|||
25086357|NCT02141854|50194507|FG005|Treatment Period|Pregnancy|0|||
25086358|NCT02141854|50194502|FG000|Treatment Period|Other|0|||
25086359|NCT02141854|50194503|FG001|Treatment Period|Other|1|||
25086360|NCT02141854|50194504|FG002|Treatment Period|Other|2|||
25086361|NCT02141854|50194505|FG003|Treatment Period|Other|0|||
25086362|NCT02141854|50194506|FG004|Treatment Period|Other|1|||
25086363|NCT02141854|50194507|FG005|Treatment Period|Other|2|||
25086364|NCT02141854|50194502|FG000|Treatment Period|Adverse Event|0|||
25086365|NCT02141854|50194503|FG001|Treatment Period|Adverse Event|2|||
25086366|NCT02141854|50194504|FG002|Treatment Period|Adverse Event|2|||
25086367|NCT02141854|50194505|FG003|Treatment Period|Adverse Event|0|||
25086368|NCT02141854|50194506|FG004|Treatment Period|Adverse Event|2|||
25086369|NCT02141854|50194507|FG005|Treatment Period|Adverse Event|2|||
25086370|NCT02141854|50194502|FG000|Treatment Period|Withdrawal by Subject|0|||
25086371|NCT02141854|50194503|FG001|Treatment Period|Withdrawal by Subject|2|||
25172674|NCT01740791|50313355|FG005|Overall Study|Adverse Event|1|||
25172675|NCT01740323|50313412|FG000|Overall Study|Adverse Event|1|||
25086372|NCT02141854|50194504|FG002|Treatment Period|Withdrawal by Subject|3|||
25086373|NCT02141854|50194505|FG003|Treatment Period|Withdrawal by Subject|3|||
25086374|NCT02141854|50194506|FG004|Treatment Period|Withdrawal by Subject|4|||
25086375|NCT02141854|50194507|FG005|Treatment Period|Withdrawal by Subject|7|||
25086376|NCT02141854|50194502|FG000|Treatment Period|Disease progression|0|||
25172676|NCT01740323|50313413|FG001|Overall Study|Adverse Event|0|||
25172677|NCT01740323|50313412|FG000|Overall Study|Randomized but did not take study drug|1|||
25086377|NCT02141854|50194503|FG001|Treatment Period|Disease progression|2|||
25086378|NCT02141854|50194504|FG002|Treatment Period|Disease progression|1|||
25086379|NCT02141854|50194505|FG003|Treatment Period|Disease progression|3|||
25086380|NCT02141854|50194506|FG004|Treatment Period|Disease progression|0|||
25086381|NCT02141854|50194507|FG005|Treatment Period|Disease progression|18|||
25086382|NCT02141854|50194502|FG000|Treatment Period|Lost to Follow-up|0|||
25086383|NCT02141854|50194503|FG001|Treatment Period|Lost to Follow-up|1|||
25086384|NCT02141854|50194504|FG002|Treatment Period|Lost to Follow-up|1|||
25086385|NCT02141854|50194505|FG003|Treatment Period|Lost to Follow-up|1|||
25086386|NCT02141854|50194506|FG004|Treatment Period|Lost to Follow-up|0|||
25086387|NCT02141854|50194507|FG005|Treatment Period|Lost to Follow-up|1|||
25086388|NCT02587221|50194521|FG000|Overall Study|Adverse Event|3|||
25086389|NCT02587221|50194522|FG001|Overall Study|Adverse Event|3|||
25086390|NCT02587221|50194521|FG000|Overall Study|Death|33|||
25086391|NCT02587221|50194522|FG001|Overall Study|Death|34|||
25086392|NCT02587221|50194521|FG000|Overall Study|Withdrawal by Subject|66|||
25086393|NCT02587221|50194522|FG001|Overall Study|Withdrawal by Subject|61|||
25086394|NCT02587221|50194521|FG000|Overall Study|Lost to Follow-up|21|||
25086395|NCT02587221|50194522|FG001|Overall Study|Lost to Follow-up|19|||
25086396|NCT02587221|50194521|FG000|Overall Study|Protocol Violation|6|||
25086397|NCT02587221|50194522|FG001|Overall Study|Protocol Violation|5|||
25086398|NCT02587221|50194521|FG000|Overall Study|Other Reason or Unspecified|2|||
25086399|NCT02587221|50194522|FG001|Overall Study|Other Reason or Unspecified|1|||
25086400|NCT02141620|50194528|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
25086401|NCT02141620|50194529|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
25086402|NCT02106910|50194537|FG000|Overall Study|Lost to Follow-up|1|||
25086403|NCT02106910|50194538|FG001|Overall Study|Lost to Follow-up|1|||
25086404|NCT01664949|50194547|FG000|Overall Study|Adverse Event|11|||
25086405|NCT01664949|50194548|FG001|Overall Study|Adverse Event|12|||
25086406|NCT01664949|50194547|FG000|Overall Study|Lack of Efficacy|1|||
25086407|NCT01664949|50194548|FG001|Overall Study|Lack of Efficacy|1|||
25086408|NCT01664949|50194547|FG000|Overall Study|Lost to Follow-up|1|||
25086409|NCT01664949|50194548|FG001|Overall Study|Lost to Follow-up|2|||
25086410|NCT01664949|50194547|FG000|Overall Study|Personal Reasons|3|||
25086411|NCT01664949|50194548|FG001|Overall Study|Personal Reasons|4|||
25086412|NCT01664949|50194547|FG000|Overall Study|Protocol Violation|5|||
25086413|NCT01664949|50194548|FG001|Overall Study|Protocol Violation|5|||
25086414|NCT01664949|50194547|FG000|Overall Study|Other Miscellaneous Reasons|3|||
25086415|NCT01664949|50194548|FG001|Overall Study|Other Miscellaneous Reasons|1|||
25086416|NCT02587143|50194556|FG000|Overall Study|Adverse Event|1|||
25086417|NCT02587143|50194557|FG001|Overall Study|Adverse Event|0|||
25086418|NCT02587065|50194563|FG000|Overall Study|Adverse Event|14|||
25086419|NCT02587065|50194563|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
25086420|NCT02587065|50194563|FG000|Overall Study|Non-adherence to the Protocol|3|||
25086421|NCT02587065|50194563|FG000|Overall Study|Discontinuation of Study Medication|2|||
25086422|NCT02587065|50194563|FG000|Overall Study|Reason not Specified|3|||
25086423|NCT02106832|50194571|FG000|Overall Study|Adverse Event|1|||
25086424|NCT02106832|50194572|FG001|Overall Study|Adverse Event|2|||
25086425|NCT02106832|50194573|FG002|Overall Study|Adverse Event|3|||
25086426|NCT02106832|50194574|FG003|Overall Study|Adverse Event|0|||
25086427|NCT02106832|50194571|FG000|Overall Study|Death|4|||
25086428|NCT02106832|50194572|FG001|Overall Study|Death|4|||
25086429|NCT02106832|50194573|FG002|Overall Study|Death|1|||
25086430|NCT02106832|50194574|FG003|Overall Study|Death|4|||
25086431|NCT02106832|50194571|FG000|Overall Study|Deterioration of general conditions|0|||
25086432|NCT02106832|50194572|FG001|Overall Study|Deterioration of general conditions|0|||
25086433|NCT02106832|50194573|FG002|Overall Study|Deterioration of general conditions|1|||
25086434|NCT02106832|50194574|FG003|Overall Study|Deterioration of general conditions|0|||
25086435|NCT02106832|50194571|FG000|Overall Study|Lost to Follow-up|0|||
25086436|NCT02106832|50194572|FG001|Overall Study|Lost to Follow-up|1|||
25086437|NCT02106832|50194573|FG002|Overall Study|Lost to Follow-up|1|||
25086438|NCT02106832|50194574|FG003|Overall Study|Lost to Follow-up|3|||
25086439|NCT02106832|50194571|FG000|Overall Study|Physician Decision|1|||
25086440|NCT02106832|50194572|FG001|Overall Study|Physician Decision|0|||
25086441|NCT02106832|50194573|FG002|Overall Study|Physician Decision|0|||
25086442|NCT02106832|50194574|FG003|Overall Study|Physician Decision|0|||
25086443|NCT02106832|50194571|FG000|Overall Study|Protocol Violation|0|||
25086444|NCT02106832|50194572|FG001|Overall Study|Protocol Violation|0|||
25086445|NCT02106832|50194573|FG002|Overall Study|Protocol Violation|0|||
25086446|NCT02106832|50194574|FG003|Overall Study|Protocol Violation|1|||
24996840|NCT02963506|50088005|FG010|Double-Blind Period|No compliance|0|||
25086447|NCT02106832|50194571|FG000|Overall Study|Withdrawal by Subject|17|||
25086448|NCT02106832|50194572|FG001|Overall Study|Withdrawal by Subject|17|||
25086449|NCT02106832|50194573|FG002|Overall Study|Withdrawal by Subject|10|||
25086450|NCT02106832|50194574|FG003|Overall Study|Withdrawal by Subject|7|||
25086451|NCT02106832|50194571|FG000|Overall Study|Technical problems|0|||
25086452|NCT02106832|50194572|FG001|Overall Study|Technical problems|1|||
25086453|NCT02106832|50194573|FG002|Overall Study|Technical problems|0|||
25086454|NCT02106832|50194574|FG003|Overall Study|Technical problems|0|||
25086455|NCT02106442|50194586|FG000|Overall Study|Case Report Forms Uncollected|7|||
25086456|NCT02106442|50194586|FG000|Overall Study|Protocol Deviation|30|||
25086457|NCT02105116|50194590|FG000|Overall Study|not eligible for step 2 of trial|5|||
25086458|NCT02105116|50194590|FG000|Overall Study|Death|1|||
25086459|NCT02104804|50194596|FG000|Overall Study|Did not take study medication|0|||
25086460|NCT02104804|50194597|FG001|Overall Study|Did not take study medication|1|||
25086461|NCT02104804|50194596|FG000|Overall Study|Study specific discontinuation criteria|6|||
25086462|NCT02104804|50194597|FG001|Overall Study|Study specific discontinuation criteria|1|||
25086463|NCT02104804|50194596|FG000|Overall Study|Other listed|2|||
25086464|NCT02104804|50194597|FG001|Overall Study|Other listed|1|||
25086465|NCT02104804|50194596|FG000|Overall Study|Protocol Violation|0|||
25086466|NCT02104804|50194597|FG001|Overall Study|Protocol Violation|1|||
25086467|NCT02104804|50194596|FG000|Overall Study|Adverse Event|4|||
25086468|NCT02104804|50194597|FG001|Overall Study|Adverse Event|3|||
25086469|NCT02104804|50194596|FG000|Overall Study|Withdrawal by Subject|4|||
25086470|NCT02104804|50194597|FG001|Overall Study|Withdrawal by Subject|12|||
25086471|NCT02075008|50194603|FG000|Overall Study|Technical problems|1|||
25086472|NCT02075008|50194603|FG000|Overall Study|Pregnancy|1|||
25086473|NCT02075008|50194603|FG000|Overall Study|Physician Decision|1|||
25086474|NCT02075008|50194603|FG000|Overall Study|Lost to Follow-up|1|||
25086475|NCT02075008|50194603|FG000|Overall Study|Lack of Efficacy|1|||
25086476|NCT02075008|50194603|FG000|Overall Study|Death|1|||
25086477|NCT02075008|50194603|FG000|Overall Study|Adverse Event|5|||
25086478|NCT02075008|50194603|FG000|Overall Study|Withdrawal by Subject|6|||
25086479|NCT02075008|50194603|FG000|Overall Study|Study terminated by Sponsor|159|||
25086480|NCT01666119|50194634|FG000|Overall Study|Adverse Event|6|||
25086481|NCT01666119|50194634|FG000|Overall Study|Withdrawal by Subject|16|||
25086482|NCT01666119|50194634|FG000|Overall Study|Lost to Follow-up|7|||
25086483|NCT01666119|50194634|FG000|Overall Study|non compliance with study medication, pa|18|||
25086484|NCT01666119|50194634|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
25086485|NCT05128773|50194638|FG000|Overall Study|Sponsor decision to terminate study|3|||
25086486|NCT01665807|50194646|FG000|Overall Study|Withdrawal by Subject|2|||
25086487|NCT01665807|50194647|FG001|Overall Study|Withdrawal by Subject|0|||
25086488|NCT01665807|50194648|FG002|Overall Study|Withdrawal by Subject|1|||
25086489|NCT02584959|50194659|FG000|Period 1|Withdrawn from study|3|||
25086490|NCT02584959|50194660|FG001|Period 1|Withdrawn from study|4|||
25086491|NCT02584959|50194661|FG002|Period 1|Withdrawn from study|0|||
25086492|NCT02584959|50194659|FG000|Period 2|Withdrawn from study|6|||
25086493|NCT02584959|50194660|FG001|Period 2|Withdrawn from study|1|||
25086494|NCT02584959|50194661|FG002|Period 2|Withdrawn from study|2|||
25086495|NCT02584257|50194678|FG000|Period 1|Withdrawal by Subject|0|||
25086496|NCT02584257|50194679|FG001|Period 1|Withdrawal by Subject|0|||
25086497|NCT02584257|50194680|FG002|Period 1|Withdrawal by Subject|0|||
25086498|NCT02584257|50194681|FG003|Period 1|Withdrawal by Subject|0|||
25086499|NCT02584257|50194682|FG004|Period 1|Withdrawal by Subject|0|||
25086500|NCT02584257|50194683|FG005|Period 1|Withdrawal by Subject|0|||
25086501|NCT02584257|50194684|FG006|Period 1|Withdrawal by Subject|1|||
25086502|NCT02584257|50194685|FG007|Period 1|Withdrawal by Subject|0|||
25086503|NCT02584257|50194686|FG008|Period 1|Withdrawal by Subject|0|||
25086504|NCT02584257|50194678|FG000|Period 2|Physician Decision|1|||
25086505|NCT02584257|50194679|FG001|Period 2|Physician Decision|0|||
25086506|NCT02584257|50194680|FG002|Period 2|Physician Decision|0|||
25086507|NCT02584257|50194681|FG003|Period 2|Physician Decision|0|||
25086508|NCT02584257|50194682|FG004|Period 2|Physician Decision|0|||
25086509|NCT02584257|50194683|FG005|Period 2|Physician Decision|0|||
25086510|NCT02584257|50194684|FG006|Period 2|Physician Decision|0|||
25086511|NCT02584257|50194685|FG007|Period 2|Physician Decision|0|||
25086512|NCT02584257|50194686|FG008|Period 2|Physician Decision|0|||
25086513|NCT02584257|50194678|FG000|Period 2|Adverse Event|0|||
25086514|NCT02584257|50194679|FG001|Period 2|Adverse Event|1|||
25086515|NCT02584257|50194680|FG002|Period 2|Adverse Event|0|||
25086516|NCT02584257|50194681|FG003|Period 2|Adverse Event|0|||
25086517|NCT02584257|50194682|FG004|Period 2|Adverse Event|0|||
25086518|NCT02584257|50194683|FG005|Period 2|Adverse Event|0|||
25086519|NCT02584257|50194684|FG006|Period 2|Adverse Event|0|||
25086520|NCT02584257|50194685|FG007|Period 2|Adverse Event|0|||
25086521|NCT02584257|50194686|FG008|Period 2|Adverse Event|0|||
25086522|NCT02583711|50194701|FG000|Overall Study|Withdrawal by Subject|0|||
25086523|NCT02583711|50194702|FG001|Overall Study|Withdrawal by Subject|10|||
25086524|NCT02583711|50194703|FG002|Overall Study|Withdrawal by Subject|0|||
25172678|NCT01740323|50313413|FG001|Overall Study|Randomized but did not take study drug|0|||
25086525|NCT02583477|50194715|FG000|Overall Study|Adverse Event|0|||
25086526|NCT02583477|50194716|FG001|Overall Study|Adverse Event|2|||
25086527|NCT02583477|50194715|FG000|Overall Study|Death|1|||
25086528|NCT02583477|50194716|FG001|Overall Study|Death|16|||
25086529|NCT02583477|50194715|FG000|Overall Study|Study terminated|2|||
25086530|NCT02583477|50194716|FG001|Overall Study|Study terminated|2|||
25086531|NCT02583399|50194723|FG000|Overall Study|Able to be discharged|3|||
25086532|NCT02583399|50194723|FG000|Overall Study|Wanted to use a restricted medication|3|||
25086533|NCT02580591|50194731|FG000|Overall Study|Adverse Event|0|||
25086534|NCT02580591|50194732|FG001|Overall Study|Adverse Event|1|||
25086535|NCT02580591|50194733|FG002|Overall Study|Adverse Event|2|||
25086536|NCT02580591|50194734|FG003|Overall Study|Adverse Event|5|||
25086537|NCT02580591|50194731|FG000|Overall Study|Protocol Violation|3|||
25086538|NCT02580591|50194732|FG001|Overall Study|Protocol Violation|2|||
25086539|NCT02580591|50194733|FG002|Overall Study|Protocol Violation|1|||
25086540|NCT02580591|50194734|FG003|Overall Study|Protocol Violation|1|||
25086541|NCT02580591|50194731|FG000|Overall Study|Lost to Follow-up|5|||
25086542|NCT02580591|50194732|FG001|Overall Study|Lost to Follow-up|3|||
25086543|NCT02580591|50194733|FG002|Overall Study|Lost to Follow-up|3|||
25086544|NCT02580591|50194734|FG003|Overall Study|Lost to Follow-up|1|||
25086545|NCT02580591|50194731|FG000|Overall Study|Withdrawal by Subject|6|||
25086546|NCT02580591|50194732|FG001|Overall Study|Withdrawal by Subject|1|||
25086547|NCT02580591|50194733|FG002|Overall Study|Withdrawal by Subject|2|||
25086548|NCT02580591|50194734|FG003|Overall Study|Withdrawal by Subject|3|||
25086549|NCT02580591|50194731|FG000|Overall Study|Not treated|1|||
25086550|NCT02580591|50194732|FG001|Overall Study|Not treated|1|||
25086551|NCT02580591|50194733|FG002|Overall Study|Not treated|0|||
25086552|NCT02580591|50194734|FG003|Overall Study|Not treated|0|||
25086553|NCT02580591|50194731|FG000|Overall Study|Other than specified|3|||
25086554|NCT02580591|50194732|FG001|Overall Study|Other than specified|2|||
25086555|NCT02580591|50194733|FG002|Overall Study|Other than specified|5|||
25086556|NCT02580591|50194734|FG003|Overall Study|Other than specified|2|||
25086557|NCT02580357|50194747|FG000|Overall Study|Lost to Follow-up|2|||
25086558|NCT02580357|50194748|FG001|Overall Study|Lost to Follow-up|0|||
25086559|NCT02580357|50194749|FG002|Overall Study|Lost to Follow-up|0|||
25086560|NCT02580357|50194747|FG000|Overall Study|Protocol Violation|1|||
25086561|NCT02580357|50194748|FG001|Overall Study|Protocol Violation|0|||
25086562|NCT02580357|50194749|FG002|Overall Study|Protocol Violation|0|||
25086563|NCT01664091|50194757|FG000|Overall Study|Death|1|||
25086564|NCT01664091|50194757|FG000|Overall Study|Disease Progression|2|||
25086565|NCT01664091|50194757|FG000|Overall Study|Lost to Follow-up|2|||
25086566|NCT01664091|50194757|FG000|Overall Study|Withdrawal by Subject|1|||
25086567|NCT02577315|50194764|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
25086568|NCT02577315|50194765|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
25086569|NCT02711345|50194781|FG000|Overall Study|Adverse Event|0|||
25086570|NCT02711345|50194782|FG001|Overall Study|Adverse Event|0|||
25086571|NCT02711345|50194783|FG002|Overall Study|Adverse Event|0|||
25086572|NCT02711345|50194784|FG003|Overall Study|Adverse Event|1|||
25086573|NCT02711345|50194785|FG004|Overall Study|Adverse Event|1|||
25086574|NCT02711345|50194786|FG005|Overall Study|Adverse Event|2|||
25086575|NCT02711345|50194787|FG006|Overall Study|Adverse Event|1|||
25086576|NCT02711345|50194788|FG007|Overall Study|Adverse Event|0|||
25086577|NCT02711345|50194789|FG008|Overall Study|Adverse Event|0|||
25086578|NCT02711345|50194790|FG009|Overall Study|Adverse Event|2|||
25086579|NCT02711345|50194781|FG000|Overall Study|Physician Decision|0|||
25086580|NCT02711345|50194782|FG001|Overall Study|Physician Decision|0|||
25086581|NCT02711345|50194783|FG002|Overall Study|Physician Decision|1|||
25086582|NCT02711345|50194784|FG003|Overall Study|Physician Decision|0|||
25086583|NCT02711345|50194785|FG004|Overall Study|Physician Decision|0|||
25086584|NCT02711345|50194786|FG005|Overall Study|Physician Decision|0|||
25086585|NCT02711345|50194787|FG006|Overall Study|Physician Decision|0|||
25086586|NCT02711345|50194788|FG007|Overall Study|Physician Decision|0|||
25086587|NCT02711345|50194789|FG008|Overall Study|Physician Decision|1|||
25086588|NCT02711345|50194790|FG009|Overall Study|Physician Decision|0|||
25086589|NCT02711345|50194781|FG000|Overall Study|Progressive disease|1|||
25086590|NCT02711345|50194782|FG001|Overall Study|Progressive disease|3|||
25086591|NCT02711345|50194783|FG002|Overall Study|Progressive disease|5|||
25086592|NCT02711345|50194784|FG003|Overall Study|Progressive disease|3|||
25086593|NCT02711345|50194785|FG004|Overall Study|Progressive disease|7|||
25086594|NCT02711345|50194786|FG005|Overall Study|Progressive disease|2|||
25086595|NCT02711345|50194787|FG006|Overall Study|Progressive disease|8|||
25086596|NCT02711345|50194788|FG007|Overall Study|Progressive disease|4|||
25086597|NCT02711345|50194789|FG008|Overall Study|Progressive disease|5|||
25086598|NCT02711345|50194790|FG009|Overall Study|Progressive disease|6|||
25086599|NCT02711345|50194781|FG000|Overall Study|Subject/guardian decision|0|||
25086600|NCT02711345|50194782|FG001|Overall Study|Subject/guardian decision|0|||
25086601|NCT02711345|50194783|FG002|Overall Study|Subject/guardian decision|0|||
25086602|NCT02711345|50194784|FG003|Overall Study|Subject/guardian decision|0|||
25086603|NCT02711345|50194785|FG004|Overall Study|Subject/guardian decision|0|||
25086604|NCT02711345|50194786|FG005|Overall Study|Subject/guardian decision|2|||
25086605|NCT02711345|50194787|FG006|Overall Study|Subject/guardian decision|3|||
25086606|NCT02711345|50194788|FG007|Overall Study|Subject/guardian decision|1|||
25086607|NCT02711345|50194789|FG008|Overall Study|Subject/guardian decision|0|||
25086608|NCT02711345|50194790|FG009|Overall Study|Subject/guardian decision|4|||
25086609|NCT02711345|50194781|FG000|Overall Study|Death|1|||
25086610|NCT02711345|50194782|FG001|Overall Study|Death|0|||
25086611|NCT02711345|50194783|FG002|Overall Study|Death|0|||
25086612|NCT02711345|50194784|FG003|Overall Study|Death|0|||
25086613|NCT02711345|50194785|FG004|Overall Study|Death|0|||
25086614|NCT02711345|50194786|FG005|Overall Study|Death|0|||
25086615|NCT02711345|50194787|FG006|Overall Study|Death|0|||
25086616|NCT02711345|50194788|FG007|Overall Study|Death|1|||
25086617|NCT02711345|50194789|FG008|Overall Study|Death|0|||
25086618|NCT02711345|50194790|FG009|Overall Study|Death|0|||
25086619|NCT02581995|50194827|FG000|Overall Study|Unspecified other|3|||
25086620|NCT02581995|50194827|FG000|Overall Study|Adverse Event|6|||
25086621|NCT02581995|50194827|FG000|Overall Study|Lost to Follow-up|5|||
25086622|NCT02581995|50194827|FG000|Overall Study|Withdrawal by participant|12|||
25086623|NCT02581995|50194827|FG000|Overall Study|Physician Decision|1|||
25086624|NCT02581995|50194827|FG000|Overall Study|Death|4|||
25086625|NCT02577003|50194833|FG000|Overall Study|Adverse Event|2|||
25086626|NCT02577003|50194834|FG001|Overall Study|Adverse Event|4|||
25086627|NCT02577003|50194833|FG000|Overall Study|Withdrawal by Subject|0|||
25086628|NCT02577003|50194834|FG001|Overall Study|Withdrawal by Subject|1|||
25086629|NCT02446899|50194842|FG000|Overall Study|Adverse Event|4|||
25086630|NCT02446899|50194843|FG001|Overall Study|Adverse Event|7|||
25086631|NCT02446899|50194842|FG000|Overall Study|Condition Under Investigation Worsened|1|||
25086632|NCT02446899|50194843|FG001|Overall Study|Condition Under Investigation Worsened|4|||
25086633|NCT02446899|50194842|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
25086634|NCT02446899|50194843|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
25086635|NCT02446899|50194842|FG000|Overall Study|Lack of Efficacy|2|||
25086636|NCT02446899|50194843|FG001|Overall Study|Lack of Efficacy|8|||
25086637|NCT02446899|50194842|FG000|Overall Study|Lost to Follow-up|1|||
25086638|NCT02446899|50194843|FG001|Overall Study|Lost to Follow-up|3|||
25086639|NCT02446899|50194842|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
25086640|NCT02446899|50194843|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
25086641|NCT02446899|50194842|FG000|Overall Study|Withdrawal by Subject|11|||
25086642|NCT02446899|50194843|FG001|Overall Study|Withdrawal by Subject|19|||
25086643|NCT02446899|50194842|FG000|Overall Study|Miscellaneous|5|||
25086644|NCT02446899|50194843|FG001|Overall Study|Miscellaneous|4|||
25086645|NCT02446899|50194842|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
25086646|NCT02446899|50194843|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
25086647|NCT02709785|50194852|FG000|Overall Study|Withdrawal by Subject|1|||
25086648|NCT02709785|50194853|FG001|Overall Study|Withdrawal by Subject|2|||
25086649|NCT02709785|50194854|FG002|Overall Study|Withdrawal by Subject|1|||
25086650|NCT02356887|50194862|FG000|Overall Study|poor compliance|2|||
25086651|NCT01604265|50194874|FG000|Overall Study|Adverse Event|1|||
25086652|NCT01604265|50194875|FG001|Overall Study|Adverse Event|0|||
25086653|NCT01604265|50194874|FG000|Overall Study|Withdrawal by Subject|1|||
25086654|NCT01604265|50194875|FG001|Overall Study|Withdrawal by Subject|0|||
25086655|NCT01664247|50194883|FG000|Overall Study|Adverse Event|5|||
25086656|NCT01664247|50194884|FG001|Overall Study|Adverse Event|3|||
25086657|NCT01664247|50194883|FG000|Overall Study|Protocol Violation|3|||
25086658|NCT01664247|50194884|FG001|Overall Study|Protocol Violation|5|||
25086659|NCT01664247|50194883|FG000|Overall Study|Withdrawal Criteria|1|||
25086660|NCT01664247|50194884|FG001|Overall Study|Withdrawal Criteria|4|||
25086661|NCT01664247|50194883|FG000|Overall Study|Unclassified|5|||
25086662|NCT01664247|50194884|FG001|Overall Study|Unclassified|29|||
25086663|NCT03191903|50194908|FG000|Overall Study|Withdrawal by Subject|6|||
25086664|NCT03191903|50194909|FG001|Overall Study|Withdrawal by Subject|5|||
25086665|NCT03191903|50194910|FG002|Overall Study|Withdrawal by Subject|4|||
25086666|NCT03191903|50194908|FG000|Overall Study|Adverse Event|1|||
25086667|NCT03191903|50194909|FG001|Overall Study|Adverse Event|0|||
25086668|NCT03191903|50194910|FG002|Overall Study|Adverse Event|0|||
25086669|NCT02576535|50194923|FG000|Overall Study|Withdrawal by Subject|2|||
25086670|NCT02576145|50194929|FG000|Overall Study|Adverse Event|1|||
25086671|NCT02576145|50194930|FG001|Overall Study|Adverse Event|0|||
25086672|NCT02576145|50194929|FG000|Overall Study|Withdrawal by Subject|1|||
25086673|NCT02576145|50194930|FG001|Overall Study|Withdrawal by Subject|0|||
25086674|NCT02576145|50194929|FG000|Overall Study|Acute rejection|1|||
25086675|NCT02576145|50194930|FG001|Overall Study|Acute rejection|0|||
25086676|NCT02576145|50194929|FG000|Overall Study|Tetanus Titers Decreased|0|||
25086677|NCT02576145|50194930|FG001|Overall Study|Tetanus Titers Decreased|1|||
25086678|NCT02576067|50194975|FG000|Overall Study|Death|0|||
25086679|NCT02576067|50194976|FG001|Overall Study|Death|1|||
25086680|NCT02576067|50194975|FG000|Overall Study|Lack of Efficacy|1|||
25086681|NCT02576067|50194976|FG001|Overall Study|Lack of Efficacy|0|||
25086682|NCT02576067|50194975|FG000|Overall Study|Lost to Follow-up|11|||
25086683|NCT02576067|50194976|FG001|Overall Study|Lost to Follow-up|0|||
25086684|NCT02576067|50194975|FG000|Overall Study|Withdrawal by Subject|11|||
25086685|NCT02576067|50194976|FG001|Overall Study|Withdrawal by Subject|2|||
25086686|NCT02576067|50194975|FG000|Overall Study|study closure of main CIRT trial)|0|||
25086687|NCT02576067|50194976|FG001|Overall Study|study closure of main CIRT trial)|8|||
25086688|NCT02576067|50194975|FG000|Overall Study|not randomized, failed run-in|7|||
25086689|NCT02576067|50194976|FG001|Overall Study|not randomized, failed run-in|0|||
25086690|NCT02576067|50194975|FG000|Overall Study|screen failure/ re-enrolled|0|||
25086691|NCT02576067|50194976|FG001|Overall Study|screen failure/ re-enrolled|25|||
25086692|NCT02576067|50194975|FG000|Overall Study|Physician Decision|4|||
25086693|NCT02576067|50194976|FG001|Overall Study|Physician Decision|0|||
25086694|NCT02575911|50194982|FG000|Overall Study|Lost to Follow-up|1|||
25086695|NCT02575833|50194996|FG000|Overall Study|Withdrawal by Subject|0|||
25086696|NCT02575833|50194997|FG001|Overall Study|Withdrawal by Subject|1|||
25086697|NCT02575833|50194996|FG000|Overall Study|Lost to Follow-up|1|||
25086698|NCT02575833|50194997|FG001|Overall Study|Lost to Follow-up|0|||
25086699|NCT02709083|50195003|FG000|Overall Study|Original PI left institution|7|||
25086700|NCT02709005|50195009|FG000|Overall Study|Lost to Follow-up|1|||
25086701|NCT02709005|50195010|FG001|Overall Study|Lost to Follow-up|1|||
25086702|NCT02709005|50195009|FG000|Overall Study|Withdrawal by Subject|3|||
25086703|NCT02709005|50195010|FG001|Overall Study|Withdrawal by Subject|0|||
25086704|NCT02573883|50195018|FG000|Six Month Follow Up|Lost to Follow-up|1|||
25086705|NCT02573883|50195019|FG001|Six Month Follow Up|Lost to Follow-up|0|||
25086706|NCT02573883|50195020|FG002|Six Month Follow Up|Lost to Follow-up|0|||
25086707|NCT02573883|50195021|FG003|Six Month Follow Up|Lost to Follow-up|0|||
25086708|NCT02573883|50195018|FG000|One Year Follow Up|Lost to Follow-up|2|||
25086709|NCT02573883|50195019|FG001|One Year Follow Up|Lost to Follow-up|1|||
25086710|NCT02573883|50195020|FG002|One Year Follow Up|Lost to Follow-up|0|||
25086711|NCT02573883|50195021|FG003|One Year Follow Up|Lost to Follow-up|0|||
25086712|NCT02575365|50195036|FG000|Overall Study|Lost to Follow-up|4|||
25086713|NCT02707991|50195042|FG000|Overall Study|Protocol Violation|1|||
25086714|NCT02707991|50195043|FG001|Overall Study|Protocol Violation|0|||
25086715|NCT02707991|50195042|FG000|Overall Study|Became ineligible|0|||
25086716|NCT02707991|50195043|FG001|Overall Study|Became ineligible|1|||
25086717|NCT02707757|50195051|FG000|Overall Study|Protocol Violation|3|||
25086718|NCT02707757|50195052|FG001|Overall Study|Protocol Violation|2|||
25086719|NCT02707757|50195051|FG000|Overall Study|Withdrawal by Subject|2|||
25086720|NCT02707757|50195052|FG001|Overall Study|Withdrawal by Subject|0|||
25086721|NCT02707757|50195051|FG000|Overall Study|Death|0|||
25086722|NCT02707757|50195052|FG001|Overall Study|Death|1|||
25086723|NCT02707757|50195051|FG000|Overall Study|Adverse Event|6|||
25086724|NCT02707757|50195052|FG001|Overall Study|Adverse Event|4|||
25086725|NCT02707757|50195051|FG000|Overall Study|Renal transplant/elective operation|1|||
25086726|NCT02707757|50195052|FG001|Overall Study|Renal transplant/elective operation|5|||
25086727|NCT02572401|50195062|FG000|Overall Study|Lost to Follow-up|5|||
25086728|NCT02572401|50195063|FG001|Overall Study|Lost to Follow-up|8|||
25086729|NCT02572401|50195064|FG002|Overall Study|Lost to Follow-up|9|||
25086730|NCT02572401|50195065|FG003|Overall Study|Lost to Follow-up|9|||
25086731|NCT02572401|50195062|FG000|Overall Study|Death|0|||
25086732|NCT02572401|50195063|FG001|Overall Study|Death|0|||
25086733|NCT02572401|50195064|FG002|Overall Study|Death|0|||
25086734|NCT02572401|50195065|FG003|Overall Study|Death|1|||
25086735|NCT02431325|50195077|FG000|Overall Study|Adverse Event|3|||
25086736|NCT02431325|50195078|FG001|Overall Study|Adverse Event|0|||
25086737|NCT02431325|50195077|FG000|Overall Study|Lost to Follow-up|0|||
25086738|NCT02431325|50195078|FG001|Overall Study|Lost to Follow-up|1|||
25086739|NCT02431325|50195077|FG000|Overall Study|Withdrawal by Subject|1|||
25086740|NCT02431325|50195078|FG001|Overall Study|Withdrawal by Subject|2|||
25086741|NCT02431325|50195077|FG000|Overall Study|Declined to take study medication|1|||
25086742|NCT02431325|50195078|FG001|Overall Study|Declined to take study medication|0|||
25086743|NCT02431325|50195077|FG000|Overall Study|Withdrew before starting study medication|1|||
25086744|NCT02431325|50195078|FG001|Overall Study|Withdrew before starting study medication|0|||
25086745|NCT02431325|50195077|FG000|Overall Study|Placebo shortage|2|||
25086746|NCT02431325|50195078|FG001|Overall Study|Placebo shortage|0|||
25086747|NCT02103478|50195091|FG000|Overall Study|Adverse Event|0|||
25086748|NCT02103478|50195092|FG001|Overall Study|Adverse Event|0|||
25086749|NCT02103478|50195093|FG002|Overall Study|Adverse Event|1|||
25086750|NCT02103478|50195094|FG003|Overall Study|Adverse Event|1|||
25086751|NCT02103478|50195095|FG004|Overall Study|Adverse Event|2|||
25086752|NCT02103478|50195096|FG005|Overall Study|Adverse Event|1|||
25086753|NCT02103478|50195097|FG006|Overall Study|Adverse Event|0|||
25086754|NCT02103478|50195098|FG007|Overall Study|Adverse Event|0|||
25086755|NCT02103478|50195099|FG008|Overall Study|Adverse Event|0|||
25086756|NCT02103478|50195091|FG000|Overall Study|Death|2|||
25086757|NCT02103478|50195092|FG001|Overall Study|Death|2|||
25086758|NCT02103478|50195093|FG002|Overall Study|Death|1|||
25086759|NCT02103478|50195094|FG003|Overall Study|Death|1|||
25086760|NCT02103478|50195095|FG004|Overall Study|Death|5|||
25086761|NCT02103478|50195096|FG005|Overall Study|Death|15|||
25086762|NCT02103478|50195097|FG006|Overall Study|Death|14|||
25086763|NCT02103478|50195098|FG007|Overall Study|Death|10|||
25086764|NCT02103478|50195099|FG008|Overall Study|Death|11|||
25086765|NCT02103478|50195091|FG000|Overall Study|Progressive Disease|2|||
25086766|NCT02103478|50195092|FG001|Overall Study|Progressive Disease|1|||
25086767|NCT02103478|50195093|FG002|Overall Study|Progressive Disease|2|||
25086768|NCT02103478|50195094|FG003|Overall Study|Progressive Disease|0|||
25086769|NCT02103478|50195095|FG004|Overall Study|Progressive Disease|9|||
25086770|NCT02103478|50195096|FG005|Overall Study|Progressive Disease|1|||
25086771|NCT02103478|50195097|FG006|Overall Study|Progressive Disease|2|||
25086772|NCT02103478|50195098|FG007|Overall Study|Progressive Disease|0|||
25086773|NCT02103478|50195099|FG008|Overall Study|Progressive Disease|1|||
25086774|NCT02103478|50195091|FG000|Overall Study|Withdrawal by Subject|2|||
25086775|NCT02103478|50195092|FG001|Overall Study|Withdrawal by Subject|0|||
25086776|NCT02103478|50195093|FG002|Overall Study|Withdrawal by Subject|0|||
25086777|NCT02103478|50195094|FG003|Overall Study|Withdrawal by Subject|4|||
25086778|NCT02103478|50195095|FG004|Overall Study|Withdrawal by Subject|0|||
25086779|NCT02103478|50195096|FG005|Overall Study|Withdrawal by Subject|0|||
25086780|NCT02103478|50195097|FG006|Overall Study|Withdrawal by Subject|1|||
25086781|NCT02103478|50195098|FG007|Overall Study|Withdrawal by Subject|1|||
25086782|NCT02103478|50195099|FG008|Overall Study|Withdrawal by Subject|0|||
25086783|NCT02103478|50195091|FG000|Overall Study|Lost to Follow-up|0|||
25086784|NCT02103478|50195092|FG001|Overall Study|Lost to Follow-up|0|||
25086785|NCT02103478|50195093|FG002|Overall Study|Lost to Follow-up|0|||
25086786|NCT02103478|50195094|FG003|Overall Study|Lost to Follow-up|0|||
25086787|NCT02103478|50195095|FG004|Overall Study|Lost to Follow-up|0|||
25086788|NCT02103478|50195096|FG005|Overall Study|Lost to Follow-up|0|||
25086789|NCT02103478|50195097|FG006|Overall Study|Lost to Follow-up|0|||
25086790|NCT02103478|50195098|FG007|Overall Study|Lost to Follow-up|1|||
25086791|NCT02103478|50195099|FG008|Overall Study|Lost to Follow-up|0|||
25086792|NCT02103478|50195091|FG000|Overall Study|Other|1|||
25086793|NCT02103478|50195092|FG001|Overall Study|Other|3|||
25086794|NCT02103478|50195093|FG002|Overall Study|Other|2|||
25086795|NCT02103478|50195094|FG003|Overall Study|Other|0|||
25086796|NCT02103478|50195095|FG004|Overall Study|Other|3|||
25086797|NCT02103478|50195096|FG005|Overall Study|Other|8|||
25086798|NCT02103478|50195097|FG006|Overall Study|Other|8|||
25086799|NCT02103478|50195098|FG007|Overall Study|Other|4|||
25086800|NCT02103478|50195099|FG008|Overall Study|Other|2|||
25086801|NCT02102464|50195131|FG000|Randomized Study|Withdrawal by Subject|0|||
25086802|NCT02102464|50195132|FG001|Randomized Study|Withdrawal by Subject|1|||
25086803|NCT02102464|50195133|FG002|Randomized Study|Withdrawal by Subject|0|||
25086804|NCT02707601|50195144|FG000|Overall Study|Death|0|||
25086805|NCT02707601|50195145|FG001|Overall Study|Death|1|||
25086806|NCT02707601|50195144|FG000|Overall Study|Lack of Efficacy|0|||
25086807|NCT02707601|50195145|FG001|Overall Study|Lack of Efficacy|1|||
25086808|NCT02707601|50195144|FG000|Overall Study|Investigator's Discretion|1|||
25086809|NCT02707601|50195145|FG001|Overall Study|Investigator's Discretion|0|||
25086810|NCT02707601|50195144|FG000|Overall Study|Withdrew Consent|0|||
25086811|NCT02707601|50195145|FG001|Overall Study|Withdrew Consent|1|||
25086812|NCT02707601|50195144|FG000|Overall Study|Lost to Follow-up|1|||
25086813|NCT02707601|50195145|FG001|Overall Study|Lost to Follow-up|1|||
25086814|NCT02707601|50195144|FG000|Overall Study|Participants Randomized but Not Treated|2|||
25086815|NCT02707601|50195145|FG001|Overall Study|Participants Randomized but Not Treated|0|||
25086816|NCT02707055|50195157|FG000|Phase 1|Withdrawal by Subject|1|||
25086817|NCT02707055|50195158|FG001|Phase 1|Withdrawal by Subject|2|||
25086818|NCT02707055|50195157|FG000|Phase 1|Physician Decision|0|||
25086819|NCT02707055|50195158|FG001|Phase 1|Physician Decision|1|||
25086820|NCT02707055|50195157|FG000|Phase 2|Adverse Event|1|||
25086821|NCT02707055|50195158|FG001|Phase 2|Adverse Event|2|||
25086822|NCT02073682|50195166|FG000|Overall Study|Low Creatinine Clearance|1|||
25086823|NCT02073682|50195167|FG001|Overall Study|Low Creatinine Clearance|2|||
25086824|NCT02073682|50195166|FG000|Overall Study|Death|86|||
25086825|NCT02073682|50195167|FG001|Overall Study|Death|100|||
25086826|NCT02073682|50195166|FG000|Overall Study|Cancer Cured|10|||
25086827|NCT02073682|50195167|FG001|Overall Study|Cancer Cured|15|||
25086828|NCT02073682|50195166|FG000|Overall Study|ID: Patient Noncompliance|1|||
25086829|NCT02073682|50195167|FG001|Overall Study|ID: Patient Noncompliance|2|||
25086830|NCT02073682|50195166|FG000|Overall Study|ID: Palliative Treatment Only|10|||
25086831|NCT02073682|50195167|FG001|Overall Study|ID: Palliative Treatment Only|7|||
25086832|NCT02073682|50195166|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
25086833|NCT02073682|50195167|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
25086834|NCT02073682|50195166|FG000|Overall Study|Platelet Count <50,000/mL|1|||
25086835|NCT02073682|50195167|FG001|Overall Study|Platelet Count <50,000/mL|2|||
25086836|NCT02073682|50195166|FG000|Overall Study|Surgery/Medical Procedure|3|||
25086837|NCT02073682|50195167|FG001|Overall Study|Surgery/Medical Procedure|1|||
25086838|NCT02073682|50195166|FG000|Overall Study|Withdrawal by Subject|6|||
25086839|NCT02073682|50195167|FG001|Overall Study|Withdrawal by Subject|8|||
25086840|NCT02073682|50195166|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
25086841|NCT02073682|50195167|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
25086842|NCT02073682|50195166|FG000|Overall Study|Cancer Progression|53|||
25086843|NCT02073682|50195167|FG001|Overall Study|Cancer Progression|33|||
25086844|NCT02073682|50195166|FG000|Overall Study|Protocol Violation|1|||
25086845|NCT02073682|50195167|FG001|Overall Study|Protocol Violation|0|||
25086846|NCT02073682|50195166|FG000|Overall Study|Adverse Event|79|||
25086847|NCT02073682|50195167|FG001|Overall Study|Adverse Event|62|||
25086848|NCT02073682|50195166|FG000|Overall Study|No reason provided|11|||
25086849|NCT02073682|50195167|FG001|Overall Study|No reason provided|9|||
25086850|NCT02073682|50195166|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
25086851|NCT02073682|50195167|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
25086852|NCT02073682|50195166|FG000|Overall Study|Lost to Follow-up|1|||
25086853|NCT02073682|50195167|FG001|Overall Study|Lost to Follow-up|1|||
25086854|NCT02073682|50195166|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
25086855|NCT02073682|50195167|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
25086856|NCT02072980|50195173|FG000|Period 2, Second Wear|Adverse Event|0|||
25086857|NCT02072980|50195174|FG001|Period 2, Second Wear|Adverse Event|1|||
25086858|NCT02706899|50195182|FG000|Overall Study|Withdrawal by Subject|1|||
25086859|NCT02706899|50195183|FG001|Overall Study|Withdrawal by Subject|0|||
25086860|NCT02706899|50195182|FG000|Overall Study|Death|8|||
25086861|NCT02706899|50195183|FG001|Overall Study|Death|0|||
25086862|NCT02706899|50195182|FG000|Overall Study|Study Termination by Sponsor|4|||
25086863|NCT02706899|50195183|FG001|Overall Study|Study Termination by Sponsor|6|||
25086864|NCT02072824|50195192|FG000|Overall Study|Insufficient clinical response|1|||
25086865|NCT02072824|50195193|FG001|Overall Study|Insufficient clinical response|0|||
25086866|NCT02072824|50195194|FG002|Overall Study|Insufficient clinical response|1|||
25086867|NCT02072824|50195192|FG000|Overall Study|No longer willing to participate|1|||
25086868|NCT02072824|50195193|FG001|Overall Study|No longer willing to participate|0|||
25086869|NCT02072824|50195194|FG002|Overall Study|No longer willing to participate|1|||
25086870|NCT02072824|50195192|FG000|Overall Study|Medication error|0|||
25086871|NCT02072824|50195193|FG001|Overall Study|Medication error|1|||
25086872|NCT02072824|50195194|FG002|Overall Study|Medication error|0|||
25086873|NCT02072824|50195192|FG000|Overall Study|Adverse Event|0|||
25086874|NCT02072824|50195193|FG001|Overall Study|Adverse Event|0|||
25086875|NCT02072824|50195194|FG002|Overall Study|Adverse Event|1|||
25086876|NCT02072668|50195202|FG000|Second Intervention|Lost to Follow-up|1|||
25086877|NCT02072668|50195203|FG001|Second Intervention|Lost to Follow-up|0|||
25086878|NCT02140762|50195213|FG000|Overall Study|Adverse Event|1|||
25086879|NCT02140762|50195214|FG001|Overall Study|Adverse Event|1|||
25086880|NCT02140762|50195213|FG000|Overall Study|Lost to Follow-up|9|||
25086881|NCT02140762|50195214|FG001|Overall Study|Lost to Follow-up|5|||
25086882|NCT02140762|50195213|FG000|Overall Study|Protocol Violation|1|||
25086883|NCT02140762|50195214|FG001|Overall Study|Protocol Violation|1|||
25086884|NCT02140762|50195213|FG000|Overall Study|Withdrawal by Subject|6|||
25086885|NCT02140762|50195214|FG001|Overall Study|Withdrawal by Subject|4|||
25086886|NCT02140762|50195213|FG000|Overall Study|Other|0|||
25086887|NCT02140762|50195214|FG001|Overall Study|Other|1|||
25086888|NCT02101294|50195225|FG000|Overall Study|Withdrawal by Subject|5|||
25086889|NCT02101294|50195225|FG000|Overall Study|Lost to Follow-up|6|||
25086890|NCT01598506|50195232|FG000|Overall Study|Withdrawal by Subject|2|||
25086891|NCT02140060|50195243|FG000|Overall Study|Adverse Event|0|||
25086892|NCT02140060|50195244|FG001|Overall Study|Adverse Event|0|||
25086893|NCT02140060|50195245|FG002|Overall Study|Adverse Event|0|||
25086894|NCT02140060|50195246|FG003|Overall Study|Adverse Event|1|||
25086895|NCT02140060|50195247|FG004|Overall Study|Adverse Event|1|||
25086896|NCT02140060|50195248|FG005|Overall Study|Adverse Event|1|||
25086897|NCT02140060|50195243|FG000|Overall Study|Lack of Efficacy|0|||
25086898|NCT02140060|50195244|FG001|Overall Study|Lack of Efficacy|0|||
25086899|NCT02140060|50195245|FG002|Overall Study|Lack of Efficacy|0|||
25172679|NCT01740089|50313431|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
25172680|NCT01740089|50313432|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
25086900|NCT02140060|50195246|FG003|Overall Study|Lack of Efficacy|1|||
25086901|NCT02140060|50195247|FG004|Overall Study|Lack of Efficacy|0|||
25086902|NCT02140060|50195248|FG005|Overall Study|Lack of Efficacy|0|||
25086903|NCT02139982|50195273|FG000|Overall Study|Lack of Efficacy|0|||
25086904|NCT02139982|50195274|FG001|Overall Study|Lack of Efficacy|1|||
25086905|NCT02139982|50195275|FG002|Overall Study|Lack of Efficacy|0|||
25086906|NCT02139982|50195276|FG003|Overall Study|Lack of Efficacy|1|||
25086907|NCT02139982|50195277|FG004|Overall Study|Lack of Efficacy|0|||
25086908|NCT02139982|50195278|FG005|Overall Study|Lack of Efficacy|0|||
25086909|NCT02139982|50195279|FG006|Overall Study|Lack of Efficacy|0|||
25086910|NCT02139982|50195280|FG007|Overall Study|Lack of Efficacy|0|||
25086911|NCT02139982|50195281|FG008|Overall Study|Lack of Efficacy|0|||
25086912|NCT02139982|50195282|FG009|Overall Study|Lack of Efficacy|0|||
25086913|NCT02139826|50195304|FG000|Overall Study|Adverse Event|1|||
25086914|NCT02139592|50195314|FG000|Overall Study|Case Report Forms Uncollected|8|||
25086915|NCT02139280|50195320|FG000|Overall Study|No longer eligible|2|||
25086916|NCT02139280|50195321|FG001|Overall Study|No longer eligible|0|||
25086917|NCT02072434|50195329|FG000|Overall Study|Protocol Violation|10|||
25086918|NCT02072434|50195330|FG001|Overall Study|Protocol Violation|9|||
25086919|NCT02072434|50195329|FG000|Overall Study|Physician Decision|5|||
25086920|NCT02072434|50195330|FG001|Overall Study|Physician Decision|10|||
25086921|NCT02072434|50195329|FG000|Overall Study|Adverse event, serious fatal|1|||
25086922|NCT02072434|50195330|FG001|Overall Study|Adverse event, serious fatal|6|||
25086923|NCT02072434|50195329|FG000|Overall Study|Adverse Event|7|||
25086924|NCT02072434|50195330|FG001|Overall Study|Adverse Event|6|||
25086925|NCT02072434|50195329|FG000|Overall Study|Withdrawal by Subject|17|||
25086926|NCT02072434|50195330|FG001|Overall Study|Withdrawal by Subject|29|||
25086927|NCT02072434|50195329|FG000|Overall Study|Other|14|||
25086928|NCT02072434|50195330|FG001|Overall Study|Other|29|||
25086929|NCT02072434|50195329|FG000|Overall Study|Lost to Follow-up|0|||
25086930|NCT02072434|50195330|FG001|Overall Study|Lost to Follow-up|1|||
25086931|NCT02101060|50195338|FG000|Overall Study|Adverse Event|1|||
25086932|NCT02101060|50195339|FG001|Overall Study|Adverse Event|0|||
25086933|NCT02101060|50195338|FG000|Overall Study|Withdrawal by Subject|1|||
25086934|NCT02101060|50195339|FG001|Overall Study|Withdrawal by Subject|1|||
25086935|NCT02101060|50195338|FG000|Overall Study|Lost to Follow-up|3|||
25086936|NCT02101060|50195339|FG001|Overall Study|Lost to Follow-up|3|||
25086937|NCT02139124|50195350|FG000|Overall Study|Adverse Event|2|||
25086938|NCT02139124|50195351|FG001|Overall Study|Adverse Event|0|||
25086939|NCT02139124|50195352|FG002|Overall Study|Adverse Event|1|||
25086940|NCT02139124|50195353|FG003|Overall Study|Adverse Event|2|||
25086941|NCT02139124|50195354|FG004|Overall Study|Adverse Event|5|||
25086942|NCT02139124|50195350|FG000|Overall Study|Withdrawal by Subject|2|||
25086943|NCT02139124|50195351|FG001|Overall Study|Withdrawal by Subject|2|||
25086944|NCT02139124|50195352|FG002|Overall Study|Withdrawal by Subject|2|||
25086945|NCT02139124|50195353|FG003|Overall Study|Withdrawal by Subject|2|||
25086946|NCT02139124|50195354|FG004|Overall Study|Withdrawal by Subject|3|||
25086947|NCT02139124|50195350|FG000|Overall Study|Protocol Violation|0|||
25086948|NCT02139124|50195351|FG001|Overall Study|Protocol Violation|0|||
25086949|NCT02139124|50195352|FG002|Overall Study|Protocol Violation|0|||
25086950|NCT02139124|50195353|FG003|Overall Study|Protocol Violation|1|||
25086951|NCT02139124|50195354|FG004|Overall Study|Protocol Violation|1|||
25086952|NCT02139124|50195350|FG000|Overall Study|non-compliant|1|||
25086953|NCT02139124|50195351|FG001|Overall Study|non-compliant|0|||
25086954|NCT02139124|50195352|FG002|Overall Study|non-compliant|0|||
25086955|NCT02139124|50195353|FG003|Overall Study|non-compliant|2|||
25086956|NCT02139124|50195354|FG004|Overall Study|non-compliant|0|||
25086957|NCT02139124|50195350|FG000|Overall Study|incarceration|0|||
25086958|NCT02139124|50195351|FG001|Overall Study|incarceration|0|||
25086959|NCT02139124|50195352|FG002|Overall Study|incarceration|1|||
25086960|NCT02139124|50195353|FG003|Overall Study|incarceration|0|||
25086961|NCT02139124|50195354|FG004|Overall Study|incarceration|0|||
25086962|NCT02139124|50195350|FG000|Overall Study|subject moved|1|||
25086963|NCT02139124|50195351|FG001|Overall Study|subject moved|0|||
25086964|NCT02139124|50195352|FG002|Overall Study|subject moved|0|||
25086965|NCT02139124|50195353|FG003|Overall Study|subject moved|0|||
25086966|NCT02139124|50195354|FG004|Overall Study|subject moved|0|||
25086967|NCT02139124|50195350|FG000|Overall Study|Lost to Follow-up|3|||
25086968|NCT02139124|50195351|FG001|Overall Study|Lost to Follow-up|2|||
25086969|NCT02139124|50195352|FG002|Overall Study|Lost to Follow-up|0|||
25086970|NCT02139124|50195353|FG003|Overall Study|Lost to Follow-up|5|||
25086971|NCT02139124|50195354|FG004|Overall Study|Lost to Follow-up|4|||
25086972|NCT02139046|50195371|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
25086973|NCT02139046|50195372|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
25086974|NCT02139046|50195373|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
25086975|NCT02139046|50195374|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
25086976|NCT02139046|50195375|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
25086977|NCT02139046|50195371|FG000|Overall Study|Major Protocol Deviation|9|||
25086978|NCT02139046|50195372|FG001|Overall Study|Major Protocol Deviation|10|||
25086979|NCT02139046|50195373|FG002|Overall Study|Major Protocol Deviation|16|||
25086980|NCT02139046|50195374|FG003|Overall Study|Major Protocol Deviation|12|||
25086981|NCT02139046|50195375|FG004|Overall Study|Major Protocol Deviation|6|||
25086982|NCT02139046|50195371|FG000|Overall Study|Lost to Follow-up|13|||
25086983|NCT02139046|50195372|FG001|Overall Study|Lost to Follow-up|16|||
25086984|NCT02139046|50195373|FG002|Overall Study|Lost to Follow-up|16|||
25086985|NCT02139046|50195374|FG003|Overall Study|Lost to Follow-up|18|||
25086986|NCT02139046|50195375|FG004|Overall Study|Lost to Follow-up|13|||
25086987|NCT02139046|50195371|FG000|Overall Study|Voluntary Withdrawal|20|||
25086988|NCT02139046|50195372|FG001|Overall Study|Voluntary Withdrawal|8|||
25086989|NCT02139046|50195373|FG002|Overall Study|Voluntary Withdrawal|10|||
25172681|NCT01740089|50313433|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
25172682|NCT01740089|50313431|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
25172683|NCT01740089|50313432|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
25086990|NCT02139046|50195374|FG003|Overall Study|Voluntary Withdrawal|15|||
25086991|NCT02139046|50195375|FG004|Overall Study|Voluntary Withdrawal|16|||
25086992|NCT02139046|50195371|FG000|Overall Study|Lack of Efficacy|0|||
25086993|NCT02139046|50195372|FG001|Overall Study|Lack of Efficacy|1|||
25086994|NCT02139046|50195373|FG002|Overall Study|Lack of Efficacy|2|||
25086995|NCT02139046|50195374|FG003|Overall Study|Lack of Efficacy|1|||
25086996|NCT02139046|50195375|FG004|Overall Study|Lack of Efficacy|2|||
25086997|NCT02139046|50195371|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
25086998|NCT02139046|50195372|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
25086999|NCT02139046|50195373|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
25087000|NCT02139046|50195374|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
25087001|NCT02139046|50195375|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
25087002|NCT02139046|50195371|FG000|Overall Study|Other Miscellaneous Reasons|10|||
25087003|NCT02139046|50195372|FG001|Overall Study|Other Miscellaneous Reasons|9|||
25087004|NCT02139046|50195373|FG002|Overall Study|Other Miscellaneous Reasons|4|||
25087005|NCT02139046|50195374|FG003|Overall Study|Other Miscellaneous Reasons|9|||
25087006|NCT02139046|50195375|FG004|Overall Study|Other Miscellaneous Reasons|12|||
25087007|NCT02138890|50195389|FG000|Overall Study|Adverse Event|1|||
25087008|NCT02138890|50195390|FG001|Overall Study|Adverse Event|0|||
25087009|NCT02100670|50195401|FG000|Overall Study|Adverse Event|10|||
25087010|NCT02100670|50195402|FG001|Overall Study|Adverse Event|3|||
25087011|NCT02100670|50195403|FG002|Overall Study|Adverse Event|3|||
25087012|NCT02100670|50195404|FG003|Overall Study|Adverse Event|0|||
25087013|NCT02100670|50195401|FG000|Overall Study|Lost to Follow-up|1|||
25087014|NCT02100670|50195402|FG001|Overall Study|Lost to Follow-up|0|||
25172684|NCT01740089|50313433|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
25172685|NCT01740089|50313431|FG000|After 12 Weeks|Lack of Efficacy|3|||
25172686|NCT01740089|50313432|FG001|After 12 Weeks|Lack of Efficacy|1|||
25172687|NCT01740089|50313433|FG002|After 12 Weeks|Lack of Efficacy|4|||
25172688|NCT01740089|50313431|FG000|After 12 Weeks|Adverse Event|2|||
25172689|NCT01740089|50313432|FG001|After 12 Weeks|Adverse Event|0|||
25172690|NCT01740089|50313433|FG002|After 12 Weeks|Adverse Event|5|||
25172691|NCT01740089|50313431|FG000|After 12 Weeks|Protocol Violation|1|||
25087015|NCT02100670|50195403|FG002|Overall Study|Lost to Follow-up|0|||
25087016|NCT02100670|50195404|FG003|Overall Study|Lost to Follow-up|0|||
25087017|NCT02100670|50195401|FG000|Overall Study|Protocol Violation|0|||
25087018|NCT02100670|50195402|FG001|Overall Study|Protocol Violation|1|||
25087019|NCT02100670|50195403|FG002|Overall Study|Protocol Violation|0|||
25087020|NCT02100670|50195404|FG003|Overall Study|Protocol Violation|1|||
25087021|NCT02100670|50195401|FG000|Overall Study|Withdrawal of Consent|0|||
25087022|NCT02100670|50195402|FG001|Overall Study|Withdrawal of Consent|1|||
25087023|NCT02100670|50195403|FG002|Overall Study|Withdrawal of Consent|1|||
25087024|NCT02100670|50195404|FG003|Overall Study|Withdrawal of Consent|0|||
25087025|NCT02100670|50195401|FG000|Overall Study|No swelling no pain|1|||
25087026|NCT02100670|50195402|FG001|Overall Study|No swelling no pain|0|||
25087027|NCT02100670|50195403|FG002|Overall Study|No swelling no pain|0|||
25087028|NCT02100670|50195404|FG003|Overall Study|No swelling no pain|0|||
25087029|NCT02100670|50195401|FG000|Overall Study|Poor Efficacy|0|||
25087030|NCT02100670|50195402|FG001|Overall Study|Poor Efficacy|1|||
25087031|NCT02100670|50195403|FG002|Overall Study|Poor Efficacy|0|||
25087032|NCT02100670|50195404|FG003|Overall Study|Poor Efficacy|0|||
25087033|NCT02100670|50195401|FG000|Overall Study|Physician Decision|0|||
25087034|NCT02100670|50195402|FG001|Overall Study|Physician Decision|1|||
25087035|NCT02100670|50195403|FG002|Overall Study|Physician Decision|0|||
25087036|NCT02100670|50195404|FG003|Overall Study|Physician Decision|0|||
25087037|NCT02100670|50195401|FG000|Overall Study|Withdrawal by Subject|1|||
25087038|NCT02100670|50195402|FG001|Overall Study|Withdrawal by Subject|0|||
25087039|NCT02100670|50195403|FG002|Overall Study|Withdrawal by Subject|0|||
25087040|NCT02100670|50195404|FG003|Overall Study|Withdrawal by Subject|0|||
25087041|NCT02070484|50195423|FG000|Overall Study|Withdrawal by Subject|1|||
25087042|NCT02070484|50195424|FG001|Overall Study|Withdrawal by Subject|0|||
25087043|NCT02100514|50195432|FG000|Treatment Period|Adverse Event|0|||
25172692|NCT01740089|50313432|FG001|After 12 Weeks|Protocol Violation|1|||
25172693|NCT01740089|50313433|FG002|After 12 Weeks|Protocol Violation|1|||
25172694|NCT01740089|50313431|FG000|After 12 Weeks|Withdrawal by Subject|1|||
25172695|NCT01740089|50313432|FG001|After 12 Weeks|Withdrawal by Subject|1|||
25172696|NCT01740089|50313433|FG002|After 12 Weeks|Withdrawal by Subject|1|||
25172697|NCT01739933|50313444|FG000|Overall Study|Death|89|||
25172698|NCT01739933|50313445|FG001|Overall Study|Death|86|||
25172699|NCT01739933|50313444|FG000|Overall Study|Withdrawal by Subject|10|||
25172700|NCT01739933|50313445|FG001|Overall Study|Withdrawal by Subject|8|||
25172701|NCT01739933|50313444|FG000|Overall Study|Lost to Follow-up|3|||
25087044|NCT02100514|50195433|FG001|Treatment Period|Adverse Event|5|||
25087045|NCT02100514|50195434|FG002|Treatment Period|Adverse Event|0|||
25087046|NCT02100514|50195435|FG003|Treatment Period|Adverse Event|0|||
25087047|NCT02100514|50195436|FG004|Treatment Period|Adverse Event|0|||
25087048|NCT02100514|50195432|FG000|Treatment Period|Death|2|||
25087049|NCT02100514|50195433|FG001|Treatment Period|Death|2|||
25087050|NCT02100514|50195434|FG002|Treatment Period|Death|0|||
25087051|NCT02100514|50195435|FG003|Treatment Period|Death|0|||
25087052|NCT02100514|50195436|FG004|Treatment Period|Death|0|||
25087053|NCT02100514|50195432|FG000|Treatment Period|Lost to Follow-up|5|||
25087054|NCT02100514|50195433|FG001|Treatment Period|Lost to Follow-up|17|||
25087055|NCT02100514|50195434|FG002|Treatment Period|Lost to Follow-up|0|||
25087056|NCT02100514|50195435|FG003|Treatment Period|Lost to Follow-up|0|||
25087057|NCT02100514|50195436|FG004|Treatment Period|Lost to Follow-up|0|||
25087058|NCT02100514|50195432|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
25087059|NCT02100514|50195433|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
25172702|NCT01739933|50313445|FG001|Overall Study|Lost to Follow-up|10|||
25172703|NCT01739933|50313444|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
25172704|NCT01739933|50313445|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
25172705|NCT01738919|50313462|FG000|Overall Study|Lost to Follow-up|1|||
25172706|NCT01738919|50313463|FG001|Overall Study|Lost to Follow-up|0|||
25172707|NCT01738919|50313462|FG000|Overall Study|Immigrated|0|||
24996841|NCT02963506|50088006|FG011|Double-Blind Period|No compliance|0|||
25087060|NCT02100514|50195434|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
25087061|NCT02100514|50195435|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
25087062|NCT02100514|50195436|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
25087063|NCT02100514|50195432|FG000|Treatment Period|Protocol Violation|1|||
25087064|NCT02100514|50195433|FG001|Treatment Period|Protocol Violation|1|||
25087065|NCT02100514|50195434|FG002|Treatment Period|Protocol Violation|0|||
25087066|NCT02100514|50195435|FG003|Treatment Period|Protocol Violation|0|||
25087067|NCT02100514|50195436|FG004|Treatment Period|Protocol Violation|0|||
25087068|NCT02100514|50195432|FG000|Treatment Period|Withdrawal by Subject|12|||
25087069|NCT02100514|50195433|FG001|Treatment Period|Withdrawal by Subject|37|||
25087070|NCT02100514|50195434|FG002|Treatment Period|Withdrawal by Subject|0|||
25087071|NCT02100514|50195435|FG003|Treatment Period|Withdrawal by Subject|0|||
25087072|NCT02100514|50195436|FG004|Treatment Period|Withdrawal by Subject|0|||
25087073|NCT02100514|50195432|FG000|Treatment Period|Other|9|||
25087074|NCT02100514|50195433|FG001|Treatment Period|Other|11|||
25087075|NCT02100514|50195434|FG002|Treatment Period|Other|0|||
25087076|NCT02100514|50195435|FG003|Treatment Period|Other|0|||
25087077|NCT02100514|50195436|FG004|Treatment Period|Other|0|||
25087078|NCT02100514|50195432|FG000|Extension Period|Withdrew consent|0|||
25087079|NCT02100514|50195433|FG001|Extension Period|Withdrew consent|0|||
25087080|NCT02100514|50195434|FG002|Extension Period|Withdrew consent|2|||
25087081|NCT02100514|50195435|FG003|Extension Period|Withdrew consent|0|||
25087082|NCT02100514|50195436|FG004|Extension Period|Withdrew consent|0|||
25087083|NCT02069392|50195452|FG000|Overall Study|Withdrawal by Subject|4|||
25087084|NCT02069392|50195453|FG001|Overall Study|Withdrawal by Subject|2|||
25087085|NCT02047318|50195461|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
25087086|NCT02047318|50195461|FG000|Core Study Period|Adverse Event|1|||
25087087|NCT02047318|50195461|FG000|Core Study Period|Withdrawal by caregiver|3|||
25087088|NCT02047318|50195461|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
25087089|NCT02100124|50195479|FG000|Overall Study|Lost to Follow-up|5|||
25087090|NCT02100124|50195480|FG001|Overall Study|Lost to Follow-up|11|||
25087091|NCT02100124|50195481|FG002|Overall Study|Lost to Follow-up|3|||
25087092|NCT02100124|50195479|FG000|Overall Study|Withdrawal by Subject|1|||
25087093|NCT02100124|50195480|FG001|Overall Study|Withdrawal by Subject|0|||
25087094|NCT02100124|50195481|FG002|Overall Study|Withdrawal by Subject|0|||
25087095|NCT02068768|50195489|FG000|Overall Study|Lost to Follow-up|5|||
25087096|NCT02068768|50195489|FG000|Overall Study|Early Termination by Sponsor|2|||
25087097|NCT02046616|50195493|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
25087098|NCT02046616|50195493|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
25087099|NCT02046616|50195493|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
25087100|NCT02046616|50195493|FG000|24-Week Treatment Period|Physician Decision|3|||
25087101|NCT02046616|50195493|FG000|24-Week Treatment Period|Other|1|||
25087102|NCT02046616|50195493|FG000|8-Week FU Period|Lost to Follow-up|1|||
25087103|NCT02099344|50195499|FG000|Overall Study|Physician Decision|1|||
25087104|NCT02099344|50195500|FG001|Overall Study|Physician Decision|0|||
25087105|NCT02068222|50195508|FG000|Overall Study|Lost to Follow-up|1|||
25087106|NCT02099110|50195517|FG000|Overall Study|Protocol Violation|2|||
25087107|NCT02099110|50195518|FG001|Overall Study|Protocol Violation|1|||
25172708|NCT01738919|50313463|FG001|Overall Study|Immigrated|1|||
25172709|NCT01738919|50313462|FG000|Overall Study|Withdrawal by Subject|0|||
25087108|NCT02099110|50195519|FG002|Overall Study|Protocol Violation|0|||
25087109|NCT02099110|50195520|FG003|Overall Study|Protocol Violation|3|||
25087110|NCT02099110|50195521|FG004|Overall Study|Protocol Violation|1|||
25087111|NCT02099110|50195517|FG000|Overall Study|Participant moved|1|||
25087112|NCT02099110|50195518|FG001|Overall Study|Participant moved|1|||
25087113|NCT02099110|50195519|FG002|Overall Study|Participant moved|1|||
25087114|NCT02099110|50195520|FG003|Overall Study|Participant moved|0|||
25087115|NCT02099110|50195521|FG004|Overall Study|Participant moved|2|||
25087116|NCT02099110|50195517|FG000|Overall Study|Withdrawal by Subject|7|||
25087117|NCT02099110|50195518|FG001|Overall Study|Withdrawal by Subject|11|||
25087118|NCT02099110|50195519|FG002|Overall Study|Withdrawal by Subject|13|||
25087119|NCT02099110|50195520|FG003|Overall Study|Withdrawal by Subject|9|||
25087120|NCT02099110|50195521|FG004|Overall Study|Withdrawal by Subject|13|||
25087121|NCT02099110|50195517|FG000|Overall Study|Adverse Event|3|||
25087122|NCT02099110|50195518|FG001|Overall Study|Adverse Event|5|||
25087123|NCT02099110|50195519|FG002|Overall Study|Adverse Event|2|||
25087124|NCT02099110|50195520|FG003|Overall Study|Adverse Event|3|||
25087125|NCT02099110|50195521|FG004|Overall Study|Adverse Event|2|||
25087126|NCT02099110|50195517|FG000|Overall Study|Lost to Follow-up|6|||
25172710|NCT01738919|50313463|FG001|Overall Study|Withdrawal by Subject|1|||
25087127|NCT02099110|50195518|FG001|Overall Study|Lost to Follow-up|12|||
25087128|NCT02099110|50195519|FG002|Overall Study|Lost to Follow-up|11|||
25087129|NCT02099110|50195520|FG003|Overall Study|Lost to Follow-up|5|||
25087130|NCT02099110|50195521|FG004|Overall Study|Lost to Follow-up|6|||
25087131|NCT02099110|50195517|FG000|Overall Study|Death|0|||
25087132|NCT02099110|50195518|FG001|Overall Study|Death|1|||
25087133|NCT02099110|50195519|FG002|Overall Study|Death|0|||
25087134|NCT02099110|50195520|FG003|Overall Study|Death|0|||
25087135|NCT02099110|50195521|FG004|Overall Study|Death|0|||
25087136|NCT02099110|50195517|FG000|Overall Study|Screen failure|0|||
25087137|NCT02099110|50195518|FG001|Overall Study|Screen failure|0|||
25087138|NCT02099110|50195519|FG002|Overall Study|Screen failure|0|||
25087139|NCT02099110|50195520|FG003|Overall Study|Screen failure|0|||
25087140|NCT02099110|50195521|FG004|Overall Study|Screen failure|1|||
25087141|NCT02099110|50195517|FG000|Overall Study|Non-compliance with study drug|2|||
25087142|NCT02099110|50195518|FG001|Overall Study|Non-compliance with study drug|0|||
25087143|NCT02099110|50195519|FG002|Overall Study|Non-compliance with study drug|0|||
25087144|NCT02099110|50195520|FG003|Overall Study|Non-compliance with study drug|0|||
25087145|NCT02099110|50195521|FG004|Overall Study|Non-compliance with study drug|1|||
25087146|NCT02099110|50195517|FG000|Overall Study|Physician Decision|3|||
25087147|NCT02099110|50195518|FG001|Overall Study|Physician Decision|0|||
25087148|NCT02099110|50195519|FG002|Overall Study|Physician Decision|1|||
25087149|NCT02099110|50195520|FG003|Overall Study|Physician Decision|2|||
25087150|NCT02099110|50195521|FG004|Overall Study|Physician Decision|1|||
25087151|NCT02098876|50195535|FG000|Overall Study|Withdrawal by Subject|5|||
25087152|NCT02098876|50195536|FG001|Overall Study|Withdrawal by Subject|5|||
25087153|NCT01624090|50195546|FG000|Overall Study|DLT, taken off therapy|0|||
25087154|NCT01624090|50195547|FG001|Overall Study|DLT, taken off therapy|1|||
25087155|NCT01624090|50195548|FG002|Overall Study|DLT, taken off therapy|0|||
25087156|NCT01624090|50195549|FG003|Overall Study|DLT, taken off therapy|0|||
25087157|NCT01624090|50195546|FG000|Overall Study|Withdrew prior to treatment|0|||
25087158|NCT01624090|50195547|FG001|Overall Study|Withdrew prior to treatment|1|||
25087159|NCT01624090|50195548|FG002|Overall Study|Withdrew prior to treatment|0|||
25087160|NCT01624090|50195549|FG003|Overall Study|Withdrew prior to treatment|0|||
25087161|NCT01624090|50195546|FG000|Overall Study|Died on study|0|||
25087162|NCT01624090|50195547|FG001|Overall Study|Died on study|0|||
25087163|NCT01624090|50195548|FG002|Overall Study|Died on study|2|||
25087164|NCT01624090|50195549|FG003|Overall Study|Died on study|0|||
25087165|NCT01624090|50195546|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
25087166|NCT01624090|50195547|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
25087167|NCT01624090|50195548|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
25087168|NCT01624090|50195549|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
25087169|NCT01624090|50195546|FG000|Overall Study|Dose escalated|0|||
25087170|NCT01624090|50195547|FG001|Overall Study|Dose escalated|0|||
25087171|NCT01624090|50195548|FG002|Overall Study|Dose escalated|3|||
25087172|NCT01624090|50195549|FG003|Overall Study|Dose escalated|0|||
25087173|NCT02571777|50195564|FG000|Overall Study|Subject/guardian decision|34|||
25087174|NCT02571777|50195565|FG001|Overall Study|Subject/guardian decision|26|||
25087175|NCT02571777|50195566|FG002|Overall Study|Subject/guardian decision|26|||
25087176|NCT02571777|50195567|FG003|Overall Study|Subject/guardian decision|25|||
25087177|NCT02571777|50195568|FG004|Overall Study|Subject/guardian decision|27|||
25087178|NCT02571777|50195564|FG000|Overall Study|Protocol Deviation|2|||
25087179|NCT02571777|50195565|FG001|Overall Study|Protocol Deviation|3|||
25087180|NCT02571777|50195566|FG002|Overall Study|Protocol Deviation|4|||
25087181|NCT02571777|50195567|FG003|Overall Study|Protocol Deviation|8|||
25087182|NCT02571777|50195568|FG004|Overall Study|Protocol Deviation|4|||
25087183|NCT02571777|50195564|FG000|Overall Study|Death|1|||
25087184|NCT02571777|50195565|FG001|Overall Study|Death|1|||
25087185|NCT02571777|50195566|FG002|Overall Study|Death|4|||
25087186|NCT02571777|50195567|FG003|Overall Study|Death|0|||
25087187|NCT02571777|50195568|FG004|Overall Study|Death|0|||
25087188|NCT02571777|50195564|FG000|Overall Study|Lost to Follow-up|1|||
25087189|NCT02571777|50195565|FG001|Overall Study|Lost to Follow-up|1|||
25087190|NCT02571777|50195566|FG002|Overall Study|Lost to Follow-up|2|||
25172711|NCT01738919|50313462|FG000|Overall Study|Not treated in accordance to guidelines|0|||
25172712|NCT01738919|50313463|FG001|Overall Study|Not treated in accordance to guidelines|1|||
25087191|NCT02571777|50195567|FG003|Overall Study|Lost to Follow-up|0|||
25087192|NCT02571777|50195568|FG004|Overall Study|Lost to Follow-up|1|||
25087193|NCT02571777|50195564|FG000|Overall Study|Physician Decision|1|||
25087194|NCT02571777|50195565|FG001|Overall Study|Physician Decision|7|||
25087195|NCT02571777|50195566|FG002|Overall Study|Physician Decision|5|||
25087196|NCT02571777|50195567|FG003|Overall Study|Physician Decision|2|||
25087197|NCT02571777|50195568|FG004|Overall Study|Physician Decision|4|||
25087198|NCT02571777|50195564|FG000|Overall Study|Pregnancy|0|||
25087199|NCT02571777|50195565|FG001|Overall Study|Pregnancy|0|||
25087200|NCT02571777|50195566|FG002|Overall Study|Pregnancy|0|||
25087201|NCT02571777|50195567|FG003|Overall Study|Pregnancy|2|||
25087202|NCT02571777|50195568|FG004|Overall Study|Pregnancy|0|||
25087203|NCT02571075|50195582|FG000|Overall Study|Lost to Follow-up|20|||
25087204|NCT02571075|50195583|FG001|Overall Study|Lost to Follow-up|24|||
25087205|NCT02705105|50195597|FG000|Treatment|Objective Disease Progression|1|||
25087206|NCT02705105|50195598|FG001|Treatment|Objective Disease Progression|50|||
25087207|NCT02705105|50195597|FG000|Treatment|Withdrawal by Subject|3|||
25087208|NCT02705105|50195598|FG001|Treatment|Withdrawal by Subject|5|||
25087209|NCT02705105|50195597|FG000|Treatment|Adverse Event|0|||
25087210|NCT02705105|50195598|FG001|Treatment|Adverse Event|17|||
25087211|NCT02705105|50195597|FG000|Treatment|Clinical Disease Progression|0|||
25087212|NCT02705105|50195598|FG001|Treatment|Clinical Disease Progression|32|||
25087213|NCT02705105|50195597|FG000|Treatment|Physician Decision|0|||
25087214|NCT02705105|50195598|FG001|Treatment|Physician Decision|3|||
25087215|NCT02705105|50195597|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
25087216|NCT02705105|50195598|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
25087217|NCT02705105|50195597|FG000|Follow-Up|Death|3|||
25087218|NCT02705105|50195598|FG001|Follow-Up|Death|68|||
25087219|NCT02705105|50195597|FG000|Follow-Up|Withdrawal by Subject|1|||
25087220|NCT02705105|50195598|FG001|Follow-Up|Withdrawal by Subject|14|||
25087221|NCT02705105|50195597|FG000|Follow-Up|Study Terminated|0|||
25087222|NCT02705105|50195598|FG001|Follow-Up|Study Terminated|26|||
25087223|NCT02705105|50195597|FG000|Follow-Up|Discontinued per Amendment 3|0|||
25087224|NCT02705105|50195598|FG001|Follow-Up|Discontinued per Amendment 3|2|||
25087225|NCT02097472|50195624|FG000|Received Vaccination 2|Adverse Event|0|||
25087226|NCT02097472|50195625|FG001|Received Vaccination 2|Adverse Event|0|||
25087227|NCT02097472|50195626|FG002|Received Vaccination 2|Adverse Event|0|||
25087228|NCT02097472|50195627|FG003|Received Vaccination 2|Adverse Event|0|||
25087229|NCT02097472|50195628|FG004|Received Vaccination 2|Adverse Event|0|||
25087230|NCT02097472|50195629|FG005|Received Vaccination 2|Adverse Event|0|||
25087231|NCT02097472|50195630|FG006|Received Vaccination 2|Adverse Event|1|||
25087232|NCT02097472|50195631|FG007|Received Vaccination 2|Adverse Event|0|||
25087233|NCT01623310|50195715|FG000|Overall Study|Adverse Event|21|||
25087234|NCT01623310|50195715|FG000|Overall Study|Lost to Follow-up|18|||
25087235|NCT01623310|50195715|FG000|Overall Study|Lack of Efficacy|6|||
25087236|NCT01623310|50195715|FG000|Overall Study|Protocol Violation|6|||
25087237|NCT01623310|50195715|FG000|Overall Study|Withdrawal by Subject|25|||
25087238|NCT01623310|50195715|FG000|Overall Study|Became potentially child-bearing|1|||
25087239|NCT01623310|50195715|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
25087240|NCT01623310|50195715|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
25087241|NCT02046226|50195719|FG000|Overall Study|Lost to Follow-up|7|||
25087242|NCT02046148|50195726|FG000|Overall Study|Lost to Follow-up|1|||
25087243|NCT02046148|50195727|FG001|Overall Study|Lost to Follow-up|1|||
25087244|NCT02046148|50195726|FG000|Overall Study|Withdrawal by Subject|0|||
25087245|NCT02046148|50195727|FG001|Overall Study|Withdrawal by Subject|2|||
25087246|NCT02097238|50195733|FG000|Overall Study|Death|1|||
25087247|NCT02097238|50195733|FG000|Overall Study|Physician Decision|1|||
25087248|NCT02097238|50195733|FG000|Overall Study|Progressive Disease|17|||
25087249|NCT02704091|50195740|FG000|Overall Study|Adverse Event|4|||
25087250|NCT02704091|50195741|FG001|Overall Study|Adverse Event|3|||
25087251|NCT02704091|50195740|FG000|Overall Study|Protocol Violation|5|||
25087252|NCT02704091|50195741|FG001|Overall Study|Protocol Violation|3|||
25087253|NCT02704091|50195740|FG000|Overall Study|Consent withdrawn|4|||
25087254|NCT02704091|50195741|FG001|Overall Study|Consent withdrawn|4|||
25087255|NCT02704091|50195740|FG000|Overall Study|Lost to Follow-up|13|||
25087256|NCT02704091|50195741|FG001|Overall Study|Lost to Follow-up|5|||
25087257|NCT02704091|50195740|FG000|Overall Study|Other|2|||
25087258|NCT02704091|50195741|FG001|Overall Study|Other|8|||
25087259|NCT02702609|50195749|FG000|Overall Study|Lost to Follow-up|8|||
25087260|NCT02702609|50195750|FG001|Overall Study|Lost to Follow-up|4|||
25087261|NCT02702609|50195749|FG000|Overall Study|Physician Decision|1|||
25087262|NCT02702609|50195750|FG001|Overall Study|Physician Decision|0|||
25087263|NCT02046070|50195759|FG000|Overall Study|Progressive Disease|18|||
25087264|NCT02046070|50195760|FG001|Overall Study|Progressive Disease|11|||
25172713|NCT01712399|50313484|FG000|Overall Study|Lost to Follow-up|1|||
24996842|NCT02963506|50088007|FG012|Double-Blind Period|No compliance|0|||
24996843|NCT02963506|50087995|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
25087265|NCT02046070|50195761|FG002|Overall Study|Progressive Disease|40|||
25087266|NCT02046070|50195759|FG000|Overall Study|Adverse Event|8|||
25087267|NCT02046070|50195760|FG001|Overall Study|Adverse Event|10|||
25087268|NCT02046070|50195761|FG002|Overall Study|Adverse Event|17|||
25087269|NCT02046070|50195759|FG000|Overall Study|Withdrawal by Subject|1|||
25087270|NCT02046070|50195760|FG001|Overall Study|Withdrawal by Subject|2|||
25087271|NCT02046070|50195761|FG002|Overall Study|Withdrawal by Subject|6|||
25087272|NCT02046070|50195759|FG000|Overall Study|Study Terminated by Sponsor|1|||
25087273|NCT02046070|50195760|FG001|Overall Study|Study Terminated by Sponsor|1|||
25087274|NCT02046070|50195761|FG002|Overall Study|Study Terminated by Sponsor|1|||
25087275|NCT02046070|50195759|FG000|Overall Study|Reason not Specified|4|||
25087276|NCT02046070|50195760|FG001|Overall Study|Reason not Specified|4|||
25087277|NCT02046070|50195761|FG002|Overall Study|Reason not Specified|6|||
25087278|NCT01663857|50195773|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
25087279|NCT01663857|50195774|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
25087280|NCT01663857|50195775|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
25087281|NCT01663857|50195776|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
25087282|NCT01663857|50195773|FG000|Overall Study|Lost to Follow-up|0|||
25087283|NCT01663857|50195774|FG001|Overall Study|Lost to Follow-up|0|||
25087284|NCT01663857|50195775|FG002|Overall Study|Lost to Follow-up|3|||
25087285|NCT01663857|50195776|FG003|Overall Study|Lost to Follow-up|1|||
25087286|NCT02094898|50195792|FG000|Overall Study|Clinical Worsening|2|||
25087287|NCT02094898|50195792|FG000|Overall Study|Adverse Event|2|||
25087288|NCT02094898|50195792|FG000|Overall Study|Lack of Efficacy|1|||
25087289|NCT02045836|50195800|FG000|Overall Study|Adverse Event|4|||
25087290|NCT02045836|50195801|FG001|Overall Study|Adverse Event|4|||
25087291|NCT02045836|50195800|FG000|Overall Study|Withdrawal by Subject|1|||
25087292|NCT02045836|50195801|FG001|Overall Study|Withdrawal by Subject|1|||
25087293|NCT02045836|50195800|FG000|Overall Study|Lost to Follow-up|4|||
25087294|NCT02045836|50195801|FG001|Overall Study|Lost to Follow-up|7|||
25087295|NCT02045836|50195800|FG000|Overall Study|Migrated from study area|0|||
25087296|NCT02045836|50195801|FG001|Overall Study|Migrated from study area|2|||
25087297|NCT02569437|50195810|FG000|Overall Study|Lost to Follow-up|12|||
25087298|NCT02569437|50195811|FG001|Overall Study|Lost to Follow-up|14|||
25087299|NCT02045212|50195819|FG000|Overall Study|Adverse Event|0|||
25087300|NCT02045212|50195820|FG001|Overall Study|Adverse Event|1|||
25087301|NCT02045212|50195819|FG000|Overall Study|Withdrawal by Subject|1|||
25087302|NCT02045212|50195820|FG001|Overall Study|Withdrawal by Subject|0|||
25087303|NCT02045212|50195819|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
25087304|NCT02045212|50195820|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
25087305|NCT02044822|50195830|FG000|Overall Study|Study Terminated by Sponsor|77|||
25087306|NCT02044822|50195830|FG000|Overall Study|Investigator's Discretion|10|||
25087307|NCT02044822|50195830|FG000|Overall Study|Withdrew Consent|3|||
25087308|NCT02044822|50195830|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
25087309|NCT02044822|50195830|FG000|Overall Study|Lost to Follow-up|1|||
25087310|NCT02044510|50195836|FG000|Overall Study|Adverse Event|1|||
25087311|NCT02044510|50195837|FG001|Overall Study|Adverse Event|2|||
25087312|NCT02067676|50195849|FG000|Overall Study|Withdrawal by Subject|1|||
25087313|NCT02067676|50195850|FG001|Overall Study|Withdrawal by Subject|0|||
25087314|NCT02067676|50195851|FG002|Overall Study|Withdrawal by Subject|0|||
25087315|NCT02067676|50195852|FG003|Overall Study|Withdrawal by Subject|0|||
25087316|NCT02067676|50195853|FG004|Overall Study|Withdrawal by Subject|0|||
25087317|NCT02067676|50195854|FG005|Overall Study|Withdrawal by Subject|0|||
25087318|NCT01623154|50195873|FG000|Overall Study|Did not drink Pranactin Citric|4|||
25087319|NCT00702689|50195879|FG000|Overall Study|Withdrawal by Subject|4|||
25087320|NCT00702689|50195879|FG000|Overall Study|Recurrent malignancy|1|||
25087321|NCT00702689|50195879|FG000|Overall Study|Adverse Event|1|||
25087322|NCT02065570|50195885|FG000|Induction Study|Adverse Event|5|||
25087323|NCT02065570|50195886|FG001|Induction Study|Adverse Event|12|||
25087324|NCT02065570|50195887|FG002|Induction Study|Adverse Event|0|||
25087325|NCT02065570|50195888|FG003|Induction Study|Adverse Event|0|||
25087326|NCT02065570|50195885|FG000|Induction Study|Withdrawal by Subject|2|||
25087327|NCT02065570|50195886|FG001|Induction Study|Withdrawal by Subject|3|||
25087328|NCT02065570|50195887|FG002|Induction Study|Withdrawal by Subject|0|||
25087329|NCT02065570|50195888|FG003|Induction Study|Withdrawal by Subject|0|||
25087330|NCT02065570|50195885|FG000|Induction Study|Lost to Follow-up|1|||
25087331|NCT02065570|50195886|FG001|Induction Study|Lost to Follow-up|1|||
25087332|NCT02065570|50195887|FG002|Induction Study|Lost to Follow-up|0|||
25087333|NCT02065570|50195888|FG003|Induction Study|Lost to Follow-up|0|||
25087334|NCT02065570|50195885|FG000|Induction Study|Other, Not Specified|6|||
25087335|NCT02065570|50195886|FG001|Induction Study|Other, Not Specified|5|||
25087336|NCT02065570|50195887|FG002|Induction Study|Other, Not Specified|0|||
25087337|NCT02065570|50195888|FG003|Induction Study|Other, Not Specified|0|||
25087338|NCT02065570|50195885|FG000|Maintenance Study|Adverse Event|0|||
25087339|NCT02065570|50195886|FG001|Maintenance Study|Adverse Event|0|||
25087340|NCT02065570|50195887|FG002|Maintenance Study|Adverse Event|8|||
25087341|NCT02065570|50195888|FG003|Maintenance Study|Adverse Event|8|||
25087342|NCT02065570|50195885|FG000|Maintenance Study|Withdrawal by Subject|0|||
25087343|NCT02065570|50195886|FG001|Maintenance Study|Withdrawal by Subject|0|||
25087344|NCT02065570|50195887|FG002|Maintenance Study|Withdrawal by Subject|1|||
25087345|NCT02065570|50195888|FG003|Maintenance Study|Withdrawal by Subject|4|||
25087346|NCT02065570|50195885|FG000|Maintenance Study|Lost to Follow-up|0|||
25087347|NCT02065570|50195886|FG001|Maintenance Study|Lost to Follow-up|0|||
25087348|NCT02065570|50195887|FG002|Maintenance Study|Lost to Follow-up|2|||
25087349|NCT02065570|50195888|FG003|Maintenance Study|Lost to Follow-up|2|||
25087350|NCT02065570|50195885|FG000|Maintenance Study|Other, Not Specified|0|||
25087351|NCT02065570|50195886|FG001|Maintenance Study|Other, Not Specified|0|||
25087352|NCT02065570|50195887|FG002|Maintenance Study|Other, Not Specified|11|||
25087353|NCT02065570|50195888|FG003|Maintenance Study|Other, Not Specified|5|||
25087354|NCT02566005|50195901|FG000|Overall Study|vaginal bleeding|0|||
25087355|NCT02566005|50195902|FG001|Overall Study|vaginal bleeding|1|||
25087356|NCT02566005|50195901|FG000|Overall Study|received foley|8|||
25087357|NCT02566005|50195902|FG001|Overall Study|received foley|0|||
25087358|NCT02566005|50195901|FG000|Overall Study|did not receive foley|0|||
25087359|NCT02566005|50195902|FG001|Overall Study|did not receive foley|1|||
25087360|NCT02566005|50195901|FG000|Overall Study|labor after randomization|0|||
25087361|NCT02566005|50195902|FG001|Overall Study|labor after randomization|4|||
25087362|NCT02065336|50195920|FG000|Extension Phase|Study Terminated by Sponsor|0|||
25087363|NCT02065336|50195921|FG001|Extension Phase|Study Terminated by Sponsor|0|||
25087364|NCT02065336|50195922|FG002|Extension Phase|Study Terminated by Sponsor|0|||
25087365|NCT02065336|50195923|FG003|Extension Phase|Study Terminated by Sponsor|0|||
25087366|NCT02065336|50195924|FG004|Extension Phase|Study Terminated by Sponsor|0|||
25087367|NCT02065336|50195925|FG005|Extension Phase|Study Terminated by Sponsor|0|||
25087368|NCT02065336|50195926|FG006|Extension Phase|Study Terminated by Sponsor|0|||
25087369|NCT02065336|50195927|FG007|Extension Phase|Study Terminated by Sponsor|0|||
25087370|NCT02065336|50195928|FG008|Extension Phase|Study Terminated by Sponsor|2|||
25172714|NCT01712399|50313484|FG000|Overall Study|Withdrawal by Subject|39|||
25172715|NCT01712399|50313484|FG000|Overall Study|Death|1|||
25172716|NCT01712399|50313484|FG000|Overall Study|Adverse Event|11|||
25087371|NCT02065336|50195929|FG009|Extension Phase|Study Terminated by Sponsor|8|||
25087372|NCT02701985|50195962|FG000|Overall Study|Withdrawal by Subject|1|||
25087373|NCT02701985|50195963|FG001|Overall Study|Withdrawal by Subject|1|||
25087374|NCT02701985|50195962|FG000|Overall Study|Lost to Follow-up|1|||
25087375|NCT02701985|50195963|FG001|Overall Study|Lost to Follow-up|0|||
25087376|NCT02701985|50195962|FG000|Overall Study|Death|1|||
25087377|NCT02701985|50195963|FG001|Overall Study|Death|0|||
25087378|NCT02701985|50195962|FG000|Overall Study|Adverse Event|0|||
25087379|NCT02701985|50195963|FG001|Overall Study|Adverse Event|5|||
25087380|NCT02064868|50195972|FG000|Overall Study|Lost to Follow-up|14|||
25087381|NCT02064868|50195973|FG001|Overall Study|Lost to Follow-up|8|||
25087382|NCT02064868|50195972|FG000|Overall Study|Physician Decision|1|||
25087383|NCT02064868|50195973|FG001|Overall Study|Physician Decision|0|||
25087384|NCT02064868|50195972|FG000|Overall Study|Withdrawal by Subject|14|||
25087385|NCT02064868|50195973|FG001|Overall Study|Withdrawal by Subject|3|||
25087386|NCT02064868|50195972|FG000|Overall Study|Technical Problems or Missing|5|||
25087387|NCT02064868|50195973|FG001|Overall Study|Technical Problems or Missing|2|||
25087388|NCT02064166|50195981|FG000|Overall Study|Adverse Event|1|||
25087389|NCT02064166|50195982|FG001|Overall Study|Adverse Event|0|||
25087390|NCT02565615|50196015|FG000|Overall Study|Death|0|||
25087391|NCT02565615|50196016|FG001|Overall Study|Death|1|||
25087392|NCT02565615|50196017|FG002|Overall Study|Death|0|||
25087393|NCT02565615|50196018|FG003|Overall Study|Death|0|||
25087394|NCT02565615|50196019|FG004|Overall Study|Death|4|||
25087395|NCT02565615|50196015|FG000|Overall Study|Not willing to participate in study|2|||
25087396|NCT02565615|50196016|FG001|Overall Study|Not willing to participate in study|21|||
25087397|NCT02565615|50196017|FG002|Overall Study|Not willing to participate in study|0|||
25087398|NCT02565615|50196018|FG003|Overall Study|Not willing to participate in study|1|||
25087399|NCT02565615|50196019|FG004|Overall Study|Not willing to participate in study|169|||
25087400|NCT02565615|50196015|FG000|Overall Study|Lost to Follow-up|0|||
25087401|NCT02565615|50196016|FG001|Overall Study|Lost to Follow-up|4|||
25087402|NCT02565615|50196017|FG002|Overall Study|Lost to Follow-up|0|||
25087403|NCT02565615|50196018|FG003|Overall Study|Lost to Follow-up|1|||
25087404|NCT02565615|50196019|FG004|Overall Study|Lost to Follow-up|765|||
25087405|NCT02565615|50196015|FG000|Overall Study|Not meeting eligibility criteria|0|||
25087406|NCT02565615|50196016|FG001|Overall Study|Not meeting eligibility criteria|7|||
25087407|NCT02565615|50196017|FG002|Overall Study|Not meeting eligibility criteria|0|||
25087408|NCT02565615|50196018|FG003|Overall Study|Not meeting eligibility criteria|0|||
25087409|NCT02565615|50196019|FG004|Overall Study|Not meeting eligibility criteria|25|||
25087410|NCT02565615|50196015|FG000|Overall Study|Reason not defined|0|||
25087411|NCT02565615|50196016|FG001|Overall Study|Reason not defined|2|||
25087412|NCT02565615|50196017|FG002|Overall Study|Reason not defined|0|||
25087413|NCT02565615|50196018|FG003|Overall Study|Reason not defined|1|||
25087414|NCT02565615|50196019|FG004|Overall Study|Reason not defined|62|||
25087415|NCT02565615|50196015|FG000|Overall Study|Adverse Event|1|||
25087416|NCT02565615|50196016|FG001|Overall Study|Adverse Event|1|||
25087417|NCT02565615|50196017|FG002|Overall Study|Adverse Event|0|||
25087418|NCT02565615|50196018|FG003|Overall Study|Adverse Event|0|||
25087419|NCT02565615|50196019|FG004|Overall Study|Adverse Event|9|||
25087420|NCT02565615|50196015|FG000|Overall Study|Untreated|0|||
25087421|NCT02565615|50196016|FG001|Overall Study|Untreated|0|||
25087422|NCT02565615|50196017|FG002|Overall Study|Untreated|0|||
25087423|NCT02565615|50196018|FG003|Overall Study|Untreated|0|||
25087424|NCT02565615|50196019|FG004|Overall Study|Untreated|567|||
25087425|NCT02701361|50196034|FG000|Overall Study|Lost to Follow-up|5|||
25172717|NCT01712399|50313484|FG000|Overall Study|Study closure|345|||
25087426|NCT02701361|50196035|FG001|Overall Study|Lost to Follow-up|2|||
25087427|NCT02701361|50196036|FG002|Overall Study|Lost to Follow-up|1|||
25172718|NCT03225846|50313591|FG000|Overall Study|Adverse Event|0|||
25087428|NCT02701361|50196034|FG000|Overall Study|Withdrawal by Subject|4|||
25087429|NCT02701361|50196035|FG001|Overall Study|Withdrawal by Subject|0|||
25087430|NCT02701361|50196036|FG002|Overall Study|Withdrawal by Subject|0|||
25087431|NCT02701361|50196034|FG000|Overall Study|timed out in rehab center|0|||
25087432|NCT02701361|50196035|FG001|Overall Study|timed out in rehab center|1|||
25087433|NCT02701361|50196036|FG002|Overall Study|timed out in rehab center|0|||
25087434|NCT02701361|50196034|FG000|Overall Study|incarceration|0|||
25087435|NCT02701361|50196035|FG001|Overall Study|incarceration|0|||
25087436|NCT02701361|50196036|FG002|Overall Study|incarceration|1|||
25087437|NCT02566785|50196057|FG000|Overall Study|Lost to Follow-up|0|||
25087438|NCT02566785|50196058|FG001|Overall Study|Lost to Follow-up|2|||
25087439|NCT02566785|50196057|FG000|Overall Study|Worsening condition|1|||
25087440|NCT02566785|50196058|FG001|Overall Study|Worsening condition|1|||
25087441|NCT01662999|50196070|FG000|Period 3|Withdrawal by Subject|0|||
25087442|NCT01662999|50196071|FG001|Period 3|Withdrawal by Subject|1|||
25087443|NCT01662999|50196072|FG002|Period 3|Withdrawal by Subject|0|||
25087444|NCT01662999|50196073|FG003|Period 3|Withdrawal by Subject|0|||
25087445|NCT01662999|50196074|FG004|Period 3|Withdrawal by Subject|0|||
25087446|NCT01662999|50196075|FG005|Period 3|Withdrawal by Subject|0|||
25087447|NCT02565381|50196108|FG000|Overall Study|Lost to Follow-up|1|||
25087448|NCT02565381|50196109|FG001|Overall Study|Lost to Follow-up|0|||
25087449|NCT02565381|50196110|FG002|Overall Study|Lost to Follow-up|1|||
25087450|NCT02063854|50196125|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
25087451|NCT02063854|50196126|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
25087452|NCT02063854|50196127|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
25087453|NCT02063854|50196128|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
25087454|NCT02063854|50196129|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
25087455|NCT02063854|50196130|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
25087456|NCT02063854|50196131|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
25087457|NCT02063854|50196125|FG000|Overall Study|Major Protocol Deviation|0|||
25087458|NCT02063854|50196126|FG001|Overall Study|Major Protocol Deviation|0|||
25087459|NCT02063854|50196127|FG002|Overall Study|Major Protocol Deviation|3|||
25087460|NCT02063854|50196128|FG003|Overall Study|Major Protocol Deviation|0|||
25087461|NCT02063854|50196129|FG004|Overall Study|Major Protocol Deviation|0|||
25087462|NCT02063854|50196130|FG005|Overall Study|Major Protocol Deviation|0|||
25087463|NCT02063854|50196131|FG006|Overall Study|Major Protocol Deviation|0|||
25087464|NCT02063854|50196125|FG000|Overall Study|Voluntary Withdrawal|2|||
25087465|NCT02063854|50196126|FG001|Overall Study|Voluntary Withdrawal|0|||
25087466|NCT02063854|50196127|FG002|Overall Study|Voluntary Withdrawal|8|||
25087467|NCT02063854|50196128|FG003|Overall Study|Voluntary Withdrawal|1|||
25087468|NCT02063854|50196129|FG004|Overall Study|Voluntary Withdrawal|3|||
25087469|NCT02063854|50196130|FG005|Overall Study|Voluntary Withdrawal|6|||
25087470|NCT02063854|50196131|FG006|Overall Study|Voluntary Withdrawal|1|||
25087471|NCT02063854|50196125|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
25087472|NCT02063854|50196126|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
25087473|NCT02063854|50196127|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
25087474|NCT02063854|50196128|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
25087475|NCT02063854|50196129|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
25087476|NCT02063854|50196130|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
25087477|NCT02063854|50196131|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
25087478|NCT02063854|50196125|FG000|Overall Study|Reason Not Specified|1|||
25087479|NCT02063854|50196126|FG001|Overall Study|Reason Not Specified|0|||
25087480|NCT02063854|50196127|FG002|Overall Study|Reason Not Specified|0|||
25087481|NCT02063854|50196128|FG003|Overall Study|Reason Not Specified|0|||
25087482|NCT02063854|50196129|FG004|Overall Study|Reason Not Specified|0|||
25087483|NCT02063854|50196130|FG005|Overall Study|Reason Not Specified|0|||
25087484|NCT02063854|50196131|FG006|Overall Study|Reason Not Specified|0|||
25087485|NCT02063854|50196125|FG000|Overall Study|Did Not Receive Study Drug|0|||
25087486|NCT02063854|50196126|FG001|Overall Study|Did Not Receive Study Drug|0|||
25087487|NCT02063854|50196127|FG002|Overall Study|Did Not Receive Study Drug|0|||
25087488|NCT02063854|50196128|FG003|Overall Study|Did Not Receive Study Drug|0|||
25087489|NCT02063854|50196129|FG004|Overall Study|Did Not Receive Study Drug|0|||
25087490|NCT02063854|50196130|FG005|Overall Study|Did Not Receive Study Drug|1|||
25087491|NCT02063854|50196131|FG006|Overall Study|Did Not Receive Study Drug|0|||
25172719|NCT03225846|50313592|FG001|Overall Study|Adverse Event|0|||
25087492|NCT02063698|50196151|FG000|Overall Study|did not complete booklet for days 2-8|1|||
25087493|NCT02063698|50196152|FG001|Overall Study|did not complete booklet for days 2-8|2|||
25087494|NCT04701333|50196160|FG000|Overall Study|Lost to Follow-up|3|||
25087495|NCT04701333|50196161|FG001|Overall Study|Lost to Follow-up|7|||
25087496|NCT04701333|50196160|FG000|Overall Study|Withdrawal by Subject|0|||
25087497|NCT04701333|50196161|FG001|Overall Study|Withdrawal by Subject|1|||
25087498|NCT02062450|50196169|FG000|Overall Study|No follow-up visit|124|||
25087499|NCT02561247|50196177|FG000|Overall Study|Protocol Violation|1|||
25087500|NCT02561247|50196177|FG000|Overall Study|Withdrawal by Subject|1|||
25168540|NCT01857869|50297877|FG004|Primary/Challenge Phase|Protocol Violation|0|||
25087501|NCT02561247|50196177|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
25087502|NCT02061592|50196183|FG000|Period 1|Withdrawal by Subject|1|||
25087503|NCT02061592|50196184|FG001|Period 1|Withdrawal by Subject|0|||
25087504|NCT02061592|50196183|FG000|Period 1|Protocol Violation|1|||
25087505|NCT02061592|50196184|FG001|Period 1|Protocol Violation|0|||
25087506|NCT02061592|50196183|FG000|Period 2|Lost to Follow-up|0|||
25087507|NCT02061592|50196184|FG001|Period 2|Lost to Follow-up|1|||
25087508|NCT01663623|50196194|FG000|Overall Study|Adverse Event|3|||
25087509|NCT01663623|50196195|FG001|Overall Study|Adverse Event|7|||
25087510|NCT01663623|50196194|FG000|Overall Study|Lack of Efficacy|5|||
25087511|NCT01663623|50196195|FG001|Overall Study|Lack of Efficacy|6|||
25087512|NCT01663623|50196194|FG000|Overall Study|Protocol Violation|0|||
25087513|NCT01663623|50196195|FG001|Overall Study|Protocol Violation|1|||
25087514|NCT01663623|50196194|FG000|Overall Study|Other-Study closed/terminated|1|||
25087515|NCT01663623|50196195|FG001|Overall Study|Other-Study closed/terminated|1|||
25087516|NCT01663623|50196194|FG000|Overall Study|Physician Decision|1|||
25087517|NCT01663623|50196195|FG001|Overall Study|Physician Decision|4|||
25087518|NCT01663623|50196194|FG000|Overall Study|Withdrawal by Subject|2|||
25087519|NCT01663623|50196195|FG001|Overall Study|Withdrawal by Subject|1|||
25087520|NCT02042950|50196201|FG000|Overall Study|Progressive Disease|4|||
25087521|NCT02042404|50196205|FG000|Overall Study|Death|1|||
25087522|NCT02042404|50196206|FG001|Overall Study|Death|0|||
25087523|NCT02042404|50196205|FG000|Overall Study|Unrelated Adverse Event|3|||
25087524|NCT02042404|50196206|FG001|Overall Study|Unrelated Adverse Event|0|||
25087525|NCT02042404|50196205|FG000|Overall Study|Inability to meet time requirements|1|||
25087526|NCT02042404|50196206|FG001|Overall Study|Inability to meet time requirements|0|||
25087527|NCT02042014|50196213|FG000|Overall Study|Adverse Event|1|||
25087528|NCT02042014|50196213|FG000|Overall Study|Physician Decision|7|||
25087529|NCT02041702|50196219|FG000|Overall Study|Lost to Follow-up|1|||
25087530|NCT02041702|50196220|FG001|Overall Study|Lost to Follow-up|6|||
25087531|NCT02041702|50196219|FG000|Overall Study|Death|4|||
25087532|NCT02041702|50196220|FG001|Overall Study|Death|0|||
25087533|NCT02041702|50196219|FG000|Overall Study|Withdrawal by Subject|4|||
25087534|NCT02041702|50196220|FG001|Overall Study|Withdrawal by Subject|3|||
25087535|NCT02041702|50196219|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
25087536|NCT02041702|50196220|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
25087537|NCT02041702|50196219|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
25087538|NCT02041702|50196220|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
25087539|NCT02565147|50196228|FG000|Overall Study|Withdrawal by Subject|5|||
25087540|NCT02565147|50196229|FG001|Overall Study|Withdrawal by Subject|1|||
25087541|NCT02565147|50196228|FG000|Overall Study|Lost to Follow-up|0|||
25087542|NCT02565147|50196229|FG001|Overall Study|Lost to Follow-up|1|||
25087543|NCT02565147|50196228|FG000|Overall Study|Death|1|||
25087544|NCT02565147|50196229|FG001|Overall Study|Death|1|||
25087545|NCT02061280|50196237|FG000|Overall Study|Protocol Violation|12|||
25087546|NCT02061280|50196238|FG001|Overall Study|Protocol Violation|8|||
25087547|NCT02061280|50196237|FG000|Overall Study|moved out of state|0|||
25087548|NCT02061280|50196238|FG001|Overall Study|moved out of state|1|||
25087549|NCT02061280|50196237|FG000|Overall Study|Withdrawal by Subject|1|||
25087550|NCT02061280|50196238|FG001|Overall Study|Withdrawal by Subject|2|||
25087551|NCT02061280|50196237|FG000|Overall Study|Lost to Follow-up|5|||
25087552|NCT02061280|50196238|FG001|Overall Study|Lost to Follow-up|1|||
25087553|NCT02061202|50196249|FG000|Overall Study|Lost to Follow-up|1|||
25087554|NCT02061202|50196250|FG001|Overall Study|Lost to Follow-up|1|||
25087555|NCT02059408|50196259|FG000|Overall Study|Did not get tested|0|||
25087556|NCT02059408|50196260|FG001|Overall Study|Did not get tested|330|||
25087557|NCT02059408|50196261|FG002|Overall Study|Did not get tested|358|||
25087558|NCT01625338|50196274|FG000|Overall Study|Enrolled but not Treated|0|||
25087559|NCT01625338|50196275|FG001|Overall Study|Enrolled but not Treated|0|||
25087560|NCT01625338|50196276|FG002|Overall Study|Enrolled but not Treated|1|||
25087561|NCT01625338|50196274|FG000|Overall Study|Efficacy Failure|27|||
25087562|NCT01625338|50196275|FG001|Overall Study|Efficacy Failure|39|||
25172720|NCT03225846|50313593|FG002|Overall Study|Adverse Event|0|||
25087563|NCT01625338|50196276|FG002|Overall Study|Efficacy Failure|31|||
25087564|NCT01625338|50196274|FG000|Overall Study|Lost to Follow-up|3|||
25087565|NCT01625338|50196275|FG001|Overall Study|Lost to Follow-up|3|||
25087566|NCT01625338|50196276|FG002|Overall Study|Lost to Follow-up|2|||
25087567|NCT01625338|50196274|FG000|Overall Study|Investigator Decision|0|||
25087568|NCT01625338|50196275|FG001|Overall Study|Investigator Decision|2|||
25087569|NCT01625338|50196276|FG002|Overall Study|Investigator Decision|1|||
25087570|NCT01625338|50196274|FG000|Overall Study|Subject Withdrew Consent|1|||
25087571|NCT01625338|50196275|FG001|Overall Study|Subject Withdrew Consent|0|||
25087572|NCT01625338|50196276|FG002|Overall Study|Subject Withdrew Consent|2|||
25087573|NCT01625338|50196274|FG000|Overall Study|Adverse Event|1|||
25087574|NCT01625338|50196275|FG001|Overall Study|Adverse Event|0|||
25087575|NCT01625338|50196276|FG002|Overall Study|Adverse Event|1|||
25087576|NCT01625338|50196274|FG000|Overall Study|Study Discontinued by Sponsor|0|||
25172721|NCT03225846|50313594|FG003|Overall Study|Adverse Event|0|||
25087577|NCT01625338|50196275|FG001|Overall Study|Study Discontinued by Sponsor|0|||
25087578|NCT01625338|50196276|FG002|Overall Study|Study Discontinued by Sponsor|1|||
25087579|NCT02560623|50196288|FG000|Overall Study|Unable to swallow sponge|0|||
25087580|NCT02560623|50196289|FG001|Overall Study|Unable to swallow sponge|1|||
25172722|NCT03225846|50313595|FG004|Overall Study|Adverse Event|0|||
25172723|NCT03225846|50313596|FG005|Overall Study|Adverse Event|0|||
25172724|NCT03225846|50313597|FG006|Overall Study|Adverse Event|6|||
24996844|NCT02963506|50087996|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
25087581|NCT02560623|50196290|FG002|Overall Study|Unable to swallow sponge|0|||
25087582|NCT02560623|50196291|FG003|Overall Study|Unable to swallow sponge|0|||
25087583|NCT02560623|50196288|FG000|Overall Study|Intervention prior to sponge administration|0|||
25087584|NCT02560623|50196289|FG001|Overall Study|Intervention prior to sponge administration|1|||
25087585|NCT02560623|50196290|FG002|Overall Study|Intervention prior to sponge administration|0|||
25087586|NCT02560623|50196291|FG003|Overall Study|Intervention prior to sponge administration|0|||
25087587|NCT02560389|50196304|FG000|Overall Study|Lost to Follow-up|1|||
25087588|NCT02560389|50196305|FG001|Overall Study|Lost to Follow-up|2|||
25087589|NCT02560389|50196306|FG002|Overall Study|Lost to Follow-up|2|||
25087590|NCT02560389|50196304|FG000|Overall Study|Tested positive for illicit substance|0|||
25087591|NCT02560389|50196305|FG001|Overall Study|Tested positive for illicit substance|1|||
25087592|NCT02560389|50196306|FG002|Overall Study|Tested positive for illicit substance|0|||
25087593|NCT02564211|50196314|FG000|Overall Study|Adverse Event|4|||
25087594|NCT02093026|50196318|FG000|Overall Study|Adverse Event|26|||
25087595|NCT02093026|50196318|FG000|Overall Study|Death|10|||
25087596|NCT02093026|50196318|FG000|Overall Study|Other|157|||
25087597|NCT02040844|50196326|FG000|Overall Study|Adverse Event|0|||
25087598|NCT02040844|50196327|FG001|Overall Study|Adverse Event|0|||
25087599|NCT02040844|50196328|FG002|Overall Study|Adverse Event|1|||
25087600|NCT02040844|50196326|FG000|Overall Study|Withdrawal by Subject|16|||
25087601|NCT02040844|50196327|FG001|Overall Study|Withdrawal by Subject|22|||
25087602|NCT02040844|50196328|FG002|Overall Study|Withdrawal by Subject|25|||
25087603|NCT02040844|50196326|FG000|Overall Study|Lost to Follow-up|12|||
25087604|NCT02040844|50196327|FG001|Overall Study|Lost to Follow-up|9|||
25087605|NCT02040844|50196328|FG002|Overall Study|Lost to Follow-up|13|||
25087606|NCT02040844|50196326|FG000|Overall Study|Missing|13|||
25087607|NCT02040844|50196327|FG001|Overall Study|Missing|3|||
25087608|NCT02040844|50196328|FG002|Overall Study|Missing|2|||
25087609|NCT02040844|50196326|FG000|Overall Study|Non-specified|8|||
25087610|NCT02040844|50196327|FG001|Overall Study|Non-specified|2|||
25087611|NCT02040844|50196328|FG002|Overall Study|Non-specified|5|||
25087612|NCT02040844|50196326|FG000|Overall Study|Concomitant medication|1|||
25087613|NCT02040844|50196327|FG001|Overall Study|Concomitant medication|3|||
25087614|NCT02040844|50196328|FG002|Overall Study|Concomitant medication|1|||
25087615|NCT02059174|50196336|FG000|Period 1|Withdrawal by Subject|0|||
25087616|NCT02059174|50196337|FG001|Period 1|Withdrawal by Subject|2|||
25087617|NCT02059174|50196336|FG000|Period 2|Withdrawal by Subject|0|||
25087618|NCT02059174|50196337|FG001|Period 2|Withdrawal by Subject|2|||
25087619|NCT02059174|50196336|FG000|Period 2|Protocol Violation|1|||
25087620|NCT02059174|50196337|FG001|Period 2|Protocol Violation|0|||
25087621|NCT02059174|50196336|FG000|Period 3|Physician Decision|1|||
25087622|NCT02059174|50196337|FG001|Period 3|Physician Decision|0|||
25087623|NCT02092324|50196345|FG000|Overall Study|Adverse Event|1|||
25087624|NCT02092324|50196345|FG000|Overall Study|Lack of Efficacy|6|||
25087625|NCT02092324|50196345|FG000|Overall Study|Proceed to Transplant|3|||
25087626|NCT02092324|50196345|FG000|Overall Study|Physician Decision|7|||
25087627|NCT02092324|50196345|FG000|Overall Study|Misdiagnosis|2|||
25087628|NCT02040766|50196357|FG000|Overall Study|Adverse Event|1|||
25087629|NCT02040766|50196358|FG001|Overall Study|Adverse Event|1|||
25087630|NCT02040766|50196359|FG002|Overall Study|Adverse Event|1|||
25087631|NCT02040766|50196360|FG003|Overall Study|Adverse Event|0|||
25087632|NCT02040766|50196361|FG004|Overall Study|Adverse Event|2|||
25087633|NCT02040766|50196357|FG000|Overall Study|Withdrawal by Subject|4|||
25087634|NCT02040766|50196358|FG001|Overall Study|Withdrawal by Subject|3|||
25087635|NCT02040766|50196359|FG002|Overall Study|Withdrawal by Subject|2|||
25087636|NCT02040766|50196360|FG003|Overall Study|Withdrawal by Subject|3|||
25087637|NCT02040766|50196361|FG004|Overall Study|Withdrawal by Subject|2|||
25087638|NCT02040766|50196357|FG000|Overall Study|Non-compliance|0|||
25087639|NCT02040766|50196358|FG001|Overall Study|Non-compliance|1|||
25087640|NCT02040766|50196359|FG002|Overall Study|Non-compliance|0|||
25087641|NCT02040766|50196360|FG003|Overall Study|Non-compliance|0|||
25172725|NCT03225846|50313591|FG000|Overall Study|Withdrawal by Subject|0|||
25087642|NCT02040766|50196361|FG004|Overall Study|Non-compliance|0|||
25087643|NCT02040766|50196357|FG000|Overall Study|Protocol Violation|2|||
25087644|NCT02040766|50196358|FG001|Overall Study|Protocol Violation|1|||
25087645|NCT02040766|50196359|FG002|Overall Study|Protocol Violation|2|||
25172726|NCT03225846|50313592|FG001|Overall Study|Withdrawal by Subject|1|||
25087646|NCT02040766|50196360|FG003|Overall Study|Protocol Violation|3|||
25087647|NCT02040766|50196361|FG004|Overall Study|Protocol Violation|0|||
25172727|NCT03225846|50313593|FG002|Overall Study|Withdrawal by Subject|0|||
25087648|NCT02040766|50196357|FG000|Overall Study|Lost to Follow-up|4|||
25087649|NCT02040766|50196358|FG001|Overall Study|Lost to Follow-up|1|||
25087650|NCT02040766|50196359|FG002|Overall Study|Lost to Follow-up|3|||
25087651|NCT02040766|50196360|FG003|Overall Study|Lost to Follow-up|1|||
25087652|NCT02040766|50196361|FG004|Overall Study|Lost to Follow-up|4|||
25087653|NCT02040766|50196357|FG000|Overall Study|Not reported|1|||
25087654|NCT02040766|50196358|FG001|Overall Study|Not reported|0|||
25087655|NCT02040766|50196359|FG002|Overall Study|Not reported|0|||
25087656|NCT02040766|50196360|FG003|Overall Study|Not reported|0|||
25087657|NCT02040766|50196361|FG004|Overall Study|Not reported|0|||
25087658|NCT02040766|50196357|FG000|Overall Study|Lack of Efficacy|6|||
25087659|NCT02040766|50196358|FG001|Overall Study|Lack of Efficacy|3|||
25087660|NCT02040766|50196359|FG002|Overall Study|Lack of Efficacy|4|||
25087661|NCT02040766|50196360|FG003|Overall Study|Lack of Efficacy|6|||
25087662|NCT02040766|50196361|FG004|Overall Study|Lack of Efficacy|5|||
25087663|NCT02040532|50196374|FG000|Overall Study|Lost to Follow-up|1|||
25087664|NCT02040532|50196374|FG000|Overall Study|Physician Decision|4|||
25087665|NCT02040532|50196374|FG000|Overall Study|Adverse Event|4|||
25087666|NCT02040532|50196374|FG000|Overall Study|Withdrawal by Subject|3|||
25087667|NCT02039908|50196378|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
25087668|NCT02039908|50196379|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
25087669|NCT02039908|50196380|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
25087670|NCT02039908|50196381|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
25087671|NCT02039908|50196378|FG000|Phase 1-Summer|Protocol Violation|6|||
25172728|NCT03225846|50313594|FG003|Overall Study|Withdrawal by Subject|0|||
25172729|NCT03225846|50313595|FG004|Overall Study|Withdrawal by Subject|0|||
25172730|NCT03225846|50313596|FG005|Overall Study|Withdrawal by Subject|0|||
25172731|NCT03225846|50313597|FG006|Overall Study|Withdrawal by Subject|0|||
25172732|NCT03225846|50313591|FG000|Overall Study|Death|0|||
25172733|NCT03225846|50313592|FG001|Overall Study|Death|1|||
25172734|NCT03225846|50313593|FG002|Overall Study|Death|0|||
25172735|NCT03225846|50313594|FG003|Overall Study|Death|0|||
25172736|NCT03225846|50313595|FG004|Overall Study|Death|0|||
25172737|NCT03225846|50313596|FG005|Overall Study|Death|0|||
25172738|NCT03225846|50313597|FG006|Overall Study|Death|0|||
25172739|NCT03225846|50313591|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
25172740|NCT03225846|50313592|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
25172741|NCT03225846|50313593|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
25172742|NCT03225846|50313594|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
25172743|NCT03225846|50313595|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
25172744|NCT03225846|50313596|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
25172745|NCT03225846|50313597|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
25172746|NCT03225846|50313591|FG000|Overall Study|Patient decision|0|||
25172747|NCT03225846|50313592|FG001|Overall Study|Patient decision|0|||
25172748|NCT03225846|50313593|FG002|Overall Study|Patient decision|0|||
25172749|NCT03225846|50313594|FG003|Overall Study|Patient decision|0|||
25172750|NCT03225846|50313595|FG004|Overall Study|Patient decision|0|||
25172751|NCT03225846|50313596|FG005|Overall Study|Patient decision|0|||
25172752|NCT03225846|50313597|FG006|Overall Study|Patient decision|1|||
25172753|NCT01712009|50313662|FG000|Overall Study|Withdrawal by Subject|24|||
25172754|NCT01712009|50313663|FG001|Overall Study|Withdrawal by Subject|15|||
25172755|NCT01712009|50313664|FG002|Overall Study|Withdrawal by Subject|8|||
25172756|NCT01712009|50313662|FG000|Overall Study|Lost to Follow-up|2|||
25172757|NCT01712009|50313663|FG001|Overall Study|Lost to Follow-up|0|||
25172758|NCT01712009|50313664|FG002|Overall Study|Lost to Follow-up|1|||
25172759|NCT01712009|50313662|FG000|Overall Study|Decision by Sponsor|12|||
25172760|NCT01712009|50313663|FG001|Overall Study|Decision by Sponsor|14|||
25172761|NCT01712009|50313664|FG002|Overall Study|Decision by Sponsor|12|||
25172762|NCT01711853|50313693|FG000|Overall Study|Not treated|3|||
25172763|NCT01708187|50313699|FG000|Overall Study|Lost to Follow-up|0|||
25172764|NCT01708187|50313700|FG001|Overall Study|Lost to Follow-up|1|||
25172765|NCT01740401|50313776|FG000|Overall Study|Progression of disease|6|||
25172766|NCT01740401|50313776|FG000|Overall Study|Adverse Event|2|||
25087672|NCT02039908|50196379|FG001|Phase 1-Summer|Protocol Violation|0|||
25172767|NCT01740401|50313776|FG000|Overall Study|Did not reach primary endpoint|2|||
25172768|NCT01711619|50313797|FG000|Overall Study|Early study termination|10|||
25087673|NCT02039908|50196380|FG002|Phase 1-Summer|Protocol Violation|0|||
25087674|NCT02039908|50196381|FG003|Phase 1-Summer|Protocol Violation|0|||
25172769|NCT01711619|50313798|FG001|Overall Study|Early study termination|14|||
25172770|NCT01711619|50313797|FG000|Overall Study|Withdrawal by Subject|3|||
25172771|NCT01711619|50313798|FG001|Overall Study|Withdrawal by Subject|7|||
25172772|NCT01711619|50313797|FG000|Overall Study|Protocol Violation|2|||
25087675|NCT02039908|50196378|FG000|Phase 2-School Year|Lost to Follow-up|0|||
25087676|NCT02039908|50196379|FG001|Phase 2-School Year|Lost to Follow-up|0|||
25087677|NCT02039908|50196380|FG002|Phase 2-School Year|Lost to Follow-up|1|||
25172773|NCT01711619|50313798|FG001|Overall Study|Protocol Violation|3|||
25172774|NCT01711619|50313797|FG000|Overall Study|Adverse Event|2|||
25172775|NCT01711619|50313798|FG001|Overall Study|Adverse Event|0|||
25172776|NCT01711619|50313797|FG000|Overall Study|Lost to Follow-up|1|||
25172777|NCT01711619|50313798|FG001|Overall Study|Lost to Follow-up|0|||
25172778|NCT01710527|50313813|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
25172779|NCT01710527|50313814|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
25172780|NCT01706939|50313822|FG000|Pre Randomization|Screen Failure|1|||
25172781|NCT01706939|50313823|FG001|Pre Randomization|Screen Failure|0|||
25172782|NCT01706939|50313824|FG002|Pre Randomization|Screen Failure|0|||
25172783|NCT01706939|50313822|FG000|Pre Randomization|Ineligible for Randomization|1|||
25172784|NCT01706939|50313823|FG001|Pre Randomization|Ineligible for Randomization|0|||
25172785|NCT01706939|50313824|FG002|Pre Randomization|Ineligible for Randomization|0|||
25172786|NCT01706939|50313822|FG000|Pre Randomization|Withdrawal by Subject|1|||
25172787|NCT01706939|50313823|FG001|Pre Randomization|Withdrawal by Subject|0|||
25172788|NCT01706939|50313824|FG002|Pre Randomization|Withdrawal by Subject|0|||
25172789|NCT01706939|50313822|FG000|Randomization|Insufficient QoL survey compliance|0|||
25172790|NCT01706939|50313823|FG001|Randomization|Insufficient QoL survey compliance|1|||
25172791|NCT01706939|50313824|FG002|Randomization|Insufficient QoL survey compliance|1|||
25172792|NCT01706939|50313822|FG000|Randomization|Progression of disease|0|||
25172793|NCT01706939|50313823|FG001|Randomization|Progression of disease|2|||
25172794|NCT01706939|50313824|FG002|Randomization|Progression of disease|1|||
25172795|NCT01709903|50313833|FG000|Overall Study|administrative problems|2|||
25172796|NCT01709903|50313834|FG001|Overall Study|administrative problems|6|||
25172797|NCT01709903|50313833|FG000|Overall Study|Abnormal test procedure results|1|||
25172798|NCT01709903|50313834|FG001|Overall Study|Abnormal test procedure results|0|||
25172799|NCT01709903|50313833|FG000|Overall Study|In ability to use device|1|||
25172800|NCT01709903|50313834|FG001|Overall Study|In ability to use device|1|||
25172801|NCT01709903|50313833|FG000|Overall Study|no longer needed study drug|0|||
25172802|NCT01709903|50313834|FG001|Overall Study|no longer needed study drug|1|||
25172803|NCT01709903|50313833|FG000|Overall Study|Lost to Follow-up|0|||
25172804|NCT01709903|50313834|FG001|Overall Study|Lost to Follow-up|2|||
25172805|NCT01709903|50313833|FG000|Overall Study|Death|2|||
25172806|NCT01709903|50313834|FG001|Overall Study|Death|0|||
25172807|NCT01709903|50313833|FG000|Overall Study|Protocol Violation|3|||
25172808|NCT01709903|50313834|FG001|Overall Study|Protocol Violation|2|||
25172809|NCT01709903|50313833|FG000|Overall Study|Lack of Efficacy|3|||
25172810|NCT01709903|50313834|FG001|Overall Study|Lack of Efficacy|3|||
25172811|NCT01709903|50313833|FG000|Overall Study|Withdrawal by Subject|6|||
25172812|NCT01709903|50313834|FG001|Overall Study|Withdrawal by Subject|6|||
25172813|NCT01709903|50313833|FG000|Overall Study|Adverse Event|11|||
25172814|NCT01709903|50313834|FG001|Overall Study|Adverse Event|18|||
25172815|NCT04492618|50313840|FG000|Overall Study|Withdrawal by Subject|1|||
25172816|NCT01605227|50313846|FG000|Overall Study|Did not receive study treatment|2|||
25172817|NCT01605227|50313847|FG001|Overall Study|Did not receive study treatment|3|||
25172818|NCT01605227|50313846|FG000|Overall Study|Adverse Event|228|||
25172819|NCT01605227|50313847|FG001|Overall Study|Adverse Event|42|||
25172820|NCT01605227|50313846|FG000|Overall Study|Progressive Disease|132|||
25172821|NCT01605227|50313847|FG001|Overall Study|Progressive Disease|128|||
25172822|NCT01605227|50313846|FG000|Overall Study|Clinical Deterioration|227|||
25172823|NCT01605227|50313847|FG001|Overall Study|Clinical Deterioration|133|||
25172824|NCT01605227|50313846|FG000|Overall Study|Lost to Follow-up|1|||
25172825|NCT01605227|50313847|FG001|Overall Study|Lost to Follow-up|0|||
25172826|NCT01605227|50313846|FG000|Overall Study|Protocol Violation|1|||
25172827|NCT01605227|50313847|FG001|Overall Study|Protocol Violation|0|||
25172828|NCT01605227|50313846|FG000|Overall Study|Physician Decision|9|||
25172829|NCT01605227|50313847|FG001|Overall Study|Physician Decision|7|||
25172830|NCT01605227|50313846|FG000|Overall Study|Withdrawal by Subject|18|||
25172831|NCT01605227|50313847|FG001|Overall Study|Withdrawal by Subject|14|||
25172832|NCT01605227|50313846|FG000|Overall Study|Sponsor Decision|2|||
25172833|NCT01605227|50313847|FG001|Overall Study|Sponsor Decision|0|||
24996845|NCT02963506|50087997|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
24996846|NCT02963506|50087998|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
24996847|NCT02963506|50087999|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
24996848|NCT02963506|50088000|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
24996849|NCT02963506|50088001|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
24996850|NCT02963506|50088002|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
24996851|NCT02963506|50088003|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
24996852|NCT02963506|50088004|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
24996853|NCT02963506|50088005|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
24996854|NCT02963506|50088006|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
24996855|NCT02963506|50088007|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
24996856|NCT02963506|50087995|FG000|Dose-Blind Period|Adverse Event|0|||
24996857|NCT02963506|50087996|FG001|Dose-Blind Period|Adverse Event|0|||
24996858|NCT02963506|50087997|FG002|Dose-Blind Period|Adverse Event|0|||
25172834|NCT01605227|50313846|FG000|Overall Study|Started New Therapy|1|||
25172835|NCT01605227|50313847|FG001|Overall Study|Started New Therapy|0|||
25172836|NCT01605227|50313846|FG000|Overall Study|Subject Decision|0|||
25087678|NCT02039908|50196381|FG003|Phase 2-School Year|Lost to Follow-up|3|||
25087679|NCT02039908|50196378|FG000|Phase 2-School Year|Protocol Violation|0|||
25087680|NCT02039908|50196379|FG001|Phase 2-School Year|Protocol Violation|0|||
25087681|NCT02039908|50196380|FG002|Phase 2-School Year|Protocol Violation|3|||
25087682|NCT02039908|50196381|FG003|Phase 2-School Year|Protocol Violation|0|||
25087683|NCT02039908|50196378|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
25087684|NCT02039908|50196379|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
25087685|NCT02039908|50196380|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
25087686|NCT02039908|50196381|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
25087687|NCT02058940|50196389|FG000|Overall Study|Discharged from Critical Care Unit|1|||
25087688|NCT02058628|50196395|FG000|Overall Study|Adverse Event|1|||
25087689|NCT02058628|50196396|FG001|Overall Study|Adverse Event|0|||
25087690|NCT02058628|50196395|FG000|Overall Study|Withdrawal by Subject|2|||
25087691|NCT02058628|50196396|FG001|Overall Study|Withdrawal by Subject|2|||
25087692|NCT02058628|50196395|FG000|Overall Study|Lost to Follow-up|2|||
25087693|NCT02058628|50196396|FG001|Overall Study|Lost to Follow-up|4|||
25087694|NCT02058628|50196395|FG000|Overall Study|Not in time schedule|0|||
25087695|NCT02058628|50196396|FG001|Overall Study|Not in time schedule|1|||
25087696|NCT02058628|50196395|FG000|Overall Study|The visit date was not in timeline|0|||
25087697|NCT02058628|50196396|FG001|Overall Study|The visit date was not in timeline|1|||
25087698|NCT02058628|50196395|FG000|Overall Study|A lot of time for study for participant|1|||
25087699|NCT02058628|50196396|FG001|Overall Study|A lot of time for study for participant|0|||
25087700|NCT02058628|50196395|FG000|Overall Study|Non compliance|1|||
25087701|NCT02058628|50196396|FG001|Overall Study|Non compliance|0|||
25087702|NCT02058160|50196407|FG000|Overall Study|Randomized but not treated|2|||
25087703|NCT02058160|50196408|FG001|Overall Study|Randomized but not treated|4|||
25087704|NCT02058160|50196407|FG000|Overall Study|Poor compliance to protocol|4|||
25087705|NCT02058160|50196408|FG001|Overall Study|Poor compliance to protocol|1|||
25087706|NCT02058160|50196407|FG000|Overall Study|Adverse Event|12|||
25087707|NCT02058160|50196408|FG001|Overall Study|Adverse Event|3|||
25087708|NCT02058160|50196407|FG000|Overall Study|Lost to Follow-up|1|||
25087709|NCT02058160|50196408|FG001|Overall Study|Lost to Follow-up|0|||
25087710|NCT02058160|50196407|FG000|Overall Study|Other than specified above|12|||
25087711|NCT02058160|50196408|FG001|Overall Study|Other than specified above|6|||
25087712|NCT02090764|50196416|FG000|Overall Study|Adverse Event|1|||
25087713|NCT02090764|50196417|FG001|Overall Study|Adverse Event|3|||
25087714|NCT02090764|50196416|FG000|Overall Study|Lack of Efficacy|0|||
25087715|NCT02090764|50196417|FG001|Overall Study|Lack of Efficacy|13|||
25087716|NCT02090764|50196416|FG000|Overall Study|Withdrawal by Subject|2|||
25087717|NCT02090764|50196417|FG001|Overall Study|Withdrawal by Subject|1|||
25087718|NCT02090764|50196416|FG000|Overall Study|Intercurrent illness and other|1|||
25087719|NCT02090764|50196417|FG001|Overall Study|Intercurrent illness and other|1|||
25087720|NCT02090764|50196416|FG000|Overall Study|Lost to Follow-up|2|||
25087721|NCT02090764|50196417|FG001|Overall Study|Lost to Follow-up|2|||
25087722|NCT02057692|50196427|FG000|Overall Study|Adverse Event|1|||
25087723|NCT02057692|50196428|FG001|Overall Study|Adverse Event|0|||
25087724|NCT02057692|50196429|FG002|Overall Study|Adverse Event|0|||
25087725|NCT02057692|50196430|FG003|Overall Study|Adverse Event|0|||
25087726|NCT02057692|50196427|FG000|Overall Study|Lost to Follow-up|0|||
25087727|NCT02057692|50196428|FG001|Overall Study|Lost to Follow-up|0|||
25087728|NCT02057692|50196429|FG002|Overall Study|Lost to Follow-up|0|||
25087729|NCT02057692|50196430|FG003|Overall Study|Lost to Follow-up|1|||
25087730|NCT02038036|50196448|FG000|Core Study|Adverse Event|7|||
25087731|NCT02038036|50196449|FG001|Core Study|Adverse Event|7|||
25087732|NCT02038036|50196448|FG000|Core Study|Death|1|||
25087733|NCT02038036|50196449|FG001|Core Study|Death|1|||
25087734|NCT02038036|50196448|FG000|Core Study|Disease progression|2|||
25087735|NCT02038036|50196449|FG001|Core Study|Disease progression|2|||
25087736|NCT02038036|50196448|FG000|Core Study|Lost to Follow-up|0|||
25087737|NCT02038036|50196449|FG001|Core Study|Lost to Follow-up|1|||
25087738|NCT02038036|50196448|FG000|Core Study|Physician Decision|2|||
25087739|NCT02038036|50196449|FG001|Core Study|Physician Decision|1|||
25087740|NCT02038036|50196448|FG000|Core Study|Subject/guardian decision|0|||
25087741|NCT02038036|50196449|FG001|Core Study|Subject/guardian decision|1|||
25087742|NCT02038036|50196448|FG000|Core Study|Withdrawal by Subject|3|||
25087743|NCT02038036|50196449|FG001|Core Study|Withdrawal by Subject|1|||
25087744|NCT02038036|50196448|FG000|Crossover Period|Withdrawal by Subject|0|||
25087745|NCT02038036|50196449|FG001|Crossover Period|Withdrawal by Subject|3|||
25087746|NCT02038036|50196448|FG000|Crossover Period|Adverse Event|0|||
25087747|NCT02038036|50196449|FG001|Crossover Period|Adverse Event|9|||
25087748|NCT02038036|50196448|FG000|Crossover Period|Death|0|||
25087749|NCT02038036|50196449|FG001|Crossover Period|Death|2|||
25087750|NCT02038036|50196448|FG000|Crossover Period|Disease progression|0|||
25087751|NCT02038036|50196449|FG001|Crossover Period|Disease progression|3|||
25087752|NCT02038036|50196448|FG000|Crossover Period|Lost to Follow-up|0|||
25087753|NCT02038036|50196449|FG001|Crossover Period|Lost to Follow-up|1|||
25087754|NCT02038036|50196448|FG000|Crossover Period|Physician Decision|0|||
25087755|NCT02038036|50196449|FG001|Crossover Period|Physician Decision|2|||
25087756|NCT02037568|50196460|FG000|Overall Study|Withdrawal by Subject|17|||
25087757|NCT02037568|50196461|FG001|Overall Study|Withdrawal by Subject|24|||
25087758|NCT02037568|50196460|FG000|Overall Study|Lost to Follow-up|16|||
25172837|NCT01605227|50313847|FG001|Overall Study|Subject Decision|1|||
25172838|NCT01605227|50313846|FG000|Overall Study|Dose Held >6 weeks|0|||
25172839|NCT01605227|50313847|FG001|Overall Study|Dose Held >6 weeks|1|||
25172840|NCT01709513|50313856|FG000|Overall Study|Randomized but not treated|0|||
25172841|NCT01709513|50313857|FG001|Overall Study|Randomized but not treated|1|||
25172842|NCT01709513|50313858|FG002|Overall Study|Randomized but not treated|0|||
25172843|NCT01709513|50313856|FG000|Overall Study|Adverse Event|16|||
25172844|NCT01709513|50313857|FG001|Overall Study|Adverse Event|31|||
25172845|NCT01709513|50313858|FG002|Overall Study|Adverse Event|23|||
25172846|NCT01709513|50313856|FG000|Overall Study|Poor compliance to protocol|2|||
25172847|NCT01709513|50313857|FG001|Overall Study|Poor compliance to protocol|0|||
25172848|NCT01709513|50313858|FG002|Overall Study|Poor compliance to protocol|0|||
25172849|NCT01709513|50313856|FG000|Overall Study|Other|3|||
25172850|NCT01709513|50313857|FG001|Overall Study|Other|11|||
25172851|NCT01709513|50313858|FG002|Overall Study|Other|7|||
25172852|NCT01605071|50313871|FG000|Overall Study|Withdrawal by Subject|3|||
25172853|NCT01605071|50313872|FG001|Overall Study|Withdrawal by Subject|2|||
25172854|NCT02710422|50313882|FG000|Overall Study|Termination of study|9|||
25172855|NCT02710422|50313883|FG001|Overall Study|Termination of study|9|||
25172856|NCT01706159|50313893|FG000|Overall Study|Withdrawal Criteria|2|||
25172857|NCT01706159|50313894|FG001|Overall Study|Withdrawal Criteria|1|||
25172858|NCT01706159|50313893|FG000|Overall Study|Unclassified|6|||
25172859|NCT01706159|50313894|FG001|Overall Study|Unclassified|1|||
25172860|NCT01706003|50313902|FG000|Overall Study|Withdrawal by Subject|2|||
25172861|NCT01706003|50313903|FG001|Overall Study|Withdrawal by Subject|0|||
25172862|NCT01706003|50313902|FG000|Overall Study|Not scheduled|3|||
25172863|NCT01706003|50313903|FG001|Overall Study|Not scheduled|0|||
25172864|NCT01706003|50313902|FG000|Overall Study|Lost to Follow-up|6|||
25172865|NCT01706003|50313903|FG001|Overall Study|Lost to Follow-up|4|||
25172866|NCT01705691|50313911|FG000|Overall Study|Death|1|||
25172867|NCT01705691|50313912|FG001|Overall Study|Death|2|||
25172868|NCT01705691|50313911|FG000|Overall Study|Withdrawal by Subject|1|||
25172869|NCT01705691|50313912|FG001|Overall Study|Withdrawal by Subject|2|||
25172870|NCT01705691|50313911|FG000|Overall Study|Lost to Follow-up|1|||
25172871|NCT01705691|50313912|FG001|Overall Study|Lost to Follow-up|1|||
25172872|NCT01705691|50313911|FG000|Overall Study|Other|0|||
25172873|NCT01705691|50313912|FG001|Overall Study|Other|1|||
25172874|NCT03766906|50313918|FG000|Overall Study|Withdrawal by Subject|6|||
25172875|NCT01705145|50313922|FG000|Part B|Adverse Event|1|||
25172876|NCT01704755|50313940|FG000|Overall Study|Adverse Event|4|||
25172877|NCT01704755|50313941|FG001|Overall Study|Adverse Event|1|||
25172878|NCT01704755|50313940|FG000|Overall Study|Lost to Follow-up|3|||
25172879|NCT01704755|50313941|FG001|Overall Study|Lost to Follow-up|4|||
25172880|NCT01704755|50313940|FG000|Overall Study|Withdrew consent|1|||
25172881|NCT01704755|50313941|FG001|Overall Study|Withdrew consent|1|||
25172882|NCT01704755|50313940|FG000|Overall Study|Other (not specified)|3|||
25172883|NCT01704755|50313941|FG001|Overall Study|Other (not specified)|1|||
25087759|NCT02037568|50196461|FG001|Overall Study|Lost to Follow-up|13|||
25087760|NCT02037568|50196460|FG000|Overall Study|Screen Failure|3|||
25087761|NCT02037568|50196461|FG001|Overall Study|Screen Failure|1|||
25087762|NCT02037568|50196460|FG000|Overall Study|Patient did not receive transplant|0|||
25087763|NCT02037568|50196461|FG001|Overall Study|Patient did not receive transplant|1|||
25087764|NCT02088034|50196470|FG000|Overall Study|Lost to Follow-up|1|||
25087765|NCT02088034|50196471|FG001|Overall Study|Lost to Follow-up|1|||
25087766|NCT02088034|50196472|FG002|Overall Study|Lost to Follow-up|0|||
25087767|NCT02088034|50196470|FG000|Overall Study|Pregnancy|2|||
25087768|NCT02088034|50196471|FG001|Overall Study|Pregnancy|1|||
25087769|NCT02088034|50196472|FG002|Overall Study|Pregnancy|2|||
25087770|NCT02037256|50196482|FG000|Overall Study|Protocol Violation|0|||
25087771|NCT02037256|50196483|FG001|Overall Study|Protocol Violation|1|||
25172884|NCT01704755|50313940|FG000|Overall Study|Withdrew consent and personal issues|1|||
25172885|NCT01704755|50313941|FG001|Overall Study|Withdrew consent and personal issues|0|||
25172886|NCT01704599|50313947|FG000|Overall Study|Adverse Event|1|||
25172887|NCT03599518|50313979|FG000|Overall Study|Clinical progression|0|||
25172888|NCT03599518|50313980|FG001|Overall Study|Clinical progression|0|||
25172889|NCT03599518|50313981|FG002|Overall Study|Clinical progression|0|||
25172890|NCT03599518|50313982|FG003|Overall Study|Clinical progression|0|||
25172891|NCT03599518|50313983|FG004|Overall Study|Clinical progression|1|||
25172892|NCT03599518|50313979|FG000|Overall Study|Adverse Event|0|||
25172893|NCT03599518|50313980|FG001|Overall Study|Adverse Event|0|||
25172894|NCT03599518|50313981|FG002|Overall Study|Adverse Event|0|||
25172895|NCT03599518|50313982|FG003|Overall Study|Adverse Event|0|||
25172896|NCT03599518|50313983|FG004|Overall Study|Adverse Event|1|||
25172897|NCT03599518|50313979|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
25172898|NCT03599518|50313980|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
25172899|NCT03599518|50313981|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
25172900|NCT03599518|50313982|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
25172901|NCT03599518|50313983|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
25172902|NCT03599518|50313979|FG000|Overall Study|Participant withdrawal from study treatment|0|||
25172903|NCT03599518|50313980|FG001|Overall Study|Participant withdrawal from study treatment|0|||
25172904|NCT03599518|50313981|FG002|Overall Study|Participant withdrawal from study treatment|1|||
25172905|NCT03599518|50313982|FG003|Overall Study|Participant withdrawal from study treatment|0|||
25172906|NCT03599518|50313983|FG004|Overall Study|Participant withdrawal from study treatment|0|||
25172907|NCT02709486|50314060|FG000|Overall Study|Adverse Event|2|||
25172908|NCT02709486|50314061|FG001|Overall Study|Adverse Event|5|||
25172909|NCT02709486|50314062|FG002|Overall Study|Adverse Event|3|||
25172910|NCT02709486|50314060|FG000|Overall Study|Death|0|||
25172911|NCT02709486|50314061|FG001|Overall Study|Death|0|||
25172912|NCT02709486|50314062|FG002|Overall Study|Death|2|||
25172913|NCT02709486|50314060|FG000|Overall Study|Insufficient clinical response|7|||
25172914|NCT02709486|50314061|FG001|Overall Study|Insufficient clinical response|3|||
25172915|NCT02709486|50314062|FG002|Overall Study|Insufficient clinical response|3|||
25172916|NCT02709486|50314060|FG000|Overall Study|Lost to Follow-up|3|||
25172917|NCT02709486|50314061|FG001|Overall Study|Lost to Follow-up|2|||
25172918|NCT02709486|50314062|FG002|Overall Study|Lost to Follow-up|2|||
25172919|NCT02709486|50314060|FG000|Overall Study|Other|0|||
25172920|NCT02709486|50314061|FG001|Overall Study|Other|2|||
25172921|NCT02709486|50314062|FG002|Overall Study|Other|3|||
25172922|NCT02709486|50314060|FG000|Overall Study|Withdrawal by Subject|32|||
25172923|NCT02709486|50314061|FG001|Overall Study|Withdrawal by Subject|22|||
25172924|NCT02709486|50314062|FG002|Overall Study|Withdrawal by Subject|32|||
25172925|NCT03110770|50314079|FG000|Overall Study|Death|1|||
25172926|NCT03110770|50314080|FG001|Overall Study|Death|0|||
25087772|NCT02037256|50196482|FG000|Overall Study|Withdrawn prior to Velcade|0|||
25087773|NCT02037256|50196483|FG001|Overall Study|Withdrawn prior to Velcade|2|||
25087774|NCT02035696|50196495|FG000|Overall Study|Lost to Follow-up|0|||
25087775|NCT02035696|50196496|FG001|Overall Study|Lost to Follow-up|3|||
25087776|NCT02035696|50196497|FG002|Overall Study|Lost to Follow-up|1|||
25087777|NCT02035696|50196498|FG003|Overall Study|Lost to Follow-up|2|||
25087778|NCT02035696|50196495|FG000|Overall Study|Withdrawal by Subject|3|||
25087779|NCT02035696|50196496|FG001|Overall Study|Withdrawal by Subject|0|||
25087780|NCT02035696|50196497|FG002|Overall Study|Withdrawal by Subject|2|||
25087781|NCT02035696|50196498|FG003|Overall Study|Withdrawal by Subject|1|||
25087782|NCT02057458|50196512|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
25087783|NCT02057458|50196513|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
25087784|NCT02057458|50196514|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
25087785|NCT02057458|50196512|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
25087786|NCT02057458|50196513|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
25087787|NCT02057458|50196514|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
25087788|NCT02057458|50196512|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
25087789|NCT02057458|50196513|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
25087790|NCT02057458|50196514|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
25087791|NCT02057068|50196546|FG000|Overall Study|Withdrawal by Subject|2|||
25087792|NCT02057068|50196547|FG001|Overall Study|Withdrawal by Subject|2|||
25087793|NCT02057068|50196546|FG000|Overall Study|Caregiver (CG) Health|0|||
25087794|NCT02057068|50196547|FG001|Overall Study|Caregiver (CG) Health|2|||
25087795|NCT02057068|50196546|FG000|Overall Study|Carepartner (CP) Health|4|||
25087796|NCT02057068|50196547|FG001|Overall Study|Carepartner (CP) Health|2|||
25087797|NCT02057068|50196546|FG000|Overall Study|Lost to Follow-up|2|||
25087798|NCT02057068|50196547|FG001|Overall Study|Lost to Follow-up|2|||
25087799|NCT02056834|50196555|FG000|Overall Study|Lost to Follow-up|7|||
25087800|NCT02087176|50196560|FG000|Overall Study|Withdrawal by Subject|1|||
25087801|NCT02087176|50196560|FG000|Overall Study|Death|10|||
25087802|NCT02087176|50196560|FG000|Overall Study|Censored|19|||
25087803|NCT02087176|50196560|FG000|Overall Study|Study Terminated by Sponsor|2|||
25087804|NCT02056288|50196566|FG000|In-Hospital Data|Surgery cancelled|1|||
25087805|NCT02056288|50196567|FG001|In-Hospital Data|Surgery cancelled|0|||
25087806|NCT02056288|50196566|FG000|In-Hospital Data|Protocol Violation|3|||
25087807|NCT02056288|50196567|FG001|In-Hospital Data|Protocol Violation|0|||
25087808|NCT02056288|50196566|FG000|In-Hospital Data|Physician Decision|1|||
25172927|NCT03110770|50314081|FG002|Overall Study|Death|0|||
25172928|NCT03110770|50314082|FG003|Overall Study|Death|1|||
25172929|NCT03110770|50314083|FG004|Overall Study|Death|0|||
25172930|NCT03110770|50314079|FG000|Overall Study|Enrolled but did not receive product|0|||
25172931|NCT03110770|50314080|FG001|Overall Study|Enrolled but did not receive product|0|||
25172932|NCT03110770|50314081|FG002|Overall Study|Enrolled but did not receive product|0|||
25172933|NCT03110770|50314082|FG003|Overall Study|Enrolled but did not receive product|8|||
25087809|NCT02056288|50196567|FG001|In-Hospital Data|Physician Decision|0|||
25087810|NCT02056288|50196566|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
25087811|NCT02056288|50196567|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
25087812|NCT02086162|50196575|FG000|Overall Study|Withdrawal by Subject|4|||
25087813|NCT02086162|50196576|FG001|Overall Study|Withdrawal by Subject|4|||
25087814|NCT02086162|50196575|FG000|Overall Study|moved|1|||
25087815|NCT02086162|50196576|FG001|Overall Study|moved|1|||
25087816|NCT02086162|50196575|FG000|Overall Study|Lost to Follow-up|4|||
25087817|NCT02086162|50196576|FG001|Overall Study|Lost to Follow-up|2|||
25087818|NCT02086162|50196575|FG000|Overall Study|Death|1|||
25087819|NCT02086162|50196576|FG001|Overall Study|Death|0|||
25087820|NCT02700815|50196590|FG000|Overall Study|Adverse Event|0|||
25087821|NCT02700815|50196591|FG001|Overall Study|Adverse Event|6|||
25087822|NCT02700815|50196592|FG002|Overall Study|Adverse Event|2|||
25087823|NCT02700815|50196593|FG003|Overall Study|Adverse Event|3|||
25087824|NCT02700815|50196590|FG000|Overall Study|Lack of Efficacy|0|||
25087825|NCT02700815|50196591|FG001|Overall Study|Lack of Efficacy|0|||
25087826|NCT02700815|50196592|FG002|Overall Study|Lack of Efficacy|1|||
25087827|NCT02700815|50196593|FG003|Overall Study|Lack of Efficacy|2|||
25087828|NCT02700815|50196590|FG000|Overall Study|Lost to Follow-up|1|||
25087829|NCT02700815|50196591|FG001|Overall Study|Lost to Follow-up|0|||
25087830|NCT02700815|50196592|FG002|Overall Study|Lost to Follow-up|0|||
25087831|NCT02700815|50196593|FG003|Overall Study|Lost to Follow-up|1|||
25087832|NCT02700815|50196590|FG000|Overall Study|Refusal to continue medication|0|||
25087833|NCT02700815|50196591|FG001|Overall Study|Refusal to continue medication|1|||
25087834|NCT02700815|50196592|FG002|Overall Study|Refusal to continue medication|0|||
25087835|NCT02700815|50196593|FG003|Overall Study|Refusal to continue medication|1|||
25087836|NCT02700815|50196590|FG000|Overall Study|Withdrawal by Subject|0|||
25087837|NCT02700815|50196591|FG001|Overall Study|Withdrawal by Subject|0|||
25087838|NCT02700815|50196592|FG002|Overall Study|Withdrawal by Subject|1|||
25087839|NCT02700815|50196593|FG003|Overall Study|Withdrawal by Subject|0|||
25087840|NCT00708305|50196603|FG000|Period 1|Protocol Violation|1|||
25087841|NCT00708305|50196604|FG001|Period 1|Protocol Violation|0|||
25087842|NCT00708305|50196605|FG002|Period 1|Protocol Violation|1|||
25087843|NCT00708305|50196606|FG003|Period 1|Protocol Violation|0|||
25087844|NCT00708305|50196603|FG000|Period 1|Other Reason|0|||
25087845|NCT00708305|50196604|FG001|Period 1|Other Reason|0|||
25087846|NCT00708305|50196605|FG002|Period 1|Other Reason|0|||
25087847|NCT00708305|50196606|FG003|Period 1|Other Reason|2|||
25087848|NCT00708305|50196603|FG000|Period 2|Lost to Follow-up|0|||
25087849|NCT00708305|50196604|FG001|Period 2|Lost to Follow-up|1|||
25087850|NCT00708305|50196605|FG002|Period 2|Lost to Follow-up|0|||
25087851|NCT00708305|50196606|FG003|Period 2|Lost to Follow-up|0|||
25087852|NCT00708305|50196603|FG000|Period 2|Protocol Violation|0|||
25087853|NCT00708305|50196604|FG001|Period 2|Protocol Violation|1|||
25087854|NCT00708305|50196605|FG002|Period 2|Protocol Violation|0|||
25087855|NCT00708305|50196606|FG003|Period 2|Protocol Violation|0|||
25087856|NCT00708305|50196603|FG000|Period 2|Other Reason|1|||
25087857|NCT00708305|50196604|FG001|Period 2|Other Reason|0|||
25087858|NCT00708305|50196605|FG002|Period 2|Other Reason|0|||
25087859|NCT00708305|50196606|FG003|Period 2|Other Reason|1|||
25087860|NCT00708305|50196603|FG000|Period 3|Protocol Violation|0|||
25087861|NCT00708305|50196604|FG001|Period 3|Protocol Violation|2|||
25087862|NCT00708305|50196605|FG002|Period 3|Protocol Violation|0|||
25087863|NCT00708305|50196606|FG003|Period 3|Protocol Violation|0|||
25087864|NCT00708305|50196603|FG000|Period 3|Other Reason|1|||
25087865|NCT00708305|50196604|FG001|Period 3|Other Reason|0|||
25087866|NCT00708305|50196605|FG002|Period 3|Other Reason|0|||
25087867|NCT00708305|50196606|FG003|Period 3|Other Reason|0|||
25087868|NCT02055976|50196628|FG000|Overall Study|Other|0|||
25087869|NCT02055976|50196629|FG001|Overall Study|Other|0|||
25087870|NCT02055976|50196630|FG002|Overall Study|Other|1|||
25087871|NCT02055976|50196631|FG003|Overall Study|Other|0|||
25087872|NCT02055976|50196632|FG004|Overall Study|Other|0|||
25087873|NCT02055976|50196633|FG005|Overall Study|Other|0|||
25087874|NCT02055976|50196634|FG006|Overall Study|Other|0|||
25087875|NCT02055976|50196635|FG007|Overall Study|Other|0|||
25087876|NCT02055976|50196636|FG008|Overall Study|Other|0|||
25087877|NCT02055976|50196628|FG000|Overall Study|Adverse Event|0|||
25087878|NCT02055976|50196629|FG001|Overall Study|Adverse Event|0|||
25087879|NCT02055976|50196630|FG002|Overall Study|Adverse Event|0|||
25087880|NCT02055976|50196631|FG003|Overall Study|Adverse Event|0|||
25087881|NCT02055976|50196632|FG004|Overall Study|Adverse Event|0|||
25087882|NCT02055976|50196633|FG005|Overall Study|Adverse Event|1|||
25087883|NCT02055976|50196634|FG006|Overall Study|Adverse Event|1|||
25087884|NCT02055976|50196635|FG007|Overall Study|Adverse Event|0|||
25087885|NCT02055976|50196636|FG008|Overall Study|Adverse Event|0|||
25087886|NCT02055976|50196628|FG000|Overall Study|Does not meet entrance criteria|0|||
25172934|NCT03110770|50314083|FG004|Overall Study|Enrolled but did not receive product|7|||
25087887|NCT02055976|50196629|FG001|Overall Study|Does not meet entrance criteria|0|||
25087888|NCT02055976|50196630|FG002|Overall Study|Does not meet entrance criteria|0|||
25087889|NCT02055976|50196631|FG003|Overall Study|Does not meet entrance criteria|0|||
25087890|NCT02055976|50196632|FG004|Overall Study|Does not meet entrance criteria|0|||
25087891|NCT02055976|50196633|FG005|Overall Study|Does not meet entrance criteria|0|||
25087892|NCT02055976|50196634|FG006|Overall Study|Does not meet entrance criteria|1|||
25087893|NCT02055976|50196635|FG007|Overall Study|Does not meet entrance criteria|0|||
25087894|NCT02055976|50196636|FG008|Overall Study|Does not meet entrance criteria|0|||
25087895|NCT02055976|50196628|FG000|Overall Study|Lost to Follow-up|0|||
25087896|NCT02055976|50196629|FG001|Overall Study|Lost to Follow-up|0|||
25087897|NCT02055976|50196630|FG002|Overall Study|Lost to Follow-up|0|||
25087898|NCT02055976|50196631|FG003|Overall Study|Lost to Follow-up|1|||
25087899|NCT02055976|50196632|FG004|Overall Study|Lost to Follow-up|0|||
25087900|NCT02055976|50196633|FG005|Overall Study|Lost to Follow-up|0|||
25087901|NCT02055976|50196634|FG006|Overall Study|Lost to Follow-up|0|||
25087902|NCT02055976|50196635|FG007|Overall Study|Lost to Follow-up|0|||
25087903|NCT02055976|50196636|FG008|Overall Study|Lost to Follow-up|0|||
25087904|NCT02055898|50196665|FG000|First Intervention (5 Days)|Physician Decision|2|||
25087905|NCT02055898|50196666|FG001|First Intervention (5 Days)|Physician Decision|0|||
25087906|NCT02055898|50196665|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
25087907|NCT02055898|50196666|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
25087908|NCT02564055|50196678|FG000|Overall Study|Adverse Event|1|||
25087909|NCT02564055|50196679|FG001|Overall Study|Adverse Event|0|||
25087910|NCT02564055|50196680|FG002|Overall Study|Adverse Event|4|||
25087911|NCT02564055|50196681|FG003|Overall Study|Adverse Event|1|||
25087912|NCT02564055|50196682|FG004|Overall Study|Adverse Event|4|||
25087913|NCT02564055|50196683|FG005|Overall Study|Adverse Event|1|||
25087914|NCT02564055|50196678|FG000|Overall Study|Protocol Violation|1|||
25172935|NCT03110770|50314079|FG000|Overall Study|Lost to Follow-up|0|||
25172936|NCT03110770|50314080|FG001|Overall Study|Lost to Follow-up|0|||
25172937|NCT03110770|50314081|FG002|Overall Study|Lost to Follow-up|0|||
25172938|NCT03110770|50314082|FG003|Overall Study|Lost to Follow-up|53|||
25172939|NCT03110770|50314083|FG004|Overall Study|Lost to Follow-up|45|||
25172940|NCT03110770|50314079|FG000|Overall Study|Investigator Decision|0|||
25172941|NCT03110770|50314080|FG001|Overall Study|Investigator Decision|0|||
25172942|NCT03110770|50314081|FG002|Overall Study|Investigator Decision|0|||
25172943|NCT03110770|50314082|FG003|Overall Study|Investigator Decision|5|||
25172944|NCT03110770|50314083|FG004|Overall Study|Investigator Decision|3|||
25172945|NCT03110770|50314079|FG000|Overall Study|Withdrawal by Subject|0|||
25172946|NCT03110770|50314080|FG001|Overall Study|Withdrawal by Subject|0|||
25172947|NCT03110770|50314081|FG002|Overall Study|Withdrawal by Subject|0|||
25172948|NCT03110770|50314082|FG003|Overall Study|Withdrawal by Subject|24|||
25172949|NCT03110770|50314083|FG004|Overall Study|Withdrawal by Subject|24|||
25172950|NCT03110770|50314079|FG000|Overall Study|Moved from area|5|||
25172951|NCT03110770|50314080|FG001|Overall Study|Moved from area|0|||
25172952|NCT03110770|50314081|FG002|Overall Study|Moved from area|2|||
25172953|NCT03110770|50314082|FG003|Overall Study|Moved from area|42|||
25172954|NCT03110770|50314083|FG004|Overall Study|Moved from area|43|||
25172955|NCT03110770|50314079|FG000|Overall Study|Illness/Injury unrelated to product|0|||
25172956|NCT03110770|50314080|FG001|Overall Study|Illness/Injury unrelated to product|0|||
25172957|NCT03110770|50314081|FG002|Overall Study|Illness/Injury unrelated to product|0|||
25172958|NCT03110770|50314082|FG003|Overall Study|Illness/Injury unrelated to product|0|||
25172959|NCT03110770|50314083|FG004|Overall Study|Illness/Injury unrelated to product|1|||
25172960|NCT00703326|50314289|FG000|Overall Study|Lost to Follow-up|47|||
25172961|NCT00703326|50314290|FG001|Overall Study|Lost to Follow-up|18|||
25172962|NCT00703326|50314289|FG000|Overall Study|Withdrawal by Subject|54|||
25172963|NCT00703326|50314290|FG001|Overall Study|Withdrawal by Subject|20|||
25172964|NCT00703326|50314289|FG000|Overall Study|Adverse Event|1|||
25172965|NCT00703326|50314290|FG001|Overall Study|Adverse Event|0|||
25172966|NCT04868500|50314343|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
25172967|NCT04868500|50314344|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
25172968|NCT04868500|50314343|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
25087915|NCT02564055|50196679|FG001|Overall Study|Protocol Violation|0|||
25087916|NCT02564055|50196680|FG002|Overall Study|Protocol Violation|0|||
25087917|NCT02564055|50196681|FG003|Overall Study|Protocol Violation|0|||
25087918|NCT02564055|50196682|FG004|Overall Study|Protocol Violation|0|||
25087919|NCT02564055|50196683|FG005|Overall Study|Protocol Violation|0|||
25087920|NCT02564055|50196678|FG000|Overall Study|Reached stopping criteria|0|||
25087921|NCT02564055|50196679|FG001|Overall Study|Reached stopping criteria|0|||
25087922|NCT02564055|50196680|FG002|Overall Study|Reached stopping criteria|0|||
25087923|NCT02564055|50196681|FG003|Overall Study|Reached stopping criteria|0|||
25172969|NCT04868500|50314344|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
25172970|NCT04372186|50314352|FG000|Overall Study|Death|24|||
25172971|NCT04372186|50314353|FG001|Overall Study|Death|11|||
25172972|NCT04372186|50314352|FG000|Overall Study|Transferred to a different facility for care|0|||
25172973|NCT04372186|50314353|FG001|Overall Study|Transferred to a different facility for care|2|||
25172974|NCT04317040|50314383|FG000|Overall Study|Lost to Follow-up|2|||
25087924|NCT02564055|50196682|FG004|Overall Study|Reached stopping criteria|0|||
25087925|NCT02564055|50196683|FG005|Overall Study|Reached stopping criteria|1|||
25087926|NCT02564055|50196678|FG000|Overall Study|Lost to Follow-up|0|||
25087927|NCT02564055|50196679|FG001|Overall Study|Lost to Follow-up|1|||
25087928|NCT02564055|50196680|FG002|Overall Study|Lost to Follow-up|4|||
25087929|NCT02564055|50196681|FG003|Overall Study|Lost to Follow-up|2|||
25087930|NCT02564055|50196682|FG004|Overall Study|Lost to Follow-up|1|||
25087931|NCT02564055|50196683|FG005|Overall Study|Lost to Follow-up|0|||
25087932|NCT02564055|50196678|FG000|Overall Study|Physician Decision|0|||
25087933|NCT02564055|50196679|FG001|Overall Study|Physician Decision|0|||
25087934|NCT02564055|50196680|FG002|Overall Study|Physician Decision|1|||
25087935|NCT02564055|50196681|FG003|Overall Study|Physician Decision|0|||
25087936|NCT02564055|50196682|FG004|Overall Study|Physician Decision|0|||
25087937|NCT02564055|50196683|FG005|Overall Study|Physician Decision|0|||
25087938|NCT02564055|50196678|FG000|Overall Study|Withdrawal by Subject|4|||
25087939|NCT02564055|50196679|FG001|Overall Study|Withdrawal by Subject|4|||
25087940|NCT02564055|50196680|FG002|Overall Study|Withdrawal by Subject|3|||
25087941|NCT02564055|50196681|FG003|Overall Study|Withdrawal by Subject|3|||
25087942|NCT02564055|50196682|FG004|Overall Study|Withdrawal by Subject|10|||
25087943|NCT02564055|50196683|FG005|Overall Study|Withdrawal by Subject|10|||
25087944|NCT02563899|50196701|FG000|Overall Study|Protocol Violation|1|||
25087945|NCT02563899|50196702|FG001|Overall Study|Protocol Violation|0|||
25087946|NCT02563899|50196703|FG002|Overall Study|Protocol Violation|0|||
25087947|NCT02563899|50196704|FG003|Overall Study|Protocol Violation|0|||
25172975|NCT04317040|50314384|FG001|Overall Study|Lost to Follow-up|0|||
25172976|NCT04317040|50314383|FG000|Overall Study|Death|16|||
25172977|NCT04317040|50314384|FG001|Overall Study|Death|18|||
25172978|NCT04317040|50314383|FG000|Overall Study|Withdrawal by Subject|0|||
25172979|NCT04317040|50314384|FG001|Overall Study|Withdrawal by Subject|1|||
25172980|NCT04317040|50314383|FG000|Overall Study|Incomplete assessments|0|||
25172981|NCT04317040|50314384|FG001|Overall Study|Incomplete assessments|1|||
25172982|NCT00703014|50314464|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
25172983|NCT00703014|50314465|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
25172984|NCT00703014|50314466|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
25172985|NCT00703014|50314467|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
25172986|NCT00703014|50314464|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
25172987|NCT00703014|50314465|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
25172988|NCT00703014|50314466|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
25172989|NCT00703014|50314467|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
25172990|NCT03915496|50314519|FG000|Overall Study|Adverse Event|2|||
25087948|NCT02563899|50196701|FG000|Overall Study|Withdrawal by Subject|0|||
25172991|NCT03915496|50314520|FG001|Overall Study|Adverse Event|1|||
25172992|NCT03915496|50314521|FG002|Overall Study|Adverse Event|2|||
25172993|NCT02709330|50314538|FG000|Overall Study|Death|5|||
25172994|NCT02709330|50314539|FG001|Overall Study|Death|0|||
25172995|NCT02709330|50314538|FG000|Overall Study|Lost to Follow-up|2|||
25172996|NCT02709330|50314539|FG001|Overall Study|Lost to Follow-up|0|||
25172997|NCT02709330|50314538|FG000|Overall Study|Physician Decision|2|||
25172998|NCT02709330|50314539|FG001|Overall Study|Physician Decision|0|||
25172999|NCT02709330|50314538|FG000|Overall Study|Withdrawal by Subject|4|||
25173000|NCT02709330|50314539|FG001|Overall Study|Withdrawal by Subject|0|||
25173001|NCT02709096|50314547|FG000|Overall Study|non-compliance|1|||
25173002|NCT02709096|50314548|FG001|Overall Study|non-compliance|1|||
25173003|NCT01372410|50314554|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
25173004|NCT01372410|50314555|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
25173005|NCT01372410|50314556|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
25173006|NCT01372410|50314557|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
25087949|NCT02563899|50196702|FG001|Overall Study|Withdrawal by Subject|0|||
25087950|NCT02563899|50196703|FG002|Overall Study|Withdrawal by Subject|1|||
25087951|NCT02563899|50196704|FG003|Overall Study|Withdrawal by Subject|0|||
25087952|NCT02699099|50196718|FG000|Overall Study|Adverse Event|1|||
25087953|NCT02699099|50196719|FG001|Overall Study|Adverse Event|0|||
25087954|NCT02699099|50196720|FG002|Overall Study|Adverse Event|2|||
25173007|NCT01372410|50314558|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
25087955|NCT02699099|50196718|FG000|Overall Study|Lost to Follow-up|0|||
25087956|NCT02699099|50196719|FG001|Overall Study|Lost to Follow-up|1|||
25087957|NCT02699099|50196720|FG002|Overall Study|Lost to Follow-up|0|||
25087958|NCT02699099|50196718|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
25087959|NCT02699099|50196719|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
25087960|NCT02699099|50196720|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
25087961|NCT04399551|50196730|FG000|Overall Study|Adverse Event|12|||
25173008|NCT01372410|50314559|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
25173009|NCT01372410|50314560|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
25173010|NCT01372410|50314561|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
25173011|NCT01372410|50314554|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
25173012|NCT01372410|50314555|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
25173013|NCT01372410|50314556|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
25173014|NCT01372410|50314557|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
25173015|NCT01372410|50314558|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
25173016|NCT01372410|50314559|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
25173017|NCT01372410|50314560|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
25173018|NCT01372410|50314561|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
25173019|NCT01372410|50314554|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
25173020|NCT01372410|50314555|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
25173021|NCT01372410|50314556|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
25173022|NCT01372410|50314557|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
25173023|NCT01372410|50314558|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
25173024|NCT01372410|50314559|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
25173025|NCT01372410|50314560|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
25173026|NCT01372410|50314561|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
25173027|NCT01372410|50314554|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
25173028|NCT01372410|50314555|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
25173029|NCT01372410|50314556|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
25173030|NCT01372410|50314557|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
25173031|NCT01372410|50314558|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
25173032|NCT01372410|50314559|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
25173033|NCT01372410|50314560|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
25173034|NCT01372410|50314561|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
25173035|NCT01372410|50314554|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
25173036|NCT01372410|50314555|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
25173037|NCT01372410|50314556|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
25173038|NCT01372410|50314557|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
25173039|NCT01372410|50314558|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
25173040|NCT01372410|50314559|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
25087962|NCT04399551|50196730|FG000|Overall Study|Withdrawal by Subject|6|||
25087963|NCT04399551|50196730|FG000|Overall Study|Physician Decision|3|||
25087964|NCT04399551|50196730|FG000|Overall Study|Lost to Follow-up|1|||
25087965|NCT04399551|50196730|FG000|Overall Study|Protocol Deviation|2|||
25087966|NCT04399551|50196730|FG000|Overall Study|Ongoing|100|||
25087967|NCT02698865|50196744|FG000|Overall Study|Other|11|||
25087968|NCT02698865|50196745|FG001|Overall Study|Other|11|||
25087969|NCT02698865|50196744|FG000|Overall Study|Withdrawal by Subject|20|||
25087970|NCT02698865|50196745|FG001|Overall Study|Withdrawal by Subject|16|||
25087971|NCT02698865|50196744|FG000|Overall Study|Physician Decision|0|||
25087972|NCT02698865|50196745|FG001|Overall Study|Physician Decision|4|||
25087973|NCT02698865|50196744|FG000|Overall Study|Lost to Follow-up|4|||
25087974|NCT02698865|50196745|FG001|Overall Study|Lost to Follow-up|2|||
25087975|NCT02698787|50196753|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
25087976|NCT02698787|50196754|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
25087977|NCT02698475|50196761|FG000|Main Study Period|Lack of Efficacy|1|||
25087978|NCT02698475|50196761|FG000|Main Study Period|Protocol Violation|2|||
25087979|NCT02698475|50196761|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
25087980|NCT02698475|50196761|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
25087981|NCT02698475|50196761|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
25087982|NCT02698475|50196761|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
25087983|NCT02698475|50196761|FG000|Long-Term Extension Period|Other|1|||
25087984|NCT02559687|50196768|FG000|Overall Study|Death|112|||
25087985|NCT02559687|50196768|FG000|Overall Study|Sponsor Decision|5|||
25087986|NCT02559687|50196768|FG000|Overall Study|Withdrawal by Subject|4|||
25087987|NCT04294719|50196782|FG000|Overall Study|Withdrawal by Subject|1|||
25087988|NCT02703311|50196790|FG000|Overall Study|Death|5|||
25087989|NCT02703311|50196790|FG000|Overall Study|Withdrawal by Subject|3|||
25087990|NCT02697617|50196794|FG000|Overall Study|Withdrawal by Subject|0|||
25087991|NCT02697617|50196795|FG001|Overall Study|Withdrawal by Subject|2|||
25087992|NCT02697617|50196794|FG000|Overall Study|Pregnancy|1|||
25087993|NCT02697617|50196795|FG001|Overall Study|Pregnancy|0|||
25087994|NCT02698241|50196805|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
25087995|NCT02698241|50196805|FG000|Overall Study|Screening not met|7|||
25087996|NCT02698241|50196805|FG000|Overall Study|Withdrawal by Subject|7|||
25087997|NCT02698241|50196805|FG000|Overall Study|Physician Decision|2|||
25087998|NCT02698241|50196805|FG000|Overall Study|Subject underwent system modification|2|||
25087999|NCT02698241|50196805|FG000|Overall Study|Lost to Follow-up|3|||
25088000|NCT02698241|50196805|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
25088001|NCT02698241|50196805|FG000|Overall Study|geographic and licensing issue|1|||
25173041|NCT01372410|50314560|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
25173042|NCT01372410|50314561|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
25173043|NCT01372410|50314554|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
25173044|NCT01372410|50314555|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
25173045|NCT01372410|50314556|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
25173046|NCT01372410|50314557|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
25173047|NCT01372410|50314558|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
25088002|NCT02698241|50196805|FG000|Overall Study|Death|2|||
25088003|NCT01663233|50196811|FG000|Overall Study|Withdrawal by Subject|3|||
25088004|NCT01663233|50196812|FG001|Overall Study|Withdrawal by Subject|2|||
25088005|NCT01663233|50196811|FG000|Overall Study|Protocol Deviation|1|||
25088006|NCT01663233|50196812|FG001|Overall Study|Protocol Deviation|4|||
25088007|NCT01663233|50196811|FG000|Overall Study|Lost to Follow-up|0|||
25088008|NCT01663233|50196812|FG001|Overall Study|Lost to Follow-up|1|||
25088009|NCT02556255|50196831|FG000|Overall Study|Lost to Follow-up|4|||
25088010|NCT02556801|50196839|FG000|Overall Study|Lost to Follow-up|1|||
25088011|NCT02556801|50196840|FG001|Overall Study|Lost to Follow-up|0|||
25088012|NCT02556801|50196841|FG002|Overall Study|Lost to Follow-up|2|||
25088013|NCT02556801|50196842|FG003|Overall Study|Lost to Follow-up|0|||
25088014|NCT02556801|50196839|FG000|Overall Study|Withdrawal by Subject|1|||
25088015|NCT02556801|50196840|FG001|Overall Study|Withdrawal by Subject|1|||
25088016|NCT02556801|50196841|FG002|Overall Study|Withdrawal by Subject|1|||
25088017|NCT02556801|50196842|FG003|Overall Study|Withdrawal by Subject|0|||
25088018|NCT02556801|50196839|FG000|Overall Study|Protocol Violation|0|||
25088019|NCT02556801|50196840|FG001|Overall Study|Protocol Violation|3|||
25088020|NCT02556801|50196841|FG002|Overall Study|Protocol Violation|1|||
25088021|NCT02556801|50196842|FG003|Overall Study|Protocol Violation|1|||
25088022|NCT02556801|50196839|FG000|Overall Study|Adverse Event|0|||
25088023|NCT02556801|50196840|FG001|Overall Study|Adverse Event|2|||
25088024|NCT02556801|50196841|FG002|Overall Study|Adverse Event|0|||
25088025|NCT02556801|50196842|FG003|Overall Study|Adverse Event|3|||
25088026|NCT02556801|50196839|FG000|Overall Study|Pregnancy|0|||
25088027|NCT02556801|50196840|FG001|Overall Study|Pregnancy|1|||
25088028|NCT02556801|50196841|FG002|Overall Study|Pregnancy|0|||
25088029|NCT02556801|50196842|FG003|Overall Study|Pregnancy|0|||
25088030|NCT02556801|50196839|FG000|Overall Study|Personal reasons patient|0|||
25088031|NCT02556801|50196840|FG001|Overall Study|Personal reasons patient|0|||
25088032|NCT02556801|50196841|FG002|Overall Study|Personal reasons patient|0|||
25088033|NCT02556801|50196842|FG003|Overall Study|Personal reasons patient|1|||
25088034|NCT02556177|50196854|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
25088035|NCT02556177|50196855|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
25088036|NCT02554929|50196863|FG000|Overall Study|Lost to Follow-up|4|||
25088037|NCT02554929|50196864|FG001|Overall Study|Lost to Follow-up|4|||
25088038|NCT02554929|50196863|FG000|Overall Study|Withdrawal by Subject|2|||
25088039|NCT02554929|50196864|FG001|Overall Study|Withdrawal by Subject|8|||
25088040|NCT03745989|50196882|FG000|Overall Study|Death|3|||
25088041|NCT03745989|50196883|FG001|Overall Study|Death|7|||
25088042|NCT03745989|50196884|FG002|Overall Study|Death|4|||
25088043|NCT03745989|50196882|FG000|Overall Study|Lost to Follow-up|0|||
25088044|NCT03745989|50196883|FG001|Overall Study|Lost to Follow-up|2|||
25088045|NCT03745989|50196884|FG002|Overall Study|Lost to Follow-up|0|||
25088046|NCT03745989|50196882|FG000|Overall Study|Sponsor Decision|0|||
25088047|NCT03745989|50196883|FG001|Overall Study|Sponsor Decision|2|||
25088048|NCT03745989|50196884|FG002|Overall Study|Sponsor Decision|8|||
25088049|NCT03745989|50196882|FG000|Overall Study|Withdrawal by Subject|0|||
25088050|NCT03745989|50196883|FG001|Overall Study|Withdrawal by Subject|1|||
25088051|NCT03745989|50196884|FG002|Overall Study|Withdrawal by Subject|3|||
25088052|NCT02697773|50196895|FG000|Overall Study|Adverse Event|2|||
25088053|NCT02697773|50196896|FG001|Overall Study|Adverse Event|1|||
25088054|NCT02697773|50196897|FG002|Overall Study|Adverse Event|2|||
25088055|NCT02697773|50196895|FG000|Overall Study|Death|0|||
25088056|NCT02697773|50196896|FG001|Overall Study|Death|0|||
25088057|NCT02697773|50196897|FG002|Overall Study|Death|2|||
25088058|NCT02697773|50196895|FG000|Overall Study|Lack of Efficacy|4|||
25088059|NCT02697773|50196896|FG001|Overall Study|Lack of Efficacy|6|||
25088060|NCT02697773|50196897|FG002|Overall Study|Lack of Efficacy|6|||
25088061|NCT02697773|50196895|FG000|Overall Study|Lost to Follow-up|5|||
25088062|NCT02697773|50196896|FG001|Overall Study|Lost to Follow-up|5|||
25088063|NCT02697773|50196897|FG002|Overall Study|Lost to Follow-up|7|||
25088064|NCT02697773|50196895|FG000|Overall Study|Other|15|||
25088065|NCT02697773|50196896|FG001|Overall Study|Other|11|||
25088066|NCT02697773|50196897|FG002|Overall Study|Other|10|||
25088067|NCT02697773|50196895|FG000|Overall Study|Protocol Violation|1|||
25088068|NCT02697773|50196896|FG001|Overall Study|Protocol Violation|1|||
25088069|NCT02697773|50196897|FG002|Overall Study|Protocol Violation|0|||
25088070|NCT02697773|50196895|FG000|Overall Study|Withdrawal by Subject|10|||
25088071|NCT02697773|50196896|FG001|Overall Study|Withdrawal by Subject|13|||
25088072|NCT02697773|50196897|FG002|Overall Study|Withdrawal by Subject|13|||
25088073|NCT02697773|50196895|FG000|Overall Study|Randomized but not treated|1|||
25088074|NCT02697773|50196896|FG001|Overall Study|Randomized but not treated|1|||
25173048|NCT01372410|50314559|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
25088075|NCT02697773|50196897|FG002|Overall Study|Randomized but not treated|0|||
25088076|NCT02693171|50196905|FG000|Overall Study|Adverse Event|1|||
25088077|NCT02693171|50196905|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
25088078|NCT02692703|50196909|FG000|Overall Study|Lost to Follow-up|1|||
25088079|NCT02692703|50196909|FG000|Overall Study|Other|1|||
25088080|NCT02692235|50196915|FG000|Overall Study|Withdrawal by Subject|2|||
25088081|NCT02692235|50196916|FG001|Overall Study|Withdrawal by Subject|1|||
25088082|NCT02692235|50196915|FG000|Overall Study|Adverse Event|1|||
25088083|NCT02692235|50196916|FG001|Overall Study|Adverse Event|2|||
25088084|NCT02552121|50196930|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
25088085|NCT02552121|50196931|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
25088086|NCT02552121|50196932|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
25088087|NCT02552121|50196933|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
25088088|NCT02552121|50196934|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
25088089|NCT02552121|50196935|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
25088090|NCT02552121|50196936|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
25088091|NCT02552121|50196937|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
25088092|NCT02552121|50196930|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
25088093|NCT02552121|50196931|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
25088094|NCT02552121|50196932|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
25088095|NCT02552121|50196933|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
25088096|NCT02552121|50196934|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
25088097|NCT02552121|50196935|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
25088098|NCT02552121|50196936|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
25088099|NCT02552121|50196937|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
25088100|NCT02552121|50196930|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
25088101|NCT02552121|50196931|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
25088102|NCT02552121|50196932|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
25088103|NCT02552121|50196933|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
25088104|NCT02552121|50196934|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
25088105|NCT02552121|50196935|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
25088106|NCT02552121|50196936|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
25088107|NCT02552121|50196937|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
25088108|NCT02552121|50196930|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
25088109|NCT02552121|50196931|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
25088110|NCT02552121|50196932|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
25088111|NCT02552121|50196933|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
25088112|NCT02552121|50196934|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
25088113|NCT02552121|50196935|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
25088114|NCT02552121|50196936|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
25088115|NCT02552121|50196937|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
25088116|NCT02552121|50196930|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
25088117|NCT02552121|50196931|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
25088118|NCT02552121|50196932|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
25088119|NCT02552121|50196933|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
25088120|NCT02552121|50196934|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
25088121|NCT02552121|50196935|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
25088122|NCT02552121|50196936|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
25088123|NCT02552121|50196937|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
25088124|NCT02552121|50196930|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
25088125|NCT02552121|50196931|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
25088126|NCT02552121|50196932|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
25088127|NCT02552121|50196933|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
25088128|NCT02552121|50196934|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
25088129|NCT02552121|50196935|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
25088130|NCT02552121|50196936|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
25088131|NCT02552121|50196937|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
25088132|NCT02552121|50196930|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
25088133|NCT02552121|50196931|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
25088134|NCT02552121|50196932|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
25088135|NCT02552121|50196933|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
25088136|NCT02552121|50196934|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
25173049|NCT01372410|50314560|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
25173050|NCT01372410|50314561|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
25173051|NCT01372410|50314554|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
25088137|NCT02552121|50196935|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
25088138|NCT02552121|50196936|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
25088139|NCT02552121|50196937|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
25088140|NCT02552121|50196930|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
25173052|NCT01372410|50314555|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
25088141|NCT02552121|50196931|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
25088142|NCT02552121|50196932|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
25088143|NCT02552121|50196933|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
25088144|NCT02552121|50196934|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
25088145|NCT02552121|50196935|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
25088146|NCT02552121|50196936|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
25088147|NCT02552121|50196937|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
25088148|NCT02552121|50196930|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
25088149|NCT02552121|50196931|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
25088150|NCT02552121|50196932|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
25088151|NCT02552121|50196933|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
25088152|NCT02552121|50196934|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
25088153|NCT02552121|50196935|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
25088154|NCT02552121|50196936|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
25088155|NCT02552121|50196937|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
25088156|NCT02552121|50196930|FG000|Part 2: Cohort Expansion|Death|0|||
25088157|NCT02552121|50196931|FG001|Part 2: Cohort Expansion|Death|0|||
25088158|NCT02552121|50196932|FG002|Part 2: Cohort Expansion|Death|1|||
25088159|NCT02552121|50196933|FG003|Part 2: Cohort Expansion|Death|0|||
25088160|NCT02552121|50196934|FG004|Part 2: Cohort Expansion|Death|0|||
25088161|NCT02552121|50196935|FG005|Part 2: Cohort Expansion|Death|0|||
25173053|NCT01372410|50314556|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
25088162|NCT02552121|50196936|FG006|Part 2: Cohort Expansion|Death|0|||
25088163|NCT02552121|50196937|FG007|Part 2: Cohort Expansion|Death|0|||
25088164|NCT02552355|50196982|FG000|Overall Study|Adverse Event|0|||
25088165|NCT02552355|50196983|FG001|Overall Study|Adverse Event|2|||
25088166|NCT02552355|50196984|FG002|Overall Study|Adverse Event|2|||
25088167|NCT02552355|50196985|FG003|Overall Study|Adverse Event|0|||
25088168|NCT02552355|50196982|FG000|Overall Study|Withdrawal by Subject|0|||
25088169|NCT02552355|50196983|FG001|Overall Study|Withdrawal by Subject|0|||
25088170|NCT02552355|50196984|FG002|Overall Study|Withdrawal by Subject|0|||
25088171|NCT02552355|50196985|FG003|Overall Study|Withdrawal by Subject|1|||
25088172|NCT02551731|50196995|FG000|Overall Study|Withdrawal by Subject|2|||
25088173|NCT02542605|50196999|FG000|Part B: Challenge Phase|Sponsor decision|1|||
25088174|NCT02542605|50197000|FG001|Part B: Challenge Phase|Sponsor decision|0|||
25088175|NCT02542605|50197001|FG002|Part B: Challenge Phase|Sponsor decision|0|||
25088176|NCT02542605|50196999|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
25088177|NCT02542605|50197000|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
25088178|NCT02542605|50197001|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
25088179|NCT02550873|50197012|FG000|Randomized Double Blind|Adverse Event|3|||
25088180|NCT02550873|50197013|FG001|Randomized Double Blind|Adverse Event|1|||
25088181|NCT02550873|50197014|FG002|Randomized Double Blind|Adverse Event|0|||
25088182|NCT02550873|50197012|FG000|Randomized Double Blind|Disease progression|1|||
25088183|NCT02550873|50197013|FG001|Randomized Double Blind|Disease progression|1|||
25088184|NCT02550873|50197014|FG002|Randomized Double Blind|Disease progression|0|||
25088185|NCT02550873|50197012|FG000|Open Label Extension|Study ongoing|0|||
25088186|NCT02550873|50197013|FG001|Open Label Extension|Study ongoing|0|||
25088187|NCT02550873|50197014|FG002|Open Label Extension|Study ongoing|111|||
25088188|NCT02535741|50197036|FG000|Overall Study|Adverse Event|3|||
25088189|NCT02535741|50197036|FG000|Overall Study|Withdrawal by Subject|9|||
25088190|NCT02535741|50197036|FG000|Overall Study|Lost to Follow-up|10|||
25088191|NCT02535741|50197036|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
25088192|NCT02535741|50197036|FG000|Overall Study|Missing data|6|||
25088193|NCT03299049|50197056|FG000|Overall Study|On-going|486|||
25088194|NCT03299049|50197057|FG001|Overall Study|On-going|481|||
25088195|NCT03299049|50197056|FG000|Overall Study|Withdrawal by Subject|6|||
25088196|NCT03299049|50197057|FG001|Overall Study|Withdrawal by Subject|21|||
25088197|NCT03299049|50197056|FG000|Overall Study|Physician Decision|5|||
25088198|NCT03299049|50197057|FG001|Overall Study|Physician Decision|1|||
25088199|NCT03299049|50197056|FG000|Overall Study|Lost to Follow-up|2|||
25088200|NCT03299049|50197057|FG001|Overall Study|Lost to Follow-up|0|||
25088201|NCT03299049|50197056|FG000|Overall Study|Pregnancy|1|||
25088202|NCT03299049|50197057|FG001|Overall Study|Pregnancy|3|||
25088203|NCT03299049|50197056|FG000|Overall Study|Protocol Violation|1|||
25088204|NCT03299049|50197057|FG001|Overall Study|Protocol Violation|1|||
25088205|NCT03299049|50197056|FG000|Overall Study|Lack of Efficacy|9|||
25088206|NCT03299049|50197057|FG001|Overall Study|Lack of Efficacy|3|||
25088207|NCT03299049|50197056|FG000|Overall Study|Adverse Event|12|||
25088208|NCT03299049|50197057|FG001|Overall Study|Adverse Event|13|||
25088209|NCT02550795|50197073|FG000|Overall Study|Physician Decision|0|||
25088210|NCT02550795|50197074|FG001|Overall Study|Physician Decision|1|||
25088211|NCT02550795|50197075|FG002|Overall Study|Physician Decision|0|||
25088212|NCT02541903|50197083|FG000|Overall Study|Death|1|||
25088213|NCT02541669|50197092|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
25088214|NCT02541669|50197093|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
25088215|NCT02541669|50197094|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
25088216|NCT02541669|50197095|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
25088217|NCT02541669|50197096|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
25088218|NCT02549859|50197107|FG000|Long-term 60 Hz DBS|Study Closed|1|||
25088219|NCT02688647|50197117|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
25088220|NCT02688647|50197118|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
25088221|NCT02688647|50197117|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
25088222|NCT02688647|50197118|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
25088223|NCT02688647|50197117|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
25088224|NCT02688647|50197118|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
25088225|NCT02688647|50197117|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
25088226|NCT02688647|50197118|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
25088227|NCT02688647|50197117|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
25088228|NCT02688647|50197118|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
25088229|NCT02688647|50197117|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
25088230|NCT02688647|50197118|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
25088231|NCT02688647|50197117|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
25088232|NCT02688647|50197118|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
25088233|NCT02687711|50197136|FG000|Overall Study|Adverse Event|89|||
25088234|NCT02687711|50197136|FG000|Overall Study|Lack of Efficacy|70|||
25088235|NCT02687711|50197136|FG000|Overall Study|Lost to Follow-up|20|||
25088236|NCT02687711|50197136|FG000|Overall Study|Consent withdrawn|15|||
25088237|NCT02687711|50197136|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
25088238|NCT02687711|50197136|FG000|Overall Study|Too expensive|4|||
25088239|NCT02687711|50197136|FG000|Overall Study|Participant moved abroad|1|||
25088240|NCT02687711|50197136|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
25088241|NCT02687711|50197136|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
25088242|NCT02687711|50197136|FG000|Overall Study|Disliked taste|1|||
25088243|NCT02687711|50197136|FG000|Overall Study|Low mood|1|||
25088244|NCT02687711|50197136|FG000|Overall Study|Side effects|1|||
25088245|NCT02687711|50197136|FG000|Overall Study|Change of Hospital|1|||
25088246|NCT02687711|50197136|FG000|Overall Study|Liver Encephalopathy|1|||
25088247|NCT02687711|50197136|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
25088248|NCT02687711|50197136|FG000|Overall Study|Withdrawn due to intake interruption|1|||
25088249|NCT02687711|50197136|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
25088250|NCT02687711|50197136|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
25088251|NCT02687711|50197136|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
25088252|NCT01662063|50197142|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
25088253|NCT01662063|50197143|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
25088254|NCT01662063|50197144|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
25088255|NCT01662063|50197142|FG000|Overall Study|Lack of Efficacy|1|||
25088256|NCT01662063|50197143|FG001|Overall Study|Lack of Efficacy|6|||
25088257|NCT01662063|50197144|FG002|Overall Study|Lack of Efficacy|0|||
25088258|NCT01662063|50197142|FG000|Overall Study|Lost to Follow-up|0|||
25088259|NCT01662063|50197143|FG001|Overall Study|Lost to Follow-up|4|||
25088260|NCT01662063|50197144|FG002|Overall Study|Lost to Follow-up|0|||
25088261|NCT01662063|50197142|FG000|Overall Study|Protocol Violation|1|||
25088262|NCT01662063|50197143|FG001|Overall Study|Protocol Violation|0|||
25088263|NCT01662063|50197144|FG002|Overall Study|Protocol Violation|0|||
25088264|NCT01662063|50197142|FG000|Overall Study|Withdrawal by Subject|2|||
25088265|NCT01662063|50197143|FG001|Overall Study|Withdrawal by Subject|4|||
25088266|NCT01662063|50197144|FG002|Overall Study|Withdrawal by Subject|1|||
25088267|NCT01662063|50197142|FG000|Overall Study|Physician Decision|0|||
25088268|NCT01662063|50197143|FG001|Overall Study|Physician Decision|2|||
25088269|NCT01662063|50197144|FG002|Overall Study|Physician Decision|0|||
25088270|NCT01662063|50197142|FG000|Overall Study|Other|0|||
25088271|NCT01662063|50197143|FG001|Overall Study|Other|1|||
25088272|NCT01662063|50197144|FG002|Overall Study|Other|0|||
25088273|NCT02548455|50197152|FG000|Overall Study|Withdrawal by Subject|27|||
25088274|NCT02548455|50197152|FG000|Overall Study|Death|26|||
25088275|NCT02548455|50197152|FG000|Overall Study|Lost to Follow-up|14|||
25088276|NCT02548455|50197152|FG000|Overall Study|Visit not completed|173|||
25088277|NCT02691455|50197158|FG000|Overall Study|Withdrawal by Subject|1|||
25088278|NCT02691455|50197159|FG001|Overall Study|Withdrawal by Subject|2|||
25088279|NCT02691455|50197158|FG000|Overall Study|Lost to Follow-up|15|||
25088280|NCT02691455|50197159|FG001|Overall Study|Lost to Follow-up|15|||
25088281|NCT02534883|50197167|FG000|Overall Study|Early Termination|8|||
25088282|NCT02534883|50197168|FG001|Overall Study|Early Termination|3|||
25088283|NCT02685995|50197176|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
25088284|NCT02685995|50197177|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
25088285|NCT02548143|50197185|FG000|Overall Study|Adverse Event|1|||
25088286|NCT02548143|50197186|FG001|Overall Study|Adverse Event|0|||
25088287|NCT02548143|50197185|FG000|Overall Study|Withdrawal by Subject|0|||
25088288|NCT02548143|50197186|FG001|Overall Study|Withdrawal by Subject|1|||
25088289|NCT02547441|50197194|FG000|Double-Blind Study Period|Adverse Event|4|||
25088290|NCT02547441|50197195|FG001|Double-Blind Study Period|Adverse Event|9|||
25088291|NCT02547441|50197194|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
25088292|NCT02547441|50197195|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
25088293|NCT02547441|50197194|FG000|Double-Blind Study Period|Physician Decision|1|||
25088294|NCT02547441|50197195|FG001|Double-Blind Study Period|Physician Decision|0|||
25088295|NCT02547441|50197194|FG000|Double-Blind Study Period|Protocol Violation|1|||
25088296|NCT02547441|50197195|FG001|Double-Blind Study Period|Protocol Violation|2|||
25088297|NCT02547441|50197194|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
25088298|NCT02547441|50197195|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
25088299|NCT02547441|50197194|FG000|Double-Blind Study Period|Sponsor Decision|1|||
25088300|NCT02547441|50197195|FG001|Double-Blind Study Period|Sponsor Decision|0|||
25088301|NCT02547441|50197194|FG000|Open-Label Study Period|Adverse Event|10|||
25088302|NCT02547441|50197195|FG001|Open-Label Study Period|Adverse Event|11|||
25088303|NCT02547441|50197194|FG000|Open-Label Study Period|Lack of Efficacy|3|||
25088304|NCT02547441|50197195|FG001|Open-Label Study Period|Lack of Efficacy|2|||
25088305|NCT02547441|50197194|FG000|Open-Label Study Period|Lost to Follow-up|7|||
25088306|NCT02547441|50197195|FG001|Open-Label Study Period|Lost to Follow-up|8|||
25088307|NCT02547441|50197194|FG000|Open-Label Study Period|Physician Decision|1|||
25088308|NCT02547441|50197195|FG001|Open-Label Study Period|Physician Decision|0|||
25088309|NCT02547441|50197194|FG000|Open-Label Study Period|Protocol Violation|2|||
25088310|NCT02547441|50197195|FG001|Open-Label Study Period|Protocol Violation|0|||
25088311|NCT02547441|50197194|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
25088312|NCT02547441|50197195|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
25088313|NCT02547441|50197194|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
25088314|NCT02547441|50197195|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
25088315|NCT02540265|50197205|FG000|Overall Study|Lost to Follow-up|0|||
25088316|NCT02540265|50197206|FG001|Overall Study|Lost to Follow-up|0|||
25088317|NCT02540265|50197207|FG002|Overall Study|Lost to Follow-up|1|||
25088318|NCT02547363|50197217|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
25088319|NCT02547363|50197218|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
25088320|NCT02547363|50197217|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
25088321|NCT02547363|50197218|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
25088322|NCT02547363|50197217|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
25088323|NCT02547363|50197218|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
25088324|NCT02547363|50197217|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
25088325|NCT02547363|50197218|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
25088326|NCT02547363|50197217|FG000|12-month Follow-up|Withdrawal by Subject|4|||
25088327|NCT02547363|50197218|FG001|12-month Follow-up|Withdrawal by Subject|3|||
25088328|NCT02547363|50197217|FG000|12-month Follow-up|Lost to Follow-up|4|||
25088329|NCT02547363|50197218|FG001|12-month Follow-up|Lost to Follow-up|1|||
25088330|NCT02547363|50197217|FG000|12-month Follow-up|Lack of Efficacy|1|||
25088331|NCT02547363|50197218|FG001|12-month Follow-up|Lack of Efficacy|1|||
25088332|NCT02547363|50197217|FG000|12-month Follow-up|Other|1|||
25088333|NCT02547363|50197218|FG001|12-month Follow-up|Other|0|||
25088334|NCT02539797|50197226|FG000|Overall Study|Lost to Follow-up|0|||
25088335|NCT02539797|50197227|FG001|Overall Study|Lost to Follow-up|1|||
25088336|NCT02539797|50197228|FG002|Overall Study|Lost to Follow-up|0|||
25088337|NCT02684357|50197239|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
25088338|NCT02684357|50197240|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
25088339|NCT02684357|50197241|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
25088340|NCT02684357|50197242|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
25088341|NCT02684357|50197243|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
25088342|NCT02684357|50197244|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
25088343|NCT02684357|50197239|FG000|Part A|Lost to Follow-up|0|||
25088344|NCT02684357|50197240|FG001|Part A|Lost to Follow-up|2|||
25088345|NCT02684357|50197241|FG002|Part A|Lost to Follow-up|2|||
25088346|NCT02684357|50197242|FG003|Part A|Lost to Follow-up|0|||
25088347|NCT02684357|50197243|FG004|Part A|Lost to Follow-up|0|||
25088348|NCT02684357|50197244|FG005|Part A|Lost to Follow-up|0|||
25088349|NCT02684357|50197239|FG000|Part A|Withdrawal by Subject|3|||
25088350|NCT02684357|50197240|FG001|Part A|Withdrawal by Subject|0|||
25088351|NCT02684357|50197241|FG002|Part A|Withdrawal by Subject|0|||
25088352|NCT02684357|50197242|FG003|Part A|Withdrawal by Subject|0|||
25088353|NCT02684357|50197243|FG004|Part A|Withdrawal by Subject|0|||
25088354|NCT02684357|50197244|FG005|Part A|Withdrawal by Subject|0|||
25088355|NCT02684357|50197239|FG000|Part A|Other|0|||
25088356|NCT02684357|50197240|FG001|Part A|Other|1|||
25088357|NCT02684357|50197241|FG002|Part A|Other|0|||
25088358|NCT02684357|50197242|FG003|Part A|Other|0|||
25088359|NCT02684357|50197243|FG004|Part A|Other|0|||
25088360|NCT02684357|50197244|FG005|Part A|Other|0|||
25088361|NCT02684357|50197239|FG000|Part B|Adverse Event (Other)|0|||
25088362|NCT02684357|50197240|FG001|Part B|Adverse Event (Other)|0|||
25088363|NCT02684357|50197241|FG002|Part B|Adverse Event (Other)|0|||
25088364|NCT02684357|50197242|FG003|Part B|Adverse Event (Other)|1|||
25088365|NCT02684357|50197243|FG004|Part B|Adverse Event (Other)|1|||
25088366|NCT02684357|50197244|FG005|Part B|Adverse Event (Other)|1|||
25088367|NCT02684357|50197239|FG000|Part B|Lost to Follow-up|0|||
25088368|NCT02684357|50197240|FG001|Part B|Lost to Follow-up|0|||
25088369|NCT02684357|50197241|FG002|Part B|Lost to Follow-up|0|||
25088370|NCT02684357|50197242|FG003|Part B|Lost to Follow-up|1|||
25088371|NCT02684357|50197243|FG004|Part B|Lost to Follow-up|1|||
25088372|NCT02684357|50197244|FG005|Part B|Lost to Follow-up|7|||
25088373|NCT02684357|50197239|FG000|Part B|Withdrawal by Subject|0|||
25088374|NCT02684357|50197240|FG001|Part B|Withdrawal by Subject|0|||
25088375|NCT02684357|50197241|FG002|Part B|Withdrawal by Subject|0|||
25088376|NCT02684357|50197242|FG003|Part B|Withdrawal by Subject|0|||
25088377|NCT02684357|50197243|FG004|Part B|Withdrawal by Subject|2|||
25088378|NCT02684357|50197244|FG005|Part B|Withdrawal by Subject|4|||
25088379|NCT02684357|50197239|FG000|Part B|Other|0|||
25088380|NCT02684357|50197240|FG001|Part B|Other|0|||
25088381|NCT02684357|50197241|FG002|Part B|Other|0|||
25088382|NCT02684357|50197242|FG003|Part B|Other|1|||
25088383|NCT02684357|50197243|FG004|Part B|Other|0|||
25088384|NCT02684357|50197244|FG005|Part B|Other|1|||
25088385|NCT02684279|50197257|FG000|Overall Study|Adverse Event|87|||
25088386|NCT02684279|50197257|FG000|Overall Study|Lack of Efficacy|4|||
25088387|NCT02684279|50197257|FG000|Overall Study|Lost to Follow-up|61|||
25088388|NCT02684279|50197257|FG000|Overall Study|Protocol Violation|6|||
25088389|NCT02684279|50197257|FG000|Overall Study|Pregnancy|8|||
25088390|NCT02684279|50197257|FG000|Overall Study|Withdrawal by Subject|92|||
25088391|NCT02684279|50197257|FG000|Overall Study|non-compliance with study drug|9|||
25088392|NCT02684279|50197257|FG000|Overall Study|non compliance with study visits|2|||
25088393|NCT02684279|50197257|FG000|Overall Study|subject to have surgery|1|||
25088394|NCT02684279|50197257|FG000|Overall Study|family emergency|1|||
25088395|NCT02684279|50197257|FG000|Overall Study|Site closures|7|||
25088396|NCT02684279|50197257|FG000|Overall Study|Physician Decision|1|||
25088397|NCT03206073|50197265|FG000|Overall Study|Participant Noncompliance|0|||
25088398|NCT03206073|50197266|FG001|Overall Study|Participant Noncompliance|1|||
25088399|NCT03206073|50197267|FG002|Overall Study|Participant Noncompliance|0|||
25088400|NCT03206073|50197268|FG003|Overall Study|Participant Noncompliance|0|||
25088401|NCT03206073|50197265|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
25088402|NCT03206073|50197266|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
25088403|NCT03206073|50197267|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
25088404|NCT03206073|50197268|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
25088405|NCT03206073|50197265|FG000|Overall Study|Death|0|||
25088406|NCT03206073|50197266|FG001|Overall Study|Death|0|||
25088407|NCT03206073|50197267|FG002|Overall Study|Death|1|||
25088408|NCT03206073|50197268|FG003|Overall Study|Death|0|||
25088409|NCT03206073|50197265|FG000|Overall Study|Taken off active treatment|0|||
25088410|NCT03206073|50197266|FG001|Overall Study|Taken off active treatment|0|||
25088411|NCT03206073|50197267|FG002|Overall Study|Taken off active treatment|3|||
25088412|NCT03206073|50197268|FG003|Overall Study|Taken off active treatment|0|||
25088413|NCT02534493|50197278|FG000|Overall Study|Lost to Follow-up|1|||
25088414|NCT02534493|50197278|FG000|Overall Study|Withdrawal by Subject|1|||
25088415|NCT02547129|50197286|FG000|Overall Study|Difficulty with ongoing infection|1|||
25088416|NCT02547129|50197287|FG001|Overall Study|Difficulty with ongoing infection|0|||
25088417|NCT02546193|50197295|FG000|Overall Study|Withdrawal by Subject|2|||
25088418|NCT02546193|50197296|FG001|Overall Study|Withdrawal by Subject|0|||
25088419|NCT02546193|50197297|FG002|Overall Study|Withdrawal by Subject|1|||
25173054|NCT01372410|50314557|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
25173055|NCT01372410|50314558|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
25173056|NCT01372410|50314559|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
25173057|NCT01372410|50314560|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
25173058|NCT01372410|50314561|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
25173059|NCT01372410|50314554|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
25088420|NCT02546193|50197298|FG003|Overall Study|Withdrawal by Subject|0|||
25088421|NCT02546193|50197295|FG000|Overall Study|Not eligible at time of induction|4|||
25088422|NCT02546193|50197296|FG001|Overall Study|Not eligible at time of induction|6|||
25088423|NCT02546193|50197297|FG002|Overall Study|Not eligible at time of induction|1|||
25088424|NCT02546193|50197298|FG003|Overall Study|Not eligible at time of induction|0|||
25088425|NCT02538471|50197304|FG000|Overall Study|Progression of disease|2|||
25088426|NCT01661595|50197312|FG000|Phase 1: Week 0-4|Adverse Event|1|||
25173060|NCT01372410|50314555|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
25088427|NCT01661595|50197313|FG001|Phase 1: Week 0-4|Adverse Event|0|||
25088428|NCT01661595|50197314|FG002|Phase 1: Week 0-4|Adverse Event|0|||
25088429|NCT01661595|50197315|FG003|Phase 1: Week 0-4|Adverse Event|0|||
25088430|NCT01661595|50197312|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
25088431|NCT01661595|50197313|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
25088432|NCT01661595|50197314|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
25088433|NCT01661595|50197315|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
25088434|NCT02213133|50197335|FG000|Overall Study|Participant discontinued study therapy|2|||
25088435|NCT02213133|50197336|FG001|Overall Study|Participant discontinued study therapy|0|||
25088436|NCT02213133|50197337|FG002|Overall Study|Participant discontinued study therapy|0|||
25088437|NCT02213133|50197335|FG000|Overall Study|Participant withdrew informed consent|2|||
25088438|NCT02213133|50197336|FG001|Overall Study|Participant withdrew informed consent|1|||
25173061|NCT01372410|50314556|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
25173062|NCT01372410|50314557|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
25173063|NCT01372410|50314558|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
25173064|NCT01372410|50314559|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
25173065|NCT01372410|50314560|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
25173066|NCT01372410|50314561|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
25173067|NCT01372410|50314554|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
25173068|NCT01372410|50314555|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
25173069|NCT01372410|50314556|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
25173070|NCT01372410|50314557|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
25088439|NCT02213133|50197337|FG002|Overall Study|Participant withdrew informed consent|2|||
25088440|NCT02213133|50197335|FG000|Overall Study|Disease progression|11|||
25088441|NCT02213133|50197336|FG001|Overall Study|Disease progression|2|||
25088442|NCT02213133|50197337|FG002|Overall Study|Disease progression|0|||
25088443|NCT02213133|50197335|FG000|Overall Study|Adverse Event (AE)|1|||
25088444|NCT02213133|50197336|FG001|Overall Study|Adverse Event (AE)|0|||
25088445|NCT02213133|50197337|FG002|Overall Study|Adverse Event (AE)|0|||
25088446|NCT02213133|50197335|FG000|Overall Study|Death|16|||
25088447|NCT02213133|50197336|FG001|Overall Study|Death|2|||
25088448|NCT02213133|50197337|FG002|Overall Study|Death|1|||
25088449|NCT02213133|50197335|FG000|Overall Study|Other|5|||
25088450|NCT02213133|50197336|FG001|Overall Study|Other|0|||
25088451|NCT02213133|50197337|FG002|Overall Study|Other|0|||
25088452|NCT02684981|50197349|FG000|Overall Study|Permanently discontinued the treatment|157|||
25088453|NCT02684981|50197350|FG001|Overall Study|Permanently discontinued the treatment|161|||
25088454|NCT02684981|50197351|FG002|Overall Study|Permanently discontinued the treatment|110|||
25088455|NCT02684981|50197349|FG000|Overall Study|Other|83|||
25088456|NCT02684981|50197350|FG001|Overall Study|Other|49|||
25088457|NCT02684981|50197351|FG002|Overall Study|Other|17|||
25088458|NCT02146833|50197365|FG000|Overall Study|Death|10|||
25088459|NCT02146833|50197365|FG000|Overall Study|No longer consented to study treatment|1|||
25088460|NCT02690207|50197369|FG000|Overall Study|Lost to Follow-up|48|||
25088461|NCT02690207|50197369|FG000|Overall Study|Withdrawal by Subject|46|||
25088462|NCT02690207|50197369|FG000|Overall Study|Protocol Violation|2|||
25088463|NCT02690207|50197369|FG000|Overall Study|Serious adverse event|110|||
25088464|NCT02690207|50197369|FG000|Overall Study|Non-serious Adverse Event|18|||
25088465|NCT02690207|50197369|FG000|Overall Study|Migrated/moved from study area|5|||
25088466|NCT02690207|50197369|FG000|Overall Study|Suspected HZ Episode|1|||
25088467|NCT02690207|50197369|FG000|Overall Study|Other reasons for withdrawal|23|||
25088468|NCT02689349|50197375|FG000|Overall Study|Not implanted|4|||
25088469|NCT02689349|50197376|FG001|Overall Study|Not implanted|0|||
25088470|NCT02689349|50197375|FG000|Overall Study|Withdrawal by Subject|9|||
25088471|NCT02689349|50197376|FG001|Overall Study|Withdrawal by Subject|0|||
25088472|NCT02679287|50197387|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
25088473|NCT02679287|50197388|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
25088474|NCT02679287|50197387|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
25088475|NCT02679287|50197388|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
25088476|NCT02679287|50197387|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
25088477|NCT02679287|50197388|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
25088478|NCT02679287|50197387|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
25088479|NCT02679287|50197388|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
25088480|NCT02679287|50197387|FG000|Period 2|Work/Scheduling Conflict|1|||
25088481|NCT02679287|50197388|FG001|Period 2|Work/Scheduling Conflict|0|||
25088482|NCT02679287|50197387|FG000|Period 2|Disliked Mobile System|2|||
25088483|NCT02679287|50197388|FG001|Period 2|Disliked Mobile System|0|||
25088484|NCT02679287|50197387|FG000|Period 3|Work/Scheduling Conflict|0|||
25088485|NCT02679287|50197388|FG001|Period 3|Work/Scheduling Conflict|1|||
25088486|NCT02544633|50197404|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
25088487|NCT02544633|50197405|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
25088488|NCT02544633|50197406|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
25088489|NCT02544633|50197407|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
25088490|NCT02544633|50197404|FG000|Treatment Period|Adverse Event|7|||
25088491|NCT02544633|50197405|FG001|Treatment Period|Adverse Event|4|||
25088492|NCT02544633|50197406|FG002|Treatment Period|Adverse Event|0|||
25088493|NCT02544633|50197407|FG003|Treatment Period|Adverse Event|5|||
25088494|NCT02544633|50197404|FG000|Treatment Period|Lack of Efficacy|17|||
25088495|NCT02544633|50197405|FG001|Treatment Period|Lack of Efficacy|11|||
25088496|NCT02544633|50197406|FG002|Treatment Period|Lack of Efficacy|5|||
25088497|NCT02544633|50197407|FG003|Treatment Period|Lack of Efficacy|5|||
25088498|NCT02544633|50197404|FG000|Treatment Period|Global Deterioration of Health|3|||
25088499|NCT02544633|50197405|FG001|Treatment Period|Global Deterioration of Health|3|||
25088500|NCT02544633|50197406|FG002|Treatment Period|Global Deterioration of Health|0|||
25088501|NCT02544633|50197407|FG003|Treatment Period|Global Deterioration of Health|1|||
25088502|NCT02544633|50197404|FG000|Treatment Period|Withdrawal by Subject|1|||
25088503|NCT02544633|50197405|FG001|Treatment Period|Withdrawal by Subject|0|||
25088504|NCT02544633|50197406|FG002|Treatment Period|Withdrawal by Subject|0|||
25088505|NCT02544633|50197407|FG003|Treatment Period|Withdrawal by Subject|0|||
25088506|NCT02544633|50197404|FG000|Treatment Period|Lost to Follow-up|0|||
25088507|NCT02544633|50197405|FG001|Treatment Period|Lost to Follow-up|1|||
25088508|NCT02544633|50197406|FG002|Treatment Period|Lost to Follow-up|0|||
25088509|NCT02544633|50197407|FG003|Treatment Period|Lost to Follow-up|0|||
25088510|NCT02544633|50197404|FG000|Treatment Period|Death|0|||
25088511|NCT02544633|50197405|FG001|Treatment Period|Death|0|||
25088512|NCT02544633|50197406|FG002|Treatment Period|Death|1|||
25088513|NCT02544633|50197407|FG003|Treatment Period|Death|0|||
25088514|NCT02544633|50197404|FG000|Treatment Period|Non-compliance|0|||
25088515|NCT02544633|50197405|FG001|Treatment Period|Non-compliance|0|||
25088516|NCT02544633|50197406|FG002|Treatment Period|Non-compliance|1|||
25088517|NCT02544633|50197407|FG003|Treatment Period|Non-compliance|0|||
25088518|NCT02544633|50197404|FG000|Treatment Period|Clinical Disease Progression|0|||
25088519|NCT02544633|50197405|FG001|Treatment Period|Clinical Disease Progression|0|||
25088520|NCT02544633|50197406|FG002|Treatment Period|Clinical Disease Progression|0|||
25088521|NCT02544633|50197407|FG003|Treatment Period|Clinical Disease Progression|1|||
25088522|NCT02544633|50197404|FG000|Survival Follow-up Period|Death|12|||
25088523|NCT02544633|50197405|FG001|Survival Follow-up Period|Death|14|||
25088524|NCT02544633|50197406|FG002|Survival Follow-up Period|Death|3|||
25088525|NCT02544633|50197407|FG003|Survival Follow-up Period|Death|9|||
25088526|NCT02544633|50197404|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
25088527|NCT02544633|50197405|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
25088528|NCT02544633|50197406|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
25088529|NCT02544633|50197407|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
25088530|NCT02544633|50197404|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
25088531|NCT02544633|50197405|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
25088532|NCT02544633|50197406|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
25088533|NCT02544633|50197407|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
25088534|NCT02544633|50197404|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
25088535|NCT02544633|50197405|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
25088536|NCT02544633|50197406|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
25088537|NCT02544633|50197407|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
25088538|NCT02678351|50197429|FG000|Overall Study|Withdrawal by Subject|1|||
25088539|NCT02683187|50197433|FG000|Overall Study|Failed IV access|3|||
25088540|NCT02683187|50197433|FG000|Overall Study|Withdrawal by Subject|5|||
25088541|NCT02683109|50197443|FG000|Overall Study|Adverse Event|1|||
25088542|NCT02683109|50197444|FG001|Overall Study|Adverse Event|0|||
25088543|NCT02544321|50197453|FG000|Overall Study|Withdrawal by Subject|1|||
25088544|NCT02544321|50197454|FG001|Overall Study|Withdrawal by Subject|2|||
25088545|NCT02544321|50197453|FG000|Overall Study|Adverse Event|1|||
25088546|NCT02544321|50197454|FG001|Overall Study|Adverse Event|1|||
25088547|NCT02544321|50197453|FG000|Overall Study|Protocol Violation|0|||
25088548|NCT02544321|50197454|FG001|Overall Study|Protocol Violation|1|||
25088549|NCT02533401|50197469|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
25088550|NCT02533401|50197469|FG000|Overall Study|Death|5|||
25088551|NCT02533401|50197469|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
25088552|NCT02533401|50197469|FG000|Overall Study|Lost to Follow-up|1|||
25088553|NCT02533401|50197469|FG000|Overall Study|Violation of Selection Criteria|1|||
25088554|NCT02536833|50197477|FG000|Overall Study|Discontinued Before Treatment|0|||
25088555|NCT02536833|50197478|FG001|Overall Study|Discontinued Before Treatment|0|||
25088556|NCT02536833|50197479|FG002|Overall Study|Discontinued Before Treatment|1|||
25088557|NCT02536833|50197480|FG003|Overall Study|Discontinued Before Treatment|2|||
25088558|NCT02536833|50197477|FG000|Overall Study|Adverse Event|1|||
25088559|NCT02536833|50197478|FG001|Overall Study|Adverse Event|3|||
25088560|NCT02536833|50197479|FG002|Overall Study|Adverse Event|4|||
25088561|NCT02536833|50197480|FG003|Overall Study|Adverse Event|1|||
25088562|NCT02536833|50197477|FG000|Overall Study|Lost to Follow-up|2|||
25088563|NCT02536833|50197478|FG001|Overall Study|Lost to Follow-up|1|||
25088564|NCT02536833|50197479|FG002|Overall Study|Lost to Follow-up|2|||
25088565|NCT02536833|50197480|FG003|Overall Study|Lost to Follow-up|2|||
25088566|NCT02536833|50197477|FG000|Overall Study|Physician Decision|0|||
25088567|NCT02536833|50197478|FG001|Overall Study|Physician Decision|0|||
25088568|NCT02536833|50197479|FG002|Overall Study|Physician Decision|0|||
25088569|NCT02536833|50197480|FG003|Overall Study|Physician Decision|1|||
25088570|NCT02536833|50197477|FG000|Overall Study|Site Terminated by Sponsor|2|||
25088571|NCT02536833|50197478|FG001|Overall Study|Site Terminated by Sponsor|2|||
25088572|NCT02536833|50197479|FG002|Overall Study|Site Terminated by Sponsor|2|||
25088573|NCT02536833|50197480|FG003|Overall Study|Site Terminated by Sponsor|2|||
25088574|NCT02536833|50197477|FG000|Overall Study|Subject Non-Compliance|0|||
25088575|NCT02536833|50197478|FG001|Overall Study|Subject Non-Compliance|1|||
25088576|NCT02536833|50197479|FG002|Overall Study|Subject Non-Compliance|1|||
25088577|NCT02536833|50197480|FG003|Overall Study|Subject Non-Compliance|0|||
25088578|NCT02536833|50197477|FG000|Overall Study|Withdrawal by Subject|4|||
25088579|NCT02536833|50197478|FG001|Overall Study|Withdrawal by Subject|3|||
25088580|NCT02536833|50197479|FG002|Overall Study|Withdrawal by Subject|5|||
25088581|NCT02536833|50197480|FG003|Overall Study|Withdrawal by Subject|11|||
25088582|NCT02680847|50197494|FG000|Overall Study|Other|2|||
25088583|NCT02680847|50197495|FG001|Overall Study|Other|0|||
25088584|NCT02680847|50197496|FG002|Overall Study|Other|0|||
25088585|NCT02680847|50197494|FG000|Overall Study|No longer met eligibility criteria|2|||
25088586|NCT02680847|50197495|FG001|Overall Study|No longer met eligibility criteria|2|||
25088587|NCT02680847|50197496|FG002|Overall Study|No longer met eligibility criteria|0|||
25088588|NCT02680847|50197494|FG000|Overall Study|Unwilling to participate in study|1|||
25088589|NCT02680847|50197495|FG001|Overall Study|Unwilling to participate in study|1|||
25088590|NCT02680847|50197496|FG002|Overall Study|Unwilling to participate in study|0|||
25088591|NCT02680847|50197494|FG000|Overall Study|Lack of Efficacy|0|||
25088592|NCT02680847|50197495|FG001|Overall Study|Lack of Efficacy|0|||
25088593|NCT02680847|50197496|FG002|Overall Study|Lack of Efficacy|2|||
25088594|NCT02680847|50197494|FG000|Overall Study|Adverse Event|0|||
25088595|NCT02680847|50197495|FG001|Overall Study|Adverse Event|0|||
25088596|NCT02680847|50197496|FG002|Overall Study|Adverse Event|1|||
25088597|NCT02532855|50197506|FG000|Overall Study|Lost to Follow-up|4|||
25088598|NCT02532855|50197507|FG001|Overall Study|Lost to Follow-up|3|||
25088599|NCT02532855|50197506|FG000|Overall Study|Withdrawal by Subject|4|||
25088600|NCT02532855|50197507|FG001|Overall Study|Withdrawal by Subject|8|||
25088601|NCT02530125|50197513|FG000|Completed Treatment|Early termination of study|1|||
25088602|NCT02530125|50197513|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
25088603|NCT01661205|50197517|FG000|Overall Study|Physician Decision|2|||
25088604|NCT02055820|50197531|FG000|Phase I: Dose-Finding|Death|1|||
25088605|NCT02055820|50197532|FG001|Phase I: Dose-Finding|Death|0|||
25173071|NCT01372410|50314558|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
25173072|NCT01372410|50314559|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
25173073|NCT01372410|50314560|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
25173074|NCT01372410|50314561|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
25173075|NCT01372410|50314554|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
25173076|NCT01372410|50314555|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
25173077|NCT01372410|50314556|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
25173078|NCT01372410|50314557|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
25173079|NCT01372410|50314558|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
25173080|NCT01372410|50314559|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
25173081|NCT01372410|50314560|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
25088606|NCT02055820|50197533|FG002|Phase I: Dose-Finding|Death|1|||
25088607|NCT02055820|50197534|FG003|Phase I: Dose-Finding|Death|2|||
25088608|NCT02055820|50197535|FG004|Phase I: Dose-Finding|Death|0|||
25088609|NCT02055820|50197536|FG005|Phase I: Dose-Finding|Death|1|||
25088610|NCT02055820|50197537|FG006|Phase I: Dose-Finding|Death|1|||
25088611|NCT02055820|50197538|FG007|Phase I: Dose-Finding|Death|0|||
25088612|NCT02055820|50197539|FG008|Phase I: Dose-Finding|Death|0|||
25088613|NCT02055820|50197540|FG009|Phase I: Dose-Finding|Death|0|||
25088614|NCT02055820|50197531|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
25088615|NCT02055820|50197532|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
25088616|NCT02055820|50197533|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
25088617|NCT02055820|50197534|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
25088618|NCT02055820|50197535|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
25088619|NCT02055820|50197536|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
25088620|NCT02055820|50197537|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
25088621|NCT02055820|50197538|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
25088622|NCT02055820|50197539|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
25088623|NCT02055820|50197540|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
25088624|NCT02055820|50197531|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
25173082|NCT01372410|50314561|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
25088625|NCT02055820|50197532|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
25088626|NCT02055820|50197533|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
25088627|NCT02055820|50197534|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
25088628|NCT02055820|50197535|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
25088629|NCT02055820|50197536|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
25088630|NCT02055820|50197537|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
25088631|NCT02055820|50197538|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
25173083|NCT04624672|50314582|FG000|Overall Study|Early Study Closure|2|||
25088632|NCT02055820|50197539|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
25088633|NCT02055820|50197540|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
25088634|NCT02055820|50197531|FG000|Phase II: Expansion|Death|0|||
25088635|NCT02055820|50197532|FG001|Phase II: Expansion|Death|0|||
25088636|NCT02055820|50197533|FG002|Phase II: Expansion|Death|0|||
25088637|NCT02055820|50197534|FG003|Phase II: Expansion|Death|0|||
25088638|NCT02055820|50197535|FG004|Phase II: Expansion|Death|33|||
25088639|NCT02055820|50197536|FG005|Phase II: Expansion|Death|0|||
25088640|NCT02055820|50197537|FG006|Phase II: Expansion|Death|0|||
25088641|NCT02055820|50197538|FG007|Phase II: Expansion|Death|0|||
25088642|NCT02055820|50197539|FG008|Phase II: Expansion|Death|0|||
25088643|NCT02055820|50197540|FG009|Phase II: Expansion|Death|0|||
25088644|NCT02055820|50197531|FG000|Phase II: Expansion|Lost to Follow-up|0|||
25088645|NCT02055820|50197532|FG001|Phase II: Expansion|Lost to Follow-up|0|||
25088646|NCT02055820|50197533|FG002|Phase II: Expansion|Lost to Follow-up|0|||
25173084|NCT04624672|50314583|FG001|Overall Study|Early Study Closure|1|||
25173085|NCT03795922|50314607|FG000|Overall Study|Adverse Event|2|||
25173086|NCT03795922|50314608|FG001|Overall Study|Adverse Event|1|||
25173087|NCT03795922|50314607|FG000|Overall Study|Withdrawal by Subject|5|||
25088647|NCT02055820|50197534|FG003|Phase II: Expansion|Lost to Follow-up|0|||
25088648|NCT02055820|50197535|FG004|Phase II: Expansion|Lost to Follow-up|4|||
25088649|NCT02055820|50197536|FG005|Phase II: Expansion|Lost to Follow-up|0|||
25088650|NCT02055820|50197537|FG006|Phase II: Expansion|Lost to Follow-up|0|||
25088651|NCT02055820|50197538|FG007|Phase II: Expansion|Lost to Follow-up|0|||
25088652|NCT02055820|50197539|FG008|Phase II: Expansion|Lost to Follow-up|0|||
25088653|NCT02055820|50197540|FG009|Phase II: Expansion|Lost to Follow-up|0|||
25088654|NCT02055820|50197531|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
25088655|NCT02055820|50197532|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
25088656|NCT02055820|50197533|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
25088657|NCT02055820|50197534|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
25088658|NCT02055820|50197535|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
25088659|NCT02055820|50197536|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
25088660|NCT02055820|50197537|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
25088661|NCT02055820|50197538|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
25088662|NCT02055820|50197539|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
25088663|NCT02055820|50197540|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
25088664|NCT02055352|50197584|FG000|Overall Study|Adverse Event|0|||
25088665|NCT02055352|50197585|FG001|Overall Study|Adverse Event|1|||
25088666|NCT02055352|50197584|FG000|Overall Study|Non-eligible|0|||
25088667|NCT02055352|50197585|FG001|Overall Study|Non-eligible|1|||
25088668|NCT02055352|50197584|FG000|Overall Study|Poor compliance|1|||
25088669|NCT02055352|50197585|FG001|Overall Study|Poor compliance|1|||
25088670|NCT02055352|50197584|FG000|Overall Study|Death|1|||
25173088|NCT03795922|50314608|FG001|Overall Study|Withdrawal by Subject|13|||
25173089|NCT03795922|50314607|FG000|Overall Study|Lost to Follow-up|2|||
25173090|NCT03795922|50314608|FG001|Overall Study|Lost to Follow-up|3|||
25173091|NCT03795922|50314607|FG000|Overall Study|Pregnancy|0|||
25173092|NCT03795922|50314608|FG001|Overall Study|Pregnancy|1|||
25173093|NCT03795922|50314607|FG000|Overall Study|Physician Decision|1|||
25173094|NCT03795922|50314608|FG001|Overall Study|Physician Decision|2|||
25173095|NCT03795922|50314607|FG000|Overall Study|Protocol Violation|0|||
25173096|NCT03795922|50314608|FG001|Overall Study|Protocol Violation|1|||
25173097|NCT03795922|50314607|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
25173098|NCT03795922|50314608|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
25173099|NCT01704287|50314619|FG000|Initial Treatment Period|Death|139|||
25173100|NCT01704287|50314620|FG001|Initial Treatment Period|Death|129|||
25173101|NCT01704287|50314621|FG002|Initial Treatment Period|Death|71|||
25173102|NCT01704287|50314622|FG003|Initial Treatment Period|Death|0|||
25173103|NCT01704287|50314623|FG004|Initial Treatment Period|Death|0|||
25173104|NCT01704287|50314619|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
25173105|NCT01704287|50314620|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
25173106|NCT01704287|50314621|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
25173107|NCT01704287|50314622|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
25173108|NCT01704287|50314623|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
25173109|NCT01704287|50314619|FG000|Initial Treatment Period|Lost to Follow-up|5|||
25173110|NCT01704287|50314620|FG001|Initial Treatment Period|Lost to Follow-up|3|||
25173111|NCT01704287|50314621|FG002|Initial Treatment Period|Lost to Follow-up|0|||
25173112|NCT01704287|50314622|FG003|Initial Treatment Period|Lost to Follow-up|0|||
25173113|NCT01704287|50314623|FG004|Initial Treatment Period|Lost to Follow-up|0|||
25088671|NCT02055352|50197585|FG001|Overall Study|Death|2|||
25088672|NCT02055352|50197584|FG000|Overall Study|Patient decision|1|||
25088673|NCT02055352|50197585|FG001|Overall Study|Patient decision|1|||
25088674|NCT02055352|50197584|FG000|Overall Study|Use of prohibited treatment|0|||
25088675|NCT02055352|50197585|FG001|Overall Study|Use of prohibited treatment|3|||
25088676|NCT02055352|50197584|FG000|Overall Study|AE, study drug would be detrimental|1|||
25088677|NCT02055352|50197585|FG001|Overall Study|AE, study drug would be detrimental|3|||
25173114|NCT01704287|50314619|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
25173115|NCT01704287|50314620|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
25173116|NCT01704287|50314621|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
25173117|NCT01704287|50314622|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
25173118|NCT01704287|50314623|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
25173119|NCT01704287|50314619|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
25173120|NCT01704287|50314620|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
25173121|NCT01704287|50314621|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
25173122|NCT01704287|50314622|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
25173123|NCT01704287|50314623|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
25173124|NCT01704287|50314619|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
25173125|NCT01704287|50314620|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
25173126|NCT01704287|50314621|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
25173127|NCT01704287|50314622|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
25173128|NCT01704287|50314623|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
25173129|NCT01704287|50314619|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
25173130|NCT01704287|50314620|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
25173131|NCT01704287|50314621|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
25173132|NCT01704287|50314622|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
25173133|NCT01704287|50314623|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
25173134|NCT01682837|50314651|FG000|Baseline|Withdrawal by Subject|5|||
25173135|NCT01703819|50314688|FG000|Overall Study|Adverse Event|0|||
25173136|NCT01703819|50314689|FG001|Overall Study|Adverse Event|1|||
25173137|NCT01703819|50314688|FG000|Overall Study|Withdrawal by Subject|0|||
25173138|NCT01703819|50314689|FG001|Overall Study|Withdrawal by Subject|1|||
25173139|NCT01682759|50314701|FG000|Overall Study|Death|2|||
25173140|NCT01682759|50314702|FG001|Overall Study|Death|1|||
25173141|NCT01682759|50314701|FG000|Overall Study|Lost to Follow-up|10|||
25173142|NCT01682759|50314702|FG001|Overall Study|Lost to Follow-up|13|||
25173143|NCT01682759|50314701|FG000|Overall Study|Physician Decision|1|||
25173144|NCT01682759|50314702|FG001|Overall Study|Physician Decision|1|||
25173145|NCT01682759|50314701|FG000|Overall Study|Withdrawal by Subject|56|||
25173146|NCT01682759|50314702|FG001|Overall Study|Withdrawal by Subject|55|||
25173147|NCT01682681|50314712|FG000|Overall Study|Lack of Efficacy|62|||
25173148|NCT01682681|50314712|FG000|Overall Study|Withdrawal by Subject|1|||
25173149|NCT01682681|50314712|FG000|Overall Study|Moved to other hospital|10|||
25173150|NCT01682681|50314712|FG000|Overall Study|Lost to Follow-up|174|||
25173151|NCT01682681|50314712|FG000|Overall Study|Adverse Event|46|||
25173152|NCT01682681|50314712|FG000|Overall Study|tapering of topiramate|5|||
25173153|NCT01682681|50314712|FG000|Overall Study|Other|21|||
25173154|NCT01682681|50314712|FG000|Overall Study|Low compliance|13|||
25173155|NCT01682603|50314716|FG000|Overall Study|Lost to Follow-up|3|||
25173156|NCT01682213|50314732|FG000|Overall Study|Withdrawal by Subject|2|||
25173157|NCT01703741|50314741|FG000|Overall Study|Withdrawal by Subject|6|||
25173158|NCT01703741|50314741|FG000|Overall Study|Adverse Event|2|||
25173159|NCT01703741|50314741|FG000|Overall Study|Physician Decision|2|||
25173160|NCT01703741|50314741|FG000|Overall Study|Protocol Violation|1|||
25173161|NCT01703741|50314741|FG000|Overall Study|Lost to Follow-up|3|||
25173162|NCT01703741|50314741|FG000|Overall Study|Subject did not want to continue|2|||
25173163|NCT01703741|50314741|FG000|Overall Study|Subject cannot comply with study visits|1|||
25173164|NCT01703741|50314741|FG000|Overall Study|Subject started testosterone injections|1|||
25173165|NCT01681511|50314747|FG000|Overall Study|No Treatment Received|1|||
25173166|NCT01681511|50314748|FG001|Overall Study|No Treatment Received|3|||
25173167|NCT01681511|50314747|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
25173168|NCT01681511|50314748|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
25173169|NCT01681511|50314747|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
25173170|NCT01681511|50314748|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
25173171|NCT01681511|50314747|FG000|Overall Study|No Daily Urine Sample Collected|0|||
25173172|NCT01681511|50314748|FG001|Overall Study|No Daily Urine Sample Collected|1|||
25173173|NCT01681511|50314747|FG000|Overall Study|No post-catheter sample collected|11|||
25173174|NCT01681511|50314748|FG001|Overall Study|No post-catheter sample collected|4|||
25173175|NCT02175004|50314756|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
25173176|NCT02175004|50314757|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
25173177|NCT02175004|50314756|FG000|Overall Study|Investigator Judgment|1|||
25173178|NCT02175004|50314757|FG001|Overall Study|Investigator Judgment|4|||
25173179|NCT02175004|50314756|FG000|Overall Study|Voluntary Withdrawal|6|||
25173180|NCT02175004|50314757|FG001|Overall Study|Voluntary Withdrawal|19|||
25173181|NCT02175004|50314756|FG000|Overall Study|Liver Transplant|1|||
25173182|NCT02175004|50314757|FG001|Overall Study|Liver Transplant|0|||
25173183|NCT02175004|50314756|FG000|Overall Study|Disease Progression|1|||
25173184|NCT02175004|50314757|FG001|Overall Study|Disease Progression|0|||
25173185|NCT02175004|50314756|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
25173186|NCT02175004|50314757|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
25173187|NCT01681433|50314765|FG000|Overall Study|Lack of Efficacy|23|||
25173188|NCT01681433|50314766|FG001|Overall Study|Lack of Efficacy|23|||
25173189|NCT01681433|50314765|FG000|Overall Study|Withdrawal by Subject|5|||
25088678|NCT02055352|50197584|FG000|Overall Study|Withdrawal of informed consent|1|||
25088679|NCT02055352|50197585|FG001|Overall Study|Withdrawal of informed consent|0|||
25088680|NCT02055352|50197584|FG000|Overall Study|Reason unknown|1|||
25088681|NCT02055352|50197585|FG001|Overall Study|Reason unknown|5|||
25088682|NCT02034916|50197593|FG000|Overall Study|Death|39|||
25088683|NCT02034916|50197594|FG001|Overall Study|Death|28|||
25088684|NCT02034916|50197593|FG000|Overall Study|Withdrawal by Subject|2|||
25088685|NCT02034916|50197594|FG001|Overall Study|Withdrawal by Subject|1|||
25088686|NCT02034916|50197593|FG000|Overall Study|Lost to Follow-up|4|||
25088687|NCT02034916|50197594|FG001|Overall Study|Lost to Follow-up|1|||
25088688|NCT02034916|50197593|FG000|Overall Study|Study terminated by sponsor|4|||
25088689|NCT02034916|50197594|FG001|Overall Study|Study terminated by sponsor|5|||
25088690|NCT01374425|50197603|FG000|Overall Study|Radiographic Disease Progression|86|||
25088691|NCT01374425|50197604|FG001|Overall Study|Radiographic Disease Progression|81|||
25088692|NCT01374425|50197603|FG000|Overall Study|Clinical Disease Progression|9|||
25088693|NCT01374425|50197604|FG001|Overall Study|Clinical Disease Progression|6|||
25088694|NCT01374425|50197603|FG000|Overall Study|Adverse Event|29|||
25088695|NCT01374425|50197604|FG001|Overall Study|Adverse Event|18|||
25088696|NCT01374425|50197603|FG000|Overall Study|Death (Progression of Disease)|1|||
25088697|NCT01374425|50197604|FG001|Overall Study|Death (Progression of Disease)|0|||
25088698|NCT01374425|50197603|FG000|Overall Study|Death (Adverse Event)|2|||
25088699|NCT01374425|50197604|FG001|Overall Study|Death (Adverse Event)|4|||
25088700|NCT01374425|50197603|FG000|Overall Study|Withdrawal by Subject|6|||
25088701|NCT01374425|50197604|FG001|Overall Study|Withdrawal by Subject|7|||
25088702|NCT01374425|50197603|FG000|Overall Study|Refused Treatment|10|||
25088703|NCT01374425|50197604|FG001|Overall Study|Refused Treatment|24|||
25088704|NCT01374425|50197603|FG000|Overall Study|Protocol Violation|2|||
25088705|NCT01374425|50197604|FG001|Overall Study|Protocol Violation|3|||
25088706|NCT01374425|50197603|FG000|Overall Study|Sponsor Decision|0|||
25088707|NCT01374425|50197604|FG001|Overall Study|Sponsor Decision|1|||
25088708|NCT01374425|50197603|FG000|Overall Study|Lost to Follow-up|2|||
25088709|NCT01374425|50197604|FG001|Overall Study|Lost to Follow-up|1|||
25088710|NCT01374425|50197603|FG000|Overall Study|Other|41|||
25088711|NCT01374425|50197604|FG001|Overall Study|Other|43|||
25088712|NCT02085460|50197634|FG000|Overall Study|Adverse Event|2|||
25088713|NCT02085460|50197635|FG001|Overall Study|Adverse Event|2|||
25088714|NCT02085460|50197636|FG002|Overall Study|Adverse Event|1|||
25088715|NCT02085460|50197634|FG000|Overall Study|Physician Decision|1|||
25088716|NCT02085460|50197635|FG001|Overall Study|Physician Decision|1|||
25088717|NCT02085460|50197636|FG002|Overall Study|Physician Decision|2|||
25088718|NCT02085460|50197634|FG000|Overall Study|Withdrawal by Subject|11|||
25088719|NCT02085460|50197635|FG001|Overall Study|Withdrawal by Subject|5|||
25088720|NCT02085460|50197636|FG002|Overall Study|Withdrawal by Subject|7|||
25088721|NCT02084134|50197646|FG000|Overall Study|Protocol Violation|4|||
25088722|NCT02084134|50197647|FG001|Overall Study|Protocol Violation|2|||
25088723|NCT02084134|50197646|FG000|Overall Study|Death|0|||
25088724|NCT02084134|50197647|FG001|Overall Study|Death|1|||
25088725|NCT02034058|50197653|FG000|Overall Study|Death|3|||
25088726|NCT01374269|50197659|FG000|Overall Study|Withdrawal by Subject|4|||
25088727|NCT01374269|50197660|FG001|Overall Study|Withdrawal by Subject|0|||
25088728|NCT01374269|50197659|FG000|Overall Study|Lost to Follow-up|1|||
25088729|NCT01374269|50197660|FG001|Overall Study|Lost to Follow-up|3|||
25088730|NCT01374269|50197659|FG000|Overall Study|closed research|1|||
25088731|NCT01374269|50197660|FG001|Overall Study|closed research|2|||
25088732|NCT02679755|50197668|FG000|Overall Study|Death|0|||
25088733|NCT02679755|50197669|FG001|Overall Study|Death|3|||
25088734|NCT02679755|50197668|FG000|Overall Study|Global deterioration of health status|1|||
25088735|NCT02679755|50197669|FG001|Overall Study|Global deterioration of health status|8|||
25088736|NCT02679755|50197668|FG000|Overall Study|Lost to Follow-up|1|||
25088737|NCT02679755|50197669|FG001|Overall Study|Lost to Follow-up|0|||
25088738|NCT02679755|50197668|FG000|Overall Study|Objective progression or relapse|24|||
25088739|NCT02679755|50197669|FG001|Overall Study|Objective progression or relapse|83|||
25088740|NCT02679755|50197668|FG000|Overall Study|Not defined|0|||
25088741|NCT02679755|50197669|FG001|Overall Study|Not defined|2|||
25088742|NCT02679755|50197668|FG000|Overall Study|Withdrawal by participant|6|||
25088743|NCT02679755|50197669|FG001|Overall Study|Withdrawal by participant|3|||
25088744|NCT02679755|50197668|FG000|Overall Study|Adverse Event|1|||
25088745|NCT02679755|50197669|FG001|Overall Study|Adverse Event|4|||
25088746|NCT02679755|50197668|FG000|Overall Study|Adverse events not related to study drug|1|||
25088747|NCT02679755|50197669|FG001|Overall Study|Adverse events not related to study drug|2|||
25088748|NCT02675231|50197681|FG000|Overall Study|Withdrawal by Subject|1|||
25088749|NCT02675231|50197682|FG001|Overall Study|Withdrawal by Subject|3|||
25088750|NCT02675231|50197683|FG002|Overall Study|Withdrawal by Subject|1|||
25088751|NCT02675231|50197681|FG000|Overall Study|Lost to Follow-up|2|||
25088752|NCT02675231|50197682|FG001|Overall Study|Lost to Follow-up|2|||
25088753|NCT02675231|50197683|FG002|Overall Study|Lost to Follow-up|2|||
25088754|NCT02675231|50197681|FG000|Overall Study|On study treatment/follow up|23|||
25088755|NCT02675231|50197682|FG001|Overall Study|On study treatment/follow up|31|||
25088756|NCT02675231|50197683|FG002|Overall Study|On study treatment/follow up|23|||
25088757|NCT02675075|50197694|FG000|Overall Study|Lost to Follow-up|3|||
25088758|NCT02675075|50197695|FG001|Overall Study|Lost to Follow-up|0|||
25088759|NCT02673515|50197705|FG000|Overall Study|Lack of motivation|2|||
25088760|NCT02673515|50197706|FG001|Overall Study|Lack of motivation|1|||
25088761|NCT02667275|50197714|FG000|Overall Study|Protocol Violation|11|||
25088762|NCT02667275|50197715|FG001|Overall Study|Protocol Violation|7|||
25088763|NCT02667275|50197714|FG000|Overall Study|Lost to Follow-up|0|||
25088764|NCT02667275|50197715|FG001|Overall Study|Lost to Follow-up|2|||
25088765|NCT02667275|50197714|FG000|Overall Study|Withdrawal by Subject|0|||
25088766|NCT02667275|50197715|FG001|Overall Study|Withdrawal by Subject|5|||
25088767|NCT02667275|50197714|FG000|Overall Study|Discontinued early without completing|0|||
25088768|NCT02667275|50197715|FG001|Overall Study|Discontinued early without completing|1|||
25088769|NCT02672423|50197724|FG000|Period 1|Adverse Event|0|||
25088770|NCT02672423|50197725|FG001|Period 1|Adverse Event|0|||
25088771|NCT02672423|50197726|FG002|Period 1|Adverse Event|0|||
25088772|NCT02672423|50197727|FG003|Period 1|Adverse Event|0|||
25088773|NCT02672423|50197728|FG004|Period 1|Adverse Event|1|||
25088774|NCT02672423|50197729|FG005|Period 1|Adverse Event|0|||
25088775|NCT02672423|50197730|FG006|Period 1|Adverse Event|0|||
25088776|NCT02672423|50197731|FG007|Period 1|Adverse Event|0|||
25088777|NCT02672423|50197732|FG008|Period 1|Adverse Event|0|||
25088778|NCT02672423|50197733|FG009|Period 1|Adverse Event|0|||
25088779|NCT02672423|50197724|FG000|Period 2|Withdrawal by Subject|0|||
25088780|NCT02672423|50197725|FG001|Period 2|Withdrawal by Subject|0|||
25088781|NCT02672423|50197726|FG002|Period 2|Withdrawal by Subject|1|||
25088782|NCT02672423|50197727|FG003|Period 2|Withdrawal by Subject|0|||
25088783|NCT02672423|50197728|FG004|Period 2|Withdrawal by Subject|0|||
25088784|NCT02672423|50197729|FG005|Period 2|Withdrawal by Subject|0|||
25088785|NCT02672423|50197730|FG006|Period 2|Withdrawal by Subject|0|||
25088786|NCT02672423|50197731|FG007|Period 2|Withdrawal by Subject|0|||
25088787|NCT02672423|50197732|FG008|Period 2|Withdrawal by Subject|0|||
25088788|NCT02672423|50197733|FG009|Period 2|Withdrawal by Subject|0|||
25088789|NCT02672423|50197724|FG000|Period 3|Withdrawal by Subject|0|||
25088790|NCT02672423|50197725|FG001|Period 3|Withdrawal by Subject|0|||
25088791|NCT02672423|50197726|FG002|Period 3|Withdrawal by Subject|0|||
25088792|NCT02672423|50197727|FG003|Period 3|Withdrawal by Subject|0|||
25088793|NCT02672423|50197728|FG004|Period 3|Withdrawal by Subject|0|||
25088794|NCT02672423|50197729|FG005|Period 3|Withdrawal by Subject|0|||
25088795|NCT02672423|50197730|FG006|Period 3|Withdrawal by Subject|0|||
25088796|NCT02672423|50197731|FG007|Period 3|Withdrawal by Subject|1|||
25088797|NCT02672423|50197732|FG008|Period 3|Withdrawal by Subject|0|||
25088798|NCT02672423|50197733|FG009|Period 3|Withdrawal by Subject|0|||
25088799|NCT02672423|50197724|FG000|Period 3|Physician Decision|0|||
25088800|NCT02672423|50197725|FG001|Period 3|Physician Decision|0|||
25088801|NCT02672423|50197726|FG002|Period 3|Physician Decision|0|||
25088802|NCT02672423|50197727|FG003|Period 3|Physician Decision|0|||
25088803|NCT02672423|50197728|FG004|Period 3|Physician Decision|0|||
25173190|NCT01681433|50314766|FG001|Overall Study|Withdrawal by Subject|5|||
25173191|NCT01681433|50314765|FG000|Overall Study|Protocol Violation|2|||
25173192|NCT01681433|50314766|FG001|Overall Study|Protocol Violation|0|||
25173193|NCT01681433|50314765|FG000|Overall Study|Adverse Event|2|||
25088804|NCT02672423|50197729|FG005|Period 3|Physician Decision|1|||
25088805|NCT02672423|50197730|FG006|Period 3|Physician Decision|0|||
25088806|NCT02672423|50197731|FG007|Period 3|Physician Decision|0|||
25088807|NCT02672423|50197732|FG008|Period 3|Physician Decision|0|||
25088808|NCT02672423|50197733|FG009|Period 3|Physician Decision|0|||
25088809|NCT02670551|50197757|FG000|Overall Study|Adverse Event|4|||
25088810|NCT02670551|50197758|FG001|Overall Study|Adverse Event|7|||
25088811|NCT02670551|50197759|FG002|Overall Study|Adverse Event|9|||
25088812|NCT02670551|50197757|FG000|Overall Study|Lack of Efficacy|2|||
25088813|NCT02670551|50197758|FG001|Overall Study|Lack of Efficacy|0|||
25088814|NCT02670551|50197759|FG002|Overall Study|Lack of Efficacy|3|||
25173194|NCT01681433|50314766|FG001|Overall Study|Adverse Event|4|||
25173195|NCT01681433|50314765|FG000|Overall Study|Lost to Follow-up|0|||
25173196|NCT01681433|50314766|FG001|Overall Study|Lost to Follow-up|1|||
25173197|NCT01681277|50314777|FG000|Overall Study|Adverse Event|1|||
25088815|NCT02670551|50197757|FG000|Overall Study|Withdrawal of Consent|6|||
25088816|NCT02670551|50197758|FG001|Overall Study|Withdrawal of Consent|3|||
25088817|NCT02670551|50197759|FG002|Overall Study|Withdrawal of Consent|8|||
25088818|NCT02670551|50197757|FG000|Overall Study|Lost to Follow-up|5|||
25088819|NCT02670551|50197758|FG001|Overall Study|Lost to Follow-up|7|||
25088820|NCT02670551|50197759|FG002|Overall Study|Lost to Follow-up|6|||
25088821|NCT02670551|50197757|FG000|Overall Study|Protocol Violation|1|||
25088822|NCT02670551|50197758|FG001|Overall Study|Protocol Violation|0|||
25088823|NCT02670551|50197759|FG002|Overall Study|Protocol Violation|0|||
25088824|NCT02670551|50197757|FG000|Overall Study|Noncompliance with study drug|3|||
25088825|NCT02670551|50197758|FG001|Overall Study|Noncompliance with study drug|3|||
25088826|NCT02670551|50197759|FG002|Overall Study|Noncompliance with study drug|2|||
25088827|NCT02670551|50197757|FG000|Overall Study|Other Miscellaneous Reasons|2|||
25173198|NCT01681277|50314778|FG001|Overall Study|Adverse Event|0|||
25173199|NCT01681277|50314779|FG002|Overall Study|Adverse Event|0|||
25173200|NCT01681277|50314780|FG003|Overall Study|Adverse Event|0|||
25173201|NCT01681277|50314781|FG004|Overall Study|Adverse Event|0|||
25173202|NCT01703117|50314799|FG000|Overall Study|Adverse Event|4|||
25173203|NCT01703117|50314800|FG001|Overall Study|Adverse Event|3|||
25088828|NCT02670551|50197758|FG001|Overall Study|Other Miscellaneous Reasons|3|||
25088829|NCT02670551|50197759|FG002|Overall Study|Other Miscellaneous Reasons|3|||
25088830|NCT02670551|50197757|FG000|Overall Study|Did Not Receive Treatment|5|||
25088831|NCT02670551|50197758|FG001|Overall Study|Did Not Receive Treatment|3|||
25088832|NCT02670551|50197759|FG002|Overall Study|Did Not Receive Treatment|0|||
25088833|NCT02670473|50197767|FG000|Overall Study|Withdrawal by Subject|1|||
25088834|NCT02667119|50197782|FG000|Overall Study|Lost to Follow-up|3|||
25088835|NCT02667119|50197783|FG001|Overall Study|Lost to Follow-up|0|||
25088836|NCT02670083|50197791|FG000|Overall Study|Adverse Event|16|||
25088837|NCT02670083|50197792|FG001|Overall Study|Adverse Event|13|||
25088838|NCT02670083|50197791|FG000|Overall Study|Death|4|||
25088839|NCT02670083|50197792|FG001|Overall Study|Death|6|||
25088840|NCT02670083|50197791|FG000|Overall Study|Lost to Follow-up|2|||
25088841|NCT02670083|50197792|FG001|Overall Study|Lost to Follow-up|2|||
25088842|NCT02670083|50197791|FG000|Overall Study|Multiple Reasons|9|||
25088843|NCT02670083|50197792|FG001|Overall Study|Multiple Reasons|9|||
25088844|NCT02670083|50197791|FG000|Overall Study|Physician Decision|0|||
25088845|NCT02670083|50197792|FG001|Overall Study|Physician Decision|2|||
25088846|NCT02670083|50197791|FG000|Overall Study|Study Terminated By Sponsor|257|||
25088847|NCT02670083|50197792|FG001|Overall Study|Study Terminated By Sponsor|254|||
25088848|NCT02670083|50197791|FG000|Overall Study|Symptomatic Deterioration|0|||
25088849|NCT02670083|50197792|FG001|Overall Study|Symptomatic Deterioration|2|||
25088850|NCT02670083|50197791|FG000|Overall Study|Withdrawal by Subject|32|||
25088851|NCT02670083|50197792|FG001|Overall Study|Withdrawal by Subject|31|||
25088852|NCT02670083|50197791|FG000|Overall Study|Non-Compliance With Study Drug|1|||
25088853|NCT02670083|50197792|FG001|Overall Study|Non-Compliance With Study Drug|0|||
25088854|NCT02669849|50197802|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
25088855|NCT02669849|50197803|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
25088856|NCT02669849|50197804|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
25088857|NCT02669849|50197802|FG000|Overall Study|Lost to Follow-up|1|||
25088858|NCT02669849|50197803|FG001|Overall Study|Lost to Follow-up|0|||
25088859|NCT02669849|50197804|FG002|Overall Study|Lost to Follow-up|3|||
25088860|NCT02669849|50197802|FG000|Overall Study|Death|1|||
25088861|NCT02669849|50197803|FG001|Overall Study|Death|1|||
25088862|NCT02669849|50197804|FG002|Overall Study|Death|2|||
25088863|NCT02669849|50197802|FG000|Overall Study|Study terminated by sponsor|16|||
25088864|NCT02669849|50197803|FG001|Overall Study|Study terminated by sponsor|1|||
25088865|NCT02669849|50197804|FG002|Overall Study|Study terminated by sponsor|14|||
25088866|NCT02669849|50197802|FG000|Overall Study|Other|0|||
25088867|NCT02669849|50197803|FG001|Overall Study|Other|0|||
25088868|NCT02669849|50197804|FG002|Overall Study|Other|2|||
25088869|NCT03625895|50197812|FG000|Overall Study|Protocol Violation|585|||
25088870|NCT02663687|50197821|FG000|Overall Study|Adverse Event|1|||
25088871|NCT02663687|50197822|FG001|Overall Study|Adverse Event|0|||
25088872|NCT02663687|50197823|FG002|Overall Study|Adverse Event|0|||
25088873|NCT02663687|50197824|FG003|Overall Study|Adverse Event|0|||
25088874|NCT02663687|50197825|FG004|Overall Study|Adverse Event|0|||
25088875|NCT02663687|50197821|FG000|Overall Study|Other|1|||
25088876|NCT02663687|50197822|FG001|Overall Study|Other|0|||
25088877|NCT02663687|50197823|FG002|Overall Study|Other|1|||
25088878|NCT02663687|50197824|FG003|Overall Study|Other|0|||
25088879|NCT02663687|50197825|FG004|Overall Study|Other|0|||
25088880|NCT02663453|50197856|FG000|Overall Study|Death|4|||
25088881|NCT02663453|50197857|FG001|Overall Study|Death|4|||
25088882|NCT02663453|50197856|FG000|Overall Study|Withdrawal by Subject|1|||
25088883|NCT02663453|50197857|FG001|Overall Study|Withdrawal by Subject|0|||
25088884|NCT02055118|50197866|FG000|Overall Study|Withdrawal by Subject|0|||
25088885|NCT02055118|50197867|FG001|Overall Study|Withdrawal by Subject|2|||
25088886|NCT02055118|50197868|FG002|Overall Study|Withdrawal by Subject|0|||
25088887|NCT02084056|50197879|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
25173204|NCT01703117|50314799|FG000|Overall Study|Withdrawal by Subject|0|||
25088888|NCT02084056|50197880|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
25173205|NCT01703117|50314800|FG001|Overall Study|Withdrawal by Subject|1|||
25173206|NCT01702961|50314808|FG000|Overall Study|Additional treatment|3|||
25088889|NCT02084056|50197881|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
25088890|NCT02084056|50197882|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
25088891|NCT02084056|50197879|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
25088892|NCT02084056|50197880|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
25088893|NCT02084056|50197881|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
25088894|NCT02084056|50197882|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
25088895|NCT01625182|50197894|FG000|Overall Study|Administrative problems|1|||
25088896|NCT01625182|50197895|FG001|Overall Study|Administrative problems|0|||
25088897|NCT01625182|50197894|FG000|Overall Study|Protocol deviation|0|||
25088898|NCT01625182|50197895|FG001|Overall Study|Protocol deviation|2|||
25088899|NCT01625182|50197894|FG000|Overall Study|Adverse Event|2|||
25088900|NCT01625182|50197895|FG001|Overall Study|Adverse Event|0|||
25088901|NCT01625182|50197894|FG000|Overall Study|Withdrawal by Subject|5|||
25088902|NCT01625182|50197895|FG001|Overall Study|Withdrawal by Subject|1|||
25088903|NCT01625182|50197894|FG000|Overall Study|Lack of Efficacy|12|||
25088904|NCT01625182|50197895|FG001|Overall Study|Lack of Efficacy|8|||
25088905|NCT02661815|50197906|FG000|Overall Study|Withdrawal by Subject|1|||
25088906|NCT02661815|50197907|FG001|Overall Study|Withdrawal by Subject|0|||
25088907|NCT02661815|50197908|FG002|Overall Study|Withdrawal by Subject|0|||
25088908|NCT02661815|50197909|FG003|Overall Study|Withdrawal by Subject|0|||
25088909|NCT02053792|50197925|FG000|Overall Study|Physician Decision|0|||
25173207|NCT01702961|50314808|FG000|Overall Study|Progressive disease|5|||
25173208|NCT01702961|50314808|FG000|Overall Study|Relapse|20|||
25173209|NCT01702961|50314808|FG000|Overall Study|Death|6|||
25173210|NCT01702961|50314808|FG000|Overall Study|Lost to Follow-up|2|||
25173211|NCT01702961|50314808|FG000|Overall Study|Ongoing|11|||
25173212|NCT01593917|50314812|FG000|Overall Study|Death|67|||
25173213|NCT01593917|50314812|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
25173214|NCT01593917|50314812|FG000|Overall Study|Withdrawal by Subject|23|||
25173215|NCT01593917|50314812|FG000|Overall Study|Lost to Follow-up|12|||
25173216|NCT01593917|50314812|FG000|Overall Study|Protocol Violation|5|||
25173217|NCT01593917|50314812|FG000|Overall Study|Physician Decision|3|||
25173218|NCT01593761|50314816|FG000|Overall Study|Lost to Follow-up|1|||
25173219|NCT01593761|50314816|FG000|Overall Study|culture negative for MRSA at baseline|5|||
25173220|NCT01593761|50314816|FG000|Overall Study|positive for hepatitis C virus|1|||
25173221|NCT01593761|50314816|FG000|Overall Study|secondary cellulitis|1|||
25173222|NCT02706834|50314837|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
25088910|NCT02053792|50197926|FG001|Overall Study|Physician Decision|1|||
25088911|NCT02053792|50197925|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
25088912|NCT02053792|50197926|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
25088913|NCT02053792|50197925|FG000|Overall Study|Lack of Efficacy|1|||
25088914|NCT02053792|50197926|FG001|Overall Study|Lack of Efficacy|0|||
25088915|NCT02053792|50197925|FG000|Overall Study|Adverse Event|1|||
25088916|NCT02053792|50197926|FG001|Overall Study|Adverse Event|0|||
25088917|NCT02053792|50197925|FG000|Overall Study|Withdrawal by Subject|2|||
25088918|NCT02053792|50197926|FG001|Overall Study|Withdrawal by Subject|2|||
25088919|NCT02053792|50197925|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
25088920|NCT02053792|50197926|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
25088921|NCT02053792|50197925|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
25088922|NCT02053792|50197926|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
25088923|NCT02082340|50197934|FG000|Overall Study|Lost to Follow-up|1|||
25088924|NCT02082340|50197935|FG001|Overall Study|Lost to Follow-up|1|||
25088925|NCT02053246|50197941|FG000|Overall Study|Withdrawal by Subject|3|||
25088926|NCT02053246|50197941|FG000|Overall Study|Physician Decision|1|||
25088927|NCT02053168|50197945|FG000|Overall Study|Withdrawal by Subject|1|||
25088928|NCT02053168|50197945|FG000|Overall Study|Physician Decision|1|||
25088929|NCT02053168|50197945|FG000|Overall Study|Lost to Follow-up|1|||
25088930|NCT02052466|50197949|FG000|Overall Study|Withdrawal by Subject|1|||
25088931|NCT02052466|50197949|FG000|Overall Study|Acromial fracture|1|||
25088932|NCT02032888|50197956|FG000|Treatment Period|Poor compliance/noncompliance|1|||
25088933|NCT02032888|50197957|FG001|Treatment Period|Poor compliance/noncompliance|1|||
25088934|NCT02032888|50197958|FG002|Treatment Period|Poor compliance/noncompliance|0|||
25088935|NCT02032888|50197956|FG000|Treatment Period|Other|1|||
25088936|NCT02032888|50197957|FG001|Treatment Period|Other|1|||
25088937|NCT02032888|50197958|FG002|Treatment Period|Other|0|||
25088938|NCT02032888|50197956|FG000|Follow-up Period|Lost to Follow-up|1|||
25088939|NCT02032888|50197957|FG001|Follow-up Period|Lost to Follow-up|1|||
25088940|NCT02032888|50197958|FG002|Follow-up Period|Lost to Follow-up|0|||
25088941|NCT02032888|50197956|FG000|Follow-up Period|Death|1|||
25088942|NCT02032888|50197957|FG001|Follow-up Period|Death|1|||
25088943|NCT02032888|50197958|FG002|Follow-up Period|Death|0|||
25088944|NCT02032888|50197956|FG000|Follow-up Period|Other|1|||
25088945|NCT02032888|50197957|FG001|Follow-up Period|Other|0|||
25088946|NCT02032888|50197958|FG002|Follow-up Period|Other|0|||
25173223|NCT02706834|50314838|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
25173224|NCT02706834|50314839|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
25173225|NCT02706834|50314840|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
25173226|NCT02706834|50314841|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
25088947|NCT02082262|50197975|FG000|Overall Study|Withdrawal by Subject|3|||
25088948|NCT02082262|50197975|FG000|Overall Study|Adverse Event|48|||
25173227|NCT02706834|50314842|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
25173228|NCT02706834|50314843|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
25088949|NCT04697069|50197981|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
25088950|NCT04697069|50197982|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
25088951|NCT04697069|50197981|FG000|Overall Study|Study termination|2|||
25088952|NCT04697069|50197982|FG001|Overall Study|Study termination|1|||
25088953|NCT02082184|50197990|FG000|Overall Study|Adverse Event|1|||
25088954|NCT02082184|50197991|FG001|Overall Study|Adverse Event|0|||
25088955|NCT02082184|50197990|FG000|Overall Study|Medical diagnosis|1|||
25088956|NCT02082184|50197991|FG001|Overall Study|Medical diagnosis|2|||
25088957|NCT02082184|50197990|FG000|Overall Study|Device associated symptoms|5|||
25088958|NCT02082184|50197991|FG001|Overall Study|Device associated symptoms|0|||
25088959|NCT02082184|50197990|FG000|Overall Study|Withdrawal by Subject|3|||
25088960|NCT02082184|50197991|FG001|Overall Study|Withdrawal by Subject|2|||
25088961|NCT02082184|50197990|FG000|Overall Study|Protocol Violation|0|||
25088962|NCT02082184|50197991|FG001|Overall Study|Protocol Violation|6|||
25088963|NCT02082184|50197990|FG000|Overall Study|Lost to Follow-up|0|||
25088964|NCT02082184|50197991|FG001|Overall Study|Lost to Follow-up|2|||
25088965|NCT02082184|50197990|FG000|Overall Study|Subject non-compliance|0|||
25088966|NCT02082184|50197991|FG001|Overall Study|Subject non-compliance|1|||
25088967|NCT01624870|50197997|FG000|Overall Study|Death|19|||
25088968|NCT01624870|50197997|FG000|Overall Study|Withdrawal by Subject|1|||
25088969|NCT01624870|50197997|FG000|Overall Study|CoreValve not implanted|6|||
25088970|NCT01624870|50197997|FG000|Overall Study|Lost to follow up|1|||
25088971|NCT02031640|50198008|FG000|Screening Period|Adverse Event|1|||
25088972|NCT02031640|50198009|FG001|Screening Period|Adverse Event|0|||
25088973|NCT02031640|50198010|FG002|Screening Period|Adverse Event|0|||
25088974|NCT02031640|50198011|FG003|Screening Period|Adverse Event|0|||
25088975|NCT02031640|50198012|FG004|Screening Period|Adverse Event|0|||
25088976|NCT02031640|50198013|FG005|Screening Period|Adverse Event|0|||
25088977|NCT02031640|50198008|FG000|Screening Period|Withdrawal by Subject|29|||
25088978|NCT02031640|50198009|FG001|Screening Period|Withdrawal by Subject|0|||
25088979|NCT02031640|50198010|FG002|Screening Period|Withdrawal by Subject|0|||
25088980|NCT02031640|50198011|FG003|Screening Period|Withdrawal by Subject|0|||
25088981|NCT02031640|50198012|FG004|Screening Period|Withdrawal by Subject|0|||
25088982|NCT02031640|50198013|FG005|Screening Period|Withdrawal by Subject|0|||
25088983|NCT02031640|50198008|FG000|Screening Period|Inclusion criteria not met|312|||
25088984|NCT02031640|50198009|FG001|Screening Period|Inclusion criteria not met|0|||
25088985|NCT02031640|50198010|FG002|Screening Period|Inclusion criteria not met|0|||
25088986|NCT02031640|50198011|FG003|Screening Period|Inclusion criteria not met|0|||
25088987|NCT02031640|50198012|FG004|Screening Period|Inclusion criteria not met|0|||
25088988|NCT02031640|50198013|FG005|Screening Period|Inclusion criteria not met|0|||
25088989|NCT02031640|50198008|FG000|Screening Period|Exclusion criteria met|30|||
25088990|NCT02031640|50198009|FG001|Screening Period|Exclusion criteria met|0|||
25088991|NCT02031640|50198010|FG002|Screening Period|Exclusion criteria met|0|||
25088992|NCT02031640|50198011|FG003|Screening Period|Exclusion criteria met|0|||
25088993|NCT02031640|50198012|FG004|Screening Period|Exclusion criteria met|0|||
25088994|NCT02031640|50198013|FG005|Screening Period|Exclusion criteria met|0|||
25088995|NCT02031640|50198008|FG000|Screening Period|Lost to Follow-up|14|||
25088996|NCT02031640|50198009|FG001|Screening Period|Lost to Follow-up|0|||
25088997|NCT02031640|50198010|FG002|Screening Period|Lost to Follow-up|0|||
25088998|NCT02031640|50198011|FG003|Screening Period|Lost to Follow-up|0|||
25088999|NCT02031640|50198012|FG004|Screening Period|Lost to Follow-up|0|||
25089000|NCT02031640|50198013|FG005|Screening Period|Lost to Follow-up|0|||
25089001|NCT02031640|50198008|FG000|Screening Period|Enrollment closed|26|||
25089002|NCT02031640|50198009|FG001|Screening Period|Enrollment closed|0|||
25089003|NCT02031640|50198010|FG002|Screening Period|Enrollment closed|0|||
25089004|NCT02031640|50198011|FG003|Screening Period|Enrollment closed|0|||
25089005|NCT02031640|50198012|FG004|Screening Period|Enrollment closed|0|||
25089006|NCT02031640|50198013|FG005|Screening Period|Enrollment closed|0|||
25089007|NCT02031640|50198008|FG000|Run-In Period|Adverse Event|4|||
25173229|NCT02706834|50314844|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
25173230|NCT02706834|50314845|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
25173231|NCT02706834|50314846|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
25173232|NCT02706834|50314847|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
25173233|NCT02706834|50314837|FG000|Overall Study|Lost to Follow-up|0|||
25173234|NCT02706834|50314838|FG001|Overall Study|Lost to Follow-up|0|||
25173235|NCT02706834|50314839|FG002|Overall Study|Lost to Follow-up|1|||
25173236|NCT02706834|50314840|FG003|Overall Study|Lost to Follow-up|0|||
25173237|NCT02706834|50314841|FG004|Overall Study|Lost to Follow-up|0|||
25089008|NCT02031640|50198009|FG001|Run-In Period|Adverse Event|0|||
25089009|NCT02031640|50198010|FG002|Run-In Period|Adverse Event|0|||
25089010|NCT02031640|50198011|FG003|Run-In Period|Adverse Event|0|||
25089011|NCT02031640|50198012|FG004|Run-In Period|Adverse Event|0|||
25089012|NCT02031640|50198013|FG005|Run-In Period|Adverse Event|0|||
25089013|NCT02031640|50198008|FG000|Run-In Period|Withdrawal by Subject|17|||
25089014|NCT02031640|50198009|FG001|Run-In Period|Withdrawal by Subject|0|||
25089015|NCT02031640|50198010|FG002|Run-In Period|Withdrawal by Subject|0|||
25089016|NCT02031640|50198011|FG003|Run-In Period|Withdrawal by Subject|0|||
25089017|NCT02031640|50198012|FG004|Run-In Period|Withdrawal by Subject|0|||
25089018|NCT02031640|50198013|FG005|Run-In Period|Withdrawal by Subject|0|||
25089019|NCT02031640|50198008|FG000|Run-In Period|Inclusion criteria not met|38|||
25089020|NCT02031640|50198009|FG001|Run-In Period|Inclusion criteria not met|0|||
25089021|NCT02031640|50198010|FG002|Run-In Period|Inclusion criteria not met|0|||
25089022|NCT02031640|50198011|FG003|Run-In Period|Inclusion criteria not met|0|||
25173238|NCT02706834|50314842|FG005|Overall Study|Lost to Follow-up|0|||
25173239|NCT02706834|50314843|FG006|Overall Study|Lost to Follow-up|0|||
25173240|NCT02706834|50314844|FG007|Overall Study|Lost to Follow-up|0|||
25173241|NCT02706834|50314845|FG008|Overall Study|Lost to Follow-up|0|||
25173242|NCT02706834|50314846|FG009|Overall Study|Lost to Follow-up|0|||
25089023|NCT02031640|50198012|FG004|Run-In Period|Inclusion criteria not met|0|||
25089024|NCT02031640|50198013|FG005|Run-In Period|Inclusion criteria not met|0|||
25089025|NCT02031640|50198008|FG000|Run-In Period|Exclusion criteria met|8|||
25089026|NCT02031640|50198009|FG001|Run-In Period|Exclusion criteria met|0|||
25089027|NCT02031640|50198010|FG002|Run-In Period|Exclusion criteria met|0|||
25089028|NCT02031640|50198011|FG003|Run-In Period|Exclusion criteria met|0|||
25089029|NCT02031640|50198012|FG004|Run-In Period|Exclusion criteria met|0|||
25089030|NCT02031640|50198013|FG005|Run-In Period|Exclusion criteria met|0|||
25089031|NCT02031640|50198008|FG000|Run-In Period|Randomization criteria not met|85|||
25089032|NCT02031640|50198009|FG001|Run-In Period|Randomization criteria not met|0|||
25089033|NCT02031640|50198010|FG002|Run-In Period|Randomization criteria not met|0|||
25089034|NCT02031640|50198011|FG003|Run-In Period|Randomization criteria not met|0|||
25089035|NCT02031640|50198012|FG004|Run-In Period|Randomization criteria not met|0|||
25089036|NCT02031640|50198013|FG005|Run-In Period|Randomization criteria not met|0|||
25089037|NCT02031640|50198008|FG000|Run-In Period|Various administrative reasons|17|||
25089038|NCT02031640|50198009|FG001|Run-In Period|Various administrative reasons|0|||
25089039|NCT02031640|50198010|FG002|Run-In Period|Various administrative reasons|0|||
25089040|NCT02031640|50198011|FG003|Run-In Period|Various administrative reasons|0|||
25089041|NCT02031640|50198012|FG004|Run-In Period|Various administrative reasons|0|||
25089042|NCT02031640|50198013|FG005|Run-In Period|Various administrative reasons|0|||
25089043|NCT02031640|50198008|FG000|Double-blind Treatment Period|Protocol deviation|0|||
25089044|NCT02031640|50198009|FG001|Double-blind Treatment Period|Protocol deviation|2|||
25089045|NCT02031640|50198010|FG002|Double-blind Treatment Period|Protocol deviation|0|||
25089046|NCT02031640|50198011|FG003|Double-blind Treatment Period|Protocol deviation|1|||
25089047|NCT02031640|50198012|FG004|Double-blind Treatment Period|Protocol deviation|3|||
25089048|NCT02031640|50198013|FG005|Double-blind Treatment Period|Protocol deviation|1|||
25089049|NCT02031640|50198008|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
25089050|NCT02031640|50198009|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
25089051|NCT02031640|50198010|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
25089052|NCT02031640|50198011|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
25089053|NCT02031640|50198012|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
25089054|NCT02031640|50198013|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
25089055|NCT02031640|50198008|FG000|Double-blind Treatment Period|Non-compliance|0|||
25089056|NCT02031640|50198009|FG001|Double-blind Treatment Period|Non-compliance|1|||
25089057|NCT02031640|50198010|FG002|Double-blind Treatment Period|Non-compliance|0|||
25089058|NCT02031640|50198011|FG003|Double-blind Treatment Period|Non-compliance|1|||
25089059|NCT02031640|50198012|FG004|Double-blind Treatment Period|Non-compliance|1|||
25089060|NCT02031640|50198013|FG005|Double-blind Treatment Period|Non-compliance|0|||
25089061|NCT02031640|50198008|FG000|Double-blind Treatment Period|Adverse Event|0|||
25089062|NCT02031640|50198009|FG001|Double-blind Treatment Period|Adverse Event|0|||
25089063|NCT02031640|50198010|FG002|Double-blind Treatment Period|Adverse Event|0|||
25089064|NCT02031640|50198011|FG003|Double-blind Treatment Period|Adverse Event|2|||
25089065|NCT02031640|50198012|FG004|Double-blind Treatment Period|Adverse Event|0|||
25089066|NCT02031640|50198013|FG005|Double-blind Treatment Period|Adverse Event|0|||
25089067|NCT02031640|50198008|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
25089068|NCT02031640|50198009|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
25089069|NCT02031640|50198010|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
25089070|NCT02031640|50198011|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
25089071|NCT02031640|50198012|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
25089072|NCT02031640|50198013|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
25089073|NCT02031640|50198008|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
25089074|NCT02031640|50198009|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
25089075|NCT02031640|50198010|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
25089076|NCT02031640|50198011|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
25089077|NCT02031640|50198012|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
25173243|NCT02706834|50314847|FG010|Overall Study|Lost to Follow-up|0|||
25173244|NCT02706834|50314837|FG000|Overall Study|Voluntary Withdrawal|1|||
25173245|NCT02706834|50314838|FG001|Overall Study|Voluntary Withdrawal|0|||
25173246|NCT02706834|50314839|FG002|Overall Study|Voluntary Withdrawal|0|||
25173247|NCT02706834|50314840|FG003|Overall Study|Voluntary Withdrawal|0|||
25173248|NCT02706834|50314841|FG004|Overall Study|Voluntary Withdrawal|0|||
25089078|NCT02031640|50198013|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
25089079|NCT02370173|50198039|FG000|Overall Study|Protocol Violation|1|||
25089080|NCT02370173|50198040|FG001|Overall Study|Protocol Violation|1|||
25089081|NCT02370173|50198039|FG000|Overall Study|Withdrawal by Subject|2|||
25089082|NCT02370173|50198040|FG001|Overall Study|Withdrawal by Subject|2|||
25089083|NCT02660489|50198050|FG000|Overall Study|Lost to Follow-up|1|||
25089084|NCT02660489|50198051|FG001|Overall Study|Lost to Follow-up|1|||
25089085|NCT02660489|50198050|FG000|Overall Study|Adverse Event|1|||
25089086|NCT02660489|50198051|FG001|Overall Study|Adverse Event|3|||
25089087|NCT02660489|50198050|FG000|Overall Study|no rhinovirus infection|4|||
25089088|NCT02660489|50198051|FG001|Overall Study|no rhinovirus infection|4|||
25089089|NCT02052310|50198059|FG000|Overall Study|Death|64|||
25089090|NCT02052310|50198060|FG001|Overall Study|Death|54|||
25089091|NCT02052310|50198059|FG000|Overall Study|Withdrawal by Subject|37|||
25089092|NCT02052310|50198060|FG001|Overall Study|Withdrawal by Subject|49|||
25089093|NCT02052310|50198059|FG000|Overall Study|Other than specified|32|||
25089094|NCT02052310|50198060|FG001|Overall Study|Other than specified|29|||
25089095|NCT02052310|50198059|FG000|Overall Study|Adverse Event|29|||
25089096|NCT02052310|50198060|FG001|Overall Study|Adverse Event|22|||
25089097|NCT02052310|50198059|FG000|Overall Study|Kidney Transplant|23|||
25089098|NCT02052310|50198060|FG001|Overall Study|Kidney Transplant|29|||
25089099|NCT02052310|50198059|FG000|Overall Study|Physician Decision|14|||
25089100|NCT02052310|50198060|FG001|Overall Study|Physician Decision|7|||
25089101|NCT02052310|50198059|FG000|Overall Study|Lack of Efficacy|6|||
25089102|NCT02052310|50198060|FG001|Overall Study|Lack of Efficacy|1|||
25089103|NCT02052310|50198059|FG000|Overall Study|Site Terminated by Sponsor|5|||
25089104|NCT02052310|50198060|FG001|Overall Study|Site Terminated by Sponsor|13|||
25089105|NCT02052310|50198059|FG000|Overall Study|Lost to Follow-up|4|||
25089106|NCT02052310|50198060|FG001|Overall Study|Lost to Follow-up|2|||
25089107|NCT02052310|50198059|FG000|Overall Study|Protocol Violation|1|||
25089108|NCT02052310|50198060|FG001|Overall Study|Protocol Violation|6|||
25089109|NCT02051764|50198068|FG000|Overall Study|Study terminated by sponsor|0|||
25089110|NCT02051764|50198069|FG001|Overall Study|Study terminated by sponsor|7|||
25089111|NCT02051296|50198077|FG000|Overall Study|Lost to Follow-up|1|||
25089112|NCT02051296|50198078|FG001|Overall Study|Lost to Follow-up|2|||
25089113|NCT02051296|50198077|FG000|Overall Study|withdraw prior to treatment|7|||
25089114|NCT02051296|50198078|FG001|Overall Study|withdraw prior to treatment|7|||
25089115|NCT02050048|50198086|FG000|Overall Study|Lost to Follow-up|0|||
25089116|NCT02050048|50198087|FG001|Overall Study|Lost to Follow-up|1|||
25089117|NCT02050048|50198086|FG000|Overall Study|Death|1|||
25089118|NCT02050048|50198087|FG001|Overall Study|Death|0|||
25089119|NCT02050048|50198086|FG000|Overall Study|Ineligible after ERCP|4|||
25089120|NCT02050048|50198087|FG001|Overall Study|Ineligible after ERCP|1|||
25089121|NCT02049814|50198095|FG000|Overall Study|Reason not Specified|4|||
25089122|NCT02049814|50198096|FG001|Overall Study|Reason not Specified|3|||
25089123|NCT02049814|50198095|FG000|Overall Study|Pregnancy|1|||
25089124|NCT02049814|50198096|FG001|Overall Study|Pregnancy|0|||
25089125|NCT02049814|50198095|FG000|Overall Study|Lost to Follow-up|2|||
25089126|NCT02049814|50198096|FG001|Overall Study|Lost to Follow-up|3|||
25089127|NCT02049814|50198095|FG000|Overall Study|Serious Protocol Violation|5|||
25089128|NCT02049814|50198096|FG001|Overall Study|Serious Protocol Violation|7|||
25089129|NCT02049814|50198095|FG000|Overall Study|Study Termination|0|||
25089130|NCT02049814|50198096|FG001|Overall Study|Study Termination|1|||
25089131|NCT02049814|50198095|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
25089132|NCT02049814|50198096|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
25089133|NCT02049814|50198095|FG000|Overall Study|Voluntary withdrawal|9|||
25089134|NCT02049814|50198096|FG001|Overall Study|Voluntary withdrawal|8|||
25089135|NCT02079844|50198114|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
25089136|NCT02079844|50198115|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
25089137|NCT02079844|50198116|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
25173249|NCT02706834|50314842|FG005|Overall Study|Voluntary Withdrawal|0|||
25173250|NCT02706834|50314843|FG006|Overall Study|Voluntary Withdrawal|0|||
25173251|NCT02706834|50314844|FG007|Overall Study|Voluntary Withdrawal|0|||
25173252|NCT02706834|50314845|FG008|Overall Study|Voluntary Withdrawal|0|||
25173253|NCT02706834|50314846|FG009|Overall Study|Voluntary Withdrawal|1|||
25173254|NCT02706834|50314847|FG010|Overall Study|Voluntary Withdrawal|0|||
25173255|NCT02706834|50314837|FG000|Overall Study|Other Reason Not Specified|1|||
25089138|NCT02079844|50198114|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
25089139|NCT02079844|50198115|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
25089140|NCT02079844|50198116|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
25089141|NCT02048722|50198136|FG000|2 Cycles of Treatment|Adverse Event|2|||
25089142|NCT02048722|50198136|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
25089143|NCT02048722|50198136|FG000|2 Cycles of Treatment|Progressive Disease|2|||
25089144|NCT02048722|50198136|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
25089145|NCT02048722|50198136|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
25089146|NCT02048722|50198136|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
25173256|NCT02706834|50314838|FG001|Overall Study|Other Reason Not Specified|0|||
25089147|NCT02030002|50198140|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
25089148|NCT02030002|50198140|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
25089149|NCT02030002|50198140|FG000|Follow-up|Lost to Follow-up|2|||
25089150|NCT02079610|50198148|FG000|Overall Study|Withdrawal by Subject|1|||
25089151|NCT02079610|50198149|FG001|Overall Study|Withdrawal by Subject|1|||
25089152|NCT02079532|50198155|FG000|Overall Study|Adverse Event|7|||
25089153|NCT02079532|50198155|FG000|Overall Study|Additional or changed therapy|2|||
25089154|NCT02079532|50198155|FG000|Overall Study|Lack of Efficacy|9|||
25089155|NCT02079532|50198155|FG000|Overall Study|Protocol Violation|3|||
25089156|NCT02079532|50198155|FG000|Overall Study|Withdrawal by Subject|1|||
25089157|NCT02079532|50198155|FG000|Overall Study|Administrative problems|1|||
25089158|NCT02079532|50198155|FG000|Overall Study|Inclusion into ReFIRST|3|||
25089159|NCT02079532|50198155|FG000|Overall Study|Other|3|||
25089160|NCT02709889|50198208|FG000|Overall Study|Withdrawal by Subject|11|||
25089161|NCT02709889|50198209|FG001|Overall Study|Withdrawal by Subject|10|||
25089162|NCT02709889|50198210|FG002|Overall Study|Withdrawal by Subject|2|||
25089163|NCT02709889|50198211|FG003|Overall Study|Withdrawal by Subject|12|||
25089164|NCT02709889|50198208|FG000|Overall Study|Death|25|||
25089165|NCT02709889|50198209|FG001|Overall Study|Death|38|||
25089166|NCT02709889|50198210|FG002|Overall Study|Death|4|||
25089167|NCT02709889|50198211|FG003|Overall Study|Death|44|||
25089168|NCT02709889|50198208|FG000|Overall Study|Physician Decision|1|||
25089169|NCT02709889|50198209|FG001|Overall Study|Physician Decision|2|||
25089170|NCT02709889|50198210|FG002|Overall Study|Physician Decision|3|||
25089171|NCT02709889|50198211|FG003|Overall Study|Physician Decision|5|||
25089172|NCT02709889|50198208|FG000|Overall Study|Lost to Follow-up|2|||
25089173|NCT02709889|50198209|FG001|Overall Study|Lost to Follow-up|0|||
25089174|NCT02709889|50198210|FG002|Overall Study|Lost to Follow-up|0|||
25089175|NCT02709889|50198211|FG003|Overall Study|Lost to Follow-up|4|||
25089176|NCT02709889|50198208|FG000|Overall Study|Study Terminated by Sponsor|4|||
25089177|NCT02709889|50198209|FG001|Overall Study|Study Terminated by Sponsor|6|||
25089178|NCT02709889|50198210|FG002|Overall Study|Study Terminated by Sponsor|2|||
25089179|NCT02709889|50198211|FG003|Overall Study|Study Terminated by Sponsor|17|||
25089180|NCT02709889|50198208|FG000|Overall Study|Other, Not Specified|0|||
25089181|NCT02709889|50198209|FG001|Overall Study|Other, Not Specified|1|||
25089182|NCT02709889|50198210|FG002|Overall Study|Other, Not Specified|1|||
25089183|NCT02709889|50198211|FG003|Overall Study|Other, Not Specified|6|||
25089184|NCT02711995|50198256|FG000|Washout (90 Days)|Conflicting medication|1|||
25089185|NCT02514239|50198294|FG000|Overall Study|Refused to continue trial medication|0|||
25089186|NCT02514239|50198295|FG001|Overall Study|Refused to continue trial medication|0|||
25089187|NCT02514239|50198296|FG002|Overall Study|Refused to continue trial medication|0|||
25089188|NCT02514239|50198297|FG003|Overall Study|Refused to continue trial medication|0|||
25089189|NCT02514239|50198298|FG004|Overall Study|Refused to continue trial medication|0|||
25089190|NCT02514239|50198299|FG005|Overall Study|Refused to continue trial medication|0|||
25089191|NCT02514239|50198300|FG006|Overall Study|Refused to continue trial medication|0|||
25089192|NCT02514239|50198301|FG007|Overall Study|Refused to continue trial medication|0|||
25089193|NCT02514239|50198302|FG008|Overall Study|Refused to continue trial medication|0|||
25089194|NCT02514239|50198303|FG009|Overall Study|Refused to continue trial medication|1|||
25089195|NCT02514239|50198294|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
25089196|NCT02514239|50198295|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
25089197|NCT02514239|50198296|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
25173257|NCT02706834|50314839|FG002|Overall Study|Other Reason Not Specified|0|||
25173258|NCT02706834|50314840|FG003|Overall Study|Other Reason Not Specified|0|||
25173259|NCT02706834|50314841|FG004|Overall Study|Other Reason Not Specified|1|||
25173260|NCT02706834|50314842|FG005|Overall Study|Other Reason Not Specified|0|||
25089198|NCT02514239|50198297|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
25089199|NCT02514239|50198298|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
25089200|NCT02514239|50198299|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
25089201|NCT02514239|50198300|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
25089202|NCT02514239|50198301|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
25173261|NCT02706834|50314843|FG006|Overall Study|Other Reason Not Specified|0|||
25173262|NCT02706834|50314844|FG007|Overall Study|Other Reason Not Specified|0|||
25173263|NCT02706834|50314845|FG008|Overall Study|Other Reason Not Specified|0|||
25173264|NCT02706834|50314846|FG009|Overall Study|Other Reason Not Specified|0|||
25173265|NCT02706834|50314847|FG010|Overall Study|Other Reason Not Specified|0|||
25089203|NCT02514239|50198302|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
25089204|NCT02514239|50198303|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
25089205|NCT02514239|50198294|FG000|Overall Study|Not treated|0|||
25089206|NCT02514239|50198295|FG001|Overall Study|Not treated|1|||
25089207|NCT02514239|50198296|FG002|Overall Study|Not treated|0|||
25089208|NCT02514239|50198297|FG003|Overall Study|Not treated|0|||
25089209|NCT02514239|50198298|FG004|Overall Study|Not treated|0|||
25089210|NCT02514239|50198299|FG005|Overall Study|Not treated|0|||
25089211|NCT02514239|50198300|FG006|Overall Study|Not treated|0|||
25089212|NCT02514239|50198301|FG007|Overall Study|Not treated|0|||
25089213|NCT02514239|50198302|FG008|Overall Study|Not treated|0|||
25089214|NCT02514239|50198303|FG009|Overall Study|Not treated|0|||
25089215|NCT02514239|50198294|FG000|Overall Study|Other Adverse Events|2|||
25089216|NCT02514239|50198295|FG001|Overall Study|Other Adverse Events|0|||
25089217|NCT02514239|50198296|FG002|Overall Study|Other Adverse Events|0|||
25089218|NCT02514239|50198297|FG003|Overall Study|Other Adverse Events|1|||
25089219|NCT02514239|50198298|FG004|Overall Study|Other Adverse Events|0|||
25089220|NCT02514239|50198299|FG005|Overall Study|Other Adverse Events|1|||
25089221|NCT02514239|50198300|FG006|Overall Study|Other Adverse Events|0|||
25089222|NCT02514239|50198301|FG007|Overall Study|Other Adverse Events|1|||
25089223|NCT02514239|50198302|FG008|Overall Study|Other Adverse Events|2|||
25089224|NCT02514239|50198303|FG009|Overall Study|Other Adverse Events|0|||
25089225|NCT02514239|50198294|FG000|Overall Study|Progressive disease|3|||
25089226|NCT02514239|50198295|FG001|Overall Study|Progressive disease|3|||
25089227|NCT02514239|50198296|FG002|Overall Study|Progressive disease|2|||
25089228|NCT02514239|50198297|FG003|Overall Study|Progressive disease|2|||
25089229|NCT02514239|50198298|FG004|Overall Study|Progressive disease|3|||
25089230|NCT02514239|50198299|FG005|Overall Study|Progressive disease|3|||
25089231|NCT02514239|50198300|FG006|Overall Study|Progressive disease|4|||
25089232|NCT02514239|50198301|FG007|Overall Study|Progressive disease|2|||
25089233|NCT02514239|50198302|FG008|Overall Study|Progressive disease|5|||
25089234|NCT02514239|50198303|FG009|Overall Study|Progressive disease|0|||
25089235|NCT02709109|50198347|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
25089236|NCT02709109|50198348|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
25089237|NCT02709109|50198349|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
25089238|NCT02709109|50198350|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
25089239|NCT02709109|50198347|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
25089240|NCT02709109|50198348|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
25089241|NCT02709109|50198349|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
25089242|NCT02709109|50198350|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
25089243|NCT02709109|50198347|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
25089244|NCT02709109|50198348|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
25173266|NCT01702025|50314896|FG000|Overall Study|Equipment failure|1|||
25173267|NCT01702025|50314897|FG001|Overall Study|Equipment failure|0|||
25173268|NCT01702025|50314898|FG002|Overall Study|Equipment failure|0|||
25089245|NCT02709109|50198349|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
25089246|NCT02709109|50198350|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
25089247|NCT02709109|50198347|FG000|Washout Period (28 Days)|Other|2|||
25089248|NCT02709109|50198348|FG001|Washout Period (28 Days)|Other|2|||
25089249|NCT02709109|50198349|FG002|Washout Period (28 Days)|Other|3|||
25089250|NCT02709109|50198350|FG003|Washout Period (28 Days)|Other|0|||
25089251|NCT02709109|50198347|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
25089252|NCT02709109|50198348|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
25089253|NCT02709109|50198349|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
25089254|NCT02709109|50198350|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
25089255|NCT02709109|50198347|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
25089256|NCT02709109|50198348|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
25089257|NCT02709109|50198349|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
25089258|NCT02709109|50198350|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
25089259|NCT02709109|50198347|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
25089260|NCT02709109|50198348|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
25089261|NCT02709109|50198349|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
25089262|NCT02709109|50198350|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
25089263|NCT02709109|50198347|FG000|Treatment Period 2 (28 Days)|Other|0|||
25089264|NCT02709109|50198348|FG001|Treatment Period 2 (28 Days)|Other|0|||
25089265|NCT02709109|50198349|FG002|Treatment Period 2 (28 Days)|Other|1|||
25089266|NCT02709109|50198350|FG003|Treatment Period 2 (28 Days)|Other|0|||
25173269|NCT01702025|50314899|FG003|Overall Study|Equipment failure|0|||
25173270|NCT01702025|50314896|FG000|Overall Study|Adverse Event|1|||
25173271|NCT01702025|50314897|FG001|Overall Study|Adverse Event|1|||
25173272|NCT01702025|50314898|FG002|Overall Study|Adverse Event|1|||
25173273|NCT01702025|50314899|FG003|Overall Study|Adverse Event|0|||
25173274|NCT01592747|50314916|FG000|Overall Study|Loss of Therapeutic Response|107|||
25173275|NCT01592747|50314917|FG001|Overall Study|Loss of Therapeutic Response|108|||
25089267|NCT04289051|50198365|FG000|Overall Study|Lost to Follow-up|0|||
25089268|NCT04289051|50198366|FG001|Overall Study|Lost to Follow-up|0|||
25089269|NCT04289051|50198367|FG002|Overall Study|Lost to Follow-up|2|||
25089270|NCT02709655|50198375|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
25089271|NCT02709655|50198376|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
25089272|NCT02709655|50198377|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
25089273|NCT02709655|50198378|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
25173276|NCT01592747|50314918|FG002|Overall Study|Loss of Therapeutic Response|100|||
25089274|NCT02709655|50198379|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
25089275|NCT02709655|50198375|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
25089276|NCT02709655|50198376|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
25089277|NCT02709655|50198377|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
25089278|NCT02709655|50198378|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
25089279|NCT02709655|50198379|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
25089280|NCT02709655|50198375|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
25089281|NCT02709655|50198376|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
25089282|NCT02709655|50198377|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
25089283|NCT02709655|50198378|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
25089284|NCT02709655|50198379|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
25089285|NCT02709655|50198375|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
25089286|NCT02709655|50198376|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
25089287|NCT02709655|50198377|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
25089288|NCT02709655|50198378|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
25089289|NCT02709655|50198379|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
25089290|NCT02709655|50198375|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
25089291|NCT02709655|50198376|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
25089292|NCT02709655|50198377|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
25089293|NCT02709655|50198378|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
25089294|NCT02709655|50198379|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
25089295|NCT02709655|50198375|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
25089296|NCT02709655|50198376|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
25089297|NCT02709655|50198377|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
25089298|NCT02709655|50198378|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
25089299|NCT02709655|50198379|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
25089300|NCT02709655|50198375|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
25089301|NCT02709655|50198376|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
25089302|NCT02709655|50198377|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
25089303|NCT02709655|50198378|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
25089304|NCT02709655|50198379|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
25089305|NCT02709655|50198375|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
25089306|NCT02709655|50198376|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
25089307|NCT02709655|50198377|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
25089308|NCT02709655|50198378|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
25089309|NCT02709655|50198379|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
25089310|NCT02709655|50198375|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
25089311|NCT02709655|50198376|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
25089312|NCT02709655|50198377|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
25089313|NCT02709655|50198378|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
25089314|NCT02709655|50198379|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
25089315|NCT02709655|50198375|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
25089316|NCT02709655|50198376|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
25089317|NCT02709655|50198377|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
25089318|NCT02709655|50198378|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
25089319|NCT02709655|50198379|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
25089320|NCT02709655|50198375|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
25089321|NCT02709655|50198376|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
25089322|NCT02709655|50198377|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
25089323|NCT02709655|50198378|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
25089324|NCT02709655|50198379|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
25089325|NCT02709655|50198375|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
25089326|NCT02709655|50198376|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
25089327|NCT02709655|50198377|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
25089328|NCT02709655|50198378|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
25089329|NCT02709655|50198379|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
25089330|NCT02709655|50198375|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
25089331|NCT02709655|50198376|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
25089332|NCT02709655|50198377|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
25089333|NCT02709655|50198378|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
25089334|NCT02709655|50198379|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
25089335|NCT02709655|50198375|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
25089336|NCT02709655|50198376|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
25089337|NCT02709655|50198377|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
25089338|NCT02709655|50198378|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
25173277|NCT01592747|50314916|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
25089339|NCT02709655|50198379|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
25089340|NCT02709655|50198375|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
25089341|NCT02709655|50198376|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
25089342|NCT02709655|50198377|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
25089343|NCT02709655|50198378|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
25089344|NCT02709655|50198379|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
25089345|NCT02709655|50198375|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
25089346|NCT02709655|50198376|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
25089347|NCT02709655|50198377|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
25089348|NCT02709655|50198378|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
25089349|NCT02709655|50198379|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
25089350|NCT02708485|50198393|FG000|Overall Study|Withdrawal by Subject|3|||
25089351|NCT02708485|50198394|FG001|Overall Study|Withdrawal by Subject|2|||
25089352|NCT02709577|50198406|FG000|Overall Study|non-accommodating anatomy|0|||
25089353|NCT02709577|50198407|FG001|Overall Study|non-accommodating anatomy|1|||
25089354|NCT02709577|50198408|FG002|Overall Study|non-accommodating anatomy|0|||
25089355|NCT02709577|50198409|FG003|Overall Study|non-accommodating anatomy|0|||
25089356|NCT02709577|50198406|FG000|Overall Study|procedural complication|0|||
25089357|NCT02709577|50198407|FG001|Overall Study|procedural complication|1|||
25089358|NCT02709577|50198408|FG002|Overall Study|procedural complication|0|||
25089359|NCT02709577|50198409|FG003|Overall Study|procedural complication|0|||
25089360|NCT02709577|50198406|FG000|Overall Study|Withdrawal by Subject|2|||
25089361|NCT02709577|50198407|FG001|Overall Study|Withdrawal by Subject|3|||
25089362|NCT02709577|50198408|FG002|Overall Study|Withdrawal by Subject|2|||
25089363|NCT02709577|50198409|FG003|Overall Study|Withdrawal by Subject|0|||
25089364|NCT02078752|50198430|FG000|Overall Study|Death|0|||
25089365|NCT02078752|50198431|FG001|Overall Study|Death|3|||
25089366|NCT02078752|50198432|FG002|Overall Study|Death|0|||
25089367|NCT02078752|50198433|FG003|Overall Study|Death|0|||
25089368|NCT02078752|50198434|FG004|Overall Study|Death|0|||
25089369|NCT02078752|50198435|FG005|Overall Study|Death|1|||
25089370|NCT02078752|50198436|FG006|Overall Study|Death|0|||
25089371|NCT02078752|50198437|FG007|Overall Study|Death|1|||
25089372|NCT02078752|50198438|FG008|Overall Study|Death|0|||
25089373|NCT02078752|50198439|FG009|Overall Study|Death|4|||
25089374|NCT02078752|50198430|FG000|Overall Study|Lost to Follow-up|1|||
25089375|NCT02078752|50198431|FG001|Overall Study|Lost to Follow-up|0|||
25089376|NCT02078752|50198432|FG002|Overall Study|Lost to Follow-up|0|||
25089377|NCT02078752|50198433|FG003|Overall Study|Lost to Follow-up|1|||
25089378|NCT02078752|50198434|FG004|Overall Study|Lost to Follow-up|0|||
25089379|NCT02078752|50198435|FG005|Overall Study|Lost to Follow-up|0|||
25089380|NCT02078752|50198436|FG006|Overall Study|Lost to Follow-up|0|||
25089381|NCT02078752|50198437|FG007|Overall Study|Lost to Follow-up|0|||
25089382|NCT02078752|50198438|FG008|Overall Study|Lost to Follow-up|0|||
25089383|NCT02078752|50198439|FG009|Overall Study|Lost to Follow-up|0|||
25089384|NCT02078752|50198430|FG000|Overall Study|Withdrawal by Subject|1|||
25089385|NCT02078752|50198431|FG001|Overall Study|Withdrawal by Subject|1|||
25089386|NCT02078752|50198432|FG002|Overall Study|Withdrawal by Subject|1|||
25089387|NCT02078752|50198433|FG003|Overall Study|Withdrawal by Subject|1|||
25089388|NCT02078752|50198434|FG004|Overall Study|Withdrawal by Subject|0|||
25089389|NCT02078752|50198435|FG005|Overall Study|Withdrawal by Subject|3|||
25089390|NCT02078752|50198436|FG006|Overall Study|Withdrawal by Subject|2|||
25089391|NCT02078752|50198437|FG007|Overall Study|Withdrawal by Subject|1|||
25089392|NCT02078752|50198438|FG008|Overall Study|Withdrawal by Subject|0|||
25089393|NCT02078752|50198439|FG009|Overall Study|Withdrawal by Subject|1|||
25089394|NCT02078752|50198430|FG000|Overall Study|Other|0|||
25089395|NCT02078752|50198431|FG001|Overall Study|Other|3|||
24996859|NCT02963506|50087998|FG003|Dose-Blind Period|Adverse Event|0|||
24996860|NCT02963506|50087999|FG004|Dose-Blind Period|Adverse Event|0|||
24996861|NCT02963506|50088000|FG005|Dose-Blind Period|Adverse Event|1|||
24996862|NCT02963506|50088001|FG006|Dose-Blind Period|Adverse Event|3|||
24996863|NCT02963506|50088002|FG007|Dose-Blind Period|Adverse Event|2|||
24996864|NCT02963506|50088003|FG008|Dose-Blind Period|Adverse Event|2|||
24996865|NCT02963506|50088004|FG009|Dose-Blind Period|Adverse Event|2|||
24996866|NCT02963506|50088005|FG010|Dose-Blind Period|Adverse Event|1|||
24996867|NCT02963506|50088006|FG011|Dose-Blind Period|Adverse Event|1|||
24996868|NCT02963506|50088007|FG012|Dose-Blind Period|Adverse Event|6|||
24996869|NCT02963506|50087995|FG000|Dose-Blind Period|Lack of Efficacy|0|||
25089396|NCT02078752|50198432|FG002|Overall Study|Other|0|||
25089397|NCT02078752|50198433|FG003|Overall Study|Other|0|||
25089398|NCT02078752|50198434|FG004|Overall Study|Other|1|||
25089399|NCT02078752|50198435|FG005|Overall Study|Other|0|||
25089400|NCT02078752|50198436|FG006|Overall Study|Other|0|||
25089401|NCT02078752|50198437|FG007|Overall Study|Other|1|||
25089402|NCT02078752|50198438|FG008|Overall Study|Other|0|||
25089403|NCT02078752|50198439|FG009|Overall Study|Other|0|||
24996870|NCT02963506|50087996|FG001|Dose-Blind Period|Lack of Efficacy|0|||
25089404|NCT02078752|50198430|FG000|Overall Study|Study terminated by sponsor|0|||
25089405|NCT02078752|50198431|FG001|Overall Study|Study terminated by sponsor|0|||
25089406|NCT02078752|50198432|FG002|Overall Study|Study terminated by sponsor|0|||
25089407|NCT02078752|50198433|FG003|Overall Study|Study terminated by sponsor|0|||
25089408|NCT02078752|50198434|FG004|Overall Study|Study terminated by sponsor|0|||
25089409|NCT02078752|50198435|FG005|Overall Study|Study terminated by sponsor|0|||
25089410|NCT02078752|50198436|FG006|Overall Study|Study terminated by sponsor|0|||
25089411|NCT02078752|50198437|FG007|Overall Study|Study terminated by sponsor|0|||
25089412|NCT02078752|50198438|FG008|Overall Study|Study terminated by sponsor|0|||
25089413|NCT02078752|50198439|FG009|Overall Study|Study terminated by sponsor|5|||
25089414|NCT02022748|50198472|FG000|Overall Study|Adverse Event|1|||
25089415|NCT02022748|50198473|FG001|Overall Study|Adverse Event|1|||
25089416|NCT02022748|50198474|FG002|Overall Study|Adverse Event|0|||
25089417|NCT02022748|50198472|FG000|Overall Study|Withdrawal by Subject|0|||
25089418|NCT02022748|50198473|FG001|Overall Study|Withdrawal by Subject|1|||
25089419|NCT02022748|50198474|FG002|Overall Study|Withdrawal by Subject|0|||
25089420|NCT02022670|50198485|FG000|Overall Study|Adverse Event|1|||
25089421|NCT02022670|50198486|FG001|Overall Study|Adverse Event|0|||
25089422|NCT02022670|50198487|FG002|Overall Study|Adverse Event|1|||
25089423|NCT02076334|50198500|FG000|Overall Study|Protocol Violation|1|||
25089424|NCT02076334|50198501|FG001|Overall Study|Protocol Violation|0|||
25089425|NCT02076334|50198502|FG002|Overall Study|Protocol Violation|0|||
25089426|NCT02076334|50198503|FG003|Overall Study|Protocol Violation|0|||
25089427|NCT02076334|50198500|FG000|Overall Study|Lost to Follow-up|0|||
25089428|NCT02076334|50198501|FG001|Overall Study|Lost to Follow-up|1|||
25089429|NCT02076334|50198502|FG002|Overall Study|Lost to Follow-up|1|||
25089430|NCT02076334|50198503|FG003|Overall Study|Lost to Follow-up|0|||
25089431|NCT02076334|50198500|FG000|Overall Study|muscle soreness|0|||
25173278|NCT01592747|50314917|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
25173279|NCT01592747|50314918|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
25173280|NCT01592747|50314916|FG000|Overall Study|Adverse Event|1|||
25173281|NCT01592747|50314917|FG001|Overall Study|Adverse Event|0|||
25173282|NCT01592747|50314918|FG002|Overall Study|Adverse Event|0|||
25173283|NCT01592747|50314916|FG000|Overall Study|Protocol Violation|4|||
25173284|NCT01592747|50314917|FG001|Overall Study|Protocol Violation|0|||
25173285|NCT01592747|50314918|FG002|Overall Study|Protocol Violation|4|||
25173286|NCT01592747|50314916|FG000|Overall Study|Lack of Efficacy|0|||
25089432|NCT02076334|50198501|FG001|Overall Study|muscle soreness|0|||
25089433|NCT02076334|50198502|FG002|Overall Study|muscle soreness|0|||
25089434|NCT02076334|50198503|FG003|Overall Study|muscle soreness|1|||
25089435|NCT02021812|50198513|FG000|Overall Study|Death|8|||
25089436|NCT02021812|50198513|FG000|Overall Study|Withdrawal by Subject|3|||
25089437|NCT02021812|50198513|FG000|Overall Study|Lost to Follow-up|2|||
25089438|NCT02021812|50198513|FG000|Overall Study|Refuse to return, COVD 19|2|||
25089439|NCT02021656|50198517|FG000|Overall Study|Adverse Event|1|||
25089440|NCT02021656|50198517|FG000|Overall Study|Lack of Efficacy|2|||
25089441|NCT02021656|50198517|FG000|Overall Study|Lost to Follow-up|1|||
25089442|NCT02021656|50198517|FG000|Overall Study|Withdrew Consent|2|||
25089443|NCT02076022|50198527|FG000|Overall Study|Withdrawal by Subject|2|||
25089444|NCT02076022|50198528|FG001|Overall Study|Withdrawal by Subject|0|||
25089445|NCT02075632|50198536|FG000|Overall Study|Adverse Event|1|||
25089446|NCT02075632|50198537|FG001|Overall Study|Adverse Event|1|||
25089447|NCT02075632|50198536|FG000|Overall Study|Lost to Follow-up|0|||
25089448|NCT02075632|50198537|FG001|Overall Study|Lost to Follow-up|3|||
25089449|NCT02075632|50198536|FG000|Overall Study|Withdrawal by Subject|0|||
25089450|NCT02075632|50198537|FG001|Overall Study|Withdrawal by Subject|1|||
25089451|NCT02075554|50198543|FG000|Overall Study|Lost to Follow-up|7|||
25089452|NCT02075554|50198543|FG000|Overall Study|Withdrawal by Subject|5|||
25089453|NCT02075554|50198543|FG000|Overall Study|Physician Decision|3|||
25089454|NCT02075476|50198549|FG000|Overall Study|Death|2|||
25089455|NCT02075476|50198550|FG001|Overall Study|Death|2|||
25089456|NCT02075476|50198549|FG000|Overall Study|Lost to Follow-up|1|||
25089457|NCT02075476|50198550|FG001|Overall Study|Lost to Follow-up|3|||
25089458|NCT02075320|50198556|FG000|Overall Study|Withdrawal by Subject|2|||
25089459|NCT02708095|50198563|FG000|Overall Study|Adverse Event|4|||
25173287|NCT01592747|50314917|FG001|Overall Study|Lack of Efficacy|1|||
25173288|NCT01592747|50314918|FG002|Overall Study|Lack of Efficacy|0|||
25089460|NCT02708095|50198564|FG001|Overall Study|Adverse Event|10|||
25089461|NCT02708095|50198565|FG002|Overall Study|Adverse Event|11|||
25089462|NCT02708095|50198563|FG000|Overall Study|Lack of Efficacy|9|||
25089463|NCT02708095|50198564|FG001|Overall Study|Lack of Efficacy|3|||
25173289|NCT01592747|50314916|FG000|Overall Study|Withdrawal by Subject|2|||
25089464|NCT02708095|50198565|FG002|Overall Study|Lack of Efficacy|0|||
25089465|NCT02708095|50198563|FG000|Overall Study|Lost to Follow-up|2|||
25173290|NCT01592747|50314917|FG001|Overall Study|Withdrawal by Subject|0|||
25173291|NCT01592747|50314918|FG002|Overall Study|Withdrawal by Subject|2|||
25089466|NCT02708095|50198564|FG001|Overall Study|Lost to Follow-up|0|||
25089467|NCT02708095|50198565|FG002|Overall Study|Lost to Follow-up|0|||
25089468|NCT02708095|50198563|FG000|Overall Study|Physician Decision|2|||
25089469|NCT02708095|50198564|FG001|Overall Study|Physician Decision|3|||
25089470|NCT02708095|50198565|FG002|Overall Study|Physician Decision|2|||
25089471|NCT02708095|50198563|FG000|Overall Study|Protocol Violation|0|||
25089472|NCT02708095|50198564|FG001|Overall Study|Protocol Violation|0|||
25089473|NCT02708095|50198565|FG002|Overall Study|Protocol Violation|1|||
25089474|NCT02708095|50198563|FG000|Overall Study|Withdrawal by Subject|5|||
25089475|NCT02708095|50198564|FG001|Overall Study|Withdrawal by Subject|3|||
25089476|NCT02708095|50198565|FG002|Overall Study|Withdrawal by Subject|4|||
25089477|NCT02707861|50198577|FG000|Overall Study|Went onto commercial drug|30|||
25089478|NCT02707861|50198578|FG001|Overall Study|Went onto commercial drug|23|||
25089479|NCT02707861|50198577|FG000|Overall Study|Adverse Event|2|||
25089480|NCT02707861|50198578|FG001|Overall Study|Adverse Event|3|||
25089481|NCT02707861|50198577|FG000|Overall Study|Death|5|||
25089482|NCT02707861|50198578|FG001|Overall Study|Death|2|||
25089483|NCT02707861|50198577|FG000|Overall Study|Lack of Efficacy|0|||
25089484|NCT02707861|50198578|FG001|Overall Study|Lack of Efficacy|2|||
25089485|NCT02707861|50198577|FG000|Overall Study|Physician Decision|1|||
25089486|NCT02707861|50198578|FG001|Overall Study|Physician Decision|4|||
25089487|NCT02707861|50198577|FG000|Overall Study|Withdrawal by Subject|2|||
25089488|NCT02707861|50198578|FG001|Overall Study|Withdrawal by Subject|1|||
25173292|NCT01592747|50314916|FG000|Overall Study|Lost to Follow-up|1|||
25173293|NCT01592747|50314917|FG001|Overall Study|Lost to Follow-up|0|||
25089489|NCT02707861|50198577|FG000|Overall Study|Lost to Follow-up|1|||
25089490|NCT02707861|50198578|FG001|Overall Study|Lost to Follow-up|3|||
25089491|NCT02027428|50198586|FG000|Induction|Never treated|7|||
25089492|NCT02027428|50198587|FG001|Induction|Never treated|0|||
25089493|NCT02027428|50198588|FG002|Induction|Never treated|0|||
25089494|NCT02027428|50198586|FG000|Induction|Progressive disease|77|||
25089495|NCT02027428|50198587|FG001|Induction|Progressive disease|0|||
25089496|NCT02027428|50198588|FG002|Induction|Progressive disease|0|||
25089497|NCT02027428|50198586|FG000|Induction|Adverse Event|51|||
25089498|NCT02027428|50198587|FG001|Induction|Adverse Event|0|||
25089499|NCT02027428|50198588|FG002|Induction|Adverse Event|0|||
25089500|NCT02027428|50198586|FG000|Induction|Withdrawal by Subject|22|||
25089501|NCT02027428|50198587|FG001|Induction|Withdrawal by Subject|0|||
25089502|NCT02027428|50198588|FG002|Induction|Withdrawal by Subject|0|||
25173294|NCT01592747|50314918|FG002|Overall Study|Lost to Follow-up|1|||
25173295|NCT01592747|50314916|FG000|Overall Study|Other Reasons|1|||
25089503|NCT02027428|50198586|FG000|Induction|Death|21|||
25089504|NCT02027428|50198587|FG001|Induction|Death|0|||
25089505|NCT02027428|50198588|FG002|Induction|Death|0|||
25173296|NCT01592747|50314917|FG001|Overall Study|Other Reasons|1|||
25173297|NCT01592747|50314918|FG002|Overall Study|Other Reasons|0|||
25089506|NCT02027428|50198586|FG000|Induction|Symptomatic deterioration|16|||
25089507|NCT02027428|50198587|FG001|Induction|Symptomatic deterioration|0|||
25173298|NCT02051608|50314931|FG000|Part 1: Double Blind Treatment|Death|3|||
25173299|NCT02051608|50314932|FG001|Part 1: Double Blind Treatment|Death|3|||
25173300|NCT02051608|50314933|FG002|Part 1: Double Blind Treatment|Death|0|||
25173301|NCT02051608|50314934|FG003|Part 1: Double Blind Treatment|Death|0|||
25173302|NCT02051608|50314931|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
25173303|NCT02051608|50314932|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
25173304|NCT02051608|50314933|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
25173305|NCT02051608|50314934|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
25173306|NCT02051608|50314931|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
25173307|NCT02051608|50314932|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
25173308|NCT02051608|50314933|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
25173309|NCT02051608|50314934|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
25173310|NCT02051608|50314931|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
25173311|NCT02051608|50314932|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
25173312|NCT02051608|50314933|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
25173313|NCT02051608|50314934|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
25173314|NCT02051608|50314931|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
25173315|NCT02051608|50314932|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
25173316|NCT02051608|50314933|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
25173317|NCT02051608|50314934|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
25173318|NCT02051608|50314931|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
25173319|NCT02051608|50314932|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
25173320|NCT02051608|50314933|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
25173321|NCT02051608|50314934|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
25089508|NCT02027428|50198588|FG002|Induction|Symptomatic deterioration|0|||
25089509|NCT02027428|50198586|FG000|Induction|Study terminated by sponsor|12|||
25089510|NCT02027428|50198587|FG001|Induction|Study terminated by sponsor|0|||
25089511|NCT02027428|50198588|FG002|Induction|Study terminated by sponsor|0|||
25089512|NCT02027428|50198586|FG000|Induction|Protocol Violation|1|||
25089513|NCT02027428|50198587|FG001|Induction|Protocol Violation|0|||
25089514|NCT02027428|50198588|FG002|Induction|Protocol Violation|0|||
25089515|NCT02027428|50198586|FG000|Induction|Miscellaneous|14|||
25089516|NCT02027428|50198587|FG001|Induction|Miscellaneous|0|||
25089517|NCT02027428|50198588|FG002|Induction|Miscellaneous|0|||
25089518|NCT02027428|50198586|FG000|Induction|Induction Treatment Ongoing|4|||
25089519|NCT02027428|50198587|FG001|Induction|Induction Treatment Ongoing|0|||
25089520|NCT02027428|50198588|FG002|Induction|Induction Treatment Ongoing|0|||
25089521|NCT02027428|50198586|FG000|Maintenance|Death|0|||
25089522|NCT02027428|50198587|FG001|Maintenance|Death|3|||
25089523|NCT02027428|50198588|FG002|Maintenance|Death|2|||
25089524|NCT02027428|50198586|FG000|Maintenance|Adverse Event|0|||
25089525|NCT02027428|50198587|FG001|Maintenance|Adverse Event|21|||
25089526|NCT02027428|50198588|FG002|Maintenance|Adverse Event|1|||
25089527|NCT02027428|50198586|FG000|Maintenance|Progressive disease|0|||
25089528|NCT02027428|50198587|FG001|Maintenance|Progressive disease|84|||
25089529|NCT02027428|50198588|FG002|Maintenance|Progressive disease|47|||
25089530|NCT02027428|50198586|FG000|Maintenance|Symptomatic deterioration|0|||
25089531|NCT02027428|50198587|FG001|Maintenance|Symptomatic deterioration|4|||
25089532|NCT02027428|50198588|FG002|Maintenance|Symptomatic deterioration|1|||
25089533|NCT02027428|50198586|FG000|Maintenance|Withdrawal by Subject|0|||
25089534|NCT02027428|50198587|FG001|Maintenance|Withdrawal by Subject|6|||
25089535|NCT02027428|50198588|FG002|Maintenance|Withdrawal by Subject|5|||
25089536|NCT02027428|50198586|FG000|Maintenance|Protocol Violation|0|||
25089537|NCT02027428|50198587|FG001|Maintenance|Protocol Violation|0|||
25089538|NCT02027428|50198588|FG002|Maintenance|Protocol Violation|1|||
25089539|NCT02027428|50198586|FG000|Maintenance|Other|0|||
25089540|NCT02027428|50198587|FG001|Maintenance|Other|6|||
25089541|NCT02027428|50198588|FG002|Maintenance|Other|3|||
25089542|NCT02027428|50198586|FG000|Survival Follow-up|Death|0|||
25089543|NCT02027428|50198587|FG001|Survival Follow-up|Death|78|||
25089544|NCT02027428|50198588|FG002|Survival Follow-up|Death|45|||
25089545|NCT02027428|50198586|FG000|Survival Follow-up|Lost to Follow-up|0|||
25089546|NCT02027428|50198587|FG001|Survival Follow-up|Lost to Follow-up|1|||
25089547|NCT02027428|50198588|FG002|Survival Follow-up|Lost to Follow-up|1|||
25089548|NCT01995136|50198611|FG000|Overall Study|Change in residence|1|||
25089549|NCT01994902|50198615|FG000|Test Period 1|Withdrawal by Subject|3|||
25089550|NCT01994902|50198616|FG001|Test Period 1|Withdrawal by Subject|0|||
25089551|NCT01994902|50198615|FG000|Test Period 1|device deficiency with adverse event|0|||
25089552|NCT01994902|50198616|FG001|Test Period 1|device deficiency with adverse event|1|||
25089553|NCT01994902|50198615|FG000|Test Period 1|Adverse Event|2|||
25089554|NCT01994902|50198616|FG001|Test Period 1|Adverse Event|1|||
25089555|NCT01994902|50198615|FG000|Test Period 1|Lack of Efficacy|0|||
25089556|NCT01994902|50198616|FG001|Test Period 1|Lack of Efficacy|1|||
25089557|NCT01994902|50198615|FG000|Test Period 1|bag too small|1|||
25089558|NCT01994902|50198616|FG001|Test Period 1|bag too small|0|||
25089559|NCT01994902|50198615|FG000|Test Period 2|Withdrawal by Subject|0|||
25089560|NCT01994902|50198616|FG001|Test Period 2|Withdrawal by Subject|2|||
25089561|NCT01994902|50198615|FG000|Test Period 2|Lack of Efficacy|0|||
25089562|NCT01994902|50198616|FG001|Test Period 2|Lack of Efficacy|1|||
25089563|NCT01994902|50198615|FG000|Test Period 2|Other|0|||
25089564|NCT01994902|50198616|FG001|Test Period 2|Other|3|||
25089565|NCT02026258|50198624|FG000|Randomized|Did not start treatment|2|||
25089566|NCT02026258|50198625|FG001|Randomized|Did not start treatment|1|||
25089567|NCT02026258|50198624|FG000|Randomized|Change in treatment plan|1|||
25089568|NCT02026258|50198625|FG001|Randomized|Change in treatment plan|0|||
25089569|NCT02026258|50198624|FG000|Randomized|Presence of periodontal disease|1|||
25173322|NCT02051608|50314931|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
25173323|NCT02051608|50314932|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
25173324|NCT02051608|50314933|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
25173325|NCT02051608|50314934|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
25173326|NCT02051608|50314931|FG000|Part 1: Double Blind Treatment|Other|6|||
25173327|NCT02051608|50314932|FG001|Part 1: Double Blind Treatment|Other|3|||
25173328|NCT02051608|50314933|FG002|Part 1: Double Blind Treatment|Other|0|||
25173329|NCT02051608|50314934|FG003|Part 1: Double Blind Treatment|Other|0|||
25173330|NCT02051608|50314931|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
25173331|NCT02051608|50314932|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
25173332|NCT02051608|50314933|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
25173333|NCT02051608|50314934|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
25173334|NCT02051608|50314931|FG000|Part 2: Open-label Extension|Adverse Event|0|||
25173335|NCT02051608|50314932|FG001|Part 2: Open-label Extension|Adverse Event|0|||
25173336|NCT02051608|50314933|FG002|Part 2: Open-label Extension|Adverse Event|6|||
25173337|NCT02051608|50314934|FG003|Part 2: Open-label Extension|Adverse Event|8|||
25173338|NCT02051608|50314931|FG000|Part 2: Open-label Extension|Death|0|||
25089570|NCT02026258|50198625|FG001|Randomized|Presence of periodontal disease|1|||
25089571|NCT02026258|50198624|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
25089572|NCT02026258|50198625|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
25089573|NCT02026258|50198624|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
25089574|NCT02026258|50198625|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
25089575|NCT01994590|50198632|FG000|Overall Study|Adverse Event|1|||
25089576|NCT01994590|50198632|FG000|Overall Study|Trial Terminated|1|||
25173339|NCT02051608|50314932|FG001|Part 2: Open-label Extension|Death|0|||
25173340|NCT02051608|50314933|FG002|Part 2: Open-label Extension|Death|7|||
25089577|NCT02019550|50198638|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
25089578|NCT02019550|50198639|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
25089579|NCT02019472|50198650|FG000|Overall Study|Adverse Event|14|||
25089580|NCT02019472|50198651|FG001|Overall Study|Adverse Event|23|||
25089581|NCT02019472|50198652|FG002|Overall Study|Adverse Event|17|||
25173341|NCT02051608|50314934|FG003|Part 2: Open-label Extension|Death|4|||
25173342|NCT02051608|50314931|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
25173343|NCT02051608|50314932|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
25173344|NCT02051608|50314933|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
25173345|NCT02051608|50314934|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
25173346|NCT02051608|50314931|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
25173347|NCT02051608|50314932|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
25173348|NCT02051608|50314933|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
25173349|NCT02051608|50314934|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
25173350|NCT02051608|50314931|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
25173351|NCT02051608|50314932|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
25173352|NCT02051608|50314933|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
25173353|NCT02051608|50314934|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
25173354|NCT02051608|50314931|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
25173355|NCT02051608|50314932|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
25173356|NCT02051608|50314933|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
25173357|NCT02051608|50314934|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
25173358|NCT02051608|50314931|FG000|Part 2: Open-label Extension|Physician Decision|0|||
25173359|NCT02051608|50314932|FG001|Part 2: Open-label Extension|Physician Decision|0|||
25173360|NCT02051608|50314933|FG002|Part 2: Open-label Extension|Physician Decision|8|||
25173361|NCT02051608|50314934|FG003|Part 2: Open-label Extension|Physician Decision|5|||
25173362|NCT02051608|50314931|FG000|Part 2: Open-label Extension|Other|0|||
25173363|NCT02051608|50314932|FG001|Part 2: Open-label Extension|Other|0|||
25173364|NCT02051608|50314933|FG002|Part 2: Open-label Extension|Other|9|||
25173365|NCT02051608|50314934|FG003|Part 2: Open-label Extension|Other|9|||
25173366|NCT02705586|50314947|FG000|Overall Study|Health Issues|2|||
25173367|NCT02705586|50314947|FG000|Overall Study|Transportation Difficulties|5|||
25173368|NCT02705586|50314947|FG000|Overall Study|Vacation/Planned Absence|1|||
25173369|NCT01592045|50314953|FG000|Overall Study|Disease Progression|1|||
25173370|NCT01592045|50314954|FG001|Overall Study|Disease Progression|1|||
25173371|NCT01592045|50314953|FG000|Overall Study|Adverse Event|1|||
25173372|NCT01592045|50314954|FG001|Overall Study|Adverse Event|1|||
25089582|NCT02019472|50198650|FG000|Overall Study|Death|0|||
25089583|NCT02019472|50198651|FG001|Overall Study|Death|1|||
25089584|NCT02019472|50198652|FG002|Overall Study|Death|1|||
25089585|NCT02019472|50198650|FG000|Overall Study|Lack of Efficacy|7|||
25089586|NCT02019472|50198651|FG001|Overall Study|Lack of Efficacy|4|||
25173373|NCT01592045|50314953|FG000|Overall Study|Withdrawal by Subject|1|||
25173374|NCT01592045|50314954|FG001|Overall Study|Withdrawal by Subject|0|||
25173375|NCT01592045|50314953|FG000|Overall Study|Moved out of country|2|||
25173376|NCT01592045|50314954|FG001|Overall Study|Moved out of country|0|||
25173377|NCT01591499|50314962|FG000|Baseline Visit|Withdrawal by Subject|0|||
25173378|NCT01591499|50314963|FG001|Baseline Visit|Withdrawal by Subject|2|||
25173379|NCT01591499|50314964|FG002|Baseline Visit|Withdrawal by Subject|0|||
25173380|NCT01591499|50314965|FG003|Baseline Visit|Withdrawal by Subject|2|||
25173381|NCT01591499|50314962|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
25173382|NCT01591499|50314963|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
25173383|NCT01591499|50314964|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
25173384|NCT01591499|50314965|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
25173385|NCT01591499|50314962|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
25173386|NCT01591499|50314963|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
25173387|NCT01591499|50314964|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
25173388|NCT01591499|50314965|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
25173389|NCT01981720|50314989|FG000|Overall Study|Adverse Event|1|||
25173390|NCT01981720|50314989|FG000|Overall Study|Withdrawal by Subject|3|||
25173391|NCT01981720|50314989|FG000|Overall Study|Pregnancy|1|||
25173392|NCT01590797|50314999|FG000|Overall Study|Adverse Event|4|||
25173393|NCT01590797|50315000|FG001|Overall Study|Adverse Event|3|||
25173394|NCT01590797|50314999|FG000|Overall Study|Lack of Efficacy|0|||
25173395|NCT01590797|50315000|FG001|Overall Study|Lack of Efficacy|2|||
25173396|NCT01590797|50314999|FG000|Overall Study|Lost to Follow-up|0|||
25173397|NCT01590797|50315000|FG001|Overall Study|Lost to Follow-up|1|||
25089587|NCT02019472|50198652|FG002|Overall Study|Lack of Efficacy|4|||
25173398|NCT01590797|50314999|FG000|Overall Study|Protocol Violation|4|||
25173399|NCT01590797|50315000|FG001|Overall Study|Protocol Violation|1|||
25173400|NCT01590797|50314999|FG000|Overall Study|Withdrawal by Subject|7|||
25173401|NCT01590797|50315000|FG001|Overall Study|Withdrawal by Subject|5|||
25173402|NCT01590797|50314999|FG000|Overall Study|Other Protocol Specified Criteria|2|||
25173403|NCT01590797|50315000|FG001|Overall Study|Other Protocol Specified Criteria|4|||
25173404|NCT01590563|50315006|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
25173405|NCT01867606|50315013|FG000|Overall Study|Withdrawal by Subject|10|||
25173406|NCT01867606|50315014|FG001|Overall Study|Withdrawal by Subject|14|||
25173407|NCT01867606|50315013|FG000|Overall Study|Protocol Violation|0|||
25173408|NCT01867606|50315014|FG001|Overall Study|Protocol Violation|1|||
25173409|NCT01701401|50315030|FG000|Overall Study|Randomized But Not Treated|3|||
25173410|NCT01701401|50315031|FG001|Overall Study|Randomized But Not Treated|1|||
25173411|NCT01701401|50315032|FG002|Overall Study|Randomized But Not Treated|0|||
25089588|NCT02019472|50198650|FG000|Overall Study|Lost to Follow-up|0|||
25089589|NCT02019472|50198651|FG001|Overall Study|Lost to Follow-up|2|||
25089590|NCT02019472|50198652|FG002|Overall Study|Lost to Follow-up|1|||
25089591|NCT02019472|50198650|FG000|Overall Study|Physician Decision|1|||
25089592|NCT02019472|50198651|FG001|Overall Study|Physician Decision|2|||
25089593|NCT02019472|50198652|FG002|Overall Study|Physician Decision|0|||
25089594|NCT02019472|50198650|FG000|Overall Study|Pregnancy|1|||
25089595|NCT02019472|50198651|FG001|Overall Study|Pregnancy|2|||
25089596|NCT02019472|50198652|FG002|Overall Study|Pregnancy|2|||
25089597|NCT02019472|50198650|FG000|Overall Study|Withdrawal by Subject|11|||
25089598|NCT02019472|50198651|FG001|Overall Study|Withdrawal by Subject|10|||
25089599|NCT02019472|50198652|FG002|Overall Study|Withdrawal by Subject|11|||
25173412|NCT01701401|50315033|FG003|Overall Study|Randomized But Not Treated|1|||
25173413|NCT01701401|50315030|FG000|Overall Study|Lost to Follow-up|5|||
25173414|NCT01701401|50315031|FG001|Overall Study|Lost to Follow-up|5|||
25173415|NCT01701401|50315032|FG002|Overall Study|Lost to Follow-up|1|||
25173416|NCT01701401|50315033|FG003|Overall Study|Lost to Follow-up|3|||
25173417|NCT01701401|50315030|FG000|Overall Study|Withdrew Consent|0|||
25173418|NCT01701401|50315031|FG001|Overall Study|Withdrew Consent|3|||
25173419|NCT01701401|50315032|FG002|Overall Study|Withdrew Consent|1|||
25173420|NCT01701401|50315033|FG003|Overall Study|Withdrew Consent|2|||
25173421|NCT01701401|50315030|FG000|Overall Study|Lack of Efficacy|1|||
25173422|NCT01701401|50315031|FG001|Overall Study|Lack of Efficacy|0|||
25173423|NCT01701401|50315032|FG002|Overall Study|Lack of Efficacy|2|||
25173424|NCT01701401|50315033|FG003|Overall Study|Lack of Efficacy|0|||
25173425|NCT01701401|50315030|FG000|Overall Study|Adverse Event|1|||
25173426|NCT01701401|50315031|FG001|Overall Study|Adverse Event|0|||
25173427|NCT01701401|50315032|FG002|Overall Study|Adverse Event|0|||
25173428|NCT01701401|50315033|FG003|Overall Study|Adverse Event|0|||
25173429|NCT01701401|50315030|FG000|Overall Study|Protocol Violation|0|||
25173430|NCT01701401|50315031|FG001|Overall Study|Protocol Violation|0|||
25173431|NCT01701401|50315032|FG002|Overall Study|Protocol Violation|1|||
25173432|NCT01701401|50315033|FG003|Overall Study|Protocol Violation|0|||
25173433|NCT01701245|50315045|FG000|Overall Study|Protocol Violation|1|||
25173434|NCT01701245|50315046|FG001|Overall Study|Protocol Violation|3|||
25173435|NCT01701245|50315045|FG000|Overall Study|Did not complete the open label period|11|||
25173436|NCT01701245|50315046|FG001|Overall Study|Did not complete the open label period|12|||
25173437|NCT01590017|50315052|FG000|Overall Study|Adverse Event|1|||
25173438|NCT01590017|50315052|FG000|Overall Study|Withdrawal by Subject|1|||
25173439|NCT01590017|50315052|FG000|Overall Study|Lack of Efficacy|1|||
25173440|NCT01590017|50315052|FG000|Overall Study|Physician Decision|1|||
25173441|NCT01700621|50315058|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
25089600|NCT02019472|50198650|FG000|Overall Study|Other|3|||
25089601|NCT02019472|50198651|FG001|Overall Study|Other|8|||
25089602|NCT02019472|50198652|FG002|Overall Study|Other|6|||
25089603|NCT02705755|50198664|FG000|Part A (6 Days)|Adverse Event|1|||
25089604|NCT02705755|50198665|FG001|Part A (6 Days)|Adverse Event|0|||
25089605|NCT02705755|50198666|FG002|Part A (6 Days)|Adverse Event|0|||
25089606|NCT02705755|50198667|FG003|Part A (6 Days)|Adverse Event|0|||
25089607|NCT02705755|50198664|FG000|Part A (6 Days)|Physician Decision|3|||
25089608|NCT02705755|50198665|FG001|Part A (6 Days)|Physician Decision|0|||
25089609|NCT02705755|50198666|FG002|Part A (6 Days)|Physician Decision|0|||
25089610|NCT02705755|50198667|FG003|Part A (6 Days)|Physician Decision|0|||
25089611|NCT02705755|50198664|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
25173442|NCT01700621|50315059|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
25173443|NCT01700621|50315058|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
25173444|NCT01700621|50315059|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
25089612|NCT02705755|50198665|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
25173445|NCT01700621|50315058|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
25173446|NCT01700621|50315059|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
25089613|NCT02705755|50198666|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
25089614|NCT02705755|50198667|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
25089615|NCT02705755|50198664|FG000|Part C (20 Weeks)|Physician Decision|0|||
25089616|NCT02705755|50198665|FG001|Part C (20 Weeks)|Physician Decision|0|||
25173447|NCT01589237|50315070|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
25173448|NCT01589237|50315071|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
25173449|NCT01589237|50315072|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
25089617|NCT02705755|50198666|FG002|Part C (20 Weeks)|Physician Decision|0|||
25089618|NCT02705755|50198667|FG003|Part C (20 Weeks)|Physician Decision|2|||
25089619|NCT02705755|50198664|FG000|Part C (20 Weeks)|Adverse Event|0|||
25089620|NCT02705755|50198665|FG001|Part C (20 Weeks)|Adverse Event|0|||
25089621|NCT02705755|50198666|FG002|Part C (20 Weeks)|Adverse Event|0|||
25089622|NCT02705755|50198667|FG003|Part C (20 Weeks)|Adverse Event|6|||
25089623|NCT02705755|50198664|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
25089624|NCT02705755|50198665|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
25089625|NCT02705755|50198666|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
25089626|NCT02705755|50198667|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
25089627|NCT02024932|50198700|FG000|Overall Study|Adverse Event|2|||
25089628|NCT02024932|50198701|FG001|Overall Study|Adverse Event|3|||
25089629|NCT02024932|50198702|FG002|Overall Study|Adverse Event|0|||
25089630|NCT02024932|50198703|FG003|Overall Study|Adverse Event|0|||
25089631|NCT02024932|50198704|FG004|Overall Study|Adverse Event|2|||
25089632|NCT02024932|50198705|FG005|Overall Study|Adverse Event|0|||
25089633|NCT02024932|50198700|FG000|Overall Study|Abnormal laboratory value|0|||
25089634|NCT02024932|50198701|FG001|Overall Study|Abnormal laboratory value|0|||
25089635|NCT02024932|50198702|FG002|Overall Study|Abnormal laboratory value|0|||
25089636|NCT02024932|50198703|FG003|Overall Study|Abnormal laboratory value|2|||
25089637|NCT02024932|50198704|FG004|Overall Study|Abnormal laboratory value|0|||
25089638|NCT02024932|50198705|FG005|Overall Study|Abnormal laboratory value|0|||
25089639|NCT01993888|50198736|FG000|Overall Study|Death|1|||
25089640|NCT01993888|50198737|FG001|Overall Study|Death|1|||
25089641|NCT01993888|50198736|FG000|Overall Study|Lost to Follow-up|1|||
25089642|NCT01993888|50198737|FG001|Overall Study|Lost to Follow-up|1|||
25089643|NCT01993888|50198736|FG000|Overall Study|Withdrawal by Subject|0|||
25089644|NCT01993888|50198737|FG001|Overall Study|Withdrawal by Subject|1|||
25089645|NCT02024698|50198743|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
25089646|NCT02024698|50198744|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
25089647|NCT02018458|50198750|FG000|Overall Study|Death|4|||
25089648|NCT02017522|50198754|FG000|Overall Study|Withdrawal by Subject|1|||
25089649|NCT02017444|50198761|FG000|Overall Study|Physician Decision|1|||
25089650|NCT02017444|50198762|FG001|Overall Study|Physician Decision|0|||
25089651|NCT02017444|50198761|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
25089652|NCT02017444|50198762|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
25089653|NCT01993186|50198770|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
25089654|NCT01993186|50198771|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
25089655|NCT01993186|50198770|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
25089656|NCT01993186|50198771|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
25089657|NCT01993186|50198770|FG000|Open-Label Extension Period|Other, Not Specified|0|||
25089658|NCT01993186|50198771|FG001|Open-Label Extension Period|Other, Not Specified|1|||
25089659|NCT01993186|50198770|FG000|Open-Label Extension Period|Adverse Event|1|||
25089660|NCT01993186|50198771|FG001|Open-Label Extension Period|Adverse Event|0|||
25089661|NCT01993186|50198770|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
25089662|NCT01993186|50198771|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
25089663|NCT01993186|50198770|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
25089664|NCT01993186|50198771|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
25089665|NCT01993186|50198770|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
25089666|NCT01993186|50198771|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
25089667|NCT02016898|50198780|FG000|Overall Study|Death|1|||
25089668|NCT02016898|50198781|FG001|Overall Study|Death|1|||
25089669|NCT02016898|50198780|FG000|Overall Study|Lost to Follow-up|4|||
25089670|NCT02016898|50198781|FG001|Overall Study|Lost to Follow-up|4|||
25089671|NCT01993030|50198789|FG000|Overall Study|Adverse Event|0|||
25089672|NCT01993030|50198790|FG001|Overall Study|Adverse Event|4|||
25089673|NCT01992094|50198799|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
25089674|NCT01992094|50198800|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
25089675|NCT01992094|50198801|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
25089676|NCT01992094|50198799|FG000|Overall Study|Adverse Event|1|||
25089677|NCT01992094|50198800|FG001|Overall Study|Adverse Event|0|||
25089678|NCT01992094|50198801|FG002|Overall Study|Adverse Event|0|||
25173450|NCT01589237|50315073|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
25173451|NCT01589237|50315070|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
25089679|NCT01992094|50198799|FG000|Overall Study|Death|5|||
25089680|NCT01992094|50198800|FG001|Overall Study|Death|5|||
25089681|NCT01992094|50198801|FG002|Overall Study|Death|2|||
25089682|NCT01992094|50198799|FG000|Overall Study|Lost to Follow-up|26|||
25089683|NCT01992094|50198800|FG001|Overall Study|Lost to Follow-up|9|||
25089684|NCT01992094|50198801|FG002|Overall Study|Lost to Follow-up|13|||
25089685|NCT01992094|50198799|FG000|Overall Study|OTHER|4|||
25089686|NCT01992094|50198800|FG001|Overall Study|OTHER|0|||
25089687|NCT01992094|50198801|FG002|Overall Study|OTHER|0|||
25089688|NCT01992094|50198799|FG000|Overall Study|Protocol Violation|1|||
25089689|NCT01992094|50198800|FG001|Overall Study|Protocol Violation|0|||
25089690|NCT01992094|50198801|FG002|Overall Study|Protocol Violation|1|||
25089691|NCT01992094|50198799|FG000|Overall Study|Withdrawal by Subject|7|||
25089692|NCT01992094|50198800|FG001|Overall Study|Withdrawal by Subject|3|||
25089693|NCT01992094|50198801|FG002|Overall Study|Withdrawal by Subject|4|||
25089694|NCT02706691|50198825|FG000|Overall Study|Adverse Event|1|||
25089695|NCT01991470|50198830|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
25089696|NCT01991470|50198830|FG000|Enlite 1 Period|Adverse Event|1|||
25089697|NCT01991470|50198830|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
25089698|NCT01991470|50198830|FG000|Enlite 3 Period|Lost to Follow-up|1|||
25089699|NCT01991470|50198830|FG000|Enlite 3 Period|Physician Decision|2|||
25089700|NCT01991470|50198830|FG000|Enlite 3 Period|Physician Decision|8|||
25089701|NCT01991470|50198830|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
25173452|NCT01589237|50315071|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
25089702|NCT01991314|50198844|FG000|Overall Study|Adverse Event|5|||
24996871|NCT02963506|50087997|FG002|Dose-Blind Period|Lack of Efficacy|0|||
24996872|NCT02963506|50087998|FG003|Dose-Blind Period|Lack of Efficacy|0|||
24996873|NCT02963506|50087999|FG004|Dose-Blind Period|Lack of Efficacy|0|||
25089703|NCT01991314|50198845|FG001|Overall Study|Adverse Event|1|||
25089704|NCT01991314|50198844|FG000|Overall Study|Lost to Follow-up|6|||
25089705|NCT01991314|50198845|FG001|Overall Study|Lost to Follow-up|10|||
25089706|NCT01990768|50198854|FG000|Intervention Started|Found to be ineligible|14|||
25089707|NCT01990768|50198855|FG001|Intervention Started|Found to be ineligible|13|||
25173453|NCT01589237|50315072|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
25173454|NCT01589237|50315073|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
25173455|NCT01589237|50315070|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
25173456|NCT01589237|50315071|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
25173457|NCT01589237|50315072|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
25173458|NCT01589237|50315073|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
25173459|NCT01589237|50315070|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
25173460|NCT01589237|50315071|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
24996874|NCT02963506|50088000|FG005|Dose-Blind Period|Lack of Efficacy|0|||
25089708|NCT01990768|50198856|FG002|Intervention Started|Found to be ineligible|11|||
25089709|NCT01990768|50198854|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
25089710|NCT01990768|50198855|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
25089711|NCT01990768|50198856|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
25089712|NCT01990768|50198854|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
25089713|NCT01990768|50198855|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
25089714|NCT01990768|50198856|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
25089715|NCT01990768|50198854|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
25089716|NCT01990768|50198855|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
25089717|NCT01990768|50198856|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
25089718|NCT01990768|50198854|FG000|Intervention Started|Patient care priority|1|||
25089719|NCT01990768|50198855|FG001|Intervention Started|Patient care priority|2|||
25089720|NCT01990768|50198856|FG002|Intervention Started|Patient care priority|3|||
25089721|NCT01990768|50198854|FG000|Intervention Started|IV lost|2|||
25089722|NCT01990768|50198855|FG001|Intervention Started|IV lost|2|||
25089723|NCT01990768|50198856|FG002|Intervention Started|IV lost|2|||
25089724|NCT01990768|50198854|FG000|Intervention Started|Required CPR|1|||
25089725|NCT01990768|50198855|FG001|Intervention Started|Required CPR|1|||
25089726|NCT01990768|50198856|FG002|Intervention Started|Required CPR|0|||
25089727|NCT01990768|50198854|FG000|Intervention Started|Seizure or hx of seizure|0|||
25089728|NCT01990768|50198855|FG001|Intervention Started|Seizure or hx of seizure|0|||
25089729|NCT01990768|50198856|FG002|Intervention Started|Seizure or hx of seizure|2|||
25089730|NCT01990768|50198854|FG000|Intervention Started|Discovered to be pregnant|0|||
25089731|NCT01990768|50198855|FG001|Intervention Started|Discovered to be pregnant|1|||
25089732|NCT01990768|50198856|FG002|Intervention Started|Discovered to be pregnant|0|||
25089733|NCT01990768|50198854|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
25089734|NCT01990768|50198855|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
25089735|NCT01990768|50198856|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
25089736|NCT01990768|50198854|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
24996875|NCT02963506|50088001|FG006|Dose-Blind Period|Lack of Efficacy|0|||
24996876|NCT02963506|50088002|FG007|Dose-Blind Period|Lack of Efficacy|1|||
25089737|NCT01990768|50198855|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
25089738|NCT01990768|50198856|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
25089739|NCT01990768|50198854|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
25089740|NCT01990768|50198855|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
25089741|NCT01990768|50198856|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
25089742|NCT01990768|50198854|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
25089743|NCT01990768|50198855|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
25173461|NCT01589237|50315072|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
25173462|NCT01589237|50315073|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
25173463|NCT01700387|50315089|FG000|Overall Study|Withdrawal by Subject|1|||
25173464|NCT01700387|50315090|FG001|Overall Study|Withdrawal by Subject|2|||
25173465|NCT01700387|50315089|FG000|Overall Study|Adverse Event|1|||
25089744|NCT01990768|50198856|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
25089745|NCT01990768|50198854|FG000|Prehospital Study Drug Infusion|Death|3|||
25173466|NCT01700387|50315090|FG001|Overall Study|Adverse Event|1|||
25089746|NCT01990768|50198855|FG001|Prehospital Study Drug Infusion|Death|1|||
25089747|NCT01990768|50198856|FG002|Prehospital Study Drug Infusion|Death|1|||
25089748|NCT01990768|50198854|FG000|Prehospital Study Drug Infusion|Discharged|2|||
25089749|NCT01990768|50198855|FG001|Prehospital Study Drug Infusion|Discharged|1|||
25089750|NCT01990768|50198856|FG002|Prehospital Study Drug Infusion|Discharged|0|||
25089751|NCT01990768|50198854|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
25089752|NCT01990768|50198855|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
25089753|NCT01990768|50198856|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
25089754|NCT01990768|50198854|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
25089755|NCT01990768|50198855|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
25173467|NCT01700387|50315089|FG000|Overall Study|Lost to Follow-up|2|||
25173468|NCT01700387|50315090|FG001|Overall Study|Lost to Follow-up|1|||
25173469|NCT01699685|50315102|FG000|Period 1|Adverse Event|1|||
25173470|NCT01699685|50315103|FG001|Period 1|Adverse Event|1|||
25173471|NCT01699685|50315102|FG000|Period 1|Medical or ethical, noncompliance|2|||
25173472|NCT01699685|50315103|FG001|Period 1|Medical or ethical, noncompliance|0|||
25173473|NCT01699685|50315102|FG000|Period 1|Other|0|||
25173474|NCT01699685|50315103|FG001|Period 1|Other|1|||
25173475|NCT01699685|50315102|FG000|Period 1|Patient request|0|||
25173476|NCT01699685|50315103|FG001|Period 1|Patient request|1|||
25173477|NCT01699685|50315102|FG000|Period 2|Lost to Follow-up|1|||
25173478|NCT01699685|50315103|FG001|Period 2|Lost to Follow-up|0|||
25173479|NCT01587989|50315111|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
25173480|NCT01587989|50315112|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
25173481|NCT01587989|50315113|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
25173482|NCT01587989|50315111|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
25173483|NCT01587989|50315112|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
25173484|NCT01587989|50315113|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
25173485|NCT01587989|50315111|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
25173486|NCT01587989|50315112|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
25173487|NCT01587989|50315113|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
25173488|NCT01587989|50315111|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
25173489|NCT01587989|50315112|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
25173490|NCT01587989|50315113|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
25173491|NCT01587989|50315111|FG000|Randomized Study Treatment|Screening failure|0|||
25173492|NCT01587989|50315112|FG001|Randomized Study Treatment|Screening failure|1|||
25173493|NCT01587989|50315113|FG002|Randomized Study Treatment|Screening failure|0|||
25173494|NCT01587989|50315111|FG000|Randomized Study Treatment|Physician Decision|0|||
25173495|NCT01587989|50315112|FG001|Randomized Study Treatment|Physician Decision|0|||
25173496|NCT01587989|50315113|FG002|Randomized Study Treatment|Physician Decision|1|||
25173497|NCT01697969|50315119|FG000|Overall Study|Did not meet inc/exc criteria|3|||
25173498|NCT01586819|50315126|FG000|Overall Study|Withdrawal by Subject|1|||
25173499|NCT01586819|50315127|FG001|Overall Study|Withdrawal by Subject|0|||
25173500|NCT01697579|50315138|FG000|Base Study-Cycle 1|Adverse Event|1|||
25173501|NCT01697579|50315139|FG001|Base Study-Cycle 1|Adverse Event|0|||
25173502|NCT01697579|50315140|FG002|Base Study-Cycle 1|Adverse Event|0|||
25173503|NCT01697579|50315141|FG003|Base Study-Cycle 1|Adverse Event|0|||
25173504|NCT01697579|50315142|FG004|Base Study-Cycle 1|Adverse Event|0|||
25173505|NCT01697579|50315143|FG005|Base Study-Cycle 1|Adverse Event|0|||
25173506|NCT01697579|50315144|FG006|Base Study-Cycle 1|Adverse Event|0|||
25173507|NCT01697579|50315138|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
25173508|NCT01697579|50315139|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
25173509|NCT01697579|50315140|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
25089756|NCT01990768|50198856|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
25089757|NCT01990768|50198854|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
25089758|NCT01990768|50198855|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
25089759|NCT01990768|50198856|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
25173510|NCT01697579|50315141|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
25173511|NCT01697579|50315142|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
25173512|NCT01697579|50315143|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
25173513|NCT01697579|50315144|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
25173514|NCT01697579|50315138|FG000|Base Study-Cycle 1|Protocol Violation|0|||
25173515|NCT01697579|50315139|FG001|Base Study-Cycle 1|Protocol Violation|0|||
25173516|NCT01697579|50315140|FG002|Base Study-Cycle 1|Protocol Violation|0|||
25089760|NCT01990768|50198854|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
25089761|NCT01990768|50198855|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
25089762|NCT01990768|50198856|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
25089763|NCT01990768|50198854|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
25089764|NCT01990768|50198855|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
25089765|NCT01990768|50198856|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
25173517|NCT01697579|50315141|FG003|Base Study-Cycle 1|Protocol Violation|0|||
25173518|NCT01697579|50315142|FG004|Base Study-Cycle 1|Protocol Violation|3|||
25173519|NCT01697579|50315143|FG005|Base Study-Cycle 1|Protocol Violation|0|||
25173520|NCT01697579|50315144|FG006|Base Study-Cycle 1|Protocol Violation|0|||
25173521|NCT01697579|50315138|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
25173522|NCT01697579|50315139|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
25089766|NCT01990768|50198854|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
25089767|NCT01990768|50198855|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
25089768|NCT01990768|50198856|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
25089769|NCT01990768|50198854|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
25089770|NCT01990768|50198855|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
25089771|NCT01990768|50198856|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
25089772|NCT01990768|50198854|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
25089773|NCT01990768|50198855|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
25089774|NCT01990768|50198856|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
25089775|NCT01990768|50198854|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
25089776|NCT01990768|50198855|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
25089777|NCT01990768|50198856|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
25089778|NCT01990768|50198854|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
25089779|NCT01990768|50198855|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
25173523|NCT01697579|50315140|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
25173524|NCT01697579|50315141|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
25173525|NCT01697579|50315142|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
25173526|NCT01697579|50315143|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
25173527|NCT01697579|50315144|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
25173528|NCT01697579|50315138|FG000|Base Study-Cycle 1|Technical Problems|0|||
25089780|NCT01990768|50198856|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
25089781|NCT01990768|50198854|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
25089782|NCT01990768|50198855|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
25173529|NCT01697579|50315139|FG001|Base Study-Cycle 1|Technical Problems|0|||
25173530|NCT01697579|50315140|FG002|Base Study-Cycle 1|Technical Problems|1|||
25173531|NCT01697579|50315141|FG003|Base Study-Cycle 1|Technical Problems|1|||
25173532|NCT01697579|50315142|FG004|Base Study-Cycle 1|Technical Problems|0|||
25173533|NCT01697579|50315143|FG005|Base Study-Cycle 1|Technical Problems|0|||
25089783|NCT01990768|50198856|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
25089784|NCT01990768|50198854|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
25089785|NCT01990768|50198855|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
25089786|NCT01990768|50198856|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
25089787|NCT01990768|50198854|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
25089788|NCT01990768|50198855|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
25089789|NCT01990768|50198856|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
25089790|NCT01990768|50198854|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
25089791|NCT01990768|50198855|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
25089792|NCT01990768|50198856|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
25089793|NCT01990768|50198854|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
25089794|NCT01990768|50198855|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
25089795|NCT01990768|50198856|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
25089796|NCT01990768|50198854|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
25173534|NCT01697579|50315144|FG006|Base Study-Cycle 1|Technical Problems|0|||
25173535|NCT01697579|50315138|FG000|Optional Extension-Cycles 2-6|Death|0|||
25173536|NCT01697579|50315139|FG001|Optional Extension-Cycles 2-6|Death|0|||
25173537|NCT01697579|50315140|FG002|Optional Extension-Cycles 2-6|Death|0|||
25173538|NCT01697579|50315141|FG003|Optional Extension-Cycles 2-6|Death|0|||
25173539|NCT01697579|50315142|FG004|Optional Extension-Cycles 2-6|Death|0|||
25173540|NCT01697579|50315143|FG005|Optional Extension-Cycles 2-6|Death|0|||
25173541|NCT01697579|50315144|FG006|Optional Extension-Cycles 2-6|Death|2|||
25173542|NCT01697579|50315138|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
25173543|NCT01697579|50315139|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
25173544|NCT01697579|50315140|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
25173545|NCT01697579|50315141|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
25173546|NCT01697579|50315142|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
25173547|NCT01697579|50315143|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
25173548|NCT01697579|50315144|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
25173549|NCT01697579|50315138|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
25173550|NCT01697579|50315139|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
25173551|NCT01697579|50315140|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
25173552|NCT01697579|50315141|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
25173553|NCT01697579|50315142|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
25173554|NCT01697579|50315143|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
25173555|NCT01697579|50315144|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
25173556|NCT01697579|50315138|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
25173557|NCT01697579|50315139|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
25173558|NCT01697579|50315140|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
25173559|NCT01697579|50315141|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
25173560|NCT01697579|50315142|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
25173561|NCT01697579|50315143|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
25173562|NCT01697579|50315144|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
25173563|NCT01697579|50315138|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
25173564|NCT01697579|50315139|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
25173565|NCT01697579|50315140|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
25173566|NCT01697579|50315141|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
25173567|NCT01697579|50315142|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
25173568|NCT01697579|50315143|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
25173569|NCT01697579|50315144|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
25173570|NCT01697579|50315138|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
25173571|NCT01697579|50315139|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
25173572|NCT01697579|50315140|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
25173573|NCT01697579|50315141|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
25173574|NCT01697579|50315142|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
25173575|NCT01697579|50315143|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
25173576|NCT01697579|50315144|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
25173577|NCT01697579|50315138|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
25173578|NCT01697579|50315139|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
25173579|NCT01697579|50315140|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
25173580|NCT01697579|50315141|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
25173581|NCT01697579|50315142|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
25173582|NCT01697579|50315143|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
25173583|NCT01697579|50315144|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
25173584|NCT01697579|50315138|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
25173585|NCT01697579|50315139|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
25173586|NCT01697579|50315140|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
25173587|NCT01697579|50315141|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
25173588|NCT01697579|50315142|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
25173589|NCT01697579|50315143|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
25173590|NCT01697579|50315144|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
25173591|NCT01697579|50315138|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
25173592|NCT01697579|50315139|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
25173593|NCT01697579|50315140|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
25173594|NCT01697579|50315141|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
25173595|NCT01697579|50315142|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
25173596|NCT01697579|50315143|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
25173597|NCT01697579|50315144|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
25173598|NCT01697579|50315138|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
25173599|NCT01697579|50315139|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
25173600|NCT01697579|50315140|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
25173601|NCT01697579|50315141|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
25173602|NCT01697579|50315142|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
25173603|NCT01697579|50315143|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
25173604|NCT01697579|50315144|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
25173605|NCT01697579|50315138|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
25173606|NCT01697579|50315139|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
25173607|NCT01697579|50315140|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
25173608|NCT01697579|50315141|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
25173609|NCT01697579|50315142|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
25173610|NCT01697579|50315143|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
25173611|NCT01697579|50315144|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
25173612|NCT01697579|50315138|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
25173613|NCT01697579|50315139|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
25173614|NCT01697579|50315140|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
25173615|NCT01697579|50315141|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
25173616|NCT01697579|50315142|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
25173617|NCT01697579|50315143|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
25173618|NCT01697579|50315144|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
25173619|NCT01697579|50315138|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
25173620|NCT01697579|50315139|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
25173621|NCT01697579|50315140|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
25089797|NCT01990768|50198855|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
25089798|NCT01990768|50198856|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
25089799|NCT01990768|50198854|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
25089800|NCT01990768|50198855|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
25089801|NCT01990768|50198856|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
25089802|NCT01990768|50198854|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
25089803|NCT01990768|50198855|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
25089804|NCT01990768|50198856|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
25089805|NCT01990768|50198854|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
25089806|NCT01990768|50198855|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
25089807|NCT01990768|50198856|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
25089808|NCT01990768|50198854|FG000|6-Month Follow-up|No contact information|5|||
25089809|NCT01990768|50198855|FG001|6-Month Follow-up|No contact information|6|||
25089810|NCT01990768|50198856|FG002|6-Month Follow-up|No contact information|5|||
25089811|NCT01990768|50198854|FG000|6-Month Follow-up|Homeless|4|||
25089812|NCT01990768|50198855|FG001|6-Month Follow-up|Homeless|3|||
25089813|NCT01990768|50198856|FG002|6-Month Follow-up|Homeless|6|||
25089814|NCT01990768|50198854|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
25089815|NCT01990768|50198855|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
25089816|NCT01990768|50198856|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
25089817|NCT01990768|50198854|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
25089818|NCT01990768|50198855|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
25089819|NCT01990768|50198856|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
25089820|NCT01990768|50198854|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
25089821|NCT01990768|50198855|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
25089822|NCT01990768|50198856|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
25089823|NCT01990612|50198867|FG000|Overall Study|Lost to Follow-up|2|||
25089824|NCT01990612|50198868|FG001|Overall Study|Lost to Follow-up|1|||
25089825|NCT01990612|50198867|FG000|Overall Study|Withdrawal by Subject|5|||
25089826|NCT01990612|50198868|FG001|Overall Study|Withdrawal by Subject|2|||
25089827|NCT01990534|50198874|FG000|Overall Study|Death|22|||
25089828|NCT01990534|50198874|FG000|Overall Study|Progressive disease|3|||
25089829|NCT01990534|50198874|FG000|Overall Study|Protocol Violation|1|||
25173622|NCT01697579|50315141|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
25173623|NCT01697579|50315142|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
25173624|NCT01697579|50315143|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
25089830|NCT01990534|50198874|FG000|Overall Study|Withdrawal of Informed Consent|2|||
25173625|NCT01697579|50315144|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
25173626|NCT01586195|50315172|FG000|Overall Study|Death|11|||
25173627|NCT01586195|50315172|FG000|Overall Study|Withdrawal of Consent|5|||
25173628|NCT01586195|50315172|FG000|Overall Study|Started new anti-melanoma therapy|1|||
25173629|NCT01586195|50315172|FG000|Overall Study|Reason not specified|9|||
25173630|NCT01585961|50315176|FG000|Overall Study|Death|6|||
25173631|NCT01585961|50315176|FG000|Overall Study|Physician Decision|1|||
25173632|NCT01585961|50315176|FG000|Overall Study|Decision to use non-study catheter|1|||
25173633|NCT01585961|50315176|FG000|Overall Study|Withdrawal by Subject|1|||
25173634|NCT01585961|50315176|FG000|Overall Study|Lost to Follow-up|23|||
25173635|NCT01585961|50315176|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
25173636|NCT01697501|50315180|FG000|Overall Study|Protocol Violation|2|||
25173637|NCT01697345|50315193|FG000|Overall Study|Withdrawal by Subject|1|||
25173638|NCT01697267|50315262|FG000|Overall Study|Death|3|||
25173639|NCT01697267|50315263|FG001|Overall Study|Death|1|||
25089831|NCT01990534|50198874|FG000|Overall Study|Symptomatic Deterioration|1|||
25089832|NCT01990534|50198874|FG000|Overall Study|Withdrawal by Subject|3|||
25089833|NCT01990534|50198874|FG000|Overall Study|Reason not Specified|2|||
25089834|NCT01990534|50198874|FG000|Overall Study|Lost to Follow-up|1|||
25089835|NCT01967134|50198881|FG000|Overall Study|Lost to Follow-up|0|||
25089836|NCT01967134|50198882|FG001|Overall Study|Lost to Follow-up|1|||
25173640|NCT01697267|50315262|FG000|Overall Study|Withdrawal by Subject|5|||
25173641|NCT01697267|50315263|FG001|Overall Study|Withdrawal by Subject|5|||
25173642|NCT01697267|50315262|FG000|Overall Study|Adverse Event|2|||
25173643|NCT01697267|50315263|FG001|Overall Study|Adverse Event|1|||
25173644|NCT01697267|50315262|FG000|Overall Study|Lost to Follow-up|2|||
25173645|NCT01697267|50315263|FG001|Overall Study|Lost to Follow-up|4|||
25173646|NCT01697267|50315262|FG000|Overall Study|Physician Decision|2|||
25089837|NCT01967134|50198883|FG002|Overall Study|Lost to Follow-up|0|||
25089838|NCT01990300|50198891|FG000|Overall Study|Case Report Forms Uncollected|89|||
25089839|NCT01990300|50198891|FG000|Overall Study|Protocol Deviation|53|||
25089840|NCT01966432|50198898|FG000|Overall Study|Lost to Follow-up|3|||
25089841|NCT01966432|50198899|FG001|Overall Study|Lost to Follow-up|2|||
25089842|NCT01966432|50198900|FG002|Overall Study|Lost to Follow-up|5|||
25089843|NCT01966432|50198898|FG000|Overall Study|Withdrawal by Subject|1|||
25089844|NCT01966432|50198899|FG001|Overall Study|Withdrawal by Subject|3|||
25089845|NCT01966432|50198900|FG002|Overall Study|Withdrawal by Subject|0|||
25173647|NCT01697267|50315263|FG001|Overall Study|Physician Decision|4|||
25173648|NCT01696955|50315325|FG000|Main Study|Protocol Violation|1|||
25173649|NCT01696955|50315326|FG001|Main Study|Protocol Violation|0|||
25173650|NCT01696955|50315325|FG000|Main Study|Withdrawal by Subject|1|||
25173651|NCT01696955|50315326|FG001|Main Study|Withdrawal by Subject|1|||
25173652|NCT02702388|50315350|FG000|Overall Study|Disease Progression|18|||
25173653|NCT02702388|50315351|FG001|Overall Study|Disease Progression|25|||
25173654|NCT02702388|50315350|FG000|Overall Study|Withdrawal by Subject|9|||
25089846|NCT01966432|50198898|FG000|Overall Study|Subject Incarcerated|0|||
25089847|NCT01966432|50198899|FG001|Overall Study|Subject Incarcerated|0|||
25089848|NCT01966432|50198900|FG002|Overall Study|Subject Incarcerated|1|||
25089849|NCT01966432|50198898|FG000|Overall Study|SBIRT program ended|1|||
25089850|NCT01966432|50198899|FG001|Overall Study|SBIRT program ended|8|||
25089851|NCT01966432|50198900|FG002|Overall Study|SBIRT program ended|20|||
25089852|NCT01966120|50198912|FG000|Overall Study|Withdrawal by Subject|0|||
25089853|NCT01966120|50198913|FG001|Overall Study|Withdrawal by Subject|5|||
25089854|NCT01966120|50198912|FG000|Overall Study|Lost to Follow-up|1|||
25089855|NCT01966120|50198913|FG001|Overall Study|Lost to Follow-up|1|||
25089856|NCT02702401|50198921|FG000|Overall Study|Death|242|||
25173655|NCT02702388|50315351|FG001|Overall Study|Withdrawal by Subject|7|||
25173656|NCT02702388|50315350|FG000|Overall Study|Adverse Event|11|||
25089857|NCT02702401|50198922|FG001|Overall Study|Death|125|||
25089858|NCT02702401|50198921|FG000|Overall Study|Withdrawal by Subject|15|||
25089859|NCT02702401|50198922|FG001|Overall Study|Withdrawal by Subject|5|||
25089860|NCT02702401|50198921|FG000|Overall Study|Sponsor Decision|19|||
25089861|NCT02702401|50198922|FG001|Overall Study|Sponsor Decision|3|||
25089862|NCT02702401|50198921|FG000|Overall Study|Physician Decision|1|||
25089863|NCT02702401|50198922|FG001|Overall Study|Physician Decision|2|||
25089864|NCT02702401|50198921|FG000|Overall Study|Lost to Follow-up|1|||
25089865|NCT02702401|50198922|FG001|Overall Study|Lost to Follow-up|0|||
25173657|NCT02702388|50315351|FG001|Overall Study|Adverse Event|15|||
25173658|NCT02702388|50315350|FG000|Overall Study|Other|2|||
25173659|NCT02702388|50315351|FG001|Overall Study|Other|4|||
25173660|NCT01696877|50315377|FG000|Overall Study|Adverse Event|0|||
25173661|NCT01696877|50315378|FG001|Overall Study|Adverse Event|1|||
25173662|NCT02703636|50315574|FG000|Overall Study|Adverse Event|14|||
25173663|NCT02703636|50315574|FG000|Overall Study|Study stopped by sponsor|1|||
25173664|NCT02703636|50315574|FG000|Overall Study|Withdrawal by Subject|1|||
25173665|NCT02703324|50315802|FG000|Period Two|Withdrawal by Subject|0|||
25173666|NCT02703324|50315803|FG001|Period Two|Withdrawal by Subject|0|||
25173667|NCT02703324|50315804|FG002|Period Two|Withdrawal by Subject|1|||
25173668|NCT02703324|50315805|FG003|Period Two|Withdrawal by Subject|0|||
25173669|NCT02703324|50315806|FG004|Period Two|Withdrawal by Subject|0|||
25173670|NCT02703324|50315807|FG005|Period Two|Withdrawal by Subject|0|||
25173671|NCT02701764|50315818|FG000|Overall Study|Lost to Follow-up|0|||
25173672|NCT02701764|50315819|FG001|Overall Study|Lost to Follow-up|1|||
25173673|NCT01696643|50316000|FG000|Overall Study|Adverse Event|15|||
25173674|NCT01696643|50316001|FG001|Overall Study|Adverse Event|7|||
25173675|NCT01696643|50316000|FG000|Overall Study|Death|1|||
25173676|NCT01696643|50316001|FG001|Overall Study|Death|2|||
25089866|NCT02703337|50198929|FG000|Period One (Part A)|Withdrawal by Subject|0|||
25089867|NCT02703337|50198930|FG001|Period One (Part A)|Withdrawal by Subject|0|||
25089868|NCT02703337|50198931|FG002|Period One (Part A)|Withdrawal by Subject|0|||
25173677|NCT01696643|50316000|FG000|Overall Study|Lack of Efficacy|3|||
25173678|NCT01696643|50316001|FG001|Overall Study|Lack of Efficacy|0|||
25173679|NCT01696643|50316000|FG000|Overall Study|Lost to Follow-up|67|||
25173680|NCT01696643|50316001|FG001|Overall Study|Lost to Follow-up|67|||
25173681|NCT01696643|50316000|FG000|Overall Study|Physician Decision|3|||
25089869|NCT02703337|50198932|FG003|Period One (Part A)|Withdrawal by Subject|0|||
25173682|NCT01696643|50316001|FG001|Overall Study|Physician Decision|2|||
25173683|NCT01696643|50316000|FG000|Overall Study|Pregnancy|0|||
25173684|NCT01696643|50316001|FG001|Overall Study|Pregnancy|1|||
25173685|NCT01696643|50316000|FG000|Overall Study|Protocol Violation|7|||
25173686|NCT01696643|50316001|FG001|Overall Study|Protocol Violation|7|||
25089870|NCT02703337|50198933|FG004|Period One (Part A)|Withdrawal by Subject|1|||
25089871|NCT02703337|50198934|FG005|Period One (Part A)|Withdrawal by Subject|0|||
25089872|NCT02703337|50198935|FG006|Period One (Part A)|Withdrawal by Subject|0|||
25089873|NCT02703337|50198936|FG007|Period One (Part A)|Withdrawal by Subject|0|||
25173687|NCT01696643|50316000|FG000|Overall Study|Study Terminated by Sponsor|286|||
25089874|NCT01680497|50198954|FG000|Overall Study|Lost to Follow-up|2|||
25089875|NCT01680341|50198960|FG000|Overall Study|Adverse Event|3|||
25089876|NCT01680341|50198961|FG001|Overall Study|Adverse Event|2|||
25089877|NCT01680341|50198960|FG000|Overall Study|Unclassified|18|||
25089878|NCT01680341|50198961|FG001|Overall Study|Unclassified|15|||
25089879|NCT01679405|50198969|FG000|Overall Study|Death|2|||
25089880|NCT01679405|50198970|FG001|Overall Study|Death|5|||
25089881|NCT01603355|50198976|FG000|Overall Study|Lack of Efficacy|2|||
25173688|NCT01696643|50316001|FG001|Overall Study|Study Terminated by Sponsor|294|||
25173689|NCT01696643|50316000|FG000|Overall Study|Withdrawal by Subject|142|||
25173690|NCT01696643|50316001|FG001|Overall Study|Withdrawal by Subject|149|||
25173691|NCT01696643|50316000|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
25173692|NCT01696643|50316001|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
25173693|NCT01696643|50316000|FG000|Overall Study|Site Error|2|||
25173694|NCT01696643|50316001|FG001|Overall Study|Site Error|1|||
25173695|NCT01696643|50316000|FG000|Overall Study|Participant Incarcerated|0|||
25173696|NCT01696643|50316001|FG001|Overall Study|Participant Incarcerated|1|||
25173697|NCT01696643|50316000|FG000|Overall Study|Medical Monitor Decision|0|||
25173698|NCT01696643|50316001|FG001|Overall Study|Medical Monitor Decision|2|||
25173699|NCT01696643|50316000|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
25173700|NCT01696643|50316001|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
25173701|NCT01695317|50316013|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
25173702|NCT01695317|50316014|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
25173703|NCT01695317|50316013|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
25173704|NCT01695317|50316014|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
25173705|NCT02701296|50316070|FG000|Overall Study|Incomplete Data|0|||
25173706|NCT02701296|50316071|FG001|Overall Study|Incomplete Data|2|||
25173707|NCT01582451|50316088|FG000|Overall Study|Adverse Event|1|||
25173708|NCT01582451|50316089|FG001|Overall Study|Adverse Event|3|||
25173709|NCT01582451|50316088|FG000|Overall Study|Death|3|||
25173710|NCT01582451|50316089|FG001|Overall Study|Death|3|||
25173711|NCT01582451|50316088|FG000|Overall Study|Lost to Follow-up|0|||
25173712|NCT01582451|50316089|FG001|Overall Study|Lost to Follow-up|2|||
25173713|NCT01582451|50316088|FG000|Overall Study|Protocol Violation|11|||
25173714|NCT01582451|50316089|FG001|Overall Study|Protocol Violation|3|||
25173715|NCT01582451|50316088|FG000|Overall Study|Withdrawal by Subject|13|||
25173716|NCT01582451|50316089|FG001|Overall Study|Withdrawal by Subject|9|||
25173717|NCT01582451|50316088|FG000|Overall Study|Physician Decision|3|||
25173718|NCT01582451|50316089|FG001|Overall Study|Physician Decision|0|||
25173719|NCT01582451|50316088|FG000|Overall Study|Sponsor Decision|1|||
25173720|NCT01582451|50316089|FG001|Overall Study|Sponsor Decision|0|||
25173721|NCT02700984|50316182|FG000|Overall Study|Death|2|||
25173722|NCT02700984|50316183|FG001|Overall Study|Death|1|||
25173723|NCT02700984|50316182|FG000|Overall Study|Lost to Follow-up|2|||
25173724|NCT02700984|50316183|FG001|Overall Study|Lost to Follow-up|1|||
25173725|NCT02700984|50316182|FG000|Overall Study|Physician Decision|0|||
25173726|NCT02700984|50316183|FG001|Overall Study|Physician Decision|1|||
25173727|NCT02700984|50316182|FG000|Overall Study|Withdrawal by Subject|8|||
25173728|NCT02700984|50316183|FG001|Overall Study|Withdrawal by Subject|9|||
25173729|NCT02700984|50316182|FG000|Overall Study|Reason not specified|3|||
25173730|NCT02700984|50316183|FG001|Overall Study|Reason not specified|2|||
25173731|NCT02696850|50316257|FG000|Overall Study|Withdrawal by Subject|3|||
25173732|NCT02696850|50316258|FG001|Overall Study|Withdrawal by Subject|3|||
25173733|NCT02696850|50316257|FG000|Overall Study|Lost to Follow-up|8|||
25173734|NCT02696850|50316258|FG001|Overall Study|Lost to Follow-up|5|||
25173735|NCT02698410|50316421|FG000|Overall Study|Adverse Event|2|||
25173736|NCT02698410|50316421|FG000|Overall Study|Withdrawal by Subject|1|||
25173737|NCT02698410|50316421|FG000|Overall Study|Other|1|||
25173738|NCT02699892|50316425|FG000|Overall Study|Other|36|||
25173739|NCT02698176|50316432|FG000|Overall Study|Progressive disease|4|||
25173740|NCT02698176|50316433|FG001|Overall Study|Progressive disease|3|||
25173741|NCT02698176|50316434|FG002|Overall Study|Progressive disease|1|||
25173742|NCT02698176|50316435|FG003|Overall Study|Progressive disease|0|||
25173743|NCT02698176|50316432|FG000|Overall Study|Adverse Event|2|||
25173744|NCT02698176|50316433|FG001|Overall Study|Adverse Event|0|||
25173745|NCT02698176|50316434|FG002|Overall Study|Adverse Event|0|||
25173746|NCT02698176|50316435|FG003|Overall Study|Adverse Event|0|||
25173747|NCT02698176|50316432|FG000|Overall Study|Clinical progression|3|||
25173748|NCT02698176|50316433|FG001|Overall Study|Clinical progression|0|||
25173749|NCT02698176|50316434|FG002|Overall Study|Clinical progression|0|||
25173750|NCT02698176|50316435|FG003|Overall Study|Clinical progression|0|||
25173751|NCT02693418|50316451|FG000|Overall Study|Lost to Follow-up|1|||
25089882|NCT02703259|50198982|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
25089883|NCT02703259|50198983|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
25173752|NCT02693418|50316452|FG001|Overall Study|Lost to Follow-up|2|||
25173753|NCT02693418|50316453|FG002|Overall Study|Lost to Follow-up|0|||
25173754|NCT02693418|50316454|FG003|Overall Study|Lost to Follow-up|0|||
25173755|NCT02693418|50316455|FG004|Overall Study|Lost to Follow-up|0|||
25173756|NCT02693418|50316451|FG000|Overall Study|Menses during study period|0|||
25173757|NCT02693418|50316452|FG001|Overall Study|Menses during study period|0|||
25173758|NCT02693418|50316453|FG002|Overall Study|Menses during study period|2|||
25173759|NCT02693418|50316454|FG003|Overall Study|Menses during study period|0|||
25173760|NCT02693418|50316455|FG004|Overall Study|Menses during study period|0|||
25173761|NCT02693106|50316488|FG000|Overall Study|No time|3|||
25173762|NCT02546986|50316500|FG000|Treatment Period|Progressive Disease|20|||
25173763|NCT02546986|50316501|FG001|Treatment Period|Progressive Disease|22|||
25173764|NCT02546986|50316500|FG000|Treatment Period|Adverse Event|14|||
25173765|NCT02546986|50316501|FG001|Treatment Period|Adverse Event|6|||
25173766|NCT02546986|50316500|FG000|Treatment Period|Symptomatic Deterioration|4|||
25173767|NCT02546986|50316501|FG001|Treatment Period|Symptomatic Deterioration|3|||
25173768|NCT02546986|50316500|FG000|Treatment Period|Death|3|||
25173769|NCT02546986|50316501|FG001|Treatment Period|Death|4|||
25173770|NCT02546986|50316500|FG000|Treatment Period|Physician Decision|1|||
25173771|NCT02546986|50316501|FG001|Treatment Period|Physician Decision|2|||
25173772|NCT02546986|50316500|FG000|Treatment Period|Protocol Violation|1|||
25089884|NCT02703259|50198982|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
25089885|NCT02703259|50198983|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
25173773|NCT02546986|50316501|FG001|Treatment Period|Protocol Violation|0|||
25173774|NCT02546986|50316500|FG000|Treatment Period|Withdrawal by Subject|1|||
25173775|NCT02546986|50316501|FG001|Treatment Period|Withdrawal by Subject|1|||
25173776|NCT02546986|50316500|FG000|Treatment Period|Non-compliance with Study Drug|0|||
25173777|NCT02546986|50316501|FG001|Treatment Period|Non-compliance with Study Drug|1|||
25173778|NCT02546986|50316500|FG000|Treatment Period|Study Terminated by Sponsor|0|||
25173779|NCT02546986|50316501|FG001|Treatment Period|Study Terminated by Sponsor|1|||
25173780|NCT02546986|50316500|FG000|Treatment Period|Miscellaneous|7|||
25173781|NCT02546986|50316501|FG001|Treatment Period|Miscellaneous|9|||
25173782|NCT02546986|50316500|FG000|Survival Follow-Up Phase|Missing Status|3|||
25173783|NCT02546986|50316501|FG001|Survival Follow-Up Phase|Missing Status|5|||
25173784|NCT02546986|50316500|FG000|Survival Follow-Up Phase|Death|18|||
25089886|NCT02703259|50198982|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
25173785|NCT02546986|50316501|FG001|Survival Follow-Up Phase|Death|12|||
25089887|NCT02703259|50198983|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
25173786|NCT02546986|50316500|FG000|Survival Follow-Up Phase|Alive|13|||
25173787|NCT02546986|50316501|FG001|Survival Follow-Up Phase|Alive|16|||
25173788|NCT02546986|50316500|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
25173789|NCT02546986|50316501|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
25173790|NCT02689206|50316512|FG000|Overall Study|Adverse Event|0|||
25089888|NCT00701701|50198991|FG000|Overall Study|Withdrawal by Subject|0|||
25173791|NCT02689206|50316513|FG001|Overall Study|Adverse Event|0|||
25173792|NCT02689206|50316514|FG002|Overall Study|Adverse Event|1|||
25173793|NCT02689206|50316515|FG003|Overall Study|Adverse Event|0|||
25173794|NCT02689206|50316516|FG004|Overall Study|Adverse Event|2|||
25173795|NCT02689206|50316512|FG000|Overall Study|Protocol Violation|1|||
25173796|NCT02689206|50316513|FG001|Overall Study|Protocol Violation|0|||
25173797|NCT02689206|50316514|FG002|Overall Study|Protocol Violation|0|||
25089889|NCT00701701|50198992|FG001|Overall Study|Withdrawal by Subject|1|||
25089890|NCT00701701|50198991|FG000|Overall Study|Adverse Event|0|||
25089891|NCT00701701|50198992|FG001|Overall Study|Adverse Event|1|||
25089892|NCT01989754|50199001|FG000|Overall Study|Withdrawal by Subject|10|||
25089893|NCT01989754|50199002|FG001|Overall Study|Withdrawal by Subject|14|||
25089894|NCT01989754|50199001|FG000|Overall Study|Lost to Follow-up|28|||
25089895|NCT01989754|50199002|FG001|Overall Study|Lost to Follow-up|20|||
25089896|NCT01989754|50199001|FG000|Overall Study|Closed Site|1|||
25089897|NCT01989754|50199002|FG001|Overall Study|Closed Site|1|||
25089898|NCT01619878|50199008|FG000|6 Week Follow-up Phase|Adverse Event|1|||
25089899|NCT01619878|50199008|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
25089900|NCT01619878|50199008|FG000|Follow-up at 12 Months of Age|Death|2|||
25089901|NCT02015104|50199014|FG000|Overall Study|Withdrew consent after first dose drug|1|||
25089902|NCT02015104|50199015|FG001|Overall Study|Withdrew consent after first dose drug|0|||
25089903|NCT02015104|50199014|FG000|Overall Study|Withdrew consent prior to treatment|0|||
25089904|NCT02015104|50199015|FG001|Overall Study|Withdrew consent prior to treatment|1|||
25089905|NCT01619800|50199026|FG000|Overall Study|study terminated|2|||
25089906|NCT01619800|50199027|FG001|Overall Study|study terminated|0|||
25089907|NCT01989208|50199035|FG000|200 mg (7 Days)|Protocol Violation|0|||
25173798|NCT02689206|50316515|FG003|Overall Study|Protocol Violation|1|||
25173799|NCT02689206|50316516|FG004|Overall Study|Protocol Violation|2|||
25173800|NCT02689206|50316512|FG000|Overall Study|Other: Reached stopping criteria|0|||
25173801|NCT02689206|50316513|FG001|Overall Study|Other: Reached stopping criteria|1|||
25173802|NCT02689206|50316514|FG002|Overall Study|Other: Reached stopping criteria|2|||
25173803|NCT02689206|50316515|FG003|Overall Study|Other: Reached stopping criteria|3|||
25173804|NCT02689206|50316516|FG004|Overall Study|Other: Reached stopping criteria|4|||
25173805|NCT02689206|50316512|FG000|Overall Study|Physician Decision|1|||
25173806|NCT02689206|50316513|FG001|Overall Study|Physician Decision|0|||
25173807|NCT02689206|50316514|FG002|Overall Study|Physician Decision|0|||
25173808|NCT02689206|50316515|FG003|Overall Study|Physician Decision|0|||
25173809|NCT02689206|50316516|FG004|Overall Study|Physician Decision|0|||
25173810|NCT02689206|50316512|FG000|Overall Study|Withdrawal by Subject|1|||
25173811|NCT02689206|50316513|FG001|Overall Study|Withdrawal by Subject|0|||
25173812|NCT02689206|50316514|FG002|Overall Study|Withdrawal by Subject|1|||
25173813|NCT02689206|50316515|FG003|Overall Study|Withdrawal by Subject|0|||
25173814|NCT02689206|50316516|FG004|Overall Study|Withdrawal by Subject|0|||
25089908|NCT01989208|50199036|FG001|200 mg (7 Days)|Protocol Violation|1|||
25089909|NCT01619410|50199056|FG000|Overall Study|Lost to Follow-up|7|||
25089910|NCT01619410|50199057|FG001|Overall Study|Lost to Follow-up|4|||
25089911|NCT01966042|50199063|FG000|Overall Study|Death|2|||
25089912|NCT02014480|50199067|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
25089913|NCT02014480|50199068|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
25089914|NCT02014480|50199069|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
25089915|NCT02014480|50199070|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
25173815|NCT01695239|50316536|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
25173816|NCT01695239|50316537|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
25173817|NCT01695239|50316538|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
25173818|NCT01695239|50316539|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
25173819|NCT01695239|50316540|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
25173820|NCT01695239|50316541|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
25173821|NCT01695239|50316542|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
25173822|NCT01695239|50316543|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
25173823|NCT01695239|50316544|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
25173824|NCT01695239|50316545|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
25173825|NCT01695239|50316546|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
25173826|NCT01695239|50316547|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
25173827|NCT01695239|50316548|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
25173828|NCT01695239|50316549|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
25173829|NCT01695239|50316536|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
25089916|NCT02014480|50199071|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
25089917|NCT02014480|50199072|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
25089918|NCT02014480|50199067|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
25089919|NCT02014480|50199068|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
25089920|NCT02014480|50199069|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
25089921|NCT02014480|50199070|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
25089922|NCT02014480|50199071|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
25089923|NCT02014480|50199072|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
25089924|NCT02014480|50199067|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
25089925|NCT02014480|50199068|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
25089926|NCT02014480|50199069|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
25089927|NCT02014480|50199070|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
25089928|NCT02014480|50199071|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
25089929|NCT02014480|50199072|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
25089930|NCT02014480|50199067|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
25089931|NCT02014480|50199068|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
25089932|NCT02014480|50199069|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
25089933|NCT02014480|50199070|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
25089934|NCT02014480|50199071|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
25173830|NCT01695239|50316537|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
25173831|NCT01695239|50316538|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
25173832|NCT01695239|50316539|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
25173833|NCT01695239|50316540|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
25173834|NCT01695239|50316541|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
25173835|NCT01695239|50316542|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
25173836|NCT01695239|50316543|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
25173837|NCT01695239|50316544|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
25173838|NCT01695239|50316545|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
25173839|NCT01695239|50316546|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
25173840|NCT01695239|50316547|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
25173841|NCT01695239|50316548|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
25173842|NCT01695239|50316549|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
25173843|NCT01695239|50316536|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
25173844|NCT01695239|50316537|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
25173845|NCT01695239|50316538|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
25173846|NCT01695239|50316539|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
25173847|NCT01695239|50316540|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
25173848|NCT01695239|50316541|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
25089935|NCT02014480|50199072|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
25173849|NCT01695239|50316542|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
25089936|NCT02014480|50199067|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
25173850|NCT01695239|50316543|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
25173851|NCT01695239|50316544|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
25173852|NCT01695239|50316545|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
25173853|NCT01695239|50316546|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
25173854|NCT01695239|50316547|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
25173855|NCT01695239|50316548|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
25173856|NCT01695239|50316549|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
25173857|NCT01695239|50316536|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
25173858|NCT01695239|50316537|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
25173859|NCT01695239|50316538|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
25173860|NCT01695239|50316539|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
25173861|NCT01695239|50316540|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
25173862|NCT01695239|50316541|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
25173863|NCT01695239|50316542|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
25173864|NCT01695239|50316543|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
25173865|NCT01695239|50316544|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
25173866|NCT01695239|50316545|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
25173867|NCT01695239|50316546|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
25173868|NCT01695239|50316547|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
25173869|NCT01695239|50316548|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
25173870|NCT01695239|50316549|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
25173871|NCT01695239|50316536|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
25173872|NCT01695239|50316537|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
25173873|NCT01695239|50316538|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
25173874|NCT01695239|50316539|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
25089937|NCT02014480|50199068|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
25089938|NCT02014480|50199069|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
25173875|NCT01695239|50316540|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
25173876|NCT01695239|50316541|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
25173877|NCT01695239|50316542|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
25173878|NCT01695239|50316543|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
25173879|NCT01695239|50316544|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
25173880|NCT01695239|50316545|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
25173881|NCT01695239|50316546|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
25173882|NCT01695239|50316547|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
25173883|NCT01695239|50316548|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
25173884|NCT01695239|50316549|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
25173885|NCT01695239|50316536|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
25173886|NCT01695239|50316537|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
25173887|NCT01695239|50316538|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
25173888|NCT01695239|50316539|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
25173889|NCT01695239|50316540|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
25173890|NCT01695239|50316541|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
25089939|NCT02014480|50199070|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
25173891|NCT01695239|50316542|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
25089940|NCT02014480|50199071|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
25173892|NCT01695239|50316543|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
25173893|NCT01695239|50316544|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
25089941|NCT02014480|50199072|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
25089942|NCT02014480|50199067|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
25089943|NCT02014480|50199068|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
25089944|NCT02014480|50199069|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
25089945|NCT02014480|50199070|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
25089946|NCT02014480|50199071|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
25089947|NCT02014480|50199072|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
25089948|NCT02014480|50199067|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
25089949|NCT02014480|50199068|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
25089950|NCT02014480|50199069|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
25089951|NCT02014480|50199070|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
25089952|NCT02014480|50199071|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
25173894|NCT01695239|50316545|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
25089953|NCT02014480|50199072|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
24996877|NCT02963506|50088003|FG008|Dose-Blind Period|Lack of Efficacy|0|||
24996878|NCT02963506|50088004|FG009|Dose-Blind Period|Lack of Efficacy|1|||
25089954|NCT01261247|50199080|FG000|Overall Study|Ineligible|2|||
25173895|NCT01695239|50316546|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
25173896|NCT01695239|50316547|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
25173897|NCT01695239|50316548|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
25089955|NCT01677767|50199084|FG000|Overall Study|Adverse Event|1|||
25089956|NCT01677767|50199084|FG000|Overall Study|Death|4|||
25089957|NCT01677767|50199084|FG000|Overall Study|Protocol Violation|4|||
25089958|NCT01677767|50199084|FG000|Overall Study|Withdrawal by Subject|10|||
25089959|NCT01677767|50199084|FG000|Overall Study|Non-compliance by the participants|3|||
25089960|NCT01603277|50199105|FG000|Overall Study|Adverse Event|1|||
25173898|NCT01695239|50316549|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
25173899|NCT01695239|50316536|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
25173900|NCT01695239|50316537|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
25173901|NCT01695239|50316538|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
25173902|NCT01695239|50316539|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
25173903|NCT01695239|50316540|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
25173904|NCT01695239|50316541|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
25173905|NCT01695239|50316542|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
25173906|NCT01695239|50316543|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
25173907|NCT01695239|50316544|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
25173908|NCT01695239|50316545|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
25173909|NCT01695239|50316546|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
25173910|NCT01695239|50316547|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
25173911|NCT01695239|50316548|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
25173912|NCT01695239|50316549|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
25173913|NCT01695239|50316536|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
25173914|NCT01695239|50316537|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
25173915|NCT01695239|50316538|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
25173916|NCT01695239|50316539|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
25089961|NCT01603277|50199106|FG001|Overall Study|Adverse Event|2|||
25089962|NCT01603277|50199105|FG000|Overall Study|Physician Decision|0|||
25173917|NCT01695239|50316540|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
25173918|NCT01695239|50316541|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
25173919|NCT01695239|50316542|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
25173920|NCT01695239|50316543|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
25173921|NCT01695239|50316544|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
25173922|NCT01695239|50316545|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
25173923|NCT01695239|50316546|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
25173924|NCT01695239|50316547|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
25173925|NCT01695239|50316548|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
25173926|NCT01695239|50316549|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
25173927|NCT01695239|50316536|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
25173928|NCT01695239|50316537|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
25173929|NCT01695239|50316538|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
25173930|NCT01695239|50316539|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
25173931|NCT01695239|50316540|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
25173932|NCT01695239|50316541|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
25089963|NCT01603277|50199106|FG001|Overall Study|Physician Decision|1|||
25089964|NCT01603277|50199105|FG000|Overall Study|Protocol Violation|6|||
25173933|NCT01695239|50316542|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
25173934|NCT01695239|50316543|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
25173935|NCT01695239|50316544|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
25173936|NCT01695239|50316545|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
25173937|NCT01695239|50316546|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
25173938|NCT01695239|50316547|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
25173939|NCT01695239|50316548|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
25173940|NCT01695239|50316549|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
25173941|NCT01695239|50316536|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
25173942|NCT01695239|50316537|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
25173943|NCT01695239|50316538|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
25089965|NCT01603277|50199106|FG001|Overall Study|Protocol Violation|10|||
25089966|NCT01603277|50199105|FG000|Overall Study|Withdrawal by Subject|5|||
25089967|NCT01603277|50199106|FG001|Overall Study|Withdrawal by Subject|4|||
25089968|NCT01603277|50199105|FG000|Overall Study|Non-Compliance|2|||
25089969|NCT01603277|50199106|FG001|Overall Study|Non-Compliance|1|||
25089970|NCT01678313|50199114|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
25089971|NCT01678313|50199115|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
25089972|NCT01678313|50199114|FG000|Completed the 3-month Therapy|Physician Decision|3|||
25089973|NCT01678313|50199115|FG001|Completed the 3-month Therapy|Physician Decision|4|||
25089974|NCT01678313|50199114|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
25089975|NCT01678313|50199115|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
25173944|NCT01695239|50316539|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
25089976|NCT01678313|50199114|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
25089977|NCT01678313|50199115|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
25089978|NCT01603121|50199121|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
25089979|NCT01603121|50199122|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
25089980|NCT01603043|50199130|FG000|Overall Study|Study Futility|7|||
25089981|NCT01603043|50199131|FG001|Overall Study|Study Futility|3|||
25089982|NCT02014402|50199141|FG000|Overall Study|Adverse Event|1|||
25089983|NCT02014402|50199142|FG001|Overall Study|Adverse Event|0|||
25089984|NCT02014402|50199143|FG002|Overall Study|Adverse Event|0|||
25089985|NCT02014402|50199144|FG003|Overall Study|Adverse Event|0|||
25089986|NCT02014402|50199141|FG000|Overall Study|Withdrawal by Subject|1|||
25089987|NCT02014402|50199142|FG001|Overall Study|Withdrawal by Subject|2|||
25089988|NCT02014402|50199143|FG002|Overall Study|Withdrawal by Subject|2|||
25089989|NCT02014402|50199144|FG003|Overall Study|Withdrawal by Subject|1|||
25089990|NCT02014402|50199141|FG000|Overall Study|Subject did not have transportation|0|||
25173945|NCT01695239|50316540|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
25173946|NCT01695239|50316541|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
25173947|NCT01695239|50316542|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
25173948|NCT01695239|50316543|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
25173949|NCT01695239|50316544|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
25173950|NCT01695239|50316545|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
25173951|NCT01695239|50316546|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
25173952|NCT01695239|50316547|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
25173953|NCT01695239|50316548|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
25173954|NCT01695239|50316549|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
25173955|NCT01695239|50316536|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
25173956|NCT01695239|50316537|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
25173957|NCT01695239|50316538|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
25173958|NCT01695239|50316539|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
25173959|NCT01695239|50316540|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
25089991|NCT02014402|50199142|FG001|Overall Study|Subject did not have transportation|1|||
25089992|NCT02014402|50199143|FG002|Overall Study|Subject did not have transportation|0|||
25089993|NCT02014402|50199144|FG003|Overall Study|Subject did not have transportation|0|||
25089994|NCT02014402|50199141|FG000|Overall Study|Lost to Follow-up|0|||
25089995|NCT02014402|50199142|FG001|Overall Study|Lost to Follow-up|0|||
25089996|NCT02014402|50199143|FG002|Overall Study|Lost to Follow-up|1|||
25089997|NCT02014402|50199144|FG003|Overall Study|Lost to Follow-up|2|||
25089998|NCT01988662|50199163|FG000|Overall Study|Subject/guardian decision|1|||
25089999|NCT01988662|50199164|FG001|Overall Study|Subject/guardian decision|1|||
25090000|NCT01988662|50199163|FG000|Overall Study|Adverse Event|3|||
25090001|NCT01988662|50199164|FG001|Overall Study|Adverse Event|1|||
25090002|NCT02839343|50199173|FG000|Overall Study|Withdrawal by Subject|3|||
25090003|NCT02839343|50199174|FG001|Overall Study|Withdrawal by Subject|1|||
25090004|NCT02839343|50199173|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
25090005|NCT02839343|50199174|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
25090006|NCT02839343|50199173|FG000|Overall Study|Adverse Event|1|||
25090007|NCT02839343|50199174|FG001|Overall Study|Adverse Event|0|||
25090008|NCT01965652|50199203|FG000|Overall Study|Adverse Event|40|||
25090009|NCT01965652|50199204|FG001|Overall Study|Adverse Event|37|||
25090010|NCT01965652|50199203|FG000|Overall Study|Withdrawal by Subject|62|||
25090011|NCT01965652|50199204|FG001|Overall Study|Withdrawal by Subject|69|||
25090012|NCT01965652|50199203|FG000|Overall Study|Lost to Follow-up|53|||
25090013|NCT01965652|50199204|FG001|Overall Study|Lost to Follow-up|40|||
25090014|NCT01965652|50199203|FG000|Overall Study|Protocol Violation|34|||
25090015|NCT01965652|50199204|FG001|Overall Study|Protocol Violation|38|||
25090016|NCT01965652|50199203|FG000|Overall Study|Death|3|||
25090017|NCT01965652|50199204|FG001|Overall Study|Death|4|||
25090018|NCT01965652|50199203|FG000|Overall Study|Other - Miscellaneous|18|||
25090019|NCT01965652|50199204|FG001|Overall Study|Other - Miscellaneous|21|||
25090020|NCT01965652|50199203|FG000|Overall Study|Pregnancy|0|||
25090021|NCT01965652|50199204|FG001|Overall Study|Pregnancy|1|||
25090022|NCT01602965|50199212|FG000|Overall Study|Lost to Follow-up|4|||
25090023|NCT01602965|50199213|FG001|Overall Study|Lost to Follow-up|2|||
25090024|NCT01987960|50199221|FG000|Period 1|Adverse Event|24|||
25090025|NCT01987960|50199222|FG001|Period 1|Adverse Event|0|||
25090026|NCT01987960|50199223|FG002|Period 1|Adverse Event|0|||
25090027|NCT01987960|50199224|FG003|Period 1|Adverse Event|0|||
25090028|NCT01987960|50199221|FG000|Period 1|Lack of Efficacy|4|||
25090029|NCT01987960|50199222|FG001|Period 1|Lack of Efficacy|0|||
25090030|NCT01987960|50199223|FG002|Period 1|Lack of Efficacy|0|||
25090031|NCT01987960|50199224|FG003|Period 1|Lack of Efficacy|0|||
25090032|NCT01987960|50199221|FG000|Period 1|Non-compliance with IMP|6|||
25090033|NCT01987960|50199222|FG001|Period 1|Non-compliance with IMP|0|||
25090034|NCT01987960|50199223|FG002|Period 1|Non-compliance with IMP|0|||
25090035|NCT01987960|50199224|FG003|Period 1|Non-compliance with IMP|0|||
25090036|NCT01987960|50199221|FG000|Period 1|Protocol Violation|12|||
25090037|NCT01987960|50199222|FG001|Period 1|Protocol Violation|0|||
25090038|NCT01987960|50199223|FG002|Period 1|Protocol Violation|0|||
25090039|NCT01987960|50199224|FG003|Period 1|Protocol Violation|0|||
25090040|NCT01987960|50199221|FG000|Period 1|Withdrawal by Subject|21|||
25090041|NCT01987960|50199222|FG001|Period 1|Withdrawal by Subject|0|||
25090042|NCT01987960|50199223|FG002|Period 1|Withdrawal by Subject|0|||
25090043|NCT01987960|50199224|FG003|Period 1|Withdrawal by Subject|0|||
25090044|NCT01987960|50199221|FG000|Period 1|Lost to Follow-up|40|||
25090045|NCT01987960|50199222|FG001|Period 1|Lost to Follow-up|0|||
25090046|NCT01987960|50199223|FG002|Period 1|Lost to Follow-up|0|||
25090047|NCT01987960|50199224|FG003|Period 1|Lost to Follow-up|0|||
25090048|NCT01987960|50199221|FG000|Period 1|administrative or other reason|75|||
25090049|NCT01987960|50199222|FG001|Period 1|administrative or other reason|0|||
25090050|NCT01987960|50199223|FG002|Period 1|administrative or other reason|0|||
25090051|NCT01987960|50199224|FG003|Period 1|administrative or other reason|0|||
25090052|NCT01987960|50199221|FG000|Period 1|Withdrawal of consent before treatment|4|||
25090053|NCT01987960|50199222|FG001|Period 1|Withdrawal of consent before treatment|0|||
25090054|NCT01987960|50199223|FG002|Period 1|Withdrawal of consent before treatment|0|||
25090055|NCT01987960|50199224|FG003|Period 1|Withdrawal of consent before treatment|0|||
25090056|NCT01987960|50199221|FG000|Period 2|Adverse Event|0|||
25090057|NCT01987960|50199222|FG001|Period 2|Adverse Event|0|||
25090058|NCT01987960|50199223|FG002|Period 2|Adverse Event|1|||
25090059|NCT01987960|50199224|FG003|Period 2|Adverse Event|0|||
25090060|NCT01987960|50199221|FG000|Period 2|Withdrawal by Subject|0|||
25173960|NCT01695239|50316541|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
25090061|NCT01987960|50199222|FG001|Period 2|Withdrawal by Subject|0|||
25090062|NCT01987960|50199223|FG002|Period 2|Withdrawal by Subject|1|||
25090063|NCT01987960|50199224|FG003|Period 2|Withdrawal by Subject|0|||
25090064|NCT01987960|50199221|FG000|Period 2|Administrative or other reason|0|||
25090065|NCT01987960|50199222|FG001|Period 2|Administrative or other reason|5|||
25090066|NCT01987960|50199223|FG002|Period 2|Administrative or other reason|7|||
25090067|NCT01987960|50199224|FG003|Period 2|Administrative or other reason|0|||
25090068|NCT01987960|50199221|FG000|Period 3|Adverse Event|0|||
25090069|NCT01987960|50199222|FG001|Period 3|Adverse Event|0|||
25090070|NCT01987960|50199223|FG002|Period 3|Adverse Event|0|||
25090071|NCT01987960|50199224|FG003|Period 3|Adverse Event|7|||
25090072|NCT01987960|50199221|FG000|Period 3|Non-compliance with IMP|0|||
25090073|NCT01987960|50199222|FG001|Period 3|Non-compliance with IMP|0|||
25090074|NCT01987960|50199223|FG002|Period 3|Non-compliance with IMP|0|||
25090075|NCT01987960|50199224|FG003|Period 3|Non-compliance with IMP|1|||
25090076|NCT01987960|50199221|FG000|Period 3|Protocol Violation|0|||
25090077|NCT01987960|50199222|FG001|Period 3|Protocol Violation|0|||
25090078|NCT01987960|50199223|FG002|Period 3|Protocol Violation|0|||
25090079|NCT01987960|50199224|FG003|Period 3|Protocol Violation|6|||
25090080|NCT01987960|50199221|FG000|Period 3|Withdrawal by Subject|0|||
25090081|NCT01987960|50199222|FG001|Period 3|Withdrawal by Subject|0|||
25090082|NCT01987960|50199223|FG002|Period 3|Withdrawal by Subject|0|||
25090083|NCT01987960|50199224|FG003|Period 3|Withdrawal by Subject|9|||
25090084|NCT01987960|50199221|FG000|Period 3|Lost to Follow-up|0|||
25090085|NCT01987960|50199222|FG001|Period 3|Lost to Follow-up|0|||
25090086|NCT01987960|50199223|FG002|Period 3|Lost to Follow-up|0|||
25090087|NCT01987960|50199224|FG003|Period 3|Lost to Follow-up|5|||
25090088|NCT01987960|50199221|FG000|Period 3|Administrative or other reason|0|||
25090089|NCT01987960|50199222|FG001|Period 3|Administrative or other reason|0|||
25090090|NCT01987960|50199223|FG002|Period 3|Administrative or other reason|0|||
25090091|NCT01987960|50199224|FG003|Period 3|Administrative or other reason|43|||
25090092|NCT02013778|50199234|FG000|Overall Study|Death|4|||
25090093|NCT02013778|50199234|FG000|Overall Study|Withdrawal by Subject|1|||
25090094|NCT02013778|50199234|FG000|Overall Study|Physician Decision|1|||
25090095|NCT02013778|50199234|FG000|Overall Study|Adverse Event|1|||
25090096|NCT02013622|50199238|FG000|Overall Study|Lost to Follow-up|10|||
25090097|NCT02013622|50199238|FG000|Overall Study|Adverse Event|3|||
25090098|NCT02013622|50199238|FG000|Overall Study|Met Withdrawal Criteria|3|||
25090099|NCT02013622|50199238|FG000|Overall Study|Withdrawal by Subject|6|||
25090100|NCT02013622|50199238|FG000|Overall Study|Protocol Deviation|1|||
25090101|NCT02013622|50199238|FG000|Overall Study|Lack of Efficacy|1|||
25090102|NCT01987102|50199244|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
25090103|NCT01987102|50199245|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
25090104|NCT01987102|50199244|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
25090105|NCT01987102|50199245|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
25090106|NCT01987102|50199244|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
25090107|NCT01987102|50199245|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
25090108|NCT01987102|50199244|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
25090109|NCT01987102|50199245|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
25090110|NCT01987102|50199244|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
25090111|NCT01987102|50199245|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
25090112|NCT01987102|50199244|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
25090113|NCT01987102|50199245|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
25090114|NCT02013544|50199254|FG000|Overall Study|Adverse Event|5|||
25090115|NCT02013544|50199255|FG001|Overall Study|Adverse Event|5|||
25090116|NCT02013544|50199254|FG000|Overall Study|Lost to Follow-up|2|||
25173961|NCT01695239|50316542|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
25173962|NCT01695239|50316543|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
25173963|NCT01695239|50316544|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
25173964|NCT01695239|50316545|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
25173965|NCT01695239|50316546|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
25173966|NCT01695239|50316547|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
25173967|NCT01695239|50316548|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
25173968|NCT01695239|50316549|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
25173969|NCT01695239|50316536|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
25173970|NCT01695239|50316537|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
25173971|NCT01695239|50316538|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
25173972|NCT01695239|50316539|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
25173973|NCT01695239|50316540|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
25173974|NCT01695239|50316541|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
25173975|NCT01695239|50316542|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
25173976|NCT01695239|50316543|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
25173977|NCT01695239|50316544|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
25173978|NCT01695239|50316545|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
25173979|NCT01695239|50316546|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
25173980|NCT01695239|50316547|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
25173981|NCT01695239|50316548|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
25173982|NCT01695239|50316549|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
25173983|NCT01695239|50316536|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
25173984|NCT01695239|50316537|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
25173985|NCT01695239|50316538|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
25173986|NCT01695239|50316539|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
25173987|NCT01695239|50316540|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
25173988|NCT01695239|50316541|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
25173989|NCT01695239|50316542|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
25173990|NCT01695239|50316543|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
25173991|NCT01695239|50316544|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
25173992|NCT01695239|50316545|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
25173993|NCT01695239|50316546|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
25173994|NCT01695239|50316547|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
25173995|NCT01695239|50316548|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
25173996|NCT01695239|50316549|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
25173997|NCT01695239|50316536|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
25173998|NCT01695239|50316537|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
25173999|NCT01695239|50316538|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
25174000|NCT01695239|50316539|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
25174001|NCT01695239|50316540|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
25174002|NCT01695239|50316541|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
25174003|NCT01695239|50316542|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
25174004|NCT01695239|50316543|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
25174005|NCT01695239|50316544|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
25174006|NCT01695239|50316545|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
25174007|NCT01695239|50316546|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
25174008|NCT01695239|50316547|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
25174009|NCT01695239|50316548|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
25174010|NCT01695239|50316549|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
25174011|NCT01695239|50316536|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
25174012|NCT01695239|50316537|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
25174013|NCT01695239|50316538|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
25174014|NCT01695239|50316539|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
25174015|NCT01695239|50316540|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
25090117|NCT02013544|50199255|FG001|Overall Study|Lost to Follow-up|3|||
25174016|NCT01695239|50316541|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
25174017|NCT01695239|50316542|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
25174018|NCT01695239|50316543|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
25174019|NCT01695239|50316544|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
25174020|NCT01695239|50316545|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
25174021|NCT01695239|50316546|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
25174022|NCT01695239|50316547|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
25174023|NCT01695239|50316548|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
25174024|NCT01695239|50316549|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
25174025|NCT01695239|50316536|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
25174026|NCT01695239|50316537|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
25174027|NCT01695239|50316538|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
25174028|NCT01695239|50316539|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
25174029|NCT01695239|50316540|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
25174030|NCT01695239|50316541|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
25174031|NCT01695239|50316542|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
25174032|NCT01695239|50316543|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
25174033|NCT01695239|50316544|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
25174034|NCT01695239|50316545|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
25174035|NCT01695239|50316546|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
25174036|NCT01695239|50316547|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
25174037|NCT01695239|50316548|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
25174038|NCT01695239|50316549|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
25174039|NCT01695239|50316536|FG000|Extension Long-Term Extension Periods|Death|0|||
25174040|NCT01695239|50316537|FG001|Extension Long-Term Extension Periods|Death|0|||
25174041|NCT01695239|50316538|FG002|Extension Long-Term Extension Periods|Death|0|||
25174042|NCT01695239|50316539|FG003|Extension Long-Term Extension Periods|Death|0|||
25174043|NCT01695239|50316540|FG004|Extension Long-Term Extension Periods|Death|0|||
25174044|NCT01695239|50316541|FG005|Extension Long-Term Extension Periods|Death|0|||
25174045|NCT01695239|50316542|FG006|Extension Long-Term Extension Periods|Death|0|||
25174046|NCT01695239|50316543|FG007|Extension Long-Term Extension Periods|Death|0|||
25174047|NCT01695239|50316544|FG008|Extension Long-Term Extension Periods|Death|1|||
25174048|NCT01695239|50316545|FG009|Extension Long-Term Extension Periods|Death|0|||
25174049|NCT01695239|50316546|FG010|Extension Long-Term Extension Periods|Death|0|||
25174050|NCT01695239|50316547|FG011|Extension Long-Term Extension Periods|Death|0|||
25174051|NCT01695239|50316548|FG012|Extension Long-Term Extension Periods|Death|0|||
25174052|NCT01695239|50316549|FG013|Extension Long-Term Extension Periods|Death|0|||
25090118|NCT02013544|50199254|FG000|Overall Study|Withdrawal by Subject|2|||
25090119|NCT02013544|50199255|FG001|Overall Study|Withdrawal by Subject|8|||
25174053|NCT01695239|50316536|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25174054|NCT01695239|50316537|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25174055|NCT01695239|50316538|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25174056|NCT01695239|50316539|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25174057|NCT01695239|50316540|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25090120|NCT02013544|50199254|FG000|Overall Study|Physician Decision|0|||
25090121|NCT02013544|50199255|FG001|Overall Study|Physician Decision|1|||
25090122|NCT02013544|50199254|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
25090123|NCT02013544|50199255|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
25090124|NCT02013388|50199269|FG000|Overall Study|work emergency|1|||
25090125|NCT02013388|50199270|FG001|Overall Study|work emergency|0|||
25090126|NCT02013388|50199271|FG002|Overall Study|work emergency|0|||
25090127|NCT02013388|50199272|FG003|Overall Study|work emergency|0|||
25090128|NCT02013388|50199273|FG004|Overall Study|work emergency|1|||
25090129|NCT02013388|50199274|FG005|Overall Study|work emergency|0|||
25090130|NCT02013388|50199275|FG006|Overall Study|work emergency|0|||
25090131|NCT02013388|50199276|FG007|Overall Study|work emergency|0|||
25090132|NCT02012686|50199300|FG000|Overall Study|muscle contraction|0|||
25090133|NCT02012686|50199301|FG001|Overall Study|muscle contraction|1|||
25090134|NCT02012686|50199300|FG000|Overall Study|electrocardiography monitoring noise|0|||
25090135|NCT02012686|50199301|FG001|Overall Study|electrocardiography monitoring noise|1|||
25090136|NCT02012452|50199309|FG000|Overall Study|Lost to Follow-up|2|||
25090137|NCT02012452|50199310|FG001|Overall Study|Lost to Follow-up|1|||
25090138|NCT02012452|50199309|FG000|Overall Study|Withdrawal by Subject|4|||
25090139|NCT02012452|50199310|FG001|Overall Study|Withdrawal by Subject|0|||
25090140|NCT01676909|50199318|FG000|Overall Study|Withdrawal by Subject|3|||
25174058|NCT01695239|50316541|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25174059|NCT01695239|50316542|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25090141|NCT01676909|50199319|FG001|Overall Study|Withdrawal by Subject|5|||
25090142|NCT01676909|50199318|FG000|Overall Study|Lost to Follow-up|15|||
25090143|NCT01676909|50199319|FG001|Overall Study|Lost to Follow-up|9|||
25090144|NCT02012296|50199330|FG000|Overall Study|Lack of Efficacy|0|||
25174060|NCT01695239|50316543|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25174061|NCT01695239|50316544|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25174062|NCT01695239|50316545|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25174063|NCT01695239|50316546|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25174064|NCT01695239|50316547|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
25174065|NCT01695239|50316548|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
25174066|NCT01695239|50316549|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
25174067|NCT01695239|50316536|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25174068|NCT01695239|50316537|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25174069|NCT01695239|50316538|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25174070|NCT01695239|50316539|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25174071|NCT01695239|50316540|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25174072|NCT01695239|50316541|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25174073|NCT01695239|50316542|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25174074|NCT01695239|50316543|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25174075|NCT01695239|50316544|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25174076|NCT01695239|50316545|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25174077|NCT01695239|50316546|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25174078|NCT01695239|50316547|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25174079|NCT01695239|50316548|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
25174080|NCT01695239|50316549|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
25174081|NCT01695239|50316536|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
25174082|NCT01695239|50316537|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
25174083|NCT01695239|50316538|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
25174084|NCT01695239|50316539|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
25174085|NCT01695239|50316540|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
25174086|NCT01695239|50316541|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
25174087|NCT01695239|50316542|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
25090145|NCT02012296|50199331|FG001|Overall Study|Lack of Efficacy|0|||
25090146|NCT02012296|50199332|FG002|Overall Study|Lack of Efficacy|15|||
25090147|NCT02012296|50199330|FG000|Overall Study|Adverse Event|0|||
25090148|NCT02012296|50199331|FG001|Overall Study|Adverse Event|0|||
25090149|NCT02012296|50199332|FG002|Overall Study|Adverse Event|2|||
25090150|NCT02012296|50199330|FG000|Overall Study|Early study closure|0|||
25090151|NCT02012296|50199331|FG001|Overall Study|Early study closure|0|||
25090152|NCT02012296|50199332|FG002|Overall Study|Early study closure|5|||
25090153|NCT02012296|50199330|FG000|Overall Study|Protocol Violation|0|||
25090154|NCT02012296|50199331|FG001|Overall Study|Protocol Violation|1|||
25090155|NCT02012296|50199332|FG002|Overall Study|Protocol Violation|0|||
25090156|NCT02012218|50199349|FG000|Overall Study|Withdrawal by Subject|1|||
25174088|NCT01695239|50316543|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
25174089|NCT01695239|50316544|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
25174090|NCT01695239|50316545|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
25174091|NCT01695239|50316546|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
25174092|NCT01695239|50316547|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
25174093|NCT01695239|50316548|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
25174094|NCT01695239|50316549|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
25174095|NCT01695239|50316536|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25174096|NCT01695239|50316537|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25174097|NCT01695239|50316538|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25174098|NCT01695239|50316539|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25174099|NCT01695239|50316540|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25174100|NCT01695239|50316541|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25174101|NCT01695239|50316542|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25174102|NCT01695239|50316543|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25174103|NCT01695239|50316544|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25174104|NCT01695239|50316545|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25174105|NCT01695239|50316546|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25174106|NCT01695239|50316547|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25174107|NCT01695239|50316548|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25174108|NCT01695239|50316549|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
25174109|NCT02163694|50316573|FG000|Overall Study|Adverse event- related to progression|3|||
25174110|NCT02163694|50316574|FG001|Overall Study|Adverse event- related to progression|8|||
25174111|NCT02163694|50316573|FG000|Overall Study|Adverse event- not related to progression|7|||
25174112|NCT02163694|50316574|FG001|Overall Study|Adverse event- not related to progression|17|||
25090157|NCT02012218|50199350|FG001|Overall Study|Withdrawal by Subject|0|||
25090158|NCT02012218|50199351|FG002|Overall Study|Withdrawal by Subject|1|||
25090159|NCT02012218|50199352|FG003|Overall Study|Withdrawal by Subject|1|||
25174113|NCT02163694|50316573|FG000|Overall Study|Withdrew consent|8|||
25174114|NCT02163694|50316574|FG001|Overall Study|Withdrew consent|21|||
25174115|NCT02163694|50316573|FG000|Overall Study|Lost to Follow-up|1|||
25174116|NCT02163694|50316574|FG001|Overall Study|Lost to Follow-up|2|||
25090160|NCT02012218|50199353|FG004|Overall Study|Withdrawal by Subject|1|||
25090161|NCT02012218|50199349|FG000|Overall Study|Adverse Event|1|||
25090162|NCT02012218|50199350|FG001|Overall Study|Adverse Event|0|||
25090163|NCT02012218|50199351|FG002|Overall Study|Adverse Event|0|||
25090164|NCT02012218|50199352|FG003|Overall Study|Adverse Event|1|||
25090165|NCT02012218|50199353|FG004|Overall Study|Adverse Event|0|||
25090166|NCT02012218|50199349|FG000|Overall Study|Lost to Follow-up|0|||
25090167|NCT02012218|50199350|FG001|Overall Study|Lost to Follow-up|1|||
25090168|NCT02012218|50199351|FG002|Overall Study|Lost to Follow-up|1|||
25090169|NCT02012218|50199352|FG003|Overall Study|Lost to Follow-up|0|||
25090170|NCT02012218|50199353|FG004|Overall Study|Lost to Follow-up|0|||
25090171|NCT02012218|50199349|FG000|Overall Study|Protocol Specified|1|||
25090172|NCT02012218|50199350|FG001|Overall Study|Protocol Specified|0|||
25090173|NCT02012218|50199351|FG002|Overall Study|Protocol Specified|0|||
25090174|NCT02012218|50199352|FG003|Overall Study|Protocol Specified|0|||
25090175|NCT02012218|50199353|FG004|Overall Study|Protocol Specified|0|||
25174117|NCT02163694|50316573|FG000|Overall Study|Progressive disease per protocol|122|||
25174118|NCT02163694|50316574|FG001|Overall Study|Progressive disease per protocol|197|||
25174119|NCT02163694|50316573|FG000|Overall Study|Other, not specified|13|||
25174120|NCT02163694|50316574|FG001|Overall Study|Other, not specified|22|||
25174121|NCT01694849|50316608|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
25174122|NCT01694849|50316609|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
25174123|NCT01694849|50316610|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
25174124|NCT01694849|50316608|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
25174125|NCT01694849|50316609|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
25174126|NCT01694849|50316610|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
25174127|NCT01694849|50316608|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
25174128|NCT01694849|50316609|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
25174129|NCT01694849|50316610|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
25174130|NCT01694849|50316608|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
25174131|NCT01694849|50316609|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
25174132|NCT01694849|50316610|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
25174133|NCT01694849|50316608|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
25174134|NCT01694849|50316609|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
25174135|NCT01694849|50316610|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
25174136|NCT01694849|50316608|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
25174137|NCT01694849|50316609|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
25174138|NCT01694849|50316610|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
25174139|NCT01694849|50316608|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
25174140|NCT01694849|50316609|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
25090176|NCT02012218|50199349|FG000|Overall Study|Protocol Deviation|1|||
25090177|NCT02012218|50199350|FG001|Overall Study|Protocol Deviation|0|||
25174141|NCT01694849|50316610|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
25174142|NCT01694849|50316608|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
25174143|NCT01694849|50316609|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
25174144|NCT01694849|50316610|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
25174145|NCT01694771|50316659|FG000|Overall Study|Adverse Event|18|||
25174146|NCT01694771|50316660|FG001|Overall Study|Adverse Event|16|||
25174147|NCT01694771|50316659|FG000|Overall Study|Lack of Efficacy|1|||
25174148|NCT01694771|50316660|FG001|Overall Study|Lack of Efficacy|0|||
25174149|NCT01694771|50316659|FG000|Overall Study|Non compliance protocol|7|||
25174150|NCT01694771|50316660|FG001|Overall Study|Non compliance protocol|6|||
25174151|NCT01694771|50316659|FG000|Overall Study|Lost to Follow-up|2|||
25174152|NCT01694771|50316660|FG001|Overall Study|Lost to Follow-up|3|||
25174153|NCT01694771|50316659|FG000|Overall Study|Consent withdrawn|7|||
25174154|NCT01694771|50316660|FG001|Overall Study|Consent withdrawn|9|||
25174155|NCT01694771|50316659|FG000|Overall Study|Other reasons|5|||
25174156|NCT01694771|50316660|FG001|Overall Study|Other reasons|6|||
25174157|NCT01582061|50316689|FG000|Overall Study|Lack of Efficacy|3|||
25174158|NCT01582061|50316690|FG001|Overall Study|Lack of Efficacy|23|||
25174159|NCT01582061|50316689|FG000|Overall Study|Adverse Event|12|||
25174160|NCT01582061|50316690|FG001|Overall Study|Adverse Event|8|||
25090178|NCT02012218|50199351|FG002|Overall Study|Protocol Deviation|0|||
25174161|NCT01582061|50316689|FG000|Overall Study|Withdrawal by Subject|10|||
25174162|NCT01582061|50316690|FG001|Overall Study|Withdrawal by Subject|4|||
25090179|NCT02012218|50199352|FG003|Overall Study|Protocol Deviation|0|||
25090180|NCT02012218|50199353|FG004|Overall Study|Protocol Deviation|0|||
25090181|NCT01965262|50199365|FG000|Second Intervention (7 Days)|Discontinued|0|||
25174163|NCT01582061|50316689|FG000|Overall Study|Abnormal laboratory value(s)|1|||
25174164|NCT01582061|50316690|FG001|Overall Study|Abnormal laboratory value(s)|0|||
25174165|NCT01582061|50316689|FG000|Overall Study|Death|0|||
25174166|NCT01582061|50316690|FG001|Overall Study|Death|1|||
25090182|NCT01965262|50199366|FG001|Second Intervention (7 Days)|Discontinued|1|||
25090183|NCT01965262|50199365|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
25090184|NCT01965262|50199366|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
25090185|NCT01965262|50199365|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
25090186|NCT01965262|50199366|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
25090187|NCT01677377|50199375|FG000|Overall Study|Protocol Violation|1|||
25090188|NCT01677377|50199376|FG001|Overall Study|Protocol Violation|0|||
25174167|NCT01582061|50316689|FG000|Overall Study|condition no longer requires study drug|1|||
25174168|NCT01582061|50316690|FG001|Overall Study|condition no longer requires study drug|0|||
25174169|NCT01582061|50316689|FG000|Overall Study|Lost to Follow-up|1|||
25174170|NCT01582061|50316690|FG001|Overall Study|Lost to Follow-up|0|||
25174171|NCT01693523|50316709|FG000|Overall Study|Adverse Event|2|||
25174172|NCT01693523|50316710|FG001|Overall Study|Adverse Event|1|||
25174173|NCT01693523|50316711|FG002|Overall Study|Adverse Event|0|||
25174174|NCT01693523|50316709|FG000|Overall Study|Death|0|||
25174175|NCT01693523|50316710|FG001|Overall Study|Death|1|||
25174176|NCT01693523|50316711|FG002|Overall Study|Death|1|||
25174177|NCT01693523|50316709|FG000|Overall Study|Lost to Follow-up|0|||
25174178|NCT01693523|50316710|FG001|Overall Study|Lost to Follow-up|0|||
25174179|NCT01693523|50316711|FG002|Overall Study|Lost to Follow-up|4|||
25174180|NCT01693523|50316709|FG000|Overall Study|Physician Decision|0|||
25174181|NCT01693523|50316710|FG001|Overall Study|Physician Decision|0|||
25174182|NCT01693523|50316711|FG002|Overall Study|Physician Decision|1|||
25174183|NCT01693523|50316709|FG000|Overall Study|Withdrawal by Subject|1|||
25174184|NCT01693523|50316710|FG001|Overall Study|Withdrawal by Subject|2|||
25174185|NCT01693523|50316711|FG002|Overall Study|Withdrawal by Subject|2|||
25174186|NCT01693523|50316709|FG000|Overall Study|Lack of compliance study medication|1|||
25174187|NCT01693523|50316710|FG001|Overall Study|Lack of compliance study medication|2|||
25174188|NCT01693523|50316711|FG002|Overall Study|Lack of compliance study medication|0|||
25174189|NCT01693523|50316709|FG000|Overall Study|Chemotherapy was held|1|||
25174190|NCT01693523|50316710|FG001|Overall Study|Chemotherapy was held|2|||
25174191|NCT01693523|50316711|FG002|Overall Study|Chemotherapy was held|0|||
25174192|NCT01581593|50316727|FG000|Overall Study|Withdrawal by Subject|1|||
25174193|NCT01581281|50316738|FG000|Overall Study|Early Study Closure|15|||
25174194|NCT01581281|50316739|FG001|Overall Study|Early Study Closure|6|||
25174195|NCT01581281|50316740|FG002|Overall Study|Early Study Closure|12|||
25174196|NCT02692716|50316751|FG000|Overall Study|Lost to Follow-up|2|||
25174197|NCT02692716|50316752|FG001|Overall Study|Lost to Follow-up|5|||
25174198|NCT02692716|50316751|FG000|Overall Study|Withdrawal by Subject|3|||
25174199|NCT02692716|50316752|FG001|Overall Study|Withdrawal by Subject|1|||
25174200|NCT01580969|50316761|FG000|Overall Study|Physician Decision|3|||
25174201|NCT01580969|50316762|FG001|Overall Study|Physician Decision|0|||
25174202|NCT01580969|50316763|FG002|Overall Study|Physician Decision|0|||
25174203|NCT01693367|50316773|FG000|Overall Study|Withdrawal by Subject|1|||
25174204|NCT01693367|50316774|FG001|Overall Study|Withdrawal by Subject|1|||
25174205|NCT01693367|50316773|FG000|Overall Study|Physician Decision|0|||
25174206|NCT01693367|50316774|FG001|Overall Study|Physician Decision|1|||
25174207|NCT02696226|50316784|FG000|Overall Study|Study terminated - lack of enrollment|1|||
25174208|NCT02696226|50316785|FG001|Overall Study|Study terminated - lack of enrollment|0|||
25174209|NCT02696226|50316786|FG002|Overall Study|Study terminated - lack of enrollment|2|||
25174210|NCT02696226|50316787|FG003|Overall Study|Study terminated - lack of enrollment|0|||
25174211|NCT01692275|50316803|FG000|Overall Study|Lost to Follow-up|57|||
25174212|NCT01692275|50316804|FG001|Overall Study|Lost to Follow-up|48|||
25174213|NCT01692275|50316803|FG000|Overall Study|Withdrawal by Subject|9|||
25174214|NCT01692275|50316804|FG001|Overall Study|Withdrawal by Subject|11|||
25174215|NCT02692560|50316824|FG000|Overall Study|Withdrawal by Subject|0|||
25174216|NCT02692560|50316825|FG001|Overall Study|Withdrawal by Subject|6|||
25174217|NCT02688192|50316833|FG000|Overall Study|Lost to Follow-up|11|||
25090189|NCT01677377|50199377|FG002|Overall Study|Protocol Violation|0|||
25090190|NCT01677377|50199375|FG000|Overall Study|Lost to Follow-up|0|||
25090191|NCT01677377|50199376|FG001|Overall Study|Lost to Follow-up|1|||
25090192|NCT01677377|50199377|FG002|Overall Study|Lost to Follow-up|1|||
25090193|NCT01677377|50199375|FG000|Overall Study|Withdrawal by Subject|0|||
25090194|NCT01677377|50199376|FG001|Overall Study|Withdrawal by Subject|0|||
25090195|NCT01677377|50199377|FG002|Overall Study|Withdrawal by Subject|3|||
25174218|NCT02688192|50316834|FG001|Overall Study|Lost to Follow-up|5|||
25174219|NCT02688192|50316833|FG000|Overall Study|Physician Decision|1|||
25174220|NCT02688192|50316834|FG001|Overall Study|Physician Decision|0|||
25174221|NCT01579565|50316843|FG000|Randomized|Adverse Event|1|||
25174222|NCT01579565|50316844|FG001|Randomized|Adverse Event|3|||
25174223|NCT01579565|50316843|FG000|Randomized|Withdrawal by Subject|3|||
25174224|NCT01579565|50316844|FG001|Randomized|Withdrawal by Subject|0|||
25174225|NCT01579565|50316843|FG000|Randomized|inadequate preoperative pupil dilation|0|||
25174226|NCT01579565|50316844|FG001|Randomized|inadequate preoperative pupil dilation|1|||
25090196|NCT01677377|50199375|FG000|Overall Study|Lack of Efficacy|0|||
25174227|NCT01579565|50316843|FG000|Randomized|prohibited preoperative eating|1|||
25174228|NCT01579565|50316844|FG001|Randomized|prohibited preoperative eating|0|||
25174229|NCT01579565|50316843|FG000|Randomized|prohibited preoperative medication|0|||
25174230|NCT01579565|50316844|FG001|Randomized|prohibited preoperative medication|1|||
25174231|NCT01579565|50316843|FG000|Treated|Physician Decision|0|||
25174232|NCT01579565|50316844|FG001|Treated|Physician Decision|1|||
25174233|NCT01579565|50316843|FG000|Treated|Lost to Follow-up|2|||
25174234|NCT01579565|50316844|FG001|Treated|Lost to Follow-up|1|||
25174235|NCT01579565|50316843|FG000|Treated|declined to return for final visit|0|||
25174236|NCT01579565|50316844|FG001|Treated|declined to return for final visit|1|||
25174237|NCT01578785|50316854|FG000|Overall Study|Withdrawal by Subject|0|||
25174238|NCT01578785|50316855|FG001|Overall Study|Withdrawal by Subject|1|||
25174239|NCT01578785|50316854|FG000|Overall Study|Study terminated by sponsor|59|||
25174240|NCT01578785|50316855|FG001|Overall Study|Study terminated by sponsor|118|||
25174241|NCT02692482|50316863|FG000|Overall Study|Death|2|||
25174242|NCT02692482|50316864|FG001|Overall Study|Death|2|||
25174243|NCT02692482|50316863|FG000|Overall Study|Withdrawal by Subject|1|||
25174244|NCT02692482|50316864|FG001|Overall Study|Withdrawal by Subject|2|||
25174245|NCT01578551|50316873|FG000|Overall Study|Adverse Event|1|||
25174246|NCT01578551|50316874|FG001|Overall Study|Adverse Event|0|||
25174247|NCT01692197|50316881|FG000|Overall Study|Failed Screening|3|||
25174248|NCT01692119|50316888|FG000|Overall Study|Protocol Violation|3|||
25174249|NCT01692119|50316889|FG001|Overall Study|Protocol Violation|1|||
25174250|NCT01692119|50316888|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
25174251|NCT01692119|50316889|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
25174252|NCT01691885|50316895|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
25174253|NCT01691885|50316896|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
25174254|NCT01691885|50316895|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
25174255|NCT01691885|50316896|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
25174256|NCT01587703|50316929|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
25174257|NCT01587703|50316930|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174258|NCT01587703|50316931|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174259|NCT01587703|50316932|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174260|NCT01587703|50316933|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174261|NCT01587703|50316934|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174262|NCT01587703|50316935|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174263|NCT01587703|50316936|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174264|NCT01587703|50316937|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174265|NCT01587703|50316938|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174266|NCT01587703|50316939|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174267|NCT01587703|50316940|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174268|NCT01587703|50316941|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174269|NCT01587703|50316942|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174270|NCT01587703|50316943|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174271|NCT01587703|50316944|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174272|NCT01587703|50316945|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174273|NCT01587703|50316946|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174274|NCT01587703|50316947|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
25174275|NCT01587703|50316929|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
25174276|NCT01587703|50316930|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
25174277|NCT01587703|50316931|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
25174278|NCT01587703|50316932|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
25174279|NCT01587703|50316933|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
25174280|NCT01587703|50316934|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
25174281|NCT01587703|50316935|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
25174282|NCT01587703|50316936|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
25174283|NCT01587703|50316937|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
25174284|NCT01587703|50316938|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
25174285|NCT01587703|50316939|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
25174286|NCT01587703|50316940|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
25090197|NCT01677377|50199376|FG001|Overall Study|Lack of Efficacy|0|||
25090198|NCT01677377|50199377|FG002|Overall Study|Lack of Efficacy|1|||
25090199|NCT01677377|50199375|FG000|Overall Study|Pregnancy|0|||
25090200|NCT01677377|50199376|FG001|Overall Study|Pregnancy|0|||
25090201|NCT01677377|50199377|FG002|Overall Study|Pregnancy|1|||
25090202|NCT01964950|50199387|FG000|Overall Study|Protocol Violation|25|||
25090203|NCT01964716|50199396|FG000|Overall Study|Withdrawal by Subject|2|||
25090204|NCT01964716|50199397|FG001|Overall Study|Withdrawal by Subject|3|||
25090205|NCT01964716|50199396|FG000|Overall Study|Lost to Follow-up|1|||
25090206|NCT01964716|50199397|FG001|Overall Study|Lost to Follow-up|2|||
25174287|NCT01587703|50316941|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
25174288|NCT01587703|50316942|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
25174289|NCT01587703|50316943|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
25174290|NCT01587703|50316944|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
25174291|NCT01587703|50316945|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
25174292|NCT01587703|50316946|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
25174293|NCT01587703|50316947|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
25174294|NCT01587703|50316929|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174295|NCT01587703|50316930|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174296|NCT01587703|50316931|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174297|NCT01587703|50316932|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174298|NCT01587703|50316933|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174299|NCT01587703|50316934|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174300|NCT01587703|50316935|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
25174301|NCT01587703|50316936|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174302|NCT01587703|50316937|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174303|NCT01587703|50316938|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174304|NCT01587703|50316939|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174305|NCT01587703|50316940|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174306|NCT01587703|50316941|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174307|NCT01587703|50316942|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174308|NCT01587703|50316943|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174309|NCT01587703|50316944|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174310|NCT01587703|50316945|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174311|NCT01587703|50316946|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174312|NCT01587703|50316947|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
25174313|NCT01587703|50316929|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
25174314|NCT01587703|50316930|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
25174315|NCT01587703|50316931|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
25174316|NCT01587703|50316932|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
25174317|NCT01587703|50316933|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
25174318|NCT01587703|50316934|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
25174319|NCT01587703|50316935|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
25174320|NCT01587703|50316936|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
25174321|NCT01587703|50316937|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
25174322|NCT01587703|50316938|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
25174323|NCT01587703|50316939|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
25174324|NCT01587703|50316940|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
25174325|NCT01587703|50316941|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
25174326|NCT01587703|50316942|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
25174327|NCT01587703|50316943|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
25174328|NCT01587703|50316944|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
25174329|NCT01587703|50316945|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
25174330|NCT01587703|50316946|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
25174331|NCT01587703|50316947|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
25174332|NCT01587703|50316929|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
25174333|NCT01587703|50316930|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
25174334|NCT01587703|50316931|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
25174335|NCT01587703|50316932|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
25174336|NCT01587703|50316933|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
25174337|NCT01587703|50316934|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
24996879|NCT02963506|50088005|FG010|Dose-Blind Period|Lack of Efficacy|0|||
25090207|NCT01964716|50199396|FG000|Overall Study|No longer met eligibility criteria|1|||
25090208|NCT01964716|50199397|FG001|Overall Study|No longer met eligibility criteria|1|||
25090209|NCT01964716|50199396|FG000|Overall Study|Death|1|||
25090210|NCT01964716|50199397|FG001|Overall Study|Death|0|||
25090211|NCT01964560|50199411|FG000|Overall Study|Adverse Event|23|||
25090212|NCT01964560|50199411|FG000|Overall Study|Lack of Efficacy|46|||
25090213|NCT01964560|50199411|FG000|Overall Study|Protocol deviation|2|||
25090214|NCT01964560|50199411|FG000|Overall Study|Lost to Follow-up|4|||
25090215|NCT01964560|50199411|FG000|Overall Study|Withdrawal by Subject|64|||
25090216|NCT01964560|50199411|FG000|Overall Study|Surgery-hemispherotomy|1|||
25090217|NCT01964560|50199411|FG000|Overall Study|Surgery|1|||
25090218|NCT01964560|50199411|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
25090219|NCT01964560|50199411|FG000|Overall Study|Patient and Investigator choice|1|||
25090220|NCT01964560|50199411|FG000|Overall Study|Patient was prescribed CBD|1|||
25090221|NCT01964560|50199411|FG000|Overall Study|Participant moved to another country|1|||
25090222|NCT02659943|50199422|FG000|Overall Study|Switched to alternative treatment|1|||
25090223|NCT02659943|50199423|FG001|Overall Study|Switched to alternative treatment|1|||
25174338|NCT01587703|50316935|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
25174339|NCT01587703|50316936|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
25174340|NCT01587703|50316937|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
25174341|NCT01587703|50316938|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
25174342|NCT01587703|50316939|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
25174343|NCT01587703|50316940|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
25174344|NCT01587703|50316941|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
25174345|NCT01587703|50316942|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
25174346|NCT01587703|50316943|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
25174347|NCT01587703|50316944|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
25174348|NCT01587703|50316945|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
25174349|NCT01587703|50316946|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
25174350|NCT01587703|50316947|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
25174351|NCT01587703|50316929|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
25174352|NCT01587703|50316930|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
25174353|NCT01587703|50316931|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
25174354|NCT01587703|50316932|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
25174355|NCT01587703|50316933|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
25174356|NCT01587703|50316934|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
25174357|NCT01587703|50316935|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
25174358|NCT01587703|50316936|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
25174359|NCT01587703|50316937|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
25174360|NCT01587703|50316938|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
25174361|NCT01587703|50316939|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
25174362|NCT01587703|50316940|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
25174363|NCT01587703|50316941|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
25174364|NCT01587703|50316942|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
25174365|NCT01587703|50316943|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
25174366|NCT01587703|50316944|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
25174367|NCT01587703|50316945|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
25174368|NCT01587703|50316946|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
25174369|NCT01587703|50316947|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
25174370|NCT01587703|50316929|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
25174371|NCT01587703|50316930|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
25174372|NCT01587703|50316931|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
25174373|NCT01587703|50316932|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
25174374|NCT01587703|50316933|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
25174375|NCT01587703|50316934|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
25174376|NCT01587703|50316935|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
25174377|NCT01587703|50316936|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
25174378|NCT01587703|50316937|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
25174379|NCT01587703|50316938|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
25174380|NCT01587703|50316939|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
25174381|NCT01587703|50316940|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
25174382|NCT01587703|50316941|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
25174383|NCT01587703|50316942|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
25174384|NCT01587703|50316943|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
25174385|NCT01587703|50316944|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
25174386|NCT01587703|50316945|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
25174387|NCT01587703|50316946|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
25174388|NCT01587703|50316947|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
25174389|NCT01587703|50316929|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
25174390|NCT01587703|50316930|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
25174391|NCT01587703|50316931|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
25174392|NCT01587703|50316932|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
24996880|NCT02963506|50088006|FG011|Dose-Blind Period|Lack of Efficacy|0|||
24996881|NCT02963506|50088007|FG012|Dose-Blind Period|Lack of Efficacy|0|||
24996882|NCT02963506|50087995|FG000|Dose-Blind Period|Lost to Follow-up|0|||
24996883|NCT02963506|50087996|FG001|Dose-Blind Period|Lost to Follow-up|0|||
24996884|NCT02963506|50087997|FG002|Dose-Blind Period|Lost to Follow-up|0|||
24996885|NCT02963506|50087998|FG003|Dose-Blind Period|Lost to Follow-up|0|||
24996886|NCT02963506|50087999|FG004|Dose-Blind Period|Lost to Follow-up|0|||
24996887|NCT02963506|50088000|FG005|Dose-Blind Period|Lost to Follow-up|1|||
24996888|NCT02963506|50088001|FG006|Dose-Blind Period|Lost to Follow-up|0|||
24996889|NCT02963506|50088002|FG007|Dose-Blind Period|Lost to Follow-up|0|||
24996890|NCT02963506|50088003|FG008|Dose-Blind Period|Lost to Follow-up|1|||
25174393|NCT01587703|50316933|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
25174394|NCT01587703|50316934|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
25174395|NCT01587703|50316935|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
25174396|NCT01587703|50316936|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
25174397|NCT01587703|50316937|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
25174398|NCT01587703|50316938|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
25174399|NCT01587703|50316939|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
25174400|NCT01587703|50316940|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
25174401|NCT01587703|50316941|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
25174402|NCT01587703|50316942|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
25174403|NCT01587703|50316943|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
25174404|NCT01587703|50316944|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
25174405|NCT01587703|50316945|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
25174406|NCT01587703|50316946|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
25174407|NCT01587703|50316947|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
25174408|NCT01587703|50316929|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174409|NCT01587703|50316930|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174410|NCT01587703|50316931|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174411|NCT01587703|50316932|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174412|NCT01587703|50316933|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174413|NCT01587703|50316934|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174414|NCT01587703|50316935|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174415|NCT01587703|50316936|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174416|NCT01587703|50316937|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174417|NCT01587703|50316938|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174418|NCT01587703|50316939|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174419|NCT01587703|50316940|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174420|NCT01587703|50316941|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174421|NCT01587703|50316942|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174422|NCT01587703|50316943|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174423|NCT01587703|50316944|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174424|NCT01587703|50316945|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174425|NCT01587703|50316946|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
25174426|NCT01587703|50316947|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
25174427|NCT01587703|50316929|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
25174428|NCT01587703|50316930|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
25174429|NCT01587703|50316931|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
25174430|NCT01587703|50316932|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
25174431|NCT01587703|50316933|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
25174432|NCT01587703|50316934|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
25174433|NCT01587703|50316935|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
25174434|NCT01587703|50316936|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
25174435|NCT01587703|50316937|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
25174436|NCT01587703|50316938|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
25174437|NCT01587703|50316939|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
25174438|NCT01587703|50316940|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
25174439|NCT01587703|50316941|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
25174440|NCT01587703|50316942|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
25174441|NCT01587703|50316943|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
25174442|NCT01587703|50316944|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
25174443|NCT01587703|50316945|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
25174444|NCT01587703|50316946|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
25174445|NCT01587703|50316947|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
25174446|NCT01587703|50316929|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174447|NCT01587703|50316930|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174448|NCT01587703|50316931|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174449|NCT01587703|50316932|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174450|NCT01587703|50316933|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174451|NCT01587703|50316934|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174452|NCT01587703|50316935|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174453|NCT01587703|50316936|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174454|NCT01587703|50316937|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174455|NCT01587703|50316938|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174456|NCT01587703|50316939|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174457|NCT01587703|50316940|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174458|NCT01587703|50316941|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174459|NCT01587703|50316942|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174460|NCT01587703|50316943|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174461|NCT01587703|50316944|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
25174462|NCT01587703|50316945|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174463|NCT01587703|50316946|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174464|NCT01587703|50316947|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
25174465|NCT01587703|50316929|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
25174466|NCT01587703|50316930|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
25174467|NCT01587703|50316931|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
25174468|NCT01587703|50316932|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
25174469|NCT01587703|50316933|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
25174470|NCT01587703|50316934|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
25174471|NCT01587703|50316935|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
25174472|NCT01587703|50316936|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
25174473|NCT01587703|50316937|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
25174474|NCT01587703|50316938|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
25174475|NCT01587703|50316939|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
25174476|NCT01587703|50316940|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
25174477|NCT01587703|50316941|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
25174478|NCT01587703|50316942|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
25174479|NCT01587703|50316943|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
25174480|NCT01587703|50316944|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
25174481|NCT01587703|50316945|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
25174482|NCT01587703|50316946|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
25174483|NCT01587703|50316947|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
25174484|NCT01587703|50316929|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
25174485|NCT01587703|50316930|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
25090224|NCT02659943|50199424|FG002|Overall Study|Switched to alternative treatment|0|||
25090225|NCT02659943|50199425|FG003|Overall Study|Switched to alternative treatment|2|||
25090226|NCT02659943|50199426|FG004|Overall Study|Switched to alternative treatment|1|||
25090227|NCT02659943|50199427|FG005|Overall Study|Switched to alternative treatment|0|||
25090228|NCT02659943|50199428|FG006|Overall Study|Switched to alternative treatment|1|||
25090229|NCT02659943|50199422|FG000|Overall Study|Disease progression on study|0|||
25090230|NCT02659943|50199423|FG001|Overall Study|Disease progression on study|1|||
25090231|NCT02659943|50199424|FG002|Overall Study|Disease progression on study|1|||
25090232|NCT02659943|50199425|FG003|Overall Study|Disease progression on study|1|||
25090233|NCT02659943|50199426|FG004|Overall Study|Disease progression on study|1|||
25174486|NCT01587703|50316931|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
25174487|NCT01587703|50316932|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
25174488|NCT01587703|50316933|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
25174489|NCT01587703|50316934|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
25174490|NCT01587703|50316935|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
25174491|NCT01587703|50316936|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
25174492|NCT01587703|50316937|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
25174493|NCT01587703|50316938|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
25174494|NCT01587703|50316939|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
25174495|NCT01587703|50316940|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
25174496|NCT01587703|50316941|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
25174497|NCT01587703|50316942|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
25174498|NCT01587703|50316943|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
25174499|NCT01587703|50316944|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
25174500|NCT01587703|50316945|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
25174501|NCT01587703|50316946|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
25174502|NCT01587703|50316947|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
25174503|NCT01587703|50316929|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
25174504|NCT01587703|50316930|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
25174505|NCT01587703|50316931|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
25174506|NCT01587703|50316932|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
25174507|NCT01587703|50316933|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
25174508|NCT01587703|50316934|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
25174509|NCT01587703|50316935|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
25090234|NCT02659943|50199427|FG005|Overall Study|Disease progression on study|4|||
25174510|NCT01587703|50316936|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
25090235|NCT02659943|50199428|FG006|Overall Study|Disease progression on study|0|||
25090236|NCT02659943|50199422|FG000|Overall Study|Patient's condition per principal investigator|0|||
25174511|NCT01587703|50316937|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
25174512|NCT01587703|50316938|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
25174513|NCT01587703|50316939|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
25174514|NCT01587703|50316940|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
25174515|NCT01587703|50316941|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
25174516|NCT01587703|50316942|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
25174517|NCT01587703|50316943|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
25174518|NCT01587703|50316944|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
25090237|NCT02659943|50199423|FG001|Overall Study|Patient's condition per principal investigator|0|||
25090238|NCT02659943|50199424|FG002|Overall Study|Patient's condition per principal investigator|0|||
25090239|NCT02659943|50199425|FG003|Overall Study|Patient's condition per principal investigator|0|||
25090240|NCT02659943|50199426|FG004|Overall Study|Patient's condition per principal investigator|0|||
25174519|NCT01587703|50316945|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
25174520|NCT01587703|50316946|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
25174521|NCT01587703|50316947|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
25174522|NCT01587703|50316929|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25174523|NCT01587703|50316930|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25174524|NCT01587703|50316931|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25174525|NCT01587703|50316932|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25174526|NCT01587703|50316933|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25174527|NCT01587703|50316934|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25090241|NCT02659943|50199427|FG005|Overall Study|Patient's condition per principal investigator|1|||
25174528|NCT01587703|50316935|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25174529|NCT01587703|50316936|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25174530|NCT01587703|50316937|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25174531|NCT01587703|50316938|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25174532|NCT01587703|50316939|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25174533|NCT01587703|50316940|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
25174534|NCT01587703|50316941|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25174535|NCT01587703|50316942|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25174536|NCT01587703|50316943|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25174537|NCT01587703|50316944|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25174538|NCT01587703|50316945|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25174539|NCT01587703|50316946|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25174540|NCT01587703|50316947|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
25174541|NCT01577381|50317010|FG000|Overall Study|Discontinued|2|||
25174542|NCT01577381|50317011|FG001|Overall Study|Discontinued|1|||
25174543|NCT01577381|50317012|FG002|Overall Study|Discontinued|2|||
25174544|NCT01577381|50317013|FG003|Overall Study|Discontinued|2|||
25174545|NCT01577381|50317010|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
25174546|NCT01577381|50317011|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
25174547|NCT01577381|50317012|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
25174548|NCT01577381|50317013|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
25174549|NCT02686164|50317023|FG000|Overall Study|Adverse Event|1|||
25174550|NCT02686164|50317023|FG000|Overall Study|Withdrawal of consent|1|||
25174551|NCT02686164|50317023|FG000|Overall Study|Clinical progression|1|||
25174552|NCT01691105|50317044|FG000|1 Month Follow-up|Lost to Follow-up|41|||
25174553|NCT01691105|50317045|FG001|1 Month Follow-up|Lost to Follow-up|38|||
25174554|NCT01691105|50317044|FG000|1 Month Follow-up|Death|2|||
25174555|NCT01691105|50317045|FG001|1 Month Follow-up|Death|3|||
25174556|NCT01691105|50317044|FG000|6 Month Follow-up|Lost to Follow-up|39|||
25174557|NCT01691105|50317045|FG001|6 Month Follow-up|Lost to Follow-up|58|||
25174558|NCT01691105|50317044|FG000|6 Month Follow-up|Death|13|||
25174559|NCT01691105|50317045|FG001|6 Month Follow-up|Death|13|||
25174560|NCT01691105|50317044|FG000|12 Month Follow-up|Lost to Follow-up|50|||
25174561|NCT01691105|50317045|FG001|12 Month Follow-up|Lost to Follow-up|71|||
25174562|NCT01691105|50317044|FG000|12 Month Follow-up|Death|22|||
25174563|NCT01691105|50317045|FG001|12 Month Follow-up|Death|30|||
25174564|NCT01691105|50317044|FG000|12 Month Biochemical Verification|Death|22|||
25174565|NCT01691105|50317045|FG001|12 Month Biochemical Verification|Death|30|||
25174566|NCT01691105|50317044|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
25174567|NCT01691105|50317045|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
25174568|NCT01691105|50317044|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
25174569|NCT01691105|50317045|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
25174570|NCT02685072|50317053|FG000|Treatment Period|Lost to Follow-up|12|||
25174571|NCT02685072|50317054|FG001|Treatment Period|Lost to Follow-up|6|||
25174572|NCT02685072|50317053|FG000|Treatment Period|Withdrawal by Subject|1|||
25090242|NCT02659943|50199428|FG006|Overall Study|Patient's condition per principal investigator|0|||
25090243|NCT02659943|50199422|FG000|Overall Study|Ineligible|0|||
25090244|NCT02659943|50199423|FG001|Overall Study|Ineligible|0|||
25090245|NCT02659943|50199424|FG002|Overall Study|Ineligible|0|||
25090246|NCT02659943|50199425|FG003|Overall Study|Ineligible|0|||
25090247|NCT02659943|50199426|FG004|Overall Study|Ineligible|0|||
25174573|NCT02685072|50317054|FG001|Treatment Period|Withdrawal by Subject|3|||
25174574|NCT02685072|50317053|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
25174575|NCT02685072|50317054|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
25090248|NCT02659943|50199427|FG005|Overall Study|Ineligible|0|||
25090249|NCT02659943|50199428|FG006|Overall Study|Ineligible|1|||
25090250|NCT02659943|50199422|FG000|Overall Study|No longer meets eligibility|0|||
25090251|NCT02659943|50199423|FG001|Overall Study|No longer meets eligibility|0|||
25090252|NCT02659943|50199424|FG002|Overall Study|No longer meets eligibility|0|||
25090253|NCT02659943|50199425|FG003|Overall Study|No longer meets eligibility|0|||
25090254|NCT02659943|50199426|FG004|Overall Study|No longer meets eligibility|0|||
25174576|NCT02695524|50317124|FG000|Overall Study|Lost to Follow-up|3|||
25174577|NCT02695524|50317125|FG001|Overall Study|Lost to Follow-up|2|||
25174578|NCT02695524|50317124|FG000|Overall Study|Death|0|||
25174579|NCT02695524|50317125|FG001|Overall Study|Death|1|||
25174580|NCT01576367|50317131|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
25174581|NCT01576367|50317131|FG000|Overall Study|Moved to commercial use after 6 months|1|||
25174582|NCT01689857|50317142|FG000|Overall Study|Lost to Follow-up|5|||
25174583|NCT01689857|50317143|FG001|Overall Study|Lost to Follow-up|2|||
25174584|NCT01587079|50317158|FG000|Overall Study|Protocol-specified criteria|9|||
25174585|NCT01587079|50317158|FG000|Overall Study|Protocol Violation|5|||
25090255|NCT02659943|50199427|FG005|Overall Study|No longer meets eligibility|0|||
25090256|NCT02659943|50199428|FG006|Overall Study|No longer meets eligibility|1|||
25090257|NCT02659943|50199422|FG000|Overall Study|No treatment, per protocol|0|||
25090258|NCT02659943|50199423|FG001|Overall Study|No treatment, per protocol|0|||
25174586|NCT01587079|50317158|FG000|Overall Study|Lost to Follow-up|2|||
25174587|NCT01587079|50317158|FG000|Overall Study|Physician Decision|2|||
25174588|NCT01587079|50317158|FG000|Overall Study|Withdrawal by Subject|7|||
25174589|NCT01587079|50317158|FG000|Overall Study|Adverse Event|14|||
25174590|NCT01587001|50317211|FG000|Overall Study|Lost to Follow-up|2|||
25174591|NCT01587001|50317212|FG001|Overall Study|Lost to Follow-up|0|||
25174592|NCT01587001|50317211|FG000|Overall Study|Insufficient samples to complete testing|4|||
25174593|NCT01587001|50317212|FG001|Overall Study|Insufficient samples to complete testing|1|||
25174594|NCT01568047|50317242|FG000|Overall Study|Ineligibility|1|||
25174595|NCT01568047|50317243|FG001|Overall Study|Ineligibility|0|||
25174596|NCT01568047|50317244|FG002|Overall Study|Ineligibility|0|||
25174597|NCT01568047|50317245|FG003|Overall Study|Ineligibility|0|||
25174598|NCT01568047|50317242|FG000|Overall Study|Withdrawal by Subject|0|||
25174599|NCT01568047|50317243|FG001|Overall Study|Withdrawal by Subject|1|||
25174600|NCT01568047|50317244|FG002|Overall Study|Withdrawal by Subject|0|||
25174601|NCT01568047|50317245|FG003|Overall Study|Withdrawal by Subject|0|||
25174602|NCT01568047|50317242|FG000|Overall Study|Adverse Event|0|||
25174603|NCT01568047|50317243|FG001|Overall Study|Adverse Event|0|||
25174604|NCT01568047|50317244|FG002|Overall Study|Adverse Event|1|||
25174605|NCT01568047|50317245|FG003|Overall Study|Adverse Event|1|||
25174606|NCT02694978|50317257|FG000|Overall Study|Adverse Event|10|||
25174607|NCT02694978|50317258|FG001|Overall Study|Adverse Event|9|||
25174608|NCT02694978|50317257|FG000|Overall Study|Withdrawal by Subject|22|||
25174609|NCT02694978|50317258|FG001|Overall Study|Withdrawal by Subject|19|||
25174610|NCT02694978|50317257|FG000|Overall Study|Lost to Follow-up|14|||
25174611|NCT02694978|50317258|FG001|Overall Study|Lost to Follow-up|17|||
25174612|NCT02694978|50317257|FG000|Overall Study|Death|4|||
25174613|NCT02694978|50317258|FG001|Overall Study|Death|1|||
25174614|NCT02694978|50317257|FG000|Overall Study|Other-Decision of Participant|6|||
25174615|NCT02694978|50317258|FG001|Overall Study|Other-Decision of Participant|1|||
25174616|NCT02694978|50317257|FG000|Overall Study|Other-Investigator's decision|1|||
25174617|NCT02694978|50317258|FG001|Overall Study|Other-Investigator's decision|0|||
25174618|NCT02694978|50317257|FG000|Overall Study|Other-Unable to be reached|0|||
25174619|NCT02694978|50317258|FG001|Overall Study|Other-Unable to be reached|1|||
25174620|NCT02694978|50317257|FG000|Overall Study|Other-Protocol noncompliant|2|||
25174621|NCT02694978|50317258|FG001|Overall Study|Other-Protocol noncompliant|1|||
25174622|NCT02694978|50317257|FG000|Overall Study|Other-Personal reasons|3|||
25174623|NCT02694978|50317258|FG001|Overall Study|Other-Personal reasons|3|||
25174624|NCT02694978|50317257|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
25174625|NCT02694978|50317258|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
25174626|NCT01688999|50317267|FG000|Overall Study|Withdrawal by Subject|5|||
25174627|NCT01688999|50317268|FG001|Overall Study|Withdrawal by Subject|1|||
25174628|NCT01688999|50317269|FG002|Overall Study|Withdrawal by Subject|1|||
25174629|NCT01688999|50317267|FG000|Overall Study|Adverse Event|2|||
25174630|NCT01688999|50317268|FG001|Overall Study|Adverse Event|0|||
25174631|NCT01688999|50317269|FG002|Overall Study|Adverse Event|2|||
25174632|NCT01688999|50317267|FG000|Overall Study|Ineligible/Not treated|1|||
25090259|NCT02659943|50199424|FG002|Overall Study|No treatment, per protocol|0|||
25090260|NCT02659943|50199425|FG003|Overall Study|No treatment, per protocol|0|||
25090261|NCT02659943|50199426|FG004|Overall Study|No treatment, per protocol|0|||
25090262|NCT02659943|50199427|FG005|Overall Study|No treatment, per protocol|0|||
25174633|NCT01688999|50317268|FG001|Overall Study|Ineligible/Not treated|0|||
25174634|NCT01688999|50317269|FG002|Overall Study|Ineligible/Not treated|0|||
25174635|NCT01541917|50317293|FG000|Overall Study|Lost to Follow-up|2|||
25174636|NCT01541917|50317294|FG001|Overall Study|Lost to Follow-up|2|||
25174637|NCT01541917|50317293|FG000|Overall Study|Withdrawal by Subject|13|||
25174638|NCT01541917|50317294|FG001|Overall Study|Withdrawal by Subject|7|||
25174639|NCT01688921|50317314|FG000|Overall Study|Lost to Follow-up|7|||
25174640|NCT01688921|50317315|FG001|Overall Study|Lost to Follow-up|13|||
25174641|NCT01688921|50317314|FG000|Overall Study|Physician Decision|6|||
25174642|NCT01688921|50317315|FG001|Overall Study|Physician Decision|1|||
25174643|NCT01688921|50317314|FG000|Overall Study|Protocol Violation|0|||
25174644|NCT01688921|50317315|FG001|Overall Study|Protocol Violation|1|||
25174645|NCT01688921|50317314|FG000|Overall Study|informed consent|3|||
25174646|NCT01688921|50317315|FG001|Overall Study|informed consent|0|||
25174647|NCT01541371|50317337|FG000|Overall Study|Withdrawal by Subject|14|||
25174648|NCT01541371|50317337|FG000|Overall Study|Lost to Follow-up|21|||
25090263|NCT02659943|50199428|FG006|Overall Study|No treatment, per protocol|3|||
25090264|NCT01677299|50199453|FG000|Overall Study|Adverse Event|0|||
25090265|NCT01677299|50199454|FG001|Overall Study|Adverse Event|2|||
25090266|NCT01677299|50199455|FG002|Overall Study|Adverse Event|1|||
25090267|NCT01677299|50199456|FG003|Overall Study|Adverse Event|0|||
25090268|NCT01677299|50199453|FG000|Overall Study|Withdrawal by Subject|0|||
25090269|NCT01677299|50199454|FG001|Overall Study|Withdrawal by Subject|1|||
25090270|NCT01677299|50199455|FG002|Overall Study|Withdrawal by Subject|0|||
25090271|NCT01677299|50199456|FG003|Overall Study|Withdrawal by Subject|1|||
25090272|NCT01964326|50199470|FG000|Overall Study|Adverse Event|48|||
25090273|NCT01964326|50199470|FG000|Overall Study|Death|2|||
25090274|NCT01964326|50199470|FG000|Overall Study|Protocol Violation|4|||
25090275|NCT01964326|50199470|FG000|Overall Study|Lost to Follow-up|88|||
25090276|NCT01964326|50199470|FG000|Overall Study|Withdrawal by Subject|87|||
25090277|NCT01964326|50199470|FG000|Overall Study|Pregnancy|1|||
25090278|NCT01964326|50199470|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
25090279|NCT01964326|50199470|FG000|Overall Study|Physician Decision|55|||
25090280|NCT01964326|50199470|FG000|Overall Study|Investigator Discretion|1|||
25090281|NCT01964326|50199470|FG000|Overall Study|Other|9|||
25090282|NCT01964326|50199470|FG000|Overall Study|Did not meet eligibility criteria|1|||
25174649|NCT01541371|50317337|FG000|Overall Study|Adverse Event|15|||
25174650|NCT01541371|50317337|FG000|Overall Study|Lack of Efficacy|12|||
25174651|NCT01541371|50317337|FG000|Overall Study|Protocol Violation|6|||
25174652|NCT01541371|50317337|FG000|Overall Study|Study medication non-compliance|3|||
25174653|NCT01541371|50317337|FG000|Overall Study|Other|6|||
25174654|NCT01687673|50317370|FG000|Overall Study|Physician Decision|1|||
25174655|NCT01687595|50317450|FG000|Overall Study|Withdrawal by Subject|8|||
25174656|NCT01687595|50317451|FG001|Overall Study|Withdrawal by Subject|0|||
25090283|NCT02699749|50199488|FG000|Overall Study|Other|0|||
25090284|NCT02699749|50199489|FG001|Overall Study|Other|0|||
25090285|NCT02699749|50199490|FG002|Overall Study|Other|2|||
25090286|NCT02699749|50199491|FG003|Overall Study|Other|0|||
25174657|NCT01687595|50317450|FG000|Overall Study|Lost to Follow-up|3|||
25174658|NCT01687595|50317451|FG001|Overall Study|Lost to Follow-up|1|||
25174659|NCT01687595|50317450|FG000|Overall Study|Investigator's decision|1|||
25174660|NCT01687595|50317451|FG001|Overall Study|Investigator's decision|0|||
25174661|NCT01687595|50317450|FG000|Overall Study|Sponsor's decision|1|||
25174662|NCT01687595|50317451|FG001|Overall Study|Sponsor's decision|0|||
25174663|NCT01687595|50317450|FG000|Overall Study|Noncompliance|1|||
25174664|NCT01687595|50317451|FG001|Overall Study|Noncompliance|2|||
25174665|NCT01687595|50317450|FG000|Overall Study|Other than specified|56|||
25174666|NCT01687595|50317451|FG001|Overall Study|Other than specified|7|||
25174667|NCT01687283|50317459|FG000|Overall Study|Adverse Event|11|||
25174668|NCT01687283|50317460|FG001|Overall Study|Adverse Event|4|||
24996891|NCT02963506|50088004|FG009|Dose-Blind Period|Lost to Follow-up|0|||
24996892|NCT02963506|50088005|FG010|Dose-Blind Period|Lost to Follow-up|0|||
25090287|NCT02699749|50199492|FG004|Overall Study|Other|0|||
25090288|NCT02699749|50199493|FG005|Overall Study|Other|1|||
25090289|NCT02699749|50199494|FG006|Overall Study|Other|1|||
25090290|NCT02699749|50199495|FG007|Overall Study|Other|0|||
25090291|NCT02699749|50199496|FG008|Overall Study|Other|0|||
25174669|NCT01687283|50317459|FG000|Overall Study|Lack of Efficacy|3|||
25174670|NCT01687283|50317460|FG001|Overall Study|Lack of Efficacy|1|||
25174671|NCT01687283|50317459|FG000|Overall Study|Protocol Violation|1|||
25174672|NCT01687283|50317460|FG001|Overall Study|Protocol Violation|3|||
25174673|NCT01687283|50317459|FG000|Overall Study|protocol defined stopping criteria|8|||
25174674|NCT01687283|50317460|FG001|Overall Study|protocol defined stopping criteria|10|||
24996893|NCT02963506|50088006|FG011|Dose-Blind Period|Lost to Follow-up|1|||
25090292|NCT02699749|50199497|FG009|Overall Study|Other|0|||
25090293|NCT02699749|50199498|FG010|Overall Study|Other|1|||
25090294|NCT02699749|50199499|FG011|Overall Study|Other|0|||
25090295|NCT02699749|50199500|FG012|Overall Study|Other|0|||
25090296|NCT02699749|50199501|FG013|Overall Study|Other|0|||
25090297|NCT02699749|50199488|FG000|Overall Study|Progressive Disease|3|||
25090298|NCT02699749|50199489|FG001|Overall Study|Progressive Disease|3|||
24996894|NCT02963506|50088007|FG012|Dose-Blind Period|Lost to Follow-up|0|||
24996895|NCT02963506|50087995|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
24996896|NCT02963506|50087996|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
24996897|NCT02963506|50087997|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
24996898|NCT02963506|50087998|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
24996899|NCT02963506|50087999|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
24996900|NCT02963506|50088000|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
24996901|NCT02963506|50088001|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
24996902|NCT02963506|50088002|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
24996903|NCT02963506|50088003|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
24996904|NCT02963506|50088004|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
24996905|NCT02963506|50088005|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
24996906|NCT02963506|50088006|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
24996907|NCT02963506|50088007|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
24996908|NCT02963506|50087995|FG000|Dose-Blind Period|Sponsor decision|0|||
24996909|NCT02963506|50087996|FG001|Dose-Blind Period|Sponsor decision|0|||
25090299|NCT02699749|50199490|FG002|Overall Study|Progressive Disease|14|||
25090300|NCT02699749|50199491|FG003|Overall Study|Progressive Disease|3|||
25090301|NCT02699749|50199492|FG004|Overall Study|Progressive Disease|3|||
25090302|NCT02699749|50199493|FG005|Overall Study|Progressive Disease|7|||
25090303|NCT02699749|50199494|FG006|Overall Study|Progressive Disease|5|||
25090304|NCT02699749|50199495|FG007|Overall Study|Progressive Disease|5|||
25090305|NCT02699749|50199496|FG008|Overall Study|Progressive Disease|6|||
25090306|NCT02699749|50199497|FG009|Overall Study|Progressive Disease|6|||
25090307|NCT02699749|50199498|FG010|Overall Study|Progressive Disease|5|||
25090308|NCT02699749|50199499|FG011|Overall Study|Progressive Disease|4|||
25090309|NCT02699749|50199500|FG012|Overall Study|Progressive Disease|3|||
25090310|NCT02699749|50199501|FG013|Overall Study|Progressive Disease|5|||
25090311|NCT02699749|50199488|FG000|Overall Study|Death|0|||
25090312|NCT02699749|50199489|FG001|Overall Study|Death|0|||
25090313|NCT02699749|50199490|FG002|Overall Study|Death|0|||
25090314|NCT02699749|50199491|FG003|Overall Study|Death|0|||
25090315|NCT02699749|50199492|FG004|Overall Study|Death|0|||
25090316|NCT02699749|50199493|FG005|Overall Study|Death|0|||
25090317|NCT02699749|50199494|FG006|Overall Study|Death|0|||
25090318|NCT02699749|50199495|FG007|Overall Study|Death|0|||
25090319|NCT02699749|50199496|FG008|Overall Study|Death|0|||
25090320|NCT02699749|50199497|FG009|Overall Study|Death|0|||
25090321|NCT02699749|50199498|FG010|Overall Study|Death|0|||
25090322|NCT02699749|50199499|FG011|Overall Study|Death|0|||
25090323|NCT02699749|50199500|FG012|Overall Study|Death|0|||
25090324|NCT02699749|50199501|FG013|Overall Study|Death|1|||
25090325|NCT02699749|50199488|FG000|Overall Study|Lost to Follow-up|0|||
25090326|NCT02699749|50199489|FG001|Overall Study|Lost to Follow-up|0|||
25090327|NCT02699749|50199490|FG002|Overall Study|Lost to Follow-up|0|||
25090328|NCT02699749|50199491|FG003|Overall Study|Lost to Follow-up|0|||
25090329|NCT02699749|50199492|FG004|Overall Study|Lost to Follow-up|0|||
25090330|NCT02699749|50199493|FG005|Overall Study|Lost to Follow-up|1|||
25090331|NCT02699749|50199494|FG006|Overall Study|Lost to Follow-up|0|||
25090332|NCT02699749|50199495|FG007|Overall Study|Lost to Follow-up|1|||
25090333|NCT02699749|50199496|FG008|Overall Study|Lost to Follow-up|0|||
25090334|NCT02699749|50199497|FG009|Overall Study|Lost to Follow-up|0|||
25090335|NCT02699749|50199498|FG010|Overall Study|Lost to Follow-up|0|||
25090336|NCT02699749|50199499|FG011|Overall Study|Lost to Follow-up|0|||
25090337|NCT02699749|50199500|FG012|Overall Study|Lost to Follow-up|0|||
25090338|NCT02699749|50199501|FG013|Overall Study|Lost to Follow-up|0|||
25090339|NCT02699593|50199531|FG000|Period 1|Unsatisfactory Visual Response|0|||
25090340|NCT02699593|50199532|FG001|Period 1|Unsatisfactory Visual Response|1|||
25090341|NCT02699593|50199531|FG000|Period 1|Torn Contact Len|4|||
25090342|NCT02699593|50199532|FG001|Period 1|Torn Contact Len|3|||
25090343|NCT02699593|50199531|FG000|Period 1|Protocol Violation|0|||
25090344|NCT02699593|50199532|FG001|Period 1|Protocol Violation|1|||
25090345|NCT02699593|50199531|FG000|Period 1|Withdrawal by Subject|0|||
25090346|NCT02699593|50199532|FG001|Period 1|Withdrawal by Subject|1|||
25090347|NCT02699593|50199531|FG000|Period 1|Adverse Event|1|||
25090348|NCT02699593|50199532|FG001|Period 1|Adverse Event|1|||
25090349|NCT02699593|50199531|FG000|Period 2|Adverse Event|1|||
25090350|NCT02699593|50199532|FG001|Period 2|Adverse Event|1|||
25090351|NCT02699593|50199531|FG000|Period 2|Lost Contact Lens|0|||
25090352|NCT02699593|50199532|FG001|Period 2|Lost Contact Lens|1|||
24996910|NCT02963506|50087997|FG002|Dose-Blind Period|Sponsor decision|0|||
24996911|NCT02963506|50087998|FG003|Dose-Blind Period|Sponsor decision|0|||
24996912|NCT02963506|50087999|FG004|Dose-Blind Period|Sponsor decision|0|||
25090353|NCT02699593|50199531|FG000|Period 2|Torn Contact Lens|1|||
25090354|NCT02699593|50199532|FG001|Period 2|Torn Contact Lens|0|||
25090355|NCT00708097|50199538|FG000|Period 1|Protocol Violation|0|||
25090356|NCT00708097|50199539|FG001|Period 1|Protocol Violation|1|||
25090357|NCT00708097|50199540|FG002|Period 1|Protocol Violation|0|||
25090358|NCT00708097|50199541|FG003|Period 1|Protocol Violation|2|||
25090359|NCT00708097|50199542|FG004|Period 1|Protocol Violation|0|||
25174675|NCT01687283|50317459|FG000|Overall Study|Lost to Follow-up|1|||
25174676|NCT01687283|50317460|FG001|Overall Study|Lost to Follow-up|1|||
25174677|NCT01687283|50317459|FG000|Overall Study|Investigator discretion|2|||
25174678|NCT01687283|50317460|FG001|Overall Study|Investigator discretion|0|||
25174679|NCT01687283|50317459|FG000|Overall Study|Withdrawal by Subject|9|||
25174680|NCT01687283|50317460|FG001|Overall Study|Withdrawal by Subject|8|||
25174681|NCT02684370|50317469|FG000|Part A|Adverse Event|2|||
25174682|NCT02684370|50317470|FG001|Part A|Adverse Event|0|||
25174683|NCT02684370|50317471|FG002|Part A|Adverse Event|1|||
25174684|NCT02684370|50317472|FG003|Part A|Adverse Event|0|||
25174685|NCT02684370|50317473|FG004|Part A|Adverse Event|0|||
25174686|NCT02684370|50317474|FG005|Part A|Adverse Event|0|||
25174687|NCT02684370|50317469|FG000|Part A|Lost to Follow-up|1|||
25174688|NCT02684370|50317470|FG001|Part A|Lost to Follow-up|1|||
25174689|NCT02684370|50317471|FG002|Part A|Lost to Follow-up|0|||
25174690|NCT02684370|50317472|FG003|Part A|Lost to Follow-up|0|||
25174691|NCT02684370|50317473|FG004|Part A|Lost to Follow-up|0|||
25174692|NCT02684370|50317474|FG005|Part A|Lost to Follow-up|0|||
25174693|NCT02684370|50317469|FG000|Part A|Subject Withdrawal|1|||
25174694|NCT02684370|50317470|FG001|Part A|Subject Withdrawal|0|||
25174695|NCT02684370|50317471|FG002|Part A|Subject Withdrawal|3|||
25174696|NCT02684370|50317472|FG003|Part A|Subject Withdrawal|0|||
25174697|NCT02684370|50317473|FG004|Part A|Subject Withdrawal|0|||
25174698|NCT02684370|50317474|FG005|Part A|Subject Withdrawal|0|||
25174699|NCT02684370|50317469|FG000|Part A|Other|0|||
25174700|NCT02684370|50317470|FG001|Part A|Other|0|||
25174701|NCT02684370|50317471|FG002|Part A|Other|1|||
25174702|NCT02684370|50317472|FG003|Part A|Other|0|||
25174703|NCT02684370|50317473|FG004|Part A|Other|0|||
25174704|NCT02684370|50317474|FG005|Part A|Other|0|||
25174705|NCT02684370|50317469|FG000|Part B|Adverse Event|0|||
25174706|NCT02684370|50317470|FG001|Part B|Adverse Event|0|||
25174707|NCT02684370|50317471|FG002|Part B|Adverse Event|0|||
25174708|NCT02684370|50317472|FG003|Part B|Adverse Event|0|||
25174709|NCT02684370|50317473|FG004|Part B|Adverse Event|2|||
25174710|NCT02684370|50317474|FG005|Part B|Adverse Event|1|||
25174711|NCT02684370|50317469|FG000|Part B|Lost to Follow-up|0|||
25174712|NCT02684370|50317470|FG001|Part B|Lost to Follow-up|0|||
25174713|NCT02684370|50317471|FG002|Part B|Lost to Follow-up|0|||
25174714|NCT02684370|50317472|FG003|Part B|Lost to Follow-up|1|||
25174715|NCT02684370|50317473|FG004|Part B|Lost to Follow-up|2|||
25174716|NCT02684370|50317474|FG005|Part B|Lost to Follow-up|5|||
25174717|NCT02684370|50317469|FG000|Part B|Subject Withdrawal|0|||
25174718|NCT02684370|50317470|FG001|Part B|Subject Withdrawal|0|||
25174719|NCT02684370|50317471|FG002|Part B|Subject Withdrawal|0|||
25174720|NCT02684370|50317472|FG003|Part B|Subject Withdrawal|1|||
25174721|NCT02684370|50317473|FG004|Part B|Subject Withdrawal|1|||
25174722|NCT02684370|50317474|FG005|Part B|Subject Withdrawal|2|||
25174723|NCT01686581|50317501|FG000|Overall Study|Side-effects or Health Problems|15|||
25174724|NCT01686581|50317501|FG000|Overall Study|Lack of Efficacy|90|||
25174725|NCT01686581|50317501|FG000|Overall Study|Participant Concerned about Risks|6|||
25174726|NCT01686581|50317501|FG000|Overall Study|Thinks Injections Too Painful|8|||
25174727|NCT01686581|50317501|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
25174728|NCT01686581|50317501|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
25174729|NCT01686581|50317501|FG000|Overall Study|Thinks it is Inconvenient|17|||
25174730|NCT01686581|50317501|FG000|Overall Study|Other Miscellaneous Reasons|36|||
25174731|NCT01686581|50317501|FG000|Overall Study|Reason Missing|1|||
25174732|NCT02691936|50317519|FG000|Overall Study|Withdrawal by Subject|2|||
25174733|NCT02691936|50317520|FG001|Overall Study|Withdrawal by Subject|5|||
25174734|NCT01685801|50317567|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
25174735|NCT01685801|50317568|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
25174736|NCT01685801|50317569|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
25174737|NCT01685801|50317570|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
25174738|NCT01685801|50317567|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
25174739|NCT01685801|50317568|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
25174740|NCT01685801|50317569|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
25174741|NCT01685801|50317570|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
25174742|NCT01353222|50317589|FG000|Overall Study|Death|30|||
25174743|NCT01353222|50317590|FG001|Overall Study|Death|30|||
25174744|NCT01353222|50317589|FG000|Overall Study|Withdrawal by Subject|8|||
25174745|NCT01353222|50317590|FG001|Overall Study|Withdrawal by Subject|5|||
25174746|NCT01353222|50317589|FG000|Overall Study|Study Terminated|31|||
25174747|NCT01353222|50317590|FG001|Overall Study|Study Terminated|37|||
25174748|NCT01353222|50317589|FG000|Overall Study|Site closed research department|1|||
25174749|NCT01353222|50317590|FG001|Overall Study|Site closed research department|0|||
25174750|NCT01684943|50317620|FG000|Overall Study|Inadequate Venous Access|3|||
25174751|NCT01684943|50317621|FG001|Overall Study|Inadequate Venous Access|0|||
25174752|NCT01684943|50317622|FG002|Overall Study|Inadequate Venous Access|0|||
25174753|NCT01684943|50317620|FG000|Overall Study|Principal Investigator Determination|1|||
25174754|NCT01684943|50317621|FG001|Overall Study|Principal Investigator Determination|0|||
25174755|NCT01684943|50317622|FG002|Overall Study|Principal Investigator Determination|0|||
25174756|NCT01684943|50317620|FG000|Overall Study|Excluded from Analysis|1|||
25174757|NCT01684943|50317621|FG001|Overall Study|Excluded from Analysis|1|||
25090360|NCT00708097|50199538|FG000|Period 1|Other Reason|0|||
25090361|NCT00708097|50199539|FG001|Period 1|Other Reason|0|||
25090362|NCT00708097|50199540|FG002|Period 1|Other Reason|0|||
25090363|NCT00708097|50199541|FG003|Period 1|Other Reason|0|||
25090364|NCT00708097|50199542|FG004|Period 1|Other Reason|1|||
25090365|NCT00708097|50199538|FG000|Period 2|Protocol Violation|0|||
25090366|NCT00708097|50199539|FG001|Period 2|Protocol Violation|1|||
25090367|NCT00708097|50199540|FG002|Period 2|Protocol Violation|1|||
25090368|NCT00708097|50199541|FG003|Period 2|Protocol Violation|1|||
25090369|NCT00708097|50199542|FG004|Period 2|Protocol Violation|0|||
25090370|NCT02659631|50199569|FG000|Overall Study|Lost to Follow-up|0|||
25090371|NCT02659631|50199570|FG001|Overall Study|Lost to Follow-up|0|||
25090372|NCT02659631|50199571|FG002|Overall Study|Lost to Follow-up|2|||
25090373|NCT02659631|50199572|FG003|Overall Study|Lost to Follow-up|0|||
25090374|NCT02659631|50199573|FG004|Overall Study|Lost to Follow-up|0|||
25090375|NCT02659631|50199574|FG005|Overall Study|Lost to Follow-up|1|||
25090376|NCT02659631|50199575|FG006|Overall Study|Lost to Follow-up|0|||
25090377|NCT02659631|50199576|FG007|Overall Study|Lost to Follow-up|0|||
25090378|NCT02659631|50199577|FG008|Overall Study|Lost to Follow-up|0|||
25090379|NCT02659631|50199578|FG009|Overall Study|Lost to Follow-up|0|||
25090380|NCT02659631|50199569|FG000|Overall Study|Withdrawal prior to treatment|0|||
25090381|NCT02659631|50199570|FG001|Overall Study|Withdrawal prior to treatment|0|||
25090382|NCT02659631|50199571|FG002|Overall Study|Withdrawal prior to treatment|0|||
25090383|NCT02659631|50199572|FG003|Overall Study|Withdrawal prior to treatment|0|||
25090384|NCT02659631|50199573|FG004|Overall Study|Withdrawal prior to treatment|1|||
25090385|NCT02659631|50199574|FG005|Overall Study|Withdrawal prior to treatment|0|||
25090386|NCT02659631|50199575|FG006|Overall Study|Withdrawal prior to treatment|0|||
25090387|NCT02659631|50199576|FG007|Overall Study|Withdrawal prior to treatment|0|||
25090388|NCT02659631|50199577|FG008|Overall Study|Withdrawal prior to treatment|0|||
25090389|NCT02659631|50199578|FG009|Overall Study|Withdrawal prior to treatment|0|||
25090390|NCT02659631|50199569|FG000|Overall Study|Participant refused further follow-up|0|||
25090391|NCT02659631|50199570|FG001|Overall Study|Participant refused further follow-up|0|||
25090392|NCT02659631|50199571|FG002|Overall Study|Participant refused further follow-up|0|||
25090393|NCT02659631|50199572|FG003|Overall Study|Participant refused further follow-up|1|||
25090394|NCT02659631|50199573|FG004|Overall Study|Participant refused further follow-up|0|||
25090395|NCT02659631|50199574|FG005|Overall Study|Participant refused further follow-up|0|||
25090396|NCT02659631|50199575|FG006|Overall Study|Participant refused further follow-up|0|||
25090397|NCT02659631|50199576|FG007|Overall Study|Participant refused further follow-up|0|||
25090398|NCT02659631|50199577|FG008|Overall Study|Participant refused further follow-up|1|||
25090399|NCT02659631|50199578|FG009|Overall Study|Participant refused further follow-up|0|||
25090400|NCT02659631|50199569|FG000|Overall Study|Death (follow-up phase)|1|||
25090401|NCT02659631|50199570|FG001|Overall Study|Death (follow-up phase)|2|||
25090402|NCT02659631|50199571|FG002|Overall Study|Death (follow-up phase)|1|||
25090403|NCT02659631|50199572|FG003|Overall Study|Death (follow-up phase)|1|||
25090404|NCT02659631|50199573|FG004|Overall Study|Death (follow-up phase)|3|||
25090405|NCT02659631|50199574|FG005|Overall Study|Death (follow-up phase)|2|||
25090406|NCT02659631|50199575|FG006|Overall Study|Death (follow-up phase)|0|||
25090407|NCT02659631|50199576|FG007|Overall Study|Death (follow-up phase)|3|||
25174758|NCT01684943|50317622|FG002|Overall Study|Excluded from Analysis|1|||
25174759|NCT01684943|50317620|FG000|Overall Study|Lost to Follow-up|3|||
25090408|NCT02659631|50199577|FG008|Overall Study|Death (follow-up phase)|1|||
25090409|NCT02659631|50199578|FG009|Overall Study|Death (follow-up phase)|0|||
25090410|NCT02659631|50199569|FG000|Overall Study|Death (treatment phase)|0|||
25090411|NCT02659631|50199570|FG001|Overall Study|Death (treatment phase)|0|||
25090412|NCT02659631|50199571|FG002|Overall Study|Death (treatment phase)|0|||
25090413|NCT02659631|50199572|FG003|Overall Study|Death (treatment phase)|0|||
25090414|NCT02659631|50199573|FG004|Overall Study|Death (treatment phase)|1|||
25090415|NCT02659631|50199574|FG005|Overall Study|Death (treatment phase)|0|||
25090416|NCT02659631|50199575|FG006|Overall Study|Death (treatment phase)|1|||
25090417|NCT02659631|50199576|FG007|Overall Study|Death (treatment phase)|0|||
25090418|NCT02659631|50199577|FG008|Overall Study|Death (treatment phase)|0|||
25090419|NCT02659631|50199578|FG009|Overall Study|Death (treatment phase)|0|||
25090420|NCT02699125|50199602|FG000|Placebo|Lost to Follow-up|2|||
25090421|NCT02699125|50199603|FG001|Placebo|Lost to Follow-up|0|||
25090422|NCT02699125|50199602|FG000|Placebo|Protocol Violation|1|||
25090423|NCT02699125|50199603|FG001|Placebo|Protocol Violation|0|||
25090424|NCT02699125|50199602|FG000|Placebo|Withdrawal by Subject|0|||
25090425|NCT02699125|50199603|FG001|Placebo|Withdrawal by Subject|4|||
25090426|NCT02699125|50199602|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
25090427|NCT02699125|50199603|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
25090428|NCT02698891|50199613|FG000|Overall Study|Withdrawal by Subject|2|||
25174760|NCT01684943|50317621|FG001|Overall Study|Lost to Follow-up|0|||
25090429|NCT02698891|50199613|FG000|Overall Study|deemed ineligible|1|||
25174761|NCT01684943|50317622|FG002|Overall Study|Lost to Follow-up|0|||
25174762|NCT01684943|50317620|FG000|Overall Study|Planning Pregnancy|1|||
25174763|NCT01684943|50317621|FG001|Overall Study|Planning Pregnancy|0|||
25174764|NCT01684943|50317622|FG002|Overall Study|Planning Pregnancy|0|||
25174765|NCT01683383|50317637|FG000|Overall Study|Infant was not transported|1|||
25174766|NCT01683383|50317638|FG001|Overall Study|Infant was not transported|0|||
25174767|NCT02694744|50317646|FG000|Overall Study|Adverse Event|2|||
25174768|NCT02694744|50317647|FG001|Overall Study|Adverse Event|1|||
25174769|NCT02694744|50317646|FG000|Overall Study|Withdrawal by Subject|2|||
25090430|NCT02698891|50199613|FG000|Overall Study|Adverse Event|9|||
25090431|NCT02698423|50199619|FG000|Overall Study|Lost to Follow-up|19|||
25090432|NCT02698423|50199620|FG001|Overall Study|Lost to Follow-up|24|||
25090433|NCT02700997|50199628|FG000|Overall Study|Did not undergo CT imaging|1|||
25090434|NCT02700997|50199628|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
25090435|NCT02658149|50199634|FG000|Overall Study|Physician Decision|1|||
25090436|NCT02658149|50199635|FG001|Overall Study|Physician Decision|0|||
25090437|NCT02698189|50199643|FG000|Overall Study|Physician Decision|3|||
25090438|NCT02698189|50199644|FG001|Overall Study|Physician Decision|0|||
25090439|NCT02698189|50199643|FG000|Overall Study|Progressive disease|0|||
25090440|NCT02698189|50199644|FG001|Overall Study|Progressive disease|5|||
25090441|NCT02698189|50199643|FG000|Overall Study|Study terminated by sponsor|0|||
25090442|NCT02698189|50199644|FG001|Overall Study|Study terminated by sponsor|1|||
25090443|NCT02702011|50199656|FG000|Overall Study|Withdrawal by Subject|0|||
25090444|NCT02702011|50199657|FG001|Overall Study|Withdrawal by Subject|1|||
25090445|NCT02702011|50199658|FG002|Overall Study|Withdrawal by Subject|0|||
25090446|NCT02702011|50199659|FG003|Overall Study|Withdrawal by Subject|0|||
25090447|NCT02657369|50199669|FG000|Overall Study|Death|27|||
25090448|NCT02657369|50199669|FG000|Overall Study|Study terminated by sponsor|7|||
25090449|NCT02701777|50199677|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
25090450|NCT02701777|50199678|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
25090451|NCT02701777|50199679|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
25090452|NCT02701777|50199680|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
25090453|NCT02701777|50199677|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
25090454|NCT02701777|50199678|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
25090455|NCT02701777|50199679|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
25090456|NCT02701777|50199680|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
25090457|NCT01675661|50199696|FG000|Overall Study|Lost to Follow-up|22|||
25090458|NCT01675661|50199697|FG001|Overall Study|Lost to Follow-up|23|||
25090459|NCT01675661|50199696|FG000|Overall Study|Practical problems|9|||
25090460|NCT01675661|50199697|FG001|Overall Study|Practical problems|5|||
25090461|NCT01675661|50199696|FG000|Overall Study|Moved away|5|||
25090462|NCT01675661|50199697|FG001|Overall Study|Moved away|6|||
25090463|NCT01675661|50199696|FG000|Overall Study|Withdrawal by Subject|3|||
25090464|NCT01675661|50199697|FG001|Overall Study|Withdrawal by Subject|7|||
25090465|NCT01675661|50199696|FG000|Overall Study|Physician Decision|0|||
25090466|NCT01675661|50199697|FG001|Overall Study|Physician Decision|2|||
25090467|NCT01675661|50199696|FG000|Overall Study|Death|0|||
25090468|NCT01675661|50199697|FG001|Overall Study|Death|1|||
25090469|NCT01675661|50199696|FG000|Overall Study|Other reason|1|||
25090470|NCT01675661|50199697|FG001|Overall Study|Other reason|2|||
25090471|NCT01602341|50199705|FG000|Overall Study|Adverse Event|0|||
25090472|NCT01602341|50199706|FG001|Overall Study|Adverse Event|1|||
25090473|NCT02700919|50199719|FG000|Overall Study|Physician Decision|1|||
25090474|NCT02700919|50199720|FG001|Overall Study|Physician Decision|0|||
25090475|NCT02700919|50199721|FG002|Overall Study|Physician Decision|0|||
25090476|NCT02700919|50199719|FG000|Overall Study|Protocol Violation|1|||
25090477|NCT02700919|50199720|FG001|Overall Study|Protocol Violation|0|||
25090478|NCT02700919|50199721|FG002|Overall Study|Protocol Violation|0|||
25090479|NCT02700919|50199719|FG000|Overall Study|Adverse Event|1|||
25090480|NCT02700919|50199720|FG001|Overall Study|Adverse Event|3|||
25090481|NCT02700919|50199721|FG002|Overall Study|Adverse Event|1|||
25090482|NCT02700919|50199719|FG000|Overall Study|Withdrawal by Subject|5|||
25090483|NCT02700919|50199720|FG001|Overall Study|Withdrawal by Subject|8|||
25090484|NCT02700919|50199721|FG002|Overall Study|Withdrawal by Subject|2|||
25090485|NCT02700919|50199719|FG000|Overall Study|Lost to Follow-up|2|||
25090486|NCT02700919|50199720|FG001|Overall Study|Lost to Follow-up|0|||
25090487|NCT02700919|50199721|FG002|Overall Study|Lost to Follow-up|0|||
25090488|NCT02700919|50199719|FG000|Overall Study|Other|2|||
25090489|NCT02700919|50199720|FG001|Overall Study|Other|1|||
25090490|NCT02700919|50199721|FG002|Overall Study|Other|1|||
25090491|NCT01986010|50199746|FG000|Overall Study|Adverse Event|0|||
25090492|NCT01986010|50199747|FG001|Overall Study|Adverse Event|1|||
25090493|NCT01986010|50199748|FG002|Overall Study|Adverse Event|0|||
25090494|NCT01986010|50199749|FG003|Overall Study|Adverse Event|0|||
25090495|NCT01986010|50199750|FG004|Overall Study|Adverse Event|0|||
25090496|NCT01986010|50199751|FG005|Overall Study|Adverse Event|0|||
25174770|NCT02694744|50317647|FG001|Overall Study|Withdrawal by Subject|1|||
25174771|NCT02694744|50317646|FG000|Overall Study|Physician Decision|1|||
25090497|NCT01986010|50199752|FG006|Overall Study|Adverse Event|0|||
25090498|NCT01986010|50199753|FG007|Overall Study|Adverse Event|0|||
25090499|NCT01986010|50199754|FG008|Overall Study|Adverse Event|0|||
25090500|NCT01986010|50199755|FG009|Overall Study|Adverse Event|0|||
25090501|NCT01986010|50199756|FG010|Overall Study|Adverse Event|0|||
25090502|NCT01986010|50199757|FG011|Overall Study|Adverse Event|0|||
25090503|NCT01986010|50199758|FG012|Overall Study|Adverse Event|0|||
25090504|NCT01986010|50199759|FG013|Overall Study|Adverse Event|0|||
25090505|NCT01986010|50199760|FG014|Overall Study|Adverse Event|0|||
25090506|NCT01986010|50199761|FG015|Overall Study|Adverse Event|1|||
25090507|NCT01986010|50199762|FG016|Overall Study|Adverse Event|0|||
25090508|NCT01986010|50199746|FG000|Overall Study|Lost to Follow-up|2|||
25090509|NCT01986010|50199747|FG001|Overall Study|Lost to Follow-up|1|||
25090510|NCT01986010|50199748|FG002|Overall Study|Lost to Follow-up|2|||
25090511|NCT01986010|50199749|FG003|Overall Study|Lost to Follow-up|2|||
25090512|NCT01986010|50199750|FG004|Overall Study|Lost to Follow-up|2|||
25090513|NCT01986010|50199751|FG005|Overall Study|Lost to Follow-up|2|||
25090514|NCT01986010|50199752|FG006|Overall Study|Lost to Follow-up|0|||
25090515|NCT01986010|50199753|FG007|Overall Study|Lost to Follow-up|0|||
25090516|NCT01986010|50199754|FG008|Overall Study|Lost to Follow-up|4|||
25090517|NCT01986010|50199755|FG009|Overall Study|Lost to Follow-up|2|||
25090518|NCT01986010|50199756|FG010|Overall Study|Lost to Follow-up|0|||
25090519|NCT01986010|50199757|FG011|Overall Study|Lost to Follow-up|1|||
25090520|NCT01986010|50199758|FG012|Overall Study|Lost to Follow-up|1|||
25090521|NCT01986010|50199759|FG013|Overall Study|Lost to Follow-up|1|||
25090522|NCT01986010|50199760|FG014|Overall Study|Lost to Follow-up|2|||
25090523|NCT01986010|50199761|FG015|Overall Study|Lost to Follow-up|0|||
25090524|NCT01986010|50199762|FG016|Overall Study|Lost to Follow-up|0|||
25090525|NCT01986010|50199746|FG000|Overall Study|Physician Decision|0|||
25174772|NCT02694744|50317647|FG001|Overall Study|Physician Decision|2|||
25174773|NCT02694744|50317646|FG000|Overall Study|Lost to Follow-up|1|||
25174774|NCT02694744|50317647|FG001|Overall Study|Lost to Follow-up|0|||
25174775|NCT02694744|50317646|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
25174776|NCT02694744|50317647|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
25174777|NCT01683071|50317661|FG000|Part 1|Lack of Efficacy|1|||
25174778|NCT01683071|50317662|FG001|Part 1|Lack of Efficacy|0|||
25174779|NCT01683071|50317663|FG002|Part 1|Lack of Efficacy|0|||
25174780|NCT01683071|50317664|FG003|Part 1|Lack of Efficacy|3|||
25174781|NCT01683071|50317665|FG004|Part 1|Lack of Efficacy|0|||
25174782|NCT01683071|50317666|FG005|Part 1|Lack of Efficacy|0|||
25174783|NCT01683071|50317661|FG000|Part 1|Withdrawal by Subject|1|||
25174784|NCT01683071|50317662|FG001|Part 1|Withdrawal by Subject|2|||
25174785|NCT01683071|50317663|FG002|Part 1|Withdrawal by Subject|2|||
25174786|NCT01683071|50317664|FG003|Part 1|Withdrawal by Subject|1|||
25174787|NCT01683071|50317665|FG004|Part 1|Withdrawal by Subject|0|||
25174788|NCT01683071|50317666|FG005|Part 1|Withdrawal by Subject|0|||
25174789|NCT01683071|50317661|FG000|Part 1|Surgery Cancelled|1|||
25174790|NCT01683071|50317662|FG001|Part 1|Surgery Cancelled|0|||
25174791|NCT01683071|50317663|FG002|Part 1|Surgery Cancelled|0|||
25174792|NCT01683071|50317664|FG003|Part 1|Surgery Cancelled|0|||
25174793|NCT01683071|50317665|FG004|Part 1|Surgery Cancelled|0|||
25174794|NCT01683071|50317666|FG005|Part 1|Surgery Cancelled|0|||
25174795|NCT01683071|50317661|FG000|Part 1|Did not receive study drug|1|||
25174796|NCT01683071|50317662|FG001|Part 1|Did not receive study drug|0|||
25174797|NCT01683071|50317663|FG002|Part 1|Did not receive study drug|0|||
25174798|NCT01683071|50317664|FG003|Part 1|Did not receive study drug|1|||
25174799|NCT01683071|50317665|FG004|Part 1|Did not receive study drug|0|||
25174800|NCT01683071|50317666|FG005|Part 1|Did not receive study drug|0|||
25174801|NCT01683071|50317661|FG000|Part 1|Early termination; met exclusion criteria|0|||
25174802|NCT01683071|50317662|FG001|Part 1|Early termination; met exclusion criteria|2|||
25174803|NCT01683071|50317663|FG002|Part 1|Early termination; met exclusion criteria|1|||
25174804|NCT01683071|50317664|FG003|Part 1|Early termination; met exclusion criteria|0|||
25174805|NCT01683071|50317665|FG004|Part 1|Early termination; met exclusion criteria|0|||
25174806|NCT01683071|50317666|FG005|Part 1|Early termination; met exclusion criteria|0|||
25090526|NCT01986010|50199747|FG001|Overall Study|Physician Decision|0|||
25090527|NCT01986010|50199748|FG002|Overall Study|Physician Decision|0|||
25090528|NCT01986010|50199749|FG003|Overall Study|Physician Decision|0|||
25090529|NCT01986010|50199750|FG004|Overall Study|Physician Decision|0|||
25090530|NCT01986010|50199751|FG005|Overall Study|Physician Decision|0|||
25090531|NCT01986010|50199752|FG006|Overall Study|Physician Decision|0|||
25090532|NCT01986010|50199753|FG007|Overall Study|Physician Decision|0|||
25090533|NCT01986010|50199754|FG008|Overall Study|Physician Decision|0|||
25090534|NCT01986010|50199755|FG009|Overall Study|Physician Decision|0|||
25174807|NCT01683071|50317661|FG000|Part 2|Lack of Efficacy|0|||
25174808|NCT01683071|50317662|FG001|Part 2|Lack of Efficacy|0|||
25174809|NCT01683071|50317663|FG002|Part 2|Lack of Efficacy|0|||
25174810|NCT01683071|50317664|FG003|Part 2|Lack of Efficacy|0|||
25174811|NCT01683071|50317665|FG004|Part 2|Lack of Efficacy|3|||
25174812|NCT01683071|50317666|FG005|Part 2|Lack of Efficacy|4|||
25174813|NCT01683071|50317661|FG000|Part 2|Lost to Follow-up|0|||
25174814|NCT01683071|50317662|FG001|Part 2|Lost to Follow-up|0|||
25174815|NCT01683071|50317663|FG002|Part 2|Lost to Follow-up|0|||
25174816|NCT01683071|50317664|FG003|Part 2|Lost to Follow-up|0|||
25174817|NCT01683071|50317665|FG004|Part 2|Lost to Follow-up|2|||
25174818|NCT01683071|50317666|FG005|Part 2|Lost to Follow-up|0|||
25174819|NCT01683071|50317661|FG000|Part 2|Withdrawal by Subject|0|||
25174820|NCT01683071|50317662|FG001|Part 2|Withdrawal by Subject|0|||
25174821|NCT01683071|50317663|FG002|Part 2|Withdrawal by Subject|0|||
25174822|NCT01683071|50317664|FG003|Part 2|Withdrawal by Subject|0|||
25174823|NCT01683071|50317665|FG004|Part 2|Withdrawal by Subject|3|||
25174824|NCT01683071|50317666|FG005|Part 2|Withdrawal by Subject|3|||
25174825|NCT01683071|50317661|FG000|Part 2|Surgery cancelled|0|||
25174826|NCT01683071|50317662|FG001|Part 2|Surgery cancelled|0|||
25174827|NCT01683071|50317663|FG002|Part 2|Surgery cancelled|0|||
25174828|NCT01683071|50317664|FG003|Part 2|Surgery cancelled|0|||
25174829|NCT01683071|50317665|FG004|Part 2|Surgery cancelled|4|||
25174830|NCT01683071|50317666|FG005|Part 2|Surgery cancelled|2|||
25174831|NCT01683071|50317661|FG000|Part 2|Did not receive study drug|0|||
25174832|NCT01683071|50317662|FG001|Part 2|Did not receive study drug|0|||
25174833|NCT01683071|50317663|FG002|Part 2|Did not receive study drug|0|||
25174834|NCT01683071|50317664|FG003|Part 2|Did not receive study drug|0|||
25174835|NCT01683071|50317665|FG004|Part 2|Did not receive study drug|2|||
25174836|NCT01683071|50317666|FG005|Part 2|Did not receive study drug|1|||
25174837|NCT01683071|50317661|FG000|Part 2|Met exclusion criterion|0|||
25174838|NCT01683071|50317662|FG001|Part 2|Met exclusion criterion|0|||
25174839|NCT01683071|50317663|FG002|Part 2|Met exclusion criterion|0|||
25174840|NCT01683071|50317664|FG003|Part 2|Met exclusion criterion|0|||
25174841|NCT01683071|50317665|FG004|Part 2|Met exclusion criterion|1|||
25174842|NCT01683071|50317666|FG005|Part 2|Met exclusion criterion|1|||
25174843|NCT01683071|50317661|FG000|Part 2|Protocol deviation|0|||
25174844|NCT01683071|50317662|FG001|Part 2|Protocol deviation|0|||
25174845|NCT01683071|50317663|FG002|Part 2|Protocol deviation|0|||
25174846|NCT01683071|50317664|FG003|Part 2|Protocol deviation|0|||
25174847|NCT01683071|50317665|FG004|Part 2|Protocol deviation|1|||
25174848|NCT01683071|50317666|FG005|Part 2|Protocol deviation|2|||
25174849|NCT01683071|50317661|FG000|Part 2|Withdrawal by investigator decision|0|||
25174850|NCT01683071|50317662|FG001|Part 2|Withdrawal by investigator decision|0|||
25174851|NCT01683071|50317663|FG002|Part 2|Withdrawal by investigator decision|0|||
25174852|NCT01683071|50317664|FG003|Part 2|Withdrawal by investigator decision|0|||
25174853|NCT01683071|50317665|FG004|Part 2|Withdrawal by investigator decision|1|||
25174854|NCT01683071|50317666|FG005|Part 2|Withdrawal by investigator decision|2|||
25174855|NCT01567865|50317690|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
25174856|NCT01567865|50317691|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
25174857|NCT01567865|50317692|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
25174858|NCT01567865|50317693|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
25174859|NCT01567865|50317690|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
25090535|NCT01986010|50199756|FG010|Overall Study|Physician Decision|0|||
25090536|NCT01986010|50199757|FG011|Overall Study|Physician Decision|0|||
25090537|NCT01986010|50199758|FG012|Overall Study|Physician Decision|0|||
25090538|NCT01986010|50199759|FG013|Overall Study|Physician Decision|0|||
25090539|NCT01986010|50199760|FG014|Overall Study|Physician Decision|1|||
25090540|NCT01986010|50199761|FG015|Overall Study|Physician Decision|0|||
25090541|NCT01986010|50199762|FG016|Overall Study|Physician Decision|0|||
25090542|NCT01986010|50199746|FG000|Overall Study|Withdrawal by Subject|2|||
25090543|NCT01986010|50199747|FG001|Overall Study|Withdrawal by Subject|2|||
25090544|NCT01986010|50199748|FG002|Overall Study|Withdrawal by Subject|3|||
25090545|NCT01986010|50199749|FG003|Overall Study|Withdrawal by Subject|0|||
25090546|NCT01986010|50199750|FG004|Overall Study|Withdrawal by Subject|2|||
25090547|NCT01986010|50199751|FG005|Overall Study|Withdrawal by Subject|4|||
25090548|NCT01986010|50199752|FG006|Overall Study|Withdrawal by Subject|0|||
25090549|NCT01986010|50199753|FG007|Overall Study|Withdrawal by Subject|0|||
25090550|NCT01986010|50199754|FG008|Overall Study|Withdrawal by Subject|0|||
25090551|NCT01986010|50199755|FG009|Overall Study|Withdrawal by Subject|0|||
25090552|NCT01986010|50199756|FG010|Overall Study|Withdrawal by Subject|0|||
25090553|NCT01986010|50199757|FG011|Overall Study|Withdrawal by Subject|2|||
25090554|NCT01986010|50199758|FG012|Overall Study|Withdrawal by Subject|0|||
25174860|NCT01567865|50317691|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
25174861|NCT01567865|50317692|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
25174862|NCT01567865|50317693|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
25174863|NCT01567163|50317704|FG000|Overall Study|Progressive Disease|2|||
25174864|NCT01567163|50317704|FG000|Overall Study|Lost to Follow-up|2|||
25174865|NCT01567085|50317713|FG000|Overall Study|Death|6|||
25174866|NCT01567085|50317713|FG000|Overall Study|Adverse Event|6|||
25174867|NCT01567085|50317713|FG000|Overall Study|Lost to Follow-up|3|||
25174868|NCT01567085|50317713|FG000|Overall Study|Graft loss|2|||
25174869|NCT01567085|50317713|FG000|Overall Study|Renal transplantectomy|1|||
25174870|NCT01567085|50317713|FG000|Overall Study|Returned to chronic dialysis|1|||
25174871|NCT01567085|50317713|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
25174872|NCT01566773|50317717|FG000|Overall Study|Protocol specified criteria|4|||
25090555|NCT01986010|50199759|FG013|Overall Study|Withdrawal by Subject|1|||
25090556|NCT01986010|50199760|FG014|Overall Study|Withdrawal by Subject|2|||
25090557|NCT01986010|50199761|FG015|Overall Study|Withdrawal by Subject|0|||
25090558|NCT01986010|50199762|FG016|Overall Study|Withdrawal by Subject|0|||
25090559|NCT01986010|50199746|FG000|Overall Study|Status Not Recorded|2|||
25090560|NCT01986010|50199747|FG001|Overall Study|Status Not Recorded|4|||
25090561|NCT01986010|50199748|FG002|Overall Study|Status Not Recorded|2|||
25090562|NCT01986010|50199749|FG003|Overall Study|Status Not Recorded|0|||
25090563|NCT01986010|50199750|FG004|Overall Study|Status Not Recorded|1|||
25090564|NCT01986010|50199751|FG005|Overall Study|Status Not Recorded|2|||
25090565|NCT01986010|50199752|FG006|Overall Study|Status Not Recorded|0|||
25090566|NCT01986010|50199753|FG007|Overall Study|Status Not Recorded|0|||
25090567|NCT01986010|50199754|FG008|Overall Study|Status Not Recorded|2|||
25090568|NCT01986010|50199755|FG009|Overall Study|Status Not Recorded|1|||
25090569|NCT01986010|50199756|FG010|Overall Study|Status Not Recorded|7|||
25090570|NCT01986010|50199757|FG011|Overall Study|Status Not Recorded|7|||
25174873|NCT01566773|50317717|FG000|Overall Study|Protocol Violation|4|||
25174874|NCT01566773|50317717|FG000|Overall Study|Withdrawal by Subject|9|||
25174875|NCT01566773|50317717|FG000|Overall Study|Administrative reason|1|||
25174876|NCT01566773|50317717|FG000|Overall Study|Adverse Event|10|||
25174877|NCT01566773|50317717|FG000|Overall Study|Physician Decision|2|||
25174878|NCT01566149|50317739|FG000|Overall Study|Adverse Event|0|||
25174879|NCT01566149|50317740|FG001|Overall Study|Adverse Event|1|||
25174880|NCT01566149|50317739|FG000|Overall Study|Non-compliance with study medication|2|||
25174881|NCT01566149|50317740|FG001|Overall Study|Non-compliance with study medication|0|||
25174882|NCT01566149|50317739|FG000|Overall Study|Protocol Violation|0|||
25174883|NCT01566149|50317740|FG001|Overall Study|Protocol Violation|1|||
25174884|NCT01566149|50317739|FG000|Overall Study|Withdrawal by Subject|1|||
25174885|NCT01566149|50317740|FG001|Overall Study|Withdrawal by Subject|0|||
25174886|NCT01565993|50317748|FG000|Overall Study|Physician Decision|0|||
25174887|NCT01565993|50317749|FG001|Overall Study|Physician Decision|3|||
25174888|NCT01565291|50317757|FG000|Overall Study|Withdrawal by Subject|1|||
25174889|NCT01565291|50317758|FG001|Overall Study|Withdrawal by Subject|0|||
25174890|NCT03382834|50317766|FG000|Overall Study|Lost to Follow-up|1|||
25174891|NCT03382834|50317767|FG001|Overall Study|Lost to Follow-up|0|||
25174892|NCT03382834|50317766|FG000|Overall Study|Withdrawal by Subject|0|||
25174893|NCT03382834|50317767|FG001|Overall Study|Withdrawal by Subject|1|||
25174894|NCT02691702|50317784|FG000|Overall Study|Adverse Event|1|||
25174895|NCT02691702|50317785|FG001|Overall Study|Adverse Event|0|||
25174896|NCT02691702|50317786|FG002|Overall Study|Adverse Event|0|||
25174897|NCT02691702|50317787|FG003|Overall Study|Adverse Event|0|||
25174898|NCT02691702|50317788|FG004|Overall Study|Adverse Event|0|||
25174899|NCT02691702|50317789|FG005|Overall Study|Adverse Event|0|||
25174900|NCT02691702|50317790|FG006|Overall Study|Adverse Event|0|||
25174901|NCT02691702|50317791|FG007|Overall Study|Adverse Event|0|||
25174902|NCT02691702|50317792|FG008|Overall Study|Adverse Event|1|||
25174903|NCT02691702|50317793|FG009|Overall Study|Adverse Event|0|||
25174904|NCT02691702|50317794|FG010|Overall Study|Adverse Event|1|||
25174905|NCT02691702|50317784|FG000|Overall Study|Lost to Follow-up|0|||
25174906|NCT02691702|50317785|FG001|Overall Study|Lost to Follow-up|0|||
25174907|NCT02691702|50317786|FG002|Overall Study|Lost to Follow-up|1|||
25174908|NCT02691702|50317787|FG003|Overall Study|Lost to Follow-up|0|||
25174909|NCT02691702|50317788|FG004|Overall Study|Lost to Follow-up|0|||
25090571|NCT01986010|50199758|FG012|Overall Study|Status Not Recorded|9|||
25090572|NCT01986010|50199759|FG013|Overall Study|Status Not Recorded|9|||
25090573|NCT01986010|50199760|FG014|Overall Study|Status Not Recorded|5|||
25090574|NCT01986010|50199761|FG015|Overall Study|Status Not Recorded|10|||
25174910|NCT02691702|50317789|FG005|Overall Study|Lost to Follow-up|2|||
25174911|NCT02691702|50317790|FG006|Overall Study|Lost to Follow-up|0|||
25174912|NCT02691702|50317791|FG007|Overall Study|Lost to Follow-up|0|||
25174913|NCT02691702|50317792|FG008|Overall Study|Lost to Follow-up|0|||
25174914|NCT02691702|50317793|FG009|Overall Study|Lost to Follow-up|0|||
25174915|NCT02691702|50317794|FG010|Overall Study|Lost to Follow-up|1|||
25174916|NCT02691702|50317784|FG000|Overall Study|Withdrawal by Subject|1|||
25174917|NCT02691702|50317785|FG001|Overall Study|Withdrawal by Subject|1|||
25174918|NCT02691702|50317786|FG002|Overall Study|Withdrawal by Subject|0|||
25174919|NCT02691702|50317787|FG003|Overall Study|Withdrawal by Subject|0|||
25174920|NCT02691702|50317788|FG004|Overall Study|Withdrawal by Subject|0|||
25174921|NCT02691702|50317789|FG005|Overall Study|Withdrawal by Subject|1|||
25174922|NCT02691702|50317790|FG006|Overall Study|Withdrawal by Subject|2|||
25174923|NCT02691702|50317791|FG007|Overall Study|Withdrawal by Subject|0|||
25174924|NCT02691702|50317792|FG008|Overall Study|Withdrawal by Subject|0|||
25174925|NCT02691702|50317793|FG009|Overall Study|Withdrawal by Subject|0|||
25174926|NCT02691702|50317794|FG010|Overall Study|Withdrawal by Subject|0|||
25174927|NCT02691702|50317784|FG000|Overall Study|Other|0|||
25174928|NCT02691702|50317785|FG001|Overall Study|Other|0|||
25174929|NCT02691702|50317786|FG002|Overall Study|Other|0|||
25090575|NCT01986010|50199762|FG016|Overall Study|Status Not Recorded|4|||
25174930|NCT02691702|50317787|FG003|Overall Study|Other|0|||
25174931|NCT02691702|50317788|FG004|Overall Study|Other|0|||
25174932|NCT02691702|50317789|FG005|Overall Study|Other|0|||
25174933|NCT02691702|50317790|FG006|Overall Study|Other|1|||
25174934|NCT02691702|50317791|FG007|Overall Study|Other|0|||
25174935|NCT02691702|50317792|FG008|Overall Study|Other|1|||
25174936|NCT02691702|50317793|FG009|Overall Study|Other|0|||
25174937|NCT02691702|50317794|FG010|Overall Study|Other|0|||
25174938|NCT02691702|50317784|FG000|Overall Study|Protocol Violation|0|||
25174939|NCT02691702|50317785|FG001|Overall Study|Protocol Violation|0|||
25174940|NCT02691702|50317786|FG002|Overall Study|Protocol Violation|0|||
25174941|NCT02691702|50317787|FG003|Overall Study|Protocol Violation|0|||
25174942|NCT02691702|50317788|FG004|Overall Study|Protocol Violation|0|||
25174943|NCT02691702|50317789|FG005|Overall Study|Protocol Violation|0|||
25174944|NCT02691702|50317790|FG006|Overall Study|Protocol Violation|0|||
25174945|NCT02691702|50317791|FG007|Overall Study|Protocol Violation|0|||
25090576|NCT01963780|50199808|FG000|Overall Study|Death|7|||
25090577|NCT02009878|50199815|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
25090578|NCT02009878|50199816|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
25090579|NCT02009878|50199817|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
25090580|NCT02009722|50199827|FG000|Overall Study|Protocol Violation|1|||
25090581|NCT02009722|50199828|FG001|Overall Study|Protocol Violation|2|||
25090582|NCT02009722|50199827|FG000|Overall Study|Did not receive intervention|0|||
25090583|NCT02009722|50199828|FG001|Overall Study|Did not receive intervention|1|||
25090584|NCT02655419|50199836|FG000|Overall Study|Enrolled but not treated|1|||
25090585|NCT02655419|50199837|FG001|Overall Study|Enrolled but not treated|5|||
25090586|NCT02655419|50199836|FG000|Overall Study|Withdrawal by Subject|4|||
25090587|NCT02655419|50199837|FG001|Overall Study|Withdrawal by Subject|1|||
25090588|NCT02655419|50199836|FG000|Overall Study|Other|0|||
25090589|NCT02655419|50199837|FG001|Overall Study|Other|1|||
25090590|NCT01962922|50199849|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
25090591|NCT01962922|50199850|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
25090592|NCT01962922|50199849|FG000|PK Portion Day 7|non-compliance|1|||
25090593|NCT01962922|50199850|FG001|PK Portion Day 7|non-compliance|0|||
25090594|NCT01962922|50199849|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
25090595|NCT01962922|50199850|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
25090596|NCT01962922|50199849|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
25174946|NCT02691702|50317792|FG008|Overall Study|Protocol Violation|0|||
25174947|NCT02691702|50317793|FG009|Overall Study|Protocol Violation|2|||
25174948|NCT02691702|50317794|FG010|Overall Study|Protocol Violation|0|||
25174949|NCT01564277|50317828|FG000|Overall Study|Protocol Violation|0|||
25174950|NCT01564277|50317829|FG001|Overall Study|Protocol Violation|1|||
25174951|NCT01564277|50317828|FG000|Overall Study|Physician Decision|1|||
25174952|NCT01564277|50317829|FG001|Overall Study|Physician Decision|0|||
25174953|NCT02679222|50317835|FG000|Overall Study|No time for project|1|||
25174954|NCT01563185|50317847|FG000|Overall Study|Withdrawal by Subject|1|||
25174955|NCT01563185|50317847|FG000|Overall Study|Non-Compliance with study drug|1|||
25174956|NCT03305848|50317851|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
25174957|NCT03305848|50317851|FG000|Overall Study|Physician Decision|2|||
25174958|NCT01563029|50317860|FG000|Overall Study|Adverse Event|1|||
25174959|NCT01563029|50317861|FG001|Overall Study|Adverse Event|0|||
25174960|NCT01563029|50317862|FG002|Overall Study|Adverse Event|1|||
25174961|NCT01563029|50317863|FG003|Overall Study|Adverse Event|2|||
25174962|NCT01563029|50317864|FG004|Overall Study|Adverse Event|1|||
25174963|NCT01563029|50317860|FG000|Overall Study|Lack of Efficacy|42|||
25090597|NCT01962922|50199850|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
25090598|NCT01984684|50199858|FG000|Overall Study|Lost to Follow-up|25|||
25090599|NCT01984684|50199859|FG001|Overall Study|Lost to Follow-up|24|||
25090600|NCT01984684|50199858|FG000|Overall Study|Adverse Event|8|||
25090601|NCT01984684|50199859|FG001|Overall Study|Adverse Event|12|||
25174964|NCT01563029|50317861|FG001|Overall Study|Lack of Efficacy|16|||
25174965|NCT01563029|50317862|FG002|Overall Study|Lack of Efficacy|23|||
25174966|NCT01563029|50317863|FG003|Overall Study|Lack of Efficacy|21|||
25174967|NCT01563029|50317864|FG004|Overall Study|Lack of Efficacy|19|||
25174968|NCT01563029|50317860|FG000|Overall Study|Protocol Violation|1|||
25174969|NCT01563029|50317861|FG001|Overall Study|Protocol Violation|2|||
25174970|NCT01563029|50317862|FG002|Overall Study|Protocol Violation|3|||
25174971|NCT01563029|50317863|FG003|Overall Study|Protocol Violation|1|||
25174972|NCT01563029|50317864|FG004|Overall Study|Protocol Violation|3|||
25174973|NCT01563029|50317860|FG000|Overall Study|Protocol defined stopping criteria|1|||
25174974|NCT01563029|50317861|FG001|Overall Study|Protocol defined stopping criteria|0|||
25174975|NCT01563029|50317862|FG002|Overall Study|Protocol defined stopping criteria|0|||
25174976|NCT01563029|50317863|FG003|Overall Study|Protocol defined stopping criteria|0|||
25174977|NCT01563029|50317864|FG004|Overall Study|Protocol defined stopping criteria|0|||
25174978|NCT01563029|50317860|FG000|Overall Study|Lost to Follow-up|1|||
25174979|NCT01563029|50317861|FG001|Overall Study|Lost to Follow-up|0|||
25174980|NCT01563029|50317862|FG002|Overall Study|Lost to Follow-up|1|||
25174981|NCT01563029|50317863|FG003|Overall Study|Lost to Follow-up|1|||
25090602|NCT01984684|50199858|FG000|Overall Study|Withdrawal by Subject|9|||
25090603|NCT01984684|50199859|FG001|Overall Study|Withdrawal by Subject|9|||
25090604|NCT01984684|50199858|FG000|Overall Study|Lack of Efficacy|3|||
25090605|NCT01984684|50199859|FG001|Overall Study|Lack of Efficacy|6|||
25090606|NCT01984684|50199858|FG000|Overall Study|Physician Decision|4|||
25090607|NCT01984684|50199859|FG001|Overall Study|Physician Decision|2|||
25090608|NCT01984684|50199858|FG000|Overall Study|Protocol Violation|4|||
25090609|NCT01984684|50199859|FG001|Overall Study|Protocol Violation|2|||
25090610|NCT01984684|50199858|FG000|Overall Study|Death|0|||
25090611|NCT01984684|50199859|FG001|Overall Study|Death|1|||
25090612|NCT01984684|50199858|FG000|Overall Study|Noncompliance with study drug|2|||
25090613|NCT01984684|50199859|FG001|Overall Study|Noncompliance with study drug|1|||
25090614|NCT01984684|50199858|FG000|Overall Study|Subject incarcerated|1|||
25090615|NCT01984684|50199859|FG001|Overall Study|Subject incarcerated|0|||
25090616|NCT01984684|50199858|FG000|Overall Study|Study drug not available at site|1|||
25090617|NCT01984684|50199859|FG001|Overall Study|Study drug not available at site|1|||
25090618|NCT01984684|50199858|FG000|Overall Study|Subject had inadequate IV access|0|||
25090619|NCT01984684|50199859|FG001|Overall Study|Subject had inadequate IV access|1|||
25090620|NCT02694523|50199867|FG000|Part A|Adverse Event|7|||
25090621|NCT02694523|50199868|FG001|Part A|Adverse Event|3|||
25090622|NCT02694523|50199869|FG002|Part A|Adverse Event|0|||
25090623|NCT02694523|50199870|FG003|Part A|Adverse Event|0|||
25090624|NCT02694523|50199871|FG004|Part A|Adverse Event|0|||
25090625|NCT02694523|50199872|FG005|Part A|Adverse Event|0|||
25090626|NCT02694523|50199873|FG006|Part A|Adverse Event|0|||
25090627|NCT02694523|50199867|FG000|Part A|Protocol Violation|1|||
25090628|NCT02694523|50199868|FG001|Part A|Protocol Violation|0|||
25090629|NCT02694523|50199869|FG002|Part A|Protocol Violation|0|||
25090630|NCT02694523|50199870|FG003|Part A|Protocol Violation|0|||
25090631|NCT02694523|50199871|FG004|Part A|Protocol Violation|0|||
25090632|NCT02694523|50199872|FG005|Part A|Protocol Violation|0|||
25090633|NCT02694523|50199873|FG006|Part A|Protocol Violation|0|||
25090634|NCT02694523|50199867|FG000|Part A|Lost to Follow-up|1|||
25090635|NCT02694523|50199868|FG001|Part A|Lost to Follow-up|2|||
25090636|NCT02694523|50199869|FG002|Part A|Lost to Follow-up|0|||
25090637|NCT02694523|50199870|FG003|Part A|Lost to Follow-up|0|||
25090638|NCT02694523|50199871|FG004|Part A|Lost to Follow-up|0|||
25090639|NCT02694523|50199872|FG005|Part A|Lost to Follow-up|0|||
25090640|NCT02694523|50199873|FG006|Part A|Lost to Follow-up|0|||
25090641|NCT02694523|50199867|FG000|Part A|Withdrawal by Subject|3|||
25090642|NCT02694523|50199868|FG001|Part A|Withdrawal by Subject|1|||
25090643|NCT02694523|50199869|FG002|Part A|Withdrawal by Subject|0|||
25090644|NCT02694523|50199870|FG003|Part A|Withdrawal by Subject|0|||
25090645|NCT02694523|50199871|FG004|Part A|Withdrawal by Subject|0|||
25090646|NCT02694523|50199872|FG005|Part A|Withdrawal by Subject|0|||
25090647|NCT02694523|50199873|FG006|Part A|Withdrawal by Subject|0|||
25090648|NCT02694523|50199867|FG000|Part A|Other|1|||
25090649|NCT02694523|50199868|FG001|Part A|Other|1|||
25090650|NCT02694523|50199869|FG002|Part A|Other|0|||
25090651|NCT02694523|50199870|FG003|Part A|Other|0|||
25090652|NCT02694523|50199871|FG004|Part A|Other|0|||
25090653|NCT02694523|50199872|FG005|Part A|Other|0|||
25090654|NCT02694523|50199873|FG006|Part A|Other|0|||
25090655|NCT02694523|50199867|FG000|Part B|Adverse Event|0|||
25090656|NCT02694523|50199868|FG001|Part B|Adverse Event|0|||
25090657|NCT02694523|50199869|FG002|Part B|Adverse Event|7|||
25090658|NCT02694523|50199870|FG003|Part B|Adverse Event|1|||
25090659|NCT02694523|50199871|FG004|Part B|Adverse Event|1|||
25090660|NCT02694523|50199872|FG005|Part B|Adverse Event|2|||
25090661|NCT02694523|50199873|FG006|Part B|Adverse Event|0|||
25090662|NCT02694523|50199867|FG000|Part B|Protocol Violation|0|||
25090663|NCT02694523|50199868|FG001|Part B|Protocol Violation|0|||
25090664|NCT02694523|50199869|FG002|Part B|Protocol Violation|1|||
25090665|NCT02694523|50199870|FG003|Part B|Protocol Violation|0|||
25090666|NCT02694523|50199871|FG004|Part B|Protocol Violation|0|||
25090667|NCT02694523|50199872|FG005|Part B|Protocol Violation|0|||
25090668|NCT02694523|50199873|FG006|Part B|Protocol Violation|0|||
25090669|NCT02694523|50199867|FG000|Part B|Lost to Follow-up|0|||
25090670|NCT02694523|50199868|FG001|Part B|Lost to Follow-up|0|||
25090671|NCT02694523|50199869|FG002|Part B|Lost to Follow-up|2|||
25090672|NCT02694523|50199870|FG003|Part B|Lost to Follow-up|3|||
25090673|NCT02694523|50199871|FG004|Part B|Lost to Follow-up|2|||
25090674|NCT02694523|50199872|FG005|Part B|Lost to Follow-up|0|||
25090675|NCT02694523|50199873|FG006|Part B|Lost to Follow-up|1|||
25090676|NCT02694523|50199867|FG000|Part B|Withdrawal by Subject|0|||
25090677|NCT02694523|50199868|FG001|Part B|Withdrawal by Subject|0|||
25090678|NCT02694523|50199869|FG002|Part B|Withdrawal by Subject|9|||
25090679|NCT02694523|50199870|FG003|Part B|Withdrawal by Subject|0|||
25090680|NCT02694523|50199871|FG004|Part B|Withdrawal by Subject|1|||
25090681|NCT02694523|50199872|FG005|Part B|Withdrawal by Subject|3|||
25090682|NCT02694523|50199873|FG006|Part B|Withdrawal by Subject|0|||
25090683|NCT02694523|50199867|FG000|Part B|Other|0|||
25090684|NCT02694523|50199868|FG001|Part B|Other|0|||
25090685|NCT02694523|50199869|FG002|Part B|Other|1|||
25174982|NCT01563029|50317864|FG004|Overall Study|Lost to Follow-up|1|||
25174983|NCT01563029|50317860|FG000|Overall Study|Physician Decision|3|||
25174984|NCT01563029|50317861|FG001|Overall Study|Physician Decision|5|||
25174985|NCT01563029|50317862|FG002|Overall Study|Physician Decision|2|||
25174986|NCT01563029|50317863|FG003|Overall Study|Physician Decision|4|||
25174987|NCT01563029|50317864|FG004|Overall Study|Physician Decision|2|||
25174988|NCT01563029|50317860|FG000|Overall Study|Withdrawal by Subject|4|||
25174989|NCT01563029|50317861|FG001|Overall Study|Withdrawal by Subject|1|||
25174990|NCT01563029|50317862|FG002|Overall Study|Withdrawal by Subject|3|||
25174991|NCT01563029|50317863|FG003|Overall Study|Withdrawal by Subject|4|||
25174992|NCT01563029|50317864|FG004|Overall Study|Withdrawal by Subject|3|||
25174993|NCT01562873|50317877|FG000|Overall Study|Disease Progression per RECIST|10|||
25174994|NCT01562873|50317878|FG001|Overall Study|Disease Progression per RECIST|0|||
25174995|NCT01562873|50317877|FG000|Overall Study|Adverse Event|1|||
25174996|NCT01562873|50317878|FG001|Overall Study|Adverse Event|0|||
25174997|NCT01562873|50317877|FG000|Overall Study|Clinical Disease Progression|9|||
25174998|NCT01562873|50317878|FG001|Overall Study|Clinical Disease Progression|0|||
25174999|NCT01562873|50317877|FG000|Overall Study|Clinical PD and adverse event|1|||
25175000|NCT01562873|50317878|FG001|Overall Study|Clinical PD and adverse event|0|||
25175001|NCT03273712|50317882|FG000|Overall Study|Death|5|||
25175002|NCT03273712|50317882|FG000|Overall Study|Adverse Event|1|||
25175003|NCT03273712|50317882|FG000|Overall Study|Disease Progression|1|||
25175004|NCT01562327|50317887|FG000|Overall Study|Adverse Event|2|||
25175005|NCT01562327|50317887|FG000|Overall Study|Lack of Efficacy|1|||
25175006|NCT01562327|50317887|FG000|Overall Study|Participant drop-out|1|||
25175007|NCT01562327|50317887|FG000|Overall Study|Infusion not received at 6 month window|4|||
25175008|NCT01561313|50317894|FG000|Overall Study|Withdrawal by Subject|1|||
25175009|NCT01561313|50317895|FG001|Overall Study|Withdrawal by Subject|0|||
25175010|NCT01561313|50317894|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
25175011|NCT01561313|50317895|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
25175012|NCT01561079|50317901|FG000|Overall Study|Physician Decision|17|||
25175013|NCT01561079|50317901|FG000|Overall Study|Withdrawal by Subject|59|||
25175014|NCT01561079|50317901|FG000|Overall Study|Protocol Violation|2|||
25175015|NCT01559675|50317946|FG000|Overall Study|Protocol Violation|1|||
25175016|NCT01559675|50317947|FG001|Overall Study|Protocol Violation|2|||
25175017|NCT01559675|50317946|FG000|Overall Study|2nd operation on same patient excluded|14|||
25175018|NCT01559675|50317947|FG001|Overall Study|2nd operation on same patient excluded|12|||
25175019|NCT01374906|50317955|FG000|Overall Study|Abnormal laboratory value(s)|0|||
25175020|NCT01374906|50317956|FG001|Overall Study|Abnormal laboratory value(s)|3|||
25175021|NCT01374906|50317955|FG000|Overall Study|Administrative problems|2|||
25175022|NCT01374906|50317956|FG001|Overall Study|Administrative problems|2|||
25175023|NCT01374906|50317955|FG000|Overall Study|Adverse Event|10|||
25175024|NCT01374906|50317956|FG001|Overall Study|Adverse Event|11|||
25175025|NCT01374906|50317955|FG000|Overall Study|Death|0|||
25175026|NCT01374906|50317956|FG001|Overall Study|Death|2|||
25175027|NCT01374906|50317955|FG000|Overall Study|Protocol Violation|2|||
25175028|NCT01374906|50317956|FG001|Overall Study|Protocol Violation|2|||
25175029|NCT01374906|50317955|FG000|Overall Study|Withdrawal by Subject|15|||
25175030|NCT01374906|50317956|FG001|Overall Study|Withdrawal by Subject|9|||
25175031|NCT01374906|50317955|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
25175032|NCT01374906|50317956|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
25175033|NCT03228394|50317974|FG000|Overall Study|Lost to Follow-up|0|||
25175034|NCT03228394|50317975|FG001|Overall Study|Lost to Follow-up|0|||
25175035|NCT03228394|50317976|FG002|Overall Study|Lost to Follow-up|1|||
25175036|NCT03228394|50317977|FG003|Overall Study|Lost to Follow-up|1|||
25175037|NCT03228394|50317978|FG004|Overall Study|Lost to Follow-up|0|||
25175038|NCT03228394|50317979|FG005|Overall Study|Lost to Follow-up|0|||
25175039|NCT03228394|50317980|FG006|Overall Study|Lost to Follow-up|2|||
25175040|NCT03228394|50317981|FG007|Overall Study|Lost to Follow-up|0|||
25175041|NCT03228394|50317974|FG000|Overall Study|Withdrawal by Subject|0|||
25175042|NCT03228394|50317975|FG001|Overall Study|Withdrawal by Subject|0|||
25175043|NCT03228394|50317976|FG002|Overall Study|Withdrawal by Subject|1|||
25175044|NCT03228394|50317977|FG003|Overall Study|Withdrawal by Subject|0|||
25175045|NCT03228394|50317978|FG004|Overall Study|Withdrawal by Subject|0|||
25175046|NCT03228394|50317979|FG005|Overall Study|Withdrawal by Subject|0|||
25175047|NCT03228394|50317980|FG006|Overall Study|Withdrawal by Subject|1|||
25175048|NCT03228394|50317981|FG007|Overall Study|Withdrawal by Subject|3|||
25175049|NCT03228394|50317974|FG000|Overall Study|Protocol Violation|0|||
25175050|NCT03228394|50317975|FG001|Overall Study|Protocol Violation|0|||
25175051|NCT03228394|50317976|FG002|Overall Study|Protocol Violation|0|||
25175052|NCT03228394|50317977|FG003|Overall Study|Protocol Violation|1|||
25175053|NCT03228394|50317978|FG004|Overall Study|Protocol Violation|0|||
25175054|NCT03228394|50317979|FG005|Overall Study|Protocol Violation|0|||
25175055|NCT03228394|50317980|FG006|Overall Study|Protocol Violation|0|||
25175056|NCT03228394|50317981|FG007|Overall Study|Protocol Violation|0|||
25175057|NCT03228394|50317974|FG000|Overall Study|Physician Decision|0|||
25175058|NCT03228394|50317975|FG001|Overall Study|Physician Decision|0|||
25175059|NCT03228394|50317976|FG002|Overall Study|Physician Decision|0|||
25175060|NCT03228394|50317977|FG003|Overall Study|Physician Decision|0|||
25175061|NCT03228394|50317978|FG004|Overall Study|Physician Decision|0|||
25175062|NCT03228394|50317979|FG005|Overall Study|Physician Decision|0|||
25175063|NCT03228394|50317980|FG006|Overall Study|Physician Decision|1|||
25175064|NCT03228394|50317981|FG007|Overall Study|Physician Decision|0|||
25175065|NCT03228394|50317974|FG000|Overall Study|Noncompliance|0|||
25175066|NCT03228394|50317975|FG001|Overall Study|Noncompliance|0|||
25175067|NCT03228394|50317976|FG002|Overall Study|Noncompliance|0|||
25175068|NCT03228394|50317977|FG003|Overall Study|Noncompliance|0|||
25175069|NCT03228394|50317978|FG004|Overall Study|Noncompliance|0|||
25175070|NCT03228394|50317979|FG005|Overall Study|Noncompliance|0|||
25175071|NCT03228394|50317980|FG006|Overall Study|Noncompliance|1|||
25175072|NCT03228394|50317981|FG007|Overall Study|Noncompliance|0|||
25175073|NCT02683746|50318020|FG000|Overall Study|Adverse Event|3|||
25175074|NCT02683746|50318021|FG001|Overall Study|Adverse Event|2|||
25090686|NCT02694523|50199870|FG003|Part B|Other|0|||
25090687|NCT02694523|50199871|FG004|Part B|Other|0|||
25175075|NCT02683746|50318020|FG000|Overall Study|Lost to Follow-up|5|||
25175076|NCT02683746|50318021|FG001|Overall Study|Lost to Follow-up|6|||
25175077|NCT02683746|50318020|FG000|Overall Study|Withdrawal by Subject|6|||
25090688|NCT02694523|50199872|FG005|Part B|Other|0|||
25090689|NCT02694523|50199873|FG006|Part B|Other|1|||
25090690|NCT01353703|50199887|FG000|Overall Study|Migrated/moved from study area|1|||
25090691|NCT01353703|50199888|FG001|Overall Study|Migrated/moved from study area|0|||
25090692|NCT02009332|50199902|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
25090693|NCT02009332|50199903|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
25090694|NCT02009332|50199904|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
25090695|NCT02009332|50199905|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
25090696|NCT02009332|50199906|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
25090697|NCT02009332|50199907|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
25090698|NCT02009332|50199902|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
25090699|NCT02009332|50199903|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
25090700|NCT02009332|50199904|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
25090701|NCT02009332|50199905|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
25090702|NCT02009332|50199906|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
25090703|NCT02009332|50199907|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
25175078|NCT02683746|50318021|FG001|Overall Study|Withdrawal by Subject|5|||
25175079|NCT02683746|50318020|FG000|Overall Study|Physician Decision|2|||
25175080|NCT02683746|50318021|FG001|Overall Study|Physician Decision|1|||
25175081|NCT01559129|50318029|FG000|Treatment Phase|Adverse Event|0|||
25175082|NCT01559129|50318030|FG001|Treatment Phase|Adverse Event|2|||
25175083|NCT01559129|50318029|FG000|Treatment Phase|Progressive Disease|1|||
25175084|NCT01559129|50318030|FG001|Treatment Phase|Progressive Disease|1|||
25175085|NCT01559129|50318029|FG000|Treatment Phase|Lack of Efficacy|0|||
25175086|NCT01559129|50318030|FG001|Treatment Phase|Lack of Efficacy|1|||
25175087|NCT01559129|50318029|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
25175088|NCT01559129|50318030|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
25175089|NCT01559129|50318029|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
25175090|NCT01559129|50318030|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
25175091|NCT01559129|50318029|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
25175092|NCT01559129|50318030|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
25175093|NCT01559129|50318029|FG000|Open-label Extension Period|Adverse Event|1|||
25175094|NCT01559129|50318030|FG001|Open-label Extension Period|Adverse Event|0|||
25175095|NCT01559129|50318029|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
25175096|NCT01559129|50318030|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
25175097|NCT02691468|50318044|FG000|Overall Study|Bronchial blocker use|2|||
25090704|NCT02009332|50199902|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
25090705|NCT02009332|50199903|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
25090706|NCT02009332|50199904|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
25090707|NCT02009332|50199905|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
25175098|NCT02691468|50318045|FG001|Overall Study|Bronchial blocker use|1|||
25175099|NCT02691468|50318044|FG000|Overall Study|Lost to Follow-up|2|||
25175100|NCT02691468|50318045|FG001|Overall Study|Lost to Follow-up|1|||
25175101|NCT02691468|50318044|FG000|Overall Study|Failure to advance FOB|2|||
25175102|NCT02691468|50318045|FG001|Overall Study|Failure to advance FOB|0|||
25175103|NCT02678676|50318053|FG000|Overall Study|Death|619|||
25175104|NCT02678676|50318054|FG001|Overall Study|Death|649|||
25175105|NCT02678676|50318053|FG000|Overall Study|Withdrawal by Subject|13|||
25175106|NCT02678676|50318054|FG001|Overall Study|Withdrawal by Subject|5|||
25175107|NCT02678676|50318053|FG000|Overall Study|Lost to Follow-up|171|||
25175108|NCT02678676|50318054|FG001|Overall Study|Lost to Follow-up|151|||
25175109|NCT02678676|50318053|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
25175110|NCT02678676|50318054|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
25175111|NCT01558739|50318060|FG000|Overall Study|Adverse Event|7|||
25175112|NCT01558739|50318060|FG000|Overall Study|Withdrawal by Subject|2|||
25175113|NCT01558739|50318060|FG000|Overall Study|Death|3|||
25175114|NCT01558739|50318060|FG000|Overall Study|Disease Progression|4|||
25175115|NCT01558739|50318060|FG000|Overall Study|Protocol Violation|1|||
25175116|NCT02683668|50318064|FG000|Period 2|Withdrawal by Subject|0|||
25175117|NCT02683668|50318065|FG001|Period 2|Withdrawal by Subject|1|||
25175118|NCT02683668|50318066|FG002|Period 2|Withdrawal by Subject|0|||
25175119|NCT02678286|50318074|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
25175120|NCT02678286|50318075|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
25175121|NCT02678286|50318074|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
25175122|NCT02678286|50318075|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
25175123|NCT02678286|50318074|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
25175124|NCT02678286|50318075|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
25175125|NCT02678286|50318074|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
25175126|NCT02678286|50318075|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
25175127|NCT02678286|50318074|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
25175128|NCT02678286|50318075|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
25175129|NCT02682264|50318083|FG000|Overall Study|Withdrawal by Subject|56|||
25175130|NCT02682264|50318084|FG001|Overall Study|Withdrawal by Subject|45|||
25175131|NCT02682264|50318083|FG000|Overall Study|Lost to Follow-up|49|||
25175132|NCT02682264|50318084|FG001|Overall Study|Lost to Follow-up|41|||
25175133|NCT02682264|50318083|FG000|Overall Study|Lack of Efficacy|14|||
25175134|NCT02682264|50318084|FG001|Overall Study|Lack of Efficacy|16|||
25175135|NCT02682264|50318083|FG000|Overall Study|Withdrawal by Parent|6|||
25175136|NCT02682264|50318084|FG001|Overall Study|Withdrawal by Parent|7|||
25175137|NCT02682264|50318083|FG000|Overall Study|Adverse Event|9|||
25175138|NCT02682264|50318084|FG001|Overall Study|Adverse Event|0|||
25175139|NCT02682264|50318083|FG000|Overall Study|Noncompliance with study drug|1|||
25175140|NCT02682264|50318084|FG001|Overall Study|Noncompliance with study drug|4|||
25175141|NCT02682264|50318083|FG000|Overall Study|Pregnancy|1|||
25175142|NCT02682264|50318084|FG001|Overall Study|Pregnancy|2|||
25175143|NCT02682264|50318083|FG000|Overall Study|Recovery|1|||
25175144|NCT02682264|50318084|FG001|Overall Study|Recovery|2|||
25175145|NCT02682264|50318083|FG000|Overall Study|Progressive Disease|1|||
25175146|NCT02682264|50318084|FG001|Overall Study|Progressive Disease|0|||
25175147|NCT02682264|50318083|FG000|Overall Study|Technical Problems|0|||
25175148|NCT02682264|50318084|FG001|Overall Study|Technical Problems|1|||
25175149|NCT02682264|50318083|FG000|Overall Study|Moved abroad and unable to continue|0|||
25175150|NCT02682264|50318084|FG001|Overall Study|Moved abroad and unable to continue|3|||
25175151|NCT02682264|50318083|FG000|Overall Study|Stopped test article application|0|||
25175152|NCT02682264|50318084|FG001|Overall Study|Stopped test article application|1|||
25175153|NCT01566721|50318092|FG000|Treatment Period|Withdrawal by Subject|35|||
25090708|NCT02009332|50199906|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
25090709|NCT02009332|50199907|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
25090710|NCT01984294|50199924|FG000|Overall Study|Randomized but Never Treated|0|||
25090711|NCT01984294|50199925|FG001|Overall Study|Randomized but Never Treated|0|||
25090712|NCT01984294|50199926|FG002|Overall Study|Randomized but Never Treated|1|||
25090713|NCT01984294|50199924|FG000|Overall Study|Lack of Efficacy|4|||
25090714|NCT01984294|50199925|FG001|Overall Study|Lack of Efficacy|2|||
25090715|NCT01984294|50199926|FG002|Overall Study|Lack of Efficacy|6|||
25090716|NCT01984294|50199924|FG000|Overall Study|Adverse Event|0|||
25090717|NCT01984294|50199925|FG001|Overall Study|Adverse Event|1|||
25090718|NCT01984294|50199926|FG002|Overall Study|Adverse Event|0|||
25090719|NCT01962298|50199939|FG000|Overall Study|Protocol Violation|1|||
25090720|NCT01962298|50199940|FG001|Overall Study|Protocol Violation|0|||
25090721|NCT01962298|50199941|FG002|Overall Study|Protocol Violation|1|||
25090722|NCT01962298|50199942|FG003|Overall Study|Protocol Violation|1|||
25175154|NCT01566721|50318093|FG001|Treatment Period|Withdrawal by Subject|9|||
25175155|NCT01566721|50318092|FG000|Treatment Period|Disease Progression/Recurrence|37|||
25175156|NCT01566721|50318093|FG001|Treatment Period|Disease Progression/Recurrence|13|||
25175157|NCT01566721|50318092|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
25175158|NCT01566721|50318093|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
25175159|NCT01566721|50318092|FG000|Treatment Period|Other|13|||
25175160|NCT01566721|50318093|FG001|Treatment Period|Other|2|||
25175161|NCT01566721|50318092|FG000|Treatment Period|Lack of Compliance|5|||
25175162|NCT01566721|50318093|FG001|Treatment Period|Lack of Compliance|1|||
25175163|NCT01566721|50318092|FG000|Treatment Period|Adverse Event|100|||
25175164|NCT01566721|50318093|FG001|Treatment Period|Adverse Event|30|||
25090723|NCT01962298|50199943|FG004|Overall Study|Protocol Violation|0|||
25090724|NCT01962298|50199939|FG000|Overall Study|Data quality insufficient|2|||
25090725|NCT01962298|50199940|FG001|Overall Study|Data quality insufficient|0|||
25090726|NCT01962298|50199941|FG002|Overall Study|Data quality insufficient|3|||
25175165|NCT01566721|50318092|FG000|Treatment Period|Pregnancy|1|||
25175166|NCT01566721|50318093|FG001|Treatment Period|Pregnancy|0|||
25175167|NCT01566721|50318092|FG000|Safety Follow-up|Physician Decision|6|||
25175168|NCT01566721|50318093|FG001|Safety Follow-up|Physician Decision|4|||
25090727|NCT01962298|50199942|FG003|Overall Study|Data quality insufficient|1|||
25090728|NCT01962298|50199943|FG004|Overall Study|Data quality insufficient|4|||
25090729|NCT01962298|50199939|FG000|Overall Study|Insufficient data|0|||
25090730|NCT01962298|50199940|FG001|Overall Study|Insufficient data|2|||
25090731|NCT01962298|50199941|FG002|Overall Study|Insufficient data|1|||
25090732|NCT01962298|50199942|FG003|Overall Study|Insufficient data|0|||
25090733|NCT01962298|50199943|FG004|Overall Study|Insufficient data|1|||
25090734|NCT01962298|50199939|FG000|Overall Study|Incorrect data recorded|0|||
25090735|NCT01962298|50199940|FG001|Overall Study|Incorrect data recorded|1|||
25090736|NCT01962298|50199941|FG002|Overall Study|Incorrect data recorded|0|||
25090737|NCT01962298|50199942|FG003|Overall Study|Incorrect data recorded|0|||
25090738|NCT01962298|50199943|FG004|Overall Study|Incorrect data recorded|0|||
25090739|NCT01962298|50199939|FG000|Overall Study|Physician Decision|0|||
25090740|NCT01962298|50199940|FG001|Overall Study|Physician Decision|1|||
25090741|NCT01962298|50199941|FG002|Overall Study|Physician Decision|0|||
25090742|NCT01962298|50199942|FG003|Overall Study|Physician Decision|0|||
25090743|NCT01962298|50199943|FG004|Overall Study|Physician Decision|1|||
25090744|NCT02693743|50199957|FG000|Overall Study|Physician Decision|1|||
25090745|NCT02693743|50199958|FG001|Overall Study|Physician Decision|0|||
25090746|NCT02655887|50199964|FG000|Overall Study|Lost to Follow-up|3|||
25090747|NCT02655887|50199964|FG000|Overall Study|Death|4|||
25090748|NCT02655887|50199964|FG000|Overall Study|Withdrawal by Subject|3|||
25090749|NCT02655887|50199964|FG000|Overall Study|Missed 12-month follow-up visit|4|||
25090750|NCT02008318|50199970|FG000|Overall Study|Adverse Event|4|||
25090751|NCT02008318|50199971|FG001|Overall Study|Adverse Event|0|||
25090752|NCT02008318|50199970|FG000|Overall Study|Physician Decision|2|||
25090753|NCT02008318|50199971|FG001|Overall Study|Physician Decision|0|||
25090754|NCT02008318|50199970|FG000|Overall Study|Progressive Disease|2|||
25090755|NCT02008318|50199971|FG001|Overall Study|Progressive Disease|0|||
25090756|NCT02008318|50199970|FG000|Overall Study|Protocol Violation|1|||
25090757|NCT02008318|50199971|FG001|Overall Study|Protocol Violation|1|||
25090758|NCT02008318|50199970|FG000|Overall Study|Withdrawal by Subject|3|||
25090759|NCT02008318|50199971|FG001|Overall Study|Withdrawal by Subject|0|||
25090760|NCT01982812|50199982|FG000|Overall Study|Death|1|||
25090761|NCT01982812|50199983|FG001|Overall Study|Death|5|||
25090762|NCT01982812|50199982|FG000|Overall Study|Adverse Event|0|||
25090763|NCT01982812|50199983|FG001|Overall Study|Adverse Event|5|||
25090764|NCT02007070|50199989|FG000|Overall Study|Adverse Event|4|||
25090765|NCT02007070|50199989|FG000|Overall Study|Clinical Progression|4|||
25090766|NCT02007070|50199989|FG000|Overall Study|Death|1|||
25090767|NCT02007070|50199989|FG000|Overall Study|Protocol Violation|2|||
25090768|NCT02007070|50199989|FG000|Overall Study|Physician Decision|1|||
25090769|NCT02007070|50199989|FG000|Overall Study|Progressive Disease|21|||
25090770|NCT02006758|50199993|FG000|Overall Study|Protocol Violation|1|||
25090771|NCT02006758|50199993|FG000|Overall Study|Death|1|||
25090772|NCT02006758|50199993|FG000|Overall Study|Lost to Follow-up|4|||
25090773|NCT02006758|50199993|FG000|Overall Study|Withdrawal by Subject|4|||
25090774|NCT02006758|50199993|FG000|Overall Study|Procedurally excluded|1|||
25090775|NCT02006758|50199993|FG000|Overall Study|Other|2|||
25090776|NCT01960816|50199998|FG000|Overall Study|Lost to Follow-up|1|||
25090777|NCT01602419|50200002|FG000|Overall Study|Not treated with Wilate|9|||
25090778|NCT01602419|50200002|FG000|Overall Study|Adverse Drug Reaction|4|||
25090779|NCT01602419|50200002|FG000|Overall Study|Insurance issues|3|||
25090780|NCT01602419|50200002|FG000|Overall Study|Changed treatment centre|1|||
25090781|NCT01602419|50200002|FG000|Overall Study|Treatment centre closed|1|||
25090782|NCT01602419|50200002|FG000|Overall Study|Withdrawal by Subject|5|||
25090783|NCT01602419|50200002|FG000|Overall Study|Lost to Follow-up|6|||
25090784|NCT01981954|50200047|FG000|Titration Period|Protocol Deviation|1|||
25090785|NCT01981954|50200047|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
25090786|NCT02693119|50200053|FG000|Open-Label Period|Withdrawal by Subject|0|||
25090787|NCT02693119|50200054|FG001|Open-Label Period|Withdrawal by Subject|1|||
25090788|NCT01960348|50200092|FG000|Overall Study|Adverse event, not serious|2|||
25090789|NCT01960348|50200093|FG001|Overall Study|Adverse event, not serious|2|||
25090790|NCT01960348|50200092|FG000|Overall Study|Adverse event, serious fatal|6|||
25090791|NCT01960348|50200093|FG001|Overall Study|Adverse event, serious fatal|5|||
25090792|NCT01960348|50200092|FG000|Overall Study|Adverse event, serious non-fatal|0|||
25090793|NCT01960348|50200093|FG001|Overall Study|Adverse event, serious non-fatal|3|||
25090794|NCT01960348|50200092|FG000|Overall Study|Withdrawal by Subject|1|||
25090795|NCT01960348|50200093|FG001|Overall Study|Withdrawal by Subject|11|||
25090796|NCT01960348|50200092|FG000|Overall Study|Physician Decision|0|||
25090797|NCT01960348|50200093|FG001|Overall Study|Physician Decision|1|||
25090798|NCT01960348|50200092|FG000|Overall Study|Protocol Violation|1|||
25090799|NCT01960348|50200093|FG001|Overall Study|Protocol Violation|0|||
25090800|NCT02653625|50200099|FG000|Overall Study|Adverse Event|1|||
25090801|NCT02653625|50200099|FG000|Overall Study|Non-compliance with Study Drug|1|||
25090802|NCT02653625|50200099|FG000|Overall Study|Protocol Violation|1|||
25090803|NCT02653625|50200099|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
25090804|NCT01981096|50200105|FG000|Overall Study|Parent illness|1|||
25175169|NCT01566721|50318092|FG000|Safety Follow-up|Lost to Follow-up|101|||
25175170|NCT01566721|50318093|FG001|Safety Follow-up|Lost to Follow-up|48|||
25175171|NCT01566721|50318092|FG000|Safety Follow-up|Withdrawal by Subject|155|||
25175172|NCT01566721|50318093|FG001|Safety Follow-up|Withdrawal by Subject|49|||
25175173|NCT01566721|50318092|FG000|Safety Follow-up|Death|28|||
25175174|NCT01566721|50318093|FG001|Safety Follow-up|Death|4|||
25175175|NCT01566721|50318092|FG000|Safety Follow-up|Non-compliance|7|||
25175176|NCT01566721|50318093|FG001|Safety Follow-up|Non-compliance|3|||
25175177|NCT01566721|50318092|FG000|Safety Follow-up|Protocol Violation|7|||
25175178|NCT01566721|50318093|FG001|Safety Follow-up|Protocol Violation|0|||
25175179|NCT01566721|50318092|FG000|Safety Follow-up|Site closure|2|||
25175180|NCT01566721|50318093|FG001|Safety Follow-up|Site closure|3|||
25175181|NCT01566721|50318092|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
25175182|NCT01566721|50318093|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
25175183|NCT01566721|50318092|FG000|Safety Follow-up|Missing|7|||
25175184|NCT01566721|50318093|FG001|Safety Follow-up|Missing|2|||
25175185|NCT01566721|50318092|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
25175186|NCT01566721|50318093|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
25175187|NCT01566721|50318092|FG000|Safety Follow-up|Sponsor decision|1|||
25175188|NCT01566721|50318093|FG001|Safety Follow-up|Sponsor decision|0|||
25175189|NCT01566721|50318092|FG000|Safety Follow-up|Adverse Event|8|||
25175190|NCT01566721|50318093|FG001|Safety Follow-up|Adverse Event|4|||
25175191|NCT01541215|50318108|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
25175192|NCT01541215|50318109|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
25175193|NCT01541215|50318108|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
25175194|NCT01541215|50318109|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
25175195|NCT01541215|50318108|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
25175196|NCT01541215|50318109|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
25175197|NCT01541215|50318108|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
25175198|NCT01541215|50318109|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
25175199|NCT01541215|50318108|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
25175200|NCT01541215|50318109|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
25175201|NCT01541215|50318108|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
25175202|NCT01541215|50318109|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
25175203|NCT01540981|50318121|FG000|Overall Study|Withdrawal by Subject|1|||
25175204|NCT01540981|50318122|FG001|Overall Study|Withdrawal by Subject|0|||
25175205|NCT01585987|50318130|FG000|Randomized|Withdrawal by Subject|0|||
25175206|NCT01585987|50318131|FG001|Randomized|Withdrawal by Subject|4|||
25175207|NCT01585987|50318130|FG000|Randomized|No longer met criteria|0|||
25175208|NCT01585987|50318131|FG001|Randomized|No longer met criteria|2|||
25175209|NCT01585987|50318130|FG000|Treated|Disease Progression|39|||
25175210|NCT01585987|50318131|FG001|Treated|Disease Progression|36|||
25175211|NCT01585987|50318130|FG000|Treated|Study Drug Toxicity|9|||
25175212|NCT01585987|50318131|FG001|Treated|Study Drug Toxicity|5|||
25175213|NCT01585987|50318130|FG000|Treated|Adverse Event|3|||
25175214|NCT01585987|50318131|FG001|Treated|Adverse Event|0|||
25175215|NCT01585987|50318130|FG000|Treated|Withdrawal by Subject|1|||
25175216|NCT01585987|50318131|FG001|Treated|Withdrawal by Subject|2|||
25175217|NCT01585987|50318130|FG000|Treated|Death|1|||
25175218|NCT01585987|50318131|FG001|Treated|Death|0|||
25175219|NCT01585987|50318130|FG000|Treated|Lost to Follow-up|0|||
25175220|NCT01585987|50318131|FG001|Treated|Lost to Follow-up|1|||
25175221|NCT01585987|50318130|FG000|Treated|Maximum Clinical Benefit|0|||
25175222|NCT01585987|50318131|FG001|Treated|Maximum Clinical Benefit|1|||
25175223|NCT01585987|50318130|FG000|Treated|Non-Specified|1|||
25175224|NCT01585987|50318131|FG001|Treated|Non-Specified|2|||
25175225|NCT01585987|50318130|FG000|Treated|Subject Request|0|||
25175226|NCT01585987|50318131|FG001|Treated|Subject Request|1|||
25175227|NCT01585987|50318130|FG000|Treated|Poor/Non-Compliance|0|||
25175228|NCT01585987|50318131|FG001|Treated|Poor/Non-Compliance|1|||
25175229|NCT01585831|50318140|FG000|Overall Study|Physician Decision|0|||
25175230|NCT01585831|50318141|FG001|Overall Study|Physician Decision|1|||
25175231|NCT01585831|50318140|FG000|Overall Study|Withdrawal by Subject|2|||
25175232|NCT01585831|50318141|FG001|Overall Study|Withdrawal by Subject|1|||
25175233|NCT01565941|50318149|FG000|Overall Study|Withdrawn by parent/guardian|3|||
25175234|NCT01565941|50318150|FG001|Overall Study|Withdrawn by parent/guardian|2|||
25175235|NCT01565941|50318149|FG000|Overall Study|Randomized; did not receive intevention|8|||
25175236|NCT01565941|50318150|FG001|Overall Study|Randomized; did not receive intevention|2|||
25175237|NCT01558271|50318165|FG000|Overall Study|Adverse Event|6|||
25175238|NCT01558271|50318166|FG001|Overall Study|Adverse Event|3|||
25175239|NCT01558271|50318167|FG002|Overall Study|Adverse Event|4|||
25175240|NCT01558271|50318165|FG000|Overall Study|Lost to Follow-up|1|||
25175241|NCT01558271|50318166|FG001|Overall Study|Lost to Follow-up|0|||
25175242|NCT01558271|50318167|FG002|Overall Study|Lost to Follow-up|0|||
25175243|NCT01558271|50318165|FG000|Overall Study|Protocol Violation|1|||
25175244|NCT01558271|50318166|FG001|Overall Study|Protocol Violation|0|||
25175245|NCT01558271|50318167|FG002|Overall Study|Protocol Violation|0|||
25175246|NCT01558271|50318165|FG000|Overall Study|Withdrawal by Subject|10|||
25175247|NCT01558271|50318166|FG001|Overall Study|Withdrawal by Subject|6|||
25175248|NCT01558271|50318167|FG002|Overall Study|Withdrawal by Subject|12|||
25175249|NCT01558271|50318165|FG000|Overall Study|Physician Decision|0|||
25175250|NCT01558271|50318166|FG001|Overall Study|Physician Decision|2|||
25175251|NCT01558271|50318167|FG002|Overall Study|Physician Decision|1|||
25175252|NCT01565707|50318183|FG000|Overall Study|Adverse Event|1|||
25175253|NCT01565707|50318184|FG001|Overall Study|Adverse Event|6|||
25175254|NCT01565707|50318185|FG002|Overall Study|Adverse Event|2|||
25175255|NCT01565707|50318186|FG003|Overall Study|Adverse Event|1|||
25175256|NCT01565707|50318183|FG000|Overall Study|Lost to Follow-up|1|||
25175257|NCT01565707|50318184|FG001|Overall Study|Lost to Follow-up|0|||
25175258|NCT01565707|50318185|FG002|Overall Study|Lost to Follow-up|0|||
25175259|NCT01565707|50318186|FG003|Overall Study|Lost to Follow-up|0|||
25175260|NCT01565707|50318183|FG000|Overall Study|Protocol Violation|1|||
25175261|NCT01565707|50318184|FG001|Overall Study|Protocol Violation|0|||
25175262|NCT01565707|50318185|FG002|Overall Study|Protocol Violation|0|||
25175263|NCT01565707|50318186|FG003|Overall Study|Protocol Violation|1|||
25175264|NCT01565707|50318183|FG000|Overall Study|Withdrawal by Subject|3|||
25175265|NCT01565707|50318184|FG001|Overall Study|Withdrawal by Subject|1|||
25175266|NCT01565707|50318185|FG002|Overall Study|Withdrawal by Subject|1|||
25175267|NCT01565707|50318186|FG003|Overall Study|Withdrawal by Subject|1|||
25175268|NCT01565707|50318183|FG000|Overall Study|Randomized but not evaluable|2|||
25175269|NCT01565707|50318184|FG001|Overall Study|Randomized but not evaluable|0|||
25175270|NCT01565707|50318185|FG002|Overall Study|Randomized but not evaluable|0|||
25175271|NCT01565707|50318186|FG003|Overall Study|Randomized but not evaluable|0|||
25175272|NCT01565707|50318183|FG000|Overall Study|Miscellaneous|1|||
25175273|NCT01565707|50318184|FG001|Overall Study|Miscellaneous|1|||
25175274|NCT01565707|50318185|FG002|Overall Study|Miscellaneous|0|||
25175275|NCT01565707|50318186|FG003|Overall Study|Miscellaneous|2|||
25175276|NCT01557569|50318205|FG000|Overall Study|Adverse Event|2|||
25175277|NCT01557569|50318206|FG001|Overall Study|Adverse Event|0|||
25175278|NCT01557569|50318205|FG000|Overall Study|high blood pressure|0|||
25175279|NCT01557569|50318206|FG001|Overall Study|high blood pressure|1|||
25175280|NCT01557569|50318205|FG000|Overall Study|Withdrawal by Subject|3|||
25175281|NCT01557569|50318206|FG001|Overall Study|Withdrawal by Subject|5|||
25175282|NCT01557569|50318205|FG000|Overall Study|noncompliance with rules of residential|0|||
25175283|NCT01557569|50318206|FG001|Overall Study|noncompliance with rules of residential|1|||
25175284|NCT01538719|50318214|FG000|Overall Study|Lost to Follow-up|2|||
25175285|NCT01538719|50318215|FG001|Overall Study|Lost to Follow-up|0|||
25175286|NCT01537783|50318223|FG000|Overall Study|Lost to Follow-up|11|||
25175287|NCT01537783|50318224|FG001|Overall Study|Lost to Follow-up|2|||
25175288|NCT01556165|50318232|FG000|Overall Study|Adverse Event|5|||
25175289|NCT01556165|50318233|FG001|Overall Study|Adverse Event|3|||
25175290|NCT01556165|50318232|FG000|Overall Study|Protocol Violation|0|||
25175291|NCT01556165|50318233|FG001|Overall Study|Protocol Violation|3|||
25175292|NCT01556165|50318232|FG000|Overall Study|Withdrawal of Consent|7|||
25175293|NCT01556165|50318233|FG001|Overall Study|Withdrawal of Consent|1|||
25175294|NCT01537549|50318239|FG000|Overall Study|Lost to Follow-up|1|||
25175295|NCT01537549|50318239|FG000|Overall Study|Withdrawal by Subject|2|||
25175296|NCT01555931|50318247|FG000|Overall Study|Lost to Follow-up|2|||
25175297|NCT01555931|50318248|FG001|Overall Study|Lost to Follow-up|5|||
25175298|NCT01583179|50318256|FG000|Overall Study|Screen failure|1|||
25175299|NCT01583179|50318257|FG001|Overall Study|Screen failure|2|||
25175300|NCT01582945|50318263|FG000|Overall Study|Intolerable side-effects|1|||
25175301|NCT01582945|50318263|FG000|Overall Study|Scheduling conflicts|1|||
25175302|NCT01565083|50318269|FG000|Overall Study|Withdrawal by Subject|6|||
25175303|NCT01565083|50318270|FG001|Overall Study|Withdrawal by Subject|4|||
25175304|NCT01565083|50318269|FG000|Overall Study|Lost to Follow-up|2|||
25175305|NCT01565083|50318270|FG001|Overall Study|Lost to Follow-up|7|||
25175306|NCT01565083|50318269|FG000|Overall Study|Death|22|||
25175307|NCT01565083|50318270|FG001|Overall Study|Death|23|||
25175308|NCT01565083|50318269|FG000|Overall Study|Other|3|||
25175309|NCT01565083|50318270|FG001|Overall Study|Other|5|||
25175310|NCT01582789|50318276|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
25175311|NCT01582789|50318277|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
25175312|NCT01537393|50318287|FG000|Overall Study|Exclude prior to study|32|||
25175313|NCT01537393|50318288|FG001|Overall Study|Exclude prior to study|44|||
25175314|NCT01537393|50318287|FG000|Overall Study|Death|20|||
25175315|NCT01537393|50318288|FG001|Overall Study|Death|32|||
25175316|NCT01537393|50318287|FG000|Overall Study|Withdrawal by Subject|18|||
25175317|NCT01537393|50318288|FG001|Overall Study|Withdrawal by Subject|17|||
25175318|NCT01537393|50318287|FG000|Overall Study|Lost to Follow-up|53|||
25175319|NCT01537393|50318288|FG001|Overall Study|Lost to Follow-up|48|||
25175320|NCT01537393|50318287|FG000|Overall Study|Failure - Regrafted|28|||
25175321|NCT01537393|50318288|FG001|Overall Study|Failure - Regrafted|43|||
25175322|NCT01537393|50318287|FG000|Overall Study|Failure - Not regrafted|2|||
25175323|NCT01537393|50318288|FG001|Overall Study|Failure - Not regrafted|6|||
25175324|NCT01537393|50318287|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
25175325|NCT01537393|50318288|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
25175326|NCT01555151|50318298|FG000|Overall Study|Withdrawal by Subject|6|||
25175327|NCT01555151|50318299|FG001|Overall Study|Withdrawal by Subject|2|||
25175328|NCT01555151|50318300|FG002|Overall Study|Withdrawal by Subject|0|||
25175329|NCT01555151|50318301|FG003|Overall Study|Withdrawal by Subject|2|||
25175330|NCT01555151|50318298|FG000|Overall Study|Administrative|3|||
25175331|NCT01555151|50318299|FG001|Overall Study|Administrative|1|||
25175332|NCT01555151|50318300|FG002|Overall Study|Administrative|2|||
25175333|NCT01555151|50318301|FG003|Overall Study|Administrative|0|||
25175334|NCT01555151|50318298|FG000|Overall Study|Protocol Violation|3|||
25175335|NCT01555151|50318299|FG001|Overall Study|Protocol Violation|3|||
25175336|NCT01555151|50318300|FG002|Overall Study|Protocol Violation|3|||
25175337|NCT01555151|50318301|FG003|Overall Study|Protocol Violation|5|||
25175338|NCT01555151|50318298|FG000|Overall Study|Adverse Event|1|||
25175339|NCT01555151|50318299|FG001|Overall Study|Adverse Event|2|||
25175340|NCT01555151|50318300|FG002|Overall Study|Adverse Event|1|||
25175341|NCT01555151|50318301|FG003|Overall Study|Adverse Event|2|||
25175342|NCT01555151|50318298|FG000|Overall Study|Lost to Follow-up|0|||
25175343|NCT01555151|50318299|FG001|Overall Study|Lost to Follow-up|0|||
25175344|NCT01555151|50318300|FG002|Overall Study|Lost to Follow-up|0|||
25175345|NCT01555151|50318301|FG003|Overall Study|Lost to Follow-up|1|||
25175346|NCT01537081|50318315|FG000|Overall Study|Adverse Event|5|||
25175347|NCT01537081|50318316|FG001|Overall Study|Adverse Event|2|||
25175348|NCT01537081|50318317|FG002|Overall Study|Adverse Event|2|||
25175349|NCT01537081|50318315|FG000|Overall Study|Lack of Efficacy|2|||
25175350|NCT01537081|50318316|FG001|Overall Study|Lack of Efficacy|1|||
25175351|NCT01537081|50318317|FG002|Overall Study|Lack of Efficacy|0|||
25175352|NCT01537081|50318315|FG000|Overall Study|Lost to Follow-up|17|||
25175353|NCT01537081|50318316|FG001|Overall Study|Lost to Follow-up|15|||
25175354|NCT01537081|50318317|FG002|Overall Study|Lost to Follow-up|9|||
25175355|NCT01537081|50318315|FG000|Overall Study|Protocol Violation|3|||
25175356|NCT01537081|50318316|FG001|Overall Study|Protocol Violation|2|||
25175357|NCT01537081|50318317|FG002|Overall Study|Protocol Violation|2|||
25175358|NCT01537081|50318315|FG000|Overall Study|Withdrawal by Subject|6|||
25175359|NCT01537081|50318316|FG001|Overall Study|Withdrawal by Subject|11|||
25175360|NCT01537081|50318317|FG002|Overall Study|Withdrawal by Subject|3|||
25175361|NCT01537081|50318315|FG000|Overall Study|Physician Decision|5|||
25175362|NCT01537081|50318316|FG001|Overall Study|Physician Decision|6|||
25175363|NCT01537081|50318317|FG002|Overall Study|Physician Decision|0|||
25175364|NCT01537081|50318315|FG000|Overall Study|Sponsor decision|0|||
25175365|NCT01537081|50318316|FG001|Overall Study|Sponsor decision|1|||
25175366|NCT01537081|50318317|FG002|Overall Study|Sponsor decision|0|||
25175367|NCT01537081|50318315|FG000|Overall Study|Assigned but never dosed|1|||
25175368|NCT01537081|50318316|FG001|Overall Study|Assigned but never dosed|0|||
25175369|NCT01537081|50318317|FG002|Overall Study|Assigned but never dosed|0|||
25175370|NCT01564459|50318329|FG000|Run-In|Adverse Event|7|||
25175371|NCT01564459|50318330|FG001|Run-In|Adverse Event|0|||
25175372|NCT01564459|50318331|FG002|Run-In|Adverse Event|0|||
25175373|NCT01564459|50318329|FG000|Run-In|Lost to Follow-up|1|||
25175374|NCT01564459|50318330|FG001|Run-In|Lost to Follow-up|0|||
25175375|NCT01564459|50318331|FG002|Run-In|Lost to Follow-up|0|||
25175376|NCT01564459|50318329|FG000|Run-In|Non-compliance with study drug|2|||
25175377|NCT01564459|50318330|FG001|Run-In|Non-compliance with study drug|0|||
25175378|NCT01564459|50318331|FG002|Run-In|Non-compliance with study drug|0|||
25175379|NCT01564459|50318329|FG000|Run-In|Protocol Violation|1|||
25175380|NCT01564459|50318330|FG001|Run-In|Protocol Violation|0|||
25175381|NCT01564459|50318331|FG002|Run-In|Protocol Violation|0|||
25175382|NCT01564459|50318329|FG000|Run-In|Withdrawal by Subject|1|||
25175383|NCT01564459|50318330|FG001|Run-In|Withdrawal by Subject|0|||
25175384|NCT01564459|50318331|FG002|Run-In|Withdrawal by Subject|0|||
25175385|NCT01564459|50318329|FG000|Double-blind Treatment|Adverse Event|0|||
25175386|NCT01564459|50318330|FG001|Double-blind Treatment|Adverse Event|0|||
25175387|NCT01564459|50318331|FG002|Double-blind Treatment|Adverse Event|1|||
25175388|NCT01555073|50318346|FG000|Overall Study|Lost to Follow-up|1|||
24996913|NCT02963506|50088000|FG005|Dose-Blind Period|Sponsor decision|1|||
24996914|NCT02963506|50088001|FG006|Dose-Blind Period|Sponsor decision|0|||
25175389|NCT01555073|50318347|FG001|Overall Study|Lost to Follow-up|2|||
25175390|NCT01555073|50318348|FG002|Overall Study|Lost to Follow-up|0|||
25175391|NCT01555073|50318349|FG003|Overall Study|Lost to Follow-up|5|||
25175392|NCT01582243|50318359|FG000|Overall Study|Withdrawal by Subject|1|||
25175393|NCT01582243|50318359|FG000|Overall Study|Adverse Event|1|||
25175394|NCT01582243|50318359|FG000|Overall Study|Lost to Follow-up|1|||
25175395|NCT01536535|50318365|FG000|Overall Study|Withdrawal by Subject|10|||
25175396|NCT01536535|50318366|FG001|Overall Study|Withdrawal by Subject|5|||
25175397|NCT01536535|50318365|FG000|Overall Study|Lost to Follow-up|4|||
25175398|NCT01536535|50318366|FG001|Overall Study|Lost to Follow-up|6|||
25175399|NCT01536535|50318365|FG000|Overall Study|Physician Decision|1|||
24996915|NCT02963506|50088002|FG007|Dose-Blind Period|Sponsor decision|0|||
25175400|NCT01536535|50318366|FG001|Overall Study|Physician Decision|1|||
25175401|NCT01536535|50318365|FG000|Overall Study|Participant moved|0|||
25090805|NCT01981096|50200106|FG001|Overall Study|Parent illness|0|||
25090806|NCT01981096|50200105|FG000|Overall Study|Withdrawal by Subject|0|||
25090807|NCT01981096|50200106|FG001|Overall Study|Withdrawal by Subject|1|||
25090808|NCT01981096|50200105|FG000|Overall Study|Lost to Follow-up|2|||
25090809|NCT01981096|50200106|FG001|Overall Study|Lost to Follow-up|0|||
25090810|NCT02652767|50200112|FG000|Overall Study|Death|2|||
25090811|NCT02652767|50200112|FG000|Overall Study|Lost to Follow-up|1|||
25090812|NCT02652767|50200112|FG000|Overall Study|Withdrawal by Subject|1|||
25090813|NCT01980940|50200126|FG000|Overall Study|Protocol Violation|0|||
25090814|NCT01980940|50200127|FG001|Overall Study|Protocol Violation|0|||
25090815|NCT01980940|50200128|FG002|Overall Study|Protocol Violation|0|||
25090816|NCT01980940|50200129|FG003|Overall Study|Protocol Violation|0|||
25090817|NCT01980940|50200130|FG004|Overall Study|Protocol Violation|0|||
25090818|NCT01980940|50200131|FG005|Overall Study|Protocol Violation|2|||
25090819|NCT01980940|50200132|FG006|Overall Study|Protocol Violation|0|||
25090820|NCT01980940|50200133|FG007|Overall Study|Protocol Violation|0|||
25090821|NCT02699983|50200159|FG000|Overall Study|Withdrawal by Subject|1|||
25090822|NCT02699983|50200160|FG001|Overall Study|Withdrawal by Subject|0|||
25090823|NCT01960114|50200172|FG000|Overall Study|Adverse Event|1|||
25090824|NCT01960114|50200173|FG001|Overall Study|Adverse Event|0|||
25090825|NCT01960114|50200172|FG000|Overall Study|Could not swallow study medication|0|||
25090826|NCT01960114|50200173|FG001|Overall Study|Could not swallow study medication|1|||
25090827|NCT02005276|50200183|FG000|Overall Study|No longer interested|5|||
25090828|NCT02005276|50200184|FG001|Overall Study|No longer interested|2|||
25090829|NCT02005276|50200185|FG002|Overall Study|No longer interested|3|||
25090830|NCT02005276|50200186|FG003|Overall Study|No longer interested|3|||
25090831|NCT01980706|50200201|FG000|Overall Study|Withdrawal by Subject|9|||
25090832|NCT01980706|50200202|FG001|Overall Study|Withdrawal by Subject|6|||
25090833|NCT01980706|50200203|FG002|Overall Study|Withdrawal by Subject|2|||
25090834|NCT01980706|50200201|FG000|Overall Study|Adverse Event|1|||
25090835|NCT01980706|50200202|FG001|Overall Study|Adverse Event|2|||
25090836|NCT01980706|50200203|FG002|Overall Study|Adverse Event|5|||
25090837|NCT01980706|50200201|FG000|Overall Study|Lost to Follow-up|3|||
25090838|NCT01980706|50200202|FG001|Overall Study|Lost to Follow-up|4|||
25090839|NCT01980706|50200203|FG002|Overall Study|Lost to Follow-up|3|||
25090840|NCT01980706|50200201|FG000|Overall Study|miscellaneous|4|||
25090841|NCT01980706|50200202|FG001|Overall Study|miscellaneous|5|||
25090842|NCT01980706|50200203|FG002|Overall Study|miscellaneous|3|||
25090843|NCT02692417|50200213|FG000|Overall Study|Withdrawal by Subject|5|||
25090844|NCT02692417|50200214|FG001|Overall Study|Withdrawal by Subject|1|||
25090845|NCT02692417|50200213|FG000|Overall Study|Adverse Event|1|||
25090846|NCT02692417|50200214|FG001|Overall Study|Adverse Event|0|||
25090847|NCT02004886|50200224|FG000|Overall Study|Adverse Event|0|||
25090848|NCT02004886|50200225|FG001|Overall Study|Adverse Event|1|||
25090849|NCT02004886|50200226|FG002|Overall Study|Adverse Event|0|||
25090850|NCT02004886|50200227|FG003|Overall Study|Adverse Event|0|||
25090851|NCT02004886|50200224|FG000|Overall Study|Unable to attend future visits|1|||
25090852|NCT02004886|50200225|FG001|Overall Study|Unable to attend future visits|0|||
25090853|NCT02004886|50200226|FG002|Overall Study|Unable to attend future visits|0|||
25090854|NCT02004886|50200227|FG003|Overall Study|Unable to attend future visits|0|||
25090855|NCT01959880|50200241|FG000|Overall Study|Withdrawal by Subject|11|||
25090856|NCT01959880|50200242|FG001|Overall Study|Withdrawal by Subject|13|||
25090857|NCT01959880|50200243|FG002|Overall Study|Withdrawal by Subject|8|||
25090858|NCT01959880|50200244|FG003|Overall Study|Withdrawal by Subject|7|||
25090859|NCT01959880|50200241|FG000|Overall Study|Death|1|||
25090860|NCT01959880|50200242|FG001|Overall Study|Death|10|||
25090861|NCT01959880|50200243|FG002|Overall Study|Death|1|||
25090862|NCT01959880|50200244|FG003|Overall Study|Death|2|||
25090863|NCT01959880|50200241|FG000|Overall Study|Lost to Follow-up|95|||
25090864|NCT01959880|50200242|FG001|Overall Study|Lost to Follow-up|18|||
25090865|NCT01959880|50200243|FG002|Overall Study|Lost to Follow-up|15|||
25090866|NCT01959880|50200244|FG003|Overall Study|Lost to Follow-up|8|||
25090867|NCT01959880|50200241|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
25090868|NCT01959880|50200242|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
25090869|NCT01959880|50200243|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
25090870|NCT01959880|50200244|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
25090871|NCT01959880|50200241|FG000|Overall Study|Study completed early-FDA approved|1003|||
25090872|NCT01959880|50200242|FG001|Overall Study|Study completed early-FDA approved|311|||
25090873|NCT01959880|50200243|FG002|Overall Study|Study completed early-FDA approved|179|||
25090874|NCT01959880|50200244|FG003|Overall Study|Study completed early-FDA approved|152|||
25090875|NCT01980628|50200254|FG000|Overall Study|Adverse Event|12|||
25090876|NCT01980628|50200254|FG000|Overall Study|Physician Decision|5|||
25090877|NCT01980628|50200254|FG000|Overall Study|Withdrawal by Subject|4|||
25090878|NCT01980628|50200254|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
25090879|NCT01979614|50200261|FG000|Overall Study|Adverse Event|1|||
25090880|NCT01979614|50200262|FG001|Overall Study|Adverse Event|1|||
25090881|NCT02654717|50200270|FG000|Overall Study|Adverse Event|2|||
25175402|NCT01536535|50318366|FG001|Overall Study|Participant moved|1|||
25175403|NCT01554527|50318376|FG000|Overall Study|Withdrawal by Subject|1|||
25175404|NCT01554527|50318377|FG001|Overall Study|Withdrawal by Subject|0|||
25175405|NCT01554527|50318378|FG002|Overall Study|Withdrawal by Subject|3|||
25175406|NCT01554527|50318376|FG000|Overall Study|Lost to Follow-up|0|||
25175407|NCT01554527|50318377|FG001|Overall Study|Lost to Follow-up|0|||
25175408|NCT01554527|50318378|FG002|Overall Study|Lost to Follow-up|4|||
25175409|NCT01554527|50318376|FG000|Overall Study|Physician Decision|0|||
25175410|NCT01554527|50318377|FG001|Overall Study|Physician Decision|0|||
25175411|NCT01554527|50318378|FG002|Overall Study|Physician Decision|1|||
25175412|NCT01563913|50318389|FG000|Overall Study|Physician Decision|1|||
25175413|NCT01563913|50318390|FG001|Overall Study|Physician Decision|0|||
25175414|NCT01563913|50318389|FG000|Overall Study|Spouse Passed Away|1|||
25175415|NCT01563913|50318390|FG001|Overall Study|Spouse Passed Away|0|||
25175416|NCT01553747|50318399|FG000|Overall Study|Protocol Violation|0|||
25175417|NCT01553747|50318400|FG001|Overall Study|Protocol Violation|2|||
25175418|NCT01553747|50318401|FG002|Overall Study|Protocol Violation|0|||
25175419|NCT01553747|50318399|FG000|Overall Study|Voluntarily withdrew|70|||
25175420|NCT01553747|50318400|FG001|Overall Study|Voluntarily withdrew|66|||
25175421|NCT01553747|50318401|FG002|Overall Study|Voluntarily withdrew|74|||
25175422|NCT01553747|50318399|FG000|Overall Study|Adverse event or SAE|32|||
25175423|NCT01553747|50318400|FG001|Overall Study|Adverse event or SAE|28|||
25175424|NCT01553747|50318401|FG002|Overall Study|Adverse event or SAE|19|||
25175425|NCT01553747|50318399|FG000|Overall Study|Physician decision: other|10|||
25175426|NCT01553747|50318400|FG001|Overall Study|Physician decision: other|8|||
25175427|NCT01553747|50318401|FG002|Overall Study|Physician decision: other|7|||
25090882|NCT02654717|50200271|FG001|Overall Study|Adverse Event|2|||
25090883|NCT02654717|50200270|FG000|Overall Study|Protocol Violation|1|||
25090884|NCT02654717|50200271|FG001|Overall Study|Protocol Violation|2|||
25090885|NCT02654717|50200270|FG000|Overall Study|Withdrawal by Subject|0|||
25090886|NCT02654717|50200271|FG001|Overall Study|Withdrawal by Subject|1|||
25090887|NCT02654717|50200270|FG000|Overall Study|Non-permitted medication|3|||
25090888|NCT02654717|50200271|FG001|Overall Study|Non-permitted medication|0|||
25090889|NCT03343301|50200279|FG000|Overall Study|Withdrawal by Subject|1|||
25090890|NCT03343301|50200280|FG001|Overall Study|Withdrawal by Subject|1|||
25090891|NCT03343301|50200279|FG000|Overall Study|Death|0|||
25090892|NCT03343301|50200280|FG001|Overall Study|Death|2|||
25090893|NCT03343301|50200279|FG000|Overall Study|Other|0|||
25090894|NCT03343301|50200280|FG001|Overall Study|Other|6|||
25090895|NCT03343301|50200279|FG000|Overall Study|Missing|2|||
25090896|NCT03343301|50200280|FG001|Overall Study|Missing|0|||
25090897|NCT02696785|50200290|FG000|Blinded Treatment Period|Adverse Event|0|||
25090898|NCT02696785|50200291|FG001|Blinded Treatment Period|Adverse Event|1|||
25090899|NCT02696785|50200292|FG002|Blinded Treatment Period|Adverse Event|3|||
25090900|NCT02696785|50200293|FG003|Blinded Treatment Period|Adverse Event|0|||
25090901|NCT02696785|50200290|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
25090902|NCT02696785|50200291|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
25090903|NCT02696785|50200292|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
25090904|NCT02696785|50200293|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
25090905|NCT02696785|50200290|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
25090906|NCT02696785|50200291|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
25090907|NCT02696785|50200292|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
25090908|NCT02696785|50200293|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
25090909|NCT02696785|50200290|FG000|Blinded Treatment Period|Screen Failure|1|||
25090910|NCT02696785|50200291|FG001|Blinded Treatment Period|Screen Failure|0|||
25090911|NCT02696785|50200292|FG002|Blinded Treatment Period|Screen Failure|0|||
25090912|NCT02696785|50200293|FG003|Blinded Treatment Period|Screen Failure|0|||
25090913|NCT02696785|50200290|FG000|Washout Period|Withdrawal by Subject|0|||
25090914|NCT02696785|50200291|FG001|Washout Period|Withdrawal by Subject|1|||
25090915|NCT02696785|50200292|FG002|Washout Period|Withdrawal by Subject|0|||
25090916|NCT02696785|50200293|FG003|Washout Period|Withdrawal by Subject|0|||
25090917|NCT02696785|50200290|FG000|Washout Period|Lack of Efficacy|0|||
25175428|NCT01553747|50318399|FG000|Overall Study|Lost to Follow-up|11|||
25175429|NCT01553747|50318400|FG001|Overall Study|Lost to Follow-up|5|||
25175430|NCT01553747|50318401|FG002|Overall Study|Lost to Follow-up|6|||
25175431|NCT01553747|50318399|FG000|Overall Study|Sponsor decision, specify|7|||
25175432|NCT01553747|50318400|FG001|Overall Study|Sponsor decision, specify|5|||
25090918|NCT02696785|50200291|FG001|Washout Period|Lack of Efficacy|1|||
25090919|NCT02696785|50200292|FG002|Washout Period|Lack of Efficacy|0|||
25090920|NCT02696785|50200293|FG003|Washout Period|Lack of Efficacy|0|||
25090921|NCT02696785|50200290|FG000|Extended Treatment Period|Adverse Event|2|||
25090922|NCT02696785|50200291|FG001|Extended Treatment Period|Adverse Event|3|||
25090923|NCT02696785|50200292|FG002|Extended Treatment Period|Adverse Event|2|||
25175433|NCT01553747|50318401|FG002|Overall Study|Sponsor decision, specify|0|||
25090924|NCT02696785|50200293|FG003|Extended Treatment Period|Adverse Event|1|||
25090925|NCT02696785|50200290|FG000|Extended Treatment Period|Lack of Efficacy|0|||
25090926|NCT02696785|50200291|FG001|Extended Treatment Period|Lack of Efficacy|1|||
25175434|NCT01553747|50318399|FG000|Overall Study|Physician decision: lack of efficacy|1|||
25175435|NCT01553747|50318400|FG001|Overall Study|Physician decision: lack of efficacy|5|||
25175436|NCT01553747|50318401|FG002|Overall Study|Physician decision: lack of efficacy|3|||
25175437|NCT01536379|50318414|FG000|Overall Study|Adverse Event|1|||
25175438|NCT01536379|50318415|FG001|Overall Study|Adverse Event|2|||
25175439|NCT01536379|50318414|FG000|Overall Study|Withdrawal by Subject|1|||
25175440|NCT01536379|50318415|FG001|Overall Study|Withdrawal by Subject|1|||
25175441|NCT01536145|50318421|FG000|Overall Study|Progressive disease|3|||
25175442|NCT01536145|50318422|FG001|Overall Study|Progressive disease|4|||
25175443|NCT01536145|50318423|FG002|Overall Study|Progressive disease|1|||
25175444|NCT01536145|50318424|FG003|Overall Study|Progressive disease|2|||
25175445|NCT01536145|50318425|FG004|Overall Study|Progressive disease|1|||
25175446|NCT01536145|50318426|FG005|Overall Study|Progressive disease|2|||
25175447|NCT01536145|50318427|FG006|Overall Study|Progressive disease|1|||
25175448|NCT01536145|50318428|FG007|Overall Study|Progressive disease|2|||
25175449|NCT01536145|50318429|FG008|Overall Study|Progressive disease|1|||
25175450|NCT01536145|50318430|FG009|Overall Study|Progressive disease|3|||
25175451|NCT01536145|50318431|FG010|Overall Study|Progressive disease|3|||
25175452|NCT01536145|50318421|FG000|Overall Study|Withdrawal by Subject|0|||
25175453|NCT01536145|50318422|FG001|Overall Study|Withdrawal by Subject|0|||
25175454|NCT01536145|50318423|FG002|Overall Study|Withdrawal by Subject|1|||
25175455|NCT01536145|50318424|FG003|Overall Study|Withdrawal by Subject|0|||
25175456|NCT01536145|50318425|FG004|Overall Study|Withdrawal by Subject|0|||
25175457|NCT01536145|50318426|FG005|Overall Study|Withdrawal by Subject|1|||
25175458|NCT01536145|50318427|FG006|Overall Study|Withdrawal by Subject|0|||
25175459|NCT01536145|50318428|FG007|Overall Study|Withdrawal by Subject|0|||
25175460|NCT01536145|50318429|FG008|Overall Study|Withdrawal by Subject|2|||
25175461|NCT01536145|50318430|FG009|Overall Study|Withdrawal by Subject|0|||
25175462|NCT01536145|50318431|FG010|Overall Study|Withdrawal by Subject|2|||
25175463|NCT01536145|50318421|FG000|Overall Study|Other|0|||
25175464|NCT01536145|50318422|FG001|Overall Study|Other|0|||
25175465|NCT01536145|50318423|FG002|Overall Study|Other|0|||
25175466|NCT01536145|50318424|FG003|Overall Study|Other|0|||
25175467|NCT01536145|50318425|FG004|Overall Study|Other|1|||
25175468|NCT01536145|50318426|FG005|Overall Study|Other|0|||
25175469|NCT01536145|50318427|FG006|Overall Study|Other|0|||
25175470|NCT01536145|50318428|FG007|Overall Study|Other|0|||
25175471|NCT01536145|50318429|FG008|Overall Study|Other|0|||
25175472|NCT01536145|50318430|FG009|Overall Study|Other|3|||
25175473|NCT01536145|50318431|FG010|Overall Study|Other|2|||
25175474|NCT01536145|50318421|FG000|Overall Study|Death|0|||
25175475|NCT01536145|50318422|FG001|Overall Study|Death|0|||
25175476|NCT01536145|50318423|FG002|Overall Study|Death|0|||
25175477|NCT01536145|50318424|FG003|Overall Study|Death|0|||
25090927|NCT02696785|50200292|FG002|Extended Treatment Period|Lack of Efficacy|0|||
25090928|NCT02696785|50200293|FG003|Extended Treatment Period|Lack of Efficacy|0|||
25090929|NCT02696785|50200290|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
25090930|NCT02696785|50200291|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
25090931|NCT02696785|50200292|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
25090932|NCT02696785|50200293|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
25090933|NCT02696785|50200290|FG000|Follow-up Period|Adverse Event|0|||
25090934|NCT02696785|50200291|FG001|Follow-up Period|Adverse Event|0|||
25090935|NCT02696785|50200292|FG002|Follow-up Period|Adverse Event|8|||
25090936|NCT02696785|50200293|FG003|Follow-up Period|Adverse Event|2|||
25090937|NCT02696785|50200290|FG000|Follow-up Period|Lost to Follow-up|0|||
25175478|NCT01536145|50318425|FG004|Overall Study|Death|0|||
25175479|NCT01536145|50318426|FG005|Overall Study|Death|0|||
25175480|NCT01536145|50318427|FG006|Overall Study|Death|1|||
25175481|NCT01536145|50318428|FG007|Overall Study|Death|0|||
25175482|NCT01536145|50318429|FG008|Overall Study|Death|0|||
25175483|NCT01536145|50318430|FG009|Overall Study|Death|0|||
25175484|NCT01536145|50318431|FG010|Overall Study|Death|0|||
25175485|NCT01536145|50318421|FG000|Overall Study|Adverse Event|0|||
25175486|NCT01536145|50318422|FG001|Overall Study|Adverse Event|0|||
25090938|NCT02696785|50200291|FG001|Follow-up Period|Lost to Follow-up|0|||
25175487|NCT01536145|50318423|FG002|Overall Study|Adverse Event|0|||
25175488|NCT01536145|50318424|FG003|Overall Study|Adverse Event|0|||
25175489|NCT01536145|50318425|FG004|Overall Study|Adverse Event|0|||
25175490|NCT01536145|50318426|FG005|Overall Study|Adverse Event|0|||
25175491|NCT01536145|50318427|FG006|Overall Study|Adverse Event|0|||
25175492|NCT01536145|50318428|FG007|Overall Study|Adverse Event|2|||
25175493|NCT01536145|50318429|FG008|Overall Study|Adverse Event|0|||
25175494|NCT01536145|50318430|FG009|Overall Study|Adverse Event|0|||
24996916|NCT02963506|50088003|FG008|Dose-Blind Period|Sponsor decision|0|||
25090939|NCT02696785|50200292|FG002|Follow-up Period|Lost to Follow-up|0|||
25090940|NCT02696785|50200293|FG003|Follow-up Period|Lost to Follow-up|1|||
25175495|NCT01536145|50318431|FG010|Overall Study|Adverse Event|3|||
25090941|NCT02696785|50200290|FG000|Follow-up Period|Lack of Efficacy|0|||
25175496|NCT01536067|50318462|FG000|Overall Study|Disease Progression|1|||
25175497|NCT01582009|50318466|FG000|Overall Study|Withdrawal by Subject|1|||
25175498|NCT01582009|50318466|FG000|Overall Study|Physician Decision|1|||
25175499|NCT01553591|50318473|FG000|Overall Study|Voluntarily withdrew|94|||
25175500|NCT01553591|50318474|FG001|Overall Study|Voluntarily withdrew|79|||
25175501|NCT01553591|50318475|FG002|Overall Study|Voluntarily withdrew|96|||
25175502|NCT01553591|50318473|FG000|Overall Study|Adverse Event|36|||
25175503|NCT01553591|50318474|FG001|Overall Study|Adverse Event|45|||
25175504|NCT01553591|50318475|FG002|Overall Study|Adverse Event|16|||
25175505|NCT01553591|50318473|FG000|Overall Study|Lost to Follow-up|25|||
25175506|NCT01553591|50318474|FG001|Overall Study|Lost to Follow-up|23|||
25175507|NCT01553591|50318475|FG002|Overall Study|Lost to Follow-up|16|||
25175508|NCT01553591|50318473|FG000|Overall Study|Physician decision: other|11|||
25175509|NCT01553591|50318474|FG001|Overall Study|Physician decision: other|14|||
25175510|NCT01553591|50318475|FG002|Overall Study|Physician decision: other|16|||
25175511|NCT01553591|50318473|FG000|Overall Study|Physician decision: lack of efficacy|2|||
25175512|NCT01553591|50318474|FG001|Overall Study|Physician decision: lack of efficacy|3|||
25175513|NCT01553591|50318475|FG002|Overall Study|Physician decision: lack of efficacy|7|||
25175514|NCT01553591|50318473|FG000|Overall Study|Protocol Violation|3|||
25175515|NCT01553591|50318474|FG001|Overall Study|Protocol Violation|4|||
25175516|NCT01553591|50318475|FG002|Overall Study|Protocol Violation|4|||
25175517|NCT01553591|50318473|FG000|Overall Study|Sponsor decision|1|||
25175518|NCT01553591|50318474|FG001|Overall Study|Sponsor decision|0|||
25175519|NCT01553591|50318475|FG002|Overall Study|Sponsor decision|3|||
25175520|NCT01553591|50318473|FG000|Overall Study|Randomized and never dispensed drug|0|||
25175521|NCT01553591|50318474|FG001|Overall Study|Randomized and never dispensed drug|1|||
25175522|NCT01553591|50318475|FG002|Overall Study|Randomized and never dispensed drug|0|||
25175523|NCT01581931|50318483|FG000|Washout|Adverse Event|0|||
25175524|NCT01581931|50318484|FG001|Washout|Adverse Event|1|||
25175525|NCT01581619|50318490|FG000|Overall Study|Withdrawal by Subject|1|||
25175526|NCT01581619|50318490|FG000|Overall Study|Lost to Follow-up|1|||
25175527|NCT01581307|50318496|FG000|Overall Study|Withdrawal by Subject|1|||
25175528|NCT01580995|50318502|FG000|Overall Study|Lost to Follow-up|2|||
25175529|NCT01580995|50318503|FG001|Overall Study|Lost to Follow-up|2|||
25175530|NCT01535599|50318511|FG000|Overall Study|Adverse Event|6|||
25175531|NCT01535599|50318512|FG001|Overall Study|Adverse Event|15|||
25175532|NCT01535599|50318511|FG000|Overall Study|Lost to Follow-up|3|||
25175533|NCT01535599|50318512|FG001|Overall Study|Lost to Follow-up|4|||
25175534|NCT01535599|50318511|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
25175535|NCT01535599|50318512|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
25175536|NCT01535599|50318511|FG000|Overall Study|Treatment Failure|33|||
25175537|NCT01535599|50318512|FG001|Overall Study|Treatment Failure|66|||
25175538|NCT01535599|50318511|FG000|Overall Study|BL Culture + for Group A Strep|0|||
25175539|NCT01535599|50318512|FG001|Overall Study|BL Culture + for Group A Strep|1|||
25175540|NCT01535599|50318511|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
25175541|NCT01535599|50318512|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
25175542|NCT01535599|50318511|FG000|Overall Study|Randomized in Error|2|||
25175543|NCT01535599|50318512|FG001|Overall Study|Randomized in Error|4|||
25175544|NCT01535599|50318511|FG000|Overall Study|Did not use product|1|||
25175545|NCT01535599|50318512|FG001|Overall Study|Did not use product|0|||
25175546|NCT01535599|50318511|FG000|Overall Study|Other|1|||
24996917|NCT02963506|50088004|FG009|Dose-Blind Period|Sponsor decision|0|||
25090942|NCT02696785|50200291|FG001|Follow-up Period|Lack of Efficacy|0|||
25090943|NCT02696785|50200292|FG002|Follow-up Period|Lack of Efficacy|0|||
25090944|NCT02696785|50200293|FG003|Follow-up Period|Lack of Efficacy|1|||
25090945|NCT02696785|50200290|FG000|Follow-up Period|Withdrawal by Subject|1|||
25090946|NCT02696785|50200291|FG001|Follow-up Period|Withdrawal by Subject|0|||
25090947|NCT02696785|50200292|FG002|Follow-up Period|Withdrawal by Subject|5|||
25090948|NCT02696785|50200293|FG003|Follow-up Period|Withdrawal by Subject|4|||
25090949|NCT02004262|50200327|FG000|Overall Study|Death|67|||
25090950|NCT02004262|50200328|FG001|Overall Study|Death|64|||
25090951|NCT02004262|50200329|FG002|Overall Study|Death|66|||
25090952|NCT02004262|50200330|FG003|Overall Study|Death|28|||
25090953|NCT02004262|50200331|FG004|Overall Study|Death|29|||
25090954|NCT02004262|50200332|FG005|Overall Study|Death|22|||
25090955|NCT02004262|50200327|FG000|Overall Study|Withdrawal by Subject|1|||
25090956|NCT02004262|50200328|FG001|Overall Study|Withdrawal by Subject|0|||
25090957|NCT02004262|50200329|FG002|Overall Study|Withdrawal by Subject|4|||
25090958|NCT02004262|50200330|FG003|Overall Study|Withdrawal by Subject|0|||
25090959|NCT02004262|50200331|FG004|Overall Study|Withdrawal by Subject|1|||
25090960|NCT02004262|50200332|FG005|Overall Study|Withdrawal by Subject|3|||
25090961|NCT02004262|50200327|FG000|Overall Study|Lost to Follow-up|1|||
25090962|NCT02004262|50200328|FG001|Overall Study|Lost to Follow-up|1|||
25090963|NCT02004262|50200329|FG002|Overall Study|Lost to Follow-up|0|||
25090964|NCT02004262|50200330|FG003|Overall Study|Lost to Follow-up|0|||
25090965|NCT02004262|50200331|FG004|Overall Study|Lost to Follow-up|0|||
25090966|NCT02004262|50200332|FG005|Overall Study|Lost to Follow-up|0|||
25090967|NCT02004262|50200327|FG000|Overall Study|Study Terminated by Sponsor|4|||
25175547|NCT01535599|50318512|FG001|Overall Study|Other|0|||
25175548|NCT01535599|50318511|FG000|Overall Study|Stopped medication|0|||
25175549|NCT01535599|50318512|FG001|Overall Study|Stopped medication|1|||
25175550|NCT01535599|50318511|FG000|Overall Study|Noncompliance|0|||
25175551|NCT01535599|50318512|FG001|Overall Study|Noncompliance|1|||
25175552|NCT01553279|50318520|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
25175553|NCT01553279|50318521|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
25175554|NCT01553279|50318520|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
25175555|NCT01553279|50318521|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
25090968|NCT02004262|50200328|FG001|Overall Study|Study Terminated by Sponsor|3|||
25175556|NCT01553279|50318520|FG000|Interim Period|Withdrawal by Subject|2|||
25175557|NCT01553279|50318521|FG001|Interim Period|Withdrawal by Subject|2|||
25175558|NCT01553279|50318520|FG000|Interim Period|Lost to Follow-up|1|||
25175559|NCT01553279|50318521|FG001|Interim Period|Lost to Follow-up|0|||
25175560|NCT01553279|50318520|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
25175561|NCT01553279|50318521|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
25175562|NCT01553279|50318520|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
25175563|NCT01553279|50318521|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
25175564|NCT01562743|50318528|FG000|Overall Study|Adverse Event|29|||
25175565|NCT01562743|50318528|FG000|Overall Study|Lack of Efficacy|3|||
25175566|NCT01562743|50318528|FG000|Overall Study|Withdrawal by Subject|13|||
25175567|NCT01562743|50318528|FG000|Overall Study|Protocol Violation|1|||
25175568|NCT01562743|50318528|FG000|Overall Study|Discontinuation criteria|2|||
25175569|NCT01562743|50318528|FG000|Overall Study|Lost to Follow-up|2|||
25175570|NCT01562743|50318528|FG000|Overall Study|Physician Decision|2|||
25175571|NCT01535443|50318532|FG000|Overall Study|Physician Decision|3|||
25175572|NCT01535287|50318539|FG000|Overall Study|drug not prepared in time|5|||
25175573|NCT01535287|50318540|FG001|Overall Study|drug not prepared in time|6|||
25175574|NCT01551173|50318548|FG000|Overall Study|Withdrawal by Subject|11|||
25175575|NCT01551173|50318549|FG001|Overall Study|Withdrawal by Subject|16|||
25175576|NCT01551173|50318548|FG000|Overall Study|Adverse Event|7|||
25175577|NCT01551173|50318549|FG001|Overall Study|Adverse Event|6|||
25175578|NCT01551173|50318548|FG000|Overall Study|Lost to Follow-up|5|||
25175579|NCT01551173|50318549|FG001|Overall Study|Lost to Follow-up|7|||
25175580|NCT01551173|50318548|FG000|Overall Study|Other|5|||
25175581|NCT01551173|50318549|FG001|Overall Study|Other|3|||
25175582|NCT01549613|50318558|FG000|Overall Study|Lost to Follow-up|11|||
25175583|NCT01549613|50318559|FG001|Overall Study|Lost to Follow-up|11|||
25175584|NCT01548599|50318567|FG000|Overall Study|Lost to Follow-up|0|||
25175585|NCT01548599|50318568|FG001|Overall Study|Lost to Follow-up|1|||
25175586|NCT01548599|50318567|FG000|Overall Study|Withdrawal by Subject|4|||
25175587|NCT01548599|50318568|FG001|Overall Study|Withdrawal by Subject|0|||
25175588|NCT01548599|50318567|FG000|Overall Study|Death|2|||
25175589|NCT01548599|50318568|FG001|Overall Study|Death|1|||
25175590|NCT01548287|50318581|FG000|Screening|No reason provided|0|||
25175591|NCT01548287|50318582|FG001|Screening|No reason provided|0|||
25175592|NCT01548287|50318583|FG002|Screening|No reason provided|0|||
25175593|NCT01548287|50318584|FG003|Screening|No reason provided|0|||
25175594|NCT01548287|50318585|FG004|Screening|No reason provided|9|||
25175595|NCT01548287|50318581|FG000|Screening|Did not meet eligibility criteria|0|||
25175596|NCT01548287|50318582|FG001|Screening|Did not meet eligibility criteria|0|||
25175597|NCT01548287|50318583|FG002|Screening|Did not meet eligibility criteria|0|||
25175598|NCT01548287|50318584|FG003|Screening|Did not meet eligibility criteria|0|||
25175599|NCT01548287|50318585|FG004|Screening|Did not meet eligibility criteria|74|||
25175600|NCT01548287|50318581|FG000|Randomized Period|Did not meet inclusion criteria|0|||
25175601|NCT01548287|50318582|FG001|Randomized Period|Did not meet inclusion criteria|0|||
25175602|NCT01548287|50318583|FG002|Randomized Period|Did not meet inclusion criteria|2|||
25090969|NCT02004262|50200329|FG002|Overall Study|Study Terminated by Sponsor|2|||
25090970|NCT02004262|50200330|FG003|Overall Study|Study Terminated by Sponsor|1|||
25090971|NCT02004262|50200331|FG004|Overall Study|Study Terminated by Sponsor|1|||
25090972|NCT02004262|50200332|FG005|Overall Study|Study Terminated by Sponsor|5|||
25090973|NCT01675427|50200346|FG000|Overall Study|Withdrawal by Subject|7|||
25090974|NCT01675427|50200346|FG000|Overall Study|Participant Refused Sample Collection|18|||
25090975|NCT01675427|50200346|FG000|Overall Study|Sample not Collected by Mistake|2|||
25090976|NCT01675427|50200346|FG000|Overall Study|Lost to Follow-up|5|||
25090977|NCT01675427|50200346|FG000|Overall Study|Other|2|||
25090978|NCT01978912|50200384|FG000|Overall Study|Adverse Event|0|||
25175603|NCT01548287|50318584|FG003|Randomized Period|Did not meet inclusion criteria|0|||
25175604|NCT01548287|50318585|FG004|Randomized Period|Did not meet inclusion criteria|0|||
25175605|NCT01548287|50318581|FG000|Randomized Period|Adverse Event|0|||
25175606|NCT01548287|50318582|FG001|Randomized Period|Adverse Event|2|||
25175607|NCT01548287|50318583|FG002|Randomized Period|Adverse Event|5|||
25175608|NCT01548287|50318584|FG003|Randomized Period|Adverse Event|0|||
25090979|NCT01978912|50200385|FG001|Overall Study|Adverse Event|1|||
25090980|NCT01978912|50200386|FG002|Overall Study|Adverse Event|0|||
25090981|NCT01978912|50200387|FG003|Overall Study|Adverse Event|0|||
25175609|NCT01548287|50318585|FG004|Randomized Period|Adverse Event|0|||
25175610|NCT01546883|50318595|FG000|Overall Study|Withdrawal by Subject|3|||
25175611|NCT01546883|50318595|FG000|Overall Study|Adverse Event|4|||
25175612|NCT01546883|50318595|FG000|Overall Study|Lost to Follow-up|2|||
25175613|NCT01546883|50318595|FG000|Overall Study|early closure of study|2|||
25175614|NCT01546883|50318595|FG000|Overall Study|other unrelated illness|1|||
25175615|NCT01580293|50318606|FG000|Part A_Main Trial|Adverse Event|0|||
25175616|NCT01580293|50318607|FG001|Part A_Main Trial|Adverse Event|2|||
25175617|NCT01580293|50318608|FG002|Part A_Main Trial|Adverse Event|0|||
25175618|NCT01580293|50318606|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
25175619|NCT01580293|50318607|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
25175620|NCT01580293|50318608|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
25175621|NCT01580293|50318606|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
25175622|NCT01580293|50318607|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
25175623|NCT01580293|50318608|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
25175624|NCT01580293|50318606|FG000|Part A_Extension|Adverse Event|0|||
25090982|NCT01978912|50200384|FG000|Overall Study|Lost to Follow-up|1|||
25090983|NCT01978912|50200385|FG001|Overall Study|Lost to Follow-up|1|||
25090984|NCT01978912|50200386|FG002|Overall Study|Lost to Follow-up|0|||
25090985|NCT01978912|50200387|FG003|Overall Study|Lost to Follow-up|1|||
25090986|NCT01978912|50200384|FG000|Overall Study|Withdrawal by Subject|1|||
25090987|NCT01978912|50200385|FG001|Overall Study|Withdrawal by Subject|0|||
25090988|NCT01978912|50200386|FG002|Overall Study|Withdrawal by Subject|2|||
25175625|NCT01580293|50318607|FG001|Part A_Extension|Adverse Event|2|||
25175626|NCT01580293|50318608|FG002|Part A_Extension|Adverse Event|0|||
25175627|NCT01580293|50318606|FG000|Part A_Extension|Withdrawal by Subject|0|||
25175628|NCT01580293|50318607|FG001|Part A_Extension|Withdrawal by Subject|3|||
25175629|NCT01580293|50318608|FG002|Part A_Extension|Withdrawal by Subject|0|||
25175630|NCT01580293|50318606|FG000|Part A_Extension|Lost to Follow-up|0|||
25175631|NCT01580293|50318607|FG001|Part A_Extension|Lost to Follow-up|1|||
25175632|NCT01580293|50318608|FG002|Part A_Extension|Lost to Follow-up|0|||
25175633|NCT01580293|50318606|FG000|Part A_Extension|Other Reason|0|||
25175634|NCT01580293|50318607|FG001|Part A_Extension|Other Reason|1|||
25175635|NCT01580293|50318608|FG002|Part A_Extension|Other Reason|0|||
25175636|NCT01580293|50318606|FG000|Part A_Extension|Completed Japan only|0|||
25175637|NCT01580293|50318607|FG001|Part A_Extension|Completed Japan only|5|||
25175638|NCT01580293|50318608|FG002|Part A_Extension|Completed Japan only|0|||
25175639|NCT01580293|50318606|FG000|Part B|Withdrawal by Subject|0|||
25175640|NCT01580293|50318607|FG001|Part B|Withdrawal by Subject|0|||
25175641|NCT01580293|50318608|FG002|Part B|Withdrawal by Subject|1|||
25175642|NCT01580293|50318606|FG000|Part B|Other reason|0|||
25175643|NCT01580293|50318607|FG001|Part B|Other reason|0|||
25175644|NCT01580293|50318608|FG002|Part B|Other reason|1|||
25175645|NCT01546649|50318637|FG000|Overall Study|Adverse Event|4|||
25175646|NCT01546649|50318638|FG001|Overall Study|Adverse Event|5|||
25175647|NCT01546649|50318637|FG000|Overall Study|Protocol Violation|1|||
25175648|NCT01546649|50318638|FG001|Overall Study|Protocol Violation|0|||
25175649|NCT01546649|50318637|FG000|Overall Study|Lack of Efficacy|1|||
25175650|NCT01546649|50318638|FG001|Overall Study|Lack of Efficacy|0|||
25175651|NCT01546649|50318637|FG000|Overall Study|Recurrence|1|||
25175652|NCT01546649|50318638|FG001|Overall Study|Recurrence|1|||
25175653|NCT01546649|50318637|FG000|Overall Study|Discovery of secondary cancer|0|||
25175654|NCT01546649|50318638|FG001|Overall Study|Discovery of secondary cancer|1|||
25175655|NCT01546649|50318637|FG000|Overall Study|Withdrawal by Subject|1|||
25175656|NCT01546649|50318638|FG001|Overall Study|Withdrawal by Subject|2|||
25175657|NCT01544309|50318646|FG000|Overall Study|Withdrawal by Subject|12|||
25175658|NCT01544309|50318647|FG001|Overall Study|Withdrawal by Subject|7|||
25175659|NCT01544309|50318646|FG000|Overall Study|Protocol Violation|2|||
25090989|NCT01978912|50200387|FG003|Overall Study|Withdrawal by Subject|2|||
25175660|NCT01544309|50318647|FG001|Overall Study|Protocol Violation|1|||
25175661|NCT01544309|50318646|FG000|Overall Study|Physician Decision|4|||
25175662|NCT01544309|50318647|FG001|Overall Study|Physician Decision|1|||
25175663|NCT01544309|50318646|FG000|Overall Study|Not performed pre-dose examination|1|||
25175664|NCT01544309|50318647|FG001|Overall Study|Not performed pre-dose examination|2|||
25175665|NCT01544309|50318646|FG000|Overall Study|Administered prohibit prior medication|1|||
25175666|NCT01544309|50318647|FG001|Overall Study|Administered prohibit prior medication|0|||
25175667|NCT01544153|50318659|FG000|Overall Study|Under 18|0|||
25175668|NCT01544153|50318660|FG001|Overall Study|Under 18|1|||
25090990|NCT01978912|50200384|FG000|Overall Study|Lumbar Surgery|1|||
25090991|NCT01978912|50200385|FG001|Overall Study|Lumbar Surgery|0|||
25090992|NCT01978912|50200386|FG002|Overall Study|Lumbar Surgery|1|||
25175669|NCT01544153|50318661|FG002|Overall Study|Under 18|0|||
25175670|NCT01544153|50318662|FG003|Overall Study|Under 18|0|||
25175671|NCT01544153|50318659|FG000|Overall Study|Non-smoker|0|||
25175672|NCT01544153|50318660|FG001|Overall Study|Non-smoker|0|||
25090993|NCT01978912|50200387|FG003|Overall Study|Lumbar Surgery|0|||
25175673|NCT01544153|50318661|FG002|Overall Study|Non-smoker|1|||
25175674|NCT01544153|50318662|FG003|Overall Study|Non-smoker|0|||
25175675|NCT01543685|50318677|FG000|Overall Study|Lack of Efficacy|1|||
25175676|NCT01543685|50318678|FG001|Overall Study|Lack of Efficacy|2|||
25175677|NCT01543685|50318679|FG002|Overall Study|Lack of Efficacy|2|||
25175678|NCT01543685|50318680|FG003|Overall Study|Lack of Efficacy|0|||
25175679|NCT01543685|50318681|FG004|Overall Study|Lack of Efficacy|2|||
25175680|NCT01543685|50318677|FG000|Overall Study|Adverse Event|2|||
25175681|NCT01543685|50318678|FG001|Overall Study|Adverse Event|1|||
25175682|NCT01543685|50318679|FG002|Overall Study|Adverse Event|0|||
25175683|NCT01543685|50318680|FG003|Overall Study|Adverse Event|0|||
25175684|NCT01543685|50318681|FG004|Overall Study|Adverse Event|2|||
25175685|NCT01541969|50318695|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
25175686|NCT01541969|50318696|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
25175687|NCT01541969|50318695|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
25175688|NCT01541969|50318696|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
25175689|NCT01541969|50318695|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
25175690|NCT01541969|50318696|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
25175691|NCT01541969|50318695|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
25175692|NCT01541969|50318696|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
25175693|NCT01541969|50318695|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
25175694|NCT01541969|50318696|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
25175695|NCT01541969|50318695|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
25175696|NCT01541969|50318696|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
25175697|NCT01541969|50318695|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
25175698|NCT01541969|50318696|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
25175699|NCT01541969|50318695|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
25175700|NCT01541969|50318696|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
25175701|NCT01541969|50318695|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
25175702|NCT01541969|50318696|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
25175703|NCT01541969|50318695|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
25175704|NCT01541969|50318696|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
25175705|NCT01540565|50318705|FG000|Overall Study|Ineligible|2|||
25175706|NCT01540487|50318711|FG000|Overall Study|Protocol Violation|1|||
25175707|NCT01540487|50318712|FG001|Overall Study|Protocol Violation|0|||
25175708|NCT01539863|50318724|FG000|Overall Study|Lost to Follow-up|5|||
25175709|NCT01539863|50318725|FG001|Overall Study|Lost to Follow-up|4|||
25175710|NCT01539317|50318733|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
25175711|NCT01539317|50318734|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
25175712|NCT01539239|50318745|FG000|Overall Study|Death|5|||
25175713|NCT01539239|50318746|FG001|Overall Study|Death|5|||
25175714|NCT01539239|50318745|FG000|Overall Study|Lost to Follow-up|7|||
25175715|NCT01539239|50318746|FG001|Overall Study|Lost to Follow-up|12|||
25175716|NCT01539083|50318752|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
25175717|NCT01539083|50318753|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
25175718|NCT01539083|50318754|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
25175719|NCT01539083|50318752|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
25175720|NCT01539083|50318753|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
25175721|NCT01539083|50318754|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
25175722|NCT01539083|50318752|FG000|Before Randomization (VCD Induction)|Death|6|||
25175723|NCT01539083|50318753|FG001|Before Randomization (VCD Induction)|Death|0|||
25175724|NCT01539083|50318754|FG002|Before Randomization (VCD Induction)|Death|0|||
25175725|NCT01539083|50318752|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
25175726|NCT01539083|50318753|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
25175727|NCT01539083|50318754|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
25175728|NCT01539083|50318752|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
25175729|NCT01539083|50318753|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
25175730|NCT01539083|50318754|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
25175731|NCT01539083|50318752|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
25175732|NCT01539083|50318753|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
25175733|NCT01539083|50318754|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
25090994|NCT01978912|50200384|FG000|Overall Study|Intradiscal Steroid Injection|0|||
25090995|NCT01978912|50200385|FG001|Overall Study|Intradiscal Steroid Injection|1|||
25090996|NCT01978912|50200386|FG002|Overall Study|Intradiscal Steroid Injection|0|||
25090997|NCT01978912|50200387|FG003|Overall Study|Intradiscal Steroid Injection|0|||
25090998|NCT01977898|50200399|FG000|Overall Study|Non functioning catheter|1|||
25090999|NCT01977898|50200400|FG001|Overall Study|Non functioning catheter|1|||
25091000|NCT02003638|50200408|FG000|Overall Study|Withdrawal by Subject|1|||
25091001|NCT02003638|50200409|FG001|Overall Study|Withdrawal by Subject|0|||
25091002|NCT02696317|50200415|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
25091003|NCT02696317|50200416|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
25091004|NCT02696317|50200415|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
25175734|NCT01539083|50318752|FG000|Before Randomization (VCD Induction)|Other|5|||
25175735|NCT01539083|50318753|FG001|Before Randomization (VCD Induction)|Other|0|||
25175736|NCT01539083|50318754|FG002|Before Randomization (VCD Induction)|Other|0|||
25175737|NCT01539083|50318752|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
25175738|NCT01539083|50318753|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
25175739|NCT01539083|50318754|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
25175740|NCT01539083|50318752|FG000|After Randomization (TP and VTP)|Other|0|||
25175741|NCT01539083|50318753|FG001|After Randomization (TP and VTP)|Other|1|||
25175742|NCT01539083|50318754|FG002|After Randomization (TP and VTP)|Other|1|||
25175743|NCT01539083|50318752|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
25175744|NCT01539083|50318753|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
25175745|NCT01539083|50318754|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
25175746|NCT01539083|50318752|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
25175747|NCT01539083|50318753|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
25175748|NCT01539083|50318754|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
25175749|NCT01539083|50318752|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
25175750|NCT01539083|50318753|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
25175751|NCT01539083|50318754|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
25175752|NCT01539083|50318752|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
25175753|NCT01539083|50318753|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
25175754|NCT01539083|50318754|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
25175755|NCT01539083|50318752|FG000|After Randomization (TP and VTP)|Death|0|||
25175756|NCT01539083|50318753|FG001|After Randomization (TP and VTP)|Death|6|||
25175757|NCT01539083|50318754|FG002|After Randomization (TP and VTP)|Death|11|||
25175758|NCT01537211|50318763|FG000|Overall Study|Lost to Follow-up|0|||
25175759|NCT01537211|50318764|FG001|Overall Study|Lost to Follow-up|1|||
25175760|NCT01537133|50318778|FG000|Overall Study|Withdrawal by Subject|2|||
25175761|NCT01537133|50318779|FG001|Overall Study|Withdrawal by Subject|0|||
25175762|NCT01537133|50318780|FG002|Overall Study|Withdrawal by Subject|0|||
25175763|NCT01537133|50318781|FG003|Overall Study|Withdrawal by Subject|0|||
25175764|NCT01537133|50318778|FG000|Overall Study|Lost to Follow-up|1|||
25175765|NCT01537133|50318779|FG001|Overall Study|Lost to Follow-up|0|||
25175766|NCT01537133|50318780|FG002|Overall Study|Lost to Follow-up|0|||
25175767|NCT01537133|50318781|FG003|Overall Study|Lost to Follow-up|0|||
25175768|NCT01536587|50318789|FG000|Overall Study|Adverse Event|2|||
25175769|NCT01536119|50318795|FG000|Overall Study|Lost to Follow-up|17|||
25175770|NCT01536119|50318796|FG001|Overall Study|Lost to Follow-up|14|||
25175771|NCT01535729|50318802|FG000|Overall Study|Withdrawal by Subject|2|||
25175772|NCT01535729|50318802|FG000|Overall Study|Disease progression|230|||
25175773|NCT01535729|50318802|FG000|Overall Study|Discontinued treatment|25|||
25175774|NCT01535729|50318802|FG000|Overall Study|Lost to Follow-up|8|||
25175775|NCT01535729|50318802|FG000|Overall Study|Death|52|||
25175776|NCT01535729|50318802|FG000|Overall Study|Other|19|||
25175777|NCT01535729|50318802|FG000|Overall Study|Did not sign informed consent|1|||
25175778|NCT01535729|50318802|FG000|Overall Study|No previous chemotherapy|33|||
25175779|NCT01535729|50318802|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
25175780|NCT01535729|50318802|FG000|Overall Study|Protocol Violation|11|||
25175781|NCT01535729|50318802|FG000|Overall Study|Screening failure|1|||
25175782|NCT01535729|50318802|FG000|Overall Study|Not treated|9|||
25175783|NCT01535729|50318802|FG000|Overall Study|No participant record available|5|||
25175784|NCT01535261|50318806|FG000|Overall Study|Physician Decision|8|||
25175785|NCT01535261|50318806|FG000|Overall Study|Protocol Violation|3|||
25175786|NCT01535261|50318806|FG000|Overall Study|Death|5|||
25175787|NCT01535261|50318806|FG000|Overall Study|Lost to Follow-up|8|||
25175788|NCT01535261|50318806|FG000|Overall Study|Withdrawal by Subject|14|||
25175789|NCT01535261|50318806|FG000|Overall Study|Adverse Event|12|||
25175790|NCT01534637|50318810|FG000|Overall Study|Physician Decision|3|||
25175791|NCT01534637|50318810|FG000|Overall Study|Lack of Efficacy|3|||
25175792|NCT01534637|50318810|FG000|Overall Study|Withdrawal by Subject|1|||
25175793|NCT01534637|50318810|FG000|Overall Study|Adverse Event|1|||
25175794|NCT01534637|50318810|FG000|Overall Study|Liver Mets before treatment|1|||
25175795|NCT02655016|50318816|FG000|Overall Study|Disease progression|6|||
25175796|NCT02655016|50318817|FG001|Overall Study|Disease progression|4|||
25175797|NCT02655016|50318816|FG000|Overall Study|Site closed|0|||
25175798|NCT02655016|50318817|FG001|Overall Study|Site closed|1|||
25175799|NCT02655016|50318816|FG000|Overall Study|Death|30|||
25175800|NCT02655016|50318817|FG001|Overall Study|Death|48|||
24996918|NCT02963506|50088005|FG010|Dose-Blind Period|Sponsor decision|0|||
25175801|NCT02655016|50318816|FG000|Overall Study|Lost to Follow-up|1|||
25175802|NCT02655016|50318817|FG001|Overall Study|Lost to Follow-up|1|||
25175803|NCT02655016|50318816|FG000|Overall Study|Withdrawal by Subject|18|||
25175804|NCT02655016|50318817|FG001|Overall Study|Withdrawal by Subject|36|||
25175805|NCT01533935|50318824|FG000|Overall Study|Adverse Event|5|||
25175806|NCT01533935|50318825|FG001|Overall Study|Adverse Event|7|||
25175807|NCT01533935|50318826|FG002|Overall Study|Adverse Event|1|||
25175808|NCT01533935|50318827|FG003|Overall Study|Adverse Event|5|||
25175809|NCT01533935|50318828|FG004|Overall Study|Adverse Event|3|||
25175810|NCT01533935|50318824|FG000|Overall Study|Protocol Violation|0|||
25175811|NCT01533935|50318825|FG001|Overall Study|Protocol Violation|2|||
25175812|NCT01533935|50318826|FG002|Overall Study|Protocol Violation|0|||
25175813|NCT01533935|50318827|FG003|Overall Study|Protocol Violation|0|||
25175814|NCT01533935|50318828|FG004|Overall Study|Protocol Violation|0|||
25175815|NCT01533935|50318824|FG000|Overall Study|Lost to Follow-up|0|||
25175816|NCT01533935|50318825|FG001|Overall Study|Lost to Follow-up|0|||
25175817|NCT01533935|50318826|FG002|Overall Study|Lost to Follow-up|1|||
25175818|NCT01533935|50318827|FG003|Overall Study|Lost to Follow-up|0|||
25175819|NCT01533935|50318828|FG004|Overall Study|Lost to Follow-up|0|||
25175820|NCT01533935|50318824|FG000|Overall Study|Withdrawal by Subject|0|||
25175821|NCT01533935|50318825|FG001|Overall Study|Withdrawal by Subject|4|||
24996919|NCT02963506|50088006|FG011|Dose-Blind Period|Sponsor decision|0|||
24996920|NCT02963506|50088007|FG012|Dose-Blind Period|Sponsor decision|0|||
24996921|NCT02963506|50087995|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
25175822|NCT01533935|50318826|FG002|Overall Study|Withdrawal by Subject|5|||
25175823|NCT01533935|50318827|FG003|Overall Study|Withdrawal by Subject|2|||
25175824|NCT01533935|50318828|FG004|Overall Study|Withdrawal by Subject|4|||
25175825|NCT01533935|50318824|FG000|Overall Study|Other reason not defined above|1|||
25175826|NCT01533935|50318825|FG001|Overall Study|Other reason not defined above|0|||
25175827|NCT01533935|50318826|FG002|Overall Study|Other reason not defined above|1|||
25175828|NCT01533935|50318827|FG003|Overall Study|Other reason not defined above|0|||
25175829|NCT01533935|50318828|FG004|Overall Study|Other reason not defined above|1|||
25175830|NCT01532999|50318842|FG000|Overall Study|Lost to Follow-up|14|||
25175831|NCT01532999|50318843|FG001|Overall Study|Lost to Follow-up|8|||
25175832|NCT01532999|50318842|FG000|Overall Study|Physician Decision|1|||
25175833|NCT01532999|50318843|FG001|Overall Study|Physician Decision|2|||
25175834|NCT01532999|50318842|FG000|Overall Study|Withdrawal by Subject|5|||
25175835|NCT01532999|50318843|FG001|Overall Study|Withdrawal by Subject|0|||
25175836|NCT01532999|50318842|FG000|Overall Study|Relocated|2|||
25175837|NCT01532999|50318843|FG001|Overall Study|Relocated|0|||
25175838|NCT01532999|50318842|FG000|Overall Study|should not have been randomized|1|||
25175839|NCT01532999|50318843|FG001|Overall Study|should not have been randomized|0|||
25175840|NCT01532999|50318842|FG000|Overall Study|substantial noncompliance|2|||
25175841|NCT01532999|50318843|FG001|Overall Study|substantial noncompliance|0|||
25175842|NCT01532999|50318842|FG000|Overall Study|no show for week 9 assessments|6|||
25175843|NCT01532999|50318843|FG001|Overall Study|no show for week 9 assessments|4|||
25175844|NCT01532999|50318842|FG000|Overall Study|Adverse Event|0|||
25175845|NCT01532999|50318843|FG001|Overall Study|Adverse Event|1|||
25175846|NCT01532999|50318842|FG000|Overall Study|incarcerated|0|||
25175847|NCT01532999|50318843|FG001|Overall Study|incarcerated|1|||
25175848|NCT01532999|50318842|FG000|Overall Study|New job|0|||
25175849|NCT01532999|50318843|FG001|Overall Study|New job|2|||
25175850|NCT01532921|50318849|FG000|Overall Study|Death|3|||
25175851|NCT01532921|50318849|FG000|Overall Study|Withdrawal by Subject|2|||
25175852|NCT01532921|50318849|FG000|Overall Study|Lost to Follow-up|3|||
25175853|NCT01532921|50318849|FG000|Overall Study|Physician Decision|7|||
25175854|NCT01532921|50318849|FG000|Overall Study|Device was explanted during procedure|1|||
25175855|NCT01532687|50318859|FG000|Overall Study|Death|2|||
25175856|NCT01532687|50318860|FG001|Overall Study|Death|0|||
24996922|NCT02963506|50087996|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
25175857|NCT01532687|50318859|FG000|Overall Study|Adverse Event|6|||
25175858|NCT01532687|50318860|FG001|Overall Study|Adverse Event|1|||
25175859|NCT01532687|50318859|FG000|Overall Study|Withdrawal by Subject|1|||
25175860|NCT01532687|50318860|FG001|Overall Study|Withdrawal by Subject|0|||
25175861|NCT01532687|50318859|FG000|Overall Study|Physician Decision|2|||
25175862|NCT01532687|50318860|FG001|Overall Study|Physician Decision|1|||
25175863|NCT01532687|50318859|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
25175864|NCT01532687|50318860|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
25175865|NCT02677116|50318877|FG000|Overall Study|Adverse Event|0|||
25175866|NCT02677116|50318878|FG001|Overall Study|Adverse Event|1|||
25175867|NCT02677116|50318879|FG002|Overall Study|Adverse Event|0|||
25175868|NCT02677116|50318880|FG003|Overall Study|Adverse Event|0|||
25175869|NCT02677116|50318881|FG004|Overall Study|Adverse Event|0|||
25175870|NCT02677116|50318882|FG005|Overall Study|Adverse Event|1|||
25175871|NCT02677116|50318883|FG006|Overall Study|Adverse Event|1|||
25175872|NCT02677116|50318884|FG007|Overall Study|Adverse Event|0|||
25175873|NCT02677116|50318885|FG008|Overall Study|Adverse Event|0|||
25175874|NCT02677116|50318877|FG000|Overall Study|Physician Decision|0|||
25175875|NCT02677116|50318878|FG001|Overall Study|Physician Decision|2|||
25175876|NCT02677116|50318879|FG002|Overall Study|Physician Decision|3|||
25175877|NCT02677116|50318880|FG003|Overall Study|Physician Decision|2|||
25175878|NCT02677116|50318881|FG004|Overall Study|Physician Decision|1|||
25175879|NCT02677116|50318882|FG005|Overall Study|Physician Decision|3|||
25175880|NCT02677116|50318883|FG006|Overall Study|Physician Decision|1|||
25175881|NCT02677116|50318884|FG007|Overall Study|Physician Decision|1|||
25175882|NCT02677116|50318885|FG008|Overall Study|Physician Decision|2|||
25175883|NCT02677116|50318877|FG000|Overall Study|Withdrawal by parent or guardian|2|||
24996923|NCT02963506|50087997|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
25175884|NCT02677116|50318878|FG001|Overall Study|Withdrawal by parent or guardian|1|||
25175885|NCT02677116|50318879|FG002|Overall Study|Withdrawal by parent or guardian|0|||
25175886|NCT02677116|50318880|FG003|Overall Study|Withdrawal by parent or guardian|1|||
25175887|NCT02677116|50318881|FG004|Overall Study|Withdrawal by parent or guardian|0|||
25175888|NCT02677116|50318882|FG005|Overall Study|Withdrawal by parent or guardian|0|||
25175889|NCT02677116|50318883|FG006|Overall Study|Withdrawal by parent or guardian|2|||
25175890|NCT02677116|50318884|FG007|Overall Study|Withdrawal by parent or guardian|1|||
25175891|NCT02677116|50318885|FG008|Overall Study|Withdrawal by parent or guardian|0|||
25175892|NCT02677116|50318877|FG000|Overall Study|Withdrawal by Subject|1|||
25175893|NCT02677116|50318878|FG001|Overall Study|Withdrawal by Subject|0|||
25175894|NCT02677116|50318879|FG002|Overall Study|Withdrawal by Subject|0|||
25175895|NCT02677116|50318880|FG003|Overall Study|Withdrawal by Subject|0|||
25175896|NCT02677116|50318881|FG004|Overall Study|Withdrawal by Subject|0|||
25175897|NCT02677116|50318882|FG005|Overall Study|Withdrawal by Subject|0|||
25175898|NCT02677116|50318883|FG006|Overall Study|Withdrawal by Subject|0|||
25175899|NCT02677116|50318884|FG007|Overall Study|Withdrawal by Subject|0|||
25175900|NCT02677116|50318885|FG008|Overall Study|Withdrawal by Subject|0|||
25175901|NCT02689518|50318928|FG000|Overall Study|Withdrawal by Subject|3|||
25175902|NCT02681094|50318935|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
25175903|NCT02681094|50318936|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
25175904|NCT02681094|50318937|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
25175905|NCT02681094|50318935|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
25175906|NCT02681094|50318936|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
25175907|NCT02681094|50318937|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
25175908|NCT02681094|50318935|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
25175909|NCT02681094|50318936|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
25175910|NCT02681094|50318937|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
25175911|NCT02681094|50318935|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
25175912|NCT02681094|50318936|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
25175913|NCT02681094|50318937|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
25175914|NCT02681094|50318935|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
25175915|NCT02681094|50318936|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
25175916|NCT02681094|50318937|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
25175917|NCT02681094|50318935|FG000|1 -Modified Enrolled Participants Set|Other|6|||
25175918|NCT02681094|50318936|FG001|1 -Modified Enrolled Participants Set|Other|6|||
25175919|NCT02681094|50318937|FG002|1 -Modified Enrolled Participants Set|Other|7|||
25175920|NCT02681094|50318935|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
25175921|NCT02681094|50318936|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
25175922|NCT02681094|50318937|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
25175923|NCT02681094|50318935|FG000|2 - Enrolled Participants Set|Participant decision|7|||
25175924|NCT02681094|50318936|FG001|2 - Enrolled Participants Set|Participant decision|10|||
25175925|NCT02681094|50318937|FG002|2 - Enrolled Participants Set|Participant decision|9|||
25175926|NCT02681094|50318935|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
25175927|NCT02681094|50318936|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
25175928|NCT02681094|50318937|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
25175929|NCT02681094|50318935|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
25175930|NCT02681094|50318936|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
25175931|NCT02681094|50318937|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
25175932|NCT02681094|50318935|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
25175933|NCT02681094|50318936|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
25175934|NCT02681094|50318937|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
25175935|NCT02681094|50318935|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
25175936|NCT02681094|50318936|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
25175937|NCT02681094|50318937|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
25175938|NCT02681094|50318935|FG000|2 - Enrolled Participants Set|Other|6|||
25175939|NCT02681094|50318936|FG001|2 - Enrolled Participants Set|Other|6|||
25175940|NCT02681094|50318937|FG002|2 - Enrolled Participants Set|Other|7|||
25175941|NCT02681094|50318935|FG000|2 - Enrolled Participants Set|No treatment given|0|||
25175942|NCT02681094|50318936|FG001|2 - Enrolled Participants Set|No treatment given|1|||
25175943|NCT02681094|50318937|FG002|2 - Enrolled Participants Set|No treatment given|1|||
25175944|NCT02689284|50318948|FG000|Overall Study|Adverse Event|1|||
25175945|NCT02689284|50318949|FG001|Overall Study|Adverse Event|8|||
25175946|NCT02689284|50318948|FG000|Overall Study|Death|0|||
25175947|NCT02689284|50318949|FG001|Overall Study|Death|1|||
25175948|NCT02689284|50318948|FG000|Overall Study|Physician Decision|1|||
25175949|NCT02689284|50318949|FG001|Overall Study|Physician Decision|2|||
25175950|NCT02689284|50318948|FG000|Overall Study|Withdrawal by Subject|0|||
25175951|NCT02689284|50318949|FG001|Overall Study|Withdrawal by Subject|1|||
25175952|NCT02689284|50318948|FG000|Overall Study|progression of cancer|1|||
25175953|NCT02689284|50318949|FG001|Overall Study|progression of cancer|72|||
25175954|NCT02689284|50318948|FG000|Overall Study|decreased heart function|0|||
25175955|NCT02689284|50318949|FG001|Overall Study|decreased heart function|1|||
25175956|NCT02689284|50318948|FG000|Overall Study|concern for anemia|0|||
25175957|NCT02689284|50318949|FG001|Overall Study|concern for anemia|1|||
25175958|NCT02689284|50318948|FG000|Overall Study|no measurable cancer for evaluation|0|||
25175959|NCT02689284|50318949|FG001|Overall Study|no measurable cancer for evaluation|1|||
25175960|NCT02676882|50318958|FG000|Overall Study|Adverse Event|1|||
25175961|NCT02676882|50318959|FG001|Overall Study|Adverse Event|0|||
25175962|NCT02676882|50318958|FG000|Overall Study|Lost to Follow-up|1|||
25175963|NCT02676882|50318959|FG001|Overall Study|Lost to Follow-up|0|||
25175964|NCT02676882|50318958|FG000|Overall Study|Withdrawal by Subject|1|||
25175965|NCT02676882|50318959|FG001|Overall Study|Withdrawal by Subject|2|||
25175966|NCT02674386|50318968|FG000|Overall Study|Lost to Follow-up|0|||
25175967|NCT02674386|50318969|FG001|Overall Study|Lost to Follow-up|1|||
25175968|NCT02674386|50318970|FG002|Overall Study|Lost to Follow-up|1|||
25175969|NCT02674386|50318968|FG000|Overall Study|Withdrawal by Subject|0|||
25175970|NCT02674386|50318969|FG001|Overall Study|Withdrawal by Subject|4|||
25175971|NCT02674386|50318970|FG002|Overall Study|Withdrawal by Subject|0|||
24996924|NCT02963506|50087998|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
24996925|NCT02963506|50087999|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
24996926|NCT02963506|50088000|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
24996927|NCT02963506|50088001|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
24996928|NCT02963506|50088002|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
24996929|NCT02963506|50088003|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
24996930|NCT02963506|50088004|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
25175972|NCT02674386|50318968|FG000|Overall Study|Other|0|||
25175973|NCT02674386|50318969|FG001|Overall Study|Other|1|||
25175974|NCT02674386|50318970|FG002|Overall Study|Other|0|||
25175975|NCT02674386|50318968|FG000|Overall Study|Enrolled but not evaluated|0|||
25175976|NCT02674386|50318969|FG001|Overall Study|Enrolled but not evaluated|4|||
25175977|NCT02674386|50318970|FG002|Overall Study|Enrolled but not evaluated|0|||
25175978|NCT02680002|50318989|FG000|Overall Study|Lost to Follow-up|5|||
25175979|NCT02680002|50318990|FG001|Overall Study|Lost to Follow-up|1|||
25175980|NCT02680002|50318991|FG002|Overall Study|Lost to Follow-up|4|||
25175981|NCT02680002|50318992|FG003|Overall Study|Lost to Follow-up|2|||
25175982|NCT02680002|50318993|FG004|Overall Study|Lost to Follow-up|0|||
25175983|NCT02680002|50318994|FG005|Overall Study|Lost to Follow-up|2|||
25175984|NCT02680002|50318989|FG000|Overall Study|Physician Decision|5|||
25175985|NCT02680002|50318990|FG001|Overall Study|Physician Decision|1|||
25175986|NCT02680002|50318991|FG002|Overall Study|Physician Decision|1|||
25175987|NCT02680002|50318992|FG003|Overall Study|Physician Decision|1|||
25175988|NCT02680002|50318993|FG004|Overall Study|Physician Decision|1|||
25175989|NCT02680002|50318994|FG005|Overall Study|Physician Decision|1|||
25175990|NCT02680002|50318989|FG000|Overall Study|Protocol Violation|1|||
25175991|NCT02680002|50318990|FG001|Overall Study|Protocol Violation|0|||
25175992|NCT02680002|50318991|FG002|Overall Study|Protocol Violation|1|||
25175993|NCT02680002|50318992|FG003|Overall Study|Protocol Violation|0|||
25175994|NCT02680002|50318993|FG004|Overall Study|Protocol Violation|1|||
25175995|NCT02680002|50318994|FG005|Overall Study|Protocol Violation|2|||
25175996|NCT02680002|50318989|FG000|Overall Study|Withdrawal by Subject|0|||
25175997|NCT02680002|50318990|FG001|Overall Study|Withdrawal by Subject|0|||
25175998|NCT02680002|50318991|FG002|Overall Study|Withdrawal by Subject|1|||
25175999|NCT02680002|50318992|FG003|Overall Study|Withdrawal by Subject|0|||
25176000|NCT02680002|50318993|FG004|Overall Study|Withdrawal by Subject|2|||
25176001|NCT02680002|50318994|FG005|Overall Study|Withdrawal by Subject|2|||
25176002|NCT02680002|50318989|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
25176003|NCT02680002|50318990|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
25176004|NCT02680002|50318991|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
25176005|NCT02680002|50318992|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
25176006|NCT02680002|50318993|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
25176007|NCT02680002|50318994|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
25176008|NCT02680002|50318989|FG000|Overall Study|Other|0|||
25176009|NCT02680002|50318990|FG001|Overall Study|Other|1|||
25176010|NCT02680002|50318991|FG002|Overall Study|Other|0|||
25176011|NCT02680002|50318992|FG003|Overall Study|Other|0|||
25176012|NCT02680002|50318993|FG004|Overall Study|Other|1|||
25176013|NCT02680002|50318994|FG005|Overall Study|Other|0|||
25176014|NCT02680002|50318989|FG000|Overall Study|Adverse Event|0|||
25176015|NCT02680002|50318990|FG001|Overall Study|Adverse Event|0|||
25176016|NCT02680002|50318991|FG002|Overall Study|Adverse Event|0|||
25176017|NCT02680002|50318992|FG003|Overall Study|Adverse Event|0|||
25176018|NCT02680002|50318993|FG004|Overall Study|Adverse Event|1|||
25176019|NCT02680002|50318994|FG005|Overall Study|Adverse Event|2|||
25176020|NCT04557384|50319011|FG000|Overall Study|Study Terminated by Sponsor|1|||
25176021|NCT04557384|50319011|FG000|Overall Study|Death|1|||
25176022|NCT02673684|50319017|FG000|Overall Study|Study not completed d/t loss of funding|9|||
25176023|NCT02673684|50319018|FG001|Overall Study|Study not completed d/t loss of funding|8|||
25176024|NCT02675634|50319026|FG000|Test Period 1|Adverse Event|0|||
25176025|NCT02675634|50319027|FG001|Test Period 1|Adverse Event|1|||
25176026|NCT02675634|50319028|FG002|Test Period 1|Adverse Event|0|||
25176027|NCT02675634|50319029|FG003|Test Period 1|Adverse Event|1|||
25176028|NCT02675634|50319030|FG004|Test Period 1|Adverse Event|0|||
25176029|NCT02675634|50319031|FG005|Test Period 1|Adverse Event|0|||
25176030|NCT02675634|50319026|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
25176031|NCT02675634|50319027|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
25176032|NCT02675634|50319028|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
25176033|NCT02675634|50319029|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
25176034|NCT02675634|50319030|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
25176035|NCT02675634|50319031|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
25176036|NCT02675634|50319026|FG000|Test Period 2|Lack of Efficacy|1|||
25176037|NCT02675634|50319027|FG001|Test Period 2|Lack of Efficacy|0|||
25176038|NCT02675634|50319028|FG002|Test Period 2|Lack of Efficacy|0|||
25176039|NCT02675634|50319029|FG003|Test Period 2|Lack of Efficacy|0|||
25176040|NCT02675634|50319030|FG004|Test Period 2|Lack of Efficacy|0|||
25176041|NCT02675634|50319031|FG005|Test Period 2|Lack of Efficacy|0|||
25176042|NCT02675634|50319026|FG000|Test Period 2|Adverse Event|0|||
25176043|NCT02675634|50319027|FG001|Test Period 2|Adverse Event|0|||
25176044|NCT02675634|50319028|FG002|Test Period 2|Adverse Event|0|||
25176045|NCT02675634|50319029|FG003|Test Period 2|Adverse Event|0|||
25176046|NCT02675634|50319030|FG004|Test Period 2|Adverse Event|0|||
25176047|NCT02675634|50319031|FG005|Test Period 2|Adverse Event|1|||
25176048|NCT02671500|50319039|FG000|Overall Study|Lack of Efficacy|12|||
25091005|NCT02696317|50200416|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
25091006|NCT01959412|50200424|FG000|Overall Study|Protocol deviation|1|||
25091007|NCT01959412|50200425|FG001|Overall Study|Protocol deviation|1|||
25091008|NCT01959412|50200426|FG002|Overall Study|Protocol deviation|0|||
25091009|NCT01959412|50200427|FG003|Overall Study|Protocol deviation|1|||
25091010|NCT01959412|50200428|FG004|Overall Study|Protocol deviation|3|||
25091011|NCT01959412|50200429|FG005|Overall Study|Protocol deviation|0|||
25091012|NCT01959412|50200424|FG000|Overall Study|Adverse Event|0|||
25091013|NCT01959412|50200425|FG001|Overall Study|Adverse Event|0|||
25091014|NCT01959412|50200426|FG002|Overall Study|Adverse Event|0|||
25091015|NCT01959412|50200427|FG003|Overall Study|Adverse Event|1|||
25091016|NCT01959412|50200428|FG004|Overall Study|Adverse Event|0|||
25091017|NCT01959412|50200429|FG005|Overall Study|Adverse Event|0|||
25091018|NCT01977820|50200445|FG000|Overall Study|Sponsor terminated the study|1|||
25091019|NCT01977820|50200446|FG001|Overall Study|Sponsor terminated the study|1|||
25091020|NCT02003014|50200452|FG000|Overall Study|Case report forms uncollected|9|||
25091021|NCT02003014|50200452|FG000|Overall Study|Treatment started after contract period|1|||
25091022|NCT02003014|50200452|FG000|Overall Study|Patient did not visit the study site|5|||
25091023|NCT02003014|50200452|FG000|Overall Study|Investigator's transfer|4|||
25091024|NCT01977352|50200458|FG000|Overall Study|Lost to Follow-up|1|||
25091025|NCT01977352|50200459|FG001|Overall Study|Lost to Follow-up|2|||
25091026|NCT02001688|50200468|FG000|Overall Study|Withdrawal by Subject|0|||
25091027|NCT02001688|50200469|FG001|Overall Study|Withdrawal by Subject|0|||
25091028|NCT02001688|50200470|FG002|Overall Study|Withdrawal by Subject|1|||
25091029|NCT02001688|50200468|FG000|Overall Study|Adverse Event|0|||
25176049|NCT02671500|50319039|FG000|Overall Study|Lost to Follow-up|2|||
25176050|NCT02671422|50319047|FG000|Overall Study|Lost to Follow-up|1|||
25176051|NCT02671422|50319047|FG000|Overall Study|Adverse Event|68|||
25176052|NCT02671422|50319047|FG000|Overall Study|Lack of Efficacy|1|||
25176053|NCT02671422|50319047|FG000|Overall Study|Lost to Follow-up|4|||
25176054|NCT02671422|50319047|FG000|Overall Study|Withdrawal by Subject|7|||
25176055|NCT02671422|50319047|FG000|Overall Study|Progressive Disease|156|||
25176056|NCT02671422|50319047|FG000|Overall Study|Worsening of Disease|4|||
25176057|NCT02671422|50319047|FG000|Overall Study|Sponsor decision|5|||
25176058|NCT02671422|50319047|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
25176059|NCT02671422|50319047|FG000|Overall Study|Not treated with Vargatef®|3|||
25176060|NCT02671422|50319047|FG000|Overall Study|Other not defined above|3|||
25176061|NCT02671266|50319053|FG000|Overall Study|Withdrawal by Subject|1|||
25176062|NCT02671266|50319054|FG001|Overall Study|Withdrawal by Subject|1|||
25176063|NCT03320070|50319062|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
25176064|NCT03320070|50319063|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
25176065|NCT03320070|50319062|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
25091030|NCT02001688|50200469|FG001|Overall Study|Adverse Event|1|||
25091031|NCT02001688|50200470|FG002|Overall Study|Adverse Event|0|||
25176066|NCT03320070|50319063|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
25176067|NCT03320070|50319062|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
25176068|NCT03320070|50319063|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
25176069|NCT03320070|50319062|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
25176070|NCT03320070|50319063|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
25176071|NCT03320070|50319062|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
25176072|NCT03320070|50319063|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
25176073|NCT03320070|50319062|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
25176074|NCT03320070|50319063|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
25176075|NCT02667912|50319074|FG000|Overall Study|Death|3|||
25176076|NCT02667912|50319075|FG001|Overall Study|Death|1|||
25176077|NCT02667912|50319074|FG000|Overall Study|Withdrawal by Subject|1|||
25176078|NCT02667912|50319075|FG001|Overall Study|Withdrawal by Subject|2|||
25176079|NCT02667912|50319074|FG000|Overall Study|Withdrawal by Subject|1|||
25176080|NCT02667912|50319075|FG001|Overall Study|Withdrawal by Subject|0|||
25176081|NCT01373346|50319081|FG000|Overall Study|Death|1|||
25176082|NCT03284424|50319092|FG000|Overall Study|Death|56|||
25176083|NCT03284424|50319093|FG001|Overall Study|Death|13|||
25176084|NCT03284424|50319092|FG000|Overall Study|Lost to Follow-up|1|||
25176085|NCT03284424|50319093|FG001|Overall Study|Lost to Follow-up|0|||
25176086|NCT03284424|50319092|FG000|Overall Study|Physician Decision|1|||
25176087|NCT03284424|50319093|FG001|Overall Study|Physician Decision|0|||
25176088|NCT03284424|50319092|FG000|Overall Study|Withdrawal by Subject|3|||
25176089|NCT03284424|50319093|FG001|Overall Study|Withdrawal by Subject|2|||
25176090|NCT03284424|50319092|FG000|Overall Study|Ongoing in study|44|||
25176091|NCT03284424|50319093|FG001|Overall Study|Ongoing in study|39|||
25176092|NCT02674854|50319101|FG000|Overall Study|Adverse Event|17|||
25176093|NCT02674854|50319102|FG001|Overall Study|Adverse Event|15|||
25176094|NCT02674854|50319103|FG002|Overall Study|Adverse Event|5|||
25176095|NCT02674854|50319101|FG000|Overall Study|Withdrawal by Subject|1|||
25176096|NCT02674854|50319102|FG001|Overall Study|Withdrawal by Subject|5|||
25176097|NCT02674854|50319103|FG002|Overall Study|Withdrawal by Subject|4|||
25176098|NCT02674854|50319101|FG000|Overall Study|No-compliant subject|1|||
25176099|NCT02674854|50319102|FG001|Overall Study|No-compliant subject|0|||
25176100|NCT02674854|50319103|FG002|Overall Study|No-compliant subject|1|||
25176101|NCT02674854|50319101|FG000|Overall Study|Lost to Follow-up|1|||
25176102|NCT02674854|50319102|FG001|Overall Study|Lost to Follow-up|0|||
25176103|NCT02674854|50319103|FG002|Overall Study|Lost to Follow-up|2|||
25176104|NCT02674854|50319101|FG000|Overall Study|Lack of Efficacy|0|||
25176105|NCT02674854|50319102|FG001|Overall Study|Lack of Efficacy|3|||
25176106|NCT02674854|50319103|FG002|Overall Study|Lack of Efficacy|0|||
25176107|NCT02674854|50319101|FG000|Overall Study|Disallowed Concurrent Medication|2|||
25176108|NCT02674854|50319102|FG001|Overall Study|Disallowed Concurrent Medication|2|||
25176109|NCT02674854|50319103|FG002|Overall Study|Disallowed Concurrent Medication|0|||
25176110|NCT02674854|50319101|FG000|Overall Study|Protocol Violation|1|||
25176111|NCT02674854|50319102|FG001|Overall Study|Protocol Violation|1|||
25176112|NCT02674854|50319103|FG002|Overall Study|Protocol Violation|2|||
25176113|NCT02674854|50319101|FG000|Overall Study|Death|0|||
25176114|NCT02674854|50319102|FG001|Overall Study|Death|1|||
25176115|NCT02674854|50319103|FG002|Overall Study|Death|0|||
25176116|NCT02674854|50319101|FG000|Overall Study|Subject missed V6.2|1|||
25176117|NCT02674854|50319102|FG001|Overall Study|Subject missed V6.2|0|||
25176118|NCT02674854|50319103|FG002|Overall Study|Subject missed V6.2|0|||
25176119|NCT02667288|50319111|FG000|Overall Study|Protocol Violation|5|||
25176120|NCT02667288|50319111|FG000|Overall Study|Lost to Follow-up|3|||
25176121|NCT02667288|50319111|FG000|Overall Study|Withdrawal by Subject|5|||
25176122|NCT02670330|50319117|FG000|Overall Study|Protocol Deviation|1|||
25176123|NCT02670330|50319118|FG001|Overall Study|Protocol Deviation|0|||
25176124|NCT02670330|50319117|FG000|Overall Study|Study Terminated By Sponsor|36|||
25176125|NCT02670330|50319118|FG001|Overall Study|Study Terminated By Sponsor|43|||
25176126|NCT02670330|50319117|FG000|Overall Study|Adverse Event|1|||
25176127|NCT02670330|50319118|FG001|Overall Study|Adverse Event|3|||
25176128|NCT02670330|50319117|FG000|Overall Study|Withdrawal by Subject|34|||
25176129|NCT02670330|50319118|FG001|Overall Study|Withdrawal by Subject|29|||
25176130|NCT02670330|50319117|FG000|Overall Study|Lost to Follow-up|3|||
25176131|NCT02670330|50319118|FG001|Overall Study|Lost to Follow-up|2|||
25176132|NCT02669940|50319126|FG000|Overall Study|Failure to return|0|||
25176133|NCT02669940|50319127|FG001|Overall Study|Failure to return|3|||
25176134|NCT02669940|50319126|FG000|Overall Study|Insufficient follow-up data|1|||
25176135|NCT02669940|50319127|FG001|Overall Study|Insufficient follow-up data|0|||
25176136|NCT02669862|50319143|FG000|Overall Study|Lost to Follow-up|0|||
25176137|NCT02669862|50319144|FG001|Overall Study|Lost to Follow-up|2|||
25176138|NCT02669862|50319145|FG002|Overall Study|Lost to Follow-up|1|||
25176139|NCT02669862|50319143|FG000|Overall Study|Withdrawal by Subject|2|||
25176140|NCT02669862|50319144|FG001|Overall Study|Withdrawal by Subject|2|||
25176141|NCT02669862|50319145|FG002|Overall Study|Withdrawal by Subject|3|||
25176142|NCT02669862|50319143|FG000|Overall Study|moved|0|||
25176143|NCT02669862|50319144|FG001|Overall Study|moved|1|||
25176144|NCT02669862|50319145|FG002|Overall Study|moved|0|||
25176145|NCT02669862|50319143|FG000|Overall Study|Protocol Violation|0|||
25176146|NCT02669862|50319144|FG001|Overall Study|Protocol Violation|0|||
25176147|NCT02669862|50319145|FG002|Overall Study|Protocol Violation|1|||
25176148|NCT01531673|50319169|FG000|Overall Study|Non-Compliance|0|||
25176149|NCT01531673|50319170|FG001|Overall Study|Non-Compliance|0|||
25176150|NCT01531673|50319171|FG002|Overall Study|Non-Compliance|0|||
25176151|NCT01531673|50319172|FG003|Overall Study|Non-Compliance|0|||
25176152|NCT01531673|50319173|FG004|Overall Study|Non-Compliance|0|||
25176153|NCT01531673|50319174|FG005|Overall Study|Non-Compliance|1|||
25176154|NCT01531673|50319175|FG006|Overall Study|Non-Compliance|0|||
25176155|NCT01531673|50319176|FG007|Overall Study|Non-Compliance|0|||
25176156|NCT01531673|50319177|FG008|Overall Study|Non-Compliance|0|||
25176157|NCT01531673|50319178|FG009|Overall Study|Non-Compliance|0|||
25176158|NCT01531673|50319179|FG010|Overall Study|Non-Compliance|0|||
25176159|NCT01531673|50319180|FG011|Overall Study|Non-Compliance|0|||
25176160|NCT01531673|50319181|FG012|Overall Study|Non-Compliance|0|||
25176161|NCT01531673|50319169|FG000|Overall Study|Adverse Event|0|||
25176162|NCT01531673|50319170|FG001|Overall Study|Adverse Event|1|||
25176163|NCT01531673|50319171|FG002|Overall Study|Adverse Event|0|||
25176164|NCT01531673|50319172|FG003|Overall Study|Adverse Event|0|||
25176165|NCT01531673|50319173|FG004|Overall Study|Adverse Event|0|||
25176166|NCT01531673|50319174|FG005|Overall Study|Adverse Event|0|||
25176167|NCT01531673|50319175|FG006|Overall Study|Adverse Event|0|||
25176168|NCT01531673|50319176|FG007|Overall Study|Adverse Event|0|||
25176169|NCT01531673|50319177|FG008|Overall Study|Adverse Event|0|||
25176170|NCT01531673|50319178|FG009|Overall Study|Adverse Event|0|||
25176171|NCT01531673|50319179|FG010|Overall Study|Adverse Event|0|||
25176172|NCT01531673|50319180|FG011|Overall Study|Adverse Event|0|||
25176173|NCT01531673|50319181|FG012|Overall Study|Adverse Event|0|||
25176174|NCT01531673|50319169|FG000|Overall Study|Lost to Follow-up|0|||
25176175|NCT01531673|50319170|FG001|Overall Study|Lost to Follow-up|0|||
25176176|NCT01531673|50319171|FG002|Overall Study|Lost to Follow-up|0|||
25176177|NCT01531673|50319172|FG003|Overall Study|Lost to Follow-up|0|||
25176178|NCT01531673|50319173|FG004|Overall Study|Lost to Follow-up|1|||
25176179|NCT01531673|50319174|FG005|Overall Study|Lost to Follow-up|0|||
25176180|NCT01531673|50319175|FG006|Overall Study|Lost to Follow-up|0|||
25176181|NCT01531673|50319176|FG007|Overall Study|Lost to Follow-up|0|||
25176182|NCT01531673|50319177|FG008|Overall Study|Lost to Follow-up|0|||
25176183|NCT01531673|50319178|FG009|Overall Study|Lost to Follow-up|0|||
25176184|NCT01531673|50319179|FG010|Overall Study|Lost to Follow-up|0|||
25176185|NCT01531673|50319180|FG011|Overall Study|Lost to Follow-up|0|||
25176186|NCT01531673|50319181|FG012|Overall Study|Lost to Follow-up|0|||
25176187|NCT01531673|50319169|FG000|Overall Study|Other|0|||
25176188|NCT01531673|50319170|FG001|Overall Study|Other|0|||
25176189|NCT01531673|50319171|FG002|Overall Study|Other|0|||
25176190|NCT01531673|50319172|FG003|Overall Study|Other|1|||
24996931|NCT02963506|50088005|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
24996932|NCT02963506|50088006|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
24996933|NCT02963506|50088007|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
24996934|NCT01345162|50088026|FG000|Overall Study|Protocol Violation|2|||
24996935|NCT01345162|50088027|FG001|Overall Study|Protocol Violation|4|||
24996936|NCT01345318|50088033|FG000|Overall Study|Adverse Event|16|||
24996937|NCT01345318|50088033|FG000|Overall Study|Lack of Efficacy|17|||
24996938|NCT01345318|50088033|FG000|Overall Study|Lost to Follow-up|2|||
24996939|NCT01345318|50088033|FG000|Overall Study|Protocol Violation|1|||
24996940|NCT01345318|50088033|FG000|Overall Study|Withdrawal by Subject|41|||
24996941|NCT01345318|50088033|FG000|Overall Study|Other|3|||
24996942|NCT02961244|50088040|FG000|Overall Study|Protocol Violation|0|||
24996943|NCT02961244|50088041|FG001|Overall Study|Protocol Violation|1|||
24996944|NCT02961244|50088040|FG000|Overall Study|Withdrawal by Subject|1|||
24996945|NCT02961244|50088041|FG001|Overall Study|Withdrawal by Subject|2|||
24996946|NCT02961244|50088040|FG000|Overall Study|Surgery plan change after study approval|0|||
24996947|NCT02961244|50088041|FG001|Overall Study|Surgery plan change after study approval|2|||
24996948|NCT02961244|50088040|FG000|Overall Study|Lost to Follow-up|0|||
24996949|NCT02961244|50088041|FG001|Overall Study|Lost to Follow-up|2|||
24996950|NCT02961244|50088040|FG000|Overall Study|İnadequate data|0|||
24996951|NCT02961244|50088041|FG001|Overall Study|İnadequate data|2|||
24996952|NCT03771963|50088047|FG000|Overall Study|Lost to Follow-up|22|||
25176191|NCT01531673|50319173|FG004|Overall Study|Other|0|||
25176192|NCT01531673|50319174|FG005|Overall Study|Other|0|||
25176193|NCT01531673|50319175|FG006|Overall Study|Other|0|||
25176194|NCT01531673|50319176|FG007|Overall Study|Other|0|||
25176195|NCT01531673|50319177|FG008|Overall Study|Other|0|||
25176196|NCT01531673|50319178|FG009|Overall Study|Other|1|||
25176197|NCT01531673|50319179|FG010|Overall Study|Other|0|||
25176198|NCT01531673|50319180|FG011|Overall Study|Other|0|||
25176199|NCT01531673|50319181|FG012|Overall Study|Other|0|||
25176200|NCT01531205|50319233|FG000|Overall Study|Did not proceed to surgery|1|||
25176201|NCT01529645|50319249|FG000|Overall Study|Lost to Follow-up|0|||
25176202|NCT01529645|50319250|FG001|Overall Study|Lost to Follow-up|1|||
25176203|NCT01529645|50319251|FG002|Overall Study|Lost to Follow-up|1|||
25176204|NCT01529645|50319252|FG003|Overall Study|Lost to Follow-up|1|||
25176205|NCT01529645|50319253|FG004|Overall Study|Lost to Follow-up|1|||
24996953|NCT03771963|50088047|FG000|Overall Study|Withdrawal of Consent|10|||
24996954|NCT02962648|50088051|FG000|Overall Study|Withdrawal by Subject|3|||
24996955|NCT02962648|50088051|FG000|Overall Study|Lost to Follow-up|3|||
24996956|NCT02962648|50088051|FG000|Overall Study|Physician Decision|1|||
24996957|NCT02962648|50088051|FG000|Overall Study|Subject had problems with transportation|2|||
24996958|NCT02962882|50088055|FG000|Overall Study|Adverse Event|2|||
24996959|NCT02962882|50088055|FG000|Overall Study|Withdrawal by Subject|2|||
24996960|NCT02962882|50088055|FG000|Overall Study|Transfer from ICU|32|||
24996961|NCT02961790|50088064|FG000|Overall Study|Canceled|4|||
24996962|NCT02961790|50088065|FG001|Overall Study|Canceled|5|||
24996963|NCT02961790|50088066|FG002|Overall Study|Canceled|1|||
24996964|NCT02961790|50088067|FG003|Overall Study|Canceled|4|||
24996965|NCT02961790|50088064|FG000|Overall Study|without baseline data|4|||
24996966|NCT02961790|50088065|FG001|Overall Study|without baseline data|0|||
24996967|NCT02961790|50088066|FG002|Overall Study|without baseline data|1|||
24996968|NCT02961790|50088067|FG003|Overall Study|without baseline data|0|||
24996969|NCT02961790|50088064|FG000|Overall Study|without post baseline data|7|||
24996970|NCT02961790|50088065|FG001|Overall Study|without post baseline data|6|||
24996971|NCT02961790|50088066|FG002|Overall Study|without post baseline data|4|||
25176206|NCT01529645|50319254|FG005|Overall Study|Lost to Follow-up|0|||
25176207|NCT01529645|50319255|FG006|Overall Study|Lost to Follow-up|2|||
25176208|NCT01529645|50319256|FG007|Overall Study|Lost to Follow-up|0|||
25176209|NCT01529645|50319257|FG008|Overall Study|Lost to Follow-up|1|||
25176210|NCT01529645|50319258|FG009|Overall Study|Lost to Follow-up|0|||
25176211|NCT01529645|50319249|FG000|Overall Study|SAE - Premature contractions|0|||
25176212|NCT01529645|50319250|FG001|Overall Study|SAE - Premature contractions|0|||
24996972|NCT02961790|50088067|FG003|Overall Study|without post baseline data|1|||
24996973|NCT02960854|50088089|FG000|Overall Study|Not Disclosed|2|||
24996974|NCT02960854|50088090|FG001|Overall Study|Not Disclosed|2|||
24996975|NCT02960854|50088089|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
24996976|NCT02960854|50088090|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
24996977|NCT02960854|50088089|FG000|Overall Study|Subject Withdrew Consent|0|||
24996978|NCT02960854|50088090|FG001|Overall Study|Subject Withdrew Consent|1|||
24996979|NCT02960854|50088089|FG000|Overall Study|Death|4|||
24996980|NCT02960854|50088090|FG001|Overall Study|Death|6|||
24996981|NCT01344538|50088098|FG000|Overall Study|Adverse Event|1|||
24996982|NCT01344538|50088099|FG001|Overall Study|Adverse Event|1|||
24996983|NCT01344538|50088098|FG000|Overall Study|Lost to Follow-up|1|||
24996984|NCT01344538|50088099|FG001|Overall Study|Lost to Follow-up|0|||
24996985|NCT01344460|50088105|FG000|Overall Study|Withdrawal by Subject|1|||
24996986|NCT01344460|50088105|FG000|Overall Study|Lost to Follow-up|2|||
24996987|NCT03764631|50088115|FG000|Overall Study|Personal Reasons|3|||
24996988|NCT03764631|50088116|FG001|Overall Study|Personal Reasons|2|||
24996989|NCT03764631|50088115|FG000|Overall Study|Switching Therapy|3|||
24996990|NCT03764631|50088116|FG001|Overall Study|Switching Therapy|3|||
24996991|NCT03764631|50088115|FG000|Overall Study|Adverse Event|0|||
24996992|NCT03764631|50088116|FG001|Overall Study|Adverse Event|1|||
24996993|NCT03764631|50088115|FG000|Overall Study|Lost to Follow-up|33|||
24996994|NCT03764631|50088116|FG001|Overall Study|Lost to Follow-up|41|||
24996995|NCT03764631|50088115|FG000|Overall Study|No data as study site was closed|2|||
24996996|NCT03764631|50088116|FG001|Overall Study|No data as study site was closed|6|||
24996997|NCT02956486|50088135|FG000|Core Phase|Adverse Event|51|||
24996998|NCT02956486|50088136|FG001|Core Phase|Adverse Event|88|||
24996999|NCT02956486|50088137|FG002|Core Phase|Adverse Event|0|||
24997000|NCT02956486|50088135|FG000|Core Phase|Lost to Follow-up|8|||
24997001|NCT02956486|50088136|FG001|Core Phase|Lost to Follow-up|6|||
24997002|NCT02956486|50088137|FG002|Core Phase|Lost to Follow-up|0|||
24997003|NCT02956486|50088135|FG000|Core Phase|Inadequate therapeutic effect|4|||
24997004|NCT02956486|50088136|FG001|Core Phase|Inadequate therapeutic effect|5|||
24997005|NCT02956486|50088137|FG002|Core Phase|Inadequate therapeutic effect|0|||
24997006|NCT02956486|50088135|FG000|Core Phase|Withdrawal by Subject|101|||
24997007|NCT02956486|50088136|FG001|Core Phase|Withdrawal by Subject|104|||
24997008|NCT02956486|50088137|FG002|Core Phase|Withdrawal by Subject|0|||
24997009|NCT02956486|50088135|FG000|Core Phase|Study terminated by sponsor|888|||
24997010|NCT02956486|50088136|FG001|Core Phase|Study terminated by sponsor|848|||
24997011|NCT02956486|50088137|FG002|Core Phase|Study terminated by sponsor|0|||
24997012|NCT02956486|50088135|FG000|Core Phase|Other|27|||
24997013|NCT02956486|50088136|FG001|Core Phase|Other|18|||
24997014|NCT02956486|50088137|FG002|Core Phase|Other|0|||
24997015|NCT02956486|50088135|FG000|Core Phase|Not treated|0|||
24997016|NCT02956486|50088136|FG001|Core Phase|Not treated|3|||
24997017|NCT02956486|50088137|FG002|Core Phase|Not treated|0|||
24997018|NCT02956486|50088135|FG000|Extension Phase|Adverse Event|0|||
24997019|NCT02956486|50088136|FG001|Extension Phase|Adverse Event|0|||
24997020|NCT02956486|50088137|FG002|Extension Phase|Adverse Event|2|||
24997021|NCT02956486|50088135|FG000|Extension Phase|Study terminated by sponsor|0|||
24997022|NCT02956486|50088136|FG001|Extension Phase|Study terminated by sponsor|0|||
24997023|NCT02956486|50088137|FG002|Extension Phase|Study terminated by sponsor|16|||
24997024|NCT02956486|50088135|FG000|Extension Phase|Not Treated|0|||
24997025|NCT02956486|50088136|FG001|Extension Phase|Not Treated|0|||
24997026|NCT02956486|50088137|FG002|Extension Phase|Not Treated|1|||
24997027|NCT03445533|50088152|FG000|Overall Study|Progressive Disease|48|||
24997028|NCT03445533|50088153|FG001|Overall Study|Progressive Disease|81|||
24997029|NCT03445533|50088152|FG000|Overall Study|Adverse Event|60|||
24997030|NCT03445533|50088153|FG001|Overall Study|Adverse Event|64|||
24997031|NCT03445533|50088152|FG000|Overall Study|Death|9|||
24997032|NCT03445533|50088153|FG001|Overall Study|Death|19|||
24997033|NCT03445533|50088152|FG000|Overall Study|Miscellaneous|0|||
24997034|NCT03445533|50088153|FG001|Overall Study|Miscellaneous|16|||
24997035|NCT03445533|50088152|FG000|Overall Study|Withdrawal by Subject|3|||
24997036|NCT03445533|50088153|FG001|Overall Study|Withdrawal by Subject|4|||
24997037|NCT03445533|50088152|FG000|Overall Study|Physician Decision|1|||
24997038|NCT03445533|50088153|FG001|Overall Study|Physician Decision|3|||
24997039|NCT03445533|50088152|FG000|Overall Study|Sponsor Decision|0|||
24997040|NCT03445533|50088153|FG001|Overall Study|Sponsor Decision|1|||
24997041|NCT03445533|50088152|FG000|Overall Study|Lost to Follow-up|0|||
24997042|NCT03445533|50088153|FG001|Overall Study|Lost to Follow-up|1|||
24997043|NCT03445533|50088152|FG000|Overall Study|Never Received any Study Treatment|7|||
24997044|NCT03445533|50088153|FG001|Overall Study|Never Received any Study Treatment|4|||
24997045|NCT01337050|50088162|FG000|Overall Study|Death|0|||
24997046|NCT01337050|50088163|FG001|Overall Study|Death|0|||
24997047|NCT01337050|50088164|FG002|Overall Study|Death|4|||
24997048|NCT01337050|50088162|FG000|Overall Study|Other|4|||
24997049|NCT01337050|50088163|FG001|Overall Study|Other|6|||
24997050|NCT01337050|50088164|FG002|Overall Study|Other|8|||
24997051|NCT01337050|50088162|FG000|Overall Study|Participants refused further follow-up|0|||
24997052|NCT01337050|50088163|FG001|Overall Study|Participants refused further follow-up|7|||
24997053|NCT01337050|50088164|FG002|Overall Study|Participants refused further follow-up|7|||
24997054|NCT01336972|50088176|FG000|Overall Study|Adverse Event|1|||
24997055|NCT01336972|50088177|FG001|Overall Study|Adverse Event|1|||
25176213|NCT01529645|50319251|FG002|Overall Study|SAE - Premature contractions|1|||
24997056|NCT01336972|50088178|FG002|Overall Study|Adverse Event|0|||
24997057|NCT03762681|50088195|FG000|Part 1|Withdrawal by Subject|0|||
24997058|NCT03762681|50088196|FG001|Part 1|Withdrawal by Subject|0|||
24997059|NCT03762681|50088197|FG002|Part 1|Withdrawal by Subject|0|||
24997060|NCT03762681|50088198|FG003|Part 1|Withdrawal by Subject|1|||
24997061|NCT03762681|50088199|FG004|Part 1|Withdrawal by Subject|0|||
24997062|NCT03762681|50088200|FG005|Part 1|Withdrawal by Subject|0|||
24997063|NCT03762681|50088201|FG006|Part 1|Withdrawal by Subject|0|||
25176214|NCT01529645|50319252|FG003|Overall Study|SAE - Premature contractions|0|||
25176215|NCT01529645|50319253|FG004|Overall Study|SAE - Premature contractions|0|||
25176216|NCT01529645|50319254|FG005|Overall Study|SAE - Premature contractions|0|||
25176217|NCT01529645|50319255|FG006|Overall Study|SAE - Premature contractions|0|||
25176218|NCT01529645|50319256|FG007|Overall Study|SAE - Premature contractions|0|||
25176219|NCT01529645|50319257|FG008|Overall Study|SAE - Premature contractions|0|||
24997064|NCT03762681|50088202|FG007|Part 1|Withdrawal by Subject|0|||
24997065|NCT03762681|50088195|FG000|Part 2a|Pandemic Travel Restrictions|0|||
24997066|NCT03762681|50088196|FG001|Part 2a|Pandemic Travel Restrictions|0|||
24997067|NCT03762681|50088197|FG002|Part 2a|Pandemic Travel Restrictions|0|||
24997068|NCT03762681|50088198|FG003|Part 2a|Pandemic Travel Restrictions|0|||
24997069|NCT03762681|50088199|FG004|Part 2a|Pandemic Travel Restrictions|0|||
24997070|NCT03762681|50088200|FG005|Part 2a|Pandemic Travel Restrictions|0|||
24997071|NCT03762681|50088201|FG006|Part 2a|Pandemic Travel Restrictions|0|||
24997072|NCT03762681|50088202|FG007|Part 2a|Pandemic Travel Restrictions|1|||
24997073|NCT03764475|50088231|FG000|Overall Study|Adverse Event|11|||
24997074|NCT03764475|50088232|FG001|Overall Study|Adverse Event|2|||
24997075|NCT03764475|50088231|FG000|Overall Study|Lost to Follow-up|24|||
24997076|NCT03764475|50088232|FG001|Overall Study|Lost to Follow-up|10|||
24997077|NCT03764475|50088231|FG000|Overall Study|Withdrawal by Subject|26|||
24997078|NCT03764475|50088232|FG001|Overall Study|Withdrawal by Subject|10|||
24997079|NCT03764475|50088231|FG000|Overall Study|Lack of Efficacy|3|||
24997080|NCT03764475|50088232|FG001|Overall Study|Lack of Efficacy|0|||
24997081|NCT03764475|50088231|FG000|Overall Study|COVID-19 Disruption|2|||
24997082|NCT03764475|50088232|FG001|Overall Study|COVID-19 Disruption|0|||
24997083|NCT02873338|50088245|FG000|Overall Study|Adverse Event|0|||
24997084|NCT02873338|50088246|FG001|Overall Study|Adverse Event|2|||
24997085|NCT02873338|50088247|FG002|Overall Study|Adverse Event|1|||
24997086|NCT02873338|50088245|FG000|Overall Study|Death|2|||
24997087|NCT02873338|50088246|FG001|Overall Study|Death|1|||
24997088|NCT02873338|50088247|FG002|Overall Study|Death|1|||
24997089|NCT02873338|50088245|FG000|Overall Study|Withdrawal by Subject|2|||
24997090|NCT02873338|50088246|FG001|Overall Study|Withdrawal by Subject|1|||
24997091|NCT02873338|50088247|FG002|Overall Study|Withdrawal by Subject|3|||
24997092|NCT02873338|50088245|FG000|Overall Study|Lack of Efficacy|0|||
24997093|NCT02873338|50088246|FG001|Overall Study|Lack of Efficacy|2|||
24997094|NCT02873338|50088247|FG002|Overall Study|Lack of Efficacy|0|||
24997095|NCT02873338|50088245|FG000|Overall Study|Other or Missing|14|||
24997096|NCT02873338|50088246|FG001|Overall Study|Other or Missing|15|||
24997097|NCT02873338|50088247|FG002|Overall Study|Other or Missing|13|||
24997098|NCT02872012|50088260|FG000|Overall Study|Withdrawal by Subject|1|||
24997099|NCT02872012|50088261|FG001|Overall Study|Withdrawal by Subject|0|||
24997100|NCT02872012|50088262|FG002|Overall Study|Withdrawal by Subject|0|||
24997101|NCT02872012|50088263|FG003|Overall Study|Withdrawal by Subject|0|||
24997102|NCT02872012|50088264|FG004|Overall Study|Withdrawal by Subject|0|||
24997103|NCT02959138|50088281|FG000|Overall Study|Enrolled but Never Treated|0|||
24997104|NCT02959138|50088282|FG001|Overall Study|Enrolled but Never Treated|1|||
24997105|NCT02959138|50088283|FG002|Overall Study|Enrolled but Never Treated|0|||
25176220|NCT01529645|50319258|FG009|Overall Study|SAE - Premature contractions|0|||
25176221|NCT01529645|50319249|FG000|Overall Study|Withdrawal by Subject|2|||
24997106|NCT01344226|50088295|FG000|Overall Study|Protocol Violation|2|||
24997107|NCT01344226|50088295|FG000|Overall Study|Withdrawal by Subject|3|||
24997108|NCT01344226|50088295|FG000|Overall Study|Lack of Efficacy|3|||
24997109|NCT02869438|50088301|FG000|Overall Study|Lost to Follow-up|1|||
24997110|NCT02869438|50088302|FG001|Overall Study|Lost to Follow-up|0|||
24997111|NCT02869438|50088301|FG000|Overall Study|Adverse Event|1|||
24997112|NCT02869438|50088302|FG001|Overall Study|Adverse Event|0|||
24997113|NCT02869438|50088301|FG000|Overall Study|Withdrawal by Subject|1|||
24997114|NCT02869438|50088302|FG001|Overall Study|Withdrawal by Subject|2|||
24997115|NCT02868892|50088308|FG000|Overall Study|Investigator left site and no follow-up|6|||
24997116|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|Death|1|||
24997117|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|Death|1|||
25176222|NCT01529645|50319250|FG001|Overall Study|Withdrawal by Subject|0|||
24997118|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|Death|0|||
24997119|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|Death|0|||
24997120|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|Death|1|||
24997121|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|Death|0|||
24997122|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|Death|0|||
24997123|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|Death|0|||
24997124|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|Death|0|||
24997125|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|Death|0|||
24997126|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
24997127|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
24997128|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
24997129|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
24997130|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
24997131|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
24997132|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
24997133|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
24997134|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
24997135|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
24997136|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
24997137|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
24997138|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
24997139|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
24997140|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
24997141|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
24997142|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
24997143|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
24997144|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
24997145|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
24997146|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
24997147|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
24997148|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
24997149|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
24997150|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
24997151|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
24997152|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
24997153|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
24997154|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
24997155|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
24997156|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
24997157|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
24997158|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
24997159|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
24997160|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
24997161|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
24997162|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
24997163|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
24997164|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
24997165|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
24997166|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
24997167|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
24997168|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
24997169|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
24997170|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
24997171|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
24997172|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
24997173|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
24997174|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
24997175|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
24997176|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
24997177|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
24997178|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
24997179|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
24997180|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
24997181|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
24997182|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
24997183|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
24997184|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
24997185|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
24997186|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
24997187|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
24997188|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
24997189|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
24997190|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
24997191|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
24997192|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
24997193|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
24997194|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
24997195|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
24997196|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
24997197|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
24997198|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
24997199|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
24997200|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
24997201|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
24997202|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
24997203|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
24997204|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
24997205|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
24997206|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
24997207|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
24997208|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
25176223|NCT01529645|50319251|FG002|Overall Study|Withdrawal by Subject|0|||
25176224|NCT01529645|50319252|FG003|Overall Study|Withdrawal by Subject|1|||
25176225|NCT01529645|50319253|FG004|Overall Study|Withdrawal by Subject|1|||
25176226|NCT01529645|50319254|FG005|Overall Study|Withdrawal by Subject|1|||
25176227|NCT01529645|50319255|FG006|Overall Study|Withdrawal by Subject|0|||
24997209|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
25091032|NCT02001064|50200481|FG000|Overall Study|Withdrawal by Subject|2|||
25091033|NCT02001064|50200482|FG001|Overall Study|Withdrawal by Subject|1|||
25091034|NCT02000752|50200490|FG000|Overall Study|Dystocic delivery|19|||
25091035|NCT02000752|50200491|FG001|Overall Study|Dystocic delivery|8|||
25091036|NCT02000752|50200490|FG000|Overall Study|Shift Changes|12|||
25091037|NCT02000752|50200491|FG001|Overall Study|Shift Changes|5|||
25091038|NCT02000440|50200497|FG000|Overall Study|Adverse Event|3|||
25091039|NCT02000440|50200497|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
25176228|NCT01529645|50319256|FG007|Overall Study|Withdrawal by Subject|0|||
25176229|NCT01529645|50319257|FG008|Overall Study|Withdrawal by Subject|0|||
25176230|NCT01529645|50319258|FG009|Overall Study|Withdrawal by Subject|0|||
25176231|NCT01528787|50319292|FG000|Overall Study|Withdrawal by Subject|0|||
25176232|NCT01528787|50319293|FG001|Overall Study|Withdrawal by Subject|0|||
25176233|NCT01528787|50319294|FG002|Overall Study|Withdrawal by Subject|0|||
25176234|NCT01528787|50319295|FG003|Overall Study|Withdrawal by Subject|1|||
25176235|NCT01528787|50319292|FG000|Overall Study|Family Emergency|0|||
25176236|NCT01528787|50319293|FG001|Overall Study|Family Emergency|0|||
25176237|NCT01528787|50319294|FG002|Overall Study|Family Emergency|1|||
25176238|NCT01528787|50319295|FG003|Overall Study|Family Emergency|0|||
25176239|NCT01528709|50319307|FG000|Overall Study|Death|2|||
25176240|NCT01528709|50319308|FG001|Overall Study|Death|0|||
25176241|NCT01528709|50319307|FG000|Overall Study|Withdrawal by Subject|10|||
25176242|NCT01528709|50319308|FG001|Overall Study|Withdrawal by Subject|15|||
25176243|NCT01528709|50319307|FG000|Overall Study|allergy|1|||
25176244|NCT01528709|50319308|FG001|Overall Study|allergy|0|||
24997210|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
24997211|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
24997212|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
25091040|NCT02687815|50200503|FG000|Overall Study|Lost to Follow-up|2|||
25091041|NCT02687815|50200504|FG001|Overall Study|Lost to Follow-up|4|||
25176245|NCT01527383|50319316|FG000|Overall Study|Adverse Event|5|||
25176246|NCT01527383|50319317|FG001|Overall Study|Adverse Event|0|||
25176247|NCT01527383|50319316|FG000|Overall Study|Lost to Follow-up|3|||
25176248|NCT01527383|50319317|FG001|Overall Study|Lost to Follow-up|0|||
25176249|NCT01527383|50319316|FG000|Overall Study|Physician Decision|2|||
25176250|NCT01527383|50319317|FG001|Overall Study|Physician Decision|0|||
25176251|NCT01527383|50319316|FG000|Overall Study|Pregnancy|1|||
24997213|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
24997214|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
24997215|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
24997216|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
24997217|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
24997218|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
24997219|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
24997220|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
24997221|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
24997222|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
24997223|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
24997224|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
24997225|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
24997226|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
24997227|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
24997228|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
24997229|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
24997230|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
24997231|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
24997232|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
24997233|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
24997234|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
24997235|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
24997236|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
24997237|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
24997238|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
24997239|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
24997240|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
24997241|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
24997242|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
24997243|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
24997244|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
24997245|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
24997246|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
24997247|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
24997248|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
24997249|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
24997250|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
24997251|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
24997252|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
24997253|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
24997254|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
24997255|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
24997256|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
24997257|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
24997258|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
24997259|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
24997260|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
24997261|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
24997262|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
24997263|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
24997264|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
24997265|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
25067256|NCT02745119|50172821|FG002|Overall Study|Reason Not Specified|0|||
25176252|NCT01527383|50319317|FG001|Overall Study|Pregnancy|0|||
25176253|NCT01527383|50319316|FG000|Overall Study|Protocol Violation|1|||
25176254|NCT01527383|50319317|FG001|Overall Study|Protocol Violation|0|||
25176255|NCT01527383|50319316|FG000|Overall Study|Screen failure|1|||
25176256|NCT01527383|50319317|FG001|Overall Study|Screen failure|0|||
25176257|NCT01527383|50319316|FG000|Overall Study|Participant moved|0|||
25176258|NCT01527383|50319317|FG001|Overall Study|Participant moved|1|||
25176259|NCT01527383|50319316|FG000|Overall Study|Withdrawal by Subject|2|||
25176260|NCT01527383|50319317|FG001|Overall Study|Withdrawal by Subject|3|||
25176261|NCT01526057|50319326|FG000|Overall Study|Withdrawal by Subject|3|||
25176262|NCT01526057|50319327|FG001|Overall Study|Withdrawal by Subject|2|||
25176263|NCT01526057|50319328|FG002|Overall Study|Withdrawal by Subject|2|||
25176264|NCT01526057|50319326|FG000|Overall Study|Adverse Event|3|||
25176265|NCT01526057|50319327|FG001|Overall Study|Adverse Event|1|||
25176266|NCT01526057|50319328|FG002|Overall Study|Adverse Event|1|||
25176267|NCT01526057|50319326|FG000|Overall Study|Death|1|||
25176268|NCT01526057|50319327|FG001|Overall Study|Death|0|||
25176269|NCT01526057|50319328|FG002|Overall Study|Death|0|||
25176270|NCT01526057|50319326|FG000|Overall Study|Lost to Follow-up|1|||
25176271|NCT01526057|50319327|FG001|Overall Study|Lost to Follow-up|0|||
25176272|NCT01526057|50319328|FG002|Overall Study|Lost to Follow-up|1|||
25176273|NCT01526057|50319326|FG000|Overall Study|Other|1|||
25176274|NCT01526057|50319327|FG001|Overall Study|Other|0|||
25091042|NCT02687815|50200503|FG000|Overall Study|Withdrawal by Subject|2|||
24997266|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
24997267|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
24997268|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
24997269|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
24997270|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
24997271|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
24997272|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
24997273|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
24997274|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
24997275|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
24997276|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
24997277|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
24997278|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
24997279|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
24997280|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
24997281|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
24997282|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
24997283|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
24997284|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
24997285|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
24997286|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
25091043|NCT02687815|50200504|FG001|Overall Study|Withdrawal by Subject|4|||
25091044|NCT01959334|50200512|FG000|Second Dose|Adverse Event|1|||
25091045|NCT01959334|50200513|FG001|Second Dose|Adverse Event|0|||
25091046|NCT01959334|50200512|FG000|Third Dose|Adverse Event|0|||
25091047|NCT01959334|50200513|FG001|Third Dose|Adverse Event|1|||
25091048|NCT02687581|50200523|FG000|Overall Study|Withdrawal by Subject|1|||
25091049|NCT02687581|50200524|FG001|Overall Study|Withdrawal by Subject|0|||
25091050|NCT02687581|50200525|FG002|Overall Study|Withdrawal by Subject|0|||
25091051|NCT02687581|50200526|FG003|Overall Study|Withdrawal by Subject|1|||
25091052|NCT02687581|50200523|FG000|Overall Study|Lost to Follow-up|2|||
25091053|NCT02687581|50200524|FG001|Overall Study|Lost to Follow-up|2|||
25091054|NCT02687581|50200525|FG002|Overall Study|Lost to Follow-up|0|||
25176275|NCT01526057|50319328|FG002|Overall Study|Other|1|||
25176276|NCT01526057|50319326|FG000|Overall Study|Protocol Violation|0|||
25176277|NCT01526057|50319327|FG001|Overall Study|Protocol Violation|0|||
25176278|NCT01526057|50319328|FG002|Overall Study|Protocol Violation|1|||
25176279|NCT01525901|50319340|FG000|Period 2: 12 Weeks|Adverse Event|0|||
25091055|NCT02687581|50200526|FG003|Overall Study|Lost to Follow-up|0|||
25091056|NCT02687581|50200523|FG000|Overall Study|the device is too small for the patient.|1|||
25091057|NCT02687581|50200524|FG001|Overall Study|the device is too small for the patient.|0|||
25176280|NCT01525901|50319341|FG001|Period 2: 12 Weeks|Adverse Event|1|||
25176281|NCT01525901|50319342|FG002|Period 2: 12 Weeks|Adverse Event|0|||
25176282|NCT01525901|50319343|FG003|Period 2: 12 Weeks|Adverse Event|0|||
25176283|NCT01525589|50319456|FG000|Overall Study|Non-treatment-related AE|1|||
25176284|NCT01525589|50319457|FG001|Overall Study|Non-treatment-related AE|0|||
25176285|NCT01525589|50319458|FG002|Overall Study|Non-treatment-related AE|0|||
25176286|NCT01525589|50319456|FG000|Overall Study|Progressive disease|48|||
25176287|NCT01525589|50319457|FG001|Overall Study|Progressive disease|15|||
25176288|NCT01525589|50319458|FG002|Overall Study|Progressive disease|29|||
25176289|NCT01525589|50319456|FG000|Overall Study|Never treated|2|||
25176290|NCT01525589|50319457|FG001|Overall Study|Never treated|0|||
25176291|NCT01525589|50319458|FG002|Overall Study|Never treated|0|||
25176292|NCT01525589|50319456|FG000|Overall Study|Physician Decision|4|||
25176293|NCT01525589|50319457|FG001|Overall Study|Physician Decision|2|||
25176294|NCT01525589|50319458|FG002|Overall Study|Physician Decision|2|||
25176295|NCT01525589|50319456|FG000|Overall Study|Death|0|||
25176296|NCT01525589|50319457|FG001|Overall Study|Death|0|||
25176297|NCT01525589|50319458|FG002|Overall Study|Death|2|||
25176298|NCT01525589|50319456|FG000|Overall Study|Treatment-related AE|1|||
25176299|NCT01525589|50319457|FG001|Overall Study|Treatment-related AE|1|||
25176300|NCT01525589|50319458|FG002|Overall Study|Treatment-related AE|2|||
25176301|NCT01525589|50319456|FG000|Overall Study|Other reasons|0|||
24997287|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
24997288|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
24997289|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
24997290|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
24997291|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
24997292|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
24997293|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
24997294|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
24997295|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
24997296|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
24997297|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
24997298|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
24997299|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
24997300|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
24997301|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
24997302|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
24997303|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
24997304|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
24997305|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
24997306|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|Other|5|||
24997307|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|Other|1|||
24997308|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|Other|0|||
24997309|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|Other|3|||
24997310|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|Other|0|||
24997311|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|Other|0|||
24997312|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|Other|0|||
24997313|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|Other|0|||
24997314|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|Other|0|||
24997315|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|Other|0|||
24997316|NCT03352557|50088317|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
24997317|NCT03352557|50088318|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
24997318|NCT03352557|50088319|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
24997319|NCT03352557|50088320|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
24997320|NCT03352557|50088321|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
25091058|NCT02687581|50200525|FG002|Overall Study|the device is too small for the patient.|0|||
25091059|NCT02687581|50200526|FG003|Overall Study|the device is too small for the patient.|0|||
25091060|NCT01977040|50200536|FG000|Overall Study|Vasa previa not confirmed|2|||
25091061|NCT01958476|50200546|FG000|Overall Study|Parent requested exclusion from analysis|1|||
25091062|NCT01958476|50200547|FG001|Overall Study|Parent requested exclusion from analysis|0|||
25091063|NCT02695537|50200583|FG000|Overall Study|Adverse Event|3|||
25091064|NCT02695537|50200583|FG000|Overall Study|Lack of Efficacy|28|||
25091065|NCT02695537|50200583|FG000|Overall Study|Withdrawal by Subject|4|||
25091066|NCT02695537|50200583|FG000|Overall Study|Protocol Violation|3|||
25091067|NCT01353313|50200589|FG000|Overall Study|Lost to Follow-up|22|||
25091068|NCT01353313|50200590|FG001|Overall Study|Lost to Follow-up|23|||
25091069|NCT01353313|50200589|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
25091070|NCT01353313|50200590|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
25091071|NCT02691247|50200599|FG000|Overall Study|Withdrawal by Subject|1|||
25091072|NCT02691247|50200600|FG001|Overall Study|Withdrawal by Subject|2|||
25091073|NCT02691247|50200601|FG002|Overall Study|Withdrawal by Subject|2|||
24997321|NCT03352557|50088322|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
24997322|NCT03352557|50088323|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
24997323|NCT03352557|50088324|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
25176302|NCT01525589|50319457|FG001|Overall Study|Other reasons|1|||
25176303|NCT01525589|50319458|FG002|Overall Study|Other reasons|0|||
25176304|NCT01525589|50319456|FG000|Overall Study|Withdrawal by Subject|0|||
25176305|NCT01525589|50319457|FG001|Overall Study|Withdrawal by Subject|1|||
24997324|NCT03352557|50088325|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
24997325|NCT03352557|50088326|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
24997326|NCT03352557|50088317|FG000|LTE Period: Week 80 to Week 173|Death|0|||
24997327|NCT03352557|50088318|FG001|LTE Period: Week 80 to Week 173|Death|0|||
24997328|NCT03352557|50088319|FG002|LTE Period: Week 80 to Week 173|Death|0|||
24997329|NCT03352557|50088320|FG003|LTE Period: Week 80 to Week 173|Death|0|||
24997330|NCT03352557|50088321|FG004|LTE Period: Week 80 to Week 173|Death|0|||
24997331|NCT03352557|50088322|FG005|LTE Period: Week 80 to Week 173|Death|1|||
24997332|NCT03352557|50088323|FG006|LTE Period: Week 80 to Week 173|Death|0|||
24997333|NCT03352557|50088324|FG007|LTE Period: Week 80 to Week 173|Death|1|||
25091074|NCT02691247|50200599|FG000|Overall Study|Lost to Follow-up|2|||
25091075|NCT02691247|50200600|FG001|Overall Study|Lost to Follow-up|0|||
25091076|NCT02691247|50200601|FG002|Overall Study|Lost to Follow-up|1|||
25091077|NCT01362491|50200612|FG000|Overall Study|Ineligible|1|||
25091078|NCT01362491|50200613|FG001|Overall Study|Ineligible|0|||
25091079|NCT01362491|50200614|FG002|Overall Study|Ineligible|0|||
25091080|NCT02687191|50200629|FG000|Overall Study|Death|0|||
25091081|NCT02687191|50200630|FG001|Overall Study|Death|1|||
25091082|NCT02687191|50200631|FG002|Overall Study|Death|1|||
25091083|NCT02687191|50200632|FG003|Overall Study|Death|0|||
25091084|NCT02687191|50200633|FG004|Overall Study|Death|1|||
25091085|NCT02687191|50200634|FG005|Overall Study|Death|1|||
25091086|NCT02687191|50200629|FG000|Overall Study|Withdrawal by Subject|0|||
25091087|NCT02687191|50200630|FG001|Overall Study|Withdrawal by Subject|0|||
25091088|NCT02687191|50200631|FG002|Overall Study|Withdrawal by Subject|0|||
25091089|NCT02687191|50200632|FG003|Overall Study|Withdrawal by Subject|1|||
25091090|NCT02687191|50200633|FG004|Overall Study|Withdrawal by Subject|0|||
25091091|NCT02687191|50200634|FG005|Overall Study|Withdrawal by Subject|0|||
25091092|NCT02687035|50200648|FG000|Overall Study|Withdrawal by Subject|1|||
25091093|NCT02687035|50200648|FG000|Overall Study|Death|87|||
25091094|NCT02687035|50200648|FG000|Overall Study|Lost to Follow-up|1|||
25091095|NCT02687035|50200648|FG000|Overall Study|Missed Visit|87|||
25091096|NCT02687035|50200648|FG000|Overall Study|Did not receive Study Device|8|||
25091097|NCT02691013|50200654|FG000|Overall Study|Withdrawal by Subject|3|||
25091098|NCT02691013|50200655|FG001|Overall Study|Withdrawal by Subject|0|||
25091099|NCT02690701|50200665|FG000|Treatment Period 1|Adverse Event|2|||
25091100|NCT02690701|50200666|FG001|Treatment Period 1|Adverse Event|2|||
25091101|NCT02690701|50200665|FG000|Treatment Period 1|Withdrawal by Subject|0|||
25091102|NCT02690701|50200666|FG001|Treatment Period 1|Withdrawal by Subject|1|||
25091103|NCT02690701|50200665|FG000|Treatment Period 2|Adverse Event|2|||
25091104|NCT02690701|50200666|FG001|Treatment Period 2|Adverse Event|0|||
25091105|NCT02690701|50200665|FG000|Treatment Period 2|Lack of Efficacy|1|||
25091106|NCT02690701|50200666|FG001|Treatment Period 2|Lack of Efficacy|0|||
25091107|NCT02690701|50200665|FG000|Treatment Period 2|Lost to Follow-up|0|||
25091108|NCT02690701|50200666|FG001|Treatment Period 2|Lost to Follow-up|2|||
25091109|NCT02690701|50200665|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25091110|NCT02690701|50200666|FG001|Treatment Period 2|Withdrawal by Subject|2|||
25091111|NCT02690701|50200665|FG000|Treatment Period 2|Protocol Violation|0|||
25091112|NCT02690701|50200666|FG001|Treatment Period 2|Protocol Violation|1|||
25091113|NCT02694757|50200673|FG000|Overall Study|Lack of Efficacy|3|||
25091114|NCT03805841|50200680|FG000|Overall Study|Clinical Progression|2|||
25091115|NCT03805841|50200681|FG001|Overall Study|Clinical Progression|0|||
25091116|NCT03805841|50200682|FG002|Overall Study|Clinical Progression|0|||
25091117|NCT03805841|50200680|FG000|Overall Study|Death|0|||
25091118|NCT03805841|50200681|FG001|Overall Study|Death|3|||
25091119|NCT03805841|50200682|FG002|Overall Study|Death|1|||
25091120|NCT03805841|50200680|FG000|Overall Study|Lost to Follow-up|0|||
25091121|NCT03805841|50200681|FG001|Overall Study|Lost to Follow-up|0|||
25091122|NCT03805841|50200682|FG002|Overall Study|Lost to Follow-up|1|||
25091123|NCT03805841|50200680|FG000|Overall Study|Withdrawal by Subject|2|||
25091124|NCT03805841|50200681|FG001|Overall Study|Withdrawal by Subject|3|||
25091125|NCT03805841|50200682|FG002|Overall Study|Withdrawal by Subject|0|||
25091126|NCT03805841|50200680|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
25091127|NCT03805841|50200681|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
25176306|NCT01525589|50319458|FG002|Overall Study|Withdrawal by Subject|0|||
25091128|NCT03805841|50200682|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
25091129|NCT02684617|50200693|FG000|Overall Study|Adverse Event|1|||
25091130|NCT02684617|50200694|FG001|Overall Study|Adverse Event|0|||
25176307|NCT01524887|50319469|FG000|Overall Study|Withdrawal by Subject|6|||
24997334|NCT03352557|50088325|FG008|LTE Period: Week 80 to Week 173|Death|1|||
24997335|NCT03352557|50088326|FG009|LTE Period: Week 80 to Week 173|Death|1|||
25091131|NCT02684617|50200695|FG002|Overall Study|Adverse Event|1|||
25091132|NCT02684617|50200693|FG000|Overall Study|Death|8|||
25091133|NCT02684617|50200694|FG001|Overall Study|Death|16|||
25091134|NCT02684617|50200695|FG002|Overall Study|Death|28|||
25091135|NCT02684617|50200693|FG000|Overall Study|Withdrawal by Subject|2|||
25091136|NCT02684617|50200694|FG001|Overall Study|Withdrawal by Subject|0|||
24997336|NCT03352557|50088317|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
24997337|NCT03352557|50088318|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
24997338|NCT03352557|50088319|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
24997339|NCT03352557|50088320|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
24997340|NCT03352557|50088321|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
24997341|NCT03352557|50088322|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
24997342|NCT03352557|50088323|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
24997343|NCT03352557|50088324|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
24997344|NCT03352557|50088325|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
24997345|NCT03352557|50088326|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
24997346|NCT03352557|50088317|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
24997347|NCT03352557|50088318|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
24997348|NCT03352557|50088319|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
24997349|NCT03352557|50088320|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
24997350|NCT03352557|50088321|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
24997351|NCT03352557|50088322|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
24997352|NCT03352557|50088323|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
24997353|NCT03352557|50088324|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
24997354|NCT03352557|50088325|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
24997355|NCT03352557|50088326|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
24997356|NCT03352557|50088317|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
24997357|NCT03352557|50088318|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
24997358|NCT03352557|50088319|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
24997359|NCT03352557|50088320|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
24997360|NCT03352557|50088321|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
25091137|NCT02684617|50200695|FG002|Overall Study|Withdrawal by Subject|4|||
25091138|NCT02684617|50200693|FG000|Overall Study|Screen Failure|1|||
25091139|NCT02684617|50200694|FG001|Overall Study|Screen Failure|0|||
25091140|NCT02684617|50200695|FG002|Overall Study|Screen Failure|2|||
25091141|NCT02684617|50200693|FG000|Overall Study|Study Terminated by Sponsor|6|||
25091142|NCT02684617|50200694|FG001|Overall Study|Study Terminated by Sponsor|1|||
25091143|NCT02684617|50200695|FG002|Overall Study|Study Terminated by Sponsor|5|||
25091144|NCT01999972|50200709|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
25091145|NCT01999972|50200710|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
25091146|NCT01999972|50200711|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
25091147|NCT01999972|50200712|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
25091148|NCT01999972|50200713|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
25091149|NCT01999972|50200714|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
25091150|NCT01999972|50200709|FG000|Dose Escalation Part|Death|0|||
25091151|NCT01999972|50200710|FG001|Dose Escalation Part|Death|1|||
25091152|NCT01999972|50200711|FG002|Dose Escalation Part|Death|0|||
25091153|NCT01999972|50200712|FG003|Dose Escalation Part|Death|0|||
25091154|NCT01999972|50200713|FG004|Dose Escalation Part|Death|0|||
25091155|NCT01999972|50200714|FG005|Dose Escalation Part|Death|0|||
25091156|NCT01999972|50200709|FG000|Dose Escalation Part|Enrolled but not treated|0|||
25091157|NCT01999972|50200710|FG001|Dose Escalation Part|Enrolled but not treated|0|||
25091158|NCT01999972|50200711|FG002|Dose Escalation Part|Enrolled but not treated|1|||
25091159|NCT01999972|50200712|FG003|Dose Escalation Part|Enrolled but not treated|1|||
25091160|NCT01999972|50200713|FG004|Dose Escalation Part|Enrolled but not treated|0|||
25091161|NCT01999972|50200714|FG005|Dose Escalation Part|Enrolled but not treated|0|||
25091162|NCT01999972|50200709|FG000|Dose Escalation Part|Disease progression|3|||
25091163|NCT01999972|50200710|FG001|Dose Escalation Part|Disease progression|2|||
24997361|NCT03352557|50088322|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
24997362|NCT03352557|50088323|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
24997363|NCT03352557|50088324|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
24997364|NCT03352557|50088325|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
24997365|NCT03352557|50088326|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
24997366|NCT03352557|50088317|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
24997367|NCT03352557|50088318|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
24997368|NCT03352557|50088319|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
24997369|NCT03352557|50088320|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
24997370|NCT03352557|50088321|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
25067257|NCT02745119|50172822|FG003|Overall Study|Reason Not Specified|1|||
25091164|NCT01999972|50200711|FG002|Dose Escalation Part|Disease progression|3|||
25091165|NCT01999972|50200712|FG003|Dose Escalation Part|Disease progression|6|||
25091166|NCT01999972|50200713|FG004|Dose Escalation Part|Disease progression|0|||
24997371|NCT03352557|50088322|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
24997372|NCT03352557|50088323|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
24997373|NCT03352557|50088324|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
24997374|NCT03352557|50088325|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
24997375|NCT03352557|50088326|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
24997376|NCT03352557|50088317|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
24997377|NCT03352557|50088318|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
24997378|NCT03352557|50088319|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
24997379|NCT03352557|50088320|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
24997380|NCT03352557|50088321|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
24997381|NCT03352557|50088322|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
24997382|NCT03352557|50088323|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
24997383|NCT03352557|50088324|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
24997384|NCT03352557|50088325|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
24997385|NCT03352557|50088326|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
24997386|NCT03352557|50088317|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
24997387|NCT03352557|50088318|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
24997388|NCT03352557|50088319|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
24997389|NCT03352557|50088320|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
24997390|NCT03352557|50088321|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
24997391|NCT03352557|50088322|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
24997392|NCT03352557|50088323|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
24997393|NCT03352557|50088324|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
24997394|NCT03352557|50088325|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
24997395|NCT03352557|50088326|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
24997396|NCT03352557|50088317|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
24997397|NCT03352557|50088318|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
24997398|NCT03352557|50088319|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
24997399|NCT03352557|50088320|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
24997400|NCT03352557|50088321|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
24997401|NCT03352557|50088322|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
24997402|NCT03352557|50088323|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
24997403|NCT03352557|50088324|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
24997404|NCT03352557|50088325|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
24997405|NCT03352557|50088326|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
24997406|NCT03352557|50088317|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
24997407|NCT03352557|50088318|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
24997408|NCT03352557|50088319|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
24997409|NCT03352557|50088320|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
24997410|NCT03352557|50088321|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
24997411|NCT03352557|50088322|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
24997412|NCT03352557|50088323|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
24997413|NCT03352557|50088324|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
24997414|NCT03352557|50088325|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
24997415|NCT03352557|50088326|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
24997416|NCT03352557|50088317|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
24997417|NCT03352557|50088318|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
24997418|NCT03352557|50088319|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
24997419|NCT03352557|50088320|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
24997420|NCT03352557|50088321|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
24997421|NCT03352557|50088322|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
24997422|NCT03352557|50088323|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
24997423|NCT03352557|50088324|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
25176308|NCT01524887|50319470|FG001|Overall Study|Withdrawal by Subject|2|||
25176309|NCT01524887|50319471|FG002|Overall Study|Withdrawal by Subject|3|||
24997424|NCT03352557|50088325|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
24997425|NCT03352557|50088326|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
24997426|NCT03352557|50088317|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
24997427|NCT03352557|50088318|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
24997428|NCT03352557|50088319|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
24997429|NCT03352557|50088320|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
24997430|NCT03352557|50088321|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
24997431|NCT03352557|50088322|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
24997432|NCT03352557|50088323|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
24997433|NCT03352557|50088324|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
24997434|NCT03352557|50088325|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
24997435|NCT03352557|50088326|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
24997436|NCT03352557|50088317|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
24997437|NCT03352557|50088318|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
24997438|NCT03352557|50088319|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
24997439|NCT03352557|50088320|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
24997440|NCT03352557|50088321|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
24997441|NCT03352557|50088322|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
24997442|NCT03352557|50088323|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
24997443|NCT03352557|50088324|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
24997444|NCT03352557|50088325|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
24997445|NCT03352557|50088326|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
24997446|NCT03352557|50088317|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
24997447|NCT03352557|50088318|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
24997448|NCT03352557|50088319|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
24997449|NCT03352557|50088320|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
24997450|NCT03352557|50088321|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
24997451|NCT03352557|50088322|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
24997452|NCT03352557|50088323|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
24997453|NCT03352557|50088324|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
24997454|NCT03352557|50088325|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
24997455|NCT03352557|50088326|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
24997456|NCT03352557|50088317|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
24997457|NCT03352557|50088318|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
24997458|NCT03352557|50088319|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
24997459|NCT03352557|50088320|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
24997460|NCT03352557|50088321|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
24997461|NCT03352557|50088322|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
24997462|NCT03352557|50088323|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
24997463|NCT03352557|50088324|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
24997464|NCT03352557|50088325|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
24997465|NCT03352557|50088326|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
24997466|NCT03352557|50088317|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
24997467|NCT03352557|50088318|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
24997468|NCT03352557|50088319|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
24997469|NCT03352557|50088320|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
24997470|NCT03352557|50088321|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
24997471|NCT03352557|50088322|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
24997472|NCT03352557|50088323|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
24997473|NCT03352557|50088324|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
24997474|NCT03352557|50088325|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
24997475|NCT03352557|50088326|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
24997476|NCT03352557|50088317|FG000|LTE Period: Week 80 to Week 173|Other|0|||
24997477|NCT03352557|50088318|FG001|LTE Period: Week 80 to Week 173|Other|0|||
24997478|NCT03352557|50088319|FG002|LTE Period: Week 80 to Week 173|Other|0|||
24997479|NCT03352557|50088320|FG003|LTE Period: Week 80 to Week 173|Other|0|||
24997480|NCT03352557|50088321|FG004|LTE Period: Week 80 to Week 173|Other|0|||
24997481|NCT03352557|50088322|FG005|LTE Period: Week 80 to Week 173|Other|0|||
24997482|NCT03352557|50088323|FG006|LTE Period: Week 80 to Week 173|Other|0|||
24997483|NCT03352557|50088324|FG007|LTE Period: Week 80 to Week 173|Other|1|||
24997484|NCT03352557|50088325|FG008|LTE Period: Week 80 to Week 173|Other|0|||
25091167|NCT01999972|50200714|FG005|Dose Escalation Part|Disease progression|0|||
25091168|NCT01999972|50200709|FG000|Dose Escalation Part|Adverse Event|0|||
24997485|NCT03352557|50088326|FG009|LTE Period: Week 80 to Week 173|Other|0|||
24997486|NCT02866942|50088351|FG000|Overall Study|Invalid consent|1|||
24997487|NCT02908672|50088405|FG000|Overall Study|Death|112|||
24997488|NCT02908672|50088406|FG001|Overall Study|Death|93|||
24997489|NCT02908672|50088405|FG000|Overall Study|Lost to Follow-up|3|||
24997490|NCT02908672|50088406|FG001|Overall Study|Lost to Follow-up|3|||
24997491|NCT02908672|50088405|FG000|Overall Study|Other|2|||
24997492|NCT02908672|50088406|FG001|Overall Study|Other|0|||
24997493|NCT02908672|50088405|FG000|Overall Study|Protocol Violation|1|||
24997494|NCT02908672|50088406|FG001|Overall Study|Protocol Violation|1|||
24997495|NCT02908672|50088405|FG000|Overall Study|Withdrawal by Subject|13|||
24997496|NCT02908672|50088406|FG001|Overall Study|Withdrawal by Subject|18|||
24997497|NCT02908672|50088405|FG000|Overall Study|Study is ongoing|124|||
24997498|NCT02908672|50088406|FG001|Overall Study|Study is ongoing|141|||
24997499|NCT02908672|50088405|FG000|Overall Study|Discontinued the study during run-in|3|||
24997500|NCT02908672|50088406|FG001|Overall Study|Discontinued the study during run-in|0|||
24997501|NCT01336894|50088414|FG000|Follow-up|Study terminated prematurely|2|||
24997502|NCT01336894|50088415|FG001|Follow-up|Study terminated prematurely|7|||
24997503|NCT02572167|50088424|FG000|Overall Study|Withdrawal by Subject|0|||
24997504|NCT02572167|50088425|FG001|Overall Study|Withdrawal by Subject|3|||
24997505|NCT02572167|50088426|FG002|Overall Study|Withdrawal by Subject|0|||
24997506|NCT02572167|50088424|FG000|Overall Study|Lost to Follow-up|2|||
24997507|NCT02572167|50088425|FG001|Overall Study|Lost to Follow-up|5|||
24997508|NCT02572167|50088426|FG002|Overall Study|Lost to Follow-up|3|||
24997509|NCT02572167|50088424|FG000|Overall Study|Death|0|||
24997510|NCT02572167|50088425|FG001|Overall Study|Death|8|||
24997511|NCT02572167|50088426|FG002|Overall Study|Death|3|||
24997512|NCT02572167|50088424|FG000|Overall Study|Did not meet inclusion criteria|0|||
24997513|NCT02572167|50088425|FG001|Overall Study|Did not meet inclusion criteria|0|||
24997514|NCT02572167|50088426|FG002|Overall Study|Did not meet inclusion criteria|1|||
24997515|NCT02572167|50088424|FG000|Overall Study|Study closure by Sponsor|4|||
24997516|NCT02572167|50088425|FG001|Overall Study|Study closure by Sponsor|40|||
24997517|NCT02572167|50088426|FG002|Overall Study|Study closure by Sponsor|24|||
24997518|NCT01336738|50088440|FG000|Overall Study|Adverse Event|0|||
24997519|NCT01336738|50088441|FG001|Overall Study|Adverse Event|3|||
24997520|NCT01336738|50088442|FG002|Overall Study|Adverse Event|2|||
24997521|NCT01336738|50088443|FG003|Overall Study|Adverse Event|1|||
24997522|NCT01336738|50088444|FG004|Overall Study|Adverse Event|3|||
24997523|NCT01336738|50088440|FG000|Overall Study|Lost to Follow-up|2|||
24997524|NCT01336738|50088441|FG001|Overall Study|Lost to Follow-up|1|||
24997525|NCT01336738|50088442|FG002|Overall Study|Lost to Follow-up|2|||
24997526|NCT01336738|50088443|FG003|Overall Study|Lost to Follow-up|2|||
24997527|NCT01336738|50088444|FG004|Overall Study|Lost to Follow-up|2|||
24997528|NCT01336738|50088440|FG000|Overall Study|Did not meet entrance criteria|0|||
24997529|NCT01336738|50088441|FG001|Overall Study|Did not meet entrance criteria|1|||
24997530|NCT01336738|50088442|FG002|Overall Study|Did not meet entrance criteria|0|||
24997531|NCT01336738|50088443|FG003|Overall Study|Did not meet entrance criteria|0|||
24997532|NCT01336738|50088444|FG004|Overall Study|Did not meet entrance criteria|0|||
24997533|NCT01336738|50088440|FG000|Overall Study|Protocol Violation|0|||
24997534|NCT01336738|50088441|FG001|Overall Study|Protocol Violation|1|||
24997535|NCT01336738|50088442|FG002|Overall Study|Protocol Violation|0|||
24997536|NCT01336738|50088443|FG003|Overall Study|Protocol Violation|0|||
24997537|NCT01336738|50088444|FG004|Overall Study|Protocol Violation|0|||
24997538|NCT01336738|50088440|FG000|Overall Study|Withdrawal by Subject|2|||
24997539|NCT01336738|50088441|FG001|Overall Study|Withdrawal by Subject|0|||
24997540|NCT01336738|50088442|FG002|Overall Study|Withdrawal by Subject|2|||
24997541|NCT01336738|50088443|FG003|Overall Study|Withdrawal by Subject|1|||
24997542|NCT01336738|50088444|FG004|Overall Study|Withdrawal by Subject|1|||
24997543|NCT01336738|50088440|FG000|Overall Study|Other|3|||
24997544|NCT01336738|50088441|FG001|Overall Study|Other|3|||
24997545|NCT01336738|50088442|FG002|Overall Study|Other|2|||
24997546|NCT01336738|50088443|FG003|Overall Study|Other|3|||
24997547|NCT01336738|50088444|FG004|Overall Study|Other|4|||
24997548|NCT02258451|50088458|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|88|||
24997549|NCT02258451|50088459|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|95|||
24997550|NCT02258451|50088458|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|6|||
24997551|NCT02258451|50088459|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
24997552|NCT02258451|50088458|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
24997553|NCT02258451|50088459|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
24997554|NCT02258451|50088458|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
24997555|NCT02258451|50088459|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
24997556|NCT02258451|50088458|FG000|Overall Study|Death|4|||
24997557|NCT02258451|50088459|FG001|Overall Study|Death|3|||
25067258|NCT01367665|50172836|FG000|Overall Study|Death|102|||
24997558|NCT02258451|50088458|FG000|Overall Study|Withdrawal by Subject|21|||
24997559|NCT02258451|50088459|FG001|Overall Study|Withdrawal by Subject|12|||
24997560|NCT02258451|50088458|FG000|Overall Study|Discontinuation all treatment due to TS-1 started|1|||
24997561|NCT02258451|50088459|FG001|Overall Study|Discontinuation all treatment due to TS-1 started|0|||
24997562|NCT02258451|50088458|FG000|Overall Study|Discontinuation all treatment due to event point reached|1|||
24997563|NCT02258451|50088459|FG001|Overall Study|Discontinuation all treatment due to event point reached|1|||
24997564|NCT02258451|50088458|FG000|Overall Study|Physician Decision|0|||
24997565|NCT02258451|50088459|FG001|Overall Study|Physician Decision|2|||
24997566|NCT02258451|50088458|FG000|Overall Study|Never treated|2|||
24997567|NCT02258451|50088459|FG001|Overall Study|Never treated|3|||
24997568|NCT02258451|50088458|FG000|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|3|||
24997569|NCT02258451|50088459|FG001|Overall Study|Ongoing with any Treatment of radium 223 or placebo, exemestane, or everolimus|11|||
24997570|NCT02865538|50088472|FG000|Overall Study|Withdrawal by Subject|0|||
24997571|NCT02865538|50088473|FG001|Overall Study|Withdrawal by Subject|0|||
24997572|NCT02865538|50088474|FG002|Overall Study|Withdrawal by Subject|1|||
24997573|NCT02865538|50088475|FG003|Overall Study|Withdrawal by Subject|0|||
24997574|NCT02865538|50088476|FG004|Overall Study|Withdrawal by Subject|0|||
24997575|NCT02865538|50088472|FG000|Overall Study|Lost to Follow-up|1|||
24997576|NCT02865538|50088473|FG001|Overall Study|Lost to Follow-up|0|||
24997577|NCT02865538|50088474|FG002|Overall Study|Lost to Follow-up|0|||
24997578|NCT02865538|50088475|FG003|Overall Study|Lost to Follow-up|0|||
24997579|NCT02865538|50088476|FG004|Overall Study|Lost to Follow-up|0|||
24997580|NCT02860546|50088488|FG000|Overall Study|Clinical Progression|6|||
24997581|NCT02860546|50088488|FG000|Overall Study|Radiological Progression|12|||
24997582|NCT01982955|50088497|FG000|Overall Study|Randomized but not treated|0|||
24997583|NCT01982955|50088498|FG001|Overall Study|Randomized but not treated|0|||
24997584|NCT01982955|50088499|FG002|Overall Study|Randomized but not treated|0|||
24997585|NCT01982955|50088500|FG003|Overall Study|Randomized but not treated|1|||
24997586|NCT01982955|50088501|FG004|Overall Study|Randomized but not treated|0|||
24997587|NCT00396279|50088514|FG000|Overall Study|Ongoing in study|26|||
24997588|NCT00396279|50088514|FG000|Overall Study|Disease progression|2|||
24997589|NCT00396279|50088514|FG000|Overall Study|Withdrawal by Subject|1|||
24997590|NCT00396279|50088514|FG000|Overall Study|Physician Decision|1|||
24997591|NCT01347866|50088535|FG000|Overall Study|Death|0|||
24997592|NCT01347866|50088536|FG001|Overall Study|Death|0|||
24997593|NCT01347866|50088537|FG002|Overall Study|Death|0|||
24997594|NCT01347866|50088538|FG003|Overall Study|Death|1|||
24997595|NCT01347866|50088539|FG004|Overall Study|Death|2|||
24997596|NCT01347866|50088540|FG005|Overall Study|Death|2|||
24997597|NCT01347866|50088541|FG006|Overall Study|Death|1|||
24997598|NCT01347866|50088542|FG007|Overall Study|Death|0|||
24997599|NCT01347866|50088543|FG008|Overall Study|Death|4|||
24997600|NCT01347866|50088544|FG009|Overall Study|Death|1|||
24997601|NCT01347866|50088545|FG010|Overall Study|Death|3|||
24997602|NCT01347866|50088546|FG011|Overall Study|Death|1|||
24997603|NCT01347866|50088547|FG012|Overall Study|Death|2|||
24997604|NCT01347866|50088548|FG013|Overall Study|Death|0|||
24997605|NCT01347866|50088549|FG014|Overall Study|Death|0|||
24997606|NCT01347866|50088550|FG015|Overall Study|Death|1|||
24997607|NCT01347866|50088551|FG016|Overall Study|Death|0|||
24997608|NCT01347866|50088535|FG000|Overall Study|Lost to Follow-up|0|||
24997609|NCT01347866|50088536|FG001|Overall Study|Lost to Follow-up|0|||
24997610|NCT01347866|50088537|FG002|Overall Study|Lost to Follow-up|0|||
24997611|NCT01347866|50088538|FG003|Overall Study|Lost to Follow-up|0|||
24997612|NCT01347866|50088539|FG004|Overall Study|Lost to Follow-up|0|||
24997613|NCT01347866|50088540|FG005|Overall Study|Lost to Follow-up|0|||
24997614|NCT01347866|50088541|FG006|Overall Study|Lost to Follow-up|0|||
24997615|NCT01347866|50088542|FG007|Overall Study|Lost to Follow-up|1|||
24997616|NCT01347866|50088543|FG008|Overall Study|Lost to Follow-up|1|||
24997617|NCT01347866|50088544|FG009|Overall Study|Lost to Follow-up|0|||
24997618|NCT01347866|50088545|FG010|Overall Study|Lost to Follow-up|0|||
24997619|NCT01347866|50088546|FG011|Overall Study|Lost to Follow-up|0|||
24997620|NCT01347866|50088547|FG012|Overall Study|Lost to Follow-up|0|||
24997621|NCT01347866|50088548|FG013|Overall Study|Lost to Follow-up|0|||
24997622|NCT01347866|50088549|FG014|Overall Study|Lost to Follow-up|0|||
24997623|NCT01347866|50088550|FG015|Overall Study|Lost to Follow-up|0|||
24997624|NCT01347866|50088551|FG016|Overall Study|Lost to Follow-up|0|||
24997625|NCT01347866|50088535|FG000|Overall Study|Other|3|||
24997626|NCT01347866|50088536|FG001|Overall Study|Other|1|||
24997627|NCT01347866|50088537|FG002|Overall Study|Other|1|||
25176310|NCT01524887|50319469|FG000|Overall Study|Adverse Event|5|||
24997628|NCT01347866|50088538|FG003|Overall Study|Other|4|||
24997629|NCT01347866|50088539|FG004|Overall Study|Other|5|||
24997630|NCT01347866|50088540|FG005|Overall Study|Other|0|||
24997631|NCT01347866|50088541|FG006|Overall Study|Other|5|||
24997632|NCT01347866|50088542|FG007|Overall Study|Other|3|||
24997633|NCT01347866|50088543|FG008|Overall Study|Other|22|||
24997634|NCT01347866|50088544|FG009|Overall Study|Other|5|||
24997635|NCT01347866|50088545|FG010|Overall Study|Other|0|||
25176311|NCT01524887|50319470|FG001|Overall Study|Adverse Event|1|||
24997636|NCT01347866|50088546|FG011|Overall Study|Other|3|||
24997637|NCT01347866|50088547|FG012|Overall Study|Other|4|||
24997638|NCT01347866|50088548|FG013|Overall Study|Other|4|||
24997639|NCT01347866|50088549|FG014|Overall Study|Other|2|||
24997640|NCT01347866|50088550|FG015|Overall Study|Other|3|||
24997641|NCT01347866|50088551|FG016|Overall Study|Other|0|||
24997642|NCT01347866|50088535|FG000|Overall Study|Subject refused further follow-up|2|||
24997643|NCT01347866|50088536|FG001|Overall Study|Subject refused further follow-up|0|||
24997644|NCT01347866|50088537|FG002|Overall Study|Subject refused further follow-up|0|||
24997645|NCT01347866|50088538|FG003|Overall Study|Subject refused further follow-up|2|||
24997646|NCT01347866|50088539|FG004|Overall Study|Subject refused further follow-up|0|||
24997647|NCT01347866|50088540|FG005|Overall Study|Subject refused further follow-up|1|||
24997648|NCT01347866|50088541|FG006|Overall Study|Subject refused further follow-up|0|||
24997649|NCT01347866|50088542|FG007|Overall Study|Subject refused further follow-up|0|||
24997650|NCT01347866|50088543|FG008|Overall Study|Subject refused further follow-up|4|||
24997651|NCT01347866|50088544|FG009|Overall Study|Subject refused further follow-up|1|||
24997652|NCT01347866|50088545|FG010|Overall Study|Subject refused further follow-up|0|||
24997653|NCT01347866|50088546|FG011|Overall Study|Subject refused further follow-up|0|||
24997654|NCT01347866|50088547|FG012|Overall Study|Subject refused further follow-up|1|||
24997655|NCT01347866|50088548|FG013|Overall Study|Subject refused further follow-up|3|||
24997656|NCT01347866|50088549|FG014|Overall Study|Subject refused further follow-up|1|||
24997657|NCT01347866|50088550|FG015|Overall Study|Subject refused further follow-up|0|||
24997658|NCT01347866|50088551|FG016|Overall Study|Subject refused further follow-up|2|||
24997659|NCT01347710|50088622|FG000|Overall Study|Withdrawal by Subject|2|||
24997660|NCT01347710|50088622|FG000|Overall Study|Adverse Event|4|||
24997661|NCT01347710|50088622|FG000|Overall Study|Angio or SPECT not completed|18|||
24997662|NCT01347710|50088622|FG000|Overall Study|issue with vitals prior to dosing|1|||
24997663|NCT01347710|50088622|FG000|Overall Study|Lost to Follow-up|1|||
24997664|NCT01347710|50088622|FG000|Overall Study|Physician Decision|2|||
24997665|NCT01347710|50088622|FG000|Overall Study|Other|3|||
24997666|NCT03485222|50088632|FG000|Overall Study|Death|0|||
24997667|NCT03485222|50088633|FG001|Overall Study|Death|1|||
24997668|NCT03485222|50088632|FG000|Overall Study|Lost to Follow-up|2|||
24997669|NCT03485222|50088633|FG001|Overall Study|Lost to Follow-up|1|||
24997670|NCT01347554|50088641|FG000|Overall Study|Lack of Efficacy|7|||
24997671|NCT01347554|50088642|FG001|Overall Study|Lack of Efficacy|11|||
24997672|NCT03482882|50088648|FG000|Overall Study|Adverse Event|3|||
24997673|NCT03482882|50088648|FG000|Overall Study|Lost to Follow-up|1|||
24997674|NCT03482882|50088648|FG000|Overall Study|Protocol Violation|2|||
24997675|NCT03482882|50088648|FG000|Overall Study|Not further specified|1|||
24997676|NCT03480932|50088655|FG000|Overall Study|Death|1|||
24997677|NCT03480932|50088656|FG001|Overall Study|Death|1|||
24997678|NCT03480932|50088657|FG002|Overall Study|Death|0|||
24997679|NCT03480932|50088655|FG000|Overall Study|Lost to Follow-up|0|||
24997680|NCT03480932|50088656|FG001|Overall Study|Lost to Follow-up|2|||
24997681|NCT03480932|50088657|FG002|Overall Study|Lost to Follow-up|3|||
24997682|NCT03480932|50088655|FG000|Overall Study|Incarcerated|2|||
24997683|NCT03480932|50088656|FG001|Overall Study|Incarcerated|2|||
24997684|NCT03480932|50088657|FG002|Overall Study|Incarcerated|2|||
24997685|NCT03387020|50088668|FG000|Overall Study|Adverse Event|0|||
24997686|NCT03387020|50088669|FG001|Overall Study|Adverse Event|2|||
24997687|NCT03387020|50088670|FG002|Overall Study|Adverse Event|0|||
24997688|NCT03387020|50088668|FG000|Overall Study|Withdrawal by Subject|2|||
24997689|NCT03387020|50088669|FG001|Overall Study|Withdrawal by Subject|0|||
24997690|NCT03387020|50088670|FG002|Overall Study|Withdrawal by Subject|0|||
24997691|NCT03386474|50088690|FG000|Overall Study|Death|1|||
24997692|NCT03386474|50088691|FG001|Overall Study|Death|0|||
24997693|NCT03386474|50088690|FG000|Overall Study|Adverse Event|0|||
24997694|NCT03386474|50088691|FG001|Overall Study|Adverse Event|1|||
24997695|NCT03405818|50088702|FG000|Overall Study|Withdrawal by Subject|4|||
24997696|NCT03405818|50088702|FG000|Overall Study|Lost to Follow-up|4|||
24997697|NCT03403634|50088706|FG000|Overall Study|Disease progression|3|||
24997698|NCT03403634|50088706|FG000|Overall Study|Did not meet eligibility criteria|4|||
24997699|NCT03403400|50088713|FG000|Overall Study|Lost to Follow-up|1|||
24997700|NCT03403400|50088714|FG001|Overall Study|Lost to Follow-up|0|||
24997701|NCT03403400|50088715|FG002|Overall Study|Lost to Follow-up|1|||
24997702|NCT03403400|50088713|FG000|Overall Study|Hospitalization|1|||
25091169|NCT01999972|50200710|FG001|Dose Escalation Part|Adverse Event|0|||
25091170|NCT01999972|50200711|FG002|Dose Escalation Part|Adverse Event|0|||
24997703|NCT03403400|50088714|FG001|Overall Study|Hospitalization|0|||
24997704|NCT03403400|50088715|FG002|Overall Study|Hospitalization|0|||
24997705|NCT03403400|50088713|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
24997706|NCT03403400|50088714|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
24997707|NCT03403400|50088715|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
24997708|NCT02863354|50088740|FG000|Year 1|Lost to Follow-up|1|||
24997709|NCT02863354|50088741|FG001|Year 1|Lost to Follow-up|1|||
24997710|NCT02863354|50088740|FG000|Year 1|Withdrawal by Subject|3|||
25091171|NCT01999972|50200712|FG003|Dose Escalation Part|Adverse Event|2|||
24997711|NCT02863354|50088741|FG001|Year 1|Withdrawal by Subject|0|||
24997712|NCT02863354|50088740|FG000|Year 1|Death|0|||
24997713|NCT02863354|50088741|FG001|Year 1|Death|1|||
24997714|NCT02863354|50088740|FG000|Year 2|Lost to Follow-up|2|||
24997715|NCT02863354|50088741|FG001|Year 2|Lost to Follow-up|2|||
24997716|NCT03480152|50088749|FG000|Phase I|Signed consent. Died before treatment.|1|||
24997717|NCT03480152|50088750|FG001|Phase I|Signed consent. Died before treatment.|0|||
24997718|NCT03480152|50088751|FG002|Phase I|Signed consent. Died before treatment.|0|||
24997719|NCT02859454|50088759|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
24997720|NCT02862730|50088766|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
24997721|NCT02862730|50088767|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
24997722|NCT02862730|50088768|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
24997723|NCT02862730|50088769|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
24997724|NCT02862730|50088770|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
24997725|NCT02862730|50088771|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
24997726|NCT02862730|50088772|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
24997727|NCT02862730|50088766|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
24997728|NCT02862730|50088767|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
24997729|NCT02862730|50088768|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
24997730|NCT02862730|50088769|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
24997731|NCT02862730|50088770|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
24997732|NCT02862730|50088771|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
24997733|NCT02862730|50088772|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
24997734|NCT02862730|50088766|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
24997735|NCT02862730|50088767|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
24997736|NCT02862730|50088768|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
24997737|NCT02862730|50088769|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
24997738|NCT02862730|50088770|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
24997739|NCT02862730|50088771|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
24997740|NCT02862730|50088772|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
24997741|NCT02862730|50088766|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
24997742|NCT02862730|50088767|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
24997743|NCT02862730|50088768|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
24997744|NCT02862730|50088769|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
24997745|NCT02862730|50088770|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
24997746|NCT02862730|50088771|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
24997747|NCT02862730|50088772|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
24997748|NCT03402386|50088787|FG000|Overall Study|Adverse Event|3|||
24997749|NCT03402386|50088787|FG000|Overall Study|Physician Decision|1|||
24997750|NCT03402386|50088787|FG000|Overall Study|Difficult to control Hb|2|||
24997751|NCT03401450|50088793|FG000|Overall Study|Lost to Follow-up|4|||
24997752|NCT03401450|50088794|FG001|Overall Study|Lost to Follow-up|6|||
24997753|NCT03401450|50088793|FG000|Overall Study|Anesthesia plan changed|2|||
24997754|NCT03401450|50088794|FG001|Overall Study|Anesthesia plan changed|2|||
24997755|NCT03401450|50088793|FG000|Overall Study|Did not complete medication diary|4|||
24997756|NCT03401450|50088794|FG001|Overall Study|Did not complete medication diary|2|||
24997757|NCT03401450|50088793|FG000|Overall Study|post surgery medication change|2|||
24997758|NCT03401450|50088794|FG001|Overall Study|post surgery medication change|1|||
24997759|NCT03401450|50088793|FG000|Overall Study|Cancelled surgery|0|||
24997760|NCT03401450|50088794|FG001|Overall Study|Cancelled surgery|2|||
24997761|NCT03353792|50088802|FG000|Overall Study|Lost to Follow-up|1|||
24997762|NCT03353792|50088803|FG001|Overall Study|Lost to Follow-up|0|||
24997763|NCT03353792|50088802|FG000|Overall Study|Participant Unable to Manage Device|1|||
24997764|NCT03353792|50088803|FG001|Overall Study|Participant Unable to Manage Device|0|||
24997765|NCT02862574|50088812|FG000|Double-Blind Treatment Period|Adverse Event|0|||
24997766|NCT02862574|50088813|FG001|Double-Blind Treatment Period|Adverse Event|1|||
24997767|NCT02862574|50088814|FG002|Double-Blind Treatment Period|Adverse Event|0|||
24997768|NCT02862574|50088812|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
24997769|NCT02862574|50088813|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
24997770|NCT02862574|50088814|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
24997771|NCT02862574|50088812|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
24997772|NCT02862574|50088813|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
24997773|NCT02862574|50088814|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
25091172|NCT01999972|50200713|FG004|Dose Escalation Part|Adverse Event|0|||
24997774|NCT02862106|50088829|FG000|Overall Study|Adverse Event|4|||
24997775|NCT02862106|50088830|FG001|Overall Study|Adverse Event|0|||
24997776|NCT02862106|50088829|FG000|Overall Study|Protocol Violation|16|||
24997777|NCT02862106|50088830|FG001|Overall Study|Protocol Violation|1|||
24997778|NCT02862106|50088829|FG000|Overall Study|Lost to Follow-up|15|||
24997779|NCT02862106|50088830|FG001|Overall Study|Lost to Follow-up|5|||
25091173|NCT01999972|50200714|FG005|Dose Escalation Part|Adverse Event|0|||
24997780|NCT02862106|50088829|FG000|Overall Study|Withdrawal by Subject|2|||
24997781|NCT02862106|50088830|FG001|Overall Study|Withdrawal by Subject|0|||
24997782|NCT02862106|50088829|FG000|Overall Study|Subjects moved to other city|1|||
24997783|NCT02862106|50088830|FG001|Overall Study|Subjects moved to other city|0|||
24997784|NCT04157296|50088845|FG000|Overall Study|Withdrawal by Subject|0|||
24997785|NCT04157296|50088846|FG001|Overall Study|Withdrawal by Subject|1|||
24997786|NCT04157296|50088845|FG000|Overall Study|Did not obtain second fMRI.|0|||
24997787|NCT04157296|50088846|FG001|Overall Study|Did not obtain second fMRI.|1|||
24997788|NCT04157296|50088845|FG000|Overall Study|MRI failed/no second fMRI|0|||
24997789|NCT04157296|50088846|FG001|Overall Study|MRI failed/no second fMRI|1|||
24997790|NCT02859142|50088854|FG000|Overall Study|Adverse Event|1|||
24997791|NCT02859142|50088855|FG001|Overall Study|Adverse Event|2|||
24997792|NCT02859142|50088854|FG000|Overall Study|Lost to Follow-up|1|||
24997793|NCT02859142|50088855|FG001|Overall Study|Lost to Follow-up|4|||
24997794|NCT02859142|50088854|FG000|Overall Study|Withdrawal by Subject|2|||
24997795|NCT02859142|50088855|FG001|Overall Study|Withdrawal by Subject|0|||
24997796|NCT02859142|50088854|FG000|Overall Study|Scheduling difficulties|0|||
24997797|NCT02859142|50088855|FG001|Overall Study|Scheduling difficulties|3|||
24997798|NCT03351608|50088866|FG000|Overall Study|Lost to Follow-up|0|||
24997799|NCT03351608|50088867|FG001|Overall Study|Lost to Follow-up|1|||
24997800|NCT03351608|50088868|FG002|Overall Study|Lost to Follow-up|1|||
24997801|NCT03351608|50088869|FG003|Overall Study|Lost to Follow-up|1|||
24997802|NCT03351608|50088870|FG004|Overall Study|Lost to Follow-up|1|||
24997803|NCT03351608|50088866|FG000|Overall Study|Physician Decision|1|||
24997804|NCT03351608|50088867|FG001|Overall Study|Physician Decision|0|||
24997805|NCT03351608|50088868|FG002|Overall Study|Physician Decision|0|||
24997806|NCT03351608|50088869|FG003|Overall Study|Physician Decision|2|||
24997807|NCT03351608|50088870|FG004|Overall Study|Physician Decision|1|||
24997808|NCT03351608|50088866|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
24997809|NCT03351608|50088867|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
24997810|NCT03351608|50088868|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
24997811|NCT03351608|50088869|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
24997812|NCT03351608|50088870|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
24997813|NCT03351608|50088866|FG000|Overall Study|Withdrawal by parent/guardian|0|||
24997814|NCT03351608|50088867|FG001|Overall Study|Withdrawal by parent/guardian|0|||
24997815|NCT03351608|50088868|FG002|Overall Study|Withdrawal by parent/guardian|1|||
24997816|NCT03351608|50088869|FG003|Overall Study|Withdrawal by parent/guardian|1|||
24997817|NCT03351608|50088870|FG004|Overall Study|Withdrawal by parent/guardian|0|||
24997818|NCT03351608|50088866|FG000|Overall Study|Other|0|||
24997819|NCT03351608|50088867|FG001|Overall Study|Other|1|||
24997820|NCT03351608|50088868|FG002|Overall Study|Other|1|||
24997821|NCT03351608|50088869|FG003|Overall Study|Other|3|||
24997822|NCT03351608|50088870|FG004|Overall Study|Other|0|||
24997823|NCT02857816|50088893|FG000|Overall Study|Screen Failure|33|||
24997824|NCT02857816|50088893|FG000|Overall Study|Withdrawal by Subject|4|||
24997825|NCT02857816|50088893|FG000|Overall Study|Lost to Follow-up|1|||
24997826|NCT02858440|50088898|FG000|Overall Study|Lost to Follow-up|3|||
24997827|NCT02858440|50088898|FG000|Overall Study|Protocol Violation|2|||
24997828|NCT02858440|50088898|FG000|Overall Study|Consent withdrawal|3|||
24997829|NCT02858440|50088898|FG000|Overall Study|Migrated/moved from study area|4|||
24997830|NCT03382418|50088905|FG000|Overall Study|Withdrawal by Subject|1|||
24997831|NCT03382418|50088906|FG001|Overall Study|Withdrawal by Subject|0|||
24997832|NCT03382418|50088907|FG002|Overall Study|Withdrawal by Subject|0|||
24997833|NCT03382418|50088905|FG000|Overall Study|Lost to Follow-up|2|||
24997834|NCT03382418|50088906|FG001|Overall Study|Lost to Follow-up|3|||
24997835|NCT03382418|50088907|FG002|Overall Study|Lost to Follow-up|0|||
24997836|NCT02858362|50088919|FG000|Overall Study|Protocol Violation|0|||
24997837|NCT02858362|50088920|FG001|Overall Study|Protocol Violation|1|||
24997838|NCT02858362|50088921|FG002|Overall Study|Protocol Violation|0|||
24997839|NCT02858362|50088919|FG000|Overall Study|Withdrawal by Subject|1|||
24997840|NCT02858362|50088920|FG001|Overall Study|Withdrawal by Subject|0|||
24997841|NCT02858362|50088921|FG002|Overall Study|Withdrawal by Subject|0|||
24997842|NCT02858362|50088919|FG000|Overall Study|Early Study Termination|0|||
24997843|NCT02858362|50088920|FG001|Overall Study|Early Study Termination|0|||
24997844|NCT02858362|50088921|FG002|Overall Study|Early Study Termination|3|||
24997845|NCT02858362|50088919|FG000|Overall Study|Lost to Follow-up|1|||
24997846|NCT02858362|50088920|FG001|Overall Study|Lost to Follow-up|0|||
24997847|NCT02858362|50088921|FG002|Overall Study|Lost to Follow-up|0|||
24997848|NCT03382262|50088938|FG000|Overall Study|Physician Decision|0|||
24997849|NCT03382262|50088939|FG001|Overall Study|Physician Decision|0|||
24997850|NCT03382262|50088940|FG002|Overall Study|Physician Decision|1|||
24997851|NCT03382262|50088941|FG003|Overall Study|Physician Decision|0|||
24997852|NCT03382262|50088938|FG000|Overall Study|Withdrawal by Subject|0|||
24997853|NCT03382262|50088939|FG001|Overall Study|Withdrawal by Subject|0|||
24997854|NCT03382262|50088940|FG002|Overall Study|Withdrawal by Subject|0|||
25176312|NCT01524887|50319471|FG002|Overall Study|Adverse Event|1|||
24997855|NCT03382262|50088941|FG003|Overall Study|Withdrawal by Subject|1|||
24997856|NCT03350750|50088953|FG000|Overall Study|Death|1|||
24997857|NCT03350750|50088954|FG001|Overall Study|Death|1|||
24997858|NCT03394508|50088964|FG000|Overall Study|Protocol Violation|0|||
24997859|NCT03394508|50088965|FG001|Overall Study|Protocol Violation|3|||
24997860|NCT03394508|50088964|FG000|Overall Study|Lost to Follow-up|1|||
24997861|NCT03394508|50088965|FG001|Overall Study|Lost to Follow-up|0|||
24997862|NCT02856880|50088975|FG000|Overall Study|Withdrawal of consent|1|||
24997863|NCT03393806|50088996|FG000|Overall Study|Physician Decision|1|||
24997864|NCT03393806|50088997|FG001|Overall Study|Physician Decision|0|||
24997865|NCT02856802|50089006|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
24997866|NCT02856802|50089007|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
24997867|NCT02856802|50089006|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
24997868|NCT02856802|50089007|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
24997869|NCT02856802|50089006|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
24997870|NCT02856802|50089007|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
24997871|NCT02856802|50089006|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
24997872|NCT02856802|50089007|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
24997873|NCT02856802|50089006|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
24997874|NCT02856802|50089007|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
24997875|NCT02856802|50089006|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
24997876|NCT02856802|50089007|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
24997877|NCT03381248|50089019|FG000|Overall Study|Withdrawal by Subject|5|||
24997878|NCT03381248|50089020|FG001|Overall Study|Withdrawal by Subject|3|||
24997879|NCT03381248|50089019|FG000|Overall Study|Lost to Follow-up|3|||
24997880|NCT03381248|50089020|FG001|Overall Study|Lost to Follow-up|2|||
24997881|NCT03381248|50089019|FG000|Overall Study|Lack of Efficacy|1|||
24997882|NCT03381248|50089020|FG001|Overall Study|Lack of Efficacy|0|||
24997883|NCT03381248|50089019|FG000|Overall Study|Adverse Event|2|||
24997884|NCT03381248|50089020|FG001|Overall Study|Adverse Event|0|||
24997885|NCT03381248|50089019|FG000|Overall Study|Protocol Violation|2|||
24997886|NCT03381248|50089020|FG001|Overall Study|Protocol Violation|1|||
24997887|NCT03380390|50089026|FG000|Overall Study|Adverse Event|3|||
24997888|NCT03350672|50089033|FG000|Overall Study|Withdrawal by Subject|7|||
24997889|NCT03350672|50089034|FG001|Overall Study|Withdrawal by Subject|0|||
24997890|NCT03350672|50089035|FG002|Overall Study|Withdrawal by Subject|0|||
24997891|NCT03392168|50089047|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
24997892|NCT03392168|50089048|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
24997893|NCT03392168|50089049|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
24997894|NCT03392168|50089050|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
24997895|NCT03392168|50089047|FG000|Period 2: Cohort 2|Other|0|||
24997896|NCT03392168|50089048|FG001|Period 2: Cohort 2|Other|1|||
24997897|NCT03392168|50089049|FG002|Period 2: Cohort 2|Other|0|||
24997898|NCT03392168|50089050|FG003|Period 2: Cohort 2|Other|0|||
24997899|NCT03391232|50089061|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
24997900|NCT03391232|50089062|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
24997901|NCT03391232|50089061|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
24997902|NCT03391232|50089062|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
24997903|NCT03379376|50089070|FG000|Overall Study|Lost to Follow-up|2|||
24997904|NCT03379376|50089070|FG000|Overall Study|Did not wish to complete follow up|1|||
24997905|NCT03379376|50089070|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
24997906|NCT03379376|50089070|FG000|Overall Study|Death|1|||
24997907|NCT03349034|50089076|FG000|Overall Study|catheters dislodged during transport|2|||
24997908|NCT03349034|50089077|FG001|Overall Study|catheters dislodged during transport|0|||
24997909|NCT03349034|50089076|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
24997910|NCT03349034|50089077|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
24997911|NCT03349034|50089076|FG000|Overall Study|soft tissue flap used|1|||
24997912|NCT03349034|50089077|FG001|Overall Study|soft tissue flap used|0|||
24997913|NCT03349034|50089076|FG000|Overall Study|Other|0|||
24997914|NCT03349034|50089077|FG001|Overall Study|Other|1|||
24997915|NCT00358215|50089087|FG000|Overall Study|Ineligibility determined|4|||
24997916|NCT00358215|50089088|FG001|Overall Study|Ineligibility determined|3|||
24997917|NCT00358215|50089087|FG000|Overall Study|Adverse Event|83|||
24997918|NCT00358215|50089088|FG001|Overall Study|Adverse Event|65|||
24997919|NCT00358215|50089087|FG000|Overall Study|Withdrawal by Subject|111|||
24997920|NCT00358215|50089088|FG001|Overall Study|Withdrawal by Subject|102|||
24997921|NCT00358215|50089087|FG000|Overall Study|Participant request|65|||
24997922|NCT00358215|50089088|FG001|Overall Study|Participant request|64|||
24997923|NCT00358215|50089087|FG000|Overall Study|Physician Decision|47|||
24997924|NCT00358215|50089088|FG001|Overall Study|Physician Decision|39|||
24997925|NCT00358215|50089087|FG000|Overall Study|Lost to Follow-up|16|||
24997926|NCT00358215|50089088|FG001|Overall Study|Lost to Follow-up|22|||
24997927|NCT00358215|50089087|FG000|Overall Study|Death|265|||
24997928|NCT00358215|50089088|FG001|Overall Study|Death|281|||
24997929|NCT00358215|50089087|FG000|Overall Study|Protocol Violation|64|||
24997930|NCT00358215|50089088|FG001|Overall Study|Protocol Violation|59|||
24997931|NCT00358215|50089087|FG000|Overall Study|Pregnancy|1|||
24997932|NCT00358215|50089088|FG001|Overall Study|Pregnancy|0|||
24997933|NCT00358215|50089087|FG000|Overall Study|Other|21|||
24997934|NCT00358215|50089088|FG001|Overall Study|Other|14|||
24997935|NCT00358215|50089087|FG000|Overall Study|Did not receive investigational product|2|||
24997936|NCT00358215|50089088|FG001|Overall Study|Did not receive investigational product|3|||
24997937|NCT02855164|50089102|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
24997938|NCT02855164|50089103|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
24997939|NCT02855164|50089104|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
24997940|NCT02855164|50089105|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
24997941|NCT02855164|50089106|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
24997942|NCT02855164|50089107|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
24997943|NCT02855164|50089108|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
24997944|NCT02855164|50089109|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
24997945|NCT02855164|50089102|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
24997946|NCT02855164|50089103|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
24997947|NCT02855164|50089104|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
24997948|NCT02855164|50089105|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
24997949|NCT02855164|50089106|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
24997950|NCT02855164|50089107|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
24997951|NCT02855164|50089108|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
24997952|NCT02855164|50089109|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
24997953|NCT02855164|50089102|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
24997954|NCT02855164|50089103|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
24997955|NCT02855164|50089104|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
24997956|NCT02855164|50089105|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
24997957|NCT02855164|50089106|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
24997958|NCT02855164|50089107|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
24997959|NCT02855164|50089108|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
24997960|NCT02855164|50089109|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
24997961|NCT02855164|50089102|FG000|Part C (Randomized Set)|Adverse Event|0|||
24997962|NCT02855164|50089103|FG001|Part C (Randomized Set)|Adverse Event|0|||
24997963|NCT02855164|50089104|FG002|Part C (Randomized Set)|Adverse Event|0|||
24997964|NCT02855164|50089105|FG003|Part C (Randomized Set)|Adverse Event|0|||
24997965|NCT02855164|50089106|FG004|Part C (Randomized Set)|Adverse Event|0|||
24997966|NCT02855164|50089107|FG005|Part C (Randomized Set)|Adverse Event|5|||
25176313|NCT01524887|50319469|FG000|Overall Study|Protocol Violation|0|||
25176314|NCT01524887|50319470|FG001|Overall Study|Protocol Violation|0|||
24997967|NCT02855164|50089108|FG006|Part C (Randomized Set)|Adverse Event|9|||
24997968|NCT02855164|50089109|FG007|Part C (Randomized Set)|Adverse Event|2|||
24997969|NCT02855164|50089102|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
24997970|NCT02855164|50089103|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
24997971|NCT02855164|50089104|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
24997972|NCT02855164|50089105|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
24997973|NCT02855164|50089106|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
24997974|NCT02855164|50089107|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
24997975|NCT02855164|50089108|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
24997976|NCT02855164|50089109|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
24997977|NCT02855164|50089102|FG000|Part C (Randomized Set)|Physician Decision|0|||
24997978|NCT02855164|50089103|FG001|Part C (Randomized Set)|Physician Decision|0|||
24997979|NCT02855164|50089104|FG002|Part C (Randomized Set)|Physician Decision|0|||
24997980|NCT02855164|50089105|FG003|Part C (Randomized Set)|Physician Decision|0|||
24997981|NCT02855164|50089106|FG004|Part C (Randomized Set)|Physician Decision|0|||
24997982|NCT02855164|50089107|FG005|Part C (Randomized Set)|Physician Decision|1|||
24997983|NCT02855164|50089108|FG006|Part C (Randomized Set)|Physician Decision|0|||
24997984|NCT02855164|50089109|FG007|Part C (Randomized Set)|Physician Decision|1|||
24997985|NCT02855164|50089102|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
24997986|NCT02855164|50089103|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
24997987|NCT02855164|50089104|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
24997988|NCT02855164|50089105|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
24997989|NCT02855164|50089106|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
24997990|NCT02855164|50089107|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
24997991|NCT02855164|50089108|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
24997992|NCT02855164|50089109|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
24997993|NCT01002742|50089149|FG000|Overall Study|Determined to be ineligible|0|||
24997994|NCT01002742|50089150|FG001|Overall Study|Determined to be ineligible|1|||
24997995|NCT02853760|50089156|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
24997996|NCT02853760|50089157|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
24997997|NCT02853760|50089158|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
24997998|NCT02853760|50089159|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
24997999|NCT02853760|50089160|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
24998000|NCT02853760|50089161|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
24998001|NCT02852434|50089171|FG000|Overall Study|Withdrawal by Subject|0|||
24998002|NCT02852434|50089172|FG001|Overall Study|Withdrawal by Subject|1|||
24998003|NCT02852434|50089171|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
24998004|NCT02852434|50089172|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
24998005|NCT02903368|50089180|FG000|Overall Study|Adverse Event|3|||
24998006|NCT02903368|50089181|FG001|Overall Study|Adverse Event|0|||
24998007|NCT02903368|50089180|FG000|Overall Study|Withdrawal by Subject|1|||
24998008|NCT02903368|50089181|FG001|Overall Study|Withdrawal by Subject|0|||
24998009|NCT02850016|50089189|FG000|Overall Study|Withdrawal by Subject|1|||
24998010|NCT02850016|50089190|FG001|Overall Study|Withdrawal by Subject|2|||
24998011|NCT02849704|50089198|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
24998012|NCT02849704|50089199|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
24998013|NCT02849704|50089198|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
24998014|NCT02849704|50089199|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
24998015|NCT02849704|50089198|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
24998016|NCT02849704|50089199|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
24998017|NCT03347396|50089220|FG000|Part A (26 Weeks)|Adverse Event|1|||
24998018|NCT03347396|50089221|FG001|Part A (26 Weeks)|Adverse Event|0|||
24998019|NCT03347396|50089220|FG000|Part A (26 Weeks)|Death|0|||
24998020|NCT03347396|50089221|FG001|Part A (26 Weeks)|Death|1|||
24998021|NCT03347396|50089220|FG000|Part B (149 Weeks)|Adverse Event|1|||
24998022|NCT03347396|50089221|FG001|Part B (149 Weeks)|Adverse Event|1|||
24998023|NCT03347396|50089220|FG000|Part B (149 Weeks)|Death|1|||
24998024|NCT03347396|50089221|FG001|Part B (149 Weeks)|Death|0|||
24998025|NCT03335150|50089232|FG000|Overall Study|Withdrawal by Subject|10|||
24998026|NCT03335150|50089233|FG001|Overall Study|Withdrawal by Subject|4|||
24998027|NCT03335150|50089232|FG000|Overall Study|Adverse Event|0|||
24998028|NCT03335150|50089233|FG001|Overall Study|Adverse Event|1|||
24998029|NCT03334448|50089239|FG000|Washout|Personal Reason|0|||
24998030|NCT03334448|50089240|FG001|Washout|Personal Reason|1|||
24998031|NCT03334448|50089241|FG002|Washout|Personal Reason|0|||
24998032|NCT03334448|50089242|FG003|Washout|Personal Reason|0|||
24998033|NCT03334448|50089239|FG000|Washout|Protocol Violation|0|||
24998034|NCT03334448|50089240|FG001|Washout|Protocol Violation|0|||
24998035|NCT03334448|50089241|FG002|Washout|Protocol Violation|0|||
24998036|NCT03334448|50089242|FG003|Washout|Protocol Violation|1|||
24998037|NCT02849080|50089250|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
24998038|NCT02849080|50089251|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
24998039|NCT02849080|50089252|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
24998040|NCT02849080|50089253|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
24998041|NCT02849080|50089250|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
24998042|NCT02849080|50089251|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
24998043|NCT02849080|50089252|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
24998044|NCT02849080|50089253|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
24998045|NCT02849080|50089250|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
24998046|NCT02849080|50089251|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
24998047|NCT02849080|50089252|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
24998048|NCT02849080|50089253|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
24998049|NCT02849080|50089250|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
24998050|NCT02849080|50089251|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
24998051|NCT02849080|50089252|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
24998052|NCT02849080|50089253|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
24998053|NCT02849080|50089250|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
24998054|NCT02849080|50089251|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
24998055|NCT02849080|50089252|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
24998056|NCT02849080|50089253|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
24998057|NCT02849080|50089250|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
24998058|NCT02849080|50089251|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
24998059|NCT02849080|50089252|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
24998060|NCT02849080|50089253|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
24998061|NCT03346070|50089270|FG000|Overall Study|Death|0|||
24998062|NCT03346070|50089271|FG001|Overall Study|Death|0|||
24998063|NCT03346070|50089272|FG002|Overall Study|Death|0|||
24998064|NCT03346070|50089273|FG003|Overall Study|Death|0|||
24998065|NCT03346070|50089274|FG004|Overall Study|Death|1|||
24998066|NCT03346070|50089270|FG000|Overall Study|Lost to Follow-up|0|||
24998067|NCT03346070|50089271|FG001|Overall Study|Lost to Follow-up|1|||
24998068|NCT03346070|50089272|FG002|Overall Study|Lost to Follow-up|2|||
24998069|NCT03346070|50089273|FG003|Overall Study|Lost to Follow-up|0|||
24998070|NCT03346070|50089274|FG004|Overall Study|Lost to Follow-up|0|||
24998071|NCT03346070|50089270|FG000|Overall Study|Physician Decision|0|||
24998072|NCT03346070|50089271|FG001|Overall Study|Physician Decision|0|||
24998073|NCT03346070|50089272|FG002|Overall Study|Physician Decision|0|||
24998074|NCT03346070|50089273|FG003|Overall Study|Physician Decision|1|||
24998075|NCT03346070|50089274|FG004|Overall Study|Physician Decision|1|||
24998076|NCT03346070|50089270|FG000|Overall Study|Withdrawal by Subject|1|||
24998077|NCT03346070|50089271|FG001|Overall Study|Withdrawal by Subject|0|||
24998078|NCT03346070|50089272|FG002|Overall Study|Withdrawal by Subject|0|||
24998079|NCT03346070|50089273|FG003|Overall Study|Withdrawal by Subject|1|||
24998080|NCT03346070|50089274|FG004|Overall Study|Withdrawal by Subject|0|||
24998081|NCT03346070|50089270|FG000|Overall Study|Study medication not received as planned|2|||
24998082|NCT03346070|50089271|FG001|Overall Study|Study medication not received as planned|3|||
24998083|NCT03346070|50089272|FG002|Overall Study|Study medication not received as planned|2|||
24998084|NCT03346070|50089273|FG003|Overall Study|Study medication not received as planned|3|||
24998085|NCT03346070|50089274|FG004|Overall Study|Study medication not received as planned|2|||
24998086|NCT03346070|50089270|FG000|Overall Study|Screen Failure|0|||
24998087|NCT03346070|50089271|FG001|Overall Study|Screen Failure|0|||
24998088|NCT03346070|50089272|FG002|Overall Study|Screen Failure|0|||
24998089|NCT03346070|50089273|FG003|Overall Study|Screen Failure|1|||
24998090|NCT03346070|50089274|FG004|Overall Study|Screen Failure|1|||
24998091|NCT02951780|50089297|FG000|Period 1|Adverse Event|0|||
24998092|NCT02951780|50089298|FG001|Period 1|Adverse Event|0|||
24998093|NCT02951780|50089299|FG002|Period 1|Adverse Event|0|||
24998094|NCT02951780|50089300|FG003|Period 1|Adverse Event|1|||
24998095|NCT02951780|50089301|FG004|Period 1|Adverse Event|0|||
24998096|NCT02951780|50089302|FG005|Period 1|Adverse Event|0|||
24998097|NCT02951780|50089303|FG006|Period 1|Adverse Event|0|||
24998098|NCT02951780|50089304|FG007|Period 1|Adverse Event|0|||
24998099|NCT02951780|50089305|FG008|Period 1|Adverse Event|0|||
24998100|NCT02951780|50089297|FG000|Period 1|Scheduling Conflicts|0|||
24998101|NCT02951780|50089298|FG001|Period 1|Scheduling Conflicts|0|||
24998102|NCT02951780|50089299|FG002|Period 1|Scheduling Conflicts|0|||
24998103|NCT02951780|50089300|FG003|Period 1|Scheduling Conflicts|0|||
24998104|NCT02951780|50089301|FG004|Period 1|Scheduling Conflicts|0|||
24998105|NCT02951780|50089302|FG005|Period 1|Scheduling Conflicts|0|||
24998106|NCT02951780|50089303|FG006|Period 1|Scheduling Conflicts|0|||
24998107|NCT02951780|50089304|FG007|Period 1|Scheduling Conflicts|1|||
24998108|NCT02951780|50089305|FG008|Period 1|Scheduling Conflicts|0|||
24998109|NCT02951780|50089297|FG000|Period 2|Scheduling Conflicts|0|||
24998110|NCT02951780|50089298|FG001|Period 2|Scheduling Conflicts|0|||
24998111|NCT02951780|50089299|FG002|Period 2|Scheduling Conflicts|0|||
24998112|NCT02951780|50089300|FG003|Period 2|Scheduling Conflicts|0|||
24998113|NCT02951780|50089301|FG004|Period 2|Scheduling Conflicts|0|||
24998114|NCT02951780|50089302|FG005|Period 2|Scheduling Conflicts|0|||
24998115|NCT02951780|50089303|FG006|Period 2|Scheduling Conflicts|0|||
24998116|NCT02951780|50089304|FG007|Period 2|Scheduling Conflicts|1|||
24998117|NCT02951780|50089305|FG008|Period 2|Scheduling Conflicts|0|||
24998118|NCT03334214|50089327|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
24998119|NCT03334214|50089328|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
24998120|NCT03334214|50089327|FG000|Overall Study|Withdrawal by Subject|0|||
24998121|NCT03334214|50089328|FG001|Overall Study|Withdrawal by Subject|1|||
24998122|NCT03334214|50089327|FG000|Overall Study|Other|1|||
24998123|NCT03334214|50089328|FG001|Overall Study|Other|0|||
24998124|NCT02250664|50089338|FG000|Overall Study|Lost to Follow-up|18|||
24998125|NCT02250664|50089339|FG001|Overall Study|Lost to Follow-up|28|||
24998126|NCT02250664|50089340|FG002|Overall Study|Lost to Follow-up|33|||
24998127|NCT02250664|50089338|FG000|Overall Study|Personal Reasons|7|||
24998128|NCT02250664|50089339|FG001|Overall Study|Personal Reasons|8|||
24998129|NCT02250664|50089340|FG002|Overall Study|Personal Reasons|14|||
24998130|NCT02250664|50089338|FG000|Overall Study|Adverse Event|6|||
24998131|NCT02250664|50089339|FG001|Overall Study|Adverse Event|3|||
24998132|NCT02250664|50089340|FG002|Overall Study|Adverse Event|8|||
24998133|NCT02250664|50089338|FG000|Overall Study|Incarcerated|2|||
24998134|NCT02250664|50089339|FG001|Overall Study|Incarcerated|1|||
24998135|NCT02250664|50089340|FG002|Overall Study|Incarcerated|2|||
24998136|NCT02250664|50089338|FG000|Overall Study|Withdrawal by Subject|0|||
24998137|NCT02250664|50089339|FG001|Overall Study|Withdrawal by Subject|1|||
24998138|NCT02250664|50089340|FG002|Overall Study|Withdrawal by Subject|2|||
24998139|NCT02250664|50089338|FG000|Overall Study|Death|0|||
24998140|NCT02250664|50089339|FG001|Overall Study|Death|1|||
24998141|NCT02250664|50089340|FG002|Overall Study|Death|1|||
24998142|NCT02250664|50089338|FG000|Overall Study|Physician Decision|1|||
24998143|NCT02250664|50089339|FG001|Overall Study|Physician Decision|3|||
24998144|NCT02250664|50089340|FG002|Overall Study|Physician Decision|1|||
24998145|NCT02250664|50089338|FG000|Overall Study|Protocol Violation|1|||
24998146|NCT02250664|50089339|FG001|Overall Study|Protocol Violation|0|||
24998147|NCT02250664|50089340|FG002|Overall Study|Protocol Violation|1|||
24998148|NCT02250664|50089338|FG000|Overall Study|Reason unknown|1|||
24998149|NCT02250664|50089339|FG001|Overall Study|Reason unknown|0|||
24998150|NCT02250664|50089340|FG002|Overall Study|Reason unknown|0|||
24998151|NCT02646982|50089350|FG000|Overall Study|Adverse Event|1|||
24998152|NCT02646982|50089351|FG001|Overall Study|Adverse Event|1|||
24998153|NCT02646982|50089350|FG000|Overall Study|Withdrawal by Subject|2|||
24998154|NCT02646982|50089351|FG001|Overall Study|Withdrawal by Subject|1|||
24998155|NCT02845336|50089359|FG000|Overall Study|Lost to Follow-up|3|||
24998156|NCT02845336|50089360|FG001|Overall Study|Lost to Follow-up|1|||
24998157|NCT02845336|50089359|FG000|Overall Study|Inability to get medication|2|||
24998158|NCT02845336|50089360|FG001|Overall Study|Inability to get medication|0|||
24998159|NCT02844946|50089368|FG000|Overall Study|Lost to Follow-up|7|||
24998160|NCT02844946|50089369|FG001|Overall Study|Lost to Follow-up|0|||
24998161|NCT02951156|50089378|FG000|Overall Study|Death|3|||
24998162|NCT02951156|50089379|FG001|Overall Study|Death|8|||
24998163|NCT02951156|50089380|FG002|Overall Study|Death|5|||
24998164|NCT02951156|50089378|FG000|Overall Study|Progressive disease|1|||
24998165|NCT02951156|50089379|FG001|Overall Study|Progressive disease|0|||
24998166|NCT02951156|50089380|FG002|Overall Study|Progressive disease|1|||
24998167|NCT02951156|50089378|FG000|Overall Study|Withdrawal by Subject|0|||
24998168|NCT02951156|50089379|FG001|Overall Study|Withdrawal by Subject|0|||
24998169|NCT02951156|50089380|FG002|Overall Study|Withdrawal by Subject|1|||
24998170|NCT02951156|50089378|FG000|Overall Study|Study terminated by sponsor|0|||
24998171|NCT02951156|50089379|FG001|Overall Study|Study terminated by sponsor|0|||
24998172|NCT02951156|50089380|FG002|Overall Study|Study terminated by sponsor|1|||
24998173|NCT02951156|50089378|FG000|Overall Study|Other|5|||
24998174|NCT02951156|50089379|FG001|Overall Study|Other|1|||
24998175|NCT02951156|50089380|FG002|Overall Study|Other|2|||
24998176|NCT03345914|50089392|FG000|Overall Study|Transition to another study at week 16|80|||
24998177|NCT03345914|50089393|FG001|Overall Study|Transition to another study at week 16|86|||
24998178|NCT03345914|50089394|FG002|Overall Study|Transition to another study at week 16|78|||
24998179|NCT03345914|50089392|FG000|Overall Study|Transition to OLE during follow-up|37|||
24998180|NCT03345914|50089393|FG001|Overall Study|Transition to OLE during follow-up|33|||
24998181|NCT03345914|50089394|FG002|Overall Study|Transition to OLE during follow-up|39|||
24998182|NCT03345914|50089392|FG000|Overall Study|Physician Decision|0|||
25176315|NCT01524887|50319471|FG002|Overall Study|Protocol Violation|1|||
24998183|NCT03345914|50089393|FG001|Overall Study|Physician Decision|1|||
24998184|NCT03345914|50089394|FG002|Overall Study|Physician Decision|1|||
24998185|NCT03345914|50089392|FG000|Overall Study|Withdrawal by Subject|5|||
24998186|NCT03345914|50089393|FG001|Overall Study|Withdrawal by Subject|1|||
24998187|NCT03345914|50089394|FG002|Overall Study|Withdrawal by Subject|2|||
24998188|NCT03345914|50089392|FG000|Overall Study|Other|1|||
24998189|NCT03345914|50089393|FG001|Overall Study|Other|1|||
24998190|NCT03345914|50089394|FG002|Overall Study|Other|1|||
24998191|NCT03345914|50089392|FG000|Overall Study|Ongoing|0|||
24998192|NCT03345914|50089393|FG001|Overall Study|Ongoing|0|||
24998193|NCT03345914|50089394|FG002|Overall Study|Ongoing|1|||
24998194|NCT03369704|50089404|FG000|Treatment Epoch|technical problems|1|||
24998195|NCT03369704|50089405|FG001|Treatment Epoch|technical problems|0|||
24998196|NCT03369704|50089404|FG000|Treatment Epoch|Protocol Violation|1|||
24998197|NCT03369704|50089405|FG001|Treatment Epoch|Protocol Violation|0|||
24998198|NCT03369704|50089404|FG000|Treatment Epoch|Lost to Follow-up|0|||
24998199|NCT03369704|50089405|FG001|Treatment Epoch|Lost to Follow-up|1|||
24998200|NCT03369704|50089404|FG000|Treatment Epoch|Lack of Efficacy|0|||
24998201|NCT03369704|50089405|FG001|Treatment Epoch|Lack of Efficacy|2|||
24998202|NCT03369704|50089404|FG000|Treatment Epoch|Adverse Event|2|||
24998203|NCT03369704|50089405|FG001|Treatment Epoch|Adverse Event|0|||
24998204|NCT03369704|50089404|FG000|Follow-up Epoch|Lost to Follow-up|1|||
24998205|NCT03369704|50089405|FG001|Follow-up Epoch|Lost to Follow-up|0|||
24998206|NCT03366428|50089411|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
24998207|NCT03366428|50089411|FG000|Overall Study|Adverse Event|12|||
24998208|NCT03366428|50089411|FG000|Overall Study|Clinical progression|2|||
24998209|NCT03366428|50089411|FG000|Overall Study|Withdrawal by Subject|4|||
24998210|NCT02839876|50089419|FG000|Overall Study|Protocol Violation|10|||
24998211|NCT02839876|50089420|FG001|Overall Study|Protocol Violation|11|||
24998212|NCT03366194|50089426|FG000|Overall Study|Lost to Follow-up|2|||
24998213|NCT02839798|50089431|FG000|Overall Study|Withdrawal by Subject|2|||
24998214|NCT03345836|50089438|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
24998215|NCT03345836|50089439|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
24998216|NCT03345836|50089440|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
24998217|NCT03345836|50089441|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
24998218|NCT03345836|50089442|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
24998219|NCT03345836|50089443|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
24998220|NCT03345836|50089438|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
24998221|NCT03345836|50089439|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
24998222|NCT03345836|50089440|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
24998223|NCT03345836|50089441|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
24998224|NCT03345836|50089442|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
24998225|NCT03345836|50089443|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
24998226|NCT03345836|50089438|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
24998227|NCT03345836|50089439|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
24998228|NCT03345836|50089440|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
24998229|NCT03345836|50089441|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
24998230|NCT03345836|50089442|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
24998231|NCT03345836|50089443|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
24998232|NCT03345836|50089438|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
24998233|NCT03345836|50089439|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
24998234|NCT03345836|50089440|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
24998235|NCT03345836|50089441|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
24998236|NCT03345836|50089442|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
24998237|NCT03345836|50089443|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
24998238|NCT03345836|50089438|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
24998239|NCT03345836|50089439|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
24998240|NCT03345836|50089440|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
24998241|NCT03345836|50089441|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
24998242|NCT03345836|50089442|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
24998243|NCT03345836|50089443|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
24998244|NCT03345836|50089438|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
24998245|NCT03345836|50089439|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
24998246|NCT03345836|50089440|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
24998247|NCT03345836|50089441|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
24998248|NCT03345836|50089442|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
24998249|NCT03345836|50089443|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
24998250|NCT03345836|50089438|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
24998251|NCT03345836|50089439|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
24998252|NCT03345836|50089440|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
24998253|NCT03345836|50089441|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
24998254|NCT03345836|50089442|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
24998255|NCT03345836|50089443|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
24998256|NCT03345836|50089438|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
24998257|NCT03345836|50089439|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
24998258|NCT03345836|50089440|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
24998259|NCT03345836|50089441|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
24998260|NCT03345836|50089442|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
24998261|NCT03345836|50089443|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
24998262|NCT03345836|50089438|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
24998263|NCT03345836|50089439|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
24998264|NCT03345836|50089440|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
24998265|NCT03345836|50089441|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
24998266|NCT03345836|50089442|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
24998267|NCT03345836|50089443|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
24998268|NCT03345836|50089438|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
24998269|NCT03345836|50089439|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
24998270|NCT03345836|50089440|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
24998271|NCT03345836|50089441|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
24998272|NCT03345836|50089442|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
24998273|NCT03345836|50089443|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
24998274|NCT03345836|50089438|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
24998275|NCT03345836|50089439|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
24998276|NCT03345836|50089440|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
24998277|NCT03345836|50089441|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
24998278|NCT03345836|50089442|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
24998279|NCT03345836|50089443|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
24998280|NCT02839330|50089463|FG000|Overall Study|Adverse Event|0|||
24998281|NCT02839330|50089464|FG001|Overall Study|Adverse Event|1|||
24998282|NCT02839330|50089465|FG002|Overall Study|Adverse Event|2|||
24998283|NCT02839330|50089466|FG003|Overall Study|Adverse Event|2|||
24998284|NCT02839330|50089463|FG000|Overall Study|Death|4|||
24998285|NCT02839330|50089464|FG001|Overall Study|Death|6|||
24998286|NCT02839330|50089465|FG002|Overall Study|Death|1|||
24998287|NCT02839330|50089466|FG003|Overall Study|Death|1|||
24998288|NCT02839330|50089463|FG000|Overall Study|Withdrawal by Subject|27|||
24998289|NCT02839330|50089464|FG001|Overall Study|Withdrawal by Subject|19|||
24998290|NCT02839330|50089465|FG002|Overall Study|Withdrawal by Subject|11|||
24998291|NCT02839330|50089466|FG003|Overall Study|Withdrawal by Subject|13|||
24998292|NCT02839330|50089463|FG000|Overall Study|Lost to Follow-up|22|||
24998293|NCT02839330|50089464|FG001|Overall Study|Lost to Follow-up|27|||
24998294|NCT02839330|50089465|FG002|Overall Study|Lost to Follow-up|29|||
24998295|NCT02839330|50089466|FG003|Overall Study|Lost to Follow-up|25|||
24998296|NCT02839330|50089463|FG000|Overall Study|Administrative Reason|0|||
24998297|NCT02839330|50089464|FG001|Overall Study|Administrative Reason|0|||
24998298|NCT02839330|50089465|FG002|Overall Study|Administrative Reason|0|||
24998299|NCT02839330|50089466|FG003|Overall Study|Administrative Reason|1|||
24998300|NCT02839330|50089463|FG000|Overall Study|Protocol Violation|1|||
24998301|NCT02839330|50089464|FG001|Overall Study|Protocol Violation|2|||
24998302|NCT02839330|50089465|FG002|Overall Study|Protocol Violation|2|||
24998303|NCT02839330|50089466|FG003|Overall Study|Protocol Violation|3|||
24998304|NCT02839330|50089463|FG000|Overall Study|Other reason, not specified|4|||
24998305|NCT02839330|50089464|FG001|Overall Study|Other reason, not specified|3|||
24998306|NCT02839330|50089465|FG002|Overall Study|Other reason, not specified|3|||
24998307|NCT02839330|50089466|FG003|Overall Study|Other reason, not specified|6|||
24998308|NCT03363776|50089480|FG000|Overall Study|Progressive disease|2|||
24998309|NCT03363776|50089481|FG001|Overall Study|Progressive disease|3|||
24998310|NCT03363776|50089482|FG002|Overall Study|Progressive disease|1|||
24998311|NCT03363776|50089480|FG000|Overall Study|Study drug toxicity|0|||
24998312|NCT03363776|50089481|FG001|Overall Study|Study drug toxicity|0|||
24998313|NCT03363776|50089482|FG002|Overall Study|Study drug toxicity|1|||
24998314|NCT03363776|50089480|FG000|Overall Study|Death|1|||
24998315|NCT03363776|50089481|FG001|Overall Study|Death|0|||
24998316|NCT03363776|50089482|FG002|Overall Study|Death|0|||
24998317|NCT03360344|50089493|FG000|Overall Study|Withdrawal by Subject|0|||
24998318|NCT03360344|50089494|FG001|Overall Study|Withdrawal by Subject|1|||
24998319|NCT03360344|50089495|FG002|Overall Study|Withdrawal by Subject|1|||
24998320|NCT02838628|50089505|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
24998321|NCT02838628|50089506|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
24998322|NCT02838628|50089505|FG000|Recurrence Follow-up Period|Adverse Event|1|||
24998323|NCT02838628|50089506|FG001|Recurrence Follow-up Period|Adverse Event|0|||
24998324|NCT02838628|50089505|FG000|Recurrence Follow-up Period|Non-compliance|0|||
24998325|NCT02838628|50089506|FG001|Recurrence Follow-up Period|Non-compliance|1|||
24998326|NCT02838628|50089505|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
24998327|NCT02838628|50089506|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
24998328|NCT02838628|50089505|FG000|Recurrence Follow-up Period|Other un-specified|1|||
24998329|NCT02838628|50089506|FG001|Recurrence Follow-up Period|Other un-specified|1|||
24998330|NCT02835820|50089515|FG000|Overall Study|Baseline Screen Failure|0|||
24998331|NCT02835820|50089516|FG001|Overall Study|Baseline Screen Failure|3|||
24998332|NCT03359174|50089522|FG000|Overall Study|Adverse Event|1|||
24998333|NCT02832622|50089526|FG000|Overall Study|MPP not programmed|1259|||
24998334|NCT02832622|50089526|FG000|Overall Study|Withdrawal by Subject|123|||
24998335|NCT02832622|50089526|FG000|Overall Study|Death|119|||
24998336|NCT02832622|50089526|FG000|Overall Study|Unsuccessful CRT implant|93|||
24998337|NCT02832622|50089526|FG000|Overall Study|Lost to Follow-up|45|||
24998338|NCT02832622|50089526|FG000|Overall Study|Patient non-compliance|42|||
24998339|NCT02832622|50089526|FG000|Overall Study|Withdrawal by other reasons|25|||
24998340|NCT02832622|50089526|FG000|Overall Study|System explant|24|||
24998341|NCT02832622|50089526|FG000|Overall Study|Physician Decision|6|||
24998342|NCT00093015|50089533|FG000|Overall Study|Withdrawal by Subject|194|||
24998343|NCT00093015|50089534|FG001|Overall Study|Withdrawal by Subject|171|||
24998344|NCT00093015|50089533|FG000|Overall Study|Lost to Follow-up|96|||
24998345|NCT00093015|50089534|FG001|Overall Study|Lost to Follow-up|108|||
24998346|NCT00093015|50089533|FG000|Overall Study|Death|375|||
24998347|NCT00093015|50089534|FG001|Overall Study|Death|385|||
24998348|NCT03358472|50089543|FG000|Overall Study|Death|6|||
24998349|NCT03358472|50089544|FG001|Overall Study|Death|3|||
24998350|NCT03358472|50089545|FG002|Overall Study|Death|10|||
24998351|NCT03358472|50089543|FG000|Overall Study|Physician Decision|0|||
24998352|NCT03358472|50089544|FG001|Overall Study|Physician Decision|1|||
24998353|NCT03358472|50089545|FG002|Overall Study|Physician Decision|0|||
24998354|NCT03358472|50089543|FG000|Overall Study|Withdrawal by Subject|0|||
24998355|NCT03358472|50089544|FG001|Overall Study|Withdrawal by Subject|0|||
24998356|NCT03358472|50089545|FG002|Overall Study|Withdrawal by Subject|1|||
24998357|NCT03358472|50089543|FG000|Overall Study|On-going at clinical cut off date|9|||
24998358|NCT03358472|50089544|FG001|Overall Study|On-going at clinical cut off date|6|||
24998359|NCT03358472|50089545|FG002|Overall Study|On-going at clinical cut off date|5|||
24998360|NCT03358238|50089555|FG000|Overall Study|Withdrawal by Subject|0|||
24998361|NCT03358238|50089556|FG001|Overall Study|Withdrawal by Subject|1|||
24998362|NCT03342638|50089568|FG000|Overall Study|Withdrawal by Subject|1|||
24998363|NCT03342638|50089569|FG001|Overall Study|Withdrawal by Subject|0|||
24998364|NCT03342638|50089568|FG000|Overall Study|Physician Decision|0|||
24998365|NCT03342638|50089569|FG001|Overall Study|Physician Decision|1|||
24998366|NCT03342560|50089575|FG000|Overall Study|Lost to Follow-up|2|||
24998367|NCT03355742|50089592|FG000|Overall Study|Lost to Follow-up|4|||
24998368|NCT03355742|50089592|FG000|Overall Study|Withdrawal by Subject|29|||
24998369|NCT03355742|50089592|FG000|Overall Study|Physician Decision|6|||
24998370|NCT03355742|50089592|FG000|Overall Study|Death|55|||
24998371|NCT03355742|50089592|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
24998372|NCT03341312|50089596|FG000|Period 1|Withdrawal by Subject|0|||
24998373|NCT03341312|50089597|FG001|Period 1|Withdrawal by Subject|1|||
24998374|NCT03341312|50089598|FG002|Period 1|Withdrawal by Subject|0|||
24998375|NCT03341312|50089599|FG003|Period 1|Withdrawal by Subject|0|||
24998376|NCT02949908|50089611|FG000|Overall Study|Study termination|2|||
24998377|NCT01358734|50089618|FG000|Overall Study|Adverse Event|4|||
24998378|NCT01358734|50089619|FG001|Overall Study|Adverse Event|7|||
24998379|NCT01358734|50089620|FG002|Overall Study|Adverse Event|3|||
24998380|NCT01358734|50089618|FG000|Overall Study|Lack of Efficacy|0|||
24998381|NCT01358734|50089619|FG001|Overall Study|Lack of Efficacy|1|||
24998382|NCT01358734|50089620|FG002|Overall Study|Lack of Efficacy|3|||
24998383|NCT01358734|50089618|FG000|Overall Study|Withdrawal by Subject|1|||
24998384|NCT01358734|50089619|FG001|Overall Study|Withdrawal by Subject|6|||
24998385|NCT01358734|50089620|FG002|Overall Study|Withdrawal by Subject|3|||
24998386|NCT01358734|50089618|FG000|Overall Study|Death|3|||
24998387|NCT01358734|50089619|FG001|Overall Study|Death|7|||
24998388|NCT01358734|50089620|FG002|Overall Study|Death|2|||
24998389|NCT01358734|50089618|FG000|Overall Study|Progressive Disease|5|||
24998390|NCT01358734|50089619|FG001|Overall Study|Progressive Disease|13|||
24998391|NCT01358734|50089620|FG002|Overall Study|Progressive Disease|16|||
24998392|NCT01358734|50089618|FG000|Overall Study|Non-compliance with study drug|0|||
24998393|NCT01358734|50089619|FG001|Overall Study|Non-compliance with study drug|0|||
24998394|NCT01358734|50089620|FG002|Overall Study|Non-compliance with study drug|1|||
24998395|NCT01358734|50089618|FG000|Overall Study|Other|2|||
24998396|NCT01358734|50089619|FG001|Overall Study|Other|5|||
24998397|NCT01358734|50089620|FG002|Overall Study|Other|4|||
24998398|NCT01358734|50089618|FG000|Overall Study|Protocol Violation|0|||
24998399|NCT01358734|50089619|FG001|Overall Study|Protocol Violation|0|||
24998400|NCT01358734|50089620|FG002|Overall Study|Protocol Violation|2|||
24998401|NCT01341652|50089630|FG000|Overall Study|Incorrect Random Assignment|0|||
24998402|NCT01341652|50089631|FG001|Overall Study|Incorrect Random Assignment|1|||
25176316|NCT01524887|50319469|FG000|Overall Study|Study termination|73|||
24998403|NCT01341652|50089630|FG000|Overall Study|ineligible; presence metastatic disease|0|||
24998404|NCT01341652|50089631|FG001|Overall Study|ineligible; presence metastatic disease|1|||
24998405|NCT02828644|50089639|FG000|Overall Study|Lost to Follow-up|23|||
24998406|NCT02828644|50089640|FG001|Overall Study|Lost to Follow-up|22|||
24998407|NCT02949362|50089649|FG000|Retrospective Period|Inform consent not signed by participant|4|||
24998408|NCT02949362|50089650|FG001|Retrospective Period|Inform consent not signed by participant|1|||
24998409|NCT02949362|50089651|FG002|Retrospective Period|Inform consent not signed by participant|0|||
24998410|NCT02949362|50089652|FG003|Retrospective Period|Inform consent not signed by participant|0|||
24998411|NCT02949362|50089649|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
25067259|NCT01367665|50172837|FG001|Overall Study|Death|19|||
24998412|NCT02949362|50089650|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
24998413|NCT02949362|50089651|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
24998414|NCT02949362|50089652|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
24998415|NCT02949362|50089649|FG000|Prospective Period|Other|0|||
24998416|NCT02949362|50089650|FG001|Prospective Period|Other|0|||
24998417|NCT02949362|50089651|FG002|Prospective Period|Other|0|||
24998418|NCT02949362|50089652|FG003|Prospective Period|Other|4|||
24998419|NCT02947022|50089664|FG000|Overall Study|Study Stopped|1|||
24998420|NCT03338972|50089675|FG000|Overall Study|Death|1|||
24998421|NCT03338972|50089676|FG001|Overall Study|Death|1|||
24998422|NCT03338972|50089677|FG002|Overall Study|Death|0|||
24998423|NCT03338972|50089678|FG003|Overall Study|Death|0|||
24998424|NCT03338972|50089675|FG000|Overall Study|Withdrawal by Subject|1|||
24998425|NCT03338972|50089676|FG001|Overall Study|Withdrawal by Subject|0|||
24998426|NCT03338972|50089677|FG002|Overall Study|Withdrawal by Subject|0|||
24998427|NCT03338972|50089678|FG003|Overall Study|Withdrawal by Subject|0|||
24998428|NCT03338894|50089688|FG000|Overall Study|not able able to attend 9 or more classes|10|||
24998429|NCT03338816|50089694|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
24998430|NCT03338816|50089695|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
24998431|NCT03338816|50089696|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
24998432|NCT03338816|50089697|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
24998433|NCT03338816|50089694|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
24998434|NCT03338816|50089695|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
24998435|NCT03338816|50089696|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
24998436|NCT03338816|50089697|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
24998437|NCT03338816|50089694|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
24998438|NCT03338816|50089695|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
24998439|NCT03338816|50089696|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
24998440|NCT03338816|50089697|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
24998441|NCT03338816|50089694|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
24998442|NCT03338816|50089695|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
24998443|NCT03338816|50089696|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
24998444|NCT03338816|50089697|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
24998445|NCT03338816|50089694|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
24998446|NCT03338816|50089695|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
24998447|NCT03338816|50089696|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
24998448|NCT03338816|50089697|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
24998449|NCT03338816|50089694|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
24998450|NCT03338816|50089695|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
24998451|NCT03338816|50089696|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
24998452|NCT03338816|50089697|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
24998453|NCT03338816|50089694|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
24998454|NCT03338816|50089695|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
24998455|NCT03338816|50089696|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
24998456|NCT03338816|50089697|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
24998457|NCT03337490|50089709|FG000|Overall Study|Withdrawal by Subject|1|||
24998458|NCT03337490|50089710|FG001|Overall Study|Withdrawal by Subject|0|||
24998459|NCT03337490|50089711|FG002|Overall Study|Withdrawal by Subject|0|||
24998460|NCT03337490|50089709|FG000|Overall Study|Lack of Efficacy|10|||
24998461|NCT03337490|50089710|FG001|Overall Study|Lack of Efficacy|12|||
24998462|NCT03337490|50089711|FG002|Overall Study|Lack of Efficacy|35|||
24998463|NCT03337490|50089709|FG000|Overall Study|Physician Decision|0|||
24998464|NCT03337490|50089710|FG001|Overall Study|Physician Decision|1|||
24998465|NCT03337490|50089711|FG002|Overall Study|Physician Decision|0|||
24998466|NCT03337490|50089709|FG000|Overall Study|Lost to Follow-up|0|||
24998467|NCT03337490|50089710|FG001|Overall Study|Lost to Follow-up|1|||
24998468|NCT03337490|50089711|FG002|Overall Study|Lost to Follow-up|0|||
24998469|NCT02944448|50089721|FG000|Overall Study|Adverse Event|37|||
24998470|NCT02944448|50089722|FG001|Overall Study|Adverse Event|6|||
24998471|NCT02944448|50089721|FG000|Overall Study|Lack of Efficacy|8|||
24998472|NCT02944448|50089722|FG001|Overall Study|Lack of Efficacy|5|||
24998473|NCT02944448|50089721|FG000|Overall Study|Lost to Follow-up|3|||
24998474|NCT02944448|50089722|FG001|Overall Study|Lost to Follow-up|1|||
24998475|NCT02944448|50089721|FG000|Overall Study|Protocol Violation|25|||
25176317|NCT01524887|50319470|FG001|Overall Study|Study termination|87|||
24998476|NCT02944448|50089722|FG001|Overall Study|Protocol Violation|7|||
24998477|NCT02944448|50089721|FG000|Overall Study|Withdrawal by Subject|14|||
24998478|NCT02944448|50089722|FG001|Overall Study|Withdrawal by Subject|4|||
24998479|NCT02944448|50089721|FG000|Overall Study|Sponsor did not supply drug in time|0|||
24998480|NCT02944448|50089722|FG001|Overall Study|Sponsor did not supply drug in time|1|||
24998481|NCT02944448|50089721|FG000|Overall Study|Noncompliant with dosing|1|||
24998482|NCT02944448|50089722|FG001|Overall Study|Noncompliant with dosing|0|||
24998483|NCT02944448|50089721|FG000|Overall Study|Abnormal laboratory values|1|||
24998484|NCT02944448|50089722|FG001|Overall Study|Abnormal laboratory values|0|||
24998485|NCT02943668|50089729|FG000|Overall Study|Disease Progression|1|||
24998486|NCT02891408|50089764|FG000|Overall Study|Lost to Follow-up|0|||
24998487|NCT02891408|50089765|FG001|Overall Study|Lost to Follow-up|0|||
24998488|NCT02891408|50089766|FG002|Overall Study|Lost to Follow-up|1|||
24998489|NCT02891408|50089767|FG003|Overall Study|Lost to Follow-up|0|||
24998490|NCT02891408|50089768|FG004|Overall Study|Lost to Follow-up|0|||
24998491|NCT02891408|50089769|FG005|Overall Study|Lost to Follow-up|0|||
24998492|NCT02891408|50089770|FG006|Overall Study|Lost to Follow-up|0|||
24998493|NCT03283670|50089796|FG000|Placebo Gas|Withdrawal by Subject|2|||
24998494|NCT03283670|50089796|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
24998495|NCT03283670|50089796|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
24998496|NCT01358578|50089817|FG000|Induction Period|Adverse Event|2|||
24998497|NCT01358578|50089818|FG001|Induction Period|Adverse Event|4|||
24998498|NCT01358578|50089819|FG002|Induction Period|Adverse Event|2|||
24998499|NCT01358578|50089820|FG003|Induction Period|Adverse Event|6|||
24998500|NCT01358578|50089821|FG004|Induction Period|Adverse Event|0|||
24998501|NCT01358578|50089822|FG005|Induction Period|Adverse Event|0|||
24998502|NCT01358578|50089817|FG000|Induction Period|Lack of Efficacy|0|||
24998503|NCT01358578|50089818|FG001|Induction Period|Lack of Efficacy|0|||
24998504|NCT01358578|50089819|FG002|Induction Period|Lack of Efficacy|9|||
24998505|NCT01358578|50089820|FG003|Induction Period|Lack of Efficacy|1|||
24998506|NCT01358578|50089821|FG004|Induction Period|Lack of Efficacy|0|||
24998507|NCT01358578|50089822|FG005|Induction Period|Lack of Efficacy|0|||
24998508|NCT01358578|50089817|FG000|Induction Period|Lost to Follow-up|0|||
24998509|NCT01358578|50089818|FG001|Induction Period|Lost to Follow-up|0|||
24998510|NCT01358578|50089819|FG002|Induction Period|Lost to Follow-up|1|||
24998511|NCT01358578|50089820|FG003|Induction Period|Lost to Follow-up|4|||
24998512|NCT01358578|50089821|FG004|Induction Period|Lost to Follow-up|0|||
24998513|NCT01358578|50089822|FG005|Induction Period|Lost to Follow-up|0|||
24998514|NCT01358578|50089817|FG000|Induction Period|Physician Decision|2|||
24998515|NCT01358578|50089818|FG001|Induction Period|Physician Decision|1|||
24998516|NCT01358578|50089819|FG002|Induction Period|Physician Decision|2|||
24998517|NCT01358578|50089820|FG003|Induction Period|Physician Decision|0|||
24998518|NCT01358578|50089821|FG004|Induction Period|Physician Decision|0|||
24998519|NCT01358578|50089822|FG005|Induction Period|Physician Decision|0|||
24998520|NCT01358578|50089817|FG000|Induction Period|Protocol Deviation|3|||
24998521|NCT01358578|50089818|FG001|Induction Period|Protocol Deviation|5|||
24998522|NCT01358578|50089819|FG002|Induction Period|Protocol Deviation|0|||
24998523|NCT01358578|50089820|FG003|Induction Period|Protocol Deviation|3|||
24998524|NCT01358578|50089821|FG004|Induction Period|Protocol Deviation|0|||
24998525|NCT01358578|50089822|FG005|Induction Period|Protocol Deviation|0|||
24998526|NCT01358578|50089817|FG000|Induction Period|technical problems|0|||
24998527|NCT01358578|50089818|FG001|Induction Period|technical problems|0|||
24998528|NCT01358578|50089819|FG002|Induction Period|technical problems|1|||
24998529|NCT01358578|50089820|FG003|Induction Period|technical problems|1|||
24998530|NCT01358578|50089821|FG004|Induction Period|technical problems|0|||
24998531|NCT01358578|50089822|FG005|Induction Period|technical problems|0|||
24998532|NCT01358578|50089817|FG000|Induction Period|Withdrawal by Subject|5|||
24998533|NCT01358578|50089818|FG001|Induction Period|Withdrawal by Subject|5|||
24998534|NCT01358578|50089819|FG002|Induction Period|Withdrawal by Subject|10|||
24998535|NCT01358578|50089820|FG003|Induction Period|Withdrawal by Subject|6|||
24998536|NCT01358578|50089821|FG004|Induction Period|Withdrawal by Subject|0|||
24998537|NCT01358578|50089822|FG005|Induction Period|Withdrawal by Subject|0|||
24998538|NCT01358578|50089817|FG000|Maintenance Period|Adverse Event|2|||
24998539|NCT01358578|50089818|FG001|Maintenance Period|Adverse Event|7|||
24998540|NCT01358578|50089819|FG002|Maintenance Period|Adverse Event|0|||
24998541|NCT01358578|50089820|FG003|Maintenance Period|Adverse Event|6|||
24998542|NCT01358578|50089821|FG004|Maintenance Period|Adverse Event|4|||
24998543|NCT01358578|50089822|FG005|Maintenance Period|Adverse Event|3|||
24998544|NCT01358578|50089817|FG000|Maintenance Period|Lack of Efficacy|10|||
24998545|NCT01358578|50089818|FG001|Maintenance Period|Lack of Efficacy|2|||
24998546|NCT01358578|50089819|FG002|Maintenance Period|Lack of Efficacy|0|||
24998547|NCT01358578|50089820|FG003|Maintenance Period|Lack of Efficacy|11|||
24998548|NCT01358578|50089821|FG004|Maintenance Period|Lack of Efficacy|3|||
24998549|NCT01358578|50089822|FG005|Maintenance Period|Lack of Efficacy|0|||
24998550|NCT01358578|50089817|FG000|Maintenance Period|Lost to Follow-up|4|||
24998551|NCT01358578|50089818|FG001|Maintenance Period|Lost to Follow-up|0|||
24998552|NCT01358578|50089819|FG002|Maintenance Period|Lost to Follow-up|0|||
24998553|NCT01358578|50089820|FG003|Maintenance Period|Lost to Follow-up|5|||
24998554|NCT01358578|50089821|FG004|Maintenance Period|Lost to Follow-up|1|||
24998555|NCT01358578|50089822|FG005|Maintenance Period|Lost to Follow-up|1|||
24998556|NCT01358578|50089817|FG000|Maintenance Period|Non-compliance with study treatment|3|||
24998557|NCT01358578|50089818|FG001|Maintenance Period|Non-compliance with study treatment|1|||
24998558|NCT01358578|50089819|FG002|Maintenance Period|Non-compliance with study treatment|0|||
24998559|NCT01358578|50089820|FG003|Maintenance Period|Non-compliance with study treatment|2|||
24998560|NCT01358578|50089821|FG004|Maintenance Period|Non-compliance with study treatment|1|||
24998561|NCT01358578|50089822|FG005|Maintenance Period|Non-compliance with study treatment|2|||
24998562|NCT01358578|50089817|FG000|Maintenance Period|Physician Decision|0|||
24998563|NCT01358578|50089818|FG001|Maintenance Period|Physician Decision|1|||
24998564|NCT01358578|50089819|FG002|Maintenance Period|Physician Decision|0|||
24998565|NCT01358578|50089820|FG003|Maintenance Period|Physician Decision|1|||
24998566|NCT01358578|50089821|FG004|Maintenance Period|Physician Decision|0|||
24998567|NCT01358578|50089822|FG005|Maintenance Period|Physician Decision|0|||
24998568|NCT01358578|50089817|FG000|Maintenance Period|Pregnancy|1|||
24998569|NCT01358578|50089818|FG001|Maintenance Period|Pregnancy|0|||
24998570|NCT01358578|50089819|FG002|Maintenance Period|Pregnancy|0|||
24998571|NCT01358578|50089820|FG003|Maintenance Period|Pregnancy|0|||
24998572|NCT01358578|50089821|FG004|Maintenance Period|Pregnancy|0|||
24998573|NCT01358578|50089822|FG005|Maintenance Period|Pregnancy|0|||
24998574|NCT01358578|50089817|FG000|Maintenance Period|Protocol deviation|7|||
24998575|NCT01358578|50089818|FG001|Maintenance Period|Protocol deviation|4|||
24998576|NCT01358578|50089819|FG002|Maintenance Period|Protocol deviation|0|||
24998577|NCT01358578|50089820|FG003|Maintenance Period|Protocol deviation|2|||
24998578|NCT01358578|50089821|FG004|Maintenance Period|Protocol deviation|2|||
24998579|NCT01358578|50089822|FG005|Maintenance Period|Protocol deviation|2|||
24998580|NCT01358578|50089817|FG000|Maintenance Period|Withdrawal by Subject|12|||
24998581|NCT01358578|50089818|FG001|Maintenance Period|Withdrawal by Subject|7|||
24998582|NCT01358578|50089819|FG002|Maintenance Period|Withdrawal by Subject|2|||
24998583|NCT01358578|50089820|FG003|Maintenance Period|Withdrawal by Subject|15|||
24998584|NCT01358578|50089821|FG004|Maintenance Period|Withdrawal by Subject|6|||
24998585|NCT01358578|50089822|FG005|Maintenance Period|Withdrawal by Subject|3|||
24998586|NCT01358578|50089817|FG000|Follow-up Period|Adverse Event|1|||
25176318|NCT01524887|50319471|FG002|Overall Study|Study termination|79|||
25176319|NCT01524887|50319469|FG000|Overall Study|Withdrawal by Caregiver|0|||
25176320|NCT01524887|50319470|FG001|Overall Study|Withdrawal by Caregiver|0|||
25176321|NCT01524887|50319471|FG002|Overall Study|Withdrawal by Caregiver|2|||
25176322|NCT01524887|50319469|FG000|Overall Study|Use of prohibited medication|1|||
25176323|NCT01524887|50319470|FG001|Overall Study|Use of prohibited medication|0|||
25176324|NCT01524887|50319471|FG002|Overall Study|Use of prohibited medication|0|||
24998587|NCT01358578|50089818|FG001|Follow-up Period|Adverse Event|1|||
25091174|NCT01999972|50200709|FG000|Dose Escalation Part|Global deterioration of health status|1|||
24998588|NCT01358578|50089819|FG002|Follow-up Period|Adverse Event|0|||
25091175|NCT01999972|50200710|FG001|Dose Escalation Part|Global deterioration of health status|0|||
25091176|NCT01999972|50200711|FG002|Dose Escalation Part|Global deterioration of health status|0|||
25091177|NCT01999972|50200712|FG003|Dose Escalation Part|Global deterioration of health status|1|||
25091178|NCT01999972|50200713|FG004|Dose Escalation Part|Global deterioration of health status|0|||
25091179|NCT01999972|50200714|FG005|Dose Escalation Part|Global deterioration of health status|0|||
25091180|NCT01999972|50200709|FG000|Dose Expansion Part|Death|0|||
25091181|NCT01999972|50200710|FG001|Dose Expansion Part|Death|0|||
25091182|NCT01999972|50200711|FG002|Dose Expansion Part|Death|0|||
25091183|NCT01999972|50200712|FG003|Dose Expansion Part|Death|0|||
25091184|NCT01999972|50200713|FG004|Dose Expansion Part|Death|2|||
25091185|NCT01999972|50200714|FG005|Dose Expansion Part|Death|1|||
25091186|NCT01999972|50200709|FG000|Dose Expansion Part|Disease progression|0|||
25091187|NCT01999972|50200710|FG001|Dose Expansion Part|Disease progression|0|||
25091188|NCT01999972|50200711|FG002|Dose Expansion Part|Disease progression|0|||
25091189|NCT01999972|50200712|FG003|Dose Expansion Part|Disease progression|0|||
25091190|NCT01999972|50200713|FG004|Dose Expansion Part|Disease progression|9|||
25091191|NCT01999972|50200714|FG005|Dose Expansion Part|Disease progression|3|||
25091192|NCT01999972|50200709|FG000|Dose Expansion Part|Sponsor decision|0|||
25176325|NCT01523873|50319497|FG000|Overall Study|Protocol Violation|422|||
24998589|NCT01358578|50089820|FG003|Follow-up Period|Adverse Event|0|||
24998590|NCT01358578|50089821|FG004|Follow-up Period|Adverse Event|0|||
24998591|NCT01358578|50089822|FG005|Follow-up Period|Adverse Event|0|||
24998592|NCT01358578|50089817|FG000|Follow-up Period|Lack of Efficacy|3|||
24998593|NCT01358578|50089818|FG001|Follow-up Period|Lack of Efficacy|0|||
25091193|NCT01999972|50200710|FG001|Dose Expansion Part|Sponsor decision|0|||
25091194|NCT01999972|50200711|FG002|Dose Expansion Part|Sponsor decision|0|||
25091195|NCT01999972|50200712|FG003|Dose Expansion Part|Sponsor decision|0|||
25091196|NCT01999972|50200713|FG004|Dose Expansion Part|Sponsor decision|1|||
25176326|NCT01522235|50319522|FG000|Overall Study|Physician Decision|1|||
24998594|NCT01358578|50089819|FG002|Follow-up Period|Lack of Efficacy|4|||
24998595|NCT01358578|50089820|FG003|Follow-up Period|Lack of Efficacy|1|||
25176327|NCT01522235|50319523|FG001|Overall Study|Physician Decision|1|||
24998596|NCT01358578|50089821|FG004|Follow-up Period|Lack of Efficacy|0|||
24998597|NCT01358578|50089822|FG005|Follow-up Period|Lack of Efficacy|0|||
24998598|NCT01358578|50089817|FG000|Follow-up Period|Lost to Follow-up|0|||
24998599|NCT01358578|50089818|FG001|Follow-up Period|Lost to Follow-up|1|||
24998600|NCT01358578|50089819|FG002|Follow-up Period|Lost to Follow-up|0|||
24998601|NCT01358578|50089820|FG003|Follow-up Period|Lost to Follow-up|4|||
24998602|NCT01358578|50089821|FG004|Follow-up Period|Lost to Follow-up|0|||
24998603|NCT01358578|50089822|FG005|Follow-up Period|Lost to Follow-up|0|||
24998604|NCT01358578|50089817|FG000|Follow-up Period|non- compliance with study treatment|1|||
24998605|NCT01358578|50089818|FG001|Follow-up Period|non- compliance with study treatment|0|||
24998606|NCT01358578|50089819|FG002|Follow-up Period|non- compliance with study treatment|0|||
24998607|NCT01358578|50089820|FG003|Follow-up Period|non- compliance with study treatment|0|||
24998608|NCT01358578|50089821|FG004|Follow-up Period|non- compliance with study treatment|0|||
24998609|NCT01358578|50089822|FG005|Follow-up Period|non- compliance with study treatment|0|||
24998610|NCT01358578|50089817|FG000|Follow-up Period|Pregnancy|1|||
24998611|NCT01358578|50089818|FG001|Follow-up Period|Pregnancy|0|||
24998612|NCT01358578|50089819|FG002|Follow-up Period|Pregnancy|0|||
24998613|NCT01358578|50089820|FG003|Follow-up Period|Pregnancy|0|||
24998614|NCT01358578|50089821|FG004|Follow-up Period|Pregnancy|0|||
24998615|NCT01358578|50089822|FG005|Follow-up Period|Pregnancy|0|||
24998616|NCT01358578|50089817|FG000|Follow-up Period|Withdrawal by Subject|3|||
24998617|NCT01358578|50089818|FG001|Follow-up Period|Withdrawal by Subject|3|||
24998618|NCT01358578|50089819|FG002|Follow-up Period|Withdrawal by Subject|1|||
24998619|NCT01358578|50089820|FG003|Follow-up Period|Withdrawal by Subject|12|||
24998620|NCT01358578|50089821|FG004|Follow-up Period|Withdrawal by Subject|0|||
24998621|NCT01358578|50089822|FG005|Follow-up Period|Withdrawal by Subject|0|||
24998622|NCT01358578|50089817|FG000|Follow-up Period|Physician Decision|1|||
24998623|NCT01358578|50089818|FG001|Follow-up Period|Physician Decision|1|||
24998624|NCT01358578|50089819|FG002|Follow-up Period|Physician Decision|0|||
24998625|NCT01358578|50089820|FG003|Follow-up Period|Physician Decision|2|||
24998626|NCT01358578|50089821|FG004|Follow-up Period|Physician Decision|0|||
24998627|NCT01358578|50089822|FG005|Follow-up Period|Physician Decision|0|||
24998628|NCT02833948|50089852|FG000|Overall Study|Death|2|||
24998629|NCT02833948|50089853|FG001|Overall Study|Death|3|||
24998630|NCT02833948|50089852|FG000|Overall Study|were not scanned|8|||
24998631|NCT02833948|50089853|FG001|Overall Study|were not scanned|13|||
24998632|NCT02833948|50089852|FG000|Overall Study|scans could not be evaluated|5|||
24998633|NCT02833948|50089853|FG001|Overall Study|scans could not be evaluated|2|||
24998634|NCT02828020|50089866|FG000|Treatment Period|Adverse Event|3|||
24998635|NCT02828020|50089867|FG001|Treatment Period|Adverse Event|1|||
24998636|NCT02828020|50089868|FG002|Treatment Period|Adverse Event|1|||
24998637|NCT02828020|50089866|FG000|Treatment Period|Withdrawal of Consent|10|||
24998638|NCT02828020|50089867|FG001|Treatment Period|Withdrawal of Consent|14|||
24998639|NCT02828020|50089868|FG002|Treatment Period|Withdrawal of Consent|9|||
24998640|NCT02828020|50089866|FG000|Treatment Period|Lost to Follow-up|21|||
24998641|NCT02828020|50089867|FG001|Treatment Period|Lost to Follow-up|24|||
24998642|NCT02828020|50089868|FG002|Treatment Period|Lost to Follow-up|18|||
24998643|NCT02828020|50089866|FG000|Treatment Period|Lack of Qualifying Event|44|||
24998644|NCT02828020|50089867|FG001|Treatment Period|Lack of Qualifying Event|53|||
24998645|NCT02828020|50089868|FG002|Treatment Period|Lack of Qualifying Event|43|||
24998646|NCT02828020|50089866|FG000|Treatment Period|Pregnancy|0|||
24998647|NCT02828020|50089867|FG001|Treatment Period|Pregnancy|2|||
24998648|NCT02828020|50089868|FG002|Treatment Period|Pregnancy|0|||
24998649|NCT02828020|50089866|FG000|Treatment Period|Protocol Violation|2|||
24998650|NCT02828020|50089867|FG001|Treatment Period|Protocol Violation|4|||
24998651|NCT02828020|50089868|FG002|Treatment Period|Protocol Violation|7|||
24998652|NCT02828020|50089866|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
24998653|NCT02828020|50089867|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
24998654|NCT02828020|50089868|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
24998655|NCT02828020|50089866|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
24998656|NCT02828020|50089867|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
24998657|NCT02828020|50089868|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
24998658|NCT02828020|50089866|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
25091197|NCT01999972|50200714|FG005|Dose Expansion Part|Sponsor decision|0|||
25091198|NCT01999972|50200709|FG000|Dose Expansion Part|Adverse Event|0|||
25091199|NCT01999972|50200710|FG001|Dose Expansion Part|Adverse Event|0|||
25091200|NCT01999972|50200711|FG002|Dose Expansion Part|Adverse Event|0|||
25091201|NCT01999972|50200712|FG003|Dose Expansion Part|Adverse Event|0|||
24998659|NCT02828020|50089867|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
24998660|NCT02828020|50089868|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
24998661|NCT02828020|50089866|FG000|Safety Follow-up Period|Protocol Violation|0|||
24998662|NCT02828020|50089867|FG001|Safety Follow-up Period|Protocol Violation|2|||
24998663|NCT02828020|50089868|FG002|Safety Follow-up Period|Protocol Violation|1|||
24998664|NCT02828020|50089866|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
25091202|NCT01999972|50200713|FG004|Dose Expansion Part|Adverse Event|4|||
24998665|NCT02828020|50089867|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
24998666|NCT02828020|50089868|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
24998667|NCT02827708|50089887|FG000|Overall Study|Lost to Follow-up|3|||
24998668|NCT02827708|50089888|FG001|Overall Study|Lost to Follow-up|1|||
24998669|NCT02827708|50089887|FG000|Overall Study|Withdrawal by Subject|1|||
24998670|NCT02827708|50089888|FG001|Overall Study|Withdrawal by Subject|2|||
24998671|NCT02827708|50089887|FG000|Overall Study|Death|1|||
24998672|NCT02827708|50089888|FG001|Overall Study|Death|2|||
24998673|NCT03760185|50089894|FG000|Overall Study|Lost to Follow-up|1|||
24998674|NCT03760185|50089895|FG001|Overall Study|Lost to Follow-up|1|||
24998675|NCT02891174|50089905|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
24998676|NCT02891174|50089906|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
24998677|NCT02891174|50089905|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
24998678|NCT02891174|50089906|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
24998679|NCT02891174|50089905|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
24998680|NCT02891174|50089906|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
24998681|NCT02891174|50089905|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
24998682|NCT02891174|50089906|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
24998683|NCT02891174|50089905|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
24998684|NCT02891174|50089906|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
24998685|NCT02891174|50089905|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
24998686|NCT02891174|50089906|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
24998687|NCT02891174|50089905|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
24998688|NCT02891174|50089906|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
24998689|NCT01751984|50089927|FG000|Overall Study|Adverse Event|5|||
24998690|NCT01751984|50089928|FG001|Overall Study|Adverse Event|3|||
24998691|NCT01751984|50089927|FG000|Overall Study|Withdrawal by Subject|0|||
24998692|NCT01751984|50089928|FG001|Overall Study|Withdrawal by Subject|1|||
24998693|NCT01751984|50089927|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
24998694|NCT01751984|50089928|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
24998695|NCT03330236|50089936|FG000|Overall Study|Death|2|||
24998696|NCT03330236|50089937|FG001|Overall Study|Death|1|||
24998697|NCT03330236|50089936|FG000|Overall Study|Withdrawal by Subject|2|||
24998698|NCT03330236|50089937|FG001|Overall Study|Withdrawal by Subject|4|||
24998699|NCT03330236|50089936|FG000|Overall Study|Lost to Follow-up|0|||
24998700|NCT03330236|50089937|FG001|Overall Study|Lost to Follow-up|2|||
24998701|NCT03330236|50089936|FG000|Overall Study|Physician Decision|2|||
24998702|NCT03330236|50089937|FG001|Overall Study|Physician Decision|0|||
24998703|NCT03330236|50089936|FG000|Overall Study|Protocol Violation|4|||
24998704|NCT03330236|50089937|FG001|Overall Study|Protocol Violation|3|||
24998705|NCT03330236|50089936|FG000|Overall Study|SedLine malfunction/blinding|19|||
24998706|NCT03330236|50089937|FG001|Overall Study|SedLine malfunction/blinding|14|||
24998707|NCT03330236|50089936|FG000|Overall Study|Volatile anesthetics used|11|||
24998708|NCT03330236|50089937|FG001|Overall Study|Volatile anesthetics used|8|||
24998709|NCT03330236|50089936|FG000|Overall Study|Surgery aborted/converted to open|60|||
24998710|NCT03330236|50089937|FG001|Overall Study|Surgery aborted/converted to open|52|||
24998711|NCT02831764|50089945|FG000|Overall Study|Protocol specific withdrawal criteria|0|||
24998712|NCT02831764|50089946|FG001|Overall Study|Protocol specific withdrawal criteria|2|||
24998713|NCT02831764|50089945|FG000|Overall Study|Withdrawal by Subject|7|||
24998714|NCT02831764|50089946|FG001|Overall Study|Withdrawal by Subject|6|||
24998715|NCT02831764|50089945|FG000|Overall Study|Physician Decision|2|||
24998716|NCT02831764|50089946|FG001|Overall Study|Physician Decision|2|||
24998717|NCT02831764|50089945|FG000|Overall Study|Lost to Follow-up|6|||
24998718|NCT02831764|50089946|FG001|Overall Study|Lost to Follow-up|5|||
24998719|NCT02831764|50089945|FG000|Overall Study|Adverse Event|8|||
24998720|NCT02831764|50089946|FG001|Overall Study|Adverse Event|5|||
24998721|NCT02831764|50089945|FG000|Overall Study|Lack of Efficacy|2|||
24998722|NCT02831764|50089946|FG001|Overall Study|Lack of Efficacy|2|||
24998723|NCT02831764|50089945|FG000|Overall Study|Protocol Violation|5|||
24998724|NCT02831764|50089946|FG001|Overall Study|Protocol Violation|2|||
24998725|NCT02831764|50089945|FG000|Overall Study|Ongoing at the time of the analysis|330|||
24998726|NCT02831764|50089946|FG001|Overall Study|Ongoing at the time of the analysis|335|||
24998727|NCT03330002|50089952|FG000|Overall Study|Lost to Follow-up|15|||
24998728|NCT03330002|50089952|FG000|Overall Study|Death|7|||
24998729|NCT02948582|50089956|FG000|Washout Period 1|Adverse Event|0|||
24998730|NCT02948582|50089957|FG001|Washout Period 1|Adverse Event|2|||
24998731|NCT02948582|50089958|FG002|Washout Period 1|Adverse Event|0|||
24998732|NCT02948582|50089959|FG003|Washout Period 1|Adverse Event|0|||
24998733|NCT02948582|50089960|FG004|Washout Period 1|Adverse Event|0|||
24998734|NCT02948582|50089961|FG005|Washout Period 1|Adverse Event|0|||
24998735|NCT02948582|50089956|FG000|Washout Period 1|Protocol Violation|0|||
24998736|NCT02948582|50089957|FG001|Washout Period 1|Protocol Violation|0|||
24998737|NCT02948582|50089958|FG002|Washout Period 1|Protocol Violation|0|||
24998738|NCT02948582|50089959|FG003|Washout Period 1|Protocol Violation|0|||
24998739|NCT02948582|50089960|FG004|Washout Period 1|Protocol Violation|0|||
24998740|NCT02948582|50089961|FG005|Washout Period 1|Protocol Violation|1|||
24998741|NCT02948582|50089956|FG000|Washout Period 2|Adverse Event|0|||
24998742|NCT02948582|50089957|FG001|Washout Period 2|Adverse Event|1|||
24998743|NCT02948582|50089958|FG002|Washout Period 2|Adverse Event|0|||
24998744|NCT02948582|50089959|FG003|Washout Period 2|Adverse Event|0|||
24998745|NCT02948582|50089960|FG004|Washout Period 2|Adverse Event|0|||
24998746|NCT02948582|50089961|FG005|Washout Period 2|Adverse Event|0|||
24998747|NCT02948582|50089956|FG000|Washout Period 2|personal reasons|0|||
24998748|NCT02948582|50089957|FG001|Washout Period 2|personal reasons|0|||
24998749|NCT02948582|50089958|FG002|Washout Period 2|personal reasons|0|||
24998750|NCT02948582|50089959|FG003|Washout Period 2|personal reasons|1|||
24998751|NCT02948582|50089960|FG004|Washout Period 2|personal reasons|0|||
24998752|NCT02948582|50089961|FG005|Washout Period 2|personal reasons|0|||
24998753|NCT02948582|50089956|FG000|Washout Period 4|Adverse Event|1|||
24998754|NCT02948582|50089957|FG001|Washout Period 4|Adverse Event|0|||
24998755|NCT02948582|50089958|FG002|Washout Period 4|Adverse Event|1|||
24998756|NCT02948582|50089959|FG003|Washout Period 4|Adverse Event|0|||
24998757|NCT02948582|50089960|FG004|Washout Period 4|Adverse Event|0|||
24998758|NCT02948582|50089961|FG005|Washout Period 4|Adverse Event|0|||
24998759|NCT03756285|50089977|FG000|Overall Study|Lost to Follow-up|0|||
24998760|NCT03756285|50089978|FG001|Overall Study|Lost to Follow-up|1|||
24998761|NCT03756285|50089977|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
24998762|NCT03756285|50089978|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
24998763|NCT03756285|50089977|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
24998764|NCT03756285|50089978|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
24998765|NCT02825992|50090004|FG000|Overall Study|Withdrawal by Subject|4|||
24998766|NCT02825992|50090004|FG000|Overall Study|Lost to Follow-up|2|||
24998767|NCT02825992|50090004|FG000|Overall Study|Procedure terminated|2|||
24998768|NCT01339000|50090016|FG000|Overall Study|study closed due to lack of drug supply|1|||
24998769|NCT01339000|50090017|FG001|Overall Study|study closed due to lack of drug supply|0|||
24998770|NCT03755661|50090028|FG000|Overall Study|Lost to Follow-up|1|||
24998771|NCT03755661|50090029|FG001|Overall Study|Lost to Follow-up|0|||
24998772|NCT03752151|50090035|FG000|Overall Study|Withdrawal by Subject|1|||
24998773|NCT03752151|50090035|FG000|Overall Study|Protocol Violation|1|||
24998774|NCT01336634|50090043|FG000|Overall Study|Study closed/terminated|5|||
24998775|NCT01336634|50090044|FG001|Overall Study|Study closed/terminated|6|||
24998776|NCT01336634|50090045|FG002|Overall Study|Study closed/terminated|6|||
24998777|NCT01336634|50090043|FG000|Overall Study|Lost to Follow-up|2|||
24998778|NCT01336634|50090044|FG001|Overall Study|Lost to Follow-up|1|||
24998779|NCT01336634|50090045|FG002|Overall Study|Lost to Follow-up|1|||
24998780|NCT01336634|50090043|FG000|Overall Study|Physician Decision|1|||
24998781|NCT01336634|50090044|FG001|Overall Study|Physician Decision|1|||
24998782|NCT01336634|50090045|FG002|Overall Study|Physician Decision|0|||
24998783|NCT01336634|50090043|FG000|Overall Study|Withdrawal by Subject|6|||
24998784|NCT01336634|50090044|FG001|Overall Study|Withdrawal by Subject|0|||
24998785|NCT01336634|50090045|FG002|Overall Study|Withdrawal by Subject|2|||
24998786|NCT02947100|50090060|FG000|Overall Study|study terminated early|3|||
24998787|NCT02947100|50090060|FG000|Overall Study|did not meet inclusion criteria|1|||
24998788|NCT03329846|50090066|FG000|Overall Study|Disease progression|4|||
24998789|NCT03329846|50090067|FG001|Overall Study|Disease progression|6|||
24998790|NCT03329846|50090066|FG000|Overall Study|Study drug toxicity|1|||
24998791|NCT03329846|50090067|FG001|Overall Study|Study drug toxicity|0|||
24998792|NCT03329846|50090066|FG000|Overall Study|Participant request to discontinue treatment|0|||
24998793|NCT03329846|50090067|FG001|Overall Study|Participant request to discontinue treatment|1|||
24998794|NCT03329846|50090066|FG000|Overall Study|Participant withdrew consent|1|||
24998795|NCT03329846|50090067|FG001|Overall Study|Participant withdrew consent|0|||
24998796|NCT03329846|50090066|FG000|Overall Study|Other reasons|2|||
24998797|NCT03329846|50090067|FG001|Overall Study|Other reasons|2|||
24998798|NCT03325010|50090075|FG000|Overall Study|Adverse Event|3|||
24998799|NCT03325010|50090076|FG001|Overall Study|Adverse Event|8|||
24998800|NCT03325010|50090075|FG000|Overall Study|Protocol Violation|1|||
24998801|NCT03325010|50090076|FG001|Overall Study|Protocol Violation|8|||
24998802|NCT03325010|50090075|FG000|Overall Study|Withdrawal by Subject|1|||
24998803|NCT03325010|50090076|FG001|Overall Study|Withdrawal by Subject|3|||
24998804|NCT03325010|50090075|FG000|Overall Study|Lost to Follow-up|1|||
24998805|NCT03325010|50090076|FG001|Overall Study|Lost to Follow-up|0|||
24998806|NCT03325010|50090075|FG000|Overall Study|Physician Decision|1|||
24998807|NCT03325010|50090076|FG001|Overall Study|Physician Decision|1|||
24998808|NCT03325010|50090075|FG000|Overall Study|Lack of Efficacy|2|||
24998809|NCT03325010|50090076|FG001|Overall Study|Lack of Efficacy|0|||
24998810|NCT02824432|50090084|FG000|Overall Study|Major Protocol Deviation|1|||
24998811|NCT02824432|50090085|FG001|Overall Study|Major Protocol Deviation|0|||
24998812|NCT02823964|50090091|FG000|Overall Study|Adverse Event|2|||
24998813|NCT02823964|50090091|FG000|Overall Study|Physician Decision|1|||
24998814|NCT02823964|50090091|FG000|Overall Study|Lack of Efficacy|1|||
24998815|NCT02823964|50090091|FG000|Overall Study|Withdrawal by Subject|1|||
24998816|NCT01338610|50090098|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
24998817|NCT01338610|50090099|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
24998818|NCT01338610|50090100|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
24998819|NCT01338610|50090098|FG000|Overall Study|Protocol Violation|1|||
24998820|NCT01338610|50090099|FG001|Overall Study|Protocol Violation|0|||
24998821|NCT01338610|50090100|FG002|Overall Study|Protocol Violation|1|||
24998822|NCT01338610|50090098|FG000|Overall Study|Adverse Event|3|||
24998823|NCT01338610|50090099|FG001|Overall Study|Adverse Event|0|||
24998824|NCT01338610|50090100|FG002|Overall Study|Adverse Event|0|||
24998825|NCT01355302|50090107|FG000|Phase 1b|Death|4|||
24998826|NCT01355302|50090108|FG001|Phase 1b|Death|0|||
24998827|NCT01355302|50090109|FG002|Phase 1b|Death|0|||
24998828|NCT01355302|50090107|FG000|Phase 1b|Study terminated by sponsor|2|||
24998829|NCT01355302|50090108|FG001|Phase 1b|Study terminated by sponsor|0|||
24998830|NCT01355302|50090109|FG002|Phase 1b|Study terminated by sponsor|0|||
24998831|NCT01355068|50090117|FG000|First Intervention Period|Adverse Event|0|||
24998832|NCT01355068|50090118|FG001|First Intervention Period|Adverse Event|1|||
24998833|NCT01355068|50090117|FG000|First Intervention Period|Withdrawal by Subject|0|||
24998834|NCT01355068|50090118|FG001|First Intervention Period|Withdrawal by Subject|1|||
24998835|NCT03756129|50090130|FG000|Overall Study|Adverse Event|1|||
24998836|NCT03756129|50090131|FG001|Overall Study|Adverse Event|1|||
24998837|NCT03756129|50090132|FG002|Overall Study|Adverse Event|0|||
24998838|NCT03756129|50090133|FG003|Overall Study|Adverse Event|2|||
24998839|NCT03756129|50090134|FG004|Overall Study|Adverse Event|0|||
24998840|NCT03756129|50090135|FG005|Overall Study|Adverse Event|0|||
24998841|NCT03756129|50090130|FG000|Overall Study|Withdrawal by Subject|2|||
24998842|NCT03756129|50090131|FG001|Overall Study|Withdrawal by Subject|1|||
24998843|NCT03756129|50090132|FG002|Overall Study|Withdrawal by Subject|3|||
24998844|NCT03756129|50090133|FG003|Overall Study|Withdrawal by Subject|1|||
24998845|NCT03756129|50090134|FG004|Overall Study|Withdrawal by Subject|1|||
24998846|NCT03756129|50090135|FG005|Overall Study|Withdrawal by Subject|3|||
24998847|NCT03756129|50090130|FG000|Overall Study|Lost to Follow-up|0|||
24998848|NCT03756129|50090131|FG001|Overall Study|Lost to Follow-up|0|||
24998849|NCT03756129|50090132|FG002|Overall Study|Lost to Follow-up|0|||
24998850|NCT03756129|50090133|FG003|Overall Study|Lost to Follow-up|0|||
24998851|NCT03756129|50090134|FG004|Overall Study|Lost to Follow-up|0|||
24998852|NCT03756129|50090135|FG005|Overall Study|Lost to Follow-up|1|||
24998853|NCT03756129|50090130|FG000|Overall Study|Physician Decision|0|||
24998854|NCT03756129|50090131|FG001|Overall Study|Physician Decision|0|||
24998855|NCT03756129|50090132|FG002|Overall Study|Physician Decision|0|||
24998856|NCT03756129|50090133|FG003|Overall Study|Physician Decision|0|||
24998857|NCT03756129|50090134|FG004|Overall Study|Physician Decision|0|||
24998858|NCT03756129|50090135|FG005|Overall Study|Physician Decision|1|||
24998859|NCT02822794|50090161|FG000|Overall Study|Withdrew Consent|1|||
24998860|NCT02822794|50090162|FG001|Overall Study|Withdrew Consent|0|||
24998861|NCT01338298|50090177|FG000|Overall Study|Withdrawal by Subject|1|||
24998862|NCT01338298|50090178|FG001|Overall Study|Withdrawal by Subject|1|||
24998863|NCT01338298|50090177|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
24998864|NCT01338298|50090178|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
24998865|NCT01338298|50090177|FG000|Overall Study|Administrative error|0|||
24998866|NCT01338298|50090178|FG001|Overall Study|Administrative error|1|||
24998867|NCT01338298|50090177|FG000|Overall Study|Positive symptom worsening|1|||
24998868|NCT01338298|50090178|FG001|Overall Study|Positive symptom worsening|0|||
24998869|NCT01338298|50090177|FG000|Overall Study|Depressive symptoms and nausea|1|||
24998870|NCT01338298|50090178|FG001|Overall Study|Depressive symptoms and nausea|0|||
24998871|NCT01338298|50090177|FG000|Overall Study|Non-adherence|1|||
24998872|NCT01338298|50090178|FG001|Overall Study|Non-adherence|0|||
24998873|NCT01354132|50090186|FG000|Randomization|Physician Decision|1|||
24998874|NCT01354132|50090187|FG001|Randomization|Physician Decision|0|||
24998875|NCT01354132|50090186|FG000|Randomization|Withdrawal by Subject|0|||
24998876|NCT01354132|50090187|FG001|Randomization|Withdrawal by Subject|1|||
24998877|NCT01354132|50090186|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
24998878|NCT01354132|50090187|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
24998879|NCT01354132|50090186|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
24998880|NCT01354132|50090187|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
25176328|NCT01521923|50319560|FG000|Overall Study|AE, serious fatal|1|||
25176329|NCT01521923|50319561|FG001|Overall Study|AE, serious fatal|0|||
25176330|NCT01521923|50319562|FG002|Overall Study|AE, serious fatal|0|||
24998881|NCT01354132|50090186|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
24998882|NCT01354132|50090187|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
24998883|NCT01353898|50090202|FG000|Overall Study|Study site terminated|0|||
24998884|NCT01353898|50090203|FG001|Overall Study|Study site terminated|0|||
24998885|NCT01353898|50090204|FG002|Overall Study|Study site terminated|0|||
24998886|NCT01353898|50090205|FG003|Overall Study|Study site terminated|0|||
24998887|NCT01353898|50090206|FG004|Overall Study|Study site terminated|0|||
24998888|NCT01353898|50090207|FG005|Overall Study|Study site terminated|1|||
24998889|NCT01372150|50090224|FG000|Overall Study|Lack of Efficacy|3|||
24998890|NCT01372150|50090225|FG001|Overall Study|Lack of Efficacy|0|||
24998891|NCT01372150|50090226|FG002|Overall Study|Lack of Efficacy|1|||
24998892|NCT01372150|50090224|FG000|Overall Study|Lost to Follow-up|4|||
24998893|NCT01372150|50090225|FG001|Overall Study|Lost to Follow-up|5|||
24998894|NCT01372150|50090226|FG002|Overall Study|Lost to Follow-up|6|||
24998895|NCT01372150|50090224|FG000|Overall Study|Protocol Violation|1|||
24998896|NCT01372150|50090225|FG001|Overall Study|Protocol Violation|0|||
24998897|NCT01372150|50090226|FG002|Overall Study|Protocol Violation|3|||
24998898|NCT01372150|50090224|FG000|Overall Study|Withdrawal by Subject|2|||
24998899|NCT01372150|50090225|FG001|Overall Study|Withdrawal by Subject|7|||
24998900|NCT01372150|50090226|FG002|Overall Study|Withdrawal by Subject|2|||
24998901|NCT01372150|50090224|FG000|Overall Study|Other|1|||
24998902|NCT01372150|50090225|FG001|Overall Study|Other|0|||
24998903|NCT01372150|50090226|FG002|Overall Study|Other|2|||
24998904|NCT01372150|50090224|FG000|Overall Study|Adverse Event|2|||
24998905|NCT01372150|50090225|FG001|Overall Study|Adverse Event|1|||
24998906|NCT01372150|50090226|FG002|Overall Study|Adverse Event|2|||
24998907|NCT01372150|50090224|FG000|Overall Study|Randomized but not treated|0|||
24998908|NCT01372150|50090225|FG001|Overall Study|Randomized but not treated|1|||
24998909|NCT01372150|50090226|FG002|Overall Study|Randomized but not treated|0|||
24998910|NCT03749109|50090236|FG000|Overall Study|Adverse Event|2|||
24998911|NCT03749109|50090237|FG001|Overall Study|Adverse Event|0|||
24998912|NCT03329690|50090249|FG000|Overall Study|Progressive disease per RECIST|85|||
24998913|NCT03329690|50090250|FG001|Overall Study|Progressive disease per RECIST|44|||
24998914|NCT03329690|50090251|FG002|Overall Study|Progressive disease per RECIST|6|||
24998915|NCT03329690|50090252|FG003|Overall Study|Progressive disease per RECIST|16|||
24998916|NCT03329690|50090253|FG004|Overall Study|Progressive disease per RECIST|20|||
24998917|NCT03329690|50090249|FG000|Overall Study|Clinical progression|7|||
24998918|NCT03329690|50090250|FG001|Overall Study|Clinical progression|4|||
24998919|NCT03329690|50090251|FG002|Overall Study|Clinical progression|1|||
24998920|NCT03329690|50090252|FG003|Overall Study|Clinical progression|1|||
24998921|NCT03329690|50090253|FG004|Overall Study|Clinical progression|1|||
24998922|NCT03329690|50090249|FG000|Overall Study|Adverse Event|22|||
24998923|NCT03329690|50090250|FG001|Overall Study|Adverse Event|4|||
24998924|NCT03329690|50090251|FG002|Overall Study|Adverse Event|0|||
24998925|NCT03329690|50090252|FG003|Overall Study|Adverse Event|1|||
24998926|NCT03329690|50090253|FG004|Overall Study|Adverse Event|2|||
24998927|NCT03329690|50090249|FG000|Overall Study|Death|2|||
24998928|NCT03329690|50090250|FG001|Overall Study|Death|0|||
24998929|NCT03329690|50090251|FG002|Overall Study|Death|0|||
24998930|NCT03329690|50090252|FG003|Overall Study|Death|1|||
24998931|NCT03329690|50090253|FG004|Overall Study|Death|0|||
24998932|NCT03329690|50090249|FG000|Overall Study|Withdrawal by Subject|2|||
24998933|NCT03329690|50090250|FG001|Overall Study|Withdrawal by Subject|3|||
24998934|NCT03329690|50090251|FG002|Overall Study|Withdrawal by Subject|0|||
24998935|NCT03329690|50090252|FG003|Overall Study|Withdrawal by Subject|1|||
24998936|NCT03329690|50090253|FG004|Overall Study|Withdrawal by Subject|0|||
24998937|NCT03329690|50090249|FG000|Overall Study|Physician Decision|1|||
24998938|NCT03329690|50090250|FG001|Overall Study|Physician Decision|0|||
24998939|NCT03329690|50090251|FG002|Overall Study|Physician Decision|0|||
24998940|NCT03329690|50090252|FG003|Overall Study|Physician Decision|0|||
24998941|NCT03329690|50090253|FG004|Overall Study|Physician Decision|1|||
24998942|NCT03329690|50090249|FG000|Overall Study|Miscellaneous|6|||
24998943|NCT03329690|50090250|FG001|Overall Study|Miscellaneous|0|||
24998944|NCT03329690|50090251|FG002|Overall Study|Miscellaneous|0|||
24998945|NCT03329690|50090252|FG003|Overall Study|Miscellaneous|0|||
24998946|NCT03329690|50090253|FG004|Overall Study|Miscellaneous|0|||
24998947|NCT03329690|50090249|FG000|Overall Study|Did not receive treatment|1|||
24998948|NCT03329690|50090250|FG001|Overall Study|Did not receive treatment|0|||
24998949|NCT03329690|50090251|FG002|Overall Study|Did not receive treatment|0|||
24998950|NCT03329690|50090252|FG003|Overall Study|Did not receive treatment|1|||
24998951|NCT03329690|50090253|FG004|Overall Study|Did not receive treatment|0|||
24998952|NCT03328832|50090273|FG000|Overall Study|Lost to Follow-up|0|||
24998953|NCT03328832|50090274|FG001|Overall Study|Lost to Follow-up|1|||
24998954|NCT02820844|50090282|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
24998955|NCT02820844|50090283|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
24998956|NCT02820844|50090284|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
24998957|NCT02820844|50090285|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
24998958|NCT02820844|50090286|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
24998959|NCT02820844|50090287|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
24998960|NCT02820844|50090282|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
24998961|NCT02820844|50090283|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
24998962|NCT02820844|50090284|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
24998963|NCT02820844|50090285|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
24998964|NCT02820844|50090286|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
24998965|NCT02820844|50090287|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
24998966|NCT02820844|50090282|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
25091203|NCT01999972|50200714|FG005|Dose Expansion Part|Adverse Event|2|||
24998967|NCT02820844|50090283|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
24998968|NCT02820844|50090284|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
24998969|NCT02820844|50090285|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
24998970|NCT02820844|50090286|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
24998971|NCT02820844|50090287|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
24998972|NCT02820844|50090282|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
24998973|NCT02820844|50090283|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
24998974|NCT02820844|50090284|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
24998975|NCT02820844|50090285|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
24998976|NCT02820844|50090286|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
24998977|NCT02820844|50090287|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
24998978|NCT02820844|50090282|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
24998979|NCT02820844|50090283|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
24998980|NCT02820844|50090284|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
24998981|NCT02820844|50090285|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
24998982|NCT02820844|50090286|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
24998983|NCT02820844|50090287|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
24998984|NCT02820844|50090282|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
24998985|NCT02820844|50090283|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
24998986|NCT02820844|50090284|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
24998987|NCT02820844|50090285|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
24998988|NCT02820844|50090286|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
24998989|NCT02820844|50090287|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
24998990|NCT02820844|50090282|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
24998991|NCT02820844|50090283|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
24998992|NCT02820844|50090284|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
24998993|NCT02820844|50090285|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
24998994|NCT02820844|50090286|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
24998995|NCT02820844|50090287|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
24998996|NCT02820844|50090282|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
24998997|NCT02820844|50090283|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
24998998|NCT02820844|50090284|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
24998999|NCT02820844|50090285|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
24999000|NCT02820844|50090286|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
24999001|NCT02820844|50090287|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
24999002|NCT02820844|50090282|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
24999003|NCT02820844|50090283|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
24999004|NCT02820844|50090284|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
24999005|NCT02820844|50090285|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
24999006|NCT02820844|50090286|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
24999007|NCT02820844|50090287|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
24999008|NCT02820844|50090282|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
24999009|NCT02820844|50090283|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
24999010|NCT02820844|50090284|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
24999011|NCT02820844|50090285|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
24999012|NCT02820844|50090286|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
24999013|NCT02820844|50090287|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
24999014|NCT02942576|50090306|FG000|Overall Study|Adverse Event|28|||
24999015|NCT02942576|50090307|FG001|Overall Study|Adverse Event|6|||
24999016|NCT02942576|50090306|FG000|Overall Study|Withdrawal by Subject|7|||
24999017|NCT02942576|50090307|FG001|Overall Study|Withdrawal by Subject|5|||
24999018|NCT02942576|50090306|FG000|Overall Study|Physician Decision|1|||
24999019|NCT02942576|50090307|FG001|Overall Study|Physician Decision|4|||
24999020|NCT02942576|50090306|FG000|Overall Study|Other|10|||
24999021|NCT02942576|50090307|FG001|Overall Study|Other|8|||
24999022|NCT02820298|50090315|FG000|Overall Study|Withdrawal by Subject|0|||
24999023|NCT02820298|50090316|FG001|Overall Study|Withdrawal by Subject|1|||
24999024|NCT02820298|50090315|FG000|Overall Study|Physician Decision|1|||
24999025|NCT02820298|50090316|FG001|Overall Study|Physician Decision|0|||
24999026|NCT02820298|50090315|FG000|Overall Study|Protocol Violation|0|||
24999027|NCT02820298|50090316|FG001|Overall Study|Protocol Violation|1|||
24999028|NCT02819440|50090330|FG000|Overall Study|Adverse Event|3|||
25176331|NCT01521923|50319563|FG003|Overall Study|AE, serious fatal|0|||
24999029|NCT02819440|50090331|FG001|Overall Study|Adverse Event|1|||
24999030|NCT02819440|50090330|FG000|Overall Study|Lost to Follow-up|1|||
24999031|NCT02819440|50090331|FG001|Overall Study|Lost to Follow-up|3|||
24999032|NCT02819440|50090330|FG000|Overall Study|Withdrawal by Subject|9|||
24999033|NCT02819440|50090331|FG001|Overall Study|Withdrawal by Subject|8|||
24999034|NCT03814720|50090342|FG000|Overall Study|Lost to Follow-up|0|||
24999035|NCT03814720|50090343|FG001|Overall Study|Lost to Follow-up|1|||
24999036|NCT03814720|50090344|FG002|Overall Study|Lost to Follow-up|0|||
24999037|NCT03814720|50090345|FG003|Overall Study|Lost to Follow-up|0|||
24999038|NCT03814720|50090346|FG004|Overall Study|Lost to Follow-up|0|||
24999039|NCT02818036|50090362|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
24999040|NCT02818036|50090363|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
24999041|NCT02818036|50090362|FG000|Overall Study|Withdrawal by Subject|1|||
24999042|NCT02818036|50090363|FG001|Overall Study|Withdrawal by Subject|0|||
24999043|NCT01287741|50090371|FG000|Overall Study|Withdrawal by Subject|35|||
24999044|NCT01287741|50090372|FG001|Overall Study|Withdrawal by Subject|38|||
24999045|NCT01287741|50090371|FG000|Overall Study|Protocol Violation|2|||
24999046|NCT01287741|50090372|FG001|Overall Study|Protocol Violation|0|||
24999047|NCT01287741|50090371|FG000|Overall Study|Physician Decision|15|||
24999048|NCT01287741|50090372|FG001|Overall Study|Physician Decision|23|||
24999049|NCT01287741|50090371|FG000|Overall Study|Non-compliance|8|||
24999050|NCT01287741|50090372|FG001|Overall Study|Non-compliance|6|||
24999051|NCT01287741|50090371|FG000|Overall Study|Lost to Follow-up|10|||
24999052|NCT01287741|50090372|FG001|Overall Study|Lost to Follow-up|8|||
24999053|NCT01287741|50090371|FG000|Overall Study|Death|32|||
24999054|NCT01287741|50090372|FG001|Overall Study|Death|44|||
24999055|NCT01287741|50090371|FG000|Overall Study|Adverse Event|4|||
24999056|NCT01287741|50090372|FG001|Overall Study|Adverse Event|6|||
24999057|NCT01287741|50090371|FG000|Overall Study|Study terminated by Sponsor|307|||
24999058|NCT01287741|50090372|FG001|Overall Study|Study terminated by Sponsor|315|||
24999059|NCT01287741|50090371|FG000|Overall Study|Progressive disease|190|||
24999060|NCT01287741|50090372|FG001|Overall Study|Progressive disease|166|||
24999061|NCT01287741|50090371|FG000|Overall Study|Reason not specified|23|||
24999062|NCT01287741|50090372|FG001|Overall Study|Reason not specified|9|||
24999063|NCT03739203|50090386|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
24999064|NCT03739203|50090387|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
24999065|NCT03739203|50090388|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
24999066|NCT03739203|50090386|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
24999067|NCT03739203|50090387|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
24999068|NCT03739203|50090388|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
24999069|NCT03739203|50090386|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
24999070|NCT03739203|50090387|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
24999071|NCT03739203|50090388|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
24999072|NCT03739203|50090386|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
24999073|NCT03739203|50090387|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
24999074|NCT03739203|50090388|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
24999075|NCT03739203|50090386|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
24999076|NCT03739203|50090387|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
24999077|NCT03739203|50090388|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
24999078|NCT03739203|50090386|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
24999079|NCT03739203|50090387|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
24999080|NCT03739203|50090388|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
24999081|NCT03739203|50090386|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
24999082|NCT03739203|50090387|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
24999083|NCT03739203|50090388|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
24999084|NCT03739203|50090386|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
24999085|NCT03739203|50090387|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
24999086|NCT03739203|50090388|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
24999087|NCT03739203|50090386|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
24999088|NCT03739203|50090387|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
24999089|NCT03739203|50090388|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
24999090|NCT03739203|50090386|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
24999091|NCT03739203|50090387|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
24999092|NCT03739203|50090388|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
24999093|NCT03739203|50090386|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
24999094|NCT03739203|50090387|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
25091204|NCT01999972|50200709|FG000|Dose Expansion Part|Participant's non-compliance|0|||
24999095|NCT03739203|50090388|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
24999096|NCT02942264|50090405|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
24999097|NCT02942264|50090406|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
24999098|NCT02942264|50090407|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
24999099|NCT02942264|50090408|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
24999100|NCT02942264|50090409|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
24999101|NCT02942264|50090410|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
25091205|NCT01999972|50200710|FG001|Dose Expansion Part|Participant's non-compliance|0|||
24999102|NCT02942264|50090411|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
24999103|NCT02942264|50090412|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
24999104|NCT02942264|50090413|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
24999105|NCT02942264|50090405|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
24999106|NCT02942264|50090406|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
24999107|NCT02942264|50090407|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
24999108|NCT02942264|50090408|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
24999109|NCT02942264|50090409|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
24999110|NCT02942264|50090410|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
24999111|NCT02942264|50090411|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
24999112|NCT02942264|50090412|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
24999113|NCT02942264|50090413|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
24999114|NCT03322514|50090440|FG000|Overall Study|Withdrawal by Subject|1|||
24999115|NCT03322514|50090441|FG001|Overall Study|Withdrawal by Subject|1|||
24999116|NCT03325712|50090455|FG000|Overall Study|Protocol Violation|0|||
24999117|NCT03325712|50090456|FG001|Overall Study|Protocol Violation|0|||
24999118|NCT03325712|50090457|FG002|Overall Study|Protocol Violation|0|||
24999119|NCT03325712|50090458|FG003|Overall Study|Protocol Violation|0|||
24999120|NCT03325712|50090459|FG004|Overall Study|Protocol Violation|1|||
24999121|NCT03325712|50090460|FG005|Overall Study|Protocol Violation|0|||
24999122|NCT03325712|50090461|FG006|Overall Study|Protocol Violation|0|||
24999123|NCT03325712|50090462|FG007|Overall Study|Protocol Violation|0|||
24999124|NCT03325712|50090455|FG000|Overall Study|Adverse Event|0|||
24999125|NCT03325712|50090456|FG001|Overall Study|Adverse Event|0|||
24999126|NCT03325712|50090457|FG002|Overall Study|Adverse Event|0|||
24999127|NCT03325712|50090458|FG003|Overall Study|Adverse Event|0|||
24999128|NCT03325712|50090459|FG004|Overall Study|Adverse Event|1|||
24999129|NCT03325712|50090460|FG005|Overall Study|Adverse Event|0|||
24999130|NCT03325712|50090461|FG006|Overall Study|Adverse Event|0|||
24999131|NCT03325712|50090462|FG007|Overall Study|Adverse Event|0|||
24999132|NCT03734679|50090490|FG000|Overall Study|Missed Visit|1|||
24999133|NCT03325556|50090494|FG000|Open-label Period|Lack of Response in OL period|70|||
24999134|NCT03325556|50090495|FG001|Open-label Period|Lack of Response in OL period|0|||
24999135|NCT03325556|50090496|FG002|Open-label Period|Lack of Response in OL period|0|||
24999136|NCT03325556|50090494|FG000|Open-label Period|Adverse Event|27|||
24999137|NCT03325556|50090495|FG001|Open-label Period|Adverse Event|0|||
24999138|NCT03325556|50090496|FG002|Open-label Period|Adverse Event|0|||
24999139|NCT03325556|50090494|FG000|Open-label Period|Death|1|||
24999140|NCT03325556|50090495|FG001|Open-label Period|Death|0|||
24999141|NCT03325556|50090496|FG002|Open-label Period|Death|0|||
24999142|NCT03325556|50090494|FG000|Open-label Period|Lost to Follow-up|1|||
24999143|NCT03325556|50090495|FG001|Open-label Period|Lost to Follow-up|0|||
24999144|NCT03325556|50090496|FG002|Open-label Period|Lost to Follow-up|0|||
24999145|NCT03325556|50090494|FG000|Open-label Period|Non-compliance with study drug|5|||
24999146|NCT03325556|50090495|FG001|Open-label Period|Non-compliance with study drug|0|||
24999147|NCT03325556|50090496|FG002|Open-label Period|Non-compliance with study drug|0|||
24999148|NCT03325556|50090494|FG000|Open-label Period|Use of prohibited medication|1|||
24999149|NCT03325556|50090495|FG001|Open-label Period|Use of prohibited medication|0|||
24999150|NCT03325556|50090496|FG002|Open-label Period|Use of prohibited medication|0|||
24999151|NCT03325556|50090494|FG000|Open-label Period|Protocol Violation|4|||
24999152|NCT03325556|50090495|FG001|Open-label Period|Protocol Violation|0|||
24999153|NCT03325556|50090496|FG002|Open-label Period|Protocol Violation|0|||
24999154|NCT03325556|50090494|FG000|Open-label Period|Withdrawal by Subject|17|||
24999155|NCT03325556|50090495|FG001|Open-label Period|Withdrawal by Subject|0|||
24999156|NCT03325556|50090496|FG002|Open-label Period|Withdrawal by Subject|0|||
24999157|NCT03325556|50090494|FG000|Open-label Period|Not otherwise specified|8|||
24999158|NCT03325556|50090495|FG001|Open-label Period|Not otherwise specified|0|||
24999159|NCT03325556|50090496|FG002|Open-label Period|Not otherwise specified|0|||
24999160|NCT03325556|50090494|FG000|Open-label Period|Administrative discont. at study termination|41|||
24999161|NCT03325556|50090495|FG001|Open-label Period|Administrative discont. at study termination|0|||
24999162|NCT03325556|50090496|FG002|Open-label Period|Administrative discont. at study termination|0|||
24999163|NCT03325556|50090494|FG000|Double-blind Period|Relapse|0|||
24999164|NCT03325556|50090495|FG001|Double-blind Period|Relapse|15|||
24999165|NCT03325556|50090496|FG002|Double-blind Period|Relapse|34|||
24999166|NCT03325556|50090494|FG000|Double-blind Period|Adverse Event|0|||
24999167|NCT03325556|50090495|FG001|Double-blind Period|Adverse Event|3|||
24999168|NCT03325556|50090496|FG002|Double-blind Period|Adverse Event|1|||
24999169|NCT03325556|50090494|FG000|Double-blind Period|Noncompliance with study drug|0|||
24999170|NCT03325556|50090495|FG001|Double-blind Period|Noncompliance with study drug|0|||
24999171|NCT03325556|50090496|FG002|Double-blind Period|Noncompliance with study drug|1|||
24999172|NCT03325556|50090494|FG000|Double-blind Period|Use of prohibited medication|0|||
24999173|NCT03325556|50090495|FG001|Double-blind Period|Use of prohibited medication|1|||
24999174|NCT03325556|50090496|FG002|Double-blind Period|Use of prohibited medication|0|||
24999175|NCT03325556|50090494|FG000|Double-blind Period|Physician Decision|0|||
24999176|NCT03325556|50090495|FG001|Double-blind Period|Physician Decision|0|||
24999177|NCT03325556|50090496|FG002|Double-blind Period|Physician Decision|1|||
24999178|NCT03325556|50090494|FG000|Double-blind Period|Withdrawal by Subject|0|||
24999179|NCT03325556|50090495|FG001|Double-blind Period|Withdrawal by Subject|6|||
24999180|NCT03325556|50090496|FG002|Double-blind Period|Withdrawal by Subject|4|||
24999181|NCT03325556|50090494|FG000|Double-blind Period|Not otherwise specified|0|||
24999182|NCT03325556|50090495|FG001|Double-blind Period|Not otherwise specified|1|||
24999183|NCT03325556|50090496|FG002|Double-blind Period|Not otherwise specified|5|||
24999184|NCT03325556|50090494|FG000|Double-blind Period|Administrative discont. at study termination|0|||
24999185|NCT03325556|50090495|FG001|Double-blind Period|Administrative discont. at study termination|35|||
24999186|NCT03325556|50090496|FG002|Double-blind Period|Administrative discont. at study termination|31|||
24999187|NCT03320564|50090503|FG000|Overall Study|Protocol Violation|1|||
24999188|NCT03325166|50090507|FG000|Overall Study|Adverse Event|1|||
24999189|NCT02888756|50090514|FG000|Analytical Treatment Interruption|Physician Decision|10|||
24999190|NCT02888756|50090515|FG001|Analytical Treatment Interruption|Physician Decision|6|||
24999191|NCT02888756|50090516|FG002|Analytical Treatment Interruption|Physician Decision|5|||
24999192|NCT03305666|50090526|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
24999193|NCT03305666|50090527|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
24999194|NCT03304184|50090535|FG000|Overall Study|Withdrawal by Subject|1|||
24999195|NCT03304184|50090536|FG001|Overall Study|Withdrawal by Subject|2|||
24999196|NCT03736785|50090546|FG000|Overall Study|Adverse Event|1|||
24999197|NCT03736785|50090547|FG001|Overall Study|Adverse Event|1|||
24999198|NCT03736785|50090548|FG002|Overall Study|Adverse Event|1|||
24999199|NCT03736785|50090546|FG000|Overall Study|Death|1|||
24999200|NCT03736785|50090547|FG001|Overall Study|Death|0|||
24999201|NCT03736785|50090548|FG002|Overall Study|Death|1|||
24999202|NCT03736785|50090546|FG000|Overall Study|Lost to Follow-up|0|||
24999203|NCT03736785|50090547|FG001|Overall Study|Lost to Follow-up|2|||
24999204|NCT03736785|50090548|FG002|Overall Study|Lost to Follow-up|3|||
24999205|NCT03736785|50090546|FG000|Overall Study|Non compliance with study drug|1|||
24999206|NCT03736785|50090547|FG001|Overall Study|Non compliance with study drug|1|||
24999207|NCT03736785|50090548|FG002|Overall Study|Non compliance with study drug|0|||
24999208|NCT03736785|50090546|FG000|Overall Study|Physician Decision|0|||
24999209|NCT03736785|50090547|FG001|Overall Study|Physician Decision|1|||
24999210|NCT03736785|50090548|FG002|Overall Study|Physician Decision|1|||
24999211|NCT03736785|50090546|FG000|Overall Study|Protocol Violation|1|||
24999212|NCT03736785|50090547|FG001|Overall Study|Protocol Violation|4|||
24999213|NCT03736785|50090548|FG002|Overall Study|Protocol Violation|3|||
24999214|NCT03736785|50090546|FG000|Overall Study|Sponsor Decision|1|||
24999215|NCT03736785|50090547|FG001|Overall Study|Sponsor Decision|0|||
24999216|NCT03736785|50090548|FG002|Overall Study|Sponsor Decision|0|||
24999217|NCT03736785|50090546|FG000|Overall Study|Unknown/Missing data|3|||
24999218|NCT03736785|50090547|FG001|Overall Study|Unknown/Missing data|2|||
24999219|NCT03736785|50090548|FG002|Overall Study|Unknown/Missing data|1|||
24999220|NCT03736785|50090546|FG000|Overall Study|Withdrawal by Subject|9|||
24999221|NCT03736785|50090547|FG001|Overall Study|Withdrawal by Subject|6|||
24999222|NCT03736785|50090548|FG002|Overall Study|Withdrawal by Subject|4|||
24999223|NCT03734991|50090559|FG000|Overall Study|Adverse Event|4|||
24999224|NCT03734991|50090560|FG001|Overall Study|Adverse Event|0|||
24999225|NCT03734991|50090559|FG000|Overall Study|Lost to Follow-up|4|||
24999226|NCT03734991|50090560|FG001|Overall Study|Lost to Follow-up|0|||
24999227|NCT03734991|50090559|FG000|Overall Study|Physician Decision|0|||
24999228|NCT03734991|50090560|FG001|Overall Study|Physician Decision|1|||
24999229|NCT03734991|50090559|FG000|Overall Study|Pregnancy|1|||
24999230|NCT03734991|50090560|FG001|Overall Study|Pregnancy|0|||
24999231|NCT03734991|50090559|FG000|Overall Study|Withdrawal by Subject|6|||
24999232|NCT03734991|50090560|FG001|Overall Study|Withdrawal by Subject|3|||
24999233|NCT03734991|50090559|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
24999234|NCT03734991|50090560|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
24999235|NCT03734991|50090559|FG000|Overall Study|Other|2|||
24999236|NCT03734991|50090560|FG001|Overall Study|Other|2|||
24999237|NCT03303092|50090569|FG000|Overall Study|Adverse Event|1|||
24999238|NCT03303092|50090570|FG001|Overall Study|Adverse Event|0|||
24999239|NCT03303092|50090571|FG002|Overall Study|Adverse Event|1|||
24999240|NCT03303092|50090569|FG000|Overall Study|Protocol Violation|1|||
24999241|NCT03303092|50090570|FG001|Overall Study|Protocol Violation|5|||
24999242|NCT03303092|50090571|FG002|Overall Study|Protocol Violation|1|||
24999243|NCT03303092|50090569|FG000|Overall Study|Withdrawal by Subject|1|||
25176332|NCT01521923|50319560|FG000|Overall Study|SAE, non-fatal|0|||
24999244|NCT03303092|50090570|FG001|Overall Study|Withdrawal by Subject|1|||
24999245|NCT03303092|50090571|FG002|Overall Study|Withdrawal by Subject|3|||
24999246|NCT04517864|50090581|FG000|Placebo-Controlled Phase|Adverse Event|1|||
24999247|NCT04517864|50090582|FG001|Placebo-Controlled Phase|Adverse Event|0|||
25176333|NCT01521923|50319561|FG001|Overall Study|SAE, non-fatal|2|||
25176334|NCT01521923|50319562|FG002|Overall Study|SAE, non-fatal|2|||
24999248|NCT04517864|50090581|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
24999249|NCT04517864|50090582|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
24999250|NCT04517864|50090581|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
24999251|NCT04517864|50090582|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
24999252|NCT04517864|50090581|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
24999253|NCT04517864|50090582|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
24999254|NCT04517864|50090581|FG000|Active Therapy Extension Phase|Adverse Event|1|||
24999255|NCT04517864|50090582|FG001|Active Therapy Extension Phase|Adverse Event|0|||
24999256|NCT03302936|50090603|FG000|Overall Study|Protocol Violation|3|||
24999257|NCT03302936|50090604|FG001|Overall Study|Protocol Violation|4|||
24999258|NCT03733899|50090614|FG000|Period 1|Protocol Violation|0|||
24999259|NCT03733899|50090615|FG001|Period 1|Protocol Violation|0|||
24999260|NCT03733899|50090616|FG002|Period 1|Protocol Violation|0|||
24999261|NCT03733899|50090617|FG003|Period 1|Protocol Violation|0|||
24999262|NCT03733899|50090618|FG004|Period 1|Protocol Violation|0|||
24999263|NCT03733899|50090619|FG005|Period 1|Protocol Violation|1|||
24999264|NCT03733899|50090614|FG000|Period 2|Unscuccessful Treatment|0|||
24999265|NCT03733899|50090615|FG001|Period 2|Unscuccessful Treatment|1|||
24999266|NCT03733899|50090616|FG002|Period 2|Unscuccessful Treatment|0|||
24999267|NCT03733899|50090617|FG003|Period 2|Unscuccessful Treatment|0|||
24999268|NCT03733899|50090618|FG004|Period 2|Unscuccessful Treatment|0|||
24999269|NCT03733899|50090619|FG005|Period 2|Unscuccessful Treatment|0|||
24999270|NCT03733899|50090614|FG000|Period 3|Withdrawal by Subject|1|||
24999271|NCT03733899|50090615|FG001|Period 3|Withdrawal by Subject|0|||
24999272|NCT03733899|50090616|FG002|Period 3|Withdrawal by Subject|0|||
24999273|NCT03733899|50090617|FG003|Period 3|Withdrawal by Subject|0|||
24999274|NCT03733899|50090618|FG004|Period 3|Withdrawal by Subject|0|||
24999275|NCT03733899|50090619|FG005|Period 3|Withdrawal by Subject|0|||
24999276|NCT03727347|50090632|FG000|Overall Study|Withdrawal by Subject|2|||
24999277|NCT03727347|50090632|FG000|Overall Study|Lost to Follow-up|1|||
24999278|NCT03302234|50090647|FG000|Overall Study|Death|137|||
24999279|NCT03302234|50090648|FG001|Overall Study|Death|135|||
24999280|NCT03302234|50090647|FG000|Overall Study|Withdrawal by Subject|1|||
24999281|NCT03302234|50090648|FG001|Overall Study|Withdrawal by Subject|1|||
24999282|NCT03302234|50090647|FG000|Overall Study|Laryngeal carcinoma|0|||
24999283|NCT03302234|50090648|FG001|Overall Study|Laryngeal carcinoma|1|||
24999284|NCT03915626|50090655|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
24999285|NCT03301844|50090667|FG000|Overall Study|suspected colon cancer|1|||
24999286|NCT03301844|50090668|FG001|Overall Study|suspected colon cancer|1|||
24999287|NCT03313310|50090676|FG000|Phase 2|Lost to Follow-up|4|||
24999288|NCT03313310|50090677|FG001|Phase 2|Lost to Follow-up|0|||
24999289|NCT03313310|50090676|FG000|Phase 3|Lost to Follow-up|0|||
24999290|NCT03313310|50090677|FG001|Phase 3|Lost to Follow-up|1|||
24999291|NCT03313076|50090687|FG000|Overall Study|Withdrawal by Subject|2|||
24999292|NCT03313076|50090688|FG001|Overall Study|Withdrawal by Subject|0|||
24999293|NCT03313076|50090689|FG002|Overall Study|Withdrawal by Subject|0|||
24999294|NCT03313076|50090690|FG003|Overall Study|Withdrawal by Subject|0|||
24999295|NCT03313076|50090687|FG000|Overall Study|Lost to Follow-up|0|||
24999296|NCT03313076|50090688|FG001|Overall Study|Lost to Follow-up|2|||
24999297|NCT03313076|50090689|FG002|Overall Study|Lost to Follow-up|2|||
24999298|NCT03313076|50090690|FG003|Overall Study|Lost to Follow-up|2|||
24999299|NCT02940626|50090708|FG000|Overall Study|Death|40|||
24999300|NCT02940626|50090709|FG001|Overall Study|Death|32|||
24999301|NCT02940626|50090708|FG000|Overall Study|Lost to Follow-up|5|||
24999302|NCT02940626|50090709|FG001|Overall Study|Lost to Follow-up|2|||
24999303|NCT02940626|50090708|FG000|Overall Study|Withdrawal by Subject|1|||
24999304|NCT02940626|50090709|FG001|Overall Study|Withdrawal by Subject|0|||
24999305|NCT02940626|50090708|FG000|Overall Study|Transfer to Hospice Care|1|||
24999306|NCT02940626|50090709|FG001|Overall Study|Transfer to Hospice Care|0|||
25176335|NCT01521923|50319563|FG003|Overall Study|SAE, non-fatal|0|||
25176336|NCT01521923|50319560|FG000|Overall Study|AE, non-serious, non-fatal|1|||
25176337|NCT01521923|50319561|FG001|Overall Study|AE, non-serious, non-fatal|3|||
25176338|NCT01521923|50319562|FG002|Overall Study|AE, non-serious, non-fatal|6|||
25176339|NCT01521923|50319563|FG003|Overall Study|AE, non-serious, non-fatal|2|||
25176340|NCT01521923|50319560|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
25176341|NCT01521923|50319561|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
25176342|NCT01521923|50319562|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
25176343|NCT01521923|50319563|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
24999307|NCT02940626|50090708|FG000|Overall Study|Prohibited Concomitant Medication|0|||
25176344|NCT01521923|50319560|FG000|Overall Study|Lack of Efficacy|1|||
25176345|NCT01521923|50319561|FG001|Overall Study|Lack of Efficacy|1|||
24999308|NCT02940626|50090709|FG001|Overall Study|Prohibited Concomitant Medication|1|||
24999309|NCT03300050|50090722|FG000|Overall Study|Lost to Follow-up|2|||
24999310|NCT03300050|50090723|FG001|Overall Study|Lost to Follow-up|1|||
24999311|NCT03300050|50090724|FG002|Overall Study|Lost to Follow-up|0|||
25176346|NCT01521923|50319562|FG002|Overall Study|Lack of Efficacy|0|||
24999312|NCT03300050|50090725|FG003|Overall Study|Lost to Follow-up|0|||
24999313|NCT03300050|50090726|FG004|Overall Study|Lost to Follow-up|1|||
24999314|NCT03300050|50090722|FG000|Overall Study|Withdrawal by Subject|1|||
24999315|NCT03300050|50090723|FG001|Overall Study|Withdrawal by Subject|1|||
24999316|NCT03300050|50090724|FG002|Overall Study|Withdrawal by Subject|1|||
24999317|NCT03300050|50090725|FG003|Overall Study|Withdrawal by Subject|0|||
24999318|NCT03300050|50090726|FG004|Overall Study|Withdrawal by Subject|0|||
24999319|NCT03300050|50090722|FG000|Overall Study|Death|0|||
24999320|NCT03300050|50090723|FG001|Overall Study|Death|0|||
24999321|NCT03300050|50090724|FG002|Overall Study|Death|1|||
24999322|NCT03300050|50090725|FG003|Overall Study|Death|0|||
24999323|NCT03300050|50090726|FG004|Overall Study|Death|0|||
24999324|NCT03300050|50090722|FG000|Overall Study|Not Eligible at Randomization|0|||
24999325|NCT03300050|50090723|FG001|Overall Study|Not Eligible at Randomization|0|||
24999326|NCT03300050|50090724|FG002|Overall Study|Not Eligible at Randomization|1|||
24999327|NCT03300050|50090725|FG003|Overall Study|Not Eligible at Randomization|1|||
24999328|NCT03300050|50090726|FG004|Overall Study|Not Eligible at Randomization|0|||
24999329|NCT03725085|50090738|FG000|Overall Study|Lost to Follow-up|2|||
24999330|NCT02940392|50090743|FG000|Overall Study|Lost to Follow-up|3|||
24999331|NCT02940392|50090743|FG000|Overall Study|Retreatment|3|||
24999332|NCT02940392|50090743|FG000|Overall Study|Death|2|||
24999333|NCT03298412|50090756|FG000|Run-in Period|Other, Not Specified|1|||
24999334|NCT03298412|50090756|FG000|Run-in Period|Disease Progression|1|||
24999335|NCT03298412|50090756|FG000|Run-in Period|Ineligibility Determined|1|||
24999336|NCT03298412|50090756|FG000|Run-in Period|Decision by Sponsor|6|||
24999337|NCT03297398|50090763|FG000|Overall Study|Sponsor's decision|6|||
24999338|NCT03297398|50090764|FG001|Overall Study|Sponsor's decision|9|||
24999339|NCT03297398|50090765|FG002|Overall Study|Sponsor's decision|7|||
24999340|NCT03297398|50090763|FG000|Overall Study|Adverse Event|1|||
24999341|NCT03297398|50090764|FG001|Overall Study|Adverse Event|4|||
24999342|NCT03297398|50090765|FG002|Overall Study|Adverse Event|4|||
24999343|NCT03297398|50090763|FG000|Overall Study|Withdrawal by Subject|1|||
25091206|NCT01999972|50200711|FG002|Dose Expansion Part|Participant's non-compliance|0|||
25091207|NCT01999972|50200712|FG003|Dose Expansion Part|Participant's non-compliance|0|||
25091208|NCT01999972|50200713|FG004|Dose Expansion Part|Participant's non-compliance|0|||
25091209|NCT01999972|50200714|FG005|Dose Expansion Part|Participant's non-compliance|1|||
25091210|NCT01999972|50200709|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
25091211|NCT01999972|50200710|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
25091212|NCT01999972|50200711|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
25091213|NCT01999972|50200712|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
25091214|NCT01999972|50200713|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
25091215|NCT01999972|50200714|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
25091216|NCT01999972|50200709|FG000|Dose Expansion Part|Changed to standard of care|0|||
25091217|NCT01999972|50200710|FG001|Dose Expansion Part|Changed to standard of care|0|||
25091218|NCT01999972|50200711|FG002|Dose Expansion Part|Changed to standard of care|0|||
25091219|NCT01999972|50200712|FG003|Dose Expansion Part|Changed to standard of care|0|||
25091220|NCT01999972|50200713|FG004|Dose Expansion Part|Changed to standard of care|1|||
25176347|NCT01521923|50319563|FG003|Overall Study|Lack of Efficacy|0|||
24999344|NCT03297398|50090764|FG001|Overall Study|Withdrawal by Subject|2|||
24999345|NCT03297398|50090765|FG002|Overall Study|Withdrawal by Subject|2|||
24999346|NCT03297398|50090763|FG000|Overall Study|Protocol Violation|0|||
24999347|NCT03297398|50090764|FG001|Overall Study|Protocol Violation|2|||
24999348|NCT03297398|50090765|FG002|Overall Study|Protocol Violation|0|||
24999349|NCT03297398|50090763|FG000|Overall Study|Physician Decision|0|||
24999350|NCT03297398|50090764|FG001|Overall Study|Physician Decision|0|||
24999351|NCT03297398|50090765|FG002|Overall Study|Physician Decision|1|||
24999352|NCT03297398|50090763|FG000|Overall Study|Lost to Follow-up|0|||
24999353|NCT03297398|50090764|FG001|Overall Study|Lost to Follow-up|0|||
24999354|NCT03297398|50090765|FG002|Overall Study|Lost to Follow-up|1|||
24999355|NCT03293654|50090776|FG000|Overall Study|Lost to Follow-up|0|||
24999356|NCT03293654|50090777|FG001|Overall Study|Lost to Follow-up|1|||
24999357|NCT03293654|50090778|FG002|Overall Study|Lost to Follow-up|0|||
24999358|NCT03312218|50090788|FG000|Overall Study|Never signed in to access the app|54|||
24999359|NCT03312218|50090789|FG001|Overall Study|Never signed in to access the app|58|||
24999360|NCT03930615|50090797|FG000|Overall Study|Death|9|||
24999361|NCT03930615|50090798|FG001|Overall Study|Death|3|||
24999362|NCT03930615|50090797|FG000|Overall Study|Lost to Follow-up|1|||
24999363|NCT03930615|50090798|FG001|Overall Study|Lost to Follow-up|2|||
24999364|NCT03930615|50090797|FG000|Overall Study|Physician Decision|3|||
24999365|NCT03930615|50090798|FG001|Overall Study|Physician Decision|4|||
24999366|NCT03930615|50090797|FG000|Overall Study|Withdrawal by Subject|13|||
24999367|NCT03930615|50090798|FG001|Overall Study|Withdrawal by Subject|2|||
25091221|NCT01999972|50200714|FG005|Dose Expansion Part|Changed to standard of care|0|||
25091222|NCT01999894|50200730|FG000|Overall Study|Adverse Event|9|||
24999368|NCT03930615|50090797|FG000|Overall Study|Not treated|1|||
24999369|NCT03930615|50090798|FG001|Overall Study|Not treated|1|||
24999370|NCT03292640|50090806|FG000|Overall Study|Withdrawal by Subject|17|||
24999371|NCT03292640|50090807|FG001|Overall Study|Withdrawal by Subject|16|||
24999372|NCT03292640|50090806|FG000|Overall Study|Adverse Event|20|||
24999373|NCT03292640|50090807|FG001|Overall Study|Adverse Event|2|||
24999374|NCT03292640|50090806|FG000|Overall Study|Lost to Follow-up|24|||
24999375|NCT03292640|50090807|FG001|Overall Study|Lost to Follow-up|24|||
24999376|NCT03292406|50090820|FG000|Overall Study|Progressive Disease|6|||
24999377|NCT03292406|50090821|FG001|Overall Study|Progressive Disease|3|||
24999378|NCT03292406|50090822|FG002|Overall Study|Progressive Disease|4|||
24999379|NCT03292406|50090820|FG000|Overall Study|Adverse Event|7|||
24999380|NCT03292406|50090821|FG001|Overall Study|Adverse Event|1|||
24999381|NCT03292406|50090822|FG002|Overall Study|Adverse Event|4|||
24999382|NCT03292406|50090820|FG000|Overall Study|Withdrawal by Subject|0|||
24999383|NCT03292406|50090821|FG001|Overall Study|Withdrawal by Subject|7|||
24999384|NCT03292406|50090822|FG002|Overall Study|Withdrawal by Subject|2|||
24999385|NCT03292406|50090820|FG000|Overall Study|Protocol Violation|0|||
24999386|NCT03292406|50090821|FG001|Overall Study|Protocol Violation|1|||
24999387|NCT03292406|50090822|FG002|Overall Study|Protocol Violation|1|||
24999388|NCT03292406|50090820|FG000|Overall Study|Other|0|||
24999389|NCT03292406|50090821|FG001|Overall Study|Other|1|||
24999390|NCT03292406|50090822|FG002|Overall Study|Other|2|||
24999391|NCT03292016|50090859|FG000|Second Washout|Adverse Event|0|||
24999392|NCT03292016|50090860|FG001|Second Washout|Adverse Event|1|||
24999393|NCT03292016|50090861|FG002|Second Washout|Adverse Event|0|||
24999394|NCT03292016|50090862|FG003|Second Washout|Adverse Event|0|||
24999395|NCT03292016|50090863|FG004|Second Washout|Adverse Event|0|||
24999396|NCT03292016|50090864|FG005|Second Washout|Adverse Event|0|||
24999397|NCT03290300|50090872|FG000|Overall Study|Lost to Follow-up|3|||
24999398|NCT03289676|50090885|FG000|Overall Study|Withdrawal by Subject|2|||
24999399|NCT03289676|50090886|FG001|Overall Study|Withdrawal by Subject|0|||
24999400|NCT03289676|50090885|FG000|Overall Study|Protocol Violation|2|||
24999401|NCT03289676|50090886|FG001|Overall Study|Protocol Violation|0|||
24999402|NCT03289676|50090885|FG000|Overall Study|Lost to Follow-up|0|||
24999403|NCT03289676|50090886|FG001|Overall Study|Lost to Follow-up|1|||
24999404|NCT03287804|50090902|FG000|Overall Study|Death|1|||
24999405|NCT03287804|50090902|FG000|Overall Study|Physician Decision|2|||
24999406|NCT03287804|50090902|FG000|Overall Study|Progressive disease|8|||
24999407|NCT03286400|50090907|FG000|Overall Study|Death|10|||
24999408|NCT03286400|50090907|FG000|Overall Study|Lost to Follow-up|10|||
24999409|NCT03286400|50090907|FG000|Overall Study|Physician Decision|1|||
24999410|NCT03286400|50090907|FG000|Overall Study|Scheduling difficulty|4|||
24999411|NCT03310970|50090911|FG000|Overall Study|Withdrawal by Subject|0|||
24999412|NCT03310970|50090912|FG001|Overall Study|Withdrawal by Subject|1|||
24999413|NCT03285308|50090921|FG000|Overall Study|Adverse Event|3|||
24999414|NCT03285308|50090922|FG001|Overall Study|Adverse Event|7|||
24999415|NCT03285308|50090921|FG000|Overall Study|Withdrawal by Subject|8|||
24999416|NCT03285308|50090922|FG001|Overall Study|Withdrawal by Subject|9|||
24999417|NCT03285308|50090921|FG000|Overall Study|Lost to Follow-up|3|||
24999418|NCT03285308|50090922|FG001|Overall Study|Lost to Follow-up|1|||
24999419|NCT03285308|50090921|FG000|Overall Study|Protocol Deviation|6|||
24999420|NCT03285308|50090922|FG001|Overall Study|Protocol Deviation|5|||
24999421|NCT03285308|50090921|FG000|Overall Study|Reason not Specified|0|||
24999422|NCT03285308|50090922|FG001|Overall Study|Reason not Specified|1|||
24999423|NCT03537651|50090929|FG000|Overall Study|Adverse Event|2|||
24999424|NCT03537651|50090929|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
24999425|NCT03537651|50090929|FG000|Overall Study|Commercial Drug is Available for Participant|56|||
24999426|NCT03537651|50090929|FG000|Overall Study|Other|1|||
24999427|NCT03723915|50090945|FG000|Screening|Failed to meet screening requirements.|2|||
24999428|NCT03723915|50090945|FG000|On Treatment|Failed to meet treatment requirements|2|||
24999429|NCT03281876|50090951|FG000|Overall Study|Adverse Event|4|||
24999430|NCT03281876|50090952|FG001|Overall Study|Adverse Event|15|||
24999431|NCT03281876|50090951|FG000|Overall Study|Lost to Follow-up|1|||
24999432|NCT03281876|50090952|FG001|Overall Study|Lost to Follow-up|4|||
24999433|NCT03281876|50090951|FG000|Overall Study|Withdrawal by Subject|11|||
24999434|NCT03281876|50090952|FG001|Overall Study|Withdrawal by Subject|15|||
24999435|NCT03281876|50090951|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
24999436|NCT03281876|50090952|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
24999437|NCT03281876|50090951|FG000|Overall Study|OTHER|5|||
24999438|NCT03281876|50090952|FG001|Overall Study|OTHER|5|||
24999439|NCT02819518|50090963|FG000|Overall Study|Death|9|||
24999440|NCT02819518|50090964|FG001|Overall Study|Death|11|||
24999441|NCT02819518|50090965|FG002|Overall Study|Death|9|||
25091223|NCT01999894|50200730|FG000|Overall Study|Lack of Efficacy|5|||
24999442|NCT02819518|50090966|FG003|Overall Study|Death|447|||
24999443|NCT02819518|50090967|FG004|Overall Study|Death|233|||
24999444|NCT02819518|50090963|FG000|Overall Study|Withdrawal by Subject|0|||
24999445|NCT02819518|50090964|FG001|Overall Study|Withdrawal by Subject|0|||
24999446|NCT02819518|50090965|FG002|Overall Study|Withdrawal by Subject|0|||
24999447|NCT02819518|50090966|FG003|Overall Study|Withdrawal by Subject|21|||
24999448|NCT02819518|50090967|FG004|Overall Study|Withdrawal by Subject|6|||
24999449|NCT02819518|50090963|FG000|Overall Study|Ongoing in Study|2|||
24999450|NCT02819518|50090964|FG001|Overall Study|Ongoing in Study|3|||
24999451|NCT02819518|50090965|FG002|Overall Study|Ongoing in Study|1|||
24999452|NCT02819518|50090966|FG003|Overall Study|Ongoing in Study|98|||
24999453|NCT02819518|50090967|FG004|Overall Study|Ongoing in Study|42|||
24999454|NCT03310580|50090984|FG000|Overall Study|Adverse Event|0|||
24999455|NCT03310580|50090985|FG001|Overall Study|Adverse Event|1|||
24999456|NCT03310580|50090986|FG002|Overall Study|Adverse Event|0|||
24999457|NCT03415022|50091009|FG000|Overall Study|Withdrawal by Subject|1|||
24999458|NCT03415022|50091010|FG001|Overall Study|Withdrawal by Subject|2|||
24999459|NCT03415022|50091009|FG000|Overall Study|COVID-19 Suspension|2|||
24999460|NCT03415022|50091010|FG001|Overall Study|COVID-19 Suspension|3|||
24999461|NCT03415022|50091009|FG000|Overall Study|Lost to Follow-up|2|||
24999462|NCT03415022|50091010|FG001|Overall Study|Lost to Follow-up|0|||
24999463|NCT02816398|50091016|FG000|Overall Study|Death|5|||
24999464|NCT02816398|50091016|FG000|Overall Study|Lack of Efficacy|8|||
24999465|NCT02816398|50091016|FG000|Overall Study|Lost to Follow-up|1|||
24999466|NCT02812186|50091022|FG000|Period 1|Post randomization screen failure|5|||
24999467|NCT02812186|50091023|FG001|Period 1|Post randomization screen failure|9|||
24999468|NCT02812186|50091022|FG000|Period 1|nonevaluable data sets|6|||
24999469|NCT02812186|50091023|FG001|Period 1|nonevaluable data sets|6|||
24999470|NCT02811640|50091032|FG000|Overall Study|Technology malfunction|2|||
24999471|NCT03310268|50091039|FG000|Overall Study|(Not specified)|1|||
24999472|NCT03310268|50091040|FG001|Overall Study|(Not specified)|5|||
24999473|NCT03310268|50091041|FG002|Overall Study|(Not specified)|0|||
24999474|NCT02810392|50091051|FG000|Overall Study|Subject too ill to continue|1|||
24999475|NCT02810392|50091052|FG001|Overall Study|Subject too ill to continue|0|||
24999476|NCT02810392|50091051|FG000|Overall Study|COVID 19 research restrictions|0|||
24999477|NCT02810392|50091052|FG001|Overall Study|COVID 19 research restrictions|1|||
24999478|NCT02815540|50091058|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
24999479|NCT03280550|50091064|FG000|Overall Study|Withdrawal by Subject|2|||
24999480|NCT03280550|50091065|FG001|Overall Study|Withdrawal by Subject|2|||
24999481|NCT03280550|50091064|FG000|Overall Study|Physician Decision|0|||
24999482|NCT03280550|50091065|FG001|Overall Study|Physician Decision|1|||
24999483|NCT03276026|50091073|FG000|Overall Study|Protocol Violation|1|||
24999484|NCT03276026|50091074|FG001|Overall Study|Protocol Violation|0|||
24999485|NCT01589523|50091080|FG000|Overall Study|Withdrawal by Subject|1|||
24999486|NCT03277352|50091086|FG000|Overall Study|Study Terminated By Sponsor|2|||
24999487|NCT03277352|50091086|FG000|Overall Study|Withdrawal by Subject|4|||
24999488|NCT03277352|50091086|FG000|Overall Study|Death|4|||
24999489|NCT02814838|50091093|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
24999490|NCT02814838|50091094|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
24999491|NCT02814838|50091093|FG000|Overall Study|Consent withdrawal|1|||
24999492|NCT02814838|50091094|FG001|Overall Study|Consent withdrawal|1|||
24999493|NCT03276728|50091108|FG000|Overall Study|Lost to Follow-up|0|||
24999494|NCT03276728|50091109|FG001|Overall Study|Lost to Follow-up|0|||
24999495|NCT03276728|50091110|FG002|Overall Study|Lost to Follow-up|2|||
24999496|NCT03276728|50091111|FG003|Overall Study|Lost to Follow-up|2|||
24999497|NCT03276728|50091112|FG004|Overall Study|Lost to Follow-up|0|||
24999498|NCT03276728|50091113|FG005|Overall Study|Lost to Follow-up|0|||
24999499|NCT03276728|50091114|FG006|Overall Study|Lost to Follow-up|0|||
24999500|NCT03276728|50091115|FG007|Overall Study|Lost to Follow-up|0|||
24999501|NCT03276728|50091108|FG000|Overall Study|Withdrawal by Subject|0|||
24999502|NCT03276728|50091109|FG001|Overall Study|Withdrawal by Subject|0|||
24999503|NCT03276728|50091110|FG002|Overall Study|Withdrawal by Subject|0|||
24999504|NCT03276728|50091111|FG003|Overall Study|Withdrawal by Subject|3|||
24999505|NCT03276728|50091112|FG004|Overall Study|Withdrawal by Subject|0|||
24999506|NCT03276728|50091113|FG005|Overall Study|Withdrawal by Subject|0|||
24999507|NCT03276728|50091114|FG006|Overall Study|Withdrawal by Subject|0|||
24999508|NCT03276728|50091115|FG007|Overall Study|Withdrawal by Subject|0|||
24999509|NCT03276728|50091108|FG000|Overall Study|Decision by sponsor|0|||
24999510|NCT03276728|50091109|FG001|Overall Study|Decision by sponsor|0|||
24999511|NCT03276728|50091110|FG002|Overall Study|Decision by sponsor|0|||
25176348|NCT01521923|50319560|FG000|Overall Study|Protocol Violation|0|||
24999512|NCT03276728|50091111|FG003|Overall Study|Decision by sponsor|0|||
24999513|NCT03276728|50091112|FG004|Overall Study|Decision by sponsor|1|||
25176349|NCT01521923|50319561|FG001|Overall Study|Protocol Violation|0|||
24999514|NCT03276728|50091113|FG005|Overall Study|Decision by sponsor|0|||
24999515|NCT03276728|50091114|FG006|Overall Study|Decision by sponsor|2|||
24999516|NCT03276728|50091115|FG007|Overall Study|Decision by sponsor|1|||
24999517|NCT03275246|50091135|FG000|Overall Study|Protocol Violation|5|||
24999518|NCT03275246|50091135|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
24999519|NCT02940860|50091141|FG000|Overall Study|Non-serious AE|1|||
24999520|NCT02940860|50091142|FG001|Overall Study|Non-serious AE|2|||
24999521|NCT02940860|50091141|FG000|Overall Study|Serious AE|7|||
24999522|NCT02940860|50091142|FG001|Overall Study|Serious AE|3|||
24999523|NCT02940860|50091141|FG000|Overall Study|Withdrawal by Subject|19|||
24999524|NCT02940860|50091142|FG001|Overall Study|Withdrawal by Subject|9|||
24999525|NCT02940860|50091141|FG000|Overall Study|Lost to Follow-up|13|||
24999526|NCT02940860|50091142|FG001|Overall Study|Lost to Follow-up|7|||
24999527|NCT02940860|50091141|FG000|Overall Study|Physician Decision|5|||
24999528|NCT02940860|50091142|FG001|Overall Study|Physician Decision|3|||
24999529|NCT02940860|50091141|FG000|Overall Study|Sponsor Decision|0|||
24999530|NCT02940860|50091142|FG001|Overall Study|Sponsor Decision|1|||
24999531|NCT02940860|50091141|FG000|Overall Study|Protocol Violation|0|||
24999532|NCT02940860|50091142|FG001|Overall Study|Protocol Violation|2|||
24999533|NCT02940860|50091141|FG000|Overall Study|Death|3|||
24999534|NCT02940860|50091142|FG001|Overall Study|Death|2|||
24999535|NCT02940860|50091141|FG000|Overall Study|Moved, poor venous access, transport|6|||
24999536|NCT02940860|50091142|FG001|Overall Study|Moved, poor venous access, transport|4|||
24999537|NCT02940860|50091141|FG000|Overall Study|Not treated|2|||
24999538|NCT02940860|50091142|FG001|Overall Study|Not treated|2|||
24999539|NCT03309020|50091152|FG000|Overall Study|Death|1|||
24999540|NCT03309020|50091153|FG001|Overall Study|Death|0|||
24999541|NCT03309020|50091152|FG000|Overall Study|Did not undergo surgery|2|||
24999542|NCT03309020|50091153|FG001|Overall Study|Did not undergo surgery|1|||
24999543|NCT02806960|50091161|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
24999544|NCT02806960|50091162|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
24999545|NCT02806960|50091163|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
24999546|NCT02806960|50091164|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
24999547|NCT03718143|50091174|FG000|Overall Study|Death|1|||
24999548|NCT03718143|50091175|FG001|Overall Study|Death|0|||
24999549|NCT03718143|50091176|FG002|Overall Study|Death|0|||
24999550|NCT03718143|50091174|FG000|Overall Study|Progression of Disease|1|||
24999551|NCT03718143|50091175|FG001|Overall Study|Progression of Disease|0|||
24999552|NCT03718143|50091176|FG002|Overall Study|Progression of Disease|0|||
24999553|NCT03718143|50091174|FG000|Overall Study|Withdrawal of Informed Consent|1|||
24999554|NCT03718143|50091175|FG001|Overall Study|Withdrawal of Informed Consent|2|||
24999555|NCT03718143|50091176|FG002|Overall Study|Withdrawal of Informed Consent|1|||
24999556|NCT03274466|50091186|FG000|Overall Study|Withdrawal by Subject|7|||
24999557|NCT03274466|50091187|FG001|Overall Study|Withdrawal by Subject|3|||
24999558|NCT03274466|50091186|FG000|Overall Study|Protocol Specified Withdrawal|5|||
24999559|NCT03274466|50091187|FG001|Overall Study|Protocol Specified Withdrawal|11|||
24999560|NCT03274466|50091186|FG000|Overall Study|Lost to Follow-up|5|||
24999561|NCT03274466|50091187|FG001|Overall Study|Lost to Follow-up|7|||
24999562|NCT03274466|50091186|FG000|Overall Study|Subject Non-compliance|0|||
24999563|NCT03274466|50091187|FG001|Overall Study|Subject Non-compliance|1|||
24999564|NCT03274466|50091186|FG000|Overall Study|Adverse Event|3|||
24999565|NCT03274466|50091187|FG001|Overall Study|Adverse Event|3|||
24999566|NCT03274466|50091186|FG000|Overall Study|Physician Decision|0|||
24999567|NCT03274466|50091187|FG001|Overall Study|Physician Decision|1|||
24999568|NCT03274466|50091186|FG000|Overall Study|Protocol Violation|3|||
24999569|NCT03274466|50091187|FG001|Overall Study|Protocol Violation|3|||
24999570|NCT02806726|50091193|FG000|Overall Study|Lost to Follow-up|1|||
24999571|NCT02806414|50091198|FG000|Overall Study|Lost to Follow-up|2|||
24999572|NCT02806024|50091204|FG000|Overall Study|Night Delivery|1|||
24999573|NCT02806024|50091205|FG001|Overall Study|Night Delivery|1|||
24999574|NCT02806024|50091204|FG000|Overall Study|DVT during antepartum admission|0|||
24999575|NCT02806024|50091205|FG001|Overall Study|DVT during antepartum admission|1|||
24999576|NCT02805790|50091213|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
24999577|NCT02805790|50091214|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
24999578|NCT02802592|50091220|FG000|Overall Study|Study terminated due to loss of funding|4|||
24999579|NCT02803138|50091225|FG000|Overall Study|Failure to return|38|||
24999580|NCT02803138|50091225|FG000|Overall Study|Insufficient virological response|2|||
24999581|NCT02803138|50091225|FG000|Overall Study|Withdrawn consent|1|||
24999582|NCT02803138|50091225|FG000|Overall Study|Death|1|||
24999583|NCT02803138|50091225|FG000|Overall Study|Other, not specified|28|||
24999584|NCT02801578|50091231|FG000|Overall Study|Adverse Event|2|||
25176350|NCT01521923|50319562|FG002|Overall Study|Protocol Violation|1|||
25176351|NCT01521923|50319563|FG003|Overall Study|Protocol Violation|0|||
24999585|NCT02799472|50091237|FG000|Overall Study|Withdrawal by Subject|2|||
24999586|NCT02799472|50091238|FG001|Overall Study|Withdrawal by Subject|4|||
24999587|NCT02799472|50091237|FG000|Overall Study|Lack of Efficacy|2|||
24999588|NCT02799472|50091238|FG001|Overall Study|Lack of Efficacy|0|||
24999589|NCT02799472|50091237|FG000|Overall Study|Lost to Follow-up|0|||
24999590|NCT02799472|50091238|FG001|Overall Study|Lost to Follow-up|1|||
24999591|NCT03245450|50091251|FG000|Overall Study|Radiological disease progression|3|||
24999592|NCT03245450|50091252|FG001|Overall Study|Radiological disease progression|3|||
24999593|NCT03245450|50091253|FG002|Overall Study|Radiological disease progression|2|||
24999594|NCT03245450|50091254|FG003|Overall Study|Radiological disease progression|2|||
24999595|NCT03245450|50091255|FG004|Overall Study|Radiological disease progression|7|||
24999596|NCT03245450|50091256|FG005|Overall Study|Radiological disease progression|6|||
24999597|NCT03245450|50091257|FG006|Overall Study|Radiological disease progression|6|||
24999598|NCT03245450|50091251|FG000|Overall Study|Clinical disease progression|0|||
25067260|NCT01367665|50172836|FG000|Overall Study|Lost to Follow-up|222|||
24999599|NCT03245450|50091252|FG001|Overall Study|Clinical disease progression|0|||
24999600|NCT03245450|50091253|FG002|Overall Study|Clinical disease progression|1|||
24999601|NCT03245450|50091254|FG003|Overall Study|Clinical disease progression|0|||
24999602|NCT03245450|50091255|FG004|Overall Study|Clinical disease progression|0|||
24999603|NCT03245450|50091256|FG005|Overall Study|Clinical disease progression|2|||
24999604|NCT03245450|50091257|FG006|Overall Study|Clinical disease progression|0|||
24999605|NCT03245450|50091251|FG000|Overall Study|Other|0|||
24999606|NCT03245450|50091252|FG001|Overall Study|Other|0|||
24999607|NCT03245450|50091253|FG002|Overall Study|Other|0|||
24999608|NCT03245450|50091254|FG003|Overall Study|Other|1|||
24999609|NCT03245450|50091255|FG004|Overall Study|Other|1|||
24999610|NCT03245450|50091256|FG005|Overall Study|Other|1|||
24999611|NCT03245450|50091257|FG006|Overall Study|Other|1|||
24999612|NCT03245450|50091251|FG000|Overall Study|Withdrawal by Subject|0|||
24999613|NCT03245450|50091252|FG001|Overall Study|Withdrawal by Subject|1|||
24999614|NCT03245450|50091253|FG002|Overall Study|Withdrawal by Subject|0|||
24999615|NCT03245450|50091254|FG003|Overall Study|Withdrawal by Subject|0|||
24999616|NCT03245450|50091255|FG004|Overall Study|Withdrawal by Subject|0|||
24999617|NCT03245450|50091256|FG005|Overall Study|Withdrawal by Subject|0|||
24999618|NCT03245450|50091257|FG006|Overall Study|Withdrawal by Subject|0|||
24999619|NCT03245450|50091251|FG000|Overall Study|Adverse Event|0|||
24999620|NCT03245450|50091252|FG001|Overall Study|Adverse Event|0|||
24999621|NCT03245450|50091253|FG002|Overall Study|Adverse Event|0|||
24999622|NCT03245450|50091254|FG003|Overall Study|Adverse Event|0|||
24999623|NCT03245450|50091255|FG004|Overall Study|Adverse Event|1|||
24999624|NCT03245450|50091256|FG005|Overall Study|Adverse Event|0|||
24999625|NCT03245450|50091257|FG006|Overall Study|Adverse Event|2|||
24999626|NCT03712917|50091282|FG000|Overall Study|Pregnancy|0|||
24999627|NCT03712917|50091283|FG001|Overall Study|Pregnancy|0|||
24999628|NCT03712917|50091284|FG002|Overall Study|Pregnancy|1|||
24999629|NCT03712917|50091282|FG000|Overall Study|Adverse Event|0|||
24999630|NCT03712917|50091283|FG001|Overall Study|Adverse Event|4|||
24999631|NCT03712917|50091284|FG002|Overall Study|Adverse Event|3|||
24999632|NCT03712917|50091282|FG000|Overall Study|Lost to Follow-up|9|||
24999633|NCT03712917|50091283|FG001|Overall Study|Lost to Follow-up|4|||
24999634|NCT03712917|50091284|FG002|Overall Study|Lost to Follow-up|5|||
24999635|NCT02748694|50091307|FG000|Overall Study|Voluntary Withdrawal|0|||
24999636|NCT02748694|50091308|FG001|Overall Study|Voluntary Withdrawal|0|||
24999637|NCT02748694|50091309|FG002|Overall Study|Voluntary Withdrawal|0|||
24999638|NCT02748694|50091310|FG003|Overall Study|Voluntary Withdrawal|0|||
24999639|NCT02748694|50091311|FG004|Overall Study|Voluntary Withdrawal|0|||
24999640|NCT02748694|50091312|FG005|Overall Study|Voluntary Withdrawal|0|||
24999641|NCT02748694|50091313|FG006|Overall Study|Voluntary Withdrawal|0|||
24999642|NCT02748694|50091314|FG007|Overall Study|Voluntary Withdrawal|0|||
24999643|NCT02748694|50091315|FG008|Overall Study|Voluntary Withdrawal|0|||
24999644|NCT02748694|50091316|FG009|Overall Study|Voluntary Withdrawal|0|||
24999645|NCT02748694|50091317|FG010|Overall Study|Voluntary Withdrawal|0|||
24999646|NCT02748694|50091318|FG011|Overall Study|Voluntary Withdrawal|0|||
24999647|NCT02748694|50091319|FG012|Overall Study|Voluntary Withdrawal|0|||
24999648|NCT02748694|50091320|FG013|Overall Study|Voluntary Withdrawal|0|||
24999649|NCT02748694|50091321|FG014|Overall Study|Voluntary Withdrawal|2|||
24999650|NCT02800642|50091377|FG000|Overall Study|Death|3|||
24999651|NCT02800642|50091377|FG000|Overall Study|Other|10|||
24999652|NCT02800642|50091377|FG000|Overall Study|Physician Decision|2|||
24999653|NCT02800642|50091377|FG000|Overall Study|Adverse Event|6|||
24999654|NCT02800642|50091377|FG000|Overall Study|Withdrawal by Subject|3|||
24999655|NCT02800642|50091377|FG000|Overall Study|Lost to Follow-up|1|||
24999656|NCT02799784|50091381|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
24999657|NCT02799784|50091382|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
24999658|NCT02799784|50091381|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
25091224|NCT01999894|50200730|FG000|Overall Study|Protocol Violation|1|||
24999659|NCT02799784|50091382|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
24999660|NCT02799784|50091381|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
24999661|NCT02799784|50091382|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
24999662|NCT02799784|50091381|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
24999663|NCT02799784|50091382|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
24999664|NCT02799784|50091381|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
24999665|NCT02799784|50091382|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
24999666|NCT02799784|50091381|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
24999667|NCT02799784|50091382|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
24999668|NCT01333072|50091390|FG000|Overall Study|Lost to Follow-up|3|||
24999669|NCT01333072|50091391|FG001|Overall Study|Lost to Follow-up|0|||
24999670|NCT01333072|50091390|FG000|Overall Study|Adverse Event|2|||
24999671|NCT01333072|50091391|FG001|Overall Study|Adverse Event|4|||
24999672|NCT01333072|50091390|FG000|Overall Study|Physician Decision|1|||
24999673|NCT01333072|50091391|FG001|Overall Study|Physician Decision|0|||
24999674|NCT01315353|50091400|FG000|Overall Study|Death|2|||
24999675|NCT01315353|50091401|FG001|Overall Study|Death|1|||
24999676|NCT01315353|50091402|FG002|Overall Study|Death|0|||
24999677|NCT01315353|50091400|FG000|Overall Study|Withdrawal by Subject|2|||
24999678|NCT01315353|50091401|FG001|Overall Study|Withdrawal by Subject|6|||
24999679|NCT01315353|50091402|FG002|Overall Study|Withdrawal by Subject|1|||
24999680|NCT01315353|50091400|FG000|Overall Study|Lost to Follow-up|13|||
24999681|NCT01315353|50091401|FG001|Overall Study|Lost to Follow-up|6|||
24999682|NCT01315353|50091402|FG002|Overall Study|Lost to Follow-up|6|||
24999683|NCT01315353|50091400|FG000|Overall Study|Unwilling to adhere to requirements|5|||
24999684|NCT01315353|50091401|FG001|Overall Study|Unwilling to adhere to requirements|5|||
24999685|NCT01315353|50091402|FG002|Overall Study|Unwilling to adhere to requirements|4|||
24999686|NCT01315353|50091400|FG000|Overall Study|Site closing|7|||
24999687|NCT01315353|50091401|FG001|Overall Study|Site closing|4|||
24999688|NCT01315353|50091402|FG002|Overall Study|Site closing|0|||
24999689|NCT01315353|50091400|FG000|Overall Study|Taken off study by site in error|0|||
24999690|NCT01315353|50091401|FG001|Overall Study|Taken off study by site in error|1|||
24999691|NCT01315353|50091402|FG002|Overall Study|Taken off study by site in error|0|||
24999692|NCT01315353|50091400|FG000|Overall Study|Inadvertent randomization/assignment|0|||
24999693|NCT01315353|50091401|FG001|Overall Study|Inadvertent randomization/assignment|0|||
24999694|NCT01315353|50091402|FG002|Overall Study|Inadvertent randomization/assignment|2|||
24999695|NCT03712449|50091412|FG000|Overall Study|Withdraw Consent|0|||
24999696|NCT03712449|50091413|FG001|Overall Study|Withdraw Consent|1|||
24999697|NCT03517540|50091423|FG000|Overall Study|Protocol Violation|2|||
24999698|NCT03517540|50091424|FG001|Overall Study|Protocol Violation|0|||
24999699|NCT03517540|50091425|FG002|Overall Study|Protocol Violation|0|||
24999700|NCT03517540|50091426|FG003|Overall Study|Protocol Violation|1|||
24999701|NCT03517540|50091423|FG000|Overall Study|Adverse Event|9|||
24999702|NCT03517540|50091424|FG001|Overall Study|Adverse Event|3|||
24999703|NCT03517540|50091425|FG002|Overall Study|Adverse Event|8|||
24999704|NCT03517540|50091426|FG003|Overall Study|Adverse Event|1|||
24999705|NCT03517540|50091423|FG000|Overall Study|Withdrawal by Subject|3|||
24999706|NCT03517540|50091424|FG001|Overall Study|Withdrawal by Subject|4|||
24999707|NCT03517540|50091425|FG002|Overall Study|Withdrawal by Subject|1|||
24999708|NCT03517540|50091426|FG003|Overall Study|Withdrawal by Subject|3|||
24999709|NCT02799082|50091438|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
24999710|NCT02799082|50091439|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
24999711|NCT02799082|50091438|FG000|Overall Study|Protocol Violation|0|||
24999712|NCT02799082|50091439|FG001|Overall Study|Protocol Violation|1|||
24999713|NCT03710889|50091445|FG000|Overall Study|Adverse Event|2|||
24999714|NCT03710889|50091445|FG000|Overall Study|Protocol Deviation|1|||
24999715|NCT02797678|50091449|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
24999716|NCT02797678|50091450|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
24999717|NCT02797678|50091451|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
24999718|NCT02797678|50091452|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
24999719|NCT02797678|50091449|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
24999720|NCT02797678|50091450|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
24999721|NCT02797678|50091451|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
24999722|NCT02797678|50091452|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
24999723|NCT02797678|50091449|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
24999724|NCT02797678|50091450|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
24999725|NCT02797678|50091451|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
24999726|NCT02797678|50091452|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
24999727|NCT03308942|50091470|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
24999728|NCT03308942|50091471|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
24999729|NCT03308942|50091472|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
24999730|NCT03308942|50091473|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
24999731|NCT03308942|50091474|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
24999732|NCT03308942|50091470|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
24999733|NCT03308942|50091471|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
24999734|NCT03308942|50091472|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
24999735|NCT03308942|50091473|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
24999736|NCT03308942|50091474|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
24999737|NCT03308942|50091470|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
24999738|NCT03308942|50091471|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
24999739|NCT03308942|50091472|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
24999740|NCT03308942|50091473|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
24999741|NCT03308942|50091474|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
24999742|NCT03308942|50091470|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
24999743|NCT03308942|50091471|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
24999744|NCT03308942|50091472|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
24999745|NCT03308942|50091473|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
24999746|NCT03308942|50091474|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
24999747|NCT03308942|50091470|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
24999748|NCT03308942|50091471|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
24999749|NCT03308942|50091472|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
24999750|NCT03308942|50091473|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
24999751|NCT03308942|50091474|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
24999752|NCT03308942|50091470|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
24999753|NCT03308942|50091471|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
24999754|NCT03308942|50091472|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
24999755|NCT03308942|50091473|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
24999756|NCT03308942|50091474|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
24999757|NCT03308942|50091470|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
24999758|NCT03308942|50091471|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
24999759|NCT03308942|50091472|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
24999760|NCT03308942|50091473|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
24999761|NCT03308942|50091474|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
24999762|NCT03308786|50091487|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
24999763|NCT03274076|50091494|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
24999764|NCT03274076|50091495|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
24999765|NCT03274076|50091496|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
24999766|NCT03274076|50091497|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
24999767|NCT03274076|50091494|FG000|24 Weeks Open Label|Adverse Event|0|||
24999768|NCT03274076|50091495|FG001|24 Weeks Open Label|Adverse Event|0|||
24999769|NCT03274076|50091496|FG002|24 Weeks Open Label|Adverse Event|2|||
24999770|NCT03274076|50091497|FG003|24 Weeks Open Label|Adverse Event|0|||
24999771|NCT03274076|50091494|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
24999772|NCT03274076|50091495|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
24999773|NCT03274076|50091496|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
24999774|NCT03274076|50091497|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
24999775|NCT02797522|50091527|FG000|Overall Study|Study Terminated by Sponsor|0|||
24999776|NCT02797522|50091528|FG001|Overall Study|Study Terminated by Sponsor|0|||
24999777|NCT02797522|50091529|FG002|Overall Study|Study Terminated by Sponsor|0|||
24999778|NCT02797522|50091530|FG003|Overall Study|Study Terminated by Sponsor|0|||
24999779|NCT02797522|50091531|FG004|Overall Study|Study Terminated by Sponsor|0|||
24999780|NCT02797522|50091532|FG005|Overall Study|Study Terminated by Sponsor|0|||
24999781|NCT02797522|50091533|FG006|Overall Study|Study Terminated by Sponsor|0|||
24999782|NCT02797522|50091534|FG007|Overall Study|Study Terminated by Sponsor|4|||
24999783|NCT02797522|50091535|FG008|Overall Study|Study Terminated by Sponsor|2|||
24999784|NCT02797522|50091536|FG009|Overall Study|Study Terminated by Sponsor|4|||
24999785|NCT02797522|50091537|FG010|Overall Study|Study Terminated by Sponsor|1|||
24999786|NCT02659514|50091576|FG000|Overall Study|Adverse Event|3|||
24999787|NCT02659514|50091577|FG001|Overall Study|Adverse Event|12|||
24999788|NCT02659514|50091576|FG000|Overall Study|Disease Progression|23|||
24999789|NCT02659514|50091577|FG001|Overall Study|Disease Progression|13|||
24999790|NCT02659514|50091576|FG000|Overall Study|Withdrawal by Subject|0|||
24999791|NCT02659514|50091577|FG001|Overall Study|Withdrawal by Subject|4|||
24999792|NCT02659514|50091576|FG000|Overall Study|Lost to Follow-up|0|||
24999793|NCT02659514|50091577|FG001|Overall Study|Lost to Follow-up|1|||
24999794|NCT02659514|50091576|FG000|Overall Study|Death|6|||
24999795|NCT02659514|50091577|FG001|Overall Study|Death|1|||
24999796|NCT02659514|50091576|FG000|Overall Study|Reason Unspecified|0|||
24999797|NCT02659514|50091577|FG001|Overall Study|Reason Unspecified|3|||
24999798|NCT04570670|50091585|FG000|Overall Study|Withdrawal by Subject|1|||
24999799|NCT04570670|50091586|FG001|Overall Study|Withdrawal by Subject|0|||
24999800|NCT02797132|50091592|FG000|Part A (15 Days)|Adverse Event|1|||
24999801|NCT02797132|50091592|FG000|Part B (24 Weeks)|Adverse Event|3|||
24999802|NCT03270644|50091605|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
24999803|NCT03270644|50091605|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
24999804|NCT03269552|50091616|FG000|Overall Study|Adverse Event|2|||
24999805|NCT02796664|50091623|FG000|Overall Study|Withdrawal by Subject|0|||
24999806|NCT02796664|50091624|FG001|Overall Study|Withdrawal by Subject|3|||
24999807|NCT02796664|50091623|FG000|Overall Study|Noncompliance|1|||
24999808|NCT02796664|50091624|FG001|Overall Study|Noncompliance|1|||
24999809|NCT02796664|50091623|FG000|Overall Study|Death|0|||
24999810|NCT02796664|50091624|FG001|Overall Study|Death|1|||
24999811|NCT01370356|50091634|FG000|Overall Study|Death|1|||
24999812|NCT01370356|50091635|FG001|Overall Study|Death|0|||
25176352|NCT01521923|50319560|FG000|Overall Study|Lost to Follow-up|1|||
24999813|NCT01370356|50091634|FG000|Overall Study|Lack of Efficacy|6|||
24999814|NCT01370356|50091635|FG001|Overall Study|Lack of Efficacy|28|||
24999815|NCT01370356|50091634|FG000|Overall Study|Lost to Follow-up|76|||
24999816|NCT01370356|50091635|FG001|Overall Study|Lost to Follow-up|81|||
24999817|NCT01370356|50091634|FG000|Overall Study|Withdrawal by Subject|54|||
24999818|NCT01370356|50091635|FG001|Overall Study|Withdrawal by Subject|59|||
24999819|NCT01370356|50091634|FG000|Overall Study|Reason not specified|39|||
24999820|NCT01370356|50091635|FG001|Overall Study|Reason not specified|43|||
24999821|NCT01370356|50091634|FG000|Overall Study|Protocol Violation|3|||
24999822|NCT01370356|50091635|FG001|Overall Study|Protocol Violation|3|||
24999823|NCT01370356|50091634|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
24999824|NCT01370356|50091635|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
24999825|NCT01370356|50091634|FG000|Overall Study|AE Not Related to Study Drug|1|||
24999826|NCT01370356|50091635|FG001|Overall Study|AE Not Related to Study Drug|4|||
24999827|NCT02794870|50091643|FG000|Overall Study|Withdrawal by Subject|2|||
24999828|NCT02794870|50091644|FG001|Overall Study|Withdrawal by Subject|0|||
24999829|NCT01370590|50091652|FG000|Period 1|Adverse Event|8|||
24999830|NCT01370590|50091653|FG001|Period 1|Adverse Event|4|||
24999831|NCT01370590|50091652|FG000|Period 1|Lost to Follow-up|2|||
24999832|NCT01370590|50091653|FG001|Period 1|Lost to Follow-up|2|||
24999833|NCT01370590|50091652|FG000|Period 1|Protocol Violation|2|||
24999834|NCT01370590|50091653|FG001|Period 1|Protocol Violation|2|||
24999835|NCT01370590|50091652|FG000|Period 1|Withdrawal by Subject|4|||
24999836|NCT01370590|50091653|FG001|Period 1|Withdrawal by Subject|2|||
24999837|NCT01370590|50091652|FG000|Period 1|Could not access randomization system|0|||
24999838|NCT01370590|50091653|FG001|Period 1|Could not access randomization system|1|||
24999839|NCT01370590|50091652|FG000|Crossover Washout Period|Adverse Event|1|||
24999840|NCT01370590|50091653|FG001|Crossover Washout Period|Adverse Event|4|||
24999841|NCT01370590|50091652|FG000|Crossover Washout Period|Lost to Follow-up|2|||
24999842|NCT01370590|50091653|FG001|Crossover Washout Period|Lost to Follow-up|0|||
24999843|NCT01370590|50091652|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
24999844|NCT01370590|50091653|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
24999845|NCT01370590|50091652|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
24999846|NCT01370590|50091653|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
24999847|NCT01370590|50091652|FG000|Period 2|Adverse Event|0|||
24999848|NCT01370590|50091653|FG001|Period 2|Adverse Event|1|||
24999849|NCT01370590|50091652|FG000|Period 2|Withdrawal by Subject|1|||
24999850|NCT01370590|50091653|FG001|Period 2|Withdrawal by Subject|1|||
24999851|NCT05200455|50091664|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
24999852|NCT04646109|50091671|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
24999853|NCT04646109|50091672|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
24999854|NCT04502979|50091681|FG000|Overall Study|Lost to Follow-up|1|||
24999855|NCT04502979|50091682|FG001|Overall Study|Lost to Follow-up|3|||
24999856|NCT04502979|50091681|FG000|Overall Study|Withdrawal by Subject|2|||
24999857|NCT04502979|50091682|FG001|Overall Study|Withdrawal by Subject|1|||
24999858|NCT04590027|50091690|FG000|Overall Study|Lost to Follow-up|17|||
24999859|NCT04590027|50091691|FG001|Overall Study|Lost to Follow-up|14|||
24999860|NCT04590027|50091690|FG000|Overall Study|Protocol Violation|0|||
24999861|NCT04590027|50091691|FG001|Overall Study|Protocol Violation|3|||
24999862|NCT04587453|50091703|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
24999863|NCT04587453|50091704|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
24999864|NCT02793232|50091721|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
24999865|NCT02793232|50091722|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
24999866|NCT02793232|50091723|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
24999867|NCT02793232|50091724|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
24999868|NCT02793232|50091725|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
24999869|NCT02793232|50091726|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
24999870|NCT02793232|50091727|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
24999871|NCT02793232|50091728|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
24999872|NCT02793232|50091729|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
24999873|NCT04584645|50091765|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
24999874|NCT04584645|50091766|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
24999875|NCT03695367|50091792|FG000|Overall Study|Missed the Day 28 visit.|1|||
24999876|NCT03695367|50091793|FG001|Overall Study|Missed the Day 28 visit.|0|||
24999877|NCT03695367|50091792|FG000|Overall Study|Lost to Follow-up|0|||
24999878|NCT03695367|50091793|FG001|Overall Study|Lost to Follow-up|1|||
24999879|NCT03695367|50091792|FG000|Overall Study|Withdrawal by Subject|0|||
24999880|NCT03695367|50091793|FG001|Overall Study|Withdrawal by Subject|1|||
24999881|NCT03695367|50091792|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
24999882|NCT03695367|50091793|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
24999883|NCT02794480|50091801|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
24999884|NCT02794480|50091802|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
24999885|NCT02794480|50091803|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
24999886|NCT02794480|50091804|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
24999887|NCT02794480|50091801|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
24999888|NCT02794480|50091802|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
24999889|NCT02794480|50091803|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
24999890|NCT02794480|50091804|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
24999891|NCT02794480|50091801|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
24999892|NCT02794480|50091802|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
24999893|NCT02794480|50091803|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
24999894|NCT02794480|50091804|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
24999895|NCT02794480|50091801|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
24999896|NCT02794480|50091802|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
24999897|NCT02794480|50091803|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
24999898|NCT02794480|50091804|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
24999899|NCT02794480|50091801|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
24999900|NCT02794480|50091802|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
24999901|NCT02794480|50091803|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
24999902|NCT02794480|50091804|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
24999903|NCT04558125|50091812|FG000|Overall Study|Death|1|||
24999904|NCT02793622|50091818|FG000|Overall Study|Lost to Follow-up|31|||
24999905|NCT02793622|50091819|FG001|Overall Study|Lost to Follow-up|19|||
24999906|NCT02793622|50091818|FG000|Overall Study|Withdrawal by Subject|21|||
24999907|NCT02793622|50091819|FG001|Overall Study|Withdrawal by Subject|17|||
24999908|NCT02793622|50091818|FG000|Overall Study|Adverse Event|0|||
24999909|NCT02793622|50091819|FG001|Overall Study|Adverse Event|1|||
24999910|NCT02793622|50091818|FG000|Overall Study|Protocol Violation|1|||
24999911|NCT02793622|50091819|FG001|Overall Study|Protocol Violation|5|||
24999912|NCT04493931|50091832|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
24999913|NCT04493931|50091833|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
24999914|NCT04493931|50091834|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
24999915|NCT04493931|50091835|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
24999916|NCT04493931|50091836|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
24999917|NCT04493931|50091837|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
24999918|NCT04493931|50091838|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
24999919|NCT04493931|50091832|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
24999920|NCT04493931|50091833|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
24999921|NCT04493931|50091834|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
24999922|NCT04493931|50091835|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
24999923|NCT04493931|50091836|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
24999924|NCT04493931|50091837|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
24999925|NCT04493931|50091838|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
24999926|NCT04493931|50091832|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
24999927|NCT04493931|50091833|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
24999928|NCT04493931|50091834|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
24999929|NCT04493931|50091835|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
24999930|NCT04493931|50091836|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
24999931|NCT04493931|50091837|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
24999932|NCT04493931|50091838|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
24999933|NCT04493931|50091832|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
24999934|NCT04493931|50091833|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
24999935|NCT04493931|50091834|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
24999936|NCT04493931|50091835|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
24999937|NCT04493931|50091836|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
24999938|NCT04493931|50091837|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
24999939|NCT04493931|50091838|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
24999940|NCT03437278|50091871|FG000|Overall Study|Adverse Event|0|||
24999941|NCT03437278|50091872|FG001|Overall Study|Adverse Event|0|||
24999942|NCT03437278|50091873|FG002|Overall Study|Adverse Event|1|||
24999943|NCT03437278|50091871|FG000|Overall Study|Progressive disease|1|||
24999944|NCT03437278|50091872|FG001|Overall Study|Progressive disease|0|||
24999945|NCT03437278|50091873|FG002|Overall Study|Progressive disease|0|||
24999946|NCT03437278|50091871|FG000|Overall Study|Physician Decision|1|||
24999947|NCT03437278|50091872|FG001|Overall Study|Physician Decision|0|||
24999948|NCT03437278|50091873|FG002|Overall Study|Physician Decision|1|||
24999949|NCT04553913|50091883|FG000|Overall Study|patient's block resolved prior to PACU|1|||
24999950|NCT04553913|50091883|FG000|Overall Study|did not use the device properly|5|||
24999951|NCT04490499|50091888|FG000|Overall Study|Withdrawal by Subject|2|||
24999952|NCT01332994|50091892|FG000|Overall Study|Adverse Event|34|||
24999953|NCT01332994|50091892|FG000|Overall Study|Death|1|||
24999954|NCT01332994|50091892|FG000|Overall Study|Lack of Efficacy|1|||
24999955|NCT01332994|50091892|FG000|Overall Study|Lost to Follow-up|4|||
24999956|NCT01332994|50091892|FG000|Overall Study|Protocol Violation|6|||
24999957|NCT01332994|50091892|FG000|Overall Study|Withdrawal by Subject|15|||
24999958|NCT01332994|50091892|FG000|Overall Study|Administrative Problem|2|||
24999959|NCT01332994|50091892|FG000|Overall Study|Other|8|||
24999960|NCT03698331|50091898|FG000|Overall Study|Adverse Event|2|||
24999961|NCT03698331|50091899|FG001|Overall Study|Adverse Event|3|||
24999962|NCT03698331|50091898|FG000|Overall Study|Withdrawal by Subject|1|||
24999963|NCT03698331|50091899|FG001|Overall Study|Withdrawal by Subject|1|||
24999964|NCT03698331|50091898|FG000|Overall Study|Lost to Follow-up|0|||
24999965|NCT03698331|50091899|FG001|Overall Study|Lost to Follow-up|2|||
24999966|NCT03698331|50091898|FG000|Overall Study|Non-compliance with study drug|1|||
24999967|NCT03698331|50091899|FG001|Overall Study|Non-compliance with study drug|0|||
24999968|NCT04889625|50091905|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
24999969|NCT04889625|50091906|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
24999970|NCT04889625|50091905|FG000|Period 1|Subject out of window|0|||
24999971|NCT04889625|50091906|FG001|Period 1|Subject out of window|1|||
24999972|NCT04889625|50091905|FG000|Period 1|Wrong add power dispensed|0|||
24999973|NCT04889625|50091906|FG001|Period 1|Wrong add power dispensed|1|||
24999974|NCT04889625|50091905|FG000|Period 1|Discontinued due to fitting guide error|1|||
24999975|NCT04889625|50091906|FG001|Period 1|Discontinued due to fitting guide error|1|||
24999976|NCT04889625|50091905|FG000|Period 2|Test article no longer available|1|||
24999977|NCT04889625|50091906|FG001|Period 2|Test article no longer available|0|||
24999978|NCT04889625|50091905|FG000|Period 2|Incorrect lens dispensed|1|||
24999979|NCT04889625|50091906|FG001|Period 2|Incorrect lens dispensed|0|||
24999980|NCT04889625|50091905|FG000|Period 2|Wrong add power dispensed|0|||
24999981|NCT04889625|50091906|FG001|Period 2|Wrong add power dispensed|1|||
24999982|NCT04883541|50091914|FG000|Overall Study|Not attending regular yoga class|16|||
24999983|NCT04883541|50091915|FG001|Overall Study|Not attending regular yoga class|0|||
24999984|NCT04883541|50091914|FG000|Overall Study|Not attending the pregnancy school|0|||
24999985|NCT04883541|50091915|FG001|Overall Study|Not attending the pregnancy school|9|||
24999986|NCT04882995|50091923|FG000|Overall Study|Withdrawal by Subject|1|||
24999987|NCT04882995|50091924|FG001|Overall Study|Withdrawal by Subject|2|||
24999988|NCT04882995|50091923|FG000|Overall Study|Protocol Violation|4|||
24999989|NCT04882995|50091924|FG001|Overall Study|Protocol Violation|4|||
24999990|NCT04882995|50091923|FG000|Overall Study|Surgery postponed due to COVID|1|||
24999991|NCT04882995|50091924|FG001|Overall Study|Surgery postponed due to COVID|1|||
24999992|NCT04483011|50091932|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
24999993|NCT04483011|50091933|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
24999994|NCT04545567|50091943|FG000|Overall Study|tested positive for SARS-co-V2|1|||
24999995|NCT04545567|50091944|FG001|Overall Study|tested positive for SARS-co-V2|1|||
24999996|NCT04545567|50091943|FG000|Overall Study|Withdrawal by Subject|0|||
24999997|NCT04545567|50091944|FG001|Overall Study|Withdrawal by Subject|1|||
24999998|NCT04534491|50091950|FG000|Overall Study|Not completed end-of-study interview|24|||
24999999|NCT04534491|50091950|FG000|Overall Study|Non-users|70|||
25000000|NCT04534491|50091950|FG000|Overall Study|Non-verifiable users|58|||
25000001|NCT03694821|50091957|FG000|Overall Study|Study terminated|4|||
25000002|NCT03694821|50091958|FG001|Overall Study|Study terminated|8|||
25000003|NCT03694821|50091959|FG002|Overall Study|Study terminated|4|||
25000004|NCT04531527|50091967|FG000|Overall Study|Found to be Ineligible|3|||
25000005|NCT04474197|50091975|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
25000006|NCT04474197|50091976|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
25000007|NCT04474197|50091977|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
25000008|NCT04474197|50091978|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
25000009|NCT02079766|50091995|FG000|Overall Study|Physician Decision|1|||
25000010|NCT02079766|50091996|FG001|Overall Study|Physician Decision|0|||
25000011|NCT02079766|50091995|FG000|Overall Study|Withdrawal by Subject|1|||
25000012|NCT02079766|50091996|FG001|Overall Study|Withdrawal by Subject|0|||
25000013|NCT04841577|50092004|FG000|Overall Study|Adverse Event|5|||
25000014|NCT04841577|50092005|FG001|Overall Study|Adverse Event|10|||
25000015|NCT04841577|50092004|FG000|Overall Study|Lost to Follow-up|8|||
25000016|NCT04841577|50092005|FG001|Overall Study|Lost to Follow-up|7|||
25000017|NCT04841577|50092004|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
25000018|NCT04841577|50092005|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
25000019|NCT04841577|50092004|FG000|Overall Study|Other|0|||
25000020|NCT04841577|50092005|FG001|Overall Study|Other|1|||
25000021|NCT04529109|50092011|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
25000022|NCT04529109|50092012|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
25000023|NCT04528641|50092024|FG000|Overall Study|Withdrawal by Subject|0|||
25000024|NCT04528641|50092025|FG001|Overall Study|Withdrawal by Subject|0|||
25000025|NCT04528641|50092026|FG002|Overall Study|Withdrawal by Subject|0|||
25000026|NCT04528641|50092027|FG003|Overall Study|Withdrawal by Subject|1|||
25091225|NCT01999894|50200730|FG000|Overall Study|Withdrawal by Subject|7|||
25000027|NCT04528641|50092028|FG004|Overall Study|Withdrawal by Subject|0|||
25000028|NCT04528641|50092029|FG005|Overall Study|Withdrawal by Subject|1|||
25000029|NCT04527471|50092048|FG000|Overall Study|Adverse Event|1|||
25000030|NCT04527471|50092049|FG001|Overall Study|Adverse Event|0|||
25000031|NCT04527471|50092048|FG000|Overall Study|Lost to Follow-up|1|||
25000032|NCT04527471|50092049|FG001|Overall Study|Lost to Follow-up|0|||
25000033|NCT04471935|50092055|FG000|Overall Study|Withdrawal by Subject|1|||
25000034|NCT04471935|50092055|FG000|Overall Study|Deemed ineligible to participate|1|||
25000035|NCT04468347|50092063|FG000|Overall Study|Withdrawal by Subject|0|||
25000036|NCT04468347|50092064|FG001|Overall Study|Withdrawal by Subject|1|||
25000037|NCT04468347|50092065|FG002|Overall Study|Withdrawal by Subject|3|||
25000038|NCT04468347|50092066|FG003|Overall Study|Withdrawal by Subject|3|||
25000039|NCT04468347|50092063|FG000|Overall Study|Lost to Follow-up|0|||
25000040|NCT04468347|50092064|FG001|Overall Study|Lost to Follow-up|0|||
25000041|NCT04468347|50092065|FG002|Overall Study|Lost to Follow-up|1|||
25000042|NCT04468347|50092066|FG003|Overall Study|Lost to Follow-up|1|||
25000043|NCT04468347|50092063|FG000|Overall Study|Physician Decision|1|||
25000044|NCT04468347|50092064|FG001|Overall Study|Physician Decision|0|||
25000045|NCT04468347|50092065|FG002|Overall Study|Physician Decision|2|||
25000046|NCT04468347|50092066|FG003|Overall Study|Physician Decision|0|||
25000047|NCT04468347|50092063|FG000|Overall Study|Protocol Violation|1|||
25000048|NCT04468347|50092064|FG001|Overall Study|Protocol Violation|0|||
25000049|NCT04468347|50092065|FG002|Overall Study|Protocol Violation|0|||
25000050|NCT04468347|50092066|FG003|Overall Study|Protocol Violation|0|||
25000051|NCT04822701|50092082|FG000|Overall Study|Not treated|2|||
25000052|NCT04822701|50092083|FG001|Overall Study|Not treated|0|||
25000053|NCT04822701|50092082|FG000|Overall Study|Lost to Follow-up|1|||
25000054|NCT04822701|50092083|FG001|Overall Study|Lost to Follow-up|0|||
25000055|NCT04822701|50092082|FG000|Overall Study|Withdrawal by Subject|1|||
25000056|NCT04822701|50092083|FG001|Overall Study|Withdrawal by Subject|0|||
25000057|NCT04461795|50092089|FG000|Overall Study|Lost to Follow-up|2|||
25000058|NCT04461795|50092089|FG000|Overall Study|Withdrawal by Subject|2|||
25000059|NCT04461795|50092089|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
25000060|NCT04461015|50092096|FG000|Overall Study|IV access lost during the study|0|||
25000061|NCT04461015|50092097|FG001|Overall Study|IV access lost during the study|1|||
25000062|NCT04461015|50092096|FG000|Overall Study|Withdrawal by Subject|0|||
25000063|NCT04461015|50092097|FG001|Overall Study|Withdrawal by Subject|1|||
25000064|NCT04810221|50092103|FG000|Overall Study|Physician Decision|3|||
25000065|NCT03694353|50092107|FG000|Overall Study|Withdrawal by Subject|1|||
25000066|NCT03694353|50092107|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
25000067|NCT04521777|50092111|FG000|Overall Study|Death|2|||
25000068|NCT04521777|50092111|FG000|Overall Study|Withdrawal by Subject|2|||
25000069|NCT03700671|50092117|FG000|Overall Study|Lack of Efficacy|1|||
25000070|NCT03700671|50092118|FG001|Overall Study|Lack of Efficacy|2|||
25000071|NCT04764669|50092130|FG000|Overall Study|Adverse Event|1|||
25000072|NCT04764669|50092131|FG001|Overall Study|Adverse Event|0|||
25000073|NCT04764669|50092132|FG002|Overall Study|Adverse Event|1|||
25000074|NCT04764669|50092133|FG003|Overall Study|Adverse Event|0|||
25000075|NCT04764669|50092130|FG000|Overall Study|Subject Choice|0|||
25000076|NCT04764669|50092131|FG001|Overall Study|Subject Choice|0|||
25000077|NCT04764669|50092132|FG002|Overall Study|Subject Choice|1|||
25000078|NCT04764669|50092133|FG003|Overall Study|Subject Choice|0|||
25000079|NCT04764669|50092130|FG000|Overall Study|Withdrawal by Subject|2|||
25000080|NCT04764669|50092131|FG001|Overall Study|Withdrawal by Subject|0|||
25000081|NCT04764669|50092132|FG002|Overall Study|Withdrawal by Subject|0|||
25000082|NCT04764669|50092133|FG003|Overall Study|Withdrawal by Subject|0|||
25000083|NCT04439253|50092143|FG000|Overall Study|Adverse Event|1|||
25000084|NCT04439253|50092143|FG000|Overall Study|Disease progression|2|||
25000085|NCT04439253|50092143|FG000|Overall Study|Complicating disease|1|||
25000086|NCT04438785|50092149|FG000|Overall Study|change of weight, give up intervention|2|||
25000087|NCT04438785|50092150|FG001|Overall Study|change of weight, give up intervention|10|||
25000088|NCT04741503|50092158|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
25000089|NCT04741503|50092159|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
25000090|NCT04741503|50092160|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
25000091|NCT04741503|50092158|FG000|Initial Enrollment|Overquotas removed|0|||
25000092|NCT04741503|50092159|FG001|Initial Enrollment|Overquotas removed|0|||
25000093|NCT04741503|50092160|FG002|Initial Enrollment|Overquotas removed|186|||
25000094|NCT04741503|50092158|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
25000095|NCT04741503|50092159|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
25000096|NCT04741503|50092160|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
25000097|NCT04734873|50092169|FG000|Overall Study|Lost to Follow-up|1|||
25000098|NCT04734873|50092170|FG001|Overall Study|Lost to Follow-up|3|||
25000099|NCT04734873|50092171|FG002|Overall Study|Lost to Follow-up|2|||
25000100|NCT04734873|50092169|FG000|Overall Study|Randomized but not dosed|1|||
25000101|NCT04734873|50092170|FG001|Overall Study|Randomized but not dosed|0|||
25000102|NCT04734873|50092171|FG002|Overall Study|Randomized but not dosed|1|||
25000103|NCT04435665|50092183|FG000|Overall Study|Lost to Follow-up|0|||
25000104|NCT04435665|50092184|FG001|Overall Study|Lost to Follow-up|0|||
25000105|NCT04435665|50092185|FG002|Overall Study|Lost to Follow-up|0|||
25000106|NCT04435665|50092186|FG003|Overall Study|Lost to Follow-up|1|||
25000107|NCT04428411|50092196|FG000|Overall Study|Lost to Follow-up|114|||
25000108|NCT04422561|50092205|FG000|Overall Study|Lost to Follow-up|25|||
25000109|NCT04422561|50092206|FG001|Overall Study|Lost to Follow-up|11|||
25000110|NCT01369498|50092216|FG000|Overall Study|Lack of Efficacy|9|||
25000111|NCT01369498|50092217|FG001|Overall Study|Lack of Efficacy|9|||
25000112|NCT01369498|50092218|FG002|Overall Study|Lack of Efficacy|1|||
25000113|NCT01369498|50092219|FG003|Overall Study|Lack of Efficacy|3|||
25000114|NCT01369498|50092216|FG000|Overall Study|Adverse Event|1|||
25000115|NCT01369498|50092217|FG001|Overall Study|Adverse Event|2|||
25000116|NCT01369498|50092218|FG002|Overall Study|Adverse Event|0|||
25000117|NCT01369498|50092219|FG003|Overall Study|Adverse Event|1|||
25000118|NCT01369498|50092216|FG000|Overall Study|Withdrawal of Consent|0|||
25000119|NCT01369498|50092217|FG001|Overall Study|Withdrawal of Consent|1|||
25000120|NCT01369498|50092218|FG002|Overall Study|Withdrawal of Consent|1|||
25000121|NCT01369498|50092219|FG003|Overall Study|Withdrawal of Consent|1|||
25000122|NCT01369498|50092216|FG000|Overall Study|Death|0|||
25000123|NCT01369498|50092217|FG001|Overall Study|Death|0|||
25000124|NCT01369498|50092218|FG002|Overall Study|Death|1|||
25000125|NCT01369498|50092219|FG003|Overall Study|Death|0|||
25000126|NCT01369498|50092216|FG000|Overall Study|Investigator's Discretion|1|||
25000127|NCT01369498|50092217|FG001|Overall Study|Investigator's Discretion|0|||
25000128|NCT01369498|50092218|FG002|Overall Study|Investigator's Discretion|1|||
25000129|NCT01369498|50092219|FG003|Overall Study|Investigator's Discretion|3|||
25000130|NCT01369498|50092216|FG000|Overall Study|Unknown Reason|1|||
25000131|NCT01369498|50092217|FG001|Overall Study|Unknown Reason|0|||
25000132|NCT01369498|50092218|FG002|Overall Study|Unknown Reason|11|||
25000133|NCT01369498|50092219|FG003|Overall Study|Unknown Reason|6|||
25000134|NCT01369498|50092216|FG000|Overall Study|Disease Progression|0|||
25000135|NCT01369498|50092217|FG001|Overall Study|Disease Progression|0|||
25000136|NCT01369498|50092218|FG002|Overall Study|Disease Progression|0|||
25000137|NCT01369498|50092219|FG003|Overall Study|Disease Progression|1|||
25000138|NCT04709835|50092233|FG000|Overall Study|Withdrawal by Subject|0|||
25000139|NCT04709835|50092234|FG001|Overall Study|Withdrawal by Subject|1|||
25000140|NCT04709835|50092235|FG002|Overall Study|Withdrawal by Subject|0|||
25000141|NCT04407507|50092249|FG000|Overall Study|Withdrawal by Subject|0|||
25000142|NCT04407507|50092250|FG001|Overall Study|Withdrawal by Subject|1|||
25000143|NCT04698993|50092258|FG000|Overall Study|PCR results not accessible|2|||
25000144|NCT04698993|50092259|FG001|Overall Study|PCR results not accessible|7|||
25000145|NCT04698993|50092258|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
25000146|NCT04698993|50092259|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
25000147|NCT04359771|50092267|FG000|Overall Study|Lack of Efficacy|2|||
25000148|NCT04359771|50092268|FG001|Overall Study|Lack of Efficacy|2|||
25000149|NCT04356573|50092276|FG000|Overall Study|Didn't Qualify|1|||
25000150|NCT04356573|50092277|FG001|Overall Study|Didn't Qualify|0|||
25000151|NCT04352127|50092293|FG000|Overall Study|Unable to obtain readings|4|||
25000152|NCT04352127|50092294|FG001|Overall Study|Unable to obtain readings|1|||
25000153|NCT04351269|50092303|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
25000154|NCT04351269|50092304|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
25000155|NCT04351269|50092305|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
25000156|NCT04351269|50092303|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
25000157|NCT04351269|50092304|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
25000158|NCT04351269|50092305|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
25000159|NCT04351269|50092303|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
25000160|NCT04351269|50092304|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
25000161|NCT04351269|50092305|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
25000162|NCT04351269|50092303|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
25000163|NCT04351269|50092304|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
25000164|NCT04351269|50092305|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
25000165|NCT04351269|50092303|FG000|Overall Study|Lost to Follow-up|1|||
25000166|NCT04351269|50092304|FG001|Overall Study|Lost to Follow-up|3|||
25000167|NCT04351269|50092305|FG002|Overall Study|Lost to Follow-up|0|||
25000168|NCT04348851|50092320|FG000|Post-Test 1|Withdrawal by Subject|0|||
25000169|NCT04348851|50092321|FG001|Post-Test 1|Withdrawal by Subject|1|||
25000170|NCT04348851|50092322|FG002|Post-Test 1|Withdrawal by Subject|0|||
25000171|NCT04348851|50092323|FG003|Post-Test 1|Withdrawal by Subject|0|||
25000172|NCT04348851|50092320|FG000|Post-Test 1|Lost to Follow-up|0|||
25000173|NCT04348851|50092321|FG001|Post-Test 1|Lost to Follow-up|1|||
25000174|NCT04348851|50092322|FG002|Post-Test 1|Lost to Follow-up|0|||
25000175|NCT04348851|50092323|FG003|Post-Test 1|Lost to Follow-up|0|||
25000176|NCT04348851|50092320|FG000|Post-Test 2|Stroke survivor death|0|||
25000177|NCT04348851|50092321|FG001|Post-Test 2|Stroke survivor death|1|||
25000178|NCT04348851|50092322|FG002|Post-Test 2|Stroke survivor death|0|||
25000179|NCT04348851|50092323|FG003|Post-Test 2|Stroke survivor death|1|||
25000180|NCT04346199|50092335|FG000|Overall Study|Death|8|||
25000181|NCT04346199|50092336|FG001|Overall Study|Death|9|||
25000182|NCT04346199|50092335|FG000|Overall Study|Lost to Follow-up|0|||
25000183|NCT04346199|50092336|FG001|Overall Study|Lost to Follow-up|1|||
25176353|NCT01521923|50319561|FG001|Overall Study|Lost to Follow-up|0|||
25176354|NCT01521923|50319562|FG002|Overall Study|Lost to Follow-up|2|||
25176355|NCT01521923|50319563|FG003|Overall Study|Lost to Follow-up|1|||
25176356|NCT01521923|50319560|FG000|Overall Study|Withdrawal by Subject|1|||
25000184|NCT04346199|50092335|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
25000185|NCT04346199|50092336|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
25000186|NCT04346199|50092335|FG000|Overall Study|Withdrawal by Subject|5|||
25000187|NCT04346199|50092336|FG001|Overall Study|Withdrawal by Subject|1|||
25000188|NCT04345653|50092342|FG000|Overall Study|Withdrawal by Subject|2|||
25000189|NCT04342689|50092349|FG000|Overall Study|Withdrawal by Subject|32|||
25000190|NCT04342689|50092350|FG001|Overall Study|Withdrawal by Subject|33|||
25000191|NCT04342689|50092349|FG000|Overall Study|Lost to Follow-up|10|||
25000192|NCT04342689|50092350|FG001|Overall Study|Lost to Follow-up|12|||
25000193|NCT04169061|50092358|FG000|Overall Study|Adverse Event|2|||
25000194|NCT04169061|50092358|FG000|Overall Study|Death|1|||
25000195|NCT04169061|50092358|FG000|Overall Study|Withdrawal by Subject|1|||
25000196|NCT04169061|50092358|FG000|Overall Study|Protocol Violation|1|||
25000197|NCT02792218|50092364|FG000|Overall Study|Patient/guardian decision|15|||
25000198|NCT02792218|50092365|FG001|Overall Study|Patient/guardian decision|42|||
25000199|NCT02792218|50092364|FG000|Overall Study|Adverse Event|15|||
25000200|NCT02792218|50092365|FG001|Overall Study|Adverse Event|14|||
25000201|NCT02792218|50092364|FG000|Overall Study|Lost to Follow-up|10|||
25000202|NCT02792218|50092365|FG001|Overall Study|Lost to Follow-up|5|||
25000203|NCT02792218|50092364|FG000|Overall Study|Lack of Efficacy|1|||
25000204|NCT02792218|50092365|FG001|Overall Study|Lack of Efficacy|12|||
25000205|NCT02792218|50092364|FG000|Overall Study|Physician Decision|4|||
25000206|NCT02792218|50092365|FG001|Overall Study|Physician Decision|4|||
25000207|NCT02792218|50092364|FG000|Overall Study|Protocol deviation|3|||
25000208|NCT02792218|50092365|FG001|Overall Study|Protocol deviation|2|||
25000209|NCT02792218|50092364|FG000|Overall Study|New therapy for study indication|0|||
25000210|NCT02792218|50092365|FG001|Overall Study|New therapy for study indication|1|||
25000211|NCT02792218|50092364|FG000|Overall Study|Non-compliance with study treatment|0|||
25000212|NCT02792218|50092365|FG001|Overall Study|Non-compliance with study treatment|1|||
25000213|NCT02792218|50092364|FG000|Overall Study|Pregnancy|1|||
25176357|NCT01521923|50319561|FG001|Overall Study|Withdrawal by Subject|1|||
25176358|NCT01521923|50319562|FG002|Overall Study|Withdrawal by Subject|1|||
25176359|NCT01521923|50319563|FG003|Overall Study|Withdrawal by Subject|2|||
25176360|NCT01521923|50319560|FG000|Overall Study|Other|2|||
25176361|NCT01521923|50319561|FG001|Overall Study|Other|1|||
25176362|NCT01521923|50319562|FG002|Overall Study|Other|3|||
25176363|NCT01521923|50319563|FG003|Overall Study|Other|6|||
25176364|NCT01521923|50319560|FG000|Overall Study|AE, captured in Period 1|0|||
25176365|NCT01521923|50319561|FG001|Overall Study|AE, captured in Period 1|1|||
25176366|NCT01521923|50319562|FG002|Overall Study|AE, captured in Period 1|0|||
25176367|NCT01521923|50319563|FG003|Overall Study|AE, captured in Period 1|1|||
25176368|NCT01520987|50319687|FG000|Overall Study|Withdrawal by Subject|1|||
25176369|NCT01520987|50319688|FG001|Overall Study|Withdrawal by Subject|0|||
25176370|NCT01520987|50319689|FG002|Overall Study|Withdrawal by Subject|0|||
25176371|NCT01520987|50319690|FG003|Overall Study|Withdrawal by Subject|0|||
25176372|NCT01520987|50319691|FG004|Overall Study|Withdrawal by Subject|0|||
25176373|NCT01520987|50319692|FG005|Overall Study|Withdrawal by Subject|1|||
25176374|NCT01520987|50319693|FG006|Overall Study|Withdrawal by Subject|0|||
25176375|NCT01520987|50319694|FG007|Overall Study|Withdrawal by Subject|0|||
25176376|NCT01562275|50319768|FG000|Stage 1|Adverse Event|0|||
25176377|NCT01562275|50319769|FG001|Stage 1|Adverse Event|0|||
25176378|NCT01562275|50319770|FG002|Stage 1|Adverse Event|0|||
25176379|NCT01562275|50319771|FG003|Stage 1|Adverse Event|1|||
25176380|NCT01562275|50319772|FG004|Stage 1|Adverse Event|1|||
25176381|NCT01562275|50319773|FG005|Stage 1|Adverse Event|0|||
25176382|NCT01562275|50319774|FG006|Stage 1|Adverse Event|0|||
25000214|NCT02792218|50092365|FG001|Overall Study|Pregnancy|0|||
25000215|NCT00153101|50092376|FG000|Overall Study|Lost to Follow-up|14|||
25000216|NCT00153101|50092377|FG001|Overall Study|Lost to Follow-up|14|||
25000217|NCT00153101|50092378|FG002|Overall Study|Lost to Follow-up|12|||
25000218|NCT00153101|50092379|FG003|Overall Study|Lost to Follow-up|5|||
25000219|NCT00153101|50092380|FG004|Overall Study|Lost to Follow-up|5|||
25000220|NCT00153101|50092376|FG000|Overall Study|Withdrawal by Subject|3|||
25000221|NCT00153101|50092377|FG001|Overall Study|Withdrawal by Subject|4|||
25176383|NCT01562275|50319775|FG007|Stage 1|Adverse Event|0|||
25176384|NCT01562275|50319776|FG008|Stage 1|Adverse Event|0|||
25176385|NCT01562275|50319777|FG009|Stage 1|Adverse Event|1|||
25176386|NCT01562275|50319778|FG010|Stage 1|Adverse Event|0|||
25176387|NCT01562275|50319779|FG011|Stage 1|Adverse Event|0|||
25176388|NCT01562275|50319780|FG012|Stage 1|Adverse Event|0|||
25176389|NCT01562275|50319768|FG000|Stage 1|Death|1|||
25176390|NCT01562275|50319769|FG001|Stage 1|Death|0|||
25176391|NCT01562275|50319770|FG002|Stage 1|Death|0|||
25176392|NCT01562275|50319771|FG003|Stage 1|Death|0|||
25176393|NCT01562275|50319772|FG004|Stage 1|Death|0|||
25176394|NCT01562275|50319773|FG005|Stage 1|Death|0|||
25176395|NCT01562275|50319774|FG006|Stage 1|Death|0|||
25176396|NCT01562275|50319775|FG007|Stage 1|Death|0|||
25176397|NCT01562275|50319776|FG008|Stage 1|Death|0|||
25176398|NCT01562275|50319777|FG009|Stage 1|Death|0|||
25176399|NCT01562275|50319778|FG010|Stage 1|Death|0|||
25176400|NCT01562275|50319779|FG011|Stage 1|Death|0|||
25176401|NCT01562275|50319780|FG012|Stage 1|Death|0|||
25176402|NCT01562275|50319768|FG000|Stage 1|Non Compliance|0|||
25176403|NCT01562275|50319769|FG001|Stage 1|Non Compliance|0|||
25176404|NCT01562275|50319770|FG002|Stage 1|Non Compliance|1|||
25176405|NCT01562275|50319771|FG003|Stage 1|Non Compliance|0|||
25176406|NCT01562275|50319772|FG004|Stage 1|Non Compliance|0|||
25176407|NCT01562275|50319773|FG005|Stage 1|Non Compliance|0|||
25176408|NCT01562275|50319774|FG006|Stage 1|Non Compliance|0|||
25176409|NCT01562275|50319775|FG007|Stage 1|Non Compliance|0|||
25176410|NCT01562275|50319776|FG008|Stage 1|Non Compliance|0|||
25176411|NCT01562275|50319777|FG009|Stage 1|Non Compliance|0|||
25176412|NCT01562275|50319778|FG010|Stage 1|Non Compliance|0|||
25176413|NCT01562275|50319779|FG011|Stage 1|Non Compliance|0|||
25176414|NCT01562275|50319780|FG012|Stage 1|Non Compliance|0|||
25176415|NCT01562275|50319768|FG000|Stage 1|Physician Decision|0|||
25176416|NCT01562275|50319769|FG001|Stage 1|Physician Decision|0|||
25176417|NCT01562275|50319770|FG002|Stage 1|Physician Decision|0|||
25176418|NCT01562275|50319771|FG003|Stage 1|Physician Decision|0|||
25176419|NCT01562275|50319772|FG004|Stage 1|Physician Decision|1|||
25176420|NCT01562275|50319773|FG005|Stage 1|Physician Decision|0|||
25176421|NCT01562275|50319774|FG006|Stage 1|Physician Decision|1|||
25176422|NCT01562275|50319775|FG007|Stage 1|Physician Decision|0|||
25176423|NCT01562275|50319776|FG008|Stage 1|Physician Decision|1|||
25176424|NCT01562275|50319777|FG009|Stage 1|Physician Decision|0|||
25176425|NCT01562275|50319778|FG010|Stage 1|Physician Decision|0|||
25176426|NCT01562275|50319779|FG011|Stage 1|Physician Decision|0|||
25176427|NCT01562275|50319780|FG012|Stage 1|Physician Decision|0|||
25176428|NCT01562275|50319768|FG000|Stage 1|Progression of Disease|2|||
25176429|NCT01562275|50319769|FG001|Stage 1|Progression of Disease|6|||
25176430|NCT01562275|50319770|FG002|Stage 1|Progression of Disease|2|||
25176431|NCT01562275|50319771|FG003|Stage 1|Progression of Disease|1|||
25176432|NCT01562275|50319772|FG004|Stage 1|Progression of Disease|2|||
25176433|NCT01562275|50319773|FG005|Stage 1|Progression of Disease|4|||
25176434|NCT01562275|50319774|FG006|Stage 1|Progression of Disease|1|||
25176435|NCT01562275|50319775|FG007|Stage 1|Progression of Disease|7|||
25176436|NCT01562275|50319776|FG008|Stage 1|Progression of Disease|2|||
25176437|NCT01562275|50319777|FG009|Stage 1|Progression of Disease|5|||
25176438|NCT01562275|50319778|FG010|Stage 1|Progression of Disease|3|||
25176439|NCT01562275|50319779|FG011|Stage 1|Progression of Disease|0|||
25176440|NCT01562275|50319780|FG012|Stage 1|Progression of Disease|0|||
25176441|NCT01562275|50319768|FG000|Stage 1|Withdrawal by Subject|0|||
25176442|NCT01562275|50319769|FG001|Stage 1|Withdrawal by Subject|1|||
25176443|NCT01562275|50319770|FG002|Stage 1|Withdrawal by Subject|0|||
25176444|NCT01562275|50319771|FG003|Stage 1|Withdrawal by Subject|2|||
25176445|NCT01562275|50319772|FG004|Stage 1|Withdrawal by Subject|0|||
25176446|NCT01562275|50319773|FG005|Stage 1|Withdrawal by Subject|0|||
25176447|NCT01562275|50319774|FG006|Stage 1|Withdrawal by Subject|1|||
25000222|NCT00153101|50092378|FG002|Overall Study|Withdrawal by Subject|3|||
25000223|NCT00153101|50092379|FG003|Overall Study|Withdrawal by Subject|3|||
25000224|NCT00153101|50092380|FG004|Overall Study|Withdrawal by Subject|5|||
25000225|NCT04401579|50092396|FG000|Overall Study|Death|23|||
25176448|NCT01562275|50319775|FG007|Stage 1|Withdrawal by Subject|0|||
25176449|NCT01562275|50319776|FG008|Stage 1|Withdrawal by Subject|0|||
25176450|NCT01562275|50319777|FG009|Stage 1|Withdrawal by Subject|1|||
25176451|NCT01562275|50319778|FG010|Stage 1|Withdrawal by Subject|0|||
25000226|NCT04401579|50092397|FG001|Overall Study|Death|36|||
25176452|NCT01562275|50319779|FG011|Stage 1|Withdrawal by Subject|0|||
25176453|NCT01562275|50319780|FG012|Stage 1|Withdrawal by Subject|0|||
25176454|NCT01562275|50319768|FG000|Stage 2|Death|0|||
25176455|NCT01562275|50319769|FG001|Stage 2|Death|0|||
25176456|NCT01562275|50319770|FG002|Stage 2|Death|0|||
25176457|NCT01562275|50319771|FG003|Stage 2|Death|0|||
25176458|NCT01562275|50319772|FG004|Stage 2|Death|0|||
25176459|NCT01562275|50319773|FG005|Stage 2|Death|0|||
25176460|NCT01562275|50319774|FG006|Stage 2|Death|0|||
25176461|NCT01562275|50319775|FG007|Stage 2|Death|0|||
25176462|NCT01562275|50319776|FG008|Stage 2|Death|0|||
25176463|NCT01562275|50319777|FG009|Stage 2|Death|0|||
25000227|NCT04401579|50092396|FG000|Overall Study|Lost to Follow-up|40|||
25000228|NCT04401579|50092397|FG001|Overall Study|Lost to Follow-up|41|||
25000229|NCT04401579|50092396|FG000|Overall Study|Withdrawal by Subject|8|||
25000230|NCT04401579|50092397|FG001|Overall Study|Withdrawal by Subject|16|||
25000231|NCT04401579|50092396|FG000|Overall Study|Physician Decision|1|||
25000232|NCT04401579|50092397|FG001|Overall Study|Physician Decision|2|||
25000233|NCT04401579|50092396|FG000|Overall Study|Became ineligible after enrollment|1|||
25000234|NCT04401579|50092397|FG001|Overall Study|Became ineligible after enrollment|1|||
25000235|NCT04401579|50092396|FG000|Overall Study|Enrolled but treatment not administered|7|||
25000236|NCT04401579|50092397|FG001|Overall Study|Enrolled but treatment not administered|9|||
25000237|NCT04401579|50092396|FG000|Overall Study|Adverse Event|2|||
25000238|NCT04401579|50092397|FG001|Overall Study|Adverse Event|1|||
25000239|NCT04401579|50092396|FG000|Overall Study|Scheduling error|1|||
25000240|NCT04401579|50092397|FG001|Overall Study|Scheduling error|2|||
25000241|NCT04401579|50092396|FG000|Overall Study|Transferred to another hospital|1|||
25000242|NCT04401579|50092397|FG001|Overall Study|Transferred to another hospital|2|||
25000243|NCT04161807|50092403|FG000|Overall Study|Withdrawal by Subject|2|||
25000244|NCT04161807|50092403|FG000|Overall Study|Performed only 1 treatment|2|||
25000245|NCT04401423|50092409|FG000|Overall Study|Withdrawal by Subject|3|||
25000246|NCT04401423|50092410|FG001|Overall Study|Withdrawal by Subject|1|||
25000247|NCT04401423|50092409|FG000|Overall Study|Physician Decision|2|||
25000248|NCT04401423|50092410|FG001|Overall Study|Physician Decision|1|||
25000249|NCT04399161|50092421|FG000|Overall Study|Withdrawal by Subject|1|||
25000250|NCT04399161|50092422|FG001|Overall Study|Withdrawal by Subject|0|||
25000251|NCT04399161|50092423|FG002|Overall Study|Withdrawal by Subject|2|||
25000252|NCT04399161|50092421|FG000|Overall Study|Protocol Violation|1|||
25000253|NCT04399161|50092422|FG001|Overall Study|Protocol Violation|2|||
25000254|NCT04399161|50092423|FG002|Overall Study|Protocol Violation|0|||
25000255|NCT02076178|50092433|FG000|Oral Phase|Adverse Event|0|||
25000256|NCT02076178|50092434|FG001|Oral Phase|Adverse Event|7|||
25000257|NCT02076178|50092433|FG000|Oral Phase|Withdrawal by Subject|0|||
25000258|NCT02076178|50092434|FG001|Oral Phase|Withdrawal by Subject|4|||
25000259|NCT02076178|50092433|FG000|Oral Phase|Physician Decision|0|||
25000260|NCT02076178|50092434|FG001|Oral Phase|Physician Decision|1|||
25000261|NCT02076178|50092433|FG000|Injection Phase|Protocol defined stopping criteria|1|||
25000262|NCT02076178|50092434|FG001|Injection Phase|Protocol defined stopping criteria|0|||
25000263|NCT02076178|50092433|FG000|Injection Phase|Withdrawal by Subject|0|||
25000264|NCT02076178|50092434|FG001|Injection Phase|Withdrawal by Subject|3|||
25000265|NCT02076178|50092433|FG000|Injection Phase|Physician Decision|0|||
25000266|NCT02076178|50092434|FG001|Injection Phase|Physician Decision|3|||
25000267|NCT02076178|50092433|FG000|Injection Phase|Lost to Follow-up|0|||
25000268|NCT02076178|50092434|FG001|Injection Phase|Lost to Follow-up|1|||
25000269|NCT04160091|50092446|FG000|Overall Study|Terminated by Sponsor|7|||
25000270|NCT04160091|50092447|FG001|Overall Study|Terminated by Sponsor|3|||
25000271|NCT04160091|50092448|FG002|Overall Study|Terminated by Sponsor|5|||
25000272|NCT04160091|50092449|FG003|Overall Study|Terminated by Sponsor|2|||
25091226|NCT01999894|50200730|FG000|Overall Study|Lost to Follow-up|10|||
25091227|NCT01999894|50200730|FG000|Overall Study|Other Reason|3|||
25091228|NCT01999894|50200730|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
25176464|NCT01562275|50319778|FG010|Stage 2|Death|0|||
25176465|NCT01562275|50319779|FG011|Stage 2|Death|2|||
25176466|NCT01562275|50319780|FG012|Stage 2|Death|1|||
25176467|NCT01562275|50319768|FG000|Stage 2|Progression of Disease|0|||
25176468|NCT01562275|50319769|FG001|Stage 2|Progression of Disease|0|||
25176469|NCT01562275|50319770|FG002|Stage 2|Progression of Disease|0|||
25176470|NCT01562275|50319771|FG003|Stage 2|Progression of Disease|0|||
25176471|NCT01562275|50319772|FG004|Stage 2|Progression of Disease|0|||
25176472|NCT01562275|50319773|FG005|Stage 2|Progression of Disease|0|||
25176473|NCT01562275|50319774|FG006|Stage 2|Progression of Disease|0|||
25176474|NCT01562275|50319775|FG007|Stage 2|Progression of Disease|0|||
25176475|NCT01562275|50319776|FG008|Stage 2|Progression of Disease|0|||
25000273|NCT04160091|50092446|FG000|Overall Study|Noncompliance|0|||
25000274|NCT04160091|50092447|FG001|Overall Study|Noncompliance|0|||
25000275|NCT04160091|50092448|FG002|Overall Study|Noncompliance|0|||
25000276|NCT04160091|50092449|FG003|Overall Study|Noncompliance|1|||
25000277|NCT04160091|50092446|FG000|Overall Study|Withdrawal by Subject|0|||
25000278|NCT04160091|50092447|FG001|Overall Study|Withdrawal by Subject|0|||
25000279|NCT04160091|50092448|FG002|Overall Study|Withdrawal by Subject|0|||
25000280|NCT04160091|50092449|FG003|Overall Study|Withdrawal by Subject|1|||
25091229|NCT02679235|50200735|FG000|Overall Study|Withdrawal by Subject|3|||
25000281|NCT00149825|50092461|FG000|Overall Study|Intolerance to medication side effects|1|||
25091230|NCT02679235|50200735|FG000|Overall Study|Adverse Event|1|||
25091231|NCT01976806|50200741|FG000|Overall Study|Lost to Follow-up|1|||
25091232|NCT01976806|50200742|FG001|Overall Study|Lost to Follow-up|4|||
25091233|NCT01976806|50200741|FG000|Overall Study|Adverse Event|1|||
25091234|NCT01976806|50200742|FG001|Overall Study|Adverse Event|1|||
25176476|NCT01562275|50319777|FG009|Stage 2|Progression of Disease|0|||
25000282|NCT00149825|50092462|FG001|Overall Study|Intolerance to medication side effects|2|||
25000283|NCT00149825|50092461|FG000|Overall Study|Time commitments|2|||
25000284|NCT00149825|50092462|FG001|Overall Study|Time commitments|1|||
25000285|NCT00149825|50092461|FG000|Overall Study|Not liking insomnia therapy|1|||
25000286|NCT00149825|50092462|FG001|Overall Study|Not liking insomnia therapy|0|||
25000287|NCT00149825|50092461|FG000|Overall Study|Other|1|||
25000288|NCT00149825|50092462|FG001|Overall Study|Other|0|||
25000289|NCT04397757|50092470|FG000|Overall Study|Death|3|||
25000290|NCT04397757|50092471|FG001|Overall Study|Death|11|||
25000291|NCT04397757|50092470|FG000|Overall Study|Withdrawal by Subject|2|||
25000292|NCT04397757|50092471|FG001|Overall Study|Withdrawal by Subject|0|||
25000293|NCT04397757|50092470|FG000|Overall Study|Lost to Follow-up|4|||
25000294|NCT04397757|50092471|FG001|Overall Study|Lost to Follow-up|3|||
25000295|NCT02792062|50092488|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
25000296|NCT02792062|50092489|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
25000297|NCT02792062|50092490|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
25000298|NCT02792062|50092491|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
25000299|NCT02792062|50092492|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
25000300|NCT02792062|50092493|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
25000301|NCT00196937|50092504|FG000|Overall Study|Serious Adverse Event|1|||
25000302|NCT00196937|50092505|FG001|Overall Study|Serious Adverse Event|0|||
25000303|NCT00196937|50092506|FG002|Overall Study|Serious Adverse Event|0|||
25000304|NCT00196937|50092504|FG000|Overall Study|Non-serious adverse event|1|||
25000305|NCT00196937|50092505|FG001|Overall Study|Non-serious adverse event|1|||
25000306|NCT00196937|50092506|FG002|Overall Study|Non-serious adverse event|1|||
25000307|NCT00196937|50092504|FG000|Overall Study|Withdrawal by Subject|0|||
25000308|NCT00196937|50092505|FG001|Overall Study|Withdrawal by Subject|0|||
25000309|NCT00196937|50092506|FG002|Overall Study|Withdrawal by Subject|2|||
25000310|NCT00196937|50092504|FG000|Overall Study|Lost to Follow-up|4|||
25000311|NCT00196937|50092505|FG001|Overall Study|Lost to Follow-up|3|||
25000312|NCT00196937|50092506|FG002|Overall Study|Lost to Follow-up|3|||
25000313|NCT00196937|50092504|FG000|Overall Study|Other|3|||
25000314|NCT00196937|50092505|FG001|Overall Study|Other|1|||
25000315|NCT00196937|50092506|FG002|Overall Study|Other|1|||
25000316|NCT04397445|50092515|FG000|Overall Study|Withdrawal by Subject|1|||
25000317|NCT04397445|50092516|FG001|Overall Study|Withdrawal by Subject|0|||
25000318|NCT04397445|50092517|FG002|Overall Study|Withdrawal by Subject|0|||
25000319|NCT04397445|50092518|FG003|Overall Study|Withdrawal by Subject|0|||
25000320|NCT00191945|50092535|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
25000321|NCT00191945|50092536|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
25000322|NCT00191945|50092535|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
25000323|NCT00191945|50092536|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
25000324|NCT00191945|50092535|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
25000325|NCT00191945|50092536|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
25000326|NCT00191945|50092535|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
25000327|NCT00191945|50092536|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
25000328|NCT01369342|50092546|FG000|Overall Study|Withdrawal by Subject|7|||
25000329|NCT01369342|50092547|FG001|Overall Study|Withdrawal by Subject|7|||
25000330|NCT01369342|50092548|FG002|Overall Study|Withdrawal by Subject|2|||
25000331|NCT01369342|50092546|FG000|Overall Study|Lost to Follow-up|5|||
25000332|NCT01369342|50092547|FG001|Overall Study|Lost to Follow-up|2|||
25000333|NCT01369342|50092548|FG002|Overall Study|Lost to Follow-up|1|||
25000334|NCT01369342|50092546|FG000|Overall Study|Not Treated|1|||
25000335|NCT01369342|50092547|FG001|Overall Study|Not Treated|0|||
25000336|NCT01369342|50092548|FG002|Overall Study|Not Treated|0|||
25000337|NCT00191477|50092558|FG000|Overall Study|Tumor Recurrence|49|||
25000338|NCT00191477|50092559|FG001|Overall Study|Tumor Recurrence|48|||
25000339|NCT00191477|50092558|FG000|Overall Study|Death, Study Disease|1|||
25000340|NCT00191477|50092559|FG001|Overall Study|Death, Study Disease|1|||
25000341|NCT00191477|50092558|FG000|Overall Study|Death, Other Cause|3|||
25000342|NCT00191477|50092559|FG001|Overall Study|Death, Other Cause|6|||
25000343|NCT00191477|50092558|FG000|Overall Study|Lost to Follow-up|23|||
25000344|NCT00191477|50092559|FG001|Overall Study|Lost to Follow-up|21|||
25000345|NCT00191477|50092558|FG000|Overall Study|Protocol Violation|1|||
25091235|NCT01976806|50200741|FG000|Overall Study|Withdrawal by Subject|1|||
25091236|NCT01976806|50200742|FG001|Overall Study|Withdrawal by Subject|1|||
25000346|NCT00191477|50092559|FG001|Overall Study|Protocol Violation|1|||
25000347|NCT00191477|50092558|FG000|Overall Study|Treatment Change|2|||
25000348|NCT00191477|50092559|FG001|Overall Study|Treatment Change|0|||
25000349|NCT00191477|50092558|FG000|Overall Study|Withdrawal by Subject|2|||
25000350|NCT00191477|50092559|FG001|Overall Study|Withdrawal by Subject|0|||
25000351|NCT00191477|50092558|FG000|Overall Study|Other|2|||
25000352|NCT00191477|50092559|FG001|Overall Study|Other|0|||
25000353|NCT00191477|50092558|FG000|Overall Study|Not Eligible|41|||
25000354|NCT00191477|50092559|FG001|Overall Study|Not Eligible|38|||
25000355|NCT00191477|50092558|FG000|Overall Study|Pathological Specimen Lost|1|||
25091237|NCT02679079|50200751|FG000|Overall Study|Adverse Event|2|||
25000356|NCT00191477|50092559|FG001|Overall Study|Pathological Specimen Lost|0|||
25000357|NCT00191477|50092558|FG000|Overall Study|Discontinued Prior to Instillation|13|||
25000358|NCT00191477|50092559|FG001|Overall Study|Discontinued Prior to Instillation|14|||
25000359|NCT04320615|50092567|FG000|Overall Study|Withdrawal by Subject|4|||
25000360|NCT04320615|50092568|FG001|Overall Study|Withdrawal by Subject|10|||
25000361|NCT04320615|50092567|FG000|Overall Study|Physician Decision|2|||
25000362|NCT04320615|50092568|FG001|Overall Study|Physician Decision|0|||
25000363|NCT04320615|50092567|FG000|Overall Study|Other|2|||
25000364|NCT04320615|50092568|FG001|Overall Study|Other|0|||
25000365|NCT04320615|50092567|FG000|Overall Study|Lost to Follow-up|5|||
25000366|NCT04320615|50092568|FG001|Overall Study|Lost to Follow-up|23|||
25000367|NCT04320615|50092567|FG000|Overall Study|Death|35|||
25000368|NCT04320615|50092568|FG001|Overall Study|Death|71|||
25000369|NCT00149747|50092580|FG000|Overall Study|Death|1|||
25000370|NCT00149747|50092581|FG001|Overall Study|Death|0|||
25000371|NCT00149747|50092580|FG000|Overall Study|Withdrawal by Subject|3|||
25000372|NCT00149747|50092581|FG001|Overall Study|Withdrawal by Subject|3|||
25000373|NCT00187889|50092589|FG000|Overall Study|Withdrawal by Subject|6|||
25000374|NCT00187889|50092590|FG001|Overall Study|Withdrawal by Subject|4|||
25000375|NCT00148343|50092599|FG000|Overall Study|Withdrawal by Subject|12|||
25000376|NCT00148343|50092600|FG001|Overall Study|Withdrawal by Subject|7|||
25000377|NCT00148343|50092599|FG000|Overall Study|Physician Decision|3|||
25000378|NCT00148343|50092600|FG001|Overall Study|Physician Decision|4|||
25000379|NCT04150341|50092606|FG000|Overall Study|Physician Decision|0|||
25000380|NCT04150341|50092607|FG001|Overall Study|Physician Decision|0|||
25000381|NCT04150341|50092608|FG002|Overall Study|Physician Decision|1|||
25000382|NCT04150341|50092609|FG003|Overall Study|Physician Decision|0|||
25000383|NCT04150341|50092610|FG004|Overall Study|Physician Decision|0|||
25000384|NCT04150341|50092611|FG005|Overall Study|Physician Decision|0|||
25000385|NCT04150341|50092606|FG000|Overall Study|Adverse Event|0|||
25000386|NCT04150341|50092607|FG001|Overall Study|Adverse Event|0|||
25000387|NCT04150341|50092608|FG002|Overall Study|Adverse Event|0|||
25000388|NCT04150341|50092609|FG003|Overall Study|Adverse Event|0|||
25000389|NCT04150341|50092610|FG004|Overall Study|Adverse Event|1|||
25000390|NCT04150341|50092611|FG005|Overall Study|Adverse Event|0|||
25000391|NCT00148109|50092623|FG000|Overall Study|Lack of Efficacy|10|||
25000392|NCT00148109|50092624|FG001|Overall Study|Lack of Efficacy|18|||
25000393|NCT00148109|50092623|FG000|Overall Study|Adverse Event|0|||
25000394|NCT00148109|50092624|FG001|Overall Study|Adverse Event|2|||
25000395|NCT00148109|50092623|FG000|Overall Study|Withdrawal by Subject|2|||
25000396|NCT00148109|50092624|FG001|Overall Study|Withdrawal by Subject|0|||
25000397|NCT00186485|50092630|FG000|Overall Study|Lost to Follow-up|3|||
25000398|NCT00147251|50092636|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
25000399|NCT00147251|50092637|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
25000400|NCT04390191|50092647|FG000|Overall Study|Withdrawal by Subject|1|||
25000401|NCT04390191|50092648|FG001|Overall Study|Withdrawal by Subject|0|||
25000402|NCT04405076|50092660|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
25000403|NCT04405076|50092661|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
25000404|NCT04405076|50092662|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
25000405|NCT04405076|50092663|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
25000406|NCT04405076|50092664|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
25000407|NCT04405076|50092665|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
25000408|NCT04405076|50092666|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
25000409|NCT04405076|50092667|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
25000410|NCT04405076|50092668|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
25000411|NCT04405076|50092660|FG000|Part A (Blinded Phase)|Physician Decision|1|||
25000412|NCT04405076|50092661|FG001|Part A (Blinded Phase)|Physician Decision|2|||
25000413|NCT04405076|50092662|FG002|Part A (Blinded Phase)|Physician Decision|0|||
25000414|NCT04405076|50092663|FG003|Part A (Blinded Phase)|Physician Decision|0|||
25000415|NCT04405076|50092664|FG004|Part A (Blinded Phase)|Physician Decision|0|||
25000416|NCT04405076|50092665|FG005|Part A (Blinded Phase)|Physician Decision|0|||
25000417|NCT04405076|50092666|FG006|Part A (Blinded Phase)|Physician Decision|0|||
25000418|NCT04405076|50092667|FG007|Part A (Blinded Phase)|Physician Decision|0|||
25000419|NCT04405076|50092668|FG008|Part A (Blinded Phase)|Physician Decision|0|||
25000420|NCT04405076|50092660|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
25000421|NCT04405076|50092661|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
25000422|NCT04405076|50092662|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
25000423|NCT04405076|50092663|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
25000424|NCT04405076|50092664|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
25000425|NCT04405076|50092665|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
25000426|NCT04405076|50092666|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
25000427|NCT04405076|50092667|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
25000428|NCT04405076|50092668|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
25000429|NCT04405076|50092660|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
25000430|NCT04405076|50092661|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
25000431|NCT04405076|50092662|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
25000432|NCT04405076|50092663|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
25000433|NCT04405076|50092664|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
25000434|NCT04405076|50092665|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
25000435|NCT04405076|50092666|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
25000436|NCT04405076|50092667|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
25000437|NCT04405076|50092668|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
25000438|NCT04405076|50092660|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
25000439|NCT04405076|50092661|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
25000440|NCT04405076|50092662|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
25000441|NCT04405076|50092663|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
25000442|NCT04405076|50092664|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
25000443|NCT04405076|50092665|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
25000444|NCT04405076|50092666|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
25000445|NCT04405076|50092667|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
25000446|NCT04405076|50092668|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
25000447|NCT04405076|50092660|FG000|Part A (Blinded Phase)|Other than Specified|0|||
25000448|NCT04405076|50092661|FG001|Part A (Blinded Phase)|Other than Specified|0|||
25000449|NCT04405076|50092662|FG002|Part A (Blinded Phase)|Other than Specified|3|||
25000450|NCT04405076|50092663|FG003|Part A (Blinded Phase)|Other than Specified|0|||
25000451|NCT04405076|50092664|FG004|Part A (Blinded Phase)|Other than Specified|0|||
25000452|NCT04405076|50092665|FG005|Part A (Blinded Phase)|Other than Specified|0|||
25000453|NCT04405076|50092666|FG006|Part A (Blinded Phase)|Other than Specified|0|||
25000454|NCT04405076|50092667|FG007|Part A (Blinded Phase)|Other than Specified|0|||
25000455|NCT04405076|50092668|FG008|Part A (Blinded Phase)|Other than Specified|0|||
25000456|NCT04405076|50092660|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
25000457|NCT04405076|50092661|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
25000458|NCT04405076|50092662|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
25176477|NCT01562275|50319778|FG010|Stage 2|Progression of Disease|0|||
25176478|NCT01562275|50319779|FG011|Stage 2|Progression of Disease|12|||
25000459|NCT04405076|50092663|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
25000460|NCT04405076|50092664|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
25000461|NCT04405076|50092665|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
25000462|NCT04405076|50092666|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
25000463|NCT04405076|50092667|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
25000464|NCT04405076|50092668|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
25000465|NCT04405076|50092660|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
25000466|NCT04405076|50092661|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
25000467|NCT04405076|50092662|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
25000468|NCT04405076|50092663|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
25000469|NCT04405076|50092664|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
25000470|NCT04405076|50092665|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
25000471|NCT04405076|50092666|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
25000472|NCT04405076|50092667|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
25000473|NCT04405076|50092668|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
25000474|NCT04405076|50092660|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
25000475|NCT04405076|50092661|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
25000476|NCT04405076|50092662|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
25000477|NCT04405076|50092663|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
25000478|NCT04405076|50092664|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
25000479|NCT04405076|50092665|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
25000480|NCT04405076|50092666|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
25000481|NCT04405076|50092667|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
25000482|NCT04405076|50092668|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
25000483|NCT04405076|50092660|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
25000484|NCT04405076|50092661|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
25000485|NCT04405076|50092662|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
25176479|NCT01562275|50319780|FG012|Stage 2|Progression of Disease|4|||
25176480|NCT01535053|50319812|FG000|Overall Study|Ineligible|1|||
25176481|NCT01535053|50319813|FG001|Overall Study|Ineligible|2|||
25176482|NCT01534663|50319821|FG000|Overall Study|Lost to Follow-up|0|||
25176483|NCT01534663|50319822|FG001|Overall Study|Lost to Follow-up|2|||
25176484|NCT01534663|50319821|FG000|Overall Study|Adverse Event|2|||
25176485|NCT01534663|50319822|FG001|Overall Study|Adverse Event|1|||
25176486|NCT01520909|50319830|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
25176487|NCT01520909|50319831|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
25000486|NCT04405076|50092663|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
25000487|NCT04405076|50092664|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
25000488|NCT04405076|50092665|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
25000489|NCT04405076|50092666|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
25000490|NCT04405076|50092667|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
25000491|NCT04405076|50092668|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
25000492|NCT04405076|50092660|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
25000493|NCT04405076|50092661|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
25000494|NCT04405076|50092662|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
25000495|NCT04405076|50092663|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
25000496|NCT04405076|50092664|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
25000497|NCT04405076|50092665|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
25000498|NCT04405076|50092666|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
25000499|NCT04405076|50092667|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
25000500|NCT04405076|50092668|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
25000501|NCT04311177|50092696|FG000|Overall Study|Adverse Event|3|||
25000502|NCT04311177|50092697|FG001|Overall Study|Adverse Event|1|||
25000503|NCT04311177|50092696|FG000|Overall Study|Physician Decision|4|||
25000504|NCT04311177|50092697|FG001|Overall Study|Physician Decision|3|||
25000505|NCT04311177|50092696|FG000|Overall Study|Withdrawal by Subject|1|||
25000506|NCT04311177|50092697|FG001|Overall Study|Withdrawal by Subject|0|||
25000507|NCT03267212|50092703|FG000|First Intervention|Lost to Follow-up|0|||
25000508|NCT03267212|50092704|FG001|First Intervention|Lost to Follow-up|2|||
25000509|NCT03267212|50092703|FG000|First Intervention|Withdrawal by Subject|1|||
25000510|NCT03267212|50092704|FG001|First Intervention|Withdrawal by Subject|1|||
25000511|NCT03267212|50092703|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
25000512|NCT03267212|50092704|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
25000513|NCT04292535|50092724|FG000|Overall Study|Withdrawal by Subject|0|||
25000514|NCT04292535|50092725|FG001|Overall Study|Withdrawal by Subject|0|||
25000515|NCT04292535|50092726|FG002|Overall Study|Withdrawal by Subject|0|||
25000516|NCT04292535|50092727|FG003|Overall Study|Withdrawal by Subject|0|||
25000517|NCT04292535|50092728|FG004|Overall Study|Withdrawal by Subject|0|||
25000518|NCT04292535|50092729|FG005|Overall Study|Withdrawal by Subject|0|||
25000519|NCT04292535|50092730|FG006|Overall Study|Withdrawal by Subject|0|||
25000520|NCT04292535|50092731|FG007|Overall Study|Withdrawal by Subject|1|||
25000521|NCT04292535|50092732|FG008|Overall Study|Withdrawal by Subject|0|||
25000522|NCT04292535|50092733|FG009|Overall Study|Withdrawal by Subject|0|||
25000523|NCT04292535|50092734|FG010|Overall Study|Withdrawal by Subject|0|||
25000524|NCT04292535|50092735|FG011|Overall Study|Withdrawal by Subject|0|||
25000525|NCT04292535|50092736|FG012|Overall Study|Withdrawal by Subject|0|||
25000526|NCT04292535|50092737|FG013|Overall Study|Withdrawal by Subject|0|||
25000527|NCT04292535|50092724|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
25000528|NCT04292535|50092725|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
25000529|NCT04292535|50092726|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
25000530|NCT04292535|50092727|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
25000531|NCT04292535|50092728|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
25000532|NCT04292535|50092729|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
25000533|NCT04292535|50092730|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
25000534|NCT04292535|50092731|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
25000535|NCT04292535|50092732|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
25000536|NCT04292535|50092733|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
25000537|NCT04292535|50092734|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
25000538|NCT04292535|50092735|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
25000539|NCT04292535|50092736|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
25000540|NCT04292535|50092737|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
25000541|NCT04292535|50092724|FG000|Overall Study|Report of Dizziness|0|||
25000542|NCT04292535|50092725|FG001|Overall Study|Report of Dizziness|0|||
25000543|NCT04292535|50092726|FG002|Overall Study|Report of Dizziness|0|||
25000544|NCT04292535|50092727|FG003|Overall Study|Report of Dizziness|0|||
25000545|NCT04292535|50092728|FG004|Overall Study|Report of Dizziness|0|||
25000546|NCT04292535|50092729|FG005|Overall Study|Report of Dizziness|0|||
25000547|NCT04292535|50092730|FG006|Overall Study|Report of Dizziness|0|||
25000548|NCT04292535|50092731|FG007|Overall Study|Report of Dizziness|0|||
25000549|NCT04292535|50092732|FG008|Overall Study|Report of Dizziness|0|||
25000550|NCT04292535|50092733|FG009|Overall Study|Report of Dizziness|0|||
25091238|NCT02679079|50200752|FG001|Overall Study|Adverse Event|0|||
25000551|NCT04292535|50092734|FG010|Overall Study|Report of Dizziness|0|||
25000552|NCT04292535|50092735|FG011|Overall Study|Report of Dizziness|0|||
25000553|NCT04292535|50092736|FG012|Overall Study|Report of Dizziness|0|||
25000554|NCT04292535|50092737|FG013|Overall Study|Report of Dizziness|1|||
25091239|NCT02679079|50200753|FG002|Overall Study|Adverse Event|2|||
25000555|NCT04292535|50092724|FG000|Overall Study|Equipment Failure|0|||
25000556|NCT04292535|50092725|FG001|Overall Study|Equipment Failure|0|||
25000557|NCT04292535|50092726|FG002|Overall Study|Equipment Failure|0|||
25000558|NCT04292535|50092727|FG003|Overall Study|Equipment Failure|0|||
25000559|NCT04292535|50092728|FG004|Overall Study|Equipment Failure|0|||
25000560|NCT04292535|50092729|FG005|Overall Study|Equipment Failure|0|||
25000561|NCT04292535|50092730|FG006|Overall Study|Equipment Failure|0|||
25000562|NCT04292535|50092731|FG007|Overall Study|Equipment Failure|0|||
25000563|NCT04292535|50092732|FG008|Overall Study|Equipment Failure|0|||
25000564|NCT04292535|50092733|FG009|Overall Study|Equipment Failure|0|||
25000565|NCT04292535|50092734|FG010|Overall Study|Equipment Failure|0|||
25000566|NCT04292535|50092735|FG011|Overall Study|Equipment Failure|1|||
25000567|NCT04292535|50092736|FG012|Overall Study|Equipment Failure|0|||
25000568|NCT04292535|50092737|FG013|Overall Study|Equipment Failure|0|||
25000569|NCT04385199|50092769|FG000|Overall Study|Withdrawal by Subject|1|||
25000570|NCT04385199|50092770|FG001|Overall Study|Withdrawal by Subject|0|||
25000571|NCT04284813|50092776|FG000|Overall Study|Withdrawal by Subject|1|||
25000572|NCT03263780|50092780|FG000|Overall Study|Withdrawal by Subject|3|||
25000573|NCT03263780|50092780|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
25000574|NCT02791438|50092786|FG000|Treatment Period|Adverse Event|1|||
25000575|NCT02791438|50092787|FG001|Treatment Period|Adverse Event|0|||
25000576|NCT02791438|50092786|FG000|Treatment Period|Withdrawal by Subject|0|||
25000577|NCT02791438|50092787|FG001|Treatment Period|Withdrawal by Subject|1|||
25000578|NCT02791438|50092786|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
25000579|NCT02791438|50092787|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
25000580|NCT03712124|50092795|FG000|Overall Study|Protocol Violation|1|||
25000581|NCT03712124|50092796|FG001|Overall Study|Protocol Violation|0|||
25000582|NCT02791516|50092810|FG000|Overall Study|Withdrawal by Subject|1|||
25000583|NCT02791516|50092811|FG001|Overall Study|Withdrawal by Subject|1|||
25000584|NCT03263702|50092819|FG000|Overall Study|Lost to Follow-up|2|||
25000585|NCT03263702|50092820|FG001|Overall Study|Lost to Follow-up|2|||
25000586|NCT03263702|50092819|FG000|Overall Study|Withdrawal by Subject|1|||
25000587|NCT03263702|50092820|FG001|Overall Study|Withdrawal by Subject|2|||
25000588|NCT03692871|50092828|FG000|Overall Study|Death|1|||
25000589|NCT03692871|50092829|FG001|Overall Study|Death|1|||
25000590|NCT03692871|50092828|FG000|Overall Study|Lost to Follow-up|24|||
25000591|NCT03692871|50092829|FG001|Overall Study|Lost to Follow-up|9|||
25000592|NCT03692871|50092828|FG000|Overall Study|Physician Decision|22|||
25000593|NCT03692871|50092829|FG001|Overall Study|Physician Decision|7|||
25000594|NCT03692871|50092828|FG000|Overall Study|Protocol Deviation|1|||
25000595|NCT03692871|50092829|FG001|Overall Study|Protocol Deviation|0|||
25000596|NCT03692871|50092828|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
25000597|NCT03692871|50092829|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
25000598|NCT04384107|50092837|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
25000599|NCT04384107|50092838|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
25000600|NCT04384107|50092837|FG000|Overall Study|Lost to Follow-up|1|||
25000601|NCT04384107|50092838|FG001|Overall Study|Lost to Follow-up|0|||
25000602|NCT04130919|50092847|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
25000603|NCT04130919|50092848|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
25000604|NCT04130919|50092849|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
25000605|NCT04130919|50092850|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
25000606|NCT04130919|50092851|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
25000607|NCT04130919|50092852|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
25000608|NCT04130919|50092847|FG000|Blinded Treatment Phase|Adverse Event|0|||
25000609|NCT04130919|50092848|FG001|Blinded Treatment Phase|Adverse Event|0|||
25000610|NCT04130919|50092849|FG002|Blinded Treatment Phase|Adverse Event|1|||
25000611|NCT04130919|50092850|FG003|Blinded Treatment Phase|Adverse Event|0|||
25000612|NCT04130919|50092851|FG004|Blinded Treatment Phase|Adverse Event|0|||
25000613|NCT04130919|50092852|FG005|Blinded Treatment Phase|Adverse Event|0|||
25000614|NCT04130919|50092847|FG000|Blinded Treatment Phase|Disease worsening|0|||
25000615|NCT04130919|50092848|FG001|Blinded Treatment Phase|Disease worsening|0|||
25000616|NCT04130919|50092849|FG002|Blinded Treatment Phase|Disease worsening|1|||
25000617|NCT04130919|50092850|FG003|Blinded Treatment Phase|Disease worsening|0|||
25091240|NCT02679079|50200751|FG000|Overall Study|Protocol Violation|0|||
25000618|NCT04130919|50092851|FG004|Blinded Treatment Phase|Disease worsening|0|||
25000619|NCT04130919|50092852|FG005|Blinded Treatment Phase|Disease worsening|0|||
25000620|NCT04130919|50092847|FG000|Blinded Treatment Phase|Investigator's decision|0|||
25000621|NCT04130919|50092848|FG001|Blinded Treatment Phase|Investigator's decision|1|||
25000622|NCT04130919|50092849|FG002|Blinded Treatment Phase|Investigator's decision|0|||
25000623|NCT04130919|50092850|FG003|Blinded Treatment Phase|Investigator's decision|0|||
25000624|NCT04130919|50092851|FG004|Blinded Treatment Phase|Investigator's decision|0|||
25000625|NCT04130919|50092852|FG005|Blinded Treatment Phase|Investigator's decision|0|||
25000626|NCT04130919|50092847|FG000|Blinded Treatment Phase|Withdrew consent|1|||
25000627|NCT04130919|50092848|FG001|Blinded Treatment Phase|Withdrew consent|0|||
25000628|NCT04130919|50092849|FG002|Blinded Treatment Phase|Withdrew consent|0|||
25091241|NCT02679079|50200752|FG001|Overall Study|Protocol Violation|1|||
25000629|NCT04130919|50092850|FG003|Blinded Treatment Phase|Withdrew consent|0|||
25000630|NCT04130919|50092851|FG004|Blinded Treatment Phase|Withdrew consent|0|||
25000631|NCT04130919|50092852|FG005|Blinded Treatment Phase|Withdrew consent|0|||
25000632|NCT04130919|50092847|FG000|Open-label Treatment Phase|Withdrew consent|0|||
25000633|NCT04130919|50092848|FG001|Open-label Treatment Phase|Withdrew consent|0|||
25000634|NCT04130919|50092849|FG002|Open-label Treatment Phase|Withdrew consent|0|||
25000635|NCT04130919|50092850|FG003|Open-label Treatment Phase|Withdrew consent|1|||
25000636|NCT04130919|50092851|FG004|Open-label Treatment Phase|Withdrew consent|1|||
25000637|NCT04130919|50092852|FG005|Open-label Treatment Phase|Withdrew consent|1|||
25000638|NCT04130919|50092847|FG000|Open-label Treatment Phase|Disease worsening|0|||
25000639|NCT04130919|50092848|FG001|Open-label Treatment Phase|Disease worsening|0|||
25000640|NCT04130919|50092849|FG002|Open-label Treatment Phase|Disease worsening|0|||
25000641|NCT04130919|50092850|FG003|Open-label Treatment Phase|Disease worsening|1|||
25000642|NCT04130919|50092851|FG004|Open-label Treatment Phase|Disease worsening|0|||
25000643|NCT04130919|50092852|FG005|Open-label Treatment Phase|Disease worsening|1|||
25000644|NCT04130919|50092847|FG000|Open-label Treatment Phase|Investigator's decision|0|||
25000645|NCT04130919|50092848|FG001|Open-label Treatment Phase|Investigator's decision|0|||
25000646|NCT04130919|50092849|FG002|Open-label Treatment Phase|Investigator's decision|0|||
25000647|NCT04130919|50092850|FG003|Open-label Treatment Phase|Investigator's decision|1|||
25000648|NCT04130919|50092851|FG004|Open-label Treatment Phase|Investigator's decision|0|||
25000649|NCT04130919|50092852|FG005|Open-label Treatment Phase|Investigator's decision|0|||
25000650|NCT04130919|50092847|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
25000651|NCT04130919|50092848|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
25000652|NCT04130919|50092849|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
25000653|NCT04130919|50092850|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
25000654|NCT04130919|50092851|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
25000655|NCT04130919|50092852|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
25000656|NCT04130919|50092847|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
25000657|NCT04130919|50092848|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
25000658|NCT04130919|50092849|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
25000659|NCT04130919|50092850|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
25000660|NCT04130919|50092851|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
25000661|NCT04130919|50092852|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
25000662|NCT04128267|50092866|FG000|Overall Study|Withdrawal by Subject|6|||
25000663|NCT04128267|50092866|FG000|Overall Study|Death|2|||
25000664|NCT04128267|50092866|FG000|Overall Study|Disease progression|1|||
25000665|NCT04128267|50092866|FG000|Overall Study|Participant had other medical issues|4|||
25000666|NCT04128267|50092866|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
25000667|NCT03691779|50092870|FG000|Part B (24 Weeks)|Adverse Event|0|||
25000668|NCT03691779|50092871|FG001|Part B (24 Weeks)|Adverse Event|1|||
25000669|NCT03691779|50092870|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
25000670|NCT03691779|50092871|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
25000671|NCT04258995|50092880|FG000|Overall Study|Lost to Follow-up|1|||
25000672|NCT04258995|50092881|FG001|Overall Study|Lost to Follow-up|1|||
25000673|NCT04247061|50092887|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
25000674|NCT04247061|50092887|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
25000675|NCT04247061|50092887|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
25000676|NCT04241133|50092893|FG000|Overall Study|COVID19 Precautions|14|||
25000677|NCT04241133|50092894|FG001|Overall Study|COVID19 Precautions|34|||
25000678|NCT04123665|50092902|FG000|Overall Study|Withdrawal by Subject|7|||
25000679|NCT04123665|50092903|FG001|Overall Study|Withdrawal by Subject|0|||
25000680|NCT04123665|50092902|FG000|Overall Study|Lost to Follow-up|1|||
25000681|NCT04123665|50092903|FG001|Overall Study|Lost to Follow-up|0|||
25000682|NCT04232943|50092912|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
25000683|NCT04232943|50092913|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
25000684|NCT04232943|50092914|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
25000685|NCT04232943|50092912|FG000|Overall Study|Withdrawal by Subject|1|||
25000686|NCT04232943|50092913|FG001|Overall Study|Withdrawal by Subject|1|||
25000687|NCT04232943|50092914|FG002|Overall Study|Withdrawal by Subject|0|||
25000688|NCT03694275|50092925|FG000|Overall Study|Adverse Event|0|||
25000689|NCT03694275|50092926|FG001|Overall Study|Adverse Event|1|||
25000690|NCT03694275|50092925|FG000|Overall Study|Reason not Specified|0|||
25000691|NCT03694275|50092926|FG001|Overall Study|Reason not Specified|1|||
25000692|NCT04230213|50092933|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
25000693|NCT04230213|50092934|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
25000694|NCT04230213|50092935|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
25000695|NCT04230213|50092933|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
25000696|NCT04230213|50092934|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
25000697|NCT04230213|50092935|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
25000698|NCT04230213|50092933|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
25000699|NCT04230213|50092934|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
25000700|NCT04230213|50092935|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
25000701|NCT04230213|50092933|FG000|TP2: Week 10 to Week 16|Other|0|||
25000702|NCT04230213|50092934|FG001|TP2: Week 10 to Week 16|Other|2|||
25000703|NCT04230213|50092935|FG002|TP2: Week 10 to Week 16|Other|1|||
25000704|NCT04230213|50092933|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
25000705|NCT04230213|50092934|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
25091242|NCT02679079|50200753|FG002|Overall Study|Protocol Violation|0|||
25091243|NCT02679079|50200751|FG000|Overall Study|Withdrawal by Subject|2|||
25091244|NCT02679079|50200752|FG001|Overall Study|Withdrawal by Subject|1|||
25091245|NCT02679079|50200753|FG002|Overall Study|Withdrawal by Subject|0|||
25091246|NCT02678923|50200763|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
25091247|NCT02678923|50200764|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
25091248|NCT02678923|50200763|FG000|Overall Study|Withdrawal by Subject|3|||
25091249|NCT02678923|50200764|FG001|Overall Study|Withdrawal by Subject|2|||
25091250|NCT02678923|50200763|FG000|Overall Study|Lost to Follow-up|1|||
25091251|NCT02678923|50200764|FG001|Overall Study|Lost to Follow-up|0|||
25091252|NCT02678923|50200763|FG000|Overall Study|Did Not Return for Study Visits|1|||
25091253|NCT02678923|50200764|FG001|Overall Study|Did Not Return for Study Visits|0|||
25091254|NCT01976728|50200774|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
25091255|NCT01976728|50200775|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
25091256|NCT01976728|50200776|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
25091257|NCT01976728|50200777|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
25091258|NCT02689219|50200805|FG000|Overall Study|Death|1|||
25091259|NCT02689219|50200806|FG001|Overall Study|Death|1|||
25091260|NCT02689219|50200805|FG000|Overall Study|Disease Progression|10|||
25091261|NCT02689219|50200806|FG001|Overall Study|Disease Progression|6|||
25091262|NCT02683525|50200812|FG000|Overall Study|Lost to Follow-up|1|||
25091263|NCT02683525|50200812|FG000|Overall Study|Physician Decision|1|||
25091264|NCT02683525|50200812|FG000|Overall Study|Disease Progression|6|||
25091265|NCT01976338|50200818|FG000|Overall Study|Physician Decision|0|||
25091266|NCT01976338|50200819|FG001|Overall Study|Physician Decision|1|||
25091267|NCT01976338|50200818|FG000|Overall Study|Lost to Follow-up|3|||
25000706|NCT04230213|50092935|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
25091268|NCT01976338|50200819|FG001|Overall Study|Lost to Follow-up|0|||
25091269|NCT01976338|50200818|FG000|Overall Study|Withdrawal by Subject|5|||
25091270|NCT01976338|50200819|FG001|Overall Study|Withdrawal by Subject|2|||
25091271|NCT01976338|50200818|FG000|Overall Study|Adverse Event|5|||
25091272|NCT01976338|50200819|FG001|Overall Study|Adverse Event|1|||
25091273|NCT02674633|50200828|FG000|Overall Study|Lost to Follow-up|3|||
25091274|NCT02674633|50200829|FG001|Overall Study|Lost to Follow-up|2|||
25091275|NCT02674633|50200828|FG000|Overall Study|Physician Decision|1|||
25091276|NCT02674633|50200829|FG001|Overall Study|Physician Decision|0|||
25091277|NCT02674633|50200828|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
25091278|NCT02674633|50200829|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
25091279|NCT02651987|50200837|FG000|Overall Study|Adverse Event|2|||
25091280|NCT02651987|50200838|FG001|Overall Study|Adverse Event|2|||
25091281|NCT02651987|50200837|FG000|Overall Study|Consent Withdrawn|2|||
25091282|NCT02651987|50200838|FG001|Overall Study|Consent Withdrawn|0|||
25091283|NCT02651987|50200837|FG000|Overall Study|Local PD|0|||
25091284|NCT02651987|50200838|FG001|Overall Study|Local PD|2|||
25091285|NCT02651987|50200837|FG000|Overall Study|Investigator Decision|1|||
25091286|NCT02651987|50200838|FG001|Overall Study|Investigator Decision|1|||
25091287|NCT02677987|50200849|FG000|Overall Study|Withdrawal by Subject|3|||
25091288|NCT02677987|50200850|FG001|Overall Study|Withdrawal by Subject|0|||
25091289|NCT02677987|50200849|FG000|Overall Study|Lost to Follow-up|1|||
25091290|NCT02677987|50200850|FG001|Overall Study|Lost to Follow-up|0|||
25091291|NCT01999114|50200869|FG000|Overall Study|Adverse Event|8|||
25091292|NCT01999114|50200870|FG001|Overall Study|Adverse Event|7|||
25091293|NCT01999114|50200871|FG002|Overall Study|Adverse Event|2|||
25091294|NCT01999114|50200872|FG003|Overall Study|Adverse Event|2|||
25091295|NCT01999114|50200873|FG004|Overall Study|Adverse Event|1|||
25091296|NCT01999114|50200869|FG000|Overall Study|Withdrawal by Subject|0|||
25091297|NCT01999114|50200870|FG001|Overall Study|Withdrawal by Subject|0|||
25091298|NCT01999114|50200871|FG002|Overall Study|Withdrawal by Subject|1|||
25091299|NCT01999114|50200872|FG003|Overall Study|Withdrawal by Subject|0|||
25091300|NCT01999114|50200873|FG004|Overall Study|Withdrawal by Subject|1|||
25091301|NCT01999114|50200869|FG000|Overall Study|Lost to Follow-up|0|||
25091302|NCT01999114|50200870|FG001|Overall Study|Lost to Follow-up|0|||
25091303|NCT01999114|50200871|FG002|Overall Study|Lost to Follow-up|1|||
25091304|NCT01999114|50200872|FG003|Overall Study|Lost to Follow-up|0|||
25091305|NCT01999114|50200873|FG004|Overall Study|Lost to Follow-up|0|||
25091306|NCT01999114|50200869|FG000|Overall Study|Administrative|0|||
25091307|NCT01999114|50200870|FG001|Overall Study|Administrative|0|||
25091308|NCT01999114|50200871|FG002|Overall Study|Administrative|1|||
25000707|NCT04230213|50092933|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
25000708|NCT04230213|50092934|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
25000709|NCT04230213|50092935|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
25000710|NCT04230213|50092933|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
25000711|NCT04230213|50092934|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
25000712|NCT04230213|50092935|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
25000713|NCT04230213|50092933|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
25000714|NCT04230213|50092934|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
25000715|NCT04230213|50092935|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
25000716|NCT04230213|50092933|FG000|TP3: Week 16 to Week 22|Other|0|||
25000717|NCT04230213|50092934|FG001|TP3: Week 16 to Week 22|Other|1|||
25000718|NCT04230213|50092935|FG002|TP3: Week 16 to Week 22|Other|3|||
25000719|NCT04230213|50092933|FG000|TP4: Week 22 to Week 32|Other|0|||
25000720|NCT04230213|50092934|FG001|TP4: Week 22 to Week 32|Other|5|||
25000721|NCT04230213|50092935|FG002|TP4: Week 22 to Week 32|Other|5|||
25000722|NCT04230213|50092933|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
25000723|NCT04230213|50092934|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
25000724|NCT04230213|50092935|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
25000725|NCT04230213|50092933|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
25000726|NCT04230213|50092934|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
25000727|NCT04230213|50092935|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
25000728|NCT04230213|50092933|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
25000729|NCT04230213|50092934|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
25000730|NCT04230213|50092935|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
25000731|NCT04230213|50092933|FG000|Follow up: Week 32 to Week 36|Other|0|||
25000732|NCT04230213|50092934|FG001|Follow up: Week 32 to Week 36|Other|1|||
25000733|NCT04230213|50092935|FG002|Follow up: Week 32 to Week 36|Other|1|||
25000734|NCT04222725|50092947|FG000|Overall Study|Adverse Event|0|||
25000735|NCT04222725|50092948|FG001|Overall Study|Adverse Event|1|||
25000736|NCT04222725|50092949|FG002|Overall Study|Adverse Event|0|||
25000737|NCT04222725|50092950|FG003|Overall Study|Adverse Event|0|||
25000738|NCT04213989|50092962|FG000|Overall Study|Withdrawal by Subject|3|||
25000739|NCT04213989|50092963|FG001|Overall Study|Withdrawal by Subject|2|||
25000740|NCT04213989|50092962|FG000|Overall Study|Physician Decision|1|||
25000741|NCT04213989|50092963|FG001|Overall Study|Physician Decision|0|||
25000742|NCT04213989|50092962|FG000|Overall Study|Lost to Follow-up|0|||
25000743|NCT04213989|50092963|FG001|Overall Study|Lost to Follow-up|4|||
25000744|NCT03242252|50092972|FG000|Overall Study|At the Participant's own Request|18|||
25000745|NCT03242252|50092973|FG001|Overall Study|At the Participant's own Request|10|||
25000746|NCT03242252|50092974|FG002|Overall Study|At the Participant's own Request|15|||
25000747|NCT03242252|50092972|FG000|Overall Study|Adverse Event|8|||
25000748|NCT03242252|50092973|FG001|Overall Study|Adverse Event|6|||
25000749|NCT03242252|50092974|FG002|Overall Study|Adverse Event|9|||
25000750|NCT03242252|50092972|FG000|Overall Study|Poor Compliance to Protocol|0|||
25000751|NCT03242252|50092973|FG001|Overall Study|Poor Compliance to Protocol|2|||
25000752|NCT03242252|50092974|FG002|Overall Study|Poor Compliance to Protocol|3|||
25000753|NCT03242252|50092972|FG000|Overall Study|Study Terminated by Sponsor|1|||
25000754|NCT03242252|50092973|FG001|Overall Study|Study Terminated by Sponsor|0|||
25000755|NCT03242252|50092974|FG002|Overall Study|Study Terminated by Sponsor|0|||
25000756|NCT03242252|50092972|FG000|Overall Study|Reason not Specified|4|||
25000757|NCT03242252|50092973|FG001|Overall Study|Reason not Specified|4|||
25000758|NCT03242252|50092974|FG002|Overall Study|Reason not Specified|1|||
25000759|NCT03242252|50092972|FG000|Overall Study|Lost to Follow-up|5|||
25000760|NCT03242252|50092973|FG001|Overall Study|Lost to Follow-up|1|||
25000761|NCT03242252|50092974|FG002|Overall Study|Lost to Follow-up|4|||
25000762|NCT04109391|50092991|FG000|Overall Study|Adverse Event|2|||
25000763|NCT04109391|50092992|FG001|Overall Study|Adverse Event|2|||
25000764|NCT04109391|50092993|FG002|Overall Study|Adverse Event|0|||
25000765|NCT04109391|50092991|FG000|Overall Study|Withdrawal by Subject|2|||
25000766|NCT04109391|50092992|FG001|Overall Study|Withdrawal by Subject|0|||
25000767|NCT04109391|50092993|FG002|Overall Study|Withdrawal by Subject|0|||
25000768|NCT04109391|50092991|FG000|Overall Study|Pregnancy|1|||
25000769|NCT04109391|50092992|FG001|Overall Study|Pregnancy|0|||
25000770|NCT04109391|50092993|FG002|Overall Study|Pregnancy|0|||
25000771|NCT04109391|50092991|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
25000772|NCT04109391|50092992|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
25000773|NCT04109391|50092993|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
25000774|NCT04109391|50092991|FG000|Overall Study|Lost to Follow-up|0|||
25000775|NCT04109391|50092992|FG001|Overall Study|Lost to Follow-up|0|||
25000776|NCT04109391|50092993|FG002|Overall Study|Lost to Follow-up|1|||
25000777|NCT04109391|50092991|FG000|Overall Study|Lack of Efficacy|2|||
25000778|NCT04109391|50092992|FG001|Overall Study|Lack of Efficacy|2|||
25000779|NCT04109391|50092993|FG002|Overall Study|Lack of Efficacy|3|||
25000780|NCT04106817|50093004|FG000|Overall Study|Lost to Follow-up|1|||
25000781|NCT04106817|50093005|FG001|Overall Study|Lost to Follow-up|0|||
25000782|NCT04106817|50093006|FG002|Overall Study|Lost to Follow-up|0|||
25000783|NCT04097925|50093014|FG000|Overall Study|Withdrawal by Subject|1|||
25000784|NCT04195893|50093018|FG000|Second Intervention|Withdrawal by Subject|1|||
25000785|NCT04195893|50093019|FG001|Second Intervention|Withdrawal by Subject|0|||
25000786|NCT04195581|50093025|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
25000787|NCT04195581|50093025|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
25000788|NCT04195581|50093025|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
25000789|NCT04195581|50093025|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
25000790|NCT04195581|50093025|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
25000791|NCT04195581|50093025|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
25000792|NCT04096365|50093043|FG000|Overall Study|Adverse Event|1|||
25000793|NCT04194489|50093047|FG000|Overall Study|Withdrawal by Subject|5|||
25000794|NCT04194489|50093047|FG000|Overall Study|Lost to Follow-up|48|||
25000795|NCT04094883|50093051|FG000|Overall Study|Withdrawal by Subject|1|||
25000796|NCT01368562|50093055|FG000|Overall Study|Adverse Event|1|||
25000797|NCT01368562|50093055|FG000|Overall Study|Disease progression|1|||
25000798|NCT01368562|50093055|FG000|Overall Study|Lost to Follow-up|1|||
25000799|NCT01368562|50093055|FG000|Overall Study|Death|6|||
25000800|NCT01368562|50093055|FG000|Overall Study|Unresponsive to treatment|5|||
25000801|NCT01368562|50093055|FG000|Overall Study|Other|3|||
25000802|NCT01368562|50093055|FG000|Overall Study|Other than specified|2|||
25000803|NCT03242018|50093062|FG000|Overall Study|Adverse Event|7|||
25000804|NCT03242018|50093063|FG001|Overall Study|Adverse Event|7|||
25000805|NCT03242018|50093064|FG002|Overall Study|Adverse Event|6|||
25000806|NCT03242018|50093062|FG000|Overall Study|Lost to Follow-up|2|||
25000807|NCT03242018|50093063|FG001|Overall Study|Lost to Follow-up|2|||
25000808|NCT03242018|50093064|FG002|Overall Study|Lost to Follow-up|2|||
25000809|NCT03242018|50093062|FG000|Overall Study|At the Participant's Own Request|5|||
25000810|NCT03242018|50093063|FG001|Overall Study|At the Participant's Own Request|1|||
25000811|NCT03242018|50093064|FG002|Overall Study|At the Participant's Own Request|4|||
25000812|NCT03242018|50093062|FG000|Overall Study|Reason Not Specified|3|||
25000813|NCT03242018|50093063|FG001|Overall Study|Reason Not Specified|4|||
25000814|NCT03242018|50093064|FG002|Overall Study|Reason Not Specified|1|||
25000815|NCT03242018|50093062|FG000|Overall Study|Study Terminated by Sponsor|1|||
25000816|NCT03242018|50093063|FG001|Overall Study|Study Terminated by Sponsor|0|||
25000817|NCT03242018|50093064|FG002|Overall Study|Study Terminated by Sponsor|1|||
25000818|NCT02789176|50093077|FG000|Overall Study|Death|0|||
25000819|NCT02789176|50093078|FG001|Overall Study|Death|0|||
25000820|NCT02789176|50093079|FG002|Overall Study|Death|3|||
25000821|NCT02789176|50093080|FG003|Overall Study|Death|0|||
25000822|NCT02789176|50093077|FG000|Overall Study|Withdrawal by Subject|0|||
25000823|NCT02789176|50093078|FG001|Overall Study|Withdrawal by Subject|0|||
25000824|NCT02789176|50093079|FG002|Overall Study|Withdrawal by Subject|1|||
25000825|NCT02789176|50093080|FG003|Overall Study|Withdrawal by Subject|0|||
25000826|NCT02789176|50093077|FG000|Overall Study|Lost to Follow-up|8|||
25000827|NCT02789176|50093078|FG001|Overall Study|Lost to Follow-up|2|||
25000828|NCT02789176|50093079|FG002|Overall Study|Lost to Follow-up|6|||
25000829|NCT02789176|50093080|FG003|Overall Study|Lost to Follow-up|1|||
25000830|NCT03259490|50093092|FG000|Period 1|Withdrawal by Subject|0|||
25000831|NCT03259490|50093093|FG001|Period 1|Withdrawal by Subject|1|||
25000832|NCT03259490|50093092|FG000|Period 2|Protocol Violation|1|||
25000833|NCT03259490|50093093|FG001|Period 2|Protocol Violation|0|||
25000834|NCT03259334|50093102|FG000|Overall Study|Adverse Event|3|||
25000835|NCT03259334|50093103|FG001|Overall Study|Adverse Event|8|||
25000836|NCT03259334|50093104|FG002|Overall Study|Adverse Event|5|||
25000837|NCT03259334|50093102|FG000|Overall Study|Withdrawal by Subject|4|||
25000838|NCT03259334|50093103|FG001|Overall Study|Withdrawal by Subject|2|||
25000839|NCT03259334|50093104|FG002|Overall Study|Withdrawal by Subject|4|||
25000840|NCT03259334|50093102|FG000|Overall Study|Physician Decision|1|||
25000841|NCT03259334|50093103|FG001|Overall Study|Physician Decision|0|||
25000842|NCT03259334|50093104|FG002|Overall Study|Physician Decision|0|||
25000843|NCT03259334|50093102|FG000|Overall Study|Lost to Follow-up|0|||
25000844|NCT03259334|50093103|FG001|Overall Study|Lost to Follow-up|2|||
25000845|NCT03259334|50093104|FG002|Overall Study|Lost to Follow-up|1|||
25000846|NCT03259334|50093102|FG000|Overall Study|Protocol Deviation|0|||
25000847|NCT03259334|50093103|FG001|Overall Study|Protocol Deviation|3|||
25000848|NCT03259334|50093104|FG002|Overall Study|Protocol Deviation|2|||
25091309|NCT01999114|50200872|FG003|Overall Study|Administrative|1|||
25000849|NCT03259334|50093102|FG000|Overall Study|Lack of Efficacy|2|||
25000850|NCT03259334|50093103|FG001|Overall Study|Lack of Efficacy|0|||
25000851|NCT03259334|50093104|FG002|Overall Study|Lack of Efficacy|1|||
25000852|NCT03259334|50093102|FG000|Overall Study|Randomized but never treated|0|||
25000853|NCT03259334|50093103|FG001|Overall Study|Randomized but never treated|2|||
25000854|NCT03259334|50093104|FG002|Overall Study|Randomized but never treated|0|||
25091310|NCT01999114|50200873|FG004|Overall Study|Administrative|2|||
25091311|NCT02682823|50200904|FG000|Overall Study|Withdrawal by Subject|0|||
25091312|NCT02682823|50200905|FG001|Overall Study|Withdrawal by Subject|0|||
25000855|NCT01331824|50093112|FG000|Overall Study|Adverse Event|2|||
25000856|NCT01331824|50093112|FG000|Overall Study|Death|1|||
25000857|NCT01331824|50093112|FG000|Overall Study|Disease Progression|9|||
25000858|NCT01331824|50093112|FG000|Overall Study|Withdrawal by Subject|1|||
25000859|NCT03258710|50093116|FG000|Overall Study|Adverse Event|1|||
25000860|NCT03258710|50093116|FG000|Overall Study|Protocol-defined stopping criteria|1|||
25000861|NCT03258710|50093116|FG000|Overall Study|Physician Decision|1|||
25000862|NCT03240692|50093120|FG000|Overall Study|Physician Decision|1|||
25000863|NCT03240692|50093120|FG000|Overall Study|Withdrawal by Subject|1|||
25000864|NCT03233048|50093124|FG000|Overall Study|Withdrawal by Subject|1|||
25000865|NCT02937740|50093130|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
25000866|NCT02937740|50093131|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
25000867|NCT02937740|50093130|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
25000868|NCT02937740|50093131|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
25000869|NCT02937740|50093130|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
25000870|NCT02937740|50093131|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
25000871|NCT02937740|50093130|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
25000872|NCT02937740|50093131|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
25000873|NCT02937740|50093130|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
25000874|NCT02937740|50093131|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
25000875|NCT02937740|50093130|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
25000876|NCT02937740|50093131|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
25000877|NCT04173741|50093154|FG000|Overall Study|IVC measurement cannot be done|1|||
25000878|NCT04173741|50093155|FG001|Overall Study|IVC measurement cannot be done|1|||
25000879|NCT03231800|50093163|FG000|Overall Study|Lost to Follow-up|0|||
25000880|NCT03231800|50093164|FG001|Overall Study|Lost to Follow-up|2|||
25000881|NCT03231800|50093163|FG000|Overall Study|Protocol Violation|1|||
25000882|NCT03231800|50093164|FG001|Overall Study|Protocol Violation|1|||
25000883|NCT03231800|50093163|FG000|Overall Study|reason not provided|2|||
25000884|NCT03231800|50093164|FG001|Overall Study|reason not provided|0|||
25000885|NCT04085601|50093172|FG000|Overall Study|Lost to Follow-up|1|||
25000886|NCT04085601|50093173|FG001|Overall Study|Lost to Follow-up|0|||
25000887|NCT04085601|50093172|FG000|Overall Study|Death|1|||
25000888|NCT04085601|50093173|FG001|Overall Study|Death|1|||
25000889|NCT03230864|50093182|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
25000890|NCT03230864|50093183|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
25000891|NCT03230864|50093184|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
25000892|NCT03230864|50093185|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
25000893|NCT03230864|50093182|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
25000894|NCT03230864|50093183|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
25000895|NCT03230864|50093184|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
25000896|NCT03230864|50093185|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
25000897|NCT03230864|50093182|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
25000898|NCT03230864|50093183|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
25000899|NCT03230864|50093184|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
25000900|NCT03230864|50093185|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
25000901|NCT03230864|50093182|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
25000902|NCT03230864|50093183|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
25000903|NCT03230864|50093184|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
25000904|NCT03230864|50093185|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
25000905|NCT03230864|50093182|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
25000906|NCT03230864|50093183|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
25000907|NCT03230864|50093184|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
25000908|NCT03230864|50093185|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
25000909|NCT03230864|50093182|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
25000910|NCT03230864|50093183|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
25000911|NCT03230864|50093184|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
25000912|NCT03230864|50093185|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
25000913|NCT03230864|50093182|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
25000914|NCT03230864|50093183|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
25000915|NCT03230864|50093184|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
25000916|NCT03230864|50093185|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
25000917|NCT03230864|50093182|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
25000918|NCT03230864|50093183|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
25000919|NCT03230864|50093184|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
25000920|NCT03230864|50093185|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
25067261|NCT01367665|50172837|FG001|Overall Study|Lost to Follow-up|22|||
25091313|NCT02682823|50200906|FG002|Overall Study|Withdrawal by Subject|1|||
25091314|NCT02682823|50200907|FG003|Overall Study|Withdrawal by Subject|0|||
25000921|NCT03230864|50093182|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
25000922|NCT03230864|50093183|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
25000923|NCT03230864|50093184|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
25000924|NCT03230864|50093185|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
25000925|NCT03230864|50093182|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
25000926|NCT03230864|50093183|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
25000927|NCT03230864|50093184|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
25000928|NCT03230864|50093185|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
25000929|NCT04085367|50093197|FG000|Overall Study|Adverse Event|1|||
25000930|NCT04085367|50093198|FG001|Overall Study|Adverse Event|1|||
25000931|NCT04085367|50093197|FG000|Overall Study|Withdrawal by Subject|13|||
25000932|NCT04085367|50093198|FG001|Overall Study|Withdrawal by Subject|4|||
25000933|NCT04085367|50093197|FG000|Overall Study|Lost to Follow-up|3|||
25000934|NCT04085367|50093198|FG001|Overall Study|Lost to Follow-up|1|||
25000935|NCT04085367|50093197|FG000|Overall Study|Other unspecified|2|||
25000936|NCT04085367|50093198|FG001|Overall Study|Other unspecified|1|||
25000937|NCT04085367|50093197|FG000|Overall Study|Status Unknown|1|||
25000938|NCT04085367|50093198|FG001|Overall Study|Status Unknown|1|||
25000939|NCT03228836|50093204|FG000|Overall Study|Adverse Event|3|||
25000940|NCT03228836|50093204|FG000|Overall Study|Withdrawal by Subject|1|||
25000941|NCT03228836|50093204|FG000|Overall Study|Death|1|||
25000942|NCT03228836|50093204|FG000|Overall Study|Physician Decision|1|||
25000943|NCT03228836|50093204|FG000|Overall Study|Disease Progression|7|||
25000944|NCT03228836|50093204|FG000|Overall Study|Other|4|||
25000945|NCT02937350|50093211|FG000|Overall Study|Withdrawal by Subject|0|||
25000946|NCT02937350|50093212|FG001|Overall Study|Withdrawal by Subject|1|||
25000947|NCT02937350|50093213|FG002|Overall Study|Withdrawal by Subject|0|||
25000948|NCT04085289|50093222|FG000|Overall Study|Withdrawal by Subject|0|||
25000949|NCT04085289|50093223|FG001|Overall Study|Withdrawal by Subject|0|||
25000950|NCT04085289|50093224|FG002|Overall Study|Withdrawal by Subject|1|||
25000951|NCT04080297|50093233|FG000|Overall Study|Adverse Event|1|||
25000952|NCT04080297|50093234|FG001|Overall Study|Adverse Event|3|||
25000953|NCT04080297|50093233|FG000|Overall Study|concurrent illness|1|||
25000954|NCT04080297|50093234|FG001|Overall Study|concurrent illness|0|||
25000955|NCT04013529|50093242|FG000|Overall Study|Withdrawal by Subject|1|||
25000956|NCT04013529|50093243|FG001|Overall Study|Withdrawal by Subject|1|||
25000957|NCT04011735|50093252|FG000|Overall Study|Withdrawal by Subject|1|||
25000958|NCT04011735|50093253|FG001|Overall Study|Withdrawal by Subject|0|||
25000959|NCT04011735|50093254|FG002|Overall Study|Withdrawal by Subject|1|||
25000960|NCT04011735|50093252|FG000|Overall Study|Met exclusion criteria after study entry|0|||
25000961|NCT04011735|50093253|FG001|Overall Study|Met exclusion criteria after study entry|1|||
25000962|NCT04011735|50093254|FG002|Overall Study|Met exclusion criteria after study entry|0|||
25000963|NCT04009629|50093266|FG000|Overall Study|Withdrawal by Subject|2|||
25000964|NCT04009629|50093267|FG001|Overall Study|Withdrawal by Subject|0|||
25000965|NCT04007367|50093276|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
25000966|NCT04007367|50093277|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
25000967|NCT04007367|50093278|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
25000968|NCT04007367|50093276|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
25000969|NCT04007367|50093277|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
25000970|NCT04007367|50093278|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
25000971|NCT04007367|50093276|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
25000972|NCT04007367|50093277|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
25000973|NCT04007367|50093278|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
25000974|NCT04007367|50093276|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
25000975|NCT04007367|50093277|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
25000976|NCT04007367|50093278|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
25000977|NCT04007367|50093276|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
25000978|NCT04007367|50093277|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
25000979|NCT04007367|50093278|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
25000980|NCT03694197|50093288|FG000|Overall Study|Adverse Event|9|||
25000981|NCT03694197|50093288|FG000|Overall Study|Protocol became inconvenient to participate|1|||
25000982|NCT03694197|50093288|FG000|Overall Study|Physician Decision|4|||
25000983|NCT03694197|50093288|FG000|Overall Study|Study terminated by sponsor|1350|||
25000984|NCT03694197|50093288|FG000|Overall Study|Participant moved|5|||
25000985|NCT03694197|50093288|FG000|Overall Study|Participant withdrew consent|10|||
25000986|NCT03694197|50093288|FG000|Overall Study|Related to IMP administration|1|||
25000987|NCT03694197|50093288|FG000|Overall Study|Not disclosed|5|||
25000988|NCT04365699|50093295|FG000|Overall Study|Death|2|||
25000989|NCT04365699|50093296|FG001|Overall Study|Death|5|||
25000990|NCT04365699|50093297|FG002|Overall Study|Death|15|||
25000991|NCT04005885|50093305|FG000|First Intervention|Withdrawal by Subject|1|||
25000992|NCT04005885|50093306|FG001|First Intervention|Withdrawal by Subject|1|||
25000993|NCT04005885|50093305|FG000|Second Intervention|Withdrawal by Subject|0|||
25000994|NCT04005885|50093306|FG001|Second Intervention|Withdrawal by Subject|2|||
25000995|NCT04003623|50093319|FG000|Overall Study|Withdrawal by Subject|1|||
25000996|NCT04003623|50093320|FG001|Overall Study|Withdrawal by Subject|0|||
25000997|NCT04480424|50093328|FG000|Overall Study|Withdrawal by Subject|0|||
25000998|NCT04480424|50093329|FG001|Overall Study|Withdrawal by Subject|2|||
25000999|NCT04480424|50093328|FG000|Overall Study|Lost to Follow-up|3|||
25001000|NCT04480424|50093329|FG001|Overall Study|Lost to Follow-up|3|||
25001001|NCT04480424|50093328|FG000|Overall Study|Death|14|||
25001002|NCT04480424|50093329|FG001|Overall Study|Death|16|||
25001003|NCT04480424|50093328|FG000|Overall Study|Reason not Specified|5|||
25001004|NCT04480424|50093329|FG001|Overall Study|Reason not Specified|5|||
25001005|NCT03256526|50093338|FG000|Overall Study|Adverse Event|1|||
25001006|NCT03256526|50093339|FG001|Overall Study|Adverse Event|0|||
25001007|NCT03256526|50093340|FG002|Overall Study|Adverse Event|1|||
25001008|NCT03256526|50093338|FG000|Overall Study|Lost to Follow-up|1|||
25001009|NCT03256526|50093339|FG001|Overall Study|Lost to Follow-up|0|||
25001010|NCT03256526|50093340|FG002|Overall Study|Lost to Follow-up|2|||
25001011|NCT03255980|50093352|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
25001012|NCT03255980|50093353|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
25001013|NCT03255980|50093354|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
25001014|NCT03255980|50093355|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
25001015|NCT03255980|50093352|FG000|Overall Study|Adverse Event|1|||
25001016|NCT03255980|50093353|FG001|Overall Study|Adverse Event|1|||
25001017|NCT03255980|50093354|FG002|Overall Study|Adverse Event|0|||
25001018|NCT03255980|50093355|FG003|Overall Study|Adverse Event|1|||
25001019|NCT03255980|50093352|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
25001020|NCT03255980|50093353|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
25001021|NCT03255980|50093354|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
25001022|NCT03255980|50093355|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
25001023|NCT03255980|50093352|FG000|Overall Study|Lost to Follow-up|1|||
25001024|NCT03255980|50093353|FG001|Overall Study|Lost to Follow-up|1|||
25001025|NCT03255980|50093354|FG002|Overall Study|Lost to Follow-up|0|||
25001026|NCT03255980|50093355|FG003|Overall Study|Lost to Follow-up|3|||
25001027|NCT03255980|50093352|FG000|Overall Study|Withdrawal by Subject|0|||
25001028|NCT03255980|50093353|FG001|Overall Study|Withdrawal by Subject|1|||
25001029|NCT03255980|50093354|FG002|Overall Study|Withdrawal by Subject|0|||
25001030|NCT03255980|50093355|FG003|Overall Study|Withdrawal by Subject|3|||
25001031|NCT03228212|50093365|FG000|Period 1|Adverse Event|1|||
25001032|NCT03228212|50093366|FG001|Period 1|Adverse Event|0|||
25001033|NCT03228212|50093365|FG000|Period 1|no longer meets eligibility criteria|0|||
25001034|NCT03228212|50093366|FG001|Period 1|no longer meets eligibility criteria|1|||
25001035|NCT03228212|50093365|FG000|Period 2|Lost to Follow-up|1|||
25001036|NCT03228212|50093366|FG001|Period 2|Lost to Follow-up|0|||
25001037|NCT04003155|50093375|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
25001038|NCT04003155|50093376|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
25001039|NCT04003155|50093377|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
25001040|NCT04003155|50093378|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
25001041|NCT04003155|50093379|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
25001042|NCT04003155|50093375|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
25001043|NCT04003155|50093376|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
25001044|NCT04003155|50093377|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
25001045|NCT04003155|50093378|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
25001046|NCT04003155|50093379|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
25001047|NCT04003155|50093375|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
25001048|NCT04003155|50093376|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
25001049|NCT04003155|50093377|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
25001050|NCT04003155|50093378|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
25001051|NCT04003155|50093379|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
25001052|NCT04003155|50093375|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
25001053|NCT04003155|50093376|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
25001054|NCT04003155|50093377|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
25001055|NCT04003155|50093378|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
25001056|NCT04003155|50093379|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
25001057|NCT04003155|50093375|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
25001058|NCT04003155|50093376|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
25001059|NCT04003155|50093377|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
25001060|NCT04003155|50093378|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
25001061|NCT04003155|50093379|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
25001062|NCT04003155|50093375|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
25001063|NCT04003155|50093376|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
25001064|NCT04003155|50093377|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
25001065|NCT04003155|50093378|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
25001066|NCT04003155|50093379|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
25001067|NCT04003155|50093375|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
25001068|NCT04003155|50093376|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
25001069|NCT04003155|50093377|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
25001070|NCT04003155|50093378|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
25001071|NCT04003155|50093379|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
25001072|NCT04003155|50093375|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
25001073|NCT04003155|50093376|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
25001074|NCT04003155|50093377|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
25001075|NCT04003155|50093378|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
25001076|NCT04003155|50093379|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
25001077|NCT04003155|50093375|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
25001078|NCT04003155|50093376|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
25001079|NCT04003155|50093377|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
25001080|NCT04003155|50093378|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
25001081|NCT04003155|50093379|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
25001082|NCT04000815|50093400|FG000|Overall Study|Lost to Follow-up|9|||
25001083|NCT04000815|50093401|FG001|Overall Study|Lost to Follow-up|2|||
25001084|NCT04000815|50093402|FG002|Overall Study|Lost to Follow-up|3|||
25001085|NCT04000815|50093400|FG000|Overall Study|Withdrawal by Subject|4|||
25001086|NCT04000815|50093401|FG001|Overall Study|Withdrawal by Subject|3|||
25001087|NCT04000815|50093402|FG002|Overall Study|Withdrawal by Subject|2|||
25001088|NCT04000815|50093400|FG000|Overall Study|Right ovarian cyst occured|1|||
25001089|NCT04000815|50093401|FG001|Overall Study|Right ovarian cyst occured|0|||
25001090|NCT04000815|50093402|FG002|Overall Study|Right ovarian cyst occured|0|||
25001091|NCT04000815|50093400|FG000|Overall Study|Hypertension occured on follow up|0|||
25001092|NCT04000815|50093401|FG001|Overall Study|Hypertension occured on follow up|0|||
25001093|NCT04000815|50093402|FG002|Overall Study|Hypertension occured on follow up|2|||
25001094|NCT04000581|50093412|FG000|Overall Study|Withdrawal by Subject|0|||
25001095|NCT04000581|50093413|FG001|Overall Study|Withdrawal by Subject|1|||
25001096|NCT03848403|50093419|FG000|Period 2 (Day 8)|Adverse Event|1|||
25001097|NCT03848403|50093420|FG001|Period 2 (Day 8)|Adverse Event|2|||
25001098|NCT03848403|50093421|FG002|Period 2 (Day 8)|Adverse Event|2|||
25001099|NCT03848403|50093419|FG000|Period 2 (Day 8)|Physician Decision|0|||
25001100|NCT03848403|50093420|FG001|Period 2 (Day 8)|Physician Decision|1|||
25001101|NCT03848403|50093421|FG002|Period 2 (Day 8)|Physician Decision|0|||
25001102|NCT03848403|50093419|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
25001103|NCT03848403|50093420|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
25001104|NCT03848403|50093421|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
25001105|NCT03995355|50093431|FG000|Overall Study|Adverse Event|1|||
25001106|NCT03995355|50093432|FG001|Overall Study|Adverse Event|0|||
25001107|NCT03995355|50093431|FG000|Overall Study|Withdrawal by Subject|1|||
25001108|NCT03995355|50093432|FG001|Overall Study|Withdrawal by Subject|0|||
25001109|NCT03995355|50093431|FG000|Overall Study|Scheduling Issues|0|||
25001110|NCT03995355|50093432|FG001|Overall Study|Scheduling Issues|1|||
25001111|NCT04054011|50093438|FG000|Overall Study|COVID|3|||
25001112|NCT04053465|50093446|FG000|Overall Study|Withdrawal by Subject|4|||
25001113|NCT04053465|50093447|FG001|Overall Study|Withdrawal by Subject|4|||
25001114|NCT00143507|50093455|FG000|Overall Study|Death|572|||
25001115|NCT00143507|50093456|FG001|Overall Study|Death|547|||
25001116|NCT00143507|50093455|FG000|Overall Study|Withdrawal by Subject|114|||
25001117|NCT00143507|50093456|FG001|Overall Study|Withdrawal by Subject|102|||
25001118|NCT00143507|50093455|FG000|Overall Study|Lost to Follow-up|1|||
25001119|NCT00143507|50093456|FG001|Overall Study|Lost to Follow-up|0|||
25001120|NCT00143507|50093455|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
25001121|NCT00143507|50093456|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
25001122|NCT03988803|50093462|FG000|Period 2|Prematurely discontinued from medication|2|||
25001123|NCT03988803|50093462|FG000|Period 2|Adverse Event|1|||
25001124|NCT00181883|50093470|FG000|Overall Study|Lack of Efficacy|2|||
25001125|NCT00181883|50093470|FG000|Overall Study|Treatment Limiting AEs|3|||
25001126|NCT00181883|50093470|FG000|Overall Study|Withdrawal by Subject|4|||
25001127|NCT00181883|50093470|FG000|Overall Study|Lost to Follow-up|1|||
25001128|NCT00180713|50093476|FG000|Overall Study|Withdrawal by Subject|2|||
25001129|NCT00180713|50093477|FG001|Overall Study|Withdrawal by Subject|0|||
25001130|NCT00180713|50093476|FG000|Overall Study|Adverse Event|3|||
25001131|NCT00180713|50093477|FG001|Overall Study|Adverse Event|3|||
25001132|NCT03988023|50093485|FG000|Overall Study|Non-compliance|3|||
25001133|NCT03988023|50093486|FG001|Overall Study|Non-compliance|0|||
25001134|NCT03988023|50093485|FG000|Overall Study|Withdrawal by Subject|39|||
25001135|NCT03988023|50093486|FG001|Overall Study|Withdrawal by Subject|37|||
25001136|NCT03988023|50093485|FG000|Overall Study|Adverse Event|0|||
25001137|NCT03988023|50093486|FG001|Overall Study|Adverse Event|2|||
25001138|NCT03988023|50093485|FG000|Overall Study|Physician Decision|0|||
25001139|NCT03988023|50093486|FG001|Overall Study|Physician Decision|1|||
25001140|NCT03988023|50093485|FG000|Overall Study|Lost to Follow-up|5|||
25001141|NCT03988023|50093486|FG001|Overall Study|Lost to Follow-up|8|||
25001142|NCT03988023|50093485|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
25067262|NCT01367665|50172836|FG000|Overall Study|Not Done|118|||
25001143|NCT03988023|50093486|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
25001144|NCT03988023|50093485|FG000|Overall Study|Lack of Efficacy|3|||
25001145|NCT03988023|50093486|FG001|Overall Study|Lack of Efficacy|1|||
25001146|NCT03988023|50093485|FG000|Overall Study|COVID-19 pandemic|225|||
25001147|NCT03988023|50093486|FG001|Overall Study|COVID-19 pandemic|227|||
25001148|NCT04052139|50093495|FG000|Overall Study|Lost to Follow-up|2|||
25001149|NCT04052139|50093496|FG001|Overall Study|Lost to Follow-up|0|||
25001150|NCT04052139|50093497|FG002|Overall Study|Lost to Follow-up|0|||
25001151|NCT04052139|50093495|FG000|Overall Study|Withdrawal by Subject|1|||
25001152|NCT04052139|50093496|FG001|Overall Study|Withdrawal by Subject|0|||
25001153|NCT04052139|50093497|FG002|Overall Study|Withdrawal by Subject|0|||
25001154|NCT03984825|50093505|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
25001155|NCT03984825|50093505|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
25001156|NCT03984825|50093505|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
25001157|NCT03981861|50093514|FG000|Overall Study|Withdrawal by Subject|3|||
25001158|NCT01332266|50093523|FG000|Phase 1b|Death|3|||
25001159|NCT01332266|50093524|FG001|Phase 1b|Death|3|||
25001160|NCT01332266|50093525|FG002|Phase 1b|Death|2|||
25001161|NCT01332266|50093526|FG003|Phase 1b|Death|0|||
25001162|NCT01332266|50093527|FG004|Phase 1b|Death|0|||
25001163|NCT01332266|50093523|FG000|Phase 1b|Lost to Follow-up|0|||
25001164|NCT01332266|50093524|FG001|Phase 1b|Lost to Follow-up|1|||
25001165|NCT01332266|50093525|FG002|Phase 1b|Lost to Follow-up|0|||
25001166|NCT01332266|50093526|FG003|Phase 1b|Lost to Follow-up|0|||
25001167|NCT01332266|50093527|FG004|Phase 1b|Lost to Follow-up|0|||
25001168|NCT01332266|50093523|FG000|Phase 1b|Withdrawal by Subject|1|||
25001169|NCT01332266|50093524|FG001|Phase 1b|Withdrawal by Subject|1|||
25001170|NCT01332266|50093525|FG002|Phase 1b|Withdrawal by Subject|1|||
25001171|NCT01332266|50093526|FG003|Phase 1b|Withdrawal by Subject|0|||
25001172|NCT01332266|50093527|FG004|Phase 1b|Withdrawal by Subject|0|||
25001173|NCT01332266|50093523|FG000|Phase 2|Death|0|||
25001174|NCT01332266|50093524|FG001|Phase 2|Death|0|||
25001175|NCT01332266|50093525|FG002|Phase 2|Death|0|||
25001176|NCT01332266|50093526|FG003|Phase 2|Death|33|||
25001177|NCT01332266|50093527|FG004|Phase 2|Death|36|||
25001178|NCT01332266|50093523|FG000|Phase 2|Lost to Follow-up|0|||
25001179|NCT01332266|50093524|FG001|Phase 2|Lost to Follow-up|0|||
25001180|NCT01332266|50093525|FG002|Phase 2|Lost to Follow-up|0|||
25001181|NCT01332266|50093526|FG003|Phase 2|Lost to Follow-up|2|||
25001182|NCT01332266|50093527|FG004|Phase 2|Lost to Follow-up|0|||
25001183|NCT01332266|50093523|FG000|Phase 2|Physician Decision|0|||
25001184|NCT01332266|50093524|FG001|Phase 2|Physician Decision|0|||
25001185|NCT01332266|50093525|FG002|Phase 2|Physician Decision|0|||
25001186|NCT01332266|50093526|FG003|Phase 2|Physician Decision|3|||
25001187|NCT01332266|50093527|FG004|Phase 2|Physician Decision|1|||
25001188|NCT01332266|50093523|FG000|Phase 2|Symptomatic deterioration|0|||
25001189|NCT01332266|50093524|FG001|Phase 2|Symptomatic deterioration|0|||
25001190|NCT01332266|50093525|FG002|Phase 2|Symptomatic deterioration|0|||
25001191|NCT01332266|50093526|FG003|Phase 2|Symptomatic deterioration|0|||
25001192|NCT01332266|50093527|FG004|Phase 2|Symptomatic deterioration|1|||
25001193|NCT01332266|50093523|FG000|Phase 2|Progression Disease|0|||
25001194|NCT01332266|50093524|FG001|Phase 2|Progression Disease|0|||
25001195|NCT01332266|50093525|FG002|Phase 2|Progression Disease|0|||
25001196|NCT01332266|50093526|FG003|Phase 2|Progression Disease|2|||
25001197|NCT01332266|50093527|FG004|Phase 2|Progression Disease|1|||
25001198|NCT01332266|50093523|FG000|Phase 2|Withdrawal by Subject|0|||
25001199|NCT01332266|50093524|FG001|Phase 2|Withdrawal by Subject|0|||
25001200|NCT01332266|50093525|FG002|Phase 2|Withdrawal by Subject|0|||
25001201|NCT01332266|50093526|FG003|Phase 2|Withdrawal by Subject|2|||
25001202|NCT01332266|50093527|FG004|Phase 2|Withdrawal by Subject|2|||
25001203|NCT03255824|50093542|FG000|Overall Study|Under-sedation|2|||
25001204|NCT03255824|50093543|FG001|Overall Study|Under-sedation|1|||
25001205|NCT03238352|50093552|FG000|Overall Study|Lost to Follow-up|0|||
25001206|NCT03238352|50093553|FG001|Overall Study|Lost to Follow-up|2|||
25001207|NCT03238352|50093554|FG002|Overall Study|Lost to Follow-up|1|||
25001208|NCT03238352|50093552|FG000|Overall Study|Withdrawal by Subject|0|||
25001209|NCT03238352|50093553|FG001|Overall Study|Withdrawal by Subject|1|||
25001210|NCT03238352|50093554|FG002|Overall Study|Withdrawal by Subject|0|||
25001211|NCT00180479|50093564|FG000|Overall Study|Death|4|||
25001212|NCT00180479|50093565|FG001|Overall Study|Death|2|||
25001213|NCT00180479|50093564|FG000|Overall Study|Lost to Follow-up|9|||
25001214|NCT00180479|50093565|FG001|Overall Study|Lost to Follow-up|7|||
25001215|NCT00180479|50093564|FG000|Overall Study|Withdrawal by Subject|3|||
25001216|NCT00180479|50093565|FG001|Overall Study|Withdrawal by Subject|3|||
25001217|NCT00180479|50093564|FG000|Overall Study|Informed consent not signed|0|||
25001218|NCT00180479|50093565|FG001|Overall Study|Informed consent not signed|1|||
25001219|NCT03224234|50093575|FG000|Main Study|Lost to Follow-up|5|||
25001220|NCT03224234|50093576|FG001|Main Study|Lost to Follow-up|5|||
25001221|NCT02955069|50093590|FG000|Overall Study|Adverse Event|7|||
25001222|NCT02955069|50093591|FG001|Overall Study|Adverse Event|2|||
25001223|NCT02955069|50093590|FG000|Overall Study|Death|7|||
25001224|NCT02955069|50093591|FG001|Overall Study|Death|3|||
25001225|NCT02955069|50093590|FG000|Overall Study|Physician Decision|10|||
25001226|NCT02955069|50093591|FG001|Overall Study|Physician Decision|2|||
25001227|NCT02955069|50093590|FG000|Overall Study|Progressive disease|64|||
25001228|NCT02955069|50093591|FG001|Overall Study|Progressive disease|13|||
25001229|NCT02955069|50093590|FG000|Overall Study|Study terminated by sponsor|4|||
25001230|NCT02955069|50093591|FG001|Overall Study|Study terminated by sponsor|0|||
25001231|NCT02955069|50093590|FG000|Overall Study|Subject/Guardian decision|3|||
25001232|NCT02955069|50093591|FG001|Overall Study|Subject/Guardian decision|1|||
25001233|NCT03254108|50093604|FG000|Overall Study|Adverse Event|0|||
25001234|NCT03254108|50093605|FG001|Overall Study|Adverse Event|2|||
25001235|NCT03254108|50093606|FG002|Overall Study|Adverse Event|0|||
25001236|NCT03254108|50093607|FG003|Overall Study|Adverse Event|1|||
25001237|NCT03254108|50093608|FG004|Overall Study|Adverse Event|1|||
25001238|NCT03254108|50093604|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
25001239|NCT03254108|50093605|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
25001240|NCT03254108|50093606|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
25001241|NCT03254108|50093607|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
25001242|NCT03254108|50093608|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
25001243|NCT03773978|50093632|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
25001244|NCT03773978|50093633|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
25001245|NCT03773978|50093632|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
25001246|NCT03773978|50093633|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
25001247|NCT03773978|50093632|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
25001248|NCT03773978|50093633|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
25001249|NCT03773978|50093632|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
25001250|NCT03773978|50093633|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
25001251|NCT03773978|50093632|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
25001252|NCT03773978|50093633|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
25001253|NCT03773978|50093632|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
25001254|NCT03773978|50093633|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
25001255|NCT03773978|50093632|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
25001256|NCT03773978|50093633|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
25001257|NCT03773978|50093632|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
25001258|NCT03773978|50093633|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
25001259|NCT03773978|50093632|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
25001260|NCT03773978|50093633|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
25001261|NCT03773978|50093632|FG000|DBW Period|Adverse Event|2|||
25001262|NCT03773978|50093633|FG001|DBW Period|Adverse Event|2|||
25001263|NCT03773978|50093632|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
25001264|NCT03773978|50093633|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
25001265|NCT03773978|50093632|FG000|DBW Period|Withdrawal by Subject|2|||
25001266|NCT03773978|50093633|FG001|DBW Period|Withdrawal by Subject|1|||
25001267|NCT03773978|50093632|FG000|DBW Period|Due to epidemic or pandemic|5|||
25001268|NCT03773978|50093633|FG001|DBW Period|Due to epidemic or pandemic|6|||
25001269|NCT03773978|50093632|FG000|DBW Period|Study team decision|1|||
25001270|NCT03773978|50093633|FG001|DBW Period|Study team decision|0|||
25001271|NCT03253796|50093649|FG000|Period 1: Run-In|Adverse Event|4|||
25001272|NCT03253796|50093650|FG001|Period 1: Run-In|Adverse Event|0|||
25001273|NCT03253796|50093651|FG002|Period 1: Run-In|Adverse Event|0|||
25001274|NCT03253796|50093652|FG003|Period 1: Run-In|Adverse Event|0|||
25001275|NCT03253796|50093653|FG004|Period 1: Run-In|Adverse Event|0|||
25001276|NCT03253796|50093649|FG000|Period 1: Run-In|Lack of Efficacy|1|||
25001277|NCT03253796|50093650|FG001|Period 1: Run-In|Lack of Efficacy|0|||
25001278|NCT03253796|50093651|FG002|Period 1: Run-In|Lack of Efficacy|0|||
25001279|NCT03253796|50093652|FG003|Period 1: Run-In|Lack of Efficacy|0|||
25001280|NCT03253796|50093653|FG004|Period 1: Run-In|Lack of Efficacy|0|||
25001281|NCT03253796|50093649|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
25001282|NCT03253796|50093650|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
25001283|NCT03253796|50093651|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
25001284|NCT03253796|50093652|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
25001285|NCT03253796|50093653|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
25001286|NCT03253796|50093649|FG000|Period 1: Run-In|Protocol Violation|5|||
25001287|NCT03253796|50093650|FG001|Period 1: Run-In|Protocol Violation|0|||
25001288|NCT03253796|50093651|FG002|Period 1: Run-In|Protocol Violation|0|||
25001289|NCT03253796|50093652|FG003|Period 1: Run-In|Protocol Violation|0|||
25001290|NCT03253796|50093653|FG004|Period 1: Run-In|Protocol Violation|0|||
25001291|NCT03253796|50093649|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
25001292|NCT03253796|50093650|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
25001293|NCT03253796|50093651|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
25001294|NCT03253796|50093652|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
25001295|NCT03253796|50093653|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
25067263|NCT01367665|50172837|FG001|Overall Study|Not Done|14|||
25001296|NCT03253796|50093649|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
25001297|NCT03253796|50093650|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
25001298|NCT03253796|50093651|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
25001299|NCT03253796|50093652|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
25001300|NCT03253796|50093653|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
25001301|NCT03253796|50093649|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
25001302|NCT03253796|50093650|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
25001303|NCT03253796|50093651|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
25001304|NCT03253796|50093652|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
25001305|NCT03253796|50093653|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
25001306|NCT03253796|50093649|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
25001307|NCT03253796|50093650|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
25001308|NCT03253796|50093651|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
25001309|NCT03253796|50093652|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
25001310|NCT03253796|50093653|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
25001311|NCT03253796|50093649|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
25001312|NCT03253796|50093650|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
25001313|NCT03253796|50093651|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
25001314|NCT03253796|50093652|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
25001315|NCT03253796|50093653|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
25001316|NCT03253796|50093649|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
25001317|NCT03253796|50093650|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
25001318|NCT03253796|50093651|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
25001319|NCT03253796|50093652|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
25001320|NCT03253796|50093653|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
25001321|NCT03253796|50093649|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
25001322|NCT03253796|50093650|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
25001323|NCT03253796|50093651|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
25001324|NCT03253796|50093652|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
25001325|NCT03253796|50093653|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
25001326|NCT03682107|50093673|FG000|Overall Study|Withdrawal by Subject|0|||
25001327|NCT03682107|50093674|FG001|Overall Study|Withdrawal by Subject|1|||
25001328|NCT03682107|50093675|FG002|Overall Study|Withdrawal by Subject|0|||
25001329|NCT03682107|50093676|FG003|Overall Study|Withdrawal by Subject|0|||
25001330|NCT03682107|50093677|FG004|Overall Study|Withdrawal by Subject|0|||
25001331|NCT03673046|50093691|FG000|Overall Study|Adverse Event|1|||
25001332|NCT03673046|50093692|FG001|Overall Study|Adverse Event|1|||
25001333|NCT03673046|50093691|FG000|Overall Study|Withdrawal by Subject|8|||
25001334|NCT03673046|50093692|FG001|Overall Study|Withdrawal by Subject|2|||
25001335|NCT02956005|50093698|FG000|Overall Study|Not eligible|1|||
25001336|NCT02956005|50093698|FG000|Overall Study|Withdrawal by Subject|3|||
25001337|NCT02956005|50093698|FG000|Overall Study|Physician Decision|12|||
25001338|NCT03253094|50093708|FG000|Overall Study|Adverse Event|2|||
25001339|NCT03253094|50093709|FG001|Overall Study|Adverse Event|0|||
25001340|NCT03253094|50093710|FG002|Overall Study|Adverse Event|0|||
25001341|NCT03253094|50093711|FG003|Overall Study|Adverse Event|0|||
25001342|NCT03253094|50093712|FG004|Overall Study|Adverse Event|0|||
25001343|NCT03253094|50093713|FG005|Overall Study|Adverse Event|0|||
25001344|NCT03253094|50093708|FG000|Overall Study|Lack of Efficacy|0|||
25001345|NCT03253094|50093709|FG001|Overall Study|Lack of Efficacy|0|||
25001346|NCT03253094|50093710|FG002|Overall Study|Lack of Efficacy|2|||
25001347|NCT03253094|50093711|FG003|Overall Study|Lack of Efficacy|1|||
25001348|NCT03253094|50093712|FG004|Overall Study|Lack of Efficacy|2|||
25091315|NCT02682823|50200908|FG004|Overall Study|Withdrawal by Subject|1|||
25091316|NCT02682823|50200904|FG000|Overall Study|Protocol Deviation|0|||
25091317|NCT02682823|50200905|FG001|Overall Study|Protocol Deviation|1|||
25091318|NCT02682823|50200906|FG002|Overall Study|Protocol Deviation|0|||
25001349|NCT03253094|50093713|FG005|Overall Study|Lack of Efficacy|1|||
25001350|NCT03253094|50093708|FG000|Overall Study|Lost to Follow-up|0|||
25001351|NCT03253094|50093709|FG001|Overall Study|Lost to Follow-up|0|||
25091319|NCT02682823|50200907|FG003|Overall Study|Protocol Deviation|0|||
25091320|NCT02682823|50200908|FG004|Overall Study|Protocol Deviation|0|||
25091321|NCT02682823|50200904|FG000|Overall Study|Adverse Event|0|||
25091322|NCT02682823|50200905|FG001|Overall Study|Adverse Event|0|||
25091323|NCT02682823|50200906|FG002|Overall Study|Adverse Event|0|||
25091324|NCT02682823|50200907|FG003|Overall Study|Adverse Event|1|||
25091325|NCT02682823|50200908|FG004|Overall Study|Adverse Event|0|||
25001352|NCT03253094|50093710|FG002|Overall Study|Lost to Follow-up|1|||
25001353|NCT03253094|50093711|FG003|Overall Study|Lost to Follow-up|1|||
25091326|NCT01374451|50200922|FG000|Overall Study|Administrative problems|1|||
25001354|NCT03253094|50093712|FG004|Overall Study|Lost to Follow-up|0|||
25001355|NCT03253094|50093713|FG005|Overall Study|Lost to Follow-up|1|||
25001356|NCT03253094|50093708|FG000|Overall Study|Physician Decision|1|||
25001357|NCT03253094|50093709|FG001|Overall Study|Physician Decision|0|||
25001358|NCT03253094|50093710|FG002|Overall Study|Physician Decision|0|||
25001359|NCT03253094|50093711|FG003|Overall Study|Physician Decision|1|||
25001360|NCT03253094|50093712|FG004|Overall Study|Physician Decision|0|||
25001361|NCT03253094|50093713|FG005|Overall Study|Physician Decision|2|||
25001362|NCT03253094|50093708|FG000|Overall Study|Withdrawal by Subject|1|||
25001363|NCT03253094|50093709|FG001|Overall Study|Withdrawal by Subject|2|||
25001364|NCT03253094|50093710|FG002|Overall Study|Withdrawal by Subject|1|||
25001365|NCT03253094|50093711|FG003|Overall Study|Withdrawal by Subject|0|||
25001366|NCT03253094|50093712|FG004|Overall Study|Withdrawal by Subject|3|||
25001367|NCT03253094|50093713|FG005|Overall Study|Withdrawal by Subject|0|||
25001368|NCT03253094|50093708|FG000|Overall Study|Other|0|||
25001369|NCT03253094|50093709|FG001|Overall Study|Other|1|||
25001370|NCT03253094|50093710|FG002|Overall Study|Other|2|||
25001371|NCT03253094|50093711|FG003|Overall Study|Other|1|||
25001372|NCT03253094|50093712|FG004|Overall Study|Other|0|||
25001373|NCT03253094|50093713|FG005|Overall Study|Other|0|||
25001374|NCT03654885|50093729|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
25001375|NCT03654885|50093730|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
25001376|NCT03654885|50093729|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
25176488|NCT01520909|50319832|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
25176489|NCT01520909|50319830|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
25176490|NCT01520909|50319831|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
25176491|NCT01520909|50319832|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
25176492|NCT01520909|50319830|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
25176493|NCT01520909|50319831|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
25176494|NCT01520909|50319832|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
25176495|NCT01520909|50319830|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
25176496|NCT01520909|50319831|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
25176497|NCT01520909|50319832|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
25176498|NCT01520363|50319854|FG000|Overall Study|Withdrawal by Subject|2|||
25176499|NCT01520363|50319855|FG001|Overall Study|Withdrawal by Subject|0|||
25176500|NCT01578499|50319887|FG000|Overall Study|Reason not Specified|0|||
25176501|NCT01578499|50319888|FG001|Overall Study|Reason not Specified|1|||
25176502|NCT01578499|50319887|FG000|Overall Study|Lost to Follow-up|2|||
25176503|NCT01578499|50319888|FG001|Overall Study|Lost to Follow-up|1|||
25176504|NCT01578499|50319887|FG000|Overall Study|Withdrawal by Subject|10|||
25176505|NCT01578499|50319888|FG001|Overall Study|Withdrawal by Subject|16|||
25176506|NCT01578499|50319887|FG000|Overall Study|Death|20|||
25176507|NCT01578499|50319888|FG001|Overall Study|Death|25|||
25176508|NCT01578499|50319887|FG000|Overall Study|Died and End of Study Page not Completed|2|||
25176509|NCT01578499|50319888|FG001|Overall Study|Died and End of Study Page not Completed|0|||
25176510|NCT01578187|50319898|FG000|Usability Phase|Withdrawal by Subject|1|||
25176511|NCT01561963|50319904|FG000|Overall Study|Adverse Event|1|||
25176512|NCT01576783|50319915|FG000|Overall Study|Change in Medical Care|1|||
25176513|NCT01576783|50319916|FG001|Overall Study|Change in Medical Care|0|||
25176514|NCT01576783|50319915|FG000|Overall Study|Lost to Follow-up|14|||
25176515|NCT01576783|50319916|FG001|Overall Study|Lost to Follow-up|16|||
25176516|NCT01576783|50319915|FG000|Overall Study|Withdrawal by Subject|5|||
25176517|NCT01576783|50319916|FG001|Overall Study|Withdrawal by Subject|1|||
25176518|NCT01534351|50319925|FG000|Overall Study|Study Terminated Early|1|||
25176519|NCT01534351|50319926|FG001|Overall Study|Study Terminated Early|0|||
25176520|NCT01534351|50319927|FG002|Overall Study|Study Terminated Early|0|||
25176521|NCT01534273|50319939|FG000|Period 1|Physician Decision|0|||
25176522|NCT01534273|50319940|FG001|Period 1|Physician Decision|0|||
25176523|NCT01534273|50319941|FG002|Period 1|Physician Decision|0|||
25176524|NCT01534273|50319942|FG003|Period 1|Physician Decision|1|||
25001377|NCT03654885|50093730|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
25001378|NCT03654885|50093729|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
25001379|NCT03654885|50093730|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
25176525|NCT01534273|50319943|FG004|Period 1|Physician Decision|0|||
25176526|NCT01534273|50319944|FG005|Period 1|Physician Decision|0|||
25001380|NCT03654885|50093729|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
25176527|NCT01534273|50319945|FG006|Period 1|Physician Decision|0|||
25176528|NCT01534195|50319968|FG000|Overall Study|Withdrawal by Subject|1|||
25176529|NCT01534195|50319969|FG001|Overall Study|Withdrawal by Subject|1|||
25176530|NCT01560949|50319975|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
25176531|NCT01560949|50319975|FG000|Surgery Phase|Physician Decision|3|||
25001381|NCT03654885|50093730|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
25067264|NCT02576847|50172844|FG000|Overall Study|Adverse Event|27|||
25001382|NCT03654885|50093729|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
25001383|NCT03654885|50093730|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
25001384|NCT03654885|50093729|FG000|Overall Study|Adverse Event in Study Eye|3|||
25001385|NCT03654885|50093730|FG001|Overall Study|Adverse Event in Study Eye|0|||
25001386|NCT03654885|50093729|FG000|Overall Study|Consent Withdrawn|1|||
25001387|NCT03654885|50093730|FG001|Overall Study|Consent Withdrawn|0|||
25001388|NCT03654885|50093729|FG000|Overall Study|Death|3|||
25001389|NCT03654885|50093730|FG001|Overall Study|Death|1|||
25001390|NCT03654885|50093729|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
25001391|NCT03654885|50093730|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
25001392|NCT03654885|50093729|FG000|Overall Study|Lost to Follow-up|3|||
25001393|NCT03654885|50093730|FG001|Overall Study|Lost to Follow-up|3|||
25001394|NCT03236246|50093738|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
25001395|NCT03236246|50093739|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
25001396|NCT03236246|50093738|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
25001397|NCT03236246|50093739|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
25001398|NCT03236246|50093738|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
25001399|NCT03236246|50093739|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
25001400|NCT03236246|50093738|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
25001401|NCT03236246|50093739|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
25001402|NCT03236246|50093738|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
25001403|NCT03236246|50093739|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
25001404|NCT03236246|50093738|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
25001405|NCT03236246|50093739|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
25001406|NCT03236246|50093738|FG000|24-Week Dose Titration Period|Death|3|||
25001407|NCT03236246|50093739|FG001|24-Week Dose Titration Period|Death|1|||
25001408|NCT03236246|50093738|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
25001409|NCT03236246|50093739|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
25001410|NCT03236246|50093738|FG000|24-Week Dose Titration Period|Adverse Event|7|||
25001411|NCT03236246|50093739|FG001|24-Week Dose Titration Period|Adverse Event|8|||
25001412|NCT03236246|50093738|FG000|24-Week Dose Titration Period|Captured as Other|1|||
25001413|NCT03236246|50093739|FG001|24-Week Dose Titration Period|Captured as Other|2|||
25001414|NCT03236246|50093738|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
25001415|NCT03236246|50093739|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
25001416|NCT03236246|50093738|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
25001417|NCT03236246|50093739|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
25001418|NCT03236246|50093738|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
25001419|NCT03236246|50093739|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
25001420|NCT03236246|50093738|FG000|24-Week Dose Maintenance Period|Death|0|||
25001421|NCT03236246|50093739|FG001|24-Week Dose Maintenance Period|Death|1|||
25001422|NCT03236246|50093738|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
25001423|NCT03236246|50093739|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
25001424|NCT02937584|50093745|FG000|Period 1|Adverse Event|1|||
25001425|NCT02937584|50093746|FG001|Period 1|Adverse Event|2|||
25001426|NCT02937584|50093745|FG000|Washout|Adverse Event|0|||
25001427|NCT02937584|50093746|FG001|Washout|Adverse Event|1|||
25001428|NCT00179621|50093755|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
25001429|NCT00179621|50093756|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
25001430|NCT00179621|50093757|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
25001431|NCT00179621|50093758|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
25001432|NCT00179621|50093755|FG000|Double-Blind Period|Adverse Event|2|||
25001433|NCT00179621|50093756|FG001|Double-Blind Period|Adverse Event|7|||
25001434|NCT00179621|50093757|FG002|Double-Blind Period|Adverse Event|4|||
25001435|NCT00179621|50093758|FG003|Double-Blind Period|Adverse Event|0|||
25001436|NCT00179621|50093755|FG000|Double-Blind Period|Withdrawal by Subject|2|||
25001437|NCT00179621|50093756|FG001|Double-Blind Period|Withdrawal by Subject|1|||
25001438|NCT00179621|50093757|FG002|Double-Blind Period|Withdrawal by Subject|3|||
25001439|NCT00179621|50093758|FG003|Double-Blind Period|Withdrawal by Subject|0|||
25001440|NCT00179621|50093755|FG000|Double-Blind Period|Death|0|||
25001441|NCT00179621|50093756|FG001|Double-Blind Period|Death|1|||
25001442|NCT00179621|50093757|FG002|Double-Blind Period|Death|2|||
25001443|NCT00179621|50093758|FG003|Double-Blind Period|Death|0|||
25001444|NCT00179621|50093755|FG000|Double-Blind Period|Protocol Violation|1|||
25001445|NCT00179621|50093756|FG001|Double-Blind Period|Protocol Violation|0|||
25001446|NCT00179621|50093757|FG002|Double-Blind Period|Protocol Violation|0|||
25001447|NCT00179621|50093758|FG003|Double-Blind Period|Protocol Violation|0|||
25001448|NCT00179621|50093755|FG000|Double-Blind Period|Other|0|||
25001449|NCT00179621|50093756|FG001|Double-Blind Period|Other|2|||
25001450|NCT00179621|50093757|FG002|Double-Blind Period|Other|2|||
25001451|NCT00179621|50093758|FG003|Double-Blind Period|Other|0|||
25001452|NCT00179621|50093755|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
25001453|NCT00179621|50093756|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
25001454|NCT00179621|50093757|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
25001455|NCT00179621|50093758|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
25001456|NCT00179621|50093755|FG000|Open-Label Period|Adverse Event|0|||
25001457|NCT00179621|50093756|FG001|Open-Label Period|Adverse Event|6|||
25001458|NCT00179621|50093757|FG002|Open-Label Period|Adverse Event|5|||
25001459|NCT00179621|50093758|FG003|Open-Label Period|Adverse Event|6|||
25001460|NCT00179621|50093755|FG000|Open-Label Period|Withdrawal by Subject|0|||
25001461|NCT00179621|50093756|FG001|Open-Label Period|Withdrawal by Subject|2|||
25001462|NCT00179621|50093757|FG002|Open-Label Period|Withdrawal by Subject|2|||
25091327|NCT01374451|50200923|FG001|Overall Study|Administrative problems|0|||
25091328|NCT02674477|50200931|FG000|Overall Study|Protocol Violation|8|||
25091329|NCT02674477|50200932|FG001|Overall Study|Protocol Violation|2|||
25091330|NCT01352845|50200940|FG000|Overall Study|Lost to Follow-up|313|||
25091331|NCT01352845|50200941|FG001|Overall Study|Lost to Follow-up|92|||
25091332|NCT01352845|50200940|FG000|Overall Study|No Longer Willing to Participate|205|||
25091333|NCT01352845|50200941|FG001|Overall Study|No Longer Willing to Participate|58|||
25176532|NCT01372878|50319983|FG000|Overall Study|Withdrawal by Subject|63|||
25176533|NCT01372878|50319983|FG000|Overall Study|Protocol Violation|17|||
25176534|NCT01372878|50319983|FG000|Overall Study|incomplete study procedure|104|||
25176535|NCT01533493|50319989|FG000|Overall Study|Adverse Event|2|||
25176536|NCT01533493|50319990|FG001|Overall Study|Adverse Event|1|||
25176537|NCT01533493|50319989|FG000|Overall Study|Withdrawal by Subject|1|||
25176538|NCT01533493|50319990|FG001|Overall Study|Withdrawal by Subject|2|||
25176539|NCT01533493|50319989|FG000|Overall Study|Lost to Follow-up|2|||
25176540|NCT01533493|50319990|FG001|Overall Study|Lost to Follow-up|0|||
25176541|NCT01533181|50320066|FG000|Overall Study|Disease progression pre-active treatment|0|||
25176542|NCT01533181|50320067|FG001|Overall Study|Disease progression pre-active treatment|1|||
25176543|NCT01533181|50320066|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
25001463|NCT00179621|50093758|FG003|Open-Label Period|Withdrawal by Subject|2|||
25001464|NCT00179621|50093755|FG000|Open-Label Period|Death|0|||
25001465|NCT00179621|50093756|FG001|Open-Label Period|Death|0|||
25001466|NCT00179621|50093757|FG002|Open-Label Period|Death|1|||
25001467|NCT00179621|50093758|FG003|Open-Label Period|Death|2|||
25001468|NCT00179621|50093755|FG000|Open-Label Period|Other|0|||
25001469|NCT00179621|50093756|FG001|Open-Label Period|Other|1|||
25001470|NCT00179621|50093757|FG002|Open-Label Period|Other|1|||
25001471|NCT00179621|50093758|FG003|Open-Label Period|Other|2|||
25001472|NCT00179309|50093769|FG000|Treatment|Toxicity|2|||
25001473|NCT00179309|50093770|FG001|Treatment|Toxicity|3|||
25001474|NCT00179309|50093769|FG000|Treatment|Withdrawal by Subject|1|||
25001475|NCT00179309|50093770|FG001|Treatment|Withdrawal by Subject|2|||
25001476|NCT00179309|50093769|FG000|Treatment|Allergy|1|||
25001477|NCT00179309|50093770|FG001|Treatment|Allergy|0|||
25001478|NCT00178685|50093791|FG000|Overall Study|Death|3|||
25001479|NCT00178685|50093792|FG001|Overall Study|Death|3|||
25001480|NCT00178685|50093793|FG002|Overall Study|Death|6|||
25001481|NCT00178685|50093791|FG000|Overall Study|Lost to Follow-up|100|||
25001482|NCT00178685|50093792|FG001|Overall Study|Lost to Follow-up|187|||
25001483|NCT00178685|50093793|FG002|Overall Study|Lost to Follow-up|183|||
25001484|NCT00178685|50093791|FG000|Overall Study|Withdrawal by Subject|8|||
25001485|NCT00178685|50093792|FG001|Overall Study|Withdrawal by Subject|14|||
25001486|NCT00178685|50093793|FG002|Overall Study|Withdrawal by Subject|7|||
25001487|NCT02933528|50093801|FG000|Overall Study|Lost to Follow-up|2|||
25001488|NCT00177671|50093807|FG000|Overall Study|Withdrawal by Subject|5|||
25001489|NCT00177671|50093808|FG001|Overall Study|Withdrawal by Subject|6|||
25001490|NCT00177671|50093807|FG000|Overall Study|medical complications|2|||
25001491|NCT00177671|50093808|FG001|Overall Study|medical complications|0|||
25001492|NCT00177671|50093807|FG000|Overall Study|Adverse Event|6|||
25001493|NCT00177671|50093808|FG001|Overall Study|Adverse Event|0|||
25001494|NCT00177671|50093807|FG000|Overall Study|Physician Decision|12|||
25001495|NCT00177671|50093808|FG001|Overall Study|Physician Decision|8|||
25001496|NCT02933060|50093816|FG000|Overall Study|Withdrawal by Subject|0|||
25001497|NCT02933060|50093817|FG001|Overall Study|Withdrawal by Subject|1|||
25001498|NCT03235154|50093823|FG000|Overall Study|Withdrawal by Subject|1|||
25001499|NCT03235154|50093823|FG000|Overall Study|Adverse Event|1|||
25001500|NCT03235154|50093823|FG000|Overall Study|Lost to Follow-up|2|||
25001501|NCT03234608|50093831|FG000|Overall Study|Lost to Follow-up|23|||
25001502|NCT03234608|50093832|FG001|Overall Study|Lost to Follow-up|21|||
25001503|NCT03248882|50093843|FG000|Overall Study|Adverse Event|3|||
25001504|NCT03248882|50093844|FG001|Overall Study|Adverse Event|3|||
25001505|NCT03248882|50093845|FG002|Overall Study|Adverse Event|2|||
25001506|NCT03248882|50093846|FG003|Overall Study|Adverse Event|6|||
25001507|NCT03248882|50093847|FG004|Overall Study|Adverse Event|9|||
25001508|NCT03248882|50093843|FG000|Overall Study|Lost to Follow-up|0|||
25001509|NCT03248882|50093844|FG001|Overall Study|Lost to Follow-up|0|||
25001510|NCT03248882|50093845|FG002|Overall Study|Lost to Follow-up|0|||
25001511|NCT03248882|50093846|FG003|Overall Study|Lost to Follow-up|0|||
25001512|NCT03248882|50093847|FG004|Overall Study|Lost to Follow-up|1|||
25001513|NCT03248882|50093843|FG000|Overall Study|Protocol Violation|2|||
25001514|NCT03248882|50093844|FG001|Overall Study|Protocol Violation|0|||
25001515|NCT03248882|50093845|FG002|Overall Study|Protocol Violation|2|||
25001516|NCT03248882|50093846|FG003|Overall Study|Protocol Violation|0|||
25001517|NCT03248882|50093847|FG004|Overall Study|Protocol Violation|1|||
25001518|NCT03248882|50093843|FG000|Overall Study|Withdrawal by Subject|2|||
25001519|NCT03248882|50093844|FG001|Overall Study|Withdrawal by Subject|2|||
25001520|NCT03248882|50093845|FG002|Overall Study|Withdrawal by Subject|3|||
25001521|NCT03248882|50093846|FG003|Overall Study|Withdrawal by Subject|4|||
25001522|NCT03248882|50093847|FG004|Overall Study|Withdrawal by Subject|2|||
25001523|NCT03233438|50093861|FG000|Overall Study|Lost to Follow-up|4|||
25001524|NCT03233438|50093862|FG001|Overall Study|Lost to Follow-up|9|||
25001525|NCT03233438|50093861|FG000|Overall Study|Withdrawal by Subject|2|||
25001526|NCT03233438|50093862|FG001|Overall Study|Withdrawal by Subject|1|||
25001527|NCT03233438|50093861|FG000|Overall Study|No recording of dalbavancin|0|||
25001528|NCT03233438|50093862|FG001|Overall Study|No recording of dalbavancin|1|||
25001529|NCT01368406|50093870|FG000|Overall Study|Lost to Follow-up|8|||
25001530|NCT01368406|50093871|FG001|Overall Study|Lost to Follow-up|4|||
25001531|NCT01368406|50093870|FG000|Overall Study|Withdrawal by Subject|8|||
25001532|NCT01368406|50093871|FG001|Overall Study|Withdrawal by Subject|4|||
25001533|NCT01368406|50093870|FG000|Overall Study|relapse of the disease|3|||
25001534|NCT01368406|50093871|FG001|Overall Study|relapse of the disease|2|||
25001535|NCT01368406|50093870|FG000|Overall Study|started working|2|||
25001536|NCT01368406|50093871|FG001|Overall Study|started working|3|||
25001537|NCT00175877|50093877|FG000|Overall Study|Adverse Event|136|||
25001538|NCT00175877|50093877|FG000|Overall Study|Withdrawal by Subject|141|||
25001539|NCT00175877|50093877|FG000|Overall Study|Lost to Follow-up|9|||
25001540|NCT00175877|50093877|FG000|Overall Study|Lack of Efficacy|26|||
25001541|NCT00175877|50093877|FG000|Overall Study|Protocol Violation|15|||
25001542|NCT00175877|50093877|FG000|Overall Study|Other Reason|20|||
25001543|NCT00175877|50093877|FG000|Overall Study|AE & Other|1|||
25001544|NCT00175877|50093877|FG000|Overall Study|Withdrawal by subject & Other|1|||
25001545|NCT02788474|50093883|FG000|Double Blind Treatment Period|Not treated|1|||
25001546|NCT02788474|50093884|FG001|Double Blind Treatment Period|Not treated|0|||
25001547|NCT02788474|50093883|FG000|Double Blind Treatment Period|Patient's refusal|3|||
25001548|NCT02788474|50093884|FG001|Double Blind Treatment Period|Patient's refusal|0|||
25001549|NCT02788474|50093883|FG000|Double Blind Treatment Period|Adverse Event|6|||
25001550|NCT02788474|50093884|FG001|Double Blind Treatment Period|Adverse Event|4|||
25001551|NCT02788474|50093883|FG000|Open Label Treatment Period|Adverse Event|29|||
25001552|NCT02788474|50093884|FG001|Open Label Treatment Period|Adverse Event|9|||
25001553|NCT02788474|50093883|FG000|Open Label Treatment Period|Other than reason specified|1|||
25001554|NCT02788474|50093884|FG001|Open Label Treatment Period|Other than reason specified|0|||
25001555|NCT02788474|50093883|FG000|Open Label Treatment Period|Patient's refusal|1|||
25001556|NCT02788474|50093884|FG001|Open Label Treatment Period|Patient's refusal|3|||
25001557|NCT02788474|50093883|FG000|Open Label Treatment Period|Non-compliance|1|||
25001558|NCT02788474|50093884|FG001|Open Label Treatment Period|Non-compliance|0|||
25001559|NCT03248492|50093896|FG000|Overall Study|Ongoing|23|||
25001560|NCT03248492|50093897|FG001|Overall Study|Ongoing|26|||
25001561|NCT03248492|50093898|FG002|Overall Study|Ongoing|3|||
25001562|NCT03248492|50093899|FG003|Overall Study|Ongoing|85|||
25001563|NCT03248492|50093900|FG004|Overall Study|Ongoing|2|||
25001564|NCT03248492|50093896|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
25001565|NCT03248492|50093897|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
25001566|NCT03248492|50093898|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
25001567|NCT03248492|50093899|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
25001568|NCT03248492|50093900|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
25001569|NCT03248492|50093896|FG000|Overall Study|Adverse Event|6|||
25001570|NCT03248492|50093897|FG001|Overall Study|Adverse Event|6|||
25001571|NCT03248492|50093898|FG002|Overall Study|Adverse Event|8|||
25001572|NCT03248492|50093899|FG003|Overall Study|Adverse Event|8|||
25001573|NCT03248492|50093900|FG004|Overall Study|Adverse Event|1|||
25001574|NCT03248492|50093896|FG000|Overall Study|Withdrawal by Subject|3|||
25001575|NCT03248492|50093897|FG001|Overall Study|Withdrawal by Subject|3|||
25001576|NCT03248492|50093898|FG002|Overall Study|Withdrawal by Subject|0|||
25001577|NCT03248492|50093899|FG003|Overall Study|Withdrawal by Subject|3|||
25001578|NCT03248492|50093900|FG004|Overall Study|Withdrawal by Subject|1|||
25001579|NCT03248492|50093896|FG000|Overall Study|Physician Decision|1|||
25001580|NCT03248492|50093897|FG001|Overall Study|Physician Decision|0|||
25001581|NCT03248492|50093898|FG002|Overall Study|Physician Decision|1|||
25001582|NCT03248492|50093899|FG003|Overall Study|Physician Decision|2|||
25001583|NCT03248492|50093900|FG004|Overall Study|Physician Decision|0|||
25001584|NCT03248492|50093896|FG000|Overall Study|Death|1|||
25001585|NCT03248492|50093897|FG001|Overall Study|Death|0|||
25001586|NCT03248492|50093898|FG002|Overall Study|Death|0|||
25001587|NCT03248492|50093899|FG003|Overall Study|Death|6|||
25001588|NCT03248492|50093900|FG004|Overall Study|Death|0|||
25001589|NCT03248492|50093896|FG000|Overall Study|Other|0|||
25001590|NCT03248492|50093897|FG001|Overall Study|Other|1|||
25001591|NCT03248492|50093898|FG002|Overall Study|Other|0|||
25001592|NCT03248492|50093899|FG003|Overall Study|Other|4|||
25001593|NCT03248492|50093900|FG004|Overall Study|Other|0|||
25001594|NCT03247556|50093923|FG000|Overall Study|Adverse Event|1|||
25001595|NCT03247556|50093924|FG001|Overall Study|Adverse Event|4|||
25001596|NCT03247556|50093925|FG002|Overall Study|Adverse Event|5|||
25001597|NCT03247556|50093923|FG000|Overall Study|Lost to Follow-up|5|||
25001598|NCT03247556|50093924|FG001|Overall Study|Lost to Follow-up|5|||
25001599|NCT03247556|50093925|FG002|Overall Study|Lost to Follow-up|4|||
25001600|NCT03247556|50093923|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
25001601|NCT03247556|50093924|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
25001602|NCT03247556|50093925|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
25001603|NCT03247556|50093923|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
25001604|NCT03247556|50093924|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
25001605|NCT03247556|50093925|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
25001606|NCT03247556|50093923|FG000|Overall Study|Protocol Violation|2|||
25001607|NCT03247556|50093924|FG001|Overall Study|Protocol Violation|0|||
25001608|NCT03247556|50093925|FG002|Overall Study|Protocol Violation|1|||
25001609|NCT03247556|50093923|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
25001610|NCT03247556|50093924|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
25001611|NCT03247556|50093925|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
25001612|NCT03216746|50093937|FG000|Overall Study|Lost to Follow-up|6|||
25001613|NCT03216746|50093938|FG001|Overall Study|Lost to Follow-up|8|||
25001614|NCT03216746|50093939|FG002|Overall Study|Lost to Follow-up|5|||
25001615|NCT03216746|50093940|FG003|Overall Study|Lost to Follow-up|6|||
25001616|NCT02787304|50093954|FG000|Overall Study|Adverse Event|9|||
25001617|NCT02787304|50093955|FG001|Overall Study|Adverse Event|3|||
25001618|NCT02787304|50093956|FG002|Overall Study|Adverse Event|8|||
25001619|NCT02787304|50093957|FG003|Overall Study|Adverse Event|1|||
25001620|NCT02787304|50093954|FG000|Overall Study|Withdrawal by Subject|1|||
25001621|NCT02787304|50093955|FG001|Overall Study|Withdrawal by Subject|4|||
25001622|NCT02787304|50093956|FG002|Overall Study|Withdrawal by Subject|0|||
25001623|NCT02787304|50093957|FG003|Overall Study|Withdrawal by Subject|0|||
25001624|NCT02787304|50093954|FG000|Overall Study|Lost to Follow-up|1|||
25001625|NCT02787304|50093955|FG001|Overall Study|Lost to Follow-up|0|||
25001626|NCT02787304|50093956|FG002|Overall Study|Lost to Follow-up|0|||
25001627|NCT02787304|50093957|FG003|Overall Study|Lost to Follow-up|1|||
25001628|NCT02787304|50093954|FG000|Overall Study|Noncompliance with study drug|0|||
25001629|NCT02787304|50093955|FG001|Overall Study|Noncompliance with study drug|0|||
25001630|NCT02787304|50093956|FG002|Overall Study|Noncompliance with study drug|1|||
25001631|NCT02787304|50093957|FG003|Overall Study|Noncompliance with study drug|0|||
25001632|NCT02787304|50093954|FG000|Overall Study|Physician Decision|0|||
25001633|NCT02787304|50093955|FG001|Overall Study|Physician Decision|0|||
25001634|NCT02787304|50093956|FG002|Overall Study|Physician Decision|1|||
25001635|NCT02787304|50093957|FG003|Overall Study|Physician Decision|0|||
25001636|NCT02787304|50093954|FG000|Overall Study|Study terminated by sponsor|25|||
25001637|NCT02787304|50093955|FG001|Overall Study|Study terminated by sponsor|31|||
25001638|NCT02787304|50093956|FG002|Overall Study|Study terminated by sponsor|31|||
25001639|NCT02787304|50093957|FG003|Overall Study|Study terminated by sponsor|32|||
25001640|NCT02932904|50093971|FG000|Overall Study|Reason not Specified|1|||
25001641|NCT02932904|50093972|FG001|Overall Study|Reason not Specified|0|||
25001642|NCT02932904|50093973|FG002|Overall Study|Reason not Specified|2|||
25001643|NCT02932904|50093974|FG003|Overall Study|Reason not Specified|2|||
25001644|NCT02932904|50093971|FG000|Overall Study|Noncompliance with Study Drug|2|||
25001645|NCT02932904|50093972|FG001|Overall Study|Noncompliance with Study Drug|3|||
25001646|NCT02932904|50093973|FG002|Overall Study|Noncompliance with Study Drug|3|||
25001647|NCT02932904|50093974|FG003|Overall Study|Noncompliance with Study Drug|4|||
25001648|NCT02932904|50093971|FG000|Overall Study|Pregnancy|0|||
25001649|NCT02932904|50093972|FG001|Overall Study|Pregnancy|1|||
25001650|NCT02932904|50093973|FG002|Overall Study|Pregnancy|1|||
25001651|NCT02932904|50093974|FG003|Overall Study|Pregnancy|0|||
25001652|NCT02932904|50093971|FG000|Overall Study|Study Termination|0|||
25001653|NCT02932904|50093972|FG001|Overall Study|Study Termination|1|||
25001654|NCT02932904|50093973|FG002|Overall Study|Study Termination|0|||
25001655|NCT02932904|50093974|FG003|Overall Study|Study Termination|0|||
25001656|NCT02932904|50093971|FG000|Overall Study|Voluntary Withdrawal|2|||
25001657|NCT02932904|50093972|FG001|Overall Study|Voluntary Withdrawal|1|||
25001658|NCT02932904|50093973|FG002|Overall Study|Voluntary Withdrawal|4|||
25001659|NCT02932904|50093974|FG003|Overall Study|Voluntary Withdrawal|2|||
25001660|NCT02932904|50093971|FG000|Overall Study|Lost to Follow-up|5|||
25001661|NCT02932904|50093972|FG001|Overall Study|Lost to Follow-up|3|||
25001662|NCT02932904|50093973|FG002|Overall Study|Lost to Follow-up|6|||
25001663|NCT02932904|50093974|FG003|Overall Study|Lost to Follow-up|0|||
25001664|NCT02932904|50093971|FG000|Overall Study|Significant Protocol Deviation|2|||
25001665|NCT02932904|50093972|FG001|Overall Study|Significant Protocol Deviation|3|||
25001666|NCT02932904|50093973|FG002|Overall Study|Significant Protocol Deviation|6|||
25001667|NCT02932904|50093974|FG003|Overall Study|Significant Protocol Deviation|1|||
25001668|NCT02932904|50093971|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
25001669|NCT02932904|50093972|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
25001670|NCT02932904|50093973|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
25001671|NCT02932904|50093974|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
25001672|NCT02932904|50093971|FG000|Overall Study|Randomized But Not Treated|1|||
25001673|NCT02932904|50093972|FG001|Overall Study|Randomized But Not Treated|1|||
25001674|NCT02932904|50093973|FG002|Overall Study|Randomized But Not Treated|0|||
25001675|NCT02932904|50093974|FG003|Overall Study|Randomized But Not Treated|2|||
25001676|NCT00688376|50093989|FG000|Double-Blind Phase|Adverse Event|4|||
25001677|NCT00688376|50093990|FG001|Double-Blind Phase|Adverse Event|4|||
25001678|NCT00688376|50093989|FG000|Double-Blind Phase|Protocol Violation|1|||
25001679|NCT00688376|50093990|FG001|Double-Blind Phase|Protocol Violation|2|||
25001680|NCT00688376|50093989|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
25001681|NCT00688376|50093990|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
25001682|NCT00688376|50093989|FG000|Double-Blind Phase|Not treated|0|||
25001683|NCT00688376|50093990|FG001|Double-Blind Phase|Not treated|1|||
25001684|NCT00688376|50093989|FG000|Blinded Extension Phase|Adverse Event|3|||
25001685|NCT00688376|50093990|FG001|Blinded Extension Phase|Adverse Event|4|||
25001686|NCT00688376|50093989|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
25001687|NCT00688376|50093990|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
25001688|NCT00688376|50093989|FG000|Blinded Extension Phase|Physician Decision|1|||
25001689|NCT00688376|50093990|FG001|Blinded Extension Phase|Physician Decision|0|||
25001690|NCT00688376|50093989|FG000|Blinded Extension Phase|Other|1|||
25001691|NCT00688376|50093990|FG001|Blinded Extension Phase|Other|0|||
25001692|NCT03214952|50093998|FG000|Overall Study|Protocol Deviation|45|||
25001693|NCT03214952|50093998|FG000|Overall Study|Case Report Forms Uncollected|13|||
25001694|NCT01367704|50094004|FG000|Overall Study|Lost to Follow-up|47|||
25001695|NCT01367704|50094005|FG001|Overall Study|Lost to Follow-up|161|||
25001696|NCT03214094|50094011|FG000|Overall Study|Case Report Forms Uncollected|14|||
25001697|NCT03214094|50094011|FG000|Overall Study|Protocol Deviation|46|||
25001698|NCT01367236|50094017|FG000|Overall Study|Withdrawal by Subject|3|||
25001699|NCT01367236|50094018|FG001|Overall Study|Withdrawal by Subject|1|||
25001700|NCT03681951|50094032|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
25001701|NCT03681951|50094033|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
25001702|NCT03681951|50094034|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
25001703|NCT03681951|50094035|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
25001704|NCT03681951|50094036|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
25001705|NCT03681951|50094037|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
25001706|NCT03681951|50094038|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
25001707|NCT03681951|50094039|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
25001708|NCT03681951|50094032|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
25001709|NCT03681951|50094033|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
25001710|NCT03681951|50094034|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
25001711|NCT03681951|50094035|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
25001712|NCT03681951|50094036|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
25001713|NCT03681951|50094037|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
25001714|NCT03681951|50094038|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
25001715|NCT03681951|50094039|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
25001716|NCT03681951|50094032|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
25001717|NCT03681951|50094033|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
25001718|NCT03681951|50094034|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
25001719|NCT03681951|50094035|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
25001720|NCT03681951|50094036|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
25176544|NCT01533181|50320067|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
25176545|NCT02669082|50320073|FG000|Overall Study|Adverse Event|1|||
25001721|NCT03681951|50094037|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
25001722|NCT03681951|50094038|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
25001723|NCT03681951|50094039|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
25001724|NCT03681405|50094064|FG000|Overall Study|Found to be ineligible after randomized|1|||
25001725|NCT03681405|50094065|FG001|Overall Study|Found to be ineligible after randomized|0|||
25001726|NCT00174785|50094075|FG000|Overall Study|Adverse Event|293|||
25001727|NCT00174785|50094076|FG001|Overall Study|Adverse Event|191|||
25001728|NCT00174785|50094075|FG000|Overall Study|Protocol Violation|14|||
25001729|NCT00174785|50094076|FG001|Overall Study|Protocol Violation|14|||
25001730|NCT00174785|50094075|FG000|Overall Study|Withdrawal by Subject|173|||
25001731|NCT00174785|50094076|FG001|Overall Study|Withdrawal by Subject|175|||
25001732|NCT00174785|50094075|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
25001733|NCT00174785|50094076|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
25001734|NCT00174785|50094075|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
25001735|NCT00174785|50094076|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
25001736|NCT00174785|50094075|FG000|Overall Study|Other prohibited medication|5|||
25001737|NCT00174785|50094076|FG001|Overall Study|Other prohibited medication|3|||
25176546|NCT02668692|50320137|FG000|Overall Study|Adverse Event|1|||
25176547|NCT02668692|50320138|FG001|Overall Study|Adverse Event|0|||
25001738|NCT00174785|50094075|FG000|Overall Study|Family request|6|||
25001739|NCT00174785|50094076|FG001|Overall Study|Family request|8|||
25001740|NCT00174785|50094075|FG000|Overall Study|Not pre-specified/Not coded|56|||
25001741|NCT00174785|50094076|FG001|Overall Study|Not pre-specified/Not coded|70|||
25001742|NCT03681093|50094085|FG000|Overall Study|Subject decision|0|||
25001743|NCT03681093|50094086|FG001|Overall Study|Subject decision|2|||
25001744|NCT03681093|50094087|FG002|Overall Study|Subject decision|1|||
25001745|NCT00166517|50094097|FG000|Overall Study|Lost to Follow-up|1|||
25001746|NCT00166517|50094098|FG001|Overall Study|Lost to Follow-up|0|||
25001747|NCT00166517|50094097|FG000|Overall Study|Protocol Violation|4|||
25001748|NCT00166517|50094098|FG001|Overall Study|Protocol Violation|1|||
25001749|NCT00166517|50094097|FG000|Overall Study|Withdrawal by Subject|0|||
25001750|NCT00166517|50094098|FG001|Overall Study|Withdrawal by Subject|1|||
25001751|NCT00166439|50094104|FG000|Overall Study|Ineligible|5|||
25001752|NCT00138671|50094110|FG000|Overall Study|Death|0|||
25001753|NCT00138671|50094111|FG001|Overall Study|Death|3|||
25001754|NCT00138671|50094110|FG000|Overall Study|Adverse Event|6|||
25001755|NCT00138671|50094111|FG001|Overall Study|Adverse Event|3|||
25001756|NCT00138671|50094110|FG000|Overall Study|Lost to Follow-up|1|||
25001757|NCT00138671|50094111|FG001|Overall Study|Lost to Follow-up|2|||
25001758|NCT00138671|50094110|FG000|Overall Study|Withdrawal by Subject|3|||
25001759|NCT00138671|50094111|FG001|Overall Study|Withdrawal by Subject|5|||
25001760|NCT00138671|50094110|FG000|Overall Study|Other|3|||
25001761|NCT00138671|50094111|FG001|Overall Study|Other|3|||
25001762|NCT01367158|50094130|FG000|Overall Study|Withdrew consent|0|||
25001763|NCT01367158|50094131|FG001|Overall Study|Withdrew consent|2|||
25001764|NCT01367158|50094132|FG002|Overall Study|Withdrew consent|1|||
25001765|NCT01367158|50094133|FG003|Overall Study|Withdrew consent|0|||
25001766|NCT01367158|50094134|FG004|Overall Study|Withdrew consent|2|||
25001767|NCT01367158|50094135|FG005|Overall Study|Withdrew consent|0|||
25001768|NCT01367158|50094136|FG006|Overall Study|Withdrew consent|0|||
25001769|NCT01367158|50094137|FG007|Overall Study|Withdrew consent|1|||
25001770|NCT01367158|50094138|FG008|Overall Study|Withdrew consent|0|||
25001771|NCT01367158|50094139|FG009|Overall Study|Withdrew consent|0|||
25001772|NCT01367158|50094140|FG010|Overall Study|Withdrew consent|0|||
25001773|NCT01367158|50094130|FG000|Overall Study|Lost to Follow-up|0|||
25001774|NCT01367158|50094131|FG001|Overall Study|Lost to Follow-up|0|||
25001775|NCT01367158|50094132|FG002|Overall Study|Lost to Follow-up|0|||
25001776|NCT01367158|50094133|FG003|Overall Study|Lost to Follow-up|1|||
25001777|NCT01367158|50094134|FG004|Overall Study|Lost to Follow-up|0|||
25001778|NCT01367158|50094135|FG005|Overall Study|Lost to Follow-up|2|||
25001779|NCT01367158|50094136|FG006|Overall Study|Lost to Follow-up|0|||
25001780|NCT01367158|50094137|FG007|Overall Study|Lost to Follow-up|1|||
25001781|NCT01367158|50094138|FG008|Overall Study|Lost to Follow-up|0|||
25001782|NCT01367158|50094139|FG009|Overall Study|Lost to Follow-up|0|||
25001783|NCT01367158|50094140|FG010|Overall Study|Lost to Follow-up|1|||
25001784|NCT01367158|50094130|FG000|Overall Study|Protocol Violation|0|||
25001785|NCT01367158|50094131|FG001|Overall Study|Protocol Violation|1|||
25176548|NCT02662764|50320152|FG000|Overall Study|Adverse Event|6|||
25176549|NCT02662764|50320152|FG000|Overall Study|Lack of Efficacy|8|||
25001786|NCT01367158|50094132|FG002|Overall Study|Protocol Violation|0|||
25001787|NCT01367158|50094133|FG003|Overall Study|Protocol Violation|0|||
25001788|NCT01367158|50094134|FG004|Overall Study|Protocol Violation|0|||
25001789|NCT01367158|50094135|FG005|Overall Study|Protocol Violation|0|||
25001790|NCT01367158|50094136|FG006|Overall Study|Protocol Violation|0|||
25001791|NCT01367158|50094137|FG007|Overall Study|Protocol Violation|0|||
25001792|NCT01367158|50094138|FG008|Overall Study|Protocol Violation|0|||
25001793|NCT01367158|50094139|FG009|Overall Study|Protocol Violation|0|||
25001794|NCT01367158|50094140|FG010|Overall Study|Protocol Violation|0|||
25176550|NCT02662764|50320152|FG000|Overall Study|Protocol Violation|1|||
25176551|NCT02662764|50320152|FG000|Overall Study|Withdrawal by Subject|5|||
25001795|NCT00130637|50094175|FG000|Overall Study|Adverse Event|2|||
25001796|NCT00130637|50094175|FG000|Overall Study|Withdrawal by Subject|1|||
25001797|NCT03679767|50094183|FG000|Overall Study|Death|16|||
25001798|NCT03679767|50094184|FG001|Overall Study|Death|10|||
25001799|NCT03679767|50094185|FG002|Overall Study|Death|16|||
25001800|NCT03679767|50094186|FG003|Overall Study|Death|10|||
25001801|NCT03679767|50094183|FG000|Overall Study|Lost to Follow-up|1|||
25001802|NCT03679767|50094184|FG001|Overall Study|Lost to Follow-up|0|||
25001803|NCT03679767|50094185|FG002|Overall Study|Lost to Follow-up|1|||
25001804|NCT03679767|50094186|FG003|Overall Study|Lost to Follow-up|1|||
25001805|NCT03679767|50094183|FG000|Overall Study|Withdrawal by Subject|0|||
25001806|NCT03679767|50094184|FG001|Overall Study|Withdrawal by Subject|0|||
25001807|NCT03679767|50094185|FG002|Overall Study|Withdrawal by Subject|0|||
25001808|NCT03679767|50094186|FG003|Overall Study|Withdrawal by Subject|1|||
25176552|NCT02662764|50320152|FG000|Overall Study|Device failure|4|||
25001809|NCT03679767|50094183|FG000|Overall Study|Follow-up Completed|4|||
25001810|NCT03679767|50094184|FG001|Overall Study|Follow-up Completed|1|||
25001811|NCT03679767|50094185|FG002|Overall Study|Follow-up Completed|3|||
25001812|NCT03679767|50094186|FG003|Overall Study|Follow-up Completed|5|||
25001813|NCT03679767|50094183|FG000|Overall Study|Ongoing|14|||
25001814|NCT03679767|50094184|FG001|Overall Study|Ongoing|12|||
25001815|NCT03679767|50094185|FG002|Overall Study|Ongoing|9|||
25001816|NCT03679767|50094186|FG003|Overall Study|Ongoing|17|||
25001817|NCT00130247|50094200|FG000|Overall Study|Pregnancy|1|||
25001818|NCT00130247|50094201|FG001|Overall Study|Pregnancy|0|||
25001819|NCT00130247|50094200|FG000|Overall Study|Post-randomization exclusion|1|||
25001820|NCT00130247|50094201|FG001|Overall Study|Post-randomization exclusion|2|||
25001821|NCT00130247|50094200|FG000|Overall Study|Not compliant with DOT|0|||
25001822|NCT00130247|50094201|FG001|Overall Study|Not compliant with DOT|2|||
25001823|NCT03678285|50094207|FG000|Overall Study|Adverse Event|2|||
25001824|NCT03678285|50094207|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
25001825|NCT03678285|50094207|FG000|Overall Study|Dehydrated prior to start of workout|1|||
25001826|NCT04032171|50094213|FG000|Overall Study|Study Termination|1|||
25001827|NCT04032171|50094214|FG001|Overall Study|Study Termination|0|||
25001828|NCT00137423|50094222|FG000|Overall Study|Adverse Event|7|||
25001829|NCT00137423|50094223|FG001|Overall Study|Adverse Event|9|||
25001830|NCT00137423|50094222|FG000|Overall Study|consent withdrawn|1|||
25001831|NCT00137423|50094223|FG001|Overall Study|consent withdrawn|1|||
25001832|NCT00137423|50094222|FG000|Overall Study|Lack of Efficacy|31|||
25001833|NCT00137423|50094223|FG001|Overall Study|Lack of Efficacy|33|||
25001834|NCT00137423|50094222|FG000|Overall Study|Death|0|||
25001835|NCT00137423|50094223|FG001|Overall Study|Death|1|||
25001836|NCT02786836|50094233|FG000|Overall Study|Death|1|||
25001837|NCT02786836|50094233|FG000|Overall Study|Lack of Efficacy|2|||
25001838|NCT02786836|50094233|FG000|Overall Study|Protocol Violation|3|||
25001839|NCT02786836|50094233|FG000|Overall Study|Withdrawal by Subject|3|||
25001840|NCT02786836|50094233|FG000|Overall Study|Liver Transplantation|2|||
25001841|NCT02786836|50094233|FG000|Overall Study|Device or Pharmacy Issues|3|||
25001842|NCT00137267|50094240|FG000|Overall Study|Lost to Follow-up|15|||
25001843|NCT00137267|50094241|FG001|Overall Study|Lost to Follow-up|21|||
25001844|NCT00137111|50094251|FG000|Total Therapy|Death|35|||
25001845|NCT00137111|50094252|FG001|Total Therapy|Death|0|||
25001846|NCT00137111|50094253|FG002|Total Therapy|Death|0|||
25001847|NCT00137111|50094254|FG003|Total Therapy|Death|0|||
25001848|NCT00137111|50094251|FG000|Total Therapy|Non Compliance|5|||
25001849|NCT00137111|50094252|FG001|Total Therapy|Non Compliance|0|||
25001850|NCT00137111|50094253|FG002|Total Therapy|Non Compliance|0|||
25001851|NCT00137111|50094254|FG003|Total Therapy|Non Compliance|0|||
25001852|NCT00136955|50094261|FG000|Overall Study|Adverse Event|8|||
25001853|NCT00136955|50094261|FG000|Overall Study|Lost to Follow-up|1|||
25001854|NCT00136955|50094261|FG000|Overall Study|Withdrawal by Subject|2|||
25001855|NCT00136955|50094261|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
25001856|NCT00135707|50094267|FG000|Overall Study|Lost to Follow-up|94|||
25001857|NCT00135707|50094268|FG001|Overall Study|Lost to Follow-up|89|||
25001858|NCT00135707|50094267|FG000|Overall Study|Withdrawal by Subject|0|||
25001859|NCT00135707|50094268|FG001|Overall Study|Withdrawal by Subject|1|||
25001860|NCT00135707|50094267|FG000|Overall Study|Institutional review board request|1|||
25176553|NCT02662764|50320152|FG000|Overall Study|Patient changed treatment|1|||
25176554|NCT02662764|50320152|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
25176555|NCT01519817|50320161|FG000|Overall Study|Withdrawal by Subject|1|||
25091334|NCT01352845|50200940|FG000|Overall Study|Withdrawal by Subject|48|||
25176556|NCT01519817|50320162|FG001|Overall Study|Withdrawal by Subject|0|||
25176557|NCT01519817|50320163|FG002|Overall Study|Withdrawal by Subject|0|||
25176558|NCT01519817|50320164|FG003|Overall Study|Withdrawal by Subject|0|||
25176559|NCT01519817|50320161|FG000|Overall Study|Off study due to infection|0|||
25091335|NCT01352845|50200941|FG001|Overall Study|Withdrawal by Subject|16|||
25091336|NCT01352845|50200940|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
25091337|NCT01352845|50200941|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
25091338|NCT01352845|50200940|FG000|Overall Study|Pregnancy|27|||
25176560|NCT01519817|50320162|FG001|Overall Study|Off study due to infection|0|||
25001861|NCT00135707|50094268|FG001|Overall Study|Institutional review board request|0|||
25001862|NCT00129701|50094278|FG000|Overall Study|Withdrawal by Subject|33|||
25001863|NCT00129623|50094287|FG000|Overall Study|Adverse Event|3|||
25001864|NCT00129623|50094288|FG001|Overall Study|Adverse Event|7|||
25001865|NCT00129623|50094287|FG000|Overall Study|Refused Treatment|5|||
25001866|NCT00129623|50094288|FG001|Overall Study|Refused Treatment|3|||
25091339|NCT01352845|50200941|FG001|Overall Study|Pregnancy|7|||
25001867|NCT00129623|50094287|FG000|Overall Study|Failure to Return|1|||
25001868|NCT00129623|50094288|FG001|Overall Study|Failure to Return|1|||
25001869|NCT00129623|50094287|FG000|Overall Study|Relocated job out of state|1|||
25001870|NCT00129623|50094288|FG001|Overall Study|Relocated job out of state|0|||
25001871|NCT00129623|50094287|FG000|Overall Study|Uncertainty to return|0|||
25001872|NCT00129623|50094288|FG001|Overall Study|Uncertainty to return|1|||
25001873|NCT00129545|50094299|FG000|Overall Study|Death|5|||
25001874|NCT00129545|50094300|FG001|Overall Study|Death|60|||
25001875|NCT00129545|50094301|FG002|Overall Study|Death|44|||
25001876|NCT00129545|50094299|FG000|Overall Study|Withdrawal by Subject|3|||
25001877|NCT00129545|50094300|FG001|Overall Study|Withdrawal by Subject|18|||
25001878|NCT00129545|50094301|FG002|Overall Study|Withdrawal by Subject|44|||
25001879|NCT00129545|50094299|FG000|Overall Study|Lost to Follow-up|2|||
25001880|NCT00129545|50094300|FG001|Overall Study|Lost to Follow-up|22|||
25001881|NCT00129545|50094301|FG002|Overall Study|Lost to Follow-up|13|||
25001882|NCT00129545|50094299|FG000|Overall Study|Physician Decision|0|||
25001883|NCT00129545|50094300|FG001|Overall Study|Physician Decision|3|||
25001884|NCT00129545|50094301|FG002|Overall Study|Physician Decision|10|||
25001885|NCT00129545|50094299|FG000|Overall Study|Device not implanted|16|||
25001886|NCT00129545|50094300|FG001|Overall Study|Device not implanted|61|||
25001887|NCT00129545|50094301|FG002|Overall Study|Device not implanted|0|||
25001888|NCT00129467|50094311|FG000|Received Intervention|Death|1|||
25001889|NCT00129467|50094312|FG001|Received Intervention|Death|1|||
25001890|NCT00129467|50094311|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
25001891|NCT00129467|50094312|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
25001892|NCT00129467|50094311|FG000|Received Intervention|Delirium|2|||
25001893|NCT00129467|50094312|FG001|Received Intervention|Delirium|0|||
25001894|NCT00129467|50094311|FG000|Received Intervention|Withdrawal by Subject|1|||
25001895|NCT00129467|50094312|FG001|Received Intervention|Withdrawal by Subject|0|||
25001896|NCT00129467|50094311|FG000|Received Intervention|Nausea|1|||
25001897|NCT00129467|50094312|FG001|Received Intervention|Nausea|0|||
25001898|NCT00129467|50094311|FG000|Received Intervention|Intolerance to citalopram|0|||
25001899|NCT00129467|50094312|FG001|Received Intervention|Intolerance to citalopram|1|||
25001900|NCT00129467|50094311|FG000|Received Intervention|Dizzyness, fatigue|0|||
25001901|NCT00129467|50094312|FG001|Received Intervention|Dizzyness, fatigue|1|||
25001902|NCT00129467|50094311|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
25001903|NCT00129467|50094312|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
25001904|NCT00129467|50094311|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
25001905|NCT00129467|50094312|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
25001906|NCT00129311|50094320|FG000|Overall Study|Withdrawal by Subject|12|||
25001907|NCT00129311|50094321|FG001|Overall Study|Withdrawal by Subject|19|||
25001908|NCT00133991|50094327|FG000|Overall Study|Death|4|||
25001909|NCT02784106|50094333|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
25001910|NCT02784106|50094334|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
25001911|NCT02784106|50094335|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
25001912|NCT02784106|50094336|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
25176561|NCT01519817|50320163|FG002|Overall Study|Off study due to infection|0|||
25176562|NCT01519817|50320164|FG003|Overall Study|Off study due to infection|1|||
25176563|NCT03478956|50320176|FG000|Overall Study|Adverse Event|1|||
25176564|NCT03478956|50320177|FG001|Overall Study|Adverse Event|0|||
25176565|NCT03478956|50320176|FG000|Overall Study|Withdrawal by Subject|0|||
25176566|NCT03478956|50320177|FG001|Overall Study|Withdrawal by Subject|1|||
25001913|NCT02784106|50094333|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
25001914|NCT02784106|50094334|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
25001915|NCT02784106|50094335|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
25001916|NCT02784106|50094336|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
25001917|NCT02784106|50094333|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
25001918|NCT02784106|50094334|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
25001919|NCT02784106|50094335|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
25001920|NCT02784106|50094336|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
25001921|NCT02784106|50094333|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
25001922|NCT02784106|50094334|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
25001923|NCT02784106|50094335|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
25001924|NCT02784106|50094336|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
25001925|NCT02784106|50094333|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
25001926|NCT02784106|50094334|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
25001927|NCT02784106|50094335|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
25001928|NCT02784106|50094336|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
25091340|NCT01352845|50200940|FG000|Overall Study|Adverse Event|22|||
25091341|NCT01352845|50200941|FG001|Overall Study|Adverse Event|6|||
25091342|NCT01352845|50200940|FG000|Overall Study|Other|17|||
25091343|NCT01352845|50200941|FG001|Overall Study|Other|7|||
25091344|NCT01352845|50200940|FG000|Overall Study|Protocol Violation|12|||
25091345|NCT01352845|50200941|FG001|Overall Study|Protocol Violation|6|||
25091346|NCT01352845|50200940|FG000|Overall Study|Death|3|||
25091347|NCT01352845|50200941|FG001|Overall Study|Death|0|||
25001929|NCT02784106|50094333|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
25091348|NCT02674399|50200949|FG000|Overall Study|Lost to Follow-up|2|||
25091349|NCT02674399|50200950|FG001|Overall Study|Lost to Follow-up|0|||
25091350|NCT02676895|50200959|FG000|Overall Study|Administrative reason|1|||
25001930|NCT02784106|50094334|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
25001931|NCT02784106|50094335|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
25001932|NCT02784106|50094336|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
25001933|NCT02785900|50094347|FG000|Overall Study|Study Termination by Sponsor|64|||
25001934|NCT02785900|50094348|FG001|Overall Study|Study Termination by Sponsor|81|||
25001935|NCT02785900|50094347|FG000|Overall Study|Death|46|||
25001936|NCT02785900|50094348|FG001|Overall Study|Death|32|||
25001937|NCT02785900|50094347|FG000|Overall Study|Withdrawal by Subject|4|||
25001938|NCT02785900|50094348|FG001|Overall Study|Withdrawal by Subject|8|||
25001939|NCT02785900|50094347|FG000|Overall Study|Physician Decision|3|||
25001940|NCT02785900|50094348|FG001|Overall Study|Physician Decision|2|||
25001941|NCT00127205|50094357|FG000|Overall Study|Adverse Event|228|||
25001942|NCT00127205|50094358|FG001|Overall Study|Adverse Event|387|||
25001943|NCT00127205|50094359|FG002|Overall Study|Adverse Event|273|||
25001944|NCT00127205|50094357|FG000|Overall Study|Death|8|||
25001945|NCT00127205|50094358|FG001|Overall Study|Death|6|||
25001946|NCT00127205|50094359|FG002|Overall Study|Death|5|||
25001947|NCT00127205|50094357|FG000|Overall Study|Withdrawal by Subject|318|||
25001948|NCT00127205|50094358|FG001|Overall Study|Withdrawal by Subject|310|||
25001949|NCT00127205|50094359|FG002|Overall Study|Withdrawal by Subject|172|||
25001950|NCT00127205|50094357|FG000|Overall Study|Other-non protocol specified|142|||
25001951|NCT00127205|50094358|FG001|Overall Study|Other-non protocol specified|129|||
25001952|NCT00127205|50094359|FG002|Overall Study|Other-non protocol specified|77|||
25001953|NCT00127205|50094357|FG000|Overall Study|Data not reported|6|||
25001954|NCT00127205|50094358|FG001|Overall Study|Data not reported|10|||
25001955|NCT00127205|50094359|FG002|Overall Study|Data not reported|1|||
25001956|NCT00127205|50094357|FG000|Overall Study|Progression|127|||
25001957|NCT00127205|50094358|FG001|Overall Study|Progression|131|||
25001958|NCT00127205|50094359|FG002|Overall Study|Progression|84|||
25001959|NCT02785588|50094369|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
25001960|NCT02785588|50094369|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
25001961|NCT03670641|50094373|FG000|Overall Study|Lost to Follow-up|3|||
25001962|NCT04029519|50094380|FG000|Overall Study|Protocol Violation|1|||
25001963|NCT04029519|50094380|FG000|Overall Study|Withdrawal by Subject|3|||
25001964|NCT04029519|50094380|FG000|Overall Study|Lost to Follow-up|1|||
25001965|NCT03669861|50094384|FG000|Overall Study|Disease Flare|5|||
25001966|NCT03669861|50094384|FG000|Overall Study|Lack of Efficacy|2|||
25001967|NCT00127127|50094392|FG000|Overall Study|Adverse Event|0|||
25001968|NCT00127127|50094393|FG001|Overall Study|Adverse Event|2|||
25001969|NCT00127127|50094394|FG002|Overall Study|Adverse Event|0|||
25001970|NCT00127127|50094395|FG003|Overall Study|Adverse Event|1|||
25001971|NCT00127127|50094392|FG000|Overall Study|Lack of Efficacy|1|||
25001972|NCT00127127|50094393|FG001|Overall Study|Lack of Efficacy|3|||
25001973|NCT00127127|50094394|FG002|Overall Study|Lack of Efficacy|0|||
25001974|NCT00127127|50094395|FG003|Overall Study|Lack of Efficacy|2|||
25001975|NCT03669549|50094432|FG000|Overall Study|Adverse Event|4|||
25001976|NCT03669549|50094432|FG000|Overall Study|Withdrawal by Subject|1|||
25001977|NCT03669549|50094432|FG000|Overall Study|Study terminated by the Sponsor|1|||
25001978|NCT00126659|50094443|FG000|Overall Study|Adverse Event|0|||
25001979|NCT00126659|50094444|FG001|Overall Study|Adverse Event|0|||
25001980|NCT00126659|50094445|FG002|Overall Study|Adverse Event|2|||
25001981|NCT04022733|50094453|FG000|Overall Study|conversion to open surgery|3|||
25001982|NCT04022733|50094454|FG001|Overall Study|conversion to open surgery|2|||
25001983|NCT04022733|50094453|FG000|Overall Study|bradycardia|0|||
25001984|NCT04022733|50094454|FG001|Overall Study|bradycardia|1|||
25001985|NCT03669081|50094462|FG000|Overall Study|Data could not be validated|1|||
25001986|NCT03669081|50094463|FG001|Overall Study|Data could not be validated|1|||
25001987|NCT03667053|50094472|FG000|Overall Study|Withdrawal by Subject|1|||
25001988|NCT03667053|50094473|FG001|Overall Study|Withdrawal by Subject|0|||
25001989|NCT03667053|50094474|FG002|Overall Study|Withdrawal by Subject|0|||
25001990|NCT03631407|50094491|FG000|Overall Study|Withdrawal by Subject|3|||
25001991|NCT03631407|50094492|FG001|Overall Study|Withdrawal by Subject|2|||
25001992|NCT03631407|50094491|FG000|Overall Study|Sponsor Decision|0|||
25001993|NCT03631407|50094492|FG001|Overall Study|Sponsor Decision|2|||
25001994|NCT03631407|50094491|FG000|Overall Study|Death|16|||
25001995|NCT03631407|50094492|FG001|Overall Study|Death|16|||
25001996|NCT03631407|50094491|FG000|Overall Study|Randomized by mistake without study treatment|1|||
25001997|NCT03631407|50094492|FG001|Overall Study|Randomized by mistake without study treatment|0|||
25001998|NCT03630393|50094509|FG000|Overall Study|Death|1|||
25001999|NCT03630393|50094510|FG001|Overall Study|Death|0|||
25002000|NCT03628599|50094527|FG000|Overall Study|Adverse Event|0|||
25002001|NCT03628599|50094528|FG001|Overall Study|Adverse Event|1|||
25002002|NCT03627195|50094554|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
25002003|NCT03627195|50094555|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
25002004|NCT03627195|50094556|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
25002005|NCT03627195|50094557|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
25176567|NCT03478956|50320176|FG000|Overall Study|Ongoing in the Study|11|||
25002006|NCT03627195|50094558|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
25002007|NCT03627195|50094559|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
25002008|NCT00126581|50094575|FG000|Overall Study|Adverse Event|3|||
25002009|NCT00126581|50094576|FG001|Overall Study|Adverse Event|7|||
25002010|NCT00126581|50094575|FG000|Overall Study|Death|3|||
25002011|NCT00126581|50094576|FG001|Overall Study|Death|2|||
25002012|NCT00126581|50094575|FG000|Overall Study|Withdrawal by Subject|1|||
25002013|NCT00126581|50094576|FG001|Overall Study|Withdrawal by Subject|4|||
25002014|NCT00126581|50094575|FG000|Overall Study|Alternative therapy|3|||
25002015|NCT00126581|50094576|FG001|Overall Study|Alternative therapy|3|||
25002016|NCT00126581|50094575|FG000|Overall Study|Other illness/MD discretion|3|||
25002017|NCT00126581|50094576|FG001|Overall Study|Other illness/MD discretion|4|||
25002018|NCT03704584|50094586|FG000|Overall Study|Withdrawal by Subject|1|||
25002019|NCT03704584|50094587|FG001|Overall Study|Withdrawal by Subject|0|||
25002020|NCT03662997|50094597|FG000|Overall Study|Adverse Event|0|||
25002021|NCT03662997|50094598|FG001|Overall Study|Adverse Event|2|||
25002022|NCT03662997|50094599|FG002|Overall Study|Adverse Event|0|||
25002023|NCT03662997|50094600|FG003|Overall Study|Adverse Event|0|||
25002024|NCT03648879|50094612|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
25002025|NCT03647709|50094616|FG000|Overall Study|Lost to Follow-up|5|||
25002026|NCT03647709|50094616|FG000|Overall Study|Physician Decision|6|||
25002027|NCT03647709|50094616|FG000|Overall Study|Withdrawal by Subject|3|||
25002028|NCT03661983|50094622|FG000|Open Label Stabilization Phase|Adverse Event|5|||
25002029|NCT03661983|50094623|FG001|Open Label Stabilization Phase|Adverse Event|0|||
25002030|NCT03661983|50094624|FG002|Open Label Stabilization Phase|Adverse Event|0|||
25002031|NCT03661983|50094625|FG003|Open Label Stabilization Phase|Adverse Event|0|||
25002032|NCT03661983|50094622|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
25002033|NCT03661983|50094623|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
25002034|NCT03661983|50094624|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
25002035|NCT03661983|50094625|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
25002036|NCT03661983|50094622|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
25002037|NCT03661983|50094623|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
25002038|NCT03661983|50094624|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
25002039|NCT03661983|50094625|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
25002040|NCT03661983|50094622|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
25002041|NCT03661983|50094623|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
25002042|NCT03661983|50094624|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
25002043|NCT03661983|50094625|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
25002044|NCT03661983|50094622|FG000|Double-blind Randomized Phase|Adverse Event|0|||
25002045|NCT03661983|50094623|FG001|Double-blind Randomized Phase|Adverse Event|1|||
25002046|NCT03661983|50094624|FG002|Double-blind Randomized Phase|Adverse Event|0|||
25002047|NCT03661983|50094625|FG003|Double-blind Randomized Phase|Adverse Event|0|||
25002048|NCT03661983|50094622|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
25002049|NCT03661983|50094623|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
25002050|NCT03661983|50094624|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
25002051|NCT03661983|50094625|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
25002052|NCT03661983|50094622|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
25002053|NCT03661983|50094623|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
25002054|NCT03661983|50094624|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
25002055|NCT03661983|50094625|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
25002056|NCT03661983|50094622|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
25002057|NCT03661983|50094623|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
25002058|NCT03661983|50094624|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
25002059|NCT03661983|50094625|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
25002060|NCT02783170|50094636|FG000|Overall Study|Randomized but not Vaccinated|1|||
25002061|NCT02783170|50094637|FG001|Overall Study|Randomized but not Vaccinated|0|||
25002062|NCT03646305|50094648|FG000|Overall Study|Lost to Follow-up|4|||
25002063|NCT03646305|50094649|FG001|Overall Study|Lost to Follow-up|2|||
25002064|NCT03646305|50094650|FG002|Overall Study|Lost to Follow-up|2|||
25002065|NCT03646305|50094651|FG003|Overall Study|Lost to Follow-up|1|||
25002066|NCT03646305|50094648|FG000|Overall Study|Withdrawal by Subject|1|||
25002067|NCT03646305|50094649|FG001|Overall Study|Withdrawal by Subject|0|||
25002068|NCT03646305|50094650|FG002|Overall Study|Withdrawal by Subject|0|||
25002069|NCT03646305|50094651|FG003|Overall Study|Withdrawal by Subject|1|||
25002070|NCT02782780|50094667|FG000|Overall Study|dropped out after randomization.|7|||
25002071|NCT02782780|50094668|FG001|Overall Study|dropped out after randomization.|5|||
25002072|NCT02782780|50094667|FG000|Overall Study|Protocol Violation|0|||
25002073|NCT02782780|50094668|FG001|Overall Study|Protocol Violation|2|||
25002074|NCT00126503|50094680|FG000|Overall Study|disease progression|23|||
25002075|NCT00126503|50094681|FG001|Overall Study|disease progression|14|||
25002076|NCT00126503|50094680|FG000|Overall Study|Withdrawal by Subject|0|||
25002077|NCT00126503|50094681|FG001|Overall Study|Withdrawal by Subject|1|||
25002078|NCT00126503|50094680|FG000|Overall Study|alternative therapy|1|||
25002079|NCT00126503|50094681|FG001|Overall Study|alternative therapy|1|||
25002080|NCT00126503|50094680|FG000|Overall Study|other complicating disease|4|||
25002081|NCT00126503|50094681|FG001|Overall Study|other complicating disease|1|||
25002082|NCT00126503|50094680|FG000|Overall Study|Death|3|||
25002083|NCT00126503|50094681|FG001|Overall Study|Death|0|||
25002084|NCT00126503|50094680|FG000|Overall Study|Adverse Event|13|||
25002085|NCT00126503|50094681|FG001|Overall Study|Adverse Event|3|||
25002086|NCT00126503|50094680|FG000|Overall Study|non-compliant|1|||
25002087|NCT00126503|50094681|FG001|Overall Study|non-compliant|0|||
25002088|NCT00126503|50094680|FG000|Overall Study|Physician Decision|2|||
25002089|NCT00126503|50094681|FG001|Overall Study|Physician Decision|1|||
25002090|NCT00126425|50094693|FG000|Overall Study|Withdrawal by Subject|17|||
25002091|NCT00126425|50094694|FG001|Overall Study|Withdrawal by Subject|1|||
25002092|NCT00126425|50094693|FG000|Overall Study|Lost to Follow-up|8|||
25002093|NCT00126425|50094694|FG001|Overall Study|Lost to Follow-up|4|||
25002094|NCT00126425|50094693|FG000|Overall Study|Protocol Violation|9|||
25002095|NCT00126425|50094694|FG001|Overall Study|Protocol Violation|6|||
25002096|NCT00126425|50094693|FG000|Overall Study|Adverse Event|1|||
25002097|NCT00126425|50094694|FG001|Overall Study|Adverse Event|0|||
25002098|NCT00126425|50094693|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
25002099|NCT00126425|50094694|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
25002100|NCT00126425|50094693|FG000|Overall Study|Other|5|||
25002101|NCT00126425|50094694|FG001|Overall Study|Other|0|||
25002102|NCT00126191|50094702|FG000|Overall Study|Physician Decision|0|||
25002103|NCT00126191|50094703|FG001|Overall Study|Physician Decision|1|||
25002104|NCT00126191|50094702|FG000|Overall Study|Death|0|||
25002105|NCT00126191|50094703|FG001|Overall Study|Death|1|||
25002106|NCT00124943|50094713|FG000|Phase II|Adverse Event|0|||
25002107|NCT00124943|50094714|FG001|Phase II|Adverse Event|2|||
25002108|NCT00124943|50094715|FG002|Phase II|Adverse Event|0|||
25002109|NCT00124943|50094716|FG003|Phase II|Adverse Event|1|||
25002110|NCT00124943|50094713|FG000|Phase II|Protocol Violation|0|||
25002111|NCT00124943|50094714|FG001|Phase II|Protocol Violation|0|||
25002112|NCT00124943|50094715|FG002|Phase II|Protocol Violation|0|||
25002113|NCT00124943|50094716|FG003|Phase II|Protocol Violation|1|||
25002114|NCT00124943|50094713|FG000|Phase II|Lost to Follow-up|0|||
25002115|NCT00124943|50094714|FG001|Phase II|Lost to Follow-up|0|||
25002116|NCT00124943|50094715|FG002|Phase II|Lost to Follow-up|0|||
25002117|NCT00124943|50094716|FG003|Phase II|Lost to Follow-up|1|||
25002118|NCT00124943|50094713|FG000|Phase II|Withdrawal by Subject|0|||
25002119|NCT00124943|50094714|FG001|Phase II|Withdrawal by Subject|0|||
25002120|NCT00124943|50094715|FG002|Phase II|Withdrawal by Subject|0|||
25002121|NCT00124943|50094716|FG003|Phase II|Withdrawal by Subject|2|||
25002122|NCT00124709|50094728|FG000|Overall Study|Randomized but did not take medication|3|||
25002123|NCT00124709|50094729|FG001|Overall Study|Randomized but did not take medication|1|||
25002124|NCT00124709|50094728|FG000|Overall Study|Adverse Event|3|||
25002125|NCT00124709|50094729|FG001|Overall Study|Adverse Event|0|||
25002126|NCT00124709|50094728|FG000|Overall Study|Lack of Efficacy|5|||
25002127|NCT00124709|50094729|FG001|Overall Study|Lack of Efficacy|10|||
25002128|NCT00124709|50094728|FG000|Overall Study|Protocol Violation|3|||
25002129|NCT00124709|50094729|FG001|Overall Study|Protocol Violation|5|||
25002130|NCT00124709|50094728|FG000|Overall Study|Withdrawal by Subject|127|||
25002131|NCT00124709|50094729|FG001|Overall Study|Withdrawal by Subject|136|||
25002132|NCT00124709|50094728|FG000|Overall Study|Lost to Follow-up|114|||
25002133|NCT00124709|50094729|FG001|Overall Study|Lost to Follow-up|120|||
25002134|NCT00108862|50094737|FG000|Overall Study|Death|31|||
25002135|NCT00108862|50094738|FG001|Overall Study|Death|37|||
25002136|NCT00108862|50094737|FG000|Overall Study|Withdrawal by Subject|10|||
25002137|NCT00108862|50094738|FG001|Overall Study|Withdrawal by Subject|6|||
25002138|NCT00108862|50094737|FG000|Overall Study|Lost to Follow-up|27|||
25002139|NCT00108862|50094738|FG001|Overall Study|Lost to Follow-up|19|||
25002140|NCT00564850|50094744|FG000|Overall Study|Protocol Violation|2|||
25002141|NCT00561340|50094750|FG000|Overall Study|refused to drink pediasure|6|||
25002142|NCT00561340|50094751|FG001|Overall Study|refused to drink pediasure|0|||
25002143|NCT00108628|50094759|FG000|Overall Study|Withdrawal by Subject|17|||
25002144|NCT00108628|50094760|FG001|Overall Study|Withdrawal by Subject|9|||
25002145|NCT00108628|50094759|FG000|Overall Study|Lack of Efficacy|2|||
25002146|NCT00108628|50094760|FG001|Overall Study|Lack of Efficacy|1|||
25002147|NCT00108628|50094759|FG000|Overall Study|Death|1|||
25002148|NCT00108628|50094760|FG001|Overall Study|Death|0|||
25002149|NCT02715856|50094768|FG000|Overall Study|Software Issues|12|||
25002150|NCT02715856|50094769|FG001|Overall Study|Software Issues|7|||
25002151|NCT02715856|50094768|FG000|Overall Study|Death|6|||
25002152|NCT02715856|50094769|FG001|Overall Study|Death|5|||
25002153|NCT02715856|50094768|FG000|Overall Study|Non- Compliant|0|||
25002154|NCT02715856|50094769|FG001|Overall Study|Non- Compliant|40|||
25002155|NCT00108160|50094777|FG000|Overall Study|Lost to Follow-up|25|||
25002156|NCT00108160|50094778|FG001|Overall Study|Lost to Follow-up|12|||
25002157|NCT00108160|50094777|FG000|Overall Study|Death|1|||
25002158|NCT00108160|50094778|FG001|Overall Study|Death|2|||
25002159|NCT00108160|50094777|FG000|Overall Study|Withdrawal by Subject|4|||
25002160|NCT00108160|50094778|FG001|Overall Study|Withdrawal by Subject|2|||
25002161|NCT00108160|50094777|FG000|Overall Study|Protocol Violation|9|||
25002162|NCT00108160|50094778|FG001|Overall Study|Protocol Violation|5|||
25002163|NCT01366846|50094790|FG000|Overall Study|Withdrawal by Subject|2|||
25002164|NCT01366846|50094791|FG001|Overall Study|Withdrawal by Subject|0|||
25002165|NCT01366846|50094792|FG002|Overall Study|Withdrawal by Subject|0|||
25002166|NCT01366846|50094793|FG003|Overall Study|Withdrawal by Subject|0|||
25002167|NCT01366846|50094790|FG000|Overall Study|Communication Difficulties|1|||
25002168|NCT01366846|50094791|FG001|Overall Study|Communication Difficulties|4|||
25002169|NCT01366846|50094792|FG002|Overall Study|Communication Difficulties|0|||
25002170|NCT01366846|50094793|FG003|Overall Study|Communication Difficulties|1|||
25002171|NCT01366846|50094790|FG000|Overall Study|Scheduling Conflicts|0|||
25002172|NCT01366846|50094791|FG001|Overall Study|Scheduling Conflicts|0|||
25002173|NCT01366846|50094792|FG002|Overall Study|Scheduling Conflicts|1|||
25002174|NCT01366846|50094793|FG003|Overall Study|Scheduling Conflicts|0|||
25002175|NCT00108082|50094809|FG000|Overall Study|Adverse Event|14|||
25002176|NCT00108082|50094810|FG001|Overall Study|Adverse Event|12|||
25002177|NCT00108082|50094811|FG002|Overall Study|Adverse Event|17|||
25002178|NCT00108082|50094809|FG000|Overall Study|Lost to Follow-up|6|||
25002179|NCT00108082|50094810|FG001|Overall Study|Lost to Follow-up|3|||
25002180|NCT00108082|50094811|FG002|Overall Study|Lost to Follow-up|7|||
25002181|NCT00108082|50094809|FG000|Overall Study|Consent Withdrawn|3|||
25002182|NCT00108082|50094810|FG001|Overall Study|Consent Withdrawn|3|||
25002183|NCT00108082|50094811|FG002|Overall Study|Consent Withdrawn|5|||
25002184|NCT00108082|50094809|FG000|Overall Study|Protocol Violation|1|||
25002185|NCT00108082|50094810|FG001|Overall Study|Protocol Violation|2|||
25002186|NCT00108082|50094811|FG002|Overall Study|Protocol Violation|0|||
25002187|NCT00108082|50094809|FG000|Overall Study|Lack of Efficacy|3|||
25002188|NCT00108082|50094810|FG001|Overall Study|Lack of Efficacy|1|||
25002189|NCT00108082|50094811|FG002|Overall Study|Lack of Efficacy|2|||
25002190|NCT00108082|50094809|FG000|Overall Study|Amendment 4: > Month 12|5|||
25002191|NCT00108082|50094810|FG001|Overall Study|Amendment 4: > Month 12|7|||
25002192|NCT00108082|50094811|FG002|Overall Study|Amendment 4: > Month 12|5|||
25002193|NCT00108082|50094809|FG000|Overall Study|Woman of Child-bearing Potential|2|||
25002194|NCT00108082|50094810|FG001|Overall Study|Woman of Child-bearing Potential|0|||
25002195|NCT00108082|50094811|FG002|Overall Study|Woman of Child-bearing Potential|2|||
25002196|NCT00108082|50094809|FG000|Overall Study|Incorrectly Randomized|0|||
25002197|NCT00108082|50094810|FG001|Overall Study|Incorrectly Randomized|0|||
25002198|NCT00108082|50094811|FG002|Overall Study|Incorrectly Randomized|2|||
25002199|NCT00108082|50094809|FG000|Overall Study|Non-compliance|1|||
25002200|NCT00108082|50094810|FG001|Overall Study|Non-compliance|0|||
25002201|NCT00108082|50094811|FG002|Overall Study|Non-compliance|2|||
25002202|NCT00108082|50094809|FG000|Overall Study|Stopped Study Medication|0|||
25002203|NCT00108082|50094810|FG001|Overall Study|Stopped Study Medication|0|||
25002204|NCT00108082|50094811|FG002|Overall Study|Stopped Study Medication|1|||
25002205|NCT00108082|50094809|FG000|Overall Study|Site Closed Study|0|||
25002206|NCT00108082|50094810|FG001|Overall Study|Site Closed Study|2|||
25002207|NCT00108082|50094811|FG002|Overall Study|Site Closed Study|0|||
25002208|NCT00108082|50094809|FG000|Overall Study|Protocol Amendment|0|||
25002209|NCT00108082|50094810|FG001|Overall Study|Protocol Amendment|1|||
25002210|NCT00108082|50094811|FG002|Overall Study|Protocol Amendment|0|||
25002211|NCT00108082|50094809|FG000|Overall Study|Study Medication Not Tapered|0|||
25002212|NCT00108082|50094810|FG001|Overall Study|Study Medication Not Tapered|1|||
25002213|NCT00108082|50094811|FG002|Overall Study|Study Medication Not Tapered|0|||
25002214|NCT00108082|50094809|FG000|Overall Study|Subject Left Site Location|1|||
25002215|NCT00108082|50094810|FG001|Overall Study|Subject Left Site Location|0|||
25002216|NCT00108082|50094811|FG002|Overall Study|Subject Left Site Location|0|||
25002217|NCT00108082|50094809|FG000|Overall Study|Investigator Not at Site|1|||
25002218|NCT00108082|50094810|FG001|Overall Study|Investigator Not at Site|0|||
25002219|NCT00108082|50094811|FG002|Overall Study|Investigator Not at Site|0|||
25002220|NCT00108082|50094809|FG000|Overall Study|Blood Pressure Not Controlled|1|||
25002221|NCT00108082|50094810|FG001|Overall Study|Blood Pressure Not Controlled|0|||
25002222|NCT00108082|50094811|FG002|Overall Study|Blood Pressure Not Controlled|0|||
25261098|NCT01311648|50575784|FG000|Extension Study|Physician Decision|0|||
25002224|NCT00104728|50094827|FG000|Overall Study|screen failures|19|||
25002225|NCT02781844|50094835|FG000|Treatment Period 1|Adverse Event|0|||
25002226|NCT02781844|50094836|FG001|Treatment Period 1|Adverse Event|0|||
25002227|NCT02781844|50094837|FG002|Treatment Period 1|Adverse Event|0|||
25002228|NCT02781844|50094838|FG003|Treatment Period 1|Adverse Event|0|||
25002229|NCT02781844|50094839|FG004|Treatment Period 1|Adverse Event|0|||
25002230|NCT02781844|50094840|FG005|Treatment Period 1|Adverse Event|1|||
25002231|NCT02781844|50094841|FG006|Treatment Period 1|Adverse Event|0|||
25002232|NCT02781844|50094842|FG007|Treatment Period 1|Adverse Event|0|||
25002233|NCT02775916|50094860|FG000|Overall Study|Adverse Event|1|||
25002234|NCT02775916|50094861|FG001|Overall Study|Adverse Event|0|||
25002235|NCT02775916|50094860|FG000|Overall Study|Subject/Guardian Decision|2|||
25002236|NCT02775916|50094861|FG001|Overall Study|Subject/Guardian Decision|0|||
25002237|NCT00122681|50094869|FG000|Overall Study|Adverse Event|20|||
25002238|NCT00122681|50094870|FG001|Overall Study|Adverse Event|16|||
25002239|NCT00122681|50094869|FG000|Overall Study|Lost to Follow-up|1080|||
25002240|NCT00122681|50094870|FG001|Overall Study|Lost to Follow-up|1097|||
25002241|NCT00122681|50094869|FG000|Overall Study|Protocol Violation|7|||
25002242|NCT00122681|50094870|FG001|Overall Study|Protocol Violation|10|||
25002243|NCT00122681|50094869|FG000|Overall Study|Withdrawal by Subject|257|||
25002244|NCT00122681|50094870|FG001|Overall Study|Withdrawal by Subject|251|||
25002245|NCT00122681|50094869|FG000|Overall Study|Personal reasons|150|||
25002246|NCT00122681|50094870|FG001|Overall Study|Personal reasons|147|||
25002247|NCT02774278|50094884|FG000|Overall Study|Lack of Efficacy|199|||
25002248|NCT02774278|50094884|FG000|Overall Study|Death|29|||
25002249|NCT02774278|50094884|FG000|Overall Study|Adverse event/intercurrent illness|16|||
25002250|NCT02774278|50094884|FG000|Overall Study|Refused treatment/did not cooperate|9|||
25002251|NCT02774278|50094884|FG000|Overall Study|Administrative reasons|6|||
25002252|NCT02774278|50094884|FG000|Overall Study|Withdrawal by Subject|3|||
25002253|NCT02774278|50094884|FG000|Overall Study|Protocol Violation|2|||
25002254|NCT03621189|50094890|FG000|Overall Study|Withdrawal by Subject|0|||
25002255|NCT03621189|50094891|FG001|Overall Study|Withdrawal by Subject|3|||
25002256|NCT03621189|50094890|FG000|Overall Study|Physician Decision|0|||
25002257|NCT03621189|50094891|FG001|Overall Study|Physician Decision|2|||
25002258|NCT00122135|50094900|FG000|Overall Study|Withdrawal by Subject|3|||
25002259|NCT00122135|50094901|FG001|Overall Study|Withdrawal by Subject|0|||
25002260|NCT03645057|50094911|FG000|Randomization to Baseline|Lost to Follow-up|1|||
25002261|NCT03645057|50094912|FG001|Randomization to Baseline|Lost to Follow-up|0|||
25002262|NCT03645057|50094913|FG002|Randomization to Baseline|Lost to Follow-up|1|||
25002263|NCT03645057|50094914|FG003|Randomization to Baseline|Lost to Follow-up|0|||
25002264|NCT03645057|50094911|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
25002265|NCT03645057|50094912|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
25002266|NCT03645057|50094913|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
25002267|NCT03645057|50094914|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
25002268|NCT03645057|50094911|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
25002269|NCT03645057|50094912|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
25002270|NCT03645057|50094913|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
25002271|NCT03645057|50094914|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
25002272|NCT03645057|50094911|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
25002273|NCT03645057|50094912|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
25002274|NCT03645057|50094913|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
25002275|NCT03645057|50094914|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
25002276|NCT00132041|50094920|FG000|Baseline|Ineligible|6|||
25002277|NCT00132041|50094920|FG000|3 Months Post Ablation|Transplant|1|||
25002278|NCT00132041|50094920|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
25002279|NCT00132041|50094920|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
25002280|NCT00132041|50094920|FG000|6 Months Post Ablation|Death|2|||
25002281|NCT00132041|50094920|FG000|6 Months Post Ablation|Transplant|6|||
25002282|NCT00132041|50094920|FG000|9 Months Post Ablation|Death|1|||
25002283|NCT00132041|50094920|FG000|9 Months Post Ablation|Transplant|1|||
25002284|NCT00132041|50094920|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
25002285|NCT00132041|50094920|FG000|12 Months Post Ablation|Death|1|||
25002286|NCT00132041|50094920|FG000|12 Months Post Ablation|Transplant|1|||
25002287|NCT00132041|50094920|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
25002288|NCT00132041|50094920|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
25002289|NCT00132041|50094920|FG000|15 Months Post Ablation|Death|1|||
25002290|NCT00132041|50094920|FG000|15 Months Post Ablation|Transplant|5|||
25002291|NCT00132041|50094920|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
25002292|NCT00132041|50094920|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
25002293|NCT00132041|50094920|FG000|18 Months Post Ablation|Transplant|1|||
25002294|NCT00132041|50094920|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
25002295|NCT00132041|50094920|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
25002296|NCT03643575|50094930|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
25002297|NCT03643575|50094931|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
25002298|NCT03643575|50094932|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
25002299|NCT03643575|50094933|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
25002300|NCT03643575|50094934|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
25002301|NCT03643575|50094935|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
25002302|NCT03643575|50094930|FG000|Washout: 7 Days|Adverse Event|1|||
25002303|NCT03643575|50094931|FG001|Washout: 7 Days|Adverse Event|0|||
25002304|NCT03643575|50094932|FG002|Washout: 7 Days|Adverse Event|0|||
25002305|NCT03643575|50094933|FG003|Washout: 7 Days|Adverse Event|0|||
25002306|NCT03643575|50094934|FG004|Washout: 7 Days|Adverse Event|0|||
25002307|NCT03643575|50094935|FG005|Washout: 7 Days|Adverse Event|0|||
25002308|NCT03643575|50094930|FG000|Washout: 7 Days|Non compliance check in|0|||
25002309|NCT03643575|50094931|FG001|Washout: 7 Days|Non compliance check in|1|||
25067265|NCT02576847|50172844|FG000|Overall Study|Lost to Follow-up|22|||
25002310|NCT03643575|50094932|FG002|Washout: 7 Days|Non compliance check in|0|||
25002311|NCT03643575|50094933|FG003|Washout: 7 Days|Non compliance check in|0|||
25002312|NCT03643575|50094934|FG004|Washout: 7 Days|Non compliance check in|0|||
25002313|NCT03643575|50094935|FG005|Washout: 7 Days|Non compliance check in|0|||
25002314|NCT02768194|50094943|FG000|Period 1|Adverse Event|0|||
25002315|NCT02768194|50094944|FG001|Period 1|Adverse Event|0|||
25002316|NCT02768194|50094945|FG002|Period 1|Adverse Event|0|||
25002317|NCT02768194|50094946|FG003|Period 1|Adverse Event|1|||
25002318|NCT02768194|50094947|FG004|Period 1|Adverse Event|0|||
25002319|NCT02768194|50094948|FG005|Period 1|Adverse Event|0|||
25002320|NCT02768194|50094943|FG000|Period 2|Other (Reason not specified)|1|||
25002321|NCT02768194|50094944|FG001|Period 2|Other (Reason not specified)|0|||
25002322|NCT02768194|50094945|FG002|Period 2|Other (Reason not specified)|0|||
25002323|NCT02768194|50094946|FG003|Period 2|Other (Reason not specified)|0|||
25002324|NCT02768194|50094947|FG004|Period 2|Other (Reason not specified)|0|||
25002325|NCT02768194|50094948|FG005|Period 2|Other (Reason not specified)|0|||
25002326|NCT02768194|50094943|FG000|Period 3|Other (Reason not specified)|0|||
25002327|NCT02768194|50094944|FG001|Period 3|Other (Reason not specified)|1|||
25002328|NCT02768194|50094945|FG002|Period 3|Other (Reason not specified)|0|||
25002329|NCT02768194|50094946|FG003|Period 3|Other (Reason not specified)|0|||
25002330|NCT02768194|50094947|FG004|Period 3|Other (Reason not specified)|0|||
25002331|NCT02768194|50094948|FG005|Period 3|Other (Reason not specified)|0|||
25002332|NCT00130793|50094958|FG000|Overall Study|Lost to Follow-up|1|||
25002333|NCT00130793|50094959|FG001|Overall Study|Lost to Follow-up|4|||
25002334|NCT00130793|50094958|FG000|Overall Study|Withdrew consent|2|||
25002335|NCT00130793|50094959|FG001|Overall Study|Withdrew consent|0|||
25002336|NCT03818399|50094966|FG000|Overall Study|Lost to Follow-up|11|||
25002337|NCT03818399|50094966|FG000|Overall Study|Withdrawal by Subject|1|||
25002338|NCT03818399|50094966|FG000|Overall Study|Protocol Violation|2|||
25002339|NCT03642873|50094970|FG000|Third Intervention (1 Day)|Screen failure|0|||
25002340|NCT03642873|50094971|FG001|Third Intervention (1 Day)|Screen failure|0|||
25002341|NCT03642873|50094972|FG002|Third Intervention (1 Day)|Screen failure|0|||
25002342|NCT03642873|50094973|FG003|Third Intervention (1 Day)|Screen failure|0|||
25002343|NCT03642873|50094974|FG004|Third Intervention (1 Day)|Screen failure|1|||
25002344|NCT03642873|50094975|FG005|Third Intervention (1 Day)|Screen failure|0|||
25002345|NCT03818321|50094989|FG000|Overall Study|Withdrawal by Subject|1|||
25002346|NCT03818321|50094990|FG001|Overall Study|Withdrawal by Subject|2|||
25002347|NCT03616977|50094996|FG000|Period 1|Physician Decision|0|||
25002348|NCT03616977|50094997|FG001|Period 1|Physician Decision|1|||
25002349|NCT03616977|50094996|FG000|Period 3|Adverse Event|1|||
25002350|NCT03616977|50094997|FG001|Period 3|Adverse Event|1|||
25002351|NCT02767570|50095006|FG000|Overall Study|Lost to Follow-up|3|||
25002352|NCT02767570|50095007|FG001|Overall Study|Lost to Follow-up|0|||
25002353|NCT02767570|50095006|FG000|Overall Study|COVID shutdown|2|||
25002354|NCT02767570|50095007|FG001|Overall Study|COVID shutdown|5|||
25002355|NCT02767570|50095006|FG000|Overall Study|Increased pain|2|||
25002356|NCT02767570|50095007|FG001|Overall Study|Increased pain|0|||
25002357|NCT02767570|50095006|FG000|Overall Study|Withdrawal by Subject|1|||
25002358|NCT02767570|50095007|FG001|Overall Study|Withdrawal by Subject|3|||
25002359|NCT02767570|50095006|FG000|Overall Study|Unrelated medical issue|1|||
25002360|NCT02767570|50095007|FG001|Overall Study|Unrelated medical issue|1|||
25002361|NCT02767570|50095006|FG000|Overall Study|Received intra-articular injection|0|||
25002362|NCT02767570|50095007|FG001|Overall Study|Received intra-articular injection|1|||
25002363|NCT03816761|50095016|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
25002364|NCT03816761|50095017|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
25176568|NCT03478956|50320177|FG001|Overall Study|Ongoing in the Study|11|||
25176569|NCT01519661|50320183|FG000|Overall Study|Protocol deviation|6|||
25176570|NCT01519661|50320183|FG000|Overall Study|Lost to Follow-up|3|||
25176571|NCT01519661|50320183|FG000|Overall Study|Withdrawal by Subject|17|||
25176572|NCT01519661|50320183|FG000|Overall Study|Lack of Efficacy|6|||
25176573|NCT01519661|50320183|FG000|Overall Study|Adverse Event|29|||
25176574|NCT01519427|50320188|FG000|Overall Study|disease progression|2|||
25176575|NCT01518257|50320194|FG000|Overall Study|Lost to Follow-up|1|||
25002365|NCT03816761|50095018|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
25002366|NCT03816761|50095019|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
25002367|NCT03816761|50095020|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
25002368|NCT03816761|50095021|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
25002369|NCT03816761|50095016|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
25002370|NCT03816761|50095017|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
25002371|NCT03816761|50095018|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
25002372|NCT03816761|50095019|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
25002373|NCT03816761|50095020|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
25002374|NCT03816761|50095021|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
25002375|NCT02770612|50095043|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
25176576|NCT01518257|50320195|FG001|Overall Study|Lost to Follow-up|0|||
25176577|NCT01518257|50320194|FG000|Overall Study|Other Miscellaneous Reason|1|||
25176578|NCT01518257|50320195|FG001|Overall Study|Other Miscellaneous Reason|0|||
25176579|NCT02668302|50320203|FG000|Overall Study|Withdrawal by Subject|1|||
25176580|NCT02668302|50320204|FG001|Overall Study|Withdrawal by Subject|0|||
25002376|NCT03575871|50095050|FG000|Overall Study|Adverse Event|5|||
25002377|NCT03575871|50095051|FG001|Overall Study|Adverse Event|5|||
25002378|NCT03575871|50095052|FG002|Overall Study|Adverse Event|8|||
25002379|NCT03575871|50095050|FG000|Overall Study|Death|1|||
25002380|NCT03575871|50095051|FG001|Overall Study|Death|0|||
25002381|NCT03575871|50095052|FG002|Overall Study|Death|0|||
25002382|NCT03575871|50095050|FG000|Overall Study|Lack of Efficacy|5|||
25002383|NCT03575871|50095051|FG001|Overall Study|Lack of Efficacy|4|||
25002384|NCT03575871|50095052|FG002|Overall Study|Lack of Efficacy|7|||
25002385|NCT03575871|50095050|FG000|Overall Study|Lost to Follow-up|1|||
25002386|NCT03575871|50095051|FG001|Overall Study|Lost to Follow-up|1|||
25002387|NCT03575871|50095052|FG002|Overall Study|Lost to Follow-up|1|||
25002388|NCT03575871|50095050|FG000|Overall Study|Protocol Deviation|1|||
25002389|NCT03575871|50095051|FG001|Overall Study|Protocol Deviation|1|||
25002390|NCT03575871|50095052|FG002|Overall Study|Protocol Deviation|1|||
25002391|NCT03575871|50095050|FG000|Overall Study|Withdrawal by Subject|6|||
25002392|NCT03575871|50095051|FG001|Overall Study|Withdrawal by Subject|1|||
25002393|NCT03575871|50095052|FG002|Overall Study|Withdrawal by Subject|9|||
25002394|NCT03575871|50095050|FG000|Overall Study|Other than specified|2|||
25002395|NCT03575871|50095051|FG001|Overall Study|Other than specified|2|||
25002396|NCT03575871|50095052|FG002|Overall Study|Other than specified|0|||
25002397|NCT03642717|50095060|FG000|Overall Study|Lost to Follow-up|2|||
25002398|NCT03642717|50095060|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
25002399|NCT03642717|50095060|FG000|Overall Study|Taken study drug prior to contract date|3|||
25002400|NCT02766478|50095067|FG000|Overall Study|Withdrawal by Subject|1|||
25002401|NCT02766478|50095068|FG001|Overall Study|Withdrawal by Subject|1|||
25002402|NCT02766400|50095076|FG000|Overall Study|Death|1|||
25002403|NCT02766400|50095077|FG001|Overall Study|Death|2|||
25002404|NCT02766400|50095076|FG000|Overall Study|Withdrawal by Subject|1|||
25002405|NCT02766400|50095077|FG001|Overall Study|Withdrawal by Subject|0|||
25002406|NCT00104650|50095086|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
25002407|NCT00104650|50095087|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
25002408|NCT00104650|50095088|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
25002409|NCT00104650|50095086|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
25002410|NCT00104650|50095087|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
25002411|NCT00104650|50095088|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
25002412|NCT00104650|50095086|FG000|Treatment Period (25 Weeks)|Death|7|||
25002413|NCT00104650|50095087|FG001|Treatment Period (25 Weeks)|Death|5|||
25002414|NCT00104650|50095088|FG002|Treatment Period (25 Weeks)|Death|6|||
25002415|NCT00104650|50095086|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
25002416|NCT00104650|50095087|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
25002417|NCT00104650|50095088|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
25002418|NCT00104650|50095086|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
25002419|NCT00104650|50095087|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
25002420|NCT00104650|50095088|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
25002421|NCT00104650|50095086|FG000|Treatment Period (25 Weeks)|Other|1|||
25002422|NCT00104650|50095087|FG001|Treatment Period (25 Weeks)|Other|0|||
25002423|NCT00104650|50095088|FG002|Treatment Period (25 Weeks)|Other|0|||
25002424|NCT00104650|50095086|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
25002425|NCT00104650|50095087|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
25002426|NCT00104650|50095088|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
25002427|NCT00104650|50095086|FG000|Follow-up Period|Physician Decision|1|||
25002428|NCT00104650|50095087|FG001|Follow-up Period|Physician Decision|1|||
25002429|NCT00104650|50095088|FG002|Follow-up Period|Physician Decision|0|||
25002430|NCT00104650|50095086|FG000|Follow-up Period|Adverse Event|1|||
25002431|NCT00104650|50095087|FG001|Follow-up Period|Adverse Event|0|||
25002432|NCT00104650|50095088|FG002|Follow-up Period|Adverse Event|1|||
25002433|NCT00104650|50095086|FG000|Follow-up Period|Withdrawal by Subject|0|||
25002434|NCT00104650|50095087|FG001|Follow-up Period|Withdrawal by Subject|3|||
25002435|NCT00104650|50095088|FG002|Follow-up Period|Withdrawal by Subject|3|||
25002436|NCT00104650|50095086|FG000|Follow-up Period|Death|6|||
25002437|NCT00104650|50095087|FG001|Follow-up Period|Death|6|||
25002438|NCT00104650|50095088|FG002|Follow-up Period|Death|4|||
25002439|NCT00104650|50095086|FG000|Follow-up Period|Disease progression|3|||
25002440|NCT00104650|50095087|FG001|Follow-up Period|Disease progression|1|||
25002441|NCT00104650|50095088|FG002|Follow-up Period|Disease progression|0|||
25002442|NCT00104650|50095086|FG000|Follow-up Period|Lost to Follow-up|0|||
25002443|NCT00104650|50095087|FG001|Follow-up Period|Lost to Follow-up|1|||
25002444|NCT00104650|50095088|FG002|Follow-up Period|Lost to Follow-up|2|||
25002445|NCT00104650|50095086|FG000|Follow-up Period|Other|0|||
25002446|NCT00104650|50095087|FG001|Follow-up Period|Other|1|||
25176581|NCT01517867|50320212|FG000|Overall Study|never started treatment|29|||
25176582|NCT01517867|50320213|FG001|Overall Study|never started treatment|32|||
25002447|NCT00104650|50095088|FG002|Follow-up Period|Other|0|||
25002448|NCT03732807|50095103|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
25002449|NCT03732807|50095104|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
25002450|NCT03732807|50095105|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
25002451|NCT03732807|50095106|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
25002452|NCT03732807|50095107|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
25002453|NCT03732807|50095108|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
25002454|NCT03732807|50095109|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
25002455|NCT03732807|50095103|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
25002456|NCT03732807|50095104|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
25002457|NCT03732807|50095105|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
25002458|NCT03732807|50095106|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
25002459|NCT03732807|50095107|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
25002460|NCT03732807|50095108|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
25002461|NCT03732807|50095109|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
25002462|NCT03732807|50095103|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
25002463|NCT03732807|50095104|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
25002464|NCT03732807|50095105|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
25002465|NCT03732807|50095106|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
25002466|NCT03732807|50095107|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
25002467|NCT03732807|50095108|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
25002468|NCT03732807|50095109|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
25002469|NCT03732807|50095103|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
25002470|NCT03732807|50095104|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
25002471|NCT03732807|50095105|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
25002472|NCT03732807|50095106|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
25002473|NCT03732807|50095107|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
25002474|NCT03732807|50095108|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
25002475|NCT03732807|50095109|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
25002476|NCT03732807|50095103|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
25002477|NCT03732807|50095104|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
25002478|NCT03732807|50095105|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
25002479|NCT03732807|50095106|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
25002480|NCT03732807|50095107|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
25002481|NCT03732807|50095108|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
25002482|NCT03732807|50095109|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
25002483|NCT03732807|50095103|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
25002484|NCT03732807|50095104|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
25002485|NCT03732807|50095105|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
25002486|NCT03732807|50095106|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
25002487|NCT03732807|50095107|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
25002488|NCT03732807|50095108|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
25002489|NCT03732807|50095109|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
25002490|NCT03732807|50095103|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
25002491|NCT03732807|50095104|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
25002492|NCT03732807|50095105|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
25002493|NCT03732807|50095106|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
25002494|NCT03732807|50095107|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
25002495|NCT03732807|50095108|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
25002496|NCT03732807|50095109|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
25002497|NCT03732807|50095103|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
25002498|NCT03732807|50095104|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
25002499|NCT03732807|50095105|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
25002500|NCT03732807|50095106|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
25002501|NCT03732807|50095107|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
25002502|NCT03732807|50095108|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
25002503|NCT03732807|50095109|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
25002504|NCT03732807|50095103|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
25002505|NCT03732807|50095104|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
25002506|NCT03732807|50095105|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
25002507|NCT03732807|50095106|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
25002508|NCT03732807|50095107|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
25002509|NCT03732807|50095108|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
25002510|NCT03732807|50095109|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
25002511|NCT03732807|50095103|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
25002512|NCT03732807|50095104|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
25002513|NCT03732807|50095105|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
25002514|NCT03732807|50095106|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
25002515|NCT03732807|50095107|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
25002516|NCT03732807|50095108|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
25002517|NCT03732807|50095109|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
25002518|NCT03732807|50095103|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
25002519|NCT03732807|50095104|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
25002520|NCT03732807|50095105|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
25002521|NCT03732807|50095106|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
25002522|NCT03732807|50095107|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
25002523|NCT03732807|50095108|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
25002524|NCT03732807|50095109|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
25002525|NCT03732807|50095103|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
25002526|NCT03732807|50095104|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
25002527|NCT03732807|50095105|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
25002528|NCT03732807|50095106|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
25002529|NCT03732807|50095107|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
25002530|NCT03732807|50095108|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
25002531|NCT03732807|50095109|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
25002532|NCT03732807|50095103|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
25002533|NCT03732807|50095104|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
25002534|NCT03732807|50095105|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
25002535|NCT03732807|50095106|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
25002536|NCT03732807|50095107|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
25002537|NCT03732807|50095108|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
25002538|NCT03732807|50095109|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
25002539|NCT03732807|50095103|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
25002540|NCT03732807|50095104|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
25002541|NCT03732807|50095105|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
25002542|NCT03732807|50095106|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
25002543|NCT03732807|50095107|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
25002544|NCT03732807|50095108|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
25002545|NCT03732807|50095109|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
25002546|NCT00104416|50095128|FG000|Double-Blind Phase|Adverse Event|2|||
25002547|NCT00104416|50095129|FG001|Double-Blind Phase|Adverse Event|1|||
25002548|NCT00104416|50095130|FG002|Double-Blind Phase|Adverse Event|0|||
25002549|NCT00104416|50095131|FG003|Double-Blind Phase|Adverse Event|0|||
25002550|NCT00104416|50095132|FG004|Double-Blind Phase|Adverse Event|0|||
25002551|NCT00104416|50095128|FG000|Double-Blind Phase|Lost to Follow-up|0|||
25002552|NCT00104416|50095129|FG001|Double-Blind Phase|Lost to Follow-up|1|||
25002553|NCT00104416|50095130|FG002|Double-Blind Phase|Lost to Follow-up|0|||
25002554|NCT00104416|50095131|FG003|Double-Blind Phase|Lost to Follow-up|0|||
25002555|NCT00104416|50095132|FG004|Double-Blind Phase|Lost to Follow-up|0|||
25002556|NCT00104416|50095128|FG000|Double-Blind Phase|Protocol Violation|0|||
25002557|NCT00104416|50095129|FG001|Double-Blind Phase|Protocol Violation|1|||
25002558|NCT00104416|50095130|FG002|Double-Blind Phase|Protocol Violation|0|||
25002559|NCT00104416|50095131|FG003|Double-Blind Phase|Protocol Violation|0|||
25002560|NCT00104416|50095132|FG004|Double-Blind Phase|Protocol Violation|0|||
25002561|NCT00104416|50095128|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
25002562|NCT00104416|50095129|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
25002563|NCT00104416|50095130|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
25002564|NCT00104416|50095131|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
25002565|NCT00104416|50095132|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
25002566|NCT00104416|50095128|FG000|Double-Blind Phase|Pregnancy|1|||
25002567|NCT00104416|50095129|FG001|Double-Blind Phase|Pregnancy|0|||
25002568|NCT00104416|50095130|FG002|Double-Blind Phase|Pregnancy|0|||
25002569|NCT00104416|50095131|FG003|Double-Blind Phase|Pregnancy|0|||
25002570|NCT00104416|50095132|FG004|Double-Blind Phase|Pregnancy|0|||
25002571|NCT00104416|50095128|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
25002572|NCT00104416|50095129|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
25002573|NCT00104416|50095130|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
25002574|NCT00104416|50095131|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
25002575|NCT00104416|50095132|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
25002576|NCT00104416|50095128|FG000|Continuation Phase|Adverse Event|0|||
25002577|NCT00104416|50095129|FG001|Continuation Phase|Adverse Event|0|||
25002578|NCT00104416|50095130|FG002|Continuation Phase|Adverse Event|2|||
25002579|NCT00104416|50095131|FG003|Continuation Phase|Adverse Event|0|||
25002580|NCT00104416|50095132|FG004|Continuation Phase|Adverse Event|2|||
25002581|NCT00104416|50095128|FG000|Continuation Phase|Lost to Follow-up|0|||
25002582|NCT00104416|50095129|FG001|Continuation Phase|Lost to Follow-up|0|||
25091351|NCT02676895|50200960|FG001|Overall Study|Administrative reason|0|||
25091352|NCT02676895|50200961|FG002|Overall Study|Administrative reason|0|||
25002583|NCT00104416|50095130|FG002|Continuation Phase|Lost to Follow-up|1|||
25002584|NCT00104416|50095131|FG003|Continuation Phase|Lost to Follow-up|0|||
25002585|NCT00104416|50095132|FG004|Continuation Phase|Lost to Follow-up|1|||
25002586|NCT00104416|50095128|FG000|Continuation Phase|Withdrawal by Subject|0|||
25002587|NCT00104416|50095129|FG001|Continuation Phase|Withdrawal by Subject|0|||
25002588|NCT00104416|50095130|FG002|Continuation Phase|Withdrawal by Subject|2|||
25002589|NCT00104416|50095131|FG003|Continuation Phase|Withdrawal by Subject|1|||
25002590|NCT00104416|50095132|FG004|Continuation Phase|Withdrawal by Subject|1|||
25002591|NCT00104416|50095128|FG000|Continuation Phase|Pregnancy|0|||
25002592|NCT00104416|50095129|FG001|Continuation Phase|Pregnancy|0|||
25002593|NCT00104416|50095130|FG002|Continuation Phase|Pregnancy|1|||
25002594|NCT00104416|50095131|FG003|Continuation Phase|Pregnancy|1|||
25002595|NCT00104416|50095132|FG004|Continuation Phase|Pregnancy|0|||
25002596|NCT00104416|50095128|FG000|Continuation Phase|Non-compliance|0|||
25002597|NCT00104416|50095129|FG001|Continuation Phase|Non-compliance|0|||
25002598|NCT00104416|50095130|FG002|Continuation Phase|Non-compliance|0|||
25002599|NCT00104416|50095131|FG003|Continuation Phase|Non-compliance|0|||
25002600|NCT00104416|50095132|FG004|Continuation Phase|Non-compliance|1|||
25002601|NCT03639987|50095146|FG000|Overall Study|Study terminated by sponsor|26|||
25002602|NCT03639987|50095147|FG001|Overall Study|Study terminated by sponsor|25|||
25002603|NCT03639987|50095146|FG000|Overall Study|Lost to Follow-up|0|||
25002604|NCT03639987|50095147|FG001|Overall Study|Lost to Follow-up|1|||
25002605|NCT02766088|50095153|FG000|Overall Study|Sponsor study termination|498|||
25002606|NCT02766088|50095153|FG000|Overall Study|Migrated/moved from the study area|1|||
25002607|NCT02766088|50095153|FG000|Overall Study|Lost to Follow-up|5|||
25002608|NCT02766088|50095153|FG000|Overall Study|Other|1|||
25002609|NCT02766088|50095153|FG000|Overall Study|Death|1|||
25002610|NCT03639675|50095157|FG000|Overall Study|Withdrawal by Subject|1|||
25002611|NCT03635775|50095165|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
25002612|NCT03635775|50095166|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
25002613|NCT03635775|50095167|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
25002614|NCT03635775|50095168|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
25002615|NCT03610581|50095180|FG000|Overall Study|Study terminated by sponsor|2|||
25002616|NCT03610581|50095181|FG001|Overall Study|Study terminated by sponsor|0|||
25002617|NCT03610581|50095180|FG000|Overall Study|Other|0|||
25002618|NCT03610581|50095181|FG001|Overall Study|Other|1|||
25002619|NCT03610581|50095180|FG000|Overall Study|Withdrawal by Subject|1|||
25002620|NCT03610581|50095181|FG001|Overall Study|Withdrawal by Subject|0|||
25002621|NCT03610269|50095187|FG000|Overall Study|Physician Decision|10|||
25002622|NCT03610269|50095187|FG000|Overall Study|Protocol Violation|1|||
25002623|NCT03610269|50095187|FG000|Overall Study|Unable to draw blood|1|||
25002624|NCT03610269|50095187|FG000|Overall Study|Screen fail|4|||
25002625|NCT00121667|50095195|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
25002626|NCT00121667|50095196|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
25002627|NCT00121667|50095197|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
25002628|NCT00121667|50095198|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
25002629|NCT00121667|50095195|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
25002630|NCT00121667|50095196|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
25002631|NCT00121667|50095197|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
25002632|NCT00121667|50095198|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
25002633|NCT00121667|50095195|FG000|Short Term (ST) Period|Adverse Event|5|||
25002634|NCT00121667|50095196|FG001|Short Term (ST) Period|Adverse Event|6|||
25002635|NCT00121667|50095197|FG002|Short Term (ST) Period|Adverse Event|5|||
25002636|NCT00121667|50095198|FG003|Short Term (ST) Period|Adverse Event|3|||
25002637|NCT00121667|50095195|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
25002638|NCT00121667|50095196|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
25002639|NCT00121667|50095197|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
25002640|NCT00121667|50095198|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
25002641|NCT00121667|50095195|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
25002642|NCT00121667|50095196|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
25002643|NCT00121667|50095197|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
25002644|NCT00121667|50095198|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
25002645|NCT00121667|50095195|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
25002646|NCT00121667|50095196|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
25002647|NCT00121667|50095197|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
25002648|NCT00121667|50095198|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
25002649|NCT00121667|50095195|FG000|Short Term (ST) Period|Other Reason|3|||
25002650|NCT00121667|50095196|FG001|Short Term (ST) Period|Other Reason|0|||
25002651|NCT00121667|50095197|FG002|Short Term (ST) Period|Other Reason|0|||
25002652|NCT00121667|50095198|FG003|Short Term (ST) Period|Other Reason|0|||
25002653|NCT00121667|50095195|FG000|Short Term (ST) Period|Death|0|||
25002654|NCT00121667|50095196|FG001|Short Term (ST) Period|Death|0|||
25002655|NCT00121667|50095197|FG002|Short Term (ST) Period|Death|0|||
25002656|NCT00121667|50095198|FG003|Short Term (ST) Period|Death|1|||
25002657|NCT00121667|50095195|FG000|Short Term (ST) Period|Pregnancy|0|||
25002658|NCT00121667|50095196|FG001|Short Term (ST) Period|Pregnancy|0|||
25002659|NCT00121667|50095197|FG002|Short Term (ST) Period|Pregnancy|0|||
25002660|NCT00121667|50095198|FG003|Short Term (ST) Period|Pregnancy|1|||
25002661|NCT00121667|50095195|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
25002662|NCT00121667|50095196|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
25002663|NCT00121667|50095197|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
25002664|NCT00121667|50095198|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
25002665|NCT00121667|50095195|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
25002666|NCT00121667|50095196|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
25002667|NCT00121667|50095197|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
25002668|NCT00121667|50095198|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
25002669|NCT00121667|50095195|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
25002670|NCT00121667|50095196|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
25002671|NCT00121667|50095197|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
25002672|NCT00121667|50095198|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
25002673|NCT00121667|50095195|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
25002674|NCT00121667|50095196|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
25002675|NCT00121667|50095197|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
25002676|NCT00121667|50095198|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
25002677|NCT00121667|50095195|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
25002678|NCT00121667|50095196|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
25002679|NCT00121667|50095197|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
25002680|NCT00121667|50095198|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
25002681|NCT00121667|50095195|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
25002682|NCT00121667|50095196|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
25002683|NCT00121667|50095197|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
25002684|NCT00121667|50095198|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
25002685|NCT00121667|50095195|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
25002686|NCT00121667|50095196|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
25002687|NCT00121667|50095197|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
25002688|NCT00121667|50095198|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
25002689|NCT00121667|50095195|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
25002690|NCT00121667|50095196|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
25002691|NCT00121667|50095197|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
25002692|NCT00121667|50095198|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
25002693|NCT00121667|50095195|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
25002694|NCT00121667|50095196|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
25002695|NCT00121667|50095197|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
25002696|NCT00121667|50095198|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
25002697|NCT02954601|50095212|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
25002698|NCT02954601|50095213|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
25002699|NCT02954601|50095214|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
25002700|NCT02954601|50095215|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
25002701|NCT03633903|50095227|FG000|Overall Study|Withdrawal by Subject|1|||
25002702|NCT03633903|50095228|FG001|Overall Study|Withdrawal by Subject|2|||
25002703|NCT03633903|50095227|FG000|Overall Study|Lost to Follow-up|5|||
25002704|NCT03633903|50095228|FG001|Overall Study|Lost to Follow-up|5|||
25002705|NCT03607695|50095234|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
25002706|NCT03607695|50095234|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
25002707|NCT03557775|50095241|FG000|Overall Study|Withdrawal by Subject|1|||
25002708|NCT03557775|50095242|FG001|Overall Study|Withdrawal by Subject|2|||
25002709|NCT03557775|50095243|FG002|Overall Study|Withdrawal by Subject|4|||
25002710|NCT03557775|50095241|FG000|Overall Study|Physician Decision|0|||
25002711|NCT03557775|50095242|FG001|Overall Study|Physician Decision|1|||
25002712|NCT03557775|50095243|FG002|Overall Study|Physician Decision|0|||
25002713|NCT00121199|50095251|FG000|Overall Study|Adverse Event|11|||
25002714|NCT00121199|50095251|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
25002715|NCT00121199|50095251|FG000|Overall Study|Progression/Relapse|1|||
25002716|NCT00121199|50095251|FG000|Overall Study|Death|3|||
25002717|NCT00121199|50095251|FG000|Overall Study|Other - Not Protocol Specified|3|||
25002718|NCT00121199|50095251|FG000|Overall Study|Ineligible|9|||
25002719|NCT00119405|50095255|FG000|Overall Study|Withdrawal by Subject|1|||
25002720|NCT00119015|50095261|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
25002721|NCT00119015|50095262|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
25176583|NCT01517867|50320212|FG000|Overall Study|Withdrawal by Subject|34|||
25176584|NCT01517867|50320213|FG001|Overall Study|Withdrawal by Subject|30|||
25176585|NCT01517867|50320212|FG000|Overall Study|Still in treatment at study end|0|||
25002722|NCT00119015|50095263|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
25002723|NCT01981850|50095276|FG000|Main Phase Stage 1|Death|2|||
25002724|NCT01981850|50095277|FG001|Main Phase Stage 1|Death|0|||
25002725|NCT01981850|50095278|FG002|Main Phase Stage 1|Death|0|||
25002726|NCT01981850|50095279|FG003|Main Phase Stage 1|Death|0|||
25002727|NCT01981850|50095280|FG004|Main Phase Stage 1|Death|0|||
25002728|NCT01981850|50095281|FG005|Main Phase Stage 1|Death|0|||
25002729|NCT01981850|50095282|FG006|Main Phase Stage 1|Death|0|||
25002730|NCT01981850|50095283|FG007|Main Phase Stage 1|Death|0|||
25002731|NCT01981850|50095284|FG008|Main Phase Stage 1|Death|0|||
25002732|NCT01981850|50095285|FG009|Main Phase Stage 1|Death|0|||
25002733|NCT01981850|50095276|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
25002734|NCT01981850|50095277|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
25002735|NCT01981850|50095278|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
25002736|NCT01981850|50095279|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
25002737|NCT01981850|50095280|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
25002738|NCT01981850|50095281|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
25002739|NCT01981850|50095282|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
25002740|NCT01981850|50095283|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
25002741|NCT01981850|50095284|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
25002742|NCT01981850|50095285|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
25002743|NCT01981850|50095276|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
25002744|NCT01981850|50095277|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
25002745|NCT01981850|50095278|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
25002746|NCT01981850|50095279|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
25002747|NCT01981850|50095280|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
25002748|NCT01981850|50095281|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
25002749|NCT01981850|50095282|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
25002750|NCT01981850|50095283|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
25002751|NCT01981850|50095284|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
25002752|NCT01981850|50095285|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
25002753|NCT01981850|50095276|FG000|Main Phase Stage 1|Various reasons|0|||
25002754|NCT01981850|50095277|FG001|Main Phase Stage 1|Various reasons|0|||
25002755|NCT01981850|50095278|FG002|Main Phase Stage 1|Various reasons|2|||
25002756|NCT01981850|50095279|FG003|Main Phase Stage 1|Various reasons|0|||
25002757|NCT01981850|50095280|FG004|Main Phase Stage 1|Various reasons|0|||
25002758|NCT01981850|50095281|FG005|Main Phase Stage 1|Various reasons|0|||
25002759|NCT01981850|50095282|FG006|Main Phase Stage 1|Various reasons|0|||
25002760|NCT01981850|50095283|FG007|Main Phase Stage 1|Various reasons|0|||
25002761|NCT01981850|50095284|FG008|Main Phase Stage 1|Various reasons|0|||
25002762|NCT01981850|50095285|FG009|Main Phase Stage 1|Various reasons|0|||
25002763|NCT01981850|50095276|FG000|Main Phase Stage 2|Adverse Event|0|||
25002764|NCT01981850|50095277|FG001|Main Phase Stage 2|Adverse Event|0|||
25002765|NCT01981850|50095278|FG002|Main Phase Stage 2|Adverse Event|0|||
25002766|NCT01981850|50095279|FG003|Main Phase Stage 2|Adverse Event|0|||
25002767|NCT01981850|50095280|FG004|Main Phase Stage 2|Adverse Event|6|||
25002768|NCT01981850|50095281|FG005|Main Phase Stage 2|Adverse Event|5|||
25002769|NCT01981850|50095282|FG006|Main Phase Stage 2|Adverse Event|7|||
25002770|NCT01981850|50095283|FG007|Main Phase Stage 2|Adverse Event|0|||
25002771|NCT01981850|50095284|FG008|Main Phase Stage 2|Adverse Event|0|||
25002772|NCT01981850|50095285|FG009|Main Phase Stage 2|Adverse Event|0|||
25002773|NCT01981850|50095276|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
25002774|NCT01981850|50095277|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
25002775|NCT01981850|50095278|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
25002776|NCT01981850|50095279|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
25002777|NCT01981850|50095280|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
25002778|NCT01981850|50095281|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
25002779|NCT01981850|50095282|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
25002780|NCT01981850|50095283|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
25002781|NCT01981850|50095284|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
25002782|NCT01981850|50095285|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
25002783|NCT01981850|50095276|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
25002784|NCT01981850|50095277|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
25002785|NCT01981850|50095278|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
25002786|NCT01981850|50095279|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
25002787|NCT01981850|50095280|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
25002788|NCT01981850|50095281|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
25002789|NCT01981850|50095282|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
25002790|NCT01981850|50095283|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
25002791|NCT01981850|50095284|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
25002792|NCT01981850|50095285|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
25002793|NCT01981850|50095276|FG000|Main Phase Stage 2|Various reasons|0|||
25002794|NCT01981850|50095277|FG001|Main Phase Stage 2|Various reasons|0|||
25002795|NCT01981850|50095278|FG002|Main Phase Stage 2|Various reasons|0|||
25002796|NCT01981850|50095279|FG003|Main Phase Stage 2|Various reasons|0|||
25002797|NCT01981850|50095280|FG004|Main Phase Stage 2|Various reasons|2|||
25002798|NCT01981850|50095281|FG005|Main Phase Stage 2|Various reasons|0|||
25002799|NCT01981850|50095282|FG006|Main Phase Stage 2|Various reasons|1|||
25002800|NCT01981850|50095283|FG007|Main Phase Stage 2|Various reasons|0|||
25002801|NCT01981850|50095284|FG008|Main Phase Stage 2|Various reasons|0|||
25002802|NCT01981850|50095285|FG009|Main Phase Stage 2|Various reasons|0|||
25002803|NCT01981850|50095276|FG000|Main Phase Stage 2|Progressive Disease|0|||
25002804|NCT01981850|50095277|FG001|Main Phase Stage 2|Progressive Disease|0|||
25002805|NCT01981850|50095278|FG002|Main Phase Stage 2|Progressive Disease|0|||
25002806|NCT01981850|50095279|FG003|Main Phase Stage 2|Progressive Disease|0|||
25002807|NCT01981850|50095280|FG004|Main Phase Stage 2|Progressive Disease|0|||
25002808|NCT01981850|50095281|FG005|Main Phase Stage 2|Progressive Disease|6|||
25002809|NCT01981850|50095282|FG006|Main Phase Stage 2|Progressive Disease|6|||
25002810|NCT01981850|50095283|FG007|Main Phase Stage 2|Progressive Disease|0|||
25002811|NCT01981850|50095284|FG008|Main Phase Stage 2|Progressive Disease|0|||
25002812|NCT01981850|50095285|FG009|Main Phase Stage 2|Progressive Disease|0|||
25002813|NCT01981850|50095276|FG000|Open Label Extension (OLE)|Adverse Event|0|||
25002814|NCT01981850|50095277|FG001|Open Label Extension (OLE)|Adverse Event|0|||
25002815|NCT01981850|50095278|FG002|Open Label Extension (OLE)|Adverse Event|0|||
25002816|NCT01981850|50095279|FG003|Open Label Extension (OLE)|Adverse Event|0|||
25002817|NCT01981850|50095280|FG004|Open Label Extension (OLE)|Adverse Event|0|||
25002818|NCT01981850|50095281|FG005|Open Label Extension (OLE)|Adverse Event|0|||
25002819|NCT01981850|50095282|FG006|Open Label Extension (OLE)|Adverse Event|0|||
25002820|NCT01981850|50095283|FG007|Open Label Extension (OLE)|Adverse Event|2|||
25002821|NCT01981850|50095284|FG008|Open Label Extension (OLE)|Adverse Event|1|||
25002822|NCT01981850|50095285|FG009|Open Label Extension (OLE)|Adverse Event|8|||
25002823|NCT01981850|50095276|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
25176586|NCT01517867|50320213|FG001|Overall Study|Still in treatment at study end|3|||
25176587|NCT01514357|50320221|FG000|Overall Study|Screen failure|2|||
25176588|NCT01514357|50320222|FG001|Overall Study|Screen failure|0|||
25176589|NCT01514357|50320221|FG000|Overall Study|Withdrawal by Subject|2|||
25176590|NCT01514357|50320222|FG001|Overall Study|Withdrawal by Subject|0|||
25176591|NCT01532869|50320230|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
25176592|NCT01532869|50320231|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
25176593|NCT01532869|50320230|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
25176594|NCT01532869|50320231|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
25176595|NCT01532869|50320230|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
25176596|NCT01532869|50320231|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
25176597|NCT01532869|50320230|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
25176598|NCT01532869|50320231|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
25176599|NCT01532869|50320230|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
25176600|NCT01532869|50320231|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
25176601|NCT01532869|50320230|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
25176602|NCT01532869|50320231|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
25176603|NCT01532869|50320230|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
25176604|NCT01532869|50320231|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
25176605|NCT01532869|50320230|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
25176606|NCT01532869|50320231|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
25176607|NCT01532869|50320230|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
25176608|NCT01532869|50320231|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
25176609|NCT01532869|50320230|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
25176610|NCT01532869|50320231|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
25176611|NCT01532869|50320230|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
25176612|NCT01532869|50320231|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
25176613|NCT01532869|50320230|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
25002824|NCT01981850|50095277|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
25002825|NCT01981850|50095278|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
25002826|NCT01981850|50095279|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
25002827|NCT01981850|50095280|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
25002828|NCT01981850|50095281|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
25002829|NCT01981850|50095282|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
25002830|NCT01981850|50095283|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
25002831|NCT01981850|50095284|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
25002832|NCT01981850|50095285|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
25176614|NCT01532869|50320231|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
25176615|NCT01532869|50320230|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
25176616|NCT01532869|50320231|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
25002833|NCT01981850|50095276|FG000|Open Label Extension (OLE)|Various reasons|0|||
25002834|NCT01981850|50095277|FG001|Open Label Extension (OLE)|Various reasons|0|||
25176617|NCT01532869|50320230|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
25176618|NCT01532869|50320231|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
25002835|NCT01981850|50095278|FG002|Open Label Extension (OLE)|Various reasons|0|||
25002836|NCT01981850|50095279|FG003|Open Label Extension (OLE)|Various reasons|0|||
25002837|NCT01981850|50095280|FG004|Open Label Extension (OLE)|Various reasons|0|||
25002838|NCT01981850|50095281|FG005|Open Label Extension (OLE)|Various reasons|0|||
25002839|NCT01981850|50095282|FG006|Open Label Extension (OLE)|Various reasons|0|||
25002840|NCT01981850|50095283|FG007|Open Label Extension (OLE)|Various reasons|3|||
25002841|NCT01981850|50095284|FG008|Open Label Extension (OLE)|Various reasons|1|||
25002842|NCT01981850|50095285|FG009|Open Label Extension (OLE)|Various reasons|3|||
25002843|NCT01981850|50095276|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
25002844|NCT01981850|50095277|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
25002845|NCT01981850|50095278|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
25002846|NCT01981850|50095279|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
25002847|NCT01981850|50095280|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
25002848|NCT01981850|50095281|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
25002849|NCT01981850|50095282|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
25002850|NCT01981850|50095283|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
25002851|NCT01981850|50095284|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
25002852|NCT01981850|50095285|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
25002853|NCT01981850|50095276|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
25002854|NCT01981850|50095277|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
25002855|NCT01981850|50095278|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
25002856|NCT01981850|50095279|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
25002857|NCT01981850|50095280|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
25002858|NCT01981850|50095281|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
25002859|NCT01981850|50095282|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
25002860|NCT01981850|50095283|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
25002861|NCT01981850|50095284|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
25002862|NCT01981850|50095285|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
25002863|NCT01981850|50095276|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
25002864|NCT01981850|50095277|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
25002865|NCT01981850|50095278|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
25002866|NCT01981850|50095279|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
25002867|NCT01981850|50095280|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
25002868|NCT01981850|50095281|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
25002869|NCT01981850|50095282|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
25002870|NCT01981850|50095283|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
25002871|NCT01981850|50095284|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
25002872|NCT01981850|50095285|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
25002873|NCT03557307|50095317|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
25002874|NCT03557307|50095317|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
25002875|NCT03557307|50095317|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
25002876|NCT03557307|50095317|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
25002877|NCT03557307|50095317|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
25002878|NCT03557307|50095317|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
25002879|NCT03557307|50095317|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
25002880|NCT03557307|50095317|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
25002881|NCT03557307|50095317|FG000|Period 2: Maintenance Phase|Death|3|||
25002882|NCT03557307|50095317|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
25002883|NCT03557307|50095317|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
25002884|NCT03557307|50095317|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
25002885|NCT03557307|50095317|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
25002886|NCT03557307|50095317|FG000|Period 2: Maintenance Phase|other|3|||
25002887|NCT00118703|50095329|FG000|Overall Study|Protocol Violation|1|||
25002888|NCT00118703|50095330|FG001|Overall Study|Protocol Violation|0|||
25002889|NCT00118703|50095329|FG000|Overall Study|Adverse Event|1|||
25002890|NCT00118703|50095330|FG001|Overall Study|Adverse Event|1|||
25002891|NCT00118703|50095329|FG000|Overall Study|Participant took two different treatment|0|||
25002892|NCT00118703|50095330|FG001|Overall Study|Participant took two different treatment|1|||
25002893|NCT00118703|50095329|FG000|Overall Study|Withdrawal by Subject|2|||
25002894|NCT00118703|50095330|FG001|Overall Study|Withdrawal by Subject|5|||
25002895|NCT00118703|50095329|FG000|Overall Study|Lost to Follow-up|1|||
25002896|NCT00118703|50095330|FG001|Overall Study|Lost to Follow-up|2|||
25002897|NCT00104104|50095338|FG000|Overall Study|Adverse Event|8|||
25002898|NCT00104104|50095339|FG001|Overall Study|Adverse Event|8|||
25002899|NCT00104104|50095338|FG000|Overall Study|Abnormal laboratory value(s)|20|||
25002900|NCT00104104|50095339|FG001|Overall Study|Abnormal laboratory value(s)|14|||
25002901|NCT00104104|50095338|FG000|Overall Study|Lack of Efficacy|0|||
25002902|NCT00104104|50095339|FG001|Overall Study|Lack of Efficacy|3|||
25002903|NCT00104104|50095338|FG000|Overall Study|Condition no longer requires study drug|7|||
25002904|NCT00104104|50095339|FG001|Overall Study|Condition no longer requires study drug|4|||
25002905|NCT00104104|50095338|FG000|Overall Study|Protocol Violation|5|||
25002906|NCT00104104|50095339|FG001|Overall Study|Protocol Violation|2|||
25002907|NCT00104104|50095338|FG000|Overall Study|Withdrawal by Subject|11|||
25002908|NCT00104104|50095339|FG001|Overall Study|Withdrawal by Subject|15|||
25002909|NCT00104104|50095338|FG000|Overall Study|Lost to Follow-up|3|||
25002910|NCT00104104|50095339|FG001|Overall Study|Lost to Follow-up|7|||
25002911|NCT00104104|50095338|FG000|Overall Study|Administrative problems|12|||
25002912|NCT00104104|50095339|FG001|Overall Study|Administrative problems|13|||
25002913|NCT00104104|50095338|FG000|Overall Study|Death|9|||
25002914|NCT00104104|50095339|FG001|Overall Study|Death|6|||
25002915|NCT03557151|50095347|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
25002916|NCT03557151|50095348|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
25002917|NCT03557151|50095347|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
25002918|NCT03557151|50095348|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
25002919|NCT03557151|50095347|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
25002920|NCT03557151|50095348|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
25002921|NCT00115739|50095356|FG000|Overall Study|Lost to Follow-up|3|||
25002922|NCT01347086|50095372|FG000|Overall Study|failed screening visit|0|||
25002923|NCT01347086|50095373|FG001|Overall Study|failed screening visit|0|||
25002924|NCT01347086|50095374|FG002|Overall Study|failed screening visit|1|||
25002925|NCT01347086|50095375|FG003|Overall Study|failed screening visit|0|||
25002926|NCT01347086|50095376|FG004|Overall Study|failed screening visit|0|||
25002927|NCT01347086|50095377|FG005|Overall Study|failed screening visit|0|||
25002928|NCT01347086|50095378|FG006|Overall Study|failed screening visit|1|||
25002929|NCT01347086|50095379|FG007|Overall Study|failed screening visit|1|||
25002930|NCT01347086|50095380|FG008|Overall Study|failed screening visit|0|||
25002931|NCT01347086|50095381|FG009|Overall Study|failed screening visit|1|||
25002932|NCT03605745|50095413|FG000|Overall Study|Study was terminated for business reasons|47|||
25002933|NCT03246152|50095417|FG000|Overall Study|Lost to Follow-up|2|||
25002934|NCT03246152|50095417|FG000|Overall Study|Protocol Violation|1|||
25002935|NCT03571581|50095421|FG000|Overall Study|Death|2|||
25002936|NCT03571581|50095421|FG000|Overall Study|Withdrawal by Subject|2|||
25002937|NCT00115349|50095430|FG000|Overall Study|Study closed due to low enrollment.|11|||
25002938|NCT00115349|50095431|FG001|Overall Study|Study closed due to low enrollment.|9|||
25002939|NCT00115037|50095439|FG000|Phase1|Lost to Follow-up|16|||
25002940|NCT00115037|50095440|FG001|Phase1|Lost to Follow-up|23|||
25002941|NCT00115037|50095441|FG002|Phase1|Lost to Follow-up|0|||
25002942|NCT00115037|50095442|FG003|Phase1|Lost to Follow-up|0|||
25002943|NCT00115037|50095443|FG004|Phase1|Lost to Follow-up|0|||
25002944|NCT00115037|50095444|FG005|Phase1|Lost to Follow-up|0|||
25002945|NCT00115037|50095439|FG000|Phase1|Withdrawal by Subject|9|||
25002946|NCT00115037|50095440|FG001|Phase1|Withdrawal by Subject|4|||
25002947|NCT00115037|50095441|FG002|Phase1|Withdrawal by Subject|0|||
25002948|NCT00115037|50095442|FG003|Phase1|Withdrawal by Subject|0|||
25002949|NCT00115037|50095443|FG004|Phase1|Withdrawal by Subject|0|||
25002950|NCT00115037|50095444|FG005|Phase1|Withdrawal by Subject|0|||
25002951|NCT00115037|50095439|FG000|Phase2|Death|0|||
25002952|NCT00115037|50095440|FG001|Phase2|Death|0|||
25002953|NCT00115037|50095441|FG002|Phase2|Death|1|||
25002954|NCT00115037|50095442|FG003|Phase2|Death|0|||
25002955|NCT00115037|50095443|FG004|Phase2|Death|0|||
25002956|NCT00115037|50095444|FG005|Phase2|Death|1|||
25002957|NCT00115037|50095439|FG000|Phase2|Withdrawal by Subject|0|||
25002958|NCT00115037|50095440|FG001|Phase2|Withdrawal by Subject|0|||
25002959|NCT00115037|50095441|FG002|Phase2|Withdrawal by Subject|2|||
25002960|NCT00115037|50095442|FG003|Phase2|Withdrawal by Subject|1|||
25002961|NCT00115037|50095443|FG004|Phase2|Withdrawal by Subject|2|||
25002962|NCT00115037|50095444|FG005|Phase2|Withdrawal by Subject|1|||
25002963|NCT00115037|50095439|FG000|Phase2|Lost to Follow-up|0|||
25002964|NCT00115037|50095440|FG001|Phase2|Lost to Follow-up|0|||
25002965|NCT00115037|50095441|FG002|Phase2|Lost to Follow-up|12|||
25002966|NCT00115037|50095442|FG003|Phase2|Lost to Follow-up|14|||
25002967|NCT00115037|50095443|FG004|Phase2|Lost to Follow-up|4|||
25002968|NCT00115037|50095444|FG005|Phase2|Lost to Follow-up|10|||
25002969|NCT03555435|50095461|FG000|Overall Study|Lost to Follow-up|17|||
25002970|NCT03555435|50095462|FG001|Overall Study|Lost to Follow-up|19|||
25002971|NCT03555435|50095463|FG002|Overall Study|Lost to Follow-up|8|||
25002972|NCT03214640|50095475|FG000|Overall Study|Protocol Violation|1|||
25002973|NCT03214640|50095476|FG001|Overall Study|Protocol Violation|2|||
25002974|NCT03214640|50095477|FG002|Overall Study|Protocol Violation|1|||
25002975|NCT03214640|50095478|FG003|Overall Study|Protocol Violation|4|||
25002976|NCT03214406|50095490|FG000|Overall Study|did not meet enrollment criteria|9|||
25002977|NCT03214406|50095491|FG001|Overall Study|did not meet enrollment criteria|13|||
25176619|NCT01532869|50320230|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
25002978|NCT03214406|50095490|FG000|Overall Study|Withdrawal by Subject|1|||
25002979|NCT03214406|50095491|FG001|Overall Study|Withdrawal by Subject|0|||
25002980|NCT03214406|50095490|FG000|Overall Study|Lost to Follow-up|0|||
25002981|NCT03214406|50095491|FG001|Overall Study|Lost to Follow-up|2|||
25002982|NCT03213938|50095499|FG000|Overall Study|Lost to Follow-up|4|||
25002983|NCT03213938|50095500|FG001|Overall Study|Lost to Follow-up|3|||
25002984|NCT03213938|50095499|FG000|Overall Study|Lack of Efficacy|1|||
25002985|NCT03213938|50095500|FG001|Overall Study|Lack of Efficacy|0|||
25002986|NCT03213938|50095499|FG000|Overall Study|Decline to participate|5|||
25002987|NCT03213938|50095500|FG001|Overall Study|Decline to participate|4|||
25002988|NCT03213938|50095499|FG000|Overall Study|Without reason|4|||
25002989|NCT03213938|50095500|FG001|Overall Study|Without reason|5|||
25002990|NCT03604497|50095506|FG000|Overall Study|Protocol Violation|52|||
25002991|NCT03213626|50095514|FG000|Overall Study|Adverse Event|1|||
25002992|NCT03213626|50095514|FG000|Overall Study|Progressive Disease|6|||
25002993|NCT03604341|50095520|FG000|Overall Study|Withdrawal by Subject|1|||
25002994|NCT03604341|50095521|FG001|Overall Study|Withdrawal by Subject|1|||
25002995|NCT03604341|50095520|FG000|Overall Study|Adverse Event|1|||
25002996|NCT03604341|50095521|FG001|Overall Study|Adverse Event|0|||
25002997|NCT03604341|50095520|FG000|Overall Study|Protocol Violation|0|||
25002998|NCT03604341|50095521|FG001|Overall Study|Protocol Violation|1|||
25002999|NCT03603639|50095527|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
25003000|NCT03603639|50095528|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
25003001|NCT03603639|50095529|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
25003002|NCT03603639|50095530|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
25003003|NCT03603639|50095531|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
25003004|NCT03603639|50095532|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
25003005|NCT03603639|50095527|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
25003006|NCT03603639|50095528|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
25003007|NCT03603639|50095529|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
25003008|NCT03603639|50095530|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
25003009|NCT03603639|50095531|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
25003010|NCT03603639|50095532|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
25003011|NCT00114959|50095546|FG000|Overall Study|Lack of Efficacy|6|||
25003012|NCT00114959|50095546|FG000|Overall Study|Physician Decision|1|||
25003013|NCT00114959|50095546|FG000|Overall Study|Death|1|||
25003014|NCT02778100|50095552|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
25003015|NCT02778100|50095553|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
25003016|NCT00118157|50095561|FG000|Overall Study|Adverse Event|2|||
25003017|NCT00118157|50095561|FG000|Overall Study|Death|8|||
25003018|NCT00118157|50095561|FG000|Overall Study|Withdrawal by Subject|2|||
25003019|NCT02762500|50095568|FG000|Overall Study|Lack of Efficacy|1|||
25003020|NCT02762500|50095569|FG001|Overall Study|Lack of Efficacy|0|||
25003021|NCT02762500|50095568|FG000|Overall Study|Withdrawal by Subject|1|||
25003022|NCT02762500|50095569|FG001|Overall Study|Withdrawal by Subject|1|||
25003023|NCT02762500|50095568|FG000|Overall Study|Adverse Event|0|||
25003024|NCT02762500|50095569|FG001|Overall Study|Adverse Event|2|||
25003025|NCT03552549|50095577|FG000|Overall Study|Disease progression|25|||
25003026|NCT03552549|50095578|FG001|Overall Study|Disease progression|17|||
25003027|NCT03552549|50095577|FG000|Overall Study|Adverse event in first 12 months|12|||
25003028|NCT03552549|50095578|FG001|Overall Study|Adverse event in first 12 months|8|||
25003029|NCT03552549|50095577|FG000|Overall Study|Withdrawal by Subject|7|||
25003030|NCT03552549|50095578|FG001|Overall Study|Withdrawal by Subject|7|||
25003031|NCT03552549|50095577|FG000|Overall Study|Unknown (no reason provided)|4|||
25003032|NCT03552549|50095578|FG001|Overall Study|Unknown (no reason provided)|2|||
25003033|NCT03552549|50095577|FG000|Overall Study|Not in participant's best interest|2|||
25003034|NCT03552549|50095578|FG001|Overall Study|Not in participant's best interest|1|||
25003035|NCT03552549|50095577|FG000|Overall Study|Did not complete study treatment|2|||
25003036|NCT03552549|50095578|FG001|Overall Study|Did not complete study treatment|3|||
25003037|NCT03552549|50095577|FG000|Overall Study|Did not meet eligibility criteria|1|||
25003038|NCT03552549|50095578|FG001|Overall Study|Did not meet eligibility criteria|0|||
25003039|NCT03552549|50095577|FG000|Overall Study|Administrative|0|||
25003040|NCT03552549|50095578|FG001|Overall Study|Administrative|14|||
25003041|NCT00117845|50095584|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
25003042|NCT02761642|50095588|FG000|Overall Study|Did not Receive Study Treatment|3|||
25003043|NCT02761642|50095588|FG000|Overall Study|Adverse Event|13|||
25003044|NCT02761642|50095588|FG000|Overall Study|Withdrawal by Subject|2|||
25003045|NCT02761642|50095588|FG000|Overall Study|Non-compliant|7|||
25003046|NCT02761642|50095588|FG000|Overall Study|Death|3|||
25003047|NCT02761642|50095588|FG000|Overall Study|Lack of Efficacy|20|||
25003048|NCT02761642|50095588|FG000|Overall Study|Physician Decision|1|||
25003049|NCT02761642|50095588|FG000|Overall Study|Reason Unspecified|21|||
25003050|NCT00113555|50095592|FG000|Overall Study|Baseline Failure|59|||
25003051|NCT00113555|50095592|FG000|Overall Study|Permanently Explanted|7|||
25003052|NCT00113555|50095592|FG000|Overall Study|Death|1|||
25003053|NCT00113555|50095592|FG000|Overall Study|Missed Followup|4|||
25003054|NCT00113555|50095592|FG000|Overall Study|Lost to Follow-up|8|||
25003055|NCT03189524|50095600|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
25003056|NCT03189524|50095601|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
25003057|NCT03189524|50095602|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
25003058|NCT03189524|50095600|FG000|Overall Study|Death|2|||
25003059|NCT03189524|50095601|FG001|Overall Study|Death|2|||
25003060|NCT03189524|50095602|FG002|Overall Study|Death|1|||
25003061|NCT03189524|50095600|FG000|Overall Study|Lost to Follow-up|1|||
25003062|NCT03189524|50095601|FG001|Overall Study|Lost to Follow-up|0|||
25003063|NCT03189524|50095602|FG002|Overall Study|Lost to Follow-up|8|||
25003064|NCT03189524|50095600|FG000|Overall Study|Withdrawal by Subject|1|||
25003065|NCT03189524|50095601|FG001|Overall Study|Withdrawal by Subject|1|||
25003066|NCT03189524|50095602|FG002|Overall Study|Withdrawal by Subject|3|||
25003067|NCT03189524|50095600|FG000|Overall Study|Progressive Disease|0|||
25003068|NCT03189524|50095601|FG001|Overall Study|Progressive Disease|2|||
25003069|NCT03189524|50095602|FG002|Overall Study|Progressive Disease|0|||
25003070|NCT03600909|50095617|FG000|Overall Study|Not treated|0|||
25003071|NCT03600909|50095618|FG001|Overall Study|Not treated|3|||
25003072|NCT03600909|50095619|FG002|Overall Study|Not treated|0|||
25003073|NCT03189446|50095627|FG000|Overall Study|Adverse Event|2|||
25003074|NCT03189446|50095627|FG000|Overall Study|Withdrawal by Subject|2|||
25003075|NCT03189446|50095627|FG000|Overall Study|Physician Decision|1|||
25003076|NCT03212690|50095631|FG000|Overall Study|Protocol Violation|1|||
25003077|NCT03568461|50095635|FG000|Overall Study|Death|7|||
25003078|NCT03568461|50095635|FG000|Overall Study|Physician Decision|5|||
25003079|NCT03568461|50095635|FG000|Overall Study|Subject decision|5|||
25003080|NCT03568461|50095635|FG000|Overall Study|Lost to Follow-up|1|||
25003081|NCT03188120|50095639|FG000|Overall Study|Adverse Event|4|||
25003082|NCT03188120|50095639|FG000|Overall Study|Insufficient Effectiveness|8|||
25003083|NCT03188120|50095639|FG000|Overall Study|Improved|12|||
25003084|NCT03188120|50095639|FG000|Overall Study|Lost to Follow-up|7|||
25003085|NCT03188120|50095639|FG000|Overall Study|Other than specified|3|||
25003086|NCT03188120|50095639|FG000|Overall Study|No visit after the first visit|13|||
25003087|NCT02895945|50095645|FG000|Overall Study|Physician Decision|2|||
25003088|NCT02895945|50095646|FG001|Overall Study|Physician Decision|1|||
25003089|NCT02777554|50095654|FG000|Overall Study|Adverse Event|4|||
25003090|NCT02777554|50095655|FG001|Overall Study|Adverse Event|4|||
25003091|NCT02777554|50095656|FG002|Overall Study|Adverse Event|0|||
25003092|NCT02777554|50095657|FG003|Overall Study|Adverse Event|1|||
25003093|NCT02777554|50095658|FG004|Overall Study|Adverse Event|0|||
25003094|NCT02777554|50095659|FG005|Overall Study|Adverse Event|0|||
25003095|NCT02777554|50095654|FG000|Overall Study|Withdrawal by Subject|3|||
25003096|NCT02777554|50095655|FG001|Overall Study|Withdrawal by Subject|1|||
25003097|NCT02777554|50095656|FG002|Overall Study|Withdrawal by Subject|1|||
25003098|NCT02777554|50095657|FG003|Overall Study|Withdrawal by Subject|0|||
25003099|NCT02777554|50095658|FG004|Overall Study|Withdrawal by Subject|0|||
25003100|NCT02777554|50095659|FG005|Overall Study|Withdrawal by Subject|0|||
25003101|NCT02777554|50095654|FG000|Overall Study|Discharged early due to hurricane|22|||
25003102|NCT02777554|50095655|FG001|Overall Study|Discharged early due to hurricane|20|||
25003103|NCT02777554|50095656|FG002|Overall Study|Discharged early due to hurricane|0|||
25003104|NCT02777554|50095657|FG003|Overall Study|Discharged early due to hurricane|0|||
25003105|NCT02777554|50095658|FG004|Overall Study|Discharged early due to hurricane|0|||
25003106|NCT02777554|50095659|FG005|Overall Study|Discharged early due to hurricane|0|||
25003107|NCT02777554|50095654|FG000|Overall Study|Other - Miscellaneous|1|||
25003108|NCT02777554|50095655|FG001|Overall Study|Other - Miscellaneous|0|||
25003109|NCT02777554|50095656|FG002|Overall Study|Other - Miscellaneous|0|||
25003110|NCT02777554|50095657|FG003|Overall Study|Other - Miscellaneous|0|||
25003111|NCT02777554|50095658|FG004|Overall Study|Other - Miscellaneous|0|||
25003112|NCT02777554|50095659|FG005|Overall Study|Other - Miscellaneous|0|||
25003113|NCT03550209|50095683|FG000|Overall Study|Lost to Follow-up|1|||
25003114|NCT03550209|50095684|FG001|Overall Study|Lost to Follow-up|0|||
25003115|NCT03550209|50095685|FG002|Overall Study|Lost to Follow-up|1|||
25003116|NCT03550209|50095686|FG003|Overall Study|Lost to Follow-up|0|||
25003117|NCT03550209|50095683|FG000|Overall Study|Withdrawal by Subject|0|||
25003118|NCT03550209|50095684|FG001|Overall Study|Withdrawal by Subject|3|||
25003119|NCT03550209|50095685|FG002|Overall Study|Withdrawal by Subject|1|||
25003120|NCT03550209|50095686|FG003|Overall Study|Withdrawal by Subject|2|||
25003121|NCT03550209|50095683|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
25003122|NCT03550209|50095684|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
25003123|NCT03550209|50095685|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
25003124|NCT03550209|50095686|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
25003125|NCT03032510|50095698|FG000|Overall Study|Adverse Event|5|||
25003126|NCT03032510|50095699|FG001|Overall Study|Adverse Event|2|||
25003127|NCT03032510|50095698|FG000|Overall Study|Lost to Follow-up|8|||
25003128|NCT03032510|50095699|FG001|Overall Study|Lost to Follow-up|7|||
25003129|NCT03032510|50095698|FG000|Overall Study|Withdrawal by Subject|8|||
25003130|NCT03032510|50095699|FG001|Overall Study|Withdrawal by Subject|7|||
25003131|NCT03032510|50095698|FG000|Overall Study|Subject noncompliance|4|||
25003132|NCT03032510|50095699|FG001|Overall Study|Subject noncompliance|2|||
25003133|NCT03032510|50095698|FG000|Overall Study|Physician Decision|2|||
25003134|NCT03032510|50095699|FG001|Overall Study|Physician Decision|0|||
25003135|NCT03599349|50095709|FG000|Overall Study|Lost to Follow-up|1|||
25003136|NCT03599193|50095719|FG000|Overall Study|Adverse Event|0|||
25003137|NCT03599193|50095720|FG001|Overall Study|Adverse Event|2|||
25003138|NCT03599193|50095719|FG000|Overall Study|Withdrawal by Subject|1|||
25003139|NCT03599193|50095720|FG001|Overall Study|Withdrawal by Subject|0|||
25003140|NCT03599193|50095719|FG000|Overall Study|Protocol Violation|1|||
25003141|NCT03599193|50095720|FG001|Overall Study|Protocol Violation|0|||
25003142|NCT03599193|50095719|FG000|Overall Study|Lost to Follow-up|0|||
25003143|NCT03599193|50095720|FG001|Overall Study|Lost to Follow-up|1|||
25003144|NCT03166124|50095729|FG000|Treatment Period 1|Adverse Event|0|||
25003145|NCT03166124|50095730|FG001|Treatment Period 1|Adverse Event|0|||
25003146|NCT03166124|50095731|FG002|Treatment Period 1|Adverse Event|1|||
25003147|NCT03166124|50095732|FG003|Treatment Period 1|Adverse Event|0|||
25003148|NCT03166124|50095729|FG000|Wash-out Period|Withdrawal by Subject|0|||
25003149|NCT03166124|50095730|FG001|Wash-out Period|Withdrawal by Subject|1|||
25003150|NCT03166124|50095731|FG002|Wash-out Period|Withdrawal by Subject|0|||
25003151|NCT03166124|50095732|FG003|Wash-out Period|Withdrawal by Subject|1|||
25003152|NCT03166124|50095729|FG000|Wash-out Period|Adverse Event|0|||
25003153|NCT03166124|50095730|FG001|Wash-out Period|Adverse Event|1|||
25003154|NCT03166124|50095731|FG002|Wash-out Period|Adverse Event|1|||
25003155|NCT03166124|50095732|FG003|Wash-out Period|Adverse Event|0|||
25003156|NCT03567291|50095743|FG000|Period I|Adverse Event|14|||
25003157|NCT03567291|50095744|FG001|Period I|Adverse Event|0|||
25003158|NCT03567291|50095745|FG002|Period I|Adverse Event|0|||
25003159|NCT03567291|50095746|FG003|Period I|Adverse Event|0|||
25003160|NCT03567291|50095743|FG000|Period I|Protocol Violation|1|||
25003161|NCT03567291|50095744|FG001|Period I|Protocol Violation|0|||
25003162|NCT03567291|50095745|FG002|Period I|Protocol Violation|0|||
25003163|NCT03567291|50095746|FG003|Period I|Protocol Violation|0|||
25003164|NCT03567291|50095743|FG000|Period I|Withdrawal by Subject|23|||
25003165|NCT03567291|50095744|FG001|Period I|Withdrawal by Subject|0|||
25003166|NCT03567291|50095745|FG002|Period I|Withdrawal by Subject|0|||
25003167|NCT03567291|50095746|FG003|Period I|Withdrawal by Subject|0|||
25003168|NCT03567291|50095743|FG000|Period I|Lost to Follow-up|2|||
25003169|NCT03567291|50095744|FG001|Period I|Lost to Follow-up|0|||
25003170|NCT03567291|50095745|FG002|Period I|Lost to Follow-up|0|||
25003171|NCT03567291|50095746|FG003|Period I|Lost to Follow-up|0|||
25003172|NCT03567291|50095743|FG000|Period I|Terminated by sponsor|44|||
25003173|NCT03567291|50095744|FG001|Period I|Terminated by sponsor|0|||
25003174|NCT03567291|50095745|FG002|Period I|Terminated by sponsor|0|||
25003175|NCT03567291|50095746|FG003|Period I|Terminated by sponsor|0|||
25003176|NCT03567291|50095743|FG000|Period I|Missing or unknown|7|||
25003177|NCT03567291|50095744|FG001|Period I|Missing or unknown|0|||
25003178|NCT03567291|50095745|FG002|Period I|Missing or unknown|0|||
25003179|NCT03567291|50095746|FG003|Period I|Missing or unknown|0|||
25003180|NCT03567291|50095743|FG000|Period II|Adverse Event|0|||
25003181|NCT03567291|50095744|FG001|Period II|Adverse Event|1|||
25003182|NCT03567291|50095745|FG002|Period II|Adverse Event|0|||
25003183|NCT03567291|50095746|FG003|Period II|Adverse Event|0|||
25003184|NCT03567291|50095743|FG000|Period II|Missing or unknown|0|||
25003185|NCT03567291|50095744|FG001|Period II|Missing or unknown|2|||
25003186|NCT03567291|50095745|FG002|Period II|Missing or unknown|1|||
25003187|NCT03567291|50095746|FG003|Period II|Missing or unknown|0|||
25003188|NCT03567291|50095743|FG000|Period III|Adverse Event|0|||
25003189|NCT03567291|50095744|FG001|Period III|Adverse Event|0|||
25003190|NCT03567291|50095745|FG002|Period III|Adverse Event|0|||
25003191|NCT03567291|50095746|FG003|Period III|Adverse Event|4|||
25003192|NCT03567291|50095743|FG000|Period III|Withdrawal by Subject|0|||
25003193|NCT03567291|50095744|FG001|Period III|Withdrawal by Subject|0|||
25003194|NCT03567291|50095745|FG002|Period III|Withdrawal by Subject|0|||
25003195|NCT03567291|50095746|FG003|Period III|Withdrawal by Subject|4|||
25003196|NCT03567291|50095743|FG000|Period III|Lost to Follow-up|0|||
25003197|NCT03567291|50095744|FG001|Period III|Lost to Follow-up|0|||
25003198|NCT03567291|50095745|FG002|Period III|Lost to Follow-up|0|||
25003199|NCT03567291|50095746|FG003|Period III|Lost to Follow-up|1|||
25003200|NCT03567291|50095743|FG000|Period III|Terminated by sponsor|0|||
25003201|NCT03567291|50095744|FG001|Period III|Terminated by sponsor|0|||
25003202|NCT03567291|50095745|FG002|Period III|Terminated by sponsor|0|||
25003203|NCT03567291|50095746|FG003|Period III|Terminated by sponsor|68|||
25003204|NCT03567291|50095743|FG000|Period III|Missing or unknown|0|||
25003205|NCT03567291|50095744|FG001|Period III|Missing or unknown|0|||
25003206|NCT03567291|50095745|FG002|Period III|Missing or unknown|0|||
25003207|NCT03567291|50095746|FG003|Period III|Missing or unknown|8|||
25003208|NCT02777242|50095752|FG000|Overall Study|Other|2|||
25003209|NCT02777242|50095752|FG000|Overall Study|Lost to Follow-up|1|||
25003210|NCT02777242|50095752|FG000|Overall Study|Multiple|1|||
25003211|NCT02777242|50095752|FG000|Overall Study|Sponsor's request|1|||
25003212|NCT02777242|50095752|FG000|Overall Study|Withdrawal by Subject|1|||
25003213|NCT03212144|50095758|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
25003214|NCT03212144|50095759|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
25003215|NCT03212144|50095758|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
25003216|NCT03212144|50095759|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
25003217|NCT03566979|50095769|FG000|Overall Study|Withdrawal by Subject|2|||
25003218|NCT03566979|50095770|FG001|Overall Study|Withdrawal by Subject|0|||
25003219|NCT03566979|50095771|FG002|Overall Study|Withdrawal by Subject|1|||
25003220|NCT03566979|50095772|FG003|Overall Study|Withdrawal by Subject|1|||
25003221|NCT03566979|50095769|FG000|Overall Study|Lost to Follow-up|2|||
25003222|NCT03566979|50095770|FG001|Overall Study|Lost to Follow-up|7|||
25003223|NCT03566979|50095771|FG002|Overall Study|Lost to Follow-up|9|||
25003224|NCT03566979|50095772|FG003|Overall Study|Lost to Follow-up|5|||
25003225|NCT03566979|50095769|FG000|Overall Study|Adverse Event|1|||
25003226|NCT03566979|50095770|FG001|Overall Study|Adverse Event|0|||
25003227|NCT03566979|50095771|FG002|Overall Study|Adverse Event|0|||
25003228|NCT03566979|50095772|FG003|Overall Study|Adverse Event|0|||
25003229|NCT00116831|50095784|FG000|Overall Study|Adverse Event|14|||
25003230|NCT00116831|50095785|FG001|Overall Study|Adverse Event|16|||
25003231|NCT00116831|50095784|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
25003232|NCT00116831|50095785|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
25003233|NCT00116831|50095784|FG000|Overall Study|Lost to Follow-up|8|||
25003234|NCT00116831|50095785|FG001|Overall Study|Lost to Follow-up|6|||
25003235|NCT00116831|50095784|FG000|Overall Study|Protocol Violation|3|||
25003236|NCT00116831|50095785|FG001|Overall Study|Protocol Violation|6|||
25003237|NCT00116831|50095784|FG000|Overall Study|Hypoglycaemic events|1|||
25003238|NCT00116831|50095785|FG001|Overall Study|Hypoglycaemic events|0|||
25003239|NCT00116831|50095784|FG000|Overall Study|Low haemoglobin on screening|1|||
25003240|NCT00116831|50095785|FG001|Overall Study|Low haemoglobin on screening|0|||
25003241|NCT00116831|50095784|FG000|Overall Study|Withdrawn investigational product|1|||
25003242|NCT00116831|50095785|FG001|Overall Study|Withdrawn investigational product|0|||
25003243|NCT00116831|50095784|FG000|Overall Study|Withdrawal by Subject|32|||
25003244|NCT00116831|50095785|FG001|Overall Study|Withdrawal by Subject|32|||
25003245|NCT00116831|50095784|FG000|Overall Study|Insufficient therapeutic effect|0|||
25003246|NCT00116831|50095785|FG001|Overall Study|Insufficient therapeutic effect|1|||
25003247|NCT00116831|50095784|FG000|Overall Study|Missing data for participant|1|||
25003248|NCT00116831|50095785|FG001|Overall Study|Missing data for participant|0|||
25003249|NCT02777086|50095793|FG000|Overall Study|Lost to Follow-up|96|||
25003250|NCT02777086|50095794|FG001|Overall Study|Lost to Follow-up|99|||
25003251|NCT03549429|50095802|FG000|Overall Study|Protocol Violation|5|||
25003252|NCT03549429|50095803|FG001|Overall Study|Protocol Violation|3|||
25003253|NCT02784704|50095813|FG000|Overall Study|Adverse Event|4|||
25003254|NCT02784704|50095814|FG001|Overall Study|Adverse Event|2|||
25003255|NCT02784704|50095813|FG000|Overall Study|Lost to Follow-up|6|||
25003256|NCT02784704|50095814|FG001|Overall Study|Lost to Follow-up|4|||
25003257|NCT02784704|50095813|FG000|Overall Study|Withdrawal by Subject|1|||
25003258|NCT02784704|50095814|FG001|Overall Study|Withdrawal by Subject|3|||
25003259|NCT02784704|50095813|FG000|Overall Study|Subject Non Compliance|2|||
25003260|NCT02784704|50095814|FG001|Overall Study|Subject Non Compliance|0|||
25003261|NCT03566823|50095825|FG000|Overall Study|Lack of Efficacy|0|||
25003262|NCT03566823|50095826|FG001|Overall Study|Lack of Efficacy|1|||
25003263|NCT03566823|50095827|FG002|Overall Study|Lack of Efficacy|0|||
25003264|NCT03566823|50095825|FG000|Overall Study|Withdrawal by Subject|1|||
25003265|NCT03566823|50095826|FG001|Overall Study|Withdrawal by Subject|2|||
25003266|NCT03566823|50095827|FG002|Overall Study|Withdrawal by Subject|0|||
25003267|NCT03566823|50095825|FG000|Overall Study|Adverse Event|1|||
25003268|NCT03566823|50095826|FG001|Overall Study|Adverse Event|0|||
25003269|NCT03566823|50095827|FG002|Overall Study|Adverse Event|2|||
25003270|NCT03549117|50095837|FG000|Overall Study|Withdrawal by Subject|1|||
25003271|NCT03549117|50095838|FG001|Overall Study|Withdrawal by Subject|0|||
25003272|NCT03183908|50095846|FG000|Overall Study|Missing Symptom Diary Data|0|||
25003273|NCT03183908|50095847|FG001|Overall Study|Missing Symptom Diary Data|2|||
25003274|NCT03565887|50095859|FG000|Overall Study|Adverse Event|1|||
25003275|NCT03565887|50095860|FG001|Overall Study|Adverse Event|0|||
25003276|NCT03565887|50095859|FG000|Overall Study|Withdrawal by Subject|0|||
25003277|NCT03565887|50095860|FG001|Overall Study|Withdrawal by Subject|2|||
25003278|NCT03183518|50095866|FG000|Overall Study|Other (Not specified)|2|||
25003279|NCT03183518|50095866|FG000|Overall Study|Other (Withdrawal of consent)|1|||
25003280|NCT00116753|50095874|FG000|Overall Study|Adverse Event|16|||
25003281|NCT00116753|50095875|FG001|Overall Study|Adverse Event|10|||
25003282|NCT00116753|50095876|FG002|Overall Study|Adverse Event|7|||
25003283|NCT00116753|50095874|FG000|Overall Study|Withdrawal by Subject|11|||
25176620|NCT01532869|50320231|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
25003284|NCT00116753|50095875|FG001|Overall Study|Withdrawal by Subject|12|||
25003285|NCT00116753|50095876|FG002|Overall Study|Withdrawal by Subject|8|||
25003286|NCT00116753|50095874|FG000|Overall Study|Lost to Follow-up|0|||
25003287|NCT00116753|50095875|FG001|Overall Study|Lost to Follow-up|2|||
25003288|NCT00116753|50095876|FG002|Overall Study|Lost to Follow-up|1|||
25003289|NCT00116753|50095874|FG000|Overall Study|Protocol Violation|0|||
25003290|NCT00116753|50095875|FG001|Overall Study|Protocol Violation|0|||
25003291|NCT00116753|50095876|FG002|Overall Study|Protocol Violation|1|||
25003292|NCT00116753|50095874|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
25003293|NCT00116753|50095875|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
25003294|NCT00116753|50095876|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
25003295|NCT00116753|50095874|FG000|Overall Study|Disease Progression|3|||
25003296|NCT00116753|50095875|FG001|Overall Study|Disease Progression|4|||
25003297|NCT00116753|50095876|FG002|Overall Study|Disease Progression|3|||
25003298|NCT00116753|50095874|FG000|Overall Study|Abnormal Echocardiogram|0|||
25003299|NCT00116753|50095875|FG001|Overall Study|Abnormal Echocardiogram|0|||
25003300|NCT00116753|50095876|FG002|Overall Study|Abnormal Echocardiogram|1|||
25003301|NCT00116753|50095874|FG000|Overall Study|Progressive Parkinson's Disease|1|||
25003302|NCT00116753|50095875|FG001|Overall Study|Progressive Parkinson's Disease|0|||
25003303|NCT00116753|50095876|FG002|Overall Study|Progressive Parkinson's Disease|0|||
25003304|NCT00116753|50095874|FG000|Overall Study|Dosing Error|0|||
25003305|NCT00116753|50095875|FG001|Overall Study|Dosing Error|1|||
25003306|NCT00116753|50095876|FG002|Overall Study|Dosing Error|0|||
25003307|NCT00113399|50095895|FG000|Overall Study|Death|1|||
25003308|NCT00113399|50095896|FG001|Overall Study|Death|1|||
25003309|NCT00113399|50095895|FG000|Overall Study|Withdrawal by Subject|1|||
25003310|NCT00113399|50095896|FG001|Overall Study|Withdrawal by Subject|2|||
25003311|NCT00113399|50095895|FG000|Overall Study|Complete Response|0|||
25003312|NCT00113399|50095896|FG001|Overall Study|Complete Response|1|||
25003313|NCT00113399|50095895|FG000|Overall Study|Other|0|||
25003314|NCT00113399|50095896|FG001|Overall Study|Other|1|||
25003315|NCT00113087|50095904|FG000|Overall Study|Death or Transplant|14|||
25003316|NCT00113087|50095905|FG001|Overall Study|Death or Transplant|16|||
25003317|NCT00113087|50095904|FG000|Overall Study|Family or MD withdrew subject|10|||
25003318|NCT00113087|50095905|FG001|Overall Study|Family or MD withdrew subject|5|||
25003319|NCT00112463|50095911|FG000|Overall Study|Physician Decision|1|||
25003320|NCT00112463|50095911|FG000|Overall Study|Progression|30|||
25003321|NCT00112463|50095911|FG000|Overall Study|Second Primary|1|||
25003322|NCT00112463|50095911|FG000|Overall Study|Toxicity|3|||
25003323|NCT00112463|50095911|FG000|Overall Study|Withdrawal by Subject|2|||
25003324|NCT00112463|50095911|FG000|Overall Study|Never started treatment|2|||
25003325|NCT03548415|50095921|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
25003326|NCT03548415|50095922|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
25003327|NCT03548415|50095923|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
25176621|NCT01532869|50320230|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
25176622|NCT01532869|50320231|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
25176623|NCT01532869|50320230|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
25176624|NCT01532869|50320231|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
25176625|NCT01531387|50320244|FG000|Overall Study|Early termination of study|11|||
25176626|NCT01531387|50320245|FG001|Overall Study|Early termination of study|11|||
25003328|NCT03548415|50095924|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
25003329|NCT03548415|50095925|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
25003330|NCT00112385|50095941|FG000|Overall Study|Lost to Follow-up|1|||
25003331|NCT00112385|50095942|FG001|Overall Study|Lost to Follow-up|0|||
25003332|NCT00112385|50095941|FG000|Overall Study|Withdrawal by Subject|0|||
25003333|NCT00112385|50095942|FG001|Overall Study|Withdrawal by Subject|1|||
25003334|NCT03548337|50095950|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
25003335|NCT03548337|50095951|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
25003336|NCT03548337|50095950|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
25003337|NCT03548337|50095951|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
25003338|NCT03548337|50095950|FG000|Infant Series|Lost to Follow-up|2|||
25003339|NCT03548337|50095951|FG001|Infant Series|Lost to Follow-up|1|||
25003340|NCT03548337|50095950|FG000|Infant Series|Adverse Event|0|||
25003341|NCT03548337|50095951|FG001|Infant Series|Adverse Event|2|||
25003342|NCT03548337|50095950|FG000|Infant Series|Randomized but Not Vaccinated|1|||
25003343|NCT03548337|50095951|FG001|Infant Series|Randomized but Not Vaccinated|0|||
25003344|NCT03548337|50095950|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
25003345|NCT03548337|50095951|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
25003346|NCT03596151|50095963|FG000|Overall Study|Withdrawal by Subject|1|||
25003347|NCT03547635|50095970|FG000|Overall Study|Adverse Event|5|||
25003348|NCT03547635|50095971|FG001|Overall Study|Adverse Event|2|||
25003349|NCT03547635|50095972|FG002|Overall Study|Adverse Event|3|||
25003350|NCT03547635|50095970|FG000|Overall Study|Lost to Follow-up|1|||
25003351|NCT03547635|50095971|FG001|Overall Study|Lost to Follow-up|3|||
25003352|NCT03547635|50095972|FG002|Overall Study|Lost to Follow-up|4|||
25003353|NCT03547635|50095970|FG000|Overall Study|Withdrawal by Subject|1|||
25003354|NCT03547635|50095971|FG001|Overall Study|Withdrawal by Subject|0|||
25003355|NCT03547635|50095972|FG002|Overall Study|Withdrawal by Subject|0|||
25003356|NCT03547635|50095970|FG000|Overall Study|Withdrawal By PI|0|||
25003357|NCT03547635|50095971|FG001|Overall Study|Withdrawal By PI|1|||
25003358|NCT03547635|50095972|FG002|Overall Study|Withdrawal By PI|0|||
25003359|NCT03547635|50095970|FG000|Overall Study|Withdrawal by Sponsor|0|||
25003360|NCT03547635|50095971|FG001|Overall Study|Withdrawal by Sponsor|0|||
25003361|NCT03547635|50095972|FG002|Overall Study|Withdrawal by Sponsor|1|||
25003362|NCT03547635|50095970|FG000|Overall Study|Errant Randomization before Treatment|0|||
25003363|NCT03547635|50095971|FG001|Overall Study|Errant Randomization before Treatment|1|||
25003364|NCT03547635|50095972|FG002|Overall Study|Errant Randomization before Treatment|0|||
25003365|NCT03547635|50095970|FG000|Overall Study|Withdrawal by Subject|1|||
25003366|NCT03547635|50095971|FG001|Overall Study|Withdrawal by Subject|0|||
25003367|NCT03547635|50095972|FG002|Overall Study|Withdrawal by Subject|0|||
25003368|NCT03182738|50096026|FG000|Overall Study|Lost to Follow-up|9|||
25003369|NCT03182738|50096027|FG001|Overall Study|Lost to Follow-up|3|||
25003370|NCT03182738|50096026|FG000|Overall Study|Pregnancy|0|||
25003371|NCT03182738|50096027|FG001|Overall Study|Pregnancy|1|||
25003372|NCT03182738|50096026|FG000|Overall Study|Withdrawal by Subject|0|||
25003373|NCT03182738|50096027|FG001|Overall Study|Withdrawal by Subject|1|||
25003374|NCT03547167|50096035|FG000|Overall Study|Withdrawal by Subject|34|||
25003375|NCT03547167|50096036|FG001|Overall Study|Withdrawal by Subject|12|||
25003376|NCT03547167|50096035|FG000|Overall Study|Screen Failure|0|||
25003377|NCT03547167|50096036|FG001|Overall Study|Screen Failure|1|||
25003378|NCT03547167|50096035|FG000|Overall Study|Lost to Follow-up|59|||
25003379|NCT03547167|50096036|FG001|Overall Study|Lost to Follow-up|15|||
25003380|NCT03547167|50096035|FG000|Overall Study|Death|4|||
25003381|NCT03547167|50096036|FG001|Overall Study|Death|2|||
25003382|NCT03560739|50096050|FG000|Overall Study|Adverse Event|0|||
25003383|NCT03560739|50096051|FG001|Overall Study|Adverse Event|1|||
25176627|NCT01531153|50320254|FG000|Overall Study|Withdrawal by Subject|10|||
25176628|NCT01531153|50320255|FG001|Overall Study|Withdrawal by Subject|9|||
25176629|NCT01531153|50320256|FG002|Overall Study|Withdrawal by Subject|15|||
25176630|NCT01529749|50320271|FG000|Overall Study|Lost to Follow-up|0|||
25176631|NCT01529749|50320272|FG001|Overall Study|Lost to Follow-up|1|||
25176632|NCT01529749|50320273|FG002|Overall Study|Lost to Follow-up|1|||
25176633|NCT01529749|50320274|FG003|Overall Study|Lost to Follow-up|0|||
25176634|NCT01529749|50320271|FG000|Overall Study|Physician Decision|0|||
25176635|NCT01529749|50320272|FG001|Overall Study|Physician Decision|0|||
25176636|NCT01529749|50320273|FG002|Overall Study|Physician Decision|0|||
25176637|NCT01529749|50320274|FG003|Overall Study|Physician Decision|1|||
25176638|NCT01529749|50320271|FG000|Overall Study|Withdrawal by Subject|0|||
25176639|NCT01529749|50320272|FG001|Overall Study|Withdrawal by Subject|1|||
25176640|NCT01529749|50320273|FG002|Overall Study|Withdrawal by Subject|1|||
25176641|NCT01529749|50320274|FG003|Overall Study|Withdrawal by Subject|0|||
25176642|NCT01529749|50320271|FG000|Overall Study|Protocol Violation|0|||
25176643|NCT01529749|50320272|FG001|Overall Study|Protocol Violation|0|||
25176644|NCT01529749|50320273|FG002|Overall Study|Protocol Violation|0|||
25176645|NCT01529749|50320274|FG003|Overall Study|Protocol Violation|1|||
25176646|NCT01529515|50320286|FG000|TRANSITION PHASE|Adverse Event|16|||
25176647|NCT01529515|50320287|FG001|TRANSITION PHASE|Adverse Event|0|||
25176648|NCT01529515|50320288|FG002|TRANSITION PHASE|Adverse Event|0|||
25176649|NCT01529515|50320289|FG003|TRANSITION PHASE|Adverse Event|0|||
25176650|NCT01529515|50320286|FG000|TRANSITION PHASE|Death|1|||
25176651|NCT01529515|50320287|FG001|TRANSITION PHASE|Death|0|||
25176652|NCT01529515|50320288|FG002|TRANSITION PHASE|Death|0|||
25176653|NCT01529515|50320289|FG003|TRANSITION PHASE|Death|0|||
25176654|NCT01529515|50320286|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
25176655|NCT01529515|50320287|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
25176656|NCT01529515|50320288|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
25176657|NCT01529515|50320289|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
25176658|NCT01529515|50320286|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
25176659|NCT01529515|50320287|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
25176660|NCT01529515|50320288|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
25176661|NCT01529515|50320289|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
25176662|NCT01529515|50320286|FG000|TRANSITION PHASE|Protocol Violation|4|||
25176663|NCT01529515|50320287|FG001|TRANSITION PHASE|Protocol Violation|0|||
25176664|NCT01529515|50320288|FG002|TRANSITION PHASE|Protocol Violation|0|||
25176665|NCT01529515|50320289|FG003|TRANSITION PHASE|Protocol Violation|0|||
25176666|NCT01529515|50320286|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
25176667|NCT01529515|50320287|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
25176668|NCT01529515|50320288|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
25176669|NCT01529515|50320289|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
25003384|NCT03560739|50096052|FG002|Overall Study|Adverse Event|0|||
25003385|NCT03560739|50096053|FG003|Overall Study|Adverse Event|0|||
25003386|NCT00101686|50096073|FG000|Overall Study|Progressive Disease|37|||
25003387|NCT00101686|50096074|FG001|Overall Study|Progressive Disease|28|||
25003388|NCT00101686|50096075|FG002|Overall Study|Progressive Disease|37|||
25176670|NCT01529515|50320286|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
25176671|NCT01529515|50320287|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
25176672|NCT01529515|50320288|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
25176673|NCT01529515|50320289|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
25176674|NCT01529515|50320286|FG000|TRANSITION PHASE|Other|9|||
25176675|NCT01529515|50320287|FG001|TRANSITION PHASE|Other|0|||
25176676|NCT01529515|50320288|FG002|TRANSITION PHASE|Other|0|||
25176677|NCT01529515|50320289|FG003|TRANSITION PHASE|Other|0|||
25176678|NCT01529515|50320286|FG000|MAINTENANCE PHASE|Adverse Event|0|||
25176679|NCT01529515|50320287|FG001|MAINTENANCE PHASE|Adverse Event|10|||
25176680|NCT01529515|50320288|FG002|MAINTENANCE PHASE|Adverse Event|0|||
25176681|NCT01529515|50320289|FG003|MAINTENANCE PHASE|Adverse Event|0|||
25176682|NCT01529515|50320286|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
25176683|NCT01529515|50320287|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
25176684|NCT01529515|50320288|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
25176685|NCT01529515|50320289|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
25176686|NCT01529515|50320286|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
25176687|NCT01529515|50320287|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
25176688|NCT01529515|50320288|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
25176689|NCT01529515|50320289|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
25176690|NCT01529515|50320286|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
25176691|NCT01529515|50320287|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
25176692|NCT01529515|50320288|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
25176693|NCT01529515|50320289|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
25176694|NCT01529515|50320286|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
25176695|NCT01529515|50320287|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
25176696|NCT01529515|50320288|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
25176697|NCT01529515|50320289|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
25003389|NCT00101686|50096076|FG003|Overall Study|Progressive Disease|38|||
25003390|NCT00101686|50096077|FG004|Overall Study|Progressive Disease|28|||
25003391|NCT00101686|50096078|FG005|Overall Study|Progressive Disease|25|||
25003392|NCT00101686|50096079|FG006|Overall Study|Progressive Disease|5|||
25003393|NCT00101686|50096080|FG007|Overall Study|Progressive Disease|7|||
25003394|NCT00101686|50096081|FG008|Overall Study|Progressive Disease|10|||
25003395|NCT00101686|50096082|FG009|Overall Study|Progressive Disease|8|||
25003396|NCT00101686|50096073|FG000|Overall Study|initiation other anti-cancer treatment|4|||
25003397|NCT00101686|50096074|FG001|Overall Study|initiation other anti-cancer treatment|3|||
25003398|NCT00101686|50096075|FG002|Overall Study|initiation other anti-cancer treatment|4|||
25003399|NCT00101686|50096076|FG003|Overall Study|initiation other anti-cancer treatment|3|||
25003400|NCT00101686|50096077|FG004|Overall Study|initiation other anti-cancer treatment|1|||
25003401|NCT00101686|50096078|FG005|Overall Study|initiation other anti-cancer treatment|1|||
25003402|NCT00101686|50096079|FG006|Overall Study|initiation other anti-cancer treatment|2|||
25003403|NCT00101686|50096080|FG007|Overall Study|initiation other anti-cancer treatment|2|||
25003404|NCT00101686|50096081|FG008|Overall Study|initiation other anti-cancer treatment|3|||
25003405|NCT00101686|50096082|FG009|Overall Study|initiation other anti-cancer treatment|3|||
25003406|NCT00101686|50096073|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
25003407|NCT00101686|50096074|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
25003408|NCT00101686|50096075|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
25003409|NCT00101686|50096076|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
25003410|NCT00101686|50096077|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
25003411|NCT00101686|50096078|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
25003412|NCT00101686|50096079|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
25003413|NCT00101686|50096080|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
25003414|NCT00101686|50096081|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
25003415|NCT00101686|50096082|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
25003416|NCT00101686|50096073|FG000|Overall Study|unacceptable toxicity|3|||
25003417|NCT00101686|50096074|FG001|Overall Study|unacceptable toxicity|9|||
25003418|NCT00101686|50096075|FG002|Overall Study|unacceptable toxicity|10|||
25003419|NCT00101686|50096076|FG003|Overall Study|unacceptable toxicity|6|||
25003420|NCT00101686|50096077|FG004|Overall Study|unacceptable toxicity|16|||
25003421|NCT00101686|50096078|FG005|Overall Study|unacceptable toxicity|10|||
25003422|NCT00101686|50096079|FG006|Overall Study|unacceptable toxicity|4|||
25003423|NCT00101686|50096080|FG007|Overall Study|unacceptable toxicity|2|||
25003424|NCT00101686|50096081|FG008|Overall Study|unacceptable toxicity|1|||
25003425|NCT00101686|50096082|FG009|Overall Study|unacceptable toxicity|4|||
25003426|NCT00101686|50096073|FG000|Overall Study|Randomized but did not receive treament|1|||
25003427|NCT00101686|50096074|FG001|Overall Study|Randomized but did not receive treament|6|||
25003428|NCT00101686|50096075|FG002|Overall Study|Randomized but did not receive treament|2|||
25003429|NCT00101686|50096076|FG003|Overall Study|Randomized but did not receive treament|2|||
25003430|NCT00101686|50096077|FG004|Overall Study|Randomized but did not receive treament|2|||
25003431|NCT00101686|50096078|FG005|Overall Study|Randomized but did not receive treament|2|||
25176698|NCT01529515|50320286|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
25176699|NCT01529515|50320287|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
25176700|NCT01529515|50320288|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
25176701|NCT01529515|50320289|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
25003432|NCT00101686|50096079|FG006|Overall Study|Randomized but did not receive treament|0|||
25176702|NCT01529515|50320286|FG000|MAINTENANCE PHASE|Other|0|||
25003433|NCT00101686|50096080|FG007|Overall Study|Randomized but did not receive treament|1|||
25003434|NCT00101686|50096081|FG008|Overall Study|Randomized but did not receive treament|0|||
25003435|NCT00101686|50096082|FG009|Overall Study|Randomized but did not receive treament|1|||
25003436|NCT00101686|50096073|FG000|Overall Study|intercurrent non-cancer related illness|0|||
25003437|NCT00101686|50096074|FG001|Overall Study|intercurrent non-cancer related illness|0|||
25003438|NCT00101686|50096075|FG002|Overall Study|intercurrent non-cancer related illness|2|||
25003439|NCT00101686|50096076|FG003|Overall Study|intercurrent non-cancer related illness|0|||
25003440|NCT00101686|50096077|FG004|Overall Study|intercurrent non-cancer related illness|1|||
25003441|NCT00101686|50096078|FG005|Overall Study|intercurrent non-cancer related illness|3|||
25003442|NCT00101686|50096079|FG006|Overall Study|intercurrent non-cancer related illness|1|||
25003443|NCT00101686|50096080|FG007|Overall Study|intercurrent non-cancer related illness|0|||
25003444|NCT00101686|50096081|FG008|Overall Study|intercurrent non-cancer related illness|1|||
25003445|NCT00101686|50096082|FG009|Overall Study|intercurrent non-cancer related illness|1|||
25003446|NCT00101686|50096073|FG000|Overall Study|Physician Decision|10|||
25003447|NCT00101686|50096074|FG001|Overall Study|Physician Decision|13|||
25003448|NCT00101686|50096075|FG002|Overall Study|Physician Decision|6|||
25003449|NCT00101686|50096076|FG003|Overall Study|Physician Decision|7|||
25003450|NCT00101686|50096077|FG004|Overall Study|Physician Decision|8|||
25003451|NCT00101686|50096078|FG005|Overall Study|Physician Decision|9|||
25003452|NCT00101686|50096079|FG006|Overall Study|Physician Decision|5|||
25003453|NCT00101686|50096080|FG007|Overall Study|Physician Decision|5|||
25003454|NCT00101686|50096081|FG008|Overall Study|Physician Decision|1|||
25003455|NCT00101686|50096082|FG009|Overall Study|Physician Decision|1|||
25003456|NCT00101686|50096073|FG000|Overall Study|Other|1|||
25003457|NCT00101686|50096074|FG001|Overall Study|Other|4|||
25003458|NCT00101686|50096075|FG002|Overall Study|Other|1|||
25003459|NCT00101686|50096076|FG003|Overall Study|Other|6|||
25003460|NCT00101686|50096077|FG004|Overall Study|Other|2|||
25003461|NCT00101686|50096078|FG005|Overall Study|Other|12|||
25003462|NCT00101686|50096079|FG006|Overall Study|Other|1|||
25003463|NCT00101686|50096080|FG007|Overall Study|Other|5|||
25003464|NCT00101686|50096081|FG008|Overall Study|Other|3|||
25003465|NCT00101686|50096082|FG009|Overall Study|Other|3|||
25003466|NCT00101686|50096073|FG000|Overall Study|Withdrawal by Subject|9|||
25003467|NCT00101686|50096074|FG001|Overall Study|Withdrawal by Subject|8|||
25003468|NCT00101686|50096075|FG002|Overall Study|Withdrawal by Subject|6|||
25003469|NCT00101686|50096076|FG003|Overall Study|Withdrawal by Subject|8|||
25003470|NCT00101686|50096077|FG004|Overall Study|Withdrawal by Subject|8|||
25003471|NCT00101686|50096078|FG005|Overall Study|Withdrawal by Subject|7|||
25003472|NCT00101686|50096079|FG006|Overall Study|Withdrawal by Subject|7|||
25003473|NCT00101686|50096080|FG007|Overall Study|Withdrawal by Subject|7|||
25003474|NCT00101686|50096081|FG008|Overall Study|Withdrawal by Subject|8|||
25003475|NCT00101686|50096082|FG009|Overall Study|Withdrawal by Subject|9|||
25003476|NCT00101452|50096102|FG000|Overall Study|Adverse Event|2|||
25003477|NCT00101452|50096103|FG001|Overall Study|Adverse Event|0|||
25003478|NCT00101452|50096104|FG002|Overall Study|Adverse Event|1|||
25003479|NCT00101452|50096102|FG000|Overall Study|Lost to Follow-up|13|||
25003480|NCT00101452|50096103|FG001|Overall Study|Lost to Follow-up|8|||
25003481|NCT00101452|50096104|FG002|Overall Study|Lost to Follow-up|14|||
25003482|NCT00101452|50096102|FG000|Overall Study|Withdrawal by Subject|10|||
25003483|NCT00101452|50096103|FG001|Overall Study|Withdrawal by Subject|14|||
25003484|NCT00101452|50096104|FG002|Overall Study|Withdrawal by Subject|9|||
25003485|NCT00101452|50096102|FG000|Overall Study|Baseline Fail|2|||
25003486|NCT00101452|50096103|FG001|Overall Study|Baseline Fail|1|||
25003487|NCT00101452|50096104|FG002|Overall Study|Baseline Fail|2|||
25003488|NCT00101452|50096102|FG000|Overall Study|Physician Decision|0|||
25003489|NCT00101452|50096103|FG001|Overall Study|Physician Decision|3|||
25003490|NCT00101452|50096104|FG002|Overall Study|Physician Decision|2|||
25003491|NCT00101452|50096102|FG000|Overall Study|Protocol Violation|2|||
25003492|NCT00101452|50096103|FG001|Overall Study|Protocol Violation|1|||
25003493|NCT00101452|50096104|FG002|Overall Study|Protocol Violation|3|||
25003494|NCT00101452|50096102|FG000|Overall Study|Other|15|||
25003495|NCT00101452|50096103|FG001|Overall Study|Other|16|||
25003496|NCT00101452|50096104|FG002|Overall Study|Other|12|||
25003497|NCT03546621|50096120|FG000|Overall Study|Withdrawal by Subject|0|||
25003498|NCT03546621|50096121|FG001|Overall Study|Withdrawal by Subject|1|||
25003499|NCT03546621|50096122|FG002|Overall Study|Withdrawal by Subject|2|||
25003500|NCT03546621|50096123|FG003|Overall Study|Withdrawal by Subject|1|||
25003501|NCT03546621|50096120|FG000|Overall Study|Lost to Follow-up|0|||
25003502|NCT03546621|50096121|FG001|Overall Study|Lost to Follow-up|1|||
25003503|NCT03546621|50096122|FG002|Overall Study|Lost to Follow-up|0|||
25003504|NCT03546621|50096123|FG003|Overall Study|Lost to Follow-up|0|||
25003505|NCT03546621|50096120|FG000|Overall Study|Adverse Event|0|||
25003506|NCT03546621|50096121|FG001|Overall Study|Adverse Event|1|||
25003507|NCT03546621|50096122|FG002|Overall Study|Adverse Event|0|||
25003508|NCT03546621|50096123|FG003|Overall Study|Adverse Event|1|||
25003509|NCT03546621|50096120|FG000|Overall Study|Progressive disease|0|||
25003510|NCT03546621|50096121|FG001|Overall Study|Progressive disease|0|||
25003511|NCT03546621|50096122|FG002|Overall Study|Progressive disease|0|||
25003512|NCT03546621|50096123|FG003|Overall Study|Progressive disease|1|||
25003513|NCT02761330|50096133|FG000|Treatment Week 1|Withdrawal by Subject|0|||
25003514|NCT02761330|50096134|FG001|Treatment Week 1|Withdrawal by Subject|0|||
25003515|NCT02761330|50096135|FG002|Treatment Week 1|Withdrawal by Subject|0|||
25003516|NCT02761330|50096136|FG003|Treatment Week 1|Withdrawal by Subject|1|||
25003517|NCT02761330|50096137|FG004|Treatment Week 1|Withdrawal by Subject|0|||
25003518|NCT02761330|50096138|FG005|Treatment Week 1|Withdrawal by Subject|1|||
25003519|NCT03559257|50096154|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
25003520|NCT03559257|50096155|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
25003521|NCT03559257|50096154|FG000|Double Blind Treatment Period|Protocol Violation|1|||
25003522|NCT03559257|50096155|FG001|Double Blind Treatment Period|Protocol Violation|4|||
25003523|NCT03559257|50096154|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
25003524|NCT03559257|50096155|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
25003525|NCT03559257|50096154|FG000|Double Blind Treatment Period|Adverse Event|0|||
25003526|NCT03559257|50096155|FG001|Double Blind Treatment Period|Adverse Event|1|||
25003527|NCT03559257|50096154|FG000|Double Blind Treatment Period|Screen Failure|0|||
25003528|NCT03559257|50096155|FG001|Double Blind Treatment Period|Screen Failure|1|||
25003529|NCT03559257|50096154|FG000|Open-label Treatment Period|Adverse Event|1|||
25003530|NCT03559257|50096155|FG001|Open-label Treatment Period|Adverse Event|4|||
25003531|NCT03559257|50096154|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
25003532|NCT03559257|50096155|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
25003533|NCT03559257|50096154|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
25003534|NCT03559257|50096155|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
25003535|NCT03559257|50096154|FG000|Open-label Treatment Period|Protocol Violation|2|||
25003536|NCT03559257|50096155|FG001|Open-label Treatment Period|Protocol Violation|0|||
25003537|NCT03559257|50096154|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
25003538|NCT03559257|50096155|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
25003539|NCT03559257|50096154|FG000|Open-label Treatment Period|Physician Decision|0|||
25003540|NCT03559257|50096155|FG001|Open-label Treatment Period|Physician Decision|1|||
25003541|NCT02892513|50096166|FG000|Overall Study|Withdrawal by Subject|0|||
25003542|NCT02892513|50096167|FG001|Overall Study|Withdrawal by Subject|1|||
25003543|NCT03558555|50096175|FG000|Overall Study|Lost to Follow-up|2|||
25003544|NCT03558555|50096176|FG001|Overall Study|Lost to Follow-up|1|||
25003545|NCT03541317|50096184|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
25003546|NCT03541317|50096185|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
25003547|NCT03541317|50096186|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
25003548|NCT03541317|50096187|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
25003549|NCT03541317|50096188|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
25003550|NCT03541317|50096189|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
25003551|NCT03590613|50096201|FG000|Period 2, 4 Days|Physician Decision|0|||
25003552|NCT03590613|50096202|FG001|Period 2, 4 Days|Physician Decision|0|||
25003553|NCT03590613|50096203|FG002|Period 2, 4 Days|Physician Decision|0|||
25003554|NCT03590613|50096204|FG003|Period 2, 4 Days|Physician Decision|1|||
25003555|NCT03557931|50096220|FG000|Overall Study|Adverse Event|4|||
25003556|NCT03557931|50096221|FG001|Overall Study|Adverse Event|6|||
25003557|NCT03557931|50096222|FG002|Overall Study|Adverse Event|1|||
25003558|NCT03557931|50096220|FG000|Overall Study|Lost to Follow-up|4|||
25003559|NCT03557931|50096221|FG001|Overall Study|Lost to Follow-up|4|||
25003560|NCT03557931|50096222|FG002|Overall Study|Lost to Follow-up|1|||
25003561|NCT03557931|50096220|FG000|Overall Study|Protocol Violation|1|||
25003562|NCT03557931|50096221|FG001|Overall Study|Protocol Violation|4|||
25003563|NCT03557931|50096222|FG002|Overall Study|Protocol Violation|1|||
25003564|NCT03557931|50096220|FG000|Overall Study|Withdrawal by Subject|14|||
25003565|NCT03557931|50096221|FG001|Overall Study|Withdrawal by Subject|0|||
25003566|NCT03557931|50096222|FG002|Overall Study|Withdrawal by Subject|7|||
25003567|NCT03557931|50096220|FG000|Overall Study|Miscellaneous|8|||
25003568|NCT03557931|50096221|FG001|Overall Study|Miscellaneous|5|||
25003569|NCT03557931|50096222|FG002|Overall Study|Miscellaneous|3|||
25003570|NCT03522675|50096232|FG000|Overall Study|Screen fail|1|||
25003571|NCT03522675|50096232|FG000|Overall Study|Non-reactive to histamine|1|||
25003572|NCT00294047|50096242|FG000|Month 48|Adverse Event|28|||
25176703|NCT01529515|50320287|FG001|MAINTENANCE PHASE|Other|10|||
25003573|NCT00294047|50096243|FG001|Month 48|Adverse Event|13|||
25003574|NCT00294047|50096242|FG000|Month 48|Protocol Violation|4|||
25003575|NCT00294047|50096243|FG001|Month 48|Protocol Violation|4|||
25003576|NCT00294047|50096242|FG000|Month 48|Withdrawal by Subject|111|||
25003577|NCT00294047|50096243|FG001|Month 48|Withdrawal by Subject|115|||
25003578|NCT00294047|50096242|FG000|Month 48|Lost to Follow-up|272|||
25003579|NCT00294047|50096243|FG001|Month 48|Lost to Follow-up|287|||
25003580|NCT00294047|50096242|FG000|Month 48|Other|10|||
25003581|NCT00294047|50096243|FG001|Month 48|Other|14|||
25003582|NCT00294047|50096242|FG000|Month 84|Adverse Event|4|||
25003583|NCT00294047|50096243|FG001|Month 84|Adverse Event|2|||
25003584|NCT00294047|50096242|FG000|Month 84|Protocol Violation|1|||
25003585|NCT00294047|50096243|FG001|Month 84|Protocol Violation|1|||
25003586|NCT00294047|50096242|FG000|Month 84|Withdrawal by Subject|33|||
25003587|NCT00294047|50096243|FG001|Month 84|Withdrawal by Subject|31|||
25003588|NCT00294047|50096242|FG000|Month 84|Lost to Follow-up|187|||
25003589|NCT00294047|50096243|FG001|Month 84|Lost to Follow-up|190|||
25003590|NCT00294047|50096242|FG000|Month 84|Absent Cervix|2|||
25003591|NCT00294047|50096243|FG001|Month 84|Absent Cervix|0|||
25003592|NCT00294047|50096242|FG000|Month 84|Work related reasons|4|||
25003593|NCT00294047|50096243|FG001|Month 84|Work related reasons|2|||
25003594|NCT00294047|50096242|FG000|Month 84|Center closed, subject did not transfer|1|||
25003595|NCT00294047|50096243|FG001|Month 84|Center closed, subject did not transfer|0|||
25003596|NCT00294047|50096242|FG000|Month 84|Family problems|2|||
25003597|NCT00294047|50096243|FG001|Month 84|Family problems|2|||
25003598|NCT00294047|50096242|FG000|Month 84|Lack of time|3|||
25003599|NCT00294047|50096243|FG001|Month 84|Lack of time|1|||
25003600|NCT00294047|50096242|FG000|Month 84|Personal reason|2|||
25003601|NCT00294047|50096243|FG001|Month 84|Personal reason|4|||
25003602|NCT00294047|50096242|FG000|Month 84|Subject does not want male physician|1|||
25003603|NCT00294047|50096243|FG001|Month 84|Subject does not want male physician|0|||
25003604|NCT00294047|50096242|FG000|Month 84|Transport reimbursement delayed|0|||
25003605|NCT00294047|50096243|FG001|Month 84|Transport reimbursement delayed|1|||
25003606|NCT00294047|50096242|FG000|Month 84|Unable to reach study site|1|||
25003607|NCT00294047|50096243|FG001|Month 84|Unable to reach study site|0|||
25003608|NCT00294047|50096242|FG000|Month 84|Under investigation locally|1|||
25003609|NCT00294047|50096243|FG001|Month 84|Under investigation locally|0|||
25003610|NCT00294047|50096242|FG000|Month 84|Visit missed|0|||
25003611|NCT00294047|50096243|FG001|Month 84|Visit missed|1|||
25003612|NCT00294047|50096242|FG000|Month 84|No consent for Month 84 Follow-up|731|||
25003613|NCT00294047|50096243|FG001|Month 84|No consent for Month 84 Follow-up|754|||
25003614|NCT00293813|50096253|FG000|Overall Study|Physician Decision|0|||
25003615|NCT00293813|50096254|FG001|Overall Study|Physician Decision|1|||
25003616|NCT00293813|50096255|FG002|Overall Study|Physician Decision|0|||
25003617|NCT00293813|50096253|FG000|Overall Study|Adverse Event|3|||
25003618|NCT00293813|50096254|FG001|Overall Study|Adverse Event|1|||
25003619|NCT00293813|50096255|FG002|Overall Study|Adverse Event|1|||
25003620|NCT00293813|50096253|FG000|Overall Study|Withdrawal by Subject|7|||
25003621|NCT00293813|50096254|FG001|Overall Study|Withdrawal by Subject|4|||
25003622|NCT00293813|50096255|FG002|Overall Study|Withdrawal by Subject|4|||
25003623|NCT00293813|50096253|FG000|Overall Study|Lost to Follow-up|3|||
25003624|NCT00293813|50096254|FG001|Overall Study|Lost to Follow-up|2|||
25003625|NCT00293813|50096255|FG002|Overall Study|Lost to Follow-up|3|||
25003626|NCT00293813|50096253|FG000|Overall Study|Noncompliance|0|||
25003627|NCT00293813|50096254|FG001|Overall Study|Noncompliance|1|||
25003628|NCT00293813|50096255|FG002|Overall Study|Noncompliance|0|||
25003629|NCT00293579|50096263|FG000|Overall Study|Withdrawal by Subject|1|||
25003630|NCT00293423|50096270|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
25003631|NCT00293423|50096271|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
25003632|NCT00293423|50096270|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
25003633|NCT00293423|50096271|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
25003634|NCT00293423|50096270|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
25003635|NCT00293423|50096271|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
25003636|NCT00293423|50096270|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
25003637|NCT00293423|50096271|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
25003638|NCT00293423|50096270|FG000|Surgical Resection|processing error during surgical resection|1|||
25003639|NCT00293423|50096271|FG001|Surgical Resection|processing error during surgical resection|0|||
25003640|NCT00293423|50096270|FG000|Surgical Resection|Withdrawal by Subject|4|||
25003641|NCT00293423|50096271|FG001|Surgical Resection|Withdrawal by Subject|0|||
25003642|NCT00293423|50096270|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
25003643|NCT00293423|50096271|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
25003644|NCT03538743|50096286|FG000|Overall Study|Adverse Event|0|||
25003645|NCT03538743|50096287|FG001|Overall Study|Adverse Event|0|||
25003646|NCT03538743|50096288|FG002|Overall Study|Adverse Event|1|||
25003647|NCT03538743|50096289|FG003|Overall Study|Adverse Event|1|||
25003648|NCT03538743|50096290|FG004|Overall Study|Adverse Event|0|||
25003649|NCT03538743|50096291|FG005|Overall Study|Adverse Event|0|||
25003650|NCT03538743|50096292|FG006|Overall Study|Adverse Event|0|||
25003651|NCT03538743|50096293|FG007|Overall Study|Adverse Event|0|||
25003652|NCT03538743|50096294|FG008|Overall Study|Adverse Event|0|||
25003653|NCT03538743|50096286|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
25003654|NCT03538743|50096287|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
25003655|NCT03538743|50096288|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
25003656|NCT03538743|50096289|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
25003657|NCT03538743|50096290|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
25003658|NCT03538743|50096291|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
25003659|NCT03538743|50096292|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
25003660|NCT03538743|50096293|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
25003661|NCT03538743|50096294|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
25003662|NCT03538743|50096286|FG000|Overall Study|Withdrawal by Subject|0|||
25003663|NCT03538743|50096287|FG001|Overall Study|Withdrawal by Subject|0|||
25003664|NCT03538743|50096288|FG002|Overall Study|Withdrawal by Subject|0|||
25003665|NCT03538743|50096289|FG003|Overall Study|Withdrawal by Subject|1|||
25003666|NCT03538743|50096290|FG004|Overall Study|Withdrawal by Subject|0|||
25003667|NCT03538743|50096291|FG005|Overall Study|Withdrawal by Subject|0|||
25003668|NCT03538743|50096292|FG006|Overall Study|Withdrawal by Subject|0|||
25003669|NCT03538743|50096293|FG007|Overall Study|Withdrawal by Subject|0|||
25003670|NCT03538743|50096294|FG008|Overall Study|Withdrawal by Subject|0|||
25003671|NCT03521817|50096324|FG000|Overall Study|Protocol Violation|0|||
25003672|NCT03521817|50096325|FG001|Overall Study|Protocol Violation|1|||
25003673|NCT03538431|50096331|FG000|Overall Study|Physician Decision|0|||
25003674|NCT03538431|50096332|FG001|Overall Study|Physician Decision|1|||
25003675|NCT03538431|50096331|FG000|Overall Study|Withdrawal by Subject|1|||
25003676|NCT03538431|50096332|FG001|Overall Study|Withdrawal by Subject|0|||
25003677|NCT03521193|50096342|FG000|Overall Study|Withdrawal by Subject|8|||
25003678|NCT03521193|50096343|FG001|Overall Study|Withdrawal by Subject|0|||
25003679|NCT03521193|50096342|FG000|Overall Study|non compliant to ASA treatment|8|||
25003680|NCT03521193|50096343|FG001|Overall Study|non compliant to ASA treatment|0|||
25003681|NCT03538041|50096352|FG000|12-Week Treatment Period|Adverse Event|1|||
25003682|NCT03538041|50096353|FG001|12-Week Treatment Period|Adverse Event|1|||
25003683|NCT03538041|50096352|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
25003684|NCT03538041|50096353|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
25003685|NCT03538041|50096352|FG000|Treatment Extension Period|Adverse Event|4|||
25003686|NCT03538041|50096353|FG001|Treatment Extension Period|Adverse Event|0|||
25003687|NCT03538041|50096352|FG000|Treatment Extension Period|Physician Decision|1|||
25003688|NCT03538041|50096353|FG001|Treatment Extension Period|Physician Decision|0|||
25003689|NCT03538041|50096352|FG000|Treatment Extension Period|Lack of Efficacy|1|||
25003690|NCT03538041|50096353|FG001|Treatment Extension Period|Lack of Efficacy|3|||
25003691|NCT03538041|50096352|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1|||
25003692|NCT03538041|50096353|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7|||
25003693|NCT03521115|50096364|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
25003694|NCT03521115|50096365|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
25003695|NCT03521115|50096364|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
25003696|NCT03521115|50096365|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
25003697|NCT00293267|50096379|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
25003698|NCT00293267|50096380|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
25003699|NCT00293267|50096379|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
25003700|NCT00293267|50096380|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
25003701|NCT00293267|50096379|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
25003702|NCT00293267|50096380|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
25003703|NCT00293267|50096379|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
25003704|NCT00293267|50096380|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
25003705|NCT00293267|50096379|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
25003706|NCT00293267|50096380|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
25003707|NCT00293267|50096379|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
25003708|NCT00293267|50096380|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
25003709|NCT00293267|50096379|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
25003710|NCT00293267|50096380|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
25003711|NCT00293267|50096379|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
25003712|NCT00293267|50096380|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
25003713|NCT00293267|50096379|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
25003714|NCT00293267|50096380|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
25003715|NCT00293267|50096379|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
25003716|NCT00293267|50096380|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
25003717|NCT00293267|50096379|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
25003718|NCT00293267|50096380|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
25003719|NCT00293267|50096379|FG000|Extension - Double-Blind Week 49-156|Death|3|||
25003720|NCT00293267|50096380|FG001|Extension - Double-Blind Week 49-156|Death|0|||
25003721|NCT00293267|50096379|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
25003722|NCT00293267|50096380|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
25003723|NCT00293267|50096379|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
25003724|NCT00293267|50096380|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
25003725|NCT00293267|50096379|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
25003726|NCT00293267|50096380|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
25003727|NCT00293267|50096379|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
25091353|NCT02676895|50200959|FG000|Overall Study|Protocol Violation|1|||
25091354|NCT02676895|50200960|FG001|Overall Study|Protocol Violation|0|||
25003728|NCT00293267|50096380|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
25003729|NCT00293267|50096379|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
25003730|NCT00293267|50096380|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
25003731|NCT00293267|50096379|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
25003732|NCT00293267|50096380|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
25003733|NCT00293267|50096379|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
25003734|NCT00293267|50096380|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
25003735|NCT00293267|50096379|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
25003736|NCT00293267|50096380|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
25003737|NCT00293267|50096379|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
25003738|NCT00293267|50096380|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
25003739|NCT00293267|50096379|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
25003740|NCT00293267|50096380|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
25003741|NCT00293267|50096379|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
25003742|NCT00293267|50096380|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
25003743|NCT00293267|50096379|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
25003744|NCT00293267|50096380|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
25003745|NCT00293267|50096379|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
25003746|NCT00293267|50096380|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
25003747|NCT00293267|50096379|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
25003748|NCT00293267|50096380|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
25003749|NCT00293267|50096379|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
25003750|NCT00293267|50096380|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
25003751|NCT00293267|50096379|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
25003752|NCT00293267|50096380|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
25003753|NCT03520959|50096390|FG000|Overall Study|Study terminated by Sponsor|0|||
25003754|NCT03520959|50096391|FG001|Overall Study|Study terminated by Sponsor|1|||
25003755|NCT03537261|50096399|FG000|Overall Study|Lost to Follow-up|4|||
25003756|NCT03537261|50096400|FG001|Overall Study|Lost to Follow-up|5|||
25003757|NCT03537261|50096399|FG000|Overall Study|Withdrawal by Subject|4|||
25003758|NCT03537261|50096400|FG001|Overall Study|Withdrawal by Subject|6|||
25003759|NCT03537261|50096399|FG000|Overall Study|Did not return study questionnaires|0|||
25003760|NCT03537261|50096400|FG001|Overall Study|Did not return study questionnaires|1|||
25003761|NCT03536949|50096408|FG000|Overall Study|Adverse Event|4|||
25003762|NCT03536949|50096409|FG001|Overall Study|Adverse Event|0|||
25003763|NCT03536949|50096408|FG000|Overall Study|Lost to Follow-up|2|||
25003764|NCT03536949|50096409|FG001|Overall Study|Lost to Follow-up|1|||
25003765|NCT03536949|50096408|FG000|Overall Study|Withdrawal by Subject|6|||
25003766|NCT03536949|50096409|FG001|Overall Study|Withdrawal by Subject|0|||
25003767|NCT03536949|50096408|FG000|Overall Study|Non-compliance|2|||
25003768|NCT03536949|50096409|FG001|Overall Study|Non-compliance|1|||
25003769|NCT03588741|50096415|FG000|Overall Study|Withdrawal by Subject|1|||
25003770|NCT00111917|50096421|FG000|Overall Study|Withdrawal by Subject|1|||
25003771|NCT00111917|50096422|FG001|Overall Study|Withdrawal by Subject|1|||
25003772|NCT03520569|50096432|FG000|Overall Study|Withdrawal by Subject|1|||
25003773|NCT00111839|50096445|FG000|Overall Study|Disease Progression|30|||
25003774|NCT00111839|50096446|FG001|Overall Study|Disease Progression|33|||
25003775|NCT00111839|50096447|FG002|Overall Study|Disease Progression|33|||
25003776|NCT00111839|50096445|FG000|Overall Study|Adverse Event|5|||
25003777|NCT00111839|50096446|FG001|Overall Study|Adverse Event|3|||
25003778|NCT00111839|50096447|FG002|Overall Study|Adverse Event|1|||
25003779|NCT00111839|50096445|FG000|Overall Study|Protocol Violation|2|||
25003780|NCT00111839|50096446|FG001|Overall Study|Protocol Violation|4|||
25003781|NCT00111839|50096447|FG002|Overall Study|Protocol Violation|2|||
25003782|NCT00111839|50096445|FG000|Overall Study|Death|1|||
25003783|NCT00111839|50096446|FG001|Overall Study|Death|1|||
25003784|NCT00111839|50096447|FG002|Overall Study|Death|6|||
25176704|NCT01529515|50320288|FG002|MAINTENANCE PHASE|Other|0|||
25176705|NCT01529515|50320289|FG003|MAINTENANCE PHASE|Other|0|||
25003785|NCT00111839|50096445|FG000|Overall Study|Withdrawal by Subject|2|||
25003786|NCT00111839|50096446|FG001|Overall Study|Withdrawal by Subject|2|||
25091355|NCT02676895|50200961|FG002|Overall Study|Protocol Violation|0|||
25091356|NCT02676895|50200959|FG000|Overall Study|Adverse Event|0|||
25091357|NCT02676895|50200960|FG001|Overall Study|Adverse Event|3|||
25091358|NCT02676895|50200961|FG002|Overall Study|Adverse Event|1|||
25091359|NCT02676895|50200959|FG000|Overall Study|Lost to Follow-up|0|||
25091360|NCT02676895|50200960|FG001|Overall Study|Lost to Follow-up|0|||
25091361|NCT02676895|50200961|FG002|Overall Study|Lost to Follow-up|1|||
25091362|NCT02676895|50200959|FG000|Overall Study|Withdrawal by Subject|0|||
25091363|NCT02676895|50200960|FG001|Overall Study|Withdrawal by Subject|0|||
25091364|NCT02676895|50200961|FG002|Overall Study|Withdrawal by Subject|1|||
25091365|NCT02673697|50200972|FG000|Overall Study|Adverse Event|2|||
25091366|NCT02673697|50200973|FG001|Overall Study|Adverse Event|0|||
25003787|NCT00111839|50096447|FG002|Overall Study|Withdrawal by Subject|2|||
25003788|NCT00111839|50096445|FG000|Overall Study|Lost to Follow-up|1|||
25003789|NCT00111839|50096446|FG001|Overall Study|Lost to Follow-up|0|||
25003790|NCT00111839|50096447|FG002|Overall Study|Lost to Follow-up|0|||
25003791|NCT00111839|50096445|FG000|Overall Study|Logistical Constraint|1|||
25003792|NCT00111839|50096446|FG001|Overall Study|Logistical Constraint|0|||
25003793|NCT00111839|50096447|FG002|Overall Study|Logistical Constraint|0|||
25003794|NCT00111839|50096445|FG000|Overall Study|Other|6|||
25003795|NCT00111839|50096446|FG001|Overall Study|Other|3|||
25003796|NCT00111839|50096447|FG002|Overall Study|Other|3|||
25003797|NCT00111839|50096445|FG000|Overall Study|Randomized but Not Treated|0|||
25003798|NCT00111839|50096446|FG001|Overall Study|Randomized but Not Treated|0|||
25003799|NCT00111839|50096447|FG002|Overall Study|Randomized but Not Treated|2|||
25003800|NCT00111761|50096457|FG000|Part 1|Physician Decision|0|||
25003801|NCT00111761|50096458|FG001|Part 1|Physician Decision|1|||
25003802|NCT00111761|50096457|FG000|Part 1|Death|0|||
25003803|NCT00111761|50096458|FG001|Part 1|Death|2|||
25003804|NCT00111761|50096457|FG000|Part 1|Other|0|||
25003805|NCT00111761|50096458|FG001|Part 1|Other|1|||
25003806|NCT00111761|50096457|FG000|Part 1|Withdrawal by Subject|0|||
25003807|NCT00111761|50096458|FG001|Part 1|Withdrawal by Subject|1|||
25003808|NCT00111761|50096457|FG000|Part 2|Adverse Event|1|||
25003809|NCT00111761|50096458|FG001|Part 2|Adverse Event|0|||
25003810|NCT00111761|50096457|FG000|Part 2|Physician Decision|1|||
25003811|NCT00111761|50096458|FG001|Part 2|Physician Decision|0|||
25003812|NCT00111761|50096457|FG000|Part 2|Death|1|||
25003813|NCT00111761|50096458|FG001|Part 2|Death|0|||
25003814|NCT00111761|50096457|FG000|Part 2|Disease progression|3|||
25003815|NCT00111761|50096458|FG001|Part 2|Disease progression|0|||
25003816|NCT00111761|50096457|FG000|Part 2|Protocol-specified criteria|1|||
25003817|NCT00111761|50096458|FG001|Part 2|Protocol-specified criteria|0|||
25003818|NCT00111761|50096457|FG000|Part 2|Other|1|||
25003819|NCT00111761|50096458|FG001|Part 2|Other|0|||
25003820|NCT03519867|50096474|FG000|Overall Study|Adverse Event|1|||
25003821|NCT03519867|50096475|FG001|Overall Study|Adverse Event|1|||
25003822|NCT03519867|50096476|FG002|Overall Study|Adverse Event|0|||
25003823|NCT03519867|50096477|FG003|Overall Study|Adverse Event|0|||
25003824|NCT03519867|50096478|FG004|Overall Study|Adverse Event|0|||
25003825|NCT03519867|50096479|FG005|Overall Study|Adverse Event|0|||
25003826|NCT03519867|50096480|FG006|Overall Study|Adverse Event|0|||
25003827|NCT03519867|50096481|FG007|Overall Study|Adverse Event|0|||
25003828|NCT03519867|50096482|FG008|Overall Study|Adverse Event|0|||
25003829|NCT03519867|50096483|FG009|Overall Study|Adverse Event|0|||
25003830|NCT03519867|50096474|FG000|Overall Study|Protocol Violation|0|||
25003831|NCT03519867|50096475|FG001|Overall Study|Protocol Violation|0|||
25003832|NCT03519867|50096476|FG002|Overall Study|Protocol Violation|0|||
25003833|NCT03519867|50096477|FG003|Overall Study|Protocol Violation|0|||
25003834|NCT03519867|50096478|FG004|Overall Study|Protocol Violation|0|||
25003835|NCT03519867|50096479|FG005|Overall Study|Protocol Violation|1|||
25003836|NCT03519867|50096480|FG006|Overall Study|Protocol Violation|0|||
25003837|NCT03519867|50096481|FG007|Overall Study|Protocol Violation|0|||
25003838|NCT03519867|50096482|FG008|Overall Study|Protocol Violation|0|||
25003839|NCT03519867|50096483|FG009|Overall Study|Protocol Violation|0|||
25176706|NCT01529515|50320286|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
25176707|NCT01529515|50320287|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
25176708|NCT01529515|50320288|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
25176709|NCT01529515|50320289|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
25176710|NCT01529515|50320286|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
25176711|NCT01529515|50320287|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
25176712|NCT01529515|50320288|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
25176713|NCT01529515|50320289|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
25176714|NCT01529515|50320286|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
25176715|NCT01529515|50320287|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
25176716|NCT01529515|50320288|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
25176717|NCT01529515|50320289|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
25176718|NCT01529515|50320286|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
25176719|NCT01529515|50320287|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
25003840|NCT03519867|50096474|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
25003841|NCT03519867|50096475|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
25003842|NCT03519867|50096476|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
25003843|NCT03519867|50096477|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
25003844|NCT03519867|50096478|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
25003845|NCT03519867|50096479|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
25003846|NCT03519867|50096480|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
25003847|NCT03519867|50096481|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
25003848|NCT03519867|50096482|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
25003849|NCT03519867|50096483|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
25003850|NCT03519867|50096474|FG000|Overall Study|Admin. of other reversal agent|1|||
25003851|NCT03519867|50096475|FG001|Overall Study|Admin. of other reversal agent|1|||
25003852|NCT03519867|50096476|FG002|Overall Study|Admin. of other reversal agent|0|||
25003853|NCT03519867|50096477|FG003|Overall Study|Admin. of other reversal agent|0|||
25003854|NCT03519867|50096478|FG004|Overall Study|Admin. of other reversal agent|0|||
25003855|NCT03519867|50096479|FG005|Overall Study|Admin. of other reversal agent|1|||
25003856|NCT03519867|50096480|FG006|Overall Study|Admin. of other reversal agent|0|||
25003857|NCT03519867|50096481|FG007|Overall Study|Admin. of other reversal agent|0|||
25003858|NCT03519867|50096482|FG008|Overall Study|Admin. of other reversal agent|0|||
25003859|NCT03519867|50096483|FG009|Overall Study|Admin. of other reversal agent|0|||
25003860|NCT03519867|50096474|FG000|Overall Study|Reason not provided|1|||
25003861|NCT03519867|50096475|FG001|Overall Study|Reason not provided|1|||
25003862|NCT03519867|50096476|FG002|Overall Study|Reason not provided|1|||
25003863|NCT03519867|50096477|FG003|Overall Study|Reason not provided|1|||
25003864|NCT03519867|50096478|FG004|Overall Study|Reason not provided|0|||
25003865|NCT03519867|50096479|FG005|Overall Study|Reason not provided|1|||
25003866|NCT03519867|50096480|FG006|Overall Study|Reason not provided|0|||
25003867|NCT03519867|50096481|FG007|Overall Study|Reason not provided|1|||
25003868|NCT03519867|50096482|FG008|Overall Study|Reason not provided|1|||
25003869|NCT03519867|50096483|FG009|Overall Study|Reason not provided|0|||
25003870|NCT03519087|50096507|FG000|Clinic Evaluation|Physician Decision|15|||
25003871|NCT03519087|50096508|FG001|Clinic Evaluation|Physician Decision|18|||
25003872|NCT03519087|50096509|FG002|Clinic Evaluation|Physician Decision|0|||
25003873|NCT03519087|50096510|FG003|Clinic Evaluation|Physician Decision|0|||
25003874|NCT03519087|50096511|FG004|Clinic Evaluation|Physician Decision|0|||
25003875|NCT03519087|50096507|FG000|Clinic Evaluation|Protocol Violation|1|||
25003876|NCT03519087|50096508|FG001|Clinic Evaluation|Protocol Violation|0|||
25003877|NCT03519087|50096509|FG002|Clinic Evaluation|Protocol Violation|0|||
25003878|NCT03519087|50096510|FG003|Clinic Evaluation|Protocol Violation|0|||
25003879|NCT03519087|50096511|FG004|Clinic Evaluation|Protocol Violation|0|||
25003880|NCT03519087|50096507|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
25003881|NCT03519087|50096508|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
25003882|NCT03519087|50096509|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
25003883|NCT03519087|50096510|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
25003884|NCT03519087|50096511|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
25003885|NCT03519087|50096507|FG000|Re-randomization for Treatment|Not appropriate|2|||
25003886|NCT03519087|50096508|FG001|Re-randomization for Treatment|Not appropriate|3|||
25003887|NCT03519087|50096509|FG002|Re-randomization for Treatment|Not appropriate|0|||
25003888|NCT03519087|50096510|FG003|Re-randomization for Treatment|Not appropriate|0|||
25003889|NCT03519087|50096511|FG004|Re-randomization for Treatment|Not appropriate|0|||
25003890|NCT03519087|50096507|FG000|Laboratory Testing|Lost to Follow-up|0|||
25003891|NCT03519087|50096508|FG001|Laboratory Testing|Lost to Follow-up|0|||
25003892|NCT03519087|50096509|FG002|Laboratory Testing|Lost to Follow-up|2|||
25003893|NCT03519087|50096510|FG003|Laboratory Testing|Lost to Follow-up|3|||
25003894|NCT03519087|50096511|FG004|Laboratory Testing|Lost to Follow-up|6|||
25003895|NCT03519087|50096507|FG000|Laboratory Testing|Protocol Violation|0|||
25003896|NCT03519087|50096508|FG001|Laboratory Testing|Protocol Violation|0|||
25003897|NCT03519087|50096509|FG002|Laboratory Testing|Protocol Violation|0|||
25003898|NCT03519087|50096510|FG003|Laboratory Testing|Protocol Violation|1|||
25003899|NCT03519087|50096511|FG004|Laboratory Testing|Protocol Violation|0|||
25003900|NCT02763046|50096530|FG000|Overall Study|Adverse Event|5|||
25003901|NCT02763046|50096531|FG001|Overall Study|Adverse Event|4|||
25003902|NCT02763046|50096532|FG002|Overall Study|Adverse Event|0|||
25003903|NCT02763046|50096530|FG000|Overall Study|Lack of Efficacy|1|||
25003904|NCT02763046|50096531|FG001|Overall Study|Lack of Efficacy|1|||
25003905|NCT02763046|50096532|FG002|Overall Study|Lack of Efficacy|3|||
25003906|NCT02763046|50096530|FG000|Overall Study|Physician Decision|1|||
25003907|NCT02763046|50096531|FG001|Overall Study|Physician Decision|0|||
25003908|NCT02763046|50096532|FG002|Overall Study|Physician Decision|1|||
25003909|NCT02763046|50096530|FG000|Overall Study|Subject/guardian decision|2|||
25003910|NCT02763046|50096531|FG001|Overall Study|Subject/guardian decision|0|||
25003911|NCT02763046|50096532|FG002|Overall Study|Subject/guardian decision|4|||
25003912|NCT03518073|50096549|FG000|Overall Study|Adverse Event|2|||
25003913|NCT03518073|50096550|FG001|Overall Study|Adverse Event|4|||
25003914|NCT03518073|50096551|FG002|Overall Study|Adverse Event|2|||
25003915|NCT03518073|50096549|FG000|Overall Study|Death|2|||
25003916|NCT03518073|50096550|FG001|Overall Study|Death|1|||
25003917|NCT03518073|50096551|FG002|Overall Study|Death|3|||
25003918|NCT03518073|50096549|FG000|Overall Study|Lost to Follow-up|1|||
25003919|NCT03518073|50096550|FG001|Overall Study|Lost to Follow-up|0|||
25003920|NCT03518073|50096551|FG002|Overall Study|Lost to Follow-up|1|||
25176720|NCT01529515|50320288|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
25003921|NCT03518073|50096549|FG000|Overall Study|Physician Decision|5|||
25003922|NCT03518073|50096550|FG001|Overall Study|Physician Decision|0|||
25003923|NCT03518073|50096551|FG002|Overall Study|Physician Decision|2|||
25176721|NCT01529515|50320289|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
25003924|NCT03518073|50096549|FG000|Overall Study|Progressive disease|1|||
25003925|NCT03518073|50096550|FG001|Overall Study|Progressive disease|1|||
25003926|NCT03518073|50096551|FG002|Overall Study|Progressive disease|1|||
25003927|NCT03518073|50096549|FG000|Overall Study|Protocol Violation|1|||
25003928|NCT03518073|50096550|FG001|Overall Study|Protocol Violation|0|||
25003929|NCT03518073|50096551|FG002|Overall Study|Protocol Violation|0|||
25003930|NCT03518073|50096549|FG000|Overall Study|Withdrawal by Subject|30|||
25003931|NCT03518073|50096550|FG001|Overall Study|Withdrawal by Subject|34|||
25003932|NCT03518073|50096551|FG002|Overall Study|Withdrawal by Subject|29|||
25003933|NCT03518073|50096549|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
25003934|NCT03518073|50096550|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
25003935|NCT03518073|50096551|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
25003936|NCT03518073|50096549|FG000|Overall Study|Covid-19|1|||
25003937|NCT03518073|50096550|FG001|Overall Study|Covid-19|2|||
25003938|NCT03518073|50096551|FG002|Overall Study|Covid-19|1|||
25003939|NCT02759692|50096561|FG000|Period 1|Test article no longer available|1|||
25003940|NCT02759692|50096562|FG001|Period 1|Test article no longer available|1|||
25003941|NCT02759692|50096561|FG000|Period 1|No longer meets eligibility criteria.|1|||
25003942|NCT02759692|50096562|FG001|Period 1|No longer meets eligibility criteria.|0|||
25003943|NCT02759692|50096561|FG000|Period 1|Miss-Randomized|1|||
25003944|NCT02759692|50096562|FG001|Period 1|Miss-Randomized|1|||
25003945|NCT02759692|50096561|FG000|Period 2|Lost to Follow-up|1|||
25003946|NCT02759692|50096562|FG001|Period 2|Lost to Follow-up|0|||
25003947|NCT02759692|50096561|FG000|Period 2|Test article no longer available|0|||
25003948|NCT02759692|50096562|FG001|Period 2|Test article no longer available|1|||
25003949|NCT03586167|50096570|FG000|Overall Study|Other|1|||
25003950|NCT03586167|50096571|FG001|Overall Study|Other|0|||
25003951|NCT02762578|50096579|FG000|Overall Study|Adverse Event|1|||
25003952|NCT02762578|50096580|FG001|Overall Study|Adverse Event|6|||
25003953|NCT02762578|50096579|FG000|Overall Study|Protocol Violation|4|||
25003954|NCT02762578|50096580|FG001|Overall Study|Protocol Violation|2|||
25003955|NCT02762578|50096579|FG000|Overall Study|Withdrawal by Subject|4|||
25003956|NCT02762578|50096580|FG001|Overall Study|Withdrawal by Subject|2|||
25003957|NCT02762578|50096579|FG000|Overall Study|Unclassified|6|||
25003958|NCT02762578|50096580|FG001|Overall Study|Unclassified|0|||
25003959|NCT03514641|50096590|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
25003960|NCT03514641|50096591|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
25003961|NCT03514641|50096592|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
25003962|NCT03514641|50096593|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
25003963|NCT03514641|50096590|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
25003964|NCT03514641|50096591|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
25003965|NCT03514641|50096592|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
25003966|NCT03514641|50096593|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
25003967|NCT03514641|50096590|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
25003968|NCT03514641|50096591|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
25003969|NCT03514641|50096592|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
25003970|NCT03514641|50096593|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
25003971|NCT03514641|50096590|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
25003972|NCT03514641|50096591|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
25003973|NCT03514641|50096592|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
25003974|NCT03514641|50096593|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
25003975|NCT03514641|50096590|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
25003976|NCT03514641|50096591|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
25003977|NCT03514641|50096592|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
25003978|NCT03514641|50096593|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
25003979|NCT03514641|50096590|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
25003980|NCT03514641|50096591|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
25003981|NCT03514641|50096592|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
25003982|NCT03514641|50096593|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
25003983|NCT03514641|50096590|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
25003984|NCT03514641|50096591|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
25003985|NCT03514641|50096592|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
25003986|NCT03514641|50096593|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
25003987|NCT03514641|50096590|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
25003988|NCT03514641|50096591|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
25003989|NCT03514641|50096592|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
25003990|NCT03514641|50096593|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
25003991|NCT03514641|50096590|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
25003992|NCT03514641|50096591|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
25003993|NCT03514641|50096592|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
25003994|NCT03514641|50096593|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
25003995|NCT03514641|50096590|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
25003996|NCT03514641|50096591|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
25067266|NCT02576847|50172844|FG000|Overall Study|Physician Decision|1|||
25003997|NCT03514641|50096592|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
25003998|NCT03514641|50096593|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
25003999|NCT03514641|50096590|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
25004000|NCT03514641|50096591|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
25004001|NCT03514641|50096592|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
25004002|NCT03514641|50096593|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
25004003|NCT03514641|50096590|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
25004004|NCT03514641|50096591|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
25004005|NCT03514641|50096592|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
25004006|NCT03514641|50096593|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
25004007|NCT00100828|50096605|FG000|Overall Study|Physician Decision|6|||
25004008|NCT00100048|50096614|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
25004009|NCT00100048|50096615|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
25004010|NCT00100048|50096616|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
25004011|NCT00100048|50096617|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
25004012|NCT00100048|50096618|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
25004013|NCT00100048|50096619|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
25004014|NCT00100048|50096614|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
25004015|NCT00100048|50096615|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
25004016|NCT00100048|50096616|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
25004017|NCT00100048|50096617|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
25004018|NCT00100048|50096618|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
25004019|NCT00100048|50096619|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
25004020|NCT00100048|50096614|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
25004021|NCT00100048|50096615|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
25004022|NCT00100048|50096616|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
25004023|NCT00100048|50096617|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
25004024|NCT00100048|50096618|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
25004025|NCT00100048|50096619|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
25004026|NCT00100048|50096614|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
25004027|NCT00100048|50096615|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
25004028|NCT00100048|50096616|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
25004029|NCT00100048|50096617|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
25004030|NCT00100048|50096618|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
25004031|NCT00100048|50096619|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
25004032|NCT00100048|50096614|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
25004033|NCT00100048|50096615|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
25004034|NCT00100048|50096616|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
25004035|NCT00100048|50096617|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
25004036|NCT00100048|50096618|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
25004037|NCT00100048|50096619|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
25004038|NCT00100048|50096614|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
25004039|NCT00100048|50096615|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
25004040|NCT00100048|50096616|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
25004041|NCT00100048|50096617|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
25004042|NCT00100048|50096618|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
25004043|NCT00100048|50096619|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
25004044|NCT00100048|50096614|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
25004045|NCT00100048|50096615|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
25004046|NCT00100048|50096616|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
25004047|NCT00100048|50096617|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
25004048|NCT00100048|50096618|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
25004049|NCT00100048|50096619|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
25004050|NCT00100048|50096614|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
25004051|NCT00100048|50096615|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
25004052|NCT00100048|50096616|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
25004053|NCT00100048|50096617|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
25004054|NCT00100048|50096618|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
25004055|NCT00100048|50096619|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
25004056|NCT02757430|50096644|FG000|Overall Study|Physician Decision|6|||
25004057|NCT02757430|50096644|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
25004058|NCT02757430|50096644|FG000|Overall Study|No informed consent|1|||
25004059|NCT02757430|50096644|FG000|Overall Study|No procedure performed|2|||
25004060|NCT02757352|50096660|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
25004061|NCT02757352|50096661|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
25004062|NCT02757352|50096662|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
25004063|NCT02757352|50096663|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
25004064|NCT02757352|50096664|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
25004065|NCT02757352|50096665|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
25004066|NCT02757352|50096666|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
25004067|NCT02757352|50096667|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
25004068|NCT02757352|50096668|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
25004069|NCT02757352|50096669|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
25004070|NCT02757352|50096660|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
25004071|NCT02757352|50096661|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
25004072|NCT02757352|50096662|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
25004073|NCT02757352|50096663|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
25004074|NCT02757352|50096664|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
25004075|NCT02757352|50096665|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
25004076|NCT02757352|50096666|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
25004077|NCT02757352|50096667|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
25004078|NCT02757352|50096668|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
25004079|NCT02757352|50096669|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
25004080|NCT02757352|50096660|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
25004081|NCT02757352|50096661|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
25004082|NCT02757352|50096662|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
25004083|NCT02757352|50096663|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
25004084|NCT02757352|50096664|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
25004085|NCT02757352|50096665|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
25004086|NCT02757352|50096666|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
25004087|NCT02757352|50096667|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
25004088|NCT02757352|50096668|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
25004089|NCT02757352|50096669|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
25004090|NCT02757352|50096660|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
25004091|NCT02757352|50096661|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
25004092|NCT02757352|50096662|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
25004093|NCT02757352|50096663|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
25004094|NCT02757352|50096664|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
25004095|NCT02757352|50096665|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
25004096|NCT02757352|50096666|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
25004097|NCT02757352|50096667|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
25004098|NCT02757352|50096668|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
25004099|NCT02757352|50096669|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
25004100|NCT02757352|50096660|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
25004101|NCT02757352|50096661|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
25004102|NCT02757352|50096662|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
25004103|NCT02757352|50096663|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
25004104|NCT02757352|50096664|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
25004105|NCT02757352|50096665|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
25004106|NCT02757352|50096666|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
25004107|NCT02757352|50096667|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
25004108|NCT02757352|50096668|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
25004109|NCT02757352|50096669|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
25004110|NCT02757352|50096660|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
25004111|NCT02757352|50096661|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
25004112|NCT02757352|50096662|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
25004113|NCT02757352|50096663|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
25004114|NCT02757352|50096664|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
25004115|NCT02757352|50096665|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
25004116|NCT02757352|50096666|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
25004117|NCT02757352|50096667|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
25004118|NCT02757352|50096668|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
25004119|NCT02757352|50096669|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
25004120|NCT02757352|50096660|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
25004121|NCT02757352|50096661|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
25004122|NCT02757352|50096662|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
25176722|NCT01529515|50320286|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
25176723|NCT01529515|50320287|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
25004123|NCT02757352|50096663|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
25004124|NCT02757352|50096664|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
25004125|NCT02757352|50096665|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
25004126|NCT02757352|50096666|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
25004127|NCT02757352|50096667|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
25004128|NCT02757352|50096668|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
25004129|NCT02757352|50096669|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
25004130|NCT02757352|50096660|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
25004131|NCT02757352|50096661|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
25004132|NCT02757352|50096662|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
25004133|NCT02757352|50096663|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
25004134|NCT02757352|50096664|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
25004135|NCT02757352|50096665|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
25004136|NCT02757352|50096666|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
25004137|NCT02757352|50096667|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
25004138|NCT02757352|50096668|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
25004139|NCT02757352|50096669|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
25004140|NCT02757352|50096660|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
25004141|NCT02757352|50096661|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
25004142|NCT02757352|50096662|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
25004143|NCT02757352|50096663|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
25004144|NCT02757352|50096664|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
25004145|NCT02757352|50096665|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
25004146|NCT02757352|50096666|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
25004147|NCT02757352|50096667|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
25004148|NCT02757352|50096668|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
25004149|NCT02757352|50096669|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
25004150|NCT02757352|50096660|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
25004151|NCT02757352|50096661|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
25004152|NCT02757352|50096662|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
25004153|NCT02757352|50096663|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
25004154|NCT02757352|50096664|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
25004155|NCT02757352|50096665|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
25004156|NCT02757352|50096666|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
25004157|NCT02757352|50096667|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
25004158|NCT02757352|50096668|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
25004159|NCT02757352|50096669|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
25004160|NCT02757352|50096660|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
25004161|NCT02757352|50096661|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
25004162|NCT02757352|50096662|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
25004163|NCT02757352|50096663|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
25004164|NCT02757352|50096664|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
25004165|NCT02757352|50096665|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
25004166|NCT02757352|50096666|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
25004167|NCT02757352|50096667|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
25004168|NCT02757352|50096668|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
25004169|NCT02757352|50096669|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
25004170|NCT02757352|50096660|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
25004171|NCT02757352|50096661|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
25004172|NCT02757352|50096662|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
25004173|NCT02757352|50096663|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
25004174|NCT02757352|50096664|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
25004175|NCT02757352|50096665|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
25004176|NCT02757352|50096666|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
25004177|NCT02757352|50096667|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
25004178|NCT02757352|50096668|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
25004179|NCT02757352|50096669|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
25004180|NCT02757352|50096660|FG000|Follow-Up Period|Adverse Event|0|||
25004181|NCT02757352|50096661|FG001|Follow-Up Period|Adverse Event|0|||
25004182|NCT02757352|50096662|FG002|Follow-Up Period|Adverse Event|0|||
25004183|NCT02757352|50096663|FG003|Follow-Up Period|Adverse Event|0|||
25004184|NCT02757352|50096664|FG004|Follow-Up Period|Adverse Event|0|||
25004185|NCT02757352|50096665|FG005|Follow-Up Period|Adverse Event|0|||
25004186|NCT02757352|50096666|FG006|Follow-Up Period|Adverse Event|1|||
25004187|NCT02757352|50096667|FG007|Follow-Up Period|Adverse Event|0|||
25004188|NCT02757352|50096668|FG008|Follow-Up Period|Adverse Event|2|||
25004189|NCT02757352|50096669|FG009|Follow-Up Period|Adverse Event|0|||
25004190|NCT02757352|50096660|FG000|Follow-Up Period|Lost to Follow-up|0|||
25004191|NCT02757352|50096661|FG001|Follow-Up Period|Lost to Follow-up|0|||
25004192|NCT02757352|50096662|FG002|Follow-Up Period|Lost to Follow-up|0|||
25004193|NCT02757352|50096663|FG003|Follow-Up Period|Lost to Follow-up|0|||
25004194|NCT02757352|50096664|FG004|Follow-Up Period|Lost to Follow-up|0|||
25004195|NCT02757352|50096665|FG005|Follow-Up Period|Lost to Follow-up|0|||
25004196|NCT02757352|50096666|FG006|Follow-Up Period|Lost to Follow-up|0|||
25004197|NCT02757352|50096667|FG007|Follow-Up Period|Lost to Follow-up|0|||
25004198|NCT02757352|50096668|FG008|Follow-Up Period|Lost to Follow-up|1|||
25004199|NCT02757352|50096669|FG009|Follow-Up Period|Lost to Follow-up|0|||
25004200|NCT02757352|50096660|FG000|Follow-Up Period|Lack of Efficacy|0|||
25004201|NCT02757352|50096661|FG001|Follow-Up Period|Lack of Efficacy|0|||
25004202|NCT02757352|50096662|FG002|Follow-Up Period|Lack of Efficacy|0|||
25004203|NCT02757352|50096663|FG003|Follow-Up Period|Lack of Efficacy|0|||
25004204|NCT02757352|50096664|FG004|Follow-Up Period|Lack of Efficacy|0|||
25004205|NCT02757352|50096665|FG005|Follow-Up Period|Lack of Efficacy|0|||
25004206|NCT02757352|50096666|FG006|Follow-Up Period|Lack of Efficacy|0|||
25004207|NCT02757352|50096667|FG007|Follow-Up Period|Lack of Efficacy|0|||
25004208|NCT02757352|50096668|FG008|Follow-Up Period|Lack of Efficacy|1|||
25004209|NCT02757352|50096669|FG009|Follow-Up Period|Lack of Efficacy|1|||
25004210|NCT02757352|50096660|FG000|Follow-Up Period|Withdrawal by Subject|0|||
25004211|NCT02757352|50096661|FG001|Follow-Up Period|Withdrawal by Subject|0|||
25004212|NCT02757352|50096662|FG002|Follow-Up Period|Withdrawal by Subject|0|||
25004213|NCT02757352|50096663|FG003|Follow-Up Period|Withdrawal by Subject|0|||
25004214|NCT02757352|50096664|FG004|Follow-Up Period|Withdrawal by Subject|0|||
25004215|NCT02757352|50096665|FG005|Follow-Up Period|Withdrawal by Subject|0|||
25004216|NCT02757352|50096666|FG006|Follow-Up Period|Withdrawal by Subject|0|||
25004217|NCT02757352|50096667|FG007|Follow-Up Period|Withdrawal by Subject|1|||
25004218|NCT02757352|50096668|FG008|Follow-Up Period|Withdrawal by Subject|6|||
25004219|NCT02757352|50096669|FG009|Follow-Up Period|Withdrawal by Subject|2|||
25004220|NCT04588480|50096702|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
25004221|NCT04588480|50096703|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
25004222|NCT04588480|50096704|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
25004223|NCT04588480|50096702|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
25004224|NCT04588480|50096703|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
25004225|NCT04588480|50096704|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
25004226|NCT02756650|50096711|FG000|Overall Study|Physician Decision|1|||
25004227|NCT02756650|50096711|FG000|Overall Study|Adverse Event|1|||
25004228|NCT00110357|50096717|FG000|Overall Study|Deterioration without progression|2|||
25004229|NCT00110357|50096718|FG001|Overall Study|Deterioration without progression|0|||
25004230|NCT00110357|50096717|FG000|Overall Study|Disease progression/relapse|20|||
25004231|NCT00110357|50096718|FG001|Overall Study|Disease progression/relapse|15|||
25004232|NCT00110357|50096717|FG000|Overall Study|Study Closure|1|||
25004233|NCT00110357|50096718|FG001|Overall Study|Study Closure|0|||
25004234|NCT00110357|50096717|FG000|Overall Study|Study Drug Toxicity|1|||
25004235|NCT00110357|50096718|FG001|Overall Study|Study Drug Toxicity|3|||
25004236|NCT00110357|50096717|FG000|Overall Study|Withdrawal by Subject|3|||
25004237|NCT00110357|50096718|FG001|Overall Study|Withdrawal by Subject|1|||
25004238|NCT02752906|50096753|FG000|Overall Study|Protocol Violation|2|||
25004239|NCT02752906|50096754|FG001|Overall Study|Protocol Violation|1|||
25004240|NCT02752906|50096753|FG000|Overall Study|Withdrawal by Subject|2|||
25004241|NCT02752906|50096754|FG001|Overall Study|Withdrawal by Subject|2|||
25004242|NCT02752906|50096753|FG000|Overall Study|Lost to Follow-up|3|||
25004243|NCT02752906|50096754|FG001|Overall Study|Lost to Follow-up|2|||
25004244|NCT02756338|50096760|FG000|Overall Study|Withdrawn by Investigator|1|||
25004245|NCT02756338|50096760|FG000|Overall Study|Device Replaced with Pacemaker|4|||
25004246|NCT00293033|50096764|FG000|Open-label Titration Period|Adverse Event|10|||
25004247|NCT00293033|50096764|FG000|Open-label Titration Period|Death|3|||
25004248|NCT00293033|50096764|FG000|Open-label Titration Period|Lack of Efficacy|5|||
25004249|NCT00293033|50096764|FG000|Open-label Titration Period|Protocol Violation|2|||
25004250|NCT00293033|50096764|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
25004251|NCT00293033|50096764|FG000|Open-label Titration Period|Noncompliance and other|27|||
25004252|NCT00293033|50096764|FG000|Double-blind Treatment Period|Adverse Event|3|||
25004253|NCT00293033|50096764|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
25004254|NCT00293033|50096764|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
25004255|NCT00293033|50096764|FG000|Double-blind Treatment Period|Noncompliance|4|||
25004256|NCT02756182|50096772|FG000|Overall Study|StudyTechnical Difficulties|4|||
25004257|NCT03823703|50096781|FG000|Overall Study|Sponsor request|0|||
25004258|NCT03823703|50096782|FG001|Overall Study|Sponsor request|3|||
25004259|NCT03823703|50096783|FG002|Overall Study|Sponsor request|4|||
25004260|NCT03823703|50096781|FG000|Overall Study|Adverse Event|3|||
25004261|NCT03823703|50096782|FG001|Overall Study|Adverse Event|1|||
25004262|NCT03823703|50096783|FG002|Overall Study|Adverse Event|0|||
25004263|NCT03823703|50096781|FG000|Overall Study|Withdrawal by Subject|0|||
25004264|NCT03823703|50096782|FG001|Overall Study|Withdrawal by Subject|1|||
25004265|NCT03823703|50096783|FG002|Overall Study|Withdrawal by Subject|0|||
25004266|NCT00109577|50096793|FG000|Overall Study|Withdrawal by Subject|3|||
25004267|NCT00109577|50096794|FG001|Overall Study|Withdrawal by Subject|3|||
25004268|NCT02755090|50096802|FG000|Overall Study|equipment malfunction|1|||
25004269|NCT02755090|50096803|FG001|Overall Study|equipment malfunction|0|||
25004270|NCT00109343|50096812|FG000|Overall Study|Adverse Event|1|||
25004271|NCT00109343|50096813|FG001|Overall Study|Adverse Event|0|||
25004272|NCT00109343|50096814|FG002|Overall Study|Adverse Event|2|||
25004273|NCT00109343|50096812|FG000|Overall Study|Lack of Efficacy|1|||
25004274|NCT00109343|50096813|FG001|Overall Study|Lack of Efficacy|0|||
25004275|NCT00109343|50096814|FG002|Overall Study|Lack of Efficacy|0|||
25004276|NCT00109343|50096812|FG000|Overall Study|Lost to Follow-up|35|||
25004277|NCT00109343|50096813|FG001|Overall Study|Lost to Follow-up|20|||
25004278|NCT00109343|50096814|FG002|Overall Study|Lost to Follow-up|14|||
25004279|NCT00109343|50096812|FG000|Overall Study|Protocol Violation|1|||
25004280|NCT00109343|50096813|FG001|Overall Study|Protocol Violation|2|||
25004281|NCT00109343|50096814|FG002|Overall Study|Protocol Violation|2|||
25004282|NCT00109343|50096812|FG000|Overall Study|Withdrawal by Subject|15|||
25004283|NCT00109343|50096813|FG001|Overall Study|Withdrawal by Subject|11|||
25004284|NCT00109343|50096814|FG002|Overall Study|Withdrawal by Subject|10|||
25004285|NCT00109343|50096812|FG000|Overall Study|Subject Moved|6|||
25004286|NCT00109343|50096813|FG001|Overall Study|Subject Moved|2|||
25004287|NCT00109343|50096814|FG002|Overall Study|Subject Moved|1|||
25004288|NCT00109343|50096812|FG000|Overall Study|Other|5|||
25004289|NCT00109343|50096813|FG001|Overall Study|Other|2|||
25004290|NCT00109343|50096814|FG002|Overall Study|Other|1|||
25004291|NCT00108485|50096824|FG000|Overall Study|Withdrawal by Subject|3|||
25004292|NCT00108485|50096825|FG001|Overall Study|Withdrawal by Subject|0|||
25004293|NCT00108485|50096824|FG000|Overall Study|Lost to Follow-up|0|||
25004294|NCT00108485|50096825|FG001|Overall Study|Lost to Follow-up|2|||
25004295|NCT00107783|50096833|FG000|Overall Study|Adverse Event|0|||
25004296|NCT00107783|50096834|FG001|Overall Study|Adverse Event|2|||
25004297|NCT00107783|50096833|FG000|Overall Study|Death|0|||
25004298|NCT00107783|50096834|FG001|Overall Study|Death|1|||
25004299|NCT00107783|50096833|FG000|Overall Study|Withdrawal by Subject|2|||
25004300|NCT00107783|50096834|FG001|Overall Study|Withdrawal by Subject|0|||
25004301|NCT00107783|50096833|FG000|Overall Study|Second hip replacement|1|||
25004302|NCT00107783|50096834|FG001|Overall Study|Second hip replacement|1|||
25004303|NCT00095303|50096842|FG000|Main Study|Lost to Follow-up|91|||
25004304|NCT00095303|50096843|FG001|Main Study|Lost to Follow-up|87|||
25004305|NCT00095303|50096842|FG000|Follow Up Study|Lost to Follow-up|59|||
25004306|NCT00095303|50096843|FG001|Follow Up Study|Lost to Follow-up|58|||
25004307|NCT00105521|50096853|FG000|Overall Study|Other|1|||
25004308|NCT00105521|50096854|FG001|Overall Study|Other|1|||
25004309|NCT00105521|50096855|FG002|Overall Study|Other|2|||
25004310|NCT00105521|50096856|FG003|Overall Study|Other|0|||
25004311|NCT00105521|50096853|FG000|Overall Study|Adverse Event|10|||
25004312|NCT00105521|50096854|FG001|Overall Study|Adverse Event|4|||
25004313|NCT00105521|50096855|FG002|Overall Study|Adverse Event|10|||
25004314|NCT00105521|50096856|FG003|Overall Study|Adverse Event|8|||
25004315|NCT00105521|50096853|FG000|Overall Study|Withdrawal by Subject|1|||
25004316|NCT00105521|50096854|FG001|Overall Study|Withdrawal by Subject|0|||
25004317|NCT00105521|50096855|FG002|Overall Study|Withdrawal by Subject|1|||
25004318|NCT00105521|50096856|FG003|Overall Study|Withdrawal by Subject|4|||
25004319|NCT00105521|50096853|FG000|Overall Study|Lack of Efficacy|0|||
25004320|NCT00105521|50096854|FG001|Overall Study|Lack of Efficacy|0|||
25004321|NCT00105521|50096855|FG002|Overall Study|Lack of Efficacy|0|||
25004322|NCT00105521|50096856|FG003|Overall Study|Lack of Efficacy|1|||
25004323|NCT00105521|50096853|FG000|Overall Study|Protocol Violation|3|||
25004324|NCT00105521|50096854|FG001|Overall Study|Protocol Violation|5|||
25004325|NCT00105521|50096855|FG002|Overall Study|Protocol Violation|4|||
25004326|NCT00105521|50096856|FG003|Overall Study|Protocol Violation|4|||
25004327|NCT00105521|50096853|FG000|Overall Study|Lost to Follow-up|0|||
25004328|NCT00105521|50096854|FG001|Overall Study|Lost to Follow-up|1|||
25004329|NCT00105521|50096855|FG002|Overall Study|Lost to Follow-up|0|||
25004330|NCT00105521|50096856|FG003|Overall Study|Lost to Follow-up|0|||
25004331|NCT00291551|50096866|FG000|Overall Study|Death|7|||
25004332|NCT00291551|50096866|FG000|Overall Study|Withdrawal by Subject|6|||
25004333|NCT02752048|50096895|FG000|Overall Study|Withdrawal by Subject|0|||
25004334|NCT02752048|50096896|FG001|Overall Study|Withdrawal by Subject|0|||
25004335|NCT02752048|50096897|FG002|Overall Study|Withdrawal by Subject|3|||
25004336|NCT00095147|50096912|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
25004337|NCT00095147|50096913|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
25004338|NCT00095147|50096914|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
25004339|NCT00095147|50096915|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
25004340|NCT00095147|50096916|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
25004341|NCT00095147|50096912|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
25004342|NCT00095147|50096913|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
25004343|NCT00095147|50096914|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
25004344|NCT00095147|50096915|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
25004345|NCT00095147|50096916|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
25004346|NCT00095147|50096912|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
25004347|NCT00095147|50096913|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
25004348|NCT00095147|50096914|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
25004349|NCT00095147|50096915|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
25004350|NCT00095147|50096916|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
25004351|NCT00095147|50096912|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
25004352|NCT00095147|50096913|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
25004353|NCT00095147|50096914|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
25004354|NCT00095147|50096915|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
25004355|NCT00095147|50096916|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
25004356|NCT00095147|50096912|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
25004357|NCT00095147|50096913|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
25004358|NCT00095147|50096914|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
25004359|NCT00095147|50096915|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
25004360|NCT00095147|50096916|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
25004361|NCT00095147|50096912|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
25004362|NCT00095147|50096913|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
25004363|NCT00095147|50096914|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
25004364|NCT00095147|50096915|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
25004365|NCT00095147|50096916|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
25004366|NCT00095147|50096912|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
25004367|NCT00095147|50096913|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
25004368|NCT00095147|50096914|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
25004369|NCT00095147|50096915|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
25004370|NCT00095147|50096916|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
25004371|NCT00095147|50096912|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
25004372|NCT00095147|50096913|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
25004373|NCT00095147|50096914|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
25004374|NCT00095147|50096915|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
25004375|NCT00095147|50096916|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
25004376|NCT00095147|50096912|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
25004377|NCT00095147|50096913|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
25004378|NCT00095147|50096914|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
25004379|NCT00095147|50096915|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
25004380|NCT00095147|50096916|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
25004381|NCT00095147|50096912|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
25004382|NCT00095147|50096913|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
25004383|NCT00095147|50096914|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
25004384|NCT00095147|50096915|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
25004385|NCT00095147|50096916|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
25004386|NCT00095147|50096912|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
25004387|NCT00095147|50096913|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
25004388|NCT00095147|50096914|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
25004389|NCT00095147|50096915|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
25004390|NCT00095147|50096916|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
25004391|NCT00095147|50096912|FG000|Long-term Extension Period|Death|0|||
25004392|NCT00095147|50096913|FG001|Long-term Extension Period|Death|0|||
25004393|NCT00095147|50096914|FG002|Long-term Extension Period|Death|0|||
25004394|NCT00095147|50096915|FG003|Long-term Extension Period|Death|0|||
25004395|NCT00095147|50096916|FG004|Long-term Extension Period|Death|3|||
25004396|NCT00095147|50096912|FG000|Long-term Extension Period|Adverse Event|0|||
25004397|NCT00095147|50096913|FG001|Long-term Extension Period|Adverse Event|0|||
25004398|NCT00095147|50096914|FG002|Long-term Extension Period|Adverse Event|0|||
25004399|NCT00095147|50096915|FG003|Long-term Extension Period|Adverse Event|0|||
25004400|NCT00095147|50096916|FG004|Long-term Extension Period|Adverse Event|11|||
25004401|NCT00095147|50096912|FG000|Long-term Extension Period|Lack of Efficacy|0|||
25004402|NCT00095147|50096913|FG001|Long-term Extension Period|Lack of Efficacy|0|||
25004403|NCT00095147|50096914|FG002|Long-term Extension Period|Lack of Efficacy|0|||
25004404|NCT00095147|50096915|FG003|Long-term Extension Period|Lack of Efficacy|0|||
25004405|NCT00095147|50096916|FG004|Long-term Extension Period|Lack of Efficacy|9|||
25004406|NCT00095147|50096912|FG000|Long-term Extension Period|Lost to Follow-up|0|||
25004407|NCT00095147|50096913|FG001|Long-term Extension Period|Lost to Follow-up|0|||
25004408|NCT00095147|50096914|FG002|Long-term Extension Period|Lost to Follow-up|0|||
25004409|NCT00095147|50096915|FG003|Long-term Extension Period|Lost to Follow-up|0|||
25004410|NCT00095147|50096916|FG004|Long-term Extension Period|Lost to Follow-up|6|||
25004411|NCT00095147|50096912|FG000|Long-term Extension Period|Withdrawal of consent|0|||
25004412|NCT00095147|50096913|FG001|Long-term Extension Period|Withdrawal of consent|0|||
25004413|NCT00095147|50096914|FG002|Long-term Extension Period|Withdrawal of consent|0|||
25004414|NCT00095147|50096915|FG003|Long-term Extension Period|Withdrawal of consent|0|||
25004415|NCT00095147|50096916|FG004|Long-term Extension Period|Withdrawal of consent|12|||
25004416|NCT00095147|50096912|FG000|Long-term Extension Period|Pregnancy|0|||
25004417|NCT00095147|50096913|FG001|Long-term Extension Period|Pregnancy|0|||
25004418|NCT00095147|50096914|FG002|Long-term Extension Period|Pregnancy|0|||
25004419|NCT00095147|50096915|FG003|Long-term Extension Period|Pregnancy|0|||
25004420|NCT00095147|50096916|FG004|Long-term Extension Period|Pregnancy|1|||
25004421|NCT00095147|50096912|FG000|Long-term Extension Period|No longer meets study criteria|0|||
25004422|NCT00095147|50096913|FG001|Long-term Extension Period|No longer meets study criteria|0|||
25004423|NCT00095147|50096914|FG002|Long-term Extension Period|No longer meets study criteria|0|||
25004424|NCT00095147|50096915|FG003|Long-term Extension Period|No longer meets study criteria|0|||
25004425|NCT00095147|50096916|FG004|Long-term Extension Period|No longer meets study criteria|1|||
25004426|NCT00095147|50096912|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
25004427|NCT00095147|50096913|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
25004428|NCT00095147|50096914|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
25004429|NCT00095147|50096915|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
25004430|NCT00095147|50096916|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
25004431|NCT00095147|50096912|FG000|Long-term Extension Period|Leaving country|0|||
25004432|NCT00095147|50096913|FG001|Long-term Extension Period|Leaving country|0|||
25004433|NCT00095147|50096914|FG002|Long-term Extension Period|Leaving country|0|||
25004434|NCT00095147|50096915|FG003|Long-term Extension Period|Leaving country|0|||
25004435|NCT00095147|50096916|FG004|Long-term Extension Period|Leaving country|1|||
25004436|NCT02751580|50096934|FG000|Overall Study|Lost to Follow-up|4|||
25004437|NCT02751580|50096934|FG000|Overall Study|Death|2|||
25004438|NCT02751502|50096938|FG000|Overall Study|Lack of funding|4|||
25004439|NCT02257918|50096945|FG000|Overall Study|Lost to Follow-up|4|||
25004440|NCT02257918|50096946|FG001|Overall Study|Lost to Follow-up|1|||
25004441|NCT02257918|50096947|FG002|Overall Study|Lost to Follow-up|0|||
25004442|NCT02257918|50096945|FG000|Overall Study|Withdrawal by Subject|0|||
25004443|NCT02257918|50096946|FG001|Overall Study|Withdrawal by Subject|0|||
25004444|NCT02257918|50096947|FG002|Overall Study|Withdrawal by Subject|1|||
25004445|NCT02257918|50096945|FG000|Overall Study|Pregnancy|0|||
25004446|NCT02257918|50096946|FG001|Overall Study|Pregnancy|0|||
25004447|NCT02257918|50096947|FG002|Overall Study|Pregnancy|1|||
25004448|NCT02751424|50096964|FG000|Part 2|Adverse Event|0|||
25004449|NCT02751424|50096965|FG001|Part 2|Adverse Event|0|||
25004450|NCT02751424|50096966|FG002|Part 2|Adverse Event|0|||
25004451|NCT02751424|50096967|FG003|Part 2|Adverse Event|0|||
25004452|NCT02751424|50096968|FG004|Part 2|Adverse Event|0|||
25004453|NCT02751424|50096969|FG005|Part 2|Adverse Event|0|||
25004454|NCT02751424|50096970|FG006|Part 2|Adverse Event|0|||
25004455|NCT02751424|50096971|FG007|Part 2|Adverse Event|5|||
25004456|NCT02751424|50096972|FG008|Part 2|Adverse Event|0|||
25004457|NCT00094835|50097002|FG000|Overall Study|Physician Decision|1|||
25004458|NCT00094835|50097003|FG001|Overall Study|Physician Decision|0|||
25004459|NCT00094835|50097004|FG002|Overall Study|Physician Decision|0|||
25004460|NCT00094835|50097005|FG003|Overall Study|Physician Decision|0|||
25004461|NCT00094835|50097006|FG004|Overall Study|Physician Decision|0|||
25004462|NCT00094835|50097007|FG005|Overall Study|Physician Decision|1|||
25004463|NCT00094835|50097008|FG006|Overall Study|Physician Decision|0|||
25004464|NCT00094835|50097002|FG000|Overall Study|Withdrawal by Subject|0|||
25004465|NCT00094835|50097003|FG001|Overall Study|Withdrawal by Subject|0|||
25004466|NCT00094835|50097004|FG002|Overall Study|Withdrawal by Subject|0|||
25004467|NCT00094835|50097005|FG003|Overall Study|Withdrawal by Subject|0|||
25004468|NCT00094835|50097006|FG004|Overall Study|Withdrawal by Subject|0|||
25004469|NCT00094835|50097007|FG005|Overall Study|Withdrawal by Subject|0|||
25004470|NCT00094835|50097008|FG006|Overall Study|Withdrawal by Subject|1|||
25004471|NCT00094835|50097002|FG000|Overall Study|Lost to Follow-up|0|||
25004472|NCT00094835|50097003|FG001|Overall Study|Lost to Follow-up|0|||
25004473|NCT00094835|50097004|FG002|Overall Study|Lost to Follow-up|0|||
25004474|NCT00094835|50097005|FG003|Overall Study|Lost to Follow-up|0|||
25004475|NCT00094835|50097006|FG004|Overall Study|Lost to Follow-up|1|||
25004476|NCT00094835|50097007|FG005|Overall Study|Lost to Follow-up|0|||
25004477|NCT00094835|50097008|FG006|Overall Study|Lost to Follow-up|0|||
25004478|NCT00094835|50097002|FG000|Overall Study|Death|1|||
25004479|NCT00094835|50097003|FG001|Overall Study|Death|0|||
25004480|NCT00094835|50097004|FG002|Overall Study|Death|0|||
25004481|NCT00094835|50097005|FG003|Overall Study|Death|0|||
25004482|NCT00094835|50097006|FG004|Overall Study|Death|1|||
25004483|NCT00094835|50097007|FG005|Overall Study|Death|0|||
25004484|NCT00094835|50097008|FG006|Overall Study|Death|0|||
25004485|NCT00094835|50097002|FG000|Overall Study|Non-compliance|1|||
25004486|NCT00094835|50097003|FG001|Overall Study|Non-compliance|2|||
25004487|NCT00094835|50097004|FG002|Overall Study|Non-compliance|2|||
25004488|NCT00094835|50097005|FG003|Overall Study|Non-compliance|0|||
25004489|NCT00094835|50097006|FG004|Overall Study|Non-compliance|2|||
25004490|NCT00094835|50097007|FG005|Overall Study|Non-compliance|2|||
25004491|NCT00094835|50097008|FG006|Overall Study|Non-compliance|1|||
25004492|NCT00094835|50097002|FG000|Overall Study|Other|1|||
25004493|NCT00094835|50097003|FG001|Overall Study|Other|1|||
25004494|NCT00094835|50097004|FG002|Overall Study|Other|1|||
25004495|NCT00094835|50097005|FG003|Overall Study|Other|1|||
25004496|NCT00094835|50097006|FG004|Overall Study|Other|0|||
25004497|NCT00094835|50097007|FG005|Overall Study|Other|0|||
25004498|NCT00094835|50097008|FG006|Overall Study|Other|0|||
25004499|NCT00094757|50097032|FG000|Overall Study|Adverse Event|11|||
25004500|NCT00094757|50097033|FG001|Overall Study|Adverse Event|9|||
25004501|NCT00094757|50097034|FG002|Overall Study|Adverse Event|6|||
25004502|NCT00094757|50097032|FG000|Overall Study|Lack of Efficacy|11|||
25004503|NCT00094757|50097033|FG001|Overall Study|Lack of Efficacy|15|||
25004504|NCT00094757|50097034|FG002|Overall Study|Lack of Efficacy|8|||
25004505|NCT00094757|50097032|FG000|Overall Study|Lost to Follow-up|3|||
25004506|NCT00094757|50097033|FG001|Overall Study|Lost to Follow-up|5|||
25004507|NCT00094757|50097034|FG002|Overall Study|Lost to Follow-up|6|||
25004508|NCT00094757|50097032|FG000|Overall Study|Patient Moved|2|||
25004509|NCT00094757|50097033|FG001|Overall Study|Patient Moved|1|||
25004510|NCT00094757|50097034|FG002|Overall Study|Patient Moved|1|||
25004511|NCT00094757|50097032|FG000|Overall Study|Protocol Violation|8|||
25004512|NCT00094757|50097033|FG001|Overall Study|Protocol Violation|5|||
25004513|NCT00094757|50097034|FG002|Overall Study|Protocol Violation|3|||
25004514|NCT00094757|50097032|FG000|Overall Study|Withdrawal by Subject|14|||
25004515|NCT00094757|50097033|FG001|Overall Study|Withdrawal by Subject|21|||
25004516|NCT00094757|50097034|FG002|Overall Study|Withdrawal by Subject|5|||
25004517|NCT00094757|50097032|FG000|Overall Study|Other|3|||
25004518|NCT00094757|50097033|FG001|Overall Study|Other|3|||
25004519|NCT00094757|50097034|FG002|Overall Study|Other|1|||
25004520|NCT00094757|50097032|FG000|Overall Study|Protocol specified discontinuation|1|||
25004521|NCT00094757|50097033|FG001|Overall Study|Protocol specified discontinuation|3|||
25004522|NCT00094757|50097034|FG002|Overall Study|Protocol specified discontinuation|0|||
25004523|NCT00082433|50097044|FG000|Overall Study|Adverse Event|12|||
25004524|NCT00082433|50097045|FG001|Overall Study|Adverse Event|17|||
25004525|NCT00082433|50097044|FG000|Overall Study|Death|8|||
25004526|NCT00082433|50097045|FG001|Overall Study|Death|18|||
25004527|NCT00082433|50097044|FG000|Overall Study|Disease Progression/Relapse|270|||
25004528|NCT00082433|50097045|FG001|Overall Study|Disease Progression/Relapse|388|||
25004529|NCT00082433|50097044|FG000|Overall Study|Physician Decision|50|||
25004530|NCT00082433|50097045|FG001|Overall Study|Physician Decision|61|||
25004531|NCT00082433|50097044|FG000|Overall Study|Lost to Follow-up|1|||
25004532|NCT00082433|50097045|FG001|Overall Study|Lost to Follow-up|2|||
25004533|NCT00082433|50097044|FG000|Overall Study|Study Drug Toxicity|179|||
25004534|NCT00082433|50097045|FG001|Overall Study|Study Drug Toxicity|66|||
25004535|NCT00082433|50097044|FG000|Overall Study|Withdrawal by Subject|55|||
25004536|NCT00082433|50097045|FG001|Overall Study|Withdrawal by Subject|30|||
25004537|NCT00082433|50097044|FG000|Overall Study|Still On Treatment|2|||
25004538|NCT00082433|50097045|FG001|Overall Study|Still On Treatment|1|||
25004539|NCT00082433|50097044|FG000|Overall Study|Not Treated|12|||
25004540|NCT00082433|50097045|FG001|Overall Study|Not Treated|11|||
25004541|NCT00082433|50097044|FG000|Overall Study|Ineligible|2|||
25004542|NCT00082433|50097045|FG001|Overall Study|Ineligible|1|||
25004543|NCT00082433|50097044|FG000|Overall Study|Noncompliance|2|||
25004544|NCT00082433|50097045|FG001|Overall Study|Noncompliance|1|||
25004545|NCT00082433|50097044|FG000|Overall Study|New primary cancer|1|||
25004546|NCT00082433|50097045|FG001|Overall Study|New primary cancer|0|||
25004547|NCT00082433|50097044|FG000|Overall Study|Impending surgery|0|||
25004548|NCT00082433|50097045|FG001|Overall Study|Impending surgery|1|||
25004549|NCT00094445|50097051|FG000|Overall Study|Withdrawal by Subject|3|||
25004550|NCT00094445|50097051|FG000|Overall Study|Lost to Follow-up|1|||
25004551|NCT00094445|50097051|FG000|Overall Study|Progressive Disease|2|||
25004552|NCT00082355|50097055|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
25176724|NCT01529515|50320288|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
25176725|NCT01529515|50320289|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
25004553|NCT00082355|50097055|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
25004554|NCT00082355|50097055|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
25176726|NCT01529515|50320286|FG000|DOUBLE BLIND PHASE|Other|0|||
25004555|NCT00094055|50097059|FG000|Overall Study|Adverse Event|11|||
25004556|NCT00094055|50097059|FG000|Overall Study|Death|4|||
25004557|NCT00094055|50097059|FG000|Overall Study|Lack of Efficacy|17|||
25176727|NCT01529515|50320287|FG001|DOUBLE BLIND PHASE|Other|0|||
25004558|NCT00094055|50097059|FG000|Overall Study|Lost to Follow-up|2|||
25004559|NCT00094055|50097059|FG000|Overall Study|progressive disease|2|||
25004560|NCT00094055|50097059|FG000|Overall Study|clinical progression|1|||
25004561|NCT00094055|50097059|FG000|Overall Study|roll-over to another study|14|||
25004562|NCT00094055|50097059|FG000|Overall Study|Withdrawal by Subject|9|||
25004563|NCT00099983|50097065|FG000|Overall Study|Lost to Follow-up|2|||
25004564|NCT00099983|50097066|FG001|Overall Study|Lost to Follow-up|3|||
25004565|NCT00099983|50097065|FG000|Overall Study|Missing Source Documents|14|||
25004566|NCT00099983|50097066|FG001|Overall Study|Missing Source Documents|15|||
25004567|NCT00099983|50097065|FG000|Overall Study|Withdrawal by Subject|3|||
25004568|NCT00099983|50097066|FG001|Overall Study|Withdrawal by Subject|2|||
25004569|NCT00099983|50097065|FG000|Overall Study|Adverse Event|1|||
25004570|NCT00099983|50097066|FG001|Overall Study|Adverse Event|1|||
25004571|NCT00099983|50097065|FG000|Overall Study|Lack of Efficacy|0|||
25004572|NCT00099983|50097066|FG001|Overall Study|Lack of Efficacy|1|||
25004573|NCT00099983|50097065|FG000|Overall Study|Unable to return for appointments|1|||
25004574|NCT00099983|50097066|FG001|Overall Study|Unable to return for appointments|1|||
25004575|NCT00099983|50097065|FG000|Overall Study|Moved|1|||
25004576|NCT00099983|50097066|FG001|Overall Study|Moved|0|||
25004577|NCT00099983|50097065|FG000|Overall Study|Other psychiatric problem|1|||
25004578|NCT00099983|50097066|FG001|Overall Study|Other psychiatric problem|0|||
25004579|NCT00099983|50097065|FG000|Overall Study|Incarcerated|0|||
25004580|NCT00099983|50097066|FG001|Overall Study|Incarcerated|1|||
25004581|NCT00099983|50097065|FG000|Overall Study|Intolerant of burden of visits|0|||
25004582|NCT00099983|50097066|FG001|Overall Study|Intolerant of burden of visits|1|||
25004583|NCT00099983|50097065|FG000|Overall Study|Other issue|1|||
25004584|NCT00099983|50097066|FG001|Overall Study|Other issue|0|||
25004585|NCT00099359|50097075|FG000|Overall Study|Death|11|||
25004586|NCT00099359|50097076|FG001|Overall Study|Death|15|||
25004587|NCT00099359|50097077|FG002|Overall Study|Death|17|||
25004588|NCT00099359|50097075|FG000|Overall Study|Withdrawal by Subject|19|||
25004589|NCT00099359|50097076|FG001|Overall Study|Withdrawal by Subject|19|||
25004590|NCT00099359|50097077|FG002|Overall Study|Withdrawal by Subject|23|||
25004591|NCT00099359|50097075|FG000|Overall Study|Lost to Follow-up|15|||
25004592|NCT00099359|50097076|FG001|Overall Study|Lost to Follow-up|24|||
25004593|NCT00099359|50097077|FG002|Overall Study|Lost to Follow-up|24|||
25004594|NCT00099359|50097075|FG000|Overall Study|moved out of area|9|||
25004595|NCT00099359|50097076|FG001|Overall Study|moved out of area|7|||
25004596|NCT00099359|50097077|FG002|Overall Study|moved out of area|4|||
25004597|NCT00092495|50097099|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
25004598|NCT00092495|50097100|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
25004599|NCT00092495|50097101|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
25004600|NCT00092495|50097102|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
25004601|NCT00092495|50097103|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
25004602|NCT00092495|50097099|FG000|Base Study Vaccination Period|Extended|0|||
25004603|NCT00092495|50097100|FG001|Base Study Vaccination Period|Extended|0|||
25004604|NCT00092495|50097101|FG002|Base Study Vaccination Period|Extended|0|||
25004605|NCT00092495|50097102|FG003|Base Study Vaccination Period|Extended|1|||
25004606|NCT00092495|50097103|FG004|Base Study Vaccination Period|Extended|0|||
25004607|NCT00092495|50097099|FG000|Base Study Vaccination Period|*Clinical AE|1|||
25004608|NCT00092495|50097100|FG001|Base Study Vaccination Period|*Clinical AE|0|||
25004609|NCT00092495|50097101|FG002|Base Study Vaccination Period|*Clinical AE|1|||
25004610|NCT00092495|50097102|FG003|Base Study Vaccination Period|*Clinical AE|2|||
25004611|NCT00092495|50097103|FG004|Base Study Vaccination Period|*Clinical AE|0|||
25004612|NCT00092495|50097099|FG000|Base Study Vaccination Period|*Other reasons|1|||
25004613|NCT00092495|50097100|FG001|Base Study Vaccination Period|*Other reasons|0|||
25004614|NCT00092495|50097101|FG002|Base Study Vaccination Period|*Other reasons|0|||
25004615|NCT00092495|50097102|FG003|Base Study Vaccination Period|*Other reasons|1|||
25004616|NCT00092495|50097103|FG004|Base Study Vaccination Period|*Other reasons|0|||
25004617|NCT00092495|50097099|FG000|Base Study Vaccination Period|*Pregnancy|0|||
25004618|NCT00092495|50097100|FG001|Base Study Vaccination Period|*Pregnancy|2|||
25004619|NCT00092495|50097101|FG002|Base Study Vaccination Period|*Pregnancy|5|||
25004620|NCT00092495|50097102|FG003|Base Study Vaccination Period|*Pregnancy|7|||
25004621|NCT00092495|50097103|FG004|Base Study Vaccination Period|*Pregnancy|0|||
25176728|NCT01529515|50320288|FG002|DOUBLE BLIND PHASE|Other|9|||
25176729|NCT01529515|50320289|FG003|DOUBLE BLIND PHASE|Other|2|||
25176730|NCT01528969|50320298|FG000|Overall Study|absent from the school at baseline|2|||
25176731|NCT01528969|50320299|FG001|Overall Study|absent from the school at baseline|0|||
25176732|NCT01514201|50320309|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
25176733|NCT01514201|50320310|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
25176734|NCT01514201|50320311|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
25004622|NCT00092495|50097099|FG000|Base Study Vaccination Period|Adverse Event|1|||
25004623|NCT00092495|50097100|FG001|Base Study Vaccination Period|Adverse Event|0|||
25004624|NCT00092495|50097101|FG002|Base Study Vaccination Period|Adverse Event|0|||
25004625|NCT00092495|50097102|FG003|Base Study Vaccination Period|Adverse Event|3|||
25004626|NCT00092495|50097103|FG004|Base Study Vaccination Period|Adverse Event|0|||
25004627|NCT00092495|50097099|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
25004628|NCT00092495|50097100|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
25004629|NCT00092495|50097101|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
25176735|NCT01514201|50320312|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
25176736|NCT01514201|50320309|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
25176737|NCT01514201|50320310|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
25176738|NCT01514201|50320311|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
25176739|NCT01514201|50320312|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
25176740|NCT01514201|50320309|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
25176741|NCT01514201|50320310|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
25176742|NCT01514201|50320311|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
25176743|NCT01514201|50320312|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
25176744|NCT01514201|50320309|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
25176745|NCT01514201|50320310|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
25176746|NCT01514201|50320311|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
25176747|NCT01514201|50320312|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
25176748|NCT01514201|50320309|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
25176749|NCT01514201|50320310|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
25176750|NCT01514201|50320311|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
25176751|NCT01514201|50320312|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
25176752|NCT01514201|50320309|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
25176753|NCT01514201|50320310|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
25176754|NCT01514201|50320311|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
25176755|NCT01514201|50320312|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
25176756|NCT01514201|50320309|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
25176757|NCT01514201|50320310|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
25004630|NCT00092495|50097102|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
25004631|NCT00092495|50097103|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
25004632|NCT00092495|50097099|FG000|Base Study Vaccination Period|Moved|3|||
25004633|NCT00092495|50097100|FG001|Base Study Vaccination Period|Moved|1|||
25004634|NCT00092495|50097101|FG002|Base Study Vaccination Period|Moved|2|||
25004635|NCT00092495|50097102|FG003|Base Study Vaccination Period|Moved|2|||
25004636|NCT00092495|50097103|FG004|Base Study Vaccination Period|Moved|0|||
25004637|NCT00092495|50097099|FG000|Base Study Vaccination Period|Other|1|||
25004638|NCT00092495|50097100|FG001|Base Study Vaccination Period|Other|1|||
25004639|NCT00092495|50097101|FG002|Base Study Vaccination Period|Other|0|||
25004640|NCT00092495|50097102|FG003|Base Study Vaccination Period|Other|2|||
25004641|NCT00092495|50097103|FG004|Base Study Vaccination Period|Other|0|||
25004642|NCT00092495|50097099|FG000|Base Study Vaccination Period|Pregnancy|2|||
25004643|NCT00092495|50097100|FG001|Base Study Vaccination Period|Pregnancy|0|||
25004644|NCT00092495|50097101|FG002|Base Study Vaccination Period|Pregnancy|0|||
25004645|NCT00092495|50097102|FG003|Base Study Vaccination Period|Pregnancy|0|||
25004646|NCT00092495|50097103|FG004|Base Study Vaccination Period|Pregnancy|0|||
25004647|NCT00092495|50097099|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
25004648|NCT00092495|50097100|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
25004649|NCT00092495|50097101|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
25004650|NCT00092495|50097102|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
25004651|NCT00092495|50097103|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
25004652|NCT00092495|50097099|FG000|Base Study Vaccination Period|Protocol Violation|1|||
25004653|NCT00092495|50097100|FG001|Base Study Vaccination Period|Protocol Violation|0|||
25004654|NCT00092495|50097101|FG002|Base Study Vaccination Period|Protocol Violation|0|||
25004655|NCT00092495|50097102|FG003|Base Study Vaccination Period|Protocol Violation|0|||
25004656|NCT00092495|50097103|FG004|Base Study Vaccination Period|Protocol Violation|0|||
25004657|NCT00092495|50097099|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
25004658|NCT00092495|50097100|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
25004659|NCT00092495|50097101|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
25004660|NCT00092495|50097102|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
25004661|NCT00092495|50097103|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
25004662|NCT00092495|50097099|FG000|Base Study Follow-up Period|Extended|0|||
25004663|NCT00092495|50097100|FG001|Base Study Follow-up Period|Extended|0|||
25004664|NCT00092495|50097101|FG002|Base Study Follow-up Period|Extended|1|||
25004665|NCT00092495|50097102|FG003|Base Study Follow-up Period|Extended|2|||
25004666|NCT00092495|50097103|FG004|Base Study Follow-up Period|Extended|0|||
25004667|NCT00092495|50097099|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
25004668|NCT00092495|50097100|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
25004669|NCT00092495|50097101|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
25004670|NCT00092495|50097102|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
25004671|NCT00092495|50097103|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
25004672|NCT00092495|50097099|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
25004673|NCT00092495|50097100|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
25004674|NCT00092495|50097101|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
25004675|NCT00092495|50097102|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
25004676|NCT00092495|50097103|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
25004677|NCT00092417|50097118|FG000|Overall Study|Lost to Follow-up|2|||
25004678|NCT00092417|50097119|FG001|Overall Study|Lost to Follow-up|0|||
25004679|NCT00092417|50097118|FG000|Overall Study|Withdrawal by Subject|2|||
25004680|NCT00092417|50097119|FG001|Overall Study|Withdrawal by Subject|1|||
25004681|NCT00092417|50097118|FG000|Overall Study|Other|1|||
25004682|NCT00092417|50097119|FG001|Overall Study|Other|0|||
25004683|NCT00091949|50097127|FG000|Overall Study|Withdrawal by Subject|117|||
25004684|NCT00091949|50097128|FG001|Overall Study|Withdrawal by Subject|110|||
25004685|NCT00091949|50097127|FG000|Overall Study|Lost to Follow-up|58|||
25004686|NCT00091949|50097128|FG001|Overall Study|Lost to Follow-up|41|||
25004687|NCT02258542|50097138|FG000|Overall Study|eg. not made to the visit|7|||
25004688|NCT02258542|50097139|FG001|Overall Study|eg. not made to the visit|4|||
25004689|NCT02258542|50097140|FG002|Overall Study|eg. not made to the visit|0|||
25004690|NCT02258542|50097141|FG003|Overall Study|eg. not made to the visit|1|||
25004691|NCT02258542|50097138|FG000|Overall Study|study specific discount. criteria|1|||
25004692|NCT02258542|50097139|FG001|Overall Study|study specific discount. criteria|1|||
25004693|NCT02258542|50097140|FG002|Overall Study|study specific discount. criteria|0|||
25004694|NCT02258542|50097141|FG003|Overall Study|study specific discount. criteria|0|||
25004695|NCT02258542|50097138|FG000|Overall Study|Withdrawal by Subject|20|||
25004696|NCT02258542|50097139|FG001|Overall Study|Withdrawal by Subject|20|||
25004697|NCT02258542|50097140|FG002|Overall Study|Withdrawal by Subject|7|||
25004698|NCT02258542|50097141|FG003|Overall Study|Withdrawal by Subject|1|||
25004699|NCT02258542|50097138|FG000|Overall Study|Lost to Follow-up|5|||
25004700|NCT02258542|50097139|FG001|Overall Study|Lost to Follow-up|12|||
25004701|NCT02258542|50097140|FG002|Overall Study|Lost to Follow-up|1|||
25004702|NCT02258542|50097141|FG003|Overall Study|Lost to Follow-up|2|||
25004703|NCT02258542|50097138|FG000|Overall Study|Death|5|||
25004704|NCT02258542|50097139|FG001|Overall Study|Death|4|||
25004705|NCT02258542|50097140|FG002|Overall Study|Death|0|||
25004706|NCT02258542|50097141|FG003|Overall Study|Death|1|||
25004707|NCT02258542|50097138|FG000|Overall Study|Adverse Event|3|||
25004708|NCT02258542|50097139|FG001|Overall Study|Adverse Event|4|||
25004709|NCT02258542|50097140|FG002|Overall Study|Adverse Event|0|||
25004710|NCT02258542|50097141|FG003|Overall Study|Adverse Event|0|||
25004711|NCT02258542|50097138|FG000|Overall Study|Protocol Violation|1|||
25004712|NCT02258542|50097139|FG001|Overall Study|Protocol Violation|2|||
25004713|NCT02258542|50097140|FG002|Overall Study|Protocol Violation|0|||
25004714|NCT02258542|50097141|FG003|Overall Study|Protocol Violation|0|||
25004715|NCT02258542|50097138|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
25004716|NCT02258542|50097139|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
25004717|NCT02258542|50097140|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
25004718|NCT02258542|50097141|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
25004719|NCT00091793|50097171|FG000|Overall Study|Adverse Event|1|||
25004720|NCT00091793|50097172|FG001|Overall Study|Adverse Event|2|||
25004721|NCT00091793|50097171|FG000|Overall Study|Withdrawal by Subject|10|||
25004722|NCT00091793|50097172|FG001|Overall Study|Withdrawal by Subject|15|||
25004723|NCT00091793|50097171|FG000|Overall Study|Ineligibility determined|2|||
25004724|NCT00091793|50097172|FG001|Overall Study|Ineligibility determined|0|||
25004725|NCT00091793|50097171|FG000|Overall Study|Lost to Follow-up|7|||
25004726|NCT00091793|50097172|FG001|Overall Study|Lost to Follow-up|5|||
25004727|NCT00091793|50097171|FG000|Overall Study|Noncompliance|2|||
25004728|NCT00091793|50097172|FG001|Overall Study|Noncompliance|0|||
25004729|NCT00091793|50097171|FG000|Overall Study|Other|2|||
25004730|NCT00091793|50097172|FG001|Overall Study|Other|0|||
25004731|NCT00098813|50097178|FG000|Overall Study|Death|8|||
25004732|NCT00098813|50097178|FG000|Overall Study|Protocol Violation|1|||
25004733|NCT00098813|50097178|FG000|Overall Study|Withdrawal by Subject|7|||
25004734|NCT00098813|50097178|FG000|Overall Study|Progression of Disease|1|||
25004735|NCT00098813|50097178|FG000|Overall Study|Other complicating disease|1|||
25004736|NCT00098813|50097178|FG000|Overall Study|Reversal of RAI resistance|1|||
25004737|NCT00091169|50097184|FG000|Overall Study|Disease progression|3|||
25004738|NCT00091169|50097185|FG001|Overall Study|Disease progression|1|||
25004739|NCT00091169|50097184|FG000|Overall Study|Adverse Event|11|||
25004740|NCT00091169|50097185|FG001|Overall Study|Adverse Event|17|||
25004741|NCT00091169|50097184|FG000|Overall Study|Death|4|||
25004742|NCT00091169|50097185|FG001|Overall Study|Death|1|||
25004743|NCT00091169|50097184|FG000|Overall Study|Withdrawal by Subject|10|||
25004744|NCT00091169|50097185|FG001|Overall Study|Withdrawal by Subject|13|||
25004745|NCT00091169|50097184|FG000|Overall Study|Other|3|||
25004746|NCT00091169|50097185|FG001|Overall Study|Other|4|||
25004747|NCT00091169|50097184|FG000|Overall Study|Not start protocol therapy|26|||
25004748|NCT00091169|50097185|FG001|Overall Study|Not start protocol therapy|17|||
25004749|NCT00090857|50097195|FG000|Overall Study|Lost to Follow-up|0|||
25004750|NCT00090857|50097196|FG001|Overall Study|Lost to Follow-up|1|||
25004751|NCT00090857|50097195|FG000|Overall Study|Withdrawal by Subject|2|||
25004752|NCT00090857|50097196|FG001|Overall Study|Withdrawal by Subject|0|||
25004753|NCT00090857|50097195|FG000|Overall Study|Adverse Event|2|||
25004754|NCT00090857|50097196|FG001|Overall Study|Adverse Event|2|||
25004755|NCT00090779|50097208|FG000|Step 1|Withdrawal by Subject|4|||
25004756|NCT00090779|50097209|FG001|Step 1|Withdrawal by Subject|2|||
25004757|NCT00090779|50097208|FG000|Step 1|Lost to Follow-up|3|||
25004758|NCT00090779|50097209|FG001|Step 1|Lost to Follow-up|2|||
25004759|NCT00090779|50097208|FG000|Step 1|Death|0|||
25004760|NCT00090779|50097209|FG001|Step 1|Death|2|||
25004761|NCT00090779|50097208|FG000|Step 1|Physician Decision|1|||
25004762|NCT00090779|50097209|FG001|Step 1|Physician Decision|0|||
25004763|NCT00090779|50097208|FG000|Step 1|Pregnancy|1|||
25004764|NCT00090779|50097209|FG001|Step 1|Pregnancy|0|||
25004765|NCT00090779|50097208|FG000|Step 1|Non-compliance to study requirements|0|||
25004766|NCT00090779|50097209|FG001|Step 1|Non-compliance to study requirements|1|||
25004767|NCT00090779|50097208|FG000|Step 1|Subject relocated|2|||
25004768|NCT00090779|50097209|FG001|Step 1|Subject relocated|8|||
25004769|NCT00090779|50097208|FG000|Step 2|Off study per study closure|6|||
25004770|NCT00090779|50097209|FG001|Step 2|Off study per study closure|16|||
25004771|NCT00090779|50097208|FG000|Step 2|Subject relocated|0|||
25004772|NCT00090779|50097209|FG001|Step 2|Subject relocated|1|||
25004773|NCT00090779|50097208|FG000|Step 2|Non-compliance to study requirements|0|||
25004774|NCT00090779|50097209|FG001|Step 2|Non-compliance to study requirements|1|||
25004775|NCT00090779|50097208|FG000|Step 3|Initiation of ART and off extended study|3|||
25004776|NCT00090779|50097209|FG001|Step 3|Initiation of ART and off extended study|2|||
25004777|NCT00090779|50097208|FG000|Step 3|Off extended study due to study closure|4|||
25004778|NCT00090779|50097209|FG001|Step 3|Off extended study due to study closure|3|||
25004779|NCT00098345|50097215|FG000|Overall Study|Adverse Event|7|||
25004780|NCT00098345|50097215|FG000|Overall Study|Withdrawal by Subject|2|||
25004781|NCT00098345|50097215|FG000|Overall Study|progression|4|||
25004782|NCT02224456|50097219|FG000|Overall Study|Lack of Efficacy|1|||
25004783|NCT02224456|50097219|FG000|Overall Study|Lost to Follow-up|15|||
25004784|NCT02224456|50097219|FG000|Overall Study|Withdrawal by Subject|9|||
25004785|NCT02224456|50097219|FG000|Overall Study|Physician Decision|3|||
25004786|NCT02224456|50097219|FG000|Overall Study|Death|2|||
25004787|NCT02224456|50097219|FG000|Overall Study|Pregnancy|4|||
25004788|NCT02224456|50097219|FG000|Overall Study|Protocol Violation|1|||
25004789|NCT02224456|50097219|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
25004790|NCT00097721|50097225|FG000|Overall Study|Adverse Event|8|||
25004791|NCT00097721|50097226|FG001|Overall Study|Adverse Event|1|||
25004792|NCT00097721|50097225|FG000|Overall Study|Withdrawal by Subject|6|||
25004793|NCT00097721|50097226|FG001|Overall Study|Withdrawal by Subject|1|||
25004794|NCT00097721|50097225|FG000|Overall Study|Progressive Disease|55|||
25004795|NCT00097721|50097226|FG001|Overall Study|Progressive Disease|27|||
25004796|NCT00097721|50097225|FG000|Overall Study|Physician Decision|1|||
25004797|NCT00097721|50097226|FG001|Overall Study|Physician Decision|3|||
25004798|NCT00097721|50097225|FG000|Overall Study|Reason not given|1|||
25004799|NCT00097721|50097226|FG001|Overall Study|Reason not given|1|||
25004800|NCT03553498|50097234|FG000|Overall Study|Missing primary outcome|1|||
25004801|NCT03553498|50097235|FG001|Overall Study|Missing primary outcome|2|||
25004802|NCT00096941|50097241|FG000|Overall Study|disease progression|3|||
25004803|NCT00096785|50097247|FG000|Overall Study|Lost to Follow-up|1|||
25004804|NCT00096785|50097248|FG001|Overall Study|Lost to Follow-up|0|||
25004805|NCT00096785|50097247|FG000|Overall Study|Withdrawal by Subject|0|||
25004806|NCT00096785|50097248|FG001|Overall Study|Withdrawal by Subject|1|||
25004807|NCT00096785|50097247|FG000|Overall Study|Relocated|1|||
25004808|NCT00096785|50097248|FG001|Overall Study|Relocated|0|||
25004809|NCT00090545|50097279|FG000|Overall Study|Disease progression on study|21|||
25004810|NCT00090545|50097280|FG001|Overall Study|Disease progression on study|17|||
25004811|NCT00090545|50097279|FG000|Overall Study|Refused further treatment|1|||
25004812|NCT00090545|50097280|FG001|Overall Study|Refused further treatment|4|||
25004813|NCT00090545|50097279|FG000|Overall Study|Death|0|||
25004814|NCT00090545|50097280|FG001|Overall Study|Death|1|||
25004815|NCT00090545|50097279|FG000|Overall Study|Adverse Event|0|||
25004816|NCT00090545|50097280|FG001|Overall Study|Adverse Event|2|||
25004817|NCT03249376|50097290|FG000|Overall Study|Adverse Event|11|||
25004818|NCT03249376|50097291|FG001|Overall Study|Adverse Event|5|||
25004819|NCT03249376|50097290|FG000|Overall Study|Lack of Efficacy|2|||
25004820|NCT03249376|50097291|FG001|Overall Study|Lack of Efficacy|4|||
25004821|NCT03249376|50097290|FG000|Overall Study|Protocol Violation|3|||
25004822|NCT03249376|50097291|FG001|Overall Study|Protocol Violation|2|||
25004823|NCT03249376|50097290|FG000|Overall Study|Physician Decision|0|||
25004824|NCT03249376|50097291|FG001|Overall Study|Physician Decision|2|||
25004825|NCT03249376|50097290|FG000|Overall Study|Withdrawal by Subject|3|||
25004826|NCT03249376|50097291|FG001|Overall Study|Withdrawal by Subject|9|||
25004827|NCT03249376|50097290|FG000|Overall Study|LTFU|2|||
25004828|NCT03249376|50097291|FG001|Overall Study|LTFU|1|||
25004829|NCT00070109|50097302|FG000|Overall Study|Death|1|||
25004830|NCT00070109|50097303|FG001|Overall Study|Death|1|||
25004831|NCT00070109|50097304|FG002|Overall Study|Death|0|||
25004832|NCT00070109|50097305|FG003|Overall Study|Death|0|||
25004833|NCT00070109|50097306|FG004|Overall Study|Death|1|||
25004834|NCT00070109|50097302|FG000|Overall Study|Lack of Efficacy|6|||
25004835|NCT00070109|50097303|FG001|Overall Study|Lack of Efficacy|4|||
25004836|NCT00070109|50097304|FG002|Overall Study|Lack of Efficacy|5|||
25004837|NCT00070109|50097305|FG003|Overall Study|Lack of Efficacy|15|||
25004838|NCT00070109|50097306|FG004|Overall Study|Lack of Efficacy|5|||
25004839|NCT00070109|50097302|FG000|Overall Study|Physician Decision|1|||
25004840|NCT00070109|50097303|FG001|Overall Study|Physician Decision|0|||
25004841|NCT00070109|50097304|FG002|Overall Study|Physician Decision|0|||
25004842|NCT00070109|50097305|FG003|Overall Study|Physician Decision|0|||
25004843|NCT00070109|50097306|FG004|Overall Study|Physician Decision|0|||
25004844|NCT00070109|50097302|FG000|Overall Study|Withdrawal by Subject|0|||
25004845|NCT00070109|50097303|FG001|Overall Study|Withdrawal by Subject|1|||
25004846|NCT00070109|50097304|FG002|Overall Study|Withdrawal by Subject|1|||
25004847|NCT00070109|50097305|FG003|Overall Study|Withdrawal by Subject|0|||
25004848|NCT00070109|50097306|FG004|Overall Study|Withdrawal by Subject|0|||
25004849|NCT00070109|50097302|FG000|Overall Study|Adverse Event|0|||
25004850|NCT00070109|50097303|FG001|Overall Study|Adverse Event|0|||
25004851|NCT00070109|50097304|FG002|Overall Study|Adverse Event|2|||
25004852|NCT00070109|50097305|FG003|Overall Study|Adverse Event|4|||
25004853|NCT00070109|50097306|FG004|Overall Study|Adverse Event|2|||
25004854|NCT00070109|50097302|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
25004855|NCT00070109|50097303|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
25004856|NCT00070109|50097304|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
25004857|NCT00070109|50097305|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
25004858|NCT00070109|50097306|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
25004859|NCT00090233|50097327|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
25004860|NCT00090233|50097328|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
25004861|NCT00090233|50097327|FG000|Overall Study|Adverse Event|214|||
25004862|NCT00090233|50097328|FG001|Overall Study|Adverse Event|198|||
25004863|NCT00090233|50097327|FG000|Overall Study|Lost to Follow-up|68|||
25004864|NCT00090233|50097328|FG001|Overall Study|Lost to Follow-up|95|||
25004865|NCT00090233|50097327|FG000|Overall Study|Protocol Violation|960|||
25004866|NCT00090233|50097328|FG001|Overall Study|Protocol Violation|1022|||
25004867|NCT00090233|50097327|FG000|Overall Study|Withdrawal by Subject|182|||
25004868|NCT00090233|50097328|FG001|Overall Study|Withdrawal by Subject|211|||
25004869|NCT00090233|50097327|FG000|Overall Study|Moved|203|||
25004870|NCT00090233|50097328|FG001|Overall Study|Moved|189|||
25004871|NCT00090233|50097327|FG000|Overall Study|Other|1211|||
25004872|NCT00090233|50097328|FG001|Overall Study|Other|1160|||
25004873|NCT00090233|50097327|FG000|Overall Study|Data not available at data cut-off point|1552|||
25004874|NCT00090233|50097328|FG001|Overall Study|Data not available at data cut-off point|1563|||
25004875|NCT00069953|50097338|FG000|Overall Study|Protocol Violation|2|||
25004876|NCT03118570|50097347|FG000|Overall Study|Adverse Event|2|||
25004877|NCT03118570|50097348|FG001|Overall Study|Adverse Event|0|||
25004878|NCT03118570|50097349|FG002|Overall Study|Adverse Event|0|||
25004879|NCT03118570|50097350|FG003|Overall Study|Adverse Event|0|||
25004880|NCT03118570|50097351|FG004|Overall Study|Adverse Event|3|||
25004881|NCT03118570|50097347|FG000|Overall Study|Withdrawal by Subject|0|||
25004882|NCT03118570|50097348|FG001|Overall Study|Withdrawal by Subject|1|||
25004883|NCT03118570|50097349|FG002|Overall Study|Withdrawal by Subject|4|||
25004884|NCT03118570|50097350|FG003|Overall Study|Withdrawal by Subject|0|||
25004885|NCT03118570|50097351|FG004|Overall Study|Withdrawal by Subject|1|||
25004886|NCT03118570|50097347|FG000|Overall Study|Lost to Follow-up|2|||
25004887|NCT03118570|50097348|FG001|Overall Study|Lost to Follow-up|3|||
25004888|NCT03118570|50097349|FG002|Overall Study|Lost to Follow-up|1|||
25004889|NCT03118570|50097350|FG003|Overall Study|Lost to Follow-up|0|||
25004890|NCT03118570|50097351|FG004|Overall Study|Lost to Follow-up|1|||
25004891|NCT03118570|50097347|FG000|Overall Study|Other, Not Specified|1|||
25004892|NCT03118570|50097348|FG001|Overall Study|Other, Not Specified|3|||
25004893|NCT03118570|50097349|FG002|Overall Study|Other, Not Specified|0|||
25004894|NCT03118570|50097350|FG003|Overall Study|Other, Not Specified|0|||
25004895|NCT03118570|50097351|FG004|Overall Study|Other, Not Specified|0|||
25004896|NCT02750800|50097370|FG000|Overall Study|Adverse Event|18|||
25004897|NCT02750800|50097370|FG000|Overall Study|Lost to Follow-up|12|||
25004898|NCT02750800|50097370|FG000|Overall Study|Investigator decision|53|||
25004899|NCT02750800|50097370|FG000|Overall Study|Patient request|12|||
25004900|NCT02750800|50097370|FG000|Overall Study|Other, not specified|3|||
25004901|NCT03690388|50097390|FG000|Overall Study|Adverse Event|8|||
25004902|NCT03690388|50097391|FG001|Overall Study|Adverse Event|1|||
25004903|NCT03690388|50097390|FG000|Overall Study|Radiographic Progression|14|||
25004904|NCT03690388|50097391|FG001|Overall Study|Radiographic Progression|29|||
25004905|NCT03690388|50097390|FG000|Overall Study|Clinical deterioration|10|||
25004906|NCT03690388|50097391|FG001|Overall Study|Clinical deterioration|6|||
25004907|NCT03690388|50097390|FG000|Overall Study|Withdrawal by Subject|2|||
25004908|NCT03690388|50097391|FG001|Overall Study|Withdrawal by Subject|0|||
25004909|NCT03690388|50097390|FG000|Overall Study|Lack of Efficacy|1|||
25004910|NCT03690388|50097391|FG001|Overall Study|Lack of Efficacy|0|||
25091367|NCT02673697|50200972|FG000|Overall Study|Death|32|||
25091368|NCT02673697|50200973|FG001|Overall Study|Death|24|||
25004911|NCT03690388|50097390|FG000|Overall Study|Lost to Follow-up|1|||
25004912|NCT03690388|50097391|FG001|Overall Study|Lost to Follow-up|0|||
25004913|NCT01329562|50097399|FG000|Overall Study|Protocol Violation|5|||
25004914|NCT01329562|50097400|FG001|Overall Study|Protocol Violation|3|||
25004915|NCT01329562|50097399|FG000|Overall Study|Lost to Follow-up|1|||
25004916|NCT01329562|50097400|FG001|Overall Study|Lost to Follow-up|1|||
25004917|NCT01329562|50097399|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
25004918|NCT01329562|50097400|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
25004919|NCT01329562|50097399|FG000|Overall Study|Physician Decision|0|||
25004920|NCT01329562|50097400|FG001|Overall Study|Physician Decision|1|||
25004921|NCT00069641|50097411|FG000|Overall Study|Death|1|||
25004922|NCT00069641|50097412|FG001|Overall Study|Death|0|||
25004923|NCT00069641|50097413|FG002|Overall Study|Death|1|||
25004924|NCT03653026|50097424|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
25004925|NCT03653026|50097425|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
25004926|NCT03653026|50097426|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
25004927|NCT03653026|50097427|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
25004928|NCT03653026|50097424|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
25004929|NCT03653026|50097425|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
25004930|NCT03653026|50097426|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
25004931|NCT03653026|50097427|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
25004932|NCT03653026|50097424|FG000|Part 1: Placebo-controlled Period|Other|0|||
25004933|NCT03653026|50097425|FG001|Part 1: Placebo-controlled Period|Other|3|||
25004934|NCT03653026|50097426|FG002|Part 1: Placebo-controlled Period|Other|0|||
25004935|NCT03653026|50097427|FG003|Part 1: Placebo-controlled Period|Other|0|||
25004936|NCT03653026|50097424|FG000|Part 2: Open-label Extension|Adverse Event|0|||
25004937|NCT03653026|50097425|FG001|Part 2: Open-label Extension|Adverse Event|0|||
25004938|NCT03653026|50097426|FG002|Part 2: Open-label Extension|Adverse Event|1|||
25004939|NCT03653026|50097427|FG003|Part 2: Open-label Extension|Adverse Event|1|||
25004940|NCT03653026|50097424|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
25004941|NCT03653026|50097425|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
25004942|NCT03653026|50097426|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
25004943|NCT03653026|50097427|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
25004944|NCT03653026|50097424|FG000|Part 2: Open-label Extension|Other|0|||
25004945|NCT03653026|50097425|FG001|Part 2: Open-label Extension|Other|0|||
25004946|NCT03653026|50097426|FG002|Part 2: Open-label Extension|Other|1|||
25004947|NCT03653026|50097427|FG003|Part 2: Open-label Extension|Other|2|||
25004948|NCT01329328|50097438|FG000|Overall Study|Withdrawal by Subject|2|||
25004949|NCT01329328|50097439|FG001|Overall Study|Withdrawal by Subject|4|||
25004950|NCT01329328|50097440|FG002|Overall Study|Withdrawal by Subject|3|||
25004951|NCT01337986|50097450|FG000|Overall Study|Adverse Event|2|||
25004952|NCT01337986|50097451|FG001|Overall Study|Adverse Event|2|||
25004953|NCT01337986|50097450|FG000|Overall Study|Lost to Follow-up|1|||
25004954|NCT01337986|50097451|FG001|Overall Study|Lost to Follow-up|0|||
25004955|NCT01337986|50097450|FG000|Overall Study|Protocol Violation|0|||
25004956|NCT01337986|50097451|FG001|Overall Study|Protocol Violation|3|||
25004957|NCT01337674|50097475|FG000|Treatment Period 1|Adverse Event|0|||
25004958|NCT01337674|50097476|FG001|Treatment Period 1|Adverse Event|1|||
25004959|NCT01337674|50097477|FG002|Treatment Period 1|Adverse Event|0|||
25004960|NCT01337674|50097478|FG003|Treatment Period 1|Adverse Event|0|||
25004961|NCT01337674|50097475|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
25004962|NCT01337674|50097476|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
25004963|NCT01337674|50097477|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
25004964|NCT01337674|50097478|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
25004965|NCT01337674|50097475|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25004966|NCT01337674|50097476|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25004967|NCT01337674|50097477|FG002|Treatment Period 2|Withdrawal by Subject|1|||
25004968|NCT01337674|50097478|FG003|Treatment Period 2|Withdrawal by Subject|0|||
25004969|NCT02750410|50097493|FG000|Double-Blind Treatment Period|Adverse Event|2|||
25004970|NCT02750410|50097494|FG001|Double-Blind Treatment Period|Adverse Event|2|||
25004971|NCT02750410|50097493|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
25004972|NCT02750410|50097494|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
25004973|NCT02750410|50097493|FG000|Open-Label Extension Period|Adverse Event|5|||
25004974|NCT02750410|50097494|FG001|Open-Label Extension Period|Adverse Event|3|||
25004975|NCT02750410|50097493|FG000|Open-Label Extension Period|Protocol Violation|0|||
25004976|NCT02750410|50097494|FG001|Open-Label Extension Period|Protocol Violation|1|||
25176758|NCT01514201|50320311|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
25176759|NCT01514201|50320312|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
25004977|NCT02750410|50097493|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
25004978|NCT02750410|50097494|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
25004979|NCT02750332|50097504|FG000|Treatment Period 1|Withdrawal by Subject|0|||
25176760|NCT01514201|50320309|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
25176761|NCT01514201|50320310|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
25004980|NCT02750332|50097505|FG001|Treatment Period 1|Withdrawal by Subject|1|||
25004981|NCT01337596|50097520|FG000|Overall Study|Withdrawal by Subject|0|||
25004982|NCT01337596|50097521|FG001|Overall Study|Withdrawal by Subject|0|||
25004983|NCT01337596|50097522|FG002|Overall Study|Withdrawal by Subject|0|||
25004984|NCT01337596|50097523|FG003|Overall Study|Withdrawal by Subject|0|||
25004985|NCT01337596|50097524|FG004|Overall Study|Withdrawal by Subject|2|||
25004986|NCT01337596|50097525|FG005|Overall Study|Withdrawal by Subject|0|||
25004987|NCT01337596|50097526|FG006|Overall Study|Withdrawal by Subject|0|||
25004988|NCT01337596|50097527|FG007|Overall Study|Withdrawal by Subject|0|||
25004989|NCT01337596|50097528|FG008|Overall Study|Withdrawal by Subject|0|||
25004990|NCT00069095|50097557|FG000|Primary Treatment Phase|Ongoing|0|||
25004991|NCT00069095|50097558|FG001|Primary Treatment Phase|Ongoing|0|||
25004992|NCT00069095|50097559|FG002|Primary Treatment Phase|Ongoing|5|||
25004993|NCT00069095|50097560|FG003|Primary Treatment Phase|Ongoing|7|||
25004994|NCT00069095|50097561|FG004|Primary Treatment Phase|Ongoing|7|||
25004995|NCT00069095|50097562|FG005|Primary Treatment Phase|Ongoing|4|||
25004996|NCT00069095|50097557|FG000|Primary Treatment Phase|Admin/Other|29|||
25004997|NCT00069095|50097558|FG001|Primary Treatment Phase|Admin/Other|38|||
25004998|NCT00069095|50097559|FG002|Primary Treatment Phase|Admin/Other|31|||
25004999|NCT00069095|50097560|FG003|Primary Treatment Phase|Admin/Other|45|||
25005000|NCT00069095|50097561|FG004|Primary Treatment Phase|Admin/Other|48|||
25005001|NCT00069095|50097562|FG005|Primary Treatment Phase|Admin/Other|42|||
25005002|NCT00069095|50097557|FG000|Primary Treatment Phase|Adverse Event|99|||
25005003|NCT00069095|50097558|FG001|Primary Treatment Phase|Adverse Event|92|||
25005004|NCT00069095|50097559|FG002|Primary Treatment Phase|Adverse Event|71|||
25005005|NCT00069095|50097560|FG003|Primary Treatment Phase|Adverse Event|72|||
25005006|NCT00069095|50097561|FG004|Primary Treatment Phase|Adverse Event|109|||
25005007|NCT00069095|50097562|FG005|Primary Treatment Phase|Adverse Event|101|||
25005008|NCT00069095|50097557|FG000|Primary Treatment Phase|Death|14|||
25005009|NCT00069095|50097558|FG001|Primary Treatment Phase|Death|8|||
25005010|NCT00069095|50097559|FG002|Primary Treatment Phase|Death|2|||
25005011|NCT00069095|50097560|FG003|Primary Treatment Phase|Death|5|||
25005012|NCT00069095|50097561|FG004|Primary Treatment Phase|Death|8|||
25005013|NCT00069095|50097562|FG005|Primary Treatment Phase|Death|8|||
25005014|NCT00069095|50097557|FG000|Primary Treatment Phase|Failure to return|5|||
25005015|NCT00069095|50097558|FG001|Primary Treatment Phase|Failure to return|5|||
25005016|NCT00069095|50097559|FG002|Primary Treatment Phase|Failure to return|0|||
25005017|NCT00069095|50097560|FG003|Primary Treatment Phase|Failure to return|0|||
25005018|NCT00069095|50097561|FG004|Primary Treatment Phase|Failure to return|0|||
25005019|NCT00069095|50097562|FG005|Primary Treatment Phase|Failure to return|2|||
25005020|NCT00069095|50097557|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
25005021|NCT00069095|50097558|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
25005022|NCT00069095|50097559|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
25005023|NCT00069095|50097560|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
25005024|NCT00069095|50097561|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
25005025|NCT00069095|50097562|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
25005026|NCT00069095|50097557|FG000|Primary Treatment Phase|Refused treatment|15|||
25005027|NCT00069095|50097558|FG001|Primary Treatment Phase|Refused treatment|26|||
25005028|NCT00069095|50097559|FG002|Primary Treatment Phase|Refused treatment|17|||
25005029|NCT00069095|50097560|FG003|Primary Treatment Phase|Refused treatment|31|||
25005030|NCT00069095|50097561|FG004|Primary Treatment Phase|Refused treatment|24|||
25005031|NCT00069095|50097562|FG005|Primary Treatment Phase|Refused treatment|27|||
25005032|NCT00069095|50097557|FG000|Primary Treatment Phase|Withdrew|2|||
25005033|NCT00069095|50097558|FG001|Primary Treatment Phase|Withdrew|3|||
25005034|NCT00069095|50097559|FG002|Primary Treatment Phase|Withdrew|8|||
25005035|NCT00069095|50097560|FG003|Primary Treatment Phase|Withdrew|2|||
25005036|NCT00069095|50097561|FG004|Primary Treatment Phase|Withdrew|4|||
25005037|NCT00069095|50097562|FG005|Primary Treatment Phase|Withdrew|9|||
25005038|NCT00069095|50097557|FG000|Primary Treatment Phase|Other Violation|0|||
25005039|NCT00069095|50097558|FG001|Primary Treatment Phase|Other Violation|1|||
25005040|NCT00069095|50097559|FG002|Primary Treatment Phase|Other Violation|1|||
25005041|NCT00069095|50097560|FG003|Primary Treatment Phase|Other Violation|1|||
25005042|NCT00069095|50097561|FG004|Primary Treatment Phase|Other Violation|0|||
25005043|NCT00069095|50097562|FG005|Primary Treatment Phase|Other Violation|1|||
25005044|NCT00069095|50097557|FG000|Primary Treatment Phase|Violation criteria|0|||
25005045|NCT00069095|50097558|FG001|Primary Treatment Phase|Violation criteria|2|||
25005046|NCT00069095|50097559|FG002|Primary Treatment Phase|Violation criteria|4|||
25005047|NCT00069095|50097560|FG003|Primary Treatment Phase|Violation criteria|3|||
25005048|NCT00069095|50097561|FG004|Primary Treatment Phase|Violation criteria|1|||
25005049|NCT00069095|50097562|FG005|Primary Treatment Phase|Violation criteria|5|||
25005050|NCT00069095|50097557|FG000|Post-study Treatment Phase|Missing reason|1|||
25005051|NCT00069095|50097558|FG001|Post-study Treatment Phase|Missing reason|3|||
25005052|NCT00069095|50097559|FG002|Post-study Treatment Phase|Missing reason|12|||
25176762|NCT01514201|50320311|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
25176763|NCT01514201|50320312|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
25005053|NCT00069095|50097560|FG003|Post-study Treatment Phase|Missing reason|8|||
25005054|NCT00069095|50097561|FG004|Post-study Treatment Phase|Missing reason|18|||
25005055|NCT00069095|50097562|FG005|Post-study Treatment Phase|Missing reason|17|||
25005056|NCT00069095|50097557|FG000|Post-study Treatment Phase|Adverse Event|2|||
25005057|NCT00069095|50097558|FG001|Post-study Treatment Phase|Adverse Event|3|||
25005058|NCT00069095|50097559|FG002|Post-study Treatment Phase|Adverse Event|1|||
25005059|NCT00069095|50097560|FG003|Post-study Treatment Phase|Adverse Event|0|||
25005060|NCT00069095|50097561|FG004|Post-study Treatment Phase|Adverse Event|5|||
25005061|NCT00069095|50097562|FG005|Post-study Treatment Phase|Adverse Event|1|||
25005062|NCT00069095|50097557|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
25005063|NCT00069095|50097558|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
25005064|NCT00069095|50097559|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
25005065|NCT00069095|50097560|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
25005066|NCT00069095|50097561|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
25005067|NCT00069095|50097562|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
25005068|NCT00069095|50097557|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
25005069|NCT00069095|50097558|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
25005070|NCT00069095|50097559|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
25005071|NCT00069095|50097560|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
25005072|NCT00069095|50097561|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
25005073|NCT00069095|50097562|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
25005074|NCT00069095|50097557|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
25005075|NCT00069095|50097558|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
25005076|NCT00069095|50097559|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
25005077|NCT00069095|50097560|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
25005078|NCT00069095|50097561|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
25005079|NCT00069095|50097562|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
25005080|NCT00069095|50097557|FG000|Post-study Treatment Phase|Participant had complete response|1|||
25005081|NCT00069095|50097558|FG001|Post-study Treatment Phase|Participant had complete response|1|||
25005082|NCT00069095|50097559|FG002|Post-study Treatment Phase|Participant had complete response|0|||
25005083|NCT00069095|50097560|FG003|Post-study Treatment Phase|Participant had complete response|0|||
25005084|NCT00069095|50097561|FG004|Post-study Treatment Phase|Participant had complete response|0|||
25005085|NCT00069095|50097562|FG005|Post-study Treatment Phase|Participant had complete response|0|||
25005086|NCT00069095|50097557|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
25005087|NCT00069095|50097558|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
25005088|NCT00069095|50097559|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
25005089|NCT00069095|50097560|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
25005090|NCT00069095|50097561|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
25005091|NCT00069095|50097562|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
25005092|NCT00069095|50097557|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
25005093|NCT00069095|50097558|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
25005094|NCT00069095|50097559|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
25005095|NCT00069095|50097560|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
25005096|NCT00069095|50097561|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
25005097|NCT00069095|50097562|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
25005098|NCT00069095|50097557|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
25005099|NCT00069095|50097558|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
25005100|NCT00069095|50097559|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
25005101|NCT00069095|50097560|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
25005102|NCT00069095|50097561|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
25005103|NCT00069095|50097562|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
25005104|NCT00069095|50097557|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
25005105|NCT00069095|50097558|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
25005106|NCT00069095|50097559|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
25005107|NCT00069095|50097560|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
25005108|NCT00069095|50097561|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
25005109|NCT00069095|50097562|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
25005110|NCT00069095|50097557|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
25005111|NCT00069095|50097558|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
25005112|NCT00069095|50097559|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
25176764|NCT01514201|50320309|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
25005113|NCT00069095|50097560|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
25176765|NCT01514201|50320310|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
25176766|NCT01514201|50320311|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
25005114|NCT00069095|50097561|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
25005115|NCT00069095|50097562|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
25005116|NCT00069095|50097557|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
25005117|NCT00069095|50097558|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
25005118|NCT00069095|50097559|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
25005119|NCT00069095|50097560|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
25005120|NCT00069095|50097561|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
25005121|NCT00069095|50097562|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
25005122|NCT00069095|50097557|FG000|Post-study Treatment Phase|Surgery|0|||
25005123|NCT00069095|50097558|FG001|Post-study Treatment Phase|Surgery|0|||
25005124|NCT00069095|50097559|FG002|Post-study Treatment Phase|Surgery|0|||
25005125|NCT00069095|50097560|FG003|Post-study Treatment Phase|Surgery|1|||
25005126|NCT00069095|50097561|FG004|Post-study Treatment Phase|Surgery|1|||
25005127|NCT00069095|50097562|FG005|Post-study Treatment Phase|Surgery|0|||
25005128|NCT00069095|50097557|FG000|Post-study Treatment Phase|Death|0|||
25005129|NCT00069095|50097558|FG001|Post-study Treatment Phase|Death|0|||
25005130|NCT00069095|50097559|FG002|Post-study Treatment Phase|Death|0|||
25005131|NCT00069095|50097560|FG003|Post-study Treatment Phase|Death|0|||
25005132|NCT00069095|50097561|FG004|Post-study Treatment Phase|Death|1|||
25005133|NCT00069095|50097562|FG005|Post-study Treatment Phase|Death|0|||
25005134|NCT00069095|50097557|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
25005135|NCT00069095|50097558|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
25005136|NCT00069095|50097559|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
25005137|NCT00069095|50097560|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
25005138|NCT00069095|50097561|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
25005139|NCT00069095|50097562|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
25005140|NCT00069095|50097557|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
25005141|NCT00069095|50097558|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
25005142|NCT00069095|50097559|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
25005143|NCT00069095|50097560|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
25005144|NCT00069095|50097561|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
25005145|NCT00069095|50097562|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
25005146|NCT00069095|50097557|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
25005147|NCT00069095|50097558|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
25005148|NCT00069095|50097559|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
25005149|NCT00069095|50097560|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
25005150|NCT00069095|50097561|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
25005151|NCT00069095|50097562|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
25005152|NCT00069095|50097557|FG000|Post-study Treatment Phase|Investigator decision|0|||
25005153|NCT00069095|50097558|FG001|Post-study Treatment Phase|Investigator decision|0|||
25005154|NCT00069095|50097559|FG002|Post-study Treatment Phase|Investigator decision|0|||
25005155|NCT00069095|50097560|FG003|Post-study Treatment Phase|Investigator decision|0|||
25005156|NCT00069095|50097561|FG004|Post-study Treatment Phase|Investigator decision|0|||
25005157|NCT00069095|50097562|FG005|Post-study Treatment Phase|Investigator decision|1|||
25005158|NCT00069095|50097557|FG000|Follow-up Phase|Death|174|||
25005159|NCT00069095|50097558|FG001|Follow-up Phase|Death|206|||
25005160|NCT00069095|50097559|FG002|Follow-up Phase|Death|120|||
25005161|NCT00069095|50097560|FG003|Follow-up Phase|Death|112|||
25005162|NCT00069095|50097561|FG004|Follow-up Phase|Death|92|||
25005163|NCT00069095|50097562|FG005|Follow-up Phase|Death|101|||
25005164|NCT00086411|50097578|FG000|Overall Study|Lost to Follow-up|11|||
25005165|NCT00086411|50097579|FG001|Overall Study|Lost to Follow-up|11|||
25005166|NCT00086411|50097580|FG002|Overall Study|Lost to Follow-up|13|||
25005167|NCT00086411|50097581|FG003|Overall Study|Lost to Follow-up|12|||
25005168|NCT00068393|50097592|FG000|Overall Study|Adverse Event|2|||
25005169|NCT00068393|50097592|FG000|Overall Study|Death|3|||
25005170|NCT00068393|50097592|FG000|Overall Study|Withdrawal by Subject|3|||
25005171|NCT00068393|50097592|FG000|Overall Study|Alternative treatment|1|||
25005172|NCT00068393|50097592|FG000|Overall Study|Quality of life worsening|1|||
25005173|NCT00068237|50097596|FG000|Overall Study|Ineligible|3|||
25005174|NCT00068237|50097596|FG000|Overall Study|No protocol treatment received|2|||
25005175|NCT00055601|50097602|FG000|Overall Study|Protocol Violation|1|||
25005176|NCT00055601|50097603|FG001|Overall Study|Protocol Violation|1|||
25005177|NCT00055601|50097602|FG000|Overall Study|No protocol treatment received|1|||
25005178|NCT00055601|50097603|FG001|Overall Study|No protocol treatment received|1|||
25005179|NCT03806231|50097611|FG000|Overall Study|Physician Decision|1|||
25005180|NCT03806231|50097612|FG001|Overall Study|Physician Decision|0|||
25005181|NCT03806231|50097611|FG000|Overall Study|Withdrawal by Subject|1|||
25005182|NCT03806231|50097612|FG001|Overall Study|Withdrawal by Subject|0|||
25005183|NCT00054275|50097618|FG000|Overall Study|Withdrawal by Subject|4|||
25005184|NCT00054275|50097618|FG000|Overall Study|Adverse Event|5|||
25005185|NCT00054275|50097618|FG000|Overall Study|Progressive disease in cycle 1|1|||
25005186|NCT00054275|50097618|FG000|Overall Study|Physician Decision|1|||
25005187|NCT00053417|50097626|FG000|Overall Study|Adverse Event|1|||
25005188|NCT00053417|50097627|FG001|Overall Study|Adverse Event|0|||
25005189|NCT00053417|50097628|FG002|Overall Study|Adverse Event|1|||
25005190|NCT00053417|50097629|FG003|Overall Study|Adverse Event|5|||
25005191|NCT00053417|50097626|FG000|Overall Study|Non-Compliance|0|||
25005192|NCT00053417|50097627|FG001|Overall Study|Non-Compliance|0|||
25005193|NCT00053417|50097628|FG002|Overall Study|Non-Compliance|0|||
25005194|NCT00053417|50097629|FG003|Overall Study|Non-Compliance|1|||
25005195|NCT00053417|50097626|FG000|Overall Study|Withdrawal by Subject|0|||
25005196|NCT00053417|50097627|FG001|Overall Study|Withdrawal by Subject|1|||
25005197|NCT00053417|50097628|FG002|Overall Study|Withdrawal by Subject|0|||
25005198|NCT00053417|50097629|FG003|Overall Study|Withdrawal by Subject|0|||
25005199|NCT00053417|50097626|FG000|Overall Study|Lost to Follow-up|1|||
25005200|NCT00053417|50097627|FG001|Overall Study|Lost to Follow-up|1|||
25005201|NCT00053417|50097628|FG002|Overall Study|Lost to Follow-up|0|||
25005202|NCT00053417|50097629|FG003|Overall Study|Lost to Follow-up|0|||
25005203|NCT00052715|50097639|FG000|Overall Study|wrong histology|1|||
25005204|NCT00051311|50097645|FG000|Overall Study|Starting new study|0|||
25005205|NCT00051311|50097646|FG001|Overall Study|Starting new study|1|||
25005206|NCT00051311|50097645|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
25005207|NCT00051311|50097646|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
25005208|NCT00051311|50097645|FG000|Overall Study|Death of recipient|8|||
25005209|NCT00051311|50097646|FG001|Overall Study|Death of recipient|8|||
25005210|NCT00051311|50097645|FG000|Overall Study|Recipient taken off study|4|||
25005211|NCT00051311|50097646|FG001|Overall Study|Recipient taken off study|4|||
25005212|NCT00049673|50097652|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
25005213|NCT00049673|50097653|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
25005214|NCT00049127|50097664|FG000|Overall Study|Withdrawal by Subject|0|||
25005215|NCT00049127|50097665|FG001|Overall Study|Withdrawal by Subject|0|||
25005216|NCT00049127|50097666|FG002|Overall Study|Withdrawal by Subject|1|||
25005217|NCT00049127|50097667|FG003|Overall Study|Withdrawal by Subject|0|||
25005218|NCT00049127|50097668|FG004|Overall Study|Withdrawal by Subject|0|||
25005219|NCT00066365|50097682|FG000|Overall Study|Adverse Event|1|||
25005220|NCT00066365|50097683|FG001|Overall Study|Adverse Event|0|||
25005221|NCT00066365|50097682|FG000|Overall Study|Lack of Efficacy|15|||
25005222|NCT00066365|50097683|FG001|Overall Study|Lack of Efficacy|12|||
25005223|NCT00066365|50097682|FG000|Overall Study|Physician Decision|1|||
25005224|NCT00066365|50097683|FG001|Overall Study|Physician Decision|0|||
25005225|NCT00066365|50097682|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
25005226|NCT00066365|50097683|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
25005227|NCT00066365|50097682|FG000|Overall Study|Ineligible|4|||
25005228|NCT00066365|50097683|FG001|Overall Study|Ineligible|2|||
25005229|NCT00048581|50097693|FG000|Double-Blind Period|Adverse Event|9|||
25005230|NCT00048581|50097694|FG001|Double-Blind Period|Adverse Event|5|||
25005231|NCT00048581|50097695|FG002|Double-Blind Period|Adverse Event|0|||
25005232|NCT00048581|50097693|FG000|Double-Blind Period|Lack of Efficacy|14|||
25005233|NCT00048581|50097694|FG001|Double-Blind Period|Lack of Efficacy|27|||
25005234|NCT00048581|50097695|FG002|Double-Blind Period|Lack of Efficacy|0|||
25005235|NCT00048581|50097693|FG000|Double-Blind Period|Lost to Follow-up|5|||
25005236|NCT00048581|50097694|FG001|Double-Blind Period|Lost to Follow-up|0|||
25005237|NCT00048581|50097695|FG002|Double-Blind Period|Lost to Follow-up|0|||
25005238|NCT00048581|50097693|FG000|Double-Blind Period|Withdrawal by Subject|5|||
25005239|NCT00048581|50097694|FG001|Double-Blind Period|Withdrawal by Subject|2|||
25005240|NCT00048581|50097695|FG002|Double-Blind Period|Withdrawal by Subject|0|||
25005241|NCT00048581|50097693|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
25005242|NCT00048581|50097694|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
25005243|NCT00048581|50097695|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
25005244|NCT00048581|50097693|FG000|Double-Blind Period|Investigator Decision|1|||
25005245|NCT00048581|50097694|FG001|Double-Blind Period|Investigator Decision|0|||
25005246|NCT00048581|50097695|FG002|Double-Blind Period|Investigator Decision|0|||
25005247|NCT00048581|50097693|FG000|Open-Label Period|Death|0|||
25005248|NCT00048581|50097694|FG001|Open-Label Period|Death|0|||
25005249|NCT00048581|50097695|FG002|Open-Label Period|Death|4|||
25176767|NCT01514201|50320312|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
25005250|NCT00048581|50097693|FG000|Open-Label Period|Adverse Event|0|||
25005251|NCT00048581|50097694|FG001|Open-Label Period|Adverse Event|0|||
25005252|NCT00048581|50097695|FG002|Open-Label Period|Adverse Event|37|||
25005253|NCT00048581|50097693|FG000|Open-Label Period|Lack of Efficacy|0|||
25005254|NCT00048581|50097694|FG001|Open-Label Period|Lack of Efficacy|0|||
25005255|NCT00048581|50097695|FG002|Open-Label Period|Lack of Efficacy|69|||
25005256|NCT00048581|50097693|FG000|Open-Label Period|Lost to Follow-up|0|||
25005257|NCT00048581|50097694|FG001|Open-Label Period|Lost to Follow-up|0|||
25005258|NCT00048581|50097695|FG002|Open-Label Period|Lost to Follow-up|14|||
25005259|NCT00048581|50097693|FG000|Open-Label Period|Withdrawal by Subject|0|||
25005260|NCT00048581|50097694|FG001|Open-Label Period|Withdrawal by Subject|0|||
25005261|NCT00048581|50097695|FG002|Open-Label Period|Withdrawal by Subject|20|||
25005262|NCT00048581|50097693|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
25005263|NCT00048581|50097694|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
25005264|NCT00048581|50097695|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
25005265|NCT00048581|50097693|FG000|Open-Label Period|Poor/Non-compliance|0|||
25005266|NCT00048581|50097694|FG001|Open-Label Period|Poor/Non-compliance|0|||
25005267|NCT00048581|50097695|FG002|Open-Label Period|Poor/Non-compliance|5|||
25005268|NCT00048581|50097693|FG000|Open-Label Period|Pregnancy|0|||
25005269|NCT00048581|50097694|FG001|Open-Label Period|Pregnancy|0|||
25005270|NCT00048581|50097695|FG002|Open-Label Period|Pregnancy|7|||
25005271|NCT00048581|50097693|FG000|Open-Label Period|Study Site Closure|0|||
25005272|NCT00048581|50097694|FG001|Open-Label Period|Study Site Closure|0|||
25005273|NCT00048581|50097695|FG002|Open-Label Period|Study Site Closure|2|||
25005274|NCT00048581|50097693|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
25005275|NCT00048581|50097694|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
25005276|NCT00048581|50097695|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
25005277|NCT00048581|50097693|FG000|Open-Label Period|Problem With Transportation To Site|0|||
25005278|NCT00048581|50097694|FG001|Open-Label Period|Problem With Transportation To Site|0|||
25005279|NCT00048581|50097695|FG002|Open-Label Period|Problem With Transportation To Site|1|||
25005280|NCT00048581|50097693|FG000|Open-Label Period|Primary Investigator Retired|0|||
25005281|NCT00048581|50097694|FG001|Open-Label Period|Primary Investigator Retired|0|||
25005282|NCT00048581|50097695|FG002|Open-Label Period|Primary Investigator Retired|2|||
25005283|NCT00048581|50097693|FG000|Open-Label Period|Study Ended By Sponsor|0|||
25005284|NCT00048581|50097694|FG001|Open-Label Period|Study Ended By Sponsor|0|||
25005285|NCT00048581|50097695|FG002|Open-Label Period|Study Ended By Sponsor|1|||
25005286|NCT00048347|50097708|FG000|Overall Study|Screen failure|2|||
25005287|NCT00065507|50097714|FG000|Overall Study|Death|16|||
25005288|NCT00065507|50097715|FG001|Overall Study|Death|17|||
25005289|NCT00065507|50097714|FG000|Overall Study|Adverse Event|4|||
25005290|NCT00065507|50097715|FG001|Overall Study|Adverse Event|3|||
25005291|NCT00065507|50097714|FG000|Overall Study|Lack of Efficacy|0|||
25176768|NCT01514201|50320309|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
25176769|NCT01514201|50320310|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
25176770|NCT01514201|50320311|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
25176771|NCT01514201|50320312|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
25176772|NCT01514201|50320309|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
25176773|NCT01514201|50320310|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
25176774|NCT01514201|50320311|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
25176775|NCT01514201|50320312|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
25176776|NCT01514201|50320309|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
25005292|NCT00065507|50097715|FG001|Overall Study|Lack of Efficacy|6|||
25005293|NCT00065507|50097714|FG000|Overall Study|Poor/Non-compliance|3|||
25005294|NCT00065507|50097715|FG001|Overall Study|Poor/Non-compliance|2|||
25005295|NCT00065507|50097714|FG000|Overall Study|Lost to Follow-up|3|||
25005296|NCT00065507|50097715|FG001|Overall Study|Lost to Follow-up|0|||
25005297|NCT00065507|50097714|FG000|Overall Study|Subject Withdrew Consent|2|||
25005298|NCT00065507|50097715|FG001|Overall Study|Subject Withdrew Consent|1|||
25005299|NCT00065507|50097714|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
25005300|NCT00065507|50097715|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
25005301|NCT00065429|50097732|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
25005302|NCT00065429|50097733|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
25005303|NCT00065429|50097734|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
25005304|NCT00065429|50097735|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
25176777|NCT01514201|50320310|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
25176778|NCT01514201|50320311|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
25176779|NCT01514201|50320312|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
25176780|NCT02666664|50320334|FG000|Overall Study|Physician Decision|0|||
25176781|NCT02666664|50320335|FG001|Overall Study|Physician Decision|1|||
25176782|NCT02666664|50320334|FG000|Overall Study|Protocol Violation|0|||
25176783|NCT02666664|50320335|FG001|Overall Study|Protocol Violation|2|||
25176784|NCT02666664|50320334|FG000|Overall Study|Other|0|||
25176785|NCT02666664|50320335|FG001|Overall Study|Other|1|||
25176786|NCT02666664|50320334|FG000|Overall Study|Adverse Event|12|||
25176787|NCT02666664|50320335|FG001|Overall Study|Adverse Event|37|||
25005305|NCT00065429|50097736|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
25005306|NCT00065429|50097737|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
25005307|NCT00065429|50097738|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
25005308|NCT00065429|50097732|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
25005309|NCT00065429|50097733|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
25005310|NCT00065429|50097734|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
25005311|NCT00065429|50097735|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
25005312|NCT00065429|50097736|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
25005313|NCT00065429|50097737|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
25005314|NCT00065429|50097738|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
25005315|NCT00065429|50097732|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
25005316|NCT00065429|50097733|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
25005317|NCT00065429|50097734|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
25005318|NCT00065429|50097735|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
25005319|NCT00065429|50097736|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
25005320|NCT00065429|50097737|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
25005321|NCT00065429|50097738|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
25005322|NCT00065429|50097732|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
25005323|NCT00065429|50097733|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
25005324|NCT00065429|50097734|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
25005325|NCT00065429|50097735|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
25005326|NCT00065429|50097736|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
25005327|NCT00065429|50097737|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
25005328|NCT00065429|50097738|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
25005329|NCT00065429|50097732|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
25005330|NCT00065429|50097733|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
25005331|NCT00065429|50097734|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
25005332|NCT00065429|50097735|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
25005333|NCT00065429|50097736|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
25005334|NCT00065429|50097737|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
25005335|NCT00065429|50097738|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
25005336|NCT00065429|50097732|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
25005337|NCT00065429|50097733|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
25005338|NCT00065429|50097734|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
25005339|NCT00065429|50097735|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
25005340|NCT00065429|50097736|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
25005341|NCT00065429|50097737|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
25005342|NCT00065429|50097738|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
25005343|NCT00065429|50097732|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
25005344|NCT00065429|50097733|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
25005345|NCT00065429|50097734|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
25005346|NCT00065429|50097735|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
25005347|NCT00065429|50097736|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
25005348|NCT00065429|50097737|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
25005349|NCT00065429|50097738|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
25005350|NCT00048035|50097755|FG000|Core Period|Early Withdrawals|4|||
25005351|NCT00048035|50097756|FG001|Core Period|Early Withdrawals|2|||
25005352|NCT00048035|50097757|FG002|Core Period|Early Withdrawals|1|||
25005353|NCT00048035|50097758|FG003|Core Period|Early Withdrawals|1|||
25005354|NCT00048035|50097759|FG004|Core Period|Early Withdrawals|1|||
25005355|NCT00048035|50097760|FG005|Core Period|Early Withdrawals|1|||
25005356|NCT00048035|50097761|FG006|Core Period|Early Withdrawals|0|||
25005357|NCT00048035|50097762|FG007|Core Period|Early Withdrawals|0|||
25005358|NCT00048035|50097755|FG000|Extension Year 1|Early Withdrawals|0|||
25005359|NCT00048035|50097756|FG001|Extension Year 1|Early Withdrawals|0|||
25005360|NCT00048035|50097757|FG002|Extension Year 1|Early Withdrawals|0|||
25005361|NCT00048035|50097758|FG003|Extension Year 1|Early Withdrawals|0|||
25005362|NCT00048035|50097759|FG004|Extension Year 1|Early Withdrawals|0|||
25005363|NCT00048035|50097760|FG005|Extension Year 1|Early Withdrawals|0|||
25005364|NCT00048035|50097761|FG006|Extension Year 1|Early Withdrawals|11|||
25005365|NCT00048035|50097762|FG007|Extension Year 1|Early Withdrawals|11|||
25005366|NCT00048035|50097755|FG000|Extension Year 2|Early Withdrawals|0|||
25091369|NCT02673697|50200972|FG000|Overall Study|Lost to Follow-up|5|||
25091370|NCT02673697|50200973|FG001|Overall Study|Lost to Follow-up|2|||
25091371|NCT02673697|50200972|FG000|Overall Study|Physician Decision|2|||
25091372|NCT02673697|50200973|FG001|Overall Study|Physician Decision|1|||
25091373|NCT02673697|50200972|FG000|Overall Study|Withdrawal by Subject|10|||
25005367|NCT00048035|50097756|FG001|Extension Year 2|Early Withdrawals|0|||
25005368|NCT00048035|50097757|FG002|Extension Year 2|Early Withdrawals|0|||
25005369|NCT00048035|50097758|FG003|Extension Year 2|Early Withdrawals|0|||
25005370|NCT00048035|50097759|FG004|Extension Year 2|Early Withdrawals|0|||
25005371|NCT00048035|50097760|FG005|Extension Year 2|Early Withdrawals|0|||
25005372|NCT00048035|50097761|FG006|Extension Year 2|Early Withdrawals|3|||
25005373|NCT00048035|50097762|FG007|Extension Year 2|Early Withdrawals|3|||
25005374|NCT00047879|50097779|FG000|Overall Study|Progressive disease|4|||
25005375|NCT00047879|50097780|FG001|Overall Study|Progressive disease|3|||
25005376|NCT00064337|50097786|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
25005377|NCT00064337|50097786|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
25005378|NCT00064337|50097786|FG000|PBSCC or Induction/PBSCC|Progression|3|||
25005379|NCT00064337|50097786|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
25005380|NCT00064337|50097786|FG000|PBSCC or Induction/PBSCC|Death|2|||
25005381|NCT00064337|50097786|FG000|Transplant|Adverse Event|9|||
25005382|NCT00064337|50097786|FG000|Transplant|Not protocol-specified|5|||
25005383|NCT00064337|50097786|FG000|Transplant|Death|3|||
25005384|NCT00064337|50097786|FG000|Transplant|Patient Refusal|2|||
25005385|NCT00064337|50097786|FG000|Transplant|Progression|2|||
25005386|NCT00064337|50097786|FG000|Maintenance|Adverse Event|3|||
25005387|NCT00064337|50097786|FG000|Maintenance|Progression|2|||
25005388|NCT00064337|50097786|FG000|Maintenance|On treatment at time of analysis|2|||
25005389|NCT00064337|50097786|FG000|Maintenance|Not protocol-specified|2|||
25005390|NCT00064337|50097786|FG000|Maintenance|Death|1|||
25261099|NCT01311648|50575785|FG001|Extension Study|Physician Decision|1|||
25261100|NCT01311648|50575784|FG000|Extension Study|ITI therapy with marketed product|0|||
25261101|NCT01311648|50575785|FG001|Extension Study|ITI therapy with marketed product|1|||
25005395|NCT00064259|50097797|FG000|Overall Study|Adverse Event|1|||
25005396|NCT00064259|50097798|FG001|Overall Study|Adverse Event|0|||
25005397|NCT00064259|50097799|FG002|Overall Study|Adverse Event|0|||
25005398|NCT00064259|50097800|FG003|Overall Study|Adverse Event|1|||
25005399|NCT00044213|50097809|FG000|Overall Study|Withdrawal by Subject|50|||
25005400|NCT00044213|50097810|FG001|Overall Study|Withdrawal by Subject|65|||
25005401|NCT00044213|50097811|FG002|Overall Study|Withdrawal by Subject|91|||
25005402|NCT00044213|50097812|FG003|Overall Study|Withdrawal by Subject|83|||
25005403|NCT00044213|50097809|FG000|Overall Study|Death|42|||
25005404|NCT00044213|50097810|FG001|Overall Study|Death|42|||
25005405|NCT00044213|50097811|FG002|Overall Study|Death|42|||
25005406|NCT00044213|50097812|FG003|Overall Study|Death|49|||
25005407|NCT00044213|50097809|FG000|Overall Study|Lost to Follow-up|8|||
25005408|NCT00044213|50097810|FG001|Overall Study|Lost to Follow-up|5|||
25005409|NCT00044213|50097811|FG002|Overall Study|Lost to Follow-up|5|||
25005410|NCT00044213|50097812|FG003|Overall Study|Lost to Follow-up|4|||
25005411|NCT00064025|50097822|FG000|Overall Study|Ineligible|4|||
25005412|NCT00064025|50097822|FG000|Overall Study|Inevaluable|3|||
25005413|NCT00043979|50097830|FG000|Period 1|recipient with progressive disease|7|||
25005414|NCT00043979|50097831|FG001|Period 1|recipient with progressive disease|4|||
25005415|NCT00043979|50097832|FG002|Period 1|recipient with progressive disease|3|||
25005416|NCT00039377|50097849|FG000|Initial Registration|Adverse Event|2|||
25005417|NCT00039377|50097850|FG001|Initial Registration|Adverse Event|0|||
25005418|NCT00039377|50097851|FG002|Initial Registration|Adverse Event|0|||
25005419|NCT00039377|50097852|FG003|Initial Registration|Adverse Event|0|||
25005420|NCT00039377|50097849|FG000|Initial Registration|Relapsed|6|||
25005421|NCT00039377|50097850|FG001|Initial Registration|Relapsed|0|||
25005422|NCT00039377|50097851|FG002|Initial Registration|Relapsed|0|||
25005423|NCT00039377|50097852|FG003|Initial Registration|Relapsed|0|||
25005424|NCT00039377|50097849|FG000|Initial Registration|Received non-protocol therapy|11|||
25005425|NCT00039377|50097850|FG001|Initial Registration|Received non-protocol therapy|0|||
25005426|NCT00039377|50097851|FG002|Initial Registration|Received non-protocol therapy|0|||
25005427|NCT00039377|50097852|FG003|Initial Registration|Received non-protocol therapy|0|||
25005428|NCT00039377|50097849|FG000|Initial Registration|Withdrawal by Subject|3|||
25005429|NCT00039377|50097850|FG001|Initial Registration|Withdrawal by Subject|0|||
25005430|NCT00039377|50097851|FG002|Initial Registration|Withdrawal by Subject|0|||
25005431|NCT00039377|50097852|FG003|Initial Registration|Withdrawal by Subject|0|||
25005432|NCT00154102|50097862|FG000|Overall Study|investigational study phase ongoing|7|||
25005433|NCT00154102|50097863|FG001|Overall Study|investigational study phase ongoing|2|||
25005434|NCT03687502|50097886|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
25005435|NCT03687502|50097886|FG000|Overall Study|Lumason not available|1|||
25005436|NCT00035555|50097895|FG000|Overall Study|Adverse Event|5|||
25005437|NCT00035555|50097896|FG001|Overall Study|Adverse Event|8|||
25005438|NCT00035555|50097897|FG002|Overall Study|Adverse Event|9|||
25005439|NCT00035555|50097895|FG000|Overall Study|Allograft loss|1|||
25005440|NCT00035555|50097896|FG001|Overall Study|Allograft loss|1|||
25005441|NCT00035555|50097897|FG002|Overall Study|Allograft loss|2|||
25005442|NCT00035555|50097895|FG000|Overall Study|Death|0|||
25005443|NCT00035555|50097896|FG001|Overall Study|Death|0|||
25005444|NCT00035555|50097897|FG002|Overall Study|Death|2|||
25005445|NCT00035555|50097895|FG000|Overall Study|Lost to Follow-up|0|||
25005446|NCT00035555|50097896|FG001|Overall Study|Lost to Follow-up|0|||
25005447|NCT00035555|50097897|FG002|Overall Study|Lost to Follow-up|1|||
25005448|NCT00035555|50097895|FG000|Overall Study|Noncompliance|0|||
25005449|NCT00035555|50097896|FG001|Overall Study|Noncompliance|1|||
25005450|NCT00035555|50097897|FG002|Overall Study|Noncompliance|1|||
25005451|NCT00035555|50097895|FG000|Overall Study|Prohibited medication|1|||
25005452|NCT00035555|50097896|FG001|Overall Study|Prohibited medication|1|||
25005453|NCT00035555|50097897|FG002|Overall Study|Prohibited medication|0|||
25005454|NCT00035555|50097895|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
25005455|NCT00035555|50097896|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
25005456|NCT00035555|50097897|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
25005457|NCT00035555|50097895|FG000|Overall Study|Withdrawal by Subject|2|||
25005458|NCT00035555|50097896|FG001|Overall Study|Withdrawal by Subject|0|||
25005459|NCT00035555|50097897|FG002|Overall Study|Withdrawal by Subject|2|||
25005460|NCT00035555|50097895|FG000|Overall Study|Investigator deemed not a good candidate|0|||
25005461|NCT00035555|50097896|FG001|Overall Study|Investigator deemed not a good candidate|0|||
25005462|NCT00035555|50097897|FG002|Overall Study|Investigator deemed not a good candidate|1|||
25005463|NCT00035555|50097895|FG000|Overall Study|Received cyclosporin in error|0|||
25005464|NCT00035555|50097896|FG001|Overall Study|Received cyclosporin in error|0|||
25005465|NCT00035555|50097897|FG002|Overall Study|Received cyclosporin in error|1|||
25005466|NCT03894046|50097909|FG000|Overall Study|Protocol Violation|1|||
25005467|NCT03894046|50097910|FG001|Overall Study|Protocol Violation|0|||
25005468|NCT03894046|50097911|FG002|Overall Study|Protocol Violation|0|||
25005469|NCT03894046|50097909|FG000|Overall Study|Adverse Event|0|||
25005470|NCT03894046|50097910|FG001|Overall Study|Adverse Event|1|||
25005471|NCT03894046|50097911|FG002|Overall Study|Adverse Event|0|||
25005472|NCT03894046|50097909|FG000|Overall Study|Withdrawal by Subject|2|||
25005473|NCT03894046|50097910|FG001|Overall Study|Withdrawal by Subject|3|||
25005474|NCT03894046|50097911|FG002|Overall Study|Withdrawal by Subject|1|||
25005475|NCT03894046|50097909|FG000|Overall Study|Death|15|||
25005476|NCT03894046|50097910|FG001|Overall Study|Death|21|||
25005477|NCT03894046|50097911|FG002|Overall Study|Death|4|||
25005478|NCT03894046|50097909|FG000|Overall Study|No growth of ABC|2|||
25005479|NCT03894046|50097910|FG001|Overall Study|No growth of ABC|1|||
25005480|NCT03894046|50097911|FG002|Overall Study|No growth of ABC|0|||
25005481|NCT03894046|50097909|FG000|Overall Study|Physician Decision|1|||
25005482|NCT03894046|50097910|FG001|Overall Study|Physician Decision|1|||
25005483|NCT03894046|50097911|FG002|Overall Study|Physician Decision|1|||
25005484|NCT03894046|50097909|FG000|Overall Study|Prohibited concomitant medication|1|||
25005485|NCT03894046|50097910|FG001|Overall Study|Prohibited concomitant medication|0|||
25005486|NCT03894046|50097911|FG002|Overall Study|Prohibited concomitant medication|0|||
25005487|NCT03894046|50097909|FG000|Overall Study|Transferred to other arm/group|1|||
25005488|NCT03894046|50097910|FG001|Overall Study|Transferred to other arm/group|1|||
25005489|NCT03894046|50097911|FG002|Overall Study|Transferred to other arm/group|0|||
25005490|NCT00033371|50097920|FG000|Overall Study|Adverse Event|1|||
25005491|NCT00033371|50097921|FG001|Overall Study|Adverse Event|5|||
25005492|NCT00033371|50097920|FG000|Overall Study|Lost to Follow-up|2|||
25005493|NCT00033371|50097921|FG001|Overall Study|Lost to Follow-up|1|||
25005494|NCT00033371|50097920|FG000|Overall Study|Withdrawal by Subject|3|||
25005495|NCT00033371|50097921|FG001|Overall Study|Withdrawal by Subject|3|||
25005496|NCT00033371|50097920|FG000|Overall Study|Disease Progression|0|||
25005497|NCT00033371|50097921|FG001|Overall Study|Disease Progression|1|||
25005498|NCT00081731|50097933|FG000|Overall Study|scientific integrity issue|8|||
25005499|NCT00081731|50097934|FG001|Overall Study|scientific integrity issue|8|||
25005500|NCT00079937|50097942|FG000|Overall Study|Adverse Event|2|||
25005501|NCT00079937|50097943|FG001|Overall Study|Adverse Event|1|||
25005502|NCT00079937|50097942|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25005503|NCT00079937|50097943|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
25005504|NCT00079937|50097942|FG000|Overall Study|Subject no longer requires study drug|3|||
25005505|NCT00079937|50097943|FG001|Overall Study|Subject no longer requires study drug|0|||
25005506|NCT00079937|50097942|FG000|Overall Study|Protocol Violation|8|||
25005507|NCT00079937|50097943|FG001|Overall Study|Protocol Violation|6|||
25005508|NCT00079937|50097942|FG000|Overall Study|Withdrawal by Subject|21|||
25005509|NCT00079937|50097943|FG001|Overall Study|Withdrawal by Subject|7|||
25005510|NCT00079937|50097942|FG000|Overall Study|Lost to Follow-up|12|||
25005511|NCT00079937|50097943|FG001|Overall Study|Lost to Follow-up|5|||
25005512|NCT00079937|50097942|FG000|Overall Study|Administrative problems|22|||
25005513|NCT00079937|50097943|FG001|Overall Study|Administrative problems|11|||
25005514|NCT00909610|50097951|FG000|Period: First Intervention|Adverse Event|0|||
25005515|NCT00909610|50097952|FG001|Period: First Intervention|Adverse Event|1|||
25005516|NCT00909610|50097951|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
25005517|NCT00909610|50097952|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
25005518|NCT00909610|50097951|FG000|Period: Second Intervention|Adverse Event|1|||
25005519|NCT00909610|50097952|FG001|Period: Second Intervention|Adverse Event|0|||
25005520|NCT03126110|50097974|FG000|Phase 1|Death|2|||
25005521|NCT03126110|50097975|FG001|Phase 1|Death|2|||
25005522|NCT03126110|50097976|FG002|Phase 1|Death|4|||
25005523|NCT03126110|50097977|FG003|Phase 1|Death|3|||
25005524|NCT03126110|50097978|FG004|Phase 1|Death|4|||
25005525|NCT03126110|50097979|FG005|Phase 1|Death|4|||
25005526|NCT03126110|50097980|FG006|Phase 1|Death|3|||
25005527|NCT03126110|50097981|FG007|Phase 1|Death|4|||
25005528|NCT03126110|50097982|FG008|Phase 1|Death|5|||
25005529|NCT03126110|50097983|FG009|Phase 1|Death|2|||
25005530|NCT03126110|50097984|FG010|Phase 1|Death|6|||
25005531|NCT03126110|50097985|FG011|Phase 1|Death|0|||
25005532|NCT03126110|50097986|FG012|Phase 1|Death|0|||
25005533|NCT03126110|50097987|FG013|Phase 1|Death|0|||
25005534|NCT03126110|50097988|FG014|Phase 1|Death|0|||
25005535|NCT03126110|50097989|FG015|Phase 1|Death|0|||
25005536|NCT03126110|50097990|FG016|Phase 1|Death|0|||
25005537|NCT03126110|50097974|FG000|Phase 1|Lost to Follow-up|0|||
25005538|NCT03126110|50097975|FG001|Phase 1|Lost to Follow-up|1|||
25005539|NCT03126110|50097976|FG002|Phase 1|Lost to Follow-up|0|||
25005540|NCT03126110|50097977|FG003|Phase 1|Lost to Follow-up|0|||
25005541|NCT03126110|50097978|FG004|Phase 1|Lost to Follow-up|0|||
25005542|NCT03126110|50097979|FG005|Phase 1|Lost to Follow-up|0|||
25005543|NCT03126110|50097980|FG006|Phase 1|Lost to Follow-up|0|||
25005544|NCT03126110|50097981|FG007|Phase 1|Lost to Follow-up|0|||
25005545|NCT03126110|50097982|FG008|Phase 1|Lost to Follow-up|1|||
25005546|NCT03126110|50097983|FG009|Phase 1|Lost to Follow-up|0|||
25176788|NCT02666664|50320334|FG000|Overall Study|Withdrawal by participant|23|||
25176789|NCT02666664|50320335|FG001|Overall Study|Withdrawal by participant|40|||
25176790|NCT02666664|50320334|FG000|Overall Study|Sponsor decision|0|||
25176791|NCT02666664|50320335|FG001|Overall Study|Sponsor decision|1|||
25005547|NCT03126110|50097984|FG010|Phase 1|Lost to Follow-up|0|||
25005548|NCT03126110|50097985|FG011|Phase 1|Lost to Follow-up|0|||
25005549|NCT03126110|50097986|FG012|Phase 1|Lost to Follow-up|0|||
25005550|NCT03126110|50097987|FG013|Phase 1|Lost to Follow-up|0|||
25005551|NCT03126110|50097988|FG014|Phase 1|Lost to Follow-up|0|||
25005552|NCT03126110|50097989|FG015|Phase 1|Lost to Follow-up|0|||
25005553|NCT03126110|50097990|FG016|Phase 1|Lost to Follow-up|0|||
25005554|NCT03126110|50097974|FG000|Phase 1|Withdrawal by Subject|1|||
25005555|NCT03126110|50097975|FG001|Phase 1|Withdrawal by Subject|0|||
25005556|NCT03126110|50097976|FG002|Phase 1|Withdrawal by Subject|0|||
25005557|NCT03126110|50097977|FG003|Phase 1|Withdrawal by Subject|1|||
25005558|NCT03126110|50097978|FG004|Phase 1|Withdrawal by Subject|1|||
25005559|NCT03126110|50097979|FG005|Phase 1|Withdrawal by Subject|0|||
25005560|NCT03126110|50097980|FG006|Phase 1|Withdrawal by Subject|0|||
25005561|NCT03126110|50097981|FG007|Phase 1|Withdrawal by Subject|0|||
25005562|NCT03126110|50097982|FG008|Phase 1|Withdrawal by Subject|2|||
25005563|NCT03126110|50097983|FG009|Phase 1|Withdrawal by Subject|1|||
25005564|NCT03126110|50097984|FG010|Phase 1|Withdrawal by Subject|0|||
25005565|NCT03126110|50097985|FG011|Phase 1|Withdrawal by Subject|0|||
25005566|NCT03126110|50097986|FG012|Phase 1|Withdrawal by Subject|0|||
25005567|NCT03126110|50097987|FG013|Phase 1|Withdrawal by Subject|0|||
25005568|NCT03126110|50097988|FG014|Phase 1|Withdrawal by Subject|0|||
25005569|NCT03126110|50097989|FG015|Phase 1|Withdrawal by Subject|0|||
25005570|NCT03126110|50097990|FG016|Phase 1|Withdrawal by Subject|0|||
25005571|NCT03126110|50097974|FG000|Phase 1|Safety follow-up no longer necessary|1|||
25005572|NCT03126110|50097975|FG001|Phase 1|Safety follow-up no longer necessary|0|||
25005573|NCT03126110|50097976|FG002|Phase 1|Safety follow-up no longer necessary|0|||
25005574|NCT03126110|50097977|FG003|Phase 1|Safety follow-up no longer necessary|0|||
25005575|NCT03126110|50097978|FG004|Phase 1|Safety follow-up no longer necessary|0|||
25005576|NCT03126110|50097979|FG005|Phase 1|Safety follow-up no longer necessary|0|||
25005577|NCT03126110|50097980|FG006|Phase 1|Safety follow-up no longer necessary|0|||
25005578|NCT03126110|50097981|FG007|Phase 1|Safety follow-up no longer necessary|0|||
25005579|NCT03126110|50097982|FG008|Phase 1|Safety follow-up no longer necessary|0|||
25005580|NCT03126110|50097983|FG009|Phase 1|Safety follow-up no longer necessary|0|||
25005581|NCT03126110|50097984|FG010|Phase 1|Safety follow-up no longer necessary|0|||
25005582|NCT03126110|50097985|FG011|Phase 1|Safety follow-up no longer necessary|0|||
25005583|NCT03126110|50097986|FG012|Phase 1|Safety follow-up no longer necessary|0|||
25005584|NCT03126110|50097987|FG013|Phase 1|Safety follow-up no longer necessary|0|||
25005585|NCT03126110|50097988|FG014|Phase 1|Safety follow-up no longer necessary|0|||
25005586|NCT03126110|50097989|FG015|Phase 1|Safety follow-up no longer necessary|0|||
25005587|NCT03126110|50097990|FG016|Phase 1|Safety follow-up no longer necessary|0|||
25005588|NCT03126110|50097974|FG000|Phase 1|Survival follow-up no longer necessary|0|||
25005589|NCT03126110|50097975|FG001|Phase 1|Survival follow-up no longer necessary|0|||
25005590|NCT03126110|50097976|FG002|Phase 1|Survival follow-up no longer necessary|1|||
25005591|NCT03126110|50097977|FG003|Phase 1|Survival follow-up no longer necessary|0|||
25005592|NCT03126110|50097978|FG004|Phase 1|Survival follow-up no longer necessary|0|||
25005593|NCT03126110|50097979|FG005|Phase 1|Survival follow-up no longer necessary|0|||
25005594|NCT03126110|50097980|FG006|Phase 1|Survival follow-up no longer necessary|0|||
25005595|NCT03126110|50097981|FG007|Phase 1|Survival follow-up no longer necessary|0|||
25005596|NCT03126110|50097982|FG008|Phase 1|Survival follow-up no longer necessary|0|||
25005597|NCT03126110|50097983|FG009|Phase 1|Survival follow-up no longer necessary|0|||
25005598|NCT03126110|50097984|FG010|Phase 1|Survival follow-up no longer necessary|0|||
25005599|NCT03126110|50097985|FG011|Phase 1|Survival follow-up no longer necessary|0|||
25005600|NCT03126110|50097986|FG012|Phase 1|Survival follow-up no longer necessary|0|||
25005601|NCT03126110|50097987|FG013|Phase 1|Survival follow-up no longer necessary|0|||
25005602|NCT03126110|50097988|FG014|Phase 1|Survival follow-up no longer necessary|0|||
25005603|NCT03126110|50097989|FG015|Phase 1|Survival follow-up no longer necessary|0|||
25005604|NCT03126110|50097990|FG016|Phase 1|Survival follow-up no longer necessary|0|||
25005605|NCT03126110|50097974|FG000|Phase 2|Study terminated by the sponsor|0|||
25005606|NCT03126110|50097975|FG001|Phase 2|Study terminated by the sponsor|0|||
25005607|NCT03126110|50097976|FG002|Phase 2|Study terminated by the sponsor|0|||
25005608|NCT03126110|50097977|FG003|Phase 2|Study terminated by the sponsor|0|||
25005609|NCT03126110|50097978|FG004|Phase 2|Study terminated by the sponsor|0|||
25005610|NCT03126110|50097979|FG005|Phase 2|Study terminated by the sponsor|0|||
25005611|NCT03126110|50097980|FG006|Phase 2|Study terminated by the sponsor|0|||
25005612|NCT03126110|50097981|FG007|Phase 2|Study terminated by the sponsor|0|||
25005613|NCT03126110|50097982|FG008|Phase 2|Study terminated by the sponsor|0|||
25005614|NCT03126110|50097983|FG009|Phase 2|Study terminated by the sponsor|0|||
25005615|NCT03126110|50097984|FG010|Phase 2|Study terminated by the sponsor|0|||
25005616|NCT03126110|50097985|FG011|Phase 2|Study terminated by the sponsor|0|||
25005617|NCT03126110|50097986|FG012|Phase 2|Study terminated by the sponsor|0|||
25005618|NCT03126110|50097987|FG013|Phase 2|Study terminated by the sponsor|4|||
25005619|NCT03126110|50097988|FG014|Phase 2|Study terminated by the sponsor|0|||
25005620|NCT03126110|50097989|FG015|Phase 2|Study terminated by the sponsor|0|||
25005621|NCT03126110|50097990|FG016|Phase 2|Study terminated by the sponsor|0|||
25005622|NCT03126110|50097974|FG000|Phase 2|Withdrawal by Subject|0|||
25005623|NCT03126110|50097975|FG001|Phase 2|Withdrawal by Subject|0|||
25005624|NCT03126110|50097976|FG002|Phase 2|Withdrawal by Subject|0|||
25005625|NCT03126110|50097977|FG003|Phase 2|Withdrawal by Subject|0|||
25005626|NCT03126110|50097978|FG004|Phase 2|Withdrawal by Subject|0|||
25005627|NCT03126110|50097979|FG005|Phase 2|Withdrawal by Subject|0|||
25005628|NCT03126110|50097980|FG006|Phase 2|Withdrawal by Subject|0|||
25005629|NCT03126110|50097981|FG007|Phase 2|Withdrawal by Subject|0|||
25005630|NCT03126110|50097982|FG008|Phase 2|Withdrawal by Subject|0|||
25005631|NCT03126110|50097983|FG009|Phase 2|Withdrawal by Subject|0|||
25005632|NCT03126110|50097984|FG010|Phase 2|Withdrawal by Subject|0|||
25005633|NCT03126110|50097985|FG011|Phase 2|Withdrawal by Subject|1|||
25005634|NCT03126110|50097986|FG012|Phase 2|Withdrawal by Subject|3|||
25005635|NCT03126110|50097987|FG013|Phase 2|Withdrawal by Subject|3|||
25005636|NCT03126110|50097988|FG014|Phase 2|Withdrawal by Subject|2|||
25005637|NCT03126110|50097989|FG015|Phase 2|Withdrawal by Subject|1|||
25005638|NCT03126110|50097990|FG016|Phase 2|Withdrawal by Subject|0|||
25005639|NCT03126110|50097974|FG000|Phase 2|Lost to Follow-up|0|||
25005640|NCT03126110|50097975|FG001|Phase 2|Lost to Follow-up|0|||
25005641|NCT03126110|50097976|FG002|Phase 2|Lost to Follow-up|0|||
25005642|NCT03126110|50097977|FG003|Phase 2|Lost to Follow-up|0|||
25005643|NCT03126110|50097978|FG004|Phase 2|Lost to Follow-up|0|||
25005644|NCT03126110|50097979|FG005|Phase 2|Lost to Follow-up|0|||
25005645|NCT03126110|50097980|FG006|Phase 2|Lost to Follow-up|0|||
25005646|NCT03126110|50097981|FG007|Phase 2|Lost to Follow-up|0|||
25005647|NCT03126110|50097982|FG008|Phase 2|Lost to Follow-up|0|||
25005648|NCT03126110|50097983|FG009|Phase 2|Lost to Follow-up|0|||
25005649|NCT03126110|50097984|FG010|Phase 2|Lost to Follow-up|0|||
25005650|NCT03126110|50097985|FG011|Phase 2|Lost to Follow-up|1|||
25005651|NCT03126110|50097986|FG012|Phase 2|Lost to Follow-up|1|||
25005652|NCT03126110|50097987|FG013|Phase 2|Lost to Follow-up|1|||
25005653|NCT03126110|50097988|FG014|Phase 2|Lost to Follow-up|2|||
25005654|NCT03126110|50097989|FG015|Phase 2|Lost to Follow-up|0|||
25005655|NCT03126110|50097990|FG016|Phase 2|Lost to Follow-up|0|||
25005656|NCT03126110|50097974|FG000|Phase 2|Death|0|||
25005657|NCT03126110|50097975|FG001|Phase 2|Death|0|||
25005658|NCT03126110|50097976|FG002|Phase 2|Death|0|||
25005659|NCT03126110|50097977|FG003|Phase 2|Death|0|||
25005660|NCT03126110|50097978|FG004|Phase 2|Death|0|||
25005661|NCT03126110|50097979|FG005|Phase 2|Death|0|||
25005662|NCT03126110|50097980|FG006|Phase 2|Death|0|||
25005663|NCT03126110|50097981|FG007|Phase 2|Death|0|||
25005664|NCT03126110|50097982|FG008|Phase 2|Death|0|||
25005665|NCT03126110|50097983|FG009|Phase 2|Death|0|||
25005666|NCT03126110|50097984|FG010|Phase 2|Death|0|||
25005667|NCT03126110|50097985|FG011|Phase 2|Death|6|||
25005668|NCT03126110|50097986|FG012|Phase 2|Death|12|||
25005669|NCT03126110|50097987|FG013|Phase 2|Death|25|||
25005670|NCT03126110|50097988|FG014|Phase 2|Death|11|||
25005671|NCT03126110|50097989|FG015|Phase 2|Death|3|||
25005672|NCT03126110|50097990|FG016|Phase 2|Death|2|||
25005673|NCT03126110|50097974|FG000|Phase 2|Progressive Disease|0|||
25176792|NCT02666664|50320334|FG000|Overall Study|Lost to Follow-up|1|||
25005674|NCT03126110|50097975|FG001|Phase 2|Progressive Disease|0|||
25005675|NCT03126110|50097976|FG002|Phase 2|Progressive Disease|0|||
25005676|NCT03126110|50097977|FG003|Phase 2|Progressive Disease|0|||
25005677|NCT03126110|50097978|FG004|Phase 2|Progressive Disease|0|||
25005678|NCT03126110|50097979|FG005|Phase 2|Progressive Disease|0|||
25005679|NCT03126110|50097980|FG006|Phase 2|Progressive Disease|0|||
25176793|NCT02666664|50320335|FG001|Overall Study|Lost to Follow-up|2|||
25005680|NCT03126110|50097981|FG007|Phase 2|Progressive Disease|0|||
25005681|NCT03126110|50097982|FG008|Phase 2|Progressive Disease|0|||
25005682|NCT03126110|50097983|FG009|Phase 2|Progressive Disease|0|||
25005683|NCT03126110|50097984|FG010|Phase 2|Progressive Disease|0|||
25005684|NCT03126110|50097985|FG011|Phase 2|Progressive Disease|0|||
25005685|NCT03126110|50097986|FG012|Phase 2|Progressive Disease|0|||
25005686|NCT03126110|50097987|FG013|Phase 2|Progressive Disease|1|||
25005687|NCT03126110|50097988|FG014|Phase 2|Progressive Disease|0|||
25005688|NCT03126110|50097989|FG015|Phase 2|Progressive Disease|0|||
25005689|NCT03126110|50097990|FG016|Phase 2|Progressive Disease|0|||
25005690|NCT03126110|50097974|FG000|Phase 2|Started new treatment|0|||
25005691|NCT03126110|50097975|FG001|Phase 2|Started new treatment|0|||
25005692|NCT03126110|50097976|FG002|Phase 2|Started new treatment|0|||
25005693|NCT03126110|50097977|FG003|Phase 2|Started new treatment|0|||
25005694|NCT03126110|50097978|FG004|Phase 2|Started new treatment|0|||
25005695|NCT03126110|50097979|FG005|Phase 2|Started new treatment|0|||
25005696|NCT03126110|50097980|FG006|Phase 2|Started new treatment|0|||
25005697|NCT03126110|50097981|FG007|Phase 2|Started new treatment|0|||
25005698|NCT03126110|50097982|FG008|Phase 2|Started new treatment|0|||
25005699|NCT03126110|50097983|FG009|Phase 2|Started new treatment|0|||
25005700|NCT03126110|50097984|FG010|Phase 2|Started new treatment|0|||
25005701|NCT03126110|50097985|FG011|Phase 2|Started new treatment|0|||
25005702|NCT03126110|50097986|FG012|Phase 2|Started new treatment|0|||
25005703|NCT03126110|50097987|FG013|Phase 2|Started new treatment|0|||
25005704|NCT03126110|50097988|FG014|Phase 2|Started new treatment|1|||
25005705|NCT03126110|50097989|FG015|Phase 2|Started new treatment|0|||
25005706|NCT03126110|50097990|FG016|Phase 2|Started new treatment|0|||
25005707|NCT00905164|50098040|FG000|Period 1|Protocol Violation|0|||
25005708|NCT00905164|50098041|FG001|Period 1|Protocol Violation|1|||
25005709|NCT03181958|50098048|FG000|Overall Study|Lost to Follow-up|17|||
25005710|NCT03181958|50098049|FG001|Overall Study|Lost to Follow-up|21|||
25005711|NCT03181958|50098050|FG002|Overall Study|Lost to Follow-up|15|||
25005712|NCT03165110|50098058|FG000|Overall Study|Anroid phone software incompatibility|1|||
25005713|NCT00079781|50098065|FG000|Pre-implant Period|Withdrawal by Subject|2|||
25005714|NCT00079781|50098066|FG001|Pre-implant Period|Withdrawal by Subject|0|||
25005715|NCT00079781|50098067|FG002|Pre-implant Period|Withdrawal by Subject|0|||
25005716|NCT00079781|50098065|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
25005717|NCT00079781|50098066|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
25005718|NCT00079781|50098067|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
25005719|NCT00079781|50098065|FG000|Follow-up Period|Withdrawal by Subject|3|||
25005720|NCT00079781|50098066|FG001|Follow-up Period|Withdrawal by Subject|0|||
25005721|NCT00079781|50098067|FG002|Follow-up Period|Withdrawal by Subject|1|||
25005722|NCT00079781|50098065|FG000|Follow-up Period|Lost to Follow-up|1|||
25005723|NCT00079781|50098066|FG001|Follow-up Period|Lost to Follow-up|0|||
25005724|NCT00079781|50098067|FG002|Follow-up Period|Lost to Follow-up|0|||
25005725|NCT00079781|50098065|FG000|Follow-up Period|Death|0|||
25005726|NCT00079781|50098066|FG001|Follow-up Period|Death|0|||
25005727|NCT00079781|50098067|FG002|Follow-up Period|Death|1|||
25005728|NCT03176966|50098075|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
25005729|NCT03176966|50098076|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
25005730|NCT03176966|50098075|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
25005731|NCT03176966|50098076|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
25005732|NCT03176966|50098075|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
25005733|NCT03176966|50098076|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
25005734|NCT03176966|50098075|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
25005735|NCT03176966|50098076|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
25005736|NCT03176966|50098075|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
25005737|NCT03176966|50098076|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
25005738|NCT03176966|50098075|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
25005739|NCT03176966|50098076|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
25005740|NCT03176966|50098075|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
25005741|NCT03176966|50098076|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
25005742|NCT03175562|50098082|FG000|Overall Study|Adverse Event|1|||
25005743|NCT03175562|50098082|FG000|Overall Study|Lost to Follow-up|3|||
25005744|NCT03175562|50098082|FG000|Overall Study|Withdrawal by Subject|7|||
25005745|NCT03175562|50098082|FG000|Overall Study|Other (Not Specified)|5|||
25005746|NCT00079391|50098089|FG000|Overall Study|Withdrawal by Subject|1|||
25005747|NCT03209570|50098097|FG000|Overall Study|Death|1|||
25005748|NCT03209570|50098098|FG001|Overall Study|Death|0|||
25005749|NCT03209570|50098097|FG000|Overall Study|Incomplete Data|8|||
25005750|NCT03209570|50098098|FG001|Overall Study|Incomplete Data|10|||
25005751|NCT03209570|50098097|FG000|Overall Study|Protocol Violation|1|||
25005752|NCT03209570|50098098|FG001|Overall Study|Protocol Violation|0|||
25005753|NCT03209570|50098097|FG000|Overall Study|Withdrawal by Subject|0|||
25005754|NCT03209570|50098098|FG001|Overall Study|Withdrawal by Subject|3|||
25005755|NCT03209492|50098104|FG000|Overall Study|Case Report Forms Uncollected|5|||
25005756|NCT03208244|50098108|FG000|Overall Study|Death|1|||
25005757|NCT03175172|50098112|FG000|Overall Study|Death|3|||
25005758|NCT03175172|50098112|FG000|Overall Study|Withdrawal by Subject|3|||
25005759|NCT03175172|50098112|FG000|Overall Study|Lost to Follow-up|1|||
25005760|NCT03175172|50098112|FG000|Overall Study|Study Terminated by Sponsor|3|||
25005761|NCT03172364|50098118|FG000|Overall Study|Adverse Event|1|||
25005762|NCT03172364|50098119|FG001|Overall Study|Adverse Event|1|||
25005763|NCT03172364|50098118|FG000|Overall Study|Protocol Violation|1|||
25005764|NCT03172364|50098119|FG001|Overall Study|Protocol Violation|0|||
25005765|NCT00078767|50098127|FG000|Overall Study|Withdrawal by Subject|1|||
25005766|NCT00078767|50098128|FG001|Overall Study|Withdrawal by Subject|1|||
25005767|NCT03208088|50098134|FG000|Period 2|Withdrawal by Subject|0|||
25005768|NCT03208088|50098135|FG001|Period 2|Withdrawal by Subject|0|||
25005769|NCT03208088|50098136|FG002|Period 2|Withdrawal by Subject|0|||
25005770|NCT03208088|50098137|FG003|Period 2|Withdrawal by Subject|0|||
25005771|NCT03208088|50098138|FG004|Period 2|Withdrawal by Subject|0|||
25005772|NCT03208088|50098139|FG005|Period 2|Withdrawal by Subject|0|||
25005773|NCT03208088|50098140|FG006|Period 2|Withdrawal by Subject|0|||
25005774|NCT03208088|50098141|FG007|Period 2|Withdrawal by Subject|0|||
25005775|NCT03208088|50098142|FG008|Period 2|Withdrawal by Subject|1|||
25005776|NCT03208088|50098143|FG009|Period 2|Withdrawal by Subject|0|||
25005777|NCT03208088|50098134|FG000|Period 3|Unsatisfactory Test Article|0|||
25005778|NCT03208088|50098135|FG001|Period 3|Unsatisfactory Test Article|0|||
25005779|NCT03208088|50098136|FG002|Period 3|Unsatisfactory Test Article|0|||
25005780|NCT03208088|50098137|FG003|Period 3|Unsatisfactory Test Article|1|||
25005781|NCT03208088|50098138|FG004|Period 3|Unsatisfactory Test Article|0|||
25005782|NCT03208088|50098139|FG005|Period 3|Unsatisfactory Test Article|0|||
25005783|NCT03208088|50098140|FG006|Period 3|Unsatisfactory Test Article|0|||
25005784|NCT03208088|50098141|FG007|Period 3|Unsatisfactory Test Article|0|||
25005785|NCT03208088|50098142|FG008|Period 3|Unsatisfactory Test Article|0|||
25005786|NCT03208088|50098143|FG009|Period 3|Unsatisfactory Test Article|0|||
25005787|NCT03208088|50098134|FG000|Period 4|Unsatisfactory Test Article|0|||
25005788|NCT03208088|50098135|FG001|Period 4|Unsatisfactory Test Article|0|||
25005789|NCT03208088|50098136|FG002|Period 4|Unsatisfactory Test Article|0|||
25005790|NCT03208088|50098137|FG003|Period 4|Unsatisfactory Test Article|1|||
25005791|NCT03208088|50098138|FG004|Period 4|Unsatisfactory Test Article|0|||
25005792|NCT03208088|50098139|FG005|Period 4|Unsatisfactory Test Article|0|||
25005793|NCT03208088|50098140|FG006|Period 4|Unsatisfactory Test Article|0|||
25005794|NCT03208088|50098141|FG007|Period 4|Unsatisfactory Test Article|0|||
25005795|NCT03208088|50098142|FG008|Period 4|Unsatisfactory Test Article|0|||
25005796|NCT03208088|50098143|FG009|Period 4|Unsatisfactory Test Article|0|||
25005797|NCT00078377|50098158|FG000|Overall Study|Adverse Event|2|||
25005798|NCT00078377|50098159|FG001|Overall Study|Adverse Event|5|||
25005799|NCT00078377|50098160|FG002|Overall Study|Adverse Event|1|||
25005800|NCT00078377|50098158|FG000|Overall Study|Lack of Efficacy|2|||
25005801|NCT00078377|50098159|FG001|Overall Study|Lack of Efficacy|0|||
25005802|NCT00078377|50098160|FG002|Overall Study|Lack of Efficacy|2|||
25005803|NCT00078377|50098158|FG000|Overall Study|Lost to Follow-up|0|||
25005804|NCT00078377|50098159|FG001|Overall Study|Lost to Follow-up|1|||
25005805|NCT00078377|50098160|FG002|Overall Study|Lost to Follow-up|1|||
25005806|NCT00078377|50098158|FG000|Overall Study|Physician Decision|2|||
25005807|NCT00078377|50098159|FG001|Overall Study|Physician Decision|0|||
25005808|NCT00078377|50098160|FG002|Overall Study|Physician Decision|0|||
25005809|NCT00078377|50098158|FG000|Overall Study|Withdrawal by Subject|3|||
25005810|NCT00078377|50098159|FG001|Overall Study|Withdrawal by Subject|4|||
25005811|NCT00078377|50098160|FG002|Overall Study|Withdrawal by Subject|4|||
25005812|NCT00078377|50098158|FG000|Overall Study|Miscellaneous|2|||
25005813|NCT00078377|50098159|FG001|Overall Study|Miscellaneous|6|||
25005814|NCT00078377|50098160|FG002|Overall Study|Miscellaneous|1|||
25005815|NCT00886600|50098173|FG000|Double-blind Monotherapy|Adverse Event|1|||
25005816|NCT00886600|50098174|FG001|Double-blind Monotherapy|Adverse Event|1|||
25005817|NCT00886600|50098175|FG002|Double-blind Monotherapy|Adverse Event|1|||
25005818|NCT00886600|50098176|FG003|Double-blind Monotherapy|Adverse Event|1|||
25005819|NCT00886600|50098173|FG000|Double-blind Monotherapy|Protocol Violation|0|||
25005820|NCT00886600|50098174|FG001|Double-blind Monotherapy|Protocol Violation|0|||
25005821|NCT00886600|50098175|FG002|Double-blind Monotherapy|Protocol Violation|0|||
25005822|NCT00886600|50098176|FG003|Double-blind Monotherapy|Protocol Violation|1|||
25005823|NCT00886600|50098173|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
25005824|NCT00886600|50098174|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
25005825|NCT00886600|50098175|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
25005826|NCT00886600|50098176|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
25005827|NCT00886600|50098173|FG000|Combination Therapy Period|Adverse Event|0|||
25005828|NCT00886600|50098174|FG001|Combination Therapy Period|Adverse Event|0|||
25005829|NCT00886600|50098175|FG002|Combination Therapy Period|Adverse Event|1|||
25005830|NCT00886600|50098176|FG003|Combination Therapy Period|Adverse Event|0|||
25005831|NCT00886600|50098173|FG000|Combination Therapy Period|Protocol Violation|0|||
25005832|NCT00886600|50098174|FG001|Combination Therapy Period|Protocol Violation|0|||
25005833|NCT00886600|50098175|FG002|Combination Therapy Period|Protocol Violation|1|||
25005834|NCT00886600|50098176|FG003|Combination Therapy Period|Protocol Violation|0|||
25005835|NCT03172130|50098184|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
25005836|NCT03172130|50098185|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
25005837|NCT00870688|50098201|FG000|Overall Study|Lost to Follow-up|2|||
25005838|NCT00870688|50098201|FG000|Overall Study|Death, Unrelated|1|||
25005839|NCT00870688|50098201|FG000|Overall Study|Granules in the Stools|1|||
25005840|NCT00869128|50098204|FG000|Overall Study|lack of Compliance|6|||
25005841|NCT00869128|50098205|FG001|Overall Study|lack of Compliance|6|||
25005842|NCT00077675|50098211|FG000|Overall Study|Adverse Event|1|||
25005843|NCT00077675|50098212|FG001|Overall Study|Adverse Event|2|||
25005844|NCT00077675|50098211|FG000|Overall Study|Lost to Follow-up|6|||
25005845|NCT00077675|50098212|FG001|Overall Study|Lost to Follow-up|3|||
25005846|NCT00077675|50098211|FG000|Overall Study|Withdrawal by Subject|1|||
25005847|NCT00077675|50098212|FG001|Overall Study|Withdrawal by Subject|0|||
25005848|NCT00077675|50098211|FG000|Overall Study|Other|0|||
25005849|NCT00077675|50098212|FG001|Overall Study|Other|1|||
25005850|NCT00077675|50098211|FG000|Overall Study|Never received study treatment|3|||
25005851|NCT00077675|50098212|FG001|Overall Study|Never received study treatment|3|||
25005852|NCT02576444|50098229|FG000|Overall Study|Death|1|||
25005853|NCT02576444|50098230|FG001|Overall Study|Death|1|||
25005854|NCT02576444|50098231|FG002|Overall Study|Death|0|||
25005855|NCT02576444|50098232|FG003|Overall Study|Death|0|||
25005856|NCT02576444|50098229|FG000|Overall Study|Withdrawal by Subject|0|||
25005857|NCT02576444|50098230|FG001|Overall Study|Withdrawal by Subject|0|||
25005858|NCT02576444|50098231|FG002|Overall Study|Withdrawal by Subject|2|||
25005859|NCT02576444|50098232|FG003|Overall Study|Withdrawal by Subject|0|||
25005860|NCT02576444|50098229|FG000|Overall Study|Adverse Event|0|||
25005861|NCT02576444|50098230|FG001|Overall Study|Adverse Event|0|||
25005862|NCT02576444|50098231|FG002|Overall Study|Adverse Event|1|||
25005863|NCT02576444|50098232|FG003|Overall Study|Adverse Event|0|||
25005864|NCT02576444|50098229|FG000|Overall Study|Physician Decision|0|||
25005865|NCT02576444|50098230|FG001|Overall Study|Physician Decision|0|||
25005866|NCT02576444|50098231|FG002|Overall Study|Physician Decision|1|||
25005867|NCT02576444|50098232|FG003|Overall Study|Physician Decision|0|||
25005868|NCT00850174|50098243|FG000|Washout: One Week|Withdrawal by Subject|0|||
25005869|NCT00850174|50098244|FG001|Washout: One Week|Withdrawal by Subject|2|||
25005870|NCT00850174|50098243|FG000|Second Intervention|Withdrawal by Subject|1|||
25005871|NCT00850174|50098244|FG001|Second Intervention|Withdrawal by Subject|0|||
25005872|NCT00077207|50098255|FG000|Overall Study|Adverse Event|5|||
25005873|NCT00077207|50098255|FG000|Overall Study|Lack of Efficacy|12|||
25005874|NCT00077207|50098255|FG000|Overall Study|Physician Decision|6|||
25005875|NCT00077207|50098255|FG000|Overall Study|Withdrawal by Subject|6|||
25005876|NCT00077207|50098255|FG000|Overall Study|Ineligible|1|||
25005877|NCT03206918|50098260|FG000|Overall Study|Death|11|||
25005878|NCT03206918|50098260|FG000|Overall Study|Withdrawal by Subject|5|||
25005879|NCT03206918|50098260|FG000|Overall Study|Study terminated by sponsor|12|||
25005880|NCT03206918|50098260|FG000|Overall Study|Lost to Follow-up|3|||
25005881|NCT03206918|50098260|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
25005882|NCT03206216|50098267|FG000|Overall Study|Withdrawal by Subject|0|||
25005883|NCT03206216|50098268|FG001|Overall Study|Withdrawal by Subject|1|||
25005884|NCT03169244|50098276|FG000|Overall Study|Lost to Follow-up|1|||
25005885|NCT03169244|50098277|FG001|Overall Study|Lost to Follow-up|2|||
25005886|NCT03169244|50098276|FG000|Overall Study|Adverse Event|1|||
25005887|NCT03169244|50098277|FG001|Overall Study|Adverse Event|0|||
25005888|NCT03169244|50098276|FG000|Overall Study|Withdrawal by Subject|2|||
25005889|NCT03169244|50098277|FG001|Overall Study|Withdrawal by Subject|2|||
25005890|NCT03169244|50098276|FG000|Overall Study|Physician Decision|1|||
25005891|NCT03169244|50098277|FG001|Overall Study|Physician Decision|0|||
25005892|NCT02486042|50098285|FG000|Overall Study|Physician Decision|1|||
25005893|NCT02486042|50098286|FG001|Overall Study|Physician Decision|7|||
25005894|NCT02486042|50098285|FG000|Overall Study|Hospital transfer|2|||
25005895|NCT02486042|50098286|FG001|Overall Study|Hospital transfer|2|||
25005896|NCT02486042|50098285|FG000|Overall Study|Withdrawal by Subject|0|||
25005897|NCT02486042|50098286|FG001|Overall Study|Withdrawal by Subject|2|||
25005898|NCT00057941|50098294|FG000|Overall Study|Death|1|||
25005899|NCT00057941|50098295|FG001|Overall Study|Death|2|||
25005900|NCT00057941|50098294|FG000|Overall Study|Adverse Event|7|||
25005901|NCT00057941|50098295|FG001|Overall Study|Adverse Event|9|||
25005902|NCT00057941|50098294|FG000|Overall Study|Lack of Efficacy|54|||
25005903|NCT00057941|50098295|FG001|Overall Study|Lack of Efficacy|53|||
25005904|NCT00057941|50098294|FG000|Overall Study|Withdrawal by Subject|6|||
25005905|NCT00057941|50098295|FG001|Overall Study|Withdrawal by Subject|1|||
25005906|NCT00057941|50098294|FG000|Overall Study|still on treatment|3|||
25005907|NCT00057941|50098295|FG001|Overall Study|still on treatment|1|||
25005908|NCT00057941|50098294|FG000|Overall Study|insurance, symptomatic deterioration|1|||
25005909|NCT00057941|50098295|FG001|Overall Study|insurance, symptomatic deterioration|3|||
25005910|NCT00057941|50098294|FG000|Overall Study|Ineligible|2|||
25005911|NCT00057941|50098295|FG001|Overall Study|Ineligible|5|||
25005912|NCT00075881|50098310|FG000|Overall Study|Lack of Efficacy|18|||
25005913|NCT00075881|50098310|FG000|Overall Study|Adverse Event|7|||
25005914|NCT00075881|50098310|FG000|Overall Study|Death|1|||
25005915|NCT00075881|50098310|FG000|Overall Study|Withdrawal by Subject|2|||
25005916|NCT00075881|50098310|FG000|Overall Study|Protocol Violation|4|||
25005917|NCT00075881|50098310|FG000|Overall Study|other complicating disease|3|||
25005918|NCT00075881|50098310|FG000|Overall Study|other|4|||
25005919|NCT00075881|50098310|FG000|Overall Study|missing data|2|||
25005920|NCT00075881|50098310|FG000|Overall Study|Ineligible|1|||
25005921|NCT00075881|50098310|FG000|Overall Study|never start protocol therapy|1|||
25005922|NCT00838630|50098318|FG000|First Intervention|Adverse Event|1|||
25005923|NCT00838630|50098319|FG001|First Intervention|Adverse Event|0|||
25005924|NCT00838630|50098318|FG000|Washout: 7 Days|Protocol Violation|1|||
25005925|NCT00838630|50098319|FG001|Washout: 7 Days|Protocol Violation|0|||
25005926|NCT02996474|50098323|FG000|Overall Study|Physician Decision|5|||
25005927|NCT03667924|50098330|FG000|Baseline Completed|Lost to Follow-up|0|||
25005928|NCT03667924|50098331|FG001|Baseline Completed|Lost to Follow-up|2|||
25005929|NCT03667924|50098332|FG002|Baseline Completed|Lost to Follow-up|0|||
25005930|NCT03667924|50098330|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
25005931|NCT03667924|50098331|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
25005932|NCT03667924|50098332|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
25005933|NCT03667924|50098330|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
25005934|NCT03667924|50098331|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
25005935|NCT03667924|50098332|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
25005936|NCT03667924|50098330|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
25005937|NCT03667924|50098331|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
25005938|NCT03667924|50098332|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
25005939|NCT03667924|50098330|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
25005940|NCT03667924|50098331|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
25005941|NCT03667924|50098332|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
25005942|NCT03667924|50098330|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
25005943|NCT03667924|50098331|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
25005944|NCT03667924|50098332|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
25005945|NCT03667924|50098330|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
25005946|NCT03667924|50098331|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
25005947|NCT03667924|50098332|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
25005948|NCT03205046|50098344|FG000|Overall Study|Death|10|||
25005949|NCT03205046|50098345|FG001|Overall Study|Death|6|||
25005950|NCT03205046|50098344|FG000|Overall Study|Withdrawal by Subject|1|||
25005951|NCT03205046|50098345|FG001|Overall Study|Withdrawal by Subject|2|||
25005952|NCT03205046|50098344|FG000|Overall Study|Lost to Follow-up|0|||
25005953|NCT03205046|50098345|FG001|Overall Study|Lost to Follow-up|1|||
25005954|NCT03205046|50098344|FG000|Overall Study|Study terminated by sponsor|2|||
25005955|NCT03205046|50098345|FG001|Overall Study|Study terminated by sponsor|1|||
25005956|NCT03204812|50098351|FG000|Overall Study|Adverse Event|3|||
25005957|NCT02339090|50098357|FG000|Overall Study|Adverse Event|1|||
25005958|NCT02339090|50098358|FG001|Overall Study|Adverse Event|0|||
25005959|NCT02339090|50098357|FG000|Overall Study|Lost to Follow-up|0|||
25005960|NCT02339090|50098358|FG001|Overall Study|Lost to Follow-up|1|||
25005961|NCT02339090|50098357|FG000|Overall Study|Non-compliance With Study Drug|0|||
25005962|NCT02339090|50098358|FG001|Overall Study|Non-compliance With Study Drug|1|||
25005963|NCT02339090|50098357|FG000|Overall Study|Withdrawal by Subject|2|||
25005964|NCT02339090|50098358|FG001|Overall Study|Withdrawal by Subject|1|||
25005965|NCT02339090|50098357|FG000|Overall Study|Poor Growth|3|||
25005966|NCT02339090|50098358|FG001|Overall Study|Poor Growth|0|||
25005967|NCT02339090|50098357|FG000|Overall Study|Randomized but not treated|0|||
25005968|NCT02339090|50098358|FG001|Overall Study|Randomized but not treated|2|||
25005969|NCT03524092|50098379|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
25005970|NCT03524092|50098380|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
25005971|NCT03524092|50098381|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
25005972|NCT03524092|50098382|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
25005973|NCT03524092|50098383|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
25005974|NCT03524092|50098384|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
25005975|NCT03524092|50098379|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
25005976|NCT03524092|50098380|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
25176794|NCT01528735|50320343|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
25005977|NCT03524092|50098381|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
25005978|NCT03524092|50098382|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
25005979|NCT03524092|50098383|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
25005980|NCT03524092|50098384|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
25005981|NCT03524092|50098379|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
25005982|NCT03524092|50098380|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
25005983|NCT03524092|50098381|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
25005984|NCT03524092|50098382|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
25005985|NCT03524092|50098383|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
25005986|NCT03524092|50098384|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
25005987|NCT03524092|50098379|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
25067267|NCT02576847|50172844|FG000|Overall Study|Pregnancy|1|||
25176795|NCT01528735|50320344|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
25176796|NCT01528735|50320343|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
25005988|NCT03524092|50098380|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
25005989|NCT03524092|50098381|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
25005990|NCT03524092|50098382|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
25005991|NCT03524092|50098383|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
25005992|NCT03524092|50098384|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
25005993|NCT03524092|50098379|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
25005994|NCT03524092|50098380|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
25005995|NCT03524092|50098381|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
25005996|NCT03524092|50098382|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
25005997|NCT03524092|50098383|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
25005998|NCT03524092|50098384|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
25005999|NCT03524092|50098379|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
25006000|NCT03524092|50098380|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
25006001|NCT03524092|50098381|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
25006002|NCT03524092|50098382|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
25006003|NCT03524092|50098383|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
25006004|NCT03524092|50098384|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
25006005|NCT03524092|50098379|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
25006006|NCT03524092|50098380|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
25006007|NCT03524092|50098381|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
25006008|NCT03524092|50098382|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
25006009|NCT03524092|50098383|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
25006010|NCT03524092|50098384|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
25006011|NCT03524092|50098379|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
25006012|NCT03524092|50098380|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
25006013|NCT03524092|50098381|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
25006014|NCT03524092|50098382|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
25006015|NCT03524092|50098383|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
25006016|NCT03524092|50098384|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
25006017|NCT03524092|50098379|FG000|Loss of Response Rescue Period|Adverse Event|0|||
25006018|NCT03524092|50098380|FG001|Loss of Response Rescue Period|Adverse Event|0|||
25006019|NCT03524092|50098381|FG002|Loss of Response Rescue Period|Adverse Event|0|||
25006020|NCT03524092|50098382|FG003|Loss of Response Rescue Period|Adverse Event|2|||
25006021|NCT03524092|50098383|FG004|Loss of Response Rescue Period|Adverse Event|0|||
25006022|NCT03524092|50098384|FG005|Loss of Response Rescue Period|Adverse Event|0|||
25006023|NCT03524092|50098379|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
25006024|NCT03524092|50098380|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
25006025|NCT03524092|50098381|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
25006026|NCT03524092|50098382|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
25006027|NCT03524092|50098383|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
25006028|NCT03524092|50098384|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
25006029|NCT03524092|50098379|FG000|Loss of Response Rescue Period|Pregnancy|0|||
25006030|NCT03524092|50098380|FG001|Loss of Response Rescue Period|Pregnancy|0|||
25006031|NCT03524092|50098381|FG002|Loss of Response Rescue Period|Pregnancy|0|||
25006032|NCT03524092|50098382|FG003|Loss of Response Rescue Period|Pregnancy|1|||
25006033|NCT03524092|50098383|FG004|Loss of Response Rescue Period|Pregnancy|0|||
25006034|NCT03524092|50098384|FG005|Loss of Response Rescue Period|Pregnancy|0|||
25006035|NCT03524092|50098379|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
25006036|NCT03524092|50098380|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
25006037|NCT03524092|50098381|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
25006038|NCT03524092|50098382|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
25006039|NCT03524092|50098383|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
25006040|NCT03524092|50098384|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
25006041|NCT03524092|50098379|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
25006042|NCT03524092|50098380|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
25006043|NCT03524092|50098381|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
25006044|NCT03524092|50098382|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
25006045|NCT03524092|50098383|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
25006046|NCT03524092|50098384|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
25006047|NCT03524092|50098379|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
25006048|NCT03524092|50098380|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
25067268|NCT02576847|50172844|FG000|Overall Study|Protocol Violation|3|||
25176797|NCT01528735|50320344|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
25176798|NCT02661594|50320356|FG000|Overall Study|Protocol Violation|1|||
25176799|NCT02661594|50320357|FG001|Overall Study|Protocol Violation|0|||
25176800|NCT02661594|50320358|FG002|Overall Study|Protocol Violation|1|||
25176801|NCT02661594|50320359|FG003|Overall Study|Protocol Violation|0|||
25006049|NCT03524092|50098381|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
25006050|NCT03524092|50098382|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
25006051|NCT03524092|50098383|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
25006052|NCT03524092|50098384|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
25006053|NCT03524092|50098379|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
25006054|NCT03524092|50098380|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
25006055|NCT03524092|50098381|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
25006056|NCT03524092|50098382|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
25006057|NCT03524092|50098383|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
25006058|NCT03524092|50098384|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
25006059|NCT03524092|50098379|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
25006060|NCT03524092|50098380|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
25006061|NCT03524092|50098381|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
25006062|NCT03524092|50098382|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
25006063|NCT03524092|50098383|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
25006064|NCT03524092|50098384|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
25006065|NCT03524092|50098379|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
25006066|NCT03524092|50098380|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
25006067|NCT03524092|50098381|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
25006068|NCT03524092|50098382|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
25006069|NCT03524092|50098383|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
25006070|NCT03524092|50098384|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
25006071|NCT03524092|50098379|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
25006072|NCT03524092|50098380|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
25006073|NCT03524092|50098381|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
25006074|NCT03524092|50098382|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
25006075|NCT03524092|50098383|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
25006076|NCT03524092|50098384|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
25006077|NCT03524092|50098379|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
25006078|NCT03524092|50098380|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
25006079|NCT03524092|50098381|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
25006080|NCT03524092|50098382|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
25006081|NCT03524092|50098383|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
25006082|NCT03524092|50098384|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
25006083|NCT03524092|50098379|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
25006084|NCT03524092|50098380|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
25006085|NCT03524092|50098381|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
25006086|NCT03524092|50098382|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
25006087|NCT03524092|50098383|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
25006088|NCT03524092|50098384|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
25006089|NCT03524092|50098379|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
25006090|NCT03524092|50098380|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
25006091|NCT03524092|50098381|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
25006092|NCT03524092|50098382|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
25006093|NCT03524092|50098383|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
25006094|NCT03524092|50098384|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
25006095|NCT03524092|50098379|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
25006096|NCT03524092|50098380|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
25006097|NCT03524092|50098381|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
25006098|NCT03524092|50098382|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
25006099|NCT03524092|50098383|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
25006100|NCT03524092|50098384|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
25006101|NCT03524092|50098379|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
25006102|NCT03524092|50098380|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
25006103|NCT03524092|50098381|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
25006104|NCT03524092|50098382|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
25006105|NCT03524092|50098383|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
25006106|NCT03524092|50098384|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
25006107|NCT03331562|50098397|FG000|Overall Study|Adverse Event|2|||
25006108|NCT03331562|50098398|FG001|Overall Study|Adverse Event|0|||
25006109|NCT03331562|50098397|FG000|Overall Study|Death|1|||
25006110|NCT03331562|50098398|FG001|Overall Study|Death|0|||
25006111|NCT02038634|50098410|FG000|Overall Study|Lost to Follow-up|0|||
25006112|NCT02038634|50098411|FG001|Overall Study|Lost to Follow-up|1|||
25006113|NCT00836056|50098419|FG000|First Intervention|Adverse Event|1|||
25006114|NCT00836056|50098420|FG001|First Intervention|Adverse Event|0|||
25006115|NCT03200912|50098427|FG000|Overall Study|Adverse Event|3|||
25006116|NCT03200912|50098428|FG001|Overall Study|Adverse Event|0|||
25006117|NCT03200912|50098429|FG002|Overall Study|Adverse Event|0|||
25006118|NCT03200912|50098427|FG000|Overall Study|Withdrawal by Subject|1|||
25006119|NCT03200912|50098428|FG001|Overall Study|Withdrawal by Subject|2|||
25006120|NCT03200912|50098429|FG002|Overall Study|Withdrawal by Subject|4|||
25006121|NCT03200912|50098427|FG000|Overall Study|Non-compliance with study drug|0|||
25006122|NCT03200912|50098428|FG001|Overall Study|Non-compliance with study drug|1|||
25006123|NCT03200912|50098429|FG002|Overall Study|Non-compliance with study drug|0|||
25006124|NCT00835666|50098439|FG000|Washout|Protocol Violation|1|||
25006125|NCT00835666|50098440|FG001|Washout|Protocol Violation|0|||
25006126|NCT00835666|50098439|FG000|Washout|Withdrawal by Subject|1|||
25006127|NCT00835666|50098440|FG001|Washout|Withdrawal by Subject|0|||
25006128|NCT03200366|50098454|FG000|Patient Navigation Intervention Given|Death|0|||
25006129|NCT03200366|50098455|FG001|Patient Navigation Intervention Given|Death|2|||
25006130|NCT03200366|50098456|FG002|Patient Navigation Intervention Given|Death|0|||
25006131|NCT03200366|50098454|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
25006132|NCT03200366|50098455|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
25006133|NCT03200366|50098456|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
25006134|NCT03200366|50098454|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
25006135|NCT03200366|50098455|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
25006136|NCT03200366|50098456|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
25006137|NCT03200366|50098454|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
25006138|NCT03200366|50098455|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
25006139|NCT03200366|50098456|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
25006140|NCT03200366|50098454|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
25006141|NCT03200366|50098455|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
25006142|NCT03200366|50098456|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
25006143|NCT03200366|50098454|FG000|6 Month Post-Baseline Interview|Death|1|||
25006144|NCT03200366|50098455|FG001|6 Month Post-Baseline Interview|Death|1|||
25006145|NCT03200366|50098456|FG002|6 Month Post-Baseline Interview|Death|1|||
25006146|NCT03200366|50098454|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
25006147|NCT03200366|50098455|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
25006148|NCT03200366|50098456|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
25006149|NCT03200366|50098454|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
25006150|NCT03200366|50098455|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
25006151|NCT03200366|50098456|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
25006152|NCT03200366|50098454|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
25006153|NCT03200366|50098455|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
25006154|NCT03200366|50098456|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
25006155|NCT03200366|50098454|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
25006156|NCT03200366|50098455|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
25006157|NCT03200366|50098456|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
25006158|NCT03200366|50098454|FG000|9 Month Post-Baseline Interview|Death|1|||
25006159|NCT03200366|50098455|FG001|9 Month Post-Baseline Interview|Death|1|||
25006160|NCT03200366|50098456|FG002|9 Month Post-Baseline Interview|Death|1|||
25006161|NCT03200366|50098454|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
25006162|NCT03200366|50098455|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
25006163|NCT03200366|50098456|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
25006164|NCT03200366|50098454|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
25006165|NCT03200366|50098455|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
25006166|NCT03200366|50098456|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
25006167|NCT03200366|50098454|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
25006168|NCT03200366|50098455|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
25006169|NCT03200366|50098456|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
25006170|NCT00835354|50098468|FG000|First Intervention|Adverse Event|0|||
25006171|NCT00835354|50098469|FG001|First Intervention|Adverse Event|1|||
25006172|NCT00835042|50098500|FG000|First Intervention|Withdrawal by Subject|3|||
25006173|NCT00835042|50098501|FG001|First Intervention|Withdrawal by Subject|0|||
25006174|NCT00835042|50098500|FG000|First Intervention|Adverse Event|1|||
25006175|NCT00835042|50098501|FG001|First Intervention|Adverse Event|2|||
25006176|NCT00835042|50098500|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
25006177|NCT00835042|50098501|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
25091374|NCT02673697|50200973|FG001|Overall Study|Withdrawal by Subject|7|||
25091375|NCT02673697|50200972|FG000|Overall Study|Change subj medical status|1|||
25006178|NCT00834418|50098538|FG000|Overall Study|Adverse Event|0|||
25006179|NCT00834418|50098539|FG001|Overall Study|Adverse Event|2|||
25006180|NCT00834340|50098545|FG000|Washout|Adverse Event|1|||
25006181|NCT00834340|50098546|FG001|Washout|Adverse Event|0|||
25006182|NCT00834340|50098545|FG000|Washout|Withdrawal by Subject|1|||
25006183|NCT00834340|50098546|FG001|Washout|Withdrawal by Subject|0|||
25006184|NCT00151996|50098552|FG000|Overall Study|Adverse Event|3|||
25006185|NCT00151996|50098553|FG001|Overall Study|Adverse Event|2|||
25006186|NCT00151996|50098552|FG000|Overall Study|Withdrawal by Subject|1|||
25006187|NCT00151996|50098553|FG001|Overall Study|Withdrawal by Subject|1|||
25006188|NCT00151996|50098552|FG000|Overall Study|Protocol Violation|1|||
25006189|NCT00151996|50098553|FG001|Overall Study|Protocol Violation|2|||
25006190|NCT00151996|50098552|FG000|Overall Study|Sponsor's decision|0|||
25006191|NCT00151996|50098553|FG001|Overall Study|Sponsor's decision|2|||
25006192|NCT00830206|50098561|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
25006193|NCT00830206|50098562|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
25006194|NCT00829504|50098568|FG000|First Intervention|Adverse Event|1|||
25006195|NCT00829504|50098569|FG001|First Intervention|Adverse Event|0|||
25006196|NCT00829504|50098568|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
25006197|NCT00829504|50098569|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
25006198|NCT00829504|50098568|FG000|Second Intervention|Physician Decision|1|||
25006199|NCT00829504|50098569|FG001|Second Intervention|Physician Decision|0|||
25006200|NCT00829426|50098575|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
25006201|NCT00829426|50098576|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
25006202|NCT00152464|50098582|FG000|Overall Study|Adverse Event|3|||
25006203|NCT00152464|50098583|FG001|Overall Study|Adverse Event|6|||
25006204|NCT00152464|50098582|FG000|Overall Study|Lost to Follow-up|8|||
25006205|NCT00152464|50098583|FG001|Overall Study|Lost to Follow-up|4|||
25006206|NCT00152464|50098582|FG000|Overall Study|Protocol Violation|3|||
25006207|NCT00152464|50098583|FG001|Overall Study|Protocol Violation|1|||
25006208|NCT00152464|50098582|FG000|Overall Study|Withdrawal by Subject|21|||
25006209|NCT00152464|50098583|FG001|Overall Study|Withdrawal by Subject|22|||
25006210|NCT00152464|50098582|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
25006211|NCT00152464|50098583|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
25006212|NCT00152464|50098582|FG000|Overall Study|Eczema deterioration|0|||
25006213|NCT00152464|50098583|FG001|Overall Study|Eczema deterioration|1|||
25006214|NCT00152464|50098582|FG000|Overall Study|Parent decision|1|||
25006215|NCT00152464|50098583|FG001|Overall Study|Parent decision|1|||
25006216|NCT00152464|50098582|FG000|Overall Study|Investigator decision|1|||
25006217|NCT00152464|50098583|FG001|Overall Study|Investigator decision|0|||
25006218|NCT00152464|50098582|FG000|Overall Study|Lack of Efficacy|1|||
25006219|NCT00152464|50098583|FG001|Overall Study|Lack of Efficacy|0|||
25006220|NCT00152464|50098582|FG000|Overall Study|Eczema poorly controlled|1|||
25006221|NCT00152464|50098583|FG001|Overall Study|Eczema poorly controlled|0|||
25006222|NCT00152464|50098582|FG000|Overall Study|Patient relocated|1|||
25006223|NCT00152464|50098583|FG001|Overall Study|Patient relocated|0|||
25006224|NCT00674440|50098589|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
25006225|NCT00674440|50098589|FG000|Overall Study|did not have surgery, so unevaluable|7|||
25006226|NCT00674440|50098589|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
25006227|NCT02742766|50098613|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25006228|NCT02742766|50098614|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25006229|NCT02742766|50098615|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25006230|NCT02742766|50098616|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25006231|NCT02742766|50098617|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25006232|NCT02742766|50098618|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25006233|NCT02742766|50098619|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25006234|NCT02742766|50098620|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25006235|NCT02742766|50098621|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25006236|NCT02742766|50098622|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25006237|NCT02742766|50098623|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25006238|NCT02742766|50098624|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25006239|NCT02742766|50098625|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25006240|NCT02742766|50098626|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
25006241|NCT02742766|50098627|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25006242|NCT02742766|50098628|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25006243|NCT02742766|50098629|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25006244|NCT02742766|50098630|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25006245|NCT02742766|50098631|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
25176802|NCT01528345|50320371|FG000|Overall Study|Adverse Event|10|||
25176803|NCT01528345|50320372|FG001|Overall Study|Adverse Event|1|||
25006246|NCT02742766|50098613|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
25006247|NCT02742766|50098614|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
25006248|NCT02742766|50098615|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
25006249|NCT02742766|50098616|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
25006250|NCT02742766|50098617|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
25006251|NCT02742766|50098618|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
25006252|NCT02742766|50098619|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
25006253|NCT02742766|50098620|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
25006254|NCT02742766|50098621|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
25006255|NCT02742766|50098622|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
25006256|NCT02742766|50098623|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
25006257|NCT02742766|50098624|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
25006258|NCT02742766|50098625|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
25006259|NCT02742766|50098626|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
25006260|NCT02742766|50098627|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
25006261|NCT02742766|50098628|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
25006262|NCT02742766|50098629|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
25006263|NCT02742766|50098630|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
25006264|NCT02742766|50098631|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
25006265|NCT01468922|50098709|FG000|Overall Study|Screening failure|0|||
25006266|NCT01468922|50098710|FG001|Overall Study|Screening failure|0|||
25006267|NCT01468922|50098711|FG002|Overall Study|Screening failure|0|||
25006268|NCT01468922|50098712|FG003|Overall Study|Screening failure|0|||
25006269|NCT01468922|50098713|FG004|Overall Study|Screening failure|0|||
25006270|NCT01468922|50098714|FG005|Overall Study|Screening failure|0|||
25006271|NCT01468922|50098715|FG006|Overall Study|Screening failure|0|||
25006272|NCT01468922|50098716|FG007|Overall Study|Screening failure|0|||
25006273|NCT01468922|50098717|FG008|Overall Study|Screening failure|1|||
25006274|NCT01468922|50098709|FG000|Overall Study|Per patient choice|1|||
25006275|NCT01468922|50098710|FG001|Overall Study|Per patient choice|0|||
25006276|NCT01468922|50098711|FG002|Overall Study|Per patient choice|0|||
25006277|NCT01468922|50098712|FG003|Overall Study|Per patient choice|0|||
25006278|NCT01468922|50098713|FG004|Overall Study|Per patient choice|0|||
25006279|NCT01468922|50098714|FG005|Overall Study|Per patient choice|0|||
25006280|NCT01468922|50098715|FG006|Overall Study|Per patient choice|0|||
25006281|NCT01468922|50098716|FG007|Overall Study|Per patient choice|0|||
25006282|NCT01468922|50098717|FG008|Overall Study|Per patient choice|0|||
25006283|NCT01468922|50098709|FG000|Overall Study|Switched to alternative treatment|1|||
25006284|NCT01468922|50098710|FG001|Overall Study|Switched to alternative treatment|0|||
25006285|NCT01468922|50098711|FG002|Overall Study|Switched to alternative treatment|0|||
25006286|NCT01468922|50098712|FG003|Overall Study|Switched to alternative treatment|0|||
25006287|NCT01468922|50098713|FG004|Overall Study|Switched to alternative treatment|1|||
25006288|NCT01468922|50098714|FG005|Overall Study|Switched to alternative treatment|0|||
25006289|NCT01468922|50098715|FG006|Overall Study|Switched to alternative treatment|0|||
25006290|NCT01468922|50098716|FG007|Overall Study|Switched to alternative treatment|0|||
25006291|NCT01468922|50098717|FG008|Overall Study|Switched to alternative treatment|0|||
25006292|NCT01468922|50098709|FG000|Overall Study|Enrolled on new protocol|0|||
25006293|NCT01468922|50098710|FG001|Overall Study|Enrolled on new protocol|0|||
25006294|NCT01468922|50098711|FG002|Overall Study|Enrolled on new protocol|0|||
25006295|NCT01468922|50098712|FG003|Overall Study|Enrolled on new protocol|0|||
25006296|NCT01468922|50098713|FG004|Overall Study|Enrolled on new protocol|1|||
25006297|NCT01468922|50098714|FG005|Overall Study|Enrolled on new protocol|0|||
25006298|NCT01468922|50098715|FG006|Overall Study|Enrolled on new protocol|0|||
25006299|NCT01468922|50098716|FG007|Overall Study|Enrolled on new protocol|0|||
25006300|NCT01468922|50098717|FG008|Overall Study|Enrolled on new protocol|0|||
25006301|NCT01468922|50098709|FG000|Overall Study|Adverse Event|0|||
25006302|NCT01468922|50098710|FG001|Overall Study|Adverse Event|0|||
25006303|NCT01468922|50098711|FG002|Overall Study|Adverse Event|0|||
25006304|NCT01468922|50098712|FG003|Overall Study|Adverse Event|0|||
25006305|NCT01468922|50098713|FG004|Overall Study|Adverse Event|0|||
25006306|NCT01468922|50098714|FG005|Overall Study|Adverse Event|0|||
25006307|NCT01468922|50098715|FG006|Overall Study|Adverse Event|0|||
25006308|NCT01468922|50098716|FG007|Overall Study|Adverse Event|1|||
25006309|NCT01468922|50098717|FG008|Overall Study|Adverse Event|0|||
25006310|NCT01468922|50098709|FG000|Overall Study|Infection of blood|0|||
25006311|NCT01468922|50098710|FG001|Overall Study|Infection of blood|0|||
25006312|NCT01468922|50098711|FG002|Overall Study|Infection of blood|0|||
25006313|NCT01468922|50098712|FG003|Overall Study|Infection of blood|0|||
25176804|NCT01528345|50320371|FG000|Overall Study|Death|1|||
25006314|NCT01468922|50098713|FG004|Overall Study|Infection of blood|0|||
25006315|NCT01468922|50098714|FG005|Overall Study|Infection of blood|0|||
25006316|NCT01468922|50098715|FG006|Overall Study|Infection of blood|0|||
25006317|NCT01468922|50098716|FG007|Overall Study|Infection of blood|1|||
25176805|NCT01528345|50320372|FG001|Overall Study|Death|1|||
25006318|NCT01468922|50098717|FG008|Overall Study|Infection of blood|0|||
25006319|NCT01468922|50098709|FG000|Overall Study|Patient choice - surgery|0|||
25006320|NCT01468922|50098710|FG001|Overall Study|Patient choice - surgery|0|||
25006321|NCT01468922|50098711|FG002|Overall Study|Patient choice - surgery|0|||
25006322|NCT01468922|50098712|FG003|Overall Study|Patient choice - surgery|0|||
25006323|NCT01468922|50098713|FG004|Overall Study|Patient choice - surgery|0|||
25006324|NCT01468922|50098714|FG005|Overall Study|Patient choice - surgery|0|||
25006325|NCT01468922|50098715|FG006|Overall Study|Patient choice - surgery|0|||
25006326|NCT01468922|50098716|FG007|Overall Study|Patient choice - surgery|1|||
25006327|NCT01468922|50098717|FG008|Overall Study|Patient choice - surgery|0|||
25006328|NCT01468922|50098709|FG000|Overall Study|Refused further treatment|0|||
25006329|NCT01468922|50098710|FG001|Overall Study|Refused further treatment|0|||
25006330|NCT01468922|50098711|FG002|Overall Study|Refused further treatment|0|||
25006331|NCT01468922|50098712|FG003|Overall Study|Refused further treatment|0|||
25006332|NCT01468922|50098713|FG004|Overall Study|Refused further treatment|0|||
25006333|NCT01468922|50098714|FG005|Overall Study|Refused further treatment|0|||
25006334|NCT01468922|50098715|FG006|Overall Study|Refused further treatment|0|||
25006335|NCT01468922|50098716|FG007|Overall Study|Refused further treatment|1|||
25006336|NCT01468922|50098717|FG008|Overall Study|Refused further treatment|0|||
25006337|NCT01381094|50098740|FG000|Overall Study|Adverse Event|1|||
25006338|NCT01381094|50098741|FG001|Overall Study|Adverse Event|2|||
25006339|NCT01381094|50098742|FG002|Overall Study|Adverse Event|0|||
25006340|NCT01381094|50098743|FG003|Overall Study|Adverse Event|1|||
25006341|NCT01381094|50098744|FG004|Overall Study|Adverse Event|0|||
25006342|NCT01381094|50098740|FG000|Overall Study|Lost to Follow-up|0|||
25006343|NCT01381094|50098741|FG001|Overall Study|Lost to Follow-up|0|||
25006344|NCT01381094|50098742|FG002|Overall Study|Lost to Follow-up|0|||
25006345|NCT01381094|50098743|FG003|Overall Study|Lost to Follow-up|0|||
25006346|NCT01381094|50098744|FG004|Overall Study|Lost to Follow-up|1|||
25006347|NCT01381094|50098740|FG000|Overall Study|Withdrawal of informed consent|0|||
25006348|NCT01381094|50098741|FG001|Overall Study|Withdrawal of informed consent|1|||
25006349|NCT01381094|50098742|FG002|Overall Study|Withdrawal of informed consent|0|||
25006350|NCT01381094|50098743|FG003|Overall Study|Withdrawal of informed consent|0|||
25006351|NCT01381094|50098744|FG004|Overall Study|Withdrawal of informed consent|0|||
25006352|NCT01381094|50098740|FG000|Overall Study|Participant given Aranesp injection|1|||
25006353|NCT01381094|50098741|FG001|Overall Study|Participant given Aranesp injection|0|||
25006354|NCT01381094|50098742|FG002|Overall Study|Participant given Aranesp injection|0|||
25006355|NCT01381094|50098743|FG003|Overall Study|Participant given Aranesp injection|0|||
25006356|NCT01381094|50098744|FG004|Overall Study|Participant given Aranesp injection|0|||
25006357|NCT03197558|50098756|FG000|Overall Study|Tubes not placed|1|||
25006358|NCT03197324|50098762|FG000|Overall Study|Adverse Event|0|||
25006359|NCT03197324|50098763|FG001|Overall Study|Adverse Event|1|||
25006360|NCT03162614|50098775|FG000|Overall Study|Lost to Follow-up|2|||
25006361|NCT03162614|50098776|FG001|Overall Study|Lost to Follow-up|1|||
25006362|NCT03162614|50098777|FG002|Overall Study|Lost to Follow-up|1|||
25006363|NCT03162614|50098778|FG003|Overall Study|Lost to Follow-up|1|||
25006364|NCT03162614|50098779|FG004|Overall Study|Lost to Follow-up|2|||
25006365|NCT03162614|50098780|FG005|Overall Study|Lost to Follow-up|0|||
25006366|NCT03162614|50098775|FG000|Overall Study|Protocol Violation|0|||
25006367|NCT03162614|50098776|FG001|Overall Study|Protocol Violation|1|||
25006368|NCT03162614|50098777|FG002|Overall Study|Protocol Violation|0|||
25006369|NCT03162614|50098778|FG003|Overall Study|Protocol Violation|1|||
25006370|NCT03162614|50098779|FG004|Overall Study|Protocol Violation|0|||
25006371|NCT03162614|50098780|FG005|Overall Study|Protocol Violation|0|||
25006372|NCT03162614|50098775|FG000|Overall Study|Withdrawal by Subject|2|||
25006373|NCT03162614|50098776|FG001|Overall Study|Withdrawal by Subject|1|||
25006374|NCT03162614|50098777|FG002|Overall Study|Withdrawal by Subject|1|||
25006375|NCT03162614|50098778|FG003|Overall Study|Withdrawal by Subject|1|||
25006376|NCT03162614|50098779|FG004|Overall Study|Withdrawal by Subject|0|||
25006377|NCT03162614|50098780|FG005|Overall Study|Withdrawal by Subject|0|||
25006378|NCT03162614|50098775|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
25006379|NCT03162614|50098776|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
25006380|NCT03162614|50098777|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
25006381|NCT03162614|50098778|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
25006382|NCT03162614|50098779|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
25006383|NCT03162614|50098780|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
25006384|NCT03160898|50098798|FG000|Overall Study|Adverse Event|4|||
25006385|NCT03160898|50098799|FG001|Overall Study|Adverse Event|8|||
25006386|NCT03160898|50098800|FG002|Overall Study|Adverse Event|7|||
25006387|NCT03160898|50098801|FG003|Overall Study|Adverse Event|10|||
25006388|NCT03160898|50098798|FG000|Overall Study|Death|1|||
25006389|NCT03160898|50098799|FG001|Overall Study|Death|0|||
25006390|NCT03160898|50098800|FG002|Overall Study|Death|0|||
25006391|NCT03160898|50098801|FG003|Overall Study|Death|1|||
25006392|NCT03160898|50098798|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
25006393|NCT03160898|50098799|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
25006394|NCT03160898|50098800|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
25006395|NCT03160898|50098801|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
25006396|NCT03160898|50098798|FG000|Overall Study|Lost to Follow-up|1|||
25006397|NCT03160898|50098799|FG001|Overall Study|Lost to Follow-up|1|||
25006398|NCT03160898|50098800|FG002|Overall Study|Lost to Follow-up|1|||
25006399|NCT03160898|50098801|FG003|Overall Study|Lost to Follow-up|2|||
25091376|NCT02673697|50200973|FG001|Overall Study|Change subj medical status|2|||
25006400|NCT03160898|50098798|FG000|Overall Study|Physician Decision|1|||
25006401|NCT03160898|50098799|FG001|Overall Study|Physician Decision|0|||
25006402|NCT03160898|50098800|FG002|Overall Study|Physician Decision|0|||
25006403|NCT03160898|50098801|FG003|Overall Study|Physician Decision|1|||
25006404|NCT03160898|50098798|FG000|Overall Study|Progressive Disease|4|||
25006405|NCT03160898|50098799|FG001|Overall Study|Progressive Disease|1|||
25006406|NCT03160898|50098800|FG002|Overall Study|Progressive Disease|2|||
25006407|NCT03160898|50098801|FG003|Overall Study|Progressive Disease|1|||
25006408|NCT03160898|50098798|FG000|Overall Study|Protocol Violation|1|||
25006409|NCT03160898|50098799|FG001|Overall Study|Protocol Violation|0|||
25006410|NCT03160898|50098800|FG002|Overall Study|Protocol Violation|2|||
25006411|NCT03160898|50098801|FG003|Overall Study|Protocol Violation|0|||
25006412|NCT03160898|50098798|FG000|Overall Study|Sponsor Discretion|2|||
25006413|NCT03160898|50098799|FG001|Overall Study|Sponsor Discretion|0|||
25006414|NCT03160898|50098800|FG002|Overall Study|Sponsor Discretion|0|||
25006415|NCT03160898|50098801|FG003|Overall Study|Sponsor Discretion|0|||
25006416|NCT03160898|50098798|FG000|Overall Study|Withdrawal by Subject|1|||
25006417|NCT03160898|50098799|FG001|Overall Study|Withdrawal by Subject|3|||
25006418|NCT03160898|50098800|FG002|Overall Study|Withdrawal by Subject|2|||
25006419|NCT03160898|50098801|FG003|Overall Study|Withdrawal by Subject|1|||
25006420|NCT03160898|50098798|FG000|Overall Study|Other|2|||
25006421|NCT03160898|50098799|FG001|Overall Study|Other|0|||
25006422|NCT03160898|50098800|FG002|Overall Study|Other|2|||
25006423|NCT03160898|50098801|FG003|Overall Study|Other|2|||
25006424|NCT03193736|50098812|FG000|Overall Study|Death|2|||
25006425|NCT03193736|50098812|FG000|Overall Study|Withdrawal by Subject|1|||
25006426|NCT03193736|50098812|FG000|Overall Study|Lost to Follow-up|1|||
25006427|NCT03193736|50098812|FG000|Overall Study|implant not received|1|||
25006428|NCT03192488|50098829|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
25006429|NCT03192488|50098830|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
25006430|NCT03192488|50098831|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
25006431|NCT03192488|50098832|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
25006432|NCT03192488|50098833|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
25006433|NCT03192488|50098834|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
25006434|NCT03192488|50098829|FG000|Third Intervention (d1)|Adverse Event|0|||
25006435|NCT03192488|50098830|FG001|Third Intervention (d1)|Adverse Event|0|||
25006436|NCT03192488|50098831|FG002|Third Intervention (d1)|Adverse Event|0|||
25006437|NCT03192488|50098832|FG003|Third Intervention (d1)|Adverse Event|0|||
25006438|NCT03192488|50098833|FG004|Third Intervention (d1)|Adverse Event|1|||
25006439|NCT03192488|50098834|FG005|Third Intervention (d1)|Adverse Event|0|||
25006440|NCT03192176|50098856|FG000|Overall Study|Adverse Event|1|||
25006441|NCT03192176|50098857|FG001|Overall Study|Adverse Event|0|||
25006442|NCT03192176|50098858|FG002|Overall Study|Adverse Event|4|||
25006443|NCT03192176|50098859|FG003|Overall Study|Adverse Event|5|||
25006444|NCT03192176|50098860|FG004|Overall Study|Adverse Event|3|||
25006445|NCT03192176|50098861|FG005|Overall Study|Adverse Event|2|||
25006446|NCT03192176|50098862|FG006|Overall Study|Adverse Event|3|||
25006447|NCT03192176|50098863|FG007|Overall Study|Adverse Event|3|||
25006448|NCT03192176|50098856|FG000|Overall Study|Lost to Follow-up|0|||
25006449|NCT03192176|50098857|FG001|Overall Study|Lost to Follow-up|0|||
25006450|NCT03192176|50098858|FG002|Overall Study|Lost to Follow-up|1|||
25006451|NCT03192176|50098859|FG003|Overall Study|Lost to Follow-up|2|||
25006452|NCT03192176|50098860|FG004|Overall Study|Lost to Follow-up|3|||
25006453|NCT03192176|50098861|FG005|Overall Study|Lost to Follow-up|1|||
25006454|NCT03192176|50098862|FG006|Overall Study|Lost to Follow-up|1|||
25006455|NCT03192176|50098863|FG007|Overall Study|Lost to Follow-up|1|||
25006456|NCT03192176|50098856|FG000|Overall Study|Physician Decision|1|||
25006457|NCT03192176|50098857|FG001|Overall Study|Physician Decision|0|||
25006458|NCT03192176|50098858|FG002|Overall Study|Physician Decision|0|||
25006459|NCT03192176|50098859|FG003|Overall Study|Physician Decision|0|||
25176806|NCT01528345|50320371|FG000|Overall Study|Non-compliance with study treatment|1|||
25176807|NCT01528345|50320372|FG001|Overall Study|Non-compliance with study treatment|0|||
25006460|NCT03192176|50098860|FG004|Overall Study|Physician Decision|0|||
25006461|NCT03192176|50098861|FG005|Overall Study|Physician Decision|2|||
25006462|NCT03192176|50098862|FG006|Overall Study|Physician Decision|1|||
25006463|NCT03192176|50098863|FG007|Overall Study|Physician Decision|0|||
25006464|NCT03192176|50098856|FG000|Overall Study|Protocol Deviation|1|||
25006465|NCT03192176|50098857|FG001|Overall Study|Protocol Deviation|1|||
25006466|NCT03192176|50098858|FG002|Overall Study|Protocol Deviation|0|||
25006467|NCT03192176|50098859|FG003|Overall Study|Protocol Deviation|0|||
25006468|NCT03192176|50098860|FG004|Overall Study|Protocol Deviation|2|||
25006469|NCT03192176|50098861|FG005|Overall Study|Protocol Deviation|0|||
25006470|NCT03192176|50098862|FG006|Overall Study|Protocol Deviation|0|||
25006471|NCT03192176|50098863|FG007|Overall Study|Protocol Deviation|0|||
25006472|NCT03192176|50098856|FG000|Overall Study|Withdrawal by Subject|3|||
25006473|NCT03192176|50098857|FG001|Overall Study|Withdrawal by Subject|4|||
25006474|NCT03192176|50098858|FG002|Overall Study|Withdrawal by Subject|0|||
25006475|NCT03192176|50098859|FG003|Overall Study|Withdrawal by Subject|4|||
25006476|NCT03192176|50098860|FG004|Overall Study|Withdrawal by Subject|3|||
25006477|NCT03192176|50098861|FG005|Overall Study|Withdrawal by Subject|4|||
25006478|NCT03192176|50098862|FG006|Overall Study|Withdrawal by Subject|4|||
25006479|NCT03192176|50098863|FG007|Overall Study|Withdrawal by Subject|2|||
25006480|NCT03192176|50098856|FG000|Overall Study|Miscellaneous|1|||
25006481|NCT03192176|50098857|FG001|Overall Study|Miscellaneous|0|||
25006482|NCT03192176|50098858|FG002|Overall Study|Miscellaneous|1|||
25006483|NCT03192176|50098859|FG003|Overall Study|Miscellaneous|1|||
25006484|NCT03192176|50098860|FG004|Overall Study|Miscellaneous|1|||
25006485|NCT03192176|50098861|FG005|Overall Study|Miscellaneous|2|||
25006486|NCT03192176|50098862|FG006|Overall Study|Miscellaneous|0|||
25006487|NCT03192176|50098863|FG007|Overall Study|Miscellaneous|1|||
25006488|NCT01642004|50098884|FG000|Randomization|Adverse Event unrelated to study drug|1|||
25006489|NCT01642004|50098885|FG001|Randomization|Adverse Event unrelated to study drug|0|||
25006490|NCT01642004|50098884|FG000|Randomization|Participant withdrew consent|1|||
25006491|NCT01642004|50098885|FG001|Randomization|Participant withdrew consent|6|||
25006492|NCT01642004|50098884|FG000|Randomization|No longer meets study criteria|2|||
25006493|NCT01642004|50098885|FG001|Randomization|No longer meets study criteria|2|||
25006494|NCT01642004|50098884|FG000|Treatment|Disease progression|95|||
25006495|NCT01642004|50098885|FG001|Treatment|Disease progression|79|||
25006496|NCT01642004|50098884|FG000|Treatment|Study drug toxicity|10|||
25006497|NCT01642004|50098885|FG001|Treatment|Study drug toxicity|13|||
25006498|NCT01642004|50098884|FG000|Treatment|Death|1|||
25006499|NCT01642004|50098885|FG001|Treatment|Death|1|||
25006500|NCT01642004|50098884|FG000|Treatment|Adverse event unrelated to study drug|9|||
25006501|NCT01642004|50098885|FG001|Treatment|Adverse event unrelated to study drug|13|||
25006502|NCT01642004|50098884|FG000|Treatment|Maximum clinical benefit|1|||
25006503|NCT01642004|50098885|FG001|Treatment|Maximum clinical benefit|9|||
25006504|NCT01642004|50098884|FG000|Treatment|Poor/non-compliance|1|||
25006505|NCT01642004|50098885|FG001|Treatment|Poor/non-compliance|0|||
25006506|NCT01642004|50098884|FG000|Treatment|No longer meets study criteria|1|||
25006507|NCT01642004|50098885|FG001|Treatment|No longer meets study criteria|2|||
25006508|NCT01642004|50098884|FG000|Treatment|Other reasons|2|||
25006509|NCT01642004|50098885|FG001|Treatment|Other reasons|0|||
25006510|NCT01642004|50098884|FG000|Treatment|Not reported|0|||
25006511|NCT01642004|50098885|FG001|Treatment|Not reported|3|||
25006512|NCT01642004|50098884|FG000|Treatment|Participant request to discontinue study treatment|6|||
25006513|NCT01642004|50098885|FG001|Treatment|Participant request to discontinue study treatment|4|||
25006514|NCT01642004|50098884|FG000|Treatment|Participant withdrew consent|5|||
25006515|NCT01642004|50098885|FG001|Treatment|Participant withdrew consent|5|||
25006516|NCT00042289|50098941|FG000|Overall Study|Lost to Follow-up|3|||
25006517|NCT00042289|50098942|FG001|Overall Study|Lost to Follow-up|0|||
25006518|NCT00042289|50098943|FG002|Overall Study|Lost to Follow-up|0|||
25006519|NCT00042289|50098944|FG003|Overall Study|Lost to Follow-up|1|||
25006520|NCT00042289|50098945|FG004|Overall Study|Lost to Follow-up|3|||
25006521|NCT00042289|50098946|FG005|Overall Study|Lost to Follow-up|3|||
25006522|NCT00042289|50098947|FG006|Overall Study|Lost to Follow-up|6|||
25006523|NCT00042289|50098948|FG007|Overall Study|Lost to Follow-up|1|||
25006524|NCT00042289|50098949|FG008|Overall Study|Lost to Follow-up|1|||
25006525|NCT00042289|50098950|FG009|Overall Study|Lost to Follow-up|0|||
25006526|NCT00042289|50098951|FG010|Overall Study|Lost to Follow-up|0|||
25006527|NCT00042289|50098952|FG011|Overall Study|Lost to Follow-up|0|||
25006528|NCT00042289|50098953|FG012|Overall Study|Lost to Follow-up|0|||
25006529|NCT00042289|50098954|FG013|Overall Study|Lost to Follow-up|0|||
25006530|NCT00042289|50098955|FG014|Overall Study|Lost to Follow-up|0|||
25006531|NCT00042289|50098956|FG015|Overall Study|Lost to Follow-up|1|||
25006532|NCT00042289|50098957|FG016|Overall Study|Lost to Follow-up|1|||
25006533|NCT00042289|50098958|FG017|Overall Study|Lost to Follow-up|0|||
25006534|NCT00042289|50098959|FG018|Overall Study|Lost to Follow-up|3|||
25006535|NCT00042289|50098960|FG019|Overall Study|Lost to Follow-up|2|||
25006536|NCT00042289|50098961|FG020|Overall Study|Lost to Follow-up|0|||
25006537|NCT00042289|50098962|FG021|Overall Study|Lost to Follow-up|0|||
25006538|NCT00042289|50098963|FG022|Overall Study|Lost to Follow-up|0|||
25006539|NCT00042289|50098964|FG023|Overall Study|Lost to Follow-up|0|||
25006540|NCT00042289|50098965|FG024|Overall Study|Lost to Follow-up|0|||
25176808|NCT01528345|50320371|FG000|Overall Study|Progressive Disease|26|||
25006541|NCT00042289|50098966|FG025|Overall Study|Lost to Follow-up|0|||
25006542|NCT00042289|50098967|FG026|Overall Study|Lost to Follow-up|2|||
25006543|NCT00042289|50098968|FG027|Overall Study|Lost to Follow-up|2|||
25006544|NCT00042289|50098969|FG028|Overall Study|Lost to Follow-up|2|||
25006545|NCT00042289|50098970|FG029|Overall Study|Lost to Follow-up|0|||
25006546|NCT00042289|50098971|FG030|Overall Study|Lost to Follow-up|0|||
25006547|NCT00042289|50098972|FG031|Overall Study|Lost to Follow-up|2|||
25006548|NCT00042289|50098973|FG032|Overall Study|Lost to Follow-up|1|||
25006549|NCT00042289|50098974|FG033|Overall Study|Lost to Follow-up|1|||
25006550|NCT00042289|50098975|FG034|Overall Study|Lost to Follow-up|1|||
25006551|NCT00042289|50098976|FG035|Overall Study|Lost to Follow-up|2|||
25006552|NCT00042289|50098977|FG036|Overall Study|Lost to Follow-up|1|||
25006553|NCT00042289|50098978|FG037|Overall Study|Lost to Follow-up|1|||
25006554|NCT00042289|50098979|FG038|Overall Study|Lost to Follow-up|0|||
25006555|NCT00042289|50098980|FG039|Overall Study|Lost to Follow-up|5|||
25006556|NCT00042289|50098981|FG040|Overall Study|Lost to Follow-up|0|||
25006557|NCT00042289|50098982|FG041|Overall Study|Lost to Follow-up|2|||
25006558|NCT00042289|50098983|FG042|Overall Study|Lost to Follow-up|2|||
25176809|NCT01528345|50320372|FG001|Overall Study|Progressive Disease|40|||
25006559|NCT00042289|50098984|FG043|Overall Study|Lost to Follow-up|0|||
25006560|NCT00042289|50098985|FG044|Overall Study|Lost to Follow-up|0|||
25006561|NCT00042289|50098986|FG045|Overall Study|Lost to Follow-up|1|||
25006562|NCT00042289|50098987|FG046|Overall Study|Lost to Follow-up|0|||
25006563|NCT00042289|50098941|FG000|Overall Study|Other reason|0|||
25006564|NCT00042289|50098942|FG001|Overall Study|Other reason|0|||
25006565|NCT00042289|50098943|FG002|Overall Study|Other reason|0|||
25006566|NCT00042289|50098944|FG003|Overall Study|Other reason|2|||
25006567|NCT00042289|50098945|FG004|Overall Study|Other reason|0|||
25006568|NCT00042289|50098946|FG005|Overall Study|Other reason|0|||
25006569|NCT00042289|50098947|FG006|Overall Study|Other reason|0|||
25006570|NCT00042289|50098948|FG007|Overall Study|Other reason|0|||
25006571|NCT00042289|50098949|FG008|Overall Study|Other reason|0|||
25006572|NCT00042289|50098950|FG009|Overall Study|Other reason|0|||
25006573|NCT00042289|50098951|FG010|Overall Study|Other reason|0|||
25006574|NCT00042289|50098952|FG011|Overall Study|Other reason|0|||
25006575|NCT00042289|50098953|FG012|Overall Study|Other reason|0|||
25006576|NCT00042289|50098954|FG013|Overall Study|Other reason|0|||
25006577|NCT00042289|50098955|FG014|Overall Study|Other reason|0|||
25006578|NCT00042289|50098956|FG015|Overall Study|Other reason|0|||
25006579|NCT00042289|50098957|FG016|Overall Study|Other reason|0|||
25006580|NCT00042289|50098958|FG017|Overall Study|Other reason|0|||
25006581|NCT00042289|50098959|FG018|Overall Study|Other reason|1|||
25006582|NCT00042289|50098960|FG019|Overall Study|Other reason|0|||
25006583|NCT00042289|50098961|FG020|Overall Study|Other reason|0|||
25006584|NCT00042289|50098962|FG021|Overall Study|Other reason|0|||
25006585|NCT00042289|50098963|FG022|Overall Study|Other reason|0|||
25006586|NCT00042289|50098964|FG023|Overall Study|Other reason|1|||
25006587|NCT00042289|50098965|FG024|Overall Study|Other reason|0|||
25006588|NCT00042289|50098966|FG025|Overall Study|Other reason|0|||
25006589|NCT00042289|50098967|FG026|Overall Study|Other reason|1|||
25006590|NCT00042289|50098968|FG027|Overall Study|Other reason|0|||
25006591|NCT00042289|50098969|FG028|Overall Study|Other reason|3|||
25006592|NCT00042289|50098970|FG029|Overall Study|Other reason|0|||
25006593|NCT00042289|50098971|FG030|Overall Study|Other reason|0|||
25006594|NCT00042289|50098972|FG031|Overall Study|Other reason|1|||
25006595|NCT00042289|50098973|FG032|Overall Study|Other reason|0|||
25006596|NCT00042289|50098974|FG033|Overall Study|Other reason|1|||
25006597|NCT00042289|50098975|FG034|Overall Study|Other reason|0|||
25006598|NCT00042289|50098976|FG035|Overall Study|Other reason|2|||
25006599|NCT00042289|50098977|FG036|Overall Study|Other reason|0|||
25006600|NCT00042289|50098978|FG037|Overall Study|Other reason|0|||
25006601|NCT00042289|50098979|FG038|Overall Study|Other reason|0|||
25006602|NCT00042289|50098980|FG039|Overall Study|Other reason|0|||
25006603|NCT00042289|50098981|FG040|Overall Study|Other reason|0|||
25006604|NCT00042289|50098982|FG041|Overall Study|Other reason|0|||
25006605|NCT00042289|50098983|FG042|Overall Study|Other reason|0|||
25006606|NCT00042289|50098984|FG043|Overall Study|Other reason|1|||
25006607|NCT00042289|50098985|FG044|Overall Study|Other reason|0|||
25006608|NCT00042289|50098986|FG045|Overall Study|Other reason|0|||
25006609|NCT00042289|50098987|FG046|Overall Study|Other reason|0|||
25006610|NCT00042289|50098941|FG000|Overall Study|Severe debilitation, unable to continue|0|||
25006611|NCT00042289|50098942|FG001|Overall Study|Severe debilitation, unable to continue|0|||
25006612|NCT00042289|50098943|FG002|Overall Study|Severe debilitation, unable to continue|0|||
25006613|NCT00042289|50098944|FG003|Overall Study|Severe debilitation, unable to continue|0|||
25006614|NCT00042289|50098945|FG004|Overall Study|Severe debilitation, unable to continue|0|||
25006615|NCT00042289|50098946|FG005|Overall Study|Severe debilitation, unable to continue|0|||
25006616|NCT00042289|50098947|FG006|Overall Study|Severe debilitation, unable to continue|0|||
25006617|NCT00042289|50098948|FG007|Overall Study|Severe debilitation, unable to continue|0|||
25006618|NCT00042289|50098949|FG008|Overall Study|Severe debilitation, unable to continue|0|||
25006619|NCT00042289|50098950|FG009|Overall Study|Severe debilitation, unable to continue|0|||
25006620|NCT00042289|50098951|FG010|Overall Study|Severe debilitation, unable to continue|0|||
25006621|NCT00042289|50098952|FG011|Overall Study|Severe debilitation, unable to continue|0|||
25006622|NCT00042289|50098953|FG012|Overall Study|Severe debilitation, unable to continue|0|||
25006623|NCT00042289|50098954|FG013|Overall Study|Severe debilitation, unable to continue|0|||
25006624|NCT00042289|50098955|FG014|Overall Study|Severe debilitation, unable to continue|0|||
25006625|NCT00042289|50098956|FG015|Overall Study|Severe debilitation, unable to continue|0|||
25006626|NCT00042289|50098957|FG016|Overall Study|Severe debilitation, unable to continue|0|||
25176810|NCT01528345|50320371|FG000|Overall Study|Study Terminated by Sponsor|4|||
25006627|NCT00042289|50098958|FG017|Overall Study|Severe debilitation, unable to continue|0|||
25006628|NCT00042289|50098959|FG018|Overall Study|Severe debilitation, unable to continue|0|||
25006629|NCT00042289|50098960|FG019|Overall Study|Severe debilitation, unable to continue|0|||
25006630|NCT00042289|50098961|FG020|Overall Study|Severe debilitation, unable to continue|0|||
25006631|NCT00042289|50098962|FG021|Overall Study|Severe debilitation, unable to continue|1|||
25006632|NCT00042289|50098963|FG022|Overall Study|Severe debilitation, unable to continue|0|||
25006633|NCT00042289|50098964|FG023|Overall Study|Severe debilitation, unable to continue|1|||
25006634|NCT00042289|50098965|FG024|Overall Study|Severe debilitation, unable to continue|0|||
25006635|NCT00042289|50098966|FG025|Overall Study|Severe debilitation, unable to continue|0|||
25006636|NCT00042289|50098967|FG026|Overall Study|Severe debilitation, unable to continue|0|||
25006637|NCT00042289|50098968|FG027|Overall Study|Severe debilitation, unable to continue|1|||
25006638|NCT00042289|50098969|FG028|Overall Study|Severe debilitation, unable to continue|0|||
25006639|NCT00042289|50098970|FG029|Overall Study|Severe debilitation, unable to continue|0|||
25006640|NCT00042289|50098971|FG030|Overall Study|Severe debilitation, unable to continue|0|||
25006641|NCT00042289|50098972|FG031|Overall Study|Severe debilitation, unable to continue|1|||
25006642|NCT00042289|50098973|FG032|Overall Study|Severe debilitation, unable to continue|1|||
25006643|NCT00042289|50098974|FG033|Overall Study|Severe debilitation, unable to continue|0|||
25006644|NCT00042289|50098975|FG034|Overall Study|Severe debilitation, unable to continue|0|||
25006645|NCT00042289|50098976|FG035|Overall Study|Severe debilitation, unable to continue|0|||
25006646|NCT00042289|50098977|FG036|Overall Study|Severe debilitation, unable to continue|0|||
25006647|NCT00042289|50098978|FG037|Overall Study|Severe debilitation, unable to continue|0|||
25006648|NCT00042289|50098979|FG038|Overall Study|Severe debilitation, unable to continue|0|||
25006649|NCT00042289|50098980|FG039|Overall Study|Severe debilitation, unable to continue|0|||
25006650|NCT00042289|50098981|FG040|Overall Study|Severe debilitation, unable to continue|0|||
25006651|NCT00042289|50098982|FG041|Overall Study|Severe debilitation, unable to continue|0|||
25006652|NCT00042289|50098983|FG042|Overall Study|Severe debilitation, unable to continue|0|||
25006653|NCT00042289|50098984|FG043|Overall Study|Severe debilitation, unable to continue|0|||
25006654|NCT00042289|50098985|FG044|Overall Study|Severe debilitation, unable to continue|0|||
25006655|NCT00042289|50098986|FG045|Overall Study|Severe debilitation, unable to continue|0|||
25006656|NCT00042289|50098987|FG046|Overall Study|Severe debilitation, unable to continue|0|||
25006657|NCT00042289|50098941|FG000|Overall Study|Site closed|0|||
25006658|NCT00042289|50098942|FG001|Overall Study|Site closed|0|||
25006659|NCT00042289|50098943|FG002|Overall Study|Site closed|0|||
25006660|NCT00042289|50098944|FG003|Overall Study|Site closed|0|||
25006661|NCT00042289|50098945|FG004|Overall Study|Site closed|0|||
25006662|NCT00042289|50098946|FG005|Overall Study|Site closed|0|||
25006663|NCT00042289|50098947|FG006|Overall Study|Site closed|0|||
25006664|NCT00042289|50098948|FG007|Overall Study|Site closed|0|||
25006665|NCT00042289|50098949|FG008|Overall Study|Site closed|0|||
25006666|NCT00042289|50098950|FG009|Overall Study|Site closed|0|||
25006667|NCT00042289|50098951|FG010|Overall Study|Site closed|0|||
25006668|NCT00042289|50098952|FG011|Overall Study|Site closed|0|||
25006669|NCT00042289|50098953|FG012|Overall Study|Site closed|0|||
25006670|NCT00042289|50098954|FG013|Overall Study|Site closed|0|||
25006671|NCT00042289|50098955|FG014|Overall Study|Site closed|0|||
25006672|NCT00042289|50098956|FG015|Overall Study|Site closed|0|||
25006673|NCT00042289|50098957|FG016|Overall Study|Site closed|0|||
25006674|NCT00042289|50098958|FG017|Overall Study|Site closed|0|||
25006675|NCT00042289|50098959|FG018|Overall Study|Site closed|0|||
25006676|NCT00042289|50098960|FG019|Overall Study|Site closed|0|||
25006677|NCT00042289|50098961|FG020|Overall Study|Site closed|0|||
25006678|NCT00042289|50098962|FG021|Overall Study|Site closed|0|||
25006679|NCT00042289|50098963|FG022|Overall Study|Site closed|0|||
25006680|NCT00042289|50098964|FG023|Overall Study|Site closed|0|||
25006681|NCT00042289|50098965|FG024|Overall Study|Site closed|0|||
25006682|NCT00042289|50098966|FG025|Overall Study|Site closed|0|||
25006683|NCT00042289|50098967|FG026|Overall Study|Site closed|0|||
25006684|NCT00042289|50098968|FG027|Overall Study|Site closed|0|||
25006685|NCT00042289|50098969|FG028|Overall Study|Site closed|0|||
25006686|NCT00042289|50098970|FG029|Overall Study|Site closed|0|||
25006687|NCT00042289|50098971|FG030|Overall Study|Site closed|0|||
25006688|NCT00042289|50098972|FG031|Overall Study|Site closed|3|||
25006689|NCT00042289|50098973|FG032|Overall Study|Site closed|0|||
25006690|NCT00042289|50098974|FG033|Overall Study|Site closed|0|||
25006691|NCT00042289|50098975|FG034|Overall Study|Site closed|0|||
25006692|NCT00042289|50098976|FG035|Overall Study|Site closed|0|||
25006693|NCT00042289|50098977|FG036|Overall Study|Site closed|1|||
25006694|NCT00042289|50098978|FG037|Overall Study|Site closed|0|||
25176811|NCT01528345|50320372|FG001|Overall Study|Study Terminated by Sponsor|8|||
25006695|NCT00042289|50098979|FG038|Overall Study|Site closed|0|||
25006696|NCT00042289|50098980|FG039|Overall Study|Site closed|0|||
25176812|NCT01528345|50320371|FG000|Overall Study|Subject/Guardian Decision|5|||
25006697|NCT00042289|50098981|FG040|Overall Study|Site closed|0|||
25006698|NCT00042289|50098982|FG041|Overall Study|Site closed|0|||
25006699|NCT00042289|50098983|FG042|Overall Study|Site closed|1|||
25006700|NCT00042289|50098984|FG043|Overall Study|Site closed|0|||
25006701|NCT00042289|50098985|FG044|Overall Study|Site closed|0|||
25006702|NCT00042289|50098986|FG045|Overall Study|Site closed|0|||
25006703|NCT00042289|50098987|FG046|Overall Study|Site closed|0|||
25006704|NCT00042289|50098941|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
25006705|NCT00042289|50098942|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
25006706|NCT00042289|50098943|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
25006707|NCT00042289|50098944|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
25006708|NCT00042289|50098945|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
25006709|NCT00042289|50098946|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
25006710|NCT00042289|50098947|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
25006711|NCT00042289|50098948|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
25006712|NCT00042289|50098949|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
25006713|NCT00042289|50098950|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
25006714|NCT00042289|50098951|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
25006715|NCT00042289|50098952|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
25006716|NCT00042289|50098953|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
25006717|NCT00042289|50098954|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
25006718|NCT00042289|50098955|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
25006719|NCT00042289|50098956|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
25006720|NCT00042289|50098957|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
25006721|NCT00042289|50098958|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
25006722|NCT00042289|50098959|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
25006723|NCT00042289|50098960|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
25006724|NCT00042289|50098961|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
25006725|NCT00042289|50098962|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
25006726|NCT00042289|50098963|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
25006727|NCT00042289|50098964|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
25006728|NCT00042289|50098965|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
25006729|NCT00042289|50098966|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
25006730|NCT00042289|50098967|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
25006731|NCT00042289|50098968|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
25006732|NCT00042289|50098969|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
25006733|NCT00042289|50098970|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
25006734|NCT00042289|50098971|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
25091377|NCT02673697|50200972|FG000|Overall Study|Explant|10|||
25091378|NCT02673697|50200973|FG001|Overall Study|Explant|5|||
25091379|NCT02673697|50200972|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
25091380|NCT02673697|50200973|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
25091381|NCT05168579|50200981|FG000|Overall Study|Lack of Consent|1|||
25091382|NCT05168579|50200982|FG001|Overall Study|Lack of Consent|0|||
25091383|NCT05168579|50200981|FG000|Overall Study|Conflicts with time|2|||
25091384|NCT05168579|50200982|FG001|Overall Study|Conflicts with time|0|||
25091385|NCT05168579|50200981|FG000|Overall Study|Time slots were full|3|||
25091386|NCT05168579|50200982|FG001|Overall Study|Time slots were full|0|||
25091387|NCT05168579|50200981|FG000|Overall Study|Lost to Follow-up|0|||
25091388|NCT05168579|50200982|FG001|Overall Study|Lost to Follow-up|15|||
25091389|NCT02673619|50200995|FG000|Overall Study|Lost to Follow-up|1|||
25091390|NCT02673619|50200996|FG001|Overall Study|Lost to Follow-up|0|||
25091391|NCT02673619|50200997|FG002|Overall Study|Lost to Follow-up|0|||
25091392|NCT02673619|50200998|FG003|Overall Study|Lost to Follow-up|0|||
25091393|NCT02673619|50200995|FG000|Overall Study|Withdrawal by Subject|1|||
25091394|NCT02673619|50200996|FG001|Overall Study|Withdrawal by Subject|1|||
25091395|NCT02673619|50200997|FG002|Overall Study|Withdrawal by Subject|1|||
25091396|NCT02673619|50200998|FG003|Overall Study|Withdrawal by Subject|0|||
25091397|NCT02673619|50200995|FG000|Overall Study|Adverse Event|0|||
25091398|NCT02673619|50200996|FG001|Overall Study|Adverse Event|0|||
25091399|NCT02673619|50200997|FG002|Overall Study|Adverse Event|1|||
25091400|NCT02673619|50200998|FG003|Overall Study|Adverse Event|0|||
25091401|NCT02673619|50200995|FG000|Overall Study|Lack of Efficacy|0|||
25091402|NCT02673619|50200996|FG001|Overall Study|Lack of Efficacy|0|||
25091403|NCT02673619|50200997|FG002|Overall Study|Lack of Efficacy|1|||
25091404|NCT02673619|50200998|FG003|Overall Study|Lack of Efficacy|0|||
25091405|NCT02680639|50201020|FG000|Screening Period|Screen Failure|7|||
25091406|NCT02680639|50201021|FG001|Screening Period|Screen Failure|0|||
25091407|NCT02680639|50201022|FG002|Screening Period|Screen Failure|0|||
25091408|NCT01674725|50201034|FG000|Overall Study|Adverse Event|1|||
25091409|NCT01674725|50201035|FG001|Overall Study|Adverse Event|0|||
25091410|NCT01674725|50201034|FG000|Overall Study|Did not receive study drug|1|||
25091411|NCT01674725|50201035|FG001|Overall Study|Did not receive study drug|0|||
25091412|NCT01674725|50201034|FG000|Overall Study|Withdrawal by Subject|1|||
25091413|NCT01674725|50201035|FG001|Overall Study|Withdrawal by Subject|0|||
25091414|NCT01674725|50201034|FG000|Overall Study|Lost to Follow-up|0|||
25091415|NCT01674725|50201035|FG001|Overall Study|Lost to Follow-up|1|||
25091416|NCT01674569|50201041|FG000|Overall Study|Adverse Event|0|||
25091417|NCT01674569|50201042|FG001|Overall Study|Adverse Event|2|||
25006735|NCT00042289|50098972|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
25006736|NCT00042289|50098973|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
25006737|NCT00042289|50098974|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
25006738|NCT00042289|50098975|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
25006739|NCT00042289|50098976|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
25006740|NCT00042289|50098977|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
25006741|NCT00042289|50098978|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
25006742|NCT00042289|50098979|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
25006743|NCT00042289|50098980|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
25006744|NCT00042289|50098981|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
25006745|NCT00042289|50098982|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
25006746|NCT00042289|50098983|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
25006747|NCT00042289|50098984|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
25006748|NCT00042289|50098985|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
25006749|NCT00042289|50098986|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
25006750|NCT00042289|50098987|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
25006751|NCT00042289|50098941|FG000|Overall Study|Protocol Violation|0|||
25006752|NCT00042289|50098942|FG001|Overall Study|Protocol Violation|0|||
25006753|NCT00042289|50098943|FG002|Overall Study|Protocol Violation|0|||
25006754|NCT00042289|50098944|FG003|Overall Study|Protocol Violation|0|||
25006755|NCT00042289|50098945|FG004|Overall Study|Protocol Violation|0|||
25006756|NCT00042289|50098946|FG005|Overall Study|Protocol Violation|1|||
25006757|NCT00042289|50098947|FG006|Overall Study|Protocol Violation|0|||
25006758|NCT00042289|50098948|FG007|Overall Study|Protocol Violation|1|||
25006759|NCT00042289|50098949|FG008|Overall Study|Protocol Violation|0|||
25006760|NCT00042289|50098950|FG009|Overall Study|Protocol Violation|0|||
25006761|NCT00042289|50098951|FG010|Overall Study|Protocol Violation|0|||
25006762|NCT00042289|50098952|FG011|Overall Study|Protocol Violation|0|||
25006763|NCT00042289|50098953|FG012|Overall Study|Protocol Violation|0|||
25006764|NCT00042289|50098954|FG013|Overall Study|Protocol Violation|0|||
25006765|NCT00042289|50098955|FG014|Overall Study|Protocol Violation|0|||
25006766|NCT00042289|50098956|FG015|Overall Study|Protocol Violation|0|||
25006767|NCT00042289|50098957|FG016|Overall Study|Protocol Violation|0|||
25006768|NCT00042289|50098958|FG017|Overall Study|Protocol Violation|0|||
25006769|NCT00042289|50098959|FG018|Overall Study|Protocol Violation|0|||
25006770|NCT00042289|50098960|FG019|Overall Study|Protocol Violation|0|||
25006771|NCT00042289|50098961|FG020|Overall Study|Protocol Violation|0|||
25006772|NCT00042289|50098962|FG021|Overall Study|Protocol Violation|0|||
25006773|NCT00042289|50098963|FG022|Overall Study|Protocol Violation|0|||
25006774|NCT00042289|50098964|FG023|Overall Study|Protocol Violation|1|||
25006775|NCT00042289|50098965|FG024|Overall Study|Protocol Violation|1|||
25006776|NCT00042289|50098966|FG025|Overall Study|Protocol Violation|0|||
25176813|NCT01528345|50320372|FG001|Overall Study|Subject/Guardian Decision|0|||
25176814|NCT01513967|50320386|FG000|Overall Study|Pregnancy|0|||
25006777|NCT00042289|50098967|FG026|Overall Study|Protocol Violation|2|||
25006778|NCT00042289|50098968|FG027|Overall Study|Protocol Violation|0|||
25006779|NCT00042289|50098969|FG028|Overall Study|Protocol Violation|0|||
25006780|NCT00042289|50098970|FG029|Overall Study|Protocol Violation|0|||
25006781|NCT00042289|50098971|FG030|Overall Study|Protocol Violation|1|||
25006782|NCT00042289|50098972|FG031|Overall Study|Protocol Violation|0|||
25006783|NCT00042289|50098973|FG032|Overall Study|Protocol Violation|0|||
25006784|NCT00042289|50098974|FG033|Overall Study|Protocol Violation|0|||
25006785|NCT00042289|50098975|FG034|Overall Study|Protocol Violation|0|||
25006786|NCT00042289|50098976|FG035|Overall Study|Protocol Violation|0|||
25006787|NCT00042289|50098977|FG036|Overall Study|Protocol Violation|0|||
25006788|NCT00042289|50098978|FG037|Overall Study|Protocol Violation|0|||
25006789|NCT00042289|50098979|FG038|Overall Study|Protocol Violation|0|||
25006790|NCT00042289|50098980|FG039|Overall Study|Protocol Violation|0|||
25006791|NCT00042289|50098981|FG040|Overall Study|Protocol Violation|0|||
25091418|NCT01674569|50201043|FG002|Overall Study|Adverse Event|0|||
25091419|NCT01674569|50201044|FG003|Overall Study|Adverse Event|1|||
25091420|NCT01674569|50201045|FG004|Overall Study|Adverse Event|2|||
25091421|NCT01674569|50201046|FG005|Overall Study|Adverse Event|2|||
25091422|NCT01674569|50201041|FG000|Overall Study|Protocol Violation|0|||
25091423|NCT01674569|50201042|FG001|Overall Study|Protocol Violation|1|||
25091424|NCT01674569|50201043|FG002|Overall Study|Protocol Violation|1|||
25091425|NCT01674569|50201044|FG003|Overall Study|Protocol Violation|0|||
25176815|NCT01513967|50320387|FG001|Overall Study|Pregnancy|0|||
25006792|NCT00042289|50098982|FG041|Overall Study|Protocol Violation|1|||
25006793|NCT00042289|50098983|FG042|Overall Study|Protocol Violation|1|||
25006794|NCT00042289|50098984|FG043|Overall Study|Protocol Violation|1|||
25006795|NCT00042289|50098985|FG044|Overall Study|Protocol Violation|0|||
25006796|NCT00042289|50098986|FG045|Overall Study|Protocol Violation|0|||
25006797|NCT00042289|50098987|FG046|Overall Study|Protocol Violation|0|||
25006798|NCT00042289|50098941|FG000|Overall Study|Withdrawal by Subject|4|||
25091426|NCT01674569|50201045|FG004|Overall Study|Protocol Violation|0|||
25006799|NCT00042289|50098942|FG001|Overall Study|Withdrawal by Subject|1|||
25006800|NCT00042289|50098943|FG002|Overall Study|Withdrawal by Subject|0|||
25006801|NCT00042289|50098944|FG003|Overall Study|Withdrawal by Subject|2|||
25006802|NCT00042289|50098945|FG004|Overall Study|Withdrawal by Subject|0|||
25006803|NCT00042289|50098946|FG005|Overall Study|Withdrawal by Subject|2|||
25006804|NCT00042289|50098947|FG006|Overall Study|Withdrawal by Subject|0|||
25006805|NCT00042289|50098948|FG007|Overall Study|Withdrawal by Subject|0|||
25006806|NCT00042289|50098949|FG008|Overall Study|Withdrawal by Subject|0|||
25006807|NCT00042289|50098950|FG009|Overall Study|Withdrawal by Subject|1|||
25006808|NCT00042289|50098951|FG010|Overall Study|Withdrawal by Subject|0|||
25006809|NCT00042289|50098952|FG011|Overall Study|Withdrawal by Subject|0|||
25006810|NCT00042289|50098953|FG012|Overall Study|Withdrawal by Subject|2|||
25006811|NCT00042289|50098954|FG013|Overall Study|Withdrawal by Subject|0|||
25006812|NCT00042289|50098955|FG014|Overall Study|Withdrawal by Subject|0|||
25006813|NCT00042289|50098956|FG015|Overall Study|Withdrawal by Subject|0|||
25006814|NCT00042289|50098957|FG016|Overall Study|Withdrawal by Subject|0|||
25006815|NCT00042289|50098958|FG017|Overall Study|Withdrawal by Subject|0|||
25006816|NCT00042289|50098959|FG018|Overall Study|Withdrawal by Subject|0|||
25006817|NCT00042289|50098960|FG019|Overall Study|Withdrawal by Subject|0|||
25006818|NCT00042289|50098961|FG020|Overall Study|Withdrawal by Subject|0|||
25006819|NCT00042289|50098962|FG021|Overall Study|Withdrawal by Subject|1|||
25006820|NCT00042289|50098963|FG022|Overall Study|Withdrawal by Subject|1|||
25006821|NCT00042289|50098964|FG023|Overall Study|Withdrawal by Subject|1|||
25006822|NCT00042289|50098965|FG024|Overall Study|Withdrawal by Subject|0|||
25006823|NCT00042289|50098966|FG025|Overall Study|Withdrawal by Subject|0|||
25006824|NCT00042289|50098967|FG026|Overall Study|Withdrawal by Subject|1|||
25006825|NCT00042289|50098968|FG027|Overall Study|Withdrawal by Subject|0|||
25006826|NCT00042289|50098969|FG028|Overall Study|Withdrawal by Subject|2|||
25006827|NCT00042289|50098970|FG029|Overall Study|Withdrawal by Subject|0|||
25006828|NCT00042289|50098971|FG030|Overall Study|Withdrawal by Subject|0|||
25006829|NCT00042289|50098972|FG031|Overall Study|Withdrawal by Subject|1|||
25006830|NCT00042289|50098973|FG032|Overall Study|Withdrawal by Subject|2|||
25006831|NCT00042289|50098974|FG033|Overall Study|Withdrawal by Subject|1|||
25006832|NCT00042289|50098975|FG034|Overall Study|Withdrawal by Subject|0|||
25006833|NCT00042289|50098976|FG035|Overall Study|Withdrawal by Subject|0|||
25006834|NCT00042289|50098977|FG036|Overall Study|Withdrawal by Subject|0|||
25006835|NCT00042289|50098978|FG037|Overall Study|Withdrawal by Subject|1|||
25006836|NCT00042289|50098979|FG038|Overall Study|Withdrawal by Subject|0|||
25006837|NCT00042289|50098980|FG039|Overall Study|Withdrawal by Subject|0|||
25006838|NCT00042289|50098981|FG040|Overall Study|Withdrawal by Subject|0|||
25006839|NCT00042289|50098982|FG041|Overall Study|Withdrawal by Subject|0|||
25006840|NCT00042289|50098983|FG042|Overall Study|Withdrawal by Subject|1|||
25006841|NCT00042289|50098984|FG043|Overall Study|Withdrawal by Subject|0|||
25006842|NCT00042289|50098985|FG044|Overall Study|Withdrawal by Subject|0|||
25006843|NCT00042289|50098986|FG045|Overall Study|Withdrawal by Subject|0|||
25006844|NCT00042289|50098987|FG046|Overall Study|Withdrawal by Subject|0|||
25006845|NCT02886728|50099159|FG000|Overall Study|Withdrew Consent|31|||
25006846|NCT02886728|50099160|FG001|Overall Study|Withdrew Consent|13|||
25006847|NCT02886728|50099161|FG002|Overall Study|Withdrew Consent|11|||
25006848|NCT02886728|50099162|FG003|Overall Study|Withdrew Consent|47|||
25006849|NCT02886728|50099159|FG000|Overall Study|Lost to Follow-up|12|||
25006850|NCT02886728|50099160|FG001|Overall Study|Lost to Follow-up|6|||
25006851|NCT02886728|50099161|FG002|Overall Study|Lost to Follow-up|13|||
25006852|NCT02886728|50099162|FG003|Overall Study|Lost to Follow-up|12|||
25006853|NCT02886728|50099159|FG000|Overall Study|Adverse Event|13|||
25006854|NCT02886728|50099160|FG001|Overall Study|Adverse Event|5|||
25006855|NCT02886728|50099161|FG002|Overall Study|Adverse Event|5|||
25006856|NCT02886728|50099162|FG003|Overall Study|Adverse Event|11|||
25006857|NCT02886728|50099159|FG000|Overall Study|Investigator's Discretion|11|||
25006858|NCT02886728|50099160|FG001|Overall Study|Investigator's Discretion|7|||
25006859|NCT02886728|50099161|FG002|Overall Study|Investigator's Discretion|5|||
25006860|NCT02886728|50099162|FG003|Overall Study|Investigator's Discretion|11|||
25006861|NCT02886728|50099159|FG000|Overall Study|Death|3|||
25006862|NCT02886728|50099160|FG001|Overall Study|Death|1|||
25006863|NCT02886728|50099161|FG002|Overall Study|Death|0|||
25006864|NCT02886728|50099162|FG003|Overall Study|Death|0|||
25006865|NCT02886728|50099159|FG000|Overall Study|Protocol Violation|0|||
25091427|NCT01674569|50201046|FG005|Overall Study|Protocol Violation|0|||
25176816|NCT01513967|50320388|FG002|Overall Study|Pregnancy|0|||
25006866|NCT02886728|50099160|FG001|Overall Study|Protocol Violation|0|||
25091428|NCT01674569|50201041|FG000|Overall Study|Withdrawal by Subject|0|||
25176817|NCT01513967|50320389|FG003|Overall Study|Pregnancy|0|||
25006867|NCT02886728|50099161|FG002|Overall Study|Protocol Violation|0|||
25006868|NCT02886728|50099162|FG003|Overall Study|Protocol Violation|4|||
25006869|NCT02886728|50099159|FG000|Overall Study|Non-Compliance with Study Drug|1|||
25006870|NCT02886728|50099160|FG001|Overall Study|Non-Compliance with Study Drug|0|||
25006871|NCT02886728|50099161|FG002|Overall Study|Non-Compliance with Study Drug|1|||
25006872|NCT02886728|50099162|FG003|Overall Study|Non-Compliance with Study Drug|0|||
25006873|NCT02886728|50099159|FG000|Overall Study|Pregnancy|0|||
25006874|NCT02886728|50099160|FG001|Overall Study|Pregnancy|0|||
25006875|NCT02886728|50099161|FG002|Overall Study|Pregnancy|1|||
25006876|NCT02886728|50099162|FG003|Overall Study|Pregnancy|0|||
25006877|NCT02886728|50099159|FG000|Overall Study|Randomized but Not Dosed|1|||
25006878|NCT02886728|50099160|FG001|Overall Study|Randomized but Not Dosed|0|||
25006879|NCT02886728|50099161|FG002|Overall Study|Randomized but Not Dosed|0|||
25006880|NCT02886728|50099162|FG003|Overall Study|Randomized but Not Dosed|2|||
25006881|NCT00039871|50099172|FG000|Overall Study|Adverse Event|165|||
25006882|NCT00039871|50099172|FG000|Overall Study|Lost to Follow-up|18|||
25006883|NCT00039871|50099172|FG000|Overall Study|Protocol Violation|24|||
25006884|NCT00039871|50099172|FG000|Overall Study|Withdrawal by Subject|97|||
25006885|NCT00039871|50099172|FG000|Overall Study|Did not meet eligibility criteria|11|||
25006886|NCT00039871|50099172|FG000|Overall Study|Administrative|1|||
25006887|NCT00039871|50099172|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
25006888|NCT00039871|50099172|FG000|Overall Study|Never entered follow-up|7|||
25006889|NCT00015457|50099176|FG000|First Intervention|Adverse Event|0|||
25006890|NCT00015457|50099177|FG001|First Intervention|Adverse Event|2|||
25006891|NCT00015457|50099176|FG000|First Intervention|Lack of Efficacy|0|||
25006892|NCT00015457|50099177|FG001|First Intervention|Lack of Efficacy|1|||
25006893|NCT00015457|50099176|FG000|Second Intervention|Withdrawal by Subject|1|||
25006894|NCT00015457|50099177|FG001|Second Intervention|Withdrawal by Subject|0|||
25006895|NCT03191630|50099190|FG000|Overall Study|Lost to Follow-up|7|||
25006896|NCT03191630|50099191|FG001|Overall Study|Lost to Follow-up|7|||
25006897|NCT03191552|50099202|FG000|Overall Study|Lost to Follow-up|1|||
25006898|NCT03191552|50099203|FG001|Overall Study|Lost to Follow-up|0|||
25006899|NCT03191552|50099204|FG002|Overall Study|Lost to Follow-up|0|||
25006900|NCT03191552|50099202|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
25006901|NCT03191552|50099203|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
25006902|NCT03191552|50099204|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
25006903|NCT03191396|50099218|FG000|Overall Study|Lost to Follow-up|0|||
25006904|NCT03191396|50099219|FG001|Overall Study|Lost to Follow-up|3|||
25006905|NCT03191396|50099218|FG000|Overall Study|Withdrawal by Subject|3|||
25006906|NCT03191396|50099219|FG001|Overall Study|Withdrawal by Subject|2|||
25006907|NCT00007345|50099227|FG000|Overall Study|Refused further treatment|0|||
25006908|NCT00007345|50099228|FG001|Overall Study|Refused further treatment|7|||
25006909|NCT00007345|50099227|FG000|Overall Study|Switched to alternative treatment|0|||
25006910|NCT00007345|50099228|FG001|Overall Study|Switched to alternative treatment|3|||
25006911|NCT00007345|50099227|FG000|Overall Study|Intercurrent illness|1|||
25006912|NCT00007345|50099228|FG001|Overall Study|Intercurrent illness|0|||
25006913|NCT00007345|50099227|FG000|Overall Study|Death on study|1|||
25006914|NCT00007345|50099228|FG001|Overall Study|Death on study|1|||
25006915|NCT03405662|50099236|FG000|Overall Study|COVID-19 restriction|1|||
25006916|NCT03405662|50099237|FG001|Overall Study|COVID-19 restriction|0|||
25006917|NCT03405662|50099236|FG000|Overall Study|unblinding|0|||
25006918|NCT03405662|50099237|FG001|Overall Study|unblinding|1|||
25006919|NCT03405662|50099236|FG000|Overall Study|placement in memory care facility|0|||
25006920|NCT03405662|50099237|FG001|Overall Study|placement in memory care facility|2|||
25006921|NCT00031447|50099245|FG000|Overall Study|Lost to Follow-up|0|||
25006922|NCT00031447|50099246|FG001|Overall Study|Lost to Follow-up|1|||
25006923|NCT00031447|50099245|FG000|Overall Study|Non-compliant|1|||
25006924|NCT00031447|50099246|FG001|Overall Study|Non-compliant|1|||
25006925|NCT00031447|50099245|FG000|Overall Study|Re-activation of Disease|2|||
25006926|NCT00031447|50099246|FG001|Overall Study|Re-activation of Disease|1|||
25006927|NCT00031447|50099245|FG000|Overall Study|Disruption of blinded study drug supply|7|||
25006928|NCT00031447|50099246|FG001|Overall Study|Disruption of blinded study drug supply|4|||
25006929|NCT00006721|50099255|FG000|Overall Study|Adverse Event|0|||
25006930|NCT00006721|50099256|FG001|Overall Study|Adverse Event|4|||
25006931|NCT00006721|50099257|FG002|Overall Study|Adverse Event|4|||
25006932|NCT00006721|50099255|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
25006933|NCT00006721|50099256|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
25006934|NCT00006721|50099257|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
25006935|NCT00006721|50099255|FG000|Overall Study|Progression/Relapse|0|||
25006936|NCT00006721|50099256|FG001|Overall Study|Progression/Relapse|1|||
25091429|NCT01674569|50201042|FG001|Overall Study|Withdrawal by Subject|0|||
25176818|NCT01513967|50320390|FG004|Overall Study|Pregnancy|0|||
25006937|NCT00006721|50099257|FG002|Overall Study|Progression/Relapse|2|||
25006938|NCT00006721|50099255|FG000|Overall Study|Death|0|||
25006939|NCT00006721|50099256|FG001|Overall Study|Death|1|||
25006940|NCT00006721|50099257|FG002|Overall Study|Death|2|||
25006941|NCT00006721|50099255|FG000|Overall Study|Other - Not Protocol Specified|0|||
25006942|NCT00006721|50099256|FG001|Overall Study|Other - Not Protocol Specified|7|||
25006943|NCT00006721|50099257|FG002|Overall Study|Other - Not Protocol Specified|7|||
25006944|NCT00006721|50099255|FG000|Overall Study|Ineligible|2|||
25006945|NCT00006721|50099256|FG001|Overall Study|Ineligible|12|||
25006946|NCT00006721|50099257|FG002|Overall Study|Ineligible|10|||
25006947|NCT00006721|50099255|FG000|Overall Study|Eligible but no Treatment Received|1|||
25006948|NCT00006721|50099256|FG001|Overall Study|Eligible but no Treatment Received|0|||
25006949|NCT00006721|50099257|FG002|Overall Study|Eligible but no Treatment Received|0|||
25006950|NCT00006409|50099273|FG000|Baseline|Protocol Violation|48|||
25006951|NCT00006409|50099274|FG001|Baseline|Protocol Violation|70|||
25006952|NCT00006409|50099275|FG002|Baseline|Protocol Violation|0|||
25006953|NCT00006409|50099276|FG003|Baseline|Protocol Violation|0|||
25006954|NCT00006409|50099277|FG004|Baseline|Protocol Violation|0|||
25006955|NCT00006409|50099278|FG005|Baseline|Protocol Violation|0|||
25006956|NCT00006409|50099273|FG000|Post-2 Year Intervention|Protocol Violation|0|||
25006957|NCT00006409|50099274|FG001|Post-2 Year Intervention|Protocol Violation|0|||
25006958|NCT00006409|50099275|FG002|Post-2 Year Intervention|Protocol Violation|251|||
25006959|NCT00006409|50099276|FG003|Post-2 Year Intervention|Protocol Violation|168|||
25006960|NCT00006409|50099277|FG004|Post-2 Year Intervention|Protocol Violation|0|||
25006961|NCT00006409|50099278|FG005|Post-2 Year Intervention|Protocol Violation|0|||
25006962|NCT00006409|50099273|FG000|Post-3 Year Intervention|Protocol Violation|0|||
25006963|NCT00006409|50099274|FG001|Post-3 Year Intervention|Protocol Violation|0|||
25006964|NCT00006409|50099275|FG002|Post-3 Year Intervention|Protocol Violation|0|||
25006965|NCT00006409|50099276|FG003|Post-3 Year Intervention|Protocol Violation|0|||
25006966|NCT00006409|50099277|FG004|Post-3 Year Intervention|Protocol Violation|62|||
25006967|NCT00006409|50099278|FG005|Post-3 Year Intervention|Protocol Violation|62|||
25006968|NCT00006289|50099294|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
25006969|NCT00006289|50099295|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
25006970|NCT00006289|50099294|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
25006971|NCT00006289|50099295|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
25006972|NCT00005947|50099313|FG000|Overall Study|Death|54|||
25006973|NCT00005947|50099314|FG001|Overall Study|Death|40|||
25006974|NCT00005947|50099313|FG000|Overall Study|Patient Refused to Continue|2|||
25006975|NCT00005947|50099314|FG001|Overall Study|Patient Refused to Continue|1|||
25006976|NCT00005947|50099313|FG000|Overall Study|Site Closure|1|||
25006977|NCT00005947|50099314|FG001|Overall Study|Site Closure|0|||
25006978|NCT00005047|50099326|FG000|Overall Study|Withdrawal by Subject|12|||
25006979|NCT00005047|50099327|FG001|Overall Study|Withdrawal by Subject|0|||
25006980|NCT00005047|50099328|FG002|Overall Study|Withdrawal by Subject|0|||
25006981|NCT00005047|50099329|FG003|Overall Study|Withdrawal by Subject|0|||
25006982|NCT00005047|50099326|FG000|Overall Study|Adverse Event|5|||
25006983|NCT00005047|50099327|FG001|Overall Study|Adverse Event|0|||
25006984|NCT00005047|50099328|FG002|Overall Study|Adverse Event|0|||
25006985|NCT00005047|50099329|FG003|Overall Study|Adverse Event|0|||
25006986|NCT00005047|50099326|FG000|Overall Study|Lost to Follow-up|1|||
25006987|NCT00005047|50099327|FG001|Overall Study|Lost to Follow-up|0|||
25006988|NCT00005047|50099328|FG002|Overall Study|Lost to Follow-up|0|||
25006989|NCT00005047|50099329|FG003|Overall Study|Lost to Follow-up|0|||
25006990|NCT00005047|50099326|FG000|Overall Study|Lack of Efficacy|1|||
25006991|NCT00005047|50099327|FG001|Overall Study|Lack of Efficacy|0|||
25006992|NCT00005047|50099328|FG002|Overall Study|Lack of Efficacy|0|||
25006993|NCT00005047|50099329|FG003|Overall Study|Lack of Efficacy|0|||
25006994|NCT00003907|50099341|FG000|Overall Study|Adverse Event|2|||
25006995|NCT00003907|50099342|FG001|Overall Study|Adverse Event|11|||
25006996|NCT00003907|50099341|FG000|Overall Study|Death|2|||
25006997|NCT00003907|50099342|FG001|Overall Study|Death|0|||
25006998|NCT00003907|50099341|FG000|Overall Study|Withdrawal by Subject|1|||
25006999|NCT00003907|50099342|FG001|Overall Study|Withdrawal by Subject|3|||
25007000|NCT00003907|50099341|FG000|Overall Study|Progressive disease|4|||
25007001|NCT00003907|50099342|FG001|Overall Study|Progressive disease|4|||
25007002|NCT00003907|50099341|FG000|Overall Study|Complicating disease|1|||
25007003|NCT00003907|50099342|FG001|Overall Study|Complicating disease|0|||
25007004|NCT00003907|50099341|FG000|Overall Study|Other|1|||
25007005|NCT00003907|50099342|FG001|Overall Study|Other|3|||
25007006|NCT00003907|50099341|FG000|Overall Study|ineligible or not treated|2|||
25007007|NCT00003907|50099342|FG001|Overall Study|ineligible or not treated|2|||
25007008|NCT00003901|50099348|FG000|Overall Study|Adverse Event|1|||
25007009|NCT00003901|50099348|FG000|Overall Study|Withdrawal by Subject|1|||
25007010|NCT00003901|50099348|FG000|Overall Study|Ineligible|6|||
25007011|NCT00003901|50099348|FG000|Overall Study|CT Scan not within protocol requirement|2|||
25007012|NCT00003901|50099348|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
25007013|NCT00003901|50099348|FG000|Overall Study|Medical problems|6|||
25007014|NCT00003895|50099357|FG000|Overall Study|Adverse Event|4|||
25007015|NCT00003895|50099358|FG001|Overall Study|Adverse Event|0|||
25091430|NCT01674569|50201043|FG002|Overall Study|Withdrawal by Subject|1|||
25007016|NCT00003895|50099357|FG000|Overall Study|Lack of Efficacy|1|||
25007017|NCT00003895|50099358|FG001|Overall Study|Lack of Efficacy|1|||
25007018|NCT00003895|50099357|FG000|Overall Study|Patient Vacation|2|||
25007019|NCT00003895|50099358|FG001|Overall Study|Patient Vacation|0|||
25007020|NCT00003895|50099357|FG000|Overall Study|Withdrawal by Subject|0|||
25007021|NCT00003895|50099358|FG001|Overall Study|Withdrawal by Subject|3|||
25007022|NCT03800173|50099369|FG000|Overall Study|Lost to Follow-up|0|||
25007023|NCT03800173|50099370|FG001|Overall Study|Lost to Follow-up|0|||
25007024|NCT03800173|50099371|FG002|Overall Study|Lost to Follow-up|0|||
25007025|NCT03800173|50099372|FG003|Overall Study|Lost to Follow-up|0|||
25007026|NCT03800173|50099373|FG004|Overall Study|Lost to Follow-up|1|||
25007027|NCT00003631|50099392|FG000|Overall Study|Patient not treated|1|||
25007028|NCT00003631|50099393|FG001|Overall Study|Patient not treated|0|||
25007029|NCT00003631|50099394|FG002|Overall Study|Patient not treated|1|||
25007030|NCT00003631|50099392|FG000|Overall Study|Protocol Violation|1|||
25007031|NCT00003631|50099393|FG001|Overall Study|Protocol Violation|0|||
25007032|NCT00003631|50099394|FG002|Overall Study|Protocol Violation|0|||
25007033|NCT00003631|50099392|FG000|Overall Study|Adverse Event|1|||
25007034|NCT00003631|50099393|FG001|Overall Study|Adverse Event|1|||
25007035|NCT00003631|50099394|FG002|Overall Study|Adverse Event|5|||
25007036|NCT00003631|50099392|FG000|Overall Study|Death|0|||
25007037|NCT00003631|50099393|FG001|Overall Study|Death|0|||
25007038|NCT00003631|50099394|FG002|Overall Study|Death|1|||
25007039|NCT00003631|50099392|FG000|Overall Study|Evaluable for toxicity only|0|||
25007040|NCT00003631|50099393|FG001|Overall Study|Evaluable for toxicity only|0|||
25007041|NCT00003631|50099394|FG002|Overall Study|Evaluable for toxicity only|2|||
25007042|NCT00003535|50099402|FG000|Overall Study|Not evaluable|5|||
25007043|NCT00003511|50099406|FG000|Overall Study|Not evaluable|4|||
25007044|NCT00003499|50099410|FG000|Overall Study|Not evaluable|8|||
25007045|NCT00003487|50099414|FG000|Overall Study|Not evaluable|2|||
25007046|NCT00003475|50099418|FG000|Overall Study|Not evaluable|13|||
25007047|NCT00003457|50099423|FG000|Overall Study|Not evaluable|9|||
25007048|NCT00030901|50099429|FG000|Initial Registration|Ineligible|167|||
25007049|NCT00030901|50099430|FG001|Initial Registration|Ineligible|0|||
25007050|NCT00030901|50099431|FG002|Initial Registration|Ineligible|0|||
25007051|NCT00030901|50099429|FG000|Randomization|Adverse Event|0|||
25007052|NCT00030901|50099430|FG001|Randomization|Adverse Event|11|||
25007053|NCT00030901|50099431|FG002|Randomization|Adverse Event|7|||
25007054|NCT00030901|50099429|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
25007055|NCT00030901|50099430|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
25007056|NCT00030901|50099431|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
25007057|NCT00030901|50099429|FG000|Randomization|Progression/Relapse|0|||
25007058|NCT00030901|50099430|FG001|Randomization|Progression/Relapse|22|||
25007059|NCT00030901|50099431|FG002|Randomization|Progression/Relapse|21|||
25007060|NCT00030901|50099429|FG000|Randomization|Death|0|||
25007061|NCT00030901|50099430|FG001|Randomization|Death|1|||
25007062|NCT00030901|50099431|FG002|Randomization|Death|3|||
25007063|NCT00030901|50099429|FG000|Randomization|Other|0|||
25007064|NCT00030901|50099430|FG001|Randomization|Other|36|||
25007065|NCT00030901|50099431|FG002|Randomization|Other|33|||
25007066|NCT00030901|50099429|FG000|Randomization|Ineligible|0|||
25007067|NCT00030901|50099430|FG001|Randomization|Ineligible|15|||
25007068|NCT00030901|50099431|FG002|Randomization|Ineligible|14|||
25007069|NCT00003199|50099437|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
25007070|NCT00003199|50099437|FG000|Overall Study|Lack of insurance clearance|2|||
25007071|NCT00003199|50099437|FG000|Overall Study|Screen fail|15|||
25007072|NCT00030823|50099441|FG000|Overall Study|Withdrawal by Subject|1|||
25007073|NCT00001849|50099445|FG000|Overall Study|Death|4|||
25007074|NCT00001849|50099445|FG000|Overall Study|Lost to Follow-up|2|||
25007075|NCT00001849|50099445|FG000|Overall Study|Withdrawal by Subject|2|||
25007076|NCT00001849|50099445|FG000|Overall Study|tumor remained occult|6|||
25007077|NCT01342952|50099462|FG000|Overall Study|Adverse Event|0|||
25007078|NCT01342952|50099463|FG001|Overall Study|Adverse Event|5|||
25007079|NCT01342952|50099464|FG002|Overall Study|Adverse Event|1|||
25007080|NCT01342952|50099465|FG003|Overall Study|Adverse Event|0|||
25007081|NCT01342952|50099462|FG000|Overall Study|Lost to Follow-up|0|||
25007082|NCT01342952|50099463|FG001|Overall Study|Lost to Follow-up|2|||
25007083|NCT01342952|50099464|FG002|Overall Study|Lost to Follow-up|0|||
25007084|NCT01342952|50099465|FG003|Overall Study|Lost to Follow-up|0|||
25007085|NCT01342952|50099462|FG000|Overall Study|Withdrawal by Subject|1|||
25007086|NCT01342952|50099463|FG001|Overall Study|Withdrawal by Subject|1|||
25007087|NCT01342952|50099464|FG002|Overall Study|Withdrawal by Subject|0|||
25007088|NCT01342952|50099465|FG003|Overall Study|Withdrawal by Subject|0|||
25007089|NCT01342952|50099462|FG000|Overall Study|Physician Decision|3|||
25007090|NCT01342952|50099463|FG001|Overall Study|Physician Decision|3|||
25007091|NCT01342952|50099464|FG002|Overall Study|Physician Decision|1|||
25007092|NCT01342952|50099465|FG003|Overall Study|Physician Decision|0|||
25007093|NCT02886884|50099492|FG000|Follow-up|Withdrawal by Subject|0|||
25007094|NCT02886884|50099493|FG001|Follow-up|Withdrawal by Subject|0|||
25007095|NCT02886884|50099494|FG002|Follow-up|Withdrawal by Subject|0|||
25007096|NCT02886884|50099495|FG003|Follow-up|Withdrawal by Subject|1|||
25007097|NCT01240694|50099514|FG000|Overall Study|Adverse Event|9|||
25007098|NCT01240694|50099514|FG000|Overall Study|Lack of Efficacy|6|||
25007099|NCT01240694|50099514|FG000|Overall Study|Withdrawal by Subject|6|||
25007100|NCT01240694|50099514|FG000|Overall Study|Protocol Violation|2|||
25007101|NCT01240694|50099514|FG000|Overall Study|Lost to Follow-up|2|||
25007102|NCT01240694|50099514|FG000|Overall Study|Other than specified|3|||
25176819|NCT01513967|50320391|FG005|Overall Study|Pregnancy|0|||
25007103|NCT01240694|50099514|FG000|Overall Study|Withdrawn due to early study termination|107|||
25007104|NCT01112306|50099518|FG000|Overall Study|Death|175|||
25007105|NCT01112306|50099518|FG000|Overall Study|Lost to Follow-up|9|||
25007106|NCT01112306|50099518|FG000|Overall Study|Withdrawal by Subject|31|||
25007107|NCT01112306|50099518|FG000|Overall Study|Other|70|||
25007108|NCT03162224|50099525|FG000|Overall Study|Death|4|||
25007109|NCT03162224|50099526|FG001|Overall Study|Death|5|||
25007110|NCT03162224|50099527|FG002|Overall Study|Death|8|||
25007111|NCT03162224|50099525|FG000|Overall Study|Withdrawal by Subject|1|||
25007112|NCT03162224|50099526|FG001|Overall Study|Withdrawal by Subject|0|||
25007113|NCT03162224|50099527|FG002|Overall Study|Withdrawal by Subject|1|||
25007114|NCT03162224|50099525|FG000|Overall Study|Lost to Follow-up|0|||
25007115|NCT03162224|50099526|FG001|Overall Study|Lost to Follow-up|1|||
25007116|NCT03162224|50099527|FG002|Overall Study|Lost to Follow-up|0|||
25007117|NCT03162224|50099525|FG000|Overall Study|Other|6|||
25007118|NCT03162224|50099526|FG001|Overall Study|Other|2|||
25007119|NCT03162224|50099527|FG002|Overall Study|Other|1|||
25007120|NCT02886338|50099566|FG000|Overall Study|Withdrawal by Subject|1|||
25007121|NCT00004124|50099572|FG000|Overall Study|Received no protocol therapy|12|||
25007122|NCT00004124|50099573|FG001|Overall Study|Received no protocol therapy|20|||
25007123|NCT00383552|50099583|FG000|Overall Study|Adverse Event|7|||
25007124|NCT00383552|50099584|FG001|Overall Study|Adverse Event|6|||
25007125|NCT00383552|50099585|FG002|Overall Study|Adverse Event|9|||
25007126|NCT00383552|50099586|FG003|Overall Study|Adverse Event|6|||
25007127|NCT00383552|50099583|FG000|Overall Study|Lack of Efficacy|4|||
25007128|NCT00383552|50099584|FG001|Overall Study|Lack of Efficacy|13|||
25007129|NCT00383552|50099585|FG002|Overall Study|Lack of Efficacy|29|||
25007130|NCT00383552|50099586|FG003|Overall Study|Lack of Efficacy|42|||
25007131|NCT00383552|50099583|FG000|Overall Study|Lost to Follow-up|0|||
25007132|NCT00383552|50099584|FG001|Overall Study|Lost to Follow-up|1|||
25007133|NCT00383552|50099585|FG002|Overall Study|Lost to Follow-up|5|||
25007134|NCT00383552|50099586|FG003|Overall Study|Lost to Follow-up|1|||
25007135|NCT00383552|50099583|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
25007136|NCT00383552|50099584|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
25007137|NCT00383552|50099585|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
25007138|NCT00383552|50099586|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
25007139|NCT00383552|50099583|FG000|Overall Study|Did not wish to continue (related)|1|||
25007140|NCT00383552|50099584|FG001|Overall Study|Did not wish to continue (related)|0|||
25007141|NCT00383552|50099585|FG002|Overall Study|Did not wish to continue (related)|2|||
25007142|NCT00383552|50099586|FG003|Overall Study|Did not wish to continue (related)|3|||
25007143|NCT00383552|50099583|FG000|Overall Study|Noncompliance with the protocol|11|||
25007144|NCT00383552|50099584|FG001|Overall Study|Noncompliance with the protocol|6|||
25007145|NCT00383552|50099585|FG002|Overall Study|Noncompliance with the protocol|8|||
25007146|NCT00383552|50099586|FG003|Overall Study|Noncompliance with the protocol|10|||
25007147|NCT00383552|50099583|FG000|Overall Study|Did not meet protocol eligibility|8|||
25007148|NCT00383552|50099584|FG001|Overall Study|Did not meet protocol eligibility|6|||
25007149|NCT00383552|50099585|FG002|Overall Study|Did not meet protocol eligibility|2|||
25007150|NCT00383552|50099586|FG003|Overall Study|Did not meet protocol eligibility|3|||
25007151|NCT00383552|50099583|FG000|Overall Study|Administrative|1|||
25007152|NCT00383552|50099584|FG001|Overall Study|Administrative|0|||
25007153|NCT00383552|50099585|FG002|Overall Study|Administrative|1|||
25007154|NCT00383552|50099586|FG003|Overall Study|Administrative|1|||
25007155|NCT03158012|50099603|FG000|Overall Study|Withdrawal by Subject|0|||
25007156|NCT03158012|50099604|FG001|Overall Study|Withdrawal by Subject|1|||
25007157|NCT01776424|50099613|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
25007158|NCT01776424|50099614|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
25007159|NCT01776424|50099615|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
25007160|NCT01776424|50099613|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
25007161|NCT01776424|50099614|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
25007162|NCT01776424|50099615|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
25007163|NCT01776424|50099613|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
25007164|NCT01776424|50099614|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
25007165|NCT01776424|50099615|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
25007166|NCT01776424|50099613|FG000|LTOLE Part (Open Label)|Refused|5|||
25007167|NCT01776424|50099614|FG001|LTOLE Part (Open Label)|Refused|2|||
25007168|NCT01776424|50099615|FG002|LTOLE Part (Open Label)|Refused|11|||
25007169|NCT01776424|50099613|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
25007170|NCT01776424|50099614|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
25007171|NCT01776424|50099615|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
25007172|NCT03799627|50099641|FG000|Overall Study|Adverse Event|1|||
25007173|NCT03799627|50099642|FG001|Overall Study|Adverse Event|2|||
25007174|NCT03799627|50099643|FG002|Overall Study|Adverse Event|0|||
25007175|NCT03799627|50099644|FG003|Overall Study|Adverse Event|0|||
25007176|NCT03799627|50099645|FG004|Overall Study|Adverse Event|2|||
25007177|NCT03799627|50099646|FG005|Overall Study|Adverse Event|5|||
25007178|NCT03799627|50099647|FG006|Overall Study|Adverse Event|0|||
25007179|NCT03799627|50099648|FG007|Overall Study|Adverse Event|2|||
25007180|NCT03799627|50099649|FG008|Overall Study|Adverse Event|0|||
25007181|NCT03799627|50099641|FG000|Overall Study|Physician Decision|2|||
25007182|NCT03799627|50099642|FG001|Overall Study|Physician Decision|2|||
25007183|NCT03799627|50099643|FG002|Overall Study|Physician Decision|0|||
25007184|NCT03799627|50099644|FG003|Overall Study|Physician Decision|0|||
25007185|NCT03799627|50099645|FG004|Overall Study|Physician Decision|2|||
25007186|NCT03799627|50099646|FG005|Overall Study|Physician Decision|2|||
25007187|NCT03799627|50099647|FG006|Overall Study|Physician Decision|0|||
25007188|NCT03799627|50099648|FG007|Overall Study|Physician Decision|0|||
25007189|NCT03799627|50099649|FG008|Overall Study|Physician Decision|0|||
25007190|NCT03799627|50099641|FG000|Overall Study|Withdrawal by Subject|1|||
25007191|NCT03799627|50099642|FG001|Overall Study|Withdrawal by Subject|1|||
25007192|NCT03799627|50099643|FG002|Overall Study|Withdrawal by Subject|0|||
25007193|NCT03799627|50099644|FG003|Overall Study|Withdrawal by Subject|2|||
25007194|NCT03799627|50099645|FG004|Overall Study|Withdrawal by Subject|0|||
25007195|NCT03799627|50099646|FG005|Overall Study|Withdrawal by Subject|3|||
25007196|NCT03799627|50099647|FG006|Overall Study|Withdrawal by Subject|0|||
25007197|NCT03799627|50099648|FG007|Overall Study|Withdrawal by Subject|0|||
25007198|NCT03799627|50099649|FG008|Overall Study|Withdrawal by Subject|0|||
25007199|NCT03799627|50099641|FG000|Overall Study|Lack of Efficacy|0|||
25007200|NCT03799627|50099642|FG001|Overall Study|Lack of Efficacy|0|||
25007201|NCT03799627|50099643|FG002|Overall Study|Lack of Efficacy|0|||
25007202|NCT03799627|50099644|FG003|Overall Study|Lack of Efficacy|1|||
25007203|NCT03799627|50099645|FG004|Overall Study|Lack of Efficacy|0|||
25007204|NCT03799627|50099646|FG005|Overall Study|Lack of Efficacy|0|||
25007205|NCT03799627|50099647|FG006|Overall Study|Lack of Efficacy|0|||
25007206|NCT03799627|50099648|FG007|Overall Study|Lack of Efficacy|0|||
25007207|NCT03799627|50099649|FG008|Overall Study|Lack of Efficacy|0|||
25007208|NCT03799627|50099641|FG000|Overall Study|Lost to Follow-up|0|||
25007209|NCT03799627|50099642|FG001|Overall Study|Lost to Follow-up|0|||
25007210|NCT03799627|50099643|FG002|Overall Study|Lost to Follow-up|0|||
25007211|NCT03799627|50099644|FG003|Overall Study|Lost to Follow-up|0|||
25007212|NCT03799627|50099645|FG004|Overall Study|Lost to Follow-up|0|||
25007213|NCT03799627|50099646|FG005|Overall Study|Lost to Follow-up|0|||
25007214|NCT03799627|50099647|FG006|Overall Study|Lost to Follow-up|1|||
25007215|NCT03799627|50099648|FG007|Overall Study|Lost to Follow-up|0|||
25007216|NCT03799627|50099649|FG008|Overall Study|Lost to Follow-up|1|||
25007217|NCT03799627|50099641|FG000|Overall Study|Death|0|||
25007218|NCT03799627|50099642|FG001|Overall Study|Death|0|||
25007219|NCT03799627|50099643|FG002|Overall Study|Death|0|||
25007220|NCT03799627|50099644|FG003|Overall Study|Death|1|||
25007221|NCT03799627|50099645|FG004|Overall Study|Death|0|||
25007222|NCT03799627|50099646|FG005|Overall Study|Death|0|||
25007223|NCT03799627|50099647|FG006|Overall Study|Death|0|||
25007224|NCT03799627|50099648|FG007|Overall Study|Death|0|||
25007225|NCT03799627|50099649|FG008|Overall Study|Death|0|||
25007226|NCT03799627|50099641|FG000|Overall Study|Study Drug Put on Hold|1|||
25007227|NCT03799627|50099642|FG001|Overall Study|Study Drug Put on Hold|0|||
25007228|NCT03799627|50099643|FG002|Overall Study|Study Drug Put on Hold|0|||
25007229|NCT03799627|50099644|FG003|Overall Study|Study Drug Put on Hold|0|||
25007230|NCT03799627|50099645|FG004|Overall Study|Study Drug Put on Hold|0|||
25007231|NCT03799627|50099646|FG005|Overall Study|Study Drug Put on Hold|0|||
25007232|NCT03799627|50099647|FG006|Overall Study|Study Drug Put on Hold|0|||
25007233|NCT03799627|50099648|FG007|Overall Study|Study Drug Put on Hold|0|||
25007234|NCT03799627|50099649|FG008|Overall Study|Study Drug Put on Hold|0|||
25007235|NCT03799627|50099641|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
25007236|NCT03799627|50099642|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
25007237|NCT03799627|50099643|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
25007238|NCT03799627|50099644|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
25007239|NCT03799627|50099645|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
25007240|NCT03799627|50099646|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
25007241|NCT03799627|50099647|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
25007242|NCT03799627|50099648|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
25007243|NCT03799627|50099649|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
25007244|NCT03799627|50099641|FG000|Overall Study|Kidney Transplantation|1|||
25007245|NCT03799627|50099642|FG001|Overall Study|Kidney Transplantation|0|||
25007246|NCT03799627|50099643|FG002|Overall Study|Kidney Transplantation|0|||
25007247|NCT03799627|50099644|FG003|Overall Study|Kidney Transplantation|1|||
25007248|NCT03799627|50099645|FG004|Overall Study|Kidney Transplantation|1|||
25007249|NCT03799627|50099646|FG005|Overall Study|Kidney Transplantation|0|||
25007250|NCT03799627|50099647|FG006|Overall Study|Kidney Transplantation|0|||
25007251|NCT03799627|50099648|FG007|Overall Study|Kidney Transplantation|0|||
25007252|NCT03799627|50099649|FG008|Overall Study|Kidney Transplantation|0|||
25007253|NCT03799627|50099641|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
25007254|NCT03799627|50099642|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
25007255|NCT03799627|50099643|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
25007256|NCT03799627|50099644|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
25007257|NCT03799627|50099645|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
25007258|NCT03799627|50099646|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
25007259|NCT03799627|50099647|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
25007260|NCT03799627|50099648|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
25007261|NCT03799627|50099649|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
25007262|NCT03799627|50099641|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
25007263|NCT03799627|50099642|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
25007264|NCT03799627|50099643|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
25007265|NCT03799627|50099644|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
25007266|NCT03799627|50099645|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
25007267|NCT03799627|50099646|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
25007268|NCT03799627|50099647|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
25007269|NCT03799627|50099648|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
25007270|NCT03799627|50099649|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
25007271|NCT03799627|50099641|FG000|Overall Study|Met Exclusion Criteria|0|||
25007272|NCT03799627|50099642|FG001|Overall Study|Met Exclusion Criteria|0|||
25007273|NCT03799627|50099643|FG002|Overall Study|Met Exclusion Criteria|0|||
25007274|NCT03799627|50099644|FG003|Overall Study|Met Exclusion Criteria|1|||
25007275|NCT03799627|50099645|FG004|Overall Study|Met Exclusion Criteria|0|||
25007276|NCT03799627|50099646|FG005|Overall Study|Met Exclusion Criteria|0|||
25007277|NCT03799627|50099647|FG006|Overall Study|Met Exclusion Criteria|0|||
25007278|NCT03799627|50099648|FG007|Overall Study|Met Exclusion Criteria|0|||
25091431|NCT01674569|50201044|FG003|Overall Study|Withdrawal by Subject|0|||
25091432|NCT01674569|50201045|FG004|Overall Study|Withdrawal by Subject|0|||
25091433|NCT01674569|50201046|FG005|Overall Study|Withdrawal by Subject|0|||
25091434|NCT01374217|50201050|FG000|Overall Study|Lack of Efficacy|13|||
25091435|NCT01674647|50201056|FG000|Treatment Period|Death|4|||
25091436|NCT01674647|50201057|FG001|Treatment Period|Death|1|||
25091437|NCT01674647|50201056|FG000|Treatment Period|Efficacy outcome reached|0|||
25091438|NCT01674647|50201057|FG001|Treatment Period|Efficacy outcome reached|1|||
25091439|NCT01674647|50201056|FG000|Treatment Period|Physician Decision|3|||
25091440|NCT01674647|50201057|FG001|Treatment Period|Physician Decision|1|||
25091441|NCT01674647|50201056|FG000|Treatment Period|Adverse Event|60|||
25091442|NCT01674647|50201057|FG001|Treatment Period|Adverse Event|22|||
25091443|NCT01674647|50201056|FG000|Treatment Period|Non-compliance with study drug|3|||
25091444|NCT01674647|50201057|FG001|Treatment Period|Non-compliance with study drug|0|||
25091445|NCT01674647|50201056|FG000|Treatment Period|Lost to Follow-up|1|||
25091446|NCT01674647|50201057|FG001|Treatment Period|Lost to Follow-up|1|||
25091447|NCT01674647|50201056|FG000|Treatment Period|Withdrawal by Subject|19|||
25091448|NCT01674647|50201057|FG001|Treatment Period|Withdrawal by Subject|16|||
25091449|NCT01674647|50201056|FG000|Treatment Period|Switching to other therapy|5|||
25091450|NCT01674647|50201057|FG001|Treatment Period|Switching to other therapy|2|||
25091451|NCT01674647|50201056|FG000|Treatment Period|Logistical difficulties|5|||
25091452|NCT01674647|50201057|FG001|Treatment Period|Logistical difficulties|8|||
25091453|NCT01674647|50201056|FG000|Treatment Period|Treatment failure|0|||
25091454|NCT01674647|50201057|FG001|Treatment Period|Treatment failure|14|||
25091455|NCT01674647|50201056|FG000|Treatment Period|Protocol Violation|56|||
25091456|NCT01674647|50201057|FG001|Treatment Period|Protocol Violation|36|||
25091457|NCT01674647|50201056|FG000|30-day Safety Follow-up Period|Death|3|||
25091458|NCT01674647|50201057|FG001|30-day Safety Follow-up Period|Death|2|||
25091459|NCT01674647|50201056|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
25091460|NCT01674647|50201057|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
25091461|NCT01674647|50201056|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
25091462|NCT01674647|50201057|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
25091463|NCT01674647|50201056|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
25091464|NCT01674647|50201057|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
25091465|NCT01674647|50201056|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
25091466|NCT01674647|50201057|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
25091467|NCT01674647|50201056|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
25091468|NCT01674647|50201057|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
25091469|NCT02669407|50201063|FG000|Overall Study|Physician Decision|3|||
25091470|NCT02667457|50201069|FG000|Overall Study|Withdrawal by Subject|1|||
25091471|NCT02667457|50201070|FG001|Overall Study|Withdrawal by Subject|0|||
25091472|NCT02667457|50201069|FG000|Overall Study|Other Reason|0|||
25091473|NCT02667457|50201070|FG001|Overall Study|Other Reason|2|||
25091474|NCT02669095|50201079|FG000|Overall Study|Adverse Event|1|||
25091475|NCT02669095|50201080|FG001|Overall Study|Adverse Event|0|||
25091476|NCT02669095|50201079|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
25091477|NCT02669095|50201080|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
25091478|NCT02669095|50201079|FG000|Overall Study|Torn Lens|0|||
25091479|NCT02669095|50201080|FG001|Overall Study|Torn Lens|1|||
25091480|NCT02669095|50201079|FG000|Overall Study|Visit 5 assessments not completed|0|||
25091481|NCT02669095|50201080|FG001|Overall Study|Visit 5 assessments not completed|1|||
25091482|NCT02667301|50201086|FG000|Overall Study|Adverse Event|1|||
25091483|NCT02667301|50201086|FG000|Overall Study|Lack of Efficacy|1|||
25091484|NCT05274165|50201094|FG000|Overall Study|Withdrawal by Subject|3|||
25091485|NCT05274165|50201095|FG001|Overall Study|Withdrawal by Subject|3|||
25091486|NCT04510090|50201137|FG000|FE-HS|Withdrawal by Subject|0|||
25091487|NCT04510090|50201138|FG001|FE-HS|Withdrawal by Subject|0|||
25091488|NCT04510090|50201139|FG002|FE-HS|Withdrawal by Subject|0|||
25091489|NCT04510090|50201140|FG003|FE-HS|Withdrawal by Subject|0|||
25091490|NCT04510090|50201141|FG004|FE-HS|Withdrawal by Subject|1|||
25091491|NCT04510090|50201142|FG005|FE-HS|Withdrawal by Subject|0|||
25091492|NCT04510090|50201143|FG006|FE-HS|Withdrawal by Subject|0|||
25091493|NCT04510090|50201144|FG007|FE-HS|Withdrawal by Subject|0|||
25091494|NCT04491006|50201174|FG000|Overall Study|Adverse Event|0|||
25091495|NCT04491006|50201175|FG001|Overall Study|Adverse Event|3|||
25091496|NCT04491006|50201176|FG002|Overall Study|Adverse Event|5|||
25091497|NCT04491006|50201174|FG000|Overall Study|Withdrawal by Subject|1|||
25091498|NCT04491006|50201175|FG001|Overall Study|Withdrawal by Subject|0|||
25091499|NCT04491006|50201176|FG002|Overall Study|Withdrawal by Subject|2|||
25091500|NCT04184622|50201223|FG000|Overall Study|Adverse Event|7|||
25091501|NCT04184622|50201224|FG001|Overall Study|Adverse Event|7|||
25091502|NCT04184622|50201225|FG002|Overall Study|Adverse Event|11|||
25091503|NCT04184622|50201226|FG003|Overall Study|Adverse Event|8|||
25091504|NCT04184622|50201223|FG000|Overall Study|Death|4|||
25091505|NCT04184622|50201224|FG001|Overall Study|Death|4|||
25091506|NCT04184622|50201225|FG002|Overall Study|Death|2|||
25091507|NCT04184622|50201226|FG003|Overall Study|Death|1|||
25091508|NCT04184622|50201223|FG000|Overall Study|Lost to Follow-up|41|||
25091509|NCT04184622|50201224|FG001|Overall Study|Lost to Follow-up|19|||
25091510|NCT04184622|50201225|FG002|Overall Study|Lost to Follow-up|20|||
25091511|NCT04184622|50201226|FG003|Overall Study|Lost to Follow-up|15|||
25091512|NCT04184622|50201223|FG000|Overall Study|Missing Weight at Week 72|1|||
25091513|NCT04184622|50201224|FG001|Overall Study|Missing Weight at Week 72|0|||
25091514|NCT04184622|50201225|FG002|Overall Study|Missing Weight at Week 72|1|||
25091515|NCT04184622|50201226|FG003|Overall Study|Missing Weight at Week 72|0|||
25091516|NCT04184622|50201223|FG000|Overall Study|Other - as reported by the investigator|22|||
25091517|NCT04184622|50201224|FG001|Overall Study|Other - as reported by the investigator|7|||
25091518|NCT04184622|50201225|FG002|Overall Study|Other - as reported by the investigator|5|||
25091519|NCT04184622|50201226|FG003|Overall Study|Other - as reported by the investigator|12|||
25091520|NCT04184622|50201223|FG000|Overall Study|Physician Decision|0|||
25091521|NCT04184622|50201224|FG001|Overall Study|Physician Decision|0|||
25091522|NCT04184622|50201225|FG002|Overall Study|Physician Decision|3|||
25091523|NCT04184622|50201226|FG003|Overall Study|Physician Decision|1|||
25091524|NCT04184622|50201223|FG000|Overall Study|Pregnancy|4|||
25091525|NCT04184622|50201224|FG001|Overall Study|Pregnancy|4|||
25091526|NCT04184622|50201225|FG002|Overall Study|Pregnancy|3|||
25091527|NCT04184622|50201226|FG003|Overall Study|Pregnancy|5|||
25091528|NCT04184622|50201223|FG000|Overall Study|Protocol Deviation|1|||
25091529|NCT04184622|50201224|FG001|Overall Study|Protocol Deviation|0|||
25091530|NCT04184622|50201225|FG002|Overall Study|Protocol Deviation|0|||
25091531|NCT04184622|50201226|FG003|Overall Study|Protocol Deviation|0|||
25091532|NCT04184622|50201223|FG000|Overall Study|Withdrawal by Subject|68|||
25091533|NCT04184622|50201224|FG001|Overall Study|Withdrawal by Subject|28|||
25091534|NCT04184622|50201225|FG002|Overall Study|Withdrawal by Subject|29|||
25091535|NCT04184622|50201226|FG003|Overall Study|Withdrawal by Subject|22|||
25091536|NCT04162470|50201241|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
25091537|NCT04122625|50201251|FG000|Part A (up to 2.92 Years)|Death|2|||
25091538|NCT04122625|50201252|FG001|Part A (up to 2.92 Years)|Death|4|||
25091539|NCT04122625|50201253|FG002|Part A (up to 2.92 Years)|Death|0|||
25091540|NCT04122625|50201254|FG003|Part A (up to 2.92 Years)|Death|0|||
25091541|NCT04122625|50201255|FG004|Part A (up to 2.92 Years)|Death|0|||
25091542|NCT04122625|50201256|FG005|Part A (up to 2.92 Years)|Death|0|||
25091543|NCT04122625|50201251|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
25007279|NCT03799627|50099649|FG008|Overall Study|Met Exclusion Criteria|0|||
25007280|NCT03799627|50099641|FG000|Overall Study|Investigational Product Noncompliance|0|||
25007281|NCT03799627|50099642|FG001|Overall Study|Investigational Product Noncompliance|0|||
25007282|NCT03799627|50099643|FG002|Overall Study|Investigational Product Noncompliance|0|||
25007283|NCT03799627|50099644|FG003|Overall Study|Investigational Product Noncompliance|1|||
25007284|NCT03799627|50099645|FG004|Overall Study|Investigational Product Noncompliance|0|||
25007285|NCT03799627|50099646|FG005|Overall Study|Investigational Product Noncompliance|0|||
25007286|NCT03799627|50099647|FG006|Overall Study|Investigational Product Noncompliance|0|||
25007287|NCT03799627|50099648|FG007|Overall Study|Investigational Product Noncompliance|0|||
25007288|NCT03799627|50099649|FG008|Overall Study|Investigational Product Noncompliance|0|||
25007289|NCT03799627|50099641|FG000|Overall Study|Participant Relocation|0|||
25007290|NCT03799627|50099642|FG001|Overall Study|Participant Relocation|0|||
25091544|NCT04122625|50201252|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
25176820|NCT01513967|50320392|FG006|Overall Study|Pregnancy|1|||
25091545|NCT04122625|50201253|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
25091546|NCT04122625|50201254|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
25091547|NCT04122625|50201255|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
25091548|NCT04122625|50201256|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
25091549|NCT04122625|50201251|FG000|Part B (up to 2.33 Years)|Death|0|||
25091550|NCT04122625|50201252|FG001|Part B (up to 2.33 Years)|Death|0|||
25091551|NCT04122625|50201253|FG002|Part B (up to 2.33 Years)|Death|5|||
25091552|NCT04122625|50201254|FG003|Part B (up to 2.33 Years)|Death|7|||
25091553|NCT04122625|50201255|FG004|Part B (up to 2.33 Years)|Death|6|||
25091554|NCT04122625|50201256|FG005|Part B (up to 2.33 Years)|Death|7|||
25091555|NCT03824704|50201274|FG000|Overall Study|Study Terminated by Sponsor|1|||
25091556|NCT03766581|50201290|FG000|Randomization|Other reasons|2|||
25091557|NCT03766581|50201291|FG001|Randomization|Other reasons|1|||
25091558|NCT03766581|50201292|FG002|Randomization|Other reasons|0|||
25091559|NCT03766581|50201293|FG003|Randomization|Other reasons|1|||
25091560|NCT03766581|50201294|FG004|Randomization|Other reasons|0|||
25091561|NCT03766581|50201295|FG005|Randomization|Other reasons|0|||
25091562|NCT03766581|50201296|FG006|Randomization|Other reasons|0|||
25091563|NCT03766581|50201297|FG007|Randomization|Other reasons|0|||
25091564|NCT03766581|50201290|FG000|Randomization|Participant no longer meets study criteria|5|||
25091565|NCT03766581|50201291|FG001|Randomization|Participant no longer meets study criteria|3|||
25091566|NCT03766581|50201292|FG002|Randomization|Participant no longer meets study criteria|4|||
25091567|NCT03766581|50201293|FG003|Randomization|Participant no longer meets study criteria|0|||
25091568|NCT03766581|50201294|FG004|Randomization|Participant no longer meets study criteria|2|||
25091569|NCT03766581|50201295|FG005|Randomization|Participant no longer meets study criteria|3|||
25091570|NCT03766581|50201296|FG006|Randomization|Participant no longer meets study criteria|0|||
25091571|NCT03766581|50201297|FG007|Randomization|Participant no longer meets study criteria|1|||
25091572|NCT03766581|50201290|FG000|Randomization|Participant request to discontinue study treatment|1|||
25091573|NCT03766581|50201291|FG001|Randomization|Participant request to discontinue study treatment|0|||
25091574|NCT03766581|50201292|FG002|Randomization|Participant request to discontinue study treatment|0|||
25091575|NCT03766581|50201293|FG003|Randomization|Participant request to discontinue study treatment|0|||
25091576|NCT03766581|50201294|FG004|Randomization|Participant request to discontinue study treatment|1|||
25091577|NCT03766581|50201295|FG005|Randomization|Participant request to discontinue study treatment|2|||
25091578|NCT03766581|50201296|FG006|Randomization|Participant request to discontinue study treatment|0|||
25091579|NCT03766581|50201297|FG007|Randomization|Participant request to discontinue study treatment|0|||
25091580|NCT03766581|50201290|FG000|Randomization|Participant withdrew consent|1|||
25091581|NCT03766581|50201291|FG001|Randomization|Participant withdrew consent|0|||
25091582|NCT03766581|50201292|FG002|Randomization|Participant withdrew consent|1|||
25091583|NCT03766581|50201293|FG003|Randomization|Participant withdrew consent|2|||
25091584|NCT03766581|50201294|FG004|Randomization|Participant withdrew consent|1|||
25091585|NCT03766581|50201295|FG005|Randomization|Participant withdrew consent|1|||
25091586|NCT03766581|50201296|FG006|Randomization|Participant withdrew consent|0|||
25091587|NCT03766581|50201297|FG007|Randomization|Participant withdrew consent|0|||
25091588|NCT03766581|50201290|FG000|Treatment|Adverse Event|82|||
25091589|NCT03766581|50201291|FG001|Treatment|Adverse Event|44|||
25091590|NCT03766581|50201292|FG002|Treatment|Adverse Event|47|||
25091591|NCT03766581|50201293|FG003|Treatment|Adverse Event|46|||
25091592|NCT03766581|50201294|FG004|Treatment|Adverse Event|50|||
25091593|NCT03766581|50201295|FG005|Treatment|Adverse Event|77|||
25091594|NCT03766581|50201296|FG006|Treatment|Adverse Event|5|||
25091595|NCT03766581|50201297|FG007|Treatment|Adverse Event|2|||
25091596|NCT03766581|50201290|FG000|Treatment|Participant request to discontinue treatment|34|||
25091597|NCT03766581|50201291|FG001|Treatment|Participant request to discontinue treatment|6|||
25091598|NCT03766581|50201292|FG002|Treatment|Participant request to discontinue treatment|10|||
25091599|NCT03766581|50201293|FG003|Treatment|Participant request to discontinue treatment|10|||
25091600|NCT03766581|50201294|FG004|Treatment|Participant request to discontinue treatment|14|||
25091601|NCT03766581|50201295|FG005|Treatment|Participant request to discontinue treatment|15|||
25091602|NCT03766581|50201296|FG006|Treatment|Participant request to discontinue treatment|0|||
25091603|NCT03766581|50201297|FG007|Treatment|Participant request to discontinue treatment|1|||
25091604|NCT03766581|50201290|FG000|Treatment|Participant withdrew consent|11|||
25091605|NCT03766581|50201291|FG001|Treatment|Participant withdrew consent|4|||
25176821|NCT01513967|50320393|FG007|Overall Study|Pregnancy|0|||
25176822|NCT01513967|50320386|FG000|Overall Study|missed a study visit|0|||
25091606|NCT03766581|50201292|FG002|Treatment|Participant withdrew consent|5|||
25091607|NCT03766581|50201293|FG003|Treatment|Participant withdrew consent|5|||
25091608|NCT03766581|50201294|FG004|Treatment|Participant withdrew consent|4|||
25091609|NCT03766581|50201295|FG005|Treatment|Participant withdrew consent|4|||
25091610|NCT03766581|50201296|FG006|Treatment|Participant withdrew consent|0|||
25091611|NCT03766581|50201297|FG007|Treatment|Participant withdrew consent|0|||
25176823|NCT01513967|50320387|FG001|Overall Study|missed a study visit|0|||
25176824|NCT01513967|50320388|FG002|Overall Study|missed a study visit|0|||
25091612|NCT03766581|50201290|FG000|Treatment|Death|1|||
25091613|NCT03766581|50201291|FG001|Treatment|Death|0|||
25091614|NCT03766581|50201292|FG002|Treatment|Death|0|||
25091615|NCT03766581|50201293|FG003|Treatment|Death|0|||
25091616|NCT03766581|50201294|FG004|Treatment|Death|0|||
25091617|NCT03766581|50201295|FG005|Treatment|Death|0|||
25091618|NCT03766581|50201296|FG006|Treatment|Death|0|||
25091619|NCT03766581|50201297|FG007|Treatment|Death|0|||
25091620|NCT03766581|50201290|FG000|Treatment|Lost to Follow-up|1|||
25091621|NCT03766581|50201291|FG001|Treatment|Lost to Follow-up|0|||
25091622|NCT03766581|50201292|FG002|Treatment|Lost to Follow-up|0|||
25091623|NCT03766581|50201293|FG003|Treatment|Lost to Follow-up|1|||
25091624|NCT03766581|50201294|FG004|Treatment|Lost to Follow-up|0|||
25091625|NCT03766581|50201295|FG005|Treatment|Lost to Follow-up|0|||
25091626|NCT03766581|50201296|FG006|Treatment|Lost to Follow-up|0|||
25091627|NCT03766581|50201297|FG007|Treatment|Lost to Follow-up|0|||
25091628|NCT03766581|50201290|FG000|Treatment|Poor/Non compliance|2|||
25091629|NCT03766581|50201291|FG001|Treatment|Poor/Non compliance|2|||
25091630|NCT03766581|50201292|FG002|Treatment|Poor/Non compliance|1|||
25091631|NCT03766581|50201293|FG003|Treatment|Poor/Non compliance|1|||
25091632|NCT03766581|50201294|FG004|Treatment|Poor/Non compliance|1|||
25091633|NCT03766581|50201295|FG005|Treatment|Poor/Non compliance|1|||
25091634|NCT03766581|50201296|FG006|Treatment|Poor/Non compliance|0|||
25091635|NCT03766581|50201297|FG007|Treatment|Poor/Non compliance|0|||
25091636|NCT03766581|50201290|FG000|Treatment|Participant no longer meets study criteria|9|||
25091637|NCT03766581|50201291|FG001|Treatment|Participant no longer meets study criteria|1|||
25091638|NCT03766581|50201292|FG002|Treatment|Participant no longer meets study criteria|5|||
25091639|NCT03766581|50201293|FG003|Treatment|Participant no longer meets study criteria|4|||
25091640|NCT03766581|50201294|FG004|Treatment|Participant no longer meets study criteria|4|||
25091641|NCT03766581|50201295|FG005|Treatment|Participant no longer meets study criteria|4|||
25091642|NCT03766581|50201296|FG006|Treatment|Participant no longer meets study criteria|2|||
25091643|NCT03766581|50201297|FG007|Treatment|Participant no longer meets study criteria|0|||
25091644|NCT03766581|50201290|FG000|Treatment|Other reasons|13|||
25091645|NCT03766581|50201291|FG001|Treatment|Other reasons|8|||
25091646|NCT03766581|50201292|FG002|Treatment|Other reasons|3|||
25091647|NCT03766581|50201293|FG003|Treatment|Other reasons|7|||
25091648|NCT03766581|50201294|FG004|Treatment|Other reasons|3|||
25091649|NCT03766581|50201295|FG005|Treatment|Other reasons|3|||
25091650|NCT03766581|50201296|FG006|Treatment|Other reasons|0|||
25091651|NCT03766581|50201297|FG007|Treatment|Other reasons|0|||
25091652|NCT03675321|50201322|FG000|Overall Study|Lack of Efficacy|2|||
25091653|NCT03675321|50201323|FG001|Overall Study|Lack of Efficacy|2|||
25091654|NCT03675321|50201322|FG000|Overall Study|Withdrawal by Subject|1|||
25091655|NCT03675321|50201323|FG001|Overall Study|Withdrawal by Subject|3|||
25091656|NCT03635983|50201331|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
25091657|NCT03635983|50201332|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
25091658|NCT03635983|50201331|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
25091659|NCT03635983|50201332|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
25091660|NCT03635983|50201331|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
25091661|NCT03635983|50201332|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25091662|NCT03635983|50201331|FG000|Pre-Treatment Period|Other reasons|1|||
25091663|NCT03635983|50201332|FG001|Pre-Treatment Period|Other reasons|2|||
25091664|NCT03635983|50201331|FG000|Pre-Treatment Period|Disease Progression|0|||
25091665|NCT03635983|50201332|FG001|Pre-Treatment Period|Disease Progression|1|||
25091666|NCT03635983|50201331|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
25091667|NCT03635983|50201332|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
25091668|NCT03635983|50201331|FG000|Treatment Period|Completed treatment period|13|||
25091669|NCT03635983|50201332|FG001|Treatment Period|Completed treatment period|20|||
25091670|NCT03635983|50201331|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
25091671|NCT03635983|50201332|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
25091672|NCT03635983|50201331|FG000|Treatment Period|Withdrawal by Subject|2|||
25091673|NCT03635983|50201332|FG001|Treatment Period|Withdrawal by Subject|4|||
25091674|NCT03635983|50201331|FG000|Treatment Period|Death|3|||
25091675|NCT03635983|50201332|FG001|Treatment Period|Death|4|||
25091676|NCT03635983|50201331|FG000|Treatment Period|Poor/Non-compliance|1|||
25091677|NCT03635983|50201332|FG001|Treatment Period|Poor/Non-compliance|0|||
25091678|NCT03635983|50201331|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
25091679|NCT03635983|50201332|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
25091680|NCT03635983|50201331|FG000|Treatment Period|Other reasons|5|||
25091681|NCT03635983|50201332|FG001|Treatment Period|Other reasons|2|||
25091682|NCT03635983|50201331|FG000|Treatment Period|Disease progression|184|||
25091683|NCT03635983|50201332|FG001|Treatment Period|Disease progression|168|||
25091684|NCT03635983|50201331|FG000|Treatment Period|Study drug toxicity|26|||
25091685|NCT03635983|50201332|FG001|Treatment Period|Study drug toxicity|29|||
25091686|NCT03635983|50201331|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
25091687|NCT03635983|50201332|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
25091688|NCT03635983|50201331|FG000|Treatment Period|Maximum clinical benefit|3|||
25091689|NCT03635983|50201332|FG001|Treatment Period|Maximum clinical benefit|2|||
25091690|NCT03527745|50201378|FG000|Overall Study|Lost to Follow-up|3|||
25091691|NCT03527745|50201379|FG001|Overall Study|Lost to Follow-up|6|||
25091692|NCT03527745|50201380|FG002|Overall Study|Lost to Follow-up|7|||
25091693|NCT03527745|50201381|FG003|Overall Study|Lost to Follow-up|9|||
25091694|NCT03527745|50201382|FG004|Overall Study|Lost to Follow-up|0|||
25091695|NCT03527745|50201383|FG005|Overall Study|Lost to Follow-up|2|||
25091696|NCT03527745|50201384|FG006|Overall Study|Lost to Follow-up|3|||
25091697|NCT03527745|50201385|FG007|Overall Study|Lost to Follow-up|2|||
25091698|NCT03527745|50201386|FG008|Overall Study|Lost to Follow-up|3|||
25091699|NCT03527745|50201387|FG009|Overall Study|Lost to Follow-up|2|||
25091700|NCT03527745|50201388|FG010|Overall Study|Lost to Follow-up|1|||
25091701|NCT03527745|50201389|FG011|Overall Study|Lost to Follow-up|1|||
25091702|NCT03527745|50201390|FG012|Overall Study|Lost to Follow-up|0|||
25091703|NCT03527745|50201391|FG013|Overall Study|Lost to Follow-up|0|||
25091704|NCT03527745|50201392|FG014|Overall Study|Lost to Follow-up|0|||
25091705|NCT03527745|50201393|FG015|Overall Study|Lost to Follow-up|0|||
25091706|NCT03527745|50201394|FG016|Overall Study|Lost to Follow-up|1|||
25091707|NCT03527745|50201395|FG017|Overall Study|Lost to Follow-up|0|||
25091708|NCT03527745|50201396|FG018|Overall Study|Lost to Follow-up|0|||
25091709|NCT03527745|50201397|FG019|Overall Study|Lost to Follow-up|1|||
25091710|NCT03527745|50201398|FG020|Overall Study|Lost to Follow-up|1|||
25091711|NCT03527745|50201399|FG021|Overall Study|Lost to Follow-up|5|||
25091712|NCT03527745|50201400|FG022|Overall Study|Lost to Follow-up|6|||
25091713|NCT03527745|50201401|FG023|Overall Study|Lost to Follow-up|8|||
25091714|NCT03527745|50201402|FG024|Overall Study|Lost to Follow-up|1|||
25091715|NCT03527745|50201403|FG025|Overall Study|Lost to Follow-up|3|||
25091716|NCT03330405|50201494|FG000|Overall Study|Other|0|||
25091717|NCT03330405|50201495|FG001|Overall Study|Other|1|||
25091718|NCT03330405|50201496|FG002|Overall Study|Other|0|||
25091719|NCT03330405|50201497|FG003|Overall Study|Other|0|||
25091720|NCT03330405|50201498|FG004|Overall Study|Other|0|||
25091721|NCT03330405|50201499|FG005|Overall Study|Other|0|||
25091722|NCT03330405|50201500|FG006|Overall Study|Other|1|||
25091723|NCT03330405|50201501|FG007|Overall Study|Other|0|||
25091724|NCT03330405|50201502|FG008|Overall Study|Other|0|||
25091725|NCT03330405|50201503|FG009|Overall Study|Other|0|||
25091726|NCT03330405|50201504|FG010|Overall Study|Other|0|||
25091727|NCT03330405|50201494|FG000|Overall Study|Ongoing|1|||
25091728|NCT03330405|50201495|FG001|Overall Study|Ongoing|4|||
25091729|NCT03330405|50201496|FG002|Overall Study|Ongoing|1|||
25091730|NCT03330405|50201497|FG003|Overall Study|Ongoing|0|||
25091731|NCT03330405|50201498|FG004|Overall Study|Ongoing|2|||
25091732|NCT03330405|50201499|FG005|Overall Study|Ongoing|0|||
25091733|NCT03330405|50201500|FG006|Overall Study|Ongoing|0|||
25091734|NCT03330405|50201501|FG007|Overall Study|Ongoing|2|||
25091735|NCT03330405|50201502|FG008|Overall Study|Ongoing|0|||
25091736|NCT03330405|50201503|FG009|Overall Study|Ongoing|0|||
25091737|NCT03330405|50201504|FG010|Overall Study|Ongoing|0|||
25091738|NCT03330405|50201494|FG000|Overall Study|Progressive disease|8|||
25091739|NCT03330405|50201495|FG001|Overall Study|Progressive disease|26|||
25091740|NCT03330405|50201496|FG002|Overall Study|Progressive disease|4|||
25091741|NCT03330405|50201497|FG003|Overall Study|Progressive disease|18|||
25091742|NCT03330405|50201498|FG004|Overall Study|Progressive disease|16|||
25091743|NCT03330405|50201499|FG005|Overall Study|Progressive disease|14|||
25091744|NCT03330405|50201500|FG006|Overall Study|Progressive disease|7|||
25091745|NCT03330405|50201501|FG007|Overall Study|Progressive disease|29|||
25091746|NCT03330405|50201502|FG008|Overall Study|Progressive disease|9|||
25091747|NCT03330405|50201503|FG009|Overall Study|Progressive disease|11|||
25091748|NCT03330405|50201504|FG010|Overall Study|Progressive disease|5|||
25091749|NCT03330405|50201494|FG000|Overall Study|Withdrawal by Subject|1|||
25091750|NCT03330405|50201495|FG001|Overall Study|Withdrawal by Subject|4|||
25091751|NCT03330405|50201496|FG002|Overall Study|Withdrawal by Subject|0|||
25091752|NCT03330405|50201497|FG003|Overall Study|Withdrawal by Subject|1|||
25091753|NCT03330405|50201498|FG004|Overall Study|Withdrawal by Subject|1|||
25091754|NCT03330405|50201499|FG005|Overall Study|Withdrawal by Subject|1|||
25091755|NCT03330405|50201500|FG006|Overall Study|Withdrawal by Subject|0|||
25091756|NCT03330405|50201501|FG007|Overall Study|Withdrawal by Subject|1|||
25091757|NCT03330405|50201502|FG008|Overall Study|Withdrawal by Subject|2|||
25007291|NCT03799627|50099643|FG002|Overall Study|Participant Relocation|0|||
25007292|NCT03799627|50099644|FG003|Overall Study|Participant Relocation|1|||
25007293|NCT03799627|50099645|FG004|Overall Study|Participant Relocation|0|||
25007294|NCT03799627|50099646|FG005|Overall Study|Participant Relocation|1|||
25007295|NCT03799627|50099647|FG006|Overall Study|Participant Relocation|0|||
25007296|NCT03799627|50099648|FG007|Overall Study|Participant Relocation|0|||
25007297|NCT03799627|50099649|FG008|Overall Study|Participant Relocation|0|||
25007298|NCT03799627|50099641|FG000|Overall Study|Eurofin Issue|0|||
25091758|NCT03330405|50201503|FG009|Overall Study|Withdrawal by Subject|1|||
25176825|NCT01513967|50320389|FG003|Overall Study|missed a study visit|0|||
25091759|NCT03330405|50201504|FG010|Overall Study|Withdrawal by Subject|1|||
25091760|NCT03330405|50201494|FG000|Overall Study|Global deterioration of health status|2|||
25091761|NCT03330405|50201495|FG001|Overall Study|Global deterioration of health status|3|||
25091762|NCT03330405|50201496|FG002|Overall Study|Global deterioration of health status|0|||
25091763|NCT03330405|50201497|FG003|Overall Study|Global deterioration of health status|2|||
25091764|NCT03330405|50201498|FG004|Overall Study|Global deterioration of health status|3|||
25091765|NCT03330405|50201499|FG005|Overall Study|Global deterioration of health status|3|||
25091766|NCT03330405|50201500|FG006|Overall Study|Global deterioration of health status|0|||
25091767|NCT03330405|50201501|FG007|Overall Study|Global deterioration of health status|2|||
25091768|NCT03330405|50201502|FG008|Overall Study|Global deterioration of health status|8|||
25091769|NCT03330405|50201503|FG009|Overall Study|Global deterioration of health status|4|||
25091770|NCT03330405|50201504|FG010|Overall Study|Global deterioration of health status|1|||
25091771|NCT03330405|50201494|FG000|Overall Study|Adverse Event|0|||
25091772|NCT03330405|50201495|FG001|Overall Study|Adverse Event|0|||
25091773|NCT03330405|50201496|FG002|Overall Study|Adverse Event|0|||
25091774|NCT03330405|50201497|FG003|Overall Study|Adverse Event|1|||
25091775|NCT03330405|50201498|FG004|Overall Study|Adverse Event|1|||
25091776|NCT03330405|50201499|FG005|Overall Study|Adverse Event|1|||
25091777|NCT03330405|50201500|FG006|Overall Study|Adverse Event|3|||
25091778|NCT03330405|50201501|FG007|Overall Study|Adverse Event|3|||
25091779|NCT03330405|50201502|FG008|Overall Study|Adverse Event|2|||
25091780|NCT03330405|50201503|FG009|Overall Study|Adverse Event|2|||
25091781|NCT03330405|50201504|FG010|Overall Study|Adverse Event|2|||
25091782|NCT03330405|50201494|FG000|Overall Study|Death|0|||
25091783|NCT03330405|50201495|FG001|Overall Study|Death|4|||
25091784|NCT03330405|50201496|FG002|Overall Study|Death|0|||
25091785|NCT03330405|50201497|FG003|Overall Study|Death|0|||
25091786|NCT03330405|50201498|FG004|Overall Study|Death|0|||
25091787|NCT03330405|50201499|FG005|Overall Study|Death|1|||
25091788|NCT03330405|50201500|FG006|Overall Study|Death|0|||
25091789|NCT03330405|50201501|FG007|Overall Study|Death|2|||
25091790|NCT03330405|50201502|FG008|Overall Study|Death|0|||
25091791|NCT03330405|50201503|FG009|Overall Study|Death|0|||
25091792|NCT03330405|50201504|FG010|Overall Study|Death|0|||
25091793|NCT03330405|50201494|FG000|Overall Study|Physician Decision|0|||
25091794|NCT03330405|50201495|FG001|Overall Study|Physician Decision|0|||
25091795|NCT03330405|50201496|FG002|Overall Study|Physician Decision|0|||
25091796|NCT03330405|50201497|FG003|Overall Study|Physician Decision|0|||
25091797|NCT03330405|50201498|FG004|Overall Study|Physician Decision|0|||
25091798|NCT03330405|50201499|FG005|Overall Study|Physician Decision|0|||
25091799|NCT03330405|50201500|FG006|Overall Study|Physician Decision|0|||
25091800|NCT03330405|50201501|FG007|Overall Study|Physician Decision|1|||
25091801|NCT03330405|50201502|FG008|Overall Study|Physician Decision|0|||
25091802|NCT03330405|50201503|FG009|Overall Study|Physician Decision|0|||
25091803|NCT03330405|50201504|FG010|Overall Study|Physician Decision|0|||
25091804|NCT03194646|50201551|FG000|Overall Study|Adverse Event|24|||
25091805|NCT03194646|50201552|FG001|Overall Study|Adverse Event|25|||
25091806|NCT03194646|50201553|FG002|Overall Study|Adverse Event|14|||
25091807|NCT03194646|50201554|FG003|Overall Study|Adverse Event|17|||
25091808|NCT03194646|50201551|FG000|Overall Study|Lack of Efficacy|4|||
25091809|NCT03194646|50201552|FG001|Overall Study|Lack of Efficacy|2|||
25091810|NCT03194646|50201553|FG002|Overall Study|Lack of Efficacy|2|||
25091811|NCT03194646|50201554|FG003|Overall Study|Lack of Efficacy|12|||
25091812|NCT03194646|50201551|FG000|Overall Study|Lost to Follow-up|30|||
25091813|NCT03194646|50201552|FG001|Overall Study|Lost to Follow-up|22|||
25091814|NCT03194646|50201553|FG002|Overall Study|Lost to Follow-up|12|||
25091815|NCT03194646|50201554|FG003|Overall Study|Lost to Follow-up|35|||
25091816|NCT03194646|50201551|FG000|Overall Study|Non-compliance with study drug|4|||
25091817|NCT03194646|50201552|FG001|Overall Study|Non-compliance with study drug|0|||
25091818|NCT03194646|50201553|FG002|Overall Study|Non-compliance with study drug|1|||
25091819|NCT03194646|50201554|FG003|Overall Study|Non-compliance with study drug|1|||
25091820|NCT03194646|50201551|FG000|Overall Study|Other|87|||
25091821|NCT03194646|50201552|FG001|Overall Study|Other|67|||
25091822|NCT03194646|50201553|FG002|Overall Study|Other|34|||
25091823|NCT03194646|50201554|FG003|Overall Study|Other|31|||
25091824|NCT03194646|50201551|FG000|Overall Study|Physician Decision|7|||
25091825|NCT03194646|50201552|FG001|Overall Study|Physician Decision|9|||
25091826|NCT03194646|50201553|FG002|Overall Study|Physician Decision|5|||
25091827|NCT03194646|50201554|FG003|Overall Study|Physician Decision|4|||
25091828|NCT03194646|50201551|FG000|Overall Study|Pregnancy|4|||
25091829|NCT03194646|50201552|FG001|Overall Study|Pregnancy|5|||
25091830|NCT03194646|50201553|FG002|Overall Study|Pregnancy|1|||
25091831|NCT03194646|50201554|FG003|Overall Study|Pregnancy|2|||
25091832|NCT03194646|50201551|FG000|Overall Study|Protocol Violation|4|||
25091833|NCT03194646|50201552|FG001|Overall Study|Protocol Violation|2|||
25091834|NCT03194646|50201553|FG002|Overall Study|Protocol Violation|1|||
25091835|NCT03194646|50201554|FG003|Overall Study|Protocol Violation|1|||
25091836|NCT03194646|50201551|FG000|Overall Study|Site terminated by sponsor|0|||
25091837|NCT03194646|50201552|FG001|Overall Study|Site terminated by sponsor|0|||
25091838|NCT03194646|50201553|FG002|Overall Study|Site terminated by sponsor|2|||
25091839|NCT03194646|50201554|FG003|Overall Study|Site terminated by sponsor|0|||
25091840|NCT03194646|50201551|FG000|Overall Study|Study terminated by sponsor|60|||
25091841|NCT03194646|50201552|FG001|Overall Study|Study terminated by sponsor|61|||
25091842|NCT03194646|50201553|FG002|Overall Study|Study terminated by sponsor|30|||
25091843|NCT03194646|50201554|FG003|Overall Study|Study terminated by sponsor|34|||
25091844|NCT03194646|50201551|FG000|Overall Study|Withdrawal by Subject|74|||
25091845|NCT03194646|50201552|FG001|Overall Study|Withdrawal by Subject|75|||
25091846|NCT03194646|50201553|FG002|Overall Study|Withdrawal by Subject|36|||
25091847|NCT03194646|50201554|FG003|Overall Study|Withdrawal by Subject|131|||
25091848|NCT03194646|50201551|FG000|Overall Study|Missing|4|||
25091849|NCT03194646|50201552|FG001|Overall Study|Missing|0|||
25091850|NCT03194646|50201553|FG002|Overall Study|Missing|1|||
25091851|NCT03194646|50201554|FG003|Overall Study|Missing|12|||
25091852|NCT03174782|50201571|FG000|Overall Study|Protocol Violation|1|||
25091853|NCT03174782|50201572|FG001|Overall Study|Protocol Violation|0|||
25091854|NCT03174782|50201571|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
25091855|NCT03174782|50201572|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
25091856|NCT02919969|50201578|FG000|Overall Study|Lack of Efficacy|22|||
25091857|NCT02919969|50201578|FG000|Overall Study|Death|4|||
25091858|NCT02919969|50201578|FG000|Overall Study|Physician Decision|3|||
25091859|NCT02919969|50201578|FG000|Overall Study|Withdrawal by Subject|2|||
25091860|NCT02231749|50201598|FG000|Overall Study|Disease progression|229|||
25091861|NCT02231749|50201599|FG001|Overall Study|Disease progression|297|||
25091862|NCT02231749|50201598|FG000|Overall Study|Study Drug Toxicity|134|||
25091863|NCT02231749|50201599|FG001|Overall Study|Study Drug Toxicity|63|||
25091864|NCT02231749|50201598|FG000|Overall Study|Death|1|||
25091865|NCT02231749|50201599|FG001|Overall Study|Death|1|||
25091866|NCT02231749|50201598|FG000|Overall Study|AE unrelated to Study drug|32|||
25091867|NCT02231749|50201599|FG001|Overall Study|AE unrelated to Study drug|31|||
25091868|NCT02231749|50201598|FG000|Overall Study|Participant's request to discontinue|10|||
25091869|NCT02231749|50201599|FG001|Overall Study|Participant's request to discontinue|21|||
25091870|NCT02231749|50201598|FG000|Overall Study|Participant withdrew Consent|8|||
25091871|NCT02231749|50201599|FG001|Overall Study|Participant withdrew Consent|15|||
25091872|NCT02231749|50201598|FG000|Overall Study|Lost to Follow-up|1|||
25091873|NCT02231749|50201599|FG001|Overall Study|Lost to Follow-up|2|||
25091874|NCT02231749|50201598|FG000|Overall Study|Maximum Clinical Benefit|5|||
25091875|NCT02231749|50201599|FG001|Overall Study|Maximum Clinical Benefit|8|||
25091876|NCT02231749|50201598|FG000|Overall Study|Poor/Non-Compliance|0|||
25091877|NCT02231749|50201599|FG001|Overall Study|Poor/Non-Compliance|3|||
25091878|NCT02231749|50201598|FG000|Overall Study|Pregnancy|1|||
25091879|NCT02231749|50201599|FG001|Overall Study|Pregnancy|0|||
25091880|NCT02231749|50201598|FG000|Overall Study|other|0|||
25091881|NCT02231749|50201599|FG001|Overall Study|other|8|||
25091882|NCT02231749|50201598|FG000|Overall Study|No longer meets Study Criteria|1|||
25091883|NCT02231749|50201599|FG001|Overall Study|No longer meets Study Criteria|0|||
25091884|NCT02003209|50201607|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
25091885|NCT02003209|50201608|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
25091886|NCT01891344|50201618|FG000|Overall Study|Ongoing|6|||
25091887|NCT01891344|50201619|FG001|Overall Study|Ongoing|2|||
25091888|NCT01891344|50201620|FG002|Overall Study|Ongoing|0|||
25091889|NCT01891344|50201621|FG003|Overall Study|Ongoing|1|||
25091890|NCT01891344|50201622|FG004|Overall Study|Ongoing|4|||
25091891|NCT01891344|50201623|FG005|Overall Study|Ongoing|1|||
25091892|NCT01891344|50201624|FG006|Overall Study|Ongoing|0|||
25091893|NCT01891344|50201625|FG007|Overall Study|Ongoing|0|||
25091894|NCT01828099|50201645|FG000|Overall Study|Adverse Event|15|||
25091895|NCT01828099|50201646|FG001|Overall Study|Adverse Event|18|||
25091896|NCT01828099|50201645|FG000|Overall Study|Death|9|||
25091897|NCT01828099|50201646|FG001|Overall Study|Death|11|||
25091898|NCT01828099|50201645|FG000|Overall Study|Lost to Follow-up|2|||
25091899|NCT01828099|50201646|FG001|Overall Study|Lost to Follow-up|0|||
25091900|NCT01828099|50201645|FG000|Overall Study|Non-compliance with study treatment|2|||
25091901|NCT01828099|50201646|FG001|Overall Study|Non-compliance with study treatment|0|||
25091902|NCT01828099|50201645|FG000|Overall Study|Physician Decision|7|||
25091903|NCT01828099|50201646|FG001|Overall Study|Physician Decision|11|||
25091904|NCT01828099|50201645|FG000|Overall Study|Progressive disease|51|||
25091905|NCT01828099|50201646|FG001|Overall Study|Progressive disease|94|||
25091906|NCT01828099|50201645|FG000|Overall Study|Protocol Violation|1|||
25091907|NCT01828099|50201646|FG001|Overall Study|Protocol Violation|0|||
25091908|NCT01828099|50201645|FG000|Overall Study|Subject/guardian decision|7|||
25091909|NCT01828099|50201646|FG001|Overall Study|Subject/guardian decision|23|||
25091910|NCT01188096|50201652|FG000|Overall Study|progression of disease|4|||
25091911|NCT01188096|50201652|FG000|Overall Study|Withdrawal by Subject|2|||
25091912|NCT00579826|50201672|FG000|Overall Study|Withdrawal by Subject|5|||
25091913|NCT00579826|50201673|FG001|Overall Study|Withdrawal by Subject|3|||
25091914|NCT00106691|50201681|FG000|Overall Study|Adverse Event|60|||
25091915|NCT00106691|50201682|FG001|Overall Study|Adverse Event|64|||
25091916|NCT00106691|50201681|FG000|Overall Study|Lost to Follow-up|23|||
25091917|NCT00106691|50201682|FG001|Overall Study|Lost to Follow-up|18|||
25091918|NCT00106691|50201681|FG000|Overall Study|Physician Decision|18|||
25091919|NCT00106691|50201682|FG001|Overall Study|Physician Decision|21|||
25091920|NCT00106691|50201681|FG000|Overall Study|Protocol Violation|13|||
25091921|NCT00106691|50201682|FG001|Overall Study|Protocol Violation|18|||
25091922|NCT00106691|50201681|FG000|Overall Study|Withdrawal by Subject|75|||
25091923|NCT00106691|50201682|FG001|Overall Study|Withdrawal by Subject|70|||
25091924|NCT00106691|50201681|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
25091925|NCT00106691|50201682|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
25091926|NCT00106691|50201681|FG000|Overall Study|QTc>480|3|||
25091927|NCT00106691|50201682|FG001|Overall Study|QTc>480|1|||
25091928|NCT00106691|50201681|FG000|Overall Study|mililtary deployment|2|||
25091929|NCT00106691|50201682|FG001|Overall Study|mililtary deployment|0|||
25091930|NCT00106691|50201681|FG000|Overall Study|Study Site Closing/PI Moved|1|||
25091931|NCT00106691|50201682|FG001|Overall Study|Study Site Closing/PI Moved|2|||
25091932|NCT00106691|50201681|FG000|Overall Study|Cardiologist recommendation|1|||
25091933|NCT00106691|50201682|FG001|Overall Study|Cardiologist recommendation|0|||
25091934|NCT00106691|50201681|FG000|Overall Study|Pt. moved to another state|1|||
25091935|NCT00106691|50201682|FG001|Overall Study|Pt. moved to another state|0|||
25091936|NCT00106691|50201681|FG000|Overall Study|Taking exclusionary avodart|1|||
25091937|NCT00106691|50201682|FG001|Overall Study|Taking exclusionary avodart|0|||
25091938|NCT00106691|50201681|FG000|Overall Study|Not able to discontinue plavix|0|||
25091939|NCT00106691|50201682|FG001|Overall Study|Not able to discontinue plavix|1|||
25091940|NCT04209725|50201690|FG000|Overall Study|Adverse Event|1|||
25091941|NCT02644967|50201783|FG000|Overall Study|Death|26|||
25091942|NCT02644967|50201783|FG000|Overall Study|Physician Decision|1|||
25091943|NCT02644967|50201783|FG000|Overall Study|Withdrawal by Subject|2|||
25091944|NCT02644967|50201783|FG000|Overall Study|Protocol Violation|1|||
25091945|NCT02644967|50201783|FG000|Overall Study|Progressive Disease|1|||
25091946|NCT02644967|50201783|FG000|Overall Study|Study Terminated by Sponsor|4|||
25091947|NCT02644343|50201787|FG000|Overall Study|Withdrawal by Subject|1|||
25091948|NCT02644109|50201793|FG000|Overall Study|Adverse Event|0|||
25091949|NCT02644109|50201794|FG001|Overall Study|Adverse Event|4|||
25091950|NCT02642159|50201802|FG000|Overall Study|Randomized but not treated|1|||
25091951|NCT02642159|50201803|FG001|Overall Study|Randomized but not treated|0|||
25091952|NCT02642159|50201802|FG000|Overall Study|Adverse Event|10|||
25091953|NCT02642159|50201803|FG001|Overall Study|Adverse Event|4|||
25091954|NCT02642159|50201802|FG000|Overall Study|Withdrawal by Subject|9|||
25091955|NCT02642159|50201803|FG001|Overall Study|Withdrawal by Subject|1|||
25091956|NCT02642159|50201802|FG000|Overall Study|Poor compliance to study protocol|1|||
25091957|NCT02642159|50201803|FG001|Overall Study|Poor compliance to study protocol|0|||
25091958|NCT02642159|50201802|FG000|Overall Study|Other than specified above|10|||
25091959|NCT02642159|50201803|FG001|Overall Study|Other than specified above|3|||
25091960|NCT02669017|50201819|FG000|Overall Study|Death|1|||
25091961|NCT02669017|50201820|FG001|Overall Study|Death|2|||
25091962|NCT02669017|50201821|FG002|Overall Study|Death|2|||
25091963|NCT02669017|50201822|FG003|Overall Study|Death|3|||
25091964|NCT02669017|50201823|FG004|Overall Study|Death|8|||
25091965|NCT02669017|50201824|FG005|Overall Study|Death|18|||
25091966|NCT02669017|50201825|FG006|Overall Study|Death|10|||
25091967|NCT02669017|50201826|FG007|Overall Study|Death|47|||
25091968|NCT02669017|50201827|FG008|Overall Study|Death|20|||
25091969|NCT02669017|50201819|FG000|Overall Study|Withdrawal by Subject|0|||
25091970|NCT02669017|50201820|FG001|Overall Study|Withdrawal by Subject|0|||
25091971|NCT02669017|50201821|FG002|Overall Study|Withdrawal by Subject|0|||
25091972|NCT02669017|50201822|FG003|Overall Study|Withdrawal by Subject|1|||
25091973|NCT02669017|50201823|FG004|Overall Study|Withdrawal by Subject|2|||
25091974|NCT02669017|50201824|FG005|Overall Study|Withdrawal by Subject|0|||
25091975|NCT02669017|50201825|FG006|Overall Study|Withdrawal by Subject|0|||
25091976|NCT02669017|50201826|FG007|Overall Study|Withdrawal by Subject|2|||
25091977|NCT02669017|50201827|FG008|Overall Study|Withdrawal by Subject|2|||
25091978|NCT02669017|50201819|FG000|Overall Study|Lost to Follow-up|0|||
25091979|NCT02669017|50201820|FG001|Overall Study|Lost to Follow-up|0|||
25091980|NCT02669017|50201821|FG002|Overall Study|Lost to Follow-up|0|||
25091981|NCT02669017|50201822|FG003|Overall Study|Lost to Follow-up|0|||
25176826|NCT01513967|50320390|FG004|Overall Study|missed a study visit|0|||
25091982|NCT02669017|50201823|FG004|Overall Study|Lost to Follow-up|0|||
25091983|NCT02669017|50201824|FG005|Overall Study|Lost to Follow-up|0|||
25091984|NCT02669017|50201825|FG006|Overall Study|Lost to Follow-up|0|||
25176827|NCT01513967|50320391|FG005|Overall Study|missed a study visit|0|||
25091985|NCT02669017|50201826|FG007|Overall Study|Lost to Follow-up|0|||
25091986|NCT02669017|50201827|FG008|Overall Study|Lost to Follow-up|1|||
25091987|NCT02669017|50201819|FG000|Overall Study|Miscellaneous|0|||
25091988|NCT02669017|50201820|FG001|Overall Study|Miscellaneous|0|||
25091989|NCT02669017|50201821|FG002|Overall Study|Miscellaneous|0|||
25091990|NCT02669017|50201822|FG003|Overall Study|Miscellaneous|0|||
25176828|NCT01513967|50320392|FG006|Overall Study|missed a study visit|1|||
25091991|NCT02669017|50201823|FG004|Overall Study|Miscellaneous|2|||
25091992|NCT02669017|50201824|FG005|Overall Study|Miscellaneous|1|||
25091993|NCT02669017|50201825|FG006|Overall Study|Miscellaneous|1|||
25091994|NCT02669017|50201826|FG007|Overall Study|Miscellaneous|13|||
25091995|NCT02669017|50201827|FG008|Overall Study|Miscellaneous|2|||
25091996|NCT02668393|50201857|FG000|Overall Study|Progressive disease|6|||
25091997|NCT02668393|50201858|FG001|Overall Study|Progressive disease|3|||
25091998|NCT02668393|50201857|FG000|Overall Study|Adverse Event|0|||
25091999|NCT02668393|50201858|FG001|Overall Study|Adverse Event|2|||
25092000|NCT02668393|50201857|FG000|Overall Study|Withdrawal from the trial|0|||
25092001|NCT02668393|50201858|FG001|Overall Study|Withdrawal from the trial|1|||
25092002|NCT02668393|50201857|FG000|Overall Study|Lack of benefit and side effects|1|||
25092003|NCT02668393|50201858|FG001|Overall Study|Lack of benefit and side effects|0|||
25092004|NCT01998958|50201872|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092005|NCT01998958|50201873|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
25092006|NCT01998958|50201874|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092007|NCT01998958|50201875|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092008|NCT01998958|50201876|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092009|NCT01998958|50201877|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092010|NCT01998958|50201878|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092011|NCT01998958|50201879|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092012|NCT01998958|50201880|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092013|NCT01998958|50201881|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092014|NCT01998958|50201882|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092015|NCT01998958|50201883|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092016|NCT01998958|50201884|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092017|NCT01998958|50201885|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092018|NCT01998958|50201886|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092019|NCT01998958|50201887|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092020|NCT01998958|50201888|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092021|NCT01998958|50201889|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092022|NCT01998958|50201890|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092023|NCT01998958|50201891|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092024|NCT01998958|50201892|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092025|NCT01998958|50201893|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092026|NCT01998958|50201894|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092027|NCT01998958|50201895|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092028|NCT01998958|50201896|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092029|NCT01998958|50201897|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092030|NCT01998958|50201898|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092031|NCT01998958|50201899|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092032|NCT01998958|50201900|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092033|NCT01998958|50201901|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092034|NCT01998958|50201902|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092035|NCT01998958|50201903|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
25092036|NCT01998958|50201872|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092037|NCT01998958|50201873|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
25092038|NCT01998958|50201874|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092039|NCT01998958|50201875|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092040|NCT01998958|50201876|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092041|NCT01998958|50201877|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092042|NCT01998958|50201878|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092043|NCT01998958|50201879|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092044|NCT01998958|50201880|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092045|NCT01998958|50201881|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092046|NCT01998958|50201882|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092047|NCT01998958|50201883|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092048|NCT01998958|50201884|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092049|NCT01998958|50201885|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092050|NCT01998958|50201886|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092051|NCT01998958|50201887|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092052|NCT01998958|50201888|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092053|NCT01998958|50201889|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092054|NCT01998958|50201890|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25007299|NCT03799627|50099642|FG001|Overall Study|Eurofin Issue|0|||
25007300|NCT03799627|50099643|FG002|Overall Study|Eurofin Issue|0|||
25007301|NCT03799627|50099644|FG003|Overall Study|Eurofin Issue|0|||
25007302|NCT03799627|50099645|FG004|Overall Study|Eurofin Issue|1|||
25007303|NCT03799627|50099646|FG005|Overall Study|Eurofin Issue|0|||
25007304|NCT03799627|50099647|FG006|Overall Study|Eurofin Issue|0|||
25007305|NCT03799627|50099648|FG007|Overall Study|Eurofin Issue|0|||
25007306|NCT03799627|50099649|FG008|Overall Study|Eurofin Issue|0|||
25007307|NCT03799627|50099641|FG000|Overall Study|Noncompliance with Site Instructions|0|||
25007308|NCT03799627|50099642|FG001|Overall Study|Noncompliance with Site Instructions|0|||
25007309|NCT03799627|50099643|FG002|Overall Study|Noncompliance with Site Instructions|0|||
25007310|NCT03799627|50099644|FG003|Overall Study|Noncompliance with Site Instructions|0|||
25092055|NCT01998958|50201891|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092056|NCT01998958|50201892|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092057|NCT01998958|50201893|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092058|NCT01998958|50201894|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092059|NCT01998958|50201895|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092060|NCT01998958|50201896|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092061|NCT01998958|50201897|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092062|NCT01998958|50201898|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092063|NCT01998958|50201899|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092064|NCT01998958|50201900|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092065|NCT01998958|50201901|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092066|NCT01998958|50201902|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092067|NCT01998958|50201903|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
25092068|NCT01998958|50201872|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
25092069|NCT01998958|50201873|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
25092070|NCT01998958|50201874|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
25092071|NCT01998958|50201875|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
25092072|NCT01998958|50201876|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
25092073|NCT01998958|50201877|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
25092074|NCT01998958|50201878|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
25092075|NCT01998958|50201879|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
25092076|NCT01998958|50201880|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
25092077|NCT01998958|50201881|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
25092078|NCT01998958|50201882|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
25092079|NCT01998958|50201883|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
25092080|NCT01998958|50201884|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
25092081|NCT01998958|50201885|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
25092082|NCT01998958|50201886|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
25092083|NCT01998958|50201887|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
25092084|NCT01998958|50201888|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
25092085|NCT01998958|50201889|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
25092086|NCT01998958|50201890|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
25092087|NCT01998958|50201891|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
25092088|NCT01998958|50201892|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
25092089|NCT01998958|50201893|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
25092090|NCT01998958|50201894|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
25092091|NCT01998958|50201895|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
25092092|NCT01998958|50201896|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
25092093|NCT01998958|50201897|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
25092094|NCT01998958|50201898|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
25092095|NCT01998958|50201899|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
25092096|NCT01998958|50201900|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
25092097|NCT01998958|50201901|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
25092098|NCT01998958|50201902|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
25092099|NCT01998958|50201903|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
25092100|NCT01998958|50201872|FG000|Period 1 (Panel A and B)|Other|1|||
25092101|NCT01998958|50201873|FG001|Period 1 (Panel A and B)|Other|0|||
25092102|NCT01998958|50201874|FG002|Period 1 (Panel A and B)|Other|0|||
25092103|NCT01998958|50201875|FG003|Period 1 (Panel A and B)|Other|0|||
25092104|NCT01998958|50201876|FG004|Period 1 (Panel A and B)|Other|0|||
25092105|NCT01998958|50201877|FG005|Period 1 (Panel A and B)|Other|0|||
25092106|NCT01998958|50201878|FG006|Period 1 (Panel A and B)|Other|0|||
25092107|NCT01998958|50201879|FG007|Period 1 (Panel A and B)|Other|0|||
25092108|NCT01998958|50201880|FG008|Period 1 (Panel A and B)|Other|0|||
25092109|NCT01998958|50201881|FG009|Period 1 (Panel A and B)|Other|0|||
25176829|NCT01513967|50320393|FG007|Overall Study|missed a study visit|0|||
25176830|NCT01513967|50320386|FG000|Overall Study|excluded due to positive drug screen|0|||
25176831|NCT01513967|50320387|FG001|Overall Study|excluded due to positive drug screen|0|||
25176832|NCT01513967|50320388|FG002|Overall Study|excluded due to positive drug screen|0|||
25176833|NCT01513967|50320389|FG003|Overall Study|excluded due to positive drug screen|0|||
25176834|NCT01513967|50320390|FG004|Overall Study|excluded due to positive drug screen|0|||
25176835|NCT01513967|50320391|FG005|Overall Study|excluded due to positive drug screen|0|||
25176836|NCT01513967|50320392|FG006|Overall Study|excluded due to positive drug screen|0|||
25176837|NCT01513967|50320393|FG007|Overall Study|excluded due to positive drug screen|2|||
25176838|NCT01513967|50320386|FG000|Overall Study|Physician Decision|0|||
25176839|NCT01513967|50320387|FG001|Overall Study|Physician Decision|0|||
25176840|NCT01513967|50320388|FG002|Overall Study|Physician Decision|0|||
25176841|NCT01513967|50320389|FG003|Overall Study|Physician Decision|0|||
25176842|NCT01513967|50320390|FG004|Overall Study|Physician Decision|0|||
25176843|NCT01513967|50320391|FG005|Overall Study|Physician Decision|1|||
25176844|NCT01513967|50320392|FG006|Overall Study|Physician Decision|0|||
25176845|NCT01513967|50320393|FG007|Overall Study|Physician Decision|0|||
25176846|NCT01511939|50320437|FG000|Overall Study|Withdrawal by Subject|2|||
25176847|NCT01511939|50320438|FG001|Overall Study|Withdrawal by Subject|1|||
25176848|NCT01511939|50320439|FG002|Overall Study|Withdrawal by Subject|0|||
25092110|NCT01998958|50201882|FG010|Period 1 (Panel A and B)|Other|0|||
25092111|NCT01998958|50201883|FG011|Period 1 (Panel A and B)|Other|0|||
25092112|NCT01998958|50201884|FG012|Period 1 (Panel A and B)|Other|0|||
25092113|NCT01998958|50201885|FG013|Period 1 (Panel A and B)|Other|0|||
25092114|NCT01998958|50201886|FG014|Period 1 (Panel A and B)|Other|0|||
25092115|NCT01998958|50201887|FG015|Period 1 (Panel A and B)|Other|0|||
25092116|NCT01998958|50201888|FG016|Period 1 (Panel A and B)|Other|0|||
25092117|NCT01998958|50201889|FG017|Period 1 (Panel A and B)|Other|0|||
25092118|NCT01998958|50201890|FG018|Period 1 (Panel A and B)|Other|0|||
25092119|NCT01998958|50201891|FG019|Period 1 (Panel A and B)|Other|0|||
25092120|NCT01998958|50201892|FG020|Period 1 (Panel A and B)|Other|0|||
25092121|NCT01998958|50201893|FG021|Period 1 (Panel A and B)|Other|0|||
25092122|NCT01998958|50201894|FG022|Period 1 (Panel A and B)|Other|0|||
25092123|NCT01998958|50201895|FG023|Period 1 (Panel A and B)|Other|0|||
25092124|NCT01998958|50201896|FG024|Period 1 (Panel A and B)|Other|0|||
25092125|NCT01998958|50201897|FG025|Period 1 (Panel A and B)|Other|0|||
25092126|NCT01998958|50201898|FG026|Period 1 (Panel A and B)|Other|0|||
25092127|NCT01998958|50201899|FG027|Period 1 (Panel A and B)|Other|0|||
25092128|NCT01998958|50201900|FG028|Period 1 (Panel A and B)|Other|0|||
25092129|NCT01998958|50201901|FG029|Period 1 (Panel A and B)|Other|0|||
25092130|NCT01998958|50201902|FG030|Period 1 (Panel A and B)|Other|0|||
25092131|NCT01998958|50201903|FG031|Period 1 (Panel A and B)|Other|0|||
25092132|NCT01998958|50201872|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
25092133|NCT01998958|50201873|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
25092134|NCT01998958|50201874|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
25092135|NCT01998958|50201875|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
25092136|NCT01998958|50201876|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
25092137|NCT01998958|50201877|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
25092138|NCT01998958|50201878|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
25092139|NCT01998958|50201879|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
25092140|NCT01998958|50201880|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
25092141|NCT01998958|50201881|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
25092142|NCT01998958|50201882|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
25092143|NCT01998958|50201883|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
25092144|NCT01998958|50201884|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
25092145|NCT01998958|50201885|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
25092146|NCT01998958|50201886|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
25092147|NCT01998958|50201887|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
25092148|NCT01998958|50201888|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
25092149|NCT01998958|50201889|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
25092150|NCT01998958|50201890|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
25092151|NCT01998958|50201891|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
25092152|NCT01998958|50201892|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
25092153|NCT01998958|50201893|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
25092154|NCT01998958|50201894|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
25092155|NCT01998958|50201895|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
25092156|NCT01998958|50201896|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
25092157|NCT01998958|50201897|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
25092158|NCT01998958|50201898|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
25092159|NCT01998958|50201899|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
25092160|NCT01998958|50201900|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
25092161|NCT01998958|50201901|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
25092162|NCT01998958|50201902|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
25092163|NCT01998958|50201903|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
25092164|NCT01998958|50201872|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092165|NCT01998958|50201873|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092166|NCT01998958|50201874|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092167|NCT01998958|50201875|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092168|NCT01998958|50201876|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092169|NCT01998958|50201877|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092170|NCT01998958|50201878|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092171|NCT01998958|50201879|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092172|NCT01998958|50201880|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092173|NCT01998958|50201881|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092174|NCT01998958|50201882|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092175|NCT01998958|50201883|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092176|NCT01998958|50201884|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092177|NCT01998958|50201885|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092178|NCT01998958|50201886|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
25092179|NCT01998958|50201887|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092180|NCT01998958|50201888|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092181|NCT01998958|50201889|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092182|NCT01998958|50201890|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
25092183|NCT01998958|50201891|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092184|NCT01998958|50201892|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092185|NCT01998958|50201893|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092186|NCT01998958|50201894|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092187|NCT01998958|50201895|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092188|NCT01998958|50201896|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092189|NCT01998958|50201897|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092190|NCT01998958|50201898|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092191|NCT01998958|50201899|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092192|NCT01998958|50201900|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092193|NCT01998958|50201901|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092194|NCT01998958|50201902|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092195|NCT01998958|50201903|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
25092196|NCT01998958|50201872|FG000|Open Label Phase (Optional)|Adverse Event|0|||
25092197|NCT01998958|50201873|FG001|Open Label Phase (Optional)|Adverse Event|0|||
25092198|NCT01998958|50201874|FG002|Open Label Phase (Optional)|Adverse Event|0|||
25092199|NCT01998958|50201875|FG003|Open Label Phase (Optional)|Adverse Event|0|||
25092200|NCT01998958|50201876|FG004|Open Label Phase (Optional)|Adverse Event|0|||
25092201|NCT01998958|50201877|FG005|Open Label Phase (Optional)|Adverse Event|0|||
25092202|NCT01998958|50201878|FG006|Open Label Phase (Optional)|Adverse Event|0|||
25092203|NCT01998958|50201879|FG007|Open Label Phase (Optional)|Adverse Event|0|||
25092204|NCT01998958|50201880|FG008|Open Label Phase (Optional)|Adverse Event|0|||
25092205|NCT01998958|50201881|FG009|Open Label Phase (Optional)|Adverse Event|0|||
25092206|NCT01998958|50201882|FG010|Open Label Phase (Optional)|Adverse Event|0|||
25092207|NCT01998958|50201883|FG011|Open Label Phase (Optional)|Adverse Event|0|||
25092208|NCT01998958|50201884|FG012|Open Label Phase (Optional)|Adverse Event|0|||
25092209|NCT01998958|50201885|FG013|Open Label Phase (Optional)|Adverse Event|0|||
25092210|NCT01998958|50201886|FG014|Open Label Phase (Optional)|Adverse Event|0|||
25092211|NCT01998958|50201887|FG015|Open Label Phase (Optional)|Adverse Event|0|||
25092212|NCT01998958|50201888|FG016|Open Label Phase (Optional)|Adverse Event|0|||
25092213|NCT01998958|50201889|FG017|Open Label Phase (Optional)|Adverse Event|0|||
25092214|NCT01998958|50201890|FG018|Open Label Phase (Optional)|Adverse Event|0|||
25092215|NCT01998958|50201891|FG019|Open Label Phase (Optional)|Adverse Event|0|||
25092216|NCT01998958|50201892|FG020|Open Label Phase (Optional)|Adverse Event|0|||
25092217|NCT01998958|50201893|FG021|Open Label Phase (Optional)|Adverse Event|0|||
25092218|NCT01998958|50201894|FG022|Open Label Phase (Optional)|Adverse Event|0|||
25092219|NCT01998958|50201895|FG023|Open Label Phase (Optional)|Adverse Event|1|||
25092220|NCT01998958|50201896|FG024|Open Label Phase (Optional)|Adverse Event|0|||
25092221|NCT01998958|50201897|FG025|Open Label Phase (Optional)|Adverse Event|0|||
25092222|NCT01998958|50201898|FG026|Open Label Phase (Optional)|Adverse Event|0|||
25092223|NCT01998958|50201899|FG027|Open Label Phase (Optional)|Adverse Event|0|||
25092224|NCT01998958|50201900|FG028|Open Label Phase (Optional)|Adverse Event|0|||
25092225|NCT01998958|50201901|FG029|Open Label Phase (Optional)|Adverse Event|0|||
25092226|NCT01998958|50201902|FG030|Open Label Phase (Optional)|Adverse Event|0|||
25092227|NCT01998958|50201903|FG031|Open Label Phase (Optional)|Adverse Event|0|||
25092228|NCT01998958|50201872|FG000|Open Label Phase (Optional)|Other|0|||
25176849|NCT01576705|50320451|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
25176850|NCT01576705|50320452|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
25007311|NCT03799627|50099645|FG004|Overall Study|Noncompliance with Site Instructions|1|||
25007312|NCT03799627|50099646|FG005|Overall Study|Noncompliance with Site Instructions|0|||
25007313|NCT03799627|50099647|FG006|Overall Study|Noncompliance with Site Instructions|0|||
25007314|NCT03799627|50099648|FG007|Overall Study|Noncompliance with Site Instructions|0|||
25007315|NCT03799627|50099649|FG008|Overall Study|Noncompliance with Site Instructions|0|||
25007316|NCT03799627|50099641|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
25007317|NCT03799627|50099642|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
25007318|NCT03799627|50099643|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
25007319|NCT03799627|50099644|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
25007320|NCT03799627|50099645|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
25007321|NCT03799627|50099646|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
25007322|NCT03799627|50099647|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
25007323|NCT03799627|50099648|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
25007324|NCT03799627|50099649|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
25007325|NCT03799627|50099641|FG000|Overall Study|Changes In Hemoglobin Values|1|||
25007326|NCT03799627|50099642|FG001|Overall Study|Changes In Hemoglobin Values|2|||
25007327|NCT03799627|50099643|FG002|Overall Study|Changes In Hemoglobin Values|1|||
25007328|NCT03799627|50099644|FG003|Overall Study|Changes In Hemoglobin Values|0|||
25007329|NCT03799627|50099645|FG004|Overall Study|Changes In Hemoglobin Values|0|||
25092229|NCT01998958|50201873|FG001|Open Label Phase (Optional)|Other|0|||
25092230|NCT01998958|50201874|FG002|Open Label Phase (Optional)|Other|0|||
25092231|NCT01998958|50201875|FG003|Open Label Phase (Optional)|Other|0|||
25092232|NCT01998958|50201876|FG004|Open Label Phase (Optional)|Other|0|||
25092233|NCT01998958|50201877|FG005|Open Label Phase (Optional)|Other|0|||
25092234|NCT01998958|50201878|FG006|Open Label Phase (Optional)|Other|0|||
25092235|NCT01998958|50201879|FG007|Open Label Phase (Optional)|Other|0|||
25176851|NCT01576705|50320453|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
25176852|NCT01576705|50320454|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
25176853|NCT01576705|50320451|FG000|Overall Study|invalid ICF|0|||
25176854|NCT01576705|50320452|FG001|Overall Study|invalid ICF|1|||
25176855|NCT01576705|50320453|FG002|Overall Study|invalid ICF|0|||
25176856|NCT01576705|50320454|FG003|Overall Study|invalid ICF|0|||
25176857|NCT02666430|50320466|FG000|Period 1|Lost to Follow-up|1|||
25176858|NCT02666430|50320467|FG001|Period 1|Lost to Follow-up|0|||
25176859|NCT02666430|50320466|FG000|Period 1|Adverse Event|0|||
25176860|NCT02666430|50320467|FG001|Period 1|Adverse Event|1|||
25176861|NCT02666430|50320466|FG000|Period 2|Withdrawal by Subject|1|||
25176862|NCT02666430|50320467|FG001|Period 2|Withdrawal by Subject|4|||
25176863|NCT02666430|50320466|FG000|Period 3|Lost to Follow-up|1|||
25176864|NCT02666430|50320467|FG001|Period 3|Lost to Follow-up|0|||
25176865|NCT01576549|50320473|FG000|Overall Study|Sponsor Decision|2|||
25176866|NCT01576159|50320486|FG000|Overall Study|Withdrawal by Subject|0|||
25176867|NCT01576159|50320487|FG001|Overall Study|Withdrawal by Subject|1|||
25176868|NCT01576159|50320488|FG002|Overall Study|Withdrawal by Subject|0|||
25176869|NCT01576159|50320489|FG003|Overall Study|Withdrawal by Subject|0|||
25176870|NCT01576159|50320486|FG000|Overall Study|Physician Decision|0|||
25176871|NCT01576159|50320487|FG001|Overall Study|Physician Decision|0|||
25176872|NCT01576159|50320488|FG002|Overall Study|Physician Decision|1|||
25176873|NCT01576159|50320489|FG003|Overall Study|Physician Decision|0|||
25176874|NCT01576159|50320486|FG000|Overall Study|Lost to Follow-up|0|||
25176875|NCT01576159|50320487|FG001|Overall Study|Lost to Follow-up|0|||
25092236|NCT01998958|50201880|FG008|Open Label Phase (Optional)|Other|0|||
25092237|NCT01998958|50201881|FG009|Open Label Phase (Optional)|Other|0|||
25092238|NCT01998958|50201882|FG010|Open Label Phase (Optional)|Other|0|||
25092239|NCT01998958|50201883|FG011|Open Label Phase (Optional)|Other|0|||
25092240|NCT01998958|50201884|FG012|Open Label Phase (Optional)|Other|0|||
25092241|NCT01998958|50201885|FG013|Open Label Phase (Optional)|Other|0|||
25092242|NCT01998958|50201886|FG014|Open Label Phase (Optional)|Other|0|||
25092243|NCT01998958|50201887|FG015|Open Label Phase (Optional)|Other|0|||
25092244|NCT01998958|50201888|FG016|Open Label Phase (Optional)|Other|0|||
25092245|NCT01998958|50201889|FG017|Open Label Phase (Optional)|Other|0|||
25092246|NCT01998958|50201890|FG018|Open Label Phase (Optional)|Other|0|||
25092247|NCT01998958|50201891|FG019|Open Label Phase (Optional)|Other|0|||
25092248|NCT01998958|50201892|FG020|Open Label Phase (Optional)|Other|0|||
25092249|NCT01998958|50201893|FG021|Open Label Phase (Optional)|Other|0|||
25092250|NCT01998958|50201894|FG022|Open Label Phase (Optional)|Other|5|||
25092251|NCT01998958|50201895|FG023|Open Label Phase (Optional)|Other|1|||
25092252|NCT01998958|50201896|FG024|Open Label Phase (Optional)|Other|0|||
25092253|NCT01998958|50201897|FG025|Open Label Phase (Optional)|Other|0|||
25092254|NCT01998958|50201898|FG026|Open Label Phase (Optional)|Other|0|||
25092255|NCT01998958|50201899|FG027|Open Label Phase (Optional)|Other|0|||
25092256|NCT01998958|50201900|FG028|Open Label Phase (Optional)|Other|0|||
25092257|NCT01998958|50201901|FG029|Open Label Phase (Optional)|Other|0|||
25092258|NCT01998958|50201902|FG030|Open Label Phase (Optional)|Other|0|||
25092259|NCT01998958|50201903|FG031|Open Label Phase (Optional)|Other|0|||
25092260|NCT01998958|50201872|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092261|NCT01998958|50201873|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092262|NCT01998958|50201874|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092263|NCT01998958|50201875|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092264|NCT01998958|50201876|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092265|NCT01998958|50201877|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092266|NCT01998958|50201878|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092267|NCT01998958|50201879|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092268|NCT01998958|50201880|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092269|NCT01998958|50201881|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092270|NCT01998958|50201882|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092271|NCT01998958|50201883|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092272|NCT01998958|50201884|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092273|NCT01998958|50201885|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092274|NCT01998958|50201886|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092275|NCT01998958|50201887|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092276|NCT01998958|50201888|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092277|NCT01998958|50201889|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092278|NCT01998958|50201890|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092279|NCT01998958|50201891|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092280|NCT01998958|50201892|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092281|NCT01998958|50201893|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092282|NCT01998958|50201894|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
25176876|NCT01576159|50320488|FG002|Overall Study|Lost to Follow-up|0|||
25176877|NCT01576159|50320489|FG003|Overall Study|Lost to Follow-up|1|||
25176878|NCT01576159|50320486|FG000|Overall Study|Protocol Violation|1|||
25176879|NCT01576159|50320487|FG001|Overall Study|Protocol Violation|0|||
25092283|NCT01998958|50201895|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092284|NCT01998958|50201896|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092285|NCT01998958|50201897|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092286|NCT01998958|50201898|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092287|NCT01998958|50201899|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092288|NCT01998958|50201900|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092289|NCT01998958|50201901|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092290|NCT01998958|50201902|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092291|NCT01998958|50201903|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
25092292|NCT01998958|50201872|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092293|NCT01998958|50201873|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092294|NCT01998958|50201874|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092295|NCT01998958|50201875|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092296|NCT01998958|50201876|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092297|NCT01998958|50201877|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092298|NCT01998958|50201878|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092299|NCT01998958|50201879|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092300|NCT01998958|50201880|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092301|NCT01998958|50201881|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092302|NCT01998958|50201882|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092303|NCT01998958|50201883|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092304|NCT01998958|50201884|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092305|NCT01998958|50201885|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092306|NCT01998958|50201886|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092307|NCT01998958|50201887|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092308|NCT01998958|50201888|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092309|NCT01998958|50201889|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092310|NCT01998958|50201890|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092311|NCT01998958|50201891|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092312|NCT01998958|50201892|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092313|NCT01998958|50201893|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
25092314|NCT01998958|50201894|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
25092315|NCT01998958|50201895|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092316|NCT01998958|50201896|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092317|NCT01998958|50201897|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092318|NCT01998958|50201898|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092319|NCT01998958|50201899|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092320|NCT01998958|50201900|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092321|NCT01998958|50201901|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092322|NCT01998958|50201902|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092323|NCT01998958|50201903|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
25092324|NCT01998958|50201872|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092325|NCT01998958|50201873|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092326|NCT01998958|50201874|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092327|NCT01998958|50201875|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092328|NCT01998958|50201876|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092329|NCT01998958|50201877|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092330|NCT01998958|50201878|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092331|NCT01998958|50201879|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092332|NCT01998958|50201880|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092333|NCT01998958|50201881|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092334|NCT01998958|50201882|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092335|NCT01998958|50201883|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092336|NCT01998958|50201884|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092337|NCT01998958|50201885|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092338|NCT01998958|50201886|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092339|NCT01998958|50201887|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092340|NCT01998958|50201888|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092341|NCT01998958|50201889|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092342|NCT01998958|50201890|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092343|NCT01998958|50201891|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092344|NCT01998958|50201892|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25176880|NCT01576159|50320488|FG002|Overall Study|Protocol Violation|0|||
25092345|NCT01998958|50201893|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
25092346|NCT01998958|50201894|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
25092347|NCT01998958|50201895|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
25092348|NCT01998958|50201896|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25176881|NCT01576159|50320489|FG003|Overall Study|Protocol Violation|0|||
25092349|NCT01998958|50201897|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092350|NCT01998958|50201898|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25176882|NCT01510769|50320520|FG000|Overall Study|Adverse Event|7|||
25092351|NCT01998958|50201899|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092352|NCT01998958|50201900|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092353|NCT01998958|50201901|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092354|NCT01998958|50201902|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092355|NCT01998958|50201903|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
25092356|NCT01958164|50201955|FG000|Overall Study|Adverse Event|0|||
25092357|NCT01958164|50201956|FG001|Overall Study|Adverse Event|2|||
25092358|NCT01958164|50201955|FG000|Overall Study|Lost to Follow-up|2|||
25092359|NCT01958164|50201956|FG001|Overall Study|Lost to Follow-up|3|||
25092360|NCT01976104|50201966|FG000|Overall Study|Adverse Event|0|||
25092361|NCT01976104|50201967|FG001|Overall Study|Adverse Event|0|||
25092362|NCT01976104|50201968|FG002|Overall Study|Adverse Event|1|||
25092363|NCT01976104|50201969|FG003|Overall Study|Adverse Event|0|||
25092364|NCT01976104|50201966|FG000|Overall Study|Lost to Follow-up|3|||
25092365|NCT01976104|50201967|FG001|Overall Study|Lost to Follow-up|0|||
25092366|NCT01976104|50201968|FG002|Overall Study|Lost to Follow-up|1|||
25092367|NCT01976104|50201969|FG003|Overall Study|Lost to Follow-up|1|||
25092368|NCT01976104|50201966|FG000|Overall Study|Subject Choice|0|||
25092369|NCT01976104|50201967|FG001|Overall Study|Subject Choice|1|||
25092370|NCT01976104|50201968|FG002|Overall Study|Subject Choice|0|||
25092371|NCT01976104|50201969|FG003|Overall Study|Subject Choice|1|||
25092372|NCT01976104|50201966|FG000|Overall Study|Withdrawal by Subject|3|||
25092373|NCT01976104|50201967|FG001|Overall Study|Withdrawal by Subject|0|||
25092374|NCT01976104|50201968|FG002|Overall Study|Withdrawal by Subject|0|||
25092375|NCT01976104|50201969|FG003|Overall Study|Withdrawal by Subject|1|||
25092376|NCT01976104|50201966|FG000|Overall Study|Other|0|||
25092377|NCT01976104|50201967|FG001|Overall Study|Other|1|||
25092378|NCT01976104|50201968|FG002|Overall Study|Other|0|||
25092379|NCT01976104|50201969|FG003|Overall Study|Other|0|||
25092380|NCT01372501|50201980|FG000|Overall Study|Adverse Event|4|||
25092381|NCT01372501|50201980|FG000|Overall Study|Device migration|1|||
25092382|NCT01958008|50201989|FG000|Overall Study|Worsening of disease under study|0|||
25092383|NCT01958008|50201990|FG001|Overall Study|Worsening of disease under study|0|||
25092384|NCT01958008|50201991|FG002|Overall Study|Worsening of disease under study|1|||
25092385|NCT01958008|50201992|FG003|Overall Study|Worsening of disease under study|0|||
25092386|NCT01958008|50201989|FG000|Overall Study|Other adverse event|1|||
25092387|NCT01958008|50201990|FG001|Overall Study|Other adverse event|0|||
25092388|NCT01958008|50201991|FG002|Overall Study|Other adverse event|0|||
25092389|NCT01958008|50201992|FG003|Overall Study|Other adverse event|0|||
25092390|NCT01998880|50202020|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
25092391|NCT01998880|50202021|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
25092392|NCT01998880|50202020|FG000|Overall Study|Disease Progression|1|||
25092393|NCT01998880|50202021|FG001|Overall Study|Disease Progression|8|||
25092394|NCT01998880|50202020|FG000|Overall Study|Withdrew Consent|2|||
25092395|NCT01998880|50202021|FG001|Overall Study|Withdrew Consent|1|||
25092396|NCT01998880|50202020|FG000|Overall Study|Death|3|||
25092397|NCT01998880|50202021|FG001|Overall Study|Death|6|||
25092398|NCT01998880|50202020|FG000|Overall Study|Insufficient Therapeutic Response|1|||
25092399|NCT01998880|50202021|FG001|Overall Study|Insufficient Therapeutic Response|5|||
25092400|NCT01998880|50202020|FG000|Overall Study|Administrative/Other|1|||
25092401|NCT01998880|50202021|FG001|Overall Study|Administrative/Other|1|||
25092402|NCT01998880|50202020|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
25092403|NCT01998880|50202021|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
25092404|NCT01998880|50202020|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
25092405|NCT01998880|50202021|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
25092406|NCT01998880|50202020|FG000|Overall Study|Did Not Receive Treatment|3|||
25092407|NCT01998880|50202021|FG001|Overall Study|Did Not Receive Treatment|2|||
25092408|NCT01975948|50202031|FG000|Overall Study|Withdrawal by Subject|17|||
25092409|NCT01975948|50202032|FG001|Overall Study|Withdrawal by Subject|21|||
25092410|NCT01975948|50202033|FG002|Overall Study|Withdrawal by Subject|7|||
25092411|NCT01975948|50202034|FG003|Overall Study|Withdrawal by Subject|6|||
25176883|NCT01510769|50320521|FG001|Overall Study|Adverse Event|6|||
25092412|NCT01975246|50202046|FG000|Overall Study|Adverse Event|2|||
25092413|NCT01975246|50202047|FG001|Overall Study|Adverse Event|1|||
25176884|NCT01510769|50320522|FG002|Overall Study|Adverse Event|4|||
25092414|NCT01975246|50202046|FG000|Overall Study|Lack of Efficacy|1|||
25092415|NCT01975246|50202047|FG001|Overall Study|Lack of Efficacy|0|||
25092416|NCT01975246|50202046|FG000|Overall Study|Protocol Violation|1|||
25092417|NCT01975246|50202047|FG001|Overall Study|Protocol Violation|0|||
25092418|NCT01975246|50202046|FG000|Overall Study|Other than stated|0|||
25092419|NCT01975246|50202047|FG001|Overall Study|Other than stated|1|||
25092420|NCT01621126|50202053|FG000|Overall Study|Physician Decision|6|||
25092421|NCT01973998|50202059|FG000|Overall Study|Death|2|||
25092422|NCT01973998|50202060|FG001|Overall Study|Death|2|||
25092423|NCT02664415|50202068|FG000|Overall Study|Adverse Event|1|||
25092424|NCT02664415|50202069|FG001|Overall Study|Adverse Event|0|||
25092425|NCT02661061|50202077|FG000|Overall Study|Lack of Efficacy|1|||
25092426|NCT02661061|50202078|FG001|Overall Study|Lack of Efficacy|1|||
25092427|NCT02661061|50202077|FG000|Overall Study|Withdrawal by Subject|1|||
25092428|NCT02661061|50202078|FG001|Overall Study|Withdrawal by Subject|1|||
25092429|NCT01995838|50202091|FG000|Overall Study|Lost to Follow-up|0|||
25092430|NCT01995838|50202092|FG001|Overall Study|Lost to Follow-up|1|||
25092431|NCT01995838|50202093|FG002|Overall Study|Lost to Follow-up|0|||
25092432|NCT01995838|50202094|FG003|Overall Study|Lost to Follow-up|0|||
25092433|NCT01995838|50202095|FG004|Overall Study|Lost to Follow-up|0|||
25092434|NCT01995838|50202096|FG005|Overall Study|Lost to Follow-up|0|||
25092435|NCT01995838|50202097|FG006|Overall Study|Lost to Follow-up|1|||
25092436|NCT01995838|50202091|FG000|Overall Study|Participant choice|2|||
25092437|NCT01995838|50202092|FG001|Overall Study|Participant choice|0|||
25092438|NCT01995838|50202093|FG002|Overall Study|Participant choice|0|||
25092439|NCT01995838|50202094|FG003|Overall Study|Participant choice|0|||
25092440|NCT01995838|50202095|FG004|Overall Study|Participant choice|0|||
25092441|NCT01995838|50202096|FG005|Overall Study|Participant choice|1|||
25092442|NCT01995838|50202097|FG006|Overall Study|Participant choice|1|||
25092443|NCT01995838|50202091|FG000|Overall Study|Adverse Event|0|||
25176885|NCT01510769|50320520|FG000|Overall Study|Gout Flare|0|||
25176886|NCT01510769|50320521|FG001|Overall Study|Gout Flare|3|||
25176887|NCT01510769|50320522|FG002|Overall Study|Gout Flare|1|||
25176888|NCT01510769|50320520|FG000|Overall Study|Protocol Violation|11|||
25176889|NCT01510769|50320521|FG001|Overall Study|Protocol Violation|10|||
25176890|NCT01510769|50320522|FG002|Overall Study|Protocol Violation|9|||
25176891|NCT01510769|50320520|FG000|Overall Study|Lost to Follow-up|5|||
25092444|NCT01995838|50202092|FG001|Overall Study|Adverse Event|0|||
25092445|NCT01995838|50202093|FG002|Overall Study|Adverse Event|0|||
25092446|NCT01995838|50202094|FG003|Overall Study|Adverse Event|0|||
25092447|NCT01995838|50202095|FG004|Overall Study|Adverse Event|0|||
25092448|NCT01995838|50202096|FG005|Overall Study|Adverse Event|0|||
25092449|NCT01995838|50202097|FG006|Overall Study|Adverse Event|1|||
25092450|NCT01995838|50202091|FG000|Overall Study|Withdrawal by Subject|0|||
25092451|NCT01995838|50202092|FG001|Overall Study|Withdrawal by Subject|0|||
25092452|NCT01995838|50202093|FG002|Overall Study|Withdrawal by Subject|0|||
25092453|NCT01995838|50202094|FG003|Overall Study|Withdrawal by Subject|0|||
25092454|NCT01995838|50202095|FG004|Overall Study|Withdrawal by Subject|1|||
25092455|NCT01995838|50202096|FG005|Overall Study|Withdrawal by Subject|0|||
25092456|NCT01995838|50202097|FG006|Overall Study|Withdrawal by Subject|0|||
25092457|NCT01995838|50202091|FG000|Overall Study|Other|3|||
25092458|NCT01995838|50202092|FG001|Overall Study|Other|1|||
25092459|NCT01995838|50202093|FG002|Overall Study|Other|0|||
25092460|NCT01995838|50202094|FG003|Overall Study|Other|2|||
25092461|NCT01995838|50202095|FG004|Overall Study|Other|1|||
25092462|NCT01995838|50202096|FG005|Overall Study|Other|1|||
25092463|NCT01995838|50202097|FG006|Overall Study|Other|2|||
25092464|NCT01957462|50202118|FG000|Test Period 1|Withdrawal by Subject|1|||
25092465|NCT01957462|50202119|FG001|Test Period 1|Withdrawal by Subject|0|||
25092466|NCT01957462|50202118|FG000|Test Period 1|Adverse Event|1|||
25092467|NCT01957462|50202119|FG001|Test Period 1|Adverse Event|0|||
25092468|NCT01957150|50202127|FG000|Overall Study|Adverse Event|23|||
25092469|NCT01957150|50202128|FG001|Overall Study|Adverse Event|20|||
25092470|NCT01957150|50202127|FG000|Overall Study|Withdrawal by Subject|13|||
25092471|NCT01957150|50202128|FG001|Overall Study|Withdrawal by Subject|17|||
25092472|NCT01957150|50202127|FG000|Overall Study|Physician Decision|3|||
25092473|NCT01957150|50202128|FG001|Overall Study|Physician Decision|6|||
25092474|NCT01957150|50202127|FG000|Overall Study|Lost to Follow-up|4|||
25092475|NCT01957150|50202128|FG001|Overall Study|Lost to Follow-up|4|||
25092476|NCT01957150|50202127|FG000|Overall Study|Protocol Violation|1|||
25092477|NCT01957150|50202128|FG001|Overall Study|Protocol Violation|0|||
25092478|NCT01957150|50202127|FG000|Overall Study|Lack of Efficacy|11|||
25092479|NCT01957150|50202128|FG001|Overall Study|Lack of Efficacy|11|||
25092480|NCT01955122|50202136|FG000|Overall Study|Physician Decision|5|||
25092481|NCT01955122|50202137|FG001|Overall Study|Physician Decision|5|||
25092482|NCT01995526|50202149|FG000|Overall Study|Physician Decision|1|||
25092483|NCT01955044|50202156|FG000|Overall Study|Death|1|||
25176892|NCT01510769|50320521|FG001|Overall Study|Lost to Follow-up|1|||
25176893|NCT01510769|50320522|FG002|Overall Study|Lost to Follow-up|5|||
25092484|NCT01955044|50202157|FG001|Overall Study|Death|1|||
25092485|NCT01955044|50202158|FG002|Overall Study|Death|0|||
25092486|NCT01973218|50202168|FG000|Overall Study|Adverse Event|1|||
25092487|NCT01973218|50202169|FG001|Overall Study|Adverse Event|0|||
25092488|NCT01973218|50202168|FG000|Overall Study|Withdrawal by Subject|1|||
25176894|NCT01510769|50320520|FG000|Overall Study|Withdrawal by Subject|3|||
25092489|NCT01973218|50202169|FG001|Overall Study|Withdrawal by Subject|0|||
25092490|NCT01954342|50202181|FG000|Overall Study|Missing data from 13-16week study visit|0|||
25092491|NCT01954342|50202182|FG001|Overall Study|Missing data from 13-16week study visit|0|||
25092492|NCT01954342|50202183|FG002|Overall Study|Missing data from 13-16week study visit|0|||
25092493|NCT01954342|50202184|FG003|Overall Study|Missing data from 13-16week study visit|1|||
25176895|NCT01510769|50320521|FG001|Overall Study|Withdrawal by Subject|4|||
25092494|NCT01954342|50202181|FG000|Overall Study|Miscarriage|0|||
25092495|NCT01954342|50202182|FG001|Overall Study|Miscarriage|0|||
25092496|NCT01954342|50202183|FG002|Overall Study|Miscarriage|0|||
25092497|NCT01954342|50202184|FG003|Overall Study|Miscarriage|3|||
25092498|NCT01954342|50202181|FG000|Overall Study|Lost to Follow-up|0|||
25092499|NCT01954342|50202182|FG001|Overall Study|Lost to Follow-up|0|||
25092500|NCT01954342|50202183|FG002|Overall Study|Lost to Follow-up|0|||
25092501|NCT01954342|50202184|FG003|Overall Study|Lost to Follow-up|5|||
25092502|NCT01954342|50202181|FG000|Overall Study|Preterm delivery|0|||
25092503|NCT01954342|50202182|FG001|Overall Study|Preterm delivery|0|||
25092504|NCT01954342|50202183|FG002|Overall Study|Preterm delivery|0|||
25092505|NCT01954342|50202184|FG003|Overall Study|Preterm delivery|3|||
25092506|NCT01954342|50202181|FG000|Overall Study|Pre-eclampsia|0|||
25092507|NCT01954342|50202182|FG001|Overall Study|Pre-eclampsia|0|||
25092508|NCT01954342|50202183|FG002|Overall Study|Pre-eclampsia|0|||
25092509|NCT01954342|50202184|FG003|Overall Study|Pre-eclampsia|4|||
25092510|NCT01954342|50202181|FG000|Overall Study|Unreliable Data|0|||
25092511|NCT01954342|50202182|FG001|Overall Study|Unreliable Data|0|||
25092512|NCT01954342|50202183|FG002|Overall Study|Unreliable Data|0|||
25092513|NCT01954342|50202184|FG003|Overall Study|Unreliable Data|2|||
25092514|NCT01972438|50202196|FG000|Baseline-Month 3 Crossover Period|Death|1|||
25092515|NCT01972438|50202197|FG001|Baseline-Month 3 Crossover Period|Death|0|||
25092516|NCT01972438|50202196|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
25092517|NCT01972438|50202197|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
25092518|NCT01972438|50202196|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
25092519|NCT01972438|50202197|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
25092520|NCT01972438|50202196|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
25092521|NCT01972438|50202197|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
25092522|NCT01972438|50202196|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
25092523|NCT01972438|50202197|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
25092524|NCT01972438|50202196|FG000|Months 6-12 Study Period|Death|1|||
25092525|NCT01972438|50202197|FG001|Months 6-12 Study Period|Death|0|||
25092526|NCT01972438|50202196|FG000|Months 6-12 Study Period|Early Study Closure|2|||
25092527|NCT01972438|50202197|FG001|Months 6-12 Study Period|Early Study Closure|2|||
25092528|NCT01972438|50202196|FG000|Post Month 12 Study Period|Early Study Closure|3|||
25092529|NCT01972438|50202197|FG001|Post Month 12 Study Period|Early Study Closure|4|||
25092530|NCT01946152|50202209|FG000|Overall Study|Adverse Event|1|||
25092531|NCT01946152|50202210|FG001|Overall Study|Adverse Event|0|||
25092532|NCT01946152|50202211|FG002|Overall Study|Adverse Event|0|||
25092533|NCT01946152|50202212|FG003|Overall Study|Adverse Event|0|||
25092534|NCT01946152|50202209|FG000|Overall Study|Withdrawal by Subject|0|||
25092535|NCT01946152|50202210|FG001|Overall Study|Withdrawal by Subject|2|||
25092536|NCT01946152|50202211|FG002|Overall Study|Withdrawal by Subject|0|||
25092537|NCT01946152|50202212|FG003|Overall Study|Withdrawal by Subject|0|||
25092538|NCT01946152|50202209|FG000|Overall Study|Progression|0|||
25092539|NCT01946152|50202210|FG001|Overall Study|Progression|1|||
25092540|NCT01946152|50202211|FG002|Overall Study|Progression|4|||
25092541|NCT01946152|50202212|FG003|Overall Study|Progression|7|||
25092542|NCT01946152|50202209|FG000|Overall Study|Physician Decision|0|||
25092543|NCT01946152|50202210|FG001|Overall Study|Physician Decision|0|||
25092544|NCT01946152|50202211|FG002|Overall Study|Physician Decision|1|||
25092545|NCT01946152|50202212|FG003|Overall Study|Physician Decision|0|||
25092546|NCT01946152|50202209|FG000|Overall Study|Second malignancy|0|||
25092547|NCT01946152|50202210|FG001|Overall Study|Second malignancy|0|||
25092548|NCT01946152|50202211|FG002|Overall Study|Second malignancy|1|||
25092549|NCT01946152|50202212|FG003|Overall Study|Second malignancy|0|||
25092550|NCT01946152|50202209|FG000|Overall Study|Adverse Event|0|||
25092551|NCT01946152|50202210|FG001|Overall Study|Adverse Event|0|||
25092552|NCT01946152|50202211|FG002|Overall Study|Adverse Event|0|||
25007330|NCT03799627|50099646|FG005|Overall Study|Changes In Hemoglobin Values|2|||
25007331|NCT03799627|50099647|FG006|Overall Study|Changes In Hemoglobin Values|1|||
25007332|NCT03799627|50099648|FG007|Overall Study|Changes In Hemoglobin Values|0|||
25007333|NCT03799627|50099649|FG008|Overall Study|Changes In Hemoglobin Values|1|||
25007334|NCT00756574|50099690|FG000|Overall Study|Withdrawal by Subject|9|||
25007335|NCT00756574|50099691|FG001|Overall Study|Withdrawal by Subject|7|||
25007336|NCT00756574|50099690|FG000|Overall Study|Lost to Follow-up|4|||
25007337|NCT00756574|50099691|FG001|Overall Study|Lost to Follow-up|4|||
25007338|NCT02743780|50099700|FG000|Part 3 (7 Days)|Adverse Event|0|||
25007339|NCT02743780|50099701|FG001|Part 3 (7 Days)|Adverse Event|0|||
25007340|NCT02743780|50099702|FG002|Part 3 (7 Days)|Adverse Event|1|||
25007341|NCT02743780|50099703|FG003|Part 3 (7 Days)|Adverse Event|0|||
25007342|NCT02743780|50099704|FG004|Part 3 (7 Days)|Adverse Event|0|||
25092553|NCT01946152|50202212|FG003|Overall Study|Adverse Event|1|||
25092554|NCT01945996|50202226|FG000|Overall Study|Lost to Follow-up|3|||
25092555|NCT01945996|50202227|FG001|Overall Study|Lost to Follow-up|5|||
25092556|NCT01971346|50202235|FG000|Overall Study|Protocol Violation|3|||
25092557|NCT01971346|50202235|FG000|Overall Study|Lost to Follow-up|2|||
25092558|NCT01971346|50202235|FG000|Overall Study|Withdrawal by Subject|2|||
25092559|NCT01971346|50202235|FG000|Overall Study|Physician Decision|1|||
25092560|NCT01945216|50202250|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
25092561|NCT01945216|50202250|FG000|Overall Study|Protocol Violation|42|||
25092562|NCT01945216|50202250|FG000|Overall Study|CRF not assured by investigators|5|||
25092563|NCT02641379|50202269|FG000|Overall Study|Exclusion criterion during screening|1|||
25092564|NCT02641379|50202270|FG001|Overall Study|Exclusion criterion during screening|0|||
25092565|NCT02641379|50202271|FG002|Overall Study|Exclusion criterion during screening|0|||
25092566|NCT02641379|50202272|FG003|Overall Study|Exclusion criterion during screening|1|||
25092567|NCT02641379|50202273|FG004|Overall Study|Exclusion criterion during screening|2|||
25092568|NCT02641379|50202274|FG005|Overall Study|Exclusion criterion during screening|0|||
25092569|NCT02641379|50202275|FG006|Overall Study|Exclusion criterion during screening|0|||
25092570|NCT02641379|50202276|FG007|Overall Study|Exclusion criterion during screening|0|||
25092571|NCT02641379|50202277|FG008|Overall Study|Exclusion criterion during screening|0|||
25092572|NCT02641379|50202278|FG009|Overall Study|Exclusion criterion during screening|0|||
25092573|NCT02641379|50202279|FG010|Overall Study|Exclusion criterion during screening|0|||
25092574|NCT02641379|50202269|FG000|Overall Study|Withdrawal of informed consent|0|||
25092575|NCT02641379|50202270|FG001|Overall Study|Withdrawal of informed consent|1|||
25092576|NCT02641379|50202271|FG002|Overall Study|Withdrawal of informed consent|0|||
25092577|NCT02641379|50202272|FG003|Overall Study|Withdrawal of informed consent|0|||
25092578|NCT02641379|50202273|FG004|Overall Study|Withdrawal of informed consent|0|||
25092579|NCT02641379|50202274|FG005|Overall Study|Withdrawal of informed consent|0|||
25092580|NCT02641379|50202275|FG006|Overall Study|Withdrawal of informed consent|0|||
25092581|NCT02641379|50202276|FG007|Overall Study|Withdrawal of informed consent|1|||
25092582|NCT02641379|50202277|FG008|Overall Study|Withdrawal of informed consent|0|||
25092583|NCT02641379|50202278|FG009|Overall Study|Withdrawal of informed consent|0|||
25092584|NCT02641379|50202279|FG010|Overall Study|Withdrawal of informed consent|0|||
25092585|NCT02641379|50202269|FG000|Overall Study|Adverse Event|7|||
25092586|NCT02641379|50202270|FG001|Overall Study|Adverse Event|8|||
25092587|NCT02641379|50202271|FG002|Overall Study|Adverse Event|2|||
25092588|NCT02641379|50202272|FG003|Overall Study|Adverse Event|2|||
25092589|NCT02641379|50202273|FG004|Overall Study|Adverse Event|5|||
25092590|NCT02641379|50202274|FG005|Overall Study|Adverse Event|1|||
25092591|NCT02641379|50202275|FG006|Overall Study|Adverse Event|5|||
25092592|NCT02641379|50202276|FG007|Overall Study|Adverse Event|0|||
25092593|NCT02641379|50202277|FG008|Overall Study|Adverse Event|1|||
25092594|NCT02641379|50202278|FG009|Overall Study|Adverse Event|1|||
25092595|NCT02641379|50202279|FG010|Overall Study|Adverse Event|5|||
25092596|NCT02641379|50202269|FG000|Overall Study|Lack of Efficacy|0|||
25092597|NCT02641379|50202270|FG001|Overall Study|Lack of Efficacy|0|||
25092598|NCT02641379|50202271|FG002|Overall Study|Lack of Efficacy|2|||
25092599|NCT02641379|50202272|FG003|Overall Study|Lack of Efficacy|0|||
25092600|NCT02641379|50202273|FG004|Overall Study|Lack of Efficacy|0|||
25092601|NCT02641379|50202274|FG005|Overall Study|Lack of Efficacy|2|||
25092602|NCT02641379|50202275|FG006|Overall Study|Lack of Efficacy|0|||
25092603|NCT02641379|50202276|FG007|Overall Study|Lack of Efficacy|5|||
25092604|NCT02641379|50202277|FG008|Overall Study|Lack of Efficacy|0|||
25092605|NCT02641379|50202278|FG009|Overall Study|Lack of Efficacy|0|||
25092606|NCT02641379|50202279|FG010|Overall Study|Lack of Efficacy|0|||
25092607|NCT02641379|50202269|FG000|Overall Study|Participant unable to attend study visit|4|||
25092608|NCT02641379|50202270|FG001|Overall Study|Participant unable to attend study visit|10|||
25092609|NCT02641379|50202271|FG002|Overall Study|Participant unable to attend study visit|1|||
25092610|NCT02641379|50202272|FG003|Overall Study|Participant unable to attend study visit|2|||
25092611|NCT02641379|50202273|FG004|Overall Study|Participant unable to attend study visit|5|||
25092612|NCT02641379|50202274|FG005|Overall Study|Participant unable to attend study visit|1|||
25092613|NCT02641379|50202275|FG006|Overall Study|Participant unable to attend study visit|1|||
25092614|NCT02641379|50202276|FG007|Overall Study|Participant unable to attend study visit|1|||
25092615|NCT02641379|50202277|FG008|Overall Study|Participant unable to attend study visit|0|||
25092616|NCT02641379|50202278|FG009|Overall Study|Participant unable to attend study visit|2|||
25092617|NCT02641379|50202279|FG010|Overall Study|Participant unable to attend study visit|0|||
25092618|NCT02641379|50202269|FG000|Overall Study|Participant's compliance|0|||
25092619|NCT02641379|50202270|FG001|Overall Study|Participant's compliance|1|||
25092620|NCT02641379|50202271|FG002|Overall Study|Participant's compliance|0|||
25092621|NCT02641379|50202272|FG003|Overall Study|Participant's compliance|1|||
25092622|NCT02641379|50202273|FG004|Overall Study|Participant's compliance|0|||
25092623|NCT02641379|50202274|FG005|Overall Study|Participant's compliance|2|||
25176896|NCT01510769|50320522|FG002|Overall Study|Withdrawal by Subject|3|||
25092624|NCT02641379|50202275|FG006|Overall Study|Participant's compliance|0|||
25092625|NCT02641379|50202276|FG007|Overall Study|Participant's compliance|0|||
25092626|NCT02641379|50202277|FG008|Overall Study|Participant's compliance|1|||
25092627|NCT02641379|50202278|FG009|Overall Study|Participant's compliance|1|||
25092628|NCT02641379|50202279|FG010|Overall Study|Participant's compliance|1|||
25092629|NCT02641379|50202269|FG000|Overall Study|Participant cannot be reached|4|||
25092630|NCT02641379|50202270|FG001|Overall Study|Participant cannot be reached|4|||
25176897|NCT01510769|50320520|FG000|Overall Study|Death|1|||
25092631|NCT02641379|50202271|FG002|Overall Study|Participant cannot be reached|0|||
25092632|NCT02641379|50202272|FG003|Overall Study|Participant cannot be reached|8|||
25092633|NCT02641379|50202273|FG004|Overall Study|Participant cannot be reached|2|||
25092634|NCT02641379|50202274|FG005|Overall Study|Participant cannot be reached|1|||
25092635|NCT02641379|50202275|FG006|Overall Study|Participant cannot be reached|0|||
25092636|NCT02641379|50202276|FG007|Overall Study|Participant cannot be reached|1|||
25092637|NCT02641379|50202277|FG008|Overall Study|Participant cannot be reached|0|||
25092638|NCT02641379|50202278|FG009|Overall Study|Participant cannot be reached|2|||
25092639|NCT02641379|50202279|FG010|Overall Study|Participant cannot be reached|1|||
25092640|NCT02641379|50202269|FG000|Overall Study|PCR positive at Week 24|15|||
25092641|NCT02641379|50202270|FG001|Overall Study|PCR positive at Week 24|21|||
25092642|NCT02641379|50202271|FG002|Overall Study|PCR positive at Week 24|62|||
25092643|NCT02641379|50202272|FG003|Overall Study|PCR positive at Week 24|0|||
25092644|NCT02641379|50202273|FG004|Overall Study|PCR positive at Week 24|0|||
25092645|NCT02641379|50202274|FG005|Overall Study|PCR positive at Week 24|6|||
25092646|NCT02641379|50202275|FG006|Overall Study|PCR positive at Week 24|3|||
25092647|NCT02641379|50202276|FG007|Overall Study|PCR positive at Week 24|8|||
25092648|NCT02641379|50202277|FG008|Overall Study|PCR positive at Week 24|0|||
25092649|NCT02641379|50202278|FG009|Overall Study|PCR positive at Week 24|1|||
25092650|NCT02641379|50202279|FG010|Overall Study|PCR positive at Week 24|0|||
25092651|NCT02641379|50202269|FG000|Overall Study|PCR positive at follow up 2|1|||
25092652|NCT02641379|50202270|FG001|Overall Study|PCR positive at follow up 2|0|||
25092653|NCT02641379|50202271|FG002|Overall Study|PCR positive at follow up 2|0|||
25092654|NCT02641379|50202272|FG003|Overall Study|PCR positive at follow up 2|0|||
25092655|NCT02641379|50202273|FG004|Overall Study|PCR positive at follow up 2|0|||
25092656|NCT02641379|50202274|FG005|Overall Study|PCR positive at follow up 2|0|||
25092657|NCT02641379|50202275|FG006|Overall Study|PCR positive at follow up 2|0|||
25092658|NCT02641379|50202276|FG007|Overall Study|PCR positive at follow up 2|0|||
25092659|NCT02641379|50202277|FG008|Overall Study|PCR positive at follow up 2|0|||
25092660|NCT02641379|50202278|FG009|Overall Study|PCR positive at follow up 2|0|||
25092661|NCT02641379|50202279|FG010|Overall Study|PCR positive at follow up 2|0|||
25092662|NCT02641379|50202269|FG000|Overall Study|Participant showed relapse|1|||
25092663|NCT02641379|50202270|FG001|Overall Study|Participant showed relapse|0|||
25092664|NCT02641379|50202271|FG002|Overall Study|Participant showed relapse|0|||
25092665|NCT02641379|50202272|FG003|Overall Study|Participant showed relapse|0|||
25092666|NCT02641379|50202273|FG004|Overall Study|Participant showed relapse|0|||
25092667|NCT02641379|50202274|FG005|Overall Study|Participant showed relapse|0|||
25092668|NCT02641379|50202275|FG006|Overall Study|Participant showed relapse|1|||
25092669|NCT02641379|50202276|FG007|Overall Study|Participant showed relapse|0|||
25092670|NCT02641379|50202277|FG008|Overall Study|Participant showed relapse|0|||
25092671|NCT02641379|50202278|FG009|Overall Study|Participant showed relapse|0|||
25092672|NCT02641379|50202279|FG010|Overall Study|Participant showed relapse|0|||
25092673|NCT02641379|50202269|FG000|Overall Study|Participant stopped study/treatment|1|||
25092674|NCT02641379|50202270|FG001|Overall Study|Participant stopped study/treatment|3|||
25092675|NCT02641379|50202271|FG002|Overall Study|Participant stopped study/treatment|1|||
25092676|NCT02641379|50202272|FG003|Overall Study|Participant stopped study/treatment|0|||
25092677|NCT02641379|50202273|FG004|Overall Study|Participant stopped study/treatment|0|||
25092678|NCT02641379|50202274|FG005|Overall Study|Participant stopped study/treatment|1|||
25092679|NCT02641379|50202275|FG006|Overall Study|Participant stopped study/treatment|2|||
25092680|NCT02641379|50202276|FG007|Overall Study|Participant stopped study/treatment|0|||
25092681|NCT02641379|50202277|FG008|Overall Study|Participant stopped study/treatment|1|||
25092682|NCT02641379|50202278|FG009|Overall Study|Participant stopped study/treatment|0|||
25092683|NCT02641379|50202279|FG010|Overall Study|Participant stopped study/treatment|0|||
25092684|NCT02641379|50202269|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
25092685|NCT02641379|50202270|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
25092686|NCT02641379|50202271|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
25092687|NCT02641379|50202272|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
25092688|NCT02641379|50202273|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
25092689|NCT02641379|50202274|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
25092690|NCT02641379|50202275|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
25092691|NCT02641379|50202276|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
25092692|NCT02641379|50202277|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
25092693|NCT02641379|50202278|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
25176898|NCT01510769|50320521|FG001|Overall Study|Death|1|||
25092694|NCT02641379|50202279|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
25092695|NCT02641379|50202269|FG000|Overall Study|Financial problems|0|||
25092696|NCT02641379|50202270|FG001|Overall Study|Financial problems|1|||
25176899|NCT01510769|50320522|FG002|Overall Study|Death|0|||
25092697|NCT02641379|50202271|FG002|Overall Study|Financial problems|0|||
25092698|NCT02641379|50202272|FG003|Overall Study|Financial problems|0|||
25092699|NCT02641379|50202273|FG004|Overall Study|Financial problems|0|||
25092700|NCT02641379|50202274|FG005|Overall Study|Financial problems|0|||
25176900|NCT01575769|50320530|FG000|Overall Study|Adverse Event|1|||
25092701|NCT02641379|50202275|FG006|Overall Study|Financial problems|0|||
25092702|NCT02641379|50202276|FG007|Overall Study|Financial problems|0|||
25092703|NCT02641379|50202277|FG008|Overall Study|Financial problems|0|||
25092704|NCT02641379|50202278|FG009|Overall Study|Financial problems|0|||
25092705|NCT02641379|50202279|FG010|Overall Study|Financial problems|0|||
25092706|NCT02641379|50202269|FG000|Overall Study|PCR positive at Week 68|0|||
25092707|NCT02641379|50202270|FG001|Overall Study|PCR positive at Week 68|1|||
25092708|NCT02641379|50202271|FG002|Overall Study|PCR positive at Week 68|0|||
25092709|NCT02641379|50202272|FG003|Overall Study|PCR positive at Week 68|0|||
25092710|NCT02641379|50202273|FG004|Overall Study|PCR positive at Week 68|0|||
25092711|NCT02641379|50202274|FG005|Overall Study|PCR positive at Week 68|0|||
25092712|NCT02641379|50202275|FG006|Overall Study|PCR positive at Week 68|0|||
25092713|NCT02641379|50202276|FG007|Overall Study|PCR positive at Week 68|0|||
25092714|NCT02641379|50202277|FG008|Overall Study|PCR positive at Week 68|0|||
25092715|NCT02641379|50202278|FG009|Overall Study|PCR positive at Week 68|0|||
25092716|NCT02641379|50202279|FG010|Overall Study|PCR positive at Week 68|0|||
25092717|NCT02641379|50202269|FG000|Overall Study|PCR positive at Week 48|0|||
25092718|NCT02641379|50202270|FG001|Overall Study|PCR positive at Week 48|1|||
25092719|NCT02641379|50202271|FG002|Overall Study|PCR positive at Week 48|0|||
25092720|NCT02641379|50202272|FG003|Overall Study|PCR positive at Week 48|0|||
25092721|NCT02641379|50202273|FG004|Overall Study|PCR positive at Week 48|0|||
25092722|NCT02641379|50202274|FG005|Overall Study|PCR positive at Week 48|0|||
25092723|NCT02641379|50202275|FG006|Overall Study|PCR positive at Week 48|0|||
25092724|NCT02641379|50202276|FG007|Overall Study|PCR positive at Week 48|0|||
25092725|NCT02641379|50202277|FG008|Overall Study|PCR positive at Week 48|0|||
25092726|NCT02641379|50202278|FG009|Overall Study|PCR positive at Week 48|0|||
25092727|NCT02641379|50202279|FG010|Overall Study|PCR positive at Week 48|0|||
25092728|NCT02641379|50202269|FG000|Overall Study|PCR not performed at Week 12|0|||
25092729|NCT02641379|50202270|FG001|Overall Study|PCR not performed at Week 12|0|||
25092730|NCT02641379|50202271|FG002|Overall Study|PCR not performed at Week 12|1|||
25092731|NCT02641379|50202272|FG003|Overall Study|PCR not performed at Week 12|0|||
25092732|NCT02641379|50202273|FG004|Overall Study|PCR not performed at Week 12|0|||
25092733|NCT02641379|50202274|FG005|Overall Study|PCR not performed at Week 12|0|||
25092734|NCT02641379|50202275|FG006|Overall Study|PCR not performed at Week 12|0|||
25092735|NCT02641379|50202276|FG007|Overall Study|PCR not performed at Week 12|0|||
25092736|NCT02641379|50202277|FG008|Overall Study|PCR not performed at Week 12|0|||
25092737|NCT02641379|50202278|FG009|Overall Study|PCR not performed at Week 12|0|||
25092738|NCT02641379|50202279|FG010|Overall Study|PCR not performed at Week 12|0|||
25092739|NCT02641379|50202269|FG000|Overall Study|No PCR at baseline|0|||
25092740|NCT02641379|50202270|FG001|Overall Study|No PCR at baseline|0|||
25092741|NCT02641379|50202271|FG002|Overall Study|No PCR at baseline|1|||
25092742|NCT02641379|50202272|FG003|Overall Study|No PCR at baseline|0|||
25092743|NCT02641379|50202273|FG004|Overall Study|No PCR at baseline|0|||
25092744|NCT02641379|50202274|FG005|Overall Study|No PCR at baseline|0|||
25092745|NCT02641379|50202275|FG006|Overall Study|No PCR at baseline|0|||
25092746|NCT02641379|50202276|FG007|Overall Study|No PCR at baseline|0|||
25092747|NCT02641379|50202277|FG008|Overall Study|No PCR at baseline|0|||
25092748|NCT02641379|50202278|FG009|Overall Study|No PCR at baseline|0|||
25092749|NCT02641379|50202279|FG010|Overall Study|No PCR at baseline|0|||
25092750|NCT02641379|50202269|FG000|Overall Study|PCR positive at Week 28|0|||
25092751|NCT02641379|50202270|FG001|Overall Study|PCR positive at Week 28|0|||
25092752|NCT02641379|50202271|FG002|Overall Study|PCR positive at Week 28|1|||
25092753|NCT02641379|50202272|FG003|Overall Study|PCR positive at Week 28|0|||
25092754|NCT02641379|50202273|FG004|Overall Study|PCR positive at Week 28|0|||
25176901|NCT01575769|50320530|FG000|Overall Study|Study terminated by sponsor|40|||
25007343|NCT02880956|50099728|FG000|Overall Study|Adverse Event|3|||
25007344|NCT02880956|50099729|FG001|Overall Study|Adverse Event|6|||
25007345|NCT02880956|50099730|FG002|Overall Study|Adverse Event|5|||
25007346|NCT02880956|50099731|FG003|Overall Study|Adverse Event|4|||
25007347|NCT02880956|50099728|FG000|Overall Study|Withdrawal by Subject|9|||
25007348|NCT02880956|50099729|FG001|Overall Study|Withdrawal by Subject|4|||
25007349|NCT02880956|50099730|FG002|Overall Study|Withdrawal by Subject|6|||
25007350|NCT02880956|50099731|FG003|Overall Study|Withdrawal by Subject|11|||
25007351|NCT02880956|50099728|FG000|Overall Study|Lost to Follow-up|0|||
25007352|NCT02880956|50099729|FG001|Overall Study|Lost to Follow-up|1|||
25007353|NCT02880956|50099730|FG002|Overall Study|Lost to Follow-up|0|||
25007354|NCT02880956|50099731|FG003|Overall Study|Lost to Follow-up|0|||
25007355|NCT02880956|50099728|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
25007356|NCT02880956|50099729|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
25007357|NCT02880956|50099730|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
25007358|NCT02880956|50099731|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
25007359|NCT02880956|50099728|FG000|Overall Study|Other, Not Specified|4|||
25092755|NCT02641379|50202274|FG005|Overall Study|PCR positive at Week 28|0|||
25092756|NCT02641379|50202275|FG006|Overall Study|PCR positive at Week 28|0|||
25092757|NCT02641379|50202276|FG007|Overall Study|PCR positive at Week 28|0|||
25092758|NCT02641379|50202277|FG008|Overall Study|PCR positive at Week 28|0|||
25092759|NCT02641379|50202278|FG009|Overall Study|PCR positive at Week 28|0|||
25092760|NCT02641379|50202279|FG010|Overall Study|PCR positive at Week 28|0|||
25092761|NCT02641379|50202269|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
25092762|NCT02641379|50202270|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
25092763|NCT02641379|50202271|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
25092764|NCT02641379|50202272|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
25092765|NCT02641379|50202273|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
25092766|NCT02641379|50202274|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
25092767|NCT02641379|50202275|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
25092768|NCT02641379|50202276|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
25092769|NCT02641379|50202277|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
25092770|NCT02641379|50202278|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
25092771|NCT02641379|50202279|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
25092772|NCT02641379|50202269|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
25092773|NCT02641379|50202270|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
25007360|NCT02880956|50099729|FG001|Overall Study|Other, Not Specified|2|||
25007361|NCT02880956|50099730|FG002|Overall Study|Other, Not Specified|0|||
25007362|NCT02880956|50099731|FG003|Overall Study|Other, Not Specified|3|||
25007363|NCT01352416|50099748|FG000|Overall Study|Physician Decision|1|||
25007364|NCT01352416|50099749|FG001|Overall Study|Physician Decision|2|||
25007365|NCT01352416|50099750|FG002|Overall Study|Physician Decision|2|||
25007366|NCT01352416|50099751|FG003|Overall Study|Physician Decision|1|||
25007367|NCT00439738|50099763|FG000|Overall Study|Withdrawal by Subject|16|||
25007368|NCT00439738|50099764|FG001|Overall Study|Withdrawal by Subject|13|||
25007369|NCT00439738|50099763|FG000|Overall Study|Adverse Event|6|||
25007370|NCT00439738|50099764|FG001|Overall Study|Adverse Event|4|||
25007371|NCT00439738|50099763|FG000|Overall Study|Lost to Follow-up|5|||
25007372|NCT00439738|50099764|FG001|Overall Study|Lost to Follow-up|6|||
25007373|NCT00439738|50099763|FG000|Overall Study|Protocol Violation|6|||
25007374|NCT00439738|50099764|FG001|Overall Study|Protocol Violation|3|||
25007375|NCT00439738|50099763|FG000|Overall Study|Lack of Efficacy|2|||
25007376|NCT00439738|50099764|FG001|Overall Study|Lack of Efficacy|2|||
25007377|NCT00439738|50099763|FG000|Overall Study|Abnormal Lab Values|1|||
25007378|NCT00439738|50099764|FG001|Overall Study|Abnormal Lab Values|0|||
25007379|NCT00338104|50099771|FG000|Overall Study|Protocol Violation|2|||
25007380|NCT00338104|50099772|FG001|Overall Study|Protocol Violation|1|||
25007381|NCT00338104|50099773|FG002|Overall Study|Protocol Violation|3|||
25007382|NCT02883452|50099784|FG000|Overall Study|Withdrawal by Subject|1|||
25007383|NCT02883452|50099785|FG001|Overall Study|Withdrawal by Subject|1|||
25007384|NCT02883452|50099786|FG002|Overall Study|Withdrawal by Subject|3|||
25007385|NCT02883452|50099787|FG003|Overall Study|Withdrawal by Subject|0|||
25007386|NCT02883452|50099788|FG004|Overall Study|Withdrawal by Subject|2|||
25007387|NCT02883452|50099789|FG005|Overall Study|Withdrawal by Subject|5|||
25007388|NCT02883452|50099784|FG000|Overall Study|Disease progression|1|||
25007389|NCT02883452|50099785|FG001|Overall Study|Disease progression|0|||
25007390|NCT02883452|50099786|FG002|Overall Study|Disease progression|0|||
25007391|NCT02883452|50099787|FG003|Overall Study|Disease progression|1|||
25007392|NCT02883452|50099788|FG004|Overall Study|Disease progression|4|||
25007393|NCT02883452|50099789|FG005|Overall Study|Disease progression|5|||
25007394|NCT02883452|50099784|FG000|Overall Study|Adverse Event|2|||
25007395|NCT02883452|50099785|FG001|Overall Study|Adverse Event|1|||
25007396|NCT02883452|50099786|FG002|Overall Study|Adverse Event|1|||
25007397|NCT02883452|50099787|FG003|Overall Study|Adverse Event|1|||
25007398|NCT02883452|50099788|FG004|Overall Study|Adverse Event|1|||
25007399|NCT02883452|50099789|FG005|Overall Study|Adverse Event|3|||
25007400|NCT02883452|50099784|FG000|Overall Study|Physician Decision|0|||
25007401|NCT02883452|50099785|FG001|Overall Study|Physician Decision|0|||
25007402|NCT02883452|50099786|FG002|Overall Study|Physician Decision|0|||
25007403|NCT02883452|50099787|FG003|Overall Study|Physician Decision|0|||
25007404|NCT02883452|50099788|FG004|Overall Study|Physician Decision|4|||
25007405|NCT02883452|50099789|FG005|Overall Study|Physician Decision|1|||
25007406|NCT02883452|50099784|FG000|Overall Study|Death|1|||
25007407|NCT02883452|50099785|FG001|Overall Study|Death|0|||
25007408|NCT02883452|50099786|FG002|Overall Study|Death|1|||
25007409|NCT02883452|50099787|FG003|Overall Study|Death|0|||
25007410|NCT02883452|50099788|FG004|Overall Study|Death|0|||
25092774|NCT02641379|50202271|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
25007411|NCT02883452|50099789|FG005|Overall Study|Death|0|||
25007412|NCT02883452|50099784|FG000|Overall Study|Other|0|||
25007413|NCT02883452|50099785|FG001|Overall Study|Other|0|||
25007414|NCT02883452|50099786|FG002|Overall Study|Other|0|||
25007415|NCT02883452|50099787|FG003|Overall Study|Other|0|||
25007416|NCT02883452|50099788|FG004|Overall Study|Other|0|||
25007417|NCT02883452|50099789|FG005|Overall Study|Other|1|||
25007418|NCT00151372|50099806|FG000|Overall Study|Death|12|||
25007419|NCT00151372|50099807|FG001|Overall Study|Death|11|||
25007420|NCT00151372|50099806|FG000|Overall Study|Lost to Follow-up|5|||
25007421|NCT00151372|50099807|FG001|Overall Study|Lost to Follow-up|5|||
25092775|NCT02641379|50202272|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
25092776|NCT02641379|50202273|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
25092777|NCT02641379|50202274|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
25092778|NCT02641379|50202275|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
25092779|NCT02641379|50202276|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
25092780|NCT02641379|50202277|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
25092781|NCT02641379|50202278|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
25092782|NCT02641379|50202279|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
25092783|NCT02641379|50202269|FG000|Overall Study|Baseline viral load unavailable|0|||
25092784|NCT02641379|50202270|FG001|Overall Study|Baseline viral load unavailable|0|||
25092785|NCT02641379|50202271|FG002|Overall Study|Baseline viral load unavailable|0|||
25092786|NCT02641379|50202272|FG003|Overall Study|Baseline viral load unavailable|1|||
25092787|NCT02641379|50202273|FG004|Overall Study|Baseline viral load unavailable|0|||
25092788|NCT02641379|50202274|FG005|Overall Study|Baseline viral load unavailable|0|||
25092789|NCT02641379|50202275|FG006|Overall Study|Baseline viral load unavailable|0|||
25092790|NCT02641379|50202276|FG007|Overall Study|Baseline viral load unavailable|0|||
25092791|NCT02641379|50202277|FG008|Overall Study|Baseline viral load unavailable|0|||
25092792|NCT02641379|50202278|FG009|Overall Study|Baseline viral load unavailable|0|||
25092793|NCT02641379|50202279|FG010|Overall Study|Baseline viral load unavailable|0|||
25092794|NCT02641379|50202269|FG000|Overall Study|Blood could not be drawn|0|||
25092795|NCT02641379|50202270|FG001|Overall Study|Blood could not be drawn|0|||
25092796|NCT02641379|50202271|FG002|Overall Study|Blood could not be drawn|0|||
25092797|NCT02641379|50202272|FG003|Overall Study|Blood could not be drawn|0|||
25092798|NCT02641379|50202273|FG004|Overall Study|Blood could not be drawn|1|||
25092799|NCT02641379|50202274|FG005|Overall Study|Blood could not be drawn|0|||
25092800|NCT02641379|50202275|FG006|Overall Study|Blood could not be drawn|0|||
25092801|NCT02641379|50202276|FG007|Overall Study|Blood could not be drawn|0|||
25092802|NCT02641379|50202277|FG008|Overall Study|Blood could not be drawn|0|||
25092803|NCT02641379|50202278|FG009|Overall Study|Blood could not be drawn|0|||
25092804|NCT02641379|50202279|FG010|Overall Study|Blood could not be drawn|0|||
25092805|NCT02641379|50202269|FG000|Overall Study|Protocol Violation|0|||
25092806|NCT02641379|50202270|FG001|Overall Study|Protocol Violation|0|||
25092807|NCT02641379|50202271|FG002|Overall Study|Protocol Violation|0|||
25092808|NCT02641379|50202272|FG003|Overall Study|Protocol Violation|0|||
25092809|NCT02641379|50202273|FG004|Overall Study|Protocol Violation|2|||
25092810|NCT02641379|50202274|FG005|Overall Study|Protocol Violation|0|||
25092811|NCT02641379|50202275|FG006|Overall Study|Protocol Violation|0|||
25092812|NCT02641379|50202276|FG007|Overall Study|Protocol Violation|0|||
25092813|NCT02641379|50202277|FG008|Overall Study|Protocol Violation|1|||
25092814|NCT02641379|50202278|FG009|Overall Study|Protocol Violation|0|||
25092815|NCT02641379|50202279|FG010|Overall Study|Protocol Violation|0|||
25092816|NCT02641379|50202269|FG000|Overall Study|Participation in sili rescue study|0|||
25092817|NCT02641379|50202270|FG001|Overall Study|Participation in sili rescue study|0|||
25092818|NCT02641379|50202271|FG002|Overall Study|Participation in sili rescue study|0|||
25092819|NCT02641379|50202272|FG003|Overall Study|Participation in sili rescue study|0|||
25092820|NCT02641379|50202273|FG004|Overall Study|Participation in sili rescue study|0|||
25092821|NCT02641379|50202274|FG005|Overall Study|Participation in sili rescue study|1|||
25092822|NCT02641379|50202275|FG006|Overall Study|Participation in sili rescue study|0|||
25092823|NCT02641379|50202276|FG007|Overall Study|Participation in sili rescue study|0|||
25092824|NCT02641379|50202277|FG008|Overall Study|Participation in sili rescue study|0|||
25092825|NCT02641379|50202278|FG009|Overall Study|Participation in sili rescue study|0|||
25092826|NCT02641379|50202279|FG010|Overall Study|Participation in sili rescue study|0|||
25092827|NCT02641379|50202269|FG000|Overall Study|Lost to Follow-up|0|||
25092828|NCT02641379|50202270|FG001|Overall Study|Lost to Follow-up|0|||
25092829|NCT02641379|50202271|FG002|Overall Study|Lost to Follow-up|0|||
25092830|NCT02641379|50202272|FG003|Overall Study|Lost to Follow-up|0|||
25092831|NCT02641379|50202273|FG004|Overall Study|Lost to Follow-up|0|||
25092832|NCT02641379|50202274|FG005|Overall Study|Lost to Follow-up|0|||
25092833|NCT02641379|50202275|FG006|Overall Study|Lost to Follow-up|0|||
25092834|NCT02641379|50202276|FG007|Overall Study|Lost to Follow-up|0|||
25092835|NCT02641379|50202277|FG008|Overall Study|Lost to Follow-up|1|||
25092836|NCT02641379|50202278|FG009|Overall Study|Lost to Follow-up|0|||
25092837|NCT02641379|50202279|FG010|Overall Study|Lost to Follow-up|0|||
25092838|NCT02641379|50202269|FG000|Overall Study|Source data not found|0|||
25092839|NCT02641379|50202270|FG001|Overall Study|Source data not found|0|||
25092840|NCT02641379|50202271|FG002|Overall Study|Source data not found|0|||
25092841|NCT02641379|50202272|FG003|Overall Study|Source data not found|0|||
25092842|NCT02641379|50202273|FG004|Overall Study|Source data not found|0|||
25092843|NCT02641379|50202274|FG005|Overall Study|Source data not found|1|||
25092844|NCT02641379|50202275|FG006|Overall Study|Source data not found|0|||
25092845|NCT02641379|50202276|FG007|Overall Study|Source data not found|0|||
25092846|NCT02641379|50202277|FG008|Overall Study|Source data not found|0|||
25092847|NCT02641379|50202278|FG009|Overall Study|Source data not found|0|||
25092848|NCT02641379|50202279|FG010|Overall Study|Source data not found|0|||
25092849|NCT02641379|50202269|FG000|Overall Study|Participant showed weight reduction|0|||
25176902|NCT01510145|50320536|FG000|Overall Study|Adverse Event|6|||
25092850|NCT02641379|50202270|FG001|Overall Study|Participant showed weight reduction|0|||
25092851|NCT02641379|50202271|FG002|Overall Study|Participant showed weight reduction|0|||
25092852|NCT02641379|50202272|FG003|Overall Study|Participant showed weight reduction|0|||
25092853|NCT02641379|50202273|FG004|Overall Study|Participant showed weight reduction|0|||
25092854|NCT02641379|50202274|FG005|Overall Study|Participant showed weight reduction|0|||
25092855|NCT02641379|50202275|FG006|Overall Study|Participant showed weight reduction|0|||
25092856|NCT02641379|50202276|FG007|Overall Study|Participant showed weight reduction|1|||
25092857|NCT02641379|50202277|FG008|Overall Study|Participant showed weight reduction|0|||
25092858|NCT02641379|50202278|FG009|Overall Study|Participant showed weight reduction|0|||
25092859|NCT02641379|50202279|FG010|Overall Study|Participant showed weight reduction|0|||
25092860|NCT02641379|50202269|FG000|Overall Study|Non-response Week 12|0|||
25092861|NCT02641379|50202270|FG001|Overall Study|Non-response Week 12|0|||
25092862|NCT02641379|50202271|FG002|Overall Study|Non-response Week 12|0|||
25092863|NCT02641379|50202272|FG003|Overall Study|Non-response Week 12|0|||
25092864|NCT02641379|50202273|FG004|Overall Study|Non-response Week 12|0|||
25092865|NCT02641379|50202274|FG005|Overall Study|Non-response Week 12|0|||
25092866|NCT02641379|50202275|FG006|Overall Study|Non-response Week 12|0|||
25092867|NCT02641379|50202276|FG007|Overall Study|Non-response Week 12|1|||
25092868|NCT02641379|50202277|FG008|Overall Study|Non-response Week 12|0|||
25092869|NCT02641379|50202278|FG009|Overall Study|Non-response Week 12|0|||
25092870|NCT02641379|50202279|FG010|Overall Study|Non-response Week 12|0|||
25092871|NCT02641379|50202269|FG000|Overall Study|No 2 Log drop at Week 12|0|||
25092872|NCT02641379|50202270|FG001|Overall Study|No 2 Log drop at Week 12|0|||
25092873|NCT02641379|50202271|FG002|Overall Study|No 2 Log drop at Week 12|0|||
25092874|NCT02641379|50202272|FG003|Overall Study|No 2 Log drop at Week 12|0|||
25092875|NCT02641379|50202273|FG004|Overall Study|No 2 Log drop at Week 12|0|||
25092876|NCT02641379|50202274|FG005|Overall Study|No 2 Log drop at Week 12|0|||
25092877|NCT02641379|50202275|FG006|Overall Study|No 2 Log drop at Week 12|0|||
25092878|NCT02641379|50202276|FG007|Overall Study|No 2 Log drop at Week 12|0|||
25092879|NCT02641379|50202277|FG008|Overall Study|No 2 Log drop at Week 12|0|||
25092880|NCT02641379|50202278|FG009|Overall Study|No 2 Log drop at Week 12|0|||
25092881|NCT02641379|50202279|FG010|Overall Study|No 2 Log drop at Week 12|1|||
25092882|NCT02641379|50202269|FG000|Overall Study|Negative PCR result|0|||
25092883|NCT02641379|50202270|FG001|Overall Study|Negative PCR result|0|||
25092884|NCT02641379|50202271|FG002|Overall Study|Negative PCR result|0|||
25092885|NCT02641379|50202272|FG003|Overall Study|Negative PCR result|0|||
25092886|NCT02641379|50202273|FG004|Overall Study|Negative PCR result|0|||
25092887|NCT02641379|50202274|FG005|Overall Study|Negative PCR result|0|||
25092888|NCT02641379|50202275|FG006|Overall Study|Negative PCR result|0|||
25092889|NCT02641379|50202276|FG007|Overall Study|Negative PCR result|0|||
25092890|NCT02641379|50202277|FG008|Overall Study|Negative PCR result|0|||
25092891|NCT02641379|50202278|FG009|Overall Study|Negative PCR result|1|||
25092892|NCT02641379|50202279|FG010|Overall Study|Negative PCR result|0|||
25092893|NCT02641379|50202269|FG000|Overall Study|Participant's PCR high|0|||
25092894|NCT02641379|50202270|FG001|Overall Study|Participant's PCR high|0|||
25092895|NCT02641379|50202271|FG002|Overall Study|Participant's PCR high|0|||
25092896|NCT02641379|50202272|FG003|Overall Study|Participant's PCR high|0|||
25092897|NCT02641379|50202273|FG004|Overall Study|Participant's PCR high|0|||
25092898|NCT02641379|50202274|FG005|Overall Study|Participant's PCR high|0|||
25092899|NCT02641379|50202275|FG006|Overall Study|Participant's PCR high|0|||
25092900|NCT02641379|50202276|FG007|Overall Study|Participant's PCR high|1|||
25092901|NCT02641379|50202277|FG008|Overall Study|Participant's PCR high|0|||
25092902|NCT02641379|50202278|FG009|Overall Study|Participant's PCR high|0|||
25092903|NCT02641379|50202279|FG010|Overall Study|Participant's PCR high|0|||
25092904|NCT02641379|50202269|FG000|Overall Study|Participant treated after Week 24|0|||
25092905|NCT02641379|50202270|FG001|Overall Study|Participant treated after Week 24|0|||
25092906|NCT02641379|50202271|FG002|Overall Study|Participant treated after Week 24|0|||
25092907|NCT02641379|50202272|FG003|Overall Study|Participant treated after Week 24|0|||
25092908|NCT02641379|50202273|FG004|Overall Study|Participant treated after Week 24|0|||
25092909|NCT02641379|50202274|FG005|Overall Study|Participant treated after Week 24|0|||
25092910|NCT02641379|50202275|FG006|Overall Study|Participant treated after Week 24|0|||
25092911|NCT02641379|50202276|FG007|Overall Study|Participant treated after Week 24|0|||
25092912|NCT02641379|50202277|FG008|Overall Study|Participant treated after Week 24|1|||
25092913|NCT02641379|50202278|FG009|Overall Study|Participant treated after Week 24|0|||
25092914|NCT02641379|50202279|FG010|Overall Study|Participant treated after Week 24|0|||
25092915|NCT02641379|50202269|FG000|Overall Study|Missing PCR result at Week 8|0|||
25092916|NCT02641379|50202270|FG001|Overall Study|Missing PCR result at Week 8|0|||
25092917|NCT02641379|50202271|FG002|Overall Study|Missing PCR result at Week 8|0|||
25092918|NCT02641379|50202272|FG003|Overall Study|Missing PCR result at Week 8|0|||
25092919|NCT02641379|50202273|FG004|Overall Study|Missing PCR result at Week 8|0|||
25092920|NCT02641379|50202274|FG005|Overall Study|Missing PCR result at Week 8|0|||
25092921|NCT02641379|50202275|FG006|Overall Study|Missing PCR result at Week 8|0|||
25092922|NCT02641379|50202276|FG007|Overall Study|Missing PCR result at Week 8|0|||
25092923|NCT02641379|50202277|FG008|Overall Study|Missing PCR result at Week 8|0|||
25092924|NCT02641379|50202278|FG009|Overall Study|Missing PCR result at Week 8|1|||
25092925|NCT02641379|50202279|FG010|Overall Study|Missing PCR result at Week 8|0|||
25092926|NCT02641379|50202269|FG000|Overall Study|PCR positive|0|||
25092927|NCT02641379|50202270|FG001|Overall Study|PCR positive|0|||
25092928|NCT02641379|50202271|FG002|Overall Study|PCR positive|0|||
25092929|NCT02641379|50202272|FG003|Overall Study|PCR positive|0|||
25092930|NCT02641379|50202273|FG004|Overall Study|PCR positive|0|||
25092931|NCT02641379|50202274|FG005|Overall Study|PCR positive|0|||
25092932|NCT02641379|50202275|FG006|Overall Study|PCR positive|1|||
25092933|NCT02641379|50202276|FG007|Overall Study|PCR positive|0|||
25092934|NCT02641379|50202277|FG008|Overall Study|PCR positive|0|||
25007422|NCT00151372|50099806|FG000|Overall Study|Too sick medically to continue|5|||
25007423|NCT00151372|50099807|FG001|Overall Study|Too sick medically to continue|6|||
25007424|NCT00151372|50099806|FG000|Overall Study|Withdrawal by Subject|7|||
25007425|NCT00151372|50099807|FG001|Overall Study|Withdrawal by Subject|7|||
25007426|NCT02603809|50099819|FG000|Overall Study|Withdrawal by Subject|4|||
25007427|NCT02603809|50099820|FG001|Overall Study|Withdrawal by Subject|1|||
25007428|NCT02603809|50099821|FG002|Overall Study|Withdrawal by Subject|2|||
25007429|NCT02603809|50099822|FG003|Overall Study|Withdrawal by Subject|3|||
25007430|NCT02603809|50099823|FG004|Overall Study|Withdrawal by Subject|3|||
25007431|NCT02603809|50099824|FG005|Overall Study|Withdrawal by Subject|4|||
25007432|NCT02603809|50099819|FG000|Overall Study|Lost to Follow-up|2|||
25007433|NCT02603809|50099820|FG001|Overall Study|Lost to Follow-up|3|||
25007434|NCT02603809|50099821|FG002|Overall Study|Lost to Follow-up|1|||
25007435|NCT02603809|50099822|FG003|Overall Study|Lost to Follow-up|4|||
25007436|NCT02603809|50099823|FG004|Overall Study|Lost to Follow-up|2|||
25007437|NCT02603809|50099824|FG005|Overall Study|Lost to Follow-up|2|||
25007438|NCT02603809|50099819|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
25007439|NCT02603809|50099820|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
25007440|NCT02603809|50099821|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
25007441|NCT02603809|50099822|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
25007442|NCT02603809|50099823|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
25007443|NCT02603809|50099824|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
25007444|NCT02603809|50099819|FG000|Overall Study|Physician Decision|0|||
25007445|NCT02603809|50099820|FG001|Overall Study|Physician Decision|0|||
25007446|NCT02603809|50099821|FG002|Overall Study|Physician Decision|0|||
25007447|NCT02603809|50099822|FG003|Overall Study|Physician Decision|1|||
25007448|NCT02603809|50099823|FG004|Overall Study|Physician Decision|2|||
25007449|NCT02603809|50099824|FG005|Overall Study|Physician Decision|1|||
25007450|NCT02603809|50099819|FG000|Overall Study|Adverse Event|3|||
25007451|NCT02603809|50099820|FG001|Overall Study|Adverse Event|0|||
25007452|NCT02603809|50099821|FG002|Overall Study|Adverse Event|2|||
25007453|NCT02603809|50099822|FG003|Overall Study|Adverse Event|2|||
25007454|NCT02603809|50099823|FG004|Overall Study|Adverse Event|1|||
25007455|NCT02603809|50099824|FG005|Overall Study|Adverse Event|1|||
25007456|NCT02603809|50099819|FG000|Overall Study|Lack of Efficacy|0|||
25007457|NCT02603809|50099820|FG001|Overall Study|Lack of Efficacy|1|||
25007458|NCT02603809|50099821|FG002|Overall Study|Lack of Efficacy|0|||
25007459|NCT02603809|50099822|FG003|Overall Study|Lack of Efficacy|0|||
25007460|NCT02603809|50099823|FG004|Overall Study|Lack of Efficacy|0|||
25007461|NCT02603809|50099824|FG005|Overall Study|Lack of Efficacy|1|||
25007462|NCT02741596|50099842|FG000|Overall Study|Adverse Event|1|||
25007463|NCT02741596|50099843|FG001|Overall Study|Adverse Event|5|||
25007464|NCT02741596|50099842|FG000|Overall Study|Lost to Follow-up|1|||
25007465|NCT02741596|50099843|FG001|Overall Study|Lost to Follow-up|1|||
25007466|NCT02741596|50099842|FG000|Overall Study|Physician Decision|2|||
25007467|NCT02741596|50099843|FG001|Overall Study|Physician Decision|1|||
25007468|NCT02741596|50099842|FG000|Overall Study|Pregnancy|3|||
25007469|NCT02741596|50099843|FG001|Overall Study|Pregnancy|1|||
25007470|NCT02741596|50099842|FG000|Overall Study|Other (Unspecified)|0|||
25007471|NCT02741596|50099843|FG001|Overall Study|Other (Unspecified)|3|||
25007472|NCT02741596|50099842|FG000|Overall Study|Subject withdrawn-Other|17|||
25007473|NCT02741596|50099843|FG001|Overall Study|Subject withdrawn-Other|4|||
25007474|NCT02741596|50099842|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
25007475|NCT02741596|50099843|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
25007476|NCT03147248|50099855|FG000|Overall Study|Adverse Event|0|||
25007477|NCT03147248|50099856|FG001|Overall Study|Adverse Event|2|||
25007478|NCT03147248|50099857|FG002|Overall Study|Adverse Event|2|||
25092935|NCT02641379|50202278|FG009|Overall Study|PCR positive|0|||
25007479|NCT03147248|50099858|FG003|Overall Study|Adverse Event|2|||
25007480|NCT03147248|50099859|FG004|Overall Study|Adverse Event|6|||
25007481|NCT03147248|50099860|FG005|Overall Study|Adverse Event|11|||
25007482|NCT03147248|50099855|FG000|Overall Study|Disease progression|1|||
25007483|NCT03147248|50099856|FG001|Overall Study|Disease progression|0|||
25007484|NCT03147248|50099857|FG002|Overall Study|Disease progression|0|||
25007485|NCT03147248|50099858|FG003|Overall Study|Disease progression|0|||
25007486|NCT03147248|50099859|FG004|Overall Study|Disease progression|0|||
25092936|NCT02641379|50202279|FG010|Overall Study|PCR positive|0|||
25092937|NCT02660983|50202310|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
25092938|NCT02660983|50202311|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
25092939|NCT02660983|50202310|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
25092940|NCT02660983|50202311|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
25092941|NCT02660983|50202310|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
25092942|NCT02660983|50202311|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
25092943|NCT02660983|50202310|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
25092944|NCT02660983|50202311|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
25092945|NCT02660983|50202310|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
25092946|NCT02660983|50202311|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
25092947|NCT02660983|50202310|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
25092948|NCT02660983|50202311|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
25092949|NCT02660983|50202310|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
25092950|NCT02660983|50202311|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
25092951|NCT01953328|50202326|FG000|Overall Study|Withdrawal by Subject|0|||
25092952|NCT01953328|50202327|FG001|Overall Study|Withdrawal by Subject|0|||
25092953|NCT01953328|50202328|FG002|Overall Study|Withdrawal by Subject|0|||
25092954|NCT01953328|50202329|FG003|Overall Study|Withdrawal by Subject|0|||
25092955|NCT01953328|50202330|FG004|Overall Study|Withdrawal by Subject|1|||
25092956|NCT01953328|50202331|FG005|Overall Study|Withdrawal by Subject|0|||
25092957|NCT01953328|50202332|FG006|Overall Study|Withdrawal by Subject|0|||
25092958|NCT01953328|50202333|FG007|Overall Study|Withdrawal by Subject|0|||
25092959|NCT01953328|50202326|FG000|Overall Study|Lost to Follow-up|0|||
25092960|NCT01953328|50202327|FG001|Overall Study|Lost to Follow-up|0|||
25092961|NCT01953328|50202328|FG002|Overall Study|Lost to Follow-up|0|||
25092962|NCT01953328|50202329|FG003|Overall Study|Lost to Follow-up|0|||
25092963|NCT01953328|50202330|FG004|Overall Study|Lost to Follow-up|1|||
25092964|NCT01953328|50202331|FG005|Overall Study|Lost to Follow-up|0|||
25092965|NCT01953328|50202332|FG006|Overall Study|Lost to Follow-up|0|||
25092966|NCT01953328|50202333|FG007|Overall Study|Lost to Follow-up|0|||
25092967|NCT02640755|50202353|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
25092968|NCT02640755|50202354|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
25092969|NCT02640755|50202353|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
25092970|NCT02640755|50202354|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
25092971|NCT02640755|50202353|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
25092972|NCT02640755|50202354|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
25092973|NCT02640677|50202361|FG000|Overall Study|Lost to Follow-up|1|||
25092974|NCT02640677|50202361|FG000|Overall Study|Withdrawal by Subject|1|||
25092975|NCT02643251|50202378|FG000|Overall Study|Adverse Event|3|||
25092976|NCT02643251|50202379|FG001|Overall Study|Adverse Event|1|||
25092977|NCT02643251|50202378|FG000|Overall Study|Withdrawal by Subject|2|||
25092978|NCT02643251|50202379|FG001|Overall Study|Withdrawal by Subject|0|||
25092979|NCT02643251|50202378|FG000|Overall Study|Lost to Follow-up|4|||
25092980|NCT02643251|50202379|FG001|Overall Study|Lost to Follow-up|1|||
25092981|NCT02643251|50202378|FG000|Overall Study|Protocol Violation|1|||
25092982|NCT02643251|50202379|FG001|Overall Study|Protocol Violation|0|||
25092983|NCT02643251|50202378|FG000|Overall Study|PI Decision to terminate patient|1|||
25092984|NCT02643251|50202379|FG001|Overall Study|PI Decision to terminate patient|0|||
25092985|NCT01970878|50202389|FG000|Overall Study|Withdrawal by Subject|11|||
25092986|NCT01970878|50202390|FG001|Overall Study|Withdrawal by Subject|10|||
25092987|NCT01970878|50202391|FG002|Overall Study|Withdrawal by Subject|14|||
25092988|NCT01970878|50202392|FG003|Overall Study|Withdrawal by Subject|7|||
25092989|NCT01970878|50202389|FG000|Overall Study|Lost to Follow-up|1|||
25092990|NCT01970878|50202390|FG001|Overall Study|Lost to Follow-up|3|||
25092991|NCT01970878|50202391|FG002|Overall Study|Lost to Follow-up|2|||
25092992|NCT01970878|50202392|FG003|Overall Study|Lost to Follow-up|4|||
25092993|NCT01970878|50202389|FG000|Overall Study|Administrative Reasons|1|||
25092994|NCT01970878|50202390|FG001|Overall Study|Administrative Reasons|0|||
25092995|NCT01970878|50202391|FG002|Overall Study|Administrative Reasons|0|||
25092996|NCT01970878|50202392|FG003|Overall Study|Administrative Reasons|4|||
25092997|NCT01970878|50202389|FG000|Overall Study|Lack of Efficacy|2|||
25092998|NCT01970878|50202390|FG001|Overall Study|Lack of Efficacy|1|||
25092999|NCT01970878|50202391|FG002|Overall Study|Lack of Efficacy|2|||
25093000|NCT01970878|50202392|FG003|Overall Study|Lack of Efficacy|0|||
25093001|NCT01970878|50202389|FG000|Overall Study|Adverse Event|12|||
25093002|NCT01970878|50202390|FG001|Overall Study|Adverse Event|7|||
25093003|NCT01970878|50202391|FG002|Overall Study|Adverse Event|4|||
25093004|NCT01970878|50202392|FG003|Overall Study|Adverse Event|3|||
25093005|NCT01970878|50202389|FG000|Overall Study|Protocol Specified Criteria|10|||
25093006|NCT01970878|50202390|FG001|Overall Study|Protocol Specified Criteria|4|||
25093007|NCT01970878|50202391|FG002|Overall Study|Protocol Specified Criteria|3|||
25093008|NCT01970878|50202392|FG003|Overall Study|Protocol Specified Criteria|6|||
25093009|NCT01970878|50202389|FG000|Overall Study|Physician Decision|0|||
25093010|NCT01970878|50202390|FG001|Overall Study|Physician Decision|1|||
25093011|NCT01970878|50202391|FG002|Overall Study|Physician Decision|1|||
25093012|NCT01970878|50202392|FG003|Overall Study|Physician Decision|0|||
25093013|NCT01970878|50202389|FG000|Overall Study|No Completion Status|0|||
25093014|NCT01970878|50202390|FG001|Overall Study|No Completion Status|1|||
25093015|NCT01970878|50202391|FG002|Overall Study|No Completion Status|0|||
25093016|NCT01970878|50202392|FG003|Overall Study|No Completion Status|0|||
25093017|NCT01970488|50202404|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
25093018|NCT01970488|50202405|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
25093019|NCT01970488|50202406|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
25093020|NCT01970488|50202407|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
25093021|NCT01970488|50202408|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
25093022|NCT01970488|50202404|FG000|Part 1: Through Week 16|Protocol Violation|1|||
25093023|NCT01970488|50202405|FG001|Part 1: Through Week 16|Protocol Violation|2|||
25093024|NCT01970488|50202406|FG002|Part 1: Through Week 16|Protocol Violation|0|||
25093025|NCT01970488|50202407|FG003|Part 1: Through Week 16|Protocol Violation|0|||
25093026|NCT01970488|50202408|FG004|Part 1: Through Week 16|Protocol Violation|0|||
25093027|NCT01970488|50202404|FG000|Part 1: Through Week 16|Adverse Event|6|||
25093028|NCT01970488|50202405|FG001|Part 1: Through Week 16|Adverse Event|5|||
25093029|NCT01970488|50202406|FG002|Part 1: Through Week 16|Adverse Event|0|||
25093030|NCT01970488|50202407|FG003|Part 1: Through Week 16|Adverse Event|0|||
25093031|NCT01970488|50202408|FG004|Part 1: Through Week 16|Adverse Event|0|||
25093032|NCT01970488|50202404|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
25093033|NCT01970488|50202405|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
25093034|NCT01970488|50202406|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
25093035|NCT01970488|50202407|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
25093036|NCT01970488|50202408|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
25093037|NCT01970488|50202404|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
25093038|NCT01970488|50202405|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
25093039|NCT01970488|50202406|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
25093040|NCT01970488|50202407|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
25093041|NCT01970488|50202408|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
25093042|NCT01970488|50202404|FG000|Part 2: Post Week 16|Physician Decision|0|||
25093043|NCT01970488|50202405|FG001|Part 2: Post Week 16|Physician Decision|0|||
25093044|NCT01970488|50202406|FG002|Part 2: Post Week 16|Physician Decision|0|||
25093045|NCT01970488|50202407|FG003|Part 2: Post Week 16|Physician Decision|0|||
25093046|NCT01970488|50202408|FG004|Part 2: Post Week 16|Physician Decision|1|||
25093047|NCT01970488|50202404|FG000|Part 2: Post Week 16|Non-compliance|0|||
25093048|NCT01970488|50202405|FG001|Part 2: Post Week 16|Non-compliance|0|||
25093049|NCT01970488|50202406|FG002|Part 2: Post Week 16|Non-compliance|1|||
25093050|NCT01970488|50202407|FG003|Part 2: Post Week 16|Non-compliance|0|||
25093051|NCT01970488|50202408|FG004|Part 2: Post Week 16|Non-compliance|0|||
25093052|NCT01970488|50202404|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
25093053|NCT01970488|50202405|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
25093054|NCT01970488|50202406|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
25007487|NCT03147248|50099860|FG005|Overall Study|Disease progression|2|||
25093055|NCT01970488|50202407|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
25093056|NCT01970488|50202408|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
25093057|NCT01970488|50202404|FG000|Part 2: Post Week 16|Adverse Event|0|||
25093058|NCT01970488|50202405|FG001|Part 2: Post Week 16|Adverse Event|0|||
25093059|NCT01970488|50202406|FG002|Part 2: Post Week 16|Adverse Event|5|||
25093060|NCT01970488|50202407|FG003|Part 2: Post Week 16|Adverse Event|1|||
25093061|NCT01970488|50202408|FG004|Part 2: Post Week 16|Adverse Event|1|||
25093062|NCT01970488|50202404|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
25093063|NCT01970488|50202405|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
25093064|NCT01970488|50202406|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
25093065|NCT01970488|50202407|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
25093066|NCT01970488|50202408|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
25093067|NCT01970488|50202404|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
25093068|NCT01970488|50202405|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
25093069|NCT01970488|50202406|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
25093070|NCT01970488|50202407|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
25093071|NCT01970488|50202408|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
25093072|NCT02661217|50202425|FG000|Overall Study|Physician Decision|12|||
25007488|NCT03147248|50099855|FG000|Overall Study|Withdrawal by Subject|0|||
25007489|NCT03147248|50099856|FG001|Overall Study|Withdrawal by Subject|0|||
25007490|NCT03147248|50099857|FG002|Overall Study|Withdrawal by Subject|0|||
25007491|NCT03147248|50099858|FG003|Overall Study|Withdrawal by Subject|0|||
25007492|NCT03147248|50099859|FG004|Overall Study|Withdrawal by Subject|12|||
25007493|NCT03147248|50099860|FG005|Overall Study|Withdrawal by Subject|9|||
25007494|NCT03147248|50099855|FG000|Overall Study|Protocol Violation|0|||
25007495|NCT03147248|50099856|FG001|Overall Study|Protocol Violation|0|||
25007496|NCT03147248|50099857|FG002|Overall Study|Protocol Violation|0|||
25007497|NCT03147248|50099858|FG003|Overall Study|Protocol Violation|0|||
25007498|NCT03147248|50099859|FG004|Overall Study|Protocol Violation|2|||
25093073|NCT02661217|50202426|FG001|Overall Study|Physician Decision|15|||
25093074|NCT02661217|50202425|FG000|Overall Study|Lost to Follow-up|1|||
25093075|NCT02661217|50202426|FG001|Overall Study|Lost to Follow-up|4|||
25093076|NCT02661217|50202425|FG000|Overall Study|Protocol Deviation|0|||
25093077|NCT02661217|50202426|FG001|Overall Study|Protocol Deviation|4|||
25093078|NCT02661217|50202425|FG000|Overall Study|Non-compliance with study treatment|5|||
25093079|NCT02661217|50202426|FG001|Overall Study|Non-compliance with study treatment|5|||
25093080|NCT02661217|50202425|FG000|Overall Study|Death|21|||
25093081|NCT02661217|50202426|FG001|Overall Study|Death|15|||
25093082|NCT02661217|50202425|FG000|Overall Study|Adverse Event|10|||
25093083|NCT02661217|50202426|FG001|Overall Study|Adverse Event|8|||
25093084|NCT02661217|50202425|FG000|Overall Study|Withdrawal by Subject|15|||
25093085|NCT02661217|50202426|FG001|Overall Study|Withdrawal by Subject|19|||
25093086|NCT02661217|50202425|FG000|Overall Study|Did not enter follow-up epoch|7|||
25093087|NCT02661217|50202426|FG001|Overall Study|Did not enter follow-up epoch|10|||
25093088|NCT02661217|50202425|FG000|Overall Study|Death - no study drug received|1|||
25093089|NCT02661217|50202426|FG001|Overall Study|Death - no study drug received|2|||
25093090|NCT02661217|50202425|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
25093091|NCT02661217|50202426|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
25093092|NCT01952080|50202437|FG000|Overall Study|Withdrawal by Subject|0|||
25093093|NCT01952080|50202438|FG001|Overall Study|Withdrawal by Subject|0|||
25093094|NCT01952080|50202439|FG002|Overall Study|Withdrawal by Subject|0|||
25093095|NCT01952080|50202440|FG003|Overall Study|Withdrawal by Subject|1|||
25093096|NCT01952080|50202437|FG000|Overall Study|Protocol Non-compliance|0|||
25093097|NCT01952080|50202438|FG001|Overall Study|Protocol Non-compliance|1|||
25093098|NCT01952080|50202439|FG002|Overall Study|Protocol Non-compliance|0|||
25093099|NCT01952080|50202440|FG003|Overall Study|Protocol Non-compliance|0|||
25093100|NCT01951378|50202452|FG000|Overall Study|Study Terminated-Not completed|23|||
25093101|NCT01951378|50202453|FG001|Overall Study|Study Terminated-Not completed|17|||
25093102|NCT01944670|50202459|FG000|Overall Study|Lost to Follow-up|2|||
25093103|NCT01361009|50202467|FG000|Overall Study|Protocol Violation|116|||
25093104|NCT01944046|50202473|FG000|Randomized to DB|Adverse Event|5|||
25093105|NCT01944046|50202474|FG001|Randomized to DB|Adverse Event|2|||
25093106|NCT01944046|50202473|FG000|Randomized to DB|Clinical Worsening|3|||
25093107|NCT01944046|50202474|FG001|Randomized to DB|Clinical Worsening|2|||
25093108|NCT01944046|50202473|FG000|Randomized to DB|Lost to Follow-up|3|||
25093109|NCT01944046|50202474|FG001|Randomized to DB|Lost to Follow-up|3|||
25093110|NCT01944046|50202473|FG000|Randomized to DB|Withdrawal by Subject|2|||
25093111|NCT01944046|50202474|FG001|Randomized to DB|Withdrawal by Subject|4|||
25093112|NCT01944046|50202473|FG000|Randomized to DB|Physician Decision|1|||
25093113|NCT01944046|50202474|FG001|Randomized to DB|Physician Decision|2|||
25093114|NCT01944046|50202473|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
25093115|NCT01944046|50202474|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
25093116|NCT01944046|50202473|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
25093117|NCT01944046|50202474|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
25093118|NCT01944046|50202473|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
25093119|NCT01944046|50202474|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
25093120|NCT01944046|50202473|FG000|Open Label Eligible and Consented|Adverse Event|6|||
25093121|NCT01944046|50202474|FG001|Open Label Eligible and Consented|Adverse Event|1|||
25093122|NCT01944046|50202473|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
25093123|NCT01944046|50202474|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
25093124|NCT01944046|50202473|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
25093125|NCT01944046|50202474|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
25093126|NCT01969084|50202486|FG000|Overall Study|Adverse Event|0|||
25093127|NCT01969084|50202487|FG001|Overall Study|Adverse Event|1|||
25093128|NCT01942486|50202497|FG000|Overall Study|Lost to Follow-up|27|||
25093129|NCT01941940|50202501|FG000|Overall Study|Adverse Event|11|||
25093130|NCT01941940|50202501|FG000|Overall Study|Lost to Follow-up|2|||
25093131|NCT01941940|50202501|FG000|Overall Study|Physician Decision|2|||
25093132|NCT01941940|50202501|FG000|Overall Study|Withdrawal by Subject|15|||
25093133|NCT01941940|50202501|FG000|Overall Study|Death|1|||
25093134|NCT01941940|50202501|FG000|Overall Study|Other|1|||
25093135|NCT01941940|50202501|FG000|Overall Study|Other|1|||
25093136|NCT01968694|50202507|FG000|Washout (1 Month)|Lost to Follow-up|0|||
25093137|NCT01968694|50202508|FG001|Washout (1 Month)|Lost to Follow-up|1|||
25093138|NCT01968226|50202516|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
25093139|NCT02640053|50202522|FG000|Overall Study|Withdrawal by Subject|2|||
25093140|NCT02640053|50202523|FG001|Overall Study|Withdrawal by Subject|1|||
25093141|NCT02640053|50202522|FG000|Overall Study|Adverse Event|1|||
25093142|NCT02640053|50202523|FG001|Overall Study|Adverse Event|1|||
25093143|NCT02640053|50202522|FG000|Overall Study|Alternative Therapy|1|||
25093144|NCT02640053|50202523|FG001|Overall Study|Alternative Therapy|1|||
25093145|NCT02640053|50202522|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
25093146|NCT02640053|50202523|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
25093147|NCT01950364|50202531|FG000|Overall Study|Adverse Event|3|||
25093148|NCT01950364|50202532|FG001|Overall Study|Adverse Event|0|||
25093149|NCT01950364|50202531|FG000|Overall Study|Stem Cell Transplant|2|||
25093150|NCT01950364|50202532|FG001|Overall Study|Stem Cell Transplant|6|||
25093151|NCT01950364|50202531|FG000|Overall Study|Disease Progression|5|||
25093152|NCT01950364|50202532|FG001|Overall Study|Disease Progression|2|||
25093153|NCT01950364|50202531|FG000|Overall Study|Withdrawal by Subject|0|||
25093154|NCT01950364|50202532|FG001|Overall Study|Withdrawal by Subject|1|||
25093155|NCT01950364|50202531|FG000|Overall Study|Protocol Violation|0|||
25093156|NCT01950364|50202532|FG001|Overall Study|Protocol Violation|1|||
25093157|NCT01968070|50202556|FG000|Period 1|Withdrawal by Subject|0|||
25093158|NCT01968070|50202557|FG001|Period 1|Withdrawal by Subject|1|||
25093159|NCT01968070|50202558|FG002|Period 1|Withdrawal by Subject|0|||
25093160|NCT01968070|50202559|FG003|Period 1|Withdrawal by Subject|0|||
25093161|NCT01968070|50202560|FG004|Period 1|Withdrawal by Subject|0|||
25093162|NCT01968070|50202561|FG005|Period 1|Withdrawal by Subject|0|||
25093163|NCT01968070|50202562|FG006|Period 1|Withdrawal by Subject|1|||
25093164|NCT01968070|50202563|FG007|Period 1|Withdrawal by Subject|0|||
25093165|NCT01968070|50202564|FG008|Period 1|Withdrawal by Subject|0|||
25093166|NCT01968070|50202565|FG009|Period 1|Withdrawal by Subject|0|||
25093167|NCT01968070|50202566|FG010|Period 1|Withdrawal by Subject|0|||
25093168|NCT01968070|50202567|FG011|Period 1|Withdrawal by Subject|0|||
25093169|NCT01968070|50202568|FG012|Period 1|Withdrawal by Subject|0|||
25093170|NCT01968070|50202569|FG013|Period 1|Withdrawal by Subject|0|||
25093171|NCT01968070|50202570|FG014|Period 1|Withdrawal by Subject|0|||
25093172|NCT01968070|50202571|FG015|Period 1|Withdrawal by Subject|1|||
25093173|NCT01968070|50202572|FG016|Period 1|Withdrawal by Subject|0|||
25093174|NCT01968070|50202573|FG017|Period 1|Withdrawal by Subject|0|||
25093175|NCT01968070|50202556|FG000|Period 1|Protocol Violation|0|||
25093176|NCT01968070|50202557|FG001|Period 1|Protocol Violation|0|||
25093177|NCT01968070|50202558|FG002|Period 1|Protocol Violation|0|||
25093178|NCT01968070|50202559|FG003|Period 1|Protocol Violation|1|||
25093179|NCT01968070|50202560|FG004|Period 1|Protocol Violation|1|||
25093180|NCT01968070|50202561|FG005|Period 1|Protocol Violation|0|||
25093181|NCT01968070|50202562|FG006|Period 1|Protocol Violation|0|||
25093182|NCT01968070|50202563|FG007|Period 1|Protocol Violation|0|||
25093183|NCT01968070|50202564|FG008|Period 1|Protocol Violation|0|||
25093184|NCT01968070|50202565|FG009|Period 1|Protocol Violation|0|||
25093185|NCT01968070|50202566|FG010|Period 1|Protocol Violation|0|||
25093186|NCT01968070|50202567|FG011|Period 1|Protocol Violation|0|||
25093187|NCT01968070|50202568|FG012|Period 1|Protocol Violation|0|||
25093188|NCT01968070|50202569|FG013|Period 1|Protocol Violation|0|||
25093189|NCT01968070|50202570|FG014|Period 1|Protocol Violation|0|||
25093190|NCT01968070|50202571|FG015|Period 1|Protocol Violation|0|||
25093191|NCT01968070|50202572|FG016|Period 1|Protocol Violation|0|||
25093192|NCT01968070|50202573|FG017|Period 1|Protocol Violation|0|||
25093193|NCT01968070|50202556|FG000|Period 1|Lost to Follow-up|0|||
25093194|NCT01968070|50202557|FG001|Period 1|Lost to Follow-up|0|||
25093195|NCT01968070|50202558|FG002|Period 1|Lost to Follow-up|0|||
25093196|NCT01968070|50202559|FG003|Period 1|Lost to Follow-up|1|||
25093197|NCT01968070|50202560|FG004|Period 1|Lost to Follow-up|0|||
25093198|NCT01968070|50202561|FG005|Period 1|Lost to Follow-up|0|||
25093199|NCT01968070|50202562|FG006|Period 1|Lost to Follow-up|0|||
25093200|NCT01968070|50202563|FG007|Period 1|Lost to Follow-up|0|||
25093201|NCT01968070|50202564|FG008|Period 1|Lost to Follow-up|0|||
25093202|NCT01968070|50202565|FG009|Period 1|Lost to Follow-up|0|||
25093203|NCT01968070|50202566|FG010|Period 1|Lost to Follow-up|0|||
25093204|NCT01968070|50202567|FG011|Period 1|Lost to Follow-up|0|||
25093205|NCT01968070|50202568|FG012|Period 1|Lost to Follow-up|0|||
25093206|NCT01968070|50202569|FG013|Period 1|Lost to Follow-up|0|||
25093207|NCT01968070|50202570|FG014|Period 1|Lost to Follow-up|0|||
25093208|NCT01968070|50202571|FG015|Period 1|Lost to Follow-up|0|||
25093209|NCT01968070|50202572|FG016|Period 1|Lost to Follow-up|0|||
25093210|NCT01968070|50202573|FG017|Period 1|Lost to Follow-up|0|||
25093211|NCT01968070|50202556|FG000|Period 1|Adverse Event|0|||
25093212|NCT01968070|50202557|FG001|Period 1|Adverse Event|0|||
25093213|NCT01968070|50202558|FG002|Period 1|Adverse Event|0|||
25093214|NCT01968070|50202559|FG003|Period 1|Adverse Event|0|||
25093215|NCT01968070|50202560|FG004|Period 1|Adverse Event|0|||
25093216|NCT01968070|50202561|FG005|Period 1|Adverse Event|0|||
25093217|NCT01968070|50202562|FG006|Period 1|Adverse Event|1|||
25093218|NCT01968070|50202563|FG007|Period 1|Adverse Event|0|||
25093219|NCT01968070|50202564|FG008|Period 1|Adverse Event|0|||
25093220|NCT01968070|50202565|FG009|Period 1|Adverse Event|0|||
25093221|NCT01968070|50202566|FG010|Period 1|Adverse Event|0|||
25093222|NCT01968070|50202567|FG011|Period 1|Adverse Event|0|||
25093223|NCT01968070|50202568|FG012|Period 1|Adverse Event|0|||
25093224|NCT01968070|50202569|FG013|Period 1|Adverse Event|0|||
25093225|NCT01968070|50202570|FG014|Period 1|Adverse Event|0|||
25093226|NCT01968070|50202571|FG015|Period 1|Adverse Event|0|||
25093227|NCT01968070|50202572|FG016|Period 1|Adverse Event|0|||
25093228|NCT01968070|50202573|FG017|Period 1|Adverse Event|0|||
25093229|NCT01968070|50202556|FG000|Period 1|Physician Decision|0|||
25093230|NCT01968070|50202557|FG001|Period 1|Physician Decision|0|||
25093231|NCT01968070|50202558|FG002|Period 1|Physician Decision|0|||
25093232|NCT01968070|50202559|FG003|Period 1|Physician Decision|0|||
25093233|NCT01968070|50202560|FG004|Period 1|Physician Decision|0|||
25093234|NCT01968070|50202561|FG005|Period 1|Physician Decision|0|||
25093235|NCT01968070|50202562|FG006|Period 1|Physician Decision|0|||
25093236|NCT01968070|50202563|FG007|Period 1|Physician Decision|0|||
25093237|NCT01968070|50202564|FG008|Period 1|Physician Decision|0|||
25093238|NCT01968070|50202565|FG009|Period 1|Physician Decision|0|||
25093239|NCT01968070|50202566|FG010|Period 1|Physician Decision|0|||
25093240|NCT01968070|50202567|FG011|Period 1|Physician Decision|1|||
25093241|NCT01968070|50202568|FG012|Period 1|Physician Decision|0|||
25093242|NCT01968070|50202569|FG013|Period 1|Physician Decision|0|||
25093243|NCT01968070|50202570|FG014|Period 1|Physician Decision|0|||
25093244|NCT01968070|50202571|FG015|Period 1|Physician Decision|0|||
25093245|NCT01968070|50202572|FG016|Period 1|Physician Decision|0|||
25093246|NCT01968070|50202573|FG017|Period 1|Physician Decision|0|||
25093247|NCT01968070|50202556|FG000|Period 2|Withdrawal by Subject|0|||
25093248|NCT01968070|50202557|FG001|Period 2|Withdrawal by Subject|0|||
25093249|NCT01968070|50202558|FG002|Period 2|Withdrawal by Subject|0|||
25093250|NCT01968070|50202559|FG003|Period 2|Withdrawal by Subject|0|||
25093251|NCT01968070|50202560|FG004|Period 2|Withdrawal by Subject|1|||
25093252|NCT01968070|50202561|FG005|Period 2|Withdrawal by Subject|0|||
25093253|NCT01968070|50202562|FG006|Period 2|Withdrawal by Subject|0|||
25093254|NCT01968070|50202563|FG007|Period 2|Withdrawal by Subject|0|||
25093255|NCT01968070|50202564|FG008|Period 2|Withdrawal by Subject|0|||
25093256|NCT01968070|50202565|FG009|Period 2|Withdrawal by Subject|0|||
25093257|NCT01968070|50202566|FG010|Period 2|Withdrawal by Subject|0|||
25093258|NCT01968070|50202567|FG011|Period 2|Withdrawal by Subject|0|||
25093259|NCT01968070|50202568|FG012|Period 2|Withdrawal by Subject|0|||
25093260|NCT01968070|50202569|FG013|Period 2|Withdrawal by Subject|0|||
25093261|NCT01968070|50202570|FG014|Period 2|Withdrawal by Subject|0|||
25093262|NCT01968070|50202571|FG015|Period 2|Withdrawal by Subject|0|||
25093263|NCT01968070|50202572|FG016|Period 2|Withdrawal by Subject|0|||
25093264|NCT01968070|50202573|FG017|Period 2|Withdrawal by Subject|0|||
25093265|NCT01949662|50202613|FG000|Overall Study|Death|9|||
25093266|NCT01949662|50202614|FG001|Overall Study|Death|7|||
25093267|NCT01949662|50202613|FG000|Overall Study|Discharged before an agitation event|8|||
25093268|NCT01949662|50202614|FG001|Overall Study|Discharged before an agitation event|3|||
25093269|NCT01949662|50202613|FG000|Overall Study|Dropped out|1|||
25093270|NCT01949662|50202614|FG001|Overall Study|Dropped out|3|||
25093271|NCT01949662|50202613|FG000|Overall Study|Ineligible|0|||
25093272|NCT01949662|50202614|FG001|Overall Study|Ineligible|1|||
25093273|NCT01918774|50202620|FG000|Overall Study|Lost prior to first CBTw session|4|||
25093274|NCT01918774|50202620|FG000|Overall Study|Lost to Follow-up|1|||
25093275|NCT01949116|50202626|FG000|Overall Study|Death|2|||
25093276|NCT01949116|50202627|FG001|Overall Study|Death|0|||
25093277|NCT01949116|50202626|FG000|Overall Study|Lost to Follow-up|1|||
25093278|NCT01949116|50202627|FG001|Overall Study|Lost to Follow-up|3|||
25093279|NCT01949116|50202626|FG000|Overall Study|Withdrawal by Subject|5|||
25093280|NCT01949116|50202627|FG001|Overall Study|Withdrawal by Subject|3|||
25093281|NCT01673009|50202637|FG000|Overall Study|Physician Decision|5|||
25093282|NCT01673009|50202637|FG000|Overall Study|Withdrawal by Subject|8|||
25093283|NCT01939366|50202646|FG000|Overall Study|Adverse Event|8|||
25093284|NCT01939366|50202647|FG001|Overall Study|Adverse Event|17|||
25093285|NCT01939366|50202648|FG002|Overall Study|Adverse Event|30|||
25093286|NCT01939366|50202649|FG003|Overall Study|Adverse Event|8|||
25093287|NCT01939366|50202650|FG004|Overall Study|Adverse Event|5|||
25093288|NCT01939366|50202646|FG000|Overall Study|Lack of Efficacy|2|||
25093289|NCT01939366|50202647|FG001|Overall Study|Lack of Efficacy|1|||
25093290|NCT01939366|50202648|FG002|Overall Study|Lack of Efficacy|1|||
25093291|NCT01939366|50202649|FG003|Overall Study|Lack of Efficacy|1|||
25093292|NCT01939366|50202650|FG004|Overall Study|Lack of Efficacy|3|||
25093293|NCT01939366|50202646|FG000|Overall Study|Lost to Follow-up|1|||
25093294|NCT01939366|50202647|FG001|Overall Study|Lost to Follow-up|1|||
25093295|NCT01939366|50202648|FG002|Overall Study|Lost to Follow-up|0|||
25093296|NCT01939366|50202649|FG003|Overall Study|Lost to Follow-up|0|||
25093297|NCT01939366|50202650|FG004|Overall Study|Lost to Follow-up|0|||
25093298|NCT01939366|50202646|FG000|Overall Study|Withdrawal by Subject|1|||
25093299|NCT01939366|50202647|FG001|Overall Study|Withdrawal by Subject|0|||
25093300|NCT01939366|50202648|FG002|Overall Study|Withdrawal by Subject|2|||
25093301|NCT01939366|50202649|FG003|Overall Study|Withdrawal by Subject|2|||
25093302|NCT01939366|50202650|FG004|Overall Study|Withdrawal by Subject|3|||
25093303|NCT01939366|50202646|FG000|Overall Study|Inclusion criteria not met|0|||
25093304|NCT01939366|50202647|FG001|Overall Study|Inclusion criteria not met|1|||
25093305|NCT01939366|50202648|FG002|Overall Study|Inclusion criteria not met|1|||
25093306|NCT01939366|50202649|FG003|Overall Study|Inclusion criteria not met|0|||
25093307|NCT01939366|50202650|FG004|Overall Study|Inclusion criteria not met|1|||
25093308|NCT01939366|50202646|FG000|Overall Study|Other|0|||
25093309|NCT01939366|50202647|FG001|Overall Study|Other|0|||
25093310|NCT01939366|50202648|FG002|Overall Study|Other|2|||
25093311|NCT01939366|50202649|FG003|Overall Study|Other|2|||
25093312|NCT01939366|50202650|FG004|Overall Study|Other|1|||
25093313|NCT01939366|50202646|FG000|Overall Study|Protocol Violation|0|||
25093314|NCT01939366|50202647|FG001|Overall Study|Protocol Violation|0|||
25093315|NCT01939366|50202648|FG002|Overall Study|Protocol Violation|0|||
25093316|NCT01939366|50202649|FG003|Overall Study|Protocol Violation|1|||
25093317|NCT01939366|50202650|FG004|Overall Study|Protocol Violation|0|||
25093318|NCT01939366|50202646|FG000|Overall Study|Sponsor decision|0|||
25093319|NCT01939366|50202647|FG001|Overall Study|Sponsor decision|0|||
25093320|NCT01939366|50202648|FG002|Overall Study|Sponsor decision|0|||
25093321|NCT01939366|50202649|FG003|Overall Study|Sponsor decision|0|||
25093322|NCT01939366|50202650|FG004|Overall Study|Sponsor decision|2|||
25093323|NCT01939366|50202646|FG000|Overall Study|GCP non-compliance at site|2|||
25093324|NCT01939366|50202647|FG001|Overall Study|GCP non-compliance at site|3|||
25093325|NCT01939366|50202648|FG002|Overall Study|GCP non-compliance at site|2|||
25093326|NCT01939366|50202649|FG003|Overall Study|GCP non-compliance at site|3|||
25093327|NCT01939366|50202650|FG004|Overall Study|GCP non-compliance at site|3|||
25093328|NCT01918306|50202664|FG000|Overall Study|progresive disease|4|||
25093329|NCT01918306|50202665|FG001|Overall Study|progresive disease|0|||
25093330|NCT01918306|50202666|FG002|Overall Study|progresive disease|1|||
25093331|NCT01918306|50202667|FG003|Overall Study|progresive disease|1|||
25093332|NCT01918306|50202664|FG000|Overall Study|Withdrawal by Subject|0|||
25093333|NCT01918306|50202665|FG001|Overall Study|Withdrawal by Subject|0|||
25093334|NCT01918306|50202666|FG002|Overall Study|Withdrawal by Subject|0|||
25093335|NCT01918306|50202667|FG003|Overall Study|Withdrawal by Subject|2|||
25093336|NCT01918306|50202664|FG000|Overall Study|neutropenia|1|||
25093337|NCT01918306|50202665|FG001|Overall Study|neutropenia|0|||
25093338|NCT01918306|50202666|FG002|Overall Study|neutropenia|0|||
25093339|NCT01918306|50202667|FG003|Overall Study|neutropenia|0|||
25093340|NCT01918306|50202664|FG000|Overall Study|Lack of Efficacy|1|||
25093341|NCT01918306|50202665|FG001|Overall Study|Lack of Efficacy|0|||
25093342|NCT01918306|50202666|FG002|Overall Study|Lack of Efficacy|0|||
25093343|NCT01918306|50202667|FG003|Overall Study|Lack of Efficacy|0|||
25093344|NCT01918306|50202664|FG000|Overall Study|progress disease, crossover|0|||
25093345|NCT01918306|50202665|FG001|Overall Study|progress disease, crossover|0|||
25093346|NCT01918306|50202666|FG002|Overall Study|progress disease, crossover|1|||
25093347|NCT01918306|50202667|FG003|Overall Study|progress disease, crossover|0|||
25093348|NCT01917526|50202689|FG000|Overall Study|Protocol Violation|1|||
25093349|NCT01917526|50202690|FG001|Overall Study|Protocol Violation|1|||
25093350|NCT01948258|50202696|FG000|Overall Study|Pregnancy|41|||
25093351|NCT01948258|50202696|FG000|Overall Study|Did not complete by cut-off date|35|||
25093352|NCT01948258|50202696|FG000|Overall Study|Lost to Follow-up|27|||
25093353|NCT01948258|50202696|FG000|Overall Study|Withdrawal by SPD|8|||
25093354|NCT01948258|50202696|FG000|Overall Study|Withdrawal by Subject|6|||
25093355|NCT01948258|50202696|FG000|Overall Study|Health Care Professional|43|||
25093356|NCT01948258|50202696|FG000|Overall Study|Removed from statistical analysis|2|||
25093357|NCT01916980|50202702|FG000|Overall Study|Adverse Event|4|||
25093358|NCT01916980|50202703|FG001|Overall Study|Adverse Event|2|||
25093359|NCT01916980|50202702|FG000|Overall Study|Lack of Efficacy|2|||
25093360|NCT01916980|50202703|FG001|Overall Study|Lack of Efficacy|2|||
25093361|NCT01916980|50202702|FG000|Overall Study|Withdrawal by Subject|1|||
25093362|NCT01916980|50202703|FG001|Overall Study|Withdrawal by Subject|0|||
25093363|NCT05062759|50202715|FG000|Overall Study|Death|0|||
25093364|NCT05062759|50202716|FG001|Overall Study|Death|1|||
25093365|NCT05062759|50202715|FG000|Overall Study|Lost to Follow-up|1|||
25093366|NCT05062759|50202716|FG001|Overall Study|Lost to Follow-up|0|||
25007499|NCT03147248|50099860|FG005|Overall Study|Protocol Violation|0|||
25007500|NCT03147248|50099855|FG000|Overall Study|Lost to Follow-up|0|||
25007501|NCT03147248|50099856|FG001|Overall Study|Lost to Follow-up|0|||
25007502|NCT03147248|50099857|FG002|Overall Study|Lost to Follow-up|0|||
25007503|NCT03147248|50099858|FG003|Overall Study|Lost to Follow-up|0|||
25007504|NCT03147248|50099859|FG004|Overall Study|Lost to Follow-up|2|||
25007505|NCT03147248|50099860|FG005|Overall Study|Lost to Follow-up|0|||
25007506|NCT03147248|50099855|FG000|Overall Study|Pregnancy|0|||
25007507|NCT03147248|50099856|FG001|Overall Study|Pregnancy|0|||
25007508|NCT03147248|50099857|FG002|Overall Study|Pregnancy|0|||
25007509|NCT03147248|50099858|FG003|Overall Study|Pregnancy|0|||
25093367|NCT05033262|50202735|FG000|Overall Study|Lost to Follow-up|1|||
25093368|NCT05033262|50202736|FG001|Overall Study|Lost to Follow-up|0|||
25093369|NCT05033262|50202737|FG002|Overall Study|Lost to Follow-up|0|||
25093370|NCT05033262|50202738|FG003|Overall Study|Lost to Follow-up|1|||
25007510|NCT03147248|50099859|FG004|Overall Study|Pregnancy|1|||
25007511|NCT03147248|50099860|FG005|Overall Study|Pregnancy|0|||
25093371|NCT04963062|50202752|FG000|Overall Study|withdrew by the study team|4|||
25093372|NCT04963062|50202753|FG001|Overall Study|withdrew by the study team|2|||
25093373|NCT04900220|50202765|FG000|Overall Study|Lost to Follow-up|1|||
25093374|NCT04900220|50202766|FG001|Overall Study|Lost to Follow-up|1|||
25093375|NCT04599062|50202778|FG000|Overall Study|Physician Decision|1|||
25093376|NCT04599062|50202779|FG001|Overall Study|Physician Decision|0|||
25176903|NCT01510145|50320536|FG000|Overall Study|Lost to Follow-up|5|||
25093377|NCT04585815|50202787|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
25093378|NCT04585815|50202788|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
25093379|NCT04585815|50202787|FG000|Sub-study A- Treatment Phase|Death|0|||
25093380|NCT04585815|50202788|FG001|Sub-study A- Treatment Phase|Death|1|||
25093381|NCT04585815|50202787|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
25093382|NCT04585815|50202788|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
25093383|NCT04585815|50202787|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
25093384|NCT04585815|50202788|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
25093385|NCT04585815|50202787|FG000|Sub-study A- Treatment Phase|Other|1|||
25093386|NCT04585815|50202788|FG001|Sub-study A- Treatment Phase|Other|0|||
25093387|NCT04585815|50202787|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
25093388|NCT04585815|50202788|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
25093389|NCT04585815|50202787|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
25093390|NCT04585815|50202788|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
25093391|NCT04537208|50202807|FG000|Overall Study|Adverse Event|0|||
25093392|NCT04537208|50202808|FG001|Overall Study|Adverse Event|0|||
25093393|NCT04537208|50202809|FG002|Overall Study|Adverse Event|0|||
25093394|NCT04537208|50202810|FG003|Overall Study|Adverse Event|0|||
25093395|NCT04537208|50202811|FG004|Overall Study|Adverse Event|0|||
25093396|NCT04537208|50202812|FG005|Overall Study|Adverse Event|0|||
25093397|NCT04537208|50202813|FG006|Overall Study|Adverse Event|0|||
25093398|NCT04537208|50202814|FG007|Overall Study|Adverse Event|0|||
25093399|NCT04537208|50202815|FG008|Overall Study|Adverse Event|1|||
25093400|NCT04537208|50202816|FG009|Overall Study|Adverse Event|0|||
25093401|NCT04537208|50202817|FG010|Overall Study|Adverse Event|0|||
25093402|NCT04537208|50202807|FG000|Overall Study|Protocol deviation|0|||
25093403|NCT04537208|50202808|FG001|Overall Study|Protocol deviation|0|||
25093404|NCT04537208|50202809|FG002|Overall Study|Protocol deviation|2|||
25093405|NCT04537208|50202810|FG003|Overall Study|Protocol deviation|0|||
25093406|NCT04537208|50202811|FG004|Overall Study|Protocol deviation|0|||
25093407|NCT04537208|50202812|FG005|Overall Study|Protocol deviation|2|||
25093408|NCT04537208|50202813|FG006|Overall Study|Protocol deviation|4|||
25093409|NCT04537208|50202814|FG007|Overall Study|Protocol deviation|0|||
25093410|NCT04537208|50202815|FG008|Overall Study|Protocol deviation|1|||
25093411|NCT04537208|50202816|FG009|Overall Study|Protocol deviation|0|||
25093412|NCT04537208|50202817|FG010|Overall Study|Protocol deviation|2|||
25093413|NCT04537208|50202807|FG000|Overall Study|Withdrawal by Subject|4|||
25093414|NCT04537208|50202808|FG001|Overall Study|Withdrawal by Subject|2|||
25093415|NCT04537208|50202809|FG002|Overall Study|Withdrawal by Subject|1|||
25093416|NCT04537208|50202810|FG003|Overall Study|Withdrawal by Subject|3|||
25093417|NCT04537208|50202811|FG004|Overall Study|Withdrawal by Subject|5|||
25093418|NCT04537208|50202812|FG005|Overall Study|Withdrawal by Subject|1|||
25093419|NCT04537208|50202813|FG006|Overall Study|Withdrawal by Subject|6|||
25093420|NCT04537208|50202814|FG007|Overall Study|Withdrawal by Subject|1|||
25093421|NCT04537208|50202815|FG008|Overall Study|Withdrawal by Subject|7|||
25093422|NCT04537208|50202816|FG009|Overall Study|Withdrawal by Subject|2|||
25093423|NCT04537208|50202817|FG010|Overall Study|Withdrawal by Subject|4|||
25093424|NCT04537208|50202807|FG000|Overall Study|Lost to Follow-up|4|||
25093425|NCT04537208|50202808|FG001|Overall Study|Lost to Follow-up|1|||
25093426|NCT04537208|50202809|FG002|Overall Study|Lost to Follow-up|3|||
25093427|NCT04537208|50202810|FG003|Overall Study|Lost to Follow-up|4|||
25093428|NCT04537208|50202811|FG004|Overall Study|Lost to Follow-up|3|||
25093429|NCT04537208|50202812|FG005|Overall Study|Lost to Follow-up|2|||
25093430|NCT04537208|50202813|FG006|Overall Study|Lost to Follow-up|3|||
25093431|NCT04537208|50202814|FG007|Overall Study|Lost to Follow-up|2|||
25093432|NCT04537208|50202815|FG008|Overall Study|Lost to Follow-up|7|||
25093433|NCT04537208|50202816|FG009|Overall Study|Lost to Follow-up|2|||
25093434|NCT04537208|50202817|FG010|Overall Study|Lost to Follow-up|2|||
25093435|NCT04502433|50202846|FG000|Overall Study|Death|2|||
25093436|NCT04502433|50202847|FG001|Overall Study|Death|4|||
25093437|NCT04502433|50202846|FG000|Overall Study|Lost to Follow-up|1|||
25093438|NCT04502433|50202847|FG001|Overall Study|Lost to Follow-up|0|||
25093439|NCT04502433|50202846|FG000|Overall Study|Physician Decision|0|||
25176904|NCT01510145|50320536|FG000|Overall Study|Withdrawal by Subject|6|||
25176905|NCT01510145|50320536|FG000|Overall Study|Relative reported subject withdrew|1|||
25176906|NCT01528033|50320542|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
25093440|NCT04502433|50202847|FG001|Overall Study|Physician Decision|1|||
25093441|NCT04442503|50202861|FG000|Overall Study|Adverse Event|1|||
25093442|NCT04442503|50202862|FG001|Overall Study|Adverse Event|1|||
25093443|NCT04442503|50202861|FG000|Overall Study|Lost to Follow-up|8|||
25093444|NCT04442503|50202862|FG001|Overall Study|Lost to Follow-up|6|||
25093445|NCT04442503|50202861|FG000|Overall Study|Physician Decision|0|||
25093446|NCT04442503|50202862|FG001|Overall Study|Physician Decision|2|||
25093447|NCT04442503|50202861|FG000|Overall Study|Withdrawal by Subject|3|||
25093448|NCT04442503|50202862|FG001|Overall Study|Withdrawal by Subject|4|||
25093449|NCT04442503|50202861|FG000|Overall Study|Reason not Specified|0|||
25093450|NCT04442503|50202862|FG001|Overall Study|Reason not Specified|1|||
25093451|NCT04442503|50202861|FG000|Overall Study|Randomized but not Treated|3|||
25093452|NCT04442503|50202862|FG001|Overall Study|Randomized but not Treated|1|||
25093453|NCT04411914|50202870|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
25093454|NCT04411914|50202871|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
25093455|NCT04389671|50202890|FG000|Overall Study|Death|7|||
25093456|NCT04381494|50202894|FG000|Overall Study|Early termination of trial|19|||
25093457|NCT04381494|50202894|FG000|Overall Study|Investigator's discretion|1|||
25093458|NCT04381494|50202894|FG000|Overall Study|Withdrawal by Subject|9|||
25093459|NCT04381494|50202894|FG000|Overall Study|NSCLC disease progression|4|||
25093460|NCT04381494|50202894|FG000|Overall Study|Device-Related Adverse Event|2|||
25093461|NCT04094584|50202949|FG000|Overall Study|No interest in study|88|||
25093462|NCT04094584|50202949|FG000|Overall Study|Unwilling to undergo screening tests|36|||
25093463|NCT04094584|50202949|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
25093464|NCT04094584|50202949|FG000|Overall Study|Opioid use|7|||
25093465|NCT04094584|50202949|FG000|Overall Study|Need for major surgery in study period|4|||
25093466|NCT04094584|50202949|FG000|Overall Study|eligible but declined enrollment|4|||
25093467|NCT04094584|50202949|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
25093468|NCT04094584|50202949|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
25093469|NCT04094584|50202949|FG000|Overall Study|Lost to Follow-up|3|||
25093470|NCT04094584|50202949|FG000|Overall Study|Withdrawal by Subject|2|||
25093471|NCT04021290|50202964|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
25093472|NCT04021290|50202965|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
25093473|NCT04021290|50202966|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
25093474|NCT04021290|50202964|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
25093475|NCT04021290|50202965|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
25093476|NCT04021290|50202966|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
25093477|NCT04021290|50202964|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
25093478|NCT04021290|50202965|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
25093479|NCT04021290|50202966|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
25093480|NCT04021290|50202964|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
25093481|NCT04021290|50202965|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
25093482|NCT04021290|50202966|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
25093483|NCT04021290|50202964|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
25093484|NCT04021290|50202965|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
25093485|NCT04021290|50202966|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
25093486|NCT04021290|50202964|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
25093487|NCT04021290|50202965|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
25093488|NCT04021290|50202966|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
25093489|NCT04021290|50202964|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
25093490|NCT04021290|50202965|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
25093491|NCT04021290|50202966|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
25093492|NCT04021290|50202964|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
25093493|NCT04021290|50202965|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
25093494|NCT04021290|50202966|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
25093495|NCT04021290|50202964|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
25093496|NCT04021290|50202965|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
25093497|NCT04021290|50202966|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
25093498|NCT04021290|50202964|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
25093499|NCT04021290|50202965|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
25093500|NCT04021290|50202966|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
25093501|NCT04021290|50202964|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
25093502|NCT04021290|50202965|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
25093503|NCT04021290|50202966|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
25093504|NCT04021290|50202964|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
25093505|NCT04021290|50202965|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
25093506|NCT04021290|50202966|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
25093507|NCT04020341|50202976|FG000|Overall Study|Adverse Event|8|||
25093508|NCT04020341|50202977|FG001|Overall Study|Adverse Event|6|||
25093509|NCT04020341|50202976|FG000|Overall Study|Lost to Follow-up|8|||
25093510|NCT04020341|50202977|FG001|Overall Study|Lost to Follow-up|2|||
25093511|NCT04020341|50202976|FG000|Overall Study|Withdrawal by Subject|16|||
25093512|NCT04020341|50202977|FG001|Overall Study|Withdrawal by Subject|16|||
25093513|NCT04020341|50202976|FG000|Overall Study|Participant not able to swallow the tablet|1|||
25093514|NCT04020341|50202977|FG001|Overall Study|Participant not able to swallow the tablet|0|||
25093515|NCT04020341|50202976|FG000|Overall Study|Physician Decision|0|||
25093516|NCT04020341|50202977|FG001|Overall Study|Physician Decision|2|||
25093517|NCT04020341|50202976|FG000|Overall Study|Protocol Deviation|0|||
25093518|NCT04020341|50202977|FG001|Overall Study|Protocol Deviation|2|||
25093519|NCT03868891|50202999|FG000|Overall Study|Adverse Event|1|||
25093520|NCT03868891|50203000|FG001|Overall Study|Adverse Event|0|||
25093521|NCT03868891|50202999|FG000|Overall Study|Lost to Follow-up|2|||
25093522|NCT03868891|50203000|FG001|Overall Study|Lost to Follow-up|1|||
25093523|NCT03868891|50202999|FG000|Overall Study|COVID-19 Restrictions|1|||
25093524|NCT03868891|50203000|FG001|Overall Study|COVID-19 Restrictions|2|||
25093525|NCT03827655|50203045|FG000|Overall Study|Death|0|||
25093526|NCT03827655|50203046|FG001|Overall Study|Death|0|||
25093527|NCT03827655|50203047|FG002|Overall Study|Death|0|||
25093528|NCT03827655|50203048|FG003|Overall Study|Death|0|||
25093529|NCT03827655|50203049|FG004|Overall Study|Death|1|||
25093530|NCT03827655|50203045|FG000|Overall Study|Protocol Deviation|1|||
25093531|NCT03827655|50203046|FG001|Overall Study|Protocol Deviation|0|||
25093532|NCT03827655|50203047|FG002|Overall Study|Protocol Deviation|1|||
25093533|NCT03827655|50203048|FG003|Overall Study|Protocol Deviation|1|||
25093534|NCT03827655|50203049|FG004|Overall Study|Protocol Deviation|0|||
25093535|NCT03827655|50203045|FG000|Overall Study|Withdrawal by Subject|3|||
25093536|NCT03827655|50203046|FG001|Overall Study|Withdrawal by Subject|2|||
25093537|NCT03827655|50203047|FG002|Overall Study|Withdrawal by Subject|2|||
25093538|NCT03827655|50203048|FG003|Overall Study|Withdrawal by Subject|0|||
25093539|NCT03827655|50203049|FG004|Overall Study|Withdrawal by Subject|1|||
25093540|NCT03827655|50203045|FG000|Overall Study|Reason not Specified|3|||
25093541|NCT03827655|50203046|FG001|Overall Study|Reason not Specified|1|||
25093542|NCT03827655|50203047|FG002|Overall Study|Reason not Specified|1|||
25093543|NCT03827655|50203048|FG003|Overall Study|Reason not Specified|1|||
25093544|NCT03827655|50203049|FG004|Overall Study|Reason not Specified|1|||
25093545|NCT03782064|50203084|FG000|Overall Study|Lack of Efficacy|2|||
25093546|NCT03782064|50203084|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
25093547|NCT03772522|50203090|FG000|Pre-intervention|Withdrawal by Subject|3|||
25093548|NCT03772522|50203091|FG001|Pre-intervention|Withdrawal by Subject|4|||
25093549|NCT03772522|50203090|FG000|Intervention|Withdrawal by Subject|1|||
25093550|NCT03772522|50203091|FG001|Intervention|Withdrawal by Subject|0|||
25093551|NCT03772522|50203090|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
25093552|NCT03772522|50203091|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
25093553|NCT03759379|50203104|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
25093554|NCT03759379|50203105|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
25093555|NCT03759379|50203104|FG000|Treatment Period|Death|2|||
25093556|NCT03759379|50203105|FG001|Treatment Period|Death|3|||
25093557|NCT03759379|50203104|FG000|Treatment Period|Lost to Follow-up|1|||
25093558|NCT03759379|50203105|FG001|Treatment Period|Lost to Follow-up|0|||
25093559|NCT03759379|50203104|FG000|Treatment Period|Physician Decision|0|||
25093560|NCT03759379|50203105|FG001|Treatment Period|Physician Decision|1|||
25093561|NCT03755518|50203111|FG000|Overall Study|Adverse Event|6|||
25093562|NCT03755518|50203111|FG000|Overall Study|Lack of Efficacy|6|||
25093563|NCT03755518|50203111|FG000|Overall Study|Bone Marrow Transplant|4|||
25093564|NCT03755518|50203111|FG000|Overall Study|Withdrawal by participant|4|||
25093565|NCT03755518|50203111|FG000|Overall Study|Progressive Disease|2|||
25093566|NCT03755518|50203111|FG000|Overall Study|Death|1|||
25093567|NCT03755518|50203111|FG000|Overall Study|Physician Decision|1|||
25093568|NCT03755518|50203111|FG000|Overall Study|Withdrawal by investigator for non compliance|1|||
25093569|NCT03739112|50203117|FG000|Overall Study|Adverse Event|2|||
25093570|NCT03739112|50203118|FG001|Overall Study|Adverse Event|2|||
25093571|NCT03739112|50203117|FG000|Overall Study|Withdrawal by Subject|38|||
25093572|NCT03739112|50203118|FG001|Overall Study|Withdrawal by Subject|19|||
25093573|NCT03739112|50203117|FG000|Overall Study|Lost to Follow-up|31|||
25093574|NCT03739112|50203118|FG001|Overall Study|Lost to Follow-up|33|||
25093575|NCT03739112|50203117|FG000|Overall Study|Protocol Deviation|12|||
25093576|NCT03739112|50203118|FG001|Overall Study|Protocol Deviation|9|||
25093577|NCT03739112|50203117|FG000|Overall Study|Physician Decision|1|||
25093578|NCT03739112|50203118|FG001|Overall Study|Physician Decision|0|||
25093579|NCT03739112|50203117|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
25093580|NCT03739112|50203118|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
25093581|NCT03739112|50203117|FG000|Overall Study|Site went on hold|65|||
25093582|NCT03739112|50203118|FG001|Overall Study|Site went on hold|67|||
25093583|NCT03739112|50203117|FG000|Overall Study|Other than specified|8|||
25093584|NCT03739112|50203118|FG001|Overall Study|Other than specified|5|||
25093585|NCT03739112|50203117|FG000|Overall Study|Randomized but not vaccinated|31|||
25093586|NCT03739112|50203118|FG001|Overall Study|Randomized but not vaccinated|25|||
25093587|NCT03622593|50203138|FG000|Overall Study|Withdrawal by Subject|11|||
25093588|NCT03622593|50203139|FG001|Overall Study|Withdrawal by Subject|9|||
25093589|NCT03622593|50203140|FG002|Overall Study|Withdrawal by Subject|13|||
25093590|NCT03622593|50203138|FG000|Overall Study|Death|12|||
25093591|NCT03622593|50203139|FG001|Overall Study|Death|9|||
25093592|NCT03622593|50203140|FG002|Overall Study|Death|10|||
25093593|NCT03622593|50203138|FG000|Overall Study|Lost to Follow-up|11|||
25093594|NCT03622593|50203139|FG001|Overall Study|Lost to Follow-up|5|||
25093595|NCT03622593|50203140|FG002|Overall Study|Lost to Follow-up|8|||
25093596|NCT03622593|50203138|FG000|Overall Study|Adverse Event|4|||
25093597|NCT03622593|50203139|FG001|Overall Study|Adverse Event|5|||
25093598|NCT03622593|50203140|FG002|Overall Study|Adverse Event|6|||
25093599|NCT03622593|50203138|FG000|Overall Study|Physician Decision|2|||
25093600|NCT03622593|50203139|FG001|Overall Study|Physician Decision|1|||
25093601|NCT03622593|50203140|FG002|Overall Study|Physician Decision|6|||
25093602|NCT03622593|50203138|FG000|Overall Study|Other|2|||
25093603|NCT03622593|50203139|FG001|Overall Study|Other|2|||
25093604|NCT03622593|50203140|FG002|Overall Study|Other|3|||
25093605|NCT03622593|50203138|FG000|Overall Study|Protocol Violation|0|||
25093606|NCT03622593|50203139|FG001|Overall Study|Protocol Violation|0|||
25093607|NCT03622593|50203140|FG002|Overall Study|Protocol Violation|1|||
25093608|NCT03622593|50203138|FG000|Overall Study|Pregnancy|0|||
25093609|NCT03622593|50203139|FG001|Overall Study|Pregnancy|0|||
25093610|NCT03622593|50203140|FG002|Overall Study|Pregnancy|1|||
25093611|NCT03593655|50203151|FG000|First Product Use Period|Withdrawal by Subject|1|||
25093612|NCT03593655|50203152|FG001|First Product Use Period|Withdrawal by Subject|1|||
25093613|NCT03593655|50203151|FG000|First Product Use Period|Lost to Follow-up|1|||
25093614|NCT03593655|50203152|FG001|First Product Use Period|Lost to Follow-up|3|||
25093615|NCT03593655|50203151|FG000|Second Product Use Period|Withdrawal by Subject|1|||
25093616|NCT03593655|50203152|FG001|Second Product Use Period|Withdrawal by Subject|1|||
25093617|NCT03593655|50203151|FG000|Second Product Use Period|Lost to Follow-up|1|||
25093618|NCT03593655|50203152|FG001|Second Product Use Period|Lost to Follow-up|0|||
25093619|NCT03593655|50203151|FG000|Third Product Use Period|Lost to Follow-up|1|||
25093620|NCT03593655|50203152|FG001|Third Product Use Period|Lost to Follow-up|2|||
25093621|NCT03593655|50203151|FG000|Third Product Use Period|Physician Decision|0|||
25093622|NCT03593655|50203152|FG001|Third Product Use Period|Physician Decision|1|||
25093623|NCT03593655|50203151|FG000|Third Product Use Period|Withdrawal by Subject|0|||
25176907|NCT01528033|50320543|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
25007512|NCT03147248|50099855|FG000|Overall Study|Death|0|||
25007513|NCT03147248|50099856|FG001|Overall Study|Death|0|||
25007514|NCT03147248|50099857|FG002|Overall Study|Death|0|||
25007515|NCT03147248|50099858|FG003|Overall Study|Death|0|||
25007516|NCT03147248|50099859|FG004|Overall Study|Death|0|||
25007517|NCT03147248|50099860|FG005|Overall Study|Death|4|||
25007518|NCT03147248|50099855|FG000|Overall Study|Physician Decision|0|||
25007519|NCT03147248|50099856|FG001|Overall Study|Physician Decision|0|||
25007520|NCT03147248|50099857|FG002|Overall Study|Physician Decision|0|||
25007521|NCT03147248|50099858|FG003|Overall Study|Physician Decision|0|||
25007522|NCT03147248|50099859|FG004|Overall Study|Physician Decision|2|||
25007523|NCT03147248|50099860|FG005|Overall Study|Physician Decision|4|||
25007524|NCT03147248|50099855|FG000|Overall Study|Prolonged Dosing Interval|0|||
25007525|NCT03147248|50099856|FG001|Overall Study|Prolonged Dosing Interval|0|||
25007526|NCT03147248|50099857|FG002|Overall Study|Prolonged Dosing Interval|0|||
25007527|NCT03147248|50099858|FG003|Overall Study|Prolonged Dosing Interval|0|||
25007528|NCT03147248|50099859|FG004|Overall Study|Prolonged Dosing Interval|1|||
25007529|NCT03147248|50099860|FG005|Overall Study|Prolonged Dosing Interval|1|||
25007530|NCT03796039|50099876|FG000|Overall Study|Death|2|||
25007531|NCT03796039|50099877|FG001|Overall Study|Death|1|||
25007532|NCT03796039|50099876|FG000|Overall Study|Withdrawal by Subject|7|||
25007533|NCT03796039|50099877|FG001|Overall Study|Withdrawal by Subject|4|||
25007534|NCT03794089|50099885|FG000|Overall Study|Lost to Follow-up|4|||
25007535|NCT03794089|50099886|FG001|Overall Study|Lost to Follow-up|1|||
25007536|NCT03794089|50099885|FG000|Overall Study|Withdrawal by Subject|2|||
25007537|NCT03794089|50099886|FG001|Overall Study|Withdrawal by Subject|0|||
25007538|NCT03151304|50099892|FG000|Overall Study|Termination of study by Sponsor|23|||
25007539|NCT03151304|50099892|FG000|Overall Study|missing|3|||
25007540|NCT03151304|50099892|FG000|Overall Study|Withdrawal by Subject|8|||
25007541|NCT03151304|50099892|FG000|Overall Study|multiple reasons|30|||
25007542|NCT03152552|50099901|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
25007543|NCT03152552|50099902|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
25007544|NCT03152552|50099903|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
25007545|NCT03152552|50099904|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
25007546|NCT03152552|50099905|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
25007547|NCT03152552|50099901|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
25007548|NCT03152552|50099902|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
25007549|NCT03152552|50099903|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
25007550|NCT03152552|50099904|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
25007551|NCT03152552|50099905|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
25007552|NCT03152552|50099901|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
25093624|NCT03593655|50203152|FG001|Third Product Use Period|Withdrawal by Subject|1|||
25093625|NCT03577106|50203161|FG000|Overall Study|Withdrawal by Subject|3|||
25093626|NCT03534180|50203165|FG000|Overall Study|Withdrawal by Subject|1|||
25093627|NCT03462719|50203171|FG000|Overall Study|Withdrawal by Subject|4|||
25093628|NCT03462719|50203172|FG001|Overall Study|Withdrawal by Subject|3|||
25093629|NCT03462719|50203171|FG000|Overall Study|Ongoing|87|||
25093630|NCT03462719|50203172|FG001|Overall Study|Ongoing|72|||
25093631|NCT03382561|50203184|FG000|Overall Study|Disease progression|47|||
25093632|NCT03382561|50203185|FG001|Overall Study|Disease progression|6|||
25093633|NCT03382561|50203184|FG000|Overall Study|Adverse Event|10|||
25093634|NCT03382561|50203185|FG001|Overall Study|Adverse Event|2|||
25093635|NCT03382561|50203184|FG000|Overall Study|Death|8|||
25093636|NCT03382561|50203185|FG001|Overall Study|Death|3|||
25093637|NCT03382561|50203184|FG000|Overall Study|Withdrawal by Subject|6|||
25093638|NCT03382561|50203185|FG001|Overall Study|Withdrawal by Subject|5|||
25093639|NCT03382561|50203184|FG000|Overall Study|Alternative therapy|2|||
25093640|NCT03382561|50203185|FG001|Overall Study|Alternative therapy|8|||
25093641|NCT03382561|50203184|FG000|Overall Study|Never started treatment|3|||
25093642|NCT03382561|50203185|FG001|Overall Study|Never started treatment|6|||
25093643|NCT03382561|50203184|FG000|Overall Study|Lack of Efficacy|0|||
25093644|NCT03382561|50203185|FG001|Overall Study|Lack of Efficacy|1|||
25093645|NCT03382561|50203184|FG000|Overall Study|Physician Decision|0|||
25093646|NCT03382561|50203185|FG001|Overall Study|Physician Decision|1|||
25093647|NCT03382561|50203184|FG000|Overall Study|Other complicating disease|0|||
25093648|NCT03382561|50203185|FG001|Overall Study|Other complicating disease|1|||
25093649|NCT03364231|50203193|FG000|Overall Study|Adverse Event|1|||
25093650|NCT03364231|50203194|FG001|Overall Study|Adverse Event|4|||
25093651|NCT03364231|50203193|FG000|Overall Study|Death|1|||
25093652|NCT03364231|50203194|FG001|Overall Study|Death|0|||
25093653|NCT03364231|50203193|FG000|Overall Study|Investigator Decision|2|||
25093654|NCT03364231|50203194|FG001|Overall Study|Investigator Decision|2|||
25093655|NCT03364231|50203193|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
25093656|NCT03364231|50203194|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
25093657|NCT03364231|50203193|FG000|Overall Study|Withdrawal of Subject Consent|1|||
25093658|NCT03364231|50203194|FG001|Overall Study|Withdrawal of Subject Consent|0|||
25093659|NCT03364231|50203193|FG000|Overall Study|Reason Not Specified|1|||
25093660|NCT03364231|50203194|FG001|Overall Study|Reason Not Specified|0|||
25093661|NCT03364231|50203193|FG000|Overall Study|Disease Progression|0|||
25093662|NCT03364231|50203194|FG001|Overall Study|Disease Progression|6|||
25093663|NCT03303625|50203205|FG000|Overall Study|Withdrawal by Subject|2|||
25093664|NCT03303625|50203206|FG001|Overall Study|Withdrawal by Subject|0|||
25093665|NCT03303625|50203207|FG002|Overall Study|Withdrawal by Subject|0|||
25093666|NCT03303625|50203208|FG003|Overall Study|Withdrawal by Subject|0|||
25093667|NCT03299816|50203220|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
25093668|NCT03299816|50203221|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
25093669|NCT03299816|50203220|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
25093670|NCT03299816|50203221|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
25093671|NCT03299816|50203220|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
25093672|NCT03299816|50203221|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
25093673|NCT03291431|50203229|FG000|Overall Study|Protocol Violation|2|||
25093674|NCT03291431|50203230|FG001|Overall Study|Protocol Violation|1|||
25093675|NCT03291431|50203229|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
25093676|NCT03291431|50203230|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
25093677|NCT03291431|50203229|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
25093678|NCT03291431|50203230|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
25093679|NCT03288493|50203243|FG000|Overall Study|Withdrawal by Subject|4|||
25093680|NCT03288493|50203244|FG001|Overall Study|Withdrawal by Subject|0|||
25093681|NCT03288493|50203245|FG002|Overall Study|Withdrawal by Subject|0|||
25093682|NCT03288493|50203246|FG003|Overall Study|Withdrawal by Subject|0|||
25093683|NCT03288493|50203247|FG004|Overall Study|Withdrawal by Subject|0|||
25093684|NCT03288493|50203248|FG005|Overall Study|Withdrawal by Subject|2|||
25093685|NCT03288493|50203249|FG006|Overall Study|Withdrawal by Subject|0|||
25093686|NCT03288493|50203243|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
25093687|NCT03288493|50203244|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
25093688|NCT03288493|50203245|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
25093689|NCT03288493|50203246|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
25093690|NCT03288493|50203247|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
25093691|NCT03288493|50203248|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
25093692|NCT03288493|50203249|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
25093693|NCT03288493|50203243|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
25093694|NCT03288493|50203244|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
25093695|NCT03288493|50203245|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
25093696|NCT03288493|50203246|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
25093697|NCT03288493|50203247|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
25093698|NCT03288493|50203248|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
25093699|NCT03288493|50203249|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
25093700|NCT03288493|50203243|FG000|Overall Study|Death|2|||
25093701|NCT03288493|50203244|FG001|Overall Study|Death|0|||
25093702|NCT03288493|50203245|FG002|Overall Study|Death|0|||
25093703|NCT03288493|50203246|FG003|Overall Study|Death|0|||
25093704|NCT03288493|50203247|FG004|Overall Study|Death|0|||
25093705|NCT03288493|50203248|FG005|Overall Study|Death|0|||
25093706|NCT03288493|50203249|FG006|Overall Study|Death|0|||
25093707|NCT03288493|50203243|FG000|Overall Study|other reason not listed above|2|||
25093708|NCT03288493|50203244|FG001|Overall Study|other reason not listed above|0|||
25093709|NCT03288493|50203245|FG002|Overall Study|other reason not listed above|0|||
25093710|NCT03288493|50203246|FG003|Overall Study|other reason not listed above|0|||
25093711|NCT03288493|50203247|FG004|Overall Study|other reason not listed above|0|||
25093712|NCT03288493|50203248|FG005|Overall Study|other reason not listed above|0|||
25093713|NCT03288493|50203249|FG006|Overall Study|other reason not listed above|0|||
25093714|NCT03238300|50203280|FG000|Baseline (Before Intervention)|Physician Decision|0|||
25093715|NCT03238300|50203281|FG001|Baseline (Before Intervention)|Physician Decision|1|||
25093716|NCT03238300|50203280|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
25093717|NCT03238300|50203281|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
25093718|NCT03238300|50203280|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
25093719|NCT03238300|50203281|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
25093720|NCT03238300|50203280|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
25093721|NCT03238300|50203281|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
25093722|NCT03235544|50203295|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
25093723|NCT03235544|50203296|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
25093724|NCT03235544|50203297|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
25093725|NCT03235544|50203298|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
25093726|NCT03235544|50203295|FG000|Overall Study|Death|11|||
25093727|NCT03235544|50203296|FG001|Overall Study|Death|23|||
25093728|NCT03235544|50203297|FG002|Overall Study|Death|11|||
25093729|NCT03235544|50203298|FG003|Overall Study|Death|20|||
25093730|NCT03235544|50203295|FG000|Overall Study|Lost to Follow-up|0|||
25093731|NCT03235544|50203296|FG001|Overall Study|Lost to Follow-up|1|||
25093732|NCT03235544|50203297|FG002|Overall Study|Lost to Follow-up|0|||
25093733|NCT03235544|50203298|FG003|Overall Study|Lost to Follow-up|1|||
25093734|NCT03235544|50203295|FG000|Overall Study|Withdrawal by Participant|0|||
25093735|NCT03235544|50203296|FG001|Overall Study|Withdrawal by Participant|0|||
25093736|NCT03235544|50203297|FG002|Overall Study|Withdrawal by Participant|1|||
25093737|NCT03235544|50203298|FG003|Overall Study|Withdrawal by Participant|0|||
25093738|NCT03235544|50203295|FG000|Overall Study|Reason not Specified|0|||
25093739|NCT03235544|50203296|FG001|Overall Study|Reason not Specified|4|||
25093740|NCT03235544|50203297|FG002|Overall Study|Reason not Specified|0|||
25093741|NCT03235544|50203298|FG003|Overall Study|Reason not Specified|1|||
25093742|NCT03178045|50203311|FG000|Overall Study|Withdrawal by Subject|5|||
25093743|NCT03178045|50203312|FG001|Overall Study|Withdrawal by Subject|7|||
25093744|NCT03178045|50203311|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
25093745|NCT03178045|50203312|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
25093746|NCT03178045|50203311|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
25093747|NCT03178045|50203312|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
25093748|NCT03113500|50203336|FG000|Overall Study|Withdrawal by Subject|1|||
25093749|NCT02927301|50203355|FG000|Overall Study|Adverse Event|7|||
25093750|NCT02927301|50203355|FG000|Overall Study|Withdrawal by Subject|1|||
25093751|NCT02927301|50203355|FG000|Overall Study|Physician Decision|2|||
25093752|NCT02924727|50203361|FG000|Overall Study|Withdrawal by Subject|2|||
25093753|NCT02924727|50203362|FG001|Overall Study|Withdrawal by Subject|4|||
25093754|NCT02924727|50203361|FG000|Overall Study|Lost to Follow-up|2|||
25093755|NCT02924727|50203362|FG001|Overall Study|Lost to Follow-up|5|||
25093756|NCT02924727|50203361|FG000|Overall Study|Death|221|||
25093757|NCT02924727|50203362|FG001|Overall Study|Death|247|||
25093758|NCT02924727|50203361|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
25176908|NCT01528033|50320542|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
25176909|NCT01528033|50320543|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
25093759|NCT02924727|50203362|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
25093760|NCT02901626|50203372|FG000|Overall Study|Lost to Follow-up|1|||
25093761|NCT02901626|50203373|FG001|Overall Study|Lost to Follow-up|1|||
25093762|NCT02720692|50203424|FG000|Overall Study|Withdrawal by Subject|3|||
25176910|NCT01528033|50320542|FG000|Primary Endpoint Assessment ITT|Death|2|||
25093763|NCT02720692|50203425|FG001|Overall Study|Withdrawal by Subject|0|||
25093764|NCT02720692|50203424|FG000|Overall Study|Physician Decision|1|||
25093765|NCT02720692|50203425|FG001|Overall Study|Physician Decision|0|||
25093766|NCT02720692|50203424|FG000|Overall Study|Lost to Follow-up|8|||
25093767|NCT02720692|50203425|FG001|Overall Study|Lost to Follow-up|3|||
25093768|NCT02720692|50203424|FG000|Overall Study|Subject unable to return for visit|1|||
25093769|NCT02720692|50203425|FG001|Overall Study|Subject unable to return for visit|0|||
25093770|NCT02677896|50203433|FG000|Double Blind Period (up to 35 Months)|Death|113|||
25093771|NCT02677896|50203434|FG001|Double Blind Period (up to 35 Months)|Death|189|||
25093772|NCT02677896|50203433|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
25093773|NCT02677896|50203434|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
25093774|NCT02677896|50203433|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
25093775|NCT02677896|50203434|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
25093776|NCT02677896|50203433|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
25093777|NCT02677896|50203434|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
25093778|NCT02677896|50203433|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
25093779|NCT02677896|50203434|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
25093780|NCT02677896|50203433|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
25093781|NCT02677896|50203434|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
25093782|NCT02677896|50203433|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
25093783|NCT02677896|50203434|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
25093784|NCT02677896|50203433|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
25093785|NCT02677896|50203434|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
25093786|NCT02677896|50203433|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
25093787|NCT02677896|50203434|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
25093788|NCT02677896|50203433|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
25093789|NCT02677896|50203434|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
25093790|NCT02677896|50203433|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
25093791|NCT02677896|50203434|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
25093792|NCT02677896|50203433|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
25093793|NCT02677896|50203434|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
25093794|NCT02677896|50203433|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
25093795|NCT02677896|50203434|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
25093796|NCT02677896|50203433|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
25093797|NCT02677896|50203434|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
25093798|NCT02656303|50203444|FG000|Overall Study|Adverse Event|3|||
25093799|NCT02656303|50203445|FG001|Overall Study|Adverse Event|2|||
25093800|NCT02656303|50203446|FG002|Overall Study|Adverse Event|0|||
25093801|NCT02656303|50203444|FG000|Overall Study|Death|12|||
25093802|NCT02656303|50203445|FG001|Overall Study|Death|4|||
25093803|NCT02656303|50203446|FG002|Overall Study|Death|1|||
25093804|NCT02656303|50203444|FG000|Overall Study|Lack of Efficacy|1|||
25093805|NCT02656303|50203445|FG001|Overall Study|Lack of Efficacy|0|||
25093806|NCT02656303|50203446|FG002|Overall Study|Lack of Efficacy|0|||
25093807|NCT02656303|50203444|FG000|Overall Study|Non-Compliance with Study|1|||
25093808|NCT02656303|50203445|FG001|Overall Study|Non-Compliance with Study|1|||
25093809|NCT02656303|50203446|FG002|Overall Study|Non-Compliance with Study|0|||
25093810|NCT02656303|50203444|FG000|Overall Study|Investigator Decision|2|||
25093811|NCT02656303|50203445|FG001|Overall Study|Investigator Decision|1|||
25093812|NCT02656303|50203446|FG002|Overall Study|Investigator Decision|0|||
25093813|NCT02656303|50203444|FG000|Overall Study|Progressive Disease|25|||
25093814|NCT02656303|50203445|FG001|Overall Study|Progressive Disease|14|||
25093815|NCT02656303|50203446|FG002|Overall Study|Progressive Disease|10|||
25093816|NCT02656303|50203444|FG000|Overall Study|Study Terminated by Sponsor|20|||
25093817|NCT02656303|50203445|FG001|Overall Study|Study Terminated by Sponsor|7|||
25093818|NCT02656303|50203446|FG002|Overall Study|Study Terminated by Sponsor|5|||
25093819|NCT02656303|50203444|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
25093820|NCT02656303|50203445|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
25007553|NCT03152552|50099902|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
25007554|NCT03152552|50099903|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
25007555|NCT03152552|50099904|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
25007556|NCT03152552|50099905|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
25007557|NCT03152552|50099901|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
25007558|NCT03152552|50099902|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
25007559|NCT03152552|50099903|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
25007560|NCT03152552|50099904|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
25007561|NCT03152552|50099905|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
25007562|NCT03152552|50099901|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
25007563|NCT03152552|50099902|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
25007564|NCT03152552|50099903|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
25093821|NCT02656303|50203446|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
25093822|NCT02656303|50203444|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
25007565|NCT03152552|50099904|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
25007566|NCT03152552|50099905|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
25007567|NCT03152552|50099901|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
25007568|NCT03152552|50099902|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
25007569|NCT03152552|50099903|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
25007570|NCT03152552|50099904|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
25007571|NCT03152552|50099905|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
25007572|NCT03152552|50099901|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
25007573|NCT03152552|50099902|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
25007574|NCT03152552|50099903|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
25007575|NCT03152552|50099904|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
25007576|NCT03152552|50099905|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
25007577|NCT03151226|50099918|FG000|Overall Study|Withdrawal by Subject|2|||
25007578|NCT03151226|50099918|FG000|Overall Study|not wear device correctly|1|||
25007579|NCT03151148|50099924|FG000|Overall Study|Lost to Follow-up|1|||
25007580|NCT03151148|50099925|FG001|Overall Study|Lost to Follow-up|0|||
25007581|NCT03151148|50099924|FG000|Overall Study|Withdrawal by Subject|1|||
25007582|NCT03151148|50099925|FG001|Overall Study|Withdrawal by Subject|0|||
25007583|NCT02741518|50099934|FG000|Overall Study|Withdrawal by Subject|1|||
25007584|NCT02741518|50099935|FG001|Overall Study|Withdrawal by Subject|1|||
25007585|NCT03145766|50099946|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
25007586|NCT03145766|50099947|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
25007587|NCT03145766|50099948|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
25007588|NCT03145766|50099949|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
25007589|NCT03145766|50099950|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
25007590|NCT03145766|50099946|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
25007591|NCT03145766|50099947|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
25007592|NCT03145766|50099948|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
25007593|NCT03145766|50099949|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
25007594|NCT03145766|50099950|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
25007595|NCT03145766|50099946|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
25007596|NCT03145766|50099947|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
25007597|NCT03145766|50099948|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
25007598|NCT03145766|50099949|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
25007599|NCT03145766|50099950|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
25007600|NCT03145766|50099946|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
25007601|NCT03145766|50099947|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
25007602|NCT03145766|50099948|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
25007603|NCT03145766|50099949|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
25007604|NCT03145766|50099950|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
25007605|NCT03145766|50099946|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
25007606|NCT03145766|50099947|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
25007607|NCT03145766|50099948|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
25007608|NCT03145766|50099949|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
25007609|NCT03145766|50099950|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
25007610|NCT03145766|50099946|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
25007611|NCT03145766|50099947|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
25007612|NCT03145766|50099948|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
25007613|NCT03145766|50099949|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
25007614|NCT03145766|50099950|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
25007615|NCT03145766|50099946|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
25007616|NCT03145766|50099947|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
25007617|NCT03145766|50099948|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
25007618|NCT03145766|50099949|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
25007619|NCT03145766|50099950|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
25007620|NCT03145064|50099963|FG000|Overall Study|Death|24|||
25007621|NCT03145064|50099963|FG000|Overall Study|Lost to Follow-up|3|||
25007622|NCT03145064|50099963|FG000|Overall Study|Withdrawal by Subject|6|||
25007623|NCT03145064|50099963|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
25007624|NCT03145064|50099963|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
25007625|NCT03787615|50099988|FG000|Overall Study|Withdrawal by Subject|2|||
25007626|NCT03787615|50099988|FG000|Overall Study|Lost to Follow-up|2|||
25093823|NCT02656303|50203445|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
25093824|NCT02656303|50203446|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
25093825|NCT02656303|50203444|FG000|Overall Study|Reason not Specified|1|||
25093826|NCT02656303|50203445|FG001|Overall Study|Reason not Specified|1|||
25093827|NCT02656303|50203446|FG002|Overall Study|Reason not Specified|2|||
25093828|NCT02628626|50203456|FG000|Overall Study|Withdrawal by Subject|2|||
25093829|NCT02628626|50203457|FG001|Overall Study|Withdrawal by Subject|2|||
25093830|NCT02527707|50203489|FG000|Overall Study|Adverse Event|1|||
25093831|NCT02527707|50203489|FG000|Overall Study|Adverse Event|1|||
25093832|NCT02453191|50203500|FG000|Overall Study|Withdrawal by Subject|1|||
25093833|NCT02421939|50203507|FG000|Overall Study|Progressive disease|70|||
25093834|NCT02421939|50203508|FG001|Overall Study|Progressive disease|16|||
25093835|NCT02421939|50203507|FG000|Overall Study|Lack of Efficacy|21|||
25093836|NCT02421939|50203508|FG001|Overall Study|Lack of Efficacy|31|||
25093837|NCT02421939|50203507|FG000|Overall Study|Death|36|||
25093838|NCT02421939|50203508|FG001|Overall Study|Death|10|||
25093839|NCT02421939|50203507|FG000|Overall Study|Disease relapse|33|||
25093840|NCT02421939|50203508|FG001|Overall Study|Disease relapse|2|||
25093841|NCT02421939|50203507|FG000|Overall Study|Adverse Event|28|||
25093842|NCT02421939|50203508|FG001|Overall Study|Adverse Event|5|||
25093843|NCT02421939|50203507|FG000|Overall Study|Withdrawal by Subject|5|||
25093844|NCT02421939|50203508|FG001|Overall Study|Withdrawal by Subject|24|||
25093845|NCT02421939|50203507|FG000|Overall Study|Physician Decision|11|||
25093846|NCT02421939|50203508|FG001|Overall Study|Physician Decision|11|||
25093847|NCT02421939|50203507|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
25093848|NCT02421939|50203508|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
25093849|NCT02421939|50203507|FG000|Overall Study|Miscellaneous|4|||
25093850|NCT02421939|50203508|FG001|Overall Study|Miscellaneous|5|||
25093851|NCT02421939|50203507|FG000|Overall Study|Protocol deviation|1|||
25093852|NCT02421939|50203508|FG001|Overall Study|Protocol deviation|1|||
25093853|NCT02352090|50203517|FG000|Overall Study|general malaise|1|||
25093854|NCT02352090|50203518|FG001|Overall Study|general malaise|0|||
25093855|NCT02352090|50203519|FG002|Overall Study|general malaise|0|||
25093856|NCT02352090|50203517|FG000|Overall Study|non-specified mild side-effects|0|||
25093857|NCT02352090|50203518|FG001|Overall Study|non-specified mild side-effects|0|||
25093858|NCT02352090|50203519|FG002|Overall Study|non-specified mild side-effects|2|||
25093859|NCT02294461|50203529|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
25093860|NCT02294461|50203530|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
25093861|NCT02294461|50203529|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
25093862|NCT02294461|50203530|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
25093863|NCT02294461|50203529|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
25093864|NCT02294461|50203530|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
25093865|NCT02294461|50203529|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
25093866|NCT02294461|50203530|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
25093867|NCT02294461|50203529|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
25093868|NCT02294461|50203530|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
25093869|NCT02294461|50203529|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
25093870|NCT02294461|50203530|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
25093871|NCT02294461|50203529|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
25093872|NCT02294461|50203530|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
25093873|NCT02294461|50203529|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
25093874|NCT02294461|50203530|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
25093875|NCT02294461|50203529|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
25093876|NCT02294461|50203530|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
25093877|NCT02294461|50203529|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
25093878|NCT02294461|50203530|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
25093879|NCT02294461|50203529|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
25093880|NCT02294461|50203530|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
25093881|NCT02294461|50203529|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
25093882|NCT02294461|50203530|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
25093883|NCT02294461|50203529|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
25093884|NCT02294461|50203530|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
25176911|NCT01528033|50320543|FG001|Primary Endpoint Assessment ITT|Death|2|||
25007627|NCT03784963|50099997|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
25007628|NCT03784963|50099998|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
25007629|NCT03784963|50099999|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
25007630|NCT03784963|50100000|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
25007631|NCT03787303|50100010|FG000|Overall Study|Death|1|||
25093885|NCT02294461|50203529|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
25093886|NCT02294461|50203530|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
25093887|NCT02294461|50203529|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
25093888|NCT02294461|50203530|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
25093889|NCT02135107|50203550|FG000|Treatment Period|Withdrawal by Subject|11|||
25093890|NCT02135107|50203551|FG001|Treatment Period|Withdrawal by Subject|0|||
25093891|NCT02135107|50203552|FG002|Treatment Period|Withdrawal by Subject|0|||
25093892|NCT02135107|50203553|FG003|Treatment Period|Withdrawal by Subject|0|||
25093893|NCT02135107|50203550|FG000|Treatment Period|Adverse Event|5|||
25093894|NCT02135107|50203551|FG001|Treatment Period|Adverse Event|2|||
25093895|NCT02135107|50203552|FG002|Treatment Period|Adverse Event|0|||
25093896|NCT02135107|50203553|FG003|Treatment Period|Adverse Event|0|||
25093897|NCT02135107|50203550|FG000|Treatment Period|Pregnancy|1|||
25093898|NCT02135107|50203551|FG001|Treatment Period|Pregnancy|0|||
25093899|NCT02135107|50203552|FG002|Treatment Period|Pregnancy|0|||
25093900|NCT02135107|50203553|FG003|Treatment Period|Pregnancy|0|||
25093901|NCT02135107|50203550|FG000|Treatment Period|Other|115|||
25093902|NCT02135107|50203551|FG001|Treatment Period|Other|24|||
25093903|NCT02135107|50203552|FG002|Treatment Period|Other|0|||
25093904|NCT02135107|50203553|FG003|Treatment Period|Other|0|||
25093905|NCT02135107|50203550|FG000|Maintenance Therapy Period|Adverse Event|0|||
25093906|NCT02135107|50203551|FG001|Maintenance Therapy Period|Adverse Event|0|||
25093907|NCT02135107|50203552|FG002|Maintenance Therapy Period|Adverse Event|3|||
25093908|NCT02135107|50203553|FG003|Maintenance Therapy Period|Adverse Event|7|||
25093909|NCT02135107|50203550|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
25093910|NCT02135107|50203551|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
25093911|NCT02135107|50203552|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
25093912|NCT02135107|50203553|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
25093913|NCT02135107|50203550|FG000|Maintenance Therapy Period|Pregnancy|0|||
25093914|NCT02135107|50203551|FG001|Maintenance Therapy Period|Pregnancy|0|||
25093915|NCT02135107|50203552|FG002|Maintenance Therapy Period|Pregnancy|0|||
25093916|NCT02135107|50203553|FG003|Maintenance Therapy Period|Pregnancy|1|||
25093917|NCT02135107|50203550|FG000|Maintenance Therapy Period|Other|0|||
25093918|NCT02135107|50203551|FG001|Maintenance Therapy Period|Other|0|||
25093919|NCT02135107|50203552|FG002|Maintenance Therapy Period|Other|7|||
25093920|NCT02135107|50203553|FG003|Maintenance Therapy Period|Other|8|||
25093921|NCT02030847|50203565|FG000|Overall Study|Death|10|||
25093922|NCT02030847|50203565|FG000|Overall Study|Disease Progression|15|||
25093923|NCT02030847|50203565|FG000|Overall Study|New Cancer Therapy|8|||
25093924|NCT02030847|50203565|FG000|Overall Study|Physician Decision|3|||
25093925|NCT02030847|50203565|FG000|Overall Study|Withdrawal by Subject|1|||
25093926|NCT02030834|50203573|FG000|Overall Study|Death|4|||
25093927|NCT02030834|50203574|FG001|Overall Study|Death|0|||
25093928|NCT02030834|50203575|FG002|Overall Study|Death|0|||
25176912|NCT01528033|50320542|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
25176913|NCT01528033|50320543|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
25176914|NCT01528033|50320542|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
25176915|NCT01528033|50320543|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
25176916|NCT01528033|50320542|FG000|Follow Up|No data available|46|||
25176917|NCT01528033|50320543|FG001|Follow Up|No data available|44|||
25176918|NCT01560871|50320560|FG000|Overall Study|transportation issues|2|||
25176919|NCT01560871|50320561|FG001|Overall Study|transportation issues|1|||
25176920|NCT01560871|50320560|FG000|Overall Study|relocation|1|||
25176921|NCT01560871|50320561|FG001|Overall Study|relocation|0|||
25176922|NCT01560871|50320560|FG000|Overall Study|readmission to a hospital|2|||
25093929|NCT02030834|50203573|FG000|Overall Study|Manufacturing failure|2|||
25093930|NCT02030834|50203574|FG001|Overall Study|Manufacturing failure|0|||
25093931|NCT02030834|50203575|FG002|Overall Study|Manufacturing failure|1|||
25093932|NCT02030834|50203573|FG000|Overall Study|Disease progression|2|||
25093933|NCT02030834|50203574|FG001|Overall Study|Disease progression|0|||
25093934|NCT02030834|50203575|FG002|Overall Study|Disease progression|2|||
25093935|NCT02030834|50203573|FG000|Overall Study|Lost to Follow-up|1|||
25093936|NCT02030834|50203574|FG001|Overall Study|Lost to Follow-up|0|||
25176923|NCT01560871|50320561|FG001|Overall Study|readmission to a hospital|1|||
25176924|NCT01560871|50320560|FG000|Overall Study|Lost to Follow-up|1|||
25176925|NCT01560871|50320561|FG001|Overall Study|Lost to Follow-up|0|||
25093937|NCT02030834|50203575|FG002|Overall Study|Lost to Follow-up|0|||
25093938|NCT02030834|50203573|FG000|Overall Study|Withdrawal by Subject|1|||
25093939|NCT02030834|50203574|FG001|Overall Study|Withdrawal by Subject|0|||
25093940|NCT02030834|50203575|FG002|Overall Study|Withdrawal by Subject|0|||
25093941|NCT02030834|50203573|FG000|Overall Study|Lack of funding|1|||
25093942|NCT02030834|50203574|FG001|Overall Study|Lack of funding|0|||
25093943|NCT02030834|50203575|FG002|Overall Study|Lack of funding|0|||
25093944|NCT02025010|50203583|FG000|Overall Study|Symptomatic or radiographic progression|36|||
25093945|NCT02025010|50203583|FG000|Overall Study|Adverse Event|6|||
25093946|NCT02025010|50203583|FG000|Overall Study|Physician Decision|7|||
25093947|NCT02025010|50203583|FG000|Overall Study|Withdrawal by Subject|3|||
25093948|NCT02025010|50203583|FG000|Overall Study|Intercurrent illness|3|||
25093949|NCT02025010|50203583|FG000|Overall Study|Patients still on treatment|3|||
25093950|NCT02025010|50203583|FG000|Overall Study|Never initiate the treatment|2|||
25093951|NCT01982448|50203591|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
25093952|NCT01982448|50203592|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
25093953|NCT01982448|50203591|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
25093954|NCT01982448|50203592|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
25093955|NCT01982448|50203591|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
25093956|NCT01982448|50203592|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
25093957|NCT01982448|50203591|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
25093958|NCT01982448|50203592|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
25093959|NCT01844986|50203604|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
25093960|NCT01844986|50203605|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
25093961|NCT01844986|50203604|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
25093962|NCT01844986|50203605|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
25093963|NCT01844986|50203604|FG000|Overall Study (Global Cohort)|Death|55|||
25093964|NCT01844986|50203605|FG001|Overall Study (Global Cohort)|Death|26|||
25093965|NCT01844986|50203604|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
25093966|NCT01844986|50203605|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
25093967|NCT01844986|50203604|FG000|Overall Study (China Cohort)|Death|10|||
25093968|NCT01844986|50203605|FG001|Overall Study (China Cohort)|Death|6|||
25093969|NCT01844518|50203617|FG000|Overall Study|Adverse Event|7|||
25093970|NCT01844518|50203618|FG001|Overall Study|Adverse Event|1|||
25093971|NCT01844518|50203617|FG000|Overall Study|Lack of Efficacy|17|||
25093972|NCT01844518|50203618|FG001|Overall Study|Lack of Efficacy|5|||
25093973|NCT01844518|50203617|FG000|Overall Study|Participant's request to discontinue|4|||
25093974|NCT01844518|50203618|FG001|Overall Study|Participant's request to discontinue|1|||
25093975|NCT01844518|50203617|FG000|Overall Study|Poor/Non-compliance|1|||
25093976|NCT01844518|50203618|FG001|Overall Study|Poor/Non-compliance|0|||
25093977|NCT01844518|50203617|FG000|Overall Study|No Longer Met Study Criteria|2|||
25093978|NCT01844518|50203618|FG001|Overall Study|No Longer Met Study Criteria|0|||
25093979|NCT01844518|50203617|FG000|Overall Study|Withdrawal by Subject|9|||
25093980|NCT01844518|50203618|FG001|Overall Study|Withdrawal by Subject|0|||
25093981|NCT01844518|50203617|FG000|Overall Study|Pregnancy|1|||
25093982|NCT01844518|50203618|FG001|Overall Study|Pregnancy|0|||
25093983|NCT01773421|50203631|FG000|Treatment Phase|Other|0|||
25093984|NCT01773421|50203632|FG001|Treatment Phase|Other|0|||
25093985|NCT01773421|50203633|FG002|Treatment Phase|Other|2|||
25093986|NCT01773421|50203634|FG003|Treatment Phase|Other|0|||
25093987|NCT01773421|50203635|FG004|Treatment Phase|Other|0|||
25093988|NCT01773421|50203636|FG005|Treatment Phase|Other|0|||
25093989|NCT01773421|50203637|FG006|Treatment Phase|Other|0|||
25093990|NCT01773421|50203631|FG000|Treatment Phase|Adverse Event|0|||
25093991|NCT01773421|50203632|FG001|Treatment Phase|Adverse Event|0|||
25093992|NCT01773421|50203633|FG002|Treatment Phase|Adverse Event|3|||
25093993|NCT01773421|50203634|FG003|Treatment Phase|Adverse Event|1|||
25093994|NCT01773421|50203635|FG004|Treatment Phase|Adverse Event|0|||
25093995|NCT01773421|50203636|FG005|Treatment Phase|Adverse Event|0|||
25093996|NCT01773421|50203637|FG006|Treatment Phase|Adverse Event|0|||
25093997|NCT01773421|50203631|FG000|Treatment Phase|Withdrawal by Subject|0|||
25093998|NCT01773421|50203632|FG001|Treatment Phase|Withdrawal by Subject|0|||
25093999|NCT01773421|50203633|FG002|Treatment Phase|Withdrawal by Subject|1|||
25094000|NCT01773421|50203634|FG003|Treatment Phase|Withdrawal by Subject|1|||
25094001|NCT01773421|50203635|FG004|Treatment Phase|Withdrawal by Subject|0|||
25094002|NCT01773421|50203636|FG005|Treatment Phase|Withdrawal by Subject|0|||
25094003|NCT01773421|50203637|FG006|Treatment Phase|Withdrawal by Subject|0|||
25176926|NCT01509053|50320568|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
25176927|NCT01509053|50320568|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
25176928|NCT01509053|50320568|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
25176929|NCT01509053|50320568|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
25176930|NCT01509053|50320568|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
25176931|NCT01509053|50320568|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
25176932|NCT01560403|50320582|FG000|Overall Study|Lost to Follow-up|0|||
25176933|NCT01560403|50320583|FG001|Overall Study|Lost to Follow-up|1|||
25176934|NCT01527487|50320630|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
25094004|NCT01773421|50203631|FG000|Extension Phase|Other|0|||
25094005|NCT01773421|50203632|FG001|Extension Phase|Other|0|||
25094006|NCT01773421|50203633|FG002|Extension Phase|Other|0|||
25094007|NCT01773421|50203634|FG003|Extension Phase|Other|0|||
25094008|NCT01773421|50203635|FG004|Extension Phase|Other|1|||
25094009|NCT01773421|50203636|FG005|Extension Phase|Other|2|||
25094010|NCT01773421|50203637|FG006|Extension Phase|Other|0|||
25094011|NCT01773421|50203631|FG000|Extension Phase|Adverse Event|0|||
25094012|NCT01773421|50203632|FG001|Extension Phase|Adverse Event|0|||
25094013|NCT01773421|50203633|FG002|Extension Phase|Adverse Event|0|||
25094014|NCT01773421|50203634|FG003|Extension Phase|Adverse Event|0|||
25094015|NCT01773421|50203635|FG004|Extension Phase|Adverse Event|2|||
25094016|NCT01773421|50203636|FG005|Extension Phase|Adverse Event|0|||
25094017|NCT01773421|50203637|FG006|Extension Phase|Adverse Event|0|||
25094018|NCT01757535|50203655|FG000|Overall Study|Disease Relapse|143|||
25094019|NCT01757535|50203656|FG001|Overall Study|Disease Relapse|180|||
25094020|NCT01757535|50203655|FG000|Overall Study|Adverse Event|29|||
25094021|NCT01757535|50203656|FG001|Overall Study|Adverse Event|11|||
25094022|NCT01757535|50203655|FG000|Overall Study|Withdrawal by Subject|9|||
25094023|NCT01757535|50203656|FG001|Overall Study|Withdrawal by Subject|13|||
25094024|NCT01757535|50203655|FG000|Overall Study|Miscellaneous|5|||
25094025|NCT01757535|50203656|FG001|Overall Study|Miscellaneous|2|||
25094026|NCT01757535|50203655|FG000|Overall Study|Physician Decision|6|||
25094027|NCT01757535|50203656|FG001|Overall Study|Physician Decision|0|||
25094028|NCT01757535|50203655|FG000|Overall Study|Death|1|||
25094029|NCT01757535|50203656|FG001|Overall Study|Death|2|||
25094030|NCT01747486|50203664|FG000|Stage 1|Physician Decision|3|||
25094031|NCT01747486|50203665|FG001|Stage 1|Physician Decision|0|||
25094032|NCT01747486|50203664|FG000|Stage 1|Withdrawal by Subject|4|||
25094033|NCT01747486|50203665|FG001|Stage 1|Withdrawal by Subject|3|||
25094034|NCT01747486|50203664|FG000|Stage 1|Disease progression|4|||
25094035|NCT01747486|50203665|FG001|Stage 1|Disease progression|9|||
25094036|NCT01747486|50203664|FG000|Stage 1|Death|1|||
25094037|NCT01747486|50203665|FG001|Stage 1|Death|1|||
25094038|NCT01747486|50203664|FG000|Stage 2|Physician Decision|2|||
25094039|NCT01747486|50203665|FG001|Stage 2|Physician Decision|0|||
25094040|NCT01747486|50203664|FG000|Stage 2|Withdrawal by Subject|1|||
25094041|NCT01747486|50203665|FG001|Stage 2|Withdrawal by Subject|0|||
25094042|NCT01747486|50203664|FG000|Stage 2|New Cancer Therapy|3|||
25094043|NCT01747486|50203665|FG001|Stage 2|New Cancer Therapy|0|||
25094044|NCT01747486|50203664|FG000|Stage 2|Disease Progression|3|||
25094045|NCT01747486|50203665|FG001|Stage 2|Disease Progression|0|||
25094046|NCT01659151|50203675|FG000|Overall Study|Inadequate TIL growth|1|||
25094047|NCT01593254|50203681|FG000|Overall Study|Disease progression|2|||
25094048|NCT01593254|50203682|FG001|Overall Study|Disease progression|7|||
25094049|NCT01593254|50203681|FG000|Overall Study|Study drug toxicity|6|||
25094050|NCT01593254|50203682|FG001|Overall Study|Study drug toxicity|20|||
25094051|NCT01593254|50203681|FG000|Overall Study|Death|3|||
25094052|NCT01593254|50203682|FG001|Overall Study|Death|3|||
25094053|NCT01593254|50203681|FG000|Overall Study|AE unrelated to study drug|0|||
25094054|NCT01593254|50203682|FG001|Overall Study|AE unrelated to study drug|1|||
25094055|NCT01593254|50203681|FG000|Overall Study|participant request to discontinue study treatment|1|||
25094056|NCT01593254|50203682|FG001|Overall Study|participant request to discontinue study treatment|3|||
25094057|NCT01593254|50203681|FG000|Overall Study|participant withdrew consent|0|||
25094058|NCT01593254|50203682|FG001|Overall Study|participant withdrew consent|9|||
25094059|NCT01593254|50203681|FG000|Overall Study|lost to follow up|1|||
25094060|NCT01593254|50203682|FG001|Overall Study|lost to follow up|6|||
25094061|NCT01593254|50203681|FG000|Overall Study|maximum clinical benefit|1|||
25094062|NCT01593254|50203682|FG001|Overall Study|maximum clinical benefit|2|||
25094063|NCT01593254|50203681|FG000|Overall Study|Poor/non compliance|1|||
25094064|NCT01593254|50203682|FG001|Overall Study|Poor/non compliance|1|||
25094065|NCT01593254|50203681|FG000|Overall Study|Pregnancy|0|||
25094066|NCT01593254|50203682|FG001|Overall Study|Pregnancy|3|||
25094067|NCT01593254|50203681|FG000|Overall Study|participant no longer meets study criteria|1|||
25094068|NCT01593254|50203682|FG001|Overall Study|participant no longer meets study criteria|1|||
25094069|NCT01593254|50203681|FG000|Overall Study|Admin reason by sponsor|7|||
25094070|NCT01593254|50203682|FG001|Overall Study|Admin reason by sponsor|3|||
25094071|NCT01593254|50203681|FG000|Overall Study|Imatinib treatment failure|2|||
25094072|NCT01593254|50203682|FG001|Overall Study|Imatinib treatment failure|0|||
25094073|NCT01593254|50203681|FG000|Overall Study|Other Reasons|61|||
25094074|NCT01593254|50203682|FG001|Overall Study|Other Reasons|115|||
25094075|NCT01559818|50203689|FG000|Overall Study|Physician Decision|1|||
25094076|NCT01559818|50203689|FG000|Overall Study|Pregnancy|1|||
25094077|NCT01559818|50203689|FG000|Overall Study|Study terminated by Sponsor|4|||
25094078|NCT01559818|50203689|FG000|Overall Study|Withdrawal by Subject|1|||
25094079|NCT01454934|50203696|FG000|Overall Study|Clinical progression|28|||
25094080|NCT01454934|50203697|FG001|Overall Study|Clinical progression|25|||
25094081|NCT01454934|50203696|FG000|Overall Study|Other|6|||
25094082|NCT01454934|50203697|FG001|Overall Study|Other|17|||
25094083|NCT01454934|50203696|FG000|Overall Study|Adverse Event|28|||
25094084|NCT01454934|50203697|FG001|Overall Study|Adverse Event|24|||
25094085|NCT01454934|50203696|FG000|Overall Study|Withdrawn consent|2|||
25094086|NCT01454934|50203697|FG001|Overall Study|Withdrawn consent|5|||
25094087|NCT01454934|50203696|FG000|Overall Study|Withdrawal by Subject|11|||
25094088|NCT01454934|50203697|FG001|Overall Study|Withdrawal by Subject|15|||
25094089|NCT01454934|50203696|FG000|Overall Study|Disease progression|194|||
25094090|NCT01454934|50203697|FG001|Overall Study|Disease progression|181|||
25094091|NCT01454934|50203696|FG000|Overall Study|Lost to Follow-up|0|||
25094092|NCT01454934|50203697|FG001|Overall Study|Lost to Follow-up|1|||
25094093|NCT01454934|50203696|FG000|Overall Study|Not treated|1|||
25094094|NCT01454934|50203697|FG001|Overall Study|Not treated|2|||
25094095|NCT01439282|50203705|FG000|Overall Study|Adverse Event|5|||
25094096|NCT01439282|50203706|FG001|Overall Study|Adverse Event|0|||
25094097|NCT01439282|50203705|FG000|Overall Study|Withdrawal by Subject|2|||
25094098|NCT01439282|50203706|FG001|Overall Study|Withdrawal by Subject|0|||
25094099|NCT01439282|50203705|FG000|Overall Study|Other|1|||
25094100|NCT01439282|50203706|FG001|Overall Study|Other|1|||
25094101|NCT01326312|50203716|FG000|Overall Study|Adverse Event|11|||
25094102|NCT01326312|50203717|FG001|Overall Study|Adverse Event|11|||
25094103|NCT01326312|50203718|FG002|Overall Study|Adverse Event|1|||
25094104|NCT01326312|50203716|FG000|Overall Study|Withdrawal by Subject|1|||
25094105|NCT01326312|50203717|FG001|Overall Study|Withdrawal by Subject|2|||
25094106|NCT01326312|50203718|FG002|Overall Study|Withdrawal by Subject|1|||
25094107|NCT01326312|50203716|FG000|Overall Study|Protocol Violation|0|||
25094108|NCT01326312|50203717|FG001|Overall Study|Protocol Violation|1|||
25094109|NCT01326312|50203718|FG002|Overall Study|Protocol Violation|0|||
25094110|NCT01326312|50203716|FG000|Overall Study|Lack of Efficacy|13|||
25094111|NCT01326312|50203717|FG001|Overall Study|Lack of Efficacy|7|||
25094112|NCT01326312|50203718|FG002|Overall Study|Lack of Efficacy|1|||
25094113|NCT01326312|50203716|FG000|Overall Study|Death|1|||
25094114|NCT01326312|50203717|FG001|Overall Study|Death|0|||
25094115|NCT01326312|50203718|FG002|Overall Study|Death|1|||
25094116|NCT01326312|50203716|FG000|Overall Study|progressive disease|0|||
25094117|NCT01326312|50203717|FG001|Overall Study|progressive disease|1|||
25094118|NCT01326312|50203718|FG002|Overall Study|progressive disease|1|||
25094119|NCT01326312|50203716|FG000|Overall Study|Study terminated by Sponsor|8|||
25094120|NCT01326312|50203717|FG001|Overall Study|Study terminated by Sponsor|32|||
25094121|NCT01326312|50203718|FG002|Overall Study|Study terminated by Sponsor|46|||
25094122|NCT01326312|50203716|FG000|Overall Study|Treatment arm terminated|19|||
25094123|NCT01326312|50203717|FG001|Overall Study|Treatment arm terminated|0|||
25094124|NCT01326312|50203718|FG002|Overall Study|Treatment arm terminated|0|||
25094125|NCT01326312|50203716|FG000|Overall Study|QTc > 500|0|||
25094126|NCT01326312|50203717|FG001|Overall Study|QTc > 500|1|||
25094127|NCT01326312|50203718|FG002|Overall Study|QTc > 500|0|||
25094128|NCT01269346|50203740|FG000|Treatment Phase|Disease progression|3|||
25094129|NCT01269346|50203740|FG000|Treatment Phase|Adverse Event|3|||
25094130|NCT01269346|50203740|FG000|Treatment Phase|Withdrawal by Subject|1|||
25094131|NCT01269346|50203740|FG000|Treatment Phase|Other|2|||
25094132|NCT01269346|50203740|FG000|Extension Phase|Adverse Event|6|||
25094133|NCT01269346|50203740|FG000|Extension Phase|Withdrawal by Subject|4|||
25094134|NCT01269346|50203740|FG000|Extension Phase|Disease progression|22|||
25094135|NCT01269346|50203740|FG000|Extension Phase|Physician decision or participant choice|9|||
25094136|NCT01269346|50203740|FG000|Extension Phase|Clinical progression|1|||
25094137|NCT01269346|50203740|FG000|Extension Phase|Started a prohibited con med|1|||
25094138|NCT01268293|50203745|FG000|Overall Study|Disease progression|7|||
25094139|NCT01268293|50203745|FG000|Overall Study|Adverse Event|1|||
25094140|NCT01268293|50203745|FG000|Overall Study|Subject choice|1|||
25094141|NCT01268150|50203749|FG000|Treatment Phase|Progression of disease|18|||
25094142|NCT01268150|50203749|FG000|Treatment Phase|Adverse Event|3|||
25094143|NCT01268150|50203749|FG000|Treatment Phase|Withdrawal by Subject|3|||
25094144|NCT01268150|50203749|FG000|Treatment Phase|Other|4|||
25094145|NCT01268150|50203749|FG000|Extension Phase|Adverse Event|3|||
25094146|NCT01268150|50203749|FG000|Extension Phase|Disease progression|18|||
25094147|NCT01268150|50203749|FG000|Extension Phase|Other|6|||
25094148|NCT01267175|50203753|FG000|Overall Study|Withdrawal by Subject|1|||
25094149|NCT01267175|50203753|FG000|Overall Study|Lost to Follow-up|1|||
25094150|NCT01133756|50203764|FG000|Overall Study|Adverse Event|1|||
25094151|NCT01133756|50203765|FG001|Overall Study|Adverse Event|2|||
25094152|NCT01133756|50203766|FG002|Overall Study|Adverse Event|1|||
25094153|NCT01133756|50203764|FG000|Overall Study|Investigator Decision|1|||
25094154|NCT01133756|50203765|FG001|Overall Study|Investigator Decision|0|||
25094155|NCT01133756|50203766|FG002|Overall Study|Investigator Decision|0|||
25094156|NCT01133756|50203764|FG000|Overall Study|Withdrawal by Subject|0|||
25094157|NCT01133756|50203765|FG001|Overall Study|Withdrawal by Subject|1|||
25094158|NCT01133756|50203766|FG002|Overall Study|Withdrawal by Subject|0|||
25094159|NCT01133756|50203764|FG000|Overall Study|Progression of Disease|0|||
25094160|NCT01133756|50203765|FG001|Overall Study|Progression of Disease|0|||
25094161|NCT01133756|50203766|FG002|Overall Study|Progression of Disease|1|||
25094162|NCT01126736|50203779|FG000|Overall Study|Death|2|||
25094163|NCT01126736|50203780|FG001|Overall Study|Death|2|||
25094164|NCT01126736|50203781|FG002|Overall Study|Death|1|||
25094165|NCT01126736|50203782|FG003|Overall Study|Death|19|||
25094166|NCT01126736|50203783|FG004|Overall Study|Death|19|||
25094167|NCT01126736|50203779|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
25094168|NCT01126736|50203780|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
25094169|NCT01126736|50203781|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
25094170|NCT01126736|50203782|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
25094171|NCT01126736|50203783|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
25094172|NCT01126736|50203779|FG000|Overall Study|Lost to Follow-up|0|||
25094173|NCT01126736|50203780|FG001|Overall Study|Lost to Follow-up|0|||
25094174|NCT01126736|50203781|FG002|Overall Study|Lost to Follow-up|0|||
25094175|NCT01126736|50203782|FG003|Overall Study|Lost to Follow-up|1|||
25094176|NCT01126736|50203783|FG004|Overall Study|Lost to Follow-up|1|||
25094177|NCT01126736|50203779|FG000|Overall Study|Administrative reasons|0|||
25094178|NCT01126736|50203780|FG001|Overall Study|Administrative reasons|0|||
25094179|NCT01126736|50203781|FG002|Overall Study|Administrative reasons|0|||
25094180|NCT01126736|50203782|FG003|Overall Study|Administrative reasons|0|||
25094181|NCT01126736|50203783|FG004|Overall Study|Administrative reasons|1|||
25094182|NCT01126736|50203779|FG000|Overall Study|Progressive disease|0|||
25094183|NCT01126736|50203780|FG001|Overall Study|Progressive disease|0|||
25094184|NCT01126736|50203781|FG002|Overall Study|Progressive disease|0|||
25094185|NCT01126736|50203782|FG003|Overall Study|Progressive disease|2|||
25094186|NCT01126736|50203783|FG004|Overall Study|Progressive disease|1|||
25094187|NCT01126736|50203779|FG000|Overall Study|Withdrawal by Subject|0|||
25094188|NCT01126736|50203780|FG001|Overall Study|Withdrawal by Subject|0|||
25094189|NCT01126736|50203781|FG002|Overall Study|Withdrawal by Subject|0|||
25094190|NCT01126736|50203782|FG003|Overall Study|Withdrawal by Subject|1|||
25094191|NCT01126736|50203783|FG004|Overall Study|Withdrawal by Subject|1|||
25094192|NCT01126736|50203779|FG000|Overall Study|Other|2|||
25094193|NCT01126736|50203780|FG001|Overall Study|Other|4|||
25094194|NCT01126736|50203781|FG002|Overall Study|Other|4|||
25094195|NCT01126736|50203782|FG003|Overall Study|Other|16|||
25094196|NCT01126736|50203783|FG004|Overall Study|Other|15|||
25094197|NCT01111461|50203795|FG000|Overall Study|Adverse Event|32|||
25094198|NCT01111461|50203795|FG000|Overall Study|Participant choice|11|||
25094199|NCT01111461|50203795|FG000|Overall Study|Lost to Follow-up|1|||
25094200|NCT01111461|50203795|FG000|Overall Study|Withdrawal by Subject|1|||
25094201|NCT01111461|50203795|FG000|Overall Study|Other|6|||
25094202|NCT01104155|50203801|FG000|Overall Study|Adverse Event|15|||
25094203|NCT01104155|50203802|FG001|Overall Study|Adverse Event|8|||
25094204|NCT01104155|50203801|FG000|Overall Study|Participant choice|6|||
25094205|NCT01104155|50203802|FG001|Overall Study|Participant choice|5|||
25094206|NCT01104155|50203801|FG000|Overall Study|Withdrawal of consent|1|||
25094207|NCT01104155|50203802|FG001|Overall Study|Withdrawal of consent|1|||
25094208|NCT01104155|50203801|FG000|Overall Study|Other|3|||
25094209|NCT01104155|50203802|FG001|Overall Study|Other|4|||
25094210|NCT01065597|50203808|FG000|Overall Study|Adverse Event|1|||
25094211|NCT01051856|50203814|FG000|Overall Study|Withdrawal by Subject|1|||
25094212|NCT01051856|50203815|FG001|Overall Study|Withdrawal by Subject|0|||
25094213|NCT01029366|50203823|FG000|Overall Study|Withdrawal by Subject|1|||
25094214|NCT01029366|50203824|FG001|Overall Study|Withdrawal by Subject|0|||
25094215|NCT01029366|50203823|FG000|Overall Study|Death|1|||
25094216|NCT01029366|50203824|FG001|Overall Study|Death|1|||
25094217|NCT01029366|50203823|FG000|Overall Study|disease progression|2|||
25094218|NCT01029366|50203824|FG001|Overall Study|disease progression|0|||
25094219|NCT01029366|50203823|FG000|Overall Study|manufacturing failure|0|||
25094220|NCT01029366|50203824|FG001|Overall Study|manufacturing failure|1|||
25094221|NCT01005745|50203831|FG000|Overall Study|No TIL growth|1|||
25094222|NCT01005745|50203831|FG000|Overall Study|Disease progressed during TIL growth|3|||
25094223|NCT01005745|50203831|FG000|Overall Study|Death prior to treatment|1|||
25094224|NCT01005745|50203831|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
25094225|NCT00879086|50203837|FG000|Overall Study|Adverse Event|3|||
25094226|NCT00879086|50203838|FG001|Overall Study|Adverse Event|15|||
25094227|NCT00879086|50203837|FG000|Overall Study|Participant choice|2|||
25094228|NCT00879086|50203838|FG001|Overall Study|Participant choice|2|||
25094229|NCT00879086|50203837|FG000|Overall Study|Progression of disease|40|||
25094230|NCT00879086|50203838|FG001|Overall Study|Progression of disease|26|||
25094231|NCT00879086|50203837|FG000|Overall Study|Withdrawal of consent|2|||
25094232|NCT00879086|50203838|FG001|Overall Study|Withdrawal of consent|1|||
25094233|NCT00879086|50203837|FG000|Overall Study|Other|4|||
25094234|NCT00879086|50203838|FG001|Overall Study|Other|6|||
25094235|NCT00879086|50203837|FG000|Overall Study|Death|1|||
25094236|NCT00879086|50203838|FG001|Overall Study|Death|2|||
25094237|NCT00769379|50203846|FG000|Overall Study|No follow up data mapped to Other.|3|||
25094238|NCT00769379|50203847|FG001|Overall Study|No follow up data mapped to Other.|13|||
25094239|NCT00244933|50203863|FG000|Overall Study|Not response evaluable|2|||
25094240|NCT02637557|50203944|FG000|Overall Study|Adverse Event|3|||
25094241|NCT02637557|50203945|FG001|Overall Study|Adverse Event|1|||
25094242|NCT02637557|50203946|FG002|Overall Study|Adverse Event|3|||
25094243|NCT02637557|50203947|FG003|Overall Study|Adverse Event|3|||
25094244|NCT02637557|50203944|FG000|Overall Study|Lost to Follow-up|1|||
25094245|NCT02637557|50203945|FG001|Overall Study|Lost to Follow-up|1|||
25094246|NCT02637557|50203946|FG002|Overall Study|Lost to Follow-up|0|||
25094247|NCT02637557|50203947|FG003|Overall Study|Lost to Follow-up|1|||
25094248|NCT02637557|50203944|FG000|Overall Study|Physician Decision|1|||
25094249|NCT02637557|50203945|FG001|Overall Study|Physician Decision|0|||
25094250|NCT02637557|50203946|FG002|Overall Study|Physician Decision|0|||
25094251|NCT02637557|50203947|FG003|Overall Study|Physician Decision|0|||
25094252|NCT02637557|50203944|FG000|Overall Study|Protocol Violation|2|||
25094253|NCT02637557|50203945|FG001|Overall Study|Protocol Violation|0|||
25094254|NCT02637557|50203946|FG002|Overall Study|Protocol Violation|2|||
25094255|NCT02637557|50203947|FG003|Overall Study|Protocol Violation|1|||
25094256|NCT02637557|50203944|FG000|Overall Study|Withdrawal by Subject|1|||
25094257|NCT02637557|50203945|FG001|Overall Study|Withdrawal by Subject|3|||
25094258|NCT02637557|50203946|FG002|Overall Study|Withdrawal by Subject|4|||
25094259|NCT02637557|50203947|FG003|Overall Study|Withdrawal by Subject|2|||
25094260|NCT02638493|50203960|FG000|Overall Study|Inability to provide semen samples|2|||
25094261|NCT02638493|50203961|FG001|Overall Study|Inability to provide semen samples|0|||
25094262|NCT02638493|50203962|FG002|Overall Study|Inability to provide semen samples|0|||
25094263|NCT02638337|50203972|FG000|Overall Study|Adverse Event|6|||
25094264|NCT02638337|50203973|FG001|Overall Study|Adverse Event|10|||
25094265|NCT02638337|50203972|FG000|Overall Study|Protocol Violation|3|||
25094266|NCT02638337|50203973|FG001|Overall Study|Protocol Violation|0|||
25094267|NCT02638337|50203972|FG000|Overall Study|Withdrawal by Subject|13|||
25094268|NCT02638337|50203973|FG001|Overall Study|Withdrawal by Subject|16|||
25094269|NCT02638337|50203972|FG000|Overall Study|Lost to Follow-up|7|||
25094270|NCT02638337|50203973|FG001|Overall Study|Lost to Follow-up|7|||
25094271|NCT02638337|50203972|FG000|Overall Study|Other - Miscellaneous|4|||
25094272|NCT02638337|50203973|FG001|Overall Study|Other - Miscellaneous|3|||
25094273|NCT02638259|50203981|FG000|Treatment Period 1|Adverse Event|1|||
25094274|NCT02638259|50203982|FG001|Treatment Period 1|Adverse Event|5|||
25094275|NCT02638259|50203981|FG000|Treatment Period 1|Death|0|||
25094276|NCT02638259|50203982|FG001|Treatment Period 1|Death|1|||
25094277|NCT02638259|50203981|FG000|Treatment Period 1|Lack of Efficacy|0|||
25094278|NCT02638259|50203982|FG001|Treatment Period 1|Lack of Efficacy|1|||
25094279|NCT02638259|50203981|FG000|Treatment Period 1|Protocol Violation|0|||
25094280|NCT02638259|50203982|FG001|Treatment Period 1|Protocol Violation|3|||
25094281|NCT02638259|50203981|FG000|Treatment Period 1|Withdrawal by Subject|4|||
25094282|NCT02638259|50203982|FG001|Treatment Period 1|Withdrawal by Subject|6|||
25094283|NCT02638259|50203981|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
25094284|NCT02638259|50203982|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
25094285|NCT02638259|50203981|FG000|Treatment Period 2|Adverse Event|5|||
25094286|NCT02638259|50203982|FG001|Treatment Period 2|Adverse Event|4|||
25094287|NCT02638259|50203981|FG000|Treatment Period 2|Withdrawal by Subject|1|||
25094288|NCT02638259|50203982|FG001|Treatment Period 2|Withdrawal by Subject|7|||
25094289|NCT02637323|50203994|FG000|Overall Study|Lost to Follow-up|2|||
25094290|NCT02637323|50203995|FG001|Overall Study|Lost to Follow-up|0|||
25094291|NCT02637323|50203994|FG000|Overall Study|Protocol Violation|0|||
25094292|NCT02637323|50203995|FG001|Overall Study|Protocol Violation|1|||
25094293|NCT03573817|50204004|FG000|Overall Study|Adverse Event|0|||
25094294|NCT03573817|50204005|FG001|Overall Study|Adverse Event|2|||
25094295|NCT03573817|50204004|FG000|Overall Study|Protocol Violation|0|||
25094296|NCT03573817|50204005|FG001|Overall Study|Protocol Violation|1|||
25094297|NCT03573817|50204004|FG000|Overall Study|Withdrawal by Subject|1|||
25094298|NCT03573817|50204005|FG001|Overall Study|Withdrawal by Subject|1|||
25094299|NCT02638103|50204020|FG000|Overall Study|Adverse Event|13|||
25094300|NCT02638103|50204021|FG001|Overall Study|Adverse Event|12|||
25094301|NCT02638103|50204022|FG002|Overall Study|Adverse Event|19|||
25094302|NCT02638103|50204023|FG003|Overall Study|Adverse Event|12|||
25094303|NCT02638103|50204020|FG000|Overall Study|Withdrawal by Subject|43|||
25094304|NCT02638103|50204021|FG001|Overall Study|Withdrawal by Subject|53|||
25094305|NCT02638103|50204022|FG002|Overall Study|Withdrawal by Subject|30|||
25094306|NCT02638103|50204023|FG003|Overall Study|Withdrawal by Subject|61|||
25094307|NCT02638103|50204020|FG000|Overall Study|Protocol Violation|1|||
25094308|NCT02638103|50204021|FG001|Overall Study|Protocol Violation|2|||
25094309|NCT02638103|50204022|FG002|Overall Study|Protocol Violation|1|||
25094310|NCT02638103|50204023|FG003|Overall Study|Protocol Violation|4|||
25094311|NCT02638103|50204020|FG000|Overall Study|Pregnancy|2|||
25094312|NCT02638103|50204021|FG001|Overall Study|Pregnancy|3|||
25094313|NCT02638103|50204022|FG002|Overall Study|Pregnancy|0|||
25094314|NCT02638103|50204023|FG003|Overall Study|Pregnancy|1|||
25094315|NCT02638103|50204020|FG000|Overall Study|Non-compliance to Study Procedures|2|||
25094316|NCT02638103|50204021|FG001|Overall Study|Non-compliance to Study Procedures|1|||
25094317|NCT02638103|50204022|FG002|Overall Study|Non-compliance to Study Procedures|1|||
25176935|NCT01527487|50320631|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
25094318|NCT02638103|50204023|FG003|Overall Study|Non-compliance to Study Procedures|1|||
25094319|NCT02638103|50204020|FG000|Overall Study|Lost to Follow-up|26|||
25094320|NCT02638103|50204021|FG001|Overall Study|Lost to Follow-up|33|||
25094321|NCT02638103|50204022|FG002|Overall Study|Lost to Follow-up|20|||
25094322|NCT02638103|50204023|FG003|Overall Study|Lost to Follow-up|37|||
25094323|NCT02638103|50204020|FG000|Overall Study|Lack of Efficacy|14|||
25094324|NCT02638103|50204021|FG001|Overall Study|Lack of Efficacy|10|||
25094325|NCT02638103|50204022|FG002|Overall Study|Lack of Efficacy|12|||
25094326|NCT02638103|50204023|FG003|Overall Study|Lack of Efficacy|22|||
25094327|NCT02638103|50204020|FG000|Overall Study|Other than specified|5|||
25094328|NCT02638103|50204021|FG001|Overall Study|Other than specified|4|||
25094329|NCT02638103|50204022|FG002|Overall Study|Other than specified|2|||
25094330|NCT02638103|50204023|FG003|Overall Study|Other than specified|4|||
25094331|NCT03551743|50204045|FG000|Overall Study|Adverse Event|1|||
25094332|NCT03551743|50204046|FG001|Overall Study|Adverse Event|0|||
25094333|NCT03551743|50204047|FG002|Overall Study|Adverse Event|0|||
25094334|NCT03551743|50204048|FG003|Overall Study|Adverse Event|0|||
25094335|NCT03551743|50204045|FG000|Overall Study|Withdrawal by Subject|1|||
25094336|NCT03551743|50204046|FG001|Overall Study|Withdrawal by Subject|0|||
25094337|NCT03551743|50204047|FG002|Overall Study|Withdrawal by Subject|0|||
25094338|NCT03551743|50204048|FG003|Overall Study|Withdrawal by Subject|0|||
25094339|NCT02636699|50204060|FG000|Overall Study|Adverse Event|4|||
25094340|NCT02636699|50204061|FG001|Overall Study|Adverse Event|0|||
25094341|NCT02636699|50204060|FG000|Overall Study|Lost to Follow-up|3|||
25094342|NCT02636699|50204061|FG001|Overall Study|Lost to Follow-up|3|||
25094343|NCT02636699|50204060|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
25094344|NCT02636699|50204061|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
25094345|NCT02636699|50204060|FG000|Overall Study|Physician Decision|0|||
25094346|NCT02636699|50204061|FG001|Overall Study|Physician Decision|1|||
25094347|NCT02636699|50204060|FG000|Overall Study|Withdrawal by Subject|13|||
25094348|NCT02636699|50204061|FG001|Overall Study|Withdrawal by Subject|6|||
25094349|NCT02636699|50204060|FG000|Overall Study|Other|3|||
25094350|NCT02636699|50204061|FG001|Overall Study|Other|1|||
25094351|NCT02634983|50204067|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
25094352|NCT02634983|50204068|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
25094353|NCT02633501|50204080|FG000|Overall Study|Adverse Event|0|||
25094354|NCT02633501|50204081|FG001|Overall Study|Adverse Event|0|||
25094355|NCT02633501|50204082|FG002|Overall Study|Adverse Event|1|||
25094356|NCT02633501|50204083|FG003|Overall Study|Adverse Event|0|||
25094357|NCT02633501|50204084|FG004|Overall Study|Adverse Event|1|||
25094358|NCT02633501|50204085|FG005|Overall Study|Adverse Event|1|||
25094359|NCT02633501|50204080|FG000|Overall Study|Withdrawal by Subject|2|||
25094360|NCT02633501|50204081|FG001|Overall Study|Withdrawal by Subject|1|||
25094361|NCT02633501|50204082|FG002|Overall Study|Withdrawal by Subject|2|||
25094362|NCT02633501|50204083|FG003|Overall Study|Withdrawal by Subject|2|||
25094363|NCT02633501|50204084|FG004|Overall Study|Withdrawal by Subject|1|||
25094364|NCT02633501|50204085|FG005|Overall Study|Withdrawal by Subject|3|||
25094365|NCT02633501|50204080|FG000|Overall Study|Various other reasons|0|||
25094366|NCT02633501|50204081|FG001|Overall Study|Various other reasons|2|||
25094367|NCT02633501|50204082|FG002|Overall Study|Various other reasons|4|||
25094368|NCT02633501|50204083|FG003|Overall Study|Various other reasons|1|||
25094369|NCT02633501|50204084|FG004|Overall Study|Various other reasons|7|||
25094370|NCT02633501|50204085|FG005|Overall Study|Various other reasons|11|||
25094371|NCT02633501|50204080|FG000|Overall Study|Lost to Follow-up|0|||
25094372|NCT02633501|50204081|FG001|Overall Study|Lost to Follow-up|0|||
25094373|NCT02633501|50204082|FG002|Overall Study|Lost to Follow-up|0|||
25094374|NCT02633501|50204083|FG003|Overall Study|Lost to Follow-up|1|||
25094375|NCT02633501|50204084|FG004|Overall Study|Lost to Follow-up|2|||
25094376|NCT02633501|50204085|FG005|Overall Study|Lost to Follow-up|0|||
25094377|NCT03138499|50204106|FG000|Overall Study|Lost to Follow-up|1|||
25094378|NCT03138499|50204107|FG001|Overall Study|Lost to Follow-up|0|||
25094379|NCT03138499|50204106|FG000|Overall Study|Participants withdrew consent|1|||
25094380|NCT03138499|50204107|FG001|Overall Study|Participants withdrew consent|0|||
25094381|NCT03138499|50204106|FG000|Overall Study|Participant discontinued study before treatment|0|||
25094382|NCT03138499|50204107|FG001|Overall Study|Participant discontinued study before treatment|1|||
25094383|NCT03138499|50204106|FG000|Overall Study|Disease Progression|2|||
25094384|NCT03138499|50204107|FG001|Overall Study|Disease Progression|6|||
25094385|NCT03138499|50204106|FG000|Overall Study|Study drug toxicity|2|||
25094386|NCT03138499|50204107|FG001|Overall Study|Study drug toxicity|2|||
25094387|NCT03138499|50204106|FG000|Overall Study|Participant request to discontinue study treatment|1|||
25094388|NCT03138499|50204107|FG001|Overall Study|Participant request to discontinue study treatment|1|||
25094389|NCT03138499|50204106|FG000|Overall Study|Other reasons|2|||
25094390|NCT03138499|50204107|FG001|Overall Study|Other reasons|0|||
25094391|NCT04508621|50204116|FG000|Overall Study|Adverse Event|39|||
25094392|NCT04508621|50204117|FG001|Overall Study|Adverse Event|16|||
25094393|NCT04508621|50204116|FG000|Overall Study|Lack of Efficacy|2|||
25094394|NCT04508621|50204117|FG001|Overall Study|Lack of Efficacy|8|||
25094395|NCT04508621|50204116|FG000|Overall Study|Physician Decision|0|||
25094396|NCT04508621|50204117|FG001|Overall Study|Physician Decision|1|||
25094397|NCT04508621|50204116|FG000|Overall Study|Withdrawal by Subject|10|||
25094398|NCT04508621|50204117|FG001|Overall Study|Withdrawal by Subject|14|||
25094399|NCT04508621|50204116|FG000|Overall Study|Lost to Follow-up|12|||
25094400|NCT04508621|50204117|FG001|Overall Study|Lost to Follow-up|9|||
25094401|NCT04508621|50204116|FG000|Overall Study|COVID-19 related crisis|3|||
25094402|NCT04508621|50204117|FG001|Overall Study|COVID-19 related crisis|0|||
25094403|NCT04508621|50204116|FG000|Overall Study|Subject non-compliance|1|||
25094404|NCT04508621|50204117|FG001|Overall Study|Subject non-compliance|0|||
25094405|NCT03591107|50204125|FG000|Overall Study|Same patient in both arms|1|||
25094406|NCT03591107|50204126|FG001|Overall Study|Same patient in both arms|1|||
25094407|NCT03591107|50204125|FG000|Overall Study|Sought care at other clinics|0|||
25094408|NCT03591107|50204126|FG001|Overall Study|Sought care at other clinics|2|||
25094409|NCT03591107|50204125|FG000|Overall Study|Discharged from clinic|0|||
25094410|NCT03591107|50204126|FG001|Overall Study|Discharged from clinic|1|||
25094411|NCT03591107|50204125|FG000|Overall Study|Withdrawal by Subject|0|||
25094412|NCT03591107|50204126|FG001|Overall Study|Withdrawal by Subject|1|||
25094413|NCT02922023|50204139|FG000|Overall Study|Lost to Follow-up|2|||
25094414|NCT02922023|50204140|FG001|Overall Study|Lost to Follow-up|0|||
25094415|NCT01672853|50204149|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
25094416|NCT01672853|50204150|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
25094417|NCT01672853|50204151|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
25094418|NCT01672853|50204149|FG000|Overall Study|Pregnancy|0|||
25094419|NCT01672853|50204150|FG001|Overall Study|Pregnancy|1|||
25094420|NCT01672853|50204151|FG002|Overall Study|Pregnancy|0|||
25094421|NCT01672853|50204149|FG000|Overall Study|Investigator's Discretion|1|||
25094422|NCT01672853|50204150|FG001|Overall Study|Investigator's Discretion|0|||
25094423|NCT01672853|50204151|FG002|Overall Study|Investigator's Discretion|0|||
25094424|NCT01672853|50204149|FG000|Overall Study|Withdrew Consent|5|||
25094425|NCT01672853|50204150|FG001|Overall Study|Withdrew Consent|5|||
25094426|NCT01672853|50204151|FG002|Overall Study|Withdrew Consent|5|||
25094427|NCT01672853|50204149|FG000|Overall Study|Adverse Event|4|||
25094428|NCT01672853|50204150|FG001|Overall Study|Adverse Event|6|||
25094429|NCT01672853|50204151|FG002|Overall Study|Adverse Event|8|||
25094430|NCT01672853|50204149|FG000|Overall Study|Lost to Follow-up|0|||
25094431|NCT01672853|50204150|FG001|Overall Study|Lost to Follow-up|1|||
25094432|NCT01672853|50204151|FG002|Overall Study|Lost to Follow-up|0|||
25094433|NCT01672853|50204149|FG000|Overall Study|Randomized but Never Treated|0|||
25094434|NCT01672853|50204150|FG001|Overall Study|Randomized but Never Treated|0|||
25094435|NCT01672853|50204151|FG002|Overall Study|Randomized but Never Treated|1|||
25094436|NCT01603459|50204159|FG000|Overall Study|Adverse Event|5|||
25094437|NCT01603459|50204159|FG000|Overall Study|Withdrawal by Subject|5|||
25094438|NCT01603459|50204159|FG000|Overall Study|Lost to Follow-up|3|||
25094439|NCT01603459|50204159|FG000|Overall Study|Predefined discontinuation criteria|3|||
25094440|NCT01603459|50204159|FG000|Overall Study|Non-compliance|1|||
25094441|NCT01603459|50204159|FG000|Overall Study|Administrative reason|1|||
25094442|NCT01678807|50204198|FG000|Overall Study|Adverse Event|4|||
25094443|NCT01678807|50204199|FG001|Overall Study|Adverse Event|4|||
25094444|NCT01678807|50204200|FG002|Overall Study|Adverse Event|0|||
25094445|NCT01678807|50204198|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
25094446|NCT01678807|50204199|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
25094447|NCT01678807|50204200|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
25094448|NCT03073525|50204211|FG000|Overall Study|Withdrawal by Subject|0|||
25094449|NCT03073525|50204212|FG001|Overall Study|Withdrawal by Subject|0|||
25094450|NCT03073525|50204213|FG002|Overall Study|Withdrawal by Subject|3|||
25094451|NCT02631551|50204234|FG000|Overall Study|Adverse Event|1|||
25094452|NCT02631551|50204235|FG001|Overall Study|Adverse Event|2|||
25007632|NCT03787303|50100010|FG000|Overall Study|Premature Termination of Study|1|||
25007633|NCT04170296|50100016|FG000|Overall Study|Adverse Event|1|||
25007634|NCT04170296|50100017|FG001|Overall Study|Adverse Event|0|||
25007635|NCT04170296|50100016|FG000|Overall Study|Withdrawal by Subject|3|||
25007636|NCT04170296|50100017|FG001|Overall Study|Withdrawal by Subject|2|||
25007637|NCT04170296|50100016|FG000|Overall Study|Lost to Follow-up|4|||
25007638|NCT04170296|50100017|FG001|Overall Study|Lost to Follow-up|2|||
25007639|NCT03141788|50100044|FG000|Overall Study|Lost to Follow-up|1|||
25007640|NCT03141788|50100044|FG000|Overall Study|Protocol Violation|3|||
25007641|NCT03141788|50100044|FG000|Overall Study|Withdrawal by Subject|4|||
25007642|NCT03781375|50100053|FG000|Double-blind Phase|Adverse Event|0|||
25007643|NCT03781375|50100054|FG001|Double-blind Phase|Adverse Event|1|||
25007644|NCT03781375|50100053|FG000|Double-blind Phase|Lack of Response|6|||
25007645|NCT03781375|50100054|FG001|Double-blind Phase|Lack of Response|2|||
25007646|NCT03781375|50100053|FG000|Double-blind Phase|Other|1|||
25007647|NCT03781375|50100054|FG001|Double-blind Phase|Other|3|||
25007648|NCT03781375|50100053|FG000|Open-label Phase|Protocol Issues|0|||
25007649|NCT03781375|50100054|FG001|Open-label Phase|Protocol Issues|1|||
25007650|NCT03781375|50100053|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
25007651|NCT03781375|50100054|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
25007652|NCT03781375|50100053|FG000|Open-label Phase|Other|2|||
25007653|NCT03781375|50100054|FG001|Open-label Phase|Other|2|||
25007654|NCT03779503|50100061|FG000|First Intervention|Adverse Event|0|||
25007655|NCT03779503|50100062|FG001|First Intervention|Adverse Event|1|||
25007656|NCT03779503|50100061|FG000|First Intervention|Withdrawal by Subject|1|||
25007657|NCT03779503|50100062|FG001|First Intervention|Withdrawal by Subject|0|||
25094453|NCT02631551|50204236|FG002|Overall Study|Adverse Event|4|||
25094454|NCT02631551|50204237|FG003|Overall Study|Adverse Event|0|||
25094455|NCT02631551|50204234|FG000|Overall Study|Lack of Efficacy|0|||
25094456|NCT02631551|50204235|FG001|Overall Study|Lack of Efficacy|0|||
25094457|NCT02631551|50204236|FG002|Overall Study|Lack of Efficacy|1|||
25094458|NCT02631551|50204237|FG003|Overall Study|Lack of Efficacy|0|||
25094459|NCT02631551|50204234|FG000|Overall Study|Lost to Follow-up|1|||
25094460|NCT02631551|50204235|FG001|Overall Study|Lost to Follow-up|2|||
25094461|NCT02631551|50204236|FG002|Overall Study|Lost to Follow-up|0|||
25094462|NCT02631551|50204237|FG003|Overall Study|Lost to Follow-up|3|||
25094463|NCT02631551|50204234|FG000|Overall Study|Withdrawal by Subject|2|||
25094464|NCT02631551|50204235|FG001|Overall Study|Withdrawal by Subject|2|||
25094465|NCT02631551|50204236|FG002|Overall Study|Withdrawal by Subject|0|||
25094466|NCT02631551|50204237|FG003|Overall Study|Withdrawal by Subject|5|||
25094467|NCT02631551|50204234|FG000|Overall Study|Protocol deviation|3|||
25094468|NCT02631551|50204235|FG001|Overall Study|Protocol deviation|6|||
25094469|NCT02631551|50204236|FG002|Overall Study|Protocol deviation|3|||
25094470|NCT02631551|50204237|FG003|Overall Study|Protocol deviation|0|||
25094471|NCT02631551|50204234|FG000|Overall Study|Non-compliance with study procedures|0|||
25094472|NCT02631551|50204235|FG001|Overall Study|Non-compliance with study procedures|0|||
25094473|NCT02631551|50204236|FG002|Overall Study|Non-compliance with study procedures|1|||
25094474|NCT02631551|50204237|FG003|Overall Study|Non-compliance with study procedures|1|||
25094475|NCT02631551|50204234|FG000|Overall Study|Non-compliance with study drug|1|||
25094476|NCT02631551|50204235|FG001|Overall Study|Non-compliance with study drug|0|||
25094477|NCT02631551|50204236|FG002|Overall Study|Non-compliance with study drug|0|||
25094478|NCT02631551|50204237|FG003|Overall Study|Non-compliance with study drug|0|||
25094479|NCT02631551|50204234|FG000|Overall Study|Other, specific reasons not collected|5|||
25094480|NCT02631551|50204235|FG001|Overall Study|Other, specific reasons not collected|7|||
25094481|NCT02631551|50204236|FG002|Overall Study|Other, specific reasons not collected|2|||
25094482|NCT02631551|50204237|FG003|Overall Study|Other, specific reasons not collected|2|||
25094483|NCT01680991|50204250|FG000|Overall Study|Adverse Event|1|||
25094484|NCT01680991|50204251|FG001|Overall Study|Adverse Event|0|||
25094485|NCT01680991|50204252|FG002|Overall Study|Adverse Event|0|||
25094486|NCT01680991|50204250|FG000|Overall Study|Death|1|||
25094487|NCT01680991|50204251|FG001|Overall Study|Death|0|||
25094488|NCT01680991|50204252|FG002|Overall Study|Death|1|||
25094489|NCT01680991|50204250|FG000|Overall Study|Protocol Violation|0|||
25094490|NCT01680991|50204251|FG001|Overall Study|Protocol Violation|1|||
25094491|NCT01680991|50204252|FG002|Overall Study|Protocol Violation|0|||
25094492|NCT01680991|50204250|FG000|Overall Study|Withdrawal by Subject|5|||
25094493|NCT01680991|50204251|FG001|Overall Study|Withdrawal by Subject|1|||
25094494|NCT01680991|50204252|FG002|Overall Study|Withdrawal by Subject|0|||
25094495|NCT01680991|50204250|FG000|Overall Study|Progressive disease (PD)|0|||
25094496|NCT01680991|50204251|FG001|Overall Study|Progressive disease (PD)|10|||
25094497|NCT01680991|50204252|FG002|Overall Study|Progressive disease (PD)|0|||
25094498|NCT01680991|50204250|FG000|Overall Study|Physician Decision|0|||
25094499|NCT01680991|50204251|FG001|Overall Study|Physician Decision|7|||
25094500|NCT01680991|50204252|FG002|Overall Study|Physician Decision|2|||
25094501|NCT01680991|50204250|FG000|Overall Study|Bad physical condition|0|||
25094502|NCT01680991|50204251|FG001|Overall Study|Bad physical condition|0|||
25094503|NCT01680991|50204252|FG002|Overall Study|Bad physical condition|1|||
25094504|NCT01680991|50204250|FG000|Overall Study|PD confirmed in other hospital|1|||
25094505|NCT01680991|50204251|FG001|Overall Study|PD confirmed in other hospital|0|||
25094506|NCT01680991|50204252|FG002|Overall Study|PD confirmed in other hospital|0|||
25094507|NCT02819479|50204262|FG000|Overall Study|Adverse Event|2|||
25094508|NCT04064411|50204269|FG000|Overall Study|Adverse Event|29|||
25094509|NCT04064411|50204270|FG001|Overall Study|Adverse Event|19|||
25094510|NCT04064411|50204269|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
25094511|NCT04064411|50204270|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
25094512|NCT04064411|50204269|FG000|Overall Study|Protocol Deviation|0|||
25176936|NCT01527487|50320630|FG000|Overall Study|Disease Progression|4|||
25176937|NCT01527487|50320631|FG001|Overall Study|Disease Progression|1|||
25176938|NCT01527487|50320630|FG000|Overall Study|Adverse Event|1|||
25094513|NCT04064411|50204270|FG001|Overall Study|Protocol Deviation|2|||
25094514|NCT04064411|50204269|FG000|Overall Study|Withdrawal by Subject|25|||
25094515|NCT04064411|50204270|FG001|Overall Study|Withdrawal by Subject|29|||
25094516|NCT04064411|50204269|FG000|Overall Study|Lost to Follow-up|5|||
25094517|NCT04064411|50204270|FG001|Overall Study|Lost to Follow-up|2|||
25094518|NCT04064411|50204269|FG000|Overall Study|Other than Specified|4|||
25094519|NCT04064411|50204270|FG001|Overall Study|Other than Specified|1|||
25094520|NCT04064411|50204269|FG000|Overall Study|Death|1|||
25094521|NCT04064411|50204270|FG001|Overall Study|Death|0|||
25094522|NCT02004691|50204278|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
25094523|NCT02004691|50204279|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
25094524|NCT02004691|50204278|FG000|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|1|||
25094525|NCT02004691|50204279|FG001|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|0|||
25094526|NCT02004691|50204278|FG000|ETP: Ongoing From Week 52|Withdrawal by Subject|0|||
25094527|NCT02004691|50204279|FG001|ETP: Ongoing From Week 52|Withdrawal by Subject|1|||
25094528|NCT02004691|50204278|FG000|ETP: Ongoing From Week 52|Other|0|||
25094529|NCT02004691|50204279|FG001|ETP: Ongoing From Week 52|Other|1|||
25094530|NCT02004691|50204278|FG000|ETP: Ongoing From Week 52|Ongoing|16|||
25094531|NCT02004691|50204279|FG001|ETP: Ongoing From Week 52|Ongoing|16|||
25094532|NCT02629133|50204287|FG000|Overall Study|Lost to Follow-up|3|||
25094533|NCT02629133|50204288|FG001|Overall Study|Lost to Follow-up|1|||
25094534|NCT02629133|50204287|FG000|Overall Study|Withdrawal by Subject|1|||
25094535|NCT02629133|50204288|FG001|Overall Study|Withdrawal by Subject|1|||
25094536|NCT02660359|50204297|FG000|Overall Study|Protocol Deviation|0|||
25094537|NCT02660359|50204298|FG001|Overall Study|Protocol Deviation|0|||
25094538|NCT02660359|50204299|FG002|Overall Study|Protocol Deviation|1|||
25094539|NCT02660359|50204297|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
25094540|NCT02660359|50204298|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
25094541|NCT02660359|50204299|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
25094542|NCT02660359|50204297|FG000|Overall Study|Lack of Efficacy|1|||
25094543|NCT02660359|50204298|FG001|Overall Study|Lack of Efficacy|1|||
25094544|NCT02660359|50204299|FG002|Overall Study|Lack of Efficacy|1|||
25094545|NCT02660359|50204297|FG000|Overall Study|Adverse Event|0|||
25094546|NCT02660359|50204298|FG001|Overall Study|Adverse Event|1|||
25094547|NCT02660359|50204299|FG002|Overall Study|Adverse Event|0|||
25094548|NCT02660359|50204297|FG000|Overall Study|Other|2|||
25094549|NCT02660359|50204298|FG001|Overall Study|Other|1|||
25094550|NCT02660359|50204299|FG002|Overall Study|Other|3|||
25094551|NCT02660359|50204297|FG000|Overall Study|Withdrawal by Subject|7|||
25094552|NCT02660359|50204298|FG001|Overall Study|Withdrawal by Subject|5|||
25094553|NCT02660359|50204299|FG002|Overall Study|Withdrawal by Subject|8|||
25094554|NCT02660359|50204297|FG000|Overall Study|Lost to Follow-up|3|||
25094555|NCT02660359|50204298|FG001|Overall Study|Lost to Follow-up|3|||
25094556|NCT02660359|50204299|FG002|Overall Study|Lost to Follow-up|0|||
25094557|NCT02628743|50204307|FG000|Overall Study|Other|3|||
25094558|NCT02628743|50204307|FG000|Overall Study|Withdrawal by Subject|50|||
25094559|NCT02628743|50204307|FG000|Overall Study|Study Terminated by Sponsor|76|||
25094560|NCT02628743|50204307|FG000|Overall Study|Physician Decision|2|||
25094561|NCT03839459|50204311|FG000|Overall Study|Withdrawal by Subject|2|||
25094562|NCT03839459|50204311|FG000|Overall Study|progression of disease|3|||
25094563|NCT02630693|50204317|FG000|Overall Study|No receive treatment|0|||
25094564|NCT02630693|50204318|FG001|Overall Study|No receive treatment|1|||
25094565|NCT05059301|50204327|FG000|Overall Study|Adverse Event|0|||
25094566|NCT05059301|50204328|FG001|Overall Study|Adverse Event|2|||
25094567|NCT05059301|50204329|FG002|Overall Study|Adverse Event|2|||
25094568|NCT05059301|50204327|FG000|Overall Study|Lost to Follow-up|2|||
25094569|NCT05059301|50204328|FG001|Overall Study|Lost to Follow-up|3|||
25094570|NCT05059301|50204329|FG002|Overall Study|Lost to Follow-up|3|||
25094571|NCT01938430|50204355|FG000|Overall Study|Randomized but Not Treated|0|||
25094572|NCT01938430|50204356|FG001|Overall Study|Randomized but Not Treated|0|||
25094573|NCT01938430|50204357|FG002|Overall Study|Randomized but Not Treated|0|||
25094574|NCT01938430|50204358|FG003|Overall Study|Randomized but Not Treated|0|||
25094575|NCT01938430|50204359|FG004|Overall Study|Randomized but Not Treated|0|||
25094576|NCT01938430|50204360|FG005|Overall Study|Randomized but Not Treated|0|||
25094577|NCT01938430|50204361|FG006|Overall Study|Randomized but Not Treated|0|||
25094578|NCT01938430|50204362|FG007|Overall Study|Randomized but Not Treated|0|||
25094579|NCT01938430|50204363|FG008|Overall Study|Randomized but Not Treated|0|||
25094580|NCT01938430|50204364|FG009|Overall Study|Randomized but Not Treated|0|||
25094581|NCT01938430|50204365|FG010|Overall Study|Randomized but Not Treated|1|||
25094582|NCT01938430|50204366|FG011|Overall Study|Randomized but Not Treated|0|||
25094583|NCT01938430|50204367|FG012|Overall Study|Randomized but Not Treated|0|||
25094584|NCT01938430|50204368|FG013|Overall Study|Randomized but Not Treated|1|||
25094585|NCT01938430|50204355|FG000|Overall Study|Adverse Event|0|||
25094586|NCT01938430|50204356|FG001|Overall Study|Adverse Event|0|||
25094587|NCT01938430|50204357|FG002|Overall Study|Adverse Event|0|||
25094588|NCT01938430|50204358|FG003|Overall Study|Adverse Event|0|||
25094589|NCT01938430|50204359|FG004|Overall Study|Adverse Event|0|||
25094590|NCT01938430|50204360|FG005|Overall Study|Adverse Event|0|||
25094591|NCT01938430|50204361|FG006|Overall Study|Adverse Event|1|||
25094592|NCT01938430|50204362|FG007|Overall Study|Adverse Event|0|||
25094593|NCT01938430|50204363|FG008|Overall Study|Adverse Event|0|||
25094594|NCT01938430|50204364|FG009|Overall Study|Adverse Event|0|||
25094595|NCT01938430|50204365|FG010|Overall Study|Adverse Event|0|||
25094596|NCT01938430|50204366|FG011|Overall Study|Adverse Event|0|||
25094597|NCT01938430|50204367|FG012|Overall Study|Adverse Event|0|||
25094598|NCT01938430|50204368|FG013|Overall Study|Adverse Event|0|||
25094599|NCT01938430|50204355|FG000|Overall Study|Death|1|||
25094600|NCT01938430|50204356|FG001|Overall Study|Death|2|||
25094601|NCT01938430|50204357|FG002|Overall Study|Death|2|||
25094602|NCT01938430|50204358|FG003|Overall Study|Death|1|||
25094603|NCT01938430|50204359|FG004|Overall Study|Death|0|||
25094604|NCT01938430|50204360|FG005|Overall Study|Death|0|||
25094605|NCT01938430|50204361|FG006|Overall Study|Death|1|||
25094606|NCT01938430|50204362|FG007|Overall Study|Death|1|||
25094607|NCT01938430|50204363|FG008|Overall Study|Death|2|||
25094608|NCT01938430|50204364|FG009|Overall Study|Death|3|||
25094609|NCT01938430|50204365|FG010|Overall Study|Death|0|||
25094610|NCT01938430|50204366|FG011|Overall Study|Death|0|||
25094611|NCT01938430|50204367|FG012|Overall Study|Death|0|||
25094612|NCT01938430|50204368|FG013|Overall Study|Death|0|||
25094613|NCT01938430|50204355|FG000|Overall Study|Investigator's Discretion|0|||
25094614|NCT01938430|50204356|FG001|Overall Study|Investigator's Discretion|0|||
25094615|NCT01938430|50204357|FG002|Overall Study|Investigator's Discretion|1|||
25094616|NCT01938430|50204358|FG003|Overall Study|Investigator's Discretion|0|||
25094617|NCT01938430|50204359|FG004|Overall Study|Investigator's Discretion|0|||
25094618|NCT01938430|50204360|FG005|Overall Study|Investigator's Discretion|0|||
25094619|NCT01938430|50204361|FG006|Overall Study|Investigator's Discretion|0|||
25094620|NCT01938430|50204362|FG007|Overall Study|Investigator's Discretion|0|||
25094621|NCT01938430|50204363|FG008|Overall Study|Investigator's Discretion|0|||
25094622|NCT01938430|50204364|FG009|Overall Study|Investigator's Discretion|0|||
25094623|NCT01938430|50204365|FG010|Overall Study|Investigator's Discretion|0|||
25094624|NCT01938430|50204366|FG011|Overall Study|Investigator's Discretion|0|||
25094625|NCT01938430|50204367|FG012|Overall Study|Investigator's Discretion|0|||
25094626|NCT01938430|50204368|FG013|Overall Study|Investigator's Discretion|0|||
25094627|NCT01938430|50204355|FG000|Overall Study|Lack of Efficacy|3|||
25094628|NCT01938430|50204356|FG001|Overall Study|Lack of Efficacy|1|||
25094629|NCT01938430|50204357|FG002|Overall Study|Lack of Efficacy|1|||
25094630|NCT01938430|50204358|FG003|Overall Study|Lack of Efficacy|1|||
25094631|NCT01938430|50204359|FG004|Overall Study|Lack of Efficacy|0|||
25094632|NCT01938430|50204360|FG005|Overall Study|Lack of Efficacy|0|||
25094633|NCT01938430|50204361|FG006|Overall Study|Lack of Efficacy|0|||
25094634|NCT01938430|50204362|FG007|Overall Study|Lack of Efficacy|0|||
25094635|NCT01938430|50204363|FG008|Overall Study|Lack of Efficacy|1|||
25094636|NCT01938430|50204364|FG009|Overall Study|Lack of Efficacy|0|||
25094637|NCT01938430|50204365|FG010|Overall Study|Lack of Efficacy|2|||
25094638|NCT01938430|50204366|FG011|Overall Study|Lack of Efficacy|1|||
25094639|NCT01938430|50204367|FG012|Overall Study|Lack of Efficacy|0|||
25094640|NCT01938430|50204368|FG013|Overall Study|Lack of Efficacy|0|||
25094641|NCT01938430|50204355|FG000|Overall Study|Lost to Follow-up|0|||
25094642|NCT01938430|50204356|FG001|Overall Study|Lost to Follow-up|0|||
25094643|NCT01938430|50204357|FG002|Overall Study|Lost to Follow-up|1|||
25094644|NCT01938430|50204358|FG003|Overall Study|Lost to Follow-up|0|||
25094645|NCT01938430|50204359|FG004|Overall Study|Lost to Follow-up|0|||
25094646|NCT01938430|50204360|FG005|Overall Study|Lost to Follow-up|1|||
25094647|NCT01938430|50204361|FG006|Overall Study|Lost to Follow-up|0|||
25094648|NCT01938430|50204362|FG007|Overall Study|Lost to Follow-up|0|||
25094649|NCT01938430|50204363|FG008|Overall Study|Lost to Follow-up|0|||
25094650|NCT01938430|50204364|FG009|Overall Study|Lost to Follow-up|0|||
25094651|NCT01938430|50204365|FG010|Overall Study|Lost to Follow-up|0|||
25094652|NCT01938430|50204366|FG011|Overall Study|Lost to Follow-up|0|||
25094653|NCT01938430|50204367|FG012|Overall Study|Lost to Follow-up|0|||
25094654|NCT01938430|50204368|FG013|Overall Study|Lost to Follow-up|0|||
25094655|NCT01938430|50204355|FG000|Overall Study|Withdrew Consent|0|||
25094656|NCT01938430|50204356|FG001|Overall Study|Withdrew Consent|0|||
25094657|NCT01938430|50204357|FG002|Overall Study|Withdrew Consent|0|||
25094658|NCT01938430|50204358|FG003|Overall Study|Withdrew Consent|0|||
25094659|NCT01938430|50204359|FG004|Overall Study|Withdrew Consent|0|||
25094660|NCT01938430|50204360|FG005|Overall Study|Withdrew Consent|0|||
25094661|NCT01938430|50204361|FG006|Overall Study|Withdrew Consent|0|||
25094662|NCT01938430|50204362|FG007|Overall Study|Withdrew Consent|0|||
25094663|NCT01938430|50204363|FG008|Overall Study|Withdrew Consent|1|||
25094664|NCT01938430|50204364|FG009|Overall Study|Withdrew Consent|0|||
25094665|NCT01938430|50204365|FG010|Overall Study|Withdrew Consent|0|||
25094666|NCT01938430|50204366|FG011|Overall Study|Withdrew Consent|0|||
25094667|NCT01938430|50204367|FG012|Overall Study|Withdrew Consent|0|||
25094668|NCT01938430|50204368|FG013|Overall Study|Withdrew Consent|0|||
25094669|NCT01937884|50204425|FG000|Overall Study|Withdrawal by Subject|1|||
25094670|NCT01937884|50204426|FG001|Overall Study|Withdrawal by Subject|0|||
25094671|NCT01916824|50204436|FG000|Overall Study|Lost to Follow-up|3|||
25094672|NCT01916824|50204437|FG001|Overall Study|Lost to Follow-up|6|||
25094673|NCT01916824|50204436|FG000|Overall Study|Physician Decision|2|||
25094674|NCT01916824|50204437|FG001|Overall Study|Physician Decision|0|||
25094675|NCT01916824|50204436|FG000|Overall Study|Withdrawal by Subject|2|||
25094676|NCT01916824|50204437|FG001|Overall Study|Withdrawal by Subject|3|||
25094677|NCT01915732|50204445|FG000|Overall Study|Withdrawal by Subject|18|||
25094678|NCT01915732|50204446|FG001|Overall Study|Withdrawal by Subject|18|||
25094679|NCT01915732|50204445|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
25094680|NCT01915732|50204446|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
25094681|NCT01915732|50204445|FG000|Overall Study|Adverse Event|12|||
25094682|NCT01915732|50204446|FG001|Overall Study|Adverse Event|4|||
25094683|NCT01915732|50204445|FG000|Overall Study|Protocol Violation|5|||
25094684|NCT01915732|50204446|FG001|Overall Study|Protocol Violation|5|||
25094685|NCT01915732|50204445|FG000|Overall Study|Lack of Efficacy|6|||
25094686|NCT01915732|50204446|FG001|Overall Study|Lack of Efficacy|11|||
25094687|NCT01915732|50204445|FG000|Overall Study|Lost to Follow-up|22|||
25094688|NCT01915732|50204446|FG001|Overall Study|Lost to Follow-up|26|||
25094689|NCT01915732|50204445|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
25094690|NCT01915732|50204446|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
25094691|NCT01915732|50204445|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
25094692|NCT01915732|50204446|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
25094693|NCT01915732|50204445|FG000|Overall Study|Drug Release Error|1|||
25094694|NCT01915732|50204446|FG001|Overall Study|Drug Release Error|0|||
25094695|NCT01915732|50204445|FG000|Overall Study|Recovered|1|||
25094696|NCT01915732|50204446|FG001|Overall Study|Recovered|0|||
25094697|NCT01915732|50204445|FG000|Overall Study|Pregnancy|1|||
25094698|NCT01915732|50204446|FG001|Overall Study|Pregnancy|0|||
25094699|NCT01915732|50204445|FG000|Overall Study|Poor Perceived Efficacy|1|||
25094700|NCT01915732|50204446|FG001|Overall Study|Poor Perceived Efficacy|0|||
25094701|NCT01915732|50204445|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
25094702|NCT01915732|50204446|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
25094703|NCT01915732|50204445|FG000|Overall Study|Got Well|0|||
25094704|NCT01915732|50204446|FG001|Overall Study|Got Well|1|||
25094705|NCT01915732|50204445|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
25094706|NCT01915732|50204446|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
25094707|NCT01915732|50204445|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
25094708|NCT01915732|50204446|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
25094709|NCT01915732|50204445|FG000|Overall Study|Job Transfer|0|||
25094710|NCT01915732|50204446|FG001|Overall Study|Job Transfer|1|||
25094711|NCT01915732|50204445|FG000|Overall Study|Improper Facial Procedure|0|||
25094712|NCT01915732|50204446|FG001|Overall Study|Improper Facial Procedure|1|||
25094713|NCT01915732|50204445|FG000|Overall Study|Poor Conscious Effect|0|||
25094714|NCT01915732|50204446|FG001|Overall Study|Poor Conscious Effect|1|||
25094715|NCT01936948|50204456|FG000|Overall Study|no 30-day follow-up data|0|||
25094716|NCT01936948|50204457|FG001|Overall Study|no 30-day follow-up data|3|||
25094717|NCT01936948|50204458|FG002|Overall Study|no 30-day follow-up data|3|||
25094718|NCT01936948|50204459|FG003|Overall Study|no 30-day follow-up data|3|||
25094719|NCT01936870|50204467|FG000|Overall Study|No Visit After Treatment|176|||
25094720|NCT01936870|50204467|FG000|Overall Study|Protocol Violation|12|||
25094721|NCT01936870|50204467|FG000|Overall Study|No Drug Administration|1|||
25094722|NCT01618864|50204471|FG000|Overall Study|Withdrawal by Subject|2|||
25094723|NCT01618864|50204471|FG000|Overall Study|Lost to Follow-up|2|||
25094724|NCT01618708|50204482|FG000|Overall Study|Adverse Event|10|||
25094725|NCT01618708|50204483|FG001|Overall Study|Adverse Event|10|||
25094726|NCT01618708|50204482|FG000|Overall Study|Lost to Follow-up|3|||
25094727|NCT01618708|50204483|FG001|Overall Study|Lost to Follow-up|3|||
25094728|NCT01618708|50204482|FG000|Overall Study|Withdrawal by Subject|17|||
25094729|NCT01618708|50204483|FG001|Overall Study|Withdrawal by Subject|22|||
25094730|NCT01618708|50204482|FG000|Overall Study|Lack of Efficacy|8|||
25094731|NCT01618708|50204483|FG001|Overall Study|Lack of Efficacy|8|||
25094732|NCT01618708|50204482|FG000|Overall Study|Technical problems|2|||
25094733|NCT01618708|50204483|FG001|Overall Study|Technical problems|0|||
25094734|NCT01618708|50204482|FG000|Overall Study|Other than specified above|1|||
25094735|NCT01618708|50204483|FG001|Overall Study|Other than specified above|1|||
25094736|NCT01618708|50204482|FG000|Overall Study|Randomized but not treated|3|||
25094737|NCT01618708|50204483|FG001|Overall Study|Randomized but not treated|2|||
25094738|NCT00790933|50204499|FG000|Overall Study|Adverse Event|94|||
25094739|NCT00790933|50204500|FG001|Overall Study|Adverse Event|119|||
25094740|NCT00790933|50204501|FG002|Overall Study|Adverse Event|65|||
25094741|NCT00790933|50204502|FG003|Overall Study|Adverse Event|5|||
25094742|NCT00790933|50204503|FG004|Overall Study|Adverse Event|69|||
25094743|NCT00790933|50204499|FG000|Overall Study|Protocol Violation(s)|8|||
25094744|NCT00790933|50204500|FG001|Overall Study|Protocol Violation(s)|18|||
25094745|NCT00790933|50204501|FG002|Overall Study|Protocol Violation(s)|7|||
25094746|NCT00790933|50204502|FG003|Overall Study|Protocol Violation(s)|0|||
25176939|NCT01527487|50320631|FG001|Overall Study|Adverse Event|1|||
25094747|NCT00790933|50204503|FG004|Overall Study|Protocol Violation(s)|12|||
25094748|NCT00790933|50204499|FG000|Overall Study|Lack of Efficacy|192|||
25094749|NCT00790933|50204500|FG001|Overall Study|Lack of Efficacy|176|||
25094750|NCT00790933|50204501|FG002|Overall Study|Lack of Efficacy|130|||
25094751|NCT00790933|50204502|FG003|Overall Study|Lack of Efficacy|1|||
25094752|NCT00790933|50204503|FG004|Overall Study|Lack of Efficacy|121|||
25094753|NCT00790933|50204499|FG000|Overall Study|Study Terminated by Sponsor|0|||
25094754|NCT00790933|50204500|FG001|Overall Study|Study Terminated by Sponsor|0|||
25094755|NCT00790933|50204501|FG002|Overall Study|Study Terminated by Sponsor|1|||
25094756|NCT00790933|50204502|FG003|Overall Study|Study Terminated by Sponsor|0|||
25094757|NCT00790933|50204503|FG004|Overall Study|Study Terminated by Sponsor|0|||
25094758|NCT00790933|50204499|FG000|Overall Study|Withdrawal by Subject|123|||
25176940|NCT01527487|50320630|FG000|Overall Study|Death|0|||
25176941|NCT01527487|50320631|FG001|Overall Study|Death|1|||
25094759|NCT00790933|50204500|FG001|Overall Study|Withdrawal by Subject|120|||
25094760|NCT00790933|50204501|FG002|Overall Study|Withdrawal by Subject|52|||
25094761|NCT00790933|50204502|FG003|Overall Study|Withdrawal by Subject|6|||
25094762|NCT00790933|50204503|FG004|Overall Study|Withdrawal by Subject|50|||
25094763|NCT00790933|50204499|FG000|Overall Study|Lost to Follow-up|13|||
25094764|NCT00790933|50204500|FG001|Overall Study|Lost to Follow-up|31|||
25094765|NCT00790933|50204501|FG002|Overall Study|Lost to Follow-up|10|||
25176942|NCT01506947|50320642|FG000|Overall Study|Lost to Follow-up|7|||
25176943|NCT01506947|50320642|FG000|Overall Study|Adverse Event|5|||
25176944|NCT01506947|50320642|FG000|Overall Study|Death|1|||
25094766|NCT00790933|50204502|FG003|Overall Study|Lost to Follow-up|1|||
25094767|NCT00790933|50204503|FG004|Overall Study|Lost to Follow-up|15|||
25094768|NCT00790933|50204499|FG000|Overall Study|Reason Not Specified|8|||
25094769|NCT00790933|50204500|FG001|Overall Study|Reason Not Specified|16|||
25094770|NCT00790933|50204501|FG002|Overall Study|Reason Not Specified|4|||
25094771|NCT00790933|50204502|FG003|Overall Study|Reason Not Specified|1|||
25094772|NCT00790933|50204503|FG004|Overall Study|Reason Not Specified|9|||
25094773|NCT02161211|50204522|FG000|Overall Study|Lost to Follow-up|21|||
25094774|NCT02161211|50204523|FG001|Overall Study|Lost to Follow-up|27|||
25094775|NCT02161211|50204524|FG002|Overall Study|Lost to Follow-up|21|||
25094776|NCT02161211|50204522|FG000|Overall Study|Dropped|12|||
25094777|NCT02161211|50204523|FG001|Overall Study|Dropped|5|||
25094778|NCT02161211|50204524|FG002|Overall Study|Dropped|9|||
25094779|NCT01676701|50204534|FG000|Overall Study|Protocol Violation|1|||
25094780|NCT01676701|50204535|FG001|Overall Study|Protocol Violation|0|||
25094781|NCT01676701|50204534|FG000|Overall Study|Sponsor Decision|3|||
25094782|NCT01676701|50204535|FG001|Overall Study|Sponsor Decision|4|||
25094783|NCT01670279|50204546|FG000|Overall Study|Adverse Event|0|||
25094784|NCT01670279|50204547|FG001|Overall Study|Adverse Event|1|||
25094785|NCT01670279|50204548|FG002|Overall Study|Adverse Event|0|||
25094786|NCT01670279|50204549|FG003|Overall Study|Adverse Event|0|||
25094787|NCT01670279|50204546|FG000|Overall Study|Physician Decision|0|||
25094788|NCT01670279|50204547|FG001|Overall Study|Physician Decision|1|||
25094789|NCT01670279|50204548|FG002|Overall Study|Physician Decision|0|||
25094790|NCT01670279|50204549|FG003|Overall Study|Physician Decision|0|||
25094791|NCT01670279|50204546|FG000|Overall Study|Participant met withdrawal criteria|0|||
25094792|NCT01670279|50204547|FG001|Overall Study|Participant met withdrawal criteria|0|||
25094793|NCT01670279|50204548|FG002|Overall Study|Participant met withdrawal criteria|0|||
25094794|NCT01670279|50204549|FG003|Overall Study|Participant met withdrawal criteria|1|||
25094795|NCT02627495|50204557|FG000|Overall Study|Withdrawal by Subject|4|||
25094796|NCT01670045|50204561|FG000|Overall Study|Withdrawal by Subject|3|||
25094797|NCT01670045|50204561|FG000|Overall Study|Adverse Event|1|||
25094798|NCT01670045|50204561|FG000|Overall Study|Death|1|||
25094799|NCT01670045|50204561|FG000|Overall Study|Lost to Follow-up|11|||
25094800|NCT01669421|50204565|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
25094801|NCT01669421|50204565|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
25094802|NCT01671059|50204579|FG000|Overall Study|Adverse Event|4|||
25094803|NCT01671059|50204579|FG000|Overall Study|Lack of Efficacy|1|||
25094804|NCT01669811|50204595|FG000|Overall Study|Investigator decision|0|||
25094805|NCT01669811|50204596|FG001|Overall Study|Investigator decision|1|||
25094806|NCT01669811|50204595|FG000|Overall Study|Withdrawal by Subject|1|||
25094807|NCT01669811|50204596|FG001|Overall Study|Withdrawal by Subject|2|||
25094808|NCT01669811|50204595|FG000|Overall Study|Adverse Event|2|||
25094809|NCT01669811|50204596|FG001|Overall Study|Adverse Event|6|||
25094810|NCT01669811|50204595|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
25094811|NCT01669811|50204596|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
25094812|NCT01669577|50204602|FG000|Overall Study|Death|22|||
25094813|NCT01669577|50204602|FG000|Overall Study|Lost to Follow-up|78|||
25094814|NCT01669577|50204602|FG000|Overall Study|Physician Decision|34|||
25094815|NCT02658175|50204609|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
25094816|NCT02658175|50204610|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
25094817|NCT02658175|50204611|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
25176945|NCT01506947|50320642|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
25094818|NCT02658175|50204609|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
25094819|NCT02658175|50204610|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
25094820|NCT02658175|50204611|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
25176946|NCT02665338|50320659|FG000|Overall Study|Withdrawal by Subject|0|||
25176947|NCT02665338|50320660|FG001|Overall Study|Withdrawal by Subject|1|||
25176948|NCT01506479|50320669|FG000|Overall Study|Lost to Follow-up|1|||
25176949|NCT01506479|50320670|FG001|Overall Study|Lost to Follow-up|2|||
25176950|NCT01506479|50320671|FG002|Overall Study|Lost to Follow-up|2|||
25176951|NCT01506479|50320669|FG000|Overall Study|Withdrawal by Subject|1|||
25176952|NCT01506479|50320670|FG001|Overall Study|Withdrawal by Subject|2|||
25176953|NCT01506479|50320671|FG002|Overall Study|Withdrawal by Subject|1|||
25176954|NCT01506479|50320669|FG000|Overall Study|Missing assessment|1|||
25176955|NCT01506479|50320670|FG001|Overall Study|Missing assessment|0|||
25176956|NCT01506479|50320671|FG002|Overall Study|Missing assessment|0|||
25094821|NCT02658175|50204609|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
25094822|NCT02658175|50204610|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
25094823|NCT02658175|50204611|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
25094824|NCT02658175|50204609|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
25094825|NCT02658175|50204610|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
25094826|NCT02658175|50204611|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
25094827|NCT02658175|50204609|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
25094828|NCT02658175|50204610|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
25094829|NCT02658175|50204611|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
25094830|NCT02658175|50204609|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
25094831|NCT02658175|50204610|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
25094832|NCT02658175|50204611|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
25094833|NCT02658175|50204609|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
25094834|NCT02658175|50204610|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
25094835|NCT02658175|50204611|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
25094836|NCT02658175|50204609|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
25094837|NCT02658175|50204610|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
25094838|NCT02658175|50204611|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
25094839|NCT02658175|50204609|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
25094840|NCT02658175|50204610|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
25094841|NCT02658175|50204611|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
25094842|NCT02658175|50204609|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
25094843|NCT02658175|50204610|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
25094844|NCT02658175|50204611|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
25094845|NCT02625623|50204621|FG000|Overall Study|Participants randomized but not treated|9|||
25094846|NCT02625623|50204622|FG001|Overall Study|Participants randomized but not treated|1|||
25094847|NCT02658019|50204630|FG000|Overall Study|Adverse Event|1|||
25094848|NCT02624687|50204636|FG000|Overall Study|Withdrawal by Subject|1|||
25094849|NCT02624687|50204637|FG001|Overall Study|Withdrawal by Subject|1|||
25094850|NCT02624687|50204636|FG000|Overall Study|medical leave from work|0|||
25094851|NCT02624687|50204637|FG001|Overall Study|medical leave from work|1|||
25094852|NCT01675765|50204645|FG000|Overall Study|Progressive disease|4|||
25094853|NCT01675765|50204646|FG001|Overall Study|Progressive disease|4|||
25094854|NCT01675765|50204645|FG000|Overall Study|Adverse Event|1|||
25094855|NCT01675765|50204646|FG001|Overall Study|Adverse Event|2|||
25094856|NCT01675765|50204645|FG000|Overall Study|Withdrawal by Subject|2|||
25094857|NCT01675765|50204646|FG001|Overall Study|Withdrawal by Subject|0|||
25094858|NCT01675765|50204645|FG000|Overall Study|Death|1|||
25094859|NCT01675765|50204646|FG001|Overall Study|Death|0|||
25094860|NCT01675765|50204645|FG000|Overall Study|Clinical progression|3|||
25094861|NCT01675765|50204646|FG001|Overall Study|Clinical progression|2|||
25094862|NCT02625233|50204654|FG000|Overall Study|Adverse Event|2|||
25094863|NCT02625233|50204655|FG001|Overall Study|Adverse Event|0|||
25094864|NCT02656693|50204664|FG000|Overall Study|Pregnancy|1|||
25094865|NCT02656693|50204665|FG001|Overall Study|Pregnancy|1|||
25094866|NCT02656693|50204666|FG002|Overall Study|Pregnancy|1|||
25094867|NCT02656693|50204664|FG000|Overall Study|Bariatric surgery|0|||
25094868|NCT02656693|50204665|FG001|Overall Study|Bariatric surgery|1|||
25094869|NCT02656693|50204666|FG002|Overall Study|Bariatric surgery|2|||
25094870|NCT02633293|50204674|FG000|Overall Study|Death|56|||
25094871|NCT02633293|50204674|FG000|Overall Study|Progressive Disease|12|||
25094872|NCT02633293|50204674|FG000|Overall Study|Adverse Event|29|||
25094873|NCT02633293|50204674|FG000|Overall Study|Withdrawal by Subject|41|||
25094874|NCT02633293|50204674|FG000|Overall Study|Protocol Violation|1|||
25094875|NCT02633293|50204674|FG000|Overall Study|Lost to Follow-up|1|||
25094876|NCT02633293|50204674|FG000|Overall Study|Study Terminated by Sponsor|24|||
25094877|NCT02633293|50204674|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
25094878|NCT02633293|50204674|FG000|Overall Study|Lung Transplant|5|||
25094879|NCT02633293|50204674|FG000|Overall Study|Lack of Efficacy|2|||
25094880|NCT02633293|50204674|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
25094881|NCT02623829|50204680|FG000|Overall Study|Lost to Follow-up|1|||
25094882|NCT02623829|50204681|FG001|Overall Study|Lost to Follow-up|1|||
25094883|NCT02655679|50204692|FG000|Overall Study|Adverse Event|0|||
25094884|NCT02655679|50204693|FG001|Overall Study|Adverse Event|1|||
25094885|NCT02655679|50204694|FG002|Overall Study|Adverse Event|0|||
25094886|NCT02655679|50204695|FG003|Overall Study|Adverse Event|0|||
25094887|NCT02655679|50204696|FG004|Overall Study|Adverse Event|0|||
25094888|NCT02655679|50204692|FG000|Overall Study|Withdrawal by Subject|1|||
25094889|NCT02655679|50204693|FG001|Overall Study|Withdrawal by Subject|1|||
25094890|NCT02655679|50204694|FG002|Overall Study|Withdrawal by Subject|0|||
25094891|NCT02655679|50204695|FG003|Overall Study|Withdrawal by Subject|3|||
25094892|NCT02655679|50204696|FG004|Overall Study|Withdrawal by Subject|1|||
25094893|NCT02655679|50204692|FG000|Overall Study|Inability to Comply with the Protocol|1|||
25094894|NCT02655679|50204693|FG001|Overall Study|Inability to Comply with the Protocol|0|||
25094895|NCT02655679|50204694|FG002|Overall Study|Inability to Comply with the Protocol|0|||
25094896|NCT02655679|50204695|FG003|Overall Study|Inability to Comply with the Protocol|0|||
25094897|NCT02655679|50204696|FG004|Overall Study|Inability to Comply with the Protocol|0|||
25094898|NCT02655679|50204692|FG000|Overall Study|Lost to Follow-up|0|||
25094899|NCT02655679|50204693|FG001|Overall Study|Lost to Follow-up|1|||
25094900|NCT02655679|50204694|FG002|Overall Study|Lost to Follow-up|1|||
25094901|NCT02655679|50204695|FG003|Overall Study|Lost to Follow-up|1|||
25094902|NCT02655679|50204696|FG004|Overall Study|Lost to Follow-up|0|||
25094903|NCT02655679|50204692|FG000|Overall Study|Other Miscellaneous Reasons|1|||
25094904|NCT02655679|50204693|FG001|Overall Study|Other Miscellaneous Reasons|0|||
25094905|NCT02655679|50204694|FG002|Overall Study|Other Miscellaneous Reasons|0|||
25094906|NCT02655679|50204695|FG003|Overall Study|Other Miscellaneous Reasons|0|||
25094907|NCT02655679|50204696|FG004|Overall Study|Other Miscellaneous Reasons|0|||
25094908|NCT02623361|50204711|FG000|Overall Study|Protocol Violation|0|||
25094909|NCT02623361|50204712|FG001|Overall Study|Protocol Violation|1|||
25094910|NCT02623361|50204711|FG000|Overall Study|Withdrawal by Subject|0|||
25094911|NCT02623361|50204712|FG001|Overall Study|Withdrawal by Subject|1|||
25094912|NCT01675531|50204740|FG000|Overall Study|Adverse Event|9|||
25094913|NCT01675531|50204740|FG000|Overall Study|Withdrawal by Subject|7|||
25094914|NCT01675531|50204740|FG000|Overall Study|Lack of Efficacy|1|||
25094915|NCT01675531|50204740|FG000|Overall Study|Protocol Violation|8|||
25094916|NCT02532543|50204749|FG000|Overall Study|Lost to Follow-up|0|||
25094917|NCT02532543|50204750|FG001|Overall Study|Lost to Follow-up|0|||
25094918|NCT02532543|50204751|FG002|Overall Study|Lost to Follow-up|1|||
25094919|NCT02532543|50204752|FG003|Overall Study|Lost to Follow-up|0|||
25094920|NCT02532465|50204764|FG000|Overall Study|Protocol Violation|1|||
25094921|NCT02532465|50204765|FG001|Overall Study|Protocol Violation|0|||
25094922|NCT02532465|50204764|FG000|Overall Study|Lack of Efficacy|0|||
25094923|NCT02532465|50204765|FG001|Overall Study|Lack of Efficacy|1|||
25094924|NCT02528331|50204771|FG000|Overall Study|Withdrawal by Subject|2|||
25094925|NCT02654977|50204775|FG000|Overall Study|Death|1|||
25094926|NCT02654977|50204775|FG000|Overall Study|Lost to Follow-up|1|||
25094927|NCT02654977|50204775|FG000|Overall Study|Adverse Event|1|||
25094928|NCT02654977|50204775|FG000|Overall Study|Withdrawal by Subject|1|||
25094929|NCT02654977|50204775|FG000|Overall Study|Lack of Efficacy|3|||
25094930|NCT01362517|50204779|FG000|Overall Study|Protocol Violation|1|||
25094931|NCT01362517|50204779|FG000|Overall Study|Lost to Follow-up|1|||
25094932|NCT01362439|50204786|FG000|Overall Study|Adverse Event|1|||
25094933|NCT01362439|50204786|FG000|Overall Study|Lack of Efficacy|3|||
25094934|NCT01362439|50204786|FG000|Overall Study|Lost to Follow-up|2|||
25094935|NCT01362439|50204786|FG000|Overall Study|Study medication non-compliant|1|||
25094936|NCT01362439|50204786|FG000|Overall Study|Participant who withdrew consent|8|||
25094937|NCT02653495|50204793|FG000|Overall Study|Lost to Follow-up|2|||
25094938|NCT02653495|50204794|FG001|Overall Study|Lost to Follow-up|0|||
25094939|NCT02653495|50204793|FG000|Overall Study|Screening Failure|10|||
25094940|NCT02653495|50204794|FG001|Overall Study|Screening Failure|0|||
25094941|NCT01675141|50204800|FG000|Overall Study|Lenalidomide outside NIH|3|||
25094942|NCT01675141|50204800|FG000|Overall Study|Withdrawal by Subject|3|||
25094943|NCT01675141|50204800|FG000|Overall Study|Physician Decision|4|||
25094944|NCT01675141|50204800|FG000|Overall Study|No treatment, per protocol|1|||
25094945|NCT03367819|50204835|FG000|Overall Study|Adverse Event|4|||
25094946|NCT03367819|50204836|FG001|Overall Study|Adverse Event|4|||
25094947|NCT03367819|50204835|FG000|Overall Study|Progressive Disease|15|||
25094948|NCT03367819|50204836|FG001|Overall Study|Progressive Disease|13|||
25094949|NCT03367819|50204835|FG000|Overall Study|Withdrawal by Subject|1|||
25094950|NCT03367819|50204836|FG001|Overall Study|Withdrawal by Subject|0|||
25094951|NCT03367819|50204835|FG000|Overall Study|Other|4|||
25094952|NCT03367819|50204836|FG001|Overall Study|Other|2|||
25094953|NCT01597193|50204879|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
25094954|NCT01597193|50204880|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
25094955|NCT01597193|50204881|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
25094956|NCT01597193|50204882|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
25094957|NCT01597193|50204883|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
25094958|NCT01597193|50204884|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
25094959|NCT01597193|50204885|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
25094960|NCT01597193|50204879|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
25094961|NCT01597193|50204880|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
25094962|NCT01597193|50204881|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
25094963|NCT01597193|50204882|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
25094964|NCT01597193|50204883|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
25094965|NCT01597193|50204884|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
25094966|NCT01597193|50204885|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
25094967|NCT01597193|50204879|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
25094968|NCT01597193|50204880|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
25094969|NCT01597193|50204881|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
25094970|NCT01597193|50204882|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
25094971|NCT01597193|50204883|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
25094972|NCT01597193|50204884|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
25094973|NCT01597193|50204885|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
25094974|NCT01597193|50204879|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
25094975|NCT01597193|50204880|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
25094976|NCT01597193|50204881|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
25094977|NCT01597193|50204882|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
25094978|NCT01597193|50204883|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
25094979|NCT01597193|50204884|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
25094980|NCT01597193|50204885|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
25094981|NCT01597193|50204879|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
25094982|NCT01597193|50204880|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
25094983|NCT01597193|50204881|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
25094984|NCT01597193|50204882|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
25094985|NCT01597193|50204883|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
25094986|NCT01597193|50204884|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
25094987|NCT01597193|50204885|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
25094988|NCT02649439|50204908|FG000|Overall Study|Switched to alternative treatment|6|||
25094989|NCT02649439|50204909|FG001|Overall Study|Switched to alternative treatment|4|||
25094990|NCT02649439|50204908|FG000|Overall Study|Patient decision|1|||
25094991|NCT02649439|50204909|FG001|Overall Study|Patient decision|0|||
25094992|NCT02649439|50204908|FG000|Overall Study|Patient going out of country|1|||
25094993|NCT02649439|50204909|FG001|Overall Study|Patient going out of country|0|||
25094994|NCT02649439|50204908|FG000|Overall Study|To start finasteride|1|||
25094995|NCT02649439|50204909|FG001|Overall Study|To start finasteride|0|||
25094996|NCT02649439|50204908|FG000|Overall Study|Physician Decision|1|||
25094997|NCT02649439|50204909|FG001|Overall Study|Physician Decision|0|||
25094998|NCT02649439|50204908|FG000|Overall Study|Disease progression on study|12|||
25094999|NCT02649439|50204909|FG001|Overall Study|Disease progression on study|13|||
25095000|NCT02649439|50204908|FG000|Overall Study|Refused further treatment|1|||
25095001|NCT02649439|50204909|FG001|Overall Study|Refused further treatment|0|||
25095002|NCT02649439|50204908|FG000|Overall Study|Refused further follow up|2|||
25095003|NCT02649439|50204909|FG001|Overall Study|Refused further follow up|7|||
25095004|NCT02649439|50204908|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
25095005|NCT02649439|50204909|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
25095006|NCT02649439|50204908|FG000|Overall Study|No treatment, per protocol|1|||
25095007|NCT02649439|50204909|FG001|Overall Study|No treatment, per protocol|0|||
25095008|NCT02649439|50204908|FG000|Overall Study|PSA DT makes ineligible|0|||
25095009|NCT02649439|50204909|FG001|Overall Study|PSA DT makes ineligible|1|||
25095010|NCT02649439|50204908|FG000|Overall Study|Rising PSA No Mets|0|||
25095011|NCT02649439|50204909|FG001|Overall Study|Rising PSA No Mets|1|||
25095012|NCT02649439|50204908|FG000|Overall Study|Rising PSA|0|||
25007658|NCT03150056|50100074|FG000|Overall Study|Withdrawal by Subject|0|||
25007659|NCT03150056|50100075|FG001|Overall Study|Withdrawal by Subject|0|||
25007660|NCT03150056|50100076|FG002|Overall Study|Withdrawal by Subject|0|||
25007661|NCT03150056|50100077|FG003|Overall Study|Withdrawal by Subject|0|||
25007662|NCT03150056|50100078|FG004|Overall Study|Withdrawal by Subject|0|||
25007663|NCT03150056|50100079|FG005|Overall Study|Withdrawal by Subject|2|||
25007664|NCT03150056|50100074|FG000|Overall Study|Study terminated by Sponsor|1|||
25007665|NCT03150056|50100075|FG001|Overall Study|Study terminated by Sponsor|3|||
25007666|NCT03150056|50100076|FG002|Overall Study|Study terminated by Sponsor|1|||
25007667|NCT03150056|50100077|FG003|Overall Study|Study terminated by Sponsor|1|||
25007668|NCT03150056|50100078|FG004|Overall Study|Study terminated by Sponsor|5|||
25007669|NCT03150056|50100079|FG005|Overall Study|Study terminated by Sponsor|6|||
25007670|NCT03150056|50100074|FG000|Overall Study|Death|9|||
25007671|NCT03150056|50100075|FG001|Overall Study|Death|2|||
25007672|NCT03150056|50100076|FG002|Overall Study|Death|2|||
25007673|NCT03150056|50100077|FG003|Overall Study|Death|7|||
25007674|NCT03150056|50100078|FG004|Overall Study|Death|8|||
25007675|NCT03150056|50100079|FG005|Overall Study|Death|10|||
25007676|NCT02640664|50100099|FG000|Epoch 1|Withdrawal of informed consent|1|||
25095013|NCT02649439|50204909|FG001|Overall Study|Rising PSA|1|||
25095014|NCT02649439|50204908|FG000|Overall Study|Signed follow up protocol|0|||
25176957|NCT01506479|50320669|FG000|Overall Study|Adverse Event|0|||
25007677|NCT02640664|50100100|FG001|Epoch 1|Withdrawal of informed consent|0|||
25007678|NCT02640664|50100101|FG002|Epoch 1|Withdrawal of informed consent|0|||
25007679|NCT02640664|50100099|FG000|Epoch 1|Death|0|||
25007680|NCT02640664|50100100|FG001|Epoch 1|Death|0|||
25095015|NCT02649439|50204909|FG001|Overall Study|Signed follow up protocol|1|||
25095016|NCT02622113|50204924|FG000|Overall Study|Adverse Event|4|||
25095017|NCT02622113|50204925|FG001|Overall Study|Adverse Event|4|||
25095018|NCT02622113|50204924|FG000|Overall Study|Physician Decision|0|||
25095019|NCT02622113|50204925|FG001|Overall Study|Physician Decision|1|||
25095020|NCT02622113|50204924|FG000|Overall Study|Withdrawal by Subject|0|||
25095021|NCT02622113|50204925|FG001|Overall Study|Withdrawal by Subject|2|||
25095022|NCT02622113|50204924|FG000|Overall Study|Stopping Criteria|1|||
25095023|NCT02622113|50204925|FG001|Overall Study|Stopping Criteria|3|||
25095024|NCT02651467|50204934|FG000|Overall Study|Withdrawal by Subject|0|||
25095025|NCT02651467|50204935|FG001|Overall Study|Withdrawal by Subject|0|||
25095026|NCT02651467|50204936|FG002|Overall Study|Withdrawal by Subject|2|||
25095027|NCT02651467|50204934|FG000|Overall Study|Other (Not specified)|1|||
25095028|NCT02651467|50204935|FG001|Overall Study|Other (Not specified)|0|||
25095029|NCT02651467|50204936|FG002|Overall Study|Other (Not specified)|2|||
25095030|NCT02620787|50204965|FG000|Overall Study|Adverse Event|1|||
25095031|NCT02620787|50204966|FG001|Overall Study|Adverse Event|0|||
25095032|NCT02620787|50204965|FG000|Overall Study|Eligibility Criteria Not Met|1|||
25095033|NCT02620787|50204966|FG001|Overall Study|Eligibility Criteria Not Met|0|||
25095034|NCT02651155|50204974|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
25095035|NCT02651155|50204975|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
25095036|NCT02651155|50204974|FG000|Overall Study|Voluntary Withdrawal|5|||
25095037|NCT02651155|50204975|FG001|Overall Study|Voluntary Withdrawal|0|||
25095038|NCT02619617|50204981|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
25095039|NCT02619617|50204982|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
25095040|NCT02619617|50204981|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
25095041|NCT02619617|50204982|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
25095042|NCT02650921|50205003|FG000|Overall Study|Withdrawal by Subject|4|||
25095043|NCT02650921|50205003|FG000|Overall Study|Lost to Follow-up|2|||
25095044|NCT02650921|50205003|FG000|Overall Study|Adverse Event|1|||
25095045|NCT02650921|50205003|FG000|Overall Study|Due to Medical Condition|1|||
25095046|NCT01596335|50205011|FG000|Overall Study|exacerbation of primary disease|5|||
25095047|NCT01596335|50205012|FG001|Overall Study|exacerbation of primary disease|9|||
25095048|NCT02618759|50205020|FG000|Overall Study|Lost to Follow-up|0|||
25095049|NCT02618759|50205021|FG001|Overall Study|Lost to Follow-up|1|||
25095050|NCT02618759|50205020|FG000|Overall Study|Withdrawal by Subject|1|||
25095051|NCT02618759|50205021|FG001|Overall Study|Withdrawal by Subject|0|||
25095052|NCT02618759|50205020|FG000|Overall Study|Other Reasons|1|||
25095053|NCT02618759|50205021|FG001|Overall Study|Other Reasons|4|||
25095054|NCT02614079|50205036|FG000|Overall Study|Withdrawal by Subject|1|||
25095055|NCT02616029|50205042|FG000|Overall Study|Adverse Event|1|||
25095056|NCT02616029|50205043|FG001|Overall Study|Adverse Event|0|||
25095057|NCT02616029|50205042|FG000|Overall Study|Death|0|||
25095058|NCT02616029|50205043|FG001|Overall Study|Death|1|||
25095059|NCT02616029|50205042|FG000|Overall Study|Protocol Violation|1|||
25095060|NCT02616029|50205043|FG001|Overall Study|Protocol Violation|0|||
25095061|NCT02616029|50205042|FG000|Overall Study|Withdrew Consent|1|||
25095062|NCT02616029|50205043|FG001|Overall Study|Withdrew Consent|0|||
25095063|NCT02616029|50205042|FG000|Overall Study|Enrolled and Never Treated|1|||
25095064|NCT02616029|50205043|FG001|Overall Study|Enrolled and Never Treated|1|||
25095065|NCT02614859|50205051|FG000|Overall Study|Physician Decision|0|||
25095066|NCT02614859|50205052|FG001|Overall Study|Physician Decision|1|||
25095067|NCT02615249|50205060|FG000|Overall Study|Withdrawal by Subject|1|||
25095068|NCT02615171|50205067|FG000|Overall Study|Lost to Follow-up|2|||
25095069|NCT02615171|50205068|FG001|Overall Study|Lost to Follow-up|1|||
25095070|NCT02648347|50205076|FG000|Overall Study|Death|174|||
25095071|NCT02648347|50205077|FG001|Overall Study|Death|167|||
25095072|NCT02648347|50205076|FG000|Overall Study|Withdrawal by Subject|16|||
25095073|NCT02648347|50205077|FG001|Overall Study|Withdrawal by Subject|9|||
25095074|NCT02648347|50205076|FG000|Overall Study|Lost to Follow-up|18|||
25095075|NCT02648347|50205077|FG001|Overall Study|Lost to Follow-up|21|||
25095076|NCT02648347|50205076|FG000|Overall Study|Missing|1|||
25095077|NCT02648347|50205077|FG001|Overall Study|Missing|0|||
25095078|NCT02614703|50205085|FG000|Overall Study|Withdrawal by Subject|7|||
25095079|NCT02614703|50205086|FG001|Overall Study|Withdrawal by Subject|1|||
25176958|NCT01506479|50320670|FG001|Overall Study|Adverse Event|1|||
25176959|NCT01506479|50320671|FG002|Overall Study|Adverse Event|0|||
25095080|NCT01669343|50205092|FG000|Part A: All Patients|Withdrawal by Subject|7|||
25095081|NCT01669343|50205092|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
25095082|NCT01669343|50205092|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
25095083|NCT01669343|50205092|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
25095084|NCT01669343|50205092|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
25095085|NCT01594931|50205102|FG000|Overall Study|Adverse Event|3|||
25095086|NCT01594931|50205103|FG001|Overall Study|Adverse Event|1|||
25095087|NCT01594931|50205104|FG002|Overall Study|Adverse Event|1|||
25095088|NCT01594931|50205102|FG000|Overall Study|Withdrawal by Subject|2|||
25095089|NCT01594931|50205103|FG001|Overall Study|Withdrawal by Subject|1|||
25095090|NCT01594931|50205104|FG002|Overall Study|Withdrawal by Subject|1|||
25095091|NCT01594931|50205102|FG000|Overall Study|Lack of Efficacy|7|||
25095092|NCT01594931|50205103|FG001|Overall Study|Lack of Efficacy|2|||
25095093|NCT01594931|50205104|FG002|Overall Study|Lack of Efficacy|2|||
25095094|NCT01594931|50205102|FG000|Overall Study|Lost to Follow-up|4|||
25095095|NCT01594931|50205103|FG001|Overall Study|Lost to Follow-up|3|||
25095096|NCT01594931|50205104|FG002|Overall Study|Lost to Follow-up|3|||
25095097|NCT01594931|50205102|FG000|Overall Study|Protocol Violation|2|||
25095098|NCT01594931|50205103|FG001|Overall Study|Protocol Violation|1|||
25095099|NCT01594931|50205104|FG002|Overall Study|Protocol Violation|0|||
25095100|NCT01594931|50205102|FG000|Overall Study|No defiined|11|||
25095101|NCT01594931|50205103|FG001|Overall Study|No defiined|4|||
25095102|NCT01594931|50205104|FG002|Overall Study|No defiined|7|||
25095103|NCT01594853|50205114|FG000|Overall Study|Withdrawal by Subject|1|||
25095104|NCT01594853|50205115|FG001|Overall Study|Withdrawal by Subject|1|||
25095105|NCT01594853|50205114|FG000|Overall Study|Lost to Follow-up|1|||
25095106|NCT01594853|50205115|FG001|Overall Study|Lost to Follow-up|1|||
25095107|NCT01594853|50205114|FG000|Overall Study|noncompliance with exercise|0|||
25095108|NCT01594853|50205115|FG001|Overall Study|noncompliance with exercise|1|||
25095109|NCT01668797|50205132|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
25095110|NCT01668797|50205133|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
25095111|NCT01668797|50205134|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
25095112|NCT01668797|50205135|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
25095113|NCT01668797|50205132|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
25095114|NCT01668797|50205133|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
25095115|NCT01668797|50205134|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
25095116|NCT01668797|50205135|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
25095117|NCT01668797|50205132|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
25095118|NCT01668797|50205133|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
25095119|NCT01668797|50205134|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
25095120|NCT01668797|50205135|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
25095121|NCT01668797|50205132|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
25095122|NCT01668797|50205133|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
25095123|NCT01668797|50205134|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
25095124|NCT01668797|50205135|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
25095125|NCT01668797|50205132|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
25095126|NCT01668797|50205133|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
25095127|NCT01668797|50205134|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
25095128|NCT01668797|50205135|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
25095129|NCT01668797|50205132|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
25095130|NCT01668797|50205133|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
25095131|NCT01668797|50205134|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
25095132|NCT01668797|50205135|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
25095133|NCT01668797|50205132|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
25095134|NCT01668797|50205133|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
25095135|NCT01668797|50205134|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
25095136|NCT01668797|50205135|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
25095137|NCT01668797|50205132|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
25095138|NCT01668797|50205133|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
25095139|NCT01668797|50205134|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
25095140|NCT01668797|50205135|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
25095141|NCT01668797|50205132|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
25095142|NCT01668797|50205133|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
25095143|NCT01668797|50205134|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
25095144|NCT01668797|50205135|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
25095145|NCT01668797|50205132|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
25095146|NCT01668797|50205133|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
25095147|NCT01668797|50205134|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
25095148|NCT01668797|50205135|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
25095149|NCT01668797|50205132|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
25095150|NCT01668797|50205133|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
25095151|NCT01668797|50205134|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
25095152|NCT01668797|50205135|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
25095153|NCT01668797|50205132|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
25095154|NCT01668797|50205133|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
25176960|NCT01506323|50320695|FG000|Overall Study|Lost to Follow-up|5|||
25095155|NCT01668797|50205134|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
25095156|NCT01668797|50205135|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
25095157|NCT01668797|50205132|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
25095158|NCT01668797|50205133|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
25095159|NCT01668797|50205134|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
25176961|NCT01506323|50320696|FG001|Overall Study|Lost to Follow-up|4|||
25176962|NCT01506323|50320695|FG000|Overall Study|Withdrawal by Subject|4|||
25176963|NCT01506323|50320696|FG001|Overall Study|Withdrawal by Subject|4|||
25176964|NCT01506323|50320695|FG000|Overall Study|Lack of Efficacy|1|||
25176965|NCT01506323|50320696|FG001|Overall Study|Lack of Efficacy|3|||
25176966|NCT01506323|50320695|FG000|Overall Study|Moved out of area|5|||
25176967|NCT01506323|50320696|FG001|Overall Study|Moved out of area|2|||
25176968|NCT01506323|50320695|FG000|Overall Study|Schedule or Transportation conflict|8|||
25176969|NCT01506323|50320696|FG001|Overall Study|Schedule or Transportation conflict|0|||
25176970|NCT01506323|50320695|FG000|Overall Study|Started another treatment|1|||
25095160|NCT01668797|50205135|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
25095161|NCT01668797|50205132|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
25095162|NCT01668797|50205133|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
25095163|NCT01668797|50205134|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
25095164|NCT01668797|50205135|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
25095165|NCT01668797|50205132|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
25095166|NCT01668797|50205133|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
25095167|NCT01668797|50205134|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
25095168|NCT01668797|50205135|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
25095169|NCT01668797|50205132|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
25095170|NCT01668797|50205133|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
25095171|NCT01668797|50205134|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
25095172|NCT01668797|50205135|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
25095173|NCT01668797|50205132|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
25095174|NCT01668797|50205133|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
25095175|NCT01668797|50205134|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
25095176|NCT01668797|50205135|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
25095177|NCT01668797|50205132|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
25095178|NCT01668797|50205133|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
25095179|NCT01668797|50205134|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
25095180|NCT01668797|50205135|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
25095181|NCT01668797|50205132|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
25095182|NCT01668797|50205133|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
25095183|NCT01668797|50205134|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
25095184|NCT01668797|50205135|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
25095185|NCT01668797|50205132|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
25095186|NCT01668797|50205133|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
25095187|NCT01668797|50205134|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
25095188|NCT01668797|50205135|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
25095189|NCT01668797|50205132|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
25095190|NCT01668797|50205133|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
25095191|NCT01668797|50205134|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
25095192|NCT01668797|50205135|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
25095193|NCT01668797|50205132|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
25095194|NCT01668797|50205133|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
25095195|NCT01668797|50205134|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
25095196|NCT01668797|50205135|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
25095197|NCT01668797|50205132|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
25095198|NCT01668797|50205133|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
25095199|NCT01668797|50205134|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
25095200|NCT01668797|50205135|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
25095201|NCT01668797|50205132|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
25095202|NCT01668797|50205133|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
25095203|NCT01668797|50205134|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
25095204|NCT01668797|50205135|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
25095205|NCT01668797|50205132|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
25095206|NCT01668797|50205133|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
25095207|NCT01668797|50205134|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
25095208|NCT01668797|50205135|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
25095209|NCT02613221|50205142|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
25095210|NCT02613221|50205142|FG000|Overall Study|Adverse Event|2|||
25095211|NCT02613221|50205142|FG000|Overall Study|Voluntary Discontinuation|1|||
25095212|NCT02613221|50205142|FG000|Overall Study|Delayed Treatment|1|||
25176971|NCT01506323|50320696|FG001|Overall Study|Started another treatment|0|||
25176972|NCT01505387|50320709|FG000|Overall Study|Protocol Violation|1|||
25176973|NCT01505387|50320710|FG001|Overall Study|Protocol Violation|0|||
25095213|NCT02613221|50205142|FG000|Overall Study|Enrolled but Not Treated|1|||
25095214|NCT01362049|50205150|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
25095215|NCT01362049|50205151|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
25095216|NCT01362049|50205152|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
25095217|NCT01362049|50205153|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
25095218|NCT01362049|50205150|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
25007681|NCT02640664|50100101|FG002|Epoch 1|Death|1|||
25007682|NCT02640664|50100099|FG000|Epoch 2|Withdrawal of informed consent|3|||
25007683|NCT02640664|50100100|FG001|Epoch 2|Withdrawal of informed consent|4|||
25007684|NCT02640664|50100101|FG002|Epoch 2|Withdrawal of informed consent|2|||
25007685|NCT02640664|50100099|FG000|Epoch 2|Subject/guardian decision|0|||
25007686|NCT02640664|50100100|FG001|Epoch 2|Subject/guardian decision|2|||
25007687|NCT02640664|50100101|FG002|Epoch 2|Subject/guardian decision|2|||
25007688|NCT02640664|50100099|FG000|Epoch 2|Lost to Follow-up|3|||
25007689|NCT02640664|50100100|FG001|Epoch 2|Lost to Follow-up|4|||
25007690|NCT02640664|50100101|FG002|Epoch 2|Lost to Follow-up|1|||
25007691|NCT02640664|50100099|FG000|Epoch 2|Death|0|||
25007692|NCT02640664|50100100|FG001|Epoch 2|Death|0|||
25007693|NCT02640664|50100101|FG002|Epoch 2|Death|1|||
25007694|NCT00812006|50100113|FG000|Overall Study|Lost to Follow-up|0|||
25007695|NCT00812006|50100114|FG001|Overall Study|Lost to Follow-up|0|||
25007696|NCT00812006|50100115|FG002|Overall Study|Lost to Follow-up|2|||
25007697|NCT00812006|50100113|FG000|Overall Study|Physician Decision|0|||
25007698|NCT00812006|50100114|FG001|Overall Study|Physician Decision|0|||
25007699|NCT00812006|50100115|FG002|Overall Study|Physician Decision|1|||
25007700|NCT00812006|50100113|FG000|Overall Study|Withdrawal by Subject|2|||
25007701|NCT00812006|50100114|FG001|Overall Study|Withdrawal by Subject|1|||
25007702|NCT00812006|50100115|FG002|Overall Study|Withdrawal by Subject|1|||
25007703|NCT00812006|50100113|FG000|Overall Study|Lack of Qualifying Event|4|||
25007704|NCT00812006|50100114|FG001|Overall Study|Lack of Qualifying Event|2|||
25007705|NCT00812006|50100115|FG002|Overall Study|Lack of Qualifying Event|2|||
25007706|NCT03772327|50100130|FG000|Overall Study|Lost to Follow-up|3|||
25007707|NCT03772327|50100131|FG001|Overall Study|Lost to Follow-up|4|||
25007708|NCT03772327|50100130|FG000|Overall Study|Withdrawal by Subject|2|||
25007709|NCT03772327|50100131|FG001|Overall Study|Withdrawal by Subject|3|||
25007710|NCT04364763|50100174|FG000|Overall Study|Death|1|||
25007711|NCT04364763|50100175|FG001|Overall Study|Death|2|||
25007712|NCT04364763|50100174|FG000|Overall Study|Lost to Follow-up|1|||
25007713|NCT04364763|50100175|FG001|Overall Study|Lost to Follow-up|0|||
25007714|NCT04247815|50100192|FG000|Overall Study|Adverse Event|1|||
25007715|NCT04247815|50100193|FG001|Overall Study|Adverse Event|0|||
25007716|NCT04247815|50100192|FG000|Overall Study|Withdrawal by Subject|1|||
25007717|NCT04247815|50100193|FG001|Overall Study|Withdrawal by Subject|0|||
25007718|NCT04247815|50100192|FG000|Overall Study|Protocol Violation|0|||
25007719|NCT04247815|50100193|FG001|Overall Study|Protocol Violation|1|||
25007720|NCT03432819|50100228|FG000|Overall Study|Lost to Follow-up|2|||
25007721|NCT03432819|50100229|FG001|Overall Study|Lost to Follow-up|2|||
25007722|NCT03432819|50100228|FG000|Overall Study|Withdrawal by Subject|5|||
25007723|NCT03432819|50100229|FG001|Overall Study|Withdrawal by Subject|3|||
25007724|NCT03272347|50100248|FG000|Overall Study|Death|0|||
25007725|NCT03272347|50100249|FG001|Overall Study|Death|0|||
25007726|NCT03272347|50100250|FG002|Overall Study|Death|0|||
25007727|NCT03272347|50100251|FG003|Overall Study|Death|1|||
25007728|NCT03272347|50100248|FG000|Overall Study|Lost to Follow-up|1|||
25007729|NCT03272347|50100249|FG001|Overall Study|Lost to Follow-up|3|||
25007730|NCT03272347|50100250|FG002|Overall Study|Lost to Follow-up|5|||
25007731|NCT03272347|50100251|FG003|Overall Study|Lost to Follow-up|1|||
25007732|NCT03272347|50100248|FG000|Overall Study|Physician Decision|4|||
25007733|NCT03272347|50100249|FG001|Overall Study|Physician Decision|2|||
25007734|NCT03272347|50100250|FG002|Overall Study|Physician Decision|5|||
25007735|NCT03272347|50100251|FG003|Overall Study|Physician Decision|4|||
25007736|NCT03272347|50100248|FG000|Overall Study|Screen Failure|1|||
25007737|NCT03272347|50100249|FG001|Overall Study|Screen Failure|0|||
25007738|NCT03272347|50100250|FG002|Overall Study|Screen Failure|0|||
25007739|NCT03272347|50100251|FG003|Overall Study|Screen Failure|0|||
25007740|NCT03272347|50100248|FG000|Overall Study|Withdrawal by Subject|5|||
25007741|NCT03272347|50100249|FG001|Overall Study|Withdrawal by Subject|1|||
25007742|NCT03272347|50100250|FG002|Overall Study|Withdrawal by Subject|2|||
25007743|NCT03272347|50100251|FG003|Overall Study|Withdrawal by Subject|1|||
25007744|NCT03259568|50100273|FG000|Overall Study|Participant performance was low|3|||
25007745|NCT03239470|50100283|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
25007746|NCT03239470|50100284|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
25007747|NCT03167723|50100290|FG000|Overall Study|Protocol Violation|4|||
25007748|NCT03167723|50100291|FG001|Overall Study|Protocol Violation|6|||
25007749|NCT03103152|50100303|FG000|Overall Study|Physician Decision|5|||
25007750|NCT03103152|50100304|FG001|Overall Study|Physician Decision|2|||
25007751|NCT03103152|50100305|FG002|Overall Study|Physician Decision|6|||
25007752|NCT03103152|50100306|FG003|Overall Study|Physician Decision|3|||
25095219|NCT01362049|50205151|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
25095220|NCT01362049|50205152|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
25095221|NCT01362049|50205153|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
25095222|NCT02612909|50205185|FG000|Phase 2|Withdrawal by Subject|2|||
25095223|NCT02612909|50205186|FG001|Phase 2|Withdrawal by Subject|5|||
25095224|NCT02612909|50205187|FG002|Phase 2|Withdrawal by Subject|0|||
25095225|NCT02612909|50205188|FG003|Phase 2|Withdrawal by Subject|0|||
25095226|NCT02612909|50205189|FG004|Phase 2|Withdrawal by Subject|0|||
25095227|NCT02612909|50205185|FG000|Phase 2|Pregnancy|0|||
25095228|NCT02612909|50205186|FG001|Phase 2|Pregnancy|0|||
25095229|NCT02612909|50205187|FG002|Phase 2|Pregnancy|1|||
25095230|NCT02612909|50205188|FG003|Phase 2|Pregnancy|0|||
25095231|NCT02612909|50205189|FG004|Phase 2|Pregnancy|0|||
25095232|NCT02612909|50205185|FG000|Phase 3|Withdrawal by Subject|0|||
25095233|NCT02612909|50205186|FG001|Phase 3|Withdrawal by Subject|0|||
25095234|NCT02612909|50205187|FG002|Phase 3|Withdrawal by Subject|0|||
25095235|NCT02612909|50205188|FG003|Phase 3|Withdrawal by Subject|1|||
25095236|NCT02612909|50205189|FG004|Phase 3|Withdrawal by Subject|0|||
25095237|NCT02612285|50205203|FG000|Overall Study|Withdrawal by Subject|1|||
25095238|NCT02609633|50205209|FG000|Overall Study|Consent Withdrawn|0|||
25095239|NCT02609633|50205210|FG001|Overall Study|Consent Withdrawn|1|||
25095240|NCT02609633|50205209|FG000|Overall Study|Protocol Deviation|1|||
25095241|NCT02609633|50205210|FG001|Overall Study|Protocol Deviation|0|||
25095242|NCT02609633|50205209|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
25095243|NCT02609633|50205210|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
25095244|NCT02609633|50205209|FG000|Overall Study|Reason not Specified|2|||
25095245|NCT02609633|50205210|FG001|Overall Study|Reason not Specified|1|||
25095246|NCT01371981|50205229|FG000|Overall Study|Adverse Event|12|||
25095247|NCT01371981|50205230|FG001|Overall Study|Adverse Event|17|||
25095248|NCT01371981|50205231|FG002|Overall Study|Adverse Event|0|||
25095249|NCT01371981|50205232|FG003|Overall Study|Adverse Event|4|||
25095250|NCT01371981|50205233|FG004|Overall Study|Adverse Event|1|||
25095251|NCT01371981|50205234|FG005|Overall Study|Adverse Event|0|||
25095252|NCT01371981|50205229|FG000|Overall Study|Death|22|||
25095253|NCT01371981|50205230|FG001|Overall Study|Death|16|||
25095254|NCT01371981|50205231|FG002|Overall Study|Death|0|||
25095255|NCT01371981|50205232|FG003|Overall Study|Death|0|||
25095256|NCT01371981|50205233|FG004|Overall Study|Death|2|||
25095257|NCT01371981|50205234|FG005|Overall Study|Death|2|||
25095258|NCT01371981|50205229|FG000|Overall Study|Lack of Efficacy|69|||
25095259|NCT01371981|50205230|FG001|Overall Study|Lack of Efficacy|61|||
25095260|NCT01371981|50205231|FG002|Overall Study|Lack of Efficacy|4|||
25095261|NCT01371981|50205232|FG003|Overall Study|Lack of Efficacy|8|||
25095262|NCT01371981|50205233|FG004|Overall Study|Lack of Efficacy|5|||
25095263|NCT01371981|50205234|FG005|Overall Study|Lack of Efficacy|0|||
25095264|NCT01371981|50205229|FG000|Overall Study|Physician Decision|48|||
25095265|NCT01371981|50205230|FG001|Overall Study|Physician Decision|63|||
25095266|NCT01371981|50205231|FG002|Overall Study|Physician Decision|1|||
25095267|NCT01371981|50205232|FG003|Overall Study|Physician Decision|7|||
25095268|NCT01371981|50205233|FG004|Overall Study|Physician Decision|14|||
25095269|NCT01371981|50205234|FG005|Overall Study|Physician Decision|3|||
25095270|NCT01371981|50205229|FG000|Overall Study|Withdrawal by Subject|12|||
25095271|NCT01371981|50205230|FG001|Overall Study|Withdrawal by Subject|19|||
25095272|NCT01371981|50205231|FG002|Overall Study|Withdrawal by Subject|1|||
25095273|NCT01371981|50205232|FG003|Overall Study|Withdrawal by Subject|2|||
25095274|NCT01371981|50205233|FG004|Overall Study|Withdrawal by Subject|10|||
25095275|NCT01371981|50205234|FG005|Overall Study|Withdrawal by Subject|3|||
25095276|NCT01371981|50205229|FG000|Overall Study|Ineligible|19|||
25095277|NCT01371981|50205230|FG001|Overall Study|Ineligible|13|||
25095278|NCT01371981|50205231|FG002|Overall Study|Ineligible|0|||
25095279|NCT01371981|50205232|FG003|Overall Study|Ineligible|0|||
25095280|NCT01371981|50205233|FG004|Overall Study|Ineligible|0|||
25095281|NCT01371981|50205234|FG005|Overall Study|Ineligible|4|||
25095282|NCT01371981|50205229|FG000|Overall Study|Did not start treatment|2|||
25095283|NCT01371981|50205230|FG001|Overall Study|Did not start treatment|3|||
25095284|NCT01371981|50205231|FG002|Overall Study|Did not start treatment|0|||
25095285|NCT01371981|50205232|FG003|Overall Study|Did not start treatment|0|||
25095286|NCT01371981|50205233|FG004|Overall Study|Did not start treatment|0|||
25095287|NCT01371981|50205234|FG005|Overall Study|Did not start treatment|2|||
25095288|NCT01597375|50205262|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
25095289|NCT01597375|50205263|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
25095290|NCT01597375|50205262|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
25095291|NCT01597375|50205263|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
25095292|NCT01597375|50205262|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
25095293|NCT01597375|50205263|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
25095294|NCT01597375|50205262|FG000|Washout (2 Weeks)|Adverse Event|1|||
25095295|NCT01597375|50205263|FG001|Washout (2 Weeks)|Adverse Event|0|||
25095296|NCT01597375|50205262|FG000|Second Intervention|Failed to react at both Aspirin|1|||
25095297|NCT01597375|50205263|FG001|Second Intervention|Failed to react at both Aspirin|1|||
25095298|NCT02527161|50205270|FG000|Overall Study|Failed MRI|52|||
25095299|NCT02527161|50205270|FG000|Overall Study|Withdrawal by Subject|19|||
25095300|NCT02527161|50205270|FG000|Overall Study|Delay in or unfit for surgery|16|||
25095301|NCT02527161|50205270|FG000|Overall Study|MRI contraindication|6|||
25095302|NCT02527161|50205270|FG000|Overall Study|Consent violation|4|||
25095303|NCT02527161|50205270|FG000|Overall Study|Only Recruited to Part A|27|||
25095304|NCT02527161|50205270|FG000|Overall Study|Physician Decision|1|||
25095305|NCT02527161|50205270|FG000|Overall Study|Adverse Event|1|||
25095306|NCT02527161|50205270|FG000|Overall Study|Lost to Follow-up|6|||
25095307|NCT02609399|50205277|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
25095308|NCT02609399|50205278|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
25095309|NCT02609399|50205277|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
25095310|NCT02609399|50205278|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
25095311|NCT02609399|50205277|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
25095312|NCT02609399|50205278|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
25095313|NCT02720185|50205286|FG000|Overall Study|Lost to Follow-up|1|||
25095314|NCT02526693|50205309|FG000|Overall Study|Physician Decision|3|||
25095315|NCT02526693|50205310|FG001|Overall Study|Physician Decision|1|||
25095316|NCT02710669|50205328|FG000|Overall Study|Physician Decision|2|||
25095317|NCT02710669|50205329|FG001|Overall Study|Physician Decision|1|||
25095318|NCT02710669|50205330|FG002|Overall Study|Physician Decision|0|||
25095319|NCT02710669|50205328|FG000|Overall Study|Institutional delays (including COVID)|2|||
25095320|NCT02710669|50205329|FG001|Overall Study|Institutional delays (including COVID)|2|||
25095321|NCT02710669|50205330|FG002|Overall Study|Institutional delays (including COVID)|0|||
25095322|NCT02710669|50205328|FG000|Overall Study|arrived in afib/aflutter|10|||
25095323|NCT02710669|50205329|FG001|Overall Study|arrived in afib/aflutter|8|||
25095324|NCT02710669|50205330|FG002|Overall Study|arrived in afib/aflutter|2|||
25095325|NCT02610725|50205338|FG000|Overall Study|Lost to Follow-up|197|||
25095326|NCT02610725|50205338|FG000|Overall Study|self-reported contraindication|9|||
25095327|NCT02684461|50205345|FG000|Overall Study|Adverse Event|1|||
25095328|NCT02684461|50205346|FG001|Overall Study|Adverse Event|0|||
25095329|NCT02684461|50205347|FG002|Overall Study|Adverse Event|0|||
25095330|NCT02684461|50205345|FG000|Overall Study|Lack of Efficacy|1|||
25095331|NCT02684461|50205346|FG001|Overall Study|Lack of Efficacy|2|||
25095332|NCT02684461|50205347|FG002|Overall Study|Lack of Efficacy|0|||
25095333|NCT02647645|50205372|FG000|Overall Study|Lost to Follow-up|2|||
25095334|NCT02647645|50205373|FG001|Overall Study|Lost to Follow-up|1|||
25095335|NCT02531373|50205388|FG000|Overall Study|Lack of Efficacy|0|||
25095336|NCT02531373|50205389|FG001|Overall Study|Lack of Efficacy|0|||
25095337|NCT02531373|50205390|FG002|Overall Study|Lack of Efficacy|0|||
25095338|NCT02531373|50205391|FG003|Overall Study|Lack of Efficacy|0|||
25095339|NCT02531373|50205392|FG004|Overall Study|Lack of Efficacy|3|||
25095340|NCT02531373|50205393|FG005|Overall Study|Lack of Efficacy|2|||
25095341|NCT02531373|50205394|FG006|Overall Study|Lack of Efficacy|4|||
25095342|NCT02531373|50205395|FG007|Overall Study|Lack of Efficacy|8|||
25095343|NCT02531373|50205396|FG008|Overall Study|Lack of Efficacy|5|||
25095344|NCT02531373|50205388|FG000|Overall Study|Lost to Follow-up|0|||
25095345|NCT02531373|50205389|FG001|Overall Study|Lost to Follow-up|0|||
25095346|NCT02531373|50205390|FG002|Overall Study|Lost to Follow-up|0|||
25095347|NCT02531373|50205391|FG003|Overall Study|Lost to Follow-up|0|||
25095348|NCT02531373|50205392|FG004|Overall Study|Lost to Follow-up|0|||
25095349|NCT02531373|50205393|FG005|Overall Study|Lost to Follow-up|2|||
25095350|NCT02531373|50205394|FG006|Overall Study|Lost to Follow-up|2|||
25095351|NCT02531373|50205395|FG007|Overall Study|Lost to Follow-up|0|||
25095352|NCT02531373|50205396|FG008|Overall Study|Lost to Follow-up|0|||
25095353|NCT02531373|50205388|FG000|Overall Study|Physician Decision|0|||
25095354|NCT02531373|50205389|FG001|Overall Study|Physician Decision|0|||
25095355|NCT02531373|50205390|FG002|Overall Study|Physician Decision|0|||
25095356|NCT02531373|50205391|FG003|Overall Study|Physician Decision|0|||
25095357|NCT02531373|50205392|FG004|Overall Study|Physician Decision|2|||
25095358|NCT02531373|50205393|FG005|Overall Study|Physician Decision|1|||
25095359|NCT02531373|50205394|FG006|Overall Study|Physician Decision|0|||
25095360|NCT02531373|50205395|FG007|Overall Study|Physician Decision|0|||
25095361|NCT02531373|50205396|FG008|Overall Study|Physician Decision|0|||
25095362|NCT02531373|50205388|FG000|Overall Study|Protocol Violation|0|||
25095363|NCT02531373|50205389|FG001|Overall Study|Protocol Violation|0|||
25095364|NCT02531373|50205390|FG002|Overall Study|Protocol Violation|0|||
25095365|NCT02531373|50205391|FG003|Overall Study|Protocol Violation|0|||
25095366|NCT02531373|50205392|FG004|Overall Study|Protocol Violation|0|||
25095367|NCT02531373|50205393|FG005|Overall Study|Protocol Violation|1|||
25095368|NCT02531373|50205394|FG006|Overall Study|Protocol Violation|1|||
25095369|NCT02531373|50205395|FG007|Overall Study|Protocol Violation|0|||
25095370|NCT02531373|50205396|FG008|Overall Study|Protocol Violation|1|||
25095371|NCT02531373|50205388|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
25095372|NCT02531373|50205389|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
25095373|NCT02531373|50205390|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
25095374|NCT02531373|50205391|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
25095375|NCT02531373|50205392|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
25095376|NCT02531373|50205393|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
25095377|NCT02531373|50205394|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
25095378|NCT02531373|50205395|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
25095379|NCT02531373|50205396|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
25095380|NCT02531373|50205388|FG000|Overall Study|Withdrawal by Subject|0|||
25095381|NCT02531373|50205389|FG001|Overall Study|Withdrawal by Subject|0|||
25095382|NCT02531373|50205390|FG002|Overall Study|Withdrawal by Subject|0|||
25095383|NCT02531373|50205391|FG003|Overall Study|Withdrawal by Subject|0|||
25095384|NCT02531373|50205392|FG004|Overall Study|Withdrawal by Subject|3|||
25095385|NCT02531373|50205393|FG005|Overall Study|Withdrawal by Subject|0|||
25095386|NCT02531373|50205394|FG006|Overall Study|Withdrawal by Subject|0|||
25095387|NCT02531373|50205395|FG007|Overall Study|Withdrawal by Subject|0|||
25095388|NCT02531373|50205396|FG008|Overall Study|Withdrawal by Subject|0|||
25095389|NCT02606279|50205419|FG000|Overall Study|Lost to Follow-up|0|||
25095390|NCT02606279|50205420|FG001|Overall Study|Lost to Follow-up|1|||
25095391|NCT02643355|50205434|FG000|Overall Study|Withdrawal by Subject|1|||
25095392|NCT02643355|50205435|FG001|Overall Study|Withdrawal by Subject|3|||
25095393|NCT02643355|50205434|FG000|Overall Study|Protocol Violation|0|||
25095394|NCT02643355|50205435|FG001|Overall Study|Protocol Violation|2|||
25095395|NCT02604017|50205443|FG000|Overall Study|Withdrew Consent|0|||
25095396|NCT02604017|50205444|FG001|Overall Study|Withdrew Consent|2|||
25095397|NCT02604017|50205443|FG000|Overall Study|Lost to Follow-up|5|||
25095398|NCT02604017|50205444|FG001|Overall Study|Lost to Follow-up|6|||
25095399|NCT02604017|50205443|FG000|Overall Study|Other|1|||
25095400|NCT02604017|50205444|FG001|Overall Study|Other|0|||
25095401|NCT02640547|50205450|FG000|Overall Study|Failure to Return|1|||
25095402|NCT02640547|50205450|FG000|Overall Study|Withdrawal by Subject|1|||
25095403|NCT02640547|50205450|FG000|Overall Study|Death|6|||
25095404|NCT02640547|50205450|FG000|Overall Study|Miscellaneous|3|||
25095405|NCT02530905|50205464|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
25095406|NCT02530905|50205465|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
25095407|NCT02530905|50205466|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
25095408|NCT02530671|50205490|FG000|Overall Study|Lost to Follow-up|2|||
25095409|NCT02530671|50205491|FG001|Overall Study|Lost to Follow-up|0|||
25095410|NCT02530671|50205490|FG000|Overall Study|Withdrawal by Subject|1|||
25095411|NCT02530671|50205491|FG001|Overall Study|Withdrawal by Subject|0|||
25095412|NCT02603393|50205499|FG000|Overall Study|Patient/guardian decision|32|||
25095413|NCT02603393|50205500|FG001|Overall Study|Patient/guardian decision|18|||
25095414|NCT02603393|50205499|FG000|Overall Study|Adverse Event|17|||
25095415|NCT02603393|50205500|FG001|Overall Study|Adverse Event|15|||
25095416|NCT02603393|50205499|FG000|Overall Study|Technical problems|4|||
25095417|NCT02603393|50205500|FG001|Overall Study|Technical problems|7|||
25095418|NCT02603393|50205499|FG000|Overall Study|Lack of Efficacy|7|||
25095419|NCT02603393|50205500|FG001|Overall Study|Lack of Efficacy|2|||
25095420|NCT02603393|50205499|FG000|Overall Study|Death|3|||
25095421|NCT02603393|50205500|FG001|Overall Study|Death|4|||
25095422|NCT02603393|50205499|FG000|Overall Study|Physician Decision|3|||
25095423|NCT02603393|50205500|FG001|Overall Study|Physician Decision|3|||
25095424|NCT02603393|50205499|FG000|Overall Study|Protocol deviation|2|||
25095425|NCT02603393|50205500|FG001|Overall Study|Protocol deviation|3|||
25095426|NCT02603393|50205499|FG000|Overall Study|Lost to Follow-up|1|||
25095427|NCT02603393|50205500|FG001|Overall Study|Lost to Follow-up|2|||
25095428|NCT02603393|50205499|FG000|Overall Study|Non-compliance with study treatment|1|||
25095429|NCT02603393|50205500|FG001|Overall Study|Non-compliance with study treatment|0|||
25095430|NCT02603393|50205499|FG000|Overall Study|Sponsor decision|1|||
25095431|NCT02603393|50205500|FG001|Overall Study|Sponsor decision|0|||
25095432|NCT02642653|50205508|FG000|Overall Study|Adverse Event|2|||
25095433|NCT02642653|50205509|FG001|Overall Study|Adverse Event|0|||
25095434|NCT01659567|50205515|FG000|Overall Study|Lack of Efficacy|22|||
25095435|NCT01659567|50205515|FG000|Overall Study|Switched to Pegferon|6|||
25095436|NCT01659567|50205515|FG000|Overall Study|Adverse Event|12|||
25095437|NCT01659567|50205515|FG000|Overall Study|Good result at early stage of treatment|5|||
25095438|NCT01659567|50205515|FG000|Overall Study|Withdrawal by Subject|64|||
25095439|NCT01659567|50205515|FG000|Overall Study|Progression of the main disease|1|||
25095440|NCT01659567|50205515|FG000|Overall Study|Other|13|||
25095441|NCT02605967|50205531|FG000|Overall Study|subject / guardian decision|1|||
25095442|NCT02605967|50205532|FG001|Overall Study|subject / guardian decision|2|||
25095443|NCT02605967|50205531|FG000|Overall Study|Physician Decision|10|||
25095444|NCT02605967|50205532|FG001|Overall Study|Physician Decision|1|||
25095445|NCT02605967|50205531|FG000|Overall Study|Death|4|||
25095446|NCT02605967|50205532|FG001|Overall Study|Death|2|||
25095447|NCT02605967|50205531|FG000|Overall Study|Adverse Event|1|||
25095448|NCT02605967|50205532|FG001|Overall Study|Adverse Event|0|||
25095449|NCT02605967|50205531|FG000|Overall Study|progressive disease|66|||
25095450|NCT02605967|50205532|FG001|Overall Study|progressive disease|35|||
25095451|NCT01668173|50205542|FG000|Overall Study|Adverse Event|3|||
25095452|NCT01668173|50205542|FG000|Overall Study|Trial suspension|4|||
25095453|NCT02600351|50205559|FG000|Overall Study|Lack of Efficacy|3|||
25095454|NCT02600351|50205560|FG001|Overall Study|Lack of Efficacy|0|||
25095455|NCT02600351|50205561|FG002|Overall Study|Lack of Efficacy|5|||
25095456|NCT02600351|50205562|FG003|Overall Study|Lack of Efficacy|2|||
25095457|NCT02600351|50205559|FG000|Overall Study|Lost to Follow-up|1|||
25095458|NCT02600351|50205560|FG001|Overall Study|Lost to Follow-up|0|||
25095459|NCT02600351|50205561|FG002|Overall Study|Lost to Follow-up|0|||
25095460|NCT02600351|50205562|FG003|Overall Study|Lost to Follow-up|0|||
25095461|NCT02600351|50205559|FG000|Overall Study|Randomized but Not Treated|1|||
25095462|NCT02600351|50205560|FG001|Overall Study|Randomized but Not Treated|0|||
25095463|NCT02600351|50205561|FG002|Overall Study|Randomized but Not Treated|1|||
25095464|NCT02600351|50205562|FG003|Overall Study|Randomized but Not Treated|3|||
25095465|NCT02640235|50205576|FG000|Overall Study|Withdrawal by Subject|7|||
25095466|NCT02640235|50205577|FG001|Overall Study|Withdrawal by Subject|6|||
25095467|NCT02640235|50205576|FG000|Overall Study|Lost to Follow-up|4|||
25095468|NCT02640235|50205577|FG001|Overall Study|Lost to Follow-up|3|||
25095469|NCT02640235|50205576|FG000|Overall Study|Death|2|||
25095470|NCT02640235|50205577|FG001|Overall Study|Death|3|||
25095471|NCT02640235|50205576|FG000|Overall Study|Other|1|||
25095472|NCT02640235|50205577|FG001|Overall Study|Other|2|||
25095473|NCT02599961|50205583|FG000|Overall Study|Withdrawal by Subject|1|||
25095474|NCT02599961|50205583|FG000|Overall Study|Subject Non-Compliance|2|||
25095475|NCT02599961|50205583|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
25095476|NCT02599961|50205583|FG000|Overall Study|Other, Not Specified|3|||
25095477|NCT02640157|50205608|FG000|Overall Study|Adverse Event|2|||
25095478|NCT02640157|50205609|FG001|Overall Study|Adverse Event|2|||
25095479|NCT02640157|50205610|FG002|Overall Study|Adverse Event|1|||
25095480|NCT02640157|50205608|FG000|Overall Study|Withdrew consent|2|||
25095481|NCT02640157|50205609|FG001|Overall Study|Withdrew consent|0|||
25095482|NCT02640157|50205610|FG002|Overall Study|Withdrew consent|2|||
25095483|NCT02640157|50205608|FG000|Overall Study|Lost to Follow-up|9|||
25095484|NCT02640157|50205609|FG001|Overall Study|Lost to Follow-up|2|||
25095485|NCT02640157|50205610|FG002|Overall Study|Lost to Follow-up|7|||
25095486|NCT02640157|50205608|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
25095487|NCT02640157|50205609|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
25095488|NCT02640157|50205610|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
25095489|NCT01673347|50205619|FG000|Overall Study|failure of allograft|7|||
25095490|NCT02528253|50205628|FG000|Overall Study|Adverse Event|3|||
25095491|NCT02528253|50205629|FG001|Overall Study|Adverse Event|4|||
25095492|NCT02528253|50205630|FG002|Overall Study|Adverse Event|4|||
25095493|NCT02528253|50205631|FG003|Overall Study|Adverse Event|8|||
25095494|NCT02528253|50205632|FG004|Overall Study|Adverse Event|18|||
25095495|NCT02528253|50205628|FG000|Overall Study|Death|2|||
25095496|NCT02528253|50205629|FG001|Overall Study|Death|2|||
25095497|NCT02528253|50205630|FG002|Overall Study|Death|1|||
25095498|NCT02528253|50205631|FG003|Overall Study|Death|0|||
25095499|NCT02528253|50205632|FG004|Overall Study|Death|1|||
25095500|NCT02528253|50205628|FG000|Overall Study|Insufficient clinical response|7|||
25095501|NCT02528253|50205629|FG001|Overall Study|Insufficient clinical response|10|||
25095502|NCT02528253|50205630|FG002|Overall Study|Insufficient clinical response|13|||
25095503|NCT02528253|50205631|FG003|Overall Study|Insufficient clinical response|12|||
25095504|NCT02528253|50205632|FG004|Overall Study|Insufficient clinical response|16|||
25095505|NCT02528253|50205628|FG000|Overall Study|Lost to Follow-up|16|||
25095506|NCT02528253|50205629|FG001|Overall Study|Lost to Follow-up|9|||
25095507|NCT02528253|50205630|FG002|Overall Study|Lost to Follow-up|31|||
25095508|NCT02528253|50205631|FG003|Overall Study|Lost to Follow-up|16|||
25095509|NCT02528253|50205632|FG004|Overall Study|Lost to Follow-up|34|||
25095510|NCT02528253|50205628|FG000|Overall Study|Other|21|||
25095511|NCT02528253|50205629|FG001|Overall Study|Other|22|||
25095512|NCT02528253|50205630|FG002|Overall Study|Other|58|||
25095513|NCT02528253|50205631|FG003|Overall Study|Other|52|||
25095514|NCT02528253|50205632|FG004|Overall Study|Other|76|||
25095515|NCT02528253|50205628|FG000|Overall Study|Withdrawal by Subject|25|||
25095516|NCT02528253|50205629|FG001|Overall Study|Withdrawal by Subject|20|||
25095517|NCT02528253|50205630|FG002|Overall Study|Withdrawal by Subject|29|||
25095518|NCT02528253|50205631|FG003|Overall Study|Withdrawal by Subject|48|||
25095519|NCT02528253|50205632|FG004|Overall Study|Withdrawal by Subject|73|||
25095520|NCT02528253|50205628|FG000|Overall Study|Protocol Violation|1|||
25095521|NCT02528253|50205629|FG001|Overall Study|Protocol Violation|2|||
25095522|NCT02528253|50205630|FG002|Overall Study|Protocol Violation|4|||
25095523|NCT02528253|50205631|FG003|Overall Study|Protocol Violation|0|||
25095524|NCT02528253|50205632|FG004|Overall Study|Protocol Violation|4|||
25095525|NCT02528253|50205628|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
25095526|NCT02528253|50205629|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
25095527|NCT02528253|50205630|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
25095528|NCT02528253|50205631|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
25095529|NCT02528253|50205632|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
25095530|NCT01672957|50205663|FG000|Overall Study|Protocol Violation|48|||
25095531|NCT01672957|50205663|FG000|Overall Study|Death|2|||
25095532|NCT01672957|50205663|FG000|Overall Study|ICF Signed After Transplantation|5|||
25095533|NCT02525133|50205669|FG000|Overall Study|Adverse Event|0|||
25095534|NCT02525133|50205670|FG001|Overall Study|Adverse Event|1|||
25095535|NCT02525133|50205669|FG000|Overall Study|Death|0|||
25095536|NCT02525133|50205670|FG001|Overall Study|Death|1|||
25095537|NCT02525133|50205669|FG000|Overall Study|did not meet randomization criteria|1|||
25095538|NCT02525133|50205670|FG001|Overall Study|did not meet randomization criteria|0|||
25095539|NCT02525133|50205669|FG000|Overall Study|Lost to Follow-up|5|||
25095540|NCT02525133|50205670|FG001|Overall Study|Lost to Follow-up|1|||
25095541|NCT02525133|50205669|FG000|Overall Study|randomized not enrolled|3|||
25095542|NCT02525133|50205670|FG001|Overall Study|randomized not enrolled|0|||
25095543|NCT02525133|50205669|FG000|Overall Study|Withdrawal by Subject|1|||
25095544|NCT02525133|50205670|FG001|Overall Study|Withdrawal by Subject|0|||
25095545|NCT01659255|50205697|FG000|Overall Study|Adverse Event|0|||
25095546|NCT01659255|50205698|FG001|Overall Study|Adverse Event|0|||
25095547|NCT01659255|50205699|FG002|Overall Study|Adverse Event|0|||
25095548|NCT01659255|50205700|FG003|Overall Study|Adverse Event|0|||
25095549|NCT01659255|50205701|FG004|Overall Study|Adverse Event|0|||
25095550|NCT01659255|50205702|FG005|Overall Study|Adverse Event|1|||
25095551|NCT01659255|50205703|FG006|Overall Study|Adverse Event|1|||
25095552|NCT01659255|50205704|FG007|Overall Study|Adverse Event|0|||
25095553|NCT01659255|50205705|FG008|Overall Study|Adverse Event|0|||
25095554|NCT01659255|50205706|FG009|Overall Study|Adverse Event|1|||
25095555|NCT01659255|50205707|FG010|Overall Study|Adverse Event|0|||
25095556|NCT01659255|50205708|FG011|Overall Study|Adverse Event|1|||
25095557|NCT01659255|50205709|FG012|Overall Study|Adverse Event|0|||
25095558|NCT01659255|50205710|FG013|Overall Study|Adverse Event|2|||
25095559|NCT01659255|50205711|FG014|Overall Study|Adverse Event|0|||
25095560|NCT01659255|50205712|FG015|Overall Study|Adverse Event|1|||
25095561|NCT01659255|50205713|FG016|Overall Study|Adverse Event|0|||
25095562|NCT01659255|50205697|FG000|Overall Study|Death|0|||
25095563|NCT01659255|50205698|FG001|Overall Study|Death|1|||
25095564|NCT01659255|50205699|FG002|Overall Study|Death|0|||
25095565|NCT01659255|50205700|FG003|Overall Study|Death|0|||
25095566|NCT01659255|50205701|FG004|Overall Study|Death|0|||
25095567|NCT01659255|50205702|FG005|Overall Study|Death|0|||
25095568|NCT01659255|50205703|FG006|Overall Study|Death|0|||
25095569|NCT01659255|50205704|FG007|Overall Study|Death|1|||
25095570|NCT01659255|50205705|FG008|Overall Study|Death|1|||
25095571|NCT01659255|50205706|FG009|Overall Study|Death|0|||
25095572|NCT01659255|50205707|FG010|Overall Study|Death|0|||
25095573|NCT01659255|50205708|FG011|Overall Study|Death|0|||
25095574|NCT01659255|50205709|FG012|Overall Study|Death|1|||
25095575|NCT01659255|50205710|FG013|Overall Study|Death|1|||
25095576|NCT01659255|50205711|FG014|Overall Study|Death|2|||
25095577|NCT01659255|50205712|FG015|Overall Study|Death|1|||
25095578|NCT01659255|50205713|FG016|Overall Study|Death|0|||
25095579|NCT01659255|50205697|FG000|Overall Study|Progressive Disease|2|||
25095580|NCT01659255|50205698|FG001|Overall Study|Progressive Disease|0|||
25095581|NCT01659255|50205699|FG002|Overall Study|Progressive Disease|0|||
25095582|NCT01659255|50205700|FG003|Overall Study|Progressive Disease|0|||
25095583|NCT01659255|50205701|FG004|Overall Study|Progressive Disease|0|||
25095584|NCT01659255|50205702|FG005|Overall Study|Progressive Disease|0|||
25095585|NCT01659255|50205703|FG006|Overall Study|Progressive Disease|0|||
25095586|NCT01659255|50205704|FG007|Overall Study|Progressive Disease|1|||
25095587|NCT01659255|50205705|FG008|Overall Study|Progressive Disease|0|||
25095588|NCT01659255|50205706|FG009|Overall Study|Progressive Disease|2|||
25095589|NCT01659255|50205707|FG010|Overall Study|Progressive Disease|2|||
25095590|NCT01659255|50205708|FG011|Overall Study|Progressive Disease|3|||
25095591|NCT01659255|50205709|FG012|Overall Study|Progressive Disease|5|||
25095592|NCT01659255|50205710|FG013|Overall Study|Progressive Disease|13|||
25095593|NCT01659255|50205711|FG014|Overall Study|Progressive Disease|6|||
25095594|NCT01659255|50205712|FG015|Overall Study|Progressive Disease|2|||
25095595|NCT01659255|50205713|FG016|Overall Study|Progressive Disease|3|||
25095596|NCT01659255|50205697|FG000|Overall Study|Withdrew Consent|0|||
25095597|NCT01659255|50205698|FG001|Overall Study|Withdrew Consent|0|||
25095598|NCT01659255|50205699|FG002|Overall Study|Withdrew Consent|0|||
25095599|NCT01659255|50205700|FG003|Overall Study|Withdrew Consent|0|||
25095600|NCT01659255|50205701|FG004|Overall Study|Withdrew Consent|0|||
25095601|NCT01659255|50205702|FG005|Overall Study|Withdrew Consent|0|||
25095602|NCT01659255|50205703|FG006|Overall Study|Withdrew Consent|0|||
25095603|NCT01659255|50205704|FG007|Overall Study|Withdrew Consent|0|||
25095604|NCT01659255|50205705|FG008|Overall Study|Withdrew Consent|0|||
25095605|NCT01659255|50205706|FG009|Overall Study|Withdrew Consent|0|||
25095606|NCT01659255|50205707|FG010|Overall Study|Withdrew Consent|1|||
25095607|NCT01659255|50205708|FG011|Overall Study|Withdrew Consent|0|||
25095608|NCT01659255|50205709|FG012|Overall Study|Withdrew Consent|0|||
25095609|NCT01659255|50205710|FG013|Overall Study|Withdrew Consent|1|||
25095610|NCT01659255|50205711|FG014|Overall Study|Withdrew Consent|0|||
25095611|NCT01659255|50205712|FG015|Overall Study|Withdrew Consent|0|||
25095612|NCT01659255|50205713|FG016|Overall Study|Withdrew Consent|0|||
25095613|NCT01659255|50205697|FG000|Overall Study|Investigator Decision|0|||
25095614|NCT01659255|50205698|FG001|Overall Study|Investigator Decision|0|||
25095615|NCT01659255|50205699|FG002|Overall Study|Investigator Decision|0|||
25095616|NCT01659255|50205700|FG003|Overall Study|Investigator Decision|0|||
25095617|NCT01659255|50205701|FG004|Overall Study|Investigator Decision|0|||
25095618|NCT01659255|50205702|FG005|Overall Study|Investigator Decision|0|||
25095619|NCT01659255|50205703|FG006|Overall Study|Investigator Decision|0|||
25095620|NCT01659255|50205704|FG007|Overall Study|Investigator Decision|0|||
25095621|NCT01659255|50205705|FG008|Overall Study|Investigator Decision|0|||
25095622|NCT01659255|50205706|FG009|Overall Study|Investigator Decision|0|||
25095623|NCT01659255|50205707|FG010|Overall Study|Investigator Decision|0|||
25095624|NCT01659255|50205708|FG011|Overall Study|Investigator Decision|0|||
25095625|NCT01659255|50205709|FG012|Overall Study|Investigator Decision|1|||
25095626|NCT01659255|50205710|FG013|Overall Study|Investigator Decision|1|||
25095627|NCT01659255|50205711|FG014|Overall Study|Investigator Decision|0|||
25095628|NCT01659255|50205712|FG015|Overall Study|Investigator Decision|0|||
25095629|NCT01659255|50205713|FG016|Overall Study|Investigator Decision|0|||
25095630|NCT01659255|50205697|FG000|Overall Study|Sponsor's Decision|0|||
25095631|NCT01659255|50205698|FG001|Overall Study|Sponsor's Decision|0|||
25095632|NCT01659255|50205699|FG002|Overall Study|Sponsor's Decision|0|||
25095633|NCT01659255|50205700|FG003|Overall Study|Sponsor's Decision|0|||
25095634|NCT01659255|50205701|FG004|Overall Study|Sponsor's Decision|0|||
25095635|NCT01659255|50205702|FG005|Overall Study|Sponsor's Decision|0|||
25095636|NCT01659255|50205703|FG006|Overall Study|Sponsor's Decision|1|||
25095637|NCT01659255|50205704|FG007|Overall Study|Sponsor's Decision|0|||
25095638|NCT01659255|50205705|FG008|Overall Study|Sponsor's Decision|0|||
25095639|NCT01659255|50205706|FG009|Overall Study|Sponsor's Decision|0|||
25095640|NCT01659255|50205707|FG010|Overall Study|Sponsor's Decision|0|||
25095641|NCT01659255|50205708|FG011|Overall Study|Sponsor's Decision|0|||
25095642|NCT01659255|50205709|FG012|Overall Study|Sponsor's Decision|0|||
25095643|NCT01659255|50205710|FG013|Overall Study|Sponsor's Decision|0|||
25095644|NCT01659255|50205711|FG014|Overall Study|Sponsor's Decision|0|||
25095645|NCT01659255|50205712|FG015|Overall Study|Sponsor's Decision|0|||
25095646|NCT01659255|50205713|FG016|Overall Study|Sponsor's Decision|0|||
25095647|NCT01659255|50205697|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
25095648|NCT01659255|50205698|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
25095649|NCT01659255|50205699|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
25095650|NCT01659255|50205700|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
25095651|NCT01659255|50205701|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
25095652|NCT01659255|50205702|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
25095653|NCT01659255|50205703|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
25095654|NCT01659255|50205704|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
25095655|NCT01659255|50205705|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
25095656|NCT01659255|50205706|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
25095657|NCT01659255|50205707|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
25095658|NCT01659255|50205708|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
25095659|NCT01659255|50205709|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
25095660|NCT01659255|50205710|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
25095661|NCT01659255|50205711|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
25095662|NCT01659255|50205712|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
25095663|NCT01659255|50205713|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
25095664|NCT01659255|50205697|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
25095665|NCT01659255|50205698|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
25095666|NCT01659255|50205699|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
25095667|NCT01659255|50205700|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
25095668|NCT01659255|50205701|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
25095669|NCT01659255|50205702|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
25095670|NCT01659255|50205703|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
25095671|NCT01659255|50205704|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
25095672|NCT01659255|50205705|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
25095673|NCT01659255|50205706|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
25095674|NCT01659255|50205707|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
25095675|NCT01659255|50205708|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
25095676|NCT01659255|50205709|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
25095677|NCT01659255|50205710|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
25095678|NCT01659255|50205711|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
25095679|NCT01659255|50205712|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
25095680|NCT01659255|50205713|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
25095681|NCT02637037|50205753|FG000|Overall Study|Positive drug screen at admission|1|||
25095682|NCT02637037|50205754|FG001|Overall Study|Positive drug screen at admission|0|||
25095683|NCT02637037|50205753|FG000|Overall Study|Withdrawal by Subject|2|||
25095684|NCT02637037|50205754|FG001|Overall Study|Withdrawal by Subject|1|||
25095685|NCT02637037|50205753|FG000|Overall Study|Adverse Event|1|||
25095686|NCT02637037|50205754|FG001|Overall Study|Adverse Event|0|||
25095687|NCT02637895|50205774|FG000|Overall Study|Lost to Follow-up|4|||
25095688|NCT02637895|50205775|FG001|Overall Study|Lost to Follow-up|0|||
25095689|NCT02637895|50205774|FG000|Overall Study|Protocol Violation|0|||
25095690|NCT02637895|50205775|FG001|Overall Study|Protocol Violation|1|||
25095691|NCT02637895|50205774|FG000|Overall Study|Lack of Efficacy|1|||
25095692|NCT02637895|50205775|FG001|Overall Study|Lack of Efficacy|0|||
25095693|NCT02637895|50205774|FG000|Overall Study|Withdrawal by Subject|1|||
25095694|NCT02637895|50205775|FG001|Overall Study|Withdrawal by Subject|1|||
25095695|NCT02637895|50205774|FG000|Overall Study|Abnormal baseline lab|0|||
25095696|NCT02637895|50205775|FG001|Overall Study|Abnormal baseline lab|1|||
25095697|NCT02522481|50205782|FG000|Overall Study|discontinued|1|||
25095698|NCT02522481|50205782|FG000|Overall Study|Not dosed|2|||
25095699|NCT02522403|50205795|FG000|Overall Study|Lost to Follow-up|2|||
25095700|NCT02522403|50205796|FG001|Overall Study|Lost to Follow-up|2|||
25095701|NCT02522403|50205795|FG000|Overall Study|Withdrawal by Subject|2|||
25095702|NCT02522403|50205796|FG001|Overall Study|Withdrawal by Subject|4|||
25095703|NCT02522325|50205802|FG000|Overall Study|Adverse Event|0|||
25095704|NCT02522325|50205803|FG001|Overall Study|Adverse Event|1|||
25095705|NCT01672879|50205812|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
25095706|NCT01672879|50205813|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
25095707|NCT01672879|50205814|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
25095708|NCT01672879|50205812|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
25095709|NCT01672879|50205813|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
25095710|NCT01672879|50205814|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
25095711|NCT01672879|50205812|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
25095712|NCT01672879|50205813|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
25095713|NCT01672879|50205814|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
25095714|NCT01672879|50205812|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
25095715|NCT01672879|50205813|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
25095716|NCT01672879|50205814|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
25095717|NCT01672879|50205812|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
25095718|NCT01672879|50205813|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
25095719|NCT01672879|50205814|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
25095720|NCT01672879|50205812|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
25095721|NCT01672879|50205813|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
25095722|NCT01672879|50205814|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
25095723|NCT01672879|50205812|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
25095724|NCT01672879|50205813|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
25095725|NCT01672879|50205814|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
25095726|NCT01672879|50205812|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
25095727|NCT01672879|50205813|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
25095728|NCT01672879|50205814|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
25095729|NCT01672879|50205812|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
25095730|NCT01672879|50205813|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
25095731|NCT01672879|50205814|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
25095732|NCT01672879|50205812|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
25095733|NCT01672879|50205813|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
25095734|NCT01672879|50205814|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
25095735|NCT01672879|50205812|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
25095736|NCT01672879|50205813|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
25095737|NCT01672879|50205814|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
25095738|NCT01672879|50205812|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
25095739|NCT01672879|50205813|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
25095740|NCT01672879|50205814|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
25095741|NCT01672879|50205812|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
25095742|NCT01672879|50205813|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
25095743|NCT01672879|50205814|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
25095744|NCT02601209|50205830|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
25095745|NCT02601209|50205831|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
25095746|NCT02601209|50205832|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
25095747|NCT02601209|50205833|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
25095748|NCT02601209|50205834|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
25176974|NCT01505387|50320709|FG000|Overall Study|Withdrawal by Subject|1|||
25176975|NCT01505387|50320710|FG001|Overall Study|Withdrawal by Subject|1|||
25095749|NCT02601209|50205835|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
25176976|NCT01504841|50320798|FG000|Overall Study|Withdrawal by Subject|1|||
25095750|NCT02601209|50205836|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
25095751|NCT02601209|50205837|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
25095752|NCT02601209|50205838|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
25095753|NCT02601209|50205830|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
25095754|NCT02601209|50205831|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
25095755|NCT02601209|50205832|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
25095756|NCT02601209|50205833|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
25095757|NCT02601209|50205834|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
25095758|NCT02601209|50205835|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
25095759|NCT02601209|50205836|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
25095760|NCT02601209|50205837|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
25095761|NCT02601209|50205838|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
25095762|NCT01659021|50205854|FG000|Main Study|Adverse Event|2|||
25095763|NCT01659021|50205855|FG001|Main Study|Adverse Event|3|||
25095764|NCT01659021|50205854|FG000|Main Study|Lost to Follow-up|1|||
25095765|NCT01659021|50205855|FG001|Main Study|Lost to Follow-up|0|||
25095766|NCT01659021|50205854|FG000|Main Study|Unknown Reasons|2|||
25095767|NCT01659021|50205855|FG001|Main Study|Unknown Reasons|1|||
25095768|NCT01659021|50205854|FG000|Main Study|Physician Decision|34|||
25095769|NCT01659021|50205855|FG001|Main Study|Physician Decision|16|||
25095770|NCT01659021|50205854|FG000|Main Study|Withdrawal by Subject|19|||
25095771|NCT01659021|50205855|FG001|Main Study|Withdrawal by Subject|16|||
25095772|NCT01659021|50205854|FG000|Main Study|Study Terminated by Sponsor|16|||
25095773|NCT01659021|50205855|FG001|Main Study|Study Terminated by Sponsor|1|||
25095774|NCT01659021|50205854|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
25095775|NCT01659021|50205855|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
25095776|NCT01659021|50205854|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
25095777|NCT01659021|50205855|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
25095778|NCT02524665|50205865|FG000|Overall Study|Lost to Follow-up|1|||
25095779|NCT02638129|50205872|FG000|Overall Study|Study terminated|28|||
25095780|NCT02638129|50205873|FG001|Overall Study|Study terminated|30|||
25095781|NCT02524275|50205879|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
25095782|NCT01658943|50205885|FG000|Overall Study|Adverse Event|6|||
25095783|NCT01658943|50205886|FG001|Overall Study|Adverse Event|13|||
25095784|NCT01658943|50205885|FG000|Overall Study|Withdrawal by Subject|9|||
25095785|NCT01658943|50205886|FG001|Overall Study|Withdrawal by Subject|2|||
25095786|NCT01658943|50205885|FG000|Overall Study|Progression/Relapse|39|||
25095787|NCT01658943|50205886|FG001|Overall Study|Progression/Relapse|40|||
25095788|NCT01658943|50205885|FG000|Overall Study|Death|4|||
25095789|NCT01658943|50205886|FG001|Overall Study|Death|2|||
25095790|NCT01658943|50205885|FG000|Overall Study|not protocol specified|4|||
25095791|NCT01658943|50205886|FG001|Overall Study|not protocol specified|1|||
25095792|NCT01658943|50205885|FG000|Overall Study|Not eligible|7|||
25095793|NCT01658943|50205886|FG001|Overall Study|Not eligible|9|||
25095794|NCT01658943|50205885|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
25095795|NCT01658943|50205886|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
25095796|NCT02600819|50205892|FG000|GEN Phase|Adverse Event|2|||
25095797|NCT02600819|50205893|FG001|GEN Phase|Adverse Event|0|||
25095798|NCT02600819|50205892|FG000|GEN Phase|Death|2|||
25095799|NCT02600819|50205893|FG001|GEN Phase|Death|0|||
25095800|NCT02600819|50205892|FG000|GEN Phase|Investigator's Discretion|4|||
25095801|NCT02600819|50205893|FG001|GEN Phase|Investigator's Discretion|0|||
25095802|NCT02600819|50205892|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
25095803|NCT02600819|50205893|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
25095804|NCT02600819|50205892|FG000|GEN Phase|Withdrew Consent|5|||
25095805|NCT02600819|50205893|FG001|GEN Phase|Withdrew Consent|0|||
25095806|NCT02600819|50205892|FG000|GEN Phase|Lost to Follow-up|2|||
25095807|NCT02600819|50205893|FG001|GEN Phase|Lost to Follow-up|0|||
25095808|NCT02597933|50205901|FG000|Overall Study|Withdrawal by Subject|7|||
25095809|NCT02597933|50205902|FG001|Overall Study|Withdrawal by Subject|5|||
25095810|NCT02597933|50205901|FG000|Overall Study|Protocol Violation|2|||
25095811|NCT02597933|50205902|FG001|Overall Study|Protocol Violation|2|||
25095812|NCT02597933|50205901|FG000|Overall Study|Adverse Event|20|||
25095813|NCT02597933|50205902|FG001|Overall Study|Adverse Event|28|||
25095814|NCT02597933|50205901|FG000|Overall Study|Not treated|2|||
25095815|NCT02597933|50205902|FG001|Overall Study|Not treated|2|||
25095816|NCT02597933|50205901|FG000|Overall Study|Other than stated above|7|||
25095817|NCT02597933|50205902|FG001|Overall Study|Other than stated above|14|||
25095818|NCT02597855|50205910|FG000|Overall Study|Lost to Follow-up|2|||
25095819|NCT02597855|50205911|FG001|Overall Study|Lost to Follow-up|1|||
25095820|NCT02604407|50205920|FG000|Overall Study|Adverse Event|0|||
25095821|NCT02604407|50205921|FG001|Overall Study|Adverse Event|7|||
25095822|NCT02604407|50205922|FG002|Overall Study|Adverse Event|5|||
25095823|NCT02604407|50205920|FG000|Overall Study|Protocol Violation|2|||
25095824|NCT02604407|50205921|FG001|Overall Study|Protocol Violation|0|||
25095825|NCT02604407|50205922|FG002|Overall Study|Protocol Violation|0|||
25095826|NCT02604407|50205920|FG000|Overall Study|Withdrawal by Subject|3|||
25095827|NCT02604407|50205921|FG001|Overall Study|Withdrawal by Subject|3|||
25095828|NCT02604407|50205922|FG002|Overall Study|Withdrawal by Subject|5|||
25095829|NCT02604407|50205920|FG000|Overall Study|Lost to Follow-up|2|||
25095830|NCT02604407|50205921|FG001|Overall Study|Lost to Follow-up|1|||
25095831|NCT02604407|50205922|FG002|Overall Study|Lost to Follow-up|2|||
25095832|NCT02604407|50205920|FG000|Overall Study|Lack of Efficacy|1|||
25095833|NCT02604407|50205921|FG001|Overall Study|Lack of Efficacy|0|||
25095834|NCT02604407|50205922|FG002|Overall Study|Lack of Efficacy|0|||
25095835|NCT02604407|50205920|FG000|Overall Study|Other|3|||
25095836|NCT02604407|50205921|FG001|Overall Study|Other|1|||
25095837|NCT02604407|50205922|FG002|Overall Study|Other|4|||
25095838|NCT02593097|50205932|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
25095839|NCT02593097|50205933|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
25095840|NCT02593097|50205932|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
25095841|NCT02593097|50205933|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
25095842|NCT02593097|50205932|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
25095843|NCT02593097|50205933|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
25095844|NCT02593097|50205932|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
25095845|NCT02593097|50205933|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
25095846|NCT02593097|50205932|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
25095847|NCT02593097|50205933|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
25095848|NCT01657461|50205941|FG000|Overall Study|Death|9|||
25095849|NCT01657461|50205942|FG001|Overall Study|Death|12|||
25095850|NCT01657461|50205941|FG000|Overall Study|Lost to Follow-up|0|||
25095851|NCT01657461|50205942|FG001|Overall Study|Lost to Follow-up|3|||
25095852|NCT01657461|50205941|FG000|Overall Study|Physician Decision|0|||
25095853|NCT01657461|50205942|FG001|Overall Study|Physician Decision|2|||
25095854|NCT01657461|50205941|FG000|Overall Study|Withdrawal by Subject|1|||
25095855|NCT01657461|50205942|FG001|Overall Study|Withdrawal by Subject|3|||
25095856|NCT02592551|50205951|FG000|Overall Study|Not evaluable|1|||
25095857|NCT02592551|50205952|FG001|Overall Study|Not evaluable|3|||
25095858|NCT02592551|50205953|FG002|Overall Study|Not evaluable|0|||
25095859|NCT02595749|50205964|FG000|Overall Study|Withdrawal by Subject|12|||
25095860|NCT02595749|50205965|FG001|Overall Study|Withdrawal by Subject|7|||
25095861|NCT01657305|50205971|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
25095862|NCT01657305|50205971|FG000|Overall Study|Withdrawal by Subject|4|||
25095863|NCT01657305|50205971|FG000|Overall Study|Adverse Event|1|||
25095864|NCT01657305|50205971|FG000|Overall Study|Lost to Follow-up|1|||
25095865|NCT01657305|50205971|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
25095866|NCT02634307|50206014|FG000|Overall Study|Adverse Event|50|||
25095867|NCT02634307|50206015|FG001|Overall Study|Adverse Event|24|||
25007753|NCT03103152|50100307|FG004|Overall Study|Physician Decision|3|||
25007754|NCT03103152|50100308|FG005|Overall Study|Physician Decision|1|||
25007755|NCT03103152|50100303|FG000|Overall Study|Protocol Violation|2|||
25095868|NCT02634307|50206016|FG002|Overall Study|Adverse Event|14|||
25095869|NCT02634307|50206014|FG000|Overall Study|Lost to Follow-up|21|||
25095870|NCT02634307|50206015|FG001|Overall Study|Lost to Follow-up|5|||
25095871|NCT02634307|50206016|FG002|Overall Study|Lost to Follow-up|6|||
25095872|NCT02634307|50206014|FG000|Overall Study|Pregnancy|5|||
25095873|NCT02634307|50206015|FG001|Overall Study|Pregnancy|1|||
25095874|NCT02634307|50206016|FG002|Overall Study|Pregnancy|3|||
25095875|NCT02634307|50206014|FG000|Overall Study|Withdrawal by Subject|38|||
25095876|NCT02634307|50206015|FG001|Overall Study|Withdrawal by Subject|24|||
25095877|NCT02634307|50206016|FG002|Overall Study|Withdrawal by Subject|18|||
25095878|NCT02634307|50206014|FG000|Overall Study|Non-Compliance with Study Drug|0|||
25095879|NCT02634307|50206015|FG001|Overall Study|Non-Compliance with Study Drug|2|||
25176977|NCT01504841|50320799|FG001|Overall Study|Withdrawal by Subject|1|||
25007756|NCT03103152|50100304|FG001|Overall Study|Protocol Violation|2|||
25007757|NCT03103152|50100305|FG002|Overall Study|Protocol Violation|1|||
25007758|NCT03103152|50100306|FG003|Overall Study|Protocol Violation|2|||
25007759|NCT03103152|50100307|FG004|Overall Study|Protocol Violation|1|||
25007760|NCT03103152|50100308|FG005|Overall Study|Protocol Violation|1|||
25007761|NCT03103152|50100303|FG000|Overall Study|Inter-current illness|0|||
25007762|NCT03103152|50100304|FG001|Overall Study|Inter-current illness|0|||
25007763|NCT03103152|50100305|FG002|Overall Study|Inter-current illness|1|||
25007764|NCT03103152|50100306|FG003|Overall Study|Inter-current illness|0|||
25007765|NCT03103152|50100307|FG004|Overall Study|Inter-current illness|0|||
25095880|NCT02634307|50206016|FG002|Overall Study|Non-Compliance with Study Drug|2|||
25095881|NCT02634307|50206014|FG000|Overall Study|Lack of Efficacy|1|||
25095882|NCT02634307|50206015|FG001|Overall Study|Lack of Efficacy|5|||
25095883|NCT02634307|50206016|FG002|Overall Study|Lack of Efficacy|3|||
25095884|NCT02634307|50206014|FG000|Overall Study|Physician Decision|7|||
25095885|NCT02634307|50206015|FG001|Overall Study|Physician Decision|5|||
25095886|NCT02634307|50206016|FG002|Overall Study|Physician Decision|5|||
25095887|NCT02634307|50206014|FG000|Overall Study|Reason not Specified|3|||
25095888|NCT02634307|50206015|FG001|Overall Study|Reason not Specified|5|||
25095889|NCT02634307|50206016|FG002|Overall Study|Reason not Specified|10|||
25095890|NCT01365273|50206026|FG000|Overall Study|Lost to Follow-up|1|||
25095891|NCT01365273|50206027|FG001|Overall Study|Lost to Follow-up|0|||
25095892|NCT01365273|50206026|FG000|Overall Study|Protocol Violation|0|||
25095893|NCT01365273|50206027|FG001|Overall Study|Protocol Violation|1|||
25095894|NCT01365273|50206026|FG000|Overall Study|Physician Decision|1|||
25095895|NCT01365273|50206027|FG001|Overall Study|Physician Decision|0|||
25095896|NCT02595437|50206033|FG000|Triferic Via IV|Withdrawal by Subject|1|||
25095897|NCT02594735|50206054|FG000|Overall Study|Adverse Event|1|||
25095898|NCT02634151|50206062|FG000|Overall Study|Withdrawal by Subject|1|||
25095899|NCT02634151|50206063|FG001|Overall Study|Withdrawal by Subject|0|||
25095900|NCT02634151|50206062|FG000|Overall Study|Non-Compliance|0|||
25095901|NCT02634151|50206063|FG001|Overall Study|Non-Compliance|1|||
25095902|NCT02634151|50206062|FG000|Overall Study|Other|0|||
25095903|NCT02634151|50206063|FG001|Overall Study|Other|1|||
25095904|NCT01655823|50206074|FG000|Overall Study|Lost to Follow-up|0|||
25095905|NCT01655823|50206075|FG001|Overall Study|Lost to Follow-up|1|||
25095906|NCT01655823|50206076|FG002|Overall Study|Lost to Follow-up|0|||
25095907|NCT01655823|50206077|FG003|Overall Study|Lost to Follow-up|0|||
25095908|NCT01655823|50206078|FG004|Overall Study|Lost to Follow-up|1|||
25095909|NCT01655823|50206074|FG000|Overall Study|Withdrawal by Subject|0|||
25095910|NCT01655823|50206075|FG001|Overall Study|Withdrawal by Subject|1|||
25095911|NCT01655823|50206076|FG002|Overall Study|Withdrawal by Subject|0|||
25095912|NCT01655823|50206077|FG003|Overall Study|Withdrawal by Subject|1|||
25095913|NCT01655823|50206078|FG004|Overall Study|Withdrawal by Subject|0|||
25095914|NCT01360645|50206092|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
25095915|NCT01360645|50206093|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
25095916|NCT01360645|50206094|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
25095917|NCT01360645|50206095|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
25095918|NCT01360645|50206092|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
25095919|NCT01360645|50206093|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
25095920|NCT01360645|50206094|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
25095921|NCT01360645|50206095|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
25095922|NCT01360645|50206092|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
25095923|NCT01360645|50206093|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
25095924|NCT01360645|50206094|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
25095925|NCT01360645|50206095|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
25095926|NCT01360645|50206092|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
25095927|NCT01360645|50206093|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
25095928|NCT01360645|50206094|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
25095929|NCT01360645|50206095|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
25095930|NCT01360645|50206092|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
25095931|NCT01360645|50206093|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
25095932|NCT01360645|50206094|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
25095933|NCT01360645|50206095|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
25095934|NCT01360645|50206092|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
25095935|NCT01360645|50206093|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
25095936|NCT01360645|50206094|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
25095937|NCT01360645|50206095|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
25095938|NCT01360645|50206092|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
25095939|NCT01360645|50206093|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
25095940|NCT01360645|50206094|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
25095941|NCT01360645|50206095|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
25176978|NCT01504841|50320800|FG002|Overall Study|Withdrawal by Subject|0|||
25176979|NCT01502423|50320813|FG000|Overall Study|Withdrawal by Subject|0|||
25176980|NCT01502423|50320814|FG001|Overall Study|Withdrawal by Subject|1|||
25176981|NCT01502033|50320820|FG000|Overall Study|1 participant had scalp discomfort|1|||
25176982|NCT01502033|50320820|FG000|Overall Study|1 participant had worsening depression|1|||
25176983|NCT01502033|50320820|FG000|Overall Study|1 participant went back to school|1|||
25176984|NCT01500629|50320828|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
25176985|NCT01500629|50320829|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
25176986|NCT01500317|50320845|FG000|Overall Study|Withdrawal by Subject|3|||
25176987|NCT01500317|50320846|FG001|Overall Study|Withdrawal by Subject|2|||
25095942|NCT01360645|50206092|FG000|Phase B (6 Weeks)|Adverse Event|0|||
25176988|NCT01500317|50320847|FG002|Overall Study|Withdrawal by Subject|0|||
25176989|NCT01500083|50320902|FG000|Overall Study|Adverse Event|4|||
25176990|NCT01500083|50320903|FG001|Overall Study|Adverse Event|17|||
25095943|NCT01360645|50206093|FG001|Phase B (6 Weeks)|Adverse Event|6|||
25095944|NCT01360645|50206094|FG002|Phase B (6 Weeks)|Adverse Event|0|||
25095945|NCT01360645|50206095|FG003|Phase B (6 Weeks)|Adverse Event|0|||
25095946|NCT01360645|50206092|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
25176991|NCT01500083|50320902|FG000|Overall Study|Death|0|||
25176992|NCT01500083|50320903|FG001|Overall Study|Death|2|||
25176993|NCT01500083|50320902|FG000|Overall Study|Lost to Follow-up|1|||
25176994|NCT01500083|50320903|FG001|Overall Study|Lost to Follow-up|0|||
25007766|NCT03103152|50100308|FG005|Overall Study|Inter-current illness|0|||
25007767|NCT03103152|50100303|FG000|Overall Study|Death|0|||
25007768|NCT03103152|50100304|FG001|Overall Study|Death|1|||
25007769|NCT03103152|50100305|FG002|Overall Study|Death|0|||
25007770|NCT03103152|50100306|FG003|Overall Study|Death|0|||
25007771|NCT03103152|50100307|FG004|Overall Study|Death|0|||
25095947|NCT01360645|50206093|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
25095948|NCT01360645|50206094|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
25095949|NCT01360645|50206095|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
25095950|NCT01360645|50206092|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
25095951|NCT01360645|50206093|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
25095952|NCT01360645|50206094|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
25095953|NCT01360645|50206095|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
25095954|NCT01360645|50206092|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
25095955|NCT01360645|50206093|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
25095956|NCT01360645|50206094|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
25095957|NCT01360645|50206095|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
25095958|NCT01360645|50206092|FG000|Phase A+|Lost to Follow-up|0|||
25095959|NCT01360645|50206093|FG001|Phase A+|Lost to Follow-up|0|||
25095960|NCT01360645|50206094|FG002|Phase A+|Lost to Follow-up|0|||
25095961|NCT01360645|50206095|FG003|Phase A+|Lost to Follow-up|7|||
25095962|NCT01360645|50206092|FG000|Phase A+|Adverse Event|0|||
25095963|NCT01360645|50206093|FG001|Phase A+|Adverse Event|0|||
25095964|NCT01360645|50206094|FG002|Phase A+|Adverse Event|0|||
25095965|NCT01360645|50206095|FG003|Phase A+|Adverse Event|2|||
25095966|NCT01360645|50206092|FG000|Phase A+|Met Withdrawal Criteria|0|||
25095967|NCT01360645|50206093|FG001|Phase A+|Met Withdrawal Criteria|0|||
25095968|NCT01360645|50206094|FG002|Phase A+|Met Withdrawal Criteria|0|||
25095969|NCT01360645|50206095|FG003|Phase A+|Met Withdrawal Criteria|4|||
25095970|NCT01360645|50206092|FG000|Phase A+|Physician Decision|0|||
25095971|NCT01360645|50206093|FG001|Phase A+|Physician Decision|0|||
25095972|NCT01360645|50206094|FG002|Phase A+|Physician Decision|0|||
25095973|NCT01360645|50206095|FG003|Phase A+|Physician Decision|2|||
25095974|NCT01360645|50206092|FG000|Phase A+|Withdrawal by Subject|0|||
25095975|NCT01360645|50206093|FG001|Phase A+|Withdrawal by Subject|0|||
25095976|NCT01360645|50206094|FG002|Phase A+|Withdrawal by Subject|0|||
25095977|NCT01360645|50206095|FG003|Phase A+|Withdrawal by Subject|5|||
25095978|NCT01360645|50206092|FG000|Phase A+|Protocol Deviation|0|||
25095979|NCT01360645|50206093|FG001|Phase A+|Protocol Deviation|0|||
25176995|NCT01500083|50320902|FG000|Overall Study|Withdrawal of Consent|0|||
25176996|NCT01500083|50320903|FG001|Overall Study|Withdrawal of Consent|1|||
25176997|NCT01500083|50320902|FG000|Overall Study|Disease Progression|2|||
25176998|NCT01500083|50320903|FG001|Overall Study|Disease Progression|10|||
25176999|NCT01500083|50320902|FG000|Overall Study|Investigator Discretion|3|||
25177000|NCT01500083|50320903|FG001|Overall Study|Investigator Discretion|8|||
25177001|NCT01500083|50320902|FG000|Overall Study|Other Reasons|2|||
25007772|NCT03103152|50100308|FG005|Overall Study|Death|0|||
25007773|NCT03103152|50100303|FG000|Overall Study|Adverse Event|0|||
25095980|NCT01360645|50206094|FG002|Phase A+|Protocol Deviation|0|||
25095981|NCT01360645|50206095|FG003|Phase A+|Protocol Deviation|4|||
25095982|NCT02633527|50206110|FG000|Overall Study|Failed to meet eligibility|0|||
25095983|NCT02633527|50206111|FG001|Overall Study|Failed to meet eligibility|1|||
25177002|NCT01500083|50320903|FG001|Overall Study|Other Reasons|5|||
25177003|NCT01499849|50320933|FG000|Overall Study|Adverse Event|28|||
25177004|NCT01499849|50320934|FG001|Overall Study|Adverse Event|32|||
25177005|NCT01499849|50320933|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
25177006|NCT01499849|50320934|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
25007774|NCT03103152|50100304|FG001|Overall Study|Adverse Event|0|||
25007775|NCT03103152|50100305|FG002|Overall Study|Adverse Event|1|||
25007776|NCT03103152|50100306|FG003|Overall Study|Adverse Event|0|||
25007777|NCT03103152|50100307|FG004|Overall Study|Adverse Event|0|||
25007778|NCT03103152|50100308|FG005|Overall Study|Adverse Event|1|||
25007779|NCT03103152|50100303|FG000|Overall Study|Withdrawal by Subject|1|||
25007780|NCT03103152|50100304|FG001|Overall Study|Withdrawal by Subject|0|||
25177007|NCT01499849|50320933|FG000|Overall Study|Withdrawal by Subject|43|||
25177008|NCT01499849|50320934|FG001|Overall Study|Withdrawal by Subject|43|||
25177009|NCT01499849|50320933|FG000|Overall Study|Death|5|||
25007781|NCT03103152|50100305|FG002|Overall Study|Withdrawal by Subject|1|||
25095984|NCT02633527|50206112|FG002|Overall Study|Failed to meet eligibility|1|||
25095985|NCT02633527|50206113|FG003|Overall Study|Failed to meet eligibility|0|||
25095986|NCT02633527|50206114|FG004|Overall Study|Failed to meet eligibility|1|||
25095987|NCT02633527|50206110|FG000|Overall Study|Adverse Event|0|||
25095988|NCT02633527|50206111|FG001|Overall Study|Adverse Event|4|||
25095989|NCT02633527|50206112|FG002|Overall Study|Adverse Event|3|||
25095990|NCT02633527|50206113|FG003|Overall Study|Adverse Event|1|||
25095991|NCT02633527|50206114|FG004|Overall Study|Adverse Event|5|||
25095992|NCT02633527|50206110|FG000|Overall Study|Lost to Follow-up|1|||
25095993|NCT02633527|50206111|FG001|Overall Study|Lost to Follow-up|2|||
25095994|NCT02633527|50206112|FG002|Overall Study|Lost to Follow-up|5|||
25095995|NCT02633527|50206113|FG003|Overall Study|Lost to Follow-up|5|||
25095996|NCT02633527|50206114|FG004|Overall Study|Lost to Follow-up|4|||
25095997|NCT02633527|50206110|FG000|Overall Study|Withdrawal by Subject|0|||
25095998|NCT02633527|50206111|FG001|Overall Study|Withdrawal by Subject|3|||
25095999|NCT02633527|50206112|FG002|Overall Study|Withdrawal by Subject|5|||
25096000|NCT02633527|50206113|FG003|Overall Study|Withdrawal by Subject|4|||
25096001|NCT02633527|50206114|FG004|Overall Study|Withdrawal by Subject|4|||
25096002|NCT02633527|50206110|FG000|Overall Study|Protocol Violation|0|||
25096003|NCT02633527|50206111|FG001|Overall Study|Protocol Violation|1|||
25096004|NCT02633527|50206112|FG002|Overall Study|Protocol Violation|1|||
25096005|NCT02633527|50206113|FG003|Overall Study|Protocol Violation|1|||
25096006|NCT02633527|50206114|FG004|Overall Study|Protocol Violation|1|||
25096007|NCT02633527|50206110|FG000|Overall Study|Physician Decision|0|||
25096008|NCT02633527|50206111|FG001|Overall Study|Physician Decision|0|||
25096009|NCT02633527|50206112|FG002|Overall Study|Physician Decision|0|||
25096010|NCT02633527|50206113|FG003|Overall Study|Physician Decision|0|||
25096011|NCT02633527|50206114|FG004|Overall Study|Physician Decision|1|||
25096012|NCT02633527|50206110|FG000|Overall Study|Administrative reason|1|||
25096013|NCT02633527|50206111|FG001|Overall Study|Administrative reason|0|||
25096014|NCT02633527|50206112|FG002|Overall Study|Administrative reason|0|||
25096015|NCT02633527|50206113|FG003|Overall Study|Administrative reason|1|||
25096016|NCT02633527|50206114|FG004|Overall Study|Administrative reason|0|||
25096017|NCT02633527|50206110|FG000|Overall Study|Multiple reasons|1|||
25096018|NCT02633527|50206111|FG001|Overall Study|Multiple reasons|0|||
25096019|NCT02633527|50206112|FG002|Overall Study|Multiple reasons|2|||
25096020|NCT02633527|50206113|FG003|Overall Study|Multiple reasons|2|||
25096021|NCT02633527|50206114|FG004|Overall Study|Multiple reasons|1|||
25096022|NCT01667549|50206131|FG000|Overall Study|Withdrawal by Subject|3|||
25096023|NCT01667549|50206132|FG001|Overall Study|Withdrawal by Subject|5|||
25096024|NCT01667549|50206133|FG002|Overall Study|Withdrawal by Subject|7|||
25096025|NCT01667549|50206134|FG003|Overall Study|Withdrawal by Subject|6|||
25096026|NCT01667549|50206135|FG004|Overall Study|Withdrawal by Subject|1|||
25096027|NCT01672801|50206193|FG000|Overall Study|Screen Failure|0|||
25096028|NCT01672801|50206194|FG001|Overall Study|Screen Failure|1|||
25096029|NCT01655901|50206200|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
25096030|NCT01655901|50206201|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
25096031|NCT01655901|50206202|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
25096032|NCT01655901|50206203|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
25096033|NCT01655901|50206204|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
25096034|NCT01655901|50206205|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
25096035|NCT01656759|50206216|FG000|Overall Study|Protocol Violation|2|||
25096036|NCT01656759|50206217|FG001|Overall Study|Protocol Violation|3|||
25096037|NCT02631577|50206225|FG000|Overall Study|Death|1|||
25096038|NCT02631577|50206226|FG001|Overall Study|Death|7|||
25096039|NCT02631577|50206225|FG000|Overall Study|Withdrawal by Subject|0|||
25096040|NCT02631577|50206226|FG001|Overall Study|Withdrawal by Subject|3|||
25096041|NCT01667081|50206234|FG000|Overall Study|Death|43|||
25096042|NCT01667081|50206235|FG001|Overall Study|Death|3|||
25096043|NCT01667081|50206234|FG000|Overall Study|Lost to Follow-up|99|||
25096044|NCT01667081|50206235|FG001|Overall Study|Lost to Follow-up|48|||
25096045|NCT01667081|50206234|FG000|Overall Study|Physician Decision|16|||
25096046|NCT01667081|50206235|FG001|Overall Study|Physician Decision|2|||
25096047|NCT01667081|50206234|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
25096048|NCT01667081|50206235|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
25096049|NCT01667081|50206234|FG000|Overall Study|Withdrawal by Subject|90|||
25096050|NCT01667081|50206235|FG001|Overall Study|Withdrawal by Subject|35|||
25096051|NCT04545619|50206252|FG000|Overall Study|due to equipment challenges|1|||
25096052|NCT02518971|50206258|FG000|Overall Study|Lost to Follow-up|0|||
25096053|NCT02518971|50206259|FG001|Overall Study|Lost to Follow-up|1|||
25096054|NCT02518971|50206258|FG000|Overall Study|Physician Decision|6|||
25096055|NCT02518971|50206259|FG001|Overall Study|Physician Decision|6|||
25096056|NCT02518971|50206258|FG000|Overall Study|Protocol Violation|6|||
25096057|NCT02518971|50206259|FG001|Overall Study|Protocol Violation|4|||
25096058|NCT02518971|50206258|FG000|Overall Study|Withdrawal by Subject|4|||
25096059|NCT02518971|50206259|FG001|Overall Study|Withdrawal by Subject|5|||
25096060|NCT02518971|50206258|FG000|Overall Study|Side effects|1|||
25096061|NCT02518971|50206259|FG001|Overall Study|Side effects|0|||
25096062|NCT02518971|50206258|FG000|Overall Study|medication lost in mail|0|||
25096063|NCT02518971|50206259|FG001|Overall Study|medication lost in mail|1|||
25096064|NCT02518971|50206258|FG000|Overall Study|eligibility criteria no longer met|6|||
25096065|NCT02518971|50206259|FG001|Overall Study|eligibility criteria no longer met|3|||
25096066|NCT01365039|50206268|FG000|Overall Study|Study related symptoms and complaints|1|||
25096067|NCT01365039|50206269|FG001|Overall Study|Study related symptoms and complaints|0|||
25007782|NCT03103152|50100306|FG003|Overall Study|Withdrawal by Subject|1|||
25007783|NCT03103152|50100307|FG004|Overall Study|Withdrawal by Subject|1|||
25007784|NCT03103152|50100308|FG005|Overall Study|Withdrawal by Subject|1|||
25007785|NCT03103152|50100303|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
25007786|NCT03103152|50100304|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
25007787|NCT03103152|50100305|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
25007788|NCT03103152|50100306|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
25007789|NCT03103152|50100307|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
25007790|NCT03103152|50100308|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
25007791|NCT03103152|50100303|FG000|Overall Study|Unacceptable side effects|0|||
25007792|NCT03103152|50100304|FG001|Overall Study|Unacceptable side effects|0|||
25007793|NCT03103152|50100305|FG002|Overall Study|Unacceptable side effects|0|||
25007794|NCT03103152|50100306|FG003|Overall Study|Unacceptable side effects|0|||
25007795|NCT03103152|50100307|FG004|Overall Study|Unacceptable side effects|0|||
25007796|NCT03103152|50100308|FG005|Overall Study|Unacceptable side effects|1|||
25007797|NCT03103152|50100303|FG000|Overall Study|Lost to Follow-up|0|||
25007798|NCT03103152|50100304|FG001|Overall Study|Lost to Follow-up|1|||
25007799|NCT03103152|50100305|FG002|Overall Study|Lost to Follow-up|0|||
25007800|NCT03103152|50100306|FG003|Overall Study|Lost to Follow-up|1|||
25007801|NCT03103152|50100307|FG004|Overall Study|Lost to Follow-up|0|||
25007802|NCT03103152|50100308|FG005|Overall Study|Lost to Follow-up|1|||
25007803|NCT03103152|50100303|FG000|Overall Study|Testicular pain|0|||
25007804|NCT03103152|50100304|FG001|Overall Study|Testicular pain|0|||
25007805|NCT03103152|50100305|FG002|Overall Study|Testicular pain|0|||
25007806|NCT03103152|50100306|FG003|Overall Study|Testicular pain|1|||
25007807|NCT03103152|50100307|FG004|Overall Study|Testicular pain|0|||
25007808|NCT03103152|50100308|FG005|Overall Study|Testicular pain|0|||
25007809|NCT03033901|50100322|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
25007810|NCT03033901|50100322|FG000|Overall Study|Refused PSG|23|||
25007811|NCT03033901|50100322|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
25007812|NCT03033901|50100322|FG000|Overall Study|Missing Oximetry Data|3|||
25007813|NCT02625324|50100365|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
25007814|NCT02625324|50100365|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
25007815|NCT02625324|50100365|FG000|6-Month Follow-up Subject Accountability|Death|5|||
25007816|NCT02625324|50100365|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
25007817|NCT02625324|50100365|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
25007818|NCT02625324|50100365|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
25007819|NCT02625324|50100365|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
25007820|NCT02625324|50100365|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
25007821|NCT02625324|50100365|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
25007822|NCT02625324|50100365|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
25007823|NCT02625324|50100365|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
25007824|NCT02625324|50100365|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
25007825|NCT02625324|50100365|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
25007826|NCT02625324|50100365|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
25007827|NCT02625324|50100365|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
25007828|NCT02603887|50100377|FG000|Stage 1|Adverse Event|4|||
25007829|NCT02603887|50100377|FG000|Stage 1|Disease progression|1|||
25007830|NCT02603887|50100377|FG000|Stage 2|FDA guidance|1|||
25007831|NCT02475681|50100393|FG000|Overall Study|Death|16|||
25007832|NCT02475681|50100394|FG001|Overall Study|Death|6|||
25007833|NCT02475681|50100395|FG002|Overall Study|Death|9|||
25007834|NCT02475681|50100393|FG000|Overall Study|Physician Decision|0|||
25007835|NCT02475681|50100394|FG001|Overall Study|Physician Decision|3|||
25007836|NCT02475681|50100395|FG002|Overall Study|Physician Decision|1|||
25007837|NCT02475681|50100393|FG000|Overall Study|Withdrawal by Subject|12|||
25007838|NCT02475681|50100394|FG001|Overall Study|Withdrawal by Subject|6|||
25007839|NCT02475681|50100395|FG002|Overall Study|Withdrawal by Subject|9|||
25007840|NCT02475681|50100393|FG000|Overall Study|Lost to Follow-up|2|||
25007841|NCT02475681|50100394|FG001|Overall Study|Lost to Follow-up|1|||
25007842|NCT02475681|50100395|FG002|Overall Study|Lost to Follow-up|3|||
25007843|NCT02475681|50100393|FG000|Overall Study|Ongoing in Study|0|||
25007844|NCT02475681|50100394|FG001|Overall Study|Ongoing in Study|163|||
25007845|NCT02475681|50100395|FG002|Overall Study|Ongoing in Study|157|||
25007846|NCT02475681|50100393|FG000|Overall Study|Reasons other than above listed|2|||
25007847|NCT02475681|50100394|FG001|Overall Study|Reasons other than above listed|0|||
25007848|NCT02475681|50100395|FG002|Overall Study|Reasons other than above listed|0|||
25007849|NCT02315196|50100405|FG000|Overall Study|Withdrew consent|9|||
25007850|NCT02133573|50100411|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
25007851|NCT02133573|50100412|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
25007852|NCT02133573|50100411|FG000|Overall Study|Child Deaths|3|||
25007853|NCT02133573|50100412|FG001|Overall Study|Child Deaths|5|||
25007854|NCT02133573|50100411|FG000|Overall Study|Child Declined Follow Ups|2|||
25007855|NCT02133573|50100412|FG001|Overall Study|Child Declined Follow Ups|1|||
25096068|NCT01364727|50206276|FG000|Overall Study|Not Eligible|2|||
25096069|NCT02633215|50206284|FG000|Overall Study|Lost to Follow-up|2|||
25096070|NCT02633215|50206285|FG001|Overall Study|Lost to Follow-up|3|||
25096071|NCT01364649|50206293|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
25096072|NCT01364649|50206294|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
25096073|NCT01364649|50206293|FG000|Overall Study|Lack of Efficacy|6|||
25096074|NCT01364649|50206294|FG001|Overall Study|Lack of Efficacy|0|||
25096075|NCT01364649|50206293|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
25096076|NCT01364649|50206294|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
25096077|NCT01364649|50206293|FG000|Overall Study|Protocol Deviations|4|||
25177010|NCT01499849|50320934|FG001|Overall Study|Death|7|||
25096078|NCT01364649|50206294|FG001|Overall Study|Protocol Deviations|8|||
25096079|NCT01364649|50206293|FG000|Overall Study|Withdrawal of Consent|9|||
25096080|NCT01364649|50206294|FG001|Overall Study|Withdrawal of Consent|7|||
25096081|NCT01364649|50206293|FG000|Overall Study|Lost to Follow-up|12|||
25096082|NCT01364649|50206294|FG001|Overall Study|Lost to Follow-up|13|||
25096083|NCT01364649|50206293|FG000|Overall Study|Other|4|||
25096084|NCT01364649|50206294|FG001|Overall Study|Other|1|||
25096085|NCT02588261|50206302|FG000|Overall Study|Study Terminated by Sponsor|157|||
25096086|NCT02588261|50206303|FG001|Overall Study|Study Terminated by Sponsor|142|||
25096087|NCT02588261|50206302|FG000|Overall Study|Protocol Deviation|1|||
25096088|NCT02588261|50206303|FG001|Overall Study|Protocol Deviation|0|||
25096089|NCT02588261|50206302|FG000|Overall Study|Death|1|||
25096090|NCT02588261|50206303|FG001|Overall Study|Death|2|||
25096091|NCT02588261|50206302|FG000|Overall Study|Withdrawal by Subject|12|||
25096092|NCT02588261|50206303|FG001|Overall Study|Withdrawal by Subject|8|||
25096093|NCT02588261|50206302|FG000|Overall Study|Noncompliance with Study Drug|0|||
25096094|NCT02588261|50206303|FG001|Overall Study|Noncompliance with Study Drug|1|||
25096095|NCT02588261|50206302|FG000|Overall Study|Miscellaneous|5|||
25096096|NCT02588261|50206303|FG001|Overall Study|Miscellaneous|4|||
25096097|NCT02588261|50206302|FG000|Overall Study|Progressive Disease|61|||
25096098|NCT02588261|50206303|FG001|Overall Study|Progressive Disease|82|||
25096099|NCT02588261|50206302|FG000|Overall Study|Adverse Event|29|||
25096100|NCT02588261|50206303|FG001|Overall Study|Adverse Event|24|||
25096101|NCT02588261|50206302|FG000|Overall Study|Lost to Follow-up|1|||
25096102|NCT02588261|50206303|FG001|Overall Study|Lost to Follow-up|0|||
25096103|NCT01359449|50206311|FG000|Overall Study|Lost to Follow-up|1|||
25096104|NCT01359449|50206312|FG001|Overall Study|Lost to Follow-up|0|||
25096105|NCT01359449|50206311|FG000|Overall Study|Protocol Violation|0|||
25096106|NCT01359449|50206312|FG001|Overall Study|Protocol Violation|2|||
25096107|NCT01359449|50206311|FG000|Overall Study|Withdrawal by Subject|3|||
25096108|NCT01359449|50206312|FG001|Overall Study|Withdrawal by Subject|2|||
25096109|NCT01672723|50206318|FG000|First Intervention|Adverse Event|3|||
25096110|NCT01672723|50206319|FG001|First Intervention|Adverse Event|0|||
25096111|NCT02632747|50206327|FG000|Wash-out Period|Adverse Event|1|||
25096112|NCT02632747|50206328|FG001|Wash-out Period|Adverse Event|0|||
25096113|NCT02520531|50206347|FG000|Overall Study|Revision of study device components|2|||
25096114|NCT02520531|50206348|FG001|Overall Study|Revision of study device components|2|||
25096115|NCT02520531|50206347|FG000|Overall Study|Death|1|||
25096116|NCT02520531|50206348|FG001|Overall Study|Death|2|||
25096117|NCT02520531|50206347|FG000|Overall Study|Lost to Follow-up|1|||
25096118|NCT02520531|50206348|FG001|Overall Study|Lost to Follow-up|1|||
25096119|NCT02520531|50206347|FG000|Overall Study|Meet exclusion criterion|0|||
25096120|NCT02520531|50206348|FG001|Overall Study|Meet exclusion criterion|1|||
25096121|NCT02520531|50206347|FG000|Overall Study|Withdrawal by Subject|1|||
25096122|NCT02520531|50206348|FG001|Overall Study|Withdrawal by Subject|0|||
25096123|NCT02520531|50206347|FG000|Overall Study|Not study device|1|||
25096124|NCT02520531|50206348|FG001|Overall Study|Not study device|0|||
25096125|NCT01671319|50206354|FG000|Overall Study|Withdrawal by Subject|1|||
25096126|NCT01670539|50206358|FG000|Overall Study|Death|3|||
25096127|NCT01670539|50206359|FG001|Overall Study|Death|5|||
25096128|NCT01670539|50206358|FG000|Overall Study|Withdrawal by Subject|3|||
25096129|NCT01670539|50206359|FG001|Overall Study|Withdrawal by Subject|0|||
25096130|NCT02516163|50206366|FG000|Overall Study|Withdrawal by Subject|1|||
25096131|NCT02516163|50206366|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
25096132|NCT02516163|50206366|FG000|Overall Study|Unfit/delay in surgery|3|||
25096133|NCT02516163|50206366|FG000|Overall Study|Use of incorrect measurement technique|5|||
25177011|NCT01499849|50320933|FG000|Overall Study|Disease Progression|11|||
25177012|NCT01499849|50320934|FG001|Overall Study|Disease Progression|10|||
25177013|NCT01499849|50320933|FG000|Overall Study|Protocol Violation|11|||
25096134|NCT02516163|50206366|FG000|Overall Study|Data not recorded|2|||
25096135|NCT02516163|50206366|FG000|Overall Study|MRI contraindication exclusion|6|||
25096136|NCT02589665|50206374|FG000|Induction Period|Did not receive drug|0|||
25096137|NCT02589665|50206375|FG001|Induction Period|Did not receive drug|0|||
25096138|NCT02589665|50206376|FG002|Induction Period|Did not receive drug|0|||
25096139|NCT02589665|50206377|FG003|Induction Period|Did not receive drug|1|||
25096140|NCT02589665|50206378|FG004|Induction Period|Did not receive drug|0|||
25096141|NCT02589665|50206379|FG005|Induction Period|Did not receive drug|0|||
25096142|NCT02589665|50206380|FG006|Induction Period|Did not receive drug|0|||
25096143|NCT02589665|50206381|FG007|Induction Period|Did not receive drug|0|||
25096144|NCT02589665|50206382|FG008|Induction Period|Did not receive drug|0|||
25096145|NCT02589665|50206383|FG009|Induction Period|Did not receive drug|0|||
25096146|NCT02589665|50206374|FG000|Induction Period|Adverse Event|3|||
25096147|NCT02589665|50206375|FG001|Induction Period|Adverse Event|0|||
25096148|NCT02589665|50206376|FG002|Induction Period|Adverse Event|2|||
25096149|NCT02589665|50206377|FG003|Induction Period|Adverse Event|2|||
25096150|NCT02589665|50206378|FG004|Induction Period|Adverse Event|0|||
25096151|NCT02589665|50206379|FG005|Induction Period|Adverse Event|0|||
25096152|NCT02589665|50206380|FG006|Induction Period|Adverse Event|0|||
25096153|NCT02589665|50206381|FG007|Induction Period|Adverse Event|0|||
25096154|NCT02589665|50206382|FG008|Induction Period|Adverse Event|0|||
25096155|NCT02589665|50206383|FG009|Induction Period|Adverse Event|0|||
25096156|NCT02589665|50206374|FG000|Induction Period|Withdrawal by Subject|0|||
25096157|NCT02589665|50206375|FG001|Induction Period|Withdrawal by Subject|1|||
25096158|NCT02589665|50206376|FG002|Induction Period|Withdrawal by Subject|0|||
25096159|NCT02589665|50206377|FG003|Induction Period|Withdrawal by Subject|1|||
25096160|NCT02589665|50206378|FG004|Induction Period|Withdrawal by Subject|0|||
25096161|NCT02589665|50206379|FG005|Induction Period|Withdrawal by Subject|0|||
25096162|NCT02589665|50206380|FG006|Induction Period|Withdrawal by Subject|0|||
25096163|NCT02589665|50206381|FG007|Induction Period|Withdrawal by Subject|0|||
25096164|NCT02589665|50206382|FG008|Induction Period|Withdrawal by Subject|0|||
25096165|NCT02589665|50206383|FG009|Induction Period|Withdrawal by Subject|0|||
25096166|NCT02589665|50206374|FG000|Induction Period|Protocol Violation|0|||
25096167|NCT02589665|50206375|FG001|Induction Period|Protocol Violation|1|||
25096168|NCT02589665|50206376|FG002|Induction Period|Protocol Violation|0|||
25096169|NCT02589665|50206377|FG003|Induction Period|Protocol Violation|0|||
25096170|NCT02589665|50206378|FG004|Induction Period|Protocol Violation|0|||
25096171|NCT02589665|50206379|FG005|Induction Period|Protocol Violation|0|||
25096172|NCT02589665|50206380|FG006|Induction Period|Protocol Violation|0|||
25096173|NCT02589665|50206381|FG007|Induction Period|Protocol Violation|0|||
25096174|NCT02589665|50206382|FG008|Induction Period|Protocol Violation|0|||
25096175|NCT02589665|50206383|FG009|Induction Period|Protocol Violation|0|||
25096176|NCT02589665|50206374|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
25096177|NCT02589665|50206375|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
25096178|NCT02589665|50206376|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
25096179|NCT02589665|50206377|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
25096180|NCT02589665|50206378|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
25096181|NCT02589665|50206379|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
25096182|NCT02589665|50206380|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
25096183|NCT02589665|50206381|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
25096184|NCT02589665|50206382|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
25096185|NCT02589665|50206383|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
25096186|NCT02589665|50206374|FG000|Maintenance Period|Withdrawal by Subject|0|||
25096187|NCT02589665|50206375|FG001|Maintenance Period|Withdrawal by Subject|0|||
25096188|NCT02589665|50206376|FG002|Maintenance Period|Withdrawal by Subject|0|||
25096189|NCT02589665|50206377|FG003|Maintenance Period|Withdrawal by Subject|0|||
25096190|NCT02589665|50206378|FG004|Maintenance Period|Withdrawal by Subject|4|||
25096191|NCT02589665|50206379|FG005|Maintenance Period|Withdrawal by Subject|2|||
25096192|NCT02589665|50206380|FG006|Maintenance Period|Withdrawal by Subject|4|||
25096193|NCT02589665|50206381|FG007|Maintenance Period|Withdrawal by Subject|0|||
25096194|NCT02589665|50206382|FG008|Maintenance Period|Withdrawal by Subject|0|||
25096195|NCT02589665|50206383|FG009|Maintenance Period|Withdrawal by Subject|0|||
25096196|NCT02589665|50206374|FG000|Maintenance Period|Lack of Efficacy|0|||
25096197|NCT02589665|50206375|FG001|Maintenance Period|Lack of Efficacy|0|||
25096198|NCT02589665|50206376|FG002|Maintenance Period|Lack of Efficacy|0|||
25096199|NCT02589665|50206377|FG003|Maintenance Period|Lack of Efficacy|0|||
25096200|NCT02589665|50206378|FG004|Maintenance Period|Lack of Efficacy|2|||
25096201|NCT02589665|50206379|FG005|Maintenance Period|Lack of Efficacy|1|||
25096202|NCT02589665|50206380|FG006|Maintenance Period|Lack of Efficacy|0|||
25096203|NCT02589665|50206381|FG007|Maintenance Period|Lack of Efficacy|0|||
25096204|NCT02589665|50206382|FG008|Maintenance Period|Lack of Efficacy|0|||
25096205|NCT02589665|50206383|FG009|Maintenance Period|Lack of Efficacy|0|||
25096206|NCT02589665|50206374|FG000|Maintenance Period|Adverse Event|0|||
25177014|NCT01499849|50320934|FG001|Overall Study|Protocol Violation|11|||
25096207|NCT02589665|50206375|FG001|Maintenance Period|Adverse Event|0|||
25096208|NCT02589665|50206376|FG002|Maintenance Period|Adverse Event|0|||
25096209|NCT02589665|50206377|FG003|Maintenance Period|Adverse Event|0|||
25096210|NCT02589665|50206378|FG004|Maintenance Period|Adverse Event|0|||
25096211|NCT02589665|50206379|FG005|Maintenance Period|Adverse Event|0|||
25096212|NCT02589665|50206380|FG006|Maintenance Period|Adverse Event|2|||
25096213|NCT02589665|50206381|FG007|Maintenance Period|Adverse Event|0|||
25096214|NCT02589665|50206382|FG008|Maintenance Period|Adverse Event|0|||
25096215|NCT02589665|50206383|FG009|Maintenance Period|Adverse Event|0|||
25096216|NCT02589665|50206374|FG000|Maintenance Period|Lost to Follow-up|0|||
25096217|NCT02589665|50206375|FG001|Maintenance Period|Lost to Follow-up|0|||
25096218|NCT02589665|50206376|FG002|Maintenance Period|Lost to Follow-up|0|||
25096219|NCT02589665|50206377|FG003|Maintenance Period|Lost to Follow-up|0|||
25096220|NCT02589665|50206378|FG004|Maintenance Period|Lost to Follow-up|0|||
25096221|NCT02589665|50206379|FG005|Maintenance Period|Lost to Follow-up|1|||
25096222|NCT02589665|50206380|FG006|Maintenance Period|Lost to Follow-up|0|||
25096223|NCT02589665|50206381|FG007|Maintenance Period|Lost to Follow-up|0|||
25096224|NCT02589665|50206382|FG008|Maintenance Period|Lost to Follow-up|0|||
25096225|NCT02589665|50206383|FG009|Maintenance Period|Lost to Follow-up|0|||
25096226|NCT02589665|50206374|FG000|Maintenance Period|Physician Decision|0|||
25096227|NCT02589665|50206375|FG001|Maintenance Period|Physician Decision|0|||
25096228|NCT02589665|50206376|FG002|Maintenance Period|Physician Decision|0|||
25096229|NCT02589665|50206377|FG003|Maintenance Period|Physician Decision|0|||
25096230|NCT02589665|50206378|FG004|Maintenance Period|Physician Decision|0|||
25096231|NCT02589665|50206379|FG005|Maintenance Period|Physician Decision|1|||
25096232|NCT02589665|50206380|FG006|Maintenance Period|Physician Decision|0|||
25096233|NCT02589665|50206381|FG007|Maintenance Period|Physician Decision|0|||
25096234|NCT02589665|50206382|FG008|Maintenance Period|Physician Decision|0|||
25096235|NCT02589665|50206383|FG009|Maintenance Period|Physician Decision|0|||
25096236|NCT02589665|50206374|FG000|Maintenance Period|Reason Not Collected|0|||
25096237|NCT02589665|50206375|FG001|Maintenance Period|Reason Not Collected|0|||
25096238|NCT02589665|50206376|FG002|Maintenance Period|Reason Not Collected|0|||
25096239|NCT02589665|50206377|FG003|Maintenance Period|Reason Not Collected|0|||
25096240|NCT02589665|50206378|FG004|Maintenance Period|Reason Not Collected|0|||
25096241|NCT02589665|50206379|FG005|Maintenance Period|Reason Not Collected|1|||
25096242|NCT02589665|50206380|FG006|Maintenance Period|Reason Not Collected|1|||
25096243|NCT02589665|50206381|FG007|Maintenance Period|Reason Not Collected|0|||
25096244|NCT02589665|50206382|FG008|Maintenance Period|Reason Not Collected|0|||
25096245|NCT02589665|50206383|FG009|Maintenance Period|Reason Not Collected|0|||
25096246|NCT02589665|50206374|FG000|Induction Extension Period|Adverse Event|0|||
25096247|NCT02589665|50206375|FG001|Induction Extension Period|Adverse Event|0|||
25096248|NCT02589665|50206376|FG002|Induction Extension Period|Adverse Event|0|||
25096249|NCT02589665|50206377|FG003|Induction Extension Period|Adverse Event|0|||
25096250|NCT02589665|50206378|FG004|Induction Extension Period|Adverse Event|0|||
25096251|NCT02589665|50206379|FG005|Induction Extension Period|Adverse Event|0|||
25096252|NCT02589665|50206380|FG006|Induction Extension Period|Adverse Event|0|||
25096253|NCT02589665|50206381|FG007|Induction Extension Period|Adverse Event|0|||
25096254|NCT02589665|50206382|FG008|Induction Extension Period|Adverse Event|4|||
25096255|NCT02589665|50206383|FG009|Induction Extension Period|Adverse Event|0|||
25096256|NCT02589665|50206374|FG000|Induction Extension Period|Lack of Efficacy|0|||
25096257|NCT02589665|50206375|FG001|Induction Extension Period|Lack of Efficacy|0|||
25096258|NCT02589665|50206376|FG002|Induction Extension Period|Lack of Efficacy|0|||
25096259|NCT02589665|50206377|FG003|Induction Extension Period|Lack of Efficacy|0|||
25096260|NCT02589665|50206378|FG004|Induction Extension Period|Lack of Efficacy|0|||
25096261|NCT02589665|50206379|FG005|Induction Extension Period|Lack of Efficacy|0|||
25096262|NCT02589665|50206380|FG006|Induction Extension Period|Lack of Efficacy|0|||
25096263|NCT02589665|50206381|FG007|Induction Extension Period|Lack of Efficacy|0|||
25096264|NCT02589665|50206382|FG008|Induction Extension Period|Lack of Efficacy|3|||
25096265|NCT02589665|50206383|FG009|Induction Extension Period|Lack of Efficacy|0|||
25096266|NCT02589665|50206374|FG000|Induction Extension Period|Withdrawal by Subject|0|||
25096267|NCT02589665|50206375|FG001|Induction Extension Period|Withdrawal by Subject|0|||
25096268|NCT02589665|50206376|FG002|Induction Extension Period|Withdrawal by Subject|0|||
25096269|NCT02589665|50206377|FG003|Induction Extension Period|Withdrawal by Subject|0|||
25096270|NCT02589665|50206378|FG004|Induction Extension Period|Withdrawal by Subject|0|||
25096271|NCT02589665|50206379|FG005|Induction Extension Period|Withdrawal by Subject|0|||
25096272|NCT02589665|50206380|FG006|Induction Extension Period|Withdrawal by Subject|0|||
25096273|NCT02589665|50206381|FG007|Induction Extension Period|Withdrawal by Subject|2|||
25096274|NCT02589665|50206382|FG008|Induction Extension Period|Withdrawal by Subject|3|||
25096275|NCT02589665|50206383|FG009|Induction Extension Period|Withdrawal by Subject|0|||
25096276|NCT02589665|50206374|FG000|Induction Extension Period|Physician Decision|0|||
25096277|NCT02589665|50206375|FG001|Induction Extension Period|Physician Decision|0|||
25096278|NCT02589665|50206376|FG002|Induction Extension Period|Physician Decision|0|||
25096279|NCT02589665|50206377|FG003|Induction Extension Period|Physician Decision|0|||
25096280|NCT02589665|50206378|FG004|Induction Extension Period|Physician Decision|0|||
25096281|NCT02589665|50206379|FG005|Induction Extension Period|Physician Decision|0|||
25096282|NCT02589665|50206380|FG006|Induction Extension Period|Physician Decision|0|||
25096283|NCT02589665|50206381|FG007|Induction Extension Period|Physician Decision|0|||
25096284|NCT02589665|50206382|FG008|Induction Extension Period|Physician Decision|1|||
25096285|NCT02589665|50206383|FG009|Induction Extension Period|Physician Decision|0|||
25096286|NCT02589665|50206374|FG000|Induction Extension Period|Reason Not Collected|0|||
25096287|NCT02589665|50206375|FG001|Induction Extension Period|Reason Not Collected|0|||
25007856|NCT02133573|50100411|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
25007857|NCT02133573|50100412|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
25007858|NCT02059005|50100424|FG000|Overall Study|Death|1|||
25007859|NCT02059005|50100425|FG001|Overall Study|Death|3|||
25007860|NCT02059005|50100424|FG000|Overall Study|Lost to Follow-up|19|||
25007861|NCT02059005|50100425|FG001|Overall Study|Lost to Follow-up|19|||
25007862|NCT02059005|50100424|FG000|Overall Study|Incarceration|0|||
25007863|NCT02059005|50100425|FG001|Overall Study|Incarceration|1|||
25007864|NCT02059005|50100424|FG000|Overall Study|Inpatient|0|||
25007865|NCT02059005|50100425|FG001|Overall Study|Inpatient|1|||
25007866|NCT01393821|50100435|FG000|Overall Study|Cancel|1|||
25007867|NCT01393821|50100436|FG001|Overall Study|Cancel|1|||
25007868|NCT01393821|50100435|FG000|Overall Study|not evaluable for primary endpoint|4|||
25007869|NCT01393821|50100436|FG001|Overall Study|not evaluable for primary endpoint|2|||
25007870|NCT01199575|50100442|FG000|Overall Study|Withdrawal by Subject|5|||
25007871|NCT00496873|50100453|FG000|Overall Study|Ineligible|2|||
25007872|NCT00496873|50100453|FG000|Overall Study|Death|2|||
25007873|NCT00496873|50100453|FG000|Overall Study|Withdrawal by Subject|3|||
25007874|NCT00492778|50100459|FG000|Overall Study|Ineligible by Pathology Review|8|||
25007875|NCT00492778|50100460|FG001|Overall Study|Ineligible by Pathology Review|1|||
25007876|NCT03775681|50100494|FG000|Overall Study|Physician Decision|3|||
25007877|NCT03774823|50100500|FG000|Overall Study|Withdrawal by Subject|1|||
25007878|NCT03774823|50100501|FG001|Overall Study|Withdrawal by Subject|1|||
25007879|NCT03149042|50100507|FG000|Overall Study|Invasive FFR not performed|21|||
25007880|NCT03149042|50100507|FG000|Overall Study|Poor CT Image Quality|1|||
25007881|NCT03149042|50100507|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
25007882|NCT03774433|50100512|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
25007883|NCT03136484|50100518|FG000|Overall Study|Withdrawal by Subject|19|||
25007884|NCT03136484|50100519|FG001|Overall Study|Withdrawal by Subject|14|||
25007885|NCT03136484|50100518|FG000|Overall Study|Lost to Follow-up|7|||
25007886|NCT03136484|50100519|FG001|Overall Study|Lost to Follow-up|8|||
25007887|NCT03136484|50100518|FG000|Overall Study|Death|1|||
25007888|NCT03136484|50100519|FG001|Overall Study|Death|0|||
25007889|NCT03922711|50100528|FG000|Overall Study|Adverse Event|3|||
25007890|NCT03922711|50100529|FG001|Overall Study|Adverse Event|2|||
25007891|NCT03922711|50100530|FG002|Overall Study|Adverse Event|2|||
25007892|NCT03922711|50100528|FG000|Overall Study|Protocol Violation|1|||
25007893|NCT03922711|50100529|FG001|Overall Study|Protocol Violation|0|||
25007894|NCT03922711|50100530|FG002|Overall Study|Protocol Violation|0|||
25007895|NCT03922711|50100528|FG000|Overall Study|Withdrawal by Subject|0|||
25007896|NCT03922711|50100529|FG001|Overall Study|Withdrawal by Subject|3|||
25007897|NCT03922711|50100530|FG002|Overall Study|Withdrawal by Subject|1|||
25007898|NCT03922711|50100528|FG000|Overall Study|Not further specified|0|||
25007899|NCT03922711|50100529|FG001|Overall Study|Not further specified|0|||
25007900|NCT03922711|50100530|FG002|Overall Study|Not further specified|1|||
25007901|NCT02877680|50100539|FG000|Overall Study|Lost to Follow-up|1|||
25007902|NCT02877680|50100540|FG001|Overall Study|Lost to Follow-up|1|||
25007903|NCT03141086|50100552|FG000|Overall Study|Study Terminated By Sponsor|1|||
25007904|NCT03141086|50100553|FG001|Overall Study|Study Terminated By Sponsor|1|||
25007905|NCT03141086|50100552|FG000|Overall Study|Withdrawal by Subject|0|||
25007906|NCT03141086|50100553|FG001|Overall Study|Withdrawal by Subject|1|||
25007907|NCT03141086|50100552|FG000|Overall Study|Protocol Violation|0|||
25007908|NCT03141086|50100553|FG001|Overall Study|Protocol Violation|1|||
25007909|NCT03141086|50100552|FG000|Overall Study|Adverse Event|0|||
25007910|NCT03141086|50100553|FG001|Overall Study|Adverse Event|2|||
25007911|NCT03135548|50100562|FG000|Overall Study|Lost to Follow-up|3|||
25007912|NCT03135548|50100563|FG001|Overall Study|Lost to Follow-up|0|||
25007913|NCT03135548|50100564|FG002|Overall Study|Lost to Follow-up|0|||
25007914|NCT03135548|50100562|FG000|Overall Study|Withdrawal by Subject|2|||
25007915|NCT03135548|50100563|FG001|Overall Study|Withdrawal by Subject|2|||
25007916|NCT03135548|50100564|FG002|Overall Study|Withdrawal by Subject|1|||
25007917|NCT03135548|50100562|FG000|Overall Study|Other than listed|0|||
25007918|NCT03135548|50100563|FG001|Overall Study|Other than listed|2|||
25007919|NCT03135548|50100564|FG002|Overall Study|Other than listed|2|||
25007920|NCT03134222|50100575|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
25007921|NCT03134222|50100576|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
25007922|NCT03134222|50100577|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
25007923|NCT03134222|50100578|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
25007924|NCT03134222|50100579|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
25007925|NCT03134222|50100575|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
25007926|NCT03134222|50100576|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
25177015|NCT01499849|50320933|FG000|Overall Study|Physician Decision|20|||
25007927|NCT03134222|50100577|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
25007928|NCT03134222|50100578|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
25007929|NCT03134222|50100579|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
25007930|NCT03134222|50100575|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
25096288|NCT02589665|50206376|FG002|Induction Extension Period|Reason Not Collected|0|||
25096289|NCT02589665|50206377|FG003|Induction Extension Period|Reason Not Collected|0|||
25096290|NCT02589665|50206378|FG004|Induction Extension Period|Reason Not Collected|0|||
25096291|NCT02589665|50206379|FG005|Induction Extension Period|Reason Not Collected|0|||
25096292|NCT02589665|50206380|FG006|Induction Extension Period|Reason Not Collected|0|||
25096293|NCT02589665|50206381|FG007|Induction Extension Period|Reason Not Collected|0|||
25096294|NCT02589665|50206382|FG008|Induction Extension Period|Reason Not Collected|1|||
25096295|NCT02589665|50206383|FG009|Induction Extension Period|Reason Not Collected|0|||
25096296|NCT02589665|50206374|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
25096297|NCT02589665|50206375|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
25096298|NCT02589665|50206376|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
25096299|NCT02589665|50206377|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
25096300|NCT02589665|50206378|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
25096301|NCT02589665|50206379|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
25096302|NCT02589665|50206380|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
25096303|NCT02589665|50206381|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
25096304|NCT02589665|50206382|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
25096305|NCT02589665|50206383|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
25096306|NCT02589665|50206374|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
25096307|NCT02589665|50206375|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
25096308|NCT02589665|50206376|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
25096309|NCT02589665|50206377|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
25096310|NCT02589665|50206378|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
25096311|NCT02589665|50206379|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
25096312|NCT02589665|50206380|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
25096313|NCT02589665|50206381|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
25096314|NCT02589665|50206382|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
25096315|NCT02589665|50206383|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
25096316|NCT02589665|50206374|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
25096317|NCT02589665|50206375|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
25096318|NCT02589665|50206376|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
25096319|NCT02589665|50206377|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
25096320|NCT02589665|50206378|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
25096321|NCT02589665|50206379|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
25096322|NCT02589665|50206380|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
25096323|NCT02589665|50206381|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
25096324|NCT02589665|50206382|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
25096325|NCT02589665|50206383|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
25096326|NCT02589665|50206374|FG000|Maintenance Extension Period|Adverse Event|0|||
25096327|NCT02589665|50206375|FG001|Maintenance Extension Period|Adverse Event|0|||
25096328|NCT02589665|50206376|FG002|Maintenance Extension Period|Adverse Event|0|||
25096329|NCT02589665|50206377|FG003|Maintenance Extension Period|Adverse Event|0|||
25096330|NCT02589665|50206378|FG004|Maintenance Extension Period|Adverse Event|0|||
25096331|NCT02589665|50206379|FG005|Maintenance Extension Period|Adverse Event|0|||
25096332|NCT02589665|50206380|FG006|Maintenance Extension Period|Adverse Event|0|||
25096333|NCT02589665|50206381|FG007|Maintenance Extension Period|Adverse Event|0|||
25096334|NCT02589665|50206382|FG008|Maintenance Extension Period|Adverse Event|0|||
25096335|NCT02589665|50206383|FG009|Maintenance Extension Period|Adverse Event|2|||
25096336|NCT02589665|50206374|FG000|Maintenance Extension Period|Non-responder|0|||
25096337|NCT02589665|50206375|FG001|Maintenance Extension Period|Non-responder|0|||
25096338|NCT02589665|50206376|FG002|Maintenance Extension Period|Non-responder|0|||
25096339|NCT02589665|50206377|FG003|Maintenance Extension Period|Non-responder|0|||
25096340|NCT02589665|50206378|FG004|Maintenance Extension Period|Non-responder|0|||
25096341|NCT02589665|50206379|FG005|Maintenance Extension Period|Non-responder|0|||
25096342|NCT02589665|50206380|FG006|Maintenance Extension Period|Non-responder|0|||
25096343|NCT02589665|50206381|FG007|Maintenance Extension Period|Non-responder|0|||
25096344|NCT02589665|50206382|FG008|Maintenance Extension Period|Non-responder|0|||
25096345|NCT02589665|50206383|FG009|Maintenance Extension Period|Non-responder|1|||
25096346|NCT01905397|50206409|FG000|Overall Study|Death|0|||
25096347|NCT01905397|50206410|FG001|Overall Study|Death|1|||
25096348|NCT01905397|50206409|FG000|Overall Study|Withdrawal by Subject|2|||
25096349|NCT01905397|50206410|FG001|Overall Study|Withdrawal by Subject|0|||
25096350|NCT01905397|50206409|FG000|Overall Study|Surgery canceled/aborted|9|||
25096351|NCT01905397|50206410|FG001|Overall Study|Surgery canceled/aborted|5|||
25096352|NCT01905397|50206409|FG000|Overall Study|Incision < 7 cm|2|||
25096353|NCT01905397|50206410|FG001|Overall Study|Incision < 7 cm|0|||
25096354|NCT01905397|50206409|FG000|Overall Study|Wrong treatment|1|||
25177016|NCT01499849|50320934|FG001|Overall Study|Physician Decision|19|||
25177017|NCT01499849|50320933|FG000|Overall Study|Lack of Efficacy|3|||
25096355|NCT01905397|50206410|FG001|Overall Study|Wrong treatment|1|||
25096356|NCT01905397|50206409|FG000|Overall Study|Device not applied|3|||
25007931|NCT03134222|50100576|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
25007932|NCT03134222|50100577|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
25007933|NCT03134222|50100578|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
25007934|NCT03134222|50100579|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
25007935|NCT03134222|50100575|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
25007936|NCT03134222|50100576|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
25007937|NCT03134222|50100577|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
25007938|NCT03134222|50100578|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
25007939|NCT03134222|50100579|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
25007940|NCT03134222|50100575|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
25007941|NCT03134222|50100576|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
25007942|NCT03134222|50100577|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
25007943|NCT03134222|50100578|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
25007944|NCT03134222|50100579|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
25007945|NCT03134222|50100575|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
25007946|NCT03134222|50100576|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
25007947|NCT03134222|50100577|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
25007948|NCT03134222|50100578|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
25007949|NCT03134222|50100579|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
25007950|NCT03134222|50100575|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
25007951|NCT03134222|50100576|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
25007952|NCT03134222|50100577|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
25007953|NCT03134222|50100578|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
25007954|NCT03134222|50100579|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
25007955|NCT03134222|50100575|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
25007956|NCT03134222|50100576|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
25007957|NCT03134222|50100577|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
25007958|NCT03134222|50100578|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
25007959|NCT03134222|50100579|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
25007960|NCT03769753|50100589|FG000|Overall Study|Not Treated|6|||
25007961|NCT03769753|50100589|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
25007962|NCT03263923|50100604|FG000|Overall Study|Withdrawal by Subject|10|||
25007963|NCT03263923|50100605|FG001|Overall Study|Withdrawal by Subject|8|||
25007964|NCT03263923|50100604|FG000|Overall Study|Lost to Follow-up|15|||
25007965|NCT03263923|50100605|FG001|Overall Study|Lost to Follow-up|13|||
25007966|NCT03139604|50100615|FG000|Overall Study|Other|7|||
25007967|NCT03139604|50100616|FG001|Overall Study|Other|3|||
25007968|NCT03139604|50100615|FG000|Overall Study|Withdrawal by Subject|16|||
25007969|NCT03139604|50100616|FG001|Overall Study|Withdrawal by Subject|17|||
25007970|NCT03139604|50100615|FG000|Overall Study|Physician Decision|1|||
25007971|NCT03139604|50100616|FG001|Overall Study|Physician Decision|2|||
25007972|NCT03139604|50100615|FG000|Overall Study|Lost to Follow-up|3|||
25007973|NCT03139604|50100616|FG001|Overall Study|Lost to Follow-up|1|||
25007974|NCT03139604|50100615|FG000|Overall Study|Death|65|||
25007975|NCT03139604|50100616|FG001|Overall Study|Death|67|||
25007976|NCT03139604|50100615|FG000|Overall Study|Study Terminated by Sponsor|122|||
25007977|NCT03139604|50100616|FG001|Overall Study|Study Terminated by Sponsor|127|||
25007978|NCT03139604|50100615|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
25007979|NCT03139604|50100616|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
25007980|NCT03139448|50100625|FG000|Overall Study|Lack of Efficacy|6|||
25007981|NCT03139448|50100626|FG001|Overall Study|Lack of Efficacy|7|||
25007982|NCT03139448|50100625|FG000|Overall Study|Location of procedure changed|2|||
25007983|NCT03139448|50100626|FG001|Overall Study|Location of procedure changed|8|||
25007984|NCT03139448|50100625|FG000|Overall Study|Withdrawal by Subject|3|||
25007985|NCT03139448|50100626|FG001|Overall Study|Withdrawal by Subject|6|||
25007986|NCT03139448|50100625|FG000|Overall Study|Screen fail|1|||
25007987|NCT03139448|50100626|FG001|Overall Study|Screen fail|3|||
25007988|NCT03139448|50100625|FG000|Overall Study|Physician Decision|0|||
25007989|NCT03139448|50100626|FG001|Overall Study|Physician Decision|2|||
25007990|NCT02875340|50100632|FG000|Overall Study|Death|2|||
25007991|NCT02875340|50100632|FG000|Overall Study|Withdrawal by Subject|2|||
25007992|NCT02875340|50100632|FG000|Overall Study|Physician Decision|3|||
25096357|NCT01905397|50206410|FG001|Overall Study|Device not applied|0|||
25007993|NCT02875340|50100632|FG000|Overall Study|Adverse Event|1|||
25007994|NCT03237325|50100644|FG000|Overall Study|Lost to Follow-up|3|||
25007995|NCT03237325|50100645|FG001|Overall Study|Lost to Follow-up|5|||
25007996|NCT03237325|50100644|FG000|Overall Study|Physician Decision|2|||
25007997|NCT03237325|50100645|FG001|Overall Study|Physician Decision|4|||
25007998|NCT03237325|50100644|FG000|Overall Study|Withdrawal by Subject|9|||
25177018|NCT01499849|50320934|FG001|Overall Study|Lack of Efficacy|4|||
25096358|NCT01905397|50206409|FG000|Overall Study|Dressing not applied in operating room|1|||
25096359|NCT01905397|50206410|FG001|Overall Study|Dressing not applied in operating room|0|||
25096360|NCT01905397|50206409|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
25096361|NCT01905397|50206410|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
25096362|NCT01362595|50206416|FG000|Overall Study|Screen failure|10|||
25096363|NCT01362595|50206416|FG000|Overall Study|Withdrawal by Subject|2|||
25096364|NCT02519595|50206423|FG000|Overall Study|Protocol Violation|8|||
25096365|NCT02519595|50206424|FG001|Overall Study|Protocol Violation|22|||
25096366|NCT02519595|50206425|FG002|Overall Study|Protocol Violation|16|||
25096367|NCT00660673|50206437|FG000|Overall Study|Adverse Event|84|||
25096368|NCT00660673|50206437|FG000|Overall Study|Lack of Efficacy|7|||
25096369|NCT00660673|50206437|FG000|Overall Study|Withdrawal by Subject|22|||
25096370|NCT00660673|50206437|FG000|Overall Study|Administrative|2|||
25096371|NCT00660673|50206437|FG000|Overall Study|Protocol Violation|2|||
25096372|NCT02630563|50206452|FG000|Overall Study|Administrative|1|||
25096373|NCT02588339|50206466|FG000|Overall Study|Withdrawal by Subject|1|||
25096374|NCT02588339|50206466|FG000|Overall Study|GVHD Progression prior to treatment|2|||
25096375|NCT02629159|50206473|FG000|Overall Study|Adverse Event|17|||
25096376|NCT02629159|50206474|FG001|Overall Study|Adverse Event|20|||
25096377|NCT02629159|50206475|FG002|Overall Study|Adverse Event|22|||
25096378|NCT02629159|50206473|FG000|Overall Study|Withdrawal by Subject|22|||
25096379|NCT02629159|50206474|FG001|Overall Study|Withdrawal by Subject|11|||
25096380|NCT02629159|50206475|FG002|Overall Study|Withdrawal by Subject|15|||
25096381|NCT02629159|50206473|FG000|Overall Study|Lost to Follow-up|7|||
25096382|NCT02629159|50206474|FG001|Overall Study|Lost to Follow-up|4|||
25096383|NCT02629159|50206475|FG002|Overall Study|Lost to Follow-up|5|||
25096384|NCT02629159|50206473|FG000|Overall Study|Lack of Efficacy|4|||
25096385|NCT02629159|50206474|FG001|Overall Study|Lack of Efficacy|0|||
25096386|NCT02629159|50206475|FG002|Overall Study|Lack of Efficacy|1|||
25096387|NCT02629159|50206473|FG000|Overall Study|Other|6|||
25096388|NCT02629159|50206474|FG001|Overall Study|Other|4|||
25096389|NCT02629159|50206475|FG002|Overall Study|Other|8|||
25096390|NCT02628769|50206486|FG000|First Intervention|Adverse Event|1|||
25096391|NCT02628769|50206487|FG001|First Intervention|Adverse Event|0|||
25096392|NCT02628769|50206486|FG000|First Intervention|Withdrawal by Subject|0|||
25096393|NCT02628769|50206487|FG001|First Intervention|Withdrawal by Subject|1|||
25096394|NCT02628769|50206486|FG000|Second Intervention|Adverse Event|2|||
25096395|NCT02628769|50206487|FG001|Second Intervention|Adverse Event|0|||
25096396|NCT02628769|50206486|FG000|Second Intervention|Physician Decision|0|||
25096397|NCT02628769|50206487|FG001|Second Intervention|Physician Decision|1|||
25096398|NCT02626819|50206495|FG000|Overall Study|Lost to Follow-up|3|||
25096399|NCT02626819|50206496|FG001|Overall Study|Lost to Follow-up|2|||
25096400|NCT02626819|50206495|FG000|Overall Study|Withdrawal by Subject|1|||
25096401|NCT02626819|50206496|FG001|Overall Study|Withdrawal by Subject|0|||
25096402|NCT02626819|50206495|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
25096403|NCT02626819|50206496|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
25096404|NCT02630251|50206506|FG000|Overall Study|Physician Decision|0|||
25096405|NCT02630251|50206507|FG001|Overall Study|Physician Decision|0|||
25096406|NCT02630251|50206508|FG002|Overall Study|Physician Decision|1|||
25096407|NCT02630251|50206509|FG003|Overall Study|Physician Decision|0|||
25096408|NCT02518113|50206523|FG000|Overall Study|Adverse Event|1|||
25096409|NCT02518113|50206524|FG001|Overall Study|Adverse Event|0|||
25096410|NCT02518113|50206525|FG002|Overall Study|Adverse Event|1|||
25096411|NCT02518113|50206526|FG003|Overall Study|Adverse Event|0|||
25096412|NCT02518113|50206523|FG000|Overall Study|Death|1|||
25096413|NCT02518113|50206524|FG001|Overall Study|Death|2|||
25096414|NCT02518113|50206525|FG002|Overall Study|Death|0|||
25096415|NCT02518113|50206526|FG003|Overall Study|Death|0|||
25096416|NCT02518113|50206523|FG000|Overall Study|Physician Decision|0|||
25096417|NCT02518113|50206524|FG001|Overall Study|Physician Decision|1|||
25096418|NCT02518113|50206525|FG002|Overall Study|Physician Decision|0|||
25096419|NCT02518113|50206526|FG003|Overall Study|Physician Decision|0|||
25096420|NCT02518113|50206523|FG000|Overall Study|Progressive Disease|1|||
25096421|NCT02518113|50206524|FG001|Overall Study|Progressive Disease|2|||
25096422|NCT02518113|50206525|FG002|Overall Study|Progressive Disease|3|||
25096423|NCT02518113|50206526|FG003|Overall Study|Progressive Disease|0|||
25096424|NCT02629861|50206542|FG000|Overall Study|Adverse Event|7|||
25096425|NCT02629861|50206543|FG001|Overall Study|Adverse Event|5|||
25096426|NCT02629861|50206544|FG002|Overall Study|Adverse Event|4|||
25096427|NCT02629861|50206542|FG000|Overall Study|Withdrawal by Subject|5|||
25096428|NCT02629861|50206543|FG001|Overall Study|Withdrawal by Subject|8|||
25096429|NCT02629861|50206544|FG002|Overall Study|Withdrawal by Subject|13|||
25096430|NCT02629861|50206542|FG000|Overall Study|Protocol Violation|2|||
25177019|NCT01499849|50320933|FG000|Overall Study|Lost to Follow-up|6|||
25096431|NCT02629861|50206543|FG001|Overall Study|Protocol Violation|3|||
25096432|NCT02629861|50206544|FG002|Overall Study|Protocol Violation|7|||
25096433|NCT02629861|50206542|FG000|Overall Study|Lost to Follow-up|12|||
25096434|NCT02629861|50206543|FG001|Overall Study|Lost to Follow-up|9|||
25096435|NCT02629861|50206544|FG002|Overall Study|Lost to Follow-up|4|||
25096436|NCT02629861|50206542|FG000|Overall Study|Other|1|||
25096437|NCT02629861|50206543|FG001|Overall Study|Other|1|||
25096438|NCT02629861|50206544|FG002|Overall Study|Other|0|||
25096439|NCT02629861|50206542|FG000|Overall Study|Pregnancy|2|||
25096440|NCT02629861|50206543|FG001|Overall Study|Pregnancy|1|||
25096441|NCT02629861|50206544|FG002|Overall Study|Pregnancy|0|||
25096442|NCT02482935|50206552|FG000|Period 1|Withdrawal by Subject|1|||
25096443|NCT02482935|50206553|FG001|Period 1|Withdrawal by Subject|0|||
25096444|NCT02513823|50206559|FG000|Overall Study|Lost to Follow-up|4|||
25096445|NCT02513823|50206559|FG000|Overall Study|Physician Decision|1|||
25096446|NCT02513745|50206565|FG000|Overall Study|Criteria at time of surgery not met.|3|||
25096447|NCT02513745|50206566|FG001|Overall Study|Criteria at time of surgery not met.|3|||
25096448|NCT02512965|50206574|FG000|Overall Study|Withdrawal by Subject|0|||
25096449|NCT02512965|50206575|FG001|Overall Study|Withdrawal by Subject|4|||
25096450|NCT02477553|50206583|FG000|Overall Study|Screening up-to-date|12|||
25096451|NCT02477553|50206584|FG001|Overall Study|Screening up-to-date|13|||
25096452|NCT02477553|50206583|FG000|Overall Study|No MD visit|1|||
25096453|NCT02477553|50206584|FG001|Overall Study|No MD visit|1|||
25096454|NCT02477553|50206583|FG000|Overall Study|Workup consistent w/CRC|1|||
25096455|NCT02477553|50206584|FG001|Overall Study|Workup consistent w/CRC|1|||
25096456|NCT02477553|50206583|FG000|Overall Study|Technical issues with intervention|2|||
25096457|NCT02477553|50206584|FG001|Overall Study|Technical issues with intervention|0|||
25096458|NCT02477553|50206583|FG000|Overall Study|Elevated risk for CRC|2|||
25096459|NCT02477553|50206584|FG001|Overall Study|Elevated risk for CRC|2|||
25096460|NCT02477553|50206583|FG000|Overall Study|MD advised against screening|1|||
25096461|NCT02477553|50206584|FG001|Overall Study|MD advised against screening|3|||
25096462|NCT02477553|50206583|FG000|Overall Study|patient deceased|1|||
25096463|NCT02477553|50206584|FG001|Overall Study|patient deceased|0|||
25096464|NCT01665911|50206590|FG000|Overall Study|Protocol Violation|4|||
25096465|NCT01665911|50206590|FG000|Overall Study|Withdrawal by Subject|1|||
25096466|NCT01665911|50206590|FG000|Overall Study|Adverse Event|1|||
25096467|NCT02452359|50206595|FG000|Overall Study|Adverse Event|1|||
25096468|NCT02452359|50206595|FG000|Overall Study|Lost to Follow-up|15|||
25096469|NCT02452359|50206595|FG000|Overall Study|Pregnancy|1|||
25096470|NCT02452359|50206595|FG000|Overall Study|Withdrawal by Subject|4|||
25096471|NCT02476617|50206599|FG000|Overall Study|Adverse Event|1|||
25096472|NCT02476617|50206599|FG000|Overall Study|Lost to Follow-up|1|||
25096473|NCT01665599|50206616|FG000|Overall Study|Adverse Event|1|||
25096474|NCT01665599|50206616|FG000|Overall Study|Consent Withdrawn|1|||
25096475|NCT01665599|50206616|FG000|Overall Study|Investigator/Sponsor decision|1|||
25096476|NCT01665599|50206616|FG000|Overall Study|Death|1|||
25096477|NCT01665599|50206616|FG000|Overall Study|Lost to Follow-up|2|||
25096478|NCT01665599|50206616|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
25096479|NCT01665599|50206616|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
25096480|NCT01671085|50206622|FG000|Overall Study|Withdrawal by Subject|1|||
25096481|NCT01671085|50206623|FG001|Overall Study|Withdrawal by Subject|0|||
25096482|NCT02510001|50206638|FG000|Overall Study|Early disease progression|0|||
25096483|NCT02510001|50206639|FG001|Overall Study|Early disease progression|0|||
25096484|NCT02510001|50206640|FG002|Overall Study|Early disease progression|0|||
25096485|NCT02510001|50206641|FG003|Overall Study|Early disease progression|1|||
25096486|NCT02510001|50206642|FG004|Overall Study|Early disease progression|1|||
25096487|NCT02510001|50206643|FG005|Overall Study|Early disease progression|1|||
25096488|NCT02510001|50206644|FG006|Overall Study|Early disease progression|0|||
25096489|NCT02510001|50206645|FG007|Overall Study|Early disease progression|0|||
25096490|NCT02510001|50206638|FG000|Overall Study|Adverse Event|0|||
25096491|NCT02510001|50206639|FG001|Overall Study|Adverse Event|0|||
25096492|NCT02510001|50206640|FG002|Overall Study|Adverse Event|0|||
25096493|NCT02510001|50206641|FG003|Overall Study|Adverse Event|1|||
25096494|NCT02510001|50206642|FG004|Overall Study|Adverse Event|2|||
25096495|NCT02510001|50206643|FG005|Overall Study|Adverse Event|1|||
25096496|NCT02510001|50206644|FG006|Overall Study|Adverse Event|2|||
25096497|NCT02510001|50206645|FG007|Overall Study|Adverse Event|5|||
25096498|NCT02510001|50206638|FG000|Overall Study|Physician Decision|0|||
25096499|NCT02510001|50206639|FG001|Overall Study|Physician Decision|0|||
25096500|NCT02510001|50206640|FG002|Overall Study|Physician Decision|0|||
25096501|NCT02510001|50206641|FG003|Overall Study|Physician Decision|0|||
25096502|NCT02510001|50206642|FG004|Overall Study|Physician Decision|1|||
25096503|NCT02510001|50206643|FG005|Overall Study|Physician Decision|0|||
25096504|NCT02510001|50206644|FG006|Overall Study|Physician Decision|0|||
25096505|NCT02510001|50206645|FG007|Overall Study|Physician Decision|0|||
25096506|NCT02510001|50206638|FG000|Overall Study|Withdrawal by Subject|0|||
25096507|NCT02510001|50206639|FG001|Overall Study|Withdrawal by Subject|0|||
25096508|NCT02510001|50206640|FG002|Overall Study|Withdrawal by Subject|0|||
25096509|NCT02510001|50206641|FG003|Overall Study|Withdrawal by Subject|0|||
25096510|NCT02510001|50206642|FG004|Overall Study|Withdrawal by Subject|0|||
25096511|NCT02510001|50206643|FG005|Overall Study|Withdrawal by Subject|0|||
25096512|NCT02510001|50206644|FG006|Overall Study|Withdrawal by Subject|0|||
25096513|NCT02510001|50206645|FG007|Overall Study|Withdrawal by Subject|2|||
25096514|NCT02452047|50206684|FG000|Overall Study|Adverse Event|0|||
25096515|NCT02452047|50206685|FG001|Overall Study|Adverse Event|1|||
25096516|NCT02452047|50206686|FG002|Overall Study|Adverse Event|1|||
25096517|NCT02452047|50206684|FG000|Overall Study|Death|1|||
25096518|NCT02452047|50206685|FG001|Overall Study|Death|3|||
25096519|NCT02452047|50206686|FG002|Overall Study|Death|1|||
25096520|NCT02452047|50206684|FG000|Overall Study|Physician Decision|1|||
25096521|NCT02452047|50206685|FG001|Overall Study|Physician Decision|0|||
25096522|NCT02452047|50206686|FG002|Overall Study|Physician Decision|0|||
25096523|NCT02452047|50206684|FG000|Overall Study|Lost to Follow-up|1|||
25096524|NCT02452047|50206685|FG001|Overall Study|Lost to Follow-up|1|||
25096525|NCT02452047|50206686|FG002|Overall Study|Lost to Follow-up|0|||
25096526|NCT02452047|50206684|FG000|Overall Study|Withdrawal by Subject|1|||
25096527|NCT02452047|50206685|FG001|Overall Study|Withdrawal by Subject|0|||
25096528|NCT02452047|50206686|FG002|Overall Study|Withdrawal by Subject|0|||
25096529|NCT02475369|50206694|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
25096530|NCT02475369|50206695|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
25096531|NCT02474589|50206708|FG000|Overall Study|Adverse Event|6|||
25096532|NCT02474589|50206709|FG001|Overall Study|Adverse Event|2|||
25096533|NCT02474589|50206708|FG000|Overall Study|Lost to Follow-up|6|||
25096534|NCT02474589|50206709|FG001|Overall Study|Lost to Follow-up|1|||
25096535|NCT02474589|50206708|FG000|Overall Study|Protocol Violation|4|||
25096536|NCT02474589|50206709|FG001|Overall Study|Protocol Violation|1|||
25096537|NCT02474589|50206708|FG000|Overall Study|Withdrawal by Subject|4|||
25096538|NCT02474589|50206709|FG001|Overall Study|Withdrawal by Subject|0|||
25096539|NCT02474589|50206708|FG000|Overall Study|Inability to complete study procedures|5|||
25096540|NCT02474589|50206709|FG001|Overall Study|Inability to complete study procedures|1|||
25096541|NCT02586233|50206722|FG000|Overall Study|Randomized but did not receive treatment|0|||
25096542|NCT02586233|50206723|FG001|Overall Study|Randomized but did not receive treatment|1|||
25096543|NCT02586233|50206724|FG002|Overall Study|Randomized but did not receive treatment|0|||
25096544|NCT02586233|50206725|FG003|Overall Study|Randomized but did not receive treatment|0|||
25096545|NCT02586233|50206726|FG004|Overall Study|Randomized but did not receive treatment|0|||
25096546|NCT02586233|50206727|FG005|Overall Study|Randomized but did not receive treatment|2|||
25096547|NCT02586233|50206728|FG006|Overall Study|Randomized but did not receive treatment|2|||
25096548|NCT02586233|50206722|FG000|Overall Study|Death|0|||
25096549|NCT02586233|50206723|FG001|Overall Study|Death|1|||
25096550|NCT02586233|50206724|FG002|Overall Study|Death|0|||
25096551|NCT02586233|50206725|FG003|Overall Study|Death|0|||
25096552|NCT02586233|50206726|FG004|Overall Study|Death|2|||
25096553|NCT02586233|50206727|FG005|Overall Study|Death|0|||
25096554|NCT02586233|50206728|FG006|Overall Study|Death|0|||
25096555|NCT02474355|50206748|FG000|Overall Study|Other|43|||
25096556|NCT02474355|50206748|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
25096557|NCT02474355|50206748|FG000|Overall Study|Lost to Follow-up|98|||
25096558|NCT02474355|50206748|FG000|Overall Study|Withdrawal by Subject|124|||
25096559|NCT02474355|50206748|FG000|Overall Study|Death|1361|||
25096560|NCT02474199|50206754|FG000|Overall Study|Lost to Follow-up|1|||
25096561|NCT02474199|50206755|FG001|Overall Study|Lost to Follow-up|0|||
25096562|NCT02474199|50206756|FG002|Overall Study|Lost to Follow-up|0|||
25096563|NCT02474199|50206757|FG003|Overall Study|Lost to Follow-up|0|||
25096564|NCT02474199|50206754|FG000|Overall Study|Withdrawal by Subject|1|||
25096565|NCT02474199|50206755|FG001|Overall Study|Withdrawal by Subject|2|||
25096566|NCT02474199|50206756|FG002|Overall Study|Withdrawal by Subject|0|||
25096567|NCT02474199|50206757|FG003|Overall Study|Withdrawal by Subject|1|||
25096568|NCT02474199|50206754|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
25096569|NCT02474199|50206755|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
25096570|NCT02474199|50206756|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
25096571|NCT02474199|50206757|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
25096572|NCT02474199|50206754|FG000|Overall Study|Did not meet eligibility criteria|0|||
25096573|NCT02474199|50206755|FG001|Overall Study|Did not meet eligibility criteria|0|||
25096574|NCT02474199|50206756|FG002|Overall Study|Did not meet eligibility criteria|2|||
25096575|NCT02474199|50206757|FG003|Overall Study|Did not meet eligibility criteria|2|||
25096576|NCT02450487|50206764|FG000|Overall Study|Lost to Follow-up|3|||
25096577|NCT02473965|50206771|FG000|Overall Study|Adverse Event|6|||
25096578|NCT02473965|50206772|FG001|Overall Study|Adverse Event|4|||
25096579|NCT02473965|50206771|FG000|Overall Study|MG worsening|4|||
25096580|NCT02473965|50206772|FG001|Overall Study|MG worsening|1|||
25177020|NCT01499849|50320934|FG001|Overall Study|Lost to Follow-up|3|||
25177021|NCT01499849|50320933|FG000|Overall Study|Other Reasons|27|||
25096581|NCT02473965|50206771|FG000|Overall Study|Withdrawal by Subject|2|||
25096582|NCT02473965|50206772|FG001|Overall Study|Withdrawal by Subject|3|||
25096583|NCT02473965|50206771|FG000|Overall Study|Physician Decision|0|||
25096584|NCT02473965|50206772|FG001|Overall Study|Physician Decision|2|||
25096585|NCT02472795|50206783|FG000|Overall Study|Adverse Event|0|||
25096586|NCT02472795|50206784|FG001|Overall Study|Adverse Event|1|||
25096587|NCT02472795|50206785|FG002|Overall Study|Adverse Event|0|||
25096588|NCT02472795|50206786|FG003|Overall Study|Adverse Event|0|||
25096589|NCT02472795|50206787|FG004|Overall Study|Adverse Event|2|||
25096590|NCT02472795|50206783|FG000|Overall Study|Withdrawal by Subject|0|||
25096591|NCT02472795|50206784|FG001|Overall Study|Withdrawal by Subject|0|||
25096592|NCT02472795|50206785|FG002|Overall Study|Withdrawal by Subject|0|||
25096593|NCT02472795|50206786|FG003|Overall Study|Withdrawal by Subject|0|||
25096594|NCT02472795|50206787|FG004|Overall Study|Withdrawal by Subject|1|||
25096595|NCT02507349|50206801|FG000|Overall Study|Death|12|||
25096596|NCT02507349|50206802|FG001|Overall Study|Death|16|||
25096597|NCT02507349|50206801|FG000|Overall Study|Withdrawal by Subject|1|||
25096598|NCT02507349|50206802|FG001|Overall Study|Withdrawal by Subject|1|||
25096599|NCT02507349|50206801|FG000|Overall Study|Lost to Follow-up|174|||
25096600|NCT02507349|50206802|FG001|Overall Study|Lost to Follow-up|144|||
25096601|NCT02506881|50206812|FG000|First Intervention (Day 1)|Protocol Violation|0|||
25096602|NCT02506881|50206813|FG001|First Intervention (Day 1)|Protocol Violation|0|||
25096603|NCT02506881|50206814|FG002|First Intervention (Day 1)|Protocol Violation|1|||
25096604|NCT02506881|50206815|FG003|First Intervention (Day 1)|Protocol Violation|0|||
25096605|NCT02506881|50206812|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
25096606|NCT02506881|50206813|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
25096607|NCT02506881|50206814|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
25096608|NCT02506881|50206815|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
25096609|NCT02506881|50206812|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
25096610|NCT02506881|50206813|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
25096611|NCT02506881|50206814|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
25096612|NCT02506881|50206815|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
25096613|NCT02506257|50206839|FG000|Overall Study|Adverse Event|0|||
25096614|NCT02506257|50206840|FG001|Overall Study|Adverse Event|2|||
25096615|NCT02506257|50206841|FG002|Overall Study|Adverse Event|3|||
25096616|NCT02506257|50206842|FG003|Overall Study|Adverse Event|0|||
25096617|NCT02506257|50206839|FG000|Overall Study|Protocol Violation|0|||
25096618|NCT02506257|50206840|FG001|Overall Study|Protocol Violation|0|||
25096619|NCT02506257|50206841|FG002|Overall Study|Protocol Violation|1|||
25096620|NCT02506257|50206842|FG003|Overall Study|Protocol Violation|0|||
25096621|NCT02506101|50206854|FG000|Overall Study|Transportation issues|1|||
25096622|NCT02506101|50206855|FG001|Overall Study|Transportation issues|0|||
25096623|NCT02506101|50206854|FG000|Overall Study|No enrollment and staff unavailability|1|||
25096624|NCT02506101|50206855|FG001|Overall Study|No enrollment and staff unavailability|0|||
25096625|NCT01671007|50206870|FG000|Overall Study|Other reasons than listed|166|||
25096626|NCT01671007|50206871|FG001|Overall Study|Other reasons than listed|373|||
25096627|NCT01671007|50206872|FG002|Overall Study|Other reasons than listed|197|||
25096628|NCT01671007|50206873|FG003|Overall Study|Other reasons than listed|228|||
25096629|NCT01671007|50206874|FG004|Overall Study|Other reasons than listed|14|||
25096630|NCT01671007|50206875|FG005|Overall Study|Other reasons than listed|71|||
25096631|NCT01671007|50206876|FG006|Overall Study|Other reasons than listed|17|||
25096632|NCT01671007|50206877|FG007|Overall Study|Other reasons than listed|66|||
25096633|NCT01671007|50206878|FG008|Overall Study|Other reasons than listed|0|||
25096634|NCT01671007|50206870|FG000|Overall Study|Withdrawal by Subject|36|||
25096635|NCT01671007|50206871|FG001|Overall Study|Withdrawal by Subject|59|||
25096636|NCT01671007|50206872|FG002|Overall Study|Withdrawal by Subject|53|||
25096637|NCT01671007|50206873|FG003|Overall Study|Withdrawal by Subject|58|||
25096638|NCT01671007|50206874|FG004|Overall Study|Withdrawal by Subject|4|||
25096639|NCT01671007|50206875|FG005|Overall Study|Withdrawal by Subject|15|||
25096640|NCT01671007|50206876|FG006|Overall Study|Withdrawal by Subject|1|||
25096641|NCT01671007|50206877|FG007|Overall Study|Withdrawal by Subject|19|||
25096642|NCT01671007|50206878|FG008|Overall Study|Withdrawal by Subject|0|||
25096643|NCT01671007|50206870|FG000|Overall Study|Lost to Follow-up|93|||
25096644|NCT01671007|50206871|FG001|Overall Study|Lost to Follow-up|142|||
25096645|NCT01671007|50206872|FG002|Overall Study|Lost to Follow-up|91|||
25096646|NCT01671007|50206873|FG003|Overall Study|Lost to Follow-up|63|||
25096647|NCT01671007|50206874|FG004|Overall Study|Lost to Follow-up|7|||
25096648|NCT01671007|50206875|FG005|Overall Study|Lost to Follow-up|20|||
25096649|NCT01671007|50206876|FG006|Overall Study|Lost to Follow-up|2|||
25096650|NCT01671007|50206877|FG007|Overall Study|Lost to Follow-up|28|||
25096651|NCT01671007|50206878|FG008|Overall Study|Lost to Follow-up|0|||
25096652|NCT01671007|50206870|FG000|Overall Study|No end of study case report form|3|||
25096653|NCT01671007|50206871|FG001|Overall Study|No end of study case report form|1|||
25096654|NCT01671007|50206872|FG002|Overall Study|No end of study case report form|0|||
25096655|NCT01671007|50206873|FG003|Overall Study|No end of study case report form|2|||
25096656|NCT01671007|50206874|FG004|Overall Study|No end of study case report form|0|||
25096657|NCT01671007|50206875|FG005|Overall Study|No end of study case report form|0|||
25096658|NCT01671007|50206876|FG006|Overall Study|No end of study case report form|0|||
25096659|NCT01671007|50206877|FG007|Overall Study|No end of study case report form|0|||
25096660|NCT01671007|50206878|FG008|Overall Study|No end of study case report form|0|||
25096661|NCT01671007|50206870|FG000|Overall Study|Not eligible|23|||
25096662|NCT01671007|50206871|FG001|Overall Study|Not eligible|76|||
25096663|NCT01671007|50206872|FG002|Overall Study|Not eligible|25|||
25096664|NCT01671007|50206873|FG003|Overall Study|Not eligible|17|||
25096665|NCT01671007|50206874|FG004|Overall Study|Not eligible|0|||
25096666|NCT01671007|50206875|FG005|Overall Study|Not eligible|6|||
25096667|NCT01671007|50206876|FG006|Overall Study|Not eligible|1|||
25096668|NCT01671007|50206877|FG007|Overall Study|Not eligible|19|||
25096669|NCT01671007|50206878|FG008|Overall Study|Not eligible|0|||
25096670|NCT02505945|50206891|FG000|Overall Study|Withdrawal by Subject|13|||
25096671|NCT02505945|50206892|FG001|Overall Study|Withdrawal by Subject|2|||
25096672|NCT02505945|50206891|FG000|Overall Study|Adverse Event|1|||
25096673|NCT02505945|50206892|FG001|Overall Study|Adverse Event|0|||
25096674|NCT02505945|50206891|FG000|Overall Study|Physician Decision|2|||
25096675|NCT02505945|50206892|FG001|Overall Study|Physician Decision|1|||
25096676|NCT02505945|50206891|FG000|Overall Study|Lost to Follow-up|6|||
25096677|NCT02505945|50206892|FG001|Overall Study|Lost to Follow-up|1|||
25096678|NCT02505867|50206900|FG000|Overall Study|Lack of Efficacy|6|||
25096679|NCT02505867|50206901|FG001|Overall Study|Lack of Efficacy|6|||
25096680|NCT02472639|50206909|FG000|Overall Study|Physician Decision|4|||
25096681|NCT02472639|50206910|FG001|Overall Study|Physician Decision|3|||
25096682|NCT02472405|50206916|FG000|Overall Study|Lost to Follow-up|9|||
25096683|NCT02472405|50206916|FG000|Overall Study|Adverse Event|1|||
25096684|NCT02448771|50206922|FG000|Overall Study|Disease Progression|30|||
25096685|NCT02448771|50206922|FG000|Overall Study|Unacceptable Toxicity|1|||
25096686|NCT02448771|50206922|FG000|Overall Study|Physician Decision|3|||
25096687|NCT02448771|50206922|FG000|Overall Study|Started new therapy|2|||
25096688|NCT02504541|50206927|FG000|Overall Study|Adverse Event|4|||
25096689|NCT02504541|50206927|FG000|Overall Study|Withdrawal by Subject|4|||
25096690|NCT02504541|50206927|FG000|Overall Study|Lost to Follow-up|1|||
25096691|NCT02504541|50206927|FG000|Overall Study|Met Stopping Criteria|1|||
25096692|NCT02504541|50206927|FG000|Overall Study|Protocol Violation|2|||
25096693|NCT02504541|50206927|FG000|Overall Study|Termination by Sponsor|1|||
25096694|NCT02504541|50206927|FG000|Overall Study|Other|2|||
25096695|NCT02504541|50206927|FG000|Overall Study|Multiple|5|||
25096696|NCT02725177|50206931|FG000|Overall Study|Physician Decision|4|||
25096697|NCT02725177|50206931|FG000|Overall Study|Adverse Event|1|||
25096698|NCT02448537|50206938|FG000|Overall Study|Withdrawal by Subject|1|||
25096699|NCT02448537|50206939|FG001|Overall Study|Withdrawal by Subject|1|||
25096700|NCT02448537|50206940|FG002|Overall Study|Withdrawal by Subject|1|||
25096701|NCT02504151|50206950|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
25096702|NCT02504151|50206951|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
25096703|NCT02504151|50206950|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
25096704|NCT02504151|50206951|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
25096705|NCT02504151|50206950|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
25096706|NCT02504151|50206951|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
25096707|NCT02504151|50206950|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
25096708|NCT02504151|50206951|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
25096709|NCT02448381|50206959|FG000|Overall Study|Adverse Event|2|||
25096710|NCT02448381|50206960|FG001|Overall Study|Adverse Event|0|||
25096711|NCT02448381|50206959|FG000|Overall Study|Lost to Follow-up|16|||
25096712|NCT02448381|50206960|FG001|Overall Study|Lost to Follow-up|9|||
25096713|NCT02448381|50206959|FG000|Overall Study|Physician Decision|1|||
25096714|NCT02448381|50206960|FG001|Overall Study|Physician Decision|1|||
25096715|NCT02448381|50206959|FG000|Overall Study|Pregnancy|1|||
25096716|NCT02448381|50206960|FG001|Overall Study|Pregnancy|0|||
25096717|NCT02448381|50206959|FG000|Overall Study|Withdrawal by Subject|13|||
25096718|NCT02448381|50206960|FG001|Overall Study|Withdrawal by Subject|9|||
25096719|NCT02448381|50206959|FG000|Overall Study|Noncompliance with Study Procedures|2|||
25096720|NCT02448381|50206960|FG001|Overall Study|Noncompliance with Study Procedures|0|||
25096721|NCT02448225|50206972|FG000|Overall Study|Withdrawal by Subject|1|||
25096722|NCT02448225|50206972|FG000|Overall Study|Did not get FSPG scan|18|||
25096723|NCT02448225|50206972|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
25096724|NCT02503215|50206979|FG000|Overall Study|Unable to wear compression stockings|1|||
25096725|NCT02503215|50206979|FG000|Overall Study|Unable to use positive airway pressure|2|||
25096726|NCT02447991|50206985|FG000|Overall Study|Withdrawn by subject - no data|0|||
25096727|NCT02447991|50206986|FG001|Overall Study|Withdrawn by subject - no data|2|||
25096728|NCT02447991|50206985|FG000|Overall Study|Withdrawn by Subject - with data|4|||
25096729|NCT02447991|50206986|FG001|Overall Study|Withdrawn by Subject - with data|4|||
25096730|NCT02447991|50206985|FG000|Overall Study|Lost to Follow-up - no data|3|||
25096731|NCT02447991|50206986|FG001|Overall Study|Lost to Follow-up - no data|6|||
25096732|NCT02447991|50206985|FG000|Overall Study|Lost to follow-up - with data|0|||
25096733|NCT02447991|50206986|FG001|Overall Study|Lost to follow-up - with data|3|||
25096734|NCT02447991|50206985|FG000|Overall Study|End of study - no treatment results|3|||
25096735|NCT02447991|50206986|FG001|Overall Study|End of study - no treatment results|6|||
25096736|NCT02447991|50206985|FG000|Overall Study|End of study - partial treatment results|0|||
25096737|NCT02447991|50206986|FG001|Overall Study|End of study - partial treatment results|9|||
25096738|NCT02586155|50206998|FG000|Overall Study|Adverse Event|2|||
25096739|NCT02586155|50206999|FG001|Overall Study|Adverse Event|3|||
25096740|NCT02586155|50206998|FG000|Overall Study|Withdrawal by Subject|31|||
25096741|NCT02586155|50206999|FG001|Overall Study|Withdrawal by Subject|24|||
25096742|NCT02586155|50206998|FG000|Overall Study|Lost to Follow-up|7|||
25096743|NCT02586155|50206999|FG001|Overall Study|Lost to Follow-up|13|||
25096744|NCT02586155|50206998|FG000|Overall Study|Death|61|||
25096745|NCT02586155|50206999|FG001|Overall Study|Death|72|||
25096746|NCT02586155|50206998|FG000|Overall Study|Other reasons|26|||
25096747|NCT02586155|50206999|FG001|Overall Study|Other reasons|15|||
25096748|NCT02446743|50207007|FG000|Overall Study|Withdrawal by Subject|1|||
25096749|NCT02446743|50207008|FG001|Overall Study|Withdrawal by Subject|1|||
25096750|NCT02446743|50207007|FG000|Overall Study|Lost to Follow-up|1|||
25096751|NCT02446743|50207008|FG001|Overall Study|Lost to Follow-up|0|||
25096752|NCT02446743|50207007|FG000|Overall Study|Adverse Event|1|||
25096753|NCT02446743|50207008|FG001|Overall Study|Adverse Event|1|||
25096754|NCT02446743|50207007|FG000|Overall Study|Other|2|||
25096755|NCT02446743|50207008|FG001|Overall Study|Other|3|||
25096756|NCT02586077|50207023|FG000|Overall Study|Withdrawal by Subject|1|||
25096757|NCT02586077|50207023|FG000|Overall Study|Physician Decision|4|||
25096758|NCT02586077|50207023|FG000|Overall Study|Lost to Follow-up|3|||
25096759|NCT02583425|50207028|FG000|Screening|Did not meet entry criteria|12|||
25096760|NCT02583425|50207028|FG000|Baseline|Did not meet continued criteria|5|||
25096761|NCT02583425|50207028|FG000|Treatment Period|Adverse Event|1|||
25096762|NCT02581163|50207033|FG000|Overall Study|Failure to return|15|||
25096763|NCT02581163|50207033|FG000|Overall Study|Insufficient virological response|3|||
25096764|NCT02581163|50207033|FG000|Overall Study|Withdrew consent|1|||
25096765|NCT02581163|50207033|FG000|Overall Study|Death|1|||
25096766|NCT02581163|50207033|FG000|Overall Study|Other, not specified|9|||
25096767|NCT02627677|50207043|FG000|Overall Study|Adverse event (not progressive disease)|1|||
25096768|NCT02627677|50207044|FG001|Overall Study|Adverse event (not progressive disease)|4|||
25096769|NCT02627677|50207045|FG002|Overall Study|Adverse event (not progressive disease)|1|||
25096770|NCT02627677|50207043|FG000|Overall Study|Progressive disease|1|||
25096771|NCT02627677|50207044|FG001|Overall Study|Progressive disease|3|||
25096772|NCT02627677|50207045|FG002|Overall Study|Progressive disease|0|||
25096773|NCT02627677|50207043|FG000|Overall Study|Lack of Efficacy|1|||
25096774|NCT02627677|50207044|FG001|Overall Study|Lack of Efficacy|2|||
25096775|NCT02627677|50207045|FG002|Overall Study|Lack of Efficacy|0|||
25096776|NCT02627677|50207043|FG000|Overall Study|Lost to Follow-up|0|||
25096777|NCT02627677|50207044|FG001|Overall Study|Lost to Follow-up|0|||
25096778|NCT02627677|50207045|FG002|Overall Study|Lost to Follow-up|1|||
25096779|NCT02627677|50207043|FG000|Overall Study|Pregnancy|0|||
25096780|NCT02627677|50207044|FG001|Overall Study|Pregnancy|1|||
25096781|NCT02627677|50207045|FG002|Overall Study|Pregnancy|0|||
25096782|NCT02627677|50207043|FG000|Overall Study|Study Terminated by Sponsor|5|||
25096783|NCT02627677|50207044|FG001|Overall Study|Study Terminated by Sponsor|10|||
25096784|NCT02627677|50207045|FG002|Overall Study|Study Terminated by Sponsor|6|||
25096785|NCT02627677|50207043|FG000|Overall Study|Physician Decision|0|||
25096786|NCT02627677|50207044|FG001|Overall Study|Physician Decision|0|||
25096787|NCT02627677|50207045|FG002|Overall Study|Physician Decision|2|||
25096788|NCT02627677|50207043|FG000|Overall Study|Withdrawal by Subject|2|||
25096789|NCT02627677|50207044|FG001|Overall Study|Withdrawal by Subject|1|||
25096790|NCT02627677|50207045|FG002|Overall Study|Withdrawal by Subject|1|||
25096791|NCT02627677|50207043|FG000|Overall Study|Reason not Specified|0|||
25096792|NCT02627677|50207044|FG001|Overall Study|Reason not Specified|0|||
25096793|NCT02627677|50207045|FG002|Overall Study|Reason not Specified|1|||
25096794|NCT02627677|50207043|FG000|Overall Study|Randomized but not Treated|1|||
25096795|NCT02627677|50207044|FG001|Overall Study|Randomized but not Treated|0|||
25096796|NCT02627677|50207045|FG002|Overall Study|Randomized but not Treated|0|||
25096797|NCT02501811|50207058|FG000|Overall Study|Death|1|||
25096798|NCT02501811|50207059|FG001|Overall Study|Death|3|||
25096799|NCT02501811|50207060|FG002|Overall Study|Death|2|||
25096800|NCT02501811|50207061|FG003|Overall Study|Death|3|||
25177022|NCT01499849|50320934|FG001|Overall Study|Other Reasons|30|||
25177023|NCT01499303|50320953|FG000|Overall Study|Ongoing|2|||
25096801|NCT02501811|50207058|FG000|Overall Study|Withdrawal by Subject|3|||
25177024|NCT01499303|50320954|FG001|Overall Study|Ongoing|1|||
25096802|NCT02501811|50207059|FG001|Overall Study|Withdrawal by Subject|3|||
25096803|NCT02501811|50207060|FG002|Overall Study|Withdrawal by Subject|2|||
25096804|NCT02501811|50207061|FG003|Overall Study|Withdrawal by Subject|3|||
25096805|NCT02501811|50207058|FG000|Overall Study|Lost to Follow-up|0|||
25096806|NCT02501811|50207059|FG001|Overall Study|Lost to Follow-up|0|||
25096807|NCT02501811|50207060|FG002|Overall Study|Lost to Follow-up|2|||
25096808|NCT02501811|50207061|FG003|Overall Study|Lost to Follow-up|1|||
25096809|NCT02585999|50207071|FG000|Overall Study|Lost to Follow-up|1|||
25096810|NCT02585999|50207071|FG000|Overall Study|Protocol Violation|1|||
25096811|NCT02582255|50207078|FG000|Overall Study|Protocol Violation|0|||
25096812|NCT02582255|50207079|FG001|Overall Study|Protocol Violation|3|||
25096813|NCT02500719|50207088|FG000|Overall Study|Lost to Follow-up|2|||
25177025|NCT01499303|50320953|FG000|Overall Study|Withdrawal by Subject|0|||
25096814|NCT02500719|50207089|FG001|Overall Study|Lost to Follow-up|3|||
25096815|NCT02500719|50207088|FG000|Overall Study|Trauma history|1|||
25096816|NCT02500719|50207089|FG001|Overall Study|Trauma history|0|||
25096817|NCT02500719|50207088|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
25096818|NCT02500719|50207089|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
25096819|NCT02500719|50207088|FG000|Overall Study|Did not meet criteria for PTSD|0|||
25096820|NCT02500719|50207089|FG001|Overall Study|Did not meet criteria for PTSD|1|||
25096821|NCT02500719|50207088|FG000|Overall Study|Claustrophobia|0|||
25096822|NCT02500719|50207089|FG001|Overall Study|Claustrophobia|1|||
25096823|NCT02500719|50207088|FG000|Overall Study|History of head trauma|0|||
25096824|NCT02500719|50207089|FG001|Overall Study|History of head trauma|1|||
25096825|NCT02500641|50207097|FG000|Overall Study|Adverse Event|0|||
25096826|NCT02500641|50207098|FG001|Overall Study|Adverse Event|2|||
25096827|NCT02500641|50207097|FG000|Overall Study|Withdrawal by Subject|4|||
25096828|NCT02500641|50207098|FG001|Overall Study|Withdrawal by Subject|5|||
25096829|NCT02500641|50207097|FG000|Overall Study|Unable to follow study procedures|3|||
25096830|NCT02500641|50207098|FG001|Overall Study|Unable to follow study procedures|2|||
25096831|NCT02500641|50207097|FG000|Overall Study|Protocol Violation|1|||
25096832|NCT02500641|50207098|FG001|Overall Study|Protocol Violation|2|||
25096833|NCT02500641|50207097|FG000|Overall Study|Lost to Follow-up|1|||
25096834|NCT02500641|50207098|FG001|Overall Study|Lost to Follow-up|0|||
25096835|NCT02500641|50207097|FG000|Overall Study|Sponsor decision|1|||
25096836|NCT02500641|50207098|FG001|Overall Study|Sponsor decision|0|||
25096837|NCT02500641|50207097|FG000|Overall Study|Non compliance to study drug|0|||
25096838|NCT02500641|50207098|FG001|Overall Study|Non compliance to study drug|1|||
25096839|NCT02499783|50207106|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
25096840|NCT02499783|50207107|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
25096841|NCT02499783|50207108|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
25096842|NCT02499783|50207106|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
25096843|NCT02499783|50207107|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
25096844|NCT02499783|50207108|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
25096845|NCT02499783|50207106|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
25096846|NCT02499783|50207107|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
25096847|NCT02499783|50207108|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
25096848|NCT02499783|50207106|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
25096849|NCT02499783|50207107|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
25096850|NCT02499783|50207108|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
25096851|NCT02499783|50207106|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
25096852|NCT02499783|50207107|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
25096853|NCT02499783|50207108|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
25096854|NCT02499783|50207106|FG000|DB Period: Weeks 0-8|Other|1|||
25096855|NCT02499783|50207107|FG001|DB Period: Weeks 0-8|Other|1|||
25096856|NCT02499783|50207108|FG002|DB Period: Weeks 0-8|Other|0|||
25096857|NCT02499783|50207106|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
25096858|NCT02499783|50207107|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
25096859|NCT02499783|50207108|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
25096860|NCT02499783|50207106|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
25096861|NCT02499783|50207107|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
25096862|NCT02499783|50207108|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
25096863|NCT02499783|50207106|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
25096864|NCT02499783|50207107|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
25096865|NCT02499783|50207108|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
25096866|NCT02499783|50207106|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
25096867|NCT02499783|50207107|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
25096868|NCT02499783|50207108|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
25096869|NCT02468193|50207118|FG000|Overall Study|Adverse Event|4|||
25096870|NCT02468193|50207118|FG000|Overall Study|Subject/ Guardian decision|2|||
25096871|NCT02466555|50207138|FG000|Overall Study|Lost to Follow-up|2|||
25096872|NCT02466399|50207145|FG000|Overall Study|Adverse Event|1|||
25096873|NCT02466399|50207146|FG001|Overall Study|Adverse Event|0|||
25096874|NCT02466399|50207145|FG000|Overall Study|Early exit due to family emergency|1|||
25096875|NCT02466399|50207146|FG001|Overall Study|Early exit due to family emergency|0|||
25096876|NCT02465931|50207154|FG000|Overall Study|Lost to Follow-up|9|||
25096877|NCT02465931|50207155|FG001|Overall Study|Lost to Follow-up|11|||
25096878|NCT02465931|50207154|FG000|Overall Study|Protocol Violation|1|||
25096879|NCT02465931|50207155|FG001|Overall Study|Protocol Violation|0|||
25096880|NCT02465931|50207154|FG000|Overall Study|Withdrawal by Subject|1|||
25096881|NCT02465931|50207155|FG001|Overall Study|Withdrawal by Subject|0|||
25096882|NCT02465463|50207163|FG000|Overall Study|Lost to Follow-up|2|||
25096883|NCT02465463|50207164|FG001|Overall Study|Lost to Follow-up|1|||
25096884|NCT02465463|50207163|FG000|Overall Study|Death|1|||
25096885|NCT02465463|50207164|FG001|Overall Study|Death|0|||
25096886|NCT02465463|50207163|FG000|Overall Study|Protocol Violation|1|||
25096887|NCT02465463|50207164|FG001|Overall Study|Protocol Violation|0|||
25096888|NCT02464059|50207171|FG000|Overall Study|Lost to Follow-up|6|||
25096889|NCT02463357|50207180|FG000|Overall Study|Withdrawal by Subject|1|||
25096890|NCT02463357|50207181|FG001|Overall Study|Withdrawal by Subject|0|||
25096891|NCT02463357|50207182|FG002|Overall Study|Withdrawal by Subject|0|||
25096892|NCT02463357|50207183|FG003|Overall Study|Withdrawal by Subject|0|||
25096893|NCT02463357|50207184|FG004|Overall Study|Withdrawal by Subject|0|||
25096894|NCT02463357|50207180|FG000|Overall Study|Withdrawal by Subject|0|||
25096895|NCT02463357|50207181|FG001|Overall Study|Withdrawal by Subject|0|||
25096896|NCT02463357|50207182|FG002|Overall Study|Withdrawal by Subject|0|||
25096897|NCT02463357|50207183|FG003|Overall Study|Withdrawal by Subject|0|||
25096898|NCT02463357|50207184|FG004|Overall Study|Withdrawal by Subject|1|||
25096899|NCT02579759|50207199|FG000|Overall Study|Protocol Violation|2|||
25096900|NCT02579759|50207200|FG001|Overall Study|Protocol Violation|0|||
25096901|NCT02579759|50207201|FG002|Overall Study|Protocol Violation|0|||
25096902|NCT02579759|50207199|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
25096903|NCT02579759|50207200|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
25096904|NCT02579759|50207201|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
25096905|NCT02579759|50207199|FG000|Overall Study|BfArM hold|13|||
25096906|NCT02579759|50207200|FG001|Overall Study|BfArM hold|12|||
25096907|NCT02579759|50207201|FG002|Overall Study|BfArM hold|12|||
25096908|NCT02579759|50207199|FG000|Overall Study|Sponsor stopped Dose 2|0|||
25096909|NCT02579759|50207200|FG001|Overall Study|Sponsor stopped Dose 2|41|||
25096910|NCT02579759|50207201|FG002|Overall Study|Sponsor stopped Dose 2|0|||
25096911|NCT02579759|50207199|FG000|Overall Study|Non compliance|0|||
25096912|NCT02579759|50207200|FG001|Overall Study|Non compliance|1|||
25096913|NCT02579759|50207201|FG002|Overall Study|Non compliance|0|||
25096914|NCT02579759|50207199|FG000|Overall Study|Pregnancy|0|||
25096915|NCT02579759|50207200|FG001|Overall Study|Pregnancy|1|||
25096916|NCT02579759|50207201|FG002|Overall Study|Pregnancy|0|||
25096917|NCT02579759|50207199|FG000|Overall Study|Inclusion/exclusion criteria|0|||
25096918|NCT02579759|50207200|FG001|Overall Study|Inclusion/exclusion criteria|0|||
25096919|NCT02579759|50207201|FG002|Overall Study|Inclusion/exclusion criteria|1|||
25096920|NCT02579759|50207199|FG000|Overall Study|Adverse Event|4|||
25096921|NCT02579759|50207200|FG001|Overall Study|Adverse Event|3|||
25096922|NCT02579759|50207201|FG002|Overall Study|Adverse Event|1|||
25096923|NCT02579759|50207199|FG000|Overall Study|Withdrawal by Subject|3|||
25096924|NCT02579759|50207200|FG001|Overall Study|Withdrawal by Subject|3|||
25096925|NCT02579759|50207201|FG002|Overall Study|Withdrawal by Subject|5|||
25096926|NCT02579759|50207199|FG000|Overall Study|Lost to Follow-up|2|||
25096927|NCT02579759|50207200|FG001|Overall Study|Lost to Follow-up|2|||
25096928|NCT02579759|50207201|FG002|Overall Study|Lost to Follow-up|2|||
25096929|NCT02445963|50207215|FG000|Overall Study|Lost to Follow-up|1|||
25096930|NCT02445963|50207216|FG001|Overall Study|Lost to Follow-up|0|||
25096931|NCT02445963|50207217|FG002|Overall Study|Lost to Follow-up|0|||
25096932|NCT02445963|50207218|FG003|Overall Study|Lost to Follow-up|0|||
25096933|NCT02445963|50207215|FG000|Overall Study|Change in employment|1|||
25096934|NCT02445963|50207216|FG001|Overall Study|Change in employment|0|||
25096935|NCT02445963|50207217|FG002|Overall Study|Change in employment|0|||
25096936|NCT02445963|50207218|FG003|Overall Study|Change in employment|0|||
25096937|NCT02445963|50207215|FG000|Overall Study|Symptoms post-vaccination|0|||
25096938|NCT02445963|50207216|FG001|Overall Study|Symptoms post-vaccination|0|||
25096939|NCT02445963|50207217|FG002|Overall Study|Symptoms post-vaccination|1|||
25096940|NCT02445963|50207218|FG003|Overall Study|Symptoms post-vaccination|0|||
25096941|NCT02499159|50207232|FG000|Randomization|Protocol Violation|1|||
25096942|NCT02499159|50207233|FG001|Randomization|Protocol Violation|1|||
25096943|NCT02499159|50207232|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
25096944|NCT02499159|50207233|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
25096945|NCT02499159|50207232|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
25096946|NCT02499159|50207233|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
25096947|NCT02499159|50207232|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
25096948|NCT02499159|50207233|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
25096949|NCT02499159|50207232|FG000|30-Day Follow-Up Phone Call|Other|1|||
25096950|NCT02499159|50207233|FG001|30-Day Follow-Up Phone Call|Other|0|||
25096951|NCT01664039|50207241|FG000|Overall Study|Adverse Event|3|||
25096952|NCT01664039|50207242|FG001|Overall Study|Adverse Event|4|||
25096953|NCT01664039|50207241|FG000|Overall Study|Lost to Follow-up|1|||
25096954|NCT01664039|50207242|FG001|Overall Study|Lost to Follow-up|1|||
25096955|NCT01664039|50207241|FG000|Overall Study|Withdrawal by Subject|1|||
25096956|NCT01664039|50207242|FG001|Overall Study|Withdrawal by Subject|3|||
25096957|NCT01664039|50207241|FG000|Overall Study|Noncompliance|1|||
25096958|NCT01664039|50207242|FG001|Overall Study|Noncompliance|1|||
25096959|NCT02445573|50207250|FG000|Overall Study|Withdrawal by Subject|1|||
25096960|NCT02445573|50207251|FG001|Overall Study|Withdrawal by Subject|1|||
25096961|NCT02445573|50207250|FG000|Overall Study|Lost to Follow-up|0|||
25096962|NCT02445573|50207251|FG001|Overall Study|Lost to Follow-up|1|||
25096963|NCT02445339|50207259|FG000|Overall Study|Physician Decision|1|||
25096964|NCT02445339|50207260|FG001|Overall Study|Physician Decision|0|||
25096965|NCT02445339|50207259|FG000|Overall Study|Lost to Follow-up|11|||
25096966|NCT02445339|50207260|FG001|Overall Study|Lost to Follow-up|15|||
25096967|NCT02579603|50207268|FG000|Overall Study|Not treated|1|||
25096968|NCT02579603|50207269|FG001|Overall Study|Not treated|0|||
25096969|NCT02579603|50207268|FG000|Overall Study|Adverse Event|2|||
25096970|NCT02579603|50207269|FG001|Overall Study|Adverse Event|2|||
25096971|NCT02579603|50207268|FG000|Overall Study|Other than stated|1|||
25096972|NCT02579603|50207269|FG001|Overall Study|Other than stated|0|||
25096973|NCT02625259|50207281|FG000|First Intervention (Day 1)|Other|0|||
25096974|NCT02625259|50207282|FG001|First Intervention (Day 1)|Other|0|||
25096975|NCT02625259|50207283|FG002|First Intervention (Day 1)|Other|1|||
25096976|NCT02625259|50207284|FG003|First Intervention (Day 1)|Other|0|||
25096977|NCT02625259|50207285|FG004|First Intervention (Day 1)|Other|0|||
25096978|NCT02625259|50207281|FG000|First Intervention (Day 1)|Adverse Event|2|||
25096979|NCT02625259|50207282|FG001|First Intervention (Day 1)|Adverse Event|1|||
25096980|NCT02625259|50207283|FG002|First Intervention (Day 1)|Adverse Event|0|||
25096981|NCT02625259|50207284|FG003|First Intervention (Day 1)|Adverse Event|0|||
25096982|NCT02625259|50207285|FG004|First Intervention (Day 1)|Adverse Event|0|||
25096983|NCT02625259|50207281|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
25096984|NCT02625259|50207282|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
25096985|NCT02625259|50207283|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
25096986|NCT02625259|50207284|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
25096987|NCT02625259|50207285|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
25096988|NCT02577107|50207302|FG000|Overall Study|Protocol deviation|0|||
25096989|NCT02577107|50207303|FG001|Overall Study|Protocol deviation|1|||
25096990|NCT02444793|50207313|FG000|Overall Study|Lost to Follow-up|2|||
25096991|NCT02444793|50207314|FG001|Overall Study|Lost to Follow-up|2|||
25096992|NCT02444793|50207315|FG002|Overall Study|Lost to Follow-up|0|||
25096993|NCT02444793|50207316|FG003|Overall Study|Lost to Follow-up|0|||
25096994|NCT02444793|50207313|FG000|Overall Study|Death|0|||
25096995|NCT02444793|50207314|FG001|Overall Study|Death|3|||
25096996|NCT02444793|50207315|FG002|Overall Study|Death|0|||
25096997|NCT02444793|50207316|FG003|Overall Study|Death|0|||
25096998|NCT02444793|50207313|FG000|Overall Study|Other|0|||
25096999|NCT02444793|50207314|FG001|Overall Study|Other|0|||
25097000|NCT02444793|50207315|FG002|Overall Study|Other|2|||
25097001|NCT02444793|50207316|FG003|Overall Study|Other|0|||
25097002|NCT02444793|50207313|FG000|Overall Study|Objective progression or relapse|9|||
25097003|NCT02444793|50207314|FG001|Overall Study|Objective progression or relapse|1|||
25097004|NCT02444793|50207315|FG002|Overall Study|Objective progression or relapse|2|||
25097005|NCT02444793|50207316|FG003|Overall Study|Objective progression or relapse|3|||
25097006|NCT02624713|50207329|FG000|Overall Study|Lost to Follow-up|14|||
25097007|NCT02624713|50207330|FG001|Overall Study|Lost to Follow-up|0|||
25097008|NCT02624791|50207337|FG000|Overall Study|Withdrawal by Subject|2|||
25097009|NCT02624791|50207338|FG001|Overall Study|Withdrawal by Subject|0|||
25097010|NCT02624791|50207339|FG002|Overall Study|Withdrawal by Subject|0|||
25097011|NCT02624791|50207340|FG003|Overall Study|Withdrawal by Subject|0|||
25097012|NCT02624791|50207341|FG004|Overall Study|Withdrawal by Subject|0|||
25097013|NCT02624791|50207342|FG005|Overall Study|Withdrawal by Subject|0|||
25097014|NCT02577029|50207354|FG000|Overall Study|Adverse Event|1|||
25097015|NCT02577029|50207355|FG001|Overall Study|Adverse Event|0|||
25097016|NCT02577029|50207356|FG002|Overall Study|Adverse Event|2|||
25097017|NCT02577029|50207357|FG003|Overall Study|Adverse Event|0|||
25097018|NCT02577029|50207358|FG004|Overall Study|Adverse Event|1|||
25097019|NCT02577029|50207359|FG005|Overall Study|Adverse Event|0|||
25097020|NCT02577029|50207360|FG006|Overall Study|Adverse Event|0|||
25097021|NCT02577029|50207361|FG007|Overall Study|Adverse Event|0|||
25097022|NCT02577029|50207354|FG000|Overall Study|Withdrawal by Subject|0|||
25097023|NCT02577029|50207355|FG001|Overall Study|Withdrawal by Subject|0|||
25097024|NCT02577029|50207356|FG002|Overall Study|Withdrawal by Subject|0|||
25097025|NCT02577029|50207357|FG003|Overall Study|Withdrawal by Subject|0|||
25097026|NCT02577029|50207358|FG004|Overall Study|Withdrawal by Subject|0|||
25097027|NCT02577029|50207359|FG005|Overall Study|Withdrawal by Subject|1|||
25097028|NCT02577029|50207360|FG006|Overall Study|Withdrawal by Subject|0|||
25097029|NCT02577029|50207361|FG007|Overall Study|Withdrawal by Subject|0|||
25097030|NCT02577029|50207354|FG000|Overall Study|Sponsor Termination of the Study|9|||
25097031|NCT02577029|50207355|FG001|Overall Study|Sponsor Termination of the Study|2|||
25097032|NCT02577029|50207356|FG002|Overall Study|Sponsor Termination of the Study|5|||
25097033|NCT02577029|50207357|FG003|Overall Study|Sponsor Termination of the Study|12|||
25177026|NCT01499303|50320954|FG001|Overall Study|Withdrawal by Subject|1|||
25097034|NCT02577029|50207358|FG004|Overall Study|Sponsor Termination of the Study|10|||
25097035|NCT02577029|50207359|FG005|Overall Study|Sponsor Termination of the Study|12|||
25097036|NCT02577029|50207360|FG006|Overall Study|Sponsor Termination of the Study|12|||
25097037|NCT02577029|50207361|FG007|Overall Study|Sponsor Termination of the Study|12|||
25177027|NCT01499303|50320953|FG000|Overall Study|Adverse Event|1|||
25097038|NCT02577887|50207379|FG000|Overall Study|Death|93|||
25177028|NCT01499303|50320954|FG001|Overall Study|Adverse Event|4|||
25177029|NCT01499303|50320953|FG000|Overall Study|Other|0|||
25097039|NCT02577887|50207379|FG000|Overall Study|Protocol Violation|125|||
25097040|NCT02577887|50207379|FG000|Overall Study|Withdrawal by Subject|80|||
25097041|NCT03597347|50207386|FG000|Overall Study|Withdrawal by Subject|1|||
25097042|NCT03597347|50207387|FG001|Overall Study|Withdrawal by Subject|1|||
25097043|NCT03597347|50207388|FG002|Overall Study|Withdrawal by Subject|0|||
25097044|NCT03597347|50207386|FG000|Overall Study|Withdrawal due to Covid-19|3|||
25097045|NCT03597347|50207387|FG001|Overall Study|Withdrawal due to Covid-19|0|||
25097046|NCT03597347|50207388|FG002|Overall Study|Withdrawal due to Covid-19|0|||
25097047|NCT03597347|50207386|FG000|Overall Study|Sponsor decision to terminate study|3|||
25097048|NCT03597347|50207387|FG001|Overall Study|Sponsor decision to terminate study|2|||
25097049|NCT03597347|50207388|FG002|Overall Study|Sponsor decision to terminate study|4|||
25097050|NCT02576951|50207400|FG000|Overall Study|Lost to Follow-up|0|||
25097051|NCT02576951|50207401|FG001|Overall Study|Lost to Follow-up|0|||
25097052|NCT02576951|50207402|FG002|Overall Study|Lost to Follow-up|2|||
25097053|NCT02576951|50207403|FG003|Overall Study|Lost to Follow-up|2|||
25097054|NCT02576951|50207400|FG000|Overall Study|Withdrawal by Subject|1|||
25097055|NCT02576951|50207401|FG001|Overall Study|Withdrawal by Subject|0|||
25097056|NCT02576951|50207402|FG002|Overall Study|Withdrawal by Subject|0|||
25097057|NCT02576951|50207403|FG003|Overall Study|Withdrawal by Subject|2|||
25097058|NCT02576951|50207400|FG000|Overall Study|Protocol Violation|0|||
25097059|NCT02576951|50207401|FG001|Overall Study|Protocol Violation|0|||
25097060|NCT02576951|50207402|FG002|Overall Study|Protocol Violation|0|||
25097061|NCT02576951|50207403|FG003|Overall Study|Protocol Violation|1|||
25097062|NCT02621047|50207418|FG000|Overall Study|Adverse Event|0|||
25097063|NCT02621047|50207419|FG001|Overall Study|Adverse Event|0|||
25097064|NCT02621047|50207420|FG002|Overall Study|Adverse Event|1|||
25097065|NCT02443155|50207433|FG000|Overall Study|Adverse Event|3|||
25097066|NCT02443155|50207434|FG001|Overall Study|Adverse Event|4|||
25097067|NCT02443155|50207435|FG002|Overall Study|Adverse Event|1|||
25097068|NCT02443155|50207436|FG003|Overall Study|Adverse Event|2|||
25097069|NCT02443155|50207433|FG000|Overall Study|Unclassified|0|||
25097070|NCT02443155|50207434|FG001|Overall Study|Unclassified|0|||
25097071|NCT02443155|50207435|FG002|Overall Study|Unclassified|2|||
25097072|NCT02443155|50207436|FG003|Overall Study|Unclassified|1|||
25097073|NCT02443155|50207433|FG000|Overall Study|Withdrawal by Subject|4|||
25097074|NCT02443155|50207434|FG001|Overall Study|Withdrawal by Subject|7|||
25097075|NCT02443155|50207435|FG002|Overall Study|Withdrawal by Subject|3|||
25097076|NCT02443155|50207436|FG003|Overall Study|Withdrawal by Subject|9|||
25097077|NCT02443155|50207433|FG000|Overall Study|Pregnancy|3|||
25097078|NCT02443155|50207434|FG001|Overall Study|Pregnancy|1|||
25097079|NCT02443155|50207435|FG002|Overall Study|Pregnancy|1|||
25097080|NCT02443155|50207436|FG003|Overall Study|Pregnancy|2|||
25097081|NCT02443155|50207433|FG000|Overall Study|Lost to Follow-up|1|||
25097082|NCT02443155|50207434|FG001|Overall Study|Lost to Follow-up|2|||
25097083|NCT02443155|50207435|FG002|Overall Study|Lost to Follow-up|0|||
25097084|NCT02443155|50207436|FG003|Overall Study|Lost to Follow-up|1|||
25097085|NCT02443155|50207433|FG000|Overall Study|Protocol Violation|1|||
25097086|NCT02443155|50207434|FG001|Overall Study|Protocol Violation|0|||
25097087|NCT02443155|50207435|FG002|Overall Study|Protocol Violation|1|||
25097088|NCT02443155|50207436|FG003|Overall Study|Protocol Violation|1|||
25097089|NCT02443155|50207433|FG000|Overall Study|Death|0|||
25097090|NCT02443155|50207434|FG001|Overall Study|Death|0|||
25097091|NCT02443155|50207435|FG002|Overall Study|Death|1|||
25097092|NCT02443155|50207436|FG003|Overall Study|Death|0|||
25097093|NCT02460159|50207449|FG000|Overall Study|Adverse Event|4|||
25097094|NCT02460159|50207450|FG001|Overall Study|Adverse Event|1|||
25097095|NCT02460159|50207449|FG000|Overall Study|Withdrawal by Subject|2|||
25097096|NCT02460159|50207450|FG001|Overall Study|Withdrawal by Subject|0|||
25097097|NCT02498067|50207456|FG000|Overall Study|Lost to Follow-up|22|||
25097098|NCT02498067|50207456|FG000|Overall Study|Did not meet inclusion criteria|11|||
25097099|NCT02497755|50207464|FG000|Overall Study|Protocol Violation|1|||
25097100|NCT02497755|50207465|FG001|Overall Study|Protocol Violation|0|||
25097101|NCT02619175|50207474|FG000|Overall Study|Withdrawal by Subject|1|||
25097102|NCT02619175|50207475|FG001|Overall Study|Withdrawal by Subject|0|||
25097103|NCT02619175|50207474|FG000|Overall Study|foot pain|1|||
25097104|NCT02619175|50207475|FG001|Overall Study|foot pain|0|||
25097105|NCT01360021|50207492|FG000|Overall Study|Eligibility criteria + other|2|||
25097106|NCT01360021|50207493|FG001|Overall Study|Eligibility criteria + other|1|||
25097107|NCT01360021|50207494|FG002|Overall Study|Eligibility criteria + other|1|||
25097108|NCT01360021|50207492|FG000|Overall Study|Protocol Violation|0|||
25097109|NCT01360021|50207493|FG001|Overall Study|Protocol Violation|0|||
25097110|NCT01360021|50207494|FG002|Overall Study|Protocol Violation|1|||
25097111|NCT01360021|50207492|FG000|Overall Study|Withdrawal by Subject|4|||
25097112|NCT01360021|50207493|FG001|Overall Study|Withdrawal by Subject|0|||
25097113|NCT01360021|50207494|FG002|Overall Study|Withdrawal by Subject|2|||
25097114|NCT01360021|50207492|FG000|Overall Study|Adverse Event|2|||
25097115|NCT01360021|50207493|FG001|Overall Study|Adverse Event|3|||
25097116|NCT01360021|50207494|FG002|Overall Study|Adverse Event|3|||
25097117|NCT02497287|50207511|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
25097118|NCT02497287|50207511|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
25097119|NCT02497287|50207511|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
25097120|NCT02497287|50207511|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
25097121|NCT02497287|50207511|FG000|Induction Phase (4 Weeks)|Other|13|||
25097122|NCT02497287|50207511|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
25097123|NCT02497287|50207511|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
25097124|NCT02497287|50207511|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
25097125|NCT02497287|50207511|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
25097126|NCT02497287|50207511|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
25097127|NCT02497287|50207511|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
25097128|NCT02497287|50207511|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
25097129|NCT02497287|50207511|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
25097130|NCT02497287|50207511|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
25097131|NCT02497287|50207511|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
25097132|NCT02497287|50207511|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
25097133|NCT02497287|50207511|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
25097134|NCT02497287|50207511|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
25097135|NCT02497287|50207511|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
25097136|NCT02497287|50207511|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
25097137|NCT02497287|50207511|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
25097138|NCT02497287|50207511|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
25097139|NCT02497287|50207511|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
25097140|NCT02497287|50207511|FG000|Follow-up Phase (4 Week)|Other|1|||
25097141|NCT02458287|50207521|FG000|Overall Study|Adverse Event|0|||
25097142|NCT02458287|50207522|FG001|Overall Study|Adverse Event|0|||
25097143|NCT02458287|50207523|FG002|Overall Study|Adverse Event|0|||
25097144|NCT02458287|50207524|FG003|Overall Study|Adverse Event|1|||
25097145|NCT02458287|50207521|FG000|Overall Study|Lost to Follow-up|0|||
25097146|NCT02458287|50207522|FG001|Overall Study|Lost to Follow-up|1|||
25097147|NCT02458287|50207523|FG002|Overall Study|Lost to Follow-up|1|||
25097148|NCT02458287|50207524|FG003|Overall Study|Lost to Follow-up|0|||
25097149|NCT02458287|50207521|FG000|Overall Study|Protocol Violation|0|||
25097150|NCT02458287|50207522|FG001|Overall Study|Protocol Violation|1|||
25097151|NCT02458287|50207523|FG002|Overall Study|Protocol Violation|0|||
25097152|NCT02458287|50207524|FG003|Overall Study|Protocol Violation|0|||
25097153|NCT02458287|50207521|FG000|Overall Study|Withdrawal by Subject|0|||
25097154|NCT02458287|50207522|FG001|Overall Study|Withdrawal by Subject|2|||
25097155|NCT02458287|50207523|FG002|Overall Study|Withdrawal by Subject|2|||
25097156|NCT02458287|50207524|FG003|Overall Study|Withdrawal by Subject|1|||
25097157|NCT02458287|50207521|FG000|Overall Study|Relocated Out of State|0|||
25097158|NCT02458287|50207522|FG001|Overall Study|Relocated Out of State|0|||
25097159|NCT02458287|50207523|FG002|Overall Study|Relocated Out of State|0|||
25097160|NCT02458287|50207524|FG003|Overall Study|Relocated Out of State|1|||
25097161|NCT02441517|50207540|FG000|Overall Study|Lost to Follow-up|1|||
25097162|NCT02441517|50207540|FG000|Overall Study|Withdrawal by Subject|2|||
25097163|NCT02441517|50207540|FG000|Overall Study|Study Terminated by Sponsor|1|||
25097164|NCT02457819|50207544|FG000|Overall Study|reason not given|8|||
25097165|NCT02457819|50207544|FG000|Overall Study|Withdrawal by Subject|24|||
25097166|NCT02457819|50207544|FG000|Overall Study|Protocol Violation|1|||
25097167|NCT02457819|50207544|FG000|Overall Study|non compliance with study drug|4|||
25097168|NCT02457819|50207544|FG000|Overall Study|Lost to Follow-up|10|||
25097169|NCT02457819|50207544|FG000|Overall Study|Lack of Efficacy|19|||
25097170|NCT02457819|50207544|FG000|Overall Study|Adverse Event|33|||
25097171|NCT02496039|50207548|FG000|Overall Study|Adverse Event|3|||
25097172|NCT02496039|50207548|FG000|Overall Study|Protocol Violation|1|||
25097173|NCT02441283|50207552|FG000|Overall Study|Withdrew consent|15|||
25097174|NCT02441283|50207552|FG000|Overall Study|Lost to Follow-up|42|||
25097175|NCT02441283|50207552|FG000|Overall Study|Death|1|||
25097176|NCT02441283|50207552|FG000|Overall Study|Other, not specified|32|||
25097177|NCT02495883|50207558|FG000|Overall Study|Excessive head motion|1|||
25097178|NCT02495883|50207559|FG001|Overall Study|Excessive head motion|0|||
25097179|NCT02495025|50207566|FG000|Overall Study|Lost to Follow-up|21|||
25097180|NCT02495025|50207567|FG001|Overall Study|Lost to Follow-up|14|||
25097181|NCT02495025|50207566|FG000|Overall Study|Withdrawal by Subject|5|||
25097182|NCT02495025|50207567|FG001|Overall Study|Withdrawal by Subject|0|||
25097183|NCT02439957|50207575|FG000|Overall Study|Study Terminated|3|||
25097184|NCT02439957|50207576|FG001|Overall Study|Study Terminated|3|||
25097185|NCT02494401|50207584|FG000|Overall Study|Lost to Follow-up|22|||
25097186|NCT02494401|50207585|FG001|Overall Study|Lost to Follow-up|25|||
25097187|NCT02494401|50207584|FG000|Overall Study|Withdrawal by Subject|3|||
25097188|NCT02494401|50207585|FG001|Overall Study|Withdrawal by Subject|2|||
25097189|NCT02457195|50207591|FG000|Overall Study|Adverse Event|3|||
25097190|NCT02457195|50207591|FG000|Overall Study|Protocol Violation|2|||
25097191|NCT02457195|50207591|FG000|Overall Study|Withdrawal by Subject|4|||
25097192|NCT02456727|50207597|FG000|Overall Study|Lost to Follow-up|63|||
25097193|NCT02456727|50207598|FG001|Overall Study|Lost to Follow-up|65|||
25097194|NCT02456727|50207597|FG000|Overall Study|Death|2|||
25097195|NCT02456727|50207598|FG001|Overall Study|Death|1|||
25097196|NCT02456727|50207597|FG000|Overall Study|Withdrawal by Subject|1|||
25097197|NCT02456727|50207598|FG001|Overall Study|Withdrawal by Subject|10|||
25097198|NCT02456727|50207597|FG000|Overall Study|Never Initiated Treatment|43|||
25097199|NCT02456727|50207598|FG001|Overall Study|Never Initiated Treatment|30|||
25097200|NCT02456103|50207620|FG000|Overall Study|Study Closure|207|||
25097201|NCT02456103|50207620|FG000|Overall Study|Physician Decision|1|||
25097202|NCT02456103|50207620|FG000|Overall Study|Required prohibited medications|5|||
25097203|NCT02456103|50207620|FG000|Overall Study|Protocol Violation|1|||
25097204|NCT02456103|50207620|FG000|Overall Study|Adverse Event|5|||
25097205|NCT02456103|50207620|FG000|Overall Study|Abnormal Laboratory Value|2|||
25097206|NCT02456103|50207620|FG000|Overall Study|Lost to Follow-up|1|||
25097207|NCT02456103|50207620|FG000|Overall Study|Withdrawal by Subject|24|||
25097208|NCT01653327|50207624|FG000|Overall Study|Withdrawal by Subject|1|||
25097209|NCT02493855|50207633|FG000|Overall Study|Non-compliance|1|||
25097210|NCT02493855|50207634|FG001|Overall Study|Non-compliance|0|||
25097211|NCT02493855|50207635|FG002|Overall Study|Non-compliance|0|||
25097212|NCT02493855|50207633|FG000|Overall Study|Adverse Event|0|||
25097213|NCT02493855|50207634|FG001|Overall Study|Adverse Event|1|||
25097214|NCT02493855|50207635|FG002|Overall Study|Adverse Event|0|||
25097215|NCT02493855|50207633|FG000|Overall Study|Withdrawal by Subject|1|||
25097216|NCT02493855|50207634|FG001|Overall Study|Withdrawal by Subject|0|||
25097217|NCT02493855|50207635|FG002|Overall Study|Withdrawal by Subject|0|||
25097218|NCT02438787|50207646|FG000|Overall Study|Adverse Event|1|||
25097219|NCT02438787|50207647|FG001|Overall Study|Adverse Event|0|||
25097220|NCT02438787|50207648|FG002|Overall Study|Adverse Event|2|||
25097221|NCT02438787|50207646|FG000|Overall Study|Lack of Efficacy|1|||
25097222|NCT02438787|50207647|FG001|Overall Study|Lack of Efficacy|2|||
25097223|NCT02438787|50207648|FG002|Overall Study|Lack of Efficacy|0|||
25097224|NCT02438787|50207646|FG000|Overall Study|Lost to Follow-up|0|||
25097225|NCT02438787|50207647|FG001|Overall Study|Lost to Follow-up|1|||
25097226|NCT02438787|50207648|FG002|Overall Study|Lost to Follow-up|0|||
25097227|NCT02438787|50207646|FG000|Overall Study|Protocol Violation|0|||
25097228|NCT02438787|50207647|FG001|Overall Study|Protocol Violation|0|||
25097229|NCT02438787|50207648|FG002|Overall Study|Protocol Violation|1|||
25097230|NCT02438787|50207646|FG000|Overall Study|Withdrawal by Subject|15|||
25097231|NCT02438787|50207647|FG001|Overall Study|Withdrawal by Subject|7|||
25097232|NCT02438787|50207648|FG002|Overall Study|Withdrawal by Subject|10|||
25097233|NCT02438787|50207646|FG000|Overall Study|Study discontinued by sponsor|64|||
25097234|NCT02438787|50207647|FG001|Overall Study|Study discontinued by sponsor|72|||
25097235|NCT02438787|50207648|FG002|Overall Study|Study discontinued by sponsor|69|||
25097236|NCT02438787|50207646|FG000|Overall Study|Other|0|||
25097237|NCT02438787|50207647|FG001|Overall Study|Other|1|||
25097238|NCT02438787|50207648|FG002|Overall Study|Other|0|||
25097239|NCT02438787|50207646|FG000|Overall Study|Site terminated by sponsor|0|||
25097240|NCT02438787|50207647|FG001|Overall Study|Site terminated by sponsor|0|||
25097241|NCT02438787|50207648|FG002|Overall Study|Site terminated by sponsor|1|||
25097242|NCT02493777|50207663|FG000|Overall Study|Lost to Follow-up|0|||
25097243|NCT02493777|50207664|FG001|Overall Study|Lost to Follow-up|1|||
25097244|NCT02616601|50207673|FG000|Overall Study|Withdrawal by Subject|4|||
25097245|NCT02616601|50207674|FG001|Overall Study|Withdrawal by Subject|4|||
25097246|NCT02616601|50207675|FG002|Overall Study|Withdrawal by Subject|3|||
25097247|NCT02616601|50207673|FG000|Overall Study|Adverse Event|2|||
25097248|NCT02616601|50207674|FG001|Overall Study|Adverse Event|0|||
25097249|NCT02616601|50207675|FG002|Overall Study|Adverse Event|2|||
25097250|NCT02616601|50207673|FG000|Overall Study|Death|1|||
25097251|NCT02616601|50207674|FG001|Overall Study|Death|0|||
25097252|NCT02616601|50207675|FG002|Overall Study|Death|0|||
25097253|NCT02616601|50207673|FG000|Overall Study|Lost to Follow-up|1|||
25097254|NCT02616601|50207674|FG001|Overall Study|Lost to Follow-up|0|||
25097255|NCT02616601|50207675|FG002|Overall Study|Lost to Follow-up|1|||
25097256|NCT02616601|50207673|FG000|Overall Study|Non-Compliance with Test Article|1|||
25097257|NCT02616601|50207674|FG001|Overall Study|Non-Compliance with Test Article|0|||
25097258|NCT02616601|50207675|FG002|Overall Study|Non-Compliance with Test Article|1|||
25097259|NCT02492997|50207685|FG000|Overall Study|Withdrawal by Subject|1|||
25097260|NCT02492997|50207686|FG001|Overall Study|Withdrawal by Subject|0|||
25097261|NCT02492997|50207685|FG000|Overall Study|Gained Weight|1|||
25177030|NCT01499303|50320954|FG001|Overall Study|Other|1|||
25177031|NCT01498679|50320975|FG000|Overall Study|Adverse Event|1|||
25097262|NCT02492997|50207686|FG001|Overall Study|Gained Weight|0|||
25097263|NCT02492997|50207685|FG000|Overall Study|Lost to Follow-up|0|||
25097264|NCT02492997|50207686|FG001|Overall Study|Lost to Follow-up|1|||
25097265|NCT02437305|50207694|FG000|Overall Study|Lost to Follow-up|18|||
25097266|NCT02437305|50207695|FG001|Overall Study|Lost to Follow-up|12|||
25097267|NCT02492841|50207704|FG000|Overall Study|Lost to Follow-up|34|||
25097268|NCT02492841|50207705|FG001|Overall Study|Lost to Follow-up|31|||
25097269|NCT02492841|50207706|FG002|Overall Study|Lost to Follow-up|35|||
25097270|NCT02436915|50207719|FG000|Overall Study|Withdrawal by Subject|0|||
25097271|NCT02436915|50207720|FG001|Overall Study|Withdrawal by Subject|1|||
25097272|NCT02492763|50207732|FG000|Overall Study|Withdrawal by Subject|0|||
25097273|NCT02492763|50207733|FG001|Overall Study|Withdrawal by Subject|2|||
25097274|NCT02492763|50207734|FG002|Overall Study|Withdrawal by Subject|1|||
25097275|NCT02492763|50207735|FG003|Overall Study|Withdrawal by Subject|0|||
25097276|NCT02492763|50207732|FG000|Overall Study|Adverse Event|3|||
25097277|NCT02492763|50207733|FG001|Overall Study|Adverse Event|1|||
25097278|NCT02492763|50207734|FG002|Overall Study|Adverse Event|1|||
25097279|NCT02492763|50207735|FG003|Overall Study|Adverse Event|2|||
25097280|NCT02492763|50207732|FG000|Overall Study|Death|0|||
25097281|NCT02492763|50207733|FG001|Overall Study|Death|0|||
25097282|NCT02492763|50207734|FG002|Overall Study|Death|1|||
25097283|NCT02492763|50207735|FG003|Overall Study|Death|0|||
25097284|NCT02492763|50207732|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
25097285|NCT02492763|50207733|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
25097286|NCT02492763|50207734|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
25097287|NCT02492763|50207735|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
25097288|NCT02492763|50207732|FG000|Overall Study|Lost to Follow-up|0|||
25097289|NCT02492763|50207733|FG001|Overall Study|Lost to Follow-up|0|||
25097290|NCT02492763|50207734|FG002|Overall Study|Lost to Follow-up|1|||
25097291|NCT02492763|50207735|FG003|Overall Study|Lost to Follow-up|0|||
25097292|NCT02492763|50207732|FG000|Overall Study|Non-Compliance With Study Drug|0|||
25097293|NCT02492763|50207733|FG001|Overall Study|Non-Compliance With Study Drug|1|||
25097294|NCT02492763|50207734|FG002|Overall Study|Non-Compliance With Study Drug|0|||
25097295|NCT02492763|50207735|FG003|Overall Study|Non-Compliance With Study Drug|0|||
25097296|NCT02492763|50207732|FG000|Overall Study|Screen Failure|0|||
25097297|NCT02492763|50207733|FG001|Overall Study|Screen Failure|0|||
25097298|NCT02492763|50207734|FG002|Overall Study|Screen Failure|0|||
25097299|NCT02492763|50207735|FG003|Overall Study|Screen Failure|1|||
25097300|NCT02492763|50207732|FG000|Overall Study|Study Terminated by Sponsor|13|||
25097301|NCT02492763|50207733|FG001|Overall Study|Study Terminated by Sponsor|10|||
25097302|NCT02492763|50207734|FG002|Overall Study|Study Terminated by Sponsor|6|||
25097303|NCT02492763|50207735|FG003|Overall Study|Study Terminated by Sponsor|10|||
25097304|NCT02491671|50207747|FG000|Overall Study|Adverse Event|6|||
25097305|NCT02491671|50207748|FG001|Overall Study|Adverse Event|8|||
25097306|NCT02491671|50207747|FG000|Overall Study|Death|0|||
25097307|NCT02491671|50207748|FG001|Overall Study|Death|2|||
25097308|NCT02491671|50207747|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
25097309|NCT02491671|50207748|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
25097310|NCT02453841|50207754|FG000|Overall Study|Protocol Violation|1|||
25097311|NCT02453841|50207754|FG000|Overall Study|Unable to obtain blood samples|2|||
25097312|NCT02453685|50207760|FG000|Overall Study|Adverse Event|0|||
25097313|NCT02453685|50207761|FG001|Overall Study|Adverse Event|1|||
25097314|NCT02453685|50207760|FG000|Overall Study|Protocol Violation|7|||
25097315|NCT02453685|50207761|FG001|Overall Study|Protocol Violation|4|||
25097316|NCT02453685|50207760|FG000|Overall Study|Lost to Follow-up|0|||
25097317|NCT02453685|50207761|FG001|Overall Study|Lost to Follow-up|1|||
25097318|NCT02453685|50207760|FG000|Overall Study|Withdrawal by Subject|8|||
25097319|NCT02453685|50207761|FG001|Overall Study|Withdrawal by Subject|4|||
25097320|NCT02453685|50207760|FG000|Overall Study|Unclassified|4|||
25097321|NCT02453685|50207761|FG001|Overall Study|Unclassified|2|||
25097322|NCT02436759|50207769|FG000|Overall Study|Adverse Event|3|||
25097323|NCT02436759|50207770|FG001|Overall Study|Adverse Event|0|||
25097324|NCT02436759|50207769|FG000|Overall Study|Protocol Violation|1|||
25097325|NCT02436759|50207770|FG001|Overall Study|Protocol Violation|0|||
25097326|NCT02436759|50207769|FG000|Overall Study|Withdrawal by Subject|0|||
25097327|NCT02436759|50207770|FG001|Overall Study|Withdrawal by Subject|1|||
25097328|NCT02436681|50207776|FG000|Overall Study|Lost to Follow-up|10|||
25097329|NCT02436681|50207776|FG000|Overall Study|Withdrawal by Subject|2|||
25097330|NCT02436681|50207776|FG000|Overall Study|Death|2|||
25097331|NCT02436135|50207782|FG000|Overall Study|Progressive Disease|3|||
25097332|NCT02436135|50207783|FG001|Overall Study|Progressive Disease|1|||
25097333|NCT02436135|50207782|FG000|Overall Study|Investigator Discretion|1|||
25097334|NCT02436135|50207783|FG001|Overall Study|Investigator Discretion|2|||
25097335|NCT02436135|50207782|FG000|Overall Study|Adverse Event|1|||
25097336|NCT02436135|50207783|FG001|Overall Study|Adverse Event|0|||
25097337|NCT02436135|50207782|FG000|Overall Study|Withdrawal by Participant|1|||
25097338|NCT02436135|50207783|FG001|Overall Study|Withdrawal by Participant|0|||
25097339|NCT02436135|50207782|FG000|Overall Study|Study Terminated By Sponsor|0|||
25097340|NCT02436135|50207783|FG001|Overall Study|Study Terminated By Sponsor|1|||
25097341|NCT02489799|50207791|FG000|Overall Study|Lost to Follow-up|4|||
25097342|NCT02489799|50207792|FG001|Overall Study|Lost to Follow-up|1|||
25097343|NCT02489799|50207791|FG000|Overall Study|Failure to Maintain Eligibility|4|||
25097344|NCT02489799|50207792|FG001|Overall Study|Failure to Maintain Eligibility|6|||
25097345|NCT02489799|50207791|FG000|Overall Study|Withdrawal by Subject|1|||
25097346|NCT02489799|50207792|FG001|Overall Study|Withdrawal by Subject|1|||
25097347|NCT02489799|50207791|FG000|Overall Study|Death|0|||
25097348|NCT02489799|50207792|FG001|Overall Study|Death|1|||
25097349|NCT02435277|50207802|FG000|Overall Study|Adverse Event|1|||
25097350|NCT02435277|50207803|FG001|Overall Study|Adverse Event|1|||
25097351|NCT02435277|50207804|FG002|Overall Study|Adverse Event|0|||
25097352|NCT02435277|50207805|FG003|Overall Study|Adverse Event|0|||
25097353|NCT02435277|50207802|FG000|Overall Study|Withdrawal by Subject|1|||
25097354|NCT02435277|50207803|FG001|Overall Study|Withdrawal by Subject|0|||
25097355|NCT02435277|50207804|FG002|Overall Study|Withdrawal by Subject|0|||
25097356|NCT02435277|50207805|FG003|Overall Study|Withdrawal by Subject|0|||
25097357|NCT02420223|50207817|FG000|Overall Study|Adverse Event|1|||
25097358|NCT02420223|50207818|FG001|Overall Study|Adverse Event|0|||
25097359|NCT02420223|50207817|FG000|Overall Study|Physician Decision|0|||
25097360|NCT02420223|50207818|FG001|Overall Study|Physician Decision|2|||
25097361|NCT02433483|50207824|FG000|Overall Study|Unacceptable toxicity|1|||
25097362|NCT02433483|50207824|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
25097363|NCT02419755|50207830|FG000|Overall Study|Death|1|||
25097364|NCT02419755|50207831|FG001|Overall Study|Death|3|||
25097365|NCT02419755|50207830|FG000|Overall Study|Relapse|0|||
25097366|NCT02419755|50207831|FG001|Overall Study|Relapse|1|||
25097367|NCT02419755|50207830|FG000|Overall Study|Ineligible|1|||
25097368|NCT02419755|50207831|FG001|Overall Study|Ineligible|0|||
25097369|NCT02419755|50207830|FG000|Overall Study|Withdrawal by Subject|1|||
25097370|NCT02419755|50207831|FG001|Overall Study|Withdrawal by Subject|0|||
25097371|NCT02488551|50207841|FG000|Overall Study|Lost to Follow-up|4|||
25097372|NCT02488551|50207842|FG001|Overall Study|Lost to Follow-up|7|||
25097373|NCT02488551|50207843|FG002|Overall Study|Lost to Follow-up|0|||
25097374|NCT02488551|50207844|FG003|Overall Study|Lost to Follow-up|0|||
25097375|NCT02488551|50207841|FG000|Overall Study|Military Deployment|1|||
25097376|NCT02488551|50207842|FG001|Overall Study|Military Deployment|1|||
25097377|NCT02488551|50207843|FG002|Overall Study|Military Deployment|0|||
25097378|NCT02488551|50207844|FG003|Overall Study|Military Deployment|0|||
25097379|NCT02488239|50207854|FG000|Overall Study|Death|3|||
25097380|NCT02488239|50207854|FG000|Overall Study|Withdrawal by Subject|3|||
25097381|NCT02488239|50207854|FG000|Overall Study|Physician Decision|2|||
25097382|NCT02488239|50207854|FG000|Overall Study|Consent ineligible|1|||
25097383|NCT02488239|50207854|FG000|Overall Study|Did not undergo implant procedure|1|||
25097384|NCT02488005|50207859|FG000|Overall Study|Lost to Follow-up|2|||
25097385|NCT02487771|50207865|FG000|Overall Study|Lost to Follow-up|2|||
25097386|NCT02487771|50207866|FG001|Overall Study|Lost to Follow-up|3|||
25097387|NCT02487771|50207865|FG000|Overall Study|Moved out of area|5|||
25097388|NCT02487771|50207866|FG001|Overall Study|Moved out of area|6|||
25097389|NCT02487771|50207865|FG000|Overall Study|Withdrawal by Subject|3|||
25097390|NCT02487771|50207866|FG001|Overall Study|Withdrawal by Subject|5|||
25097391|NCT01359943|50207875|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
25097392|NCT01359943|50207876|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
25097393|NCT01359943|50207877|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
25097394|NCT01359943|50207875|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
25097395|NCT01359943|50207876|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
25097396|NCT01359943|50207877|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
25007999|NCT03237325|50100645|FG001|Overall Study|Withdrawal by Subject|12|||
25008000|NCT03237325|50100644|FG000|Overall Study|Noncompliance with Study Procedures|1|||
25008001|NCT03237325|50100645|FG001|Overall Study|Noncompliance with Study Procedures|1|||
25008002|NCT03237325|50100644|FG000|Overall Study|Termination by Sponsor|0|||
25008003|NCT03237325|50100645|FG001|Overall Study|Termination by Sponsor|1|||
25008004|NCT03237325|50100644|FG000|Overall Study|Reason other than described|0|||
25008005|NCT03237325|50100645|FG001|Overall Study|Reason other than described|2|||
25008006|NCT03113383|50100651|FG000|Overall Study|Death|4|||
25008007|NCT03113383|50100652|FG001|Overall Study|Death|0|||
25008008|NCT03762265|50100673|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
25008009|NCT03762265|50100674|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
25008010|NCT03762265|50100673|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
25008011|NCT03762265|50100674|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
25008012|NCT03762265|50100673|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
25008013|NCT03762265|50100674|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
25008014|NCT03762265|50100673|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
25008015|NCT03762265|50100674|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
25008016|NCT03762265|50100673|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
25008017|NCT03762265|50100674|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
25008018|NCT03762265|50100673|FG000|BT Period: Weeks 1 to 37|Other|0|||
25008019|NCT03762265|50100674|FG001|BT Period: Weeks 1 to 37|Other|1|||
25008020|NCT03762265|50100673|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
25097397|NCT01359943|50207875|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
25097398|NCT01359943|50207876|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
25097399|NCT01359943|50207877|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
25097400|NCT01359943|50207875|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
25008021|NCT03762265|50100674|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
25097401|NCT01359943|50207876|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
25097402|NCT01359943|50207877|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
25097403|NCT01359943|50207875|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
25097404|NCT01359943|50207876|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
25097405|NCT01359943|50207877|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
25097406|NCT01359943|50207875|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
25097407|NCT01359943|50207876|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
25097408|NCT01359943|50207877|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
25097409|NCT01359943|50207875|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
25097410|NCT01359943|50207876|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
25097411|NCT01359943|50207877|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
25097412|NCT01359943|50207875|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
25097413|NCT01359943|50207876|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
25097414|NCT01359943|50207877|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
25097415|NCT01359943|50207875|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
25097416|NCT01359943|50207876|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
25097417|NCT01359943|50207877|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
25097418|NCT01359943|50207875|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
25097419|NCT01359943|50207876|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
25097420|NCT01359943|50207877|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
25097421|NCT01359943|50207875|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
25097422|NCT01359943|50207876|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
25097423|NCT01359943|50207877|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
25097424|NCT01359943|50207875|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
25097425|NCT01359943|50207876|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
25097426|NCT01359943|50207877|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
25097427|NCT01359943|50207875|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
25097428|NCT01359943|50207876|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
25097429|NCT01359943|50207877|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
25097430|NCT01359943|50207875|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
25097431|NCT01359943|50207876|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
25097432|NCT01359943|50207877|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
25097433|NCT01359943|50207875|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
25097434|NCT01359943|50207876|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
25097435|NCT01359943|50207877|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
25097436|NCT02432703|50207889|FG000|Overall Study|Adverse Event|1|||
25097437|NCT02432703|50207890|FG001|Overall Study|Adverse Event|4|||
25097438|NCT02432703|50207889|FG000|Overall Study|Lack of Efficacy|1|||
25097439|NCT02432703|50207890|FG001|Overall Study|Lack of Efficacy|0|||
25097440|NCT02432703|50207889|FG000|Overall Study|Lost to Follow-up|5|||
25097441|NCT02432703|50207890|FG001|Overall Study|Lost to Follow-up|3|||
25097442|NCT02432703|50207889|FG000|Overall Study|Withdrawal by Subject|9|||
25097443|NCT02432703|50207890|FG001|Overall Study|Withdrawal by Subject|6|||
25097444|NCT02432703|50207889|FG000|Overall Study|Other|6|||
25097445|NCT02432703|50207890|FG001|Overall Study|Other|5|||
25097446|NCT02486757|50207896|FG000|Overall Study|Lost to Follow-up|1|||
25097447|NCT02418819|50207904|FG000|Overall Study|Adverse Event|0|||
25097448|NCT02418819|50207905|FG001|Overall Study|Adverse Event|0|||
25097449|NCT02418819|50207906|FG002|Overall Study|Adverse Event|1|||
25097450|NCT02418819|50207907|FG003|Overall Study|Adverse Event|0|||
25097451|NCT02418819|50207904|FG000|Overall Study|Lost to Follow-up|1|||
25097452|NCT02418819|50207905|FG001|Overall Study|Lost to Follow-up|0|||
25097453|NCT02418819|50207906|FG002|Overall Study|Lost to Follow-up|0|||
25097454|NCT02418819|50207907|FG003|Overall Study|Lost to Follow-up|0|||
25097455|NCT02418819|50207904|FG000|Overall Study|No longer meets eligibility criteria|0|||
25097456|NCT02418819|50207905|FG001|Overall Study|No longer meets eligibility criteria|0|||
25097457|NCT02418819|50207906|FG002|Overall Study|No longer meets eligibility criteria|1|||
25097458|NCT02418819|50207907|FG003|Overall Study|No longer meets eligibility criteria|0|||
25097459|NCT02418819|50207904|FG000|Overall Study|No longer willing to participate|0|||
25097460|NCT02418819|50207905|FG001|Overall Study|No longer willing to participate|0|||
25097461|NCT02418819|50207906|FG002|Overall Study|No longer willing to participate|2|||
25097462|NCT02418819|50207907|FG003|Overall Study|No longer willing to participate|1|||
25097463|NCT02576639|50207922|FG000|Overall Study|Withdrawal by Subject|1|||
25097464|NCT02576639|50207923|FG001|Overall Study|Withdrawal by Subject|2|||
25097465|NCT02576639|50207924|FG002|Overall Study|Withdrawal by Subject|1|||
25097466|NCT02576639|50207925|FG003|Overall Study|Withdrawal by Subject|0|||
25097467|NCT02576639|50207926|FG004|Overall Study|Withdrawal by Subject|1|||
25097468|NCT02576639|50207922|FG000|Overall Study|Adverse Event|1|||
25097469|NCT02576639|50207923|FG001|Overall Study|Adverse Event|0|||
25097470|NCT02576639|50207924|FG002|Overall Study|Adverse Event|1|||
25097471|NCT02576639|50207925|FG003|Overall Study|Adverse Event|1|||
25097472|NCT02576639|50207926|FG004|Overall Study|Adverse Event|2|||
25097473|NCT02576639|50207922|FG000|Overall Study|Physician Decision|0|||
25097474|NCT02576639|50207923|FG001|Overall Study|Physician Decision|0|||
25097475|NCT02576639|50207924|FG002|Overall Study|Physician Decision|0|||
25097476|NCT02576639|50207925|FG003|Overall Study|Physician Decision|0|||
25097477|NCT02576639|50207926|FG004|Overall Study|Physician Decision|1|||
25097478|NCT02418585|50207944|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
25097479|NCT02418585|50207945|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
25097480|NCT02418585|50207944|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
25097481|NCT02418585|50207945|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
25097482|NCT02418585|50207944|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
25097483|NCT02418585|50207945|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
25097484|NCT02418585|50207944|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
25097485|NCT02418585|50207945|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
25097486|NCT02418585|50207944|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
25097487|NCT02418585|50207945|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
25097488|NCT02418585|50207944|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
25097489|NCT02418585|50207945|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
25097490|NCT02418585|50207944|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
25097491|NCT02418585|50207945|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
25097492|NCT02418585|50207944|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
25097493|NCT02418585|50207945|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
25097494|NCT02418585|50207944|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
25097495|NCT02418585|50207945|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
25097496|NCT02418585|50207944|FG000|Follow-up Phase (24 Weeks)|Other|3|||
25097497|NCT02418585|50207945|FG001|Follow-up Phase (24 Weeks)|Other|2|||
25097498|NCT02417961|50207953|FG000|Overall Study|Adverse Event|1|||
25097499|NCT02417961|50207953|FG000|Overall Study|Lost to Follow-up|1|||
25097500|NCT02417961|50207953|FG000|Overall Study|Withdrawal by Subject|2|||
25097501|NCT01596127|50207957|FG000|Overall Study|Patient Ineligible|1|||
25097502|NCT01595581|50207972|FG000|Overall Study|Withdrawal by Subject|1|||
25097503|NCT01595581|50207973|FG001|Overall Study|Withdrawal by Subject|0|||
25097504|NCT01610687|50207981|FG000|Overall Study|Lack of Efficacy|26|||
25097505|NCT01610687|50207981|FG000|Overall Study|Adverse Event|18|||
25097506|NCT01610687|50207981|FG000|Overall Study|Moved out of area|6|||
25097507|NCT01610687|50207981|FG000|Overall Study|Withdrawal by Subject|7|||
25097508|NCT01610687|50207981|FG000|Overall Study|Lost to Follow-up|4|||
25097509|NCT01610687|50207981|FG000|Overall Study|Symptom control without study medication|2|||
25097510|NCT01610687|50207981|FG000|Overall Study|Unable to make journey|1|||
25097511|NCT01610687|50207981|FG000|Overall Study|Death|1|||
25097512|NCT01610687|50207981|FG000|Overall Study|Cannabis affecting job|1|||
25097513|NCT01610687|50207981|FG000|Overall Study|Felt more alter without study medication|1|||
25097514|NCT02615509|50207985|FG000|Overall Study|Lost to Follow-up|134|||
25097515|NCT02615509|50207985|FG000|Overall Study|Death|4|||
25097516|NCT02615509|50207985|FG000|Overall Study|Withdrawal by Subject|8|||
25097517|NCT02575079|50207991|FG000|Overall Study|Death|3|||
25097518|NCT02575079|50207992|FG001|Overall Study|Death|0|||
25097519|NCT02575079|50207991|FG000|Overall Study|Withdrawal by Subject|3|||
25097520|NCT02575079|50207992|FG001|Overall Study|Withdrawal by Subject|0|||
25097521|NCT02574845|50208003|FG000|Overall Study|Consent withdrawn further participation|0|||
25097522|NCT02574845|50208004|FG001|Overall Study|Consent withdrawn further participation|0|||
25097523|NCT02574845|50208005|FG002|Overall Study|Consent withdrawn further participation|0|||
25097524|NCT02574845|50208006|FG003|Overall Study|Consent withdrawn further participation|0|||
25097525|NCT02574845|50208007|FG004|Overall Study|Consent withdrawn further participation|1|||
25097526|NCT02574845|50208008|FG005|Overall Study|Consent withdrawn further participation|0|||
25097527|NCT02574845|50208003|FG000|Overall Study|Adverse Event|0|||
25097528|NCT02574845|50208004|FG001|Overall Study|Adverse Event|1|||
25097529|NCT02574845|50208005|FG002|Overall Study|Adverse Event|0|||
25097530|NCT02574845|50208006|FG003|Overall Study|Adverse Event|0|||
25097531|NCT02574845|50208007|FG004|Overall Study|Adverse Event|0|||
25097532|NCT02574845|50208008|FG005|Overall Study|Adverse Event|1|||
25097533|NCT02614183|50208025|FG000|Double Blind Treatment Phase|Adverse Event|10|||
25097534|NCT02614183|50208026|FG001|Double Blind Treatment Phase|Adverse Event|9|||
25097535|NCT02614183|50208027|FG002|Double Blind Treatment Phase|Adverse Event|7|||
25097536|NCT02614183|50208025|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
25097537|NCT02614183|50208026|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
25097538|NCT02614183|50208027|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
25097539|NCT02614183|50208025|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
25097540|NCT02614183|50208026|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
25097541|NCT02614183|50208027|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
25097542|NCT02614183|50208025|FG000|Double Blind Treatment Phase|Physician Decision|7|||
25097543|NCT02614183|50208026|FG001|Double Blind Treatment Phase|Physician Decision|3|||
25097544|NCT02614183|50208027|FG002|Double Blind Treatment Phase|Physician Decision|2|||
25097545|NCT02614183|50208025|FG000|Double Blind Treatment Phase|Pregnancy|2|||
25097546|NCT02614183|50208026|FG001|Double Blind Treatment Phase|Pregnancy|1|||
25097547|NCT02614183|50208027|FG002|Double Blind Treatment Phase|Pregnancy|3|||
25097548|NCT02614183|50208025|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
25097549|NCT02614183|50208026|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
25097550|NCT02614183|50208027|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
25097551|NCT02614183|50208025|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
25097552|NCT02614183|50208026|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
25097553|NCT02614183|50208027|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
25097554|NCT02614183|50208025|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
25097555|NCT02614183|50208026|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
25097556|NCT02614183|50208027|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
25097557|NCT02614183|50208025|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
25097558|NCT02614183|50208026|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
25097559|NCT02614183|50208027|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
25097560|NCT02614183|50208025|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
25097561|NCT02614183|50208026|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
25097562|NCT02614183|50208027|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
25097563|NCT02614183|50208025|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
25097564|NCT02614183|50208026|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
25097565|NCT02614183|50208027|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
25097566|NCT02614183|50208025|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
25097567|NCT02614183|50208026|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
25097568|NCT02614183|50208027|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
25097569|NCT02612155|50208052|FG000|Overall Study|Death|1|||
25097570|NCT02612155|50208053|FG001|Overall Study|Death|1|||
25097571|NCT02612155|50208052|FG000|Overall Study|Lost to Follow-up|2|||
25097572|NCT02612155|50208053|FG001|Overall Study|Lost to Follow-up|2|||
25097573|NCT02614729|50208061|FG000|Overall Study|Withdrawal by Subject|1|||
25097574|NCT02614729|50208062|FG001|Overall Study|Withdrawal by Subject|0|||
25097575|NCT02613871|50208070|FG000|Overall Study|Death|2|||
25097576|NCT02613871|50208070|FG000|Overall Study|Withdrew Consent|1|||
25097577|NCT05021081|50208076|FG000|Phase 2|Subject enrolled in error|1|||
25097578|NCT05021081|50208077|FG001|Phase 2|Subject enrolled in error|1|||
25097579|NCT05021081|50208078|FG002|Phase 2|Subject enrolled in error|0|||
25097580|NCT02612077|50208094|FG000|Overall Study|Adverse Event|3|||
25097581|NCT02612077|50208094|FG000|Overall Study|Withdrawal by Subject|9|||
25097582|NCT02612077|50208094|FG000|Overall Study|Protocol Violation|28|||
25097583|NCT02612077|50208094|FG000|Overall Study|Lost to Follow-up|20|||
25097584|NCT02612077|50208094|FG000|Overall Study|Death|377|||
25097585|NCT02612077|50208094|FG000|Overall Study|Moved or Changed Medical Team|23|||
25097586|NCT02612077|50208094|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
25097587|NCT02612077|50208094|FG000|Overall Study|Disease Progression|3|||
25097588|NCT02612077|50208094|FG000|Overall Study|Unknown reason|2|||
25097589|NCT02613481|50208101|FG000|Overall Study|Lost to Follow-up|7|||
25097590|NCT02613481|50208101|FG000|Overall Study|Withdrawal by Subject|2|||
25097591|NCT02613403|50208109|FG000|Overall Study|Lost to Follow-up|0|||
25097592|NCT02613403|50208110|FG001|Overall Study|Lost to Follow-up|1|||
25097593|NCT02613403|50208111|FG002|Overall Study|Lost to Follow-up|0|||
25097594|NCT02613403|50208112|FG003|Overall Study|Lost to Follow-up|0|||
25097595|NCT02613403|50208113|FG004|Overall Study|Lost to Follow-up|0|||
25097596|NCT02613403|50208109|FG000|Overall Study|Withdrawal by Subject|2|||
25097597|NCT02613403|50208110|FG001|Overall Study|Withdrawal by Subject|0|||
25097598|NCT02613403|50208111|FG002|Overall Study|Withdrawal by Subject|0|||
25097599|NCT02613403|50208112|FG003|Overall Study|Withdrawal by Subject|0|||
25097600|NCT02613403|50208113|FG004|Overall Study|Withdrawal by Subject|0|||
25097601|NCT02572817|50208125|FG000|Overall Study|Death|6|||
25097602|NCT02572817|50208126|FG001|Overall Study|Death|3|||
25097603|NCT02572817|50208125|FG000|Overall Study|Lost to Follow-up|3|||
25097604|NCT02572817|50208126|FG001|Overall Study|Lost to Follow-up|3|||
25097605|NCT02566109|50208132|FG000|Overall Study|Withdrawal by Subject|1|||
25097606|NCT02566031|50208138|FG000|Overall Study|Patient/guardian decision|14|||
25097607|NCT02566031|50208139|FG001|Overall Study|Patient/guardian decision|7|||
25097608|NCT02566031|50208138|FG000|Overall Study|Protocol deviation|2|||
25097609|NCT02566031|50208139|FG001|Overall Study|Protocol deviation|3|||
25097610|NCT02566031|50208138|FG000|Overall Study|Adverse Event|3|||
25097611|NCT02566031|50208139|FG001|Overall Study|Adverse Event|1|||
25177032|NCT01498679|50320976|FG001|Overall Study|Adverse Event|4|||
25177033|NCT01498679|50320975|FG000|Overall Study|Lack of Efficacy|72|||
25097612|NCT02566031|50208138|FG000|Overall Study|Lost to Follow-up|1|||
25097613|NCT02566031|50208139|FG001|Overall Study|Lost to Follow-up|1|||
25097614|NCT02569853|50208148|FG000|Overall Study|Adverse Event|2|||
25097615|NCT02569853|50208149|FG001|Overall Study|Adverse Event|0|||
25097616|NCT02569853|50208148|FG000|Overall Study|Withdrawal by Subject|3|||
25097617|NCT02569853|50208149|FG001|Overall Study|Withdrawal by Subject|2|||
25097618|NCT02569853|50208148|FG000|Overall Study|Lost to Follow-up|3|||
25097619|NCT02569853|50208149|FG001|Overall Study|Lost to Follow-up|3|||
25097620|NCT02569853|50208148|FG000|Overall Study|Protocol Violation|1|||
25097621|NCT02569853|50208149|FG001|Overall Study|Protocol Violation|1|||
25097622|NCT02569853|50208148|FG000|Overall Study|Did not experience migraine attack|10|||
25097623|NCT02569853|50208149|FG001|Overall Study|Did not experience migraine attack|7|||
25097624|NCT02569853|50208148|FG000|Overall Study|Physician Decision|1|||
25097625|NCT02569853|50208149|FG001|Overall Study|Physician Decision|1|||
25097626|NCT02570711|50208159|FG000|Overall Study|Death|1|||
25097627|NCT02570711|50208160|FG001|Overall Study|Death|0|||
25097628|NCT02570711|50208159|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
25097629|NCT02570711|50208160|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
25097630|NCT02570165|50208173|FG000|Overall Study|Adverse Event|1|||
25097631|NCT02570165|50208174|FG001|Overall Study|Adverse Event|0|||
25097632|NCT02570165|50208175|FG002|Overall Study|Adverse Event|2|||
25097633|NCT02570165|50208176|FG003|Overall Study|Adverse Event|0|||
25097634|NCT02570165|50208177|FG004|Overall Study|Adverse Event|0|||
25097635|NCT02570165|50208178|FG005|Overall Study|Adverse Event|0|||
25097636|NCT02570165|50208179|FG006|Overall Study|Adverse Event|0|||
25097637|NCT02570165|50208173|FG000|Overall Study|Lack of Efficacy|0|||
25097638|NCT02570165|50208174|FG001|Overall Study|Lack of Efficacy|1|||
25097639|NCT02570165|50208175|FG002|Overall Study|Lack of Efficacy|0|||
25097640|NCT02570165|50208176|FG003|Overall Study|Lack of Efficacy|0|||
25097641|NCT02570165|50208177|FG004|Overall Study|Lack of Efficacy|4|||
25097642|NCT02570165|50208178|FG005|Overall Study|Lack of Efficacy|0|||
25097643|NCT02570165|50208179|FG006|Overall Study|Lack of Efficacy|0|||
25097644|NCT02570165|50208173|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
25097645|NCT02570165|50208174|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
25097646|NCT02570165|50208175|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
25097647|NCT02570165|50208176|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
25097648|NCT02570165|50208177|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
25097649|NCT02570165|50208178|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
25097650|NCT02570165|50208179|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
25097651|NCT02570165|50208173|FG000|Overall Study|Lost to Follow-up|0|||
25097652|NCT02570165|50208174|FG001|Overall Study|Lost to Follow-up|0|||
25097653|NCT02570165|50208175|FG002|Overall Study|Lost to Follow-up|1|||
25097654|NCT02570165|50208176|FG003|Overall Study|Lost to Follow-up|1|||
25097655|NCT02570165|50208177|FG004|Overall Study|Lost to Follow-up|0|||
25097656|NCT02570165|50208178|FG005|Overall Study|Lost to Follow-up|0|||
25097657|NCT02570165|50208179|FG006|Overall Study|Lost to Follow-up|0|||
25097658|NCT02570165|50208173|FG000|Overall Study|Physician Decision|0|||
25097659|NCT02570165|50208174|FG001|Overall Study|Physician Decision|1|||
25097660|NCT02570165|50208175|FG002|Overall Study|Physician Decision|0|||
25097661|NCT02570165|50208176|FG003|Overall Study|Physician Decision|0|||
25097662|NCT02570165|50208177|FG004|Overall Study|Physician Decision|0|||
25097663|NCT02570165|50208178|FG005|Overall Study|Physician Decision|0|||
25097664|NCT02570165|50208179|FG006|Overall Study|Physician Decision|0|||
25097665|NCT02570165|50208173|FG000|Overall Study|Withdrawal by Subject|0|||
25097666|NCT02570165|50208174|FG001|Overall Study|Withdrawal by Subject|0|||
25097667|NCT02570165|50208175|FG002|Overall Study|Withdrawal by Subject|0|||
25097668|NCT02570165|50208176|FG003|Overall Study|Withdrawal by Subject|2|||
25097669|NCT02570165|50208177|FG004|Overall Study|Withdrawal by Subject|1|||
25097670|NCT02570165|50208178|FG005|Overall Study|Withdrawal by Subject|0|||
25097671|NCT02570165|50208179|FG006|Overall Study|Withdrawal by Subject|0|||
25097672|NCT02570165|50208173|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
25097673|NCT02570165|50208174|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
25097674|NCT02570165|50208175|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
25097675|NCT02570165|50208176|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
25097676|NCT02570165|50208177|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
25097677|NCT02570165|50208178|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
25097678|NCT02570165|50208179|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
25097679|NCT02570165|50208173|FG000|Overall Study|Withdrawal Request by GSK|0|||
25097680|NCT02570165|50208174|FG001|Overall Study|Withdrawal Request by GSK|0|||
25097681|NCT02570165|50208175|FG002|Overall Study|Withdrawal Request by GSK|2|||
25097682|NCT02570165|50208176|FG003|Overall Study|Withdrawal Request by GSK|0|||
25097683|NCT02570165|50208177|FG004|Overall Study|Withdrawal Request by GSK|0|||
25097684|NCT02570165|50208178|FG005|Overall Study|Withdrawal Request by GSK|0|||
25097685|NCT02570165|50208179|FG006|Overall Study|Withdrawal Request by GSK|0|||
25097686|NCT02564471|50208199|FG000|Overall Study|Adverse Event|1|||
25097687|NCT02564471|50208200|FG001|Overall Study|Adverse Event|0|||
25097688|NCT02564471|50208201|FG002|Overall Study|Adverse Event|0|||
25097689|NCT02564471|50208202|FG003|Overall Study|Adverse Event|0|||
25097690|NCT02564471|50208199|FG000|Overall Study|Withdrawal by Subject|2|||
25097691|NCT02564471|50208200|FG001|Overall Study|Withdrawal by Subject|1|||
25097692|NCT02564471|50208201|FG002|Overall Study|Withdrawal by Subject|3|||
25097693|NCT02564471|50208202|FG003|Overall Study|Withdrawal by Subject|0|||
25097694|NCT02564471|50208199|FG000|Overall Study|Lost to Follow-up|0|||
25097695|NCT02564471|50208200|FG001|Overall Study|Lost to Follow-up|2|||
25097696|NCT02564471|50208201|FG002|Overall Study|Lost to Follow-up|0|||
25097697|NCT02564471|50208202|FG003|Overall Study|Lost to Follow-up|0|||
25097698|NCT02563067|50208215|FG000|Overall Study|Subject/guardian decision|14|||
25097699|NCT02563067|50208216|FG001|Overall Study|Subject/guardian decision|20|||
25097700|NCT02563067|50208217|FG002|Overall Study|Subject/guardian decision|16|||
25097701|NCT02563067|50208215|FG000|Overall Study|Physician Decision|0|||
25097702|NCT02563067|50208216|FG001|Overall Study|Physician Decision|1|||
25097703|NCT02563067|50208217|FG002|Overall Study|Physician Decision|3|||
25097704|NCT02563067|50208215|FG000|Overall Study|Lost to Follow-up|1|||
25097705|NCT02563067|50208216|FG001|Overall Study|Lost to Follow-up|2|||
25097706|NCT02563067|50208217|FG002|Overall Study|Lost to Follow-up|0|||
25097707|NCT02563067|50208215|FG000|Overall Study|Technical problems|0|||
25097708|NCT02563067|50208216|FG001|Overall Study|Technical problems|1|||
25097709|NCT02563067|50208217|FG002|Overall Study|Technical problems|0|||
25097710|NCT02563067|50208215|FG000|Overall Study|Lack of Efficacy|1|||
25097711|NCT02563067|50208216|FG001|Overall Study|Lack of Efficacy|0|||
25097712|NCT02563067|50208217|FG002|Overall Study|Lack of Efficacy|0|||
25097713|NCT02563067|50208215|FG000|Overall Study|Death|0|||
25097714|NCT02563067|50208216|FG001|Overall Study|Death|1|||
25097715|NCT02563067|50208217|FG002|Overall Study|Death|1|||
25097716|NCT02563067|50208215|FG000|Overall Study|Adverse Event|2|||
25097717|NCT02563067|50208216|FG001|Overall Study|Adverse Event|1|||
25097718|NCT02563067|50208217|FG002|Overall Study|Adverse Event|0|||
25097719|NCT02563067|50208215|FG000|Overall Study|Death post Treatment/safety period|1|||
25097720|NCT02563067|50208216|FG001|Overall Study|Death post Treatment/safety period|0|||
25097721|NCT02563067|50208217|FG002|Overall Study|Death post Treatment/safety period|0|||
25097722|NCT02568683|50208227|FG000|Overall Study|Death|0|||
25097723|NCT02568683|50208228|FG001|Overall Study|Death|2|||
25097724|NCT02568683|50208227|FG000|Overall Study|Withdrew Consent|1|||
25097725|NCT02568683|50208228|FG001|Overall Study|Withdrew Consent|0|||
25097726|NCT02568683|50208227|FG000|Overall Study|Study Terminated By Sponsor|5|||
25097727|NCT02568683|50208228|FG001|Overall Study|Study Terminated By Sponsor|2|||
25097728|NCT02563925|50208234|FG000|Overall Study|Withdrawal by Subject|2|||
25097729|NCT01663727|50208241|FG000|Overall Study|Death|161|||
25097730|NCT01663727|50208242|FG001|Overall Study|Death|155|||
25097731|NCT01663727|50208241|FG000|Overall Study|Lost to Follow-up|10|||
25097732|NCT01663727|50208242|FG001|Overall Study|Lost to Follow-up|8|||
25097733|NCT01663727|50208241|FG000|Overall Study|Withdrawal by Subject|18|||
25097734|NCT01663727|50208242|FG001|Overall Study|Withdrawal by Subject|25|||
25097735|NCT01663727|50208241|FG000|Overall Study|Study Terminated|51|||
25097736|NCT01663727|50208242|FG001|Overall Study|Study Terminated|50|||
25097737|NCT01663727|50208241|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
25097738|NCT01663727|50208242|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
25097739|NCT01663727|50208241|FG000|Overall Study|Withdrawal prior to dosing.|1|||
25097740|NCT01663727|50208242|FG001|Overall Study|Withdrawal prior to dosing.|0|||
25097741|NCT02614261|50208251|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
25097742|NCT02614261|50208252|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
25097743|NCT02614261|50208253|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
25097744|NCT02614261|50208254|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
25097745|NCT02614261|50208251|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
25097746|NCT02614261|50208252|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
25097747|NCT02614261|50208253|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
25097748|NCT02614261|50208254|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
25097749|NCT02614261|50208251|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
25097750|NCT02614261|50208252|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
25097751|NCT02614261|50208253|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
25097752|NCT02614261|50208254|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
25177034|NCT01498679|50320976|FG001|Overall Study|Lack of Efficacy|12|||
25008022|NCT03762265|50100673|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
25008023|NCT03762265|50100674|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
25008024|NCT03762265|50100673|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
25008025|NCT03762265|50100674|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
25008026|NCT03762265|50100673|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
25008027|NCT03762265|50100674|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
25008028|NCT03762265|50100673|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
25008029|NCT03762265|50100674|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
25008030|NCT03762265|50100673|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
25008031|NCT03762265|50100674|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
25008032|NCT03762265|50100673|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
25008033|NCT03762265|50100674|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
25097753|NCT02614261|50208251|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
25177035|NCT01498679|50320975|FG000|Overall Study|Protocol Violation|4|||
25097754|NCT02614261|50208252|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
25097755|NCT02614261|50208253|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
25097756|NCT02614261|50208254|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
25097757|NCT02614261|50208251|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
25097758|NCT02614261|50208252|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
25097759|NCT02614261|50208253|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
25097760|NCT02614261|50208254|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
25097761|NCT02614261|50208251|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
25097762|NCT02614261|50208252|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
25097763|NCT02614261|50208253|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
25097764|NCT02614261|50208254|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
25097765|NCT02614261|50208251|FG000|Double-Blind Treatment Phase|Screen failure|0|||
25097766|NCT02614261|50208252|FG001|Double-Blind Treatment Phase|Screen failure|1|||
25097767|NCT02614261|50208253|FG002|Double-Blind Treatment Phase|Screen failure|2|||
25097768|NCT02614261|50208254|FG003|Double-Blind Treatment Phase|Screen failure|0|||
25097769|NCT02614261|50208251|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
25097770|NCT02614261|50208252|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
25097771|NCT02614261|50208253|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
25097772|NCT02614261|50208254|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
25097773|NCT02614261|50208251|FG000|Open-Label Extension Phase|Adverse Event|23|||
25097774|NCT02614261|50208252|FG001|Open-Label Extension Phase|Adverse Event|12|||
25097775|NCT02614261|50208253|FG002|Open-Label Extension Phase|Adverse Event|11|||
25097776|NCT02614261|50208254|FG003|Open-Label Extension Phase|Adverse Event|0|||
25097777|NCT02614261|50208251|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
25097778|NCT02614261|50208252|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
25097779|NCT02614261|50208253|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
25097780|NCT02614261|50208254|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
25097781|NCT02614261|50208251|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
25097782|NCT02614261|50208252|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
25097783|NCT02614261|50208253|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
25097784|NCT02614261|50208254|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
25097785|NCT02614261|50208251|FG000|Open-Label Extension Phase|Physician Decision|2|||
25097786|NCT02614261|50208252|FG001|Open-Label Extension Phase|Physician Decision|0|||
25097787|NCT02614261|50208253|FG002|Open-Label Extension Phase|Physician Decision|0|||
25097788|NCT02614261|50208254|FG003|Open-Label Extension Phase|Physician Decision|0|||
25097789|NCT02614261|50208251|FG000|Open-Label Extension Phase|Pregnancy|1|||
25097790|NCT02614261|50208252|FG001|Open-Label Extension Phase|Pregnancy|2|||
25097791|NCT02614261|50208253|FG002|Open-Label Extension Phase|Pregnancy|1|||
25097792|NCT02614261|50208254|FG003|Open-Label Extension Phase|Pregnancy|0|||
25097793|NCT02614261|50208251|FG000|Open-Label Extension Phase|Protocol Violation|3|||
25097794|NCT02614261|50208252|FG001|Open-Label Extension Phase|Protocol Violation|4|||
25097795|NCT02614261|50208253|FG002|Open-Label Extension Phase|Protocol Violation|1|||
25097796|NCT02614261|50208254|FG003|Open-Label Extension Phase|Protocol Violation|0|||
25097797|NCT02614261|50208251|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
25097798|NCT02614261|50208252|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
25097799|NCT02614261|50208253|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
25097800|NCT02614261|50208254|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
25097801|NCT02614261|50208251|FG000|Follow-up Phase|Adverse Event|2|||
25097802|NCT02614261|50208252|FG001|Follow-up Phase|Adverse Event|0|||
25097803|NCT02614261|50208253|FG002|Follow-up Phase|Adverse Event|1|||
25097804|NCT02614261|50208254|FG003|Follow-up Phase|Adverse Event|0|||
25097805|NCT02614261|50208251|FG000|Follow-up Phase|Lost to Follow-up|12|||
25097806|NCT02614261|50208252|FG001|Follow-up Phase|Lost to Follow-up|5|||
25097807|NCT02614261|50208253|FG002|Follow-up Phase|Lost to Follow-up|2|||
25097808|NCT02614261|50208254|FG003|Follow-up Phase|Lost to Follow-up|0|||
25097809|NCT02614261|50208251|FG000|Follow-up Phase|Physician Decision|5|||
25097810|NCT02614261|50208252|FG001|Follow-up Phase|Physician Decision|1|||
25097811|NCT02614261|50208253|FG002|Follow-up Phase|Physician Decision|0|||
25097812|NCT02614261|50208254|FG003|Follow-up Phase|Physician Decision|0|||
25097813|NCT02614261|50208251|FG000|Follow-up Phase|Pregnancy|0|||
25097814|NCT02614261|50208252|FG001|Follow-up Phase|Pregnancy|1|||
25097815|NCT02614261|50208253|FG002|Follow-up Phase|Pregnancy|0|||
25097816|NCT02614261|50208254|FG003|Follow-up Phase|Pregnancy|0|||
25097817|NCT02614261|50208251|FG000|Follow-up Phase|Protocol Violation|1|||
25097818|NCT02614261|50208252|FG001|Follow-up Phase|Protocol Violation|0|||
25097819|NCT02614261|50208253|FG002|Follow-up Phase|Protocol Violation|0|||
25097820|NCT02614261|50208254|FG003|Follow-up Phase|Protocol Violation|0|||
25097821|NCT02614261|50208251|FG000|Follow-up Phase|Withdrawal by Subject|12|||
25097822|NCT02614261|50208252|FG001|Follow-up Phase|Withdrawal by Subject|4|||
25097823|NCT02614261|50208253|FG002|Follow-up Phase|Withdrawal by Subject|11|||
25097824|NCT02614261|50208254|FG003|Follow-up Phase|Withdrawal by Subject|0|||
25097825|NCT02614261|50208251|FG000|Israel Addendum|Withdrawal by Subject|0|||
25097826|NCT02614261|50208252|FG001|Israel Addendum|Withdrawal by Subject|0|||
25097827|NCT02614261|50208253|FG002|Israel Addendum|Withdrawal by Subject|0|||
25097828|NCT02614261|50208254|FG003|Israel Addendum|Withdrawal by Subject|4|||
25097829|NCT01594411|50208280|FG000|Overall Study|Lost to Follow-up|2|||
25097830|NCT01594333|50208289|FG000|Overall Study|Death|96|||
25097831|NCT01594333|50208290|FG001|Overall Study|Death|83|||
25097832|NCT01594333|50208289|FG000|Overall Study|Lost to Follow-up|5|||
25097833|NCT01594333|50208290|FG001|Overall Study|Lost to Follow-up|5|||
25097834|NCT01594333|50208289|FG000|Overall Study|Withdrawal by Subject|60|||
25097835|NCT01594333|50208290|FG001|Overall Study|Withdrawal by Subject|63|||
25097836|NCT02609659|50208296|FG000|Overall Study|Adverse Event|1|||
25097837|NCT02609659|50208296|FG000|Overall Study|Lost to Follow-up|6|||
25097838|NCT02609659|50208296|FG000|Overall Study|Other|1|||
25097839|NCT02612779|50208302|FG000|Overall Study|Administrative reason by sponsor|4|||
25097840|NCT02612779|50208303|FG001|Overall Study|Administrative reason by sponsor|1|||
25097841|NCT02612779|50208302|FG000|Overall Study|No longer meet study criteria|0|||
25097842|NCT02612779|50208303|FG001|Overall Study|No longer meet study criteria|1|||
25097843|NCT02612779|50208302|FG000|Overall Study|Disease progression|29|||
25097844|NCT02612779|50208303|FG001|Overall Study|Disease progression|2|||
25097845|NCT02612779|50208302|FG000|Overall Study|Study drug toxicity|10|||
25097846|NCT02612779|50208303|FG001|Overall Study|Study drug toxicity|1|||
25097847|NCT02612779|50208302|FG000|Overall Study|Death|1|||
25097848|NCT02612779|50208303|FG001|Overall Study|Death|0|||
25097849|NCT02612779|50208302|FG000|Overall Study|Adverse event unrelated to study drug|5|||
25097850|NCT02612779|50208303|FG001|Overall Study|Adverse event unrelated to study drug|0|||
25097851|NCT02612779|50208302|FG000|Overall Study|Participant withdrew consent|4|||
25097852|NCT02612779|50208303|FG001|Overall Study|Participant withdrew consent|0|||
25097853|NCT02612779|50208302|FG000|Overall Study|Lost to Follow-up|1|||
25097854|NCT02612779|50208303|FG001|Overall Study|Lost to Follow-up|0|||
25097855|NCT02612779|50208302|FG000|Overall Study|Maximum clinical benefit|10|||
25097856|NCT02612779|50208303|FG001|Overall Study|Maximum clinical benefit|1|||
25097857|NCT02612779|50208302|FG000|Overall Study|Other reasons|4|||
25097858|NCT02612779|50208303|FG001|Overall Study|Other reasons|0|||
25097859|NCT02612623|50208314|FG000|Overall Study|Withdrawal by Subject|0|||
25097860|NCT02612623|50208315|FG001|Overall Study|Withdrawal by Subject|1|||
25097861|NCT02612623|50208316|FG002|Overall Study|Withdrawal by Subject|0|||
25097862|NCT02612623|50208317|FG003|Overall Study|Withdrawal by Subject|0|||
25097863|NCT02612623|50208314|FG000|Overall Study|Adverse Event|1|||
25097864|NCT02612623|50208315|FG001|Overall Study|Adverse Event|0|||
25097865|NCT02612623|50208316|FG002|Overall Study|Adverse Event|1|||
25097866|NCT02612623|50208317|FG003|Overall Study|Adverse Event|0|||
25097867|NCT02607865|50208331|FG000|Overall Study|Lost to Follow-up|9|||
25097868|NCT02607865|50208332|FG001|Overall Study|Lost to Follow-up|7|||
25097869|NCT02607865|50208333|FG002|Overall Study|Lost to Follow-up|7|||
25097870|NCT02607865|50208334|FG003|Overall Study|Lost to Follow-up|5|||
25097871|NCT02607865|50208331|FG000|Overall Study|Withdrawal by Subject|18|||
25097872|NCT02607865|50208332|FG001|Overall Study|Withdrawal by Subject|18|||
25097873|NCT02607865|50208333|FG002|Overall Study|Withdrawal by Subject|17|||
25097874|NCT02607865|50208334|FG003|Overall Study|Withdrawal by Subject|8|||
25097875|NCT02607865|50208331|FG000|Overall Study|Death|5|||
25097876|NCT02607865|50208332|FG001|Overall Study|Death|4|||
25097877|NCT02607865|50208333|FG002|Overall Study|Death|1|||
25097878|NCT02607865|50208334|FG003|Overall Study|Death|3|||
25097879|NCT02607865|50208331|FG000|Overall Study|Unclassified|1|||
25097880|NCT02607865|50208332|FG001|Overall Study|Unclassified|1|||
25097881|NCT02607865|50208333|FG002|Overall Study|Unclassified|2|||
25097882|NCT02607865|50208334|FG003|Overall Study|Unclassified|0|||
25097883|NCT01668667|50208348|FG000|Overall Study|Adverse Event|3|||
25097884|NCT01668667|50208349|FG001|Overall Study|Adverse Event|6|||
25097885|NCT01668667|50208350|FG002|Overall Study|Adverse Event|4|||
25097886|NCT01668667|50208351|FG003|Overall Study|Adverse Event|4|||
25097887|NCT01668667|50208348|FG000|Overall Study|Lack of Efficacy|3|||
25097888|NCT01668667|50208349|FG001|Overall Study|Lack of Efficacy|2|||
25097889|NCT01668667|50208350|FG002|Overall Study|Lack of Efficacy|2|||
25097890|NCT01668667|50208351|FG003|Overall Study|Lack of Efficacy|3|||
25097891|NCT01668667|50208348|FG000|Overall Study|Protocol Violation|6|||
25097892|NCT01668667|50208349|FG001|Overall Study|Protocol Violation|10|||
25097893|NCT01668667|50208350|FG002|Overall Study|Protocol Violation|12|||
25097894|NCT01668667|50208351|FG003|Overall Study|Protocol Violation|5|||
25097895|NCT01668667|50208348|FG000|Overall Study|Lost to Follow-up|9|||
25097896|NCT01668667|50208349|FG001|Overall Study|Lost to Follow-up|4|||
25097897|NCT01668667|50208350|FG002|Overall Study|Lost to Follow-up|7|||
25097898|NCT01668667|50208351|FG003|Overall Study|Lost to Follow-up|6|||
25097899|NCT01668667|50208348|FG000|Overall Study|Physician Decision|3|||
25097900|NCT01668667|50208349|FG001|Overall Study|Physician Decision|0|||
25097901|NCT01668667|50208350|FG002|Overall Study|Physician Decision|1|||
25097902|NCT01668667|50208351|FG003|Overall Study|Physician Decision|0|||
25177036|NCT01498679|50320976|FG001|Overall Study|Protocol Violation|0|||
25097903|NCT01668667|50208348|FG000|Overall Study|Withdrawal by Subject|7|||
25097904|NCT01668667|50208349|FG001|Overall Study|Withdrawal by Subject|4|||
25097905|NCT01668667|50208350|FG002|Overall Study|Withdrawal by Subject|5|||
25097906|NCT01668667|50208351|FG003|Overall Study|Withdrawal by Subject|5|||
25097907|NCT02608879|50208364|FG000|Overall Study|Lost to Follow-up|1|||
25097908|NCT02608879|50208365|FG001|Overall Study|Lost to Follow-up|0|||
25097909|NCT02608879|50208366|FG002|Overall Study|Lost to Follow-up|0|||
25097910|NCT02608879|50208364|FG000|Overall Study|Did not meet continuation criteria|0|||
25097911|NCT02608879|50208365|FG001|Overall Study|Did not meet continuation criteria|0|||
25097912|NCT02608879|50208366|FG002|Overall Study|Did not meet continuation criteria|3|||
25097913|NCT02608099|50208376|FG000|Overall Study|Ablation procedure not initiated|3|||
25097914|NCT02608099|50208377|FG001|Overall Study|Ablation procedure not initiated|2|||
25097915|NCT01668589|50208387|FG000|Overall Study|Lost to Follow-up|29|||
25097916|NCT01668589|50208388|FG001|Overall Study|Lost to Follow-up|37|||
25097917|NCT01668589|50208389|FG002|Overall Study|Lost to Follow-up|15|||
25097918|NCT01668589|50208390|FG003|Overall Study|Lost to Follow-up|5|||
25097919|NCT01668589|50208387|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
25097920|NCT01668589|50208388|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
25097921|NCT01668589|50208389|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
25097922|NCT01668589|50208390|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
25097923|NCT01668589|50208387|FG000|Overall Study|Death|12|||
25097924|NCT01668589|50208388|FG001|Overall Study|Death|3|||
25097925|NCT01668589|50208389|FG002|Overall Study|Death|2|||
25097926|NCT01668589|50208390|FG003|Overall Study|Death|11|||
25097927|NCT01668589|50208387|FG000|Overall Study|Other|44|||
25097928|NCT01668589|50208388|FG001|Overall Study|Other|10|||
25097929|NCT01668589|50208389|FG002|Overall Study|Other|7|||
25097930|NCT01668589|50208390|FG003|Overall Study|Other|15|||
25097931|NCT02432235|50208412|FG000|Overall Study|Death|1|||
25097932|NCT02432235|50208413|FG001|Overall Study|Death|1|||
25097933|NCT02432235|50208414|FG002|Overall Study|Death|2|||
25097934|NCT02432235|50208415|FG003|Overall Study|Death|2|||
25097935|NCT02432235|50208416|FG004|Overall Study|Death|1|||
25097936|NCT02432235|50208417|FG005|Overall Study|Death|3|||
25097937|NCT02432235|50208418|FG006|Overall Study|Death|11|||
25097938|NCT02432235|50208419|FG007|Overall Study|Death|15|||
25097939|NCT02432235|50208420|FG008|Overall Study|Death|15|||
25097940|NCT02432235|50208421|FG009|Overall Study|Death|3|||
25097941|NCT02432235|50208422|FG010|Overall Study|Death|1|||
25097942|NCT02432235|50208423|FG011|Overall Study|Death|0|||
25097943|NCT02432235|50208412|FG000|Overall Study|Withdrawal by Subject|0|||
25097944|NCT02432235|50208413|FG001|Overall Study|Withdrawal by Subject|1|||
25097945|NCT02432235|50208414|FG002|Overall Study|Withdrawal by Subject|0|||
25097946|NCT02432235|50208415|FG003|Overall Study|Withdrawal by Subject|0|||
25097947|NCT02432235|50208416|FG004|Overall Study|Withdrawal by Subject|0|||
25097948|NCT02432235|50208417|FG005|Overall Study|Withdrawal by Subject|2|||
25097949|NCT02432235|50208418|FG006|Overall Study|Withdrawal by Subject|5|||
25097950|NCT02432235|50208419|FG007|Overall Study|Withdrawal by Subject|3|||
25097951|NCT02432235|50208420|FG008|Overall Study|Withdrawal by Subject|1|||
25097952|NCT02432235|50208421|FG009|Overall Study|Withdrawal by Subject|0|||
25097953|NCT02432235|50208422|FG010|Overall Study|Withdrawal by Subject|0|||
25097954|NCT02432235|50208423|FG011|Overall Study|Withdrawal by Subject|0|||
25097955|NCT02432235|50208412|FG000|Overall Study|Lost to Follow-up|0|||
25097956|NCT02432235|50208413|FG001|Overall Study|Lost to Follow-up|0|||
25097957|NCT02432235|50208414|FG002|Overall Study|Lost to Follow-up|0|||
25097958|NCT02432235|50208415|FG003|Overall Study|Lost to Follow-up|0|||
25097959|NCT02432235|50208416|FG004|Overall Study|Lost to Follow-up|0|||
25097960|NCT02432235|50208417|FG005|Overall Study|Lost to Follow-up|1|||
25097961|NCT02432235|50208418|FG006|Overall Study|Lost to Follow-up|0|||
25097962|NCT02432235|50208419|FG007|Overall Study|Lost to Follow-up|0|||
25097963|NCT02432235|50208420|FG008|Overall Study|Lost to Follow-up|1|||
25097964|NCT02432235|50208421|FG009|Overall Study|Lost to Follow-up|0|||
25097965|NCT02432235|50208422|FG010|Overall Study|Lost to Follow-up|0|||
25097966|NCT02432235|50208423|FG011|Overall Study|Lost to Follow-up|0|||
25097967|NCT02432235|50208412|FG000|Overall Study|Miscellaneous|0|||
25097968|NCT02432235|50208413|FG001|Overall Study|Miscellaneous|0|||
25097969|NCT02432235|50208414|FG002|Overall Study|Miscellaneous|0|||
25097970|NCT02432235|50208415|FG003|Overall Study|Miscellaneous|0|||
25097971|NCT02432235|50208416|FG004|Overall Study|Miscellaneous|1|||
25097972|NCT02432235|50208417|FG005|Overall Study|Miscellaneous|6|||
25097973|NCT02432235|50208418|FG006|Overall Study|Miscellaneous|2|||
25097974|NCT02432235|50208419|FG007|Overall Study|Miscellaneous|2|||
25097975|NCT02432235|50208420|FG008|Overall Study|Miscellaneous|4|||
25097976|NCT02432235|50208421|FG009|Overall Study|Miscellaneous|0|||
25097977|NCT02432235|50208422|FG010|Overall Study|Miscellaneous|0|||
25097978|NCT02432235|50208423|FG011|Overall Study|Miscellaneous|1|||
25097979|NCT02431533|50208453|FG000|Overall Study|Withdrawal by Subject|1|||
25097980|NCT02431533|50208454|FG001|Overall Study|Withdrawal by Subject|3|||
25097981|NCT02431533|50208453|FG000|Overall Study|Developed Exclusionary criteria|1|||
25097982|NCT02431533|50208454|FG001|Overall Study|Developed Exclusionary criteria|0|||
25097983|NCT02416791|50208463|FG000|6 Months|Lost to Follow-up|0|||
25097984|NCT02416791|50208464|FG001|6 Months|Lost to Follow-up|0|||
25097985|NCT02416791|50208465|FG002|6 Months|Lost to Follow-up|1|||
25097986|NCT02414841|50208475|FG000|Overall Study|Withdrawal by Subject|7|||
25097987|NCT02414841|50208476|FG001|Overall Study|Withdrawal by Subject|5|||
25097988|NCT02414841|50208475|FG000|Overall Study|Lost to Follow-up|13|||
25097989|NCT02414841|50208476|FG001|Overall Study|Lost to Follow-up|6|||
25097990|NCT02414841|50208475|FG000|Overall Study|Death|17|||
25097991|NCT02414841|50208476|FG001|Overall Study|Death|14|||
25097992|NCT02414841|50208475|FG000|Overall Study|Received a Kidney Transplant|13|||
25097993|NCT02414841|50208476|FG001|Overall Study|Received a Kidney Transplant|4|||
25097994|NCT02414841|50208475|FG000|Overall Study|Randomized But Not Treated|6|||
25097995|NCT02414841|50208476|FG001|Overall Study|Randomized But Not Treated|4|||
25097996|NCT02413593|50208484|FG000|Overall Study|Lost to Follow-up|3|||
25097997|NCT02413593|50208484|FG000|Overall Study|Adverse Event|1|||
25097998|NCT01652703|50208494|FG000|Overall Study|Withdrawal by Subject|0|||
25097999|NCT01652703|50208495|FG001|Overall Study|Withdrawal by Subject|1|||
25098000|NCT01652703|50208496|FG002|Overall Study|Withdrawal by Subject|3|||
25098001|NCT01652703|50208497|FG003|Overall Study|Withdrawal by Subject|1|||
25098002|NCT01652703|50208498|FG004|Overall Study|Withdrawal by Subject|0|||
25098003|NCT01652703|50208499|FG005|Overall Study|Withdrawal by Subject|1|||
25098004|NCT01652703|50208494|FG000|Overall Study|Other|0|||
25098005|NCT01652703|50208495|FG001|Overall Study|Other|0|||
25098006|NCT01652703|50208496|FG002|Overall Study|Other|0|||
25098007|NCT01652703|50208497|FG003|Overall Study|Other|1|||
25098008|NCT01652703|50208498|FG004|Overall Study|Other|1|||
25098009|NCT01652703|50208499|FG005|Overall Study|Other|1|||
25098010|NCT01652469|50208515|FG000|Overall Study|Withdrawal by Subject|1|||
25098011|NCT01652469|50208516|FG001|Overall Study|Withdrawal by Subject|4|||
25098012|NCT01652469|50208515|FG000|Overall Study|Lost to Follow-up|0|||
25098013|NCT01652469|50208516|FG001|Overall Study|Lost to Follow-up|2|||
25098014|NCT02429427|50208524|FG000|Overall Study|Adverse Event|220|||
25098015|NCT02429427|50208525|FG001|Overall Study|Adverse Event|92|||
25098016|NCT02429427|50208524|FG000|Overall Study|Protocol Violation|10|||
25098017|NCT02429427|50208525|FG001|Overall Study|Protocol Violation|6|||
25098018|NCT02429427|50208524|FG000|Overall Study|Lost to Follow-up|15|||
25098019|NCT02429427|50208525|FG001|Overall Study|Lost to Follow-up|6|||
25098020|NCT02429427|50208524|FG000|Overall Study|Withdrawal by Subject|64|||
25098021|NCT02429427|50208525|FG001|Overall Study|Withdrawal by Subject|34|||
25098022|NCT02429427|50208524|FG000|Overall Study|Other|62|||
25098023|NCT02429427|50208525|FG001|Overall Study|Other|41|||
25098024|NCT02412735|50208534|FG000|Overall Study|Adverse Event|0|||
25098025|NCT02412735|50208535|FG001|Overall Study|Adverse Event|1|||
25098026|NCT02412735|50208536|FG002|Overall Study|Adverse Event|2|||
25098027|NCT02412735|50208534|FG000|Overall Study|Withdrawal by Subject|23|||
25098028|NCT02412735|50208535|FG001|Overall Study|Withdrawal by Subject|27|||
25098029|NCT02412735|50208536|FG002|Overall Study|Withdrawal by Subject|22|||
25098030|NCT02412735|50208534|FG000|Overall Study|Investigator Decision|3|||
25098031|NCT02412735|50208535|FG001|Overall Study|Investigator Decision|3|||
25098032|NCT02412735|50208536|FG002|Overall Study|Investigator Decision|2|||
25098033|NCT02412735|50208534|FG000|Overall Study|Lost to Follow-up|17|||
25098034|NCT02412735|50208535|FG001|Overall Study|Lost to Follow-up|11|||
25098035|NCT02412735|50208536|FG002|Overall Study|Lost to Follow-up|18|||
25098036|NCT02412735|50208534|FG000|Overall Study|Reason not Specified|3|||
25098037|NCT02412735|50208535|FG001|Overall Study|Reason not Specified|2|||
25098038|NCT02412735|50208536|FG002|Overall Study|Reason not Specified|2|||
25098039|NCT02412657|50208547|FG000|Overall Study|Lost to Follow-up|1|||
25098040|NCT02412657|50208548|FG001|Overall Study|Lost to Follow-up|0|||
25098041|NCT02412657|50208549|FG002|Overall Study|Lost to Follow-up|0|||
25098042|NCT02412657|50208547|FG000|Overall Study|Protocol Violation|0|||
25098043|NCT02412657|50208548|FG001|Overall Study|Protocol Violation|2|||
25098044|NCT02412657|50208549|FG002|Overall Study|Protocol Violation|3|||
25098045|NCT02428413|50208559|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
25098046|NCT02428413|50208560|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
25098047|NCT02428413|50208559|FG000|Overall Study|Protocol Violation|1|||
25098048|NCT02428413|50208560|FG001|Overall Study|Protocol Violation|2|||
25098049|NCT02428413|50208559|FG000|Overall Study|Case Cancelled|2|||
25098050|NCT02428413|50208560|FG001|Overall Study|Case Cancelled|0|||
25098051|NCT02428413|50208559|FG000|Overall Study|Missed Cases|1|||
25098052|NCT02428413|50208560|FG001|Overall Study|Missed Cases|2|||
25098053|NCT02428413|50208559|FG000|Overall Study|Nurse Refusal|1|||
25098054|NCT02428413|50208560|FG001|Overall Study|Nurse Refusal|0|||
25098055|NCT02412111|50208568|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
25098056|NCT02412111|50208569|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
25098057|NCT02412111|50208570|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
25098058|NCT02412111|50208568|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
25098059|NCT02412111|50208569|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
25098060|NCT02412111|50208570|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
25098061|NCT02412111|50208568|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
25098062|NCT02412111|50208569|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
25098063|NCT02412111|50208570|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
25098064|NCT02412111|50208568|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
25098065|NCT02412111|50208569|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
25098066|NCT02412111|50208570|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
25098067|NCT02412111|50208568|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
25098068|NCT02412111|50208569|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
25098069|NCT02412111|50208570|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
25098070|NCT02412111|50208568|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
25098071|NCT02412111|50208569|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
25098072|NCT02412111|50208570|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
25098073|NCT02412111|50208568|FG000|Active Comparator Period (8 Weeks)|Other|0|||
25098074|NCT02412111|50208569|FG001|Active Comparator Period (8 Weeks)|Other|0|||
25098075|NCT02412111|50208570|FG002|Active Comparator Period (8 Weeks)|Other|2|||
25098076|NCT02427477|50208582|FG000|Period 1|Adverse Event|1|||
25098077|NCT02427477|50208583|FG001|Period 1|Adverse Event|0|||
25098078|NCT02427399|50208594|FG000|Overall Study|Protocol Violation|14|||
25098079|NCT02427399|50208595|FG001|Overall Study|Protocol Violation|16|||
25098080|NCT02427399|50208596|FG002|Overall Study|Protocol Violation|12|||
25098081|NCT02427399|50208597|FG003|Overall Study|Protocol Violation|18|||
25098082|NCT02427399|50208598|FG004|Overall Study|Protocol Violation|15|||
25098083|NCT02426541|50208612|FG000|Overall Study|Protocol Violation|1|||
25098084|NCT02426541|50208613|FG001|Overall Study|Protocol Violation|0|||
25098085|NCT02484651|50208621|FG000|Overall Study|Patients' data files were corrupted.|1|||
25098086|NCT02484651|50208622|FG001|Overall Study|Patients' data files were corrupted.|1|||
25098087|NCT02484651|50208621|FG000|Overall Study|BIS monitoring failed.|1|||
25098088|NCT02484651|50208622|FG001|Overall Study|BIS monitoring failed.|1|||
25098089|NCT02484651|50208621|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
25098090|NCT02484651|50208622|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
25098091|NCT02410551|50208629|FG000|Overall Study|Adverse Event|1|||
25098092|NCT02410551|50208629|FG000|Overall Study|Withdrawal by Subject|1|||
25098093|NCT02410551|50208629|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
25098094|NCT02424591|50208636|FG000|Overall Study|Protocol Violation|2|||
25098095|NCT02424591|50208637|FG001|Overall Study|Protocol Violation|3|||
25098096|NCT02408523|50208645|FG000|Overall Study|Adverse Event|4|||
25098097|NCT02408523|50208646|FG001|Overall Study|Adverse Event|10|||
25098098|NCT02408523|50208645|FG000|Overall Study|Lack of Efficacy|0|||
25098099|NCT02408523|50208646|FG001|Overall Study|Lack of Efficacy|1|||
25098100|NCT02408523|50208645|FG000|Overall Study|Protocol Violation|1|||
25098101|NCT02408523|50208646|FG001|Overall Study|Protocol Violation|2|||
25098102|NCT02408523|50208645|FG000|Overall Study|Lost to Follow-up|2|||
25098103|NCT02408523|50208646|FG001|Overall Study|Lost to Follow-up|3|||
25098104|NCT02408523|50208645|FG000|Overall Study|Withdrawal by Subject|3|||
25098105|NCT02408523|50208646|FG001|Overall Study|Withdrawal by Subject|1|||
25177037|NCT01498679|50320975|FG000|Overall Study|Physician Decision|0|||
25008034|NCT03762265|50100673|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
25008035|NCT03762265|50100674|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
25008036|NCT03762265|50100673|FG000|LTE Period: Weeks 61 to 109|Other|1|||
25008037|NCT03762265|50100674|FG001|LTE Period: Weeks 61 to 109|Other|0|||
25008038|NCT03131960|50100698|FG000|Overall Study|Adverse Event|0|||
25008039|NCT03131960|50100699|FG001|Overall Study|Adverse Event|1|||
25008040|NCT03225170|50100708|FG000|Overall Study|Lost to Follow-up|4|||
25008041|NCT03225170|50100709|FG001|Overall Study|Lost to Follow-up|4|||
25008042|NCT03225170|50100710|FG002|Overall Study|Lost to Follow-up|0|||
25008043|NCT03225170|50100708|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
25008044|NCT03225170|50100709|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
25008045|NCT03225170|50100710|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
25008046|NCT02115139|50100716|FG000|Overall Study|Protocol Violation|1|||
25008047|NCT02115139|50100716|FG000|Overall Study|treatment discontinuation|6|||
25008048|NCT01763827|50100764|FG000|Overall Study|Withdrawal by Subject|1|||
25008049|NCT01763827|50100765|FG001|Overall Study|Withdrawal by Subject|0|||
25008050|NCT01763827|50100766|FG002|Overall Study|Withdrawal by Subject|0|||
25008051|NCT01763827|50100767|FG003|Overall Study|Withdrawal by Subject|0|||
25008052|NCT01763827|50100768|FG004|Overall Study|Withdrawal by Subject|2|||
25008053|NCT01763827|50100769|FG005|Overall Study|Withdrawal by Subject|0|||
25008054|NCT01763827|50100764|FG000|Overall Study|Decision by sponsor|2|||
25008055|NCT01763827|50100765|FG001|Overall Study|Decision by sponsor|0|||
25008056|NCT01763827|50100766|FG002|Overall Study|Decision by sponsor|3|||
25008057|NCT01763827|50100767|FG003|Overall Study|Decision by sponsor|0|||
25008058|NCT01763827|50100768|FG004|Overall Study|Decision by sponsor|2|||
25008059|NCT01763827|50100769|FG005|Overall Study|Decision by sponsor|1|||
25008060|NCT01763827|50100764|FG000|Overall Study|Lost to Follow-up|0|||
25008061|NCT01763827|50100765|FG001|Overall Study|Lost to Follow-up|1|||
25008062|NCT01763827|50100766|FG002|Overall Study|Lost to Follow-up|1|||
25098106|NCT02408523|50208645|FG000|Overall Study|Sponsor request|1|||
25098107|NCT02408523|50208646|FG001|Overall Study|Sponsor request|0|||
25098108|NCT02408523|50208645|FG000|Overall Study|Did not satisfy extension conditions|0|||
25098109|NCT02408523|50208646|FG001|Overall Study|Did not satisfy extension conditions|1|||
25098110|NCT02603419|50208666|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
25098111|NCT02603419|50208667|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
25098112|NCT02603419|50208668|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
25098113|NCT02603419|50208669|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
25098114|NCT02603419|50208670|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
25098115|NCT02603419|50208671|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
25098116|NCT02603419|50208666|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
25098117|NCT02603419|50208667|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
25098118|NCT02603419|50208668|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
25098119|NCT02603419|50208669|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
25098120|NCT02603419|50208670|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
25098121|NCT02603419|50208671|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
25098122|NCT02603419|50208666|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
25098123|NCT02603419|50208667|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
25098124|NCT02603419|50208668|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
25098125|NCT02603419|50208669|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
25098126|NCT02603419|50208670|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
25098127|NCT02603419|50208671|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
25098128|NCT02603419|50208666|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
25098129|NCT02603419|50208667|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
25098130|NCT02603419|50208668|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
25098131|NCT02603419|50208669|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
25098132|NCT02603419|50208670|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
25098133|NCT02603419|50208671|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
25098134|NCT02603419|50208666|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
25098135|NCT02603419|50208667|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
25098136|NCT02603419|50208668|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
25098137|NCT02603419|50208669|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
25098138|NCT02603419|50208670|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
25098139|NCT02603419|50208671|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
25098140|NCT02603419|50208666|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
25098141|NCT02603419|50208667|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
25098142|NCT02603419|50208668|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
25098143|NCT02603419|50208669|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
25098144|NCT02603419|50208670|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
25098145|NCT02603419|50208671|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
25098146|NCT02603419|50208666|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
25098147|NCT02603419|50208667|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
25098148|NCT02603419|50208668|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
25098149|NCT02603419|50208669|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
25098150|NCT02603419|50208670|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
25098151|NCT02603419|50208671|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
25098152|NCT02603419|50208666|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
25098153|NCT02603419|50208667|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
25098154|NCT02603419|50208668|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
25098155|NCT02603419|50208669|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
25098156|NCT02603419|50208670|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
25098157|NCT02603419|50208671|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
25098158|NCT02603419|50208666|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
25098159|NCT02603419|50208667|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
25098160|NCT02603419|50208668|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
25098161|NCT02603419|50208669|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
25098162|NCT02603419|50208670|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
25098163|NCT02603419|50208671|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
25098164|NCT02603419|50208666|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
25098165|NCT02603419|50208667|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
25098166|NCT02603419|50208668|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
25098167|NCT02603419|50208669|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
25098168|NCT02603419|50208670|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
25098169|NCT02603419|50208671|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
25098170|NCT01668355|50208688|FG000|Overall Study|Death|3|||
25098171|NCT01668355|50208689|FG001|Overall Study|Death|1|||
25098172|NCT01668355|50208688|FG000|Overall Study|Withdrawal by Subject|6|||
25098173|NCT01668355|50208689|FG001|Overall Study|Withdrawal by Subject|1|||
25098174|NCT01667731|50208701|FG000|Overall Study|Enrolled but not treated|0|||
25098175|NCT01667731|50208702|FG001|Overall Study|Enrolled but not treated|0|||
25098176|NCT01667731|50208703|FG002|Overall Study|Enrolled but not treated|0|||
25098177|NCT01667731|50208704|FG003|Overall Study|Enrolled but not treated|0|||
25098178|NCT01667731|50208705|FG004|Overall Study|Enrolled but not treated|1|||
25098179|NCT01667731|50208701|FG000|Overall Study|Efficacy Failure|1|||
25098180|NCT01667731|50208702|FG001|Overall Study|Efficacy Failure|12|||
25098181|NCT01667731|50208703|FG002|Overall Study|Efficacy Failure|0|||
25098182|NCT01667731|50208704|FG003|Overall Study|Efficacy Failure|1|||
25098183|NCT01667731|50208705|FG004|Overall Study|Efficacy Failure|24|||
25098184|NCT01667731|50208701|FG000|Overall Study|Lost to Follow-up|2|||
25098185|NCT01667731|50208702|FG001|Overall Study|Lost to Follow-up|3|||
25098186|NCT01667731|50208703|FG002|Overall Study|Lost to Follow-up|1|||
25098187|NCT01667731|50208704|FG003|Overall Study|Lost to Follow-up|1|||
25098188|NCT01667731|50208705|FG004|Overall Study|Lost to Follow-up|2|||
25098189|NCT01667731|50208701|FG000|Overall Study|Subject Withdrew Consent|2|||
25098190|NCT01667731|50208702|FG001|Overall Study|Subject Withdrew Consent|0|||
25098191|NCT01667731|50208703|FG002|Overall Study|Subject Withdrew Consent|1|||
25098192|NCT01667731|50208704|FG003|Overall Study|Subject Withdrew Consent|0|||
25098193|NCT01667731|50208705|FG004|Overall Study|Subject Withdrew Consent|1|||
25098194|NCT01667731|50208701|FG000|Overall Study|Death|0|||
25098195|NCT01667731|50208702|FG001|Overall Study|Death|1|||
25098196|NCT01667731|50208703|FG002|Overall Study|Death|0|||
25098197|NCT01667731|50208704|FG003|Overall Study|Death|0|||
25098198|NCT01667731|50208705|FG004|Overall Study|Death|0|||
25098199|NCT02605837|50208720|FG000|Overall Study|Adverse Event|3|||
25098200|NCT02605837|50208721|FG001|Overall Study|Adverse Event|1|||
25098201|NCT02605837|50208720|FG000|Overall Study|Non-Compliance with Study Drug|0|||
25098202|NCT02605837|50208721|FG001|Overall Study|Non-Compliance with Study Drug|1|||
25098203|NCT02605837|50208720|FG000|Overall Study|Withdrawal by Subject|8|||
25098204|NCT02605837|50208721|FG001|Overall Study|Withdrawal by Subject|8|||
25098205|NCT02605837|50208720|FG000|Overall Study|Physician Decision|0|||
25098206|NCT02605837|50208721|FG001|Overall Study|Physician Decision|1|||
25098207|NCT02423343|50208734|FG000|Overall Study|Withdrawal by Subject|0|||
25098208|NCT02423343|50208735|FG001|Overall Study|Withdrawal by Subject|1|||
25098209|NCT02423343|50208736|FG002|Overall Study|Withdrawal by Subject|0|||
25098210|NCT02423343|50208737|FG003|Overall Study|Withdrawal by Subject|0|||
25098211|NCT02423343|50208738|FG004|Overall Study|Withdrawal by Subject|0|||
25098212|NCT02423343|50208739|FG005|Overall Study|Withdrawal by Subject|0|||
25098213|NCT02423343|50208734|FG000|Overall Study|Progressive Disease|0|||
25098214|NCT02423343|50208735|FG001|Overall Study|Progressive Disease|0|||
25098215|NCT02423343|50208736|FG002|Overall Study|Progressive Disease|0|||
25098216|NCT02423343|50208737|FG003|Overall Study|Progressive Disease|0|||
25177038|NCT01498679|50320976|FG001|Overall Study|Physician Decision|2|||
25008063|NCT01763827|50100767|FG003|Overall Study|Lost to Follow-up|1|||
25008064|NCT01763827|50100768|FG004|Overall Study|Lost to Follow-up|2|||
25008065|NCT01763827|50100769|FG005|Overall Study|Lost to Follow-up|1|||
25008066|NCT01732783|50100822|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
25008067|NCT01732783|50100823|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
25008068|NCT01732783|50100824|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
25008069|NCT01732783|50100822|FG000|Overall Study|Death|13|||
25008070|NCT01732783|50100823|FG001|Overall Study|Death|4|||
25008071|NCT01732783|50100824|FG002|Overall Study|Death|1|||
25008072|NCT01732783|50100822|FG000|Overall Study|Lost to Follow-up|7|||
25008073|NCT01732783|50100823|FG001|Overall Study|Lost to Follow-up|1|||
25008074|NCT01732783|50100824|FG002|Overall Study|Lost to Follow-up|1|||
25008075|NCT01732783|50100822|FG000|Overall Study|Administrative Decision|8|||
25008076|NCT01732783|50100823|FG001|Overall Study|Administrative Decision|2|||
25008077|NCT01732783|50100824|FG002|Overall Study|Administrative Decision|1|||
25008078|NCT01732783|50100822|FG000|Overall Study|Withdrawal by Subject|1|||
25008079|NCT01732783|50100823|FG001|Overall Study|Withdrawal by Subject|0|||
25008080|NCT01732783|50100824|FG002|Overall Study|Withdrawal by Subject|0|||
25008081|NCT02787850|50100851|FG000|Overall Study|Withdrawal by Subject|0|||
25098217|NCT02423343|50208738|FG004|Overall Study|Progressive Disease|2|||
25098218|NCT02423343|50208739|FG005|Overall Study|Progressive Disease|0|||
25098219|NCT02423343|50208734|FG000|Overall Study|Adverse Event|0|||
25008082|NCT02787850|50100852|FG001|Overall Study|Withdrawal by Subject|1|||
25008083|NCT01375777|50100876|FG000|Overall Study|Withdrawal by Subject|0|||
25098220|NCT02423343|50208735|FG001|Overall Study|Adverse Event|0|||
25098221|NCT02423343|50208736|FG002|Overall Study|Adverse Event|0|||
25098222|NCT02423343|50208737|FG003|Overall Study|Adverse Event|0|||
25098223|NCT02423343|50208738|FG004|Overall Study|Adverse Event|2|||
25098224|NCT02423343|50208739|FG005|Overall Study|Adverse Event|0|||
25098225|NCT02423343|50208734|FG000|Overall Study|Death|0|||
25098226|NCT02423343|50208735|FG001|Overall Study|Death|0|||
25098227|NCT02423343|50208736|FG002|Overall Study|Death|0|||
25098228|NCT02423343|50208737|FG003|Overall Study|Death|0|||
25008084|NCT01375777|50100877|FG001|Overall Study|Withdrawal by Subject|2|||
25008085|NCT01375777|50100878|FG002|Overall Study|Withdrawal by Subject|1|||
25098229|NCT02423343|50208738|FG004|Overall Study|Death|1|||
25098230|NCT02423343|50208739|FG005|Overall Study|Death|0|||
25177039|NCT01498679|50320975|FG000|Overall Study|Withdrawal by Subject|12|||
25098231|NCT02605447|50208767|FG000|Overall Study|Death|66|||
25098232|NCT02605447|50208767|FG000|Overall Study|Physician Decision|1|||
25098233|NCT02605447|50208767|FG000|Overall Study|Lost to Follow-up|24|||
25098234|NCT02605447|50208767|FG000|Overall Study|Withdrawal by Subject|10|||
25098235|NCT02605447|50208767|FG000|Overall Study|Not disclosed|1|||
25098236|NCT02485899|50208774|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
25098237|NCT02485899|50208775|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
25098238|NCT02485899|50208774|FG000|Overall Study|Withdrawal by Subject|1|||
25098239|NCT02485899|50208775|FG001|Overall Study|Withdrawal by Subject|0|||
25098240|NCT02485899|50208774|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
25098241|NCT02485899|50208775|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
25098242|NCT02423109|50208781|FG000|Lens 1|Adverse Event|1|||
25098243|NCT02423109|50208782|FG001|Lens 1|Adverse Event|0|||
25098244|NCT02420691|50208790|FG000|Overall Study|Adverse Event|3|||
25098245|NCT02420691|50208790|FG000|Overall Study|Withdrawal by Subject|3|||
25098246|NCT02406651|50208794|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
25098247|NCT02406261|50208801|FG000|Period 1|Lost to Follow-up|2|||
25098248|NCT02406261|50208802|FG001|Period 1|Lost to Follow-up|0|||
25098249|NCT02406261|50208801|FG000|Period 1|Adverse Event|1|||
25098250|NCT02406261|50208802|FG001|Period 1|Adverse Event|0|||
25098251|NCT02406261|50208801|FG000|Period 2|Physician Decision|0|||
25098252|NCT02406261|50208802|FG001|Period 2|Physician Decision|1|||
25098253|NCT02406261|50208801|FG000|Period 2|Protocol Violation|0|||
25098254|NCT02406261|50208802|FG001|Period 2|Protocol Violation|1|||
25098255|NCT02406261|50208801|FG000|Period 2|Withdrawal by Subject|0|||
25098256|NCT02406261|50208802|FG001|Period 2|Withdrawal by Subject|1|||
25098257|NCT02405091|50208812|FG000|Overall Study|Adverse Event|16|||
25098258|NCT02405091|50208813|FG001|Overall Study|Adverse Event|10|||
25098259|NCT02405091|50208814|FG002|Overall Study|Adverse Event|0|||
25098260|NCT02405091|50208812|FG000|Overall Study|Protocol Violation|1|||
25098261|NCT02405091|50208813|FG001|Overall Study|Protocol Violation|0|||
25098262|NCT02405091|50208814|FG002|Overall Study|Protocol Violation|0|||
25098263|NCT02405091|50208812|FG000|Overall Study|Noncompliance|1|||
25098264|NCT02405091|50208813|FG001|Overall Study|Noncompliance|6|||
25098265|NCT02405091|50208814|FG002|Overall Study|Noncompliance|2|||
25098266|NCT02405091|50208812|FG000|Overall Study|Withdrawal by Subject|4|||
25098267|NCT02405091|50208813|FG001|Overall Study|Withdrawal by Subject|8|||
25098268|NCT02405091|50208814|FG002|Overall Study|Withdrawal by Subject|0|||
25098269|NCT02405091|50208812|FG000|Overall Study|Death|0|||
25098270|NCT02405091|50208813|FG001|Overall Study|Death|1|||
25098271|NCT02405091|50208814|FG002|Overall Study|Death|0|||
25098272|NCT02405091|50208812|FG000|Overall Study|Lost to Follow-up|5|||
25098273|NCT02405091|50208813|FG001|Overall Study|Lost to Follow-up|6|||
25098274|NCT02405091|50208814|FG002|Overall Study|Lost to Follow-up|0|||
25098275|NCT02405091|50208812|FG000|Overall Study|Physician Decision|2|||
25098276|NCT02405091|50208813|FG001|Overall Study|Physician Decision|2|||
25098277|NCT02405091|50208814|FG002|Overall Study|Physician Decision|0|||
25098278|NCT02485353|50208825|FG000|Overall Study|Death|1|||
25098279|NCT02485353|50208825|FG000|Overall Study|Disease Progression|1|||
25098280|NCT02603107|50208831|FG000|Randomized Phase|Withdrew consent|8|||
25098281|NCT02603107|50208832|FG001|Randomized Phase|Withdrew consent|15|||
25098282|NCT02603107|50208831|FG000|Randomized Phase|Lost to Follow-up|1|||
25098283|NCT02603107|50208832|FG001|Randomized Phase|Lost to Follow-up|3|||
25098284|NCT02603107|50208831|FG000|Randomized Phase|Adverse Event|2|||
25098285|NCT02603107|50208832|FG001|Randomized Phase|Adverse Event|0|||
25098286|NCT02603107|50208831|FG000|Randomized Phase|Death|1|||
25098287|NCT02603107|50208832|FG001|Randomized Phase|Death|1|||
25098288|NCT02603107|50208831|FG000|Randomized Phase|Non-compliance with study drug|1|||
25098289|NCT02603107|50208832|FG001|Randomized Phase|Non-compliance with study drug|1|||
25098290|NCT02603107|50208831|FG000|Randomized Phase|Investigator's discretion|0|||
25098291|NCT02603107|50208832|FG001|Randomized Phase|Investigator's discretion|1|||
25098292|NCT02603107|50208831|FG000|Randomized Phase|Lack of Efficacy|1|||
25177040|NCT01498679|50320976|FG001|Overall Study|Withdrawal by Subject|4|||
25098293|NCT02603107|50208832|FG001|Randomized Phase|Lack of Efficacy|0|||
25098294|NCT02603107|50208831|FG000|Randomized Phase|Protocol Violation|1|||
25098295|NCT02603107|50208832|FG001|Randomized Phase|Protocol Violation|0|||
25098296|NCT02603107|50208831|FG000|Optional Extension Phase|Lost to Follow-up|3|||
25098297|NCT02603107|50208832|FG001|Optional Extension Phase|Lost to Follow-up|3|||
25098298|NCT02603107|50208831|FG000|Optional Extension Phase|Withdrew consent|3|||
25098299|NCT02603107|50208832|FG001|Optional Extension Phase|Withdrew consent|2|||
25098300|NCT02603107|50208831|FG000|Optional Extension Phase|Investigator's discretion|2|||
25098301|NCT02603107|50208832|FG001|Optional Extension Phase|Investigator's discretion|2|||
25098302|NCT02603107|50208831|FG000|Optional Extension Phase|Pregnancy|0|||
25098303|NCT02603107|50208832|FG001|Optional Extension Phase|Pregnancy|3|||
25098304|NCT02603107|50208831|FG000|Optional Extension Phase|Adverse Event|0|||
25098305|NCT02603107|50208832|FG001|Optional Extension Phase|Adverse Event|2|||
25098306|NCT02603107|50208831|FG000|Optional Extension Phase|Not treated in extension phase|0|||
25098307|NCT02603107|50208832|FG001|Optional Extension Phase|Not treated in extension phase|1|||
25098308|NCT02603107|50208831|FG000|Optional Extension Phase|Protocol Violation|1|||
25098309|NCT02603107|50208832|FG001|Optional Extension Phase|Protocol Violation|0|||
25098310|NCT02484729|50208850|FG000|Overall Study|Failure of IntelliCap Error|0|||
25098311|NCT02484729|50208851|FG001|Overall Study|Failure of IntelliCap Error|0|||
25098312|NCT02484729|50208852|FG002|Overall Study|Failure of IntelliCap Error|0|||
25098313|NCT02484729|50208853|FG003|Overall Study|Failure of IntelliCap Error|0|||
25098314|NCT02484729|50208854|FG004|Overall Study|Failure of IntelliCap Error|0|||
25098315|NCT02484729|50208855|FG005|Overall Study|Failure of IntelliCap Error|0|||
25098316|NCT02484729|50208856|FG006|Overall Study|Failure of IntelliCap Error|0|||
25098317|NCT02484729|50208857|FG007|Overall Study|Failure of IntelliCap Error|0|||
25098318|NCT02484729|50208858|FG008|Overall Study|Failure of IntelliCap Error|0|||
25098319|NCT02484729|50208859|FG009|Overall Study|Failure of IntelliCap Error|1|||
25098320|NCT02601625|50208897|FG000|Overall Study|Lost to Follow-up|0|||
25098321|NCT02601625|50208898|FG001|Overall Study|Lost to Follow-up|0|||
25098322|NCT02601625|50208899|FG002|Overall Study|Lost to Follow-up|1|||
25098323|NCT02601625|50208900|FG003|Overall Study|Lost to Follow-up|1|||
25098324|NCT02601469|50208926|FG000|Overall Study|Enrolled in Error|1|||
25098325|NCT02601469|50208927|FG001|Overall Study|Enrolled in Error|0|||
25098326|NCT02604589|50208936|FG000|Overall Study|catheter dislodgement|0|||
25098327|NCT02604589|50208937|FG001|Overall Study|catheter dislodgement|0|||
25098328|NCT02604589|50208938|FG002|Overall Study|catheter dislodgement|1|||
25098329|NCT02601001|50208949|FG000|Dosing Period 2|Adverse Event|0|||
25098330|NCT02601001|50208950|FG001|Dosing Period 2|Adverse Event|0|||
25098331|NCT02601001|50208951|FG002|Dosing Period 2|Adverse Event|0|||
25098332|NCT02601001|50208952|FG003|Dosing Period 2|Adverse Event|0|||
25098333|NCT02601001|50208953|FG004|Dosing Period 2|Adverse Event|0|||
25098334|NCT02601001|50208954|FG005|Dosing Period 2|Adverse Event|0|||
25098335|NCT02601001|50208955|FG006|Dosing Period 2|Adverse Event|1|||
25098336|NCT02604199|50208980|FG000|Overall Study|Pregnancy|0|||
25098337|NCT02604199|50208981|FG001|Overall Study|Pregnancy|0|||
25098338|NCT02604199|50208982|FG002|Overall Study|Pregnancy|0|||
25098339|NCT02604199|50208983|FG003|Overall Study|Pregnancy|1|||
25098340|NCT02604199|50208980|FG000|Overall Study|Study terminated by sponsor|0|||
25098341|NCT02604199|50208981|FG001|Overall Study|Study terminated by sponsor|2|||
25098342|NCT02604199|50208982|FG002|Overall Study|Study terminated by sponsor|0|||
25098343|NCT02604199|50208983|FG003|Overall Study|Study terminated by sponsor|2|||
25098344|NCT02604199|50208980|FG000|Overall Study|Withdrawal by Subject|0|||
25098345|NCT02604199|50208981|FG001|Overall Study|Withdrawal by Subject|1|||
25098346|NCT02604199|50208982|FG002|Overall Study|Withdrawal by Subject|0|||
25098347|NCT02604199|50208983|FG003|Overall Study|Withdrawal by Subject|0|||
25098348|NCT02600845|50208996|FG000|Overall Study|Reason Not Specified|3|||
25098349|NCT02600845|50208996|FG000|Overall Study|Non-compliance with Study Procedures|10|||
25098350|NCT02600845|50208996|FG000|Overall Study|Consent Withdrawal|5|||
25098351|NCT02599129|50209002|FG000|Overall Study|Lack of Efficacy|2|||
25098352|NCT02599129|50209003|FG001|Overall Study|Lack of Efficacy|2|||
25098353|NCT02599129|50209002|FG000|Overall Study|Lost to Follow-up|1|||
25098354|NCT02599129|50209003|FG001|Overall Study|Lost to Follow-up|0|||
25098355|NCT02599129|50209002|FG000|Overall Study|Withdrawal by Subject|2|||
25098356|NCT02599129|50209003|FG001|Overall Study|Withdrawal by Subject|1|||
25098357|NCT02596711|50209012|FG000|Overall Study|Lost to Follow-up|1|||
25098358|NCT02596711|50209013|FG001|Overall Study|Lost to Follow-up|2|||
25098359|NCT02596711|50209014|FG002|Overall Study|Lost to Follow-up|3|||
25098360|NCT02596009|50209022|FG000|Overall Study|Administrative problems|0|||
25098361|NCT02596009|50209023|FG001|Overall Study|Administrative problems|1|||
25098362|NCT02596009|50209024|FG002|Overall Study|Administrative problems|0|||
25098363|NCT02596009|50209025|FG003|Overall Study|Administrative problems|0|||
25098364|NCT02596009|50209026|FG004|Overall Study|Administrative problems|0|||
25098365|NCT02596009|50209027|FG005|Overall Study|Administrative problems|0|||
25098366|NCT02590939|50209035|FG000|Overall Study|Withdrawal by Subject|3|||
25098367|NCT02590939|50209036|FG001|Overall Study|Withdrawal by Subject|1|||
25098368|NCT02590939|50209035|FG000|Overall Study|Failed the nociceptive test|2|||
25098369|NCT02590939|50209036|FG001|Overall Study|Failed the nociceptive test|1|||
25098370|NCT04351087|50209044|FG000|Overall Study|Lost to Follow-up|7|||
25098371|NCT04351087|50209045|FG001|Overall Study|Lost to Follow-up|3|||
25098372|NCT04351087|50209044|FG000|Overall Study|Withdrawal by Subject|3|||
25098373|NCT04351087|50209045|FG001|Overall Study|Withdrawal by Subject|4|||
25098374|NCT04351087|50209044|FG000|Overall Study|Lack of Efficacy|3|||
25098375|NCT04351087|50209045|FG001|Overall Study|Lack of Efficacy|2|||
25098376|NCT02598193|50209051|FG000|Overall Study|Adverse Event|13|||
25098377|NCT02598193|50209051|FG000|Overall Study|Withdrawal by Subject|1|||
25098378|NCT02598193|50209051|FG000|Overall Study|Listed in active lung transplant list|1|||
25098379|NCT02598193|50209051|FG000|Overall Study|Does not want to take Nintedanib|1|||
25098380|NCT02595073|50209057|FG000|Overall Study|Progressive Disease|0|||
25098381|NCT02595073|50209058|FG001|Overall Study|Progressive Disease|1|||
25098382|NCT02595073|50209057|FG000|Overall Study|Protocol Violation|2|||
25098383|NCT02595073|50209058|FG001|Overall Study|Protocol Violation|0|||
25098384|NCT02593825|50209066|FG000|Intervention|Lost to Follow-up|10|||
25098385|NCT02593825|50209067|FG001|Intervention|Lost to Follow-up|12|||
25098386|NCT02388165|50209077|FG000|Overall Study|Study terminated by sponsor|5|||
25098387|NCT02388165|50209078|FG001|Overall Study|Study terminated by sponsor|5|||
25098388|NCT02388165|50209077|FG000|Overall Study|Other|11|||
25098389|NCT02388165|50209078|FG001|Overall Study|Other|13|||
25098390|NCT02388165|50209077|FG000|Overall Study|No longer meet eligibility criteria|40|||
25098391|NCT02388165|50209078|FG001|Overall Study|No longer meet eligibility criteria|43|||
25098392|NCT02388165|50209077|FG000|Overall Study|Withdrawal of consent|31|||
25098393|NCT02388165|50209078|FG001|Overall Study|Withdrawal of consent|32|||
25098394|NCT02388165|50209077|FG000|Overall Study|Lost to Follow-up|19|||
25098395|NCT02388165|50209078|FG001|Overall Study|Lost to Follow-up|20|||
25098396|NCT02388165|50209077|FG000|Overall Study|Death|13|||
25098397|NCT02388165|50209078|FG001|Overall Study|Death|10|||
25098398|NCT02388165|50209077|FG000|Overall Study|Adverse Event|3|||
25098399|NCT02388165|50209078|FG001|Overall Study|Adverse Event|5|||
25098400|NCT02388165|50209077|FG000|Overall Study|Did not meet entrance criteria|5|||
25098401|NCT02388165|50209078|FG001|Overall Study|Did not meet entrance criteria|2|||
25098402|NCT02404545|50209086|FG000|Overall Study|Sponsor Termination|6|||
25098403|NCT02404545|50209087|FG001|Overall Study|Sponsor Termination|6|||
25098404|NCT02420379|50209096|FG000|Overall Study|Withdrawal by Subject|0|||
25098405|NCT02420379|50209097|FG001|Overall Study|Withdrawal by Subject|3|||
25098406|NCT02420379|50209096|FG000|Overall Study|Unable to complete due to schooling|0|||
25098407|NCT02420379|50209097|FG001|Overall Study|Unable to complete due to schooling|1|||
25098408|NCT02420379|50209096|FG000|Overall Study|Transitioned to commercial drug|1|||
25098409|NCT02420379|50209097|FG001|Overall Study|Transitioned to commercial drug|0|||
25098410|NCT02347761|50209106|FG000|All Collected|Death|1|||
25098411|NCT02347761|50209107|FG001|All Collected|Death|0|||
25098412|NCT02347761|50209108|FG002|All Collected|Death|0|||
25098413|NCT02347761|50209106|FG000|All Collected|Lost to Follow-up|3|||
25098414|NCT02347761|50209107|FG001|All Collected|Lost to Follow-up|2|||
25098415|NCT02347761|50209108|FG002|All Collected|Lost to Follow-up|3|||
25098416|NCT02347761|50209106|FG000|All Collected|Withdrawal by Subject|11|||
25098417|NCT02347761|50209107|FG001|All Collected|Withdrawal by Subject|11|||
25098418|NCT02347761|50209108|FG002|All Collected|Withdrawal by Subject|22|||
25098419|NCT02347761|50209106|FG000|All Collected|invetigator disretion|2|||
25098420|NCT02347761|50209107|FG001|All Collected|invetigator disretion|0|||
25098421|NCT02347761|50209108|FG002|All Collected|invetigator disretion|0|||
25098422|NCT02347761|50209106|FG000|All Collected|instillation site pain|0|||
25098423|NCT02347761|50209107|FG001|All Collected|instillation site pain|0|||
25098424|NCT02347761|50209108|FG002|All Collected|instillation site pain|1|||
25098425|NCT02347761|50209106|FG000|All Collected|exacerbation of COPD|0|||
25098426|NCT02347761|50209107|FG001|All Collected|exacerbation of COPD|0|||
25098427|NCT02347761|50209108|FG002|All Collected|exacerbation of COPD|1|||
25098428|NCT02347761|50209106|FG000|All Collected|moved/travel|0|||
25098429|NCT02347761|50209107|FG001|All Collected|moved/travel|1|||
25098430|NCT02347761|50209108|FG002|All Collected|moved/travel|0|||
25098431|NCT02347761|50209106|FG000|On Study Treatment|Lack of Efficacy|2|||
25098432|NCT02347761|50209107|FG001|On Study Treatment|Lack of Efficacy|3|||
25098433|NCT02347761|50209108|FG002|On Study Treatment|Lack of Efficacy|4|||
25098434|NCT02347761|50209106|FG000|On Study Treatment|non-compliance with study medication|0|||
25098435|NCT02347761|50209107|FG001|On Study Treatment|non-compliance with study medication|0|||
25098436|NCT02347761|50209108|FG002|On Study Treatment|non-compliance with study medication|2|||
25098437|NCT02347761|50209106|FG000|On Study Treatment|Withdrawal by Subject|7|||
25098438|NCT02347761|50209107|FG001|On Study Treatment|Withdrawal by Subject|3|||
25098439|NCT02347761|50209108|FG002|On Study Treatment|Withdrawal by Subject|5|||
25098440|NCT02347761|50209106|FG000|On Study Treatment|move/travel|2|||
25098441|NCT02347761|50209107|FG001|On Study Treatment|move/travel|6|||
25098442|NCT02347761|50209108|FG002|On Study Treatment|move/travel|5|||
25098443|NCT02347761|50209106|FG000|On Study Treatment|dissastisfaction with device|2|||
25098444|NCT02347761|50209107|FG001|On Study Treatment|dissastisfaction with device|1|||
25098445|NCT02347761|50209108|FG002|On Study Treatment|dissastisfaction with device|4|||
25098446|NCT02347761|50209106|FG000|On Study Treatment|Lost to Follow-up|2|||
25098447|NCT02347761|50209107|FG001|On Study Treatment|Lost to Follow-up|1|||
25098448|NCT02347761|50209108|FG002|On Study Treatment|Lost to Follow-up|1|||
25098449|NCT02347761|50209106|FG000|On Study Treatment|investigator discretion|2|||
25098450|NCT02347761|50209107|FG001|On Study Treatment|investigator discretion|0|||
25098451|NCT02347761|50209108|FG002|On Study Treatment|investigator discretion|0|||
25098452|NCT02347761|50209106|FG000|On Study Treatment|durg not working|0|||
25098453|NCT02347761|50209107|FG001|On Study Treatment|durg not working|1|||
25098454|NCT02347761|50209108|FG002|On Study Treatment|durg not working|1|||
25098455|NCT02347761|50209106|FG000|On Study Treatment|Adverse Event|10|||
25098456|NCT02347761|50209107|FG001|On Study Treatment|Adverse Event|8|||
25098457|NCT02347761|50209108|FG002|On Study Treatment|Adverse Event|20|||
25098458|NCT02596945|50209116|FG000|Overall Study|No documentation of study drug dosing|3|||
25098459|NCT02596945|50209116|FG000|Overall Study|Other|32|||
25098460|NCT02596945|50209116|FG000|Overall Study|Change to hemodialysis|15|||
25098461|NCT02596945|50209116|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
25098462|NCT02596945|50209116|FG000|Overall Study|Withdrawal by Subject|1|||
25098463|NCT02596945|50209116|FG000|Overall Study|Missing|1|||
25098464|NCT02404389|50209134|FG000|Overall Study|Adverse Event|1|||
25098465|NCT02404389|50209135|FG001|Overall Study|Adverse Event|0|||
25098466|NCT02404389|50209136|FG002|Overall Study|Adverse Event|1|||
25098467|NCT02404389|50209137|FG003|Overall Study|Adverse Event|0|||
25098468|NCT02404389|50209138|FG004|Overall Study|Adverse Event|2|||
25098469|NCT02404389|50209134|FG000|Overall Study|Subject/guardian decision|1|||
25098470|NCT02404389|50209135|FG001|Overall Study|Subject/guardian decision|0|||
25098471|NCT02404389|50209136|FG002|Overall Study|Subject/guardian decision|0|||
25098472|NCT02404389|50209137|FG003|Overall Study|Subject/guardian decision|1|||
25098473|NCT02404389|50209138|FG004|Overall Study|Subject/guardian decision|1|||
25098474|NCT01667419|50209156|FG000|Overall Study|Reason Not Specified|1|||
25098475|NCT01667419|50209157|FG001|Overall Study|Reason Not Specified|0|||
25098476|NCT01667419|50209158|FG002|Overall Study|Reason Not Specified|0|||
25098477|NCT01667419|50209159|FG003|Overall Study|Reason Not Specified|0|||
25098478|NCT01667419|50209156|FG000|Overall Study|Withdrawal by Subject|16|||
25098479|NCT01667419|50209157|FG001|Overall Study|Withdrawal by Subject|8|||
25098480|NCT01667419|50209158|FG002|Overall Study|Withdrawal by Subject|9|||
25098481|NCT01667419|50209159|FG003|Overall Study|Withdrawal by Subject|8|||
25098482|NCT01667419|50209156|FG000|Overall Study|Non-compliance|0|||
25098483|NCT01667419|50209157|FG001|Overall Study|Non-compliance|0|||
25098484|NCT01667419|50209158|FG002|Overall Study|Non-compliance|0|||
25098485|NCT01667419|50209159|FG003|Overall Study|Non-compliance|1|||
25098486|NCT01667419|50209156|FG000|Overall Study|Protocol Violation|1|||
25098487|NCT01667419|50209157|FG001|Overall Study|Protocol Violation|0|||
25098488|NCT01667419|50209158|FG002|Overall Study|Protocol Violation|0|||
25098489|NCT01667419|50209159|FG003|Overall Study|Protocol Violation|0|||
25098490|NCT01667419|50209156|FG000|Overall Study|Lost to Follow-up|7|||
25098491|NCT01667419|50209157|FG001|Overall Study|Lost to Follow-up|6|||
25098492|NCT01667419|50209158|FG002|Overall Study|Lost to Follow-up|2|||
25098493|NCT01667419|50209159|FG003|Overall Study|Lost to Follow-up|4|||
25098494|NCT01667419|50209156|FG000|Overall Study|Death|18|||
25098495|NCT01667419|50209157|FG001|Overall Study|Death|33|||
25098496|NCT01667419|50209158|FG002|Overall Study|Death|25|||
25098497|NCT01667419|50209159|FG003|Overall Study|Death|26|||
25098498|NCT02588833|50209176|FG000|Part 1|Withdrawal by Subject|1|||
25098499|NCT02588833|50209177|FG001|Part 1|Withdrawal by Subject|0|||
25098500|NCT02588833|50209176|FG000|Part 2A|Physician Decision|0|||
25098501|NCT02588833|50209177|FG001|Part 2A|Physician Decision|1|||
25098502|NCT02588833|50209176|FG000|Part 2A|Withdrawal by Subject|0|||
25098503|NCT02588833|50209177|FG001|Part 2A|Withdrawal by Subject|1|||
25098504|NCT02588833|50209176|FG000|Part 2B|Adverse Event|0|||
25098505|NCT02588833|50209177|FG001|Part 2B|Adverse Event|1|||
25098506|NCT02588833|50209176|FG000|Part 2C|Adverse Event|0|||
25098507|NCT02588833|50209177|FG001|Part 2C|Adverse Event|1|||
25098508|NCT02588833|50209176|FG000|Part 2C|Withdrawal by Subject|0|||
25098509|NCT02588833|50209177|FG001|Part 2C|Withdrawal by Subject|1|||
25098510|NCT02588833|50209176|FG000|Part 3 (Safety Follow-up)|Other|0|||
25098511|NCT02588833|50209177|FG001|Part 3 (Safety Follow-up)|Other|2|||
25098512|NCT01667107|50209186|FG000|Overall Study|Adverse Event|4|||
25098513|NCT01667107|50209187|FG001|Overall Study|Adverse Event|3|||
25098514|NCT01667107|50209186|FG000|Overall Study|Tolerability issues|0|||
25098515|NCT01667107|50209187|FG001|Overall Study|Tolerability issues|2|||
25098516|NCT01667107|50209186|FG000|Overall Study|Protocol Violation|0|||
25098517|NCT01667107|50209187|FG001|Overall Study|Protocol Violation|1|||
25098518|NCT01667107|50209186|FG000|Overall Study|Lack of Efficacy|0|||
25098519|NCT01667107|50209187|FG001|Overall Study|Lack of Efficacy|1|||
25098520|NCT02590003|50209211|FG000|Overall Study|Death|1|||
25098521|NCT02590003|50209212|FG001|Overall Study|Death|2|||
25098522|NCT02404311|50209241|FG000|Part A: Month 0-18|Death|2|||
25098523|NCT02404311|50209242|FG001|Part A: Month 0-18|Death|0|||
25098524|NCT02404311|50209243|FG002|Part A: Month 0-18|Death|0|||
25098525|NCT02404311|50209244|FG003|Part A: Month 0-18|Death|0|||
25098526|NCT02404311|50209245|FG004|Part A: Month 0-18|Death|0|||
25098527|NCT02404311|50209241|FG000|Part A: Month 0-18|Physician Decision|1|||
25098528|NCT02404311|50209242|FG001|Part A: Month 0-18|Physician Decision|0|||
25177041|NCT01526785|50320999|FG000|Overall Study|Study Terminated by Sponsor|8|||
25098529|NCT02404311|50209243|FG002|Part A: Month 0-18|Physician Decision|0|||
25098530|NCT02404311|50209244|FG003|Part A: Month 0-18|Physician Decision|0|||
25098531|NCT02404311|50209245|FG004|Part A: Month 0-18|Physician Decision|0|||
25098532|NCT02404311|50209241|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
25098533|NCT02404311|50209242|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
25177042|NCT01526785|50320999|FG000|Overall Study|Death|2|||
25098534|NCT02404311|50209243|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
25098535|NCT02404311|50209244|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
25098536|NCT02404311|50209245|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
25098537|NCT02404311|50209241|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
25098538|NCT02404311|50209242|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
25098539|NCT02404311|50209243|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
25098540|NCT02404311|50209244|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
25098541|NCT02404311|50209245|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
25098542|NCT02404311|50209241|FG000|Part A: Month 0-18|HIV Infection|6|||
25098543|NCT02404311|50209242|FG001|Part A: Month 0-18|HIV Infection|2|||
25098544|NCT02404311|50209243|FG002|Part A: Month 0-18|HIV Infection|0|||
25098545|NCT02404311|50209244|FG003|Part A: Month 0-18|HIV Infection|0|||
25098546|NCT02404311|50209245|FG004|Part A: Month 0-18|HIV Infection|0|||
25098547|NCT02404311|50209241|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
25098548|NCT02404311|50209242|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
25098549|NCT02404311|50209243|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
25098550|NCT02404311|50209244|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
25098551|NCT02404311|50209245|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
25098552|NCT01650519|50209259|FG000|Overall Study|Withdrawal by Subject|1|||
25098553|NCT01650519|50209260|FG001|Overall Study|Withdrawal by Subject|0|||
25098554|NCT01650285|50209266|FG000|Overall Study|Adverse Event|1|||
25098555|NCT02347527|50209274|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
25098556|NCT02347527|50209275|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
25098557|NCT02347527|50209276|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
25098558|NCT02347527|50209277|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
25098559|NCT02347527|50209274|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
25098560|NCT02347527|50209275|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
25098561|NCT02347527|50209276|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
25098562|NCT02347527|50209277|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
25098563|NCT02347527|50209274|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
25098564|NCT02347527|50209275|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
25098565|NCT02347527|50209276|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
25098566|NCT02347527|50209277|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
25098567|NCT02347527|50209274|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
25098568|NCT02347527|50209275|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
25098569|NCT02347527|50209276|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
25098570|NCT02347527|50209277|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
25098571|NCT02347527|50209274|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
25098572|NCT02347527|50209275|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
25098573|NCT02347527|50209276|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
25098574|NCT02347527|50209277|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
25098575|NCT02386839|50209291|FG000|Overall Study|Death|1|||
25098576|NCT02386839|50209292|FG001|Overall Study|Death|0|||
25098577|NCT02386839|50209291|FG000|Overall Study|Withdrawal by Subject|9|||
25098578|NCT02386839|50209292|FG001|Overall Study|Withdrawal by Subject|10|||
25098579|NCT02386839|50209291|FG000|Overall Study|Lost to Follow-up|4|||
25098580|NCT02386839|50209292|FG001|Overall Study|Lost to Follow-up|4|||
25098581|NCT02386839|50209291|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
25098582|NCT02386839|50209292|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
25098583|NCT02386839|50209291|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
25098584|NCT02386839|50209292|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
25098585|NCT02386839|50209291|FG000|Overall Study|Other (unspecified)|1|||
25098586|NCT02386839|50209292|FG001|Overall Study|Other (unspecified)|0|||
25098587|NCT01649271|50209304|FG000|Overall Study|Progressive disease|4|||
25098588|NCT01649271|50209305|FG001|Overall Study|Progressive disease|5|||
25098589|NCT01649271|50209304|FG000|Overall Study|Other Adverse Event|0|||
25098590|NCT01649271|50209305|FG001|Overall Study|Other Adverse Event|2|||
25098591|NCT01649271|50209304|FG000|Overall Study|Withdrawal by Subject|1|||
25098592|NCT01649271|50209305|FG001|Overall Study|Withdrawal by Subject|0|||
25098593|NCT01649271|50209304|FG000|Overall Study|Other than stated above|1|||
25098594|NCT01649271|50209305|FG001|Overall Study|Other than stated above|0|||
25098595|NCT02385669|50209312|FG000|Overall Study|Adverse Event|2|||
25098596|NCT02402907|50209318|FG000|Overall Study|Delivered vaginally|9|||
25098597|NCT02402907|50209319|FG001|Overall Study|Delivered vaginally|3|||
25098598|NCT02402907|50209318|FG000|Overall Study|Delivered outside of Sinai|1|||
25098599|NCT02402907|50209319|FG001|Overall Study|Delivered outside of Sinai|1|||
25098600|NCT02402907|50209318|FG000|Overall Study|Lost to follow up after C-Section|10|||
25098601|NCT02402907|50209319|FG001|Overall Study|Lost to follow up after C-Section|23|||
25098602|NCT02345889|50209329|FG000|Overall Study|Inadequate Bowel Prep|17|||
25098603|NCT02345889|50209330|FG001|Overall Study|Inadequate Bowel Prep|16|||
25177043|NCT01526785|50320999|FG000|Overall Study|Physician Decision|1|||
25177044|NCT01526785|50320999|FG000|Overall Study|Withdrawal by Subject|2|||
25177045|NCT01559389|50321005|FG000|Overall Study|Withdrawal by Subject|20|||
25098604|NCT02345889|50209331|FG002|Overall Study|Inadequate Bowel Prep|18|||
25098605|NCT02345889|50209332|FG003|Overall Study|Inadequate Bowel Prep|14|||
25098606|NCT02345889|50209329|FG000|Overall Study|Polyposis identified during procedure|1|||
25098607|NCT02345889|50209330|FG001|Overall Study|Polyposis identified during procedure|1|||
25098608|NCT02345889|50209331|FG002|Overall Study|Polyposis identified during procedure|0|||
25098609|NCT02345889|50209332|FG003|Overall Study|Polyposis identified during procedure|1|||
25098610|NCT02345889|50209329|FG000|Overall Study|Recognized ineligible post-randomization|1|||
25098611|NCT02345889|50209330|FG001|Overall Study|Recognized ineligible post-randomization|0|||
25098612|NCT02345889|50209331|FG002|Overall Study|Recognized ineligible post-randomization|2|||
25098613|NCT02345889|50209332|FG003|Overall Study|Recognized ineligible post-randomization|1|||
25098614|NCT02345889|50209329|FG000|Overall Study|Ulcerative Colitis identified|1|||
25098615|NCT02345889|50209330|FG001|Overall Study|Ulcerative Colitis identified|0|||
25098616|NCT02345889|50209331|FG002|Overall Study|Ulcerative Colitis identified|0|||
25098617|NCT02345889|50209332|FG003|Overall Study|Ulcerative Colitis identified|0|||
25098618|NCT02345889|50209329|FG000|Overall Study|Cecum not intubated|1|||
25098619|NCT02345889|50209330|FG001|Overall Study|Cecum not intubated|0|||
25098620|NCT02345889|50209331|FG002|Overall Study|Cecum not intubated|0|||
25098621|NCT02345889|50209332|FG003|Overall Study|Cecum not intubated|0|||
25098622|NCT02345811|50209342|FG000|First Intervention|Withdrawal by Subject|1|||
25098623|NCT02345811|50209343|FG001|First Intervention|Withdrawal by Subject|1|||
25098624|NCT02344173|50209351|FG000|Procedure|Ablation Procedure Not Performed|7|||
25098625|NCT02344173|50209351|FG000|12-month Visit|Death|8|||
25098626|NCT02344173|50209351|FG000|12-month Visit|Withdrawal by Subject|30|||
25098627|NCT02344173|50209351|FG000|12-month Visit|Lost to Follow-up|58|||
25098628|NCT02586493|50209357|FG000|Overall Study|Adverse Event|4|||
25098629|NCT02586493|50209357|FG000|Overall Study|Protocol Violation|6|||
25098630|NCT02586493|50209357|FG000|Overall Study|Lost to Follow-up|1|||
25098631|NCT02586493|50209357|FG000|Overall Study|Withdrawal by Subject|1|||
25098632|NCT02400333|50209365|FG000|Overall Study|Withdrawal by Subject|0|||
25098633|NCT02400333|50209366|FG001|Overall Study|Withdrawal by Subject|1|||
25098634|NCT02400333|50209367|FG002|Overall Study|Withdrawal by Subject|0|||
25098635|NCT02400333|50209368|FG003|Overall Study|Withdrawal by Subject|1|||
25098636|NCT02400333|50209365|FG000|Overall Study|Protocol Violation|1|||
25098637|NCT02400333|50209366|FG001|Overall Study|Protocol Violation|0|||
25098638|NCT02400333|50209367|FG002|Overall Study|Protocol Violation|2|||
25098639|NCT02400333|50209368|FG003|Overall Study|Protocol Violation|1|||
25098640|NCT02399475|50209381|FG000|Overall Study|Physician Decision|1|||
25098641|NCT02399475|50209382|FG001|Overall Study|Physician Decision|0|||
25098642|NCT02399163|50209388|FG000|Overall Study|Adverse Event|2|||
25098643|NCT02399163|50209388|FG000|Overall Study|Protocol Deviation|2|||
25098644|NCT02399163|50209388|FG000|Overall Study|Withdrawal by Participant|5|||
25098645|NCT02398227|50209402|FG000|Overall Study|Lost to Follow-up|21|||
25098646|NCT02398227|50209403|FG001|Overall Study|Lost to Follow-up|12|||
25098647|NCT02398227|50209402|FG000|Overall Study|Withdrawal by Subject|5|||
25098648|NCT02398227|50209403|FG001|Overall Study|Withdrawal by Subject|6|||
25098649|NCT02398227|50209402|FG000|Overall Study|Removed from treatment and dropped out|1|||
25098650|NCT02398227|50209403|FG001|Overall Study|Removed from treatment and dropped out|0|||
25098651|NCT02397915|50209409|FG000|Period 1|Protocol Violation|0|||
25098652|NCT02397915|50209410|FG001|Period 1|Protocol Violation|1|||
25098653|NCT02397915|50209411|FG002|Period 1|Protocol Violation|0|||
25098654|NCT02397915|50209412|FG003|Period 1|Protocol Violation|0|||
25098655|NCT02397915|50209409|FG000|Period 1|Physician Decision|1|||
25098656|NCT02397915|50209410|FG001|Period 1|Physician Decision|0|||
25098657|NCT02397915|50209411|FG002|Period 1|Physician Decision|0|||
25098658|NCT02397915|50209412|FG003|Period 1|Physician Decision|0|||
25098659|NCT02397837|50209422|FG000|Overall Study|Withdrawal by Subject|6|||
25098660|NCT02397837|50209423|FG001|Overall Study|Withdrawal by Subject|5|||
25098661|NCT02397837|50209422|FG000|Overall Study|Physician Decision|1|||
25098662|NCT02397837|50209423|FG001|Overall Study|Physician Decision|1|||
25098663|NCT02586415|50209431|FG000|Overall Study|Death|13|||
25008086|NCT01375777|50100879|FG003|Overall Study|Withdrawal by Subject|0|||
25008087|NCT01375777|50100880|FG004|Overall Study|Withdrawal by Subject|1|||
25008088|NCT01375777|50100881|FG005|Overall Study|Withdrawal by Subject|1|||
25008089|NCT01375777|50100882|FG006|Overall Study|Withdrawal by Subject|1|||
25008090|NCT01375777|50100883|FG007|Overall Study|Withdrawal by Subject|2|||
25008091|NCT01375777|50100884|FG008|Overall Study|Withdrawal by Subject|1|||
25008092|NCT01375777|50100876|FG000|Overall Study|Lost to Follow-up|1|||
25008093|NCT01375777|50100877|FG001|Overall Study|Lost to Follow-up|0|||
25008094|NCT01375777|50100878|FG002|Overall Study|Lost to Follow-up|0|||
25008095|NCT01375777|50100879|FG003|Overall Study|Lost to Follow-up|0|||
25008096|NCT01375777|50100880|FG004|Overall Study|Lost to Follow-up|0|||
25008097|NCT01375777|50100881|FG005|Overall Study|Lost to Follow-up|0|||
25008098|NCT01375777|50100882|FG006|Overall Study|Lost to Follow-up|1|||
25008099|NCT01375777|50100883|FG007|Overall Study|Lost to Follow-up|0|||
25098664|NCT02586415|50209432|FG001|Overall Study|Death|23|||
25098665|NCT02586415|50209431|FG000|Overall Study|Lost to Follow-up|1|||
25098666|NCT02586415|50209432|FG001|Overall Study|Lost to Follow-up|2|||
25098667|NCT02383173|50209441|FG000|Overall Study|Palliative Care Team withdrew|0|||
25098668|NCT02383173|50209442|FG001|Overall Study|Palliative Care Team withdrew|2|||
25098669|NCT02383017|50209450|FG000|Overall Study|Injury Sustained Outside Study|1|||
25098670|NCT02383017|50209451|FG001|Overall Study|Injury Sustained Outside Study|0|||
25098671|NCT02383017|50209450|FG000|Overall Study|Compliance|3|||
25098672|NCT02383017|50209451|FG001|Overall Study|Compliance|2|||
25098673|NCT02383017|50209450|FG000|Overall Study|Found to be Hypogonadal|1|||
25098674|NCT02383017|50209451|FG001|Overall Study|Found to be Hypogonadal|0|||
25098675|NCT02382939|50209459|FG000|Overall Study|Adverse Event|1|||
25098676|NCT02382939|50209460|FG001|Overall Study|Adverse Event|1|||
25098677|NCT02382939|50209459|FG000|Overall Study|Withdrawal by Subject|2|||
25098678|NCT02382939|50209460|FG001|Overall Study|Withdrawal by Subject|2|||
25098679|NCT02587819|50209467|FG000|Overall Study|Adverse Event|1|||
25098680|NCT02587819|50209467|FG000|Overall Study|Lost to Follow-up|1|||
25098681|NCT01666951|50209474|FG000|Overall Study|Not dosed|1|||
25098682|NCT01666951|50209475|FG001|Overall Study|Not dosed|1|||
25098683|NCT02586805|50209485|FG000|Overall Study|Withdrawal by Subject|3|||
25098684|NCT02586805|50209486|FG001|Overall Study|Withdrawal by Subject|1|||
25098685|NCT02586805|50209487|FG002|Overall Study|Withdrawal by Subject|1|||
25098686|NCT02586805|50209488|FG003|Overall Study|Withdrawal by Subject|2|||
25098687|NCT02586805|50209485|FG000|Overall Study|Adverse Event|2|||
25098688|NCT02586805|50209486|FG001|Overall Study|Adverse Event|0|||
25098689|NCT02586805|50209487|FG002|Overall Study|Adverse Event|1|||
25098690|NCT02586805|50209488|FG003|Overall Study|Adverse Event|0|||
25098691|NCT02586805|50209485|FG000|Overall Study|Lost to Follow-up|0|||
25098692|NCT02586805|50209486|FG001|Overall Study|Lost to Follow-up|0|||
25098693|NCT02586805|50209487|FG002|Overall Study|Lost to Follow-up|1|||
25098694|NCT02586805|50209488|FG003|Overall Study|Lost to Follow-up|0|||
25098695|NCT02586805|50209485|FG000|Overall Study|Physician Decision|1|||
25098696|NCT02586805|50209486|FG001|Overall Study|Physician Decision|0|||
25098697|NCT02586805|50209487|FG002|Overall Study|Physician Decision|0|||
25098698|NCT02586805|50209488|FG003|Overall Study|Physician Decision|0|||
25098699|NCT02586727|50209500|FG000|Overall Study|Lost to Follow-up|1|||
25098700|NCT02586727|50209501|FG001|Overall Study|Lost to Follow-up|0|||
25098701|NCT02580877|50209509|FG000|Overall Study|Withdrawal by Subject|1|||
25098702|NCT02580877|50209510|FG001|Overall Study|Withdrawal by Subject|3|||
25098703|NCT02580877|50209509|FG000|Overall Study|Adverse Event|0|||
25098704|NCT02580877|50209510|FG001|Overall Study|Adverse Event|1|||
25098705|NCT02582983|50209526|FG000|Overall Study|Death|3|||
25098706|NCT02582983|50209526|FG000|Overall Study|Withdrawal by Subject|2|||
25098707|NCT02582983|50209526|FG000|Overall Study|Adverse Event|1|||
25098708|NCT02582749|50209532|FG000|Overall Study|Study terminated by funder|5|||
25098709|NCT02582749|50209533|FG001|Overall Study|Study terminated by funder|10|||
25098710|NCT02582749|50209532|FG000|Overall Study|Withdrawal by Subject|0|||
25098711|NCT02582749|50209533|FG001|Overall Study|Withdrawal by Subject|1|||
25098712|NCT02582671|50209539|FG000|Overall Study|Failure to return|1|||
25098713|NCT02582671|50209539|FG000|Overall Study|Other, not specified|1|||
25098714|NCT02585713|50209546|FG000|Overall Study|Withdrew prior to treatment|2|||
25098715|NCT02585713|50209547|FG001|Overall Study|Withdrew prior to treatment|7|||
25098716|NCT02585713|50209546|FG000|Overall Study|Other|3|||
25098717|NCT02585713|50209547|FG001|Overall Study|Other|1|||
25098718|NCT02579863|50209555|FG000|Overall Study|Final Disposition Unknown|2|||
25098719|NCT02579863|50209556|FG001|Overall Study|Final Disposition Unknown|1|||
25098720|NCT02579863|50209555|FG000|Overall Study|Adverse Event|18|||
25098721|NCT02579863|50209556|FG001|Overall Study|Adverse Event|11|||
25098722|NCT02579863|50209555|FG000|Overall Study|Death|31|||
25098723|NCT02579863|50209556|FG001|Overall Study|Death|29|||
25098724|NCT02579863|50209555|FG000|Overall Study|Lost to Follow-up|2|||
25098725|NCT02579863|50209556|FG001|Overall Study|Lost to Follow-up|1|||
25098726|NCT02579863|50209555|FG000|Overall Study|Physician Decision|1|||
25098727|NCT02579863|50209556|FG001|Overall Study|Physician Decision|2|||
25098728|NCT02579863|50209555|FG000|Overall Study|Screen Failure|0|||
25098729|NCT02579863|50209556|FG001|Overall Study|Screen Failure|2|||
25098730|NCT02579863|50209555|FG000|Overall Study|Study Terminated at Selected Sites|82|||
25098731|NCT02579863|50209556|FG001|Overall Study|Study Terminated at Selected Sites|88|||
25098732|NCT02579863|50209555|FG000|Overall Study|Withdrawal by Subject|20|||
25098733|NCT02579863|50209556|FG001|Overall Study|Withdrawal by Subject|20|||
25098734|NCT02582515|50209564|FG000|Overall Study|Withdrawal by Subject|0|||
25098735|NCT02582515|50209565|FG001|Overall Study|Withdrawal by Subject|1|||
25098736|NCT02579629|50209574|FG000|Overall Study|Withdrawal by Subject|0|||
25098737|NCT02579629|50209575|FG001|Overall Study|Withdrawal by Subject|1|||
25098738|NCT02579629|50209576|FG002|Overall Study|Withdrawal by Subject|0|||
25098739|NCT02579629|50209574|FG000|Overall Study|Screen Failure|2|||
25098740|NCT02579629|50209575|FG001|Overall Study|Screen Failure|0|||
25098741|NCT02579629|50209576|FG002|Overall Study|Screen Failure|2|||
25098742|NCT02343939|50209593|FG000|Overall Study|Death|0|||
25098743|NCT02343939|50209594|FG001|Overall Study|Death|15|||
25098744|NCT02343939|50209595|FG002|Overall Study|Death|4|||
25098745|NCT02343939|50209596|FG003|Overall Study|Death|2|||
25098746|NCT02343939|50209597|FG004|Overall Study|Death|5|||
25098747|NCT02343939|50209598|FG005|Overall Study|Death|11|||
25098748|NCT02343939|50209599|FG006|Overall Study|Death|8|||
25098749|NCT02343939|50209600|FG007|Overall Study|Death|22|||
25098750|NCT02343939|50209601|FG008|Overall Study|Death|1|||
25098751|NCT02343939|50209593|FG000|Overall Study|Study terminated by sponsor|0|||
25098752|NCT02343939|50209594|FG001|Overall Study|Study terminated by sponsor|27|||
25098753|NCT02343939|50209595|FG002|Overall Study|Study terminated by sponsor|0|||
25098754|NCT02343939|50209596|FG003|Overall Study|Study terminated by sponsor|1|||
25098755|NCT02343939|50209597|FG004|Overall Study|Study terminated by sponsor|1|||
25098756|NCT02343939|50209598|FG005|Overall Study|Study terminated by sponsor|5|||
25098757|NCT02343939|50209599|FG006|Overall Study|Study terminated by sponsor|3|||
25098758|NCT02343939|50209600|FG007|Overall Study|Study terminated by sponsor|4|||
25098759|NCT02343939|50209601|FG008|Overall Study|Study terminated by sponsor|0|||
25098760|NCT02343939|50209593|FG000|Overall Study|Withdrew consent|3|||
25098761|NCT02343939|50209594|FG001|Overall Study|Withdrew consent|6|||
25098762|NCT02343939|50209595|FG002|Overall Study|Withdrew consent|1|||
25098763|NCT02343939|50209596|FG003|Overall Study|Withdrew consent|2|||
25098764|NCT02343939|50209597|FG004|Overall Study|Withdrew consent|2|||
25098765|NCT02343939|50209598|FG005|Overall Study|Withdrew consent|0|||
25098766|NCT02343939|50209599|FG006|Overall Study|Withdrew consent|0|||
25098767|NCT02343939|50209600|FG007|Overall Study|Withdrew consent|8|||
25098768|NCT02343939|50209601|FG008|Overall Study|Withdrew consent|6|||
25098769|NCT02343939|50209593|FG000|Overall Study|Treatment failure|0|||
25098770|NCT02343939|50209594|FG001|Overall Study|Treatment failure|0|||
25098771|NCT02343939|50209595|FG002|Overall Study|Treatment failure|0|||
25098772|NCT02343939|50209596|FG003|Overall Study|Treatment failure|0|||
25098773|NCT02343939|50209597|FG004|Overall Study|Treatment failure|0|||
25098774|NCT02343939|50209598|FG005|Overall Study|Treatment failure|0|||
25098775|NCT02343939|50209599|FG006|Overall Study|Treatment failure|2|||
25098776|NCT02343939|50209600|FG007|Overall Study|Treatment failure|1|||
25098777|NCT02343939|50209601|FG008|Overall Study|Treatment failure|0|||
25098778|NCT02343939|50209593|FG000|Overall Study|Investigator's discretion|0|||
25098779|NCT02343939|50209594|FG001|Overall Study|Investigator's discretion|0|||
25098780|NCT02343939|50209595|FG002|Overall Study|Investigator's discretion|0|||
25098781|NCT02343939|50209596|FG003|Overall Study|Investigator's discretion|1|||
25098782|NCT02343939|50209597|FG004|Overall Study|Investigator's discretion|0|||
25098783|NCT02343939|50209598|FG005|Overall Study|Investigator's discretion|0|||
25098784|NCT02343939|50209599|FG006|Overall Study|Investigator's discretion|1|||
25098785|NCT02343939|50209600|FG007|Overall Study|Investigator's discretion|0|||
25098786|NCT02343939|50209601|FG008|Overall Study|Investigator's discretion|0|||
25098787|NCT02343939|50209593|FG000|Overall Study|Adverse Event|0|||
25098788|NCT02343939|50209594|FG001|Overall Study|Adverse Event|0|||
25098789|NCT02343939|50209595|FG002|Overall Study|Adverse Event|0|||
25098790|NCT02343939|50209596|FG003|Overall Study|Adverse Event|0|||
25098791|NCT02343939|50209597|FG004|Overall Study|Adverse Event|0|||
25098792|NCT02343939|50209598|FG005|Overall Study|Adverse Event|1|||
25098793|NCT02343939|50209599|FG006|Overall Study|Adverse Event|0|||
25098794|NCT02343939|50209600|FG007|Overall Study|Adverse Event|0|||
25098795|NCT02343939|50209601|FG008|Overall Study|Adverse Event|0|||
25098796|NCT02343939|50209593|FG000|Overall Study|Never Treated With ENTO|0|||
25098797|NCT02343939|50209594|FG001|Overall Study|Never Treated With ENTO|0|||
25098798|NCT02343939|50209595|FG002|Overall Study|Never Treated With ENTO|0|||
25098799|NCT02343939|50209596|FG003|Overall Study|Never Treated With ENTO|0|||
25098800|NCT02343939|50209597|FG004|Overall Study|Never Treated With ENTO|0|||
25098801|NCT02343939|50209598|FG005|Overall Study|Never Treated With ENTO|0|||
25098802|NCT02343939|50209599|FG006|Overall Study|Never Treated With ENTO|1|||
25098803|NCT02343939|50209600|FG007|Overall Study|Never Treated With ENTO|2|||
25098804|NCT02343939|50209601|FG008|Overall Study|Never Treated With ENTO|0|||
25098805|NCT02397447|50209637|FG000|Overall Study|Lost to Follow-up|2|||
25098806|NCT02397447|50209638|FG001|Overall Study|Lost to Follow-up|2|||
25098807|NCT02397057|50209646|FG000|Overall Study|Withdrawal by Subject|6|||
25098808|NCT02397057|50209647|FG001|Overall Study|Withdrawal by Subject|7|||
25098809|NCT02397057|50209646|FG000|Overall Study|Lost to Follow-up|4|||
25098810|NCT02397057|50209647|FG001|Overall Study|Lost to Follow-up|3|||
25098811|NCT02397057|50209646|FG000|Overall Study|Death|1|||
25098812|NCT02397057|50209647|FG001|Overall Study|Death|0|||
25098813|NCT02397057|50209646|FG000|Overall Study|Adverse Event|0|||
25098814|NCT02397057|50209647|FG001|Overall Study|Adverse Event|1|||
25098815|NCT02397057|50209646|FG000|Overall Study|Physician Decision|0|||
25098816|NCT02397057|50209647|FG001|Overall Study|Physician Decision|1|||
25098817|NCT02397057|50209646|FG000|Overall Study|Subject did not receive study drug|0|||
25098818|NCT02397057|50209647|FG001|Overall Study|Subject did not receive study drug|1|||
25098819|NCT02343549|50209653|FG000|Overall Study|Death|11|||
25098820|NCT02343549|50209653|FG000|Overall Study|Withdrawal by Subject|2|||
25098821|NCT02343159|50209660|FG000|Overall Study|Early Study Termination|16|||
25177046|NCT01559389|50321006|FG001|Overall Study|Withdrawal by Subject|20|||
25098822|NCT02343159|50209661|FG001|Overall Study|Early Study Termination|19|||
25098823|NCT02343159|50209662|FG002|Overall Study|Early Study Termination|23|||
25098824|NCT02343159|50209660|FG000|Overall Study|Physician Decision|2|||
25098825|NCT02343159|50209661|FG001|Overall Study|Physician Decision|0|||
25098826|NCT02343159|50209662|FG002|Overall Study|Physician Decision|1|||
25098827|NCT02343159|50209660|FG000|Overall Study|Withdrawal by Subject|3|||
25098828|NCT02343159|50209661|FG001|Overall Study|Withdrawal by Subject|0|||
25098829|NCT02343159|50209662|FG002|Overall Study|Withdrawal by Subject|2|||
25098830|NCT02343159|50209660|FG000|Overall Study|Lost to Follow-up|0|||
25098831|NCT02343159|50209661|FG001|Overall Study|Lost to Follow-up|2|||
25098832|NCT02343159|50209662|FG002|Overall Study|Lost to Follow-up|2|||
25098833|NCT02343159|50209660|FG000|Overall Study|Adverse Event|4|||
25098834|NCT02343159|50209661|FG001|Overall Study|Adverse Event|4|||
25098835|NCT02343159|50209662|FG002|Overall Study|Adverse Event|2|||
25098836|NCT02343159|50209660|FG000|Overall Study|Sponsor Decision|0|||
25098837|NCT02343159|50209661|FG001|Overall Study|Sponsor Decision|1|||
25098838|NCT02343159|50209662|FG002|Overall Study|Sponsor Decision|0|||
25098839|NCT02343159|50209660|FG000|Overall Study|Enrollment Error|1|||
25098840|NCT02343159|50209661|FG001|Overall Study|Enrollment Error|0|||
25098841|NCT02343159|50209662|FG002|Overall Study|Enrollment Error|0|||
25098842|NCT02395653|50209671|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
25098843|NCT02395653|50209671|FG000|Overall Study|Consent Withdrawn at Screening|1|||
25098844|NCT02395653|50209671|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
25098845|NCT02395653|50209671|FG000|Overall Study|Investigator Decision at Screening|1|||
25098846|NCT02395653|50209671|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
25098847|NCT02395653|50209671|FG000|Overall Study|Withdrawal by Subject|1|||
25098848|NCT02395653|50209671|FG000|Overall Study|Lost to Follow-up|1|||
25098849|NCT01664923|50209677|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
25098850|NCT01664923|50209678|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
25098851|NCT01664923|50209677|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
25098852|NCT01664923|50209678|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
25098853|NCT01664923|50209677|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
25098854|NCT01664923|50209678|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
25098855|NCT01664923|50209677|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
25098856|NCT01664923|50209678|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
25098857|NCT01664923|50209677|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
25098858|NCT01664923|50209678|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
25098859|NCT01664923|50209677|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
25098860|NCT01664923|50209678|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
25098861|NCT01664923|50209677|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
25098862|NCT01664923|50209678|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
25098863|NCT01664923|50209677|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
25098864|NCT01664923|50209678|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
25098865|NCT01664923|50209677|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
25098866|NCT01664923|50209678|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
25098867|NCT01664923|50209677|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
25098868|NCT01664923|50209678|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
25098869|NCT01664923|50209677|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
25098870|NCT01664923|50209678|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
25098871|NCT01664923|50209677|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
25098872|NCT01664923|50209678|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
25098873|NCT01664923|50209677|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
25098874|NCT01664923|50209678|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
25098875|NCT01664923|50209677|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
25098876|NCT01664923|50209678|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
25098877|NCT01664533|50209688|FG000|Overall Study|Death|42|||
25098878|NCT01664533|50209688|FG000|Overall Study|Lost to Follow-up|3|||
25098879|NCT01664533|50209688|FG000|Overall Study|Study termination|9|||
25098880|NCT01664533|50209688|FG000|Overall Study|Protocol Violation|3|||
25098881|NCT02584855|50209693|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
25098882|NCT02584855|50209694|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
25098883|NCT02584855|50209695|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
25098884|NCT02584855|50209696|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
25098885|NCT02584855|50209697|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
25098886|NCT02584855|50209698|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
25098887|NCT02584855|50209693|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
25098888|NCT02584855|50209694|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
25098889|NCT02584855|50209695|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
25098890|NCT02584855|50209696|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
25098891|NCT02584855|50209697|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
25098892|NCT02584855|50209698|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
25098893|NCT02584855|50209693|FG000|Open-Label Treatment Period|Adverse Event|14|||
25098894|NCT02584855|50209694|FG001|Open-Label Treatment Period|Adverse Event|0|||
25098895|NCT02584855|50209695|FG002|Open-Label Treatment Period|Adverse Event|0|||
25098896|NCT02584855|50209696|FG003|Open-Label Treatment Period|Adverse Event|0|||
25098897|NCT02584855|50209697|FG004|Open-Label Treatment Period|Adverse Event|0|||
25098898|NCT02584855|50209698|FG005|Open-Label Treatment Period|Adverse Event|0|||
25098899|NCT02584855|50209693|FG000|Open-Label Treatment Period|Death|2|||
25098900|NCT02584855|50209694|FG001|Open-Label Treatment Period|Death|0|||
25098901|NCT02584855|50209695|FG002|Open-Label Treatment Period|Death|0|||
25098902|NCT02584855|50209696|FG003|Open-Label Treatment Period|Death|0|||
25098903|NCT02584855|50209697|FG004|Open-Label Treatment Period|Death|0|||
25098904|NCT02584855|50209698|FG005|Open-Label Treatment Period|Death|0|||
25098905|NCT02584855|50209693|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
25098906|NCT02584855|50209694|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
25098907|NCT02584855|50209695|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
25098908|NCT02584855|50209696|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
25098909|NCT02584855|50209697|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
25098910|NCT02584855|50209698|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
25098911|NCT02584855|50209693|FG000|Open-Label Treatment Period|Protocol Violation|1|||
25098912|NCT02584855|50209694|FG001|Open-Label Treatment Period|Protocol Violation|0|||
25098913|NCT02584855|50209695|FG002|Open-Label Treatment Period|Protocol Violation|0|||
25098914|NCT02584855|50209696|FG003|Open-Label Treatment Period|Protocol Violation|0|||
25098915|NCT02584855|50209697|FG004|Open-Label Treatment Period|Protocol Violation|0|||
25098916|NCT02584855|50209698|FG005|Open-Label Treatment Period|Protocol Violation|0|||
25098917|NCT02584855|50209693|FG000|Open-Label Treatment Period|No PI Available|2|||
25098918|NCT02584855|50209694|FG001|Open-Label Treatment Period|No PI Available|0|||
25098919|NCT02584855|50209695|FG002|Open-Label Treatment Period|No PI Available|0|||
25098920|NCT02584855|50209696|FG003|Open-Label Treatment Period|No PI Available|0|||
25098921|NCT02584855|50209697|FG004|Open-Label Treatment Period|No PI Available|0|||
25098922|NCT02584855|50209698|FG005|Open-Label Treatment Period|No PI Available|0|||
25098923|NCT02584855|50209693|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
25098924|NCT02584855|50209694|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
25098925|NCT02584855|50209695|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
25098926|NCT02584855|50209696|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
25098927|NCT02584855|50209697|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
25098928|NCT02584855|50209698|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
25098929|NCT02584855|50209693|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
25098930|NCT02584855|50209694|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
25098931|NCT02584855|50209695|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
25098932|NCT02584855|50209696|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
25098933|NCT02584855|50209697|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
25098934|NCT02584855|50209698|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
25098935|NCT02584855|50209693|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
25098936|NCT02584855|50209694|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
25098937|NCT02584855|50209695|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
25098938|NCT02584855|50209696|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
25098939|NCT02584855|50209697|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
25098940|NCT02584855|50209698|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
25098941|NCT02584855|50209693|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
25098942|NCT02584855|50209694|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
25098943|NCT02584855|50209695|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
25098944|NCT02584855|50209696|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
25098945|NCT02584855|50209697|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
25098946|NCT02584855|50209698|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
25098947|NCT02584855|50209693|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
25098948|NCT02584855|50209694|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
25098949|NCT02584855|50209695|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
25098950|NCT02584855|50209696|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
25098951|NCT02584855|50209697|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
25098952|NCT02584855|50209698|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
25098953|NCT02584855|50209693|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
25098954|NCT02584855|50209694|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
25098955|NCT02584855|50209695|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
25098956|NCT02584855|50209696|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
25008100|NCT01375777|50100884|FG008|Overall Study|Lost to Follow-up|0|||
25008101|NCT01375777|50100876|FG000|Overall Study|Other|1|||
25008102|NCT01375777|50100877|FG001|Overall Study|Other|1|||
25008103|NCT01375777|50100878|FG002|Overall Study|Other|0|||
25008104|NCT01375777|50100879|FG003|Overall Study|Other|0|||
25008105|NCT01375777|50100880|FG004|Overall Study|Other|0|||
25008106|NCT01375777|50100881|FG005|Overall Study|Other|0|||
25008107|NCT01375777|50100882|FG006|Overall Study|Other|0|||
25008108|NCT01375777|50100883|FG007|Overall Study|Other|0|||
25008109|NCT01375777|50100884|FG008|Overall Study|Other|1|||
25098957|NCT02584855|50209697|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
25098958|NCT02584855|50209698|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
25098959|NCT02584855|50209693|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
25098960|NCT02584855|50209694|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
25098961|NCT02584855|50209695|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
25098962|NCT02584855|50209696|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
25098963|NCT02584855|50209697|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
25098964|NCT02584855|50209698|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
25098965|NCT02581891|50209713|FG000|Overall Study|Adverse Event|4|||
25098966|NCT02581891|50209714|FG001|Overall Study|Adverse Event|6|||
25098967|NCT02581891|50209713|FG000|Overall Study|Death|3|||
25098968|NCT02581891|50209714|FG001|Overall Study|Death|4|||
25098969|NCT02581891|50209713|FG000|Overall Study|Lost to Follow-up|1|||
25098970|NCT02581891|50209714|FG001|Overall Study|Lost to Follow-up|2|||
25098971|NCT02581891|50209713|FG000|Overall Study|Physician Decision|0|||
25098972|NCT02581891|50209714|FG001|Overall Study|Physician Decision|1|||
25098973|NCT02581891|50209713|FG000|Overall Study|Withdrawal by Subject|4|||
25098974|NCT02581891|50209714|FG001|Overall Study|Withdrawal by Subject|5|||
25098975|NCT02581891|50209713|FG000|Overall Study|Other Reasons|3|||
25098976|NCT02581891|50209714|FG001|Overall Study|Other Reasons|1|||
25098977|NCT02581891|50209713|FG000|Overall Study|Discontinued during followup|1|||
25098978|NCT02581891|50209714|FG001|Overall Study|Discontinued during followup|0|||
25098979|NCT02581345|50209723|FG000|Part 1: up to Week 16|Adverse Event|3|||
25098980|NCT02581345|50209724|FG001|Part 1: up to Week 16|Adverse Event|8|||
25098981|NCT02581345|50209725|FG002|Part 1: up to Week 16|Adverse Event|0|||
25098982|NCT02581345|50209726|FG003|Part 1: up to Week 16|Adverse Event|0|||
25098983|NCT02581345|50209723|FG000|Part 1: up to Week 16|Physician Decision|2|||
25098984|NCT02581345|50209724|FG001|Part 1: up to Week 16|Physician Decision|4|||
25098985|NCT02581345|50209725|FG002|Part 1: up to Week 16|Physician Decision|0|||
25098986|NCT02581345|50209726|FG003|Part 1: up to Week 16|Physician Decision|0|||
25098987|NCT02581345|50209723|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
25098988|NCT02581345|50209724|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
25098989|NCT02581345|50209725|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
25098990|NCT02581345|50209726|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
25098991|NCT02581345|50209723|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
25098992|NCT02581345|50209724|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
25098993|NCT02581345|50209725|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
25098994|NCT02581345|50209726|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
25098995|NCT02581345|50209723|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
25098996|NCT02581345|50209724|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
25098997|NCT02581345|50209725|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
25098998|NCT02581345|50209726|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
25098999|NCT02581345|50209723|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
25099000|NCT02581345|50209724|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
25099001|NCT02581345|50209725|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
25099002|NCT02581345|50209726|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
25099003|NCT02581345|50209723|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
25099004|NCT02581345|50209724|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
25099005|NCT02581345|50209725|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
25099006|NCT02581345|50209726|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
25099007|NCT02581345|50209723|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
25099008|NCT02581345|50209724|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
25099009|NCT02581345|50209725|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
25099010|NCT02581345|50209726|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
25099011|NCT02581345|50209723|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
25099012|NCT02581345|50209724|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
25099013|NCT02581345|50209725|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
25099014|NCT02581345|50209726|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
25099015|NCT02581345|50209723|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
25099016|NCT02581345|50209724|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
25099017|NCT02581345|50209725|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
25099018|NCT02581345|50209726|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
25099019|NCT02581345|50209723|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
25099020|NCT02581345|50209724|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
25099021|NCT02581345|50209725|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
25099022|NCT02581345|50209726|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
25099023|NCT02581345|50209723|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
25099024|NCT02581345|50209724|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
25099025|NCT02581345|50209725|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
25099026|NCT02581345|50209726|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
25177047|NCT01526551|50321016|FG000|Overall Study|Lack of returned parental consent form|424|||
25177048|NCT01559311|50321094|FG000|Overall Study|Protocol Violation|0|||
25099027|NCT02581189|50209744|FG000|Overall Study|Failure to return|36|||
25099028|NCT02581189|50209744|FG000|Overall Study|Withdrew consent|5|||
25099029|NCT02581189|50209744|FG000|Overall Study|Death|3|||
25099030|NCT02581189|50209744|FG000|Overall Study|Insufficient virological response|2|||
25099031|NCT02581189|50209744|FG000|Overall Study|Other, not specified|7|||
25099032|NCT00352027|50209751|FG000|Overall Study|Progressive disease|3|||
25099033|NCT02576977|50209779|FG000|Overall Study|Adverse Event|13|||
25099034|NCT02576977|50209780|FG001|Overall Study|Adverse Event|2|||
25099035|NCT02576977|50209779|FG000|Overall Study|Death|73|||
25099036|NCT02576977|50209780|FG001|Overall Study|Death|60|||
25099037|NCT02576977|50209779|FG000|Overall Study|Screen failure|1|||
25099038|NCT02576977|50209780|FG001|Overall Study|Screen failure|0|||
25099039|NCT02576977|50209779|FG000|Overall Study|Study Terminated at Selected Sites|27|||
25099040|NCT02576977|50209780|FG001|Overall Study|Study Terminated at Selected Sites|50|||
25099041|NCT02576977|50209779|FG000|Overall Study|Withdrawal by Subject|11|||
25099042|NCT02576977|50209780|FG001|Overall Study|Withdrawal by Subject|11|||
25099043|NCT02576977|50209779|FG000|Overall Study|Final Disposition Unknown|0|||
25099044|NCT02576977|50209780|FG001|Overall Study|Final Disposition Unknown|1|||
25099045|NCT02576977|50209779|FG000|Overall Study|Lost to Follow-up|1|||
25099046|NCT02576977|50209780|FG001|Overall Study|Lost to Follow-up|0|||
25099047|NCT02576977|50209779|FG000|Overall Study|Progressive Disease|0|||
25099048|NCT02576977|50209780|FG001|Overall Study|Progressive Disease|1|||
25099049|NCT05150964|50209786|FG000|Overall Study|Lost to Follow-up|2|||
25099050|NCT04952402|50209794|FG000|Overall Study|Lost to Follow-up|1|||
25099051|NCT04952402|50209795|FG001|Overall Study|Lost to Follow-up|3|||
25099052|NCT04952402|50209794|FG000|Overall Study|Lack Of Venous Access|0|||
25099053|NCT04952402|50209795|FG001|Overall Study|Lack Of Venous Access|1|||
25099054|NCT04378010|50209834|FG000|Overall Study|Adverse Event|8|||
25099055|NCT04378010|50209835|FG001|Overall Study|Adverse Event|14|||
25099056|NCT04378010|50209836|FG002|Overall Study|Adverse Event|4|||
25099057|NCT04378010|50209834|FG000|Overall Study|Withdrawal by Subject|0|||
25099058|NCT04378010|50209835|FG001|Overall Study|Withdrawal by Subject|2|||
25099059|NCT04378010|50209836|FG002|Overall Study|Withdrawal by Subject|1|||
25099060|NCT04378010|50209834|FG000|Overall Study|Protocol Violation|2|||
25099061|NCT04378010|50209835|FG001|Overall Study|Protocol Violation|1|||
25099062|NCT04378010|50209836|FG002|Overall Study|Protocol Violation|4|||
25099063|NCT04378010|50209834|FG000|Overall Study|Study terminated by Sponsor|22|||
25099064|NCT04378010|50209835|FG001|Overall Study|Study terminated by Sponsor|16|||
25099065|NCT04378010|50209836|FG002|Overall Study|Study terminated by Sponsor|22|||
25099066|NCT04378010|50209834|FG000|Overall Study|Subject inability to complete study visit|0|||
25099067|NCT04378010|50209835|FG001|Overall Study|Subject inability to complete study visit|0|||
25099068|NCT04378010|50209836|FG002|Overall Study|Subject inability to complete study visit|1|||
25099069|NCT04378010|50209834|FG000|Overall Study|Subject never dosed|0|||
25099070|NCT04378010|50209835|FG001|Overall Study|Subject never dosed|1|||
25099071|NCT04378010|50209836|FG002|Overall Study|Subject never dosed|0|||
25099072|NCT04349072|50209847|FG000|Randomization Period|Found ineligible post enrollment|0|||
25099073|NCT04349072|50209848|FG001|Randomization Period|Found ineligible post enrollment|1|||
25099074|NCT04349072|50209847|FG000|Treatment Period|Permanent Stopping Criteria Met|0|||
25099075|NCT04349072|50209848|FG001|Treatment Period|Permanent Stopping Criteria Met|2|||
25099076|NCT04349072|50209847|FG000|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|3|||
25099077|NCT04349072|50209848|FG001|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|5|||
25008110|NCT02431702|50100904|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
25008111|NCT02431702|50100905|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
25008112|NCT02431702|50100906|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
25008113|NCT02431702|50100907|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
25008114|NCT02431702|50100908|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
25008115|NCT02431702|50100909|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
25008116|NCT02431702|50100910|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
25008117|NCT02431702|50100904|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
25008118|NCT02431702|50100905|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
25008119|NCT02431702|50100906|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
25008120|NCT02431702|50100907|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
25099078|NCT04349072|50209847|FG000|Treatment Period|Physician Decision|0|||
25099079|NCT04349072|50209848|FG001|Treatment Period|Physician Decision|1|||
25099080|NCT04349072|50209847|FG000|Treatment Period|Protocol Violation|0|||
25099081|NCT04349072|50209848|FG001|Treatment Period|Protocol Violation|1|||
25099082|NCT04349072|50209847|FG000|Treatment Period|Withdrawal by Subject|1|||
25099083|NCT04349072|50209848|FG001|Treatment Period|Withdrawal by Subject|1|||
25099084|NCT04240886|50209854|FG000|Treatment Phase|Death|4|||
25099085|NCT04240886|50209854|FG000|Treatment Phase|Discontinuation by Subject|1|||
25099086|NCT04240886|50209854|FG000|Treatment Phase|Adverse Event|5|||
25099087|NCT04240886|50209854|FG000|Follow-up Phase|Withdrawal by Subject|1|||
25099088|NCT04240886|50209854|FG000|Follow-up Phase|Discontinuation by Subject|1|||
25099089|NCT04240886|50209854|FG000|Follow-up Phase|Death|2|||
25099090|NCT04074161|50209870|FG000|Overall Study|Withdrawal by Subject|2|||
25099091|NCT04074161|50209871|FG001|Overall Study|Withdrawal by Subject|4|||
25099092|NCT04074161|50209872|FG002|Overall Study|Withdrawal by Subject|1|||
25099093|NCT04074161|50209870|FG000|Overall Study|Lost to Follow-up|4|||
25099094|NCT04074161|50209871|FG001|Overall Study|Lost to Follow-up|5|||
25099095|NCT04074161|50209872|FG002|Overall Study|Lost to Follow-up|3|||
25099096|NCT03966157|50209882|FG000|Overall Study|Physician Decision|1|||
25099097|NCT03966157|50209883|FG001|Overall Study|Physician Decision|0|||
25099098|NCT03733210|50209891|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
25099099|NCT03733210|50209892|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
25099100|NCT03698994|50209898|FG000|Overall Study|Adverse Event|2|||
25099101|NCT03698994|50209898|FG000|Overall Study|Death|1|||
25099102|NCT03698994|50209898|FG000|Overall Study|Physician Decision|1|||
25099103|NCT03698994|50209898|FG000|Overall Study|Withdrawal by Subject|3|||
25099104|NCT03698994|50209898|FG000|Overall Study|Progressive Disease|12|||
25099105|NCT03627468|50209904|FG000|Overall Study|Adverse Event|5|||
25099106|NCT03627468|50209905|FG001|Overall Study|Adverse Event|33|||
25099107|NCT03627468|50209904|FG000|Overall Study|Withdrawal by Subject|13|||
25099108|NCT03627468|50209905|FG001|Overall Study|Withdrawal by Subject|23|||
25099109|NCT03627468|50209904|FG000|Overall Study|Physician Decision|1|||
25099110|NCT03627468|50209905|FG001|Overall Study|Physician Decision|0|||
25099111|NCT03627468|50209904|FG000|Overall Study|Protocol Violation|0|||
25099112|NCT03627468|50209905|FG001|Overall Study|Protocol Violation|2|||
25099113|NCT03627468|50209904|FG000|Overall Study|Lost to Follow-up|10|||
25099114|NCT03627468|50209905|FG001|Overall Study|Lost to Follow-up|16|||
25099115|NCT03627468|50209904|FG000|Overall Study|Death|1|||
25099116|NCT03627468|50209905|FG001|Overall Study|Death|0|||
25099117|NCT03627468|50209904|FG000|Overall Study|Pregnancy|1|||
25099118|NCT03627468|50209905|FG001|Overall Study|Pregnancy|1|||
25099119|NCT03627468|50209904|FG000|Overall Study|Lack of Efficacy|0|||
25099120|NCT03627468|50209905|FG001|Overall Study|Lack of Efficacy|2|||
25099121|NCT03627468|50209904|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
25099122|NCT03627468|50209905|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
25099123|NCT03595176|50209913|FG000|Overall Study|Death|0|||
25099124|NCT03595176|50209914|FG001|Overall Study|Death|2|||
25099125|NCT03595176|50209913|FG000|Overall Study|Lost to Follow-up|0|||
25099126|NCT03595176|50209914|FG001|Overall Study|Lost to Follow-up|1|||
25099127|NCT03052816|50209932|FG000|Overall Study|Withdrawal by Subject|1|||
25099128|NCT03052816|50209933|FG001|Overall Study|Withdrawal by Subject|0|||
25099129|NCT03052816|50209932|FG000|Overall Study|Desired opioids|2|||
25099130|NCT03052816|50209933|FG001|Overall Study|Desired opioids|0|||
25099131|NCT02684058|50209953|FG000|Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|61|||
25099132|NCT02684058|50209954|FG001|Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|8|||
25099133|NCT02684058|50209955|FG002|Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|21|||
25099134|NCT02684058|50209953|FG000|Treatment Period|Progressive disease|5|||
25099135|NCT02684058|50209954|FG001|Treatment Period|Progressive disease|9|||
25099136|NCT02684058|50209955|FG002|Treatment Period|Progressive disease|16|||
25099137|NCT02684058|50209953|FG000|Treatment Period|Adverse Event|3|||
25099138|NCT02684058|50209954|FG001|Treatment Period|Adverse Event|6|||
25099139|NCT02684058|50209955|FG002|Treatment Period|Adverse Event|1|||
25099140|NCT02684058|50209953|FG000|Treatment Period|Physician Decision|2|||
25099141|NCT02684058|50209954|FG001|Treatment Period|Physician Decision|1|||
25099142|NCT02684058|50209955|FG002|Treatment Period|Physician Decision|1|||
25099143|NCT02684058|50209953|FG000|Treatment Period|New therapy for study indication|1|||
25099144|NCT02684058|50209954|FG001|Treatment Period|New therapy for study indication|0|||
25099145|NCT02684058|50209955|FG002|Treatment Period|New therapy for study indication|0|||
25099146|NCT02684058|50209953|FG000|Treatment Period|Protocol deviation|0|||
25099147|NCT02684058|50209954|FG001|Treatment Period|Protocol deviation|1|||
25099148|NCT02684058|50209955|FG002|Treatment Period|Protocol deviation|0|||
25099149|NCT02684058|50209953|FG000|Treatment Period|Patient/guardian decision|1|||
25099150|NCT02684058|50209954|FG001|Treatment Period|Patient/guardian decision|3|||
25099151|NCT02684058|50209955|FG002|Treatment Period|Patient/guardian decision|0|||
25099152|NCT02684058|50209953|FG000|Treatment Period|Death|0|||
25099153|NCT02684058|50209954|FG001|Treatment Period|Death|0|||
25099154|NCT02684058|50209955|FG002|Treatment Period|Death|2|||
25099155|NCT02684058|50209953|FG000|Post-treatment Efficacy Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|5|||
25099156|NCT02684058|50209954|FG001|Post-treatment Efficacy Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|13|||
25099157|NCT02684058|50209955|FG002|Post-treatment Efficacy Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|2|||
25099158|NCT02684058|50209953|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
25099159|NCT02684058|50209954|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
25177049|NCT01559311|50321095|FG001|Overall Study|Protocol Violation|0|||
25177050|NCT01559311|50321096|FG002|Overall Study|Protocol Violation|2|||
25099160|NCT02684058|50209955|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
25099161|NCT02684058|50209953|FG000|Post-treatment Efficacy Follow-up|Progressive disease|0|||
25099162|NCT02684058|50209954|FG001|Post-treatment Efficacy Follow-up|Progressive disease|1|||
25099163|NCT02684058|50209955|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
25099164|NCT02684058|50209953|FG000|Post-treatment Efficacy Follow-up|Patient/guardian decision|1|||
25099165|NCT02684058|50209954|FG001|Post-treatment Efficacy Follow-up|Patient/guardian decision|0|||
25099166|NCT02684058|50209955|FG002|Post-treatment Efficacy Follow-up|Patient/guardian decision|0|||
25099167|NCT02684058|50209953|FG000|Post-treatment Efficacy Follow-up|Death|0|||
25099168|NCT02684058|50209954|FG001|Post-treatment Efficacy Follow-up|Death|0|||
25099169|NCT02684058|50209955|FG002|Post-treatment Efficacy Follow-up|Death|3|||
25099170|NCT02684058|50209953|FG000|Survival Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|4|||
25099171|NCT02684058|50209954|FG001|Survival Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|0|||
25099172|NCT02684058|50209955|FG002|Survival Follow-up|Ongoing at the time of the cut-off, 23-Aug-2021|2|||
25099173|NCT02684058|50209953|FG000|Survival Follow-up|Other|2|||
25099174|NCT02684058|50209954|FG001|Survival Follow-up|Other|1|||
25099175|NCT02684058|50209955|FG002|Survival Follow-up|Other|0|||
25099176|NCT02684058|50209953|FG000|Survival Follow-up|Death|0|||
25099177|NCT02684058|50209954|FG001|Survival Follow-up|Death|0|||
25099178|NCT02684058|50209955|FG002|Survival Follow-up|Death|6|||
25099179|NCT02684058|50209953|FG000|Crossover Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|0|||
25099180|NCT02684058|50209954|FG001|Crossover Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|8|||
25099181|NCT02684058|50209955|FG002|Crossover Treatment Period|Treatment ongoing at the time of the cut-off, 23-Aug-2021|0|||
25099182|NCT02684058|50209953|FG000|Crossover Treatment Period|Progressive disease|0|||
25099183|NCT02684058|50209954|FG001|Crossover Treatment Period|Progressive disease|1|||
25099184|NCT02684058|50209955|FG002|Crossover Treatment Period|Progressive disease|0|||
25099185|NCT02684058|50209953|FG000|Crossover Survival Follow-up|Death|0|||
25099186|NCT02684058|50209954|FG001|Crossover Survival Follow-up|Death|1|||
25099187|NCT02684058|50209955|FG002|Crossover Survival Follow-up|Death|0|||
25099188|NCT02682238|50209971|FG000|Overall Study|Lost to Follow-up|0|||
25099189|NCT02682238|50209972|FG001|Overall Study|Lost to Follow-up|2|||
25099190|NCT02682238|50209971|FG000|Overall Study|Withdrawal by Subject|1|||
25099191|NCT02682238|50209972|FG001|Overall Study|Withdrawal by Subject|0|||
25099192|NCT02682238|50209971|FG000|Overall Study|Adverse Event|1|||
25099193|NCT02682238|50209972|FG001|Overall Study|Adverse Event|0|||
25099194|NCT02682238|50209971|FG000|Overall Study|Non-compliance with Study Drug|1|||
25099195|NCT02682238|50209972|FG001|Overall Study|Non-compliance with Study Drug|0|||
25099196|NCT02682238|50209971|FG000|Overall Study|Non-compliance with Protocol|0|||
25099197|NCT02682238|50209972|FG001|Overall Study|Non-compliance with Protocol|2|||
25099198|NCT02657356|50209996|FG000|Overall Study|Death|1|||
25099199|NCT02657356|50209997|FG001|Overall Study|Death|0|||
25099200|NCT02657356|50209996|FG000|Overall Study|Withdrawal by Subject|5|||
25099201|NCT02657356|50209997|FG001|Overall Study|Withdrawal by Subject|6|||
25099202|NCT02657356|50209996|FG000|Overall Study|Terminated by Sponsor|8|||
25099203|NCT02657356|50209997|FG001|Overall Study|Terminated by Sponsor|5|||
25099204|NCT02657356|50209996|FG000|Overall Study|Rolled over to EAP study|6|||
25099205|NCT02657356|50209997|FG001|Overall Study|Rolled over to EAP study|4|||
25099206|NCT01719562|50210032|FG000|Overall Study|Lost to Follow-up|1|||
25099207|NCT01719562|50210033|FG001|Overall Study|Lost to Follow-up|0|||
25099208|NCT01719562|50210032|FG000|Overall Study|Death|1|||
25099209|NCT01719562|50210033|FG001|Overall Study|Death|0|||
25099210|NCT01719562|50210032|FG000|Overall Study|New cancer diagnosis|1|||
25099211|NCT01719562|50210033|FG001|Overall Study|New cancer diagnosis|0|||
25099212|NCT01700439|50210039|FG000|Overall Study|Lost to Follow-up|47|||
25099213|NCT01700439|50210039|FG000|Overall Study|Withdrawal by Subject|183|||
25099214|NCT01700439|50210039|FG000|Overall Study|Death|186|||
25099215|NCT01433289|50210061|FG000|Overall Study|Pregnancy|0|||
25099216|NCT01433289|50210062|FG001|Overall Study|Pregnancy|1|||
25099217|NCT01433289|50210063|FG002|Overall Study|Pregnancy|0|||
25099218|NCT01433289|50210064|FG003|Overall Study|Pregnancy|0|||
25099219|NCT00980460|50210089|FG000|Overall Study|Death|0|||
25099220|NCT00980460|50210090|FG001|Overall Study|Death|0|||
25099221|NCT00980460|50210091|FG002|Overall Study|Death|1|||
25099222|NCT00980460|50210092|FG003|Overall Study|Death|2|||
25099223|NCT00980460|50210093|FG004|Overall Study|Death|1|||
25099224|NCT00980460|50210089|FG000|Overall Study|Lack of Efficacy|0|||
25099225|NCT00980460|50210090|FG001|Overall Study|Lack of Efficacy|0|||
25099226|NCT00980460|50210091|FG002|Overall Study|Lack of Efficacy|10|||
25099227|NCT00980460|50210092|FG003|Overall Study|Lack of Efficacy|6|||
25099228|NCT00980460|50210093|FG004|Overall Study|Lack of Efficacy|8|||
25099229|NCT00980460|50210089|FG000|Overall Study|Lost to Follow-up|0|||
25099230|NCT00980460|50210090|FG001|Overall Study|Lost to Follow-up|0|||
25099231|NCT00980460|50210091|FG002|Overall Study|Lost to Follow-up|0|||
25099232|NCT00980460|50210092|FG003|Overall Study|Lost to Follow-up|1|||
25099233|NCT00980460|50210093|FG004|Overall Study|Lost to Follow-up|0|||
25099234|NCT00980460|50210089|FG000|Overall Study|Physician Decision|0|||
25099235|NCT00980460|50210090|FG001|Overall Study|Physician Decision|0|||
25099236|NCT00980460|50210091|FG002|Overall Study|Physician Decision|11|||
25099237|NCT00980460|50210092|FG003|Overall Study|Physician Decision|5|||
25099238|NCT00980460|50210093|FG004|Overall Study|Physician Decision|3|||
25099239|NCT00980460|50210089|FG000|Overall Study|Withdrawal by Subject|0|||
25099240|NCT00980460|50210090|FG001|Overall Study|Withdrawal by Subject|0|||
25099241|NCT00980460|50210091|FG002|Overall Study|Withdrawal by Subject|1|||
25099242|NCT00980460|50210092|FG003|Overall Study|Withdrawal by Subject|0|||
25099243|NCT00980460|50210093|FG004|Overall Study|Withdrawal by Subject|0|||
25099244|NCT00980460|50210089|FG000|Overall Study|Ineligible|0|||
25099245|NCT00980460|50210090|FG001|Overall Study|Ineligible|2|||
25099246|NCT00980460|50210091|FG002|Overall Study|Ineligible|3|||
25099247|NCT00980460|50210092|FG003|Overall Study|Ineligible|1|||
25099248|NCT00980460|50210093|FG004|Overall Study|Ineligible|4|||
25099249|NCT00980460|50210089|FG000|Overall Study|Refusal of further therapy|0|||
25099250|NCT00980460|50210090|FG001|Overall Study|Refusal of further therapy|2|||
25099251|NCT00980460|50210091|FG002|Overall Study|Refusal of further therapy|3|||
25099252|NCT00980460|50210092|FG003|Overall Study|Refusal of further therapy|2|||
25099253|NCT00980460|50210093|FG004|Overall Study|Refusal of further therapy|0|||
25099254|NCT00980460|50210089|FG000|Overall Study|No therapy within 42 days of resection|0|||
25099255|NCT00980460|50210090|FG001|Overall Study|No therapy within 42 days of resection|0|||
25099256|NCT00980460|50210091|FG002|Overall Study|No therapy within 42 days of resection|3|||
25099257|NCT00980460|50210092|FG003|Overall Study|No therapy within 42 days of resection|1|||
25099258|NCT00980460|50210093|FG004|Overall Study|No therapy within 42 days of resection|0|||
25099259|NCT00980460|50210089|FG000|Overall Study|No transplant by protocol timepoints|0|||
25099260|NCT00980460|50210090|FG001|Overall Study|No transplant by protocol timepoints|0|||
25099261|NCT00980460|50210091|FG002|Overall Study|No transplant by protocol timepoints|3|||
25099262|NCT00980460|50210092|FG003|Overall Study|No transplant by protocol timepoints|0|||
25099263|NCT00980460|50210093|FG004|Overall Study|No transplant by protocol timepoints|0|||
25099264|NCT02576587|50210136|FG000|Baseline|Equipment failure|0|||
25099265|NCT02576587|50210137|FG001|Baseline|Equipment failure|1|||
25099266|NCT02576587|50210136|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
25099267|NCT02576587|50210137|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
25099268|NCT02576587|50210136|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
25099269|NCT02576587|50210137|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
25099270|NCT02576587|50210136|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
25099271|NCT02576587|50210137|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
25099272|NCT03016975|50210161|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
25099273|NCT03016975|50210162|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
25099274|NCT03016975|50210163|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
25099275|NCT03016975|50210161|FG000|At 6 Months Follow-up|Death|2|||
25099276|NCT03016975|50210162|FG001|At 6 Months Follow-up|Death|0|||
25099277|NCT03016975|50210163|FG002|At 6 Months Follow-up|Death|0|||
25099278|NCT03016975|50210161|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
25099279|NCT03016975|50210162|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
25099280|NCT03016975|50210163|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
25099281|NCT03016975|50210161|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
25099282|NCT03016975|50210162|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
25099283|NCT03016975|50210163|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
25099284|NCT03016975|50210161|FG000|At 6 Months Follow-up|Aborted implant|1|||
25099285|NCT03016975|50210162|FG001|At 6 Months Follow-up|Aborted implant|0|||
25099286|NCT03016975|50210163|FG002|At 6 Months Follow-up|Aborted implant|0|||
25099287|NCT03016975|50210161|FG000|At 2 Year Follow-up|Death|1|||
25099288|NCT03016975|50210162|FG001|At 2 Year Follow-up|Death|0|||
25099289|NCT03016975|50210163|FG002|At 2 Year Follow-up|Death|0|||
25099290|NCT03016975|50210161|FG000|At 3 Year Follow-up|Death|1|||
25099291|NCT03016975|50210162|FG001|At 3 Year Follow-up|Death|0|||
25099292|NCT03016975|50210163|FG002|At 3 Year Follow-up|Death|0|||
25099293|NCT03016975|50210161|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
25099294|NCT03016975|50210162|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
25099295|NCT03016975|50210163|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
25099296|NCT05340751|50210217|FG000|Overall Study|Physician Decision|3|||
25099297|NCT02575807|50210226|FG000|Overall Study|Death|8|||
25099298|NCT02575807|50210227|FG001|Overall Study|Death|3|||
25099299|NCT02575807|50210228|FG002|Overall Study|Death|7|||
25099300|NCT02575807|50210229|FG003|Overall Study|Death|0|||
25099301|NCT02575807|50210230|FG004|Overall Study|Death|1|||
25099302|NCT02575807|50210226|FG000|Overall Study|Study terminated by Sponsor|0|||
25099303|NCT02575807|50210227|FG001|Overall Study|Study terminated by Sponsor|1|||
25099304|NCT02575807|50210228|FG002|Overall Study|Study terminated by Sponsor|7|||
25099305|NCT02575807|50210229|FG003|Overall Study|Study terminated by Sponsor|0|||
25099306|NCT02575807|50210230|FG004|Overall Study|Study terminated by Sponsor|1|||
25099307|NCT02575807|50210226|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
25177051|NCT01559311|50321094|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
25099308|NCT02575807|50210227|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
25099309|NCT02575807|50210228|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
25099310|NCT02575807|50210229|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
25099311|NCT02575807|50210230|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
25099312|NCT02575807|50210226|FG000|Overall Study|Terminated due to physician decision|0|||
25099313|NCT02575807|50210227|FG001|Overall Study|Terminated due to physician decision|0|||
25099314|NCT02575807|50210228|FG002|Overall Study|Terminated due to physician decision|1|||
25099315|NCT02575807|50210229|FG003|Overall Study|Terminated due to physician decision|0|||
25099316|NCT02575807|50210230|FG004|Overall Study|Terminated due to physician decision|0|||
25099317|NCT02575807|50210226|FG000|Overall Study|Subject ineligible - medical implant|0|||
25099318|NCT02575807|50210227|FG001|Overall Study|Subject ineligible - medical implant|0|||
25099319|NCT02575807|50210228|FG002|Overall Study|Subject ineligible - medical implant|0|||
25099320|NCT02575807|50210229|FG003|Overall Study|Subject ineligible - medical implant|1|||
25099321|NCT02575807|50210230|FG004|Overall Study|Subject ineligible - medical implant|0|||
25099322|NCT02575807|50210226|FG000|Overall Study|Withdrawal by Subject|0|||
25099323|NCT02575807|50210227|FG001|Overall Study|Withdrawal by Subject|0|||
25099324|NCT02575807|50210228|FG002|Overall Study|Withdrawal by Subject|1|||
25099325|NCT02575807|50210229|FG003|Overall Study|Withdrawal by Subject|1|||
25099326|NCT02575807|50210230|FG004|Overall Study|Withdrawal by Subject|2|||
25099327|NCT02575339|50210265|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
25099328|NCT02575339|50210266|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
25099329|NCT02575339|50210267|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
25099330|NCT02575339|50210265|FG000|Study Treatment|Disease Progression|5|||
25099331|NCT02575339|50210266|FG001|Study Treatment|Disease Progression|2|||
25099332|NCT02575339|50210267|FG002|Study Treatment|Disease Progression|0|||
25099333|NCT02575339|50210265|FG000|Study Treatment|Adverse Event|1|||
25099334|NCT02575339|50210266|FG001|Study Treatment|Adverse Event|2|||
25099335|NCT02575339|50210267|FG002|Study Treatment|Adverse Event|0|||
25099336|NCT02575339|50210265|FG000|Follow up|Death|6|||
25099337|NCT02575339|50210266|FG001|Follow up|Death|2|||
25099338|NCT02575339|50210267|FG002|Follow up|Death|0|||
25099339|NCT02575339|50210265|FG000|Follow up|Study Terminated|0|||
25099340|NCT02575339|50210266|FG001|Follow up|Study Terminated|2|||
25099341|NCT02575339|50210267|FG002|Follow up|Study Terminated|0|||
25099342|NCT02575339|50210265|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
25099343|NCT02575339|50210266|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
25099344|NCT02575339|50210267|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
25099345|NCT01712659|50210280|FG000|Dose Escalation|Physician Decision|0|||
25099346|NCT01712659|50210281|FG001|Dose Escalation|Physician Decision|1|||
25099347|NCT01712659|50210282|FG002|Dose Escalation|Physician Decision|0|||
25099348|NCT01712659|50210283|FG003|Dose Escalation|Physician Decision|0|||
25099349|NCT01712659|50210284|FG004|Dose Escalation|Physician Decision|0|||
25099350|NCT01712659|50210280|FG000|Dose Escalation|Unable to take study drug|0|||
25099351|NCT01712659|50210281|FG001|Dose Escalation|Unable to take study drug|1|||
25099352|NCT01712659|50210282|FG002|Dose Escalation|Unable to take study drug|0|||
25099353|NCT01712659|50210283|FG003|Dose Escalation|Unable to take study drug|0|||
25099354|NCT01712659|50210284|FG004|Dose Escalation|Unable to take study drug|0|||
25099355|NCT01712659|50210280|FG000|Dose Expansion|Early disease progression|1|||
25099356|NCT01712659|50210281|FG001|Dose Expansion|Early disease progression|0|||
25099357|NCT01712659|50210282|FG002|Dose Expansion|Early disease progression|0|||
25099358|NCT01712659|50210283|FG003|Dose Expansion|Early disease progression|0|||
25099359|NCT01712659|50210284|FG004|Dose Expansion|Early disease progression|0|||
25099360|NCT01712659|50210280|FG000|Dose Expansion|Physician Decision|1|||
25099361|NCT01712659|50210281|FG001|Dose Expansion|Physician Decision|0|||
25099362|NCT01712659|50210282|FG002|Dose Expansion|Physician Decision|0|||
25099363|NCT01712659|50210283|FG003|Dose Expansion|Physician Decision|0|||
25099364|NCT01712659|50210284|FG004|Dose Expansion|Physician Decision|0|||
25099365|NCT01610713|50210310|FG000|Overall Study|Adverse Event|3|||
25099366|NCT01610713|50210311|FG001|Overall Study|Adverse Event|0|||
25099367|NCT01610713|50210310|FG000|Overall Study|Lack of Efficacy|1|||
25099368|NCT01610713|50210311|FG001|Overall Study|Lack of Efficacy|0|||
25099369|NCT01610713|50210310|FG000|Overall Study|low mood and poor motivation|1|||
25099370|NCT01610713|50210311|FG001|Overall Study|low mood and poor motivation|0|||
25099371|NCT01610713|50210310|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
25099372|NCT01610713|50210311|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
25099373|NCT01610713|50210310|FG000|Overall Study|Lost to Follow-up|0|||
25099374|NCT01610713|50210311|FG001|Overall Study|Lost to Follow-up|1|||
25099375|NCT01606189|50210317|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
25099376|NCT01606189|50210318|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
25099377|NCT01606189|50210319|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
25099378|NCT01606189|50210320|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
25099379|NCT01606189|50210321|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
25099380|NCT01606189|50210322|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
25099381|NCT01606189|50210317|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
25099382|NCT01606189|50210318|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
25099383|NCT01606189|50210319|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
25099384|NCT01606189|50210320|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
25099385|NCT01606189|50210321|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
25099386|NCT01606189|50210322|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
25099387|NCT01663987|50210332|FG000|Overall Study|Adverse Event|7|||
25099388|NCT01663987|50210333|FG001|Overall Study|Adverse Event|2|||
25099389|NCT01663987|50210332|FG000|Overall Study|Lost to Follow-up|1|||
25099390|NCT01663987|50210333|FG001|Overall Study|Lost to Follow-up|1|||
25099391|NCT01663987|50210332|FG000|Overall Study|Withdrawal by Subject|2|||
25099392|NCT01663987|50210333|FG001|Overall Study|Withdrawal by Subject|3|||
25099393|NCT01663987|50210332|FG000|Overall Study|Other reason not defined above|3|||
25099394|NCT01663987|50210333|FG001|Overall Study|Other reason not defined above|0|||
25099395|NCT02380677|50210351|FG000|Overall Study|Adverse Event|0|||
25099396|NCT02380677|50210352|FG001|Overall Study|Adverse Event|0|||
25099397|NCT02380677|50210353|FG002|Overall Study|Adverse Event|0|||
25099398|NCT02380677|50210354|FG003|Overall Study|Adverse Event|1|||
25099399|NCT02380677|50210355|FG004|Overall Study|Adverse Event|1|||
25099400|NCT02380677|50210356|FG005|Overall Study|Adverse Event|4|||
25099401|NCT02380677|50210357|FG006|Overall Study|Adverse Event|2|||
25099402|NCT02380677|50210358|FG007|Overall Study|Adverse Event|2|||
25099403|NCT02380677|50210359|FG008|Overall Study|Adverse Event|2|||
25099404|NCT02380677|50210360|FG009|Overall Study|Adverse Event|1|||
25099405|NCT02380677|50210361|FG010|Overall Study|Adverse Event|2|||
25099406|NCT02380677|50210362|FG011|Overall Study|Adverse Event|1|||
25099407|NCT02380677|50210351|FG000|Overall Study|Physician Decision|1|||
25099408|NCT02380677|50210352|FG001|Overall Study|Physician Decision|0|||
25099409|NCT02380677|50210353|FG002|Overall Study|Physician Decision|1|||
25099410|NCT02380677|50210354|FG003|Overall Study|Physician Decision|1|||
25099411|NCT02380677|50210355|FG004|Overall Study|Physician Decision|0|||
25099412|NCT02380677|50210356|FG005|Overall Study|Physician Decision|0|||
25099413|NCT02380677|50210357|FG006|Overall Study|Physician Decision|0|||
25099414|NCT02380677|50210358|FG007|Overall Study|Physician Decision|0|||
25099415|NCT02380677|50210359|FG008|Overall Study|Physician Decision|0|||
25099416|NCT02380677|50210360|FG009|Overall Study|Physician Decision|0|||
25099417|NCT02380677|50210361|FG010|Overall Study|Physician Decision|0|||
25099418|NCT02380677|50210362|FG011|Overall Study|Physician Decision|0|||
25099419|NCT02380677|50210351|FG000|Overall Study|Lack of Efficacy|0|||
25099420|NCT02380677|50210352|FG001|Overall Study|Lack of Efficacy|1|||
25099421|NCT02380677|50210353|FG002|Overall Study|Lack of Efficacy|2|||
25099422|NCT02380677|50210354|FG003|Overall Study|Lack of Efficacy|0|||
25099423|NCT02380677|50210355|FG004|Overall Study|Lack of Efficacy|4|||
25099424|NCT02380677|50210356|FG005|Overall Study|Lack of Efficacy|1|||
25099425|NCT02380677|50210357|FG006|Overall Study|Lack of Efficacy|1|||
25099426|NCT02380677|50210358|FG007|Overall Study|Lack of Efficacy|2|||
25099427|NCT02380677|50210359|FG008|Overall Study|Lack of Efficacy|2|||
25099428|NCT02380677|50210360|FG009|Overall Study|Lack of Efficacy|0|||
25099429|NCT02380677|50210361|FG010|Overall Study|Lack of Efficacy|2|||
25099430|NCT02380677|50210362|FG011|Overall Study|Lack of Efficacy|1|||
25099431|NCT02380677|50210351|FG000|Overall Study|Withdrawal by Subject|0|||
25099432|NCT02380677|50210352|FG001|Overall Study|Withdrawal by Subject|0|||
25099433|NCT02380677|50210353|FG002|Overall Study|Withdrawal by Subject|0|||
25099434|NCT02380677|50210354|FG003|Overall Study|Withdrawal by Subject|0|||
25099435|NCT02380677|50210355|FG004|Overall Study|Withdrawal by Subject|0|||
25099436|NCT02380677|50210356|FG005|Overall Study|Withdrawal by Subject|0|||
25099437|NCT02380677|50210357|FG006|Overall Study|Withdrawal by Subject|0|||
25099438|NCT02380677|50210358|FG007|Overall Study|Withdrawal by Subject|0|||
25099439|NCT02380677|50210359|FG008|Overall Study|Withdrawal by Subject|0|||
25099440|NCT02380677|50210360|FG009|Overall Study|Withdrawal by Subject|1|||
25099441|NCT02380677|50210361|FG010|Overall Study|Withdrawal by Subject|0|||
25099442|NCT02380677|50210362|FG011|Overall Study|Withdrawal by Subject|3|||
25099443|NCT02380677|50210351|FG000|Overall Study|Other|0|||
25099444|NCT02380677|50210352|FG001|Overall Study|Other|0|||
25099445|NCT02380677|50210353|FG002|Overall Study|Other|0|||
25099446|NCT02380677|50210354|FG003|Overall Study|Other|1|||
25099447|NCT02380677|50210355|FG004|Overall Study|Other|1|||
25099448|NCT02380677|50210356|FG005|Overall Study|Other|1|||
25099449|NCT02380677|50210357|FG006|Overall Study|Other|0|||
25099450|NCT02380677|50210358|FG007|Overall Study|Other|0|||
25099451|NCT02380677|50210359|FG008|Overall Study|Other|0|||
25099452|NCT02380677|50210360|FG009|Overall Study|Other|0|||
25099453|NCT02380677|50210361|FG010|Overall Study|Other|0|||
25099454|NCT02380677|50210362|FG011|Overall Study|Other|0|||
25099455|NCT02380287|50210398|FG000|Overall Study|Adverse Event|0|||
25099456|NCT02380287|50210399|FG001|Overall Study|Adverse Event|0|||
25099457|NCT02380287|50210400|FG002|Overall Study|Adverse Event|1|||
25099458|NCT02380287|50210401|FG003|Overall Study|Adverse Event|0|||
25099459|NCT02380287|50210402|FG004|Overall Study|Adverse Event|0|||
25099460|NCT02380287|50210403|FG005|Overall Study|Adverse Event|0|||
25099461|NCT02380287|50210404|FG006|Overall Study|Adverse Event|0|||
25099462|NCT02380287|50210405|FG007|Overall Study|Adverse Event|0|||
25099463|NCT02343003|50210432|FG000|Overall Study|Withdrawal by Subject|9|||
25099464|NCT02343003|50210433|FG001|Overall Study|Withdrawal by Subject|4|||
25099465|NCT02343003|50210432|FG000|Overall Study|Lost to Follow-up|5|||
25099466|NCT02343003|50210433|FG001|Overall Study|Lost to Follow-up|1|||
25099467|NCT02343003|50210432|FG000|Overall Study|Protocol Violation|1|||
25099468|NCT02343003|50210433|FG001|Overall Study|Protocol Violation|0|||
25099469|NCT02343003|50210432|FG000|Overall Study|Death|0|||
25099470|NCT02343003|50210433|FG001|Overall Study|Death|1|||
25099471|NCT02343003|50210432|FG000|Overall Study|exclusion criteria met|1|||
25099472|NCT02343003|50210433|FG001|Overall Study|exclusion criteria met|1|||
25099473|NCT02343003|50210432|FG000|Overall Study|terminated by sponsor|2|||
25099474|NCT02343003|50210433|FG001|Overall Study|terminated by sponsor|0|||
25099475|NCT02394561|50210441|FG000|CORE Phase|Adverse Event|7|||
25099476|NCT02394561|50210442|FG001|CORE Phase|Adverse Event|9|||
25099477|NCT02394561|50210441|FG000|CORE Phase|Death|0|||
25099478|NCT02394561|50210442|FG001|CORE Phase|Death|1|||
25099479|NCT02394561|50210441|FG000|CORE Phase|Pregnancy|1|||
25099480|NCT02394561|50210442|FG001|CORE Phase|Pregnancy|0|||
25099481|NCT02394561|50210441|FG000|CORE Phase|Lost to Follow-up|1|||
25099482|NCT02394561|50210442|FG001|CORE Phase|Lost to Follow-up|0|||
25099483|NCT02394561|50210441|FG000|CORE Phase|Physician Decision|1|||
25099484|NCT02394561|50210442|FG001|CORE Phase|Physician Decision|1|||
25099485|NCT02394561|50210441|FG000|CORE Phase|Withdrawal by Subject|2|||
25099486|NCT02394561|50210442|FG001|CORE Phase|Withdrawal by Subject|2|||
25099487|NCT02394561|50210441|FG000|CORE Phase|Lack of Efficacy|1|||
25099488|NCT02394561|50210442|FG001|CORE Phase|Lack of Efficacy|6|||
25099489|NCT02394561|50210441|FG000|Extension Phase|Adverse Event|6|||
25099490|NCT02394561|50210442|FG001|Extension Phase|Adverse Event|1|||
25099491|NCT02394561|50210441|FG000|Extension Phase|Death|0|||
25099492|NCT02394561|50210442|FG001|Extension Phase|Death|1|||
25099493|NCT02394561|50210441|FG000|Extension Phase|Protocol Violation|1|||
25099494|NCT02394561|50210442|FG001|Extension Phase|Protocol Violation|0|||
25099495|NCT02394561|50210441|FG000|Extension Phase|Lost to Follow-up|1|||
25099496|NCT02394561|50210442|FG001|Extension Phase|Lost to Follow-up|0|||
25099497|NCT02394561|50210441|FG000|Extension Phase|Physician Decision|0|||
25099498|NCT02394561|50210442|FG001|Extension Phase|Physician Decision|2|||
25099499|NCT02394561|50210441|FG000|Extension Phase|Withdrawal by Subject|0|||
25099500|NCT02394561|50210442|FG001|Extension Phase|Withdrawal by Subject|5|||
25099501|NCT02394561|50210441|FG000|Extension Phase|Lack of Efficacy|3|||
25099502|NCT02394561|50210442|FG001|Extension Phase|Lack of Efficacy|3|||
25099503|NCT02342223|50210451|FG000|Overall Study|Lost to Follow-up|1|||
25099504|NCT02393547|50210455|FG000|Overall Study|Adverse Event|2|||
25099505|NCT02393547|50210455|FG000|Overall Study|Withdrawal by Subject|3|||
25099506|NCT02393547|50210455|FG000|Overall Study|Lost to Follow-up|1|||
25099507|NCT02574637|50210464|FG000|Double-blind Period|Adverse Event|1|||
25099508|NCT02574637|50210465|FG001|Double-blind Period|Adverse Event|0|||
25099509|NCT02574637|50210466|FG002|Double-blind Period|Adverse Event|0|||
25099510|NCT02574637|50210467|FG003|Double-blind Period|Adverse Event|0|||
25099511|NCT02574637|50210468|FG004|Double-blind Period|Adverse Event|0|||
25099512|NCT02574637|50210469|FG005|Double-blind Period|Adverse Event|0|||
25099513|NCT02574637|50210470|FG006|Double-blind Period|Adverse Event|0|||
25099514|NCT02574637|50210471|FG007|Double-blind Period|Adverse Event|0|||
25099515|NCT02574637|50210472|FG008|Double-blind Period|Adverse Event|0|||
25099516|NCT02574637|50210473|FG009|Double-blind Period|Adverse Event|0|||
25099517|NCT02574637|50210464|FG000|Double-blind Period|Lack of Efficacy|0|||
25099518|NCT02574637|50210465|FG001|Double-blind Period|Lack of Efficacy|0|||
25099519|NCT02574637|50210466|FG002|Double-blind Period|Lack of Efficacy|2|||
25099520|NCT02574637|50210467|FG003|Double-blind Period|Lack of Efficacy|0|||
25099521|NCT02574637|50210468|FG004|Double-blind Period|Lack of Efficacy|0|||
25099522|NCT02574637|50210469|FG005|Double-blind Period|Lack of Efficacy|0|||
25099523|NCT02574637|50210470|FG006|Double-blind Period|Lack of Efficacy|0|||
25099524|NCT02574637|50210471|FG007|Double-blind Period|Lack of Efficacy|0|||
25099525|NCT02574637|50210472|FG008|Double-blind Period|Lack of Efficacy|0|||
25099526|NCT02574637|50210473|FG009|Double-blind Period|Lack of Efficacy|0|||
25099527|NCT02574637|50210464|FG000|Double-blind Period|Protocol Deviation|1|||
25099528|NCT02574637|50210465|FG001|Double-blind Period|Protocol Deviation|0|||
25099529|NCT02574637|50210466|FG002|Double-blind Period|Protocol Deviation|0|||
25008121|NCT02431702|50100908|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
25008122|NCT02431702|50100909|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
25099530|NCT02574637|50210467|FG003|Double-blind Period|Protocol Deviation|0|||
25099531|NCT02574637|50210468|FG004|Double-blind Period|Protocol Deviation|0|||
25099532|NCT02574637|50210469|FG005|Double-blind Period|Protocol Deviation|0|||
25099533|NCT02574637|50210470|FG006|Double-blind Period|Protocol Deviation|0|||
25099534|NCT02574637|50210471|FG007|Double-blind Period|Protocol Deviation|0|||
25099535|NCT02574637|50210472|FG008|Double-blind Period|Protocol Deviation|0|||
25099536|NCT02574637|50210473|FG009|Double-blind Period|Protocol Deviation|0|||
25099537|NCT02574637|50210464|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
25099538|NCT02574637|50210465|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
25099539|NCT02574637|50210466|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
25099540|NCT02574637|50210467|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
25099541|NCT02574637|50210468|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
25099542|NCT02574637|50210469|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
25099543|NCT02574637|50210470|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
25099544|NCT02574637|50210471|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
25099545|NCT02574637|50210472|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
25099546|NCT02574637|50210473|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
25099547|NCT02574637|50210464|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
25099548|NCT02574637|50210465|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
25099549|NCT02574637|50210466|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
25099550|NCT02574637|50210467|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
25099551|NCT02574637|50210468|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
25099552|NCT02574637|50210469|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
25099553|NCT02574637|50210470|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
25099554|NCT02574637|50210471|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
25099555|NCT02574637|50210472|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
25099556|NCT02574637|50210473|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
25099557|NCT02574637|50210464|FG000|Double-blind Period|Reason Not Specified|0|||
25099558|NCT02574637|50210465|FG001|Double-blind Period|Reason Not Specified|0|||
25099559|NCT02574637|50210466|FG002|Double-blind Period|Reason Not Specified|0|||
25099560|NCT02574637|50210467|FG003|Double-blind Period|Reason Not Specified|1|||
25099561|NCT02574637|50210468|FG004|Double-blind Period|Reason Not Specified|0|||
25099562|NCT02574637|50210469|FG005|Double-blind Period|Reason Not Specified|0|||
25099563|NCT02574637|50210470|FG006|Double-blind Period|Reason Not Specified|0|||
25099564|NCT02574637|50210471|FG007|Double-blind Period|Reason Not Specified|0|||
25099565|NCT02574637|50210472|FG008|Double-blind Period|Reason Not Specified|0|||
25099566|NCT02574637|50210473|FG009|Double-blind Period|Reason Not Specified|0|||
25099567|NCT02574637|50210464|FG000|Open-label (OL) Period|Adverse Event|0|||
25099568|NCT02574637|50210465|FG001|Open-label (OL) Period|Adverse Event|0|||
25099569|NCT02574637|50210466|FG002|Open-label (OL) Period|Adverse Event|0|||
25099570|NCT02574637|50210467|FG003|Open-label (OL) Period|Adverse Event|0|||
25099571|NCT02574637|50210468|FG004|Open-label (OL) Period|Adverse Event|0|||
25099572|NCT02574637|50210469|FG005|Open-label (OL) Period|Adverse Event|0|||
25099573|NCT02574637|50210470|FG006|Open-label (OL) Period|Adverse Event|0|||
25099574|NCT02574637|50210471|FG007|Open-label (OL) Period|Adverse Event|0|||
25099575|NCT02574637|50210472|FG008|Open-label (OL) Period|Adverse Event|1|||
25099576|NCT02574637|50210473|FG009|Open-label (OL) Period|Adverse Event|0|||
25099577|NCT02574637|50210464|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
25099578|NCT02574637|50210465|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
25099579|NCT02574637|50210466|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
25099580|NCT02574637|50210467|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
25099581|NCT02574637|50210468|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
25099582|NCT02574637|50210469|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
25099583|NCT02574637|50210470|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
25099584|NCT02574637|50210471|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
25099585|NCT02574637|50210472|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
25099586|NCT02574637|50210473|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
25099587|NCT02574637|50210464|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
25099588|NCT02574637|50210465|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
25099589|NCT02574637|50210466|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
25099590|NCT02574637|50210467|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
25099591|NCT02574637|50210468|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
25099592|NCT02574637|50210469|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
25099593|NCT02574637|50210470|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
25099594|NCT02574637|50210471|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
25099595|NCT02574637|50210472|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
25099596|NCT02574637|50210473|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
25099597|NCT02392611|50210503|FG000|Overall Study|Adverse Event|0|||
25099598|NCT02392611|50210504|FG001|Overall Study|Adverse Event|0|||
25099599|NCT02392611|50210505|FG002|Overall Study|Adverse Event|0|||
25099600|NCT02392611|50210506|FG003|Overall Study|Adverse Event|1|||
25099601|NCT02392611|50210507|FG004|Overall Study|Adverse Event|0|||
25099602|NCT02392611|50210508|FG005|Overall Study|Adverse Event|0|||
25099603|NCT02392611|50210509|FG006|Overall Study|Adverse Event|0|||
25099604|NCT02392611|50210510|FG007|Overall Study|Adverse Event|0|||
25099605|NCT02392611|50210511|FG008|Overall Study|Adverse Event|0|||
25099606|NCT02392611|50210503|FG000|Overall Study|Progressive disease|0|||
25099607|NCT02392611|50210504|FG001|Overall Study|Progressive disease|0|||
25099608|NCT02392611|50210505|FG002|Overall Study|Progressive disease|0|||
25099609|NCT02392611|50210506|FG003|Overall Study|Progressive disease|2|||
25099610|NCT02392611|50210507|FG004|Overall Study|Progressive disease|1|||
25099611|NCT02392611|50210508|FG005|Overall Study|Progressive disease|0|||
25099612|NCT02392611|50210509|FG006|Overall Study|Progressive disease|0|||
25099613|NCT02392611|50210510|FG007|Overall Study|Progressive disease|0|||
25099614|NCT02392611|50210511|FG008|Overall Study|Progressive disease|0|||
25099615|NCT02392611|50210503|FG000|Overall Study|Death|1|||
25099616|NCT02392611|50210504|FG001|Overall Study|Death|0|||
25099617|NCT02392611|50210505|FG002|Overall Study|Death|0|||
25099618|NCT02392611|50210506|FG003|Overall Study|Death|0|||
25099619|NCT02392611|50210507|FG004|Overall Study|Death|0|||
25099620|NCT02392611|50210508|FG005|Overall Study|Death|1|||
25099621|NCT02392611|50210509|FG006|Overall Study|Death|0|||
25099622|NCT02392611|50210510|FG007|Overall Study|Death|0|||
25099623|NCT02392611|50210511|FG008|Overall Study|Death|0|||
25099624|NCT02392611|50210503|FG000|Overall Study|Withdrawal by Subject|0|||
25099625|NCT02392611|50210504|FG001|Overall Study|Withdrawal by Subject|0|||
25099626|NCT02392611|50210505|FG002|Overall Study|Withdrawal by Subject|0|||
25099627|NCT02392611|50210506|FG003|Overall Study|Withdrawal by Subject|1|||
25099628|NCT02392611|50210507|FG004|Overall Study|Withdrawal by Subject|0|||
25099629|NCT02392611|50210508|FG005|Overall Study|Withdrawal by Subject|0|||
25099630|NCT02392611|50210509|FG006|Overall Study|Withdrawal by Subject|0|||
25099631|NCT02392611|50210510|FG007|Overall Study|Withdrawal by Subject|0|||
25099632|NCT02392611|50210511|FG008|Overall Study|Withdrawal by Subject|0|||
25099633|NCT02392611|50210503|FG000|Overall Study|Lost to Follow-up|0|||
25099634|NCT02392611|50210504|FG001|Overall Study|Lost to Follow-up|0|||
25099635|NCT02392611|50210505|FG002|Overall Study|Lost to Follow-up|0|||
25099636|NCT02392611|50210506|FG003|Overall Study|Lost to Follow-up|0|||
25099637|NCT02392611|50210507|FG004|Overall Study|Lost to Follow-up|0|||
25099638|NCT02392611|50210508|FG005|Overall Study|Lost to Follow-up|0|||
25099639|NCT02392611|50210509|FG006|Overall Study|Lost to Follow-up|1|||
25099640|NCT02392611|50210510|FG007|Overall Study|Lost to Follow-up|0|||
25099641|NCT02392611|50210511|FG008|Overall Study|Lost to Follow-up|0|||
25099642|NCT02392611|50210503|FG000|Overall Study|Enrolled, not treated|0|||
25099643|NCT02392611|50210504|FG001|Overall Study|Enrolled, not treated|0|||
25099644|NCT02392611|50210505|FG002|Overall Study|Enrolled, not treated|0|||
25099645|NCT02392611|50210506|FG003|Overall Study|Enrolled, not treated|2|||
25099646|NCT02392611|50210507|FG004|Overall Study|Enrolled, not treated|0|||
25099647|NCT02392611|50210508|FG005|Overall Study|Enrolled, not treated|0|||
25099648|NCT02392611|50210509|FG006|Overall Study|Enrolled, not treated|0|||
25099649|NCT02392611|50210510|FG007|Overall Study|Enrolled, not treated|0|||
25099650|NCT02392611|50210511|FG008|Overall Study|Enrolled, not treated|0|||
25099651|NCT02378961|50210535|FG000|Overall Study|Lack of Efficacy|4|||
25099652|NCT02378961|50210536|FG001|Overall Study|Lack of Efficacy|2|||
25099653|NCT02378961|50210537|FG002|Overall Study|Lack of Efficacy|0|||
25099654|NCT02378961|50210538|FG003|Overall Study|Lack of Efficacy|1|||
25099655|NCT02378961|50210535|FG000|Overall Study|Death|0|||
25099656|NCT02378961|50210536|FG001|Overall Study|Death|0|||
25099657|NCT02378961|50210537|FG002|Overall Study|Death|1|||
25099658|NCT02378961|50210538|FG003|Overall Study|Death|0|||
25099659|NCT02378883|50210548|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
25099660|NCT02378883|50210548|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
25099661|NCT02378883|50210548|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
25099662|NCT02378883|50210548|FG000|30 Day Follow-Up|Physician Decision|2|||
25099663|NCT02378883|50210548|FG000|30 Day Follow-Up|Missed Visit|2|||
25099664|NCT02378883|50210548|FG000|30 Day Follow-Up|Death|1|||
25099665|NCT02378883|50210548|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
25099666|NCT02378883|50210548|FG000|12 Months Follow-Up|Death|2|||
25099667|NCT02340975|50210559|FG000|Overall Study|Death|6|||
25099668|NCT02340975|50210560|FG001|Overall Study|Death|23|||
25099669|NCT02340975|50210561|FG002|Overall Study|Death|21|||
25099670|NCT02340975|50210562|FG003|Overall Study|Death|7|||
25099671|NCT02340975|50210563|FG004|Overall Study|Death|21|||
25099672|NCT02340975|50210564|FG005|Overall Study|Death|13|||
25099673|NCT02340975|50210559|FG000|Overall Study|Lost to Follow-up|0|||
25099674|NCT02340975|50210560|FG001|Overall Study|Lost to Follow-up|0|||
25099675|NCT02340975|50210561|FG002|Overall Study|Lost to Follow-up|0|||
25099676|NCT02340975|50210562|FG003|Overall Study|Lost to Follow-up|0|||
25177052|NCT01559311|50321095|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
25099677|NCT02340975|50210563|FG004|Overall Study|Lost to Follow-up|2|||
25099678|NCT02340975|50210564|FG005|Overall Study|Lost to Follow-up|0|||
25099679|NCT02340975|50210559|FG000|Overall Study|Withdrawal by Subject|0|||
25099680|NCT02340975|50210560|FG001|Overall Study|Withdrawal by Subject|0|||
25099681|NCT02340975|50210561|FG002|Overall Study|Withdrawal by Subject|3|||
25099682|NCT02340975|50210562|FG003|Overall Study|Withdrawal by Subject|3|||
25099683|NCT02340975|50210563|FG004|Overall Study|Withdrawal by Subject|2|||
25099684|NCT02340975|50210564|FG005|Overall Study|Withdrawal by Subject|0|||
25099685|NCT02340975|50210559|FG000|Overall Study|Other|0|||
25099686|NCT02340975|50210560|FG001|Overall Study|Other|4|||
25099687|NCT02340975|50210561|FG002|Overall Study|Other|0|||
25099688|NCT02340975|50210562|FG003|Overall Study|Other|2|||
25099689|NCT02340975|50210563|FG004|Overall Study|Other|0|||
25099690|NCT02340975|50210564|FG005|Overall Study|Other|6|||
25099691|NCT02392377|50210581|FG000|Overall Study|Withdrawal by Subject|0|||
25099692|NCT02392377|50210582|FG001|Overall Study|Withdrawal by Subject|1|||
25099693|NCT02340819|50210590|FG000|Overall Study|Adverse Event|1|||
25099694|NCT02340819|50210590|FG000|Overall Study|Withdrawal by Subject|2|||
25099695|NCT02340819|50210590|FG000|Overall Study|Discontinued with other reason|1|||
25099696|NCT02340663|50210596|FG000|Overall Study|Lost to Follow-up|1|||
25099697|NCT02340663|50210597|FG001|Overall Study|Lost to Follow-up|0|||
25099698|NCT02340663|50210596|FG000|Overall Study|Protocol Violation|1|||
25099699|NCT02340663|50210597|FG001|Overall Study|Protocol Violation|0|||
25099700|NCT02340663|50210596|FG000|Overall Study|Withdrawal by Subject|3|||
25099701|NCT02340663|50210597|FG001|Overall Study|Withdrawal by Subject|1|||
25099702|NCT02573467|50210607|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
25099703|NCT02573467|50210608|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
25099704|NCT02573467|50210609|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
25099705|NCT02573467|50210610|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
25099706|NCT02573467|50210607|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
25099707|NCT02573467|50210608|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
25099708|NCT02573467|50210609|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
25099709|NCT02573467|50210610|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
25099710|NCT02573467|50210607|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
25099711|NCT02573467|50210608|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
25099712|NCT02573467|50210609|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
25099713|NCT02573467|50210610|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
25099714|NCT02573467|50210607|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
25099715|NCT02573467|50210608|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
25099716|NCT02573467|50210609|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
25099717|NCT02573467|50210610|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
25099718|NCT02573467|50210607|FG000|Post-treatment Follow up Epoch|Death|1|||
25099719|NCT02573467|50210608|FG001|Post-treatment Follow up Epoch|Death|1|||
25099720|NCT02573467|50210609|FG002|Post-treatment Follow up Epoch|Death|0|||
25099721|NCT02573467|50210610|FG003|Post-treatment Follow up Epoch|Death|1|||
25099722|NCT02573467|50210607|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
25099723|NCT02573467|50210608|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
25099724|NCT02573467|50210609|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
25099725|NCT02573467|50210610|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
25099726|NCT02573467|50210607|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
25099727|NCT02573467|50210608|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
25099728|NCT02573467|50210609|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
25099729|NCT02573467|50210610|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
25099730|NCT02337387|50210625|FG000|Overall Study|Adverse Event|0|||
25099731|NCT02337387|50210626|FG001|Overall Study|Adverse Event|1|||
25099732|NCT02337387|50210627|FG002|Overall Study|Adverse Event|0|||
25099733|NCT02337387|50210628|FG003|Overall Study|Adverse Event|0|||
25099734|NCT02337387|50210625|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
25099735|NCT02337387|50210626|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
25099736|NCT02337387|50210627|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
25099737|NCT02337387|50210628|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
25099738|NCT02574247|50210641|FG000|Overall Study|Withdrawal by Subject|1|||
25099739|NCT02574247|50210642|FG001|Overall Study|Withdrawal by Subject|0|||
25008123|NCT02431702|50100910|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
25008124|NCT02431702|50100904|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
25008125|NCT02431702|50100905|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
25008126|NCT02431702|50100906|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
25008127|NCT02431702|50100907|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
25008128|NCT02431702|50100908|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
25008129|NCT02431702|50100909|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
25008130|NCT02431702|50100910|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
25008131|NCT02431702|50100904|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
25008132|NCT02431702|50100905|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
25008133|NCT02431702|50100906|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
25008134|NCT02431702|50100907|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
25008135|NCT02431702|50100908|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
25008136|NCT02431702|50100909|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
25008137|NCT02431702|50100910|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
25008138|NCT02431702|50100904|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
25008139|NCT02431702|50100905|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
25008140|NCT02431702|50100906|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
25008141|NCT02431702|50100907|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
25099740|NCT02574247|50210643|FG002|Overall Study|Withdrawal by Subject|0|||
25099741|NCT02574247|50210641|FG000|Overall Study|Did not meet inclusion criteria|4|||
25099742|NCT02574247|50210642|FG001|Overall Study|Did not meet inclusion criteria|3|||
25099743|NCT02574247|50210643|FG002|Overall Study|Did not meet inclusion criteria|5|||
25099744|NCT02391363|50210655|FG000|Overall Study|Lost to Follow-up|5|||
25099745|NCT02391363|50210656|FG001|Overall Study|Lost to Follow-up|5|||
25099746|NCT02391363|50210655|FG000|Overall Study|Withdrawal by Subject|6|||
25099747|NCT02391363|50210656|FG001|Overall Study|Withdrawal by Subject|3|||
25099748|NCT02569957|50210664|FG000|Overall Study|Withdrawal by Subject|0|||
25099749|NCT02569957|50210665|FG001|Overall Study|Withdrawal by Subject|1|||
25099750|NCT01649427|50210673|FG000|Overall Study|Adverse Event|1|||
25099751|NCT01649427|50210674|FG001|Overall Study|Adverse Event|1|||
25099752|NCT01649427|50210673|FG000|Overall Study|Withdrawal by Subject|8|||
25099753|NCT01649427|50210674|FG001|Overall Study|Withdrawal by Subject|7|||
25099754|NCT01649427|50210673|FG000|Overall Study|Lost to Follow-up|0|||
25099755|NCT01649427|50210674|FG001|Overall Study|Lost to Follow-up|1|||
25099756|NCT01649427|50210673|FG000|Overall Study|Graft loss|0|||
25099757|NCT01649427|50210674|FG001|Overall Study|Graft loss|1|||
25099758|NCT01649427|50210673|FG000|Overall Study|Surgical problems during nephrectomy|2|||
25099759|NCT01649427|50210674|FG001|Overall Study|Surgical problems during nephrectomy|2|||
25099760|NCT02375373|50210680|FG000|Overall Study|Withdrawal by Subject|11|||
25099761|NCT02336607|50210688|FG000|Overall Study|Physician Decision|1|||
25099762|NCT02336607|50210689|FG001|Overall Study|Physician Decision|4|||
25099763|NCT02336607|50210690|FG002|Overall Study|Physician Decision|3|||
25099764|NCT02336607|50210691|FG003|Overall Study|Physician Decision|15|||
25099765|NCT02336607|50210688|FG000|Overall Study|Lack of Efficacy|1|||
25099766|NCT02336607|50210689|FG001|Overall Study|Lack of Efficacy|0|||
25099767|NCT02336607|50210690|FG002|Overall Study|Lack of Efficacy|0|||
25099768|NCT02336607|50210691|FG003|Overall Study|Lack of Efficacy|2|||
25099769|NCT02336607|50210688|FG000|Overall Study|Lost to Follow-up|2|||
25099770|NCT02336607|50210689|FG001|Overall Study|Lost to Follow-up|1|||
25099771|NCT02336607|50210690|FG002|Overall Study|Lost to Follow-up|0|||
25099772|NCT02336607|50210691|FG003|Overall Study|Lost to Follow-up|21|||
25099773|NCT02336607|50210688|FG000|Overall Study|Protocol Violation|0|||
25099774|NCT02336607|50210689|FG001|Overall Study|Protocol Violation|1|||
25099775|NCT02336607|50210690|FG002|Overall Study|Protocol Violation|1|||
25099776|NCT02336607|50210691|FG003|Overall Study|Protocol Violation|3|||
25099777|NCT02336607|50210688|FG000|Overall Study|Adverse Event|0|||
25099778|NCT02336607|50210689|FG001|Overall Study|Adverse Event|2|||
25099779|NCT02336607|50210690|FG002|Overall Study|Adverse Event|2|||
25099780|NCT02336607|50210691|FG003|Overall Study|Adverse Event|26|||
25099781|NCT02336607|50210688|FG000|Overall Study|Withdrawal by Subject|0|||
25099782|NCT02336607|50210689|FG001|Overall Study|Withdrawal by Subject|2|||
25099783|NCT02336607|50210690|FG002|Overall Study|Withdrawal by Subject|0|||
25099784|NCT02336607|50210691|FG003|Overall Study|Withdrawal by Subject|20|||
25099785|NCT02374671|50210704|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
25099786|NCT02374671|50210705|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
25099787|NCT02374671|50210706|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
25099788|NCT02374671|50210704|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
25099789|NCT02374671|50210705|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
25099790|NCT02374671|50210706|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
25099791|NCT02374671|50210704|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
25099792|NCT02374671|50210705|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
25099793|NCT02374671|50210706|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
25099794|NCT02374671|50210704|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
25099795|NCT02374671|50210705|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
25099796|NCT02374671|50210706|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
25099797|NCT02374671|50210704|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
25099798|NCT02374671|50210705|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
25099799|NCT02374671|50210706|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
25099800|NCT02569801|50210714|FG000|Overall Study|Withdrawal by Subject|9|||
25099801|NCT02569801|50210715|FG001|Overall Study|Withdrawal by Subject|9|||
25099802|NCT02569801|50210714|FG000|Overall Study|Sponsor Decision|13|||
25099803|NCT02569801|50210715|FG001|Overall Study|Sponsor Decision|14|||
25099804|NCT02569801|50210714|FG000|Overall Study|Progressive Disease|2|||
25099805|NCT02569801|50210715|FG001|Overall Study|Progressive Disease|7|||
25099806|NCT02569801|50210714|FG000|Overall Study|Lost to Follow-up|0|||
25099807|NCT02569801|50210715|FG001|Overall Study|Lost to Follow-up|1|||
25099808|NCT02569801|50210714|FG000|Overall Study|Death|12|||
25177053|NCT01559311|50321096|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
25177054|NCT01559311|50321094|FG000|Overall Study|Withdrawal by Subject|2|||
25099809|NCT02569801|50210715|FG001|Overall Study|Death|4|||
25099810|NCT02573311|50210723|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
25099811|NCT02573311|50210724|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
25099812|NCT02573311|50210723|FG000|Disposition for Part 2|Physician Decision|25|||
25099813|NCT02573311|50210724|FG001|Disposition for Part 2|Physician Decision|7|||
25099814|NCT02573311|50210723|FG000|Disposition for Part 2|Adverse Event|36|||
25099815|NCT02573311|50210724|FG001|Disposition for Part 2|Adverse Event|5|||
25099816|NCT02573311|50210723|FG000|Disposition for Part 2|Lost to Follow-up|76|||
25099817|NCT02573311|50210724|FG001|Disposition for Part 2|Lost to Follow-up|7|||
25099818|NCT02573311|50210723|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
25099819|NCT02573311|50210724|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
25099820|NCT02573311|50210723|FG000|Disposition for Part 2|Investigator decision|0|||
25099821|NCT02573311|50210724|FG001|Disposition for Part 2|Investigator decision|1|||
25099822|NCT02573311|50210723|FG000|Disposition for Part 2|Other than specified above|13|||
25099823|NCT02573311|50210724|FG001|Disposition for Part 2|Other than specified above|3|||
25099824|NCT02571049|50210730|FG000|Screening|Did not meet entry criteria|2|||
25099825|NCT02571049|50210731|FG001|Screening|Did not meet entry criteria|2|||
25099826|NCT02571049|50210730|FG000|Randomization|No migraine attack|0|||
25099827|NCT02571049|50210731|FG001|Randomization|No migraine attack|1|||
25099828|NCT02571049|50210730|FG000|Randomization|Adverse Event|0|||
25099829|NCT02571049|50210731|FG001|Randomization|Adverse Event|1|||
25099830|NCT02573155|50210739|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
25099831|NCT02573155|50210740|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
25099832|NCT02573155|50210739|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
25099833|NCT02573155|50210740|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
25099834|NCT02573155|50210739|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
25099835|NCT02573155|50210740|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
25099836|NCT02573155|50210739|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
25099837|NCT02573155|50210740|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
25099838|NCT02573155|50210739|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
25099839|NCT02573155|50210740|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
25099840|NCT02573155|50210739|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
25099841|NCT02573155|50210740|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
25099842|NCT02573155|50210739|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
25099843|NCT02573155|50210740|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
25099844|NCT02573155|50210739|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
25099845|NCT02573155|50210740|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
25099846|NCT02568475|50210768|FG000|Overall Study|Lost to Follow-up|40|||
25099847|NCT02568475|50210769|FG001|Overall Study|Lost to Follow-up|39|||
25099848|NCT02568475|50210768|FG000|Overall Study|Withdrawal by Subject|2|||
25099849|NCT02568475|50210769|FG001|Overall Study|Withdrawal by Subject|0|||
25099850|NCT02568475|50210768|FG000|Overall Study|Discharged home|4|||
25099851|NCT02568475|50210769|FG001|Overall Study|Discharged home|4|||
25099852|NCT02568475|50210768|FG000|Overall Study|Short-term: Discharge location unknown|4|||
25099853|NCT02568475|50210769|FG001|Overall Study|Short-term: Discharge location unknown|0|||
25099854|NCT02568475|50210768|FG000|Overall Study|Transferred to another facility|1|||
25099855|NCT02568475|50210769|FG001|Overall Study|Transferred to another facility|0|||
25099856|NCT02568397|50210775|FG000|Period 2|Withdrawal by Subject|0|||
25099857|NCT02568397|50210776|FG001|Period 2|Withdrawal by Subject|1|||
25099858|NCT02568397|50210775|FG000|Period 2|Physician Decision|0|||
25099859|NCT02568397|50210776|FG001|Period 2|Physician Decision|1|||
25099860|NCT02566525|50210793|FG000|Overall Study|Protocol Violation|3|||
25099861|NCT02566525|50210794|FG001|Overall Study|Protocol Violation|5|||
25099862|NCT02567227|50210804|FG000|9 Weeks|Adverse Event|5|||
25099863|NCT02567227|50210805|FG001|9 Weeks|Adverse Event|5|||
25099864|NCT02567227|50210804|FG000|9 Weeks|Withdrawal by Subject|18|||
25099865|NCT02567227|50210805|FG001|9 Weeks|Withdrawal by Subject|8|||
25099866|NCT02567227|50210804|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
25099867|NCT02567227|50210805|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
25099868|NCT02567227|50210804|FG000|6 Month|Death|2|||
25099869|NCT02567227|50210805|FG001|6 Month|Death|0|||
25099870|NCT02567227|50210804|FG000|6 Month|Lost to Follow-up|43|||
25099871|NCT02567227|50210805|FG001|6 Month|Lost to Follow-up|40|||
25099872|NCT02567227|50210804|FG000|12 Months|Lost to Follow-up|31|||
25099873|NCT02567227|50210805|FG001|12 Months|Lost to Follow-up|32|||
25099874|NCT02567227|50210804|FG000|12 Months|Death|0|||
25099875|NCT02567227|50210805|FG001|12 Months|Death|2|||
25099876|NCT02336451|50210816|FG000|Overall Study|Adverse Event|1|||
25099877|NCT02336451|50210817|FG001|Overall Study|Adverse Event|2|||
25099878|NCT02336451|50210818|FG002|Overall Study|Adverse Event|0|||
25099879|NCT02336451|50210819|FG003|Overall Study|Adverse Event|6|||
25099880|NCT02336451|50210820|FG004|Overall Study|Adverse Event|4|||
25099881|NCT02336451|50210816|FG000|Overall Study|Death|6|||
25099882|NCT02336451|50210817|FG001|Overall Study|Death|2|||
25099883|NCT02336451|50210818|FG002|Overall Study|Death|3|||
25099884|NCT02336451|50210819|FG003|Overall Study|Death|6|||
25099885|NCT02336451|50210820|FG004|Overall Study|Death|6|||
25099886|NCT02336451|50210816|FG000|Overall Study|Physician Decision|9|||
25099887|NCT02336451|50210817|FG001|Overall Study|Physician Decision|6|||
25099888|NCT02336451|50210818|FG002|Overall Study|Physician Decision|7|||
25099889|NCT02336451|50210819|FG003|Overall Study|Physician Decision|16|||
25099890|NCT02336451|50210820|FG004|Overall Study|Physician Decision|3|||
25177055|NCT01559311|50321095|FG001|Overall Study|Withdrawal by Subject|1|||
25099891|NCT02336451|50210816|FG000|Overall Study|Progressive disease|23|||
25099892|NCT02336451|50210817|FG001|Overall Study|Progressive disease|26|||
25099893|NCT02336451|50210818|FG002|Overall Study|Progressive disease|2|||
25099894|NCT02336451|50210819|FG003|Overall Study|Progressive disease|14|||
25099895|NCT02336451|50210820|FG004|Overall Study|Progressive disease|4|||
25099896|NCT02336451|50210816|FG000|Overall Study|Protocol Violation|1|||
25099897|NCT02336451|50210817|FG001|Overall Study|Protocol Violation|0|||
25099898|NCT02336451|50210818|FG002|Overall Study|Protocol Violation|0|||
25099899|NCT02336451|50210819|FG003|Overall Study|Protocol Violation|0|||
25099900|NCT02336451|50210820|FG004|Overall Study|Protocol Violation|0|||
25099901|NCT02336451|50210816|FG000|Overall Study|Patient/guardian decision|2|||
25099902|NCT02336451|50210817|FG001|Overall Study|Patient/guardian decision|4|||
25099903|NCT02336451|50210818|FG002|Overall Study|Patient/guardian decision|0|||
25099904|NCT02336451|50210819|FG003|Overall Study|Patient/guardian decision|2|||
25099905|NCT02336451|50210820|FG004|Overall Study|Patient/guardian decision|1|||
25099906|NCT02374593|50210836|FG000|Overall Study|non-compliant|2|||
25099907|NCT02374593|50210837|FG001|Overall Study|non-compliant|0|||
25099908|NCT01648101|50210850|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
25099909|NCT01648101|50210851|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
25099910|NCT01648101|50210852|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
25099911|NCT01648101|50210850|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
25099912|NCT01648101|50210851|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
25099913|NCT01648101|50210852|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
25099914|NCT01648101|50210850|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
25099915|NCT01648101|50210851|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
25099916|NCT01648101|50210852|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
25099917|NCT01648101|50210850|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
25099918|NCT01648101|50210851|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
25099919|NCT01648101|50210852|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
25099920|NCT01648101|50210850|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
25099921|NCT01648101|50210851|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
25099922|NCT01648101|50210852|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
25099923|NCT01648101|50210850|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
25099924|NCT01648101|50210851|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
25099925|NCT01648101|50210852|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
25099926|NCT01648101|50210850|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
25099927|NCT01648101|50210851|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
25099928|NCT01648101|50210852|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
25099929|NCT01648101|50210850|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
25099930|NCT01648101|50210851|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
25099931|NCT01648101|50210852|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
25099932|NCT01648101|50210850|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
25099933|NCT01648101|50210851|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
25099934|NCT01648101|50210852|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
25099935|NCT01648101|50210850|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
25099936|NCT01648101|50210851|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
25099937|NCT01648101|50210852|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
25099938|NCT01648101|50210850|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
25099939|NCT01648101|50210851|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
25099940|NCT01648101|50210852|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
25099941|NCT02336373|50210864|FG000|Overall Study|Protocol closed early|4|||
25099942|NCT02336373|50210864|FG000|Overall Study|Physician Decision|14|||
25099943|NCT02372799|50210873|FG000|Treatment Period|Adverse Event|3|||
25099944|NCT02372799|50210874|FG001|Treatment Period|Adverse Event|10|||
25099945|NCT02372799|50210875|FG002|Treatment Period|Adverse Event|6|||
25099946|NCT02372799|50210873|FG000|Treatment Period|Insufficient therapeutic response|2|||
25099947|NCT02372799|50210874|FG001|Treatment Period|Insufficient therapeutic response|2|||
25099948|NCT02372799|50210875|FG002|Treatment Period|Insufficient therapeutic response|0|||
25099949|NCT02372799|50210873|FG000|Treatment Period|Withdrawal by Subject|10|||
25099950|NCT02372799|50210874|FG001|Treatment Period|Withdrawal by Subject|10|||
25099951|NCT02372799|50210875|FG002|Treatment Period|Withdrawal by Subject|2|||
25099952|NCT02372799|50210873|FG000|Treatment Period|Lost to Follow-up|11|||
25099953|NCT02372799|50210874|FG001|Treatment Period|Lost to Follow-up|5|||
25099954|NCT02372799|50210875|FG002|Treatment Period|Lost to Follow-up|3|||
25099955|NCT02372799|50210873|FG000|Treatment Period|Protocol Violation|3|||
25099956|NCT02372799|50210874|FG001|Treatment Period|Protocol Violation|0|||
25099957|NCT02372799|50210875|FG002|Treatment Period|Protocol Violation|0|||
25099958|NCT02372799|50210873|FG000|Treatment Period|Non-compliance with study drug|4|||
25099959|NCT02372799|50210874|FG001|Treatment Period|Non-compliance with study drug|4|||
25099960|NCT02372799|50210875|FG002|Treatment Period|Non-compliance with study drug|4|||
25099961|NCT02372799|50210873|FG000|Treatment Period|Miscellaneous Reasons|1|||
25099962|NCT02372799|50210874|FG001|Treatment Period|Miscellaneous Reasons|1|||
25177056|NCT01559311|50321096|FG002|Overall Study|Withdrawal by Subject|0|||
25099963|NCT02372799|50210875|FG002|Treatment Period|Miscellaneous Reasons|0|||
25099964|NCT02372799|50210873|FG000|Down-taper Period|Lost to Follow-up|1|||
25099965|NCT02372799|50210874|FG001|Down-taper Period|Lost to Follow-up|2|||
25099966|NCT02372799|50210875|FG002|Down-taper Period|Lost to Follow-up|2|||
25099967|NCT02566993|50210885|FG000|Overall Study|Randomized but not treated|5|||
25099968|NCT02566993|50210886|FG001|Overall Study|Randomized but not treated|16|||
25099969|NCT02566993|50210885|FG000|Overall Study|Progressive disease|213|||
25099970|NCT02566993|50210886|FG001|Overall Study|Progressive disease|152|||
25099971|NCT02566993|50210885|FG000|Overall Study|Withdrawal by Subject|12|||
25099972|NCT02566993|50210886|FG001|Overall Study|Withdrawal by Subject|28|||
25099973|NCT02566993|50210885|FG000|Overall Study|Death|17|||
25099974|NCT02566993|50210886|FG001|Overall Study|Death|23|||
25099975|NCT02566993|50210885|FG000|Overall Study|Physician Decision|10|||
25099976|NCT02566993|50210886|FG001|Overall Study|Physician Decision|17|||
25099977|NCT02566993|50210885|FG000|Overall Study|Study drug-related adverse event|20|||
25099978|NCT02566993|50210886|FG001|Overall Study|Study drug-related adverse event|41|||
25099979|NCT02566993|50210885|FG000|Overall Study|Non study drug-related adverse event|9|||
25099980|NCT02566993|50210886|FG001|Overall Study|Non study drug-related adverse event|9|||
25099981|NCT02566993|50210885|FG000|Overall Study|Symptomatic deterioration|9|||
25099982|NCT02566993|50210886|FG001|Overall Study|Symptomatic deterioration|16|||
25099983|NCT02566993|50210885|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
25099984|NCT02566993|50210886|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
25099985|NCT02566993|50210885|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
25099986|NCT02566993|50210886|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
25099987|NCT02566993|50210885|FG000|Overall Study|Screening failure|2|||
25099988|NCT02566993|50210886|FG001|Overall Study|Screening failure|0|||
25099989|NCT02566993|50210885|FG000|Overall Study|Lost to Follow-up|0|||
25099990|NCT02566993|50210886|FG001|Overall Study|Lost to Follow-up|1|||
25099991|NCT02566993|50210885|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
25099992|NCT02566993|50210886|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
25099993|NCT02311881|50210897|FG000|Overall Study|Did not meet the study criteria|2|||
25099994|NCT02311881|50210898|FG001|Overall Study|Did not meet the study criteria|2|||
25099995|NCT02311881|50210899|FG002|Overall Study|Did not meet the study criteria|0|||
25099996|NCT02311881|50210897|FG000|Overall Study|Adverse Event|7|||
25099997|NCT02311881|50210898|FG001|Overall Study|Adverse Event|15|||
25099998|NCT02311881|50210899|FG002|Overall Study|Adverse Event|8|||
25099999|NCT02311881|50210897|FG000|Overall Study|Lost to Follow-up|3|||
25100000|NCT02311881|50210898|FG001|Overall Study|Lost to Follow-up|3|||
25100001|NCT02311881|50210899|FG002|Overall Study|Lost to Follow-up|2|||
25100002|NCT02311881|50210897|FG000|Overall Study|Protocol Violation|1|||
25100003|NCT02311881|50210898|FG001|Overall Study|Protocol Violation|2|||
25100004|NCT02311881|50210899|FG002|Overall Study|Protocol Violation|3|||
25100005|NCT02311881|50210897|FG000|Overall Study|Withdrawal of consent|14|||
25100006|NCT02311881|50210898|FG001|Overall Study|Withdrawal of consent|16|||
25100007|NCT02311881|50210899|FG002|Overall Study|Withdrawal of consent|17|||
25100008|NCT02311881|50210897|FG000|Overall Study|Other|0|||
25100009|NCT02311881|50210898|FG001|Overall Study|Other|0|||
25100010|NCT02311881|50210899|FG002|Overall Study|Other|1|||
25100011|NCT02311881|50210897|FG000|Overall Study|Lack of Efficacy|1|||
25100012|NCT02311881|50210898|FG001|Overall Study|Lack of Efficacy|2|||
25100013|NCT02311881|50210899|FG002|Overall Study|Lack of Efficacy|0|||
25100014|NCT02311881|50210897|FG000|Overall Study|Subject has border line pregnancy test|1|||
25100015|NCT02311881|50210898|FG001|Overall Study|Subject has border line pregnancy test|0|||
25100016|NCT02311881|50210899|FG002|Overall Study|Subject has border line pregnancy test|0|||
25100017|NCT02311881|50210897|FG000|Overall Study|Withdrawal by Subject|3|||
25100018|NCT02311881|50210898|FG001|Overall Study|Withdrawal by Subject|1|||
25100019|NCT02311881|50210899|FG002|Overall Study|Withdrawal by Subject|4|||
25100020|NCT02311881|50210897|FG000|Overall Study|Sponsor Decision|1|||
25100021|NCT02311881|50210898|FG001|Overall Study|Sponsor Decision|1|||
25100022|NCT02311881|50210899|FG002|Overall Study|Sponsor Decision|1|||
25100023|NCT02311881|50210897|FG000|Overall Study|Protocol Deviation|1|||
25100024|NCT02311881|50210898|FG001|Overall Study|Protocol Deviation|0|||
25100025|NCT02311881|50210899|FG002|Overall Study|Protocol Deviation|0|||
25100026|NCT02311881|50210897|FG000|Overall Study|Non-Compliance|1|||
25100027|NCT02311881|50210898|FG001|Overall Study|Non-Compliance|0|||
25100028|NCT02311881|50210899|FG002|Overall Study|Non-Compliance|2|||
25100029|NCT02311881|50210897|FG000|Overall Study|Physician Decision|0|||
25100030|NCT02311881|50210898|FG001|Overall Study|Physician Decision|0|||
25100031|NCT02311881|50210899|FG002|Overall Study|Physician Decision|1|||
25100032|NCT02311881|50210897|FG000|Overall Study|Medical Monitor Discretion|0|||
25100033|NCT02311881|50210898|FG001|Overall Study|Medical Monitor Discretion|0|||
25100034|NCT02311881|50210899|FG002|Overall Study|Medical Monitor Discretion|1|||
25100035|NCT02311881|50210897|FG000|Overall Study|Participant taking another medication|0|||
25100036|NCT02311881|50210898|FG001|Overall Study|Participant taking another medication|0|||
25100037|NCT02311881|50210899|FG002|Overall Study|Participant taking another medication|1|||
25100038|NCT02311881|50210897|FG000|Overall Study|Serious Adverse Event|0|||
25100039|NCT02311881|50210898|FG001|Overall Study|Serious Adverse Event|1|||
25100040|NCT02311881|50210899|FG002|Overall Study|Serious Adverse Event|0|||
25100041|NCT02565511|50210914|FG000|Overall Study|Study terminated by Sponsor|35|||
25100042|NCT02565511|50210915|FG001|Overall Study|Study terminated by Sponsor|22|||
25100043|NCT02565511|50210916|FG002|Overall Study|Study terminated by Sponsor|235|||
25100044|NCT02565511|50210917|FG003|Overall Study|Study terminated by Sponsor|156|||
25100045|NCT02565511|50210914|FG000|Overall Study|Withdrawal by Subject|3|||
25100046|NCT02565511|50210915|FG001|Overall Study|Withdrawal by Subject|0|||
25100047|NCT02565511|50210916|FG002|Overall Study|Withdrawal by Subject|12|||
25100048|NCT02565511|50210917|FG003|Overall Study|Withdrawal by Subject|5|||
25100049|NCT02565511|50210914|FG000|Overall Study|Adverse Event|0|||
25100050|NCT02565511|50210915|FG001|Overall Study|Adverse Event|0|||
25100051|NCT02565511|50210916|FG002|Overall Study|Adverse Event|1|||
25100052|NCT02565511|50210917|FG003|Overall Study|Adverse Event|1|||
25100053|NCT02565511|50210914|FG000|Overall Study|Lost to Follow-up|4|||
25100054|NCT02565511|50210915|FG001|Overall Study|Lost to Follow-up|1|||
25100055|NCT02565511|50210916|FG002|Overall Study|Lost to Follow-up|0|||
25100056|NCT02565511|50210917|FG003|Overall Study|Lost to Follow-up|1|||
25100057|NCT02565511|50210914|FG000|Overall Study|Physician Decision|0|||
25100058|NCT02565511|50210915|FG001|Overall Study|Physician Decision|0|||
25100059|NCT02565511|50210916|FG002|Overall Study|Physician Decision|0|||
25100060|NCT02565511|50210917|FG003|Overall Study|Physician Decision|1|||
25100061|NCT02565511|50210914|FG000|Overall Study|Protocol deviation|0|||
25100062|NCT02565511|50210915|FG001|Overall Study|Protocol deviation|0|||
25100063|NCT02565511|50210916|FG002|Overall Study|Protocol deviation|3|||
25100064|NCT02565511|50210917|FG003|Overall Study|Protocol deviation|0|||
25100065|NCT02561455|50210931|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
25100066|NCT02561455|50210932|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
25100067|NCT02561455|50210933|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
25100068|NCT02561455|50210934|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
25100069|NCT02561455|50210931|FG000|Overall Study|Withdrawal by Subject|1|||
25100070|NCT02561455|50210932|FG001|Overall Study|Withdrawal by Subject|0|||
25100071|NCT02561455|50210933|FG002|Overall Study|Withdrawal by Subject|1|||
25100072|NCT02561455|50210934|FG003|Overall Study|Withdrawal by Subject|0|||
25100073|NCT02561455|50210931|FG000|Overall Study|Disease Progression|0|||
25100074|NCT02561455|50210932|FG001|Overall Study|Disease Progression|1|||
25100075|NCT02561455|50210933|FG002|Overall Study|Disease Progression|0|||
25100076|NCT02561455|50210934|FG003|Overall Study|Disease Progression|0|||
25100077|NCT02561299|50210946|FG000|Overall Study|Death|2|||
25100078|NCT02561299|50210947|FG001|Overall Study|Death|4|||
25100079|NCT02561299|50210946|FG000|Overall Study|Lost to Follow-up|1|||
25100080|NCT02561299|50210947|FG001|Overall Study|Lost to Follow-up|0|||
25100081|NCT02561299|50210946|FG000|Overall Study|Withdrawal by Subject|2|||
25100082|NCT02561299|50210947|FG001|Overall Study|Withdrawal by Subject|2|||
25100083|NCT02566759|50210970|FG000|All Parts|Withdrawal by Subject|0|||
25100084|NCT02566759|50210971|FG001|All Parts|Withdrawal by Subject|1|||
25100085|NCT02566759|50210972|FG002|All Parts|Withdrawal by Subject|0|||
25100086|NCT02566759|50210973|FG003|All Parts|Withdrawal by Subject|0|||
25100087|NCT02566759|50210974|FG004|All Parts|Withdrawal by Subject|0|||
25100088|NCT02566759|50210975|FG005|All Parts|Withdrawal by Subject|0|||
25100089|NCT02566759|50210976|FG006|All Parts|Withdrawal by Subject|0|||
25100090|NCT02566759|50210977|FG007|All Parts|Withdrawal by Subject|0|||
25100091|NCT02566759|50210978|FG008|All Parts|Withdrawal by Subject|0|||
25100092|NCT02566759|50210979|FG009|All Parts|Withdrawal by Subject|0|||
25100093|NCT02566759|50210980|FG010|All Parts|Withdrawal by Subject|0|||
25100094|NCT02566759|50210981|FG011|All Parts|Withdrawal by Subject|0|||
25100095|NCT02566759|50210982|FG012|All Parts|Withdrawal by Subject|0|||
25100096|NCT02566759|50210983|FG013|All Parts|Withdrawal by Subject|0|||
25100097|NCT02566759|50210984|FG014|All Parts|Withdrawal by Subject|0|||
25100098|NCT02566759|50210985|FG015|All Parts|Withdrawal by Subject|0|||
25100099|NCT02566759|50210986|FG016|All Parts|Withdrawal by Subject|0|||
25100100|NCT02566759|50210970|FG000|All Parts|Adverse Event|0|||
25100101|NCT02566759|50210971|FG001|All Parts|Adverse Event|0|||
25100102|NCT02566759|50210972|FG002|All Parts|Adverse Event|0|||
25100103|NCT02566759|50210973|FG003|All Parts|Adverse Event|0|||
25100104|NCT02566759|50210974|FG004|All Parts|Adverse Event|0|||
25100105|NCT02566759|50210975|FG005|All Parts|Adverse Event|0|||
25100106|NCT02566759|50210976|FG006|All Parts|Adverse Event|0|||
25008142|NCT02431702|50100908|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
25100107|NCT02566759|50210977|FG007|All Parts|Adverse Event|0|||
25100108|NCT02566759|50210978|FG008|All Parts|Adverse Event|0|||
25100109|NCT02566759|50210979|FG009|All Parts|Adverse Event|0|||
25100110|NCT02566759|50210980|FG010|All Parts|Adverse Event|0|||
25100111|NCT02566759|50210981|FG011|All Parts|Adverse Event|0|||
25100112|NCT02566759|50210982|FG012|All Parts|Adverse Event|1|||
25100113|NCT02566759|50210983|FG013|All Parts|Adverse Event|3|||
25100114|NCT02566759|50210984|FG014|All Parts|Adverse Event|0|||
25100115|NCT02566759|50210985|FG015|All Parts|Adverse Event|0|||
25100116|NCT02566759|50210986|FG016|All Parts|Adverse Event|0|||
25100117|NCT02566759|50210970|FG000|All Parts|Other|0|||
25100118|NCT02566759|50210971|FG001|All Parts|Other|0|||
25100119|NCT02566759|50210972|FG002|All Parts|Other|0|||
25100120|NCT02566759|50210973|FG003|All Parts|Other|0|||
25100121|NCT02566759|50210974|FG004|All Parts|Other|0|||
25100122|NCT02566759|50210975|FG005|All Parts|Other|0|||
25100123|NCT02566759|50210976|FG006|All Parts|Other|0|||
25100124|NCT02566759|50210977|FG007|All Parts|Other|0|||
25100125|NCT02566759|50210978|FG008|All Parts|Other|0|||
25100126|NCT02566759|50210979|FG009|All Parts|Other|0|||
25100127|NCT02566759|50210980|FG010|All Parts|Other|0|||
25100128|NCT02566759|50210981|FG011|All Parts|Other|0|||
25100129|NCT02566759|50210982|FG012|All Parts|Other|0|||
25100130|NCT02566759|50210983|FG013|All Parts|Other|2|||
25100131|NCT02566759|50210984|FG014|All Parts|Other|0|||
25100132|NCT02566759|50210985|FG015|All Parts|Other|0|||
25100133|NCT02566759|50210986|FG016|All Parts|Other|0|||
25100134|NCT02566759|50210970|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
25100135|NCT02566759|50210971|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
25100136|NCT02566759|50210972|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
25100137|NCT02566759|50210973|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
25100138|NCT02566759|50210974|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
25100139|NCT02566759|50210975|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
25100140|NCT02566759|50210976|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
25100141|NCT02566759|50210977|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
25100142|NCT02566759|50210978|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
25100143|NCT02566759|50210979|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
25100144|NCT02566759|50210980|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
25100145|NCT02566759|50210981|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
25100146|NCT02566759|50210982|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
25100147|NCT02566759|50210983|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
25100148|NCT02566759|50210984|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
25100149|NCT02566759|50210985|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
25100150|NCT02566759|50210986|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
25100151|NCT02335983|50211051|FG000|Overall Study|Sponsor Decision|0|||
25100152|NCT02335983|50211052|FG001|Overall Study|Sponsor Decision|0|||
25100153|NCT02335983|50211053|FG002|Overall Study|Sponsor Decision|1|||
25100154|NCT02335983|50211054|FG003|Overall Study|Sponsor Decision|1|||
25100155|NCT02335983|50211055|FG004|Overall Study|Sponsor Decision|0|||
25100156|NCT02335983|50211056|FG005|Overall Study|Sponsor Decision|1|||
25100157|NCT02335983|50211051|FG000|Overall Study|Withdrawal by Subject|3|||
25100158|NCT02335983|50211052|FG001|Overall Study|Withdrawal by Subject|2|||
25100159|NCT02335983|50211053|FG002|Overall Study|Withdrawal by Subject|2|||
25100160|NCT02335983|50211054|FG003|Overall Study|Withdrawal by Subject|1|||
25100161|NCT02335983|50211055|FG004|Overall Study|Withdrawal by Subject|3|||
25100162|NCT02335983|50211056|FG005|Overall Study|Withdrawal by Subject|9|||
25100163|NCT02335983|50211051|FG000|Overall Study|Death|0|||
25100164|NCT02335983|50211052|FG001|Overall Study|Death|0|||
25100165|NCT02335983|50211053|FG002|Overall Study|Death|2|||
25100166|NCT02335983|50211054|FG003|Overall Study|Death|0|||
25100167|NCT02335983|50211055|FG004|Overall Study|Death|0|||
25100168|NCT02335983|50211056|FG005|Overall Study|Death|0|||
25100169|NCT02335983|50211051|FG000|Overall Study|Lost to Follow-up|0|||
25100170|NCT02335983|50211052|FG001|Overall Study|Lost to Follow-up|0|||
25100171|NCT02335983|50211053|FG002|Overall Study|Lost to Follow-up|0|||
25100172|NCT02335983|50211054|FG003|Overall Study|Lost to Follow-up|0|||
25100173|NCT02335983|50211055|FG004|Overall Study|Lost to Follow-up|0|||
25100174|NCT02335983|50211056|FG005|Overall Study|Lost to Follow-up|1|||
25100175|NCT02335983|50211051|FG000|Overall Study|Protocol Specified Criteria|5|||
25100176|NCT02335983|50211052|FG001|Overall Study|Protocol Specified Criteria|7|||
25100177|NCT02335983|50211053|FG002|Overall Study|Protocol Specified Criteria|27|||
25100178|NCT02335983|50211054|FG003|Overall Study|Protocol Specified Criteria|7|||
25100179|NCT02335983|50211055|FG004|Overall Study|Protocol Specified Criteria|5|||
25100180|NCT02335983|50211056|FG005|Overall Study|Protocol Specified Criteria|21|||
25100181|NCT04640311|50211092|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
25100182|NCT04640311|50211093|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100183|NCT04640311|50211094|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100184|NCT04640311|50211095|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100185|NCT04640311|50211096|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100186|NCT04640311|50211097|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100187|NCT04640311|50211098|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100188|NCT04640311|50211099|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100189|NCT04640311|50211100|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100190|NCT04640311|50211101|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100191|NCT04640311|50211102|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100192|NCT04640311|50211103|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100193|NCT04640311|50211104|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100194|NCT04640311|50211092|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
25100195|NCT04640311|50211093|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
25100196|NCT04640311|50211094|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
25100197|NCT04640311|50211095|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
25100198|NCT04640311|50211096|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
25100199|NCT04640311|50211097|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
25100200|NCT04640311|50211098|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
25100201|NCT04640311|50211099|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
25100202|NCT04640311|50211100|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
25100203|NCT04640311|50211101|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
25100204|NCT04640311|50211102|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
25100205|NCT04640311|50211103|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
25100206|NCT04640311|50211104|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
25100207|NCT04640311|50211092|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100208|NCT04640311|50211093|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
25100209|NCT04640311|50211094|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100210|NCT04640311|50211095|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100211|NCT04640311|50211096|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100212|NCT04640311|50211097|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100213|NCT04640311|50211098|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100214|NCT04640311|50211099|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100215|NCT04640311|50211100|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100216|NCT04640311|50211101|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100217|NCT04640311|50211102|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100218|NCT04640311|50211103|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100219|NCT04640311|50211104|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100220|NCT04640311|50211092|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
25100221|NCT04640311|50211093|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
25100222|NCT04640311|50211094|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
25100223|NCT04640311|50211095|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100224|NCT04640311|50211096|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100225|NCT04640311|50211097|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100226|NCT04640311|50211098|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100227|NCT04640311|50211099|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100228|NCT04640311|50211100|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100229|NCT04640311|50211101|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100230|NCT04640311|50211102|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100231|NCT04640311|50211103|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100232|NCT04640311|50211104|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
25100233|NCT04640311|50211092|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
25100234|NCT04640311|50211093|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
25100235|NCT04640311|50211094|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
25100236|NCT04640311|50211095|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
25100237|NCT04640311|50211096|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
25100238|NCT04640311|50211097|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
25100239|NCT04640311|50211098|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
25100240|NCT04640311|50211099|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
25100241|NCT04640311|50211100|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
25100242|NCT04640311|50211101|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
25100243|NCT04640311|50211102|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
25100244|NCT04640311|50211103|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
25100245|NCT04640311|50211104|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
25177057|NCT01559311|50321094|FG000|Overall Study|Death|0|||
25100246|NCT04640311|50211092|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
25100247|NCT04640311|50211093|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
25100248|NCT04640311|50211094|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
25100249|NCT04640311|50211095|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
25100250|NCT04640311|50211096|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
25100251|NCT04640311|50211097|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
25100252|NCT04640311|50211098|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
25100253|NCT04640311|50211099|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
25100254|NCT04640311|50211100|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
25100255|NCT04640311|50211101|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
25100256|NCT04640311|50211102|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
25100257|NCT04640311|50211103|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
25100258|NCT04640311|50211104|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
25100259|NCT04640311|50211092|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100260|NCT04640311|50211093|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100261|NCT04640311|50211094|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100262|NCT04640311|50211095|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100263|NCT04640311|50211096|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100264|NCT04640311|50211097|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
25100265|NCT04640311|50211098|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100266|NCT04640311|50211099|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100267|NCT04640311|50211100|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
25100268|NCT04640311|50211101|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100269|NCT04640311|50211102|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100270|NCT04640311|50211103|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100271|NCT04640311|50211104|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
25100272|NCT04640311|50211092|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
25100273|NCT04640311|50211093|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
25100274|NCT04640311|50211094|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
25100275|NCT04640311|50211095|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
25100276|NCT04640311|50211096|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
25100277|NCT04640311|50211097|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
25100278|NCT04640311|50211098|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
25100279|NCT04640311|50211099|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
25100280|NCT04640311|50211100|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
25100281|NCT04640311|50211101|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
25100282|NCT04640311|50211102|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
25100283|NCT04640311|50211103|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
25100284|NCT04640311|50211104|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
25100285|NCT04640311|50211092|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
25100286|NCT04640311|50211093|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
25100287|NCT04640311|50211094|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
25100288|NCT04640311|50211095|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
25100289|NCT04640311|50211096|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
25100290|NCT04640311|50211097|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
25100291|NCT04640311|50211098|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
25100292|NCT04640311|50211099|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
25100293|NCT04640311|50211100|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
25100294|NCT04640311|50211101|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
25100295|NCT04640311|50211102|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
25100296|NCT04640311|50211103|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
25100297|NCT04640311|50211104|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
25100298|NCT02334423|50211135|FG000|Overall Study|Protocol Violation|10|||
25100299|NCT02334423|50211136|FG001|Overall Study|Protocol Violation|3|||
25100300|NCT02310789|50211142|FG000|Overall Study|Adverse Event|1|||
25100301|NCT02372253|50211148|FG000|Overall Study|Non Compliance|2|||
25100302|NCT02372253|50211149|FG001|Overall Study|Non Compliance|0|||
25100303|NCT02559895|50211161|FG000|Overall Study|Adverse Event|3|||
25100304|NCT02559895|50211162|FG001|Overall Study|Adverse Event|3|||
25100305|NCT02559895|50211163|FG002|Overall Study|Adverse Event|2|||
25100306|NCT02559895|50211164|FG003|Overall Study|Adverse Event|1|||
25100307|NCT02559895|50211161|FG000|Overall Study|Lack of Efficacy|2|||
25100308|NCT02559895|50211162|FG001|Overall Study|Lack of Efficacy|3|||
25100309|NCT02559895|50211163|FG002|Overall Study|Lack of Efficacy|2|||
25100310|NCT02559895|50211164|FG003|Overall Study|Lack of Efficacy|8|||
25100311|NCT02559895|50211161|FG000|Overall Study|Lost to Follow-up|22|||
25100312|NCT02559895|50211162|FG001|Overall Study|Lost to Follow-up|16|||
25100313|NCT02559895|50211163|FG002|Overall Study|Lost to Follow-up|12|||
25100314|NCT02559895|50211164|FG003|Overall Study|Lost to Follow-up|17|||
25100315|NCT02559895|50211161|FG000|Overall Study|Physician Decision|1|||
25100316|NCT02559895|50211162|FG001|Overall Study|Physician Decision|1|||
25100317|NCT02559895|50211163|FG002|Overall Study|Physician Decision|3|||
25100318|NCT02559895|50211164|FG003|Overall Study|Physician Decision|0|||
25100319|NCT02559895|50211161|FG000|Overall Study|Withdrawal by Subject|16|||
25100320|NCT02559895|50211162|FG001|Overall Study|Withdrawal by Subject|9|||
25100321|NCT02559895|50211163|FG002|Overall Study|Withdrawal by Subject|20|||
25100322|NCT02559895|50211164|FG003|Overall Study|Withdrawal by Subject|9|||
25100323|NCT02559895|50211161|FG000|Overall Study|Study Burden|10|||
25100324|NCT02559895|50211162|FG001|Overall Study|Study Burden|16|||
25100325|NCT02559895|50211163|FG002|Overall Study|Study Burden|12|||
25100326|NCT02559895|50211164|FG003|Overall Study|Study Burden|22|||
25100327|NCT02559895|50211161|FG000|Overall Study|Other|1|||
25100328|NCT02559895|50211162|FG001|Overall Study|Other|5|||
25100329|NCT02559895|50211163|FG002|Overall Study|Other|3|||
25100330|NCT02559895|50211164|FG003|Overall Study|Other|3|||
25100331|NCT02371629|50211176|FG000|Overall Study|Patient decision|14|||
25100332|NCT02371629|50211177|FG001|Overall Study|Patient decision|10|||
25100333|NCT02371629|50211176|FG000|Overall Study|Adverse Event|8|||
25100334|NCT02371629|50211177|FG001|Overall Study|Adverse Event|8|||
25100335|NCT02371629|50211176|FG000|Overall Study|Physician Decision|2|||
25177058|NCT01559311|50321095|FG001|Overall Study|Death|2|||
25177059|NCT01559311|50321096|FG002|Overall Study|Death|3|||
25177060|NCT01559311|50321094|FG000|Overall Study|Lost to Follow-up|0|||
25177061|NCT01559311|50321095|FG001|Overall Study|Lost to Follow-up|3|||
25177062|NCT01559311|50321096|FG002|Overall Study|Lost to Follow-up|2|||
25177063|NCT01559311|50321094|FG000|Overall Study|Adverse Event|0|||
25177064|NCT01559311|50321095|FG001|Overall Study|Adverse Event|0|||
25177065|NCT01559311|50321096|FG002|Overall Study|Adverse Event|1|||
25177066|NCT01498445|50321119|FG000|Overall Study|Lack of Efficacy|0|||
25177067|NCT01498445|50321120|FG001|Overall Study|Lack of Efficacy|0|||
25177068|NCT01498445|50321121|FG002|Overall Study|Lack of Efficacy|1|||
25177069|NCT01498445|50321122|FG003|Overall Study|Lack of Efficacy|2|||
25177070|NCT01498445|50321123|FG004|Overall Study|Lack of Efficacy|0|||
25177071|NCT01498445|50321124|FG005|Overall Study|Lack of Efficacy|0|||
25177072|NCT01498445|50321119|FG000|Overall Study|Screen Failure|0|||
25177073|NCT01498445|50321120|FG001|Overall Study|Screen Failure|0|||
25177074|NCT01498445|50321121|FG002|Overall Study|Screen Failure|0|||
25177075|NCT01498445|50321122|FG003|Overall Study|Screen Failure|0|||
25177076|NCT01498445|50321123|FG004|Overall Study|Screen Failure|1|||
25177077|NCT01498445|50321124|FG005|Overall Study|Screen Failure|1|||
25177078|NCT01558297|50321141|FG000|Overall Study|Withdrawal by Subject|2|||
25177079|NCT01558297|50321142|FG001|Overall Study|Withdrawal by Subject|2|||
25177080|NCT01558297|50321143|FG002|Overall Study|Withdrawal by Subject|1|||
25177081|NCT01525849|50321153|FG000|Overall Study|Lost to Follow-up|3|||
25177082|NCT01525849|50321154|FG001|Overall Study|Lost to Follow-up|2|||
25100336|NCT02371629|50211177|FG001|Overall Study|Physician Decision|3|||
25100337|NCT02371629|50211176|FG000|Overall Study|Death|1|||
25177083|NCT01525849|50321153|FG000|Overall Study|Withdrawal by Subject|1|||
25177084|NCT01525849|50321154|FG001|Overall Study|Withdrawal by Subject|9|||
25177085|NCT01525849|50321153|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
25177086|NCT01525849|50321154|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
25177087|NCT01525849|50321153|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
25177088|NCT01525849|50321154|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
25177089|NCT01525615|50321173|FG000|Overall Study|Adverse Event|11|||
25177090|NCT01525615|50321174|FG001|Overall Study|Adverse Event|7|||
25177091|NCT01525615|50321175|FG002|Overall Study|Adverse Event|5|||
25177092|NCT01525615|50321173|FG000|Overall Study|Lost to Follow-up|1|||
25177093|NCT01525615|50321174|FG001|Overall Study|Lost to Follow-up|0|||
25177094|NCT01525615|50321175|FG002|Overall Study|Lost to Follow-up|0|||
25177095|NCT01525615|50321173|FG000|Overall Study|Withdrawal by Subject|1|||
25177096|NCT01525615|50321174|FG001|Overall Study|Withdrawal by Subject|0|||
25177097|NCT01525615|50321175|FG002|Overall Study|Withdrawal by Subject|0|||
25177098|NCT01525615|50321173|FG000|Overall Study|Other reason not described above|1|||
25177099|NCT01525615|50321174|FG001|Overall Study|Other reason not described above|0|||
25177100|NCT01525615|50321175|FG002|Overall Study|Other reason not described above|1|||
25177101|NCT01525225|50321217|FG000|Enrollment|No longer met study criteria|1|||
25177102|NCT01525225|50321217|FG000|Enrollment|Other|1|||
25100338|NCT02371629|50211177|FG001|Overall Study|Death|1|||
25100339|NCT02371629|50211176|FG000|Overall Study|Noncompliance with study treatment|1|||
25100340|NCT02371629|50211177|FG001|Overall Study|Noncompliance with study treatment|0|||
25177103|NCT02660580|50321236|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
25261102|NCT01311648|50575784|FG000|Extension Study|Incorrect visit planning|0|||
25261103|NCT01311648|50575785|FG001|Extension Study|Incorrect visit planning|1|||
25261104|NCT01311648|50575784|FG000|Extension Study|Family's decision|0|||
25100341|NCT02371629|50211176|FG000|Overall Study|Lack of Efficacy|0|||
25100342|NCT02371629|50211177|FG001|Overall Study|Lack of Efficacy|2|||
25100343|NCT02371629|50211176|FG000|Overall Study|Protocol deviation|0|||
25100344|NCT02371629|50211177|FG001|Overall Study|Protocol deviation|1|||
25100345|NCT02559817|50211188|FG000|Treatment Period|Adverse Event|1|||
25100346|NCT02559817|50211189|FG001|Treatment Period|Adverse Event|0|||
25100347|NCT02559817|50211190|FG002|Treatment Period|Adverse Event|1|||
25100348|NCT02559817|50211191|FG003|Treatment Period|Adverse Event|0|||
25100349|NCT02559817|50211192|FG004|Treatment Period|Adverse Event|0|||
25100350|NCT02559817|50211188|FG000|Treatment Period|Lack of Efficacy|0|||
25100351|NCT02559817|50211189|FG001|Treatment Period|Lack of Efficacy|1|||
25100352|NCT02559817|50211190|FG002|Treatment Period|Lack of Efficacy|0|||
25100353|NCT02559817|50211191|FG003|Treatment Period|Lack of Efficacy|0|||
25100354|NCT02559817|50211192|FG004|Treatment Period|Lack of Efficacy|0|||
25100355|NCT02559817|50211188|FG000|Treatment Period|Lost to Follow-up|0|||
25100356|NCT02559817|50211189|FG001|Treatment Period|Lost to Follow-up|1|||
25100357|NCT02559817|50211190|FG002|Treatment Period|Lost to Follow-up|0|||
25100358|NCT02559817|50211191|FG003|Treatment Period|Lost to Follow-up|1|||
25100359|NCT02559817|50211192|FG004|Treatment Period|Lost to Follow-up|0|||
25100360|NCT02559817|50211188|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
25100361|NCT02559817|50211189|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
25100362|NCT02559817|50211190|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
25100363|NCT02559817|50211191|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
25100364|NCT02559817|50211192|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
25100365|NCT02559817|50211188|FG000|Treatment Period|Protocol Violation|0|||
25100366|NCT02559817|50211189|FG001|Treatment Period|Protocol Violation|0|||
25100367|NCT02559817|50211190|FG002|Treatment Period|Protocol Violation|0|||
25100368|NCT02559817|50211191|FG003|Treatment Period|Protocol Violation|1|||
25100369|NCT02559817|50211192|FG004|Treatment Period|Protocol Violation|0|||
25100370|NCT02564887|50211206|FG000|Overall Study|Lost to Follow-up|6|||
25100371|NCT02564887|50211207|FG001|Overall Study|Lost to Follow-up|0|||
25100372|NCT02333487|50211218|FG000|Overall Study|Adverse Event|0|||
25100373|NCT02333487|50211219|FG001|Overall Study|Adverse Event|2|||
25100374|NCT02333487|50211220|FG002|Overall Study|Adverse Event|0|||
25100375|NCT02333331|50211233|FG000|Overall Study|Adverse Event|1|||
25100376|NCT02333331|50211234|FG001|Overall Study|Adverse Event|0|||
25100377|NCT02333331|50211235|FG002|Overall Study|Adverse Event|4|||
25100378|NCT02333331|50211236|FG003|Overall Study|Adverse Event|1|||
25100379|NCT02333331|50211233|FG000|Overall Study|Death|0|||
25100380|NCT02333331|50211234|FG001|Overall Study|Death|0|||
25100381|NCT02333331|50211235|FG002|Overall Study|Death|2|||
25100382|NCT02333331|50211236|FG003|Overall Study|Death|0|||
25100383|NCT02333331|50211233|FG000|Overall Study|Lost to Follow-up|0|||
25100384|NCT02333331|50211234|FG001|Overall Study|Lost to Follow-up|0|||
25100385|NCT02333331|50211235|FG002|Overall Study|Lost to Follow-up|1|||
25100386|NCT02333331|50211236|FG003|Overall Study|Lost to Follow-up|0|||
25100387|NCT02333331|50211233|FG000|Overall Study|Physician Decision|0|||
25100388|NCT02333331|50211234|FG001|Overall Study|Physician Decision|1|||
25100389|NCT02333331|50211235|FG002|Overall Study|Physician Decision|0|||
25100390|NCT02333331|50211236|FG003|Overall Study|Physician Decision|0|||
25100391|NCT02333331|50211233|FG000|Overall Study|Protocol Deviation|0|||
25100392|NCT02333331|50211234|FG001|Overall Study|Protocol Deviation|3|||
25100393|NCT02333331|50211235|FG002|Overall Study|Protocol Deviation|2|||
25100394|NCT02333331|50211236|FG003|Overall Study|Protocol Deviation|1|||
25100395|NCT02333331|50211233|FG000|Overall Study|Patient/Guardian Decision|1|||
25100396|NCT02333331|50211234|FG001|Overall Study|Patient/Guardian Decision|2|||
25100397|NCT02333331|50211235|FG002|Overall Study|Patient/Guardian Decision|9|||
25100398|NCT02333331|50211236|FG003|Overall Study|Patient/Guardian Decision|1|||
25100399|NCT02563561|50211249|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
25100400|NCT02563561|50211250|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
25100401|NCT02563561|50211251|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
25100402|NCT02563561|50211249|FG000|Overall Study|Withdrew of Consent|1|||
25100403|NCT02563561|50211250|FG001|Overall Study|Withdrew of Consent|1|||
25100404|NCT02563561|50211251|FG002|Overall Study|Withdrew of Consent|2|||
25100405|NCT02563561|50211249|FG000|Overall Study|Lost to Follow-up|1|||
25100406|NCT02563561|50211250|FG001|Overall Study|Lost to Follow-up|1|||
25100407|NCT02563561|50211251|FG002|Overall Study|Lost to Follow-up|0|||
25100408|NCT02563561|50211249|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
25100409|NCT02563561|50211250|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
25100410|NCT02563561|50211251|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
25100411|NCT02563561|50211249|FG000|Overall Study|Investigator Decision|3|||
25100412|NCT02563561|50211250|FG001|Overall Study|Investigator Decision|4|||
25100413|NCT02563561|50211251|FG002|Overall Study|Investigator Decision|2|||
25100414|NCT02563561|50211249|FG000|Overall Study|Sponsor Decision|5|||
25100415|NCT02563561|50211250|FG001|Overall Study|Sponsor Decision|2|||
25100416|NCT02563561|50211251|FG002|Overall Study|Sponsor Decision|4|||
25100417|NCT02563561|50211249|FG000|Overall Study|Other|1|||
25100418|NCT02563561|50211250|FG001|Overall Study|Other|5|||
25100419|NCT02563561|50211251|FG002|Overall Study|Other|2|||
25100420|NCT02559505|50211267|FG000|Overall Study|Lost to Follow-up|23|||
25100421|NCT02559505|50211268|FG001|Overall Study|Lost to Follow-up|20|||
25100422|NCT02559505|50211267|FG000|Overall Study|Withdrawal by Subject|4|||
25100423|NCT02559505|50211268|FG001|Overall Study|Withdrawal by Subject|2|||
25100424|NCT04191967|50211290|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
25100425|NCT04191967|50211290|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
25100426|NCT02556307|50211296|FG000|Overall Study|Premature treatment interruption|11|||
25100427|NCT02556307|50211296|FG000|Overall Study|Lost to Follow-up|36|||
25100428|NCT02556307|50211296|FG000|Overall Study|Change to triple therapy|4|||
25100429|NCT02556307|50211296|FG000|Overall Study|Enrolled but not treated|2|||
25100430|NCT04364737|50211302|FG000|Overall Study|Withdrawal by Subject|4|||
25100431|NCT04364737|50211303|FG001|Overall Study|Withdrawal by Subject|9|||
25100432|NCT04364737|50211302|FG000|Overall Study|Lost to Follow-up|1|||
25100433|NCT04364737|50211303|FG001|Overall Study|Lost to Follow-up|1|||
25100434|NCT02559115|50211309|FG000|Overall Study|Withdrawal by Subject|3|||
25100435|NCT01662895|50211327|FG000|Overall Study|Lost to Follow-up|0|||
25100436|NCT01662895|50211328|FG001|Overall Study|Lost to Follow-up|1|||
25100437|NCT04147195|50211336|FG000|Overall Study|Adverse Event|0|||
25100438|NCT04147195|50211337|FG001|Overall Study|Adverse Event|3|||
25100439|NCT04147195|50211336|FG000|Overall Study|Study Terminated by Sponsor|4|||
25100440|NCT04147195|50211337|FG001|Overall Study|Study Terminated by Sponsor|2|||
25100441|NCT04147195|50211336|FG000|Overall Study|Withdrawal by Subject|0|||
25100442|NCT04147195|50211337|FG001|Overall Study|Withdrawal by Subject|1|||
25100443|NCT02557399|50211346|FG000|Overall Study|Adverse Event|6|||
25100444|NCT02557399|50211347|FG001|Overall Study|Adverse Event|5|||
25100445|NCT02557399|50211346|FG000|Overall Study|Protocol Violation|0|||
25100446|NCT02557399|50211347|FG001|Overall Study|Protocol Violation|1|||
25100447|NCT02557399|50211346|FG000|Overall Study|Protocol-defined stopping criteria|0|||
25100448|NCT02557399|50211347|FG001|Overall Study|Protocol-defined stopping criteria|1|||
25100449|NCT02557399|50211346|FG000|Overall Study|Withdrawal by Subject|1|||
25100450|NCT02557399|50211347|FG001|Overall Study|Withdrawal by Subject|1|||
25100451|NCT02555371|50211356|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
25100452|NCT02555371|50211357|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
25100453|NCT02555371|50211358|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
25100454|NCT02555371|50211359|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
25100455|NCT02555371|50211360|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
25100456|NCT02555371|50211356|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
25100457|NCT02555371|50211357|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
25100458|NCT02555371|50211358|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
25100459|NCT02555371|50211359|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
25100460|NCT02555371|50211360|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
25100461|NCT02555371|50211356|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
25100462|NCT02555371|50211357|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
25100463|NCT02555371|50211358|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
25100464|NCT02555371|50211359|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
25100465|NCT02555371|50211360|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
25100466|NCT02555371|50211356|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
25100467|NCT02555371|50211357|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
25100468|NCT02555371|50211358|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
25100469|NCT02555371|50211359|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
25100470|NCT02555371|50211360|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
25100471|NCT02555371|50211356|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
25100472|NCT02555371|50211357|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
25100473|NCT02555371|50211358|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
25100474|NCT02555371|50211359|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
25100475|NCT02555371|50211360|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
25100476|NCT02555371|50211356|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
25100477|NCT02555371|50211357|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
25100478|NCT02555371|50211358|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
25100479|NCT02555371|50211359|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
25100480|NCT02555371|50211360|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
25100481|NCT02555371|50211356|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
25100482|NCT02555371|50211357|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
25100483|NCT02555371|50211358|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
25100484|NCT02555371|50211359|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
25100485|NCT02555371|50211360|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
25100486|NCT02555371|50211356|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
25100487|NCT02555371|50211357|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
25100488|NCT02555371|50211358|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
25100489|NCT02555371|50211359|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
25100490|NCT02555371|50211360|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
25100491|NCT02555371|50211356|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
25100492|NCT02555371|50211357|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
25100493|NCT02555371|50211358|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
25100494|NCT02555371|50211359|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
25100495|NCT02555371|50211360|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
25100496|NCT02555371|50211356|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
25100497|NCT02555371|50211357|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
25100498|NCT02555371|50211358|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
25100499|NCT02555371|50211359|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
25100500|NCT02555371|50211360|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
25100501|NCT02555371|50211356|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
25100502|NCT02555371|50211357|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
25100503|NCT02555371|50211358|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
25100504|NCT02555371|50211359|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
25100505|NCT02555371|50211360|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
25100506|NCT02555371|50211356|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
25100507|NCT02555371|50211357|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
25100508|NCT02555371|50211358|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
25100509|NCT02555371|50211359|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
25100510|NCT02555371|50211360|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
25100511|NCT02555371|50211356|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
25100512|NCT02555371|50211357|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
25100513|NCT02555371|50211358|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
25100514|NCT02555371|50211359|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
25100515|NCT02555371|50211360|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
25100516|NCT02555371|50211356|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
25100517|NCT02555371|50211357|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
25100518|NCT02555371|50211358|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
25100519|NCT02555371|50211359|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
25100520|NCT02555371|50211360|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
25100521|NCT02555215|50211369|FG000|Overall Study|Other|1|||
25100522|NCT02555215|50211369|FG000|Overall Study|Investigator Decision|2|||
25100523|NCT02555683|50211376|FG000|Overall Study|Physician Decision|1|||
25100524|NCT02555683|50211377|FG001|Overall Study|Physician Decision|0|||
25100525|NCT02555683|50211378|FG002|Overall Study|Physician Decision|2|||
25100526|NCT02555683|50211376|FG000|Overall Study|Lost to Follow-up|2|||
25100527|NCT02555683|50211377|FG001|Overall Study|Lost to Follow-up|1|||
25100528|NCT02555683|50211378|FG002|Overall Study|Lost to Follow-up|2|||
25100529|NCT02555683|50211376|FG000|Overall Study|Technical Problems|1|||
25100530|NCT02555683|50211377|FG001|Overall Study|Technical Problems|1|||
25100531|NCT02555683|50211378|FG002|Overall Study|Technical Problems|0|||
25100532|NCT02555683|50211376|FG000|Overall Study|Protocol deviation|0|||
25100533|NCT02555683|50211377|FG001|Overall Study|Protocol deviation|1|||
25100534|NCT02555683|50211378|FG002|Overall Study|Protocol deviation|0|||
25100535|NCT02555683|50211376|FG000|Overall Study|Lack of Efficacy|2|||
25100536|NCT02555683|50211377|FG001|Overall Study|Lack of Efficacy|0|||
25100537|NCT02555683|50211378|FG002|Overall Study|Lack of Efficacy|0|||
25100538|NCT02555683|50211376|FG000|Overall Study|Death|0|||
25100539|NCT02555683|50211377|FG001|Overall Study|Death|1|||
25100540|NCT02555683|50211378|FG002|Overall Study|Death|2|||
25100541|NCT02555683|50211376|FG000|Overall Study|Adverse Event|1|||
25100542|NCT02555683|50211377|FG001|Overall Study|Adverse Event|0|||
25100543|NCT02555683|50211378|FG002|Overall Study|Adverse Event|1|||
25100544|NCT02555683|50211376|FG000|Overall Study|Subject/guardian decision|12|||
25100545|NCT02555683|50211377|FG001|Overall Study|Subject/guardian decision|12|||
25100546|NCT02555683|50211378|FG002|Overall Study|Subject/guardian decision|22|||
25100547|NCT02555683|50211376|FG000|Overall Study|Death post Treatment/safety period|0|||
25100548|NCT02555683|50211377|FG001|Overall Study|Death post Treatment/safety period|1|||
25100549|NCT02555683|50211378|FG002|Overall Study|Death post Treatment/safety period|0|||
25100550|NCT02554981|50211386|FG000|Overall Study|Adverse Event|1|||
25100551|NCT02554981|50211386|FG000|Overall Study|Administrative Reasons|1|||
25100552|NCT02554981|50211386|FG000|Overall Study|Other Miscellaneous Reasons|3|||
25100553|NCT02556775|50211394|FG000|Overall Study|Withdrawal by Subject|1|||
25100554|NCT02556775|50211395|FG001|Overall Study|Withdrawal by Subject|0|||
25100555|NCT02556775|50211396|FG002|Overall Study|Withdrawal by Subject|1|||
25100556|NCT02556775|50211397|FG003|Overall Study|Withdrawal by Subject|0|||
25100557|NCT02556775|50211394|FG000|Overall Study|Lost to Follow-up|1|||
25100558|NCT02556775|50211395|FG001|Overall Study|Lost to Follow-up|0|||
25100559|NCT02556775|50211396|FG002|Overall Study|Lost to Follow-up|0|||
25177104|NCT02660580|50321237|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
25100560|NCT02556775|50211397|FG003|Overall Study|Lost to Follow-up|0|||
25100561|NCT01662505|50211412|FG000|Overall Study|Progressive disease|6|||
25100562|NCT01662505|50211413|FG001|Overall Study|Progressive disease|1|||
25100563|NCT01662505|50211414|FG002|Overall Study|Progressive disease|5|||
25100564|NCT01662505|50211412|FG000|Overall Study|Refused cont. medication|0|||
25100565|NCT01662505|50211413|FG001|Overall Study|Refused cont. medication|0|||
25100566|NCT01662505|50211414|FG002|Overall Study|Refused cont. medication|1|||
25100567|NCT01662505|50211412|FG000|Overall Study|Not specified above|1|||
25100568|NCT01662505|50211413|FG001|Overall Study|Not specified above|3|||
25100569|NCT01662505|50211414|FG002|Overall Study|Not specified above|2|||
25100570|NCT03796195|50211423|FG000|Overall Study|Study closed early|1|||
25100571|NCT02554513|50211457|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
25100572|NCT02554513|50211458|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
25100573|NCT02554279|50211472|FG000|Overall Study|Adverse Event|2|||
25100574|NCT02554279|50211473|FG001|Overall Study|Adverse Event|5|||
25100575|NCT02554279|50211472|FG000|Overall Study|Lost to Follow-up|3|||
25100576|NCT02554279|50211473|FG001|Overall Study|Lost to Follow-up|2|||
25100577|NCT02554279|50211472|FG000|Overall Study|Withdrawal by Subject|6|||
25100578|NCT02554279|50211473|FG001|Overall Study|Withdrawal by Subject|4|||
25100579|NCT02554279|50211472|FG000|Overall Study|Protocol Violation|2|||
25100580|NCT02554279|50211473|FG001|Overall Study|Protocol Violation|1|||
25100581|NCT02554279|50211472|FG000|Overall Study|Other reason|19|||
25100582|NCT02554279|50211473|FG001|Overall Study|Other reason|6|||
25100583|NCT02554903|50211488|FG000|Overall Study|Death|1|||
25100584|NCT02554903|50211489|FG001|Overall Study|Death|1|||
25100585|NCT02554903|50211488|FG000|Overall Study|Physician Decision|2|||
25100586|NCT02554903|50211489|FG001|Overall Study|Physician Decision|2|||
25100587|NCT02554903|50211488|FG000|Overall Study|Heart Transplant|1|||
25100588|NCT02554903|50211489|FG001|Overall Study|Heart Transplant|2|||
25100589|NCT02332707|50211514|FG000|Overall Study|Adverse Event|0|||
25100590|NCT02332707|50211515|FG001|Overall Study|Adverse Event|0|||
25100591|NCT02332707|50211516|FG002|Overall Study|Adverse Event|0|||
25100592|NCT02332707|50211517|FG003|Overall Study|Adverse Event|0|||
25100593|NCT02332707|50211518|FG004|Overall Study|Adverse Event|0|||
25100594|NCT02332707|50211519|FG005|Overall Study|Adverse Event|0|||
25100595|NCT02332707|50211520|FG006|Overall Study|Adverse Event|0|||
25100596|NCT02332707|50211521|FG007|Overall Study|Adverse Event|0|||
25100597|NCT02332707|50211522|FG008|Overall Study|Adverse Event|0|||
25100598|NCT02332707|50211523|FG009|Overall Study|Adverse Event|0|||
25100599|NCT02332707|50211524|FG010|Overall Study|Adverse Event|0|||
25100600|NCT02332707|50211525|FG011|Overall Study|Adverse Event|0|||
25100601|NCT02332707|50211526|FG012|Overall Study|Adverse Event|1|||
25100602|NCT02332707|50211527|FG013|Overall Study|Adverse Event|0|||
25100603|NCT02332707|50211528|FG014|Overall Study|Adverse Event|0|||
25100604|NCT02332707|50211529|FG015|Overall Study|Adverse Event|0|||
25100605|NCT02332707|50211530|FG016|Overall Study|Adverse Event|0|||
25100606|NCT02332707|50211531|FG017|Overall Study|Adverse Event|0|||
25100607|NCT02332707|50211514|FG000|Overall Study|Lost to Follow-up|0|||
25100608|NCT02332707|50211515|FG001|Overall Study|Lost to Follow-up|0|||
25100609|NCT02332707|50211516|FG002|Overall Study|Lost to Follow-up|0|||
25100610|NCT02332707|50211517|FG003|Overall Study|Lost to Follow-up|0|||
25100611|NCT02332707|50211518|FG004|Overall Study|Lost to Follow-up|0|||
25100612|NCT02332707|50211519|FG005|Overall Study|Lost to Follow-up|1|||
25100613|NCT02332707|50211520|FG006|Overall Study|Lost to Follow-up|0|||
25100614|NCT02332707|50211521|FG007|Overall Study|Lost to Follow-up|0|||
25100615|NCT02332707|50211522|FG008|Overall Study|Lost to Follow-up|0|||
25100616|NCT02332707|50211523|FG009|Overall Study|Lost to Follow-up|0|||
25100617|NCT02332707|50211524|FG010|Overall Study|Lost to Follow-up|2|||
25100618|NCT02332707|50211525|FG011|Overall Study|Lost to Follow-up|0|||
25100619|NCT02332707|50211526|FG012|Overall Study|Lost to Follow-up|3|||
25100620|NCT02332707|50211527|FG013|Overall Study|Lost to Follow-up|0|||
25100621|NCT02332707|50211528|FG014|Overall Study|Lost to Follow-up|0|||
25100622|NCT02332707|50211529|FG015|Overall Study|Lost to Follow-up|0|||
25100623|NCT02332707|50211530|FG016|Overall Study|Lost to Follow-up|0|||
25100624|NCT02332707|50211531|FG017|Overall Study|Lost to Follow-up|0|||
25100625|NCT02332707|50211514|FG000|Overall Study|Physician Decision|0|||
25100626|NCT02332707|50211515|FG001|Overall Study|Physician Decision|0|||
25100627|NCT02332707|50211516|FG002|Overall Study|Physician Decision|0|||
25100628|NCT02332707|50211517|FG003|Overall Study|Physician Decision|1|||
25100629|NCT02332707|50211518|FG004|Overall Study|Physician Decision|0|||
25100630|NCT02332707|50211519|FG005|Overall Study|Physician Decision|0|||
25100631|NCT02332707|50211520|FG006|Overall Study|Physician Decision|0|||
25100632|NCT02332707|50211521|FG007|Overall Study|Physician Decision|0|||
25100633|NCT02332707|50211522|FG008|Overall Study|Physician Decision|0|||
25100634|NCT02332707|50211523|FG009|Overall Study|Physician Decision|0|||
25100635|NCT02332707|50211524|FG010|Overall Study|Physician Decision|0|||
25100636|NCT02332707|50211525|FG011|Overall Study|Physician Decision|0|||
25100637|NCT02332707|50211526|FG012|Overall Study|Physician Decision|1|||
25100638|NCT02332707|50211527|FG013|Overall Study|Physician Decision|0|||
25100639|NCT02332707|50211528|FG014|Overall Study|Physician Decision|0|||
25100640|NCT02332707|50211529|FG015|Overall Study|Physician Decision|0|||
25100641|NCT02332707|50211530|FG016|Overall Study|Physician Decision|0|||
25100642|NCT02332707|50211531|FG017|Overall Study|Physician Decision|0|||
25100643|NCT02332707|50211514|FG000|Overall Study|Withdrawal by Subject|0|||
25100644|NCT02332707|50211515|FG001|Overall Study|Withdrawal by Subject|0|||
25100645|NCT02332707|50211516|FG002|Overall Study|Withdrawal by Subject|1|||
25100646|NCT02332707|50211517|FG003|Overall Study|Withdrawal by Subject|0|||
25100647|NCT02332707|50211518|FG004|Overall Study|Withdrawal by Subject|0|||
25100648|NCT02332707|50211519|FG005|Overall Study|Withdrawal by Subject|0|||
25100649|NCT02332707|50211520|FG006|Overall Study|Withdrawal by Subject|0|||
25100650|NCT02332707|50211521|FG007|Overall Study|Withdrawal by Subject|0|||
25100651|NCT02332707|50211522|FG008|Overall Study|Withdrawal by Subject|0|||
25100652|NCT02332707|50211523|FG009|Overall Study|Withdrawal by Subject|3|||
25100653|NCT02332707|50211524|FG010|Overall Study|Withdrawal by Subject|0|||
25100654|NCT02332707|50211525|FG011|Overall Study|Withdrawal by Subject|0|||
25100655|NCT02332707|50211526|FG012|Overall Study|Withdrawal by Subject|0|||
25100656|NCT02332707|50211527|FG013|Overall Study|Withdrawal by Subject|0|||
25100657|NCT02332707|50211528|FG014|Overall Study|Withdrawal by Subject|0|||
25100658|NCT02332707|50211529|FG015|Overall Study|Withdrawal by Subject|0|||
25100659|NCT02332707|50211530|FG016|Overall Study|Withdrawal by Subject|0|||
25100660|NCT02332707|50211531|FG017|Overall Study|Withdrawal by Subject|0|||
25100661|NCT02370615|50211571|FG000|Overall Study|Adverse Event|1|||
25100662|NCT02370615|50211572|FG001|Overall Study|Adverse Event|0|||
25100663|NCT02307513|50211587|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
25100664|NCT02307513|50211588|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
25100665|NCT02307513|50211587|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
25100666|NCT02307513|50211588|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
25100667|NCT02307513|50211587|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
25100668|NCT02307513|50211588|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
25100669|NCT02307513|50211587|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
25100670|NCT02307513|50211588|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
25100671|NCT02307513|50211587|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
25100672|NCT02307513|50211588|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
25100673|NCT02307513|50211587|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
25100674|NCT02307513|50211588|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
25100675|NCT02307513|50211587|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
25100676|NCT02307513|50211588|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
25100677|NCT02307513|50211587|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
25100678|NCT02307513|50211588|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
25100679|NCT02307513|50211587|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
25100680|NCT02307513|50211588|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
25100681|NCT02307513|50211587|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
25100682|NCT02307513|50211588|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
25100683|NCT02307513|50211587|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
25100684|NCT02307513|50211588|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
25100685|NCT02307513|50211587|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
25100686|NCT02307513|50211588|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
25100687|NCT02307513|50211587|FG000|Long-term Extension|Physician Decision|1|||
25100688|NCT02307513|50211588|FG001|Long-term Extension|Physician Decision|0|||
25100689|NCT02332239|50211600|FG000|Overall Study|Lost to Follow-up|4|||
25100690|NCT02332239|50211601|FG001|Overall Study|Lost to Follow-up|6|||
25100691|NCT02370537|50211612|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
25100692|NCT02370537|50211613|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
25100693|NCT02370537|50211614|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
25100694|NCT02370537|50211612|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
25100695|NCT02370537|50211613|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
25100696|NCT02370537|50211614|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
25100697|NCT02370537|50211612|FG000|Part B|Not randomised to receive treatment|1|||
25100698|NCT02370537|50211613|FG001|Part B|Not randomised to receive treatment|2|||
25100699|NCT02370537|50211614|FG002|Part B|Not randomised to receive treatment|259|||
25100700|NCT02370537|50211612|FG000|Part B|Withdrawal by Subject|0|||
25100701|NCT02370537|50211613|FG001|Part B|Withdrawal by Subject|1|||
25100702|NCT02370537|50211614|FG002|Part B|Withdrawal by Subject|0|||
25261105|NCT01311648|50575785|FG001|Extension Study|Family's decision|1|||
25261106|NCT01311648|50575784|FG000|Extension Study|Failure of ITI therapy|0|||
25261107|NCT01311648|50575785|FG001|Extension Study|Failure of ITI therapy|3|||
25100703|NCT02330055|50211633|FG000|Overall Study|technical issues|2|||
25100704|NCT02330055|50211634|FG001|Overall Study|technical issues|0|||
25100705|NCT02330055|50211633|FG000|Overall Study|participant forgot to wear device|5|||
25100706|NCT02330055|50211634|FG001|Overall Study|participant forgot to wear device|5|||
25100707|NCT02330055|50211633|FG000|Overall Study|data for less than 60 minutes|3|||
25100708|NCT02330055|50211634|FG001|Overall Study|data for less than 60 minutes|3|||
25100709|NCT02330055|50211633|FG000|Overall Study|participant did not sleep|0|||
25100710|NCT02330055|50211634|FG001|Overall Study|participant did not sleep|1|||
25100711|NCT02306265|50211640|FG000|Overall Study|Withdrawal by Subject|1|||
25100712|NCT02329743|50211648|FG000|Overall Study|Adverse Event|1|||
25100713|NCT02329743|50211649|FG001|Overall Study|Adverse Event|1|||
25100714|NCT02329743|50211650|FG002|Overall Study|Adverse Event|3|||
25100715|NCT02329743|50211648|FG000|Overall Study|Lost to Follow-up|1|||
25100716|NCT02329743|50211649|FG001|Overall Study|Lost to Follow-up|0|||
25100717|NCT02329743|50211650|FG002|Overall Study|Lost to Follow-up|1|||
25100718|NCT02329743|50211648|FG000|Overall Study|Withdrawal by Subject|4|||
25100719|NCT02329743|50211649|FG001|Overall Study|Withdrawal by Subject|4|||
25100720|NCT02329743|50211650|FG002|Overall Study|Withdrawal by Subject|1|||
25100721|NCT02329743|50211648|FG000|Overall Study|Other|0|||
25100722|NCT02329743|50211649|FG001|Overall Study|Other|2|||
25100723|NCT02329743|50211650|FG002|Overall Study|Other|3|||
25100724|NCT02329431|50211660|FG000|Overall Study|Lost to Follow-up|20|||
25100725|NCT02329431|50211661|FG001|Overall Study|Lost to Follow-up|13|||
25100726|NCT02328105|50211667|FG000|Overall Study|Death|6|||
25100727|NCT02328105|50211667|FG000|Overall Study|Withdrawal by Subject|1|||
25100728|NCT02328105|50211667|FG000|Overall Study|Still On Study in Follow-Up|4|||
25100729|NCT02305797|50211673|FG000|Overall Study|Adverse Event|11|||
25100730|NCT02305797|50211674|FG001|Overall Study|Adverse Event|2|||
25100731|NCT02305797|50211673|FG000|Overall Study|Withdrawal by Subject|9|||
25100732|NCT02305797|50211674|FG001|Overall Study|Withdrawal by Subject|10|||
25100733|NCT02305797|50211673|FG000|Overall Study|Lack of Efficacy|6|||
25100734|NCT02305797|50211674|FG001|Overall Study|Lack of Efficacy|0|||
25100735|NCT02305797|50211673|FG000|Overall Study|Lost to Follow-up|5|||
25100736|NCT02305797|50211674|FG001|Overall Study|Lost to Follow-up|11|||
25100737|NCT02305797|50211673|FG000|Overall Study|Pregnancy|0|||
25100738|NCT02305797|50211674|FG001|Overall Study|Pregnancy|2|||
25100739|NCT02305797|50211673|FG000|Overall Study|Noncompliance|14|||
25100740|NCT02305797|50211674|FG001|Overall Study|Noncompliance|12|||
25100741|NCT02305797|50211673|FG000|Overall Study|Reason not collected|0|||
25100742|NCT02305797|50211674|FG001|Overall Study|Reason not collected|1|||
25100743|NCT01646073|50211682|FG000|Period A (12 Weeks)|Adverse Event|0|||
25100744|NCT01646073|50211683|FG001|Period A (12 Weeks)|Adverse Event|2|||
25100745|NCT01646073|50211682|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
25100746|NCT01646073|50211683|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
25100747|NCT01646073|50211682|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
25100748|NCT01646073|50211683|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
25100749|NCT01646073|50211682|FG000|Period A (12 Weeks)|Protocol Violation|0|||
25100750|NCT01646073|50211683|FG001|Period A (12 Weeks)|Protocol Violation|1|||
25100751|NCT01646073|50211682|FG000|Period A (12 Weeks)|Other|0|||
25100752|NCT01646073|50211683|FG001|Period A (12 Weeks)|Other|1|||
25100753|NCT01646073|50211682|FG000|Period B (12 Weeks)|Adverse Event|0|||
25100754|NCT01646073|50211683|FG001|Period B (12 Weeks)|Adverse Event|7|||
25100755|NCT01646073|50211682|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
25100756|NCT01646073|50211683|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
25100757|NCT01646073|50211682|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
25100758|NCT01646073|50211683|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
25100759|NCT02328027|50211694|FG000|Overall Study|Withdrawal by Subject|0|||
25100760|NCT02328027|50211695|FG001|Overall Study|Withdrawal by Subject|1|||
25100761|NCT02551159|50211705|FG000|Overall Study|Death|352|||
25100762|NCT02551159|50211706|FG001|Overall Study|Death|174|||
25100763|NCT02551159|50211707|FG002|Overall Study|Death|161|||
25100764|NCT02551159|50211705|FG000|Overall Study|Withdrawal by Subject|8|||
25100765|NCT02551159|50211706|FG001|Overall Study|Withdrawal by Subject|5|||
25100766|NCT02551159|50211707|FG002|Overall Study|Withdrawal by Subject|16|||
25100767|NCT02551159|50211705|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
25100768|NCT02551159|50211706|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
25100769|NCT02551159|50211707|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
25100770|NCT02305563|50211720|FG000|Treatment Period|Disease progression|0|||
25100771|NCT02305563|50211721|FG001|Treatment Period|Disease progression|0|||
25100772|NCT02305563|50211722|FG002|Treatment Period|Disease progression|15|||
25100773|NCT02305563|50211723|FG003|Treatment Period|Disease progression|6|||
25100774|NCT02305563|50211724|FG004|Treatment Period|Disease progression|6|||
25100775|NCT02305563|50211720|FG000|Treatment Period|Study drug toxicity|0|||
25100776|NCT02305563|50211721|FG001|Treatment Period|Study drug toxicity|0|||
25100777|NCT02305563|50211722|FG002|Treatment Period|Study drug toxicity|0|||
25100778|NCT02305563|50211723|FG003|Treatment Period|Study drug toxicity|1|||
25100779|NCT02305563|50211724|FG004|Treatment Period|Study drug toxicity|2|||
25100780|NCT02305563|50211720|FG000|Treatment Period|Death|0|||
25100781|NCT02305563|50211721|FG001|Treatment Period|Death|0|||
25100782|NCT02305563|50211722|FG002|Treatment Period|Death|1|||
25100783|NCT02305563|50211723|FG003|Treatment Period|Death|2|||
25100784|NCT02305563|50211724|FG004|Treatment Period|Death|1|||
25100785|NCT02305563|50211720|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
25100786|NCT02305563|50211721|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
25100787|NCT02305563|50211722|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
25100788|NCT02305563|50211723|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
25100789|NCT02305563|50211724|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
25100790|NCT02305563|50211720|FG000|Treatment Period|Participant request to stop therapy|0|||
25100791|NCT02305563|50211721|FG001|Treatment Period|Participant request to stop therapy|2|||
25100792|NCT02305563|50211722|FG002|Treatment Period|Participant request to stop therapy|0|||
25100793|NCT02305563|50211723|FG003|Treatment Period|Participant request to stop therapy|1|||
25177105|NCT02660580|50321238|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
25177106|NCT02660580|50321239|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
25177107|NCT02660580|50321240|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
25177108|NCT02660580|50321236|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
25177109|NCT02660580|50321237|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
25177110|NCT02660580|50321238|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
25177111|NCT02660580|50321239|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
25177112|NCT02660580|50321240|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
25177113|NCT02660580|50321236|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
25177114|NCT02660580|50321237|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
25177115|NCT02660580|50321238|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
25177116|NCT02660580|50321239|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
25177117|NCT02660580|50321240|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
25177118|NCT02660580|50321236|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
25177119|NCT02660580|50321237|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
25177120|NCT02660580|50321238|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
25100794|NCT02305563|50211724|FG004|Treatment Period|Participant request to stop therapy|0|||
25100795|NCT02305563|50211720|FG000|Treatment Period|Participant withdrew consent|0|||
25100796|NCT02305563|50211721|FG001|Treatment Period|Participant withdrew consent|0|||
25100797|NCT02305563|50211722|FG002|Treatment Period|Participant withdrew consent|1|||
25100798|NCT02305563|50211723|FG003|Treatment Period|Participant withdrew consent|1|||
25100799|NCT02305563|50211724|FG004|Treatment Period|Participant withdrew consent|1|||
25100800|NCT02305563|50211720|FG000|Treatment Period|Maximum clinical benefit|0|||
25100801|NCT02305563|50211721|FG001|Treatment Period|Maximum clinical benefit|0|||
25100802|NCT02305563|50211722|FG002|Treatment Period|Maximum clinical benefit|0|||
25100803|NCT02305563|50211723|FG003|Treatment Period|Maximum clinical benefit|0|||
25100804|NCT02305563|50211724|FG004|Treatment Period|Maximum clinical benefit|1|||
25100805|NCT02305563|50211720|FG000|Treatment Period|Poor/non-compliance|0|||
25100806|NCT02305563|50211721|FG001|Treatment Period|Poor/non-compliance|0|||
25100807|NCT02305563|50211722|FG002|Treatment Period|Poor/non-compliance|0|||
25100808|NCT02305563|50211723|FG003|Treatment Period|Poor/non-compliance|0|||
25100809|NCT02305563|50211724|FG004|Treatment Period|Poor/non-compliance|1|||
25100810|NCT02305563|50211720|FG000|Treatment Period|Administrative reason by Sponsor|0|||
25100811|NCT02305563|50211721|FG001|Treatment Period|Administrative reason by Sponsor|0|||
25100812|NCT02305563|50211722|FG002|Treatment Period|Administrative reason by Sponsor|0|||
25100813|NCT02305563|50211723|FG003|Treatment Period|Administrative reason by Sponsor|0|||
25100814|NCT02305563|50211724|FG004|Treatment Period|Administrative reason by Sponsor|1|||
25100815|NCT02305563|50211720|FG000|Treatment Period|other reason|2|||
25100816|NCT02305563|50211721|FG001|Treatment Period|other reason|0|||
25100817|NCT02305563|50211722|FG002|Treatment Period|other reason|2|||
25100818|NCT02305563|50211723|FG003|Treatment Period|other reason|2|||
25100819|NCT02305563|50211724|FG004|Treatment Period|other reason|1|||
25100820|NCT02305563|50211720|FG000|Treatment Period|Randomized but not treated|0|||
25100821|NCT02305563|50211721|FG001|Treatment Period|Randomized but not treated|0|||
25100822|NCT02305563|50211722|FG002|Treatment Period|Randomized but not treated|0|||
25100823|NCT02305563|50211723|FG003|Treatment Period|Randomized but not treated|0|||
25100824|NCT02305563|50211724|FG004|Treatment Period|Randomized but not treated|2|||
25100825|NCT02305563|50211720|FG000|Treatment Period|added ULO, then disease progression|0|||
25100826|NCT02305563|50211721|FG001|Treatment Period|added ULO, then disease progression|0|||
25100827|NCT02305563|50211722|FG002|Treatment Period|added ULO, then disease progression|0|||
25100828|NCT02305563|50211723|FG003|Treatment Period|added ULO, then disease progression|0|||
25100829|NCT02305563|50211724|FG004|Treatment Period|added ULO, then disease progression|4|||
25100830|NCT02305563|50211720|FG000|Treatment Period|added ULO; then other reason|0|||
25100831|NCT02305563|50211721|FG001|Treatment Period|added ULO; then other reason|0|||
25100832|NCT02305563|50211722|FG002|Treatment Period|added ULO; then other reason|0|||
25100833|NCT02305563|50211723|FG003|Treatment Period|added ULO; then other reason|0|||
25100834|NCT02305563|50211724|FG004|Treatment Period|added ULO; then other reason|1|||
25100835|NCT02305563|50211720|FG000|Treatment Period|added ULO, then request to stop|0|||
25100836|NCT02305563|50211721|FG001|Treatment Period|added ULO, then request to stop|0|||
25100837|NCT02305563|50211722|FG002|Treatment Period|added ULO, then request to stop|0|||
25177121|NCT02660580|50321239|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
25100838|NCT02305563|50211723|FG003|Treatment Period|added ULO, then request to stop|0|||
25100839|NCT02305563|50211724|FG004|Treatment Period|added ULO, then request to stop|1|||
25100840|NCT02305563|50211720|FG000|Follow-up Period|Death|0|||
25100841|NCT02305563|50211721|FG001|Follow-up Period|Death|0|||
25100842|NCT02305563|50211722|FG002|Follow-up Period|Death|5|||
25100843|NCT02305563|50211723|FG003|Follow-up Period|Death|4|||
25100844|NCT02305563|50211724|FG004|Follow-up Period|Death|7|||
25100845|NCT02305563|50211720|FG000|Follow-up Period|Participant withdrew consent|0|||
25100846|NCT02305563|50211721|FG001|Follow-up Period|Participant withdrew consent|0|||
25100847|NCT02305563|50211722|FG002|Follow-up Period|Participant withdrew consent|2|||
25100848|NCT02305563|50211723|FG003|Follow-up Period|Participant withdrew consent|1|||
25100849|NCT02305563|50211724|FG004|Follow-up Period|Participant withdrew consent|0|||
25100850|NCT02305563|50211720|FG000|Follow-up Period|other reason|0|||
25100851|NCT02305563|50211721|FG001|Follow-up Period|other reason|0|||
25100852|NCT02305563|50211722|FG002|Follow-up Period|other reason|0|||
25100853|NCT02305563|50211723|FG003|Follow-up Period|other reason|0|||
25100854|NCT02305563|50211724|FG004|Follow-up Period|other reason|1|||
25100855|NCT02305563|50211720|FG000|Follow-up Period|Followup no longer required per protocol|3|||
25100856|NCT02305563|50211721|FG001|Follow-up Period|Followup no longer required per protocol|3|||
25100857|NCT02305563|50211722|FG002|Follow-up Period|Followup no longer required per protocol|4|||
25100858|NCT02305563|50211723|FG003|Follow-up Period|Followup no longer required per protocol|1|||
25100859|NCT02305563|50211724|FG004|Follow-up Period|Followup no longer required per protocol|4|||
25100860|NCT02327325|50211743|FG000|Overall Study|Withdrawal by Subject|1|||
25100861|NCT02327325|50211744|FG001|Overall Study|Withdrawal by Subject|4|||
25100862|NCT02327325|50211745|FG002|Overall Study|Withdrawal by Subject|4|||
25100863|NCT02327325|50211743|FG000|Overall Study|Excluded by Study Team|0|||
25100864|NCT02327325|50211744|FG001|Overall Study|Excluded by Study Team|0|||
25100865|NCT02327325|50211745|FG002|Overall Study|Excluded by Study Team|1|||
25100866|NCT02304705|50211755|FG000|Overall Study|Withdrawal by Subject|2|||
25100867|NCT02304705|50211756|FG001|Overall Study|Withdrawal by Subject|0|||
25100868|NCT02304705|50211755|FG000|Overall Study|Physician Decision|2|||
25100869|NCT02304705|50211756|FG001|Overall Study|Physician Decision|4|||
25100870|NCT02304705|50211755|FG000|Overall Study|Death|0|||
25100871|NCT02304705|50211756|FG001|Overall Study|Death|1|||
25100872|NCT02304705|50211755|FG000|Overall Study|Lost to Follow-up|0|||
25100873|NCT02304705|50211756|FG001|Overall Study|Lost to Follow-up|2|||
25100874|NCT02553499|50211776|FG000|Overall Study|Adverse Event|0|||
25100875|NCT02553499|50211777|FG001|Overall Study|Adverse Event|0|||
25100876|NCT02553499|50211778|FG002|Overall Study|Adverse Event|0|||
25100877|NCT02553499|50211779|FG003|Overall Study|Adverse Event|0|||
25100878|NCT02553499|50211780|FG004|Overall Study|Adverse Event|0|||
25100879|NCT02553499|50211781|FG005|Overall Study|Adverse Event|0|||
25100880|NCT02553499|50211782|FG006|Overall Study|Adverse Event|1|||
25100881|NCT02553499|50211783|FG007|Overall Study|Adverse Event|1|||
25100882|NCT02553499|50211784|FG008|Overall Study|Adverse Event|0|||
25100883|NCT02553499|50211785|FG009|Overall Study|Adverse Event|0|||
25100884|NCT02553499|50211786|FG010|Overall Study|Adverse Event|0|||
25100885|NCT02553499|50211787|FG011|Overall Study|Adverse Event|0|||
25100886|NCT02553499|50211788|FG012|Overall Study|Adverse Event|0|||
25100887|NCT02553499|50211789|FG013|Overall Study|Adverse Event|1|||
25100888|NCT02553499|50211776|FG000|Overall Study|Death|0|||
25100889|NCT02553499|50211777|FG001|Overall Study|Death|1|||
25100890|NCT02553499|50211778|FG002|Overall Study|Death|1|||
25100891|NCT02553499|50211779|FG003|Overall Study|Death|0|||
25100892|NCT02553499|50211780|FG004|Overall Study|Death|1|||
25100893|NCT02553499|50211781|FG005|Overall Study|Death|2|||
25100894|NCT02553499|50211782|FG006|Overall Study|Death|0|||
25100895|NCT02553499|50211783|FG007|Overall Study|Death|0|||
25100896|NCT02553499|50211784|FG008|Overall Study|Death|0|||
25100897|NCT02553499|50211785|FG009|Overall Study|Death|0|||
25100898|NCT02553499|50211786|FG010|Overall Study|Death|1|||
25100899|NCT02553499|50211787|FG011|Overall Study|Death|0|||
25100900|NCT02553499|50211788|FG012|Overall Study|Death|0|||
25100901|NCT02553499|50211789|FG013|Overall Study|Death|0|||
25100902|NCT02553499|50211776|FG000|Overall Study|Lost to Follow-up|0|||
25100903|NCT02553499|50211777|FG001|Overall Study|Lost to Follow-up|0|||
25100904|NCT02553499|50211778|FG002|Overall Study|Lost to Follow-up|0|||
25100905|NCT02553499|50211779|FG003|Overall Study|Lost to Follow-up|0|||
25100906|NCT02553499|50211780|FG004|Overall Study|Lost to Follow-up|0|||
25100907|NCT02553499|50211781|FG005|Overall Study|Lost to Follow-up|0|||
25100908|NCT02553499|50211782|FG006|Overall Study|Lost to Follow-up|1|||
25100909|NCT02553499|50211783|FG007|Overall Study|Lost to Follow-up|0|||
25100910|NCT02553499|50211784|FG008|Overall Study|Lost to Follow-up|0|||
25100911|NCT02553499|50211785|FG009|Overall Study|Lost to Follow-up|0|||
25100912|NCT02553499|50211786|FG010|Overall Study|Lost to Follow-up|0|||
25100913|NCT02553499|50211787|FG011|Overall Study|Lost to Follow-up|0|||
25100914|NCT02553499|50211788|FG012|Overall Study|Lost to Follow-up|0|||
25100915|NCT02553499|50211789|FG013|Overall Study|Lost to Follow-up|0|||
25100916|NCT02553499|50211776|FG000|Overall Study|Physician Decision|0|||
25100917|NCT02553499|50211777|FG001|Overall Study|Physician Decision|1|||
25100918|NCT02553499|50211778|FG002|Overall Study|Physician Decision|1|||
25100919|NCT02553499|50211779|FG003|Overall Study|Physician Decision|0|||
25100920|NCT02553499|50211780|FG004|Overall Study|Physician Decision|1|||
25100921|NCT02553499|50211781|FG005|Overall Study|Physician Decision|0|||
25100922|NCT02553499|50211782|FG006|Overall Study|Physician Decision|0|||
25100923|NCT02553499|50211783|FG007|Overall Study|Physician Decision|1|||
25100924|NCT02553499|50211784|FG008|Overall Study|Physician Decision|1|||
25100925|NCT02553499|50211785|FG009|Overall Study|Physician Decision|2|||
25100926|NCT02553499|50211786|FG010|Overall Study|Physician Decision|1|||
25100927|NCT02553499|50211787|FG011|Overall Study|Physician Decision|3|||
25100928|NCT02553499|50211788|FG012|Overall Study|Physician Decision|1|||
25100929|NCT02553499|50211789|FG013|Overall Study|Physician Decision|0|||
25100930|NCT02553499|50211776|FG000|Overall Study|Progressive Disease|0|||
25100931|NCT02553499|50211777|FG001|Overall Study|Progressive Disease|0|||
25100932|NCT02553499|50211778|FG002|Overall Study|Progressive Disease|0|||
25100933|NCT02553499|50211779|FG003|Overall Study|Progressive Disease|2|||
25100934|NCT02553499|50211780|FG004|Overall Study|Progressive Disease|1|||
25100935|NCT02553499|50211781|FG005|Overall Study|Progressive Disease|1|||
25100936|NCT02553499|50211782|FG006|Overall Study|Progressive Disease|1|||
25100937|NCT02553499|50211783|FG007|Overall Study|Progressive Disease|0|||
25100938|NCT02553499|50211784|FG008|Overall Study|Progressive Disease|0|||
25100939|NCT02553499|50211785|FG009|Overall Study|Progressive Disease|1|||
25100940|NCT02553499|50211786|FG010|Overall Study|Progressive Disease|0|||
25100941|NCT02553499|50211787|FG011|Overall Study|Progressive Disease|0|||
25100942|NCT02553499|50211788|FG012|Overall Study|Progressive Disease|2|||
25100943|NCT02553499|50211789|FG013|Overall Study|Progressive Disease|1|||
25100944|NCT02553499|50211776|FG000|Overall Study|Study Terminated by Sponsor|0|||
25100945|NCT02553499|50211777|FG001|Overall Study|Study Terminated by Sponsor|0|||
25100946|NCT02553499|50211778|FG002|Overall Study|Study Terminated by Sponsor|0|||
25100947|NCT02553499|50211779|FG003|Overall Study|Study Terminated by Sponsor|0|||
25100948|NCT02553499|50211780|FG004|Overall Study|Study Terminated by Sponsor|0|||
25100949|NCT02553499|50211781|FG005|Overall Study|Study Terminated by Sponsor|0|||
25100950|NCT02553499|50211782|FG006|Overall Study|Study Terminated by Sponsor|0|||
25100951|NCT02553499|50211783|FG007|Overall Study|Study Terminated by Sponsor|0|||
25100952|NCT02553499|50211784|FG008|Overall Study|Study Terminated by Sponsor|1|||
25100953|NCT02553499|50211785|FG009|Overall Study|Study Terminated by Sponsor|0|||
25100954|NCT02553499|50211786|FG010|Overall Study|Study Terminated by Sponsor|0|||
25100955|NCT02553499|50211787|FG011|Overall Study|Study Terminated by Sponsor|0|||
25100956|NCT02553499|50211788|FG012|Overall Study|Study Terminated by Sponsor|0|||
25100957|NCT02553499|50211789|FG013|Overall Study|Study Terminated by Sponsor|0|||
25100958|NCT02553499|50211776|FG000|Overall Study|Withdrawal by Subject|2|||
25100959|NCT02553499|50211777|FG001|Overall Study|Withdrawal by Subject|0|||
25100960|NCT02553499|50211778|FG002|Overall Study|Withdrawal by Subject|0|||
25100961|NCT02553499|50211779|FG003|Overall Study|Withdrawal by Subject|0|||
25100962|NCT02553499|50211780|FG004|Overall Study|Withdrawal by Subject|0|||
25100963|NCT02553499|50211781|FG005|Overall Study|Withdrawal by Subject|0|||
25100964|NCT02553499|50211782|FG006|Overall Study|Withdrawal by Subject|0|||
25100965|NCT02553499|50211783|FG007|Overall Study|Withdrawal by Subject|1|||
25100966|NCT02553499|50211784|FG008|Overall Study|Withdrawal by Subject|1|||
25100967|NCT02553499|50211785|FG009|Overall Study|Withdrawal by Subject|0|||
25100968|NCT02553499|50211786|FG010|Overall Study|Withdrawal by Subject|1|||
25100969|NCT02553499|50211787|FG011|Overall Study|Withdrawal by Subject|0|||
25100970|NCT02553499|50211788|FG012|Overall Study|Withdrawal by Subject|0|||
25100971|NCT02553499|50211789|FG013|Overall Study|Withdrawal by Subject|0|||
25100972|NCT02553421|50211822|FG000|Overall Study|Lost to Follow-up|21|||
25100973|NCT02553421|50211823|FG001|Overall Study|Lost to Follow-up|1|||
25100974|NCT02553421|50211822|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
25100975|NCT02553421|50211823|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
25100976|NCT02553421|50211822|FG000|Overall Study|Improper Device Placement|3|||
25100977|NCT02553421|50211823|FG001|Overall Study|Improper Device Placement|0|||
25100978|NCT02549287|50211832|FG000|Overall Study|Lost to Follow-up|65|||
25100979|NCT02549287|50211833|FG001|Overall Study|Lost to Follow-up|26|||
25100980|NCT02549287|50211832|FG000|Overall Study|Withdrawal by Subject|15|||
25100981|NCT02549287|50211833|FG001|Overall Study|Withdrawal by Subject|6|||
25100982|NCT02553265|50211839|FG000|Enrollment|Death|0|||
25100983|NCT02553265|50211840|FG001|Enrollment|Death|0|||
25100984|NCT02553265|50211841|FG002|Enrollment|Death|1|||
25100985|NCT02553265|50211839|FG000|First Intervention (28 Days)|Adverse Event|1|||
25100986|NCT02553265|50211840|FG001|First Intervention (28 Days)|Adverse Event|0|||
25100987|NCT02553265|50211841|FG002|First Intervention (28 Days)|Adverse Event|0|||
25100988|NCT02553265|50211839|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
25100989|NCT02553265|50211840|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
25100990|NCT02553265|50211841|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
25100991|NCT02553265|50211839|FG000|Second Intervention (28 Days)|Adverse Event|1|||
25177122|NCT02660580|50321240|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
25177123|NCT02660580|50321236|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
25177124|NCT02660580|50321237|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
25100992|NCT02553265|50211840|FG001|Second Intervention (28 Days)|Adverse Event|0|||
25100993|NCT02553265|50211841|FG002|Second Intervention (28 Days)|Adverse Event|0|||
25100994|NCT02553265|50211839|FG000|Third Intervention (28 Days)|Adverse Event|1|||
25100995|NCT02553265|50211840|FG001|Third Intervention (28 Days)|Adverse Event|0|||
25100996|NCT02553265|50211841|FG002|Third Intervention (28 Days)|Adverse Event|0|||
25100997|NCT02553265|50211839|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
25100998|NCT02553265|50211840|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
25100999|NCT02553265|50211841|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
25101000|NCT02561195|50211858|FG000|Vaccination 1 to 3|Adverse Event|4|||
25101001|NCT02561195|50211859|FG001|Vaccination 1 to 3|Adverse Event|5|||
25101002|NCT02561195|50211860|FG002|Vaccination 1 to 3|Adverse Event|0|||
25101003|NCT02561195|50211861|FG003|Vaccination 1 to 3|Adverse Event|3|||
25101004|NCT02561195|50211862|FG004|Vaccination 1 to 3|Adverse Event|4|||
25101005|NCT02561195|50211863|FG005|Vaccination 1 to 3|Adverse Event|0|||
25101006|NCT02561195|50211864|FG006|Vaccination 1 to 3|Adverse Event|0|||
25101007|NCT02561195|50211865|FG007|Vaccination 1 to 3|Adverse Event|0|||
25101008|NCT02561195|50211866|FG008|Vaccination 1 to 3|Adverse Event|0|||
25101009|NCT02561195|50211867|FG009|Vaccination 1 to 3|Adverse Event|0|||
25101010|NCT02561195|50211868|FG010|Vaccination 1 to 3|Adverse Event|0|||
25101011|NCT02561195|50211869|FG011|Vaccination 1 to 3|Adverse Event|0|||
25101012|NCT02561195|50211870|FG012|Vaccination 1 to 3|Adverse Event|0|||
25101013|NCT02561195|50211871|FG013|Vaccination 1 to 3|Adverse Event|0|||
25101014|NCT02561195|50211858|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
25101015|NCT02561195|50211859|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
25101016|NCT02561195|50211860|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
25101017|NCT02561195|50211861|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
25101018|NCT02561195|50211862|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
25101019|NCT02561195|50211863|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
25101020|NCT02561195|50211864|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
25101021|NCT02561195|50211865|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
25101022|NCT02561195|50211866|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
25101023|NCT02561195|50211867|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
25101024|NCT02561195|50211868|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
25101025|NCT02561195|50211869|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
25101026|NCT02561195|50211870|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
25101027|NCT02561195|50211871|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
25101028|NCT02561195|50211858|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
25101029|NCT02561195|50211859|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
25101030|NCT02561195|50211860|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
25101031|NCT02561195|50211861|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
25101032|NCT02561195|50211862|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
25101033|NCT02561195|50211863|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
25101034|NCT02561195|50211864|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
25101035|NCT02561195|50211865|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
25101036|NCT02561195|50211866|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
25101037|NCT02561195|50211867|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
25101038|NCT02561195|50211868|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
25101039|NCT02561195|50211869|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
25101040|NCT02561195|50211870|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
25101041|NCT02561195|50211871|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
25101042|NCT02561195|50211858|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
25101043|NCT02561195|50211859|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
25101044|NCT02561195|50211860|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
25101045|NCT02561195|50211861|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
25101046|NCT02561195|50211862|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
25101047|NCT02561195|50211863|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
25101048|NCT02561195|50211864|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
25101049|NCT02561195|50211865|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
25101050|NCT02561195|50211866|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
25101051|NCT02561195|50211867|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
25101052|NCT02561195|50211868|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
25101053|NCT02561195|50211869|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
25101054|NCT02561195|50211870|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
25101055|NCT02561195|50211871|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
25101056|NCT02561195|50211858|FG000|Vaccination 1 to 3|Other|7|||
25101057|NCT02561195|50211859|FG001|Vaccination 1 to 3|Other|3|||
25101058|NCT02561195|50211860|FG002|Vaccination 1 to 3|Other|1|||
25101059|NCT02561195|50211861|FG003|Vaccination 1 to 3|Other|7|||
25101060|NCT02561195|50211862|FG004|Vaccination 1 to 3|Other|5|||
25101061|NCT02561195|50211863|FG005|Vaccination 1 to 3|Other|1|||
25261108|NCT01311648|50575784|FG000|Extension Study|Long travel|0|||
25261109|NCT01311648|50575785|FG001|Extension Study|Long travel|1|||
25101062|NCT02561195|50211864|FG006|Vaccination 1 to 3|Other|0|||
25101063|NCT02561195|50211865|FG007|Vaccination 1 to 3|Other|0|||
25101064|NCT02561195|50211866|FG008|Vaccination 1 to 3|Other|0|||
25101065|NCT02561195|50211867|FG009|Vaccination 1 to 3|Other|0|||
25101066|NCT02561195|50211868|FG010|Vaccination 1 to 3|Other|0|||
25101067|NCT02561195|50211869|FG011|Vaccination 1 to 3|Other|0|||
25101068|NCT02561195|50211870|FG012|Vaccination 1 to 3|Other|0|||
25101069|NCT02561195|50211871|FG013|Vaccination 1 to 3|Other|0|||
25101070|NCT02561195|50211858|FG000|Vaccination 1 to 3|Protocol Violation|1|||
25101071|NCT02561195|50211859|FG001|Vaccination 1 to 3|Protocol Violation|0|||
25101072|NCT02561195|50211860|FG002|Vaccination 1 to 3|Protocol Violation|1|||
25101073|NCT02561195|50211861|FG003|Vaccination 1 to 3|Protocol Violation|2|||
25101074|NCT02561195|50211862|FG004|Vaccination 1 to 3|Protocol Violation|5|||
25101075|NCT02561195|50211863|FG005|Vaccination 1 to 3|Protocol Violation|2|||
25101076|NCT02561195|50211864|FG006|Vaccination 1 to 3|Protocol Violation|0|||
25101077|NCT02561195|50211865|FG007|Vaccination 1 to 3|Protocol Violation|0|||
25101078|NCT02561195|50211866|FG008|Vaccination 1 to 3|Protocol Violation|0|||
25101079|NCT02561195|50211867|FG009|Vaccination 1 to 3|Protocol Violation|0|||
25101080|NCT02561195|50211868|FG010|Vaccination 1 to 3|Protocol Violation|0|||
25101081|NCT02561195|50211869|FG011|Vaccination 1 to 3|Protocol Violation|0|||
25101082|NCT02561195|50211870|FG012|Vaccination 1 to 3|Protocol Violation|0|||
25101083|NCT02561195|50211871|FG013|Vaccination 1 to 3|Protocol Violation|0|||
25101084|NCT02561195|50211858|FG000|Vaccination 1 to 3|Death|2|||
25101085|NCT02561195|50211859|FG001|Vaccination 1 to 3|Death|1|||
25101086|NCT02561195|50211860|FG002|Vaccination 1 to 3|Death|0|||
25101087|NCT02561195|50211861|FG003|Vaccination 1 to 3|Death|2|||
25101088|NCT02561195|50211862|FG004|Vaccination 1 to 3|Death|0|||
25101089|NCT02561195|50211863|FG005|Vaccination 1 to 3|Death|0|||
25101090|NCT02561195|50211864|FG006|Vaccination 1 to 3|Death|0|||
25101091|NCT02561195|50211865|FG007|Vaccination 1 to 3|Death|0|||
25101092|NCT02561195|50211866|FG008|Vaccination 1 to 3|Death|0|||
25101093|NCT02561195|50211867|FG009|Vaccination 1 to 3|Death|0|||
25101094|NCT02561195|50211868|FG010|Vaccination 1 to 3|Death|0|||
25101095|NCT02561195|50211869|FG011|Vaccination 1 to 3|Death|0|||
25101096|NCT02561195|50211870|FG012|Vaccination 1 to 3|Death|0|||
25101097|NCT02561195|50211871|FG013|Vaccination 1 to 3|Death|0|||
25101098|NCT02561195|50211858|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
25101099|NCT02561195|50211859|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
25101100|NCT02561195|50211860|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
25101101|NCT02561195|50211861|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
25101102|NCT02561195|50211862|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
25101103|NCT02561195|50211863|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
25101104|NCT02561195|50211864|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
25101105|NCT02561195|50211865|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
25101106|NCT02561195|50211866|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
25101107|NCT02561195|50211867|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
25101108|NCT02561195|50211868|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
25101109|NCT02561195|50211869|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
25101110|NCT02561195|50211870|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
25101111|NCT02561195|50211871|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
25101112|NCT02561195|50211858|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
25101113|NCT02561195|50211859|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
25101114|NCT02561195|50211860|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
25101115|NCT02561195|50211861|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
25101116|NCT02561195|50211862|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
25101117|NCT02561195|50211863|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
25101118|NCT02561195|50211864|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
25101119|NCT02561195|50211865|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
25101120|NCT02561195|50211866|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
25101121|NCT02561195|50211867|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
25101122|NCT02561195|50211868|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
25101123|NCT02561195|50211869|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
25101124|NCT02561195|50211870|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
25101125|NCT02561195|50211871|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
25101126|NCT02561195|50211858|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
25101127|NCT02561195|50211859|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
25101128|NCT02561195|50211860|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
25261110|NCT01311648|50575784|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
25261111|NCT01311648|50575785|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
25261112|NCT01311648|50575784|FG000|Extension Study|Withdrawal by Subject|0|||
25101129|NCT02561195|50211861|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
25101130|NCT02561195|50211862|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
25101131|NCT02561195|50211863|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
25101132|NCT02561195|50211864|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
25101133|NCT02561195|50211865|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
25101134|NCT02561195|50211866|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
25261113|NCT01311648|50575785|FG001|Extension Study|Withdrawal by Subject|1|||
25261114|NCT01311648|50575784|FG000|Extension Study|Inhibitor management|0|||
25261115|NCT01311648|50575785|FG001|Extension Study|Inhibitor management|2|||
25261116|NCT01011439|50575798|FG000|Overall Study|Death|37|||
25261117|NCT01011439|50575798|FG000|Overall Study|Lost to Follow-up|4|||
25261118|NCT01011439|50575798|FG000|Overall Study|Withdrawal by Subject|1|||
25261119|NCT01011439|50575798|FG000|Overall Study|Sponsor's decision|15|||
25261120|NCT01311024|50575805|FG000|Overall Study|Protocol Violation|35|||
25261121|NCT01311024|50575806|FG001|Overall Study|Protocol Violation|22|||
25261122|NCT01310868|50575812|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
25261123|NCT01273155|50575820|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
25261124|NCT01273155|50575821|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
25261125|NCT01273155|50575822|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
25261126|NCT01273155|50575823|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
25261127|NCT01273155|50575824|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
25101135|NCT02561195|50211867|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
25101136|NCT02561195|50211868|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
25101137|NCT02561195|50211869|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
25101138|NCT02561195|50211870|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
25101139|NCT02561195|50211871|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
25101140|NCT02561195|50211858|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
25101141|NCT02561195|50211859|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
25101142|NCT02561195|50211860|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
25101143|NCT02561195|50211861|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
25101144|NCT02561195|50211862|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
25101145|NCT02561195|50211863|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
25101146|NCT02561195|50211864|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
25101147|NCT02561195|50211865|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
25101148|NCT02561195|50211866|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
25101149|NCT02561195|50211867|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
25101150|NCT02561195|50211868|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
25101151|NCT02561195|50211869|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
25101152|NCT02561195|50211870|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
25101153|NCT02561195|50211871|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
25101154|NCT02561195|50211858|FG000|Extension Stage (Vaccination 4)|Death|0|||
25101155|NCT02561195|50211859|FG001|Extension Stage (Vaccination 4)|Death|0|||
25101156|NCT02561195|50211860|FG002|Extension Stage (Vaccination 4)|Death|0|||
25101157|NCT02561195|50211861|FG003|Extension Stage (Vaccination 4)|Death|0|||
25101158|NCT02561195|50211862|FG004|Extension Stage (Vaccination 4)|Death|0|||
25101159|NCT02561195|50211863|FG005|Extension Stage (Vaccination 4)|Death|0|||
25101160|NCT02561195|50211864|FG006|Extension Stage (Vaccination 4)|Death|0|||
25101161|NCT02561195|50211865|FG007|Extension Stage (Vaccination 4)|Death|0|||
25101162|NCT02561195|50211866|FG008|Extension Stage (Vaccination 4)|Death|0|||
25101163|NCT02561195|50211867|FG009|Extension Stage (Vaccination 4)|Death|1|||
25101164|NCT02561195|50211868|FG010|Extension Stage (Vaccination 4)|Death|0|||
25101165|NCT02561195|50211869|FG011|Extension Stage (Vaccination 4)|Death|0|||
25101166|NCT02561195|50211870|FG012|Extension Stage (Vaccination 4)|Death|0|||
25101167|NCT02561195|50211871|FG013|Extension Stage (Vaccination 4)|Death|0|||
25101168|NCT02561195|50211858|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
25101169|NCT02561195|50211859|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
25101170|NCT02561195|50211860|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
25101171|NCT02561195|50211861|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
25101172|NCT02561195|50211862|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
25101173|NCT02561195|50211863|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
25101174|NCT02561195|50211864|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
25101175|NCT02561195|50211865|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
25101176|NCT02561195|50211866|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
25101177|NCT02561195|50211867|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
25101178|NCT02561195|50211868|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
25261128|NCT01273155|50575825|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
25261129|NCT01273155|50575826|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
25261130|NCT01273155|50575820|FG000|Overall Study|Change in liver function/no longer eval.|0|||
25101179|NCT02561195|50211869|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
25101180|NCT02561195|50211870|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
25101181|NCT02561195|50211871|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
25101182|NCT02561195|50211858|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
25101183|NCT02561195|50211859|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
25101184|NCT02561195|50211860|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
25101185|NCT02561195|50211861|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
25101186|NCT02561195|50211862|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
25101187|NCT02561195|50211863|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
25101188|NCT02561195|50211864|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
25101189|NCT02561195|50211865|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
25101190|NCT02561195|50211866|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
25101191|NCT02561195|50211867|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
25101192|NCT02561195|50211868|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
25101193|NCT02561195|50211869|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
25101194|NCT02561195|50211870|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
25101195|NCT02561195|50211871|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
25101196|NCT02561195|50211858|FG000|Extension Stage (Vaccination 4)|Other|0|||
25101197|NCT02561195|50211859|FG001|Extension Stage (Vaccination 4)|Other|0|||
25101198|NCT02561195|50211860|FG002|Extension Stage (Vaccination 4)|Other|0|||
25101199|NCT02561195|50211861|FG003|Extension Stage (Vaccination 4)|Other|0|||
25101200|NCT02561195|50211862|FG004|Extension Stage (Vaccination 4)|Other|0|||
25101201|NCT02561195|50211863|FG005|Extension Stage (Vaccination 4)|Other|0|||
25101202|NCT02561195|50211864|FG006|Extension Stage (Vaccination 4)|Other|0|||
25101203|NCT02561195|50211865|FG007|Extension Stage (Vaccination 4)|Other|0|||
25101204|NCT02561195|50211866|FG008|Extension Stage (Vaccination 4)|Other|0|||
25101205|NCT02561195|50211867|FG009|Extension Stage (Vaccination 4)|Other|0|||
25101206|NCT02561195|50211868|FG010|Extension Stage (Vaccination 4)|Other|2|||
25101207|NCT02561195|50211869|FG011|Extension Stage (Vaccination 4)|Other|2|||
25101208|NCT02561195|50211870|FG012|Extension Stage (Vaccination 4)|Other|1|||
25101209|NCT02561195|50211871|FG013|Extension Stage (Vaccination 4)|Other|0|||
25101210|NCT02561195|50211858|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
25101211|NCT02561195|50211859|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
25101212|NCT02561195|50211860|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
25101213|NCT02561195|50211861|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
25101214|NCT02561195|50211862|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
25101215|NCT02561195|50211863|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
25101216|NCT02561195|50211864|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
25101217|NCT02561195|50211865|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
25101218|NCT02561195|50211866|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
25101219|NCT02561195|50211867|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
25101220|NCT02561195|50211868|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
25101221|NCT02561195|50211869|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
25101222|NCT02561195|50211870|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
25101223|NCT02561195|50211871|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
25101224|NCT01663103|50211905|FG000|Overall Study|Withdrawal by Subject|1|||
25101225|NCT01663103|50211906|FG001|Overall Study|Withdrawal by Subject|2|||
25101226|NCT01663103|50211905|FG000|Overall Study|Adverse Event|1|||
25101227|NCT01663103|50211906|FG001|Overall Study|Adverse Event|0|||
25101228|NCT01663103|50211905|FG000|Overall Study|dog bite|1|||
25101229|NCT01663103|50211906|FG001|Overall Study|dog bite|0|||
25101230|NCT02560025|50211925|FG000|Overall Study|Ineligible after consent/ registration|3|||
25101231|NCT02566889|50211940|FG000|Overall Study|Withdrawal by Subject|3|||
25101232|NCT02566889|50211941|FG001|Overall Study|Withdrawal by Subject|1|||
25101233|NCT02566889|50211940|FG000|Overall Study|Adverse Event|4|||
25101234|NCT02566889|50211941|FG001|Overall Study|Adverse Event|2|||
25101235|NCT02566889|50211940|FG000|Overall Study|Other|6|||
25101236|NCT02566889|50211941|FG001|Overall Study|Other|2|||
25101237|NCT02566577|50211948|FG000|Overall Study|Withdrawal by Subject|1|||
25101238|NCT02566577|50211949|FG001|Overall Study|Withdrawal by Subject|1|||
25101239|NCT02566577|50211948|FG000|Overall Study|Equipment failure|1|||
25101240|NCT02566577|50211949|FG001|Overall Study|Equipment failure|1|||
25101241|NCT02566577|50211948|FG000|Overall Study|Physical limitation|1|||
25101242|NCT02566577|50211949|FG001|Overall Study|Physical limitation|0|||
25101243|NCT02559713|50211957|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
25101244|NCT01358981|50211968|FG000|Period 1|Withdrawal by Subject|0|||
25101245|NCT01358981|50211969|FG001|Period 1|Withdrawal by Subject|0|||
25101246|NCT01358981|50211970|FG002|Period 1|Withdrawal by Subject|0|||
25101247|NCT01358981|50211971|FG003|Period 1|Withdrawal by Subject|1|||
25101248|NCT01358981|50211972|FG004|Period 1|Withdrawal by Subject|0|||
25101249|NCT01358981|50211973|FG005|Period 1|Withdrawal by Subject|0|||
25261131|NCT01273155|50575821|FG001|Overall Study|Change in liver function/no longer eval.|1|||
25261132|NCT01273155|50575822|FG002|Overall Study|Change in liver function/no longer eval.|0|||
25101250|NCT01358981|50211974|FG006|Period 1|Withdrawal by Subject|0|||
25101251|NCT02548585|50212006|FG000|Overall Study|Withdrawal by Subject|0|||
25101252|NCT02548585|50212007|FG001|Overall Study|Withdrawal by Subject|0|||
25101253|NCT02548585|50212008|FG002|Overall Study|Withdrawal by Subject|0|||
25101254|NCT02548585|50212009|FG003|Overall Study|Withdrawal by Subject|0|||
25101255|NCT02548585|50212010|FG004|Overall Study|Withdrawal by Subject|0|||
25101256|NCT02548585|50212011|FG005|Overall Study|Withdrawal by Subject|1|||
25101257|NCT02548585|50212012|FG006|Overall Study|Withdrawal by Subject|0|||
25101258|NCT02548585|50212006|FG000|Overall Study|Lost to Follow-up|1|||
25101259|NCT02548585|50212007|FG001|Overall Study|Lost to Follow-up|0|||
25101260|NCT02548585|50212008|FG002|Overall Study|Lost to Follow-up|0|||
25101261|NCT02548585|50212009|FG003|Overall Study|Lost to Follow-up|0|||
25101262|NCT02548585|50212010|FG004|Overall Study|Lost to Follow-up|0|||
25101263|NCT02548585|50212011|FG005|Overall Study|Lost to Follow-up|0|||
25101264|NCT02548585|50212012|FG006|Overall Study|Lost to Follow-up|0|||
25101265|NCT02548585|50212006|FG000|Overall Study|Other|1|||
25101266|NCT02548585|50212007|FG001|Overall Study|Other|0|||
25101267|NCT02548585|50212008|FG002|Overall Study|Other|0|||
25101268|NCT02548585|50212009|FG003|Overall Study|Other|2|||
25101269|NCT02548585|50212010|FG004|Overall Study|Other|3|||
25101270|NCT02548585|50212011|FG005|Overall Study|Other|0|||
25101271|NCT02548585|50212012|FG006|Overall Study|Other|1|||
25101272|NCT02548585|50212006|FG000|Overall Study|Randomized but not treated|0|||
25101273|NCT02548585|50212007|FG001|Overall Study|Randomized but not treated|0|||
25101274|NCT02548585|50212008|FG002|Overall Study|Randomized but not treated|0|||
25101275|NCT02548585|50212009|FG003|Overall Study|Randomized but not treated|0|||
25101276|NCT02548585|50212010|FG004|Overall Study|Randomized but not treated|0|||
25101277|NCT02548585|50212011|FG005|Overall Study|Randomized but not treated|1|||
25101278|NCT02548585|50212012|FG006|Overall Study|Randomized but not treated|0|||
25101279|NCT02547649|50212056|FG000|Overall Study|Lost to Follow-up|3|||
25101280|NCT02547649|50212057|FG001|Overall Study|Lost to Follow-up|1|||
25101281|NCT02547649|50212058|FG002|Overall Study|Lost to Follow-up|1|||
25101282|NCT02547649|50212056|FG000|Overall Study|Not vaccinated|0|||
25101283|NCT02547649|50212057|FG001|Overall Study|Not vaccinated|0|||
25101284|NCT02547649|50212058|FG002|Overall Study|Not vaccinated|1|||
25101285|NCT02547649|50212056|FG000|Overall Study|Withdrawal by Subject|0|||
25101286|NCT02547649|50212057|FG001|Overall Study|Withdrawal by Subject|4|||
25101287|NCT02547649|50212058|FG002|Overall Study|Withdrawal by Subject|2|||
25101288|NCT02535715|50212078|FG000|Overall Study|Withdrawal by Subject|0|||
25101289|NCT02535715|50212079|FG001|Overall Study|Withdrawal by Subject|0|||
25101290|NCT02535715|50212080|FG002|Overall Study|Withdrawal by Subject|1|||
25101291|NCT02336815|50212093|FG000|Overall Study|Disease Progression|45|||
25101292|NCT02336815|50212094|FG001|Overall Study|Disease Progression|70|||
25101293|NCT02336815|50212093|FG000|Overall Study|Adverse Event|18|||
25101294|NCT02336815|50212094|FG001|Overall Study|Adverse Event|39|||
25101295|NCT02336815|50212093|FG000|Overall Study|Physician Decision|11|||
25101296|NCT02336815|50212094|FG001|Overall Study|Physician Decision|4|||
25101297|NCT02336815|50212093|FG000|Overall Study|Withdrawal by Subject|3|||
25101298|NCT02336815|50212094|FG001|Overall Study|Withdrawal by Subject|2|||
25101299|NCT02336815|50212093|FG000|Overall Study|Lost to Follow-up|1|||
25101300|NCT02336815|50212094|FG001|Overall Study|Lost to Follow-up|3|||
25101301|NCT02336815|50212093|FG000|Overall Study|Other|1|||
25101302|NCT02336815|50212094|FG001|Overall Study|Other|5|||
25101303|NCT02543203|50212104|FG000|Overall Study|Unpalatable Fragrance|2|||
25101304|NCT02543203|50212105|FG001|Overall Study|Unpalatable Fragrance|2|||
25101305|NCT02543203|50212104|FG000|Overall Study|Lost to Follow-up|1|||
25101306|NCT02543203|50212105|FG001|Overall Study|Lost to Follow-up|0|||
25101307|NCT02543203|50212104|FG000|Overall Study|Increased Irritability|1|||
25101308|NCT02543203|50212105|FG001|Overall Study|Increased Irritability|0|||
25101309|NCT02543203|50212104|FG000|Overall Study|Family|1|||
25101310|NCT02543203|50212105|FG001|Overall Study|Family|2|||
25101311|NCT02543203|50212104|FG000|Overall Study|Negative Behavior|1|||
25101312|NCT02543203|50212105|FG001|Overall Study|Negative Behavior|0|||
25101313|NCT02543203|50212104|FG000|Overall Study|Withdrawal by Subject|0|||
25101314|NCT02543203|50212105|FG001|Overall Study|Withdrawal by Subject|1|||
25101315|NCT02546323|50212121|FG000|Overall Study|Withdrawal by Subject|36|||
25101316|NCT02546323|50212122|FG001|Overall Study|Withdrawal by Subject|33|||
25101317|NCT02546323|50212121|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
25101318|NCT02546323|50212122|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
25101319|NCT02546323|50212121|FG000|Overall Study|Adverse Event|17|||
25101320|NCT02546323|50212122|FG001|Overall Study|Adverse Event|11|||
25101321|NCT02546323|50212121|FG000|Overall Study|Patient Specific Reasons|1|||
25101322|NCT02546323|50212122|FG001|Overall Study|Patient Specific Reasons|2|||
25101323|NCT02546323|50212121|FG000|Overall Study|Lost to Follow-up|2|||
25101324|NCT02546323|50212122|FG001|Overall Study|Lost to Follow-up|3|||
25101325|NCT02546323|50212121|FG000|Overall Study|Non-compliance with Study Drug|2|||
25101326|NCT02546323|50212122|FG001|Overall Study|Non-compliance with Study Drug|2|||
25101327|NCT02546323|50212121|FG000|Overall Study|Met Withdrawal Criteria|2|||
25101328|NCT02546323|50212122|FG001|Overall Study|Met Withdrawal Criteria|14|||
25101329|NCT02545933|50212131|FG000|Overall Study|Adverse Event|3|||
25101330|NCT02545933|50212132|FG001|Overall Study|Adverse Event|0|||
25101331|NCT02545933|50212133|FG002|Overall Study|Adverse Event|0|||
25101332|NCT02545933|50212131|FG000|Overall Study|Withdrawal by Subject|2|||
25101333|NCT02545933|50212132|FG001|Overall Study|Withdrawal by Subject|3|||
25101334|NCT02545933|50212133|FG002|Overall Study|Withdrawal by Subject|3|||
25101335|NCT02545933|50212131|FG000|Overall Study|Protocol Violation|1|||
25101336|NCT02545933|50212132|FG001|Overall Study|Protocol Violation|0|||
25101337|NCT02545933|50212133|FG002|Overall Study|Protocol Violation|1|||
25101338|NCT01661179|50212141|FG000|Overall Study|Death|1|||
25101339|NCT01661179|50212141|FG000|Overall Study|Withdrawal by Subject|1|||
25101340|NCT01661179|50212141|FG000|Overall Study|Other Eligibility criteria|4|||
25101341|NCT02545543|50212147|FG000|Overall Study|Lost to Follow-up|67|||
25101342|NCT02545543|50212148|FG001|Overall Study|Lost to Follow-up|25|||
25101343|NCT02545543|50212147|FG000|Overall Study|Physician Decision|3|||
25101344|NCT02545543|50212148|FG001|Overall Study|Physician Decision|0|||
25101345|NCT02545543|50212147|FG000|Overall Study|Withdrawal by Subject|9|||
25101346|NCT02545543|50212148|FG001|Overall Study|Withdrawal by Subject|8|||
25101347|NCT02545543|50212147|FG000|Overall Study|Noncomplaince|1|||
25101348|NCT02545543|50212148|FG001|Overall Study|Noncomplaince|0|||
25101349|NCT02545543|50212147|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
25101350|NCT02545543|50212148|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
25101351|NCT02542267|50212156|FG000|Overall Study|Withdrawal by Subject|10|||
25101352|NCT02542267|50212156|FG000|Overall Study|Physician Decision|6|||
25101353|NCT02542267|50212156|FG000|Overall Study|Lost to Follow-up|4|||
25101354|NCT02542267|50212156|FG000|Overall Study|Death|13|||
25101355|NCT02542267|50212156|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
25101356|NCT02542267|50212156|FG000|Overall Study|Other|9|||
25101357|NCT02545075|50212162|FG000|Randomization|Lost to Follow-up|0|||
25101358|NCT02545075|50212163|FG001|Randomization|Lost to Follow-up|1|||
25101359|NCT02545075|50212162|FG000|Randomization|Withdrawal by Subject|0|||
25101360|NCT02545075|50212163|FG001|Randomization|Withdrawal by Subject|6|||
25101361|NCT02545075|50212162|FG000|Treatment|Disease progression|71|||
25101362|NCT02545075|50212163|FG001|Treatment|Disease progression|32|||
25101363|NCT02545075|50212162|FG000|Treatment|Participant dicontinued study treatment|7|||
25101364|NCT02545075|50212163|FG001|Treatment|Participant dicontinued study treatment|9|||
25101365|NCT02545075|50212162|FG000|Treatment|Withdrawal by Subject|1|||
25101366|NCT02545075|50212163|FG001|Treatment|Withdrawal by Subject|0|||
25101367|NCT02545075|50212162|FG000|Treatment|Adverse event not related to study drug|1|||
25101368|NCT02545075|50212163|FG001|Treatment|Adverse event not related to study drug|0|||
25101369|NCT02545075|50212162|FG000|Treatment|Death|1|||
25101370|NCT02545075|50212163|FG001|Treatment|Death|0|||
25101371|NCT02545075|50212162|FG000|Treatment|Participant drug toxicity|1|||
25101372|NCT02545075|50212163|FG001|Treatment|Participant drug toxicity|0|||
25101373|NCT02545075|50212162|FG000|Treatment|Completed treatment|40|||
25101374|NCT02545075|50212163|FG001|Treatment|Completed treatment|12|||
25101375|NCT03004183|50212178|FG000|Overall Study|Adverse Event|7|||
25101376|NCT03004183|50212178|FG000|Overall Study|Lost to Follow-up|1|||
25101377|NCT03004183|50212178|FG000|Overall Study|Physician Decision|40|||
25101378|NCT03004183|50212178|FG000|Overall Study|Withdrawal by Subject|1|||
25101379|NCT03004183|50212178|FG000|Overall Study|COVID-19|1|||
25101380|NCT02544763|50212185|FG000|Overall Study|Adverse Event|8|||
25101381|NCT02544763|50212186|FG001|Overall Study|Adverse Event|8|||
25101382|NCT02544763|50212187|FG002|Overall Study|Adverse Event|0|||
25101383|NCT02544763|50212185|FG000|Overall Study|Withdrawn by parent/guardian|1|||
25101384|NCT02544763|50212186|FG001|Overall Study|Withdrawn by parent/guardian|1|||
25101385|NCT02544763|50212187|FG002|Overall Study|Withdrawn by parent/guardian|1|||
25101386|NCT02544763|50212185|FG000|Overall Study|Met withdrawal criteria|0|||
25101387|NCT02544763|50212186|FG001|Overall Study|Met withdrawal criteria|2|||
25101388|NCT02544763|50212187|FG002|Overall Study|Met withdrawal criteria|0|||
25101389|NCT02544763|50212185|FG000|Overall Study|Physician Decision|0|||
25101390|NCT02544763|50212186|FG001|Overall Study|Physician Decision|1|||
25101391|NCT02544763|50212187|FG002|Overall Study|Physician Decision|0|||
25101392|NCT02544763|50212185|FG000|Overall Study|Difficulties taking IMP|1|||
25101393|NCT02544763|50212186|FG001|Overall Study|Difficulties taking IMP|0|||
25101394|NCT02544763|50212187|FG002|Overall Study|Difficulties taking IMP|0|||
25101395|NCT02556203|50212197|FG000|Overall Study|Withdrawal by Subject|21|||
25101396|NCT02556203|50212198|FG001|Overall Study|Withdrawal by Subject|21|||
25101397|NCT02556203|50212197|FG000|Overall Study|Lost to Follow-up|5|||
25101398|NCT02556203|50212198|FG001|Overall Study|Lost to Follow-up|5|||
25101399|NCT02556203|50212197|FG000|Overall Study|Adverse Event|1|||
25101400|NCT02556203|50212198|FG001|Overall Study|Adverse Event|0|||
25101401|NCT02558231|50212215|FG000|Overall Study|Death|4|||
25101402|NCT02558231|50212216|FG001|Overall Study|Death|12|||
25101403|NCT02558231|50212215|FG000|Overall Study|Lost to Follow-up|7|||
25101404|NCT02558231|50212216|FG001|Overall Study|Lost to Follow-up|4|||
25101405|NCT02558231|50212215|FG000|Overall Study|Withdrawal by Subject|7|||
25101406|NCT02558231|50212216|FG001|Overall Study|Withdrawal by Subject|4|||
25101407|NCT02558231|50212215|FG000|Overall Study|Physician Decision|7|||
25101408|NCT02558231|50212216|FG001|Overall Study|Physician Decision|5|||
25101409|NCT02558231|50212215|FG000|Overall Study|Sponsor Decision|0|||
25101410|NCT02558231|50212216|FG001|Overall Study|Sponsor Decision|1|||
25101411|NCT02554877|50212226|FG000|Overall Study|Adverse Event|2|||
25101412|NCT02554877|50212227|FG001|Overall Study|Adverse Event|0|||
25101413|NCT02554877|50212228|FG002|Overall Study|Adverse Event|0|||
25101414|NCT02554877|50212229|FG003|Overall Study|Adverse Event|1|||
25101415|NCT02554877|50212226|FG000|Overall Study|Lost to Follow-up|1|||
25101416|NCT02554877|50212227|FG001|Overall Study|Lost to Follow-up|1|||
25101417|NCT02554877|50212228|FG002|Overall Study|Lost to Follow-up|1|||
25101418|NCT02554877|50212229|FG003|Overall Study|Lost to Follow-up|2|||
25101419|NCT02554877|50212226|FG000|Overall Study|Did not meet entrance criteria|0|||
25101420|NCT02554877|50212227|FG001|Overall Study|Did not meet entrance criteria|0|||
25101421|NCT02554877|50212228|FG002|Overall Study|Did not meet entrance criteria|1|||
25101422|NCT02554877|50212229|FG003|Overall Study|Did not meet entrance criteria|0|||
25101423|NCT02554877|50212226|FG000|Overall Study|No longer met eligibility criteria|1|||
25101424|NCT02554877|50212227|FG001|Overall Study|No longer met eligibility criteria|0|||
25101425|NCT02554877|50212228|FG002|Overall Study|No longer met eligibility criteria|1|||
25101426|NCT02554877|50212229|FG003|Overall Study|No longer met eligibility criteria|1|||
25101427|NCT02554877|50212226|FG000|Overall Study|Protocol Violation|3|||
25101428|NCT02554877|50212227|FG001|Overall Study|Protocol Violation|1|||
25101429|NCT02554877|50212228|FG002|Overall Study|Protocol Violation|1|||
25101430|NCT02554877|50212229|FG003|Overall Study|Protocol Violation|0|||
25101431|NCT02554877|50212226|FG000|Overall Study|Other|1|||
25101432|NCT02554877|50212227|FG001|Overall Study|Other|3|||
25101433|NCT02554877|50212228|FG002|Overall Study|Other|0|||
25101434|NCT02554877|50212229|FG003|Overall Study|Other|3|||
25101435|NCT02554877|50212226|FG000|Overall Study|Insufficient clinical response|4|||
25101436|NCT02554877|50212227|FG001|Overall Study|Insufficient clinical response|0|||
25101437|NCT02554877|50212228|FG002|Overall Study|Insufficient clinical response|0|||
25101438|NCT02554877|50212229|FG003|Overall Study|Insufficient clinical response|0|||
25101439|NCT02554877|50212226|FG000|Overall Study|No longer willing to participate|0|||
25101440|NCT02554877|50212227|FG001|Overall Study|No longer willing to participate|2|||
25101441|NCT02554877|50212228|FG002|Overall Study|No longer willing to participate|2|||
25101442|NCT02554877|50212229|FG003|Overall Study|No longer willing to participate|0|||
25101443|NCT02554721|50212244|FG000|Overall Study|Adverse Event|1|||
25101444|NCT02554721|50212245|FG001|Overall Study|Adverse Event|0|||
25101445|NCT02554721|50212246|FG002|Overall Study|Adverse Event|0|||
25101446|NCT02554721|50212247|FG003|Overall Study|Adverse Event|0|||
25101447|NCT02554721|50212248|FG004|Overall Study|Adverse Event|1|||
25101448|NCT02554721|50212244|FG000|Overall Study|Noncompliance|0|||
25101449|NCT02554721|50212245|FG001|Overall Study|Noncompliance|0|||
25101450|NCT02554721|50212246|FG002|Overall Study|Noncompliance|0|||
25101451|NCT02554721|50212247|FG003|Overall Study|Noncompliance|0|||
25101452|NCT02554721|50212248|FG004|Overall Study|Noncompliance|1|||
25101453|NCT02552225|50212259|FG000|Overall Study|Withdrawal by Subject|1|||
25101454|NCT02552225|50212260|FG001|Overall Study|Withdrawal by Subject|0|||
25101455|NCT02552147|50212266|FG000|First Intervention (7 Days)|Protocol Violation|1|||
25101456|NCT02552147|50212267|FG001|First Intervention (7 Days)|Protocol Violation|0|||
25101457|NCT02552147|50212266|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
25101458|NCT02552147|50212267|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
25101459|NCT01662635|50212273|FG000|Overall Study|scarce samples for evaluation|30|||
25101460|NCT02534935|50212282|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
25101461|NCT02534935|50212283|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
25101462|NCT02534935|50212284|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
25101463|NCT02534935|50212282|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
25101464|NCT02534935|50212283|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
25101465|NCT02534935|50212284|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
25101466|NCT02534935|50212282|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
25101467|NCT02534935|50212283|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
25101468|NCT02534935|50212284|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
25101469|NCT02534935|50212282|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
25101470|NCT02534935|50212283|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
25101471|NCT02534935|50212284|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
25101472|NCT02534935|50212282|FG000|Stage 1: 24 Months|Adverse Event|0|||
25101473|NCT02534935|50212283|FG001|Stage 1: 24 Months|Adverse Event|2|||
25101474|NCT02534935|50212284|FG002|Stage 1: 24 Months|Adverse Event|0|||
25101475|NCT02534935|50212282|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
25101476|NCT02534935|50212283|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
25101477|NCT02534935|50212284|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
25101478|NCT02534935|50212282|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
25101479|NCT02534935|50212283|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
25101480|NCT02534935|50212284|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
25101481|NCT02544451|50212313|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
25101482|NCT02544451|50212314|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
25101483|NCT02544451|50212315|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
25101484|NCT02544451|50212316|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
25101485|NCT02544451|50212313|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
25101486|NCT02544451|50212314|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
25101487|NCT02544451|50212315|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
25101488|NCT02544451|50212316|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
25101489|NCT02544451|50212313|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
25101490|NCT02544451|50212314|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
25101491|NCT02544451|50212315|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
25101492|NCT02544451|50212316|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
25101493|NCT02544451|50212313|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
25101494|NCT02544451|50212314|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
25101495|NCT02544451|50212315|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
25101496|NCT02544451|50212316|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
25101497|NCT02544451|50212313|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
25101498|NCT02544451|50212314|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
25101499|NCT02544451|50212315|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
25101500|NCT02544451|50212316|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
25101501|NCT02544451|50212313|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
25101502|NCT02544451|50212314|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
25101503|NCT02544451|50212315|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
25101504|NCT02544451|50212316|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
25101505|NCT02544373|50212336|FG000|Overall Study|Lost to Follow-up|5|||
25101506|NCT02544373|50212337|FG001|Overall Study|Lost to Follow-up|3|||
25101507|NCT02544373|50212336|FG000|Overall Study|Withdrawal by Subject|8|||
25101508|NCT02544373|50212337|FG001|Overall Study|Withdrawal by Subject|2|||
25101509|NCT02551991|50212349|FG000|Overall Study|Death|5|||
25101510|NCT02551991|50212350|FG001|Overall Study|Death|7|||
25101511|NCT02551991|50212351|FG002|Overall Study|Death|8|||
25101512|NCT02551991|50212352|FG003|Overall Study|Death|7|||
25101513|NCT02551991|50212353|FG004|Overall Study|Death|17|||
25101514|NCT02551991|50212349|FG000|Overall Study|Withdrawal by Subject|1|||
25101515|NCT02551991|50212350|FG001|Overall Study|Withdrawal by Subject|0|||
25101516|NCT02551991|50212351|FG002|Overall Study|Withdrawal by Subject|0|||
25101517|NCT02551991|50212352|FG003|Overall Study|Withdrawal by Subject|0|||
25101518|NCT02551991|50212353|FG004|Overall Study|Withdrawal by Subject|2|||
25101519|NCT02551991|50212349|FG000|Overall Study|Lost to Follow-up|0|||
25101520|NCT02551991|50212350|FG001|Overall Study|Lost to Follow-up|0|||
25101521|NCT02551991|50212351|FG002|Overall Study|Lost to Follow-up|1|||
25101522|NCT02551991|50212352|FG003|Overall Study|Lost to Follow-up|0|||
25101523|NCT02551991|50212353|FG004|Overall Study|Lost to Follow-up|0|||
25101524|NCT02551991|50212349|FG000|Overall Study|Sponsor Decision|1|||
25101525|NCT02551991|50212350|FG001|Overall Study|Sponsor Decision|0|||
25101526|NCT02551991|50212351|FG002|Overall Study|Sponsor Decision|1|||
25101527|NCT02551991|50212352|FG003|Overall Study|Sponsor Decision|0|||
25101528|NCT02551991|50212353|FG004|Overall Study|Sponsor Decision|5|||
25101529|NCT02551991|50212349|FG000|Overall Study|Other|0|||
25101530|NCT02551991|50212350|FG001|Overall Study|Other|0|||
25101531|NCT02551991|50212351|FG002|Overall Study|Other|0|||
25101532|NCT02551991|50212352|FG003|Overall Study|Other|0|||
25101533|NCT02551991|50212353|FG004|Overall Study|Other|1|||
25101534|NCT01661933|50212366|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
25101535|NCT01661933|50212366|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
25101536|NCT02544217|50212378|FG000|Overall Study|Withdrawal by Subject|1|||
25101537|NCT02544217|50212379|FG001|Overall Study|Withdrawal by Subject|1|||
25101538|NCT02544217|50212380|FG002|Overall Study|Withdrawal by Subject|0|||
25101539|NCT02544217|50212381|FG003|Overall Study|Withdrawal by Subject|0|||
25101540|NCT02544217|50212382|FG004|Overall Study|Withdrawal by Subject|0|||
25101541|NCT02544217|50212383|FG005|Overall Study|Withdrawal by Subject|0|||
25101542|NCT02533999|50212452|FG000|Overall Study|Lost to Follow-up|3|||
25101543|NCT02533999|50212453|FG001|Overall Study|Lost to Follow-up|5|||
25101544|NCT02533999|50212452|FG000|Overall Study|Protocol Violation|3|||
25101545|NCT02533999|50212453|FG001|Overall Study|Protocol Violation|0|||
25101546|NCT02533999|50212452|FG000|Overall Study|Adverse Event|0|||
25101547|NCT02533999|50212453|FG001|Overall Study|Adverse Event|1|||
25101548|NCT02533999|50212452|FG000|Overall Study|Randomized but intervention not received|0|||
25101549|NCT02533999|50212453|FG001|Overall Study|Randomized but intervention not received|1|||
25101550|NCT02533531|50212459|FG000|Overall Study|Device did not turn on|1|||
25101551|NCT02533453|50212463|FG000|Overall Study|Adverse Event|6|||
25101552|NCT02533453|50212463|FG000|Overall Study|Protocol Violation|1|||
25101553|NCT02533453|50212463|FG000|Overall Study|Withdrawal by Subject|2|||
25101554|NCT02533375|50212467|FG000|Overall Study|Lack of Efficacy|3|||
25101555|NCT02533375|50212467|FG000|Overall Study|Adverse Event|2|||
25101556|NCT01553149|50212473|FG000|Overall Study|Adverse Event|0|||
25261133|NCT01273155|50575823|FG003|Overall Study|Change in liver function/no longer eval.|0|||
25101557|NCT01553149|50212474|FG001|Overall Study|Adverse Event|9|||
25101558|NCT01553149|50212473|FG000|Overall Study|Physician Decision|5|||
25101559|NCT01553149|50212474|FG001|Overall Study|Physician Decision|10|||
25101560|NCT01553149|50212473|FG000|Overall Study|Ineligible|0|||
25101561|NCT01553149|50212474|FG001|Overall Study|Ineligible|1|||
25101562|NCT02551055|50212487|FG000|Overall Study|Death|2|||
25101563|NCT02551055|50212488|FG001|Overall Study|Death|4|||
25101564|NCT02551055|50212489|FG002|Overall Study|Death|2|||
25101565|NCT02551055|50212490|FG003|Overall Study|Death|2|||
25101566|NCT02551055|50212491|FG004|Overall Study|Death|2|||
25101567|NCT02551055|50212492|FG005|Overall Study|Death|1|||
25101568|NCT02551055|50212493|FG006|Overall Study|Death|2|||
25101569|NCT02551055|50212494|FG007|Overall Study|Death|0|||
25101570|NCT02551055|50212487|FG000|Overall Study|Study Terminated by Sponsor|1|||
25101571|NCT02551055|50212488|FG001|Overall Study|Study Terminated by Sponsor|1|||
25101572|NCT02551055|50212489|FG002|Overall Study|Study Terminated by Sponsor|0|||
25101573|NCT02551055|50212490|FG003|Overall Study|Study Terminated by Sponsor|2|||
25101574|NCT02551055|50212491|FG004|Overall Study|Study Terminated by Sponsor|2|||
25101575|NCT02551055|50212492|FG005|Overall Study|Study Terminated by Sponsor|0|||
25101576|NCT02551055|50212493|FG006|Overall Study|Study Terminated by Sponsor|0|||
25101577|NCT02551055|50212494|FG007|Overall Study|Study Terminated by Sponsor|0|||
25101578|NCT02551055|50212487|FG000|Overall Study|Withdrawal by Subject|1|||
25101579|NCT02551055|50212488|FG001|Overall Study|Withdrawal by Subject|1|||
25101580|NCT02551055|50212489|FG002|Overall Study|Withdrawal by Subject|0|||
25101581|NCT02551055|50212490|FG003|Overall Study|Withdrawal by Subject|1|||
25101582|NCT02551055|50212491|FG004|Overall Study|Withdrawal by Subject|2|||
25101583|NCT02551055|50212492|FG005|Overall Study|Withdrawal by Subject|0|||
25101584|NCT02551055|50212493|FG006|Overall Study|Withdrawal by Subject|0|||
25101585|NCT02551055|50212494|FG007|Overall Study|Withdrawal by Subject|0|||
25101586|NCT02551055|50212487|FG000|Overall Study|Reason not specified|0|||
25101587|NCT02551055|50212488|FG001|Overall Study|Reason not specified|0|||
25101588|NCT02551055|50212489|FG002|Overall Study|Reason not specified|0|||
25101589|NCT02551055|50212490|FG003|Overall Study|Reason not specified|0|||
25101590|NCT02551055|50212491|FG004|Overall Study|Reason not specified|1|||
25101591|NCT02551055|50212492|FG005|Overall Study|Reason not specified|0|||
25101592|NCT02551055|50212493|FG006|Overall Study|Reason not specified|1|||
25101593|NCT02551055|50212494|FG007|Overall Study|Reason not specified|0|||
25101594|NCT02542943|50212515|FG000|Overall Study|Lost to Follow-up|1|||
25101595|NCT02542943|50212516|FG001|Overall Study|Lost to Follow-up|0|||
25101596|NCT02542943|50212517|FG002|Overall Study|Lost to Follow-up|0|||
25101597|NCT02542943|50212515|FG000|Overall Study|Withdrawal by Subject|0|||
25101598|NCT02542943|50212516|FG001|Overall Study|Withdrawal by Subject|1|||
25101599|NCT02542943|50212517|FG002|Overall Study|Withdrawal by Subject|0|||
25101600|NCT02542865|50212528|FG000|Overall Study|Identified as screen failure|1|||
25101601|NCT02542865|50212529|FG001|Overall Study|Identified as screen failure|0|||
25101602|NCT02542865|50212528|FG000|Overall Study|Withdrawal by Subject|16|||
25101603|NCT02542865|50212529|FG001|Overall Study|Withdrawal by Subject|0|||
25101604|NCT03644927|50212535|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
25101605|NCT03644927|50212536|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
25101606|NCT02542631|50212543|FG000|Overall Study|Adverse Event|1|||
25101607|NCT02542631|50212544|FG001|Overall Study|Adverse Event|1|||
25101608|NCT02542631|50212543|FG000|Overall Study|Sponsor Termination|1|||
25101609|NCT02542631|50212544|FG001|Overall Study|Sponsor Termination|0|||
25101610|NCT02542631|50212543|FG000|Overall Study|Withdrawal by Subject|11|||
25101611|NCT02542631|50212544|FG001|Overall Study|Withdrawal by Subject|16|||
25101612|NCT02542631|50212543|FG000|Overall Study|Protocol Violation|1|||
25101613|NCT02542631|50212544|FG001|Overall Study|Protocol Violation|1|||
25101614|NCT02542631|50212543|FG000|Overall Study|Physician Decision|6|||
25101615|NCT02542631|50212544|FG001|Overall Study|Physician Decision|4|||
25101616|NCT02542631|50212543|FG000|Overall Study|Lost to Follow-up|6|||
25101617|NCT02542631|50212544|FG001|Overall Study|Lost to Follow-up|5|||
25101618|NCT02542631|50212543|FG000|Overall Study|Death|1|||
25101619|NCT02542631|50212544|FG001|Overall Study|Death|2|||
25101620|NCT02542631|50212543|FG000|Overall Study|Other|2|||
25101621|NCT02542631|50212544|FG001|Overall Study|Other|1|||
25101622|NCT02542631|50212543|FG000|Overall Study|Used Prohibited Medication|2|||
25101623|NCT02542631|50212544|FG001|Overall Study|Used Prohibited Medication|1|||
25101624|NCT02549573|50212552|FG000|Overall Study|Withdrawal by Subject|0|||
25101625|NCT02549573|50212553|FG001|Overall Study|Withdrawal by Subject|2|||
25101626|NCT02549573|50212552|FG000|Overall Study|Protocol Violation|0|||
25177125|NCT02660580|50321238|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
25101627|NCT02549573|50212553|FG001|Overall Study|Protocol Violation|1|||
25101628|NCT02542397|50212559|FG000|Overall Study|Death|2|||
25101629|NCT02542397|50212559|FG000|Overall Study|Physician Decision|6|||
25101630|NCT02542397|50212559|FG000|Overall Study|Withdrawal by Subject|6|||
25101631|NCT02542397|50212559|FG000|Overall Study|Lost to Follow-up|2|||
25101632|NCT02549339|50212566|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
25101633|NCT02549339|50212567|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
25101634|NCT02549339|50212566|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
25101635|NCT02549339|50212567|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
25101636|NCT02549339|50212566|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
25101637|NCT02549339|50212567|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
25101638|NCT02549339|50212566|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
25101639|NCT02549339|50212567|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
25101640|NCT02549339|50212566|FG000|12-month Follow-up|Lack of Efficacy|0|||
25101641|NCT02549339|50212567|FG001|12-month Follow-up|Lack of Efficacy|2|||
25101642|NCT02549339|50212566|FG000|12-month Follow-up|Withdrawal by Subject|8|||
25101643|NCT02549339|50212567|FG001|12-month Follow-up|Withdrawal by Subject|3|||
25101644|NCT02549339|50212566|FG000|12-month Follow-up|Lost to Follow-up|1|||
25101645|NCT02549339|50212567|FG001|12-month Follow-up|Lost to Follow-up|3|||
25101646|NCT02549339|50212566|FG000|12-month Follow-up|Other|0|||
25101647|NCT02549339|50212567|FG001|12-month Follow-up|Other|3|||
25177126|NCT02660580|50321239|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
25101648|NCT02549027|50212575|FG000|Washout After Period 4|Withdrawal by Subject|0|||
25101649|NCT02549027|50212576|FG001|Washout After Period 4|Withdrawal by Subject|1|||
25101650|NCT02549027|50212577|FG002|Washout After Period 4|Withdrawal by Subject|1|||
25101651|NCT02549027|50212578|FG003|Washout After Period 4|Withdrawal by Subject|1|||
25101652|NCT02549027|50212579|FG004|Washout After Period 4|Withdrawal by Subject|0|||
25101653|NCT02549027|50212580|FG005|Washout After Period 4|Withdrawal by Subject|0|||
25101654|NCT02549027|50212575|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
25101655|NCT02549027|50212576|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
25101656|NCT02549027|50212577|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
25101657|NCT02549027|50212578|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
25101658|NCT02549027|50212579|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
25101659|NCT02549027|50212580|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
25101660|NCT02529553|50212608|FG000|Overall Study|Progressive Disease|1|||
25101661|NCT02529553|50212609|FG001|Overall Study|Progressive Disease|0|||
25101662|NCT02529553|50212610|FG002|Overall Study|Progressive Disease|1|||
25101663|NCT02529553|50212611|FG003|Overall Study|Progressive Disease|3|||
25101664|NCT02529553|50212612|FG004|Overall Study|Progressive Disease|2|||
25101665|NCT02529553|50212613|FG005|Overall Study|Progressive Disease|3|||
25101666|NCT02529553|50212614|FG006|Overall Study|Progressive Disease|3|||
25101667|NCT02529553|50212615|FG007|Overall Study|Progressive Disease|5|||
25101668|NCT02529553|50212616|FG008|Overall Study|Progressive Disease|3|||
25101669|NCT02529553|50212608|FG000|Overall Study|Physician Decision|0|||
25101670|NCT02529553|50212609|FG001|Overall Study|Physician Decision|1|||
25101671|NCT02529553|50212610|FG002|Overall Study|Physician Decision|0|||
25101672|NCT02529553|50212611|FG003|Overall Study|Physician Decision|0|||
25101673|NCT02529553|50212612|FG004|Overall Study|Physician Decision|1|||
25101674|NCT02529553|50212613|FG005|Overall Study|Physician Decision|0|||
25101675|NCT02529553|50212614|FG006|Overall Study|Physician Decision|0|||
25101676|NCT02529553|50212615|FG007|Overall Study|Physician Decision|0|||
25101677|NCT02529553|50212616|FG008|Overall Study|Physician Decision|0|||
25101678|NCT02529553|50212608|FG000|Overall Study|Withdrawal by Subject|0|||
25101679|NCT02529553|50212609|FG001|Overall Study|Withdrawal by Subject|0|||
25101680|NCT02529553|50212610|FG002|Overall Study|Withdrawal by Subject|0|||
25101681|NCT02529553|50212611|FG003|Overall Study|Withdrawal by Subject|0|||
25101682|NCT02529553|50212612|FG004|Overall Study|Withdrawal by Subject|0|||
25101683|NCT02529553|50212613|FG005|Overall Study|Withdrawal by Subject|1|||
25101684|NCT02529553|50212614|FG006|Overall Study|Withdrawal by Subject|0|||
25101685|NCT02529553|50212615|FG007|Overall Study|Withdrawal by Subject|1|||
25101686|NCT02529553|50212616|FG008|Overall Study|Withdrawal by Subject|0|||
25101687|NCT02547935|50212640|FG000|Overall Study|Other|0|||
25101688|NCT02547935|50212641|FG001|Overall Study|Other|1|||
25101689|NCT02547935|50212642|FG002|Overall Study|Other|0|||
25101690|NCT02547935|50212640|FG000|Overall Study|Withdrawal by Subject|2|||
25101691|NCT02547935|50212641|FG001|Overall Study|Withdrawal by Subject|3|||
25101692|NCT02547935|50212642|FG002|Overall Study|Withdrawal by Subject|4|||
25101693|NCT02547935|50212640|FG000|Overall Study|Screen Failure|2|||
25101694|NCT02547935|50212641|FG001|Overall Study|Screen Failure|0|||
25101695|NCT02547935|50212642|FG002|Overall Study|Screen Failure|0|||
25101696|NCT02547935|50212640|FG000|Overall Study|Physician Decision|0|||
25101697|NCT02547935|50212641|FG001|Overall Study|Physician Decision|1|||
25101698|NCT02547935|50212642|FG002|Overall Study|Physician Decision|0|||
25101699|NCT02547935|50212640|FG000|Overall Study|Lost to Follow-up|0|||
25101700|NCT02547935|50212641|FG001|Overall Study|Lost to Follow-up|2|||
25101701|NCT02547935|50212642|FG002|Overall Study|Lost to Follow-up|1|||
25101702|NCT02547935|50212640|FG000|Overall Study|Death|1|||
25101703|NCT02547935|50212641|FG001|Overall Study|Death|1|||
25101704|NCT02547935|50212642|FG002|Overall Study|Death|0|||
25101705|NCT02554019|50212655|FG000|Overall Study|Withdrawal by Subject|1|||
25101706|NCT02554019|50212656|FG001|Overall Study|Withdrawal by Subject|0|||
25101707|NCT02554019|50212657|FG002|Overall Study|Withdrawal by Subject|2|||
25101708|NCT02554019|50212655|FG000|Overall Study|Adverse Event|1|||
25101709|NCT02554019|50212656|FG001|Overall Study|Adverse Event|0|||
25101710|NCT02554019|50212657|FG002|Overall Study|Adverse Event|0|||
25101711|NCT02327169|50212680|FG000|Overall Study|Progressive Disease|1|||
25101712|NCT02327169|50212681|FG001|Overall Study|Progressive Disease|3|||
25101713|NCT02327169|50212682|FG002|Overall Study|Progressive Disease|4|||
25101714|NCT02327169|50212683|FG003|Overall Study|Progressive Disease|3|||
25101715|NCT02327169|50212684|FG004|Overall Study|Progressive Disease|4|||
25101716|NCT02327169|50212685|FG005|Overall Study|Progressive Disease|3|||
25101717|NCT02327169|50212686|FG006|Overall Study|Progressive Disease|3|||
25101718|NCT02327169|50212687|FG007|Overall Study|Progressive Disease|3|||
25101719|NCT02327169|50212688|FG008|Overall Study|Progressive Disease|4|||
25101720|NCT02327169|50212689|FG009|Overall Study|Progressive Disease|4|||
25101721|NCT02327169|50212690|FG010|Overall Study|Progressive Disease|4|||
25101722|NCT02327169|50212691|FG011|Overall Study|Progressive Disease|3|||
25101723|NCT02327169|50212692|FG012|Overall Study|Progressive Disease|1|||
25101724|NCT02327169|50212693|FG013|Overall Study|Progressive Disease|3|||
25101725|NCT02327169|50212694|FG014|Overall Study|Progressive Disease|3|||
25101726|NCT02327169|50212680|FG000|Overall Study|Adverse Event|2|||
25101727|NCT02327169|50212681|FG001|Overall Study|Adverse Event|0|||
25101728|NCT02327169|50212682|FG002|Overall Study|Adverse Event|1|||
25101729|NCT02327169|50212683|FG003|Overall Study|Adverse Event|0|||
25101730|NCT02327169|50212684|FG004|Overall Study|Adverse Event|1|||
25101731|NCT02327169|50212685|FG005|Overall Study|Adverse Event|0|||
25101732|NCT02327169|50212686|FG006|Overall Study|Adverse Event|0|||
25101733|NCT02327169|50212687|FG007|Overall Study|Adverse Event|0|||
25101734|NCT02327169|50212688|FG008|Overall Study|Adverse Event|0|||
25101735|NCT02327169|50212689|FG009|Overall Study|Adverse Event|2|||
25101736|NCT02327169|50212690|FG010|Overall Study|Adverse Event|0|||
25101737|NCT02327169|50212691|FG011|Overall Study|Adverse Event|3|||
25101738|NCT02327169|50212692|FG012|Overall Study|Adverse Event|0|||
25101739|NCT02327169|50212693|FG013|Overall Study|Adverse Event|2|||
25101740|NCT02327169|50212694|FG014|Overall Study|Adverse Event|1|||
25101741|NCT02327169|50212680|FG000|Overall Study|Symptomatic Deterioration|0|||
25101742|NCT02327169|50212681|FG001|Overall Study|Symptomatic Deterioration|0|||
25101743|NCT02327169|50212682|FG002|Overall Study|Symptomatic Deterioration|1|||
25101744|NCT02327169|50212683|FG003|Overall Study|Symptomatic Deterioration|0|||
25101745|NCT02327169|50212684|FG004|Overall Study|Symptomatic Deterioration|1|||
25101746|NCT02327169|50212685|FG005|Overall Study|Symptomatic Deterioration|1|||
25101747|NCT02327169|50212686|FG006|Overall Study|Symptomatic Deterioration|0|||
25101748|NCT02327169|50212687|FG007|Overall Study|Symptomatic Deterioration|0|||
25101749|NCT02327169|50212688|FG008|Overall Study|Symptomatic Deterioration|2|||
25101750|NCT02327169|50212689|FG009|Overall Study|Symptomatic Deterioration|1|||
25101751|NCT02327169|50212690|FG010|Overall Study|Symptomatic Deterioration|0|||
25101752|NCT02327169|50212691|FG011|Overall Study|Symptomatic Deterioration|0|||
25101753|NCT02327169|50212692|FG012|Overall Study|Symptomatic Deterioration|0|||
25101754|NCT02327169|50212693|FG013|Overall Study|Symptomatic Deterioration|2|||
25101755|NCT02327169|50212694|FG014|Overall Study|Symptomatic Deterioration|1|||
25101756|NCT02327169|50212680|FG000|Overall Study|Reason Not Specified|0|||
25101757|NCT02327169|50212681|FG001|Overall Study|Reason Not Specified|0|||
25101758|NCT02327169|50212682|FG002|Overall Study|Reason Not Specified|1|||
25101759|NCT02327169|50212683|FG003|Overall Study|Reason Not Specified|0|||
25101760|NCT02327169|50212684|FG004|Overall Study|Reason Not Specified|0|||
25101761|NCT02327169|50212685|FG005|Overall Study|Reason Not Specified|0|||
25101762|NCT02327169|50212686|FG006|Overall Study|Reason Not Specified|0|||
25101763|NCT02327169|50212687|FG007|Overall Study|Reason Not Specified|0|||
25101764|NCT02327169|50212688|FG008|Overall Study|Reason Not Specified|0|||
25101765|NCT02327169|50212689|FG009|Overall Study|Reason Not Specified|1|||
25101766|NCT02327169|50212690|FG010|Overall Study|Reason Not Specified|2|||
25101767|NCT02327169|50212691|FG011|Overall Study|Reason Not Specified|1|||
25101768|NCT02327169|50212692|FG012|Overall Study|Reason Not Specified|0|||
25101769|NCT02327169|50212693|FG013|Overall Study|Reason Not Specified|0|||
25101770|NCT02327169|50212694|FG014|Overall Study|Reason Not Specified|2|||
25101771|NCT02327169|50212680|FG000|Overall Study|Withdrawal by Subject|1|||
25101772|NCT02327169|50212681|FG001|Overall Study|Withdrawal by Subject|0|||
25101773|NCT02327169|50212682|FG002|Overall Study|Withdrawal by Subject|0|||
25101774|NCT02327169|50212683|FG003|Overall Study|Withdrawal by Subject|0|||
25101775|NCT02327169|50212684|FG004|Overall Study|Withdrawal by Subject|1|||
25101776|NCT02327169|50212685|FG005|Overall Study|Withdrawal by Subject|0|||
25101777|NCT02327169|50212686|FG006|Overall Study|Withdrawal by Subject|0|||
25101778|NCT02327169|50212687|FG007|Overall Study|Withdrawal by Subject|1|||
25101779|NCT02327169|50212688|FG008|Overall Study|Withdrawal by Subject|0|||
25101780|NCT02327169|50212689|FG009|Overall Study|Withdrawal by Subject|0|||
25101781|NCT02327169|50212690|FG010|Overall Study|Withdrawal by Subject|0|||
25101782|NCT02327169|50212691|FG011|Overall Study|Withdrawal by Subject|0|||
25101783|NCT02327169|50212692|FG012|Overall Study|Withdrawal by Subject|0|||
25101784|NCT02327169|50212693|FG013|Overall Study|Withdrawal by Subject|0|||
25101785|NCT02327169|50212694|FG014|Overall Study|Withdrawal by Subject|3|||
25101786|NCT02327169|50212680|FG000|Overall Study|Lost to Follow-up|0|||
25101787|NCT02327169|50212681|FG001|Overall Study|Lost to Follow-up|0|||
25101788|NCT02327169|50212682|FG002|Overall Study|Lost to Follow-up|0|||
25101789|NCT02327169|50212683|FG003|Overall Study|Lost to Follow-up|0|||
25101790|NCT02327169|50212684|FG004|Overall Study|Lost to Follow-up|1|||
25101791|NCT02327169|50212685|FG005|Overall Study|Lost to Follow-up|0|||
25101792|NCT02327169|50212686|FG006|Overall Study|Lost to Follow-up|0|||
25101793|NCT02327169|50212687|FG007|Overall Study|Lost to Follow-up|0|||
25101794|NCT02327169|50212688|FG008|Overall Study|Lost to Follow-up|0|||
25101795|NCT02327169|50212689|FG009|Overall Study|Lost to Follow-up|0|||
25101796|NCT02327169|50212690|FG010|Overall Study|Lost to Follow-up|0|||
25101797|NCT02327169|50212691|FG011|Overall Study|Lost to Follow-up|0|||
25101798|NCT02327169|50212692|FG012|Overall Study|Lost to Follow-up|0|||
25101799|NCT02327169|50212693|FG013|Overall Study|Lost to Follow-up|0|||
25101800|NCT02327169|50212694|FG014|Overall Study|Lost to Follow-up|0|||
25101801|NCT02327013|50212739|FG000|Overall Study|Adverse Event|4|||
25101802|NCT02327013|50212740|FG001|Overall Study|Adverse Event|4|||
25101803|NCT02327013|50212741|FG002|Overall Study|Adverse Event|3|||
25101804|NCT02327013|50212742|FG003|Overall Study|Adverse Event|0|||
25101805|NCT02327013|50212743|FG004|Overall Study|Adverse Event|1|||
25101806|NCT02327013|50212739|FG000|Overall Study|Lack of Efficacy|2|||
25101807|NCT02327013|50212740|FG001|Overall Study|Lack of Efficacy|0|||
25101808|NCT02327013|50212741|FG002|Overall Study|Lack of Efficacy|5|||
25101809|NCT02327013|50212742|FG003|Overall Study|Lack of Efficacy|0|||
25101810|NCT02327013|50212743|FG004|Overall Study|Lack of Efficacy|1|||
25101811|NCT02327013|50212739|FG000|Overall Study|Non-compliance with IMP|1|||
25101812|NCT02327013|50212740|FG001|Overall Study|Non-compliance with IMP|2|||
25101813|NCT02327013|50212741|FG002|Overall Study|Non-compliance with IMP|7|||
25101814|NCT02327013|50212742|FG003|Overall Study|Non-compliance with IMP|0|||
25101815|NCT02327013|50212743|FG004|Overall Study|Non-compliance with IMP|0|||
25101816|NCT02327013|50212739|FG000|Overall Study|Withdrawal of Consent|1|||
25101817|NCT02327013|50212740|FG001|Overall Study|Withdrawal of Consent|0|||
25101818|NCT02327013|50212741|FG002|Overall Study|Withdrawal of Consent|3|||
25101819|NCT02327013|50212742|FG003|Overall Study|Withdrawal of Consent|0|||
25101820|NCT02327013|50212743|FG004|Overall Study|Withdrawal of Consent|0|||
25101821|NCT02327013|50212739|FG000|Overall Study|Lost to Follow-up|2|||
25101822|NCT02327013|50212740|FG001|Overall Study|Lost to Follow-up|4|||
25101823|NCT02327013|50212741|FG002|Overall Study|Lost to Follow-up|5|||
25101824|NCT02327013|50212742|FG003|Overall Study|Lost to Follow-up|0|||
25101825|NCT02327013|50212743|FG004|Overall Study|Lost to Follow-up|0|||
25101826|NCT02327013|50212739|FG000|Overall Study|Administrative or other reason(s)|1|||
25101827|NCT02327013|50212740|FG001|Overall Study|Administrative or other reason(s)|5|||
25101828|NCT02327013|50212741|FG002|Overall Study|Administrative or other reason(s)|11|||
25101829|NCT02327013|50212742|FG003|Overall Study|Administrative or other reason(s)|1|||
25101830|NCT02327013|50212743|FG004|Overall Study|Administrative or other reason(s)|1|||
25101831|NCT02327013|50212739|FG000|Overall Study|Protocol Violation|0|||
25101832|NCT02327013|50212740|FG001|Overall Study|Protocol Violation|0|||
25101833|NCT02327013|50212741|FG002|Overall Study|Protocol Violation|3|||
25101834|NCT02327013|50212742|FG003|Overall Study|Protocol Violation|0|||
25101835|NCT02327013|50212743|FG004|Overall Study|Protocol Violation|1|||
25101836|NCT02327013|50212739|FG000|Overall Study|Withdrawal before treatment|2|||
25101837|NCT02327013|50212740|FG001|Overall Study|Withdrawal before treatment|1|||
25101838|NCT02327013|50212741|FG002|Overall Study|Withdrawal before treatment|5|||
25101839|NCT02327013|50212742|FG003|Overall Study|Withdrawal before treatment|0|||
25101840|NCT02327013|50212743|FG004|Overall Study|Withdrawal before treatment|0|||
25101841|NCT02301975|50212766|FG000|Overall Study|Adverse Event|8|||
25101842|NCT02301975|50212767|FG001|Overall Study|Adverse Event|3|||
25101843|NCT02301975|50212768|FG002|Overall Study|Adverse Event|2|||
25101844|NCT02301975|50212766|FG000|Overall Study|Lack of Efficacy|1|||
25101845|NCT02301975|50212767|FG001|Overall Study|Lack of Efficacy|1|||
25101846|NCT02301975|50212768|FG002|Overall Study|Lack of Efficacy|1|||
25101847|NCT02301975|50212766|FG000|Overall Study|Protocol Violation|3|||
25101848|NCT02301975|50212767|FG001|Overall Study|Protocol Violation|5|||
25101849|NCT02301975|50212768|FG002|Overall Study|Protocol Violation|3|||
25101850|NCT02301975|50212766|FG000|Overall Study|Lost to Follow-up|0|||
25101851|NCT02301975|50212767|FG001|Overall Study|Lost to Follow-up|2|||
25101852|NCT02301975|50212768|FG002|Overall Study|Lost to Follow-up|2|||
25101853|NCT02301975|50212766|FG000|Overall Study|Physician Decision|4|||
25101854|NCT02301975|50212767|FG001|Overall Study|Physician Decision|2|||
25101855|NCT02301975|50212768|FG002|Overall Study|Physician Decision|3|||
25101856|NCT02301975|50212766|FG000|Overall Study|Withdrawal by Subject|15|||
25101857|NCT02301975|50212767|FG001|Overall Study|Withdrawal by Subject|12|||
25101858|NCT02301975|50212768|FG002|Overall Study|Withdrawal by Subject|11|||
25101859|NCT02301897|50212779|FG000|Treatment Course 1|Non-Compliance|0|||
25101860|NCT02301897|50212780|FG001|Treatment Course 1|Non-Compliance|0|||
25101861|NCT02301897|50212781|FG002|Treatment Course 1|Non-Compliance|1|||
25101862|NCT02301897|50212779|FG000|Treatment Course 1|Adverse Event|1|||
25101863|NCT02301897|50212780|FG001|Treatment Course 1|Adverse Event|1|||
25101864|NCT02301897|50212781|FG002|Treatment Course 1|Adverse Event|0|||
25101865|NCT02301897|50212779|FG000|Treatment Course 1|Lost to Follow-up|1|||
25101866|NCT02301897|50212780|FG001|Treatment Course 1|Lost to Follow-up|2|||
25101867|NCT02301897|50212781|FG002|Treatment Course 1|Lost to Follow-up|1|||
25101868|NCT02301897|50212779|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
25101869|NCT02301897|50212780|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
25101870|NCT02301897|50212781|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
25101871|NCT02301897|50212779|FG000|Treatment Course 1|Withdrawal by Subject|0|||
25101872|NCT02301897|50212780|FG001|Treatment Course 1|Withdrawal by Subject|0|||
25101873|NCT02301897|50212781|FG002|Treatment Course 1|Withdrawal by Subject|2|||
25101874|NCT02301897|50212779|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
25101875|NCT02301897|50212780|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
25101876|NCT02301897|50212781|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
25101877|NCT02301897|50212779|FG000|Treatment Course 2|Lost to Follow-up|0|||
25101878|NCT02301897|50212780|FG001|Treatment Course 2|Lost to Follow-up|2|||
25101879|NCT02301897|50212781|FG002|Treatment Course 2|Lost to Follow-up|0|||
25101880|NCT02301897|50212779|FG000|Treatment Course 2|Pregnancy|0|||
25101881|NCT02301897|50212780|FG001|Treatment Course 2|Pregnancy|1|||
25101882|NCT02301897|50212781|FG002|Treatment Course 2|Pregnancy|1|||
25101883|NCT02301897|50212779|FG000|Treatment Course 2|Withdrawal by Subject|0|||
25101884|NCT02301897|50212780|FG001|Treatment Course 2|Withdrawal by Subject|2|||
25101885|NCT02301897|50212781|FG002|Treatment Course 2|Withdrawal by Subject|0|||
25101886|NCT02301897|50212779|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
25101887|NCT02301897|50212780|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
25101888|NCT02301897|50212781|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
25101889|NCT02301429|50212789|FG000|Overall Study|not acceptable vascular anatomy|3|||
25101890|NCT02300259|50212796|FG000|Period 1|Adverse Event|0|||
25101891|NCT02300259|50212797|FG001|Period 1|Adverse Event|0|||
25101892|NCT02300259|50212798|FG002|Period 1|Adverse Event|1|||
25101893|NCT02300259|50212796|FG000|Period 1|Withdrawal by Subject|0|||
25101894|NCT02300259|50212797|FG001|Period 1|Withdrawal by Subject|0|||
25101895|NCT02300259|50212798|FG002|Period 1|Withdrawal by Subject|1|||
25101896|NCT02300259|50212796|FG000|Period 2|Adverse Event|1|||
25101897|NCT02300259|50212797|FG001|Period 2|Adverse Event|0|||
25101898|NCT02300259|50212798|FG002|Period 2|Adverse Event|0|||
25101899|NCT02300259|50212796|FG000|Period 2|Withdrawal by Subject|0|||
25101900|NCT02300259|50212797|FG001|Period 2|Withdrawal by Subject|0|||
25101901|NCT02300259|50212798|FG002|Period 2|Withdrawal by Subject|1|||
25101902|NCT02367885|50212820|FG000|Overall Study|Lost to Follow-up|1|||
25101903|NCT02367885|50212821|FG001|Overall Study|Lost to Follow-up|0|||
25101904|NCT02367885|50212822|FG002|Overall Study|Lost to Follow-up|0|||
25101905|NCT02367885|50212820|FG000|Overall Study|Withdrawal by Subject|1|||
25101906|NCT02367885|50212821|FG001|Overall Study|Withdrawal by Subject|0|||
25101907|NCT02367885|50212822|FG002|Overall Study|Withdrawal by Subject|0|||
25101908|NCT02367729|50212835|FG000|Overall Study|Organic disorder diagnosed|2|||
25101909|NCT02367729|50212836|FG001|Overall Study|Organic disorder diagnosed|1|||
25101910|NCT02367729|50212835|FG000|Overall Study|Adverse Event|1|||
25101911|NCT02367729|50212836|FG001|Overall Study|Adverse Event|2|||
25101912|NCT02367729|50212835|FG000|Overall Study|Withdrawal by Subject|0|||
25101913|NCT02367729|50212836|FG001|Overall Study|Withdrawal by Subject|5|||
25101914|NCT02366637|50212843|FG000|First Intervention Period|Adverse Event|0|||
25101915|NCT02366637|50212844|FG001|First Intervention Period|Adverse Event|1|||
25101916|NCT02366637|50212843|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
25101917|NCT02366637|50212844|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
25101918|NCT02366637|50212843|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
25101919|NCT02366637|50212844|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
25101920|NCT02300103|50212850|FG000|Overall Study|Lack of Efficacy|3|||
25101921|NCT02300103|50212850|FG000|Overall Study|Protocol Violation|1|||
25101922|NCT02300103|50212850|FG000|Overall Study|Withdrew Consent|2|||
25101923|NCT02326467|50212854|FG000|Overall Study|Withdrawal by Subject|1|||
25101924|NCT02299635|50212859|FG000|Overall Study|Adverse Event|2|||
25101925|NCT02299635|50212859|FG000|Overall Study|Death|1|||
25101926|NCT02299635|50212859|FG000|Overall Study|Global deterioration of health status|1|||
25101927|NCT02299635|50212859|FG000|Overall Study|Objective progression or relapse|10|||
25101928|NCT02299635|50212859|FG000|Overall Study|Withdrawal by Subject|2|||
25101929|NCT02299635|50212859|FG000|Overall Study|Other|3|||
25101930|NCT02366091|50212867|FG000|Overall Study|Withdrawal by Subject|3|||
25101931|NCT02366091|50212868|FG001|Overall Study|Withdrawal by Subject|7|||
25101932|NCT02366091|50212869|FG002|Overall Study|Withdrawal by Subject|3|||
25101933|NCT02366091|50212870|FG003|Overall Study|Withdrawal by Subject|1|||
25101934|NCT02326155|50212882|FG000|Overall Study|Adverse Event|21|||
25101935|NCT02326155|50212883|FG001|Overall Study|Adverse Event|5|||
25101936|NCT02326155|50212882|FG000|Overall Study|Death|3|||
25101937|NCT02326155|50212883|FG001|Overall Study|Death|0|||
25101938|NCT02326155|50212882|FG000|Overall Study|Lack of Efficacy|49|||
25101939|NCT02326155|50212883|FG001|Overall Study|Lack of Efficacy|5|||
25101940|NCT02326155|50212882|FG000|Overall Study|Lost to Follow-up|14|||
25101941|NCT02326155|50212883|FG001|Overall Study|Lost to Follow-up|3|||
25101942|NCT02326155|50212882|FG000|Overall Study|Protocol Violation|2|||
25101943|NCT02326155|50212883|FG001|Overall Study|Protocol Violation|0|||
25101944|NCT02326155|50212882|FG000|Overall Study|Withdrawal by Subject|34|||
25101945|NCT02326155|50212883|FG001|Overall Study|Withdrawal by Subject|11|||
25101946|NCT02326155|50212882|FG000|Overall Study|Disease progression|37|||
25101947|NCT02326155|50212883|FG001|Overall Study|Disease progression|4|||
25101948|NCT02326155|50212882|FG000|Overall Study|Study close|188|||
25101949|NCT02326155|50212883|FG001|Overall Study|Study close|21|||
25101950|NCT02326155|50212882|FG000|Overall Study|except for study close|46|||
25101951|NCT02326155|50212883|FG001|Overall Study|except for study close|13|||
25101952|NCT02299167|50212889|FG000|Overall Study|patients were excluded from the study|11|||
25101953|NCT01647711|50212898|FG000|Overall Study|Progressive disease|6|||
25101954|NCT01647711|50212899|FG001|Overall Study|Progressive disease|2|||
25101955|NCT01647711|50212900|FG002|Overall Study|Progressive disease|6|||
25101956|NCT01647711|50212901|FG003|Overall Study|Progressive disease|8|||
25101957|NCT01647711|50212902|FG004|Overall Study|Progressive disease|2|||
25101958|NCT01647711|50212898|FG000|Overall Study|Other adverse event|0|||
25101959|NCT01647711|50212899|FG001|Overall Study|Other adverse event|0|||
25101960|NCT01647711|50212900|FG002|Overall Study|Other adverse event|2|||
25101961|NCT01647711|50212901|FG003|Overall Study|Other adverse event|0|||
25101962|NCT01647711|50212902|FG004|Overall Study|Other adverse event|2|||
25101963|NCT01647711|50212898|FG000|Overall Study|Protocol Violation|0|||
25101964|NCT01647711|50212899|FG001|Overall Study|Protocol Violation|0|||
25101965|NCT01647711|50212900|FG002|Overall Study|Protocol Violation|0|||
25101966|NCT01647711|50212901|FG003|Overall Study|Protocol Violation|0|||
25101967|NCT01647711|50212902|FG004|Overall Study|Protocol Violation|1|||
25101968|NCT01647711|50212898|FG000|Overall Study|Refused to continue taking medication|0|||
25101969|NCT01647711|50212899|FG001|Overall Study|Refused to continue taking medication|0|||
25101970|NCT01647711|50212900|FG002|Overall Study|Refused to continue taking medication|0|||
25101971|NCT01647711|50212901|FG003|Overall Study|Refused to continue taking medication|2|||
25101972|NCT01647711|50212902|FG004|Overall Study|Refused to continue taking medication|1|||
25101973|NCT01647711|50212898|FG000|Overall Study|Other reason not defined|0|||
25101974|NCT01647711|50212899|FG001|Overall Study|Other reason not defined|1|||
25101975|NCT01647711|50212900|FG002|Overall Study|Other reason not defined|1|||
25101976|NCT01647711|50212901|FG003|Overall Study|Other reason not defined|1|||
25101977|NCT01647711|50212902|FG004|Overall Study|Other reason not defined|0|||
25101978|NCT02540993|50212918|FG000|Overall Study|Lost to Follow-up|5|||
25101979|NCT02540993|50212919|FG001|Overall Study|Lost to Follow-up|3|||
25101980|NCT02540993|50212918|FG000|Overall Study|Withdrawal by Subject|4|||
25101981|NCT02540993|50212919|FG001|Overall Study|Withdrawal by Subject|6|||
25101982|NCT02540993|50212918|FG000|Overall Study|GCP violations|33|||
25101983|NCT02540993|50212919|FG001|Overall Study|GCP violations|27|||
25101984|NCT02547233|50212927|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
25101985|NCT02547233|50212928|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
25101986|NCT02547233|50212927|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
25101987|NCT02547233|50212928|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
25101988|NCT02547233|50212927|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
25101989|NCT02547233|50212928|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
25101990|NCT02547233|50212927|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
25101991|NCT02547233|50212928|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
25101992|NCT02547233|50212927|FG000|12-month Follow-up|Withdrawal by Subject|10|||
25101993|NCT02547233|50212928|FG001|12-month Follow-up|Withdrawal by Subject|10|||
25101994|NCT02547233|50212927|FG000|12-month Follow-up|Lost to Follow-up|3|||
25101995|NCT02547233|50212928|FG001|12-month Follow-up|Lost to Follow-up|3|||
25101996|NCT02547233|50212927|FG000|12-month Follow-up|Lack of Efficacy|1|||
25101997|NCT02547233|50212928|FG001|12-month Follow-up|Lack of Efficacy|2|||
25101998|NCT02547233|50212927|FG000|12-month Follow-up|Protocol Violation|0|||
25101999|NCT02547233|50212928|FG001|12-month Follow-up|Protocol Violation|1|||
25102000|NCT02547233|50212927|FG000|12-month Follow-up|Other|0|||
25102001|NCT02547233|50212928|FG001|12-month Follow-up|Other|1|||
25102002|NCT02546765|50212940|FG000|Overall Study|Withdrawal by Subject|0|||
25102003|NCT02546765|50212941|FG001|Overall Study|Withdrawal by Subject|1|||
25102004|NCT02546765|50212942|FG002|Overall Study|Withdrawal by Subject|0|||
25102005|NCT02546765|50212943|FG003|Overall Study|Withdrawal by Subject|0|||
25102006|NCT02553629|50212966|FG000|Overall Study|Logistic reasons|3|||
25102007|NCT02553629|50212967|FG001|Overall Study|Logistic reasons|6|||
25102008|NCT02546609|50212976|FG000|Overall Study|Withdrawal by Subject|0|||
25102009|NCT02546609|50212977|FG001|Overall Study|Withdrawal by Subject|1|||
25102010|NCT02546609|50212978|FG002|Overall Study|Withdrawal by Subject|2|||
25102011|NCT02546609|50212976|FG000|Overall Study|Adverse Event|0|||
25102012|NCT02546609|50212977|FG001|Overall Study|Adverse Event|6|||
25102013|NCT02546609|50212978|FG002|Overall Study|Adverse Event|1|||
25102014|NCT02546609|50212976|FG000|Overall Study|Protocol Violation|0|||
25102015|NCT02546609|50212977|FG001|Overall Study|Protocol Violation|1|||
25102016|NCT02546609|50212978|FG002|Overall Study|Protocol Violation|1|||
25102017|NCT02546609|50212976|FG000|Overall Study|Lost to Follow-up|2|||
25102018|NCT02546609|50212977|FG001|Overall Study|Lost to Follow-up|3|||
25102019|NCT02546609|50212978|FG002|Overall Study|Lost to Follow-up|1|||
25102020|NCT02546609|50212976|FG000|Overall Study|travel or work schedule restriction|0|||
25102021|NCT02546609|50212977|FG001|Overall Study|travel or work schedule restriction|0|||
25102022|NCT02546609|50212978|FG002|Overall Study|travel or work schedule restriction|2|||
25102023|NCT02553317|50212988|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
25102024|NCT02553317|50212989|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
25102025|NCT02553317|50212988|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
25102026|NCT02553317|50212989|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
25102027|NCT02553317|50212988|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
25102028|NCT02553317|50212989|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
25102029|NCT02553317|50212988|FG000|Overall Treatment Period + Follow-up|Death|1|||
25102030|NCT02553317|50212989|FG001|Overall Treatment Period + Follow-up|Death|3|||
25102031|NCT02553317|50212988|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
25102032|NCT02553317|50212989|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
25102033|NCT02553317|50212988|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
25102034|NCT02553317|50212989|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
25102035|NCT02553317|50212988|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
25102036|NCT02553317|50212989|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
25102037|NCT02553317|50212988|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
25102038|NCT02553317|50212989|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
25102039|NCT02553317|50212988|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
25102040|NCT02553317|50212989|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
25102041|NCT02553317|50212988|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
25102042|NCT02553317|50212989|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
25102043|NCT02325219|50212999|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
25102044|NCT02325219|50213000|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
25102045|NCT02325219|50213001|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
25102046|NCT02325219|50213002|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
25102047|NCT02325219|50213003|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
25102048|NCT02325219|50212999|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
25102049|NCT02325219|50213000|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
25102050|NCT02325219|50213001|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
25102051|NCT02325219|50213002|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
25102052|NCT02325219|50213003|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
25102053|NCT02325219|50212999|FG000|Controlled Period (Week 0 - 16)|Other|0|||
25102054|NCT02325219|50213000|FG001|Controlled Period (Week 0 - 16)|Other|0|||
25102055|NCT02325219|50213001|FG002|Controlled Period (Week 0 - 16)|Other|1|||
25102056|NCT02325219|50213002|FG003|Controlled Period (Week 0 - 16)|Other|0|||
25102057|NCT02325219|50213003|FG004|Controlled Period (Week 0 - 16)|Other|0|||
25102058|NCT02325219|50212999|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
25102059|NCT02325219|50213000|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
25102060|NCT02325219|50213001|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
25102061|NCT02325219|50213002|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
25102062|NCT02325219|50213003|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
25102063|NCT02325219|50212999|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
25102064|NCT02325219|50213000|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
25102065|NCT02325219|50213001|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
25102066|NCT02325219|50213002|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
25102067|NCT02325219|50213003|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
25102068|NCT02325219|50212999|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
25102069|NCT02325219|50213000|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
25102070|NCT02325219|50213001|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
25102071|NCT02325219|50213002|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
25102072|NCT02325219|50213003|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
25102073|NCT02297841|50213019|FG000|Overall Study|Withdrawal by Subject|1|||
25102074|NCT02297841|50213019|FG000|Overall Study|Protocol Violation|7|||
25102075|NCT02365467|50213023|FG000|Overall Study|Death|3|||
25102076|NCT02324361|50213029|FG000|Overall Study|Lost to Follow-up|5|||
25102077|NCT02324361|50213030|FG001|Overall Study|Lost to Follow-up|2|||
25102078|NCT02365233|50213039|FG000|Overall Study|IRB withheld the data|1|||
25102079|NCT02365233|50213040|FG001|Overall Study|IRB withheld the data|2|||
25102080|NCT02365233|50213041|FG002|Overall Study|IRB withheld the data|2|||
25102081|NCT02324205|50213049|FG000|Overall Study|Withdrawal by Subject|37|||
25102082|NCT02324049|50213053|FG000|Part C|Study terminated|11|||
25102083|NCT02364999|50213059|FG000|Overall Study|Death|136|||
25102084|NCT02364999|50213060|FG001|Overall Study|Death|138|||
25102085|NCT02364999|50213059|FG000|Overall Study|Lost to Follow-up|10|||
25102086|NCT02364999|50213060|FG001|Overall Study|Lost to Follow-up|15|||
25102087|NCT02364999|50213059|FG000|Overall Study|Protocol Violation|3|||
25102088|NCT02364999|50213060|FG001|Overall Study|Protocol Violation|2|||
25102089|NCT02364999|50213059|FG000|Overall Study|Withdrawal by Subject|14|||
25102090|NCT02364999|50213060|FG001|Overall Study|Withdrawal by Subject|14|||
25102091|NCT02364999|50213059|FG000|Overall Study|Other|0|||
25102092|NCT02364999|50213060|FG001|Overall Study|Other|1|||
25102093|NCT02364999|50213059|FG000|Overall Study|Randomized but did not receive treatment|2|||
25102094|NCT02364999|50213060|FG001|Overall Study|Randomized but did not receive treatment|3|||
25102095|NCT02322879|50213069|FG000|First Intervention|Physician Decision|1|||
25102096|NCT02322879|50213070|FG001|First Intervention|Physician Decision|0|||
25102097|NCT02322411|50213078|FG000|Overall Study|Lost to Follow-up|4|||
25102098|NCT02322411|50213079|FG001|Overall Study|Lost to Follow-up|7|||
25102099|NCT02322411|50213078|FG000|Overall Study|Withdrawal by Subject|1|||
25102100|NCT02322411|50213079|FG001|Overall Study|Withdrawal by Subject|0|||
25102101|NCT02322021|50213089|FG000|Core Phase|Adverse Event|1|||
25102102|NCT02322021|50213090|FG001|Core Phase|Adverse Event|3|||
25102103|NCT02322021|50213091|FG002|Core Phase|Adverse Event|4|||
25102104|NCT02322021|50213092|FG003|Core Phase|Adverse Event|2|||
25102105|NCT02322021|50213093|FG004|Core Phase|Adverse Event|0|||
25102106|NCT02322021|50213089|FG000|Core Phase|Participant Choice|4|||
25102107|NCT02322021|50213090|FG001|Core Phase|Participant Choice|5|||
25102108|NCT02322021|50213091|FG002|Core Phase|Participant Choice|4|||
25102109|NCT02322021|50213092|FG003|Core Phase|Participant Choice|2|||
25102110|NCT02322021|50213093|FG004|Core Phase|Participant Choice|0|||
25102111|NCT02322021|50213089|FG000|Core Phase|Lost to Follow-up|0|||
25102112|NCT02322021|50213090|FG001|Core Phase|Lost to Follow-up|0|||
25102113|NCT02322021|50213091|FG002|Core Phase|Lost to Follow-up|0|||
25102114|NCT02322021|50213092|FG003|Core Phase|Lost to Follow-up|1|||
25102115|NCT02322021|50213093|FG004|Core Phase|Lost to Follow-up|0|||
25102116|NCT02322021|50213089|FG000|Core Phase|Other|0|||
25102117|NCT02322021|50213090|FG001|Core Phase|Other|0|||
25102118|NCT02322021|50213091|FG002|Core Phase|Other|1|||
25102119|NCT02322021|50213092|FG003|Core Phase|Other|0|||
25102120|NCT02322021|50213093|FG004|Core Phase|Other|0|||
25102121|NCT02322021|50213089|FG000|Extension Phase|Adverse Event|0|||
25102122|NCT02322021|50213090|FG001|Extension Phase|Adverse Event|0|||
25177127|NCT02660580|50321240|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
25008143|NCT02431702|50100909|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
25008144|NCT02431702|50100910|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
25008145|NCT02431702|50100904|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
25008146|NCT02431702|50100905|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
25008147|NCT02431702|50100906|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
25008148|NCT02431702|50100907|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
25008149|NCT02431702|50100908|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
25008150|NCT02431702|50100909|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
25008151|NCT02431702|50100910|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
25008152|NCT02431702|50100904|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
25008153|NCT02431702|50100905|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
25008154|NCT02431702|50100906|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
25008155|NCT02431702|50100907|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
25008156|NCT02431702|50100908|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
25008157|NCT02431702|50100909|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
25008158|NCT02431702|50100910|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
25008159|NCT02431702|50100904|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
25008160|NCT02431702|50100905|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
25008161|NCT02431702|50100906|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
25008162|NCT02431702|50100907|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
25008163|NCT02431702|50100908|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
25008164|NCT02431702|50100909|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
25008165|NCT02431702|50100910|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
25008166|NCT02431702|50100904|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
25008167|NCT02431702|50100905|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
25008168|NCT02431702|50100906|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
25008169|NCT02431702|50100907|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
25008170|NCT02431702|50100908|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
25102123|NCT02322021|50213091|FG002|Extension Phase|Adverse Event|0|||
25102124|NCT02322021|50213092|FG003|Extension Phase|Adverse Event|0|||
25102125|NCT02322021|50213093|FG004|Extension Phase|Adverse Event|3|||
25102126|NCT02322021|50213089|FG000|Extension Phase|Participant Choice|0|||
25102127|NCT02322021|50213090|FG001|Extension Phase|Participant Choice|0|||
25102128|NCT02322021|50213091|FG002|Extension Phase|Participant Choice|0|||
25102129|NCT02322021|50213092|FG003|Extension Phase|Participant Choice|0|||
25102130|NCT02322021|50213093|FG004|Extension Phase|Participant Choice|6|||
25102131|NCT02322021|50213089|FG000|Extension Phase|Other|0|||
25102132|NCT02322021|50213090|FG001|Extension Phase|Other|0|||
25008171|NCT02431702|50100909|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
25008172|NCT02431702|50100910|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
25008173|NCT02431702|50100904|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
25008174|NCT02431702|50100905|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
25008175|NCT02431702|50100906|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
25008176|NCT02431702|50100907|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
25008177|NCT02431702|50100908|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
25008178|NCT02431702|50100909|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
25008179|NCT02431702|50100910|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
25008180|NCT02431702|50100904|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
25008181|NCT02431702|50100905|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
25008182|NCT02431702|50100906|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
25008183|NCT02431702|50100907|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
25008184|NCT02431702|50100908|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
25008185|NCT02431702|50100909|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
25008186|NCT02431702|50100910|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
25008187|NCT02431702|50100904|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
25008188|NCT02431702|50100905|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
25008189|NCT02431702|50100906|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
25008190|NCT02431702|50100907|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
25008191|NCT02431702|50100908|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
25008192|NCT02431702|50100909|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
25008193|NCT02431702|50100910|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
25008194|NCT02431702|50100904|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
25008195|NCT02431702|50100905|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
25008196|NCT02431702|50100906|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
25008197|NCT02431702|50100907|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
25008198|NCT02431702|50100908|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
25008199|NCT02431702|50100909|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
25008200|NCT02431702|50100910|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
25008201|NCT02431702|50100904|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
25008202|NCT02431702|50100905|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
25008203|NCT02431702|50100906|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
25008204|NCT02431702|50100907|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
25008205|NCT02431702|50100908|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
25008206|NCT02431702|50100909|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
25008207|NCT02431702|50100910|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
25008208|NCT02431702|50100904|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
25008209|NCT02431702|50100905|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
25008210|NCT02431702|50100906|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
25008211|NCT02431702|50100907|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
25008212|NCT02431702|50100908|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
25008213|NCT02431702|50100909|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
25008214|NCT02431702|50100910|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
25008215|NCT02086552|50100943|FG000|Overall Study|Withdrawal by Subject|1|||
25008216|NCT03131570|50100988|FG000|Overall Study|Adverse Event|1|||
25008217|NCT03131570|50100989|FG001|Overall Study|Adverse Event|0|||
25008218|NCT02930018|50100999|FG000|Overall Study|Lost to Follow-up|1|||
25008219|NCT02930018|50101000|FG001|Overall Study|Lost to Follow-up|1|||
25008220|NCT02930018|50100999|FG000|Overall Study|Withdrawal by Subject|5|||
25008221|NCT02930018|50101000|FG001|Overall Study|Withdrawal by Subject|2|||
25008222|NCT02875028|50101008|FG000|Washout Period|Withdrawal by Subject|0|||
25008223|NCT02875028|50101009|FG001|Washout Period|Withdrawal by Subject|1|||
25008224|NCT00943618|50101020|FG000|Overall Study|Lost to Follow-up|38|||
25102133|NCT02322021|50213091|FG002|Extension Phase|Other|0|||
25102134|NCT02322021|50213092|FG003|Extension Phase|Other|0|||
25102135|NCT02322021|50213093|FG004|Extension Phase|Other|3|||
25102136|NCT02322021|50213089|FG000|Extension Phase|Lost to Follow-up|0|||
25102137|NCT02322021|50213090|FG001|Extension Phase|Lost to Follow-up|0|||
25102138|NCT02322021|50213091|FG002|Extension Phase|Lost to Follow-up|0|||
25102139|NCT02322021|50213092|FG003|Extension Phase|Lost to Follow-up|0|||
25102140|NCT02322021|50213093|FG004|Extension Phase|Lost to Follow-up|1|||
25102141|NCT02322021|50213089|FG000|Extension Phase|Study terminated by sponsor|0|||
25177128|NCT02660580|50321236|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
25177129|NCT02660580|50321237|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
25102142|NCT02322021|50213090|FG001|Extension Phase|Study terminated by sponsor|0|||
25102143|NCT02322021|50213091|FG002|Extension Phase|Study terminated by sponsor|0|||
25102144|NCT02322021|50213092|FG003|Extension Phase|Study terminated by sponsor|0|||
25008225|NCT00943618|50101021|FG001|Overall Study|Lost to Follow-up|48|||
25261134|NCT01273155|50575824|FG004|Overall Study|Change in liver function/no longer eval.|1|||
25261135|NCT01273155|50575825|FG005|Overall Study|Change in liver function/no longer eval.|0|||
25261136|NCT01273155|50575826|FG006|Overall Study|Change in liver function/no longer eval.|0|||
25261137|NCT01273155|50575820|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
25261138|NCT01273155|50575821|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
25261139|NCT01273155|50575822|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
25261140|NCT01273155|50575823|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
25261141|NCT01273155|50575824|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
25261142|NCT01273155|50575825|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
25261143|NCT01273155|50575826|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
25261144|NCT01273155|50575820|FG000|Overall Study|Died during Cycle 1|0|||
25261145|NCT01273155|50575821|FG001|Overall Study|Died during Cycle 1|0|||
25261146|NCT01273155|50575822|FG002|Overall Study|Died during Cycle 1|1|||
25261147|NCT01273155|50575823|FG003|Overall Study|Died during Cycle 1|1|||
25261148|NCT01273155|50575824|FG004|Overall Study|Died during Cycle 1|0|||
25261149|NCT01273155|50575825|FG005|Overall Study|Died during Cycle 1|2|||
25261150|NCT01273155|50575826|FG006|Overall Study|Died during Cycle 1|2|||
25261151|NCT01273155|50575820|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
25261152|NCT01273155|50575821|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
25261153|NCT01273155|50575822|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
25261154|NCT01273155|50575823|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
25261155|NCT01273155|50575824|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
25261156|NCT01273155|50575825|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
25261157|NCT01273155|50575826|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
25261158|NCT01005901|50575851|FG000|Overall Study|Withdrawal by Subject|38|||
25261159|NCT01005901|50575852|FG001|Overall Study|Withdrawal by Subject|14|||
25261160|NCT01005901|50575851|FG000|Overall Study|Adverse Event|30|||
25261161|NCT01005901|50575852|FG001|Overall Study|Adverse Event|16|||
25261162|NCT01005901|50575851|FG000|Overall Study|Administrative problems|21|||
25261163|NCT01005901|50575852|FG001|Overall Study|Administrative problems|13|||
25261164|NCT01005901|50575851|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
25261165|NCT01005901|50575852|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
25261166|NCT01005901|50575851|FG000|Overall Study|Protocol Violation|4|||
25261167|NCT01005901|50575852|FG001|Overall Study|Protocol Violation|3|||
25261168|NCT01005901|50575851|FG000|Overall Study|Death|2|||
25261169|NCT01005901|50575852|FG001|Overall Study|Death|3|||
25261170|NCT01005901|50575851|FG000|Overall Study|Lost to Follow-up|1|||
25261171|NCT01005901|50575852|FG001|Overall Study|Lost to Follow-up|2|||
25261172|NCT01005901|50575851|FG000|Overall Study|Patient's inability to use the device|1|||
25261173|NCT01005901|50575852|FG001|Overall Study|Patient's inability to use the device|1|||
25261174|NCT01005901|50575851|FG000|Overall Study|No longer requires study drug|0|||
25261175|NCT01005901|50575852|FG001|Overall Study|No longer requires study drug|1|||
25261176|NCT04968925|50575860|FG000|Phase I- Period 1|COVID-19 related|0|||
25261177|NCT04968925|50575861|FG001|Phase I- Period 1|COVID-19 related|1|||
25261178|NCT04968925|50575862|FG002|Phase I- Period 1|COVID-19 related|0|||
25261179|NCT04968925|50575863|FG003|Phase I- Period 1|COVID-19 related|0|||
25261180|NCT04968925|50575860|FG000|Phase I- Period 1|Subject enrolled in error|1|||
25261181|NCT04968925|50575861|FG001|Phase I- Period 1|Subject enrolled in error|1|||
25008226|NCT00943618|50101022|FG002|Overall Study|Lost to Follow-up|20|||
25261182|NCT04968925|50575862|FG002|Phase I- Period 1|Subject enrolled in error|0|||
25261183|NCT04968925|50575863|FG003|Phase I- Period 1|Subject enrolled in error|0|||
25261184|NCT04968925|50575860|FG000|Phase II- Period 1|COVID-19 Related|0|||
25261185|NCT04968925|50575861|FG001|Phase II- Period 1|COVID-19 Related|0|||
25261186|NCT04968925|50575862|FG002|Phase II- Period 1|COVID-19 Related|6|||
25261187|NCT04968925|50575863|FG003|Phase II- Period 1|COVID-19 Related|6|||
25261188|NCT04968925|50575860|FG000|Phase II- Period 1|Subject enrolled in error|0|||
25261189|NCT04968925|50575861|FG001|Phase II- Period 1|Subject enrolled in error|0|||
25008227|NCT00943618|50101020|FG000|Overall Study|Discontinued Medication|17|||
25008228|NCT00943618|50101021|FG001|Overall Study|Discontinued Medication|29|||
25177130|NCT02660580|50321238|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
25177131|NCT02660580|50321239|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
25177132|NCT02660580|50321240|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
25177133|NCT02660580|50321236|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
25177134|NCT02660580|50321237|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
25177135|NCT02660580|50321238|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
25177136|NCT02660580|50321239|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
25177137|NCT02660580|50321240|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
25177138|NCT02660580|50321236|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
25177139|NCT02660580|50321237|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
25177140|NCT02660580|50321238|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
25008229|NCT00943618|50101022|FG002|Overall Study|Discontinued Medication|11|||
25008230|NCT02710084|50101045|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
25008231|NCT02710084|50101046|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
25008232|NCT02849990|50101053|FG000|Overall Study|Adverse Event|1|||
25008233|NCT02849990|50101053|FG000|Overall Study|Withdrawal by Subject|1|||
25008234|NCT02017964|50101057|FG000|Overall Study|Patient deemed ineligible|1|||
25008235|NCT01956110|50101063|FG000|Overall Study|Protocol Violation|25|||
25008236|NCT01956110|50101064|FG001|Overall Study|Protocol Violation|11|||
25008237|NCT01956110|50101063|FG000|Overall Study|Adverse Event|9|||
25008238|NCT01956110|50101064|FG001|Overall Study|Adverse Event|10|||
25008239|NCT01956110|50101063|FG000|Overall Study|Personal reasons|1|||
25008240|NCT01956110|50101064|FG001|Overall Study|Personal reasons|1|||
25008241|NCT03116828|50101095|FG000|Overall Study|Adverse Event|1|||
25008242|NCT03116828|50101096|FG001|Overall Study|Adverse Event|10|||
25102145|NCT02322021|50213093|FG004|Extension Phase|Study terminated by sponsor|28|||
25102146|NCT02363439|50213108|FG000|Overall Study|Lack of Efficacy|4|||
25102147|NCT02363283|50213112|FG000|Overall Study|Withdrawal by Subject|1|||
25102148|NCT02363283|50213112|FG000|Overall Study|Not eligible due to transaminitis|1|||
25102149|NCT02321319|50213116|FG000|Overall Study|Product discontinued|5|||
25102150|NCT02294175|50213122|FG000|Overall Study|Withdrawal by Subject|1|||
25102151|NCT02294175|50213123|FG001|Overall Study|Withdrawal by Subject|2|||
25102152|NCT02294175|50213122|FG000|Overall Study|pt taking excluded medication|3|||
25102153|NCT02294175|50213123|FG001|Overall Study|pt taking excluded medication|1|||
25102154|NCT02294175|50213122|FG000|Overall Study|Protocol Violation|1|||
25102155|NCT02294175|50213123|FG001|Overall Study|Protocol Violation|0|||
25102156|NCT02294175|50213122|FG000|Overall Study|Lost to Follow-up|0|||
25102157|NCT02294175|50213123|FG001|Overall Study|Lost to Follow-up|1|||
25102158|NCT02294175|50213122|FG000|Overall Study|wound healed|0|||
25102159|NCT02294175|50213123|FG001|Overall Study|wound healed|2|||
25102160|NCT02088541|50213134|FG000|Overall Study|Adverse Event|3|||
25102161|NCT02088541|50213135|FG001|Overall Study|Adverse Event|0|||
25102162|NCT02088541|50213136|FG002|Overall Study|Adverse Event|3|||
25102163|NCT02088541|50213137|FG003|Overall Study|Adverse Event|3|||
25102164|NCT02088541|50213138|FG004|Overall Study|Adverse Event|0|||
25102165|NCT02088541|50213134|FG000|Overall Study|Death|51|||
25102166|NCT02088541|50213135|FG001|Overall Study|Death|21|||
25102167|NCT02088541|50213136|FG002|Overall Study|Death|85|||
25102168|NCT02088541|50213137|FG003|Overall Study|Death|28|||
25102169|NCT02088541|50213138|FG004|Overall Study|Death|38|||
25102170|NCT02088541|50213134|FG000|Overall Study|Lost to Follow-up|2|||
25102171|NCT02088541|50213135|FG001|Overall Study|Lost to Follow-up|0|||
25102172|NCT02088541|50213136|FG002|Overall Study|Lost to Follow-up|1|||
25102173|NCT02088541|50213137|FG003|Overall Study|Lost to Follow-up|0|||
25102174|NCT02088541|50213138|FG004|Overall Study|Lost to Follow-up|0|||
25102175|NCT02088541|50213134|FG000|Overall Study|Physician Decision|2|||
25102176|NCT02088541|50213135|FG001|Overall Study|Physician Decision|1|||
25102177|NCT02088541|50213136|FG002|Overall Study|Physician Decision|2|||
25102178|NCT02088541|50213137|FG003|Overall Study|Physician Decision|0|||
25102179|NCT02088541|50213138|FG004|Overall Study|Physician Decision|2|||
25102180|NCT02088541|50213134|FG000|Overall Study|Disease progression|7|||
25102181|NCT02088541|50213135|FG001|Overall Study|Disease progression|1|||
25102182|NCT02088541|50213136|FG002|Overall Study|Disease progression|2|||
25102183|NCT02088541|50213137|FG003|Overall Study|Disease progression|3|||
25102184|NCT02088541|50213138|FG004|Overall Study|Disease progression|1|||
25102185|NCT02088541|50213134|FG000|Overall Study|Study terminated by sponsor|1|||
25102186|NCT02088541|50213135|FG001|Overall Study|Study terminated by sponsor|1|||
25102187|NCT02088541|50213136|FG002|Overall Study|Study terminated by sponsor|12|||
25102188|NCT02088541|50213137|FG003|Overall Study|Study terminated by sponsor|2|||
25102189|NCT02088541|50213138|FG004|Overall Study|Study terminated by sponsor|6|||
25102190|NCT02088541|50213134|FG000|Overall Study|Withdrawal by Subject|3|||
25102191|NCT02088541|50213135|FG001|Overall Study|Withdrawal by Subject|2|||
25102192|NCT02088541|50213136|FG002|Overall Study|Withdrawal by Subject|9|||
25102193|NCT02088541|50213137|FG003|Overall Study|Withdrawal by Subject|7|||
25102194|NCT02088541|50213138|FG004|Overall Study|Withdrawal by Subject|10|||
25102195|NCT02088541|50213134|FG000|Overall Study|Other|2|||
25102196|NCT02088541|50213135|FG001|Overall Study|Other|1|||
25102197|NCT02088541|50213136|FG002|Overall Study|Other|3|||
25102198|NCT02088541|50213137|FG003|Overall Study|Other|1|||
25102199|NCT02088541|50213138|FG004|Overall Study|Other|1|||
25102200|NCT02294019|50213148|FG000|Overall Study|Adverse Event|2|||
25008243|NCT03116828|50101095|FG000|Overall Study|Withdrawal by Subject|4|||
25008244|NCT03116828|50101096|FG001|Overall Study|Withdrawal by Subject|8|||
25008245|NCT03116828|50101095|FG000|Overall Study|OTHER|3|||
25008246|NCT03116828|50101096|FG001|Overall Study|OTHER|3|||
25102201|NCT02294019|50213148|FG000|Overall Study|Protocol Violation|68|||
25102202|NCT02294019|50213148|FG000|Overall Study|Lost to Follow-up|31|||
25102203|NCT02294019|50213148|FG000|Overall Study|Other|1|||
25102204|NCT02294019|50213148|FG000|Overall Study|Withdrawal by Subject|1|||
25102205|NCT02320149|50213154|FG000|Overall Study|Adverse Event|3|||
25102206|NCT02320149|50213155|FG001|Overall Study|Adverse Event|7|||
25102207|NCT02320149|50213154|FG000|Overall Study|Withdrawal of Consent|28|||
25102208|NCT02320149|50213155|FG001|Overall Study|Withdrawal of Consent|32|||
25102209|NCT02320149|50213154|FG000|Overall Study|Lost to Follow-up|21|||
25102210|NCT02320149|50213155|FG001|Overall Study|Lost to Follow-up|34|||
25102211|NCT02320149|50213154|FG000|Overall Study|Protocol Violation|2|||
25102212|NCT02320149|50213155|FG001|Overall Study|Protocol Violation|1|||
25102213|NCT02320149|50213154|FG000|Overall Study|Noncompliance with Study Treatment|7|||
25102214|NCT02320149|50213155|FG001|Overall Study|Noncompliance with Study Treatment|2|||
25102215|NCT02320149|50213154|FG000|Overall Study|Lack of Efficacy|0|||
25102216|NCT02320149|50213155|FG001|Overall Study|Lack of Efficacy|1|||
25102217|NCT02320149|50213154|FG000|Overall Study|Other Miscellaneous Reasons|2|||
25102218|NCT02320149|50213155|FG001|Overall Study|Other Miscellaneous Reasons|3|||
25102219|NCT02540083|50213161|FG000|Overall Study|Withdrawal by Subject|16|||
25102220|NCT02293863|50213168|FG000|Overall Study|Death|4|||
25102221|NCT02293863|50213169|FG001|Overall Study|Death|6|||
25102222|NCT02293863|50213170|FG002|Overall Study|Death|4|||
25102223|NCT02293863|50213168|FG000|Overall Study|Lost to Follow-up|2|||
25102224|NCT02293863|50213169|FG001|Overall Study|Lost to Follow-up|2|||
25102225|NCT02293863|50213170|FG002|Overall Study|Lost to Follow-up|2|||
25102226|NCT02293863|50213168|FG000|Overall Study|Withdrawal by Subject|3|||
25102227|NCT02293863|50213169|FG001|Overall Study|Withdrawal by Subject|3|||
25102228|NCT02293863|50213170|FG002|Overall Study|Withdrawal by Subject|1|||
25102229|NCT02293863|50213168|FG000|Overall Study|Reason Not Specified|0|||
25102230|NCT02293863|50213169|FG001|Overall Study|Reason Not Specified|2|||
25102231|NCT02293863|50213170|FG002|Overall Study|Reason Not Specified|2|||
25102232|NCT02293395|50213182|FG000|Overall Study|Lost to Follow-up|1|||
25102233|NCT02293395|50213183|FG001|Overall Study|Lost to Follow-up|0|||
25102234|NCT02293395|50213182|FG000|Overall Study|Withdrawal by Subject|8|||
25102235|NCT02293395|50213183|FG001|Overall Study|Withdrawal by Subject|7|||
25102236|NCT02025985|50213194|FG000|Overall Study|Consent withdrawn|0|||
25102237|NCT02025985|50213195|FG001|Overall Study|Consent withdrawn|0|||
25102238|NCT02025985|50213196|FG002|Overall Study|Consent withdrawn|1|||
25102239|NCT02025985|50213197|FG003|Overall Study|Consent withdrawn|0|||
25102240|NCT02025985|50213198|FG004|Overall Study|Consent withdrawn|0|||
25102241|NCT02025985|50213194|FG000|Overall Study|Termination of study by Sponsor|4|||
25102242|NCT02025985|50213195|FG001|Overall Study|Termination of study by Sponsor|3|||
25102243|NCT02025985|50213196|FG002|Overall Study|Termination of study by Sponsor|1|||
25102244|NCT02025985|50213197|FG003|Overall Study|Termination of study by Sponsor|1|||
25102245|NCT02025985|50213198|FG004|Overall Study|Termination of study by Sponsor|3|||
25102246|NCT02025985|50213194|FG000|Overall Study|Death|21|||
25102247|NCT02025985|50213195|FG001|Overall Study|Death|20|||
25102248|NCT02025985|50213196|FG002|Overall Study|Death|23|||
25102249|NCT02025985|50213197|FG003|Overall Study|Death|20|||
25102250|NCT02025985|50213198|FG004|Overall Study|Death|17|||
25102251|NCT02528305|50213212|FG000|Overall Study|Withdrawal by Subject|1|||
25102252|NCT02528305|50213212|FG000|Overall Study|Adverse Event|1|||
25102253|NCT02528305|50213212|FG000|Overall Study|Physician Decision|1|||
25102254|NCT02532517|50213218|FG000|Overall Study|Did not complete 24-Month visit|4|||
25102255|NCT02532517|50213218|FG000|Overall Study|Failed Angiographic eligibility|1|||
25102256|NCT02532517|50213218|FG000|Overall Study|Lost to Follow-up|4|||
25102257|NCT02532517|50213218|FG000|Overall Study|Withdrawal by Subject|4|||
25102258|NCT02532517|50213218|FG000|Overall Study|Death|4|||
25102259|NCT02545049|50213224|FG000|Overall Study|Withdrawal by Subject|1|||
25102260|NCT02545049|50213225|FG001|Overall Study|Withdrawal by Subject|7|||
25102261|NCT02545049|50213224|FG000|Overall Study|Lost to Follow-up|4|||
25102262|NCT02545049|50213225|FG001|Overall Study|Lost to Follow-up|6|||
25102263|NCT02545049|50213224|FG000|Overall Study|GCP violations|37|||
25102264|NCT02545049|50213225|FG001|Overall Study|GCP violations|48|||
25102265|NCT02532283|50213233|FG000|Overall Study|Adverse Event|0|||
25102266|NCT02532283|50213234|FG001|Overall Study|Adverse Event|1|||
25177141|NCT02660580|50321239|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
25102267|NCT02532283|50213233|FG000|Overall Study|Death|1|||
25102268|NCT02532283|50213234|FG001|Overall Study|Death|0|||
25102269|NCT02532283|50213233|FG000|Overall Study|Lost to Follow-up|0|||
25102270|NCT02532283|50213234|FG001|Overall Study|Lost to Follow-up|1|||
25102271|NCT02532283|50213233|FG000|Overall Study|Withdrawal by Subject|8|||
25102272|NCT02532283|50213234|FG001|Overall Study|Withdrawal by Subject|3|||
25102273|NCT01349959|50213255|FG000|Overall Study|Adverse Event|7|||
25102274|NCT01295125|50213259|FG000|Overall Study|Study stopped prematurely|9|||
25177142|NCT02660580|50321240|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
25102275|NCT02540291|50213267|FG000|Overall Study|Death|7|||
25102276|NCT02540291|50213268|FG001|Overall Study|Death|7|||
25102277|NCT02540291|50213269|FG002|Overall Study|Death|5|||
25102278|NCT02540291|50213270|FG003|Overall Study|Death|7|||
25102279|NCT02540291|50213267|FG000|Overall Study|Lost to Follow-up|0|||
25102280|NCT02540291|50213268|FG001|Overall Study|Lost to Follow-up|0|||
25102281|NCT02540291|50213269|FG002|Overall Study|Lost to Follow-up|1|||
25102282|NCT02540291|50213270|FG003|Overall Study|Lost to Follow-up|0|||
25102283|NCT02540291|50213267|FG000|Overall Study|Withdrawal Of Consent|0|||
25102284|NCT02540291|50213268|FG001|Overall Study|Withdrawal Of Consent|1|||
25102285|NCT02540291|50213269|FG002|Overall Study|Withdrawal Of Consent|0|||
25102286|NCT02540291|50213270|FG003|Overall Study|Withdrawal Of Consent|0|||
25102287|NCT02540291|50213267|FG000|Overall Study|Study Terminated By Sponsor|1|||
25102288|NCT02540291|50213268|FG001|Overall Study|Study Terminated By Sponsor|0|||
25102289|NCT02540291|50213269|FG002|Overall Study|Study Terminated By Sponsor|0|||
25102290|NCT02540291|50213270|FG003|Overall Study|Study Terminated By Sponsor|0|||
25102291|NCT02540291|50213267|FG000|Overall Study|Other|0|||
25102292|NCT02540291|50213268|FG001|Overall Study|Other|0|||
25102293|NCT02540291|50213269|FG002|Overall Study|Other|1|||
25102294|NCT02540291|50213270|FG003|Overall Study|Other|0|||
25102295|NCT02540213|50213282|FG000|Overall Study|Death/adverse event|18|||
25102296|NCT02540213|50213282|FG000|Overall Study|Administrative reasons|3|||
25102297|NCT02540213|50213282|FG000|Overall Study|Kidney transplant|3|||
25102298|NCT02540213|50213282|FG000|Overall Study|Lack of Efficacy|6|||
25102299|NCT02540213|50213282|FG000|Overall Study|Consent withdrawn|7|||
25102300|NCT02540213|50213282|FG000|Overall Study|Enrolled but not treated|2|||
25102301|NCT02544503|50213288|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
25102302|NCT02544503|50213289|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
25102303|NCT02544503|50213288|FG000|Overall Study|Lost to Follow-up|9|||
25102304|NCT02544503|50213289|FG001|Overall Study|Lost to Follow-up|0|||
25102305|NCT02544503|50213288|FG000|Overall Study|Withdrawal by Subject|1|||
25102306|NCT02544503|50213289|FG001|Overall Study|Withdrawal by Subject|0|||
25102307|NCT02552303|50213299|FG000|Allocation|Withdrawal by Subject|2|||
25102308|NCT02552303|50213300|FG001|Allocation|Withdrawal by Subject|1|||
25102309|NCT02552303|50213301|FG002|Allocation|Withdrawal by Subject|1|||
25102310|NCT02552303|50213302|FG003|Allocation|Withdrawal by Subject|1|||
25102311|NCT02552303|50213299|FG000|Allocation|ineligible|1|||
25102312|NCT02552303|50213300|FG001|Allocation|ineligible|1|||
25102313|NCT02552303|50213301|FG002|Allocation|ineligible|0|||
25102314|NCT02552303|50213302|FG003|Allocation|ineligible|0|||
25102315|NCT02552303|50213299|FG000|Follow-Up|Lost to Follow-up|0|||
25102316|NCT02552303|50213300|FG001|Follow-Up|Lost to Follow-up|0|||
25102317|NCT02552303|50213301|FG002|Follow-Up|Lost to Follow-up|1|||
25102318|NCT02552303|50213302|FG003|Follow-Up|Lost to Follow-up|0|||
25102319|NCT02552303|50213299|FG000|Follow-Up|ineligible|0|||
25102320|NCT02552303|50213300|FG001|Follow-Up|ineligible|2|||
25102321|NCT02552303|50213301|FG002|Follow-Up|ineligible|0|||
25102322|NCT02552303|50213302|FG003|Follow-Up|ineligible|0|||
25102323|NCT01660711|50213312|FG000|Overall Study|Adverse Event|7|||
25102324|NCT01660711|50213312|FG000|Overall Study|Withdrawal by Subject|1|||
25102325|NCT02544113|50213318|FG000|Overall Study|Death|3|||
25102326|NCT02544113|50213319|FG001|Overall Study|Death|4|||
25102327|NCT02538965|50213325|FG000|Treatment Period|Other = Death due to disease progression|1|||
25102328|NCT02538965|50213325|FG000|Treatment Period|Adverse Event|2|||
25102329|NCT02538965|50213325|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
25102330|NCT02538965|50213325|FG000|Treatment Period|Treatment Failure|9|||
25102331|NCT02538965|50213325|FG000|Treatment Period|Disease Progression|1|||
25102332|NCT02538965|50213325|FG000|Treatment Period|Physician Decision|2|||
25102333|NCT02538965|50213325|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
25102334|NCT02538965|50213325|FG000|Follow-Up Period|Withdrawal by Parent|4|||
25102335|NCT02543801|50213333|FG000|Overall Study|Protocol Violation|1|||
25102336|NCT02543801|50213334|FG001|Overall Study|Protocol Violation|2|||
25102337|NCT02543801|50213335|FG002|Overall Study|Protocol Violation|0|||
25102338|NCT02543801|50213336|FG003|Overall Study|Protocol Violation|0|||
25102339|NCT02470091|50213348|FG000|Overall Study|Withdrawal by Subject|1|||
25102340|NCT02470091|50213349|FG001|Overall Study|Withdrawal by Subject|0|||
25102341|NCT02470091|50213348|FG000|Overall Study|Ineligible|0|||
25102342|NCT02470091|50213349|FG001|Overall Study|Ineligible|2|||
25102343|NCT02362503|50213360|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
25102344|NCT02362503|50213361|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
25102345|NCT02362503|50213362|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
25102346|NCT02362503|50213360|FG000|Double-blind Period-Up to 8 Days|Death|1|||
25102347|NCT02362503|50213361|FG001|Double-blind Period-Up to 8 Days|Death|0|||
25102348|NCT02362503|50213362|FG002|Double-blind Period-Up to 8 Days|Death|0|||
25102349|NCT02362503|50213360|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
25102350|NCT02362503|50213361|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
25102351|NCT02362503|50213362|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
25102352|NCT02362503|50213360|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
25102353|NCT02362503|50213361|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
25102354|NCT02362503|50213362|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
25102355|NCT02362503|50213360|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
25102356|NCT02362503|50213361|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
25102357|NCT02362503|50213362|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
25102358|NCT02362503|50213360|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
25102359|NCT02362503|50213361|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
25102360|NCT02362503|50213362|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
25102361|NCT02362503|50213360|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
25102362|NCT02362503|50213361|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
25102363|NCT02362503|50213362|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
25102364|NCT02362503|50213360|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
25102365|NCT02362503|50213361|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
25102366|NCT02362503|50213362|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
25102367|NCT02362503|50213360|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
25102368|NCT02362503|50213361|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
25102369|NCT02362503|50213362|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
25102370|NCT02362503|50213360|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
25102371|NCT02362503|50213361|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
25102372|NCT02362503|50213362|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
25102373|NCT02362503|50213360|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
25102374|NCT02362503|50213361|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
25102375|NCT02362503|50213362|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
25102376|NCT02362503|50213360|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
25102377|NCT02362503|50213361|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
25102378|NCT02362503|50213362|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
25102379|NCT02362503|50213360|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
25102380|NCT02362503|50213361|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
25102381|NCT02362503|50213362|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
25102382|NCT02362503|50213360|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
25102383|NCT02362503|50213361|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
25102384|NCT02362503|50213362|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
25102385|NCT02535065|50213373|FG000|Overall Study|Death|13|||
25102386|NCT02535065|50213373|FG000|Overall Study|Lost to Follow-up|1|||
25102387|NCT02535065|50213373|FG000|Overall Study|Withdrawal by Subject|6|||
25102388|NCT02530619|50213377|FG000|Registered for Study|Withdrawal by Subject|2|||
25102389|NCT02530619|50213377|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
25102390|NCT02530619|50213377|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
25102391|NCT02530619|50213377|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
25102392|NCT02530619|50213377|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
25102393|NCT02530619|50213377|FG000|Follow-up Period (6 Months)|Death|4|||
25102394|NCT02530619|50213377|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
25102395|NCT02530619|50213377|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
25102396|NCT02530385|50213383|FG000|Overall Study|Withdrawal by Subject|0|||
25102397|NCT02530385|50213384|FG001|Overall Study|Withdrawal by Subject|1|||
25102398|NCT02362425|50213394|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
25102399|NCT02362425|50213395|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
25102400|NCT02362425|50213396|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
25102401|NCT02362425|50213397|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
25102402|NCT02362425|50213394|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
25102403|NCT02362425|50213395|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
25102404|NCT02362425|50213396|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
25102405|NCT02362425|50213397|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
25102406|NCT02362425|50213394|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
25102407|NCT02362425|50213395|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
25102408|NCT02362425|50213396|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
25102409|NCT02362425|50213397|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
25102410|NCT02362425|50213394|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
25102411|NCT02362425|50213395|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
25102412|NCT02362425|50213396|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
25102413|NCT02362425|50213397|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
25102414|NCT02362425|50213394|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
25102415|NCT02362425|50213395|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
25102416|NCT02362425|50213396|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
25102417|NCT02362425|50213397|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
25102418|NCT02362425|50213394|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
25102419|NCT02362425|50213395|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
25102420|NCT02362425|50213396|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
25102421|NCT02362425|50213397|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
25102422|NCT02362425|50213394|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
25102423|NCT02362425|50213395|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
25008247|NCT03938272|50101104|FG000|Overall Study|Withdrawal by Subject|1|||
25008248|NCT03938272|50101105|FG001|Overall Study|Withdrawal by Subject|0|||
25008249|NCT03938272|50101104|FG000|Overall Study|Physician Decision|0|||
25102424|NCT02362425|50213396|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
25102425|NCT02362425|50213397|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
25102426|NCT02362425|50213394|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
25102427|NCT02362425|50213395|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
25102428|NCT02362425|50213396|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
25102429|NCT02362425|50213397|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
25102430|NCT02362269|50213410|FG000|Overall Study|Moved|1|||
25102431|NCT02362269|50213411|FG001|Overall Study|Moved|0|||
25102432|NCT02362269|50213410|FG000|Overall Study|Lost to Follow-up|0|||
25102433|NCT02362269|50213411|FG001|Overall Study|Lost to Follow-up|6|||
25102434|NCT02529995|50213419|FG000|Part A|Ongoing Study at Data Cut-off|14|||
25102435|NCT02529995|50213420|FG001|Part A|Ongoing Study at Data Cut-off|16|||
25102436|NCT02529995|50213419|FG000|Part A|Discontinued Study|1|||
25102437|NCT02529995|50213420|FG001|Part A|Discontinued Study|0|||
25102438|NCT02529995|50213419|FG000|Part B|Ongoing Study at Data Cut-off|0|||
25102439|NCT02529995|50213420|FG001|Part B|Ongoing Study at Data Cut-off|7|||
25102440|NCT02529995|50213419|FG000|Part B|Discontinued Study|6|||
25102441|NCT02529995|50213420|FG001|Part B|Discontinued Study|5|||
25102442|NCT02529137|50213426|FG000|Overall Study|Discontinuation for different reasons|8|||
25102443|NCT02319759|50213433|FG000|Week 0 - 16|Lack of Efficacy|1|||
25102444|NCT02319759|50213434|FG001|Week 0 - 16|Lack of Efficacy|0|||
25102445|NCT02319759|50213435|FG002|Week 0 - 16|Lack of Efficacy|0|||
25102446|NCT02319759|50213436|FG003|Week 0 - 16|Lack of Efficacy|0|||
25102447|NCT02319759|50213437|FG004|Week 0 - 16|Lack of Efficacy|0|||
25102448|NCT02319759|50213433|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
25102449|NCT02319759|50213434|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
25102450|NCT02319759|50213435|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
25102451|NCT02319759|50213436|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
25102452|NCT02319759|50213437|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
25102453|NCT02319759|50213433|FG000|Week 16 - 24|Lack of Efficacy|1|||
25102454|NCT02319759|50213434|FG001|Week 16 - 24|Lack of Efficacy|0|||
25102455|NCT02319759|50213435|FG002|Week 16 - 24|Lack of Efficacy|1|||
25102456|NCT02319759|50213436|FG003|Week 16 - 24|Lack of Efficacy|0|||
25102457|NCT02319759|50213437|FG004|Week 16 - 24|Lack of Efficacy|0|||
25102458|NCT02319759|50213433|FG000|Week 16 - 24|Lost to Follow-up|1|||
25102459|NCT02319759|50213434|FG001|Week 16 - 24|Lost to Follow-up|0|||
25102460|NCT02319759|50213435|FG002|Week 16 - 24|Lost to Follow-up|0|||
25102461|NCT02319759|50213436|FG003|Week 16 - 24|Lost to Follow-up|0|||
25102462|NCT02319759|50213437|FG004|Week 16 - 24|Lost to Follow-up|0|||
25102463|NCT02319759|50213433|FG000|Week 16 - 24|Withdrawal by Subject|0|||
25102464|NCT02319759|50213434|FG001|Week 16 - 24|Withdrawal by Subject|0|||
25102465|NCT02319759|50213435|FG002|Week 16 - 24|Withdrawal by Subject|2|||
25102466|NCT02319759|50213436|FG003|Week 16 - 24|Withdrawal by Subject|0|||
25102467|NCT02319759|50213437|FG004|Week 16 - 24|Withdrawal by Subject|0|||
25102468|NCT02319759|50213433|FG000|Week 24 - 56|Adverse Event|0|||
25102469|NCT02319759|50213434|FG001|Week 24 - 56|Adverse Event|0|||
25102470|NCT02319759|50213435|FG002|Week 24 - 56|Adverse Event|2|||
25102471|NCT02319759|50213436|FG003|Week 24 - 56|Adverse Event|0|||
25102472|NCT02319759|50213437|FG004|Week 24 - 56|Adverse Event|0|||
25102473|NCT02319759|50213433|FG000|Week 24 - 56|Lack of Efficacy|0|||
25102474|NCT02319759|50213434|FG001|Week 24 - 56|Lack of Efficacy|0|||
25102475|NCT02319759|50213435|FG002|Week 24 - 56|Lack of Efficacy|0|||
25102476|NCT02319759|50213436|FG003|Week 24 - 56|Lack of Efficacy|2|||
25102477|NCT02319759|50213437|FG004|Week 24 - 56|Lack of Efficacy|1|||
25102478|NCT02319759|50213433|FG000|Week 24 - 56|Withdrawal by Subject|0|||
25102479|NCT02319759|50213434|FG001|Week 24 - 56|Withdrawal by Subject|1|||
25102480|NCT02319759|50213435|FG002|Week 24 - 56|Withdrawal by Subject|0|||
25102481|NCT02319759|50213436|FG003|Week 24 - 56|Withdrawal by Subject|0|||
25102482|NCT02319759|50213437|FG004|Week 24 - 56|Withdrawal by Subject|0|||
25102483|NCT02319759|50213433|FG000|Week 24 - 56|Lost to Follow-up|0|||
25102484|NCT02319759|50213434|FG001|Week 24 - 56|Lost to Follow-up|0|||
25102485|NCT02319759|50213435|FG002|Week 24 - 56|Lost to Follow-up|0|||
25102486|NCT02319759|50213436|FG003|Week 24 - 56|Lost to Follow-up|0|||
25102487|NCT02319759|50213437|FG004|Week 24 - 56|Lost to Follow-up|1|||
25102488|NCT02293005|50213450|FG000|Overall Study|Adverse Event|2|||
25102489|NCT02293005|50213450|FG000|Overall Study|Death|4|||
25102490|NCT02293005|50213450|FG000|Overall Study|Lost to Follow-up|1|||
25102491|NCT02293005|50213450|FG000|Overall Study|Withdrawal by Subject|2|||
25102492|NCT02293005|50213450|FG000|Overall Study|Progression|17|||
25102493|NCT02319525|50213456|FG000|Overall Study|Withdrawal by Subject|2|||
25102494|NCT02319525|50213457|FG001|Overall Study|Withdrawal by Subject|1|||
25102495|NCT02292927|50213465|FG000|Overall Study|Protocol Violation|13|||
25102496|NCT02292927|50213466|FG001|Overall Study|Protocol Violation|7|||
25102497|NCT02292849|50213478|FG000|Overall Study|Lost to Follow-up|0|||
25102498|NCT02292849|50213479|FG001|Overall Study|Lost to Follow-up|2|||
25102499|NCT02292849|50213480|FG002|Overall Study|Lost to Follow-up|2|||
25102500|NCT02292849|50213478|FG000|Overall Study|Physician Decision|4|||
25102501|NCT02292849|50213479|FG001|Overall Study|Physician Decision|0|||
25102502|NCT02292849|50213480|FG002|Overall Study|Physician Decision|0|||
25102503|NCT02318667|50213488|FG000|Overall Study|Adverse Event|1|||
25102504|NCT02318667|50213488|FG000|Overall Study|Lack of Efficacy|6|||
25102505|NCT02318667|50213488|FG000|Overall Study|Protocol Violation|2|||
25102506|NCT02292771|50213498|FG000|Overall Study|Withdrawal by Subject|2|||
25102507|NCT02292771|50213499|FG001|Overall Study|Withdrawal by Subject|1|||
25102508|NCT02292771|50213498|FG000|Overall Study|Lost to Follow-up|2|||
25102509|NCT02292771|50213499|FG001|Overall Study|Lost to Follow-up|1|||
25102510|NCT02291913|50213509|FG000|Overall Study|Progressive Disease|32|||
25102511|NCT02291913|50213509|FG000|Overall Study|Adverse Event|11|||
25102512|NCT02291913|50213509|FG000|Overall Study|Death|2|||
25102513|NCT02291913|50213509|FG000|Overall Study|Physician Decision|1|||
25102514|NCT02291913|50213509|FG000|Overall Study|Withdrawal by Subject|1|||
25102515|NCT02291913|50213509|FG000|Overall Study|Protocol Violation|1|||
25102516|NCT02291679|50213516|FG000|Overall Study|Adverse Event|2|||
25102517|NCT02291679|50213517|FG001|Overall Study|Adverse Event|12|||
25102518|NCT02291679|50213518|FG002|Overall Study|Adverse Event|19|||
25102519|NCT02291679|50213516|FG000|Overall Study|Protocol Violation|5|||
25102520|NCT02291679|50213517|FG001|Overall Study|Protocol Violation|1|||
25102521|NCT02291679|50213518|FG002|Overall Study|Protocol Violation|7|||
25102522|NCT02291679|50213516|FG000|Overall Study|Withdrew Consent|18|||
25102523|NCT02291679|50213517|FG001|Overall Study|Withdrew Consent|10|||
25102524|NCT02291679|50213518|FG002|Overall Study|Withdrew Consent|15|||
25102525|NCT02291679|50213516|FG000|Overall Study|Lost to Follow-up|12|||
25102526|NCT02291679|50213517|FG001|Overall Study|Lost to Follow-up|10|||
25102527|NCT02291679|50213518|FG002|Overall Study|Lost to Follow-up|9|||
25102528|NCT02291679|50213516|FG000|Overall Study|Insufficient Therapeutic Response|5|||
25102529|NCT02291679|50213517|FG001|Overall Study|Insufficient Therapeutic Response|5|||
25102530|NCT02291679|50213518|FG002|Overall Study|Insufficient Therapeutic Response|7|||
25102531|NCT02291679|50213516|FG000|Overall Study|Other|2|||
25102532|NCT02291679|50213517|FG001|Overall Study|Other|4|||
25102533|NCT02291679|50213518|FG002|Overall Study|Other|2|||
25102534|NCT02291601|50213525|FG000|Abdomen|Did not qualify|333|||
25102535|NCT02291601|50213526|FG001|Abdomen|Did not qualify|54|||
25102536|NCT02291601|50213527|FG002|Abdomen|Did not qualify|339|||
25102537|NCT02291601|50213525|FG000|Groin|Did not qualify|183|||
25102538|NCT02291601|50213526|FG001|Groin|Did not qualify|30|||
25102539|NCT02291601|50213527|FG002|Groin|Did not qualify|177|||
25102540|NCT02360475|50213542|FG000|Overall Study|Lost to Follow-up|4|||
25102541|NCT02360475|50213543|FG001|Overall Study|Lost to Follow-up|12|||
25102542|NCT02360475|50213544|FG002|Overall Study|Lost to Follow-up|6|||
25102543|NCT02360475|50213545|FG003|Overall Study|Lost to Follow-up|4|||
25102544|NCT02360475|50213542|FG000|Overall Study|Withdrawal by Subject|0|||
25102545|NCT02360475|50213543|FG001|Overall Study|Withdrawal by Subject|1|||
25102546|NCT02360475|50213544|FG002|Overall Study|Withdrawal by Subject|2|||
25102547|NCT02360475|50213545|FG003|Overall Study|Withdrawal by Subject|0|||
25102548|NCT02360475|50213542|FG000|Overall Study|Migrated/moved from study area|0|||
25102549|NCT02360475|50213543|FG001|Overall Study|Migrated/moved from study area|0|||
25102550|NCT02360475|50213544|FG002|Overall Study|Migrated/moved from study area|0|||
25102551|NCT02360475|50213545|FG003|Overall Study|Migrated/moved from study area|1|||
25102552|NCT02360397|50213555|FG000|Overall Study|Incomplete screening|3|||
25102553|NCT02360397|50213555|FG000|Overall Study|Adverse Event|1|||
25102554|NCT02317809|50213560|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
25102555|NCT02317809|50213561|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
25102556|NCT02317809|50213560|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
25102557|NCT02317809|50213561|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
25102558|NCT02359851|50213570|FG000|Overall Study|Death|1|||
25102559|NCT02359851|50213570|FG000|Overall Study|Disease progression|1|||
25102560|NCT01607905|50213581|FG000|Overall Study|Withdrawal by participant|7|||
25102561|NCT01607905|50213582|FG001|Overall Study|Withdrawal by participant|2|||
25102562|NCT01607905|50213583|FG002|Overall Study|Withdrawal by participant|4|||
25102563|NCT01607905|50213584|FG003|Overall Study|Withdrawal by participant|6|||
25102564|NCT01607905|50213585|FG004|Overall Study|Withdrawal by participant|0|||
25102565|NCT01607905|50213586|FG005|Overall Study|Withdrawal by participant|4|||
25102566|NCT01607905|50213587|FG006|Overall Study|Withdrawal by participant|12|||
25102567|NCT01607905|50213581|FG000|Overall Study|Incidence or severity of AEs|5|||
25102568|NCT01607905|50213582|FG001|Overall Study|Incidence or severity of AEs|1|||
25102569|NCT01607905|50213583|FG002|Overall Study|Incidence or severity of AEs|1|||
25102570|NCT01607905|50213584|FG003|Overall Study|Incidence or severity of AEs|3|||
25102571|NCT01607905|50213585|FG004|Overall Study|Incidence or severity of AEs|0|||
25102572|NCT01607905|50213586|FG005|Overall Study|Incidence or severity of AEs|2|||
25102573|NCT01607905|50213587|FG006|Overall Study|Incidence or severity of AEs|8|||
25102574|NCT01607905|50213581|FG000|Overall Study|Disease progression|44|||
25102575|NCT01607905|50213582|FG001|Overall Study|Disease progression|16|||
25102576|NCT01607905|50213583|FG002|Overall Study|Disease progression|15|||
25102577|NCT01607905|50213584|FG003|Overall Study|Disease progression|11|||
25102578|NCT01607905|50213585|FG004|Overall Study|Disease progression|6|||
25102579|NCT01607905|50213586|FG005|Overall Study|Disease progression|7|||
25102580|NCT01607905|50213587|FG006|Overall Study|Disease progression|21|||
25102581|NCT01607905|50213581|FG000|Overall Study|Non-compliance with study procedures|0|||
25102582|NCT01607905|50213582|FG001|Overall Study|Non-compliance with study procedures|0|||
25102583|NCT01607905|50213583|FG002|Overall Study|Non-compliance with study procedures|0|||
25102584|NCT01607905|50213584|FG003|Overall Study|Non-compliance with study procedures|0|||
25102585|NCT01607905|50213585|FG004|Overall Study|Non-compliance with study procedures|0|||
25102586|NCT01607905|50213586|FG005|Overall Study|Non-compliance with study procedures|0|||
25102587|NCT01607905|50213587|FG006|Overall Study|Non-compliance with study procedures|1|||
25102588|NCT01607905|50213581|FG000|Overall Study|Death|1|||
25102589|NCT01607905|50213582|FG001|Overall Study|Death|1|||
25102590|NCT01607905|50213583|FG002|Overall Study|Death|1|||
25102591|NCT01607905|50213584|FG003|Overall Study|Death|1|||
25102592|NCT01607905|50213585|FG004|Overall Study|Death|0|||
25102593|NCT01607905|50213586|FG005|Overall Study|Death|0|||
25102594|NCT01607905|50213587|FG006|Overall Study|Death|3|||
25102595|NCT01607905|50213581|FG000|Overall Study|Other treatments become available|1|||
25102596|NCT01607905|50213582|FG001|Overall Study|Other treatments become available|0|||
25102597|NCT01607905|50213583|FG002|Overall Study|Other treatments become available|0|||
25102598|NCT01607905|50213584|FG003|Overall Study|Other treatments become available|0|||
25102599|NCT01607905|50213585|FG004|Overall Study|Other treatments become available|0|||
25102600|NCT01607905|50213586|FG005|Overall Study|Other treatments become available|0|||
25102601|NCT01607905|50213587|FG006|Overall Study|Other treatments become available|1|||
25102602|NCT01607905|50213581|FG000|Overall Study|Investigator discretion|0|||
25102603|NCT01607905|50213582|FG001|Overall Study|Investigator discretion|0|||
25102604|NCT01607905|50213583|FG002|Overall Study|Investigator discretion|0|||
25102605|NCT01607905|50213584|FG003|Overall Study|Investigator discretion|0|||
25102606|NCT01607905|50213585|FG004|Overall Study|Investigator discretion|0|||
25102607|NCT01607905|50213586|FG005|Overall Study|Investigator discretion|1|||
25102608|NCT01607905|50213587|FG006|Overall Study|Investigator discretion|0|||
25102609|NCT01607905|50213581|FG000|Overall Study|Other|1|||
25102610|NCT01607905|50213582|FG001|Overall Study|Other|0|||
25102611|NCT01607905|50213583|FG002|Overall Study|Other|0|||
25102612|NCT01607905|50213584|FG003|Overall Study|Other|0|||
25102613|NCT01607905|50213585|FG004|Overall Study|Other|0|||
25102614|NCT01607905|50213586|FG005|Overall Study|Other|0|||
25102615|NCT01607905|50213587|FG006|Overall Study|Other|1|||
25102616|NCT01607905|50213581|FG000|Overall Study|Randomized but not treated|1|||
25102617|NCT01607905|50213582|FG001|Overall Study|Randomized but not treated|0|||
25102618|NCT01607905|50213583|FG002|Overall Study|Randomized but not treated|0|||
25102619|NCT01607905|50213584|FG003|Overall Study|Randomized but not treated|0|||
25102620|NCT01607905|50213585|FG004|Overall Study|Randomized but not treated|1|||
25102621|NCT01607905|50213586|FG005|Overall Study|Randomized but not treated|1|||
25102622|NCT01607905|50213587|FG006|Overall Study|Randomized but not treated|0|||
25102623|NCT02536963|50213645|FG000|Overall Study|Withdrawal by Subject|18|||
25102624|NCT00602641|50213651|FG000|Overall Study|Never started protocol therapy|6|||
25102625|NCT00602641|50213652|FG001|Overall Study|Never started protocol therapy|2|||
25102626|NCT00602641|50213651|FG000|Overall Study|Still on treatment at time of analysis|8|||
25102627|NCT00602641|50213652|FG001|Overall Study|Still on treatment at time of analysis|15|||
25102628|NCT00602641|50213651|FG000|Overall Study|Adverse Event|62|||
25102629|NCT00602641|50213652|FG001|Overall Study|Adverse Event|53|||
25102630|NCT00602641|50213651|FG000|Overall Study|Disease progression|38|||
25102631|NCT00602641|50213652|FG001|Overall Study|Disease progression|55|||
25102632|NCT00602641|50213651|FG000|Overall Study|Death|6|||
25102633|NCT00602641|50213652|FG001|Overall Study|Death|5|||
25102634|NCT00602641|50213651|FG000|Overall Study|Withdrawal by Subject|15|||
25102635|NCT00602641|50213652|FG001|Overall Study|Withdrawal by Subject|12|||
25102636|NCT00602641|50213651|FG000|Overall Study|Alternative therapy|5|||
25102637|NCT00602641|50213652|FG001|Overall Study|Alternative therapy|2|||
25102638|NCT00602641|50213651|FG000|Overall Study|Other Complicating Disease|5|||
25102639|NCT00602641|50213652|FG001|Overall Study|Other Complicating Disease|2|||
25102640|NCT00602641|50213651|FG000|Overall Study|Physician Decision|5|||
25102641|NCT00602641|50213652|FG001|Overall Study|Physician Decision|4|||
25102642|NCT00602641|50213651|FG000|Overall Study|Administrative Closure|1|||
25102643|NCT00602641|50213652|FG001|Overall Study|Administrative Closure|1|||
25102644|NCT00602641|50213651|FG000|Overall Study|Other|3|||
25102645|NCT00602641|50213652|FG001|Overall Study|Other|1|||
25102646|NCT02531035|50213660|FG000|Overall Study|Death|0|||
25102647|NCT02531035|50213661|FG001|Overall Study|Death|1|||
25102648|NCT02531035|50213660|FG000|Overall Study|Protocol Violation|1|||
25102649|NCT02531035|50213661|FG001|Overall Study|Protocol Violation|1|||
25102650|NCT02531035|50213660|FG000|Overall Study|Noncompliance with study drug|8|||
25102651|NCT02531035|50213661|FG001|Overall Study|Noncompliance with study drug|3|||
25102652|NCT02531035|50213660|FG000|Overall Study|Physician Decision|1|||
25102653|NCT02531035|50213661|FG001|Overall Study|Physician Decision|0|||
25102654|NCT02531035|50213660|FG000|Overall Study|Adverse Event|16|||
25102655|NCT02531035|50213661|FG001|Overall Study|Adverse Event|45|||
25102656|NCT02531035|50213660|FG000|Overall Study|Other|3|||
25102657|NCT02531035|50213661|FG001|Overall Study|Other|2|||
25102658|NCT02531035|50213660|FG000|Overall Study|Withdrawal by Subject|42|||
25102659|NCT02531035|50213661|FG001|Overall Study|Withdrawal by Subject|32|||
25102660|NCT02531035|50213660|FG000|Overall Study|Lost to Follow-up|8|||
25102661|NCT02531035|50213661|FG001|Overall Study|Lost to Follow-up|10|||
25102662|NCT02531035|50213660|FG000|Overall Study|Randomized, not treated|2|||
25102663|NCT02531035|50213661|FG001|Overall Study|Randomized, not treated|1|||
25102664|NCT01659853|50213677|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
25102665|NCT01659853|50213678|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
25102666|NCT01659853|50213677|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
25102667|NCT01659853|50213678|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
25102668|NCT01660243|50213690|FG000|Overall Study|Adverse Event|1|||
25102669|NCT01660243|50213691|FG001|Overall Study|Adverse Event|0|||
25102670|NCT01660243|50213692|FG002|Overall Study|Adverse Event|1|||
25102671|NCT01660243|50213693|FG003|Overall Study|Adverse Event|0|||
25102672|NCT01660243|50213690|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
25102673|NCT01660243|50213691|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
25102674|NCT01660243|50213692|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
25102675|NCT01660243|50213693|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
25102676|NCT01660243|50213690|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
25102677|NCT01660243|50213691|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
25102678|NCT01660243|50213692|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
25102679|NCT01660243|50213693|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
25102680|NCT01660243|50213690|FG000|Overall Study|Randomization error|0|||
25102681|NCT01660243|50213691|FG001|Overall Study|Randomization error|0|||
25102682|NCT01660243|50213692|FG002|Overall Study|Randomization error|0|||
25102683|NCT01660243|50213693|FG003|Overall Study|Randomization error|1|||
25102684|NCT02531113|50213703|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
25102685|NCT02531113|50213703|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
25102686|NCT02531113|50213703|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
25102687|NCT02531113|50213703|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
25102688|NCT02531113|50213703|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
25102689|NCT02531113|50213703|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
25102690|NCT02531113|50213703|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
25102691|NCT02531113|50213703|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
25102692|NCT02522767|50213713|FG000|Double-blind|Withdrawal by Subject|8|||
25102693|NCT02522767|50213714|FG001|Double-blind|Withdrawal by Subject|11|||
25102694|NCT02522767|50213713|FG000|Double-blind|Lost to Follow-up|1|||
25102695|NCT02522767|50213714|FG001|Double-blind|Lost to Follow-up|0|||
25102696|NCT02522767|50213713|FG000|Double-blind|Adverse Event|1|||
25102697|NCT02522767|50213714|FG001|Double-blind|Adverse Event|10|||
25102698|NCT02522767|50213713|FG000|Double-blind|Protocol Violation|0|||
25102699|NCT02522767|50213714|FG001|Double-blind|Protocol Violation|1|||
25102700|NCT02522767|50213713|FG000|Double-blind|Lack of Efficacy|0|||
25102701|NCT02522767|50213714|FG001|Double-blind|Lack of Efficacy|2|||
25102702|NCT02522767|50213713|FG000|Double-blind|Protocol Deviation|1|||
25102703|NCT02522767|50213714|FG001|Double-blind|Protocol Deviation|0|||
25102704|NCT02522767|50213713|FG000|Open-label|Withdrawal by Subject|2|||
25102705|NCT02522767|50213714|FG001|Open-label|Withdrawal by Subject|3|||
25102706|NCT02522767|50213713|FG000|Open-label|Lost to Follow-up|0|||
25102707|NCT02522767|50213714|FG001|Open-label|Lost to Follow-up|1|||
25102708|NCT02522767|50213713|FG000|Open-label|Adverse Event|2|||
25102709|NCT02522767|50213714|FG001|Open-label|Adverse Event|1|||
25102710|NCT02522767|50213713|FG000|Open-label|Lack of Efficacy|1|||
25102711|NCT02522767|50213714|FG001|Open-label|Lack of Efficacy|1|||
25102712|NCT02522767|50213713|FG000|Open-label|Protocol Violation|0|||
25102713|NCT02522767|50213714|FG001|Open-label|Protocol Violation|1|||
25102714|NCT02522377|50213724|FG000|Overall Study|Withdrawal by Subject|1|||
25102715|NCT02522377|50213725|FG001|Overall Study|Withdrawal by Subject|0|||
25102716|NCT02522377|50213724|FG000|Overall Study|Remission Achieved|3|||
25102717|NCT02522377|50213725|FG001|Overall Study|Remission Achieved|0|||
25102718|NCT01657903|50213731|FG000|Overall Study|Lost to Follow-up|1|||
25102719|NCT01657903|50213731|FG000|Overall Study|Withdrawal by Subject|1|||
25102720|NCT01656733|50213744|FG000|Overall Study|No permission to collect birth outcomes|0|||
25102721|NCT01656733|50213745|FG001|Overall Study|No permission to collect birth outcomes|1|||
25102722|NCT01656733|50213744|FG000|Overall Study|Delivery at another hospital|0|||
25102723|NCT01656733|50213745|FG001|Overall Study|Delivery at another hospital|2|||
25102724|NCT01656733|50213744|FG000|Overall Study|Spontaneous abortion|0|||
25102725|NCT01656733|50213745|FG001|Overall Study|Spontaneous abortion|1|||
25102726|NCT01656967|50213753|FG000|Overall Study|faulty monitor|1|||
25102727|NCT01656967|50213754|FG001|Overall Study|faulty monitor|0|||
25102728|NCT01656967|50213753|FG000|Overall Study|unsuccessful ETT insertion|3|||
25102729|NCT01656967|50213754|FG001|Overall Study|unsuccessful ETT insertion|2|||
25102730|NCT01656889|50213766|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
25102731|NCT01656889|50213767|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
25102732|NCT01656889|50213766|FG000|Treatment Period, 12 Weeks|Death|0|||
25102733|NCT01656889|50213767|FG001|Treatment Period, 12 Weeks|Death|1|||
25102734|NCT01656889|50213766|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
25102735|NCT01656889|50213767|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
25102736|NCT01656889|50213766|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
25102737|NCT01656889|50213767|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
25102738|NCT01656889|50213766|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
25102739|NCT01656889|50213767|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
25102740|NCT01656889|50213766|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
25102741|NCT01656889|50213767|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
25102742|NCT01656889|50213766|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
25102743|NCT01656889|50213767|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
25102744|NCT01656889|50213766|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
25102745|NCT01656889|50213767|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
25102746|NCT01656889|50213766|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
25102747|NCT01656889|50213767|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
25102748|NCT01656889|50213766|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
25102749|NCT01656889|50213767|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
25102750|NCT02522299|50213775|FG000|Overall Study|Adverse Event|2|||
25102751|NCT02522299|50213776|FG001|Overall Study|Adverse Event|0|||
25102752|NCT02522299|50213775|FG000|Overall Study|Physician Decision|0|||
25102753|NCT02522299|50213776|FG001|Overall Study|Physician Decision|1|||
25102754|NCT02522299|50213775|FG000|Overall Study|Withdrawal by Subject|2|||
25102755|NCT02522299|50213776|FG001|Overall Study|Withdrawal by Subject|0|||
25102756|NCT01365091|50213800|FG000|Period 1|Adverse Event|1|||
25102757|NCT01365091|50213801|FG001|Period 1|Adverse Event|0|||
25102758|NCT01365091|50213802|FG002|Period 1|Adverse Event|2|||
25102759|NCT01365091|50213803|FG003|Period 1|Adverse Event|3|||
25102760|NCT01365091|50213800|FG000|Period 1|Positive test result for drugs of abuse|1|||
25102761|NCT01365091|50213801|FG001|Period 1|Positive test result for drugs of abuse|0|||
25102762|NCT01365091|50213802|FG002|Period 1|Positive test result for drugs of abuse|0|||
25102763|NCT01365091|50213803|FG003|Period 1|Positive test result for drugs of abuse|0|||
25102764|NCT01365091|50213800|FG000|Period 1|No longer met study criteria|0|||
25102765|NCT01365091|50213801|FG001|Period 1|No longer met study criteria|1|||
25102766|NCT01365091|50213802|FG002|Period 1|No longer met study criteria|0|||
25102767|NCT01365091|50213803|FG003|Period 1|No longer met study criteria|0|||
25102768|NCT01365091|50213800|FG000|Period 1|Withdrawal by Subject|0|||
25102769|NCT01365091|50213801|FG001|Period 1|Withdrawal by Subject|1|||
25102770|NCT01365091|50213802|FG002|Period 1|Withdrawal by Subject|0|||
25102771|NCT01365091|50213803|FG003|Period 1|Withdrawal by Subject|0|||
25102772|NCT01365091|50213800|FG000|Period 1|Personal reasons|0|||
25102773|NCT01365091|50213801|FG001|Period 1|Personal reasons|0|||
25102774|NCT01365091|50213802|FG002|Period 1|Personal reasons|1|||
25102775|NCT01365091|50213803|FG003|Period 1|Personal reasons|0|||
25102776|NCT01365091|50213800|FG000|Period 2|Withdrawal by Subject|1|||
25102777|NCT01365091|50213801|FG001|Period 2|Withdrawal by Subject|0|||
25102778|NCT01365091|50213802|FG002|Period 2|Withdrawal by Subject|0|||
25102779|NCT01365091|50213803|FG003|Period 2|Withdrawal by Subject|0|||
25102780|NCT01365091|50213800|FG000|Period 2|Adverse Event|0|||
25102781|NCT01365091|50213801|FG001|Period 2|Adverse Event|0|||
25102782|NCT01365091|50213802|FG002|Period 2|Adverse Event|1|||
25102783|NCT01365091|50213803|FG003|Period 2|Adverse Event|0|||
25102784|NCT01364467|50213829|FG000|Overall Study|Lost to Follow-up|1|||
25102785|NCT01364467|50213830|FG001|Overall Study|Lost to Follow-up|2|||
25102786|NCT02520661|50213838|FG000|Overall Study|Lost to Follow-up|7|||
25102787|NCT02520661|50213839|FG001|Overall Study|Lost to Follow-up|3|||
25102788|NCT02520661|50213838|FG000|Overall Study|Admitted from ED|49|||
25102789|NCT02520661|50213839|FG001|Overall Study|Admitted from ED|48|||
25102790|NCT02520661|50213838|FG000|Overall Study|ED greater than 24 hours|29|||
25102791|NCT02520661|50213839|FG001|Overall Study|ED greater than 24 hours|38|||
25102792|NCT02520661|50213838|FG000|Overall Study|other ineligibility|14|||
25261190|NCT04968925|50575862|FG002|Phase II- Period 1|Subject enrolled in error|1|||
25261191|NCT04968925|50575863|FG003|Phase II- Period 1|Subject enrolled in error|0|||
25261192|NCT04968925|50575860|FG000|Phase II -Period 2|COVID-19 related|0|||
25261193|NCT04968925|50575861|FG001|Phase II -Period 2|COVID-19 related|0|||
25102793|NCT02520661|50213839|FG001|Overall Study|other ineligibility|22|||
25102794|NCT02520661|50213838|FG000|Overall Study|Withdrawal by Subject|7|||
25102795|NCT02520661|50213839|FG001|Overall Study|Withdrawal by Subject|16|||
25102796|NCT01364389|50213852|FG000|Overall Study|Withdrawal by Subject|0|||
25102797|NCT01364389|50213853|FG001|Overall Study|Withdrawal by Subject|1|||
25261194|NCT04968925|50575862|FG002|Phase II -Period 2|COVID-19 related|4|||
25261195|NCT04968925|50575863|FG003|Phase II -Period 2|COVID-19 related|3|||
25102798|NCT01364389|50213854|FG002|Overall Study|Withdrawal by Subject|0|||
25102799|NCT01364389|50213852|FG000|Overall Study|Protocol deviation|0|||
25102800|NCT01364389|50213853|FG001|Overall Study|Protocol deviation|0|||
25102801|NCT01364389|50213854|FG002|Overall Study|Protocol deviation|1|||
25102802|NCT01364389|50213852|FG000|Overall Study|Administrative problems|1|||
25102803|NCT01364389|50213853|FG001|Overall Study|Administrative problems|0|||
25102804|NCT01364389|50213854|FG002|Overall Study|Administrative problems|0|||
25102805|NCT01364389|50213852|FG000|Overall Study|Adverse Event|1|||
25102806|NCT01364389|50213853|FG001|Overall Study|Adverse Event|0|||
25102807|NCT01364389|50213854|FG002|Overall Study|Adverse Event|0|||
25102808|NCT01364233|50213862|FG000|Overall Study|Lost to Follow-up|1|||
25168541|NCT01857869|50297878|FG005|Primary/Challenge Phase|Protocol Violation|0|||
25168542|NCT01857869|50297879|FG006|Primary/Challenge Phase|Protocol Violation|0|||
25168543|NCT01857869|50297880|FG007|Primary/Challenge Phase|Protocol Violation|0|||
25168544|NCT01857869|50297881|FG008|Primary/Challenge Phase|Protocol Violation|0|||
25168545|NCT01857869|50297882|FG009|Primary/Challenge Phase|Protocol Violation|0|||
25168546|NCT01857869|50297873|FG000|Primary/Challenge Phase|Other|1|||
25168547|NCT01857869|50297874|FG001|Primary/Challenge Phase|Other|1|||
25168548|NCT01857869|50297875|FG002|Primary/Challenge Phase|Other|0|||
25168549|NCT01857869|50297876|FG003|Primary/Challenge Phase|Other|0|||
25168550|NCT01857869|50297877|FG004|Primary/Challenge Phase|Other|0|||
25168551|NCT01857869|50297878|FG005|Primary/Challenge Phase|Other|0|||
25168552|NCT01857869|50297879|FG006|Primary/Challenge Phase|Other|0|||
25168553|NCT01857869|50297880|FG007|Primary/Challenge Phase|Other|0|||
25168554|NCT01857869|50297881|FG008|Primary/Challenge Phase|Other|0|||
25168555|NCT01857869|50297882|FG009|Primary/Challenge Phase|Other|0|||
25168556|NCT01857869|50297873|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
25168557|NCT01857869|50297874|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
25168558|NCT01857869|50297875|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
25168559|NCT01857869|50297876|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
25168560|NCT01857869|50297877|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
25168561|NCT01857869|50297878|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
25168562|NCT01857869|50297879|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
25168563|NCT01857869|50297880|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
25168564|NCT01857869|50297881|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
25168565|NCT01857869|50297882|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
25168566|NCT01857869|50297873|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
25168567|NCT01857869|50297874|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
25168568|NCT01857869|50297875|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
25168569|NCT01857869|50297876|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
25168570|NCT01857869|50297877|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
25168571|NCT01857869|50297878|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
25168572|NCT01857869|50297879|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
25168573|NCT01857869|50297880|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
25168574|NCT01857869|50297881|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
25168575|NCT01857869|50297882|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
25168576|NCT04452318|50297970|FG000|Overall Study|Physician Decision|1|||
25168577|NCT04452318|50297971|FG001|Overall Study|Physician Decision|2|||
25168578|NCT04452318|50297972|FG002|Overall Study|Physician Decision|0|||
25168579|NCT04452318|50297973|FG003|Overall Study|Physician Decision|2|||
25168580|NCT04452318|50297974|FG004|Overall Study|Physician Decision|0|||
25168581|NCT04452318|50297975|FG005|Overall Study|Physician Decision|2|||
25168582|NCT04452318|50297976|FG006|Overall Study|Physician Decision|5|||
25168583|NCT04452318|50297970|FG000|Overall Study|Death|2|||
25168584|NCT04452318|50297971|FG001|Overall Study|Death|3|||
25168585|NCT04452318|50297972|FG002|Overall Study|Death|0|||
25168586|NCT04452318|50297973|FG003|Overall Study|Death|0|||
25168587|NCT04452318|50297974|FG004|Overall Study|Death|0|||
25261196|NCT04968925|50575860|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
25261197|NCT04968925|50575861|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
25261198|NCT04968925|50575862|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
25168588|NCT04452318|50297975|FG005|Overall Study|Death|0|||
25168589|NCT04452318|50297976|FG006|Overall Study|Death|0|||
25168590|NCT04452318|50297970|FG000|Overall Study|Lost to Follow-up|38|||
25168591|NCT04452318|50297971|FG001|Overall Study|Lost to Follow-up|28|||
25168592|NCT04452318|50297972|FG002|Overall Study|Lost to Follow-up|0|||
25168593|NCT04452318|50297973|FG003|Overall Study|Lost to Follow-up|3|||
25168594|NCT04452318|50297974|FG004|Overall Study|Lost to Follow-up|3|||
25168595|NCT04452318|50297975|FG005|Overall Study|Lost to Follow-up|2|||
25168596|NCT04452318|50297976|FG006|Overall Study|Lost to Follow-up|1|||
25168597|NCT04452318|50297970|FG000|Overall Study|Withdrawal by Subject|46|||
25168598|NCT04452318|50297971|FG001|Overall Study|Withdrawal by Subject|40|||
25168599|NCT04452318|50297972|FG002|Overall Study|Withdrawal by Subject|0|||
25168600|NCT04452318|50297973|FG003|Overall Study|Withdrawal by Subject|18|||
25168601|NCT04452318|50297974|FG004|Overall Study|Withdrawal by Subject|6|||
25102809|NCT02291289|50213870|FG000|Induction Treatment|Not Dosed|2|||
25102810|NCT02291289|50213871|FG001|Induction Treatment|Not Dosed|0|||
25102811|NCT02291289|50213872|FG002|Induction Treatment|Not Dosed|0|||
25102812|NCT02291289|50213873|FG003|Induction Treatment|Not Dosed|9|||
25102813|NCT02291289|50213874|FG004|Induction Treatment|Not Dosed|0|||
25102814|NCT02291289|50213875|FG005|Induction Treatment|Not Dosed|0|||
25102815|NCT02291289|50213876|FG006|Induction Treatment|Not Dosed|0|||
25102816|NCT02291289|50213877|FG007|Induction Treatment|Not Dosed|0|||
25102817|NCT02291289|50213878|FG008|Induction Treatment|Not Dosed|0|||
25102818|NCT02291289|50213879|FG009|Induction Treatment|Not Dosed|1|||
25102819|NCT02291289|50213880|FG010|Induction Treatment|Not Dosed|0|||
25102820|NCT02291289|50213881|FG011|Induction Treatment|Not Dosed|0|||
25102821|NCT02291289|50213870|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
25102822|NCT02291289|50213871|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
25102823|NCT02291289|50213872|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
25102824|NCT02291289|50213873|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
25102825|NCT02291289|50213874|FG004|Maintenance Treatment Phase|Withdrawal by Subject|13|||
25102826|NCT02291289|50213875|FG005|Maintenance Treatment Phase|Withdrawal by Subject|11|||
25102827|NCT02291289|50213876|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
25102828|NCT02291289|50213877|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
25102829|NCT02291289|50213878|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
25102830|NCT02291289|50213879|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
25102831|NCT02291289|50213880|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
25102832|NCT02291289|50213881|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
25102833|NCT02291289|50213870|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
25102834|NCT02291289|50213871|FG001|Maintenance Treatment Phase|Protocol Violation|1|||
25102835|NCT02291289|50213872|FG002|Maintenance Treatment Phase|Protocol Violation|0|||
25102836|NCT02291289|50213873|FG003|Maintenance Treatment Phase|Protocol Violation|0|||
25102837|NCT02291289|50213874|FG004|Maintenance Treatment Phase|Protocol Violation|2|||
25102838|NCT02291289|50213875|FG005|Maintenance Treatment Phase|Protocol Violation|1|||
25102839|NCT02291289|50213876|FG006|Maintenance Treatment Phase|Protocol Violation|0|||
25102840|NCT02291289|50213877|FG007|Maintenance Treatment Phase|Protocol Violation|0|||
25102841|NCT02291289|50213878|FG008|Maintenance Treatment Phase|Protocol Violation|0|||
25102842|NCT02291289|50213879|FG009|Maintenance Treatment Phase|Protocol Violation|0|||
25102843|NCT02291289|50213880|FG010|Maintenance Treatment Phase|Protocol Violation|0|||
25102844|NCT02291289|50213881|FG011|Maintenance Treatment Phase|Protocol Violation|0|||
25102845|NCT02291289|50213870|FG000|Maintenance Treatment Phase|Death|0|||
25102846|NCT02291289|50213871|FG001|Maintenance Treatment Phase|Death|23|||
25102847|NCT02291289|50213872|FG002|Maintenance Treatment Phase|Death|13|||
25102848|NCT02291289|50213873|FG003|Maintenance Treatment Phase|Death|0|||
25102849|NCT02291289|50213874|FG004|Maintenance Treatment Phase|Death|185|||
25102850|NCT02291289|50213875|FG005|Maintenance Treatment Phase|Death|100|||
25102851|NCT02291289|50213876|FG006|Maintenance Treatment Phase|Death|0|||
25102852|NCT02291289|50213877|FG007|Maintenance Treatment Phase|Death|1|||
25102853|NCT02291289|50213878|FG008|Maintenance Treatment Phase|Death|1|||
25102854|NCT02291289|50213879|FG009|Maintenance Treatment Phase|Death|0|||
25102855|NCT02291289|50213880|FG010|Maintenance Treatment Phase|Death|26|||
25102856|NCT02291289|50213881|FG011|Maintenance Treatment Phase|Death|11|||
25102857|NCT02291289|50213870|FG000|Maintenance Treatment Phase|Adverse Event|0|||
25102858|NCT02291289|50213871|FG001|Maintenance Treatment Phase|Adverse Event|0|||
25102859|NCT02291289|50213872|FG002|Maintenance Treatment Phase|Adverse Event|0|||
25102860|NCT02291289|50213873|FG003|Maintenance Treatment Phase|Adverse Event|0|||
25102861|NCT02291289|50213874|FG004|Maintenance Treatment Phase|Adverse Event|1|||
25102862|NCT02291289|50213875|FG005|Maintenance Treatment Phase|Adverse Event|0|||
25102863|NCT02291289|50213876|FG006|Maintenance Treatment Phase|Adverse Event|0|||
25102864|NCT02291289|50213877|FG007|Maintenance Treatment Phase|Adverse Event|0|||
25102865|NCT02291289|50213878|FG008|Maintenance Treatment Phase|Adverse Event|0|||
25102866|NCT02291289|50213879|FG009|Maintenance Treatment Phase|Adverse Event|0|||
25102867|NCT02291289|50213880|FG010|Maintenance Treatment Phase|Adverse Event|0|||
25102868|NCT02291289|50213881|FG011|Maintenance Treatment Phase|Adverse Event|0|||
25102869|NCT02291289|50213870|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
25102870|NCT02291289|50213871|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
25102871|NCT02291289|50213872|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
25102872|NCT02291289|50213873|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
25102873|NCT02291289|50213874|FG004|Maintenance Treatment Phase|Lost to Follow-up|12|||
25102874|NCT02291289|50213875|FG005|Maintenance Treatment Phase|Lost to Follow-up|3|||
25102875|NCT02291289|50213876|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
25102876|NCT02291289|50213877|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
25102877|NCT02291289|50213878|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
25102878|NCT02291289|50213879|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
25008250|NCT03938272|50101105|FG001|Overall Study|Physician Decision|2|||
25008251|NCT03938272|50101104|FG000|Overall Study|Study termination by sponsor|10|||
25102879|NCT02291289|50213880|FG010|Maintenance Treatment Phase|Lost to Follow-up|2|||
25102880|NCT02291289|50213881|FG011|Maintenance Treatment Phase|Lost to Follow-up|1|||
25102881|NCT02291289|50213870|FG000|Maintenance Treatment Phase|Other|0|||
25102882|NCT02291289|50213871|FG001|Maintenance Treatment Phase|Other|0|||
25102883|NCT02291289|50213872|FG002|Maintenance Treatment Phase|Other|1|||
25102884|NCT02291289|50213873|FG003|Maintenance Treatment Phase|Other|0|||
25102885|NCT02291289|50213874|FG004|Maintenance Treatment Phase|Other|29|||
25102886|NCT02291289|50213875|FG005|Maintenance Treatment Phase|Other|8|||
25102887|NCT02291289|50213876|FG006|Maintenance Treatment Phase|Other|0|||
25102888|NCT02291289|50213877|FG007|Maintenance Treatment Phase|Other|0|||
25102889|NCT02291289|50213878|FG008|Maintenance Treatment Phase|Other|1|||
25102890|NCT02291289|50213879|FG009|Maintenance Treatment Phase|Other|0|||
25102891|NCT02291289|50213880|FG010|Maintenance Treatment Phase|Other|0|||
25102892|NCT02291289|50213881|FG011|Maintenance Treatment Phase|Other|0|||
25102893|NCT02291289|50213870|FG000|Maintenance Treatment Phase|Physician Decision|0|||
25102894|NCT02291289|50213871|FG001|Maintenance Treatment Phase|Physician Decision|0|||
25102895|NCT02291289|50213872|FG002|Maintenance Treatment Phase|Physician Decision|0|||
25102896|NCT02291289|50213873|FG003|Maintenance Treatment Phase|Physician Decision|0|||
25102897|NCT02291289|50213874|FG004|Maintenance Treatment Phase|Physician Decision|2|||
25102898|NCT02291289|50213875|FG005|Maintenance Treatment Phase|Physician Decision|0|||
25102899|NCT02291289|50213876|FG006|Maintenance Treatment Phase|Physician Decision|0|||
25102900|NCT02291289|50213877|FG007|Maintenance Treatment Phase|Physician Decision|0|||
25102901|NCT02291289|50213878|FG008|Maintenance Treatment Phase|Physician Decision|0|||
25102902|NCT02291289|50213879|FG009|Maintenance Treatment Phase|Physician Decision|0|||
25102903|NCT02291289|50213880|FG010|Maintenance Treatment Phase|Physician Decision|0|||
25102904|NCT02291289|50213881|FG011|Maintenance Treatment Phase|Physician Decision|1|||
25102905|NCT02291289|50213870|FG000|Maintenance Treatment Phase|Multiple Reasons|0|||
25102906|NCT02291289|50213871|FG001|Maintenance Treatment Phase|Multiple Reasons|0|||
25102907|NCT02291289|50213872|FG002|Maintenance Treatment Phase|Multiple Reasons|0|||
25102908|NCT02291289|50213873|FG003|Maintenance Treatment Phase|Multiple Reasons|0|||
25102909|NCT02291289|50213874|FG004|Maintenance Treatment Phase|Multiple Reasons|4|||
25102910|NCT02291289|50213875|FG005|Maintenance Treatment Phase|Multiple Reasons|1|||
25102911|NCT02291289|50213876|FG006|Maintenance Treatment Phase|Multiple Reasons|0|||
25102912|NCT02291289|50213877|FG007|Maintenance Treatment Phase|Multiple Reasons|0|||
25102913|NCT02291289|50213878|FG008|Maintenance Treatment Phase|Multiple Reasons|0|||
25102914|NCT02291289|50213879|FG009|Maintenance Treatment Phase|Multiple Reasons|0|||
25102915|NCT02291289|50213880|FG010|Maintenance Treatment Phase|Multiple Reasons|0|||
25102916|NCT02291289|50213881|FG011|Maintenance Treatment Phase|Multiple Reasons|0|||
25102917|NCT02291289|50213870|FG000|Maintenance Treatment Phase|No Treatment Received|0|||
25102918|NCT02291289|50213871|FG001|Maintenance Treatment Phase|No Treatment Received|0|||
25102919|NCT02291289|50213872|FG002|Maintenance Treatment Phase|No Treatment Received|2|||
25102920|NCT02291289|50213873|FG003|Maintenance Treatment Phase|No Treatment Received|0|||
25102921|NCT02291289|50213874|FG004|Maintenance Treatment Phase|No Treatment Received|4|||
25102922|NCT02291289|50213875|FG005|Maintenance Treatment Phase|No Treatment Received|5|||
25102923|NCT02291289|50213876|FG006|Maintenance Treatment Phase|No Treatment Received|0|||
25102924|NCT02291289|50213877|FG007|Maintenance Treatment Phase|No Treatment Received|0|||
25102925|NCT02291289|50213878|FG008|Maintenance Treatment Phase|No Treatment Received|0|||
25102926|NCT02291289|50213879|FG009|Maintenance Treatment Phase|No Treatment Received|0|||
25102927|NCT02291289|50213880|FG010|Maintenance Treatment Phase|No Treatment Received|1|||
25102928|NCT02291289|50213881|FG011|Maintenance Treatment Phase|No Treatment Received|0|||
25102929|NCT02317575|50213906|FG000|Period 1|Difficulty with venous cannulation|0|||
25102930|NCT02317575|50213907|FG001|Period 1|Difficulty with venous cannulation|1|||
25102931|NCT02317575|50213908|FG002|Period 1|Difficulty with venous cannulation|0|||
25102932|NCT02317575|50213909|FG003|Period 1|Difficulty with venous cannulation|0|||
25102933|NCT02317575|50213910|FG004|Period 1|Difficulty with venous cannulation|0|||
25102934|NCT02317575|50213906|FG000|Period 1|Withdrawal by Subject|1|||
25102935|NCT02317575|50213907|FG001|Period 1|Withdrawal by Subject|0|||
25102936|NCT02317575|50213908|FG002|Period 1|Withdrawal by Subject|0|||
25102937|NCT02317575|50213909|FG003|Period 1|Withdrawal by Subject|0|||
25102938|NCT02317575|50213910|FG004|Period 1|Withdrawal by Subject|0|||
25102939|NCT02316717|50213931|FG000|Overall Study|Adverse Event|2|||
25102940|NCT02316717|50213932|FG001|Overall Study|Adverse Event|2|||
25102941|NCT02316717|50213933|FG002|Overall Study|Adverse Event|0|||
25102942|NCT02316717|50213931|FG000|Overall Study|Lost to Follow-up|1|||
25102943|NCT02316717|50213932|FG001|Overall Study|Lost to Follow-up|2|||
25102944|NCT02316717|50213933|FG002|Overall Study|Lost to Follow-up|1|||
25102945|NCT02316717|50213931|FG000|Overall Study|Non compliance|3|||
25102946|NCT02316717|50213932|FG001|Overall Study|Non compliance|1|||
25102947|NCT02316717|50213933|FG002|Overall Study|Non compliance|0|||
25102948|NCT02316717|50213931|FG000|Overall Study|Protocol Violation|2|||
25102949|NCT02316717|50213932|FG001|Overall Study|Protocol Violation|0|||
25102950|NCT02316717|50213933|FG002|Overall Study|Protocol Violation|0|||
25102951|NCT02316717|50213931|FG000|Overall Study|Withdrawal by Subject|2|||
25102952|NCT02316717|50213932|FG001|Overall Study|Withdrawal by Subject|1|||
25102953|NCT02316717|50213933|FG002|Overall Study|Withdrawal by Subject|1|||
25102954|NCT02316717|50213931|FG000|Overall Study|Death|0|||
25102955|NCT02316717|50213932|FG001|Overall Study|Death|0|||
25102956|NCT02316717|50213933|FG002|Overall Study|Death|1|||
25102957|NCT02316717|50213931|FG000|Overall Study|Physician Decision|0|||
25102958|NCT02316717|50213932|FG001|Overall Study|Physician Decision|1|||
25102959|NCT02316717|50213933|FG002|Overall Study|Physician Decision|0|||
25102960|NCT02316717|50213931|FG000|Overall Study|TBC|1|||
25102961|NCT02316717|50213932|FG001|Overall Study|TBC|0|||
25102962|NCT02316717|50213933|FG002|Overall Study|TBC|0|||
25102963|NCT02290821|50213946|FG000|Overall Study|Withdrawal by Subject|1|||
25102964|NCT02290821|50213947|FG001|Overall Study|Withdrawal by Subject|1|||
25102965|NCT02290821|50213946|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
25102966|NCT02290821|50213947|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
25102967|NCT02290821|50213946|FG000|Overall Study|Lost to Follow-up|3|||
25102968|NCT02290821|50213947|FG001|Overall Study|Lost to Follow-up|2|||
25102969|NCT02289963|50213955|FG000|Overall Study|Adverse Event|1|||
25102970|NCT02289963|50213956|FG001|Overall Study|Adverse Event|2|||
25102971|NCT02289963|50213955|FG000|Overall Study|Poor compliance to protocol|1|||
25102972|NCT02289963|50213956|FG001|Overall Study|Poor compliance to protocol|0|||
25102973|NCT02289963|50213955|FG000|Overall Study|Withdrawal by Subject|1|||
25102974|NCT02289963|50213956|FG001|Overall Study|Withdrawal by Subject|0|||
25102975|NCT02289963|50213955|FG000|Overall Study|Last injection missed|2|||
25102976|NCT02289963|50213956|FG001|Overall Study|Last injection missed|2|||
25102977|NCT02289963|50213955|FG000|Overall Study|End treatment visit outside visit window|0|||
25102978|NCT02289963|50213956|FG001|Overall Study|End treatment visit outside visit window|4|||
25102979|NCT02289963|50213955|FG000|Overall Study|Other than specified above|0|||
25102980|NCT02289963|50213956|FG001|Overall Study|Other than specified above|2|||
25102981|NCT02358369|50213965|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
25102982|NCT02358369|50213966|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
25102983|NCT02358369|50213967|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
25102984|NCT02358369|50213968|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
25102985|NCT02358369|50213969|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
25102986|NCT02358369|50213965|FG000|Treatment Period A/B|Adverse Event|0|||
25102987|NCT02358369|50213966|FG001|Treatment Period A/B|Adverse Event|0|||
25102988|NCT02358369|50213967|FG002|Treatment Period A/B|Adverse Event|1|||
25102989|NCT02358369|50213968|FG003|Treatment Period A/B|Adverse Event|2|||
25102990|NCT02358369|50213969|FG004|Treatment Period A/B|Adverse Event|0|||
25102991|NCT02358369|50213965|FG000|Treatment Period A/B|Death|0|||
25102992|NCT02358369|50213966|FG001|Treatment Period A/B|Death|0|||
25102993|NCT02358369|50213967|FG002|Treatment Period A/B|Death|1|||
25102994|NCT02358369|50213968|FG003|Treatment Period A/B|Death|0|||
25102995|NCT02358369|50213969|FG004|Treatment Period A/B|Death|0|||
25102996|NCT02358369|50213965|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
25102997|NCT02358369|50213966|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
25102998|NCT02358369|50213967|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
25102999|NCT02358369|50213968|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
25103000|NCT02358369|50213969|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
25103001|NCT02358369|50213965|FG000|Treatment Period C|Adverse Event|0|||
25103002|NCT02358369|50213966|FG001|Treatment Period C|Adverse Event|0|||
25103003|NCT02358369|50213967|FG002|Treatment Period C|Adverse Event|0|||
25103004|NCT02358369|50213968|FG003|Treatment Period C|Adverse Event|0|||
25103005|NCT02358369|50213969|FG004|Treatment Period C|Adverse Event|7|||
25103006|NCT02316171|50213981|FG000|Overall Study|difficulties with urinary catheter|1|||
25103007|NCT02316171|50213982|FG001|Overall Study|difficulties with urinary catheter|0|||
25103008|NCT02316171|50213983|FG002|Overall Study|difficulties with urinary catheter|0|||
25103009|NCT02316171|50213984|FG003|Overall Study|difficulties with urinary catheter|0|||
25103010|NCT02289729|50213990|FG000|Overall Study|Lack of Efficacy|3|||
25103011|NCT02289729|50213990|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
25103012|NCT02289729|50213990|FG000|Overall Study|Withdrawal by Subject|1|||
25103013|NCT02289729|50213990|FG000|Overall Study|Death|1|||
25103014|NCT02315625|50213996|FG000|First Intervention|Disease Progression|1|||
25103015|NCT02315625|50213997|FG001|First Intervention|Disease Progression|0|||
25103016|NCT02315625|50213996|FG000|Second Intervention|Physician Decision|2|||
25103017|NCT02315625|50213997|FG001|Second Intervention|Physician Decision|1|||
25103018|NCT02315625|50213996|FG000|Second Intervention|Study closure|1|||
25103019|NCT02315625|50213997|FG001|Second Intervention|Study closure|0|||
25103020|NCT02315625|50213996|FG000|Second Intervention|Disease Progression|1|||
25103021|NCT02315625|50213997|FG001|Second Intervention|Disease Progression|0|||
25103022|NCT02357979|50214007|FG000|Overall Study|Lost to Follow-up|5|||
25103023|NCT02357979|50214008|FG001|Overall Study|Lost to Follow-up|5|||
25103024|NCT02357901|50214017|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
25103025|NCT02357901|50214018|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
25103026|NCT02357901|50214019|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
25103027|NCT02357901|50214020|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
25103028|NCT02357901|50214017|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
25103029|NCT02357901|50214018|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
25103030|NCT02357901|50214019|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
25103031|NCT02357901|50214020|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
25103032|NCT02357901|50214017|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
25103033|NCT02357901|50214018|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
25103034|NCT02357901|50214019|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
25103035|NCT02357901|50214020|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
25103036|NCT02357901|50214017|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
25103037|NCT02357901|50214018|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
25103038|NCT02357901|50214019|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
25103039|NCT02357901|50214020|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
25103040|NCT02357901|50214017|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
25103041|NCT02357901|50214018|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
25103042|NCT02357901|50214019|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
25103043|NCT02357901|50214020|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
25103044|NCT02357901|50214017|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
25103045|NCT02357901|50214018|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
25103046|NCT02357901|50214019|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
25103047|NCT02357901|50214020|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
25103048|NCT02357901|50214017|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
25103049|NCT02357901|50214018|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
25103050|NCT02357901|50214019|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
25103051|NCT02357901|50214020|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
25103052|NCT02357901|50214017|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
25103053|NCT02357901|50214018|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
25103054|NCT02357901|50214019|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
25103055|NCT02357901|50214020|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
25103056|NCT02357901|50214017|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
25103057|NCT02357901|50214018|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
25103058|NCT02357901|50214019|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
25103059|NCT02357901|50214020|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
25103060|NCT02357901|50214017|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
25103061|NCT02357901|50214018|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
25103062|NCT02357901|50214019|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
25103063|NCT02357901|50214020|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
25103064|NCT02357901|50214017|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
25103065|NCT02357901|50214018|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
25103066|NCT02357901|50214019|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
25103067|NCT02357901|50214020|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
25103068|NCT01601847|50214030|FG000|Overall Study|Death|1|||
25103069|NCT01601847|50214031|FG001|Overall Study|Death|0|||
25103070|NCT01601847|50214030|FG000|Overall Study|Withdrawal by Subject|11|||
25103071|NCT01601847|50214031|FG001|Overall Study|Withdrawal by Subject|7|||
25103072|NCT01601847|50214030|FG000|Overall Study|Lost to Follow-up|1|||
25103073|NCT01601847|50214031|FG001|Overall Study|Lost to Follow-up|3|||
25103074|NCT02515669|50214041|FG000|228 Week Open-Label Phase|Other|0|||
25103075|NCT02515669|50214042|FG001|228 Week Open-Label Phase|Other|0|||
25103076|NCT02515669|50214043|FG002|228 Week Open-Label Phase|Other|1|||
25103077|NCT02515669|50214044|FG003|228 Week Open-Label Phase|Other|4|||
25103078|NCT02515669|50214041|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
25103079|NCT02515669|50214042|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
25103080|NCT02515669|50214043|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
25103081|NCT02515669|50214044|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
25103082|NCT02515669|50214041|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
25103083|NCT02515669|50214042|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
25103084|NCT02515669|50214043|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
25103085|NCT02515669|50214044|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
25103086|NCT02515669|50214041|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
25103087|NCT02515669|50214042|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
25103088|NCT02515669|50214043|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
25103089|NCT02515669|50214044|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
25103090|NCT02515669|50214041|FG000|228 Week Open-Label Phase|Missing|0|||
25103091|NCT02515669|50214042|FG001|228 Week Open-Label Phase|Missing|2|||
25103092|NCT02515669|50214043|FG002|228 Week Open-Label Phase|Missing|2|||
25261199|NCT04968925|50575863|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
25008252|NCT03938272|50101105|FG001|Overall Study|Study termination by sponsor|8|||
25008253|NCT02565914|50101111|FG000|Overall Study|Adverse Event|17|||
25103093|NCT02515669|50214044|FG003|228 Week Open-Label Phase|Missing|2|||
25103094|NCT02515279|50214074|FG000|Overall Study|Adverse Event|7|||
25103095|NCT02515279|50214074|FG000|Overall Study|Lack of Efficacy|31|||
25103096|NCT02515279|50214074|FG000|Overall Study|Lost to Follow-up|9|||
25103097|NCT02515279|50214074|FG000|Overall Study|Withdrawal by Subject|18|||
25103098|NCT02515279|50214074|FG000|Overall Study|End-of-treatment visit not attended|17|||
25103099|NCT02515279|50214074|FG000|Overall Study|Other|22|||
25103100|NCT02515045|50214080|FG000|Overall Study|Adverse Event|0|||
25103101|NCT02515045|50214081|FG001|Overall Study|Adverse Event|3|||
25103102|NCT02515045|50214082|FG002|Overall Study|Adverse Event|3|||
25103103|NCT02515045|50214080|FG000|Overall Study|Lost to Follow-up|0|||
25103104|NCT02515045|50214081|FG001|Overall Study|Lost to Follow-up|1|||
25103105|NCT02515045|50214082|FG002|Overall Study|Lost to Follow-up|1|||
25103106|NCT02514577|50214092|FG000|Overall Study|Lost to Follow-up|6|||
25103107|NCT02514577|50214093|FG001|Overall Study|Lost to Follow-up|6|||
25103108|NCT02514577|50214092|FG000|Overall Study|Protocol Violation|1|||
25103109|NCT02514577|50214093|FG001|Overall Study|Protocol Violation|0|||
25103110|NCT02514577|50214092|FG000|Overall Study|Withdrawal by Subject|6|||
25103111|NCT02514577|50214093|FG001|Overall Study|Withdrawal by Subject|6|||
25103112|NCT02514577|50214092|FG000|Overall Study|Adverse Event|1|||
25103113|NCT02514577|50214093|FG001|Overall Study|Adverse Event|1|||
25103114|NCT02513485|50214101|FG000|Overall Study|Adverse Event|1|||
25103115|NCT02513485|50214102|FG001|Overall Study|Adverse Event|0|||
25103116|NCT02289417|50214111|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
25103117|NCT02289417|50214112|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
25103118|NCT02289417|50214113|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
25103119|NCT02289417|50214114|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
25103120|NCT02289417|50214115|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
25103121|NCT02289417|50214116|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
25103122|NCT02289417|50214117|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
25103123|NCT02289417|50214118|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
25103124|NCT02289417|50214119|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
25103125|NCT02289417|50214111|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
25103126|NCT02289417|50214112|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
25103127|NCT02289417|50214113|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
25103128|NCT02289417|50214114|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
25103129|NCT02289417|50214115|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
25103130|NCT02289417|50214116|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
25103131|NCT02289417|50214117|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
25103132|NCT02289417|50214118|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
25103133|NCT02289417|50214119|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
25103134|NCT02289417|50214111|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
25103135|NCT02289417|50214112|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
25103136|NCT02289417|50214113|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
25103137|NCT02289417|50214114|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
25103138|NCT02289417|50214115|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
25103139|NCT02289417|50214116|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
25103140|NCT02289417|50214117|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
25103141|NCT02289417|50214118|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
25103142|NCT02289417|50214119|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
25103143|NCT02289417|50214111|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
25103144|NCT02289417|50214112|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
25103145|NCT02289417|50214113|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
25103146|NCT02289417|50214114|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
25103147|NCT02289417|50214115|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
25103148|NCT02289417|50214116|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
25103149|NCT02289417|50214117|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
25103150|NCT02289417|50214118|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
25103151|NCT02289417|50214119|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
25103152|NCT02289417|50214111|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
25103153|NCT02289417|50214112|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
25103154|NCT02289417|50214113|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
25103155|NCT02289417|50214114|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
25103156|NCT02289417|50214115|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
25103157|NCT02289417|50214116|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
25103158|NCT02289417|50214117|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
25103159|NCT02289417|50214118|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
25103160|NCT02289417|50214119|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
25103161|NCT02289417|50214111|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
25103162|NCT02289417|50214112|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
25103163|NCT02289417|50214113|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
25103164|NCT02289417|50214114|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
25103165|NCT02289417|50214115|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
25103166|NCT02289417|50214116|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
25103167|NCT02289417|50214117|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
25103168|NCT02289417|50214118|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
25103169|NCT02289417|50214119|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
25103170|NCT02289417|50214111|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
25103171|NCT02289417|50214112|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
25103172|NCT02289417|50214113|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
25103173|NCT02289417|50214114|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
25103174|NCT02289417|50214115|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
25103175|NCT02289417|50214116|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
25103176|NCT02289417|50214117|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
25103177|NCT02289417|50214118|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
25103178|NCT02289417|50214119|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
25103179|NCT02289417|50214111|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
25103180|NCT02289417|50214112|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
25103181|NCT02289417|50214113|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
25103182|NCT02289417|50214114|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
25103183|NCT02289417|50214115|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
25103184|NCT02289417|50214116|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
25103185|NCT02289417|50214117|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
25103186|NCT02289417|50214118|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
25103187|NCT02289417|50214119|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
25103188|NCT02289417|50214111|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
25103189|NCT02289417|50214112|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
25103190|NCT02289417|50214113|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
25103191|NCT02289417|50214114|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
25103192|NCT02289417|50214115|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
25103193|NCT02289417|50214116|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
25103194|NCT02289417|50214117|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
25103195|NCT02289417|50214118|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
25103196|NCT02289417|50214119|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
25103197|NCT02289417|50214111|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
25103198|NCT02289417|50214112|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
25103199|NCT02289417|50214113|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
25103200|NCT02289417|50214114|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
25103201|NCT02289417|50214115|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
25103202|NCT02289417|50214116|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
25103203|NCT02289417|50214117|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
25103204|NCT02289417|50214118|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
25103205|NCT02289417|50214119|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
25103206|NCT02289417|50214111|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
25103207|NCT02289417|50214112|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
25103208|NCT02289417|50214113|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
25103209|NCT02289417|50214114|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
25103210|NCT02289417|50214115|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
25103211|NCT02289417|50214116|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
25103212|NCT02289417|50214117|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
25103213|NCT02289417|50214118|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
25103214|NCT02289417|50214119|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
25103215|NCT02289417|50214111|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
25103216|NCT02289417|50214112|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
25103217|NCT02289417|50214113|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
25103218|NCT02289417|50214114|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
25103219|NCT02289417|50214115|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
25103220|NCT02289417|50214116|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
25103221|NCT02289417|50214117|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
25103222|NCT02289417|50214118|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
25103223|NCT02289417|50214119|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
25103224|NCT02289417|50214111|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
25177143|NCT02660580|50321236|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
25103225|NCT02289417|50214112|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
25103226|NCT02289417|50214113|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
25103227|NCT02289417|50214114|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
25103228|NCT02289417|50214115|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
25103229|NCT02289417|50214116|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
25103230|NCT02289417|50214117|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
25103231|NCT02289417|50214118|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
25103232|NCT02289417|50214119|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
25103233|NCT02289417|50214111|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
25103234|NCT02289417|50214112|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
25103235|NCT02289417|50214113|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
25103236|NCT02289417|50214114|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
25103237|NCT02289417|50214115|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
25103238|NCT02289417|50214116|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
25103239|NCT02289417|50214117|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
25103240|NCT02289417|50214118|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
25103241|NCT02289417|50214119|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
25103242|NCT02512861|50214137|FG000|Overall Study|Protocol Violation|3|||
25103243|NCT02512861|50214138|FG001|Overall Study|Protocol Violation|7|||
25103244|NCT02512861|50214137|FG000|Overall Study|Physician Decision|3|||
25103245|NCT02512861|50214138|FG001|Overall Study|Physician Decision|1|||
25103246|NCT02512861|50214137|FG000|Overall Study|Withdrawal by Subject|0|||
25103247|NCT02512861|50214138|FG001|Overall Study|Withdrawal by Subject|1|||
25103248|NCT02288559|50214148|FG000|Overall Study|Adverse Event|1|||
25103249|NCT02288559|50214149|FG001|Overall Study|Adverse Event|1|||
25103250|NCT02288559|50214150|FG002|Overall Study|Adverse Event|5|||
25103251|NCT02288559|50214151|FG003|Overall Study|Adverse Event|0|||
25103252|NCT02288559|50214148|FG000|Overall Study|Death|0|||
25103253|NCT02288559|50214149|FG001|Overall Study|Death|0|||
25103254|NCT02288559|50214150|FG002|Overall Study|Death|1|||
25103255|NCT02288559|50214151|FG003|Overall Study|Death|0|||
25103256|NCT02288559|50214148|FG000|Overall Study|Lost to Follow-up|0|||
25103257|NCT02288559|50214149|FG001|Overall Study|Lost to Follow-up|0|||
25103258|NCT02288559|50214150|FG002|Overall Study|Lost to Follow-up|0|||
25103259|NCT02288559|50214151|FG003|Overall Study|Lost to Follow-up|1|||
25103260|NCT02288559|50214148|FG000|Overall Study|Withdrawal by Subject|0|||
25103261|NCT02288559|50214149|FG001|Overall Study|Withdrawal by Subject|0|||
25103262|NCT02288559|50214150|FG002|Overall Study|Withdrawal by Subject|2|||
25103263|NCT02288559|50214151|FG003|Overall Study|Withdrawal by Subject|1|||
25103264|NCT02288559|50214148|FG000|Overall Study|Reason Not Specified|0|||
25103265|NCT02288559|50214149|FG001|Overall Study|Reason Not Specified|0|||
25103266|NCT02288559|50214150|FG002|Overall Study|Reason Not Specified|3|||
25103267|NCT02288559|50214151|FG003|Overall Study|Reason Not Specified|0|||
25103268|NCT02288325|50214163|FG000|Run-in Period|Adverse Event|48|||
25103269|NCT02288325|50214164|FG001|Run-in Period|Adverse Event|0|||
25103270|NCT02288325|50214165|FG002|Run-in Period|Adverse Event|0|||
25103271|NCT02288325|50214163|FG000|Run-in Period|Lack of Efficacy|16|||
25103272|NCT02288325|50214164|FG001|Run-in Period|Lack of Efficacy|0|||
25103273|NCT02288325|50214165|FG002|Run-in Period|Lack of Efficacy|0|||
25103274|NCT02288325|50214163|FG000|Run-in Period|Withdrawal of Consent|28|||
25103275|NCT02288325|50214164|FG001|Run-in Period|Withdrawal of Consent|0|||
25103276|NCT02288325|50214165|FG002|Run-in Period|Withdrawal of Consent|0|||
25103277|NCT02288325|50214163|FG000|Run-in Period|Lost to Follow-up|25|||
25103278|NCT02288325|50214164|FG001|Run-in Period|Lost to Follow-up|0|||
25103279|NCT02288325|50214165|FG002|Run-in Period|Lost to Follow-up|0|||
25103280|NCT02288325|50214163|FG000|Run-in Period|Protocol Violation|17|||
25103281|NCT02288325|50214164|FG001|Run-in Period|Protocol Violation|0|||
25103282|NCT02288325|50214165|FG002|Run-in Period|Protocol Violation|0|||
25103283|NCT02288325|50214163|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
25103284|NCT02288325|50214164|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
25103285|NCT02288325|50214165|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
25103286|NCT02288325|50214163|FG000|Run-in Period|Reason not Specified|8|||
25008254|NCT02565914|50101111|FG000|Overall Study|Withdrawal of consent (not due to AE)|25|||
25008255|NCT02565914|50101111|FG000|Overall Study|Lost to Follow-up|12|||
25008256|NCT02565914|50101111|FG000|Overall Study|Death (not treatment emergent)|1|||
25103287|NCT02288325|50214164|FG001|Run-in Period|Reason not Specified|0|||
25103288|NCT02288325|50214165|FG002|Run-in Period|Reason not Specified|0|||
25103289|NCT02288325|50214163|FG000|Stabilization Period|Adverse Event|13|||
25103290|NCT02288325|50214164|FG001|Stabilization Period|Adverse Event|0|||
25103291|NCT02288325|50214165|FG002|Stabilization Period|Adverse Event|0|||
25008257|NCT02565914|50101111|FG000|Overall Study|Other noncompliance|6|||
25103292|NCT02288325|50214163|FG000|Stabilization Period|Lack of Efficacy|22|||
25103293|NCT02288325|50214164|FG001|Stabilization Period|Lack of Efficacy|0|||
25103294|NCT02288325|50214165|FG002|Stabilization Period|Lack of Efficacy|0|||
25103295|NCT02288325|50214163|FG000|Stabilization Period|Withdrawal of Consent|23|||
25103296|NCT02288325|50214164|FG001|Stabilization Period|Withdrawal of Consent|0|||
25103297|NCT02288325|50214165|FG002|Stabilization Period|Withdrawal of Consent|0|||
25103298|NCT02288325|50214163|FG000|Stabilization Period|Lost to Follow-up|12|||
25103299|NCT02288325|50214164|FG001|Stabilization Period|Lost to Follow-up|0|||
25103300|NCT02288325|50214165|FG002|Stabilization Period|Lost to Follow-up|0|||
25103301|NCT02288325|50214163|FG000|Stabilization Period|Protocol Violation|8|||
25103302|NCT02288325|50214164|FG001|Stabilization Period|Protocol Violation|0|||
25103303|NCT02288325|50214165|FG002|Stabilization Period|Protocol Violation|0|||
25103304|NCT02288325|50214163|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
25103305|NCT02288325|50214164|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
25103306|NCT02288325|50214165|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
25103307|NCT02288325|50214163|FG000|Stabilization Period|Reason not Specified|15|||
25103308|NCT02288325|50214164|FG001|Stabilization Period|Reason not Specified|0|||
25103309|NCT02288325|50214165|FG002|Stabilization Period|Reason not Specified|0|||
25103310|NCT02288325|50214163|FG000|Double-blind Treatment Period|Adverse Event|0|||
25103311|NCT02288325|50214164|FG001|Double-blind Treatment Period|Adverse Event|2|||
25103312|NCT02288325|50214165|FG002|Double-blind Treatment Period|Adverse Event|5|||
25103313|NCT02288325|50214163|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
25103314|NCT02288325|50214164|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
25103315|NCT02288325|50214165|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
25103316|NCT02288325|50214163|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
25103317|NCT02288325|50214164|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
25103318|NCT02288325|50214165|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
25103319|NCT02288325|50214163|FG000|Double-blind Treatment Period|Protocol Violation|0|||
25103320|NCT02288325|50214164|FG001|Double-blind Treatment Period|Protocol Violation|1|||
25103321|NCT02288325|50214165|FG002|Double-blind Treatment Period|Protocol Violation|2|||
25103322|NCT02288325|50214163|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
25103323|NCT02288325|50214164|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
25103324|NCT02288325|50214165|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
25103325|NCT02288325|50214163|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
25103326|NCT02288325|50214164|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
25103327|NCT02288325|50214165|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
25103328|NCT02509117|50214182|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
25103329|NCT02509117|50214183|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
25103330|NCT02509117|50214184|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
25103331|NCT02509117|50214185|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
25103332|NCT02509117|50214186|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
25103333|NCT02509117|50214187|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
25103334|NCT02509117|50214188|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
25103335|NCT02509117|50214189|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
25103336|NCT02509117|50214190|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
25103337|NCT02509117|50214191|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
25103338|NCT02509117|50214182|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
25103339|NCT02509117|50214183|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
25103340|NCT02509117|50214184|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
25103341|NCT02509117|50214185|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
25103342|NCT02509117|50214186|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
25103343|NCT02509117|50214187|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
25103344|NCT02509117|50214188|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
25103345|NCT02509117|50214189|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
25103346|NCT02509117|50214190|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
25103347|NCT02509117|50214191|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
25103348|NCT02509117|50214182|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
25103349|NCT02509117|50214183|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
25103350|NCT02509117|50214184|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
25103351|NCT02509117|50214185|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
25103352|NCT02509117|50214186|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
25103353|NCT02509117|50214187|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
25103354|NCT02509117|50214188|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
25103355|NCT02509117|50214189|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
25103356|NCT02509117|50214190|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
25103357|NCT02509117|50214191|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
25103358|NCT01654549|50214231|FG000|Overall Study|H.pylori eradication not successful|0|||
25103359|NCT01654549|50214232|FG001|Overall Study|H.pylori eradication not successful|1|||
25103360|NCT02508649|50214246|FG000|Overall Study|Withdrawal by Subject|4|||
25008258|NCT02565914|50101111|FG000|Overall Study|Physician Decision|6|||
25008259|NCT02565914|50101111|FG000|Overall Study|Parent study termination by sponsor|1|||
25008260|NCT02565914|50101111|FG000|Overall Study|Commercial drug available|5|||
25103361|NCT02508649|50214247|FG001|Overall Study|Withdrawal by Subject|6|||
25103362|NCT02508649|50214248|FG002|Overall Study|Withdrawal by Subject|5|||
25103363|NCT02508649|50214249|FG003|Overall Study|Withdrawal by Subject|6|||
25103364|NCT02508649|50214246|FG000|Overall Study|Investigator withdrew the subject|1|||
25103365|NCT02508649|50214247|FG001|Overall Study|Investigator withdrew the subject|2|||
25103366|NCT02508649|50214248|FG002|Overall Study|Investigator withdrew the subject|1|||
25103367|NCT02508649|50214249|FG003|Overall Study|Investigator withdrew the subject|0|||
25103368|NCT02508649|50214246|FG000|Overall Study|Post randomization screening failure|12|||
25103369|NCT02508649|50214247|FG001|Overall Study|Post randomization screening failure|4|||
25103370|NCT02508649|50214248|FG002|Overall Study|Post randomization screening failure|9|||
25103371|NCT02508649|50214249|FG003|Overall Study|Post randomization screening failure|3|||
25103372|NCT02508649|50214246|FG000|Overall Study|Lost to Follow-up|1|||
25103373|NCT02508649|50214247|FG001|Overall Study|Lost to Follow-up|1|||
25103374|NCT02508649|50214248|FG002|Overall Study|Lost to Follow-up|0|||
25103375|NCT02508649|50214249|FG003|Overall Study|Lost to Follow-up|1|||
25103376|NCT02505217|50214264|FG000|Overall Study|Withdrawal by Subject|1|||
25103377|NCT02505217|50214265|FG001|Overall Study|Withdrawal by Subject|2|||
25103378|NCT02504827|50214271|FG000|Overall Study|Could not produce sputum|1|||
25103379|NCT02504671|50214281|FG000|Overall Study|Withdrawal by Subject|1|||
25103380|NCT02504671|50214282|FG001|Overall Study|Withdrawal by Subject|5|||
25103381|NCT02504671|50214283|FG002|Overall Study|Withdrawal by Subject|4|||
25103382|NCT02504671|50214284|FG003|Overall Study|Withdrawal by Subject|4|||
25103383|NCT02504671|50214285|FG004|Overall Study|Withdrawal by Subject|5|||
25103384|NCT02504671|50214286|FG005|Overall Study|Withdrawal by Subject|3|||
25103385|NCT02504671|50214281|FG000|Overall Study|Lack of Efficacy|1|||
25103386|NCT02504671|50214282|FG001|Overall Study|Lack of Efficacy|3|||
25103387|NCT02504671|50214283|FG002|Overall Study|Lack of Efficacy|1|||
25103388|NCT02504671|50214284|FG003|Overall Study|Lack of Efficacy|0|||
25103389|NCT02504671|50214285|FG004|Overall Study|Lack of Efficacy|4|||
25103390|NCT02504671|50214286|FG005|Overall Study|Lack of Efficacy|4|||
25103391|NCT02504671|50214281|FG000|Overall Study|Adverse Event|1|||
25103392|NCT02504671|50214282|FG001|Overall Study|Adverse Event|1|||
25103393|NCT02504671|50214283|FG002|Overall Study|Adverse Event|0|||
25103394|NCT02504671|50214284|FG003|Overall Study|Adverse Event|1|||
25103395|NCT02504671|50214285|FG004|Overall Study|Adverse Event|0|||
25103396|NCT02504671|50214286|FG005|Overall Study|Adverse Event|2|||
25103397|NCT02504671|50214281|FG000|Overall Study|Protocol Violation|2|||
25103398|NCT02504671|50214282|FG001|Overall Study|Protocol Violation|1|||
25103399|NCT02504671|50214283|FG002|Overall Study|Protocol Violation|0|||
25103400|NCT02504671|50214284|FG003|Overall Study|Protocol Violation|0|||
25103401|NCT02504671|50214285|FG004|Overall Study|Protocol Violation|0|||
25103402|NCT02504671|50214286|FG005|Overall Study|Protocol Violation|1|||
25103403|NCT02504671|50214281|FG000|Overall Study|Lost to Follow-up|0|||
25103404|NCT02504671|50214282|FG001|Overall Study|Lost to Follow-up|0|||
25103405|NCT02504671|50214283|FG002|Overall Study|Lost to Follow-up|2|||
25103406|NCT02504671|50214284|FG003|Overall Study|Lost to Follow-up|0|||
25103407|NCT02504671|50214285|FG004|Overall Study|Lost to Follow-up|0|||
25103408|NCT02504671|50214286|FG005|Overall Study|Lost to Follow-up|1|||
25103409|NCT02504671|50214281|FG000|Overall Study|Protocol defined stopping criteria|7|||
25103410|NCT02504671|50214282|FG001|Overall Study|Protocol defined stopping criteria|4|||
25103411|NCT02504671|50214283|FG002|Overall Study|Protocol defined stopping criteria|3|||
25103412|NCT02504671|50214284|FG003|Overall Study|Protocol defined stopping criteria|5|||
25103413|NCT02504671|50214285|FG004|Overall Study|Protocol defined stopping criteria|3|||
25103414|NCT02504671|50214286|FG005|Overall Study|Protocol defined stopping criteria|3|||
25103415|NCT02314143|50214303|FG000|Overall Study|Adverse Event|0|||
25103416|NCT02314143|50214304|FG001|Overall Study|Adverse Event|6|||
25103417|NCT02314143|50214305|FG002|Overall Study|Adverse Event|4|||
25103418|NCT02314143|50214303|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
25103419|NCT02314143|50214304|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
25103420|NCT02314143|50214305|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
25103421|NCT02314143|50214303|FG000|Overall Study|Physician Decision|2|||
25103422|NCT02314143|50214304|FG001|Overall Study|Physician Decision|1|||
25103423|NCT02314143|50214305|FG002|Overall Study|Physician Decision|0|||
25103424|NCT02314143|50214303|FG000|Overall Study|Withdrawal by Subject|1|||
25103425|NCT02314143|50214304|FG001|Overall Study|Withdrawal by Subject|0|||
25103426|NCT02314143|50214305|FG002|Overall Study|Withdrawal by Subject|1|||
25103427|NCT02288091|50214314|FG000|Overall Study|Lost to Follow-up|1|||
25008261|NCT02565914|50101111|FG000|Overall Study|Other|18|||
25103428|NCT02288091|50214314|FG000|Overall Study|Screen fail|7|||
25103429|NCT02503501|50214320|FG000|Overall Study|Physician Decision|1|||
25103430|NCT02503501|50214321|FG001|Overall Study|Physician Decision|0|||
25103431|NCT02503501|50214320|FG000|Overall Study|Protocol Violation|0|||
25103432|NCT02503501|50214321|FG001|Overall Study|Protocol Violation|1|||
25103433|NCT02503501|50214320|FG000|Overall Study|Withdrawal by Subject|0|||
25103434|NCT02503501|50214321|FG001|Overall Study|Withdrawal by Subject|2|||
25103435|NCT02502097|50214331|FG000|Period 1|Adverse Event|0|||
25103436|NCT02502097|50214332|FG001|Period 1|Adverse Event|0|||
25103437|NCT02502097|50214333|FG002|Period 1|Adverse Event|1|||
25103438|NCT02502097|50214334|FG003|Period 1|Adverse Event|0|||
25103439|NCT02502097|50214331|FG000|Wash Out Period|Adverse Event|0|||
25103440|NCT02502097|50214332|FG001|Wash Out Period|Adverse Event|1|||
25103441|NCT02502097|50214333|FG002|Wash Out Period|Adverse Event|1|||
25103442|NCT02502097|50214334|FG003|Wash Out Period|Adverse Event|1|||
25103443|NCT02502097|50214331|FG000|Period 2|Adverse Event|0|||
25103444|NCT02502097|50214332|FG001|Period 2|Adverse Event|0|||
25103445|NCT02502097|50214333|FG002|Period 2|Adverse Event|1|||
25103446|NCT02502097|50214334|FG003|Period 2|Adverse Event|0|||
25103447|NCT02501629|50214343|FG000|Overall Study|Death|0|||
25103448|NCT02501629|50214344|FG001|Overall Study|Death|1|||
25103449|NCT02501629|50214343|FG000|Overall Study|Withdrawn from study by sponsor|1|||
25103450|NCT02501629|50214344|FG001|Overall Study|Withdrawn from study by sponsor|0|||
25103451|NCT02501629|50214343|FG000|Overall Study|Early termination by sponsor|1|||
25103452|NCT02501629|50214344|FG001|Overall Study|Early termination by sponsor|0|||
25103453|NCT02501629|50214343|FG000|Overall Study|Withdrawal by Subject|3|||
25103454|NCT02501629|50214344|FG001|Overall Study|Withdrawal by Subject|5|||
25103455|NCT02501629|50214343|FG000|Overall Study|Subject did not return to site|0|||
25103456|NCT02501629|50214344|FG001|Overall Study|Subject did not return to site|1|||
25103457|NCT02501473|50214357|FG000|Overall Study|Study Terminated|2|||
25103458|NCT02501473|50214358|FG001|Overall Study|Study Terminated|3|||
25103459|NCT02501473|50214359|FG002|Overall Study|Study Terminated|7|||
25103460|NCT02501473|50214360|FG003|Overall Study|Study Terminated|9|||
25103461|NCT02501473|50214361|FG004|Overall Study|Study Terminated|2|||
25103462|NCT02501473|50214362|FG005|Overall Study|Study Terminated|10|||
25103463|NCT02501473|50214363|FG006|Overall Study|Study Terminated|1|||
25103464|NCT02501473|50214364|FG007|Overall Study|Study Terminated|0|||
25103465|NCT02501473|50214357|FG000|Overall Study|Withdrawal by Subject|0|||
25103466|NCT02501473|50214358|FG001|Overall Study|Withdrawal by Subject|0|||
25103467|NCT02501473|50214359|FG002|Overall Study|Withdrawal by Subject|3|||
25103468|NCT02501473|50214360|FG003|Overall Study|Withdrawal by Subject|3|||
25103469|NCT02501473|50214361|FG004|Overall Study|Withdrawal by Subject|2|||
25103470|NCT02501473|50214362|FG005|Overall Study|Withdrawal by Subject|2|||
25103471|NCT02501473|50214363|FG006|Overall Study|Withdrawal by Subject|0|||
25103472|NCT02501473|50214364|FG007|Overall Study|Withdrawal by Subject|0|||
25103473|NCT02501473|50214357|FG000|Overall Study|Death|0|||
25103474|NCT02501473|50214358|FG001|Overall Study|Death|0|||
25103475|NCT02501473|50214359|FG002|Overall Study|Death|1|||
25103476|NCT02501473|50214360|FG003|Overall Study|Death|1|||
25103477|NCT02501473|50214361|FG004|Overall Study|Death|0|||
25103478|NCT02501473|50214362|FG005|Overall Study|Death|1|||
25103479|NCT02501473|50214363|FG006|Overall Study|Death|0|||
25103480|NCT02501473|50214364|FG007|Overall Study|Death|0|||
25103481|NCT02501473|50214357|FG000|Overall Study|Lost to Follow-up|1|||
25103482|NCT02501473|50214358|FG001|Overall Study|Lost to Follow-up|0|||
25103483|NCT02501473|50214359|FG002|Overall Study|Lost to Follow-up|1|||
25103484|NCT02501473|50214360|FG003|Overall Study|Lost to Follow-up|0|||
25103485|NCT02501473|50214361|FG004|Overall Study|Lost to Follow-up|0|||
25103486|NCT02501473|50214362|FG005|Overall Study|Lost to Follow-up|1|||
25103487|NCT02501473|50214363|FG006|Overall Study|Lost to Follow-up|0|||
25103488|NCT02501473|50214364|FG007|Overall Study|Lost to Follow-up|0|||
25103489|NCT02501473|50214357|FG000|Overall Study|Reason not specified|0|||
25103490|NCT02501473|50214358|FG001|Overall Study|Reason not specified|0|||
25103491|NCT02501473|50214359|FG002|Overall Study|Reason not specified|1|||
25103492|NCT02501473|50214360|FG003|Overall Study|Reason not specified|1|||
25103493|NCT02501473|50214361|FG004|Overall Study|Reason not specified|0|||
25103494|NCT02501473|50214362|FG005|Overall Study|Reason not specified|0|||
25103495|NCT02501473|50214363|FG006|Overall Study|Reason not specified|0|||
25103496|NCT02501473|50214364|FG007|Overall Study|Reason not specified|0|||
25103497|NCT02501161|50214382|FG000|Overall Study|Adverse Event|2|||
25103498|NCT02501161|50214383|FG001|Overall Study|Adverse Event|6|||
25103499|NCT02501161|50214382|FG000|Overall Study|Lost to Follow-up|7|||
25103500|NCT02501161|50214383|FG001|Overall Study|Lost to Follow-up|4|||
25103501|NCT02501161|50214382|FG000|Overall Study|Withdrawal by Subject|10|||
25103502|NCT02501161|50214383|FG001|Overall Study|Withdrawal by Subject|15|||
25103503|NCT02501161|50214382|FG000|Overall Study|Other|3|||
25103504|NCT02501161|50214383|FG001|Overall Study|Other|0|||
25103505|NCT02500537|50214391|FG000|Overall Study|Death|2|||
25103506|NCT02500537|50214392|FG001|Overall Study|Death|0|||
25103507|NCT02500537|50214391|FG000|Overall Study|Lost to Follow-up|0|||
25103508|NCT02500537|50214392|FG001|Overall Study|Lost to Follow-up|1|||
25103509|NCT02500537|50214391|FG000|Overall Study|Withdrawal by Subject|1|||
25103510|NCT02500537|50214392|FG001|Overall Study|Withdrawal by Subject|0|||
25103511|NCT02498821|50214401|FG000|Overall Study|Screen failure|3|||
25103512|NCT02498821|50214402|FG001|Overall Study|Screen failure|5|||
25103513|NCT02313909|50214410|FG000|Overall Study|Consent withdrawn by participant|33|||
25103514|NCT02313909|50214411|FG001|Overall Study|Consent withdrawn by participant|33|||
25103515|NCT02313909|50214410|FG000|Overall Study|Lost to Follow-up|24|||
25103516|NCT02313909|50214411|FG001|Overall Study|Lost to Follow-up|17|||
25103517|NCT02287467|50214419|FG000|Overall Study|Protocol Violation|12|||
25103518|NCT02287467|50214420|FG001|Overall Study|Protocol Violation|9|||
25103519|NCT02287233|50214432|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
25103520|NCT02287233|50214433|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
25103521|NCT02287233|50214434|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
25103522|NCT02287233|50214432|FG000|Overall Study|Adverse Event Related to Progression|0|||
25103523|NCT02287233|50214433|FG001|Overall Study|Adverse Event Related to Progression|2|||
25103524|NCT02287233|50214434|FG002|Overall Study|Adverse Event Related to Progression|8|||
25103525|NCT02287233|50214432|FG000|Overall Study|Physician Decision|1|||
25103526|NCT02287233|50214433|FG001|Overall Study|Physician Decision|2|||
25103527|NCT02287233|50214434|FG002|Overall Study|Physician Decision|4|||
25103528|NCT02287233|50214432|FG000|Overall Study|Progressive Disease with Death|0|||
25103529|NCT02287233|50214433|FG001|Overall Study|Progressive Disease with Death|0|||
25103530|NCT02287233|50214434|FG002|Overall Study|Progressive Disease with Death|10|||
25103531|NCT02287233|50214432|FG000|Overall Study|Progressive Disease Without Death|2|||
25103532|NCT02287233|50214433|FG001|Overall Study|Progressive Disease Without Death|3|||
25103533|NCT02287233|50214434|FG002|Overall Study|Progressive Disease Without Death|20|||
25103534|NCT02287233|50214432|FG000|Overall Study|Withdrawal by Subject|1|||
25103535|NCT02287233|50214433|FG001|Overall Study|Withdrawal by Subject|1|||
25103536|NCT02287233|50214434|FG002|Overall Study|Withdrawal by Subject|7|||
25103537|NCT02287233|50214432|FG000|Overall Study|Other|3|||
25103538|NCT02287233|50214433|FG001|Overall Study|Other|0|||
25103539|NCT02287233|50214434|FG002|Overall Study|Other|15|||
25103540|NCT02287233|50214432|FG000|Overall Study|Did Not Receive Treatment|0|||
25103541|NCT02287233|50214433|FG001|Overall Study|Did Not Receive Treatment|0|||
25103542|NCT02287233|50214434|FG002|Overall Study|Did Not Receive Treatment|2|||
25103543|NCT01646385|50214447|FG000|Overall Study|Death|202|||
25103544|NCT01646385|50214448|FG001|Overall Study|Death|222|||
25103545|NCT01646385|50214447|FG000|Overall Study|Switched to alternate biologic|636|||
25103546|NCT01646385|50214448|FG001|Overall Study|Switched to alternate biologic|649|||
25103547|NCT02286843|50214454|FG000|Overall Study|Not Treated|4|||
25103548|NCT02286843|50214454|FG000|Overall Study|Protocol Violation|1|||
25103549|NCT02286843|50214454|FG000|Overall Study|Withdrawal by Subject|1|||
25103550|NCT02282163|50214458|FG000|Overall Study|Protocol Violation|1|||
25103551|NCT02281773|50214476|FG000|Overall Study|Adverse Event|6|||
25103552|NCT02281773|50214477|FG001|Overall Study|Adverse Event|1|||
25103553|NCT02281773|50214478|FG002|Overall Study|Adverse Event|4|||
25103554|NCT02281773|50214479|FG003|Overall Study|Adverse Event|8|||
25103555|NCT02281773|50214480|FG004|Overall Study|Adverse Event|9|||
25103556|NCT02281773|50214476|FG000|Overall Study|Protocol Violation|1|||
25103557|NCT02281773|50214477|FG001|Overall Study|Protocol Violation|0|||
25103558|NCT02281773|50214478|FG002|Overall Study|Protocol Violation|0|||
25103559|NCT02281773|50214479|FG003|Overall Study|Protocol Violation|2|||
25103560|NCT02281773|50214480|FG004|Overall Study|Protocol Violation|2|||
25103561|NCT02281773|50214476|FG000|Overall Study|Lost to Follow-up|2|||
25103562|NCT02281773|50214477|FG001|Overall Study|Lost to Follow-up|2|||
25103563|NCT02281773|50214478|FG002|Overall Study|Lost to Follow-up|6|||
25103564|NCT02281773|50214479|FG003|Overall Study|Lost to Follow-up|2|||
25103565|NCT02281773|50214480|FG004|Overall Study|Lost to Follow-up|10|||
25103566|NCT02281773|50214476|FG000|Overall Study|Withdrawal by Subject|2|||
25103567|NCT02281773|50214477|FG001|Overall Study|Withdrawal by Subject|8|||
25103568|NCT02281773|50214478|FG002|Overall Study|Withdrawal by Subject|6|||
25103569|NCT02281773|50214479|FG003|Overall Study|Withdrawal by Subject|6|||
25103570|NCT02281773|50214480|FG004|Overall Study|Withdrawal by Subject|8|||
25103571|NCT02281773|50214476|FG000|Overall Study|Other Reason|0|||
25103572|NCT02281773|50214477|FG001|Overall Study|Other Reason|4|||
25103573|NCT02281773|50214478|FG002|Overall Study|Other Reason|2|||
25103574|NCT02281773|50214479|FG003|Overall Study|Other Reason|3|||
25103575|NCT02281773|50214480|FG004|Overall Study|Other Reason|1|||
25103576|NCT02285361|50214492|FG000|Overall Study|Protocol Violation|43|||
25103577|NCT02285361|50214492|FG000|Overall Study|Lost to Follow-up|5|||
25103578|NCT02285361|50214492|FG000|Overall Study|Not taken GIOTRIF|2|||
25103579|NCT02285361|50214492|FG000|Overall Study|Consented prior to the contract date|1|||
25103580|NCT02354235|50214498|FG000|Overall Study|Adverse Event|2|||
25103581|NCT02354235|50214499|FG001|Overall Study|Adverse Event|2|||
25103582|NCT02354235|50214498|FG000|Overall Study|Physician Decision|0|||
25103583|NCT02354235|50214499|FG001|Overall Study|Physician Decision|1|||
25103584|NCT02354235|50214498|FG000|Overall Study|Withdrawal by Subject|1|||
25103585|NCT02354235|50214499|FG001|Overall Study|Withdrawal by Subject|3|||
25103586|NCT02354235|50214498|FG000|Overall Study|Conflict with the stopping criteria|0|||
25103587|NCT02354235|50214499|FG001|Overall Study|Conflict with the stopping criteria|1|||
25103588|NCT02280291|50214509|FG000|Overall Study|Lost to Follow-up|2|||
25103589|NCT02280291|50214510|FG001|Overall Study|Lost to Follow-up|1|||
25103590|NCT02280291|50214511|FG002|Overall Study|Lost to Follow-up|3|||
25103591|NCT02280291|50214512|FG003|Overall Study|Lost to Follow-up|8|||
25103592|NCT02280291|50214509|FG000|Overall Study|Protocol Violation|1|||
25103593|NCT02280291|50214510|FG001|Overall Study|Protocol Violation|0|||
25103594|NCT02280291|50214511|FG002|Overall Study|Protocol Violation|0|||
25103595|NCT02280291|50214512|FG003|Overall Study|Protocol Violation|0|||
25103596|NCT02280291|50214509|FG000|Overall Study|Other|1|||
25103597|NCT02280291|50214510|FG001|Overall Study|Other|1|||
25103598|NCT02280291|50214511|FG002|Overall Study|Other|0|||
25103599|NCT02280291|50214512|FG003|Overall Study|Other|0|||
25103600|NCT02284893|50214526|FG000|26 Week (Short Term)|Adverse Event|1|||
25103601|NCT02284893|50214527|FG001|26 Week (Short Term)|Adverse Event|9|||
25103602|NCT02284893|50214526|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
25103603|NCT02284893|50214527|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
25103604|NCT02284893|50214526|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
25103605|NCT02284893|50214527|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
25103606|NCT02284893|50214526|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
25103607|NCT02284893|50214527|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
25103608|NCT02284893|50214526|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
25103609|NCT02284893|50214527|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
25103610|NCT02284893|50214526|FG000|26 Week (Short Term)|Other|1|||
25103611|NCT02284893|50214527|FG001|26 Week (Short Term)|Other|1|||
25103612|NCT02284893|50214526|FG000|52 Week (Long Term)|Adverse Event|3|||
25103613|NCT02284893|50214527|FG001|52 Week (Long Term)|Adverse Event|1|||
25103614|NCT02284893|50214526|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
25103615|NCT02284893|50214527|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
25103616|NCT02284893|50214526|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
25103617|NCT02284893|50214527|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
25103618|NCT02284893|50214526|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
25103619|NCT02284893|50214527|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
25103620|NCT02284893|50214526|FG000|52 Week (Long Term)|Non-Compliance|2|||
25103621|NCT02284893|50214527|FG001|52 Week (Long Term)|Non-Compliance|3|||
25103622|NCT02284347|50214533|FG000|Overall Study|Lost to Follow-up|2|||
25103623|NCT02284347|50214533|FG000|Overall Study|Withdrawn prior to treatment|1|||
25103624|NCT02279043|50214540|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
25103625|NCT02279043|50214541|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
25103626|NCT02279043|50214542|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
25103627|NCT02279043|50214540|FG000|Overall Study|Lost to Follow-up|46|||
25103628|NCT02279043|50214541|FG001|Overall Study|Lost to Follow-up|88|||
25103629|NCT02279043|50214542|FG002|Overall Study|Lost to Follow-up|0|||
25103630|NCT02283411|50214548|FG000|Overall Study|Withdrawal by Subject|3|||
25103631|NCT02283411|50214548|FG000|Overall Study|Screen Failed|28|||
25103632|NCT02351817|50214552|FG000|Period 1|Adverse Event|1|||
25103633|NCT02351817|50214553|FG001|Period 1|Adverse Event|2|||
25103634|NCT02351817|50214552|FG000|Period 1|Lack of Efficacy|0|||
25103635|NCT02351817|50214553|FG001|Period 1|Lack of Efficacy|1|||
25103636|NCT02351817|50214552|FG000|Period 2|Adverse Event|0|||
25103637|NCT02351817|50214553|FG001|Period 2|Adverse Event|2|||
25103638|NCT02351817|50214552|FG000|Period 2|Protocol Violation|1|||
25103639|NCT02351817|50214553|FG001|Period 2|Protocol Violation|0|||
25103640|NCT02351349|50214562|FG000|Overall Study|Withdrawal by Subject|2|||
25103641|NCT02351349|50214563|FG001|Overall Study|Withdrawal by Subject|3|||
25103642|NCT02484547|50214577|FG000|Placebo-Controlled Period|Adverse Event|10|||
25103643|NCT02484547|50214578|FG001|Placebo-Controlled Period|Adverse Event|13|||
25103644|NCT02484547|50214579|FG002|Placebo-Controlled Period|Adverse Event|20|||
25103645|NCT02484547|50214580|FG003|Placebo-Controlled Period|Adverse Event|0|||
25103646|NCT02484547|50214581|FG004|Placebo-Controlled Period|Adverse Event|0|||
25103647|NCT02484547|50214582|FG005|Placebo-Controlled Period|Adverse Event|0|||
25103648|NCT02484547|50214583|FG006|Placebo-Controlled Period|Adverse Event|0|||
25103649|NCT02484547|50214577|FG000|Placebo-Controlled Period|Change of Treatment|0|||
25103650|NCT02484547|50214578|FG001|Placebo-Controlled Period|Change of Treatment|0|||
25103651|NCT02484547|50214579|FG002|Placebo-Controlled Period|Change of Treatment|1|||
25103652|NCT02484547|50214580|FG003|Placebo-Controlled Period|Change of Treatment|0|||
25103653|NCT02484547|50214581|FG004|Placebo-Controlled Period|Change of Treatment|0|||
25103654|NCT02484547|50214582|FG005|Placebo-Controlled Period|Change of Treatment|0|||
25103655|NCT02484547|50214583|FG006|Placebo-Controlled Period|Change of Treatment|0|||
25103656|NCT02484547|50214577|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
25103657|NCT02484547|50214578|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
25103658|NCT02484547|50214579|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
25103659|NCT02484547|50214580|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
25103660|NCT02484547|50214581|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
25103661|NCT02484547|50214582|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
25103662|NCT02484547|50214583|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
25103663|NCT02484547|50214577|FG000|Placebo-Controlled Period|Death|5|||
25103664|NCT02484547|50214578|FG001|Placebo-Controlled Period|Death|0|||
25103665|NCT02484547|50214579|FG002|Placebo-Controlled Period|Death|6|||
25103666|NCT02484547|50214580|FG003|Placebo-Controlled Period|Death|0|||
25103667|NCT02484547|50214581|FG004|Placebo-Controlled Period|Death|0|||
25103668|NCT02484547|50214582|FG005|Placebo-Controlled Period|Death|0|||
25103669|NCT02484547|50214583|FG006|Placebo-Controlled Period|Death|0|||
25103670|NCT02484547|50214577|FG000|Placebo-Controlled Period|Disease Progression|2|||
25103671|NCT02484547|50214578|FG001|Placebo-Controlled Period|Disease Progression|0|||
25103672|NCT02484547|50214579|FG002|Placebo-Controlled Period|Disease Progression|1|||
25103673|NCT02484547|50214580|FG003|Placebo-Controlled Period|Disease Progression|0|||
25103674|NCT02484547|50214581|FG004|Placebo-Controlled Period|Disease Progression|0|||
25103675|NCT02484547|50214582|FG005|Placebo-Controlled Period|Disease Progression|0|||
25103676|NCT02484547|50214583|FG006|Placebo-Controlled Period|Disease Progression|0|||
25103677|NCT02484547|50214577|FG000|Placebo-Controlled Period|Investigator Decision|2|||
25103678|NCT02484547|50214578|FG001|Placebo-Controlled Period|Investigator Decision|2|||
25103679|NCT02484547|50214579|FG002|Placebo-Controlled Period|Investigator Decision|5|||
25103680|NCT02484547|50214580|FG003|Placebo-Controlled Period|Investigator Decision|0|||
25103681|NCT02484547|50214581|FG004|Placebo-Controlled Period|Investigator Decision|0|||
25103682|NCT02484547|50214582|FG005|Placebo-Controlled Period|Investigator Decision|0|||
25103683|NCT02484547|50214583|FG006|Placebo-Controlled Period|Investigator Decision|0|||
25103684|NCT02484547|50214577|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
25103685|NCT02484547|50214578|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
25103686|NCT02484547|50214579|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
25103687|NCT02484547|50214580|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
25103688|NCT02484547|50214581|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
25103689|NCT02484547|50214582|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
25103690|NCT02484547|50214583|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
25103691|NCT02484547|50214577|FG000|Placebo-Controlled Period|Relocation|1|||
25103692|NCT02484547|50214578|FG001|Placebo-Controlled Period|Relocation|1|||
25103693|NCT02484547|50214579|FG002|Placebo-Controlled Period|Relocation|1|||
25103694|NCT02484547|50214580|FG003|Placebo-Controlled Period|Relocation|0|||
25103695|NCT02484547|50214581|FG004|Placebo-Controlled Period|Relocation|0|||
25103696|NCT02484547|50214582|FG005|Placebo-Controlled Period|Relocation|0|||
25103697|NCT02484547|50214583|FG006|Placebo-Controlled Period|Relocation|0|||
25103698|NCT02484547|50214577|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
25103699|NCT02484547|50214578|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
25103700|NCT02484547|50214579|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
25103701|NCT02484547|50214580|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
25103702|NCT02484547|50214581|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
25103703|NCT02484547|50214582|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
25103704|NCT02484547|50214583|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
25103705|NCT02484547|50214577|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
25103706|NCT02484547|50214578|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
25103707|NCT02484547|50214579|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
25103708|NCT02484547|50214580|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
25103709|NCT02484547|50214581|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
25103710|NCT02484547|50214582|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
25103711|NCT02484547|50214583|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
25103712|NCT02484547|50214577|FG000|Placebo-Controlled Period|Reason not Specified|216|||
25103713|NCT02484547|50214578|FG001|Placebo-Controlled Period|Reason not Specified|194|||
25103714|NCT02484547|50214579|FG002|Placebo-Controlled Period|Reason not Specified|183|||
25103715|NCT02484547|50214580|FG003|Placebo-Controlled Period|Reason not Specified|0|||
25103716|NCT02484547|50214581|FG004|Placebo-Controlled Period|Reason not Specified|0|||
25103717|NCT02484547|50214582|FG005|Placebo-Controlled Period|Reason not Specified|0|||
25103718|NCT02484547|50214583|FG006|Placebo-Controlled Period|Reason not Specified|0|||
25103719|NCT02484547|50214577|FG000|Long-Term Extension Period|Adverse Event|0|||
25103720|NCT02484547|50214578|FG001|Long-Term Extension Period|Adverse Event|0|||
25103721|NCT02484547|50214579|FG002|Long-Term Extension Period|Adverse Event|0|||
25103722|NCT02484547|50214580|FG003|Long-Term Extension Period|Adverse Event|0|||
25103723|NCT02484547|50214581|FG004|Long-Term Extension Period|Adverse Event|1|||
25103724|NCT02484547|50214582|FG005|Long-Term Extension Period|Adverse Event|3|||
25103725|NCT02484547|50214583|FG006|Long-Term Extension Period|Adverse Event|2|||
25103726|NCT02484547|50214577|FG000|Long-Term Extension Period|Death|0|||
25103727|NCT02484547|50214578|FG001|Long-Term Extension Period|Death|0|||
25103728|NCT02484547|50214579|FG002|Long-Term Extension Period|Death|0|||
25103729|NCT02484547|50214580|FG003|Long-Term Extension Period|Death|0|||
25103730|NCT02484547|50214581|FG004|Long-Term Extension Period|Death|0|||
25103731|NCT02484547|50214582|FG005|Long-Term Extension Period|Death|3|||
25103732|NCT02484547|50214583|FG006|Long-Term Extension Period|Death|0|||
25103733|NCT02484547|50214577|FG000|Long-Term Extension Period|Disease Progression|0|||
25103734|NCT02484547|50214578|FG001|Long-Term Extension Period|Disease Progression|0|||
25103735|NCT02484547|50214579|FG002|Long-Term Extension Period|Disease Progression|0|||
25103736|NCT02484547|50214580|FG003|Long-Term Extension Period|Disease Progression|0|||
25103737|NCT02484547|50214581|FG004|Long-Term Extension Period|Disease Progression|2|||
25103738|NCT02484547|50214582|FG005|Long-Term Extension Period|Disease Progression|4|||
25103739|NCT02484547|50214583|FG006|Long-Term Extension Period|Disease Progression|0|||
25103740|NCT02484547|50214577|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
25103741|NCT02484547|50214578|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
25103742|NCT02484547|50214579|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
25103743|NCT02484547|50214580|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
25103744|NCT02484547|50214581|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
25103745|NCT02484547|50214582|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
25103746|NCT02484547|50214583|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
25103747|NCT02484547|50214577|FG000|Long-Term Extension Period|Loss of Capacity|0|||
25103748|NCT02484547|50214578|FG001|Long-Term Extension Period|Loss of Capacity|0|||
25103749|NCT02484547|50214579|FG002|Long-Term Extension Period|Loss of Capacity|0|||
25103750|NCT02484547|50214580|FG003|Long-Term Extension Period|Loss of Capacity|0|||
25103751|NCT02484547|50214581|FG004|Long-Term Extension Period|Loss of Capacity|1|||
25103752|NCT02484547|50214582|FG005|Long-Term Extension Period|Loss of Capacity|0|||
25103753|NCT02484547|50214583|FG006|Long-Term Extension Period|Loss of Capacity|0|||
25103754|NCT02484547|50214577|FG000|Long-Term Extension Period|Change of Treatment|0|||
25103755|NCT02484547|50214578|FG001|Long-Term Extension Period|Change of Treatment|0|||
25103756|NCT02484547|50214579|FG002|Long-Term Extension Period|Change of Treatment|0|||
25103757|NCT02484547|50214580|FG003|Long-Term Extension Period|Change of Treatment|0|||
25103758|NCT02484547|50214581|FG004|Long-Term Extension Period|Change of Treatment|0|||
25103759|NCT02484547|50214582|FG005|Long-Term Extension Period|Change of Treatment|0|||
25103760|NCT02484547|50214583|FG006|Long-Term Extension Period|Change of Treatment|1|||
25103761|NCT02484547|50214577|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
25103762|NCT02484547|50214578|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
25103763|NCT02484547|50214579|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
25103764|NCT02484547|50214580|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
25103765|NCT02484547|50214581|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
25103766|NCT02484547|50214582|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
25103767|NCT02484547|50214583|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
25103768|NCT02484547|50214577|FG000|Long-Term Extension Period|Investigator Decision|0|||
25103769|NCT02484547|50214578|FG001|Long-Term Extension Period|Investigator Decision|0|||
25103770|NCT02484547|50214579|FG002|Long-Term Extension Period|Investigator Decision|0|||
25103771|NCT02484547|50214580|FG003|Long-Term Extension Period|Investigator Decision|2|||
25103772|NCT02484547|50214581|FG004|Long-Term Extension Period|Investigator Decision|1|||
25103773|NCT02484547|50214582|FG005|Long-Term Extension Period|Investigator Decision|0|||
25103774|NCT02484547|50214583|FG006|Long-Term Extension Period|Investigator Decision|1|||
25103775|NCT02484547|50214577|FG000|Long-Term Extension Period|Relocation|0|||
25103776|NCT02484547|50214578|FG001|Long-Term Extension Period|Relocation|0|||
25103777|NCT02484547|50214579|FG002|Long-Term Extension Period|Relocation|0|||
25103778|NCT02484547|50214580|FG003|Long-Term Extension Period|Relocation|1|||
25103779|NCT02484547|50214581|FG004|Long-Term Extension Period|Relocation|1|||
25103780|NCT02484547|50214582|FG005|Long-Term Extension Period|Relocation|0|||
25103781|NCT02484547|50214583|FG006|Long-Term Extension Period|Relocation|0|||
25103782|NCT02484547|50214577|FG000|Long-Term Extension Period|Study Visit Burden|0|||
25103783|NCT02484547|50214578|FG001|Long-Term Extension Period|Study Visit Burden|0|||
25103784|NCT02484547|50214579|FG002|Long-Term Extension Period|Study Visit Burden|0|||
25103785|NCT02484547|50214580|FG003|Long-Term Extension Period|Study Visit Burden|2|||
25103786|NCT02484547|50214581|FG004|Long-Term Extension Period|Study Visit Burden|0|||
25103787|NCT02484547|50214582|FG005|Long-Term Extension Period|Study Visit Burden|0|||
25103788|NCT02484547|50214583|FG006|Long-Term Extension Period|Study Visit Burden|3|||
25103789|NCT02484547|50214577|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
25103790|NCT02484547|50214578|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
25103791|NCT02484547|50214579|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
25103792|NCT02484547|50214580|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
25103793|NCT02484547|50214581|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
25103794|NCT02484547|50214582|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
25103795|NCT02484547|50214583|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
25103796|NCT02484547|50214577|FG000|Long-Term Extension Period|Reason not Specified|0|||
25103797|NCT02484547|50214578|FG001|Long-Term Extension Period|Reason not Specified|0|||
25103798|NCT02484547|50214579|FG002|Long-Term Extension Period|Reason not Specified|0|||
25103799|NCT02484547|50214580|FG003|Long-Term Extension Period|Reason not Specified|119|||
25103800|NCT02484547|50214581|FG004|Long-Term Extension Period|Reason not Specified|117|||
25103801|NCT02484547|50214582|FG005|Long-Term Extension Period|Reason not Specified|223|||
25103802|NCT02484547|50214583|FG006|Long-Term Extension Period|Reason not Specified|231|||
25103803|NCT02517541|50214595|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
25103804|NCT02517541|50214595|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
25103805|NCT02517541|50214595|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
25103806|NCT02517541|50214595|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
25103807|NCT02517541|50214595|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
25103808|NCT02517541|50214595|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
25103809|NCT02496091|50214601|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
25103810|NCT02483611|50214609|FG000|Overall Study|Protocol Violation|0|||
25103811|NCT02483611|50214610|FG001|Overall Study|Protocol Violation|0|||
25103812|NCT02483611|50214611|FG002|Overall Study|Protocol Violation|1|||
25103813|NCT02483533|50214621|FG000|Overall Study|Lack of Efficacy|50|||
25103814|NCT02483533|50214622|FG001|Overall Study|Lack of Efficacy|50|||
25103815|NCT02482129|50214630|FG000|Overall Study|Adverse Event-prior to treatment|0|||
25103816|NCT02482129|50214631|FG001|Overall Study|Adverse Event-prior to treatment|1|||
25103817|NCT02482129|50214630|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
25103818|NCT02482129|50214631|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
25103819|NCT02482129|50214630|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
25103820|NCT02482129|50214631|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
25103821|NCT02482129|50214630|FG000|Overall Study|Criteria not met-prior to treatment|1|||
25103822|NCT02482129|50214631|FG001|Overall Study|Criteria not met-prior to treatment|0|||
25103823|NCT02482129|50214630|FG000|Overall Study|Adverse Event|1|||
25103824|NCT02482129|50214631|FG001|Overall Study|Adverse Event|0|||
25103825|NCT02482129|50214630|FG000|Overall Study|Withdrawal by Subject|2|||
25103826|NCT02482129|50214631|FG001|Overall Study|Withdrawal by Subject|0|||
25103827|NCT02482129|50214630|FG000|Overall Study|Criteria not met|1|||
25103828|NCT02482129|50214631|FG001|Overall Study|Criteria not met|0|||
25103829|NCT02495857|50214642|FG000|Overall Study|Adverse Event|5|||
25103830|NCT02495857|50214643|FG001|Overall Study|Adverse Event|0|||
25103831|NCT02495857|50214644|FG002|Overall Study|Adverse Event|1|||
25103832|NCT02495857|50214642|FG000|Overall Study|Withdrawal by Subject|9|||
25103833|NCT02495857|50214643|FG001|Overall Study|Withdrawal by Subject|6|||
25103834|NCT02495857|50214644|FG002|Overall Study|Withdrawal by Subject|10|||
25103835|NCT02495857|50214642|FG000|Overall Study|Physician Decision|0|||
25103836|NCT02495857|50214643|FG001|Overall Study|Physician Decision|1|||
25103837|NCT02495857|50214644|FG002|Overall Study|Physician Decision|0|||
25103838|NCT02495857|50214642|FG000|Overall Study|Protocol Violation|1|||
25103839|NCT02495857|50214643|FG001|Overall Study|Protocol Violation|1|||
25103840|NCT02495857|50214644|FG002|Overall Study|Protocol Violation|2|||
25103841|NCT02495857|50214642|FG000|Overall Study|Lost to Follow-up|4|||
25103842|NCT02495857|50214643|FG001|Overall Study|Lost to Follow-up|5|||
25103843|NCT02495857|50214644|FG002|Overall Study|Lost to Follow-up|3|||
25103844|NCT02495857|50214642|FG000|Overall Study|Other|3|||
25103845|NCT02495857|50214643|FG001|Overall Study|Other|3|||
25103846|NCT02495857|50214644|FG002|Overall Study|Other|2|||
25103847|NCT02495389|50214652|FG000|Overall Study|Withdrawal by Subject|40|||
25103848|NCT02495233|50214658|FG000|Overall Study|Miscellaneous|0|||
25103849|NCT02495233|50214659|FG001|Overall Study|Miscellaneous|1|||
25103850|NCT02495077|50214667|FG000|Overall Study|Adverse Event|0|||
25103851|NCT02495077|50214668|FG001|Overall Study|Adverse Event|1|||
25103852|NCT02495077|50214669|FG002|Overall Study|Adverse Event|1|||
25103853|NCT02495077|50214670|FG003|Overall Study|Adverse Event|0|||
25103854|NCT02495077|50214667|FG000|Overall Study|Death|3|||
25103855|NCT02495077|50214668|FG001|Overall Study|Death|5|||
25103856|NCT02495077|50214669|FG002|Overall Study|Death|0|||
25103857|NCT02495077|50214670|FG003|Overall Study|Death|0|||
25103858|NCT02495077|50214667|FG000|Overall Study|Lost to Follow-up|6|||
25103859|NCT02495077|50214668|FG001|Overall Study|Lost to Follow-up|4|||
25103860|NCT02495077|50214669|FG002|Overall Study|Lost to Follow-up|0|||
25103861|NCT02495077|50214670|FG003|Overall Study|Lost to Follow-up|0|||
25103862|NCT02495077|50214667|FG000|Overall Study|Physician Decision|2|||
25103863|NCT02495077|50214668|FG001|Overall Study|Physician Decision|1|||
25103864|NCT02495077|50214669|FG002|Overall Study|Physician Decision|4|||
25103865|NCT02495077|50214670|FG003|Overall Study|Physician Decision|0|||
25103866|NCT02495077|50214667|FG000|Overall Study|Protocol Violation|0|||
25103867|NCT02495077|50214668|FG001|Overall Study|Protocol Violation|1|||
25103868|NCT02495077|50214669|FG002|Overall Study|Protocol Violation|0|||
25103869|NCT02495077|50214670|FG003|Overall Study|Protocol Violation|0|||
25103870|NCT02495077|50214667|FG000|Overall Study|Screen Failure|0|||
25103871|NCT02495077|50214668|FG001|Overall Study|Screen Failure|0|||
25103872|NCT02495077|50214669|FG002|Overall Study|Screen Failure|0|||
25103873|NCT02495077|50214670|FG003|Overall Study|Screen Failure|48|||
25103874|NCT02495077|50214667|FG000|Overall Study|Withdrawal by Subject|7|||
25103875|NCT02495077|50214668|FG001|Overall Study|Withdrawal by Subject|7|||
25103876|NCT02495077|50214669|FG002|Overall Study|Withdrawal by Subject|7|||
25103877|NCT02495077|50214670|FG003|Overall Study|Withdrawal by Subject|0|||
25103878|NCT02495077|50214667|FG000|Overall Study|Covid-19 research restrictions|1|||
25008262|NCT02565914|50101111|FG000|Overall Study|Enrolled, but did not receive study drug|2|||
25103879|NCT02495077|50214668|FG001|Overall Study|Covid-19 research restrictions|0|||
25103880|NCT02495077|50214669|FG002|Overall Study|Covid-19 research restrictions|0|||
25103881|NCT02495077|50214670|FG003|Overall Study|Covid-19 research restrictions|0|||
25103882|NCT02495077|50214667|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
25103883|NCT02495077|50214668|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
25103884|NCT02495077|50214669|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
25103885|NCT02495077|50214670|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
25103886|NCT02495077|50214667|FG000|Overall Study|Incarcerated|0|||
25103887|NCT02495077|50214668|FG001|Overall Study|Incarcerated|1|||
25103888|NCT02495077|50214669|FG002|Overall Study|Incarcerated|0|||
25103889|NCT02495077|50214670|FG003|Overall Study|Incarcerated|0|||
25103890|NCT02495077|50214667|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
25103891|NCT02495077|50214668|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
25103892|NCT02495077|50214669|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
25103893|NCT02495077|50214670|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
25103894|NCT02495077|50214667|FG000|Overall Study|Timing of transplant and randomization|0|||
25103895|NCT02495077|50214668|FG001|Overall Study|Timing of transplant and randomization|0|||
25103896|NCT02495077|50214669|FG002|Overall Study|Timing of transplant and randomization|5|||
25103897|NCT02495077|50214670|FG003|Overall Study|Timing of transplant and randomization|0|||
25103898|NCT02278341|50214678|FG000|Overall Study|Randomized but never received study drug|1|||
25103899|NCT02278341|50214679|FG001|Overall Study|Randomized but never received study drug|1|||
25103900|NCT02278341|50214678|FG000|Overall Study|Adverse Event|3|||
25103901|NCT02278341|50214679|FG001|Overall Study|Adverse Event|0|||
25103902|NCT02278341|50214678|FG000|Overall Study|Death|68|||
25103903|NCT02278341|50214679|FG001|Overall Study|Death|56|||
25103904|NCT02278341|50214678|FG000|Overall Study|Withdrawal by Subject|30|||
25103905|NCT02278341|50214679|FG001|Overall Study|Withdrawal by Subject|19|||
25103906|NCT02278341|50214678|FG000|Overall Study|Lost to Follow-up|0|||
25103907|NCT02278341|50214679|FG001|Overall Study|Lost to Follow-up|1|||
25103908|NCT02278341|50214678|FG000|Overall Study|Physician Decision|1|||
25103909|NCT02278341|50214679|FG001|Overall Study|Physician Decision|1|||
25103910|NCT02278341|50214678|FG000|Overall Study|Miscellaneous|15|||
25103911|NCT02278341|50214679|FG001|Overall Study|Miscellaneous|14|||
25103912|NCT02282631|50214688|FG000|Overall Study|Lost to Follow-up|2|||
25103913|NCT02282631|50214689|FG001|Overall Study|Lost to Follow-up|0|||
25103914|NCT02278263|50214704|FG000|Overall Study|Protocol Violation|7|||
25103915|NCT02278263|50214705|FG001|Overall Study|Protocol Violation|0|||
25103916|NCT02278263|50214706|FG002|Overall Study|Protocol Violation|9|||
25103917|NCT02349789|50214717|FG000|Overall Study|Withdrawal by Subject|2|||
25103918|NCT02349711|50214723|FG000|Overall Study|Withdrawal by Subject|2|||
25103919|NCT02349711|50214724|FG001|Overall Study|Withdrawal by Subject|1|||
25103920|NCT02349711|50214723|FG000|Overall Study|Lost to Follow-up|1|||
25103921|NCT02349711|50214724|FG001|Overall Study|Lost to Follow-up|1|||
25103922|NCT02494921|50214735|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
25103923|NCT02494921|50214736|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
25103924|NCT02494921|50214737|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
25103925|NCT02494921|50214738|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
25103926|NCT02494921|50214739|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
25103927|NCT02494921|50214735|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
25103928|NCT02494921|50214736|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
25103929|NCT02494921|50214737|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
25103930|NCT02494921|50214738|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
25103931|NCT02494921|50214739|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
25103932|NCT02494921|50214735|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
25103933|NCT02494921|50214736|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
25103934|NCT02494921|50214737|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
25103935|NCT02494921|50214738|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
25103936|NCT02494921|50214739|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
25103937|NCT01653847|50214759|FG000|Overall Study|Withdrawal by Subject|1|||
25103938|NCT01653847|50214760|FG001|Overall Study|Withdrawal by Subject|0|||
25103939|NCT02493751|50214768|FG000|Overall Study|Withdrawal by Subject|2|||
25103940|NCT02493751|50214769|FG001|Overall Study|Withdrawal by Subject|8|||
25103941|NCT02493751|50214768|FG000|Overall Study|Death|6|||
25103942|NCT02493751|50214769|FG001|Overall Study|Death|13|||
25103943|NCT02493751|50214768|FG000|Overall Study|Lost to Follow-up|2|||
25103944|NCT02493751|50214769|FG001|Overall Study|Lost to Follow-up|3|||
25103945|NCT02493751|50214768|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
25103946|NCT02493751|50214769|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
25103947|NCT02493517|50214778|FG000|Overall Study|Protocol Violation|1|||
25103948|NCT02493517|50214779|FG001|Overall Study|Protocol Violation|2|||
25103949|NCT02493517|50214778|FG000|Overall Study|Withdrawal by Subject|1|||
25103950|NCT02493517|50214779|FG001|Overall Study|Withdrawal by Subject|2|||
25103951|NCT02493517|50214778|FG000|Overall Study|Adverse Event|0|||
25103952|NCT02493517|50214779|FG001|Overall Study|Adverse Event|2|||
25103953|NCT02493517|50214778|FG000|Overall Study|Missed study visit|0|||
25103954|NCT02493517|50214779|FG001|Overall Study|Missed study visit|1|||
25103955|NCT02493361|50214787|FG000|Overall Study|Withdrawal by Subject|3|||
25103956|NCT02493127|50214793|FG000|Overall Study|Lost to Follow-up|1|||
25103957|NCT02493127|50214794|FG001|Overall Study|Lost to Follow-up|1|||
25103958|NCT02478463|50214802|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
25103959|NCT02478463|50214802|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
25103960|NCT02478463|50214802|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
25103961|NCT02491411|50214808|FG000|Overall Study|Physician Decision|4|||
25103962|NCT02517463|50214814|FG000|Overall Study|Lost to Follow-up|5|||
25103963|NCT02517463|50214815|FG001|Overall Study|Lost to Follow-up|2|||
25103964|NCT02516605|50214826|FG000|Overall Study|Protocol Violation|0|||
25103965|NCT02516605|50214827|FG001|Overall Study|Protocol Violation|0|||
25103966|NCT02516605|50214828|FG002|Overall Study|Protocol Violation|0|||
25103967|NCT02516605|50214829|FG003|Overall Study|Protocol Violation|0|||
25103968|NCT02516605|50214830|FG004|Overall Study|Protocol Violation|1|||
25103969|NCT02516605|50214826|FG000|Overall Study|Withdrawal by Subject|0|||
25103970|NCT02516605|50214827|FG001|Overall Study|Withdrawal by Subject|0|||
25103971|NCT02516605|50214828|FG002|Overall Study|Withdrawal by Subject|0|||
25103972|NCT02516605|50214829|FG003|Overall Study|Withdrawal by Subject|1|||
25103973|NCT02516605|50214830|FG004|Overall Study|Withdrawal by Subject|0|||
25103974|NCT02490475|50214850|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
25103975|NCT02490475|50214851|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
25103976|NCT02490475|50214852|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
25103977|NCT02490475|50214853|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
25103978|NCT02490475|50214850|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
25103979|NCT02490475|50214851|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
25103980|NCT02490475|50214852|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
25103981|NCT02490475|50214853|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
25103982|NCT02490475|50214850|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
25103983|NCT02490475|50214851|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
25103984|NCT02490475|50214852|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
25103985|NCT02490475|50214853|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
25103986|NCT02490475|50214850|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
25103987|NCT02490475|50214851|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
25103988|NCT02490475|50214852|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
25103989|NCT02490475|50214853|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
25103990|NCT02490475|50214850|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
25103991|NCT02490475|50214851|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
25103992|NCT02490475|50214852|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
25103993|NCT02490475|50214853|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
25103994|NCT02490475|50214850|FG000|Period 2: Extension Phase|Refused Treatment|0|||
25103995|NCT02490475|50214851|FG001|Period 2: Extension Phase|Refused Treatment|0|||
25103996|NCT02490475|50214852|FG002|Period 2: Extension Phase|Refused Treatment|0|||
25103997|NCT02490475|50214853|FG003|Period 2: Extension Phase|Refused Treatment|1|||
25103998|NCT02490475|50214850|FG000|Period 2: Extension Phase|Adverse Event|0|||
25103999|NCT02490475|50214851|FG001|Period 2: Extension Phase|Adverse Event|0|||
25104000|NCT02490475|50214852|FG002|Period 2: Extension Phase|Adverse Event|1|||
25104001|NCT02490475|50214853|FG003|Period 2: Extension Phase|Adverse Event|0|||
25104002|NCT02477839|50214876|FG000|Overall Study|Adverse Event|0|||
25104003|NCT02477839|50214877|FG001|Overall Study|Adverse Event|1|||
25104004|NCT02477839|50214876|FG000|Overall Study|Protocol Violation|0|||
25104005|NCT02477839|50214877|FG001|Overall Study|Protocol Violation|2|||
25104006|NCT02477839|50214876|FG000|Overall Study|Withdrawal by Subject|3|||
25104007|NCT02477839|50214877|FG001|Overall Study|Withdrawal by Subject|3|||
25104008|NCT02477839|50214876|FG000|Overall Study|Participant had PGS during V6|0|||
25104009|NCT02477839|50214877|FG001|Overall Study|Participant had PGS during V6|1|||
25104010|NCT02477839|50214876|FG000|Overall Study|Parents decided to stop medication|0|||
25104011|NCT02477839|50214877|FG001|Overall Study|Parents decided to stop medication|1|||
25104012|NCT02477839|50214876|FG000|Overall Study|Lack of tolerability|0|||
25104013|NCT02477839|50214877|FG001|Overall Study|Lack of tolerability|1|||
25104014|NCT02477839|50214876|FG000|Overall Study|Exclusion criterion|0|||
25104015|NCT02477839|50214877|FG001|Overall Study|Exclusion criterion|1|||
25104016|NCT02489773|50214887|FG000|Overall Study|Lost to Follow-up|4|||
25104017|NCT02489773|50214888|FG001|Overall Study|Lost to Follow-up|1|||
25104018|NCT02489773|50214887|FG000|Overall Study|Physician Decision|1|||
25104019|NCT02489773|50214888|FG001|Overall Study|Physician Decision|0|||
25104020|NCT02489773|50214887|FG000|Overall Study|Withdrawal by Subject|1|||
25104021|NCT02489773|50214888|FG001|Overall Study|Withdrawal by Subject|0|||
25104022|NCT02489773|50214887|FG000|Overall Study|Leave the country or the state|1|||
25104023|NCT02489773|50214888|FG001|Overall Study|Leave the country or the state|1|||
25104024|NCT02488915|50214894|FG000|Overall Study|Death|21|||
25104025|NCT02488915|50214894|FG000|Overall Study|Lost to Follow-up|4|||
25104026|NCT02488915|50214894|FG000|Overall Study|Withdrawal by Subject|1|||
25104027|NCT02488681|50214898|FG000|Overall Study|Implant unsuccessful|7|||
25104028|NCT02477605|50214904|FG000|Overall Study|Discontinued prior to treatment|1|||
25104029|NCT02477605|50214905|FG001|Overall Study|Discontinued prior to treatment|0|||
25104030|NCT02477605|50214904|FG000|Overall Study|Lost to Follow-up|0|||
25104031|NCT02477605|50214905|FG001|Overall Study|Lost to Follow-up|2|||
25104032|NCT02477605|50214904|FG000|Overall Study|Withdrawal by Subject|0|||
25104033|NCT02477605|50214905|FG001|Overall Study|Withdrawal by Subject|1|||
25104034|NCT02477605|50214904|FG000|Overall Study|Administered gas during surgery|0|||
25104035|NCT02477605|50214905|FG001|Overall Study|Administered gas during surgery|1|||
25104036|NCT02477527|50214915|FG000|Overall Study|Lost to Follow-up|2|||
25104037|NCT02477527|50214915|FG000|Overall Study|Withdrawal by Subject|1|||
25104038|NCT02477527|50214915|FG000|Overall Study|Screen Failure|3|||
25104039|NCT02477215|50214923|FG000|Dose Escalation Phase|Physician Decision|1|||
25104040|NCT02477215|50214924|FG001|Dose Escalation Phase|Physician Decision|2|||
25104041|NCT02477215|50214925|FG002|Dose Escalation Phase|Physician Decision|0|||
25104042|NCT02477215|50214923|FG000|Fixed Dose Phase|Physician Decision|0|||
25104043|NCT02477215|50214924|FG001|Fixed Dose Phase|Physician Decision|7|||
25104044|NCT02477215|50214925|FG002|Fixed Dose Phase|Physician Decision|0|||
25104045|NCT02487199|50214938|FG000|Overall Study|Withdrew Consent|0|||
25104046|NCT02487199|50214939|FG001|Overall Study|Withdrew Consent|1|||
25104047|NCT02475733|50214947|FG000|Overall Study|Withdrawal by Subject|1|||
25104048|NCT02475733|50214948|FG001|Overall Study|Withdrawal by Subject|0|||
25104049|NCT02475733|50214947|FG000|Overall Study|Physician Decision|1|||
25104050|NCT02475733|50214948|FG001|Overall Study|Physician Decision|0|||
25104051|NCT02486653|50214956|FG000|Overall Study|Withdrawal by Subject|1|||
25104052|NCT02486653|50214957|FG001|Overall Study|Withdrawal by Subject|3|||
25104053|NCT02486653|50214956|FG000|Overall Study|Protocol Violation|1|||
25104054|NCT02486653|50214957|FG001|Overall Study|Protocol Violation|0|||
25104055|NCT02486653|50214956|FG000|Overall Study|surgery cancelled|4|||
25104056|NCT02486653|50214957|FG001|Overall Study|surgery cancelled|1|||
25104057|NCT02475655|50214965|FG000|Overall Study|Lost to Follow-up|0|||
25104058|NCT02475655|50214966|FG001|Overall Study|Lost to Follow-up|1|||
25104059|NCT02475265|50214972|FG000|Overall Study|Physician Decision|1|||
25104060|NCT02475265|50214972|FG000|Overall Study|Withdrawal by Subject|2|||
25104061|NCT02485717|50214979|FG000|Overall Study|Lost to Follow-up|6|||
25104062|NCT02485717|50214980|FG001|Overall Study|Lost to Follow-up|0|||
25104063|NCT02485717|50214981|FG002|Overall Study|Lost to Follow-up|0|||
25104064|NCT02485717|50214979|FG000|Overall Study|Withdrawal by Subject|0|||
25104065|NCT02485717|50214980|FG001|Overall Study|Withdrawal by Subject|0|||
25104066|NCT02485717|50214981|FG002|Overall Study|Withdrawal by Subject|1|||
25104067|NCT02485717|50214979|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
25104068|NCT02485717|50214980|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
25104069|NCT02485717|50214981|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
25104070|NCT02485717|50214979|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
25104071|NCT02485717|50214980|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
25104072|NCT02485717|50214981|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
25104073|NCT02451007|50214989|FG000|Overall Study|Withdrawal by Subject|4|||
25104074|NCT02451007|50214989|FG000|Overall Study|Adverse Event|1|||
25104075|NCT02451007|50214989|FG000|Overall Study|Disease Progression|2|||
25104076|NCT02485483|50214995|FG000|Overall Study|Depression at baseline|15|||
25104077|NCT02485483|50214996|FG001|Overall Study|Depression at baseline|0|||
25104078|NCT02485483|50214995|FG000|Overall Study|Discontinued after baseline|39|||
25104079|NCT02485483|50214996|FG001|Overall Study|Discontinued after baseline|0|||
25104080|NCT02473471|50215002|FG000|Overall Study|poor oral hygiene|2|||
25104081|NCT02473471|50215002|FG000|Overall Study|Lost to Follow-up|1|||
25104082|NCT02450539|50215014|FG000|Overall Study|Withdrawal by Subject|12|||
25104083|NCT02450539|50215015|FG001|Overall Study|Withdrawal by Subject|6|||
25104084|NCT02450539|50215014|FG000|Overall Study|Lost to Follow-up|4|||
25104085|NCT02450539|50215015|FG001|Overall Study|Lost to Follow-up|1|||
25104086|NCT02449915|50215026|FG000|Overall Study|Exclusion criteria - drug use|1|||
25104087|NCT02449915|50215027|FG001|Overall Study|Exclusion criteria - drug use|0|||
25104088|NCT02449915|50215026|FG000|Overall Study|Withdrawal by Subject|0|||
25104089|NCT02449915|50215027|FG001|Overall Study|Withdrawal by Subject|2|||
25104090|NCT02449915|50215026|FG000|Overall Study|Intraoperative surgical findings|1|||
25104091|NCT02449915|50215027|FG001|Overall Study|Intraoperative surgical findings|1|||
25104092|NCT02449915|50215026|FG000|Overall Study|Abnormal preop lab|0|||
25104093|NCT02449915|50215027|FG001|Overall Study|Abnormal preop lab|1|||
25104094|NCT02420119|50215033|FG000|Overall Study|insufficient laboratory data|5|||
25104095|NCT02473393|50215041|FG000|Overall Study|Adverse Event|0|||
25104096|NCT02473393|50215042|FG001|Overall Study|Adverse Event|0|||
25104097|NCT02473393|50215043|FG002|Overall Study|Adverse Event|1|||
25104098|NCT02473393|50215044|FG003|Overall Study|Adverse Event|0|||
25104099|NCT02473393|50215041|FG000|Overall Study|Withdrawal by Subject|0|||
25104100|NCT02473393|50215042|FG001|Overall Study|Withdrawal by Subject|0|||
25104101|NCT02473393|50215043|FG002|Overall Study|Withdrawal by Subject|1|||
25104102|NCT02473393|50215044|FG003|Overall Study|Withdrawal by Subject|1|||
25104103|NCT02419573|50215056|FG000|Overall Study|Lost to Follow-up|3|||
25104104|NCT02419573|50215057|FG001|Overall Study|Lost to Follow-up|0|||
25104105|NCT02419573|50215056|FG000|Overall Study|Withdrawal by Subject|1|||
25104106|NCT02419573|50215057|FG001|Overall Study|Withdrawal by Subject|0|||
25104107|NCT02472847|50215065|FG000|Overall Study|Withdrawal by Subject|1|||
25104108|NCT02472847|50215066|FG001|Overall Study|Withdrawal by Subject|5|||
25104109|NCT02472145|50215075|FG000|Overall Study|Death|10|||
25104110|NCT02472145|50215076|FG001|Overall Study|Death|101|||
25104111|NCT02472145|50215077|FG002|Overall Study|Death|99|||
25104112|NCT02472145|50215075|FG000|Overall Study|Lost to Follow-up|0|||
25104113|NCT02472145|50215076|FG001|Overall Study|Lost to Follow-up|1|||
25104114|NCT02472145|50215077|FG002|Overall Study|Lost to Follow-up|0|||
25104115|NCT02472145|50215075|FG000|Overall Study|Withdrawal by Subject|0|||
25104116|NCT02472145|50215076|FG001|Overall Study|Withdrawal by Subject|9|||
25104117|NCT02472145|50215077|FG002|Overall Study|Withdrawal by Subject|13|||
25104118|NCT02472145|50215075|FG000|Overall Study|Sponsor decision|0|||
25104119|NCT02472145|50215076|FG001|Overall Study|Sponsor decision|3|||
25104120|NCT02472145|50215077|FG002|Overall Study|Sponsor decision|2|||
25104121|NCT02472145|50215075|FG000|Overall Study|Other|0|||
25104122|NCT02472145|50215076|FG001|Overall Study|Other|45|||
25104123|NCT02472145|50215077|FG002|Overall Study|Other|43|||
25104124|NCT02418949|50215088|FG000|Overall Study|Withdrawal by Subject|1|||
25104125|NCT02418949|50215089|FG001|Overall Study|Withdrawal by Subject|0|||
25104126|NCT02418949|50215090|FG002|Overall Study|Withdrawal by Subject|1|||
25104127|NCT02418949|50215091|FG003|Overall Study|Withdrawal by Subject|1|||
25104128|NCT02418949|50215088|FG000|Overall Study|Lost to Follow-up|1|||
25104129|NCT02418949|50215089|FG001|Overall Study|Lost to Follow-up|0|||
25104130|NCT02418949|50215090|FG002|Overall Study|Lost to Follow-up|1|||
25104131|NCT02418949|50215091|FG003|Overall Study|Lost to Follow-up|0|||
25104132|NCT02418949|50215088|FG000|Overall Study|Physician Decision|1|||
25104133|NCT02418949|50215089|FG001|Overall Study|Physician Decision|1|||
25104134|NCT02418949|50215090|FG002|Overall Study|Physician Decision|1|||
25104135|NCT02418949|50215091|FG003|Overall Study|Physician Decision|0|||
25104136|NCT02448043|50215103|FG000|Overall Study|Withdrawal by Subject|2|||
25104137|NCT02448043|50215104|FG001|Overall Study|Withdrawal by Subject|2|||
25104138|NCT02448043|50215103|FG000|Overall Study|Protocol Violation|1|||
25104139|NCT02448043|50215104|FG001|Overall Study|Protocol Violation|2|||
25104140|NCT02447887|50215113|FG000|Overall Study|Study was terminated|3|||
25104141|NCT02471755|50215119|FG000|Overall Study|Withdrawal by Subject|1|||
25104142|NCT02471755|50215120|FG001|Overall Study|Withdrawal by Subject|0|||
25104143|NCT02471755|50215119|FG000|Overall Study|Lost to Follow-up|0|||
25104144|NCT02471755|50215120|FG001|Overall Study|Lost to Follow-up|1|||
25104145|NCT02470429|50215128|FG000|Overall Study|Adverse Event|1|||
25104146|NCT02470429|50215129|FG001|Overall Study|Adverse Event|0|||
25104147|NCT02470429|50215128|FG000|Overall Study|Withdrawal by Subject|1|||
25104148|NCT02470429|50215129|FG001|Overall Study|Withdrawal by Subject|0|||
25104149|NCT02447497|50215140|FG000|Overall Study|Did not meet treatment day baseline.|6|||
25104150|NCT02447497|50215141|FG001|Overall Study|Did not meet treatment day baseline.|5|||
25104151|NCT02447497|50215142|FG002|Overall Study|Did not meet treatment day baseline.|2|||
25104152|NCT02447497|50215143|FG003|Overall Study|Did not meet treatment day baseline.|2|||
25104153|NCT02447497|50215140|FG000|Overall Study|Dressing was compromised|0|||
25104154|NCT02447497|50215141|FG001|Overall Study|Dressing was compromised|1|||
25104155|NCT02447497|50215142|FG002|Overall Study|Dressing was compromised|0|||
25104156|NCT02447497|50215143|FG003|Overall Study|Dressing was compromised|0|||
25104157|NCT02417935|50215163|FG000|Treatment Period|Adverse Event|12|||
25104158|NCT02417935|50215164|FG001|Treatment Period|Adverse Event|10|||
25104159|NCT02417935|50215163|FG000|Treatment Period|Lost to Follow-up|1|||
25104160|NCT02417935|50215164|FG001|Treatment Period|Lost to Follow-up|0|||
25104161|NCT02417935|50215163|FG000|Treatment Period|Entry Criteria not met|0|||
25104162|NCT02417935|50215164|FG001|Treatment Period|Entry Criteria not met|1|||
25104163|NCT02417935|50215163|FG000|Treatment Period|Protocol Violation|2|||
25104164|NCT02417935|50215164|FG001|Treatment Period|Protocol Violation|1|||
25104165|NCT02417935|50215163|FG000|Treatment Period|Withdrawal by Subject|3|||
25104166|NCT02417935|50215164|FG001|Treatment Period|Withdrawal by Subject|3|||
25104167|NCT02417935|50215163|FG000|Treatment Period|Physician Decision|3|||
25104168|NCT02417935|50215164|FG001|Treatment Period|Physician Decision|1|||
25104169|NCT02417233|50215173|FG000|Overall Study|Death|4|||
25104170|NCT02417233|50215174|FG001|Overall Study|Death|10|||
25104171|NCT02417233|50215175|FG002|Overall Study|Death|14|||
25104172|NCT02417233|50215173|FG000|Overall Study|Lost to Follow-up|27|||
25104173|NCT02417233|50215174|FG001|Overall Study|Lost to Follow-up|39|||
25104174|NCT02417233|50215175|FG002|Overall Study|Lost to Follow-up|34|||
25104175|NCT02417233|50215173|FG000|Overall Study|Protocol Violation|2|||
25104176|NCT02417233|50215174|FG001|Overall Study|Protocol Violation|0|||
25104177|NCT02417233|50215175|FG002|Overall Study|Protocol Violation|2|||
25104178|NCT02417233|50215173|FG000|Overall Study|Withdrawal by Subject|2|||
25104179|NCT02417233|50215174|FG001|Overall Study|Withdrawal by Subject|1|||
25104180|NCT02417233|50215175|FG002|Overall Study|Withdrawal by Subject|8|||
25008263|NCT03126344|50101135|FG000|Overall Study|Lost to Follow-up|0|||
25008264|NCT03126344|50101136|FG001|Overall Study|Lost to Follow-up|0|||
25008265|NCT03126344|50101137|FG002|Overall Study|Lost to Follow-up|5|||
25104181|NCT02417233|50215173|FG000|Overall Study|Relocation out of study area|1|||
25104182|NCT02417233|50215174|FG001|Overall Study|Relocation out of study area|0|||
25104183|NCT02417233|50215175|FG002|Overall Study|Relocation out of study area|1|||
25104184|NCT02417233|50215173|FG000|Overall Study|Mentally unstable|0|||
25104185|NCT02417233|50215174|FG001|Overall Study|Mentally unstable|1|||
25104186|NCT02417233|50215175|FG002|Overall Study|Mentally unstable|0|||
25104187|NCT02447029|50215186|FG000|Overall Study|Withdrawal by Subject|3|||
25104188|NCT02447029|50215187|FG001|Overall Study|Withdrawal by Subject|2|||
25104189|NCT02416453|50215204|FG000|Overall Study|Adverse Event|0|||
25104190|NCT02416453|50215205|FG001|Overall Study|Adverse Event|0|||
25104191|NCT02416453|50215206|FG002|Overall Study|Adverse Event|0|||
25104192|NCT02416453|50215207|FG003|Overall Study|Adverse Event|2|||
25104193|NCT02416453|50215208|FG004|Overall Study|Adverse Event|0|||
25104194|NCT02416453|50215209|FG005|Overall Study|Adverse Event|1|||
25104195|NCT02416453|50215210|FG006|Overall Study|Adverse Event|0|||
25104196|NCT02416453|50215211|FG007|Overall Study|Adverse Event|0|||
25104197|NCT02416453|50215212|FG008|Overall Study|Adverse Event|0|||
25104198|NCT02416453|50215213|FG009|Overall Study|Adverse Event|0|||
25104199|NCT02416453|50215214|FG010|Overall Study|Adverse Event|0|||
25104200|NCT02416453|50215204|FG000|Overall Study|Lost to Follow-up|1|||
25104201|NCT02416453|50215205|FG001|Overall Study|Lost to Follow-up|3|||
25104202|NCT02416453|50215206|FG002|Overall Study|Lost to Follow-up|0|||
25104203|NCT02416453|50215207|FG003|Overall Study|Lost to Follow-up|8|||
25104204|NCT02416453|50215208|FG004|Overall Study|Lost to Follow-up|0|||
25104205|NCT02416453|50215209|FG005|Overall Study|Lost to Follow-up|5|||
25104206|NCT02416453|50215210|FG006|Overall Study|Lost to Follow-up|1|||
25104207|NCT02416453|50215211|FG007|Overall Study|Lost to Follow-up|3|||
25104208|NCT02416453|50215212|FG008|Overall Study|Lost to Follow-up|1|||
25104209|NCT02416453|50215213|FG009|Overall Study|Lost to Follow-up|0|||
25104210|NCT02416453|50215214|FG010|Overall Study|Lost to Follow-up|0|||
25104211|NCT02416453|50215204|FG000|Overall Study|Physician Decision|0|||
25104212|NCT02416453|50215205|FG001|Overall Study|Physician Decision|0|||
25104213|NCT02416453|50215206|FG002|Overall Study|Physician Decision|0|||
25104214|NCT02416453|50215207|FG003|Overall Study|Physician Decision|0|||
25104215|NCT02416453|50215208|FG004|Overall Study|Physician Decision|0|||
25104216|NCT02416453|50215209|FG005|Overall Study|Physician Decision|1|||
25104217|NCT02416453|50215210|FG006|Overall Study|Physician Decision|1|||
25104218|NCT02416453|50215211|FG007|Overall Study|Physician Decision|1|||
25104219|NCT02416453|50215212|FG008|Overall Study|Physician Decision|0|||
25104220|NCT02416453|50215213|FG009|Overall Study|Physician Decision|0|||
25104221|NCT02416453|50215214|FG010|Overall Study|Physician Decision|0|||
25104222|NCT02416453|50215204|FG000|Overall Study|Withdrawal by Subject|2|||
25104223|NCT02416453|50215205|FG001|Overall Study|Withdrawal by Subject|0|||
25104224|NCT02416453|50215206|FG002|Overall Study|Withdrawal by Subject|0|||
25104225|NCT02416453|50215207|FG003|Overall Study|Withdrawal by Subject|5|||
25104226|NCT02416453|50215208|FG004|Overall Study|Withdrawal by Subject|1|||
25104227|NCT02416453|50215209|FG005|Overall Study|Withdrawal by Subject|8|||
25104228|NCT02416453|50215210|FG006|Overall Study|Withdrawal by Subject|0|||
25104229|NCT02416453|50215211|FG007|Overall Study|Withdrawal by Subject|8|||
25104230|NCT02416453|50215212|FG008|Overall Study|Withdrawal by Subject|4|||
25104231|NCT02416453|50215213|FG009|Overall Study|Withdrawal by Subject|0|||
25104232|NCT02416453|50215214|FG010|Overall Study|Withdrawal by Subject|0|||
25104233|NCT02416453|50215204|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
25104234|NCT02416453|50215205|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
25104235|NCT02416453|50215206|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
25104236|NCT02416453|50215207|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
25104237|NCT02416453|50215208|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
25104238|NCT02416453|50215209|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
25104239|NCT02416453|50215210|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
25104240|NCT02416453|50215211|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
25104241|NCT02416453|50215212|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
25104242|NCT02416453|50215213|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
25104243|NCT02416453|50215214|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
25104244|NCT02416453|50215204|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
25104245|NCT02416453|50215205|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
25104246|NCT02416453|50215206|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
25104247|NCT02416453|50215207|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
25104248|NCT02416453|50215208|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
25104249|NCT02416453|50215209|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
25104250|NCT02416453|50215210|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
25104251|NCT02416453|50215211|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
25104252|NCT02416453|50215212|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
25104253|NCT02416453|50215213|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
25104254|NCT02416453|50215214|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
25104255|NCT02469961|50215246|FG000|Overall Study|Physician Decision|4|||
25104256|NCT02469961|50215247|FG001|Overall Study|Physician Decision|1|||
25104257|NCT02415595|50215262|FG000|Overall Study|Administrative reason by sponsor|39|||
25104258|NCT02415595|50215263|FG001|Overall Study|Administrative reason by sponsor|40|||
25104259|NCT02415595|50215264|FG002|Overall Study|Administrative reason by sponsor|41|||
25104260|NCT02415595|50215265|FG003|Overall Study|Administrative reason by sponsor|39|||
25104261|NCT02415595|50215262|FG000|Overall Study|Adverse Event|1|||
25104262|NCT02415595|50215263|FG001|Overall Study|Adverse Event|3|||
25104263|NCT02415595|50215264|FG002|Overall Study|Adverse Event|5|||
25104264|NCT02415595|50215265|FG003|Overall Study|Adverse Event|10|||
25104265|NCT02415595|50215262|FG000|Overall Study|Lack of Efficacy|4|||
25104266|NCT02415595|50215263|FG001|Overall Study|Lack of Efficacy|4|||
25104267|NCT02415595|50215264|FG002|Overall Study|Lack of Efficacy|0|||
25104268|NCT02415595|50215265|FG003|Overall Study|Lack of Efficacy|0|||
25104269|NCT02415595|50215262|FG000|Overall Study|Lost to Follow-up|1|||
25104270|NCT02415595|50215263|FG001|Overall Study|Lost to Follow-up|3|||
25104271|NCT02415595|50215264|FG002|Overall Study|Lost to Follow-up|1|||
25104272|NCT02415595|50215265|FG003|Overall Study|Lost to Follow-up|1|||
25104273|NCT02415595|50215262|FG000|Overall Study|Poor/Non-compliance|1|||
25104274|NCT02415595|50215263|FG001|Overall Study|Poor/Non-compliance|0|||
25104275|NCT02415595|50215264|FG002|Overall Study|Poor/Non-compliance|1|||
25104276|NCT02415595|50215265|FG003|Overall Study|Poor/Non-compliance|0|||
25104277|NCT02415595|50215262|FG000|Overall Study|Reached stopping criteria|0|||
25104278|NCT02415595|50215263|FG001|Overall Study|Reached stopping criteria|1|||
25104279|NCT02415595|50215264|FG002|Overall Study|Reached stopping criteria|1|||
25104280|NCT02415595|50215265|FG003|Overall Study|Reached stopping criteria|0|||
25104281|NCT02415595|50215262|FG000|Overall Study|Withdrawal by Subject|4|||
25104282|NCT02415595|50215263|FG001|Overall Study|Withdrawal by Subject|0|||
25104283|NCT02415595|50215264|FG002|Overall Study|Withdrawal by Subject|1|||
25104284|NCT02415595|50215265|FG003|Overall Study|Withdrawal by Subject|3|||
25104285|NCT02415595|50215262|FG000|Overall Study|Other|0|||
25104286|NCT02415595|50215263|FG001|Overall Study|Other|1|||
25104287|NCT02415595|50215264|FG002|Overall Study|Other|1|||
25104288|NCT02415595|50215265|FG003|Overall Study|Other|0|||
25104289|NCT02446717|50215281|FG000|Overall Study|Adverse Event|0|||
25104290|NCT02446717|50215282|FG001|Overall Study|Adverse Event|0|||
25104291|NCT02446717|50215283|FG002|Overall Study|Adverse Event|1|||
25104292|NCT02446717|50215284|FG003|Overall Study|Adverse Event|0|||
25104293|NCT02446717|50215285|FG004|Overall Study|Adverse Event|0|||
25104294|NCT02446717|50215281|FG000|Overall Study|Lost to Follow-up|0|||
25104295|NCT02446717|50215282|FG001|Overall Study|Lost to Follow-up|1|||
25104296|NCT02446717|50215283|FG002|Overall Study|Lost to Follow-up|1|||
25104297|NCT02446717|50215284|FG003|Overall Study|Lost to Follow-up|0|||
25104298|NCT02446717|50215285|FG004|Overall Study|Lost to Follow-up|1|||
25104299|NCT02446717|50215281|FG000|Overall Study|Withdrew consent|0|||
25104300|NCT02446717|50215282|FG001|Overall Study|Withdrew consent|0|||
25104301|NCT02446717|50215283|FG002|Overall Study|Withdrew consent|0|||
25104302|NCT02446717|50215284|FG003|Overall Study|Withdrew consent|1|||
25104303|NCT02446717|50215285|FG004|Overall Study|Withdrew consent|0|||
25104304|NCT02469415|50215297|FG000|Overall Study|Withdrawal by Subject|1|||
25104305|NCT02469415|50215297|FG000|Overall Study|Investigational agent placed on hold|2|||
25104306|NCT02446171|50215305|FG000|Overall Study|Withdrawal by Subject|0|||
25104307|NCT02446171|50215306|FG001|Overall Study|Withdrawal by Subject|0|||
25104308|NCT02446171|50215307|FG002|Overall Study|Withdrawal by Subject|2|||
25104309|NCT02446171|50215308|FG003|Overall Study|Withdrawal by Subject|0|||
25104310|NCT02446015|50215322|FG000|Overall Study|Adverse Event|0|||
25104311|NCT02446015|50215323|FG001|Overall Study|Adverse Event|1|||
25104312|NCT02446015|50215322|FG000|Overall Study|Withdrawal by Subject|1|||
25104313|NCT02446015|50215323|FG001|Overall Study|Withdrawal by Subject|0|||
25104314|NCT02415127|50215332|FG000|Overall Study|Adverse Event|1|||
25104315|NCT02415127|50215333|FG001|Overall Study|Adverse Event|0|||
25104316|NCT02468557|50215339|FG000|Overall Study|Adverse Event|1|||
25104317|NCT02468557|50215339|FG000|Overall Study|Death|1|||
25104318|NCT02468557|50215339|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
25104319|NCT02468557|50215339|FG000|Overall Study|All Enrolled but Never Dosed|4|||
25104320|NCT02413489|50215350|FG000|Overall Study|Death|11|||
25104321|NCT02413489|50215351|FG001|Overall Study|Death|3|||
25104322|NCT02413489|50215352|FG002|Overall Study|Death|4|||
25104323|NCT02413489|50215350|FG000|Overall Study|Withdrawal by Subject|2|||
25104324|NCT02413489|50215351|FG001|Overall Study|Withdrawal by Subject|0|||
25104325|NCT02413489|50215352|FG002|Overall Study|Withdrawal by Subject|0|||
25261200|NCT01266993|50575875|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
25261201|NCT01266993|50575876|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
25104326|NCT02413489|50215350|FG000|Overall Study|Study Terminated By Sponsor|2|||
25104327|NCT02413489|50215351|FG001|Overall Study|Study Terminated By Sponsor|13|||
25104328|NCT02413489|50215352|FG002|Overall Study|Study Terminated By Sponsor|1|||
25104329|NCT02413333|50215364|FG000|Period 1|Adverse Event|1|||
25104330|NCT02413333|50215365|FG001|Period 1|Adverse Event|0|||
25104331|NCT02413333|50215364|FG000|Period 1|Reason Not Specified|0|||
25104332|NCT02413333|50215365|FG001|Period 1|Reason Not Specified|1|||
25104333|NCT02413333|50215364|FG000|Period 2|Protocol Deviation|1|||
25104334|NCT02413333|50215365|FG001|Period 2|Protocol Deviation|0|||
25104335|NCT02413255|50215388|FG000|Overall Study|Voluntary Withdrawal|0|||
25104336|NCT02413255|50215389|FG001|Overall Study|Voluntary Withdrawal|0|||
25104337|NCT02413255|50215390|FG002|Overall Study|Voluntary Withdrawal|0|||
25104338|NCT02413255|50215391|FG003|Overall Study|Voluntary Withdrawal|0|||
25104339|NCT02413255|50215392|FG004|Overall Study|Voluntary Withdrawal|0|||
25104340|NCT02413255|50215393|FG005|Overall Study|Voluntary Withdrawal|0|||
25104341|NCT02413255|50215394|FG006|Overall Study|Voluntary Withdrawal|0|||
25104342|NCT02413255|50215395|FG007|Overall Study|Voluntary Withdrawal|0|||
25104343|NCT02413255|50215396|FG008|Overall Study|Voluntary Withdrawal|0|||
25104344|NCT02413255|50215397|FG009|Overall Study|Voluntary Withdrawal|0|||
25104345|NCT02413255|50215398|FG010|Overall Study|Voluntary Withdrawal|0|||
25104346|NCT02413255|50215399|FG011|Overall Study|Voluntary Withdrawal|0|||
25104347|NCT02413255|50215400|FG012|Overall Study|Voluntary Withdrawal|0|||
25104348|NCT02413255|50215401|FG013|Overall Study|Voluntary Withdrawal|0|||
25104349|NCT02413255|50215402|FG014|Overall Study|Voluntary Withdrawal|1|||
25104350|NCT02413255|50215403|FG015|Overall Study|Voluntary Withdrawal|0|||
25104351|NCT02413255|50215404|FG016|Overall Study|Voluntary Withdrawal|0|||
25104352|NCT02444533|50215457|FG000|Overall Study|Not able to complete forms|0|||
25104353|NCT02444533|50215458|FG001|Overall Study|Not able to complete forms|2|||
25104354|NCT02444533|50215457|FG000|Overall Study|Only gave post-procedure complications|2|||
25104355|NCT02444533|50215458|FG001|Overall Study|Only gave post-procedure complications|2|||
25104356|NCT01651039|50215464|FG000|Overall Study|Non-evaluables|5|||
25104357|NCT01651039|50215464|FG000|Overall Study|Physician Decision|2|||
25104358|NCT01651039|50215464|FG000|Overall Study|Withdrawal by Subject|1|||
25104359|NCT01651039|50215464|FG000|Overall Study|Progressive Disease|22|||
25104360|NCT02349633|50215482|FG000|Overall Study|Death|0|||
25104361|NCT02349633|50215483|FG001|Overall Study|Death|1|||
25104362|NCT02349633|50215484|FG002|Overall Study|Death|0|||
25104363|NCT02349633|50215485|FG003|Overall Study|Death|0|||
25104364|NCT02349633|50215486|FG004|Overall Study|Death|0|||
25104365|NCT02349633|50215487|FG005|Overall Study|Death|1|||
25104366|NCT02349633|50215488|FG006|Overall Study|Death|1|||
25104367|NCT02349633|50215489|FG007|Overall Study|Death|1|||
25104368|NCT02349633|50215490|FG008|Overall Study|Death|0|||
25104369|NCT02349633|50215491|FG009|Overall Study|Death|1|||
25104370|NCT02349633|50215492|FG010|Overall Study|Death|0|||
25104371|NCT02349633|50215493|FG011|Overall Study|Death|0|||
25104372|NCT02349633|50215494|FG012|Overall Study|Death|0|||
25104373|NCT02349633|50215495|FG013|Overall Study|Death|0|||
25104374|NCT02349633|50215482|FG000|Overall Study|Withdrawal by Subject|0|||
25104375|NCT02349633|50215483|FG001|Overall Study|Withdrawal by Subject|0|||
25104376|NCT02349633|50215484|FG002|Overall Study|Withdrawal by Subject|0|||
25104377|NCT02349633|50215485|FG003|Overall Study|Withdrawal by Subject|1|||
25104378|NCT02349633|50215486|FG004|Overall Study|Withdrawal by Subject|0|||
25104379|NCT02349633|50215487|FG005|Overall Study|Withdrawal by Subject|0|||
25104380|NCT02349633|50215488|FG006|Overall Study|Withdrawal by Subject|0|||
25104381|NCT02349633|50215489|FG007|Overall Study|Withdrawal by Subject|2|||
25104382|NCT02349633|50215490|FG008|Overall Study|Withdrawal by Subject|2|||
25104383|NCT02349633|50215491|FG009|Overall Study|Withdrawal by Subject|1|||
25104384|NCT02349633|50215492|FG010|Overall Study|Withdrawal by Subject|0|||
25104385|NCT02349633|50215493|FG011|Overall Study|Withdrawal by Subject|0|||
25104386|NCT02349633|50215494|FG012|Overall Study|Withdrawal by Subject|0|||
25104387|NCT02349633|50215495|FG013|Overall Study|Withdrawal by Subject|0|||
25104388|NCT02349633|50215482|FG000|Overall Study|Withdrawal of informed consent|0|||
25104389|NCT02349633|50215483|FG001|Overall Study|Withdrawal of informed consent|0|||
25104390|NCT02349633|50215484|FG002|Overall Study|Withdrawal of informed consent|0|||
25104391|NCT02349633|50215485|FG003|Overall Study|Withdrawal of informed consent|1|||
25104392|NCT02349633|50215486|FG004|Overall Study|Withdrawal of informed consent|1|||
25104393|NCT02349633|50215487|FG005|Overall Study|Withdrawal of informed consent|0|||
25104394|NCT02349633|50215488|FG006|Overall Study|Withdrawal of informed consent|0|||
25104395|NCT02349633|50215489|FG007|Overall Study|Withdrawal of informed consent|3|||
25104396|NCT02349633|50215490|FG008|Overall Study|Withdrawal of informed consent|0|||
25104397|NCT02349633|50215491|FG009|Overall Study|Withdrawal of informed consent|0|||
25104398|NCT02349633|50215492|FG010|Overall Study|Withdrawal of informed consent|0|||
25104399|NCT02349633|50215493|FG011|Overall Study|Withdrawal of informed consent|0|||
25104400|NCT02349633|50215494|FG012|Overall Study|Withdrawal of informed consent|0|||
25104401|NCT02349633|50215495|FG013|Overall Study|Withdrawal of informed consent|0|||
25104402|NCT02349633|50215482|FG000|Overall Study|Transition to compassionate use|0|||
25104403|NCT02349633|50215483|FG001|Overall Study|Transition to compassionate use|0|||
25104404|NCT02349633|50215484|FG002|Overall Study|Transition to compassionate use|0|||
25104405|NCT02349633|50215485|FG003|Overall Study|Transition to compassionate use|0|||
25104406|NCT02349633|50215486|FG004|Overall Study|Transition to compassionate use|1|||
25104407|NCT02349633|50215487|FG005|Overall Study|Transition to compassionate use|0|||
25104408|NCT02349633|50215488|FG006|Overall Study|Transition to compassionate use|0|||
25104409|NCT02349633|50215489|FG007|Overall Study|Transition to compassionate use|3|||
25104410|NCT02349633|50215490|FG008|Overall Study|Transition to compassionate use|0|||
25177144|NCT02660580|50321237|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
25104411|NCT02349633|50215491|FG009|Overall Study|Transition to compassionate use|1|||
25104412|NCT02349633|50215492|FG010|Overall Study|Transition to compassionate use|0|||
25104413|NCT02349633|50215493|FG011|Overall Study|Transition to compassionate use|0|||
25104414|NCT02349633|50215494|FG012|Overall Study|Transition to compassionate use|0|||
25104415|NCT02349633|50215495|FG013|Overall Study|Transition to compassionate use|0|||
25104416|NCT02349633|50215482|FG000|Overall Study|Early termination of survival follow-up|0|||
25104417|NCT02349633|50215483|FG001|Overall Study|Early termination of survival follow-up|0|||
25104418|NCT02349633|50215484|FG002|Overall Study|Early termination of survival follow-up|0|||
25104419|NCT02349633|50215485|FG003|Overall Study|Early termination of survival follow-up|0|||
25104420|NCT02349633|50215486|FG004|Overall Study|Early termination of survival follow-up|0|||
25104421|NCT02349633|50215487|FG005|Overall Study|Early termination of survival follow-up|0|||
25104422|NCT02349633|50215488|FG006|Overall Study|Early termination of survival follow-up|0|||
25104423|NCT02349633|50215489|FG007|Overall Study|Early termination of survival follow-up|4|||
25104424|NCT02349633|50215490|FG008|Overall Study|Early termination of survival follow-up|0|||
25104425|NCT02349633|50215491|FG009|Overall Study|Early termination of survival follow-up|0|||
25104426|NCT02349633|50215492|FG010|Overall Study|Early termination of survival follow-up|0|||
25104427|NCT02349633|50215493|FG011|Overall Study|Early termination of survival follow-up|0|||
25104428|NCT02349633|50215494|FG012|Overall Study|Early termination of survival follow-up|0|||
25104429|NCT02349633|50215495|FG013|Overall Study|Early termination of survival follow-up|0|||
25104430|NCT02349633|50215482|FG000|Overall Study|Termination by sponsor|0|||
25104431|NCT02349633|50215483|FG001|Overall Study|Termination by sponsor|0|||
25104432|NCT02349633|50215484|FG002|Overall Study|Termination by sponsor|0|||
25104433|NCT02349633|50215485|FG003|Overall Study|Termination by sponsor|0|||
25104434|NCT02349633|50215486|FG004|Overall Study|Termination by sponsor|0|||
25104435|NCT02349633|50215487|FG005|Overall Study|Termination by sponsor|0|||
25104436|NCT02349633|50215488|FG006|Overall Study|Termination by sponsor|0|||
25104437|NCT02349633|50215489|FG007|Overall Study|Termination by sponsor|1|||
25104438|NCT02349633|50215490|FG008|Overall Study|Termination by sponsor|0|||
25104439|NCT02349633|50215491|FG009|Overall Study|Termination by sponsor|2|||
25104440|NCT02349633|50215492|FG010|Overall Study|Termination by sponsor|0|||
25104441|NCT02349633|50215493|FG011|Overall Study|Termination by sponsor|0|||
25104442|NCT02349633|50215494|FG012|Overall Study|Termination by sponsor|0|||
25104443|NCT02349633|50215495|FG013|Overall Study|Termination by sponsor|0|||
25104444|NCT02349633|50215482|FG000|Overall Study|Other|0|||
25104445|NCT02349633|50215483|FG001|Overall Study|Other|0|||
25104446|NCT02349633|50215484|FG002|Overall Study|Other|0|||
25104447|NCT02349633|50215485|FG003|Overall Study|Other|0|||
25104448|NCT02349633|50215486|FG004|Overall Study|Other|0|||
25104449|NCT02349633|50215487|FG005|Overall Study|Other|0|||
25104450|NCT02349633|50215488|FG006|Overall Study|Other|0|||
25104451|NCT02349633|50215489|FG007|Overall Study|Other|2|||
25104452|NCT02349633|50215490|FG008|Overall Study|Other|0|||
25104453|NCT02349633|50215491|FG009|Overall Study|Other|0|||
25104454|NCT02349633|50215492|FG010|Overall Study|Other|0|||
25104455|NCT02349633|50215493|FG011|Overall Study|Other|0|||
25104456|NCT02349633|50215494|FG012|Overall Study|Other|0|||
25104457|NCT02349633|50215495|FG013|Overall Study|Other|0|||
25104458|NCT02275611|50215560|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
25104459|NCT02275611|50215561|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
25104460|NCT02275611|50215562|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
25104461|NCT02275611|50215563|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
25104462|NCT02275065|50215580|FG000|Overall Study|Randomized but not treated|1|||
25104463|NCT02275065|50215581|FG001|Overall Study|Randomized but not treated|0|||
25104464|NCT02275065|50215582|FG002|Overall Study|Randomized but not treated|1|||
25104465|NCT02275065|50215583|FG003|Overall Study|Randomized but not treated|1|||
25104466|NCT02275065|50215584|FG004|Overall Study|Randomized but not treated|0|||
25104467|NCT02273973|50215598|FG000|Overall Study|Adverse Event|4|||
25104468|NCT02273973|50215599|FG001|Overall Study|Adverse Event|0|||
25104469|NCT02273973|50215598|FG000|Overall Study|Withdrawal by Subject|2|||
25104470|NCT02273973|50215599|FG001|Overall Study|Withdrawal by Subject|3|||
25104471|NCT02273973|50215598|FG000|Overall Study|Death|1|||
25104472|NCT02273973|50215599|FG001|Overall Study|Death|0|||
25104473|NCT02273973|50215598|FG000|Overall Study|Non-compliance|1|||
25104474|NCT02273973|50215599|FG001|Overall Study|Non-compliance|0|||
25104475|NCT02273973|50215598|FG000|Overall Study|Protocol Violation|1|||
25104476|NCT02273973|50215599|FG001|Overall Study|Protocol Violation|0|||
25104477|NCT02273973|50215598|FG000|Overall Study|Progression of disease|0|||
25104478|NCT02273973|50215599|FG001|Overall Study|Progression of disease|2|||
25104479|NCT02273973|50215598|FG000|Overall Study|Lost to Follow-up|0|||
25104480|NCT02273973|50215599|FG001|Overall Study|Lost to Follow-up|1|||
25104481|NCT02273973|50215598|FG000|Overall Study|Physician Decision|0|||
25104482|NCT02273973|50215599|FG001|Overall Study|Physician Decision|1|||
25104483|NCT02273973|50215598|FG000|Overall Study|Reason not specified|0|||
25104484|NCT02273973|50215599|FG001|Overall Study|Reason not specified|1|||
25104485|NCT02273739|50215609|FG000|Overall Study|Progression of Disease|3|||
25104486|NCT02273739|50215610|FG001|Overall Study|Progression of Disease|4|||
25104487|NCT02273739|50215611|FG002|Overall Study|Progression of Disease|5|||
25104488|NCT02273739|50215612|FG003|Overall Study|Progression of Disease|2|||
25104489|NCT02273739|50215609|FG000|Overall Study|Death|0|||
25104490|NCT02273739|50215610|FG001|Overall Study|Death|0|||
25104491|NCT02273739|50215611|FG002|Overall Study|Death|0|||
25104492|NCT02273739|50215612|FG003|Overall Study|Death|2|||
25104493|NCT02273739|50215609|FG000|Overall Study|Adverse Event|0|||
25104494|NCT02273739|50215610|FG001|Overall Study|Adverse Event|0|||
25104495|NCT02273739|50215611|FG002|Overall Study|Adverse Event|0|||
25104496|NCT02273739|50215612|FG003|Overall Study|Adverse Event|1|||
25104497|NCT02273739|50215609|FG000|Overall Study|Withdrawal by Subject|0|||
25104498|NCT02273739|50215610|FG001|Overall Study|Withdrawal by Subject|0|||
25104499|NCT02273739|50215611|FG002|Overall Study|Withdrawal by Subject|2|||
25104500|NCT02273739|50215612|FG003|Overall Study|Withdrawal by Subject|1|||
25104501|NCT02273739|50215609|FG000|Overall Study|Physician Decision|0|||
25104502|NCT02273739|50215610|FG001|Overall Study|Physician Decision|0|||
25104503|NCT02273739|50215611|FG002|Overall Study|Physician Decision|0|||
25104504|NCT02273739|50215612|FG003|Overall Study|Physician Decision|1|||
25104505|NCT02273037|50215629|FG000|Overall Study|Lost to Follow-up|1|||
25104506|NCT02273037|50215630|FG001|Overall Study|Lost to Follow-up|0|||
25104507|NCT02273037|50215629|FG000|Overall Study|Delivered before monitoring initiated|1|||
25104508|NCT02273037|50215630|FG001|Overall Study|Delivered before monitoring initiated|3|||
25104509|NCT02273037|50215629|FG000|Overall Study|Breech delivery|2|||
25104510|NCT02273037|50215630|FG001|Overall Study|Breech delivery|3|||
25104511|NCT02273037|50215629|FG000|Overall Study|Multiple delivery|2|||
25104512|NCT02273037|50215630|FG001|Overall Study|Multiple delivery|2|||
25104513|NCT02273037|50215629|FG000|Overall Study|Other complication|2|||
25104514|NCT02273037|50215630|FG001|Overall Study|Other complication|0|||
25104515|NCT02465515|50215640|FG000|Overall Study|Investigator site closed|4|||
25104516|NCT02465515|50215641|FG001|Overall Study|Investigator site closed|5|||
25104517|NCT02465515|50215640|FG000|Overall Study|Withdrawal by Subject|74|||
25104518|NCT02465515|50215641|FG001|Overall Study|Withdrawal by Subject|43|||
25104519|NCT02465515|50215640|FG000|Overall Study|Physician Decision|8|||
25104520|NCT02465515|50215641|FG001|Overall Study|Physician Decision|12|||
25104521|NCT02465515|50215640|FG000|Overall Study|Lost to Follow-up|68|||
25104522|NCT02465515|50215641|FG001|Overall Study|Lost to Follow-up|51|||
25104523|NCT02412631|50215649|FG000|Overall Study|Adverse Event|1|||
25104524|NCT02412631|50215650|FG001|Overall Study|Adverse Event|2|||
25104525|NCT02412631|50215649|FG000|Overall Study|Lost to Follow-up|5|||
25008266|NCT03115112|50101158|FG000|Overall Study|Adverse Event|5|||
25008267|NCT03115112|50101159|FG001|Overall Study|Adverse Event|1|||
25008268|NCT03115112|50101158|FG000|Overall Study|Withdrawal by Subject|4|||
25008269|NCT03115112|50101159|FG001|Overall Study|Withdrawal by Subject|2|||
25008270|NCT03115112|50101158|FG000|Overall Study|Lost to Follow-up|0|||
25008271|NCT03115112|50101159|FG001|Overall Study|Lost to Follow-up|1|||
25104526|NCT02412631|50215650|FG001|Overall Study|Lost to Follow-up|9|||
25104527|NCT02412631|50215649|FG000|Overall Study|Withdrawal by Subject|9|||
25104528|NCT02412631|50215650|FG001|Overall Study|Withdrawal by Subject|3|||
25104529|NCT02412631|50215649|FG000|Overall Study|Early stop by FDA|5|||
25104530|NCT02412631|50215650|FG001|Overall Study|Early stop by FDA|2|||
25104531|NCT02412631|50215649|FG000|Overall Study|Unspecified reason|6|||
25104532|NCT02412631|50215650|FG001|Overall Study|Unspecified reason|8|||
25104533|NCT02272803|50215658|FG000|Overall Study|Disease progression|16|||
25104534|NCT02272803|50215659|FG001|Overall Study|Disease progression|8|||
25104535|NCT02272803|50215658|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
25104536|NCT02272803|50215659|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
25104537|NCT02272803|50215658|FG000|Overall Study|Study drug toxicity|4|||
25104538|NCT02272803|50215659|FG001|Overall Study|Study drug toxicity|9|||
25104539|NCT02272803|50215658|FG000|Overall Study|Participant request to discontinue study treatment|3|||
25104540|NCT02272803|50215659|FG001|Overall Study|Participant request to discontinue study treatment|7|||
25104541|NCT02272803|50215658|FG000|Overall Study|Maximum clinical benefit|4|||
25104542|NCT02272803|50215659|FG001|Overall Study|Maximum clinical benefit|2|||
25104543|NCT02272803|50215658|FG000|Overall Study|Poor/non-compliance|2|||
25104544|NCT02272803|50215659|FG001|Overall Study|Poor/non-compliance|2|||
25104545|NCT02272803|50215658|FG000|Overall Study|Withdrawal by Subject|2|||
25104546|NCT02272803|50215659|FG001|Overall Study|Withdrawal by Subject|1|||
25104547|NCT02272803|50215658|FG000|Overall Study|Death|0|||
25104548|NCT02272803|50215659|FG001|Overall Study|Death|1|||
25104549|NCT02272803|50215658|FG000|Overall Study|Other reasons|1|||
25104550|NCT02272803|50215659|FG001|Overall Study|Other reasons|3|||
25104551|NCT02272803|50215658|FG000|Overall Study|Administrative reason by sponsor|5|||
25104552|NCT02272803|50215659|FG001|Overall Study|Administrative reason by sponsor|4|||
25104553|NCT02272725|50215667|FG000|Overall Study|equipment malfunction|2|||
25104554|NCT02272725|50215668|FG001|Overall Study|equipment malfunction|0|||
25008272|NCT03115112|50101158|FG000|Overall Study|Death|1|||
25104555|NCT01650805|50215676|FG000|Overall Study|Withdrawal by Subject|1|||
25104556|NCT01650805|50215677|FG001|Overall Study|Withdrawal by Subject|0|||
25104557|NCT02442349|50215683|FG000|Overall Study|Death|14|||
25104558|NCT02442349|50215683|FG000|Overall Study|Withdrawal by Subject|8|||
25104559|NCT02442349|50215683|FG000|Overall Study|On-going Study at Data Cut-off|149|||
25104560|NCT02411539|50215689|FG000|Overall Study|Lost to Follow-up|2|||
25104561|NCT02411539|50215690|FG001|Overall Study|Lost to Follow-up|0|||
25104562|NCT02411539|50215689|FG000|Overall Study|Confounding medical condition|0|||
25104563|NCT02411539|50215690|FG001|Overall Study|Confounding medical condition|1|||
25104564|NCT02465437|50215703|FG000|Overall Study|Physician Decision|0|||
25104565|NCT02465437|50215704|FG001|Overall Study|Physician Decision|0|||
25104566|NCT02465437|50215705|FG002|Overall Study|Physician Decision|1|||
25104567|NCT02465437|50215706|FG003|Overall Study|Physician Decision|0|||
25104568|NCT02465437|50215703|FG000|Overall Study|Withdrawal by Subject|1|||
25104569|NCT02465437|50215704|FG001|Overall Study|Withdrawal by Subject|0|||
25104570|NCT02465437|50215705|FG002|Overall Study|Withdrawal by Subject|0|||
25104571|NCT02465437|50215706|FG003|Overall Study|Withdrawal by Subject|1|||
25104572|NCT02465437|50215703|FG000|Overall Study|Adverse Event|0|||
25104573|NCT02465437|50215704|FG001|Overall Study|Adverse Event|1|||
25104574|NCT02465437|50215705|FG002|Overall Study|Adverse Event|0|||
25104575|NCT02465437|50215706|FG003|Overall Study|Adverse Event|0|||
25104576|NCT02442271|50215714|FG000|Overall Study|Adverse Event|1|||
25104577|NCT02442271|50215714|FG000|Overall Study|Withdrew Consent|1|||
25104578|NCT02442271|50215714|FG000|Overall Study|Lost to Follow-up|1|||
25104579|NCT02442271|50215714|FG000|Overall Study|Other|1|||
25104580|NCT02465203|50215735|FG000|Overall Study|Protocol Violation|1|||
25104581|NCT02465203|50215736|FG001|Overall Study|Protocol Violation|1|||
25104582|NCT02465203|50215737|FG002|Overall Study|Protocol Violation|1|||
25104583|NCT02465203|50215735|FG000|Overall Study|Study terminated by sponsor|50|||
25104584|NCT02465203|50215736|FG001|Overall Study|Study terminated by sponsor|34|||
25104585|NCT02465203|50215737|FG002|Overall Study|Study terminated by sponsor|11|||
25104586|NCT02465203|50215735|FG000|Overall Study|New therapy for study indication|4|||
25104587|NCT02465203|50215736|FG001|Overall Study|New therapy for study indication|0|||
25104588|NCT02465203|50215737|FG002|Overall Study|New therapy for study indication|0|||
25104589|NCT02465203|50215735|FG000|Overall Study|Patient/guardian decision|1|||
25104590|NCT02465203|50215736|FG001|Overall Study|Patient/guardian decision|1|||
25104591|NCT02465203|50215737|FG002|Overall Study|Patient/guardian decision|1|||
25104592|NCT02463409|50215744|FG000|Overall Study|Withdrawal by Subject|1|||
25104593|NCT02463409|50215744|FG000|Overall Study|Screen failure|1|||
25104594|NCT02528357|50215767|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104595|NCT02528357|50215768|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
25104596|NCT02528357|50215769|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104597|NCT02528357|50215770|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104598|NCT02528357|50215771|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104599|NCT02528357|50215772|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104600|NCT02528357|50215773|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104601|NCT02528357|50215774|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104602|NCT02528357|50215775|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104603|NCT02528357|50215776|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104604|NCT02528357|50215777|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104605|NCT02528357|50215778|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104606|NCT02528357|50215779|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104607|NCT02528357|50215780|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104608|NCT02528357|50215781|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104609|NCT02528357|50215782|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104610|NCT02528357|50215783|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104611|NCT02528357|50215784|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104612|NCT02528357|50215785|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
25104613|NCT02528357|50215767|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
25104614|NCT02528357|50215768|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
25104615|NCT02528357|50215769|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
25104616|NCT02528357|50215770|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
25104617|NCT02528357|50215771|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
25104618|NCT02528357|50215772|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
25104619|NCT02528357|50215773|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
25104620|NCT02528357|50215774|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
25104621|NCT02528357|50215775|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
25104622|NCT02528357|50215776|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
25177145|NCT02660580|50321238|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
25104623|NCT02528357|50215777|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
25104624|NCT02528357|50215778|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
25104625|NCT02528357|50215779|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
25177146|NCT02660580|50321239|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
25104626|NCT02528357|50215780|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
25104627|NCT02528357|50215781|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
25104628|NCT02528357|50215782|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
25104629|NCT02528357|50215783|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
25104630|NCT02528357|50215784|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
25104631|NCT02528357|50215785|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
25104632|NCT02528357|50215767|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
25104633|NCT02528357|50215768|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
25104634|NCT02528357|50215769|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
25104635|NCT02528357|50215770|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
25104636|NCT02528357|50215771|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
25104637|NCT02528357|50215772|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
25104638|NCT02528357|50215773|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
25104639|NCT02528357|50215774|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
25104640|NCT02528357|50215775|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
25104641|NCT02528357|50215776|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
25104642|NCT02528357|50215777|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
25104643|NCT02528357|50215778|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
25104644|NCT02528357|50215779|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
25104645|NCT02528357|50215780|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
25104646|NCT02528357|50215781|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
25104647|NCT02528357|50215782|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
25104648|NCT02528357|50215783|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
25104649|NCT02528357|50215784|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
25104650|NCT02528357|50215785|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
25104651|NCT02528357|50215767|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104652|NCT02528357|50215768|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104653|NCT02528357|50215769|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104654|NCT02528357|50215770|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104655|NCT02528357|50215771|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
25104656|NCT02528357|50215772|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104657|NCT02528357|50215773|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104658|NCT02528357|50215774|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104659|NCT02528357|50215775|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104660|NCT02528357|50215776|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104661|NCT02528357|50215777|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104662|NCT02528357|50215778|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104663|NCT02528357|50215779|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104664|NCT02528357|50215780|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104665|NCT02528357|50215781|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104666|NCT02528357|50215782|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104667|NCT02528357|50215783|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104668|NCT02528357|50215784|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104669|NCT02528357|50215785|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104670|NCT02528357|50215767|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
25104671|NCT02528357|50215768|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
25104672|NCT02528357|50215769|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
25104673|NCT02528357|50215770|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
25104674|NCT02528357|50215771|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
25104675|NCT02528357|50215772|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
25177147|NCT02660580|50321240|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
25177148|NCT02660580|50321236|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
25177149|NCT02660580|50321237|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
25177150|NCT02660580|50321238|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
25177151|NCT02660580|50321239|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
25177152|NCT02660580|50321240|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
25177153|NCT02660580|50321236|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
25177154|NCT02660580|50321237|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
25177155|NCT02660580|50321238|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
25177156|NCT02660580|50321239|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
25177157|NCT02660580|50321240|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
25177158|NCT02660580|50321236|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
25177159|NCT02660580|50321237|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
25177160|NCT02660580|50321238|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
25177161|NCT02660580|50321239|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
25177162|NCT02660580|50321240|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
25177163|NCT02660580|50321236|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
25177164|NCT02660580|50321237|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
25177165|NCT02660580|50321238|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
25177166|NCT02660580|50321239|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
25177167|NCT02660580|50321240|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
25177168|NCT01524991|50321259|FG000|Overall Study|Adverse Event|12|||
25177169|NCT01524991|50321259|FG000|Overall Study|Death|1|||
25177170|NCT01524991|50321259|FG000|Overall Study|Disease ProgressionDu|17|||
25177171|NCT01524991|50321259|FG000|Overall Study|Other complicating disease|1|||
25177172|NCT01524991|50321259|FG000|Overall Study|Withdrawal by Subject|2|||
25177173|NCT01524991|50321259|FG000|Overall Study|Symptomatic Deterioration|1|||
25177174|NCT01524913|50321266|FG000|Overall Study|Lost to Follow-up|4|||
25177175|NCT01524913|50321267|FG001|Overall Study|Lost to Follow-up|0|||
25177176|NCT01524913|50321268|FG002|Overall Study|Lost to Follow-up|0|||
25177177|NCT01524679|50321278|FG000|Overall Study|Lost to Follow-up|1|||
25177178|NCT01524679|50321279|FG001|Overall Study|Lost to Follow-up|4|||
25177179|NCT01524679|50321278|FG000|Overall Study|Withdrawal by Subject|4|||
25177180|NCT01524679|50321279|FG001|Overall Study|Withdrawal by Subject|4|||
25177181|NCT01524679|50321278|FG000|Overall Study|Adverse Event|9|||
25177182|NCT01524679|50321279|FG001|Overall Study|Adverse Event|0|||
25177183|NCT01524679|50321278|FG000|Overall Study|Protocol Violation|1|||
25104676|NCT02528357|50215773|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
25104677|NCT02528357|50215774|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
25104678|NCT02528357|50215775|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
25104679|NCT02528357|50215776|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
25104680|NCT02528357|50215777|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
25104681|NCT02528357|50215778|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
25104682|NCT02528357|50215779|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
25104683|NCT02528357|50215780|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
25104684|NCT02528357|50215781|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
25104685|NCT02528357|50215782|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
25104686|NCT02528357|50215783|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
25104687|NCT02528357|50215784|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
25104688|NCT02528357|50215785|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
25104689|NCT02528357|50215767|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104690|NCT02528357|50215768|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104691|NCT02528357|50215769|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104692|NCT02528357|50215770|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104693|NCT02528357|50215771|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104694|NCT02528357|50215772|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104695|NCT02528357|50215773|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104696|NCT02528357|50215774|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104697|NCT02528357|50215775|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104698|NCT02528357|50215776|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104699|NCT02528357|50215777|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104700|NCT02528357|50215778|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104701|NCT02528357|50215779|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104702|NCT02528357|50215780|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
25177184|NCT01524679|50321279|FG001|Overall Study|Protocol Violation|0|||
25177185|NCT01524679|50321278|FG000|Overall Study|Lack of Efficacy|2|||
25177186|NCT01524679|50321279|FG001|Overall Study|Lack of Efficacy|0|||
25177187|NCT01524679|50321278|FG000|Overall Study|e.g.wish for children, relocation|6|||
25177188|NCT01524679|50321279|FG001|Overall Study|e.g.wish for children, relocation|1|||
25177189|NCT01524289|50321296|FG000|Overall Study|Lost to Follow-up|0|||
25177190|NCT01524289|50321297|FG001|Overall Study|Lost to Follow-up|1|||
25177191|NCT01524289|50321296|FG000|Overall Study|Physician Decision|1|||
25177192|NCT01524289|50321297|FG001|Overall Study|Physician Decision|0|||
25177193|NCT01524289|50321296|FG000|Overall Study|Protocol Violation|5|||
25177194|NCT01524289|50321297|FG001|Overall Study|Protocol Violation|1|||
25177195|NCT01524289|50321296|FG000|Overall Study|Withdrawal by Subject|11|||
25177196|NCT01524289|50321297|FG001|Overall Study|Withdrawal by Subject|7|||
25177197|NCT01524289|50321296|FG000|Overall Study|Adverse Event|12|||
25177198|NCT01524289|50321297|FG001|Overall Study|Adverse Event|5|||
25177199|NCT01524289|50321296|FG000|Overall Study|Did not take study medication|1|||
25104703|NCT02528357|50215781|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104704|NCT02528357|50215782|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104705|NCT02528357|50215783|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104706|NCT02528357|50215784|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104707|NCT02528357|50215785|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
25104708|NCT02528357|50215767|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
25104709|NCT02528357|50215768|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
25104710|NCT02528357|50215769|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
25104711|NCT02528357|50215770|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
25104712|NCT02528357|50215771|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
25104713|NCT02528357|50215772|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
25104714|NCT02528357|50215773|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
25104715|NCT02528357|50215774|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
25104716|NCT02528357|50215775|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
25104717|NCT02528357|50215776|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
25104718|NCT02528357|50215777|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
25104719|NCT02528357|50215778|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
25104720|NCT02528357|50215779|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
25104721|NCT02528357|50215780|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
25104722|NCT02528357|50215781|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
25104723|NCT02528357|50215782|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
25104724|NCT02528357|50215783|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
25104725|NCT02528357|50215784|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
25104726|NCT02528357|50215785|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
25104727|NCT02528357|50215767|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104728|NCT02528357|50215768|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104729|NCT02528357|50215769|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104730|NCT02528357|50215770|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104731|NCT02528357|50215771|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104732|NCT02528357|50215772|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104733|NCT02528357|50215773|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104734|NCT02528357|50215774|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104735|NCT02528357|50215775|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
25104736|NCT02528357|50215776|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
25104737|NCT02528357|50215777|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104738|NCT02528357|50215778|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
25104739|NCT02528357|50215779|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
25104740|NCT02528357|50215780|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
25104741|NCT02528357|50215781|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
25104742|NCT02528357|50215782|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104743|NCT02528357|50215783|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104744|NCT02528357|50215784|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104745|NCT02528357|50215785|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104746|NCT02528357|50215767|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25104747|NCT02528357|50215768|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25104748|NCT02528357|50215769|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25104749|NCT02528357|50215770|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25104750|NCT02528357|50215771|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25104751|NCT02528357|50215772|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25104752|NCT02528357|50215773|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25104753|NCT02528357|50215774|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25177200|NCT01524289|50321297|FG001|Overall Study|Did not take study medication|0|||
25177201|NCT01498289|50321307|FG000|Overall Study|Adverse Event|16|||
25104754|NCT02528357|50215775|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25104755|NCT02528357|50215776|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25104756|NCT02528357|50215777|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25104757|NCT02528357|50215778|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25104758|NCT02528357|50215779|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25104759|NCT02528357|50215780|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25104760|NCT02528357|50215781|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25104761|NCT02528357|50215782|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25104762|NCT02528357|50215783|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
25104763|NCT02528357|50215784|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25104764|NCT02528357|50215785|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
25104765|NCT02528357|50215767|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104766|NCT02528357|50215768|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104767|NCT02528357|50215769|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104768|NCT02528357|50215770|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104769|NCT02528357|50215771|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104770|NCT02528357|50215772|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104771|NCT02528357|50215773|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104772|NCT02528357|50215774|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104773|NCT02528357|50215775|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104774|NCT02528357|50215776|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104775|NCT02528357|50215777|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104776|NCT02528357|50215778|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104777|NCT02528357|50215779|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104778|NCT02528357|50215780|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104779|NCT02528357|50215781|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104780|NCT02528357|50215782|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
25104781|NCT02528357|50215783|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
25104782|NCT02528357|50215784|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
25104783|NCT02528357|50215785|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
25104784|NCT02463331|50215827|FG000|Overall Study|Adverse Event|4|||
25104785|NCT02463331|50215828|FG001|Overall Study|Adverse Event|2|||
25104786|NCT02463331|50215827|FG000|Overall Study|Lost to Follow-up|1|||
25104787|NCT02463331|50215828|FG001|Overall Study|Lost to Follow-up|1|||
25104788|NCT02463331|50215827|FG000|Overall Study|Pregnancy|2|||
25104789|NCT02463331|50215828|FG001|Overall Study|Pregnancy|3|||
25104790|NCT02463331|50215827|FG000|Overall Study|Lack of Efficacy|6|||
25104791|NCT02463331|50215828|FG001|Overall Study|Lack of Efficacy|0|||
25104792|NCT02463331|50215827|FG000|Overall Study|Physician Decision|3|||
25104793|NCT02463331|50215828|FG001|Overall Study|Physician Decision|0|||
25104794|NCT02410837|50215834|FG000|Overall Study|Death|387|||
25104795|NCT02410837|50215834|FG000|Overall Study|Lost to Follow-up|50|||
25104796|NCT02410837|50215834|FG000|Overall Study|Withdrawal by Subject|44|||
25104797|NCT02410837|50215834|FG000|Overall Study|Physician Decision|6|||
25104798|NCT02410837|50215834|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
25104799|NCT02314247|50215840|FG000|Overall Study|Adverse Event|2|||
25104800|NCT02314247|50215841|FG001|Overall Study|Adverse Event|1|||
25104801|NCT02314247|50215842|FG002|Overall Study|Adverse Event|0|||
25104802|NCT02314247|50215840|FG000|Overall Study|Withdrawal by Subject|1|||
25104803|NCT02314247|50215841|FG001|Overall Study|Withdrawal by Subject|3|||
25104804|NCT02314247|50215842|FG002|Overall Study|Withdrawal by Subject|1|||
25104805|NCT02314247|50215840|FG000|Overall Study|Progression of Disease|6|||
25104806|NCT02314247|50215841|FG001|Overall Study|Progression of Disease|2|||
25104807|NCT02314247|50215842|FG002|Overall Study|Progression of Disease|0|||
25104808|NCT02463097|50215852|FG000|Overall Study|Withdrawal by Subject|1|||
25104809|NCT02441179|50215858|FG000|Overall Study|Withdrawal by Subject|1|||
25104810|NCT02441179|50215859|FG001|Overall Study|Withdrawal by Subject|1|||
25104811|NCT02462473|50215866|FG000|Overall Study|Death|1|||
25104812|NCT02462473|50215866|FG000|Overall Study|Other|3|||
25104813|NCT02440789|50215879|FG000|Overall Study|Withdrawal by Subject|3|||
25104814|NCT02440789|50215879|FG000|Overall Study|Not willing to adhere to reqs|1|||
25104815|NCT02462083|50215883|FG000|Overall Study|Sponsor request|39|||
25104816|NCT02462083|50215883|FG000|Overall Study|Withdrawal by Subject|87|||
25104817|NCT02462083|50215883|FG000|Overall Study|Lost to Follow-up|41|||
25104818|NCT02462083|50215883|FG000|Overall Study|Lack of Efficacy|151|||
25104819|NCT02462083|50215883|FG000|Overall Study|Pregnancy|1|||
25104820|NCT02462083|50215883|FG000|Overall Study|Protocol Violation|6|||
25104821|NCT02462083|50215883|FG000|Overall Study|Adverse Event|33|||
25104822|NCT02462083|50215883|FG000|Overall Study|Worsening condition|16|||
25104823|NCT02462083|50215883|FG000|Overall Study|Other than specified|45|||
25104824|NCT02538341|50215889|FG000|Overall Study|Lost to Follow-up|51|||
25104825|NCT02538341|50215890|FG001|Overall Study|Lost to Follow-up|46|||
25104826|NCT02538341|50215889|FG000|Overall Study|Withdrawal by Subject|3|||
25104827|NCT02538341|50215890|FG001|Overall Study|Withdrawal by Subject|1|||
25104828|NCT02538341|50215889|FG000|Overall Study|Death|2|||
25104829|NCT02538341|50215890|FG001|Overall Study|Death|0|||
25104830|NCT02538107|50215896|FG000|Overall Study|Did not receive any Mircera dose|11|||
25104831|NCT02538107|50215896|FG000|Overall Study|Missing|5|||
25104832|NCT02538107|50215896|FG000|Overall Study|Necessity of dialysis|20|||
25104833|NCT02538107|50215896|FG000|Overall Study|Administration of other ESA|11|||
25104834|NCT02538107|50215896|FG000|Overall Study|No further treatment necessary|18|||
25104835|NCT02538107|50215896|FG000|Overall Study|Withdrawal by Subject|17|||
25104836|NCT02538107|50215896|FG000|Overall Study|Death|4|||
25104837|NCT02538107|50215896|FG000|Overall Study|Administrative reason|5|||
25104838|NCT02538107|50215896|FG000|Overall Study|Adverse Event|4|||
25104839|NCT02538107|50215896|FG000|Overall Study|Surgery|1|||
25104840|NCT02538107|50215896|FG000|Overall Study|Other|7|||
25104841|NCT02538107|50215896|FG000|Overall Study|Not recorded|7|||
25104842|NCT02538029|50215913|FG000|Overall Study|unable to complete cognitive assessments|1|||
25104843|NCT02538029|50215914|FG001|Overall Study|unable to complete cognitive assessments|0|||
25104844|NCT02538029|50215915|FG002|Overall Study|unable to complete cognitive assessments|1|||
25104845|NCT02272413|50215927|FG000|Randomized Through Treatment Start|Not treated|3|||
25104846|NCT02272413|50215928|FG001|Randomized Through Treatment Start|Not treated|5|||
25104847|NCT02272413|50215927|FG000|Pre-switch Period|Adverse Event|38|||
25104848|NCT02272413|50215928|FG001|Pre-switch Period|Adverse Event|37|||
25104849|NCT02272413|50215927|FG000|Pre-switch Period|Death|26|||
25104850|NCT02272413|50215928|FG001|Pre-switch Period|Death|26|||
25104851|NCT02272413|50215927|FG000|Pre-switch Period|Withdrawal by Subject|27|||
25104852|NCT02272413|50215928|FG001|Pre-switch Period|Withdrawal by Subject|15|||
25104853|NCT02272413|50215927|FG000|Pre-switch Period|Physician Decision|6|||
25104854|NCT02272413|50215928|FG001|Pre-switch Period|Physician Decision|18|||
25104855|NCT02272413|50215927|FG000|Pre-switch Period|Progressive disease|185|||
25104856|NCT02272413|50215928|FG001|Pre-switch Period|Progressive disease|173|||
25104857|NCT02272413|50215927|FG000|Pre-switch Period|Lost to Follow-up|0|||
25104858|NCT02272413|50215928|FG001|Pre-switch Period|Lost to Follow-up|2|||
25104859|NCT02272413|50215927|FG000|Pre-switch Period|Protocol Violation|1|||
25104860|NCT02272413|50215928|FG001|Pre-switch Period|Protocol Violation|0|||
25104861|NCT02272413|50215927|FG000|Pre-switch Period|Other than listed|10|||
25104862|NCT02272413|50215928|FG001|Pre-switch Period|Other than listed|11|||
25104863|NCT02272413|50215927|FG000|Post-switch Period|Adverse Event|4|||
25104864|NCT02272413|50215928|FG001|Post-switch Period|Adverse Event|4|||
25104865|NCT02272413|50215927|FG000|Post-switch Period|Death|3|||
25104866|NCT02272413|50215928|FG001|Post-switch Period|Death|2|||
25104867|NCT02272413|50215927|FG000|Post-switch Period|Withdrawal by Subject|1|||
25104868|NCT02272413|50215928|FG001|Post-switch Period|Withdrawal by Subject|2|||
25104869|NCT02272413|50215927|FG000|Post-switch Period|Physician Decision|1|||
25104870|NCT02272413|50215928|FG001|Post-switch Period|Physician Decision|1|||
25104871|NCT02272413|50215927|FG000|Post-switch Period|Progressive disease|21|||
25104872|NCT02272413|50215928|FG001|Post-switch Period|Progressive disease|21|||
25104873|NCT02272413|50215927|FG000|Post-switch Period|Study terminated by sponsor|8|||
25104874|NCT02272413|50215928|FG001|Post-switch Period|Study terminated by sponsor|11|||
25104875|NCT02272413|50215927|FG000|Post-switch Period|Other than listed|4|||
25104876|NCT02272413|50215928|FG001|Post-switch Period|Other than listed|5|||
25104877|NCT02396381|50215940|FG000|Overall Study|Adverse Event|3|||
25104878|NCT02396381|50215941|FG001|Overall Study|Adverse Event|2|||
25104879|NCT02396381|50215940|FG000|Overall Study|Withdrawal by Subject|33|||
25104880|NCT02396381|50215941|FG001|Overall Study|Withdrawal by Subject|24|||
25104881|NCT02396381|50215940|FG000|Overall Study|Lost to Follow-up|49|||
25104882|NCT02396381|50215941|FG001|Overall Study|Lost to Follow-up|31|||
25104883|NCT02396381|50215940|FG000|Overall Study|Protocol Violation|1|||
25104884|NCT02396381|50215941|FG001|Overall Study|Protocol Violation|0|||
25104885|NCT02396381|50215940|FG000|Overall Study|Site terminated by sponsor|7|||
25104886|NCT02396381|50215941|FG001|Overall Study|Site terminated by sponsor|8|||
25104887|NCT02396381|50215940|FG000|Overall Study|Physician Decision|5|||
25104888|NCT02396381|50215941|FG001|Overall Study|Physician Decision|5|||
25104889|NCT02396381|50215940|FG000|Overall Study|Pregnancy|2|||
25104890|NCT02396381|50215941|FG001|Overall Study|Pregnancy|0|||
25104891|NCT02396381|50215940|FG000|Overall Study|Non-compliance with study procedures|1|||
25104892|NCT02396381|50215941|FG001|Overall Study|Non-compliance with study procedures|0|||
25104893|NCT02396381|50215940|FG000|Overall Study|Moved out of town/state|1|||
25104894|NCT02396381|50215941|FG001|Overall Study|Moved out of town/state|3|||
25104895|NCT02396381|50215940|FG000|Overall Study|Could not complete visit|1|||
25104896|NCT02396381|50215941|FG001|Overall Study|Could not complete visit|0|||
25104897|NCT02396381|50215940|FG000|Overall Study|Possible conflict of interest|1|||
25104898|NCT02396381|50215941|FG001|Overall Study|Possible conflict of interest|0|||
25104899|NCT02396381|50215940|FG000|Overall Study|Randomization/Screening Error|3|||
25104900|NCT02396381|50215941|FG001|Overall Study|Randomization/Screening Error|1|||
25104901|NCT02532647|50215953|FG000|Overall Study|Did not receive trial medication|1|||
25104902|NCT02532647|50215954|FG001|Overall Study|Did not receive trial medication|0|||
25104903|NCT02532647|50215955|FG002|Overall Study|Did not receive trial medication|1|||
25104904|NCT02537015|50215963|FG000|Overall Study|Adverse Event|3|||
25104905|NCT02537015|50215963|FG000|Overall Study|Withdrawal by Subject|2|||
25104906|NCT02537015|50215963|FG000|Overall Study|Other Miscellaneous Reasons|1|||
25104907|NCT02271945|50215969|FG000|Overall Study|Death|3|||
25104908|NCT02271945|50215970|FG001|Overall Study|Death|3|||
25104909|NCT02271945|50215969|FG000|Overall Study|Withdrawal by Subject|1|||
25104910|NCT02271945|50215970|FG001|Overall Study|Withdrawal by Subject|1|||
25104911|NCT02271945|50215969|FG000|Overall Study|Other|1|||
25104912|NCT02271945|50215970|FG001|Overall Study|Other|1|||
25104913|NCT01660763|50215978|FG000|Overall Study|Lack of Efficacy|45|||
25104914|NCT01660763|50215979|FG001|Overall Study|Lack of Efficacy|50|||
25104915|NCT01660763|50215978|FG000|Overall Study|Adverse Event|22|||
25104916|NCT01660763|50215979|FG001|Overall Study|Adverse Event|7|||
25104917|NCT01660763|50215978|FG000|Overall Study|Protocol Violation|1|||
25104918|NCT01660763|50215979|FG001|Overall Study|Protocol Violation|0|||
25104919|NCT01660763|50215978|FG000|Overall Study|Withdrawal by Subject|4|||
25104920|NCT01660763|50215979|FG001|Overall Study|Withdrawal by Subject|0|||
25104921|NCT01660763|50215978|FG000|Overall Study|Patient ready for early discharge|28|||
25104922|NCT01660763|50215979|FG001|Overall Study|Patient ready for early discharge|4|||
25104923|NCT01937117|50215985|FG000|Overall Study|Disease Progression|7|||
25104924|NCT01937117|50215985|FG000|Overall Study|Physician Decision|4|||
25104925|NCT01937117|50215985|FG000|Overall Study|Adverse Event|2|||
25104926|NCT02268045|50215991|FG000|Overall Study|Death|4|||
25104927|NCT02268045|50215992|FG001|Overall Study|Death|4|||
25104928|NCT02268045|50215991|FG000|Overall Study|Disease Progression|2|||
25104929|NCT02268045|50215992|FG001|Overall Study|Disease Progression|1|||
25104930|NCT02268045|50215991|FG000|Overall Study|Adverse Event|7|||
25104931|NCT02268045|50215992|FG001|Overall Study|Adverse Event|7|||
25104932|NCT02268045|50215991|FG000|Overall Study|Withdrawal by Subject|2|||
25104933|NCT02268045|50215992|FG001|Overall Study|Withdrawal by Subject|6|||
25104934|NCT02268045|50215991|FG000|Overall Study|Physician Decision|0|||
25104935|NCT02268045|50215992|FG001|Overall Study|Physician Decision|1|||
25104936|NCT02268045|50215991|FG000|Overall Study|Protocol Violation|1|||
25104937|NCT02268045|50215992|FG001|Overall Study|Protocol Violation|1|||
25104938|NCT02536781|50216002|FG000|Overall Study|Lost to Follow-up|2|||
25104939|NCT02536781|50216003|FG001|Overall Study|Lost to Follow-up|0|||
25104940|NCT02267187|50216009|FG000|Overall Study|Physician Decision|2|||
25104941|NCT02267187|50216009|FG000|Overall Study|Screen fail|3|||
25104942|NCT02532179|50216013|FG000|Overall Study|Lost to Follow-up|1|||
25104943|NCT02532179|50216013|FG000|Overall Study|Pregnancy|1|||
25104944|NCT02532179|50216013|FG000|Overall Study|Subject received depot steroid injection|1|||
25104945|NCT02409667|50216017|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
25104946|NCT02409667|50216018|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
25104947|NCT02409667|50216019|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
25104948|NCT02409667|50216020|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
25104949|NCT02409667|50216021|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
25104950|NCT02409667|50216017|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
25104951|NCT02409667|50216018|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
25104952|NCT02409667|50216019|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
25104953|NCT02409667|50216020|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
25104954|NCT02409667|50216021|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
25104955|NCT02409667|50216017|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
25104956|NCT02409667|50216018|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
25104957|NCT02409667|50216019|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
25104958|NCT02409667|50216020|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
25104959|NCT02409667|50216021|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
25104960|NCT02409667|50216017|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
25104961|NCT02409667|50216018|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
25104962|NCT02409667|50216019|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
25104963|NCT02409667|50216020|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
25104964|NCT02409667|50216021|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
25104965|NCT02409667|50216017|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
25104966|NCT02409667|50216018|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
25104967|NCT02409667|50216019|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
25104968|NCT02409667|50216020|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
25104969|NCT02409667|50216021|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
25104970|NCT02409667|50216017|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
25104971|NCT02409667|50216018|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
25104972|NCT02409667|50216019|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
25104973|NCT02409667|50216020|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
25104974|NCT02409667|50216021|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
25104975|NCT02409667|50216017|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
25104976|NCT02409667|50216018|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
25104977|NCT02409667|50216019|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
25104978|NCT02409667|50216020|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
25104979|NCT02409667|50216021|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
25104980|NCT02409667|50216017|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
25104981|NCT02409667|50216018|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
25104982|NCT02409667|50216019|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
25104983|NCT02409667|50216020|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
25104984|NCT02409667|50216021|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
25104985|NCT02409667|50216017|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
25104986|NCT02409667|50216018|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
25104987|NCT02409667|50216019|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
25104988|NCT02409667|50216020|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
25104989|NCT02409667|50216021|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
25104990|NCT02409667|50216017|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
25104991|NCT02409667|50216018|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
25104992|NCT02409667|50216019|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
25104993|NCT02409667|50216020|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
25104994|NCT02409667|50216021|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
25104995|NCT02409667|50216017|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
25104996|NCT02409667|50216018|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
25104997|NCT02409667|50216019|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
25104998|NCT02409667|50216020|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
25104999|NCT02409667|50216021|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
25105000|NCT02409667|50216017|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
25105001|NCT02409667|50216018|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
25105002|NCT02409667|50216019|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
25105003|NCT02409667|50216020|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
25105004|NCT02409667|50216021|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
25105005|NCT02409667|50216017|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
25105006|NCT02409667|50216018|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
25105007|NCT02409667|50216019|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
25105008|NCT02409667|50216020|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
25105009|NCT02409667|50216021|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
25105010|NCT02409667|50216017|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
25105011|NCT02409667|50216018|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
25105012|NCT02409667|50216019|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
25105013|NCT02409667|50216020|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
25105014|NCT02409667|50216021|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
25105015|NCT02409667|50216017|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
25105016|NCT02409667|50216018|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
25105017|NCT02409667|50216019|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
25105018|NCT02409667|50216020|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
25105019|NCT02409667|50216021|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
25105020|NCT02409667|50216017|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
25105021|NCT02409667|50216018|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
25105022|NCT02409667|50216019|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
25105023|NCT02409667|50216020|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
25105024|NCT02409667|50216021|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
25105025|NCT01641939|50216035|FG000|Overall Study|Death|90|||
25105026|NCT01641939|50216036|FG001|Overall Study|Death|187|||
25105027|NCT01641939|50216037|FG002|Overall Study|Death|61|||
25105028|NCT01641939|50216035|FG000|Overall Study|Lost to Follow-up|3|||
25105029|NCT01641939|50216036|FG001|Overall Study|Lost to Follow-up|2|||
25105030|NCT01641939|50216037|FG002|Overall Study|Lost to Follow-up|1|||
25105031|NCT01641939|50216035|FG000|Overall Study|Withdrawal by Subject|14|||
25105032|NCT01641939|50216036|FG001|Overall Study|Withdrawal by Subject|11|||
25105033|NCT01641939|50216037|FG002|Overall Study|Withdrawal by Subject|5|||
25105034|NCT01641939|50216035|FG000|Overall Study|Study Terminated by Sponsor|10|||
25105035|NCT01641939|50216036|FG001|Overall Study|Study Terminated by Sponsor|28|||
25105036|NCT01641939|50216037|FG002|Overall Study|Study Terminated by Sponsor|3|||
25105037|NCT01641861|50216049|FG000|Overall Study|Lost to Follow-up|21|||
25105038|NCT01641861|50216050|FG001|Overall Study|Lost to Follow-up|16|||
25105039|NCT01641861|50216049|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
25105040|NCT01641861|50216050|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
25105041|NCT01641861|50216049|FG000|Overall Study|Died due to drowning|0|||
25105042|NCT01641861|50216050|FG001|Overall Study|Died due to drowning|1|||
25105043|NCT02409355|50216058|FG000|Overall Study|Withdrawal by Subject|1|||
25105044|NCT02409355|50216059|FG001|Overall Study|Withdrawal by Subject|0|||
25105045|NCT02409355|50216058|FG000|Overall Study|Death|1|||
25105046|NCT02409355|50216059|FG001|Overall Study|Death|1|||
25105047|NCT02409355|50216058|FG000|Overall Study|Study terminated by Sponsor|2|||
25105048|NCT02409355|50216059|FG001|Overall Study|Study terminated by Sponsor|3|||
25105049|NCT02408887|50216067|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
25105050|NCT02408887|50216068|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
25105051|NCT02408887|50216067|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
25105052|NCT02408887|50216068|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
25105053|NCT02266875|50216076|FG000|Overall Study|Withdrawal by Subject|9|||
25105054|NCT02266875|50216077|FG001|Overall Study|Withdrawal by Subject|0|||
25105055|NCT02266875|50216076|FG000|Overall Study|Lost to Follow-up|2|||
25105056|NCT02266875|50216077|FG001|Overall Study|Lost to Follow-up|0|||
25105057|NCT02438371|50216085|FG000|Overall Study|Lost to Follow-up|3|||
25105058|NCT02438371|50216086|FG001|Overall Study|Lost to Follow-up|2|||
25105059|NCT02438371|50216085|FG000|Overall Study|Withdrawal by Subject|1|||
25105060|NCT02438371|50216086|FG001|Overall Study|Withdrawal by Subject|1|||
25105061|NCT02438137|50216094|FG000|Overall Study|Lost to Follow-up|3|||
25105062|NCT02438137|50216095|FG001|Overall Study|Lost to Follow-up|2|||
25105063|NCT02438137|50216094|FG000|Overall Study|Adverse Event|1|||
25105064|NCT02438137|50216095|FG001|Overall Study|Adverse Event|0|||
25105065|NCT02438137|50216094|FG000|Overall Study|Withdrawal by Subject|4|||
25105066|NCT02438137|50216095|FG001|Overall Study|Withdrawal by Subject|3|||
25105067|NCT02438137|50216094|FG000|Overall Study|Physician Decision|0|||
25105068|NCT02438137|50216095|FG001|Overall Study|Physician Decision|1|||
25105069|NCT02437903|50216103|FG000|Overall Study|Adverse Event|1|||
25105070|NCT02437903|50216103|FG000|Overall Study|Withdrawal by Subject|1|||
25105071|NCT02437903|50216103|FG000|Overall Study|Lost to Follow-up|3|||
25105072|NCT02437513|50216108|FG000|Overall Study|Withdrawal by Subject|2|||
25105073|NCT02460991|50216114|FG000|Overall Study|Withdrawal by Subject|0|||
25105074|NCT02460991|50216115|FG001|Overall Study|Withdrawal by Subject|2|||
25105075|NCT02407249|50216126|FG000|Overall Study|Did not complete 12-month follow-up|13|||
25105076|NCT02407249|50216126|FG000|Overall Study|Not treated|13|||
25105077|NCT02460679|50216130|FG000|Overall Study|Investigator Decision|1|||
25105078|NCT02460679|50216130|FG000|Overall Study|Withdrawal by Subject|4|||
25105079|NCT02459899|50216138|FG000|Overall Study|Adverse Event|1|||
25105080|NCT02459899|50216139|FG001|Overall Study|Adverse Event|1|||
25105081|NCT02459899|50216140|FG002|Overall Study|Adverse Event|0|||
25105082|NCT02459899|50216141|FG003|Overall Study|Adverse Event|0|||
25105083|NCT02459899|50216138|FG000|Overall Study|Lost to Follow-up|1|||
25105084|NCT02459899|50216139|FG001|Overall Study|Lost to Follow-up|2|||
25105085|NCT02459899|50216140|FG002|Overall Study|Lost to Follow-up|0|||
25105086|NCT02459899|50216141|FG003|Overall Study|Lost to Follow-up|1|||
25105087|NCT02459899|50216138|FG000|Overall Study|Non-compliance with the treatment|0|||
25105088|NCT02459899|50216139|FG001|Overall Study|Non-compliance with the treatment|0|||
25105089|NCT02459899|50216140|FG002|Overall Study|Non-compliance with the treatment|0|||
25105090|NCT02459899|50216141|FG003|Overall Study|Non-compliance with the treatment|1|||
25105091|NCT02459899|50216138|FG000|Overall Study|Withdrawal by Subject|1|||
25105092|NCT02459899|50216139|FG001|Overall Study|Withdrawal by Subject|3|||
25105093|NCT02459899|50216140|FG002|Overall Study|Withdrawal by Subject|0|||
25105094|NCT02459899|50216141|FG003|Overall Study|Withdrawal by Subject|0|||
25105095|NCT02436889|50216153|FG000|Overall Study|No improvement in symptoms|1|||
25105096|NCT02436889|50216154|FG001|Overall Study|No improvement in symptoms|0|||
25105097|NCT02436889|50216153|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
25105098|NCT02436889|50216154|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
25105099|NCT02436811|50216163|FG000|Overall Study|Lost to Follow-up|2|||
25105100|NCT02436811|50216164|FG001|Overall Study|Lost to Follow-up|9|||
25105101|NCT02436811|50216165|FG002|Overall Study|Lost to Follow-up|7|||
25105102|NCT02436577|50216179|FG000|Overall Study|Protocol Deviation|0|||
25105103|NCT02436577|50216180|FG001|Overall Study|Protocol Deviation|1|||
25105104|NCT02436577|50216181|FG002|Overall Study|Protocol Deviation|0|||
25105105|NCT02436577|50216182|FG003|Overall Study|Protocol Deviation|0|||
25105106|NCT02436577|50216183|FG004|Overall Study|Protocol Deviation|0|||
25105107|NCT02436577|50216184|FG005|Overall Study|Protocol Deviation|0|||
25105108|NCT02265705|50216194|FG000|Treatment Period Week 0-24|Adverse Event|3|||
25105109|NCT02265705|50216195|FG001|Treatment Period Week 0-24|Adverse Event|2|||
25105110|NCT02265705|50216196|FG002|Treatment Period Week 0-24|Adverse Event|0|||
25105111|NCT02265705|50216197|FG003|Treatment Period Week 0-24|Adverse Event|0|||
25105112|NCT02265705|50216198|FG004|Treatment Period Week 0-24|Adverse Event|0|||
25105113|NCT02265705|50216199|FG005|Treatment Period Week 0-24|Adverse Event|0|||
25105114|NCT02265705|50216200|FG006|Treatment Period Week 0-24|Adverse Event|0|||
25105115|NCT02265705|50216194|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
25105116|NCT02265705|50216195|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
25105117|NCT02265705|50216196|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
25105118|NCT02265705|50216197|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
25105119|NCT02265705|50216198|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
25105120|NCT02265705|50216199|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
25105121|NCT02265705|50216200|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
25105122|NCT02265705|50216194|FG000|Treatment Period Week 0-24|Physician Decision|1|||
25105123|NCT02265705|50216195|FG001|Treatment Period Week 0-24|Physician Decision|0|||
25105124|NCT02265705|50216196|FG002|Treatment Period Week 0-24|Physician Decision|0|||
25105125|NCT02265705|50216197|FG003|Treatment Period Week 0-24|Physician Decision|0|||
25105126|NCT02265705|50216198|FG004|Treatment Period Week 0-24|Physician Decision|0|||
25105127|NCT02265705|50216199|FG005|Treatment Period Week 0-24|Physician Decision|0|||
25105128|NCT02265705|50216200|FG006|Treatment Period Week 0-24|Physician Decision|0|||
25105129|NCT02265705|50216194|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
25105130|NCT02265705|50216195|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
25105131|NCT02265705|50216196|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
25105132|NCT02265705|50216197|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
25105133|NCT02265705|50216198|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
25105134|NCT02265705|50216199|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
25105135|NCT02265705|50216200|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
25105136|NCT02265705|50216194|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
25105137|NCT02265705|50216195|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
25105138|NCT02265705|50216196|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
25105139|NCT02265705|50216197|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
25105140|NCT02265705|50216198|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
25105141|NCT02265705|50216199|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
25105142|NCT02265705|50216200|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
25105143|NCT02265705|50216194|FG000|Rescue Period|Withdrawal by Subject|0|||
25105144|NCT02265705|50216195|FG001|Rescue Period|Withdrawal by Subject|0|||
25105145|NCT02265705|50216196|FG002|Rescue Period|Withdrawal by Subject|1|||
25105146|NCT02265705|50216197|FG003|Rescue Period|Withdrawal by Subject|0|||
25105147|NCT02265705|50216198|FG004|Rescue Period|Withdrawal by Subject|0|||
25105148|NCT02265705|50216199|FG005|Rescue Period|Withdrawal by Subject|0|||
25105149|NCT02265705|50216200|FG006|Rescue Period|Withdrawal by Subject|0|||
25105150|NCT02265705|50216194|FG000|Rescue Period|Death|0|||
25105151|NCT02265705|50216195|FG001|Rescue Period|Death|0|||
25105152|NCT02265705|50216196|FG002|Rescue Period|Death|1|||
25105153|NCT02265705|50216197|FG003|Rescue Period|Death|0|||
25105154|NCT02265705|50216198|FG004|Rescue Period|Death|0|||
25105155|NCT02265705|50216199|FG005|Rescue Period|Death|0|||
25105156|NCT02265705|50216200|FG006|Rescue Period|Death|0|||
25105157|NCT02265705|50216194|FG000|Rescue Period|Lack of Efficacy|0|||
25105158|NCT02265705|50216195|FG001|Rescue Period|Lack of Efficacy|0|||
25105159|NCT02265705|50216196|FG002|Rescue Period|Lack of Efficacy|1|||
25105160|NCT02265705|50216197|FG003|Rescue Period|Lack of Efficacy|0|||
25105161|NCT02265705|50216198|FG004|Rescue Period|Lack of Efficacy|0|||
25105162|NCT02265705|50216199|FG005|Rescue Period|Lack of Efficacy|0|||
25105163|NCT02265705|50216200|FG006|Rescue Period|Lack of Efficacy|0|||
25105164|NCT02265705|50216194|FG000|Open Label Period|Adverse Event|0|||
25105165|NCT02265705|50216195|FG001|Open Label Period|Adverse Event|0|||
25105166|NCT02265705|50216196|FG002|Open Label Period|Adverse Event|0|||
25105167|NCT02265705|50216197|FG003|Open Label Period|Adverse Event|2|||
25105168|NCT02265705|50216198|FG004|Open Label Period|Adverse Event|2|||
25105169|NCT02265705|50216199|FG005|Open Label Period|Adverse Event|0|||
25105170|NCT02265705|50216200|FG006|Open Label Period|Adverse Event|0|||
25105171|NCT02265705|50216194|FG000|Open Label Period|Physician Decision|0|||
25105172|NCT02265705|50216195|FG001|Open Label Period|Physician Decision|0|||
25105173|NCT02265705|50216196|FG002|Open Label Period|Physician Decision|0|||
25105174|NCT02265705|50216197|FG003|Open Label Period|Physician Decision|0|||
25105175|NCT02265705|50216198|FG004|Open Label Period|Physician Decision|1|||
25105176|NCT02265705|50216199|FG005|Open Label Period|Physician Decision|0|||
25105177|NCT02265705|50216200|FG006|Open Label Period|Physician Decision|0|||
25105178|NCT02265705|50216194|FG000|Open Label Period|Withdrawal by Subject|0|||
25105179|NCT02265705|50216195|FG001|Open Label Period|Withdrawal by Subject|0|||
25105180|NCT02265705|50216196|FG002|Open Label Period|Withdrawal by Subject|0|||
25105181|NCT02265705|50216197|FG003|Open Label Period|Withdrawal by Subject|0|||
25105182|NCT02265705|50216198|FG004|Open Label Period|Withdrawal by Subject|2|||
25105183|NCT02265705|50216199|FG005|Open Label Period|Withdrawal by Subject|0|||
25105184|NCT02265705|50216200|FG006|Open Label Period|Withdrawal by Subject|0|||
25105185|NCT02265705|50216194|FG000|Follow-up Period|Sponsor Decision|0|||
25105186|NCT02265705|50216195|FG001|Follow-up Period|Sponsor Decision|0|||
25105187|NCT02265705|50216196|FG002|Follow-up Period|Sponsor Decision|0|||
25105188|NCT02265705|50216197|FG003|Follow-up Period|Sponsor Decision|0|||
25105189|NCT02265705|50216198|FG004|Follow-up Period|Sponsor Decision|0|||
25105190|NCT02265705|50216199|FG005|Follow-up Period|Sponsor Decision|1|||
25105191|NCT02265705|50216200|FG006|Follow-up Period|Sponsor Decision|6|||
25105192|NCT02265705|50216194|FG000|Follow-up Period|Adverse Event|0|||
25105193|NCT02265705|50216195|FG001|Follow-up Period|Adverse Event|0|||
25105194|NCT02265705|50216196|FG002|Follow-up Period|Adverse Event|0|||
25105195|NCT02265705|50216197|FG003|Follow-up Period|Adverse Event|0|||
25105196|NCT02265705|50216198|FG004|Follow-up Period|Adverse Event|0|||
25105197|NCT02265705|50216199|FG005|Follow-up Period|Adverse Event|0|||
25105198|NCT02265705|50216200|FG006|Follow-up Period|Adverse Event|3|||
25105199|NCT02265705|50216194|FG000|Follow-up Period|Physician Decision|0|||
25105200|NCT02265705|50216195|FG001|Follow-up Period|Physician Decision|0|||
25105201|NCT02265705|50216196|FG002|Follow-up Period|Physician Decision|0|||
25105202|NCT02265705|50216197|FG003|Follow-up Period|Physician Decision|0|||
25105203|NCT02265705|50216198|FG004|Follow-up Period|Physician Decision|0|||
25105204|NCT02265705|50216199|FG005|Follow-up Period|Physician Decision|0|||
25105205|NCT02265705|50216200|FG006|Follow-up Period|Physician Decision|1|||
25105206|NCT02265705|50216194|FG000|Follow-up Period|Withdrawal by Subject|0|||
25105207|NCT02265705|50216195|FG001|Follow-up Period|Withdrawal by Subject|0|||
25105208|NCT02265705|50216196|FG002|Follow-up Period|Withdrawal by Subject|0|||
25105209|NCT02265705|50216197|FG003|Follow-up Period|Withdrawal by Subject|0|||
25105210|NCT02265705|50216198|FG004|Follow-up Period|Withdrawal by Subject|0|||
25105211|NCT02265705|50216199|FG005|Follow-up Period|Withdrawal by Subject|0|||
25105212|NCT02265705|50216200|FG006|Follow-up Period|Withdrawal by Subject|1|||
25105213|NCT02459665|50216215|FG000|Overall Study|Withdrawal by Subject|0|||
25105214|NCT02459665|50216216|FG001|Overall Study|Withdrawal by Subject|1|||
25105215|NCT02459665|50216217|FG002|Overall Study|Withdrawal by Subject|1|||
25105216|NCT02459665|50216218|FG003|Overall Study|Withdrawal by Subject|2|||
25105217|NCT02459587|50216237|FG000|3-Month Follow-up Assessment|Death|0|||
25105218|NCT02459587|50216238|FG001|3-Month Follow-up Assessment|Death|2|||
25105219|NCT02459587|50216237|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
25105220|NCT02459587|50216238|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
25105221|NCT02459587|50216237|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
25105222|NCT02459587|50216238|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
25105223|NCT02459587|50216237|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
25105224|NCT02459587|50216238|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
25105225|NCT02459587|50216237|FG000|6-month Follow-up Assessment|Death|2|||
25105226|NCT02459587|50216238|FG001|6-month Follow-up Assessment|Death|1|||
25105227|NCT02459587|50216237|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
25105228|NCT02459587|50216238|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
25105229|NCT02459587|50216237|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
25105230|NCT02459587|50216238|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
25105231|NCT02459587|50216237|FG000|12-month Follow-up Assessment|Death|2|||
25105232|NCT02459587|50216238|FG001|12-month Follow-up Assessment|Death|0|||
25105233|NCT02459587|50216237|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
25105234|NCT02459587|50216238|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
25105235|NCT02459587|50216237|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
25105236|NCT02459587|50216238|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
25105237|NCT02459587|50216237|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
25105238|NCT02459587|50216238|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
25105239|NCT02265237|50216249|FG000|As Treated (Overall Study)|Adverse Event|1|||
25105240|NCT02265237|50216250|FG001|As Treated (Overall Study)|Adverse Event|1|||
25105241|NCT02265237|50216251|FG002|As Treated (Overall Study)|Adverse Event|0|||
25105242|NCT02265237|50216252|FG003|As Treated (Overall Study)|Adverse Event|0|||
25105243|NCT02265237|50216249|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
25105244|NCT02265237|50216250|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
25105245|NCT02265237|50216251|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
25105246|NCT02265237|50216252|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
25105247|NCT02265237|50216249|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
25105248|NCT02265237|50216250|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
25105249|NCT02265237|50216251|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
25105250|NCT02265237|50216252|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
25105251|NCT02265237|50216249|FG000|As Treated (Overall Study)|Other|2|||
25105252|NCT02265237|50216250|FG001|As Treated (Overall Study)|Other|0|||
25105253|NCT02265237|50216251|FG002|As Treated (Overall Study)|Other|3|||
25105254|NCT02265237|50216252|FG003|As Treated (Overall Study)|Other|1|||
25105255|NCT02263365|50216265|FG000|Overall Study|Physician Decision|22|||
25105256|NCT02263365|50216266|FG001|Overall Study|Physician Decision|18|||
25105257|NCT02261493|50216276|FG000|Overall Study|Noncompliance|0|||
25105258|NCT02261493|50216277|FG001|Overall Study|Noncompliance|0|||
25105259|NCT02261493|50216278|FG002|Overall Study|Noncompliance|2|||
25105260|NCT02261493|50216276|FG000|Overall Study|Physician Decision|0|||
25105261|NCT02261493|50216277|FG001|Overall Study|Physician Decision|1|||
25105262|NCT02261493|50216278|FG002|Overall Study|Physician Decision|0|||
25105263|NCT02261493|50216276|FG000|Overall Study|Undisclosed alcohol abuse|0|||
25105264|NCT02261493|50216277|FG001|Overall Study|Undisclosed alcohol abuse|1|||
25105265|NCT02261493|50216278|FG002|Overall Study|Undisclosed alcohol abuse|0|||
25105266|NCT02261493|50216276|FG000|Overall Study|Protocol Violation|1|||
25105267|NCT02261493|50216277|FG001|Overall Study|Protocol Violation|0|||
25105268|NCT02261493|50216278|FG002|Overall Study|Protocol Violation|0|||
25105269|NCT02261493|50216276|FG000|Overall Study|Personal Reasons|14|||
25105270|NCT02261493|50216277|FG001|Overall Study|Personal Reasons|14|||
25105271|NCT02261493|50216278|FG002|Overall Study|Personal Reasons|16|||
25105272|NCT02261493|50216276|FG000|Overall Study|Lost to Follow-up|14|||
25105273|NCT02261493|50216277|FG001|Overall Study|Lost to Follow-up|27|||
25105274|NCT02261493|50216278|FG002|Overall Study|Lost to Follow-up|8|||
25105275|NCT02261493|50216276|FG000|Overall Study|Pregnancy|1|||
25105276|NCT02261493|50216277|FG001|Overall Study|Pregnancy|2|||
25105277|NCT02261493|50216278|FG002|Overall Study|Pregnancy|0|||
25105278|NCT02261493|50216276|FG000|Overall Study|Lack of Efficacy|0|||
25105279|NCT02261493|50216277|FG001|Overall Study|Lack of Efficacy|1|||
25105280|NCT02261493|50216278|FG002|Overall Study|Lack of Efficacy|0|||
25105281|NCT02261493|50216276|FG000|Overall Study|Adverse Event|0|||
25105282|NCT02261493|50216277|FG001|Overall Study|Adverse Event|1|||
25105283|NCT02261493|50216278|FG002|Overall Study|Adverse Event|0|||
25105284|NCT02260791|50216288|FG000|Overall Study|Lost to Follow-up|4|||
25105285|NCT02260791|50216289|FG001|Overall Study|Lost to Follow-up|4|||
25105286|NCT02260791|50216288|FG000|Overall Study|Lack of Efficacy|2|||
25105287|NCT02260791|50216289|FG001|Overall Study|Lack of Efficacy|1|||
25105288|NCT02260791|50216288|FG000|Overall Study|Adverse Event|13|||
25105289|NCT02260791|50216289|FG001|Overall Study|Adverse Event|9|||
25105290|NCT02260791|50216288|FG000|Overall Study|Death|1|||
25105291|NCT02260791|50216289|FG001|Overall Study|Death|0|||
25105292|NCT02260791|50216288|FG000|Overall Study|Withdrawal by Subject|11|||
25105293|NCT02260791|50216289|FG001|Overall Study|Withdrawal by Subject|16|||
25105294|NCT02260791|50216288|FG000|Overall Study|Screen failure|0|||
25105295|NCT02260791|50216289|FG001|Overall Study|Screen failure|1|||
25105296|NCT02260791|50216288|FG000|Overall Study|Protocol deviation|2|||
25105297|NCT02260791|50216289|FG001|Overall Study|Protocol deviation|3|||
25105298|NCT02260635|50216297|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
25105299|NCT02260635|50216298|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
25105300|NCT02260635|50216297|FG000|Open-Label Extension|Study Termination|25|||
25105301|NCT02260635|50216298|FG001|Open-Label Extension|Study Termination|25|||
25105302|NCT02260635|50216297|FG000|Open-Label Extension|Withdrawal by Subject|1|||
25105303|NCT02260635|50216298|FG001|Open-Label Extension|Withdrawal by Subject|0|||
25105304|NCT02259231|50216313|FG000|Overall Study|Adverse Event|1|||
25105305|NCT02259231|50216314|FG001|Overall Study|Adverse Event|1|||
25105306|NCT02259231|50216315|FG002|Overall Study|Adverse Event|2|||
25105307|NCT02259231|50216316|FG003|Overall Study|Adverse Event|0|||
25105308|NCT02259231|50216317|FG004|Overall Study|Adverse Event|0|||
25105309|NCT02259231|50216318|FG005|Overall Study|Adverse Event|0|||
25105310|NCT02259231|50216319|FG006|Overall Study|Adverse Event|0|||
25105311|NCT02259231|50216313|FG000|Overall Study|Progressive Disease|4|||
25105312|NCT02259231|50216314|FG001|Overall Study|Progressive Disease|5|||
25105313|NCT02259231|50216315|FG002|Overall Study|Progressive Disease|4|||
25105314|NCT02259231|50216316|FG003|Overall Study|Progressive Disease|5|||
25105315|NCT02259231|50216317|FG004|Overall Study|Progressive Disease|4|||
25105316|NCT02259231|50216318|FG005|Overall Study|Progressive Disease|5|||
25105317|NCT02259231|50216319|FG006|Overall Study|Progressive Disease|4|||
25177202|NCT01498289|50321308|FG001|Overall Study|Adverse Event|18|||
25177203|NCT01498289|50321307|FG000|Overall Study|Death|6|||
25177204|NCT01498289|50321308|FG001|Overall Study|Death|8|||
25105318|NCT02259231|50216313|FG000|Overall Study|Sponsor termination of study|1|||
25105319|NCT02259231|50216314|FG001|Overall Study|Sponsor termination of study|0|||
25105320|NCT02259231|50216315|FG002|Overall Study|Sponsor termination of study|0|||
25105321|NCT02259231|50216316|FG003|Overall Study|Sponsor termination of study|1|||
25105322|NCT02259231|50216317|FG004|Overall Study|Sponsor termination of study|2|||
25105323|NCT02259231|50216318|FG005|Overall Study|Sponsor termination of study|1|||
25105324|NCT02259231|50216319|FG006|Overall Study|Sponsor termination of study|1|||
25105325|NCT02258529|50216335|FG000|Overall Study|Study Terminated by Sponsor|9|||
25105326|NCT02258529|50216335|FG000|Overall Study|Adverse Event|1|||
25105327|NCT02256969|50216342|FG000|Overall Study|Screenfailed or withdrew|2|||
25105328|NCT02256969|50216343|FG001|Overall Study|Screenfailed or withdrew|1|||
25177205|NCT01498289|50321307|FG000|Overall Study|Withdrawal unrelated to AE|16|||
25105329|NCT02256969|50216344|FG002|Overall Study|Screenfailed or withdrew|1|||
25105330|NCT02256891|50216354|FG000|Overall Study|Death|0|||
25105331|NCT02256891|50216355|FG001|Overall Study|Death|2|||
25105332|NCT02256891|50216354|FG000|Overall Study|Lost to Follow-up|0|||
25105333|NCT02256891|50216355|FG001|Overall Study|Lost to Follow-up|3|||
25105334|NCT02256891|50216354|FG000|Overall Study|Physician Decision|7|||
25105335|NCT02256891|50216355|FG001|Overall Study|Physician Decision|3|||
25105336|NCT02256891|50216354|FG000|Overall Study|Screen Fail|5|||
25105337|NCT02256891|50216355|FG001|Overall Study|Screen Fail|4|||
25105338|NCT02256891|50216354|FG000|Overall Study|Equipment Malfunction|0|||
25105339|NCT02256891|50216355|FG001|Overall Study|Equipment Malfunction|1|||
25105340|NCT02256267|50216363|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
25105341|NCT02256267|50216363|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
25105342|NCT01641471|50216372|FG000|Overall Study|Withdrawal by Subject|19|||
25105343|NCT01641471|50216373|FG001|Overall Study|Withdrawal by Subject|19|||
25105344|NCT01641471|50216372|FG000|Overall Study|Lost to Follow-up|2|||
25105345|NCT01641471|50216373|FG001|Overall Study|Lost to Follow-up|4|||
25105346|NCT01641471|50216372|FG000|Overall Study|Protocol Violation|2|||
25105347|NCT01641471|50216373|FG001|Overall Study|Protocol Violation|4|||
25105348|NCT02255565|50216382|FG000|Overall Study|Withdrawal by Subject|0|||
25105349|NCT02255565|50216383|FG001|Overall Study|Withdrawal by Subject|1|||
25105350|NCT02255565|50216384|FG002|Overall Study|Withdrawal by Subject|0|||
25105351|NCT01640301|50216427|FG000|Overall Study|Death|0|||
25105352|NCT01640301|50216428|FG001|Overall Study|Death|8|||
25105353|NCT01642407|50216436|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
25105354|NCT01642407|50216436|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
25105355|NCT01642407|50216436|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
25105356|NCT02255097|50216440|FG000|Overall Study|Death|151|||
25105357|NCT02255097|50216440|FG000|Overall Study|Lost to Follow-up|5|||
25105358|NCT02255097|50216440|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
25105359|NCT02255097|50216440|FG000|Overall Study|Withdrawal by Subject|7|||
25105360|NCT02255097|50216440|FG000|Overall Study|Allocated but not treated|1|||
25105361|NCT02254551|50216445|FG000|Dose Escalation|Physician Decision|1|||
25105362|NCT02254551|50216445|FG000|Dose Escalation|Dose-limiting toxicity|2|||
25105363|NCT01641237|50216452|FG000|Period II|Withdrawal by Subject|1|||
25105364|NCT01641237|50216453|FG001|Period II|Withdrawal by Subject|0|||
25105365|NCT01641237|50216454|FG002|Period II|Withdrawal by Subject|0|||
25105366|NCT01641237|50216455|FG003|Period II|Withdrawal by Subject|0|||
25105367|NCT01641237|50216452|FG000|Period III|Lost to Follow-up|1|||
25105368|NCT01641237|50216453|FG001|Period III|Lost to Follow-up|0|||
25105369|NCT01641237|50216454|FG002|Period III|Lost to Follow-up|0|||
25105370|NCT01641237|50216455|FG003|Period III|Lost to Follow-up|0|||
25105371|NCT01639833|50216467|FG000|Overall Study|Death|4|||
25105372|NCT01639833|50216468|FG001|Overall Study|Death|2|||
25105373|NCT01639833|50216467|FG000|Overall Study|Withdrawal by Subject|2|||
25105374|NCT01639833|50216468|FG001|Overall Study|Withdrawal by Subject|2|||
25105375|NCT01639131|50216474|FG000|Overall Study|Disease Progression|6|||
25105376|NCT01641159|50216480|FG000|Overall Study|Lost to Follow-up|2|||
25105377|NCT01641159|50216481|FG001|Overall Study|Lost to Follow-up|1|||
25105378|NCT01641159|50216480|FG000|Overall Study|Withdrawal by Subject|0|||
25105379|NCT01641159|50216481|FG001|Overall Study|Withdrawal by Subject|1|||
25105380|NCT01641081|50216487|FG000|Period 1|Sponsor request (potential unblinding)|0|||
25105381|NCT01641081|50216488|FG001|Period 1|Sponsor request (potential unblinding)|0|||
25105382|NCT01641081|50216489|FG002|Period 1|Sponsor request (potential unblinding)|0|||
25105383|NCT01641081|50216490|FG003|Period 1|Sponsor request (potential unblinding)|0|||
25105384|NCT01641081|50216491|FG004|Period 1|Sponsor request (potential unblinding)|0|||
25105385|NCT01641081|50216492|FG005|Period 1|Sponsor request (potential unblinding)|0|||
25105386|NCT01641081|50216493|FG006|Period 1|Sponsor request (potential unblinding)|1|||
25105387|NCT01641081|50216494|FG007|Period 1|Sponsor request (potential unblinding)|0|||
25105388|NCT01641081|50216495|FG008|Period 1|Sponsor request (potential unblinding)|0|||
25105389|NCT01641081|50216496|FG009|Period 1|Sponsor request (potential unblinding)|0|||
25105390|NCT01641081|50216487|FG000|Period 1|Protocol Violation|0|||
25105391|NCT01641081|50216488|FG001|Period 1|Protocol Violation|0|||
25105392|NCT01641081|50216489|FG002|Period 1|Protocol Violation|0|||
25105393|NCT01641081|50216490|FG003|Period 1|Protocol Violation|0|||
25105394|NCT01641081|50216491|FG004|Period 1|Protocol Violation|1|||
25105395|NCT01641081|50216492|FG005|Period 1|Protocol Violation|0|||
25105396|NCT01641081|50216493|FG006|Period 1|Protocol Violation|0|||
25105397|NCT01641081|50216494|FG007|Period 1|Protocol Violation|1|||
25105398|NCT01641081|50216495|FG008|Period 1|Protocol Violation|0|||
25105399|NCT01641081|50216496|FG009|Period 1|Protocol Violation|0|||
25008273|NCT03115112|50101159|FG001|Overall Study|Death|0|||
25105400|NCT01641081|50216487|FG000|Period 1|Adverse Event|1|||
25105401|NCT01641081|50216488|FG001|Period 1|Adverse Event|0|||
25105402|NCT01641081|50216489|FG002|Period 1|Adverse Event|0|||
25008274|NCT03115112|50101158|FG000|Overall Study|Pregnancy|1|||
25105403|NCT01641081|50216490|FG003|Period 1|Adverse Event|0|||
25105404|NCT01641081|50216491|FG004|Period 1|Adverse Event|0|||
25105405|NCT01641081|50216492|FG005|Period 1|Adverse Event|0|||
25105406|NCT01641081|50216493|FG006|Period 1|Adverse Event|0|||
25105407|NCT01641081|50216494|FG007|Period 1|Adverse Event|2|||
25105408|NCT01641081|50216495|FG008|Period 1|Adverse Event|0|||
25105409|NCT01641081|50216496|FG009|Period 1|Adverse Event|0|||
25105410|NCT01641081|50216487|FG000|Period 2|Adverse Event|0|||
25105411|NCT01641081|50216488|FG001|Period 2|Adverse Event|0|||
25105412|NCT01641081|50216489|FG002|Period 2|Adverse Event|0|||
25105413|NCT01641081|50216490|FG003|Period 2|Adverse Event|0|||
25105414|NCT01641081|50216491|FG004|Period 2|Adverse Event|0|||
25105415|NCT01641081|50216492|FG005|Period 2|Adverse Event|1|||
25105416|NCT01641081|50216493|FG006|Period 2|Adverse Event|0|||
25105417|NCT01641081|50216494|FG007|Period 2|Adverse Event|0|||
25105418|NCT01641081|50216495|FG008|Period 2|Adverse Event|0|||
25105419|NCT01641081|50216496|FG009|Period 2|Adverse Event|0|||
25105420|NCT01641081|50216487|FG000|Period 2|Withdrawal by Subject|0|||
25105421|NCT01641081|50216488|FG001|Period 2|Withdrawal by Subject|0|||
25105422|NCT01641081|50216489|FG002|Period 2|Withdrawal by Subject|0|||
25105423|NCT01641081|50216490|FG003|Period 2|Withdrawal by Subject|1|||
25105424|NCT01641081|50216491|FG004|Period 2|Withdrawal by Subject|0|||
25105425|NCT01641081|50216492|FG005|Period 2|Withdrawal by Subject|0|||
25105426|NCT01641081|50216493|FG006|Period 2|Withdrawal by Subject|2|||
25105427|NCT01641081|50216494|FG007|Period 2|Withdrawal by Subject|0|||
25105428|NCT01641081|50216495|FG008|Period 2|Withdrawal by Subject|0|||
25105429|NCT01641081|50216496|FG009|Period 2|Withdrawal by Subject|0|||
25105430|NCT01641081|50216487|FG000|Period 2|Protocol Violation|1|||
25105431|NCT01641081|50216488|FG001|Period 2|Protocol Violation|0|||
25105432|NCT01641081|50216489|FG002|Period 2|Protocol Violation|0|||
25105433|NCT01641081|50216490|FG003|Period 2|Protocol Violation|0|||
25105434|NCT01641081|50216491|FG004|Period 2|Protocol Violation|0|||
25105435|NCT01641081|50216492|FG005|Period 2|Protocol Violation|0|||
25105436|NCT01641081|50216493|FG006|Period 2|Protocol Violation|0|||
25105437|NCT01641081|50216494|FG007|Period 2|Protocol Violation|0|||
25105438|NCT01641081|50216495|FG008|Period 2|Protocol Violation|0|||
25105439|NCT01641081|50216496|FG009|Period 2|Protocol Violation|0|||
25105440|NCT01641081|50216487|FG000|Period 3|Adverse Event|0|||
25105441|NCT01641081|50216488|FG001|Period 3|Adverse Event|0|||
25105442|NCT01641081|50216489|FG002|Period 3|Adverse Event|1|||
25105443|NCT01641081|50216490|FG003|Period 3|Adverse Event|0|||
25105444|NCT01641081|50216491|FG004|Period 3|Adverse Event|0|||
25105445|NCT01641081|50216492|FG005|Period 3|Adverse Event|0|||
25105446|NCT01641081|50216493|FG006|Period 3|Adverse Event|0|||
25105447|NCT01641081|50216494|FG007|Period 3|Adverse Event|0|||
25105448|NCT01641081|50216495|FG008|Period 3|Adverse Event|0|||
25105449|NCT01641081|50216496|FG009|Period 3|Adverse Event|0|||
25105450|NCT01641081|50216487|FG000|Period 3|Withdrawal by Subject|0|||
25105451|NCT01641081|50216488|FG001|Period 3|Withdrawal by Subject|0|||
25105452|NCT01641081|50216489|FG002|Period 3|Withdrawal by Subject|0|||
25105453|NCT01641081|50216490|FG003|Period 3|Withdrawal by Subject|0|||
25105454|NCT01641081|50216491|FG004|Period 3|Withdrawal by Subject|0|||
25105455|NCT01641081|50216492|FG005|Period 3|Withdrawal by Subject|0|||
25105456|NCT01641081|50216493|FG006|Period 3|Withdrawal by Subject|0|||
25105457|NCT01641081|50216494|FG007|Period 3|Withdrawal by Subject|0|||
25105458|NCT01641081|50216495|FG008|Period 3|Withdrawal by Subject|1|||
25105459|NCT01641081|50216496|FG009|Period 3|Withdrawal by Subject|0|||
25105460|NCT01641081|50216487|FG000|Period 4|Adverse Event|0|||
25105461|NCT01641081|50216488|FG001|Period 4|Adverse Event|1|||
25105462|NCT01641081|50216489|FG002|Period 4|Adverse Event|0|||
25105463|NCT01641081|50216490|FG003|Period 4|Adverse Event|1|||
25105464|NCT01641081|50216491|FG004|Period 4|Adverse Event|0|||
25105465|NCT01641081|50216492|FG005|Period 4|Adverse Event|0|||
25105466|NCT01641081|50216493|FG006|Period 4|Adverse Event|0|||
25105467|NCT01641081|50216494|FG007|Period 4|Adverse Event|0|||
25105468|NCT01641081|50216495|FG008|Period 4|Adverse Event|0|||
25105469|NCT01641081|50216496|FG009|Period 4|Adverse Event|0|||
25105470|NCT01641081|50216487|FG000|Period 5|Adverse Event|0|||
25177206|NCT01498289|50321308|FG001|Overall Study|Withdrawal unrelated to AE|16|||
25177207|NCT01498289|50321307|FG000|Overall Study|Progression/relapse|53|||
25177208|NCT01498289|50321308|FG001|Overall Study|Progression/relapse|59|||
25008275|NCT03115112|50101159|FG001|Overall Study|Pregnancy|0|||
25105471|NCT01641081|50216488|FG001|Period 5|Adverse Event|0|||
25105472|NCT01641081|50216489|FG002|Period 5|Adverse Event|2|||
25105473|NCT01641081|50216490|FG003|Period 5|Adverse Event|0|||
25105474|NCT01641081|50216491|FG004|Period 5|Adverse Event|0|||
25105475|NCT01641081|50216492|FG005|Period 5|Adverse Event|0|||
25177209|NCT01498289|50321307|FG000|Overall Study|Not protocol specified|7|||
25105476|NCT01641081|50216493|FG006|Period 5|Adverse Event|0|||
25105477|NCT01641081|50216494|FG007|Period 5|Adverse Event|0|||
25105478|NCT01641081|50216495|FG008|Period 5|Adverse Event|0|||
25105479|NCT01641081|50216496|FG009|Period 5|Adverse Event|0|||
25008276|NCT03115112|50101158|FG000|Overall Study|Site closure|1|||
25105480|NCT01640925|50216510|FG000|Overall Study|Withdrawal by Subject|1|||
25105481|NCT01640925|50216511|FG001|Overall Study|Withdrawal by Subject|0|||
25105482|NCT01640925|50216510|FG000|Overall Study|Previously enrolled in this trial|13|||
25105483|NCT01640925|50216511|FG001|Overall Study|Previously enrolled in this trial|11|||
25105484|NCT01638429|50216517|FG000|Overall Study|Withdrawal by Subject|1|||
25105485|NCT01639755|50216525|FG000|Overall Study|Study Ongoing|15|||
25105486|NCT01639755|50216525|FG000|Overall Study|Patient had device explantation|4|||
25105487|NCT01601535|50216535|FG000|Phase 1|Adverse Event|1|||
25261202|NCT01266993|50575875|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
25261203|NCT01266993|50575876|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
25261204|NCT01309386|50575884|FG000|Overall Study|Other|2|||
25261205|NCT01309386|50575885|FG001|Overall Study|Other|0|||
25261206|NCT01309386|50575884|FG000|Overall Study|Withdrawal by Subject|2|||
25261207|NCT01309386|50575885|FG001|Overall Study|Withdrawal by Subject|0|||
25261208|NCT01309386|50575884|FG000|Overall Study|Progressive disease|9|||
25261209|NCT01309386|50575885|FG001|Overall Study|Progressive disease|11|||
25261210|NCT01309386|50575884|FG000|Overall Study|Physician Decision|1|||
25261211|NCT01309386|50575885|FG001|Overall Study|Physician Decision|1|||
25261212|NCT01309386|50575884|FG000|Overall Study|Lack of Efficacy|3|||
25261213|NCT01309386|50575885|FG001|Overall Study|Lack of Efficacy|1|||
25105488|NCT01601535|50216536|FG001|Phase 1|Adverse Event|0|||
25105489|NCT01601535|50216537|FG002|Phase 1|Adverse Event|2|||
25105490|NCT01601535|50216538|FG003|Phase 1|Adverse Event|1|||
25105491|NCT01601535|50216539|FG004|Phase 1|Adverse Event|0|||
25105492|NCT01601535|50216540|FG005|Phase 1|Adverse Event|0|||
25105493|NCT01601535|50216535|FG000|Phase 1|Withdrawal by Subject|2|||
25105494|NCT01601535|50216536|FG001|Phase 1|Withdrawal by Subject|1|||
25105495|NCT01601535|50216537|FG002|Phase 1|Withdrawal by Subject|1|||
25105496|NCT01601535|50216538|FG003|Phase 1|Withdrawal by Subject|2|||
25105497|NCT01601535|50216539|FG004|Phase 1|Withdrawal by Subject|0|||
25105498|NCT01601535|50216540|FG005|Phase 1|Withdrawal by Subject|0|||
25105499|NCT01601535|50216535|FG000|Phase 1|Progressive Disease|2|||
25105500|NCT01601535|50216536|FG001|Phase 1|Progressive Disease|3|||
25105501|NCT01601535|50216537|FG002|Phase 1|Progressive Disease|2|||
25105502|NCT01601535|50216538|FG003|Phase 1|Progressive Disease|1|||
25105503|NCT01601535|50216539|FG004|Phase 1|Progressive Disease|0|||
25105504|NCT01601535|50216540|FG005|Phase 1|Progressive Disease|0|||
25105505|NCT01601535|50216535|FG000|Phase 1|Started Another Treatment|1|||
25105506|NCT01601535|50216536|FG001|Phase 1|Started Another Treatment|2|||
25105507|NCT01601535|50216537|FG002|Phase 1|Started Another Treatment|0|||
25105508|NCT01601535|50216538|FG003|Phase 1|Started Another Treatment|0|||
25105509|NCT01601535|50216539|FG004|Phase 1|Started Another Treatment|0|||
25105510|NCT01601535|50216540|FG005|Phase 1|Started Another Treatment|0|||
25105511|NCT01601535|50216535|FG000|Phase 2|Adverse Event|0|||
25105512|NCT01601535|50216536|FG001|Phase 2|Adverse Event|0|||
25105513|NCT01601535|50216537|FG002|Phase 2|Adverse Event|0|||
25105514|NCT01601535|50216538|FG003|Phase 2|Adverse Event|0|||
25105515|NCT01601535|50216539|FG004|Phase 2|Adverse Event|5|||
25105516|NCT01601535|50216540|FG005|Phase 2|Adverse Event|1|||
25105517|NCT01601535|50216535|FG000|Phase 2|Withdrawal by Subject|0|||
25105518|NCT01601535|50216536|FG001|Phase 2|Withdrawal by Subject|0|||
25105519|NCT01601535|50216537|FG002|Phase 2|Withdrawal by Subject|0|||
25105520|NCT01601535|50216538|FG003|Phase 2|Withdrawal by Subject|0|||
25105521|NCT01601535|50216539|FG004|Phase 2|Withdrawal by Subject|8|||
25105522|NCT01601535|50216540|FG005|Phase 2|Withdrawal by Subject|2|||
25105523|NCT01601535|50216535|FG000|Phase 2|Progressive Disease|0|||
25105524|NCT01601535|50216536|FG001|Phase 2|Progressive Disease|0|||
25105525|NCT01601535|50216537|FG002|Phase 2|Progressive Disease|0|||
25105526|NCT01601535|50216538|FG003|Phase 2|Progressive Disease|0|||
25105527|NCT01601535|50216539|FG004|Phase 2|Progressive Disease|5|||
25105528|NCT01601535|50216540|FG005|Phase 2|Progressive Disease|7|||
25105529|NCT01601535|50216535|FG000|Phase 2|Started Another Treatment|0|||
25105530|NCT01601535|50216536|FG001|Phase 2|Started Another Treatment|0|||
25105531|NCT01601535|50216537|FG002|Phase 2|Started Another Treatment|0|||
25105532|NCT01601535|50216538|FG003|Phase 2|Started Another Treatment|0|||
25105533|NCT01601535|50216539|FG004|Phase 2|Started Another Treatment|1|||
25105534|NCT01601535|50216540|FG005|Phase 2|Started Another Treatment|2|||
25105535|NCT01638819|50216565|FG000|Overall Study|Lost to Follow-up|1|||
25105536|NCT01638819|50216566|FG001|Overall Study|Lost to Follow-up|0|||
25105537|NCT01363713|50216571|FG000|Overall Study|Adverse Event|1|||
25105538|NCT01363713|50216571|FG000|Overall Study|Protocol Violation|3|||
25105539|NCT01363713|50216571|FG000|Overall Study|Withdrawal by Subject|2|||
25105540|NCT01637961|50216575|FG000|Overall Study|Ineligible: wrong primary|1|||
25105541|NCT01637961|50216575|FG000|Overall Study|Ineligible: inadequate pathology|1|||
25105542|NCT04183335|50216587|FG000|Overall Study|Adverse Event|1|||
25105543|NCT04183335|50216588|FG001|Overall Study|Adverse Event|0|||
25105544|NCT04183335|50216587|FG000|Overall Study|Withdrawal by Subject|12|||
25105545|NCT04183335|50216588|FG001|Overall Study|Withdrawal by Subject|3|||
25261214|NCT01309386|50575884|FG000|Overall Study|Adverse Event|5|||
25261215|NCT01309386|50575885|FG001|Overall Study|Adverse Event|8|||
25261216|NCT01266603|50575891|FG000|Overall Study|Adverse Event|1|||
25105546|NCT04199793|50216596|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
25105547|NCT04199793|50216597|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
25105548|NCT04199793|50216596|FG000|Overall Study|Withdrawal by Subject|1|||
25105549|NCT04199793|50216597|FG001|Overall Study|Withdrawal by Subject|1|||
25105550|NCT01636947|50216605|FG000|Overall Study|Not Treated|2|||
25105551|NCT01636947|50216606|FG001|Overall Study|Not Treated|2|||
25105552|NCT01636947|50216605|FG000|Overall Study|Lost to Follow-up|4|||
25105553|NCT01636947|50216606|FG001|Overall Study|Lost to Follow-up|0|||
25105554|NCT01636947|50216605|FG000|Overall Study|Protocol Violation|1|||
25105555|NCT01636947|50216606|FG001|Overall Study|Protocol Violation|1|||
25105556|NCT01636947|50216605|FG000|Overall Study|Withdrawal by Subject|3|||
25105557|NCT01636947|50216606|FG001|Overall Study|Withdrawal by Subject|3|||
25105558|NCT01636947|50216605|FG000|Overall Study|Adverse Event|1|||
25105559|NCT01636947|50216606|FG001|Overall Study|Adverse Event|1|||
25105560|NCT01636947|50216605|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
25105561|NCT01636947|50216606|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
25105562|NCT01635933|50216614|FG000|Overall Study|Adverse Event|1|||
25105563|NCT01635933|50216615|FG001|Overall Study|Adverse Event|0|||
25105564|NCT01635933|50216614|FG000|Overall Study|Lost to Follow-up|0|||
25105565|NCT01635933|50216615|FG001|Overall Study|Lost to Follow-up|5|||
25105566|NCT01635933|50216614|FG000|Overall Study|Subject decision|1|||
25105567|NCT01635933|50216615|FG001|Overall Study|Subject decision|1|||
25105568|NCT01635933|50216614|FG000|Overall Study|Noncompliance|0|||
25105569|NCT01635933|50216615|FG001|Overall Study|Noncompliance|1|||
25105570|NCT01635933|50216614|FG000|Overall Study|No longer had transportation|0|||
25105571|NCT01635933|50216615|FG001|Overall Study|No longer had transportation|1|||
25105572|NCT01635855|50216621|FG000|Overall Study|Withdrawal by Subject|4|||
25105573|NCT03052725|50216627|FG000|Overall Study|Adverse Event|2|||
25105574|NCT03052725|50216628|FG001|Overall Study|Adverse Event|0|||
25105575|NCT03052725|50216627|FG000|Overall Study|Withdrawal by Subject|3|||
25105576|NCT03052725|50216628|FG001|Overall Study|Withdrawal by Subject|4|||
25105577|NCT03052725|50216627|FG000|Overall Study|Pregnancy|0|||
25105578|NCT03052725|50216628|FG001|Overall Study|Pregnancy|1|||
25105579|NCT03052725|50216627|FG000|Overall Study|Site closure|0|||
25105580|NCT03052725|50216628|FG001|Overall Study|Site closure|1|||
25105581|NCT03052725|50216627|FG000|Overall Study|Study terminated by sponsor|143|||
25105582|NCT03052725|50216628|FG001|Overall Study|Study terminated by sponsor|144|||
25105583|NCT02775435|50216635|FG000|Overall Study|Adverse Event|48|||
25105584|NCT02775435|50216636|FG001|Overall Study|Adverse Event|25|||
25105585|NCT02775435|50216635|FG000|Overall Study|Lost to Follow-up|0|||
25105586|NCT02775435|50216636|FG001|Overall Study|Lost to Follow-up|2|||
25105587|NCT02775435|50216635|FG000|Overall Study|Physician Decision|5|||
25105588|NCT02775435|50216636|FG001|Overall Study|Physician Decision|6|||
25105589|NCT02775435|50216635|FG000|Overall Study|Withdrawal by Subject|5|||
25105590|NCT02775435|50216636|FG001|Overall Study|Withdrawal by Subject|9|||
25105591|NCT02775435|50216635|FG000|Overall Study|Progressive Disease|86|||
25105592|NCT02775435|50216636|FG001|Overall Study|Progressive Disease|140|||
25105593|NCT02775435|50216635|FG000|Overall Study|Clinical Progression|13|||
25105594|NCT02775435|50216636|FG001|Overall Study|Clinical Progression|26|||
25105595|NCT02775435|50216635|FG000|Overall Study|Ongoing in Study|121|||
25105596|NCT02775435|50216636|FG001|Overall Study|Ongoing in Study|72|||
25105597|NCT02775435|50216635|FG000|Overall Study|Not Treated|0|||
25105598|NCT02775435|50216636|FG001|Overall Study|Not Treated|1|||
25105599|NCT01635153|50216661|FG000|Overall Study|Lost to Follow-up|40|||
25105600|NCT01635153|50216662|FG001|Overall Study|Lost to Follow-up|43|||
25105601|NCT01636713|50216671|FG000|Overall Study|Adverse Event|16|||
25105602|NCT01636713|50216672|FG001|Overall Study|Adverse Event|16|||
25105603|NCT01636713|50216673|FG002|Overall Study|Adverse Event|7|||
25105604|NCT01636713|50216671|FG000|Overall Study|Lack of Efficacy|6|||
25105605|NCT01636713|50216672|FG001|Overall Study|Lack of Efficacy|6|||
25105606|NCT01636713|50216673|FG002|Overall Study|Lack of Efficacy|2|||
25105607|NCT01636713|50216671|FG000|Overall Study|Protocol Violation|3|||
25105608|NCT01636713|50216672|FG001|Overall Study|Protocol Violation|0|||
25105609|NCT01636713|50216673|FG002|Overall Study|Protocol Violation|1|||
25261217|NCT01266603|50575891|FG000|Overall Study|Lack of Efficacy|14|||
25261218|NCT01266603|50575891|FG000|Overall Study|Withdrawal by Subject|1|||
25261219|NCT01266603|50575891|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
25261220|NCT01309308|50575897|FG000|Overall Study|Lost to Follow-up|6|||
25261221|NCT01309308|50575898|FG001|Overall Study|Lost to Follow-up|4|||
25261222|NCT01266291|50575904|FG000|Overall Study|Adverse Event|1|||
25105610|NCT01636713|50216671|FG000|Overall Study|Lost to Follow-up|0|||
25105611|NCT01636713|50216672|FG001|Overall Study|Lost to Follow-up|0|||
25105612|NCT01636713|50216673|FG002|Overall Study|Lost to Follow-up|1|||
25105613|NCT01636713|50216671|FG000|Overall Study|Withdrawal by Subject|5|||
25105614|NCT01636713|50216672|FG001|Overall Study|Withdrawal by Subject|4|||
25105615|NCT01636713|50216673|FG002|Overall Study|Withdrawal by Subject|8|||
25105616|NCT01636713|50216671|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
25105617|NCT01636713|50216672|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
25105618|NCT01636713|50216673|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
25105619|NCT01600053|50216681|FG000|Overall Study|Adverse Event|2|||
25105620|NCT01600053|50216681|FG000|Overall Study|trial will not meet the interim endpoint|9|||
25105621|NCT01068249|50216685|FG000|Overall Study|Death|1|||
25261223|NCT01004263|50575908|FG000|Overall Study|Adverse Event|15|||
25105622|NCT01068249|50216685|FG000|Overall Study|Withdrawal by Subject|3|||
25105623|NCT00098475|50216701|FG000|Step 1|Progressive disease|33|||
25105624|NCT00098475|50216702|FG001|Step 1|Progressive disease|35|||
25105625|NCT00098475|50216703|FG002|Step 1|Progressive disease|2|||
25105626|NCT00098475|50216704|FG003|Step 1|Progressive disease|1|||
25105627|NCT00098475|50216701|FG000|Step 1|Adverse Event|56|||
25105628|NCT00098475|50216702|FG001|Step 1|Adverse Event|37|||
25105629|NCT00098475|50216703|FG002|Step 1|Adverse Event|0|||
25105630|NCT00098475|50216704|FG003|Step 1|Adverse Event|1|||
25105631|NCT00098475|50216701|FG000|Step 1|Death|8|||
25105632|NCT00098475|50216702|FG001|Step 1|Death|5|||
25105633|NCT00098475|50216703|FG002|Step 1|Death|0|||
25105634|NCT00098475|50216704|FG003|Step 1|Death|1|||
25105635|NCT00098475|50216701|FG000|Step 1|Withdrawal by Subject|14|||
25105636|NCT00098475|50216702|FG001|Step 1|Withdrawal by Subject|11|||
25105637|NCT00098475|50216703|FG002|Step 1|Withdrawal by Subject|0|||
25105638|NCT00098475|50216704|FG003|Step 1|Withdrawal by Subject|0|||
25105639|NCT00098475|50216701|FG000|Step 1|Physician Decision|5|||
25105640|NCT00098475|50216702|FG001|Step 1|Physician Decision|2|||
25105641|NCT00098475|50216703|FG002|Step 1|Physician Decision|0|||
25105642|NCT00098475|50216704|FG003|Step 1|Physician Decision|0|||
25105643|NCT00098475|50216701|FG000|Step 1|Alternative therapy|31|||
25105644|NCT00098475|50216702|FG001|Step 1|Alternative therapy|43|||
25105645|NCT00098475|50216703|FG002|Step 1|Alternative therapy|1|||
25105646|NCT00098475|50216704|FG003|Step 1|Alternative therapy|0|||
25105647|NCT00098475|50216701|FG000|Step 1|Other disease|2|||
25105648|NCT00098475|50216702|FG001|Step 1|Other disease|1|||
25105649|NCT00098475|50216703|FG002|Step 1|Other disease|1|||
25105650|NCT00098475|50216704|FG003|Step 1|Other disease|0|||
25105651|NCT00098475|50216701|FG000|Step 1|Never started treatment|0|||
25105652|NCT00098475|50216702|FG001|Step 1|Never started treatment|2|||
25105653|NCT00098475|50216703|FG002|Step 1|Never started treatment|0|||
25105654|NCT00098475|50216704|FG003|Step 1|Never started treatment|0|||
25105655|NCT00098475|50216701|FG000|Step 1|Still on treatment as of this analysis|14|||
25105656|NCT00098475|50216702|FG001|Step 1|Still on treatment as of this analysis|27|||
25105657|NCT00098475|50216703|FG002|Step 1|Still on treatment as of this analysis|0|||
25105658|NCT00098475|50216704|FG003|Step 1|Still on treatment as of this analysis|0|||
25105659|NCT00098475|50216701|FG000|Step 1|Knee surgery|1|||
25105660|NCT00098475|50216702|FG001|Step 1|Knee surgery|0|||
25105661|NCT00098475|50216703|FG002|Step 1|Knee surgery|0|||
25105662|NCT00098475|50216704|FG003|Step 1|Knee surgery|0|||
25105663|NCT00098475|50216701|FG000|Step 1|Complications|1|||
25105664|NCT00098475|50216702|FG001|Step 1|Complications|0|||
25105665|NCT00098475|50216703|FG002|Step 1|Complications|0|||
25105666|NCT00098475|50216704|FG003|Step 1|Complications|0|||
25105667|NCT00098475|50216701|FG000|Step 1|Cannot comply due to other tx|0|||
25105668|NCT00098475|50216702|FG001|Step 1|Cannot comply due to other tx|1|||
25105669|NCT00098475|50216703|FG002|Step 1|Cannot comply due to other tx|0|||
25105670|NCT00098475|50216704|FG003|Step 1|Cannot comply due to other tx|0|||
25105671|NCT00098475|50216701|FG000|Step 1|Both patient and physician's decision|2|||
25105672|NCT00098475|50216702|FG001|Step 1|Both patient and physician's decision|1|||
25105673|NCT00098475|50216703|FG002|Step 1|Both patient and physician's decision|0|||
25105674|NCT00098475|50216704|FG003|Step 1|Both patient and physician's decision|0|||
25105675|NCT00098475|50216701|FG000|Step 1|Incorrect disease assessment|2|||
25105676|NCT00098475|50216702|FG001|Step 1|Incorrect disease assessment|0|||
25105677|NCT00098475|50216703|FG002|Step 1|Incorrect disease assessment|0|||
25105678|NCT00098475|50216704|FG003|Step 1|Incorrect disease assessment|0|||
25105679|NCT00098475|50216701|FG000|Step 1|Off treatment for > specified timeframe|1|||
25105680|NCT00098475|50216702|FG001|Step 1|Off treatment for > specified timeframe|1|||
25105681|NCT00098475|50216703|FG002|Step 1|Off treatment for > specified timeframe|0|||
25105682|NCT00098475|50216704|FG003|Step 1|Off treatment for > specified timeframe|0|||
25105683|NCT00098475|50216701|FG000|Step 1|Declining performance status|0|||
25105684|NCT00098475|50216702|FG001|Step 1|Declining performance status|1|||
25105685|NCT00098475|50216703|FG002|Step 1|Declining performance status|0|||
25105686|NCT00098475|50216704|FG003|Step 1|Declining performance status|0|||
25105687|NCT00098475|50216701|FG000|Step 1|Insurance issue|0|||
25105688|NCT00098475|50216702|FG001|Step 1|Insurance issue|1|||
25105689|NCT00098475|50216703|FG002|Step 1|Insurance issue|0|||
25105690|NCT00098475|50216704|FG003|Step 1|Insurance issue|0|||
25105691|NCT00098475|50216701|FG000|Step 1|Rising paraprotein|0|||
25105692|NCT00098475|50216702|FG001|Step 1|Rising paraprotein|1|||
25105693|NCT00098475|50216703|FG002|Step 1|Rising paraprotein|0|||
25105694|NCT00098475|50216704|FG003|Step 1|Rising paraprotein|0|||
25105695|NCT00098475|50216701|FG000|Step 1|Referred to other physicians|0|||
25105696|NCT00098475|50216702|FG001|Step 1|Referred to other physicians|1|||
25105697|NCT00098475|50216703|FG002|Step 1|Referred to other physicians|0|||
25105698|NCT00098475|50216704|FG003|Step 1|Referred to other physicians|0|||
25105699|NCT00098475|50216701|FG000|Step 1|Criteria to continue treatment not met|0|||
25105700|NCT00098475|50216702|FG001|Step 1|Criteria to continue treatment not met|1|||
25105701|NCT00098475|50216703|FG002|Step 1|Criteria to continue treatment not met|0|||
25105702|NCT00098475|50216704|FG003|Step 1|Criteria to continue treatment not met|0|||
25105703|NCT00098475|50216701|FG000|Step 1|Misinterpretation of lab data|0|||
25105704|NCT00098475|50216702|FG001|Step 1|Misinterpretation of lab data|1|||
25105705|NCT00098475|50216703|FG002|Step 1|Misinterpretation of lab data|0|||
25105706|NCT00098475|50216704|FG003|Step 1|Misinterpretation of lab data|0|||
25105707|NCT00098475|50216701|FG000|Step 1|Patient fell with fracture|1|||
25105708|NCT00098475|50216702|FG001|Step 1|Patient fell with fracture|0|||
25105709|NCT00098475|50216703|FG002|Step 1|Patient fell with fracture|0|||
25105710|NCT00098475|50216704|FG003|Step 1|Patient fell with fracture|0|||
25105711|NCT00098475|50216701|FG000|Step 1|Not documented|0|||
25105712|NCT00098475|50216702|FG001|Step 1|Not documented|1|||
25105713|NCT00098475|50216703|FG002|Step 1|Not documented|0|||
25105714|NCT00098475|50216704|FG003|Step 1|Not documented|0|||
25105715|NCT00098475|50216701|FG000|Step 2|Disease progression|1|||
25105716|NCT00098475|50216702|FG001|Step 2|Disease progression|4|||
25105717|NCT00098475|50216703|FG002|Step 2|Disease progression|0|||
25105718|NCT00098475|50216704|FG003|Step 2|Disease progression|0|||
25105719|NCT00098475|50216701|FG000|Step 2|Adverse Event|2|||
25105720|NCT00098475|50216702|FG001|Step 2|Adverse Event|0|||
25105721|NCT00098475|50216703|FG002|Step 2|Adverse Event|0|||
25105722|NCT00098475|50216704|FG003|Step 2|Adverse Event|0|||
25105723|NCT00098475|50216701|FG000|Step 2|Withdrawal by Subject|0|||
25105724|NCT00098475|50216702|FG001|Step 2|Withdrawal by Subject|2|||
25105725|NCT00098475|50216703|FG002|Step 2|Withdrawal by Subject|0|||
25105726|NCT00098475|50216704|FG003|Step 2|Withdrawal by Subject|0|||
25105727|NCT00098475|50216701|FG000|Step 2|Physician Decision|0|||
25105728|NCT00098475|50216702|FG001|Step 2|Physician Decision|1|||
25105729|NCT00098475|50216703|FG002|Step 2|Physician Decision|0|||
25105730|NCT00098475|50216704|FG003|Step 2|Physician Decision|0|||
25105731|NCT00098475|50216701|FG000|Step 2|Alternative therapy|1|||
25105732|NCT00098475|50216702|FG001|Step 2|Alternative therapy|2|||
25105733|NCT00098475|50216703|FG002|Step 2|Alternative therapy|0|||
25105734|NCT00098475|50216704|FG003|Step 2|Alternative therapy|0|||
25105735|NCT00098475|50216701|FG000|Step 2|Never started treatment|1|||
25105736|NCT00098475|50216702|FG001|Step 2|Never started treatment|1|||
25105737|NCT00098475|50216703|FG002|Step 2|Never started treatment|0|||
25105738|NCT00098475|50216704|FG003|Step 2|Never started treatment|0|||
25105739|NCT02246673|50216719|FG000|Overall Study|Sponsor Decision|1|||
25105740|NCT02246673|50216720|FG001|Overall Study|Sponsor Decision|0|||
25105741|NCT02246673|50216721|FG002|Overall Study|Sponsor Decision|0|||
25105742|NCT02246673|50216722|FG003|Overall Study|Sponsor Decision|0|||
25105743|NCT02246673|50216723|FG004|Overall Study|Sponsor Decision|0|||
25105744|NCT02246673|50216719|FG000|Overall Study|Withdrawal by Subject|0|||
25105745|NCT02246673|50216720|FG001|Overall Study|Withdrawal by Subject|0|||
25105746|NCT02246673|50216721|FG002|Overall Study|Withdrawal by Subject|0|||
25105747|NCT02246673|50216722|FG003|Overall Study|Withdrawal by Subject|0|||
25105748|NCT02246673|50216723|FG004|Overall Study|Withdrawal by Subject|1|||
25105749|NCT02246673|50216719|FG000|Overall Study|Lost to Follow-up|0|||
25105750|NCT02246673|50216720|FG001|Overall Study|Lost to Follow-up|0|||
25105751|NCT02246673|50216721|FG002|Overall Study|Lost to Follow-up|0|||
25105752|NCT02246673|50216722|FG003|Overall Study|Lost to Follow-up|1|||
25105753|NCT02246673|50216723|FG004|Overall Study|Lost to Follow-up|0|||
25105754|NCT02246673|50216719|FG000|Overall Study|Protocol Violation|0|||
25105755|NCT02246673|50216720|FG001|Overall Study|Protocol Violation|0|||
25105756|NCT02246673|50216721|FG002|Overall Study|Protocol Violation|0|||
25105757|NCT02246673|50216722|FG003|Overall Study|Protocol Violation|1|||
25105758|NCT02246673|50216723|FG004|Overall Study|Protocol Violation|0|||
25105759|NCT02246439|50216785|FG000|Overall Study|Adverse Event|3|||
25105760|NCT02246439|50216786|FG001|Overall Study|Adverse Event|0|||
25105761|NCT02246439|50216785|FG000|Overall Study|Lost to Follow-up|7|||
25105762|NCT02246439|50216786|FG001|Overall Study|Lost to Follow-up|5|||
25105763|NCT02246439|50216785|FG000|Overall Study|Protocol Violation|0|||
25105764|NCT02246439|50216786|FG001|Overall Study|Protocol Violation|2|||
25261224|NCT01004263|50575908|FG000|Overall Study|Withdrawal by Subject|58|||
25261225|NCT01004263|50575908|FG000|Overall Study|Protocol Violation|10|||
25105765|NCT02246439|50216785|FG000|Overall Study|Physician Decision|0|||
25105766|NCT02246439|50216786|FG001|Overall Study|Physician Decision|1|||
25105767|NCT02246439|50216785|FG000|Overall Study|Unkonwn|1|||
25105768|NCT02246439|50216786|FG001|Overall Study|Unkonwn|3|||
25105769|NCT02246439|50216785|FG000|Overall Study|Withdrawal by Subject|1|||
25105770|NCT02246439|50216786|FG001|Overall Study|Withdrawal by Subject|0|||
25105771|NCT02245737|50216795|FG000|Overall Study|Adverse Event|23|||
25105772|NCT02245737|50216796|FG001|Overall Study|Adverse Event|26|||
25105773|NCT02245737|50216797|FG002|Overall Study|Adverse Event|33|||
25105774|NCT02245737|50216795|FG000|Overall Study|Condition Worsened|9|||
25105775|NCT02245737|50216796|FG001|Overall Study|Condition Worsened|10|||
25105776|NCT02245737|50216797|FG002|Overall Study|Condition Worsened|9|||
25105777|NCT02245737|50216795|FG000|Overall Study|Death|2|||
25105778|NCT02245737|50216796|FG001|Overall Study|Death|4|||
25105779|NCT02245737|50216797|FG002|Overall Study|Death|4|||
25105780|NCT02245737|50216795|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
25008277|NCT03115112|50101159|FG001|Overall Study|Site closure|1|||
25105781|NCT02245737|50216796|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
25105782|NCT02245737|50216797|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
25105783|NCT02245737|50216795|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
25105784|NCT02245737|50216796|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
25105785|NCT02245737|50216797|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
25105786|NCT02245737|50216795|FG000|Overall Study|Lost to Follow-up|2|||
25105787|NCT02245737|50216796|FG001|Overall Study|Lost to Follow-up|5|||
25105788|NCT02245737|50216797|FG002|Overall Study|Lost to Follow-up|4|||
25105789|NCT02245737|50216795|FG000|Overall Study|Other-determined by Investigator|9|||
25105790|NCT02245737|50216796|FG001|Overall Study|Other-determined by Investigator|10|||
25105791|NCT02245737|50216797|FG002|Overall Study|Other-determined by Investigator|10|||
25105792|NCT02245737|50216795|FG000|Overall Study|Physician Decision|6|||
25105793|NCT02245737|50216796|FG001|Overall Study|Physician Decision|3|||
25105794|NCT02245737|50216797|FG002|Overall Study|Physician Decision|6|||
25105795|NCT02245737|50216795|FG000|Overall Study|Protocol Violation|3|||
25105796|NCT02245737|50216796|FG001|Overall Study|Protocol Violation|2|||
25105797|NCT02245737|50216797|FG002|Overall Study|Protocol Violation|3|||
25105798|NCT02245737|50216795|FG000|Overall Study|Withdrawal by Subject|40|||
25105799|NCT02245737|50216796|FG001|Overall Study|Withdrawal by Subject|41|||
25105800|NCT02245737|50216797|FG002|Overall Study|Withdrawal by Subject|44|||
25105801|NCT02245737|50216795|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
25105802|NCT02245737|50216796|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
25105803|NCT02245737|50216797|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
25105804|NCT02245737|50216795|FG000|Overall Study|Sponsor Decision|445|||
25105805|NCT02245737|50216796|FG001|Overall Study|Sponsor Decision|430|||
25105806|NCT02245737|50216797|FG002|Overall Study|Sponsor Decision|432|||
25105807|NCT02244957|50216809|FG000|Overall Study|Lack of Efficacy|1|||
25105808|NCT02244957|50216810|FG001|Overall Study|Lack of Efficacy|0|||
25105809|NCT02243865|50216820|FG000|Overall Study|Protocol Violation|1|||
25105810|NCT02243865|50216821|FG001|Overall Study|Protocol Violation|3|||
25105811|NCT02243865|50216820|FG000|Overall Study|Lost to Follow-up|1|||
25105812|NCT02243865|50216821|FG001|Overall Study|Lost to Follow-up|1|||
25105813|NCT02243865|50216820|FG000|Overall Study|Withdrawal by Subject|1|||
25105814|NCT02243865|50216821|FG001|Overall Study|Withdrawal by Subject|0|||
25105815|NCT02243865|50216820|FG000|Overall Study|Adverse Event|1|||
25105816|NCT02243865|50216821|FG001|Overall Study|Adverse Event|1|||
25105817|NCT02243631|50216831|FG000|Overall Study|no synovial fluid on second aspirate|0|||
25105818|NCT02243631|50216832|FG001|Overall Study|no synovial fluid on second aspirate|1|||
25105819|NCT02242305|50216840|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
25105820|NCT02242305|50216841|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
25105821|NCT02242305|50216840|FG000|Overall Study|Adverse Event|1|||
25105822|NCT02242305|50216841|FG001|Overall Study|Adverse Event|0|||
25105823|NCT02242305|50216840|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
25105824|NCT02242305|50216841|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
25105825|NCT02242305|50216840|FG000|Overall Study|Subject withdraws inform consent|0|||
25105826|NCT02242305|50216841|FG001|Overall Study|Subject withdraws inform consent|4|||
25105827|NCT02242305|50216840|FG000|Overall Study|Lost to Follow-up|2|||
25105828|NCT02242305|50216841|FG001|Overall Study|Lost to Follow-up|0|||
25105829|NCT02240121|50216849|FG000|Overall Study|Protocol Violation|1|||
25105830|NCT02240121|50216850|FG001|Overall Study|Protocol Violation|2|||
25105831|NCT02240121|50216849|FG000|Overall Study|Physician Decision|0|||
25105832|NCT02240121|50216850|FG001|Overall Study|Physician Decision|1|||
25105833|NCT02240121|50216849|FG000|Overall Study|Change in protocol interpretation|1|||
25105834|NCT02240121|50216850|FG001|Overall Study|Change in protocol interpretation|0|||
25105835|NCT02240121|50216849|FG000|Overall Study|Lack of Efficacy|2|||
25105836|NCT02240121|50216850|FG001|Overall Study|Lack of Efficacy|3|||
25105837|NCT02240121|50216849|FG000|Overall Study|Site closed|1|||
25105838|NCT02240121|50216850|FG001|Overall Study|Site closed|1|||
25105839|NCT02240121|50216849|FG000|Overall Study|Pregnancy|1|||
25105840|NCT02240121|50216850|FG001|Overall Study|Pregnancy|0|||
25105841|NCT02240121|50216849|FG000|Overall Study|Adverse Event|2|||
25105842|NCT02240121|50216850|FG001|Overall Study|Adverse Event|4|||
25105843|NCT02240121|50216849|FG000|Overall Study|Withdrawal by Subject|6|||
25105844|NCT02240121|50216850|FG001|Overall Study|Withdrawal by Subject|2|||
25105845|NCT02240121|50216849|FG000|Overall Study|Lost to Follow-up|3|||
25177210|NCT01498289|50321308|FG001|Overall Study|Not protocol specified|2|||
25177211|NCT01498289|50321307|FG000|Overall Study|Reason under review|0|||
25177212|NCT01498289|50321308|FG001|Overall Study|Reason under review|1|||
25177213|NCT01524133|50321321|FG000|Treatment Phase|Withdrawal by Subject|13|||
25105846|NCT02240121|50216850|FG001|Overall Study|Lost to Follow-up|4|||
25105847|NCT02240121|50216849|FG000|Overall Study|Other than specified|1|||
25105848|NCT02240121|50216850|FG001|Overall Study|Other than specified|3|||
25105849|NCT02239263|50216856|FG000|Overall Study|Protocol Violation|6|||
25105850|NCT02238483|50216864|FG000|Overall Study|Withdrawal by Subject|2|||
25105851|NCT02238483|50216865|FG001|Overall Study|Withdrawal by Subject|7|||
25105852|NCT02238483|50216864|FG000|Overall Study|Lost to Follow-up|1|||
25105853|NCT02238483|50216865|FG001|Overall Study|Lost to Follow-up|1|||
25105854|NCT02238483|50216864|FG000|Overall Study|Protocol Violation|1|||
25105855|NCT02238483|50216865|FG001|Overall Study|Protocol Violation|2|||
25105856|NCT02238483|50216864|FG000|Overall Study|Death|1|||
25105857|NCT02238483|50216865|FG001|Overall Study|Death|0|||
25105858|NCT02238483|50216864|FG000|Overall Study|Adverse Event|7|||
25105859|NCT02238483|50216865|FG001|Overall Study|Adverse Event|3|||
25105860|NCT02238483|50216864|FG000|Overall Study|Withdrawn due to physician decision|1|||
25105861|NCT02238483|50216865|FG001|Overall Study|Withdrawn due to physician decision|0|||
25105862|NCT02238483|50216864|FG000|Overall Study|Completion status not recorded|1|||
25105863|NCT02238483|50216865|FG001|Overall Study|Completion status not recorded|1|||
25105864|NCT02238483|50216864|FG000|Overall Study|Illness in family member|1|||
25105865|NCT02238483|50216865|FG001|Overall Study|Illness in family member|0|||
25105866|NCT01632891|50216873|FG000|Overall Study|Lost to Follow-up|0|||
25105867|NCT01632891|50216874|FG001|Overall Study|Lost to Follow-up|1|||
25105868|NCT01632891|50216873|FG000|Overall Study|Withdrawal by Subject|1|||
25105869|NCT01632891|50216874|FG001|Overall Study|Withdrawal by Subject|0|||
25105870|NCT02208999|50216886|FG000|Overall Study|Lost to Follow-up|1|||
25105871|NCT02208843|50216905|FG000|Overall Study|Clinical symptoms of progression|2|||
25105872|NCT02208843|50216905|FG000|Overall Study|Progression disease according to RECIST|24|||
25105873|NCT02208843|50216905|FG000|Overall Study|Adverse Event|12|||
25105874|NCT02208843|50216905|FG000|Overall Study|Protocol Violation|1|||
25105875|NCT02208843|50216905|FG000|Overall Study|Withdrawal by Subject|1|||
25105876|NCT02208843|50216905|FG000|Overall Study|Switched to commercial afatinib|20|||
25105877|NCT02208063|50216911|FG000|Overall Study|Death|3|||
25105878|NCT02208063|50216912|FG001|Overall Study|Death|5|||
25105879|NCT02208063|50216911|FG000|Overall Study|Not Specified in report|3|||
25105880|NCT02208063|50216912|FG001|Overall Study|Not Specified in report|4|||
25105881|NCT02208063|50216911|FG000|Overall Study|Withdrawal by Subject|5|||
25105882|NCT02208063|50216912|FG001|Overall Study|Withdrawal by Subject|2|||
25105883|NCT02208063|50216911|FG000|Overall Study|Lost to Follow-up|1|||
25105884|NCT02208063|50216912|FG001|Overall Study|Lost to Follow-up|0|||
25105885|NCT02207907|50216920|FG000|Overall Study|Lost to Follow-up|3|||
25105886|NCT02207907|50216921|FG001|Overall Study|Lost to Follow-up|1|||
25105887|NCT02207907|50216920|FG000|Overall Study|Withdrawal by Subject|5|||
25105888|NCT02207907|50216921|FG001|Overall Study|Withdrawal by Subject|6|||
25105889|NCT02207907|50216920|FG000|Overall Study|Did not meet study criteria|3|||
25105890|NCT02207907|50216921|FG001|Overall Study|Did not meet study criteria|0|||
25105891|NCT02207907|50216920|FG000|Overall Study|Pregnancy|0|||
25105892|NCT02207907|50216921|FG001|Overall Study|Pregnancy|1|||
25105893|NCT02207829|50216930|FG000|Overall Study|Adverse Event|10|||
25105894|NCT02207829|50216931|FG001|Overall Study|Adverse Event|9|||
25105895|NCT02207829|50216930|FG000|Overall Study|Lack of Efficacy|7|||
25105896|NCT02207829|50216931|FG001|Overall Study|Lack of Efficacy|5|||
25105897|NCT02207829|50216930|FG000|Overall Study|Lost to Follow-up|2|||
25105898|NCT02207829|50216931|FG001|Overall Study|Lost to Follow-up|2|||
25105899|NCT02207829|50216930|FG000|Overall Study|Protocol deviation|5|||
25105900|NCT02207829|50216931|FG001|Overall Study|Protocol deviation|4|||
25105901|NCT02207829|50216930|FG000|Overall Study|Withdrew consent|18|||
25105902|NCT02207829|50216931|FG001|Overall Study|Withdrew consent|14|||
25105903|NCT02237157|50216937|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
25105904|NCT02237157|50216938|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
25105905|NCT02237157|50216939|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
25105906|NCT02237157|50216940|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
25105907|NCT02237157|50216937|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
25105908|NCT02237157|50216938|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
25105909|NCT02237157|50216939|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
25105910|NCT02237157|50216940|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
25105911|NCT02237001|50216947|FG000|Overall Study|Lost to Follow-up|2|||
25105912|NCT02237001|50216947|FG000|Overall Study|Withdrawal by Subject|1|||
25105913|NCT02237001|50216947|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
25105914|NCT02237001|50216947|FG000|Overall Study|Re-operation|4|||
25105915|NCT02237001|50216947|FG000|Overall Study|Incarceration|1|||
25105916|NCT02236611|50216953|FG000|Overall Study|Adverse Event|10|||
25105917|NCT02236611|50216954|FG001|Overall Study|Adverse Event|16|||
25105918|NCT02236611|50216953|FG000|Overall Study|Lack of Efficacy|4|||
25105919|NCT02236611|50216954|FG001|Overall Study|Lack of Efficacy|7|||
25105920|NCT02236611|50216953|FG000|Overall Study|Lost to Follow-up|0|||
25105921|NCT02236611|50216954|FG001|Overall Study|Lost to Follow-up|2|||
25105922|NCT02236611|50216953|FG000|Overall Study|Protocol deviation|3|||
25105923|NCT02236611|50216954|FG001|Overall Study|Protocol deviation|5|||
25105924|NCT02236611|50216953|FG000|Overall Study|Withdrew consent|9|||
25105925|NCT02236611|50216954|FG001|Overall Study|Withdrew consent|4|||
25105926|NCT02234583|50216962|FG000|Overall Study|Adverse Event|172|||
25105927|NCT02234583|50216963|FG001|Overall Study|Adverse Event|156|||
25105928|NCT02234583|50216962|FG000|Overall Study|Withdrawal by Subject|109|||
25105929|NCT02234583|50216963|FG001|Overall Study|Withdrawal by Subject|157|||
25105930|NCT02234583|50216962|FG000|Overall Study|Lost to Follow-up|0|||
25105931|NCT02234583|50216963|FG001|Overall Study|Lost to Follow-up|1|||
25105932|NCT02234583|50216962|FG000|Overall Study|Lack of Efficacy|58|||
25105933|NCT02234583|50216963|FG001|Overall Study|Lack of Efficacy|103|||
25105934|NCT02234583|50216962|FG000|Overall Study|Protocol Violation|35|||
25105935|NCT02234583|50216963|FG001|Overall Study|Protocol Violation|42|||
25105936|NCT02234583|50216962|FG000|Overall Study|Other|39|||
25105937|NCT02234583|50216963|FG001|Overall Study|Other|97|||
25105938|NCT03686397|50216977|FG000|Overall Study|Lack of Efficacy|3|||
25105939|NCT03686397|50216978|FG001|Overall Study|Lack of Efficacy|5|||
25105940|NCT03686397|50216977|FG000|Overall Study|Adverse Event|0|||
25105941|NCT03686397|50216978|FG001|Overall Study|Adverse Event|1|||
25105942|NCT03686397|50216977|FG000|Overall Study|Protocol Violation|0|||
25105943|NCT03686397|50216978|FG001|Overall Study|Protocol Violation|1|||
25105944|NCT03686397|50216977|FG000|Overall Study|Withdrawal by Subject|0|||
25105945|NCT03686397|50216978|FG001|Overall Study|Withdrawal by Subject|1|||
25105946|NCT03686397|50216977|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
25105947|NCT03686397|50216978|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
25105948|NCT02233803|50216984|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
25105949|NCT02233803|50216985|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
25105950|NCT02233803|50216984|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
25105951|NCT02233803|50216985|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
25105952|NCT02233803|50216984|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
25105953|NCT02233803|50216985|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
25105954|NCT02233803|50216984|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
25105955|NCT02233803|50216985|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
25105956|NCT02233803|50216984|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
25105957|NCT02233803|50216985|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
25105958|NCT02233803|50216984|FG000|Washout Period (4-Wks)|Physician Decision|1|||
25105959|NCT02233803|50216985|FG001|Washout Period (4-Wks)|Physician Decision|0|||
25105960|NCT02233803|50216984|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
25105961|NCT02233803|50216985|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
25105962|NCT02233803|50216984|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
25105963|NCT02233803|50216985|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
25105964|NCT02233803|50216984|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
25105965|NCT02233803|50216985|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
25105966|NCT02233647|50216993|FG000|Overall Study|Adverse Event|1|||
25105967|NCT02233413|50216999|FG000|Overall Study|Lost to Follow-up|7|||
25105968|NCT02233413|50217000|FG001|Overall Study|Lost to Follow-up|9|||
25105969|NCT02233413|50216999|FG000|Overall Study|Withdrawal by Subject|4|||
25105970|NCT02233413|50217000|FG001|Overall Study|Withdrawal by Subject|5|||
25105971|NCT01632579|50217006|FG000|Washout Period|Adverse Event|1|||
25105972|NCT01632579|50217007|FG001|Washout Period|Adverse Event|0|||
25105973|NCT01632579|50217008|FG002|Washout Period|Adverse Event|0|||
25105974|NCT01632579|50217009|FG003|Washout Period|Adverse Event|0|||
25105975|NCT01632579|50217010|FG004|Washout Period|Adverse Event|0|||
25105976|NCT01632579|50217011|FG005|Washout Period|Adverse Event|0|||
25105977|NCT01632579|50217012|FG006|Washout Period|Adverse Event|0|||
25105978|NCT01632579|50217013|FG007|Washout Period|Adverse Event|0|||
25105979|NCT01632579|50217014|FG008|Washout Period|Adverse Event|0|||
25105980|NCT01632579|50217006|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
25105981|NCT01632579|50217007|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
25105982|NCT01632579|50217008|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
25105983|NCT01632579|50217009|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
25105984|NCT01632579|50217010|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
25105985|NCT01632579|50217011|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
25105986|NCT01632579|50217012|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
25105987|NCT01632579|50217013|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
25105988|NCT01632579|50217014|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
25105989|NCT01632345|50217043|FG000|Treatment: Part I|Adverse Event|1|||
25105990|NCT01632345|50217044|FG001|Treatment: Part I|Adverse Event|4|||
25105991|NCT01632345|50217045|FG002|Treatment: Part I|Adverse Event|2|||
25105992|NCT01632345|50217046|FG003|Treatment: Part I|Adverse Event|1|||
25105993|NCT01632345|50217047|FG004|Treatment: Part I|Adverse Event|3|||
25105994|NCT01632345|50217048|FG005|Treatment: Part I|Adverse Event|0|||
25105995|NCT01632345|50217049|FG006|Treatment: Part I|Adverse Event|0|||
25177214|NCT01524133|50321322|FG001|Treatment Phase|Withdrawal by Subject|28|||
25177215|NCT01524133|50321323|FG002|Treatment Phase|Withdrawal by Subject|31|||
25177216|NCT01524133|50321321|FG000|Treatment Phase|Physician Decision|6|||
25177217|NCT01524133|50321322|FG001|Treatment Phase|Physician Decision|3|||
25105996|NCT01632345|50217043|FG000|Treatment: Part I|Lack of Efficacy|0|||
25105997|NCT01632345|50217044|FG001|Treatment: Part I|Lack of Efficacy|1|||
25105998|NCT01632345|50217045|FG002|Treatment: Part I|Lack of Efficacy|0|||
25177218|NCT01524133|50321323|FG002|Treatment Phase|Physician Decision|3|||
25177219|NCT01524133|50321321|FG000|Treatment Phase|Lost to Follow-up|0|||
25105999|NCT01632345|50217046|FG003|Treatment: Part I|Lack of Efficacy|1|||
25106000|NCT01632345|50217047|FG004|Treatment: Part I|Lack of Efficacy|1|||
25106001|NCT01632345|50217048|FG005|Treatment: Part I|Lack of Efficacy|0|||
25106002|NCT01632345|50217049|FG006|Treatment: Part I|Lack of Efficacy|0|||
25106003|NCT01632345|50217043|FG000|Treatment: Part I|Lost to Follow-up|3|||
25106004|NCT01632345|50217044|FG001|Treatment: Part I|Lost to Follow-up|2|||
25106005|NCT01632345|50217045|FG002|Treatment: Part I|Lost to Follow-up|1|||
25106006|NCT01632345|50217046|FG003|Treatment: Part I|Lost to Follow-up|3|||
25106007|NCT01632345|50217047|FG004|Treatment: Part I|Lost to Follow-up|4|||
25106008|NCT01632345|50217048|FG005|Treatment: Part I|Lost to Follow-up|0|||
25106009|NCT01632345|50217049|FG006|Treatment: Part I|Lost to Follow-up|0|||
25106010|NCT01632345|50217043|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
25106011|NCT01632345|50217044|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
25106012|NCT01632345|50217045|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
25106013|NCT01632345|50217046|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
25106014|NCT01632345|50217047|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
25106015|NCT01632345|50217048|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
25106016|NCT01632345|50217049|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
25106017|NCT01632345|50217043|FG000|Treatment: Part I|Physician Decision|2|||
25106018|NCT01632345|50217044|FG001|Treatment: Part I|Physician Decision|1|||
25106019|NCT01632345|50217045|FG002|Treatment: Part I|Physician Decision|0|||
25106020|NCT01632345|50217046|FG003|Treatment: Part I|Physician Decision|0|||
25106021|NCT01632345|50217047|FG004|Treatment: Part I|Physician Decision|1|||
25106022|NCT01632345|50217048|FG005|Treatment: Part I|Physician Decision|0|||
25106023|NCT01632345|50217049|FG006|Treatment: Part I|Physician Decision|0|||
25106024|NCT01632345|50217043|FG000|Treatment: Part I|Pregnancy|0|||
25106025|NCT01632345|50217044|FG001|Treatment: Part I|Pregnancy|1|||
25106026|NCT01632345|50217045|FG002|Treatment: Part I|Pregnancy|0|||
25106027|NCT01632345|50217046|FG003|Treatment: Part I|Pregnancy|0|||
25106028|NCT01632345|50217047|FG004|Treatment: Part I|Pregnancy|0|||
25106029|NCT01632345|50217048|FG005|Treatment: Part I|Pregnancy|0|||
25106030|NCT01632345|50217049|FG006|Treatment: Part I|Pregnancy|0|||
25106031|NCT01632345|50217043|FG000|Treatment: Part I|Protocol Deviation|0|||
25106032|NCT01632345|50217044|FG001|Treatment: Part I|Protocol Deviation|0|||
25106033|NCT01632345|50217045|FG002|Treatment: Part I|Protocol Deviation|1|||
25106034|NCT01632345|50217046|FG003|Treatment: Part I|Protocol Deviation|1|||
25106035|NCT01632345|50217047|FG004|Treatment: Part I|Protocol Deviation|0|||
25106036|NCT01632345|50217048|FG005|Treatment: Part I|Protocol Deviation|0|||
25106037|NCT01632345|50217049|FG006|Treatment: Part I|Protocol Deviation|0|||
25106038|NCT01632345|50217043|FG000|Treatment: Part I|Withdrawal by Subject|3|||
25106039|NCT01632345|50217044|FG001|Treatment: Part I|Withdrawal by Subject|4|||
25106040|NCT01632345|50217045|FG002|Treatment: Part I|Withdrawal by Subject|4|||
25106041|NCT01632345|50217046|FG003|Treatment: Part I|Withdrawal by Subject|1|||
25106042|NCT01632345|50217047|FG004|Treatment: Part I|Withdrawal by Subject|4|||
25106043|NCT01632345|50217048|FG005|Treatment: Part I|Withdrawal by Subject|0|||
25106044|NCT01632345|50217049|FG006|Treatment: Part I|Withdrawal by Subject|0|||
25106045|NCT01632345|50217043|FG000|Treatment: Part II|Adverse Event|0|||
25106046|NCT01632345|50217044|FG001|Treatment: Part II|Adverse Event|0|||
25106047|NCT01632345|50217045|FG002|Treatment: Part II|Adverse Event|0|||
25106048|NCT01632345|50217046|FG003|Treatment: Part II|Adverse Event|0|||
25106049|NCT01632345|50217047|FG004|Treatment: Part II|Adverse Event|0|||
25106050|NCT01632345|50217048|FG005|Treatment: Part II|Adverse Event|3|||
25106051|NCT01632345|50217049|FG006|Treatment: Part II|Adverse Event|8|||
25106052|NCT01632345|50217043|FG000|Treatment: Part II|Lost to Follow-up|0|||
25106053|NCT01632345|50217044|FG001|Treatment: Part II|Lost to Follow-up|0|||
25106054|NCT01632345|50217045|FG002|Treatment: Part II|Lost to Follow-up|0|||
25106055|NCT01632345|50217046|FG003|Treatment: Part II|Lost to Follow-up|0|||
25106056|NCT01632345|50217047|FG004|Treatment: Part II|Lost to Follow-up|0|||
25106057|NCT01632345|50217048|FG005|Treatment: Part II|Lost to Follow-up|3|||
25106058|NCT01632345|50217049|FG006|Treatment: Part II|Lost to Follow-up|1|||
25106059|NCT01632345|50217043|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
25106060|NCT01632345|50217044|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
25106061|NCT01632345|50217045|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
25106062|NCT01632345|50217046|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
25106063|NCT01632345|50217047|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
25106064|NCT01632345|50217048|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
25106065|NCT01632345|50217049|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
25106066|NCT01632345|50217043|FG000|Treatment: Part II|Withdrawal by Subject|0|||
25106067|NCT01632345|50217044|FG001|Treatment: Part II|Withdrawal by Subject|0|||
25106068|NCT01632345|50217045|FG002|Treatment: Part II|Withdrawal by Subject|0|||
25106069|NCT01632345|50217046|FG003|Treatment: Part II|Withdrawal by Subject|0|||
25106070|NCT01632345|50217047|FG004|Treatment: Part II|Withdrawal by Subject|0|||
25106071|NCT01632345|50217048|FG005|Treatment: Part II|Withdrawal by Subject|2|||
25106072|NCT01632345|50217049|FG006|Treatment: Part II|Withdrawal by Subject|2|||
25106073|NCT02232243|50217067|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
25106074|NCT02232243|50217068|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
25106075|NCT02232243|50217069|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
25106076|NCT02205333|50217087|FG000|Overall Study|Death|5|||
25106077|NCT02205333|50217088|FG001|Overall Study|Death|6|||
25106078|NCT02205333|50217089|FG002|Overall Study|Death|2|||
25106079|NCT02205333|50217090|FG003|Overall Study|Death|6|||
25106080|NCT02205333|50217091|FG004|Overall Study|Death|5|||
25106081|NCT02205333|50217092|FG005|Overall Study|Death|3|||
25106082|NCT02205333|50217093|FG006|Overall Study|Death|3|||
25106083|NCT02205333|50217094|FG007|Overall Study|Death|2|||
25106084|NCT02205333|50217095|FG008|Overall Study|Death|0|||
25106085|NCT02205333|50217087|FG000|Overall Study|Withdrawal by Subject|1|||
25106086|NCT02205333|50217088|FG001|Overall Study|Withdrawal by Subject|0|||
25106087|NCT02205333|50217089|FG002|Overall Study|Withdrawal by Subject|0|||
25106088|NCT02205333|50217090|FG003|Overall Study|Withdrawal by Subject|1|||
25106089|NCT02205333|50217091|FG004|Overall Study|Withdrawal by Subject|0|||
25106090|NCT02205333|50217092|FG005|Overall Study|Withdrawal by Subject|0|||
25106091|NCT02205333|50217093|FG006|Overall Study|Withdrawal by Subject|2|||
25106092|NCT02205333|50217094|FG007|Overall Study|Withdrawal by Subject|0|||
25106093|NCT02205333|50217095|FG008|Overall Study|Withdrawal by Subject|0|||
25106094|NCT02230683|50217115|FG000|Overall Study|Adverse Event|1|||
25106095|NCT02230527|50217127|FG000|Overall Study|Withdrawal by Subject|1|||
25106096|NCT02230527|50217128|FG001|Overall Study|Withdrawal by Subject|1|||
25106097|NCT02230527|50217127|FG000|Overall Study|Death|1|||
25106098|NCT02230527|50217128|FG001|Overall Study|Death|0|||
25106099|NCT02230527|50217127|FG000|Overall Study|Lost to Follow-up|2|||
25106100|NCT02230527|50217128|FG001|Overall Study|Lost to Follow-up|1|||
25106101|NCT02230527|50217127|FG000|Overall Study|Other|1|||
25106102|NCT02230527|50217128|FG001|Overall Study|Other|0|||
25106103|NCT02204319|50217134|FG000|Overall Study|Pregnancy|1|||
25106104|NCT02204319|50217134|FG000|Overall Study|Withdrawal by Subject|2|||
25106105|NCT02204007|50217141|FG000|Overall Study|Surgery Canceled|1|||
25106106|NCT02204007|50217142|FG001|Overall Study|Surgery Canceled|1|||
25106107|NCT02203851|50217148|FG000|Overall Study|Lost to Follow-up|4|||
25106108|NCT02203851|50217148|FG000|Overall Study|Withdrawal by Subject|6|||
25106109|NCT02203851|50217148|FG000|Overall Study|Other|1|||
25106110|NCT02228967|50217161|FG000|Overall Study|Lost to Follow-up|146|||
25106111|NCT02228967|50217162|FG001|Overall Study|Lost to Follow-up|142|||
25106112|NCT02228967|50217161|FG000|Overall Study|Withdrawal by Subject|13|||
25106113|NCT02228967|50217162|FG001|Overall Study|Withdrawal by Subject|18|||
25106114|NCT02227875|50217170|FG000|Overall Study|Protocol Violation|10|||
25106115|NCT02227875|50217171|FG001|Overall Study|Protocol Violation|7|||
25106116|NCT02227875|50217170|FG000|Overall Study|Other|1|||
25106117|NCT02227875|50217171|FG001|Overall Study|Other|3|||
25106118|NCT02227875|50217170|FG000|Overall Study|Physician Decision|1|||
25106119|NCT02227875|50217171|FG001|Overall Study|Physician Decision|0|||
25106120|NCT02227875|50217170|FG000|Overall Study|Adverse Event|3|||
25106121|NCT02227875|50217171|FG001|Overall Study|Adverse Event|0|||
25106122|NCT02227875|50217170|FG000|Overall Study|Withdrawal by Subject|12|||
25106123|NCT02227875|50217171|FG001|Overall Study|Withdrawal by Subject|13|||
25106124|NCT02227875|50217170|FG000|Overall Study|Lost to Follow-up|10|||
25106125|NCT02227875|50217171|FG001|Overall Study|Lost to Follow-up|10|||
25106126|NCT02203149|50217182|FG000|Part 1|Adverse Event|0|||
25106127|NCT02203149|50217183|FG001|Part 1|Adverse Event|1|||
25106128|NCT02203149|50217184|FG002|Part 1|Adverse Event|0|||
25106129|NCT02203149|50217185|FG003|Part 1|Adverse Event|0|||
25106130|NCT02203149|50217186|FG004|Part 1|Adverse Event|0|||
25106131|NCT02203149|50217182|FG000|Part 2|Death|0|||
25106132|NCT02203149|50217183|FG001|Part 2|Death|0|||
25106133|NCT02203149|50217184|FG002|Part 2|Death|1|||
25106134|NCT02203149|50217185|FG003|Part 2|Death|1|||
25106135|NCT02203149|50217186|FG004|Part 2|Death|0|||
25106136|NCT02203149|50217182|FG000|Part 2|Withdrawal by Subject|0|||
25106137|NCT02203149|50217183|FG001|Part 2|Withdrawal by Subject|0|||
25106138|NCT02203149|50217184|FG002|Part 2|Withdrawal by Subject|0|||
25106139|NCT02203149|50217185|FG003|Part 2|Withdrawal by Subject|1|||
25106140|NCT02203149|50217186|FG004|Part 2|Withdrawal by Subject|0|||
25106141|NCT02203149|50217182|FG000|Part 2|Adverse Event|0|||
25106142|NCT02203149|50217183|FG001|Part 2|Adverse Event|0|||
25106143|NCT02203149|50217184|FG002|Part 2|Adverse Event|0|||
25106144|NCT02203149|50217185|FG003|Part 2|Adverse Event|1|||
25106145|NCT02203149|50217186|FG004|Part 2|Adverse Event|1|||
25106146|NCT02203071|50217210|FG000|Overall Study|Lost to Follow-up|3|||
25106147|NCT02203071|50217211|FG001|Overall Study|Lost to Follow-up|1|||
25106148|NCT02202837|50217219|FG000|Overall Study|Enbrel treatment discontinued|36|||
25106149|NCT02202837|50217220|FG001|Overall Study|Enbrel treatment discontinued|4|||
25106150|NCT02202837|50217219|FG000|Overall Study|Other|10|||
25106151|NCT02202837|50217220|FG001|Overall Study|Other|0|||
25106152|NCT02202837|50217219|FG000|Overall Study|Lost to Follow-up|7|||
25106153|NCT02202837|50217220|FG001|Overall Study|Lost to Follow-up|1|||
25106154|NCT02202759|50217229|FG000|Overall Study|Study Terminated by Sponsor|3|||
25106155|NCT02202759|50217230|FG001|Overall Study|Study Terminated by Sponsor|3|||
25106156|NCT02202759|50217231|FG002|Overall Study|Study Terminated by Sponsor|3|||
25106157|NCT02202759|50217229|FG000|Overall Study|Withdrawal by Subject|2|||
25106158|NCT02202759|50217230|FG001|Overall Study|Withdrawal by Subject|1|||
25106159|NCT02202759|50217231|FG002|Overall Study|Withdrawal by Subject|1|||
25106160|NCT02202759|50217229|FG000|Overall Study|Reason not Specified|4|||
25106161|NCT02202759|50217230|FG001|Overall Study|Reason not Specified|11|||
25106162|NCT02202759|50217231|FG002|Overall Study|Reason not Specified|10|||
25106163|NCT02226549|50217240|FG000|Overall Study|Randomized but Never Treated|1|||
25106164|NCT02226549|50217241|FG001|Overall Study|Randomized but Never Treated|0|||
25106165|NCT02226549|50217240|FG000|Overall Study|Lost to Follow-up|0|||
25106166|NCT02226549|50217241|FG001|Overall Study|Lost to Follow-up|1|||
25106167|NCT02226003|50217250|FG000|Overall Study|Lost to Follow-up|2|||
25106168|NCT02226003|50217251|FG001|Overall Study|Lost to Follow-up|1|||
25106169|NCT02226003|50217252|FG002|Overall Study|Lost to Follow-up|3|||
25106170|NCT02226003|50217250|FG000|Overall Study|Withdrawal by Subject|0|||
25106171|NCT02226003|50217251|FG001|Overall Study|Withdrawal by Subject|0|||
25106172|NCT02226003|50217252|FG002|Overall Study|Withdrawal by Subject|3|||
25106173|NCT02225223|50217262|FG000|Overall Study|Death|10|||
25106174|NCT02225223|50217263|FG001|Overall Study|Death|1|||
25106175|NCT02225223|50217262|FG000|Overall Study|Lost to Follow-up|5|||
25106176|NCT02225223|50217263|FG001|Overall Study|Lost to Follow-up|0|||
25106177|NCT02225223|50217262|FG000|Overall Study|Other|1|||
25106178|NCT02225223|50217263|FG001|Overall Study|Other|2|||
25106179|NCT02225223|50217262|FG000|Overall Study|Physician Decision|1|||
25106180|NCT02225223|50217263|FG001|Overall Study|Physician Decision|0|||
25106181|NCT02225223|50217262|FG000|Overall Study|Withdrawal by Subject|2|||
25106182|NCT02225223|50217263|FG001|Overall Study|Withdrawal by Subject|2|||
25106183|NCT01634139|50217272|FG000|Overall Study|Non compliant with protocol|1|||
25106184|NCT01634139|50217273|FG001|Overall Study|Non compliant with protocol|0|||
25106185|NCT01634139|50217274|FG002|Overall Study|Non compliant with protocol|0|||
25106186|NCT01634139|50217272|FG000|Overall Study|Consent withdrawn not due to AE|4|||
25106187|NCT01634139|50217273|FG001|Overall Study|Consent withdrawn not due to AE|3|||
25106188|NCT01634139|50217274|FG002|Overall Study|Consent withdrawn not due to AE|2|||
25106189|NCT01634139|50217272|FG000|Overall Study|Other|4|||
25106190|NCT01634139|50217273|FG001|Overall Study|Other|0|||
25106191|NCT01634139|50217274|FG002|Overall Study|Other|3|||
25106192|NCT01634139|50217272|FG000|Overall Study|Lost to Follow-up|0|||
25106193|NCT01634139|50217273|FG001|Overall Study|Lost to Follow-up|2|||
25106194|NCT01634139|50217274|FG002|Overall Study|Lost to Follow-up|0|||
25106195|NCT01634139|50217272|FG000|Overall Study|Not treated|1|||
25106196|NCT01634139|50217273|FG001|Overall Study|Not treated|1|||
25106197|NCT01634139|50217274|FG002|Overall Study|Not treated|0|||
25106198|NCT02224755|50217284|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
25106199|NCT02224755|50217285|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
25106200|NCT02224755|50217284|FG000|Two Year Follow up Post-implant|Death|103|||
25106201|NCT02224755|50217285|FG001|Two Year Follow up Post-implant|Death|98|||
25106202|NCT02224755|50217284|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
25106203|NCT02224755|50217285|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
25106204|NCT02224755|50217284|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
25106205|NCT02224755|50217285|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
25106206|NCT02224755|50217284|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
25106207|NCT02224755|50217285|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
25106208|NCT02404441|50217305|FG000|Phase 1 Part|Adverse Event|1|||
25106209|NCT02404441|50217306|FG001|Phase 1 Part|Adverse Event|0|||
25106210|NCT02404441|50217307|FG002|Phase 1 Part|Adverse Event|0|||
25106211|NCT02404441|50217308|FG003|Phase 1 Part|Adverse Event|0|||
25106212|NCT02404441|50217309|FG004|Phase 1 Part|Adverse Event|0|||
25106213|NCT02404441|50217310|FG005|Phase 1 Part|Adverse Event|0|||
25106214|NCT02404441|50217311|FG006|Phase 1 Part|Adverse Event|0|||
25106215|NCT02404441|50217312|FG007|Phase 1 Part|Adverse Event|0|||
25106216|NCT02404441|50217313|FG008|Phase 1 Part|Adverse Event|0|||
25106217|NCT02404441|50217314|FG009|Phase 1 Part|Adverse Event|0|||
25106218|NCT02404441|50217305|FG000|Phase 1 Part|Physician Decision|0|||
25106219|NCT02404441|50217306|FG001|Phase 1 Part|Physician Decision|1|||
25106220|NCT02404441|50217307|FG002|Phase 1 Part|Physician Decision|0|||
25106221|NCT02404441|50217308|FG003|Phase 1 Part|Physician Decision|0|||
25106222|NCT02404441|50217309|FG004|Phase 1 Part|Physician Decision|0|||
25106223|NCT02404441|50217310|FG005|Phase 1 Part|Physician Decision|0|||
25106224|NCT02404441|50217311|FG006|Phase 1 Part|Physician Decision|0|||
25106225|NCT02404441|50217312|FG007|Phase 1 Part|Physician Decision|0|||
25106226|NCT02404441|50217313|FG008|Phase 1 Part|Physician Decision|0|||
25106227|NCT02404441|50217314|FG009|Phase 1 Part|Physician Decision|0|||
25106228|NCT02404441|50217305|FG000|Phase 1 Part|Progressive Disease|14|||
25106229|NCT02404441|50217306|FG001|Phase 1 Part|Progressive Disease|11|||
25106230|NCT02404441|50217307|FG002|Phase 1 Part|Progressive Disease|7|||
25106231|NCT02404441|50217308|FG003|Phase 1 Part|Progressive Disease|6|||
25106232|NCT02404441|50217309|FG004|Phase 1 Part|Progressive Disease|9|||
25106233|NCT02404441|50217310|FG005|Phase 1 Part|Progressive Disease|0|||
25106234|NCT02404441|50217311|FG006|Phase 1 Part|Progressive Disease|0|||
25106235|NCT02404441|50217312|FG007|Phase 1 Part|Progressive Disease|0|||
25106236|NCT02404441|50217313|FG008|Phase 1 Part|Progressive Disease|0|||
25106237|NCT02404441|50217314|FG009|Phase 1 Part|Progressive Disease|0|||
25106238|NCT02404441|50217305|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
25106239|NCT02404441|50217306|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
25106240|NCT02404441|50217307|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
25106241|NCT02404441|50217308|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
25106242|NCT02404441|50217309|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
25106243|NCT02404441|50217310|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
25106244|NCT02404441|50217311|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
25106245|NCT02404441|50217312|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
25106246|NCT02404441|50217313|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
25106247|NCT02404441|50217314|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
25106248|NCT02404441|50217305|FG000|Phase 1 Part|Death|1|||
25106249|NCT02404441|50217306|FG001|Phase 1 Part|Death|1|||
25106250|NCT02404441|50217307|FG002|Phase 1 Part|Death|1|||
25106251|NCT02404441|50217308|FG003|Phase 1 Part|Death|0|||
25106252|NCT02404441|50217309|FG004|Phase 1 Part|Death|1|||
25106253|NCT02404441|50217310|FG005|Phase 1 Part|Death|0|||
25106254|NCT02404441|50217311|FG006|Phase 1 Part|Death|0|||
25106255|NCT02404441|50217312|FG007|Phase 1 Part|Death|0|||
25106256|NCT02404441|50217313|FG008|Phase 1 Part|Death|0|||
25106257|NCT02404441|50217314|FG009|Phase 1 Part|Death|0|||
25106258|NCT02404441|50217305|FG000|Phase 2 Part|Adverse Event|0|||
25106259|NCT02404441|50217306|FG001|Phase 2 Part|Adverse Event|0|||
25106260|NCT02404441|50217307|FG002|Phase 2 Part|Adverse Event|0|||
25106261|NCT02404441|50217308|FG003|Phase 2 Part|Adverse Event|0|||
25106262|NCT02404441|50217309|FG004|Phase 2 Part|Adverse Event|0|||
25106263|NCT02404441|50217310|FG005|Phase 2 Part|Adverse Event|2|||
25106264|NCT02404441|50217311|FG006|Phase 2 Part|Adverse Event|3|||
25106265|NCT02404441|50217312|FG007|Phase 2 Part|Adverse Event|3|||
25106266|NCT02404441|50217313|FG008|Phase 2 Part|Adverse Event|6|||
25106267|NCT02404441|50217314|FG009|Phase 2 Part|Adverse Event|1|||
25106268|NCT02404441|50217305|FG000|Phase 2 Part|Physician Decision|0|||
25106269|NCT02404441|50217306|FG001|Phase 2 Part|Physician Decision|0|||
25106270|NCT02404441|50217307|FG002|Phase 2 Part|Physician Decision|0|||
25106271|NCT02404441|50217308|FG003|Phase 2 Part|Physician Decision|0|||
25106272|NCT02404441|50217309|FG004|Phase 2 Part|Physician Decision|0|||
25106273|NCT02404441|50217310|FG005|Phase 2 Part|Physician Decision|7|||
25106274|NCT02404441|50217311|FG006|Phase 2 Part|Physician Decision|9|||
25106275|NCT02404441|50217312|FG007|Phase 2 Part|Physician Decision|2|||
25106276|NCT02404441|50217313|FG008|Phase 2 Part|Physician Decision|1|||
25106277|NCT02404441|50217314|FG009|Phase 2 Part|Physician Decision|3|||
25106278|NCT02404441|50217305|FG000|Phase 2 Part|Progressive disease|0|||
25106279|NCT02404441|50217306|FG001|Phase 2 Part|Progressive disease|0|||
25106280|NCT02404441|50217307|FG002|Phase 2 Part|Progressive disease|0|||
25106281|NCT02404441|50217308|FG003|Phase 2 Part|Progressive disease|0|||
25106282|NCT02404441|50217309|FG004|Phase 2 Part|Progressive disease|0|||
25106283|NCT02404441|50217310|FG005|Phase 2 Part|Progressive disease|43|||
25106284|NCT02404441|50217311|FG006|Phase 2 Part|Progressive disease|32|||
25106285|NCT02404441|50217312|FG007|Phase 2 Part|Progressive disease|31|||
25106286|NCT02404441|50217313|FG008|Phase 2 Part|Progressive disease|39|||
25106287|NCT02404441|50217314|FG009|Phase 2 Part|Progressive disease|27|||
25106288|NCT02404441|50217305|FG000|Phase 2 Part|Subject/guardian decision|0|||
25106289|NCT02404441|50217306|FG001|Phase 2 Part|Subject/guardian decision|0|||
25106290|NCT02404441|50217307|FG002|Phase 2 Part|Subject/guardian decision|0|||
25106291|NCT02404441|50217308|FG003|Phase 2 Part|Subject/guardian decision|0|||
25106292|NCT02404441|50217309|FG004|Phase 2 Part|Subject/guardian decision|0|||
25106293|NCT02404441|50217310|FG005|Phase 2 Part|Subject/guardian decision|3|||
25106294|NCT02404441|50217311|FG006|Phase 2 Part|Subject/guardian decision|9|||
25106295|NCT02404441|50217312|FG007|Phase 2 Part|Subject/guardian decision|0|||
25106296|NCT02404441|50217313|FG008|Phase 2 Part|Subject/guardian decision|3|||
25106297|NCT02404441|50217314|FG009|Phase 2 Part|Subject/guardian decision|2|||
25008278|NCT03556358|50101178|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
25106298|NCT02404441|50217305|FG000|Phase 2 Part|Death|0|||
25106299|NCT02404441|50217306|FG001|Phase 2 Part|Death|0|||
25106300|NCT02404441|50217307|FG002|Phase 2 Part|Death|0|||
25106301|NCT02404441|50217308|FG003|Phase 2 Part|Death|0|||
25106302|NCT02404441|50217309|FG004|Phase 2 Part|Death|0|||
25106303|NCT02404441|50217310|FG005|Phase 2 Part|Death|4|||
25106304|NCT02404441|50217311|FG006|Phase 2 Part|Death|8|||
25106305|NCT02404441|50217312|FG007|Phase 2 Part|Death|4|||
25106306|NCT02404441|50217313|FG008|Phase 2 Part|Death|10|||
25106307|NCT02404441|50217314|FG009|Phase 2 Part|Death|9|||
25106308|NCT02101281|50217360|FG000|Overall Study|Adverse Event|0|||
25106309|NCT02101281|50217361|FG001|Overall Study|Adverse Event|1|||
25106310|NCT02224599|50217373|FG000|Overall Study|Physician Decision|1|||
25106311|NCT02224599|50217373|FG000|Overall Study|Progression of Disease|1|||
25106312|NCT02201901|50217380|FG000|Overall Study|Randomized but never treated|0|||
25106313|NCT02201901|50217381|FG001|Overall Study|Randomized but never treated|1|||
25106314|NCT02201901|50217382|FG002|Overall Study|Randomized but never treated|0|||
25106315|NCT02201901|50217380|FG000|Overall Study|Lack of Efficacy|7|||
25106316|NCT02201901|50217381|FG001|Overall Study|Lack of Efficacy|1|||
25106317|NCT02201901|50217382|FG002|Overall Study|Lack of Efficacy|6|||
25106318|NCT02201901|50217380|FG000|Overall Study|Death|3|||
25106319|NCT02201901|50217381|FG001|Overall Study|Death|3|||
25106320|NCT02201901|50217382|FG002|Overall Study|Death|3|||
25106321|NCT02201901|50217380|FG000|Overall Study|Lost to Follow-up|2|||
25106322|NCT02201901|50217381|FG001|Overall Study|Lost to Follow-up|3|||
25106323|NCT02201901|50217382|FG002|Overall Study|Lost to Follow-up|2|||
25106324|NCT02201901|50217380|FG000|Overall Study|Withdrew Consent|2|||
25106325|NCT02201901|50217381|FG001|Overall Study|Withdrew Consent|0|||
25106326|NCT02201901|50217382|FG002|Overall Study|Withdrew Consent|2|||
25106327|NCT02201901|50217380|FG000|Overall Study|Adverse Event|1|||
25106328|NCT02201901|50217381|FG001|Overall Study|Adverse Event|1|||
25106329|NCT02201901|50217382|FG002|Overall Study|Adverse Event|0|||
25106330|NCT02201277|50217393|FG000|Overall Study|Death|3|||
25106331|NCT02201277|50217394|FG001|Overall Study|Death|4|||
25106332|NCT02201277|50217393|FG000|Overall Study|Lost to Follow-up|2|||
25106333|NCT02201277|50217394|FG001|Overall Study|Lost to Follow-up|1|||
25106334|NCT02201277|50217393|FG000|Overall Study|Failed retrieval|1|||
25106335|NCT02201277|50217394|FG001|Overall Study|Failed retrieval|0|||
25106336|NCT02201277|50217393|FG000|Overall Study|Physician Decision|1|||
25106337|NCT02201277|50217394|FG001|Overall Study|Physician Decision|0|||
25106338|NCT02224053|50217404|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
25106339|NCT02224053|50217404|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
25106340|NCT02224053|50217404|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
25106341|NCT02224053|50217404|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
25106342|NCT02224053|50217404|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
25106343|NCT02457793|50217416|FG000|Overall Study|Reason not specified|0|||
25106344|NCT02457793|50217417|FG001|Overall Study|Reason not specified|0|||
25106345|NCT02457793|50217418|FG002|Overall Study|Reason not specified|0|||
25106346|NCT02457793|50217419|FG003|Overall Study|Reason not specified|1|||
25106347|NCT02457793|50217420|FG004|Overall Study|Reason not specified|1|||
25106348|NCT02457793|50217421|FG005|Overall Study|Reason not specified|1|||
25106349|NCT02457793|50217416|FG000|Overall Study|Withdrawal by Subject|0|||
25106350|NCT02457793|50217417|FG001|Overall Study|Withdrawal by Subject|4|||
25106351|NCT02457793|50217418|FG002|Overall Study|Withdrawal by Subject|2|||
25106352|NCT02457793|50217419|FG003|Overall Study|Withdrawal by Subject|2|||
25106353|NCT02457793|50217420|FG004|Overall Study|Withdrawal by Subject|2|||
25106354|NCT02457793|50217421|FG005|Overall Study|Withdrawal by Subject|2|||
25106355|NCT02457793|50217416|FG000|Overall Study|Adverse Event|0|||
25106356|NCT02457793|50217417|FG001|Overall Study|Adverse Event|0|||
25106357|NCT02457793|50217418|FG002|Overall Study|Adverse Event|0|||
25106358|NCT02457793|50217419|FG003|Overall Study|Adverse Event|1|||
25106359|NCT02457793|50217420|FG004|Overall Study|Adverse Event|0|||
25106360|NCT02457793|50217421|FG005|Overall Study|Adverse Event|0|||
25106361|NCT02457793|50217416|FG000|Overall Study|Physician Decision|1|||
25106362|NCT02457793|50217417|FG001|Overall Study|Physician Decision|0|||
25106363|NCT02457793|50217418|FG002|Overall Study|Physician Decision|1|||
25106364|NCT02457793|50217419|FG003|Overall Study|Physician Decision|1|||
25106365|NCT02457793|50217420|FG004|Overall Study|Physician Decision|1|||
25106366|NCT02457793|50217421|FG005|Overall Study|Physician Decision|3|||
25106367|NCT01650259|50217438|FG000|Overall Study|Improvement|105|||
25106368|NCT01650259|50217439|FG001|Overall Study|Improvement|0|||
25106369|NCT01650259|50217438|FG000|Overall Study|Adverse Event|127|||
25106370|NCT01650259|50217439|FG001|Overall Study|Adverse Event|0|||
25106371|NCT01650259|50217438|FG000|Overall Study|Lack of Efficacy|143|||
25106372|NCT01650259|50217439|FG001|Overall Study|Lack of Efficacy|0|||
25106373|NCT01650259|50217438|FG000|Overall Study|Lost to Follow-up|435|||
25106374|NCT01650259|50217439|FG001|Overall Study|Lost to Follow-up|0|||
25106375|NCT01650259|50217438|FG000|Overall Study|Patients had no visit after entry|70|||
25106376|NCT01650259|50217439|FG001|Overall Study|Patients had no visit after entry|0|||
25106377|NCT01650259|50217438|FG000|Overall Study|CRF not collected|98|||
25106378|NCT01650259|50217439|FG001|Overall Study|CRF not collected|82|||
25106379|NCT01650259|50217438|FG000|Overall Study|Not treated|1|||
25106380|NCT01650259|50217439|FG001|Overall Study|Not treated|7|||
25106381|NCT01650259|50217438|FG000|Overall Study|Other than listed|64|||
25106382|NCT01650259|50217439|FG001|Overall Study|Other than listed|146|||
25106383|NCT02434939|50217445|FG000|Overall Study|Lack of Efficacy|34|||
25106384|NCT02434939|50217446|FG001|Overall Study|Lack of Efficacy|48|||
25106385|NCT02434939|50217445|FG000|Overall Study|Withdrawal by Subject|3|||
25106386|NCT02434939|50217446|FG001|Overall Study|Withdrawal by Subject|0|||
25106387|NCT02434939|50217445|FG000|Overall Study|Adverse Event|0|||
25106388|NCT02434939|50217446|FG001|Overall Study|Adverse Event|1|||
25106389|NCT02434471|50217453|FG000|Overall Study|Physician Decision|9|||
25106390|NCT02457637|50217458|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
25106391|NCT02457325|50217465|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
25106392|NCT02457325|50217466|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
25106393|NCT02434081|50217472|FG000|Overall Study|Death (never started treatment)|2|||
25106394|NCT02434081|50217472|FG000|Overall Study|Death|2|||
25106395|NCT02434081|50217472|FG000|Overall Study|Progression|20|||
25106396|NCT02434081|50217472|FG000|Overall Study|Adverse Event|20|||
25106397|NCT02434081|50217472|FG000|Overall Study|Physician Decision|2|||
25106398|NCT02434081|50217472|FG000|Overall Study|Withdrawal by Subject|1|||
25106399|NCT02434081|50217472|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
25106400|NCT02222493|50217478|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
25106401|NCT02222493|50217479|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
25106402|NCT02222493|50217478|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
25106403|NCT02222493|50217479|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
25106404|NCT02222493|50217478|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
25106405|NCT02222493|50217479|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
25106406|NCT02222493|50217478|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
25106407|NCT02222493|50217479|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
25106408|NCT02222493|50217478|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
25106409|NCT02222493|50217479|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
25106410|NCT02222493|50217478|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
25106411|NCT02222493|50217479|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
25106412|NCT02222493|50217478|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
25106413|NCT02222493|50217479|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
25106414|NCT02222493|50217478|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
25106415|NCT02222493|50217479|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
25106416|NCT02222493|50217478|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
25106417|NCT02222493|50217479|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
25106418|NCT02222493|50217478|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
25106419|NCT02222493|50217479|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
25106420|NCT02222493|50217478|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
25106421|NCT02222493|50217479|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
25106422|NCT02222493|50217478|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
25106423|NCT02222493|50217479|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
25106424|NCT02222493|50217478|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
25106425|NCT02222493|50217479|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
25106426|NCT02222493|50217478|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
25106427|NCT02222493|50217479|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
25106428|NCT02222493|50217478|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
25106429|NCT02222493|50217479|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
25106430|NCT02222493|50217478|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
25106431|NCT02222493|50217479|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
25106432|NCT02222493|50217478|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
25106433|NCT02222493|50217479|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
25106434|NCT02222493|50217478|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
25106435|NCT02222493|50217479|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
25106436|NCT02222493|50217478|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
25106437|NCT02222493|50217479|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
25106438|NCT02222493|50217478|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
25106439|NCT02222493|50217479|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
25106440|NCT02222493|50217478|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
25106441|NCT02222493|50217479|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
25106442|NCT02222493|50217478|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
25106443|NCT02222493|50217479|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
25106444|NCT02433379|50217498|FG000|Overall Study|Screen Failures|55|||
25106445|NCT02433379|50217498|FG000|Overall Study|Death|57|||
25106446|NCT02433379|50217498|FG000|Overall Study|Total Withdrawals|209|||
25106447|NCT02199795|50217506|FG000|Overall Study|no longer met inclusion criteria|1|||
25106448|NCT02199795|50217507|FG001|Overall Study|no longer met inclusion criteria|0|||
25106449|NCT02199795|50217506|FG000|Overall Study|withdrew due to shoulder pain|1|||
25106450|NCT02199795|50217507|FG001|Overall Study|withdrew due to shoulder pain|0|||
25106451|NCT02403817|50217515|FG000|Overall Study|Withdrawal by Subject|5|||
25106452|NCT02403817|50217516|FG001|Overall Study|Withdrawal by Subject|0|||
25106453|NCT02403271|50217522|FG000|Period 1|Other varied reasons|1|||
25106454|NCT02403271|50217523|FG001|Period 1|Other varied reasons|0|||
25106455|NCT02403271|50217522|FG000|Period 2|Withdrawal by Subject|0|||
25177220|NCT01524133|50321322|FG001|Treatment Phase|Lost to Follow-up|1|||
25106456|NCT02403271|50217523|FG001|Period 2|Withdrawal by Subject|14|||
25106457|NCT02403271|50217522|FG000|Period 2|Death|0|||
25106458|NCT02403271|50217523|FG001|Period 2|Death|84|||
25106459|NCT02403271|50217522|FG000|Period 2|Lost to Follow-up|0|||
25106460|NCT02403271|50217523|FG001|Period 2|Lost to Follow-up|2|||
25106461|NCT02403271|50217522|FG000|Period 2|Study Terminated by Sponsor|0|||
25106462|NCT02403271|50217523|FG001|Period 2|Study Terminated by Sponsor|14|||
25106463|NCT02403271|50217522|FG000|Period 2|Other varied reasons|0|||
25106464|NCT02403271|50217523|FG001|Period 2|Other varied reasons|10|||
25106465|NCT02219685|50217531|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
25106466|NCT02219685|50217532|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
25106467|NCT02219685|50217531|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
25106468|NCT02219685|50217532|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
25106469|NCT02457247|50217544|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
25106470|NCT02457247|50217545|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
25106471|NCT02457247|50217546|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
25106472|NCT02457247|50217547|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
25106473|NCT02457247|50217544|FG000|Period 1|Significant Protocol Deviation|1|||
25106474|NCT02457247|50217545|FG001|Period 1|Significant Protocol Deviation|1|||
25106475|NCT02457247|50217546|FG002|Period 1|Significant Protocol Deviation|0|||
25106476|NCT02457247|50217547|FG003|Period 1|Significant Protocol Deviation|0|||
25106477|NCT02457247|50217544|FG000|Period 1|Voluntary Withdrawal|1|||
25106478|NCT02457247|50217545|FG001|Period 1|Voluntary Withdrawal|0|||
25106479|NCT02457247|50217546|FG002|Period 1|Voluntary Withdrawal|0|||
25106480|NCT02457247|50217547|FG003|Period 1|Voluntary Withdrawal|0|||
25106481|NCT02457247|50217544|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
25106482|NCT02457247|50217545|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
25106483|NCT02457247|50217546|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
25106484|NCT02457247|50217547|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
25106485|NCT02457247|50217544|FG000|Period 2|Significant Protocol Deviation|1|||
25106486|NCT02457247|50217545|FG001|Period 2|Significant Protocol Deviation|0|||
25106487|NCT02457247|50217546|FG002|Period 2|Significant Protocol Deviation|0|||
25106488|NCT02457247|50217547|FG003|Period 2|Significant Protocol Deviation|0|||
25106489|NCT02457247|50217544|FG000|Period 2|Lost to Follow-up|0|||
25106490|NCT02457247|50217545|FG001|Period 2|Lost to Follow-up|1|||
25106491|NCT02457247|50217546|FG002|Period 2|Lost to Follow-up|0|||
25106492|NCT02457247|50217547|FG003|Period 2|Lost to Follow-up|0|||
25106493|NCT02457247|50217544|FG000|Period 2|Voluntary Withdrawal|1|||
25106494|NCT02457247|50217545|FG001|Period 2|Voluntary Withdrawal|1|||
25106495|NCT02457247|50217546|FG002|Period 2|Voluntary Withdrawal|0|||
25106496|NCT02457247|50217547|FG003|Period 2|Voluntary Withdrawal|0|||
25106497|NCT02401867|50217563|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
25106498|NCT02401867|50217563|FG000|Analysis|Cervical assay could not be conducted|9|||
25106499|NCT02198235|50217571|FG000|Overall Study|Lost to Follow-up|3|||
25106500|NCT02198235|50217572|FG001|Overall Study|Lost to Follow-up|2|||
25106501|NCT02198235|50217573|FG002|Overall Study|Lost to Follow-up|2|||
25106502|NCT02253147|50217581|FG000|Overall Study|Protocol Violation|30|||
25106503|NCT02253147|50217581|FG000|Overall Study|Did not consent to study extension|9|||
25106504|NCT02253147|50217581|FG000|Overall Study|Conditional re-treatment at W52|5|||
25106505|NCT02253147|50217581|FG000|Overall Study|Lost to Follow-up|2|||
25106506|NCT02253147|50217581|FG000|Overall Study|Withdrawal by Subject|1|||
25106507|NCT02217501|50217589|FG000|Overall Study|Death|3|||
25106508|NCT02217501|50217590|FG001|Overall Study|Death|4|||
25106509|NCT01649869|50217598|FG000|Overall Study|Family member illness|1|||
25106510|NCT01649869|50217599|FG001|Overall Study|Family member illness|0|||
25106511|NCT01649869|50217598|FG000|Overall Study|Required treatment outside protocol|1|||
25106512|NCT01649869|50217599|FG001|Overall Study|Required treatment outside protocol|0|||
25106513|NCT01649869|50217598|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
25106514|NCT01649869|50217599|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
25106515|NCT02197377|50217609|FG000|Overall Study|Insertion Failure|0|||
25106516|NCT02197377|50217610|FG001|Overall Study|Insertion Failure|3|||
25106517|NCT02400307|50217618|FG000|Overall Study|Enrolled and Never Dosed|1|||
25106518|NCT02400307|50217619|FG001|Overall Study|Enrolled and Never Dosed|0|||
25106519|NCT02196675|50217628|FG000|Overall Study|Withdrawal by Subject|1|||
25106520|NCT02196675|50217629|FG001|Overall Study|Withdrawal by Subject|0|||
25106521|NCT02196675|50217630|FG002|Overall Study|Withdrawal by Subject|0|||
25106522|NCT02196675|50217628|FG000|Overall Study|Intra-operative surgical exclusion|1|||
25106523|NCT02196675|50217629|FG001|Overall Study|Intra-operative surgical exclusion|1|||
25106524|NCT02196675|50217630|FG002|Overall Study|Intra-operative surgical exclusion|0|||
25106525|NCT02196675|50217628|FG000|Overall Study|Protocol Violation|0|||
25106526|NCT02196675|50217629|FG001|Overall Study|Protocol Violation|1|||
25106527|NCT02196675|50217630|FG002|Overall Study|Protocol Violation|0|||
25106528|NCT02196675|50217628|FG000|Overall Study|Death|0|||
25106529|NCT02196675|50217629|FG001|Overall Study|Death|0|||
25106530|NCT02196675|50217630|FG002|Overall Study|Death|1|||
25106531|NCT02399449|50217640|FG000|Overall Study|Withdrawal by Subject|3|||
25106532|NCT02399449|50217641|FG001|Overall Study|Withdrawal by Subject|9|||
25106533|NCT02399449|50217640|FG000|Overall Study|Physician Decision|0|||
25106534|NCT02399449|50217641|FG001|Overall Study|Physician Decision|1|||
25106535|NCT02217345|50217649|FG000|Overall Study|Lost to Follow-up|2|||
25106536|NCT02217345|50217650|FG001|Overall Study|Lost to Follow-up|1|||
25106537|NCT02217345|50217649|FG000|Overall Study|Withdrawal by Subject|3|||
25106538|NCT02217345|50217650|FG001|Overall Study|Withdrawal by Subject|2|||
25106539|NCT02217345|50217649|FG000|Overall Study|Adverse Event|2|||
25106540|NCT02217345|50217650|FG001|Overall Study|Adverse Event|1|||
25106541|NCT02217345|50217649|FG000|Overall Study|Physician Decision|0|||
25106542|NCT02217345|50217650|FG001|Overall Study|Physician Decision|1|||
25106543|NCT01652287|50217658|FG000|Overall Study|Withdrawal by Subject|2|||
25106544|NCT01652287|50217659|FG001|Overall Study|Withdrawal by Subject|0|||
25106545|NCT02251743|50217667|FG000|Overall Study|Withdrawal by Subject|1|||
25106546|NCT02251743|50217668|FG001|Overall Study|Withdrawal by Subject|1|||
25106547|NCT02428855|50217674|FG000|Overall Study|Withdrawal by Subject|2|||
25106548|NCT02428699|50217678|FG000|Washout Period 1|Screen Failure|1|||
25106549|NCT02428699|50217679|FG001|Washout Period 1|Screen Failure|2|||
25106550|NCT02428231|50217692|FG000|Overall Study|Other|10|||
25106551|NCT02428231|50217693|FG001|Overall Study|Other|16|||
25106552|NCT02428231|50217692|FG000|Overall Study|Required Symptomatic Therapy|0|||
25106553|NCT02428231|50217693|FG001|Overall Study|Required Symptomatic Therapy|1|||
25106554|NCT02428231|50217692|FG000|Overall Study|Adverse Event|3|||
25106555|NCT02428231|50217693|FG001|Overall Study|Adverse Event|0|||
25106556|NCT02427841|50217699|FG000|Overall Study|Physician Decision|8|||
25106557|NCT02397889|50217705|FG000|Overall Study|Physician Decision|1|||
25106558|NCT02397889|50217706|FG001|Overall Study|Physician Decision|0|||
25106559|NCT02397655|50217712|FG000|Overall Study|data not completed|1301|||
25106560|NCT02396953|50217719|FG000|Overall Study|Withdrawal by Subject|0|||
25106561|NCT02396953|50217720|FG001|Overall Study|Withdrawal by Subject|0|||
25106562|NCT02396953|50217721|FG002|Overall Study|Withdrawal by Subject|1|||
25106563|NCT02396953|50217719|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
25106564|NCT02396953|50217720|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
25106565|NCT02396953|50217721|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
25106566|NCT02396953|50217719|FG000|Overall Study|Personal Reasons|1|||
25106567|NCT02396953|50217720|FG001|Overall Study|Personal Reasons|1|||
25106568|NCT02396953|50217721|FG002|Overall Study|Personal Reasons|0|||
25106569|NCT02387983|50217736|FG000|Overall Study|Adverse Event|4|||
25106570|NCT02387983|50217736|FG000|Overall Study|Protocol Violation|1|||
25106571|NCT02387983|50217736|FG000|Overall Study|Withdrawal by Subject|2|||
25106572|NCT02395627|50217743|FG000|Overall Study|Withdrawal by Subject|0|||
25106573|NCT02395627|50217744|FG001|Overall Study|Withdrawal by Subject|2|||
25106574|NCT02395627|50217745|FG002|Overall Study|Withdrawal by Subject|0|||
25106575|NCT02395627|50217743|FG000|Overall Study|Did not receive pembrolizumab|3|||
25106576|NCT02395627|50217744|FG001|Overall Study|Did not receive pembrolizumab|1|||
25106577|NCT02395627|50217745|FG002|Overall Study|Did not receive pembrolizumab|0|||
25106578|NCT02395471|50217757|FG000|Overall Study|Lost to Follow-up|2|||
25106579|NCT02395471|50217758|FG001|Overall Study|Lost to Follow-up|0|||
25106580|NCT02395471|50217757|FG000|Overall Study|Withdrawal by Subject|2|||
25106581|NCT02395471|50217758|FG001|Overall Study|Withdrawal by Subject|1|||
25106582|NCT02395471|50217757|FG000|Overall Study|Physician Decision|1|||
25106583|NCT02395471|50217758|FG001|Overall Study|Physician Decision|0|||
25106584|NCT02395471|50217757|FG000|Overall Study|Protocol Violation|0|||
25106585|NCT02395471|50217758|FG001|Overall Study|Protocol Violation|1|||
25106586|NCT02395471|50217757|FG000|Overall Study|Failure to swollow sponge twice|1|||
25106587|NCT02395471|50217758|FG001|Overall Study|Failure to swollow sponge twice|0|||
25106588|NCT02395471|50217757|FG000|Overall Study|Patient did not return for procedure|0|||
25106589|NCT02395471|50217758|FG001|Overall Study|Patient did not return for procedure|1|||
25106590|NCT02395471|50217757|FG000|Overall Study|Subject not eligible|1|||
25106591|NCT02395471|50217758|FG001|Overall Study|Subject not eligible|0|||
25106592|NCT02395081|50217776|FG000|Overall Study|Withdrawal by Subject|1|||
25106593|NCT02395081|50217777|FG001|Overall Study|Withdrawal by Subject|1|||
25106594|NCT02395081|50217778|FG002|Overall Study|Withdrawal by Subject|0|||
25106595|NCT02395081|50217776|FG000|Overall Study|Moved where blood couldn't be collected|4|||
25106596|NCT02395081|50217777|FG001|Overall Study|Moved where blood couldn't be collected|1|||
25106597|NCT02395081|50217778|FG002|Overall Study|Moved where blood couldn't be collected|3|||
25106598|NCT02395081|50217776|FG000|Overall Study|Fetal Loss|2|||
25106599|NCT02395081|50217777|FG001|Overall Study|Fetal Loss|3|||
25106600|NCT02395081|50217778|FG002|Overall Study|Fetal Loss|1|||
25106601|NCT02394925|50217789|FG000|Overall Study|Adverse Event|1|||
25106602|NCT02394925|50217789|FG000|Overall Study|Lens Discomfort|3|||
25106603|NCT02394925|50217789|FG000|Overall Study|Lens handling difficulities|5|||
25106604|NCT02394925|50217789|FG000|Overall Study|Lost to Follow-up|9|||
25261226|NCT01004263|50575908|FG000|Overall Study|Lost to Follow-up|64|||
25008279|NCT03556358|50101179|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
25106605|NCT02394925|50217789|FG000|Overall Study|Protocol Violation|5|||
25106606|NCT02394925|50217789|FG000|Overall Study|No longer meet eligibility criteria|1|||
25106607|NCT02394925|50217789|FG000|Overall Study|Unsatisfactory Visual Response|5|||
25106608|NCT02427607|50217793|FG000|Overall Study|Withdrawal by Subject|1|||
25106609|NCT02426125|50217799|FG000|Overall Study|Lost to Follow-up|12|||
25106610|NCT02426125|50217800|FG001|Overall Study|Lost to Follow-up|10|||
25106611|NCT02426125|50217799|FG000|Overall Study|Protocol Violation|1|||
25106612|NCT02426125|50217800|FG001|Overall Study|Protocol Violation|0|||
25106613|NCT02426125|50217799|FG000|Overall Study|Withdrawal by Subject|16|||
25106614|NCT02426125|50217800|FG001|Overall Study|Withdrawal by Subject|16|||
25106615|NCT02425111|50217808|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
25106616|NCT02425111|50217808|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
25106617|NCT02425111|50217808|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
25106618|NCT02425111|50217808|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
25106619|NCT02425111|50217808|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
25106620|NCT02425111|50217808|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
25106621|NCT02424565|50217813|FG000|Period 1 (D0)|Protocol Violation|0|||
25106622|NCT02424565|50217814|FG001|Period 1 (D0)|Protocol Violation|1|||
25106623|NCT02424253|50217822|FG000|Overall Study|Other, unspecified|1|||
25106624|NCT02424253|50217823|FG001|Overall Study|Other, unspecified|0|||
25106625|NCT02424253|50217822|FG000|Overall Study|Compliance problems|1|||
25106626|NCT02424253|50217823|FG001|Overall Study|Compliance problems|0|||
25106627|NCT02424253|50217822|FG000|Overall Study|Physician Decision|2|||
25106628|NCT02424253|50217823|FG001|Overall Study|Physician Decision|0|||
25106629|NCT02424253|50217822|FG000|Overall Study|Lack of Efficacy|0|||
25106630|NCT02424253|50217823|FG001|Overall Study|Lack of Efficacy|7|||
25106631|NCT02424253|50217822|FG000|Overall Study|Adverse Event|2|||
25106632|NCT02424253|50217823|FG001|Overall Study|Adverse Event|0|||
25106633|NCT02424253|50217822|FG000|Overall Study|Consent withdrawn by subject|4|||
25106634|NCT02424253|50217823|FG001|Overall Study|Consent withdrawn by subject|1|||
25106635|NCT02424253|50217822|FG000|Overall Study|Lost to Follow-up|1|||
25106636|NCT02424253|50217823|FG001|Overall Study|Lost to Follow-up|1|||
25106637|NCT02393755|50217831|FG000|Overall Study|Withdrawal by Subject|0|||
25106638|NCT02393755|50217832|FG001|Overall Study|Withdrawal by Subject|3|||
25106639|NCT02393755|50217831|FG000|Overall Study|Adverse Event|0|||
25106640|NCT02393755|50217832|FG001|Overall Study|Adverse Event|2|||
25106641|NCT02393755|50217831|FG000|Overall Study|Physician Decision|0|||
25106642|NCT02393755|50217832|FG001|Overall Study|Physician Decision|2|||
25106643|NCT02393209|50217839|FG000|Overall Study|Study Terminated by Sponsor|1|||
25106644|NCT02393209|50217840|FG001|Overall Study|Study Terminated by Sponsor|1|||
25106645|NCT02393209|50217841|FG002|Overall Study|Study Terminated by Sponsor|0|||
25106646|NCT02393209|50217842|FG003|Overall Study|Study Terminated by Sponsor|0|||
25106647|NCT02393209|50217839|FG000|Overall Study|Withdrawal by Patient|1|||
25106648|NCT02393209|50217840|FG001|Overall Study|Withdrawal by Patient|0|||
25106649|NCT02393209|50217841|FG002|Overall Study|Withdrawal by Patient|0|||
25106650|NCT02393209|50217842|FG003|Overall Study|Withdrawal by Patient|0|||
25106651|NCT02393209|50217839|FG000|Overall Study|Death|2|||
25106652|NCT02393209|50217840|FG001|Overall Study|Death|2|||
25106653|NCT02393209|50217841|FG002|Overall Study|Death|0|||
25106654|NCT02393209|50217842|FG003|Overall Study|Death|0|||
25106655|NCT02393209|50217839|FG000|Overall Study|Death due to Disease Progression|2|||
25106656|NCT02393209|50217840|FG001|Overall Study|Death due to Disease Progression|2|||
25106657|NCT02393209|50217841|FG002|Overall Study|Death due to Disease Progression|0|||
25106658|NCT02393209|50217842|FG003|Overall Study|Death due to Disease Progression|0|||
25106659|NCT02393209|50217839|FG000|Overall Study|Death from Legionella Infection|0|||
25106660|NCT02393209|50217840|FG001|Overall Study|Death from Legionella Infection|1|||
25106661|NCT02393209|50217841|FG002|Overall Study|Death from Legionella Infection|0|||
25106662|NCT02393209|50217842|FG003|Overall Study|Death from Legionella Infection|0|||
25106663|NCT02393209|50217839|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
25106664|NCT02393209|50217840|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
25106665|NCT02393209|50217841|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
25106666|NCT02393209|50217842|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
25106667|NCT02393209|50217839|FG000|Overall Study|Lost to Follow-up|0|||
25106668|NCT02393209|50217840|FG001|Overall Study|Lost to Follow-up|1|||
25106669|NCT02393209|50217841|FG002|Overall Study|Lost to Follow-up|0|||
25106670|NCT02393209|50217842|FG003|Overall Study|Lost to Follow-up|0|||
25106671|NCT02424097|50217853|FG000|Overall Study|Lost to Follow-up|1|||
25106672|NCT02424097|50217854|FG001|Overall Study|Lost to Follow-up|2|||
25106673|NCT02392507|50217860|FG000|Induction Regimen|Death|3|||
25106674|NCT02392507|50217860|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
25106675|NCT02392507|50217860|FG000|Induction Regimen|Physician Decision|1|||
25106676|NCT02392507|50217860|FG000|Induction Regimen|Withdrawal by Subject|2|||
25106677|NCT02392507|50217860|FG000|Maintenance Regimen|Death|1|||
25106678|NCT02392507|50217860|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
25106679|NCT02386345|50217869|FG000|Overall Study|Not treated|14|||
25106680|NCT02386345|50217869|FG000|Overall Study|Lost to Follow-up|1|||
25106681|NCT02386345|50217869|FG000|Overall Study|Adverse Event|5|||
25106682|NCT02386345|50217869|FG000|Overall Study|Repeat Procedure|10|||
25106683|NCT02386345|50217869|FG000|Overall Study|Did not complete 12-month follow-up|72|||
25106684|NCT01651117|50217877|FG000|Overall Study|Death|2|||
25106685|NCT01651117|50217878|FG001|Overall Study|Death|3|||
25106686|NCT01651117|50217879|FG002|Overall Study|Death|2|||
25106687|NCT01651117|50217880|FG003|Overall Study|Death|2|||
25106688|NCT02386189|50217895|FG000|Overall Study|Lost to Follow-up|2|||
25106689|NCT02386189|50217896|FG001|Overall Study|Lost to Follow-up|3|||
25106690|NCT02386189|50217895|FG000|Overall Study|Withdrawal by Subject|1|||
25106691|NCT02386189|50217896|FG001|Overall Study|Withdrawal by Subject|0|||
25106692|NCT02386189|50217895|FG000|Overall Study|Death|1|||
25106693|NCT02386189|50217896|FG001|Overall Study|Death|0|||
25106694|NCT02385799|50217904|FG000|Overall Study|Lost to Follow-up|1|||
25106695|NCT02385799|50217905|FG001|Overall Study|Lost to Follow-up|2|||
25106696|NCT02385799|50217904|FG000|Overall Study|Adverse Event|4|||
25106697|NCT02385799|50217905|FG001|Overall Study|Adverse Event|2|||
25106698|NCT02385799|50217904|FG000|Overall Study|Withdrawal by Subject|0|||
25106699|NCT02385799|50217905|FG001|Overall Study|Withdrawal by Subject|4|||
25106700|NCT02422303|50217913|FG000|Overall Study|Lost to Follow-up|1|||
25106701|NCT02422303|50217914|FG001|Overall Study|Lost to Follow-up|1|||
25106702|NCT02392195|50217920|FG000|Overall Study|Lost to Follow-up|4|||
25106703|NCT02392195|50217920|FG000|Overall Study|Withdrawal by Subject|4|||
25106704|NCT02391961|50217926|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
25106705|NCT02391961|50217927|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
25106706|NCT02391961|50217926|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
25106707|NCT02391961|50217927|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
25106708|NCT02391961|50217926|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
25106709|NCT02391961|50217927|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
25106710|NCT02384941|50217936|FG000|Overall Study|Adverse Event|11|||
25106711|NCT02384941|50217937|FG001|Overall Study|Adverse Event|13|||
25106712|NCT02384941|50217938|FG002|Overall Study|Adverse Event|17|||
25106713|NCT02384941|50217936|FG000|Overall Study|Lost to Follow-up|3|||
25106714|NCT02384941|50217937|FG001|Overall Study|Lost to Follow-up|2|||
25106715|NCT02384941|50217938|FG002|Overall Study|Lost to Follow-up|1|||
25106716|NCT02384941|50217936|FG000|Overall Study|Non-Compliance With Study Drug|2|||
25106717|NCT02384941|50217937|FG001|Overall Study|Non-Compliance With Study Drug|0|||
25106718|NCT02384941|50217938|FG002|Overall Study|Non-Compliance With Study Drug|1|||
25106719|NCT02384941|50217936|FG000|Overall Study|Physician Decision|1|||
25106720|NCT02384941|50217937|FG001|Overall Study|Physician Decision|1|||
25106721|NCT02384941|50217938|FG002|Overall Study|Physician Decision|0|||
25106722|NCT02384941|50217936|FG000|Overall Study|Protocol Violation|3|||
25106723|NCT02384941|50217937|FG001|Overall Study|Protocol Violation|0|||
25106724|NCT02384941|50217938|FG002|Overall Study|Protocol Violation|0|||
25106725|NCT02384941|50217936|FG000|Overall Study|Withdrawal by Subject|26|||
25106726|NCT02384941|50217937|FG001|Overall Study|Withdrawal by Subject|19|||
25106727|NCT02384941|50217938|FG002|Overall Study|Withdrawal by Subject|20|||
25106728|NCT02384941|50217936|FG000|Overall Study|Pregnancy|0|||
25106729|NCT02384941|50217937|FG001|Overall Study|Pregnancy|0|||
25106730|NCT02384941|50217938|FG002|Overall Study|Pregnancy|1|||
25106731|NCT02384941|50217936|FG000|Overall Study|Other than specified above|4|||
25106732|NCT02384941|50217937|FG001|Overall Study|Other than specified above|0|||
25106733|NCT02384941|50217938|FG002|Overall Study|Other than specified above|1|||
25106734|NCT02384395|50217947|FG000|Overall Study|Physician Decision|4|||
25106735|NCT02384395|50217947|FG000|Overall Study|Withdrawal by Subject|3|||
25106736|NCT02384395|50217947|FG000|Overall Study|Lost to Follow-up|3|||
25106737|NCT02420353|50217953|FG000|Overall Study|Withdrawal by Subject|0|||
25106738|NCT02420353|50217954|FG001|Overall Study|Withdrawal by Subject|1|||
25106739|NCT02391337|50217962|FG000|6 Months Follow-up|Death|5|||
25106740|NCT02391337|50217963|FG001|6 Months Follow-up|Death|4|||
25106741|NCT02391337|50217962|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
25106742|NCT02391337|50217963|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
25106743|NCT02391337|50217962|FG000|12 Months Follow-up|Death|2|||
25106744|NCT02391337|50217963|FG001|12 Months Follow-up|Death|0|||
25106745|NCT02391337|50217962|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
25106746|NCT02391337|50217963|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
25106747|NCT02391337|50217962|FG000|12 Months Follow-up|Lost to Follow-up|0|||
25106748|NCT02391337|50217963|FG001|12 Months Follow-up|Lost to Follow-up|2|||
25106749|NCT02382991|50217971|FG000|Overall Study|Adverse Event|1|||
25106750|NCT02382991|50217972|FG001|Overall Study|Adverse Event|2|||
25106751|NCT02382991|50217971|FG000|Overall Study|Lost to Follow-up|1|||
25106752|NCT02382991|50217972|FG001|Overall Study|Lost to Follow-up|0|||
25106753|NCT02382991|50217971|FG000|Overall Study|Withdrawal by Subject|0|||
25106754|NCT02382991|50217972|FG001|Overall Study|Withdrawal by Subject|1|||
25106755|NCT02390557|50217980|FG000|Wave 2|Survey non-respondent|72|||
25106756|NCT02390557|50217981|FG001|Wave 2|Survey non-respondent|41|||
25106757|NCT02390557|50217982|FG002|Wave 2|Survey non-respondent|23|||
25106758|NCT01649791|50217990|FG000|Overall Study|Disease Progression|2|||
25106759|NCT01649791|50217990|FG000|Overall Study|Adverse Event|1|||
25106760|NCT01649557|50217997|FG000|Overall Study|Lost to Follow-up|5|||
25106761|NCT01649557|50217998|FG001|Overall Study|Lost to Follow-up|0|||
25106762|NCT01649557|50217999|FG002|Overall Study|Lost to Follow-up|3|||
25106763|NCT01649557|50217997|FG000|Overall Study|Adverse Event|7|||
25106764|NCT01649557|50217998|FG001|Overall Study|Adverse Event|5|||
25106765|NCT01649557|50217999|FG002|Overall Study|Adverse Event|1|||
25106766|NCT01649557|50217997|FG000|Overall Study|Met withdrawal criteria|4|||
25106767|NCT01649557|50217998|FG001|Overall Study|Met withdrawal criteria|0|||
25106768|NCT01649557|50217999|FG002|Overall Study|Met withdrawal criteria|0|||
25106769|NCT01649557|50217997|FG000|Overall Study|Physician Decision|8|||
25106770|NCT01649557|50217998|FG001|Overall Study|Physician Decision|2|||
25106771|NCT01649557|50217999|FG002|Overall Study|Physician Decision|1|||
25106772|NCT01649557|50217997|FG000|Overall Study|Withdrawal by Subject|15|||
25106773|NCT01649557|50217998|FG001|Overall Study|Withdrawal by Subject|5|||
25177221|NCT01524133|50321323|FG002|Treatment Phase|Lost to Follow-up|2|||
25177222|NCT01524133|50321321|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
25177223|NCT01524133|50321322|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
25177224|NCT01524133|50321323|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
25177225|NCT01524133|50321321|FG000|Overall Study 52 Weeks|Physician Decision|1|||
25177226|NCT01524133|50321322|FG001|Overall Study 52 Weeks|Physician Decision|0|||
25177227|NCT01524133|50321323|FG002|Overall Study 52 Weeks|Physician Decision|2|||
25177228|NCT01524133|50321321|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
25177229|NCT01524133|50321322|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
25177230|NCT01524133|50321323|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
25177231|NCT04304534|50321348|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
25177232|NCT04304534|50321349|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
25177233|NCT04304534|50321350|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
25177234|NCT04304534|50321351|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
25177235|NCT04304534|50321348|FG000|Overall Study|Non-Compliance with study drug|0|||
25177236|NCT04304534|50321349|FG001|Overall Study|Non-Compliance with study drug|1|||
25177237|NCT04304534|50321350|FG002|Overall Study|Non-Compliance with study drug|1|||
25177238|NCT04304534|50321351|FG003|Overall Study|Non-Compliance with study drug|1|||
25177239|NCT04304534|50321348|FG000|Overall Study|Lost to Follow-up|0|||
25177240|NCT04304534|50321349|FG001|Overall Study|Lost to Follow-up|1|||
25177241|NCT04304534|50321350|FG002|Overall Study|Lost to Follow-up|2|||
25177242|NCT04304534|50321351|FG003|Overall Study|Lost to Follow-up|3|||
25177243|NCT04304534|50321348|FG000|Overall Study|Unspecific|4|||
25177244|NCT04304534|50321349|FG001|Overall Study|Unspecific|2|||
25177245|NCT04304534|50321350|FG002|Overall Study|Unspecific|2|||
25177246|NCT04304534|50321351|FG003|Overall Study|Unspecific|2|||
25177247|NCT04304534|50321348|FG000|Overall Study|Technical Problems|2|||
25177248|NCT04304534|50321349|FG001|Overall Study|Technical Problems|2|||
25177249|NCT04304534|50321350|FG002|Overall Study|Technical Problems|3|||
25177250|NCT04304534|50321351|FG003|Overall Study|Technical Problems|4|||
25177251|NCT04304534|50321348|FG000|Overall Study|Death|7|||
25177252|NCT04304534|50321349|FG001|Overall Study|Death|2|||
25177253|NCT04304534|50321350|FG002|Overall Study|Death|4|||
25177254|NCT04304534|50321351|FG003|Overall Study|Death|3|||
25177255|NCT04304534|50321348|FG000|Overall Study|Withdrawal by Subject|7|||
25177256|NCT04304534|50321349|FG001|Overall Study|Withdrawal by Subject|2|||
25177257|NCT04304534|50321350|FG002|Overall Study|Withdrawal by Subject|7|||
25177258|NCT04304534|50321351|FG003|Overall Study|Withdrawal by Subject|4|||
25261227|NCT01004263|50575908|FG000|Overall Study|Lack of Efficacy|13|||
25067269|NCT02576847|50172844|FG000|Overall Study|Withdrawal by Subject|78|||
25067270|NCT02576847|50172844|FG000|Overall Study|Other|5|||
25067271|NCT02135029|50172860|FG000|Overall Study|Adverse Event|2|||
25067272|NCT02135029|50172861|FG001|Overall Study|Adverse Event|2|||
25067273|NCT02135029|50172862|FG002|Overall Study|Adverse Event|2|||
25067274|NCT02135029|50172860|FG000|Overall Study|Lost to Follow-up|0|||
25067275|NCT02135029|50172861|FG001|Overall Study|Lost to Follow-up|1|||
25067276|NCT02135029|50172862|FG002|Overall Study|Lost to Follow-up|0|||
25067277|NCT02135029|50172860|FG000|Overall Study|Withdrawal by Subject|2|||
25067278|NCT02135029|50172861|FG001|Overall Study|Withdrawal by Subject|0|||
25067279|NCT02135029|50172862|FG002|Overall Study|Withdrawal by Subject|1|||
25067280|NCT02135029|50172860|FG000|Overall Study|Other|0|||
25067281|NCT02135029|50172861|FG001|Overall Study|Other|1|||
25067282|NCT02135029|50172862|FG002|Overall Study|Other|0|||
25067283|NCT02135029|50172860|FG000|Overall Study|Death|0|||
25067284|NCT02135029|50172861|FG001|Overall Study|Death|1|||
25067285|NCT02135029|50172862|FG002|Overall Study|Death|0|||
25067286|NCT02842151|50172871|FG000|Overall Study|Adverse Event|1|||
25067287|NCT02842151|50172871|FG000|Overall Study|Subject moved too far away|1|||
25067288|NCT02842073|50172877|FG000|Overall Study|Withdrawal by Subject|1|||
25067289|NCT02784535|50172881|FG000|Overall Study|Adverse Event|1|||
25067290|NCT02784535|50172882|FG001|Overall Study|Adverse Event|0|||
25067291|NCT02784535|50172881|FG000|Overall Study|Withdrawal by Subject|0|||
25067292|NCT02784535|50172882|FG001|Overall Study|Withdrawal by Subject|1|||
25067293|NCT02784535|50172881|FG000|Overall Study|Physician Decision|0|||
25067294|NCT02784535|50172882|FG001|Overall Study|Physician Decision|1|||
25067295|NCT01367275|50172891|FG000|Overall Study|Ineligible|1|||
25067296|NCT01367275|50172891|FG000|Overall Study|Disease Progression|2|||
25067297|NCT02842853|50172899|FG000|Overall Study|Non-compliance with the protocol|3|||
25177259|NCT04304534|50321348|FG000|Overall Study|Physician Decision|4|||
25177260|NCT04304534|50321349|FG001|Overall Study|Physician Decision|9|||
25177261|NCT04304534|50321350|FG002|Overall Study|Physician Decision|9|||
25177262|NCT04304534|50321351|FG003|Overall Study|Physician Decision|5|||
25177263|NCT04304534|50321348|FG000|Overall Study|Subject Decision|34|||
25177264|NCT04304534|50321349|FG001|Overall Study|Subject Decision|25|||
25177265|NCT04304534|50321350|FG002|Overall Study|Subject Decision|25|||
25177266|NCT04304534|50321351|FG003|Overall Study|Subject Decision|26|||
25177267|NCT04304534|50321348|FG000|Overall Study|Adverse Event|35|||
25177268|NCT04304534|50321349|FG001|Overall Study|Adverse Event|40|||
25177269|NCT04304534|50321350|FG002|Overall Study|Adverse Event|39|||
25177270|NCT04304534|50321351|FG003|Overall Study|Adverse Event|44|||
25106774|NCT01649557|50217999|FG002|Overall Study|Withdrawal by Subject|4|||
25106775|NCT01649557|50217997|FG000|Overall Study|Protocol deviation|0|||
25106776|NCT01649557|50217998|FG001|Overall Study|Protocol deviation|2|||
25106777|NCT01649557|50217999|FG002|Overall Study|Protocol deviation|0|||
25106778|NCT01649557|50217997|FG000|Overall Study|Lack of Efficacy|5|||
25106779|NCT01649557|50217998|FG001|Overall Study|Lack of Efficacy|0|||
25106780|NCT01649557|50217999|FG002|Overall Study|Lack of Efficacy|0|||
25106781|NCT02390245|50218007|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
25106782|NCT02390245|50218008|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
25106783|NCT02390245|50218009|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
25106784|NCT02390245|50218007|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
25106785|NCT02390245|50218008|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
25106786|NCT02390245|50218009|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
25106787|NCT02390167|50218018|FG000|Overall Study|Lost to Follow-up|1|||
25106788|NCT02347657|50218028|FG000|Overall Study|Physician Decision|0|||
25106789|NCT02347657|50218029|FG001|Overall Study|Physician Decision|1|||
25106790|NCT02347657|50218028|FG000|Overall Study|Adverse Event|8|||
25106791|NCT02347657|50218029|FG001|Overall Study|Adverse Event|4|||
25106792|NCT02347657|50218028|FG000|Overall Study|Withdrawal by Subject|6|||
25106793|NCT02347657|50218029|FG001|Overall Study|Withdrawal by Subject|7|||
25106794|NCT02347657|50218028|FG000|Overall Study|Randomized but not treated|1|||
25106795|NCT02347657|50218029|FG001|Overall Study|Randomized but not treated|0|||
25106796|NCT02347657|50218028|FG000|Overall Study|Other|3|||
25106797|NCT02347657|50218029|FG001|Overall Study|Other|3|||
25106798|NCT02347189|50218036|FG000|Overall Study|No implant attempted of study device|9|||
25106799|NCT02347189|50218036|FG000|Overall Study|No primary outcome data available|2|||
25106800|NCT02382133|50218051|FG000|Overall Study|Death|22|||
25106801|NCT02382133|50218051|FG000|Overall Study|transfer out of ICU|4|||
25106802|NCT02382133|50218051|FG000|Overall Study|Physician Decision|2|||
25106803|NCT02382133|50218051|FG000|Overall Study|arterial catheter loss|4|||
25106804|NCT02382133|50218051|FG000|Overall Study|pressure injury both sites|1|||
25106805|NCT02346877|50218057|FG000|Overall Study|Adverse Event|1|||
25106806|NCT02346877|50218058|FG001|Overall Study|Adverse Event|0|||
25106807|NCT02346877|50218057|FG000|Overall Study|Administrative Decision|1|||
25106808|NCT02346877|50218058|FG001|Overall Study|Administrative Decision|0|||
25106809|NCT02346877|50218057|FG000|Overall Study|Sponsor Decision|12|||
25106810|NCT02346877|50218058|FG001|Overall Study|Sponsor Decision|0|||
25106811|NCT02346877|50218057|FG000|Overall Study|Missing|5|||
25106812|NCT02346877|50218058|FG001|Overall Study|Missing|0|||
25106813|NCT02346721|50218064|FG000|Overall Study|Withdrew Consent|3|||
25106814|NCT02346721|50218064|FG000|Overall Study|Lack of Efficacy|1|||
25106815|NCT02389621|50218072|FG000|Treatment Period|Withdrawal by Subject|1|||
25106816|NCT02389621|50218073|FG001|Treatment Period|Withdrawal by Subject|1|||
25106817|NCT02389621|50218072|FG000|Posttreatment Period|Adverse Event|3|||
25106818|NCT02389621|50218073|FG001|Posttreatment Period|Adverse Event|1|||
25106819|NCT02389621|50218072|FG000|Posttreatment Period|Withdrawal by Subject|3|||
25106820|NCT02389621|50218073|FG001|Posttreatment Period|Withdrawal by Subject|2|||
25106821|NCT02389621|50218072|FG000|Posttreatment Period|Lost to Follow-up|1|||
25106822|NCT02389621|50218073|FG001|Posttreatment Period|Lost to Follow-up|1|||
25106823|NCT02389621|50218072|FG000|Posttreatment Period|Other - Miscellaneous|2|||
25106824|NCT02389621|50218073|FG001|Posttreatment Period|Other - Miscellaneous|0|||
25106825|NCT02388997|50218085|FG000|Overall Study|Adverse Event|1|||
25106826|NCT02388997|50218086|FG001|Overall Study|Adverse Event|2|||
25106827|NCT02388997|50218085|FG000|Overall Study|Withdrawal by Subject|2|||
25106828|NCT02388997|50218086|FG001|Overall Study|Withdrawal by Subject|1|||
25106829|NCT02388997|50218085|FG000|Overall Study|Lung function exclusion criteria|0|||
25106830|NCT02388997|50218086|FG001|Overall Study|Lung function exclusion criteria|2|||
25106831|NCT02388997|50218085|FG000|Overall Study|Tested positive for virus during run-in|0|||
25106832|NCT02388997|50218086|FG001|Overall Study|Tested positive for virus during run-in|1|||
25106833|NCT02388763|50218092|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
25106834|NCT02388763|50218093|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
25177271|NCT04223609|50321364|FG000|Overall Study|Adverse Event|0|||
25177272|NCT04223609|50321365|FG001|Overall Study|Adverse Event|1|||
25177273|NCT04223609|50321364|FG000|Overall Study|Missed last visit|0|||
25177274|NCT04223609|50321365|FG001|Overall Study|Missed last visit|1|||
25106835|NCT02388763|50218092|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
25106836|NCT02388763|50218093|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
25106837|NCT02388295|50218105|FG000|Dose Escalation Week 1|Adverse Event|1|||
25106838|NCT02388295|50218106|FG001|Dose Escalation Week 1|Adverse Event|2|||
25106839|NCT02388295|50218107|FG002|Dose Escalation Week 1|Adverse Event|1|||
25106840|NCT02388295|50218105|FG000|Dose Escalation Week 1|Determined not eligible|1|||
25106841|NCT02388295|50218106|FG001|Dose Escalation Week 1|Determined not eligible|1|||
25106842|NCT02388295|50218107|FG002|Dose Escalation Week 1|Determined not eligible|1|||
25106843|NCT02388295|50218105|FG000|Dose Escalation Week 2|Protocol Violation|0|||
25106844|NCT02388295|50218106|FG001|Dose Escalation Week 2|Protocol Violation|1|||
25106845|NCT02388295|50218107|FG002|Dose Escalation Week 2|Protocol Violation|0|||
25106846|NCT02388295|50218105|FG000|Dose Escalation Week 2|Determined not eligible|1|||
25106847|NCT02388295|50218106|FG001|Dose Escalation Week 2|Determined not eligible|1|||
25106848|NCT02388295|50218107|FG002|Dose Escalation Week 2|Determined not eligible|1|||
25106849|NCT02388295|50218105|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
25106850|NCT02388295|50218106|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
25106851|NCT02388295|50218107|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
25106852|NCT02345161|50218117|FG000|Overall Study|Withdrawal by Subject|25|||
25106853|NCT02345161|50218118|FG001|Overall Study|Withdrawal by Subject|33|||
25106854|NCT02345161|50218117|FG000|Overall Study|Adverse Event|16|||
25106855|NCT02345161|50218118|FG001|Overall Study|Adverse Event|19|||
25106856|NCT02345161|50218117|FG000|Overall Study|Physician Decision|4|||
25106857|NCT02345161|50218118|FG001|Overall Study|Physician Decision|4|||
25106858|NCT02345161|50218117|FG000|Overall Study|Lost to Follow-up|0|||
25106859|NCT02345161|50218118|FG001|Overall Study|Lost to Follow-up|1|||
25106860|NCT02251275|50218134|FG000|Overall Study|Adverse Event|23|||
25106861|NCT02251275|50218135|FG001|Overall Study|Adverse Event|60|||
25106862|NCT02251275|50218136|FG002|Overall Study|Adverse Event|28|||
25106863|NCT02251275|50218137|FG003|Overall Study|Adverse Event|0|||
25106864|NCT02251275|50218138|FG004|Overall Study|Adverse Event|0|||
25106865|NCT02251275|50218134|FG000|Overall Study|Lost to Follow-up|5|||
25106866|NCT02251275|50218135|FG001|Overall Study|Lost to Follow-up|6|||
25106867|NCT02251275|50218136|FG002|Overall Study|Lost to Follow-up|4|||
25106868|NCT02251275|50218137|FG003|Overall Study|Lost to Follow-up|0|||
25106869|NCT02251275|50218138|FG004|Overall Study|Lost to Follow-up|0|||
25106870|NCT02251275|50218134|FG000|Overall Study|Physician Decision|19|||
25106871|NCT02251275|50218135|FG001|Overall Study|Physician Decision|30|||
25106872|NCT02251275|50218136|FG002|Overall Study|Physician Decision|26|||
25106873|NCT02251275|50218137|FG003|Overall Study|Physician Decision|0|||
25106874|NCT02251275|50218138|FG004|Overall Study|Physician Decision|1|||
25106875|NCT02251275|50218134|FG000|Overall Study|Protocol Deviation|0|||
25106876|NCT02251275|50218135|FG001|Overall Study|Protocol Deviation|0|||
25106877|NCT02251275|50218136|FG002|Overall Study|Protocol Deviation|1|||
25106878|NCT02251275|50218137|FG003|Overall Study|Protocol Deviation|0|||
25106879|NCT02251275|50218138|FG004|Overall Study|Protocol Deviation|0|||
25106880|NCT02251275|50218134|FG000|Overall Study|Withdrawal by Subject|25|||
25106881|NCT02251275|50218135|FG001|Overall Study|Withdrawal by Subject|51|||
25106882|NCT02251275|50218136|FG002|Overall Study|Withdrawal by Subject|35|||
25106883|NCT02251275|50218137|FG003|Overall Study|Withdrawal by Subject|1|||
25106884|NCT02251275|50218138|FG004|Overall Study|Withdrawal by Subject|0|||
25106885|NCT02379637|50218152|FG000|Overall Study|Protocol Violation|0|||
25106886|NCT02379637|50218153|FG001|Overall Study|Protocol Violation|1|||
25106887|NCT02379637|50218152|FG000|Overall Study|Adverse Event|1|||
25106888|NCT02379637|50218153|FG001|Overall Study|Adverse Event|0|||
25106889|NCT02379637|50218152|FG000|Overall Study|Withdrawal by Subject|1|||
25106890|NCT02379637|50218153|FG001|Overall Study|Withdrawal by Subject|0|||
25106891|NCT02195583|50218159|FG000|Overall Study|Lost to Follow-up|1|||
25106892|NCT02195583|50218159|FG000|Overall Study|Withdrawal by Subject|4|||
25106893|NCT02195583|50218159|FG000|Overall Study|Adverse Event|2|||
25106894|NCT02195583|50218159|FG000|Overall Study|Other Reason|2|||
25106895|NCT02379091|50218178|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
25106896|NCT02379091|50218179|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
25106897|NCT02379091|50218180|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
25106898|NCT02379091|50218181|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
25261228|NCT01004263|50575908|FG000|Overall Study|Pregnancy|2|||
25106899|NCT02379091|50218178|FG000|Overall Study|Principal Investigator Discretion|0|||
25106900|NCT02379091|50218179|FG001|Overall Study|Principal Investigator Discretion|1|||
25106901|NCT02379091|50218180|FG002|Overall Study|Principal Investigator Discretion|0|||
25106902|NCT02379091|50218181|FG003|Overall Study|Principal Investigator Discretion|0|||
25106903|NCT02379091|50218178|FG000|Overall Study|Lost to Follow-up|0|||
25106904|NCT02379091|50218179|FG001|Overall Study|Lost to Follow-up|0|||
25106905|NCT02379091|50218180|FG002|Overall Study|Lost to Follow-up|0|||
25106906|NCT02379091|50218181|FG003|Overall Study|Lost to Follow-up|1|||
25106907|NCT02379091|50218178|FG000|Overall Study|Voluntary Withdrawal|2|||
25106908|NCT02379091|50218179|FG001|Overall Study|Voluntary Withdrawal|5|||
25106909|NCT02379091|50218180|FG002|Overall Study|Voluntary Withdrawal|2|||
25106910|NCT02379091|50218181|FG003|Overall Study|Voluntary Withdrawal|4|||
25106911|NCT02379091|50218178|FG000|Overall Study|Study Termination|7|||
25106912|NCT02379091|50218179|FG001|Overall Study|Study Termination|2|||
25106913|NCT02379091|50218180|FG002|Overall Study|Study Termination|5|||
25106914|NCT02379091|50218181|FG003|Overall Study|Study Termination|8|||
25106915|NCT02379091|50218178|FG000|Overall Study|Lack of Efficacy|3|||
25106916|NCT02379091|50218179|FG001|Overall Study|Lack of Efficacy|0|||
25106917|NCT02379091|50218180|FG002|Overall Study|Lack of Efficacy|0|||
25106918|NCT02379091|50218181|FG003|Overall Study|Lack of Efficacy|0|||
25106919|NCT02378935|50218200|FG000|Overall Study|Lack of Efficacy|10|||
25106920|NCT02378935|50218201|FG001|Overall Study|Lack of Efficacy|0|||
25106921|NCT02378935|50218202|FG002|Overall Study|Lack of Efficacy|2|||
25106922|NCT02378935|50218203|FG003|Overall Study|Lack of Efficacy|6|||
25106923|NCT02378935|50218204|FG004|Overall Study|Lack of Efficacy|0|||
25106924|NCT02378935|50218205|FG005|Overall Study|Lack of Efficacy|0|||
25106925|NCT02378935|50218206|FG006|Overall Study|Lack of Efficacy|0|||
25106926|NCT02378935|50218200|FG000|Overall Study|Death|0|||
25106927|NCT02378935|50218201|FG001|Overall Study|Death|0|||
25106928|NCT02378935|50218202|FG002|Overall Study|Death|1|||
25106929|NCT02378935|50218203|FG003|Overall Study|Death|0|||
25106930|NCT02378935|50218204|FG004|Overall Study|Death|0|||
25106931|NCT02378935|50218205|FG005|Overall Study|Death|0|||
25106932|NCT02378935|50218206|FG006|Overall Study|Death|0|||
25106933|NCT02250651|50218225|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
25106934|NCT02250651|50218226|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
25106935|NCT02250651|50218227|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
25106936|NCT02250651|50218225|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
25106937|NCT02250651|50218226|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
25106938|NCT02250651|50218227|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
25106939|NCT02250651|50218225|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
25106940|NCT02250651|50218226|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
25106941|NCT02250651|50218227|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
25106942|NCT02250651|50218225|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
25106943|NCT02250651|50218226|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
25106944|NCT02250651|50218227|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
25106945|NCT02250651|50218225|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
25106946|NCT02250651|50218226|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
25106947|NCT02250651|50218227|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
25106948|NCT02250651|50218225|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
25106949|NCT02250651|50218226|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
25106950|NCT02250651|50218227|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
25106951|NCT02250651|50218225|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
25106952|NCT02250651|50218226|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
25106953|NCT02250651|50218227|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
25106954|NCT02250651|50218225|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
25106955|NCT02250651|50218226|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
25106956|NCT02250651|50218227|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
25106957|NCT02250651|50218225|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
25106958|NCT02250651|50218226|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
25106959|NCT02250651|50218227|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
25106960|NCT02250651|50218225|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
25106961|NCT02250651|50218226|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
25106962|NCT02250651|50218227|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
25106963|NCT02250651|50218225|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
25106964|NCT02250651|50218226|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
25106965|NCT02250651|50218227|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
25106966|NCT02250651|50218225|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
25106967|NCT02250651|50218226|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
25106968|NCT02250651|50218227|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
25106969|NCT02250651|50218225|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
25106970|NCT02250651|50218226|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
25106971|NCT02250651|50218227|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
25106972|NCT02250651|50218225|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
25106973|NCT02250651|50218226|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
25106974|NCT02250651|50218227|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
25106975|NCT02250651|50218225|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
25261229|NCT01004263|50575908|FG000|Overall Study|Physician Decision|15|||
25261230|NCT01004263|50575908|FG000|Overall Study|Lack of Qualifying Event|2|||
25261231|NCT01308762|50575915|FG000|Overall Study|Protocol Violation|0|||
25261232|NCT01308762|50575916|FG001|Overall Study|Protocol Violation|1|||
25261233|NCT01308762|50575917|FG002|Overall Study|Protocol Violation|0|||
25106976|NCT02250651|50218226|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
25106977|NCT02250651|50218227|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
25106978|NCT02377921|50218237|FG000|Overall Study|Subject non-compliance|1|||
25106979|NCT02377921|50218238|FG001|Overall Study|Subject non-compliance|1|||
25106980|NCT02311153|50218246|FG000|Overall Study|Lost to Follow-up|5|||
25106981|NCT02311153|50218247|FG001|Overall Study|Lost to Follow-up|7|||
25106982|NCT02195427|50218255|FG000|Overall Study|Did not consent to study extension|13|||
25106983|NCT02195427|50218256|FG001|Overall Study|Did not consent to study extension|9|||
25106984|NCT02195427|50218255|FG000|Overall Study|Withdrawal by Subject|4|||
25106985|NCT02195427|50218256|FG001|Overall Study|Withdrawal by Subject|2|||
25106986|NCT02195427|50218255|FG000|Overall Study|Lost to Follow-up|0|||
25106987|NCT02195427|50218256|FG001|Overall Study|Lost to Follow-up|1|||
25106988|NCT02195427|50218255|FG000|Overall Study|Protocol Violation|7|||
25106989|NCT02195427|50218256|FG001|Overall Study|Protocol Violation|14|||
25106990|NCT02195427|50218255|FG000|Overall Study|Conditional re-treatment at W52|2|||
25106991|NCT02195427|50218256|FG001|Overall Study|Conditional re-treatment at W52|1|||
25106992|NCT02214225|50218269|FG000|Overall Study|Lost to Follow-up|46|||
25106993|NCT02214225|50218270|FG001|Overall Study|Lost to Follow-up|18|||
25106994|NCT02214225|50218271|FG002|Overall Study|Lost to Follow-up|18|||
25106995|NCT02214225|50218269|FG000|Overall Study|Withdrawal by Subject|2|||
25106996|NCT02214225|50218270|FG001|Overall Study|Withdrawal by Subject|0|||
25106997|NCT02214225|50218271|FG002|Overall Study|Withdrawal by Subject|2|||
25106998|NCT02214225|50218269|FG000|Overall Study|Death|5|||
25106999|NCT02214225|50218270|FG001|Overall Study|Death|0|||
25107000|NCT02214225|50218271|FG002|Overall Study|Death|1|||
25107001|NCT02214225|50218269|FG000|Overall Study|randomized in error, not vaccinated|2|||
25107002|NCT02214225|50218270|FG001|Overall Study|randomized in error, not vaccinated|1|||
25107003|NCT02214225|50218271|FG002|Overall Study|randomized in error, not vaccinated|1|||
25107004|NCT02250183|50218302|FG000|Overall Study|Withdrawal by Subject|2|||
25107005|NCT02250183|50218302|FG000|Overall Study|Adverse Event|5|||
25107006|NCT02250183|50218302|FG000|Overall Study|Lost to Follow-up|1|||
25107007|NCT02249949|50218309|FG000|Overall Study|Cancelled prior to treatment|2|||
25107008|NCT02249091|50218315|FG000|Overall Study|Lack of Efficacy|8|||
25107009|NCT02249091|50218316|FG001|Overall Study|Lack of Efficacy|3|||
25107010|NCT02249091|50218315|FG000|Overall Study|Physician Decision|4|||
25107011|NCT02249091|50218316|FG001|Overall Study|Physician Decision|1|||
25107012|NCT02249091|50218315|FG000|Overall Study|Withdrawal by Subject|2|||
25107013|NCT02249091|50218316|FG001|Overall Study|Withdrawal by Subject|2|||
25107014|NCT02249091|50218315|FG000|Overall Study|Death|3|||
25107015|NCT02249091|50218316|FG001|Overall Study|Death|4|||
25107016|NCT02249091|50218315|FG000|Overall Study|Adverse Event|1|||
25107017|NCT02249091|50218316|FG001|Overall Study|Adverse Event|0|||
25107018|NCT02249091|50218315|FG000|Overall Study|Stable disease with following SCT|0|||
25107019|NCT02249091|50218316|FG001|Overall Study|Stable disease with following SCT|1|||
25107020|NCT02249091|50218315|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
25107021|NCT02249091|50218316|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
25107022|NCT02249091|50218315|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
25107023|NCT02249091|50218316|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
25107024|NCT02249091|50218315|FG000|Overall Study|Refractory AML|1|||
25107025|NCT02249091|50218316|FG001|Overall Study|Refractory AML|1|||
25107026|NCT02248857|50218325|FG000|3 Month|Withdrawal by Subject|9|||
25107027|NCT02248857|50218326|FG001|3 Month|Withdrawal by Subject|3|||
25107028|NCT02248857|50218327|FG002|3 Month|Withdrawal by Subject|4|||
25107029|NCT02248857|50218325|FG000|3 Month|Unable to reach for 3 month|35|||
25107030|NCT02248857|50218326|FG001|3 Month|Unable to reach for 3 month|29|||
25107031|NCT02248857|50218327|FG002|3 Month|Unable to reach for 3 month|26|||
25107032|NCT02248857|50218325|FG000|3 Month|Partially completed, unable to finish|2|||
25107033|NCT02248857|50218326|FG001|3 Month|Partially completed, unable to finish|2|||
25107034|NCT02248857|50218327|FG002|3 Month|Partially completed, unable to finish|1|||
25107035|NCT02248857|50218325|FG000|6 Month|Lost to Follow-up|27|||
25107036|NCT02248857|50218326|FG001|6 Month|Lost to Follow-up|26|||
25107037|NCT02248857|50218327|FG002|6 Month|Lost to Follow-up|15|||
25107038|NCT02248857|50218325|FG000|6 Month|Partially completed, unable to finish|0|||
25107039|NCT02248857|50218326|FG001|6 Month|Partially completed, unable to finish|1|||
25107040|NCT02248857|50218327|FG002|6 Month|Partially completed, unable to finish|0|||
25107041|NCT02248857|50218325|FG000|6 Month|Withdrawal by Subject|0|||
25107042|NCT02248857|50218326|FG001|6 Month|Withdrawal by Subject|2|||
25107043|NCT02248857|50218327|FG002|6 Month|Withdrawal by Subject|2|||
25107044|NCT02248857|50218325|FG000|6 Month|Death|1|||
25107045|NCT02248857|50218326|FG001|6 Month|Death|0|||
25107046|NCT02248857|50218327|FG002|6 Month|Death|0|||
25107047|NCT02213055|50218337|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
25107048|NCT02213055|50218338|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
25107049|NCT02213055|50218337|FG000|Overall Study|Protocol was not Followed during Study|1|||
25107050|NCT02213055|50218338|FG001|Overall Study|Protocol was not Followed during Study|0|||
25107051|NCT02213055|50218337|FG000|Overall Study|Documentation Issue at Enrollment|1|||
25107052|NCT02213055|50218338|FG001|Overall Study|Documentation Issue at Enrollment|0|||
25107053|NCT02213055|50218337|FG000|Overall Study|Documentation Issue during Study|10|||
25107054|NCT02213055|50218338|FG001|Overall Study|Documentation Issue during Study|0|||
25107055|NCT02213055|50218337|FG000|Overall Study|Did not have Live Lice|8|||
25107056|NCT02213055|50218338|FG001|Overall Study|Did not have Live Lice|0|||
25107057|NCT02213055|50218337|FG000|Overall Study|Had another Treatment during the Study|3|||
25107058|NCT02213055|50218338|FG001|Overall Study|Had another Treatment during the Study|0|||
25107059|NCT02213055|50218337|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
25107060|NCT02213055|50218338|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
25107061|NCT02213055|50218337|FG000|Overall Study|Did not Return to School|5|||
25107062|NCT02213055|50218338|FG001|Overall Study|Did not Return to School|0|||
25107063|NCT02310763|50218347|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
25107064|NCT02310763|50218348|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
25107065|NCT02310763|50218349|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
25107066|NCT02310763|50218347|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
25107067|NCT02310763|50218348|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
25107068|NCT02310763|50218349|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
25107069|NCT02310763|50218347|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
25107070|NCT02310763|50218348|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
25107071|NCT02310763|50218349|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
25107072|NCT02310763|50218347|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
25107073|NCT02310763|50218348|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
25107074|NCT02310763|50218349|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
25107075|NCT02310763|50218347|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
25107076|NCT02310763|50218348|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
25107077|NCT02310763|50218349|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
25107078|NCT02342743|50218375|FG000|Baseline Period|Withdrawal by Subject|3|||
25107079|NCT02342743|50218375|FG000|Baseline Period|Lost to Follow-up|2|||
25107080|NCT02342743|50218375|FG000|Baseline Period|Change in prophylactic medication|3|||
25107081|NCT02342743|50218375|FG000|Baseline Period|Screening failure regarding baseline|7|||
25107082|NCT02342743|50218375|FG000|Treatment Period|Withdrawal by Subject|2|||
25107083|NCT02342743|50218375|FG000|Treatment Period|Lost to Follow-up|8|||
25107084|NCT02342743|50218375|FG000|Treatment Period|Change in prophylactic medication|1|||
25107085|NCT02377063|50218379|FG000|Overall Study|Non-compliance|5|||
25107086|NCT02309515|50218385|FG000|Overall Study|Withdrawal by Subject|0|||
25107087|NCT02309515|50218386|FG001|Overall Study|Withdrawal by Subject|1|||
25107088|NCT02309359|50218397|FG000|Overall Study|Adverse Event|4|||
25107089|NCT02309359|50218398|FG001|Overall Study|Adverse Event|5|||
25107090|NCT02309359|50218399|FG002|Overall Study|Adverse Event|5|||
25107091|NCT02309359|50218400|FG003|Overall Study|Adverse Event|4|||
25107092|NCT02309359|50218401|FG004|Overall Study|Adverse Event|4|||
25107093|NCT02309359|50218397|FG000|Overall Study|Death|1|||
25107094|NCT02309359|50218398|FG001|Overall Study|Death|0|||
25107095|NCT02309359|50218399|FG002|Overall Study|Death|0|||
25107096|NCT02309359|50218400|FG003|Overall Study|Death|0|||
25107097|NCT02309359|50218401|FG004|Overall Study|Death|0|||
25107098|NCT02309359|50218397|FG000|Overall Study|Withdrawal by Subject|2|||
25107099|NCT02309359|50218398|FG001|Overall Study|Withdrawal by Subject|2|||
25107100|NCT02309359|50218399|FG002|Overall Study|Withdrawal by Subject|4|||
25107101|NCT02309359|50218400|FG003|Overall Study|Withdrawal by Subject|4|||
25107102|NCT02309359|50218401|FG004|Overall Study|Withdrawal by Subject|0|||
25107103|NCT02309359|50218397|FG000|Overall Study|Lack of Efficacy|3|||
25107104|NCT02309359|50218398|FG001|Overall Study|Lack of Efficacy|1|||
25107105|NCT02309359|50218399|FG002|Overall Study|Lack of Efficacy|0|||
25107106|NCT02309359|50218400|FG003|Overall Study|Lack of Efficacy|0|||
25107107|NCT02309359|50218401|FG004|Overall Study|Lack of Efficacy|3|||
25107108|NCT02309359|50218397|FG000|Overall Study|Lost to Follow-up|0|||
25107109|NCT02309359|50218398|FG001|Overall Study|Lost to Follow-up|0|||
25107110|NCT02309359|50218399|FG002|Overall Study|Lost to Follow-up|0|||
25107111|NCT02309359|50218400|FG003|Overall Study|Lost to Follow-up|1|||
25107112|NCT02309359|50218401|FG004|Overall Study|Lost to Follow-up|0|||
25107113|NCT02309359|50218397|FG000|Overall Study|Other|2|||
25107114|NCT02309359|50218398|FG001|Overall Study|Other|0|||
25107115|NCT02309359|50218399|FG002|Overall Study|Other|2|||
25107116|NCT02309359|50218400|FG003|Overall Study|Other|3|||
25107117|NCT02309359|50218401|FG004|Overall Study|Other|2|||
25107118|NCT02247531|50218417|FG000|Overall Study|Adverse Event|3|||
25107119|NCT02247531|50218418|FG001|Overall Study|Adverse Event|4|||
25107120|NCT02247531|50218419|FG002|Overall Study|Adverse Event|9|||
25107121|NCT02247531|50218417|FG000|Overall Study|Death|8|||
25107122|NCT02247531|50218418|FG001|Overall Study|Death|9|||
25107123|NCT02247531|50218419|FG002|Overall Study|Death|5|||
25107124|NCT02247531|50218417|FG000|Overall Study|Lost to Follow-up|1|||
25107125|NCT02247531|50218418|FG001|Overall Study|Lost to Follow-up|8|||
25107126|NCT02247531|50218419|FG002|Overall Study|Lost to Follow-up|3|||
25107127|NCT02247531|50218417|FG000|Overall Study|Non-compliance|2|||
25107128|NCT02247531|50218418|FG001|Overall Study|Non-compliance|2|||
25107129|NCT02247531|50218419|FG002|Overall Study|Non-compliance|0|||
25107130|NCT02247531|50218417|FG000|Overall Study|Withdrawal by Subject|26|||
25107131|NCT02247531|50218418|FG001|Overall Study|Withdrawal by Subject|31|||
25107132|NCT02247531|50218419|FG002|Overall Study|Withdrawal by Subject|25|||
25107133|NCT02247531|50218417|FG000|Overall Study|Study Terminated by Sponsor|64|||
25107134|NCT02247531|50218418|FG001|Overall Study|Study Terminated by Sponsor|66|||
25107135|NCT02247531|50218419|FG002|Overall Study|Study Terminated by Sponsor|62|||
25107136|NCT02247531|50218417|FG000|Overall Study|Physician Decision|0|||
25107137|NCT02247531|50218418|FG001|Overall Study|Physician Decision|2|||
25107138|NCT02247531|50218419|FG002|Overall Study|Physician Decision|2|||
25107139|NCT02247531|50218417|FG000|Overall Study|Unspecified Reason|2|||
25107140|NCT02247531|50218418|FG001|Overall Study|Unspecified Reason|3|||
25107141|NCT02247531|50218419|FG002|Overall Study|Unspecified Reason|4|||
25107142|NCT02375971|50218430|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
25107143|NCT02375971|50218431|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
25107144|NCT02375971|50218432|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
25107145|NCT02375971|50218430|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
25107146|NCT02375971|50218431|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
25107147|NCT02375971|50218432|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
25107148|NCT02375971|50218430|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
25107149|NCT02375971|50218431|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
25107150|NCT02375971|50218432|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
25107151|NCT02375971|50218430|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
25107152|NCT02375971|50218431|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
25107153|NCT02375971|50218432|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
25107154|NCT02375971|50218430|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
25107155|NCT02375971|50218431|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
25107156|NCT02375971|50218432|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
25107157|NCT02375971|50218430|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
25107158|NCT02375971|50218431|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
25107159|NCT02375971|50218432|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
25107160|NCT02375971|50218430|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
25107161|NCT02375971|50218431|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
25107162|NCT02375971|50218432|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
25107163|NCT02375971|50218430|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
25107164|NCT02375971|50218431|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
25107165|NCT02375971|50218432|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
25107166|NCT02308735|50218444|FG000|Overall Study|Physician Decision|2|||
25107167|NCT02308735|50218445|FG001|Overall Study|Physician Decision|0|||
25107168|NCT02308735|50218446|FG002|Overall Study|Physician Decision|0|||
25107169|NCT02308735|50218447|FG003|Overall Study|Physician Decision|2|||
25107170|NCT02212197|50218460|FG000|Overall Study|Need for radiotherapy|1|||
25107171|NCT02212197|50218461|FG001|Overall Study|Need for radiotherapy|0|||
25107172|NCT02212197|50218462|FG002|Overall Study|Need for radiotherapy|0|||
25107173|NCT02193165|50218473|FG000|4 Week Product Use|Lost to Follow-up|1|||
25107174|NCT02193165|50218474|FG001|4 Week Product Use|Lost to Follow-up|1|||
25107175|NCT02193165|50218475|FG002|4 Week Product Use|Lost to Follow-up|1|||
25107176|NCT02193165|50218473|FG000|6 Week Product Use|Lost to Follow-up|0|||
25107177|NCT02193165|50218474|FG001|6 Week Product Use|Lost to Follow-up|1|||
25107178|NCT02193165|50218475|FG002|6 Week Product Use|Lost to Follow-up|0|||
25107179|NCT01617460|50218483|FG000|Overall Study|Adverse Event|10|||
25107180|NCT01617460|50218483|FG000|Overall Study|Physician Decision|16|||
25107181|NCT01617460|50218483|FG000|Overall Study|Protocol Violation|5|||
25107182|NCT01617460|50218483|FG000|Overall Study|Withdrawal by Subject|9|||
25107183|NCT01890148|50218487|FG000|Overall Study|Adverse Event|1|||
25107184|NCT01889602|50218494|FG000|First Intervention|Adverse Event|1|||
25107185|NCT01889602|50218495|FG001|First Intervention|Adverse Event|1|||
25107186|NCT01889602|50218496|FG002|First Intervention|Adverse Event|1|||
25107187|NCT01889602|50218494|FG000|First Intervention|Protocol Violation|0|||
25107188|NCT01889602|50218495|FG001|First Intervention|Protocol Violation|1|||
25107189|NCT01889602|50218496|FG002|First Intervention|Protocol Violation|1|||
25107190|NCT01889602|50218494|FG000|First Intervention|Study ending|0|||
25107191|NCT01889602|50218495|FG001|First Intervention|Study ending|1|||
25107192|NCT01889602|50218496|FG002|First Intervention|Study ending|0|||
25107193|NCT01889602|50218494|FG000|Second Intervention|Adverse Event|0|||
25107194|NCT01889602|50218495|FG001|Second Intervention|Adverse Event|0|||
25107195|NCT01889602|50218496|FG002|Second Intervention|Adverse Event|1|||
25177275|NCT04176458|50321371|FG000|Overall Study|Covid 19|4|||
25107196|NCT01889602|50218494|FG000|Second Intervention|Study ending|1|||
25107197|NCT01889602|50218495|FG001|Second Intervention|Study ending|0|||
25107198|NCT01889602|50218496|FG002|Second Intervention|Study ending|0|||
25107199|NCT01889602|50218494|FG000|Second Intervention|Withdrawal by Subject|0|||
25107200|NCT01889602|50218495|FG001|Second Intervention|Withdrawal by Subject|0|||
25107201|NCT01889602|50218496|FG002|Second Intervention|Withdrawal by Subject|1|||
25107202|NCT01889602|50218494|FG000|Third Intervention|Protocol Violation|1|||
25107203|NCT01889602|50218495|FG001|Third Intervention|Protocol Violation|0|||
25107204|NCT01889602|50218496|FG002|Third Intervention|Protocol Violation|0|||
25107205|NCT01889602|50218494|FG000|Third Intervention|Withdrawal by Subject|2|||
25107206|NCT01889602|50218495|FG001|Third Intervention|Withdrawal by Subject|2|||
25107207|NCT01889602|50218496|FG002|Third Intervention|Withdrawal by Subject|0|||
25107208|NCT01935700|50218514|FG000|Overall Study|Withdrawal by Subject|1|||
25107209|NCT01935700|50218515|FG001|Overall Study|Withdrawal by Subject|0|||
25107210|NCT01935700|50218514|FG000|Overall Study|Physician Decision|4|||
25107211|NCT01935700|50218515|FG001|Overall Study|Physician Decision|0|||
25107212|NCT01618162|50218525|FG000|Overall Study|Protocol Violation|13|||
25107213|NCT01618162|50218526|FG001|Overall Study|Protocol Violation|10|||
25107214|NCT01618162|50218525|FG000|Overall Study|Adverse Event|9|||
25107215|NCT01618162|50218526|FG001|Overall Study|Adverse Event|2|||
25107216|NCT01618162|50218525|FG000|Overall Study|Withdrawal Criteria|2|||
25107217|NCT01618162|50218526|FG001|Overall Study|Withdrawal Criteria|10|||
25107218|NCT01618162|50218525|FG000|Overall Study|Unclassified|14|||
25107219|NCT01618162|50218526|FG001|Overall Study|Unclassified|13|||
25107220|NCT02193087|50218536|FG000|Overall Study|Adverse Event|2|||
25107221|NCT02193087|50218537|FG001|Overall Study|Adverse Event|0|||
25107222|NCT02193087|50218538|FG002|Overall Study|Adverse Event|0|||
25107223|NCT02193087|50218539|FG003|Overall Study|Adverse Event|11|||
25107224|NCT02193087|50218536|FG000|Overall Study|Lost to Follow-up|14|||
25107225|NCT02193087|50218537|FG001|Overall Study|Lost to Follow-up|6|||
25107226|NCT02193087|50218538|FG002|Overall Study|Lost to Follow-up|4|||
25107227|NCT02193087|50218539|FG003|Overall Study|Lost to Follow-up|37|||
25107228|NCT02193087|50218536|FG000|Overall Study|Protocol Violation|2|||
25107229|NCT02193087|50218537|FG001|Overall Study|Protocol Violation|0|||
25107230|NCT02193087|50218538|FG002|Overall Study|Protocol Violation|1|||
25107231|NCT02193087|50218539|FG003|Overall Study|Protocol Violation|2|||
25107232|NCT02193087|50218536|FG000|Overall Study|Withdrawal by Subject|10|||
25107233|NCT02193087|50218537|FG001|Overall Study|Withdrawal by Subject|3|||
25107234|NCT02193087|50218538|FG002|Overall Study|Withdrawal by Subject|1|||
25107235|NCT02193087|50218539|FG003|Overall Study|Withdrawal by Subject|19|||
25107236|NCT02193087|50218536|FG000|Overall Study|Other Reason Not Specified|7|||
25107237|NCT02193087|50218537|FG001|Overall Study|Other Reason Not Specified|2|||
25107238|NCT02193087|50218538|FG002|Overall Study|Other Reason Not Specified|1|||
25107239|NCT02193087|50218539|FG003|Overall Study|Other Reason Not Specified|9|||
25107240|NCT02193087|50218536|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
25107241|NCT02193087|50218537|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
25107242|NCT02193087|50218538|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
25107243|NCT02193087|50218539|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
25107244|NCT01617070|50218556|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
25107245|NCT02341417|50218569|FG000|Overall Study|Withdrawal by Subject|0|||
25107246|NCT02341417|50218570|FG001|Overall Study|Withdrawal by Subject|2|||
25107247|NCT02341417|50218571|FG002|Overall Study|Withdrawal by Subject|0|||
25107248|NCT02341417|50218569|FG000|Overall Study|Decision by sponsor|2|||
25107249|NCT02341417|50218570|FG001|Overall Study|Decision by sponsor|0|||
25107250|NCT02341417|50218571|FG002|Overall Study|Decision by sponsor|0|||
25107251|NCT02341417|50218569|FG000|Overall Study|Death|0|||
25107252|NCT02341417|50218570|FG001|Overall Study|Death|0|||
25107253|NCT02341417|50218571|FG002|Overall Study|Death|1|||
25107254|NCT01888900|50218582|FG000|Overall Study|failed treatment|0|||
25107255|NCT01888900|50218583|FG001|Overall Study|failed treatment|2|||
25107256|NCT02340949|50218593|FG000|Overall Study|Adverse Event|4|||
25107257|NCT02340949|50218594|FG001|Overall Study|Adverse Event|2|||
25107258|NCT02340949|50218593|FG000|Overall Study|Withdrawal by Subject|2|||
25107259|NCT02340949|50218594|FG001|Overall Study|Withdrawal by Subject|0|||
25107260|NCT02340949|50218593|FG000|Overall Study|Progression disease|6|||
25107261|NCT02340949|50218594|FG001|Overall Study|Progression disease|2|||
25107262|NCT02340949|50218593|FG000|Overall Study|Death|3|||
25107263|NCT02340949|50218594|FG001|Overall Study|Death|0|||
25107264|NCT02340949|50218593|FG000|Overall Study|Physician Decision|1|||
25107265|NCT02340949|50218594|FG001|Overall Study|Physician Decision|0|||
25107266|NCT01646203|50218603|FG000|Overall Study|Adverse Event|2|||
25107267|NCT01646203|50218604|FG001|Overall Study|Adverse Event|0|||
25107268|NCT01646203|50218605|FG002|Overall Study|Adverse Event|1|||
25107269|NCT01646203|50218603|FG000|Overall Study|Withdrawal by Subject|0|||
25107270|NCT01646203|50218604|FG001|Overall Study|Withdrawal by Subject|1|||
25107271|NCT01646203|50218605|FG002|Overall Study|Withdrawal by Subject|0|||
25107272|NCT01646203|50218603|FG000|Overall Study|Physician's Decision|0|||
25107273|NCT01646203|50218604|FG001|Overall Study|Physician's Decision|1|||
25107274|NCT01646203|50218605|FG002|Overall Study|Physician's Decision|0|||
25107275|NCT02375347|50218618|FG000|Overall Study|Protocol Violation|1|||
25107276|NCT02374957|50218624|FG000|Overall Study|Patient did not complete forms correctly|1|||
25107277|NCT02374957|50218625|FG001|Overall Study|Patient did not complete forms correctly|0|||
25107278|NCT02374255|50218635|FG000|Overall Study|Withdrawal by Subject|2|||
25107279|NCT02374255|50218636|FG001|Overall Study|Withdrawal by Subject|0|||
25107280|NCT02374255|50218637|FG002|Overall Study|Withdrawal by Subject|0|||
25107281|NCT02374255|50218638|FG003|Overall Study|Withdrawal by Subject|0|||
25107282|NCT02308033|50218656|FG000|Overall Study|Normal Gram stain at Baseline|13|||
25107283|NCT02308033|50218657|FG001|Overall Study|Normal Gram stain at Baseline|10|||
25107284|NCT02308033|50218656|FG000|Overall Study|Positive for STD at Baseline|7|||
25107285|NCT02308033|50218657|FG001|Overall Study|Positive for STD at Baseline|4|||
25107286|NCT02308033|50218656|FG000|Overall Study|Lost to Follow-up|6|||
25107287|NCT02308033|50218657|FG001|Overall Study|Lost to Follow-up|5|||
25107288|NCT02339155|50218665|FG000|Overall Study|Adverse Event|0|||
25107289|NCT02339155|50218666|FG001|Overall Study|Adverse Event|6|||
25107290|NCT02339155|50218665|FG000|Overall Study|Death|1|||
25107291|NCT02339155|50218666|FG001|Overall Study|Death|1|||
25107292|NCT02339155|50218665|FG000|Overall Study|Lost to Follow-up|8|||
25107293|NCT02339155|50218666|FG001|Overall Study|Lost to Follow-up|9|||
25107294|NCT02339155|50218665|FG000|Overall Study|Physician Decision|2|||
25107295|NCT02339155|50218666|FG001|Overall Study|Physician Decision|1|||
25107296|NCT02339155|50218665|FG000|Overall Study|Withdrawal by Subject|4|||
25107297|NCT02339155|50218666|FG001|Overall Study|Withdrawal by Subject|4|||
25107298|NCT02211261|50218685|FG000|Overall Study|Withdrawal by Subject|0|||
25107299|NCT02211261|50218686|FG001|Overall Study|Withdrawal by Subject|0|||
25107300|NCT02211261|50218687|FG002|Overall Study|Withdrawal by Subject|1|||
25107301|NCT02211261|50218688|FG003|Overall Study|Withdrawal by Subject|0|||
25107302|NCT02211261|50218689|FG004|Overall Study|Withdrawal by Subject|2|||
25107303|NCT02211261|50218690|FG005|Overall Study|Withdrawal by Subject|0|||
25107304|NCT02211261|50218691|FG006|Overall Study|Withdrawal by Subject|0|||
25107305|NCT02211261|50218692|FG007|Overall Study|Withdrawal by Subject|0|||
25107306|NCT02211261|50218693|FG008|Overall Study|Withdrawal by Subject|0|||
25107307|NCT02211261|50218694|FG009|Overall Study|Withdrawal by Subject|0|||
25107308|NCT02211261|50218695|FG010|Overall Study|Withdrawal by Subject|0|||
25107309|NCT02211261|50218685|FG000|Overall Study|Other|0|||
25107310|NCT02211261|50218686|FG001|Overall Study|Other|0|||
25107311|NCT02211261|50218687|FG002|Overall Study|Other|0|||
25107312|NCT02211261|50218688|FG003|Overall Study|Other|0|||
25107313|NCT02211261|50218689|FG004|Overall Study|Other|0|||
25107314|NCT02211261|50218690|FG005|Overall Study|Other|1|||
25107315|NCT02211261|50218691|FG006|Overall Study|Other|0|||
25107316|NCT02211261|50218692|FG007|Overall Study|Other|0|||
25107317|NCT02211261|50218693|FG008|Overall Study|Other|0|||
25107318|NCT02211261|50218694|FG009|Overall Study|Other|2|||
25107319|NCT02211261|50218695|FG010|Overall Study|Other|0|||
25107320|NCT02211261|50218685|FG000|Overall Study|Lost to Follow-up|0|||
25107321|NCT02211261|50218686|FG001|Overall Study|Lost to Follow-up|0|||
25107322|NCT02211261|50218687|FG002|Overall Study|Lost to Follow-up|0|||
25107323|NCT02211261|50218688|FG003|Overall Study|Lost to Follow-up|0|||
25107324|NCT02211261|50218689|FG004|Overall Study|Lost to Follow-up|0|||
25107325|NCT02211261|50218690|FG005|Overall Study|Lost to Follow-up|0|||
25107326|NCT02211261|50218691|FG006|Overall Study|Lost to Follow-up|0|||
25107327|NCT02211261|50218692|FG007|Overall Study|Lost to Follow-up|1|||
25107328|NCT02211261|50218693|FG008|Overall Study|Lost to Follow-up|0|||
25107329|NCT02211261|50218694|FG009|Overall Study|Lost to Follow-up|0|||
25107330|NCT02211261|50218695|FG010|Overall Study|Lost to Follow-up|0|||
25107331|NCT02170077|50218731|FG000|Overall Study|Withdrawal by Subject|3|||
25107332|NCT02170077|50218732|FG001|Overall Study|Withdrawal by Subject|4|||
25177276|NCT03941548|50321377|FG000|Overall Study|Adverse Event|0|||
25177277|NCT03941548|50321378|FG001|Overall Study|Adverse Event|1|||
25177278|NCT03941548|50321377|FG000|Overall Study|Lost to Follow-up|0|||
25177279|NCT03941548|50321378|FG001|Overall Study|Lost to Follow-up|1|||
25177280|NCT03941548|50321377|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
25177281|NCT03941548|50321378|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
25177282|NCT03925727|50321387|FG000|Overall Study|Adverse Event|4|||
25177283|NCT03925727|50321388|FG001|Overall Study|Adverse Event|0|||
25177284|NCT03925727|50321389|FG002|Overall Study|Adverse Event|3|||
25177285|NCT03925727|50321387|FG000|Overall Study|Protocol Violation|1|||
25177286|NCT03925727|50321388|FG001|Overall Study|Protocol Violation|2|||
25177287|NCT03925727|50321389|FG002|Overall Study|Protocol Violation|2|||
25177288|NCT03925727|50321387|FG000|Overall Study|Withdrawal by Subject|3|||
25177289|NCT03925727|50321388|FG001|Overall Study|Withdrawal by Subject|2|||
25107333|NCT02170077|50218733|FG002|Overall Study|Withdrawal by Subject|2|||
25107334|NCT02170077|50218731|FG000|Overall Study|Adverse Event|4|||
25177290|NCT03925727|50321389|FG002|Overall Study|Withdrawal by Subject|4|||
25107335|NCT02170077|50218732|FG001|Overall Study|Adverse Event|4|||
25107336|NCT02170077|50218733|FG002|Overall Study|Adverse Event|4|||
25107337|NCT02170077|50218731|FG000|Overall Study|Lost to Follow-up|0|||
25107338|NCT02170077|50218732|FG001|Overall Study|Lost to Follow-up|1|||
25107339|NCT02170077|50218733|FG002|Overall Study|Lost to Follow-up|0|||
25107340|NCT02170077|50218731|FG000|Overall Study|Exclusion criteria|2|||
25107341|NCT02170077|50218732|FG001|Overall Study|Exclusion criteria|2|||
25107342|NCT02170077|50218733|FG002|Overall Study|Exclusion criteria|5|||
25177291|NCT03925727|50321387|FG000|Overall Study|Administrative Reasons|3|||
25107343|NCT02170077|50218731|FG000|Overall Study|Exacerbation of seizures|0|||
25107344|NCT02170077|50218732|FG001|Overall Study|Exacerbation of seizures|2|||
25107345|NCT02170077|50218733|FG002|Overall Study|Exacerbation of seizures|1|||
25107346|NCT02210091|50218743|FG000|Overall Study|Physician Decision|0|||
25107347|NCT02210091|50218744|FG001|Overall Study|Physician Decision|1|||
25107348|NCT02210091|50218743|FG000|Overall Study|Withdrawal by Sponsor|0|||
25107349|NCT02210091|50218744|FG001|Overall Study|Withdrawal by Sponsor|1|||
25107350|NCT02338999|50218768|FG000|First Intervention|Withdrawal by Subject|3|||
25107351|NCT02338999|50218769|FG001|First Intervention|Withdrawal by Subject|1|||
25107352|NCT02338999|50218768|FG000|Washout Period|Withdrawal by Subject|0|||
25107353|NCT02338999|50218769|FG001|Washout Period|Withdrawal by Subject|2|||
25107354|NCT02338999|50218768|FG000|Second Intervention|Withdrawal by Subject|0|||
25107355|NCT02338999|50218769|FG001|Second Intervention|Withdrawal by Subject|2|||
25107356|NCT02169219|50218775|FG000|Overall Study|Lack of Efficacy|6|||
25107357|NCT02191605|50218789|FG000|Overall Study|Lost to Follow-up|9|||
25107358|NCT02191605|50218790|FG001|Overall Study|Lost to Follow-up|4|||
25107359|NCT02191605|50218791|FG002|Overall Study|Lost to Follow-up|7|||
25107360|NCT02191605|50218792|FG003|Overall Study|Lost to Follow-up|3|||
25107361|NCT02191605|50218793|FG004|Overall Study|Lost to Follow-up|4|||
25107362|NCT02191137|50218805|FG000|Treatment|Death|4|||
25107363|NCT02191137|50218805|FG000|Treatment|Withdrawal by Subject|3|||
25107364|NCT02191137|50218805|FG000|Treatment|Adverse Event|2|||
25107365|NCT02191137|50218805|FG000|Treatment|Other|1|||
25107366|NCT02191137|50218805|FG000|Follow-up|Lost to Follow-up|2|||
25107367|NCT02191137|50218805|FG000|Follow-up|Ongoing/unknown|2|||
25107368|NCT02191137|50218805|FG000|Follow-up|Adverse Event|1|||
25107369|NCT02168439|50218811|FG000|Overall Study|Protocol Violation|0|||
25107370|NCT02168439|50218812|FG001|Overall Study|Protocol Violation|2|||
25107371|NCT02190591|50218820|FG000|Overall Study|Withdrawal by Subject|1|||
25107372|NCT02190591|50218821|FG001|Overall Study|Withdrawal by Subject|8|||
25107373|NCT02190591|50218820|FG000|Overall Study|Protocol Violation|1|||
25107374|NCT02190591|50218821|FG001|Overall Study|Protocol Violation|0|||
25107375|NCT02190591|50218820|FG000|Overall Study|did not use peanut ball as instructed|0|||
25107376|NCT02190591|50218821|FG001|Overall Study|did not use peanut ball as instructed|2|||
25107377|NCT02190591|50218820|FG000|Overall Study|face presentation so she was ineligible|0|||
25107378|NCT02190591|50218821|FG001|Overall Study|face presentation so she was ineligible|1|||
25107379|NCT02190435|50218829|FG000|Overall Study|First 12 patients were lead-ins|12|||
25107380|NCT02190435|50218830|FG001|Overall Study|First 12 patients were lead-ins|0|||
25107381|NCT02190435|50218829|FG000|Overall Study|3 consented screen fails|3|||
25107382|NCT02190435|50218830|FG001|Overall Study|3 consented screen fails|0|||
25107383|NCT02338843|50218838|FG000|Overall Study|Adverse Event|2|||
25107384|NCT02338843|50218839|FG001|Overall Study|Adverse Event|1|||
25107385|NCT02338843|50218838|FG000|Overall Study|Death|40|||
25107386|NCT02338843|50218839|FG001|Overall Study|Death|53|||
25107387|NCT02338843|50218838|FG000|Overall Study|Physician Decision|1|||
25107388|NCT02338843|50218839|FG001|Overall Study|Physician Decision|0|||
25107389|NCT02338843|50218838|FG000|Overall Study|Withdrawal by Subject|0|||
25107390|NCT02338843|50218839|FG001|Overall Study|Withdrawal by Subject|2|||
25107391|NCT02338843|50218838|FG000|Overall Study|Subject Recovered|0|||
25107392|NCT02338843|50218839|FG001|Overall Study|Subject Recovered|2|||
25107393|NCT02338843|50218838|FG000|Overall Study|Discontinued prior to randomizat|1|||
25107394|NCT02338843|50218839|FG001|Overall Study|Discontinued prior to randomizat|0|||
25107395|NCT02190279|50218848|FG000|Overall Study|Withdrawal consent|1|||
25107396|NCT02190279|50218849|FG001|Overall Study|Withdrawal consent|0|||
25107397|NCT02190279|50218850|FG002|Overall Study|Withdrawal consent|1|||
25107398|NCT02190279|50218848|FG000|Overall Study|Lost to Follow-up|2|||
25107399|NCT02190279|50218849|FG001|Overall Study|Lost to Follow-up|0|||
25107400|NCT02190279|50218850|FG002|Overall Study|Lost to Follow-up|0|||
25107401|NCT02190279|50218848|FG000|Overall Study|Refused further treatment|0|||
25107402|NCT02190279|50218849|FG001|Overall Study|Refused further treatment|0|||
25107403|NCT02190279|50218850|FG002|Overall Study|Refused further treatment|1|||
25107404|NCT02190279|50218848|FG000|Overall Study|Screening failure|0|||
25107405|NCT02190279|50218849|FG001|Overall Study|Screening failure|0|||
25107406|NCT02190279|50218850|FG002|Overall Study|Screening failure|1|||
25107407|NCT02135445|50218862|FG000|Overall Study|Lost to Follow-up|1|||
25107408|NCT02135445|50218863|FG001|Overall Study|Lost to Follow-up|0|||
25107409|NCT02135445|50218862|FG000|Overall Study|Withdrawal by Subject|1|||
25107410|NCT02135445|50218863|FG001|Overall Study|Withdrawal by Subject|0|||
25107411|NCT02374099|50218871|FG000|Overall Study|Adverse Event|1|||
25107412|NCT02374099|50218872|FG001|Overall Study|Adverse Event|0|||
25107413|NCT02374099|50218871|FG000|Overall Study|Progressive Disease|35|||
25107414|NCT02374099|50218872|FG001|Overall Study|Progressive Disease|40|||
25107415|NCT02374099|50218871|FG000|Overall Study|Withdrawal by Subject|5|||
25107416|NCT02374099|50218872|FG001|Overall Study|Withdrawal by Subject|1|||
25107417|NCT02374099|50218871|FG000|Overall Study|Miscellaneous|2|||
25107418|NCT02374099|50218872|FG001|Overall Study|Miscellaneous|3|||
25107419|NCT02374099|50218871|FG000|Overall Study|Randomized, but not treated|2|||
25107420|NCT02374099|50218872|FG001|Overall Study|Randomized, but not treated|1|||
25107421|NCT02374099|50218871|FG000|Overall Study|Study Terminated by Sponsor|3|||
25107422|NCT02374099|50218872|FG001|Overall Study|Study Terminated by Sponsor|4|||
25107423|NCT02134977|50218878|FG000|Overall Study|Protocol Deviation|102|||
25107424|NCT02374021|50218884|FG000|Overall Study|Adverse Event|1|||
25107425|NCT02374021|50218885|FG001|Overall Study|Adverse Event|0|||
25107426|NCT02374021|50218884|FG000|Overall Study|Lost to Follow-up|3|||
25107427|NCT02374021|50218885|FG001|Overall Study|Lost to Follow-up|2|||
25107428|NCT02374021|50218884|FG000|Overall Study|Physician Decision|0|||
25107429|NCT02374021|50218885|FG001|Overall Study|Physician Decision|3|||
25107430|NCT02374021|50218884|FG000|Overall Study|Withdrawal by Subject|6|||
25107431|NCT02374021|50218885|FG001|Overall Study|Withdrawal by Subject|5|||
25107432|NCT02374021|50218884|FG000|Overall Study|Poor Adherence|0|||
25107433|NCT02374021|50218885|FG001|Overall Study|Poor Adherence|1|||
25107434|NCT02374021|50218884|FG000|Overall Study|Scan protocol not followed|0|||
25107435|NCT02374021|50218885|FG001|Overall Study|Scan protocol not followed|1|||
25107436|NCT02374021|50218884|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
25107437|NCT02374021|50218885|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
25107438|NCT02372383|50218893|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
25107439|NCT02372383|50218894|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
25107440|NCT02372383|50218895|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
25107441|NCT01648699|50218905|FG000|Overall Study|Death|1|||
25107442|NCT01648699|50218905|FG000|Overall Study|Lost to Follow-up|2|||
25107443|NCT01648699|50218905|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
25107444|NCT02134353|50218920|FG000|Overall Study|Adverse Event|10|||
25107445|NCT02134353|50218921|FG001|Overall Study|Adverse Event|6|||
25107446|NCT02134353|50218920|FG000|Overall Study|Lost to Follow-up|1|||
25107447|NCT02134353|50218921|FG001|Overall Study|Lost to Follow-up|1|||
25107448|NCT02134353|50218920|FG000|Overall Study|Lack of Efficacy|2|||
25107449|NCT02134353|50218921|FG001|Overall Study|Lack of Efficacy|1|||
25107450|NCT02134353|50218920|FG000|Overall Study|Withdrawal by Subject|12|||
25107451|NCT02134353|50218921|FG001|Overall Study|Withdrawal by Subject|13|||
25107452|NCT02134353|50218920|FG000|Overall Study|Death|0|||
25107453|NCT02134353|50218921|FG001|Overall Study|Death|1|||
25107454|NCT02134353|50218920|FG000|Overall Study|Pregnancy|0|||
25107455|NCT02134353|50218921|FG001|Overall Study|Pregnancy|1|||
25107456|NCT02134353|50218920|FG000|Overall Study|Relocation|1|||
25107457|NCT02134353|50218921|FG001|Overall Study|Relocation|0|||
25107458|NCT02134353|50218920|FG000|Overall Study|Other - Patient's Choice|0|||
25107459|NCT02134353|50218921|FG001|Overall Study|Other - Patient's Choice|1|||
25107460|NCT01646125|50218929|FG000|Overall Study|Untreated|2|||
25107461|NCT01646125|50218930|FG001|Overall Study|Untreated|5|||
25107462|NCT01646125|50218929|FG000|Overall Study|Adverse Event|2|||
25107463|NCT01646125|50218930|FG001|Overall Study|Adverse Event|1|||
25107464|NCT01646125|50218929|FG000|Overall Study|Death|1|||
25107465|NCT01646125|50218930|FG001|Overall Study|Death|1|||
25107466|NCT01646125|50218929|FG000|Overall Study|Physician Decision|1|||
25107467|NCT01646125|50218930|FG001|Overall Study|Physician Decision|3|||
25107468|NCT01646125|50218929|FG000|Overall Study|Progressive disease|22|||
25107469|NCT01646125|50218930|FG001|Overall Study|Progressive disease|16|||
25107470|NCT01646125|50218929|FG000|Overall Study|Study terminated by sponsor|2|||
25107471|NCT01646125|50218930|FG001|Overall Study|Study terminated by sponsor|1|||
25107472|NCT01646125|50218929|FG000|Overall Study|Subject/Guardian decision|1|||
25107473|NCT01646125|50218930|FG001|Overall Study|Subject/Guardian decision|1|||
25107474|NCT01362790|50218943|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
25107475|NCT01362790|50218944|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
25107476|NCT01362790|50218945|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
25107477|NCT01362790|50218946|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
25107478|NCT01362790|50218947|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
25107479|NCT01362790|50218948|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
25107480|NCT01362790|50218949|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
25107481|NCT01362790|50218943|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
25107482|NCT01362790|50218944|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
25107483|NCT01362790|50218945|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
25107484|NCT01362790|50218946|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
25261234|NCT01265823|50575928|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
25261235|NCT01265823|50575928|FG000|Overall Study|Failure to Return|4|||
25261236|NCT01265823|50575928|FG000|Overall Study|Protocol Violation|1|||
25261237|NCT01265823|50575928|FG000|Overall Study|Participant Request|1|||
25107485|NCT01362790|50218947|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
25107486|NCT01362790|50218948|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
25107487|NCT01362790|50218949|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
25107488|NCT01362790|50218943|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
25107489|NCT01362790|50218944|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
25107490|NCT01362790|50218945|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
25107491|NCT01362790|50218946|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
25107492|NCT01362790|50218947|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
25107493|NCT01362790|50218948|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
25107494|NCT01362790|50218949|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
25107495|NCT01362790|50218943|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
25107496|NCT01362790|50218944|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
25107497|NCT01362790|50218945|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
25107498|NCT01362790|50218946|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
25107499|NCT01362790|50218947|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
25107500|NCT01362790|50218948|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
25107501|NCT01362790|50218949|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
25107502|NCT01362790|50218943|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
25107503|NCT01362790|50218944|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
25107504|NCT01362790|50218945|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
25107505|NCT01362790|50218946|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
25107506|NCT01362790|50218947|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
25107507|NCT01362790|50218948|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
25107508|NCT01362790|50218949|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
25107509|NCT01362790|50218943|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
25107510|NCT01362790|50218944|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
25107511|NCT01362790|50218945|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
25107512|NCT01362790|50218946|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
25107513|NCT01362790|50218947|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
25107514|NCT01362790|50218948|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
25107515|NCT01362790|50218949|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
25107516|NCT01362790|50218943|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
25107517|NCT01362790|50218944|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
25107518|NCT01362790|50218945|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
25107519|NCT01362790|50218946|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
25107520|NCT01362790|50218947|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
25107521|NCT01362790|50218948|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
25107522|NCT01362790|50218949|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
25107523|NCT01362790|50218943|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
25107524|NCT01362790|50218944|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
25107525|NCT01362790|50218945|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
25107526|NCT01362790|50218946|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
25107527|NCT01362790|50218947|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
25107528|NCT01362790|50218948|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
25107529|NCT01362790|50218949|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
25107530|NCT01362790|50218943|FG000|Pilot Phase & Phase 2|Death on study|0|||
25107531|NCT01362790|50218944|FG001|Pilot Phase & Phase 2|Death on study|0|||
25107532|NCT01362790|50218945|FG002|Pilot Phase & Phase 2|Death on study|0|||
25107533|NCT01362790|50218946|FG003|Pilot Phase & Phase 2|Death on study|1|||
25107534|NCT01362790|50218947|FG004|Pilot Phase & Phase 2|Death on study|0|||
25107535|NCT01362790|50218948|FG005|Pilot Phase & Phase 2|Death on study|0|||
25107536|NCT01362790|50218949|FG006|Pilot Phase & Phase 2|Death on study|0|||
25107537|NCT01362790|50218943|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
25107538|NCT01362790|50218944|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
25107539|NCT01362790|50218945|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
25107540|NCT01362790|50218946|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
25107541|NCT01362790|50218947|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
25107542|NCT01362790|50218948|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
25107543|NCT01362790|50218949|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
25107544|NCT01362790|50218943|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
25107545|NCT01362790|50218944|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
25107546|NCT01362790|50218945|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
25107547|NCT01362790|50218946|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
25107548|NCT01362790|50218947|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
25107549|NCT01362790|50218948|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
25107550|NCT01362790|50218949|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
25107551|NCT01362790|50218943|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
25107552|NCT01362790|50218944|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
25107553|NCT01362790|50218945|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
25107554|NCT01362790|50218946|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
25177292|NCT03925727|50321388|FG001|Overall Study|Administrative Reasons|1|||
25261238|NCT01004185|50575938|FG000|Overall Study|Adverse Event|1|||
25107555|NCT01362790|50218947|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
25107556|NCT01362790|50218948|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
25107557|NCT01362790|50218949|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
25177293|NCT03925727|50321389|FG002|Overall Study|Administrative Reasons|2|||
25177294|NCT03925727|50321387|FG000|Overall Study|Randomized in error or Disqualified|8|||
25261239|NCT01004185|50575939|FG001|Overall Study|Adverse Event|1|||
25107558|NCT02167893|50218969|FG000|Overall Study|Investigator transferred|85|||
25107559|NCT02167893|50218969|FG000|Overall Study|Investigator health reasons|10|||
25107560|NCT02167893|50218969|FG000|Overall Study|Case report forms not collected|68|||
25107561|NCT02167035|50218975|FG000|Overall Study|Adverse Event|2|||
25107562|NCT02167035|50218976|FG001|Overall Study|Adverse Event|2|||
25107563|NCT02167035|50218975|FG000|Overall Study|Lost to Follow-up|3|||
25107564|NCT02167035|50218976|FG001|Overall Study|Lost to Follow-up|3|||
25107565|NCT02167035|50218975|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
25107566|NCT02167035|50218976|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
25107567|NCT01615198|50218986|FG000|Overall Study|Withdrawal by Subject|5|||
25107568|NCT01615198|50218987|FG001|Overall Study|Withdrawal by Subject|5|||
25107569|NCT01615198|50218986|FG000|Overall Study|Protocol deviation|1|||
25107570|NCT01615198|50218987|FG001|Overall Study|Protocol deviation|1|||
25107571|NCT01615198|50218986|FG000|Overall Study|Physician Decision|5|||
25107572|NCT01615198|50218987|FG001|Overall Study|Physician Decision|1|||
25107573|NCT01615198|50218986|FG000|Overall Study|Lost to Follow-up|1|||
25107574|NCT01615198|50218987|FG001|Overall Study|Lost to Follow-up|1|||
25107575|NCT01615198|50218986|FG000|Overall Study|Lack of Efficacy|1|||
25107576|NCT01615198|50218987|FG001|Overall Study|Lack of Efficacy|6|||
25107577|NCT01615198|50218986|FG000|Overall Study|Adverse Event|11|||
25107578|NCT01615198|50218987|FG001|Overall Study|Adverse Event|5|||
25107579|NCT02337907|50218999|FG000|Overall Study|Other than listed|1|||
25107580|NCT02337907|50219000|FG001|Overall Study|Other than listed|0|||
25107581|NCT02337907|50219001|FG002|Overall Study|Other than listed|0|||
25107582|NCT02337907|50219002|FG003|Overall Study|Other than listed|1|||
25107583|NCT02337907|50219003|FG004|Overall Study|Other than listed|1|||
25107584|NCT02337907|50219004|FG005|Overall Study|Other than listed|0|||
25107585|NCT02337907|50218999|FG000|Overall Study|Withdrawal by Subject|2|||
25107586|NCT02337907|50219000|FG001|Overall Study|Withdrawal by Subject|3|||
25107587|NCT02337907|50219001|FG002|Overall Study|Withdrawal by Subject|0|||
25107588|NCT02337907|50219002|FG003|Overall Study|Withdrawal by Subject|2|||
25107589|NCT02337907|50219003|FG004|Overall Study|Withdrawal by Subject|5|||
25107590|NCT02337907|50219004|FG005|Overall Study|Withdrawal by Subject|0|||
25107591|NCT02337907|50218999|FG000|Overall Study|Lost to Follow-up|0|||
25107592|NCT02337907|50219000|FG001|Overall Study|Lost to Follow-up|0|||
25107593|NCT02337907|50219001|FG002|Overall Study|Lost to Follow-up|0|||
25107594|NCT02337907|50219002|FG003|Overall Study|Lost to Follow-up|0|||
25107595|NCT02337907|50219003|FG004|Overall Study|Lost to Follow-up|0|||
25107596|NCT02337907|50219004|FG005|Overall Study|Lost to Follow-up|1|||
25107597|NCT02337907|50218999|FG000|Overall Study|Adverse Event|1|||
25107598|NCT02337907|50219000|FG001|Overall Study|Adverse Event|1|||
25107599|NCT02337907|50219001|FG002|Overall Study|Adverse Event|1|||
25107600|NCT02337907|50219002|FG003|Overall Study|Adverse Event|1|||
25107601|NCT02337907|50219003|FG004|Overall Study|Adverse Event|4|||
25107602|NCT02337907|50219004|FG005|Overall Study|Adverse Event|0|||
25107603|NCT01913470|50219021|FG000|Overall Study|Lost to Follow-up|0|||
25107604|NCT01913470|50219022|FG001|Overall Study|Lost to Follow-up|1|||
25107605|NCT01913470|50219021|FG000|Overall Study|Physician Decision|0|||
25107606|NCT01913470|50219022|FG001|Overall Study|Physician Decision|1|||
25107607|NCT01913470|50219021|FG000|Overall Study|Withdrawal by Subject|0|||
25107608|NCT01913470|50219022|FG001|Overall Study|Withdrawal by Subject|1|||
25107609|NCT02372071|50219029|FG000|Overall Study|Protocol Violation|18|||
25107610|NCT02337751|50219036|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
25107611|NCT02337751|50219037|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
25107612|NCT02337751|50219036|FG000|Overall Study|Voluntary Withdrawal|6|||
25107613|NCT02337751|50219037|FG001|Overall Study|Voluntary Withdrawal|8|||
25107614|NCT02337751|50219036|FG000|Overall Study|Lack of Efficacy|2|||
25107615|NCT02337751|50219037|FG001|Overall Study|Lack of Efficacy|5|||
25107616|NCT02337751|50219036|FG000|Overall Study|Investigator's Judgement|1|||
25107617|NCT02337751|50219037|FG001|Overall Study|Investigator's Judgement|0|||
25107618|NCT02166333|50219048|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
25107619|NCT02166333|50219049|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
25107620|NCT02166333|50219050|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
25107621|NCT02166333|50219051|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
25107622|NCT02166333|50219052|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
25107623|NCT02166333|50219053|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
25107624|NCT02166333|50219048|FG000|Stage 1|Death|4|||
25107625|NCT02166333|50219049|FG001|Stage 1|Death|0|||
25107626|NCT02166333|50219050|FG002|Stage 1|Death|2|||
25107627|NCT02166333|50219051|FG003|Stage 1|Death|0|||
25107628|NCT02166333|50219052|FG004|Stage 1|Death|3|||
25107629|NCT02166333|50219053|FG005|Stage 1|Death|2|||
25177295|NCT03925727|50321388|FG001|Overall Study|Randomized in error or Disqualified|1|||
25107630|NCT02166333|50219048|FG000|Stage 1|Lost to Follow-up|12|||
25107631|NCT02166333|50219049|FG001|Stage 1|Lost to Follow-up|0|||
25107632|NCT02166333|50219050|FG002|Stage 1|Lost to Follow-up|6|||
25107633|NCT02166333|50219051|FG003|Stage 1|Lost to Follow-up|0|||
25107634|NCT02166333|50219052|FG004|Stage 1|Lost to Follow-up|3|||
25107635|NCT02166333|50219053|FG005|Stage 1|Lost to Follow-up|3|||
25107636|NCT02166333|50219048|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
25107637|NCT02166333|50219049|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
25107638|NCT02166333|50219050|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
25107639|NCT02166333|50219051|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
25107640|NCT02166333|50219052|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
25107641|NCT02166333|50219053|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
25107642|NCT02166333|50219048|FG000|Stage 2|Death|4|||
25107643|NCT02166333|50219049|FG001|Stage 2|Death|2|||
25107644|NCT02166333|50219050|FG002|Stage 2|Death|1|||
25107645|NCT02166333|50219051|FG003|Stage 2|Death|0|||
25107646|NCT02166333|50219052|FG004|Stage 2|Death|0|||
25107647|NCT02166333|50219053|FG005|Stage 2|Death|1|||
25107648|NCT02166333|50219048|FG000|Stage 2|Lost to Follow-up|23|||
25107649|NCT02166333|50219049|FG001|Stage 2|Lost to Follow-up|4|||
25107650|NCT02166333|50219050|FG002|Stage 2|Lost to Follow-up|11|||
25107651|NCT02166333|50219051|FG003|Stage 2|Lost to Follow-up|9|||
25107652|NCT02166333|50219052|FG004|Stage 2|Lost to Follow-up|3|||
25107653|NCT02166333|50219053|FG005|Stage 2|Lost to Follow-up|6|||
25107654|NCT02132949|50219067|FG000|Overall Study|Death|7|||
25107655|NCT02132949|50219068|FG001|Overall Study|Death|13|||
25107656|NCT02132949|50219067|FG000|Overall Study|Lost to Follow-up|14|||
25107657|NCT02132949|50219068|FG001|Overall Study|Lost to Follow-up|4|||
25107658|NCT02132949|50219067|FG000|Overall Study|Withdrawal by Subject|6|||
25107659|NCT02132949|50219068|FG001|Overall Study|Withdrawal by Subject|5|||
25107660|NCT02132949|50219067|FG000|Overall Study|Noncompliance|5|||
25107661|NCT02132949|50219068|FG001|Overall Study|Noncompliance|1|||
25107662|NCT02132949|50219067|FG000|Overall Study|Physician Decision|3|||
25107663|NCT02132949|50219068|FG001|Overall Study|Physician Decision|1|||
25107664|NCT02132949|50219067|FG000|Overall Study|Disease Progression|3|||
25107665|NCT02132949|50219068|FG001|Overall Study|Disease Progression|0|||
25107666|NCT02132949|50219067|FG000|Overall Study|Adverse Event|2|||
25107667|NCT02132949|50219068|FG001|Overall Study|Adverse Event|1|||
25107668|NCT02132949|50219067|FG000|Overall Study|Withdrew Prior to Treatment|1|||
25107669|NCT02132949|50219068|FG001|Overall Study|Withdrew Prior to Treatment|2|||
25107670|NCT02132949|50219067|FG000|Overall Study|Reason Unspecified|0|||
25107671|NCT02132949|50219068|FG001|Overall Study|Reason Unspecified|1|||
25107672|NCT02165397|50219077|FG000|Overall Study|Death|7|||
25107673|NCT02165397|50219078|FG001|Overall Study|Death|10|||
25107674|NCT02165397|50219079|FG002|Overall Study|Death|8|||
25107675|NCT02165397|50219077|FG000|Overall Study|Lost to Follow-up|1|||
25107676|NCT02165397|50219078|FG001|Overall Study|Lost to Follow-up|3|||
25107677|NCT02165397|50219079|FG002|Overall Study|Lost to Follow-up|0|||
25107678|NCT02165397|50219077|FG000|Overall Study|Withdrawal by Subject|6|||
25107679|NCT02165397|50219078|FG001|Overall Study|Withdrawal by Subject|6|||
25107680|NCT02165397|50219079|FG002|Overall Study|Withdrawal by Subject|1|||
25107681|NCT02165397|50219077|FG000|Overall Study|Other, Not Specified|0|||
25107682|NCT02165397|50219078|FG001|Overall Study|Other, Not Specified|0|||
25107683|NCT02165397|50219079|FG002|Overall Study|Other, Not Specified|1|||
25107684|NCT02132637|50219091|FG000|Study Period 1|Withdrawal by Subject|0|||
25107685|NCT02132637|50219092|FG001|Study Period 1|Withdrawal by Subject|4|||
25107686|NCT02132637|50219091|FG000|Study Period 1|Physician Decision|1|||
25107687|NCT02132637|50219092|FG001|Study Period 1|Physician Decision|0|||
25107688|NCT02132637|50219091|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
25107689|NCT02132637|50219092|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
25107690|NCT02132637|50219091|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
25107691|NCT02132637|50219092|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
25107692|NCT02164929|50219102|FG000|Overall Study|Converted to open procedure|1|||
25107693|NCT02164929|50219103|FG001|Overall Study|Converted to open procedure|0|||
25107694|NCT02164929|50219104|FG002|Overall Study|Converted to open procedure|0|||
25107695|NCT02164929|50219105|FG003|Overall Study|Converted to open procedure|2|||
25107696|NCT02164929|50219102|FG000|Overall Study|Failed regional block|0|||
25107697|NCT02164929|50219103|FG001|Overall Study|Failed regional block|0|||
25107698|NCT02164929|50219104|FG002|Overall Study|Failed regional block|1|||
25107699|NCT02164929|50219105|FG003|Overall Study|Failed regional block|0|||
25107700|NCT01888432|50219117|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
25107701|NCT01888432|50219118|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
25107702|NCT01888432|50219117|FG000|12-month Analysis (FAS)|Physician Decision|1|||
25107703|NCT01888432|50219118|FG001|12-month Analysis (FAS)|Physician Decision|1|||
25107704|NCT01888432|50219117|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
25107705|NCT01888432|50219118|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
25107706|NCT01888432|50219117|FG000|12-month Analysis (FAS)|Death|4|||
25107707|NCT01888432|50219118|FG001|12-month Analysis (FAS)|Death|3|||
25107708|NCT01888432|50219117|FG000|24-month Analysis (FAS)|Graft loss|0|||
25107709|NCT01888432|50219118|FG001|24-month Analysis (FAS)|Graft loss|1|||
25107710|NCT01888432|50219117|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
25107711|NCT01888432|50219118|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
25107712|NCT01888432|50219117|FG000|24-month Analysis (FAS)|Physician Decision|2|||
25107713|NCT01888432|50219118|FG001|24-month Analysis (FAS)|Physician Decision|4|||
25107714|NCT01888432|50219117|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
25107715|NCT01888432|50219118|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
25107716|NCT01888432|50219117|FG000|24-month Analysis (FAS)|Death|8|||
25107717|NCT01888432|50219118|FG001|24-month Analysis (FAS)|Death|4|||
25107718|NCT01888432|50219117|FG000|36-month Analysis (Extension)|Death|1|||
25107719|NCT01888432|50219118|FG001|36-month Analysis (Extension)|Death|0|||
25107720|NCT02188719|50219130|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
25107721|NCT02188719|50219131|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
25107722|NCT02188719|50219132|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
25107723|NCT02188719|50219133|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
25107724|NCT01934140|50219143|FG000|Persistence Phase (Year 6-10)|Other|24|||
25107725|NCT01934140|50219144|FG001|Persistence Phase (Year 6-10)|Other|6|||
25107726|NCT01934140|50219143|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
25107727|NCT01934140|50219144|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
25107728|NCT01934140|50219143|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
25107729|NCT01934140|50219144|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
25107730|NCT01934140|50219143|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
25107731|NCT01934140|50219144|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
25107732|NCT01934140|50219143|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
25107733|NCT01934140|50219144|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
25107734|NCT01934140|50219143|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
25107735|NCT01934140|50219144|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
25107736|NCT01934140|50219143|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
25107737|NCT01934140|50219144|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
25107738|NCT01934140|50219143|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
25107739|NCT01934140|50219144|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
25107740|NCT01933672|50219152|FG000|Metformin Run-in Period|Adverse Event|1|||
25107741|NCT01933672|50219153|FG001|Metformin Run-in Period|Adverse Event|0|||
25107742|NCT01933672|50219154|FG002|Metformin Run-in Period|Adverse Event|0|||
25107743|NCT01933672|50219155|FG003|Metformin Run-in Period|Adverse Event|0|||
25107744|NCT01933672|50219156|FG004|Metformin Run-in Period|Adverse Event|0|||
25107745|NCT01933672|50219157|FG005|Metformin Run-in Period|Adverse Event|0|||
25107746|NCT01933672|50219158|FG006|Metformin Run-in Period|Adverse Event|0|||
25107747|NCT01933672|50219152|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
25107748|NCT01933672|50219153|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
25107749|NCT01933672|50219154|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
25107750|NCT01933672|50219155|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
25107751|NCT01933672|50219156|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
25107752|NCT01933672|50219157|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
25107753|NCT01933672|50219158|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
25107754|NCT01933672|50219152|FG000|Metformin Run-in Period|Other|5|||
25107755|NCT01933672|50219153|FG001|Metformin Run-in Period|Other|0|||
25107756|NCT01933672|50219154|FG002|Metformin Run-in Period|Other|0|||
25107757|NCT01933672|50219155|FG003|Metformin Run-in Period|Other|0|||
25107758|NCT01933672|50219156|FG004|Metformin Run-in Period|Other|0|||
25107759|NCT01933672|50219157|FG005|Metformin Run-in Period|Other|0|||
25107760|NCT01933672|50219158|FG006|Metformin Run-in Period|Other|0|||
25107761|NCT01933672|50219152|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
25107762|NCT01933672|50219153|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
25107763|NCT01933672|50219154|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
25107764|NCT01933672|50219155|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
25107765|NCT01933672|50219156|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
25107766|NCT01933672|50219157|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
25107767|NCT01933672|50219158|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
25107768|NCT01933672|50219152|FG000|First Intervention Period (12-16 Days)|Other|0|||
25107769|NCT01933672|50219153|FG001|First Intervention Period (12-16 Days)|Other|0|||
25107770|NCT01933672|50219154|FG002|First Intervention Period (12-16 Days)|Other|1|||
25107771|NCT01933672|50219155|FG003|First Intervention Period (12-16 Days)|Other|0|||
25107772|NCT01933672|50219156|FG004|First Intervention Period (12-16 Days)|Other|0|||
25107773|NCT01933672|50219157|FG005|First Intervention Period (12-16 Days)|Other|1|||
25107774|NCT01933672|50219158|FG006|First Intervention Period (12-16 Days)|Other|0|||
25107775|NCT01933672|50219152|FG000|Second Intervention Period (12-16 Days)|Other|0|||
25107776|NCT01933672|50219153|FG001|Second Intervention Period (12-16 Days)|Other|1|||
25107777|NCT01933672|50219154|FG002|Second Intervention Period (12-16 Days)|Other|1|||
25107778|NCT01933672|50219155|FG003|Second Intervention Period (12-16 Days)|Other|0|||
25107779|NCT01933672|50219156|FG004|Second Intervention Period (12-16 Days)|Other|0|||
25107780|NCT01933672|50219157|FG005|Second Intervention Period (12-16 Days)|Other|0|||
25107781|NCT01933672|50219158|FG006|Second Intervention Period (12-16 Days)|Other|0|||
25107782|NCT01933672|50219152|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
25107783|NCT01933672|50219153|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
25107784|NCT01933672|50219154|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
25107785|NCT01933672|50219155|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
25107786|NCT01933672|50219156|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
25107787|NCT01933672|50219157|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
25107788|NCT01933672|50219158|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
25107789|NCT01933672|50219152|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
25107790|NCT01933672|50219153|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
25107791|NCT01933672|50219154|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
25107792|NCT01933672|50219155|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
25107793|NCT01933672|50219156|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
25107794|NCT01933672|50219157|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
25107795|NCT01933672|50219158|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
25107796|NCT02164539|50219177|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
25107797|NCT02164539|50219178|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
25107798|NCT02164539|50219179|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
25107799|NCT02164539|50219180|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
25107800|NCT02164539|50219181|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
25107801|NCT02164539|50219182|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
25107802|NCT02164539|50219183|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
25107803|NCT02164539|50219177|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
25107804|NCT02164539|50219178|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
25107805|NCT02164539|50219179|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
25107806|NCT02164539|50219180|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
25107807|NCT02164539|50219181|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
25107808|NCT02164539|50219182|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
25107809|NCT02164539|50219183|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
25107810|NCT02164539|50219177|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
25107811|NCT02164539|50219178|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
25107812|NCT02164539|50219179|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
25107813|NCT02164539|50219180|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
25107814|NCT02164539|50219181|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
25107815|NCT02164539|50219182|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
25107816|NCT02164539|50219183|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
25107817|NCT02164539|50219177|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
25107818|NCT02164539|50219178|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
25107819|NCT02164539|50219179|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
25107820|NCT02164539|50219180|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
25107821|NCT02164539|50219181|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
25107822|NCT02164539|50219182|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
25107823|NCT02164539|50219183|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
25107824|NCT02164539|50219177|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
25107825|NCT02164539|50219178|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
25107826|NCT02164539|50219179|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
25107827|NCT02164539|50219180|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
25107828|NCT02164539|50219181|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
25107829|NCT02164539|50219182|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
25107830|NCT02164539|50219183|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
25107831|NCT02164539|50219177|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
25107832|NCT02164539|50219178|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
25107833|NCT02164539|50219179|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
25107834|NCT02164539|50219180|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
25261240|NCT01004185|50575938|FG000|Overall Study|Lost to Follow-up|0|||
25107835|NCT02164539|50219181|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
25107836|NCT02164539|50219182|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
25107837|NCT02164539|50219183|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
25107838|NCT02188485|50219200|FG000|Overall Study|Withdrawal by Subject|2|||
25107839|NCT02188485|50219201|FG001|Overall Study|Withdrawal by Subject|1|||
25107840|NCT02188485|50219200|FG000|Overall Study|PI withdrew, lack of capacity|0|||
25107841|NCT02188485|50219201|FG001|Overall Study|PI withdrew, lack of capacity|2|||
25107842|NCT02132247|50219209|FG000|Overall Study|Protocol Violation|1|||
25107843|NCT02132247|50219210|FG001|Overall Study|Protocol Violation|0|||
25107844|NCT01629381|50219218|FG000|Overall Study|Withdrawal by Subject|2|||
25107845|NCT01629381|50219219|FG001|Overall Study|Withdrawal by Subject|5|||
25107846|NCT02131311|50219229|FG000|Overall Study|Adverse Event|2|||
25107847|NCT02131311|50219229|FG000|Overall Study|Protocol Violation|1|||
25261241|NCT01004185|50575939|FG001|Overall Study|Lost to Follow-up|1|||
25107848|NCT02131311|50219229|FG000|Overall Study|Lost to Follow-up|1|||
25107849|NCT01628913|50219236|FG000|Overall Study|Adverse Event|12|||
25107850|NCT01628913|50219237|FG001|Overall Study|Adverse Event|5|||
25107851|NCT01628913|50219236|FG000|Overall Study|Disease Progression|11|||
25107852|NCT01628913|50219237|FG001|Overall Study|Disease Progression|14|||
25107853|NCT01628913|50219236|FG000|Overall Study|Protocol Violation|1|||
25107854|NCT01628913|50219237|FG001|Overall Study|Protocol Violation|0|||
25107855|NCT01628913|50219236|FG000|Overall Study|Death|1|||
25107856|NCT01628913|50219237|FG001|Overall Study|Death|0|||
25107857|NCT01628913|50219236|FG000|Overall Study|study terminated by Sponsor|4|||
25107858|NCT01628913|50219237|FG001|Overall Study|study terminated by Sponsor|9|||
25107859|NCT01628913|50219236|FG000|Overall Study|Withdrawal by Subject|1|||
25107860|NCT01628913|50219237|FG001|Overall Study|Withdrawal by Subject|0|||
25107861|NCT01628913|50219236|FG000|Overall Study|Physician Decision|1|||
25107862|NCT01628913|50219237|FG001|Overall Study|Physician Decision|3|||
25107863|NCT02164383|50219245|FG000|Overall Study|Lost to Follow-up|1|||
25107864|NCT02164383|50219246|FG001|Overall Study|Lost to Follow-up|0|||
25107865|NCT02131233|50219254|FG000|Overall Study|Not Treated|2|||
25107866|NCT02131233|50219255|FG001|Overall Study|Not Treated|3|||
25107867|NCT02131233|50219254|FG000|Overall Study|Adverse Event|7|||
25107868|NCT02131233|50219255|FG001|Overall Study|Adverse Event|6|||
25107869|NCT02131233|50219254|FG000|Overall Study|Death|0|||
25107870|NCT02131233|50219255|FG001|Overall Study|Death|1|||
25107871|NCT02131233|50219254|FG000|Overall Study|Lack of Efficacy|6|||
25107872|NCT02131233|50219255|FG001|Overall Study|Lack of Efficacy|3|||
25107873|NCT02131233|50219254|FG000|Overall Study|Lost to Follow-up|14|||
25107874|NCT02131233|50219255|FG001|Overall Study|Lost to Follow-up|13|||
25107875|NCT02131233|50219254|FG000|Overall Study|Non-Compliance With Study Drug|8|||
25107876|NCT02131233|50219255|FG001|Overall Study|Non-Compliance With Study Drug|5|||
25107877|NCT02131233|50219254|FG000|Overall Study|Physician Decision|7|||
25107878|NCT02131233|50219255|FG001|Overall Study|Physician Decision|0|||
25107879|NCT02131233|50219254|FG000|Overall Study|Pregnancy|4|||
25107880|NCT02131233|50219255|FG001|Overall Study|Pregnancy|0|||
25107881|NCT02131233|50219254|FG000|Overall Study|Withdrawal by Subject|18|||
25107882|NCT02131233|50219255|FG001|Overall Study|Withdrawal by Subject|11|||
25107883|NCT02131155|50219263|FG000|Overall Study|Adverse Event|1|||
25107884|NCT02131155|50219264|FG001|Overall Study|Adverse Event|0|||
25107885|NCT02131155|50219263|FG000|Overall Study|Treatment completed|1|||
25107886|NCT02131155|50219264|FG001|Overall Study|Treatment completed|0|||
25107887|NCT02131155|50219263|FG000|Overall Study|Primary tumour recurrence|2|||
25107888|NCT02131155|50219264|FG001|Overall Study|Primary tumour recurrence|1|||
25107889|NCT02131155|50219263|FG000|Overall Study|Refused to continue study medication|1|||
25107890|NCT02131155|50219264|FG001|Overall Study|Refused to continue study medication|0|||
25107891|NCT02131155|50219263|FG000|Overall Study|Study early termination|20|||
25107892|NCT02131155|50219264|FG001|Overall Study|Study early termination|10|||
25107893|NCT01933594|50219276|FG000|Overall Study|Lost to Follow-up|1|||
25107894|NCT01933594|50219277|FG001|Overall Study|Lost to Follow-up|0|||
25107895|NCT01933594|50219278|FG002|Overall Study|Lost to Follow-up|0|||
25107896|NCT01933594|50219279|FG003|Overall Study|Lost to Follow-up|0|||
25107897|NCT01933594|50219280|FG004|Overall Study|Lost to Follow-up|1|||
25107898|NCT01933594|50219281|FG005|Overall Study|Lost to Follow-up|0|||
25107899|NCT01933594|50219276|FG000|Overall Study|Ineligible for subsequent study step|0|||
25107900|NCT01933594|50219277|FG001|Overall Study|Ineligible for subsequent study step|0|||
25107901|NCT01933594|50219278|FG002|Overall Study|Ineligible for subsequent study step|0|||
25107902|NCT01933594|50219279|FG003|Overall Study|Ineligible for subsequent study step|0|||
25107903|NCT01933594|50219280|FG004|Overall Study|Ineligible for subsequent study step|1|||
25107904|NCT01933594|50219281|FG005|Overall Study|Ineligible for subsequent study step|0|||
25107905|NCT01932970|50219299|FG000|Overall Study|Withdrawal by Subject|5|||
25107906|NCT01932970|50219299|FG000|Overall Study|Death|1|||
25107907|NCT01932970|50219299|FG000|Overall Study|Lost to Follow-up|2|||
25107908|NCT01932970|50219299|FG000|Overall Study|Protocol Specified Criteria|10|||
25107909|NCT01912768|50219305|FG000|Overall Study|Adverse Event|2|||
25107910|NCT01912768|50219306|FG001|Overall Study|Adverse Event|0|||
25107911|NCT01912768|50219305|FG000|Overall Study|Lost to Follow-up|2|||
25107912|NCT01912768|50219306|FG001|Overall Study|Lost to Follow-up|1|||
25107913|NCT01912768|50219305|FG000|Overall Study|Withdrawal by Subject|5|||
25107914|NCT01912768|50219306|FG001|Overall Study|Withdrawal by Subject|3|||
25107915|NCT01912768|50219305|FG000|Overall Study|Randomized in error|1|||
25107916|NCT01912768|50219306|FG001|Overall Study|Randomized in error|0|||
25107917|NCT02305849|50219316|FG000|Overall Study|Adverse Event|10|||
25107918|NCT02305849|50219317|FG001|Overall Study|Adverse Event|12|||
25107919|NCT02305849|50219318|FG002|Overall Study|Adverse Event|7|||
25107920|NCT02305849|50219319|FG003|Overall Study|Adverse Event|3|||
25107921|NCT02305849|50219316|FG000|Overall Study|Lack of Efficacy|10|||
25107922|NCT02305849|50219317|FG001|Overall Study|Lack of Efficacy|6|||
25107923|NCT02305849|50219318|FG002|Overall Study|Lack of Efficacy|3|||
25107924|NCT02305849|50219319|FG003|Overall Study|Lack of Efficacy|9|||
25107925|NCT02305849|50219316|FG000|Overall Study|Withdrawal by Subject|2|||
25107926|NCT02305849|50219317|FG001|Overall Study|Withdrawal by Subject|2|||
25107927|NCT02305849|50219318|FG002|Overall Study|Withdrawal by Subject|1|||
25107928|NCT02305849|50219319|FG003|Overall Study|Withdrawal by Subject|4|||
25107929|NCT02305849|50219316|FG000|Overall Study|Lost to Follow-up|0|||
25107930|NCT02305849|50219317|FG001|Overall Study|Lost to Follow-up|2|||
25107931|NCT02305849|50219318|FG002|Overall Study|Lost to Follow-up|0|||
25107932|NCT02305849|50219319|FG003|Overall Study|Lost to Follow-up|0|||
25107933|NCT02305849|50219316|FG000|Overall Study|Protocol Violation|3|||
25107934|NCT02305849|50219317|FG001|Overall Study|Protocol Violation|2|||
25107935|NCT02305849|50219318|FG002|Overall Study|Protocol Violation|1|||
25107936|NCT02305849|50219319|FG003|Overall Study|Protocol Violation|1|||
25107937|NCT02305849|50219316|FG000|Overall Study|Lab data met discontinuation criteria|0|||
25107938|NCT02305849|50219317|FG001|Overall Study|Lab data met discontinuation criteria|1|||
25107939|NCT02305849|50219318|FG002|Overall Study|Lab data met discontinuation criteria|2|||
25107940|NCT02305849|50219319|FG003|Overall Study|Lab data met discontinuation criteria|1|||
25107941|NCT02305849|50219316|FG000|Overall Study|Miscellaneous|1|||
25107942|NCT02305849|50219317|FG001|Overall Study|Miscellaneous|2|||
25107943|NCT02305849|50219318|FG002|Overall Study|Miscellaneous|4|||
25107944|NCT02305849|50219319|FG003|Overall Study|Miscellaneous|1|||
25107945|NCT02305849|50219316|FG000|Overall Study|Not fulfill eligibility criteria|1|||
25107946|NCT02305849|50219317|FG001|Overall Study|Not fulfill eligibility criteria|1|||
25107947|NCT02305849|50219318|FG002|Overall Study|Not fulfill eligibility criteria|0|||
25107948|NCT02305849|50219319|FG003|Overall Study|Not fulfill eligibility criteria|0|||
25107949|NCT02371759|50219358|FG000|Overall Study|Protocol Violation|3|||
25107950|NCT02371759|50219359|FG001|Overall Study|Protocol Violation|1|||
25107951|NCT02371759|50219360|FG002|Overall Study|Protocol Violation|1|||
25107952|NCT02371759|50219361|FG003|Overall Study|Protocol Violation|0|||
25107953|NCT02371759|50219362|FG004|Overall Study|Protocol Violation|3|||
25107954|NCT02371759|50219363|FG005|Overall Study|Protocol Violation|1|||
25107955|NCT02371759|50219364|FG006|Overall Study|Protocol Violation|0|||
25107956|NCT02371759|50219365|FG007|Overall Study|Protocol Violation|3|||
25107957|NCT02371759|50219358|FG000|Overall Study|Withdrawal by Subject|0|||
25107958|NCT02371759|50219359|FG001|Overall Study|Withdrawal by Subject|0|||
25107959|NCT02371759|50219360|FG002|Overall Study|Withdrawal by Subject|0|||
25107960|NCT02371759|50219361|FG003|Overall Study|Withdrawal by Subject|0|||
25107961|NCT02371759|50219362|FG004|Overall Study|Withdrawal by Subject|0|||
25107962|NCT02371759|50219363|FG005|Overall Study|Withdrawal by Subject|0|||
25107963|NCT02371759|50219364|FG006|Overall Study|Withdrawal by Subject|0|||
25107964|NCT02371759|50219365|FG007|Overall Study|Withdrawal by Subject|1|||
25107965|NCT02531633|50219388|FG000|Part A (52 Weeks)|Sponsor request|24|||
25107966|NCT02531633|50219389|FG001|Part A (52 Weeks)|Sponsor request|24|||
25107967|NCT02531633|50219390|FG002|Part A (52 Weeks)|Sponsor request|18|||
25107968|NCT02531633|50219391|FG003|Part A (52 Weeks)|Sponsor request|18|||
25107969|NCT02531633|50219392|FG004|Part A (52 Weeks)|Sponsor request|19|||
25107970|NCT02531633|50219393|FG005|Part A (52 Weeks)|Sponsor request|0|||
25107971|NCT02531633|50219394|FG006|Part A (52 Weeks)|Sponsor request|0|||
25107972|NCT02531633|50219395|FG007|Part A (52 Weeks)|Sponsor request|0|||
25107973|NCT02531633|50219396|FG008|Part A (52 Weeks)|Sponsor request|0|||
25107974|NCT02531633|50219397|FG009|Part A (52 Weeks)|Sponsor request|0|||
25107975|NCT02531633|50219388|FG000|Part A (52 Weeks)|Protocol Violation|1|||
25107976|NCT02531633|50219389|FG001|Part A (52 Weeks)|Protocol Violation|0|||
25107977|NCT02531633|50219390|FG002|Part A (52 Weeks)|Protocol Violation|0|||
25107978|NCT02531633|50219391|FG003|Part A (52 Weeks)|Protocol Violation|0|||
25107979|NCT02531633|50219392|FG004|Part A (52 Weeks)|Protocol Violation|0|||
25107980|NCT02531633|50219393|FG005|Part A (52 Weeks)|Protocol Violation|0|||
25107981|NCT02531633|50219394|FG006|Part A (52 Weeks)|Protocol Violation|0|||
25107982|NCT02531633|50219395|FG007|Part A (52 Weeks)|Protocol Violation|0|||
25107983|NCT02531633|50219396|FG008|Part A (52 Weeks)|Protocol Violation|0|||
25107984|NCT02531633|50219397|FG009|Part A (52 Weeks)|Protocol Violation|0|||
25107985|NCT02531633|50219388|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
25107986|NCT02531633|50219389|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
25107987|NCT02531633|50219390|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
25107988|NCT02531633|50219391|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
25107989|NCT02531633|50219392|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
25107990|NCT02531633|50219393|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
25107991|NCT02531633|50219394|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
25107992|NCT02531633|50219395|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
25107993|NCT02531633|50219396|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
25107994|NCT02531633|50219397|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
25107995|NCT02531633|50219388|FG000|Part A (52 Weeks)|Physician Decision|1|||
25107996|NCT02531633|50219389|FG001|Part A (52 Weeks)|Physician Decision|4|||
25107997|NCT02531633|50219390|FG002|Part A (52 Weeks)|Physician Decision|3|||
25107998|NCT02531633|50219391|FG003|Part A (52 Weeks)|Physician Decision|1|||
25107999|NCT02531633|50219392|FG004|Part A (52 Weeks)|Physician Decision|0|||
25108000|NCT02531633|50219393|FG005|Part A (52 Weeks)|Physician Decision|0|||
25108001|NCT02531633|50219394|FG006|Part A (52 Weeks)|Physician Decision|0|||
25261242|NCT01004185|50575938|FG000|Overall Study|Lack of Efficacy|2|||
25108002|NCT02531633|50219395|FG007|Part A (52 Weeks)|Physician Decision|0|||
25108003|NCT02531633|50219396|FG008|Part A (52 Weeks)|Physician Decision|0|||
25108004|NCT02531633|50219397|FG009|Part A (52 Weeks)|Physician Decision|0|||
25108005|NCT02531633|50219388|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
25108006|NCT02531633|50219389|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
25108007|NCT02531633|50219390|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
25108008|NCT02531633|50219391|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
25108009|NCT02531633|50219392|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
25108010|NCT02531633|50219393|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
25108011|NCT02531633|50219394|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
25108012|NCT02531633|50219395|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
25108013|NCT02531633|50219396|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
25108014|NCT02531633|50219397|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
25108015|NCT02531633|50219388|FG000|Part A (52 Weeks)|Other|2|||
25108016|NCT02531633|50219389|FG001|Part A (52 Weeks)|Other|0|||
25108017|NCT02531633|50219390|FG002|Part A (52 Weeks)|Other|0|||
25108018|NCT02531633|50219391|FG003|Part A (52 Weeks)|Other|0|||
25108019|NCT02531633|50219392|FG004|Part A (52 Weeks)|Other|0|||
25108020|NCT02531633|50219393|FG005|Part A (52 Weeks)|Other|0|||
25108021|NCT02531633|50219394|FG006|Part A (52 Weeks)|Other|0|||
25108022|NCT02531633|50219395|FG007|Part A (52 Weeks)|Other|0|||
25108023|NCT02531633|50219396|FG008|Part A (52 Weeks)|Other|0|||
25108024|NCT02531633|50219397|FG009|Part A (52 Weeks)|Other|0|||
25108025|NCT02531633|50219388|FG000|Part B (104 Weeks)|Sponsor request|0|||
25108026|NCT02531633|50219389|FG001|Part B (104 Weeks)|Sponsor request|0|||
25108027|NCT02531633|50219390|FG002|Part B (104 Weeks)|Sponsor request|0|||
25108028|NCT02531633|50219391|FG003|Part B (104 Weeks)|Sponsor request|0|||
25108029|NCT02531633|50219392|FG004|Part B (104 Weeks)|Sponsor request|0|||
25108030|NCT02531633|50219393|FG005|Part B (104 Weeks)|Sponsor request|8|||
25108031|NCT02531633|50219394|FG006|Part B (104 Weeks)|Sponsor request|5|||
25108032|NCT02531633|50219395|FG007|Part B (104 Weeks)|Sponsor request|3|||
25108033|NCT02531633|50219396|FG008|Part B (104 Weeks)|Sponsor request|5|||
25108034|NCT02531633|50219397|FG009|Part B (104 Weeks)|Sponsor request|4|||
25108035|NCT02531633|50219388|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
25108036|NCT02531633|50219389|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
25108037|NCT02531633|50219390|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
25108038|NCT02531633|50219391|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
25108039|NCT02531633|50219392|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
25108040|NCT02531633|50219393|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
25108041|NCT02531633|50219394|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
25108042|NCT02531633|50219395|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
25108043|NCT02531633|50219396|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
25108044|NCT02531633|50219397|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
25108045|NCT02536313|50219439|FG000|Overall Study|Lack of Efficacy|0|||
25108046|NCT02536313|50219440|FG001|Overall Study|Lack of Efficacy|1|||
25108047|NCT02187861|50219452|FG000|Overall Study|Adverse Event|2|||
25108048|NCT02187861|50219453|FG001|Overall Study|Adverse Event|1|||
25108049|NCT02187861|50219454|FG002|Overall Study|Adverse Event|2|||
25108050|NCT02187861|50219455|FG003|Overall Study|Adverse Event|1|||
25108051|NCT02187861|50219452|FG000|Overall Study|Death|0|||
25108052|NCT02187861|50219453|FG001|Overall Study|Death|3|||
25108053|NCT02187861|50219454|FG002|Overall Study|Death|1|||
25108054|NCT02187861|50219455|FG003|Overall Study|Death|2|||
25108055|NCT02187861|50219452|FG000|Overall Study|Physician Decision|0|||
25108056|NCT02187861|50219453|FG001|Overall Study|Physician Decision|1|||
25108057|NCT02187861|50219454|FG002|Overall Study|Physician Decision|0|||
25108058|NCT02187861|50219455|FG003|Overall Study|Physician Decision|3|||
25108059|NCT02187861|50219452|FG000|Overall Study|Progressive Disease|4|||
25108060|NCT02187861|50219453|FG001|Overall Study|Progressive Disease|42|||
25108061|NCT02187861|50219454|FG002|Overall Study|Progressive Disease|19|||
25108062|NCT02187861|50219455|FG003|Overall Study|Progressive Disease|22|||
25108063|NCT02187861|50219452|FG000|Overall Study|Withdrawal by Subject|0|||
25108064|NCT02187861|50219453|FG001|Overall Study|Withdrawal by Subject|0|||
25108065|NCT02187861|50219454|FG002|Overall Study|Withdrawal by Subject|3|||
25108066|NCT02187861|50219455|FG003|Overall Study|Withdrawal by Subject|3|||
25108067|NCT02187861|50219452|FG000|Overall Study|Other|0|||
25108068|NCT02187861|50219453|FG001|Overall Study|Other|1|||
25261243|NCT01004185|50575939|FG001|Overall Study|Lack of Efficacy|1|||
25261244|NCT01004185|50575938|FG000|Overall Study|Sponsor Terminated Study|4|||
25108069|NCT02187861|50219454|FG002|Overall Study|Other|7|||
25108070|NCT02187861|50219455|FG003|Overall Study|Other|1|||
25108071|NCT02163993|50219470|FG000|Treatment Period|Adverse Event|0|||
25108072|NCT02163993|50219471|FG001|Treatment Period|Adverse Event|1|||
25108073|NCT02163993|50219472|FG002|Treatment Period|Adverse Event|0|||
25261245|NCT01004185|50575939|FG001|Overall Study|Sponsor Terminated Study|5|||
25108074|NCT02163993|50219473|FG003|Treatment Period|Adverse Event|0|||
25108075|NCT02163993|50219474|FG004|Treatment Period|Adverse Event|1|||
25108076|NCT02163993|50219470|FG000|Treatment Period|Lost to Follow-up|2|||
25108077|NCT02163993|50219471|FG001|Treatment Period|Lost to Follow-up|3|||
25108078|NCT02163993|50219472|FG002|Treatment Period|Lost to Follow-up|1|||
25108079|NCT02163993|50219473|FG003|Treatment Period|Lost to Follow-up|3|||
25108080|NCT02163993|50219474|FG004|Treatment Period|Lost to Follow-up|1|||
25108081|NCT02163993|50219470|FG000|Treatment Period|Physician Decision|1|||
25108082|NCT02163993|50219471|FG001|Treatment Period|Physician Decision|0|||
25108083|NCT02163993|50219472|FG002|Treatment Period|Physician Decision|0|||
25108084|NCT02163993|50219473|FG003|Treatment Period|Physician Decision|0|||
25108085|NCT02163993|50219474|FG004|Treatment Period|Physician Decision|0|||
25108086|NCT02163993|50219470|FG000|Treatment Period|Protocol Violation|2|||
25108087|NCT02163993|50219471|FG001|Treatment Period|Protocol Violation|1|||
25108088|NCT02163993|50219472|FG002|Treatment Period|Protocol Violation|0|||
25108089|NCT02163993|50219473|FG003|Treatment Period|Protocol Violation|1|||
25108090|NCT02163993|50219474|FG004|Treatment Period|Protocol Violation|2|||
25108091|NCT02163993|50219470|FG000|Treatment Period|Withdrawal by Subject|6|||
25108092|NCT02163993|50219471|FG001|Treatment Period|Withdrawal by Subject|4|||
25108093|NCT02163993|50219472|FG002|Treatment Period|Withdrawal by Subject|1|||
25108094|NCT02163993|50219473|FG003|Treatment Period|Withdrawal by Subject|4|||
25108095|NCT02163993|50219474|FG004|Treatment Period|Withdrawal by Subject|1|||
25108096|NCT02163993|50219470|FG000|Treatment Period|Not treated|1|||
25108097|NCT02163993|50219471|FG001|Treatment Period|Not treated|0|||
25108098|NCT02163993|50219472|FG002|Treatment Period|Not treated|0|||
25108099|NCT02163993|50219473|FG003|Treatment Period|Not treated|1|||
25108100|NCT02163993|50219474|FG004|Treatment Period|Not treated|2|||
25108101|NCT02163993|50219470|FG000|Post-treatment Period|Adverse Event|0|||
25108102|NCT02163993|50219471|FG001|Post-treatment Period|Adverse Event|0|||
25108103|NCT02163993|50219472|FG002|Post-treatment Period|Adverse Event|1|||
25108104|NCT02163993|50219473|FG003|Post-treatment Period|Adverse Event|0|||
25108105|NCT02163993|50219474|FG004|Post-treatment Period|Adverse Event|0|||
25108106|NCT02163993|50219470|FG000|Post-treatment Period|Lost to Follow-up|2|||
25108107|NCT02163993|50219471|FG001|Post-treatment Period|Lost to Follow-up|2|||
25108108|NCT02163993|50219472|FG002|Post-treatment Period|Lost to Follow-up|3|||
25108109|NCT02163993|50219473|FG003|Post-treatment Period|Lost to Follow-up|1|||
25108110|NCT02163993|50219474|FG004|Post-treatment Period|Lost to Follow-up|0|||
25108111|NCT02163993|50219470|FG000|Post-treatment Period|Protocol Violation|0|||
25108112|NCT02163993|50219471|FG001|Post-treatment Period|Protocol Violation|0|||
25108113|NCT02163993|50219472|FG002|Post-treatment Period|Protocol Violation|0|||
25108114|NCT02163993|50219473|FG003|Post-treatment Period|Protocol Violation|0|||
25108115|NCT02163993|50219474|FG004|Post-treatment Period|Protocol Violation|1|||
25108116|NCT02163993|50219470|FG000|Post-treatment Period|Withdrawal by Subject|2|||
25108117|NCT02163993|50219471|FG001|Post-treatment Period|Withdrawal by Subject|4|||
25108118|NCT02163993|50219472|FG002|Post-treatment Period|Withdrawal by Subject|0|||
25108119|NCT02163993|50219473|FG003|Post-treatment Period|Withdrawal by Subject|1|||
25108120|NCT02163993|50219474|FG004|Post-treatment Period|Withdrawal by Subject|2|||
25108121|NCT02527421|50219497|FG000|Overall Study|Withdrawal by Subject|1|||
25108122|NCT02527421|50219498|FG001|Overall Study|Withdrawal by Subject|0|||
25108123|NCT02163915|50219509|FG000|Overall Study|Withdrawal by Subject|2|||
25108124|NCT02163915|50219510|FG001|Overall Study|Withdrawal by Subject|0|||
25108125|NCT02163915|50219511|FG002|Overall Study|Withdrawal by Subject|2|||
25108126|NCT02163915|50219512|FG003|Overall Study|Withdrawal by Subject|2|||
25108127|NCT02163915|50219513|FG004|Overall Study|Withdrawal by Subject|2|||
25108128|NCT02163915|50219509|FG000|Overall Study|Study termination|1|||
25108129|NCT02163915|50219510|FG001|Overall Study|Study termination|0|||
25108130|NCT02163915|50219511|FG002|Overall Study|Study termination|0|||
25108131|NCT02163915|50219512|FG003|Overall Study|Study termination|0|||
25108132|NCT02163915|50219513|FG004|Overall Study|Study termination|2|||
25108133|NCT02163915|50219509|FG000|Overall Study|Physician Decision|0|||
25108134|NCT02163915|50219510|FG001|Overall Study|Physician Decision|0|||
25108135|NCT02163915|50219511|FG002|Overall Study|Physician Decision|0|||
25108136|NCT02163915|50219512|FG003|Overall Study|Physician Decision|1|||
25108137|NCT02163915|50219513|FG004|Overall Study|Physician Decision|0|||
25108138|NCT02163759|50219532|FG000|Overall Study|Withdrawal by Subject|1|||
25177296|NCT03925727|50321389|FG002|Overall Study|Randomized in error or Disqualified|7|||
25177297|NCT03387150|50321406|FG000|Overall Study|Withdrawal by Subject|3|||
25261246|NCT01004185|50575938|FG000|Overall Study|Withdrawal by Subject|2|||
25108139|NCT02163759|50219533|FG001|Overall Study|Withdrawal by Subject|5|||
25108140|NCT02163759|50219534|FG002|Overall Study|Withdrawal by Subject|1|||
25108141|NCT02163759|50219532|FG000|Overall Study|Adverse Event|0|||
25108142|NCT02163759|50219533|FG001|Overall Study|Adverse Event|0|||
25108143|NCT02163759|50219534|FG002|Overall Study|Adverse Event|1|||
25108144|NCT02163759|50219532|FG000|Overall Study|Death|0|||
25108145|NCT02163759|50219533|FG001|Overall Study|Death|0|||
25108146|NCT02163759|50219534|FG002|Overall Study|Death|1|||
25108147|NCT02371369|50219547|FG000|Part 1|Physician Decision|0|||
25108148|NCT02371369|50219548|FG001|Part 1|Physician Decision|3|||
25108149|NCT02371369|50219547|FG000|Part 1|Adverse Event|8|||
25108150|NCT02371369|50219548|FG001|Part 1|Adverse Event|0|||
25108151|NCT02371369|50219547|FG000|Part 1|Withdrawal by Subject|1|||
25108152|NCT02371369|50219548|FG001|Part 1|Withdrawal by Subject|6|||
25108153|NCT02371369|50219547|FG000|Part 1|Disease progression|0|||
25108154|NCT02371369|50219548|FG001|Part 1|Disease progression|1|||
25108155|NCT02371369|50219547|FG000|Part 1|Protocol Violation|0|||
25108156|NCT02371369|50219548|FG001|Part 1|Protocol Violation|1|||
25108157|NCT02371369|50219547|FG000|Part 2|Adverse Event|6|||
25108158|NCT02371369|50219548|FG001|Part 2|Adverse Event|5|||
25108159|NCT02371369|50219547|FG000|Part 2|Withdrawal by Subject|16|||
25108160|NCT02371369|50219548|FG001|Part 2|Withdrawal by Subject|6|||
25108161|NCT02371369|50219547|FG000|Part 2|Investigator decision|1|||
25108162|NCT02371369|50219548|FG001|Part 2|Investigator decision|2|||
25108163|NCT02371369|50219547|FG000|Part 2|Death|0|||
25108164|NCT02371369|50219548|FG001|Part 2|Death|1|||
25108165|NCT02371369|50219547|FG000|Part 2|Disease progression|1|||
25108166|NCT02371369|50219548|FG001|Part 2|Disease progression|0|||
25108167|NCT02371369|50219547|FG000|Part 2|Subject Noncompliance|1|||
25108168|NCT02371369|50219548|FG001|Part 2|Subject Noncompliance|0|||
25108169|NCT02371369|50219547|FG000|Part 2|Lost to Follow-up|1|||
25108170|NCT02371369|50219548|FG001|Part 2|Lost to Follow-up|1|||
25108171|NCT02371369|50219547|FG000|Part 2|Subject transitioned to commercial supply|6|||
25108172|NCT02371369|50219548|FG001|Part 2|Subject transitioned to commercial supply|4|||
25108173|NCT02371369|50219547|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
25108174|NCT02371369|50219548|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
25108175|NCT02371369|50219547|FG000|Part 2|Surgical resection of tumor|1|||
25108176|NCT02371369|50219548|FG001|Part 2|Surgical resection of tumor|1|||
25108177|NCT02371369|50219547|FG000|Part 2|Other|0|||
25108178|NCT02371369|50219548|FG001|Part 2|Other|1|||
25108179|NCT02187783|50219570|FG000|Overall Study|Adverse Event|8|||
25108180|NCT02187783|50219570|FG000|Overall Study|Death|3|||
25108181|NCT02187783|50219570|FG000|Overall Study|Progressive disease|80|||
25108182|NCT02187783|50219570|FG000|Overall Study|Protocol Violation|3|||
25108183|NCT02187783|50219570|FG000|Overall Study|Physician Decision|2|||
25108184|NCT02187783|50219570|FG000|Overall Study|Withdrawal by Subject|9|||
25108185|NCT02187783|50219570|FG000|Overall Study|Study terminated by sponsor|1|||
25108186|NCT02337361|50219576|FG000|3-month Follow-up|Lost to Follow-up|19|||
25108187|NCT02337361|50219577|FG001|3-month Follow-up|Lost to Follow-up|14|||
25108188|NCT02337361|50219576|FG000|6-month Follow-up|Lost to Follow-up|2|||
25108189|NCT02337361|50219577|FG001|6-month Follow-up|Lost to Follow-up|4|||
25108190|NCT02336737|50219584|FG000|Overall Study|Withdrawal by Subject|5|||
25108191|NCT02336737|50219584|FG000|Overall Study|Physician Decision|8|||
25108192|NCT02130765|50219593|FG000|Overall Study|Did not receive treatment|4|||
25108193|NCT02130765|50219594|FG001|Overall Study|Did not receive treatment|0|||
25108194|NCT02130765|50219595|FG002|Overall Study|Did not receive treatment|0|||
25108195|NCT02130765|50219596|FG003|Overall Study|Did not receive treatment|0|||
25108196|NCT02305381|50219611|FG000|Overall Study|Unclassified|5|||
25108197|NCT02305381|50219612|FG001|Overall Study|Unclassified|5|||
25108198|NCT02305381|50219613|FG002|Overall Study|Unclassified|7|||
25108199|NCT02336425|50219625|FG000|Overall Study|Study terminated.|2|||
25108200|NCT02336425|50219626|FG001|Overall Study|Study terminated.|2|||
25108201|NCT02336425|50219627|FG002|Overall Study|Study terminated.|3|||
25108202|NCT02336425|50219628|FG003|Overall Study|Study terminated.|3|||
25108203|NCT02163447|50219641|FG000|Overall Study|Withdrawal by Subject|2|||
25108204|NCT02163447|50219642|FG001|Overall Study|Withdrawal by Subject|0|||
25108205|NCT02163447|50219643|FG002|Overall Study|Withdrawal by Subject|1|||
25108206|NCT02163447|50219641|FG000|Overall Study|Lost to Follow-up|1|||
25108207|NCT02163447|50219642|FG001|Overall Study|Lost to Follow-up|3|||
25108208|NCT02163447|50219643|FG002|Overall Study|Lost to Follow-up|0|||
25108209|NCT02163447|50219641|FG000|Overall Study|Moved out of study area|2|||
25108210|NCT02163447|50219642|FG001|Overall Study|Moved out of study area|3|||
25108211|NCT02163447|50219643|FG002|Overall Study|Moved out of study area|2|||
25108212|NCT02163447|50219641|FG000|Overall Study|Became HIV infected at time of delivery|1|||
25108213|NCT02163447|50219642|FG001|Overall Study|Became HIV infected at time of delivery|0|||
25108214|NCT02163447|50219643|FG002|Overall Study|Became HIV infected at time of delivery|0|||
25108215|NCT02370667|50219664|FG000|Overall Study|Lost to Follow-up|0|||
25108216|NCT02370667|50219665|FG001|Overall Study|Lost to Follow-up|1|||
25108217|NCT02370667|50219666|FG002|Overall Study|Lost to Follow-up|0|||
25108218|NCT02130297|50219674|FG000|Overall Study|Lost to Follow-up|4|||
25108219|NCT01931956|50219682|FG000|Overall Study|Death|42|||
25108220|NCT01931956|50219683|FG001|Overall Study|Death|7|||
25108221|NCT01931956|50219684|FG002|Overall Study|Death|379|||
25108222|NCT01931956|50219685|FG003|Overall Study|Death|96|||
25108223|NCT01931956|50219682|FG000|Overall Study|Withdrawal by Subject|5|||
25108224|NCT01931956|50219683|FG001|Overall Study|Withdrawal by Subject|0|||
25108225|NCT01931956|50219684|FG002|Overall Study|Withdrawal by Subject|70|||
25108226|NCT01931956|50219685|FG003|Overall Study|Withdrawal by Subject|30|||
25108227|NCT01931956|50219682|FG000|Overall Study|Lost to Follow-up|2|||
25108228|NCT01931956|50219683|FG001|Overall Study|Lost to Follow-up|0|||
25108229|NCT01931956|50219684|FG002|Overall Study|Lost to Follow-up|11|||
25108230|NCT01931956|50219685|FG003|Overall Study|Lost to Follow-up|7|||
25108231|NCT01931956|50219682|FG000|Overall Study|Expected|2|||
25108232|NCT01931956|50219683|FG001|Overall Study|Expected|0|||
25108233|NCT01931956|50219684|FG002|Overall Study|Expected|6|||
25108234|NCT01931956|50219685|FG003|Overall Study|Expected|0|||
25108235|NCT01931956|50219682|FG000|Overall Study|Not due|0|||
25108236|NCT01931956|50219683|FG001|Overall Study|Not due|0|||
25108237|NCT01931956|50219684|FG002|Overall Study|Not due|21|||
25108238|NCT01931956|50219685|FG003|Overall Study|Not due|0|||
25108239|NCT01887418|50219711|FG000|Overall Study|Travelling difficulties|0|||
25108240|NCT01887418|50219712|FG001|Overall Study|Travelling difficulties|0|||
25108241|NCT01887418|50219713|FG002|Overall Study|Travelling difficulties|1|||
25108242|NCT01886716|50219725|FG000|Week 1|Lost to Follow-up|0|||
25108243|NCT01886716|50219726|FG001|Week 1|Lost to Follow-up|0|||
25108244|NCT01886716|50219727|FG002|Week 1|Lost to Follow-up|2|||
25108245|NCT01886716|50219728|FG003|Week 1|Lost to Follow-up|2|||
25108246|NCT01886716|50219725|FG000|Week 2|Lost to Follow-up|3|||
25108247|NCT01886716|50219726|FG001|Week 2|Lost to Follow-up|2|||
25108248|NCT01886716|50219727|FG002|Week 2|Lost to Follow-up|1|||
25108249|NCT01886716|50219728|FG003|Week 2|Lost to Follow-up|3|||
25108250|NCT01886716|50219725|FG000|Week 3|Lost to Follow-up|1|||
25108251|NCT01886716|50219726|FG001|Week 3|Lost to Follow-up|1|||
25108252|NCT01886716|50219727|FG002|Week 3|Lost to Follow-up|0|||
25108253|NCT01886716|50219728|FG003|Week 3|Lost to Follow-up|1|||
25108254|NCT01912612|50219740|FG000|Overall Study|Adverse Event|4|||
25108255|NCT01912612|50219741|FG001|Overall Study|Adverse Event|0|||
25108256|NCT01912612|50219742|FG002|Overall Study|Adverse Event|0|||
25108257|NCT01912612|50219740|FG000|Overall Study|Withdrew consent|1|||
25108258|NCT01912612|50219741|FG001|Overall Study|Withdrew consent|0|||
25108259|NCT01912612|50219742|FG002|Overall Study|Withdrew consent|0|||
25108260|NCT01912612|50219740|FG000|Overall Study|Study design change|0|||
25108261|NCT01912612|50219741|FG001|Overall Study|Study design change|0|||
25108262|NCT01912612|50219742|FG002|Overall Study|Study design change|3|||
25108263|NCT02370511|50219751|FG000|Overall Study|Death|10|||
25108264|NCT02370511|50219752|FG001|Overall Study|Death|7|||
25108265|NCT02370511|50219753|FG002|Overall Study|Death|1|||
25108266|NCT02370511|50219751|FG000|Overall Study|Withdrawal by Subject|2|||
25108267|NCT02370511|50219752|FG001|Overall Study|Withdrawal by Subject|0|||
25108268|NCT02370511|50219753|FG002|Overall Study|Withdrawal by Subject|0|||
25108269|NCT02370511|50219751|FG000|Overall Study|Lost to Follow-up|0|||
25108270|NCT02370511|50219752|FG001|Overall Study|Lost to Follow-up|4|||
25108271|NCT02370511|50219753|FG002|Overall Study|Lost to Follow-up|0|||
25108272|NCT02303041|50219763|FG000|Overall Study|Adverse Event|1|||
25108273|NCT02303041|50219764|FG001|Overall Study|Adverse Event|2|||
25108274|NCT02302807|50219772|FG000|Overall Study|Withdrawal by Subject|28|||
25108275|NCT02302807|50219773|FG001|Overall Study|Withdrawal by Subject|11|||
25108276|NCT02302807|50219772|FG000|Overall Study|Lost to Follow-up|4|||
25108277|NCT02302807|50219773|FG001|Overall Study|Lost to Follow-up|6|||
25108278|NCT02302807|50219772|FG000|Overall Study|Death|397|||
25108279|NCT02302807|50219773|FG001|Overall Study|Death|385|||
25108280|NCT02302807|50219772|FG000|Overall Study|Study Terminated By Sponsor|35|||
25108281|NCT02302807|50219773|FG001|Overall Study|Study Terminated By Sponsor|64|||
25108282|NCT02302807|50219772|FG000|Overall Study|Physician Decision|0|||
25108283|NCT02302807|50219773|FG001|Overall Study|Physician Decision|1|||
25108284|NCT02335489|50219792|FG000|Overall Study|Sponsor terminated study|4|||
25108285|NCT02335489|50219792|FG000|Overall Study|Lost to Follow-up|1|||
25108286|NCT02335489|50219792|FG000|Overall Study|Withdrawal by Subject|2|||
25108287|NCT02335489|50219792|FG000|Overall Study|Physician Decision|2|||
25108288|NCT02335489|50219792|FG000|Overall Study|Lack of Efficacy|1|||
25108289|NCT02527343|50219798|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
25108290|NCT02527343|50219799|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
25108291|NCT02527343|50219800|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
25108292|NCT02527343|50219801|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
25108293|NCT02527343|50219802|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
25108294|NCT02527343|50219803|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
25108295|NCT02527343|50219798|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
25108296|NCT02527343|50219799|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
25108297|NCT02527343|50219800|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
25108298|NCT02527343|50219801|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
25108299|NCT02527343|50219802|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
25108300|NCT02527343|50219803|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
25108301|NCT02527343|50219798|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
25108302|NCT02527343|50219799|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
25108303|NCT02527343|50219800|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
25108304|NCT02527343|50219801|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
25108305|NCT02527343|50219802|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
25108306|NCT02527343|50219803|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
25108307|NCT02527343|50219798|FG000|RT Period: Weeks 1 to 52|Other|4|||
25108308|NCT02527343|50219799|FG001|RT Period: Weeks 1 to 52|Other|3|||
25108309|NCT02527343|50219800|FG002|RT Period: Weeks 1 to 52|Other|0|||
25108310|NCT02527343|50219801|FG003|RT Period: Weeks 1 to 52|Other|0|||
25108311|NCT02527343|50219802|FG004|RT Period: Weeks 1 to 52|Other|0|||
25108312|NCT02527343|50219803|FG005|RT Period: Weeks 1 to 52|Other|0|||
25108313|NCT02527343|50219798|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
25108314|NCT02527343|50219799|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
25108315|NCT02527343|50219800|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
25108316|NCT02527343|50219801|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
25108317|NCT02527343|50219802|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
25108318|NCT02527343|50219803|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
25108319|NCT02527343|50219798|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
25108320|NCT02527343|50219799|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
25108321|NCT02527343|50219800|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
25108322|NCT02527343|50219801|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
25108323|NCT02527343|50219802|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
25108324|NCT02527343|50219803|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
25108325|NCT02527343|50219798|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
25108326|NCT02527343|50219799|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
25108327|NCT02527343|50219800|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
25108328|NCT02527343|50219801|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
25108329|NCT02527343|50219802|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
25108330|NCT02527343|50219803|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
25108331|NCT02527343|50219798|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
25108332|NCT02527343|50219799|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
25108333|NCT02527343|50219800|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
25108334|NCT02527343|50219801|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
25108335|NCT02527343|50219802|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
25108336|NCT02527343|50219803|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
25108337|NCT02527343|50219798|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
25108338|NCT02527343|50219799|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
25108339|NCT02527343|50219800|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
25108340|NCT02527343|50219801|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
25108341|NCT02527343|50219802|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
25108342|NCT02527343|50219803|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
25108343|NCT02527343|50219798|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
25108344|NCT02527343|50219799|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
25108345|NCT02527343|50219800|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
25108346|NCT02527343|50219801|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
25108347|NCT02527343|50219802|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
25108348|NCT02527343|50219803|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
25108349|NCT02527343|50219798|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
25108350|NCT02527343|50219799|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
25108351|NCT02527343|50219800|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
25108352|NCT02527343|50219801|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
25108353|NCT02527343|50219802|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
25108354|NCT02527343|50219803|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
25108355|NCT02527343|50219798|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
25108356|NCT02527343|50219799|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
25108357|NCT02527343|50219800|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
25108358|NCT02527343|50219801|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
25108359|NCT02527343|50219802|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
25108360|NCT02527343|50219803|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
25108361|NCT02527343|50219798|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
25108362|NCT02527343|50219799|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
25108363|NCT02527343|50219800|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
25108364|NCT02527343|50219801|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
25108365|NCT02527343|50219802|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
25108366|NCT02527343|50219803|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
25108367|NCT01931566|50219821|FG000|Overall Study|Randomized But Not Treated|6|||
25108368|NCT01931566|50219822|FG001|Overall Study|Randomized But Not Treated|9|||
25108369|NCT01931566|50219823|FG002|Overall Study|Randomized But Not Treated|14|||
25108370|NCT01931566|50219821|FG000|Overall Study|Adverse Event|37|||
25108371|NCT01931566|50219822|FG001|Overall Study|Adverse Event|167|||
25108372|NCT01931566|50219823|FG002|Overall Study|Adverse Event|132|||
25108373|NCT01931566|50219821|FG000|Overall Study|Major Protocol Deviation|5|||
25108374|NCT01931566|50219822|FG001|Overall Study|Major Protocol Deviation|14|||
25108375|NCT01931566|50219823|FG002|Overall Study|Major Protocol Deviation|21|||
25108376|NCT01931566|50219821|FG000|Overall Study|Lost to Follow-up|3|||
25177298|NCT03387150|50321407|FG001|Overall Study|Withdrawal by Subject|0|||
25108377|NCT01931566|50219822|FG001|Overall Study|Lost to Follow-up|26|||
25108378|NCT01931566|50219823|FG002|Overall Study|Lost to Follow-up|23|||
25108379|NCT01931566|50219821|FG000|Overall Study|Voluntary Withdrawal|78|||
25108380|NCT01931566|50219822|FG001|Overall Study|Voluntary Withdrawal|245|||
25108381|NCT01931566|50219823|FG002|Overall Study|Voluntary Withdrawal|225|||
25108382|NCT01931566|50219821|FG000|Overall Study|Study Termination|289|||
25108383|NCT01931566|50219822|FG001|Overall Study|Study Termination|968|||
25108384|NCT01931566|50219823|FG002|Overall Study|Study Termination|1037|||
25108385|NCT01931566|50219821|FG000|Overall Study|Reason Not Specified|11|||
25108386|NCT01931566|50219822|FG001|Overall Study|Reason Not Specified|47|||
25108387|NCT01931566|50219823|FG002|Overall Study|Reason Not Specified|53|||
25108388|NCT01931566|50219821|FG000|Overall Study|Missing|0|||
25108389|NCT01931566|50219822|FG001|Overall Study|Missing|0|||
25108390|NCT01931566|50219823|FG002|Overall Study|Missing|1|||
25108391|NCT01912456|50219834|FG000|Period 1|Physician Decision|0|||
25108392|NCT01912456|50219835|FG001|Period 1|Physician Decision|0|||
25108393|NCT01912456|50219836|FG002|Period 1|Physician Decision|1|||
25108394|NCT01912456|50219837|FG003|Period 1|Physician Decision|0|||
25108395|NCT01912456|50219834|FG000|Period 1|non-compliance|1|||
25108396|NCT01912456|50219835|FG001|Period 1|non-compliance|0|||
25108397|NCT01912456|50219836|FG002|Period 1|non-compliance|0|||
25108398|NCT01912456|50219837|FG003|Period 1|non-compliance|1|||
25108399|NCT01912456|50219834|FG000|Period 1|Adverse Event|1|||
25108400|NCT01912456|50219835|FG001|Period 1|Adverse Event|0|||
25108401|NCT01912456|50219836|FG002|Period 1|Adverse Event|0|||
25108402|NCT01912456|50219837|FG003|Period 1|Adverse Event|1|||
25108403|NCT01912456|50219834|FG000|Period 1|Withdrawal by Subject|0|||
25108404|NCT01912456|50219835|FG001|Period 1|Withdrawal by Subject|1|||
25108405|NCT01912456|50219836|FG002|Period 1|Withdrawal by Subject|1|||
25108406|NCT01912456|50219837|FG003|Period 1|Withdrawal by Subject|1|||
25108407|NCT01912456|50219834|FG000|Period 2|Lack of Efficacy|0|||
25108408|NCT01912456|50219835|FG001|Period 2|Lack of Efficacy|2|||
25108409|NCT01912456|50219836|FG002|Period 2|Lack of Efficacy|0|||
25108410|NCT01912456|50219837|FG003|Period 2|Lack of Efficacy|0|||
25108411|NCT01912456|50219834|FG000|Period 2|Adverse Event|0|||
25108412|NCT01912456|50219835|FG001|Period 2|Adverse Event|0|||
25108413|NCT01912456|50219836|FG002|Period 2|Adverse Event|0|||
25108414|NCT01912456|50219837|FG003|Period 2|Adverse Event|1|||
25108415|NCT01885936|50219849|FG000|Overall Study|Withdrawal by Subject|1|||
25108416|NCT01885936|50219850|FG001|Overall Study|Withdrawal by Subject|0|||
25108417|NCT01912222|50219859|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
25108418|NCT01912222|50219860|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
25108419|NCT01912222|50219861|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
25108420|NCT01912222|50219859|FG000|Part B: Treatment Period|Progressive disease|10|||
25108421|NCT01912222|50219860|FG001|Part B: Treatment Period|Progressive disease|12|||
25108422|NCT01912222|50219861|FG002|Part B: Treatment Period|Progressive disease|15|||
25108423|NCT01912222|50219859|FG000|Part B: Treatment Period|Adverse Event|1|||
25108424|NCT01912222|50219860|FG001|Part B: Treatment Period|Adverse Event|2|||
25108425|NCT01912222|50219861|FG002|Part B: Treatment Period|Adverse Event|3|||
25108426|NCT01912222|50219859|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
25108427|NCT01912222|50219860|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
25108428|NCT01912222|50219861|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
25108429|NCT02525861|50219872|FG000|Overall Study|Adverse Event|1|||
25108430|NCT02525861|50219873|FG001|Overall Study|Adverse Event|0|||
25108431|NCT02525861|50219872|FG000|Overall Study|Withdrawal by Subject|0|||
25108432|NCT02525861|50219873|FG001|Overall Study|Withdrawal by Subject|1|||
25108433|NCT02525861|50219872|FG000|Overall Study|Physician Decision|0|||
25108434|NCT02525861|50219873|FG001|Overall Study|Physician Decision|1|||
25108435|NCT02524847|50219881|FG000|Overall Study|Adverse Event|4|||
25108436|NCT02524847|50219881|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
25108437|NCT02524847|50219881|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
25108438|NCT02524847|50219881|FG000|Overall Study|Death|1|||
25108439|NCT02524847|50219881|FG000|Overall Study|Reason not Specified|1|||
25108440|NCT02525627|50219888|FG000|Overall Study|Revision|1|||
25108441|NCT02525627|50219889|FG001|Overall Study|Revision|1|||
25108442|NCT02525627|50219888|FG000|Overall Study|Withdrawal by Subject|1|||
25108443|NCT02525627|50219889|FG001|Overall Study|Withdrawal by Subject|2|||
25108444|NCT02525627|50219888|FG000|Overall Study|Death|1|||
25108445|NCT02525627|50219889|FG001|Overall Study|Death|0|||
25177299|NCT03387150|50321408|FG002|Overall Study|Withdrawal by Subject|3|||
25177300|NCT03387150|50321409|FG003|Overall Study|Withdrawal by Subject|4|||
25108446|NCT02525627|50219888|FG000|Overall Study|Site terminated|11|||
25108447|NCT02525627|50219889|FG001|Overall Study|Site terminated|10|||
25177301|NCT03387150|50321410|FG004|Overall Study|Withdrawal by Subject|1|||
25108448|NCT02129205|50219905|FG000|Overall Study|Withdrawal by Subject|0|||
25108449|NCT02129205|50219906|FG001|Overall Study|Withdrawal by Subject|0|||
25108450|NCT02129205|50219907|FG002|Overall Study|Withdrawal by Subject|0|||
25108451|NCT02129205|50219908|FG003|Overall Study|Withdrawal by Subject|0|||
25108452|NCT02129205|50219909|FG004|Overall Study|Withdrawal by Subject|1|||
25108453|NCT02129205|50219910|FG005|Overall Study|Withdrawal by Subject|1|||
25108454|NCT02129205|50219911|FG006|Overall Study|Withdrawal by Subject|1|||
25108455|NCT02129205|50219912|FG007|Overall Study|Withdrawal by Subject|0|||
25108456|NCT02129205|50219913|FG008|Overall Study|Withdrawal by Subject|1|||
25108457|NCT02129205|50219914|FG009|Overall Study|Withdrawal by Subject|0|||
25108458|NCT02129205|50219905|FG000|Overall Study|Other|1|||
25108459|NCT02129205|50219906|FG001|Overall Study|Other|0|||
25108460|NCT02129205|50219907|FG002|Overall Study|Other|0|||
25108461|NCT02129205|50219908|FG003|Overall Study|Other|0|||
25108462|NCT02129205|50219909|FG004|Overall Study|Other|2|||
25108463|NCT02129205|50219910|FG005|Overall Study|Other|3|||
25108464|NCT02129205|50219911|FG006|Overall Study|Other|3|||
25108465|NCT02129205|50219912|FG007|Overall Study|Other|2|||
25108466|NCT02129205|50219913|FG008|Overall Study|Other|1|||
25108467|NCT02129205|50219914|FG009|Overall Study|Other|0|||
25108468|NCT02128269|50219938|FG000|Treatment Period|Adverse Event|1|||
25108469|NCT02128269|50219938|FG000|Treatment Period|Physician Decision|1|||
25108470|NCT01626885|50219942|FG000|Overall Study|Adverse Event|8|||
25108471|NCT01626885|50219942|FG000|Overall Study|Withdrawal by Subject|4|||
25108472|NCT02524379|50219946|FG000|Overall Study|Death|1|||
25108473|NCT02524145|50219953|FG000|Overall Study|Withdrawal by Subject|2|||
25108474|NCT02524145|50219954|FG001|Overall Study|Withdrawal by Subject|2|||
25108475|NCT02524145|50219955|FG002|Overall Study|Withdrawal by Subject|3|||
25108476|NCT01658813|50219963|FG000|Overall Study|Disease progression|3|||
25108477|NCT02187471|50219975|FG000|Overall Study|Protocol Violation|4|||
25108478|NCT02187471|50219976|FG001|Overall Study|Protocol Violation|5|||
25108479|NCT02187471|50219977|FG002|Overall Study|Protocol Violation|4|||
25108480|NCT02187471|50219978|FG003|Overall Study|Protocol Violation|4|||
25108481|NCT02187471|50219975|FG000|Overall Study|Missing|0|||
25108482|NCT02187471|50219976|FG001|Overall Study|Missing|0|||
25108483|NCT02187471|50219977|FG002|Overall Study|Missing|0|||
25108484|NCT02187471|50219978|FG003|Overall Study|Missing|1|||
25108485|NCT02187471|50219975|FG000|Overall Study|Lack of Efficacy|18|||
25108486|NCT02187471|50219976|FG001|Overall Study|Lack of Efficacy|9|||
25108487|NCT02187471|50219977|FG002|Overall Study|Lack of Efficacy|13|||
25108488|NCT02187471|50219978|FG003|Overall Study|Lack of Efficacy|11|||
25108489|NCT02187471|50219975|FG000|Overall Study|Adverse Event|24|||
25108490|NCT02187471|50219976|FG001|Overall Study|Adverse Event|34|||
25108491|NCT02187471|50219977|FG002|Overall Study|Adverse Event|44|||
25108492|NCT02187471|50219978|FG003|Overall Study|Adverse Event|36|||
25108493|NCT02187471|50219975|FG000|Overall Study|Withdrawal by Subject|23|||
25108494|NCT02187471|50219976|FG001|Overall Study|Withdrawal by Subject|29|||
25108495|NCT02187471|50219977|FG002|Overall Study|Withdrawal by Subject|22|||
25108496|NCT02187471|50219978|FG003|Overall Study|Withdrawal by Subject|24|||
25108497|NCT02187471|50219975|FG000|Overall Study|Other|7|||
25108498|NCT02187471|50219976|FG001|Overall Study|Other|5|||
25108499|NCT02187471|50219977|FG002|Overall Study|Other|3|||
25108500|NCT02187471|50219978|FG003|Overall Study|Other|4|||
25108501|NCT02525471|50219989|FG000|Overall Study|Screen Failure|6|||
25108502|NCT02525471|50219989|FG000|Overall Study|Withdrawal by Subject|4|||
25108503|NCT02525471|50219989|FG000|Overall Study|Death|1|||
25108504|NCT01658735|50219997|FG000|Overall Study|Lack of Efficacy|1|||
25108505|NCT01658735|50219998|FG001|Overall Study|Lack of Efficacy|0|||
25108506|NCT01658735|50219999|FG002|Overall Study|Lack of Efficacy|1|||
25108507|NCT01658735|50219997|FG000|Overall Study|Lost to Follow-up|1|||
25108508|NCT01658735|50219998|FG001|Overall Study|Lost to Follow-up|1|||
25108509|NCT01658735|50219999|FG002|Overall Study|Lost to Follow-up|0|||
25108510|NCT01658735|50219997|FG000|Overall Study|Protocol Violation|0|||
25108511|NCT01658735|50219998|FG001|Overall Study|Protocol Violation|1|||
25108512|NCT01658735|50219999|FG002|Overall Study|Protocol Violation|0|||
25108513|NCT01658735|50219997|FG000|Overall Study|Withdrawal by Subject|3|||
25108514|NCT01658735|50219998|FG001|Overall Study|Withdrawal by Subject|5|||
25108515|NCT01658735|50219999|FG002|Overall Study|Withdrawal by Subject|3|||
25108516|NCT02523599|50220009|FG000|Overall Study|Adverse Event|1|||
25108517|NCT02523599|50220010|FG001|Overall Study|Adverse Event|0|||
25108518|NCT02523599|50220009|FG000|Overall Study|Physician Decision|1|||
25108519|NCT02523599|50220010|FG001|Overall Study|Physician Decision|0|||
25108520|NCT02523599|50220009|FG000|Overall Study|Lost to Follow-up|4|||
25108521|NCT02523599|50220010|FG001|Overall Study|Lost to Follow-up|1|||
25108522|NCT02523599|50220009|FG000|Overall Study|Did not return for Day 30 visit|2|||
25108523|NCT02523599|50220010|FG001|Overall Study|Did not return for Day 30 visit|0|||
25108524|NCT02187159|50220020|FG000|Overall Study|Protocol Violation|4|||
25108525|NCT02187159|50220021|FG001|Overall Study|Protocol Violation|6|||
25108526|NCT02187159|50220022|FG002|Overall Study|Protocol Violation|3|||
25108527|NCT02187159|50220023|FG003|Overall Study|Protocol Violation|4|||
25108528|NCT02187159|50220020|FG000|Overall Study|Lack of Efficacy|10|||
25108529|NCT02187159|50220021|FG001|Overall Study|Lack of Efficacy|5|||
25108530|NCT02187159|50220022|FG002|Overall Study|Lack of Efficacy|4|||
25108531|NCT02187159|50220023|FG003|Overall Study|Lack of Efficacy|7|||
25108532|NCT02187159|50220020|FG000|Overall Study|Adverse Event|28|||
25108533|NCT02187159|50220021|FG001|Overall Study|Adverse Event|33|||
25108534|NCT02187159|50220022|FG002|Overall Study|Adverse Event|42|||
25108535|NCT02187159|50220023|FG003|Overall Study|Adverse Event|50|||
25108536|NCT02187159|50220020|FG000|Overall Study|Withdrawal by Subject|24|||
25108537|NCT02187159|50220021|FG001|Overall Study|Withdrawal by Subject|28|||
25108538|NCT02187159|50220022|FG002|Overall Study|Withdrawal by Subject|25|||
25108539|NCT02187159|50220023|FG003|Overall Study|Withdrawal by Subject|26|||
25108540|NCT02187159|50220020|FG000|Overall Study|Other|3|||
25108541|NCT02187159|50220021|FG001|Overall Study|Other|7|||
25108542|NCT02187159|50220022|FG002|Overall Study|Other|3|||
25108543|NCT02187159|50220023|FG003|Overall Study|Other|9|||
25108544|NCT02335411|50220036|FG000|Overall Study|Death|223|||
25108545|NCT02335411|50220037|FG001|Overall Study|Death|22|||
25108546|NCT02335411|50220038|FG002|Overall Study|Death|26|||
25108547|NCT02335411|50220036|FG000|Overall Study|Physician Decision|3|||
25108548|NCT02335411|50220037|FG001|Overall Study|Physician Decision|0|||
25108549|NCT02335411|50220038|FG002|Overall Study|Physician Decision|0|||
25108550|NCT02335411|50220036|FG000|Overall Study|Protocol Violation|1|||
25108551|NCT02335411|50220037|FG001|Overall Study|Protocol Violation|0|||
25108552|NCT02335411|50220038|FG002|Overall Study|Protocol Violation|0|||
25108553|NCT02335411|50220036|FG000|Overall Study|Withdrawal by Subject|11|||
25108554|NCT02335411|50220037|FG001|Overall Study|Withdrawal by Subject|0|||
25108555|NCT02335411|50220038|FG002|Overall Study|Withdrawal by Subject|3|||
25108556|NCT02335411|50220036|FG000|Overall Study|Sponsor Decision|12|||
25108557|NCT02335411|50220037|FG001|Overall Study|Sponsor Decision|3|||
25108558|NCT02335411|50220038|FG002|Overall Study|Sponsor Decision|2|||
25108559|NCT02335411|50220036|FG000|Overall Study|Adverse Event|9|||
25108560|NCT02335411|50220037|FG001|Overall Study|Adverse Event|0|||
25108561|NCT02335411|50220038|FG002|Overall Study|Adverse Event|0|||
25108562|NCT02186301|50220052|FG000|Overall Study|Progressive Disease|7|||
25108563|NCT02186301|50220053|FG001|Overall Study|Progressive Disease|22|||
25108564|NCT02186301|50220054|FG002|Overall Study|Progressive Disease|27|||
25108565|NCT02186301|50220052|FG000|Overall Study|Adverse Event|5|||
25108566|NCT02186301|50220053|FG001|Overall Study|Adverse Event|5|||
25108567|NCT02186301|50220054|FG002|Overall Study|Adverse Event|5|||
25108568|NCT02186301|50220052|FG000|Overall Study|Death|1|||
25108569|NCT02186301|50220053|FG001|Overall Study|Death|0|||
25108570|NCT02186301|50220054|FG002|Overall Study|Death|0|||
25108571|NCT02186301|50220052|FG000|Overall Study|Withdrawal by Subject|5|||
25108572|NCT02186301|50220053|FG001|Overall Study|Withdrawal by Subject|1|||
25108573|NCT02186301|50220054|FG002|Overall Study|Withdrawal by Subject|3|||
25108574|NCT02186301|50220052|FG000|Overall Study|Physician Decision|1|||
25108575|NCT02186301|50220053|FG001|Overall Study|Physician Decision|0|||
25108576|NCT02186301|50220054|FG002|Overall Study|Physician Decision|1|||
25108577|NCT02186301|50220052|FG000|Overall Study|Study Terminated by Sponsor|1|||
25108578|NCT02186301|50220053|FG001|Overall Study|Study Terminated by Sponsor|0|||
25108579|NCT02186301|50220054|FG002|Overall Study|Study Terminated by Sponsor|11|||
25108580|NCT02186301|50220052|FG000|Overall Study|Protocol Deviation|0|||
25108581|NCT02186301|50220053|FG001|Overall Study|Protocol Deviation|2|||
25108582|NCT02186301|50220054|FG002|Overall Study|Protocol Deviation|0|||
25108583|NCT02186301|50220052|FG000|Overall Study|Missing|0|||
25108584|NCT02186301|50220053|FG001|Overall Study|Missing|0|||
25108585|NCT02186301|50220054|FG002|Overall Study|Missing|2|||
25108586|NCT02186301|50220052|FG000|Overall Study|Other|0|||
25108587|NCT02186301|50220053|FG001|Overall Study|Other|0|||
25108588|NCT02186301|50220054|FG002|Overall Study|Other|1|||
25108589|NCT02186223|50220064|FG000|Overall Study|Not eligible for device placement|6|||
25108590|NCT02186223|50220064|FG000|Overall Study|Unable to obtain femoral access|3|||
25108591|NCT02186223|50220064|FG000|Overall Study|Death|3|||
25108592|NCT02186223|50220064|FG000|Overall Study|Device in place less than 48 hours|9|||
25108593|NCT02163057|50220071|FG000|Overall Study|Participant Refusal to Continue|2|||
25108594|NCT02163057|50220072|FG001|Overall Study|Participant Refusal to Continue|2|||
25108595|NCT02163057|50220071|FG000|Overall Study|Participant Significant Noncompliance|0|||
25108596|NCT02163057|50220072|FG001|Overall Study|Participant Significant Noncompliance|1|||
25108597|NCT02163057|50220071|FG000|Overall Study|Progression of Disease|1|||
25108598|NCT02163057|50220072|FG001|Overall Study|Progression of Disease|2|||
25108599|NCT02185521|50220080|FG000|Overall Study|Withdrawal by Subject|1|||
25108600|NCT02185521|50220080|FG000|Overall Study|Protocol Violation|1|||
25261247|NCT01004185|50575939|FG001|Overall Study|Withdrawal by Subject|1|||
25108601|NCT01599585|50220087|FG000|Overall Study|Withdrawal by Subject|16|||
25108602|NCT01599585|50220088|FG001|Overall Study|Withdrawal by Subject|9|||
25108603|NCT01599585|50220087|FG000|Overall Study|Lost to Follow-up|3|||
25108604|NCT01599585|50220088|FG001|Overall Study|Lost to Follow-up|5|||
25108605|NCT01599585|50220087|FG000|Overall Study|randomized did not start treatment|3|||
25108606|NCT01599585|50220088|FG001|Overall Study|randomized did not start treatment|3|||
25108607|NCT02185053|50220094|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
25108608|NCT02185053|50220095|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
25108609|NCT02185053|50220096|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
25108610|NCT02185053|50220094|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
25108611|NCT02185053|50220095|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
25108612|NCT02185053|50220096|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
25108613|NCT02185053|50220094|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
25108614|NCT02185053|50220095|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
25108615|NCT02185053|50220096|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
25108616|NCT02185053|50220094|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
25108617|NCT02185053|50220095|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
25108618|NCT02185053|50220096|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
25108619|NCT02185053|50220094|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
25108620|NCT02185053|50220095|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
25108621|NCT02185053|50220096|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
25108622|NCT02185053|50220094|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
25108623|NCT02185053|50220095|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
25108624|NCT02185053|50220096|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
25108625|NCT02185053|50220094|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
25108626|NCT02185053|50220095|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
25108627|NCT02185053|50220096|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
25108628|NCT02185053|50220094|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
25108629|NCT02185053|50220095|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
25108630|NCT02185053|50220096|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
25108631|NCT02161731|50220105|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
25108632|NCT02161731|50220106|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
25108633|NCT02161731|50220105|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
25108634|NCT02161731|50220106|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
25108635|NCT02124759|50220116|FG000|Overall Study|Withdrawal by Subject|3|||
25108636|NCT02124759|50220117|FG001|Overall Study|Withdrawal by Subject|1|||
25108637|NCT02124759|50220118|FG002|Overall Study|Withdrawal by Subject|1|||
25108638|NCT02124759|50220116|FG000|Overall Study|Screen Fail|2|||
25108639|NCT02124759|50220117|FG001|Overall Study|Screen Fail|2|||
25108640|NCT02124759|50220118|FG002|Overall Study|Screen Fail|3|||
25108641|NCT02302339|50220135|FG000|Overall Study|Lost to Follow-up|1|||
25108642|NCT02302339|50220136|FG001|Overall Study|Lost to Follow-up|0|||
25108643|NCT02302339|50220137|FG002|Overall Study|Lost to Follow-up|0|||
25108644|NCT02302339|50220138|FG003|Overall Study|Lost to Follow-up|0|||
25108645|NCT02302339|50220135|FG000|Overall Study|Withdrawal by Subject|0|||
25108646|NCT02302339|50220136|FG001|Overall Study|Withdrawal by Subject|2|||
25108647|NCT02302339|50220137|FG002|Overall Study|Withdrawal by Subject|1|||
25108648|NCT02302339|50220138|FG003|Overall Study|Withdrawal by Subject|0|||
25108649|NCT02161575|50220149|FG000|Overall Study|Protocol Violation|8|||
25108650|NCT02161575|50220149|FG000|Overall Study|Lack of Efficacy|1|||
25108651|NCT02161575|50220149|FG000|Overall Study|Adverse Event|2|||
25108652|NCT02370121|50220155|FG000|Overall Study|Lost to Follow-up|1|||
25108653|NCT02370121|50220156|FG001|Overall Study|Lost to Follow-up|1|||
25108654|NCT02161185|50220162|FG000|Treatment Phase|Administrative/Other|7|||
25108655|NCT02159469|50220166|FG000|Overall Study|Missing Completion status|1|||
25108656|NCT02159469|50220166|FG000|Overall Study|Adverse Event|5|||
25108657|NCT02159469|50220166|FG000|Overall Study|Non-compliance|2|||
25108658|NCT02159469|50220166|FG000|Overall Study|Withdrawal by Subject|9|||
25108659|NCT02159469|50220166|FG000|Overall Study|Lost to Follow-up|1|||
25108660|NCT02159469|50220166|FG000|Overall Study|Sponsor's request|2|||
25108661|NCT02159469|50220166|FG000|Overall Study|Met Stopping Criteria|3|||
25108662|NCT02159469|50220166|FG000|Overall Study|Other|1|||
25108663|NCT02159469|50220166|FG000|Overall Study|Multiple|29|||
25108664|NCT02123511|50220173|FG000|Overall Study|Cancelled treatment|1|||
25108665|NCT02123511|50220174|FG001|Overall Study|Cancelled treatment|0|||
25108666|NCT02123511|50220173|FG000|Overall Study|Incomplete data|1|||
25108667|NCT02123511|50220174|FG001|Overall Study|Incomplete data|3|||
25108668|NCT02123511|50220173|FG000|Overall Study|Ineligible|0|||
25108669|NCT02123511|50220174|FG001|Overall Study|Ineligible|1|||
25108670|NCT02122887|50220182|FG000|Overall Study|Withdrawal by Subject|20|||
25108671|NCT02122887|50220183|FG001|Overall Study|Withdrawal by Subject|2|||
25108672|NCT02182947|50220189|FG000|Overall Study|Withdrawal by Subject|7|||
25108673|NCT02182947|50220189|FG000|Overall Study|Lost to Follow-up|3|||
25108674|NCT02182947|50220189|FG000|Overall Study|Failed screening activities|8|||
25108675|NCT02370043|50220193|FG000|Overall Study|Withdrawal by Subject|0|||
25108676|NCT02370043|50220194|FG001|Overall Study|Withdrawal by Subject|0|||
25177302|NCT03387150|50321411|FG005|Overall Study|Withdrawal by Subject|2|||
25108677|NCT02370043|50220195|FG002|Overall Study|Withdrawal by Subject|0|||
25108678|NCT02370043|50220196|FG003|Overall Study|Withdrawal by Subject|0|||
25108679|NCT02370043|50220197|FG004|Overall Study|Withdrawal by Subject|1|||
25108680|NCT02370043|50220198|FG005|Overall Study|Withdrawal by Subject|1|||
25108681|NCT02301403|50220228|FG000|Overall Study|Withdrawal by Subject|28|||
25108682|NCT02301403|50220229|FG001|Overall Study|Withdrawal by Subject|41|||
25108683|NCT02301169|50220237|FG000|Overall Study|Adverse Event|1|||
25108684|NCT02301169|50220238|FG001|Overall Study|Adverse Event|0|||
25261248|NCT01265511|50575947|FG000|Overall Study|Lack of Efficacy|2|||
25108685|NCT02333383|50220244|FG000|Overall Study|Adalimumab discontinuation|21|||
25108686|NCT02333383|50220244|FG000|Overall Study|Lost to Follow-up|15|||
25108687|NCT02333383|50220244|FG000|Overall Study|Withdrawal by Subject|3|||
25108688|NCT02333383|50220244|FG000|Overall Study|Transfer to another hospital|2|||
25108689|NCT02332915|50220250|FG000|Overall Study|Moved out of region|3|||
25108690|NCT02332915|50220251|FG001|Overall Study|Moved out of region|0|||
25108691|NCT02332915|50220250|FG000|Overall Study|Unrelated illness|1|||
25108692|NCT02332915|50220251|FG001|Overall Study|Unrelated illness|1|||
25108693|NCT02332915|50220250|FG000|Overall Study|Travel distance prohibitive|0|||
25108694|NCT02332915|50220251|FG001|Overall Study|Travel distance prohibitive|1|||
25108695|NCT02332915|50220250|FG000|Overall Study|did not meet inclusion criteria|2|||
25108696|NCT02332915|50220251|FG001|Overall Study|did not meet inclusion criteria|4|||
25108697|NCT02369341|50220264|FG000|Overall Study|Migrated/moved from study area|1|||
25108698|NCT02369341|50220265|FG001|Overall Study|Migrated/moved from study area|0|||
25108699|NCT02121795|50220277|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
25108700|NCT02121795|50220278|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
25108701|NCT02121795|50220277|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
25108702|NCT02121795|50220278|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
25108703|NCT02121795|50220277|FG000|Double-Blind Phase|Lost to Follow-up|7|||
25108704|NCT02121795|50220278|FG001|Double-Blind Phase|Lost to Follow-up|4|||
25108705|NCT02121795|50220277|FG000|Double-Blind Phase|Physician Decision|2|||
25108706|NCT02121795|50220278|FG001|Double-Blind Phase|Physician Decision|5|||
25108707|NCT02121795|50220277|FG000|Double-Blind Phase|Adverse Event|5|||
25108708|NCT02121795|50220278|FG001|Double-Blind Phase|Adverse Event|0|||
25108709|NCT02121795|50220277|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
25108710|NCT02121795|50220278|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
25108711|NCT02121795|50220277|FG000|Double-Blind Phase|Protocol Violation|0|||
25108712|NCT02121795|50220278|FG001|Double-Blind Phase|Protocol Violation|3|||
25108713|NCT02121795|50220277|FG000|Double-Blind Phase|Death|1|||
25108714|NCT02121795|50220278|FG001|Double-Blind Phase|Death|1|||
25108715|NCT02121795|50220277|FG000|Open-Label Phase|Physician Decision|8|||
25108716|NCT02121795|50220278|FG001|Open-Label Phase|Physician Decision|8|||
25108717|NCT02121795|50220277|FG000|Open-Label Phase|Withdrawal by Subject|3|||
25108718|NCT02121795|50220278|FG001|Open-Label Phase|Withdrawal by Subject|2|||
25108719|NCT02121795|50220277|FG000|Open-Label Phase|Lost to Follow-up|1|||
25108720|NCT02121795|50220278|FG001|Open-Label Phase|Lost to Follow-up|0|||
25108721|NCT02158533|50220289|FG000|Stage 1|Adverse Event|6|||
25108722|NCT02158533|50220290|FG001|Stage 1|Adverse Event|4|||
25108723|NCT02158533|50220291|FG002|Stage 1|Adverse Event|7|||
25108724|NCT02158533|50220292|FG003|Stage 1|Adverse Event|0|||
25108725|NCT02158533|50220293|FG004|Stage 1|Adverse Event|0|||
25108726|NCT02158533|50220294|FG005|Stage 1|Adverse Event|0|||
25108727|NCT02158533|50220289|FG000|Stage 1|Withdrawal by Subject|3|||
25108728|NCT02158533|50220290|FG001|Stage 1|Withdrawal by Subject|2|||
25108729|NCT02158533|50220291|FG002|Stage 1|Withdrawal by Subject|1|||
25108730|NCT02158533|50220292|FG003|Stage 1|Withdrawal by Subject|0|||
25108731|NCT02158533|50220293|FG004|Stage 1|Withdrawal by Subject|0|||
25108732|NCT02158533|50220294|FG005|Stage 1|Withdrawal by Subject|0|||
25108733|NCT02158533|50220289|FG000|Stage 1|Lack of Efficacy|1|||
25108734|NCT02158533|50220290|FG001|Stage 1|Lack of Efficacy|0|||
25108735|NCT02158533|50220291|FG002|Stage 1|Lack of Efficacy|0|||
25108736|NCT02158533|50220292|FG003|Stage 1|Lack of Efficacy|0|||
25108737|NCT02158533|50220293|FG004|Stage 1|Lack of Efficacy|0|||
25108738|NCT02158533|50220294|FG005|Stage 1|Lack of Efficacy|0|||
25108739|NCT02158533|50220289|FG000|Stage 1|Lost to Follow-up|3|||
25108740|NCT02158533|50220290|FG001|Stage 1|Lost to Follow-up|1|||
25108741|NCT02158533|50220291|FG002|Stage 1|Lost to Follow-up|0|||
25108742|NCT02158533|50220292|FG003|Stage 1|Lost to Follow-up|0|||
25108743|NCT02158533|50220293|FG004|Stage 1|Lost to Follow-up|0|||
25108744|NCT02158533|50220294|FG005|Stage 1|Lost to Follow-up|0|||
25108745|NCT02158533|50220289|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
25108746|NCT02158533|50220290|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
25108747|NCT02158533|50220291|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
25108748|NCT02158533|50220292|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
25108749|NCT02158533|50220293|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
25108750|NCT02158533|50220294|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
25108751|NCT02158533|50220289|FG000|Stage 1|Non-compliance with study visits|1|||
25108752|NCT02158533|50220290|FG001|Stage 1|Non-compliance with study visits|0|||
25108753|NCT02158533|50220291|FG002|Stage 1|Non-compliance with study visits|0|||
25108754|NCT02158533|50220292|FG003|Stage 1|Non-compliance with study visits|0|||
25108755|NCT02158533|50220293|FG004|Stage 1|Non-compliance with study visits|0|||
25108756|NCT02158533|50220294|FG005|Stage 1|Non-compliance with study visits|0|||
25108757|NCT02158533|50220289|FG000|Stage 2|Adverse Event|0|||
25108758|NCT02158533|50220290|FG001|Stage 2|Adverse Event|0|||
25108759|NCT02158533|50220291|FG002|Stage 2|Adverse Event|0|||
25108760|NCT02158533|50220292|FG003|Stage 2|Adverse Event|0|||
25108761|NCT02158533|50220293|FG004|Stage 2|Adverse Event|0|||
25108762|NCT02158533|50220294|FG005|Stage 2|Adverse Event|1|||
25108763|NCT02158533|50220289|FG000|Stage 2|Lack of Efficacy|0|||
25108764|NCT02158533|50220290|FG001|Stage 2|Lack of Efficacy|0|||
25108765|NCT02158533|50220291|FG002|Stage 2|Lack of Efficacy|0|||
25108766|NCT02158533|50220292|FG003|Stage 2|Lack of Efficacy|0|||
25108767|NCT02158533|50220293|FG004|Stage 2|Lack of Efficacy|1|||
25108768|NCT02158533|50220294|FG005|Stage 2|Lack of Efficacy|0|||
25108769|NCT02158533|50220289|FG000|Stage 2|Lost to Follow-up|0|||
25108770|NCT02158533|50220290|FG001|Stage 2|Lost to Follow-up|0|||
25108771|NCT02158533|50220291|FG002|Stage 2|Lost to Follow-up|0|||
25108772|NCT02158533|50220292|FG003|Stage 2|Lost to Follow-up|1|||
25108773|NCT02158533|50220293|FG004|Stage 2|Lost to Follow-up|1|||
25108774|NCT02158533|50220294|FG005|Stage 2|Lost to Follow-up|2|||
25108775|NCT02158533|50220289|FG000|Stage 2|Withdrawal by Subject|0|||
25108776|NCT02158533|50220290|FG001|Stage 2|Withdrawal by Subject|0|||
25108777|NCT02158533|50220291|FG002|Stage 2|Withdrawal by Subject|0|||
25108778|NCT02158533|50220292|FG003|Stage 2|Withdrawal by Subject|0|||
25108779|NCT02158533|50220293|FG004|Stage 2|Withdrawal by Subject|1|||
25108780|NCT02158533|50220294|FG005|Stage 2|Withdrawal by Subject|2|||
25108781|NCT02158533|50220289|FG000|Stage 2|Physician Decision|0|||
25108782|NCT02158533|50220290|FG001|Stage 2|Physician Decision|0|||
25108783|NCT02158533|50220291|FG002|Stage 2|Physician Decision|0|||
25108784|NCT02158533|50220292|FG003|Stage 2|Physician Decision|0|||
25108785|NCT02158533|50220293|FG004|Stage 2|Physician Decision|1|||
25108786|NCT02158533|50220294|FG005|Stage 2|Physician Decision|0|||
25108787|NCT02158533|50220289|FG000|Stage 2|Pregnancy|0|||
25108788|NCT02158533|50220290|FG001|Stage 2|Pregnancy|0|||
25108789|NCT02158533|50220291|FG002|Stage 2|Pregnancy|0|||
25108790|NCT02158533|50220292|FG003|Stage 2|Pregnancy|1|||
25108791|NCT02158533|50220293|FG004|Stage 2|Pregnancy|0|||
25108792|NCT02158533|50220294|FG005|Stage 2|Pregnancy|0|||
25108793|NCT02158533|50220289|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
25108794|NCT02158533|50220290|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
25108795|NCT02158533|50220291|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
25108796|NCT02158533|50220292|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
25108797|NCT02158533|50220293|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
25108798|NCT02158533|50220294|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
25108799|NCT02158533|50220289|FG000|Stage 2|Non-adherence with study visits|0|||
25108800|NCT02158533|50220290|FG001|Stage 2|Non-adherence with study visits|0|||
25108801|NCT02158533|50220291|FG002|Stage 2|Non-adherence with study visits|0|||
25108802|NCT02158533|50220292|FG003|Stage 2|Non-adherence with study visits|0|||
25108803|NCT02158533|50220293|FG004|Stage 2|Non-adherence with study visits|0|||
25108804|NCT02158533|50220294|FG005|Stage 2|Non-adherence with study visits|1|||
25108805|NCT02120781|50220310|FG000|Overall Study|Physician Decision|2|||
25108806|NCT02120781|50220311|FG001|Overall Study|Physician Decision|0|||
25108807|NCT02120781|50220310|FG000|Overall Study|Completion not documented|2|||
25108808|NCT02120781|50220311|FG001|Overall Study|Completion not documented|1|||
25108809|NCT02120625|50220317|FG000|Overall Study|Physician Decision|2|||
25108810|NCT02120469|50220324|FG000|Overall Study|HER-2/neu-amplified|1|||
25108811|NCT02120469|50220325|FG001|Overall Study|HER-2/neu-amplified|0|||
25108812|NCT02120469|50220326|FG002|Overall Study|HER-2/neu-amplified|1|||
25108813|NCT02157519|50220339|FG000|Overall Study|Death|3|||
25108814|NCT02157519|50220340|FG001|Overall Study|Death|1|||
25108815|NCT02157519|50220339|FG000|Overall Study|Withdrawal by Subject|7|||
25108816|NCT02157519|50220340|FG001|Overall Study|Withdrawal by Subject|0|||
25108817|NCT02157519|50220339|FG000|Overall Study|Lost to Follow-up|1|||
25108818|NCT02157519|50220340|FG001|Overall Study|Lost to Follow-up|0|||
25108819|NCT02180061|50220348|FG000|Overall Study|Adverse Event|4|||
25108820|NCT02180061|50220349|FG001|Overall Study|Adverse Event|2|||
25108821|NCT02180061|50220348|FG000|Overall Study|Clinical Progression|5|||
25108822|NCT02180061|50220349|FG001|Overall Study|Clinical Progression|1|||
25108823|NCT02180061|50220348|FG000|Overall Study|Progressive Disease|15|||
25108824|NCT02180061|50220349|FG001|Overall Study|Progressive Disease|5|||
25261249|NCT01265511|50575948|FG001|Overall Study|Lack of Efficacy|1|||
25108825|NCT02180061|50220348|FG000|Overall Study|Physician Decision|1|||
25108826|NCT02180061|50220349|FG001|Overall Study|Physician Decision|0|||
25108827|NCT02179515|50220358|FG000|Overall Study|switched to alternative treatment|0|||
25108828|NCT02179515|50220359|FG001|Overall Study|switched to alternative treatment|1|||
25108829|NCT02179515|50220360|FG002|Overall Study|switched to alternative treatment|1|||
25108830|NCT02179515|50220358|FG000|Overall Study|Death|0|||
25108831|NCT02179515|50220359|FG001|Overall Study|Death|1|||
25108832|NCT02179515|50220360|FG002|Overall Study|Death|1|||
25108833|NCT02179515|50220358|FG000|Overall Study|refused further treatment|0|||
25177303|NCT03387150|50321412|FG006|Overall Study|Withdrawal by Subject|0|||
25261250|NCT01265511|50575947|FG000|Overall Study|Met stopping rules|0|||
25108834|NCT02179515|50220359|FG001|Overall Study|refused further treatment|3|||
25108835|NCT02179515|50220360|FG002|Overall Study|refused further treatment|4|||
25108836|NCT02179515|50220358|FG000|Overall Study|Disease progression on study|2|||
25108837|NCT02179515|50220359|FG001|Overall Study|Disease progression on study|11|||
25108838|NCT02179515|50220360|FG002|Overall Study|Disease progression on study|8|||
25108839|NCT02120157|50220372|FG000|Overall Study|Death|8|||
25177304|NCT03387150|50321406|FG000|Overall Study|Lost to Follow-up|3|||
25108840|NCT02119299|50220378|FG000|Overall Study|Withdrawal by Subject|7|||
25108841|NCT02119299|50220378|FG000|Overall Study|Lack of Efficacy|1|||
25108842|NCT02119299|50220378|FG000|Overall Study|Pregnancy|1|||
25108843|NCT02156271|50220384|FG000|Overall Study|Physician Decision|4|||
25108844|NCT02156271|50220385|FG001|Overall Study|Physician Decision|3|||
25108845|NCT01365455|50220394|FG000|Induction Period|Adverse Event|5|||
25108846|NCT01365455|50220395|FG001|Induction Period|Adverse Event|3|||
25108847|NCT01365455|50220396|FG002|Induction Period|Adverse Event|4|||
25108848|NCT01365455|50220397|FG003|Induction Period|Adverse Event|0|||
25108849|NCT01365455|50220398|FG004|Induction Period|Adverse Event|0|||
25108850|NCT01365455|50220394|FG000|Induction Period|Lack of Efficacy|1|||
25108851|NCT01365455|50220395|FG001|Induction Period|Lack of Efficacy|1|||
25108852|NCT01365455|50220396|FG002|Induction Period|Lack of Efficacy|0|||
25108853|NCT01365455|50220397|FG003|Induction Period|Lack of Efficacy|0|||
25108854|NCT01365455|50220398|FG004|Induction Period|Lack of Efficacy|0|||
25108855|NCT01365455|50220394|FG000|Induction Period|Pregnancy|0|||
25108856|NCT01365455|50220395|FG001|Induction Period|Pregnancy|1|||
25108857|NCT01365455|50220396|FG002|Induction Period|Pregnancy|0|||
25108858|NCT01365455|50220397|FG003|Induction Period|Pregnancy|0|||
25108859|NCT01365455|50220398|FG004|Induction Period|Pregnancy|0|||
25108860|NCT01365455|50220394|FG000|Induction Period|Protocol deviation|0|||
25108861|NCT01365455|50220395|FG001|Induction Period|Protocol deviation|1|||
25108862|NCT01365455|50220396|FG002|Induction Period|Protocol deviation|1|||
25108863|NCT01365455|50220397|FG003|Induction Period|Protocol deviation|0|||
25108864|NCT01365455|50220398|FG004|Induction Period|Protocol deviation|0|||
25108865|NCT01365455|50220394|FG000|Induction Period|Subject/guardian decision|9|||
25108866|NCT01365455|50220395|FG001|Induction Period|Subject/guardian decision|1|||
25108867|NCT01365455|50220396|FG002|Induction Period|Subject/guardian decision|8|||
25108868|NCT01365455|50220397|FG003|Induction Period|Subject/guardian decision|0|||
25108869|NCT01365455|50220398|FG004|Induction Period|Subject/guardian decision|0|||
25108870|NCT01365455|50220394|FG000|Induction Period|Lost to Follow-up|0|||
25108871|NCT01365455|50220395|FG001|Induction Period|Lost to Follow-up|0|||
25108872|NCT01365455|50220396|FG002|Induction Period|Lost to Follow-up|3|||
25108873|NCT01365455|50220397|FG003|Induction Period|Lost to Follow-up|0|||
25108874|NCT01365455|50220398|FG004|Induction Period|Lost to Follow-up|0|||
25108875|NCT01365455|50220394|FG000|Maintenance Period|Adverse Event|12|||
25108876|NCT01365455|50220395|FG001|Maintenance Period|Adverse Event|5|||
25108877|NCT01365455|50220396|FG002|Maintenance Period|Adverse Event|1|||
25108878|NCT01365455|50220397|FG003|Maintenance Period|Adverse Event|2|||
25108879|NCT01365455|50220398|FG004|Maintenance Period|Adverse Event|4|||
25108880|NCT01365455|50220394|FG000|Maintenance Period|Lack of Efficacy|10|||
25108881|NCT01365455|50220395|FG001|Maintenance Period|Lack of Efficacy|2|||
25108882|NCT01365455|50220396|FG002|Maintenance Period|Lack of Efficacy|0|||
25108883|NCT01365455|50220397|FG003|Maintenance Period|Lack of Efficacy|2|||
25108884|NCT01365455|50220398|FG004|Maintenance Period|Lack of Efficacy|2|||
25108885|NCT01365455|50220394|FG000|Maintenance Period|Lost to Follow-up|2|||
25108886|NCT01365455|50220395|FG001|Maintenance Period|Lost to Follow-up|4|||
25108887|NCT01365455|50220396|FG002|Maintenance Period|Lost to Follow-up|0|||
25108888|NCT01365455|50220397|FG003|Maintenance Period|Lost to Follow-up|0|||
25108889|NCT01365455|50220398|FG004|Maintenance Period|Lost to Follow-up|3|||
25108890|NCT01365455|50220394|FG000|Maintenance Period|Non-compliance with study treatment|0|||
25108891|NCT01365455|50220395|FG001|Maintenance Period|Non-compliance with study treatment|0|||
25108892|NCT01365455|50220396|FG002|Maintenance Period|Non-compliance with study treatment|0|||
25108893|NCT01365455|50220397|FG003|Maintenance Period|Non-compliance with study treatment|1|||
25108894|NCT01365455|50220398|FG004|Maintenance Period|Non-compliance with study treatment|0|||
25108895|NCT01365455|50220394|FG000|Maintenance Period|Physician Decision|0|||
25108896|NCT01365455|50220395|FG001|Maintenance Period|Physician Decision|1|||
25108897|NCT01365455|50220396|FG002|Maintenance Period|Physician Decision|0|||
25108898|NCT01365455|50220397|FG003|Maintenance Period|Physician Decision|0|||
25108899|NCT01365455|50220398|FG004|Maintenance Period|Physician Decision|1|||
25108900|NCT01365455|50220394|FG000|Maintenance Period|Pregnancy|0|||
25108901|NCT01365455|50220395|FG001|Maintenance Period|Pregnancy|4|||
25108902|NCT01365455|50220396|FG002|Maintenance Period|Pregnancy|0|||
25108903|NCT01365455|50220397|FG003|Maintenance Period|Pregnancy|0|||
25108904|NCT01365455|50220398|FG004|Maintenance Period|Pregnancy|2|||
25108905|NCT01365455|50220394|FG000|Maintenance Period|Protocol deviation|1|||
25108906|NCT01365455|50220395|FG001|Maintenance Period|Protocol deviation|1|||
25108907|NCT01365455|50220396|FG002|Maintenance Period|Protocol deviation|0|||
25108908|NCT01365455|50220397|FG003|Maintenance Period|Protocol deviation|0|||
25108909|NCT01365455|50220398|FG004|Maintenance Period|Protocol deviation|0|||
25108910|NCT01365455|50220394|FG000|Maintenance Period|Subject/guardian decision|4|||
25108911|NCT01365455|50220395|FG001|Maintenance Period|Subject/guardian decision|6|||
25108912|NCT01365455|50220396|FG002|Maintenance Period|Subject/guardian decision|2|||
25108913|NCT01365455|50220397|FG003|Maintenance Period|Subject/guardian decision|4|||
25108914|NCT01365455|50220398|FG004|Maintenance Period|Subject/guardian decision|1|||
25108915|NCT02155881|50220418|FG000|Overall Study|Withdrawal by Subject|0|||
25108916|NCT02155881|50220419|FG001|Overall Study|Withdrawal by Subject|2|||
25108917|NCT02155881|50220418|FG000|Overall Study|Inappropriately randomized|2|||
25108918|NCT02155881|50220419|FG001|Overall Study|Inappropriately randomized|2|||
25108919|NCT01658579|50220429|FG000|Treatment Period A|Other|0|||
25108920|NCT01658579|50220430|FG001|Treatment Period A|Other|0|||
25108921|NCT01658579|50220431|FG002|Treatment Period A|Other|1|||
25108922|NCT01658579|50220432|FG003|Treatment Period A|Other|1|||
25108923|NCT01658579|50220429|FG000|Treatment Period A|Adverse Event|1|||
25108924|NCT01658579|50220430|FG001|Treatment Period A|Adverse Event|0|||
25108925|NCT01658579|50220431|FG002|Treatment Period A|Adverse Event|0|||
25108926|NCT01658579|50220432|FG003|Treatment Period A|Adverse Event|0|||
25108927|NCT01658579|50220429|FG000|Treatment Period B|Other|0|||
25108928|NCT01658579|50220430|FG001|Treatment Period B|Other|0|||
25108929|NCT01658579|50220431|FG002|Treatment Period B|Other|0|||
25108930|NCT01658579|50220432|FG003|Treatment Period B|Other|1|||
25108931|NCT02154087|50220438|FG000|Overall Study|Study Termination|1|||
25108932|NCT02118597|50220442|FG000|Overall Study|Sponsor terminated the study|14|||
25108933|NCT02118597|50220442|FG000|Overall Study|Serious Adverse Event|1|||
25108934|NCT02118597|50220442|FG000|Overall Study|Investigator's decision|1|||
25108935|NCT01659125|50220446|FG000|Overall Study|Withdrawal by Subject|2|||
25108936|NCT01659125|50220446|FG000|Overall Study|Lost to Follow-up|7|||
25108937|NCT01659125|50220446|FG000|Overall Study|Technical Problem|1|||
25108938|NCT01659125|50220446|FG000|Overall Study|Time Constraints|2|||
25108939|NCT01659125|50220446|FG000|Overall Study|Failed to Start Treatment|2|||
25108940|NCT01657253|50220452|FG000|Overall Study|Lost to Follow-up|6|||
25108941|NCT01657253|50220453|FG001|Overall Study|Lost to Follow-up|5|||
25108942|NCT01657253|50220452|FG000|Overall Study|Withdrawal by Subject|11|||
25108943|NCT01657253|50220453|FG001|Overall Study|Withdrawal by Subject|12|||
25108944|NCT01657253|50220452|FG000|Overall Study|Adverse Event|0|||
25108945|NCT01657253|50220453|FG001|Overall Study|Adverse Event|1|||
25108946|NCT02117427|50220462|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
25108947|NCT02117427|50220463|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
25108948|NCT02117427|50220464|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
25108949|NCT02117427|50220462|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
25108950|NCT02117427|50220463|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
25108951|NCT02117427|50220464|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
25108952|NCT02117427|50220462|FG000|Overall Study|Physician Decision|0|||
25108953|NCT02117427|50220463|FG001|Overall Study|Physician Decision|2|||
25108954|NCT02117427|50220464|FG002|Overall Study|Physician Decision|0|||
25108955|NCT02117427|50220462|FG000|Overall Study|No longer meets inclusion criteria|0|||
25108956|NCT02117427|50220463|FG001|Overall Study|No longer meets inclusion criteria|1|||
25108957|NCT02117427|50220464|FG002|Overall Study|No longer meets inclusion criteria|0|||
25108958|NCT02117427|50220462|FG000|Overall Study|Death|0|||
25108959|NCT02117427|50220463|FG001|Overall Study|Death|1|||
25108960|NCT02117427|50220464|FG002|Overall Study|Death|0|||
25108961|NCT02117349|50220472|FG000|Overall Study|Withdrawal by Subject|1|||
25108962|NCT02117349|50220473|FG001|Overall Study|Withdrawal by Subject|0|||
25108963|NCT02117349|50220472|FG000|Overall Study|Lost to Follow-up|1|||
25108964|NCT02117349|50220473|FG001|Overall Study|Lost to Follow-up|1|||
25108965|NCT02117349|50220472|FG000|Overall Study|Death|1|||
25108966|NCT02117349|50220473|FG001|Overall Study|Death|0|||
25108967|NCT01626495|50220479|FG000|Overall Study|Adverse Event|3|||
25108968|NCT01626495|50220479|FG000|Overall Study|Disease progression|27|||
25108969|NCT01626495|50220479|FG000|Overall Study|Withdrawal by Subject|1|||
25108970|NCT01626495|50220479|FG000|Overall Study|Administrative problem|1|||
25108971|NCT01626495|50220479|FG000|Overall Study|Death|2|||
25108972|NCT01626495|50220479|FG000|Overall Study|Physician Decision|1|||
25108973|NCT01626495|50220479|FG000|Overall Study|New cancer therapy|16|||
25108974|NCT01626495|50220479|FG000|Overall Study|Manufacturing failure|1|||
25108975|NCT02177175|50220485|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
25108976|NCT02177175|50220486|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
25108977|NCT02153073|50220492|FG000|Overall Study|Case Report Forms Uncollected|230|||
25108978|NCT02153073|50220492|FG000|Overall Study|Protocol Deviation|68|||
25108979|NCT01657877|50220496|FG000|Overall Study|Withdrawal by Subject|4|||
25108980|NCT01657877|50220496|FG000|Overall Study|Protocol Violation|6|||
25108981|NCT01657877|50220496|FG000|Overall Study|Adverse Event|2|||
25108982|NCT01657877|50220496|FG000|Overall Study|Other Reason|2|||
25108983|NCT02175771|50220521|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
25108984|NCT02175771|50220522|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25108985|NCT02175771|50220523|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25108986|NCT02175771|50220524|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25108987|NCT02175771|50220525|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25108988|NCT02175771|50220526|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25108989|NCT02175771|50220527|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25108990|NCT02175771|50220528|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25108991|NCT02175771|50220529|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25108992|NCT02175771|50220521|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
25108993|NCT02175771|50220522|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25108994|NCT02175771|50220523|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25108995|NCT02175771|50220524|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25108996|NCT02175771|50220525|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25108997|NCT02175771|50220526|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25108998|NCT02175771|50220527|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25108999|NCT02175771|50220528|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25109000|NCT02175771|50220529|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25109001|NCT02175771|50220521|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
25109002|NCT02175771|50220522|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25109003|NCT02175771|50220523|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25109004|NCT02175771|50220524|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25109005|NCT02175771|50220525|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25109006|NCT02175771|50220526|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25109007|NCT02175771|50220527|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25109008|NCT02175771|50220528|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25109009|NCT02175771|50220529|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25109010|NCT02175771|50220521|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
25109011|NCT02175771|50220522|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
25109012|NCT02175771|50220523|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
25109013|NCT02175771|50220524|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
25109014|NCT02175771|50220525|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
25109015|NCT02175771|50220526|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
25109016|NCT02175771|50220527|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
25109017|NCT02175771|50220528|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
25109018|NCT02175771|50220529|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
25109019|NCT02175771|50220521|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
25109020|NCT02175771|50220522|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25109021|NCT02175771|50220523|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25109022|NCT02175771|50220524|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25109023|NCT02175771|50220525|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25109024|NCT02175771|50220526|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25109025|NCT02175771|50220527|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25109026|NCT02175771|50220528|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25109027|NCT02175771|50220529|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25109028|NCT02175771|50220521|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
25109029|NCT02175771|50220522|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25109030|NCT02175771|50220523|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25109031|NCT02175771|50220524|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25109032|NCT02175771|50220525|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25109033|NCT02175771|50220526|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25109034|NCT02175771|50220527|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25109035|NCT02175771|50220528|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25109036|NCT02175771|50220529|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25109037|NCT02175771|50220521|FG000|Run-In Period (Pre-assignment)|Other|8|||
25109038|NCT02175771|50220522|FG001|Run-In Period (Pre-assignment)|Other|0|||
25109039|NCT02175771|50220523|FG002|Run-In Period (Pre-assignment)|Other|0|||
25109040|NCT02175771|50220524|FG003|Run-In Period (Pre-assignment)|Other|0|||
25109041|NCT02175771|50220525|FG004|Run-In Period (Pre-assignment)|Other|0|||
25109042|NCT02175771|50220526|FG005|Run-In Period (Pre-assignment)|Other|0|||
25109043|NCT02175771|50220527|FG006|Run-In Period (Pre-assignment)|Other|0|||
25109044|NCT02175771|50220528|FG007|Run-In Period (Pre-assignment)|Other|0|||
25109045|NCT02175771|50220529|FG008|Run-In Period (Pre-assignment)|Other|0|||
25109046|NCT02175771|50220521|FG000|Treatment Period|Adverse Event|0|||
25109047|NCT02175771|50220522|FG001|Treatment Period|Adverse Event|2|||
25109048|NCT02175771|50220523|FG002|Treatment Period|Adverse Event|1|||
25109049|NCT02175771|50220524|FG003|Treatment Period|Adverse Event|1|||
25109050|NCT02175771|50220525|FG004|Treatment Period|Adverse Event|1|||
25109051|NCT02175771|50220526|FG005|Treatment Period|Adverse Event|3|||
25109052|NCT02175771|50220527|FG006|Treatment Period|Adverse Event|2|||
25109053|NCT02175771|50220528|FG007|Treatment Period|Adverse Event|0|||
25109054|NCT02175771|50220529|FG008|Treatment Period|Adverse Event|1|||
25109055|NCT02175771|50220521|FG000|Treatment Period|Withdrawal by Subject|0|||
25109056|NCT02175771|50220522|FG001|Treatment Period|Withdrawal by Subject|9|||
25109057|NCT02175771|50220523|FG002|Treatment Period|Withdrawal by Subject|3|||
25261251|NCT01265511|50575948|FG001|Overall Study|Met stopping rules|2|||
25261252|NCT01264965|50575954|FG000|Overall Study|Withdrawal by Subject|10|||
25261253|NCT01264887|50575958|FG000|Overall Study|Adverse Event|5|||
25261254|NCT01264887|50575958|FG000|Overall Study|Death|7|||
25177305|NCT03387150|50321407|FG001|Overall Study|Lost to Follow-up|2|||
25109058|NCT02175771|50220524|FG003|Treatment Period|Withdrawal by Subject|6|||
25109059|NCT02175771|50220525|FG004|Treatment Period|Withdrawal by Subject|2|||
25109060|NCT02175771|50220526|FG005|Treatment Period|Withdrawal by Subject|4|||
25109061|NCT02175771|50220527|FG006|Treatment Period|Withdrawal by Subject|2|||
25109062|NCT02175771|50220528|FG007|Treatment Period|Withdrawal by Subject|9|||
25109063|NCT02175771|50220529|FG008|Treatment Period|Withdrawal by Subject|2|||
25109064|NCT02175771|50220521|FG000|Treatment Period|Noncompliance|0|||
25109065|NCT02175771|50220522|FG001|Treatment Period|Noncompliance|1|||
25109066|NCT02175771|50220523|FG002|Treatment Period|Noncompliance|2|||
25109067|NCT02175771|50220524|FG003|Treatment Period|Noncompliance|0|||
25109068|NCT02175771|50220525|FG004|Treatment Period|Noncompliance|0|||
25109069|NCT02175771|50220526|FG005|Treatment Period|Noncompliance|0|||
25109070|NCT02175771|50220527|FG006|Treatment Period|Noncompliance|0|||
25109071|NCT02175771|50220528|FG007|Treatment Period|Noncompliance|0|||
25109072|NCT02175771|50220529|FG008|Treatment Period|Noncompliance|1|||
25109073|NCT02175771|50220521|FG000|Treatment Period|Protocol Violation|0|||
25109074|NCT02175771|50220522|FG001|Treatment Period|Protocol Violation|0|||
25109075|NCT02175771|50220523|FG002|Treatment Period|Protocol Violation|0|||
25109076|NCT02175771|50220524|FG003|Treatment Period|Protocol Violation|0|||
25109077|NCT02175771|50220525|FG004|Treatment Period|Protocol Violation|0|||
25109078|NCT02175771|50220526|FG005|Treatment Period|Protocol Violation|0|||
25109079|NCT02175771|50220527|FG006|Treatment Period|Protocol Violation|0|||
25109080|NCT02175771|50220528|FG007|Treatment Period|Protocol Violation|1|||
25109081|NCT02175771|50220529|FG008|Treatment Period|Protocol Violation|0|||
25109082|NCT02175771|50220521|FG000|Treatment Period|Disease progression|0|||
25109083|NCT02175771|50220522|FG001|Treatment Period|Disease progression|0|||
25109084|NCT02175771|50220523|FG002|Treatment Period|Disease progression|0|||
25109085|NCT02175771|50220524|FG003|Treatment Period|Disease progression|0|||
25109086|NCT02175771|50220525|FG004|Treatment Period|Disease progression|0|||
25109087|NCT02175771|50220526|FG005|Treatment Period|Disease progression|0|||
25109088|NCT02175771|50220527|FG006|Treatment Period|Disease progression|0|||
25109089|NCT02175771|50220528|FG007|Treatment Period|Disease progression|2|||
25109090|NCT02175771|50220529|FG008|Treatment Period|Disease progression|0|||
25109091|NCT02175771|50220521|FG000|Treatment Period|Lost to Follow-up|0|||
25109092|NCT02175771|50220522|FG001|Treatment Period|Lost to Follow-up|3|||
25109093|NCT02175771|50220523|FG002|Treatment Period|Lost to Follow-up|1|||
25109094|NCT02175771|50220524|FG003|Treatment Period|Lost to Follow-up|3|||
25109095|NCT02175771|50220525|FG004|Treatment Period|Lost to Follow-up|1|||
25109096|NCT02175771|50220526|FG005|Treatment Period|Lost to Follow-up|2|||
25109097|NCT02175771|50220527|FG006|Treatment Period|Lost to Follow-up|1|||
25109098|NCT02175771|50220528|FG007|Treatment Period|Lost to Follow-up|2|||
25109099|NCT02175771|50220529|FG008|Treatment Period|Lost to Follow-up|2|||
25109100|NCT02175771|50220521|FG000|Treatment Period|Lack of Efficacy|0|||
25109101|NCT02175771|50220522|FG001|Treatment Period|Lack of Efficacy|0|||
25109102|NCT02175771|50220523|FG002|Treatment Period|Lack of Efficacy|0|||
25109103|NCT02175771|50220524|FG003|Treatment Period|Lack of Efficacy|0|||
25109104|NCT02175771|50220525|FG004|Treatment Period|Lack of Efficacy|0|||
25109105|NCT02175771|50220526|FG005|Treatment Period|Lack of Efficacy|1|||
25109106|NCT02175771|50220527|FG006|Treatment Period|Lack of Efficacy|0|||
25109107|NCT02175771|50220528|FG007|Treatment Period|Lack of Efficacy|1|||
25109108|NCT02175771|50220529|FG008|Treatment Period|Lack of Efficacy|0|||
25109109|NCT02175771|50220521|FG000|Treatment Period|Other|0|||
25109110|NCT02175771|50220522|FG001|Treatment Period|Other|1|||
25109111|NCT02175771|50220523|FG002|Treatment Period|Other|0|||
25109112|NCT02175771|50220524|FG003|Treatment Period|Other|3|||
25109113|NCT02175771|50220525|FG004|Treatment Period|Other|1|||
25109114|NCT02175771|50220526|FG005|Treatment Period|Other|0|||
25109115|NCT02175771|50220527|FG006|Treatment Period|Other|0|||
25261255|NCT01264887|50575958|FG000|Overall Study|Lack of Efficacy|5|||
25109116|NCT02175771|50220528|FG007|Treatment Period|Other|2|||
25109117|NCT02175771|50220529|FG008|Treatment Period|Other|0|||
25109118|NCT01657799|50220550|FG000|Overall Study|Adverse Event Related to progression|6|||
25109119|NCT01657799|50220551|FG001|Overall Study|Adverse Event Related to progression|8|||
25109120|NCT01657799|50220552|FG002|Overall Study|Adverse Event Related to progression|12|||
25109121|NCT01657799|50220550|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
25109122|NCT01657799|50220551|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
25109123|NCT01657799|50220552|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
25109124|NCT01657799|50220550|FG000|Overall Study|Withdrawal by Subject|13|||
25261256|NCT01264887|50575958|FG000|Overall Study|Physician Decision|4|||
25109125|NCT01657799|50220551|FG001|Overall Study|Withdrawal by Subject|10|||
25109126|NCT01657799|50220552|FG002|Overall Study|Withdrawal by Subject|10|||
25109127|NCT01657799|50220550|FG000|Overall Study|Lost to Follow-up|1|||
25109128|NCT01657799|50220551|FG001|Overall Study|Lost to Follow-up|0|||
25109129|NCT01657799|50220552|FG002|Overall Study|Lost to Follow-up|1|||
25109130|NCT01657799|50220550|FG000|Overall Study|Disease Progression|2|||
25109131|NCT01657799|50220551|FG001|Overall Study|Disease Progression|4|||
25109132|NCT01657799|50220552|FG002|Overall Study|Disease Progression|4|||
25261257|NCT01264887|50575958|FG000|Overall Study|Withdrawal by Subject|6|||
25109133|NCT01657799|50220550|FG000|Overall Study|Progressive Disease Clinical|7|||
25109134|NCT01657799|50220551|FG001|Overall Study|Progressive Disease Clinical|4|||
25109135|NCT01657799|50220552|FG002|Overall Study|Progressive Disease Clinical|7|||
25109136|NCT01657799|50220550|FG000|Overall Study|Radiographic & Clinical Progression|16|||
25109137|NCT01657799|50220551|FG001|Overall Study|Radiographic & Clinical Progression|11|||
25109138|NCT01657799|50220552|FG002|Overall Study|Radiographic & Clinical Progression|15|||
25109139|NCT01657799|50220550|FG000|Overall Study|Other|52|||
25109140|NCT01657799|50220551|FG001|Overall Study|Other|62|||
25109141|NCT01657799|50220552|FG002|Overall Study|Other|49|||
25109142|NCT02116803|50220562|FG000|Overall Study|Adverse Event|2|||
25109143|NCT02116803|50220563|FG001|Overall Study|Adverse Event|1|||
25109144|NCT02116803|50220562|FG000|Overall Study|Physician Decision|1|||
25109145|NCT02116803|50220563|FG001|Overall Study|Physician Decision|0|||
25109146|NCT02116803|50220562|FG000|Overall Study|Progressive disease|4|||
25109147|NCT02116803|50220563|FG001|Overall Study|Progressive disease|0|||
25109148|NCT02116803|50220562|FG000|Overall Study|Study terminated by sponsor|2|||
25109149|NCT02116803|50220563|FG001|Overall Study|Study terminated by sponsor|1|||
25109150|NCT02116803|50220562|FG000|Overall Study|Death|1|||
25109151|NCT02116803|50220563|FG001|Overall Study|Death|0|||
25109152|NCT02115321|50220571|FG000|Overall Study|Death|1|||
25109153|NCT02115321|50220572|FG001|Overall Study|Death|0|||
25109154|NCT02367781|50220580|FG000|Overall Study|Withdrawal by Subject|20|||
25109155|NCT02367781|50220581|FG001|Overall Study|Withdrawal by Subject|13|||
25109156|NCT02367781|50220580|FG000|Overall Study|Protocol Violation|0|||
25109157|NCT02367781|50220581|FG001|Overall Study|Protocol Violation|1|||
25109158|NCT02367781|50220580|FG000|Overall Study|Physician Decision|7|||
25109159|NCT02367781|50220581|FG001|Overall Study|Physician Decision|0|||
25109160|NCT02367781|50220580|FG000|Overall Study|Randomized in Error|5|||
25109161|NCT02367781|50220581|FG001|Overall Study|Randomized in Error|4|||
25109162|NCT02367781|50220580|FG000|Overall Study|Non-Compliance|1|||
25109163|NCT02367781|50220581|FG001|Overall Study|Non-Compliance|0|||
25109164|NCT02367781|50220580|FG000|Overall Study|Lost to Follow-up|1|||
25109165|NCT02367781|50220581|FG001|Overall Study|Lost to Follow-up|2|||
25109166|NCT02367781|50220580|FG000|Overall Study|Death|330|||
25109167|NCT02367781|50220581|FG001|Overall Study|Death|176|||
25109168|NCT02367781|50220580|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
25109169|NCT02367781|50220581|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
25109170|NCT02367781|50220580|FG000|Overall Study|Prolonged Hospitalization|1|||
25109171|NCT02367781|50220581|FG001|Overall Study|Prolonged Hospitalization|0|||
25109172|NCT02367781|50220580|FG000|Overall Study|Death Prior First Dose|1|||
25109173|NCT02367781|50220581|FG001|Overall Study|Death Prior First Dose|0|||
25109174|NCT02367781|50220580|FG000|Overall Study|Administrative-Change Facility|1|||
25109175|NCT02367781|50220581|FG001|Overall Study|Administrative-Change Facility|0|||
25109176|NCT02367781|50220580|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
25109177|NCT02367781|50220581|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
25109178|NCT02367781|50220580|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
25109179|NCT02367781|50220581|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
25109180|NCT02367781|50220580|FG000|Overall Study|Study Terminated by Sponsor|3|||
25109181|NCT02367781|50220581|FG001|Overall Study|Study Terminated by Sponsor|1|||
25109182|NCT02367781|50220580|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
25109183|NCT02367781|50220581|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
25109184|NCT02367781|50220580|FG000|Overall Study|Sponsor Decision|2|||
25109185|NCT02367781|50220581|FG001|Overall Study|Sponsor Decision|0|||
25109186|NCT02367781|50220580|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
25109187|NCT02367781|50220581|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
25109188|NCT02152761|50220593|FG000|Epoch: Treatment Epoch|Technical problems|0|||
25109189|NCT02152761|50220594|FG001|Epoch: Treatment Epoch|Technical problems|0|||
25109190|NCT02152761|50220595|FG002|Epoch: Treatment Epoch|Technical problems|0|||
25109191|NCT02152761|50220596|FG003|Epoch: Treatment Epoch|Technical problems|1|||
25109192|NCT02152761|50220593|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
25109193|NCT02152761|50220594|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
25109194|NCT02152761|50220595|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
25109195|NCT02152761|50220596|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
25109196|NCT02152761|50220593|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
25109197|NCT02152761|50220594|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
25109198|NCT02152761|50220595|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
25261258|NCT01264887|50575958|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
25261259|NCT01264887|50575958|FG000|Overall Study|Other|2|||
25109199|NCT02152761|50220596|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
25109200|NCT02152761|50220593|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
25109201|NCT02152761|50220594|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
25109202|NCT02152761|50220595|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
25109203|NCT02152761|50220596|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
25109204|NCT02152761|50220593|FG000|Epoch: Treatment Epoch|Death|0|||
25109205|NCT02152761|50220594|FG001|Epoch: Treatment Epoch|Death|3|||
25109206|NCT02152761|50220595|FG002|Epoch: Treatment Epoch|Death|1|||
25109207|NCT02152761|50220596|FG003|Epoch: Treatment Epoch|Death|0|||
25109208|NCT02152761|50220593|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
25109209|NCT02152761|50220594|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
25109210|NCT02152761|50220595|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
25109211|NCT02152761|50220596|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
25109212|NCT02152761|50220593|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
25109213|NCT02152761|50220594|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
25109214|NCT02152761|50220595|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
25109215|NCT02152761|50220596|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
25109216|NCT02152761|50220593|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
25109217|NCT02152761|50220594|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
25109218|NCT02152761|50220595|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
25109219|NCT02152761|50220596|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
25109220|NCT02152761|50220593|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
25109221|NCT02152761|50220594|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
25109222|NCT02152761|50220595|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
25109223|NCT02152761|50220596|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
25109224|NCT02152761|50220593|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
25109225|NCT02152761|50220594|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
25109226|NCT02152761|50220595|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
25109227|NCT02152761|50220596|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
25109228|NCT02152605|50220618|FG000|Overall Study|Adverse Event|6|||
25109229|NCT02152605|50220619|FG001|Overall Study|Adverse Event|8|||
25109230|NCT02152605|50220618|FG000|Overall Study|Lack of Efficacy|7|||
25109231|NCT02152605|50220619|FG001|Overall Study|Lack of Efficacy|4|||
25109232|NCT02152605|50220618|FG000|Overall Study|Protocol deviation|1|||
25109233|NCT02152605|50220619|FG001|Overall Study|Protocol deviation|4|||
25109234|NCT02152605|50220618|FG000|Overall Study|Lost to Follow-up|1|||
25109235|NCT02152605|50220619|FG001|Overall Study|Lost to Follow-up|0|||
25109236|NCT02152605|50220618|FG000|Overall Study|Withdrew consent|4|||
25109237|NCT02152605|50220619|FG001|Overall Study|Withdrew consent|2|||
25109238|NCT02152371|50220628|FG000|Overall Study|Adverse Event|6|||
25109239|NCT02152371|50220629|FG001|Overall Study|Adverse Event|2|||
25109240|NCT02152371|50220628|FG000|Overall Study|Withdrawal by Subject|3|||
25109241|NCT02152371|50220629|FG001|Overall Study|Withdrawal by Subject|7|||
25109242|NCT02152371|50220628|FG000|Overall Study|Protocol Violation|2|||
25109243|NCT02152371|50220629|FG001|Overall Study|Protocol Violation|3|||
25109244|NCT02152371|50220628|FG000|Overall Study|Lost to Follow-up|1|||
25109245|NCT02152371|50220629|FG001|Overall Study|Lost to Follow-up|0|||
25109246|NCT02152371|50220628|FG000|Overall Study|Lack of Efficacy|0|||
25109247|NCT02152371|50220629|FG001|Overall Study|Lack of Efficacy|1|||
25109248|NCT02152371|50220628|FG000|Overall Study|Physician Decision|0|||
25109249|NCT02152371|50220629|FG001|Overall Study|Physician Decision|2|||
25109250|NCT02152371|50220628|FG000|Overall Study|Reason Not Given|0|||
25109251|NCT02152371|50220629|FG001|Overall Study|Reason Not Given|1|||
25109252|NCT02332291|50220637|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
25109253|NCT02332291|50220638|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
25109254|NCT02332291|50220637|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
25109255|NCT02332291|50220638|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
25109256|NCT02332291|50220637|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
25109257|NCT02332291|50220638|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
25109258|NCT02332291|50220637|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
25109259|NCT02332291|50220638|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
25109260|NCT02332291|50220637|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
25109261|NCT02332291|50220638|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
25109262|NCT02332291|50220637|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
25109263|NCT02332291|50220638|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
25109264|NCT01656395|50220654|FG000|Overall Study|Adverse Event|1|||
25109265|NCT01656395|50220655|FG001|Overall Study|Adverse Event|14|||
25109266|NCT01656395|50220656|FG002|Overall Study|Adverse Event|5|||
25109267|NCT01656395|50220657|FG003|Overall Study|Adverse Event|4|||
25109268|NCT01656395|50220658|FG004|Overall Study|Adverse Event|5|||
25109269|NCT01656395|50220659|FG005|Overall Study|Adverse Event|7|||
25109270|NCT01656395|50220660|FG006|Overall Study|Adverse Event|0|||
25109271|NCT01656395|50220661|FG007|Overall Study|Adverse Event|0|||
25109272|NCT01656395|50220654|FG000|Overall Study|Lack of Efficacy|1|||
25109273|NCT01656395|50220655|FG001|Overall Study|Lack of Efficacy|8|||
25109274|NCT01656395|50220656|FG002|Overall Study|Lack of Efficacy|6|||
25109275|NCT01656395|50220657|FG003|Overall Study|Lack of Efficacy|1|||
25109276|NCT01656395|50220658|FG004|Overall Study|Lack of Efficacy|1|||
25109277|NCT01656395|50220659|FG005|Overall Study|Lack of Efficacy|6|||
25109278|NCT01656395|50220660|FG006|Overall Study|Lack of Efficacy|0|||
25109279|NCT01656395|50220661|FG007|Overall Study|Lack of Efficacy|0|||
25109280|NCT01656395|50220654|FG000|Overall Study|Lost to Follow-up|1|||
25109281|NCT01656395|50220655|FG001|Overall Study|Lost to Follow-up|0|||
25109282|NCT01656395|50220656|FG002|Overall Study|Lost to Follow-up|0|||
25109283|NCT01656395|50220657|FG003|Overall Study|Lost to Follow-up|0|||
25109284|NCT01656395|50220658|FG004|Overall Study|Lost to Follow-up|0|||
25109285|NCT01656395|50220659|FG005|Overall Study|Lost to Follow-up|0|||
25109286|NCT01656395|50220660|FG006|Overall Study|Lost to Follow-up|0|||
25109287|NCT01656395|50220661|FG007|Overall Study|Lost to Follow-up|0|||
25109288|NCT01656395|50220654|FG000|Overall Study|Non-Compliance with Study Drug|1|||
25109289|NCT01656395|50220655|FG001|Overall Study|Non-Compliance with Study Drug|1|||
25109290|NCT01656395|50220656|FG002|Overall Study|Non-Compliance with Study Drug|0|||
25109291|NCT01656395|50220657|FG003|Overall Study|Non-Compliance with Study Drug|0|||
25109292|NCT01656395|50220658|FG004|Overall Study|Non-Compliance with Study Drug|1|||
25109293|NCT01656395|50220659|FG005|Overall Study|Non-Compliance with Study Drug|1|||
25109294|NCT01656395|50220660|FG006|Overall Study|Non-Compliance with Study Drug|0|||
25109295|NCT01656395|50220661|FG007|Overall Study|Non-Compliance with Study Drug|0|||
25109296|NCT01656395|50220654|FG000|Overall Study|Other|0|||
25109297|NCT01656395|50220655|FG001|Overall Study|Other|0|||
25109298|NCT01656395|50220656|FG002|Overall Study|Other|1|||
25109299|NCT01656395|50220657|FG003|Overall Study|Other|0|||
25109300|NCT01656395|50220658|FG004|Overall Study|Other|0|||
25109301|NCT01656395|50220659|FG005|Overall Study|Other|1|||
25109302|NCT01656395|50220660|FG006|Overall Study|Other|0|||
25109303|NCT01656395|50220661|FG007|Overall Study|Other|0|||
25109304|NCT01656395|50220654|FG000|Overall Study|Physician Decision|2|||
25109305|NCT01656395|50220655|FG001|Overall Study|Physician Decision|3|||
25109306|NCT01656395|50220656|FG002|Overall Study|Physician Decision|3|||
25109307|NCT01656395|50220657|FG003|Overall Study|Physician Decision|2|||
25109308|NCT01656395|50220658|FG004|Overall Study|Physician Decision|3|||
25109309|NCT01656395|50220659|FG005|Overall Study|Physician Decision|3|||
25109310|NCT01656395|50220660|FG006|Overall Study|Physician Decision|0|||
25109311|NCT01656395|50220661|FG007|Overall Study|Physician Decision|0|||
25109312|NCT01656395|50220654|FG000|Overall Study|Pregnancy|0|||
25109313|NCT01656395|50220655|FG001|Overall Study|Pregnancy|0|||
25109314|NCT01656395|50220656|FG002|Overall Study|Pregnancy|1|||
25109315|NCT01656395|50220657|FG003|Overall Study|Pregnancy|0|||
25109316|NCT01656395|50220658|FG004|Overall Study|Pregnancy|0|||
25109317|NCT01656395|50220659|FG005|Overall Study|Pregnancy|0|||
25109318|NCT01656395|50220660|FG006|Overall Study|Pregnancy|0|||
25109319|NCT01656395|50220661|FG007|Overall Study|Pregnancy|0|||
25109320|NCT01656395|50220654|FG000|Overall Study|Progressive Disease|0|||
25109321|NCT01656395|50220655|FG001|Overall Study|Progressive Disease|0|||
25109322|NCT01656395|50220656|FG002|Overall Study|Progressive Disease|0|||
25109323|NCT01656395|50220657|FG003|Overall Study|Progressive Disease|0|||
25109324|NCT01656395|50220658|FG004|Overall Study|Progressive Disease|0|||
25109325|NCT01656395|50220659|FG005|Overall Study|Progressive Disease|1|||
25109326|NCT01656395|50220660|FG006|Overall Study|Progressive Disease|0|||
25109327|NCT01656395|50220661|FG007|Overall Study|Progressive Disease|0|||
25109328|NCT01656395|50220654|FG000|Overall Study|Protocol Violation|6|||
25109329|NCT01656395|50220655|FG001|Overall Study|Protocol Violation|6|||
25109330|NCT01656395|50220656|FG002|Overall Study|Protocol Violation|9|||
25109331|NCT01656395|50220657|FG003|Overall Study|Protocol Violation|2|||
25109332|NCT01656395|50220658|FG004|Overall Study|Protocol Violation|4|||
25109333|NCT01656395|50220659|FG005|Overall Study|Protocol Violation|10|||
25109334|NCT01656395|50220660|FG006|Overall Study|Protocol Violation|0|||
25109335|NCT01656395|50220661|FG007|Overall Study|Protocol Violation|0|||
25109336|NCT01656395|50220654|FG000|Overall Study|Screen Failure|2|||
25109337|NCT01656395|50220655|FG001|Overall Study|Screen Failure|1|||
25109338|NCT01656395|50220656|FG002|Overall Study|Screen Failure|7|||
25109339|NCT01656395|50220657|FG003|Overall Study|Screen Failure|1|||
25109340|NCT01656395|50220658|FG004|Overall Study|Screen Failure|0|||
25109341|NCT01656395|50220659|FG005|Overall Study|Screen Failure|8|||
25109342|NCT01656395|50220660|FG006|Overall Study|Screen Failure|0|||
25109343|NCT01656395|50220661|FG007|Overall Study|Screen Failure|0|||
25109344|NCT01656395|50220654|FG000|Overall Study|Withdrawal by Subject|3|||
25261260|NCT01306968|50575968|FG000|Overall Study|Lost to Follow-up|1|||
25109345|NCT01656395|50220655|FG001|Overall Study|Withdrawal by Subject|1|||
25109346|NCT01656395|50220656|FG002|Overall Study|Withdrawal by Subject|4|||
25109347|NCT01656395|50220657|FG003|Overall Study|Withdrawal by Subject|2|||
25109348|NCT01656395|50220658|FG004|Overall Study|Withdrawal by Subject|0|||
25109349|NCT01656395|50220659|FG005|Overall Study|Withdrawal by Subject|3|||
25109350|NCT01656395|50220660|FG006|Overall Study|Withdrawal by Subject|0|||
25109351|NCT01656395|50220661|FG007|Overall Study|Withdrawal by Subject|0|||
25109352|NCT02114931|50220677|FG000|Overall Study|Withdrawal by Subject|15|||
25109353|NCT02114931|50220678|FG001|Overall Study|Withdrawal by Subject|18|||
25109354|NCT02114931|50220677|FG000|Overall Study|Adverse Event|4|||
25109355|NCT02114931|50220678|FG001|Overall Study|Adverse Event|6|||
25109356|NCT02114931|50220677|FG000|Overall Study|Lost to Follow-up|3|||
25109357|NCT02114931|50220678|FG001|Overall Study|Lost to Follow-up|3|||
25109358|NCT02114931|50220677|FG000|Overall Study|Physician Decision|1|||
25109359|NCT02114931|50220678|FG001|Overall Study|Physician Decision|2|||
25109360|NCT02114931|50220677|FG000|Overall Study|Other|2|||
25109361|NCT02114931|50220678|FG001|Overall Study|Other|1|||
25109362|NCT01657019|50220684|FG000|Overall Study|Withdrawal by Subject|65|||
25109363|NCT01657019|50220684|FG000|Overall Study|Adverse Event|55|||
25109364|NCT01657019|50220684|FG000|Overall Study|Lost to Follow-up|48|||
25109365|NCT01657019|50220684|FG000|Overall Study|Protocol Violation|6|||
25109366|NCT01657019|50220684|FG000|Overall Study|Lack of Efficacy|3|||
25109367|NCT01657019|50220684|FG000|Overall Study|Other|58|||
25109368|NCT02329327|50220690|FG000|Overall Study|Death|78|||
25109369|NCT02329327|50220691|FG001|Overall Study|Death|0|||
25109370|NCT02329327|50220690|FG000|Overall Study|Withdrawal by Subject|3|||
25109371|NCT02329327|50220691|FG001|Overall Study|Withdrawal by Subject|0|||
25109372|NCT02329327|50220690|FG000|Overall Study|Lost to Follow-up|4|||
25109373|NCT02329327|50220691|FG001|Overall Study|Lost to Follow-up|0|||
25109374|NCT02328937|50220710|FG000|Period 1|Lost to Follow-up|0|||
25109375|NCT02328937|50220711|FG001|Period 1|Lost to Follow-up|0|||
25109376|NCT02328937|50220712|FG002|Period 1|Lost to Follow-up|0|||
25109377|NCT02328937|50220713|FG003|Period 1|Lost to Follow-up|1|||
25109378|NCT02328937|50220714|FG004|Period 1|Lost to Follow-up|0|||
25109379|NCT02328937|50220715|FG005|Period 1|Lost to Follow-up|0|||
25109380|NCT02328937|50220710|FG000|Period 2|Adverse Event|0|||
25109381|NCT02328937|50220711|FG001|Period 2|Adverse Event|0|||
25109382|NCT02328937|50220712|FG002|Period 2|Adverse Event|1|||
25109383|NCT02328937|50220713|FG003|Period 2|Adverse Event|0|||
25109384|NCT02328937|50220714|FG004|Period 2|Adverse Event|0|||
25109385|NCT02328937|50220715|FG005|Period 2|Adverse Event|0|||
25109386|NCT02328547|50220725|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
25109387|NCT02328547|50220726|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
25109388|NCT02328547|50220725|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
25109389|NCT02328547|50220726|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
25109390|NCT02300311|50220740|FG000|Overall Study|Other than the reason specified|1|||
25109391|NCT02300311|50220741|FG001|Overall Study|Other than the reason specified|0|||
25109392|NCT02300311|50220740|FG000|Overall Study|Refused to continue taking medication|18|||
25109393|NCT02300311|50220741|FG001|Overall Study|Refused to continue taking medication|0|||
25109394|NCT02300233|50220750|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
25109395|NCT02300233|50220751|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
25109396|NCT02300233|50220752|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
25109397|NCT02300233|50220750|FG000|Overall Study|Withdrawal by Subject|1|||
25109398|NCT02300233|50220751|FG001|Overall Study|Withdrawal by Subject|0|||
25109399|NCT02300233|50220752|FG002|Overall Study|Withdrawal by Subject|3|||
25109400|NCT02300233|50220750|FG000|Overall Study|Investigator Judgement|0|||
25109401|NCT02300233|50220751|FG001|Overall Study|Investigator Judgement|0|||
25109402|NCT02300233|50220752|FG002|Overall Study|Investigator Judgement|1|||
25109403|NCT02300233|50220750|FG000|Overall Study|Reason Not Specified|0|||
25109404|NCT02300233|50220751|FG001|Overall Study|Reason Not Specified|0|||
25109405|NCT02300233|50220752|FG002|Overall Study|Reason Not Specified|5|||
25109406|NCT02175225|50220763|FG000|Overall Study|Withdrawal by Subject|1|||
25109407|NCT02175225|50220764|FG001|Overall Study|Withdrawal by Subject|2|||
25109408|NCT02175225|50220763|FG000|Overall Study|Lost to Follow-up|6|||
25109409|NCT02175225|50220764|FG001|Overall Study|Lost to Follow-up|7|||
25109410|NCT02175225|50220763|FG000|Overall Study|Study drug not administered|1|||
25109411|NCT02175225|50220764|FG001|Overall Study|Study drug not administered|2|||
25109412|NCT02299375|50220772|FG000|Overall Study|Adverse Event, serious fatal|1|||
25109413|NCT02299375|50220773|FG001|Overall Study|Adverse Event, serious fatal|3|||
25109414|NCT02299375|50220772|FG000|Overall Study|Adverse Event, non-fatal|8|||
25261261|NCT01306968|50575969|FG001|Overall Study|Lost to Follow-up|1|||
25109415|NCT02299375|50220773|FG001|Overall Study|Adverse Event, non-fatal|9|||
25109416|NCT02299375|50220772|FG000|Overall Study|Lack of Efficacy|1|||
25109417|NCT02299375|50220773|FG001|Overall Study|Lack of Efficacy|3|||
25109418|NCT02299375|50220772|FG000|Overall Study|Protocol Violation|1|||
25261262|NCT01306968|50575970|FG002|Overall Study|Lost to Follow-up|0|||
25109419|NCT02299375|50220773|FG001|Overall Study|Protocol Violation|3|||
25109420|NCT02299375|50220772|FG000|Overall Study|Other: Met stopping criteria|1|||
25109421|NCT02299375|50220773|FG001|Overall Study|Other: Met stopping criteria|0|||
25109422|NCT02299375|50220772|FG000|Overall Study|Other: Study closed/terminated|66|||
25109423|NCT02299375|50220773|FG001|Overall Study|Other: Study closed/terminated|55|||
25109424|NCT02299375|50220772|FG000|Overall Study|Lost to Follow-up|0|||
25261263|NCT01306968|50575971|FG003|Overall Study|Lost to Follow-up|0|||
25109425|NCT02299375|50220773|FG001|Overall Study|Lost to Follow-up|2|||
25109426|NCT02299375|50220772|FG000|Overall Study|Physician Decision|1|||
25109427|NCT02299375|50220773|FG001|Overall Study|Physician Decision|1|||
25109428|NCT02299375|50220772|FG000|Overall Study|Withdrawal by Subject|1|||
25109429|NCT02299375|50220773|FG001|Overall Study|Withdrawal by Subject|4|||
25109430|NCT02151903|50220782|FG000|Overall Study|Withdrawal by Subject|1|||
25109431|NCT02151903|50220783|FG001|Overall Study|Withdrawal by Subject|0|||
25109432|NCT02151903|50220782|FG000|Overall Study|Progressive disease|2|||
25109433|NCT02151903|50220783|FG001|Overall Study|Progressive disease|1|||
25109434|NCT02151591|50220791|FG000|Overall Study|Lost to Follow-up|6|||
25109435|NCT02151591|50220792|FG001|Overall Study|Lost to Follow-up|3|||
25109436|NCT02174523|50220800|FG000|Overall Study|Withdrawal by Subject|1|||
25109437|NCT02174523|50220801|FG001|Overall Study|Withdrawal by Subject|0|||
25109438|NCT02297815|50220808|FG000|Overall Study|Lost to Follow-up|236|||
25109439|NCT02297815|50220809|FG001|Overall Study|Lost to Follow-up|140|||
25109440|NCT02114385|50220819|FG000|Overall Study|Withdrawal by Subject|3|||
25109441|NCT02114385|50220820|FG001|Overall Study|Withdrawal by Subject|2|||
25109442|NCT02114385|50220819|FG000|Overall Study|Lost to Follow-up|0|||
25109443|NCT02114385|50220820|FG001|Overall Study|Lost to Follow-up|6|||
25109444|NCT02114151|50220826|FG000|Overall Study|Death|1|||
25109445|NCT02114151|50220826|FG000|Overall Study|Lost to Follow-up|1|||
25109446|NCT02114151|50220826|FG000|Overall Study|Withdrawal by Subject|5|||
25109447|NCT02297503|50220832|FG000|Overall Study|Withdrawal by Subject|1|||
25109448|NCT02297503|50220833|FG001|Overall Study|Withdrawal by Subject|1|||
25109449|NCT02297503|50220832|FG000|Overall Study|Protocol Violation|1|||
25109450|NCT02297503|50220833|FG001|Overall Study|Protocol Violation|0|||
25109451|NCT02297503|50220832|FG000|Overall Study|Pregnancy|0|||
25109452|NCT02297503|50220833|FG001|Overall Study|Pregnancy|1|||
25109453|NCT02297503|50220832|FG000|Overall Study|Lost to Follow-up|0|||
25109454|NCT02297503|50220833|FG001|Overall Study|Lost to Follow-up|1|||
25109455|NCT02297503|50220832|FG000|Overall Study|Medical reason|0|||
25109456|NCT02297503|50220833|FG001|Overall Study|Medical reason|1|||
25109457|NCT02113449|50220848|FG000|Overall Study|Adverse Event|4|||
25109458|NCT02366923|50220856|FG000|Overall Study|Withdrawal by Subject|1|||
25109459|NCT02366923|50220856|FG000|Overall Study|Positive Slit Lamp Findings|2|||
25109460|NCT02366923|50220856|FG000|Overall Study|High Astigmatism|3|||
25109461|NCT02326597|50220863|FG000|Overall Study|Lost to Follow-up|42|||
25109462|NCT02326597|50220864|FG001|Overall Study|Lost to Follow-up|32|||
25109463|NCT02366767|50220874|FG000|Overall Study|left for home after 1 day at camp|1|||
25109464|NCT02366767|50220875|FG001|Overall Study|left for home after 1 day at camp|0|||
25109465|NCT02150343|50220885|FG000|Overall Study|Adverse Event|2|||
25109466|NCT02150343|50220886|FG001|Overall Study|Adverse Event|0|||
25109467|NCT02150343|50220887|FG002|Overall Study|Adverse Event|1|||
25109468|NCT02150343|50220888|FG003|Overall Study|Adverse Event|1|||
25109469|NCT02150343|50220885|FG000|Overall Study|Withdrawal by Subject|13|||
25109470|NCT02150343|50220886|FG001|Overall Study|Withdrawal by Subject|10|||
25109471|NCT02150343|50220887|FG002|Overall Study|Withdrawal by Subject|9|||
25109472|NCT02150343|50220888|FG003|Overall Study|Withdrawal by Subject|4|||
25109473|NCT02150343|50220885|FG000|Overall Study|Lost to Follow-up|4|||
25109474|NCT02150343|50220886|FG001|Overall Study|Lost to Follow-up|4|||
25109475|NCT02150343|50220887|FG002|Overall Study|Lost to Follow-up|2|||
25109476|NCT02150343|50220888|FG003|Overall Study|Lost to Follow-up|3|||
25008280|NCT03556358|50101178|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
25008281|NCT03556358|50101179|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
25008282|NCT03556358|50101178|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
25008283|NCT03556358|50101179|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
25008284|NCT03556358|50101178|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
25008285|NCT03556358|50101179|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
25008286|NCT03556358|50101178|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
25109477|NCT02150343|50220885|FG000|Overall Study|Other|2|||
25109478|NCT02150343|50220886|FG001|Overall Study|Other|6|||
25109479|NCT02150343|50220887|FG002|Overall Study|Other|0|||
25109480|NCT02150343|50220888|FG003|Overall Study|Other|2|||
25109481|NCT02149875|50220901|FG000|Overall Study|Lost to Follow-up|3|||
25109482|NCT02149875|50220902|FG001|Overall Study|Lost to Follow-up|4|||
25109483|NCT02149875|50220903|FG002|Overall Study|Lost to Follow-up|5|||
25109484|NCT02149875|50220901|FG000|Overall Study|Withdrawal by Subject|3|||
25109485|NCT02149875|50220902|FG001|Overall Study|Withdrawal by Subject|2|||
25109486|NCT02149875|50220903|FG002|Overall Study|Withdrawal by Subject|2|||
25109487|NCT02149875|50220901|FG000|Overall Study|Physician Decision|1|||
25109488|NCT02149875|50220902|FG001|Overall Study|Physician Decision|2|||
25109489|NCT02149875|50220903|FG002|Overall Study|Physician Decision|2|||
25109490|NCT02112045|50220913|FG000|Overall Study|Withdrawal by Subject|1|||
25109491|NCT02112045|50220914|FG001|Overall Study|Withdrawal by Subject|0|||
25109492|NCT01629693|50220922|FG000|Overall Study|Lost to Follow-up|2|||
25109493|NCT01629693|50220923|FG001|Overall Study|Lost to Follow-up|4|||
25109494|NCT01629693|50220922|FG000|Overall Study|Withdrawal by Subject|2|||
25109495|NCT01629693|50220923|FG001|Overall Study|Withdrawal by Subject|2|||
25109496|NCT01629693|50220922|FG000|Overall Study|Adverse Event|1|||
25109497|NCT01629693|50220923|FG001|Overall Study|Adverse Event|0|||
25109498|NCT01629693|50220922|FG000|Overall Study|Investigator decision|0|||
25109499|NCT01629693|50220923|FG001|Overall Study|Investigator decision|1|||
25109500|NCT01629693|50220922|FG000|Overall Study|Poor comfort of study lenses|0|||
25109501|NCT01629693|50220923|FG001|Overall Study|Poor comfort of study lenses|2|||
25109502|NCT01629693|50220922|FG000|Overall Study|Subject decision unrelated to AE|0|||
25109503|NCT01629693|50220923|FG001|Overall Study|Subject decision unrelated to AE|1|||
25109504|NCT02147691|50220931|FG000|Overall Study|Withdrawal by Subject|2|||
25109505|NCT02147691|50220932|FG001|Overall Study|Withdrawal by Subject|0|||
25109506|NCT02147691|50220931|FG000|Overall Study|Adverse Event|2|||
25109507|NCT02147691|50220932|FG001|Overall Study|Adverse Event|0|||
25109508|NCT02147691|50220931|FG000|Overall Study|Lost to Follow-up|0|||
25109509|NCT02147691|50220932|FG001|Overall Study|Lost to Follow-up|1|||
25109510|NCT02111811|50220940|FG000|Treatment Phase|Lost to Follow-up|22|||
25109511|NCT02111811|50220941|FG001|Treatment Phase|Lost to Follow-up|18|||
25109512|NCT02111811|50220940|FG000|Treatment Phase|Death|2|||
25109513|NCT02111811|50220941|FG001|Treatment Phase|Death|0|||
25109514|NCT02111811|50220940|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
25109515|NCT02111811|50220941|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
25109516|NCT02111811|50220940|FG000|Follow up Period (Aim 2)|Death|2|||
25109517|NCT02111811|50220941|FG001|Follow up Period (Aim 2)|Death|0|||
25109518|NCT01655693|50220950|FG000|Overall Study|Progression of Disease|92|||
25109519|NCT01655693|50220951|FG001|Overall Study|Progression of Disease|76|||
25109520|NCT01655693|50220952|FG002|Overall Study|Progression of Disease|58|||
25109521|NCT01655693|50220950|FG000|Overall Study|Death|8|||
25109522|NCT01655693|50220951|FG001|Overall Study|Death|9|||
25109523|NCT01655693|50220952|FG002|Overall Study|Death|12|||
25109524|NCT01655693|50220950|FG000|Overall Study|Serious Adverse Event|3|||
25109525|NCT01655693|50220951|FG001|Overall Study|Serious Adverse Event|15|||
25109526|NCT01655693|50220952|FG002|Overall Study|Serious Adverse Event|11|||
25109527|NCT01655693|50220950|FG000|Overall Study|Withdrawal by Subject|3|||
25109528|NCT01655693|50220951|FG001|Overall Study|Withdrawal by Subject|2|||
25109529|NCT01655693|50220952|FG002|Overall Study|Withdrawal by Subject|20|||
25109530|NCT01655693|50220950|FG000|Overall Study|Adverse Event|3|||
25109531|NCT01655693|50220951|FG001|Overall Study|Adverse Event|11|||
25109532|NCT01655693|50220952|FG002|Overall Study|Adverse Event|3|||
25109533|NCT01655693|50220950|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
25109534|NCT01655693|50220951|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
25109535|NCT01655693|50220952|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
25109536|NCT01655693|50220950|FG000|Overall Study|Non-Compliance|0|||
25109537|NCT01655693|50220951|FG001|Overall Study|Non-Compliance|0|||
25109538|NCT01655693|50220952|FG002|Overall Study|Non-Compliance|7|||
25109539|NCT01655693|50220950|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
25109540|NCT01655693|50220951|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
25109541|NCT01655693|50220952|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
25109542|NCT01655693|50220950|FG000|Overall Study|Protocol Violation|1|||
25109543|NCT01655693|50220951|FG001|Overall Study|Protocol Violation|0|||
25109544|NCT01655693|50220952|FG002|Overall Study|Protocol Violation|3|||
25109545|NCT01655693|50220950|FG000|Overall Study|Lost to Follow-up|1|||
25109546|NCT01655693|50220951|FG001|Overall Study|Lost to Follow-up|0|||
25109547|NCT01655693|50220952|FG002|Overall Study|Lost to Follow-up|1|||
25109548|NCT01655693|50220950|FG000|Overall Study|Screening Failure|1|||
25109549|NCT01655693|50220951|FG001|Overall Study|Screening Failure|0|||
25109550|NCT01655693|50220952|FG002|Overall Study|Screening Failure|0|||
25109551|NCT01655693|50220950|FG000|Overall Study|Other|8|||
25109552|NCT01655693|50220951|FG001|Overall Study|Other|6|||
25109553|NCT01655693|50220952|FG002|Overall Study|Other|15|||
25109554|NCT01655381|50220970|FG000|Overall Study|Investigator Decision|1|||
25109555|NCT01655381|50220970|FG000|Overall Study|Moved to Another City|1|||
25109556|NCT01655381|50220970|FG000|Overall Study|Insufficient Treatment Response|1|||
25109557|NCT01656161|50220975|FG000|Overall Study|Death|3|||
25109558|NCT01656161|50220975|FG000|Overall Study|Adverse Event|2|||
25109559|NCT01656161|50220975|FG000|Overall Study|Protocol Violation|1|||
25109560|NCT01656161|50220975|FG000|Overall Study|Withdrawal by Subject|1|||
25109561|NCT02111577|50220984|FG000|Overall Study|Protocol Violation|2|||
25109562|NCT02111577|50220985|FG001|Overall Study|Protocol Violation|0|||
25109563|NCT02111577|50220984|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
25177306|NCT03387150|50321408|FG002|Overall Study|Lost to Follow-up|2|||
25177307|NCT03387150|50321409|FG003|Overall Study|Lost to Follow-up|3|||
25109564|NCT02111577|50220985|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
25109565|NCT02111577|50220984|FG000|Overall Study|Failure to produce study treatment|6|||
25177308|NCT03387150|50321410|FG004|Overall Study|Lost to Follow-up|3|||
25177309|NCT03387150|50321411|FG005|Overall Study|Lost to Follow-up|3|||
25109566|NCT02111577|50220985|FG001|Overall Study|Failure to produce study treatment|0|||
25109567|NCT02111577|50220984|FG000|Overall Study|Death|518|||
25109568|NCT02111577|50220985|FG001|Overall Study|Death|254|||
25109569|NCT02111577|50220984|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
25109570|NCT02111577|50220985|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
25109571|NCT02111577|50220984|FG000|Overall Study|Adverse Event|1|||
25109572|NCT02111577|50220985|FG001|Overall Study|Adverse Event|1|||
25177310|NCT03387150|50321412|FG006|Overall Study|Lost to Follow-up|0|||
25109573|NCT02111577|50220984|FG000|Overall Study|Withdrawal by Subject|51|||
25109574|NCT02111577|50220985|FG001|Overall Study|Withdrawal by Subject|23|||
25109575|NCT02111577|50220984|FG000|Overall Study|Disease progression|0|||
25109576|NCT02111577|50220985|FG001|Overall Study|Disease progression|1|||
25109577|NCT02111577|50220984|FG000|Overall Study|Lost to Follow-up|19|||
25109578|NCT02111577|50220985|FG001|Overall Study|Lost to Follow-up|10|||
25109579|NCT02170779|50220995|FG000|Overall Study|Withdrawal by Subject|1|||
25109580|NCT02170779|50220996|FG001|Overall Study|Withdrawal by Subject|0|||
25109581|NCT02170779|50220995|FG000|Overall Study|Lost to Follow-up|0|||
25109582|NCT02170779|50220996|FG001|Overall Study|Lost to Follow-up|1|||
25109583|NCT02147067|50221004|FG000|Overall Study|Withdrawal by Subject|2|||
25109584|NCT02147067|50221005|FG001|Overall Study|Withdrawal by Subject|2|||
25109585|NCT02170389|50221011|FG000|Overall Study|Study terminated prior to start of treat|1|||
25109586|NCT02146599|50221015|FG000|Overall Study|Failed to meet inclusion criteria|5|||
25109587|NCT02146365|50221025|FG000|Overall Study|Lost to Follow-up|2|||
25109588|NCT02146365|50221026|FG001|Overall Study|Lost to Follow-up|1|||
25109589|NCT02146365|50221027|FG002|Overall Study|Lost to Follow-up|3|||
25109590|NCT02146365|50221028|FG003|Overall Study|Lost to Follow-up|3|||
25109591|NCT02146365|50221029|FG004|Overall Study|Lost to Follow-up|1|||
25109592|NCT02146365|50221030|FG005|Overall Study|Lost to Follow-up|1|||
25109593|NCT02146365|50221031|FG006|Overall Study|Lost to Follow-up|0|||
25109594|NCT02146365|50221032|FG007|Overall Study|Lost to Follow-up|1|||
25109595|NCT02146365|50221025|FG000|Overall Study|Withdrawal by Subject|1|||
25109596|NCT02146365|50221026|FG001|Overall Study|Withdrawal by Subject|2|||
25109597|NCT02146365|50221027|FG002|Overall Study|Withdrawal by Subject|1|||
25109598|NCT02146365|50221028|FG003|Overall Study|Withdrawal by Subject|5|||
25109599|NCT02146365|50221029|FG004|Overall Study|Withdrawal by Subject|1|||
25109600|NCT02146365|50221030|FG005|Overall Study|Withdrawal by Subject|0|||
25109601|NCT02146365|50221031|FG006|Overall Study|Withdrawal by Subject|0|||
25109602|NCT02146365|50221032|FG007|Overall Study|Withdrawal by Subject|0|||
25109603|NCT02146365|50221025|FG000|Overall Study|Unable to Comply with Protocol|0|||
25109604|NCT02146365|50221026|FG001|Overall Study|Unable to Comply with Protocol|1|||
25109605|NCT02146365|50221027|FG002|Overall Study|Unable to Comply with Protocol|1|||
25109606|NCT02146365|50221028|FG003|Overall Study|Unable to Comply with Protocol|0|||
25109607|NCT02146365|50221029|FG004|Overall Study|Unable to Comply with Protocol|0|||
25109608|NCT02146365|50221030|FG005|Overall Study|Unable to Comply with Protocol|0|||
25109609|NCT02146365|50221031|FG006|Overall Study|Unable to Comply with Protocol|0|||
25109610|NCT02146365|50221032|FG007|Overall Study|Unable to Comply with Protocol|0|||
25109611|NCT02146365|50221025|FG000|Overall Study|Other|1|||
25109612|NCT02146365|50221026|FG001|Overall Study|Other|0|||
25109613|NCT02146365|50221027|FG002|Overall Study|Other|2|||
25109614|NCT02146365|50221028|FG003|Overall Study|Other|1|||
25109615|NCT02146365|50221029|FG004|Overall Study|Other|0|||
25109616|NCT02146365|50221030|FG005|Overall Study|Other|0|||
25109617|NCT02146365|50221031|FG006|Overall Study|Other|0|||
25109618|NCT02146365|50221032|FG007|Overall Study|Other|0|||
25109619|NCT02146131|50221052|FG000|Overall Study|Physician Decision|61|||
25109620|NCT02146131|50221053|FG001|Overall Study|Physician Decision|56|||
25109621|NCT02107131|50221061|FG000|Overall Study|Lost to Follow-up|4|||
25109622|NCT02107131|50221062|FG001|Overall Study|Lost to Follow-up|4|||
25109623|NCT02107131|50221061|FG000|Overall Study|Physician Decision|1|||
25109624|NCT02107131|50221062|FG001|Overall Study|Physician Decision|0|||
25109625|NCT02107131|50221061|FG000|Overall Study|Withdrawal by Subject|2|||
25109626|NCT02107131|50221062|FG001|Overall Study|Withdrawal by Subject|0|||
25109627|NCT02107131|50221061|FG000|Overall Study|mental instability|1|||
25109628|NCT02107131|50221062|FG001|Overall Study|mental instability|0|||
25109629|NCT02107131|50221061|FG000|Overall Study|Death|0|||
25109630|NCT02107131|50221062|FG001|Overall Study|Death|1|||
25109631|NCT02107131|50221061|FG000|Overall Study|Protocol Violation|0|||
25109632|NCT02107131|50221062|FG001|Overall Study|Protocol Violation|4|||
25109633|NCT02106975|50221072|FG000|Overall Study|Death|25|||
25109634|NCT02106975|50221073|FG001|Overall Study|Death|39|||
25109635|NCT02145429|50221081|FG000|Overall Study|Death|4|||
25109636|NCT02145429|50221082|FG001|Overall Study|Death|5|||
25109637|NCT02145429|50221081|FG000|Overall Study|Lost to Follow-up|4|||
25109638|NCT02145429|50221082|FG001|Overall Study|Lost to Follow-up|3|||
25109639|NCT02145429|50221081|FG000|Overall Study|Withdrawal by Subject|8|||
25109640|NCT02145429|50221082|FG001|Overall Study|Withdrawal by Subject|3|||
25109641|NCT02144337|50221090|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
25109642|NCT02144337|50221091|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
25109643|NCT02144337|50221090|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
25109644|NCT02144337|50221091|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
25109645|NCT02144337|50221090|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
25109646|NCT02144337|50221091|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
25109647|NCT02144337|50221090|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
25109648|NCT02144337|50221091|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
25109649|NCT02144337|50221090|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
25109650|NCT02144337|50221091|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
25109651|NCT02520011|50221101|FG000|Overall Study|Adverse Event|0|||
25109652|NCT02520011|50221102|FG001|Overall Study|Adverse Event|1|||
25109653|NCT02520011|50221103|FG002|Overall Study|Adverse Event|2|||
25109654|NCT02520011|50221101|FG000|Overall Study|Death|0|||
25109655|NCT02520011|50221102|FG001|Overall Study|Death|8|||
25109656|NCT02520011|50221103|FG002|Overall Study|Death|1|||
25109657|NCT02520011|50221101|FG000|Overall Study|Lack of Efficacy|4|||
25109658|NCT02520011|50221102|FG001|Overall Study|Lack of Efficacy|26|||
25109659|NCT02520011|50221103|FG002|Overall Study|Lack of Efficacy|4|||
25109660|NCT02520011|50221101|FG000|Overall Study|Physician Decision|0|||
25109661|NCT02520011|50221102|FG001|Overall Study|Physician Decision|2|||
25109662|NCT02520011|50221103|FG002|Overall Study|Physician Decision|0|||
25109663|NCT02520011|50221101|FG000|Overall Study|Withdrawal by Subject|1|||
25109664|NCT02520011|50221102|FG001|Overall Study|Withdrawal by Subject|3|||
25109665|NCT02520011|50221103|FG002|Overall Study|Withdrawal by Subject|0|||
25109666|NCT02520011|50221101|FG000|Overall Study|Protocol Deviation|0|||
25109667|NCT02520011|50221102|FG001|Overall Study|Protocol Deviation|1|||
25109668|NCT02520011|50221103|FG002|Overall Study|Protocol Deviation|0|||
25109669|NCT02520011|50221101|FG000|Overall Study|Patient went to hospice|0|||
25109670|NCT02520011|50221102|FG001|Overall Study|Patient went to hospice|1|||
25109671|NCT02520011|50221103|FG002|Overall Study|Patient went to hospice|0|||
25109672|NCT02520011|50221101|FG000|Overall Study|Progressive disease following response|0|||
25109673|NCT02520011|50221102|FG001|Overall Study|Progressive disease following response|4|||
25109674|NCT02520011|50221103|FG002|Overall Study|Progressive disease following response|2|||
25109675|NCT02519231|50221118|FG000|Overall Study|Lost to Follow-up|2|||
25109676|NCT02519231|50221119|FG001|Overall Study|Lost to Follow-up|5|||
25109677|NCT02519231|50221118|FG000|Overall Study|Withdrawal by Subject|0|||
25109678|NCT02519231|50221119|FG001|Overall Study|Withdrawal by Subject|1|||
25109679|NCT02106351|50221130|FG000|Treatment Cycle 1|Adverse Event|2|||
25109680|NCT02106351|50221131|FG001|Treatment Cycle 1|Adverse Event|0|||
25109681|NCT02106351|50221132|FG002|Treatment Cycle 1|Adverse Event|0|||
25109682|NCT02106351|50221130|FG000|Treatment Cycle 1|Consent withdrawn|1|||
25109683|NCT02106351|50221131|FG001|Treatment Cycle 1|Consent withdrawn|0|||
25109684|NCT02106351|50221132|FG002|Treatment Cycle 1|Consent withdrawn|2|||
25109685|NCT02106351|50221130|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
25109686|NCT02106351|50221131|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
25109687|NCT02106351|50221132|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
25109688|NCT02106351|50221130|FG000|Treatment Cycle 1|Other|0|||
25109689|NCT02106351|50221131|FG001|Treatment Cycle 1|Other|3|||
25109690|NCT02106351|50221132|FG002|Treatment Cycle 1|Other|1|||
25109691|NCT02106351|50221130|FG000|Treatment Cycle 1|Randomised but not treated|1|||
25109692|NCT02106351|50221131|FG001|Treatment Cycle 1|Randomised but not treated|0|||
25109693|NCT02106351|50221132|FG002|Treatment Cycle 1|Randomised but not treated|1|||
25109694|NCT02106351|50221130|FG000|Treatment Cycle 2|Adverse Event|0|||
25109695|NCT02106351|50221131|FG001|Treatment Cycle 2|Adverse Event|2|||
25109696|NCT02106351|50221132|FG002|Treatment Cycle 2|Adverse Event|0|||
25109697|NCT02106351|50221130|FG000|Treatment Cycle 2|Consent withdrawn|0|||
25109698|NCT02106351|50221131|FG001|Treatment Cycle 2|Consent withdrawn|1|||
25109699|NCT02106351|50221132|FG002|Treatment Cycle 2|Consent withdrawn|1|||
25109700|NCT02106351|50221130|FG000|Treatment Cycle 2|Other|0|||
25109701|NCT02106351|50221131|FG001|Treatment Cycle 2|Other|2|||
25109702|NCT02106351|50221132|FG002|Treatment Cycle 2|Other|2|||
25109703|NCT02106351|50221130|FG000|Treatment Cycle 3|Adverse Event|0|||
25109704|NCT02106351|50221131|FG001|Treatment Cycle 3|Adverse Event|1|||
25109705|NCT02106351|50221132|FG002|Treatment Cycle 3|Adverse Event|0|||
25109706|NCT02106351|50221130|FG000|Treatment Cycle 3|Consent withdrawn|0|||
25109707|NCT02106351|50221131|FG001|Treatment Cycle 3|Consent withdrawn|0|||
25109708|NCT02106351|50221132|FG002|Treatment Cycle 3|Consent withdrawn|2|||
25109709|NCT02106351|50221130|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
25109710|NCT02106351|50221131|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
25109711|NCT02106351|50221132|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
25109712|NCT02106351|50221130|FG000|Treatment Cycle 3|Other|0|||
25109713|NCT02106351|50221131|FG001|Treatment Cycle 3|Other|2|||
25109714|NCT02106351|50221132|FG002|Treatment Cycle 3|Other|3|||
25109715|NCT02106351|50221130|FG000|Treatment Cycle 4|Consent withdrawn|0|||
25109716|NCT02106351|50221131|FG001|Treatment Cycle 4|Consent withdrawn|0|||
25177311|NCT03387150|50321406|FG000|Overall Study|Participant unable to adhere to visit|0|||
25177312|NCT03387150|50321407|FG001|Overall Study|Participant unable to adhere to visit|1|||
25109717|NCT02106351|50221132|FG002|Treatment Cycle 4|Consent withdrawn|2|||
25109718|NCT02106351|50221130|FG000|Treatment Cycle 4|Other|0|||
25109719|NCT02106351|50221131|FG001|Treatment Cycle 4|Other|1|||
25177313|NCT03387150|50321408|FG002|Overall Study|Participant unable to adhere to visit|0|||
25109720|NCT02106351|50221132|FG002|Treatment Cycle 4|Other|0|||
25109721|NCT02143947|50221148|FG000|Overall Study|Lost to Follow-up|4|||
25109722|NCT02143947|50221149|FG001|Overall Study|Lost to Follow-up|2|||
25109723|NCT02075073|50221160|FG000|Overall Study|Withdrawal by Subject|0|||
25109724|NCT02075073|50221161|FG001|Overall Study|Withdrawal by Subject|1|||
25109725|NCT02075073|50221162|FG002|Overall Study|Withdrawal by Subject|0|||
25109726|NCT02074059|50221176|FG000|Overall Study|Death|0|||
25109727|NCT02074059|50221177|FG001|Overall Study|Death|0|||
25109728|NCT02074059|50221178|FG002|Overall Study|Death|0|||
25109729|NCT02074059|50221179|FG003|Overall Study|Death|0|||
25109730|NCT02074059|50221180|FG004|Overall Study|Death|1|||
25109731|NCT02074059|50221181|FG005|Overall Study|Death|1|||
25109732|NCT01364597|50221200|FG000|Overall Study|Adverse Event|4|||
25109733|NCT01364597|50221201|FG001|Overall Study|Adverse Event|5|||
25109734|NCT01364597|50221202|FG002|Overall Study|Adverse Event|16|||
25109735|NCT01364597|50221203|FG003|Overall Study|Adverse Event|7|||
25109736|NCT01364597|50221200|FG000|Overall Study|Lack of Efficacy|4|||
25109737|NCT01364597|50221201|FG001|Overall Study|Lack of Efficacy|4|||
25109738|NCT01364597|50221202|FG002|Overall Study|Lack of Efficacy|23|||
25109739|NCT01364597|50221203|FG003|Overall Study|Lack of Efficacy|8|||
25109740|NCT01364597|50221200|FG000|Overall Study|Protocol Violation|0|||
25109741|NCT01364597|50221201|FG001|Overall Study|Protocol Violation|0|||
25109742|NCT01364597|50221202|FG002|Overall Study|Protocol Violation|2|||
25109743|NCT01364597|50221203|FG003|Overall Study|Protocol Violation|0|||
25109744|NCT01364597|50221200|FG000|Overall Study|Lost to Follow-up|0|||
25109745|NCT01364597|50221201|FG001|Overall Study|Lost to Follow-up|0|||
25109746|NCT01364597|50221202|FG002|Overall Study|Lost to Follow-up|5|||
25109747|NCT01364597|50221203|FG003|Overall Study|Lost to Follow-up|3|||
25109748|NCT01364597|50221200|FG000|Overall Study|Withdrawal by Subject|4|||
25109749|NCT01364597|50221201|FG001|Overall Study|Withdrawal by Subject|1|||
25109750|NCT01364597|50221202|FG002|Overall Study|Withdrawal by Subject|18|||
25109751|NCT01364597|50221203|FG003|Overall Study|Withdrawal by Subject|6|||
25109752|NCT01364597|50221200|FG000|Overall Study|Non compliance|1|||
25109753|NCT01364597|50221201|FG001|Overall Study|Non compliance|0|||
25109754|NCT01364597|50221202|FG002|Overall Study|Non compliance|1|||
25109755|NCT01364597|50221203|FG003|Overall Study|Non compliance|0|||
25109756|NCT01364597|50221200|FG000|Overall Study|Lack of compliance|1|||
25109757|NCT01364597|50221201|FG001|Overall Study|Lack of compliance|0|||
25109758|NCT01364597|50221202|FG002|Overall Study|Lack of compliance|0|||
25109759|NCT01364597|50221203|FG003|Overall Study|Lack of compliance|0|||
25109760|NCT01364597|50221200|FG000|Overall Study|End of treatment epilepsy|1|||
25109761|NCT01364597|50221201|FG001|Overall Study|End of treatment epilepsy|0|||
25109762|NCT01364597|50221202|FG002|Overall Study|End of treatment epilepsy|0|||
25109763|NCT01364597|50221203|FG003|Overall Study|End of treatment epilepsy|0|||
25109764|NCT01364597|50221200|FG000|Overall Study|No Seizures|1|||
25109765|NCT01364597|50221201|FG001|Overall Study|No Seizures|0|||
25109766|NCT01364597|50221202|FG002|Overall Study|No Seizures|0|||
25109767|NCT01364597|50221203|FG003|Overall Study|No Seizures|0|||
25109768|NCT01364597|50221200|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
25109769|NCT01364597|50221201|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
25109770|NCT01364597|50221202|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
25109771|NCT01364597|50221203|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
25109772|NCT01364597|50221200|FG000|Overall Study|Cure|1|||
25109773|NCT01364597|50221201|FG001|Overall Study|Cure|0|||
25109774|NCT01364597|50221202|FG002|Overall Study|Cure|0|||
25109775|NCT01364597|50221203|FG003|Overall Study|Cure|0|||
25109776|NCT01364597|50221200|FG000|Overall Study|Patient was moving|0|||
25109777|NCT01364597|50221201|FG001|Overall Study|Patient was moving|1|||
25109778|NCT01364597|50221202|FG002|Overall Study|Patient was moving|0|||
25109779|NCT01364597|50221203|FG003|Overall Study|Patient was moving|0|||
25109780|NCT01364597|50221200|FG000|Overall Study|Seizures resolved|0|||
25109781|NCT01364597|50221201|FG001|Overall Study|Seizures resolved|0|||
25109782|NCT01364597|50221202|FG002|Overall Study|Seizures resolved|1|||
25109783|NCT01364597|50221203|FG003|Overall Study|Seizures resolved|0|||
25109784|NCT01364597|50221200|FG000|Overall Study|Patient became seizure-free after surgery|0|||
25109785|NCT01364597|50221201|FG001|Overall Study|Patient became seizure-free after surgery|0|||
25109786|NCT01364597|50221202|FG002|Overall Study|Patient became seizure-free after surgery|1|||
25109787|NCT01364597|50221203|FG003|Overall Study|Patient became seizure-free after surgery|0|||
25109788|NCT01364597|50221200|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
25109789|NCT01364597|50221201|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
25109790|NCT01364597|50221202|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
25109791|NCT01364597|50221203|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
25109792|NCT01364597|50221200|FG000|Overall Study|Patient cured from Epilepsy|0|||
25109793|NCT01364597|50221201|FG001|Overall Study|Patient cured from Epilepsy|0|||
25109794|NCT01364597|50221202|FG002|Overall Study|Patient cured from Epilepsy|1|||
25109795|NCT01364597|50221203|FG003|Overall Study|Patient cured from Epilepsy|0|||
25109796|NCT01364597|50221200|FG000|Overall Study|Investigator decision|0|||
25109797|NCT01364597|50221201|FG001|Overall Study|Investigator decision|0|||
25109798|NCT01364597|50221202|FG002|Overall Study|Investigator decision|1|||
25109799|NCT01364597|50221203|FG003|Overall Study|Investigator decision|0|||
25109800|NCT01364597|50221200|FG000|Overall Study|Sponsor recommended discontinuation|0|||
25109801|NCT01364597|50221201|FG001|Overall Study|Sponsor recommended discontinuation|0|||
25109802|NCT01364597|50221202|FG002|Overall Study|Sponsor recommended discontinuation|0|||
25109803|NCT01364597|50221203|FG003|Overall Study|Sponsor recommended discontinuation|1|||
25109804|NCT01364597|50221200|FG000|Overall Study|Parents went abroad with the patient|0|||
25109805|NCT01364597|50221201|FG001|Overall Study|Parents went abroad with the patient|0|||
25109806|NCT01364597|50221202|FG002|Overall Study|Parents went abroad with the patient|1|||
25109807|NCT01364597|50221203|FG003|Overall Study|Parents went abroad with the patient|0|||
25109808|NCT01364597|50221200|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
25109809|NCT01364597|50221201|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
25109810|NCT01364597|50221202|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
25109811|NCT01364597|50221203|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
25109812|NCT01364597|50221200|FG000|Overall Study|BRV administration dropout|0|||
25109813|NCT01364597|50221201|FG001|Overall Study|BRV administration dropout|0|||
25109814|NCT01364597|50221202|FG002|Overall Study|BRV administration dropout|1|||
25109815|NCT01364597|50221203|FG003|Overall Study|BRV administration dropout|0|||
25109816|NCT01364597|50221200|FG000|Overall Study|Dropout|0|||
25109817|NCT01364597|50221201|FG001|Overall Study|Dropout|0|||
25109818|NCT01364597|50221202|FG002|Overall Study|Dropout|3|||
25109819|NCT01364597|50221203|FG003|Overall Study|Dropout|1|||
25109820|NCT01364597|50221200|FG000|Overall Study|Unreliable subject|0|||
25109821|NCT01364597|50221201|FG001|Overall Study|Unreliable subject|0|||
25109822|NCT01364597|50221202|FG002|Overall Study|Unreliable subject|0|||
25109823|NCT01364597|50221203|FG003|Overall Study|Unreliable subject|1|||
25109824|NCT01364597|50221200|FG000|Overall Study|Other|0|||
25109825|NCT01364597|50221201|FG001|Overall Study|Other|0|||
25109826|NCT01364597|50221202|FG002|Overall Study|Other|0|||
25109827|NCT01364597|50221203|FG003|Overall Study|Other|1|||
25109828|NCT02143713|50221220|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
25109829|NCT02143713|50221221|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
25109830|NCT02143713|50221222|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
25109831|NCT02143713|50221223|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
25109832|NCT02143713|50221220|FG000|Treatment Period (6 Months)|Adverse Event|7|||
25109833|NCT02143713|50221221|FG001|Treatment Period (6 Months)|Adverse Event|8|||
25109834|NCT02143713|50221222|FG002|Treatment Period (6 Months)|Adverse Event|8|||
25109835|NCT02143713|50221223|FG003|Treatment Period (6 Months)|Adverse Event|9|||
25109836|NCT02143713|50221220|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
25109837|NCT02143713|50221221|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
25109838|NCT02143713|50221222|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
25109839|NCT02143713|50221223|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
25109840|NCT02143713|50221220|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
25109841|NCT02143713|50221221|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
25109842|NCT02143713|50221222|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
25109843|NCT02143713|50221223|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
25109844|NCT02143713|50221220|FG000|Treatment Period (6 Months)|Pregnancy|0|||
25109845|NCT02143713|50221221|FG001|Treatment Period (6 Months)|Pregnancy|2|||
25109846|NCT02143713|50221222|FG002|Treatment Period (6 Months)|Pregnancy|2|||
25109847|NCT02143713|50221223|FG003|Treatment Period (6 Months)|Pregnancy|0|||
25109848|NCT02143713|50221220|FG000|Treatment Period (6 Months)|Non-compliance|1|||
25109849|NCT02143713|50221221|FG001|Treatment Period (6 Months)|Non-compliance|0|||
25109850|NCT02143713|50221222|FG002|Treatment Period (6 Months)|Non-compliance|0|||
25109851|NCT02143713|50221223|FG003|Treatment Period (6 Months)|Non-compliance|3|||
25109852|NCT02143713|50221220|FG000|Treatment Period (6 Months)|Other|3|||
25109853|NCT02143713|50221221|FG001|Treatment Period (6 Months)|Other|0|||
25109854|NCT02143713|50221222|FG002|Treatment Period (6 Months)|Other|3|||
25109855|NCT02143713|50221223|FG003|Treatment Period (6 Months)|Other|2|||
25109856|NCT02143713|50221220|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
25109857|NCT02143713|50221221|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
25109858|NCT02143713|50221222|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
25109859|NCT02143713|50221223|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
25109860|NCT02143713|50221220|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
25109861|NCT02143713|50221221|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
25109862|NCT02143713|50221222|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
25109863|NCT02143713|50221223|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
25109864|NCT02143713|50221220|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
25109865|NCT02143713|50221221|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
25109866|NCT02143713|50221222|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
25109867|NCT02143713|50221223|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
25109868|NCT02143713|50221220|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
25109869|NCT02143713|50221221|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
25109870|NCT02143713|50221222|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
25109871|NCT02143713|50221223|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
25109872|NCT02143713|50221220|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
25109873|NCT02143713|50221221|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
25109874|NCT02143713|50221222|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
25109875|NCT02143713|50221223|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
25109876|NCT02143713|50221220|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
25109877|NCT02143713|50221221|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
25109878|NCT02143713|50221222|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
25109879|NCT02143713|50221223|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
25109880|NCT02143713|50221220|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
25109881|NCT02143713|50221221|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
25109882|NCT02143713|50221222|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
25109883|NCT02143713|50221223|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
25109884|NCT02143713|50221220|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
25109885|NCT02143713|50221221|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
25109886|NCT02143713|50221222|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
25109887|NCT02143713|50221223|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
25109888|NCT02143713|50221220|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
25109889|NCT02143713|50221221|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
25109890|NCT02143713|50221222|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
25109891|NCT02143713|50221223|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
25109892|NCT02519855|50221236|FG000|Overall Study|Adverse Event|0|||
25109893|NCT02519855|50221237|FG001|Overall Study|Adverse Event|1|||
25109894|NCT02519855|50221236|FG000|Overall Study|Lost to Follow-up|3|||
25109895|NCT02519855|50221237|FG001|Overall Study|Lost to Follow-up|3|||
25109896|NCT02142387|50221245|FG000|Overall Study|<19 years old|49|||
25109897|NCT02142387|50221246|FG001|Overall Study|<19 years old|326|||
25109898|NCT02142387|50221245|FG000|Overall Study|non-cardiac etiology|504|||
25109899|NCT02142387|50221246|FG001|Overall Study|non-cardiac etiology|3431|||
25109900|NCT02142387|50221245|FG000|Overall Study|CPR not performed|74|||
25109901|NCT02142387|50221246|FG001|Overall Study|CPR not performed|473|||
25109902|NCT02142387|50221245|FG000|Overall Study|witnessed by paramedic|139|||
25109903|NCT02142387|50221246|FG001|Overall Study|witnessed by paramedic|917|||
25109904|NCT02142387|50221245|FG000|Overall Study|incomplete data|1|||
25109905|NCT02142387|50221246|FG001|Overall Study|incomplete data|9|||
25109906|NCT02142387|50221245|FG000|Overall Study|occurred not at home|298|||
25109907|NCT02142387|50221246|FG001|Overall Study|occurred not at home|2474|||
25109908|NCT02518919|50221255|FG000|Overall Study|Protocol Violation|1|||
25109909|NCT02518919|50221256|FG001|Overall Study|Protocol Violation|1|||
25109910|NCT02518919|50221257|FG002|Overall Study|Protocol Violation|2|||
25109911|NCT02518685|50221267|FG000|Overall Study|Adverse Event|29|||
25109912|NCT02518685|50221268|FG001|Overall Study|Adverse Event|1|||
25109913|NCT02518685|50221267|FG000|Overall Study|Withdrawal by Subject|10|||
25109914|NCT02518685|50221268|FG001|Overall Study|Withdrawal by Subject|3|||
25109915|NCT02518685|50221267|FG000|Overall Study|relocation, study fatigue|7|||
25109916|NCT02518685|50221268|FG001|Overall Study|relocation, study fatigue|2|||
25109917|NCT02518685|50221267|FG000|Overall Study|Pregnancy|1|||
25109918|NCT02518685|50221268|FG001|Overall Study|Pregnancy|0|||
25109919|NCT02518685|50221267|FG000|Overall Study|Physician Decision|1|||
25109920|NCT02518685|50221268|FG001|Overall Study|Physician Decision|0|||
25109921|NCT02518685|50221267|FG000|Overall Study|Lost to Follow-up|1|||
25109922|NCT02518685|50221268|FG001|Overall Study|Lost to Follow-up|4|||
25109923|NCT02520089|50221277|FG000|Overall Study|Lost to Follow-up|3|||
25109924|NCT02520089|50221278|FG001|Overall Study|Lost to Follow-up|4|||
25109925|NCT02105961|50221287|FG000|Overall Study|Adverse Event|18|||
25109926|NCT02105961|50221288|FG001|Overall Study|Adverse Event|7|||
25109927|NCT02105961|50221289|FG002|Overall Study|Adverse Event|13|||
25109928|NCT02105961|50221287|FG000|Overall Study|Lack of Efficacy|3|||
25109929|NCT02105961|50221288|FG001|Overall Study|Lack of Efficacy|0|||
25109930|NCT02105961|50221289|FG002|Overall Study|Lack of Efficacy|3|||
25109931|NCT02105961|50221287|FG000|Overall Study|Lost to Follow-up|2|||
25109932|NCT02105961|50221288|FG001|Overall Study|Lost to Follow-up|0|||
25109933|NCT02105961|50221289|FG002|Overall Study|Lost to Follow-up|1|||
25109934|NCT02105961|50221287|FG000|Overall Study|Physician Decision|3|||
25177314|NCT03387150|50321409|FG003|Overall Study|Participant unable to adhere to visit|0|||
25177315|NCT03387150|50321410|FG004|Overall Study|Participant unable to adhere to visit|2|||
25109935|NCT02105961|50221288|FG001|Overall Study|Physician Decision|3|||
25109936|NCT02105961|50221289|FG002|Overall Study|Physician Decision|2|||
25109937|NCT02105961|50221287|FG000|Overall Study|Withdrawal by Subject|15|||
25109938|NCT02105961|50221288|FG001|Overall Study|Withdrawal by Subject|7|||
25109939|NCT02105961|50221289|FG002|Overall Study|Withdrawal by Subject|11|||
25109940|NCT02141997|50221302|FG000|Overall Study|Adverse Event|0|||
25109941|NCT02141997|50221303|FG001|Overall Study|Adverse Event|2|||
25109942|NCT02141997|50221304|FG002|Overall Study|Adverse Event|0|||
25109943|NCT02141997|50221305|FG003|Overall Study|Adverse Event|1|||
25109944|NCT02141997|50221302|FG000|Overall Study|Participant noncompliance|1|||
25261264|NCT01306968|50575968|FG000|Overall Study|Physician Decision|0|||
25109945|NCT02141997|50221303|FG001|Overall Study|Participant noncompliance|0|||
25109946|NCT02141997|50221304|FG002|Overall Study|Participant noncompliance|0|||
25109947|NCT02141997|50221305|FG003|Overall Study|Participant noncompliance|0|||
25109948|NCT02141997|50221302|FG000|Overall Study|Withdrew consent|1|||
25109949|NCT02141997|50221303|FG001|Overall Study|Withdrew consent|0|||
25109950|NCT02141997|50221304|FG002|Overall Study|Withdrew consent|3|||
25109951|NCT02141997|50221305|FG003|Overall Study|Withdrew consent|0|||
25109952|NCT02141997|50221302|FG000|Overall Study|Other|1|||
25109953|NCT02141997|50221303|FG001|Overall Study|Other|4|||
25109954|NCT02141997|50221304|FG002|Overall Study|Other|0|||
25109955|NCT02141997|50221305|FG003|Overall Study|Other|0|||
25109956|NCT01628367|50221317|FG000|Overall Study|Adverse Event|1|||
25109957|NCT01628367|50221318|FG001|Overall Study|Adverse Event|0|||
25109958|NCT01627899|50221324|FG000|Overall Study|Study terminated early by sponsor.|5|||
25109959|NCT02519777|50221331|FG000|Overall Study|Death|1|||
25109960|NCT02519777|50221332|FG001|Overall Study|Death|0|||
25109961|NCT02519777|50221333|FG002|Overall Study|Death|0|||
25109962|NCT02519777|50221331|FG000|Overall Study|Lost to Follow-up|0|||
25109963|NCT02519777|50221332|FG001|Overall Study|Lost to Follow-up|4|||
25109964|NCT02519777|50221333|FG002|Overall Study|Lost to Follow-up|2|||
25109965|NCT02519777|50221331|FG000|Overall Study|Withdrawal by Subject|3|||
25109966|NCT02519777|50221332|FG001|Overall Study|Withdrawal by Subject|1|||
25109967|NCT02519777|50221333|FG002|Overall Study|Withdrawal by Subject|0|||
25109968|NCT02519777|50221331|FG000|Overall Study|Severe Debilitation|1|||
25109969|NCT02519777|50221332|FG001|Overall Study|Severe Debilitation|1|||
25109970|NCT02519777|50221333|FG002|Overall Study|Severe Debilitation|1|||
25109971|NCT02519777|50221331|FG000|Overall Study|Not able to get to clinic|1|||
25109972|NCT02519777|50221332|FG001|Overall Study|Not able to get to clinic|2|||
25109973|NCT02519777|50221333|FG002|Overall Study|Not able to get to clinic|1|||
25109974|NCT02515331|50221344|FG000|Overall Study|Withdrawal by Subject|0|||
25109975|NCT02515331|50221345|FG001|Overall Study|Withdrawal by Subject|0|||
25109976|NCT02515331|50221346|FG002|Overall Study|Withdrawal by Subject|1|||
25109977|NCT02515331|50221344|FG000|Overall Study|Protocol deviation|0|||
25109978|NCT02515331|50221345|FG001|Overall Study|Protocol deviation|0|||
25109979|NCT02515331|50221346|FG002|Overall Study|Protocol deviation|3|||
25109980|NCT02515331|50221344|FG000|Overall Study|Adverse Event|2|||
25109981|NCT02515331|50221345|FG001|Overall Study|Adverse Event|0|||
25109982|NCT02515331|50221346|FG002|Overall Study|Adverse Event|0|||
25109983|NCT02515097|50221356|FG000|Overall Study|Lost to Follow-up|4|||
25261265|NCT01306968|50575969|FG001|Overall Study|Physician Decision|1|||
25261266|NCT01306968|50575970|FG002|Overall Study|Physician Decision|0|||
25261267|NCT01306968|50575971|FG003|Overall Study|Physician Decision|0|||
25261268|NCT01306968|50575968|FG000|Overall Study|Relocated and left active duty|0|||
25261269|NCT01306968|50575969|FG001|Overall Study|Relocated and left active duty|1|||
25261270|NCT01306968|50575970|FG002|Overall Study|Relocated and left active duty|1|||
25109984|NCT02515097|50221357|FG001|Overall Study|Lost to Follow-up|2|||
25109985|NCT02515097|50221356|FG000|Overall Study|Withdrawal by Subject|1|||
25109986|NCT02515097|50221357|FG001|Overall Study|Withdrawal by Subject|3|||
25109987|NCT02515097|50221356|FG000|Overall Study|Adverse Event|2|||
25109988|NCT02515097|50221357|FG001|Overall Study|Adverse Event|1|||
25109989|NCT02141295|50221366|FG000|Overall Study|Adverse Event|1|||
25261271|NCT01306968|50575971|FG003|Overall Study|Relocated and left active duty|1|||
25261272|NCT01306968|50575968|FG000|Overall Study|Withdrew - time commitment|0|||
25261273|NCT01306968|50575969|FG001|Overall Study|Withdrew - time commitment|0|||
25261274|NCT01306968|50575970|FG002|Overall Study|Withdrew - time commitment|0|||
25261275|NCT01306968|50575971|FG003|Overall Study|Withdrew - time commitment|2|||
25261276|NCT01306968|50575968|FG000|Overall Study|Withdrew over privacy concerns|0|||
25261277|NCT01306968|50575969|FG001|Overall Study|Withdrew over privacy concerns|0|||
25261278|NCT01306968|50575970|FG002|Overall Study|Withdrew over privacy concerns|0|||
25261279|NCT01306968|50575971|FG003|Overall Study|Withdrew over privacy concerns|1|||
25261280|NCT01264419|50575983|FG000|Overall Study|Lost to Follow-up|3|||
25261281|NCT01263873|50575989|FG000|Overall Study|One provider unable to complete numbers|1|||
25261282|NCT01263873|50575990|FG001|Overall Study|One provider unable to complete numbers|1|||
25261283|NCT01263639|50575998|FG000|Overall Study|Lost to Follow-up|66|||
25261284|NCT01263639|50575999|FG001|Overall Study|Lost to Follow-up|70|||
25261285|NCT01263639|50575998|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
25261286|NCT01263639|50575999|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
25261287|NCT01011283|50576007|FG000|Overall Study|Adverse Event|4|||
25261288|NCT01011283|50576008|FG001|Overall Study|Adverse Event|2|||
25261289|NCT01011283|50576007|FG000|Overall Study|Progressive Disease|0|||
25261290|NCT01011283|50576008|FG001|Overall Study|Progressive Disease|2|||
25109990|NCT02141295|50221367|FG001|Overall Study|Adverse Event|18|||
25109991|NCT02141295|50221368|FG002|Overall Study|Adverse Event|11|||
25261291|NCT01011283|50576007|FG000|Overall Study|Terminated by Sponsor|5|||
25261292|NCT01011283|50576008|FG001|Overall Study|Terminated by Sponsor|5|||
25109992|NCT02141295|50221366|FG000|Overall Study|Physician Decision|2|||
25109993|NCT02141295|50221367|FG001|Overall Study|Physician Decision|19|||
25109994|NCT02141295|50221368|FG002|Overall Study|Physician Decision|14|||
25261293|NCT01011283|50576007|FG000|Overall Study|Other|2|||
25261294|NCT01011283|50576008|FG001|Overall Study|Other|2|||
25261295|NCT01263561|50576016|FG000|Overall Study|Death|1|||
25261296|NCT01263561|50576017|FG001|Overall Study|Death|2|||
25261297|NCT01009099|50576025|FG000|Overall Study|Lost to Follow-up|1|||
25261298|NCT01009099|50576026|FG001|Overall Study|Lost to Follow-up|0|||
25008287|NCT03556358|50101179|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
25008288|NCT03556358|50101178|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
25109995|NCT02141295|50221366|FG000|Overall Study|Study terminated by sponsor|0|||
25109996|NCT02141295|50221367|FG001|Overall Study|Study terminated by sponsor|6|||
25109997|NCT02141295|50221368|FG002|Overall Study|Study terminated by sponsor|6|||
25109998|NCT02141295|50221366|FG000|Overall Study|Non-compliance|0|||
25109999|NCT02141295|50221367|FG001|Overall Study|Non-compliance|1|||
25110000|NCT02141295|50221368|FG002|Overall Study|Non-compliance|0|||
25110001|NCT02141295|50221366|FG000|Overall Study|Progressive disease|3|||
25110002|NCT02141295|50221367|FG001|Overall Study|Progressive disease|32|||
25110003|NCT02141295|50221368|FG002|Overall Study|Progressive disease|50|||
25110004|NCT02141295|50221366|FG000|Overall Study|Reason not specified|0|||
25110005|NCT02141295|50221367|FG001|Overall Study|Reason not specified|9|||
25110006|NCT02141295|50221368|FG002|Overall Study|Reason not specified|10|||
25110007|NCT02141295|50221366|FG000|Overall Study|Withdrawal by Subject|0|||
25110008|NCT02141295|50221367|FG001|Overall Study|Withdrawal by Subject|9|||
25110009|NCT02141295|50221368|FG002|Overall Study|Withdrawal by Subject|4|||
25110010|NCT02514551|50221380|FG000|Overall Study|Lost to Follow-up|0|||
25110011|NCT02514551|50221381|FG001|Overall Study|Lost to Follow-up|1|||
25110012|NCT02514551|50221380|FG000|Overall Study|Participant Never Treated|0|||
25110013|NCT02514551|50221381|FG001|Overall Study|Participant Never Treated|2|||
25110014|NCT02141217|50221390|FG000|Overall Study|Adverse Event|1|||
25110015|NCT02141217|50221391|FG001|Overall Study|Adverse Event|2|||
25110016|NCT02141217|50221390|FG000|Overall Study|Protocol Violation|1|||
25110017|NCT02141217|50221391|FG001|Overall Study|Protocol Violation|4|||
25110018|NCT02141217|50221390|FG000|Overall Study|Withdrawal by Subject|6|||
25110019|NCT02141217|50221391|FG001|Overall Study|Withdrawal by Subject|0|||
25110020|NCT02141217|50221390|FG000|Overall Study|Lost to Follow-up|1|||
25110021|NCT02141217|50221391|FG001|Overall Study|Lost to Follow-up|1|||
25110022|NCT02141217|50221390|FG000|Overall Study|Physician Decision|1|||
25110023|NCT02141217|50221391|FG001|Overall Study|Physician Decision|0|||
25110024|NCT02141217|50221390|FG000|Overall Study|Surgical Intervention|1|||
25110025|NCT02141217|50221391|FG001|Overall Study|Surgical Intervention|1|||
25110026|NCT02138253|50221402|FG000|Overall Study|Adverse Event|3|||
25110027|NCT02138253|50221403|FG001|Overall Study|Adverse Event|3|||
25110028|NCT02138253|50221402|FG000|Overall Study|Lost to Follow-up|2|||
25110029|NCT02138253|50221403|FG001|Overall Study|Lost to Follow-up|1|||
25110030|NCT02138253|50221402|FG000|Overall Study|Physician Decision|2|||
25110031|NCT02138253|50221403|FG001|Overall Study|Physician Decision|0|||
25110032|NCT02138253|50221402|FG000|Overall Study|Non compliance|1|||
25110033|NCT02138253|50221403|FG001|Overall Study|Non compliance|0|||
25110034|NCT02138253|50221402|FG000|Overall Study|Withdrawal by Subject|1|||
25110035|NCT02138253|50221403|FG001|Overall Study|Withdrawal by Subject|0|||
25110036|NCT02514473|50221411|FG000|Overall Study|Adverse Event|0|||
25110037|NCT02514473|50221412|FG001|Overall Study|Adverse Event|2|||
25110038|NCT02514473|50221411|FG000|Overall Study|Withdrawal by Subject|2|||
25110039|NCT02514473|50221412|FG001|Overall Study|Withdrawal by Subject|1|||
25110040|NCT02514473|50221411|FG000|Overall Study|Lost to Follow-up|0|||
25110041|NCT02514473|50221412|FG001|Overall Study|Lost to Follow-up|1|||
25110042|NCT02514473|50221411|FG000|Overall Study|Other|1|||
25110043|NCT02514473|50221412|FG001|Overall Study|Other|1|||
25177316|NCT03387150|50321411|FG005|Overall Study|Participant unable to adhere to visit|2|||
25177317|NCT03387150|50321412|FG006|Overall Study|Participant unable to adhere to visit|0|||
25177318|NCT03289208|50321444|FG000|Overall Study|Adverse Event|1|||
25177319|NCT03289208|50321445|FG001|Overall Study|Adverse Event|0|||
25177320|NCT03289208|50321446|FG002|Overall Study|Adverse Event|0|||
25177321|NCT03036566|50321476|FG000|Overall Study|Lost to Follow-up|3|||
25177322|NCT02754141|50321507|FG000|Overall Study|Disease progression|11|||
25177323|NCT02754141|50321508|FG001|Overall Study|Disease progression|7|||
25177324|NCT02754141|50321509|FG002|Overall Study|Disease progression|8|||
25177325|NCT02754141|50321510|FG003|Overall Study|Disease progression|5|||
25177326|NCT02754141|50321511|FG004|Overall Study|Disease progression|7|||
25177327|NCT02754141|50321512|FG005|Overall Study|Disease progression|7|||
25177328|NCT02754141|50321513|FG006|Overall Study|Disease progression|7|||
25177329|NCT02754141|50321514|FG007|Overall Study|Disease progression|6|||
25177330|NCT02754141|50321515|FG008|Overall Study|Disease progression|11|||
25177331|NCT02754141|50321516|FG009|Overall Study|Disease progression|16|||
25177332|NCT02754141|50321517|FG010|Overall Study|Disease progression|18|||
25261299|NCT01009099|50576025|FG000|Overall Study|Physician Decision|3|||
25110044|NCT02513771|50221421|FG000|Overall Study|Lost to Follow-up|1|||
25110045|NCT02513771|50221422|FG001|Overall Study|Lost to Follow-up|1|||
25110046|NCT02513771|50221421|FG000|Overall Study|Not being able to get to clinic|1|||
25261300|NCT01009099|50576026|FG001|Overall Study|Physician Decision|2|||
25110047|NCT02513771|50221422|FG001|Overall Study|Not being able to get to clinic|0|||
25110048|NCT02104947|50221430|FG000|Overall Study|Withdrawal by Subject|10|||
25110049|NCT02104947|50221431|FG001|Overall Study|Withdrawal by Subject|3|||
25110050|NCT02104947|50221430|FG000|Overall Study|Lost to Follow-up|4|||
25110051|NCT02104947|50221431|FG001|Overall Study|Lost to Follow-up|4|||
25110052|NCT02104947|50221430|FG000|Overall Study|Protocol Violation|6|||
25110053|NCT02104947|50221431|FG001|Overall Study|Protocol Violation|8|||
25110054|NCT02104947|50221430|FG000|Overall Study|Adverse Event|57|||
25110055|NCT02104947|50221431|FG001|Overall Study|Adverse Event|38|||
25110056|NCT02104947|50221430|FG000|Overall Study|Other than stated above|2|||
25110057|NCT02104947|50221431|FG001|Overall Study|Other than stated above|3|||
25110058|NCT02513459|50221441|FG000|Overall Study|Adverse Event|7|||
25110059|NCT02513459|50221441|FG000|Overall Study|Withdrew consent|5|||
25110060|NCT02513459|50221441|FG000|Overall Study|Loss of efficacy|2|||
25110061|NCT02513459|50221441|FG000|Overall Study|Pregnancy|2|||
25110062|NCT02513459|50221441|FG000|Overall Study|Subject decision|2|||
25110063|NCT02513459|50221441|FG000|Overall Study|Lack of response|1|||
25110064|NCT02513459|50221441|FG000|Overall Study|Reproductive plans|1|||
25110065|NCT02513459|50221441|FG000|Overall Study|Surgery planned-- not done|1|||
25110066|NCT02104557|50221450|FG000|Overall Study|Adverse Event|24|||
25110067|NCT02104557|50221450|FG000|Overall Study|Lost to Follow-up|34|||
25110068|NCT02104557|50221450|FG000|Overall Study|Violated the usage and dosage|14|||
25110069|NCT02104557|50221450|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
25110070|NCT02104557|50221450|FG000|Overall Study|Administered Sayana prior to the contract|1|||
25110071|NCT02104557|50221450|FG000|Overall Study|Other|17|||
25110072|NCT02104557|50221450|FG000|Overall Study|Change to other contraception methods|5|||
25110073|NCT02104557|50221450|FG000|Overall Study|Discontinuation due to no pain|1|||
25110074|NCT02104557|50221450|FG000|Overall Study|Withdrawal consent|2|||
25110075|NCT02104557|50221450|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
25110076|NCT02104557|50221450|FG000|Overall Study|Discontinuation of contraception|9|||
25110077|NCT02069379|50221456|FG000|Baseline Measurements|Lost to Follow-up|1|||
25110078|NCT02069379|50221457|FG001|Baseline Measurements|Lost to Follow-up|0|||
25110079|NCT02069379|50221458|FG002|Baseline Measurements|Lost to Follow-up|0|||
25110080|NCT02069379|50221459|FG003|Baseline Measurements|Lost to Follow-up|0|||
25110081|NCT02069379|50221456|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
25110082|NCT02069379|50221457|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
25110083|NCT02069379|50221458|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
25110084|NCT02069379|50221459|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
25110085|NCT02069379|50221456|FG000|First Treatment Arm|Lost to Follow-up|0|||
25110086|NCT02069379|50221457|FG001|First Treatment Arm|Lost to Follow-up|1|||
25110087|NCT02069379|50221458|FG002|First Treatment Arm|Lost to Follow-up|1|||
25110088|NCT02069379|50221459|FG003|First Treatment Arm|Lost to Follow-up|0|||
25110089|NCT02069379|50221456|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
25110090|NCT02069379|50221457|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
25110091|NCT02069379|50221458|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
25261301|NCT01009099|50576025|FG000|Overall Study|Withdrawal by Subject|1|||
25261302|NCT01009099|50576026|FG001|Overall Study|Withdrawal by Subject|1|||
25261303|NCT01009099|50576025|FG000|Overall Study|Death|0|||
25261304|NCT01009099|50576026|FG001|Overall Study|Death|1|||
25261305|NCT01263483|50576035|FG000|Overall Study|Adverse Event|4|||
25261306|NCT01263483|50576036|FG001|Overall Study|Adverse Event|0|||
25261307|NCT01263483|50576037|FG002|Overall Study|Adverse Event|3|||
25261308|NCT01263483|50576035|FG000|Overall Study|Withdrawal by Subject|1|||
25261309|NCT01263483|50576036|FG001|Overall Study|Withdrawal by Subject|0|||
25261310|NCT01263483|50576037|FG002|Overall Study|Withdrawal by Subject|0|||
25261311|NCT01263483|50576035|FG000|Overall Study|Lack of Efficacy|2|||
25261312|NCT01263483|50576036|FG001|Overall Study|Lack of Efficacy|0|||
25261313|NCT01263483|50576037|FG002|Overall Study|Lack of Efficacy|0|||
25261314|NCT01263483|50576035|FG000|Overall Study|Protocol Violation|0|||
25261315|NCT01263483|50576036|FG001|Overall Study|Protocol Violation|1|||
25110092|NCT02069379|50221459|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
25110093|NCT02069379|50221456|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
25110094|NCT02069379|50221457|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
25110095|NCT02069379|50221458|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
25110096|NCT02069379|50221459|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
25110097|NCT02069379|50221456|FG000|Second Treatment Arm|Lost to Follow-up|0|||
25110098|NCT02069379|50221457|FG001|Second Treatment Arm|Lost to Follow-up|0|||
25110099|NCT02069379|50221458|FG002|Second Treatment Arm|Lost to Follow-up|1|||
25110100|NCT02069379|50221459|FG003|Second Treatment Arm|Lost to Follow-up|0|||
25110101|NCT02511431|50221475|FG000|Treatment|Lost to Follow-up|0|||
25110102|NCT02511431|50221476|FG001|Treatment|Lost to Follow-up|0|||
25110103|NCT02511431|50221477|FG002|Treatment|Lost to Follow-up|1|||
25261316|NCT01263483|50576037|FG002|Overall Study|Protocol Violation|1|||
25261317|NCT01263483|50576035|FG000|Overall Study|Participant Unavailability|0|||
25261318|NCT01263483|50576036|FG001|Overall Study|Participant Unavailability|1|||
25261319|NCT01263483|50576037|FG002|Overall Study|Participant Unavailability|1|||
25110104|NCT02511431|50221478|FG003|Treatment|Lost to Follow-up|0|||
25110105|NCT02511431|50221479|FG004|Treatment|Lost to Follow-up|0|||
25110106|NCT02511431|50221480|FG005|Treatment|Lost to Follow-up|1|||
25110107|NCT02137785|50221497|FG000|Overall Study|Lost to Follow-up|1|||
25110108|NCT02137785|50221498|FG001|Overall Study|Lost to Follow-up|0|||
25110109|NCT02137785|50221497|FG000|Overall Study|Withdrawal by Subject|1|||
25110110|NCT02137785|50221498|FG001|Overall Study|Withdrawal by Subject|4|||
25110111|NCT02137785|50221497|FG000|Overall Study|subject moved out of state|1|||
25110112|NCT02137785|50221498|FG001|Overall Study|subject moved out of state|0|||
25110113|NCT01655069|50221508|FG000|Overall Study|Physician Decision|0|||
25110114|NCT01655069|50221509|FG001|Overall Study|Physician Decision|0|||
25110115|NCT01655069|50221510|FG002|Overall Study|Physician Decision|0|||
25110116|NCT01655069|50221511|FG003|Overall Study|Physician Decision|1|||
25110117|NCT01655069|50221508|FG000|Overall Study|Adverse Event|6|||
25110118|NCT01655069|50221509|FG001|Overall Study|Adverse Event|7|||
25110119|NCT01655069|50221510|FG002|Overall Study|Adverse Event|2|||
25110120|NCT01655069|50221511|FG003|Overall Study|Adverse Event|3|||
25110121|NCT01655069|50221508|FG000|Overall Study|Lack of Efficacy|0|||
25110122|NCT01655069|50221509|FG001|Overall Study|Lack of Efficacy|1|||
25110123|NCT01655069|50221510|FG002|Overall Study|Lack of Efficacy|0|||
25110124|NCT01655069|50221511|FG003|Overall Study|Lack of Efficacy|0|||
25110125|NCT01655069|50221508|FG000|Overall Study|No Treatment Needed|0|||
25110126|NCT01655069|50221509|FG001|Overall Study|No Treatment Needed|1|||
25110127|NCT01655069|50221510|FG002|Overall Study|No Treatment Needed|0|||
25110128|NCT01655069|50221511|FG003|Overall Study|No Treatment Needed|0|||
25110129|NCT01655069|50221508|FG000|Overall Study|Withdrawal by Subject|2|||
25110130|NCT01655069|50221509|FG001|Overall Study|Withdrawal by Subject|3|||
25110131|NCT01655069|50221510|FG002|Overall Study|Withdrawal by Subject|0|||
25110132|NCT01655069|50221511|FG003|Overall Study|Withdrawal by Subject|0|||
25110133|NCT02068599|50221522|FG000|Overall Study|Adverse Event|4|||
25110134|NCT02068599|50221523|FG001|Overall Study|Adverse Event|1|||
25110135|NCT02068599|50221524|FG002|Overall Study|Adverse Event|1|||
25110136|NCT02068599|50221522|FG000|Overall Study|Withdrawal by Subject|2|||
25110137|NCT02068599|50221523|FG001|Overall Study|Withdrawal by Subject|7|||
25110138|NCT02068599|50221524|FG002|Overall Study|Withdrawal by Subject|5|||
25110139|NCT02068599|50221522|FG000|Overall Study|Protocol Violation|4|||
25110140|NCT02068599|50221523|FG001|Overall Study|Protocol Violation|2|||
25110141|NCT02068599|50221524|FG002|Overall Study|Protocol Violation|3|||
25110142|NCT02068599|50221522|FG000|Overall Study|Lost to Follow-up|1|||
25110143|NCT02068599|50221523|FG001|Overall Study|Lost to Follow-up|0|||
25110144|NCT02068599|50221524|FG002|Overall Study|Lost to Follow-up|0|||
25110145|NCT02068599|50221522|FG000|Overall Study|Lack of Efficacy|0|||
25110146|NCT02068599|50221523|FG001|Overall Study|Lack of Efficacy|0|||
25110147|NCT02068599|50221524|FG002|Overall Study|Lack of Efficacy|3|||
25110148|NCT02068599|50221522|FG000|Overall Study|Noncompliance|0|||
25110149|NCT02068599|50221523|FG001|Overall Study|Noncompliance|0|||
25110150|NCT02068599|50221524|FG002|Overall Study|Noncompliance|1|||
25110151|NCT01654601|50221534|FG000|1st Administration|Withdrawal by Subject|2|||
25110152|NCT01654601|50221535|FG001|1st Administration|Withdrawal by Subject|0|||
25110153|NCT01654601|50221534|FG000|1st Administration|Protocol Violation|0|||
25110154|NCT01654601|50221535|FG001|1st Administration|Protocol Violation|2|||
25110155|NCT01654601|50221534|FG000|2nd Administration|Adverse Event|1|||
25110156|NCT01654601|50221535|FG001|2nd Administration|Adverse Event|0|||
25110157|NCT01654601|50221534|FG000|2nd Administration|Protocol Violation|0|||
25110158|NCT01654601|50221535|FG001|2nd Administration|Protocol Violation|1|||
25110159|NCT01654523|50221541|FG000|Overall Study|Withdrawal by Subject|1|||
25110160|NCT02068443|50221548|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
25110161|NCT02068443|50221549|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
25110162|NCT02068443|50221550|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
25110163|NCT02068443|50221548|FG000|Overall Study|Voluntary Withdrawal|4|||
25110164|NCT02068443|50221549|FG001|Overall Study|Voluntary Withdrawal|0|||
25110165|NCT02068443|50221550|FG002|Overall Study|Voluntary Withdrawal|1|||
25110166|NCT02068443|50221548|FG000|Overall Study|Lack of Efficacy|2|||
25110167|NCT02068443|50221549|FG001|Overall Study|Lack of Efficacy|1|||
25110168|NCT02068443|50221550|FG002|Overall Study|Lack of Efficacy|0|||
25110169|NCT02068443|50221548|FG000|Overall Study|Other Reason Not Specified|1|||
25261320|NCT01306890|50576045|FG000|Overall Study|Adverse Event|2|||
25261321|NCT01306890|50576045|FG000|Overall Study|Death|1223|||
25110170|NCT02068443|50221549|FG001|Overall Study|Other Reason Not Specified|0|||
25110171|NCT02068443|50221550|FG002|Overall Study|Other Reason Not Specified|0|||
25110172|NCT02508935|50221558|FG000|Overall Study|Withdrawal by Subject|1|||
25110173|NCT02508935|50221558|FG000|Overall Study|Withdrawal by Caregiver|8|||
25110174|NCT02508935|50221558|FG000|Overall Study|Pain Score <4|1|||
25110175|NCT02508935|50221558|FG000|Overall Study|Emesis|3|||
25110176|NCT02508935|50221558|FG000|Overall Study|Adverse Event|3|||
25110177|NCT02508935|50221558|FG000|Overall Study|Protocol Violation|1|||
25110178|NCT02508935|50221558|FG000|Overall Study|Physician Decision|1|||
25110179|NCT02508935|50221558|FG000|Overall Study|Trial terminated by sponsor|5|||
25110180|NCT02508701|50221568|FG000|Overall Study|Lost to Follow-up|9|||
25110181|NCT02508701|50221569|FG001|Overall Study|Lost to Follow-up|5|||
25110182|NCT02508701|50221570|FG002|Overall Study|Lost to Follow-up|5|||
25110183|NCT02508701|50221571|FG003|Overall Study|Lost to Follow-up|3|||
25110184|NCT02507375|50221587|FG000|Overall Study|Progressive Disease|4|||
25110185|NCT02507375|50221588|FG001|Overall Study|Progressive Disease|5|||
25110186|NCT02507375|50221587|FG000|Overall Study|Death|0|||
25110187|NCT02507375|50221588|FG001|Overall Study|Death|1|||
25110188|NCT02507375|50221587|FG000|Overall Study|Refused treatment|0|||
25110189|NCT02507375|50221588|FG001|Overall Study|Refused treatment|1|||
25110190|NCT02507375|50221587|FG000|Overall Study|Adverse Event|0|||
25110191|NCT02507375|50221588|FG001|Overall Study|Adverse Event|1|||
25110192|NCT02507219|50221598|FG000|Overall Study|Physician Decision|1|||
25110193|NCT02507219|50221599|FG001|Overall Study|Physician Decision|0|||
25110194|NCT02507219|50221600|FG002|Overall Study|Physician Decision|0|||
25110195|NCT02507219|50221601|FG003|Overall Study|Physician Decision|0|||
25110196|NCT02507219|50221602|FG004|Overall Study|Physician Decision|0|||
25110197|NCT02507219|50221603|FG005|Overall Study|Physician Decision|0|||
25110198|NCT02507219|50221598|FG000|Overall Study|Withdrawal by Subject|0|||
25110199|NCT02507219|50221599|FG001|Overall Study|Withdrawal by Subject|0|||
25110200|NCT02507219|50221600|FG002|Overall Study|Withdrawal by Subject|0|||
25110201|NCT02507219|50221601|FG003|Overall Study|Withdrawal by Subject|0|||
25110202|NCT02507219|50221602|FG004|Overall Study|Withdrawal by Subject|1|||
25110203|NCT02507219|50221603|FG005|Overall Study|Withdrawal by Subject|0|||
25110204|NCT02483975|50221613|FG000|Overall Study|Adverse Event|0|||
25110205|NCT02483975|50221614|FG001|Overall Study|Adverse Event|1|||
25110206|NCT02483975|50221613|FG000|Overall Study|Lost to Follow-up|0|||
25110207|NCT02483975|50221614|FG001|Overall Study|Lost to Follow-up|1|||
25110208|NCT02483975|50221613|FG000|Overall Study|Physician Decision|2|||
25110209|NCT02483975|50221614|FG001|Overall Study|Physician Decision|0|||
25110210|NCT02047227|50221625|FG000|Overall Study|Adverse Event|2|||
25110211|NCT02047227|50221626|FG001|Overall Study|Adverse Event|4|||
25110212|NCT02047227|50221625|FG000|Overall Study|Lost to Follow-up|0|||
25110213|NCT02047227|50221626|FG001|Overall Study|Lost to Follow-up|3|||
25110214|NCT02047227|50221625|FG000|Overall Study|Protocol Violation|1|||
25110215|NCT02047227|50221626|FG001|Overall Study|Protocol Violation|0|||
25110216|NCT02047227|50221625|FG000|Overall Study|Spontaneous pregnancy|1|||
25110217|NCT02047227|50221626|FG001|Overall Study|Spontaneous pregnancy|0|||
25110218|NCT02047227|50221625|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
25110219|NCT02047227|50221626|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
25110220|NCT02047227|50221625|FG000|Overall Study|No oocytes retrieved|21|||
25110221|NCT02047227|50221626|FG001|Overall Study|No oocytes retrieved|20|||
25110222|NCT02047227|50221625|FG000|Overall Study|No fertilization|61|||
25110223|NCT02047227|50221626|FG001|Overall Study|No fertilization|51|||
25110224|NCT02047227|50221625|FG000|Overall Study|Intention to freeze all embryos|1|||
25110225|NCT02047227|50221626|FG001|Overall Study|Intention to freeze all embryos|0|||
25110226|NCT02047227|50221625|FG000|Overall Study|All embryos discarded|12|||
25110227|NCT02047227|50221626|FG001|Overall Study|All embryos discarded|11|||
25110228|NCT02047227|50221625|FG000|Overall Study|Other|10|||
25110229|NCT02047227|50221626|FG001|Overall Study|Other|9|||
25110230|NCT02483585|50221634|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
25110231|NCT02483585|50221635|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
25110232|NCT02483585|50221634|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
25110233|NCT02483585|50221635|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
25110234|NCT02483585|50221634|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
25110235|NCT02483585|50221635|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
25110236|NCT02483585|50221634|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
25110237|NCT02483585|50221635|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
25110238|NCT02483585|50221634|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
25110239|NCT02483585|50221635|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
25110240|NCT02483585|50221634|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
25110241|NCT02483585|50221635|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
25110242|NCT02483585|50221634|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
25110243|NCT02483585|50221635|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
25110244|NCT02046993|50221647|FG000|Overall Study|Withdrawal by Subject|2|||
25110245|NCT02046993|50221648|FG001|Overall Study|Withdrawal by Subject|10|||
25110246|NCT02046993|50221647|FG000|Overall Study|Lost to Follow-up|1|||
25110247|NCT02046993|50221648|FG001|Overall Study|Lost to Follow-up|1|||
25110248|NCT02101983|50221658|FG000|Overall Study|Physician Decision|1|||
25110249|NCT02101983|50221659|FG001|Overall Study|Physician Decision|0|||
25110250|NCT02482805|50221668|FG000|Overall Study|Lost to Follow-up|4|||
25110251|NCT02482805|50221669|FG001|Overall Study|Lost to Follow-up|4|||
25110252|NCT02482805|50221670|FG002|Overall Study|Lost to Follow-up|0|||
25110253|NCT02503865|50221681|FG000|Overall Study|Moved out of area|1|||
25110254|NCT02503865|50221682|FG001|Overall Study|Moved out of area|8|||
25110255|NCT02503865|50221683|FG002|Overall Study|Moved out of area|0|||
25110256|NCT02503865|50221681|FG000|Overall Study|Refused treatment|4|||
25110257|NCT02503865|50221682|FG001|Overall Study|Refused treatment|39|||
25110258|NCT02503865|50221683|FG002|Overall Study|Refused treatment|2|||
25110259|NCT01623531|50221694|FG000|Overall Study|Death|1|||
25110260|NCT01623531|50221695|FG001|Overall Study|Death|0|||
25110261|NCT01623531|50221694|FG000|Overall Study|Protocol Violation|2|||
25110262|NCT01623531|50221695|FG001|Overall Study|Protocol Violation|1|||
25110263|NCT01623531|50221694|FG000|Overall Study|Missing data at primary outcome time poi|1|||
25110264|NCT01623531|50221695|FG001|Overall Study|Missing data at primary outcome time poi|1|||
25110265|NCT02503787|50221704|FG000|Enrollment|Withdrawal by Subject|6|||
25110266|NCT02503787|50221704|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
25110267|NCT02503787|50221704|FG000|Enrollment|Physician Decision|2|||
25110268|NCT02503787|50221704|FG000|Enrollment|Insurance issue|2|||
25110269|NCT02503787|50221704|FG000|Enrollment|Lost to Follow-up|1|||
25110270|NCT02503787|50221704|FG000|Enrollment|Study closure|1|||
25110271|NCT02503787|50221704|FG000|Enrollment|Adverse Event|1|||
25110272|NCT02503787|50221704|FG000|Enrollment|Protocol Violation|1|||
25110273|NCT02503787|50221704|FG000|Enrollment|Inability to implant system|1|||
25110274|NCT02503787|50221704|FG000|Enrollment|Unable to be programmed|1|||
25110275|NCT02503787|50221704|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
25110276|NCT02503787|50221704|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
25110277|NCT02503787|50221704|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
25110278|NCT02503787|50221704|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
25110279|NCT02503787|50221704|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
25110280|NCT02503787|50221704|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
25110281|NCT02482571|50221708|FG000|Overall Study|Adverse Event|1|||
25110282|NCT02482571|50221708|FG000|Overall Study|Scanner or Respiract failure|3|||
25110283|NCT02482571|50221708|FG000|Overall Study|Withdrawal by Subject|4|||
25110284|NCT02481947|50221715|FG000|Overall Study|Withdrawal by Subject|24|||
25110285|NCT02481947|50221716|FG001|Overall Study|Withdrawal by Subject|10|||
25110286|NCT02481947|50221715|FG000|Overall Study|Lost to Follow-up|11|||
25110287|NCT02481947|50221716|FG001|Overall Study|Lost to Follow-up|5|||
25110288|NCT02481947|50221715|FG000|Overall Study|Adverse Event|6|||
25110289|NCT02481947|50221716|FG001|Overall Study|Adverse Event|11|||
25110290|NCT02481947|50221715|FG000|Overall Study|Physician Decision|4|||
25110291|NCT02481947|50221716|FG001|Overall Study|Physician Decision|5|||
25110292|NCT02481947|50221715|FG000|Overall Study|Protocol Violation|1|||
25110293|NCT02481947|50221716|FG001|Overall Study|Protocol Violation|5|||
25110294|NCT02503085|50221722|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
25110295|NCT02503085|50221723|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
25110296|NCT02503085|50221724|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
25110297|NCT02503085|50221725|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
25110298|NCT02481869|50221734|FG000|Overall Study|Lost to Follow-up|3|||
25110299|NCT02481869|50221735|FG001|Overall Study|Lost to Follow-up|4|||
25110300|NCT02481869|50221734|FG000|Overall Study|Withdrawal by Subject|2|||
25110301|NCT02481869|50221735|FG001|Overall Study|Withdrawal by Subject|0|||
25110302|NCT02502149|50221742|FG000|Intermediate|Discontinued prematurely|1|||
25110303|NCT02502149|50221743|FG001|Intermediate|Discontinued prematurely|0|||
25110304|NCT02502149|50221744|FG002|Intermediate|Discontinued prematurely|0|||
25110305|NCT02502149|50221745|FG003|Intermediate|Discontinued prematurely|0|||
25110306|NCT02502149|50221746|FG004|Intermediate|Discontinued prematurely|0|||
25110307|NCT02480621|50221765|FG000|Randomization|Withdrawal by Subject|1|||
25110308|NCT02480621|50221766|FG001|Randomization|Withdrawal by Subject|0|||
25110309|NCT02480621|50221765|FG000|Randomization|Surgeon did not give intervention|0|||
25110310|NCT02480621|50221766|FG001|Randomization|Surgeon did not give intervention|1|||
25110311|NCT02480621|50221765|FG000|Follow Up|Lost to Follow-up|4|||
25110312|NCT02480621|50221766|FG001|Follow Up|Lost to Follow-up|2|||
25110313|NCT02046603|50221774|FG000|Overall Study|Other|11|||
25110314|NCT02046603|50221775|FG001|Overall Study|Other|66|||
25110315|NCT02046603|50221774|FG000|Overall Study|Protocol Violation|0|||
25110316|NCT02046603|50221775|FG001|Overall Study|Protocol Violation|1|||
25110317|NCT02046603|50221774|FG000|Overall Study|Participant/legal guardian decision|1|||
25110318|NCT02046603|50221775|FG001|Overall Study|Participant/legal guardian decision|3|||
25261322|NCT01306890|50576045|FG000|Overall Study|Lost to Follow-up|58|||
25261323|NCT01306890|50576045|FG000|Overall Study|Withdrawal by Subject|88|||
25261324|NCT01306890|50576045|FG000|Overall Study|Unspecified reasons|104|||
25261325|NCT01306890|50576045|FG000|Overall Study|Study Termination|3|||
25261326|NCT01306890|50576045|FG000|Overall Study|No discontinuation documentation|41|||
25261327|NCT01011049|50576053|FG000|Overall Study|Protocol Violation|0|||
25110319|NCT02046603|50221774|FG000|Overall Study|Physician Decision|2|||
25110320|NCT02046603|50221775|FG001|Overall Study|Physician Decision|1|||
25110321|NCT02046603|50221774|FG000|Overall Study|Lost to Follow-up|1|||
25261328|NCT01011049|50576054|FG001|Overall Study|Protocol Violation|0|||
25110322|NCT02046603|50221775|FG001|Overall Study|Lost to Follow-up|2|||
25110323|NCT02046603|50221774|FG000|Overall Study|Death|0|||
25110324|NCT02046603|50221775|FG001|Overall Study|Death|1|||
25110325|NCT02046603|50221774|FG000|Overall Study|Adverse Event|0|||
25261329|NCT01011049|50576055|FG002|Overall Study|Protocol Violation|2|||
25261330|NCT01011049|50576056|FG003|Overall Study|Protocol Violation|0|||
25110326|NCT02046603|50221775|FG001|Overall Study|Adverse Event|1|||
25110327|NCT01885078|50221790|FG000|Treatment Period|Adverse Event|52|||
25110328|NCT01885078|50221791|FG001|Treatment Period|Adverse Event|136|||
25110329|NCT01885078|50221792|FG002|Treatment Period|Adverse Event|30|||
25110330|NCT01885078|50221793|FG003|Treatment Period|Adverse Event|73|||
25110331|NCT01885078|50221794|FG004|Treatment Period|Adverse Event|17|||
25110332|NCT01885078|50221795|FG005|Treatment Period|Adverse Event|72|||
25110333|NCT01885078|50221796|FG006|Treatment Period|Adverse Event|24|||
25110334|NCT01885078|50221797|FG007|Treatment Period|Adverse Event|5|||
25110335|NCT01885078|50221798|FG008|Treatment Period|Adverse Event|0|||
25110336|NCT01885078|50221799|FG009|Treatment Period|Adverse Event|0|||
25110337|NCT01885078|50221790|FG000|Treatment Period|Death|13|||
25110338|NCT01885078|50221791|FG001|Treatment Period|Death|33|||
25110339|NCT01885078|50221792|FG002|Treatment Period|Death|5|||
25110340|NCT01885078|50221793|FG003|Treatment Period|Death|9|||
25110341|NCT01885078|50221794|FG004|Treatment Period|Death|2|||
25110342|NCT01885078|50221795|FG005|Treatment Period|Death|10|||
25110343|NCT01885078|50221796|FG006|Treatment Period|Death|3|||
25110344|NCT01885078|50221797|FG007|Treatment Period|Death|2|||
25110345|NCT01885078|50221798|FG008|Treatment Period|Death|0|||
25110346|NCT01885078|50221799|FG009|Treatment Period|Death|0|||
25110347|NCT01885078|50221790|FG000|Treatment Period|Lack of Efficacy|12|||
25110348|NCT01885078|50221791|FG001|Treatment Period|Lack of Efficacy|33|||
25110349|NCT01885078|50221792|FG002|Treatment Period|Lack of Efficacy|10|||
25110350|NCT01885078|50221793|FG003|Treatment Period|Lack of Efficacy|23|||
25110351|NCT01885078|50221794|FG004|Treatment Period|Lack of Efficacy|24|||
25110352|NCT01885078|50221795|FG005|Treatment Period|Lack of Efficacy|58|||
25110353|NCT01885078|50221796|FG006|Treatment Period|Lack of Efficacy|9|||
25110354|NCT01885078|50221797|FG007|Treatment Period|Lack of Efficacy|5|||
25110355|NCT01885078|50221798|FG008|Treatment Period|Lack of Efficacy|0|||
25110356|NCT01885078|50221799|FG009|Treatment Period|Lack of Efficacy|0|||
25110357|NCT01885078|50221790|FG000|Treatment Period|Lost to Follow-up|16|||
25110358|NCT01885078|50221791|FG001|Treatment Period|Lost to Follow-up|19|||
25110359|NCT01885078|50221792|FG002|Treatment Period|Lost to Follow-up|7|||
25110360|NCT01885078|50221793|FG003|Treatment Period|Lost to Follow-up|9|||
25110361|NCT01885078|50221794|FG004|Treatment Period|Lost to Follow-up|2|||
25110362|NCT01885078|50221795|FG005|Treatment Period|Lost to Follow-up|8|||
25110363|NCT01885078|50221796|FG006|Treatment Period|Lost to Follow-up|2|||
25110364|NCT01885078|50221797|FG007|Treatment Period|Lost to Follow-up|0|||
25110365|NCT01885078|50221798|FG008|Treatment Period|Lost to Follow-up|0|||
25110366|NCT01885078|50221799|FG009|Treatment Period|Lost to Follow-up|0|||
25110367|NCT01885078|50221790|FG000|Treatment Period|Physician Decision|19|||
25110368|NCT01885078|50221791|FG001|Treatment Period|Physician Decision|21|||
25110369|NCT01885078|50221792|FG002|Treatment Period|Physician Decision|5|||
25110370|NCT01885078|50221793|FG003|Treatment Period|Physician Decision|12|||
25110371|NCT01885078|50221794|FG004|Treatment Period|Physician Decision|9|||
25110372|NCT01885078|50221795|FG005|Treatment Period|Physician Decision|24|||
25110373|NCT01885078|50221796|FG006|Treatment Period|Physician Decision|4|||
25110374|NCT01885078|50221797|FG007|Treatment Period|Physician Decision|3|||
25110375|NCT01885078|50221798|FG008|Treatment Period|Physician Decision|0|||
25110376|NCT01885078|50221799|FG009|Treatment Period|Physician Decision|0|||
25110377|NCT01885078|50221790|FG000|Treatment Period|Protocol Violation|3|||
25110378|NCT01885078|50221791|FG001|Treatment Period|Protocol Violation|5|||
25110379|NCT01885078|50221792|FG002|Treatment Period|Protocol Violation|0|||
25110380|NCT01885078|50221793|FG003|Treatment Period|Protocol Violation|3|||
25110381|NCT01885078|50221794|FG004|Treatment Period|Protocol Violation|1|||
25110382|NCT01885078|50221795|FG005|Treatment Period|Protocol Violation|6|||
25110383|NCT01885078|50221796|FG006|Treatment Period|Protocol Violation|0|||
25110384|NCT01885078|50221797|FG007|Treatment Period|Protocol Violation|0|||
25110385|NCT01885078|50221798|FG008|Treatment Period|Protocol Violation|0|||
25110386|NCT01885078|50221799|FG009|Treatment Period|Protocol Violation|0|||
25110387|NCT01885078|50221790|FG000|Treatment Period|Sponsor Decision|245|||
25110388|NCT01885078|50221791|FG001|Treatment Period|Sponsor Decision|648|||
25110389|NCT01885078|50221792|FG002|Treatment Period|Sponsor Decision|49|||
25110390|NCT01885078|50221793|FG003|Treatment Period|Sponsor Decision|90|||
25110391|NCT01885078|50221794|FG004|Treatment Period|Sponsor Decision|20|||
25110392|NCT01885078|50221795|FG005|Treatment Period|Sponsor Decision|38|||
25110393|NCT01885078|50221796|FG006|Treatment Period|Sponsor Decision|162|||
25110394|NCT01885078|50221797|FG007|Treatment Period|Sponsor Decision|3|||
25110395|NCT01885078|50221798|FG008|Treatment Period|Sponsor Decision|0|||
25110396|NCT01885078|50221799|FG009|Treatment Period|Sponsor Decision|0|||
25110397|NCT01885078|50221790|FG000|Treatment Period|Withdrawal by Subject|72|||
25110398|NCT01885078|50221791|FG001|Treatment Period|Withdrawal by Subject|132|||
25110399|NCT01885078|50221792|FG002|Treatment Period|Withdrawal by Subject|25|||
25110400|NCT01885078|50221793|FG003|Treatment Period|Withdrawal by Subject|63|||
25110401|NCT01885078|50221794|FG004|Treatment Period|Withdrawal by Subject|15|||
25110402|NCT01885078|50221795|FG005|Treatment Period|Withdrawal by Subject|34|||
25110403|NCT01885078|50221796|FG006|Treatment Period|Withdrawal by Subject|17|||
25110404|NCT01885078|50221797|FG007|Treatment Period|Withdrawal by Subject|10|||
25110405|NCT01885078|50221798|FG008|Treatment Period|Withdrawal by Subject|0|||
25110406|NCT01885078|50221799|FG009|Treatment Period|Withdrawal by Subject|0|||
25110407|NCT01885078|50221790|FG000|Treatment Period|Other|0|||
25110408|NCT01885078|50221791|FG001|Treatment Period|Other|0|||
25110409|NCT01885078|50221792|FG002|Treatment Period|Other|0|||
25110410|NCT01885078|50221793|FG003|Treatment Period|Other|1|||
25110411|NCT01885078|50221794|FG004|Treatment Period|Other|0|||
25110412|NCT01885078|50221795|FG005|Treatment Period|Other|0|||
25110413|NCT01885078|50221796|FG006|Treatment Period|Other|0|||
25110414|NCT01885078|50221797|FG007|Treatment Period|Other|0|||
25110415|NCT01885078|50221798|FG008|Treatment Period|Other|0|||
25110416|NCT01885078|50221799|FG009|Treatment Period|Other|0|||
25110417|NCT01885078|50221790|FG000|Step-down Period|Sponsor Decision|0|||
25110418|NCT01885078|50221791|FG001|Step-down Period|Sponsor Decision|0|||
25110419|NCT01885078|50221792|FG002|Step-down Period|Sponsor Decision|0|||
25110420|NCT01885078|50221793|FG003|Step-down Period|Sponsor Decision|0|||
25110421|NCT01885078|50221794|FG004|Step-down Period|Sponsor Decision|0|||
25110422|NCT01885078|50221795|FG005|Step-down Period|Sponsor Decision|0|||
25110423|NCT01885078|50221796|FG006|Step-down Period|Sponsor Decision|0|||
25110424|NCT01885078|50221797|FG007|Step-down Period|Sponsor Decision|0|||
25110425|NCT01885078|50221798|FG008|Step-down Period|Sponsor Decision|1|||
25110426|NCT01885078|50221799|FG009|Step-down Period|Sponsor Decision|1|||
25110427|NCT01885078|50221790|FG000|Step-down Period|Adverse Event|0|||
25110428|NCT01885078|50221791|FG001|Step-down Period|Adverse Event|0|||
25110429|NCT01885078|50221792|FG002|Step-down Period|Adverse Event|0|||
25110430|NCT01885078|50221793|FG003|Step-down Period|Adverse Event|0|||
25110431|NCT01885078|50221794|FG004|Step-down Period|Adverse Event|0|||
25110432|NCT01885078|50221795|FG005|Step-down Period|Adverse Event|0|||
25110433|NCT01885078|50221796|FG006|Step-down Period|Adverse Event|0|||
25110434|NCT01885078|50221797|FG007|Step-down Period|Adverse Event|0|||
25110435|NCT01885078|50221798|FG008|Step-down Period|Adverse Event|29|||
25110436|NCT01885078|50221799|FG009|Step-down Period|Adverse Event|38|||
25110437|NCT01885078|50221790|FG000|Step-down Period|Withdrawal by Subject|0|||
25110438|NCT01885078|50221791|FG001|Step-down Period|Withdrawal by Subject|0|||
25110439|NCT01885078|50221792|FG002|Step-down Period|Withdrawal by Subject|0|||
25110440|NCT01885078|50221793|FG003|Step-down Period|Withdrawal by Subject|0|||
25110441|NCT01885078|50221794|FG004|Step-down Period|Withdrawal by Subject|0|||
25110442|NCT01885078|50221795|FG005|Step-down Period|Withdrawal by Subject|0|||
25110443|NCT01885078|50221796|FG006|Step-down Period|Withdrawal by Subject|0|||
25110444|NCT01885078|50221797|FG007|Step-down Period|Withdrawal by Subject|0|||
25110445|NCT01885078|50221798|FG008|Step-down Period|Withdrawal by Subject|25|||
25110446|NCT01885078|50221799|FG009|Step-down Period|Withdrawal by Subject|15|||
25110447|NCT01885078|50221790|FG000|Step-down Period|Physician Decision|0|||
25110448|NCT01885078|50221791|FG001|Step-down Period|Physician Decision|0|||
25110449|NCT01885078|50221792|FG002|Step-down Period|Physician Decision|0|||
25110450|NCT01885078|50221793|FG003|Step-down Period|Physician Decision|0|||
25110451|NCT01885078|50221794|FG004|Step-down Period|Physician Decision|0|||
25110452|NCT01885078|50221795|FG005|Step-down Period|Physician Decision|0|||
25110453|NCT01885078|50221796|FG006|Step-down Period|Physician Decision|0|||
25110454|NCT01885078|50221797|FG007|Step-down Period|Physician Decision|0|||
25110455|NCT01885078|50221798|FG008|Step-down Period|Physician Decision|7|||
25110456|NCT01885078|50221799|FG009|Step-down Period|Physician Decision|2|||
25110457|NCT01885078|50221790|FG000|Step-down Period|Death|0|||
25110458|NCT01885078|50221791|FG001|Step-down Period|Death|0|||
25110459|NCT01885078|50221792|FG002|Step-down Period|Death|0|||
25110460|NCT01885078|50221793|FG003|Step-down Period|Death|0|||
25110461|NCT01885078|50221794|FG004|Step-down Period|Death|0|||
25110462|NCT01885078|50221795|FG005|Step-down Period|Death|0|||
25110463|NCT01885078|50221796|FG006|Step-down Period|Death|0|||
25110464|NCT01885078|50221797|FG007|Step-down Period|Death|0|||
25110465|NCT01885078|50221798|FG008|Step-down Period|Death|4|||
25110466|NCT01885078|50221799|FG009|Step-down Period|Death|3|||
25110467|NCT01885078|50221790|FG000|Step-down Period|Lost to Follow-up|0|||
25110468|NCT01885078|50221791|FG001|Step-down Period|Lost to Follow-up|0|||
25110469|NCT01885078|50221792|FG002|Step-down Period|Lost to Follow-up|0|||
25110470|NCT01885078|50221793|FG003|Step-down Period|Lost to Follow-up|0|||
25110471|NCT01885078|50221794|FG004|Step-down Period|Lost to Follow-up|0|||
25110472|NCT01885078|50221795|FG005|Step-down Period|Lost to Follow-up|0|||
25110473|NCT01885078|50221796|FG006|Step-down Period|Lost to Follow-up|0|||
25110474|NCT01885078|50221797|FG007|Step-down Period|Lost to Follow-up|0|||
25110475|NCT01885078|50221798|FG008|Step-down Period|Lost to Follow-up|1|||
25110476|NCT01885078|50221799|FG009|Step-down Period|Lost to Follow-up|1|||
25110477|NCT01885078|50221790|FG000|Step-down Period|Lack of Efficacy|0|||
25110478|NCT01885078|50221791|FG001|Step-down Period|Lack of Efficacy|0|||
25110479|NCT01885078|50221792|FG002|Step-down Period|Lack of Efficacy|0|||
25110480|NCT01885078|50221793|FG003|Step-down Period|Lack of Efficacy|0|||
25110481|NCT01885078|50221794|FG004|Step-down Period|Lack of Efficacy|0|||
25110482|NCT01885078|50221795|FG005|Step-down Period|Lack of Efficacy|0|||
25110483|NCT01885078|50221796|FG006|Step-down Period|Lack of Efficacy|0|||
25110484|NCT01885078|50221797|FG007|Step-down Period|Lack of Efficacy|0|||
25110485|NCT01885078|50221798|FG008|Step-down Period|Lack of Efficacy|1|||
25110486|NCT01885078|50221799|FG009|Step-down Period|Lack of Efficacy|0|||
25110487|NCT01885078|50221790|FG000|Step-down Period|Protocol Violation|0|||
25110488|NCT01885078|50221791|FG001|Step-down Period|Protocol Violation|0|||
25110489|NCT01885078|50221792|FG002|Step-down Period|Protocol Violation|0|||
25110490|NCT01885078|50221793|FG003|Step-down Period|Protocol Violation|0|||
25110491|NCT01885078|50221794|FG004|Step-down Period|Protocol Violation|0|||
25110492|NCT01885078|50221795|FG005|Step-down Period|Protocol Violation|0|||
25110493|NCT01885078|50221796|FG006|Step-down Period|Protocol Violation|0|||
25110494|NCT01885078|50221797|FG007|Step-down Period|Protocol Violation|0|||
25110495|NCT01885078|50221798|FG008|Step-down Period|Protocol Violation|1|||
25110496|NCT01885078|50221799|FG009|Step-down Period|Protocol Violation|1|||
25110497|NCT02046369|50221822|FG000|Overall Study|Adverse Event|3|||
25110498|NCT02046369|50221823|FG001|Overall Study|Adverse Event|3|||
25110499|NCT02046369|50221822|FG000|Overall Study|Lack of Efficacy|3|||
25110500|NCT02046369|50221823|FG001|Overall Study|Lack of Efficacy|3|||
25110501|NCT02046369|50221822|FG000|Overall Study|Lost to Follow-up|3|||
25110502|NCT02046369|50221823|FG001|Overall Study|Lost to Follow-up|3|||
25110503|NCT02046369|50221822|FG000|Overall Study|Protocol Violation|1|||
25110504|NCT02046369|50221823|FG001|Overall Study|Protocol Violation|2|||
25110505|NCT02046369|50221822|FG000|Overall Study|Withdrawal by Subject|3|||
25110506|NCT02046369|50221823|FG001|Overall Study|Withdrawal by Subject|6|||
25110507|NCT02046369|50221822|FG000|Overall Study|never received study drug|0|||
25110508|NCT02046369|50221823|FG001|Overall Study|never received study drug|1|||
25110509|NCT02046369|50221822|FG000|Overall Study|non compliance|1|||
25110510|NCT02046369|50221823|FG001|Overall Study|non compliance|0|||
25110511|NCT02101359|50221831|FG000|Overall Study|Not included|23|||
25110512|NCT02101359|50221832|FG001|Overall Study|Not included|13|||
25110513|NCT02101359|50221831|FG000|Overall Study|Withdrawal by Subject|5|||
25110514|NCT02101359|50221832|FG001|Overall Study|Withdrawal by Subject|4|||
25110515|NCT02101359|50221831|FG000|Overall Study|Lost to Follow-up|1|||
25110516|NCT02101359|50221832|FG001|Overall Study|Lost to Follow-up|0|||
25110517|NCT02101359|50221831|FG000|Overall Study|Protocol Violation|0|||
25110518|NCT02101359|50221832|FG001|Overall Study|Protocol Violation|2|||
25110519|NCT02100969|50221838|FG000|Overall Study|Did not pass screening phase|1|||
25110520|NCT01885000|50221845|FG000|Overall Study|Adverse Event|1|||
25110521|NCT01885000|50221846|FG001|Overall Study|Adverse Event|0|||
25110522|NCT01885000|50221845|FG000|Overall Study|Withdrawal by Subject|1|||
25110523|NCT01885000|50221846|FG001|Overall Study|Withdrawal by Subject|1|||
25110524|NCT01885000|50221845|FG000|Overall Study|Protocol Violation|0|||
25110525|NCT01885000|50221846|FG001|Overall Study|Protocol Violation|1|||
25110526|NCT01884688|50221852|FG000|Overall Study|Screen Failure|2|||
25110527|NCT01883362|50221858|FG000|Treatment|Adverse Event|1|||
25110528|NCT01883362|50221859|FG001|Treatment|Adverse Event|8|||
25110529|NCT01883362|50221858|FG000|Treatment|Withdrawal by Subject|6|||
25110530|NCT01883362|50221859|FG001|Treatment|Withdrawal by Subject|2|||
25008289|NCT03556358|50101179|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
25008290|NCT03556358|50101178|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
25008291|NCT03556358|50101179|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
25008292|NCT03228680|50101187|FG000|Overall Study|Adverse Event|13|||
25008293|NCT03228680|50101188|FG001|Overall Study|Adverse Event|18|||
25008294|NCT03228680|50101187|FG000|Overall Study|Randomization failure|0|||
25008295|NCT03228680|50101188|FG001|Overall Study|Randomization failure|1|||
25008296|NCT03228680|50101187|FG000|Overall Study|Withdrawal by Subject|1|||
25008297|NCT03228680|50101188|FG001|Overall Study|Withdrawal by Subject|0|||
25008298|NCT03228680|50101187|FG000|Overall Study|Other|9|||
25008299|NCT03228680|50101188|FG001|Overall Study|Other|16|||
25008300|NCT04490018|50101203|FG000|Overall Study|Protocol Violation|0|||
25008301|NCT04490018|50101204|FG001|Overall Study|Protocol Violation|2|||
25008302|NCT04490018|50101205|FG002|Overall Study|Protocol Violation|1|||
25110531|NCT01883362|50221858|FG000|Treatment|Administrative problems|4|||
25261331|NCT01011049|50576053|FG000|Overall Study|Lost to Follow-up|1|||
25008303|NCT04490018|50101203|FG000|Overall Study|Lost to Follow-up|2|||
25008304|NCT04490018|50101204|FG001|Overall Study|Lost to Follow-up|2|||
25110532|NCT01883362|50221859|FG001|Treatment|Administrative problems|1|||
25110533|NCT01883362|50221858|FG000|Treatment|Relapse|4|||
25177333|NCT02754141|50321518|FG011|Overall Study|Disease progression|13|||
25110534|NCT01883362|50221859|FG001|Treatment|Relapse|2|||
25110535|NCT01883362|50221858|FG000|Treatment|Randomized, not treated|1|||
25110536|NCT01883362|50221859|FG001|Treatment|Randomized, not treated|1|||
25110537|NCT01883362|50221858|FG000|Post Treatment Follow-up|Protocol Violation|0|||
25110538|NCT01883362|50221859|FG001|Post Treatment Follow-up|Protocol Violation|1|||
25110539|NCT01883362|50221858|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
25110540|NCT01883362|50221859|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
25110541|NCT01883362|50221858|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
25110542|NCT01883362|50221859|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
25110543|NCT01883362|50221858|FG000|Post Treatment Follow-up|Administrative problems|2|||
25110544|NCT01883362|50221859|FG001|Post Treatment Follow-up|Administrative problems|0|||
25110545|NCT01883362|50221858|FG000|Post Treatment Follow-up|Death|8|||
25110546|NCT01883362|50221859|FG001|Post Treatment Follow-up|Death|4|||
25110547|NCT01883362|50221858|FG000|Post Treatment Follow-up|Relapse|1|||
25110548|NCT01883362|50221859|FG001|Post Treatment Follow-up|Relapse|2|||
25110549|NCT02100813|50221877|FG000|Overall Study|Adverse Event|0|||
25110550|NCT02100813|50221878|FG001|Overall Study|Adverse Event|0|||
25110551|NCT02100813|50221879|FG002|Overall Study|Adverse Event|0|||
25110552|NCT02100813|50221880|FG003|Overall Study|Adverse Event|0|||
25110553|NCT02100813|50221881|FG004|Overall Study|Adverse Event|0|||
25110554|NCT02100813|50221882|FG005|Overall Study|Adverse Event|0|||
25110555|NCT02100813|50221883|FG006|Overall Study|Adverse Event|0|||
25110556|NCT02100813|50221884|FG007|Overall Study|Adverse Event|1|||
25110557|NCT01930162|50221906|FG000|Overall Study|Abnormal test procedure result(s)|4|||
25110558|NCT01930162|50221906|FG000|Overall Study|Death|1|||
25110559|NCT02045979|50221914|FG000|Overall Study|Informed Consent Withdrawn|2|||
25110560|NCT02045979|50221915|FG001|Overall Study|Informed Consent Withdrawn|0|||
25110561|NCT02045979|50221916|FG002|Overall Study|Informed Consent Withdrawn|1|||
25110562|NCT02045979|50221914|FG000|Overall Study|not specified above|0|||
25110563|NCT02045979|50221915|FG001|Overall Study|not specified above|1|||
25110564|NCT02045979|50221916|FG002|Overall Study|not specified above|0|||
25110565|NCT01929226|50221926|FG000|Overall Study|Lost to Follow-up|4|||
25110566|NCT01929226|50221927|FG001|Overall Study|Lost to Follow-up|0|||
25110567|NCT01929226|50221926|FG000|Overall Study|Withdrawal by Subject|1|||
25110568|NCT01929226|50221927|FG001|Overall Study|Withdrawal by Subject|1|||
25110569|NCT02045433|50221934|FG000|Overall Study|Withdrawal by Subject|1|||
25110570|NCT01911442|50221941|FG000|Overall Study|Adverse Event|2|||
25110571|NCT01911442|50221942|FG001|Overall Study|Adverse Event|2|||
25110572|NCT01911442|50221943|FG002|Overall Study|Adverse Event|4|||
25110573|NCT01911442|50221941|FG000|Overall Study|Lack of Efficacy|1|||
25110574|NCT01911442|50221942|FG001|Overall Study|Lack of Efficacy|1|||
25110575|NCT01911442|50221943|FG002|Overall Study|Lack of Efficacy|1|||
25110576|NCT01911442|50221941|FG000|Overall Study|Lost to Follow-up|2|||
25110577|NCT01911442|50221942|FG001|Overall Study|Lost to Follow-up|0|||
25110578|NCT01911442|50221943|FG002|Overall Study|Lost to Follow-up|1|||
25110579|NCT01911442|50221941|FG000|Overall Study|Withdrawal by Subject|1|||
25110580|NCT01911442|50221942|FG001|Overall Study|Withdrawal by Subject|0|||
25110581|NCT01911442|50221943|FG002|Overall Study|Withdrawal by Subject|6|||
25110582|NCT01911442|50221941|FG000|Overall Study|Mother's Work Schedule|0|||
25110583|NCT01911442|50221942|FG001|Overall Study|Mother's Work Schedule|1|||
25110584|NCT01911442|50221943|FG002|Overall Study|Mother's Work Schedule|0|||
25110585|NCT01928758|50221957|FG000|Overall Study|Lost to Follow-up|14|||
25110586|NCT01928758|50221958|FG001|Overall Study|Lost to Follow-up|9|||
25110587|NCT01928758|50221957|FG000|Overall Study|Withdrawal by Subject|5|||
25110588|NCT01928758|50221958|FG001|Overall Study|Withdrawal by Subject|2|||
25110589|NCT01928758|50221957|FG000|Overall Study|Adverse Event|3|||
25110590|NCT01928758|50221958|FG001|Overall Study|Adverse Event|5|||
25110591|NCT01928758|50221957|FG000|Overall Study|Protocol Violation|3|||
25110592|NCT01928758|50221958|FG001|Overall Study|Protocol Violation|4|||
25110593|NCT01910116|50221967|FG000|Overall Study|Adverse Event|0|||
25110594|NCT01910116|50221968|FG001|Overall Study|Adverse Event|3|||
25110595|NCT01910116|50221967|FG000|Overall Study|Lack of Efficacy|3|||
25110596|NCT01910116|50221968|FG001|Overall Study|Lack of Efficacy|4|||
25110597|NCT01910116|50221967|FG000|Overall Study|Lost to Follow-up|1|||
25110598|NCT01910116|50221968|FG001|Overall Study|Lost to Follow-up|0|||
25110599|NCT01910116|50221967|FG000|Overall Study|Protocol Violation|1|||
25110600|NCT01910116|50221968|FG001|Overall Study|Protocol Violation|2|||
25110601|NCT01910116|50221967|FG000|Overall Study|Withdrawal by Subject|8|||
25110602|NCT01910116|50221968|FG001|Overall Study|Withdrawal by Subject|3|||
25110603|NCT01910116|50221967|FG000|Overall Study|uncertain allocation|1|||
25110604|NCT01910116|50221968|FG001|Overall Study|uncertain allocation|3|||
25110605|NCT01910116|50221967|FG000|Overall Study|incomplete data|0|||
25110606|NCT01910116|50221968|FG001|Overall Study|incomplete data|1|||
25110607|NCT01614886|50221976|FG000|Overall Study|Adverse Event|15|||
25110608|NCT01614886|50221977|FG001|Overall Study|Adverse Event|20|||
25110609|NCT01614886|50221976|FG000|Overall Study|Withdrawal by Subject|4|||
25110610|NCT01614886|50221977|FG001|Overall Study|Withdrawal by Subject|4|||
25110611|NCT01614886|50221976|FG000|Overall Study|Death|1|||
25110612|NCT01614886|50221977|FG001|Overall Study|Death|0|||
25110613|NCT01614886|50221976|FG000|Overall Study|Protocol deviation|0|||
25110614|NCT01614886|50221977|FG001|Overall Study|Protocol deviation|2|||
25110615|NCT01880554|50221983|FG000|Overall Study|Protocol Violation|14|||
25110616|NCT01880554|50221983|FG000|Overall Study|Simon's design requirements|2|||
25110617|NCT02100657|50221991|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
25110618|NCT02100657|50221992|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
25110619|NCT02100657|50221993|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
25110620|NCT02100657|50221991|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
25110621|NCT02100657|50221992|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
25110622|NCT02100657|50221993|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
25110623|NCT02100657|50221991|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
25110624|NCT02100657|50221992|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
25110625|NCT02100657|50221993|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
25110626|NCT02100657|50221991|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
25110627|NCT02100657|50221992|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
25110628|NCT02100657|50221993|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
25110629|NCT02100657|50221991|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
25110630|NCT02100657|50221992|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
25110631|NCT02100657|50221993|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
25110632|NCT02100657|50221991|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
25110633|NCT02100657|50221992|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
25110634|NCT02100657|50221993|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
25110635|NCT02100657|50221991|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
25110636|NCT02100657|50221992|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
25110637|NCT02100657|50221993|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
25110638|NCT02100657|50221991|FG000|Cohort 3: Dose Level 3|Death|0|||
25110639|NCT02100657|50221992|FG001|Cohort 3: Dose Level 3|Death|0|||
25110640|NCT02100657|50221993|FG002|Cohort 3: Dose Level 3|Death|1|||
25110641|NCT02100657|50221991|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
25110642|NCT02100657|50221992|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
25110643|NCT02100657|50221993|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
25110644|NCT02100657|50221991|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
25110645|NCT02100657|50221992|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
25110646|NCT02100657|50221993|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
25110647|NCT02100657|50221991|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
25110648|NCT02100657|50221992|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
25110649|NCT02100657|50221993|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
25110650|NCT02100657|50221991|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
25110651|NCT02100657|50221992|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
25110652|NCT02100657|50221993|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
25110653|NCT02100657|50221991|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
25110654|NCT02100657|50221992|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
25110655|NCT02100657|50221993|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
25110656|NCT02067663|50222004|FG000|Overall Study|Lost to Follow-up|13|||
25110657|NCT02067663|50222005|FG001|Overall Study|Lost to Follow-up|14|||
25110658|NCT01909804|50222023|FG000|Overall Study|Randomized but Never Treated|0|||
25110659|NCT01909804|50222024|FG001|Overall Study|Randomized but Never Treated|0|||
25110660|NCT01909804|50222025|FG002|Overall Study|Randomized but Never Treated|0|||
25110661|NCT01909804|50222026|FG003|Overall Study|Randomized but Never Treated|0|||
25110662|NCT01909804|50222027|FG004|Overall Study|Randomized but Never Treated|0|||
25110663|NCT01909804|50222028|FG005|Overall Study|Randomized but Never Treated|0|||
25110664|NCT01909804|50222029|FG006|Overall Study|Randomized but Never Treated|1|||
25110665|NCT01909804|50222030|FG007|Overall Study|Randomized but Never Treated|0|||
25110666|NCT01909804|50222031|FG008|Overall Study|Randomized but Never Treated|0|||
25110667|NCT01909804|50222032|FG009|Overall Study|Randomized but Never Treated|0|||
25110668|NCT01909804|50222033|FG010|Overall Study|Randomized but Never Treated|0|||
25110669|NCT01909804|50222034|FG011|Overall Study|Randomized but Never Treated|1|||
25110670|NCT01909804|50222023|FG000|Overall Study|Death|0|||
25110671|NCT01909804|50222024|FG001|Overall Study|Death|0|||
25110672|NCT01909804|50222025|FG002|Overall Study|Death|0|||
25110673|NCT01909804|50222026|FG003|Overall Study|Death|0|||
25110674|NCT01909804|50222027|FG004|Overall Study|Death|0|||
25110675|NCT01909804|50222028|FG005|Overall Study|Death|0|||
25110676|NCT01909804|50222029|FG006|Overall Study|Death|0|||
25110677|NCT01909804|50222030|FG007|Overall Study|Death|0|||
25110678|NCT01909804|50222031|FG008|Overall Study|Death|0|||
25110679|NCT01909804|50222032|FG009|Overall Study|Death|0|||
25110680|NCT01909804|50222033|FG010|Overall Study|Death|1|||
25110681|NCT01909804|50222034|FG011|Overall Study|Death|0|||
25110682|NCT01909804|50222023|FG000|Overall Study|Lack of Efficacy|4|||
25110683|NCT01909804|50222024|FG001|Overall Study|Lack of Efficacy|1|||
25110684|NCT01909804|50222025|FG002|Overall Study|Lack of Efficacy|0|||
25110685|NCT01909804|50222026|FG003|Overall Study|Lack of Efficacy|0|||
25110686|NCT01909804|50222027|FG004|Overall Study|Lack of Efficacy|7|||
25261332|NCT01011049|50576054|FG001|Overall Study|Lost to Follow-up|2|||
25110687|NCT01909804|50222028|FG005|Overall Study|Lack of Efficacy|3|||
25110688|NCT01909804|50222029|FG006|Overall Study|Lack of Efficacy|1|||
25261333|NCT01011049|50576055|FG002|Overall Study|Lost to Follow-up|1|||
25008305|NCT04490018|50101205|FG002|Overall Study|Lost to Follow-up|0|||
25110689|NCT01909804|50222030|FG007|Overall Study|Lack of Efficacy|1|||
25110690|NCT01909804|50222031|FG008|Overall Study|Lack of Efficacy|0|||
25110691|NCT01909804|50222032|FG009|Overall Study|Lack of Efficacy|1|||
25110692|NCT01909804|50222033|FG010|Overall Study|Lack of Efficacy|0|||
25177334|NCT02754141|50321519|FG012|Overall Study|Disease progression|10|||
25110693|NCT01909804|50222034|FG011|Overall Study|Lack of Efficacy|1|||
25110694|NCT01909804|50222023|FG000|Overall Study|Withdrew Consent|0|||
25110695|NCT01909804|50222024|FG001|Overall Study|Withdrew Consent|0|||
25110696|NCT01909804|50222025|FG002|Overall Study|Withdrew Consent|0|||
25110697|NCT01909804|50222026|FG003|Overall Study|Withdrew Consent|0|||
25110698|NCT01909804|50222027|FG004|Overall Study|Withdrew Consent|1|||
25110699|NCT01909804|50222028|FG005|Overall Study|Withdrew Consent|1|||
25110700|NCT01909804|50222029|FG006|Overall Study|Withdrew Consent|0|||
25110701|NCT01909804|50222030|FG007|Overall Study|Withdrew Consent|0|||
25110702|NCT01909804|50222031|FG008|Overall Study|Withdrew Consent|0|||
25110703|NCT01909804|50222032|FG009|Overall Study|Withdrew Consent|0|||
25110704|NCT01909804|50222033|FG010|Overall Study|Withdrew Consent|0|||
25110705|NCT01909804|50222034|FG011|Overall Study|Withdrew Consent|0|||
25110706|NCT01909804|50222023|FG000|Overall Study|Protocol Violation|0|||
25110707|NCT01909804|50222024|FG001|Overall Study|Protocol Violation|0|||
25110708|NCT01909804|50222025|FG002|Overall Study|Protocol Violation|0|||
25110709|NCT01909804|50222026|FG003|Overall Study|Protocol Violation|0|||
25110710|NCT01909804|50222027|FG004|Overall Study|Protocol Violation|0|||
25110711|NCT01909804|50222028|FG005|Overall Study|Protocol Violation|0|||
25110712|NCT01909804|50222029|FG006|Overall Study|Protocol Violation|0|||
25110713|NCT01909804|50222030|FG007|Overall Study|Protocol Violation|0|||
25110714|NCT01909804|50222031|FG008|Overall Study|Protocol Violation|0|||
25110715|NCT01909804|50222032|FG009|Overall Study|Protocol Violation|0|||
25110716|NCT01909804|50222033|FG010|Overall Study|Protocol Violation|0|||
25110717|NCT01909804|50222034|FG011|Overall Study|Protocol Violation|1|||
25110718|NCT01880086|50222058|FG000|Overall Study|Lost to Follow-up|1|||
25110719|NCT01880086|50222059|FG001|Overall Study|Lost to Follow-up|1|||
25110720|NCT01879852|50222067|FG000|Overall Study|Withdrawal by Subject|2|||
25110721|NCT01879852|50222068|FG001|Overall Study|Withdrawal by Subject|0|||
25110722|NCT01879618|50222074|FG000|Overall Study|Does not meet entrance criteria|1|||
25110723|NCT01879618|50222074|FG000|Overall Study|Withdrawal by Subject|1|||
25110724|NCT01879618|50222074|FG000|Overall Study|Surgery;changed schedule; not available|8|||
25110725|NCT01879618|50222074|FG000|Overall Study|Protocol Violation|6|||
25110726|NCT01879618|50222074|FG000|Overall Study|Adverse Event|5|||
25110727|NCT01926886|50222078|FG000|Overall Study|Administrative/other|1|||
25110728|NCT01926886|50222079|FG001|Overall Study|Administrative/other|0|||
25110729|NCT01926886|50222078|FG000|Overall Study|Adverse event/intercurrent illness|4|||
25110730|NCT01926886|50222079|FG001|Overall Study|Adverse event/intercurrent illness|0|||
25110731|NCT01926886|50222078|FG000|Overall Study|Disease progression/recurrence|4|||
25110732|NCT01926886|50222079|FG001|Overall Study|Disease progression/recurrence|0|||
25110733|NCT01926886|50222078|FG000|Overall Study|Withdrawal by Subject|15|||
25110734|NCT01926886|50222079|FG001|Overall Study|Withdrawal by Subject|0|||
25110735|NCT01926886|50222078|FG000|Overall Study|Failure to return|3|||
25110736|NCT01926886|50222079|FG001|Overall Study|Failure to return|0|||
25110737|NCT01926886|50222078|FG000|Overall Study|Recurrence of disease|1|||
25110738|NCT01926886|50222079|FG001|Overall Study|Recurrence of disease|0|||
25110739|NCT01926886|50222078|FG000|Overall Study|Progression of disease|2|||
25110740|NCT01926886|50222079|FG001|Overall Study|Progression of disease|0|||
25110741|NCT01926886|50222078|FG000|Overall Study|Death|1|||
25110742|NCT01926886|50222079|FG001|Overall Study|Death|0|||
25110743|NCT01926886|50222078|FG000|Overall Study|Did not cooperate|1|||
25110744|NCT01926886|50222079|FG001|Overall Study|Did not cooperate|0|||
25110745|NCT01909336|50222088|FG000|Overall Study|Lost to Follow-up|4|||
25110746|NCT01909336|50222089|FG001|Overall Study|Lost to Follow-up|2|||
25110747|NCT01909336|50222090|FG002|Overall Study|Lost to Follow-up|2|||
25110748|NCT01909336|50222088|FG000|Overall Study|Physician Decision|0|||
25110749|NCT01909336|50222089|FG001|Overall Study|Physician Decision|1|||
25110750|NCT01909336|50222090|FG002|Overall Study|Physician Decision|1|||
25110751|NCT01926028|50222101|FG000|Overall Study|Lost to Follow-up|7|||
25110752|NCT01926028|50222102|FG001|Overall Study|Lost to Follow-up|6|||
25110753|NCT01926028|50222103|FG002|Overall Study|Lost to Follow-up|0|||
25110754|NCT01926028|50222101|FG000|Overall Study|Physician Decision|1|||
25110755|NCT01926028|50222102|FG001|Overall Study|Physician Decision|5|||
25110756|NCT01926028|50222103|FG002|Overall Study|Physician Decision|0|||
25110757|NCT01926028|50222101|FG000|Overall Study|Withdrawal by Subject|9|||
25261334|NCT01011049|50576056|FG003|Overall Study|Lost to Follow-up|0|||
25110758|NCT01926028|50222102|FG001|Overall Study|Withdrawal by Subject|9|||
25110759|NCT01926028|50222103|FG002|Overall Study|Withdrawal by Subject|2|||
25110760|NCT01926028|50222101|FG000|Overall Study|Non compliance or other reasons|4|||
25110761|NCT01926028|50222102|FG001|Overall Study|Non compliance or other reasons|2|||
25110762|NCT01926028|50222103|FG002|Overall Study|Non compliance or other reasons|0|||
25110763|NCT01925950|50222114|FG000|Part 2|Withdrawal by Subject|1|||
25110764|NCT01925950|50222115|FG001|Part 2|Withdrawal by Subject|0|||
25110765|NCT01878292|50222124|FG000|Randomized|Protocol Violation|1|||
25110766|NCT01878292|50222125|FG001|Randomized|Protocol Violation|0|||
25110767|NCT01878292|50222126|FG002|Randomized|Protocol Violation|0|||
25110768|NCT01878292|50222124|FG000|Randomized|Lost to Follow-up|1|||
25110769|NCT01878292|50222125|FG001|Randomized|Lost to Follow-up|0|||
25110770|NCT01878292|50222126|FG002|Randomized|Lost to Follow-up|0|||
25110771|NCT01878292|50222124|FG000|Randomized|Adverse Event|1|||
25110772|NCT01878292|50222125|FG001|Randomized|Adverse Event|0|||
25110773|NCT01878292|50222126|FG002|Randomized|Adverse Event|0|||
25110774|NCT01878292|50222124|FG000|Double-blind Treatment Period|Other Reasons|2|||
25110775|NCT01878292|50222125|FG001|Double-blind Treatment Period|Other Reasons|0|||
25110776|NCT01878292|50222126|FG002|Double-blind Treatment Period|Other Reasons|0|||
25110777|NCT01878292|50222124|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
25110778|NCT01878292|50222125|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
25110779|NCT01878292|50222126|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
25110780|NCT01878292|50222124|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
25110781|NCT01878292|50222125|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
25110782|NCT01878292|50222126|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
25110783|NCT01878292|50222124|FG000|Double-blind Treatment Period|Protocol Violation|3|||
25110784|NCT01878292|50222125|FG001|Double-blind Treatment Period|Protocol Violation|4|||
25110785|NCT01878292|50222126|FG002|Double-blind Treatment Period|Protocol Violation|2|||
25110786|NCT01878292|50222124|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
25110787|NCT01878292|50222125|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
25110788|NCT01878292|50222126|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
25110789|NCT01878292|50222124|FG000|Double-blind Treatment Period|Adverse Event|4|||
25110790|NCT01878292|50222125|FG001|Double-blind Treatment Period|Adverse Event|9|||
25110791|NCT01878292|50222126|FG002|Double-blind Treatment Period|Adverse Event|8|||
25110792|NCT01878292|50222124|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
25110793|NCT01878292|50222125|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
25110794|NCT01878292|50222126|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
25110795|NCT01908634|50222134|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
25110796|NCT01908634|50222134|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
25110797|NCT01878214|50222144|FG000|Overall Study|Withdrawal by Subject|18|||
25110798|NCT01878214|50222145|FG001|Overall Study|Withdrawal by Subject|7|||
25110799|NCT01878214|50222144|FG000|Overall Study|Death|0|||
25110800|NCT01878214|50222145|FG001|Overall Study|Death|1|||
25110801|NCT01878214|50222144|FG000|Overall Study|Lost to Follow-up|35|||
25110802|NCT01878214|50222145|FG001|Overall Study|Lost to Follow-up|36|||
25110803|NCT01907854|50222153|FG000|Overall Study|Protocol Violation|1|||
25110804|NCT01907854|50222154|FG001|Overall Study|Protocol Violation|1|||
25110805|NCT01907854|50222153|FG000|Overall Study|Withdrawal by Subject|9|||
25110806|NCT01907854|50222154|FG001|Overall Study|Withdrawal by Subject|7|||
25110807|NCT01907854|50222153|FG000|Overall Study|Lost to Follow-up|2|||
25110808|NCT01907854|50222154|FG001|Overall Study|Lost to Follow-up|2|||
25110809|NCT01907854|50222153|FG000|Overall Study|Unclassified|4|||
25110810|NCT01907854|50222154|FG001|Overall Study|Unclassified|3|||
25110811|NCT02480153|50222162|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
25110812|NCT02480153|50222163|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
25110813|NCT02480153|50222164|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
25110814|NCT02480153|50222162|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
25110815|NCT02480153|50222163|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
25110816|NCT02480153|50222164|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
25110817|NCT02480153|50222162|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
25110818|NCT02480153|50222163|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
25110819|NCT02480153|50222164|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
25110820|NCT02480153|50222162|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
25110821|NCT02480153|50222163|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
25110822|NCT02480153|50222164|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
25110823|NCT02480153|50222162|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
25110824|NCT02480153|50222163|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
25110825|NCT02480153|50222164|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
25110826|NCT02480153|50222162|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
25110827|NCT02480153|50222163|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
25110828|NCT02480153|50222164|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
25110829|NCT02480153|50222162|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
25110830|NCT02480153|50222163|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
25110831|NCT02480153|50222164|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
25110832|NCT02480153|50222162|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
25110833|NCT02480153|50222163|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
25110834|NCT02480153|50222164|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
25110835|NCT02480153|50222162|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
25110836|NCT02480153|50222163|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
25110837|NCT02480153|50222164|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
25177335|NCT02754141|50321520|FG013|Overall Study|Disease progression|12|||
25110838|NCT02480153|50222162|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
25110839|NCT02480153|50222163|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
25110840|NCT02480153|50222164|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
25110841|NCT02480153|50222162|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
25110842|NCT02480153|50222163|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
25110843|NCT02480153|50222164|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
25110844|NCT02480153|50222162|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
25110845|NCT02480153|50222163|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
25110846|NCT02480153|50222164|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
25110847|NCT02480153|50222162|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
25110848|NCT02480153|50222163|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
25110849|NCT02480153|50222164|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
25110850|NCT02480153|50222162|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
25110851|NCT02480153|50222163|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
25110852|NCT02480153|50222164|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
25110853|NCT02480153|50222162|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
25110854|NCT02480153|50222163|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
25110855|NCT02480153|50222164|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
25110856|NCT02480153|50222162|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
25110857|NCT02480153|50222163|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
25110858|NCT02480153|50222164|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
25110859|NCT02480153|50222162|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
25110860|NCT02480153|50222163|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
25110861|NCT02480153|50222164|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
25110862|NCT02480153|50222162|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
25110863|NCT02480153|50222163|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
25110864|NCT02480153|50222164|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
25110865|NCT02500979|50222189|FG000|Period 1|Hyperglycemia|1|||
25110866|NCT02500979|50222190|FG001|Period 1|Hyperglycemia|0|||
25110867|NCT02500979|50222189|FG000|Period 1|Severe non-compliance to protocol|0|||
25110868|NCT02500979|50222190|FG001|Period 1|Severe non-compliance to protocol|1|||
25110869|NCT02500979|50222189|FG000|Period 1|Adverse Event|1|||
25110870|NCT02500979|50222190|FG001|Period 1|Adverse Event|0|||
25110871|NCT02500979|50222189|FG000|Period 1|Subject decision|2|||
25110872|NCT02500979|50222190|FG001|Period 1|Subject decision|0|||
25110873|NCT02500979|50222189|FG000|Period 2|Change in risk|1|||
25110874|NCT02500979|50222190|FG001|Period 2|Change in risk|0|||
25110875|NCT02500901|50222196|FG000|Overall Study|Disease ProgressionDD|2|||
25110876|NCT02479139|50222206|FG000|Overall Study|Lost to Follow-up|2|||
25110877|NCT02479139|50222207|FG001|Overall Study|Lost to Follow-up|4|||
25110878|NCT02479139|50222208|FG002|Overall Study|Lost to Follow-up|4|||
25110879|NCT02479139|50222209|FG003|Overall Study|Lost to Follow-up|2|||
25110880|NCT02479139|50222210|FG004|Overall Study|Lost to Follow-up|3|||
25110881|NCT02479139|50222211|FG005|Overall Study|Lost to Follow-up|5|||
25110882|NCT02479139|50222206|FG000|Overall Study|Withdrew Consent|5|||
25110883|NCT02479139|50222207|FG001|Overall Study|Withdrew Consent|6|||
25110884|NCT02479139|50222208|FG002|Overall Study|Withdrew Consent|1|||
25110885|NCT02479139|50222209|FG003|Overall Study|Withdrew Consent|4|||
25110886|NCT02479139|50222210|FG004|Overall Study|Withdrew Consent|1|||
25110887|NCT02479139|50222211|FG005|Overall Study|Withdrew Consent|1|||
25110888|NCT02479139|50222206|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
25110889|NCT02479139|50222207|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
25110890|NCT02479139|50222208|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
25110891|NCT02479139|50222209|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
25110892|NCT02479139|50222210|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
25110893|NCT02479139|50222211|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
25110894|NCT02479139|50222206|FG000|Overall Study|Other Miscellaneous Reasons|1|||
25110895|NCT02479139|50222207|FG001|Overall Study|Other Miscellaneous Reasons|0|||
25110896|NCT02479139|50222208|FG002|Overall Study|Other Miscellaneous Reasons|1|||
25110897|NCT02479139|50222209|FG003|Overall Study|Other Miscellaneous Reasons|1|||
25110898|NCT02479139|50222210|FG004|Overall Study|Other Miscellaneous Reasons|1|||
25110899|NCT02479139|50222211|FG005|Overall Study|Other Miscellaneous Reasons|0|||
25110900|NCT02478359|50222227|FG000|Overall Study|Disenrolled from health plan|106|||
25110901|NCT02478359|50222228|FG001|Overall Study|Disenrolled from health plan|65|||
25110902|NCT01877668|50222241|FG000|Overall Study|Death|0|||
25110903|NCT01877668|50222242|FG001|Overall Study|Death|0|||
25110904|NCT01877668|50222243|FG002|Overall Study|Death|0|||
25110905|NCT01877668|50222244|FG003|Overall Study|Death|1|||
25110906|NCT01877668|50222245|FG004|Overall Study|Death|0|||
25177336|NCT02754141|50321521|FG014|Overall Study|Disease progression|12|||
25177337|NCT02754141|50321522|FG015|Overall Study|Disease progression|14|||
25177338|NCT02754141|50321523|FG016|Overall Study|Disease progression|0|||
25177339|NCT02754141|50321524|FG017|Overall Study|Disease progression|1|||
25177340|NCT02754141|50321507|FG000|Overall Study|Study drug toxicity|1|||
25177341|NCT02754141|50321508|FG001|Overall Study|Study drug toxicity|1|||
25110907|NCT01877668|50222241|FG000|Overall Study|No longer met study criteria|1|||
25110908|NCT01877668|50222242|FG001|Overall Study|No longer met study criteria|0|||
25110909|NCT01877668|50222243|FG002|Overall Study|No longer met study criteria|1|||
25110910|NCT01877668|50222244|FG003|Overall Study|No longer met study criteria|0|||
25110911|NCT01877668|50222245|FG004|Overall Study|No longer met study criteria|0|||
25110912|NCT01877668|50222241|FG000|Overall Study|Insufficient clinical response|0|||
25110913|NCT01877668|50222242|FG001|Overall Study|Insufficient clinical response|1|||
25110914|NCT01877668|50222243|FG002|Overall Study|Insufficient clinical response|2|||
25110915|NCT01877668|50222244|FG003|Overall Study|Insufficient clinical response|2|||
25110916|NCT01877668|50222245|FG004|Overall Study|Insufficient clinical response|0|||
25110917|NCT01877668|50222241|FG000|Overall Study|Lost to Follow-up|0|||
25110918|NCT01877668|50222242|FG001|Overall Study|Lost to Follow-up|2|||
25110919|NCT01877668|50222243|FG002|Overall Study|Lost to Follow-up|1|||
25110920|NCT01877668|50222244|FG003|Overall Study|Lost to Follow-up|0|||
25110921|NCT01877668|50222245|FG004|Overall Study|Lost to Follow-up|0|||
25110922|NCT01877668|50222241|FG000|Overall Study|Withdrawal by Subject|2|||
25110923|NCT01877668|50222242|FG001|Overall Study|Withdrawal by Subject|0|||
25110924|NCT01877668|50222243|FG002|Overall Study|Withdrawal by Subject|3|||
25110925|NCT01877668|50222244|FG003|Overall Study|Withdrawal by Subject|2|||
25110926|NCT01877668|50222245|FG004|Overall Study|Withdrawal by Subject|2|||
25110927|NCT01877668|50222241|FG000|Overall Study|Other|1|||
25110928|NCT01877668|50222242|FG001|Overall Study|Other|1|||
25110929|NCT01877668|50222243|FG002|Overall Study|Other|1|||
25110930|NCT01877668|50222244|FG003|Overall Study|Other|1|||
25110931|NCT01877668|50222245|FG004|Overall Study|Other|3|||
25110932|NCT01877668|50222241|FG000|Overall Study|Protocol Violation|1|||
25110933|NCT01877668|50222242|FG001|Overall Study|Protocol Violation|1|||
25110934|NCT01877668|50222243|FG002|Overall Study|Protocol Violation|0|||
25110935|NCT01877668|50222244|FG003|Overall Study|Protocol Violation|0|||
25110936|NCT01877668|50222245|FG004|Overall Study|Protocol Violation|3|||
25110937|NCT01877668|50222241|FG000|Overall Study|Adverse event related to study drug|2|||
25110938|NCT01877668|50222242|FG001|Overall Study|Adverse event related to study drug|2|||
25110939|NCT01877668|50222243|FG002|Overall Study|Adverse event related to study drug|2|||
25110940|NCT01877668|50222244|FG003|Overall Study|Adverse event related to study drug|2|||
25110941|NCT01877668|50222245|FG004|Overall Study|Adverse event related to study drug|1|||
25110942|NCT01877668|50222241|FG000|Overall Study|Adverse event unrelated to study drug|4|||
25110943|NCT01877668|50222242|FG001|Overall Study|Adverse event unrelated to study drug|1|||
25110944|NCT01877668|50222243|FG002|Overall Study|Adverse event unrelated to study drug|2|||
25110945|NCT01877668|50222244|FG003|Overall Study|Adverse event unrelated to study drug|0|||
25110946|NCT01877668|50222245|FG004|Overall Study|Adverse event unrelated to study drug|1|||
25110947|NCT01877278|50222263|FG000|Overall Study|Lost to Follow-up|3|||
25110948|NCT01877278|50222264|FG001|Overall Study|Lost to Follow-up|3|||
25110949|NCT01906372|50222270|FG000|Overall Study|Withdrawal by Subject|2|||
25110950|NCT01925170|50222275|FG000|Overall Study|Unverified cancer status|53|||
25110951|NCT01925014|50222283|FG000|Overall Study|Inappropriate enrollment|4|||
25110952|NCT01925014|50222284|FG001|Overall Study|Inappropriate enrollment|6|||
25110953|NCT01925014|50222283|FG000|Overall Study|Withdrawal by Subject|5|||
25110954|NCT01925014|50222284|FG001|Overall Study|Withdrawal by Subject|13|||
25110955|NCT01876810|50222290|FG000|Overall Study|Physician Decision|0|||
25110956|NCT01876810|50222291|FG001|Overall Study|Physician Decision|1|||
25110957|NCT01876732|50222300|FG000|Overall Study|MMA was not over 800mg/dL|75|||
25110958|NCT01905592|50222307|FG000|Overall Study|Disease Progression|51|||
25110959|NCT01905592|50222308|FG001|Overall Study|Disease Progression|110|||
25110960|NCT01905592|50222307|FG000|Overall Study|Toxicity|1|||
25110961|NCT01905592|50222308|FG001|Overall Study|Toxicity|16|||
25110962|NCT01905592|50222307|FG000|Overall Study|Physician Decision|0|||
25110963|NCT01905592|50222308|FG001|Overall Study|Physician Decision|2|||
25110964|NCT01905592|50222307|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
25110965|NCT01905592|50222308|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
25110966|NCT01905592|50222307|FG000|Overall Study|Protocol Violation|0|||
25110967|NCT01905592|50222308|FG001|Overall Study|Protocol Violation|1|||
25110968|NCT01905592|50222307|FG000|Overall Study|Sponsor's decision|1|||
25110969|NCT01905592|50222308|FG001|Overall Study|Sponsor's decision|1|||
25110970|NCT01905592|50222307|FG000|Overall Study|Not treated|7|||
25110971|NCT01905592|50222308|FG001|Overall Study|Not treated|3|||
25110972|NCT01905592|50222307|FG000|Overall Study|Withdrawal by Subject|10|||
25110973|NCT01905592|50222308|FG001|Overall Study|Withdrawal by Subject|2|||
25110974|NCT01876420|50222314|FG000|Overall Study|Missed 30 day visit|1|||
25110975|NCT01875874|50222318|FG000|Overall Study|Death|3|||
25110976|NCT02500121|50222325|FG000|Overall Study|Lost to Follow-up|0|||
25110977|NCT02500121|50222326|FG001|Overall Study|Lost to Follow-up|1|||
25110978|NCT02500121|50222325|FG000|Overall Study|Withdrawal by Subject|1|||
25110979|NCT02500121|50222326|FG001|Overall Study|Withdrawal by Subject|1|||
25110980|NCT02500121|50222325|FG000|Overall Study|Death|26|||
25110981|NCT02500121|50222326|FG001|Overall Study|Death|24|||
25110982|NCT01875250|50222336|FG000|Overall Study|Adverse Event|2|||
25110983|NCT01875250|50222337|FG001|Overall Study|Adverse Event|0|||
25110984|NCT01904032|50222347|FG000|Overall Study|Adverse Event|3|||
25110985|NCT01904032|50222348|FG001|Overall Study|Adverse Event|1|||
25110986|NCT01904032|50222347|FG000|Overall Study|Lost to Follow-up|4|||
25110987|NCT01904032|50222348|FG001|Overall Study|Lost to Follow-up|2|||
25110988|NCT01903876|50222356|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
25110989|NCT01903876|50222357|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
25110990|NCT01903876|50222356|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
25110991|NCT01903876|50222357|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
25110992|NCT01921348|50222365|FG000|Overall Study|Withdrawal by Subject|1|||
25110993|NCT01921348|50222366|FG001|Overall Study|Withdrawal by Subject|0|||
25110994|NCT01921348|50222365|FG000|Overall Study|Lost to Follow-up|0|||
25110995|NCT01921348|50222366|FG001|Overall Study|Lost to Follow-up|2|||
25110996|NCT01921270|50222372|FG000|Overall Study|Withdrawal by Subject|1|||
25110997|NCT02325739|50222387|FG000|Phase I Part|Adverse Event|1|||
25110998|NCT02325739|50222388|FG001|Phase I Part|Adverse Event|0|||
25110999|NCT02325739|50222389|FG002|Phase I Part|Adverse Event|1|||
25111000|NCT02325739|50222390|FG003|Phase I Part|Adverse Event|2|||
25111001|NCT02325739|50222391|FG004|Phase I Part|Adverse Event|3|||
25111002|NCT02325739|50222392|FG005|Phase I Part|Adverse Event|1|||
25111003|NCT02325739|50222393|FG006|Phase I Part|Adverse Event|0|||
25111004|NCT02325739|50222394|FG007|Phase I Part|Adverse Event|2|||
25111005|NCT02325739|50222395|FG008|Phase I Part|Adverse Event|0|||
25111006|NCT02325739|50222396|FG009|Phase I Part|Adverse Event|0|||
25111007|NCT02325739|50222397|FG010|Phase I Part|Adverse Event|0|||
25111008|NCT02325739|50222387|FG000|Phase I Part|Progressive disease|9|||
25111009|NCT02325739|50222388|FG001|Phase I Part|Progressive disease|6|||
25111010|NCT02325739|50222389|FG002|Phase I Part|Progressive disease|3|||
25111011|NCT02325739|50222390|FG003|Phase I Part|Progressive disease|23|||
25111012|NCT02325739|50222391|FG004|Phase I Part|Progressive disease|14|||
25111013|NCT02325739|50222392|FG005|Phase I Part|Progressive disease|6|||
25111014|NCT02325739|50222393|FG006|Phase I Part|Progressive disease|6|||
25111015|NCT02325739|50222394|FG007|Phase I Part|Progressive disease|3|||
25111016|NCT02325739|50222395|FG008|Phase I Part|Progressive disease|0|||
25111017|NCT02325739|50222396|FG009|Phase I Part|Progressive disease|0|||
25111018|NCT02325739|50222397|FG010|Phase I Part|Progressive disease|0|||
25111019|NCT02325739|50222387|FG000|Phase I Part|Subject/guardian decision|1|||
25111020|NCT02325739|50222388|FG001|Phase I Part|Subject/guardian decision|0|||
25111021|NCT02325739|50222389|FG002|Phase I Part|Subject/guardian decision|1|||
25111022|NCT02325739|50222390|FG003|Phase I Part|Subject/guardian decision|1|||
25111023|NCT02325739|50222391|FG004|Phase I Part|Subject/guardian decision|0|||
25111024|NCT02325739|50222392|FG005|Phase I Part|Subject/guardian decision|0|||
25111025|NCT02325739|50222393|FG006|Phase I Part|Subject/guardian decision|0|||
25111026|NCT02325739|50222394|FG007|Phase I Part|Subject/guardian decision|1|||
25111027|NCT02325739|50222395|FG008|Phase I Part|Subject/guardian decision|0|||
25111028|NCT02325739|50222396|FG009|Phase I Part|Subject/guardian decision|0|||
25111029|NCT02325739|50222397|FG010|Phase I Part|Subject/guardian decision|0|||
25111030|NCT02325739|50222387|FG000|Phase I Part|Death|0|||
25111031|NCT02325739|50222388|FG001|Phase I Part|Death|0|||
25111032|NCT02325739|50222389|FG002|Phase I Part|Death|0|||
25111033|NCT02325739|50222390|FG003|Phase I Part|Death|0|||
25111034|NCT02325739|50222391|FG004|Phase I Part|Death|2|||
25111035|NCT02325739|50222392|FG005|Phase I Part|Death|0|||
25111036|NCT02325739|50222393|FG006|Phase I Part|Death|0|||
25111037|NCT02325739|50222394|FG007|Phase I Part|Death|0|||
25111038|NCT02325739|50222395|FG008|Phase I Part|Death|0|||
25111039|NCT02325739|50222396|FG009|Phase I Part|Death|0|||
25111040|NCT02325739|50222397|FG010|Phase I Part|Death|0|||
25111041|NCT02325739|50222387|FG000|Phase II Part|Adverse Event|0|||
25111042|NCT02325739|50222388|FG001|Phase II Part|Adverse Event|0|||
25111043|NCT02325739|50222389|FG002|Phase II Part|Adverse Event|0|||
25111044|NCT02325739|50222390|FG003|Phase II Part|Adverse Event|0|||
25111045|NCT02325739|50222391|FG004|Phase II Part|Adverse Event|0|||
25111046|NCT02325739|50222392|FG005|Phase II Part|Adverse Event|0|||
25111047|NCT02325739|50222393|FG006|Phase II Part|Adverse Event|0|||
25111048|NCT02325739|50222394|FG007|Phase II Part|Adverse Event|0|||
25111049|NCT02325739|50222395|FG008|Phase II Part|Adverse Event|4|||
25111050|NCT02325739|50222396|FG009|Phase II Part|Adverse Event|5|||
25111051|NCT02325739|50222397|FG010|Phase II Part|Adverse Event|1|||
25111052|NCT02325739|50222387|FG000|Phase II Part|Physician Decision|0|||
25111053|NCT02325739|50222388|FG001|Phase II Part|Physician Decision|0|||
25111054|NCT02325739|50222389|FG002|Phase II Part|Physician Decision|0|||
25111055|NCT02325739|50222390|FG003|Phase II Part|Physician Decision|0|||
25111056|NCT02325739|50222391|FG004|Phase II Part|Physician Decision|0|||
25111057|NCT02325739|50222392|FG005|Phase II Part|Physician Decision|0|||
25111058|NCT02325739|50222393|FG006|Phase II Part|Physician Decision|0|||
25111059|NCT02325739|50222394|FG007|Phase II Part|Physician Decision|0|||
25111060|NCT02325739|50222395|FG008|Phase II Part|Physician Decision|0|||
25111061|NCT02325739|50222396|FG009|Phase II Part|Physician Decision|1|||
25111062|NCT02325739|50222397|FG010|Phase II Part|Physician Decision|0|||
25111063|NCT02325739|50222387|FG000|Phase II Part|Progressive disease|0|||
25111064|NCT02325739|50222388|FG001|Phase II Part|Progressive disease|0|||
25111065|NCT02325739|50222389|FG002|Phase II Part|Progressive disease|0|||
25111066|NCT02325739|50222390|FG003|Phase II Part|Progressive disease|0|||
25111067|NCT02325739|50222391|FG004|Phase II Part|Progressive disease|0|||
25111068|NCT02325739|50222392|FG005|Phase II Part|Progressive disease|0|||
25111069|NCT02325739|50222393|FG006|Phase II Part|Progressive disease|0|||
25111070|NCT02325739|50222394|FG007|Phase II Part|Progressive disease|0|||
25111071|NCT02325739|50222395|FG008|Phase II Part|Progressive disease|22|||
25111072|NCT02325739|50222396|FG009|Phase II Part|Progressive disease|29|||
25111073|NCT02325739|50222397|FG010|Phase II Part|Progressive disease|18|||
25111074|NCT02325739|50222387|FG000|Phase II Part|Subject/guardian decision|0|||
25111075|NCT02325739|50222388|FG001|Phase II Part|Subject/guardian decision|0|||
25111076|NCT02325739|50222389|FG002|Phase II Part|Subject/guardian decision|0|||
25111077|NCT02325739|50222390|FG003|Phase II Part|Subject/guardian decision|0|||
25111078|NCT02325739|50222391|FG004|Phase II Part|Subject/guardian decision|0|||
25111079|NCT02325739|50222392|FG005|Phase II Part|Subject/guardian decision|0|||
25111080|NCT02325739|50222393|FG006|Phase II Part|Subject/guardian decision|0|||
25111081|NCT02325739|50222394|FG007|Phase II Part|Subject/guardian decision|0|||
25111082|NCT02325739|50222395|FG008|Phase II Part|Subject/guardian decision|4|||
25111083|NCT02325739|50222396|FG009|Phase II Part|Subject/guardian decision|1|||
25111084|NCT02325739|50222397|FG010|Phase II Part|Subject/guardian decision|1|||
25111085|NCT01903720|50222442|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
25111086|NCT01903720|50222442|FG000|Overall Study|Adverse Event|1|||
25111087|NCT01903720|50222442|FG000|Overall Study|Rescinding of informed consent|2|||
25111088|NCT01903720|50222442|FG000|Overall Study|Lost to Follow-up|2|||
25111089|NCT01903720|50222442|FG000|Overall Study|Treatment with alternative drug|1|||
25111090|NCT02366689|50222449|FG000|Overall Study|Withdrawal by Subject|1|||
25111091|NCT02366689|50222450|FG001|Overall Study|Withdrawal by Subject|0|||
25111092|NCT02366689|50222451|FG002|Overall Study|Withdrawal by Subject|1|||
25111093|NCT02366689|50222449|FG000|Overall Study|Lost to Follow-up|3|||
25111094|NCT02366689|50222450|FG001|Overall Study|Lost to Follow-up|2|||
25111095|NCT02366689|50222451|FG002|Overall Study|Lost to Follow-up|0|||
25111096|NCT02366689|50222449|FG000|Overall Study|Pregnancy|0|||
25111097|NCT02366689|50222450|FG001|Overall Study|Pregnancy|1|||
25111098|NCT02366689|50222451|FG002|Overall Study|Pregnancy|1|||
25111099|NCT01903252|50222461|FG000|Double-Blind Induction|Adverse Event|20|||
25111100|NCT01903252|50222462|FG001|Double-Blind Induction|Adverse Event|18|||
25111101|NCT01903252|50222463|FG002|Double-Blind Induction|Adverse Event|0|||
25111102|NCT01903252|50222464|FG003|Double-Blind Induction|Adverse Event|0|||
25111103|NCT01903252|50222465|FG004|Double-Blind Induction|Adverse Event|0|||
25111104|NCT01903252|50222466|FG005|Double-Blind Induction|Adverse Event|0|||
25111105|NCT01903252|50222461|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
25111106|NCT01903252|50222462|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
25111107|NCT01903252|50222463|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
25111108|NCT01903252|50222464|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
25111109|NCT01903252|50222465|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
25111110|NCT01903252|50222466|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
25111111|NCT01903252|50222461|FG000|Double-Blind Induction|Physician Decision|2|||
25111112|NCT01903252|50222462|FG001|Double-Blind Induction|Physician Decision|3|||
25111113|NCT01903252|50222463|FG002|Double-Blind Induction|Physician Decision|0|||
25111114|NCT01903252|50222464|FG003|Double-Blind Induction|Physician Decision|0|||
25111115|NCT01903252|50222465|FG004|Double-Blind Induction|Physician Decision|0|||
25111116|NCT01903252|50222466|FG005|Double-Blind Induction|Physician Decision|0|||
25111117|NCT01903252|50222461|FG000|Double-Blind Induction|non-compliance,|7|||
25111118|NCT01903252|50222462|FG001|Double-Blind Induction|non-compliance,|7|||
25111119|NCT01903252|50222463|FG002|Double-Blind Induction|non-compliance,|0|||
25111120|NCT01903252|50222464|FG003|Double-Blind Induction|non-compliance,|0|||
25111121|NCT01903252|50222465|FG004|Double-Blind Induction|non-compliance,|0|||
25111122|NCT01903252|50222466|FG005|Double-Blind Induction|non-compliance,|0|||
25111123|NCT01903252|50222461|FG000|Extended Induction, Open-Label|Adverse Event|0|||
25111124|NCT01903252|50222462|FG001|Extended Induction, Open-Label|Adverse Event|0|||
25111125|NCT01903252|50222463|FG002|Extended Induction, Open-Label|Adverse Event|17|||
25111126|NCT01903252|50222464|FG003|Extended Induction, Open-Label|Adverse Event|0|||
25111127|NCT01903252|50222465|FG004|Extended Induction, Open-Label|Adverse Event|0|||
25111128|NCT01903252|50222466|FG005|Extended Induction, Open-Label|Adverse Event|0|||
25111129|NCT01903252|50222461|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
25111130|NCT01903252|50222462|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
25111131|NCT01903252|50222463|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
25111132|NCT01903252|50222464|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
25111133|NCT01903252|50222465|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
25111134|NCT01903252|50222466|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
25111135|NCT01903252|50222461|FG000|Extended Induction, Open-Label|Physician Decision|0|||
25177342|NCT02754141|50321509|FG002|Overall Study|Study drug toxicity|0|||
25177343|NCT02754141|50321510|FG003|Overall Study|Study drug toxicity|0|||
25111136|NCT01903252|50222462|FG001|Extended Induction, Open-Label|Physician Decision|0|||
25111137|NCT01903252|50222463|FG002|Extended Induction, Open-Label|Physician Decision|1|||
25111138|NCT01903252|50222464|FG003|Extended Induction, Open-Label|Physician Decision|0|||
25111139|NCT01903252|50222465|FG004|Extended Induction, Open-Label|Physician Decision|0|||
25111140|NCT01903252|50222466|FG005|Extended Induction, Open-Label|Physician Decision|0|||
25111141|NCT01903252|50222461|FG000|Maintenance, Open-Label|Adverse Event|0|||
25111142|NCT01903252|50222462|FG001|Maintenance, Open-Label|Adverse Event|0|||
25111143|NCT01903252|50222463|FG002|Maintenance, Open-Label|Adverse Event|0|||
25111144|NCT01903252|50222464|FG003|Maintenance, Open-Label|Adverse Event|3|||
25111145|NCT01903252|50222465|FG004|Maintenance, Open-Label|Adverse Event|9|||
25111146|NCT01903252|50222466|FG005|Maintenance, Open-Label|Adverse Event|14|||
25111147|NCT01903252|50222461|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
25111148|NCT01903252|50222462|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
25111149|NCT01903252|50222463|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
25111150|NCT01903252|50222464|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
25111151|NCT01903252|50222465|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
25111152|NCT01903252|50222466|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
25111153|NCT01903252|50222461|FG000|Maintenance, Open-Label|Other|0|||
25111154|NCT01903252|50222462|FG001|Maintenance, Open-Label|Other|0|||
25111155|NCT01903252|50222463|FG002|Maintenance, Open-Label|Other|0|||
25111156|NCT01903252|50222464|FG003|Maintenance, Open-Label|Other|2|||
25111157|NCT01903252|50222465|FG004|Maintenance, Open-Label|Other|6|||
25111158|NCT01903252|50222466|FG005|Maintenance, Open-Label|Other|2|||
25111159|NCT01920958|50222484|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
25111160|NCT01613716|50222488|FG000|Overall Study|screen failures|3|||
25111161|NCT01613716|50222488|FG000|Overall Study|Lost to Follow-up|4|||
25111162|NCT01872910|50222498|FG000|Overall Study|Lost to Follow-up|2|||
25111163|NCT01872910|50222499|FG001|Overall Study|Lost to Follow-up|0|||
25111164|NCT01872910|50222500|FG002|Overall Study|Lost to Follow-up|2|||
25111165|NCT01872910|50222501|FG003|Overall Study|Lost to Follow-up|0|||
25111166|NCT01872910|50222502|FG004|Overall Study|Lost to Follow-up|0|||
25111167|NCT01872910|50222503|FG005|Overall Study|Lost to Follow-up|0|||
25111168|NCT01920568|50222518|FG000|Overall Study|Adverse Event|27|||
25111169|NCT01920568|50222519|FG001|Overall Study|Adverse Event|8|||
25111170|NCT01920568|50222518|FG000|Overall Study|Protocol Violation|5|||
25111171|NCT01920568|50222519|FG001|Overall Study|Protocol Violation|3|||
25111172|NCT01920568|50222518|FG000|Overall Study|Lost to Follow-up|2|||
25111173|NCT01920568|50222519|FG001|Overall Study|Lost to Follow-up|2|||
25111174|NCT01920568|50222518|FG000|Overall Study|Physician Decision|13|||
25111175|NCT01920568|50222519|FG001|Overall Study|Physician Decision|4|||
25111176|NCT01920568|50222518|FG000|Overall Study|Withdrawal by Subject|79|||
25111177|NCT01920568|50222519|FG001|Overall Study|Withdrawal by Subject|55|||
25111178|NCT01920568|50222518|FG000|Overall Study|Death due to disease progression|25|||
25111179|NCT01920568|50222519|FG001|Overall Study|Death due to disease progression|12|||
25111180|NCT01902628|50222526|FG000|Overall Study|Withdrawal of participant's consent|7|||
25111181|NCT01902628|50222526|FG000|Overall Study|Adverse Event|41|||
25111182|NCT01902628|50222526|FG000|Overall Study|Lost to Follow-up|35|||
25111183|NCT01920178|50222532|FG000|Overall Study|Lost to Follow-up|2|||
25111184|NCT01920178|50222533|FG001|Overall Study|Lost to Follow-up|1|||
25111185|NCT01901848|50222541|FG000|Randomized and Treated|Lost to Follow-up|3|||
25111186|NCT01901848|50222542|FG001|Randomized and Treated|Lost to Follow-up|6|||
25111187|NCT01901848|50222541|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
25111188|NCT01901848|50222542|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
25111189|NCT01901614|50222550|FG000|Overall Study|Adverse Event|0|||
25111190|NCT01901614|50222551|FG001|Overall Study|Adverse Event|1|||
25111191|NCT01901614|50222550|FG000|Overall Study|Lost to Follow-up|1|||
25111192|NCT01901614|50222551|FG001|Overall Study|Lost to Follow-up|0|||
25111193|NCT01901614|50222550|FG000|Overall Study|Screen Fail|1|||
25111194|NCT01901614|50222551|FG001|Overall Study|Screen Fail|0|||
25111195|NCT01901302|50222559|FG000|Overall Study|Adverse Event|2|||
25111196|NCT01901302|50222560|FG001|Overall Study|Adverse Event|1|||
25111197|NCT01901302|50222559|FG000|Overall Study|Lack of Efficacy|0|||
25111198|NCT01901302|50222560|FG001|Overall Study|Lack of Efficacy|2|||
25111199|NCT01901302|50222559|FG000|Overall Study|Study Terminated by Sponsor|23|||
25111200|NCT01901302|50222560|FG001|Overall Study|Study Terminated by Sponsor|20|||
25111201|NCT01901302|50222559|FG000|Overall Study|Withdrawal by Subject|2|||
25111202|NCT01901302|50222560|FG001|Overall Study|Withdrawal by Subject|0|||
25111203|NCT01919398|50222569|FG000|Overall Study|Progressive Disease|0|||
25111204|NCT01919398|50222570|FG001|Overall Study|Progressive Disease|0|||
25111205|NCT01919398|50222571|FG002|Overall Study|Progressive Disease|4|||
25111206|NCT02500043|50222581|FG000|Overall Study|Randomized, but not Treated|2|||
25111207|NCT02500043|50222582|FG001|Overall Study|Randomized, but not Treated|2|||
25111208|NCT02500043|50222581|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
25111209|NCT02500043|50222582|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
25111210|NCT02500043|50222581|FG000|Overall Study|Adverse Event|33|||
25111211|NCT02500043|50222582|FG001|Overall Study|Adverse Event|11|||
25261335|NCT01011049|50576053|FG000|Overall Study|Withdrawal by Subject|0|||
25111212|NCT02500043|50222581|FG000|Overall Study|Clinical Progression|54|||
25111213|NCT02500043|50222582|FG001|Overall Study|Clinical Progression|35|||
25111214|NCT02500043|50222581|FG000|Overall Study|Radiological Progression|192|||
25111215|NCT02500043|50222582|FG001|Overall Study|Radiological Progression|110|||
25111216|NCT02500043|50222581|FG000|Overall Study|Physician's Decision|11|||
25111217|NCT02500043|50222582|FG001|Overall Study|Physician's Decision|3|||
25111218|NCT02500043|50222581|FG000|Overall Study|Withdrawal by Subject|14|||
25111219|NCT02500043|50222582|FG001|Overall Study|Withdrawal by Subject|4|||
25111220|NCT02500043|50222581|FG000|Overall Study|Death|11|||
25111221|NCT02500043|50222582|FG001|Overall Study|Death|2|||
25111222|NCT02500043|50222581|FG000|Overall Study|Protocol Deviation|1|||
25111223|NCT02500043|50222582|FG001|Overall Study|Protocol Deviation|0|||
25111224|NCT02499575|50222590|FG000|Overall Study|Protocol Violation|0|||
25111225|NCT02499575|50222591|FG001|Overall Study|Protocol Violation|1|||
25111226|NCT02065791|50222599|FG000|Overall Study|Closed Site|1|||
25111227|NCT02065791|50222600|FG001|Overall Study|Closed Site|1|||
25111228|NCT02065791|50222599|FG000|Overall Study|Withdrawal by Subject|11|||
25111229|NCT02065791|50222600|FG001|Overall Study|Withdrawal by Subject|5|||
25111230|NCT02065791|50222599|FG000|Overall Study|Lost to Follow-up|13|||
25111231|NCT02065791|50222600|FG001|Overall Study|Lost to Follow-up|9|||
25111232|NCT02499263|50222606|FG000|Overall Study|Lost to Follow-up|9|||
25111233|NCT02499263|50222606|FG000|Overall Study|Participant's withdrawal of consent|4|||
25111234|NCT02499263|50222606|FG000|Overall Study|Lack of Efficacy|22|||
25111235|NCT02499263|50222606|FG000|Overall Study|investigator's judgment|12|||
25111236|NCT02499263|50222606|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
25111237|NCT02499263|50222606|FG000|Overall Study|Participant's decision|3|||
25111238|NCT02499263|50222606|FG000|Overall Study|Pregnancy|1|||
25111239|NCT01654289|50222613|FG000|Overall Study|Withdrawal by Subject|10|||
25111240|NCT01654289|50222614|FG001|Overall Study|Withdrawal by Subject|8|||
25111241|NCT01654289|50222615|FG002|Overall Study|Withdrawal by Subject|5|||
25111242|NCT01654289|50222613|FG000|Overall Study|Withdrew from intervention only|17|||
25111243|NCT01654289|50222614|FG001|Overall Study|Withdrew from intervention only|20|||
25111244|NCT01654289|50222615|FG002|Overall Study|Withdrew from intervention only|0|||
25111245|NCT02499029|50222625|FG000|Overall Study|Lost to Follow-up|2|||
25111246|NCT02499029|50222626|FG001|Overall Study|Lost to Follow-up|2|||
25111247|NCT02499029|50222625|FG000|Overall Study|Physician Decision|2|||
25111248|NCT02499029|50222626|FG001|Overall Study|Physician Decision|1|||
25111249|NCT02499029|50222625|FG000|Overall Study|Death|1|||
25111250|NCT02499029|50222626|FG001|Overall Study|Death|0|||
25111251|NCT02477111|50222632|FG000|Overall Study|Death|5|||
25111252|NCT02477111|50222632|FG000|Overall Study|Withdrawal by Subject|2|||
25111253|NCT02477111|50222632|FG000|Overall Study|missed visit|4|||
25111254|NCT04968353|50222642|FG000|Overall Study|Non-compliance|1|||
25111255|NCT04968353|50222643|FG001|Overall Study|Non-compliance|0|||
25111256|NCT04968353|50222644|FG002|Overall Study|Non-compliance|2|||
25111257|NCT04968353|50222645|FG003|Overall Study|Non-compliance|0|||
25111258|NCT02065713|50222657|FG000|Overall Study|Adverse Event|0|||
25111259|NCT02065713|50222658|FG001|Overall Study|Adverse Event|1|||
25111260|NCT02065713|50222657|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25111261|NCT02065713|50222658|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
25111262|NCT02497781|50222666|FG000|Overall Study|Withdrawal by Subject|2|||
25111263|NCT02497781|50222667|FG001|Overall Study|Withdrawal by Subject|0|||
25111264|NCT02497781|50222666|FG000|Overall Study|Lack of Efficacy|0|||
25111265|NCT02497781|50222667|FG001|Overall Study|Lack of Efficacy|1|||
25111266|NCT02497781|50222666|FG000|Overall Study|Randomised but not treated|1|||
25111267|NCT02497781|50222667|FG001|Overall Study|Randomised but not treated|1|||
25111268|NCT02497781|50222666|FG000|Overall Study|Lost to Follow-up|1|||
25111269|NCT02497781|50222667|FG001|Overall Study|Lost to Follow-up|1|||
25111270|NCT02497469|50222675|FG000|Overall Study|Randomized but not Treated|0|||
25111271|NCT02497469|50222676|FG001|Overall Study|Randomized but not Treated|2|||
25111272|NCT02497469|50222675|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
25111273|NCT02497469|50222676|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
25111274|NCT02497469|50222675|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
25111275|NCT02497469|50222676|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
25111276|NCT02497469|50222675|FG000|Overall Study|Significant Protocol Deviation|4|||
25111277|NCT02497469|50222676|FG001|Overall Study|Significant Protocol Deviation|5|||
25111278|NCT02497469|50222675|FG000|Overall Study|Lost to Follow-up|14|||
25111279|NCT02497469|50222676|FG001|Overall Study|Lost to Follow-up|4|||
25261336|NCT01011049|50576054|FG001|Overall Study|Withdrawal by Subject|0|||
25261337|NCT01011049|50576055|FG002|Overall Study|Withdrawal by Subject|1|||
25261338|NCT01011049|50576056|FG003|Overall Study|Withdrawal by Subject|0|||
25111280|NCT02497469|50222675|FG000|Overall Study|Voluntary Withdrawal|39|||
25111281|NCT02497469|50222676|FG001|Overall Study|Voluntary Withdrawal|41|||
25111282|NCT02497469|50222675|FG000|Overall Study|Pregnancy|1|||
25111283|NCT02497469|50222676|FG001|Overall Study|Pregnancy|1|||
25111284|NCT02497469|50222675|FG000|Overall Study|Lack of Efficacy|86|||
25111285|NCT02497469|50222676|FG001|Overall Study|Lack of Efficacy|40|||
25111286|NCT02497469|50222675|FG000|Overall Study|Reason not Specified|6|||
25111287|NCT02497469|50222676|FG001|Overall Study|Reason not Specified|6|||
25111288|NCT02497391|50222682|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
25111289|NCT02497391|50222683|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
25111290|NCT02497391|50222684|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
25111291|NCT02497391|50222685|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
25111292|NCT02497391|50222686|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
25111293|NCT02497391|50222687|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
25111294|NCT02497391|50222682|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
25111295|NCT02497391|50222683|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
25111296|NCT02497391|50222684|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
25111297|NCT02497391|50222685|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
25111298|NCT02497391|50222686|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
25111299|NCT02497391|50222687|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
25111300|NCT02497391|50222682|FG000|Period 3 (14 Days)|Adverse Event|0|||
25111301|NCT02497391|50222683|FG001|Period 3 (14 Days)|Adverse Event|1|||
25111302|NCT02497391|50222684|FG002|Period 3 (14 Days)|Adverse Event|0|||
25111303|NCT02497391|50222685|FG003|Period 3 (14 Days)|Adverse Event|0|||
25111304|NCT02497391|50222686|FG004|Period 3 (14 Days)|Adverse Event|0|||
25111305|NCT02497391|50222687|FG005|Period 3 (14 Days)|Adverse Event|0|||
25111306|NCT02497391|50222682|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
25111307|NCT02497391|50222683|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
25111308|NCT02497391|50222684|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
25111309|NCT02497391|50222685|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
25111310|NCT02497391|50222686|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
25111311|NCT02497391|50222687|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
25111312|NCT02497391|50222682|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
25111313|NCT02497391|50222683|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
25111314|NCT02497391|50222684|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
25111315|NCT02497391|50222685|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
25111316|NCT02497391|50222686|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
25111317|NCT02497391|50222687|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
25111318|NCT02476175|50222695|FG000|Overall Study|Adverse Event|2|||
25111319|NCT02065557|50222702|FG000|Induction Period|Withdrawal by Subject|2|||
25111320|NCT02065557|50222703|FG001|Induction Period|Withdrawal by Subject|1|||
25111321|NCT02065557|50222704|FG002|Induction Period|Withdrawal by Subject|0|||
25111322|NCT02065557|50222705|FG003|Induction Period|Withdrawal by Subject|0|||
25111323|NCT02065557|50222706|FG004|Induction Period|Withdrawal by Subject|0|||
25111324|NCT02065557|50222707|FG005|Induction Period|Withdrawal by Subject|0|||
25111325|NCT02065557|50222702|FG000|Induction Period|Lack of Efficacy|2|||
25111326|NCT02065557|50222703|FG001|Induction Period|Lack of Efficacy|1|||
25111327|NCT02065557|50222704|FG002|Induction Period|Lack of Efficacy|1|||
25111328|NCT02065557|50222705|FG003|Induction Period|Lack of Efficacy|0|||
25111329|NCT02065557|50222706|FG004|Induction Period|Lack of Efficacy|0|||
25111330|NCT02065557|50222707|FG005|Induction Period|Lack of Efficacy|0|||
25111331|NCT02065557|50222702|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
25111332|NCT02065557|50222703|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
25111333|NCT02065557|50222704|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
25111334|NCT02065557|50222705|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
25111335|NCT02065557|50222706|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
25111336|NCT02065557|50222707|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
25111337|NCT02065557|50222702|FG000|Induction Period|Non-Responder at Week 8|4|||
25111338|NCT02065557|50222703|FG001|Induction Period|Non-Responder at Week 8|4|||
25111339|NCT02065557|50222704|FG002|Induction Period|Non-Responder at Week 8|0|||
25111340|NCT02065557|50222705|FG003|Induction Period|Non-Responder at Week 8|0|||
25111341|NCT02065557|50222706|FG004|Induction Period|Non-Responder at Week 8|0|||
25111342|NCT02065557|50222707|FG005|Induction Period|Non-Responder at Week 8|0|||
25111343|NCT02065557|50222702|FG000|Induction Period|Adverse Event|1|||
25111344|NCT02065557|50222703|FG001|Induction Period|Adverse Event|1|||
25111345|NCT02065557|50222704|FG002|Induction Period|Adverse Event|0|||
25111346|NCT02065557|50222705|FG003|Induction Period|Adverse Event|0|||
25111347|NCT02065557|50222706|FG004|Induction Period|Adverse Event|0|||
25111348|NCT02065557|50222707|FG005|Induction Period|Adverse Event|0|||
25111349|NCT02065557|50222702|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
25111350|NCT02065557|50222703|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
25111351|NCT02065557|50222704|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
25111352|NCT02065557|50222705|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
25111353|NCT02065557|50222706|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
25111354|NCT02065557|50222707|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
25111355|NCT02065557|50222702|FG000|Maintenance Period|Withdrawal by Subject|0|||
25111356|NCT02065557|50222703|FG001|Maintenance Period|Withdrawal by Subject|0|||
25111357|NCT02065557|50222704|FG002|Maintenance Period|Withdrawal by Subject|0|||
25261339|NCT01263093|50576068|FG000|Washout|Physician Decision|1|||
25177344|NCT02754141|50321511|FG004|Overall Study|Study drug toxicity|0|||
25111358|NCT02065557|50222705|FG003|Maintenance Period|Withdrawal by Subject|0|||
25261340|NCT01263093|50576069|FG001|Washout|Physician Decision|0|||
25111359|NCT02065557|50222706|FG004|Maintenance Period|Withdrawal by Subject|2|||
25111360|NCT02065557|50222707|FG005|Maintenance Period|Withdrawal by Subject|1|||
25111361|NCT02065557|50222702|FG000|Maintenance Period|Lack of Efficacy|0|||
25111362|NCT02065557|50222703|FG001|Maintenance Period|Lack of Efficacy|0|||
25111363|NCT02065557|50222704|FG002|Maintenance Period|Lack of Efficacy|0|||
25111364|NCT02065557|50222705|FG003|Maintenance Period|Lack of Efficacy|0|||
25111365|NCT02065557|50222706|FG004|Maintenance Period|Lack of Efficacy|5|||
25111366|NCT02065557|50222707|FG005|Maintenance Period|Lack of Efficacy|2|||
25111367|NCT02065557|50222702|FG000|Maintenance Period|Subject Non-Compliance|0|||
25261341|NCT01263093|50576068|FG000|Period 2|Adverse Event|1|||
25261342|NCT01263093|50576069|FG001|Period 2|Adverse Event|0|||
25008306|NCT04490018|50101203|FG000|Overall Study|Withdrawal by Subject|2|||
25008307|NCT04490018|50101204|FG001|Overall Study|Withdrawal by Subject|1|||
25008308|NCT04490018|50101205|FG002|Overall Study|Withdrawal by Subject|0|||
25008309|NCT04490018|50101203|FG000|Overall Study|Withdrawal by parent/guardian|2|||
25008310|NCT04490018|50101204|FG001|Overall Study|Withdrawal by parent/guardian|3|||
25008311|NCT04490018|50101205|FG002|Overall Study|Withdrawal by parent/guardian|0|||
25008312|NCT03118934|50101231|FG000|Overall Study|Adverse Event|0|||
25008313|NCT03118934|50101232|FG001|Overall Study|Adverse Event|0|||
25008314|NCT03118934|50101233|FG002|Overall Study|Adverse Event|0|||
25008315|NCT03118934|50101234|FG003|Overall Study|Adverse Event|0|||
25008316|NCT03118934|50101235|FG004|Overall Study|Adverse Event|0|||
25008317|NCT03118934|50101236|FG005|Overall Study|Adverse Event|1|||
25008318|NCT03118934|50101231|FG000|Overall Study|Physician Decision|0|||
25008319|NCT03118934|50101232|FG001|Overall Study|Physician Decision|0|||
25008320|NCT03118934|50101233|FG002|Overall Study|Physician Decision|0|||
25008321|NCT03118934|50101234|FG003|Overall Study|Physician Decision|0|||
25008322|NCT03118934|50101235|FG004|Overall Study|Physician Decision|0|||
25008323|NCT03118934|50101236|FG005|Overall Study|Physician Decision|1|||
25008324|NCT03118934|50101231|FG000|Overall Study|Discontinued prior to exposure|0|||
25008325|NCT03118934|50101232|FG001|Overall Study|Discontinued prior to exposure|1|||
25008326|NCT03118934|50101233|FG002|Overall Study|Discontinued prior to exposure|1|||
25008327|NCT03118934|50101234|FG003|Overall Study|Discontinued prior to exposure|1|||
25008328|NCT03118934|50101235|FG004|Overall Study|Discontinued prior to exposure|2|||
25008329|NCT03118934|50101236|FG005|Overall Study|Discontinued prior to exposure|0|||
25008330|NCT03114488|50101246|FG000|Time Period 2|Withdrawal by Subject|1|||
25008331|NCT03114488|50101247|FG001|Time Period 2|Withdrawal by Subject|3|||
25008332|NCT03135262|50101266|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
25008333|NCT03135262|50101267|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
25008334|NCT03135262|50101268|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
25008335|NCT03135262|50101269|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
25008336|NCT03135262|50101270|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
25008337|NCT03135262|50101266|FG000|Overall Study|Progression of disease|0|||
25008338|NCT03135262|50101267|FG001|Overall Study|Progression of disease|0|||
25008339|NCT03135262|50101268|FG002|Overall Study|Progression of disease|0|||
25008340|NCT03135262|50101269|FG003|Overall Study|Progression of disease|1|||
25008341|NCT03135262|50101270|FG004|Overall Study|Progression of disease|0|||
25008342|NCT03135262|50101266|FG000|Overall Study|Death|6|||
25008343|NCT03135262|50101267|FG001|Overall Study|Death|2|||
25008344|NCT03135262|50101268|FG002|Overall Study|Death|2|||
25008345|NCT03135262|50101269|FG003|Overall Study|Death|2|||
25008346|NCT03135262|50101270|FG004|Overall Study|Death|0|||
25008347|NCT03135262|50101266|FG000|Overall Study|Withdrawal by Subject|0|||
25008348|NCT03135262|50101267|FG001|Overall Study|Withdrawal by Subject|0|||
25008349|NCT03135262|50101268|FG002|Overall Study|Withdrawal by Subject|1|||
25008350|NCT03135262|50101269|FG003|Overall Study|Withdrawal by Subject|0|||
25008351|NCT03135262|50101270|FG004|Overall Study|Withdrawal by Subject|1|||
25008352|NCT03135262|50101266|FG000|Overall Study|Study terminated by sponsor|2|||
25008353|NCT03135262|50101267|FG001|Overall Study|Study terminated by sponsor|4|||
25008354|NCT03135262|50101268|FG002|Overall Study|Study terminated by sponsor|4|||
25008355|NCT03135262|50101269|FG003|Overall Study|Study terminated by sponsor|3|||
25008356|NCT03135262|50101270|FG004|Overall Study|Study terminated by sponsor|0|||
25008357|NCT03535194|50101305|FG000|Induction Period|Adverse Event|2|||
25008358|NCT03535194|50101306|FG001|Induction Period|Adverse Event|2|||
25008359|NCT03535194|50101307|FG002|Induction Period|Adverse Event|1|||
25008360|NCT03535194|50101308|FG003|Induction Period|Adverse Event|3|||
25008361|NCT03535194|50101309|FG004|Induction Period|Adverse Event|0|||
25008362|NCT03535194|50101305|FG000|Induction Period|Death|0|||
25008363|NCT03535194|50101306|FG001|Induction Period|Death|1|||
25008364|NCT03535194|50101307|FG002|Induction Period|Death|0|||
25008365|NCT03535194|50101308|FG003|Induction Period|Death|0|||
25008366|NCT03535194|50101309|FG004|Induction Period|Death|0|||
25008367|NCT03535194|50101305|FG000|Induction Period|Lack of Efficacy|1|||
25008368|NCT03535194|50101306|FG001|Induction Period|Lack of Efficacy|3|||
25111368|NCT02065557|50222703|FG001|Maintenance Period|Subject Non-Compliance|0|||
25111369|NCT02065557|50222704|FG002|Maintenance Period|Subject Non-Compliance|0|||
25008369|NCT03535194|50101307|FG002|Induction Period|Lack of Efficacy|2|||
25008370|NCT03535194|50101308|FG003|Induction Period|Lack of Efficacy|2|||
25008371|NCT03535194|50101309|FG004|Induction Period|Lack of Efficacy|0|||
25008372|NCT03535194|50101305|FG000|Induction Period|Lost to Follow-up|3|||
25008373|NCT03535194|50101306|FG001|Induction Period|Lost to Follow-up|5|||
25008374|NCT03535194|50101307|FG002|Induction Period|Lost to Follow-up|2|||
25008375|NCT03535194|50101308|FG003|Induction Period|Lost to Follow-up|3|||
25008376|NCT03535194|50101309|FG004|Induction Period|Lost to Follow-up|0|||
25008377|NCT03535194|50101305|FG000|Induction Period|Physician Decision|1|||
25008378|NCT03535194|50101306|FG001|Induction Period|Physician Decision|1|||
25008379|NCT03535194|50101307|FG002|Induction Period|Physician Decision|0|||
25008380|NCT03535194|50101308|FG003|Induction Period|Physician Decision|0|||
25008381|NCT03535194|50101309|FG004|Induction Period|Physician Decision|0|||
25008382|NCT03535194|50101305|FG000|Induction Period|Protocol Violation|1|||
25008383|NCT03535194|50101306|FG001|Induction Period|Protocol Violation|0|||
25111370|NCT02065557|50222705|FG003|Maintenance Period|Subject Non-Compliance|0|||
25111371|NCT02065557|50222706|FG004|Maintenance Period|Subject Non-Compliance|0|||
25111372|NCT02065557|50222707|FG005|Maintenance Period|Subject Non-Compliance|1|||
25111373|NCT02065245|50222739|FG000|Infusion 1|Lost to Follow-up|0|||
25111374|NCT02065245|50222740|FG001|Infusion 1|Lost to Follow-up|0|||
25111375|NCT02065245|50222741|FG002|Infusion 1|Lost to Follow-up|0|||
25111376|NCT02065245|50222742|FG003|Infusion 1|Lost to Follow-up|0|||
25111377|NCT02065245|50222743|FG004|Infusion 1|Lost to Follow-up|0|||
25111378|NCT02065245|50222744|FG005|Infusion 1|Lost to Follow-up|0|||
25111379|NCT02065245|50222745|FG006|Infusion 1|Lost to Follow-up|1|||
25111380|NCT02065245|50222739|FG000|Infusion 1|Death|0|||
25111381|NCT02065245|50222740|FG001|Infusion 1|Death|0|||
25111382|NCT02065245|50222741|FG002|Infusion 1|Death|1|||
25111383|NCT02065245|50222742|FG003|Infusion 1|Death|0|||
25111384|NCT02065245|50222743|FG004|Infusion 1|Death|1|||
25111385|NCT02065245|50222744|FG005|Infusion 1|Death|0|||
25111386|NCT02065245|50222745|FG006|Infusion 1|Death|0|||
25111387|NCT02065245|50222739|FG000|Infusion 2|Death|0|||
25111388|NCT02065245|50222740|FG001|Infusion 2|Death|0|||
25111389|NCT02065245|50222741|FG002|Infusion 2|Death|0|||
25111390|NCT02065245|50222742|FG003|Infusion 2|Death|0|||
25111391|NCT02065245|50222743|FG004|Infusion 2|Death|0|||
25111392|NCT02065245|50222744|FG005|Infusion 2|Death|0|||
25111393|NCT02065245|50222745|FG006|Infusion 2|Death|1|||
25111394|NCT02065245|50222739|FG000|Infusion 3|Lost to Follow-up|1|||
25261343|NCT01010971|50576079|FG000|Overall Study|Adverse Event|2|||
25261344|NCT01010971|50576080|FG001|Overall Study|Adverse Event|4|||
25261345|NCT01010971|50576081|FG002|Overall Study|Adverse Event|3|||
25261346|NCT01010971|50576079|FG000|Overall Study|Withdrawal by Subject|0|||
25261347|NCT01010971|50576080|FG001|Overall Study|Withdrawal by Subject|2|||
25261348|NCT01010971|50576081|FG002|Overall Study|Withdrawal by Subject|5|||
25261349|NCT01010971|50576079|FG000|Overall Study|Lost to Follow-up|0|||
25261350|NCT01010971|50576080|FG001|Overall Study|Lost to Follow-up|2|||
25261351|NCT01010971|50576081|FG002|Overall Study|Lost to Follow-up|3|||
25261352|NCT01010971|50576079|FG000|Overall Study|Other|1|||
25261353|NCT01010971|50576080|FG001|Overall Study|Other|0|||
25261354|NCT01010971|50576081|FG002|Overall Study|Other|2|||
25261355|NCT01306656|50576091|FG000|Overall Study|Lost to Follow-up|1|||
25261356|NCT01306656|50576092|FG001|Overall Study|Lost to Follow-up|0|||
25111395|NCT02065245|50222740|FG001|Infusion 3|Lost to Follow-up|1|||
25261357|NCT01008943|50576100|FG000|Overall Study|Withdrawal by Subject|1|||
25261358|NCT01003639|50576106|FG000|Overall Study|Lost to Follow-up|6|||
25261359|NCT01003639|50576107|FG001|Overall Study|Lost to Follow-up|9|||
25261360|NCT01003639|50576106|FG000|Overall Study|Withdrawal by Subject|9|||
25261361|NCT01003639|50576107|FG001|Overall Study|Withdrawal by Subject|5|||
25261362|NCT01003639|50576106|FG000|Overall Study|Lack of Efficacy|1|||
25111396|NCT02065245|50222741|FG002|Infusion 3|Lost to Follow-up|0|||
25111397|NCT02065245|50222742|FG003|Infusion 3|Lost to Follow-up|0|||
25111398|NCT02065245|50222743|FG004|Infusion 3|Lost to Follow-up|0|||
25111399|NCT02065245|50222744|FG005|Infusion 3|Lost to Follow-up|0|||
25111400|NCT02065245|50222745|FG006|Infusion 3|Lost to Follow-up|0|||
25111401|NCT02043015|50222761|FG000|Overall Study|Lost to Follow-up|4|||
25261363|NCT01003639|50576107|FG001|Overall Study|Lack of Efficacy|6|||
25008384|NCT03535194|50101307|FG002|Induction Period|Protocol Violation|0|||
25111402|NCT02043015|50222761|FG000|Overall Study|Withdrawal by Subject|4|||
25111403|NCT02043015|50222761|FG000|Overall Study|Removed once target enrollment reached|15|||
25111404|NCT02043015|50222761|FG000|Overall Study|Participant moved away from study city|4|||
25111405|NCT02043015|50222761|FG000|Overall Study|Incarceration|1|||
25111406|NCT02064231|50222767|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
25111407|NCT02064231|50222768|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
25111408|NCT02064231|50222769|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
25261364|NCT01003639|50576106|FG000|Overall Study|Adverse Event|0|||
25261365|NCT01003639|50576107|FG001|Overall Study|Adverse Event|1|||
25261366|NCT01003639|50576106|FG000|Overall Study|Protocol Violation|0|||
25261367|NCT01003639|50576107|FG001|Overall Study|Protocol Violation|1|||
25261368|NCT01003639|50576106|FG000|Overall Study|Physician Decision|1|||
25111409|NCT02064231|50222770|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
25111410|NCT02064231|50222767|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
25111411|NCT02064231|50222768|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
25111412|NCT02064231|50222769|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
25111413|NCT02064231|50222770|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
25111414|NCT02064231|50222767|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
25111415|NCT02064231|50222768|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
25111416|NCT02064231|50222769|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
25111417|NCT02064231|50222770|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
25111418|NCT02064231|50222767|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
25111419|NCT02064231|50222768|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
25111420|NCT02064231|50222769|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
25111421|NCT02064231|50222770|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
25111422|NCT02063217|50222785|FG000|Overall Study|Withdrawal by Subject|1|||
25111423|NCT02063217|50222786|FG001|Overall Study|Withdrawal by Subject|0|||
25111424|NCT02063217|50222787|FG002|Overall Study|Withdrawal by Subject|0|||
25111425|NCT02497001|50222799|FG000|Overall Study|Lost to Follow-up|10|||
25111426|NCT02497001|50222800|FG001|Overall Study|Lost to Follow-up|2|||
25111427|NCT02497001|50222801|FG002|Overall Study|Lost to Follow-up|0|||
25111428|NCT02497001|50222802|FG003|Overall Study|Lost to Follow-up|2|||
25111429|NCT02497001|50222799|FG000|Overall Study|Adverse Event|28|||
25111430|NCT02497001|50222800|FG001|Overall Study|Adverse Event|30|||
25261369|NCT01003639|50576107|FG001|Overall Study|Physician Decision|0|||
25111431|NCT02497001|50222801|FG002|Overall Study|Adverse Event|11|||
25111432|NCT02497001|50222802|FG003|Overall Study|Adverse Event|11|||
25111433|NCT02497001|50222799|FG000|Overall Study|Withdrawal by Subject|14|||
25111434|NCT02497001|50222800|FG001|Overall Study|Withdrawal by Subject|37|||
25111435|NCT02497001|50222801|FG002|Overall Study|Withdrawal by Subject|19|||
25111436|NCT02497001|50222802|FG003|Overall Study|Withdrawal by Subject|15|||
25111437|NCT02497001|50222799|FG000|Overall Study|Physician Decision|5|||
25111438|NCT02497001|50222800|FG001|Overall Study|Physician Decision|11|||
25111439|NCT02497001|50222801|FG002|Overall Study|Physician Decision|5|||
25111440|NCT02497001|50222802|FG003|Overall Study|Physician Decision|1|||
25111441|NCT02497001|50222799|FG000|Overall Study|subjects that were not treated|1|||
25111442|NCT02497001|50222800|FG001|Overall Study|subjects that were not treated|2|||
25111443|NCT02497001|50222801|FG002|Overall Study|subjects that were not treated|2|||
25111444|NCT02497001|50222802|FG003|Overall Study|subjects that were not treated|1|||
25111445|NCT02497001|50222799|FG000|Overall Study|Major Protocol Deviation|3|||
25111446|NCT02497001|50222800|FG001|Overall Study|Major Protocol Deviation|4|||
25111447|NCT02497001|50222801|FG002|Overall Study|Major Protocol Deviation|4|||
25111448|NCT02497001|50222802|FG003|Overall Study|Major Protocol Deviation|4|||
25111449|NCT02497001|50222799|FG000|Overall Study|Lack of Efficacy|10|||
25111450|NCT02497001|50222800|FG001|Overall Study|Lack of Efficacy|16|||
25111451|NCT02497001|50222801|FG002|Overall Study|Lack of Efficacy|6|||
25111452|NCT02497001|50222802|FG003|Overall Study|Lack of Efficacy|6|||
25111453|NCT02497001|50222799|FG000|Overall Study|Protocol Violation|3|||
25111454|NCT02497001|50222800|FG001|Overall Study|Protocol Violation|1|||
25111455|NCT02497001|50222801|FG002|Overall Study|Protocol Violation|3|||
25111456|NCT02497001|50222802|FG003|Overall Study|Protocol Violation|1|||
25111457|NCT02366143|50222818|FG000|Overall Study|Death|307|||
25111458|NCT02366143|50222819|FG001|Overall Study|Death|278|||
25111459|NCT02366143|50222820|FG002|Overall Study|Death|280|||
25111460|NCT02366143|50222818|FG000|Overall Study|Lost to Follow-up|2|||
25111461|NCT02366143|50222819|FG001|Overall Study|Lost to Follow-up|4|||
25111462|NCT02366143|50222820|FG002|Overall Study|Lost to Follow-up|2|||
25111463|NCT02366143|50222818|FG000|Overall Study|Physician Decision|1|||
25111464|NCT02366143|50222819|FG001|Overall Study|Physician Decision|2|||
25111465|NCT02366143|50222820|FG002|Overall Study|Physician Decision|1|||
25111466|NCT02366143|50222818|FG000|Overall Study|Protocol Violation|0|||
25111467|NCT02366143|50222819|FG001|Overall Study|Protocol Violation|0|||
25111468|NCT02366143|50222820|FG002|Overall Study|Protocol Violation|2|||
25111469|NCT02366143|50222818|FG000|Overall Study|Withdrawal by Subject|16|||
25111470|NCT02366143|50222819|FG001|Overall Study|Withdrawal by Subject|17|||
25111471|NCT02366143|50222820|FG002|Overall Study|Withdrawal by Subject|22|||
25111472|NCT02366143|50222818|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
25111473|NCT02366143|50222819|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
25111474|NCT02366143|50222820|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
25111475|NCT02366143|50222818|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
25111476|NCT02366143|50222819|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
25111477|NCT02366143|50222820|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
25111478|NCT02366143|50222818|FG000|Overall Study|Randomization Error|1|||
25177345|NCT02754141|50321512|FG005|Overall Study|Study drug toxicity|0|||
25177346|NCT02754141|50321513|FG006|Overall Study|Study drug toxicity|0|||
25261370|NCT01003249|50576113|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
25111479|NCT02366143|50222819|FG001|Overall Study|Randomization Error|0|||
25111480|NCT02366143|50222820|FG002|Overall Study|Randomization Error|0|||
25111481|NCT02366143|50222818|FG000|Overall Study|PI Move and Site Closure|1|||
25111482|NCT02366143|50222819|FG001|Overall Study|PI Move and Site Closure|0|||
25111483|NCT02366143|50222820|FG002|Overall Study|PI Move and Site Closure|1|||
25111484|NCT02366143|50222818|FG000|Overall Study|Study Terminated By Sponsor|0|||
25111485|NCT02366143|50222819|FG001|Overall Study|Study Terminated By Sponsor|0|||
25111486|NCT02366143|50222820|FG002|Overall Study|Study Terminated By Sponsor|2|||
25111487|NCT02366143|50222818|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
25111488|NCT02366143|50222819|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
25111489|NCT02366143|50222820|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
25111490|NCT02366143|50222818|FG000|Overall Study|Patient moved to roll-over study|1|||
25111491|NCT02366143|50222819|FG001|Overall Study|Patient moved to roll-over study|19|||
25111492|NCT02366143|50222820|FG002|Overall Study|Patient moved to roll-over study|28|||
25111493|NCT02366143|50222818|FG000|Overall Study|Patient moved to commercial stock|0|||
25111494|NCT02366143|50222819|FG001|Overall Study|Patient moved to commercial stock|0|||
25111495|NCT02366143|50222820|FG002|Overall Study|Patient moved to commercial stock|1|||
25111496|NCT02366143|50222818|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
25111497|NCT02366143|50222819|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
25111498|NCT02366143|50222820|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
25111499|NCT02366143|50222818|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
25111500|NCT02366143|50222819|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
25111501|NCT02366143|50222820|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
25111502|NCT02366143|50222818|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
25111503|NCT02366143|50222819|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
25111504|NCT02366143|50222820|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
25111505|NCT02366143|50222818|FG000|Overall Study|Requester's instructions|1|||
25111506|NCT02366143|50222819|FG001|Overall Study|Requester's instructions|1|||
25111507|NCT02366143|50222820|FG002|Overall Study|Requester's instructions|1|||
25111508|NCT02366143|50222818|FG000|Overall Study|Uneligible|0|||
25111509|NCT02366143|50222819|FG001|Overall Study|Uneligible|1|||
25111510|NCT02366143|50222820|FG002|Overall Study|Uneligible|0|||
25111511|NCT02366143|50222818|FG000|Overall Study|Post Trial Migration|0|||
25111512|NCT02366143|50222819|FG001|Overall Study|Post Trial Migration|1|||
25111513|NCT02366143|50222820|FG002|Overall Study|Post Trial Migration|0|||
25111514|NCT02366143|50222818|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
25111515|NCT02366143|50222819|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
25111516|NCT02366143|50222820|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
25111517|NCT02366143|50222818|FG000|Overall Study|Patient switched to PTAP|0|||
25111518|NCT02366143|50222819|FG001|Overall Study|Patient switched to PTAP|1|||
25111519|NCT02366143|50222820|FG002|Overall Study|Patient switched to PTAP|0|||
25111520|NCT02366143|50222818|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
25111521|NCT02366143|50222819|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
25111522|NCT02366143|50222820|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
25111523|NCT02098395|50222836|FG000|Overall Study|Protocol Violation|2|||
25111524|NCT02098395|50222837|FG001|Overall Study|Protocol Violation|2|||
25111525|NCT02098395|50222838|FG002|Overall Study|Protocol Violation|0|||
25111526|NCT02098395|50222839|FG003|Overall Study|Protocol Violation|7|||
25111527|NCT02098395|50222836|FG000|Overall Study|Withdrawal by Subject|10|||
25111528|NCT02098395|50222837|FG001|Overall Study|Withdrawal by Subject|10|||
25111529|NCT02098395|50222838|FG002|Overall Study|Withdrawal by Subject|5|||
25111530|NCT02098395|50222839|FG003|Overall Study|Withdrawal by Subject|13|||
25111531|NCT02098395|50222836|FG000|Overall Study|Adverse Event|12|||
25111532|NCT02098395|50222837|FG001|Overall Study|Adverse Event|19|||
25111533|NCT02098395|50222838|FG002|Overall Study|Adverse Event|34|||
25111534|NCT02098395|50222839|FG003|Overall Study|Adverse Event|2|||
25111535|NCT02098395|50222836|FG000|Overall Study|Lost to Follow-up|2|||
25111536|NCT02098395|50222837|FG001|Overall Study|Lost to Follow-up|1|||
25111537|NCT02098395|50222838|FG002|Overall Study|Lost to Follow-up|0|||
25111538|NCT02098395|50222839|FG003|Overall Study|Lost to Follow-up|3|||
25111539|NCT02098395|50222836|FG000|Overall Study|Unclassified|0|||
25111540|NCT02098395|50222837|FG001|Overall Study|Unclassified|0|||
25111541|NCT02098395|50222838|FG002|Overall Study|Unclassified|3|||
25111542|NCT02098395|50222839|FG003|Overall Study|Unclassified|2|||
25111543|NCT02041923|50222851|FG000|Overall Study|Lost to Follow-up|26|||
25111544|NCT02041923|50222852|FG001|Overall Study|Lost to Follow-up|30|||
25111545|NCT02062437|50222860|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
25111546|NCT02062437|50222860|FG000|Overall Study|Patient not available for the 2y visit|18|||
25111547|NCT02062437|50222860|FG000|Overall Study|Death|2|||
25111548|NCT02062437|50222860|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
25111549|NCT02365519|50222866|FG000|Randomized and Treated|Adverse Event|0|||
25111550|NCT02365519|50222867|FG001|Randomized and Treated|Adverse Event|1|||
25111551|NCT02365519|50222868|FG002|Randomized and Treated|Adverse Event|0|||
25111552|NCT02365519|50222866|FG000|Randomized and Treated|Withdrawal by Subject|0|||
25111553|NCT02365519|50222867|FG001|Randomized and Treated|Withdrawal by Subject|1|||
25111554|NCT02365519|50222868|FG002|Randomized and Treated|Withdrawal by Subject|1|||
25111555|NCT02061813|50222877|FG000|Overall Study|Withdrawal by Subject|1|||
25111556|NCT02061813|50222877|FG000|Overall Study|Protocol Violation|2|||
25111557|NCT02096835|50222887|FG000|Overall Study|Withdrawal by Subject|1|||
25111558|NCT02096835|50222888|FG001|Overall Study|Withdrawal by Subject|0|||
25111559|NCT02096835|50222889|FG002|Overall Study|Withdrawal by Subject|0|||
25111560|NCT02096835|50222887|FG000|Overall Study|converted to open procedures|1|||
25111561|NCT02096835|50222888|FG001|Overall Study|converted to open procedures|0|||
25111562|NCT02096835|50222889|FG002|Overall Study|converted to open procedures|0|||
25111563|NCT02096835|50222887|FG000|Overall Study|Lost to Follow-up|1|||
25111564|NCT02096835|50222888|FG001|Overall Study|Lost to Follow-up|0|||
25111565|NCT02096835|50222889|FG002|Overall Study|Lost to Follow-up|1|||
25111566|NCT02324569|50222899|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
25111567|NCT02324569|50222900|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
25111568|NCT02324569|50222899|FG000|Overall Study|Voluntary Withdrawal|3|||
25111569|NCT02324569|50222900|FG001|Overall Study|Voluntary Withdrawal|6|||
25111570|NCT02324569|50222899|FG000|Overall Study|Lack of Efficacy|2|||
25111571|NCT02324569|50222900|FG001|Overall Study|Lack of Efficacy|3|||
25111572|NCT02324569|50222899|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
25111573|NCT02324569|50222900|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
25111574|NCT02324569|50222899|FG000|Overall Study|Inconvenient Schedule|2|||
25111575|NCT02324569|50222900|FG001|Overall Study|Inconvenient Schedule|0|||
25111576|NCT02294773|50222908|FG000|Overall Study|Withdrawal by Subject|0|||
25111577|NCT02294773|50222909|FG001|Overall Study|Withdrawal by Subject|2|||
25111578|NCT02365285|50222919|FG000|Overall Study|Physician Decision|0|||
25111579|NCT02365285|50222920|FG001|Overall Study|Physician Decision|1|||
25111580|NCT02365285|50222921|FG002|Overall Study|Physician Decision|1|||
25111581|NCT02365285|50222922|FG003|Overall Study|Physician Decision|0|||
25111582|NCT02365285|50222919|FG000|Overall Study|Adverse Event|0|||
25111583|NCT02365285|50222920|FG001|Overall Study|Adverse Event|0|||
25111584|NCT02365285|50222921|FG002|Overall Study|Adverse Event|0|||
25111585|NCT02365285|50222922|FG003|Overall Study|Adverse Event|2|||
25111586|NCT02041299|50222936|FG000|Overall Study|Adverse Event|9|||
25111587|NCT02041299|50222937|FG001|Overall Study|Adverse Event|3|||
25111588|NCT02041299|50222936|FG000|Overall Study|Lost to Follow-up|4|||
25111589|NCT02041299|50222937|FG001|Overall Study|Lost to Follow-up|1|||
25111590|NCT02041299|50222936|FG000|Overall Study|Physician Decision|1|||
25111591|NCT02041299|50222937|FG001|Overall Study|Physician Decision|1|||
25111592|NCT02041299|50222936|FG000|Overall Study|Withdrawal by Subject|13|||
25111593|NCT02041299|50222937|FG001|Overall Study|Withdrawal by Subject|7|||
25111594|NCT02041299|50222936|FG000|Overall Study|Protocol Violation|11|||
25111595|NCT02041299|50222937|FG001|Overall Study|Protocol Violation|4|||
25111596|NCT02041299|50222936|FG000|Overall Study|Termination of the study|7|||
25111597|NCT02041299|50222937|FG001|Overall Study|Termination of the study|3|||
25111598|NCT02041299|50222936|FG000|Overall Study|Required bone marrow transplant|0|||
25111599|NCT02041299|50222937|FG001|Overall Study|Required bone marrow transplant|1|||
25111600|NCT02041299|50222936|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
25111601|NCT02041299|50222937|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
25111602|NCT01645735|50222949|FG000|Overall Study|Physician Decision|2|||
25111603|NCT01645735|50222950|FG001|Overall Study|Physician Decision|0|||
25111604|NCT01645735|50222949|FG000|Overall Study|Withdrawal by Subject|1|||
25111605|NCT01645735|50222950|FG001|Overall Study|Withdrawal by Subject|0|||
25111606|NCT01645735|50222949|FG000|Overall Study|Protocol Violation|1|||
25111607|NCT01645735|50222950|FG001|Overall Study|Protocol Violation|0|||
25111608|NCT01645735|50222949|FG000|Overall Study|Adverse Event|0|||
25111609|NCT01645735|50222950|FG001|Overall Study|Adverse Event|1|||
25111610|NCT02365207|50222957|FG000|Overall Study|Withdrawal by Subject|1|||
25111611|NCT02365207|50222957|FG000|Overall Study|Physician Decision|1|||
25111612|NCT01645111|50222961|FG000|Overall Study|Did not require Clevidipine|15|||
25111613|NCT02364037|50222967|FG000|Overall Study|Withdrawal by Subject|7|||
25111614|NCT02364037|50222968|FG001|Overall Study|Withdrawal by Subject|4|||
25111615|NCT02364037|50222967|FG000|Overall Study|Lost to Follow-up|37|||
25111616|NCT02364037|50222968|FG001|Overall Study|Lost to Follow-up|49|||
25111617|NCT01919164|50222979|FG000|Overall Study|Adverse Event|6|||
25111618|NCT01919164|50222980|FG001|Overall Study|Adverse Event|4|||
25111619|NCT01919164|50222981|FG002|Overall Study|Adverse Event|9|||
25111620|NCT01919164|50222982|FG003|Overall Study|Adverse Event|3|||
25111621|NCT01919164|50222983|FG004|Overall Study|Adverse Event|2|||
25111622|NCT01919164|50222979|FG000|Overall Study|Lost to Follow-up|2|||
25111623|NCT01919164|50222980|FG001|Overall Study|Lost to Follow-up|2|||
25111624|NCT01919164|50222981|FG002|Overall Study|Lost to Follow-up|2|||
25111625|NCT01919164|50222982|FG003|Overall Study|Lost to Follow-up|0|||
25111626|NCT01919164|50222983|FG004|Overall Study|Lost to Follow-up|4|||
25111627|NCT01919164|50222979|FG000|Overall Study|Death|1|||
25111628|NCT01919164|50222980|FG001|Overall Study|Death|0|||
25111629|NCT01919164|50222981|FG002|Overall Study|Death|0|||
25111630|NCT01919164|50222982|FG003|Overall Study|Death|0|||
25111631|NCT01919164|50222983|FG004|Overall Study|Death|0|||
25111632|NCT01919164|50222979|FG000|Overall Study|Protocol Violation|6|||
25111633|NCT01919164|50222980|FG001|Overall Study|Protocol Violation|0|||
25111634|NCT01919164|50222981|FG002|Overall Study|Protocol Violation|3|||
25111635|NCT01919164|50222982|FG003|Overall Study|Protocol Violation|2|||
25111636|NCT01919164|50222983|FG004|Overall Study|Protocol Violation|2|||
25111637|NCT01919164|50222979|FG000|Overall Study|Disease progression|2|||
25111638|NCT01919164|50222980|FG001|Overall Study|Disease progression|2|||
25111639|NCT01919164|50222981|FG002|Overall Study|Disease progression|1|||
25111640|NCT01919164|50222982|FG003|Overall Study|Disease progression|2|||
25111641|NCT01919164|50222983|FG004|Overall Study|Disease progression|1|||
25111642|NCT01919164|50222979|FG000|Overall Study|Withdrew consent|13|||
25111643|NCT01919164|50222980|FG001|Overall Study|Withdrew consent|13|||
25111644|NCT01919164|50222981|FG002|Overall Study|Withdrew consent|14|||
25111645|NCT01919164|50222982|FG003|Overall Study|Withdrew consent|14|||
25111646|NCT01919164|50222983|FG004|Overall Study|Withdrew consent|9|||
25111647|NCT01919164|50222979|FG000|Overall Study|Other Un-specified|13|||
25111648|NCT01919164|50222980|FG001|Overall Study|Other Un-specified|9|||
25111649|NCT01919164|50222981|FG002|Overall Study|Other Un-specified|8|||
25111650|NCT01919164|50222982|FG003|Overall Study|Other Un-specified|7|||
25111651|NCT01919164|50222983|FG004|Overall Study|Other Un-specified|15|||
25111652|NCT01901224|50222995|FG000|Overall Study|study was not funded and terminated|2|||
25111653|NCT01901146|50223001|FG000|Neoadjuvant Phase|Death|1|||
25111654|NCT01901146|50223002|FG001|Neoadjuvant Phase|Death|2|||
25111655|NCT01901146|50223003|FG002|Neoadjuvant Phase|Death|0|||
25111656|NCT01901146|50223004|FG003|Neoadjuvant Phase|Death|0|||
25111657|NCT01901146|50223005|FG004|Neoadjuvant Phase|Death|0|||
25111658|NCT01901146|50223001|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
25111659|NCT01901146|50223002|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
25111660|NCT01901146|50223003|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
25111661|NCT01901146|50223004|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
25111662|NCT01901146|50223005|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
25111663|NCT01901146|50223001|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
25111664|NCT01901146|50223002|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
25111665|NCT01901146|50223003|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
25111666|NCT01901146|50223004|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
25111667|NCT01901146|50223005|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
25111668|NCT01901146|50223001|FG000|Neoadjuvant Phase|Physician Decision|1|||
25111669|NCT01901146|50223002|FG001|Neoadjuvant Phase|Physician Decision|2|||
25111670|NCT01901146|50223003|FG002|Neoadjuvant Phase|Physician Decision|0|||
25111671|NCT01901146|50223004|FG003|Neoadjuvant Phase|Physician Decision|0|||
25111672|NCT01901146|50223005|FG004|Neoadjuvant Phase|Physician Decision|0|||
25111673|NCT01901146|50223001|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
25111674|NCT01901146|50223002|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
25111675|NCT01901146|50223003|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
25111676|NCT01901146|50223004|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
25111677|NCT01901146|50223005|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
25111678|NCT01901146|50223001|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
25111679|NCT01901146|50223002|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
25111680|NCT01901146|50223003|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
25111681|NCT01901146|50223004|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
25111682|NCT01901146|50223005|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
25111683|NCT01901146|50223001|FG000|Adjuvant Phase|Other|0|||
25111684|NCT01901146|50223002|FG001|Adjuvant Phase|Other|0|||
25111685|NCT01901146|50223003|FG002|Adjuvant Phase|Other|1|||
25111686|NCT01901146|50223004|FG003|Adjuvant Phase|Other|0|||
25111687|NCT01901146|50223005|FG004|Adjuvant Phase|Other|0|||
25111688|NCT01901146|50223001|FG000|Adjuvant Phase|Death|0|||
25111689|NCT01901146|50223002|FG001|Adjuvant Phase|Death|0|||
25111690|NCT01901146|50223003|FG002|Adjuvant Phase|Death|0|||
25111691|NCT01901146|50223004|FG003|Adjuvant Phase|Death|0|||
25111692|NCT01901146|50223005|FG004|Adjuvant Phase|Death|3|||
25111693|NCT01901146|50223001|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
25261371|NCT01003249|50576114|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
25261372|NCT01003249|50576113|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
25111694|NCT01901146|50223002|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
25111695|NCT01901146|50223003|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
25111696|NCT01901146|50223004|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
25111697|NCT01901146|50223005|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
25111698|NCT01901146|50223001|FG000|Adjuvant Phase|Physician Decision|0|||
25111699|NCT01901146|50223002|FG001|Adjuvant Phase|Physician Decision|0|||
25111700|NCT01901146|50223003|FG002|Adjuvant Phase|Physician Decision|9|||
25111701|NCT01901146|50223004|FG003|Adjuvant Phase|Physician Decision|2|||
25111702|NCT01901146|50223005|FG004|Adjuvant Phase|Physician Decision|4|||
25111703|NCT01901146|50223001|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
25111704|NCT01901146|50223002|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
25111705|NCT01901146|50223003|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
25111706|NCT01901146|50223004|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
25111707|NCT01901146|50223005|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
25111708|NCT01644643|50223018|FG000|Overall Study|Death|1|||
25111709|NCT01644643|50223019|FG001|Overall Study|Death|0|||
25111710|NCT01644643|50223020|FG002|Overall Study|Death|3|||
25111711|NCT01644643|50223021|FG003|Overall Study|Death|3|||
25111712|NCT01644643|50223018|FG000|Overall Study|Lost to Follow-up|0|||
25111713|NCT01644643|50223019|FG001|Overall Study|Lost to Follow-up|0|||
25111714|NCT01644643|50223020|FG002|Overall Study|Lost to Follow-up|0|||
25111715|NCT01644643|50223021|FG003|Overall Study|Lost to Follow-up|4|||
25111716|NCT01644643|50223018|FG000|Overall Study|Withdrawal by Subject|1|||
25111717|NCT01644643|50223019|FG001|Overall Study|Withdrawal by Subject|0|||
25111718|NCT01644643|50223020|FG002|Overall Study|Withdrawal by Subject|2|||
25111719|NCT01644643|50223021|FG003|Overall Study|Withdrawal by Subject|1|||
25111720|NCT01644643|50223018|FG000|Overall Study|Other Eligibility criteria|0|||
25111721|NCT01644643|50223019|FG001|Overall Study|Other Eligibility criteria|0|||
25111722|NCT01644643|50223020|FG002|Overall Study|Other Eligibility criteria|0|||
25111723|NCT01644643|50223021|FG003|Overall Study|Other Eligibility criteria|2|||
25111724|NCT01864564|50223039|FG000|Overall Study|Lost to Follow-up|17|||
25111725|NCT01864564|50223040|FG001|Overall Study|Lost to Follow-up|23|||
25111726|NCT01864564|50223039|FG000|Overall Study|Withdrawal by Subject|20|||
25111727|NCT01864564|50223040|FG001|Overall Study|Withdrawal by Subject|11|||
25111728|NCT01864564|50223039|FG000|Overall Study|Protocol Violation|0|||
25111729|NCT01864564|50223040|FG001|Overall Study|Protocol Violation|27|||
25111730|NCT01864564|50223039|FG000|Overall Study|not reported|0|||
25111731|NCT01864564|50223040|FG001|Overall Study|not reported|34|||
25111732|NCT01864174|50223048|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
25111733|NCT01864174|50223049|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
25111734|NCT01864174|50223048|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
25111735|NCT01864174|50223049|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
25111736|NCT01864174|50223048|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
25111737|NCT01864174|50223049|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
25111738|NCT01864174|50223048|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
25111739|NCT01864174|50223049|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
25111740|NCT01864174|50223048|FG000|Double Blind - Compliant Randomized|Death|1|||
25111741|NCT01864174|50223049|FG001|Double Blind - Compliant Randomized|Death|0|||
25111742|NCT01864174|50223048|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
25111743|NCT01864174|50223049|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
25111744|NCT01864174|50223048|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
25111745|NCT01864174|50223049|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
25111746|NCT01864174|50223048|FG000|Double Blind - Compliant Randomized|Other|6|||
25111747|NCT01864174|50223049|FG001|Double Blind - Compliant Randomized|Other|10|||
25111748|NCT01864174|50223048|FG000|Off Treatment Follow-Up|Other|2|||
25111749|NCT01864174|50223049|FG001|Off Treatment Follow-Up|Other|0|||
25111750|NCT01864174|50223048|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
25111751|NCT01864174|50223049|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
25111752|NCT01864018|50223057|FG000|Overall Study|Ineligible|3|||
25111753|NCT01864018|50223058|FG001|Overall Study|Ineligible|1|||
25111754|NCT01900444|50223069|FG000|Overall Study|Protocol Violation|2|||
25111755|NCT01900444|50223069|FG000|Overall Study|Lost to Follow-up|1|||
25111756|NCT02294227|50223076|FG000|Overall Study|Death|0|||
25111757|NCT02294227|50223077|FG001|Overall Study|Death|0|||
25111758|NCT02294227|50223078|FG002|Overall Study|Death|1|||
25111759|NCT02294227|50223076|FG000|Overall Study|Subject/Guardian Decision|6|||
25111760|NCT02294227|50223077|FG001|Overall Study|Subject/Guardian Decision|3|||
25111761|NCT02294227|50223078|FG002|Overall Study|Subject/Guardian Decision|7|||
25111762|NCT02294227|50223076|FG000|Overall Study|Physician Decision|1|||
25111763|NCT02294227|50223077|FG001|Overall Study|Physician Decision|2|||
25111764|NCT02294227|50223078|FG002|Overall Study|Physician Decision|1|||
25111765|NCT02294227|50223076|FG000|Overall Study|Lost to Follow-up|1|||
25111766|NCT02294227|50223077|FG001|Overall Study|Lost to Follow-up|0|||
25111767|NCT02294227|50223078|FG002|Overall Study|Lost to Follow-up|0|||
25111768|NCT02294227|50223076|FG000|Overall Study|Lack of Efficacy|11|||
25111769|NCT02294227|50223077|FG001|Overall Study|Lack of Efficacy|12|||
25111770|NCT02294227|50223078|FG002|Overall Study|Lack of Efficacy|8|||
25111771|NCT02294227|50223076|FG000|Overall Study|Adverse Event|6|||
25111772|NCT02294227|50223077|FG001|Overall Study|Adverse Event|8|||
25111773|NCT02294227|50223078|FG002|Overall Study|Adverse Event|2|||
25111774|NCT02496767|50223092|FG000|Open-label Lead-in Phase|Adverse Event|176|||
25111775|NCT02496767|50223093|FG001|Open-label Lead-in Phase|Adverse Event|0|||
25111776|NCT02496767|50223094|FG002|Open-label Lead-in Phase|Adverse Event|0|||
25111777|NCT02496767|50223095|FG003|Open-label Lead-in Phase|Adverse Event|0|||
25111778|NCT02496767|50223096|FG004|Open-label Lead-in Phase|Adverse Event|0|||
25111779|NCT02496767|50223097|FG005|Open-label Lead-in Phase|Adverse Event|0|||
25111780|NCT02496767|50223098|FG006|Open-label Lead-in Phase|Adverse Event|0|||
25111781|NCT02496767|50223099|FG007|Open-label Lead-in Phase|Adverse Event|0|||
25111782|NCT02496767|50223092|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
25111783|NCT02496767|50223093|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
25111784|NCT02496767|50223094|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
25111785|NCT02496767|50223095|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
25111786|NCT02496767|50223096|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
25111787|NCT02496767|50223097|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
25111788|NCT02496767|50223098|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
25111789|NCT02496767|50223099|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
25111790|NCT02496767|50223092|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
25111791|NCT02496767|50223093|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
25111792|NCT02496767|50223094|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
25111793|NCT02496767|50223095|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
25111794|NCT02496767|50223096|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
25111795|NCT02496767|50223097|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
25111796|NCT02496767|50223098|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
25111797|NCT02496767|50223099|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
25111798|NCT02496767|50223092|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
25111799|NCT02496767|50223093|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
25111800|NCT02496767|50223094|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
25111801|NCT02496767|50223095|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
25111802|NCT02496767|50223096|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
25111803|NCT02496767|50223097|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
25111804|NCT02496767|50223098|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
25111805|NCT02496767|50223099|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
25111806|NCT02496767|50223092|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
25111807|NCT02496767|50223093|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
25111808|NCT02496767|50223094|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
25111809|NCT02496767|50223095|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
25111810|NCT02496767|50223096|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
25111811|NCT02496767|50223097|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
25111812|NCT02496767|50223098|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
25261373|NCT01003249|50576114|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
25111813|NCT02496767|50223099|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
25111814|NCT02496767|50223092|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
25111815|NCT02496767|50223093|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
25111816|NCT02496767|50223094|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
25111817|NCT02496767|50223095|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
25111818|NCT02496767|50223096|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
25111819|NCT02496767|50223097|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
25111820|NCT02496767|50223098|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
25111821|NCT02496767|50223099|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
25111822|NCT02496767|50223092|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
25111823|NCT02496767|50223093|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
25111824|NCT02496767|50223094|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
25111825|NCT02496767|50223095|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
25111826|NCT02496767|50223096|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
25111827|NCT02496767|50223097|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
25111828|NCT02496767|50223098|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
25111829|NCT02496767|50223099|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
25111830|NCT02496767|50223092|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
25111831|NCT02496767|50223093|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
25111832|NCT02496767|50223094|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
25111833|NCT02496767|50223095|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
25111834|NCT02496767|50223096|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
25111835|NCT02496767|50223097|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
25111836|NCT02496767|50223098|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
25177347|NCT02754141|50321514|FG007|Overall Study|Study drug toxicity|0|||
25177348|NCT02754141|50321515|FG008|Overall Study|Study drug toxicity|0|||
25177349|NCT02754141|50321516|FG009|Overall Study|Study drug toxicity|0|||
25177350|NCT02754141|50321517|FG010|Overall Study|Study drug toxicity|2|||
25177351|NCT02754141|50321518|FG011|Overall Study|Study drug toxicity|1|||
25111837|NCT02496767|50223099|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
25111838|NCT02496767|50223092|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
25111839|NCT02496767|50223093|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
25111840|NCT02496767|50223094|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
25111841|NCT02496767|50223095|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
25111842|NCT02496767|50223096|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
25111843|NCT02496767|50223097|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
25111844|NCT02496767|50223098|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
25111845|NCT02496767|50223099|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
25111846|NCT02496767|50223092|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
25111847|NCT02496767|50223093|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
25111848|NCT02496767|50223094|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
25111849|NCT02496767|50223095|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
25111850|NCT02496767|50223096|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
25111851|NCT02496767|50223097|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
25111852|NCT02496767|50223098|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
25111853|NCT02496767|50223099|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
25111854|NCT02496767|50223092|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
25111855|NCT02496767|50223093|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
25111856|NCT02496767|50223094|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
25111857|NCT02496767|50223095|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
25111858|NCT02496767|50223096|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
25111859|NCT02496767|50223097|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
25111860|NCT02496767|50223098|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
25111861|NCT02496767|50223099|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
25111862|NCT02496767|50223092|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
25111863|NCT02496767|50223093|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
25111864|NCT02496767|50223094|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
25111865|NCT02496767|50223095|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
25111866|NCT02496767|50223096|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
25111867|NCT02496767|50223097|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
25111868|NCT02496767|50223098|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
25111869|NCT02496767|50223099|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
25111870|NCT02496767|50223092|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
25111871|NCT02496767|50223093|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
25111872|NCT02496767|50223094|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
25111873|NCT02496767|50223095|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
25111874|NCT02496767|50223096|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
25111875|NCT02496767|50223097|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
25111876|NCT02496767|50223098|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
25111877|NCT02496767|50223099|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
25111878|NCT02496767|50223092|FG000|Double-blind, Withdrawal Phase|Death|0|||
25111879|NCT02496767|50223093|FG001|Double-blind, Withdrawal Phase|Death|0|||
25111880|NCT02496767|50223094|FG002|Double-blind, Withdrawal Phase|Death|0|||
25111881|NCT02496767|50223095|FG003|Double-blind, Withdrawal Phase|Death|0|||
25111882|NCT02496767|50223096|FG004|Double-blind, Withdrawal Phase|Death|0|||
25111883|NCT02496767|50223097|FG005|Double-blind, Withdrawal Phase|Death|0|||
25111884|NCT02496767|50223098|FG006|Double-blind, Withdrawal Phase|Death|1|||
25111885|NCT02496767|50223099|FG007|Double-blind, Withdrawal Phase|Death|2|||
25111886|NCT02496767|50223092|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
25111887|NCT02496767|50223093|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
25111888|NCT02496767|50223094|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
25111889|NCT02496767|50223095|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
25111890|NCT02496767|50223096|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
25111891|NCT02496767|50223097|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
25111892|NCT02496767|50223098|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
25111893|NCT02496767|50223099|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
25111894|NCT02496533|50223115|FG000|Overall Study|Lack of data on outcome|3|||
25111895|NCT02496533|50223116|FG001|Overall Study|Lack of data on outcome|0|||
25111896|NCT02496533|50223115|FG000|Overall Study|Patient did not complete all measures|0|||
25111897|NCT02496533|50223116|FG001|Overall Study|Patient did not complete all measures|4|||
25111898|NCT02496533|50223115|FG000|Overall Study|Late for radiologic testing|0|||
25111899|NCT02496533|50223116|FG001|Overall Study|Late for radiologic testing|2|||
25111900|NCT02496221|50223122|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
25111901|NCT02496221|50223123|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
25111902|NCT02496221|50223122|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
25111903|NCT02496221|50223123|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
25111904|NCT02496221|50223122|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
25261374|NCT01003249|50576113|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
25111905|NCT02496221|50223123|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
25111906|NCT02475629|50223131|FG000|Overall Study|Adverse Event|1|||
25111907|NCT02475629|50223131|FG000|Overall Study|Death|4|||
25111908|NCT02475629|50223131|FG000|Overall Study|Physician Decision|1|||
25111909|NCT02475629|50223131|FG000|Overall Study|Withdrawal by Subject|1|||
25111910|NCT02475629|50223131|FG000|Overall Study|Lost to Follow-up|1|||
25111911|NCT02475629|50223131|FG000|Overall Study|Subject non-compliance|1|||
25111912|NCT02475395|50223137|FG000|Overall Study|Protocol Violation|30|||
25111913|NCT02475395|50223138|FG001|Overall Study|Protocol Violation|3|||
25111914|NCT01653743|50223146|FG000|Overall Study|Withdrawal by Subject|1|||
25111915|NCT01653743|50223147|FG001|Overall Study|Withdrawal by Subject|0|||
25111916|NCT01653743|50223146|FG000|Overall Study|Investigator discretion|3|||
25111917|NCT01653743|50223147|FG001|Overall Study|Investigator discretion|0|||
25111918|NCT02293993|50223157|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
25111919|NCT02293993|50223158|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
25111920|NCT02293993|50223159|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
25111921|NCT02293993|50223160|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
25111922|NCT02293993|50223157|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
25111923|NCT02293993|50223158|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
25111924|NCT02293993|50223159|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
25111925|NCT02293993|50223160|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
25111926|NCT02293993|50223157|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
25111927|NCT02293993|50223158|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
25111928|NCT02293993|50223159|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
25111929|NCT02293993|50223160|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
25111930|NCT02293993|50223157|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
25111931|NCT02293993|50223158|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
25111932|NCT02293993|50223159|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
25111933|NCT02293993|50223160|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
25111934|NCT02293993|50223157|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
25111935|NCT02293993|50223158|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
25111936|NCT02293993|50223159|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
25111937|NCT02293993|50223160|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
25111938|NCT02322775|50223180|FG000|Overall Study|Adverse Event|1|||
25111939|NCT02322775|50223181|FG001|Overall Study|Adverse Event|0|||
25111940|NCT02322775|50223180|FG000|Overall Study|Lost to Follow-up|0|||
25111941|NCT02322775|50223181|FG001|Overall Study|Lost to Follow-up|1|||
25111942|NCT02322775|50223180|FG000|Overall Study|Protocol Violation|1|||
25111943|NCT02322775|50223181|FG001|Overall Study|Protocol Violation|0|||
25111944|NCT02322775|50223180|FG000|Overall Study|Withdrawal by Subject|3|||
25111945|NCT02322775|50223181|FG001|Overall Study|Withdrawal by Subject|4|||
25111946|NCT02322775|50223180|FG000|Overall Study|Not willing to perform all FU visits|0|||
25111947|NCT02322775|50223181|FG001|Overall Study|Not willing to perform all FU visits|1|||
25111948|NCT02322229|50223187|FG000|Overall Study|Physician Decision|2|||
25111949|NCT02363959|50223194|FG000|Overall Study|Medical instability|1|||
25111950|NCT02363959|50223195|FG001|Overall Study|Medical instability|0|||
25111951|NCT02362789|50223203|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
25111952|NCT02362789|50223204|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
25111953|NCT02362789|50223205|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
25111954|NCT02362789|50223203|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
25111955|NCT02362789|50223204|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
25111956|NCT02362789|50223205|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
25111957|NCT02362789|50223203|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
25111958|NCT02362789|50223204|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
25111959|NCT02362789|50223205|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
25111960|NCT02362789|50223203|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
25111961|NCT02362789|50223204|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
25111962|NCT02362789|50223205|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
25111963|NCT02362789|50223203|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
25111964|NCT02362789|50223204|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
25111965|NCT02362789|50223205|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
25111966|NCT01646827|50223214|FG000|Overall Study|Lost to Follow-up|0|||
25111967|NCT01646827|50223215|FG001|Overall Study|Lost to Follow-up|3|||
25111968|NCT01646827|50223214|FG000|Overall Study|Physician Decision|1|||
25261375|NCT01003249|50576114|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
25111969|NCT01646827|50223215|FG001|Overall Study|Physician Decision|2|||
25111970|NCT01646827|50223214|FG000|Overall Study|Withdrawal by Subject|1|||
25111971|NCT01646827|50223215|FG001|Overall Study|Withdrawal by Subject|0|||
25111972|NCT02293837|50223225|FG000|Overall Study|Lost to Follow-up|0|||
25111973|NCT02293837|50223226|FG001|Overall Study|Lost to Follow-up|2|||
25111974|NCT02293837|50223227|FG002|Overall Study|Lost to Follow-up|1|||
25111975|NCT02293837|50223228|FG003|Overall Study|Lost to Follow-up|0|||
25111976|NCT02293837|50223225|FG000|Overall Study|Withdrawal by Subject|2|||
25111977|NCT02293837|50223226|FG001|Overall Study|Withdrawal by Subject|1|||
25111978|NCT02293837|50223227|FG002|Overall Study|Withdrawal by Subject|2|||
25111979|NCT02293837|50223228|FG003|Overall Study|Withdrawal by Subject|1|||
25111980|NCT02293837|50223225|FG000|Overall Study|COVID-19 Related|1|||
25111981|NCT02293837|50223226|FG001|Overall Study|COVID-19 Related|1|||
25111982|NCT02293837|50223227|FG002|Overall Study|COVID-19 Related|0|||
25111983|NCT02293837|50223228|FG003|Overall Study|COVID-19 Related|0|||
25111984|NCT02293837|50223225|FG000|Overall Study|Participant ill and could not be infused|0|||
25111985|NCT02293837|50223226|FG001|Overall Study|Participant ill and could not be infused|0|||
25111986|NCT02293837|50223227|FG002|Overall Study|Participant ill and could not be infused|1|||
25111987|NCT02293837|50223228|FG003|Overall Study|Participant ill and could not be infused|0|||
25111988|NCT02361307|50223244|FG000|Overall Study|Unstable medical condition.|0|||
25111989|NCT02361307|50223245|FG001|Overall Study|Unstable medical condition.|1|||
25111990|NCT02320903|50223254|FG000|Overall Study|Withdrawal by Subject|0|||
25111991|NCT02320903|50223255|FG001|Overall Study|Withdrawal by Subject|9|||
25111992|NCT02320903|50223256|FG002|Overall Study|Withdrawal by Subject|9|||
25111993|NCT02320903|50223254|FG000|Overall Study|Exited therapy; no longer eligible|8|||
25111994|NCT02320903|50223255|FG001|Overall Study|Exited therapy; no longer eligible|2|||
25111995|NCT02320903|50223256|FG002|Overall Study|Exited therapy; no longer eligible|2|||
25111996|NCT02320903|50223254|FG000|Overall Study|Lost to Follow-up|0|||
25111997|NCT02320903|50223255|FG001|Overall Study|Lost to Follow-up|5|||
25111998|NCT02320903|50223256|FG002|Overall Study|Lost to Follow-up|5|||
25111999|NCT02320123|50223267|FG000|Overall Study|Lost to Follow-up|4|||
25112000|NCT02320123|50223268|FG001|Overall Study|Lost to Follow-up|6|||
25112001|NCT02320123|50223267|FG000|Overall Study|Death|6|||
25112002|NCT02320123|50223268|FG001|Overall Study|Death|5|||
25112003|NCT02360995|50223281|FG000|Overall Study|Lost to Follow-up|2|||
25112004|NCT02360995|50223282|FG001|Overall Study|Lost to Follow-up|0|||
25112005|NCT02360995|50223283|FG002|Overall Study|Lost to Follow-up|2|||
25112006|NCT02360995|50223281|FG000|Overall Study|Withdrawal by Subject|0|||
25112007|NCT02360995|50223282|FG001|Overall Study|Withdrawal by Subject|1|||
25112008|NCT02360995|50223283|FG002|Overall Study|Withdrawal by Subject|0|||
25112009|NCT02360605|50223293|FG000|Overall Study|Withdrawal by Subject|4|||
25112010|NCT02360605|50223294|FG001|Overall Study|Withdrawal by Subject|9|||
25112011|NCT02360605|50223293|FG000|Overall Study|Lost to Follow-up|7|||
25112012|NCT02360605|50223294|FG001|Overall Study|Lost to Follow-up|8|||
25112013|NCT02360605|50223293|FG000|Overall Study|Death|0|||
25112014|NCT02360605|50223294|FG001|Overall Study|Death|1|||
25112015|NCT02360293|50223304|FG000|Overall Study|Lost to Follow-up|73|||
25112016|NCT02360293|50223305|FG001|Overall Study|Lost to Follow-up|95|||
25112017|NCT02360293|50223304|FG000|Overall Study|Withdrawal by Subject|2|||
25112018|NCT02360293|50223305|FG001|Overall Study|Withdrawal by Subject|1|||
25261376|NCT01003249|50576113|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
25261377|NCT01003249|50576114|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
25261378|NCT01001767|50576126|FG000|Overall Study|no baseline study performed|1|||
25261379|NCT01001767|50576127|FG001|Overall Study|no baseline study performed|0|||
25112019|NCT02360293|50223304|FG000|Overall Study|Excluded|1|||
25112020|NCT02360293|50223305|FG001|Overall Study|Excluded|0|||
25112021|NCT02359903|50223313|FG000|Overall Study|Adverse Event|0|||
25112022|NCT02359903|50223314|FG001|Overall Study|Adverse Event|2|||
25112023|NCT02291419|50223322|FG000|Overall Study|Early study termination|1|||
25112024|NCT02291419|50223323|FG001|Overall Study|Early study termination|5|||
25112025|NCT02319031|50223331|FG000|Treatment Period|Death|1|||
25112026|NCT02319031|50223332|FG001|Treatment Period|Death|0|||
25112027|NCT02318797|50223340|FG000|Overall Study|Death|3|||
25112028|NCT02318797|50223341|FG001|Overall Study|Death|6|||
25112029|NCT02318797|50223340|FG000|Overall Study|Lost to Follow-up|85|||
25112030|NCT02318797|50223341|FG001|Overall Study|Lost to Follow-up|96|||
25112031|NCT02359435|50223349|FG000|Overall Study|Lost to Follow-up|4|||
25112032|NCT02359435|50223350|FG001|Overall Study|Lost to Follow-up|4|||
25112033|NCT02318719|50223360|FG000|Double-blind Phase|Adverse Event|7|||
25112034|NCT02318719|50223361|FG001|Double-blind Phase|Adverse Event|6|||
25112035|NCT02318719|50223362|FG002|Double-blind Phase|Adverse Event|12|||
25112036|NCT02318719|50223363|FG003|Double-blind Phase|Adverse Event|4|||
25112037|NCT02318719|50223364|FG004|Double-blind Phase|Adverse Event|0|||
25112038|NCT02318719|50223360|FG000|Double-blind Phase|Lack of Efficacy|5|||
25112039|NCT02318719|50223361|FG001|Double-blind Phase|Lack of Efficacy|0|||
25112040|NCT02318719|50223362|FG002|Double-blind Phase|Lack of Efficacy|1|||
25112041|NCT02318719|50223363|FG003|Double-blind Phase|Lack of Efficacy|1|||
25177352|NCT02754141|50321519|FG012|Overall Study|Study drug toxicity|1|||
25112042|NCT02318719|50223364|FG004|Double-blind Phase|Lack of Efficacy|0|||
25112043|NCT02318719|50223360|FG000|Double-blind Phase|Protocol Violation|0|||
25112044|NCT02318719|50223361|FG001|Double-blind Phase|Protocol Violation|1|||
25112045|NCT02318719|50223362|FG002|Double-blind Phase|Protocol Violation|3|||
25112046|NCT02318719|50223363|FG003|Double-blind Phase|Protocol Violation|0|||
25112047|NCT02318719|50223364|FG004|Double-blind Phase|Protocol Violation|0|||
25112048|NCT02318719|50223360|FG000|Double-blind Phase|Withdrawal by Subject|25|||
25112049|NCT02318719|50223361|FG001|Double-blind Phase|Withdrawal by Subject|7|||
25112050|NCT02318719|50223362|FG002|Double-blind Phase|Withdrawal by Subject|9|||
25112051|NCT02318719|50223363|FG003|Double-blind Phase|Withdrawal by Subject|10|||
25112052|NCT02318719|50223364|FG004|Double-blind Phase|Withdrawal by Subject|0|||
25112053|NCT02318719|50223360|FG000|Double-blind Phase|Other|1|||
25112054|NCT02318719|50223361|FG001|Double-blind Phase|Other|2|||
25112055|NCT02318719|50223362|FG002|Double-blind Phase|Other|0|||
25112056|NCT02318719|50223363|FG003|Double-blind Phase|Other|0|||
25112057|NCT02318719|50223364|FG004|Double-blind Phase|Other|0|||
25112058|NCT02318719|50223360|FG000|Open-label Extension Phase|Adverse Event|0|||
25112059|NCT02318719|50223361|FG001|Open-label Extension Phase|Adverse Event|0|||
25112060|NCT02318719|50223362|FG002|Open-label Extension Phase|Adverse Event|0|||
25112061|NCT02318719|50223363|FG003|Open-label Extension Phase|Adverse Event|0|||
25112062|NCT02318719|50223364|FG004|Open-label Extension Phase|Adverse Event|15|||
25112063|NCT02318719|50223360|FG000|Open-label Extension Phase|Death|0|||
25112064|NCT02318719|50223361|FG001|Open-label Extension Phase|Death|0|||
25112065|NCT02318719|50223362|FG002|Open-label Extension Phase|Death|0|||
25112066|NCT02318719|50223363|FG003|Open-label Extension Phase|Death|0|||
25112067|NCT02318719|50223364|FG004|Open-label Extension Phase|Death|1|||
25112068|NCT02318719|50223360|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
25112069|NCT02318719|50223361|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
25112070|NCT02318719|50223362|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
25112071|NCT02318719|50223363|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
25112072|NCT02318719|50223364|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
25112073|NCT02318719|50223360|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
25112074|NCT02318719|50223361|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
25112075|NCT02318719|50223362|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
25112076|NCT02318719|50223363|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
25112077|NCT02318719|50223364|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
25112078|NCT02318719|50223360|FG000|Open-label Extension Phase|Other|0|||
25112079|NCT02318719|50223361|FG001|Open-label Extension Phase|Other|0|||
25112080|NCT02318719|50223362|FG002|Open-label Extension Phase|Other|0|||
25112081|NCT02318719|50223363|FG003|Open-label Extension Phase|Other|0|||
25112082|NCT02318719|50223364|FG004|Open-label Extension Phase|Other|7|||
25112083|NCT01870726|50223383|FG000|Overall Study|Withdrawal of informed consent|0|||
25112084|NCT01870726|50223384|FG001|Overall Study|Withdrawal of informed consent|0|||
25112085|NCT01870726|50223385|FG002|Overall Study|Withdrawal of informed consent|0|||
25112086|NCT01870726|50223386|FG003|Overall Study|Withdrawal of informed consent|1|||
25112087|NCT01870726|50223387|FG004|Overall Study|Withdrawal of informed consent|0|||
25112088|NCT01870726|50223388|FG005|Overall Study|Withdrawal of informed consent|0|||
25112089|NCT01870726|50223389|FG006|Overall Study|Withdrawal of informed consent|0|||
25112090|NCT01870726|50223383|FG000|Overall Study|Withdrawal by Subject|0|||
25112091|NCT01870726|50223384|FG001|Overall Study|Withdrawal by Subject|1|||
25112092|NCT01870726|50223385|FG002|Overall Study|Withdrawal by Subject|0|||
25112093|NCT01870726|50223386|FG003|Overall Study|Withdrawal by Subject|0|||
25112094|NCT01870726|50223387|FG004|Overall Study|Withdrawal by Subject|0|||
25112095|NCT01870726|50223388|FG005|Overall Study|Withdrawal by Subject|0|||
25112096|NCT01870726|50223389|FG006|Overall Study|Withdrawal by Subject|0|||
25112097|NCT01870726|50223383|FG000|Overall Study|Adverse Event|0|||
25112098|NCT01870726|50223384|FG001|Overall Study|Adverse Event|0|||
25112099|NCT01870726|50223385|FG002|Overall Study|Adverse Event|0|||
25112100|NCT01870726|50223386|FG003|Overall Study|Adverse Event|0|||
25112101|NCT01870726|50223387|FG004|Overall Study|Adverse Event|1|||
25112102|NCT01870726|50223388|FG005|Overall Study|Adverse Event|1|||
25112103|NCT01870726|50223389|FG006|Overall Study|Adverse Event|0|||
25112104|NCT01870726|50223383|FG000|Overall Study|Progressive disease|5|||
25112105|NCT01870726|50223384|FG001|Overall Study|Progressive disease|5|||
25112106|NCT01870726|50223385|FG002|Overall Study|Progressive disease|4|||
25112107|NCT01870726|50223386|FG003|Overall Study|Progressive disease|5|||
25112108|NCT01870726|50223387|FG004|Overall Study|Progressive disease|6|||
25112109|NCT01870726|50223388|FG005|Overall Study|Progressive disease|4|||
25112110|NCT01870726|50223389|FG006|Overall Study|Progressive disease|10|||
25261380|NCT01001767|50576126|FG000|Overall Study|Protocol Violation|1|||
25261381|NCT01001767|50576127|FG001|Overall Study|Protocol Violation|0|||
25112111|NCT01900054|50223414|FG000|Overall Study|Physician Decision|1|||
25112112|NCT01900054|50223414|FG000|Overall Study|Withdrawal by Subject|1|||
25112113|NCT01612156|50223420|FG000|Overall Study|Protocol Violation|2|||
25112114|NCT01612156|50223421|FG001|Overall Study|Protocol Violation|0|||
25112115|NCT01899742|50223429|FG000|Overall Study|Adverse Event|5|||
25112116|NCT01899742|50223430|FG001|Overall Study|Adverse Event|4|||
25112117|NCT01899742|50223429|FG000|Overall Study|Lack of Efficacy|1|||
25112118|NCT01899742|50223430|FG001|Overall Study|Lack of Efficacy|5|||
25112119|NCT01899742|50223429|FG000|Overall Study|Protocol Violation|2|||
25112120|NCT01899742|50223430|FG001|Overall Study|Protocol Violation|2|||
25112121|NCT01899742|50223429|FG000|Overall Study|Withdrawal by Subject|9|||
25112122|NCT01899742|50223430|FG001|Overall Study|Withdrawal by Subject|5|||
25112123|NCT01615822|50223439|FG000|Period 1|Withdrawal by Subject|0|||
25112124|NCT01615822|50223440|FG001|Period 1|Withdrawal by Subject|1|||
25112125|NCT01615822|50223441|FG002|Period 1|Withdrawal by Subject|0|||
25112126|NCT01615822|50223439|FG000|Period 1|Adverse Event|1|||
25112127|NCT01615822|50223440|FG001|Period 1|Adverse Event|1|||
25112128|NCT01615822|50223441|FG002|Period 1|Adverse Event|0|||
25112129|NCT01615822|50223439|FG000|Period 2|Lost to Follow-up|0|||
25112130|NCT01615822|50223440|FG001|Period 2|Lost to Follow-up|1|||
25112131|NCT01615822|50223441|FG002|Period 2|Lost to Follow-up|2|||
25112132|NCT01898884|50223457|FG000|Multiple Dose Period|Adverse Event|0|||
25112133|NCT01898884|50223458|FG001|Multiple Dose Period|Adverse Event|0|||
25112134|NCT01898884|50223459|FG002|Multiple Dose Period|Adverse Event|0|||
25112135|NCT01898884|50223460|FG003|Multiple Dose Period|Adverse Event|0|||
25112136|NCT01898884|50223461|FG004|Multiple Dose Period|Adverse Event|0|||
25112137|NCT01898884|50223462|FG005|Multiple Dose Period|Adverse Event|0|||
25112138|NCT01898884|50223463|FG006|Multiple Dose Period|Adverse Event|1|||
25112139|NCT01898884|50223464|FG007|Multiple Dose Period|Adverse Event|0|||
25112140|NCT01898884|50223465|FG008|Multiple Dose Period|Adverse Event|0|||
25112141|NCT01898884|50223457|FG000|Multiple Dose Period|Randomized Not Treated|0|||
25112142|NCT01898884|50223458|FG001|Multiple Dose Period|Randomized Not Treated|0|||
25112143|NCT01898884|50223459|FG002|Multiple Dose Period|Randomized Not Treated|0|||
25112144|NCT01898884|50223460|FG003|Multiple Dose Period|Randomized Not Treated|0|||
25112145|NCT01898884|50223461|FG004|Multiple Dose Period|Randomized Not Treated|0|||
25112146|NCT01898884|50223462|FG005|Multiple Dose Period|Randomized Not Treated|0|||
25112147|NCT01898884|50223463|FG006|Multiple Dose Period|Randomized Not Treated|0|||
25112148|NCT01898884|50223464|FG007|Multiple Dose Period|Randomized Not Treated|0|||
25112149|NCT01898884|50223465|FG008|Multiple Dose Period|Randomized Not Treated|1|||
25112150|NCT01613326|50223503|FG000|Overall Study|Adverse Event|7|||
25112151|NCT01613326|50223504|FG001|Overall Study|Adverse Event|5|||
25112152|NCT01613326|50223503|FG000|Overall Study|Withdrawal by Subject|3|||
25112153|NCT01613326|50223504|FG001|Overall Study|Withdrawal by Subject|4|||
25112154|NCT01613326|50223503|FG000|Overall Study|Abnormal test procedure result(s)|2|||
25112155|NCT01613326|50223504|FG001|Overall Study|Abnormal test procedure result(s)|0|||
25112156|NCT01613326|50223503|FG000|Overall Study|inability to use device|1|||
25112157|NCT01613326|50223504|FG001|Overall Study|inability to use device|0|||
25112158|NCT01613326|50223503|FG000|Overall Study|Lack of Efficacy|0|||
25112159|NCT01613326|50223504|FG001|Overall Study|Lack of Efficacy|1|||
25112160|NCT01613326|50223503|FG000|Overall Study|Lost to Follow-up|0|||
25112161|NCT01613326|50223504|FG001|Overall Study|Lost to Follow-up|1|||
25112162|NCT01613326|50223503|FG000|Overall Study|Administrative|0|||
25112163|NCT01613326|50223504|FG001|Overall Study|Administrative|2|||
25112164|NCT01613326|50223503|FG000|Overall Study|Protocol Violation|0|||
25112165|NCT01613326|50223504|FG001|Overall Study|Protocol Violation|1|||
25112166|NCT01613248|50223516|FG000|Overall Study|Adverse Event|0|||
25112167|NCT01613248|50223517|FG001|Overall Study|Adverse Event|0|||
25112168|NCT01613248|50223518|FG002|Overall Study|Adverse Event|0|||
25112169|NCT01613248|50223519|FG003|Overall Study|Adverse Event|1|||
25112170|NCT01613248|50223520|FG004|Overall Study|Adverse Event|0|||
25112171|NCT01613248|50223521|FG005|Overall Study|Adverse Event|0|||
25112172|NCT01613248|50223516|FG000|Overall Study|Withdrawal by Subject|3|||
25112173|NCT01613248|50223517|FG001|Overall Study|Withdrawal by Subject|2|||
25112174|NCT01613248|50223518|FG002|Overall Study|Withdrawal by Subject|2|||
25112175|NCT01613248|50223519|FG003|Overall Study|Withdrawal by Subject|5|||
25112176|NCT01613248|50223520|FG004|Overall Study|Withdrawal by Subject|0|||
25112177|NCT01613248|50223521|FG005|Overall Study|Withdrawal by Subject|1|||
25112178|NCT01613248|50223516|FG000|Overall Study|Lost to Follow-up|5|||
25112179|NCT01613248|50223517|FG001|Overall Study|Lost to Follow-up|7|||
25112180|NCT01613248|50223518|FG002|Overall Study|Lost to Follow-up|4|||
25112181|NCT01613248|50223519|FG003|Overall Study|Lost to Follow-up|8|||
25112182|NCT01613248|50223520|FG004|Overall Study|Lost to Follow-up|4|||
25112183|NCT01613248|50223521|FG005|Overall Study|Lost to Follow-up|2|||
25112184|NCT01613248|50223516|FG000|Overall Study|Study Terminated by Sponsor|4|||
25112185|NCT01613248|50223517|FG001|Overall Study|Study Terminated by Sponsor|6|||
25112186|NCT01613248|50223518|FG002|Overall Study|Study Terminated by Sponsor|8|||
25112187|NCT01613248|50223519|FG003|Overall Study|Study Terminated by Sponsor|8|||
25112188|NCT01613248|50223520|FG004|Overall Study|Study Terminated by Sponsor|9|||
25112189|NCT01613248|50223521|FG005|Overall Study|Study Terminated by Sponsor|11|||
25112190|NCT01613248|50223516|FG000|Overall Study|Physician Decision|8|||
25112191|NCT01613248|50223517|FG001|Overall Study|Physician Decision|8|||
25112192|NCT01613248|50223518|FG002|Overall Study|Physician Decision|9|||
25112193|NCT01613248|50223519|FG003|Overall Study|Physician Decision|4|||
25112194|NCT01613248|50223520|FG004|Overall Study|Physician Decision|7|||
25112195|NCT01613248|50223521|FG005|Overall Study|Physician Decision|6|||
25112196|NCT01613248|50223516|FG000|Overall Study|Lack of Qualifying Event|9|||
25112197|NCT01613248|50223517|FG001|Overall Study|Lack of Qualifying Event|11|||
25112198|NCT01613248|50223518|FG002|Overall Study|Lack of Qualifying Event|10|||
25112199|NCT01613248|50223519|FG003|Overall Study|Lack of Qualifying Event|11|||
25112200|NCT01613248|50223520|FG004|Overall Study|Lack of Qualifying Event|15|||
25112201|NCT01613248|50223521|FG005|Overall Study|Lack of Qualifying Event|18|||
25112202|NCT01613248|50223516|FG000|Overall Study|Pregnancy|0|||
25112203|NCT01613248|50223517|FG001|Overall Study|Pregnancy|0|||
25112204|NCT01613248|50223518|FG002|Overall Study|Pregnancy|0|||
25112205|NCT01613248|50223519|FG003|Overall Study|Pregnancy|1|||
25112206|NCT01613248|50223520|FG004|Overall Study|Pregnancy|0|||
25112207|NCT01613248|50223521|FG005|Overall Study|Pregnancy|0|||
25112208|NCT01898806|50223535|FG000|Overall Study|Withdrawal by Subject|2|||
25112209|NCT01898806|50223535|FG000|Overall Study|Physician Decision|1|||
25112210|NCT02291029|50223545|FG000|Overall Study|Withdrawal by Subject|0|||
25112211|NCT02291029|50223546|FG001|Overall Study|Withdrawal by Subject|0|||
25112212|NCT02291029|50223547|FG002|Overall Study|Withdrawal by Subject|1|||
25112213|NCT02291029|50223548|FG003|Overall Study|Withdrawal by Subject|0|||
25112214|NCT02291029|50223549|FG004|Overall Study|Withdrawal by Subject|0|||
25112215|NCT02291029|50223550|FG005|Overall Study|Withdrawal by Subject|0|||
25112216|NCT02291029|50223545|FG000|Overall Study|Adverse Event|0|||
25112217|NCT02291029|50223546|FG001|Overall Study|Adverse Event|1|||
25112218|NCT02291029|50223547|FG002|Overall Study|Adverse Event|0|||
25112219|NCT02291029|50223548|FG003|Overall Study|Adverse Event|0|||
25112220|NCT02291029|50223549|FG004|Overall Study|Adverse Event|0|||
25112221|NCT02291029|50223550|FG005|Overall Study|Adverse Event|0|||
25112222|NCT02290873|50223567|FG000|Overall Study|Withdrawal by Subject|0|||
25112223|NCT02290873|50223568|FG001|Overall Study|Withdrawal by Subject|1|||
25112224|NCT02290873|50223569|FG002|Overall Study|Withdrawal by Subject|1|||
25112225|NCT02290873|50223567|FG000|Overall Study|Nellcor device error|1|||
25112226|NCT02290873|50223568|FG001|Overall Study|Nellcor device error|0|||
25112227|NCT02290873|50223569|FG002|Overall Study|Nellcor device error|0|||
25112228|NCT02290873|50223567|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
25112229|NCT02290873|50223568|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
25112230|NCT02290873|50223569|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
25112231|NCT02290873|50223567|FG000|Overall Study|Protocol Violation|0|||
25112232|NCT02290873|50223568|FG001|Overall Study|Protocol Violation|0|||
25112233|NCT02290873|50223569|FG002|Overall Study|Protocol Violation|1|||
25112234|NCT02290405|50223580|FG000|Overall Study|Withdrawal by Subject|1|||
25112235|NCT02290405|50223581|FG001|Overall Study|Withdrawal by Subject|0|||
25112236|NCT02359045|50223589|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
25112237|NCT02359045|50223590|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
25112238|NCT02359045|50223589|FG000|Overall Study|Lost to Follow-up|1|||
25112239|NCT02359045|50223590|FG001|Overall Study|Lost to Follow-up|1|||
25112240|NCT02359045|50223589|FG000|Overall Study|Adverse Event|0|||
25112241|NCT02359045|50223590|FG001|Overall Study|Adverse Event|1|||
25112242|NCT02358343|50223611|FG000|Screening Intervention|Death|0|||
25112243|NCT02358343|50223612|FG001|Screening Intervention|Death|2|||
25112244|NCT02358343|50223613|FG002|Screening Intervention|Death|0|||
25112245|NCT02358343|50223614|FG003|Screening Intervention|Death|0|||
25112246|NCT02358343|50223615|FG004|Screening Intervention|Death|0|||
25112247|NCT02358343|50223611|FG000|Screening Intervention|Withdrawal by Subject|1|||
25112248|NCT02358343|50223612|FG001|Screening Intervention|Withdrawal by Subject|0|||
25112249|NCT02358343|50223613|FG002|Screening Intervention|Withdrawal by Subject|0|||
25112250|NCT02358343|50223614|FG003|Screening Intervention|Withdrawal by Subject|0|||
25112251|NCT02358343|50223615|FG004|Screening Intervention|Withdrawal by Subject|0|||
25112252|NCT02358343|50223611|FG000|Screening Intervention|Determined Ineligible|5|||
25112253|NCT02358343|50223612|FG001|Screening Intervention|Determined Ineligible|6|||
25112254|NCT02358343|50223613|FG002|Screening Intervention|Determined Ineligible|0|||
25112255|NCT02358343|50223614|FG003|Screening Intervention|Determined Ineligible|0|||
25112256|NCT02358343|50223615|FG004|Screening Intervention|Determined Ineligible|0|||
25112257|NCT02358343|50223611|FG000|Comparative Efficacy Trial / Observation|Death|0|||
25112258|NCT02358343|50223612|FG001|Comparative Efficacy Trial / Observation|Death|0|||
25112259|NCT02358343|50223613|FG002|Comparative Efficacy Trial / Observation|Death|2|||
25112260|NCT02358343|50223614|FG003|Comparative Efficacy Trial / Observation|Death|0|||
25112261|NCT02358343|50223615|FG004|Comparative Efficacy Trial / Observation|Death|0|||
25112262|NCT02358343|50223611|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
25112263|NCT02358343|50223612|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
25112264|NCT02358343|50223613|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
25112265|NCT02358343|50223614|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
25112266|NCT02358343|50223615|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
25112267|NCT02358343|50223611|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
25112268|NCT02358343|50223612|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
25112269|NCT02358343|50223613|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
25112270|NCT02358343|50223614|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
25112271|NCT02358343|50223615|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
25112272|NCT02356783|50223628|FG000|Overall Study|Lost to Follow-up|1|||
25112273|NCT02356783|50223629|FG001|Overall Study|Lost to Follow-up|3|||
25112274|NCT02289469|50223637|FG000|Overall Study|Unable to match a control|6|||
25112275|NCT02289469|50223638|FG001|Overall Study|Unable to match a control|0|||
25112276|NCT02318095|50223644|FG000|Overall Study|Adverse Event|1|||
25112277|NCT02317705|50223649|FG000|Overall Study|Withdrawal by Subject|3|||
25112278|NCT02317705|50223649|FG000|Overall Study|Physician Decision|1|||
25112279|NCT02317705|50223649|FG000|Overall Study|Drug not usable|1|||
25112280|NCT02474069|50223653|FG000|Selection Phase (SP)|Adverse Event|8|||
25112281|NCT02474069|50223654|FG001|Selection Phase (SP)|Adverse Event|0|||
25112282|NCT02474069|50223655|FG002|Selection Phase (SP)|Adverse Event|0|||
25112283|NCT02474069|50223653|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
25112284|NCT02474069|50223654|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
25112285|NCT02474069|50223655|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
25112286|NCT02474069|50223653|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
25112287|NCT02474069|50223654|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
25112288|NCT02474069|50223655|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
25112289|NCT02474069|50223653|FG000|Selection Phase (SP)|Physician Decision|1|||
25112290|NCT02474069|50223654|FG001|Selection Phase (SP)|Physician Decision|0|||
25112291|NCT02474069|50223655|FG002|Selection Phase (SP)|Physician Decision|0|||
25112292|NCT02474069|50223653|FG000|Selection Phase (SP)|Protocol Violation|1|||
25112293|NCT02474069|50223654|FG001|Selection Phase (SP)|Protocol Violation|0|||
25112294|NCT02474069|50223655|FG002|Selection Phase (SP)|Protocol Violation|0|||
25112295|NCT02474069|50223653|FG000|Selection Phase (SP)|No longer requires treatment|1|||
25112296|NCT02474069|50223654|FG001|Selection Phase (SP)|No longer requires treatment|0|||
25112297|NCT02474069|50223655|FG002|Selection Phase (SP)|No longer requires treatment|0|||
25112298|NCT02474069|50223653|FG000|Selection Phase (SP)|Technical Problem|1|||
25112299|NCT02474069|50223654|FG001|Selection Phase (SP)|Technical Problem|0|||
25112300|NCT02474069|50223655|FG002|Selection Phase (SP)|Technical Problem|0|||
25112301|NCT02474069|50223653|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
25112302|NCT02474069|50223654|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
25112303|NCT02474069|50223655|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
25112304|NCT02474069|50223653|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
25112305|NCT02474069|50223654|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
25112306|NCT02474069|50223655|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
25112307|NCT02474069|50223653|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
25112308|NCT02474069|50223654|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
25112309|NCT02474069|50223655|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
25112310|NCT02474069|50223653|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
25112311|NCT02474069|50223654|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
25112312|NCT02474069|50223655|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
25112313|NCT02474069|50223653|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
25112314|NCT02474069|50223654|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
25112315|NCT02474069|50223655|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
25112316|NCT02474069|50223653|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
25112317|NCT02474069|50223654|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
25112318|NCT02474069|50223655|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
25112319|NCT02317627|50223668|FG000|Overall Study|Withdrawal by Subject|0|||
25112320|NCT02317627|50223669|FG001|Overall Study|Withdrawal by Subject|1|||
25112321|NCT02317627|50223670|FG002|Overall Study|Withdrawal by Subject|1|||
25112322|NCT02317627|50223668|FG000|Overall Study|Lost to Follow-up|2|||
25112323|NCT02317627|50223669|FG001|Overall Study|Lost to Follow-up|0|||
25112324|NCT02317627|50223670|FG002|Overall Study|Lost to Follow-up|0|||
25112325|NCT02317627|50223668|FG000|Overall Study|Stopped by Investigator|0|||
25112326|NCT02317627|50223669|FG001|Overall Study|Stopped by Investigator|1|||
25112327|NCT02317627|50223670|FG002|Overall Study|Stopped by Investigator|0|||
25112328|NCT02317627|50223668|FG000|Overall Study|Adverse Event|0|||
25112329|NCT02317627|50223669|FG001|Overall Study|Adverse Event|2|||
25112330|NCT02317627|50223670|FG002|Overall Study|Adverse Event|3|||
25112331|NCT02317627|50223668|FG000|Overall Study|Non-compliance with study drug|0|||
25112332|NCT02317627|50223669|FG001|Overall Study|Non-compliance with study drug|1|||
25112333|NCT02317627|50223670|FG002|Overall Study|Non-compliance with study drug|0|||
25112334|NCT02517905|50223686|FG000|Overall Study|Lost to Follow-up|4|||
25112335|NCT02517905|50223687|FG001|Overall Study|Lost to Follow-up|0|||
25112336|NCT02517905|50223686|FG000|Overall Study|Withdrawal by Subject|4|||
25112337|NCT02517905|50223687|FG001|Overall Study|Withdrawal by Subject|0|||
25112338|NCT02517905|50223686|FG000|Overall Study|Screen failure|2|||
25112339|NCT02517905|50223687|FG001|Overall Study|Screen failure|2|||
25112340|NCT02473913|50223695|FG000|Overall Study|Lost to Follow-up|3|||
25112341|NCT02473913|50223696|FG001|Overall Study|Lost to Follow-up|3|||
25112342|NCT02316847|50223704|FG000|Overall Study|Adverse Event|0|||
25112343|NCT02316847|50223705|FG001|Overall Study|Adverse Event|3|||
25112344|NCT02316847|50223704|FG000|Overall Study|Lost to Follow-up|0|||
25112345|NCT02316847|50223705|FG001|Overall Study|Lost to Follow-up|2|||
25112346|NCT02316847|50223704|FG000|Overall Study|Physician Decision|0|||
25112347|NCT02316847|50223705|FG001|Overall Study|Physician Decision|1|||
25112348|NCT02316847|50223704|FG000|Overall Study|Pregnancy|0|||
25112349|NCT02316847|50223705|FG001|Overall Study|Pregnancy|1|||
25112350|NCT02316847|50223704|FG000|Overall Study|Withdrawal by Subject|2|||
25112351|NCT02316847|50223705|FG001|Overall Study|Withdrawal by Subject|9|||
25112352|NCT02316847|50223704|FG000|Overall Study|Noncompliance with study drug|0|||
25112353|NCT02316847|50223705|FG001|Overall Study|Noncompliance with study drug|3|||
25112354|NCT02316847|50223704|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
25112355|NCT02316847|50223705|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
25112356|NCT02473523|50223713|FG000|Overall Study|Death|1|||
25112357|NCT02473523|50223713|FG000|Overall Study|Lost to Follow-up|1|||
25112358|NCT02316769|50223719|FG000|Overall Study|Physician Decision|1|||
25112359|NCT02316769|50223720|FG001|Overall Study|Physician Decision|0|||
25112360|NCT02316769|50223719|FG000|Overall Study|Withdrawal by Subject|1|||
25112361|NCT02316769|50223720|FG001|Overall Study|Withdrawal by Subject|0|||
25112362|NCT02473445|50223726|FG000|Overall Study|Withdrawal by Subject|2|||
25112363|NCT02473445|50223726|FG000|Overall Study|Sponsor Decision|20|||
25112364|NCT02473367|50223730|FG000|Wait 1|Withdrawal by Subject|1|||
25112365|NCT02473367|50223730|FG000|Period 4|Lost to Follow-up|1|||
25112366|NCT02316613|50223740|FG000|Overall Study|Death|63|||
25112367|NCT02316613|50223740|FG000|Overall Study|Lost to Follow-up|9|||
25112368|NCT02316613|50223740|FG000|Overall Study|Lymphoma transformation|2|||
25112369|NCT02316613|50223740|FG000|Overall Study|Participant moved/changed medical team|11|||
25112370|NCT02316613|50223740|FG000|Overall Study|No data and duplicate cases|5|||
25112371|NCT02316613|50223740|FG000|Overall Study|Did not met selection criteria|14|||
25112372|NCT02492165|50223759|FG000|Overall Study|Withdrawal by Subject|0|||
25112373|NCT02492165|50223760|FG001|Overall Study|Withdrawal by Subject|1|||
25112374|NCT02492165|50223761|FG002|Overall Study|Withdrawal by Subject|0|||
25112375|NCT02492165|50223762|FG003|Overall Study|Withdrawal by Subject|0|||
25112376|NCT02355691|50223774|FG000|Overall Study|Loss of Research Personnel|7|||
25112377|NCT02355691|50223775|FG001|Overall Study|Loss of Research Personnel|9|||
25112378|NCT02473289|50223783|FG000|Overall Study|Adverse Event|2|||
25112379|NCT02473289|50223784|FG001|Overall Study|Adverse Event|3|||
25112380|NCT02473289|50223783|FG000|Overall Study|Lost to Follow-up|1|||
25112381|NCT02473289|50223784|FG001|Overall Study|Lost to Follow-up|1|||
25112382|NCT02473289|50223783|FG000|Overall Study|Protocol Violation|0|||
25112383|NCT02473289|50223784|FG001|Overall Study|Protocol Violation|1|||
25112384|NCT02473289|50223783|FG000|Overall Study|Withdrawal of consent|6|||
25112385|NCT02473289|50223784|FG001|Overall Study|Withdrawal of consent|7|||
25112386|NCT02473289|50223783|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
25112387|NCT02473289|50223784|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
25112388|NCT02473289|50223783|FG000|Overall Study|Other|2|||
25112389|NCT02473289|50223784|FG001|Overall Study|Other|0|||
25112390|NCT02354599|50223796|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
25112391|NCT02354599|50223797|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
25112392|NCT02354599|50223798|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
25177353|NCT02754141|50321520|FG013|Overall Study|Study drug toxicity|0|||
25177354|NCT02754141|50321521|FG014|Overall Study|Study drug toxicity|0|||
25177355|NCT02754141|50321522|FG015|Overall Study|Study drug toxicity|0|||
25177356|NCT02754141|50321523|FG016|Overall Study|Study drug toxicity|0|||
25177357|NCT02754141|50321524|FG017|Overall Study|Study drug toxicity|0|||
25177358|NCT02754141|50321507|FG000|Overall Study|AE unrelated to study drug|1|||
25177359|NCT02754141|50321508|FG001|Overall Study|AE unrelated to study drug|1|||
25177360|NCT02754141|50321509|FG002|Overall Study|AE unrelated to study drug|0|||
25177361|NCT02754141|50321510|FG003|Overall Study|AE unrelated to study drug|1|||
25112393|NCT02354599|50223799|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
25112394|NCT02354599|50223800|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
25112395|NCT02354599|50223801|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
25112396|NCT02354599|50223796|FG000|Overall Study|Withdrawal by Subject|1|||
25112397|NCT02354599|50223797|FG001|Overall Study|Withdrawal by Subject|1|||
25112398|NCT02354599|50223798|FG002|Overall Study|Withdrawal by Subject|0|||
25177362|NCT02754141|50321511|FG004|Overall Study|AE unrelated to study drug|3|||
25177363|NCT02754141|50321512|FG005|Overall Study|AE unrelated to study drug|2|||
25112399|NCT02354599|50223799|FG003|Overall Study|Withdrawal by Subject|0|||
25112400|NCT02354599|50223800|FG004|Overall Study|Withdrawal by Subject|0|||
25112401|NCT02354599|50223801|FG005|Overall Study|Withdrawal by Subject|0|||
25112402|NCT02316223|50223824|FG000|Overall Study|Lack of Efficacy|0|||
25112403|NCT02316223|50223825|FG001|Overall Study|Lack of Efficacy|1|||
25112404|NCT02316223|50223826|FG002|Overall Study|Lack of Efficacy|1|||
25112405|NCT02316223|50223824|FG000|Overall Study|Lost to Follow-up|27|||
25112406|NCT02316223|50223825|FG001|Overall Study|Lost to Follow-up|34|||
25177364|NCT02754141|50321513|FG006|Overall Study|AE unrelated to study drug|1|||
25177365|NCT02754141|50321514|FG007|Overall Study|AE unrelated to study drug|0|||
25177366|NCT02754141|50321515|FG008|Overall Study|AE unrelated to study drug|0|||
25177367|NCT02754141|50321516|FG009|Overall Study|AE unrelated to study drug|0|||
25177368|NCT02754141|50321517|FG010|Overall Study|AE unrelated to study drug|0|||
25177369|NCT02754141|50321518|FG011|Overall Study|AE unrelated to study drug|0|||
25177370|NCT02754141|50321519|FG012|Overall Study|AE unrelated to study drug|0|||
25177371|NCT02754141|50321520|FG013|Overall Study|AE unrelated to study drug|0|||
25177372|NCT02754141|50321521|FG014|Overall Study|AE unrelated to study drug|0|||
25177373|NCT02754141|50321522|FG015|Overall Study|AE unrelated to study drug|0|||
25177374|NCT02754141|50321523|FG016|Overall Study|AE unrelated to study drug|0|||
25177375|NCT02754141|50321524|FG017|Overall Study|AE unrelated to study drug|0|||
25177376|NCT02754141|50321507|FG000|Overall Study|Request to discontinue|0|||
25177377|NCT02754141|50321508|FG001|Overall Study|Request to discontinue|0|||
25177378|NCT02754141|50321509|FG002|Overall Study|Request to discontinue|0|||
25177379|NCT02754141|50321510|FG003|Overall Study|Request to discontinue|0|||
25177380|NCT02754141|50321511|FG004|Overall Study|Request to discontinue|0|||
25177381|NCT02754141|50321512|FG005|Overall Study|Request to discontinue|0|||
25177382|NCT02754141|50321513|FG006|Overall Study|Request to discontinue|0|||
25177383|NCT02754141|50321514|FG007|Overall Study|Request to discontinue|0|||
25177384|NCT02754141|50321515|FG008|Overall Study|Request to discontinue|1|||
25177385|NCT02754141|50321516|FG009|Overall Study|Request to discontinue|0|||
25177386|NCT02754141|50321517|FG010|Overall Study|Request to discontinue|0|||
25177387|NCT02754141|50321518|FG011|Overall Study|Request to discontinue|0|||
25177388|NCT02754141|50321519|FG012|Overall Study|Request to discontinue|0|||
25177389|NCT02754141|50321520|FG013|Overall Study|Request to discontinue|1|||
25177390|NCT02754141|50321521|FG014|Overall Study|Request to discontinue|1|||
25177391|NCT02754141|50321522|FG015|Overall Study|Request to discontinue|0|||
25177392|NCT02754141|50321523|FG016|Overall Study|Request to discontinue|0|||
25112407|NCT02316223|50223826|FG002|Overall Study|Lost to Follow-up|36|||
25112408|NCT02316223|50223824|FG000|Overall Study|COPD Diagnosis|3|||
25112409|NCT02316223|50223825|FG001|Overall Study|COPD Diagnosis|2|||
25112410|NCT02316223|50223826|FG002|Overall Study|COPD Diagnosis|3|||
25112411|NCT02316223|50223824|FG000|Overall Study|Reside outside study area|1|||
25112412|NCT02316223|50223825|FG001|Overall Study|Reside outside study area|1|||
25112413|NCT02316223|50223826|FG002|Overall Study|Reside outside study area|1|||
25112414|NCT02316223|50223824|FG000|Overall Study|No asthma|2|||
25112415|NCT02316223|50223825|FG001|Overall Study|No asthma|0|||
25112416|NCT02316223|50223826|FG002|Overall Study|No asthma|0|||
25112417|NCT02316223|50223824|FG000|Overall Study|Discontinued by PI|11|||
25112418|NCT02316223|50223825|FG001|Overall Study|Discontinued by PI|19|||
25112419|NCT02316223|50223826|FG002|Overall Study|Discontinued by PI|3|||
25112420|NCT02286895|50223836|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
25112421|NCT02286895|50223837|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
25112422|NCT02286895|50223836|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
25112423|NCT02286895|50223837|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
25112424|NCT02286895|50223836|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
25112425|NCT02286895|50223837|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
25112426|NCT02472977|50223846|FG000|Overall Study|Disease progression|4|||
25112427|NCT02472977|50223847|FG001|Overall Study|Disease progression|25|||
25112428|NCT02472977|50223848|FG002|Overall Study|Disease progression|6|||
25112429|NCT02472977|50223846|FG000|Overall Study|Withdrawal by Subject|0|||
25112430|NCT02472977|50223847|FG001|Overall Study|Withdrawal by Subject|1|||
25112431|NCT02472977|50223848|FG002|Overall Study|Withdrawal by Subject|0|||
25112432|NCT02472977|50223846|FG000|Overall Study|Study drug toxicity|2|||
25112433|NCT02472977|50223847|FG001|Overall Study|Study drug toxicity|0|||
25112434|NCT02472977|50223848|FG002|Overall Study|Study drug toxicity|2|||
25112435|NCT02472977|50223846|FG000|Overall Study|Subject request to discontinue treatment|0|||
25112436|NCT02472977|50223847|FG001|Overall Study|Subject request to discontinue treatment|1|||
25112437|NCT02472977|50223848|FG002|Overall Study|Subject request to discontinue treatment|0|||
25112438|NCT02060487|50223859|FG000|Overall Study|Other|1|||
25177393|NCT02754141|50321524|FG017|Overall Study|Request to discontinue|0|||
25177394|NCT02754141|50321507|FG000|Overall Study|Withdrew consent|0|||
25261382|NCT01001767|50576126|FG000|Overall Study|Lost to Follow-up|1|||
25112439|NCT02060487|50223860|FG001|Overall Study|Other|2|||
25112440|NCT02060487|50223861|FG002|Overall Study|Other|1|||
25112441|NCT02060487|50223859|FG000|Overall Study|Lack of Efficacy|0|||
25112442|NCT02060487|50223860|FG001|Overall Study|Lack of Efficacy|1|||
25112443|NCT02060487|50223861|FG002|Overall Study|Lack of Efficacy|0|||
25112444|NCT02060487|50223859|FG000|Overall Study|Withdrawal by Subject|3|||
25112445|NCT02060487|50223860|FG001|Overall Study|Withdrawal by Subject|10|||
25177395|NCT02754141|50321508|FG001|Overall Study|Withdrew consent|0|||
25177396|NCT02754141|50321509|FG002|Overall Study|Withdrew consent|0|||
25177397|NCT02754141|50321510|FG003|Overall Study|Withdrew consent|0|||
25112446|NCT02060487|50223861|FG002|Overall Study|Withdrawal by Subject|4|||
25177398|NCT02754141|50321511|FG004|Overall Study|Withdrew consent|0|||
25177399|NCT02754141|50321512|FG005|Overall Study|Withdrew consent|0|||
25112447|NCT02060487|50223859|FG000|Overall Study|Study Terminated By Sponsor|87|||
25112448|NCT02060487|50223860|FG001|Overall Study|Study Terminated By Sponsor|89|||
25112449|NCT02060487|50223861|FG002|Overall Study|Study Terminated By Sponsor|100|||
25112450|NCT02060487|50223859|FG000|Overall Study|Randomized in error|1|||
25112451|NCT02060487|50223860|FG001|Overall Study|Randomized in error|0|||
25112452|NCT02060487|50223861|FG002|Overall Study|Randomized in error|0|||
25112453|NCT02060487|50223859|FG000|Overall Study|Protocol Violation|0|||
25112454|NCT02060487|50223860|FG001|Overall Study|Protocol Violation|1|||
25112455|NCT02060487|50223861|FG002|Overall Study|Protocol Violation|1|||
25112456|NCT02060487|50223859|FG000|Overall Study|Lost to Follow-up|3|||
25112457|NCT02060487|50223860|FG001|Overall Study|Lost to Follow-up|0|||
25112458|NCT02060487|50223861|FG002|Overall Study|Lost to Follow-up|2|||
25112459|NCT02060487|50223859|FG000|Overall Study|Death|34|||
25112460|NCT02060487|50223860|FG001|Overall Study|Death|25|||
25112461|NCT02060487|50223861|FG002|Overall Study|Death|19|||
25112462|NCT02060487|50223859|FG000|Overall Study|Adverse Event|0|||
25112463|NCT02060487|50223860|FG001|Overall Study|Adverse Event|0|||
25112464|NCT02060487|50223861|FG002|Overall Study|Adverse Event|1|||
25112465|NCT02059395|50223871|FG000|Overall Study|Lost to Follow-up|2|||
25112466|NCT02059395|50223872|FG001|Overall Study|Lost to Follow-up|4|||
25112467|NCT02059239|50223880|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
25112468|NCT02059239|50223881|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
25112469|NCT02059239|50223880|FG000|Overall Study|Physician Decision|1|||
25112470|NCT02059239|50223881|FG001|Overall Study|Physician Decision|0|||
25112471|NCT02059161|50223890|FG000|Overall Study|Pregnancy|0|||
25112472|NCT02059161|50223891|FG001|Overall Study|Pregnancy|2|||
25112473|NCT02059161|50223890|FG000|Overall Study|Adverse Event|2|||
25112474|NCT02059161|50223891|FG001|Overall Study|Adverse Event|6|||
25112475|NCT02059161|50223890|FG000|Overall Study|Lost to Follow-up|20|||
25112476|NCT02059161|50223891|FG001|Overall Study|Lost to Follow-up|12|||
25112477|NCT02059161|50223890|FG000|Overall Study|Physician Decision|4|||
25112478|NCT02059161|50223891|FG001|Overall Study|Physician Decision|4|||
25112479|NCT02059161|50223890|FG000|Overall Study|Protocol Violation|1|||
25112480|NCT02059161|50223891|FG001|Overall Study|Protocol Violation|1|||
25112481|NCT02059161|50223890|FG000|Overall Study|Withdrawal by Subject|16|||
25112482|NCT02059161|50223891|FG001|Overall Study|Withdrawal by Subject|13|||
25112483|NCT02059161|50223890|FG000|Overall Study|Randomized in error, no study drug|0|||
25112484|NCT02059161|50223891|FG001|Overall Study|Randomized in error, no study drug|1|||
25112485|NCT02059161|50223890|FG000|Overall Study|Non-compliance with study drug|6|||
25112486|NCT02059161|50223891|FG001|Overall Study|Non-compliance with study drug|2|||
25112487|NCT01897714|50223903|FG000|Phase I (Dose Escalation)|Disease progression|3|||
25112488|NCT01897714|50223904|FG001|Phase I (Dose Escalation)|Disease progression|5|||
25112489|NCT01897714|50223905|FG002|Phase I (Dose Escalation)|Disease progression|1|||
25112490|NCT01897714|50223906|FG003|Phase I (Dose Escalation)|Disease progression|3|||
25112491|NCT01897714|50223907|FG004|Phase I (Dose Escalation)|Disease progression|0|||
25112492|NCT01897714|50223908|FG005|Phase I (Dose Escalation)|Disease progression|0|||
25112493|NCT01897714|50223903|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
25112494|NCT01897714|50223904|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
25112495|NCT01897714|50223905|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
25112496|NCT01897714|50223906|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
25112497|NCT01897714|50223907|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
25112498|NCT01897714|50223908|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
25112499|NCT01897714|50223903|FG000|Phase I (Dose Escalation)|Other|0|||
25112500|NCT01897714|50223904|FG001|Phase I (Dose Escalation)|Other|1|||
25112501|NCT01897714|50223905|FG002|Phase I (Dose Escalation)|Other|0|||
25112502|NCT01897714|50223906|FG003|Phase I (Dose Escalation)|Other|0|||
25112503|NCT01897714|50223907|FG004|Phase I (Dose Escalation)|Other|0|||
25112504|NCT01897714|50223908|FG005|Phase I (Dose Escalation)|Other|0|||
25112505|NCT01897714|50223903|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
25112506|NCT01897714|50223904|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
25112507|NCT01897714|50223905|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
25112508|NCT01897714|50223906|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
25112509|NCT01897714|50223907|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
25112510|NCT01897714|50223908|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
25112511|NCT01897714|50223903|FG000|Phase II (MTD)|Lost to Follow-up|0|||
25112512|NCT01897714|50223904|FG001|Phase II (MTD)|Lost to Follow-up|0|||
25112513|NCT01897714|50223905|FG002|Phase II (MTD)|Lost to Follow-up|0|||
25112514|NCT01897714|50223906|FG003|Phase II (MTD)|Lost to Follow-up|0|||
25112515|NCT01897714|50223907|FG004|Phase II (MTD)|Lost to Follow-up|1|||
25112516|NCT01897714|50223908|FG005|Phase II (MTD)|Lost to Follow-up|0|||
25112517|NCT01897714|50223903|FG000|Phase II (MTD)|Death|0|||
25112518|NCT01897714|50223904|FG001|Phase II (MTD)|Death|0|||
25112519|NCT01897714|50223905|FG002|Phase II (MTD)|Death|0|||
25112520|NCT01897714|50223906|FG003|Phase II (MTD)|Death|0|||
25112521|NCT01897714|50223907|FG004|Phase II (MTD)|Death|25|||
25112522|NCT01897714|50223908|FG005|Phase II (MTD)|Death|10|||
25112523|NCT01897714|50223903|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
25112524|NCT01897714|50223904|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
25112525|NCT01897714|50223905|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
25112526|NCT01897714|50223906|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
25112527|NCT01897714|50223907|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
25112528|NCT01897714|50223908|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
25112529|NCT01897714|50223903|FG000|Phase II (MTD)|Other|0|||
25112530|NCT01897714|50223904|FG001|Phase II (MTD)|Other|0|||
25112531|NCT01897714|50223905|FG002|Phase II (MTD)|Other|0|||
25112532|NCT01897714|50223906|FG003|Phase II (MTD)|Other|0|||
25112533|NCT01897714|50223907|FG004|Phase II (MTD)|Other|3|||
25112534|NCT01897714|50223908|FG005|Phase II (MTD)|Other|0|||
25112535|NCT01861522|50223926|FG000|Overall Study|Adverse Event|1|||
25112536|NCT01861522|50223927|FG001|Overall Study|Adverse Event|0|||
25112537|NCT01861522|50223926|FG000|Overall Study|Withdrawal by Subject|2|||
25112538|NCT01861522|50223927|FG001|Overall Study|Withdrawal by Subject|0|||
25112539|NCT01860976|50223935|FG000|Blinded Treatment|Adverse Event|1|||
25112540|NCT01860976|50223936|FG001|Blinded Treatment|Adverse Event|3|||
25112541|NCT01860976|50223935|FG000|Blinded Treatment|Lack of Efficacy|5|||
25112542|NCT01860976|50223936|FG001|Blinded Treatment|Lack of Efficacy|12|||
25112543|NCT01860976|50223935|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
25112544|NCT01860976|50223936|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
25112545|NCT01860976|50223935|FG000|Blinded Treatment|Withdrawal by Subject|3|||
25112546|NCT01860976|50223936|FG001|Blinded Treatment|Withdrawal by Subject|5|||
25112547|NCT01860976|50223935|FG000|Blinded Treatment|Subject no longer met criteria|1|||
25112548|NCT01860976|50223936|FG001|Blinded Treatment|Subject no longer met criteria|0|||
25112549|NCT01860976|50223935|FG000|Blinded Treatment|Entered Open-Label in error|0|||
25112550|NCT01860976|50223936|FG001|Blinded Treatment|Entered Open-Label in error|1|||
25112551|NCT01860976|50223935|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
25112552|NCT01860976|50223936|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
25112553|NCT01860976|50223935|FG000|Open-Label|Adverse Event|2|||
25112554|NCT01860976|50223936|FG001|Open-Label|Adverse Event|4|||
25112555|NCT01860976|50223935|FG000|Open-Label|Lack of Efficacy|16|||
25112556|NCT01860976|50223936|FG001|Open-Label|Lack of Efficacy|8|||
25112557|NCT01860976|50223935|FG000|Open-Label|Lost to Follow-up|1|||
25112558|NCT01860976|50223936|FG001|Open-Label|Lost to Follow-up|2|||
25112559|NCT01860976|50223935|FG000|Open-Label|Subject request discontinue treatment|4|||
25112560|NCT01860976|50223936|FG001|Open-Label|Subject request discontinue treatment|3|||
25112561|NCT01860976|50223935|FG000|Open-Label|Withdrawal by Subject|4|||
25112562|NCT01860976|50223936|FG001|Open-Label|Withdrawal by Subject|1|||
25112563|NCT01860976|50223935|FG000|Open-Label|Other Reasons|1|||
25112564|NCT01860976|50223936|FG001|Open-Label|Other Reasons|1|||
25112565|NCT01860976|50223935|FG000|Long Term Extension|Adverse Event|4|||
25112566|NCT01860976|50223936|FG001|Long Term Extension|Adverse Event|0|||
25112567|NCT01860976|50223935|FG000|Long Term Extension|Lack of Efficacy|2|||
25112568|NCT01860976|50223936|FG001|Long Term Extension|Lack of Efficacy|0|||
25112569|NCT01860976|50223935|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
25112570|NCT01860976|50223936|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
25112571|NCT01860976|50223935|FG000|Long Term Extension|Lost to Follow-up|2|||
25112572|NCT01860976|50223936|FG001|Long Term Extension|Lost to Follow-up|0|||
25112573|NCT01860976|50223935|FG000|Long Term Extension|subject withdrew consent|7|||
25112574|NCT01860976|50223936|FG001|Long Term Extension|subject withdrew consent|0|||
25112575|NCT01860040|50223947|FG000|Overall Study|Withdrawal by Subject|1|||
25112576|NCT01860040|50223948|FG001|Overall Study|Withdrawal by Subject|0|||
25112577|NCT01896934|50223953|FG000|Overall Study|Adverse Event|1|||
25112578|NCT01896934|50223953|FG000|Overall Study|Withdrawal by Subject|1|||
25112579|NCT02039505|50223960|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
25112580|NCT02039505|50223961|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
25112581|NCT02039505|50223962|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
25112582|NCT02039505|50223963|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
25112583|NCT02039505|50223964|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
25112584|NCT02039505|50223965|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
25112585|NCT02039505|50223966|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
25112586|NCT02039505|50223960|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
25112587|NCT02039505|50223961|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
25112588|NCT02039505|50223962|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
25112589|NCT02039505|50223963|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
25112590|NCT02039505|50223964|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
25112591|NCT02039505|50223965|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
25112592|NCT02039505|50223966|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
25112593|NCT02039505|50223960|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
25112594|NCT02039505|50223961|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
25112595|NCT02039505|50223962|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
25177400|NCT02754141|50321513|FG006|Overall Study|Withdrew consent|0|||
25112596|NCT02039505|50223963|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
25112597|NCT02039505|50223964|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
25112598|NCT02039505|50223965|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
25112599|NCT02039505|50223966|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
25112600|NCT02039505|50223960|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
25112601|NCT02039505|50223961|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
25112602|NCT02039505|50223962|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
25112603|NCT02039505|50223963|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
25112604|NCT02039505|50223964|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
25112605|NCT02039505|50223965|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
25112606|NCT02039505|50223966|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
25112607|NCT02039505|50223960|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
25112608|NCT02039505|50223961|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
25112609|NCT02039505|50223962|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
25112610|NCT02039505|50223963|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
25112611|NCT02039505|50223964|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
25112612|NCT02039505|50223965|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
25112613|NCT02039505|50223966|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
25112614|NCT02039505|50223960|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
25112615|NCT02039505|50223961|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
25112616|NCT02039505|50223962|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
25112617|NCT02039505|50223963|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
25112618|NCT02039505|50223964|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
25112619|NCT02039505|50223965|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
25112620|NCT02039505|50223966|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
25112621|NCT02039505|50223960|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
25112622|NCT02039505|50223961|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
25112623|NCT02039505|50223962|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
25112624|NCT02039505|50223963|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
25112625|NCT02039505|50223964|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
25112626|NCT02039505|50223965|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
25112627|NCT02039505|50223966|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
25112628|NCT02039505|50223960|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
25112629|NCT02039505|50223961|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
25112630|NCT02039505|50223962|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
25112631|NCT02039505|50223963|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
25112632|NCT02039505|50223964|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
25112633|NCT02039505|50223965|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
25112634|NCT02039505|50223966|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
25112635|NCT02039505|50223960|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
25112636|NCT02039505|50223961|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
25112637|NCT02039505|50223962|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
25112638|NCT02039505|50223963|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
25112639|NCT02039505|50223964|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
25112640|NCT02039505|50223965|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
25112641|NCT02039505|50223966|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
25112642|NCT02039505|50223960|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
25112643|NCT02039505|50223961|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
25112644|NCT02039505|50223962|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
25112645|NCT02039505|50223963|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
25112646|NCT02039505|50223964|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
25112647|NCT02039505|50223965|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
25112648|NCT02039505|50223966|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
25112649|NCT02039505|50223960|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
25112650|NCT02039505|50223961|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
25112651|NCT02039505|50223962|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
25112652|NCT02039505|50223963|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
25112653|NCT02039505|50223964|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
25112654|NCT02039505|50223965|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
25112655|NCT02039505|50223966|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
25112656|NCT02095197|50223988|FG000|Overall Study|Lost to Follow-up|0|||
25112657|NCT02095197|50223989|FG001|Overall Study|Lost to Follow-up|3|||
25177401|NCT02754141|50321514|FG007|Overall Study|Withdrew consent|0|||
25177402|NCT02754141|50321515|FG008|Overall Study|Withdrew consent|0|||
25112658|NCT02039427|50223999|FG000|Overall Study|Duration of surgery > 3h|1|||
25112659|NCT02039427|50224000|FG001|Overall Study|Duration of surgery > 3h|1|||
25112660|NCT02039427|50224001|FG002|Overall Study|Duration of surgery > 3h|0|||
25112661|NCT02039427|50224002|FG003|Overall Study|Duration of surgery > 3h|0|||
25112662|NCT02039427|50223999|FG000|Overall Study|Withdrawal on concent|0|||
25112663|NCT02039427|50224000|FG001|Overall Study|Withdrawal on concent|0|||
25112664|NCT02039427|50224001|FG002|Overall Study|Withdrawal on concent|0|||
25112665|NCT02039427|50224002|FG003|Overall Study|Withdrawal on concent|1|||
25112666|NCT02039427|50223999|FG000|Overall Study|Cancellation of surgery|0|||
25112667|NCT02039427|50224000|FG001|Overall Study|Cancellation of surgery|0|||
25112668|NCT02039427|50224001|FG002|Overall Study|Cancellation of surgery|1|||
25112669|NCT02039427|50224002|FG003|Overall Study|Cancellation of surgery|0|||
25112670|NCT02039427|50223999|FG000|Overall Study|Loss of follow - up|1|||
25112671|NCT02039427|50224000|FG001|Overall Study|Loss of follow - up|0|||
25112672|NCT02039427|50224001|FG002|Overall Study|Loss of follow - up|2|||
25112673|NCT02039427|50224002|FG003|Overall Study|Loss of follow - up|4|||
25112674|NCT02039427|50223999|FG000|Overall Study|Steroid Use|1|||
25112675|NCT02039427|50224000|FG001|Overall Study|Steroid Use|0|||
25112676|NCT02039427|50224001|FG002|Overall Study|Steroid Use|0|||
25112677|NCT02039427|50224002|FG003|Overall Study|Steroid Use|0|||
25112678|NCT02094885|50224018|FG000|Overall Study|Death|1|||
25112679|NCT02094885|50224019|FG001|Overall Study|Death|5|||
25112680|NCT02094885|50224018|FG000|Overall Study|Withdrawn due to age|1|||
25112681|NCT02094885|50224019|FG001|Overall Study|Withdrawn due to age|0|||
25112682|NCT01896856|50224031|FG000|Overall Study|Transportation issues / Non-compliance|0|||
25112683|NCT01896856|50224032|FG001|Overall Study|Transportation issues / Non-compliance|0|||
25112684|NCT01896856|50224033|FG002|Overall Study|Transportation issues / Non-compliance|1|||
25112685|NCT01896856|50224034|FG003|Overall Study|Transportation issues / Non-compliance|0|||
25112686|NCT01896856|50224035|FG004|Overall Study|Transportation issues / Non-compliance|0|||
25112687|NCT01896856|50224036|FG005|Overall Study|Transportation issues / Non-compliance|0|||
25112688|NCT02038959|50224053|FG000|Overall Study|Withdrawal by Subject|6|||
25112689|NCT02038959|50224054|FG001|Overall Study|Withdrawal by Subject|8|||
25112690|NCT01896700|50224062|FG000|Overall Study|Adverse Event|4|||
25112691|NCT01896700|50224063|FG001|Overall Study|Adverse Event|5|||
25112692|NCT01896700|50224062|FG000|Overall Study|Withdrawal by Subject|0|||
25112693|NCT01896700|50224063|FG001|Overall Study|Withdrawal by Subject|1|||
25112694|NCT02352493|50224087|FG000|Overall Study|Pregnancy|0|||
25112695|NCT02352493|50224088|FG001|Overall Study|Pregnancy|0|||
25112696|NCT02352493|50224089|FG002|Overall Study|Pregnancy|0|||
25112697|NCT02352493|50224090|FG003|Overall Study|Pregnancy|0|||
25112698|NCT02352493|50224091|FG004|Overall Study|Pregnancy|0|||
25112699|NCT02352493|50224092|FG005|Overall Study|Pregnancy|0|||
25112700|NCT02352493|50224093|FG006|Overall Study|Pregnancy|1|||
25112701|NCT02352493|50224094|FG007|Overall Study|Pregnancy|0|||
25112702|NCT02352493|50224095|FG008|Overall Study|Pregnancy|1|||
25112703|NCT02352493|50224096|FG009|Overall Study|Pregnancy|0|||
25112704|NCT02352493|50224097|FG010|Overall Study|Pregnancy|0|||
25112705|NCT02352493|50224098|FG011|Overall Study|Pregnancy|0|||
25112706|NCT02352493|50224099|FG012|Overall Study|Pregnancy|0|||
25112707|NCT02352493|50224100|FG013|Overall Study|Pregnancy|0|||
25112708|NCT02352493|50224101|FG014|Overall Study|Pregnancy|0|||
25112709|NCT02352493|50224102|FG015|Overall Study|Pregnancy|0|||
25112710|NCT02352493|50224103|FG016|Overall Study|Pregnancy|0|||
25112711|NCT02352493|50224104|FG017|Overall Study|Pregnancy|0|||
25112712|NCT02352493|50224087|FG000|Overall Study|Withdrawal by Subject|0|||
25112713|NCT02352493|50224088|FG001|Overall Study|Withdrawal by Subject|0|||
25112714|NCT02352493|50224089|FG002|Overall Study|Withdrawal by Subject|0|||
25112715|NCT02352493|50224090|FG003|Overall Study|Withdrawal by Subject|0|||
25112716|NCT02352493|50224091|FG004|Overall Study|Withdrawal by Subject|0|||
25112717|NCT02352493|50224092|FG005|Overall Study|Withdrawal by Subject|0|||
25112718|NCT02352493|50224093|FG006|Overall Study|Withdrawal by Subject|0|||
25112719|NCT02352493|50224094|FG007|Overall Study|Withdrawal by Subject|0|||
25112720|NCT02352493|50224095|FG008|Overall Study|Withdrawal by Subject|1|||
25112721|NCT02352493|50224096|FG009|Overall Study|Withdrawal by Subject|0|||
25112722|NCT02352493|50224097|FG010|Overall Study|Withdrawal by Subject|0|||
25112723|NCT02352493|50224098|FG011|Overall Study|Withdrawal by Subject|0|||
25112724|NCT02352493|50224099|FG012|Overall Study|Withdrawal by Subject|0|||
25112725|NCT02352493|50224100|FG013|Overall Study|Withdrawal by Subject|0|||
25112726|NCT02352493|50224101|FG014|Overall Study|Withdrawal by Subject|1|||
25112727|NCT02352493|50224102|FG015|Overall Study|Withdrawal by Subject|0|||
25112728|NCT02352493|50224103|FG016|Overall Study|Withdrawal by Subject|0|||
25112729|NCT02352493|50224104|FG017|Overall Study|Withdrawal by Subject|0|||
25112730|NCT02352493|50224087|FG000|Overall Study|Lost to Follow-up|0|||
25112731|NCT02352493|50224088|FG001|Overall Study|Lost to Follow-up|0|||
25112732|NCT02352493|50224089|FG002|Overall Study|Lost to Follow-up|0|||
25112733|NCT02352493|50224090|FG003|Overall Study|Lost to Follow-up|0|||
25112734|NCT02352493|50224091|FG004|Overall Study|Lost to Follow-up|0|||
25112735|NCT02352493|50224092|FG005|Overall Study|Lost to Follow-up|0|||
25112736|NCT02352493|50224093|FG006|Overall Study|Lost to Follow-up|0|||
25112737|NCT02352493|50224094|FG007|Overall Study|Lost to Follow-up|0|||
25112738|NCT02352493|50224095|FG008|Overall Study|Lost to Follow-up|0|||
25112739|NCT02352493|50224096|FG009|Overall Study|Lost to Follow-up|1|||
25112740|NCT02352493|50224097|FG010|Overall Study|Lost to Follow-up|0|||
25112741|NCT02352493|50224098|FG011|Overall Study|Lost to Follow-up|0|||
25112742|NCT02352493|50224099|FG012|Overall Study|Lost to Follow-up|1|||
25112743|NCT02352493|50224100|FG013|Overall Study|Lost to Follow-up|2|||
25112744|NCT02352493|50224101|FG014|Overall Study|Lost to Follow-up|0|||
25112745|NCT02352493|50224102|FG015|Overall Study|Lost to Follow-up|0|||
25112746|NCT02352493|50224103|FG016|Overall Study|Lost to Follow-up|0|||
25112747|NCT02352493|50224104|FG017|Overall Study|Lost to Follow-up|0|||
25112748|NCT02286193|50224159|FG000|Overall Study|Referred: CRS unable to make contact|62|||
25112749|NCT02286193|50224159|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
25112750|NCT02286193|50224159|FG000|Overall Study|Referred: Declined service|38|||
25112751|NCT01896232|50224166|FG000|Overall Study|Death|6|||
25112752|NCT01896232|50224167|FG001|Overall Study|Death|10|||
25112753|NCT01896232|50224166|FG000|Overall Study|Withdrawal by Subject|32|||
25112754|NCT01896232|50224167|FG001|Overall Study|Withdrawal by Subject|31|||
25112755|NCT01896232|50224166|FG000|Overall Study|Sponsor Decision|2|||
25112756|NCT01896232|50224167|FG001|Overall Study|Sponsor Decision|0|||
25112757|NCT01896232|50224166|FG000|Overall Study|Lost to Follow-up|9|||
25112758|NCT01896232|50224167|FG001|Overall Study|Lost to Follow-up|12|||
25112759|NCT02460224|50224202|FG000|Overall Study|Adverse Event|0|||
25112760|NCT02460224|50224203|FG001|Overall Study|Adverse Event|0|||
25112761|NCT02460224|50224204|FG002|Overall Study|Adverse Event|0|||
25112762|NCT02460224|50224205|FG003|Overall Study|Adverse Event|0|||
25112763|NCT02460224|50224206|FG004|Overall Study|Adverse Event|0|||
25112764|NCT02460224|50224207|FG005|Overall Study|Adverse Event|0|||
25112765|NCT02460224|50224208|FG006|Overall Study|Adverse Event|1|||
25112766|NCT02460224|50224209|FG007|Overall Study|Adverse Event|0|||
25112767|NCT02460224|50224210|FG008|Overall Study|Adverse Event|0|||
25112768|NCT02460224|50224211|FG009|Overall Study|Adverse Event|0|||
25112769|NCT02460224|50224212|FG010|Overall Study|Adverse Event|0|||
25112770|NCT02460224|50224213|FG011|Overall Study|Adverse Event|0|||
25112771|NCT02460224|50224214|FG012|Overall Study|Adverse Event|1|||
25112772|NCT02460224|50224215|FG013|Overall Study|Adverse Event|0|||
25112773|NCT02460224|50224216|FG014|Overall Study|Adverse Event|0|||
25112774|NCT02460224|50224217|FG015|Overall Study|Adverse Event|0|||
25112775|NCT02460224|50224218|FG016|Overall Study|Adverse Event|1|||
25112776|NCT02460224|50224219|FG017|Overall Study|Adverse Event|0|||
25112777|NCT02460224|50224220|FG018|Overall Study|Adverse Event|1|||
25112778|NCT02460224|50224221|FG019|Overall Study|Adverse Event|0|||
25112779|NCT02460224|50224222|FG020|Overall Study|Adverse Event|1|||
25112780|NCT02460224|50224223|FG021|Overall Study|Adverse Event|1|||
25112781|NCT02460224|50224224|FG022|Overall Study|Adverse Event|1|||
25112782|NCT02460224|50224225|FG023|Overall Study|Adverse Event|0|||
25112783|NCT02460224|50224226|FG024|Overall Study|Adverse Event|0|||
25112784|NCT02460224|50224227|FG025|Overall Study|Adverse Event|0|||
25112785|NCT02460224|50224228|FG026|Overall Study|Adverse Event|11|||
25112786|NCT02460224|50224229|FG027|Overall Study|Adverse Event|1|||
25112787|NCT02460224|50224230|FG028|Overall Study|Adverse Event|6|||
25112788|NCT02460224|50224202|FG000|Overall Study|Death|0|||
25112789|NCT02460224|50224203|FG001|Overall Study|Death|0|||
25112790|NCT02460224|50224204|FG002|Overall Study|Death|0|||
25112791|NCT02460224|50224205|FG003|Overall Study|Death|0|||
25112792|NCT02460224|50224206|FG004|Overall Study|Death|0|||
25112793|NCT02460224|50224207|FG005|Overall Study|Death|2|||
25112794|NCT02460224|50224208|FG006|Overall Study|Death|1|||
25112795|NCT02460224|50224209|FG007|Overall Study|Death|0|||
25112796|NCT02460224|50224210|FG008|Overall Study|Death|0|||
25112797|NCT02460224|50224211|FG009|Overall Study|Death|1|||
25112798|NCT02460224|50224212|FG010|Overall Study|Death|0|||
25112799|NCT02460224|50224213|FG011|Overall Study|Death|0|||
25112800|NCT02460224|50224214|FG012|Overall Study|Death|0|||
25112801|NCT02460224|50224215|FG013|Overall Study|Death|1|||
25112802|NCT02460224|50224216|FG014|Overall Study|Death|0|||
25112803|NCT02460224|50224217|FG015|Overall Study|Death|0|||
25112804|NCT02460224|50224218|FG016|Overall Study|Death|2|||
25112805|NCT02460224|50224219|FG017|Overall Study|Death|1|||
25112806|NCT02460224|50224220|FG018|Overall Study|Death|0|||
25112807|NCT02460224|50224221|FG019|Overall Study|Death|2|||
25112808|NCT02460224|50224222|FG020|Overall Study|Death|0|||
25112809|NCT02460224|50224223|FG021|Overall Study|Death|0|||
25112810|NCT02460224|50224224|FG022|Overall Study|Death|0|||
25112811|NCT02460224|50224225|FG023|Overall Study|Death|0|||
25112812|NCT02460224|50224226|FG024|Overall Study|Death|1|||
25112813|NCT02460224|50224227|FG025|Overall Study|Death|1|||
25112814|NCT02460224|50224228|FG026|Overall Study|Death|5|||
25112815|NCT02460224|50224229|FG027|Overall Study|Death|0|||
25112816|NCT02460224|50224230|FG028|Overall Study|Death|1|||
25112817|NCT02460224|50224202|FG000|Overall Study|Lost to Follow-up|0|||
25112818|NCT02460224|50224203|FG001|Overall Study|Lost to Follow-up|0|||
25112819|NCT02460224|50224204|FG002|Overall Study|Lost to Follow-up|0|||
25112820|NCT02460224|50224205|FG003|Overall Study|Lost to Follow-up|0|||
25112821|NCT02460224|50224206|FG004|Overall Study|Lost to Follow-up|0|||
25112822|NCT02460224|50224207|FG005|Overall Study|Lost to Follow-up|0|||
25112823|NCT02460224|50224208|FG006|Overall Study|Lost to Follow-up|0|||
25112824|NCT02460224|50224209|FG007|Overall Study|Lost to Follow-up|0|||
25112825|NCT02460224|50224210|FG008|Overall Study|Lost to Follow-up|0|||
25112826|NCT02460224|50224211|FG009|Overall Study|Lost to Follow-up|0|||
25112827|NCT02460224|50224212|FG010|Overall Study|Lost to Follow-up|0|||
25112828|NCT02460224|50224213|FG011|Overall Study|Lost to Follow-up|0|||
25112829|NCT02460224|50224214|FG012|Overall Study|Lost to Follow-up|0|||
25112830|NCT02460224|50224215|FG013|Overall Study|Lost to Follow-up|0|||
25112831|NCT02460224|50224216|FG014|Overall Study|Lost to Follow-up|0|||
25112832|NCT02460224|50224217|FG015|Overall Study|Lost to Follow-up|0|||
25112833|NCT02460224|50224218|FG016|Overall Study|Lost to Follow-up|0|||
25112834|NCT02460224|50224219|FG017|Overall Study|Lost to Follow-up|0|||
25112835|NCT02460224|50224220|FG018|Overall Study|Lost to Follow-up|0|||
25112836|NCT02460224|50224221|FG019|Overall Study|Lost to Follow-up|0|||
25112837|NCT02460224|50224222|FG020|Overall Study|Lost to Follow-up|0|||
25112838|NCT02460224|50224223|FG021|Overall Study|Lost to Follow-up|0|||
25112839|NCT02460224|50224224|FG022|Overall Study|Lost to Follow-up|1|||
25112840|NCT02460224|50224225|FG023|Overall Study|Lost to Follow-up|0|||
25112841|NCT02460224|50224226|FG024|Overall Study|Lost to Follow-up|0|||
25112842|NCT02460224|50224227|FG025|Overall Study|Lost to Follow-up|0|||
25112843|NCT02460224|50224228|FG026|Overall Study|Lost to Follow-up|0|||
25112844|NCT02460224|50224229|FG027|Overall Study|Lost to Follow-up|0|||
25112845|NCT02460224|50224230|FG028|Overall Study|Lost to Follow-up|0|||
25112846|NCT02460224|50224202|FG000|Overall Study|Physician Decision|0|||
25112847|NCT02460224|50224203|FG001|Overall Study|Physician Decision|1|||
25112848|NCT02460224|50224204|FG002|Overall Study|Physician Decision|0|||
25112849|NCT02460224|50224205|FG003|Overall Study|Physician Decision|0|||
25112850|NCT02460224|50224206|FG004|Overall Study|Physician Decision|1|||
25112851|NCT02460224|50224207|FG005|Overall Study|Physician Decision|0|||
25112852|NCT02460224|50224208|FG006|Overall Study|Physician Decision|0|||
25112853|NCT02460224|50224209|FG007|Overall Study|Physician Decision|1|||
25112854|NCT02460224|50224210|FG008|Overall Study|Physician Decision|0|||
25112855|NCT02460224|50224211|FG009|Overall Study|Physician Decision|0|||
25112856|NCT02460224|50224212|FG010|Overall Study|Physician Decision|0|||
25112857|NCT02460224|50224213|FG011|Overall Study|Physician Decision|1|||
25112858|NCT02460224|50224214|FG012|Overall Study|Physician Decision|0|||
25112859|NCT02460224|50224215|FG013|Overall Study|Physician Decision|1|||
25112860|NCT02460224|50224216|FG014|Overall Study|Physician Decision|0|||
25112861|NCT02460224|50224217|FG015|Overall Study|Physician Decision|0|||
25112862|NCT02460224|50224218|FG016|Overall Study|Physician Decision|2|||
25112863|NCT02460224|50224219|FG017|Overall Study|Physician Decision|1|||
25112864|NCT02460224|50224220|FG018|Overall Study|Physician Decision|1|||
25112865|NCT02460224|50224221|FG019|Overall Study|Physician Decision|2|||
25112866|NCT02460224|50224222|FG020|Overall Study|Physician Decision|1|||
25112867|NCT02460224|50224223|FG021|Overall Study|Physician Decision|1|||
25112868|NCT02460224|50224224|FG022|Overall Study|Physician Decision|0|||
25112869|NCT02460224|50224225|FG023|Overall Study|Physician Decision|0|||
25112870|NCT02460224|50224226|FG024|Overall Study|Physician Decision|1|||
25112871|NCT02460224|50224227|FG025|Overall Study|Physician Decision|0|||
25112872|NCT02460224|50224228|FG026|Overall Study|Physician Decision|14|||
25112873|NCT02460224|50224229|FG027|Overall Study|Physician Decision|1|||
25112874|NCT02460224|50224230|FG028|Overall Study|Physician Decision|6|||
25112875|NCT02460224|50224202|FG000|Overall Study|Progressive disease|15|||
25112876|NCT02460224|50224203|FG001|Overall Study|Progressive disease|11|||
25112877|NCT02460224|50224204|FG002|Overall Study|Progressive disease|5|||
25112878|NCT02460224|50224205|FG003|Overall Study|Progressive disease|6|||
25112879|NCT02460224|50224206|FG004|Overall Study|Progressive disease|3|||
25112880|NCT02460224|50224207|FG005|Overall Study|Progressive disease|26|||
25112881|NCT02460224|50224208|FG006|Overall Study|Progressive disease|28|||
25112882|NCT02460224|50224209|FG007|Overall Study|Progressive disease|4|||
25112883|NCT02460224|50224210|FG008|Overall Study|Progressive disease|5|||
25112884|NCT02460224|50224211|FG009|Overall Study|Progressive disease|9|||
25112885|NCT02460224|50224212|FG010|Overall Study|Progressive disease|5|||
25112886|NCT02460224|50224213|FG011|Overall Study|Progressive disease|4|||
25112887|NCT02460224|50224214|FG012|Overall Study|Progressive disease|5|||
25112888|NCT02460224|50224215|FG013|Overall Study|Progressive disease|4|||
25112889|NCT02460224|50224216|FG014|Overall Study|Progressive disease|5|||
25112890|NCT02460224|50224217|FG015|Overall Study|Progressive disease|5|||
25112891|NCT02460224|50224218|FG016|Overall Study|Progressive disease|15|||
25112892|NCT02460224|50224219|FG017|Overall Study|Progressive disease|3|||
25112893|NCT02460224|50224220|FG018|Overall Study|Progressive disease|8|||
25112894|NCT02460224|50224221|FG019|Overall Study|Progressive disease|3|||
25112895|NCT02460224|50224222|FG020|Overall Study|Progressive disease|4|||
25112896|NCT02460224|50224223|FG021|Overall Study|Progressive disease|9|||
25112897|NCT02460224|50224224|FG022|Overall Study|Progressive disease|4|||
25112898|NCT02460224|50224225|FG023|Overall Study|Progressive disease|11|||
25112899|NCT02460224|50224226|FG024|Overall Study|Progressive disease|4|||
25112900|NCT02460224|50224227|FG025|Overall Study|Progressive disease|5|||
25112901|NCT02460224|50224228|FG026|Overall Study|Progressive disease|85|||
25112902|NCT02460224|50224229|FG027|Overall Study|Progressive disease|17|||
25112903|NCT02460224|50224230|FG028|Overall Study|Progressive disease|77|||
25112904|NCT02460224|50224202|FG000|Overall Study|Subject/guardian decision|2|||
25112905|NCT02460224|50224203|FG001|Overall Study|Subject/guardian decision|0|||
25112906|NCT02460224|50224204|FG002|Overall Study|Subject/guardian decision|1|||
25112907|NCT02460224|50224205|FG003|Overall Study|Subject/guardian decision|0|||
25112908|NCT02460224|50224206|FG004|Overall Study|Subject/guardian decision|2|||
25112909|NCT02460224|50224207|FG005|Overall Study|Subject/guardian decision|2|||
25112910|NCT02460224|50224208|FG006|Overall Study|Subject/guardian decision|0|||
25112911|NCT02460224|50224209|FG007|Overall Study|Subject/guardian decision|0|||
25112912|NCT02460224|50224210|FG008|Overall Study|Subject/guardian decision|1|||
25112913|NCT02460224|50224211|FG009|Overall Study|Subject/guardian decision|1|||
25112914|NCT02460224|50224212|FG010|Overall Study|Subject/guardian decision|0|||
25112915|NCT02460224|50224213|FG011|Overall Study|Subject/guardian decision|1|||
25112916|NCT02460224|50224214|FG012|Overall Study|Subject/guardian decision|0|||
25112917|NCT02460224|50224215|FG013|Overall Study|Subject/guardian decision|0|||
25112918|NCT02460224|50224216|FG014|Overall Study|Subject/guardian decision|0|||
25112919|NCT02460224|50224217|FG015|Overall Study|Subject/guardian decision|1|||
25112920|NCT02460224|50224218|FG016|Overall Study|Subject/guardian decision|0|||
25112921|NCT02460224|50224219|FG017|Overall Study|Subject/guardian decision|1|||
25112922|NCT02460224|50224220|FG018|Overall Study|Subject/guardian decision|2|||
25112923|NCT02460224|50224221|FG019|Overall Study|Subject/guardian decision|0|||
25112924|NCT02460224|50224222|FG020|Overall Study|Subject/guardian decision|0|||
25112925|NCT02460224|50224223|FG021|Overall Study|Subject/guardian decision|1|||
25112926|NCT02460224|50224224|FG022|Overall Study|Subject/guardian decision|0|||
25112927|NCT02460224|50224225|FG023|Overall Study|Subject/guardian decision|0|||
25112928|NCT02460224|50224226|FG024|Overall Study|Subject/guardian decision|0|||
25112929|NCT02460224|50224227|FG025|Overall Study|Subject/guardian decision|0|||
25112930|NCT02460224|50224228|FG026|Overall Study|Subject/guardian decision|6|||
25112931|NCT02460224|50224229|FG027|Overall Study|Subject/guardian decision|2|||
25112932|NCT02460224|50224230|FG028|Overall Study|Subject/guardian decision|3|||
25112933|NCT02094573|50224304|FG000|Overall Study|Adverse Event|4|||
25112934|NCT02094573|50224305|FG001|Overall Study|Adverse Event|14|||
25112935|NCT02094573|50224304|FG000|Overall Study|Clinical Progressive Disease|9|||
25112936|NCT02094573|50224305|FG001|Overall Study|Clinical Progressive Disease|13|||
25112937|NCT02094573|50224304|FG000|Overall Study|Death|11|||
25112938|NCT02094573|50224305|FG001|Overall Study|Death|3|||
25112939|NCT02094573|50224304|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
25112940|NCT02094573|50224305|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
25112941|NCT02094573|50224304|FG000|Overall Study|Non-compliance with Study Drug|1|||
25112942|NCT02094573|50224305|FG001|Overall Study|Non-compliance with Study Drug|1|||
25112943|NCT02094573|50224304|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
25112944|NCT02094573|50224305|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
25112945|NCT02094573|50224304|FG000|Overall Study|Physician Decision|4|||
25112946|NCT02094573|50224305|FG001|Overall Study|Physician Decision|4|||
25112947|NCT02094573|50224304|FG000|Overall Study|Site Terminated by Sponsor|10|||
25112948|NCT02094573|50224305|FG001|Overall Study|Site Terminated by Sponsor|17|||
25112949|NCT02094573|50224304|FG000|Overall Study|Withdrawal by Subject|6|||
25112950|NCT02094573|50224305|FG001|Overall Study|Withdrawal by Subject|8|||
25112951|NCT02094573|50224304|FG000|Overall Study|Randomized but not Treated|3|||
25112952|NCT02094573|50224305|FG001|Overall Study|Randomized but not Treated|0|||
25112953|NCT01859494|50224311|FG000|Overall Study|Adverse Event|1|||
25112954|NCT01858636|50224315|FG000|Overall Study|No Device Deployment Attempted|24|||
25112955|NCT01858636|50224315|FG000|Overall Study|Physician Decision|1|||
25112956|NCT01858636|50224315|FG000|Overall Study|Death|1|||
25112957|NCT01858636|50224315|FG000|Overall Study|Lost to Follow-up|1|||
25112958|NCT01858636|50224315|FG000|Overall Study|Withdrawal by Subject|1|||
25112959|NCT02058849|50224322|FG000|Overall Study|Hospitalization|1|||
25112960|NCT02058849|50224323|FG001|Overall Study|Hospitalization|1|||
25112961|NCT02058849|50224322|FG000|Overall Study|Death|1|||
25112962|NCT02058849|50224323|FG001|Overall Study|Death|0|||
25112963|NCT02058849|50224322|FG000|Overall Study|Lost to Follow-up|1|||
25112964|NCT02058849|50224323|FG001|Overall Study|Lost to Follow-up|0|||
25008385|NCT03535194|50101308|FG003|Induction Period|Protocol Violation|1|||
25112965|NCT02058849|50224322|FG000|Overall Study|Withdrawal by Subject|4|||
25112966|NCT02058849|50224323|FG001|Overall Study|Withdrawal by Subject|0|||
25112967|NCT01858558|50224331|FG000|Overall Study|Death|1|||
25112968|NCT01858558|50224332|FG001|Overall Study|Death|1|||
25112969|NCT01858558|50224331|FG000|Overall Study|Lost to Follow-up|1|||
25112970|NCT01858558|50224332|FG001|Overall Study|Lost to Follow-up|0|||
25008386|NCT03535194|50101309|FG004|Induction Period|Protocol Violation|0|||
25112971|NCT01858558|50224331|FG000|Overall Study|Disease progression|3|||
25112972|NCT01858558|50224332|FG001|Overall Study|Disease progression|1|||
25112973|NCT01858558|50224331|FG000|Overall Study|Product contamination|2|||
25112974|NCT01858558|50224332|FG001|Overall Study|Product contamination|0|||
25112975|NCT01858558|50224331|FG000|Overall Study|Failed expansion of cell product|2|||
25112976|NCT01858558|50224332|FG001|Overall Study|Failed expansion of cell product|0|||
25112977|NCT02058537|50224338|FG000|Overall Study|Withdrawal by Subject|1|||
25112978|NCT01612000|50224346|FG000|Overall Study|Lost to Follow-up|6|||
25112979|NCT01612000|50224347|FG001|Overall Study|Lost to Follow-up|4|||
25112980|NCT01612000|50224348|FG002|Overall Study|Lost to Follow-up|4|||
25112981|NCT01612000|50224349|FG003|Overall Study|Lost to Follow-up|8|||
25112982|NCT01612000|50224346|FG000|Overall Study|Physician Decision|0|||
25112983|NCT01612000|50224347|FG001|Overall Study|Physician Decision|0|||
25112984|NCT01612000|50224348|FG002|Overall Study|Physician Decision|1|||
25112985|NCT01612000|50224349|FG003|Overall Study|Physician Decision|0|||
25112986|NCT01612000|50224346|FG000|Overall Study|Withdrawal by Subject|3|||
25112987|NCT01612000|50224347|FG001|Overall Study|Withdrawal by Subject|1|||
25112988|NCT01612000|50224348|FG002|Overall Study|Withdrawal by Subject|2|||
25112989|NCT01612000|50224349|FG003|Overall Study|Withdrawal by Subject|2|||
25112990|NCT01895608|50224363|FG000|Overall Study|change in health status|0|||
25112991|NCT01895608|50224364|FG001|Overall Study|change in health status|1|||
25112992|NCT01895608|50224365|FG002|Overall Study|change in health status|1|||
25112993|NCT01895608|50224366|FG003|Overall Study|change in health status|0|||
25112994|NCT01895608|50224363|FG000|Overall Study|Withdrawal by Subject|0|||
25112995|NCT01895608|50224364|FG001|Overall Study|Withdrawal by Subject|0|||
25112996|NCT01895608|50224365|FG002|Overall Study|Withdrawal by Subject|2|||
25112997|NCT01895608|50224366|FG003|Overall Study|Withdrawal by Subject|0|||
25112998|NCT02409680|50224378|FG000|Overall Study|Lost to Follow-up|15|||
25112999|NCT02409680|50224379|FG001|Overall Study|Lost to Follow-up|30|||
25113000|NCT01895452|50224387|FG000|Overall Study|Adverse Event|1|||
25113001|NCT01895452|50224388|FG001|Overall Study|Adverse Event|4|||
25113002|NCT01895452|50224387|FG000|Overall Study|Lost to Follow-up|1|||
25113003|NCT01895452|50224388|FG001|Overall Study|Lost to Follow-up|5|||
25113004|NCT01895452|50224387|FG000|Overall Study|Pregnancy|0|||
25113005|NCT01895452|50224388|FG001|Overall Study|Pregnancy|1|||
25113006|NCT01895452|50224387|FG000|Overall Study|Withdrawal by Subject|2|||
25113007|NCT01895452|50224388|FG001|Overall Study|Withdrawal by Subject|14|||
25113008|NCT01895452|50224387|FG000|Overall Study|Underlying disease|0|||
25113009|NCT01895452|50224388|FG001|Overall Study|Underlying disease|3|||
25113010|NCT01895452|50224387|FG000|Overall Study|Noncompliance with study drug|0|||
25113011|NCT01895452|50224388|FG001|Overall Study|Noncompliance with study drug|1|||
25113012|NCT02094417|50224398|FG000|Overall Study|Adverse Event|0|||
25113013|NCT02094417|50224399|FG001|Overall Study|Adverse Event|0|||
25113014|NCT02094417|50224400|FG002|Overall Study|Adverse Event|0|||
25113015|NCT02094417|50224401|FG003|Overall Study|Adverse Event|1|||
25113016|NCT02094417|50224398|FG000|Overall Study|Eligibility criteria|0|||
25113017|NCT02094417|50224399|FG001|Overall Study|Eligibility criteria|1|||
25113018|NCT02094417|50224400|FG002|Overall Study|Eligibility criteria|0|||
25113019|NCT02094417|50224401|FG003|Overall Study|Eligibility criteria|0|||
25113020|NCT02094417|50224398|FG000|Overall Study|No responder|4|||
25113021|NCT02094417|50224399|FG001|Overall Study|No responder|4|||
25113022|NCT02094417|50224400|FG002|Overall Study|No responder|4|||
25113023|NCT02094417|50224401|FG003|Overall Study|No responder|3|||
25113024|NCT02094417|50224398|FG000|Overall Study|Unable to conduct observations or assess|0|||
25113025|NCT02094417|50224399|FG001|Overall Study|Unable to conduct observations or assess|1|||
25113026|NCT02094417|50224400|FG002|Overall Study|Unable to conduct observations or assess|0|||
25113027|NCT02094417|50224401|FG003|Overall Study|Unable to conduct observations or assess|0|||
25113028|NCT02094417|50224398|FG000|Overall Study|Withdrawal by Subject|1|||
25113029|NCT02094417|50224399|FG001|Overall Study|Withdrawal by Subject|2|||
25113030|NCT02094417|50224400|FG002|Overall Study|Withdrawal by Subject|1|||
25113031|NCT02094417|50224401|FG003|Overall Study|Withdrawal by Subject|3|||
25113032|NCT01894984|50224413|FG000|Overall Study|Other|314|||
25113033|NCT01894984|50224414|FG001|Overall Study|Other|175|||
25113034|NCT02375672|50224420|FG000|Overall Study|remain on follow up|20|||
25113035|NCT01894516|50224428|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
25113036|NCT01894516|50224429|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
25113037|NCT01894516|50224430|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
25113038|NCT01894516|50224431|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
25113039|NCT01894516|50224428|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
25113040|NCT01894516|50224429|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
25113041|NCT01894516|50224430|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
25113042|NCT01894516|50224431|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
25113043|NCT01894516|50224428|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
25113044|NCT01894516|50224429|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
25113045|NCT01894516|50224430|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
25113046|NCT01894516|50224431|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
25113047|NCT01894516|50224428|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
25113048|NCT01894516|50224429|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
25113049|NCT01894516|50224430|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
25113050|NCT01894516|50224431|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
25113051|NCT01894516|50224428|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
25113052|NCT01894516|50224429|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
25113053|NCT01894516|50224430|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
25113054|NCT01894516|50224431|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
25113055|NCT01894516|50224428|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
25113056|NCT01894516|50224429|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
25113057|NCT01894516|50224430|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
25113058|NCT01894516|50224431|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
25113059|NCT01894516|50224428|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
25113060|NCT01894516|50224429|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
25113061|NCT01894516|50224430|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
25113062|NCT01894516|50224431|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
25113063|NCT01894516|50224428|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
25113064|NCT01894516|50224429|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
25113065|NCT01894516|50224430|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
25113066|NCT01894516|50224431|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
25113067|NCT02491463|50224449|FG000|Overall Study|Withdrawal by Subject|1|||
25113068|NCT02491463|50224450|FG001|Overall Study|Withdrawal by Subject|2|||
25113069|NCT02491463|50224451|FG002|Overall Study|Withdrawal by Subject|0|||
25113070|NCT02491463|50224452|FG003|Overall Study|Withdrawal by Subject|0|||
25113071|NCT02491463|50224449|FG000|Overall Study|Migrated/moved from study area|1|||
25113072|NCT02491463|50224450|FG001|Overall Study|Migrated/moved from study area|5|||
25113073|NCT02491463|50224451|FG002|Overall Study|Migrated/moved from study area|1|||
25113074|NCT02491463|50224452|FG003|Overall Study|Migrated/moved from study area|1|||
25113075|NCT02491463|50224449|FG000|Overall Study|Lost to Follow-up|0|||
25113076|NCT02491463|50224450|FG001|Overall Study|Lost to Follow-up|3|||
25113077|NCT02491463|50224451|FG002|Overall Study|Lost to Follow-up|3|||
25113078|NCT02491463|50224452|FG003|Overall Study|Lost to Follow-up|0|||
25113079|NCT02038881|50224465|FG000|Overall Study|Withdrawal by Subject|0|||
25113080|NCT02038881|50224466|FG001|Overall Study|Withdrawal by Subject|0|||
25113081|NCT02038881|50224467|FG002|Overall Study|Withdrawal by Subject|1|||
25113082|NCT02038881|50224465|FG000|Overall Study|Lost to Follow-up|2|||
25113083|NCT02038881|50224466|FG001|Overall Study|Lost to Follow-up|0|||
25113084|NCT02038881|50224467|FG002|Overall Study|Lost to Follow-up|0|||
25113085|NCT02038881|50224465|FG000|Overall Study|incarcerated|1|||
25113086|NCT02038881|50224466|FG001|Overall Study|incarcerated|0|||
25113087|NCT02038881|50224467|FG002|Overall Study|incarcerated|0|||
25113088|NCT01857622|50224480|FG000|Overall Study|Adverse Event|5|||
25113089|NCT01857622|50224481|FG001|Overall Study|Adverse Event|0|||
25113090|NCT01857622|50224482|FG002|Overall Study|Adverse Event|2|||
25113091|NCT01857622|50224480|FG000|Overall Study|Physician Decision|1|||
25113092|NCT01857622|50224481|FG001|Overall Study|Physician Decision|0|||
25113093|NCT01857622|50224482|FG002|Overall Study|Physician Decision|0|||
25113094|NCT01857622|50224480|FG000|Overall Study|Protocol Violation|4|||
25113095|NCT01857622|50224481|FG001|Overall Study|Protocol Violation|1|||
25113096|NCT01857622|50224482|FG002|Overall Study|Protocol Violation|0|||
25113097|NCT01857622|50224480|FG000|Overall Study|Withdrawal by Subject|1|||
25113098|NCT01857622|50224481|FG001|Overall Study|Withdrawal by Subject|0|||
25113099|NCT01857622|50224482|FG002|Overall Study|Withdrawal by Subject|0|||
25113100|NCT01857310|50224492|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
25113101|NCT01857310|50224493|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
25113102|NCT02472353|50224501|FG000|Overall Study|Lost to Follow-up|1|||
25113103|NCT02472353|50224502|FG001|Overall Study|Lost to Follow-up|1|||
25113104|NCT02472353|50224501|FG000|Overall Study|Withdrawal by Subject|2|||
25113105|NCT02472353|50224502|FG001|Overall Study|Withdrawal by Subject|1|||
25113106|NCT02472353|50224501|FG000|Overall Study|Study Termination|1|||
25113107|NCT02472353|50224502|FG001|Overall Study|Study Termination|4|||
25113108|NCT02491073|50224510|FG000|Overall Study|screen failure|1|||
25113109|NCT02491073|50224511|FG001|Overall Study|screen failure|0|||
25113110|NCT02314117|50224535|FG000|Overall Study|Lost to Follow-up|9|||
25113111|NCT02314117|50224536|FG001|Overall Study|Lost to Follow-up|14|||
25113112|NCT02314117|50224535|FG000|Overall Study|Withdrawal by Subject|3|||
25113113|NCT02314117|50224536|FG001|Overall Study|Withdrawal by Subject|2|||
25113114|NCT01893346|50224547|FG000|Overall Study|Lost to Follow-up|0|||
25113115|NCT01893346|50224548|FG001|Overall Study|Lost to Follow-up|1|||
25113116|NCT01893346|50224549|FG002|Overall Study|Lost to Follow-up|0|||
25261383|NCT01001767|50576127|FG001|Overall Study|Lost to Follow-up|0|||
25261384|NCT01001767|50576126|FG000|Overall Study|Physician Decision|1|||
25261385|NCT01001767|50576127|FG001|Overall Study|Physician Decision|0|||
25113117|NCT01893346|50224550|FG003|Overall Study|Lost to Follow-up|0|||
25113118|NCT01893346|50224547|FG000|Overall Study|Protocol Violation|1|||
25113119|NCT01893346|50224548|FG001|Overall Study|Protocol Violation|0|||
25113120|NCT01893346|50224549|FG002|Overall Study|Protocol Violation|0|||
25113121|NCT01893346|50224550|FG003|Overall Study|Protocol Violation|0|||
25113122|NCT01893346|50224547|FG000|Overall Study|Withdrawal by Subject|2|||
25113123|NCT01893346|50224548|FG001|Overall Study|Withdrawal by Subject|0|||
25113124|NCT01893346|50224549|FG002|Overall Study|Withdrawal by Subject|0|||
25113125|NCT01893346|50224550|FG003|Overall Study|Withdrawal by Subject|0|||
25113126|NCT02490371|50224562|FG000|Overall Study|Lost to Follow-up|1|||
25113127|NCT02490371|50224563|FG001|Overall Study|Lost to Follow-up|1|||
25113128|NCT01856686|50224571|FG000|Overall Study|Lost to Follow-up|5|||
25113129|NCT01856686|50224572|FG001|Overall Study|Lost to Follow-up|11|||
25113130|NCT02058147|50224581|FG000|Overall Study|Randomized but not treated|0|||
25113131|NCT02058147|50224582|FG001|Overall Study|Randomized but not treated|0|||
25113132|NCT02058147|50224583|FG002|Overall Study|Randomized but not treated|1|||
25113133|NCT02058147|50224581|FG000|Overall Study|Adverse Event|12|||
25113134|NCT02058147|50224582|FG001|Overall Study|Adverse Event|9|||
25113135|NCT02058147|50224583|FG002|Overall Study|Adverse Event|21|||
25113136|NCT02058147|50224581|FG000|Overall Study|Lack of Efficacy|1|||
25113137|NCT02058147|50224582|FG001|Overall Study|Lack of Efficacy|0|||
25113138|NCT02058147|50224583|FG002|Overall Study|Lack of Efficacy|3|||
25113139|NCT02058147|50224581|FG000|Overall Study|Poor compliance to protocol|8|||
25113140|NCT02058147|50224582|FG001|Overall Study|Poor compliance to protocol|9|||
25113141|NCT02058147|50224583|FG002|Overall Study|Poor compliance to protocol|4|||
25113142|NCT02058147|50224581|FG000|Overall Study|Other than specified|8|||
25113143|NCT02058147|50224582|FG001|Overall Study|Other than specified|9|||
25113144|NCT02058147|50224583|FG002|Overall Study|Other than specified|0|||
25113145|NCT02489981|50224591|FG000|Overall Study|Adverse Event|21|||
25113146|NCT02489981|50224591|FG000|Overall Study|Insufficient effectiveness|16|||
25113147|NCT02489981|50224591|FG000|Overall Study|Improved|31|||
25113148|NCT02489981|50224591|FG000|Overall Study|Lost to Follow-up|31|||
25113149|NCT02489981|50224591|FG000|Overall Study|Other than listed|28|||
25113150|NCT02471183|50224595|FG000|Main Treatment Period|Adverse Event|1|||
25113151|NCT02471183|50224595|FG000|Main Treatment Period|Withdrawal by Subject|1|||
25113152|NCT02471183|50224595|FG000|Extended Treatment Period|Lack of Efficacy|1|||
25113153|NCT01855828|50224599|FG000|Overall Study|Adverse Event|1|||
25113154|NCT01855828|50224599|FG000|Overall Study|Withdrawal by Subject|1|||
25113155|NCT02489279|50224610|FG000|Overall Study|Lost to Follow-up|12|||
25113156|NCT02489279|50224611|FG001|Overall Study|Lost to Follow-up|10|||
25113157|NCT02489045|50224617|FG000|Overall Study|unable to collect usable data|53|||
25113158|NCT02489045|50224617|FG000|Follow-up|Lost to Follow-up|10|||
25113159|NCT02488109|50224623|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
25113160|NCT02488109|50224624|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
25113161|NCT02488109|50224623|FG000|12-month Follow-Up|Lost to Follow-up|4|||
25113162|NCT02488109|50224624|FG001|12-month Follow-Up|Lost to Follow-up|7|||
25113163|NCT02351167|50224635|FG000|Overall Study|Withdrawal by Subject|19|||
25113164|NCT02351167|50224636|FG001|Overall Study|Withdrawal by Subject|18|||
25113165|NCT02351167|50224637|FG002|Overall Study|Withdrawal by Subject|21|||
25113166|NCT02350309|50224652|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
25113167|NCT02350309|50224653|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
25113168|NCT02350309|50224654|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
25113169|NCT02350309|50224655|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
25113170|NCT02350309|50224656|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
25113171|NCT02350309|50224657|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
25113172|NCT02350309|50224652|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
25113173|NCT02350309|50224653|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
25113174|NCT02350309|50224654|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
25113175|NCT02350309|50224655|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
25113176|NCT02350309|50224656|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
25113177|NCT02350309|50224657|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
25113178|NCT02038647|50224674|FG000|Overall Study|Progressive Disease|50|||
25113179|NCT02038647|50224675|FG001|Overall Study|Progressive Disease|59|||
25113180|NCT02038647|50224674|FG000|Overall Study|Adverse Event|18|||
25113181|NCT02038647|50224675|FG001|Overall Study|Adverse Event|10|||
25113182|NCT02038647|50224674|FG000|Overall Study|Symptomatic Deterioration|7|||
25113183|NCT02038647|50224675|FG001|Overall Study|Symptomatic Deterioration|7|||
25113184|NCT02038647|50224674|FG000|Overall Study|Withdrawal by Subject|5|||
25113185|NCT02038647|50224675|FG001|Overall Study|Withdrawal by Subject|2|||
25113186|NCT02038647|50224674|FG000|Overall Study|Not Reported|0|||
25113187|NCT02038647|50224675|FG001|Overall Study|Not Reported|1|||
25113188|NCT02038647|50224674|FG000|Overall Study|Ongoing at Datacut|9|||
25113189|NCT02038647|50224675|FG001|Overall Study|Ongoing at Datacut|10|||
25113190|NCT02058069|50224681|FG000|Overall Study|Exclusion due to implant size|5|||
25113191|NCT02058069|50224681|FG000|Overall Study|Withdrawal by Subject|6|||
25113192|NCT02057835|50224695|FG000|Overall Study|Withdrawal by Subject|0|||
25113193|NCT02057835|50224696|FG001|Overall Study|Withdrawal by Subject|2|||
25113194|NCT02057835|50224697|FG002|Overall Study|Withdrawal by Subject|0|||
25113195|NCT02057835|50224698|FG003|Overall Study|Withdrawal by Subject|0|||
25113196|NCT02057835|50224699|FG004|Overall Study|Withdrawal by Subject|0|||
25113197|NCT02057835|50224700|FG005|Overall Study|Withdrawal by Subject|0|||
25113198|NCT02057835|50224701|FG006|Overall Study|Withdrawal by Subject|0|||
25113199|NCT02057835|50224702|FG007|Overall Study|Withdrawal by Subject|0|||
25113200|NCT02057835|50224703|FG008|Overall Study|Withdrawal by Subject|0|||
25113201|NCT02057835|50224704|FG009|Overall Study|Withdrawal by Subject|0|||
25113202|NCT02057757|50224735|FG000|Overall Study|Withdrawal by Subject|3|||
25113203|NCT02057757|50224736|FG001|Overall Study|Withdrawal by Subject|5|||
25113204|NCT02057757|50224735|FG000|Overall Study|Death|2|||
25113205|NCT02057757|50224736|FG001|Overall Study|Death|0|||
25113206|NCT02057757|50224735|FG000|Overall Study|Lost to Follow-up|8|||
25113207|NCT02057757|50224736|FG001|Overall Study|Lost to Follow-up|3|||
25113208|NCT02057757|50224735|FG000|Overall Study|Non-compliance|1|||
25113209|NCT02057757|50224736|FG001|Overall Study|Non-compliance|0|||
25113210|NCT02037477|50224750|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
25113211|NCT02037477|50224751|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
25113212|NCT02037477|50224752|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
25113213|NCT02037477|50224753|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
25113214|NCT02057523|50224763|FG000|Overall Study|Withdrawal by Subject|1|||
25113215|NCT02057523|50224763|FG000|Overall Study|Lack of Efficacy|1|||
25113216|NCT02037165|50224772|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
25113217|NCT02037165|50224773|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
25113218|NCT02037165|50224774|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
25113219|NCT02037165|50224775|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
25113220|NCT02037165|50224776|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
25113221|NCT02470403|50224797|FG000|Overall Study|Adverse Event|1|||
25113222|NCT02470403|50224798|FG001|Overall Study|Adverse Event|0|||
25113223|NCT02470403|50224799|FG002|Overall Study|Adverse Event|0|||
25113224|NCT02470403|50224800|FG003|Overall Study|Adverse Event|0|||
25113225|NCT02470403|50224801|FG004|Overall Study|Adverse Event|0|||
25113226|NCT02470403|50224797|FG000|Overall Study|Lost to Follow-up|0|||
25113227|NCT02470403|50224798|FG001|Overall Study|Lost to Follow-up|1|||
25113228|NCT02470403|50224799|FG002|Overall Study|Lost to Follow-up|0|||
25113229|NCT02470403|50224800|FG003|Overall Study|Lost to Follow-up|0|||
25113230|NCT02470403|50224801|FG004|Overall Study|Lost to Follow-up|0|||
25113231|NCT02470403|50224797|FG000|Overall Study|Subject/guardian decision|1|||
25113232|NCT02470403|50224798|FG001|Overall Study|Subject/guardian decision|0|||
25113233|NCT02470403|50224799|FG002|Overall Study|Subject/guardian decision|0|||
25113234|NCT02470403|50224800|FG003|Overall Study|Subject/guardian decision|4|||
25113235|NCT02470403|50224801|FG004|Overall Study|Subject/guardian decision|0|||
25113236|NCT01855750|50224818|FG000|Overall Study|Death|78|||
25113237|NCT01855750|50224819|FG001|Overall Study|Death|78|||
25113238|NCT01855750|50224818|FG000|Overall Study|Lost to Follow-up|9|||
25113239|NCT01855750|50224819|FG001|Overall Study|Lost to Follow-up|23|||
25113240|NCT01855750|50224818|FG000|Overall Study|Withdrawal by Subject|35|||
25113241|NCT01855750|50224819|FG001|Overall Study|Withdrawal by Subject|28|||
25113242|NCT01855750|50224818|FG000|Overall Study|Sponsor ends the study|297|||
25113243|NCT01855750|50224819|FG001|Overall Study|Sponsor ends the study|290|||
25113244|NCT01855126|50224827|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
25113245|NCT01855126|50224828|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
25113246|NCT01855126|50224827|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
25113247|NCT01855126|50224828|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
25113248|NCT01622673|50224844|FG000|Treatment Period 1|Withdrawal by Subject|0|||
25113249|NCT01622673|50224845|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25113250|NCT01622673|50224846|FG002|Treatment Period 1|Withdrawal by Subject|0|||
25113251|NCT01622673|50224847|FG003|Treatment Period 1|Withdrawal by Subject|1|||
25113252|NCT01622673|50224848|FG004|Treatment Period 1|Withdrawal by Subject|0|||
25113253|NCT01622673|50224849|FG005|Treatment Period 1|Withdrawal by Subject|0|||
25113254|NCT01622673|50224844|FG000|Treatment Period 1|Protocol Violation|0|||
25113255|NCT01622673|50224845|FG001|Treatment Period 1|Protocol Violation|1|||
25113256|NCT01622673|50224846|FG002|Treatment Period 1|Protocol Violation|0|||
25113257|NCT01622673|50224847|FG003|Treatment Period 1|Protocol Violation|0|||
25113258|NCT01622673|50224848|FG004|Treatment Period 1|Protocol Violation|0|||
25113259|NCT01622673|50224849|FG005|Treatment Period 1|Protocol Violation|0|||
25113260|NCT01622673|50224844|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25113261|NCT01622673|50224845|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25113262|NCT01622673|50224846|FG002|Treatment Period 2|Withdrawal by Subject|0|||
25113263|NCT01622673|50224847|FG003|Treatment Period 2|Withdrawal by Subject|1|||
25113264|NCT01622673|50224848|FG004|Treatment Period 2|Withdrawal by Subject|0|||
25113265|NCT01622673|50224849|FG005|Treatment Period 2|Withdrawal by Subject|0|||
25177403|NCT02754141|50321516|FG009|Overall Study|Withdrew consent|1|||
25177404|NCT02754141|50321517|FG010|Overall Study|Withdrew consent|0|||
25261386|NCT01306032|50576139|FG000|First Intervention|Adverse Event|1|||
25261387|NCT01306032|50576140|FG001|First Intervention|Adverse Event|0|||
25113266|NCT01622673|50224844|FG000|Treatment Period 3|Protocol Violation|0|||
25113267|NCT01622673|50224845|FG001|Treatment Period 3|Protocol Violation|1|||
25177405|NCT02754141|50321518|FG011|Overall Study|Withdrew consent|0|||
25113268|NCT01622673|50224846|FG002|Treatment Period 3|Protocol Violation|0|||
25113269|NCT01622673|50224847|FG003|Treatment Period 3|Protocol Violation|0|||
25113270|NCT01622673|50224848|FG004|Treatment Period 3|Protocol Violation|0|||
25113271|NCT01622673|50224849|FG005|Treatment Period 3|Protocol Violation|0|||
25113272|NCT01855048|50224874|FG000|Overall Study|Withdrawal by Subject|0|||
25113273|NCT01855048|50224875|FG001|Overall Study|Withdrawal by Subject|1|||
25113274|NCT01855048|50224876|FG002|Overall Study|Withdrawal by Subject|0|||
25113275|NCT01855048|50224877|FG003|Overall Study|Withdrawal by Subject|0|||
25113276|NCT01855048|50224878|FG004|Overall Study|Withdrawal by Subject|1|||
25113277|NCT01855048|50224879|FG005|Overall Study|Withdrawal by Subject|0|||
25113278|NCT02469857|50224905|FG000|Overall Study|Death|24|||
25113279|NCT02469857|50224906|FG001|Overall Study|Death|29|||
25113280|NCT02469857|50224905|FG000|Overall Study|Discontinuation|1|||
25113281|NCT02469857|50224906|FG001|Overall Study|Discontinuation|3|||
25113282|NCT02036853|50224916|FG000|Overall Study|Adverse Event|0|||
25113283|NCT02036853|50224917|FG001|Overall Study|Adverse Event|2|||
25113284|NCT02036853|50224916|FG000|Overall Study|Lack of Efficacy|0|||
25113285|NCT02036853|50224917|FG001|Overall Study|Lack of Efficacy|2|||
25113286|NCT02036853|50224916|FG000|Overall Study|Physician Decision|0|||
25113287|NCT02036853|50224917|FG001|Overall Study|Physician Decision|1|||
25113288|NCT02036853|50224916|FG000|Overall Study|Withdrawal by Subject|0|||
25113289|NCT02036853|50224917|FG001|Overall Study|Withdrawal by Subject|1|||
25113290|NCT02469623|50224923|FG000|Overall Study|Not consented for long-term follow-up|4|||
25113291|NCT02469623|50224923|FG000|Overall Study|Lost to Follow-up|4|||
25113292|NCT02469623|50224923|FG000|Overall Study|Withdrawal by Subject|2|||
25113293|NCT02469623|50224923|FG000|Overall Study|Death|3|||
25113294|NCT02469077|50224930|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
25113295|NCT02469077|50224931|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
25113296|NCT02469077|50224930|FG000|Post Randomization/Intervention Period|Relocated|1|||
25113297|NCT02469077|50224931|FG001|Post Randomization/Intervention Period|Relocated|1|||
25113298|NCT02469077|50224930|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
25113299|NCT02469077|50224931|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
25113300|NCT02469077|50224930|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
25113301|NCT02469077|50224931|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
25113302|NCT02486627|50224943|FG000|Overall Study|Death|1|||
25113303|NCT02486627|50224944|FG001|Overall Study|Death|0|||
25113304|NCT02486627|50224943|FG000|Overall Study|Other Unspecified|0|||
25113305|NCT02486627|50224944|FG001|Overall Study|Other Unspecified|2|||
25113306|NCT02486627|50224943|FG000|Overall Study|Consent Withdrawn by Participant|4|||
25113307|NCT02486627|50224944|FG001|Overall Study|Consent Withdrawn by Participant|3|||
25113308|NCT02486627|50224943|FG000|Overall Study|Significant Participant Noncompliance|1|||
25113309|NCT02486627|50224944|FG001|Overall Study|Significant Participant Noncompliance|1|||
25113310|NCT02486627|50224943|FG000|Overall Study|Lost to Follow-up|1|||
25113311|NCT02486627|50224944|FG001|Overall Study|Lost to Follow-up|3|||
25113312|NCT01644565|50224950|FG000|Overall Study|Undisclosed Medical History|1|||
25113313|NCT01644565|50224951|FG001|Overall Study|Undisclosed Medical History|0|||
25113314|NCT01644565|50224952|FG002|Overall Study|Undisclosed Medical History|0|||
25113315|NCT01644565|50224953|FG003|Overall Study|Undisclosed Medical History|0|||
25113316|NCT01644565|50224954|FG004|Overall Study|Undisclosed Medical History|0|||
25113317|NCT01644565|50224955|FG005|Overall Study|Undisclosed Medical History|0|||
25113318|NCT01644565|50224956|FG006|Overall Study|Undisclosed Medical History|0|||
25113319|NCT01644565|50224957|FG007|Overall Study|Undisclosed Medical History|0|||
25113320|NCT01644565|50224958|FG008|Overall Study|Undisclosed Medical History|0|||
25113321|NCT01644565|50224950|FG000|Overall Study|Lost to Follow-up|0|||
25113322|NCT01644565|50224951|FG001|Overall Study|Lost to Follow-up|0|||
25113323|NCT01644565|50224952|FG002|Overall Study|Lost to Follow-up|0|||
25113324|NCT01644565|50224953|FG003|Overall Study|Lost to Follow-up|1|||
25113325|NCT01644565|50224954|FG004|Overall Study|Lost to Follow-up|0|||
25113326|NCT01644565|50224955|FG005|Overall Study|Lost to Follow-up|0|||
25113327|NCT01644565|50224956|FG006|Overall Study|Lost to Follow-up|0|||
25113328|NCT01644565|50224957|FG007|Overall Study|Lost to Follow-up|2|||
25113329|NCT01644565|50224958|FG008|Overall Study|Lost to Follow-up|0|||
25113330|NCT01644565|50224950|FG000|Overall Study|Family emergency|0|||
25113331|NCT01644565|50224951|FG001|Overall Study|Family emergency|0|||
25113332|NCT01644565|50224952|FG002|Overall Study|Family emergency|0|||
25113333|NCT01644565|50224953|FG003|Overall Study|Family emergency|0|||
25113334|NCT01644565|50224954|FG004|Overall Study|Family emergency|1|||
25113335|NCT01644565|50224955|FG005|Overall Study|Family emergency|0|||
25113336|NCT01644565|50224956|FG006|Overall Study|Family emergency|0|||
25113337|NCT01644565|50224957|FG007|Overall Study|Family emergency|0|||
25113338|NCT01644565|50224958|FG008|Overall Study|Family emergency|0|||
25113339|NCT01644565|50224950|FG000|Overall Study|Relocation|0|||
25113340|NCT01644565|50224951|FG001|Overall Study|Relocation|0|||
25113341|NCT01644565|50224952|FG002|Overall Study|Relocation|0|||
25113342|NCT01644565|50224953|FG003|Overall Study|Relocation|0|||
25113343|NCT01644565|50224954|FG004|Overall Study|Relocation|0|||
25113344|NCT01644565|50224955|FG005|Overall Study|Relocation|0|||
25113345|NCT01644565|50224956|FG006|Overall Study|Relocation|0|||
25113346|NCT01644565|50224957|FG007|Overall Study|Relocation|0|||
25113347|NCT01644565|50224958|FG008|Overall Study|Relocation|1|||
25113348|NCT02485925|50224978|FG000|Overall Study|Withdrawal by Subject|3|||
25113349|NCT02485925|50224978|FG000|Overall Study|Death|1|||
25113350|NCT02485925|50224978|FG000|Overall Study|Lost to Follow-up|11|||
25113351|NCT02282293|50224984|FG000|Overall Study|Lost to Follow-up|2|||
25113352|NCT02282293|50224985|FG001|Overall Study|Lost to Follow-up|2|||
25113353|NCT02282293|50224984|FG000|Overall Study|Unable to comply with study procedures|1|||
25113354|NCT02282293|50224985|FG001|Overall Study|Unable to comply with study procedures|0|||
25113355|NCT02282293|50224984|FG000|Overall Study|Moved out of study area|0|||
25113356|NCT02282293|50224985|FG001|Overall Study|Moved out of study area|1|||
25113357|NCT01854658|50224995|FG000|Overall Study|Protocol Violation|6|||
25113358|NCT01854658|50224996|FG001|Overall Study|Protocol Violation|2|||
25113359|NCT01854658|50224997|FG002|Overall Study|Protocol Violation|2|||
25113360|NCT01854658|50224998|FG003|Overall Study|Protocol Violation|1|||
25113361|NCT01854658|50224995|FG000|Overall Study|Physician Decision|7|||
25113362|NCT01854658|50224996|FG001|Overall Study|Physician Decision|5|||
25113363|NCT01854658|50224997|FG002|Overall Study|Physician Decision|2|||
25113364|NCT01854658|50224998|FG003|Overall Study|Physician Decision|4|||
25113365|NCT01854658|50224995|FG000|Overall Study|Lost to Follow-up|8|||
25113366|NCT01854658|50224996|FG001|Overall Study|Lost to Follow-up|9|||
25113367|NCT01854658|50224997|FG002|Overall Study|Lost to Follow-up|8|||
25113368|NCT01854658|50224998|FG003|Overall Study|Lost to Follow-up|4|||
25113369|NCT01854658|50224995|FG000|Overall Study|Withdrawal by Subject|28|||
25113370|NCT01854658|50224996|FG001|Overall Study|Withdrawal by Subject|21|||
25113371|NCT01854658|50224997|FG002|Overall Study|Withdrawal by Subject|29|||
25113372|NCT01854658|50224998|FG003|Overall Study|Withdrawal by Subject|15|||
25113373|NCT01854658|50224995|FG000|Overall Study|Protocol-specified criteria|15|||
25113374|NCT01854658|50224996|FG001|Overall Study|Protocol-specified criteria|15|||
25113375|NCT01854658|50224997|FG002|Overall Study|Protocol-specified criteria|10|||
25113376|NCT01854658|50224998|FG003|Overall Study|Protocol-specified criteria|7|||
25113377|NCT01854658|50224995|FG000|Overall Study|Lack of Efficacy|3|||
25113378|NCT01854658|50224996|FG001|Overall Study|Lack of Efficacy|8|||
25113379|NCT01854658|50224997|FG002|Overall Study|Lack of Efficacy|4|||
25113380|NCT01854658|50224998|FG003|Overall Study|Lack of Efficacy|7|||
25113381|NCT01854658|50224995|FG000|Overall Study|Adverse Event|21|||
25113382|NCT01854658|50224996|FG001|Overall Study|Adverse Event|14|||
25113383|NCT01854658|50224997|FG002|Overall Study|Adverse Event|23|||
25113384|NCT01854658|50224998|FG003|Overall Study|Adverse Event|19|||
25113385|NCT01854658|50224995|FG000|Overall Study|Administrative reasons|5|||
25113386|NCT01854658|50224996|FG001|Overall Study|Administrative reasons|1|||
25113387|NCT01854658|50224997|FG002|Overall Study|Administrative reasons|2|||
25113388|NCT01854658|50224998|FG003|Overall Study|Administrative reasons|2|||
25113389|NCT01892020|50225008|FG000|Period 1|Adverse Event|1|||
25113390|NCT01892020|50225009|FG001|Period 1|Adverse Event|1|||
25113391|NCT01892020|50225008|FG000|Period 1|Protocol Violation|2|||
25113392|NCT01892020|50225009|FG001|Period 1|Protocol Violation|4|||
25113393|NCT01892020|50225008|FG000|Period 1|Unclassified|0|||
25113394|NCT01892020|50225009|FG001|Period 1|Unclassified|1|||
25113395|NCT01892020|50225008|FG000|Period 2|Protocol Violation|1|||
25113396|NCT01892020|50225009|FG001|Period 2|Protocol Violation|0|||
25113397|NCT02485691|50225017|FG000|Overall Study|Adverse Event|25|||
25113398|NCT02485691|50225018|FG001|Overall Study|Adverse Event|11|||
25113399|NCT02485691|50225017|FG000|Overall Study|Poor compliance to protocol|0|||
25113400|NCT02485691|50225018|FG001|Overall Study|Poor compliance to protocol|1|||
25113401|NCT02485691|50225017|FG000|Overall Study|Disease progression|57|||
25113402|NCT02485691|50225018|FG001|Overall Study|Disease progression|92|||
25113403|NCT02485691|50225017|FG000|Overall Study|Investigator's decision|23|||
25113404|NCT02485691|50225018|FG001|Overall Study|Investigator's decision|5|||
25113405|NCT02485691|50225017|FG000|Overall Study|Participant's request|13|||
25113406|NCT02485691|50225018|FG001|Overall Study|Participant's request|6|||
25113407|NCT02485691|50225017|FG000|Overall Study|Other reason|8|||
25113408|NCT02485691|50225018|FG001|Overall Study|Other reason|9|||
25113409|NCT02485691|50225017|FG000|Overall Study|Randomized and not treated|3|||
25113410|NCT02485691|50225018|FG001|Overall Study|Randomized and not treated|2|||
25113411|NCT02517515|50225027|FG000|Overall Study|Adverse Event|0|||
25113412|NCT02517515|50225028|FG001|Overall Study|Adverse Event|1|||
25113413|NCT02517515|50225027|FG000|Overall Study|Withdrew Consent|0|||
25113414|NCT02517515|50225028|FG001|Overall Study|Withdrew Consent|1|||
25113415|NCT02517515|50225027|FG000|Overall Study|Lost to Follow-up|1|||
25113416|NCT02517515|50225028|FG001|Overall Study|Lost to Follow-up|0|||
25008387|NCT03535194|50101305|FG000|Induction Period|Screen Failure|0|||
25008388|NCT03535194|50101306|FG001|Induction Period|Screen Failure|1|||
25113417|NCT02517515|50225027|FG000|Overall Study|Other|1|||
25113418|NCT02517515|50225028|FG001|Overall Study|Other|0|||
25113419|NCT02466659|50225037|FG000|Overall Study|Lost to Follow-up|5|||
25113420|NCT02466659|50225038|FG001|Overall Study|Lost to Follow-up|2|||
25113421|NCT01891864|50225046|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
25113422|NCT01891864|50225047|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
25113423|NCT01891864|50225048|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
25113424|NCT01891864|50225049|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
25113425|NCT01891864|50225050|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
25113426|NCT01891864|50225051|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
25113427|NCT01891864|50225046|FG000|Treatment Period 1|Physician Decision|0|||
25113428|NCT01891864|50225047|FG001|Treatment Period 1|Physician Decision|1|||
25113429|NCT01891864|50225048|FG002|Treatment Period 1|Physician Decision|0|||
25113430|NCT01891864|50225049|FG003|Treatment Period 1|Physician Decision|0|||
25113431|NCT01891864|50225050|FG004|Treatment Period 1|Physician Decision|0|||
25113432|NCT01891864|50225051|FG005|Treatment Period 1|Physician Decision|0|||
25113433|NCT01891864|50225046|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
25113434|NCT01891864|50225047|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
25113435|NCT01891864|50225048|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
25113436|NCT01891864|50225049|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
25113437|NCT01891864|50225050|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
25113438|NCT01891864|50225051|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
25113439|NCT01891864|50225046|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
25113440|NCT01891864|50225047|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
25113441|NCT01891864|50225048|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
25113442|NCT01891864|50225049|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
25113443|NCT01891864|50225050|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
25113444|NCT01891864|50225051|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
25113445|NCT01891864|50225046|FG000|Treatment Period 1|Withdrawal by Subject|2|||
25113446|NCT01891864|50225047|FG001|Treatment Period 1|Withdrawal by Subject|5|||
25113447|NCT01891864|50225048|FG002|Treatment Period 1|Withdrawal by Subject|0|||
25113448|NCT01891864|50225049|FG003|Treatment Period 1|Withdrawal by Subject|0|||
25113449|NCT01891864|50225050|FG004|Treatment Period 1|Withdrawal by Subject|0|||
25113450|NCT01891864|50225051|FG005|Treatment Period 1|Withdrawal by Subject|0|||
25113451|NCT01891864|50225046|FG000|Treatment Period 1|Lost to Follow-up|1|||
25113452|NCT01891864|50225047|FG001|Treatment Period 1|Lost to Follow-up|0|||
25113453|NCT01891864|50225048|FG002|Treatment Period 1|Lost to Follow-up|0|||
25113454|NCT01891864|50225049|FG003|Treatment Period 1|Lost to Follow-up|0|||
25113455|NCT01891864|50225050|FG004|Treatment Period 1|Lost to Follow-up|0|||
25113456|NCT01891864|50225051|FG005|Treatment Period 1|Lost to Follow-up|0|||
25113457|NCT01891864|50225046|FG000|Treatment Period 2|Protocol Violation|0|||
25113458|NCT01891864|50225047|FG001|Treatment Period 2|Protocol Violation|0|||
25113459|NCT01891864|50225048|FG002|Treatment Period 2|Protocol Violation|0|||
25113460|NCT01891864|50225049|FG003|Treatment Period 2|Protocol Violation|1|||
25113461|NCT01891864|50225050|FG004|Treatment Period 2|Protocol Violation|0|||
25113462|NCT01891864|50225051|FG005|Treatment Period 2|Protocol Violation|0|||
25113463|NCT01891864|50225046|FG000|Treatment Period 2|Physician Decision|0|||
25113464|NCT01891864|50225047|FG001|Treatment Period 2|Physician Decision|0|||
25113465|NCT01891864|50225048|FG002|Treatment Period 2|Physician Decision|1|||
25113466|NCT01891864|50225049|FG003|Treatment Period 2|Physician Decision|0|||
25113467|NCT01891864|50225050|FG004|Treatment Period 2|Physician Decision|0|||
25113468|NCT01891864|50225051|FG005|Treatment Period 2|Physician Decision|0|||
25113469|NCT01891864|50225046|FG000|Treatment Period 2|Site Termination|0|||
25113470|NCT01891864|50225047|FG001|Treatment Period 2|Site Termination|0|||
25113471|NCT01891864|50225048|FG002|Treatment Period 2|Site Termination|1|||
25113472|NCT01891864|50225049|FG003|Treatment Period 2|Site Termination|2|||
25113473|NCT01891864|50225050|FG004|Treatment Period 2|Site Termination|0|||
25113474|NCT01891864|50225051|FG005|Treatment Period 2|Site Termination|0|||
25113475|NCT01891864|50225046|FG000|Treatment Period 2|Lack of Efficacy|0|||
25113476|NCT01891864|50225047|FG001|Treatment Period 2|Lack of Efficacy|0|||
25113477|NCT01891864|50225048|FG002|Treatment Period 2|Lack of Efficacy|1|||
25113478|NCT01891864|50225049|FG003|Treatment Period 2|Lack of Efficacy|0|||
25113479|NCT01891864|50225050|FG004|Treatment Period 2|Lack of Efficacy|1|||
25113480|NCT01891864|50225051|FG005|Treatment Period 2|Lack of Efficacy|0|||
25113481|NCT01891864|50225046|FG000|Treatment Period 2|Adverse Event|0|||
25113482|NCT01891864|50225047|FG001|Treatment Period 2|Adverse Event|0|||
25113483|NCT01891864|50225048|FG002|Treatment Period 2|Adverse Event|1|||
25113484|NCT01891864|50225049|FG003|Treatment Period 2|Adverse Event|2|||
25113485|NCT01891864|50225050|FG004|Treatment Period 2|Adverse Event|0|||
25113486|NCT01891864|50225051|FG005|Treatment Period 2|Adverse Event|4|||
25113487|NCT01891864|50225046|FG000|Treatment Period 2|Termination of Site|0|||
25113488|NCT01891864|50225047|FG001|Treatment Period 2|Termination of Site|0|||
25113489|NCT01891864|50225048|FG002|Treatment Period 2|Termination of Site|0|||
25113490|NCT01891864|50225049|FG003|Treatment Period 2|Termination of Site|0|||
25113491|NCT01891864|50225050|FG004|Treatment Period 2|Termination of Site|2|||
25113492|NCT01891864|50225051|FG005|Treatment Period 2|Termination of Site|0|||
25113493|NCT01891864|50225046|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25113494|NCT01891864|50225047|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25113495|NCT01891864|50225048|FG002|Treatment Period 2|Withdrawal by Subject|3|||
25113496|NCT01891864|50225049|FG003|Treatment Period 2|Withdrawal by Subject|4|||
25113497|NCT01891864|50225050|FG004|Treatment Period 2|Withdrawal by Subject|1|||
25113498|NCT01891864|50225051|FG005|Treatment Period 2|Withdrawal by Subject|1|||
25113499|NCT01891864|50225046|FG000|Extension Period|Lack of Efficacy|0|||
25113500|NCT01891864|50225047|FG001|Extension Period|Lack of Efficacy|0|||
25113501|NCT01891864|50225048|FG002|Extension Period|Lack of Efficacy|0|||
25113502|NCT01891864|50225049|FG003|Extension Period|Lack of Efficacy|1|||
25113503|NCT01891864|50225050|FG004|Extension Period|Lack of Efficacy|1|||
25113504|NCT01891864|50225051|FG005|Extension Period|Lack of Efficacy|0|||
25113505|NCT01891864|50225046|FG000|Extension Period|Pregnancy|0|||
25113506|NCT01891864|50225047|FG001|Extension Period|Pregnancy|0|||
25113507|NCT01891864|50225048|FG002|Extension Period|Pregnancy|1|||
25113508|NCT01891864|50225049|FG003|Extension Period|Pregnancy|0|||
25113509|NCT01891864|50225050|FG004|Extension Period|Pregnancy|0|||
25113510|NCT01891864|50225051|FG005|Extension Period|Pregnancy|0|||
25113511|NCT01891864|50225046|FG000|Extension Period|Adverse Event|0|||
25113512|NCT01891864|50225047|FG001|Extension Period|Adverse Event|0|||
25113513|NCT01891864|50225048|FG002|Extension Period|Adverse Event|4|||
25113514|NCT01891864|50225049|FG003|Extension Period|Adverse Event|2|||
25113515|NCT01891864|50225050|FG004|Extension Period|Adverse Event|2|||
25113516|NCT01891864|50225051|FG005|Extension Period|Adverse Event|0|||
25113517|NCT01891864|50225046|FG000|Extension Period|Withdrawal by Subject|0|||
25113518|NCT01891864|50225047|FG001|Extension Period|Withdrawal by Subject|0|||
25113519|NCT01891864|50225048|FG002|Extension Period|Withdrawal by Subject|1|||
25113520|NCT01891864|50225049|FG003|Extension Period|Withdrawal by Subject|2|||
25113521|NCT01891864|50225050|FG004|Extension Period|Withdrawal by Subject|4|||
25113522|NCT01891864|50225051|FG005|Extension Period|Withdrawal by Subject|0|||
25113523|NCT01891864|50225046|FG000|Extension Period|Lost to Follow-up|0|||
25113524|NCT01891864|50225047|FG001|Extension Period|Lost to Follow-up|0|||
25113525|NCT01891864|50225048|FG002|Extension Period|Lost to Follow-up|2|||
25113526|NCT01891864|50225049|FG003|Extension Period|Lost to Follow-up|0|||
25113527|NCT01891864|50225050|FG004|Extension Period|Lost to Follow-up|0|||
25113528|NCT01891864|50225051|FG005|Extension Period|Lost to Follow-up|0|||
25113529|NCT02485301|50225065|FG000|Overall Study|Serious Adverse Events|2|||
25113530|NCT02485301|50225066|FG001|Overall Study|Serious Adverse Events|1|||
25113531|NCT02485301|50225065|FG000|Overall Study|Protocol Violation|0|||
25113532|NCT02485301|50225066|FG001|Overall Study|Protocol Violation|1|||
25113533|NCT02485301|50225065|FG000|Overall Study|Withdrawal by Subject|6|||
25113534|NCT02485301|50225066|FG001|Overall Study|Withdrawal by Subject|7|||
25113535|NCT02485301|50225065|FG000|Overall Study|Migrated/moved from study area|10|||
25113536|NCT02485301|50225066|FG001|Overall Study|Migrated/moved from study area|19|||
25113537|NCT02485301|50225065|FG000|Overall Study|Lost to Follow-up|17|||
25113538|NCT02485301|50225066|FG001|Overall Study|Lost to Follow-up|17|||
25113539|NCT02485301|50225065|FG000|Overall Study|Other|3|||
25113540|NCT02485301|50225066|FG001|Overall Study|Other|4|||
25113541|NCT02484911|50225074|FG000|Overall Study|Withdrawal by Subject|2|||
25113542|NCT02484911|50225075|FG001|Overall Study|Withdrawal by Subject|1|||
25113543|NCT02484911|50225074|FG000|Overall Study|Protocol Violation|2|||
25113544|NCT02484911|50225075|FG001|Overall Study|Protocol Violation|1|||
25113545|NCT02466425|50225084|FG000|Overall Study|Adverse Event|3|||
25113546|NCT02466425|50225085|FG001|Overall Study|Adverse Event|11|||
25113547|NCT02466425|50225084|FG000|Overall Study|Lack of Efficacy|4|||
25113548|NCT02466425|50225085|FG001|Overall Study|Lack of Efficacy|1|||
25113549|NCT02466425|50225084|FG000|Overall Study|Lost to Follow-up|3|||
25113550|NCT02466425|50225085|FG001|Overall Study|Lost to Follow-up|0|||
25113551|NCT02466425|50225084|FG000|Overall Study|Protocol Violation|1|||
25113552|NCT02466425|50225085|FG001|Overall Study|Protocol Violation|0|||
25113553|NCT02466425|50225084|FG000|Overall Study|Withdrawal by Subject|0|||
25113554|NCT02466425|50225085|FG001|Overall Study|Withdrawal by Subject|1|||
25113555|NCT02466425|50225084|FG000|Overall Study|Other|1|||
25113556|NCT02466425|50225085|FG001|Overall Study|Other|3|||
25113557|NCT02466425|50225084|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
25113558|NCT02466425|50225085|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
25113559|NCT02451917|50225093|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
25113560|NCT02451917|50225094|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
25113561|NCT02451917|50225093|FG000|First Intervention (24 Weeks)|Death|0|||
25113562|NCT02451917|50225094|FG001|First Intervention (24 Weeks)|Death|1|||
25113563|NCT02451917|50225093|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
25113564|NCT02451917|50225094|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
25113565|NCT02349451|50225107|FG000|Overall Study|Withdrawal by Subject|0|||
25113566|NCT02349451|50225108|FG001|Overall Study|Withdrawal by Subject|1|||
25113567|NCT02349451|50225109|FG002|Overall Study|Withdrawal by Subject|2|||
25113568|NCT02349451|50225110|FG003|Overall Study|Withdrawal by Subject|1|||
25113569|NCT02409368|50225127|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
25261388|NCT01306032|50576141|FG002|First Intervention|Adverse Event|1|||
25113570|NCT02409368|50225128|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
25113571|NCT02409368|50225129|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
25113572|NCT02409368|50225130|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
25113573|NCT02409368|50225127|FG000|ECOG Reclassification|Death|1|||
25113574|NCT02409368|50225128|FG001|ECOG Reclassification|Death|5|||
25113575|NCT02409368|50225129|FG002|ECOG Reclassification|Death|0|||
25113576|NCT02409368|50225130|FG003|ECOG Reclassification|Death|0|||
25113577|NCT02409368|50225127|FG000|ECOG Reclassification|Disease Progression|113|||
25113578|NCT02409368|50225128|FG001|ECOG Reclassification|Disease Progression|382|||
25113579|NCT02409368|50225129|FG002|ECOG Reclassification|Disease Progression|70|||
25113580|NCT02409368|50225130|FG003|ECOG Reclassification|Disease Progression|1|||
25113581|NCT02409368|50225127|FG000|ECOG Reclassification|Lost to Follow-up|1|||
25113582|NCT02409368|50225128|FG001|ECOG Reclassification|Lost to Follow-up|5|||
25113583|NCT02409368|50225129|FG002|ECOG Reclassification|Lost to Follow-up|0|||
25113584|NCT02409368|50225130|FG003|ECOG Reclassification|Lost to Follow-up|0|||
25113585|NCT02409368|50225127|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
25113586|NCT02409368|50225128|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
25113587|NCT02409368|50225129|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
25113588|NCT02409368|50225130|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
25113589|NCT02409368|50225127|FG000|ECOG Reclassification|Poor/non-compliance|0|||
25113590|NCT02409368|50225128|FG001|ECOG Reclassification|Poor/non-compliance|3|||
25113591|NCT02409368|50225129|FG002|ECOG Reclassification|Poor/non-compliance|2|||
25113592|NCT02409368|50225130|FG003|ECOG Reclassification|Poor/non-compliance|0|||
25113593|NCT02409368|50225127|FG000|ECOG Reclassification|Study drug toxicity|17|||
25113594|NCT02409368|50225128|FG001|ECOG Reclassification|Study drug toxicity|42|||
25113595|NCT02409368|50225129|FG002|ECOG Reclassification|Study drug toxicity|7|||
25113596|NCT02409368|50225130|FG003|ECOG Reclassification|Study drug toxicity|0|||
25113597|NCT02409368|50225127|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
25113598|NCT02409368|50225128|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
25113599|NCT02409368|50225129|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
25113600|NCT02409368|50225130|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
25113601|NCT02409368|50225127|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
25113602|NCT02409368|50225128|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
25113603|NCT02409368|50225129|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
25113604|NCT02409368|50225130|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
25113605|NCT02409368|50225127|FG000|ECOG Reclassification|Participant withdrew consent|2|||
25113606|NCT02409368|50225128|FG001|ECOG Reclassification|Participant withdrew consent|3|||
25113607|NCT02409368|50225129|FG002|ECOG Reclassification|Participant withdrew consent|4|||
25113608|NCT02409368|50225130|FG003|ECOG Reclassification|Participant withdrew consent|0|||
25113609|NCT02409368|50225127|FG000|ECOG Reclassification|Other Reasons|5|||
25113610|NCT02409368|50225128|FG001|ECOG Reclassification|Other Reasons|26|||
25113611|NCT02409368|50225129|FG002|ECOG Reclassification|Other Reasons|2|||
25113612|NCT02409368|50225130|FG003|ECOG Reclassification|Other Reasons|0|||
25113613|NCT02409368|50225127|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
25113614|NCT02409368|50225128|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
25113615|NCT02409368|50225129|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
25113616|NCT02409368|50225130|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
25113617|NCT01853878|50225143|FG000|Overall Study|Recurrence|2|||
25113618|NCT01853878|50225144|FG001|Overall Study|Recurrence|0|||
25113619|NCT01853878|50225143|FG000|Overall Study|Adverse Event|2|||
25113620|NCT01853878|50225144|FG001|Overall Study|Adverse Event|0|||
25113621|NCT01853878|50225143|FG000|Overall Study|Withdrawal by Subject|3|||
25113622|NCT01853878|50225144|FG001|Overall Study|Withdrawal by Subject|1|||
25113623|NCT01853878|50225143|FG000|Overall Study|Migrated/moved from the study area|1|||
25113624|NCT01853878|50225144|FG001|Overall Study|Migrated/moved from the study area|0|||
25113625|NCT01853878|50225143|FG000|Overall Study|Other|55|||
25113626|NCT01853878|50225144|FG001|Overall Study|Other|43|||
25113627|NCT02342678|50225152|FG000|Overall Study|Lost to Follow-up|0|||
25113628|NCT02342678|50225153|FG001|Overall Study|Lost to Follow-up|1|||
25113629|NCT02342678|50225152|FG000|Overall Study|Too busy to complete study|0|||
25113630|NCT02342678|50225153|FG001|Overall Study|Too busy to complete study|2|||
25113631|NCT02342678|50225152|FG000|Overall Study|Family illness/emergency|0|||
25113632|NCT02342678|50225153|FG001|Overall Study|Family illness/emergency|1|||
25113633|NCT02342678|50225152|FG000|Overall Study|Illness/medical reason|1|||
25113634|NCT02342678|50225153|FG001|Overall Study|Illness/medical reason|1|||
25113635|NCT02408120|50225161|FG000|Overall Study|Withdrawal by Subject|0|||
25113636|NCT02408120|50225162|FG001|Overall Study|Withdrawal by Subject|1|||
25113637|NCT02408120|50225161|FG000|Overall Study|Treatment Refusal|1|||
25008389|NCT03535194|50101307|FG002|Induction Period|Screen Failure|0|||
25113638|NCT02408120|50225162|FG001|Overall Study|Treatment Refusal|0|||
25113639|NCT02408120|50225161|FG000|Overall Study|Received Steroids|1|||
25113640|NCT02408120|50225162|FG001|Overall Study|Received Steroids|1|||
25113641|NCT02408120|50225161|FG000|Overall Study|Discharged same day|1|||
25113642|NCT02408120|50225162|FG001|Overall Study|Discharged same day|1|||
25113643|NCT02408120|50225161|FG000|Overall Study|Did not receive insulin|1|||
25113644|NCT02408120|50225162|FG001|Overall Study|Did not receive insulin|2|||
25113645|NCT02342288|50225170|FG000|Overall Study|no protocol anesthesiologist available|3|||
25113646|NCT02342288|50225171|FG001|Overall Study|no protocol anesthesiologist available|2|||
25113647|NCT02342288|50225170|FG000|Overall Study|anesthesia leak in system|1|||
25113648|NCT02342288|50225171|FG001|Overall Study|anesthesia leak in system|0|||
25113649|NCT02342288|50225170|FG000|Overall Study|Withdrawal by Subject|1|||
25113650|NCT02342288|50225171|FG001|Overall Study|Withdrawal by Subject|0|||
25113651|NCT02342288|50225170|FG000|Overall Study|coordinator contaminated with blood|0|||
25113652|NCT02342288|50225171|FG001|Overall Study|coordinator contaminated with blood|1|||
25113653|NCT02342288|50225170|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
25113654|NCT02342288|50225171|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
25113655|NCT02342288|50225170|FG000|Overall Study|coordinator not available|0|||
25113656|NCT02342288|50225171|FG001|Overall Study|coordinator not available|2|||
25113657|NCT01853644|50225177|FG000|Registration and Treatment Start|Did not start treatment|1|||
25113658|NCT01853644|50225177|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
25113659|NCT01853644|50225177|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
25113660|NCT01853644|50225177|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
25113661|NCT01853644|50225177|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
25113662|NCT01853644|50225177|FG000|Continued Treatment After First Response|Adverse Event|2|||
25113663|NCT01853644|50225177|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
25113664|NCT02374346|50225181|FG000|Overall Study|operated or discharged during weekend|48|||
25113665|NCT01853254|50225187|FG000|Overall Study|Abnormal Laboratory Test|1|||
25113666|NCT01853254|50225187|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
25113667|NCT01853254|50225187|FG000|Overall Study|Death|1|||
25113668|NCT01853254|50225187|FG000|Overall Study|Failure to Return|43|||
25113669|NCT01853254|50225187|FG000|Overall Study|Insufficient Therapeutic Response|22|||
25113670|NCT01853254|50225187|FG000|Overall Study|Refusal of Treatment|1|||
25113671|NCT01853254|50225187|FG000|Overall Study|Other Protocol Violation|1|||
25113672|NCT01853254|50225187|FG000|Overall Study|Withdrawal of Consent|16|||
25113673|NCT01853254|50225187|FG000|Overall Study|Administrative/Other|16|||
25113674|NCT02373098|50225193|FG000|Overall Study|Lost to Follow-up|1|||
25113675|NCT02373098|50225194|FG001|Overall Study|Lost to Follow-up|0|||
25113676|NCT02373098|50225193|FG000|Overall Study|Protocol Violation|3|||
25113677|NCT02373098|50225194|FG001|Overall Study|Protocol Violation|0|||
25113678|NCT02373098|50225193|FG000|Overall Study|Withdrawal by Subject|5|||
25113679|NCT02373098|50225194|FG001|Overall Study|Withdrawal by Subject|0|||
25113680|NCT02373098|50225193|FG000|Overall Study|Adverse Event|3|||
25113681|NCT02373098|50225194|FG001|Overall Study|Adverse Event|0|||
25113682|NCT01853176|50225208|FG000|Overall Study|Study terminated|4|||
25113683|NCT01853176|50225209|FG001|Overall Study|Study terminated|0|||
25113684|NCT02372396|50225217|FG000|Overall Study|Lost to Follow-up|7|||
25113685|NCT02372396|50225218|FG001|Overall Study|Lost to Follow-up|9|||
25113686|NCT01835548|50225226|FG000|Dose Optimization Period|Adverse Event|0|||
25113687|NCT01835548|50225227|FG001|Dose Optimization Period|Adverse Event|0|||
25113688|NCT01835548|50225228|FG002|Dose Optimization Period|Adverse Event|1|||
25113689|NCT01835548|50225226|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
25113690|NCT01835548|50225227|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
25113691|NCT01835548|50225228|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
25113692|NCT01835548|50225226|FG000|Double-Blind Treatment Period|Adverse Event|0|||
25113693|NCT01835548|50225227|FG001|Double-Blind Treatment Period|Adverse Event|1|||
25113694|NCT01835548|50225228|FG002|Double-Blind Treatment Period|Adverse Event|0|||
25113695|NCT01835548|50225226|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
25113696|NCT01835548|50225227|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
25113697|NCT01835548|50225228|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
25113698|NCT02340962|50225242|FG000|Overall Study|Lost to Follow-up|1|||
25113699|NCT02340962|50225243|FG001|Overall Study|Lost to Follow-up|0|||
25113700|NCT01852942|50225251|FG000|Overall Study|Physician Decision|1|||
25113701|NCT01852942|50225252|FG001|Overall Study|Physician Decision|0|||
25113702|NCT01852942|50225251|FG000|Overall Study|Death|1|||
25113703|NCT01852942|50225252|FG001|Overall Study|Death|1|||
25113704|NCT01852942|50225251|FG000|Overall Study|Withdrawal by Subject|2|||
25113705|NCT01852942|50225252|FG001|Overall Study|Withdrawal by Subject|3|||
25113706|NCT01852942|50225251|FG000|Overall Study|Lost to Follow-up|1|||
25113707|NCT01852942|50225252|FG001|Overall Study|Lost to Follow-up|2|||
25113708|NCT01852162|50225261|FG000|Overall Study|Adverse Event|1|||
25113709|NCT01852162|50225262|FG001|Overall Study|Adverse Event|0|||
25113710|NCT01852162|50225261|FG000|Overall Study|Withdrawal by Subject|3|||
25113711|NCT01852162|50225262|FG001|Overall Study|Withdrawal by Subject|1|||
25113712|NCT01835470|50225268|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
25113713|NCT01835470|50225268|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
25113714|NCT02451137|50225275|FG000|Overall Study|Randomized but not treated|19|||
25113715|NCT02451137|50225276|FG001|Overall Study|Randomized but not treated|27|||
25113716|NCT02451137|50225275|FG000|Overall Study|Adverse Event|43|||
25113717|NCT02451137|50225276|FG001|Overall Study|Adverse Event|42|||
25113718|NCT02451137|50225275|FG000|Overall Study|Lack of Efficacy|4|||
25113719|NCT02451137|50225276|FG001|Overall Study|Lack of Efficacy|9|||
25113720|NCT02451137|50225275|FG000|Overall Study|Participant decision:discontinue insulin|41|||
25113721|NCT02451137|50225276|FG001|Overall Study|Participant decision:discontinue insulin|43|||
25113722|NCT02451137|50225275|FG000|Overall Study|Hypoglycemia|2|||
25113723|NCT02451137|50225276|FG001|Overall Study|Hypoglycemia|1|||
25113724|NCT02451137|50225275|FG000|Overall Study|Investigator's decision|23|||
25113725|NCT02451137|50225276|FG001|Overall Study|Investigator's decision|19|||
25113726|NCT02451137|50225275|FG000|Overall Study|Lost to Follow-up|53|||
25113727|NCT02451137|50225276|FG001|Overall Study|Lost to Follow-up|61|||
25113728|NCT02451137|50225275|FG000|Overall Study|Physician Decision|6|||
25113729|NCT02451137|50225276|FG001|Overall Study|Physician Decision|5|||
25113730|NCT02451137|50225275|FG000|Overall Study|Sponsor decision|13|||
25113731|NCT02451137|50225276|FG001|Overall Study|Sponsor decision|25|||
25113732|NCT02451137|50225275|FG000|Overall Study|Withdrawal by Subject|40|||
25113733|NCT02451137|50225276|FG001|Overall Study|Withdrawal by Subject|63|||
25113734|NCT02451137|50225275|FG000|Overall Study|Other than specified above|2|||
25113735|NCT02451137|50225276|FG001|Overall Study|Other than specified above|3|||
25113736|NCT02372006|50225285|FG000|Overall Study|Progressive disease|8|||
25113737|NCT02372006|50225286|FG001|Overall Study|Progressive disease|7|||
25113738|NCT02372006|50225287|FG002|Overall Study|Progressive disease|34|||
25113739|NCT02372006|50225285|FG000|Overall Study|Dose limiting toxicity|0|||
25113740|NCT02372006|50225286|FG001|Overall Study|Dose limiting toxicity|1|||
25113741|NCT02372006|50225287|FG002|Overall Study|Dose limiting toxicity|0|||
25113742|NCT02372006|50225285|FG000|Overall Study|Adverse Event|0|||
25113743|NCT02372006|50225286|FG001|Overall Study|Adverse Event|0|||
25113744|NCT02372006|50225287|FG002|Overall Study|Adverse Event|3|||
25113745|NCT02372006|50225285|FG000|Overall Study|Withdrawal by Subject|0|||
25113746|NCT02372006|50225286|FG001|Overall Study|Withdrawal by Subject|1|||
25113747|NCT02372006|50225287|FG002|Overall Study|Withdrawal by Subject|1|||
25113748|NCT02372006|50225285|FG000|Overall Study|Other reason for not completing|0|||
25113749|NCT02372006|50225286|FG001|Overall Study|Other reason for not completing|0|||
25113750|NCT02372006|50225287|FG002|Overall Study|Other reason for not completing|1|||
25113751|NCT02406248|50225296|FG000|Overall Study|Death|7|||
25113752|NCT02406248|50225296|FG000|Overall Study|Withdrawal by Subject|2|||
25113753|NCT02450903|50225300|FG000|Overall Study|Adverse Event|3|||
25113754|NCT02450903|50225300|FG000|Overall Study|Progressive disease|15|||
25113755|NCT02450903|50225300|FG000|Overall Study|Switched to commercial drug|1|||
25113756|NCT02450903|50225300|FG000|Overall Study|Subject/guardian decision|1|||
25113757|NCT02371616|50225306|FG000|Overall Study|Protocol Violation|2|||
25113758|NCT02371616|50225307|FG001|Overall Study|Protocol Violation|1|||
25113759|NCT02371616|50225306|FG000|Overall Study|Adverse Event|0|||
25113760|NCT02371616|50225307|FG001|Overall Study|Adverse Event|1|||
25113761|NCT02371616|50225306|FG000|Overall Study|Withdrawal of Consent|1|||
25113762|NCT02371616|50225307|FG001|Overall Study|Withdrawal of Consent|0|||
25113763|NCT02371616|50225306|FG000|Overall Study|Other (Not specified)|1|||
25113764|NCT02371616|50225307|FG001|Overall Study|Other (Not specified)|5|||
25113765|NCT02370914|50225313|FG000|Overall Study|Protocol Violation|2|||
25113766|NCT02370602|50225323|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
25113767|NCT02370602|50225324|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
25261389|NCT01306032|50576142|FG003|First Intervention|Adverse Event|0|||
25261390|NCT01306032|50576143|FG004|First Intervention|Adverse Event|0|||
25113768|NCT02370602|50225325|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
25113769|NCT02370602|50225326|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
25113770|NCT02370602|50225327|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
25113771|NCT02370602|50225328|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
25113772|NCT02370368|50225347|FG000|Overall Study|Adverse Event|1|||
25261391|NCT01306032|50576144|FG005|First Intervention|Adverse Event|1|||
25261392|NCT01306032|50576139|FG000|First Intervention|Withdrawal by Subject|0|||
25261393|NCT01306032|50576140|FG001|First Intervention|Withdrawal by Subject|2|||
25261394|NCT01306032|50576141|FG002|First Intervention|Withdrawal by Subject|0|||
25261395|NCT01306032|50576142|FG003|First Intervention|Withdrawal by Subject|1|||
25261396|NCT01306032|50576143|FG004|First Intervention|Withdrawal by Subject|0|||
25261397|NCT01306032|50576144|FG005|First Intervention|Withdrawal by Subject|0|||
25261398|NCT01306032|50576139|FG000|First Intervention|Death|0|||
25113773|NCT02370368|50225348|FG001|Overall Study|Adverse Event|2|||
25113774|NCT02370368|50225347|FG000|Overall Study|Withdrawal by Subject|5|||
25113775|NCT02370368|50225348|FG001|Overall Study|Withdrawal by Subject|4|||
25113776|NCT02340806|50225356|FG000|Overall Study|Protocol Violation|2|||
25113777|NCT02340806|50225357|FG001|Overall Study|Protocol Violation|0|||
25113778|NCT02340806|50225356|FG000|Overall Study|epidural catheter replaced|2|||
25113779|NCT02340806|50225357|FG001|Overall Study|epidural catheter replaced|1|||
25113780|NCT02340806|50225356|FG000|Overall Study|history of chronic pain medication|1|||
25261399|NCT01306032|50576140|FG001|First Intervention|Death|0|||
25113781|NCT02340806|50225357|FG001|Overall Study|history of chronic pain medication|0|||
25113782|NCT02340806|50225356|FG000|Overall Study|re-dose < 90 min of CSE|1|||
25261400|NCT01306032|50576141|FG002|First Intervention|Death|1|||
25113783|NCT02340806|50225357|FG001|Overall Study|re-dose < 90 min of CSE|3|||
25113784|NCT02338154|50225363|FG000|Overall Study|Death|46|||
25113785|NCT02338154|50225363|FG000|Overall Study|Valve Implant Failure|17|||
25113786|NCT02338154|50225363|FG000|Overall Study|Valve Explant|11|||
25113787|NCT02338154|50225363|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
25113788|NCT02338154|50225363|FG000|Overall Study|Lost to Follow-up|8|||
25113789|NCT02338154|50225363|FG000|Overall Study|Other Reason|3|||
25113790|NCT02338154|50225363|FG000|Overall Study|Patients Without Exit Form|47|||
25113791|NCT02338154|50225363|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
25113792|NCT01835158|50225377|FG000|Overall Study|Withdrawal by Subject|1|||
25113793|NCT01835158|50225378|FG001|Overall Study|Withdrawal by Subject|6|||
25113794|NCT02337764|50225384|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
25113795|NCT02337764|50225384|FG000|Overall Study|Voluntary Withdrawal|12|||
25113796|NCT02337764|50225384|FG000|Overall Study|Lack of Efficacy|2|||
25113797|NCT01834222|50225388|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
25113798|NCT01833832|50225392|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
25113799|NCT01833520|50225398|FG000|Overall Study|Lack of Efficacy|3|||
25113800|NCT01833520|50225399|FG001|Overall Study|Lack of Efficacy|3|||
25113801|NCT01833520|50225400|FG002|Overall Study|Lack of Efficacy|8|||
25113802|NCT01833520|50225401|FG003|Overall Study|Lack of Efficacy|3|||
25113803|NCT01850602|50225415|FG000|Overall Study|Adverse Event|7|||
25113804|NCT01850602|50225416|FG001|Overall Study|Adverse Event|10|||
25113805|NCT01850602|50225415|FG000|Overall Study|Physician Decision|2|||
25113806|NCT01850602|50225416|FG001|Overall Study|Physician Decision|1|||
25113807|NCT01850602|50225415|FG000|Overall Study|Withdrawal by Subject|2|||
25113808|NCT01850602|50225416|FG001|Overall Study|Withdrawal by Subject|4|||
25113809|NCT01850602|50225415|FG000|Overall Study|Decrease in serum calcium|2|||
25113810|NCT01850602|50225416|FG001|Overall Study|Decrease in serum calcium|3|||
25113811|NCT01850602|50225415|FG000|Overall Study|Increase in serum ferritin|1|||
25113812|NCT01850602|50225416|FG001|Overall Study|Increase in serum ferritin|0|||
25113813|NCT01832818|50225422|FG000|Overall Study|Lost to Follow-up|6|||
25113814|NCT02405780|50225430|FG000|Period I|Adverse Event|8|||
25113815|NCT02405780|50225431|FG001|Period I|Adverse Event|0|||
25113816|NCT02405780|50225432|FG002|Period I|Adverse Event|3|||
25113817|NCT02405780|50225433|FG003|Period I|Adverse Event|7|||
25113818|NCT02405780|50225430|FG000|Period I|Medical reasons|1|||
25113819|NCT02405780|50225431|FG001|Period I|Medical reasons|1|||
25113820|NCT02405780|50225432|FG002|Period I|Medical reasons|0|||
25113821|NCT02405780|50225433|FG003|Period I|Medical reasons|1|||
25113822|NCT02405780|50225430|FG000|Period I|Screening Failure|1|||
25113823|NCT02405780|50225431|FG001|Period I|Screening Failure|0|||
25113824|NCT02405780|50225432|FG002|Period I|Screening Failure|1|||
25113825|NCT02405780|50225433|FG003|Period I|Screening Failure|0|||
25113826|NCT02405780|50225430|FG000|Period I|Withdrawal by Subject|9|||
25113827|NCT02405780|50225431|FG001|Period I|Withdrawal by Subject|1|||
25113828|NCT02405780|50225432|FG002|Period I|Withdrawal by Subject|3|||
25113829|NCT02405780|50225433|FG003|Period I|Withdrawal by Subject|4|||
25113830|NCT02405780|50225430|FG000|Period I|Non-compliance with study procedures|8|||
25113831|NCT02405780|50225431|FG001|Period I|Non-compliance with study procedures|6|||
25113832|NCT02405780|50225432|FG002|Period I|Non-compliance with study procedures|8|||
25113833|NCT02405780|50225433|FG003|Period I|Non-compliance with study procedures|11|||
25113834|NCT02405780|50225430|FG000|Period II|Adverse Event|3|||
25113835|NCT02405780|50225431|FG001|Period II|Adverse Event|5|||
25113836|NCT02405780|50225432|FG002|Period II|Adverse Event|4|||
25113837|NCT02405780|50225433|FG003|Period II|Adverse Event|11|||
25113838|NCT02405780|50225430|FG000|Period II|Medical reason|0|||
25113839|NCT02405780|50225431|FG001|Period II|Medical reason|1|||
25113840|NCT02405780|50225432|FG002|Period II|Medical reason|0|||
25113841|NCT02405780|50225433|FG003|Period II|Medical reason|0|||
25113842|NCT02405780|50225430|FG000|Period II|Pregnancy|0|||
25113843|NCT02405780|50225431|FG001|Period II|Pregnancy|0|||
25113844|NCT02405780|50225432|FG002|Period II|Pregnancy|1|||
25113845|NCT02405780|50225433|FG003|Period II|Pregnancy|0|||
25113846|NCT02405780|50225430|FG000|Period II|Withdrawal by Subject|7|||
25113847|NCT02405780|50225431|FG001|Period II|Withdrawal by Subject|4|||
25008390|NCT03535194|50101308|FG003|Induction Period|Screen Failure|0|||
25113848|NCT02405780|50225432|FG002|Period II|Withdrawal by Subject|0|||
25113849|NCT02405780|50225433|FG003|Period II|Withdrawal by Subject|3|||
25113850|NCT02405780|50225430|FG000|Period II|Non-compliance with study procedures|5|||
25113851|NCT02405780|50225431|FG001|Period II|Non-compliance with study procedures|2|||
25113852|NCT02405780|50225432|FG002|Period II|Non-compliance with study procedures|7|||
25113853|NCT02405780|50225433|FG003|Period II|Non-compliance with study procedures|4|||
25113854|NCT02369510|50225461|FG000|Overall Study|Spilled Medication|1|||
25113855|NCT02369510|50225462|FG001|Overall Study|Spilled Medication|2|||
25113856|NCT02369510|50225463|FG002|Overall Study|Spilled Medication|1|||
25113857|NCT02369510|50225461|FG000|Overall Study|Epidural Activation|1|||
25113858|NCT02369510|50225462|FG001|Overall Study|Epidural Activation|1|||
25113859|NCT02369510|50225463|FG002|Overall Study|Epidural Activation|5|||
25113860|NCT01650194|50225471|FG000|Overall Study|Progressive Disease (PD)|35|||
25177406|NCT02754141|50321519|FG012|Overall Study|Withdrew consent|0|||
25113861|NCT01650194|50225471|FG000|Overall Study|Withdrawal by Subject|2|||
25113862|NCT01650194|50225471|FG000|Overall Study|Miscellaneous|10|||
25113863|NCT02367716|50225476|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
25113864|NCT02366936|50225481|FG000|Overall Study|Withdrawal by Subject|2|||
25113865|NCT02366936|50225481|FG000|Overall Study|Lost to Follow-up|4|||
25113866|NCT02366936|50225481|FG000|Overall Study|Physician Decision|2|||
25113867|NCT01648166|50225487|FG000|Overall Study|inadequate toenail samples|53|||
25113868|NCT01648166|50225488|FG001|Overall Study|inadequate toenail samples|100|||
25113869|NCT02336282|50225494|FG000|Overall Study|Unrelated illness|1|||
25113870|NCT02336282|50225494|FG000|Overall Study|Uncomfortable with technology|1|||
25113871|NCT02336282|50225494|FG000|Overall Study|Lost to Follow-up|1|||
25113872|NCT02336282|50225494|FG000|Overall Study|Not enough time to complete sessions|2|||
25113873|NCT02404220|50225510|FG000|Overall Study|Adverse Event|0|||
25113874|NCT02404220|50225511|FG001|Overall Study|Adverse Event|0|||
25113875|NCT02404220|50225512|FG002|Overall Study|Adverse Event|1|||
25113876|NCT02404220|50225513|FG003|Overall Study|Adverse Event|0|||
25113877|NCT02404220|50225510|FG000|Overall Study|Death|5|||
25113878|NCT02404220|50225511|FG001|Overall Study|Death|5|||
25113879|NCT02404220|50225512|FG002|Overall Study|Death|3|||
25113880|NCT02404220|50225513|FG003|Overall Study|Death|8|||
25113881|NCT02404220|50225510|FG000|Overall Study|Progressive Disease|0|||
25113882|NCT02404220|50225511|FG001|Overall Study|Progressive Disease|0|||
25113883|NCT02404220|50225512|FG002|Overall Study|Progressive Disease|1|||
25113884|NCT02404220|50225513|FG003|Overall Study|Progressive Disease|1|||
25113885|NCT02404220|50225510|FG000|Overall Study|Study Terminated by Sponsor|0|||
25113886|NCT02404220|50225511|FG001|Overall Study|Study Terminated by Sponsor|0|||
25113887|NCT02404220|50225512|FG002|Overall Study|Study Terminated by Sponsor|2|||
25113888|NCT02404220|50225513|FG003|Overall Study|Study Terminated by Sponsor|1|||
25113889|NCT02404220|50225510|FG000|Overall Study|Withdrawal by Subject|0|||
25113890|NCT02404220|50225511|FG001|Overall Study|Withdrawal by Subject|1|||
25113891|NCT02404220|50225512|FG002|Overall Study|Withdrawal by Subject|0|||
25113892|NCT02404220|50225513|FG003|Overall Study|Withdrawal by Subject|0|||
25113893|NCT02404220|50225510|FG000|Overall Study|Enrolled but Never Treated|0|||
25113894|NCT02404220|50225511|FG001|Overall Study|Enrolled but Never Treated|2|||
25113895|NCT02404220|50225512|FG002|Overall Study|Enrolled but Never Treated|0|||
25113896|NCT02404220|50225513|FG003|Overall Study|Enrolled but Never Treated|0|||
25113897|NCT02335658|50225525|FG000|Overall Study|Adverse Event|18|||
25113898|NCT02335658|50225526|FG001|Overall Study|Adverse Event|12|||
25113899|NCT02335658|50225525|FG000|Overall Study|Lack of Efficacy|4|||
25113900|NCT02335658|50225526|FG001|Overall Study|Lack of Efficacy|5|||
25113901|NCT02335658|50225525|FG000|Overall Study|Pregnancy|1|||
25113902|NCT02335658|50225526|FG001|Overall Study|Pregnancy|0|||
25113903|NCT02335658|50225525|FG000|Overall Study|Withdrawal by Subject|13|||
25113904|NCT02335658|50225526|FG001|Overall Study|Withdrawal by Subject|21|||
25113905|NCT02335658|50225525|FG000|Overall Study|non-compliance|2|||
25113906|NCT02335658|50225526|FG001|Overall Study|non-compliance|3|||
25113907|NCT02335658|50225525|FG000|Overall Study|other reason|2|||
25113908|NCT02335658|50225526|FG001|Overall Study|other reason|3|||
25113909|NCT02366468|50225536|FG000|Overall Study|Adverse Event|2|||
25113910|NCT02366468|50225537|FG001|Overall Study|Adverse Event|0|||
25113911|NCT02366468|50225536|FG000|Overall Study|Withdrawal by Subject|1|||
25113912|NCT02366468|50225537|FG001|Overall Study|Withdrawal by Subject|5|||
25113913|NCT02366468|50225536|FG000|Overall Study|Lost to Follow-up|2|||
25113914|NCT02366468|50225537|FG001|Overall Study|Lost to Follow-up|0|||
25113915|NCT02366468|50225536|FG000|Overall Study|Death|1|||
25113916|NCT02366468|50225537|FG001|Overall Study|Death|2|||
25113917|NCT02366468|50225536|FG000|Overall Study|Other|0|||
25113918|NCT02366468|50225537|FG001|Overall Study|Other|2|||
25113919|NCT02366312|50225545|FG000|Overall Study|Lost to Follow-up|0|||
25113920|NCT02366312|50225546|FG001|Overall Study|Lost to Follow-up|1|||
25113921|NCT02335346|50225552|FG000|Overall Study|Adverse Event|11|||
25113922|NCT02335346|50225552|FG000|Overall Study|Withdrawal by Subject|1|||
25113923|NCT02403674|50225558|FG000|Overall Study|Adverse Event|10|||
25113924|NCT02403674|50225559|FG001|Overall Study|Adverse Event|23|||
25113925|NCT02403674|50225558|FG000|Overall Study|Death|1|||
25113926|NCT02403674|50225559|FG001|Overall Study|Death|3|||
25113927|NCT02403674|50225558|FG000|Overall Study|Lack of Efficacy|18|||
25113928|NCT02403674|50225559|FG001|Overall Study|Lack of Efficacy|10|||
25113929|NCT02403674|50225558|FG000|Overall Study|Lost to Follow-up|6|||
25113930|NCT02403674|50225559|FG001|Overall Study|Lost to Follow-up|7|||
25113931|NCT02403674|50225558|FG000|Overall Study|Noncompliance with study drug|1|||
25113932|NCT02403674|50225559|FG001|Overall Study|Noncompliance with study drug|2|||
25113933|NCT02403674|50225558|FG000|Overall Study|Withdrawal by Subject|8|||
25113934|NCT02403674|50225559|FG001|Overall Study|Withdrawal by Subject|11|||
25113935|NCT02403674|50225558|FG000|Overall Study|Physician Decision|2|||
25113936|NCT02403674|50225559|FG001|Overall Study|Physician Decision|2|||
25113937|NCT02403674|50225558|FG000|Overall Study|Not treated with study drug|4|||
25113938|NCT02403674|50225559|FG001|Overall Study|Not treated with study drug|2|||
25113939|NCT02403674|50225558|FG000|Overall Study|Pregnancy|1|||
25113940|NCT02403674|50225559|FG001|Overall Study|Pregnancy|1|||
25113941|NCT02403674|50225558|FG000|Overall Study|Protocol Violation|4|||
25113942|NCT02403674|50225559|FG001|Overall Study|Protocol Violation|2|||
25113943|NCT02403206|50225567|FG000|Overall Study|Lost to Follow-up|4|||
25113944|NCT02403206|50225568|FG001|Overall Study|Lost to Follow-up|3|||
25113945|NCT02403206|50225567|FG000|Overall Study|Physician Decision|2|||
25113946|NCT02403206|50225568|FG001|Overall Study|Physician Decision|0|||
25113947|NCT02403206|50225567|FG000|Overall Study|Withdrawal by Subject|3|||
25113948|NCT02403206|50225568|FG001|Overall Study|Withdrawal by Subject|3|||
25113949|NCT02403206|50225567|FG000|Overall Study|Reason not given|2|||
25113950|NCT02403206|50225568|FG001|Overall Study|Reason not given|4|||
25113951|NCT02333630|50225577|FG000|Overall Study|Lost to Follow-up|5|||
25113952|NCT02333630|50225578|FG001|Overall Study|Lost to Follow-up|2|||
25113953|NCT02401412|50225590|FG000|Overall Study|Lost to Follow-up|1|||
25113954|NCT02401412|50225591|FG001|Overall Study|Lost to Follow-up|0|||
25113955|NCT02401412|50225590|FG000|Overall Study|Discontinued Intervention|15|||
25113956|NCT02401412|50225591|FG001|Overall Study|Discontinued Intervention|21|||
25113957|NCT02401412|50225590|FG000|Overall Study|Withdrawal by Subject|4|||
25113958|NCT02401412|50225591|FG001|Overall Study|Withdrawal by Subject|4|||
25113959|NCT02401412|50225590|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
25113960|NCT02401412|50225591|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
25113961|NCT02401412|50225590|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
25113962|NCT02401412|50225591|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
25113963|NCT02365298|50225597|FG000|Period 2|incorrect Rx dispensed|1|||
25113964|NCT02365298|50225598|FG001|Period 2|incorrect Rx dispensed|0|||
25113965|NCT02365298|50225597|FG000|Period 2|Discontinued at request of Sponsor|1|||
25113966|NCT02365298|50225598|FG001|Period 2|Discontinued at request of Sponsor|0|||
25113967|NCT02365298|50225597|FG000|Period 2|Test Article longer available|0|||
25113968|NCT02365298|50225598|FG001|Period 2|Test Article longer available|1|||
25113969|NCT02365298|50225597|FG000|Period 2|Protocol Violation|0|||
25113970|NCT02365298|50225598|FG001|Period 2|Protocol Violation|1|||
25113971|NCT02365064|50225606|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
25113972|NCT02365064|50225607|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
25113973|NCT02365064|50225606|FG000|Overall Study|Withdrawal by Subject|6|||
25113974|NCT02365064|50225607|FG001|Overall Study|Withdrawal by Subject|9|||
25113975|NCT02365064|50225606|FG000|Overall Study|Treatment intolerance|2|||
25113976|NCT02365064|50225607|FG001|Overall Study|Treatment intolerance|4|||
25113977|NCT02401256|50225613|FG000|Overall Study|Adverse Event|5|||
25113978|NCT02401256|50225613|FG000|Overall Study|Withdrawal by Subject|12|||
25113979|NCT02349295|50225622|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
25113980|NCT02349295|50225623|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
25113981|NCT02349295|50225624|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
25113982|NCT02349295|50225625|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
25113983|NCT02349295|50225626|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
25113984|NCT02349295|50225627|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
25113985|NCT02349295|50225628|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
25113986|NCT02349295|50225629|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
25113987|NCT02349295|50225630|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
25113988|NCT02349295|50225631|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
25113989|NCT02349295|50225632|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
25113990|NCT02349295|50225633|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
25113991|NCT02349295|50225634|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
25113992|NCT02349295|50225635|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
25113993|NCT02349295|50225622|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
25113994|NCT02349295|50225623|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
25113995|NCT02349295|50225624|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
25113996|NCT02349295|50225625|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
25113997|NCT02349295|50225626|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
25113998|NCT02349295|50225627|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
25113999|NCT02349295|50225628|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
25114000|NCT02349295|50225629|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
25114001|NCT02349295|50225630|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
25114002|NCT02349295|50225631|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
25114003|NCT02349295|50225632|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
25114004|NCT02349295|50225633|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
25114005|NCT02349295|50225634|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
25261401|NCT01306032|50576142|FG003|First Intervention|Death|0|||
25261402|NCT01306032|50576143|FG004|First Intervention|Death|0|||
25114006|NCT02349295|50225635|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
25114007|NCT02349295|50225622|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
25114008|NCT02349295|50225623|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
25114009|NCT02349295|50225624|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
25114010|NCT02349295|50225625|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
25114011|NCT02349295|50225626|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
25114012|NCT02349295|50225627|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
25114013|NCT02349295|50225628|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
25114014|NCT02349295|50225629|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
25114015|NCT02349295|50225630|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
25114016|NCT02349295|50225631|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
25114017|NCT02349295|50225632|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
25114018|NCT02349295|50225633|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
25114019|NCT02349295|50225634|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
25114020|NCT02349295|50225635|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
25114021|NCT02349295|50225622|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
25114022|NCT02349295|50225623|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
25114023|NCT02349295|50225624|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
25114024|NCT02349295|50225625|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
25114025|NCT02349295|50225626|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
25114026|NCT02349295|50225627|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
25114027|NCT02349295|50225628|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
25114028|NCT02349295|50225629|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
25114029|NCT02349295|50225630|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
25114030|NCT02349295|50225631|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
25114031|NCT02349295|50225632|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
25114032|NCT02349295|50225633|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
25114033|NCT02349295|50225634|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
25114034|NCT02349295|50225635|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
25114035|NCT02349295|50225622|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
25114036|NCT02349295|50225623|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
25114037|NCT02349295|50225624|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
25114038|NCT02349295|50225625|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
25114039|NCT02349295|50225626|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
25114040|NCT02349295|50225627|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
25114041|NCT02349295|50225628|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
25114042|NCT02349295|50225629|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
25114043|NCT02349295|50225630|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
25114044|NCT02349295|50225631|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
25114045|NCT02349295|50225632|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
25114046|NCT02349295|50225633|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
25114047|NCT02349295|50225634|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
25114048|NCT02349295|50225635|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
25114049|NCT02349295|50225622|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
25114050|NCT02349295|50225623|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
25114051|NCT02349295|50225624|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
25114052|NCT02349295|50225625|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
25114053|NCT02349295|50225626|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
25114054|NCT02349295|50225627|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
25114055|NCT02349295|50225628|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
25114056|NCT02349295|50225629|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
25114057|NCT02349295|50225630|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
25114058|NCT02349295|50225631|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
25114059|NCT02349295|50225632|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
25114060|NCT02349295|50225633|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
25114061|NCT02349295|50225634|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
25114062|NCT02349295|50225635|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
25114063|NCT02349295|50225622|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
25114064|NCT02349295|50225623|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
25114065|NCT02349295|50225624|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
25114066|NCT02349295|50225625|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
25114067|NCT02349295|50225626|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
25114068|NCT02349295|50225627|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
25114069|NCT02349295|50225628|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
25114070|NCT02349295|50225629|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
25114071|NCT02349295|50225630|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
25114072|NCT02349295|50225631|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
25114073|NCT02349295|50225632|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
25114074|NCT02349295|50225633|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
25114075|NCT02349295|50225634|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
25114076|NCT02349295|50225635|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
25114077|NCT02349295|50225622|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
25114078|NCT02349295|50225623|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
25114079|NCT02349295|50225624|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
25114080|NCT02349295|50225625|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
25114081|NCT02349295|50225626|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
25114082|NCT02349295|50225627|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
25114083|NCT02349295|50225628|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
25114084|NCT02349295|50225629|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
25114085|NCT02349295|50225630|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
25114086|NCT02349295|50225631|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
25114087|NCT02349295|50225632|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
25114088|NCT02349295|50225633|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
25114089|NCT02349295|50225634|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
25114090|NCT02349295|50225635|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
25114091|NCT02349295|50225622|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
25114092|NCT02349295|50225623|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
25114093|NCT02349295|50225624|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
25114094|NCT02349295|50225625|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
25114095|NCT02349295|50225626|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
25114096|NCT02349295|50225627|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
25114097|NCT02349295|50225628|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
25114098|NCT02349295|50225629|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
25114099|NCT02349295|50225630|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
25114100|NCT02349295|50225631|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
25114101|NCT02349295|50225632|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
25114102|NCT02349295|50225633|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
25114103|NCT02349295|50225634|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
25114104|NCT02349295|50225635|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
25114105|NCT02349295|50225622|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
25114106|NCT02349295|50225623|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
25114107|NCT02349295|50225624|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
25114108|NCT02349295|50225625|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
25114109|NCT02349295|50225626|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
25114110|NCT02349295|50225627|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
25114111|NCT02349295|50225628|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
25114112|NCT02349295|50225629|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
25114113|NCT02349295|50225630|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
25114114|NCT02349295|50225631|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
25114115|NCT02349295|50225632|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
25114116|NCT02349295|50225633|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
25261403|NCT01306032|50576144|FG005|First Intervention|Death|0|||
25261404|NCT01306032|50576139|FG000|First Intervention|Ineligible|0|||
25261405|NCT01306032|50576140|FG001|First Intervention|Ineligible|0|||
25114117|NCT02349295|50225634|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
25114118|NCT02349295|50225635|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
25114119|NCT02349295|50225622|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
25114120|NCT02349295|50225623|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
25114121|NCT02349295|50225624|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
25114122|NCT02349295|50225625|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
25114123|NCT02349295|50225626|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
25114124|NCT02349295|50225627|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
25114125|NCT02349295|50225628|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
25114126|NCT02349295|50225629|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
25114127|NCT02349295|50225630|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
25114128|NCT02349295|50225631|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
25114129|NCT02349295|50225632|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
25114130|NCT02349295|50225633|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
25114131|NCT02349295|50225634|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
25114132|NCT02349295|50225635|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
25114133|NCT02349295|50225622|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
25114134|NCT02349295|50225623|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
25114135|NCT02349295|50225624|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
25114136|NCT02349295|50225625|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
25114137|NCT02349295|50225626|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
25114138|NCT02349295|50225627|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
25114139|NCT02349295|50225628|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
25114140|NCT02349295|50225629|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
25114141|NCT02349295|50225630|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
25114142|NCT02349295|50225631|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
25114143|NCT02349295|50225632|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
25114144|NCT02349295|50225633|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
25114145|NCT02349295|50225634|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
25114146|NCT02349295|50225635|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
25114147|NCT02349295|50225622|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
25114148|NCT02349295|50225623|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
25114149|NCT02349295|50225624|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
25114150|NCT02349295|50225625|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
25114151|NCT02349295|50225626|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
25114152|NCT02349295|50225627|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
25114153|NCT02349295|50225628|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
25114154|NCT02349295|50225629|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
25114155|NCT02349295|50225630|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
25114156|NCT02349295|50225631|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
25114157|NCT02349295|50225632|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
25114158|NCT02349295|50225633|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
25261406|NCT01306032|50576141|FG002|First Intervention|Ineligible|0|||
25261407|NCT01306032|50576142|FG003|First Intervention|Ineligible|0|||
25261408|NCT01306032|50576143|FG004|First Intervention|Ineligible|0|||
25261409|NCT01306032|50576144|FG005|First Intervention|Ineligible|1|||
25261410|NCT01306032|50576139|FG000|First Intervention|Progressive disease|0|||
25261411|NCT01306032|50576140|FG001|First Intervention|Progressive disease|0|||
25261412|NCT01306032|50576141|FG002|First Intervention|Progressive disease|0|||
25261413|NCT01306032|50576142|FG003|First Intervention|Progressive disease|0|||
25261414|NCT01306032|50576143|FG004|First Intervention|Progressive disease|2|||
25261415|NCT01306032|50576144|FG005|First Intervention|Progressive disease|0|||
25261416|NCT01306032|50576139|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
25261417|NCT01306032|50576140|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
25261418|NCT01306032|50576141|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
25261419|NCT01306032|50576142|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
25261420|NCT01306032|50576143|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
25261421|NCT01306032|50576144|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
25261422|NCT01306032|50576139|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
25261423|NCT01306032|50576140|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
25261424|NCT01306032|50576141|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
25008391|NCT03535194|50101309|FG004|Induction Period|Screen Failure|0|||
25114159|NCT02349295|50225634|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
25177407|NCT02754141|50321520|FG013|Overall Study|Withdrew consent|0|||
25114160|NCT02349295|50225635|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
25114161|NCT02349295|50225622|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
25114162|NCT02349295|50225623|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
25114163|NCT02349295|50225624|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
25114164|NCT02349295|50225625|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
25114165|NCT02349295|50225626|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
25114166|NCT02349295|50225627|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
25114167|NCT02349295|50225628|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
25114168|NCT02349295|50225629|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
25114169|NCT02349295|50225630|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
25114170|NCT02349295|50225631|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
25114171|NCT02349295|50225632|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
25114172|NCT02349295|50225633|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
25114173|NCT02349295|50225634|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
25114174|NCT02349295|50225635|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
25114175|NCT02349295|50225622|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
25114176|NCT02349295|50225623|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
25114177|NCT02349295|50225624|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
25114178|NCT02349295|50225625|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
25114179|NCT02349295|50225626|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
25114180|NCT02349295|50225627|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
25114181|NCT02349295|50225628|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
25114182|NCT02349295|50225629|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
25114183|NCT02349295|50225630|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
25114184|NCT02349295|50225631|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
25114185|NCT02349295|50225632|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
25114186|NCT02349295|50225633|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
25114187|NCT02349295|50225634|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
25114188|NCT02349295|50225635|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
25114189|NCT02349295|50225622|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
25114190|NCT02349295|50225623|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
25114191|NCT02349295|50225624|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
25114192|NCT02349295|50225625|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
25114193|NCT02349295|50225626|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
25114194|NCT02349295|50225627|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
25114195|NCT02349295|50225628|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
25114196|NCT02349295|50225629|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
25114197|NCT02349295|50225630|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
25114198|NCT02349295|50225631|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
25114199|NCT02349295|50225632|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
25114200|NCT02349295|50225633|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
25114201|NCT02349295|50225634|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
25114202|NCT02349295|50225635|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
25114203|NCT02349295|50225622|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
25114204|NCT02349295|50225623|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
25114205|NCT02349295|50225624|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
25114206|NCT02349295|50225625|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
25114207|NCT02349295|50225626|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
25114208|NCT02349295|50225627|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
25114209|NCT02349295|50225628|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
25114210|NCT02349295|50225629|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
25114211|NCT02349295|50225630|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
25114212|NCT02349295|50225631|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
25114213|NCT02349295|50225632|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
25114214|NCT02349295|50225633|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
25114215|NCT02349295|50225634|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
25114216|NCT02349295|50225635|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
25114217|NCT02349295|50225622|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
25114218|NCT02349295|50225623|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
25114219|NCT02349295|50225624|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
25114220|NCT02349295|50225625|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
25114221|NCT02349295|50225626|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
25114222|NCT02349295|50225627|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
25114223|NCT02349295|50225628|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
25177408|NCT02754141|50321521|FG014|Overall Study|Withdrew consent|0|||
25114224|NCT02349295|50225629|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
25114225|NCT02349295|50225630|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
25114226|NCT02349295|50225631|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
25114227|NCT02349295|50225632|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
25114228|NCT02349295|50225633|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
25114229|NCT02349295|50225634|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
25114230|NCT02349295|50225635|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
25114231|NCT02281357|50225662|FG000|Overall Study|Adverse Event|2|||
25114232|NCT02281357|50225663|FG001|Overall Study|Adverse Event|1|||
25114233|NCT02281357|50225662|FG000|Overall Study|Lost to Follow-up|1|||
25114234|NCT02281357|50225663|FG001|Overall Study|Lost to Follow-up|0|||
25114235|NCT02281357|50225662|FG000|Overall Study|Withdrawal by Subject|4|||
25114236|NCT02281357|50225663|FG001|Overall Study|Withdrawal by Subject|3|||
25114237|NCT02284243|50225671|FG000|Overall Study|Lack of Efficacy|3|||
25114238|NCT02284243|50225672|FG001|Overall Study|Lack of Efficacy|3|||
25114239|NCT02284243|50225671|FG000|Overall Study|Adverse Event|1|||
25114240|NCT02284243|50225672|FG001|Overall Study|Adverse Event|0|||
25114241|NCT02284009|50225680|FG000|Overall Study|Adverse Event|3|||
25114242|NCT02284009|50225681|FG001|Overall Study|Adverse Event|0|||
25114243|NCT02284009|50225680|FG000|Overall Study|Lost to Follow-up|1|||
25114244|NCT02284009|50225681|FG001|Overall Study|Lost to Follow-up|3|||
25114245|NCT02284009|50225680|FG000|Overall Study|Physician Decision|0|||
25114246|NCT02284009|50225681|FG001|Overall Study|Physician Decision|2|||
25114247|NCT02284009|50225680|FG000|Overall Study|Withdrawal by Subject|2|||
25114248|NCT02284009|50225681|FG001|Overall Study|Withdrawal by Subject|5|||
25114249|NCT02280499|50225689|FG000|Overall Study|Death|14|||
25114250|NCT02280499|50225689|FG000|Overall Study|Lost to Follow-up|42|||
25114251|NCT02280499|50225689|FG000|Overall Study|Adverse Event|5|||
25114252|NCT02400476|50225699|FG000|Overall Study|Adverse Event|57|||
25114253|NCT02400476|50225700|FG001|Overall Study|Adverse Event|10|||
25114254|NCT02400476|50225701|FG002|Overall Study|Adverse Event|22|||
25114255|NCT02400476|50225702|FG003|Overall Study|Adverse Event|19|||
25114256|NCT02400476|50225703|FG004|Overall Study|Adverse Event|5|||
25114257|NCT02400476|50225704|FG005|Overall Study|Adverse Event|8|||
25114258|NCT02400476|50225699|FG000|Overall Study|Withdrawal by Subject|4|||
25114259|NCT02400476|50225700|FG001|Overall Study|Withdrawal by Subject|1|||
25114260|NCT02400476|50225701|FG002|Overall Study|Withdrawal by Subject|12|||
25114261|NCT02400476|50225702|FG003|Overall Study|Withdrawal by Subject|7|||
25114262|NCT02400476|50225703|FG004|Overall Study|Withdrawal by Subject|5|||
25114263|NCT02400476|50225704|FG005|Overall Study|Withdrawal by Subject|5|||
25114264|NCT02400476|50225699|FG000|Overall Study|Lost to Follow-up|0|||
25114265|NCT02400476|50225700|FG001|Overall Study|Lost to Follow-up|0|||
25114266|NCT02400476|50225701|FG002|Overall Study|Lost to Follow-up|0|||
25114267|NCT02400476|50225702|FG003|Overall Study|Lost to Follow-up|1|||
25114268|NCT02400476|50225703|FG004|Overall Study|Lost to Follow-up|3|||
25114269|NCT02400476|50225704|FG005|Overall Study|Lost to Follow-up|1|||
25114270|NCT02400476|50225699|FG000|Overall Study|Physician Decision|0|||
25114271|NCT02400476|50225700|FG001|Overall Study|Physician Decision|0|||
25114272|NCT02400476|50225701|FG002|Overall Study|Physician Decision|1|||
25114273|NCT02400476|50225702|FG003|Overall Study|Physician Decision|1|||
25114274|NCT02400476|50225703|FG004|Overall Study|Physician Decision|0|||
25114275|NCT02400476|50225704|FG005|Overall Study|Physician Decision|1|||
25114276|NCT02400476|50225699|FG000|Overall Study|Other, Disease Progression|0|||
25114277|NCT02400476|50225700|FG001|Overall Study|Other, Disease Progression|1|||
25114278|NCT02400476|50225701|FG002|Overall Study|Other, Disease Progression|2|||
25114279|NCT02400476|50225702|FG003|Overall Study|Other, Disease Progression|1|||
25114280|NCT02400476|50225703|FG004|Overall Study|Other, Disease Progression|2|||
25114281|NCT02400476|50225704|FG005|Overall Study|Other, Disease Progression|1|||
25114282|NCT02400476|50225699|FG000|Overall Study|Other, Decreased Quality of Life|0|||
25114283|NCT02400476|50225700|FG001|Overall Study|Other, Decreased Quality of Life|0|||
25114284|NCT02400476|50225701|FG002|Overall Study|Other, Decreased Quality of Life|2|||
25114285|NCT02400476|50225702|FG003|Overall Study|Other, Decreased Quality of Life|0|||
25114286|NCT02400476|50225703|FG004|Overall Study|Other, Decreased Quality of Life|0|||
25114287|NCT02400476|50225704|FG005|Overall Study|Other, Decreased Quality of Life|0|||
25114288|NCT02400476|50225699|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
25114289|NCT02400476|50225700|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
25008392|NCT03535194|50101305|FG000|Induction Period|Withdrawal by Subject|3|||
25008393|NCT03535194|50101306|FG001|Induction Period|Withdrawal by Subject|4|||
25114290|NCT02400476|50225701|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
25114291|NCT02400476|50225702|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
25114292|NCT02400476|50225703|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
25114293|NCT02400476|50225704|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
25114294|NCT02363738|50225720|FG000|Overall Study|Adverse Event|5|||
25114295|NCT02363738|50225721|FG001|Overall Study|Adverse Event|2|||
25114296|NCT02363738|50225720|FG000|Overall Study|Lack of Efficacy|1|||
25114297|NCT02363738|50225721|FG001|Overall Study|Lack of Efficacy|2|||
25114298|NCT02363738|50225720|FG000|Overall Study|Lost to Follow-up|2|||
25114299|NCT02363738|50225721|FG001|Overall Study|Lost to Follow-up|1|||
25114300|NCT02331680|50225730|FG000|Overall Study|Adverse Event|3|||
25114301|NCT02331680|50225731|FG001|Overall Study|Adverse Event|0|||
25114302|NCT02331680|50225732|FG002|Overall Study|Adverse Event|2|||
25114303|NCT02331680|50225730|FG000|Overall Study|Physician Decision|1|||
25114304|NCT02331680|50225731|FG001|Overall Study|Physician Decision|1|||
25114305|NCT02331680|50225732|FG002|Overall Study|Physician Decision|2|||
25114306|NCT02331680|50225730|FG000|Overall Study|Withdrawal by Subject|0|||
25114307|NCT02331680|50225731|FG001|Overall Study|Withdrawal by Subject|1|||
25114308|NCT02331680|50225732|FG002|Overall Study|Withdrawal by Subject|2|||
25114309|NCT02331680|50225730|FG000|Overall Study|Met withdrawal criteria|2|||
25114310|NCT02331680|50225731|FG001|Overall Study|Met withdrawal criteria|2|||
25114311|NCT02331680|50225732|FG002|Overall Study|Met withdrawal criteria|5|||
25114312|NCT02331680|50225730|FG000|Overall Study|Non-compliance with study drug|0|||
25114313|NCT02331680|50225731|FG001|Overall Study|Non-compliance with study drug|0|||
25114314|NCT02331680|50225732|FG002|Overall Study|Non-compliance with study drug|1|||
25114315|NCT02331680|50225730|FG000|Overall Study|Protocol Violation|0|||
25114316|NCT02331680|50225731|FG001|Overall Study|Protocol Violation|0|||
25114317|NCT02331680|50225732|FG002|Overall Study|Protocol Violation|3|||
25114318|NCT02331446|50225744|FG000|Overall Study|Lost to Follow-up|2|||
25114319|NCT02331446|50225745|FG001|Overall Study|Lost to Follow-up|1|||
25114320|NCT02331446|50225746|FG002|Overall Study|Lost to Follow-up|0|||
25114321|NCT02331446|50225747|FG003|Overall Study|Lost to Follow-up|1|||
25114322|NCT02331446|50225744|FG000|Overall Study|Personal Problem|2|||
25114323|NCT02331446|50225745|FG001|Overall Study|Personal Problem|0|||
25114324|NCT02331446|50225746|FG002|Overall Study|Personal Problem|0|||
25114325|NCT02331446|50225747|FG003|Overall Study|Personal Problem|0|||
25114326|NCT02331446|50225744|FG000|Overall Study|Disease|0|||
25114327|NCT02331446|50225745|FG001|Overall Study|Disease|2|||
25114328|NCT02331446|50225746|FG002|Overall Study|Disease|2|||
25114329|NCT02331446|50225747|FG003|Overall Study|Disease|1|||
25114330|NCT02331446|50225744|FG000|Overall Study|Physician Decision|0|||
25114331|NCT02331446|50225745|FG001|Overall Study|Physician Decision|1|||
25114332|NCT02331446|50225746|FG002|Overall Study|Physician Decision|0|||
25114333|NCT02331446|50225747|FG003|Overall Study|Physician Decision|1|||
25114334|NCT02331446|50225744|FG000|Overall Study|Lost before baseline analysis|0|||
25114335|NCT02331446|50225745|FG001|Overall Study|Lost before baseline analysis|1|||
25114336|NCT02331446|50225746|FG002|Overall Study|Lost before baseline analysis|1|||
25114337|NCT02331446|50225747|FG003|Overall Study|Lost before baseline analysis|0|||
25114338|NCT02349061|50225759|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
25114339|NCT02349061|50225760|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
25114340|NCT02349061|50225761|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
25114341|NCT02349061|50225759|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
25114342|NCT02349061|50225760|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
25114343|NCT02349061|50225761|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
25114344|NCT02349061|50225759|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
25114345|NCT02349061|50225760|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
25114346|NCT02349061|50225761|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
25114347|NCT02349061|50225759|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
25114348|NCT02349061|50225760|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
25114349|NCT02349061|50225761|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
25114350|NCT02349061|50225759|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
25114351|NCT02349061|50225760|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
25114352|NCT02349061|50225761|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
25114353|NCT02349061|50225759|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
25114354|NCT02349061|50225760|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
25114355|NCT02349061|50225761|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
25114356|NCT02349061|50225759|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
25114357|NCT02349061|50225760|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
25114358|NCT02349061|50225761|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
25114359|NCT02349061|50225759|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
25114360|NCT02349061|50225760|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
25114361|NCT02349061|50225761|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
25114362|NCT02349061|50225759|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
25114363|NCT02349061|50225760|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
25114364|NCT02349061|50225761|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
25114365|NCT02349061|50225759|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
25114366|NCT02349061|50225760|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
25114367|NCT02349061|50225761|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
25114368|NCT02349061|50225759|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
25114369|NCT02349061|50225760|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
25114370|NCT02349061|50225761|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
25114371|NCT02349061|50225759|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
25114372|NCT02349061|50225760|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
25114373|NCT02349061|50225761|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
25114374|NCT02349061|50225759|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
25114375|NCT02349061|50225760|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
25114376|NCT02349061|50225761|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
25114377|NCT02331368|50225771|FG000|Overall Study|Withdrawal by Subject|3|||
25114378|NCT02362724|50225777|FG000|Overall Study|Withdrawal by Subject|3|||
25114379|NCT02362724|50225778|FG001|Overall Study|Withdrawal by Subject|1|||
25114380|NCT02362724|50225777|FG000|Overall Study|Adverse Event|3|||
25114381|NCT02362724|50225778|FG001|Overall Study|Adverse Event|0|||
25114382|NCT02362646|50225786|FG000|Overall Study|Death|15|||
25114383|NCT02362646|50225787|FG001|Overall Study|Death|8|||
25114384|NCT02362646|50225786|FG000|Overall Study|Withdrawal by Subject|2|||
25114385|NCT02362646|50225787|FG001|Overall Study|Withdrawal by Subject|2|||
25114386|NCT02362646|50225786|FG000|Overall Study|received transplant|21|||
25114387|NCT02362646|50225787|FG001|Overall Study|received transplant|14|||
25114388|NCT02280421|50225797|FG000|Washout (2 Weeks)|Adverse Event|0|||
25114389|NCT02280421|50225798|FG001|Washout (2 Weeks)|Adverse Event|1|||
25114390|NCT02280421|50225797|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
25114391|NCT02280421|50225798|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
25114392|NCT02362412|50225816|FG000|Treatment Period III|Lost to Follow-up|0|||
25114393|NCT02362412|50225817|FG001|Treatment Period III|Lost to Follow-up|1|||
25114394|NCT02280187|50225829|FG000|Overall Study|Lost to Follow-up|218|||
25114395|NCT02347813|50225835|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
25114396|NCT02347813|50225836|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
25114397|NCT02347813|50225835|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
25114398|NCT02347813|50225836|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
25114399|NCT02329730|50225846|FG000|Overall Study|Protocol Violation|0|||
25114400|NCT02329730|50225847|FG001|Overall Study|Protocol Violation|0|||
25114401|NCT02329730|50225848|FG002|Overall Study|Protocol Violation|0|||
25114402|NCT02329730|50225849|FG003|Overall Study|Protocol Violation|0|||
25114403|NCT02329730|50225850|FG004|Overall Study|Protocol Violation|2|||
25114404|NCT02329730|50225851|FG005|Overall Study|Protocol Violation|2|||
25114405|NCT02329730|50225852|FG006|Overall Study|Protocol Violation|0|||
25114406|NCT02329730|50225853|FG007|Overall Study|Protocol Violation|0|||
25114407|NCT02329730|50225854|FG008|Overall Study|Protocol Violation|0|||
25114408|NCT02329730|50225855|FG009|Overall Study|Protocol Violation|0|||
25114409|NCT02329730|50225856|FG010|Overall Study|Protocol Violation|0|||
25261425|NCT01306032|50576142|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
25261426|NCT01306032|50576143|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
25261427|NCT01306032|50576144|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
25261428|NCT01263015|50576172|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
25261429|NCT01263015|50576173|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
25261430|NCT01263015|50576172|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
25114410|NCT02329730|50225857|FG011|Overall Study|Protocol Violation|0|||
25114411|NCT02329730|50225846|FG000|Overall Study|Withdrawal by Subject|0|||
25114412|NCT02329730|50225847|FG001|Overall Study|Withdrawal by Subject|0|||
25114413|NCT02329730|50225848|FG002|Overall Study|Withdrawal by Subject|0|||
25114414|NCT02329730|50225849|FG003|Overall Study|Withdrawal by Subject|0|||
25114415|NCT02329730|50225850|FG004|Overall Study|Withdrawal by Subject|1|||
25114416|NCT02329730|50225851|FG005|Overall Study|Withdrawal by Subject|0|||
25114417|NCT02329730|50225852|FG006|Overall Study|Withdrawal by Subject|1|||
25114418|NCT02329730|50225853|FG007|Overall Study|Withdrawal by Subject|1|||
25114419|NCT02329730|50225854|FG008|Overall Study|Withdrawal by Subject|1|||
25114420|NCT02329730|50225855|FG009|Overall Study|Withdrawal by Subject|1|||
25114421|NCT02329730|50225856|FG010|Overall Study|Withdrawal by Subject|0|||
25114422|NCT02329730|50225857|FG011|Overall Study|Withdrawal by Subject|0|||
25261431|NCT01263015|50576173|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
25261432|NCT01263015|50576172|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
25261433|NCT01263015|50576173|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
25261434|NCT01263015|50576172|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
25114423|NCT02328326|50225877|FG000|Overall Study|Withdrawal by Subject|10|||
25114424|NCT02328326|50225878|FG001|Overall Study|Withdrawal by Subject|3|||
25114425|NCT02328326|50225877|FG000|Overall Study|Death|2|||
25114426|NCT02328326|50225878|FG001|Overall Study|Death|1|||
25114427|NCT02328326|50225877|FG000|Overall Study|Lost to Follow-up|10|||
25114428|NCT02328326|50225878|FG001|Overall Study|Lost to Follow-up|4|||
25114429|NCT01649804|50225886|FG000|Overall Study|Administrative/Other|8|||
25114430|NCT02397278|50225892|FG000|Overall Study|Withdrawal by Subject|0|||
25114431|NCT02397278|50225893|FG001|Overall Study|Withdrawal by Subject|2|||
25114432|NCT02397278|50225892|FG000|Overall Study|Deemed ineligible following surgery|1|||
25114433|NCT02397278|50225893|FG001|Overall Study|Deemed ineligible following surgery|1|||
25114434|NCT02360228|50225902|FG000|Overall Study|Withdrawal by Subject|1|||
25114435|NCT02360228|50225903|FG001|Overall Study|Withdrawal by Subject|0|||
25114436|NCT02360228|50225904|FG002|Overall Study|Withdrawal by Subject|0|||
25114437|NCT02360228|50225902|FG000|Overall Study|Self-discontinued medication|0|||
25114438|NCT02360228|50225903|FG001|Overall Study|Self-discontinued medication|1|||
25114439|NCT02360228|50225904|FG002|Overall Study|Self-discontinued medication|0|||
25114440|NCT02360228|50225902|FG000|Overall Study|Unstable symptoms during screening|0|||
25114441|NCT02360228|50225903|FG001|Overall Study|Unstable symptoms during screening|0|||
25114442|NCT02360228|50225904|FG002|Overall Study|Unstable symptoms during screening|1|||
25114443|NCT02359994|50225914|FG000|Overall Population Study|Adverse Event|1|||
25114444|NCT02359994|50225915|FG001|Overall Population Study|Adverse Event|1|||
25114445|NCT02359994|50225914|FG000|Overall Population Study|Death|1|||
25114446|NCT02359994|50225915|FG001|Overall Population Study|Death|5|||
25114447|NCT02359994|50225914|FG000|Overall Population Study|Lost to Follow-up|1|||
25114448|NCT02359994|50225915|FG001|Overall Population Study|Lost to Follow-up|1|||
25114449|NCT02359994|50225914|FG000|Overall Population Study|Withdrawal by Subject|1|||
25114450|NCT02359994|50225915|FG001|Overall Population Study|Withdrawal by Subject|0|||
25114451|NCT02359994|50225914|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
25114452|NCT02359994|50225915|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
25114453|NCT02359994|50225914|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
25114454|NCT02359994|50225915|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
25114455|NCT02359994|50225914|FG000|Extended Oncology 24-Month Survival|Death|19|||
25114456|NCT02359994|50225915|FG001|Extended Oncology 24-Month Survival|Death|21|||
25114457|NCT02359994|50225914|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
25114458|NCT02359994|50225915|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
25114459|NCT02326298|50225924|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25114460|NCT02326298|50225925|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25114461|NCT02326298|50225926|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
25114462|NCT02326298|50225927|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25114463|NCT02326298|50225928|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25114464|NCT02326298|50225929|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25114465|NCT02326298|50225930|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25114466|NCT02326298|50225931|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25114467|NCT02326298|50225932|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25114468|NCT02326298|50225933|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25114469|NCT02326298|50225934|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25114470|NCT02326298|50225935|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25114471|NCT02326298|50225936|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25114472|NCT02326298|50225937|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25114473|NCT02326298|50225924|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
25114474|NCT02326298|50225925|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
25114475|NCT02326298|50225926|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
25114476|NCT02326298|50225927|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
25114477|NCT02326298|50225928|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
25114478|NCT02326298|50225929|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
25114479|NCT02326298|50225930|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
25114480|NCT02326298|50225931|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
25114481|NCT02326298|50225932|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
25114482|NCT02326298|50225933|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
25114483|NCT02326298|50225934|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
25114484|NCT02326298|50225935|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
25114485|NCT02326298|50225936|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
25114486|NCT02326298|50225937|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
25114487|NCT02326298|50225924|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
25114488|NCT02326298|50225925|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
25114489|NCT02326298|50225926|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25114490|NCT02326298|50225927|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25114491|NCT02326298|50225928|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25114492|NCT02326298|50225929|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25114493|NCT02326298|50225930|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25114494|NCT02326298|50225931|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25114495|NCT02326298|50225932|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25114496|NCT02326298|50225933|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25114497|NCT02326298|50225934|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25114498|NCT02326298|50225935|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25114499|NCT02326298|50225936|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25114500|NCT02326298|50225937|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25114501|NCT02326298|50225924|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
25114502|NCT02326298|50225925|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
25114503|NCT02326298|50225926|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25114504|NCT02326298|50225927|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25114505|NCT02326298|50225928|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25114506|NCT02326298|50225929|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25114507|NCT02326298|50225930|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25114508|NCT02326298|50225931|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25114509|NCT02326298|50225932|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25114510|NCT02326298|50225933|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25114511|NCT02326298|50225934|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25114512|NCT02326298|50225935|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25114513|NCT02326298|50225936|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25114514|NCT02326298|50225937|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25114515|NCT02326298|50225924|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
25114516|NCT02326298|50225925|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
25114517|NCT02326298|50225926|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
25114518|NCT02326298|50225927|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
25114519|NCT02326298|50225928|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
25114520|NCT02326298|50225929|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
25114521|NCT02326298|50225930|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
25114522|NCT02326298|50225931|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
25114523|NCT02326298|50225932|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
25114524|NCT02326298|50225933|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
25114525|NCT02326298|50225934|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
25114526|NCT02326298|50225935|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
25114527|NCT02326298|50225936|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
25114528|NCT02326298|50225937|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
25114529|NCT02326298|50225924|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25114530|NCT02326298|50225925|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25114531|NCT02326298|50225926|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25114532|NCT02326298|50225927|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25114533|NCT02326298|50225928|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25114534|NCT02326298|50225929|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
25114535|NCT02326298|50225930|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
25114536|NCT02326298|50225931|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
25114537|NCT02326298|50225932|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
25114538|NCT02326298|50225933|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
25114539|NCT02326298|50225934|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25114540|NCT02326298|50225935|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25114541|NCT02326298|50225936|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25114542|NCT02326298|50225937|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25114543|NCT02326298|50225924|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
25114544|NCT02326298|50225925|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
25114545|NCT02326298|50225926|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
25114546|NCT02326298|50225927|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
25114547|NCT02326298|50225928|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
25114548|NCT02326298|50225929|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
25114549|NCT02326298|50225930|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
25114550|NCT02326298|50225931|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
25114551|NCT02326298|50225932|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
25114552|NCT02326298|50225933|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
25114553|NCT02326298|50225934|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
25114554|NCT02326298|50225935|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
25114555|NCT02326298|50225936|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
25114556|NCT02326298|50225937|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
25114557|NCT02326298|50225924|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
25114558|NCT02326298|50225925|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
25114559|NCT02326298|50225926|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
25168602|NCT04452318|50297975|FG005|Overall Study|Withdrawal by Subject|8|||
25114560|NCT02326298|50225927|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
25114561|NCT02326298|50225928|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
25114562|NCT02326298|50225929|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
25114563|NCT02326298|50225930|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
25114564|NCT02326298|50225931|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
25114565|NCT02326298|50225932|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
25114566|NCT02326298|50225933|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
25114567|NCT02326298|50225934|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
25114568|NCT02326298|50225935|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
25114569|NCT02326298|50225936|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
25114570|NCT02326298|50225937|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
25114571|NCT02326298|50225924|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25114572|NCT02326298|50225925|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25114573|NCT02326298|50225926|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25114574|NCT02326298|50225927|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25114575|NCT02326298|50225928|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25114576|NCT02326298|50225929|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25114577|NCT02326298|50225930|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
25114578|NCT02326298|50225931|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25114579|NCT02326298|50225932|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25114580|NCT02326298|50225933|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25114581|NCT02326298|50225934|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25114582|NCT02326298|50225935|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25114583|NCT02326298|50225936|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25114584|NCT02326298|50225937|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25114585|NCT02326298|50225924|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
25114586|NCT02326298|50225925|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
25114587|NCT02326298|50225926|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
25114588|NCT02326298|50225927|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
25114589|NCT02326298|50225928|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
25114590|NCT02326298|50225929|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
25114591|NCT02326298|50225930|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
25114592|NCT02326298|50225931|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
25114593|NCT02326298|50225932|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
25114594|NCT02326298|50225933|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
25114595|NCT02326298|50225934|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
25114596|NCT02326298|50225935|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
25114597|NCT02326298|50225936|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
25114598|NCT02326298|50225937|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
25114599|NCT02326298|50225924|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25114600|NCT02326298|50225925|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25114601|NCT02326298|50225926|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25114602|NCT02326298|50225927|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25114603|NCT02326298|50225928|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25114604|NCT02326298|50225929|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25114605|NCT02326298|50225930|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
25114606|NCT02326298|50225931|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
25114607|NCT02326298|50225932|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25114608|NCT02326298|50225933|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25114609|NCT02326298|50225934|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25114610|NCT02326298|50225935|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25114611|NCT02326298|50225936|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25114612|NCT02326298|50225937|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25114613|NCT02326298|50225924|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25114614|NCT02326298|50225925|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25114615|NCT02326298|50225926|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25114616|NCT02326298|50225927|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25114617|NCT02326298|50225928|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25114618|NCT02326298|50225929|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25114619|NCT02326298|50225930|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25114620|NCT02326298|50225931|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
25114621|NCT02326298|50225932|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25114622|NCT02326298|50225933|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25114623|NCT02326298|50225934|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25114624|NCT02326298|50225935|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25114625|NCT02326298|50225936|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25114626|NCT02326298|50225937|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25114627|NCT02326298|50225924|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
25114628|NCT02326298|50225925|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
25114629|NCT02326298|50225926|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
25114630|NCT02326298|50225927|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
25114631|NCT02326298|50225928|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
25114632|NCT02326298|50225929|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
25114633|NCT02326298|50225930|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
25114634|NCT02326298|50225931|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
25114635|NCT02326298|50225932|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
25114636|NCT02326298|50225933|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
25114637|NCT02326298|50225934|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
25114638|NCT02326298|50225935|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
25114639|NCT02326298|50225936|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
25114640|NCT02326298|50225937|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
25114641|NCT02326298|50225924|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
25114642|NCT02326298|50225925|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
25261435|NCT01263015|50576173|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
25261436|NCT01263015|50576172|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
25261437|NCT01263015|50576173|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
25261438|NCT01263015|50576172|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
25261439|NCT01263015|50576173|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
25261440|NCT01263015|50576172|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
25261441|NCT01263015|50576173|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
25261442|NCT01263015|50576172|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
25261443|NCT01263015|50576173|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
25261444|NCT01263015|50576172|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
25114643|NCT02326298|50225926|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
25114644|NCT02326298|50225927|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
25114645|NCT02326298|50225928|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
25114646|NCT02326298|50225929|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
25114647|NCT02326298|50225930|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
25114648|NCT02326298|50225931|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
25114649|NCT02326298|50225932|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
25114650|NCT02326298|50225933|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
25114651|NCT02326298|50225934|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
25114652|NCT02326298|50225935|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
25114653|NCT02326298|50225936|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
25114654|NCT02326298|50225937|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
25114655|NCT02326298|50225924|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25114656|NCT02326298|50225925|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25114657|NCT02326298|50225926|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25114658|NCT02326298|50225927|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25114659|NCT02326298|50225928|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25114660|NCT02326298|50225929|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25114661|NCT02326298|50225930|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25114662|NCT02326298|50225931|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25114663|NCT02326298|50225932|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25114664|NCT02326298|50225933|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25114665|NCT02326298|50225934|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25114666|NCT02326298|50225935|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
25114667|NCT02326298|50225936|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
25114668|NCT02326298|50225937|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25114669|NCT02326298|50225924|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25114670|NCT02326298|50225925|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25114671|NCT02326298|50225926|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25114672|NCT02326298|50225927|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25114673|NCT02326298|50225928|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25114674|NCT02326298|50225929|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25114675|NCT02326298|50225930|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25114676|NCT02326298|50225931|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25114677|NCT02326298|50225932|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25114678|NCT02326298|50225933|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25114679|NCT02326298|50225934|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25114680|NCT02326298|50225935|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
25114681|NCT02326298|50225936|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
25114682|NCT02326298|50225937|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25114683|NCT02326298|50225924|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25114684|NCT02326298|50225925|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25114685|NCT02326298|50225926|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25114686|NCT02326298|50225927|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25114687|NCT02326298|50225928|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25114688|NCT02326298|50225929|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25114689|NCT02326298|50225930|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25114690|NCT02326298|50225931|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25114691|NCT02326298|50225932|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25114692|NCT02326298|50225933|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25114693|NCT02326298|50225934|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25114694|NCT02326298|50225935|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25114695|NCT02326298|50225936|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25114696|NCT02326298|50225937|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
25114697|NCT02326298|50225924|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25114698|NCT02326298|50225925|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25114699|NCT02326298|50225926|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25114700|NCT02326298|50225927|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25114701|NCT02326298|50225928|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25114702|NCT02326298|50225929|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25114703|NCT02326298|50225930|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25114704|NCT02326298|50225931|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25114705|NCT02326298|50225932|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25114706|NCT02326298|50225933|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25114707|NCT02326298|50225934|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25114708|NCT02326298|50225935|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
25114709|NCT02326298|50225936|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
25114710|NCT02326298|50225937|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
25114711|NCT02326298|50225924|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25114712|NCT02326298|50225925|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25114713|NCT02326298|50225926|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25114714|NCT02326298|50225927|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25114715|NCT02326298|50225928|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25114716|NCT02326298|50225929|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25114717|NCT02326298|50225930|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25114718|NCT02326298|50225931|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25114719|NCT02326298|50225932|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25114720|NCT02326298|50225933|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25114721|NCT02326298|50225934|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25114722|NCT02326298|50225935|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
25114723|NCT02326298|50225936|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
25114724|NCT02326298|50225937|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
25114725|NCT02326298|50225924|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25114726|NCT02326298|50225925|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25114727|NCT02326298|50225926|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25114728|NCT02326298|50225927|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25114729|NCT02326298|50225928|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25114730|NCT02326298|50225929|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25114731|NCT02326298|50225930|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25114732|NCT02326298|50225931|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25114733|NCT02326298|50225932|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25114734|NCT02326298|50225933|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25114735|NCT02326298|50225934|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25114736|NCT02326298|50225935|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
25114737|NCT02326298|50225936|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
25114738|NCT02326298|50225937|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
25261445|NCT01263015|50576173|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
25114739|NCT02396420|50225946|FG000|Overall Study|Death|1|||
25114740|NCT02279719|50225958|FG000|Overall Study|Patients randomized but never treated|0|||
25114741|NCT02279719|50225959|FG001|Overall Study|Patients randomized but never treated|0|||
25114742|NCT02279719|50225960|FG002|Overall Study|Patients randomized but never treated|0|||
25114743|NCT02279719|50225961|FG003|Overall Study|Patients randomized but never treated|0|||
25114744|NCT02279719|50225962|FG004|Overall Study|Patients randomized but never treated|3|||
25114745|NCT02279719|50225963|FG005|Overall Study|Patients randomized but never treated|0|||
25114746|NCT02279719|50225964|FG006|Overall Study|Patients randomized but never treated|3|||
25114747|NCT02279407|50226001|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
25114748|NCT02279407|50226002|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
25114749|NCT02279407|50226003|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
25114750|NCT02279407|50226004|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
25114751|NCT02279407|50226001|FG000|Overall Study|Withdrawal by Subject|1|||
25114752|NCT02279407|50226002|FG001|Overall Study|Withdrawal by Subject|0|||
25114753|NCT02279407|50226003|FG002|Overall Study|Withdrawal by Subject|1|||
25114754|NCT02279407|50226004|FG003|Overall Study|Withdrawal by Subject|1|||
25114755|NCT02279407|50226001|FG000|Overall Study|Adverse Event|1|||
25114756|NCT02279407|50226002|FG001|Overall Study|Adverse Event|1|||
25114757|NCT02279407|50226003|FG002|Overall Study|Adverse Event|2|||
25114758|NCT02279407|50226004|FG003|Overall Study|Adverse Event|0|||
25114759|NCT02326220|50226016|FG000|Double-blind Treatment Period|Adverse Event|1|||
25114760|NCT02326220|50226017|FG001|Double-blind Treatment Period|Adverse Event|2|||
25114761|NCT02326220|50226018|FG002|Double-blind Treatment Period|Adverse Event|0|||
25114762|NCT02326220|50226016|FG000|Double-blind Treatment Period|Protocol Violation|0|||
25114763|NCT02326220|50226017|FG001|Double-blind Treatment Period|Protocol Violation|1|||
25114764|NCT02326220|50226018|FG002|Double-blind Treatment Period|Protocol Violation|0|||
25114765|NCT02326220|50226016|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
25114766|NCT02326220|50226017|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
25114767|NCT02326220|50226018|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
25114768|NCT02326220|50226016|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
25114769|NCT02326220|50226017|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
25114770|NCT02326220|50226018|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
25114771|NCT02326220|50226016|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
25114772|NCT02326220|50226017|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
25114773|NCT02326220|50226018|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
25114774|NCT02279173|50226028|FG000|Overall Study|Protocol-specified Criteria|67|||
25114775|NCT02279173|50226028|FG000|Overall Study|Withdrawal by Subject|20|||
25114776|NCT02279173|50226028|FG000|Overall Study|Decision by Sponsor|4|||
25114777|NCT02279173|50226028|FG000|Overall Study|Lost to Follow-up|3|||
25114778|NCT02282917|50226034|FG000|Overall Study|Withdrawal by Subject|1|||
25114779|NCT02282917|50226034|FG000|Overall Study|Screen Failure/Not Eligible|1|||
25114780|NCT02358668|50226041|FG000|Overall Study|Adverse Event|2|||
25114781|NCT02358668|50226042|FG001|Overall Study|Adverse Event|0|||
25114782|NCT02358668|50226043|FG002|Overall Study|Adverse Event|0|||
25114783|NCT02358668|50226041|FG000|Overall Study|Withdrawal by Subject|0|||
25114784|NCT02358668|50226042|FG001|Overall Study|Withdrawal by Subject|1|||
25114785|NCT02358668|50226043|FG002|Overall Study|Withdrawal by Subject|0|||
25114786|NCT02282605|50226054|FG000|Overall Study|negative SA result on Day -1|3|||
25114787|NCT02282605|50226055|FG001|Overall Study|negative SA result on Day -1|0|||
25114788|NCT02282605|50226056|FG002|Overall Study|negative SA result on Day -1|0|||
25114789|NCT02282527|50226066|FG000|Overall Study|Lost to Follow-up|0|||
25114790|NCT02282527|50226067|FG001|Overall Study|Lost to Follow-up|1|||
25114791|NCT02282527|50226066|FG000|Overall Study|Lack of home health aid|1|||
25114792|NCT02282527|50226067|FG001|Overall Study|Lack of home health aid|0|||
25114793|NCT02278939|50226078|FG000|Overall Study|lack of time|1|||
25114794|NCT02278939|50226079|FG001|Overall Study|lack of time|0|||
25008394|NCT03535194|50101307|FG002|Induction Period|Withdrawal by Subject|3|||
25008395|NCT03535194|50101308|FG003|Induction Period|Withdrawal by Subject|2|||
25008396|NCT03535194|50101309|FG004|Induction Period|Withdrawal by Subject|0|||
25008397|NCT03535194|50101305|FG000|Maintenance Period|Adverse Event|6|||
25008398|NCT03535194|50101306|FG001|Maintenance Period|Adverse Event|5|||
25008399|NCT03535194|50101307|FG002|Maintenance Period|Adverse Event|1|||
25008400|NCT03535194|50101308|FG003|Maintenance Period|Adverse Event|11|||
25008401|NCT03535194|50101309|FG004|Maintenance Period|Adverse Event|4|||
25008402|NCT03535194|50101305|FG000|Maintenance Period|Lack of Efficacy|3|||
25008403|NCT03535194|50101306|FG001|Maintenance Period|Lack of Efficacy|2|||
25008404|NCT03535194|50101307|FG002|Maintenance Period|Lack of Efficacy|5|||
25114795|NCT02278939|50226078|FG000|Overall Study|Lost to Follow-up|1|||
25114796|NCT02278939|50226079|FG001|Overall Study|Lost to Follow-up|1|||
25114797|NCT02278939|50226078|FG000|Overall Study|death in family|1|||
25114798|NCT02278939|50226079|FG001|Overall Study|death in family|0|||
25114799|NCT02278939|50226078|FG000|Overall Study|family emergency unable to commit|2|||
25008405|NCT03535194|50101308|FG003|Maintenance Period|Lack of Efficacy|9|||
25008406|NCT03535194|50101309|FG004|Maintenance Period|Lack of Efficacy|0|||
25114800|NCT02278939|50226079|FG001|Overall Study|family emergency unable to commit|0|||
25114801|NCT02278471|50226087|FG000|Overall Study|Lost to Follow-up|6|||
25114802|NCT02278471|50226088|FG001|Overall Study|Lost to Follow-up|15|||
25114803|NCT02278471|50226087|FG000|Overall Study|Death|2|||
25114804|NCT02278471|50226088|FG001|Overall Study|Death|2|||
25114805|NCT02278471|50226087|FG000|Overall Study|Withdrawal by Subject|0|||
25114806|NCT02278471|50226088|FG001|Overall Study|Withdrawal by Subject|3|||
25114807|NCT02278003|50226097|FG000|Overall Study|Withdrawal by Subject|11|||
25114808|NCT02278003|50226098|FG001|Overall Study|Withdrawal by Subject|0|||
25114809|NCT02278003|50226097|FG000|Overall Study|Not Treated|1|||
25114810|NCT02278003|50226098|FG001|Overall Study|Not Treated|0|||
25114811|NCT02278003|50226097|FG000|Overall Study|Recognition task improperly completed|7|||
25114812|NCT02278003|50226098|FG001|Overall Study|Recognition task improperly completed|0|||
25114813|NCT02277769|50226107|FG000|Overall Study|Protocol Violation|3|||
25114814|NCT02277769|50226108|FG001|Overall Study|Protocol Violation|3|||
25114815|NCT02277769|50226109|FG002|Overall Study|Protocol Violation|5|||
25114816|NCT02277769|50226107|FG000|Overall Study|Lack of Efficacy|17|||
25114817|NCT02277769|50226108|FG001|Overall Study|Lack of Efficacy|0|||
25114818|NCT02277769|50226109|FG002|Overall Study|Lack of Efficacy|4|||
25114819|NCT02277769|50226107|FG000|Overall Study|Adverse Event|14|||
25114820|NCT02277769|50226108|FG001|Overall Study|Adverse Event|2|||
25114821|NCT02277769|50226109|FG002|Overall Study|Adverse Event|4|||
25114822|NCT02277769|50226107|FG000|Overall Study|Other than specified above|12|||
25114823|NCT02277769|50226108|FG001|Overall Study|Other than specified above|8|||
25114824|NCT02277769|50226109|FG002|Overall Study|Other than specified above|5|||
25114825|NCT01641991|50226121|FG000|Overall Study|Physician Decision|0|||
25114826|NCT01641991|50226122|FG001|Overall Study|Physician Decision|1|||
25114827|NCT01641991|50226123|FG002|Overall Study|Physician Decision|7|||
25114828|NCT01641991|50226124|FG003|Overall Study|Physician Decision|5|||
25114829|NCT01641991|50226121|FG000|Overall Study|Withdrawal by Subject|4|||
25114830|NCT01641991|50226122|FG001|Overall Study|Withdrawal by Subject|2|||
25114831|NCT01641991|50226123|FG002|Overall Study|Withdrawal by Subject|1|||
25114832|NCT01641991|50226124|FG003|Overall Study|Withdrawal by Subject|5|||
25114833|NCT01641991|50226121|FG000|Overall Study|Adverse Event|2|||
25114834|NCT01641991|50226122|FG001|Overall Study|Adverse Event|1|||
25114835|NCT01641991|50226123|FG002|Overall Study|Adverse Event|2|||
25114836|NCT01641991|50226124|FG003|Overall Study|Adverse Event|1|||
25114837|NCT01641991|50226121|FG000|Overall Study|Lost to Follow-up|0|||
25114838|NCT01641991|50226122|FG001|Overall Study|Lost to Follow-up|2|||
25114839|NCT01641991|50226123|FG002|Overall Study|Lost to Follow-up|3|||
25114840|NCT01641991|50226124|FG003|Overall Study|Lost to Follow-up|1|||
25114841|NCT01641991|50226121|FG000|Overall Study|Protocol Violation|1|||
25114842|NCT01641991|50226122|FG001|Overall Study|Protocol Violation|1|||
25114843|NCT01641991|50226123|FG002|Overall Study|Protocol Violation|3|||
25114844|NCT01641991|50226124|FG003|Overall Study|Protocol Violation|0|||
25114845|NCT01641991|50226121|FG000|Overall Study|Pregnancy|0|||
25114846|NCT01641991|50226122|FG001|Overall Study|Pregnancy|0|||
25114847|NCT01641991|50226123|FG002|Overall Study|Pregnancy|1|||
25114848|NCT01641991|50226124|FG003|Overall Study|Pregnancy|0|||
25114849|NCT01641991|50226121|FG000|Overall Study|no longer eligible|2|||
25114850|NCT01641991|50226122|FG001|Overall Study|no longer eligible|1|||
25114851|NCT01641991|50226123|FG002|Overall Study|no longer eligible|0|||
25114852|NCT01641991|50226124|FG003|Overall Study|no longer eligible|4|||
25114853|NCT02277691|50226137|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
25114854|NCT02277691|50226137|FG000|Overall Study|Voluntary Withdrawal|7|||
25114855|NCT02277691|50226137|FG000|Overall Study|Lack of Efficacy|5|||
25114856|NCT02277691|50226137|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
25114857|NCT02395172|50226143|FG000|Overall Study|Participants randomized but not treated|3|||
25114858|NCT02395172|50226144|FG001|Overall Study|Participants randomized but not treated|31|||
25114859|NCT02276053|50226150|FG000|Overall Study|Death|2|||
25114860|NCT02276053|50226150|FG000|Overall Study|Adverse Event|5|||
25114861|NCT02276053|50226150|FG000|Overall Study|Lack of Efficacy|2|||
25114862|NCT02276053|50226150|FG000|Overall Study|Withdrawal by Subject|1|||
25114863|NCT02276053|50226150|FG000|Overall Study|Patient does not meet selection criteria|3|||
25114864|NCT02276053|50226150|FG000|Overall Study|Patient needs to increase baseline AED|1|||
25114865|NCT02275819|50226157|FG000|Overall Study|Adverse Event|0|||
25114866|NCT02275819|50226158|FG001|Overall Study|Adverse Event|1|||
25114867|NCT02358044|50226166|FG000|Overall Study|Adverse Event|0|||
25114868|NCT02358044|50226167|FG001|Overall Study|Adverse Event|1|||
25114869|NCT02358044|50226166|FG000|Overall Study|Lost to Follow-up|2|||
25114870|NCT02358044|50226167|FG001|Overall Study|Lost to Follow-up|1|||
25114871|NCT02358044|50226166|FG000|Overall Study|Physician Decision|0|||
25114872|NCT02358044|50226167|FG001|Overall Study|Physician Decision|1|||
25114873|NCT02358044|50226166|FG000|Overall Study|Withdrawal by Subject|0|||
25114874|NCT02358044|50226167|FG001|Overall Study|Withdrawal by Subject|4|||
25114875|NCT02275117|50226178|FG000|Overall Study|Adverse Event|0|||
25114876|NCT02275117|50226179|FG001|Overall Study|Adverse Event|0|||
25114877|NCT02275117|50226180|FG002|Overall Study|Adverse Event|0|||
25114878|NCT02275117|50226181|FG003|Overall Study|Adverse Event|0|||
25114879|NCT02275117|50226182|FG004|Overall Study|Adverse Event|1|||
25114880|NCT02275117|50226178|FG000|Overall Study|Lack of Efficacy|6|||
25114881|NCT02275117|50226179|FG001|Overall Study|Lack of Efficacy|7|||
25114882|NCT02275117|50226180|FG002|Overall Study|Lack of Efficacy|5|||
25114883|NCT02275117|50226181|FG003|Overall Study|Lack of Efficacy|2|||
25114884|NCT02275117|50226182|FG004|Overall Study|Lack of Efficacy|10|||
25114885|NCT02275117|50226178|FG000|Overall Study|Lost to Follow-up|11|||
25114886|NCT02275117|50226179|FG001|Overall Study|Lost to Follow-up|16|||
25114887|NCT02275117|50226180|FG002|Overall Study|Lost to Follow-up|15|||
25114888|NCT02275117|50226181|FG003|Overall Study|Lost to Follow-up|16|||
25114889|NCT02275117|50226182|FG004|Overall Study|Lost to Follow-up|8|||
25114890|NCT02275117|50226178|FG000|Overall Study|Physician Decision|0|||
25114891|NCT02275117|50226179|FG001|Overall Study|Physician Decision|1|||
25114892|NCT02275117|50226180|FG002|Overall Study|Physician Decision|1|||
25114893|NCT02275117|50226181|FG003|Overall Study|Physician Decision|0|||
25114894|NCT02275117|50226182|FG004|Overall Study|Physician Decision|1|||
25114895|NCT02275117|50226178|FG000|Overall Study|Protocol Violation|1|||
25114896|NCT02275117|50226179|FG001|Overall Study|Protocol Violation|0|||
25114897|NCT02275117|50226180|FG002|Overall Study|Protocol Violation|1|||
25114898|NCT02275117|50226181|FG003|Overall Study|Protocol Violation|1|||
25114899|NCT02275117|50226182|FG004|Overall Study|Protocol Violation|0|||
25114900|NCT02275117|50226178|FG000|Overall Study|Withdrawal by Subject|6|||
25114901|NCT02275117|50226179|FG001|Overall Study|Withdrawal by Subject|4|||
25114902|NCT02275117|50226180|FG002|Overall Study|Withdrawal by Subject|7|||
25114903|NCT02275117|50226181|FG003|Overall Study|Withdrawal by Subject|3|||
25114904|NCT02275117|50226182|FG004|Overall Study|Withdrawal by Subject|3|||
25114905|NCT02275117|50226178|FG000|Overall Study|Terminated by Sponsor|4|||
25114906|NCT02275117|50226179|FG001|Overall Study|Terminated by Sponsor|4|||
25114907|NCT02275117|50226180|FG002|Overall Study|Terminated by Sponsor|4|||
25114908|NCT02275117|50226181|FG003|Overall Study|Terminated by Sponsor|6|||
25114909|NCT02275117|50226182|FG004|Overall Study|Terminated by Sponsor|4|||
25114910|NCT02275117|50226178|FG000|Overall Study|Worsening of Study Indication|0|||
25114911|NCT02275117|50226179|FG001|Overall Study|Worsening of Study Indication|1|||
25114912|NCT02275117|50226180|FG002|Overall Study|Worsening of Study Indication|2|||
25114913|NCT02275117|50226181|FG003|Overall Study|Worsening of Study Indication|0|||
25114914|NCT02275117|50226182|FG004|Overall Study|Worsening of Study Indication|0|||
25114915|NCT02275117|50226178|FG000|Overall Study|Study Burden|5|||
25114916|NCT02275117|50226179|FG001|Overall Study|Study Burden|4|||
25114917|NCT02275117|50226180|FG002|Overall Study|Study Burden|7|||
25114918|NCT02275117|50226181|FG003|Overall Study|Study Burden|5|||
25114919|NCT02275117|50226182|FG004|Overall Study|Study Burden|7|||
25114920|NCT02275117|50226178|FG000|Overall Study|Other|1|||
25114921|NCT02275117|50226179|FG001|Overall Study|Other|0|||
25114922|NCT02275117|50226180|FG002|Overall Study|Other|0|||
25114923|NCT02275117|50226181|FG003|Overall Study|Other|0|||
25114924|NCT02275117|50226182|FG004|Overall Study|Other|2|||
25114925|NCT02274493|50226194|FG000|Overall Study|Withdrawal by Subject|1|||
25114926|NCT02273167|50226201|FG000|Overall Study|Adverse Event|1|||
25114927|NCT02273167|50226202|FG001|Overall Study|Adverse Event|0|||
25114928|NCT02273167|50226203|FG002|Overall Study|Adverse Event|0|||
25114929|NCT02273167|50226201|FG000|Overall Study|Protocol Violation|3|||
25114930|NCT02273167|50226202|FG001|Overall Study|Protocol Violation|1|||
25114931|NCT02273167|50226203|FG002|Overall Study|Protocol Violation|1|||
25114932|NCT02273167|50226201|FG000|Overall Study|Lost to Follow-up|0|||
25114933|NCT02273167|50226202|FG001|Overall Study|Lost to Follow-up|1|||
25114934|NCT02273167|50226203|FG002|Overall Study|Lost to Follow-up|1|||
25114935|NCT02273167|50226201|FG000|Overall Study|Withdrawal by Subject|10|||
25114936|NCT02273167|50226202|FG001|Overall Study|Withdrawal by Subject|12|||
25261446|NCT01263015|50576172|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
25261447|NCT01263015|50576173|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
25261448|NCT01263015|50576172|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
25261449|NCT01263015|50576173|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
25261450|NCT01263015|50576172|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
25261451|NCT01263015|50576173|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
25261452|NCT01305564|50576179|FG000|Overall Study|Death|21|||
25261453|NCT01305564|50576179|FG000|Overall Study|Lost to Follow-up|12|||
25261454|NCT01305564|50576179|FG000|Overall Study|Withdrawal by Subject|1|||
25261455|NCT01305564|50576179|FG000|Overall Study|Physician Decision|3|||
25261456|NCT01305408|50576196|FG000|Overall Study|Adverse Event|10|||
25114937|NCT02273167|50226203|FG002|Overall Study|Withdrawal by Subject|11|||
25114938|NCT02273167|50226201|FG000|Overall Study|Various|10|||
25114939|NCT02273167|50226202|FG001|Overall Study|Various|9|||
25114940|NCT02273167|50226203|FG002|Overall Study|Various|8|||
25114941|NCT01850524|50226214|FG000|Overall Study|Ongoing on Treatment|57|||
25114942|NCT01850524|50226215|FG001|Overall Study|Ongoing on Treatment|54|||
25261457|NCT01305408|50576197|FG001|Overall Study|Adverse Event|7|||
25114943|NCT01850524|50226214|FG000|Overall Study|Adverse Event|96|||
25114944|NCT01850524|50226215|FG001|Overall Study|Adverse Event|122|||
25114945|NCT01850524|50226214|FG000|Overall Study|Lost to Follow-up|2|||
25114946|NCT01850524|50226215|FG001|Overall Study|Lost to Follow-up|0|||
25114947|NCT01850524|50226214|FG000|Overall Study|Progressive Disease|166|||
25114948|NCT01850524|50226215|FG001|Overall Study|Progressive Disease|123|||
25114949|NCT01850524|50226214|FG000|Overall Study|Protocol Violation|1|||
25114950|NCT01850524|50226215|FG001|Overall Study|Protocol Violation|2|||
25114951|NCT01850524|50226214|FG000|Overall Study|Withdrawal by Subject|8|||
25114952|NCT01850524|50226215|FG001|Overall Study|Withdrawal by Subject|19|||
25114953|NCT01850524|50226214|FG000|Overall Study|Participant Wished to Discontinue Treatment|15|||
25114954|NCT01850524|50226215|FG001|Overall Study|Participant Wished to Discontinue Treatment|22|||
25114955|NCT01850524|50226214|FG000|Overall Study|Investigator Decision|4|||
25114956|NCT01850524|50226215|FG001|Overall Study|Investigator Decision|4|||
25114957|NCT01850524|50226214|FG000|Overall Study|Participants Removed From Study|0|||
25114958|NCT01850524|50226215|FG001|Overall Study|Participants Removed From Study|1|||
25114959|NCT01850524|50226214|FG000|Overall Study|Medical Monitor Decision|0|||
25114960|NCT01850524|50226215|FG001|Overall Study|Medical Monitor Decision|1|||
25114961|NCT01850524|50226214|FG000|Overall Study|Participants Decision|2|||
25114962|NCT01850524|50226215|FG001|Overall Study|Participants Decision|2|||
25114963|NCT01850524|50226214|FG000|Overall Study|Progressive Disease Per Local Lab|1|||
25114964|NCT01850524|50226215|FG001|Overall Study|Progressive Disease Per Local Lab|0|||
25114965|NCT01850524|50226214|FG000|Overall Study|Lack of Improvement|0|||
25114966|NCT01850524|50226215|FG001|Overall Study|Lack of Improvement|1|||
25114967|NCT01850524|50226214|FG000|Overall Study|Minimal Response|1|||
25114968|NCT01850524|50226215|FG001|Overall Study|Minimal Response|0|||
25114969|NCT01850524|50226214|FG000|Overall Study|Comorbidities|1|||
25114970|NCT01850524|50226215|FG001|Overall Study|Comorbidities|0|||
25114971|NCT02272777|50226225|FG000|Overall Study|Adverse Event|0|||
25114972|NCT02272777|50226226|FG001|Overall Study|Adverse Event|1|||
25114973|NCT02272777|50226225|FG000|Overall Study|Withdrawal by Subject|0|||
25114974|NCT02272777|50226226|FG001|Overall Study|Withdrawal by Subject|3|||
25114975|NCT02272777|50226225|FG000|Overall Study|Lost to Follow-up|2|||
25114976|NCT02272777|50226226|FG001|Overall Study|Lost to Follow-up|0|||
25114977|NCT02272777|50226225|FG000|Overall Study|Other|2|||
25114978|NCT02272777|50226226|FG001|Overall Study|Other|0|||
25114979|NCT02357810|50226232|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
25114980|NCT02357810|50226232|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
25114981|NCT02357810|50226232|FG000|Reached 12 Weeks Response|Adverse Event|5|||
25114982|NCT02357810|50226232|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
25114983|NCT02357810|50226232|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
25114984|NCT02357810|50226232|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
25114985|NCT02357810|50226232|FG000|Reached 12 Weeks Response|Death|1|||
25114986|NCT02357810|50226232|FG000|Reached 12 Weeks Response|Physician Decision|1|||
25114987|NCT02357810|50226232|FG000|Reached 12 Weeks Response|Other|1|||
25114988|NCT02357810|50226232|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
25114989|NCT02357810|50226232|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
25114990|NCT02357810|50226232|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
25114991|NCT02357810|50226232|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
25114992|NCT02357810|50226232|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
25114993|NCT02357810|50226232|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
25114994|NCT02357576|50226238|FG000|Treatment Period|Withdrawal by Subject|0|||
25114995|NCT02357576|50226239|FG001|Treatment Period|Withdrawal by Subject|1|||
25114996|NCT02357576|50226238|FG000|Treatment Period|Physician Decision|0|||
25114997|NCT02357576|50226239|FG001|Treatment Period|Physician Decision|1|||
25114998|NCT02357576|50226238|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
25114999|NCT02357576|50226239|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
25115000|NCT02357576|50226238|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
25115001|NCT02357576|50226239|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
25115002|NCT02357576|50226238|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
25115003|NCT02357576|50226239|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
25115004|NCT02357576|50226238|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
25115005|NCT02357576|50226239|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
25115006|NCT01850446|50226247|FG000|Overall Study|Lack of Efficacy|1|||
25115007|NCT01850446|50226248|FG001|Overall Study|Lack of Efficacy|0|||
25115008|NCT01850446|50226247|FG000|Overall Study|Withdrawal by Subject|4|||
25115009|NCT01850446|50226248|FG001|Overall Study|Withdrawal by Subject|0|||
25115010|NCT01850446|50226247|FG000|Overall Study|Protocol Violation|0|||
25115011|NCT01850446|50226248|FG001|Overall Study|Protocol Violation|2|||
25115012|NCT02465567|50226258|FG000|Overall Study|Adverse Event|118|||
25115013|NCT02465567|50226259|FG001|Overall Study|Adverse Event|113|||
25115014|NCT02465567|50226260|FG002|Overall Study|Adverse Event|147|||
25115015|NCT02465567|50226261|FG003|Overall Study|Adverse Event|138|||
25115016|NCT02465567|50226258|FG000|Overall Study|Lack of Efficacy|103|||
25115017|NCT02465567|50226259|FG001|Overall Study|Lack of Efficacy|102|||
25115018|NCT02465567|50226260|FG002|Overall Study|Lack of Efficacy|171|||
25115019|NCT02465567|50226261|FG003|Overall Study|Lack of Efficacy|135|||
25115020|NCT02465567|50226258|FG000|Overall Study|Withdrawal by Subject|104|||
25115021|NCT02465567|50226259|FG001|Overall Study|Withdrawal by Subject|94|||
25115022|NCT02465567|50226260|FG002|Overall Study|Withdrawal by Subject|123|||
25115023|NCT02465567|50226261|FG003|Overall Study|Withdrawal by Subject|130|||
25115024|NCT02465567|50226258|FG000|Overall Study|Physician Decision|23|||
25115025|NCT02465567|50226259|FG001|Overall Study|Physician Decision|33|||
25115026|NCT02465567|50226260|FG002|Overall Study|Physician Decision|38|||
25115027|NCT02465567|50226261|FG003|Overall Study|Physician Decision|28|||
25115028|NCT02465567|50226258|FG000|Overall Study|Major Protocol Deviation|24|||
25115029|NCT02465567|50226259|FG001|Overall Study|Major Protocol Deviation|26|||
25115030|NCT02465567|50226260|FG002|Overall Study|Major Protocol Deviation|22|||
25115031|NCT02465567|50226261|FG003|Overall Study|Major Protocol Deviation|25|||
25115032|NCT02465567|50226258|FG000|Overall Study|Lost to Follow-up|25|||
25115033|NCT02465567|50226259|FG001|Overall Study|Lost to Follow-up|21|||
25115034|NCT02465567|50226260|FG002|Overall Study|Lost to Follow-up|19|||
25115035|NCT02465567|50226261|FG003|Overall Study|Lost to Follow-up|15|||
25115036|NCT02465567|50226258|FG000|Overall Study|Protocol Specified Criteria|20|||
25115037|NCT02465567|50226259|FG001|Overall Study|Protocol Specified Criteria|10|||
25115038|NCT02465567|50226260|FG002|Overall Study|Protocol Specified Criteria|9|||
25115039|NCT02465567|50226261|FG003|Overall Study|Protocol Specified Criteria|12|||
25115040|NCT02465567|50226258|FG000|Overall Study|Administrative Reasons|12|||
25115041|NCT02465567|50226259|FG001|Overall Study|Administrative Reasons|9|||
25115042|NCT02465567|50226260|FG002|Overall Study|Administrative Reasons|11|||
25115043|NCT02465567|50226261|FG003|Overall Study|Administrative Reasons|5|||
25115044|NCT02465567|50226258|FG000|Overall Study|Randomized but not treated|1|||
25115045|NCT02465567|50226259|FG001|Overall Study|Randomized but not treated|5|||
25115046|NCT02465567|50226260|FG002|Overall Study|Randomized but not treated|4|||
25115047|NCT02465567|50226261|FG003|Overall Study|Randomized but not treated|5|||
25115048|NCT02465567|50226258|FG000|Overall Study|enrolled in >1 studies|18|||
25115049|NCT02465567|50226259|FG001|Overall Study|enrolled in >1 studies|11|||
25115050|NCT02465567|50226260|FG002|Overall Study|enrolled in >1 studies|19|||
25115051|NCT02465567|50226261|FG003|Overall Study|enrolled in >1 studies|15|||
25115052|NCT02465567|50226258|FG000|Overall Study|missing PI Signature|1|||
25115053|NCT02465567|50226259|FG001|Overall Study|missing PI Signature|0|||
25115054|NCT02465567|50226260|FG002|Overall Study|missing PI Signature|0|||
25115055|NCT02465567|50226261|FG003|Overall Study|missing PI Signature|0|||
25115056|NCT01644175|50226273|FG000|Overall Study|Randomized But Not Treated|0|||
25115057|NCT01644175|50226274|FG001|Overall Study|Randomized But Not Treated|2|||
25115058|NCT01644175|50226273|FG000|Overall Study|Adverse Event|8|||
25115059|NCT01644175|50226274|FG001|Overall Study|Adverse Event|13|||
25115060|NCT01644175|50226273|FG000|Overall Study|Death|1|||
25115061|NCT01644175|50226274|FG001|Overall Study|Death|2|||
25115062|NCT01644175|50226273|FG000|Overall Study|Poor compliance to protocol|9|||
25115063|NCT01644175|50226274|FG001|Overall Study|Poor compliance to protocol|10|||
25115064|NCT01644175|50226273|FG000|Overall Study|Physician Decision|1|||
25115065|NCT01644175|50226274|FG001|Overall Study|Physician Decision|2|||
25115066|NCT01644175|50226273|FG000|Overall Study|Participant Moved|1|||
25261458|NCT01305408|50576196|FG000|Overall Study|Lack of Efficacy|3|||
25261459|NCT01305408|50576197|FG001|Overall Study|Lack of Efficacy|4|||
25115067|NCT01644175|50226274|FG001|Overall Study|Participant Moved|2|||
25115068|NCT01644175|50226273|FG000|Overall Study|Consent withdrawn by participant|3|||
25115069|NCT01644175|50226274|FG001|Overall Study|Consent withdrawn by participant|4|||
25115070|NCT01644175|50226273|FG000|Overall Study|Related to Autoinjector Administration|2|||
25115071|NCT01644175|50226274|FG001|Overall Study|Related to Autoinjector Administration|1|||
25115072|NCT01644175|50226273|FG000|Overall Study|Last visit outside protocol visit window|4|||
25115073|NCT01644175|50226274|FG001|Overall Study|Last visit outside protocol visit window|11|||
25115074|NCT01644175|50226273|FG000|Overall Study|Selection criteria finally not met|0|||
25115075|NCT01644175|50226274|FG001|Overall Study|Selection criteria finally not met|1|||
25115076|NCT01644175|50226273|FG000|Overall Study|Site closure|2|||
25115077|NCT01644175|50226274|FG001|Overall Study|Site closure|2|||
25115078|NCT01644175|50226273|FG000|Overall Study|Lost to Follow-up|1|||
25115079|NCT01644175|50226274|FG001|Overall Study|Lost to Follow-up|0|||
25115080|NCT01644175|50226273|FG000|Overall Study|Other than specified above|0|||
25115081|NCT01644175|50226274|FG001|Overall Study|Other than specified above|3|||
25115082|NCT02357420|50226284|FG000|Overall Study|Adverse Event|3|||
25115083|NCT02357420|50226285|FG001|Overall Study|Adverse Event|3|||
25115084|NCT02357420|50226286|FG002|Overall Study|Adverse Event|8|||
25115085|NCT02357420|50226287|FG003|Overall Study|Adverse Event|9|||
25115086|NCT02357420|50226284|FG000|Overall Study|Investigator Decision|1|||
25261460|NCT01305408|50576196|FG000|Overall Study|Withdrawal by Subject|9|||
25115087|NCT02357420|50226285|FG001|Overall Study|Investigator Decision|0|||
25115088|NCT02357420|50226286|FG002|Overall Study|Investigator Decision|0|||
25115089|NCT02357420|50226287|FG003|Overall Study|Investigator Decision|0|||
25115090|NCT02357420|50226284|FG000|Overall Study|Prohibited Medication|1|||
25115091|NCT02357420|50226285|FG001|Overall Study|Prohibited Medication|1|||
25115092|NCT02357420|50226286|FG002|Overall Study|Prohibited Medication|0|||
25115093|NCT02357420|50226287|FG003|Overall Study|Prohibited Medication|0|||
25115094|NCT02357420|50226284|FG000|Overall Study|Protocol Non-compliance|0|||
25115095|NCT02357420|50226285|FG001|Overall Study|Protocol Non-compliance|0|||
25115096|NCT02357420|50226286|FG002|Overall Study|Protocol Non-compliance|0|||
25115097|NCT02357420|50226287|FG003|Overall Study|Protocol Non-compliance|1|||
25115098|NCT02357420|50226284|FG000|Overall Study|Withdrawn Consent|4|||
25115099|NCT02357420|50226285|FG001|Overall Study|Withdrawn Consent|8|||
25115100|NCT02357420|50226286|FG002|Overall Study|Withdrawn Consent|6|||
25115101|NCT02357420|50226287|FG003|Overall Study|Withdrawn Consent|6|||
25115102|NCT02357420|50226284|FG000|Overall Study|Lost to Follow-up|3|||
25115103|NCT02357420|50226285|FG001|Overall Study|Lost to Follow-up|0|||
25115104|NCT02357420|50226286|FG002|Overall Study|Lost to Follow-up|2|||
25115105|NCT02357420|50226287|FG003|Overall Study|Lost to Follow-up|3|||
25115106|NCT01832038|50226297|FG000|Overall Study|Death|5|||
25115107|NCT01832038|50226297|FG000|Overall Study|Adverse Event|50|||
25115108|NCT01832038|50226297|FG000|Overall Study|Lack of Efficacy|81|||
25115109|NCT01832038|50226297|FG000|Overall Study|Protocol Violation|7|||
25115110|NCT01832038|50226297|FG000|Overall Study|Lost to Follow-up|10|||
25115111|NCT01832038|50226297|FG000|Overall Study|Withdrawal by Subject|49|||
25115112|NCT01832038|50226297|FG000|Overall Study|Visit non-compliance|2|||
25115113|NCT01832038|50226297|FG000|Overall Study|Subject refused to return visit|2|||
25115114|NCT01832038|50226297|FG000|Overall Study|Not convenient to come back to site|2|||
25115115|NCT01832038|50226297|FG000|Overall Study|Participant was asked to quit|5|||
25115116|NCT01832038|50226297|FG000|Overall Study|Back home|1|||
25115117|NCT01832038|50226297|FG000|Overall Study|Pregnancy|1|||
25115118|NCT01832038|50226297|FG000|Overall Study|Low compliance|3|||
25115119|NCT01832038|50226297|FG000|Overall Study|Prohibit procedure|2|||
25115120|NCT01832038|50226297|FG000|Overall Study|Not possible to visit the hospital|1|||
25115121|NCT01832038|50226297|FG000|Overall Study|Changes of implementation system|3|||
25115122|NCT01832038|50226297|FG000|Overall Study|Plan to pregnancy|7|||
25115123|NCT01832038|50226297|FG000|Overall Study|Bad mood and has suicidal thought|1|||
25115124|NCT01832038|50226297|FG000|Overall Study|Prohibited concomitant medication|1|||
25115125|NCT01832038|50226297|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
25115126|NCT01832038|50226297|FG000|Overall Study|Subject considered the efficacy was poor|1|||
25115127|NCT01849588|50226302|FG000|Overall Study|Lack of Efficacy|3|||
25115128|NCT02357342|50226308|FG000|First 6 Months|Death|2|||
25115129|NCT02357342|50226309|FG001|First 6 Months|Death|0|||
25115130|NCT02271529|50226315|FG000|Overall Study|Withdrawal by Subject|1|||
25115131|NCT02325518|50226321|FG000|Overall Study|Adverse Event|4|||
25115132|NCT02325518|50226322|FG001|Overall Study|Adverse Event|1|||
25115133|NCT02325518|50226321|FG000|Overall Study|Physician Decision|0|||
25115134|NCT02325518|50226322|FG001|Overall Study|Physician Decision|1|||
25115135|NCT02325518|50226321|FG000|Overall Study|Withdrawal by Subject|0|||
25115136|NCT02325518|50226322|FG001|Overall Study|Withdrawal by Subject|1|||
25115137|NCT02270983|50226332|FG000|Overall Study|Adverse Event|3|||
25115138|NCT02270983|50226333|FG001|Overall Study|Adverse Event|2|||
25115139|NCT02270983|50226334|FG002|Overall Study|Adverse Event|6|||
25115140|NCT02270983|50226332|FG000|Overall Study|Lack of Efficacy|2|||
25115141|NCT02270983|50226333|FG001|Overall Study|Lack of Efficacy|1|||
25115142|NCT02270983|50226334|FG002|Overall Study|Lack of Efficacy|1|||
25115143|NCT02270983|50226332|FG000|Overall Study|Withdrawal by Subject|1|||
25115144|NCT02270983|50226333|FG001|Overall Study|Withdrawal by Subject|0|||
25115145|NCT02270983|50226334|FG002|Overall Study|Withdrawal by Subject|2|||
25115146|NCT02270983|50226332|FG000|Overall Study|Lost to Follow-up|1|||
25115147|NCT02270983|50226333|FG001|Overall Study|Lost to Follow-up|1|||
25115148|NCT02270983|50226334|FG002|Overall Study|Lost to Follow-up|2|||
25115149|NCT02270983|50226332|FG000|Overall Study|Protocol Violation|1|||
25115150|NCT02270983|50226333|FG001|Overall Study|Protocol Violation|1|||
25115151|NCT02270983|50226334|FG002|Overall Study|Protocol Violation|1|||
25115152|NCT02270983|50226332|FG000|Overall Study|family emergency|0|||
25115153|NCT02270983|50226333|FG001|Overall Study|family emergency|1|||
25115154|NCT02270983|50226334|FG002|Overall Study|family emergency|0|||
25115155|NCT02270983|50226332|FG000|Overall Study|study procedure non-compliance|1|||
25115156|NCT02270983|50226333|FG001|Overall Study|study procedure non-compliance|0|||
25115157|NCT02270983|50226334|FG002|Overall Study|study procedure non-compliance|0|||
25115158|NCT02270983|50226332|FG000|Overall Study|moved away from study site|0|||
25115159|NCT02270983|50226333|FG001|Overall Study|moved away from study site|1|||
25115160|NCT02270983|50226334|FG002|Overall Study|moved away from study site|0|||
25115161|NCT02449889|50226345|FG000|Overall Study|Adverse Event|1|||
25115162|NCT02449889|50226346|FG001|Overall Study|Adverse Event|2|||
25115163|NCT02449889|50226347|FG002|Overall Study|Adverse Event|0|||
25115164|NCT02449889|50226345|FG000|Overall Study|Protocol Violation|0|||
25115165|NCT02449889|50226346|FG001|Overall Study|Protocol Violation|4|||
25115166|NCT02449889|50226347|FG002|Overall Study|Protocol Violation|1|||
25115167|NCT01831804|50226364|FG000|Overall Study|Adverse Event|0|||
25115168|NCT01831804|50226365|FG001|Overall Study|Adverse Event|0|||
25115169|NCT01831804|50226366|FG002|Overall Study|Adverse Event|0|||
25115170|NCT01831804|50226367|FG003|Overall Study|Adverse Event|0|||
25115171|NCT01831804|50226368|FG004|Overall Study|Adverse Event|0|||
25115172|NCT01831804|50226369|FG005|Overall Study|Adverse Event|0|||
25115173|NCT01831804|50226370|FG006|Overall Study|Adverse Event|1|||
25115174|NCT01831804|50226371|FG007|Overall Study|Adverse Event|0|||
25115175|NCT01831804|50226372|FG008|Overall Study|Adverse Event|1|||
25115176|NCT01831804|50226364|FG000|Overall Study|Protocol Violation|0|||
25115177|NCT01831804|50226365|FG001|Overall Study|Protocol Violation|0|||
25115178|NCT01831804|50226366|FG002|Overall Study|Protocol Violation|2|||
25115179|NCT01831804|50226367|FG003|Overall Study|Protocol Violation|0|||
25115180|NCT01831804|50226368|FG004|Overall Study|Protocol Violation|0|||
25115181|NCT01831804|50226369|FG005|Overall Study|Protocol Violation|0|||
25115182|NCT01831804|50226370|FG006|Overall Study|Protocol Violation|0|||
25115183|NCT01831804|50226371|FG007|Overall Study|Protocol Violation|0|||
25115184|NCT01831804|50226372|FG008|Overall Study|Protocol Violation|0|||
25115185|NCT01831804|50226364|FG000|Overall Study|Protocol defined stopping criteria|1|||
25115186|NCT01831804|50226365|FG001|Overall Study|Protocol defined stopping criteria|1|||
25115187|NCT01831804|50226366|FG002|Overall Study|Protocol defined stopping criteria|3|||
25115188|NCT01831804|50226367|FG003|Overall Study|Protocol defined stopping criteria|0|||
25115189|NCT01831804|50226368|FG004|Overall Study|Protocol defined stopping criteria|1|||
25115190|NCT01831804|50226369|FG005|Overall Study|Protocol defined stopping criteria|0|||
25115191|NCT01831804|50226370|FG006|Overall Study|Protocol defined stopping criteria|0|||
25115192|NCT01831804|50226371|FG007|Overall Study|Protocol defined stopping criteria|0|||
25115193|NCT01831804|50226372|FG008|Overall Study|Protocol defined stopping criteria|0|||
25115194|NCT01831804|50226364|FG000|Overall Study|Lost to Follow-up|0|||
25115195|NCT01831804|50226365|FG001|Overall Study|Lost to Follow-up|0|||
25115196|NCT01831804|50226366|FG002|Overall Study|Lost to Follow-up|1|||
25115197|NCT01831804|50226367|FG003|Overall Study|Lost to Follow-up|0|||
25115198|NCT01831804|50226368|FG004|Overall Study|Lost to Follow-up|0|||
25115199|NCT01831804|50226369|FG005|Overall Study|Lost to Follow-up|0|||
25115200|NCT01831804|50226370|FG006|Overall Study|Lost to Follow-up|0|||
25115201|NCT01831804|50226371|FG007|Overall Study|Lost to Follow-up|0|||
25115202|NCT01831804|50226372|FG008|Overall Study|Lost to Follow-up|1|||
25115203|NCT01831804|50226364|FG000|Overall Study|Investigator discretion|0|||
25115204|NCT01831804|50226365|FG001|Overall Study|Investigator discretion|0|||
25115205|NCT01831804|50226366|FG002|Overall Study|Investigator discretion|0|||
25115206|NCT01831804|50226367|FG003|Overall Study|Investigator discretion|0|||
25115207|NCT01831804|50226368|FG004|Overall Study|Investigator discretion|1|||
25115208|NCT01831804|50226369|FG005|Overall Study|Investigator discretion|0|||
25115209|NCT01831804|50226370|FG006|Overall Study|Investigator discretion|0|||
25115210|NCT01831804|50226371|FG007|Overall Study|Investigator discretion|1|||
25115211|NCT01831804|50226372|FG008|Overall Study|Investigator discretion|0|||
25115212|NCT01831804|50226364|FG000|Overall Study|Withdrew Consent|0|||
25115213|NCT01831804|50226365|FG001|Overall Study|Withdrew Consent|1|||
25115214|NCT01831804|50226366|FG002|Overall Study|Withdrew Consent|0|||
25115215|NCT01831804|50226367|FG003|Overall Study|Withdrew Consent|0|||
25115216|NCT01831804|50226368|FG004|Overall Study|Withdrew Consent|0|||
25115217|NCT01831804|50226369|FG005|Overall Study|Withdrew Consent|0|||
25115218|NCT01831804|50226370|FG006|Overall Study|Withdrew Consent|0|||
25115219|NCT01831804|50226371|FG007|Overall Study|Withdrew Consent|2|||
25115220|NCT01831804|50226372|FG008|Overall Study|Withdrew Consent|0|||
25115221|NCT02270671|50226403|FG000|Overall Study|Withdrawal by Subject|1|||
25115222|NCT02270671|50226404|FG001|Overall Study|Withdrawal by Subject|1|||
25115223|NCT02270671|50226403|FG000|Overall Study|Protocol Violation|0|||
25115224|NCT02270671|50226404|FG001|Overall Study|Protocol Violation|1|||
25115225|NCT02270671|50226403|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
25115226|NCT02270671|50226404|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
25115227|NCT02270671|50226403|FG000|Overall Study|Lost to Follow-up|2|||
25115228|NCT02270671|50226404|FG001|Overall Study|Lost to Follow-up|1|||
25115229|NCT02324270|50226413|FG000|Overall Study|Withdrawal by Subject|0|||
25115230|NCT02324270|50226414|FG001|Overall Study|Withdrawal by Subject|1|||
25115231|NCT02324270|50226415|FG002|Overall Study|Withdrawal by Subject|0|||
25115232|NCT02324270|50226413|FG000|Overall Study|Lost to Follow-up|4|||
25115233|NCT02324270|50226414|FG001|Overall Study|Lost to Follow-up|3|||
25115234|NCT02324270|50226415|FG002|Overall Study|Lost to Follow-up|4|||
25115235|NCT02324270|50226413|FG000|Overall Study|Protocol Violation|0|||
25261461|NCT01305408|50576197|FG001|Overall Study|Withdrawal by Subject|9|||
25115236|NCT02324270|50226414|FG001|Overall Study|Protocol Violation|1|||
25115237|NCT02324270|50226415|FG002|Overall Study|Protocol Violation|1|||
25261462|NCT01305408|50576196|FG000|Overall Study|Protocol Violation|4|||
25115238|NCT02324270|50226413|FG000|Overall Study|Non Compliance with Study Drug|1|||
25115239|NCT02324270|50226414|FG001|Overall Study|Non Compliance with Study Drug|2|||
25115240|NCT02324270|50226415|FG002|Overall Study|Non Compliance with Study Drug|0|||
25115241|NCT02270515|50226423|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
25115242|NCT02270515|50226423|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
25115243|NCT02270515|50226423|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
25115244|NCT02270515|50226423|FG000|Intervention Period 1: 0-6 Months|Death|7|||
25115245|NCT02270515|50226423|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
25115246|NCT02270515|50226423|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
25115247|NCT02270515|50226423|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
25115248|NCT02270515|50226423|FG000|Intervention Period 2: 6-12 Months|Death|5|||
25115249|NCT02270515|50226423|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
25115250|NCT02270515|50226423|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
25115251|NCT02270515|50226423|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
25115252|NCT02270515|50226423|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
25115253|NCT02270515|50226423|FG000|Intervention Period 3: 12-18 Months|Death|3|||
25115254|NCT02270515|50226423|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
25115255|NCT02448875|50226437|FG000|Overall Study|Adverse Event|2|||
25115256|NCT02448875|50226438|FG001|Overall Study|Adverse Event|1|||
25115257|NCT02448875|50226439|FG002|Overall Study|Adverse Event|0|||
25115258|NCT02448875|50226437|FG000|Overall Study|Lost to Follow-up|1|||
25115259|NCT02448875|50226438|FG001|Overall Study|Lost to Follow-up|0|||
25115260|NCT02448875|50226439|FG002|Overall Study|Lost to Follow-up|0|||
25115261|NCT02448875|50226437|FG000|Overall Study|Investigator Decision|3|||
25115262|NCT02448875|50226438|FG001|Overall Study|Investigator Decision|0|||
25115263|NCT02448875|50226439|FG002|Overall Study|Investigator Decision|1|||
25115264|NCT02448875|50226437|FG000|Overall Study|Withdrawal by Subject|1|||
25115265|NCT02448875|50226438|FG001|Overall Study|Withdrawal by Subject|0|||
25115266|NCT02448875|50226439|FG002|Overall Study|Withdrawal by Subject|0|||
25115267|NCT01831726|50226450|FG000|Overall Study|Adverse Event|16|||
25115268|NCT01831726|50226450|FG000|Overall Study|Death|7|||
25115269|NCT01831726|50226450|FG000|Overall Study|Disease Progression|49|||
25115270|NCT01831726|50226450|FG000|Overall Study|Physician Decision|1|||
25115271|NCT01831726|50226450|FG000|Overall Study|Subject/guardian decision|7|||
25115272|NCT01831258|50226454|FG000|Overall Study|Withdrawal by Subject|2|||
25115273|NCT01831258|50226455|FG001|Overall Study|Withdrawal by Subject|1|||
25115274|NCT01831258|50226454|FG000|Overall Study|Lost to Follow-up|3|||
25115275|NCT01831258|50226455|FG001|Overall Study|Lost to Follow-up|2|||
25115276|NCT01849276|50226463|FG000|Followed for Survival for 5 Years|Death|1|||
25115277|NCT01849276|50226463|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
25115278|NCT02465489|50226467|FG000|Overall Study|Adverse Event|5|||
25115279|NCT01829464|50226482|FG000|Overall Study|Adverse Event|1|||
25115280|NCT01829464|50226483|FG001|Overall Study|Adverse Event|0|||
25115281|NCT01829464|50226484|FG002|Overall Study|Adverse Event|0|||
25115282|NCT01829464|50226482|FG000|Overall Study|Lost to Follow-up|0|||
25115283|NCT01829464|50226483|FG001|Overall Study|Lost to Follow-up|0|||
25115284|NCT01829464|50226484|FG002|Overall Study|Lost to Follow-up|1|||
25115285|NCT01829464|50226482|FG000|Overall Study|Withdrawal by Subject|2|||
25115286|NCT01829464|50226483|FG001|Overall Study|Withdrawal by Subject|0|||
25115287|NCT01829464|50226484|FG002|Overall Study|Withdrawal by Subject|0|||
25115288|NCT01829464|50226482|FG000|Overall Study|Study terminated by sponsor|25|||
25115289|NCT01829464|50226483|FG001|Overall Study|Study terminated by sponsor|28|||
25115290|NCT01829464|50226484|FG002|Overall Study|Study terminated by sponsor|25|||
25115291|NCT01829464|50226482|FG000|Overall Study|Lack of Efficacy|0|||
25115292|NCT01829464|50226483|FG001|Overall Study|Lack of Efficacy|1|||
25115293|NCT01829464|50226484|FG002|Overall Study|Lack of Efficacy|0|||
25115294|NCT01847092|50226494|FG000|Overall Study|Adverse Event|12|||
25115295|NCT01847092|50226495|FG001|Overall Study|Adverse Event|3|||
25115296|NCT01847092|50226494|FG000|Overall Study|Withdrawal by Subject|5|||
25115297|NCT01847092|50226495|FG001|Overall Study|Withdrawal by Subject|5|||
25115298|NCT01847092|50226494|FG000|Overall Study|Protocol Specified|8|||
25115299|NCT01847092|50226495|FG001|Overall Study|Protocol Specified|0|||
25115300|NCT01847092|50226494|FG000|Overall Study|Physician Decision|1|||
25115301|NCT01847092|50226495|FG001|Overall Study|Physician Decision|1|||
25115302|NCT01847092|50226494|FG000|Overall Study|Protocol Violation|0|||
25261463|NCT01305408|50576197|FG001|Overall Study|Protocol Violation|6|||
25261464|NCT01305408|50576196|FG000|Overall Study|Lost to Follow-up|5|||
25261465|NCT01305408|50576197|FG001|Overall Study|Lost to Follow-up|3|||
25261466|NCT01305408|50576196|FG000|Overall Study|Noncompliance with study medication|0|||
25261467|NCT01305408|50576197|FG001|Overall Study|Noncompliance with study medication|1|||
25261468|NCT01305408|50576196|FG000|Overall Study|Noncompliance with study procedures|0|||
25261469|NCT01305408|50576197|FG001|Overall Study|Noncompliance with study procedures|1|||
25261470|NCT01305408|50576196|FG000|Overall Study|Other|1|||
25115303|NCT01847092|50226495|FG001|Overall Study|Protocol Violation|2|||
25115304|NCT01601821|50226503|FG000|Overall Study|Death|2|||
25261471|NCT01305408|50576197|FG001|Overall Study|Other|0|||
25115305|NCT01601821|50226504|FG001|Overall Study|Death|5|||
25115306|NCT01601821|50226503|FG000|Overall Study|Protocol Violation|2|||
25115307|NCT01601821|50226504|FG001|Overall Study|Protocol Violation|2|||
25115308|NCT01601821|50226503|FG000|Overall Study|Lost to Follow-up|6|||
25115309|NCT01601821|50226504|FG001|Overall Study|Lost to Follow-up|14|||
25115310|NCT01601821|50226503|FG000|Overall Study|Withdrawal by Subject|1|||
25261472|NCT01304940|50576205|FG000|Overall Study|not meet symptom severity requirement|3|||
25261473|NCT01304940|50576206|FG001|Overall Study|not meet symptom severity requirement|0|||
25261474|NCT01261611|50576215|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
25115311|NCT01601821|50226504|FG001|Overall Study|Withdrawal by Subject|0|||
25115312|NCT01601821|50226503|FG000|Overall Study|Graft Loss|6|||
25115313|NCT01601821|50226504|FG001|Overall Study|Graft Loss|6|||
25115314|NCT01601821|50226503|FG000|Overall Study|Study Events|7|||
25115315|NCT01601821|50226504|FG001|Overall Study|Study Events|1|||
25115316|NCT01601821|50226503|FG000|Overall Study|Other|5|||
25115317|NCT01601821|50226504|FG001|Overall Study|Other|1|||
25115318|NCT02323646|50226513|FG000|Treatment Course 1|Adverse Event|1|||
25115319|NCT02323646|50226514|FG001|Treatment Course 1|Adverse Event|0|||
25115320|NCT02323646|50226515|FG002|Treatment Course 1|Adverse Event|1|||
25115321|NCT02323646|50226513|FG000|Treatment Course 1|Heavy Bleeding|1|||
25115322|NCT02323646|50226514|FG001|Treatment Course 1|Heavy Bleeding|1|||
25115323|NCT02323646|50226515|FG002|Treatment Course 1|Heavy Bleeding|0|||
25115324|NCT02323646|50226513|FG000|Treatment Course 1|Lost to Follow-up|1|||
25115325|NCT02323646|50226514|FG001|Treatment Course 1|Lost to Follow-up|0|||
25115326|NCT02323646|50226515|FG002|Treatment Course 1|Lost to Follow-up|2|||
25115327|NCT02323646|50226513|FG000|Treatment Course 1|Withdrawal by Subject|0|||
25115328|NCT02323646|50226514|FG001|Treatment Course 1|Withdrawal by Subject|2|||
25115329|NCT02323646|50226515|FG002|Treatment Course 1|Withdrawal by Subject|0|||
25115330|NCT02323646|50226513|FG000|Treatment Course 2|Adverse Event|1|||
25115331|NCT02323646|50226514|FG001|Treatment Course 2|Adverse Event|0|||
25115332|NCT02323646|50226515|FG002|Treatment Course 2|Adverse Event|1|||
25115333|NCT02323646|50226513|FG000|Treatment Course 2|Lost to Follow-up|0|||
25115334|NCT02323646|50226514|FG001|Treatment Course 2|Lost to Follow-up|0|||
25115335|NCT02323646|50226515|FG002|Treatment Course 2|Lost to Follow-up|1|||
25115336|NCT02323646|50226513|FG000|Treatment Course 2|Non-compliance|0|||
25115337|NCT02323646|50226514|FG001|Treatment Course 2|Non-compliance|1|||
25115338|NCT02323646|50226515|FG002|Treatment Course 2|Non-compliance|1|||
25115339|NCT01846624|50226523|FG000|Overall Study|Died during induction, no midostaurin|1|||
25115340|NCT01829230|50226529|FG000|Overall Study|Protocol Violation|0|||
25115341|NCT01829230|50226530|FG001|Overall Study|Protocol Violation|2|||
25115342|NCT01829230|50226529|FG000|Overall Study|Withdrawal by Subject|0|||
25115343|NCT01829230|50226530|FG001|Overall Study|Withdrawal by Subject|1|||
25115344|NCT01829230|50226529|FG000|Overall Study|Lost to Follow-up|1|||
25115345|NCT01829230|50226530|FG001|Overall Study|Lost to Follow-up|1|||
25115346|NCT02269657|50226536|FG000|Overall Study|Protocol Violation|3|||
25115347|NCT02269423|50226546|FG000|Overall Study|Discontinued due to change in residence|0|||
25115348|NCT02269423|50226547|FG001|Overall Study|Discontinued due to change in residence|1|||
25115349|NCT02269423|50226548|FG002|Overall Study|Discontinued due to change in residence|0|||
25115350|NCT02269423|50226549|FG003|Overall Study|Discontinued due to change in residence|1|||
25115351|NCT01827670|50226561|FG000|Overall Study|Withdrawal of Consent|3|||
25115352|NCT01827670|50226562|FG001|Overall Study|Withdrawal of Consent|2|||
25115353|NCT01827670|50226561|FG000|Overall Study|Lost to Follow-up|0|||
25115354|NCT01827670|50226562|FG001|Overall Study|Lost to Follow-up|1|||
25115355|NCT02267317|50226576|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
25115356|NCT02267317|50226577|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
25115357|NCT02267317|50226578|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
25115358|NCT02267317|50226579|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
25115359|NCT02267317|50226580|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
25115360|NCT02267317|50226581|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
25115361|NCT02267317|50226576|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
25115362|NCT02267317|50226577|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
25115363|NCT02267317|50226578|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
25115364|NCT02267317|50226579|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
25115365|NCT02267317|50226580|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
25115366|NCT02267317|50226581|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
25115367|NCT01844830|50226597|FG000|Overall Study|Withdrawal by Subject|1|||
25115368|NCT01844830|50226598|FG001|Overall Study|Withdrawal by Subject|0|||
25115369|NCT01827592|50226607|FG000|Overall Study|Adverse Event|11|||
25115370|NCT01827592|50226608|FG001|Overall Study|Adverse Event|9|||
25115371|NCT01827592|50226609|FG002|Overall Study|Adverse Event|2|||
25115372|NCT01827592|50226607|FG000|Overall Study|Physician Decision|0|||
25115373|NCT01827592|50226608|FG001|Overall Study|Physician Decision|2|||
25115374|NCT01827592|50226609|FG002|Overall Study|Physician Decision|1|||
25115375|NCT01827592|50226607|FG000|Overall Study|Protocol Violation|2|||
25115376|NCT01827592|50226608|FG001|Overall Study|Protocol Violation|1|||
25115377|NCT01827592|50226609|FG002|Overall Study|Protocol Violation|0|||
25115378|NCT01827592|50226607|FG000|Overall Study|Lost to Follow-up|1|||
25115379|NCT01827592|50226608|FG001|Overall Study|Lost to Follow-up|2|||
25115380|NCT01827592|50226609|FG002|Overall Study|Lost to Follow-up|2|||
25115381|NCT01827592|50226607|FG000|Overall Study|Withdrawal by Subject|12|||
25115382|NCT01827592|50226608|FG001|Overall Study|Withdrawal by Subject|11|||
25115383|NCT01827592|50226609|FG002|Overall Study|Withdrawal by Subject|11|||
25115384|NCT01827592|50226607|FG000|Overall Study|Patient's substantial non-compliance|1|||
25115385|NCT01827592|50226608|FG001|Overall Study|Patient's substantial non-compliance|1|||
25115386|NCT01827592|50226609|FG002|Overall Study|Patient's substantial non-compliance|6|||
25115387|NCT01827592|50226607|FG000|Overall Study|Trial terminated by Sponsor|47|||
25115388|NCT01827592|50226608|FG001|Overall Study|Trial terminated by Sponsor|53|||
25115389|NCT01827592|50226609|FG002|Overall Study|Trial terminated by Sponsor|51|||
25115390|NCT01827592|50226607|FG000|Overall Study|Others|0|||
25115391|NCT01827592|50226608|FG001|Overall Study|Others|1|||
25115392|NCT01827592|50226609|FG002|Overall Study|Others|3|||
25115393|NCT02323334|50226627|FG000|Period 3|Lost to Follow-up|0|||
25115394|NCT02323334|50226628|FG001|Period 3|Lost to Follow-up|0|||
25115395|NCT02323334|50226629|FG002|Period 3|Lost to Follow-up|1|||
25115396|NCT02323334|50226630|FG003|Period 3|Lost to Follow-up|0|||
25115397|NCT02323334|50226631|FG004|Period 3|Lost to Follow-up|0|||
25115398|NCT02323334|50226632|FG005|Period 3|Lost to Follow-up|0|||
25115399|NCT02323334|50226633|FG006|Period 3|Lost to Follow-up|0|||
25115400|NCT02323334|50226634|FG007|Period 3|Lost to Follow-up|0|||
25115401|NCT02323334|50226635|FG008|Period 3|Lost to Follow-up|0|||
25115402|NCT02323334|50226636|FG009|Period 3|Lost to Follow-up|0|||
25115403|NCT02323334|50226637|FG010|Period 3|Lost to Follow-up|0|||
25115404|NCT02323334|50226638|FG011|Period 3|Lost to Follow-up|0|||
25115405|NCT02323334|50226639|FG012|Period 3|Lost to Follow-up|0|||
25115406|NCT02323334|50226640|FG013|Period 3|Lost to Follow-up|0|||
25115407|NCT02323334|50226641|FG014|Period 3|Lost to Follow-up|0|||
25115408|NCT02323334|50226642|FG015|Period 3|Lost to Follow-up|0|||
25115409|NCT02323334|50226643|FG016|Period 3|Lost to Follow-up|0|||
25115410|NCT02323334|50226627|FG000|Period 3|Withdrawal by Subject|1|||
25115411|NCT02323334|50226628|FG001|Period 3|Withdrawal by Subject|0|||
25115412|NCT02323334|50226629|FG002|Period 3|Withdrawal by Subject|0|||
25115413|NCT02323334|50226630|FG003|Period 3|Withdrawal by Subject|0|||
25115414|NCT02323334|50226631|FG004|Period 3|Withdrawal by Subject|0|||
25115415|NCT02323334|50226632|FG005|Period 3|Withdrawal by Subject|0|||
25115416|NCT02323334|50226633|FG006|Period 3|Withdrawal by Subject|0|||
25115417|NCT02323334|50226634|FG007|Period 3|Withdrawal by Subject|0|||
25115418|NCT02323334|50226635|FG008|Period 3|Withdrawal by Subject|0|||
25115419|NCT02323334|50226636|FG009|Period 3|Withdrawal by Subject|0|||
25115420|NCT02323334|50226637|FG010|Period 3|Withdrawal by Subject|0|||
25115421|NCT02323334|50226638|FG011|Period 3|Withdrawal by Subject|0|||
25115422|NCT02323334|50226639|FG012|Period 3|Withdrawal by Subject|0|||
25115423|NCT02323334|50226640|FG013|Period 3|Withdrawal by Subject|0|||
25115424|NCT02323334|50226641|FG014|Period 3|Withdrawal by Subject|0|||
25115425|NCT02323334|50226642|FG015|Period 3|Withdrawal by Subject|0|||
25115426|NCT02323334|50226643|FG016|Period 3|Withdrawal by Subject|0|||
25115427|NCT02448719|50226716|FG000|Overall Study|Withdrawal by Subject|0|||
25115428|NCT02448719|50226717|FG001|Overall Study|Withdrawal by Subject|0|||
25115429|NCT02448719|50226718|FG002|Overall Study|Withdrawal by Subject|0|||
25115430|NCT02448719|50226719|FG003|Overall Study|Withdrawal by Subject|0|||
25115431|NCT02448719|50226720|FG004|Overall Study|Withdrawal by Subject|1|||
25115432|NCT02448719|50226721|FG005|Overall Study|Withdrawal by Subject|0|||
25115433|NCT02448719|50226722|FG006|Overall Study|Withdrawal by Subject|0|||
25115434|NCT02448719|50226723|FG007|Overall Study|Withdrawal by Subject|0|||
25115435|NCT02448719|50226724|FG008|Overall Study|Withdrawal by Subject|0|||
25115436|NCT02448719|50226725|FG009|Overall Study|Withdrawal by Subject|0|||
25115437|NCT02448719|50226726|FG010|Overall Study|Withdrawal by Subject|0|||
25115438|NCT02322866|50226789|FG000|Overall Study|Adverse Event|6|||
25115439|NCT02322866|50226790|FG001|Overall Study|Adverse Event|11|||
25115440|NCT02322866|50226789|FG000|Overall Study|Withdrawal of Consent|16|||
25115441|NCT02322866|50226790|FG001|Overall Study|Withdrawal of Consent|25|||
25115442|NCT02322866|50226789|FG000|Overall Study|Lost to Follow-up|36|||
25261475|NCT01261611|50576216|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
25115443|NCT02322866|50226790|FG001|Overall Study|Lost to Follow-up|39|||
25115444|NCT02322866|50226789|FG000|Overall Study|Protocol Violation|1|||
25115445|NCT02322866|50226790|FG001|Overall Study|Protocol Violation|0|||
25115446|NCT02322866|50226789|FG000|Overall Study|Noncompliance with Treatment|3|||
25115447|NCT02322866|50226790|FG001|Overall Study|Noncompliance with Treatment|4|||
25115448|NCT02322866|50226789|FG000|Overall Study|Lack of Efficacy|3|||
25115449|NCT02322866|50226790|FG001|Overall Study|Lack of Efficacy|1|||
25115450|NCT02322866|50226789|FG000|Overall Study|Other Miscellaneous Reasons|6|||
25115451|NCT02322866|50226790|FG001|Overall Study|Other Miscellaneous Reasons|6|||
25115452|NCT01640353|50226796|FG000|Overall Study|Withdrew prior to treatment|10|||
25115453|NCT01640353|50226796|FG000|Overall Study|Withdrawn from analysis at term site|12|||
25115454|NCT01640353|50226796|FG000|Overall Study|Withdrawal by Subject|5|||
25115455|NCT01640353|50226796|FG000|Overall Study|Death|2|||
25115456|NCT01640353|50226796|FG000|Overall Study|Early site termination|3|||
25115457|NCT01640353|50226796|FG000|Overall Study|Lost to Follow-up|12|||
25115458|NCT01640353|50226796|FG000|Overall Study|Physician Decision|1|||
25115459|NCT02463071|50226803|FG000|Overall Study|Adverse Event|3|||
25115460|NCT02463071|50226804|FG001|Overall Study|Adverse Event|5|||
25115461|NCT02463071|50226805|FG002|Overall Study|Adverse Event|1|||
25115462|NCT02463071|50226803|FG000|Overall Study|Death|1|||
25115463|NCT02463071|50226804|FG001|Overall Study|Death|0|||
25115464|NCT02463071|50226805|FG002|Overall Study|Death|0|||
25115465|NCT02463071|50226803|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
25115466|NCT02463071|50226804|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
25115467|NCT02463071|50226805|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
25115468|NCT02463071|50226803|FG000|Overall Study|Reason not specified|7|||
25115469|NCT02463071|50226804|FG001|Overall Study|Reason not specified|9|||
25115470|NCT02463071|50226805|FG002|Overall Study|Reason not specified|4|||
25115471|NCT02463071|50226803|FG000|Overall Study|Protocol Violation|0|||
25115472|NCT02463071|50226804|FG001|Overall Study|Protocol Violation|2|||
25115473|NCT02463071|50226805|FG002|Overall Study|Protocol Violation|0|||
25115474|NCT02463071|50226803|FG000|Overall Study|Lost to Follow-up|0|||
25115475|NCT02463071|50226804|FG001|Overall Study|Lost to Follow-up|0|||
25115476|NCT02463071|50226805|FG002|Overall Study|Lost to Follow-up|1|||
25115477|NCT02266381|50226816|FG000|Overall Study|Physician Decision|3|||
25115478|NCT02266381|50226817|FG001|Overall Study|Physician Decision|5|||
25115479|NCT02266381|50226818|FG002|Overall Study|Physician Decision|4|||
25115480|NCT01827046|50226830|FG000|Overall Study|Lost to Follow-up|1|||
25115481|NCT01827046|50226831|FG001|Overall Study|Lost to Follow-up|5|||
25115482|NCT01827046|50226830|FG000|Overall Study|Withdrawal by Subject|0|||
25115483|NCT01827046|50226831|FG001|Overall Study|Withdrawal by Subject|4|||
25115484|NCT02356562|50226839|FG000|Overall Study|Withdrawal by Subject|0|||
25115485|NCT02356562|50226840|FG001|Overall Study|Withdrawal by Subject|1|||
25115486|NCT02356562|50226839|FG000|Overall Study|Re-entered treatment in a previous study|1|||
25115487|NCT02356562|50226840|FG001|Overall Study|Re-entered treatment in a previous study|0|||
25115488|NCT02356562|50226839|FG000|Overall Study|site closure|1|||
25115489|NCT02356562|50226840|FG001|Overall Study|site closure|0|||
25115490|NCT02448563|50226851|FG000|Overall Study|Lost to Follow-up|16|||
25115491|NCT02448563|50226852|FG001|Overall Study|Lost to Follow-up|10|||
25115492|NCT02448563|50226851|FG000|Overall Study|Withdrawal by Subject|0|||
25115493|NCT02448563|50226852|FG001|Overall Study|Withdrawal by Subject|1|||
25115494|NCT02266225|50226862|FG000|Overall Study|Lost to Follow-up|2|||
25115495|NCT02266225|50226862|FG000|Overall Study|Death|1|||
25115496|NCT02266225|50226862|FG000|Overall Study|Withdrawal by Subject|13|||
25115497|NCT02354690|50226867|FG000|Overall Study|Physician Decision|1|||
25115498|NCT02354222|50226873|FG000|Overall Study|Adverse Event|0|||
25115499|NCT02354222|50226874|FG001|Overall Study|Adverse Event|3|||
25115500|NCT02354222|50226873|FG000|Overall Study|Physician Decision|1|||
25115501|NCT02354222|50226874|FG001|Overall Study|Physician Decision|1|||
25115502|NCT02354222|50226873|FG000|Overall Study|Pregnancy|1|||
25115503|NCT02354222|50226874|FG001|Overall Study|Pregnancy|0|||
25115504|NCT02354222|50226873|FG000|Overall Study|Withdrawal by Subject|2|||
25115505|NCT02354222|50226874|FG001|Overall Study|Withdrawal by Subject|3|||
25115506|NCT02354222|50226873|FG000|Overall Study|Conflict with the stopping criteria|0|||
25115507|NCT02354222|50226874|FG001|Overall Study|Conflict with the stopping criteria|4|||
25115508|NCT02353442|50226882|FG000|Overall Study|Withdrawal by Subject|3|||
25115509|NCT02353442|50226883|FG001|Overall Study|Withdrawal by Subject|4|||
25115510|NCT02351960|50226891|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
25115511|NCT02351960|50226892|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
25115512|NCT02351960|50226891|FG000|Overall Study|Voluntary Withdrawal|5|||
25115513|NCT02351960|50226892|FG001|Overall Study|Voluntary Withdrawal|4|||
25115514|NCT02351960|50226891|FG000|Overall Study|Significant Protocol Deviation|0|||
25115515|NCT02351960|50226892|FG001|Overall Study|Significant Protocol Deviation|5|||
25115516|NCT02351180|50226901|FG000|Overall Study|Withdrawal by Subject|1|||
25115517|NCT02351180|50226902|FG001|Overall Study|Withdrawal by Subject|0|||
25115518|NCT02350478|50226910|FG000|Overall Study|Lost to Follow-up|5|||
25115519|NCT02350478|50226911|FG001|Overall Study|Lost to Follow-up|1|||
25115520|NCT02349542|50226917|FG000|Overall Study|Withdrawal by Subject|5|||
25115521|NCT02321930|50226921|FG000|Overall Study|Lost to Follow-up|1|||
25115522|NCT01647542|50226928|FG000|Overall Study|Major Protocol Deviation|1|||
25115523|NCT01647542|50226929|FG001|Overall Study|Major Protocol Deviation|0|||
25115524|NCT01647542|50226930|FG002|Overall Study|Major Protocol Deviation|0|||
25115525|NCT01647542|50226928|FG000|Overall Study|Adverse Event|4|||
25115526|NCT01647542|50226929|FG001|Overall Study|Adverse Event|5|||
25115527|NCT01647542|50226930|FG002|Overall Study|Adverse Event|4|||
25115528|NCT01647542|50226928|FG000|Overall Study|Lost to Follow-up|0|||
25115529|NCT01647542|50226929|FG001|Overall Study|Lost to Follow-up|2|||
25115530|NCT01647542|50226930|FG002|Overall Study|Lost to Follow-up|2|||
25115531|NCT01647542|50226928|FG000|Overall Study|Withdrawal by Subject|6|||
25115532|NCT01647542|50226929|FG001|Overall Study|Withdrawal by Subject|4|||
25115533|NCT01647542|50226930|FG002|Overall Study|Withdrawal by Subject|0|||
25115534|NCT01647542|50226928|FG000|Overall Study|Study Termination|64|||
25115535|NCT01647542|50226929|FG001|Overall Study|Study Termination|61|||
25115536|NCT01647542|50226930|FG002|Overall Study|Study Termination|65|||
25115537|NCT01647542|50226928|FG000|Overall Study|Lack of Efficacy|1|||
25115538|NCT01647542|50226929|FG001|Overall Study|Lack of Efficacy|1|||
25115539|NCT01647542|50226930|FG002|Overall Study|Lack of Efficacy|0|||
25115540|NCT01647542|50226928|FG000|Overall Study|Death|0|||
25115541|NCT01647542|50226929|FG001|Overall Study|Death|0|||
25115542|NCT01647542|50226930|FG002|Overall Study|Death|1|||
25115543|NCT02321462|50226940|FG000|Overall Study|Withdrawal by Subject|5|||
25115544|NCT02321462|50226941|FG001|Overall Study|Withdrawal by Subject|2|||
25115545|NCT02321462|50226940|FG000|Overall Study|Subject withdrawn before any treatment|1|||
25115546|NCT02321462|50226941|FG001|Overall Study|Subject withdrawn before any treatment|1|||
25115547|NCT02391584|50226950|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
25115548|NCT02391584|50226951|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
25115549|NCT02391584|50226950|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
25115550|NCT02391584|50226951|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
25115551|NCT02391584|50226950|FG000|3 Month|Lost to Follow-up|1|||
25115552|NCT02391584|50226951|FG001|3 Month|Lost to Follow-up|0|||
25115553|NCT02391584|50226950|FG000|6 Month|Withdrawal by Subject|1|||
25115554|NCT02391584|50226951|FG001|6 Month|Withdrawal by Subject|0|||
25115555|NCT02391584|50226950|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
25115556|NCT02391584|50226951|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
25115557|NCT02266147|50226964|FG000|PART 1: Dose Escalation|Physician Decision|0|||
25115558|NCT02266147|50226965|FG001|PART 1: Dose Escalation|Physician Decision|0|||
25115559|NCT02266147|50226966|FG002|PART 1: Dose Escalation|Physician Decision|1|||
25115560|NCT02266147|50226967|FG003|PART 1: Dose Escalation|Physician Decision|0|||
25115561|NCT02266147|50226964|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
25115562|NCT02266147|50226965|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
25115563|NCT02266147|50226966|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
25115564|NCT02266147|50226967|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
25115565|NCT02266147|50226964|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
25115566|NCT02266147|50226965|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
25115567|NCT02266147|50226966|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
25115568|NCT02266147|50226967|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
25115569|NCT02266147|50226964|FG000|PART 1: Dose Escalation|Other|1|||
25115570|NCT02266147|50226965|FG001|PART 1: Dose Escalation|Other|1|||
25115571|NCT02266147|50226966|FG002|PART 1: Dose Escalation|Other|0|||
25115572|NCT02266147|50226967|FG003|PART 1: Dose Escalation|Other|0|||
25115573|NCT02266147|50226964|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
25115574|NCT02266147|50226965|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
25115575|NCT02266147|50226966|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
25115576|NCT02266147|50226967|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
25115577|NCT02266147|50226964|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
25115578|NCT02266147|50226965|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
25115579|NCT02266147|50226966|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
25115580|NCT02266147|50226967|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
25115581|NCT02264977|50226979|FG000|Overall Study|Death|3|||
25115582|NCT02264977|50226979|FG000|Overall Study|Physician Decision|1|||
25115583|NCT02264977|50226979|FG000|Overall Study|Refuse to return|1|||
25115584|NCT02264821|50226986|FG000|Overall Study|Protocol Violation|1|||
25115585|NCT02264821|50226987|FG001|Overall Study|Protocol Violation|3|||
25115586|NCT02264821|50226988|FG002|Overall Study|Protocol Violation|6|||
25115587|NCT02261467|50226998|FG000|Overall Study|Enrolled in Error|1|||
25115588|NCT02261467|50226999|FG001|Overall Study|Enrolled in Error|0|||
25115589|NCT02261467|50226998|FG000|Overall Study|Protocol Violation|0|||
25115590|NCT02261467|50226999|FG001|Overall Study|Protocol Violation|1|||
25115591|NCT02261467|50226998|FG000|Overall Study|Personal Reasons|17|||
25115592|NCT02261467|50226999|FG001|Overall Study|Personal Reasons|22|||
25115593|NCT02261467|50226998|FG000|Overall Study|Lost to Follow-up|2|||
25115594|NCT02261467|50226999|FG001|Overall Study|Lost to Follow-up|13|||
25115595|NCT02261467|50226998|FG000|Overall Study|Adverse Event|1|||
25115596|NCT02261467|50226999|FG001|Overall Study|Adverse Event|1|||
25115597|NCT01643473|50227007|FG000|Overall Study|Lost to Follow-up|1|||
25115598|NCT01643473|50227008|FG001|Overall Study|Lost to Follow-up|0|||
25115599|NCT02258659|50227014|FG000|Overall Study|Withdrawal by Subject|1|||
25115600|NCT02320058|50227020|FG000|Overall Study|Death|25|||
25115601|NCT02320058|50227021|FG001|Overall Study|Death|10|||
25115602|NCT02320058|50227020|FG000|Overall Study|Lost to Follow-up|4|||
25115603|NCT02320058|50227021|FG001|Overall Study|Lost to Follow-up|0|||
25115604|NCT02320058|50227020|FG000|Overall Study|Other reasons|4|||
25115605|NCT02320058|50227021|FG001|Overall Study|Other reasons|1|||
25115606|NCT02320058|50227020|FG000|Overall Study|Withdrawal by Subject|8|||
25115607|NCT02320058|50227021|FG001|Overall Study|Withdrawal by Subject|2|||
25115608|NCT02320058|50227020|FG000|Overall Study|Not reported|1|||
25115609|NCT02320058|50227021|FG001|Overall Study|Not reported|0|||
25115610|NCT02319668|50227029|FG000|Overall Study|Other (Not specified)|0|||
25115611|NCT02319668|50227030|FG001|Overall Study|Other (Not specified)|2|||
25115612|NCT02092467|50227042|FG000|Overall Study|Death|49|||
25115613|NCT02092467|50227043|FG001|Overall Study|Death|66|||
25115614|NCT02092467|50227044|FG002|Overall Study|Death|38|||
25115615|NCT02092467|50227042|FG000|Overall Study|Lost to Follow-up|38|||
25115616|NCT02092467|50227043|FG001|Overall Study|Lost to Follow-up|35|||
25115617|NCT02092467|50227044|FG002|Overall Study|Lost to Follow-up|40|||
25115618|NCT02092467|50227042|FG000|Overall Study|Global Deterioration of Health Status|1|||
25115619|NCT02092467|50227043|FG001|Overall Study|Global Deterioration of Health Status|0|||
25115620|NCT02092467|50227044|FG002|Overall Study|Global Deterioration of Health Status|0|||
25115621|NCT02092467|50227042|FG000|Overall Study|Other|32|||
25115622|NCT02092467|50227043|FG001|Overall Study|Other|30|||
25115623|NCT02092467|50227044|FG002|Overall Study|Other|24|||
25115624|NCT02092467|50227042|FG000|Overall Study|Withdrawal by Subject|282|||
25115625|NCT02092467|50227043|FG001|Overall Study|Withdrawal by Subject|327|||
25115626|NCT02092467|50227044|FG002|Overall Study|Withdrawal by Subject|289|||
25115627|NCT02092467|50227042|FG000|Overall Study|Randomized but not treated|2|||
25115628|NCT02092467|50227043|FG001|Overall Study|Randomized but not treated|1|||
25115629|NCT02092467|50227044|FG002|Overall Study|Randomized but not treated|7|||
25115630|NCT02462759|50227056|FG000|Part 1: Double Blind|Death|1|||
25115631|NCT02462759|50227057|FG001|Part 1: Double Blind|Death|0|||
25115632|NCT02462759|50227058|FG002|Part 1: Double Blind|Death|0|||
25115633|NCT02349386|50227073|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
25115634|NCT02349386|50227074|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
25115635|NCT02349386|50227075|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
25115636|NCT02349386|50227076|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
25115637|NCT02349386|50227073|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
25115638|NCT02349386|50227074|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
25115639|NCT02349386|50227075|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
25115640|NCT02349386|50227076|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
25115641|NCT02349386|50227073|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
25115642|NCT02349386|50227074|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
25115643|NCT02349386|50227075|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
25115644|NCT02349386|50227076|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
25115645|NCT02349386|50227073|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
25115646|NCT02349386|50227074|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
25115647|NCT02349386|50227075|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
25115648|NCT02349386|50227076|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
25115649|NCT02349386|50227073|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
25115650|NCT02349386|50227074|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
25115651|NCT02349386|50227075|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
25115652|NCT02349386|50227076|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
25115653|NCT02349386|50227073|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
25115654|NCT02349386|50227074|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
25115655|NCT02349386|50227075|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
25115656|NCT02349386|50227076|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
25115657|NCT02036775|50227086|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
25115658|NCT02036775|50227087|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
25115659|NCT02036775|50227088|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
25115660|NCT02036775|50227089|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
25115661|NCT02036775|50227090|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
25115662|NCT02036775|50227091|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
25115663|NCT02092389|50227099|FG000|Overall Study|Adverse Event|1|||
25115664|NCT02092389|50227099|FG000|Overall Study|Other|5|||
25115665|NCT02034591|50227103|FG000|Overall Study|Withdrawal by Subject|0|||
25115666|NCT02034591|50227104|FG001|Overall Study|Withdrawal by Subject|0|||
25115667|NCT02034591|50227105|FG002|Overall Study|Withdrawal by Subject|0|||
25115668|NCT02034591|50227106|FG003|Overall Study|Withdrawal by Subject|0|||
25115669|NCT02034591|50227107|FG004|Overall Study|Withdrawal by Subject|1|||
25115670|NCT02034591|50227108|FG005|Overall Study|Withdrawal by Subject|0|||
25115671|NCT02391116|50227117|FG000|Treatment|Withdrawal by Subject|1|||
25115672|NCT02391116|50227117|FG000|Treatment|Protocol Violation|1|||
25115673|NCT02391116|50227117|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
25115674|NCT02391116|50227117|FG000|Treatment|AE with Clinical PD|3|||
25115675|NCT02391116|50227117|FG000|Safety Follow-up|Adverse Event|1|||
25115676|NCT02391116|50227117|FG000|Safety Follow-up|Withdrawal by Subject|4|||
25115677|NCT02391116|50227117|FG000|Safety Follow-up|Switching to Other Therapy|4|||
25115678|NCT02391116|50227117|FG000|Safety Follow-up|No Follow Up|1|||
25115679|NCT02391116|50227117|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
25115680|NCT02391116|50227117|FG000|Active Follow-up|Withdrawal by Subject|1|||
25115681|NCT02391116|50227117|FG000|Active Follow-up|Switching to Other Therapy|2|||
25261476|NCT01261611|50576217|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
25008407|NCT03535194|50101305|FG000|Maintenance Period|Lost to Follow-up|4|||
25115682|NCT02391116|50227117|FG000|Survival Follow-up|Withdrawal by Subject|3|||
25115683|NCT02391116|50227117|FG000|Survival Follow-up|Switching to Other Therapy|1|||
25115684|NCT02091921|50227128|FG000|Overall Study|Adverse Event|3|||
25115685|NCT02447081|50227135|FG000|Overall Study|Death|161|||
25115686|NCT02447081|50227135|FG000|Overall Study|Lost to Follow-up|36|||
25115687|NCT02447081|50227135|FG000|Overall Study|Visit not completed|17|||
25115688|NCT02447081|50227135|FG000|Overall Study|unsuccessful implant procedure|10|||
25115689|NCT02391038|50227139|FG000|Overall Study|Progressive disease|3|||
25115690|NCT02391038|50227140|FG001|Overall Study|Progressive disease|3|||
25115691|NCT02391038|50227141|FG002|Overall Study|Progressive disease|6|||
25115692|NCT02260921|50227152|FG000|Overall Study|Adverse Event|1|||
25115693|NCT02260921|50227153|FG001|Overall Study|Adverse Event|0|||
25115694|NCT02260921|50227152|FG000|Overall Study|Lost to Follow-up|4|||
25115695|NCT02260921|50227153|FG001|Overall Study|Lost to Follow-up|3|||
25115696|NCT02260921|50227152|FG000|Overall Study|Withdraw Consent|4|||
25115697|NCT02260921|50227153|FG001|Overall Study|Withdraw Consent|1|||
25115698|NCT02260921|50227152|FG000|Overall Study|Death|1|||
25115699|NCT02260921|50227153|FG001|Overall Study|Death|0|||
25115700|NCT02260921|50227152|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
25115701|NCT02260921|50227153|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
25115702|NCT02462603|50227159|FG000|Overall Study|Investigator Decision|1|||
25115703|NCT02462603|50227159|FG000|Overall Study|Non-Compliance|1|||
25115704|NCT02462603|50227159|FG000|Overall Study|Withdrawal by Subject|2|||
25115705|NCT02034513|50227165|FG000|Overall Study|Adverse Event|11|||
25115706|NCT02034513|50227166|FG001|Overall Study|Adverse Event|10|||
25115707|NCT02034513|50227165|FG000|Overall Study|Lack of Efficacy|0|||
25115708|NCT02034513|50227166|FG001|Overall Study|Lack of Efficacy|1|||
25115709|NCT02034513|50227165|FG000|Overall Study|Lost to Follow-up|6|||
25115710|NCT02034513|50227166|FG001|Overall Study|Lost to Follow-up|7|||
25115711|NCT02034513|50227165|FG000|Overall Study|Pregnancy|0|||
25115712|NCT02034513|50227166|FG001|Overall Study|Pregnancy|3|||
25115713|NCT02034513|50227165|FG000|Overall Study|Protocol Violation|7|||
25115714|NCT02034513|50227166|FG001|Overall Study|Protocol Violation|10|||
25115715|NCT02034513|50227165|FG000|Overall Study|Withdrawal by Subject|25|||
25115716|NCT02034513|50227166|FG001|Overall Study|Withdrawal by Subject|25|||
25115717|NCT02034513|50227165|FG000|Overall Study|Unclassified|0|||
25115718|NCT02034513|50227166|FG001|Overall Study|Unclassified|1|||
25115719|NCT02348840|50227178|FG000|Overall Study|Withdrawal by Subject|2|||
25115720|NCT02348840|50227179|FG001|Overall Study|Withdrawal by Subject|1|||
25115721|NCT02348840|50227180|FG002|Overall Study|Withdrawal by Subject|0|||
25115722|NCT02348840|50227181|FG003|Overall Study|Withdrawal by Subject|0|||
25115723|NCT02462057|50227196|FG000|Overall Study|Left Vitality|32|||
25115724|NCT02462057|50227197|FG001|Overall Study|Left Vitality|27|||
25115725|NCT02462057|50227198|FG002|Overall Study|Left Vitality|23|||
25115726|NCT02462057|50227199|FG003|Overall Study|Left Vitality|35|||
25115727|NCT02462057|50227200|FG004|Overall Study|Left Vitality|33|||
25115728|NCT02462057|50227196|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
25115729|NCT02462057|50227197|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
25115730|NCT02462057|50227198|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
25115731|NCT02462057|50227199|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
25115732|NCT02462057|50227200|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
25115733|NCT02461745|50227214|FG000|Overall Study|Lack of Efficacy|9|||
25115734|NCT02461745|50227215|FG001|Overall Study|Lack of Efficacy|1|||
25115735|NCT02461745|50227214|FG000|Overall Study|Lost to Follow-up|2|||
25115736|NCT02461745|50227215|FG001|Overall Study|Lost to Follow-up|2|||
25115737|NCT02461745|50227214|FG000|Overall Study|Withdrawal by Subject|3|||
25115738|NCT02461745|50227215|FG001|Overall Study|Withdrawal by Subject|1|||
25115739|NCT02034435|50227225|FG000|Overall Study|Withdrawal by Subject|1|||
25115740|NCT02034435|50227226|FG001|Overall Study|Withdrawal by Subject|0|||
25115741|NCT02034435|50227227|FG002|Overall Study|Withdrawal by Subject|0|||
25115742|NCT02034435|50227228|FG003|Overall Study|Withdrawal by Subject|0|||
25115743|NCT02034435|50227225|FG000|Overall Study|Illness|0|||
25115744|NCT02034435|50227226|FG001|Overall Study|Illness|2|||
25115745|NCT02034435|50227227|FG002|Overall Study|Illness|0|||
25115746|NCT02034435|50227228|FG003|Overall Study|Illness|0|||
25115747|NCT02034435|50227225|FG000|Overall Study|Inadequate IV access|1|||
25115748|NCT02034435|50227226|FG001|Overall Study|Inadequate IV access|0|||
25115749|NCT02034435|50227227|FG002|Overall Study|Inadequate IV access|0|||
25115750|NCT02034435|50227228|FG003|Overall Study|Inadequate IV access|1|||
25115751|NCT02033889|50227241|FG000|Overall Study|Adverse Event|3|||
25115752|NCT02033889|50227242|FG001|Overall Study|Adverse Event|1|||
25115753|NCT02033889|50227243|FG002|Overall Study|Adverse Event|3|||
25115754|NCT02033889|50227241|FG000|Overall Study|Death|3|||
25115755|NCT02033889|50227242|FG001|Overall Study|Death|1|||
25115756|NCT02033889|50227243|FG002|Overall Study|Death|2|||
25115757|NCT02033889|50227241|FG000|Overall Study|Excluded Medication|1|||
25115758|NCT02033889|50227242|FG001|Overall Study|Excluded Medication|1|||
25115759|NCT02033889|50227243|FG002|Overall Study|Excluded Medication|0|||
25115760|NCT02033889|50227241|FG000|Overall Study|Lost to Follow-up|8|||
25115761|NCT02033889|50227242|FG001|Overall Study|Lost to Follow-up|5|||
25115762|NCT02033889|50227243|FG002|Overall Study|Lost to Follow-up|6|||
25115763|NCT02033889|50227241|FG000|Overall Study|Non-Compliance With Study Drug|1|||
25115764|NCT02033889|50227242|FG001|Overall Study|Non-Compliance With Study Drug|0|||
25115765|NCT02033889|50227243|FG002|Overall Study|Non-Compliance With Study Drug|0|||
25115766|NCT02033889|50227241|FG000|Overall Study|Physician Decision|0|||
25115767|NCT02033889|50227242|FG001|Overall Study|Physician Decision|1|||
25115768|NCT02033889|50227243|FG002|Overall Study|Physician Decision|1|||
25115769|NCT02033889|50227241|FG000|Overall Study|Participant moved|0|||
25115770|NCT02033889|50227242|FG001|Overall Study|Participant moved|1|||
25115771|NCT02033889|50227243|FG002|Overall Study|Participant moved|0|||
25115772|NCT02033889|50227241|FG000|Overall Study|Withdrawal by Subject|18|||
25115773|NCT02033889|50227242|FG001|Overall Study|Withdrawal by Subject|10|||
25115774|NCT02033889|50227243|FG002|Overall Study|Withdrawal by Subject|13|||
25115775|NCT02447003|50227253|FG000|Overall Study|Other|0|||
25115776|NCT02447003|50227254|FG001|Overall Study|Other|4|||
25115777|NCT02447003|50227253|FG000|Overall Study|Site discontinued|0|||
25115778|NCT02447003|50227254|FG001|Overall Study|Site discontinued|2|||
25115779|NCT02447003|50227253|FG000|Overall Study|Physician Decision|0|||
25115780|NCT02447003|50227254|FG001|Overall Study|Physician Decision|1|||
25115781|NCT02447003|50227253|FG000|Overall Study|Withdrawal by Subject|4|||
25115782|NCT02447003|50227254|FG001|Overall Study|Withdrawal by Subject|3|||
25115783|NCT02447003|50227253|FG000|Overall Study|Sponsor Decision|6|||
25115784|NCT02447003|50227254|FG001|Overall Study|Sponsor Decision|11|||
25115785|NCT02447003|50227253|FG000|Overall Study|Progressive Disease|1|||
25115786|NCT02447003|50227254|FG001|Overall Study|Progressive Disease|0|||
25115787|NCT02447003|50227253|FG000|Overall Study|Lost to Follow-up|5|||
25115788|NCT02447003|50227254|FG001|Overall Study|Lost to Follow-up|0|||
25115789|NCT02447003|50227253|FG000|Overall Study|Death|154|||
25115790|NCT02447003|50227254|FG001|Overall Study|Death|63|||
25115791|NCT01844284|50227264|FG000|Overall Study|Lost to Follow-up|12|||
25115792|NCT01844284|50227265|FG001|Overall Study|Lost to Follow-up|7|||
25115793|NCT02054715|50227273|FG000|Baseline/Follow-up 1|Refused|1|||
25115794|NCT02054715|50227274|FG001|Baseline/Follow-up 1|Refused|3|||
25115795|NCT02054715|50227273|FG000|Baseline/Follow-up 1|Medical|0|||
25115796|NCT02054715|50227274|FG001|Baseline/Follow-up 1|Medical|1|||
25115797|NCT02054715|50227273|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
25115798|NCT02054715|50227274|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
25115799|NCT02054715|50227273|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
25115800|NCT02054715|50227274|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
25115801|NCT02054715|50227273|FG000|Baseline/Follow-up 1|No Reason|0|||
25115802|NCT02054715|50227274|FG001|Baseline/Follow-up 1|No Reason|1|||
25115803|NCT02054715|50227273|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
25115804|NCT02054715|50227274|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
25115805|NCT02054715|50227273|FG000|Baseline/Follow-up 1|Ineligible|3|||
25115806|NCT02054715|50227274|FG001|Baseline/Follow-up 1|Ineligible|0|||
25115807|NCT02054715|50227273|FG000|Baseline/Follow-up 1|Hospitalization|1|||
25115808|NCT02054715|50227274|FG001|Baseline/Follow-up 1|Hospitalization|0|||
25115809|NCT02054715|50227273|FG000|Baseline/Follow-up 1|Changed Mind|1|||
25115810|NCT02054715|50227274|FG001|Baseline/Follow-up 1|Changed Mind|0|||
25115811|NCT02054715|50227273|FG000|Follow-up 2|Lost to Followup|3|||
25115812|NCT02054715|50227274|FG001|Follow-up 2|Lost to Followup|1|||
25115813|NCT02054715|50227273|FG000|Follow-up 2|Refused|3|||
25115814|NCT02054715|50227274|FG001|Follow-up 2|Refused|2|||
25115815|NCT02054715|50227273|FG000|Follow-up 2|Followup Not Completed|3|||
25115816|NCT02054715|50227274|FG001|Follow-up 2|Followup Not Completed|4|||
25115817|NCT02054715|50227273|FG000|Follow-up 2|Ineligible|4|||
25115818|NCT02054715|50227274|FG001|Follow-up 2|Ineligible|5|||
25115819|NCT02054715|50227273|FG000|Follow-up 2|Death|3|||
25115820|NCT02054715|50227274|FG001|Follow-up 2|Death|3|||
25115821|NCT02054715|50227273|FG000|Follow-up 2|Hospitalization|0|||
25115822|NCT02054715|50227274|FG001|Follow-up 2|Hospitalization|2|||
25115823|NCT02054715|50227273|FG000|Follow-up 2|Changed MD/Facility|0|||
25115824|NCT02054715|50227274|FG001|Follow-up 2|Changed MD/Facility|1|||
25115825|NCT02054715|50227273|FG000|Follow-up 2|Changed Mind|0|||
25115826|NCT02054715|50227274|FG001|Follow-up 2|Changed Mind|1|||
25261477|NCT01261611|50576215|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
25115827|NCT02054715|50227273|FG000|Follow-up 2|No Reason|2|||
25115828|NCT02054715|50227274|FG001|Follow-up 2|No Reason|0|||
25115829|NCT02054715|50227273|FG000|Follow-up 2|Treatment Change or Delay|1|||
25115830|NCT02054715|50227274|FG001|Follow-up 2|Treatment Change or Delay|0|||
25115831|NCT02446769|50227280|FG000|Screening Period|Screen Failure|11|||
25115832|NCT02446769|50227281|FG001|Screening Period|Screen Failure|0|||
25115833|NCT02446769|50227282|FG002|Screening Period|Screen Failure|0|||
25115834|NCT02446769|50227280|FG000|Study Period|Randomized in Error|0|||
25115835|NCT02446769|50227281|FG001|Study Period|Randomized in Error|2|||
25115836|NCT02446769|50227282|FG002|Study Period|Randomized in Error|0|||
25115837|NCT02420093|50227291|FG000|Overall Study|Withdrawal by Subject|1|||
25115838|NCT02420093|50227292|FG001|Overall Study|Withdrawal by Subject|1|||
25115839|NCT02419937|50227300|FG000|Overall Study|Lost to Follow-up|1|||
25115840|NCT02419937|50227301|FG001|Overall Study|Lost to Follow-up|0|||
25115841|NCT02054481|50227311|FG000|Overall Study|Adverse Event|1|||
25115842|NCT02054481|50227312|FG001|Overall Study|Adverse Event|1|||
25115843|NCT02054481|50227313|FG002|Overall Study|Adverse Event|0|||
25115844|NCT02054481|50227314|FG003|Overall Study|Adverse Event|1|||
25115845|NCT02054481|50227311|FG000|Overall Study|Lost to Follow-up|1|||
25115846|NCT02054481|50227312|FG001|Overall Study|Lost to Follow-up|0|||
25115847|NCT02054481|50227313|FG002|Overall Study|Lost to Follow-up|0|||
25115848|NCT02054481|50227314|FG003|Overall Study|Lost to Follow-up|0|||
25115849|NCT02054481|50227311|FG000|Overall Study|Other reason|2|||
25115850|NCT02054481|50227312|FG001|Overall Study|Other reason|1|||
25115851|NCT02054481|50227313|FG002|Overall Study|Other reason|2|||
25115852|NCT02054481|50227314|FG003|Overall Study|Other reason|0|||
25115853|NCT01610752|50227328|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
25115854|NCT01610752|50227329|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
25115855|NCT01610752|50227330|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
25115856|NCT02054325|50227340|FG000|Overall Study|Lost to Follow-up|8|||
25115857|NCT02054325|50227341|FG001|Overall Study|Lost to Follow-up|5|||
25115858|NCT02446691|50227347|FG000|Overall Study|Withdrawal by Subject|2|||
25115859|NCT02446691|50227347|FG000|Overall Study|Lost to Follow-up|8|||
25115860|NCT02446691|50227347|FG000|Overall Study|Protocol Violation|1|||
25115861|NCT02091375|50227353|FG000|Overall Study|Adverse Event|8|||
25115862|NCT02091375|50227354|FG001|Overall Study|Adverse Event|1|||
25115863|NCT02091375|50227353|FG000|Overall Study|Lost to Follow-up|0|||
25115864|NCT02091375|50227354|FG001|Overall Study|Lost to Follow-up|1|||
25115865|NCT02091375|50227353|FG000|Overall Study|Withdrawal by Subject|0|||
25115866|NCT02091375|50227354|FG001|Overall Study|Withdrawal by Subject|1|||
25115867|NCT02091375|50227353|FG000|Overall Study|Withdrawn by the investigator|1|||
25115868|NCT02091375|50227354|FG001|Overall Study|Withdrawn by the investigator|0|||
25115869|NCT02032875|50227362|FG000|Treatment Period|Adverse Event|1|||
25115870|NCT02032875|50227363|FG001|Treatment Period|Adverse Event|0|||
25115871|NCT02032875|50227362|FG000|Treatment Period|Liver transplant, No extension needed|0|||
25115872|NCT02032875|50227363|FG001|Treatment Period|Liver transplant, No extension needed|1|||
25115873|NCT02032875|50227362|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
25115874|NCT02032875|50227363|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
25115875|NCT02032875|50227362|FG000|Follow-up Period|Death|0|||
25115876|NCT02032875|50227363|FG001|Follow-up Period|Death|1|||
25115877|NCT02032875|50227362|FG000|Follow-up Period|Virologic Relapse|3|||
25115878|NCT02032875|50227363|FG001|Follow-up Period|Virologic Relapse|10|||
25115879|NCT02032407|50227370|FG000|Overall Study|Lost to Follow-up|2|||
25115880|NCT02032407|50227370|FG000|Overall Study|Pregnancy|1|||
25115881|NCT02032407|50227370|FG000|Overall Study|Other Miscellaneous Reasons|2|||
25115882|NCT01843972|50227388|FG000|Overall Study|Withdrawal by Subject|0|||
25115883|NCT01843972|50227389|FG001|Overall Study|Withdrawal by Subject|0|||
25115884|NCT01843972|50227390|FG002|Overall Study|Withdrawal by Subject|0|||
25115885|NCT01843972|50227391|FG003|Overall Study|Withdrawal by Subject|0|||
25115886|NCT01843972|50227392|FG004|Overall Study|Withdrawal by Subject|1|||
25115887|NCT01843972|50227393|FG005|Overall Study|Withdrawal by Subject|0|||
25115888|NCT01843972|50227394|FG006|Overall Study|Withdrawal by Subject|0|||
25115889|NCT01843972|50227395|FG007|Overall Study|Withdrawal by Subject|0|||
25115890|NCT01843972|50227396|FG008|Overall Study|Withdrawal by Subject|0|||
25115891|NCT01843972|50227397|FG009|Overall Study|Withdrawal by Subject|0|||
25115892|NCT01826422|50227435|FG000|Overall Study|Withdrawal by Subject|1|||
25115893|NCT01826422|50227436|FG001|Overall Study|Withdrawal by Subject|3|||
25115894|NCT01843660|50227442|FG000|Overall Study|Other|30|||
25115895|NCT02090283|50227449|FG000|Overall Study|Withdrawal by Subject|6|||
25115896|NCT02090283|50227450|FG001|Overall Study|Withdrawal by Subject|6|||
25115897|NCT02090283|50227451|FG002|Overall Study|Withdrawal by Subject|6|||
25115898|NCT02090283|50227449|FG000|Overall Study|Sponsor Terminated Study|6|||
25115899|NCT02090283|50227450|FG001|Overall Study|Sponsor Terminated Study|6|||
25115900|NCT02090283|50227451|FG002|Overall Study|Sponsor Terminated Study|1|||
25115901|NCT02090283|50227449|FG000|Overall Study|Lost to Follow-up|2|||
25115902|NCT02090283|50227450|FG001|Overall Study|Lost to Follow-up|2|||
25115903|NCT02090283|50227451|FG002|Overall Study|Lost to Follow-up|3|||
25115904|NCT02090283|50227449|FG000|Overall Study|Adverse Event|1|||
25115905|NCT02090283|50227450|FG001|Overall Study|Adverse Event|1|||
25115906|NCT02090283|50227451|FG002|Overall Study|Adverse Event|0|||
25115907|NCT02090283|50227449|FG000|Overall Study|Protocol Violation|2|||
25115908|NCT02090283|50227450|FG001|Overall Study|Protocol Violation|0|||
25115909|NCT02090283|50227451|FG002|Overall Study|Protocol Violation|0|||
25115910|NCT02032173|50227459|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
25115911|NCT02031471|50227463|FG000|24 Week Treatment Period|Adverse Event|6|||
25115912|NCT02031471|50227463|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
25115913|NCT02031471|50227463|FG000|24 Week Treatment Period|Protocol Violation|1|||
25115914|NCT02031471|50227463|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
25115915|NCT02031471|50227463|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
25115916|NCT02031471|50227463|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
25115917|NCT02031471|50227463|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
25115918|NCT02461589|50227477|FG000|Overall Study|Withdrawal by Subject|5|||
25115919|NCT02461589|50227478|FG001|Overall Study|Withdrawal by Subject|1|||
25115920|NCT02461589|50227479|FG002|Overall Study|Withdrawal by Subject|3|||
25115921|NCT02461589|50227480|FG003|Overall Study|Withdrawal by Subject|2|||
25115922|NCT02461589|50227481|FG004|Overall Study|Withdrawal by Subject|1|||
25115923|NCT02461589|50227482|FG005|Overall Study|Withdrawal by Subject|2|||
25115924|NCT02461589|50227483|FG006|Overall Study|Withdrawal by Subject|1|||
25115925|NCT02461589|50227484|FG007|Overall Study|Withdrawal by Subject|3|||
25115926|NCT02461589|50227485|FG008|Overall Study|Withdrawal by Subject|3|||
25115927|NCT02461589|50227486|FG009|Overall Study|Withdrawal by Subject|1|||
25115928|NCT02461589|50227477|FG000|Overall Study|Lost to Follow-up|0|||
25115929|NCT02461589|50227478|FG001|Overall Study|Lost to Follow-up|0|||
25115930|NCT02461589|50227479|FG002|Overall Study|Lost to Follow-up|2|||
25115931|NCT02461589|50227480|FG003|Overall Study|Lost to Follow-up|3|||
25115932|NCT02461589|50227481|FG004|Overall Study|Lost to Follow-up|1|||
25115933|NCT02461589|50227482|FG005|Overall Study|Lost to Follow-up|1|||
25115934|NCT02461589|50227483|FG006|Overall Study|Lost to Follow-up|3|||
25115935|NCT02461589|50227484|FG007|Overall Study|Lost to Follow-up|1|||
25115936|NCT02461589|50227485|FG008|Overall Study|Lost to Follow-up|3|||
25115937|NCT02461589|50227486|FG009|Overall Study|Lost to Follow-up|1|||
25115938|NCT02461589|50227477|FG000|Overall Study|Death|0|||
25115939|NCT02461589|50227478|FG001|Overall Study|Death|0|||
25115940|NCT02461589|50227479|FG002|Overall Study|Death|0|||
25115941|NCT02461589|50227480|FG003|Overall Study|Death|0|||
25115942|NCT02461589|50227481|FG004|Overall Study|Death|0|||
25115943|NCT02461589|50227482|FG005|Overall Study|Death|0|||
25115944|NCT02461589|50227483|FG006|Overall Study|Death|0|||
25115945|NCT02461589|50227484|FG007|Overall Study|Death|1|||
25115946|NCT02461589|50227485|FG008|Overall Study|Death|0|||
25115947|NCT02461589|50227486|FG009|Overall Study|Death|0|||
25115948|NCT02461589|50227477|FG000|Overall Study|Unclassified|0|||
25115949|NCT02461589|50227478|FG001|Overall Study|Unclassified|0|||
25115950|NCT02461589|50227479|FG002|Overall Study|Unclassified|0|||
25115951|NCT02461589|50227480|FG003|Overall Study|Unclassified|0|||
25115952|NCT02461589|50227481|FG004|Overall Study|Unclassified|0|||
25115953|NCT02461589|50227482|FG005|Overall Study|Unclassified|0|||
25115954|NCT02461589|50227483|FG006|Overall Study|Unclassified|1|||
25115955|NCT02461589|50227484|FG007|Overall Study|Unclassified|0|||
25115956|NCT02461589|50227485|FG008|Overall Study|Unclassified|0|||
25115957|NCT02461589|50227486|FG009|Overall Study|Unclassified|2|||
25115958|NCT02461589|50227477|FG000|Overall Study|Missing follow-up information|1|||
25115959|NCT02461589|50227478|FG001|Overall Study|Missing follow-up information|1|||
25115960|NCT02461589|50227479|FG002|Overall Study|Missing follow-up information|0|||
25115961|NCT02461589|50227480|FG003|Overall Study|Missing follow-up information|0|||
25115962|NCT02461589|50227481|FG004|Overall Study|Missing follow-up information|0|||
25115963|NCT02461589|50227482|FG005|Overall Study|Missing follow-up information|0|||
25115964|NCT02461589|50227483|FG006|Overall Study|Missing follow-up information|1|||
25115965|NCT02461589|50227484|FG007|Overall Study|Missing follow-up information|0|||
25115966|NCT02461589|50227485|FG008|Overall Study|Missing follow-up information|0|||
25115967|NCT02461589|50227486|FG009|Overall Study|Missing follow-up information|0|||
25115968|NCT02461589|50227477|FG000|Overall Study|Withdrawal from trial before exposure|0|||
25115969|NCT02461589|50227478|FG001|Overall Study|Withdrawal from trial before exposure|0|||
25115970|NCT02461589|50227479|FG002|Overall Study|Withdrawal from trial before exposure|0|||
25115971|NCT02461589|50227480|FG003|Overall Study|Withdrawal from trial before exposure|0|||
25115972|NCT02461589|50227481|FG004|Overall Study|Withdrawal from trial before exposure|0|||
25115973|NCT02461589|50227482|FG005|Overall Study|Withdrawal from trial before exposure|0|||
25115974|NCT02461589|50227483|FG006|Overall Study|Withdrawal from trial before exposure|0|||
25115975|NCT02461589|50227484|FG007|Overall Study|Withdrawal from trial before exposure|0|||
25115976|NCT02461589|50227485|FG008|Overall Study|Withdrawal from trial before exposure|0|||
25115977|NCT02461589|50227486|FG009|Overall Study|Withdrawal from trial before exposure|1|||
25115978|NCT02089737|50227508|FG000|Overall Study|Survey form not completed|5|||
25115979|NCT02089737|50227508|FG000|Overall Study|Not treated|1|||
25115980|NCT02460575|50227515|FG000|Overall Study|Lost to Follow-up|1|||
25115981|NCT02460575|50227516|FG001|Overall Study|Lost to Follow-up|0|||
25115982|NCT02089347|50227524|FG000|Overall Study|Protocol Violation|1|||
25115983|NCT02089347|50227525|FG001|Overall Study|Protocol Violation|0|||
25115984|NCT02445755|50227531|FG000|Overall Study|Withdrawal by Subject|2|||
25115985|NCT02445755|50227531|FG000|Overall Study|Protocol Violation|6|||
25008408|NCT03535194|50101306|FG001|Maintenance Period|Lost to Follow-up|2|||
25008409|NCT03535194|50101307|FG002|Maintenance Period|Lost to Follow-up|1|||
25115986|NCT02445755|50227531|FG000|Overall Study|Screen Failure|5|||
25115987|NCT02419469|50227538|FG000|Overall Study|Withdrawal by Subject|1|||
25115988|NCT02419313|50227542|FG000|First Intervention|Lost to Follow-up|2|||
25115989|NCT02419313|50227543|FG001|First Intervention|Lost to Follow-up|0|||
25115990|NCT02419313|50227542|FG000|Second Intervention|Lost to Follow-up|1|||
25115991|NCT02419313|50227543|FG001|Second Intervention|Lost to Follow-up|0|||
25115992|NCT02419001|50227551|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
25115993|NCT02419001|50227552|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
25115994|NCT02031237|50227560|FG000|Overall Study|Death|1|||
25115995|NCT02031237|50227561|FG001|Overall Study|Death|5|||
25115996|NCT02031237|50227562|FG002|Overall Study|Death|0|||
25115997|NCT02031237|50227560|FG000|Overall Study|Physician Decision|0|||
25115998|NCT02031237|50227561|FG001|Overall Study|Physician Decision|1|||
25115999|NCT02031237|50227562|FG002|Overall Study|Physician Decision|0|||
25116000|NCT02031237|50227560|FG000|Overall Study|Withdrawal by Subject|2|||
25116001|NCT02031237|50227561|FG001|Overall Study|Withdrawal by Subject|2|||
25116002|NCT02031237|50227562|FG002|Overall Study|Withdrawal by Subject|0|||
25116003|NCT02031237|50227560|FG000|Overall Study|Protocol Violation|2|||
25116004|NCT02031237|50227561|FG001|Overall Study|Protocol Violation|6|||
25116005|NCT02031237|50227562|FG002|Overall Study|Protocol Violation|0|||
25116006|NCT02031237|50227560|FG000|Overall Study|Alternate Treatment Given|0|||
25116007|NCT02031237|50227561|FG001|Overall Study|Alternate Treatment Given|0|||
25116008|NCT02031237|50227562|FG002|Overall Study|Alternate Treatment Given|3|||
25116009|NCT02088957|50227569|FG000|Overall Study|Lack of Efficacy|1|||
25116010|NCT02088957|50227570|FG001|Overall Study|Lack of Efficacy|0|||
25116011|NCT02418845|50227578|FG000|Overall Study|Lost to Follow-up|7|||
25116012|NCT02418845|50227579|FG001|Overall Study|Lost to Follow-up|2|||
25116013|NCT02418845|50227578|FG000|Overall Study|Lack of Efficacy|0|||
25116014|NCT02418845|50227579|FG001|Overall Study|Lack of Efficacy|3|||
25116015|NCT02418845|50227578|FG000|Overall Study|Physician Decision|5|||
25116016|NCT02418845|50227579|FG001|Overall Study|Physician Decision|5|||
25116017|NCT02418845|50227578|FG000|Overall Study|Protocol Violation|1|||
25116018|NCT02418845|50227579|FG001|Overall Study|Protocol Violation|0|||
25116019|NCT02418845|50227578|FG000|Overall Study|Withdrawal by Subject|3|||
25116020|NCT02418845|50227579|FG001|Overall Study|Withdrawal by Subject|2|||
25261478|NCT01261611|50576216|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
25261479|NCT01261611|50576217|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
25261480|NCT01261611|50576215|FG000|Treatment Cycle 1|Adverse Event|0|||
25008410|NCT03535194|50101308|FG003|Maintenance Period|Lost to Follow-up|5|||
25116021|NCT02088177|50227585|FG000|Overall Study|Lost to Follow-up|3|||
25116022|NCT02030535|50227589|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
25116023|NCT02029989|50227605|FG000|Overall Study|Withdrawal by Subject|1|||
25116024|NCT02029989|50227606|FG001|Overall Study|Withdrawal by Subject|0|||
25116025|NCT02029989|50227605|FG000|Overall Study|Withdrawal: Fear of needles|1|||
25116026|NCT02029989|50227606|FG001|Overall Study|Withdrawal: Fear of needles|0|||
25116027|NCT02029989|50227605|FG000|Overall Study|Change of location|2|||
25116028|NCT02029989|50227606|FG001|Overall Study|Change of location|3|||
25116029|NCT02029989|50227605|FG000|Overall Study|Physician Decision|2|||
25116030|NCT02029989|50227606|FG001|Overall Study|Physician Decision|0|||
25116031|NCT02029989|50227605|FG000|Overall Study|Lost to Follow-up|9|||
25116032|NCT02029989|50227606|FG001|Overall Study|Lost to Follow-up|7|||
25116033|NCT02029989|50227605|FG000|Overall Study|Death|0|||
25116034|NCT02029989|50227606|FG001|Overall Study|Death|1|||
25116035|NCT02029989|50227605|FG000|Overall Study|Protocol Violation|1|||
25116036|NCT02029989|50227606|FG001|Overall Study|Protocol Violation|0|||
25116037|NCT02048241|50227614|FG000|Overall Study|Withdrawal by Subject|0|||
25116038|NCT02048241|50227615|FG001|Overall Study|Withdrawal by Subject|1|||
25116039|NCT02087943|50227624|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
25116040|NCT02087943|50227625|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
25116041|NCT02087943|50227626|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
25116042|NCT02087943|50227627|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
25116043|NCT02087943|50227628|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
25116044|NCT02087943|50227624|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
25116045|NCT02087943|50227625|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
25116046|NCT02087943|50227626|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
25116047|NCT02087943|50227627|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
25116048|NCT02087943|50227628|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
25116049|NCT02087943|50227624|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
25116050|NCT02087943|50227625|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
25116051|NCT02087943|50227626|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
25116052|NCT02087943|50227627|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
25116053|NCT02087943|50227628|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
25116054|NCT02087943|50227624|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
25116055|NCT02087943|50227625|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
25116056|NCT02087943|50227626|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
25116057|NCT02087943|50227627|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
25116058|NCT02087943|50227628|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
25116059|NCT02087943|50227624|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
25261481|NCT01261611|50576216|FG001|Treatment Cycle 1|Adverse Event|1|||
25116060|NCT02087943|50227625|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
25116061|NCT02087943|50227626|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
25116062|NCT02087943|50227627|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
25116063|NCT02087943|50227628|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
25116064|NCT02087943|50227624|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
25116065|NCT02087943|50227625|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
25116066|NCT02087943|50227626|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
25116067|NCT02087943|50227627|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
25116068|NCT02087943|50227628|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
25116069|NCT02087943|50227624|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
25116070|NCT02087943|50227625|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
25116071|NCT02087943|50227626|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
25116072|NCT02087943|50227627|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
25116073|NCT02087943|50227628|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
25116074|NCT02087943|50227624|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
25116075|NCT02087943|50227625|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
25116076|NCT02087943|50227626|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
25116077|NCT02087943|50227627|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
25116078|NCT02087943|50227628|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
25116079|NCT02087943|50227624|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
25116080|NCT02087943|50227625|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
25116081|NCT02087943|50227626|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
25116082|NCT02087943|50227627|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
25116083|NCT02087943|50227628|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
25116084|NCT02087943|50227624|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
25116085|NCT02087943|50227625|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
25116086|NCT02087943|50227626|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
25116087|NCT02087943|50227627|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
25116088|NCT02087943|50227628|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
25116089|NCT02029521|50227642|FG000|Overall Study|Protocol Violation|1|||
25116090|NCT02029521|50227643|FG001|Overall Study|Protocol Violation|0|||
25116091|NCT02029521|50227642|FG000|Overall Study|Withdrawal by Subject|1|||
25116092|NCT02029521|50227643|FG001|Overall Study|Withdrawal by Subject|1|||
25116093|NCT02443883|50227664|FG000|Overall Study|Adverse Event|0|||
25116094|NCT02443883|50227665|FG001|Overall Study|Adverse Event|1|||
25116095|NCT02443883|50227666|FG002|Overall Study|Adverse Event|0|||
25116096|NCT02443883|50227667|FG003|Overall Study|Adverse Event|0|||
25116097|NCT02443883|50227664|FG000|Overall Study|Lost to Follow-up|3|||
25116098|NCT02443883|50227665|FG001|Overall Study|Lost to Follow-up|2|||
25116099|NCT02443883|50227666|FG002|Overall Study|Lost to Follow-up|1|||
25116100|NCT02443883|50227667|FG003|Overall Study|Lost to Follow-up|0|||
25116101|NCT02443883|50227664|FG000|Overall Study|Physician Decision|1|||
25116102|NCT02443883|50227665|FG001|Overall Study|Physician Decision|1|||
25116103|NCT02443883|50227666|FG002|Overall Study|Physician Decision|0|||
25116104|NCT02443883|50227667|FG003|Overall Study|Physician Decision|3|||
25116105|NCT02443883|50227664|FG000|Overall Study|Withdrawal by Subject|1|||
25116106|NCT02443883|50227665|FG001|Overall Study|Withdrawal by Subject|0|||
25116107|NCT02443883|50227666|FG002|Overall Study|Withdrawal by Subject|0|||
25116108|NCT02443883|50227667|FG003|Overall Study|Withdrawal by Subject|2|||
25116109|NCT02443883|50227664|FG000|Overall Study|Randomized, but never treated|1|||
25116110|NCT02443883|50227665|FG001|Overall Study|Randomized, but never treated|0|||
25116111|NCT02443883|50227666|FG002|Overall Study|Randomized, but never treated|0|||
25116112|NCT02443883|50227667|FG003|Overall Study|Randomized, but never treated|0|||
25116113|NCT02460263|50227677|FG000|Transition Period|Withdrawal by Subject|1|||
25116114|NCT02460263|50227677|FG000|Transition Period|Death|1|||
25116115|NCT02443805|50227687|FG000|Overall Study|Adverse Event|100|||
25116116|NCT02443805|50227688|FG001|Overall Study|Adverse Event|18|||
25116117|NCT02443805|50227687|FG000|Overall Study|Withdrawal by Subject|73|||
25116118|NCT02443805|50227688|FG001|Overall Study|Withdrawal by Subject|74|||
25116119|NCT02443805|50227687|FG000|Overall Study|Lost to Follow-up|19|||
25116120|NCT02443805|50227688|FG001|Overall Study|Lost to Follow-up|14|||
25008411|NCT03535194|50101309|FG004|Maintenance Period|Lost to Follow-up|2|||
25116121|NCT02443805|50227687|FG000|Overall Study|Pregnancy|6|||
25116122|NCT02443805|50227688|FG001|Overall Study|Pregnancy|5|||
25116123|NCT02443805|50227687|FG000|Overall Study|Protocol Violation|2|||
25116124|NCT02443805|50227688|FG001|Overall Study|Protocol Violation|4|||
25116125|NCT02443805|50227687|FG000|Overall Study|Lack of Efficacy|1|||
25116126|NCT02443805|50227688|FG001|Overall Study|Lack of Efficacy|1|||
25116127|NCT02443805|50227687|FG000|Overall Study|Non-compliance with study drug|6|||
25116128|NCT02443805|50227688|FG001|Overall Study|Non-compliance with study drug|4|||
25116129|NCT02443805|50227687|FG000|Overall Study|Withdrawal by parent/guardian|3|||
25116130|NCT02443805|50227688|FG001|Overall Study|Withdrawal by parent/guardian|5|||
25116131|NCT02443805|50227687|FG000|Overall Study|Any other reason not above-mentioned|3|||
25116132|NCT02443805|50227688|FG001|Overall Study|Any other reason not above-mentioned|2|||
25116133|NCT01652885|50227694|FG000|Overall Study|Adverse Event|1|||
25116134|NCT02459951|50227698|FG000|Overall Study|Unable to meet holding requirement|1|||
25116135|NCT02087241|50227707|FG000|Overall Study|Death|2|||
25116136|NCT02087241|50227708|FG001|Overall Study|Death|1|||
25116137|NCT02087241|50227709|FG002|Overall Study|Death|1|||
25116138|NCT02087241|50227710|FG003|Overall Study|Death|1|||
25116139|NCT02087241|50227707|FG000|Overall Study|Withdrawal by Subject|1|||
25116140|NCT02087241|50227708|FG001|Overall Study|Withdrawal by Subject|0|||
25116141|NCT02087241|50227709|FG002|Overall Study|Withdrawal by Subject|0|||
25116142|NCT02087241|50227710|FG003|Overall Study|Withdrawal by Subject|1|||
25116143|NCT02087241|50227707|FG000|Overall Study|Progressive Disease|0|||
25116144|NCT02087241|50227708|FG001|Overall Study|Progressive Disease|0|||
25116145|NCT02087241|50227709|FG002|Overall Study|Progressive Disease|0|||
25116146|NCT02087241|50227710|FG003|Overall Study|Progressive Disease|1|||
25116147|NCT02087241|50227707|FG000|Overall Study|Study Terminated by Sponsor|0|||
25116148|NCT02087241|50227708|FG001|Overall Study|Study Terminated by Sponsor|2|||
25116149|NCT02087241|50227709|FG002|Overall Study|Study Terminated by Sponsor|0|||
25116150|NCT02087241|50227710|FG003|Overall Study|Study Terminated by Sponsor|4|||
25116151|NCT02087085|50227726|FG000|Overall Study|Adverse Event|10|||
25116152|NCT02087085|50227727|FG001|Overall Study|Adverse Event|14|||
25116153|NCT02087085|50227726|FG000|Overall Study|Lack of Efficacy|4|||
25116154|NCT02087085|50227727|FG001|Overall Study|Lack of Efficacy|3|||
25116155|NCT02087085|50227726|FG000|Overall Study|Lost to Follow-up|6|||
25116156|NCT02087085|50227727|FG001|Overall Study|Lost to Follow-up|4|||
25116157|NCT02087085|50227726|FG000|Overall Study|Withdrawal by Subject|9|||
25116158|NCT02087085|50227727|FG001|Overall Study|Withdrawal by Subject|11|||
25116159|NCT02087085|50227726|FG000|Overall Study|Protocol Violation|1|||
25116160|NCT02087085|50227727|FG001|Overall Study|Protocol Violation|0|||
25116161|NCT02087085|50227726|FG000|Overall Study|Study Terminated by Sponsor|87|||
25116162|NCT02087085|50227727|FG001|Overall Study|Study Terminated by Sponsor|80|||
25116163|NCT02087085|50227726|FG000|Overall Study|Other Miscellaneous Reasons|3|||
25116164|NCT02087085|50227727|FG001|Overall Study|Other Miscellaneous Reasons|4|||
25116165|NCT02443337|50227735|FG000|Overall Study|Adverse Event|0|||
25116166|NCT02443337|50227736|FG001|Overall Study|Adverse Event|1|||
25116167|NCT02443337|50227735|FG000|Overall Study|Clinical Progressive Disease|3|||
25116168|NCT02443337|50227736|FG001|Overall Study|Clinical Progressive Disease|0|||
25116169|NCT02443337|50227735|FG000|Overall Study|Withdrawal by Subject|2|||
25116170|NCT02443337|50227736|FG001|Overall Study|Withdrawal by Subject|1|||
25116171|NCT02443103|50227747|FG000|Overall Study|Adverse Event|2|||
25116172|NCT02443103|50227747|FG000|Overall Study|Noncompliance|1|||
25116173|NCT02022657|50227751|FG000|Overall Study|Withdrawal by Subject|2|||
25116174|NCT02022657|50227752|FG001|Overall Study|Withdrawal by Subject|0|||
25116175|NCT02022657|50227753|FG002|Overall Study|Withdrawal by Subject|1|||
25116176|NCT02022657|50227754|FG003|Overall Study|Withdrawal by Subject|0|||
25116177|NCT02022657|50227755|FG004|Overall Study|Withdrawal by Subject|0|||
25116178|NCT02022657|50227756|FG005|Overall Study|Withdrawal by Subject|0|||
25116179|NCT02022657|50227751|FG000|Overall Study|Physician Decision|0|||
25116180|NCT02022657|50227752|FG001|Overall Study|Physician Decision|0|||
25116181|NCT02022657|50227753|FG002|Overall Study|Physician Decision|0|||
25116182|NCT02022657|50227754|FG003|Overall Study|Physician Decision|0|||
25116183|NCT02022657|50227755|FG004|Overall Study|Physician Decision|0|||
25116184|NCT02022657|50227756|FG005|Overall Study|Physician Decision|1|||
25116185|NCT02418455|50227762|FG000|48-Week Treatment Period|Other- Not Specified|1|||
25116186|NCT02418455|50227762|FG000|Continuation Period|Sponsor Decision|7|||
25116187|NCT02417753|50227768|FG000|Overall Study|Death|1|||
25116188|NCT02417441|50227774|FG000|Overall Study|Inconclusive due to missing data|52|||
25116189|NCT02417441|50227775|FG001|Overall Study|Inconclusive due to missing data|19|||
25116190|NCT02021643|50227788|FG000|Overall Study|Enrolled but Never Treated|1|||
25116191|NCT02021643|50227789|FG001|Overall Study|Enrolled but Never Treated|0|||
25116192|NCT02021643|50227790|FG002|Overall Study|Enrolled but Never Treated|0|||
25116193|NCT02021643|50227791|FG003|Overall Study|Enrolled but Never Treated|0|||
25116194|NCT02021643|50227788|FG000|Overall Study|Adverse Event|0|||
25116195|NCT02021643|50227789|FG001|Overall Study|Adverse Event|1|||
25116196|NCT02021643|50227790|FG002|Overall Study|Adverse Event|0|||
25116197|NCT02021643|50227791|FG003|Overall Study|Adverse Event|0|||
25116198|NCT02021643|50227788|FG000|Overall Study|Death|0|||
25116199|NCT02021643|50227789|FG001|Overall Study|Death|1|||
25116200|NCT02021643|50227790|FG002|Overall Study|Death|0|||
25116201|NCT02021643|50227791|FG003|Overall Study|Death|0|||
25116202|NCT02021643|50227788|FG000|Overall Study|Investigator's Discretion|1|||
25008412|NCT03535194|50101305|FG000|Maintenance Period|Other|1|||
25116203|NCT02021643|50227789|FG001|Overall Study|Investigator's Discretion|0|||
25116204|NCT02021643|50227790|FG002|Overall Study|Investigator's Discretion|0|||
25116205|NCT02021643|50227791|FG003|Overall Study|Investigator's Discretion|0|||
25116206|NCT02021643|50227788|FG000|Overall Study|Lack of Efficacy|7|||
25116207|NCT02021643|50227789|FG001|Overall Study|Lack of Efficacy|6|||
25116208|NCT02021643|50227790|FG002|Overall Study|Lack of Efficacy|0|||
25116209|NCT02021643|50227791|FG003|Overall Study|Lack of Efficacy|12|||
25116210|NCT02021643|50227788|FG000|Overall Study|Lost to Follow-up|0|||
25116211|NCT02021643|50227789|FG001|Overall Study|Lost to Follow-up|1|||
25116212|NCT02021643|50227790|FG002|Overall Study|Lost to Follow-up|0|||
25116213|NCT02021643|50227791|FG003|Overall Study|Lost to Follow-up|0|||
25116214|NCT02021643|50227788|FG000|Overall Study|Withdrew Consent|0|||
25116215|NCT02021643|50227789|FG001|Overall Study|Withdrew Consent|1|||
25116216|NCT02021643|50227790|FG002|Overall Study|Withdrew Consent|0|||
25116217|NCT02021643|50227791|FG003|Overall Study|Withdrew Consent|0|||
25116218|NCT02415959|50227812|FG000|Overall Study|Adverse Event|0|||
25116219|NCT02415959|50227813|FG001|Overall Study|Adverse Event|1|||
25116220|NCT02415959|50227814|FG002|Overall Study|Adverse Event|0|||
25116221|NCT02415959|50227815|FG003|Overall Study|Adverse Event|0|||
25116222|NCT02415959|50227816|FG004|Overall Study|Adverse Event|0|||
25116223|NCT02415959|50227812|FG000|Overall Study|Protocol Violation|0|||
25116224|NCT02415959|50227813|FG001|Overall Study|Protocol Violation|0|||
25116225|NCT02415959|50227814|FG002|Overall Study|Protocol Violation|0|||
25116226|NCT02415959|50227815|FG003|Overall Study|Protocol Violation|1|||
25116227|NCT02415959|50227816|FG004|Overall Study|Protocol Violation|0|||
25116228|NCT02021565|50227830|FG000|Baseline Through Intervention|Death|0|||
25116229|NCT02021565|50227831|FG001|Baseline Through Intervention|Death|1|||
25116230|NCT02021565|50227830|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
25116231|NCT02021565|50227831|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
25116232|NCT02021565|50227830|FG000|Baseline Through Intervention|Protocol Violation|0|||
25116233|NCT02021565|50227831|FG001|Baseline Through Intervention|Protocol Violation|7|||
25116234|NCT02021565|50227830|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
25116235|NCT02021565|50227831|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
25116236|NCT02021565|50227830|FG000|3-month Follow-up|Death|3|||
25116237|NCT02021565|50227831|FG001|3-month Follow-up|Death|0|||
25116238|NCT02021565|50227830|FG000|3-month Follow-up|Withdrawal by Subject|4|||
25116239|NCT02021565|50227831|FG001|3-month Follow-up|Withdrawal by Subject|0|||
25116240|NCT02021565|50227830|FG000|3-month Follow-up|Protocol Violation|3|||
25116241|NCT02021565|50227831|FG001|3-month Follow-up|Protocol Violation|2|||
25116242|NCT02021331|50227841|FG000|Overall Study|Adverse Event|0|||
25116243|NCT02021331|50227842|FG001|Overall Study|Adverse Event|2|||
25116244|NCT02085135|50227850|FG000|Overall Study|Adverse Event|4|||
25116245|NCT02085135|50227851|FG001|Overall Study|Adverse Event|7|||
25116246|NCT02085135|50227850|FG000|Overall Study|Lost to Follow-up|2|||
25116247|NCT02085135|50227851|FG001|Overall Study|Lost to Follow-up|2|||
25116248|NCT02085135|50227850|FG000|Overall Study|Withdrawal by Subject|3|||
25116249|NCT02085135|50227851|FG001|Overall Study|Withdrawal by Subject|0|||
25116250|NCT02085135|50227850|FG000|Overall Study|Lack of Efficacy|2|||
25116251|NCT02085135|50227851|FG001|Overall Study|Lack of Efficacy|0|||
25116252|NCT02441309|50227860|FG000|Overall Study|Disease progression|2|||
25116253|NCT02441309|50227861|FG001|Overall Study|Disease progression|1|||
25116254|NCT02441309|50227862|FG002|Overall Study|Disease progression|2|||
25116255|NCT02441309|50227860|FG000|Overall Study|Adverse Event|0|||
25116256|NCT02441309|50227861|FG001|Overall Study|Adverse Event|1|||
25116257|NCT02441309|50227862|FG002|Overall Study|Adverse Event|0|||
25116258|NCT02441309|50227860|FG000|Overall Study|Withdrawal by Subject|1|||
25116259|NCT02441309|50227861|FG001|Overall Study|Withdrawal by Subject|0|||
25116260|NCT02441309|50227862|FG002|Overall Study|Withdrawal by Subject|1|||
25116261|NCT02027025|50227876|FG000|Overall Study|Adverse Event|0|||
25116262|NCT02027025|50227877|FG001|Overall Study|Adverse Event|1|||
25116263|NCT02027025|50227878|FG002|Overall Study|Adverse Event|1|||
25116264|NCT02027025|50227876|FG000|Overall Study|Protocol Violation|1|||
25116265|NCT02027025|50227877|FG001|Overall Study|Protocol Violation|0|||
25116266|NCT02027025|50227878|FG002|Overall Study|Protocol Violation|0|||
25261482|NCT01261611|50576217|FG002|Treatment Cycle 1|Adverse Event|0|||
25116267|NCT02027025|50227876|FG000|Overall Study|Lost to Follow-up|0|||
25116268|NCT02027025|50227877|FG001|Overall Study|Lost to Follow-up|2|||
25116269|NCT02027025|50227878|FG002|Overall Study|Lost to Follow-up|0|||
25116270|NCT02027025|50227876|FG000|Overall Study|Withdrawal by Subject|0|||
25116271|NCT02027025|50227877|FG001|Overall Study|Withdrawal by Subject|1|||
25116272|NCT02027025|50227878|FG002|Overall Study|Withdrawal by Subject|0|||
25116273|NCT02027025|50227876|FG000|Overall Study|Sponsor's decision|0|||
25116274|NCT02027025|50227877|FG001|Overall Study|Sponsor's decision|1|||
25116275|NCT02027025|50227878|FG002|Overall Study|Sponsor's decision|0|||
25116276|NCT01652729|50227900|FG000|Overall Study|Withdrawal by Subject|14|||
25116277|NCT01652729|50227901|FG001|Overall Study|Withdrawal by Subject|7|||
25116278|NCT01652729|50227902|FG002|Overall Study|Withdrawal by Subject|7|||
25116279|NCT01652729|50227900|FG000|Overall Study|Adverse Event|4|||
25116280|NCT01652729|50227901|FG001|Overall Study|Adverse Event|0|||
25116281|NCT01652729|50227902|FG002|Overall Study|Adverse Event|3|||
25116282|NCT01652729|50227900|FG000|Overall Study|Physician Decision|1|||
25116283|NCT01652729|50227901|FG001|Overall Study|Physician Decision|0|||
25116284|NCT01652729|50227902|FG002|Overall Study|Physician Decision|1|||
25116285|NCT01652729|50227900|FG000|Overall Study|Protocol Violation|1|||
25116286|NCT01652729|50227901|FG001|Overall Study|Protocol Violation|0|||
25116287|NCT01652729|50227902|FG002|Overall Study|Protocol Violation|0|||
25116288|NCT01652729|50227900|FG000|Overall Study|Lost to Follow-up|6|||
25116289|NCT01652729|50227901|FG001|Overall Study|Lost to Follow-up|6|||
25116290|NCT01652729|50227902|FG002|Overall Study|Lost to Follow-up|3|||
25116291|NCT01652729|50227900|FG000|Overall Study|Administrative|1|||
25116292|NCT01652729|50227901|FG001|Overall Study|Administrative|0|||
25116293|NCT01652729|50227902|FG002|Overall Study|Administrative|0|||
25116294|NCT02083965|50227912|FG000|Treatment Period|Other|1|||
25116295|NCT02083965|50227913|FG001|Treatment Period|Other|0|||
25116296|NCT02438813|50227921|FG000|Overall Study|Patient Decision|59|||
25116297|NCT02438813|50227921|FG000|Overall Study|Patient Lost to Follow-Up|137|||
25116298|NCT02438813|50227921|FG000|Overall Study|Study Ended by Sponsor|80|||
25116299|NCT02438813|50227921|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
25116300|NCT02437409|50227935|FG000|Overall Study|Withdrawal by Subject|3|||
25116301|NCT02437409|50227935|FG000|Overall Study|Screening failure|12|||
25116302|NCT02459093|50227942|FG000|Overall Study|Protocol Violation|6|||
25116303|NCT02459093|50227943|FG001|Overall Study|Protocol Violation|11|||
25116304|NCT02459093|50227942|FG000|Overall Study|Lost to Follow-up|6|||
25116305|NCT02459093|50227943|FG001|Overall Study|Lost to Follow-up|7|||
25116306|NCT02458469|50227949|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
25116307|NCT02458469|50227950|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
25116308|NCT02458469|50227951|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
25116309|NCT02458469|50227952|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
25116310|NCT02458469|50227953|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
25116311|NCT02458469|50227954|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
25116312|NCT02458469|50227949|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
25116313|NCT02458469|50227950|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
25116314|NCT02458469|50227951|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
25116315|NCT02458469|50227952|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
25116316|NCT02458469|50227953|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
25116317|NCT02458469|50227954|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
25116318|NCT02458469|50227949|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
25116319|NCT02458469|50227950|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
25116320|NCT02458469|50227951|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
25116321|NCT02458469|50227952|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
25116322|NCT02458469|50227953|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
25116323|NCT02458469|50227954|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
25116324|NCT01843348|50227965|FG000|Overall Study|Withdrawal by Subject|4|||
25116325|NCT01843348|50227966|FG001|Overall Study|Withdrawal by Subject|16|||
25116326|NCT01843348|50227967|FG002|Overall Study|Withdrawal by Subject|18|||
25116327|NCT01843348|50227965|FG000|Overall Study|Lost to Follow-up|5|||
25116328|NCT01843348|50227966|FG001|Overall Study|Lost to Follow-up|4|||
25116329|NCT01843348|50227967|FG002|Overall Study|Lost to Follow-up|2|||
25116330|NCT01843348|50227965|FG000|Overall Study|Death|5|||
25116331|NCT01843348|50227966|FG001|Overall Study|Death|3|||
25116332|NCT01843348|50227967|FG002|Overall Study|Death|4|||
25116333|NCT01843348|50227965|FG000|Overall Study|Graft loss/retransplantation|5|||
25116334|NCT01843348|50227966|FG001|Overall Study|Graft loss/retransplantation|8|||
25116335|NCT01843348|50227967|FG002|Overall Study|Graft loss/retransplantation|11|||
25116336|NCT01843348|50227965|FG000|Overall Study|Various reasons|4|||
25116337|NCT01843348|50227966|FG001|Overall Study|Various reasons|9|||
25116338|NCT01843348|50227967|FG002|Overall Study|Various reasons|6|||
25116339|NCT01843192|50227980|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
25116340|NCT01843192|50227981|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
25008413|NCT03535194|50101306|FG001|Maintenance Period|Other|2|||
25008414|NCT03535194|50101307|FG002|Maintenance Period|Other|0|||
25008415|NCT03535194|50101308|FG003|Maintenance Period|Other|0|||
25008416|NCT03535194|50101309|FG004|Maintenance Period|Other|0|||
25008417|NCT03535194|50101305|FG000|Maintenance Period|Physician Decision|1|||
25008418|NCT03535194|50101306|FG001|Maintenance Period|Physician Decision|2|||
25008419|NCT03535194|50101307|FG002|Maintenance Period|Physician Decision|0|||
25116341|NCT01843192|50227982|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
25116342|NCT01825876|50227990|FG000|Period 2|Withdrawal by Subject|0|||
25116343|NCT01825876|50227991|FG001|Period 2|Withdrawal by Subject|1|||
25116344|NCT01842958|50228002|FG000|Overall Study|Lost to Follow-up|1|||
25116345|NCT01842958|50228003|FG001|Overall Study|Lost to Follow-up|1|||
25116346|NCT02413229|50228017|FG000|Overall Study|Adverse Event|0|||
25116347|NCT02413229|50228018|FG001|Overall Study|Adverse Event|0|||
25116348|NCT02413229|50228019|FG002|Overall Study|Adverse Event|0|||
25116349|NCT02413229|50228020|FG003|Overall Study|Adverse Event|1|||
25116350|NCT02413229|50228021|FG004|Overall Study|Adverse Event|0|||
25116351|NCT02413229|50228022|FG005|Overall Study|Adverse Event|0|||
25116352|NCT02413229|50228023|FG006|Overall Study|Adverse Event|0|||
25116353|NCT02413229|50228024|FG007|Overall Study|Adverse Event|1|||
25116354|NCT02413229|50228017|FG000|Overall Study|Lost to Follow-up|0|||
25008420|NCT03535194|50101308|FG003|Maintenance Period|Physician Decision|2|||
25116355|NCT02413229|50228018|FG001|Overall Study|Lost to Follow-up|0|||
25116356|NCT02413229|50228019|FG002|Overall Study|Lost to Follow-up|1|||
25116357|NCT02413229|50228020|FG003|Overall Study|Lost to Follow-up|0|||
25116358|NCT02413229|50228021|FG004|Overall Study|Lost to Follow-up|2|||
25116359|NCT02413229|50228022|FG005|Overall Study|Lost to Follow-up|0|||
25116360|NCT02413229|50228023|FG006|Overall Study|Lost to Follow-up|0|||
25116361|NCT02413229|50228024|FG007|Overall Study|Lost to Follow-up|0|||
25116362|NCT02413229|50228017|FG000|Overall Study|Withdrawal by Subject|1|||
25116363|NCT02413229|50228018|FG001|Overall Study|Withdrawal by Subject|1|||
25116364|NCT02413229|50228019|FG002|Overall Study|Withdrawal by Subject|0|||
25116365|NCT02413229|50228020|FG003|Overall Study|Withdrawal by Subject|0|||
25116366|NCT02413229|50228021|FG004|Overall Study|Withdrawal by Subject|1|||
25116367|NCT02413229|50228022|FG005|Overall Study|Withdrawal by Subject|0|||
25116368|NCT02413229|50228023|FG006|Overall Study|Withdrawal by Subject|0|||
25116369|NCT02413229|50228024|FG007|Overall Study|Withdrawal by Subject|2|||
25116370|NCT02413229|50228017|FG000|Overall Study|Progressive Disease|0|||
25116371|NCT02413229|50228018|FG001|Overall Study|Progressive Disease|0|||
25116372|NCT02413229|50228019|FG002|Overall Study|Progressive Disease|0|||
25116373|NCT02413229|50228020|FG003|Overall Study|Progressive Disease|0|||
25116374|NCT02413229|50228021|FG004|Overall Study|Progressive Disease|0|||
25116375|NCT02413229|50228022|FG005|Overall Study|Progressive Disease|0|||
25116376|NCT02413229|50228023|FG006|Overall Study|Progressive Disease|0|||
25116377|NCT02413229|50228024|FG007|Overall Study|Progressive Disease|1|||
25116378|NCT01825798|50228044|FG000|Overall Study|Adverse Event|1|||
25116379|NCT01825798|50228045|FG001|Overall Study|Adverse Event|5|||
25116380|NCT01825798|50228044|FG000|Overall Study|Lost to Follow-up|1|||
25116381|NCT01825798|50228045|FG001|Overall Study|Lost to Follow-up|0|||
25116382|NCT01824472|50228054|FG000|Overall Study|Lost to Follow-up|0|||
25116383|NCT01824472|50228055|FG001|Overall Study|Lost to Follow-up|0|||
25116384|NCT01824472|50228056|FG002|Overall Study|Lost to Follow-up|1|||
25116385|NCT01824472|50228054|FG000|Overall Study|Withdrawal by Subject|1|||
25116386|NCT01824472|50228055|FG001|Overall Study|Withdrawal by Subject|5|||
25116387|NCT01824472|50228056|FG002|Overall Study|Withdrawal by Subject|3|||
25116388|NCT01824472|50228054|FG000|Overall Study|Ineligible post randomization&screening|0|||
25116389|NCT01824472|50228055|FG001|Overall Study|Ineligible post randomization&screening|2|||
25116390|NCT01824472|50228056|FG002|Overall Study|Ineligible post randomization&screening|0|||
25116391|NCT02412761|50228064|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
25116392|NCT02412761|50228065|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
25116393|NCT02412761|50228066|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
25116394|NCT02412761|50228067|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
25116395|NCT02412761|50228068|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
25116396|NCT02412761|50228069|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
25116397|NCT01842334|50228079|FG000|Overall Study|Withdrawal by Subject|3|||
25116398|NCT01842334|50228080|FG001|Overall Study|Withdrawal by Subject|3|||
25116399|NCT01842334|50228079|FG000|Overall Study|Moved away mid-study|0|||
25116400|NCT01842334|50228080|FG001|Overall Study|Moved away mid-study|1|||
25116401|NCT02457611|50228086|FG000|Overall Study|Lost to Follow-up|3|||
25116402|NCT02457065|50228092|FG000|Overall Study|Lost to Follow-up|9|||
25116403|NCT02457065|50228093|FG001|Overall Study|Lost to Follow-up|11|||
25116404|NCT02083653|50228102|FG000|Overall Study|Randomized but not Treated|0|||
25116405|NCT02083653|50228103|FG001|Overall Study|Randomized but not Treated|2|||
25116406|NCT02083653|50228104|FG002|Overall Study|Randomized but not Treated|7|||
25116407|NCT02083653|50228102|FG000|Overall Study|Adverse Event|12|||
25116408|NCT02083653|50228103|FG001|Overall Study|Adverse Event|5|||
25116409|NCT02083653|50228104|FG002|Overall Study|Adverse Event|4|||
25116410|NCT02083653|50228102|FG000|Overall Study|Lost to Follow-up|1|||
25116411|NCT02083653|50228103|FG001|Overall Study|Lost to Follow-up|0|||
25116412|NCT02083653|50228104|FG002|Overall Study|Lost to Follow-up|0|||
25116413|NCT02083653|50228102|FG000|Overall Study|Death|2|||
25116414|NCT02083653|50228103|FG001|Overall Study|Death|2|||
25116415|NCT02083653|50228104|FG002|Overall Study|Death|2|||
25116416|NCT02083653|50228102|FG000|Overall Study|Progressive Disease|65|||
25116417|NCT02083653|50228103|FG001|Overall Study|Progressive Disease|73|||
25116418|NCT02083653|50228104|FG002|Overall Study|Progressive Disease|63|||
25261483|NCT01261611|50576215|FG000|Treatment Cycle 1|Protocol Violation|0|||
25261484|NCT01261611|50576216|FG001|Treatment Cycle 1|Protocol Violation|0|||
25116419|NCT02083653|50228102|FG000|Overall Study|Withdrawal by Subject|2|||
25116420|NCT02083653|50228103|FG001|Overall Study|Withdrawal by Subject|1|||
25116421|NCT02083653|50228104|FG002|Overall Study|Withdrawal by Subject|2|||
25116422|NCT02083653|50228102|FG000|Overall Study|Other Events|0|||
25116423|NCT02083653|50228103|FG001|Overall Study|Other Events|2|||
25116424|NCT02083653|50228104|FG002|Overall Study|Other Events|2|||
25116425|NCT02083653|50228102|FG000|Overall Study|Reason Missing|0|||
25116426|NCT02083653|50228103|FG001|Overall Study|Reason Missing|0|||
25116427|NCT02083653|50228104|FG002|Overall Study|Reason Missing|4|||
25116428|NCT02436239|50228116|FG000|Open-Lable Treatment Period|Adverse Event|12|||
25261485|NCT01261611|50576217|FG002|Treatment Cycle 1|Protocol Violation|2|||
25116429|NCT02436239|50228117|FG001|Open-Lable Treatment Period|Adverse Event|3|||
25116430|NCT02436239|50228118|FG002|Open-Lable Treatment Period|Adverse Event|4|||
25116431|NCT02436239|50228119|FG003|Open-Lable Treatment Period|Adverse Event|2|||
25116432|NCT02436239|50228116|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
25116433|NCT02436239|50228117|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
25116434|NCT02436239|50228118|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
25116435|NCT02436239|50228119|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
25116436|NCT02436239|50228116|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
25116437|NCT02436239|50228117|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
25116438|NCT02436239|50228118|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
25116439|NCT02436239|50228119|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
25116440|NCT02436239|50228116|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
25116441|NCT02436239|50228117|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
25116442|NCT02436239|50228118|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
25116443|NCT02436239|50228119|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
25116444|NCT02436239|50228116|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
25116445|NCT02436239|50228117|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
25116446|NCT02436239|50228118|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
25116447|NCT02436239|50228119|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
25116448|NCT02436239|50228116|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
25116449|NCT02436239|50228117|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
25116450|NCT02436239|50228118|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
25116451|NCT02436239|50228119|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
25116452|NCT02436239|50228116|FG000|Open-Lable Treatment Period|Other Reason|1|||
25116453|NCT02436239|50228117|FG001|Open-Lable Treatment Period|Other Reason|1|||
25116454|NCT02436239|50228118|FG002|Open-Lable Treatment Period|Other Reason|0|||
25116455|NCT02436239|50228119|FG003|Open-Lable Treatment Period|Other Reason|0|||
25116456|NCT02436239|50228116|FG000|Down-Taper Period|Withdrawal by Subject|4|||
25116457|NCT02436239|50228117|FG001|Down-Taper Period|Withdrawal by Subject|4|||
25116458|NCT02436239|50228118|FG002|Down-Taper Period|Withdrawal by Subject|1|||
25116459|NCT02436239|50228119|FG003|Down-Taper Period|Withdrawal by Subject|2|||
25116460|NCT02026011|50228131|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
25116461|NCT02026011|50228132|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
25116462|NCT02026011|50228131|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
25116463|NCT02026011|50228132|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
25116464|NCT02026011|50228131|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
25116465|NCT02026011|50228132|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
25116466|NCT02026011|50228131|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
25116467|NCT02026011|50228132|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
25116468|NCT02436005|50228141|FG000|Second Intervention|Adverse Event|0|||
25116469|NCT02436005|50228142|FG001|Second Intervention|Adverse Event|1|||
25116470|NCT02456909|50228150|FG000|Overall Study|Did not receive allocated intervention|24|||
25116471|NCT02456909|50228151|FG001|Overall Study|Did not receive allocated intervention|26|||
25116472|NCT02456909|50228150|FG000|Overall Study|Did not complete the primary outcome|0|||
25116473|NCT02456909|50228151|FG001|Overall Study|Did not complete the primary outcome|1|||
25116474|NCT02025621|50228159|FG000|Overall Study|Withdrawal by Subject|1|||
25116475|NCT02025621|50228160|FG001|Overall Study|Withdrawal by Subject|0|||
25116476|NCT02025621|50228159|FG000|Overall Study|Death|0|||
25116477|NCT02025621|50228160|FG001|Overall Study|Death|1|||
25116478|NCT02025621|50228159|FG000|Overall Study|No longer eligible|10|||
25116479|NCT02025621|50228160|FG001|Overall Study|No longer eligible|15|||
25116480|NCT02025621|50228159|FG000|Overall Study|Surgery initiated before infusion|3|||
25116481|NCT02025621|50228160|FG001|Overall Study|Surgery initiated before infusion|3|||
25116482|NCT02020941|50228166|FG000|Overall Study|Adverse Event|1|||
25116483|NCT02020941|50228166|FG000|Overall Study|Physician Decision|2|||
25116484|NCT02020941|50228166|FG000|Overall Study|Withdrawal by Subject|1|||
25116485|NCT02020941|50228166|FG000|Overall Study|Disease Progression|4|||
25116486|NCT02024529|50228172|FG000|Overall Study|Withdrawal by Subject|11|||
25116487|NCT02024529|50228173|FG001|Overall Study|Withdrawal by Subject|21|||
25116488|NCT02024529|50228172|FG000|Overall Study|Lost to Follow-up|2|||
25116489|NCT02024529|50228173|FG001|Overall Study|Lost to Follow-up|4|||
25116490|NCT02020863|50228181|FG000|Overall Study|Discovery of Metastatic disease|4|||
25116491|NCT02020863|50228181|FG000|Overall Study|Team chose not to place an a line|1|||
25116492|NCT01824394|50228188|FG000|Overall Study|Early Termination|1|||
25116493|NCT01824394|50228189|FG001|Overall Study|Early Termination|1|||
25116494|NCT01824394|50228190|FG002|Overall Study|Early Termination|3|||
25116495|NCT01824394|50228188|FG000|Overall Study|Withdrawn due to Study Termination|91|||
25116496|NCT01824394|50228189|FG001|Overall Study|Withdrawn due to Study Termination|83|||
25116497|NCT01824394|50228190|FG002|Overall Study|Withdrawn due to Study Termination|41|||
25116498|NCT01824394|50228188|FG000|Overall Study|Lost to Follow-up|0|||
25116499|NCT01824394|50228189|FG001|Overall Study|Lost to Follow-up|9|||
25116500|NCT01824394|50228190|FG002|Overall Study|Lost to Follow-up|3|||
25116501|NCT01824394|50228188|FG000|Overall Study|Death|3|||
25116502|NCT01824394|50228189|FG001|Overall Study|Death|2|||
25116503|NCT01824394|50228190|FG002|Overall Study|Death|4|||
25116504|NCT01824394|50228188|FG000|Overall Study|Discontinued Subjects|1|||
25116505|NCT01824394|50228189|FG001|Overall Study|Discontinued Subjects|1|||
25116506|NCT01824394|50228190|FG002|Overall Study|Discontinued Subjects|2|||
25116507|NCT01824394|50228188|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
25116508|NCT01824394|50228189|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
25116509|NCT01824394|50228190|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
25116510|NCT01823536|50228204|FG000|Overall Study|Lost to Follow-up|1|||
25116511|NCT01823536|50228205|FG001|Overall Study|Lost to Follow-up|0|||
25116512|NCT01823536|50228206|FG002|Overall Study|Lost to Follow-up|0|||
25116513|NCT01823536|50228207|FG003|Overall Study|Lost to Follow-up|1|||
25116514|NCT01823536|50228208|FG004|Overall Study|Lost to Follow-up|1|||
25116515|NCT01823536|50228209|FG005|Overall Study|Lost to Follow-up|0|||
25116516|NCT01823536|50228204|FG000|Overall Study|Protocol Violation|0|||
25116517|NCT01823536|50228205|FG001|Overall Study|Protocol Violation|1|||
25116518|NCT01823536|50228206|FG002|Overall Study|Protocol Violation|0|||
25116519|NCT01823536|50228207|FG003|Overall Study|Protocol Violation|0|||
25116520|NCT01823536|50228208|FG004|Overall Study|Protocol Violation|0|||
25116521|NCT01823536|50228209|FG005|Overall Study|Protocol Violation|0|||
25116522|NCT01823536|50228204|FG000|Overall Study|Withdrawal by Subject|1|||
25116523|NCT01823536|50228205|FG001|Overall Study|Withdrawal by Subject|1|||
25116524|NCT01823536|50228206|FG002|Overall Study|Withdrawal by Subject|0|||
25116525|NCT01823536|50228207|FG003|Overall Study|Withdrawal by Subject|0|||
25116526|NCT01823536|50228208|FG004|Overall Study|Withdrawal by Subject|0|||
25116527|NCT01823536|50228209|FG005|Overall Study|Withdrawal by Subject|0|||
25116528|NCT01823536|50228204|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
25116529|NCT01823536|50228205|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
25116530|NCT01823536|50228206|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
25116531|NCT01823536|50228207|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
25116532|NCT01823536|50228208|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
25116533|NCT01823536|50228209|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
25116534|NCT01823536|50228204|FG000|Overall Study|Met exclusion criterion No 6|0|||
25116535|NCT01823536|50228205|FG001|Overall Study|Met exclusion criterion No 6|0|||
25116536|NCT01823536|50228206|FG002|Overall Study|Met exclusion criterion No 6|0|||
25116537|NCT01823536|50228207|FG003|Overall Study|Met exclusion criterion No 6|1|||
25116538|NCT01823536|50228208|FG004|Overall Study|Met exclusion criterion No 6|0|||
25116539|NCT01823536|50228209|FG005|Overall Study|Met exclusion criterion No 6|0|||
25116540|NCT01823536|50228204|FG000|Overall Study|Subject moved out of the state|0|||
25116541|NCT01823536|50228205|FG001|Overall Study|Subject moved out of the state|0|||
25116542|NCT01823536|50228206|FG002|Overall Study|Subject moved out of the state|0|||
25116543|NCT01823536|50228207|FG003|Overall Study|Subject moved out of the state|0|||
25116544|NCT01823536|50228208|FG004|Overall Study|Subject moved out of the state|1|||
25116545|NCT01823536|50228209|FG005|Overall Study|Subject moved out of the state|0|||
25116546|NCT01841554|50228222|FG000|Overall Study|Death|7|||
25116547|NCT01841554|50228222|FG000|Overall Study|No Implantation|1|||
25116548|NCT01841554|50228222|FG000|Overall Study|Discontinued Follow Up|5|||
25116549|NCT01841554|50228222|FG000|Overall Study|Study exit due to secondary intervention|6|||
25116550|NCT01823224|50228228|FG000|Overall Study|Lost to Follow-up|5|||
25116551|NCT01823224|50228229|FG001|Overall Study|Lost to Follow-up|6|||
25116552|NCT01823224|50228228|FG000|Overall Study|didn't qualify|1|||
25116553|NCT01823224|50228229|FG001|Overall Study|didn't qualify|2|||
25116554|NCT01823224|50228228|FG000|Overall Study|pharmacy error|0|||
25116555|NCT01823224|50228229|FG001|Overall Study|pharmacy error|1|||
25116556|NCT01823224|50228228|FG000|Overall Study|missed med dose|0|||
25116557|NCT01823224|50228229|FG001|Overall Study|missed med dose|1|||
25116558|NCT01823224|50228228|FG000|Overall Study|Withdrawal by Subject|0|||
25116559|NCT01823224|50228229|FG001|Overall Study|Withdrawal by Subject|1|||
25116560|NCT01840228|50228239|FG000|Overall Study|Lost to Follow-up|1|||
25261486|NCT01261611|50576215|FG000|Treatment Cycle 2|Completed study|4|||
25261487|NCT01261611|50576216|FG001|Treatment Cycle 2|Completed study|0|||
25261488|NCT01261611|50576217|FG002|Treatment Cycle 2|Completed study|0|||
25116561|NCT01840228|50228240|FG001|Overall Study|Lost to Follow-up|1|||
25116562|NCT01839916|50228250|FG000|Overall Study|Death|9|||
25116563|NCT01839916|50228250|FG000|Overall Study|Physician Decision|17|||
25116564|NCT01839916|50228250|FG000|Overall Study|Relapse|12|||
25116565|NCT01839916|50228250|FG000|Overall Study|GVHD|2|||
25116566|NCT01839916|50228250|FG000|Overall Study|Graft Failure|1|||
25116567|NCT01823146|50228256|FG000|Overall Study|Withdrawal by Subject|0|||
25116568|NCT01823146|50228257|FG001|Overall Study|Withdrawal by Subject|1|||
25116569|NCT01823146|50228256|FG000|Overall Study|Lost to Follow-up|2|||
25116570|NCT01823146|50228257|FG001|Overall Study|Lost to Follow-up|1|||
25116571|NCT02083185|50228266|FG000|Overall Study|Lost to Follow-up|0|||
25116572|NCT02083185|50228267|FG001|Overall Study|Lost to Follow-up|3|||
25116573|NCT02083185|50228268|FG002|Overall Study|Lost to Follow-up|0|||
25116574|NCT02083185|50228266|FG000|Overall Study|Withdrawal by Subject|9|||
25116575|NCT02083185|50228267|FG001|Overall Study|Withdrawal by Subject|15|||
25116576|NCT02083185|50228268|FG002|Overall Study|Withdrawal by Subject|1|||
25116577|NCT02083185|50228266|FG000|Overall Study|Death|2|||
25116578|NCT02083185|50228267|FG001|Overall Study|Death|2|||
25116579|NCT02083185|50228268|FG002|Overall Study|Death|1|||
25116580|NCT02083185|50228266|FG000|Overall Study|Reason not Specified|9|||
25116581|NCT02083185|50228267|FG001|Overall Study|Reason not Specified|6|||
25116582|NCT02083185|50228268|FG002|Overall Study|Reason not Specified|5|||
25116583|NCT02083185|50228266|FG000|Overall Study|Study Terminated by Sponsor|0|||
25116584|NCT02083185|50228267|FG001|Overall Study|Study Terminated by Sponsor|1|||
25116585|NCT02083185|50228268|FG002|Overall Study|Study Terminated by Sponsor|0|||
25116586|NCT02083185|50228266|FG000|Overall Study|Did not Receive Study Drug|0|||
25116587|NCT02083185|50228267|FG001|Overall Study|Did not Receive Study Drug|2|||
25116588|NCT02083185|50228268|FG002|Overall Study|Did not Receive Study Drug|0|||
25116589|NCT02019927|50228282|FG000|Overall Study|Lost to Follow-up|2|||
25116590|NCT02019927|50228283|FG001|Overall Study|Lost to Follow-up|4|||
25116591|NCT02019927|50228284|FG002|Overall Study|Lost to Follow-up|1|||
25116592|NCT02019927|50228285|FG003|Overall Study|Lost to Follow-up|2|||
25116593|NCT02019927|50228286|FG004|Overall Study|Lost to Follow-up|3|||
25116594|NCT02019927|50228287|FG005|Overall Study|Lost to Follow-up|1|||
25116595|NCT02412371|50228311|FG000|Overall Study|Withdrawal by Subject|0|||
25116596|NCT02412371|50228312|FG001|Overall Study|Withdrawal by Subject|2|||
25116597|NCT02412371|50228313|FG002|Overall Study|Withdrawal by Subject|0|||
25116598|NCT02412371|50228314|FG003|Overall Study|Withdrawal by Subject|1|||
25116599|NCT02412371|50228315|FG004|Overall Study|Withdrawal by Subject|1|||
25116600|NCT02412371|50228316|FG005|Overall Study|Withdrawal by Subject|0|||
25116601|NCT02412371|50228311|FG000|Overall Study|Sponsor Discontinued Study|1|||
25116602|NCT02412371|50228312|FG001|Overall Study|Sponsor Discontinued Study|4|||
25116603|NCT02412371|50228313|FG002|Overall Study|Sponsor Discontinued Study|6|||
25116604|NCT02412371|50228314|FG003|Overall Study|Sponsor Discontinued Study|4|||
25116605|NCT02412371|50228315|FG004|Overall Study|Sponsor Discontinued Study|5|||
25116606|NCT02412371|50228316|FG005|Overall Study|Sponsor Discontinued Study|0|||
25116607|NCT02412371|50228311|FG000|Overall Study|Death|4|||
25116608|NCT02412371|50228312|FG001|Overall Study|Death|2|||
25116609|NCT02412371|50228313|FG002|Overall Study|Death|1|||
25116610|NCT02412371|50228314|FG003|Overall Study|Death|3|||
25116611|NCT02412371|50228315|FG004|Overall Study|Death|5|||
25116612|NCT02412371|50228316|FG005|Overall Study|Death|2|||
25116613|NCT02412371|50228311|FG000|Overall Study|Other|2|||
25116614|NCT02412371|50228312|FG001|Overall Study|Other|1|||
25116615|NCT02412371|50228313|FG002|Overall Study|Other|0|||
25116616|NCT02412371|50228314|FG003|Overall Study|Other|0|||
25116617|NCT02412371|50228315|FG004|Overall Study|Other|1|||
25116618|NCT02412371|50228316|FG005|Overall Study|Other|3|||
25116619|NCT02411747|50228333|FG000|Overall Study|Withdrawal by Subject|1|||
25116620|NCT02411747|50228334|FG001|Overall Study|Withdrawal by Subject|0|||
25116621|NCT02411747|50228333|FG000|Overall Study|Protocol Violation|2|||
25116622|NCT02411747|50228334|FG001|Overall Study|Protocol Violation|4|||
25116623|NCT01822756|50228345|FG000|Overall Study|Adverse Event|0|||
25116624|NCT01822756|50228346|FG001|Overall Study|Adverse Event|0|||
25116625|NCT01822756|50228347|FG002|Overall Study|Adverse Event|0|||
25116626|NCT01822756|50228348|FG003|Overall Study|Adverse Event|2|||
25116627|NCT01822756|50228349|FG004|Overall Study|Adverse Event|0|||
25116628|NCT01822756|50228345|FG000|Overall Study|Disease progression|11|||
25116629|NCT01822756|50228346|FG001|Overall Study|Disease progression|1|||
25116630|NCT01822756|50228347|FG002|Overall Study|Disease progression|7|||
25116631|NCT01822756|50228348|FG003|Overall Study|Disease progression|2|||
25116632|NCT01822756|50228349|FG004|Overall Study|Disease progression|6|||
25116633|NCT01822756|50228345|FG000|Overall Study|Death|2|||
25116634|NCT01822756|50228346|FG001|Overall Study|Death|2|||
25116635|NCT01822756|50228347|FG002|Overall Study|Death|1|||
25116636|NCT01822756|50228348|FG003|Overall Study|Death|0|||
25116637|NCT01822756|50228349|FG004|Overall Study|Death|0|||
25116638|NCT01822756|50228345|FG000|Overall Study|Lost to Follow-up|1|||
25116639|NCT01822756|50228346|FG001|Overall Study|Lost to Follow-up|0|||
25116640|NCT01822756|50228347|FG002|Overall Study|Lost to Follow-up|1|||
25116641|NCT01822756|50228348|FG003|Overall Study|Lost to Follow-up|0|||
25116642|NCT01822756|50228349|FG004|Overall Study|Lost to Follow-up|1|||
25116643|NCT01822756|50228345|FG000|Overall Study|Physician Decision|0|||
25116644|NCT01822756|50228346|FG001|Overall Study|Physician Decision|1|||
25116645|NCT01822756|50228347|FG002|Overall Study|Physician Decision|0|||
25116646|NCT01822756|50228348|FG003|Overall Study|Physician Decision|0|||
25116647|NCT01822756|50228349|FG004|Overall Study|Physician Decision|0|||
25116648|NCT01822756|50228345|FG000|Overall Study|disease progression & patient preference|2|||
25116649|NCT01822756|50228346|FG001|Overall Study|disease progression & patient preference|0|||
25116650|NCT01822756|50228347|FG002|Overall Study|disease progression & patient preference|1|||
25116651|NCT01822756|50228348|FG003|Overall Study|disease progression & patient preference|0|||
25116652|NCT01822756|50228349|FG004|Overall Study|disease progression & patient preference|0|||
25116653|NCT01822678|50228364|FG000|Overall Study|Withdrawal by Subject|5|||
25116654|NCT01822678|50228365|FG001|Overall Study|Withdrawal by Subject|4|||
25116655|NCT01822678|50228366|FG002|Overall Study|Withdrawal by Subject|4|||
25116656|NCT01822678|50228364|FG000|Overall Study|Adverse Event|4|||
25116657|NCT01822678|50228365|FG001|Overall Study|Adverse Event|3|||
25116658|NCT01822678|50228366|FG002|Overall Study|Adverse Event|1|||
25116659|NCT01822678|50228364|FG000|Overall Study|Lack of Efficacy|3|||
25116660|NCT01822678|50228365|FG001|Overall Study|Lack of Efficacy|6|||
25116661|NCT01822678|50228366|FG002|Overall Study|Lack of Efficacy|5|||
25116662|NCT01822678|50228364|FG000|Overall Study|Lost to Follow-up|0|||
25116663|NCT01822678|50228365|FG001|Overall Study|Lost to Follow-up|2|||
25116664|NCT01822678|50228366|FG002|Overall Study|Lost to Follow-up|1|||
25116665|NCT01822366|50228378|FG000|Overall Study|Lost to Follow-up|5|||
25116666|NCT01822366|50228379|FG001|Overall Study|Lost to Follow-up|1|||
25116667|NCT01822366|50228380|FG002|Overall Study|Lost to Follow-up|5|||
25116668|NCT01822366|50228381|FG003|Overall Study|Lost to Follow-up|1|||
25116669|NCT01822366|50228378|FG000|Overall Study|Withdrawal by Subject|0|||
25116670|NCT01822366|50228379|FG001|Overall Study|Withdrawal by Subject|6|||
25116671|NCT01822366|50228380|FG002|Overall Study|Withdrawal by Subject|0|||
25116672|NCT01822366|50228381|FG003|Overall Study|Withdrawal by Subject|6|||
25116673|NCT01822366|50228378|FG000|Overall Study|Partial Intervention Completion|0|||
25116674|NCT01822366|50228379|FG001|Overall Study|Partial Intervention Completion|15|||
25116675|NCT01822366|50228380|FG002|Overall Study|Partial Intervention Completion|0|||
25116676|NCT01822366|50228381|FG003|Overall Study|Partial Intervention Completion|15|||
25116677|NCT01838590|50228413|FG000|Overall Study|Lack of Efficacy|12|||
25116678|NCT01838590|50228414|FG001|Overall Study|Lack of Efficacy|4|||
25116679|NCT01838590|50228413|FG000|Overall Study|Lost to Follow-up|0|||
25116680|NCT01838590|50228414|FG001|Overall Study|Lost to Follow-up|1|||
25116681|NCT01611454|50228426|FG000|Overall Study|Lack of Efficacy|18|||
25116682|NCT01611454|50228427|FG001|Overall Study|Lack of Efficacy|10|||
25116683|NCT01611298|50228437|FG000|Overall Study|Relapsed|2|||
25116684|NCT01822132|50228443|FG000|Overall Study|Lost to Follow-up|4|||
25116685|NCT01822132|50228444|FG001|Overall Study|Lost to Follow-up|2|||
25116686|NCT01821898|50228458|FG000|Overall Study|Withdrawal by Subject|2|||
25116687|NCT01821898|50228459|FG001|Overall Study|Withdrawal by Subject|1|||
25116688|NCT02411591|50228469|FG000|Overall Study|Adverse Event|0|||
25116689|NCT02411591|50228470|FG001|Overall Study|Adverse Event|4|||
25116690|NCT02411591|50228471|FG002|Overall Study|Adverse Event|2|||
25116691|NCT02411591|50228469|FG000|Overall Study|Withdrawal by Subject|0|||
25116692|NCT02411591|50228470|FG001|Overall Study|Withdrawal by Subject|3|||
25116693|NCT02411591|50228471|FG002|Overall Study|Withdrawal by Subject|0|||
25116694|NCT02411591|50228469|FG000|Overall Study|Physician Decision|0|||
25116695|NCT02411591|50228470|FG001|Overall Study|Physician Decision|3|||
25116696|NCT02411591|50228471|FG002|Overall Study|Physician Decision|1|||
25116697|NCT02454959|50228487|FG000|Overall Study|Protocol-Specified Criteria|3|||
25116698|NCT02454959|50228487|FG000|Overall Study|Physician Decision|1|||
25116699|NCT02454959|50228487|FG000|Overall Study|Withdrawal by Subject|3|||
25116700|NCT02454959|50228487|FG000|Overall Study|Adverse Event|2|||
25116701|NCT01821118|50228495|FG000|Overall Study|Death|0|||
25116702|NCT01821118|50228496|FG001|Overall Study|Death|1|||
25116703|NCT01650779|50228502|FG000|Overall Study|Withdrawal by Subject|1|||
25116704|NCT02411201|50228506|FG000|Overall Study|Adverse Event|2|||
25116705|NCT02411201|50228506|FG000|Overall Study|Withdrawal by Subject|2|||
25116706|NCT02411201|50228506|FG000|Overall Study|Age group completed|2|||
25116707|NCT01838044|50228514|FG000|Overall Study|Adverse Event|4|||
25116708|NCT01838044|50228515|FG001|Overall Study|Adverse Event|6|||
25116709|NCT01838044|50228514|FG000|Overall Study|Protocol Violation|3|||
25116710|NCT01838044|50228515|FG001|Overall Study|Protocol Violation|3|||
25116711|NCT01838044|50228514|FG000|Overall Study|Withdrawal by Subject|0|||
25261489|NCT01261611|50576215|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
25261490|NCT01261611|50576216|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
25261491|NCT01261611|50576217|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
25177409|NCT02754141|50321522|FG015|Overall Study|Withdrew consent|0|||
25177410|NCT02754141|50321523|FG016|Overall Study|Withdrew consent|0|||
25261492|NCT01261611|50576215|FG000|Treatment Cycle 2|Adverse Event|1|||
25116712|NCT01838044|50228515|FG001|Overall Study|Withdrawal by Subject|2|||
25116713|NCT01838044|50228514|FG000|Overall Study|Insufficient clinical response|1|||
25116714|NCT01838044|50228515|FG001|Overall Study|Insufficient clinical response|2|||
25116715|NCT01838044|50228514|FG000|Overall Study|Medication error without associated AE|0|||
25116716|NCT01838044|50228515|FG001|Overall Study|Medication error without associated AE|1|||
25116717|NCT01838044|50228514|FG000|Overall Study|Lost to Follow-up|0|||
25116718|NCT01838044|50228515|FG001|Overall Study|Lost to Follow-up|2|||
25116719|NCT02410811|50228526|FG000|Overall Study|Withdrawal by Subject|0|||
25116720|NCT02410811|50228527|FG001|Overall Study|Withdrawal by Subject|0|||
25116721|NCT02410811|50228528|FG002|Overall Study|Withdrawal by Subject|1|||
25116722|NCT02410811|50228529|FG003|Overall Study|Withdrawal by Subject|0|||
25116723|NCT02435381|50228539|FG000|Overall Study|Lost to Follow-up|2|||
25177411|NCT02754141|50321524|FG017|Overall Study|Withdrew consent|0|||
25116724|NCT02435381|50228540|FG001|Overall Study|Lost to Follow-up|1|||
25116725|NCT01837966|50228556|FG000|Overall Study|Withdrawal by Subject|2|||
25116726|NCT01837966|50228557|FG001|Overall Study|Withdrawal by Subject|1|||
25116727|NCT02435147|50228563|FG000|Overall Study|non-evaluable DXA scan|11|||
25116728|NCT02435069|50228567|FG000|Dose Response - First Intervention|Adverse Event|0|||
25116729|NCT02435069|50228568|FG001|Dose Response - First Intervention|Adverse Event|1|||
25116730|NCT02435069|50228569|FG002|Dose Response - First Intervention|Adverse Event|1|||
25116731|NCT02435069|50228570|FG003|Dose Response - First Intervention|Adverse Event|0|||
25116732|NCT02435069|50228571|FG004|Dose Response - First Intervention|Adverse Event|0|||
25116733|NCT02435069|50228567|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
25116734|NCT02435069|50228568|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
25116735|NCT02435069|50228569|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
25116736|NCT02435069|50228570|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
25116737|NCT02435069|50228571|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
25116738|NCT02454101|50228593|FG000|Overall Study|Adverse Event|2|||
25116739|NCT02454101|50228594|FG001|Overall Study|Adverse Event|3|||
25116740|NCT02454101|50228593|FG000|Overall Study|Lost to Follow-up|3|||
25116741|NCT02454101|50228594|FG001|Overall Study|Lost to Follow-up|4|||
25116742|NCT02409719|50228602|FG000|Overall Study|Lost to Follow-up|3|||
25116743|NCT02409719|50228603|FG001|Overall Study|Lost to Follow-up|3|||
25116744|NCT01820572|50228611|FG000|Randomization|Not Treated|2|||
25116745|NCT01820572|50228612|FG001|Randomization|Not Treated|1|||
25116746|NCT01820572|50228611|FG000|Treatment Period|Adverse Event|12|||
25116747|NCT01820572|50228612|FG001|Treatment Period|Adverse Event|7|||
25116748|NCT01820572|50228611|FG000|Treatment Period|Death|3|||
25116749|NCT01820572|50228612|FG001|Treatment Period|Death|3|||
25116750|NCT01820572|50228611|FG000|Treatment Period|Lack of Efficacy|1|||
25116751|NCT01820572|50228612|FG001|Treatment Period|Lack of Efficacy|0|||
25116752|NCT01820572|50228611|FG000|Treatment Period|poor/non compliance|0|||
25116753|NCT01820572|50228612|FG001|Treatment Period|poor/non compliance|3|||
25116754|NCT01820572|50228611|FG000|Treatment Period|request to discontinue|6|||
25116755|NCT01820572|50228612|FG001|Treatment Period|request to discontinue|11|||
25116756|NCT01820572|50228611|FG000|Treatment Period|No longer meets study criteria|3|||
25116757|NCT01820572|50228612|FG001|Treatment Period|No longer meets study criteria|10|||
25116758|NCT01820572|50228611|FG000|Treatment Period|withdrew consent|1|||
25008421|NCT03535194|50101309|FG004|Maintenance Period|Physician Decision|0|||
25008422|NCT03535194|50101305|FG000|Maintenance Period|Pregnancy|0|||
25008423|NCT03535194|50101306|FG001|Maintenance Period|Pregnancy|0|||
25008424|NCT03535194|50101307|FG002|Maintenance Period|Pregnancy|0|||
25008425|NCT03535194|50101308|FG003|Maintenance Period|Pregnancy|2|||
25008426|NCT03535194|50101309|FG004|Maintenance Period|Pregnancy|0|||
25008427|NCT03535194|50101305|FG000|Maintenance Period|Protocol Violation|0|||
25008428|NCT03535194|50101306|FG001|Maintenance Period|Protocol Violation|1|||
25008429|NCT03535194|50101307|FG002|Maintenance Period|Protocol Violation|0|||
25008430|NCT03535194|50101308|FG003|Maintenance Period|Protocol Violation|0|||
25008431|NCT03535194|50101309|FG004|Maintenance Period|Protocol Violation|0|||
25008432|NCT03535194|50101305|FG000|Maintenance Period|Withdrawal by Subject|7|||
25008433|NCT03535194|50101306|FG001|Maintenance Period|Withdrawal by Subject|2|||
25008434|NCT03535194|50101307|FG002|Maintenance Period|Withdrawal by Subject|1|||
25008435|NCT03535194|50101308|FG003|Maintenance Period|Withdrawal by Subject|8|||
25008436|NCT03535194|50101309|FG004|Maintenance Period|Withdrawal by Subject|0|||
25008437|NCT03535194|50101305|FG000|Post-Treatment Followup Period|Adverse Event|4|||
25008438|NCT03535194|50101306|FG001|Post-Treatment Followup Period|Adverse Event|5|||
25008439|NCT03535194|50101307|FG002|Post-Treatment Followup Period|Adverse Event|1|||
25008440|NCT03535194|50101308|FG003|Post-Treatment Followup Period|Adverse Event|8|||
25008441|NCT03535194|50101309|FG004|Post-Treatment Followup Period|Adverse Event|0|||
25008442|NCT03535194|50101305|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
25008443|NCT03535194|50101306|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
25008444|NCT03535194|50101307|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
25008445|NCT03535194|50101308|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
25008446|NCT03535194|50101309|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
25008447|NCT03535194|50101305|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
25008448|NCT03535194|50101306|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
25008449|NCT03535194|50101307|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
25008450|NCT03535194|50101308|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
25008451|NCT03535194|50101309|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
25116759|NCT01820572|50228612|FG001|Treatment Period|withdrew consent|2|||
25116760|NCT01820260|50228632|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
25116761|NCT01820260|50228633|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
25008452|NCT03535194|50101305|FG000|Post-Treatment Followup Period|Other|1|||
25008453|NCT03535194|50101306|FG001|Post-Treatment Followup Period|Other|0|||
25008454|NCT03535194|50101307|FG002|Post-Treatment Followup Period|Other|0|||
25008455|NCT03535194|50101308|FG003|Post-Treatment Followup Period|Other|5|||
25008456|NCT03535194|50101309|FG004|Post-Treatment Followup Period|Other|0|||
25008457|NCT03535194|50101305|FG000|Post-Treatment Followup Period|Physician Decision|0|||
25008458|NCT03535194|50101306|FG001|Post-Treatment Followup Period|Physician Decision|2|||
25008459|NCT03535194|50101307|FG002|Post-Treatment Followup Period|Physician Decision|1|||
25008460|NCT03535194|50101308|FG003|Post-Treatment Followup Period|Physician Decision|1|||
25261493|NCT01261611|50576216|FG001|Treatment Cycle 2|Adverse Event|0|||
25261494|NCT01261611|50576217|FG002|Treatment Cycle 2|Adverse Event|0|||
25261495|NCT01261611|50576215|FG000|Treatment Cycle 2|Protocol Violation|2|||
25261496|NCT01261611|50576216|FG001|Treatment Cycle 2|Protocol Violation|0|||
25261497|NCT01261611|50576217|FG002|Treatment Cycle 2|Protocol Violation|0|||
25261498|NCT01261611|50576215|FG000|Treatment Cycle 2|Not otherwise specified|2|||
25261499|NCT01261611|50576216|FG001|Treatment Cycle 2|Not otherwise specified|0|||
25261500|NCT01261611|50576217|FG002|Treatment Cycle 2|Not otherwise specified|0|||
25261501|NCT01261611|50576215|FG000|Treatment Cycle 3|Completed study|24|||
25261502|NCT01261611|50576216|FG001|Treatment Cycle 3|Completed study|0|||
25261503|NCT01261611|50576217|FG002|Treatment Cycle 3|Completed study|0|||
25261504|NCT01261611|50576215|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
25261505|NCT01261611|50576216|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
25261506|NCT01261611|50576217|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
25261507|NCT01261611|50576215|FG000|Treatment Cycle 3|Adverse Event|1|||
25261508|NCT01261611|50576216|FG001|Treatment Cycle 3|Adverse Event|0|||
25261509|NCT01261611|50576217|FG002|Treatment Cycle 3|Adverse Event|0|||
25261510|NCT01261611|50576215|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
25261511|NCT01261611|50576216|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
25261512|NCT01261611|50576217|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
25261513|NCT01261611|50576215|FG000|Treatment Cycle 4|Completed study|87|||
25261514|NCT01261611|50576216|FG001|Treatment Cycle 4|Completed study|0|||
25261515|NCT01261611|50576217|FG002|Treatment Cycle 4|Completed study|0|||
25261516|NCT01261611|50576215|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
25261517|NCT01261611|50576216|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
25261518|NCT01261611|50576217|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
25261519|NCT01261611|50576215|FG000|Treatment Cycle 4|Adverse Event|1|||
25261520|NCT01261611|50576216|FG001|Treatment Cycle 4|Adverse Event|0|||
25261521|NCT01261611|50576217|FG002|Treatment Cycle 4|Adverse Event|0|||
25261522|NCT01261611|50576215|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
25261523|NCT01261611|50576216|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
25261524|NCT01261611|50576217|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
25261525|NCT01261611|50576215|FG000|Treatment Cycle 4|Not otherwise specified|3|||
25261526|NCT01261611|50576216|FG001|Treatment Cycle 4|Not otherwise specified|0|||
25261527|NCT01261611|50576217|FG002|Treatment Cycle 4|Not otherwise specified|0|||
25261528|NCT01261611|50576215|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
25261529|NCT01261611|50576216|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
25261530|NCT01261611|50576217|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
25261531|NCT01261611|50576215|FG000|Treatment Cycle 5|Adverse Event|1|||
25261532|NCT01261611|50576216|FG001|Treatment Cycle 5|Adverse Event|0|||
25008461|NCT03535194|50101309|FG004|Post-Treatment Followup Period|Physician Decision|0|||
25008462|NCT03535194|50101305|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
25008463|NCT03535194|50101306|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
25008464|NCT03535194|50101307|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
25008465|NCT03535194|50101308|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
25008466|NCT03535194|50101309|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
25177412|NCT02754141|50321507|FG000|Overall Study|Maximum clinical benefit|0|||
25177413|NCT02754141|50321508|FG001|Overall Study|Maximum clinical benefit|0|||
25177414|NCT02754141|50321509|FG002|Overall Study|Maximum clinical benefit|0|||
25177415|NCT02754141|50321510|FG003|Overall Study|Maximum clinical benefit|1|||
25177416|NCT02754141|50321511|FG004|Overall Study|Maximum clinical benefit|0|||
25177417|NCT02754141|50321512|FG005|Overall Study|Maximum clinical benefit|0|||
25177418|NCT02754141|50321513|FG006|Overall Study|Maximum clinical benefit|0|||
25177419|NCT02754141|50321514|FG007|Overall Study|Maximum clinical benefit|0|||
25177420|NCT02754141|50321515|FG008|Overall Study|Maximum clinical benefit|0|||
25177421|NCT02754141|50321516|FG009|Overall Study|Maximum clinical benefit|0|||
25177422|NCT02754141|50321517|FG010|Overall Study|Maximum clinical benefit|0|||
25177423|NCT02754141|50321518|FG011|Overall Study|Maximum clinical benefit|0|||
25177424|NCT02754141|50321519|FG012|Overall Study|Maximum clinical benefit|0|||
25177425|NCT02754141|50321520|FG013|Overall Study|Maximum clinical benefit|0|||
25177426|NCT02754141|50321521|FG014|Overall Study|Maximum clinical benefit|0|||
25261533|NCT01261611|50576217|FG002|Treatment Cycle 5|Adverse Event|0|||
25261534|NCT01261611|50576215|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
25261535|NCT01261611|50576216|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
25261536|NCT01261611|50576217|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
25261537|NCT01304706|50576229|FG000|Overall Study|Adverse Event|2|||
25261538|NCT01304706|50576229|FG000|Overall Study|Lack of Efficacy|1|||
25261539|NCT01304706|50576229|FG000|Overall Study|Death|3|||
25261540|NCT01304706|50576229|FG000|Overall Study|Withdrawal by Subject|3|||
25261541|NCT01304706|50576229|FG000|Overall Study|Lost to Follow-up|7|||
25261542|NCT01304706|50576229|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
25008467|NCT03559530|50101333|FG000|Overall Study|non-location of medical records|44|||
25008468|NCT03559530|50101334|FG001|Overall Study|non-location of medical records|0|||
25008469|NCT03559530|50101333|FG000|Overall Study|culture results not considered for treat|29|||
25008470|NCT03559530|50101334|FG001|Overall Study|culture results not considered for treat|0|||
25008471|NCT03559530|50101333|FG000|Overall Study|duplicate cases|8|||
25008472|NCT03559530|50101334|FG001|Overall Study|duplicate cases|0|||
25008473|NCT03559530|50101333|FG000|Overall Study|other species of Acinetobacte|7|||
25008474|NCT03559530|50101334|FG001|Overall Study|other species of Acinetobacte|0|||
25008475|NCT03559530|50101333|FG000|Overall Study|contamination / colonization|3|||
25008476|NCT03559530|50101334|FG001|Overall Study|contamination / colonization|0|||
25008477|NCT03124784|50101362|FG000|Overall Study|Adverse Event|1|||
25008478|NCT03124784|50101362|FG000|Overall Study|Computer/Equip Malfunction|1|||
25008479|NCT03531840|50101370|FG000|Overall Study|Death on study|3|||
25008480|NCT03531840|50101371|FG001|Overall Study|Death on study|2|||
25008481|NCT03531840|50101372|FG002|Overall Study|Death on study|1|||
25008482|NCT03531840|50101373|FG003|Overall Study|Death on study|2|||
25008483|NCT03531840|50101370|FG000|Overall Study|Death during follow up|2|||
25008484|NCT03531840|50101371|FG001|Overall Study|Death during follow up|3|||
25008485|NCT03531840|50101372|FG002|Overall Study|Death during follow up|4|||
25008486|NCT03531840|50101373|FG003|Overall Study|Death during follow up|1|||
25008487|NCT03110900|50101390|FG000|Overall Study|Sponsor withdrew|1|||
25008488|NCT03110900|50101391|FG001|Overall Study|Sponsor withdrew|1|||
25008489|NCT03867734|50101397|FG000|Overall Study|Lost to Follow-up|2|||
25008490|NCT03446456|50101407|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
25008491|NCT03446456|50101408|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
25008492|NCT03446456|50101407|FG000|Overall Study|Lost to Follow-up|1|||
25008493|NCT03446456|50101408|FG001|Overall Study|Lost to Follow-up|3|||
25008494|NCT03446456|50101407|FG000|Overall Study|Participant failed the toxicology test|1|||
25008495|NCT03446456|50101408|FG001|Overall Study|Participant failed the toxicology test|0|||
25008496|NCT03446456|50101407|FG000|Overall Study|Break down of the experimental equipment|1|||
25008497|NCT03446456|50101408|FG001|Overall Study|Break down of the experimental equipment|0|||
25008498|NCT03495102|50101417|FG000|Overall Study|Adverse Event|5|||
25008499|NCT03495102|50101418|FG001|Overall Study|Adverse Event|7|||
25008500|NCT03495102|50101419|FG002|Overall Study|Adverse Event|10|||
25008501|NCT03495102|50101417|FG000|Overall Study|Death|3|||
25008502|NCT03495102|50101418|FG001|Overall Study|Death|4|||
25008503|NCT03495102|50101419|FG002|Overall Study|Death|4|||
25008504|NCT03495102|50101417|FG000|Overall Study|Lost to Follow-up|15|||
25008505|NCT03495102|50101418|FG001|Overall Study|Lost to Follow-up|16|||
25008506|NCT03495102|50101419|FG002|Overall Study|Lost to Follow-up|17|||
25008507|NCT03495102|50101417|FG000|Overall Study|Physician Decision|2|||
25008508|NCT03495102|50101418|FG001|Overall Study|Physician Decision|0|||
25008509|NCT03495102|50101419|FG002|Overall Study|Physician Decision|2|||
25008510|NCT03495102|50101417|FG000|Overall Study|Withdrawal by Subject|25|||
25008511|NCT03495102|50101418|FG001|Overall Study|Withdrawal by Subject|36|||
25008512|NCT03495102|50101419|FG002|Overall Study|Withdrawal by Subject|18|||
25008513|NCT03495102|50101417|FG000|Overall Study|Protocol Violation|1|||
25008514|NCT03495102|50101418|FG001|Overall Study|Protocol Violation|1|||
25008515|NCT03495102|50101419|FG002|Overall Study|Protocol Violation|0|||
25008516|NCT03495102|50101417|FG000|Overall Study|Site Closure|3|||
25008517|NCT03495102|50101418|FG001|Overall Study|Site Closure|1|||
25008518|NCT03495102|50101419|FG002|Overall Study|Site Closure|2|||
25008519|NCT03495102|50101417|FG000|Overall Study|Non-compliance|1|||
25008520|NCT03495102|50101418|FG001|Overall Study|Non-compliance|0|||
25008521|NCT03495102|50101419|FG002|Overall Study|Non-compliance|0|||
25008522|NCT03495102|50101417|FG000|Overall Study|Participant Duplicated at Another Site|0|||
25008523|NCT03495102|50101418|FG001|Overall Study|Participant Duplicated at Another Site|0|||
25008524|NCT03495102|50101419|FG002|Overall Study|Participant Duplicated at Another Site|1|||
25008525|NCT03495102|50101417|FG000|Overall Study|Primary Care Physician Recommendation|0|||
25008526|NCT03495102|50101418|FG001|Overall Study|Primary Care Physician Recommendation|1|||
25008527|NCT03495102|50101419|FG002|Overall Study|Primary Care Physician Recommendation|0|||
25008528|NCT03495102|50101417|FG000|Overall Study|Relocated to Another Country|0|||
25008529|NCT03495102|50101418|FG001|Overall Study|Relocated to Another Country|1|||
25008530|NCT03495102|50101419|FG002|Overall Study|Relocated to Another Country|0|||
25008531|NCT03495102|50101417|FG000|Overall Study|Participant was in Rehabilitation|1|||
25008532|NCT03495102|50101418|FG001|Overall Study|Participant was in Rehabilitation|0|||
25008533|NCT03495102|50101419|FG002|Overall Study|Participant was in Rehabilitation|0|||
25008534|NCT03105362|50101427|FG000|Overall Study|Withdrawal by Subject|1|||
25008535|NCT03105362|50101427|FG000|Overall Study|Lost to Follow-up|1|||
25008536|NCT03559218|50101436|FG000|Overall Study|Withdrawal by Subject|1|||
25008537|NCT03559218|50101437|FG001|Overall Study|Withdrawal by Subject|0|||
25008538|NCT03104816|50101446|FG000|Overall Study|Lack of Efficacy|0|||
25008539|NCT03104816|50101447|FG001|Overall Study|Lack of Efficacy|2|||
25008540|NCT03104816|50101448|FG002|Overall Study|Lack of Efficacy|0|||
25008541|NCT03104816|50101446|FG000|Overall Study|Protocol Violation|2|||
25008542|NCT03104816|50101447|FG001|Overall Study|Protocol Violation|0|||
25008543|NCT03104816|50101448|FG002|Overall Study|Protocol Violation|2|||
25008544|NCT03559062|50101459|FG000|Overall Study|Other|0|||
25008545|NCT03559062|50101460|FG001|Overall Study|Other|1|||
25008546|NCT03559062|50101461|FG002|Overall Study|Other|0|||
25008547|NCT00089791|50101472|FG000|Overall Study|Physician Decision|6|||
25008548|NCT00089791|50101473|FG001|Overall Study|Physician Decision|3|||
25008549|NCT00089791|50101472|FG000|Overall Study|Adverse Event|81|||
25008550|NCT00089791|50101473|FG001|Overall Study|Adverse Event|93|||
25008551|NCT00089791|50101472|FG000|Overall Study|Withdrawal by Subject|403|||
25008552|NCT00089791|50101473|FG001|Overall Study|Withdrawal by Subject|344|||
25008553|NCT00089791|50101472|FG000|Overall Study|Death|78|||
25008554|NCT00089791|50101473|FG001|Overall Study|Death|62|||
25008555|NCT00089791|50101472|FG000|Overall Study|Disease progression|7|||
25008556|NCT00089791|50101473|FG001|Overall Study|Disease progression|3|||
25008557|NCT00089791|50101472|FG000|Overall Study|Ineligibility determined|12|||
25008558|NCT00089791|50101473|FG001|Overall Study|Ineligibility determined|9|||
25008559|NCT00089791|50101472|FG000|Overall Study|Lost to Follow-up|57|||
25008560|NCT00089791|50101473|FG001|Overall Study|Lost to Follow-up|57|||
25008561|NCT00089791|50101472|FG000|Overall Study|Noncompliance|17|||
25008562|NCT00089791|50101473|FG001|Overall Study|Noncompliance|13|||
25008563|NCT00089791|50101472|FG000|Overall Study|Other|20|||
25008564|NCT00089791|50101473|FG001|Overall Study|Other|32|||
25008565|NCT00089791|50101472|FG000|Overall Study|Protocol deviation|12|||
25008566|NCT00089791|50101473|FG001|Overall Study|Protocol deviation|10|||
25008567|NCT00089791|50101472|FG000|Overall Study|Requirement for alternative therapy|7|||
25008568|NCT00089791|50101473|FG001|Overall Study|Requirement for alternative therapy|4|||
25008569|NCT03558672|50101479|FG000|Overall Study|Study Early Termination|10|||
25008570|NCT03558516|50101485|FG000|Overall Study|Protocol Violation|2|||
25008571|NCT03558516|50101486|FG001|Overall Study|Protocol Violation|2|||
25008572|NCT03557970|50101494|FG000|Overall Study|Study closure|1|||
25008573|NCT03557970|50101495|FG001|Overall Study|Study closure|0|||
25008574|NCT03557970|50101494|FG000|Overall Study|Physician Decision|0|||
25008575|NCT03557970|50101495|FG001|Overall Study|Physician Decision|1|||
25008576|NCT03557970|50101494|FG000|Overall Study|Death|0|||
25008577|NCT03557970|50101495|FG001|Overall Study|Death|1|||
25008578|NCT02815280|50101503|FG000|Double-Blind Phase|Adverse Event|1|||
25008579|NCT02815280|50101504|FG001|Double-Blind Phase|Adverse Event|1|||
25008580|NCT02815280|50101503|FG000|Double-Blind Phase|Lost to Follow-up|10|||
25008581|NCT02815280|50101504|FG001|Double-Blind Phase|Lost to Follow-up|9|||
25008582|NCT02815280|50101503|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
25008583|NCT02815280|50101504|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
25008584|NCT02815280|50101503|FG000|Double-Blind Phase|Protocol Violation|2|||
25008585|NCT02815280|50101504|FG001|Double-Blind Phase|Protocol Violation|2|||
25008586|NCT02815280|50101503|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
25008587|NCT02815280|50101504|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
25008588|NCT02815280|50101503|FG000|Open-Label Phase|Adverse Event|2|||
25008589|NCT02815280|50101504|FG001|Open-Label Phase|Adverse Event|3|||
25008590|NCT02815280|50101503|FG000|Open-Label Phase|Lost to Follow-up|18|||
25008591|NCT02815280|50101504|FG001|Open-Label Phase|Lost to Follow-up|9|||
25008592|NCT02815280|50101503|FG000|Open-Label Phase|Withdrawal by Subject|33|||
25008593|NCT02815280|50101504|FG001|Open-Label Phase|Withdrawal by Subject|18|||
25008594|NCT02815280|50101503|FG000|Open-Label Phase|Protocol Violation|3|||
25008595|NCT02815280|50101504|FG001|Open-Label Phase|Protocol Violation|0|||
25008596|NCT02815280|50101503|FG000|Open-Label Phase|Administrative|26|||
25008597|NCT02815280|50101504|FG001|Open-Label Phase|Administrative|12|||
25008598|NCT02815280|50101503|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
25008599|NCT02815280|50101504|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
25008600|NCT02737930|50101516|FG000|Overall Study|Withdrawal by Subject|0|||
25008601|NCT02737930|50101517|FG001|Overall Study|Withdrawal by Subject|1|||
25008602|NCT03493698|50101523|FG000|Treatment Period C|Adverse Event|1|||
25008603|NCT03493698|50101523|FG000|Treatment Period C|Withdrawal by Subject|1|||
25008604|NCT02737852|50101537|FG000|Overall Study|Withdrawal by Subject|2|||
25008605|NCT03528174|50101541|FG000|Overall Study|Adverse Event|1|||
25008606|NCT03528174|50101541|FG000|Overall Study|sensors dislodged|1|||
25008607|NCT03109184|50101551|FG000|Overall Study|Lost to Follow-up|6|||
25008608|NCT03109184|50101552|FG001|Overall Study|Lost to Follow-up|6|||
25008609|NCT03109184|50101551|FG000|Overall Study|Withdrawal by Subject|1|||
25008610|NCT03109184|50101552|FG001|Overall Study|Withdrawal by Subject|1|||
25008611|NCT03493542|50101570|FG000|Overall Study|Ongoing|2|||
25008612|NCT03493542|50101571|FG001|Overall Study|Ongoing|3|||
25008613|NCT03493542|50101570|FG000|Overall Study|Withdrawal by parent or guardian|3|||
25008614|NCT03493542|50101571|FG001|Overall Study|Withdrawal by parent or guardian|0|||
25008615|NCT03493542|50101570|FG000|Overall Study|Withdrawal by Subject|2|||
25116762|NCT01820260|50228634|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
25168603|NCT04452318|50297976|FG006|Overall Study|Withdrawal by Subject|6|||
25008616|NCT03493542|50101571|FG001|Overall Study|Withdrawal by Subject|6|||
25008617|NCT03493386|50101579|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
25008618|NCT03493386|50101580|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
25008619|NCT03493386|50101581|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
25008620|NCT03493386|50101582|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
25008621|NCT03478644|50101601|FG000|Phase 2|Withdrawal by Subject|2|||
25008622|NCT03478644|50101602|FG001|Phase 2|Withdrawal by Subject|1|||
25008623|NCT03478644|50101601|FG000|Phase 2|Lost to Follow-up|1|||
25008624|NCT03478644|50101602|FG001|Phase 2|Lost to Follow-up|0|||
25008625|NCT03527550|50101610|FG000|Overall Study|Lost to Follow-up|4|||
25008626|NCT03527550|50101611|FG001|Overall Study|Lost to Follow-up|2|||
25008627|NCT03527550|50101610|FG000|Overall Study|Withdrawal by Subject|4|||
25008628|NCT03527550|50101611|FG001|Overall Study|Withdrawal by Subject|1|||
25008629|NCT03527550|50101610|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
25008630|NCT03527550|50101611|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
25008631|NCT03475056|50101621|FG000|Overall Study|Lost to Follow-up|0|||
25008632|NCT03475056|50101622|FG001|Overall Study|Lost to Follow-up|1|||
25008633|NCT03475056|50101621|FG000|Overall Study|Moved from Area|0|||
25008634|NCT03475056|50101622|FG001|Overall Study|Moved from Area|2|||
25008635|NCT00938912|50101629|FG000|Overall Study|Withdrawal by Subject|28|||
25008636|NCT00938912|50101629|FG000|Overall Study|Lost to Follow-up|4|||
25008637|NCT00938912|50101629|FG000|Overall Study|Lack of Efficacy|43|||
25008638|NCT00938912|50101629|FG000|Overall Study|Adverse event, non-fatal|24|||
25008639|NCT00938912|50101629|FG000|Overall Study|Adverse event, fatal|1|||
25008640|NCT00938912|50101629|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
25008641|NCT00938912|50101629|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
25008642|NCT00938912|50101629|FG000|Overall Study|Participant needed prohibit medication|1|||
25008643|NCT00938912|50101629|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
25008644|NCT00938912|50101629|FG000|Overall Study|Did not meet Eligibility criteria|1|||
25008645|NCT00938912|50101629|FG000|Overall Study|Participant relocated not related to AE|1|||
25008646|NCT00938912|50101629|FG000|Overall Study|Participant moved to another city|1|||
25008647|NCT00938912|50101629|FG000|Overall Study|Participant experienced break through seizures|1|||
25008648|NCT00938912|50101629|FG000|Overall Study|No longer wished to participate in the study|1|||
25008649|NCT00938912|50101629|FG000|Overall Study|Protocol Deviation|2|||
25008650|NCT03473808|50101636|FG000|Overall Study|Withdrawal by Subject|1|||
25008651|NCT03473340|50101642|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
25008652|NCT03473340|50101643|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
25008653|NCT03473340|50101642|FG000|Overall Study|Withdrawal by Subject|1|||
25008654|NCT03473340|50101643|FG001|Overall Study|Withdrawal by Subject|0|||
25008655|NCT03473340|50101642|FG000|Overall Study|Lost to Follow-up|1|||
25008656|NCT03473340|50101643|FG001|Overall Study|Lost to Follow-up|2|||
25008657|NCT03490032|50101652|FG000|Overall Study|family issue (child custody)|1|||
25008658|NCT03490032|50101653|FG001|Overall Study|family issue (child custody)|0|||
25008659|NCT03490032|50101654|FG002|Overall Study|family issue (child custody)|0|||
25008660|NCT03489720|50101674|FG000|Overall Study|Withdrawal by Subject|2|||
25008661|NCT03489720|50101675|FG001|Overall Study|Withdrawal by Subject|0|||
25008662|NCT03527160|50101687|FG000|Overall Study|No urine collected|13|||
25008663|NCT03527160|50101687|FG000|Overall Study|No clinical serum creatinine collected|6|||
25008664|NCT03527160|50101687|FG000|Overall Study|Did not meet inclusion|2|||
25008665|NCT03739138|50101697|FG000|Overall Study|Death|0|||
25008666|NCT03739138|50101698|FG001|Overall Study|Death|7|||
25008667|NCT03739138|50101699|FG002|Overall Study|Death|4|||
25008668|NCT03739138|50101700|FG003|Overall Study|Death|13|||
25008669|NCT03739138|50101701|FG004|Overall Study|Death|0|||
25008670|NCT03739138|50101697|FG000|Overall Study|Lost to Follow-up|0|||
25008671|NCT03739138|50101698|FG001|Overall Study|Lost to Follow-up|0|||
25008672|NCT03739138|50101699|FG002|Overall Study|Lost to Follow-up|1|||
25008673|NCT03739138|50101700|FG003|Overall Study|Lost to Follow-up|0|||
25008674|NCT03739138|50101701|FG004|Overall Study|Lost to Follow-up|0|||
25008675|NCT03739138|50101697|FG000|Overall Study|Study Terminated By Sponsor|0|||
25008676|NCT03739138|50101698|FG001|Overall Study|Study Terminated By Sponsor|0|||
25008677|NCT03739138|50101699|FG002|Overall Study|Study Terminated By Sponsor|0|||
25008678|NCT03739138|50101700|FG003|Overall Study|Study Terminated By Sponsor|4|||
25008679|NCT03739138|50101701|FG004|Overall Study|Study Terminated By Sponsor|0|||
25008680|NCT03739138|50101697|FG000|Overall Study|Withdrawal by Subject|0|||
25008681|NCT03739138|50101698|FG001|Overall Study|Withdrawal by Subject|0|||
25008682|NCT03739138|50101699|FG002|Overall Study|Withdrawal by Subject|0|||
25116763|NCT01820260|50228635|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
25177427|NCT02754141|50321522|FG015|Overall Study|Maximum clinical benefit|0|||
25008683|NCT03739138|50101700|FG003|Overall Study|Withdrawal by Subject|1|||
25008684|NCT03739138|50101701|FG004|Overall Study|Withdrawal by Subject|0|||
25008685|NCT03472326|50101711|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
25008686|NCT03472326|50101712|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
25008687|NCT03472326|50101713|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
25116764|NCT01820260|50228636|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
25116765|NCT01820260|50228637|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
25116766|NCT01820260|50228638|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
25116767|NCT01820260|50228639|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
25116768|NCT01820260|50228640|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
25116769|NCT01820260|50228641|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
25116770|NCT01820260|50228642|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
25116771|NCT01820260|50228643|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
25116772|NCT01820260|50228644|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
25116773|NCT01820260|50228645|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
25116774|NCT01820260|50228632|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
25116775|NCT01820260|50228633|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
25116776|NCT01820260|50228634|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
25116777|NCT01820260|50228635|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
25116778|NCT01820260|50228636|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
25116779|NCT01820260|50228637|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
25116780|NCT01820260|50228638|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
25116781|NCT01820260|50228639|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
25116782|NCT01820260|50228640|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
25116783|NCT01820260|50228641|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
25116784|NCT01820260|50228642|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
25116785|NCT01820260|50228643|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
25116786|NCT01820260|50228644|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
25116787|NCT01820260|50228645|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
25116788|NCT01610596|50228683|FG000|Overall Study|Lost to Follow-up|0|||
25116789|NCT01610596|50228684|FG001|Overall Study|Lost to Follow-up|1|||
25116790|NCT01818700|50228690|FG000|Overall Study|Adverse Event|67|||
25116791|NCT01818700|50228690|FG000|Overall Study|Lack of Efficacy|2|||
25116792|NCT01818700|50228690|FG000|Overall Study|Lost to Follow-up|5|||
25116793|NCT01818700|50228690|FG000|Overall Study|Withdrawal by Subject|27|||
25116794|NCT01818700|50228690|FG000|Overall Study|Protocol Violation|2|||
25116795|NCT01818700|50228690|FG000|Overall Study|Other|1|||
25116796|NCT01817764|50228698|FG000|Overall Study|Adverse Event|7|||
25116797|NCT01817764|50228699|FG001|Overall Study|Adverse Event|10|||
25116798|NCT01817764|50228698|FG000|Overall Study|Lack of Efficacy|9|||
25116799|NCT01817764|50228699|FG001|Overall Study|Lack of Efficacy|7|||
25116800|NCT01817764|50228698|FG000|Overall Study|Protocol Violation|7|||
25116801|NCT01817764|50228699|FG001|Overall Study|Protocol Violation|5|||
25116802|NCT01817764|50228698|FG000|Overall Study|Lost to Follow-up|1|||
25116803|NCT01817764|50228699|FG001|Overall Study|Lost to Follow-up|4|||
25116804|NCT01817764|50228698|FG000|Overall Study|Withdrawal by Subject|10|||
25116805|NCT01817764|50228699|FG001|Overall Study|Withdrawal by Subject|12|||
25116806|NCT01803880|50228708|FG000|Overall Study|Adverse Event|1|||
25116807|NCT01803880|50228709|FG001|Overall Study|Adverse Event|0|||
25116808|NCT01803880|50228710|FG002|Overall Study|Adverse Event|0|||
25116809|NCT01803880|50228708|FG000|Overall Study|Withdrawal by Subject|1|||
25116810|NCT01803880|50228709|FG001|Overall Study|Withdrawal by Subject|1|||
25116811|NCT01803880|50228710|FG002|Overall Study|Withdrawal by Subject|4|||
25116812|NCT01803880|50228708|FG000|Overall Study|Physician Decision|0|||
25116813|NCT01803880|50228709|FG001|Overall Study|Physician Decision|0|||
25116814|NCT01803880|50228710|FG002|Overall Study|Physician Decision|1|||
25116815|NCT01803880|50228708|FG000|Overall Study|Unable to return for follow-up visits|0|||
25116816|NCT01803880|50228709|FG001|Overall Study|Unable to return for follow-up visits|1|||
25116817|NCT01803880|50228710|FG002|Overall Study|Unable to return for follow-up visits|2|||
25116818|NCT01803880|50228708|FG000|Overall Study|Lost to Follow-up|1|||
25116819|NCT01803880|50228709|FG001|Overall Study|Lost to Follow-up|2|||
25116820|NCT01803880|50228710|FG002|Overall Study|Lost to Follow-up|3|||
25116821|NCT01803880|50228708|FG000|Overall Study|Protocol Violation|1|||
25116822|NCT01803880|50228709|FG001|Overall Study|Protocol Violation|0|||
25116823|NCT01803880|50228710|FG002|Overall Study|Protocol Violation|0|||
25116824|NCT01803880|50228708|FG000|Overall Study|Early study termination|0|||
25116825|NCT01803880|50228709|FG001|Overall Study|Early study termination|6|||
25116826|NCT01803880|50228710|FG002|Overall Study|Early study termination|5|||
25116827|NCT01803880|50228708|FG000|Overall Study|Incomplete data entry by sites|2|||
25116828|NCT01803880|50228709|FG001|Overall Study|Incomplete data entry by sites|0|||
25116829|NCT01803880|50228710|FG002|Overall Study|Incomplete data entry by sites|0|||
25177428|NCT02754141|50321523|FG016|Overall Study|Maximum clinical benefit|0|||
25116830|NCT01803646|50228722|FG000|Overall Study|Protocol Violation|1|||
25116831|NCT01803646|50228723|FG001|Overall Study|Protocol Violation|0|||
25116832|NCT01803646|50228722|FG000|Overall Study|Adverse Event|1|||
25116833|NCT01803646|50228723|FG001|Overall Study|Adverse Event|1|||
25116834|NCT01803646|50228722|FG000|Overall Study|Withdrawal by Subject|9|||
25116835|NCT01803646|50228723|FG001|Overall Study|Withdrawal by Subject|6|||
25116836|NCT01803646|50228722|FG000|Overall Study|Randomization error|1|||
25116837|NCT01803646|50228723|FG001|Overall Study|Randomization error|2|||
25116838|NCT01803646|50228722|FG000|Overall Study|Lost to Follow-up|5|||
25116839|NCT01803646|50228723|FG001|Overall Study|Lost to Follow-up|1|||
25116840|NCT01817530|50228737|FG000|Overall Study|Exclusionary Medication Received|0|||
25116841|NCT01817530|50228738|FG001|Overall Study|Exclusionary Medication Received|0|||
25116842|NCT01817530|50228739|FG002|Overall Study|Exclusionary Medication Received|0|||
25116843|NCT01817530|50228740|FG003|Overall Study|Exclusionary Medication Received|0|||
25116844|NCT01817530|50228741|FG004|Overall Study|Exclusionary Medication Received|1|||
25116845|NCT01817530|50228742|FG005|Overall Study|Exclusionary Medication Received|0|||
25116846|NCT01817530|50228743|FG006|Overall Study|Exclusionary Medication Received|0|||
25116847|NCT01817530|50228744|FG007|Overall Study|Exclusionary Medication Received|0|||
25116848|NCT01817530|50228737|FG000|Overall Study|Adverse Event|6|||
25116849|NCT01817530|50228738|FG001|Overall Study|Adverse Event|3|||
25116850|NCT01817530|50228739|FG002|Overall Study|Adverse Event|2|||
25116851|NCT01817530|50228740|FG003|Overall Study|Adverse Event|5|||
25116852|NCT01817530|50228741|FG004|Overall Study|Adverse Event|0|||
25116853|NCT01817530|50228742|FG005|Overall Study|Adverse Event|10|||
25116854|NCT01817530|50228743|FG006|Overall Study|Adverse Event|5|||
25116855|NCT01817530|50228744|FG007|Overall Study|Adverse Event|8|||
25116856|NCT01817530|50228737|FG000|Overall Study|Subject Noncompliant|3|||
25116857|NCT01817530|50228738|FG001|Overall Study|Subject Noncompliant|1|||
25116858|NCT01817530|50228739|FG002|Overall Study|Subject Noncompliant|0|||
25116859|NCT01817530|50228740|FG003|Overall Study|Subject Noncompliant|4|||
25116860|NCT01817530|50228741|FG004|Overall Study|Subject Noncompliant|0|||
25116861|NCT01817530|50228742|FG005|Overall Study|Subject Noncompliant|1|||
25116862|NCT01817530|50228743|FG006|Overall Study|Subject Noncompliant|1|||
25116863|NCT01817530|50228744|FG007|Overall Study|Subject Noncompliant|1|||
25116864|NCT01817530|50228737|FG000|Overall Study|Lack of Efficacy|1|||
25116865|NCT01817530|50228738|FG001|Overall Study|Lack of Efficacy|0|||
25116866|NCT01817530|50228739|FG002|Overall Study|Lack of Efficacy|0|||
25116867|NCT01817530|50228740|FG003|Overall Study|Lack of Efficacy|0|||
25116868|NCT01817530|50228741|FG004|Overall Study|Lack of Efficacy|0|||
25116869|NCT01817530|50228742|FG005|Overall Study|Lack of Efficacy|1|||
25116870|NCT01817530|50228743|FG006|Overall Study|Lack of Efficacy|0|||
25116871|NCT01817530|50228744|FG007|Overall Study|Lack of Efficacy|1|||
25116872|NCT01817530|50228737|FG000|Overall Study|Pregnancy|0|||
25116873|NCT01817530|50228738|FG001|Overall Study|Pregnancy|0|||
25116874|NCT01817530|50228739|FG002|Overall Study|Pregnancy|0|||
25116875|NCT01817530|50228740|FG003|Overall Study|Pregnancy|0|||
25116876|NCT01817530|50228741|FG004|Overall Study|Pregnancy|0|||
25116877|NCT01817530|50228742|FG005|Overall Study|Pregnancy|1|||
25116878|NCT01817530|50228743|FG006|Overall Study|Pregnancy|0|||
25116879|NCT01817530|50228744|FG007|Overall Study|Pregnancy|0|||
25116880|NCT01817530|50228737|FG000|Overall Study|Other|0|||
25116881|NCT01817530|50228738|FG001|Overall Study|Other|1|||
25116882|NCT01817530|50228739|FG002|Overall Study|Other|0|||
25116883|NCT01817530|50228740|FG003|Overall Study|Other|0|||
25116884|NCT01817530|50228741|FG004|Overall Study|Other|1|||
25116885|NCT01817530|50228742|FG005|Overall Study|Other|0|||
25116886|NCT01817530|50228743|FG006|Overall Study|Other|5|||
25116887|NCT01817530|50228744|FG007|Overall Study|Other|0|||
25116888|NCT01817530|50228737|FG000|Overall Study|Surgery or Invasive Intervention|1|||
25116889|NCT01817530|50228738|FG001|Overall Study|Surgery or Invasive Intervention|0|||
25116890|NCT01817530|50228739|FG002|Overall Study|Surgery or Invasive Intervention|0|||
25116891|NCT01817530|50228740|FG003|Overall Study|Surgery or Invasive Intervention|0|||
25116892|NCT01817530|50228741|FG004|Overall Study|Surgery or Invasive Intervention|1|||
25116893|NCT01817530|50228742|FG005|Overall Study|Surgery or Invasive Intervention|1|||
25116894|NCT01817530|50228743|FG006|Overall Study|Surgery or Invasive Intervention|1|||
25116895|NCT01817530|50228744|FG007|Overall Study|Surgery or Invasive Intervention|0|||
25116896|NCT01817530|50228737|FG000|Overall Study|Consent Withdrawn by Subject|3|||
25116897|NCT01817530|50228738|FG001|Overall Study|Consent Withdrawn by Subject|4|||
25116898|NCT01817530|50228739|FG002|Overall Study|Consent Withdrawn by Subject|7|||
25116899|NCT01817530|50228740|FG003|Overall Study|Consent Withdrawn by Subject|3|||
25116900|NCT01817530|50228741|FG004|Overall Study|Consent Withdrawn by Subject|5|||
25116901|NCT01817530|50228742|FG005|Overall Study|Consent Withdrawn by Subject|3|||
25116902|NCT01817530|50228743|FG006|Overall Study|Consent Withdrawn by Subject|3|||
25116903|NCT01817530|50228744|FG007|Overall Study|Consent Withdrawn by Subject|10|||
25116904|NCT01817530|50228737|FG000|Overall Study|Lost to Follow-up|1|||
25116905|NCT01817530|50228738|FG001|Overall Study|Lost to Follow-up|4|||
25116906|NCT01817530|50228739|FG002|Overall Study|Lost to Follow-up|2|||
25116907|NCT01817530|50228740|FG003|Overall Study|Lost to Follow-up|1|||
25116908|NCT01817530|50228741|FG004|Overall Study|Lost to Follow-up|3|||
25116909|NCT01817530|50228742|FG005|Overall Study|Lost to Follow-up|2|||
25116910|NCT01817530|50228743|FG006|Overall Study|Lost to Follow-up|8|||
25116911|NCT01817530|50228744|FG007|Overall Study|Lost to Follow-up|4|||
25116912|NCT01816984|50228762|FG000|Overall Study|declining health status|1|||
25116913|NCT01816906|50228768|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
25116914|NCT01816906|50228769|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
25116915|NCT01816906|50228768|FG000|Six Months|Lost to Follow-up|14|||
25116916|NCT01816906|50228769|FG001|Six Months|Lost to Follow-up|16|||
25116917|NCT01816906|50228768|FG000|12 Months|Adverse Event|2|||
25116918|NCT01816906|50228769|FG001|12 Months|Adverse Event|2|||
25116919|NCT01816906|50228768|FG000|12 Months|Death|0|||
25116920|NCT01816906|50228769|FG001|12 Months|Death|2|||
25116921|NCT01816906|50228768|FG000|12 Months|Lost to Follow-up|2|||
25116922|NCT01816906|50228769|FG001|12 Months|Lost to Follow-up|1|||
25116923|NCT01816594|50228778|FG000|Overall Study|Local Progress|0|||
25116924|NCT01816594|50228779|FG001|Overall Study|Local Progress|2|||
25116925|NCT01816594|50228778|FG000|Overall Study|Adverse Event|9|||
25116926|NCT01816594|50228779|FG001|Overall Study|Adverse Event|0|||
25116927|NCT01816594|50228778|FG000|Overall Study|Withdrawal by Subject|1|||
25116928|NCT01816594|50228779|FG001|Overall Study|Withdrawal by Subject|0|||
25116929|NCT01816594|50228778|FG000|Overall Study|Physician Decision|1|||
25116930|NCT01816594|50228779|FG001|Overall Study|Physician Decision|0|||
25116931|NCT01802320|50228791|FG000|Overall Study|Death|1|||
25116932|NCT01802320|50228791|FG000|Overall Study|Withdrawal by Subject|1|||
25116933|NCT02453711|50228804|FG000|Overall Study|Withdrawal by Subject|5|||
25116934|NCT02453711|50228805|FG001|Overall Study|Withdrawal by Subject|4|||
25116935|NCT02453711|50228806|FG002|Overall Study|Withdrawal by Subject|6|||
25116936|NCT02453711|50228807|FG003|Overall Study|Withdrawal by Subject|4|||
25116937|NCT02453711|50228808|FG004|Overall Study|Withdrawal by Subject|1|||
25116938|NCT02453711|50228809|FG005|Overall Study|Withdrawal by Subject|1|||
25116939|NCT02453711|50228810|FG006|Overall Study|Withdrawal by Subject|0|||
25116940|NCT02453711|50228811|FG007|Overall Study|Withdrawal by Subject|1|||
25116941|NCT02453711|50228812|FG008|Overall Study|Withdrawal by Subject|7|||
25116942|NCT02453711|50228804|FG000|Overall Study|Lost to Follow-up|5|||
25116943|NCT02453711|50228805|FG001|Overall Study|Lost to Follow-up|3|||
25116944|NCT02453711|50228806|FG002|Overall Study|Lost to Follow-up|2|||
25116945|NCT02453711|50228807|FG003|Overall Study|Lost to Follow-up|3|||
25116946|NCT02453711|50228808|FG004|Overall Study|Lost to Follow-up|1|||
25116947|NCT02453711|50228809|FG005|Overall Study|Lost to Follow-up|5|||
25116948|NCT02453711|50228810|FG006|Overall Study|Lost to Follow-up|2|||
25116949|NCT02453711|50228811|FG007|Overall Study|Lost to Follow-up|6|||
25116950|NCT02453711|50228812|FG008|Overall Study|Lost to Follow-up|6|||
25116951|NCT02453711|50228804|FG000|Overall Study|Death|0|||
25116952|NCT02453711|50228805|FG001|Overall Study|Death|0|||
25116953|NCT02453711|50228806|FG002|Overall Study|Death|0|||
25116954|NCT02453711|50228807|FG003|Overall Study|Death|0|||
25116955|NCT02453711|50228808|FG004|Overall Study|Death|0|||
25116956|NCT02453711|50228809|FG005|Overall Study|Death|0|||
25116957|NCT02453711|50228810|FG006|Overall Study|Death|1|||
25116958|NCT02453711|50228811|FG007|Overall Study|Death|0|||
25116959|NCT02453711|50228812|FG008|Overall Study|Death|0|||
25116960|NCT02453711|50228804|FG000|Overall Study|Unclassified|1|||
25116961|NCT02453711|50228805|FG001|Overall Study|Unclassified|0|||
25116962|NCT02453711|50228806|FG002|Overall Study|Unclassified|1|||
25116963|NCT02453711|50228807|FG003|Overall Study|Unclassified|0|||
25116964|NCT02453711|50228808|FG004|Overall Study|Unclassified|0|||
25116965|NCT02453711|50228809|FG005|Overall Study|Unclassified|0|||
25116966|NCT02453711|50228810|FG006|Overall Study|Unclassified|0|||
25116967|NCT02453711|50228811|FG007|Overall Study|Unclassified|0|||
25116968|NCT02453711|50228812|FG008|Overall Study|Unclassified|0|||
25116969|NCT02453555|50228834|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
25116970|NCT02453555|50228835|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
25116971|NCT02453555|50228836|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
25116972|NCT02453555|50228837|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
25116973|NCT02453555|50228838|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
25116974|NCT02453555|50228839|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
25116975|NCT02453555|50228834|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
25116976|NCT02453555|50228835|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
25116977|NCT02453555|50228836|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
25116978|NCT02453555|50228837|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
25116979|NCT02453555|50228838|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
25116980|NCT02453555|50228839|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
25116981|NCT02453555|50228834|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
25116982|NCT02453555|50228835|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
25116983|NCT02453555|50228836|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
25116984|NCT02453555|50228837|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
25116985|NCT02453555|50228838|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
25116986|NCT02453555|50228839|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
25116987|NCT02453555|50228834|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
25116988|NCT02453555|50228835|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
25261543|NCT01303380|50576233|FG000|Overall Study|Lack of compliance to study procedures|1|||
25261544|NCT01008553|50576237|FG000|Period 1 (Titration Period)|Physician Decision|2|||
25261545|NCT01008553|50576238|FG001|Period 1 (Titration Period)|Physician Decision|0|||
25261546|NCT01008553|50576239|FG002|Period 1 (Titration Period)|Physician Decision|0|||
25261547|NCT01008553|50576237|FG000|Period 1 (Titration Period)|Adverse Event|33|||
25261548|NCT01008553|50576238|FG001|Period 1 (Titration Period)|Adverse Event|0|||
25261549|NCT01008553|50576239|FG002|Period 1 (Titration Period)|Adverse Event|0|||
25261550|NCT01008553|50576237|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
25261551|NCT01008553|50576238|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
25261552|NCT01008553|50576239|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
25261553|NCT01008553|50576237|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
25261554|NCT01008553|50576238|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
25261555|NCT01008553|50576239|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
25261556|NCT01008553|50576237|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
25261557|NCT01008553|50576238|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
25261558|NCT01008553|50576239|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
25261559|NCT01008553|50576237|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
25261560|NCT01008553|50576238|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
25261561|NCT01008553|50576239|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
25261562|NCT01008553|50576237|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
25261563|NCT01008553|50576238|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
25261564|NCT01008553|50576239|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
25261565|NCT01008553|50576237|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
25261566|NCT01008553|50576238|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
25261567|NCT01008553|50576239|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
25261568|NCT01008553|50576237|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
25261569|NCT01008553|50576238|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
25261570|NCT01008553|50576239|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
25261571|NCT01008553|50576237|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
25261572|NCT01008553|50576238|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
25261573|NCT01008553|50576239|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
25116989|NCT02453555|50228836|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
25116990|NCT02453555|50228837|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
25116991|NCT02453555|50228838|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
25116992|NCT02453555|50228839|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
25116993|NCT02453555|50228834|FG000|Extension Period|Adverse Event|0|||
25116994|NCT02453555|50228835|FG001|Extension Period|Adverse Event|0|||
25116995|NCT02453555|50228836|FG002|Extension Period|Adverse Event|1|||
25116996|NCT02453555|50228837|FG003|Extension Period|Adverse Event|2|||
25116997|NCT02453555|50228838|FG004|Extension Period|Adverse Event|1|||
25116998|NCT02453555|50228839|FG005|Extension Period|Adverse Event|1|||
25116999|NCT02453555|50228834|FG000|Extension Period|Protocol Violation|0|||
25117000|NCT02453555|50228835|FG001|Extension Period|Protocol Violation|0|||
25117001|NCT02453555|50228836|FG002|Extension Period|Protocol Violation|1|||
25117002|NCT02453555|50228837|FG003|Extension Period|Protocol Violation|0|||
25117003|NCT02453555|50228838|FG004|Extension Period|Protocol Violation|0|||
25117004|NCT02453555|50228839|FG005|Extension Period|Protocol Violation|0|||
25117005|NCT02453555|50228834|FG000|Extension Period|Withdrawal by Subject|0|||
25117006|NCT02453555|50228835|FG001|Extension Period|Withdrawal by Subject|0|||
25117007|NCT02453555|50228836|FG002|Extension Period|Withdrawal by Subject|1|||
25117008|NCT02453555|50228837|FG003|Extension Period|Withdrawal by Subject|0|||
25117009|NCT02453555|50228838|FG004|Extension Period|Withdrawal by Subject|0|||
25117010|NCT02453555|50228839|FG005|Extension Period|Withdrawal by Subject|0|||
25117011|NCT02453321|50228852|FG000|Overall Study|Weakness|1|||
25117012|NCT02453321|50228853|FG001|Overall Study|Weakness|1|||
25117013|NCT02453321|50228854|FG002|Overall Study|Weakness|2|||
25117014|NCT02453321|50228852|FG000|Overall Study|Deep Venous Thrombosis|0|||
25117015|NCT02453321|50228853|FG001|Overall Study|Deep Venous Thrombosis|1|||
25117016|NCT02453321|50228854|FG002|Overall Study|Deep Venous Thrombosis|0|||
25117017|NCT01610284|50228867|FG000|Randomization Phase|Adverse Event|1|||
25117018|NCT01610284|50228868|FG001|Randomization Phase|Adverse Event|0|||
25117019|NCT01610284|50228867|FG000|Randomization Phase|Physician Decision|1|||
25117020|NCT01610284|50228868|FG001|Randomization Phase|Physician Decision|1|||
25117021|NCT01610284|50228867|FG000|Randomization Phase|Death|0|||
25117022|NCT01610284|50228868|FG001|Randomization Phase|Death|1|||
25117023|NCT01610284|50228867|FG000|Treatment Phase|Adverse Event|80|||
25117024|NCT01610284|50228868|FG001|Treatment Phase|Adverse Event|12|||
25117025|NCT01610284|50228867|FG000|Treatment Phase|Lost to Follow-up|1|||
25117026|NCT01610284|50228868|FG001|Treatment Phase|Lost to Follow-up|0|||
25117027|NCT01610284|50228867|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
25168604|NCT00634101|50298153|FG000|Overall Study|Study Terminated|3|||
25117028|NCT01610284|50228868|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
25117029|NCT01610284|50228867|FG000|Treatment Phase|Physician Decision|27|||
25117030|NCT01610284|50228868|FG001|Treatment Phase|Physician Decision|24|||
25117031|NCT01610284|50228867|FG000|Treatment Phase|Progressive Disease|377|||
25117032|NCT01610284|50228868|FG001|Treatment Phase|Progressive Disease|486|||
25117033|NCT01610284|50228867|FG000|Treatment Phase|Protocol Deviation|2|||
25117034|NCT01610284|50228868|FG001|Treatment Phase|Protocol Deviation|3|||
25117035|NCT01610284|50228867|FG000|Treatment Phase|Study terminated by Sponsor|18|||
25117036|NCT01610284|50228868|FG001|Treatment Phase|Study terminated by Sponsor|15|||
25117037|NCT01610284|50228867|FG000|Treatment Phase|Subject/Guardian Decision|55|||
25117038|NCT01610284|50228868|FG001|Treatment Phase|Subject/Guardian Decision|23|||
25117039|NCT01610284|50228867|FG000|Treatment Phase|Death|6|||
25117040|NCT01610284|50228868|FG001|Treatment Phase|Death|5|||
25117041|NCT01610284|50228867|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
25117042|NCT01610284|50228868|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
25117043|NCT01610284|50228867|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
25117044|NCT01610284|50228868|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
25117045|NCT01610284|50228867|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
25117046|NCT01610284|50228868|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
25117047|NCT01610284|50228867|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
25117048|NCT01610284|50228868|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
25117049|NCT01610284|50228867|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
25117050|NCT01610284|50228868|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
25117051|NCT01610284|50228867|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
25117052|NCT01610284|50228868|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
25117053|NCT02452463|50228877|FG000|Overall Study|Death|1|||
25117054|NCT02452463|50228878|FG001|Overall Study|Death|0|||
25117055|NCT02452463|50228879|FG002|Overall Study|Death|0|||
25117056|NCT02452463|50228877|FG000|Overall Study|Study Suspended|1|||
25117057|NCT02452463|50228878|FG001|Overall Study|Study Suspended|0|||
25117058|NCT02452463|50228879|FG002|Overall Study|Study Suspended|0|||
25117059|NCT02452463|50228877|FG000|Overall Study|Recommended by DSMB|0|||
25117060|NCT02452463|50228878|FG001|Overall Study|Recommended by DSMB|1|||
25117061|NCT02452463|50228879|FG002|Overall Study|Recommended by DSMB|0|||
25117062|NCT02452463|50228877|FG000|Overall Study|Withdrawal by Subject|0|||
25117063|NCT02452463|50228878|FG001|Overall Study|Withdrawal by Subject|1|||
25117064|NCT02452463|50228879|FG002|Overall Study|Withdrawal by Subject|0|||
25117065|NCT02432105|50228890|FG000|Overall Study|Lost to Follow-up|1|||
25117066|NCT02432105|50228891|FG001|Overall Study|Lost to Follow-up|1|||
25117067|NCT02432105|50228892|FG002|Overall Study|Lost to Follow-up|0|||
25117068|NCT02432105|50228890|FG000|Overall Study|Withdrawal by Subject|1|||
25117069|NCT02432105|50228891|FG001|Overall Study|Withdrawal by Subject|0|||
25117070|NCT02432105|50228892|FG002|Overall Study|Withdrawal by Subject|1|||
25117071|NCT02432105|50228890|FG000|Overall Study|Culture positive for yeast|0|||
25117072|NCT02432105|50228891|FG001|Overall Study|Culture positive for yeast|1|||
25117073|NCT02432105|50228892|FG002|Overall Study|Culture positive for yeast|0|||
25117074|NCT02432105|50228890|FG000|Overall Study|Randomized in error|0|||
25117075|NCT02432105|50228891|FG001|Overall Study|Randomized in error|0|||
25117076|NCT02432105|50228892|FG002|Overall Study|Randomized in error|2|||
25117077|NCT02431793|50228904|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
25117078|NCT02431793|50228905|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
25117079|NCT02431793|50228906|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
25117080|NCT02431793|50228904|FG000|Overall Study|Withdrawal by Subject|7|||
25117081|NCT02431793|50228905|FG001|Overall Study|Withdrawal by Subject|5|||
25117082|NCT02431793|50228906|FG002|Overall Study|Withdrawal by Subject|5|||
25117083|NCT02431793|50228904|FG000|Overall Study|Lost to Follow-up|101|||
25117084|NCT02431793|50228905|FG001|Overall Study|Lost to Follow-up|122|||
25117085|NCT02431793|50228906|FG002|Overall Study|Lost to Follow-up|104|||
25117086|NCT01801930|50228918|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
25117087|NCT01801930|50228919|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
25117088|NCT01801930|50228920|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
25117089|NCT01801930|50228921|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
25117090|NCT01801930|50228918|FG000|Overall Study|DLT occurs|0|||
25117091|NCT01801930|50228919|FG001|Overall Study|DLT occurs|1|||
25117092|NCT01801930|50228920|FG002|Overall Study|DLT occurs|0|||
25117093|NCT01801930|50228921|FG003|Overall Study|DLT occurs|0|||
25117094|NCT01610206|50228933|FG000|Overall Study|Adverse Event|10|||
25117095|NCT01610206|50228934|FG001|Overall Study|Adverse Event|30|||
25117096|NCT01816048|50228940|FG000|Overall Study|Adverse Event|1|||
25117097|NCT01816048|50228940|FG000|Overall Study|Death|1|||
25117098|NCT01816048|50228940|FG000|Overall Study|Withdrawal by Subject|1|||
25261574|NCT01008553|50576237|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
25117099|NCT01816048|50228940|FG000|Overall Study|Disease Progression|3|||
25117100|NCT01612858|50228947|FG000|Overall Study|Withdrawal by Subject|5|||
25117101|NCT01612858|50228948|FG001|Overall Study|Withdrawal by Subject|1|||
25117102|NCT01612780|50228954|FG000|Overall Study|Treatment not completed|1|||
25117103|NCT01612780|50228954|FG000|Overall Study|Withdrawal by Subject|5|||
25117104|NCT01612702|50228960|FG000|Overall Study|Protocol Violation|11|||
25117105|NCT01612702|50228961|FG001|Overall Study|Protocol Violation|11|||
25117106|NCT02431559|50228971|FG000|Overall Study|Adverse Event|0|||
25117107|NCT02431559|50228972|FG001|Overall Study|Adverse Event|1|||
25117108|NCT02431559|50228973|FG002|Overall Study|Adverse Event|0|||
25117109|NCT02431559|50228974|FG003|Overall Study|Adverse Event|4|||
25117110|NCT02431559|50228971|FG000|Overall Study|Progressive disease|2|||
25117111|NCT02431559|50228972|FG001|Overall Study|Progressive disease|1|||
25117112|NCT02431559|50228973|FG002|Overall Study|Progressive disease|4|||
25117113|NCT02431559|50228974|FG003|Overall Study|Progressive disease|22|||
25117114|NCT02431559|50228971|FG000|Overall Study|Withdrawal by Subject|0|||
25117115|NCT02431559|50228972|FG001|Overall Study|Withdrawal by Subject|1|||
25117116|NCT02431559|50228973|FG002|Overall Study|Withdrawal by Subject|0|||
25117117|NCT02431559|50228974|FG003|Overall Study|Withdrawal by Subject|4|||
25117118|NCT02431559|50228971|FG000|Overall Study|Physician Decision|0|||
25117119|NCT02431559|50228972|FG001|Overall Study|Physician Decision|0|||
25117120|NCT02431559|50228973|FG002|Overall Study|Physician Decision|0|||
25117121|NCT02431559|50228974|FG003|Overall Study|Physician Decision|1|||
25117122|NCT02388269|50228988|FG000|Overall Study|Adverse Event|2|||
25117123|NCT02388269|50228989|FG001|Overall Study|Adverse Event|0|||
25117124|NCT02388269|50228990|FG002|Overall Study|Adverse Event|0|||
25117125|NCT02388269|50228988|FG000|Overall Study|Withdrawal by Subject|1|||
25117126|NCT02388269|50228989|FG001|Overall Study|Withdrawal by Subject|2|||
25117127|NCT02388269|50228990|FG002|Overall Study|Withdrawal by Subject|0|||
25117128|NCT02388269|50228988|FG000|Overall Study|less than 50% stimulations|1|||
25117129|NCT02388269|50228989|FG001|Overall Study|less than 50% stimulations|0|||
25117130|NCT02388269|50228990|FG002|Overall Study|less than 50% stimulations|0|||
25117131|NCT02388269|50228988|FG000|Overall Study|no diary data|3|||
25117132|NCT02388269|50228989|FG001|Overall Study|no diary data|0|||
25117133|NCT02388269|50228990|FG002|Overall Study|no diary data|0|||
25117134|NCT02388269|50228988|FG000|Overall Study|Protocol Violation|2|||
25117135|NCT02388269|50228989|FG001|Overall Study|Protocol Violation|0|||
25117136|NCT02388269|50228990|FG002|Overall Study|Protocol Violation|0|||
25117137|NCT02388269|50228988|FG000|Overall Study|Screen Failure|0|||
25117138|NCT02388269|50228989|FG001|Overall Study|Screen Failure|0|||
25117139|NCT02388269|50228990|FG002|Overall Study|Screen Failure|10|||
25117140|NCT01652573|50229016|FG000|Overall Study|Adverse Event|0|||
25117141|NCT01652573|50229017|FG001|Overall Study|Adverse Event|1|||
25117142|NCT02388191|50229025|FG000|Overall Study|Patient did not receive IUD|1|||
25117143|NCT02388191|50229026|FG001|Overall Study|Patient did not receive IUD|0|||
25117144|NCT01815736|50229034|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
25117145|NCT01815736|50229035|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
25117146|NCT01815736|50229034|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
25117147|NCT01815736|50229035|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
25117148|NCT01815736|50229034|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
25117149|NCT01815736|50229035|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
25117150|NCT01815736|50229034|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
25117151|NCT01815736|50229035|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
25117152|NCT01815736|50229034|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
25117153|NCT01815736|50229035|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
25117154|NCT01815736|50229034|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
25117155|NCT01815736|50229035|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
25117156|NCT01815736|50229034|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
25117157|NCT01815736|50229035|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
25117158|NCT01815736|50229034|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
25117159|NCT01815736|50229035|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
25117160|NCT01815736|50229034|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
25117161|NCT01815736|50229035|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
25117162|NCT01815736|50229034|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
25117163|NCT01815736|50229035|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
25117164|NCT01815736|50229034|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
25117165|NCT01815736|50229035|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
25117166|NCT01815736|50229034|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
25117167|NCT01815736|50229035|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
25117168|NCT01815736|50229034|FG000|Extension Treatment Phase- After Week 96|Death|1|||
25117169|NCT01815736|50229035|FG001|Extension Treatment Phase- After Week 96|Death|0|||
25117170|NCT01651949|50229046|FG000|Overall Study|Unknown status|4|||
25117171|NCT01651949|50229047|FG001|Overall Study|Unknown status|4|||
25117172|NCT01651949|50229048|FG002|Overall Study|Unknown status|0|||
25117173|NCT01651949|50229046|FG000|Overall Study|Lost to Follow-up|30|||
25117174|NCT01651949|50229047|FG001|Overall Study|Lost to Follow-up|56|||
25117175|NCT01651949|50229048|FG002|Overall Study|Lost to Follow-up|20|||
25117176|NCT01651949|50229046|FG000|Overall Study|Protocol Violation|0|||
25117177|NCT01651949|50229047|FG001|Overall Study|Protocol Violation|2|||
25117178|NCT01651949|50229048|FG002|Overall Study|Protocol Violation|1|||
25117179|NCT01651949|50229046|FG000|Overall Study|Physician Decision|0|||
25117180|NCT01651949|50229047|FG001|Overall Study|Physician Decision|2|||
25117181|NCT01651949|50229048|FG002|Overall Study|Physician Decision|0|||
25117182|NCT01651949|50229046|FG000|Overall Study|Adverse Event|0|||
25117183|NCT01651949|50229047|FG001|Overall Study|Adverse Event|2|||
25117184|NCT01651949|50229048|FG002|Overall Study|Adverse Event|1|||
25117185|NCT01651949|50229046|FG000|Overall Study|Screen failure|2|||
25117186|NCT01651949|50229047|FG001|Overall Study|Screen failure|2|||
25117187|NCT01651949|50229048|FG002|Overall Study|Screen failure|0|||
25117188|NCT01651949|50229046|FG000|Overall Study|Withdrawal by Subject|17|||
25117189|NCT01651949|50229047|FG001|Overall Study|Withdrawal by Subject|18|||
25117190|NCT01651949|50229048|FG002|Overall Study|Withdrawal by Subject|9|||
25117191|NCT02387957|50229059|FG000|Overall Study|The study was discontinued|21|||
25117192|NCT02387957|50229060|FG001|Overall Study|The study was discontinued|21|||
25117193|NCT02387957|50229061|FG002|Overall Study|The study was discontinued|20|||
25117194|NCT01800916|50229069|FG000|Test Period 1 (1 Week)|Convex product user|0|||
25117195|NCT01800916|50229070|FG001|Test Period 1 (1 Week)|Convex product user|0|||
25117196|NCT01800916|50229071|FG002|Test Period 1 (1 Week)|Convex product user|0|||
25117197|NCT01800916|50229072|FG003|Test Period 1 (1 Week)|Convex product user|1|||
25117198|NCT01800916|50229073|FG004|Test Period 1 (1 Week)|Convex product user|0|||
25117199|NCT01800916|50229074|FG005|Test Period 1 (1 Week)|Convex product user|0|||
25117200|NCT01800916|50229075|FG006|Test Period 1 (1 Week)|Convex product user|0|||
25117201|NCT01800916|50229076|FG007|Test Period 1 (1 Week)|Convex product user|0|||
25117202|NCT01800916|50229077|FG008|Test Period 1 (1 Week)|Convex product user|0|||
25117203|NCT01800916|50229069|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
25117204|NCT01800916|50229070|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
25117205|NCT01800916|50229071|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
25117206|NCT01800916|50229072|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
25117207|NCT01800916|50229073|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
25117208|NCT01800916|50229074|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
25117209|NCT01800916|50229075|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
25117210|NCT01800916|50229076|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
25117211|NCT01800916|50229077|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
25117212|NCT01800058|50229087|FG000|Overall Study|Lost to Follow-up|1|||
25117213|NCT01815580|50229094|FG000|Overall Study|Lost to Follow-up|4|||
25117214|NCT01815580|50229095|FG001|Overall Study|Lost to Follow-up|7|||
25117215|NCT01815580|50229094|FG000|Overall Study|Withdrawal by Subject|3|||
25117216|NCT01815580|50229095|FG001|Overall Study|Withdrawal by Subject|4|||
25117217|NCT01815580|50229094|FG000|Overall Study|Excluded from analysis|5|||
25117218|NCT01815580|50229095|FG001|Overall Study|Excluded from analysis|4|||
25117219|NCT01651403|50229108|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
25117220|NCT01651403|50229109|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
25117221|NCT01651403|50229108|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
25117222|NCT01651403|50229109|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
25117223|NCT01651403|50229108|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
25117224|NCT01651403|50229109|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
25117225|NCT01651403|50229108|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
25117226|NCT01651403|50229109|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
25117227|NCT01651403|50229108|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
25117228|NCT01651403|50229109|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
25117229|NCT01651403|50229108|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
25117230|NCT01651403|50229109|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
25117231|NCT01799590|50229123|FG000|Overall Study|Adverse Event|13|||
25117232|NCT01799590|50229124|FG001|Overall Study|Adverse Event|7|||
25117233|NCT01799590|50229125|FG002|Overall Study|Adverse Event|5|||
25261575|NCT01008553|50576238|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
25117234|NCT01799590|50229123|FG000|Overall Study|Pregnancy|2|||
25117235|NCT01799590|50229124|FG001|Overall Study|Pregnancy|0|||
25117236|NCT01799590|50229125|FG002|Overall Study|Pregnancy|0|||
25117237|NCT01799590|50229123|FG000|Overall Study|Lack of Efficacy|3|||
25117238|NCT01799590|50229124|FG001|Overall Study|Lack of Efficacy|1|||
25117239|NCT01799590|50229125|FG002|Overall Study|Lack of Efficacy|3|||
25117240|NCT01799590|50229123|FG000|Overall Study|Participants convenience|4|||
25117241|NCT01799590|50229124|FG001|Overall Study|Participants convenience|4|||
25117242|NCT01799590|50229125|FG002|Overall Study|Participants convenience|2|||
25117243|NCT01799590|50229123|FG000|Overall Study|Aggravation of complications|0|||
25117244|NCT01799590|50229124|FG001|Overall Study|Aggravation of complications|1|||
25117245|NCT01799590|50229125|FG002|Overall Study|Aggravation of complications|1|||
25117246|NCT01799590|50229123|FG000|Overall Study|Using drugs with restricted days of use|0|||
25117247|NCT01799590|50229124|FG001|Overall Study|Using drugs with restricted days of use|3|||
25117248|NCT01799590|50229125|FG002|Overall Study|Using drugs with restricted days of use|2|||
25117249|NCT01799590|50229123|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
25117250|NCT01799590|50229124|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
25117251|NCT01799590|50229125|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
25117252|NCT01799590|50229123|FG000|Overall Study|Other|3|||
25117253|NCT01799590|50229124|FG001|Overall Study|Other|0|||
25117254|NCT01799590|50229125|FG002|Overall Study|Other|1|||
25117255|NCT01815424|50229136|FG000|Week 0 to 16|Adverse Event|1|||
25117256|NCT01815424|50229137|FG001|Week 0 to 16|Adverse Event|3|||
25117257|NCT01815424|50229138|FG002|Week 0 to 16|Adverse Event|3|||
25117258|NCT01815424|50229139|FG003|Week 0 to 16|Adverse Event|0|||
25117259|NCT01815424|50229140|FG004|Week 0 to 16|Adverse Event|0|||
25117260|NCT01815424|50229136|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
25117261|NCT01815424|50229137|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
25117262|NCT01815424|50229138|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
25117263|NCT01815424|50229139|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
25117264|NCT01815424|50229140|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
25117265|NCT01815424|50229136|FG000|Week 0 to 16|Lost to Follow-up|0|||
25117266|NCT01815424|50229137|FG001|Week 0 to 16|Lost to Follow-up|1|||
25117267|NCT01815424|50229138|FG002|Week 0 to 16|Lost to Follow-up|0|||
25117268|NCT01815424|50229139|FG003|Week 0 to 16|Lost to Follow-up|0|||
25117269|NCT01815424|50229140|FG004|Week 0 to 16|Lost to Follow-up|0|||
25117270|NCT01815424|50229136|FG000|Week 0 to 16|Withdrawal by Subject|0|||
25117271|NCT01815424|50229137|FG001|Week 0 to 16|Withdrawal by Subject|0|||
25117272|NCT01815424|50229138|FG002|Week 0 to 16|Withdrawal by Subject|1|||
25117273|NCT01815424|50229139|FG003|Week 0 to 16|Withdrawal by Subject|0|||
25117274|NCT01815424|50229140|FG004|Week 0 to 16|Withdrawal by Subject|0|||
25117275|NCT01815424|50229136|FG000|Week 0 to 16|Other|1|||
25117276|NCT01815424|50229137|FG001|Week 0 to 16|Other|0|||
25117277|NCT01815424|50229138|FG002|Week 0 to 16|Other|3|||
25117278|NCT01815424|50229139|FG003|Week 0 to 16|Other|0|||
25117279|NCT01815424|50229140|FG004|Week 0 to 16|Other|0|||
25117280|NCT01815424|50229136|FG000|Week 0 to 16|Protocol Violation|1|||
25117281|NCT01815424|50229137|FG001|Week 0 to 16|Protocol Violation|0|||
25117282|NCT01815424|50229138|FG002|Week 0 to 16|Protocol Violation|0|||
25117283|NCT01815424|50229139|FG003|Week 0 to 16|Protocol Violation|0|||
25117284|NCT01815424|50229140|FG004|Week 0 to 16|Protocol Violation|0|||
25117285|NCT01815424|50229136|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
25117286|NCT01815424|50229137|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
25117287|NCT01815424|50229138|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
25117288|NCT01815424|50229139|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
25117289|NCT01815424|50229140|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
25117290|NCT01815424|50229136|FG000|Week 16 to 52|Other|0|||
25117291|NCT01815424|50229137|FG001|Week 16 to 52|Other|1|||
25117292|NCT01815424|50229138|FG002|Week 16 to 52|Other|0|||
25117293|NCT01815424|50229139|FG003|Week 16 to 52|Other|0|||
25117294|NCT01815424|50229140|FG004|Week 16 to 52|Other|0|||
25117295|NCT01815424|50229136|FG000|Week 16 to 52|Adverse Event|0|||
25117296|NCT01815424|50229137|FG001|Week 16 to 52|Adverse Event|0|||
25117297|NCT01815424|50229138|FG002|Week 16 to 52|Adverse Event|0|||
25117298|NCT01815424|50229139|FG003|Week 16 to 52|Adverse Event|0|||
25117299|NCT01815424|50229140|FG004|Week 16 to 52|Adverse Event|1|||
25117300|NCT01815424|50229136|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
25117301|NCT01815424|50229137|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
25117302|NCT01815424|50229138|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
25117303|NCT01815424|50229139|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
25117304|NCT01815424|50229140|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
25117305|NCT01815424|50229136|FG000|Week 16 to 52|Lost to Follow-up|0|||
25117306|NCT01815424|50229137|FG001|Week 16 to 52|Lost to Follow-up|2|||
25117307|NCT01815424|50229138|FG002|Week 16 to 52|Lost to Follow-up|0|||
25117308|NCT01815424|50229139|FG003|Week 16 to 52|Lost to Follow-up|2|||
25117309|NCT01815424|50229140|FG004|Week 16 to 52|Lost to Follow-up|1|||
25117310|NCT01815424|50229136|FG000|Week 16 to 52|Withdrawal by Subject|1|||
25117311|NCT01815424|50229137|FG001|Week 16 to 52|Withdrawal by Subject|2|||
25117312|NCT01815424|50229138|FG002|Week 16 to 52|Withdrawal by Subject|0|||
25117313|NCT01815424|50229139|FG003|Week 16 to 52|Withdrawal by Subject|0|||
25117314|NCT01815424|50229140|FG004|Week 16 to 52|Withdrawal by Subject|0|||
25117315|NCT02431247|50229155|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
25117316|NCT02431247|50229156|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
25117317|NCT02431247|50229157|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
25117318|NCT02431247|50229155|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
25117319|NCT02431247|50229156|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
25117320|NCT02431247|50229157|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
25117321|NCT02431247|50229155|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
25117322|NCT02431247|50229156|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
25117323|NCT02431247|50229157|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
25117324|NCT02431247|50229155|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
25117325|NCT02431247|50229156|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
25117326|NCT02431247|50229157|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
25117327|NCT02431247|50229155|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
25117328|NCT02431247|50229156|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
25117329|NCT02431247|50229157|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
25117330|NCT02431247|50229155|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
25117331|NCT02431247|50229156|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
25117332|NCT02431247|50229157|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
25117333|NCT02431247|50229155|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
25117334|NCT02431247|50229156|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
25117335|NCT02431247|50229157|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
25117336|NCT02431247|50229155|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
25117337|NCT02431247|50229156|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
25117338|NCT02431247|50229157|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
25117339|NCT02431247|50229155|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
25117340|NCT02431247|50229156|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
25117341|NCT02431247|50229157|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
25117342|NCT02431247|50229155|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
25117343|NCT02431247|50229156|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
25117344|NCT02431247|50229157|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
25117345|NCT02431247|50229155|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
25117346|NCT02431247|50229156|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
25117347|NCT02431247|50229157|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
25117348|NCT02431247|50229155|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
25117349|NCT02431247|50229156|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
25117350|NCT02431247|50229157|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
25117351|NCT02431247|50229155|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
25117352|NCT02431247|50229156|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
25117353|NCT02431247|50229157|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
25117354|NCT02431247|50229155|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
25117355|NCT02431247|50229156|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
25117356|NCT02431247|50229157|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
25117357|NCT01814878|50229171|FG000|Overall Study|Adverse Event|16|||
25117358|NCT01814878|50229172|FG001|Overall Study|Adverse Event|5|||
25117359|NCT01814878|50229171|FG000|Overall Study|Withdrawal by Subject|20|||
25117360|NCT01814878|50229172|FG001|Overall Study|Withdrawal by Subject|16|||
25117361|NCT01814878|50229171|FG000|Overall Study|Protocol Violation|5|||
25117362|NCT01814878|50229172|FG001|Overall Study|Protocol Violation|5|||
25117363|NCT01814878|50229171|FG000|Overall Study|Physician Decision|3|||
25117364|NCT01814878|50229172|FG001|Overall Study|Physician Decision|1|||
25117365|NCT01814878|50229171|FG000|Overall Study|Screening failure (drop-out)|0|||
25117366|NCT01814878|50229172|FG001|Overall Study|Screening failure (drop-out)|3|||
25117367|NCT01814878|50229171|FG000|Overall Study|Other|2|||
25117368|NCT01814878|50229172|FG001|Overall Study|Other|0|||
25117369|NCT02407457|50229180|FG000|1 Month|Death|3|||
25117370|NCT02407457|50229181|FG001|1 Month|Death|0|||
25117371|NCT02407457|50229180|FG000|1 Month|Lost to Follow-up|1|||
25117372|NCT02407457|50229181|FG001|1 Month|Lost to Follow-up|1|||
25117373|NCT02407457|50229180|FG000|1 Month|missed visit|2|||
25117374|NCT02407457|50229181|FG001|1 Month|missed visit|6|||
25117375|NCT02407457|50229180|FG000|6-Month|Death|2|||
25117376|NCT02407457|50229181|FG001|6-Month|Death|8|||
25117377|NCT02407457|50229180|FG000|6-Month|Lost to Follow-up|2|||
25117378|NCT02407457|50229181|FG001|6-Month|Lost to Follow-up|2|||
25117379|NCT02407457|50229180|FG000|6-Month|missed visit|15|||
25117380|NCT02407457|50229181|FG001|6-Month|missed visit|12|||
25117381|NCT02407457|50229180|FG000|6-Month|Over Due|1|||
25117382|NCT02407457|50229181|FG001|6-Month|Over Due|2|||
25117383|NCT02407457|50229180|FG000|6-Month|Open Repair|0|||
25117384|NCT02407457|50229181|FG001|6-Month|Open Repair|1|||
25117385|NCT02407457|50229180|FG000|1 Year|Death|6|||
25117386|NCT02407457|50229181|FG001|1 Year|Death|11|||
25117387|NCT02407457|50229180|FG000|1 Year|Lost to Follow-up|3|||
25117388|NCT02407457|50229181|FG001|1 Year|Lost to Follow-up|2|||
25117389|NCT02407457|50229180|FG000|1 Year|Missed Visit|18|||
25117390|NCT02407457|50229181|FG001|1 Year|Missed Visit|10|||
25117391|NCT02407457|50229180|FG000|1 Year|Over Due|6|||
25117392|NCT02407457|50229181|FG001|1 Year|Over Due|4|||
25117393|NCT02407457|50229180|FG000|1 Year|Open Repair|0|||
25117394|NCT02407457|50229181|FG001|1 Year|Open Repair|1|||
25117395|NCT02407457|50229180|FG000|2-year|Death|14|||
25177429|NCT02754141|50321524|FG017|Overall Study|Maximum clinical benefit|0|||
25117396|NCT02407457|50229181|FG001|2-year|Death|8|||
25117397|NCT02407457|50229180|FG000|2-year|Lost to Follow-up|6|||
25117398|NCT02407457|50229181|FG001|2-year|Lost to Follow-up|9|||
25117399|NCT02407457|50229180|FG000|2-year|Missed Visit|13|||
25117400|NCT02407457|50229181|FG001|2-year|Missed Visit|11|||
25117401|NCT02407457|50229180|FG000|2-year|Over Due|1|||
25117402|NCT02407457|50229181|FG001|2-year|Over Due|5|||
25117403|NCT02407457|50229180|FG000|2-year|Open Repair|0|||
25117404|NCT02407457|50229181|FG001|2-year|Open Repair|2|||
25117405|NCT02407457|50229180|FG000|3-year|Death|11|||
25117406|NCT02407457|50229181|FG001|3-year|Death|10|||
25117407|NCT02407457|50229180|FG000|3-year|Lost to Follow-up|6|||
25117408|NCT02407457|50229181|FG001|3-year|Lost to Follow-up|9|||
25117409|NCT02407457|50229180|FG000|3-year|Missed Visit|21|||
25117410|NCT02407457|50229181|FG001|3-year|Missed Visit|16|||
25117411|NCT02407457|50229180|FG000|3-year|Over Due|4|||
25117412|NCT02407457|50229181|FG001|3-year|Over Due|3|||
25117413|NCT02407457|50229180|FG000|4-year|Death|14|||
25117414|NCT02407457|50229181|FG001|4-year|Death|7|||
25117415|NCT02407457|50229180|FG000|4-year|Lost to Follow-up|9|||
25117416|NCT02407457|50229181|FG001|4-year|Lost to Follow-up|12|||
25117417|NCT02407457|50229180|FG000|4-year|Over Due|10|||
25117418|NCT02407457|50229181|FG001|4-year|Over Due|5|||
25117419|NCT02407457|50229180|FG000|4-year|Missed Visit|13|||
25117420|NCT02407457|50229181|FG001|4-year|Missed Visit|13|||
25117421|NCT02407457|50229180|FG000|4-year|Pending visit|19|||
25117422|NCT02407457|50229181|FG001|4-year|Pending visit|14|||
25117423|NCT02407457|50229180|FG000|4-year|Not Due|16|||
25117424|NCT02407457|50229181|FG001|4-year|Not Due|10|||
25117425|NCT02407457|50229180|FG000|5-year|Death|6|||
25117426|NCT02407457|50229181|FG001|5-year|Death|1|||
25117427|NCT02407457|50229180|FG000|5-year|Lost to Follow-up|4|||
25117428|NCT02407457|50229181|FG001|5-year|Lost to Follow-up|4|||
25117429|NCT02407457|50229180|FG000|5-year|Missed Visit|10|||
25117430|NCT02407457|50229181|FG001|5-year|Missed Visit|9|||
25117431|NCT02407457|50229180|FG000|5-year|Pending Visit|18|||
25117432|NCT02407457|50229181|FG001|5-year|Pending Visit|17|||
25117433|NCT02407457|50229180|FG000|5-year|Not Due|54|||
25117434|NCT02407457|50229181|FG001|5-year|Not Due|46|||
25117435|NCT01814800|50229187|FG000|Overall Study|Adverse Event|2|||
25117436|NCT01814800|50229187|FG000|Overall Study|Pregnancy|1|||
25117437|NCT01814800|50229187|FG000|Overall Study|Sponsor decision|1|||
25117438|NCT01814800|50229187|FG000|Overall Study|Subject relocation|1|||
25117439|NCT01814332|50229193|FG000|Overall Study|Adverse Event|8|||
25117440|NCT01814332|50229194|FG001|Overall Study|Adverse Event|3|||
25117441|NCT01814332|50229193|FG000|Overall Study|Withdrawal by Subject|3|||
25117442|NCT01814332|50229194|FG001|Overall Study|Withdrawal by Subject|8|||
25117443|NCT01814332|50229193|FG000|Overall Study|Protocol Violation|0|||
25117444|NCT01814332|50229194|FG001|Overall Study|Protocol Violation|4|||
25117445|NCT01814332|50229193|FG000|Overall Study|Lost to Follow-up|5|||
25117446|NCT01814332|50229194|FG001|Overall Study|Lost to Follow-up|1|||
25117447|NCT02407223|50229203|FG000|Overall Study|Adverse Event|1|||
25117448|NCT02407223|50229204|FG001|Overall Study|Adverse Event|0|||
25117449|NCT02407223|50229205|FG002|Overall Study|Adverse Event|1|||
25117450|NCT02407223|50229203|FG000|Overall Study|Lack of Efficacy|6|||
25117451|NCT02407223|50229204|FG001|Overall Study|Lack of Efficacy|6|||
25117452|NCT02407223|50229205|FG002|Overall Study|Lack of Efficacy|4|||
25117453|NCT02407223|50229203|FG000|Overall Study|Lost to Follow-up|1|||
25117454|NCT02407223|50229204|FG001|Overall Study|Lost to Follow-up|0|||
25117455|NCT02407223|50229205|FG002|Overall Study|Lost to Follow-up|2|||
25117456|NCT02407223|50229203|FG000|Overall Study|Withdrawal by Subject|2|||
25117457|NCT02407223|50229204|FG001|Overall Study|Withdrawal by Subject|4|||
25117458|NCT02407223|50229205|FG002|Overall Study|Withdrawal by Subject|4|||
25117459|NCT02407223|50229203|FG000|Overall Study|Study Terminated by Sponsor|77|||
25117460|NCT02407223|50229204|FG001|Overall Study|Study Terminated by Sponsor|80|||
25117461|NCT02407223|50229205|FG002|Overall Study|Study Terminated by Sponsor|86|||
25117462|NCT02407223|50229203|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
25117463|NCT02407223|50229204|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
25117464|NCT02407223|50229205|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
25117465|NCT02407223|50229203|FG000|Overall Study|Other|29|||
25117466|NCT02407223|50229204|FG001|Overall Study|Other|27|||
25117467|NCT02407223|50229205|FG002|Overall Study|Other|25|||
25117468|NCT01797562|50229215|FG000|Overall Study|Protocol Violation|5|||
25117469|NCT01813474|50229223|FG000|Overall Study|Withdrawal by Subject|0|||
25117470|NCT01813474|50229224|FG001|Overall Study|Withdrawal by Subject|0|||
25117471|NCT01813474|50229225|FG002|Overall Study|Withdrawal by Subject|1|||
25117472|NCT01813474|50229223|FG000|Overall Study|Adverse Event|1|||
25117473|NCT01813474|50229224|FG001|Overall Study|Adverse Event|1|||
25117474|NCT01813474|50229225|FG002|Overall Study|Adverse Event|0|||
25117475|NCT01813474|50229223|FG000|Overall Study|Lack of Efficacy|2|||
25117476|NCT01813474|50229224|FG001|Overall Study|Lack of Efficacy|6|||
25117477|NCT01813474|50229225|FG002|Overall Study|Lack of Efficacy|9|||
25117478|NCT01813474|50229223|FG000|Overall Study|Death|0|||
25117479|NCT01813474|50229224|FG001|Overall Study|Death|0|||
25117480|NCT01813474|50229225|FG002|Overall Study|Death|1|||
25117481|NCT01868542|50229236|FG000|Overall Study|Protocol Violation|0|||
25117482|NCT01868542|50229237|FG001|Overall Study|Protocol Violation|1|||
25117483|NCT01868542|50229236|FG000|Overall Study|Unclassified|0|||
25117484|NCT01868542|50229237|FG001|Overall Study|Unclassified|1|||
25117485|NCT01797094|50229245|FG000|Overall Study|Adverse Event|1|||
25117486|NCT01797094|50229246|FG001|Overall Study|Adverse Event|1|||
25117487|NCT01797094|50229245|FG000|Overall Study|Personal Reasons|4|||
25117488|NCT01797094|50229246|FG001|Overall Study|Personal Reasons|0|||
25117489|NCT01797094|50229245|FG000|Overall Study|Protocol Violation|0|||
25117490|NCT01797094|50229246|FG001|Overall Study|Protocol Violation|1|||
25117491|NCT01797094|50229245|FG000|Overall Study|Other Miscellaneous Reasons|1|||
25117492|NCT01797094|50229246|FG001|Overall Study|Other Miscellaneous Reasons|0|||
25117493|NCT02383589|50229254|FG000|Treatment Period|Adverse Event|1|||
25117494|NCT02383589|50229255|FG001|Treatment Period|Adverse Event|3|||
25117495|NCT02383589|50229254|FG000|Treatment Period|Lost to Follow-up|0|||
25117496|NCT02383589|50229255|FG001|Treatment Period|Lost to Follow-up|1|||
25117497|NCT02383589|50229254|FG000|Treatment Period|Withdrawal by Subject|0|||
25117498|NCT02383589|50229255|FG001|Treatment Period|Withdrawal by Subject|5|||
25117499|NCT02383589|50229254|FG000|Treatment Period|Non-compliance with study drug|0|||
25117500|NCT02383589|50229255|FG001|Treatment Period|Non-compliance with study drug|1|||
25117501|NCT02383589|50229254|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
25117502|NCT02383589|50229255|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
25117503|NCT02383589|50229254|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
25117504|NCT02383589|50229255|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
25117505|NCT02383589|50229254|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
25117506|NCT02383589|50229255|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
25117507|NCT01810432|50229263|FG000|Washout|Protocol Violation|0|||
25117508|NCT01810432|50229264|FG001|Washout|Protocol Violation|1|||
25117509|NCT01810432|50229263|FG000|Washout|Adverse Event|1|||
25117510|NCT01810432|50229264|FG001|Washout|Adverse Event|0|||
25117511|NCT01810432|50229263|FG000|Period 2|Withdrawal by Subject|2|||
25117512|NCT01810432|50229264|FG001|Period 2|Withdrawal by Subject|1|||
25117513|NCT01810432|50229263|FG000|Period 2|Physician Decision|1|||
25117514|NCT01810432|50229264|FG001|Period 2|Physician Decision|0|||
25117515|NCT01810432|50229263|FG000|Period 2|Lost to Follow-up|1|||
25117516|NCT01810432|50229264|FG001|Period 2|Lost to Follow-up|1|||
25117517|NCT01796860|50229270|FG000|Overall Study|Withdrawal by Subject|3|||
25117518|NCT01796548|50229274|FG000|Overall Study|Lost to Follow-up|1|||
25117519|NCT01796548|50229274|FG000|Overall Study|Other|2|||
25117520|NCT02406677|50229280|FG000|Overall Study|Death|16|||
25117521|NCT02406677|50229281|FG001|Overall Study|Death|8|||
25117522|NCT02406677|50229280|FG000|Overall Study|Discharged without P2Y12|1|||
25117523|NCT02406677|50229281|FG001|Overall Study|Discharged without P2Y12|3|||
25117524|NCT02406677|50229280|FG000|Overall Study|Discharged on prasugrel|283|||
25117525|NCT02406677|50229281|FG001|Overall Study|Discharged on prasugrel|587|||
25117526|NCT02406677|50229280|FG000|Overall Study|Withdrawal by Subject|1|||
25117527|NCT02406677|50229281|FG001|Overall Study|Withdrawal by Subject|0|||
25117528|NCT02404805|50229297|FG000|Overall Study|Withdrawal by Subject|1|||
25117529|NCT02404805|50229298|FG001|Overall Study|Withdrawal by Subject|0|||
25117530|NCT02404805|50229299|FG002|Overall Study|Withdrawal by Subject|0|||
25117531|NCT02404805|50229300|FG003|Overall Study|Withdrawal by Subject|0|||
25117532|NCT02404805|50229301|FG004|Overall Study|Withdrawal by Subject|0|||
25117533|NCT02404805|50229302|FG005|Overall Study|Withdrawal by Subject|0|||
25117534|NCT02430311|50229313|FG000|Part A|Adverse Event|0|||
25117535|NCT02430311|50229314|FG001|Part A|Adverse Event|1|||
25117536|NCT02430311|50229313|FG000|Part A|Withdrawal by Subject|1|||
25117537|NCT02430311|50229314|FG001|Part A|Withdrawal by Subject|0|||
25117538|NCT02430311|50229313|FG000|Part B|Meet study-specific withdrawal criteria|6|||
25117539|NCT02430311|50229314|FG001|Part B|Meet study-specific withdrawal criteria|6|||
25177430|NCT02754141|50321507|FG000|Overall Study|No longer meets study criteria|0|||
25177431|NCT02754141|50321508|FG001|Overall Study|No longer meets study criteria|0|||
25177432|NCT02754141|50321509|FG002|Overall Study|No longer meets study criteria|0|||
25117540|NCT02430311|50229313|FG000|Part B|Withdrawal by Subject|2|||
25117541|NCT02430311|50229314|FG001|Part B|Withdrawal by Subject|2|||
25117542|NCT02430311|50229313|FG000|Part B|Adverse Event|1|||
25117543|NCT02430311|50229314|FG001|Part B|Adverse Event|0|||
25117544|NCT02430311|50229313|FG000|Part B|Death|1|||
25117545|NCT02430311|50229314|FG001|Part B|Death|0|||
25117546|NCT02383433|50229329|FG000|Overall Study|Disease progression|2|||
25117547|NCT02404649|50229335|FG000|Overall Study|Adverse Event|1|||
25117548|NCT02404649|50229336|FG001|Overall Study|Adverse Event|2|||
25117549|NCT02383355|50229344|FG000|Overall Study|Adverse Event|2|||
25117550|NCT02383355|50229345|FG001|Overall Study|Adverse Event|0|||
25117551|NCT02381795|50229351|FG000|Overall Study|Withdrawal by Subject|1|||
25117552|NCT02381795|50229351|FG000|Overall Study|Study Terminated|2|||
25117553|NCT02404493|50229357|FG000|Overall Study|Adverse Event|1|||
25117554|NCT02404493|50229358|FG001|Overall Study|Adverse Event|1|||
25117555|NCT02380859|50229366|FG000|Overall Study|Withdrawal by Subject|2|||
25117556|NCT02380859|50229367|FG001|Overall Study|Withdrawal by Subject|0|||
25117557|NCT02380703|50229375|FG000|Overall Study|Withdrawal by Subject|12|||
25117558|NCT02380703|50229376|FG001|Overall Study|Withdrawal by Subject|9|||
25117559|NCT02380703|50229375|FG000|Overall Study|Lost to Follow-up|12|||
25117560|NCT02380703|50229376|FG001|Overall Study|Lost to Follow-up|12|||
25117561|NCT02380703|50229375|FG000|Overall Study|Caregiver death|1|||
25117562|NCT02380703|50229376|FG001|Overall Study|Caregiver death|0|||
25117563|NCT02380703|50229375|FG000|Overall Study|Person with dementia (PWD) death|7|||
25117564|NCT02380703|50229376|FG001|Overall Study|Person with dementia (PWD) death|8|||
25117565|NCT02380703|50229375|FG000|Overall Study|Entered Long-term Care|4|||
25117566|NCT02380703|50229376|FG001|Overall Study|Entered Long-term Care|7|||
25117567|NCT02379923|50229382|FG000|Overall Study|Death|5|||
25117568|NCT02379221|50229389|FG000|Overall Study|Lost to Follow-up|1|||
25117569|NCT02404103|50229400|FG000|Overall Study|Adverse Event|1|||
25117570|NCT02404103|50229401|FG001|Overall Study|Adverse Event|0|||
25117571|NCT02404103|50229400|FG000|Overall Study|Lost to Follow-up|3|||
25117572|NCT02404103|50229401|FG001|Overall Study|Lost to Follow-up|3|||
25117573|NCT02404025|50229417|FG000|Overall Study|Adverse Event|1|||
25117574|NCT02404025|50229417|FG000|Overall Study|Lack of Efficacy|3|||
25117575|NCT02377817|50229423|FG000|Overall Study|Transportation/childcare barriers.|2|||
25117576|NCT02377817|50229424|FG001|Overall Study|Transportation/childcare barriers.|0|||
25117577|NCT02377817|50229423|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
25117578|NCT02377817|50229424|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
25117579|NCT02403635|50229432|FG000|Overall Study|Not eligible|9|||
25117580|NCT02402933|50229452|FG000|Overall Study|Withdrawal by Subject|4|||
25117581|NCT02402933|50229452|FG000|Overall Study|Discontinued; Site Termination|10|||
25117582|NCT01796470|50229461|FG000|Overall Study|Adverse Event|4|||
25117583|NCT01796470|50229462|FG001|Overall Study|Adverse Event|2|||
25117584|NCT01796470|50229463|FG002|Overall Study|Adverse Event|2|||
25117585|NCT01796470|50229464|FG003|Overall Study|Adverse Event|1|||
25117586|NCT01796470|50229465|FG004|Overall Study|Adverse Event|3|||
25117587|NCT01796470|50229461|FG000|Overall Study|Death|2|||
25117588|NCT01796470|50229462|FG001|Overall Study|Death|0|||
25117589|NCT01796470|50229463|FG002|Overall Study|Death|0|||
25117590|NCT01796470|50229464|FG003|Overall Study|Death|0|||
25117591|NCT01796470|50229465|FG004|Overall Study|Death|1|||
25117592|NCT01796470|50229461|FG000|Overall Study|Initiated New Therapy|9|||
25117593|NCT01796470|50229462|FG001|Overall Study|Initiated New Therapy|0|||
25117594|NCT01796470|50229463|FG002|Overall Study|Initiated New Therapy|0|||
25117595|NCT01796470|50229464|FG003|Overall Study|Initiated New Therapy|0|||
25117596|NCT01796470|50229465|FG004|Overall Study|Initiated New Therapy|2|||
25117597|NCT01796470|50229461|FG000|Overall Study|Lost to Follow-up|0|||
25117598|NCT01796470|50229462|FG001|Overall Study|Lost to Follow-up|1|||
25117599|NCT01796470|50229463|FG002|Overall Study|Lost to Follow-up|0|||
25117600|NCT01796470|50229464|FG003|Overall Study|Lost to Follow-up|0|||
25117601|NCT01796470|50229465|FG004|Overall Study|Lost to Follow-up|0|||
25117602|NCT01796470|50229461|FG000|Overall Study|Physician Decision|5|||
25117603|NCT01796470|50229462|FG001|Overall Study|Physician Decision|4|||
25117604|NCT01796470|50229463|FG002|Overall Study|Physician Decision|1|||
25117605|NCT01796470|50229464|FG003|Overall Study|Physician Decision|0|||
25117606|NCT01796470|50229465|FG004|Overall Study|Physician Decision|1|||
25117607|NCT01796470|50229461|FG000|Overall Study|Progressive Disease|7|||
25117608|NCT01796470|50229462|FG001|Overall Study|Progressive Disease|7|||
25117609|NCT01796470|50229463|FG002|Overall Study|Progressive Disease|3|||
25117610|NCT01796470|50229464|FG003|Overall Study|Progressive Disease|2|||
25117611|NCT01796470|50229465|FG004|Overall Study|Progressive Disease|0|||
25117612|NCT01796470|50229461|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
25117613|NCT01796470|50229462|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
25117614|NCT01796470|50229463|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
25117615|NCT01796470|50229464|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
25117616|NCT01796470|50229465|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
25117617|NCT01796470|50229461|FG000|Overall Study|Withdrawal by Subject|7|||
25117618|NCT01796470|50229462|FG001|Overall Study|Withdrawal by Subject|0|||
25117619|NCT01796470|50229463|FG002|Overall Study|Withdrawal by Subject|0|||
25117620|NCT01796470|50229464|FG003|Overall Study|Withdrawal by Subject|0|||
25117621|NCT01796470|50229465|FG004|Overall Study|Withdrawal by Subject|1|||
25117622|NCT01868074|50229483|FG000|Overall Study|Lost to Follow-up|3|||
25117623|NCT01868074|50229484|FG001|Overall Study|Lost to Follow-up|2|||
25117624|NCT01868074|50229483|FG000|Overall Study|Withdrawal by Subject|4|||
25177433|NCT02754141|50321510|FG003|Overall Study|No longer meets study criteria|1|||
25117625|NCT01868074|50229484|FG001|Overall Study|Withdrawal by Subject|2|||
25117626|NCT01810042|50229490|FG000|Overall Study|Lost to Follow-up|10|||
25117627|NCT02424539|50229497|FG000|Overall Study|Adverse Event|0|||
25117628|NCT02424539|50229498|FG001|Overall Study|Adverse Event|0|||
25117629|NCT02424539|50229499|FG002|Overall Study|Adverse Event|1|||
25117630|NCT02424539|50229497|FG000|Overall Study|Physician Decision|0|||
25117631|NCT02424539|50229498|FG001|Overall Study|Physician Decision|0|||
25117632|NCT02424539|50229499|FG002|Overall Study|Physician Decision|1|||
25117633|NCT02424539|50229497|FG000|Overall Study|Withdrawal by Subject|3|||
25117634|NCT02424539|50229498|FG001|Overall Study|Withdrawal by Subject|1|||
25117635|NCT02424539|50229499|FG002|Overall Study|Withdrawal by Subject|0|||
25117636|NCT02424539|50229497|FG000|Overall Study|Other: Reached stopping criteria|11|||
25117637|NCT02424539|50229498|FG001|Overall Study|Other: Reached stopping criteria|7|||
25117638|NCT02424539|50229499|FG002|Overall Study|Other: Reached stopping criteria|6|||
25117639|NCT01809262|50229507|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
25117640|NCT01809262|50229508|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
25117641|NCT01809262|50229509|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
25117642|NCT01809262|50229510|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
25117643|NCT01809262|50229511|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
25117644|NCT01809262|50229512|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
25117645|NCT01809262|50229513|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
25117646|NCT01809262|50229514|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
25117647|NCT01809262|50229515|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
25117648|NCT01809262|50229516|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
25117649|NCT01809262|50229507|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
25117650|NCT01809262|50229508|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
25117651|NCT01809262|50229509|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
25117652|NCT01809262|50229510|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
25117653|NCT01809262|50229511|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
25117654|NCT01809262|50229512|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
25117655|NCT01809262|50229513|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
25117656|NCT01809262|50229514|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
25117657|NCT01809262|50229515|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
25117658|NCT01809262|50229516|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
25117659|NCT01808248|50229530|FG000|Overall Study|Lack of Efficacy|3|||
25117660|NCT01808248|50229530|FG000|Overall Study|Withdrawal by Subject|1|||
25117661|NCT01808248|50229530|FG000|Overall Study|Lost to Follow-up|1|||
25117662|NCT02424383|50229536|FG000|Overall Study|Withdrawal by Subject|32|||
25117663|NCT02424383|50229536|FG000|Overall Study|Death|170|||
25117664|NCT02424383|50229536|FG000|Overall Study|Sponsor's decision|3|||
25117665|NCT02424383|50229536|FG000|Overall Study|Investigator's decision|44|||
25117666|NCT02424383|50229536|FG000|Overall Study|Lost to Follow-up|81|||
25117667|NCT02424383|50229536|FG000|Overall Study|Other|7|||
25117668|NCT02424383|50229536|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
25117669|NCT01867294|50229544|FG000|Overall Study|Withdrawal by Subject|1|||
25117670|NCT01867294|50229545|FG001|Overall Study|Withdrawal by Subject|1|||
25117671|NCT01867294|50229546|FG002|Overall Study|Withdrawal by Subject|0|||
25117672|NCT01867294|50229547|FG003|Overall Study|Withdrawal by Subject|0|||
25117673|NCT02424149|50229557|FG000|Overall Study|surgery cancelled|2|||
25117674|NCT02424149|50229558|FG001|Overall Study|surgery cancelled|0|||
25117675|NCT02424149|50229557|FG000|Overall Study|Withdrawal by Subject|0|||
25117676|NCT02424149|50229558|FG001|Overall Study|Withdrawal by Subject|1|||
25117677|NCT02423291|50229564|FG000|Overall Study|Lack of Efficacy|14|||
25117678|NCT02423291|50229564|FG000|Overall Study|Adverse Event|1|||
25117679|NCT02401529|50229570|FG000|Overall Study|Lost to Follow-up|2|||
25117680|NCT02401529|50229571|FG001|Overall Study|Lost to Follow-up|1|||
25117681|NCT02401529|50229570|FG000|Overall Study|Physician Decision|2|||
25117682|NCT02401529|50229571|FG001|Overall Study|Physician Decision|6|||
25117683|NCT02401529|50229570|FG000|Overall Study|Protocol Violation|5|||
25117684|NCT02401529|50229571|FG001|Overall Study|Protocol Violation|0|||
25117685|NCT01867216|50229585|FG000|Overall Study|Withdrawal by Subject|2|||
25117686|NCT01867216|50229586|FG001|Overall Study|Withdrawal by Subject|0|||
25117687|NCT01867216|50229587|FG002|Overall Study|Withdrawal by Subject|0|||
25117688|NCT01867216|50229588|FG003|Overall Study|Withdrawal by Subject|0|||
25117689|NCT01867216|50229589|FG004|Overall Study|Withdrawal by Subject|1|||
25117690|NCT01867216|50229590|FG005|Overall Study|Withdrawal by Subject|0|||
25117691|NCT01867216|50229591|FG006|Overall Study|Withdrawal by Subject|1|||
25117692|NCT01867216|50229585|FG000|Overall Study|Physician Decision|1|||
25117693|NCT01867216|50229586|FG001|Overall Study|Physician Decision|0|||
25117694|NCT01867216|50229587|FG002|Overall Study|Physician Decision|0|||
25117695|NCT01867216|50229588|FG003|Overall Study|Physician Decision|0|||
25117696|NCT01867216|50229589|FG004|Overall Study|Physician Decision|0|||
25117697|NCT01867216|50229590|FG005|Overall Study|Physician Decision|0|||
25117698|NCT01867216|50229591|FG006|Overall Study|Physician Decision|0|||
25117699|NCT01867216|50229585|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
25117700|NCT01867216|50229586|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
25117701|NCT01867216|50229587|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
25117702|NCT01867216|50229588|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
25117703|NCT01867216|50229589|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
25117704|NCT01867216|50229590|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
25117705|NCT01867216|50229591|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
25117706|NCT01866826|50229613|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
25117707|NCT01866826|50229614|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
25117708|NCT01866826|50229613|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
25117709|NCT01866826|50229614|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
25117710|NCT01866826|50229613|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
25117711|NCT01866826|50229614|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
25117712|NCT01791244|50229631|FG000|Overall Study|Adverse Event|5|||
25117713|NCT01791244|50229632|FG001|Overall Study|Adverse Event|7|||
25117714|NCT01791244|50229631|FG000|Overall Study|Insufficient clinical response|10|||
25117715|NCT01791244|50229632|FG001|Overall Study|Insufficient clinical response|10|||
25117716|NCT01791244|50229631|FG000|Overall Study|Laboratory Abnormality|0|||
25117717|NCT01791244|50229632|FG001|Overall Study|Laboratory Abnormality|1|||
25117718|NCT01865812|50229640|FG000|Primary Treatment Phase|Adverse Event|2|||
25117719|NCT01865812|50229641|FG001|Primary Treatment Phase|Adverse Event|0|||
25117720|NCT01865812|50229640|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
25117721|NCT01865812|50229641|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
25117722|NCT01865812|50229640|FG000|Long-term Safety Extension Phase|Pruritus|0|||
25117723|NCT01865812|50229641|FG001|Long-term Safety Extension Phase|Pruritus|3|||
25117724|NCT01865812|50229640|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
25117725|NCT01865812|50229641|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
25117726|NCT01865812|50229640|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
25117727|NCT01865812|50229641|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
25117728|NCT01808092|50229650|FG000|Overall Study|Death|39|||
25117729|NCT01808092|50229651|FG001|Overall Study|Death|29|||
25117730|NCT01808092|50229650|FG000|Overall Study|Lost to Follow-up|3|||
25117731|NCT01808092|50229651|FG001|Overall Study|Lost to Follow-up|7|||
25117732|NCT01808092|50229650|FG000|Overall Study|Withdrawal by Subject|9|||
25117733|NCT01808092|50229651|FG001|Overall Study|Withdrawal by Subject|4|||
25117734|NCT01808092|50229650|FG000|Overall Study|Other Eligibility criteria|3|||
25117735|NCT01808092|50229651|FG001|Overall Study|Other Eligibility criteria|5|||
25117736|NCT01774084|50229659|FG000|Overall Study|Personal reasons|1|||
25117737|NCT01774084|50229660|FG001|Overall Study|Personal reasons|0|||
25117738|NCT01807234|50229672|FG000|Overall Study|Lost to Follow-up|2|||
25117739|NCT01807234|50229673|FG001|Overall Study|Lost to Follow-up|5|||
25117740|NCT01807234|50229674|FG002|Overall Study|Lost to Follow-up|1|||
25117741|NCT01807234|50229675|FG003|Overall Study|Lost to Follow-up|1|||
25117742|NCT01807234|50229676|FG004|Overall Study|Lost to Follow-up|1|||
25117743|NCT01807234|50229677|FG005|Overall Study|Lost to Follow-up|2|||
25117744|NCT01807234|50229672|FG000|Overall Study|Withdrawal by Subject|3|||
25117745|NCT01807234|50229673|FG001|Overall Study|Withdrawal by Subject|1|||
25117746|NCT01807234|50229674|FG002|Overall Study|Withdrawal by Subject|1|||
25117747|NCT01807234|50229675|FG003|Overall Study|Withdrawal by Subject|1|||
25117748|NCT01807234|50229676|FG004|Overall Study|Withdrawal by Subject|2|||
25117749|NCT01807234|50229677|FG005|Overall Study|Withdrawal by Subject|1|||
25117750|NCT01807234|50229672|FG000|Overall Study|Lack of Efficacy|0|||
25117751|NCT01807234|50229673|FG001|Overall Study|Lack of Efficacy|0|||
25117752|NCT01807234|50229674|FG002|Overall Study|Lack of Efficacy|0|||
25117753|NCT01807234|50229675|FG003|Overall Study|Lack of Efficacy|0|||
25117754|NCT01807234|50229676|FG004|Overall Study|Lack of Efficacy|1|||
25117755|NCT01807234|50229677|FG005|Overall Study|Lack of Efficacy|1|||
25117756|NCT01790932|50229687|FG000|Overall Study|Disease Progression|41|||
25117757|NCT01790932|50229687|FG000|Overall Study|Adverse Event|7|||
25117758|NCT01790932|50229687|FG000|Overall Study|Physician Decision|1|||
25117759|NCT01790932|50229687|FG000|Overall Study|Withdrawal by Subject|1|||
25117760|NCT02377427|50229693|FG000|Part A (Up to Week 20)|Physician Decision|1|||
25117761|NCT02377427|50229694|FG001|Part A (Up to Week 20)|Physician Decision|0|||
25117762|NCT02377427|50229695|FG002|Part A (Up to Week 20)|Physician Decision|0|||
25117763|NCT02377427|50229696|FG003|Part A (Up to Week 20)|Physician Decision|0|||
25117764|NCT02377427|50229697|FG004|Part A (Up to Week 20)|Physician Decision|0|||
25117765|NCT02377427|50229693|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
25117766|NCT02377427|50229694|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
25117767|NCT02377427|50229695|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
25117768|NCT02377427|50229696|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
25117769|NCT02377427|50229697|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
25117770|NCT02377427|50229693|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
25117771|NCT02377427|50229694|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
25117772|NCT02377427|50229695|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
25117773|NCT02377427|50229696|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
25117774|NCT02377427|50229697|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
25117775|NCT02377427|50229693|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
25117776|NCT02377427|50229694|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
25117777|NCT02377427|50229695|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
25168605|NCT00634101|50298154|FG001|Overall Study|Study Terminated|3|||
25117778|NCT02377427|50229696|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
25117779|NCT02377427|50229697|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
25117780|NCT02421887|50229712|FG000|Overall Study|Lost to Follow-up|5|||
25117781|NCT02421887|50229713|FG001|Overall Study|Lost to Follow-up|0|||
25117782|NCT02421887|50229712|FG000|Overall Study|Withdrawal by Subject|8|||
25117783|NCT02421887|50229713|FG001|Overall Study|Withdrawal by Subject|5|||
25117784|NCT02421887|50229712|FG000|Overall Study|Physician Decision|2|||
25117785|NCT02421887|50229713|FG001|Overall Study|Physician Decision|4|||
25117786|NCT02421887|50229712|FG000|Overall Study|Adverse Event|2|||
25117787|NCT02421887|50229713|FG001|Overall Study|Adverse Event|0|||
25117788|NCT01609582|50229721|FG000|Overall Study|Adverse Event|20|||
25117789|NCT01609582|50229722|FG001|Overall Study|Adverse Event|18|||
25117790|NCT01609582|50229721|FG000|Overall Study|Lost to Follow-up|10|||
25117791|NCT01609582|50229722|FG001|Overall Study|Lost to Follow-up|10|||
25117792|NCT01609582|50229721|FG000|Overall Study|Withdrawal by Subject|21|||
25117793|NCT01609582|50229722|FG001|Overall Study|Withdrawal by Subject|15|||
25117794|NCT01609582|50229721|FG000|Overall Study|Study Terminated by Sponsor|1543|||
25117795|NCT01609582|50229722|FG001|Overall Study|Study Terminated by Sponsor|1548|||
25117796|NCT01609582|50229721|FG000|Overall Study|Other|9|||
25117797|NCT01609582|50229722|FG001|Overall Study|Other|10|||
25117798|NCT01609582|50229721|FG000|Overall Study|Randomized, but not treated|0|||
25117799|NCT01609582|50229722|FG001|Overall Study|Randomized, but not treated|3|||
25117800|NCT01789606|50229730|FG000|Overall Study|Participant not Purchased the Product|0|||
25117801|NCT01789606|50229731|FG001|Overall Study|Participant not Purchased the Product|20|||
25117802|NCT01789606|50229730|FG000|Overall Study|Withdrawal by Subject|0|||
25117803|NCT01789606|50229731|FG001|Overall Study|Withdrawal by Subject|1|||
25117804|NCT01789606|50229730|FG000|Overall Study|Ineligible|6|||
25117805|NCT01789606|50229731|FG001|Overall Study|Ineligible|2|||
25117806|NCT01789606|50229730|FG000|Overall Study|Administrative Reasons|17|||
25117807|NCT01789606|50229731|FG001|Overall Study|Administrative Reasons|6|||
25117808|NCT01789606|50229730|FG000|Overall Study|No Study Medication Taken|0|||
25117809|NCT01789606|50229731|FG001|Overall Study|No Study Medication Taken|1|||
25117810|NCT01789606|50229730|FG000|Overall Study|Protocol Violation|0|||
25117811|NCT01789606|50229731|FG001|Overall Study|Protocol Violation|55|||
25117812|NCT01789606|50229730|FG000|Overall Study|Adverse Event|0|||
25117813|NCT01789606|50229731|FG001|Overall Study|Adverse Event|3|||
25117814|NCT01789606|50229730|FG000|Overall Study|Lost to Follow-up|0|||
25117815|NCT01789606|50229731|FG001|Overall Study|Lost to Follow-up|14|||
25117816|NCT01789606|50229730|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
25117817|NCT01789606|50229731|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
25117818|NCT01788358|50229736|FG000|Overall Study|Other|11|||
25117819|NCT01788358|50229736|FG000|Overall Study|Logistical difficulties|1|||
25117820|NCT01788358|50229736|FG000|Overall Study|Lost to Follow-up|5|||
25117821|NCT01788358|50229736|FG000|Overall Study|Protocol Violation|3|||
25117822|NCT01788358|50229736|FG000|Overall Study|Withdrawal by Subject|26|||
25117823|NCT01788358|50229736|FG000|Overall Study|Lack of Efficacy|1|||
25117824|NCT01788358|50229736|FG000|Overall Study|Adverse Event|51|||
25117825|NCT01773226|50229740|FG000|Overall Study|Withdrawal by Subject|1|||
25117826|NCT01773070|50229744|FG000|Overall Study|Withdrawal by Subject|24|||
25117827|NCT01773070|50229744|FG000|Overall Study|Lost to Follow-up|39|||
25117828|NCT01773070|50229744|FG000|Overall Study|Other|15|||
25117829|NCT01773070|50229744|FG000|Overall Study|Death (unrelated to study procedures)|3|||
25117830|NCT01772368|50229748|FG000|Overall Study|Adverse Event|1|||
25117831|NCT01772368|50229748|FG000|Overall Study|Withdrawal by Subject|3|||
25117832|NCT01772368|50229748|FG000|Overall Study|Protocol Violation|2|||
25117833|NCT01772368|50229748|FG000|Overall Study|Other|1|||
25117834|NCT01788046|50229766|FG000|Overall Study|Withdrawal by Subject|12|||
25117835|NCT01788046|50229767|FG001|Overall Study|Withdrawal by Subject|12|||
25117836|NCT01788046|50229766|FG000|Overall Study|Lost to Follow-up|12|||
25117837|NCT01788046|50229767|FG001|Overall Study|Lost to Follow-up|19|||
25117838|NCT01788046|50229766|FG000|Overall Study|Death|7|||
25117839|NCT01788046|50229767|FG001|Overall Study|Death|5|||
25117840|NCT01788046|50229766|FG000|Overall Study|Protocol Specified Criteria|25|||
25117841|NCT01788046|50229767|FG001|Overall Study|Protocol Specified Criteria|1|||
25117842|NCT01806298|50229773|FG000|Overall Study|Adverse Event|3|||
25117843|NCT01806298|50229773|FG000|Overall Study|Protocol Non-compliance|1|||
25117844|NCT01806298|50229773|FG000|Overall Study|Withdrawal by Subject|1|||
25177434|NCT02754141|50321511|FG004|Overall Study|No longer meets study criteria|0|||
25177435|NCT02754141|50321512|FG005|Overall Study|No longer meets study criteria|0|||
25117845|NCT01806298|50229773|FG000|Overall Study|Other|5|||
25177436|NCT02754141|50321513|FG006|Overall Study|No longer meets study criteria|0|||
25117846|NCT01772134|50229780|FG000|Overall Study|Adverse Event|6|||
25117847|NCT01772134|50229781|FG001|Overall Study|Adverse Event|5|||
25117848|NCT01772134|50229782|FG002|Overall Study|Adverse Event|10|||
25117849|NCT01772134|50229780|FG000|Overall Study|Withdrew Consent|3|||
25117850|NCT01772134|50229781|FG001|Overall Study|Withdrew Consent|1|||
25117851|NCT01772134|50229782|FG002|Overall Study|Withdrew Consent|5|||
25177437|NCT02754141|50321514|FG007|Overall Study|No longer meets study criteria|0|||
25117852|NCT01772134|50229780|FG000|Overall Study|Lost to Follow-up|2|||
25117853|NCT01772134|50229781|FG001|Overall Study|Lost to Follow-up|0|||
25117854|NCT01772134|50229782|FG002|Overall Study|Lost to Follow-up|0|||
25117855|NCT01772134|50229780|FG000|Overall Study|Protocol Deviation|4|||
25117856|NCT01772134|50229781|FG001|Overall Study|Protocol Deviation|3|||
25117857|NCT01772134|50229782|FG002|Overall Study|Protocol Deviation|3|||
25117858|NCT01772134|50229780|FG000|Overall Study|Lack of Efficacy|11|||
25117859|NCT01772134|50229781|FG001|Overall Study|Lack of Efficacy|5|||
25117860|NCT01772134|50229782|FG002|Overall Study|Lack of Efficacy|3|||
25117861|NCT01772134|50229780|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
25117862|NCT01772134|50229781|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
25117863|NCT01772134|50229782|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
25117864|NCT01772134|50229780|FG000|Overall Study|Randomized Study Medication Not Received|2|||
25117865|NCT01772134|50229781|FG001|Overall Study|Randomized Study Medication Not Received|0|||
25117866|NCT01772134|50229782|FG002|Overall Study|Randomized Study Medication Not Received|1|||
25117867|NCT01994889|50229793|FG000|Overall Study|Adverse Event|5|||
25117868|NCT01994889|50229794|FG001|Overall Study|Adverse Event|12|||
25117869|NCT01994889|50229795|FG002|Overall Study|Adverse Event|11|||
25117870|NCT01994889|50229793|FG000|Overall Study|Cardiac Device Implantation|0|||
25117871|NCT01994889|50229794|FG001|Overall Study|Cardiac Device Implantation|2|||
25117872|NCT01994889|50229795|FG002|Overall Study|Cardiac Device Implantation|0|||
25117873|NCT01994889|50229793|FG000|Overall Study|Organ Transplantation|1|||
25117874|NCT01994889|50229794|FG001|Overall Study|Organ Transplantation|5|||
25117875|NCT01994889|50229795|FG002|Overall Study|Organ Transplantation|5|||
25117876|NCT01994889|50229793|FG000|Overall Study|No longer willing to participate|8|||
25117877|NCT01994889|50229794|FG001|Overall Study|No longer willing to participate|17|||
25117878|NCT01994889|50229795|FG002|Overall Study|No longer willing to participate|37|||
25117879|NCT01994889|50229793|FG000|Overall Study|Lost to Follow-up|0|||
25117880|NCT01994889|50229794|FG001|Overall Study|Lost to Follow-up|1|||
25117881|NCT01994889|50229795|FG002|Overall Study|Lost to Follow-up|0|||
25117882|NCT01994889|50229793|FG000|Overall Study|Protocol Violation|0|||
25117883|NCT01994889|50229794|FG001|Overall Study|Protocol Violation|1|||
25117884|NCT01994889|50229795|FG002|Overall Study|Protocol Violation|1|||
25117885|NCT01994889|50229793|FG000|Overall Study|Death|14|||
25117886|NCT01994889|50229794|FG001|Overall Study|Death|25|||
25117887|NCT01994889|50229795|FG002|Overall Study|Death|38|||
25117888|NCT02082483|50229804|FG000|Overall Study|Lost to Follow-up|1|||
25117889|NCT02082483|50229805|FG001|Overall Study|Lost to Follow-up|1|||
25117890|NCT02082483|50229804|FG000|Overall Study|Withdrawal by Subject|2|||
25117891|NCT02082483|50229805|FG001|Overall Study|Withdrawal by Subject|1|||
25117892|NCT02082483|50229804|FG000|Overall Study|Physician Decision|1|||
25117893|NCT02082483|50229805|FG001|Overall Study|Physician Decision|1|||
25117894|NCT02082483|50229804|FG000|Overall Study|Death|2|||
25117895|NCT02082483|50229805|FG001|Overall Study|Death|3|||
25117896|NCT02017899|50229818|FG000|Overall Study|Withdrawal by Subject|0|||
25117897|NCT02017899|50229819|FG001|Overall Study|Withdrawal by Subject|0|||
25117898|NCT02017899|50229820|FG002|Overall Study|Withdrawal by Subject|0|||
25117899|NCT02017899|50229821|FG003|Overall Study|Withdrawal by Subject|1|||
25117900|NCT02017899|50229822|FG004|Overall Study|Withdrawal by Subject|1|||
25117901|NCT02017899|50229823|FG005|Overall Study|Withdrawal by Subject|0|||
25117902|NCT01993329|50229843|FG000|Period 2|Adverse Event|0|||
25117903|NCT01993329|50229844|FG001|Period 2|Adverse Event|0|||
25117904|NCT01993329|50229845|FG002|Period 2|Adverse Event|0|||
25117905|NCT01993329|50229846|FG003|Period 2|Adverse Event|0|||
25117906|NCT01993329|50229847|FG004|Period 2|Adverse Event|0|||
25117907|NCT01993329|50229848|FG005|Period 2|Adverse Event|1|||
25117908|NCT01993329|50229843|FG000|Wash-out|Personal reasons|0|||
25117909|NCT01993329|50229844|FG001|Wash-out|Personal reasons|1|||
25117910|NCT01993329|50229845|FG002|Wash-out|Personal reasons|0|||
25117911|NCT01993329|50229846|FG003|Wash-out|Personal reasons|0|||
25117912|NCT01993329|50229847|FG004|Wash-out|Personal reasons|0|||
25117913|NCT01993329|50229848|FG005|Wash-out|Personal reasons|0|||
25117914|NCT02016183|50229860|FG000|Overall Study|Case Report Forms Uncollected|13|||
25117915|NCT02016183|50229860|FG000|Overall Study|Protocol Violation|52|||
25117916|NCT02377349|50229866|FG000|Overall Study|Serious Adverse Event|1|||
25261576|NCT01008553|50576239|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
25117917|NCT02377349|50229867|FG001|Overall Study|Serious Adverse Event|0|||
25117918|NCT02377349|50229866|FG000|Overall Study|Protocol Violation|3|||
25117919|NCT02377349|50229867|FG001|Overall Study|Protocol Violation|2|||
25261577|NCT01008553|50576237|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
25117920|NCT02377349|50229866|FG000|Overall Study|Withdrawal by Subject|5|||
25117921|NCT02377349|50229867|FG001|Overall Study|Withdrawal by Subject|3|||
25117922|NCT02377349|50229866|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
25117923|NCT02377349|50229867|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
25117924|NCT02377349|50229866|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
25117925|NCT02377349|50229867|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
25117926|NCT02377349|50229866|FG000|Overall Study|Other|0|||
25117927|NCT02377349|50229867|FG001|Overall Study|Other|1|||
25117928|NCT02421419|50229885|FG000|Overall Study|Physician Decision|0|||
25117929|NCT02421419|50229886|FG001|Overall Study|Physician Decision|0|||
25117930|NCT02421419|50229887|FG002|Overall Study|Physician Decision|1|||
25117931|NCT02420717|50229898|FG000|Overall Study|Did not receive all study medication|2|||
25117932|NCT02420717|50229899|FG001|Overall Study|Did not receive all study medication|0|||
25117933|NCT02420717|50229900|FG002|Overall Study|Did not receive all study medication|0|||
25117934|NCT02016105|50229910|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
25117935|NCT02016105|50229911|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
25117936|NCT02016105|50229912|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
25117937|NCT02016105|50229913|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
25117938|NCT02016105|50229914|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
25117939|NCT02016105|50229915|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
25117940|NCT02016105|50229910|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
25117941|NCT02016105|50229911|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
25117942|NCT02016105|50229912|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
25117943|NCT02016105|50229913|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
25117944|NCT02016105|50229914|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
25117945|NCT02016105|50229915|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
25117946|NCT02016105|50229910|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
25117947|NCT02016105|50229911|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
25117948|NCT02016105|50229912|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
25117949|NCT02016105|50229913|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
25117950|NCT02016105|50229914|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
25117951|NCT02016105|50229915|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
25117952|NCT02016105|50229910|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
25117953|NCT02016105|50229911|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
25117954|NCT02016105|50229912|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
25117955|NCT02016105|50229913|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
25117956|NCT02016105|50229914|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
25117957|NCT02016105|50229915|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
25117958|NCT02016105|50229910|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
25117959|NCT02016105|50229911|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
25117960|NCT02016105|50229912|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
25117961|NCT02016105|50229913|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
25117962|NCT02016105|50229914|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
25117963|NCT02016105|50229915|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
25117964|NCT02016105|50229910|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
25117965|NCT02016105|50229911|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
25117966|NCT02016105|50229912|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
25117967|NCT02016105|50229913|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
25117968|NCT02016105|50229914|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
25117969|NCT02016105|50229915|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
25117970|NCT02016105|50229910|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
25117971|NCT02016105|50229911|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
25117972|NCT02016105|50229912|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
25117973|NCT02016105|50229913|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
25117974|NCT02016105|50229914|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
25117975|NCT02016105|50229915|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
25117976|NCT02016105|50229910|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
25117977|NCT02016105|50229911|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
25117978|NCT02016105|50229912|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
25117979|NCT02016105|50229913|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
25117980|NCT02016105|50229914|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
25117981|NCT02016105|50229915|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
25117982|NCT02016105|50229910|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
25117983|NCT02016105|50229911|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
25117984|NCT02016105|50229912|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
25117985|NCT02016105|50229913|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
25261578|NCT01008553|50576238|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
25117986|NCT02016105|50229914|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
25117987|NCT02016105|50229915|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
25117988|NCT02016105|50229910|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
25117989|NCT02016105|50229911|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
25117990|NCT02016105|50229912|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
25117991|NCT02016105|50229913|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
25117992|NCT02016105|50229914|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
25117993|NCT02016105|50229915|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
25117994|NCT02016105|50229910|FG000|TREATMENT PERIOD 2|Death|0|||
25117995|NCT02016105|50229911|FG001|TREATMENT PERIOD 2|Death|0|||
25117996|NCT02016105|50229912|FG002|TREATMENT PERIOD 2|Death|0|||
25117997|NCT02016105|50229913|FG003|TREATMENT PERIOD 2|Death|0|||
25117998|NCT02016105|50229914|FG004|TREATMENT PERIOD 2|Death|0|||
25117999|NCT02016105|50229915|FG005|TREATMENT PERIOD 2|Death|1|||
25118000|NCT02016105|50229910|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
25118001|NCT02016105|50229911|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
25118002|NCT02016105|50229912|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
25118003|NCT02016105|50229913|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
25118004|NCT02016105|50229914|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
25118005|NCT02016105|50229915|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
25118006|NCT02016105|50229910|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
25118007|NCT02016105|50229911|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
25118008|NCT02016105|50229912|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
25118009|NCT02016105|50229913|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
25118010|NCT02016105|50229914|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
25118011|NCT02016105|50229915|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
25118012|NCT02016105|50229910|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
25118013|NCT02016105|50229911|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
25118014|NCT02016105|50229912|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
25118015|NCT02016105|50229913|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
25118016|NCT02016105|50229914|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
25118017|NCT02016105|50229915|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
25261579|NCT01008553|50576239|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
25261580|NCT01008553|50576237|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
25261581|NCT01008553|50576238|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
25261582|NCT01008553|50576239|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
25261583|NCT01008553|50576237|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
25261584|NCT01008553|50576238|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
25261585|NCT01008553|50576239|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
25261586|NCT01302834|50576250|FG000|Overall Study|Protocol Violation|17|||
25261587|NCT01302834|50576251|FG001|Overall Study|Protocol Violation|23|||
25261588|NCT01302834|50576250|FG000|Overall Study|HIV positive|1|||
25261589|NCT01302834|50576251|FG001|Overall Study|HIV positive|3|||
25261590|NCT01259115|50576257|FG000|Period 1|Adverse Event|1|||
25261591|NCT01259115|50576258|FG001|Period 1|Adverse Event|0|||
25261592|NCT01259115|50576257|FG000|Period 1|Protocol Violation|2|||
25261593|NCT01259115|50576258|FG001|Period 1|Protocol Violation|0|||
25261594|NCT01259115|50576257|FG000|Period 1|Lost to Follow-up|0|||
25261595|NCT01259115|50576258|FG001|Period 1|Lost to Follow-up|1|||
25261596|NCT01259115|50576257|FG000|Period 2|Adverse Event|1|||
25261597|NCT01259115|50576258|FG001|Period 2|Adverse Event|0|||
25261598|NCT01302366|50576269|FG000|Overall Study|patient choice or noncompliance|5|||
25261599|NCT01302054|50576273|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
25261600|NCT01302054|50576274|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
25261601|NCT01302054|50576275|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
25261602|NCT01302054|50576273|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
25261603|NCT01302054|50576274|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
25261604|NCT01302054|50576275|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
25261605|NCT01302054|50576273|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
25261606|NCT01302054|50576274|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
25261607|NCT01302054|50576275|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
25261608|NCT01302054|50576273|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
25261609|NCT01302054|50576274|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
25261610|NCT01302054|50576275|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
25261611|NCT01302054|50576273|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
25261612|NCT01302054|50576274|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
25261613|NCT01302054|50576275|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
25261614|NCT01302054|50576273|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
25261615|NCT01302054|50576274|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
25261616|NCT01302054|50576275|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
25261617|NCT01302054|50576273|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
25261618|NCT01302054|50576274|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
25261619|NCT01302054|50576275|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
25261620|NCT01302054|50576273|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
25261621|NCT01302054|50576274|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
25261622|NCT01302054|50576275|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
25261623|NCT01302054|50576273|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
25261624|NCT01302054|50576274|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
25118018|NCT02016105|50229910|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
25118019|NCT02016105|50229911|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
25118020|NCT02016105|50229912|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
25118021|NCT02016105|50229913|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
25118022|NCT02016105|50229914|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
25168606|NCT00634101|50298153|FG000|Overall Study|Lost to Follow-up|2|||
25261625|NCT01302054|50576275|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
25261626|NCT01302054|50576273|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
25118023|NCT02016105|50229915|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
25118024|NCT02016105|50229910|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
25118025|NCT02016105|50229911|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
25118026|NCT02016105|50229912|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
25118027|NCT02016105|50229913|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
25118028|NCT02016105|50229914|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
25118029|NCT02016105|50229915|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
25118030|NCT02016105|50229910|FG000|EXTENSION PERIOD|Adverse Event|0|||
25118031|NCT02016105|50229911|FG001|EXTENSION PERIOD|Adverse Event|0|||
25118032|NCT02016105|50229912|FG002|EXTENSION PERIOD|Adverse Event|2|||
25118033|NCT02016105|50229913|FG003|EXTENSION PERIOD|Adverse Event|0|||
25118034|NCT02016105|50229914|FG004|EXTENSION PERIOD|Adverse Event|1|||
25118035|NCT02016105|50229915|FG005|EXTENSION PERIOD|Adverse Event|0|||
25118036|NCT02016105|50229910|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
25118037|NCT02016105|50229911|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
25118038|NCT02016105|50229912|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
25118039|NCT02016105|50229913|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
25118040|NCT02016105|50229914|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
25118041|NCT02016105|50229915|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
25118042|NCT02016105|50229910|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
25118043|NCT02016105|50229911|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
25118044|NCT02016105|50229912|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
25118045|NCT02016105|50229913|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
25118046|NCT02016105|50229914|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
25118047|NCT02016105|50229915|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
25118048|NCT02016105|50229910|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
25118049|NCT02016105|50229911|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
25118050|NCT02016105|50229912|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
25118051|NCT02016105|50229913|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
25118052|NCT02016105|50229914|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
25118053|NCT02016105|50229915|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
25118054|NCT02400905|50229929|FG000|Overall Study|Death|24|||
25118055|NCT02400905|50229929|FG000|Overall Study|Lost to Follow-up|18|||
25118056|NCT02400905|50229929|FG000|Overall Study|Withdrawal by Subject|16|||
25118057|NCT02400905|50229929|FG000|Overall Study|Physician Decision|4|||
25118058|NCT02400905|50229929|FG000|Overall Study|Other|1|||
25118059|NCT02400749|50229936|FG000|Week 0 -16|Withdrawal by Subject|5|||
25118060|NCT02400749|50229937|FG001|Week 0 -16|Withdrawal by Subject|5|||
25118061|NCT02400749|50229936|FG000|Week 0 -16|Adverse Event|3|||
25118062|NCT02400749|50229937|FG001|Week 0 -16|Adverse Event|1|||
25118063|NCT02400749|50229936|FG000|Week 0 -16|Lost to Follow-up|2|||
25118064|NCT02400749|50229937|FG001|Week 0 -16|Lost to Follow-up|0|||
25118065|NCT02400749|50229936|FG000|Week 0 -16|Protocol Violation|1|||
25118066|NCT02400749|50229937|FG001|Week 0 -16|Protocol Violation|0|||
25118067|NCT02400749|50229936|FG000|Week 17 - 32|Withdrawal by Subject|3|||
25118068|NCT02400749|50229937|FG001|Week 17 - 32|Withdrawal by Subject|2|||
25118069|NCT02400749|50229936|FG000|Week 17 - 32|Adverse Event|2|||
25118070|NCT02400749|50229937|FG001|Week 17 - 32|Adverse Event|1|||
25118071|NCT02420327|50229943|FG000|Overall Study|Adverse Event|7|||
25118072|NCT02420327|50229943|FG000|Overall Study|Pregnancy|1|||
25118073|NCT02420327|50229943|FG000|Overall Study|Withdrawal by Subject|6|||
25118074|NCT02420327|50229943|FG000|Overall Study|Lost to Follow-up|1|||
25118075|NCT02420327|50229943|FG000|Overall Study|Protocol Violation|1|||
25118076|NCT02374853|50229955|FG000|Overall Study|Surgery Cancelled|5|||
25118077|NCT02374853|50229956|FG001|Overall Study|Surgery Cancelled|11|||
25118078|NCT02015793|50229964|FG000|Overall Study|Adverse Event|3|||
25118079|NCT02015793|50229965|FG001|Overall Study|Adverse Event|3|||
25118080|NCT02015793|50229964|FG000|Overall Study|Withdrawal by Subject|1|||
25118081|NCT02015793|50229965|FG001|Overall Study|Withdrawal by Subject|1|||
25118082|NCT02347631|50229979|FG000|First Intervention (2 Months)|Adverse Event|1|||
25118083|NCT02347631|50229980|FG001|First Intervention (2 Months)|Adverse Event|1|||
25118084|NCT02347631|50229979|FG000|First Intervention (2 Months)|Pregnancy|1|||
25118085|NCT02347631|50229980|FG001|First Intervention (2 Months)|Pregnancy|0|||
25118086|NCT02347631|50229979|FG000|First Intervention (2 Months)|Moved out of area|0|||
25118087|NCT02347631|50229980|FG001|First Intervention (2 Months)|Moved out of area|2|||
25118088|NCT02347631|50229979|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
25118089|NCT02347631|50229980|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
25118090|NCT02347631|50229979|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
25118091|NCT02347631|50229980|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
25118092|NCT02347631|50229979|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
25118093|NCT02347631|50229980|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
25118094|NCT02347631|50229979|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
25118095|NCT02347631|50229980|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
25118096|NCT02347631|50229979|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
25118097|NCT02347631|50229980|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
25118098|NCT02015637|50229990|FG000|Overall Study|Lost to Follow-up|3|||
25118099|NCT02015637|50229991|FG001|Overall Study|Lost to Follow-up|5|||
25118100|NCT02015637|50229990|FG000|Overall Study|Adverse Event|3|||
25118101|NCT02015637|50229991|FG001|Overall Study|Adverse Event|0|||
25118102|NCT02015637|50229990|FG000|Overall Study|Did not take study drug|2|||
25118103|NCT02015637|50229991|FG001|Overall Study|Did not take study drug|0|||
25118104|NCT02347085|50229997|FG000|Overall Study|Adverse Event|2|||
25118105|NCT02347085|50229997|FG000|Overall Study|Lack of Efficacy|1|||
25118106|NCT02347085|50229997|FG000|Overall Study|Withdrawal by Subject|4|||
25118107|NCT02347085|50229997|FG000|Overall Study|Lost to Follow-up|1|||
25118108|NCT02347085|50229997|FG000|Overall Study|Protocol Criteria|2|||
25118109|NCT02374463|50230005|FG000|Overall Study|Withdrawal by Subject|3|||
25118110|NCT02374463|50230006|FG001|Overall Study|Withdrawal by Subject|3|||
25118111|NCT02015481|50230013|FG000|Overall Study|Death|1|||
25118112|NCT02374307|50230020|FG000|3-months Follow-up|Lost to Follow-up|1|||
25118113|NCT02374307|50230021|FG001|3-months Follow-up|Lost to Follow-up|2|||
25118114|NCT02374307|50230020|FG000|3-months Follow-up|Withdrawal by Subject|1|||
25118115|NCT02374307|50230021|FG001|3-months Follow-up|Withdrawal by Subject|4|||
25118116|NCT02374307|50230020|FG000|3-months Follow-up|Death|1|||
25118117|NCT02374307|50230021|FG001|3-months Follow-up|Death|2|||
25118118|NCT02374307|50230020|FG000|3-months Follow-up|Missed first follow-up|5|||
25118119|NCT02374307|50230021|FG001|3-months Follow-up|Missed first follow-up|1|||
25118120|NCT02374307|50230020|FG000|6-months Follow-up|Lost to Follow-up|1|||
25118121|NCT02374307|50230021|FG001|6-months Follow-up|Lost to Follow-up|2|||
25118122|NCT02374307|50230020|FG000|6-months Follow-up|Death|2|||
25118123|NCT02374307|50230021|FG001|6-months Follow-up|Death|1|||
25118124|NCT02374307|50230020|FG000|6-months Follow-up|Withdrawal by Subject|0|||
25118125|NCT02374307|50230021|FG001|6-months Follow-up|Withdrawal by Subject|3|||
25118126|NCT02397473|50230029|FG000|Treatment Phase|Adverse Event|1|||
25118127|NCT02397473|50230030|FG001|Treatment Phase|Adverse Event|2|||
25118128|NCT02397473|50230029|FG000|Treatment Phase|Lack of Efficacy|8|||
25118129|NCT02397473|50230030|FG001|Treatment Phase|Lack of Efficacy|1|||
25118130|NCT02397473|50230029|FG000|Treatment Phase|Lost to Follow-up|1|||
25118131|NCT02397473|50230030|FG001|Treatment Phase|Lost to Follow-up|0|||
25118132|NCT02397473|50230029|FG000|Treatment Phase|Withdrawal by Subject|2|||
25118133|NCT02397473|50230030|FG001|Treatment Phase|Withdrawal by Subject|1|||
25118134|NCT02397473|50230029|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
25118135|NCT02397473|50230030|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
25118136|NCT02397473|50230029|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
25118137|NCT02397473|50230030|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
25118138|NCT02397473|50230029|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
25118139|NCT02397473|50230030|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
25118140|NCT02397473|50230029|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
25118141|NCT02397473|50230030|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
25118142|NCT02397473|50230029|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
25118143|NCT02397473|50230030|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
25118144|NCT02344745|50230041|FG000|Overall Study|Data collection sheets were lost|2|||
25118145|NCT02344745|50230042|FG001|Overall Study|Data collection sheets were lost|0|||
25118146|NCT02370641|50230050|FG000|Overall Study|dropped study|4|||
25118147|NCT02370641|50230051|FG001|Overall Study|dropped study|2|||
25118148|NCT01621191|50230057|FG000|Overall Study|Adverse Event|9|||
25118149|NCT01621191|50230057|FG000|Overall Study|Withdrawal by Subject|8|||
25118150|NCT01621191|50230057|FG000|Overall Study|Lack of Efficacy|6|||
25118151|NCT01621191|50230057|FG000|Overall Study|Lost to Follow-up|1|||
25118152|NCT01621191|50230057|FG000|Overall Study|Site Removed From Study|1|||
25118153|NCT02343263|50230065|FG000|Overall Study|Physician Decision|5|||
25118154|NCT02343263|50230066|FG001|Overall Study|Physician Decision|3|||
25118155|NCT02343263|50230067|FG002|Overall Study|Physician Decision|1|||
25118156|NCT02081859|50230081|FG000|Overall Study|No fertilization|2|||
25118157|NCT02081859|50230082|FG001|Overall Study|No fertilization|2|||
25118158|NCT02081859|50230081|FG000|Overall Study|No sperm|1|||
25118159|NCT02081859|50230082|FG001|Overall Study|No sperm|0|||
25261627|NCT01302054|50576274|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
25118160|NCT02081859|50230081|FG000|Overall Study|Unanticipated freeze all cycle|2|||
25118161|NCT02081859|50230082|FG001|Overall Study|Unanticipated freeze all cycle|6|||
25118162|NCT02081859|50230081|FG000|Overall Study|< 4 embryos|27|||
25118163|NCT02081859|50230082|FG001|Overall Study|< 4 embryos|23|||
25118164|NCT02081859|50230081|FG000|Overall Study|Other reasons|2|||
25118165|NCT02081859|50230082|FG001|Overall Study|Other reasons|0|||
25118166|NCT02342639|50230090|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
25118167|NCT02342639|50230091|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
25118168|NCT02342639|50230090|FG000|Overall Study|Protocol Violation|0|||
25118169|NCT02342639|50230091|FG001|Overall Study|Protocol Violation|2|||
25118170|NCT01625091|50230101|FG000|Intervention|Death|1|||
25118171|NCT01625091|50230102|FG001|Intervention|Death|1|||
25118172|NCT01625091|50230101|FG000|Intervention|Withdrawal by Subject|4|||
25118173|NCT01625091|50230102|FG001|Intervention|Withdrawal by Subject|1|||
25118174|NCT01625091|50230101|FG000|Intervention|Adverse Event|0|||
25118175|NCT01625091|50230102|FG001|Intervention|Adverse Event|2|||
25118176|NCT01625091|50230101|FG000|Intervention|Lost to Follow-up|4|||
25118177|NCT01625091|50230102|FG001|Intervention|Lost to Follow-up|4|||
25118178|NCT01625091|50230101|FG000|Intervention|Study termination|2|||
25118179|NCT01625091|50230102|FG001|Intervention|Study termination|3|||
25118180|NCT01625091|50230101|FG000|Post-intervention|Death|0|||
25118181|NCT01625091|50230102|FG001|Post-intervention|Death|1|||
25118182|NCT01625091|50230101|FG000|Post-intervention|Lost to Follow-up|2|||
25118183|NCT01625091|50230102|FG001|Post-intervention|Lost to Follow-up|0|||
25118184|NCT01625091|50230101|FG000|Post-intervention|Study termination|2|||
25118185|NCT01625091|50230102|FG001|Post-intervention|Study termination|1|||
25118186|NCT02396849|50230110|FG000|Overall Study|Lost to Follow-up|1|||
25118187|NCT02396849|50230111|FG001|Overall Study|Lost to Follow-up|1|||
25118188|NCT02396849|50230110|FG000|Overall Study|Did not tolerate intervention|1|||
25118189|NCT02396849|50230111|FG001|Overall Study|Did not tolerate intervention|1|||
25118190|NCT02370251|50230119|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
25118191|NCT02370251|50230119|FG000|Overall Study|Death|4|||
25118192|NCT02396537|50230125|FG000|Overall Study|Protocol Violation|0|||
25118193|NCT02396537|50230126|FG001|Overall Study|Protocol Violation|1|||
25118194|NCT02342171|50230134|FG000|Overall Study|Death|4|||
25118195|NCT02342171|50230135|FG001|Overall Study|Death|87|||
25118196|NCT02342171|50230134|FG000|Overall Study|Received favipiravir|10|||
25118197|NCT02342171|50230135|FG001|Overall Study|Received favipiravir|0|||
25118198|NCT02342171|50230134|FG000|Overall Study|Missing cycle treshold value|1|||
25118199|NCT02342171|50230135|FG001|Overall Study|Missing cycle treshold value|0|||
25118200|NCT02342171|50230134|FG000|Overall Study|Unknown outcome|0|||
25118201|NCT02342171|50230135|FG001|Overall Study|Unknown outcome|1|||
25118202|NCT02342171|50230134|FG000|Overall Study|Missing age data|0|||
25118203|NCT02342171|50230135|FG001|Overall Study|Missing age data|1|||
25118204|NCT01624467|50230140|FG000|Overall Study|Withdrawal by Subject|2|||
25118205|NCT01624467|50230140|FG000|Overall Study|Lost to Follow-up|1|||
25118206|NCT01624467|50230140|FG000|Overall Study|Adverse Event|7|||
25118207|NCT01624467|50230140|FG000|Overall Study|Progressive Disease|19|||
25118208|NCT01624467|50230140|FG000|Overall Study|Per Sponsor Requirement|1|||
25118209|NCT01624467|50230140|FG000|Overall Study|Subject Withdrew from Treatment|1|||
25118210|NCT01624233|50230146|FG000|Period 2 - Induction|Adverse Event|1|||
25118211|NCT01624233|50230146|FG000|Period 3 - Maintenance|Adverse Event|2|||
25118212|NCT01624233|50230146|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
25118213|NCT01624233|50230146|FG000|Period 3 - Maintenance|Physician Decision|2|||
25118214|NCT01624233|50230146|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
25118215|NCT01624233|50230146|FG000|Period 4 - Drug Free Period|Relapsed|61|||
25118216|NCT01624233|50230146|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
25118217|NCT01624233|50230146|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
25118218|NCT01624233|50230146|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
25118219|NCT01624233|50230146|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
25118220|NCT01624233|50230146|FG000|Period 6: Follow-up|Adverse Event|3|||
25118221|NCT01624233|50230146|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
25118222|NCT01624233|50230146|FG000|Period 6: Follow-up|Physician Decision|1|||
25118223|NCT01624233|50230146|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
25118224|NCT01993017|50230157|FG000|Overall Study|Death|23|||
25118225|NCT01993017|50230158|FG001|Overall Study|Death|26|||
25118226|NCT01993017|50230159|FG002|Overall Study|Death|18|||
25118227|NCT01993017|50230157|FG000|Overall Study|Could not be contacted|43|||
25118228|NCT01993017|50230158|FG001|Overall Study|Could not be contacted|42|||
25118229|NCT01993017|50230159|FG002|Overall Study|Could not be contacted|38|||
25118230|NCT01993017|50230157|FG000|Overall Study|Dropped out|19|||
25118231|NCT01993017|50230158|FG001|Overall Study|Dropped out|6|||
25118232|NCT01993017|50230159|FG002|Overall Study|Dropped out|11|||
25118233|NCT01993017|50230157|FG000|Overall Study|Other reasons|17|||
25118234|NCT01993017|50230158|FG001|Overall Study|Other reasons|11|||
25118235|NCT01993017|50230159|FG002|Overall Study|Other reasons|7|||
25118236|NCT01993017|50230157|FG000|Overall Study|Ineligible after randomization|4|||
25118237|NCT01993017|50230158|FG001|Overall Study|Ineligible after randomization|5|||
25118238|NCT01993017|50230159|FG002|Overall Study|Ineligible after randomization|5|||
25118239|NCT01992549|50230168|FG000|Overall Study|Lost to Follow-up|2|||
25118240|NCT01992549|50230168|FG000|Overall Study|Serious Adverse Event|1|||
25118241|NCT01992549|50230168|FG000|Overall Study|Product Switch to Extend Half Life|1|||
25118242|NCT01992159|50230182|FG000|Overall Study|Withdrawal by Subject|4|||
25118243|NCT01992159|50230183|FG001|Overall Study|Withdrawal by Subject|7|||
25118244|NCT01992159|50230184|FG002|Overall Study|Withdrawal by Subject|0|||
25118245|NCT01992159|50230185|FG003|Overall Study|Withdrawal by Subject|3|||
25118246|NCT01992159|50230182|FG000|Overall Study|Adverse Event|0|||
25118247|NCT01992159|50230183|FG001|Overall Study|Adverse Event|1|||
25118248|NCT01992159|50230184|FG002|Overall Study|Adverse Event|0|||
25118249|NCT01992159|50230185|FG003|Overall Study|Adverse Event|1|||
25118250|NCT01992159|50230182|FG000|Overall Study|Death|0|||
25118251|NCT01992159|50230183|FG001|Overall Study|Death|0|||
25118252|NCT01992159|50230184|FG002|Overall Study|Death|1|||
25118253|NCT01992159|50230185|FG003|Overall Study|Death|0|||
25118254|NCT01988493|50230200|FG000|Overall Study|Randomized but not treated|0|||
25118255|NCT01988493|50230201|FG001|Overall Study|Randomized but not treated|0|||
25118256|NCT01988493|50230202|FG002|Overall Study|Randomized but not treated|0|||
25118257|NCT01988493|50230203|FG003|Overall Study|Randomized but not treated|0|||
25118258|NCT01988493|50230204|FG004|Overall Study|Randomized but not treated|1|||
25118259|NCT02081079|50230220|FG000|Overall Study|Lack of Efficacy|3|||
25118260|NCT02081079|50230221|FG001|Overall Study|Lack of Efficacy|2|||
25118261|NCT02081079|50230220|FG000|Overall Study|Lost to Follow-up|1|||
25118262|NCT02081079|50230221|FG001|Overall Study|Lost to Follow-up|0|||
25118263|NCT02081001|50230233|FG000|Overall Study|Adverse Event|0|||
25118264|NCT02081001|50230234|FG001|Overall Study|Adverse Event|0|||
25118265|NCT02081001|50230235|FG002|Overall Study|Adverse Event|0|||
25118266|NCT02081001|50230236|FG003|Overall Study|Adverse Event|0|||
25118267|NCT02081001|50230237|FG004|Overall Study|Adverse Event|1|||
25118268|NCT02081001|50230238|FG005|Overall Study|Adverse Event|0|||
25118269|NCT02081001|50230239|FG006|Overall Study|Adverse Event|0|||
25118270|NCT02081001|50230240|FG007|Overall Study|Adverse Event|0|||
25118271|NCT02081001|50230241|FG008|Overall Study|Adverse Event|0|||
25118272|NCT02081001|50230242|FG009|Overall Study|Adverse Event|0|||
25118273|NCT02081001|50230243|FG010|Overall Study|Adverse Event|0|||
25118274|NCT02081001|50230244|FG011|Overall Study|Adverse Event|0|||
25118275|NCT02080221|50230255|FG000|Overall Study|Withdrawal by Subject|1|||
25118276|NCT02080221|50230255|FG000|Overall Study|Clinical Progression of Disease|1|||
25118277|NCT02079909|50230262|FG000|Overall Study|Adverse Event|23|||
25118278|NCT02079909|50230263|FG001|Overall Study|Adverse Event|23|||
25118279|NCT02079909|50230264|FG002|Overall Study|Adverse Event|7|||
25118280|NCT02079909|50230262|FG000|Overall Study|Withdrawal by Subject|9|||
25118281|NCT02079909|50230263|FG001|Overall Study|Withdrawal by Subject|17|||
25118282|NCT02079909|50230264|FG002|Overall Study|Withdrawal by Subject|4|||
25118283|NCT02079909|50230262|FG000|Overall Study|Lost to Follow-up|2|||
25118284|NCT02079909|50230263|FG001|Overall Study|Lost to Follow-up|3|||
25118285|NCT02079909|50230264|FG002|Overall Study|Lost to Follow-up|1|||
25118286|NCT02079909|50230262|FG000|Overall Study|Death|2|||
25118287|NCT02079909|50230263|FG001|Overall Study|Death|2|||
25118288|NCT02079909|50230264|FG002|Overall Study|Death|0|||
25118289|NCT02079909|50230262|FG000|Overall Study|Lack of Efficacy|0|||
25118290|NCT02079909|50230263|FG001|Overall Study|Lack of Efficacy|0|||
25118291|NCT02079909|50230264|FG002|Overall Study|Lack of Efficacy|1|||
25118292|NCT02079909|50230262|FG000|Overall Study|Protocol Violation|0|||
25118293|NCT02079909|50230263|FG001|Overall Study|Protocol Violation|1|||
25118294|NCT02079909|50230264|FG002|Overall Study|Protocol Violation|1|||
25118295|NCT02079909|50230262|FG000|Overall Study|Physician Decision|0|||
25118296|NCT02079909|50230263|FG001|Overall Study|Physician Decision|1|||
25118297|NCT02079909|50230264|FG002|Overall Study|Physician Decision|1|||
25118298|NCT02079909|50230262|FG000|Overall Study|Relocation etc.|2|||
25118299|NCT02079909|50230263|FG001|Overall Study|Relocation etc.|2|||
25118300|NCT02079909|50230264|FG002|Overall Study|Relocation etc.|3|||
25118301|NCT02014467|50230274|FG000|Overall Study|Adverse Event|4|||
25118302|NCT02014467|50230275|FG001|Overall Study|Adverse Event|0|||
25118303|NCT02014467|50230274|FG000|Overall Study|Protocol Violation|3|||
25118304|NCT02014467|50230275|FG001|Overall Study|Protocol Violation|0|||
25118305|NCT02014467|50230274|FG000|Overall Study|Physician Decision|2|||
25118306|NCT02014467|50230275|FG001|Overall Study|Physician Decision|3|||
25118307|NCT02014467|50230274|FG000|Overall Study|Withdrawal by Subject|16|||
25118308|NCT02014467|50230275|FG001|Overall Study|Withdrawal by Subject|4|||
25118309|NCT02013765|50230281|FG000|Overall Study|Trial was terminated by sponsor|1|||
25118310|NCT02013687|50230289|FG000|Overall Study|Lost to Follow-up|0|||
25118311|NCT02013687|50230290|FG001|Overall Study|Lost to Follow-up|0|||
25118312|NCT02013687|50230291|FG002|Overall Study|Lost to Follow-up|1|||
25118313|NCT02013687|50230292|FG003|Overall Study|Lost to Follow-up|0|||
25118314|NCT02013687|50230289|FG000|Overall Study|Protocol Violation|0|||
25118315|NCT02013687|50230290|FG001|Overall Study|Protocol Violation|0|||
25118316|NCT02013687|50230291|FG002|Overall Study|Protocol Violation|0|||
25118317|NCT02013687|50230292|FG003|Overall Study|Protocol Violation|1|||
25118318|NCT02013687|50230289|FG000|Overall Study|Withdrawal by Subject|0|||
25118319|NCT02013687|50230290|FG001|Overall Study|Withdrawal by Subject|0|||
25118320|NCT02013687|50230291|FG002|Overall Study|Withdrawal by Subject|0|||
25118321|NCT02013687|50230292|FG003|Overall Study|Withdrawal by Subject|1|||
25118322|NCT02013687|50230289|FG000|Overall Study|Missed visits due to patient travel|0|||
25118323|NCT02013687|50230290|FG001|Overall Study|Missed visits due to patient travel|0|||
25118324|NCT02013687|50230291|FG002|Overall Study|Missed visits due to patient travel|1|||
25118325|NCT02013687|50230292|FG003|Overall Study|Missed visits due to patient travel|0|||
25118326|NCT02013609|50230306|FG000|Overall Study|Withdrawal by Subject|9|||
25118327|NCT02013609|50230306|FG000|Overall Study|Lost to Follow-up|3|||
25118328|NCT02013609|50230306|FG000|Overall Study|Adverse Event|3|||
25118329|NCT02013609|50230306|FG000|Overall Study|Met Withdrawal Criteria|3|||
25118330|NCT01988337|50230310|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
25118331|NCT02013531|50230316|FG000|Overall Study|Lost to Follow-up|3|||
25118332|NCT02013531|50230316|FG000|Overall Study|Met Withdrawal Criteria|1|||
25118333|NCT02013531|50230316|FG000|Overall Study|Withdrawal by Subject|1|||
25118334|NCT01988103|50230323|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
25118335|NCT01988103|50230324|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
25118336|NCT01988103|50230325|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
25118337|NCT01988103|50230326|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
25118338|NCT01988103|50230327|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
25118339|NCT01988103|50230323|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
25118340|NCT01988103|50230324|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
25118341|NCT01988103|50230325|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
25118342|NCT01988103|50230326|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
25118343|NCT01988103|50230327|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
25118344|NCT01988103|50230323|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
25118345|NCT01988103|50230324|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
25118346|NCT01988103|50230325|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
25118347|NCT01988103|50230326|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
25118348|NCT01988103|50230327|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
25118349|NCT01988103|50230323|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
25118350|NCT01988103|50230324|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
25118351|NCT01988103|50230325|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
25118352|NCT01988103|50230326|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
25118353|NCT01988103|50230327|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
25118354|NCT01988103|50230323|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
25118355|NCT01988103|50230324|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
25118356|NCT01988103|50230325|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
25118357|NCT01988103|50230326|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
25118358|NCT01988103|50230327|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
25118359|NCT01988103|50230323|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
25118360|NCT01988103|50230324|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
25118361|NCT01988103|50230325|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
25118362|NCT01988103|50230326|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
25118363|NCT01988103|50230327|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
25118364|NCT01988103|50230323|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
25118365|NCT01988103|50230324|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
25118366|NCT01988103|50230325|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
25118367|NCT01988103|50230326|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
25118368|NCT01988103|50230327|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
25118369|NCT02013375|50230342|FG000|Overall Study|Did not engraft|1|||
25118370|NCT02013375|50230342|FG000|Overall Study|Did not engraft|1|||
25118371|NCT02079519|50230347|FG000|Overall Study|Disease Progression|9|||
25118372|NCT02079519|50230347|FG000|Overall Study|Adverse Event|1|||
25118373|NCT01987557|50230354|FG000|Overall Study|Protocol Violation|1|||
25118374|NCT01987557|50230355|FG001|Overall Study|Protocol Violation|0|||
25118375|NCT01987557|50230356|FG002|Overall Study|Protocol Violation|1|||
25118376|NCT01987557|50230354|FG000|Overall Study|Withdrawal by Subject|2|||
25118377|NCT01987557|50230355|FG001|Overall Study|Withdrawal by Subject|1|||
25118378|NCT01987557|50230356|FG002|Overall Study|Withdrawal by Subject|2|||
25118379|NCT01987557|50230354|FG000|Overall Study|Adverse Event|0|||
25118380|NCT01987557|50230355|FG001|Overall Study|Adverse Event|2|||
25118381|NCT01987557|50230356|FG002|Overall Study|Adverse Event|0|||
25118382|NCT02078817|50230364|FG000|Overall Study|Withdrawal by Subject|1|||
25118383|NCT02011893|50230368|FG000|Enrollment to Randomization|Adverse Event|2|||
25118384|NCT02011893|50230369|FG001|Enrollment to Randomization|Adverse Event|0|||
25118385|NCT02011893|50230370|FG002|Enrollment to Randomization|Adverse Event|0|||
25118386|NCT02011893|50230368|FG000|Enrollment to Randomization|Physician Decision|10|||
25118387|NCT02011893|50230369|FG001|Enrollment to Randomization|Physician Decision|0|||
25118388|NCT02011893|50230370|FG002|Enrollment to Randomization|Physician Decision|0|||
25118389|NCT02011893|50230368|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
25118390|NCT02011893|50230369|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
25118391|NCT02011893|50230370|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
25118392|NCT02011893|50230368|FG000|Enrollment to Randomization|Screening Failure|29|||
25118393|NCT02011893|50230369|FG001|Enrollment to Randomization|Screening Failure|0|||
25118394|NCT02011893|50230370|FG002|Enrollment to Randomization|Screening Failure|0|||
25118395|NCT02011893|50230368|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
25118396|NCT02011893|50230369|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
25177438|NCT02754141|50321515|FG008|Overall Study|No longer meets study criteria|0|||
25118397|NCT02011893|50230370|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
25118398|NCT02011893|50230368|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
25118399|NCT02011893|50230369|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
25118400|NCT02011893|50230370|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
25118401|NCT02011893|50230368|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
25118402|NCT02011893|50230369|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
25118403|NCT02011893|50230370|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
25118404|NCT02011893|50230368|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
25118405|NCT02011893|50230369|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
25118406|NCT02011893|50230370|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
25118407|NCT02011893|50230368|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
25118408|NCT02011893|50230369|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
25118409|NCT02011893|50230370|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
25118410|NCT02011113|50230375|FG000|Overall Study|Adverse Event|4|||
25118411|NCT02011113|50230375|FG000|Overall Study|Disease Progression (DP)|16|||
25118412|NCT02011113|50230375|FG000|Overall Study|Death|1|||
25118413|NCT02011113|50230375|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
25118414|NCT02011113|50230375|FG000|Overall Study|Investigator's judgement- DP|3|||
25118415|NCT02011113|50230375|FG000|Overall Study|Study terminated by sponsor|11|||
25118416|NCT01807156|50230380|FG000|Overall Study|Physician Decision|1|||
25118417|NCT01987479|50230384|FG000|Overall Study|Protocol Violation|1|||
25118418|NCT01987479|50230384|FG000|Overall Study|Physician Decision|2|||
25118419|NCT01987479|50230384|FG000|Overall Study|Participant/legal guardian decision|1|||
25118420|NCT01987479|50230384|FG000|Overall Study|Other|5|||
25118421|NCT01987479|50230384|FG000|Overall Study|Lost to Follow-up|1|||
25118422|NCT01987479|50230384|FG000|Overall Study|Adverse Event|7|||
25118423|NCT01620489|50230390|FG000|Overall Study|Adverse Event|17|||
25118424|NCT01620489|50230391|FG001|Overall Study|Adverse Event|4|||
25118425|NCT01620489|50230390|FG000|Overall Study|Protocol Violation|0|||
25118426|NCT01620489|50230391|FG001|Overall Study|Protocol Violation|3|||
25118427|NCT01620489|50230390|FG000|Overall Study|Withdrawal Criteria|17|||
25118428|NCT01620489|50230391|FG001|Overall Study|Withdrawal Criteria|25|||
25118429|NCT01620489|50230390|FG000|Overall Study|Unclassified|1|||
25118430|NCT01620489|50230391|FG001|Overall Study|Unclassified|2|||
25118431|NCT02076165|50230399|FG000|Overall Study|Lost to Follow-up|7|||
25118432|NCT02076165|50230400|FG001|Overall Study|Lost to Follow-up|5|||
25118433|NCT02076165|50230399|FG000|Overall Study|Refused follow-up assessment|1|||
25118434|NCT02076165|50230400|FG001|Overall Study|Refused follow-up assessment|1|||
25118435|NCT01620255|50230411|FG000|Overall Study|Withdrawal by Subject|4|||
25118436|NCT01620255|50230412|FG001|Overall Study|Withdrawal by Subject|1|||
25118437|NCT01620255|50230413|FG002|Overall Study|Withdrawal by Subject|1|||
25118438|NCT01620255|50230414|FG003|Overall Study|Withdrawal by Subject|2|||
25118439|NCT01620255|50230415|FG004|Overall Study|Withdrawal by Subject|4|||
25118440|NCT01620255|50230411|FG000|Overall Study|Participant underwent fecal transplant|0|||
25118441|NCT01620255|50230412|FG001|Overall Study|Participant underwent fecal transplant|0|||
25118442|NCT01620255|50230413|FG002|Overall Study|Participant underwent fecal transplant|1|||
25118443|NCT01620255|50230414|FG003|Overall Study|Participant underwent fecal transplant|0|||
25118444|NCT01620255|50230415|FG004|Overall Study|Participant underwent fecal transplant|0|||
25118445|NCT01620255|50230411|FG000|Overall Study|Non-compliance|0|||
25118446|NCT01620255|50230412|FG001|Overall Study|Non-compliance|1|||
25118447|NCT01620255|50230413|FG002|Overall Study|Non-compliance|0|||
25118448|NCT01620255|50230414|FG003|Overall Study|Non-compliance|0|||
25118449|NCT01620255|50230415|FG004|Overall Study|Non-compliance|0|||
25118450|NCT01620255|50230411|FG000|Overall Study|Adverse Event|0|||
25118451|NCT01620255|50230412|FG001|Overall Study|Adverse Event|4|||
25118452|NCT01620255|50230413|FG002|Overall Study|Adverse Event|0|||
25118453|NCT01620255|50230414|FG003|Overall Study|Adverse Event|1|||
25118454|NCT01620255|50230415|FG004|Overall Study|Adverse Event|1|||
25118455|NCT01620255|50230411|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
25118456|NCT01620255|50230412|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
25118457|NCT01620255|50230413|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
25118458|NCT01620255|50230414|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
25118459|NCT01620255|50230415|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
25118460|NCT02010567|50230432|FG000|Overall Study|Adverse Event|0|||
25118461|NCT02010567|50230433|FG001|Overall Study|Adverse Event|0|||
25118462|NCT02010567|50230434|FG002|Overall Study|Adverse Event|1|||
25118463|NCT02010567|50230435|FG003|Overall Study|Adverse Event|0|||
25118464|NCT02010567|50230436|FG004|Overall Study|Adverse Event|1|||
25118465|NCT01806064|50230451|FG000|Overall Study|Randomized Not Enrolled|0|||
25118466|NCT01806064|50230452|FG001|Overall Study|Randomized Not Enrolled|0|||
25118467|NCT01806064|50230453|FG002|Overall Study|Randomized Not Enrolled|0|||
25118468|NCT01806064|50230454|FG003|Overall Study|Randomized Not Enrolled|1|||
25118469|NCT01806064|50230455|FG004|Overall Study|Randomized Not Enrolled|2|||
25118470|NCT01804582|50230473|FG000|Overall Study|Lost to Follow-up|47|||
25118471|NCT01804582|50230474|FG001|Overall Study|Lost to Follow-up|56|||
25118472|NCT01804582|50230473|FG000|Overall Study|Physician Decision|2|||
25118473|NCT01804582|50230474|FG001|Overall Study|Physician Decision|0|||
25118474|NCT01787188|50230484|FG000|Overall Study|Adverse Event|2|||
25118475|NCT01787188|50230485|FG001|Overall Study|Adverse Event|4|||
25118476|NCT01787188|50230486|FG002|Overall Study|Adverse Event|6|||
25118477|NCT01787188|50230484|FG000|Overall Study|Lack of Efficacy|7|||
25118478|NCT01787188|50230485|FG001|Overall Study|Lack of Efficacy|3|||
25118479|NCT01787188|50230486|FG002|Overall Study|Lack of Efficacy|5|||
25118480|NCT01787188|50230484|FG000|Overall Study|Non-compliance with Study Drug|0|||
25118481|NCT01787188|50230485|FG001|Overall Study|Non-compliance with Study Drug|1|||
25118482|NCT01787188|50230486|FG002|Overall Study|Non-compliance with Study Drug|0|||
25118483|NCT01787188|50230484|FG000|Overall Study|Withdrawal by Subject|4|||
25118484|NCT01787188|50230485|FG001|Overall Study|Withdrawal by Subject|3|||
25118485|NCT01787188|50230486|FG002|Overall Study|Withdrawal by Subject|2|||
25118486|NCT01787188|50230484|FG000|Overall Study|Protocol Violation|3|||
25118487|NCT01787188|50230485|FG001|Overall Study|Protocol Violation|2|||
25118488|NCT01787188|50230486|FG002|Overall Study|Protocol Violation|3|||
25118489|NCT01787188|50230484|FG000|Overall Study|Lost to Follow-up|1|||
25118490|NCT01787188|50230485|FG001|Overall Study|Lost to Follow-up|2|||
25118491|NCT01787188|50230486|FG002|Overall Study|Lost to Follow-up|2|||
25118492|NCT01787188|50230484|FG000|Overall Study|Other, including patient moved|0|||
25118493|NCT01787188|50230485|FG001|Overall Study|Other, including patient moved|3|||
25118494|NCT01787188|50230486|FG002|Overall Study|Other, including patient moved|0|||
25118495|NCT01787032|50230500|FG000|Overall Study|Protocol Violation|0|||
25118496|NCT01787032|50230501|FG001|Overall Study|Protocol Violation|0|||
25118497|NCT01787032|50230502|FG002|Overall Study|Protocol Violation|0|||
25118498|NCT01787032|50230503|FG003|Overall Study|Protocol Violation|0|||
25118499|NCT01787032|50230504|FG004|Overall Study|Protocol Violation|1|||
25118500|NCT01787032|50230505|FG005|Overall Study|Protocol Violation|1|||
25118501|NCT01737268|50230515|FG000|Overall Study|Adverse Event|6|||
25118502|NCT01737268|50230515|FG000|Overall Study|Worsening of Target Disease|2|||
25118503|NCT01737268|50230515|FG000|Overall Study|In consideration of the patient's safety|1|||
25118504|NCT01769404|50230520|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
25118505|NCT01769404|50230521|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
25118506|NCT01769404|50230520|FG000|Treatment Period 1|Withdrawal by Subject|3|||
25118507|NCT01769404|50230521|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25118508|NCT01769404|50230520|FG000|Treatment Period 1|Sponsor decision|1|||
25118509|NCT01769404|50230521|FG001|Treatment Period 1|Sponsor decision|0|||
25118510|NCT01769404|50230520|FG000|Treatment Period 2|Sponsor decision|7|||
25118511|NCT01769404|50230521|FG001|Treatment Period 2|Sponsor decision|0|||
25118512|NCT01769326|50230533|FG000|Overall Study|Lost to Follow-up|1|||
25118513|NCT01769326|50230534|FG001|Overall Study|Lost to Follow-up|2|||
25118514|NCT01769326|50230535|FG002|Overall Study|Lost to Follow-up|0|||
25118515|NCT01769326|50230536|FG003|Overall Study|Lost to Follow-up|0|||
25118516|NCT01769326|50230533|FG000|Overall Study|unrelated injry|1|||
25118517|NCT01769326|50230534|FG001|Overall Study|unrelated injry|1|||
25118518|NCT01769326|50230535|FG002|Overall Study|unrelated injry|0|||
25118519|NCT01769326|50230536|FG003|Overall Study|unrelated injry|0|||
25118520|NCT01769326|50230533|FG000|Overall Study|got a job|0|||
25118521|NCT01769326|50230534|FG001|Overall Study|got a job|1|||
25118522|NCT01769326|50230535|FG002|Overall Study|got a job|0|||
25118523|NCT01769326|50230536|FG003|Overall Study|got a job|0|||
25118524|NCT01769326|50230533|FG000|Overall Study|Got sick and could not complete study|0|||
25118525|NCT01769326|50230534|FG001|Overall Study|Got sick and could not complete study|0|||
25118526|NCT01769326|50230535|FG002|Overall Study|Got sick and could not complete study|1|||
25118527|NCT01769326|50230536|FG003|Overall Study|Got sick and could not complete study|0|||
25118528|NCT01786564|50230546|FG000|Overall Study|Lost to Follow-up|47|||
25118529|NCT01786564|50230546|FG000|Overall Study|Ineligible|17|||
25118530|NCT01786330|50230552|FG000|Overall Study|Withdrawal by Subject|0|||
25118531|NCT01786330|50230553|FG001|Overall Study|Withdrawal by Subject|1|||
25118532|NCT01786330|50230552|FG000|Overall Study|Lost to Follow-up|0|||
25118533|NCT01786330|50230553|FG001|Overall Study|Lost to Follow-up|1|||
25118534|NCT01786330|50230552|FG000|Overall Study|Excluded intraoperatively|0|||
25118535|NCT01786330|50230553|FG001|Overall Study|Excluded intraoperatively|1|||
25118536|NCT01786330|50230552|FG000|Overall Study|Protocol Violation|1|||
25118537|NCT01786330|50230553|FG001|Overall Study|Protocol Violation|0|||
25118538|NCT01786174|50230561|FG000|Overall Study|Discontinued Study Drug|2|||
25118539|NCT01786174|50230562|FG001|Overall Study|Discontinued Study Drug|0|||
25118540|NCT01736566|50230573|FG000|Long Term Follow-up|Still collecting data|42|||
25118541|NCT01736566|50230574|FG001|Long Term Follow-up|Still collecting data|0|||
25118542|NCT01736566|50230575|FG002|Long Term Follow-up|Still collecting data|49|||
25118543|NCT01736566|50230576|FG003|Long Term Follow-up|Still collecting data|0|||
25177439|NCT02754141|50321516|FG009|Overall Study|No longer meets study criteria|0|||
25118544|NCT01736566|50230577|FG004|Long Term Follow-up|Still collecting data|1|||
25177440|NCT02754141|50321517|FG010|Overall Study|No longer meets study criteria|0|||
25118545|NCT01768858|50230602|FG000|Overall Study|Lost to Follow-up|9|||
25118546|NCT01768858|50230602|FG000|Overall Study|Lack of Efficacy|8|||
25118547|NCT01768858|50230602|FG000|Overall Study|Serious Adverse Event|1|||
25118548|NCT01768858|50230602|FG000|Overall Study|Participant moved to Germany|1|||
25118549|NCT01768858|50230602|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
25118550|NCT01768858|50230602|FG000|Overall Study|Exanthema|1|||
25118551|NCT01768858|50230602|FG000|Overall Study|Withdrawal by Subject|1|||
25118552|NCT01736254|50230606|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
25118553|NCT01736254|50230606|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
25118554|NCT01767376|50230617|FG000|Overall Study|Lost to Follow-up|3|||
25118555|NCT01767376|50230618|FG001|Overall Study|Lost to Follow-up|2|||
25118556|NCT01767376|50230619|FG002|Overall Study|Lost to Follow-up|0|||
25118557|NCT01767376|50230617|FG000|Overall Study|Withdrawal by Subject|1|||
25118558|NCT01767376|50230618|FG001|Overall Study|Withdrawal by Subject|1|||
25118559|NCT01767376|50230619|FG002|Overall Study|Withdrawal by Subject|0|||
25118560|NCT01767142|50230629|FG000|Overall Study|Lost to Follow-up|3|||
25118561|NCT01785628|50230635|FG000|Overall Study|Lost to Follow-up|2|||
25118562|NCT01785628|50230636|FG001|Overall Study|Lost to Follow-up|3|||
25118563|NCT01785472|50230645|FG000|Overall Study|Adverse Event|5|||
25118564|NCT01785472|50230646|FG001|Overall Study|Adverse Event|4|||
25118565|NCT01785472|50230647|FG002|Overall Study|Adverse Event|6|||
25118566|NCT01785472|50230645|FG000|Overall Study|Lack of Efficacy|2|||
25118567|NCT01785472|50230646|FG001|Overall Study|Lack of Efficacy|0|||
25118568|NCT01785472|50230647|FG002|Overall Study|Lack of Efficacy|1|||
25118569|NCT01785472|50230645|FG000|Overall Study|Lost to Follow-up|1|||
25118570|NCT01785472|50230646|FG001|Overall Study|Lost to Follow-up|2|||
25118571|NCT01785472|50230647|FG002|Overall Study|Lost to Follow-up|0|||
25118572|NCT01785472|50230645|FG000|Overall Study|Physician Decision|1|||
25118573|NCT01785472|50230646|FG001|Overall Study|Physician Decision|1|||
25118574|NCT01785472|50230647|FG002|Overall Study|Physician Decision|1|||
25118575|NCT01785472|50230645|FG000|Overall Study|Protocol deviation|0|||
25118576|NCT01785472|50230646|FG001|Overall Study|Protocol deviation|2|||
25118577|NCT01785472|50230647|FG002|Overall Study|Protocol deviation|2|||
25118578|NCT01785472|50230645|FG000|Overall Study|Subject/guardian decision|15|||
25118579|NCT01785472|50230646|FG001|Overall Study|Subject/guardian decision|10|||
25118580|NCT01785472|50230647|FG002|Overall Study|Subject/guardian decision|11|||
25118581|NCT01785472|50230645|FG000|Overall Study|Technical problems|0|||
25118582|NCT01785472|50230646|FG001|Overall Study|Technical problems|0|||
25118583|NCT01785472|50230647|FG002|Overall Study|Technical problems|1|||
25118584|NCT01785160|50230657|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
25118585|NCT01785160|50230657|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
25118586|NCT01736176|50230663|FG000|Overall Study|Adverse Event|3|||
25118587|NCT01736176|50230663|FG000|Overall Study|Withdrawal by Subject|4|||
25118588|NCT01736176|50230663|FG000|Overall Study|Lack of Efficacy|3|||
25118589|NCT01736176|50230663|FG000|Overall Study|Unable to Complete PEG Placement|1|||
25118590|NCT01735630|50230673|FG000|Overall Study|Adverse Event|8|||
25118591|NCT01735630|50230674|FG001|Overall Study|Adverse Event|7|||
25118592|NCT01735630|50230673|FG000|Overall Study|Lost to Follow-up|1|||
25118593|NCT01735630|50230674|FG001|Overall Study|Lost to Follow-up|0|||
25118594|NCT01735630|50230673|FG000|Overall Study|Physician Decision|0|||
25118595|NCT01735630|50230674|FG001|Overall Study|Physician Decision|1|||
25118596|NCT01735630|50230673|FG000|Overall Study|Sponsor Decision|2|||
25118597|NCT01735630|50230674|FG001|Overall Study|Sponsor Decision|1|||
25118598|NCT01735630|50230673|FG000|Overall Study|Withdrawal by Subject|7|||
25118599|NCT01735630|50230674|FG001|Overall Study|Withdrawal by Subject|9|||
25118600|NCT01735396|50230680|FG000|Overall Study|not evaluable|1|||
25118601|NCT01766206|50230684|FG000|Overall Study|Withdrawal by Subject|22|||
25118602|NCT01766206|50230684|FG000|Overall Study|Lost to Follow-up|10|||
25118603|NCT01766206|50230684|FG000|Overall Study|Inappropriate enrollment|18|||
25118604|NCT01766206|50230684|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
25118605|NCT01734850|50230691|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
25118606|NCT01734850|50230692|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
25118607|NCT01734850|50230693|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
25118608|NCT01734850|50230691|FG000|Overall Study|Not infused due to manufacturing failure|0|||
25118609|NCT01734850|50230692|FG001|Overall Study|Not infused due to manufacturing failure|0|||
25118610|NCT01734850|50230693|FG002|Overall Study|Not infused due to manufacturing failure|1|||
25118611|NCT01766050|50230704|FG000|Overall Study|Adverse Event|1|||
25118612|NCT01766050|50230704|FG000|Overall Study|Lost to Follow-up|1|||
25118613|NCT01766050|50230704|FG000|Overall Study|Withdrawal by Subject|2|||
25118614|NCT02341625|50230732|FG000|Overall Study|Disease Progression|2|||
25118615|NCT02341625|50230733|FG001|Overall Study|Disease Progression|2|||
25118616|NCT02341625|50230734|FG002|Overall Study|Disease Progression|3|||
25118617|NCT02341625|50230735|FG003|Overall Study|Disease Progression|6|||
25118618|NCT02341625|50230736|FG004|Overall Study|Disease Progression|7|||
25118619|NCT02341625|50230737|FG005|Overall Study|Disease Progression|7|||
25118620|NCT02341625|50230738|FG006|Overall Study|Disease Progression|28|||
25118621|NCT02341625|50230739|FG007|Overall Study|Disease Progression|5|||
25118622|NCT02341625|50230740|FG008|Overall Study|Disease Progression|4|||
25118623|NCT02341625|50230741|FG009|Overall Study|Disease Progression|19|||
25118624|NCT02341625|50230732|FG000|Overall Study|Study Drug Toxicity|0|||
25118625|NCT02341625|50230733|FG001|Overall Study|Study Drug Toxicity|0|||
25118626|NCT02341625|50230734|FG002|Overall Study|Study Drug Toxicity|0|||
25118627|NCT02341625|50230735|FG003|Overall Study|Study Drug Toxicity|1|||
25118628|NCT02341625|50230736|FG004|Overall Study|Study Drug Toxicity|0|||
25118629|NCT02341625|50230737|FG005|Overall Study|Study Drug Toxicity|3|||
25118630|NCT02341625|50230738|FG006|Overall Study|Study Drug Toxicity|10|||
25118631|NCT02341625|50230739|FG007|Overall Study|Study Drug Toxicity|0|||
25118632|NCT02341625|50230740|FG008|Overall Study|Study Drug Toxicity|0|||
25118633|NCT02341625|50230741|FG009|Overall Study|Study Drug Toxicity|3|||
25118634|NCT02341625|50230732|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
25118635|NCT02341625|50230733|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
25118636|NCT02341625|50230734|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
25118637|NCT02341625|50230735|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
25118638|NCT02341625|50230736|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
25118639|NCT02341625|50230737|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
25118640|NCT02341625|50230738|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
25118641|NCT02341625|50230739|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
25118642|NCT02341625|50230740|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
25118643|NCT02341625|50230741|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
25118644|NCT02341625|50230732|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
25118645|NCT02341625|50230733|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
25118646|NCT02341625|50230734|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
25118647|NCT02341625|50230735|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
25118648|NCT02341625|50230736|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
25118649|NCT02341625|50230737|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
25118650|NCT02341625|50230738|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
25118651|NCT02341625|50230739|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
25118652|NCT02341625|50230740|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
25118653|NCT02341625|50230741|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
25118654|NCT02341625|50230732|FG000|Overall Study|Participant Withdrew Consent|0|||
25118655|NCT02341625|50230733|FG001|Overall Study|Participant Withdrew Consent|0|||
25118656|NCT02341625|50230734|FG002|Overall Study|Participant Withdrew Consent|0|||
25118657|NCT02341625|50230735|FG003|Overall Study|Participant Withdrew Consent|1|||
25118658|NCT02341625|50230736|FG004|Overall Study|Participant Withdrew Consent|0|||
25118659|NCT02341625|50230737|FG005|Overall Study|Participant Withdrew Consent|0|||
25118660|NCT02341625|50230738|FG006|Overall Study|Participant Withdrew Consent|0|||
25118661|NCT02341625|50230739|FG007|Overall Study|Participant Withdrew Consent|0|||
25118662|NCT02341625|50230740|FG008|Overall Study|Participant Withdrew Consent|0|||
25118663|NCT02341625|50230741|FG009|Overall Study|Participant Withdrew Consent|0|||
25118664|NCT02341625|50230732|FG000|Overall Study|Completed Treatment as per Protocol|0|||
25118665|NCT02341625|50230733|FG001|Overall Study|Completed Treatment as per Protocol|0|||
25118666|NCT02341625|50230734|FG002|Overall Study|Completed Treatment as per Protocol|0|||
25118667|NCT02341625|50230735|FG003|Overall Study|Completed Treatment as per Protocol|0|||
25118668|NCT02341625|50230736|FG004|Overall Study|Completed Treatment as per Protocol|0|||
25118669|NCT02341625|50230737|FG005|Overall Study|Completed Treatment as per Protocol|0|||
25118670|NCT02341625|50230738|FG006|Overall Study|Completed Treatment as per Protocol|0|||
25118671|NCT02341625|50230739|FG007|Overall Study|Completed Treatment as per Protocol|0|||
25118672|NCT02341625|50230740|FG008|Overall Study|Completed Treatment as per Protocol|0|||
25118673|NCT02341625|50230741|FG009|Overall Study|Completed Treatment as per Protocol|1|||
25118674|NCT02341625|50230732|FG000|Overall Study|Other Reasons|0|||
25118675|NCT02341625|50230733|FG001|Overall Study|Other Reasons|0|||
25118676|NCT02341625|50230734|FG002|Overall Study|Other Reasons|0|||
25118677|NCT02341625|50230735|FG003|Overall Study|Other Reasons|0|||
25118678|NCT02341625|50230736|FG004|Overall Study|Other Reasons|1|||
25118679|NCT02341625|50230737|FG005|Overall Study|Other Reasons|0|||
25118680|NCT02341625|50230738|FG006|Overall Study|Other Reasons|5|||
25118681|NCT02341625|50230739|FG007|Overall Study|Other Reasons|0|||
25118682|NCT02341625|50230740|FG008|Overall Study|Other Reasons|0|||
25118683|NCT02341625|50230741|FG009|Overall Study|Other Reasons|2|||
25118684|NCT02341625|50230732|FG000|Overall Study|Not Reported|0|||
25118685|NCT02341625|50230733|FG001|Overall Study|Not Reported|0|||
25118686|NCT02341625|50230734|FG002|Overall Study|Not Reported|0|||
25118687|NCT02341625|50230735|FG003|Overall Study|Not Reported|0|||
25118688|NCT02341625|50230736|FG004|Overall Study|Not Reported|0|||
25118689|NCT02341625|50230737|FG005|Overall Study|Not Reported|0|||
25118690|NCT02341625|50230738|FG006|Overall Study|Not Reported|0|||
25118691|NCT02341625|50230739|FG007|Overall Study|Not Reported|0|||
25118692|NCT02341625|50230740|FG008|Overall Study|Not Reported|0|||
25118693|NCT02341625|50230741|FG009|Overall Study|Not Reported|3|||
25118694|NCT02370095|50230788|FG000|Overall Study|Withdrawal by Subject|0|||
25118695|NCT02370095|50230789|FG001|Overall Study|Withdrawal by Subject|1|||
25118696|NCT01783678|50230801|FG000|Overall Study|Randomized but Not Treated|0|||
25118697|NCT01783678|50230802|FG001|Overall Study|Randomized but Not Treated|0|||
25118698|NCT01783678|50230803|FG002|Overall Study|Randomized but Not Treated|0|||
25118699|NCT01783678|50230804|FG003|Overall Study|Randomized but Not Treated|1|||
25118700|NCT01783678|50230805|FG004|Overall Study|Randomized but Not Treated|0|||
25118701|NCT01783678|50230806|FG005|Overall Study|Randomized but Not Treated|0|||
25118702|NCT01783678|50230801|FG000|Overall Study|Lack of Efficacy|1|||
25118703|NCT01783678|50230802|FG001|Overall Study|Lack of Efficacy|13|||
25118704|NCT01783678|50230803|FG002|Overall Study|Lack of Efficacy|1|||
25118705|NCT01783678|50230804|FG003|Overall Study|Lack of Efficacy|3|||
25118706|NCT01783678|50230805|FG004|Overall Study|Lack of Efficacy|6|||
25118707|NCT01783678|50230806|FG005|Overall Study|Lack of Efficacy|5|||
25118708|NCT01783678|50230801|FG000|Overall Study|Lost to Follow-up|0|||
25118709|NCT01783678|50230802|FG001|Overall Study|Lost to Follow-up|4|||
25118710|NCT01783678|50230803|FG002|Overall Study|Lost to Follow-up|0|||
25118711|NCT01783678|50230804|FG003|Overall Study|Lost to Follow-up|2|||
25118712|NCT01783678|50230805|FG004|Overall Study|Lost to Follow-up|1|||
25118713|NCT01783678|50230806|FG005|Overall Study|Lost to Follow-up|0|||
25118714|NCT01783678|50230801|FG000|Overall Study|Withdrew Consent|1|||
25118715|NCT01783678|50230802|FG001|Overall Study|Withdrew Consent|1|||
25118716|NCT01783678|50230803|FG002|Overall Study|Withdrew Consent|0|||
25118717|NCT01783678|50230804|FG003|Overall Study|Withdrew Consent|2|||
25118718|NCT01783678|50230805|FG004|Overall Study|Withdrew Consent|0|||
25118719|NCT01783678|50230806|FG005|Overall Study|Withdrew Consent|0|||
25118720|NCT01734772|50230823|FG000|Overall Study|Adverse Event|1|||
25118721|NCT01734772|50230824|FG001|Overall Study|Adverse Event|2|||
25118722|NCT01734772|50230823|FG000|Overall Study|Withdrawal by Subject|0|||
25118723|NCT01734772|50230824|FG001|Overall Study|Withdrawal by Subject|1|||
25118724|NCT02340221|50230838|FG000|Overall Study|Death|100|||
25118725|NCT02340221|50230839|FG001|Overall Study|Death|197|||
25118726|NCT02340221|50230838|FG000|Overall Study|Withdrawal by Participant|24|||
25118727|NCT02340221|50230839|FG001|Overall Study|Withdrawal by Participant|37|||
25118728|NCT02340221|50230838|FG000|Overall Study|Lost to Follow-up|4|||
25118729|NCT02340221|50230839|FG001|Overall Study|Lost to Follow-up|15|||
25118730|NCT02340221|50230838|FG000|Overall Study|Reason Not Specified|85|||
25118731|NCT02340221|50230839|FG001|Overall Study|Reason Not Specified|165|||
25118732|NCT02340221|50230838|FG000|Overall Study|Study Terminated by Sponsor|1|||
25118733|NCT02340221|50230839|FG001|Overall Study|Study Terminated by Sponsor|3|||
25118734|NCT02339909|50230849|FG000|Overall Study|Became ineligible after randomisation|89|||
25118735|NCT02339909|50230850|FG001|Overall Study|Became ineligible after randomisation|63|||
25118736|NCT02339909|50230851|FG002|Overall Study|Became ineligible after randomisation|71|||
25118737|NCT02395133|50230863|FG000|Overall Study|Adverse Event|4|||
25118738|NCT02395133|50230864|FG001|Overall Study|Adverse Event|1|||
25118739|NCT02395133|50230865|FG002|Overall Study|Adverse Event|3|||
25118740|NCT02395133|50230866|FG003|Overall Study|Adverse Event|0|||
25118741|NCT02395133|50230863|FG000|Overall Study|Lack of Efficacy|1|||
25118742|NCT02395133|50230864|FG001|Overall Study|Lack of Efficacy|0|||
25118743|NCT02395133|50230865|FG002|Overall Study|Lack of Efficacy|1|||
25118744|NCT02395133|50230866|FG003|Overall Study|Lack of Efficacy|1|||
25118745|NCT02395133|50230863|FG000|Overall Study|Protocol Violation|1|||
25118746|NCT02395133|50230864|FG001|Overall Study|Protocol Violation|1|||
25118747|NCT02395133|50230865|FG002|Overall Study|Protocol Violation|0|||
25118748|NCT02395133|50230866|FG003|Overall Study|Protocol Violation|3|||
25118749|NCT02395133|50230863|FG000|Overall Study|Lost to Follow-up|0|||
25118750|NCT02395133|50230864|FG001|Overall Study|Lost to Follow-up|1|||
25118751|NCT02395133|50230865|FG002|Overall Study|Lost to Follow-up|1|||
25118752|NCT02395133|50230866|FG003|Overall Study|Lost to Follow-up|0|||
25118753|NCT02395133|50230863|FG000|Overall Study|Pregnancy|0|||
25118754|NCT02395133|50230864|FG001|Overall Study|Pregnancy|0|||
25118755|NCT02395133|50230865|FG002|Overall Study|Pregnancy|3|||
25118756|NCT02395133|50230866|FG003|Overall Study|Pregnancy|0|||
25118757|NCT02395133|50230863|FG000|Overall Study|Consent withdrawn with no reason given|1|||
25118758|NCT02395133|50230864|FG001|Overall Study|Consent withdrawn with no reason given|3|||
25118759|NCT02395133|50230865|FG002|Overall Study|Consent withdrawn with no reason given|0|||
25118760|NCT02395133|50230866|FG003|Overall Study|Consent withdrawn with no reason given|2|||
25118761|NCT02395133|50230863|FG000|Overall Study|Consent withdrawn with personal reason|0|||
25118762|NCT02395133|50230864|FG001|Overall Study|Consent withdrawn with personal reason|1|||
25118763|NCT02395133|50230865|FG002|Overall Study|Consent withdrawn with personal reason|0|||
25118764|NCT02395133|50230866|FG003|Overall Study|Consent withdrawn with personal reason|3|||
25118765|NCT02395133|50230863|FG000|Overall Study|Sponsor decision|2|||
25118766|NCT02395133|50230864|FG001|Overall Study|Sponsor decision|0|||
25118767|NCT02395133|50230865|FG002|Overall Study|Sponsor decision|0|||
25118768|NCT02395133|50230866|FG003|Overall Study|Sponsor decision|1|||
25118769|NCT02395133|50230863|FG000|Overall Study|Other than specified above|5|||
25118770|NCT02395133|50230864|FG001|Overall Study|Other than specified above|2|||
25118771|NCT02395133|50230865|FG002|Overall Study|Other than specified above|2|||
25118772|NCT02395133|50230866|FG003|Overall Study|Other than specified above|4|||
25118773|NCT02395055|50230878|FG000|Overall Study|Withdrawal by Subject|7|||
25118774|NCT02395055|50230879|FG001|Overall Study|Withdrawal by Subject|3|||
25118775|NCT02369159|50230887|FG000|Overall Study|Adverse Event|0|||
25118776|NCT02369159|50230888|FG001|Overall Study|Adverse Event|1|||
25118777|NCT02369159|50230887|FG000|Overall Study|Lost to Follow-up|1|||
25118778|NCT02369159|50230888|FG001|Overall Study|Lost to Follow-up|1|||
25118779|NCT02369159|50230887|FG000|Overall Study|Withdrawal by Subject|7|||
25118780|NCT02369159|50230888|FG001|Overall Study|Withdrawal by Subject|0|||
25118781|NCT02368691|50230905|FG000|Overall Study|Death|13|||
25118782|NCT02368691|50230905|FG000|Overall Study|Lack of Efficacy|15|||
25118783|NCT02368691|50230905|FG000|Overall Study|Physician Decision|4|||
25118784|NCT02394665|50230912|FG000|Overall Study|Physician Decision|1|||
25118785|NCT02394665|50230913|FG001|Overall Study|Physician Decision|0|||
25118786|NCT02394665|50230914|FG002|Overall Study|Physician Decision|0|||
25118787|NCT02367911|50230924|FG000|Overall Study|Withdrawal by Subject|3|||
25118788|NCT02367911|50230925|FG001|Overall Study|Withdrawal by Subject|2|||
25118789|NCT02367911|50230924|FG000|Overall Study|Lost to Follow-up|2|||
25118790|NCT02367911|50230925|FG001|Overall Study|Lost to Follow-up|2|||
25118791|NCT02339285|50230934|FG000|Overall Study|Withdrawal by Subject|0|||
25118792|NCT02339285|50230935|FG001|Overall Study|Withdrawal by Subject|1|||
25118793|NCT02339285|50230936|FG002|Overall Study|Withdrawal by Subject|1|||
25118794|NCT02339285|50230934|FG000|Overall Study|Lost to Follow-up|1|||
25118795|NCT02339285|50230935|FG001|Overall Study|Lost to Follow-up|1|||
25118796|NCT02339285|50230936|FG002|Overall Study|Lost to Follow-up|1|||
25118797|NCT02339285|50230934|FG000|Overall Study|Protocol Deviation|0|||
25118798|NCT02339285|50230935|FG001|Overall Study|Protocol Deviation|1|||
25118799|NCT02339285|50230936|FG002|Overall Study|Protocol Deviation|0|||
25118800|NCT02367833|50230947|FG000|Overall Study|Withdrawal by Subject|1|||
25118801|NCT02367833|50230948|FG001|Overall Study|Withdrawal by Subject|1|||
25118802|NCT02367833|50230949|FG002|Overall Study|Withdrawal by Subject|0|||
25118803|NCT02367521|50230959|FG000|Overall Study|severe headache after intervention|2|||
25118804|NCT02367521|50230960|FG001|Overall Study|severe headache after intervention|0|||
25118805|NCT02367521|50230959|FG000|Overall Study|unable to find transportation|2|||
25118806|NCT02367521|50230960|FG001|Overall Study|unable to find transportation|0|||
25118807|NCT02338193|50230969|FG000|Overall Study|Withdrawal by Subject|0|||
25118808|NCT02338193|50230970|FG001|Overall Study|Withdrawal by Subject|0|||
25118809|NCT02338193|50230971|FG002|Overall Study|Withdrawal by Subject|2|||
25118810|NCT02338193|50230969|FG000|Overall Study|Pregnancy|0|||
25118811|NCT02338193|50230970|FG001|Overall Study|Pregnancy|1|||
25118812|NCT02338193|50230971|FG002|Overall Study|Pregnancy|1|||
25118813|NCT02338193|50230969|FG000|Overall Study|Noncompliant with visits|2|||
25118814|NCT02338193|50230970|FG001|Overall Study|Noncompliant with visits|2|||
25118815|NCT02338193|50230971|FG002|Overall Study|Noncompliant with visits|7|||
25118816|NCT02338193|50230969|FG000|Overall Study|moved out of state|0|||
25118817|NCT02338193|50230970|FG001|Overall Study|moved out of state|1|||
25118818|NCT02338193|50230971|FG002|Overall Study|moved out of state|0|||
25118819|NCT02338193|50230969|FG000|Overall Study|intolerant of side effects|1|||
25118820|NCT02338193|50230970|FG001|Overall Study|intolerant of side effects|0|||
25118821|NCT02338193|50230971|FG002|Overall Study|intolerant of side effects|0|||
25118822|NCT01783444|50230982|FG000|Treatment Phase|Adverse Event|9|||
25118823|NCT01783444|50230983|FG001|Treatment Phase|Adverse Event|20|||
25118824|NCT01783444|50230984|FG002|Treatment Phase|Adverse Event|19|||
25118825|NCT01783444|50230982|FG000|Treatment Phase|Disease Progression|76|||
25118826|NCT01783444|50230983|FG001|Treatment Phase|Disease Progression|66|||
25118827|NCT01783444|50230984|FG002|Treatment Phase|Disease Progression|64|||
25118828|NCT01783444|50230982|FG000|Treatment Phase|Death|2|||
25118829|NCT01783444|50230983|FG001|Treatment Phase|Death|2|||
25118830|NCT01783444|50230984|FG002|Treatment Phase|Death|2|||
25118831|NCT01783444|50230982|FG000|Treatment Phase|Protocol Violation|1|||
25118832|NCT01783444|50230983|FG001|Treatment Phase|Protocol Violation|1|||
25118833|NCT01783444|50230984|FG002|Treatment Phase|Protocol Violation|2|||
25118834|NCT01783444|50230982|FG000|Treatment Phase|Withdrawal by Subject|6|||
25118835|NCT01783444|50230983|FG001|Treatment Phase|Withdrawal by Subject|8|||
25118836|NCT01783444|50230984|FG002|Treatment Phase|Withdrawal by Subject|9|||
25118837|NCT01783444|50230982|FG000|Treatment Phase|Administrative problems|2|||
25118838|NCT01783444|50230983|FG001|Treatment Phase|Administrative problems|0|||
25118839|NCT01783444|50230984|FG002|Treatment Phase|Administrative problems|1|||
25118840|NCT01783444|50230982|FG000|Treatment Phase|Physician Decision|8|||
25118841|NCT01783444|50230983|FG001|Treatment Phase|Physician Decision|6|||
25118842|NCT01783444|50230984|FG002|Treatment Phase|Physician Decision|5|||
25118843|NCT01783444|50230982|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
25118844|NCT01783444|50230983|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
25118845|NCT01783444|50230984|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
25118846|NCT01783444|50230982|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
25118847|NCT01783444|50230983|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
25118848|NCT01783444|50230984|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
25118849|NCT01783444|50230982|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
25118850|NCT01783444|50230983|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
25118851|NCT01783444|50230984|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
25118852|NCT01783444|50230982|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
25118853|NCT01783444|50230983|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
25118854|NCT01783444|50230984|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
25118855|NCT01783444|50230982|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
25118856|NCT01783444|50230983|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
25118857|NCT01783444|50230984|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
25118858|NCT01783444|50230982|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
25118859|NCT01783444|50230983|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
25118860|NCT01783444|50230984|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
25118861|NCT02367131|50230993|FG000|Overall Study|Adverse Event|64|||
25118862|NCT02367131|50230993|FG000|Overall Study|No visit since the first visit|4|||
25118863|NCT02367131|50230993|FG000|Overall Study|Request by patient|54|||
25118864|NCT02367131|50230993|FG000|Overall Study|Improvement/remission|2|||
25118865|NCT02367131|50230993|FG000|Overall Study|No change/progressive disease|78|||
25118866|NCT02367131|50230993|FG000|Overall Study|Other than stated above|20|||
25118867|NCT02394275|50230997|FG000|Overall Study|Adverse Event|22|||
25118868|NCT02394275|50230997|FG000|Overall Study|Lost to Follow-up|7|||
25118869|NCT01608724|50231002|FG000|Overall Study|Withdrawal by Subject|131|||
25118870|NCT01608724|50231002|FG000|Overall Study|Lost to Follow-up|41|||
25118871|NCT01608724|50231002|FG000|Overall Study|Study-specific discontinuation criteria|32|||
25118872|NCT01608724|50231002|FG000|Overall Study|Adverse Event|29|||
25118873|NCT01608724|50231002|FG000|Overall Study|Protocol Violation|6|||
25118874|NCT01608724|50231002|FG000|Overall Study|bood sugar too high, etc.|3|||
25118875|NCT01608724|50231002|FG000|Overall Study|Safety reasons|1|||
25118876|NCT02366195|50231006|FG000|Overall Study|Protocol-specified criteria|3|||
25118877|NCT02366195|50231006|FG000|Overall Study|Withdrawal by Subject|9|||
25118878|NCT02366195|50231006|FG000|Overall Study|Lost to Follow-up|1|||
25118879|NCT02366195|50231006|FG000|Overall Study|Death|41|||
25118880|NCT02364947|50231013|FG000|Overall Study|Withdrawal by Subject|10|||
25118881|NCT02364947|50231014|FG001|Overall Study|Withdrawal by Subject|8|||
25118882|NCT02364947|50231015|FG002|Overall Study|Withdrawal by Subject|9|||
25118883|NCT02364947|50231013|FG000|Overall Study|Adverse Event|45|||
25118884|NCT02364947|50231014|FG001|Overall Study|Adverse Event|33|||
25118885|NCT02364947|50231015|FG002|Overall Study|Adverse Event|11|||
25118886|NCT02364947|50231013|FG000|Overall Study|Protocol Violation|1|||
25118887|NCT02364947|50231014|FG001|Overall Study|Protocol Violation|1|||
25118888|NCT02364947|50231015|FG002|Overall Study|Protocol Violation|1|||
25118889|NCT02364947|50231013|FG000|Overall Study|Physician Decision|3|||
25118890|NCT02364947|50231014|FG001|Overall Study|Physician Decision|2|||
25118891|NCT02364947|50231015|FG002|Overall Study|Physician Decision|5|||
25118892|NCT02364947|50231013|FG000|Overall Study|Death|0|||
25118893|NCT02364947|50231014|FG001|Overall Study|Death|1|||
25118894|NCT02364947|50231015|FG002|Overall Study|Death|0|||
25118895|NCT02392481|50231027|FG000|Overall Study|Adverse Event|0|||
25118896|NCT02392481|50231028|FG001|Overall Study|Adverse Event|0|||
25118897|NCT02392481|50231029|FG002|Overall Study|Adverse Event|1|||
25118898|NCT02392481|50231030|FG003|Overall Study|Adverse Event|2|||
25118899|NCT02392481|50231027|FG000|Overall Study|Withdrawal by Subject|0|||
25118900|NCT02392481|50231028|FG001|Overall Study|Withdrawal by Subject|0|||
25118901|NCT02392481|50231029|FG002|Overall Study|Withdrawal by Subject|1|||
25118902|NCT02392481|50231030|FG003|Overall Study|Withdrawal by Subject|0|||
25118903|NCT02392403|50231040|FG000|Overall Study|Adverse Event|1|||
25118904|NCT02392403|50231040|FG000|Overall Study|Death|1|||
25118905|NCT02392403|50231040|FG000|Overall Study|Withdrawal by Subject|1|||
25118906|NCT02392247|50231044|FG000|Overall Study|Withdrawal by Subject|1|||
25118907|NCT02392247|50231044|FG000|Overall Study|Surgery cancelled; no data|1|||
25118908|NCT02337725|50231050|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
25118909|NCT02337725|50231051|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
25118910|NCT02337725|50231050|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
25118911|NCT02337725|50231051|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
25118912|NCT02337725|50231050|FG000|Overall Study|Major Protocol Deviation|0|||
25118913|NCT02337725|50231051|FG001|Overall Study|Major Protocol Deviation|1|||
25118914|NCT02337725|50231050|FG000|Overall Study|Voluntary Withdrawal|14|||
25118915|NCT02337725|50231051|FG001|Overall Study|Voluntary Withdrawal|3|||
25118916|NCT02337725|50231050|FG000|Overall Study|Lack of Efficacy|4|||
25118917|NCT02337725|50231051|FG001|Overall Study|Lack of Efficacy|0|||
25118918|NCT02337491|50231059|FG000|Overall Study|Death|1|||
25118919|NCT02337491|50231060|FG001|Overall Study|Death|1|||
25118920|NCT02337491|50231059|FG000|Overall Study|Adverse Event|0|||
25118921|NCT02337491|50231060|FG001|Overall Study|Adverse Event|1|||
25118922|NCT02337491|50231059|FG000|Overall Study|Withdrawal by Subject|3|||
25118923|NCT02337491|50231060|FG001|Overall Study|Withdrawal by Subject|0|||
25118924|NCT02337491|50231059|FG000|Overall Study|Progressive Disease|44|||
25118925|NCT02337491|50231060|FG001|Overall Study|Progressive Disease|28|||
25118926|NCT02337491|50231059|FG000|Overall Study|On Treatment|2|||
25118927|NCT02337491|50231060|FG001|Overall Study|On Treatment|0|||
25118928|NCT01765582|50231070|FG000|Overall Study|Other|3|||
25118929|NCT01765582|50231071|FG001|Overall Study|Other|6|||
25118930|NCT01765582|50231072|FG002|Overall Study|Other|9|||
25118931|NCT01765582|50231070|FG000|Overall Study|Lost to Follow-up|2|||
25118932|NCT01765582|50231071|FG001|Overall Study|Lost to Follow-up|2|||
25118933|NCT01765582|50231072|FG002|Overall Study|Lost to Follow-up|1|||
25118934|NCT01765582|50231070|FG000|Overall Study|Death|31|||
25118935|NCT01765582|50231071|FG001|Overall Study|Death|36|||
25118936|NCT01765582|50231072|FG002|Overall Study|Death|33|||
25118937|NCT01765582|50231070|FG000|Overall Study|Sponsor Decision|46|||
25118938|NCT01765582|50231071|FG001|Overall Study|Sponsor Decision|42|||
25118939|NCT01765582|50231072|FG002|Overall Study|Sponsor Decision|42|||
25118940|NCT01765582|50231070|FG000|Overall Study|Withdrawal of Consent|11|||
25118941|NCT01765582|50231071|FG001|Overall Study|Withdrawal of Consent|6|||
25118942|NCT01765582|50231072|FG002|Overall Study|Withdrawal of Consent|10|||
25118943|NCT01649375|50231084|FG000|Up to Week 16|Adverse Event|2|||
25118944|NCT01649375|50231085|FG001|Up to Week 16|Adverse Event|5|||
25118945|NCT01649375|50231086|FG002|Up to Week 16|Adverse Event|4|||
25118946|NCT01649375|50231087|FG003|Up to Week 16|Adverse Event|0|||
25118947|NCT01649375|50231088|FG004|Up to Week 16|Adverse Event|0|||
25118948|NCT01649375|50231084|FG000|Up to Week 16|Lack of Efficacy|0|||
25118949|NCT01649375|50231085|FG001|Up to Week 16|Lack of Efficacy|0|||
25118950|NCT01649375|50231086|FG002|Up to Week 16|Lack of Efficacy|1|||
25261628|NCT01302054|50576275|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
25261629|NCT01302054|50576273|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
25118951|NCT01649375|50231087|FG003|Up to Week 16|Lack of Efficacy|0|||
25118952|NCT01649375|50231088|FG004|Up to Week 16|Lack of Efficacy|0|||
25118953|NCT01649375|50231084|FG000|Up to Week 16|Physician Decision|0|||
25118954|NCT01649375|50231085|FG001|Up to Week 16|Physician Decision|0|||
25118955|NCT01649375|50231086|FG002|Up to Week 16|Physician Decision|1|||
25118956|NCT01649375|50231087|FG003|Up to Week 16|Physician Decision|0|||
25118957|NCT01649375|50231088|FG004|Up to Week 16|Physician Decision|0|||
25118958|NCT01649375|50231084|FG000|Up to Week 16|Withdrawal by Subject|2|||
25118959|NCT01649375|50231085|FG001|Up to Week 16|Withdrawal by Subject|1|||
25118960|NCT01649375|50231086|FG002|Up to Week 16|Withdrawal by Subject|2|||
25118961|NCT01649375|50231087|FG003|Up to Week 16|Withdrawal by Subject|0|||
25118962|NCT01649375|50231088|FG004|Up to Week 16|Withdrawal by Subject|0|||
25118963|NCT01649375|50231084|FG000|Up to Week 16|Death|1|||
25118964|NCT01649375|50231085|FG001|Up to Week 16|Death|0|||
25118965|NCT01649375|50231086|FG002|Up to Week 16|Death|0|||
25118966|NCT01649375|50231087|FG003|Up to Week 16|Death|0|||
25118967|NCT01649375|50231088|FG004|Up to Week 16|Death|0|||
25118968|NCT01649375|50231084|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
25118969|NCT01649375|50231085|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
25118970|NCT01649375|50231086|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
25118971|NCT01649375|50231087|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
25118972|NCT01649375|50231088|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
25118973|NCT01649375|50231084|FG000|Week 16 up to Week 260|Non-compliance|0|||
25118974|NCT01649375|50231085|FG001|Week 16 up to Week 260|Non-compliance|1|||
25118975|NCT01649375|50231086|FG002|Week 16 up to Week 260|Non-compliance|0|||
25118976|NCT01649375|50231087|FG003|Week 16 up to Week 260|Non-compliance|1|||
25118977|NCT01649375|50231088|FG004|Week 16 up to Week 260|Non-compliance|0|||
25118978|NCT01649375|50231084|FG000|Week 16 up to Week 260|Physician Decision|0|||
25118979|NCT01649375|50231085|FG001|Week 16 up to Week 260|Physician Decision|2|||
25118980|NCT01649375|50231086|FG002|Week 16 up to Week 260|Physician Decision|0|||
25118981|NCT01649375|50231087|FG003|Week 16 up to Week 260|Physician Decision|0|||
25118982|NCT01649375|50231088|FG004|Week 16 up to Week 260|Physician Decision|0|||
25118983|NCT01649375|50231084|FG000|Week 16 up to Week 260|Technical issues|0|||
25118984|NCT01649375|50231085|FG001|Week 16 up to Week 260|Technical issues|1|||
25118985|NCT01649375|50231086|FG002|Week 16 up to Week 260|Technical issues|0|||
25118986|NCT01649375|50231087|FG003|Week 16 up to Week 260|Technical issues|1|||
25118987|NCT01649375|50231088|FG004|Week 16 up to Week 260|Technical issues|0|||
25118988|NCT01649375|50231084|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
25118989|NCT01649375|50231085|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
25118990|NCT01649375|50231086|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
25118991|NCT01649375|50231087|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
25118992|NCT01649375|50231088|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
25118993|NCT01649375|50231084|FG000|Week 16 up to Week 260|Death|1|||
25118994|NCT01649375|50231085|FG001|Week 16 up to Week 260|Death|1|||
25118995|NCT01649375|50231086|FG002|Week 16 up to Week 260|Death|0|||
25118996|NCT01649375|50231087|FG003|Week 16 up to Week 260|Death|0|||
25118997|NCT01649375|50231088|FG004|Week 16 up to Week 260|Death|0|||
25118998|NCT01649375|50231084|FG000|Week 16 up to Week 260|Adverse Event|5|||
25118999|NCT01649375|50231085|FG001|Week 16 up to Week 260|Adverse Event|2|||
25119000|NCT01649375|50231086|FG002|Week 16 up to Week 260|Adverse Event|0|||
25119001|NCT01649375|50231087|FG003|Week 16 up to Week 260|Adverse Event|3|||
25119002|NCT01649375|50231088|FG004|Week 16 up to Week 260|Adverse Event|2|||
25119003|NCT02336555|50231098|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25119004|NCT02336555|50231099|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
25119005|NCT02336555|50231098|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
25119006|NCT02336555|50231099|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
25119007|NCT02336555|50231098|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
25119008|NCT02336555|50231099|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
25119009|NCT01648283|50231105|FG000|Overall Study|Withdrawal by Subject|14|||
25119010|NCT01649297|50231116|FG000|Overall Study|Adverse Event|5|||
25119011|NCT01649297|50231117|FG001|Overall Study|Adverse Event|5|||
25119012|NCT01649297|50231118|FG002|Overall Study|Adverse Event|4|||
25119013|NCT01649297|50231119|FG003|Overall Study|Adverse Event|13|||
25119014|NCT01649297|50231120|FG004|Overall Study|Adverse Event|1|||
25119015|NCT01649297|50231116|FG000|Overall Study|Lack of Efficacy|0|||
25119016|NCT01649297|50231117|FG001|Overall Study|Lack of Efficacy|0|||
25119017|NCT01649297|50231118|FG002|Overall Study|Lack of Efficacy|0|||
25119018|NCT01649297|50231119|FG003|Overall Study|Lack of Efficacy|0|||
25119019|NCT01649297|50231120|FG004|Overall Study|Lack of Efficacy|1|||
25119020|NCT01649297|50231116|FG000|Overall Study|Non compliant with Protocol|1|||
25119021|NCT01649297|50231117|FG001|Overall Study|Non compliant with Protocol|0|||
25119022|NCT01649297|50231118|FG002|Overall Study|Non compliant with Protocol|3|||
25119023|NCT01649297|50231119|FG003|Overall Study|Non compliant with Protocol|2|||
25119024|NCT01649297|50231120|FG004|Overall Study|Non compliant with Protocol|1|||
25119025|NCT01649297|50231116|FG000|Overall Study|Lost to Follow-up|1|||
25119026|NCT01649297|50231117|FG001|Overall Study|Lost to Follow-up|1|||
25119027|NCT01649297|50231118|FG002|Overall Study|Lost to Follow-up|4|||
25119028|NCT01649297|50231119|FG003|Overall Study|Lost to Follow-up|3|||
25119029|NCT01649297|50231120|FG004|Overall Study|Lost to Follow-up|0|||
25119030|NCT01649297|50231116|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
25119031|NCT01649297|50231117|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
25119032|NCT01649297|50231118|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
25119033|NCT01649297|50231119|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
25119034|NCT01649297|50231120|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
25119035|NCT01649297|50231116|FG000|Overall Study|For other reason|4|||
25119036|NCT01649297|50231117|FG001|Overall Study|For other reason|1|||
25119037|NCT01649297|50231118|FG002|Overall Study|For other reason|2|||
25119038|NCT01649297|50231119|FG003|Overall Study|For other reason|0|||
25119039|NCT01649297|50231120|FG004|Overall Study|For other reason|0|||
25119040|NCT01648205|50231132|FG000|Placebo|Pregnancy|1|||
25119041|NCT01648205|50231132|FG000|Placebo|Withdrawal by Subject|1|||
25119042|NCT01648205|50231132|FG000|Placebo|Protocol Violation|2|||
25119043|NCT01648205|50231132|FG000|Ranolazine|Death|1|||
25119044|NCT01648205|50231132|FG000|Ranolazine|Withdrawal by Subject|1|||
25119045|NCT01648205|50231132|FG000|Ranolazine|Protocol Violation|3|||
25119046|NCT02391545|50231142|FG000|Overall Study|Death|0|||
25119047|NCT02391545|50231143|FG001|Overall Study|Death|2|||
25119048|NCT02391545|50231142|FG000|Overall Study|Lost to Follow-up|0|||
25119049|NCT02391545|50231143|FG001|Overall Study|Lost to Follow-up|1|||
25119050|NCT02391545|50231142|FG000|Overall Study|Termination of study by sponsor|20|||
25119051|NCT02391545|50231143|FG001|Overall Study|Termination of study by sponsor|20|||
25119052|NCT02391545|50231142|FG000|Overall Study|Withdrawal by Subject|0|||
25119053|NCT02391545|50231143|FG001|Overall Study|Withdrawal by Subject|1|||
25119054|NCT02391545|50231142|FG000|Overall Study|Other Reasons|6|||
25119055|NCT02391545|50231143|FG001|Overall Study|Other Reasons|4|||
25119056|NCT02362451|50231152|FG000|Overall Study|Withdrawal by Subject|0|||
25119057|NCT02362451|50231153|FG001|Overall Study|Withdrawal by Subject|1|||
25119058|NCT02362451|50231152|FG000|Overall Study|Lack of Efficacy|2|||
25119059|NCT02362451|50231153|FG001|Overall Study|Lack of Efficacy|0|||
25119060|NCT02362451|50231152|FG000|Overall Study|Progression|1|||
25119061|NCT02362451|50231153|FG001|Overall Study|Progression|0|||
25119062|NCT02362451|50231152|FG000|Overall Study|Participant chose other therapy.|1|||
25119063|NCT02362451|50231153|FG001|Overall Study|Participant chose other therapy.|0|||
25119064|NCT01734382|50231162|FG000|Part 1|Adverse Event|2|||
25119065|NCT01734382|50231163|FG001|Part 1|Adverse Event|0|||
25119066|NCT01734382|50231164|FG002|Part 1|Adverse Event|0|||
25119067|NCT01734382|50231162|FG000|Part 2|Adverse Event|0|||
25119068|NCT01734382|50231163|FG001|Part 2|Adverse Event|0|||
25119069|NCT01734382|50231164|FG002|Part 2|Adverse Event|1|||
25119070|NCT01734382|50231162|FG000|Part 2|Lack of Efficacy|0|||
25119071|NCT01734382|50231163|FG001|Part 2|Lack of Efficacy|1|||
25119072|NCT01734382|50231164|FG002|Part 2|Lack of Efficacy|1|||
25119073|NCT01734382|50231162|FG000|Part 2|Other|0|||
25119074|NCT01734382|50231163|FG001|Part 2|Other|0|||
25119075|NCT01734382|50231164|FG002|Part 2|Other|1|||
25119076|NCT01734382|50231162|FG000|Part 2|Physician Decision|0|||
25119077|NCT01734382|50231163|FG001|Part 2|Physician Decision|0|||
25119078|NCT01734382|50231164|FG002|Part 2|Physician Decision|3|||
25119079|NCT01734382|50231162|FG000|Part 2|Protocol Violation|0|||
25119080|NCT01734382|50231163|FG001|Part 2|Protocol Violation|1|||
25119081|NCT01734382|50231164|FG002|Part 2|Protocol Violation|0|||
25119082|NCT01734382|50231162|FG000|Part 2|Withdrawal by Subject|0|||
25119083|NCT01734382|50231163|FG001|Part 2|Withdrawal by Subject|0|||
25119084|NCT01734382|50231164|FG002|Part 2|Withdrawal by Subject|1|||
25119085|NCT02391311|50231178|FG000|Overall Study|Lost to Follow-up|2|||
25119086|NCT02391311|50231179|FG001|Overall Study|Lost to Follow-up|1|||
25119087|NCT02391311|50231178|FG000|Overall Study|deemed ineligible after baseline|1|||
25119088|NCT02391311|50231179|FG001|Overall Study|deemed ineligible after baseline|1|||
25119089|NCT01765426|50231189|FG000|Overall Study|Lost to Follow-up|0|||
25119090|NCT01765426|50231190|FG001|Overall Study|Lost to Follow-up|1|||
25261630|NCT01302054|50576274|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
25261631|NCT01302054|50576275|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
25261632|NCT01302054|50576273|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
25261633|NCT01302054|50576274|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
25261634|NCT01302054|50576275|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
25261635|NCT01302054|50576273|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
25261636|NCT01302054|50576274|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
25261637|NCT01302054|50576275|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
25261638|NCT01302054|50576273|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
25261639|NCT01302054|50576274|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
25261640|NCT01302054|50576275|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
25261641|NCT01302054|50576273|FG000|Double-Blind Treatment Phase|Other|0|||
25261642|NCT01302054|50576274|FG001|Double-Blind Treatment Phase|Other|4|||
25261643|NCT01302054|50576275|FG002|Double-Blind Treatment Phase|Other|9|||
25261644|NCT01301508|50576286|FG000|Overall Study|Withdrawal by Subject|1|||
25261645|NCT01301508|50576287|FG001|Overall Study|Withdrawal by Subject|2|||
25261646|NCT01301508|50576286|FG000|Overall Study|Lost to Follow-up|0|||
25261647|NCT01301508|50576287|FG001|Overall Study|Lost to Follow-up|1|||
25261648|NCT01301274|50576295|FG000|Overall Study|Physician Decision|2|||
25261649|NCT01301274|50576296|FG001|Overall Study|Physician Decision|1|||
25261650|NCT01300650|50576307|FG000|Overall Study|Adverse Event|1|||
25261651|NCT01300572|50576312|FG000|Overall Study|HAMA + post dosimetry|1|||
25261652|NCT01077154|50576319|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
25008688|NCT03472326|50101714|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
25008689|NCT03472326|50101711|FG000|Part 2: Combination Therapy|Pregnancy|0|||
25008690|NCT03472326|50101712|FG001|Part 2: Combination Therapy|Pregnancy|0|||
25008691|NCT03472326|50101713|FG002|Part 2: Combination Therapy|Pregnancy|0|||
25008692|NCT03472326|50101714|FG003|Part 2: Combination Therapy|Pregnancy|1|||
25008693|NCT02737618|50101723|FG000|Overall Study|Withdrawal by Subject|9|||
25008694|NCT03472014|50101727|FG000|Overall Study|Lost to Follow-up|4|||
25008695|NCT03526458|50101733|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
25008696|NCT03526458|50101734|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
25008697|NCT03526458|50101733|FG000|Overall Study|Stone passed, surgery cancelled|2|||
25008698|NCT03526458|50101734|FG001|Overall Study|Stone passed, surgery cancelled|1|||
25008699|NCT03526458|50101733|FG000|Overall Study|Withdrawal by Subject|1|||
25008700|NCT03526458|50101734|FG001|Overall Study|Withdrawal by Subject|0|||
25008701|NCT03526458|50101733|FG000|Overall Study|Physician Decision|2|||
25008702|NCT03526458|50101734|FG001|Overall Study|Physician Decision|1|||
25008703|NCT03526458|50101733|FG000|Overall Study|Lack of equipment|1|||
25008704|NCT03526458|50101734|FG001|Overall Study|Lack of equipment|1|||
25008705|NCT03488238|50101740|FG000|Overall Study|Equipment malfunction|1|||
25008706|NCT03488238|50101740|FG000|Overall Study|Adverse Event|1|||
25008707|NCT03525834|50101744|FG000|Overall Study|Progressive disease|1|||
25008708|NCT03525444|50101786|FG000|Overall Study|Adverse Event|0|||
25008709|NCT03525444|50101787|FG001|Overall Study|Adverse Event|1|||
25008710|NCT03525444|50101786|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
25008711|NCT03525444|50101787|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
25008712|NCT03525444|50101786|FG000|Overall Study|Other|0|||
25008713|NCT03525444|50101787|FG001|Overall Study|Other|1|||
25119091|NCT01765426|50231191|FG002|Overall Study|Lost to Follow-up|0|||
25119092|NCT01765426|50231192|FG003|Overall Study|Lost to Follow-up|0|||
25261653|NCT01077154|50576320|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
25261654|NCT01077154|50576319|FG000|Overall Study|Withdrawal by Subject|369|||
25008714|NCT03487848|50101794|FG000|Overall Study|Lost to Follow-up|1|||
25008715|NCT03524664|50101800|FG000|Overall Study|Withdrawal by Subject|1|||
25008716|NCT03524664|50101801|FG001|Overall Study|Withdrawal by Subject|2|||
25008717|NCT03524664|50101800|FG000|Overall Study|Lost to Follow-up|4|||
25008718|NCT03524664|50101801|FG001|Overall Study|Lost to Follow-up|13|||
25008719|NCT04377620|50101810|FG000|Overall Study|Death|42|||
25008720|NCT04377620|50101811|FG001|Overall Study|Death|48|||
25008721|NCT04377620|50101812|FG002|Overall Study|Death|36|||
25119093|NCT01765270|50231204|FG000|Overall Study|Physician Decision|1|||
25261655|NCT01077154|50576320|FG001|Overall Study|Withdrawal by Subject|385|||
25261656|NCT01077154|50576319|FG000|Overall Study|Death|215|||
25261657|NCT01077154|50576320|FG001|Overall Study|Death|214|||
25261658|NCT01077154|50576319|FG000|Overall Study|Lost to Follow-up|43|||
25261659|NCT01077154|50576320|FG001|Overall Study|Lost to Follow-up|35|||
25261660|NCT01077154|50576319|FG000|Overall Study|Noncompliance|22|||
25261661|NCT01077154|50576320|FG001|Overall Study|Noncompliance|20|||
25261662|NCT01077154|50576319|FG000|Overall Study|Disease Progression|18|||
25261663|NCT01077154|50576320|FG001|Overall Study|Disease Progression|20|||
25261664|NCT01077154|50576319|FG000|Overall Study|Ineligibility Determined|10|||
25261665|NCT01077154|50576320|FG001|Overall Study|Ineligibility Determined|14|||
25261666|NCT01077154|50576319|FG000|Overall Study|Other|14|||
25261667|NCT01077154|50576320|FG001|Overall Study|Other|11|||
25261668|NCT01077154|50576319|FG000|Overall Study|Adverse Event|9|||
25261669|NCT01077154|50576320|FG001|Overall Study|Adverse Event|9|||
25261670|NCT01077154|50576319|FG000|Overall Study|Administrative Decision|1|||
25261671|NCT01077154|50576320|FG001|Overall Study|Administrative Decision|6|||
25261672|NCT01077154|50576319|FG000|Overall Study|Protocol Deviation|1|||
25261673|NCT01077154|50576320|FG001|Overall Study|Protocol Deviation|0|||
25261674|NCT01258101|50576330|FG000|Overall Study|Adverse Event|5|||
25261675|NCT01258101|50576331|FG001|Overall Study|Adverse Event|6|||
25261676|NCT01258101|50576332|FG002|Overall Study|Adverse Event|0|||
25261677|NCT01258101|50576333|FG003|Overall Study|Adverse Event|0|||
25261678|NCT01258101|50576330|FG000|Overall Study|Extra exclusion criterion amended|2|||
25261679|NCT01258101|50576331|FG001|Overall Study|Extra exclusion criterion amended|1|||
25261680|NCT01258101|50576332|FG002|Overall Study|Extra exclusion criterion amended|1|||
25261681|NCT01258101|50576333|FG003|Overall Study|Extra exclusion criterion amended|1|||
25261682|NCT01258101|50576330|FG000|Overall Study|Informed consent has been withdrawn|2|||
25261683|NCT01258101|50576331|FG001|Overall Study|Informed consent has been withdrawn|2|||
25261684|NCT01258101|50576332|FG002|Overall Study|Informed consent has been withdrawn|1|||
25261685|NCT01258101|50576333|FG003|Overall Study|Informed consent has been withdrawn|1|||
25261686|NCT01258101|50576330|FG000|Overall Study|Patient is not able to attend visits|8|||
25261687|NCT01258101|50576331|FG001|Overall Study|Patient is not able to attend visits|9|||
25261688|NCT01258101|50576332|FG002|Overall Study|Patient is not able to attend visits|7|||
25261689|NCT01258101|50576333|FG003|Overall Study|Patient is not able to attend visits|6|||
25119094|NCT01765270|50231205|FG001|Overall Study|Physician Decision|0|||
25119095|NCT01765270|50231204|FG000|Overall Study|Withdrawal by Subject|0|||
25119096|NCT01765270|50231205|FG001|Overall Study|Withdrawal by Subject|1|||
25119097|NCT01733758|50231216|FG000|Overall Study|Adverse Event|5|||
25119098|NCT01733758|50231217|FG001|Overall Study|Adverse Event|7|||
25119099|NCT01733758|50231218|FG002|Overall Study|Adverse Event|8|||
25119100|NCT01733758|50231219|FG003|Overall Study|Adverse Event|1|||
25119101|NCT01733758|50231216|FG000|Overall Study|Withdrawal by Subject|1|||
25119102|NCT01733758|50231217|FG001|Overall Study|Withdrawal by Subject|1|||
25119103|NCT01733758|50231218|FG002|Overall Study|Withdrawal by Subject|5|||
25119104|NCT01733758|50231219|FG003|Overall Study|Withdrawal by Subject|3|||
25119105|NCT01733758|50231216|FG000|Overall Study|Persistent Hyperglycemia|3|||
25119106|NCT01733758|50231217|FG001|Overall Study|Persistent Hyperglycemia|2|||
25177441|NCT02754141|50321518|FG011|Overall Study|No longer meets study criteria|0|||
25177442|NCT02754141|50321519|FG012|Overall Study|No longer meets study criteria|0|||
25177443|NCT02754141|50321520|FG013|Overall Study|No longer meets study criteria|0|||
25261690|NCT01258101|50576330|FG000|Overall Study|Patient´s compliance|4|||
25261691|NCT01258101|50576331|FG001|Overall Study|Patient´s compliance|3|||
25261692|NCT01258101|50576332|FG002|Overall Study|Patient´s compliance|1|||
25261693|NCT01258101|50576333|FG003|Overall Study|Patient´s compliance|2|||
25261694|NCT01258101|50576330|FG000|Overall Study|Lost to Follow-up|5|||
25261695|NCT01258101|50576331|FG001|Overall Study|Lost to Follow-up|5|||
25261696|NCT01258101|50576332|FG002|Overall Study|Lost to Follow-up|0|||
25119107|NCT01733758|50231218|FG002|Overall Study|Persistent Hyperglycemia|0|||
25119108|NCT01733758|50231219|FG003|Overall Study|Persistent Hyperglycemia|0|||
25119109|NCT01733758|50231216|FG000|Overall Study|Protocol Violation|0|||
25177444|NCT02754141|50321521|FG014|Overall Study|No longer meets study criteria|0|||
25177445|NCT02754141|50321522|FG015|Overall Study|No longer meets study criteria|0|||
25177446|NCT02754141|50321523|FG016|Overall Study|No longer meets study criteria|0|||
25177447|NCT02754141|50321524|FG017|Overall Study|No longer meets study criteria|0|||
25177448|NCT02754141|50321507|FG000|Overall Study|Other reasons|0|||
25177449|NCT02754141|50321508|FG001|Overall Study|Other reasons|0|||
25177450|NCT02754141|50321509|FG002|Overall Study|Other reasons|0|||
25261697|NCT01258101|50576333|FG003|Overall Study|Lost to Follow-up|6|||
25261698|NCT01258101|50576330|FG000|Overall Study|PCR positive at week 24|0|||
25261699|NCT01258101|50576331|FG001|Overall Study|PCR positive at week 24|0|||
25261700|NCT01258101|50576332|FG002|Overall Study|PCR positive at week 24|0|||
25261701|NCT01258101|50576333|FG003|Overall Study|PCR positive at week 24|1|||
25261702|NCT01258101|50576330|FG000|Overall Study|Other reason|7|||
25261703|NCT01258101|50576331|FG001|Overall Study|Other reason|8|||
25261704|NCT01258101|50576332|FG002|Overall Study|Other reason|1|||
25119110|NCT01733758|50231217|FG001|Overall Study|Protocol Violation|1|||
25119111|NCT01733758|50231218|FG002|Overall Study|Protocol Violation|2|||
25119112|NCT01733758|50231219|FG003|Overall Study|Protocol Violation|2|||
25119113|NCT01733758|50231216|FG000|Overall Study|Non-compliance|1|||
25119114|NCT01733758|50231217|FG001|Overall Study|Non-compliance|0|||
25119115|NCT01733758|50231218|FG002|Overall Study|Non-compliance|0|||
25119116|NCT01733758|50231219|FG003|Overall Study|Non-compliance|0|||
25119117|NCT01733758|50231216|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
25119118|NCT01733758|50231217|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
25119119|NCT01733758|50231218|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
25119120|NCT01733758|50231219|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
25119121|NCT01733758|50231216|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
25119122|NCT01733758|50231217|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
25119123|NCT01733758|50231218|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
25119124|NCT01733758|50231219|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
25119125|NCT01607554|50231231|FG000|Overall Study|Disease progression|2|||
25119126|NCT01607476|50231238|FG000|Overall Study|Withdrawal by Subject|1|||
25119127|NCT01607476|50231239|FG001|Overall Study|Withdrawal by Subject|0|||
25119128|NCT01607476|50231240|FG002|Overall Study|Withdrawal by Subject|1|||
25119129|NCT01607476|50231238|FG000|Overall Study|Lost to Follow-up|0|||
25119130|NCT01607476|50231239|FG001|Overall Study|Lost to Follow-up|0|||
25119131|NCT01607476|50231240|FG002|Overall Study|Lost to Follow-up|2|||
25119132|NCT01765192|50231250|FG000|Treatment Period 1|Adverse Event|0|||
25119133|NCT01765192|50231251|FG001|Treatment Period 1|Adverse Event|1|||
25119134|NCT01765192|50231250|FG000|Washout Period|Voluntary Withdrawal|1|||
25119135|NCT01765192|50231251|FG001|Washout Period|Voluntary Withdrawal|1|||
25119136|NCT01765192|50231250|FG000|Washout Period|Reason not specified|1|||
25119137|NCT01765192|50231251|FG001|Washout Period|Reason not specified|0|||
25119138|NCT01765192|50231250|FG000|Treatment Period 2|Reason not specified|0|||
25119139|NCT01765192|50231251|FG001|Treatment Period 2|Reason not specified|2|||
25119140|NCT01765192|50231250|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
25119141|NCT01765192|50231251|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
25119142|NCT01733680|50231259|FG000|Overall Study|Withdrawal by Subject|0|||
25119143|NCT01733680|50231260|FG001|Overall Study|Withdrawal by Subject|1|||
25119144|NCT02348216|50231277|FG000|Overall Study|Death|4|||
25119145|NCT02348216|50231278|FG001|Overall Study|Death|27|||
25119146|NCT02348216|50231279|FG002|Overall Study|Death|3|||
25119147|NCT02348216|50231280|FG003|Overall Study|Death|18|||
25119148|NCT02348216|50231281|FG004|Overall Study|Death|9|||
25119149|NCT02348216|50231282|FG005|Overall Study|Death|23|||
25119150|NCT02348216|50231283|FG006|Overall Study|Death|6|||
25119151|NCT02348216|50231277|FG000|Overall Study|Full consent withdrawal|0|||
25119152|NCT02348216|50231278|FG001|Overall Study|Full consent withdrawal|0|||
25119153|NCT02348216|50231279|FG002|Overall Study|Full consent withdrawal|0|||
25119154|NCT02348216|50231280|FG003|Overall Study|Full consent withdrawal|1|||
25119155|NCT02348216|50231281|FG004|Overall Study|Full consent withdrawal|0|||
25119156|NCT02348216|50231282|FG005|Overall Study|Full consent withdrawal|0|||
25119157|NCT02348216|50231283|FG006|Overall Study|Full consent withdrawal|1|||
25119158|NCT02348216|50231277|FG000|Overall Study|Lost to Follow-up|0|||
25119159|NCT02348216|50231278|FG001|Overall Study|Lost to Follow-up|0|||
25119160|NCT02348216|50231279|FG002|Overall Study|Lost to Follow-up|0|||
25119161|NCT02348216|50231280|FG003|Overall Study|Lost to Follow-up|0|||
25119162|NCT02348216|50231281|FG004|Overall Study|Lost to Follow-up|0|||
25119163|NCT02348216|50231282|FG005|Overall Study|Lost to Follow-up|0|||
25119164|NCT02348216|50231283|FG006|Overall Study|Lost to Follow-up|1|||
25119165|NCT02348216|50231277|FG000|Overall Study|Still on study|3|||
25119166|NCT02348216|50231278|FG001|Overall Study|Still on study|50|||
25119167|NCT02348216|50231279|FG002|Overall Study|Still on study|21|||
25119168|NCT02348216|50231280|FG003|Overall Study|Still on study|19|||
25119169|NCT02348216|50231281|FG004|Overall Study|Still on study|32|||
25119170|NCT02348216|50231282|FG005|Overall Study|Still on study|27|||
25119171|NCT02348216|50231283|FG006|Overall Study|Still on study|32|||
25119172|NCT02348216|50231277|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
25119173|NCT02348216|50231278|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
25119174|NCT02348216|50231279|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
25119175|NCT02348216|50231280|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
25119176|NCT02348216|50231281|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
25119177|NCT02348216|50231282|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
25119178|NCT02348216|50231283|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
25119179|NCT02336165|50231326|FG000|Overall Study|Death|3|||
25119180|NCT02336165|50231327|FG001|Overall Study|Death|0|||
25119181|NCT02336165|50231328|FG002|Overall Study|Death|0|||
25119182|NCT02336165|50231329|FG003|Overall Study|Death|0|||
25119183|NCT02336165|50231330|FG004|Overall Study|Death|1|||
25119184|NCT02336165|50231326|FG000|Overall Study|Physician Decision|2|||
25119185|NCT02336165|50231327|FG001|Overall Study|Physician Decision|2|||
25119186|NCT02336165|50231328|FG002|Overall Study|Physician Decision|1|||
25119187|NCT02336165|50231329|FG003|Overall Study|Physician Decision|1|||
25119188|NCT02336165|50231330|FG004|Overall Study|Physician Decision|0|||
25119189|NCT02336165|50231326|FG000|Overall Study|Withdrawal by Subject|0|||
25119190|NCT02336165|50231327|FG001|Overall Study|Withdrawal by Subject|0|||
25119191|NCT02336165|50231328|FG002|Overall Study|Withdrawal by Subject|1|||
25119192|NCT02336165|50231329|FG003|Overall Study|Withdrawal by Subject|0|||
25119193|NCT02336165|50231330|FG004|Overall Study|Withdrawal by Subject|1|||
25119194|NCT02336165|50231326|FG000|Overall Study|Adverse Event|4|||
25119195|NCT02336165|50231327|FG001|Overall Study|Adverse Event|1|||
25119196|NCT02336165|50231328|FG002|Overall Study|Adverse Event|2|||
25119197|NCT02336165|50231329|FG003|Overall Study|Adverse Event|4|||
25119198|NCT02336165|50231330|FG004|Overall Study|Adverse Event|1|||
25119199|NCT02336165|50231326|FG000|Overall Study|Progressive disease|23|||
25119200|NCT02336165|50231327|FG001|Overall Study|Progressive disease|22|||
25119201|NCT02336165|50231328|FG002|Overall Study|Progressive disease|27|||
25119202|NCT02336165|50231329|FG003|Overall Study|Progressive disease|24|||
25119203|NCT02336165|50231330|FG004|Overall Study|Progressive disease|19|||
25119204|NCT02336165|50231326|FG000|Overall Study|Non-compliance|1|||
25119205|NCT02336165|50231327|FG001|Overall Study|Non-compliance|0|||
25119206|NCT02336165|50231328|FG002|Overall Study|Non-compliance|0|||
25119207|NCT02336165|50231329|FG003|Overall Study|Non-compliance|1|||
25119208|NCT02336165|50231330|FG004|Overall Study|Non-compliance|0|||
25119209|NCT02336165|50231326|FG000|Overall Study|Other|1|||
25119210|NCT02336165|50231327|FG001|Overall Study|Other|0|||
25119211|NCT02336165|50231328|FG002|Overall Study|Other|0|||
25119212|NCT02336165|50231329|FG003|Overall Study|Other|1|||
25119213|NCT02336165|50231330|FG004|Overall Study|Other|0|||
25119214|NCT02360111|50231346|FG000|Overall Study|Death|2|||
25119215|NCT02334683|50231352|FG000|First 12 Week Period|Lost to Follow-up|1|||
25119216|NCT02334683|50231353|FG001|First 12 Week Period|Lost to Follow-up|0|||
25119217|NCT02334683|50231352|FG000|Second 12 Week Period|Adverse Event|0|||
25119218|NCT02334683|50231353|FG001|Second 12 Week Period|Adverse Event|1|||
25119219|NCT02319044|50231362|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
25119220|NCT02319044|50231363|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
25119221|NCT02319044|50231364|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
25119222|NCT02319044|50231362|FG000|Overall Study|Withdrawal by Subject|3|||
25119223|NCT02319044|50231363|FG001|Overall Study|Withdrawal by Subject|3|||
25119224|NCT02319044|50231364|FG002|Overall Study|Withdrawal by Subject|6|||
25119225|NCT02319044|50231362|FG000|Overall Study|Condition under investigation worsened|100|||
25119226|NCT02319044|50231363|FG001|Overall Study|Condition under investigation worsened|50|||
25119227|NCT02319044|50231364|FG002|Overall Study|Condition under investigation worsened|46|||
25119228|NCT02319044|50231362|FG000|Overall Study|Adverse Event|17|||
25119229|NCT02319044|50231363|FG001|Overall Study|Adverse Event|2|||
25119230|NCT02319044|50231364|FG002|Overall Study|Adverse Event|8|||
25119231|NCT02319044|50231362|FG000|Overall Study|Study specific discontinuation criteria|2|||
25119232|NCT02319044|50231363|FG001|Overall Study|Study specific discontinuation criteria|2|||
25119233|NCT02319044|50231364|FG002|Overall Study|Study specific discontinuation criteria|1|||
25119234|NCT02319044|50231362|FG000|Overall Study|Not treated|0|||
25119235|NCT02319044|50231363|FG001|Overall Study|Not treated|2|||
25119236|NCT02319044|50231364|FG002|Overall Study|Not treated|2|||
25119237|NCT01649765|50231375|FG000|Overall Study|Adverse Event|5|||
25119238|NCT01649765|50231376|FG001|Overall Study|Adverse Event|3|||
25119239|NCT01649765|50231375|FG000|Overall Study|Lack of Efficacy|1|||
25119240|NCT01649765|50231376|FG001|Overall Study|Lack of Efficacy|1|||
25119241|NCT01649765|50231375|FG000|Overall Study|Physician Decision|0|||
25119242|NCT01649765|50231376|FG001|Overall Study|Physician Decision|3|||
25119243|NCT01649765|50231375|FG000|Overall Study|Protocol Violation|1|||
25119244|NCT01649765|50231376|FG001|Overall Study|Protocol Violation|0|||
25119245|NCT01649765|50231375|FG000|Overall Study|Withdrawal by Subject|2|||
25119246|NCT01649765|50231376|FG001|Overall Study|Withdrawal by Subject|1|||
25119247|NCT02317562|50231383|FG000|Overall Study|Physician Decision|1|||
25119248|NCT02317562|50231383|FG000|Overall Study|early termination of the study|8|||
25119249|NCT02317562|50231383|FG000|Overall Study|Lack of Efficacy|4|||
25261705|NCT01258101|50576333|FG003|Overall Study|Other reason|8|||
25119250|NCT02317562|50231383|FG000|Overall Study|Withdrawal by Subject|1|||
25119251|NCT02317016|50231387|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
25119252|NCT02317016|50231387|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
25119253|NCT02317016|50231387|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
25119254|NCT02317016|50231387|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
25119255|NCT02317016|50231387|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
25119256|NCT02317016|50231387|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
25119257|NCT02317016|50231387|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
25119258|NCT02311478|50231395|FG000|Overall Study|Withdrawal by Subject|1|||
25119259|NCT02311478|50231395|FG000|Overall Study|Lost to Follow-up|5|||
25119260|NCT02311478|50231395|FG000|Overall Study|Failed IUD Insertion|1|||
25119261|NCT02388932|50231400|FG000|Overall Study|Death|1|||
25119262|NCT02388776|50231405|FG000|Overall Study|Death|1|||
25119263|NCT02388776|50231405|FG000|Overall Study|Lost to Follow-up|1|||
25119264|NCT02316548|50231412|FG000|Overall Study|Protocol Violation|0|||
25119265|NCT02316548|50231413|FG001|Overall Study|Protocol Violation|1|||
25119266|NCT02281760|50231419|FG000|Overall Study|Withdrawal by Subject|1|||
25119267|NCT02390531|50231431|FG000|Overall Study|Death|0|||
25119268|NCT02390531|50231432|FG001|Overall Study|Death|2|||
25119269|NCT02390531|50231433|FG002|Overall Study|Death|0|||
25119270|NCT02390531|50231434|FG003|Overall Study|Death|1|||
25119271|NCT02390531|50231435|FG004|Overall Study|Death|0|||
25119272|NCT02390531|50231436|FG005|Overall Study|Death|0|||
25119273|NCT02390531|50231437|FG006|Overall Study|Death|0|||
25119274|NCT02390531|50231438|FG007|Overall Study|Death|1|||
25119275|NCT02390531|50231431|FG000|Overall Study|Protocol Violation|0|||
25119276|NCT02390531|50231432|FG001|Overall Study|Protocol Violation|0|||
25119277|NCT02390531|50231433|FG002|Overall Study|Protocol Violation|0|||
25119278|NCT02390531|50231434|FG003|Overall Study|Protocol Violation|0|||
25119279|NCT02390531|50231435|FG004|Overall Study|Protocol Violation|1|||
25119280|NCT02390531|50231436|FG005|Overall Study|Protocol Violation|0|||
25119281|NCT02390531|50231437|FG006|Overall Study|Protocol Violation|2|||
25119282|NCT02390531|50231438|FG007|Overall Study|Protocol Violation|0|||
25119283|NCT02390219|50231474|FG000|Overall Study|Death|1|||
25119284|NCT02390219|50231474|FG000|Overall Study|Physician Decision|1|||
25119285|NCT02390219|50231474|FG000|Overall Study|Adverse Event|6|||
25119286|NCT02390219|50231474|FG000|Overall Study|Withdrawal by Subject|1|||
25119287|NCT02390219|50231474|FG000|Overall Study|Lost to Follow-up|2|||
25119288|NCT02390219|50231474|FG000|Overall Study|Other|2|||
25119289|NCT02334215|50231481|FG000|Overall Study|Death|1|||
25119290|NCT02334215|50231482|FG001|Overall Study|Death|1|||
25119291|NCT02334215|50231483|FG002|Overall Study|Death|0|||
25119292|NCT02334215|50231481|FG000|Overall Study|Lost to Follow-up|1|||
25119293|NCT02334215|50231482|FG001|Overall Study|Lost to Follow-up|0|||
25119294|NCT02334215|50231483|FG002|Overall Study|Lost to Follow-up|4|||
25119295|NCT02334215|50231481|FG000|Overall Study|Withdrawal by Subject|2|||
25119296|NCT02334215|50231482|FG001|Overall Study|Withdrawal by Subject|2|||
25119297|NCT02334215|50231483|FG002|Overall Study|Withdrawal by Subject|1|||
25119298|NCT02334215|50231481|FG000|Overall Study|Not released from incarceration on time|3|||
25119299|NCT02334215|50231482|FG001|Overall Study|Not released from incarceration on time|3|||
25119300|NCT02334215|50231483|FG002|Overall Study|Not released from incarceration on time|3|||
25119301|NCT02334215|50231481|FG000|Overall Study|Incarcerated|0|||
25119302|NCT02334215|50231482|FG001|Overall Study|Incarcerated|0|||
25119303|NCT02334215|50231483|FG002|Overall Study|Incarcerated|7|||
25119304|NCT02359877|50231495|FG000|Overall Study|Withdrawal by Subject|1|||
25119305|NCT02359877|50231496|FG001|Overall Study|Withdrawal by Subject|0|||
25119306|NCT02359877|50231497|FG002|Overall Study|Withdrawal by Subject|0|||
25119307|NCT02359877|50231498|FG003|Overall Study|Withdrawal by Subject|2|||
25119308|NCT02359877|50231495|FG000|Overall Study|Adverse Event|0|||
25119309|NCT02359877|50231496|FG001|Overall Study|Adverse Event|0|||
25119310|NCT02359877|50231497|FG002|Overall Study|Adverse Event|0|||
25119311|NCT02359877|50231498|FG003|Overall Study|Adverse Event|1|||
25119312|NCT02389829|50231528|FG000|Overall Study|Lost to Follow-up|0|||
25119313|NCT02389829|50231529|FG001|Overall Study|Lost to Follow-up|1|||
25119314|NCT02358863|50231535|FG000|Overall Study|Physician Decision|3|||
25119315|NCT02358473|50231539|FG000|Overall Study|Disease Progession|6|||
25119316|NCT02358473|50231539|FG000|Overall Study|Adverse Event|3|||
25119317|NCT02358473|50231539|FG000|Overall Study|Withdrawal by Subject|2|||
25119318|NCT02358473|50231539|FG000|Overall Study|Physician Decision|2|||
25119319|NCT02357459|50231546|FG000|Overall Study|Adverse Event|0|||
25119320|NCT02357459|50231547|FG001|Overall Study|Adverse Event|1|||
25119321|NCT02357459|50231548|FG002|Overall Study|Adverse Event|1|||
25119322|NCT02357459|50231546|FG000|Overall Study|Withdrawal by Subject|5|||
25119323|NCT02357459|50231547|FG001|Overall Study|Withdrawal by Subject|3|||
25119324|NCT02357459|50231548|FG002|Overall Study|Withdrawal by Subject|3|||
25119325|NCT02357459|50231546|FG000|Overall Study|Physician Decision|0|||
25119326|NCT02357459|50231547|FG001|Overall Study|Physician Decision|2|||
25119327|NCT02357459|50231548|FG002|Overall Study|Physician Decision|0|||
25119328|NCT02357459|50231546|FG000|Overall Study|Protocol Violation|1|||
25119329|NCT02357459|50231547|FG001|Overall Study|Protocol Violation|1|||
25119330|NCT02357459|50231548|FG002|Overall Study|Protocol Violation|0|||
25119331|NCT02357459|50231546|FG000|Overall Study|Lost to Follow-up|1|||
25119332|NCT02357459|50231547|FG001|Overall Study|Lost to Follow-up|3|||
25119333|NCT02357459|50231548|FG002|Overall Study|Lost to Follow-up|0|||
25119334|NCT02357459|50231546|FG000|Overall Study|Lack of Efficacy|7|||
25119335|NCT02357459|50231547|FG001|Overall Study|Lack of Efficacy|4|||
25119336|NCT02357459|50231548|FG002|Overall Study|Lack of Efficacy|4|||
25119337|NCT02357459|50231546|FG000|Overall Study|Patient Relocated|2|||
25119338|NCT02357459|50231547|FG001|Overall Study|Patient Relocated|0|||
25119339|NCT02357459|50231548|FG002|Overall Study|Patient Relocated|0|||
25119340|NCT02357459|50231546|FG000|Overall Study|Instruction from PCP|1|||
25168607|NCT00634101|50298154|FG001|Overall Study|Lost to Follow-up|0|||
25119341|NCT02357459|50231547|FG001|Overall Study|Instruction from PCP|0|||
25119342|NCT02357459|50231548|FG002|Overall Study|Instruction from PCP|0|||
25119343|NCT02357459|50231546|FG000|Overall Study|Incarceration|0|||
25119344|NCT02357459|50231547|FG001|Overall Study|Incarceration|0|||
25119345|NCT02357459|50231548|FG002|Overall Study|Incarceration|1|||
25119346|NCT02357459|50231546|FG000|Overall Study|Pre-planned Knee surgery|0|||
25119347|NCT02357459|50231547|FG001|Overall Study|Pre-planned Knee surgery|0|||
25119348|NCT02357459|50231548|FG002|Overall Study|Pre-planned Knee surgery|2|||
25119349|NCT02357459|50231546|FG000|Overall Study|Job Commitments|0|||
25119350|NCT02357459|50231547|FG001|Overall Study|Job Commitments|0|||
25119351|NCT02357459|50231548|FG002|Overall Study|Job Commitments|1|||
25119352|NCT02332889|50231559|FG000|Overall Study|Physician Decision|1|||
25119353|NCT02357147|50231565|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
25119354|NCT02357147|50231566|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
25119355|NCT02357147|50231565|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
25119356|NCT02357147|50231566|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
25119357|NCT02357147|50231565|FG000|Combination Treatment Phase|Investigator Discretion|1|||
25119358|NCT02357147|50231566|FG001|Combination Treatment Phase|Investigator Discretion|1|||
25119359|NCT02357147|50231565|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
25119360|NCT02357147|50231566|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
25119361|NCT02357147|50231565|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
25119362|NCT02357147|50231566|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
25119363|NCT02357147|50231565|FG000|Combination Treatment Phase|Adverse Event|12|||
25119364|NCT02357147|50231566|FG001|Combination Treatment Phase|Adverse Event|4|||
25119365|NCT02357147|50231565|FG000|Combination Treatment Phase|Death|1|||
25119366|NCT02357147|50231566|FG001|Combination Treatment Phase|Death|1|||
25119367|NCT02357147|50231565|FG000|Combination Treatment Phase|Sponsor Decision|0|||
25119368|NCT02357147|50231566|FG001|Combination Treatment Phase|Sponsor Decision|12|||
25119369|NCT02357147|50231565|FG000|Combination Treatment Phase|Other|1|||
25119370|NCT02357147|50231566|FG001|Combination Treatment Phase|Other|0|||
25119371|NCT02357147|50231565|FG000|Combination Treatment Phase|Not treated|0|||
25119372|NCT02357147|50231566|FG001|Combination Treatment Phase|Not treated|2|||
25119373|NCT02357147|50231565|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
25119374|NCT02357147|50231566|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
25119375|NCT02357147|50231565|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
25119376|NCT02357147|50231566|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
25119377|NCT02357147|50231565|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
25119378|NCT02357147|50231566|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
25119379|NCT02357147|50231565|FG000|Maintenance Treatment Phase|Adverse Event|0|||
25119380|NCT02357147|50231566|FG001|Maintenance Treatment Phase|Adverse Event|3|||
25119381|NCT02357147|50231565|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
25119382|NCT02357147|50231566|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
25119383|NCT02357147|50231565|FG000|Maintenance Treatment Phase|Not Treated|1|||
25119384|NCT02357147|50231566|FG001|Maintenance Treatment Phase|Not Treated|0|||
25119385|NCT02356211|50231578|FG000|Overall Study|Withdrawal by Subject|2|||
25119386|NCT02356211|50231579|FG001|Overall Study|Withdrawal by Subject|2|||
25119387|NCT02356211|50231578|FG000|Overall Study|ineligible|1|||
25119388|NCT02356211|50231579|FG001|Overall Study|ineligible|8|||
25119389|NCT02332655|50231585|FG000|Overall Study|Lack of Efficacy|1|||
25119390|NCT02388737|50231592|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
25119391|NCT02388737|50231593|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
25119392|NCT02388737|50231594|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
25119393|NCT02388737|50231592|FG000|Overall Study|Major Protocol Deviation|18|||
25119394|NCT02388737|50231593|FG001|Overall Study|Major Protocol Deviation|25|||
25119395|NCT02388737|50231594|FG002|Overall Study|Major Protocol Deviation|22|||
25119396|NCT02388737|50231592|FG000|Overall Study|Lost to Follow-up|5|||
25119397|NCT02388737|50231593|FG001|Overall Study|Lost to Follow-up|1|||
25119398|NCT02388737|50231594|FG002|Overall Study|Lost to Follow-up|4|||
25119399|NCT02388737|50231592|FG000|Overall Study|Voluntary Withdrawal|10|||
25119400|NCT02388737|50231593|FG001|Overall Study|Voluntary Withdrawal|18|||
25119401|NCT02388737|50231594|FG002|Overall Study|Voluntary Withdrawal|17|||
25119402|NCT02388737|50231592|FG000|Overall Study|Lack of Efficacy|3|||
25119403|NCT02388737|50231593|FG001|Overall Study|Lack of Efficacy|0|||
25119404|NCT02388737|50231594|FG002|Overall Study|Lack of Efficacy|3|||
25119405|NCT02388737|50231592|FG000|Overall Study|Reason Not Specified|5|||
25119406|NCT02388737|50231593|FG001|Overall Study|Reason Not Specified|5|||
25119407|NCT02388737|50231594|FG002|Overall Study|Reason Not Specified|4|||
25119408|NCT02355743|50231602|FG000|Overall Study|Withdrawal by Subject|1|||
25119409|NCT02355743|50231602|FG000|Overall Study|Lost to Follow-up|1|||
25119410|NCT02388347|50231611|FG000|Overall Study|Withdrawal by Subject|0|||
25119411|NCT02388347|50231612|FG001|Overall Study|Withdrawal by Subject|0|||
25119412|NCT02388347|50231613|FG002|Overall Study|Withdrawal by Subject|1|||
25119413|NCT02388347|50231614|FG003|Overall Study|Withdrawal by Subject|0|||
25119414|NCT02388347|50231615|FG004|Overall Study|Withdrawal by Subject|0|||
25119415|NCT02355665|50231633|FG000|Overall Study|Adverse Event|16|||
25119416|NCT02355665|50231634|FG001|Overall Study|Adverse Event|24|||
25119417|NCT02355665|50231633|FG000|Overall Study|Protocol Violation|2|||
25119418|NCT02355665|50231634|FG001|Overall Study|Protocol Violation|0|||
25119419|NCT02355665|50231633|FG000|Overall Study|Withdrawal by Subject|90|||
25119420|NCT02355665|50231634|FG001|Overall Study|Withdrawal by Subject|100|||
25119421|NCT02355665|50231633|FG000|Overall Study|Lost to Follow-up|131|||
25119422|NCT02355665|50231634|FG001|Overall Study|Lost to Follow-up|103|||
25119423|NCT02355665|50231633|FG000|Overall Study|Death|4|||
25119424|NCT02355665|50231634|FG001|Overall Study|Death|2|||
25119425|NCT02355665|50231633|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
25119426|NCT02355665|50231634|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
25119427|NCT02010255|50231654|FG000|Overall Study|Death|0|||
25119428|NCT02010255|50231655|FG001|Overall Study|Death|1|||
25119429|NCT02010255|50231656|FG002|Overall Study|Death|4|||
25119430|NCT02010255|50231657|FG003|Overall Study|Death|4|||
25119431|NCT02010255|50231658|FG004|Overall Study|Death|2|||
25119432|NCT02010255|50231659|FG005|Overall Study|Death|0|||
25119433|NCT02010255|50231660|FG006|Overall Study|Death|1|||
25119434|NCT02010255|50231661|FG007|Overall Study|Death|1|||
25119435|NCT02010255|50231662|FG008|Overall Study|Death|1|||
25119436|NCT02010255|50231663|FG009|Overall Study|Death|0|||
25119437|NCT02010255|50231664|FG010|Overall Study|Death|1|||
25119438|NCT02010255|50231665|FG011|Overall Study|Death|1|||
25119439|NCT02010255|50231666|FG012|Overall Study|Death|0|||
25119440|NCT02010255|50231667|FG013|Overall Study|Death|0|||
25119441|NCT02010255|50231654|FG000|Overall Study|Lack of Efficacy|4|||
25119442|NCT02010255|50231655|FG001|Overall Study|Lack of Efficacy|1|||
25119443|NCT02010255|50231656|FG002|Overall Study|Lack of Efficacy|2|||
25119444|NCT02010255|50231657|FG003|Overall Study|Lack of Efficacy|1|||
25119445|NCT02010255|50231658|FG004|Overall Study|Lack of Efficacy|1|||
25119446|NCT02010255|50231659|FG005|Overall Study|Lack of Efficacy|0|||
25119447|NCT02010255|50231660|FG006|Overall Study|Lack of Efficacy|0|||
25119448|NCT02010255|50231661|FG007|Overall Study|Lack of Efficacy|0|||
25119449|NCT02010255|50231662|FG008|Overall Study|Lack of Efficacy|0|||
25119450|NCT02010255|50231663|FG009|Overall Study|Lack of Efficacy|0|||
25119451|NCT02010255|50231664|FG010|Overall Study|Lack of Efficacy|1|||
25119452|NCT02010255|50231665|FG011|Overall Study|Lack of Efficacy|0|||
25119453|NCT02010255|50231666|FG012|Overall Study|Lack of Efficacy|0|||
25119454|NCT02010255|50231667|FG013|Overall Study|Lack of Efficacy|0|||
25119455|NCT02010255|50231654|FG000|Overall Study|Withdrew Consent|1|||
25119456|NCT02010255|50231655|FG001|Overall Study|Withdrew Consent|0|||
25119457|NCT02010255|50231656|FG002|Overall Study|Withdrew Consent|0|||
25119458|NCT02010255|50231657|FG003|Overall Study|Withdrew Consent|1|||
25119459|NCT02010255|50231658|FG004|Overall Study|Withdrew Consent|0|||
25119460|NCT02010255|50231659|FG005|Overall Study|Withdrew Consent|0|||
25119461|NCT02010255|50231660|FG006|Overall Study|Withdrew Consent|0|||
25119462|NCT02010255|50231661|FG007|Overall Study|Withdrew Consent|0|||
25119463|NCT02010255|50231662|FG008|Overall Study|Withdrew Consent|0|||
25119464|NCT02010255|50231663|FG009|Overall Study|Withdrew Consent|0|||
25119465|NCT02010255|50231664|FG010|Overall Study|Withdrew Consent|0|||
25119466|NCT02010255|50231665|FG011|Overall Study|Withdrew Consent|0|||
25119467|NCT02010255|50231666|FG012|Overall Study|Withdrew Consent|0|||
25119468|NCT02010255|50231667|FG013|Overall Study|Withdrew Consent|0|||
25119469|NCT02010255|50231654|FG000|Overall Study|Adverse Event|1|||
25119470|NCT02010255|50231655|FG001|Overall Study|Adverse Event|0|||
25119471|NCT02010255|50231656|FG002|Overall Study|Adverse Event|0|||
25119472|NCT02010255|50231657|FG003|Overall Study|Adverse Event|0|||
25119473|NCT02010255|50231658|FG004|Overall Study|Adverse Event|0|||
25119474|NCT02010255|50231659|FG005|Overall Study|Adverse Event|0|||
25119475|NCT02010255|50231660|FG006|Overall Study|Adverse Event|0|||
25119476|NCT02010255|50231661|FG007|Overall Study|Adverse Event|0|||
25119477|NCT02010255|50231662|FG008|Overall Study|Adverse Event|0|||
25119478|NCT02010255|50231663|FG009|Overall Study|Adverse Event|0|||
25119479|NCT02010255|50231664|FG010|Overall Study|Adverse Event|0|||
25119480|NCT02010255|50231665|FG011|Overall Study|Adverse Event|0|||
25119481|NCT02010255|50231666|FG012|Overall Study|Adverse Event|0|||
25119482|NCT02010255|50231667|FG013|Overall Study|Adverse Event|0|||
25119483|NCT02010255|50231654|FG000|Overall Study|Lost to Follow-up|0|||
25119484|NCT02010255|50231655|FG001|Overall Study|Lost to Follow-up|0|||
25119485|NCT02010255|50231656|FG002|Overall Study|Lost to Follow-up|1|||
25119486|NCT02010255|50231657|FG003|Overall Study|Lost to Follow-up|0|||
25119487|NCT02010255|50231658|FG004|Overall Study|Lost to Follow-up|1|||
25119488|NCT02010255|50231659|FG005|Overall Study|Lost to Follow-up|0|||
25119489|NCT02010255|50231660|FG006|Overall Study|Lost to Follow-up|0|||
25119490|NCT02010255|50231661|FG007|Overall Study|Lost to Follow-up|0|||
25119491|NCT02010255|50231662|FG008|Overall Study|Lost to Follow-up|0|||
25119492|NCT02010255|50231663|FG009|Overall Study|Lost to Follow-up|0|||
25119493|NCT02010255|50231664|FG010|Overall Study|Lost to Follow-up|0|||
25119494|NCT02010255|50231665|FG011|Overall Study|Lost to Follow-up|0|||
25119495|NCT02010255|50231666|FG012|Overall Study|Lost to Follow-up|0|||
25119496|NCT02010255|50231667|FG013|Overall Study|Lost to Follow-up|0|||
25119497|NCT02010255|50231654|FG000|Overall Study|Randomized but Not Treated|0|||
25119498|NCT02010255|50231655|FG001|Overall Study|Randomized but Not Treated|0|||
25119499|NCT02010255|50231656|FG002|Overall Study|Randomized but Not Treated|0|||
25119500|NCT02010255|50231657|FG003|Overall Study|Randomized but Not Treated|0|||
25119501|NCT02010255|50231658|FG004|Overall Study|Randomized but Not Treated|0|||
25119502|NCT02010255|50231659|FG005|Overall Study|Randomized but Not Treated|0|||
25119503|NCT02010255|50231660|FG006|Overall Study|Randomized but Not Treated|0|||
25119504|NCT02010255|50231661|FG007|Overall Study|Randomized but Not Treated|0|||
25119505|NCT02010255|50231662|FG008|Overall Study|Randomized but Not Treated|0|||
25119506|NCT02010255|50231663|FG009|Overall Study|Randomized but Not Treated|0|||
25119507|NCT02010255|50231664|FG010|Overall Study|Randomized but Not Treated|0|||
25119508|NCT02010255|50231665|FG011|Overall Study|Randomized but Not Treated|0|||
25119509|NCT02010255|50231666|FG012|Overall Study|Randomized but Not Treated|0|||
25119510|NCT02010255|50231667|FG013|Overall Study|Randomized but Not Treated|1|||
25119511|NCT02354417|50231722|FG000|Overall Study|Physician Decision|1|||
25119512|NCT02332187|50231728|FG000|Overall Study|Withdrawal by Subject|2|||
25119513|NCT02332187|50231729|FG001|Overall Study|Withdrawal by Subject|2|||
25119514|NCT02332187|50231728|FG000|Overall Study|Adverse Event|0|||
25119515|NCT02332187|50231729|FG001|Overall Study|Adverse Event|1|||
25119516|NCT02330549|50231737|FG000|Overall Study|Adverse Event|1|||
25119517|NCT02330549|50231738|FG001|Overall Study|Adverse Event|0|||
25119518|NCT02330549|50231737|FG000|Overall Study|Subject withdrew consent|2|||
25119519|NCT02330549|50231738|FG001|Overall Study|Subject withdrew consent|1|||
25119520|NCT02330549|50231737|FG000|Overall Study|Failure to meet randomization criteria|1|||
25119521|NCT02330549|50231738|FG001|Overall Study|Failure to meet randomization criteria|0|||
25119522|NCT02009865|50231746|FG000|Overall Study|Adverse Event|0|||
25119523|NCT02009865|50231747|FG001|Overall Study|Adverse Event|2|||
25119524|NCT02009865|50231746|FG000|Overall Study|Protocol Violation|0|||
25119525|NCT02009865|50231747|FG001|Overall Study|Protocol Violation|2|||
25119526|NCT02009865|50231746|FG000|Overall Study|Withdrawal by Subject|1|||
25119527|NCT02009865|50231747|FG001|Overall Study|Withdrawal by Subject|1|||
25119528|NCT01620177|50231753|FG000|Overall Study|Failure at Screening Visit|43|||
25119529|NCT01620177|50231753|FG000|Overall Study|Withdrawal by Subject|26|||
25119530|NCT01620177|50231753|FG000|Overall Study|Lost to Follow-up|7|||
25119531|NCT01620177|50231753|FG000|Overall Study|Physician Decision|2|||
25119532|NCT01620177|50231753|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
25119533|NCT02075541|50231772|FG000|Overall Study|Serious Adverse Event|1|||
25119534|NCT02075541|50231773|FG001|Overall Study|Serious Adverse Event|4|||
25119535|NCT02075541|50231772|FG000|Overall Study|Protocol Violation|1|||
25119536|NCT02075541|50231773|FG001|Overall Study|Protocol Violation|0|||
25119537|NCT02075541|50231772|FG000|Overall Study|Withdrawal by Subject|1|||
25119538|NCT02075541|50231773|FG001|Overall Study|Withdrawal by Subject|3|||
25119539|NCT02075541|50231772|FG000|Overall Study|Sponsor study termination|0|||
25119540|NCT02075541|50231773|FG001|Overall Study|Sponsor study termination|1|||
25119541|NCT02075541|50231772|FG000|Overall Study|Other- unable to perform study procedure|1|||
25119542|NCT02075541|50231773|FG001|Overall Study|Other- unable to perform study procedure|0|||
25119543|NCT02330081|50231779|FG000|Overall Study|Adverse Event|1|||
25119544|NCT02330081|50231779|FG000|Overall Study|Donation did not meet criteria|1|||
25119545|NCT02330081|50231779|FG000|Overall Study|Protocol Violation|6|||
25119546|NCT01986855|50231789|FG000|Overall Study|Adverse Event|1|||
25119547|NCT01986855|50231790|FG001|Overall Study|Adverse Event|0|||
25119548|NCT01986855|50231791|FG002|Overall Study|Adverse Event|0|||
25119549|NCT01986855|50231789|FG000|Overall Study|Death|3|||
25119550|NCT01986855|50231790|FG001|Overall Study|Death|4|||
25119551|NCT01986855|50231791|FG002|Overall Study|Death|4|||
25119552|NCT01986855|50231789|FG000|Overall Study|Lost to Follow-up|2|||
25119553|NCT01986855|50231790|FG001|Overall Study|Lost to Follow-up|1|||
25119554|NCT01986855|50231791|FG002|Overall Study|Lost to Follow-up|0|||
25119555|NCT01986855|50231789|FG000|Overall Study|Screen Failure|0|||
25119556|NCT01986855|50231790|FG001|Overall Study|Screen Failure|1|||
25119557|NCT01986855|50231791|FG002|Overall Study|Screen Failure|0|||
25119558|NCT01986855|50231789|FG000|Overall Study|Participant Moved|0|||
25119559|NCT01986855|50231790|FG001|Overall Study|Participant Moved|0|||
25119560|NCT01986855|50231791|FG002|Overall Study|Participant Moved|2|||
25177451|NCT02754141|50321510|FG003|Overall Study|Other reasons|0|||
25119561|NCT01986855|50231789|FG000|Overall Study|Withdrawal by Subject|7|||
25119562|NCT01986855|50231790|FG001|Overall Study|Withdrawal by Subject|8|||
25119563|NCT01986855|50231791|FG002|Overall Study|Withdrawal by Subject|5|||
25119564|NCT02075463|50231799|FG000|Overall Study|Adverse Event|3|||
25119565|NCT02075463|50231799|FG000|Overall Study|Par. reached stopping criteria|4|||
25119566|NCT02075463|50231799|FG000|Overall Study|Withdrawal by Subject|1|||
25119567|NCT02353871|50231806|FG000|Overall Study|Protocol deviation|0|||
25119568|NCT02353871|50231807|FG001|Overall Study|Protocol deviation|1|||
25119569|NCT02353871|50231806|FG000|Overall Study|Consent withdrawn|1|||
25119570|NCT02353871|50231807|FG001|Overall Study|Consent withdrawn|8|||
25119571|NCT02353871|50231806|FG000|Overall Study|Lost to Follow-up|2|||
25119572|NCT02353871|50231807|FG001|Overall Study|Lost to Follow-up|0|||
25119573|NCT02009397|50231813|FG000|Overall Study|Protocol Violation|6|||
25119574|NCT02009397|50231813|FG000|Overall Study|Death|8|||
25119575|NCT02009397|50231813|FG000|Overall Study|Lost to Follow-up|6|||
25119576|NCT02312219|50231819|FG000|Overall Study|Withdrawal by Subject|1|||
25119577|NCT02312219|50231820|FG001|Overall Study|Withdrawal by Subject|2|||
25119578|NCT02312219|50231819|FG000|Overall Study|could not schedule imaging in time|0|||
25119579|NCT02312219|50231820|FG001|Overall Study|could not schedule imaging in time|2|||
25119580|NCT02312219|50231819|FG000|Overall Study|Other|0|||
25119581|NCT02312219|50231820|FG001|Overall Study|Other|1|||
25119582|NCT02312219|50231819|FG000|Overall Study|Not randomized. Ineligible|0|||
25119583|NCT02312219|50231820|FG001|Overall Study|Not randomized. Ineligible|1|||
25119584|NCT01986231|50231826|FG000|Overall Study|Adverse Event|1|||
25119585|NCT02312063|50231832|FG000|Overall Study|Withdrawal by Subject|0|||
25119586|NCT02312063|50231833|FG001|Overall Study|Withdrawal by Subject|1|||
25119587|NCT02353169|50231844|FG000|Overall Study|QTc > 450 msec|1|||
25119588|NCT02353169|50231845|FG001|Overall Study|QTc > 450 msec|1|||
25119589|NCT02353169|50231846|FG002|Overall Study|QTc > 450 msec|1|||
25119590|NCT02353169|50231847|FG003|Overall Study|QTc > 450 msec|1|||
25119591|NCT02353169|50231844|FG000|Overall Study|OR team declined|2|||
25119592|NCT02353169|50231845|FG001|Overall Study|OR team declined|0|||
25119593|NCT02353169|50231846|FG002|Overall Study|OR team declined|0|||
25119594|NCT02353169|50231847|FG003|Overall Study|OR team declined|0|||
25119595|NCT02353169|50231844|FG000|Overall Study|Inhalational induction|0|||
25119596|NCT02353169|50231845|FG001|Overall Study|Inhalational induction|2|||
25119597|NCT02353169|50231846|FG002|Overall Study|Inhalational induction|0|||
25119598|NCT02353169|50231847|FG003|Overall Study|Inhalational induction|0|||
25119599|NCT02353169|50231844|FG000|Overall Study|ECG data error|0|||
25119600|NCT02353169|50231845|FG001|Overall Study|ECG data error|3|||
25119601|NCT02353169|50231846|FG002|Overall Study|ECG data error|2|||
25119602|NCT02353169|50231847|FG003|Overall Study|ECG data error|2|||
25119603|NCT02353169|50231844|FG000|Overall Study|Pre-op medication|0|||
25119604|NCT02353169|50231845|FG001|Overall Study|Pre-op medication|0|||
25119605|NCT02353169|50231846|FG002|Overall Study|Pre-op medication|1|||
25119606|NCT02353169|50231847|FG003|Overall Study|Pre-op medication|0|||
25119607|NCT02009163|50231857|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
25119608|NCT02009163|50231858|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
25119609|NCT02009163|50231859|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
25119610|NCT02009163|50231857|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
25119611|NCT02009163|50231858|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
25119612|NCT02009163|50231859|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
25119613|NCT02009163|50231857|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
25119614|NCT02009163|50231858|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
25119615|NCT02009163|50231859|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
25119616|NCT02009163|50231857|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
25119617|NCT02009163|50231858|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
25119618|NCT02009163|50231859|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
25119619|NCT02009163|50231857|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
25119620|NCT02009163|50231858|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
25119621|NCT02009163|50231859|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
25119622|NCT02009163|50231857|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
25119623|NCT02009163|50231858|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
25119624|NCT02009163|50231859|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
25119625|NCT02009163|50231857|FG000|Open-label Period (Non-randomized)|Other|13|||
25119626|NCT02009163|50231858|FG001|Open-label Period (Non-randomized)|Other|0|||
25119627|NCT02009163|50231859|FG002|Open-label Period (Non-randomized)|Other|0|||
25119628|NCT02009163|50231857|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
25119629|NCT02009163|50231858|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
25119630|NCT02009163|50231859|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
25119631|NCT02009163|50231857|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
25119632|NCT02009163|50231858|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
25119633|NCT02009163|50231859|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
25119634|NCT02009163|50231857|FG000|Randomized-withdrawal Period|Adverse Event|0|||
25119635|NCT02009163|50231858|FG001|Randomized-withdrawal Period|Adverse Event|0|||
25119636|NCT02009163|50231859|FG002|Randomized-withdrawal Period|Adverse Event|6|||
25119637|NCT02009163|50231857|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
25119638|NCT02009163|50231858|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
25119639|NCT02009163|50231859|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
25119640|NCT02009163|50231857|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
25119641|NCT02009163|50231858|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
25119642|NCT02009163|50231859|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
25119643|NCT02009163|50231857|FG000|Randomized-withdrawal Period|Pregnancy|0|||
25177452|NCT02754141|50321511|FG004|Overall Study|Other reasons|0|||
25119644|NCT02009163|50231858|FG001|Randomized-withdrawal Period|Pregnancy|0|||
25119645|NCT02009163|50231859|FG002|Randomized-withdrawal Period|Pregnancy|2|||
25119646|NCT02009163|50231857|FG000|Randomized-withdrawal Period|Other|0|||
25119647|NCT02009163|50231858|FG001|Randomized-withdrawal Period|Other|9|||
25119648|NCT02009163|50231859|FG002|Randomized-withdrawal Period|Other|5|||
25119649|NCT01983969|50231872|FG000|Overall Study|Disease Progression|0|||
25119650|NCT01983969|50231873|FG001|Overall Study|Disease Progression|1|||
25119651|NCT01983969|50231874|FG002|Overall Study|Disease Progression|0|||
25119652|NCT02008773|50231890|FG000|Overall Study|Adverse Event|3|||
25119653|NCT02008773|50231891|FG001|Overall Study|Adverse Event|3|||
25119654|NCT02008773|50231892|FG002|Overall Study|Adverse Event|1|||
25119655|NCT02008773|50231893|FG003|Overall Study|Adverse Event|2|||
25119656|NCT02008773|50231890|FG000|Overall Study|Medication Non-compliance|2|||
25119657|NCT02008773|50231891|FG001|Overall Study|Medication Non-compliance|1|||
25119658|NCT02008773|50231892|FG002|Overall Study|Medication Non-compliance|3|||
25119659|NCT02008773|50231893|FG003|Overall Study|Medication Non-compliance|2|||
25119660|NCT02008773|50231890|FG000|Overall Study|Withdrawal by Subject|8|||
25119661|NCT02008773|50231891|FG001|Overall Study|Withdrawal by Subject|4|||
25119662|NCT02008773|50231892|FG002|Overall Study|Withdrawal by Subject|7|||
25119663|NCT02008773|50231893|FG003|Overall Study|Withdrawal by Subject|6|||
25119664|NCT02008773|50231890|FG000|Overall Study|Lost to Follow-up|0|||
25119665|NCT02008773|50231891|FG001|Overall Study|Lost to Follow-up|1|||
25119666|NCT02008773|50231892|FG002|Overall Study|Lost to Follow-up|3|||
25119667|NCT02008773|50231893|FG003|Overall Study|Lost to Follow-up|2|||
25119668|NCT02257567|50231912|FG000|Overall Study|Adverse Event|0|||
25119669|NCT02257567|50231913|FG001|Overall Study|Adverse Event|0|||
25119670|NCT02257567|50231914|FG002|Overall Study|Adverse Event|0|||
25119671|NCT02257567|50231915|FG003|Overall Study|Adverse Event|1|||
25119672|NCT02257567|50231916|FG004|Overall Study|Adverse Event|1|||
25119673|NCT02257567|50231917|FG005|Overall Study|Adverse Event|0|||
25119674|NCT02257567|50231918|FG006|Overall Study|Adverse Event|0|||
25119675|NCT02257567|50231919|FG007|Overall Study|Adverse Event|0|||
25119676|NCT02257567|50231920|FG008|Overall Study|Adverse Event|1|||
25119677|NCT02257567|50231921|FG009|Overall Study|Adverse Event|0|||
25119678|NCT02257567|50231922|FG010|Overall Study|Adverse Event|0|||
25119679|NCT02257567|50231912|FG000|Overall Study|Death|2|||
25119680|NCT02257567|50231913|FG001|Overall Study|Death|2|||
25119681|NCT02257567|50231914|FG002|Overall Study|Death|2|||
25119682|NCT02257567|50231915|FG003|Overall Study|Death|4|||
25119683|NCT02257567|50231916|FG004|Overall Study|Death|15|||
25119684|NCT02257567|50231917|FG005|Overall Study|Death|11|||
25119685|NCT02257567|50231918|FG006|Overall Study|Death|26|||
25119686|NCT02257567|50231919|FG007|Overall Study|Death|30|||
25119687|NCT02257567|50231920|FG008|Overall Study|Death|2|||
25119688|NCT02257567|50231921|FG009|Overall Study|Death|18|||
25119689|NCT02257567|50231922|FG010|Overall Study|Death|65|||
25119690|NCT02257567|50231912|FG000|Overall Study|Lost to Follow-up|0|||
25119691|NCT02257567|50231913|FG001|Overall Study|Lost to Follow-up|0|||
25119692|NCT02257567|50231914|FG002|Overall Study|Lost to Follow-up|0|||
25119693|NCT02257567|50231915|FG003|Overall Study|Lost to Follow-up|0|||
25119694|NCT02257567|50231916|FG004|Overall Study|Lost to Follow-up|2|||
25119695|NCT02257567|50231917|FG005|Overall Study|Lost to Follow-up|2|||
25119696|NCT02257567|50231918|FG006|Overall Study|Lost to Follow-up|0|||
25119697|NCT02257567|50231919|FG007|Overall Study|Lost to Follow-up|0|||
25119698|NCT02257567|50231920|FG008|Overall Study|Lost to Follow-up|0|||
25119699|NCT02257567|50231921|FG009|Overall Study|Lost to Follow-up|1|||
25119700|NCT02257567|50231922|FG010|Overall Study|Lost to Follow-up|1|||
25119701|NCT02257567|50231912|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
25119702|NCT02257567|50231913|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
25119703|NCT02257567|50231914|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
25119704|NCT02257567|50231915|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
25119705|NCT02257567|50231916|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
25119706|NCT02257567|50231917|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
25119707|NCT02257567|50231918|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
25008722|NCT04377620|50101810|FG000|Overall Study|Withdrawal by Subject|0|||
25008723|NCT04377620|50101811|FG001|Overall Study|Withdrawal by Subject|2|||
25119708|NCT02257567|50231919|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
25119709|NCT02257567|50231920|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
25119710|NCT02257567|50231921|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
25119711|NCT02257567|50231922|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
25119712|NCT02257567|50231912|FG000|Overall Study|Physician Decision|0|||
25119713|NCT02257567|50231913|FG001|Overall Study|Physician Decision|0|||
25119714|NCT02257567|50231914|FG002|Overall Study|Physician Decision|0|||
25119715|NCT02257567|50231915|FG003|Overall Study|Physician Decision|0|||
25119716|NCT02257567|50231916|FG004|Overall Study|Physician Decision|0|||
25119717|NCT02257567|50231917|FG005|Overall Study|Physician Decision|0|||
25119718|NCT02257567|50231918|FG006|Overall Study|Physician Decision|0|||
25119719|NCT02257567|50231919|FG007|Overall Study|Physician Decision|2|||
25119720|NCT02257567|50231920|FG008|Overall Study|Physician Decision|0|||
25119721|NCT02257567|50231921|FG009|Overall Study|Physician Decision|1|||
25119722|NCT02257567|50231922|FG010|Overall Study|Physician Decision|0|||
25119723|NCT02257567|50231912|FG000|Overall Study|Withdrawal by Subject|0|||
25119724|NCT02257567|50231913|FG001|Overall Study|Withdrawal by Subject|0|||
25119725|NCT02257567|50231914|FG002|Overall Study|Withdrawal by Subject|2|||
25119726|NCT02257567|50231915|FG003|Overall Study|Withdrawal by Subject|0|||
25119727|NCT02257567|50231916|FG004|Overall Study|Withdrawal by Subject|0|||
25119728|NCT02257567|50231917|FG005|Overall Study|Withdrawal by Subject|6|||
25119729|NCT02257567|50231918|FG006|Overall Study|Withdrawal by Subject|6|||
25119730|NCT02257567|50231919|FG007|Overall Study|Withdrawal by Subject|6|||
25119731|NCT02257567|50231920|FG008|Overall Study|Withdrawal by Subject|1|||
25119732|NCT02257567|50231921|FG009|Overall Study|Withdrawal by Subject|1|||
25119733|NCT02257567|50231922|FG010|Overall Study|Withdrawal by Subject|10|||
25119734|NCT01642615|50231979|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
25119735|NCT01642615|50231980|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
25119736|NCT01642615|50231981|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
25119737|NCT01642615|50231979|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
25119738|NCT01642615|50231980|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
25119739|NCT01642615|50231981|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
25119740|NCT01642615|50231979|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
25119741|NCT01642615|50231980|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
25119742|NCT01642615|50231981|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
25119743|NCT01642615|50231979|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
25119744|NCT01642615|50231980|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
25119745|NCT01642615|50231981|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
25119746|NCT01642615|50231979|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
25119747|NCT01642615|50231980|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
25119748|NCT01642615|50231981|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
25119749|NCT01642615|50231979|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
25119750|NCT01642615|50231980|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
25119751|NCT01642615|50231981|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
25119752|NCT01642615|50231979|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
25119753|NCT01642615|50231980|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
25119754|NCT01642615|50231981|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
25119755|NCT01642615|50231979|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
25119756|NCT01642615|50231980|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
25119757|NCT01642615|50231981|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
25119758|NCT01642615|50231979|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
25119759|NCT01642615|50231980|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
25119760|NCT01642615|50231981|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
25119761|NCT02311361|50231993|FG000|Overall Study|Did not receive treatment|0|||
25119762|NCT02311361|50231994|FG001|Overall Study|Did not receive treatment|1|||
25119763|NCT02311361|50231995|FG002|Overall Study|Did not receive treatment|0|||
25119764|NCT02311361|50231996|FG003|Overall Study|Did not receive treatment|1|||
25119765|NCT02352779|50232013|FG000|Overall Study|Personal Issues|1|||
25119766|NCT02352779|50232014|FG001|Overall Study|Personal Issues|1|||
25119767|NCT02352779|50232015|FG002|Overall Study|Personal Issues|0|||
25119768|NCT02352779|50232013|FG000|Overall Study|Too Many Forms|2|||
25119769|NCT02352779|50232014|FG001|Overall Study|Too Many Forms|0|||
25119770|NCT02352779|50232015|FG002|Overall Study|Too Many Forms|0|||
25119771|NCT02352779|50232013|FG000|Overall Study|Feeling Overwhelmed|1|||
25119772|NCT02352779|50232014|FG001|Overall Study|Feeling Overwhelmed|0|||
25119773|NCT02352779|50232015|FG002|Overall Study|Feeling Overwhelmed|0|||
25119774|NCT02352779|50232013|FG000|Overall Study|Disliked Intervention|1|||
25119775|NCT02352779|50232014|FG001|Overall Study|Disliked Intervention|0|||
25119776|NCT02352779|50232015|FG002|Overall Study|Disliked Intervention|0|||
25119777|NCT02352779|50232013|FG000|Overall Study|Changed Mind|1|||
25119778|NCT02352779|50232014|FG001|Overall Study|Changed Mind|0|||
25119779|NCT02352779|50232015|FG002|Overall Study|Changed Mind|0|||
25119780|NCT02352779|50232013|FG000|Overall Study|Study Related Symptoms|1|||
25119781|NCT02352779|50232014|FG001|Overall Study|Study Related Symptoms|0|||
25119782|NCT02352779|50232015|FG002|Overall Study|Study Related Symptoms|0|||
25119783|NCT02352779|50232013|FG000|Overall Study|Absence of Symptoms|1|||
25119784|NCT02352779|50232014|FG001|Overall Study|Absence of Symptoms|0|||
25119785|NCT02352779|50232015|FG002|Overall Study|Absence of Symptoms|0|||
25119786|NCT02352779|50232013|FG000|Overall Study|Other Medical Reason|0|||
25119787|NCT02352779|50232014|FG001|Overall Study|Other Medical Reason|0|||
25119788|NCT02352779|50232015|FG002|Overall Study|Other Medical Reason|1|||
25119789|NCT02352779|50232013|FG000|Overall Study|No Reason|0|||
25119790|NCT02352779|50232014|FG001|Overall Study|No Reason|0|||
25119791|NCT02352779|50232015|FG002|Overall Study|No Reason|1|||
25119792|NCT02257489|50232032|FG000|Overall Study|Withdrawal by Subject|0|||
25119793|NCT02257489|50232033|FG001|Overall Study|Withdrawal by Subject|0|||
25119794|NCT02257489|50232034|FG002|Overall Study|Withdrawal by Subject|0|||
25119795|NCT02257489|50232035|FG003|Overall Study|Withdrawal by Subject|1|||
25119796|NCT02257489|50232036|FG004|Overall Study|Withdrawal by Subject|0|||
25119797|NCT02257489|50232037|FG005|Overall Study|Withdrawal by Subject|0|||
25119798|NCT02257489|50232038|FG006|Overall Study|Withdrawal by Subject|0|||
25119799|NCT02257489|50232039|FG007|Overall Study|Withdrawal by Subject|0|||
25119800|NCT02257489|50232040|FG008|Overall Study|Withdrawal by Subject|0|||
25119801|NCT02329223|50232063|FG000|Overall Study|Withdrawal by Subject|1|||
25119802|NCT02329223|50232064|FG001|Overall Study|Withdrawal by Subject|2|||
25119803|NCT02329223|50232065|FG002|Overall Study|Withdrawal by Subject|5|||
25119804|NCT02329223|50232063|FG000|Overall Study|Physician Decision|0|||
25119805|NCT02329223|50232064|FG001|Overall Study|Physician Decision|0|||
25119806|NCT02329223|50232065|FG002|Overall Study|Physician Decision|1|||
25119807|NCT02329223|50232063|FG000|Overall Study|Adverse Event|0|||
25119808|NCT02329223|50232064|FG001|Overall Study|Adverse Event|1|||
25119809|NCT02329223|50232065|FG002|Overall Study|Adverse Event|0|||
25119810|NCT01641601|50232075|FG000|Overall Study|Study discontinued.|3|||
25119811|NCT01641601|50232076|FG001|Overall Study|Study discontinued.|5|||
25119812|NCT02350127|50232084|FG000|4-Month Assessment|Withdrawal by Subject|10|||
25119813|NCT02350127|50232085|FG001|4-Month Assessment|Withdrawal by Subject|9|||
25119814|NCT02350127|50232084|FG000|4-Month Assessment|Death|1|||
25119815|NCT02350127|50232085|FG001|4-Month Assessment|Death|0|||
25119816|NCT02350127|50232084|FG000|8-Month Assessment|Death|1|||
25119817|NCT02350127|50232085|FG001|8-Month Assessment|Death|1|||
25119818|NCT02350127|50232084|FG000|8-Month Assessment|Withdrawal by Subject|5|||
25119819|NCT02350127|50232085|FG001|8-Month Assessment|Withdrawal by Subject|8|||
25119820|NCT02256553|50232092|FG000|Period I|Adverse Event|5|||
25119821|NCT02256553|50232092|FG000|Period I|Protocol Violation|1|||
25119822|NCT02256553|50232092|FG000|Period II|Adverse Event|1|||
25119823|NCT02256553|50232092|FG000|Period II|Subject Moved|1|||
25119824|NCT02256553|50232092|FG000|Period III|Adverse Event|3|||
25119825|NCT02349425|50232102|FG000|Period 1|Adverse Event|1|||
25119826|NCT02349425|50232103|FG001|Period 1|Adverse Event|1|||
25119827|NCT02349425|50232104|FG002|Period 1|Adverse Event|0|||
25119828|NCT02349425|50232105|FG003|Period 1|Adverse Event|0|||
25119829|NCT02349425|50232102|FG000|Period 2|Adverse Event|0|||
25119830|NCT02349425|50232103|FG001|Period 2|Adverse Event|1|||
25119831|NCT02349425|50232104|FG002|Period 2|Adverse Event|1|||
25119832|NCT02349425|50232105|FG003|Period 2|Adverse Event|0|||
25119833|NCT02310581|50232147|FG000|Overall Study|Adverse Event|1|||
25119834|NCT02310581|50232148|FG001|Overall Study|Adverse Event|1|||
25119835|NCT02310581|50232149|FG002|Overall Study|Adverse Event|1|||
25119836|NCT02310581|50232150|FG003|Overall Study|Adverse Event|0|||
25119837|NCT02310581|50232147|FG000|Overall Study|Withdrawal by Subject|2|||
25119838|NCT02310581|50232148|FG001|Overall Study|Withdrawal by Subject|1|||
25119839|NCT02310581|50232149|FG002|Overall Study|Withdrawal by Subject|0|||
25119840|NCT02310581|50232150|FG003|Overall Study|Withdrawal by Subject|1|||
25119841|NCT02309723|50232163|FG000|Overall Study|Withdrawal by Subject|24|||
25119842|NCT02309723|50232164|FG001|Overall Study|Withdrawal by Subject|23|||
25119843|NCT02309723|50232165|FG002|Overall Study|Withdrawal by Subject|24|||
25119844|NCT02309411|50232176|FG000|Overall Study|Physician Decision|1|||
25119845|NCT02309411|50232177|FG001|Overall Study|Physician Decision|0|||
25119846|NCT02309411|50232178|FG002|Overall Study|Physician Decision|0|||
25119847|NCT02309411|50232176|FG000|Overall Study|Withdrawal by Subject|1|||
25119848|NCT02309411|50232177|FG001|Overall Study|Withdrawal by Subject|1|||
25119849|NCT02309411|50232178|FG002|Overall Study|Withdrawal by Subject|0|||
25119850|NCT02008227|50232187|FG000|Overall Study|Lost to Follow-up|7|||
25119851|NCT02008227|50232188|FG001|Overall Study|Lost to Follow-up|9|||
25119852|NCT02008227|50232187|FG000|Overall Study|Death|494|||
25119853|NCT02008227|50232188|FG001|Overall Study|Death|485|||
25119854|NCT02008227|50232187|FG000|Overall Study|Withdrawal by Subject|67|||
25119855|NCT02008227|50232188|FG001|Overall Study|Withdrawal by Subject|36|||
25119856|NCT02008227|50232187|FG000|Overall Study|Study Terminated By Sponsor|44|||
25119857|NCT02008227|50232188|FG001|Overall Study|Study Terminated By Sponsor|83|||
25119858|NCT02006979|50232197|FG000|Overall Study|Withdrawal by Subject|1|||
25119859|NCT02006979|50232198|FG001|Overall Study|Withdrawal by Subject|1|||
25119860|NCT02006979|50232197|FG000|Overall Study|Protocol Violation|0|||
25119861|NCT02006979|50232198|FG001|Overall Study|Protocol Violation|1|||
25119862|NCT02348723|50232206|FG000|Overall Study|No ablation|21|||
25119863|NCT02348723|50232207|FG001|Overall Study|No ablation|20|||
25119864|NCT02348723|50232206|FG000|Overall Study|Non-compliant with Protocol|1|||
25119865|NCT02348723|50232207|FG001|Overall Study|Non-compliant with Protocol|0|||
25119866|NCT02348723|50232206|FG000|Overall Study|Lost to Follow-up|1|||
25119867|NCT02348723|50232207|FG001|Overall Study|Lost to Follow-up|1|||
25119868|NCT02348723|50232206|FG000|Overall Study|Consent withdrawn|1|||
25119869|NCT02348723|50232207|FG001|Overall Study|Consent withdrawn|3|||
25119870|NCT02348723|50232206|FG000|Overall Study|Reason other than specified|1|||
25119871|NCT02348723|50232207|FG001|Overall Study|Reason other than specified|1|||
25119872|NCT02348723|50232206|FG000|Overall Study|Adverse Event|3|||
25119873|NCT02348723|50232207|FG001|Overall Study|Adverse Event|1|||
25119874|NCT01967277|50232215|FG000|Overall Study|Lost to Follow-up|1|||
25119875|NCT01967277|50232216|FG001|Overall Study|Lost to Follow-up|2|||
25119876|NCT01967277|50232215|FG000|Overall Study|Unrelated illness|0|||
25119877|NCT01967277|50232216|FG001|Overall Study|Unrelated illness|1|||
25119878|NCT02326883|50232225|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
25119879|NCT02326883|50232226|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
25119880|NCT02326883|50232227|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
25119881|NCT02006667|50232235|FG000|Overall Study|Adverse Event|3|||
25119882|NCT02006667|50232235|FG000|Overall Study|Death|2|||
25119883|NCT02006667|50232235|FG000|Overall Study|Withdrawal by Subject|1|||
25119884|NCT01983111|50232241|FG000|Overall Study|Withdrawal by Subject|8|||
25119885|NCT01983111|50232242|FG001|Overall Study|Withdrawal by Subject|6|||
25119886|NCT01983111|50232241|FG000|Overall Study|Adverse Event|4|||
25119887|NCT01983111|50232242|FG001|Overall Study|Adverse Event|0|||
25119888|NCT01983111|50232241|FG000|Overall Study|Protocol Violation|0|||
25119889|NCT01983111|50232242|FG001|Overall Study|Protocol Violation|1|||
25119890|NCT02348489|50232250|FG000|Overall Study|Death|336|||
25119891|NCT02348489|50232251|FG001|Overall Study|Death|335|||
25119892|NCT02348489|50232250|FG000|Overall Study|Withdrawal by Subject|14|||
25119893|NCT02348489|50232251|FG001|Overall Study|Withdrawal by Subject|27|||
25119894|NCT02348489|50232250|FG000|Overall Study|Lost to Follow-up|3|||
25119895|NCT02348489|50232251|FG001|Overall Study|Lost to Follow-up|5|||
25119896|NCT02309099|50232261|FG000|Overall Study|Adverse Event|2|||
25119897|NCT02309099|50232262|FG001|Overall Study|Adverse Event|0|||
25119898|NCT01966107|50232270|FG000|Overall Study|excluded from FAS|21|||
25119899|NCT01966107|50232271|FG001|Overall Study|excluded from FAS|20|||
25119900|NCT01966107|50232270|FG000|Overall Study|discontinued treatment|345|||
25119901|NCT01966107|50232271|FG001|Overall Study|discontinued treatment|372|||
25119902|NCT01966107|50232270|FG000|Overall Study|due to study closure|164|||
25119903|NCT01966107|50232271|FG001|Overall Study|due to study closure|186|||
25119904|NCT01966107|50232270|FG000|Overall Study|withdrew from the study|272|||
25119905|NCT01966107|50232271|FG001|Overall Study|withdrew from the study|303|||
25119906|NCT02347943|50232280|FG000|Overall Study|Study was cancelled|140|||
25119907|NCT02347943|50232281|FG001|Overall Study|Study was cancelled|67|||
25119908|NCT02347943|50232282|FG002|Overall Study|Study was cancelled|45|||
25119909|NCT01982331|50232292|FG000|Received Vaccination 2|Adverse Event|1|||
25119910|NCT01982331|50232293|FG001|Received Vaccination 2|Adverse Event|2|||
25119911|NCT01982331|50232292|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
25119912|NCT01982331|50232293|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
25119913|NCT01982331|50232292|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
25119914|NCT01982331|50232293|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
25119915|NCT02326025|50232301|FG000|Overall Study|Adverse Event|3|||
25119916|NCT02326025|50232302|FG001|Overall Study|Adverse Event|0|||
25119917|NCT02326025|50232301|FG000|Overall Study|Physician Decision|1|||
25119918|NCT02326025|50232302|FG001|Overall Study|Physician Decision|2|||
25119919|NCT02326025|50232301|FG000|Overall Study|Physician and Participant Decision|1|||
25119920|NCT02326025|50232302|FG001|Overall Study|Physician and Participant Decision|0|||
25119921|NCT02326025|50232301|FG000|Overall Study|Withdrawal by Subject|0|||
25119922|NCT02326025|50232302|FG001|Overall Study|Withdrawal by Subject|2|||
25119923|NCT02326025|50232301|FG000|Overall Study|Protocol Violation|0|||
25119924|NCT02326025|50232302|FG001|Overall Study|Protocol Violation|1|||
25119925|NCT01619865|50232321|FG000|Overall Study|Adverse Event|1|||
25119926|NCT01619865|50232321|FG000|Overall Study|Death|2|||
25119927|NCT01619865|50232321|FG000|Overall Study|subject not able to comply|1|||
25119928|NCT02006121|50232328|FG000|Double Blind Phase|Adverse Event|6|||
25119929|NCT02006121|50232329|FG001|Double Blind Phase|Adverse Event|0|||
25119930|NCT02006121|50232328|FG000|Double Blind Phase|Lack of Efficacy|1|||
25119931|NCT02006121|50232329|FG001|Double Blind Phase|Lack of Efficacy|16|||
25119932|NCT02006121|50232328|FG000|Double Blind Phase|Withdrawal by Subject|3|||
25119933|NCT02006121|50232329|FG001|Double Blind Phase|Withdrawal by Subject|4|||
25119934|NCT02006121|50232328|FG000|Double Blind Phase|Non-compliance with study drug|1|||
25119935|NCT02006121|50232329|FG001|Double Blind Phase|Non-compliance with study drug|3|||
25119936|NCT02006121|50232328|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
25119937|NCT02006121|50232329|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
25119938|NCT02006121|50232328|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
25119939|NCT02006121|50232329|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
25119940|NCT02006121|50232328|FG000|Open Label Phase|Adverse Event|15|||
25119941|NCT02006121|50232329|FG001|Open Label Phase|Adverse Event|0|||
25119942|NCT02006121|50232328|FG000|Open Label Phase|Lack of Efficacy|2|||
25119943|NCT02006121|50232329|FG001|Open Label Phase|Lack of Efficacy|0|||
25119944|NCT02006121|50232328|FG000|Open Label Phase|Protocol Violation|2|||
25119945|NCT02006121|50232329|FG001|Open Label Phase|Protocol Violation|0|||
25119946|NCT02006121|50232328|FG000|Open Label Phase|Withdrawal by Subject|3|||
25119947|NCT02006121|50232329|FG001|Open Label Phase|Withdrawal by Subject|0|||
25119948|NCT02006121|50232328|FG000|Open Label Phase|Non-compliance with study drug|3|||
25119949|NCT02006121|50232329|FG001|Open Label Phase|Non-compliance with study drug|0|||
25119950|NCT02005887|50232341|FG000|Overall Study|Protocol Violation|0|||
25119951|NCT02005887|50232342|FG001|Overall Study|Protocol Violation|2|||
25119952|NCT01982253|50232351|FG000|Overall Study|Withdrawal by Subject|1|||
25119953|NCT01982253|50232352|FG001|Overall Study|Withdrawal by Subject|0|||
25119954|NCT01982253|50232353|FG002|Overall Study|Withdrawal by Subject|0|||
25119955|NCT01982253|50232351|FG000|Overall Study|Study terminated by sponsor|1|||
25119956|NCT01982253|50232352|FG001|Overall Study|Study terminated by sponsor|4|||
25119957|NCT01982253|50232353|FG002|Overall Study|Study terminated by sponsor|4|||
25119958|NCT01619787|50232363|FG000|Overall Study|Lost to Follow-up|5|||
25119959|NCT01981473|50232372|FG000|Overall Study|Incorrect diagnosis of RA|0|||
25119960|NCT01981473|50232373|FG001|Overall Study|Incorrect diagnosis of RA|0|||
25119961|NCT01981473|50232374|FG002|Overall Study|Incorrect diagnosis of RA|1|||
25119962|NCT01981473|50232372|FG000|Overall Study|Received treatment for < 6 months|0|||
25119963|NCT01981473|50232373|FG001|Overall Study|Received treatment for < 6 months|0|||
25119964|NCT01981473|50232374|FG002|Overall Study|Received treatment for < 6 months|1|||
25119965|NCT01981473|50232372|FG000|Overall Study|Received treatment for >24 months|2|||
25119966|NCT01981473|50232373|FG001|Overall Study|Received treatment for >24 months|0|||
25119967|NCT01981473|50232374|FG002|Overall Study|Received treatment for >24 months|6|||
25119968|NCT02005029|50232387|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
25119969|NCT02005029|50232388|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
25119970|NCT02325791|50232416|FG000|Overall Study|Adverse Event|0|||
25119971|NCT02325791|50232417|FG001|Overall Study|Adverse Event|1|||
25119972|NCT02325791|50232418|FG002|Overall Study|Adverse Event|1|||
25119973|NCT02325791|50232419|FG003|Overall Study|Adverse Event|0|||
25119974|NCT02325791|50232416|FG000|Overall Study|Death|0|||
25119975|NCT02325791|50232417|FG001|Overall Study|Death|3|||
25119976|NCT02325791|50232418|FG002|Overall Study|Death|0|||
25119977|NCT02325791|50232419|FG003|Overall Study|Death|1|||
25119978|NCT02325791|50232416|FG000|Overall Study|Lost to Follow-up|0|||
25119979|NCT02325791|50232417|FG001|Overall Study|Lost to Follow-up|15|||
25119980|NCT02325791|50232418|FG002|Overall Study|Lost to Follow-up|14|||
25119981|NCT02325791|50232419|FG003|Overall Study|Lost to Follow-up|9|||
25119982|NCT02325791|50232416|FG000|Overall Study|Physician Decision|0|||
25119983|NCT02325791|50232417|FG001|Overall Study|Physician Decision|1|||
25119984|NCT02325791|50232418|FG002|Overall Study|Physician Decision|1|||
25119985|NCT02325791|50232419|FG003|Overall Study|Physician Decision|0|||
25119986|NCT02325791|50232416|FG000|Overall Study|Protocol Violation|0|||
25119987|NCT02325791|50232417|FG001|Overall Study|Protocol Violation|0|||
25119988|NCT02325791|50232418|FG002|Overall Study|Protocol Violation|1|||
25119989|NCT02325791|50232419|FG003|Overall Study|Protocol Violation|0|||
25119990|NCT02325791|50232416|FG000|Overall Study|Withdrawal by Subject|0|||
25119991|NCT02325791|50232417|FG001|Overall Study|Withdrawal by Subject|5|||
25119992|NCT02325791|50232418|FG002|Overall Study|Withdrawal by Subject|8|||
25119993|NCT02325791|50232419|FG003|Overall Study|Withdrawal by Subject|16|||
25119994|NCT02004873|50232432|FG000|Overall Study|Implant unsuccessful|6|||
25119995|NCT02004873|50232432|FG000|Overall Study|Awaiting 6-month visit|390|||
25119996|NCT02004873|50232432|FG000|Overall Study|Missed 6-month visit|4|||
25177453|NCT02754141|50321512|FG005|Overall Study|Other reasons|0|||
25177454|NCT02754141|50321513|FG006|Overall Study|Other reasons|0|||
25177455|NCT02754141|50321514|FG007|Overall Study|Other reasons|1|||
25177456|NCT02754141|50321515|FG008|Overall Study|Other reasons|0|||
25119997|NCT02004873|50232432|FG000|Overall Study|Death|23|||
25119998|NCT02004873|50232432|FG000|Overall Study|Withdrawal by Subject|1|||
25119999|NCT02347787|50232441|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
25120000|NCT02347787|50232442|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
25120001|NCT02347787|50232441|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
25120002|NCT02347787|50232442|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
25120003|NCT02347787|50232441|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
25120004|NCT02347787|50232442|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
25177457|NCT02754141|50321516|FG009|Overall Study|Other reasons|0|||
25120005|NCT02347787|50232441|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
25120006|NCT02347787|50232442|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
25120007|NCT01979835|50232453|FG000|Primary Outcome SA Measurment|failed insertion|18|||
25120008|NCT01979835|50232453|FG000|Follow-up|Lost to Follow-up|32|||
25120009|NCT02282345|50232459|FG000|Overall Study|Progression|0|||
25120010|NCT02282345|50232460|FG001|Overall Study|Progression|1|||
25120011|NCT01732822|50232471|FG000|Overall Study|Withdrawal by Subject|123|||
25120012|NCT01732822|50232472|FG001|Overall Study|Withdrawal by Subject|113|||
25120013|NCT02004093|50232502|FG000|Overall Study|Death|2|||
25120014|NCT02004093|50232503|FG001|Overall Study|Death|1|||
25120015|NCT02004093|50232502|FG000|Overall Study|Lack of Efficacy|66|||
25120016|NCT02004093|50232503|FG001|Overall Study|Lack of Efficacy|62|||
25120017|NCT02004093|50232502|FG000|Overall Study|Protocol Violation|0|||
25120018|NCT02004093|50232503|FG001|Overall Study|Protocol Violation|1|||
25120019|NCT02004093|50232502|FG000|Overall Study|Lost to Follow-up|0|||
25120020|NCT02004093|50232503|FG001|Overall Study|Lost to Follow-up|1|||
25120021|NCT02004093|50232502|FG000|Overall Study|Withdrawal by Subject|3|||
25120022|NCT02004093|50232503|FG001|Overall Study|Withdrawal by Subject|7|||
25120023|NCT02004093|50232502|FG000|Overall Study|Other|3|||
25120024|NCT02004093|50232503|FG001|Overall Study|Other|1|||
25120025|NCT01641367|50232518|FG000|Cohorts|Death|18|||
25120026|NCT01641367|50232519|FG001|Cohorts|Death|1|||
25120027|NCT01641367|50232520|FG002|Cohorts|Death|2|||
25120028|NCT01641367|50232521|FG003|Cohorts|Death|0|||
25120029|NCT01641367|50232522|FG004|Cohorts|Death|1|||
25120030|NCT01641367|50232523|FG005|Cohorts|Death|1|||
25120031|NCT01641367|50232524|FG006|Cohorts|Death|0|||
25120032|NCT01641367|50232525|FG007|Cohorts|Death|0|||
25120033|NCT01641367|50232518|FG000|Cohorts|Lost to Follow-up|16|||
25120034|NCT01641367|50232519|FG001|Cohorts|Lost to Follow-up|0|||
25120035|NCT01641367|50232520|FG002|Cohorts|Lost to Follow-up|2|||
25120036|NCT01641367|50232521|FG003|Cohorts|Lost to Follow-up|0|||
25120037|NCT01641367|50232522|FG004|Cohorts|Lost to Follow-up|2|||
25120038|NCT01641367|50232523|FG005|Cohorts|Lost to Follow-up|0|||
25120039|NCT01641367|50232524|FG006|Cohorts|Lost to Follow-up|0|||
25120040|NCT01641367|50232525|FG007|Cohorts|Lost to Follow-up|0|||
25120041|NCT01641367|50232518|FG000|Randomized Adherence Intervention|Death|0|||
25120042|NCT01641367|50232519|FG001|Randomized Adherence Intervention|Death|0|||
25120043|NCT01641367|50232520|FG002|Randomized Adherence Intervention|Death|0|||
25120044|NCT01641367|50232521|FG003|Randomized Adherence Intervention|Death|0|||
25120045|NCT01641367|50232522|FG004|Randomized Adherence Intervention|Death|0|||
25120046|NCT01641367|50232523|FG005|Randomized Adherence Intervention|Death|0|||
25120047|NCT01641367|50232524|FG006|Randomized Adherence Intervention|Death|11|||
25120048|NCT01641367|50232525|FG007|Randomized Adherence Intervention|Death|12|||
25120049|NCT01641367|50232518|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
25120050|NCT01641367|50232519|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
25120051|NCT01641367|50232520|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
25120052|NCT01641367|50232521|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
25120053|NCT01641367|50232522|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
25120054|NCT01641367|50232523|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
25120055|NCT01641367|50232524|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
25120056|NCT01641367|50232525|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
25120057|NCT02325713|50232564|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
25120058|NCT02325713|50232565|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
25120059|NCT02325713|50232566|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
25120060|NCT02325713|50232567|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
25120061|NCT02325713|50232568|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
25120062|NCT02325713|50232569|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
25120063|NCT02325713|50232570|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
25120064|NCT02325713|50232571|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
25120065|NCT02325713|50232572|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
25120066|NCT02325713|50232573|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
25120067|NCT02325713|50232574|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
25120068|NCT02325713|50232575|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
25120069|NCT02325713|50232576|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
25120070|NCT02325713|50232577|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
25120071|NCT02325713|50232578|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
25120072|NCT02325713|50232579|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
25120073|NCT02325713|50232564|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
25120074|NCT02325713|50232565|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
25120075|NCT02325713|50232566|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
25120076|NCT02325713|50232567|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
25120077|NCT02325713|50232568|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
25120078|NCT02325713|50232569|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
25120079|NCT02325713|50232570|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
25120080|NCT02325713|50232571|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
25120081|NCT02325713|50232572|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
25120082|NCT02325713|50232573|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
25120083|NCT02325713|50232574|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
25120084|NCT02325713|50232575|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
25120085|NCT02325713|50232576|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
25120086|NCT02325713|50232577|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
25120087|NCT02325713|50232578|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
25120088|NCT02325713|50232579|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
25120089|NCT02325713|50232564|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
25120090|NCT02325713|50232565|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
25120091|NCT02325713|50232566|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
25120092|NCT02325713|50232567|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
25120093|NCT02325713|50232568|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
25120094|NCT02325713|50232569|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
25120095|NCT02325713|50232570|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
25120096|NCT02325713|50232571|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
25120097|NCT02325713|50232572|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
25120098|NCT02325713|50232573|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
25120099|NCT02325713|50232574|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
25120100|NCT02325713|50232575|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
25120101|NCT02325713|50232576|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
25120102|NCT02325713|50232577|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
25120103|NCT02325713|50232578|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
25120104|NCT02325713|50232579|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
25120105|NCT02325401|50232594|FG000|Overall Study|Withdrawal by Subject|0|||
25120106|NCT02325401|50232595|FG001|Overall Study|Withdrawal by Subject|1|||
25120107|NCT02325401|50232596|FG002|Overall Study|Withdrawal by Subject|1|||
25120108|NCT02324699|50232610|FG000|Overall Study|study terminated|1|||
25120109|NCT01764256|50232618|FG000|Received All Vaccinations|Adverse Event|1|||
25120110|NCT01764256|50232619|FG001|Received All Vaccinations|Adverse Event|1|||
25120111|NCT01764256|50232620|FG002|Received All Vaccinations|Adverse Event|0|||
25120112|NCT01764256|50232621|FG003|Received All Vaccinations|Adverse Event|0|||
25120113|NCT01764256|50232618|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
25120114|NCT01764256|50232619|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
25120115|NCT01764256|50232620|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
25120116|NCT01764256|50232621|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
25120117|NCT01764256|50232618|FG000|Received All Vaccinations|Lost to Follow-up|1|||
25120118|NCT01764256|50232619|FG001|Received All Vaccinations|Lost to Follow-up|0|||
25120119|NCT01764256|50232620|FG002|Received All Vaccinations|Lost to Follow-up|0|||
25120120|NCT01764256|50232621|FG003|Received All Vaccinations|Lost to Follow-up|0|||
25120121|NCT01764256|50232618|FG000|Completed Study|Lost to Follow-up|0|||
25120122|NCT01764256|50232619|FG001|Completed Study|Lost to Follow-up|0|||
25120123|NCT01764256|50232620|FG002|Completed Study|Lost to Follow-up|0|||
25120124|NCT01764256|50232621|FG003|Completed Study|Lost to Follow-up|1|||
25120125|NCT01979523|50232637|FG000|Overall Study|Withdrawal by Subject|1|||
25120126|NCT01979523|50232638|FG001|Overall Study|Withdrawal by Subject|0|||
25120127|NCT02255461|50232650|FG000|Overall Study|Adverse Event|0|||
25120128|NCT02255461|50232651|FG001|Overall Study|Adverse Event|1|||
25120129|NCT02255461|50232652|FG002|Overall Study|Adverse Event|0|||
25120130|NCT02255461|50232653|FG003|Overall Study|Adverse Event|0|||
25120131|NCT02255461|50232654|FG004|Overall Study|Adverse Event|1|||
25120132|NCT02255461|50232650|FG000|Overall Study|Withdrawal by Subject|0|||
25120133|NCT02255461|50232651|FG001|Overall Study|Withdrawal by Subject|0|||
25120134|NCT02255461|50232652|FG002|Overall Study|Withdrawal by Subject|1|||
25120135|NCT02255461|50232653|FG003|Overall Study|Withdrawal by Subject|0|||
25120136|NCT02255461|50232654|FG004|Overall Study|Withdrawal by Subject|1|||
25120137|NCT02255461|50232650|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
25120138|NCT02255461|50232651|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
25120139|NCT02255461|50232652|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
25120140|NCT02255461|50232653|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
25120141|NCT02255461|50232654|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
25120142|NCT02255149|50232671|FG000|Overall Study|Lost to Follow-up|2|||
25120143|NCT02255149|50232671|FG000|Overall Study|Withdrawal by Subject|1|||
25120144|NCT02255149|50232671|FG000|Overall Study|Withdrawal by PI|1|||
25120145|NCT02255149|50232671|FG000|Overall Study|Implant Failure|1|||
25120146|NCT01764022|50232677|FG000|Overall Study|Death|3|||
25120147|NCT01764022|50232678|FG001|Overall Study|Death|5|||
25120148|NCT01764022|50232677|FG000|Overall Study|Withdrawal by Subject|2|||
25120149|NCT01764022|50232678|FG001|Overall Study|Withdrawal by Subject|6|||
25120150|NCT01764022|50232677|FG000|Overall Study|Lack of Efficacy|0|||
25120151|NCT01764022|50232678|FG001|Overall Study|Lack of Efficacy|1|||
25120152|NCT01764022|50232677|FG000|Overall Study|Physician Decision|0|||
25120153|NCT01764022|50232678|FG001|Overall Study|Physician Decision|2|||
25120154|NCT01764022|50232677|FG000|Overall Study|Lost to Follow-up|2|||
25120155|NCT01764022|50232678|FG001|Overall Study|Lost to Follow-up|0|||
25120156|NCT01764022|50232677|FG000|Overall Study|Protocol Violation|1|||
25120157|NCT01764022|50232678|FG001|Overall Study|Protocol Violation|0|||
25120158|NCT02003391|50232688|FG000|Overall Study|Withdrawal by Subject|2|||
25120159|NCT02003391|50232689|FG001|Overall Study|Withdrawal by Subject|1|||
25120160|NCT02003391|50232688|FG000|Overall Study|Protocol Violation|0|||
25120161|NCT02003391|50232689|FG001|Overall Study|Protocol Violation|1|||
25120162|NCT02003391|50232688|FG000|Overall Study|Adverse Event|1|||
25120163|NCT02003391|50232689|FG001|Overall Study|Adverse Event|0|||
25120164|NCT02254681|50232695|FG000|Overall Study|Lack of Efficacy|6|||
25120165|NCT01965327|50232700|FG000|Overall Study|Physician Decision|2|||
25120166|NCT02002689|50232704|FG000|Overall Study|Disease Progression|7|||
25120167|NCT02002689|50232704|FG000|Overall Study|Adverse Event|3|||
25120168|NCT01639729|50232708|FG000|Overall Study|Withdrawal by Subject|1|||
25120169|NCT01639729|50232709|FG001|Overall Study|Withdrawal by Subject|0|||
25120170|NCT01639729|50232710|FG002|Overall Study|Withdrawal by Subject|1|||
25008724|NCT04377620|50101812|FG002|Overall Study|Withdrawal by Subject|0|||
25120171|NCT01639729|50232711|FG003|Overall Study|Withdrawal by Subject|1|||
25120172|NCT01639729|50232712|FG004|Overall Study|Withdrawal by Subject|0|||
25120173|NCT01639729|50232713|FG005|Overall Study|Withdrawal by Subject|0|||
25120174|NCT02002533|50232725|FG000|Overall Study|Withdrawal by Subject|6|||
25120175|NCT02002533|50232726|FG001|Overall Study|Withdrawal by Subject|13|||
25120176|NCT02002533|50232725|FG000|Overall Study|Protocol Violation|0|||
25120177|NCT02002533|50232726|FG001|Overall Study|Protocol Violation|1|||
25120178|NCT02002533|50232725|FG000|Overall Study|Adverse Event|0|||
25120179|NCT02002533|50232726|FG001|Overall Study|Adverse Event|3|||
25120180|NCT02002533|50232725|FG000|Overall Study|Lost to Follow-up|0|||
25120181|NCT02002533|50232726|FG001|Overall Study|Lost to Follow-up|1|||
25120182|NCT02002221|50232735|FG000|Overall Study|Adverse Event|2|||
25120183|NCT02002221|50232736|FG001|Overall Study|Adverse Event|1|||
25120184|NCT02002221|50232735|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25120185|NCT02002221|50232736|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
25120186|NCT02002221|50232735|FG000|Overall Study|Patient withdrew consent|0|||
25120187|NCT02002221|50232736|FG001|Overall Study|Patient withdrew consent|1|||
25120188|NCT01639495|50232742|FG000|Overall Study|Lost to Follow-up|6|||
25120189|NCT01639495|50232742|FG000|Overall Study|Consented but didn't have study catheter|4|||
25120190|NCT01639495|50232742|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
25120191|NCT01639495|50232742|FG000|Overall Study|No radiofrequency energy applied|2|||
25120192|NCT02001987|50232746|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
25120193|NCT02001987|50232746|FG000|Core Study Period (24 Weeks)|Death|1|||
25120194|NCT02001987|50232746|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
25120195|NCT02001987|50232746|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
25120196|NCT02001987|50232746|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
25120197|NCT02001987|50232746|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
25120198|NCT02001987|50232746|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
25120199|NCT02001987|50232746|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
25120200|NCT02001987|50232746|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
25120201|NCT02001987|50232746|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
25120202|NCT02001987|50232746|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
25120203|NCT02001987|50232746|FG000|LTE Period (52 Weeks)|Other|3|||
25120204|NCT01363765|50232757|FG000|Overall Study|non-diagnostic|2621|||
25120205|NCT01363765|50232758|FG001|Overall Study|non-diagnostic|1124|||
25120206|NCT01363765|50232757|FG000|Overall Study|duplicate records|736|||
25120207|NCT01363765|50232758|FG001|Overall Study|duplicate records|3177|||
25120208|NCT01363765|50232757|FG000|Overall Study|non-resident|156|||
25120209|NCT01363765|50232758|FG001|Overall Study|non-resident|76|||
25120210|NCT01363765|50232757|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
25120211|NCT01363765|50232758|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
25120212|NCT01363765|50232757|FG000|Overall Study|smear during intervention|2170|||
25120213|NCT01363765|50232758|FG001|Overall Study|smear during intervention|0|||
25120214|NCT02001051|50232768|FG000|Overall Study|Deemed not eligible following enrollment|0|||
25120215|NCT02001051|50232769|FG001|Overall Study|Deemed not eligible following enrollment|1|||
25120216|NCT01763164|50232777|FG000|Treatment Phase|Participant/Guardian decision|26|||
25120217|NCT01763164|50232778|FG001|Treatment Phase|Participant/Guardian decision|14|||
25120218|NCT01763164|50232777|FG000|Treatment Phase|Protocol Violation|1|||
25008725|NCT03486834|50101824|FG000|Overall Study|Withdrawal by Subject|46|||
25008726|NCT03486834|50101825|FG001|Overall Study|Withdrawal by Subject|46|||
25008727|NCT03486834|50101826|FG002|Overall Study|Withdrawal by Subject|52|||
25120219|NCT01763164|50232778|FG001|Treatment Phase|Protocol Violation|1|||
25120220|NCT01763164|50232777|FG000|Treatment Phase|Progressive Disease|142|||
25120221|NCT01763164|50232778|FG001|Treatment Phase|Progressive Disease|76|||
25120222|NCT01763164|50232777|FG000|Treatment Phase|Physician Decision|24|||
25120223|NCT01763164|50232778|FG001|Treatment Phase|Physician Decision|13|||
25120224|NCT01763164|50232777|FG000|Treatment Phase|Death|10|||
25120225|NCT01763164|50232778|FG001|Treatment Phase|Death|1|||
25120226|NCT01763164|50232777|FG000|Treatment Phase|Adverse Event|66|||
25120227|NCT01763164|50232778|FG001|Treatment Phase|Adverse Event|8|||
25120228|NCT01763164|50232777|FG000|Treatment Phase|Randomized but not Treated|0|||
25120229|NCT01763164|50232778|FG001|Treatment Phase|Randomized but not Treated|19|||
25120230|NCT01763164|50232777|FG000|Treatment Phase|Other|0|||
25120231|NCT01763164|50232778|FG001|Treatment Phase|Other|1|||
25120232|NCT01763164|50232777|FG000|Follow up Phase|New therapy for study indication|12|||
25120233|NCT01763164|50232778|FG001|Follow up Phase|New therapy for study indication|3|||
25120234|NCT01763164|50232777|FG000|Follow up Phase|Death|21|||
25120235|NCT01763164|50232778|FG001|Follow up Phase|Death|4|||
25120236|NCT01763164|50232777|FG000|Follow up Phase|Subject/guardian decision|9|||
25120237|NCT01763164|50232778|FG001|Follow up Phase|Subject/guardian decision|2|||
25120238|NCT01763164|50232777|FG000|Follow up Phase|Progressive disease|127|||
25120239|NCT01763164|50232778|FG001|Follow up Phase|Progressive disease|62|||
25120240|NCT01763164|50232777|FG000|Follow up Phase|Physician Decision|10|||
25120241|NCT01763164|50232778|FG001|Follow up Phase|Physician Decision|3|||
25120242|NCT01763164|50232777|FG000|Follow up Phase|Lost to Follow-up|1|||
25120243|NCT01763164|50232778|FG001|Follow up Phase|Lost to Follow-up|0|||
25120244|NCT01763164|50232777|FG000|Follow up Phase|Adverse Event|17|||
25120245|NCT01763164|50232778|FG001|Follow up Phase|Adverse Event|1|||
25120246|NCT01782742|50232786|FG000|Double-blind Treatment Phase|Adverse Event|1|||
25120247|NCT01782742|50232787|FG001|Double-blind Treatment Phase|Adverse Event|0|||
25120248|NCT01782664|50232801|FG000|Overall Study|Adverse Event|2|||
25120249|NCT01782664|50232802|FG001|Overall Study|Adverse Event|2|||
25120250|NCT01782664|50232803|FG002|Overall Study|Adverse Event|2|||
25120251|NCT01782664|50232804|FG003|Overall Study|Adverse Event|2|||
25120252|NCT01782664|50232805|FG004|Overall Study|Adverse Event|0|||
25120253|NCT01782664|50232806|FG005|Overall Study|Adverse Event|0|||
25120254|NCT01782664|50232801|FG000|Overall Study|Lack of Efficacy|2|||
25120255|NCT01782664|50232802|FG001|Overall Study|Lack of Efficacy|0|||
25120256|NCT01782664|50232803|FG002|Overall Study|Lack of Efficacy|2|||
25120257|NCT01782664|50232804|FG003|Overall Study|Lack of Efficacy|2|||
25120258|NCT01782664|50232805|FG004|Overall Study|Lack of Efficacy|0|||
25120259|NCT01782664|50232806|FG005|Overall Study|Lack of Efficacy|0|||
25120260|NCT01782664|50232801|FG000|Overall Study|Protocol Violation|0|||
25120261|NCT01782664|50232802|FG001|Overall Study|Protocol Violation|1|||
25120262|NCT01782664|50232803|FG002|Overall Study|Protocol Violation|0|||
25120263|NCT01782664|50232804|FG003|Overall Study|Protocol Violation|1|||
25120264|NCT01782664|50232805|FG004|Overall Study|Protocol Violation|0|||
25120265|NCT01782664|50232806|FG005|Overall Study|Protocol Violation|0|||
25120266|NCT01782664|50232801|FG000|Overall Study|Withdrawal by Subject|2|||
25120267|NCT01782664|50232802|FG001|Overall Study|Withdrawal by Subject|2|||
25120268|NCT01782664|50232803|FG002|Overall Study|Withdrawal by Subject|0|||
25120269|NCT01782664|50232804|FG003|Overall Study|Withdrawal by Subject|0|||
25120270|NCT01782664|50232805|FG004|Overall Study|Withdrawal by Subject|0|||
25120271|NCT01782664|50232806|FG005|Overall Study|Withdrawal by Subject|0|||
25120272|NCT01732588|50232823|FG000|First Intervention (7 Days)|Adverse Event|0|||
25120273|NCT01732588|50232824|FG001|First Intervention (7 Days)|Adverse Event|1|||
25120274|NCT01732588|50232825|FG002|First Intervention (7 Days)|Adverse Event|0|||
25120275|NCT01781962|50232833|FG000|Overall Study|Other Miscellaneous Reasons|5|||
25120276|NCT01639339|50232839|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
25120277|NCT01639339|50232840|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
25120278|NCT01639339|50232839|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
25120279|NCT01639339|50232840|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
25120280|NCT01639339|50232839|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
25120281|NCT01639339|50232840|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
25120282|NCT01639339|50232839|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
25120283|NCT01639339|50232840|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
25120284|NCT01639339|50232839|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
25120285|NCT01639339|50232840|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
25120286|NCT01639339|50232839|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
25120287|NCT01639339|50232840|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
25120288|NCT01639339|50232839|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
25120289|NCT01639339|50232840|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
25120290|NCT01639339|50232839|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
25120291|NCT01639339|50232840|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
25120292|NCT01639339|50232839|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
25120293|NCT01639339|50232840|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
25120294|NCT01639339|50232839|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
25120295|NCT01639339|50232840|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
25120296|NCT02000817|50232854|FG000|Overall Study|Withdrawal by Subject|2|||
25120297|NCT02000817|50232855|FG001|Overall Study|Withdrawal by Subject|0|||
25120298|NCT02000817|50232856|FG002|Overall Study|Withdrawal by Subject|0|||
25120299|NCT02000817|50232857|FG003|Overall Study|Withdrawal by Subject|0|||
25120300|NCT02000817|50232854|FG000|Overall Study|Adverse Event|0|||
25120301|NCT02000817|50232855|FG001|Overall Study|Adverse Event|1|||
25120302|NCT02000817|50232856|FG002|Overall Study|Adverse Event|0|||
25120303|NCT02000817|50232857|FG003|Overall Study|Adverse Event|0|||
25120304|NCT02000817|50232854|FG000|Overall Study|Lost to Follow-up|0|||
25120305|NCT02000817|50232855|FG001|Overall Study|Lost to Follow-up|0|||
25120306|NCT02000817|50232856|FG002|Overall Study|Lost to Follow-up|1|||
25120307|NCT02000817|50232857|FG003|Overall Study|Lost to Follow-up|0|||
25120308|NCT01641133|50232873|FG000|Overall Study|Protocol Violation|0|||
25120309|NCT01641133|50232874|FG001|Overall Study|Protocol Violation|1|||
25120310|NCT01641133|50232875|FG002|Overall Study|Protocol Violation|1|||
25120311|NCT01641133|50232873|FG000|Overall Study|Migrated/moved from study area|5|||
25120312|NCT01641133|50232874|FG001|Overall Study|Migrated/moved from study area|3|||
25120313|NCT01641133|50232875|FG002|Overall Study|Migrated/moved from study area|1|||
25120314|NCT01641133|50232873|FG000|Overall Study|Adverse Event|0|||
25120315|NCT01641133|50232874|FG001|Overall Study|Adverse Event|0|||
25120316|NCT01641133|50232875|FG002|Overall Study|Adverse Event|1|||
25120317|NCT01641133|50232873|FG000|Overall Study|Withdrawal by Subject|5|||
25120318|NCT01641133|50232874|FG001|Overall Study|Withdrawal by Subject|3|||
25120319|NCT01641133|50232875|FG002|Overall Study|Withdrawal by Subject|3|||
25120320|NCT01641133|50232873|FG000|Overall Study|Lost to Follow-up|0|||
25120321|NCT01641133|50232874|FG001|Overall Study|Lost to Follow-up|2|||
25120322|NCT01641133|50232875|FG002|Overall Study|Lost to Follow-up|2|||
25120323|NCT02000427|50232883|FG000|Overall Study|Death|22|||
25120324|NCT01600885|50232887|FG000|First Period|Adverse Event|1|||
25120325|NCT01600885|50232888|FG001|First Period|Adverse Event|1|||
25120326|NCT01600885|50232887|FG000|First Period|moved out of area|1|||
25120327|NCT01600885|50232888|FG001|First Period|moved out of area|0|||
25120328|NCT01732510|50232901|FG000|Overall Study|Adverse Event|0|||
25120329|NCT01732510|50232902|FG001|Overall Study|Adverse Event|1|||
25261706|NCT01300338|50576345|FG000|Overall Study|Lost to Follow-up|5|||
25120330|NCT01732510|50232903|FG002|Overall Study|Adverse Event|1|||
25120331|NCT01732510|50232904|FG003|Overall Study|Adverse Event|0|||
25120332|NCT01732510|50232905|FG004|Overall Study|Adverse Event|0|||
25120333|NCT01732510|50232906|FG005|Overall Study|Adverse Event|0|||
25120334|NCT01732510|50232907|FG006|Overall Study|Adverse Event|1|||
25120335|NCT01732510|50232901|FG000|Overall Study|Protocol Violation|0|||
25120336|NCT01732510|50232902|FG001|Overall Study|Protocol Violation|0|||
25120337|NCT01732510|50232903|FG002|Overall Study|Protocol Violation|0|||
25120338|NCT01732510|50232904|FG003|Overall Study|Protocol Violation|1|||
25120339|NCT01732510|50232905|FG004|Overall Study|Protocol Violation|0|||
25120340|NCT01732510|50232906|FG005|Overall Study|Protocol Violation|0|||
25120341|NCT01732510|50232907|FG006|Overall Study|Protocol Violation|0|||
25120342|NCT01732510|50232901|FG000|Overall Study|Withdrawal by Subject|1|||
25120343|NCT01732510|50232902|FG001|Overall Study|Withdrawal by Subject|3|||
25120344|NCT01732510|50232903|FG002|Overall Study|Withdrawal by Subject|2|||
25120345|NCT01732510|50232904|FG003|Overall Study|Withdrawal by Subject|1|||
25120346|NCT01732510|50232905|FG004|Overall Study|Withdrawal by Subject|5|||
25120347|NCT01732510|50232906|FG005|Overall Study|Withdrawal by Subject|0|||
25120348|NCT01732510|50232907|FG006|Overall Study|Withdrawal by Subject|1|||
25120349|NCT01732510|50232901|FG000|Overall Study|Lost to Follow-up|0|||
25120350|NCT01732510|50232902|FG001|Overall Study|Lost to Follow-up|0|||
25120351|NCT01732510|50232903|FG002|Overall Study|Lost to Follow-up|1|||
25120352|NCT01732510|50232904|FG003|Overall Study|Lost to Follow-up|1|||
25120353|NCT01732510|50232905|FG004|Overall Study|Lost to Follow-up|0|||
25120354|NCT01732510|50232906|FG005|Overall Study|Lost to Follow-up|1|||
25120355|NCT01732510|50232907|FG006|Overall Study|Lost to Follow-up|0|||
25120356|NCT01732510|50232901|FG000|Overall Study|Physician Decision|0|||
25120357|NCT01732510|50232902|FG001|Overall Study|Physician Decision|1|||
25120358|NCT01732510|50232903|FG002|Overall Study|Physician Decision|0|||
25120359|NCT01732510|50232904|FG003|Overall Study|Physician Decision|0|||
25120360|NCT01732510|50232905|FG004|Overall Study|Physician Decision|0|||
25120361|NCT01732510|50232906|FG005|Overall Study|Physician Decision|0|||
25120362|NCT01732510|50232907|FG006|Overall Study|Physician Decision|0|||
25120363|NCT01732510|50232901|FG000|Overall Study|Pregnancy|0|||
25120364|NCT01732510|50232902|FG001|Overall Study|Pregnancy|0|||
25120365|NCT01732510|50232903|FG002|Overall Study|Pregnancy|0|||
25120366|NCT01732510|50232904|FG003|Overall Study|Pregnancy|1|||
25120367|NCT01732510|50232905|FG004|Overall Study|Pregnancy|0|||
25120368|NCT01732510|50232906|FG005|Overall Study|Pregnancy|0|||
25120369|NCT01732510|50232907|FG006|Overall Study|Pregnancy|0|||
25120370|NCT01732510|50232901|FG000|Overall Study|Study Terminated By Sponsor|0|||
25120371|NCT01732510|50232902|FG001|Overall Study|Study Terminated By Sponsor|0|||
25120372|NCT01732510|50232903|FG002|Overall Study|Study Terminated By Sponsor|0|||
25120373|NCT01732510|50232904|FG003|Overall Study|Study Terminated By Sponsor|1|||
25120374|NCT01732510|50232905|FG004|Overall Study|Study Terminated By Sponsor|0|||
25120375|NCT01732510|50232906|FG005|Overall Study|Study Terminated By Sponsor|12|||
25120376|NCT01732510|50232907|FG006|Overall Study|Study Terminated By Sponsor|6|||
25120377|NCT01637077|50232928|FG000|Overall Study|Cancel|1|||
25120378|NCT01637077|50232929|FG001|Overall Study|Cancel|1|||
25120379|NCT01637077|50232928|FG000|Overall Study|Withdrawal by Subject|1|||
25120380|NCT01637077|50232929|FG001|Overall Study|Withdrawal by Subject|0|||
25120381|NCT01637077|50232928|FG000|Overall Study|No cycle 1 questionnaire data|2|||
25120382|NCT01637077|50232929|FG001|Overall Study|No cycle 1 questionnaire data|0|||
25168608|NCT00633477|50298171|FG000|Overall Study|Death|1|||
25120383|NCT02308163|50232939|FG000|Overall Study|Not fulfill eligible criteria|1|||
25120384|NCT02308163|50232940|FG001|Overall Study|Not fulfill eligible criteria|2|||
25120385|NCT02308163|50232941|FG002|Overall Study|Not fulfill eligible criteria|0|||
25120386|NCT02308163|50232942|FG003|Overall Study|Not fulfill eligible criteria|1|||
25120387|NCT02308163|50232943|FG004|Overall Study|Not fulfill eligible criteria|1|||
25120388|NCT02308163|50232939|FG000|Overall Study|Adverse Event|9|||
25120389|NCT02308163|50232940|FG001|Overall Study|Adverse Event|5|||
25120390|NCT02308163|50232941|FG002|Overall Study|Adverse Event|2|||
25120391|NCT02308163|50232942|FG003|Overall Study|Adverse Event|2|||
25120392|NCT02308163|50232943|FG004|Overall Study|Adverse Event|11|||
25120393|NCT02308163|50232939|FG000|Overall Study|Lack of Efficacy|11|||
25120394|NCT02308163|50232940|FG001|Overall Study|Lack of Efficacy|3|||
25120395|NCT02308163|50232941|FG002|Overall Study|Lack of Efficacy|8|||
25120396|NCT02308163|50232942|FG003|Overall Study|Lack of Efficacy|4|||
25120397|NCT02308163|50232943|FG004|Overall Study|Lack of Efficacy|6|||
25120398|NCT02308163|50232939|FG000|Overall Study|Withdrawal of consent|2|||
25120399|NCT02308163|50232940|FG001|Overall Study|Withdrawal of consent|3|||
25120400|NCT02308163|50232941|FG002|Overall Study|Withdrawal of consent|0|||
25120401|NCT02308163|50232942|FG003|Overall Study|Withdrawal of consent|2|||
25120402|NCT02308163|50232943|FG004|Overall Study|Withdrawal of consent|6|||
25120403|NCT02308163|50232939|FG000|Overall Study|Protocol Violation|3|||
25120404|NCT02308163|50232940|FG001|Overall Study|Protocol Violation|3|||
25120405|NCT02308163|50232941|FG002|Overall Study|Protocol Violation|3|||
25120406|NCT02308163|50232942|FG003|Overall Study|Protocol Violation|2|||
25120407|NCT02308163|50232943|FG004|Overall Study|Protocol Violation|5|||
25120408|NCT02308163|50232939|FG000|Overall Study|Lab data met discontinuation criteria|3|||
25120409|NCT02308163|50232940|FG001|Overall Study|Lab data met discontinuation criteria|0|||
25120410|NCT02308163|50232941|FG002|Overall Study|Lab data met discontinuation criteria|0|||
25120411|NCT02308163|50232942|FG003|Overall Study|Lab data met discontinuation criteria|2|||
25120412|NCT02308163|50232943|FG004|Overall Study|Lab data met discontinuation criteria|0|||
25120413|NCT02308163|50232939|FG000|Overall Study|Miscellaneous|2|||
25120414|NCT02308163|50232940|FG001|Overall Study|Miscellaneous|2|||
25120415|NCT02308163|50232941|FG002|Overall Study|Miscellaneous|1|||
25120416|NCT02308163|50232942|FG003|Overall Study|Miscellaneous|0|||
25120417|NCT02308163|50232943|FG004|Overall Study|Miscellaneous|5|||
25120418|NCT02000115|50232973|FG000|Overall Study|Death|56|||
25120419|NCT02000115|50232974|FG001|Overall Study|Death|45|||
25120420|NCT02000115|50232975|FG002|Overall Study|Death|0|||
25120421|NCT02000115|50232976|FG003|Overall Study|Death|0|||
25120422|NCT02000115|50232973|FG000|Overall Study|Missed Visit|6|||
25120423|NCT02000115|50232974|FG001|Overall Study|Missed Visit|8|||
25120424|NCT02000115|50232975|FG002|Overall Study|Missed Visit|1|||
25120425|NCT02000115|50232976|FG003|Overall Study|Missed Visit|0|||
25120426|NCT02000115|50232973|FG000|Overall Study|Protocol Violation|2|||
25120427|NCT02000115|50232974|FG001|Overall Study|Protocol Violation|1|||
25120428|NCT02000115|50232975|FG002|Overall Study|Protocol Violation|0|||
25120429|NCT02000115|50232976|FG003|Overall Study|Protocol Violation|0|||
25120430|NCT02000115|50232973|FG000|Overall Study|Physician Decision|2|||
25120431|NCT02000115|50232974|FG001|Overall Study|Physician Decision|0|||
25120432|NCT02000115|50232975|FG002|Overall Study|Physician Decision|0|||
25120433|NCT02000115|50232976|FG003|Overall Study|Physician Decision|0|||
25120434|NCT02000115|50232973|FG000|Overall Study|Withdrawal by Subject|11|||
25120435|NCT02000115|50232974|FG001|Overall Study|Withdrawal by Subject|11|||
25120436|NCT02000115|50232975|FG002|Overall Study|Withdrawal by Subject|0|||
25120437|NCT02000115|50232976|FG003|Overall Study|Withdrawal by Subject|0|||
25120438|NCT02000115|50232973|FG000|Overall Study|Lost to Follow-up|0|||
25120439|NCT02000115|50232974|FG001|Overall Study|Lost to Follow-up|1|||
25120440|NCT02000115|50232975|FG002|Overall Study|Lost to Follow-up|0|||
25120441|NCT02000115|50232976|FG003|Overall Study|Lost to Follow-up|0|||
25120442|NCT02000115|50232973|FG000|Overall Study|Non-compliance|2|||
25120443|NCT02000115|50232974|FG001|Overall Study|Non-compliance|1|||
25120444|NCT02000115|50232975|FG002|Overall Study|Non-compliance|0|||
25120445|NCT02000115|50232976|FG003|Overall Study|Non-compliance|0|||
25120446|NCT02000115|50232973|FG000|Overall Study|Withdrawn on day of randomization|0|||
25120447|NCT02000115|50232974|FG001|Overall Study|Withdrawn on day of randomization|1|||
25120448|NCT02000115|50232975|FG002|Overall Study|Withdrawn on day of randomization|0|||
25120449|NCT02000115|50232976|FG003|Overall Study|Withdrawn on day of randomization|0|||
25120450|NCT02000115|50232973|FG000|Overall Study|Still on Study|0|||
25120451|NCT02000115|50232974|FG001|Overall Study|Still on Study|0|||
25120452|NCT02000115|50232975|FG002|Overall Study|Still on Study|0|||
25120453|NCT02000115|50232976|FG003|Overall Study|Still on Study|53|||
25120454|NCT01999335|50232990|FG000|Overall Study|Discontinued before receiving treatment|0|||
25120455|NCT01999335|50232991|FG001|Overall Study|Discontinued before receiving treatment|0|||
25120456|NCT01999335|50232992|FG002|Overall Study|Discontinued before receiving treatment|0|||
25120457|NCT01999335|50232993|FG003|Overall Study|Discontinued before receiving treatment|0|||
25120458|NCT01999335|50232994|FG004|Overall Study|Discontinued before receiving treatment|2|||
25120459|NCT01978119|50233009|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
25120460|NCT01978119|50233010|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
25120461|NCT01978119|50233009|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
25120462|NCT01978119|50233010|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
25120463|NCT01978119|50233009|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
25120464|NCT01978119|50233010|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
25120465|NCT01999179|50233016|FG000|Overall Study|Adverse Event|1|||
25120466|NCT01999179|50233016|FG000|Overall Study|Lost to Follow-up|1|||
25120467|NCT01999179|50233016|FG000|Overall Study|Change in Therapy|3|||
25120468|NCT01999179|50233016|FG000|Overall Study|New catheter|2|||
25120469|NCT01977729|50233020|FG000|Overall Study|Study terminated|1|||
25120470|NCT01998477|50233028|FG000|Overall Study|Lost to Follow-up|4|||
25120471|NCT01998477|50233029|FG001|Overall Study|Lost to Follow-up|5|||
25120472|NCT01998477|50233028|FG000|Overall Study|Withdrawal by Subject|6|||
25120473|NCT01998477|50233029|FG001|Overall Study|Withdrawal by Subject|0|||
25120474|NCT01998399|50233062|FG000|Overall Study|Lost to Follow-up|1|||
25120475|NCT01998399|50233063|FG001|Overall Study|Lost to Follow-up|3|||
25120476|NCT01998399|50233062|FG000|Overall Study|Death|4|||
25120477|NCT01998399|50233063|FG001|Overall Study|Death|2|||
25120478|NCT01998399|50233062|FG000|Overall Study|Study stopped before dosing completed|3|||
25120479|NCT01998399|50233063|FG001|Overall Study|Study stopped before dosing completed|3|||
25120480|NCT01998399|50233062|FG000|Overall Study|Withdrawal by Subject|0|||
25120481|NCT01998399|50233063|FG001|Overall Study|Withdrawal by Subject|1|||
25120482|NCT01781572|50233080|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
25120483|NCT01781572|50233081|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
25120484|NCT01781572|50233082|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
25120485|NCT01781572|50233080|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
25120486|NCT01781572|50233081|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
25120487|NCT01781572|50233082|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
25120488|NCT01781572|50233080|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
25120489|NCT01781572|50233081|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
25120490|NCT01781572|50233082|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
25120491|NCT01781572|50233080|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
25120492|NCT01781572|50233081|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
25120493|NCT01781572|50233082|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
25120494|NCT01781572|50233080|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
25120495|NCT01781572|50233081|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
25120496|NCT01781572|50233082|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
25120497|NCT01781572|50233080|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
25120498|NCT01781572|50233081|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
25120499|NCT01781572|50233082|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
25120500|NCT01781572|50233080|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
25120501|NCT01781572|50233081|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
25120502|NCT01781572|50233082|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
25120503|NCT01781572|50233080|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
25120504|NCT01781572|50233081|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
25120505|NCT01781572|50233082|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
25120506|NCT01781572|50233080|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
25120507|NCT01781572|50233081|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
25120508|NCT01781572|50233082|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
25120509|NCT01781572|50233080|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
25120510|NCT01781572|50233081|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
25120511|NCT01781572|50233082|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
25120512|NCT01781572|50233080|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
25120513|NCT01781572|50233081|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
25120514|NCT01781572|50233082|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
25120515|NCT01781572|50233080|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
25120516|NCT01781572|50233081|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
25120517|NCT01781572|50233082|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
25120518|NCT01781572|50233080|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
25120519|NCT01781572|50233081|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
25120520|NCT01781572|50233082|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
25120521|NCT01781572|50233080|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
25120522|NCT01781572|50233081|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
25120523|NCT01781572|50233082|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
25120524|NCT01781572|50233080|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
25120525|NCT01781572|50233081|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
25120526|NCT01781572|50233082|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
25120527|NCT01781572|50233080|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
25120528|NCT01781572|50233081|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
25120529|NCT01781572|50233082|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
25120530|NCT01781572|50233080|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
25120531|NCT01781572|50233081|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
25120532|NCT01781572|50233082|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
25120533|NCT01781572|50233080|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
25120534|NCT01781572|50233081|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
25120535|NCT01781572|50233082|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
25120536|NCT01977651|50233111|FG000|4 Month Treatment Period|Adverse Event|34|||
25120537|NCT01977651|50233111|FG000|4 Month Treatment Period|Death|3|||
25120538|NCT01977651|50233111|FG000|4 Month Treatment Period|Progressive Disease|43|||
25120539|NCT01977651|50233111|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
25120540|NCT01977651|50233111|FG000|4 Month Treatment Period|Physician Decision|4|||
25120541|NCT01977651|50233111|FG000|1 Year Extension Period|Adverse Event|14|||
25120542|NCT01977651|50233111|FG000|1 Year Extension Period|Death|10|||
25120543|NCT01977651|50233111|FG000|1 Year Extension Period|Lost to Follow-up|2|||
25120544|NCT01977651|50233111|FG000|1 Year Extension Period|Progressive Disease|86|||
25120545|NCT01977651|50233111|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
25120546|NCT01977651|50233111|FG000|1 Year Extension Period|Physician Decision|6|||
25120547|NCT01977651|50233111|FG000|1 Year Extension Period|Miscellaneous|1|||
25120548|NCT01977651|50233111|FG000|Post 1 Year Extension Period|Adverse Event|5|||
25120549|NCT01977651|50233111|FG000|Post 1 Year Extension Period|Death|13|||
25120550|NCT01977651|50233111|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
25120551|NCT01977651|50233111|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
25120552|NCT01977651|50233111|FG000|Post 1 Year Extension Period|Physician Decision|4|||
25120553|NCT01977651|50233111|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
25120554|NCT01998243|50233117|FG000|Overall Study|Pregnancy|0|||
25120555|NCT01998243|50233118|FG001|Overall Study|Pregnancy|1|||
25120556|NCT01998243|50233117|FG000|Overall Study|Protocol Violation|5|||
25120557|NCT01998243|50233118|FG001|Overall Study|Protocol Violation|2|||
25120558|NCT01998243|50233117|FG000|Overall Study|Withdrawal by Subject|3|||
25120559|NCT01998243|50233118|FG001|Overall Study|Withdrawal by Subject|4|||
25120560|NCT01977573|50233130|FG000|Overall Study|Adverse Event|7|||
25120561|NCT01977573|50233131|FG001|Overall Study|Adverse Event|0|||
25120562|NCT01977573|50233132|FG002|Overall Study|Adverse Event|2|||
25120563|NCT01977573|50233133|FG003|Overall Study|Adverse Event|1|||
25120564|NCT01977573|50233130|FG000|Overall Study|Lost to Follow-up|1|||
25120565|NCT01977573|50233131|FG001|Overall Study|Lost to Follow-up|0|||
25120566|NCT01977573|50233132|FG002|Overall Study|Lost to Follow-up|0|||
25120567|NCT01977573|50233133|FG003|Overall Study|Lost to Follow-up|1|||
25120568|NCT01977573|50233130|FG000|Overall Study|Physician Decision|1|||
25120569|NCT01977573|50233131|FG001|Overall Study|Physician Decision|0|||
25120570|NCT01977573|50233132|FG002|Overall Study|Physician Decision|0|||
25120571|NCT01977573|50233133|FG003|Overall Study|Physician Decision|0|||
25120572|NCT01977573|50233130|FG000|Overall Study|Protocol Violation|3|||
25120573|NCT01977573|50233131|FG001|Overall Study|Protocol Violation|1|||
25120574|NCT01977573|50233132|FG002|Overall Study|Protocol Violation|0|||
25120575|NCT01977573|50233133|FG003|Overall Study|Protocol Violation|0|||
25120576|NCT01977573|50233130|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
25120577|NCT01977573|50233131|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
25120578|NCT01977573|50233132|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
25120579|NCT01977573|50233133|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
25120580|NCT01977573|50233130|FG000|Overall Study|Withdrawal by Subject|6|||
25120581|NCT01977573|50233131|FG001|Overall Study|Withdrawal by Subject|1|||
25120582|NCT01977573|50233132|FG002|Overall Study|Withdrawal by Subject|1|||
25120583|NCT01977573|50233133|FG003|Overall Study|Withdrawal by Subject|1|||
25120584|NCT01963767|50233146|FG000|Overall Study|Withdrawal by Subject|4|||
25120585|NCT01963767|50233147|FG001|Overall Study|Withdrawal by Subject|2|||
25120586|NCT01963767|50233146|FG000|Overall Study|Adverse Event|2|||
25120587|NCT01963767|50233147|FG001|Overall Study|Adverse Event|0|||
25120588|NCT01761292|50233156|FG000|Part 1|Adverse Event|1|||
25120589|NCT01761292|50233156|FG000|Part 1|not receiving treatment in Part 1|1|||
25120590|NCT01761292|50233156|FG000|Extension 1|Withdrawal by Subject|1|||
25120591|NCT01731886|50233169|FG000|Overall Study|Death|1|||
25120592|NCT01731886|50233170|FG001|Overall Study|Death|0|||
25120593|NCT01731886|50233169|FG000|Overall Study|Never started treatment|0|||
25120594|NCT01731886|50233170|FG001|Overall Study|Never started treatment|1|||
25120595|NCT01731886|50233169|FG000|Overall Study|Non-compliant|1|||
25120596|NCT01731886|50233170|FG001|Overall Study|Non-compliant|0|||
25120597|NCT01759420|50233177|FG000|Overall Study|Screen failure|5|||
25120598|NCT01759420|50233177|FG000|Overall Study|Inaccurate EKG machine readings|1|||
25120599|NCT01781026|50233181|FG000|Overall Study|Lack of Efficacy|2|||
25120600|NCT01607398|50233187|FG000|Overall Study|Adverse Event|0|||
25120601|NCT01607398|50233188|FG001|Overall Study|Adverse Event|2|||
25120602|NCT01607398|50233187|FG000|Overall Study|Severe COPD|2|||
25120603|NCT01607398|50233188|FG001|Overall Study|Severe COPD|0|||
25120604|NCT01779856|50233194|FG000|Overall Study|Withdrawal by Subject|15|||
25120605|NCT01779856|50233194|FG000|Overall Study|Death|3|||
25120606|NCT01779856|50233194|FG000|Overall Study|Physician Decision|1|||
25120607|NCT01779856|50233194|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
25120608|NCT01779856|50233194|FG000|Overall Study|Delays in scheduling implant|1|||
25120609|NCT01779856|50233194|FG000|Overall Study|Subject ineligible for Implant|2|||
25120610|NCT01729156|50233208|FG000|Overall Study|Withdrawal by Subject|1|||
25120611|NCT01729156|50233209|FG001|Overall Study|Withdrawal by Subject|0|||
25120612|NCT01729156|50233210|FG002|Overall Study|Withdrawal by Subject|0|||
25120613|NCT01779700|50233221|FG000|Overall Study|Adverse Event|4|||
25120614|NCT01779700|50233222|FG001|Overall Study|Adverse Event|3|||
25120615|NCT01779700|50233221|FG000|Overall Study|Withdrawal by Subject|0|||
25120616|NCT01779700|50233222|FG001|Overall Study|Withdrawal by Subject|2|||
25120617|NCT01778530|50233228|FG000|Overall Study|Progression on study|1|||
25120618|NCT01778530|50233228|FG000|Overall Study|Adverse event/side effect|1|||
25120619|NCT01778062|50233234|FG000|Overall Study|Adverse Event|1|||
25120620|NCT01778062|50233235|FG001|Overall Study|Adverse Event|3|||
25120621|NCT01778062|50233234|FG000|Overall Study|Consent Withdrawal|1|||
25120622|NCT01778062|50233235|FG001|Overall Study|Consent Withdrawal|5|||
25120623|NCT01778062|50233234|FG000|Overall Study|major protocol deviation|4|||
25120624|NCT01778062|50233235|FG001|Overall Study|major protocol deviation|3|||
25120625|NCT01759264|50233241|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
25120626|NCT01759264|50233241|FG000|Overall Study|Adverse Event|1|||
25120627|NCT01759264|50233241|FG000|Overall Study|Other|2|||
25120628|NCT01759264|50233241|FG000|Overall Study|Lost to Follow-up|2|||
25120629|NCT01759264|50233241|FG000|Overall Study|Withdrawal by Subject|3|||
25120630|NCT01759264|50233241|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
25120631|NCT01757704|50233248|FG000|Overall Study|Protocol Violation|1|||
25120632|NCT01757704|50233249|FG001|Overall Study|Protocol Violation|3|||
25120633|NCT01757392|50233255|FG000|Overall Study|Withdrawal by Subject|1|||
25120634|NCT01757392|50233255|FG000|Overall Study|Screen Fail|3|||
25120635|NCT01756846|50233261|FG000|Overall Study|Lost to Follow-up|5|||
25120636|NCT01756846|50233262|FG001|Overall Study|Lost to Follow-up|10|||
25120637|NCT01756846|50233261|FG000|Overall Study|Withdrawal by Subject|1|||
25120638|NCT01756846|50233262|FG001|Overall Study|Withdrawal by Subject|2|||
25120639|NCT01963611|50233273|FG000|Overall Study|Adverse Event|1|||
25120640|NCT01963611|50233274|FG001|Overall Study|Adverse Event|1|||
25120641|NCT01963611|50233275|FG002|Overall Study|Adverse Event|3|||
25120642|NCT01963611|50233276|FG003|Overall Study|Adverse Event|4|||
25120643|NCT01963611|50233277|FG004|Overall Study|Adverse Event|3|||
25120644|NCT01963611|50233273|FG000|Overall Study|Protocol Violation|0|||
25120645|NCT01963611|50233274|FG001|Overall Study|Protocol Violation|0|||
25120646|NCT01963611|50233275|FG002|Overall Study|Protocol Violation|0|||
25120647|NCT01963611|50233276|FG003|Overall Study|Protocol Violation|1|||
25120648|NCT01963611|50233277|FG004|Overall Study|Protocol Violation|0|||
25120649|NCT01963611|50233273|FG000|Overall Study|Lack of Efficacy|0|||
25120650|NCT01963611|50233274|FG001|Overall Study|Lack of Efficacy|0|||
25120651|NCT01963611|50233275|FG002|Overall Study|Lack of Efficacy|0|||
25120652|NCT01963611|50233276|FG003|Overall Study|Lack of Efficacy|1|||
25120653|NCT01963611|50233277|FG004|Overall Study|Lack of Efficacy|0|||
25120654|NCT01963611|50233273|FG000|Overall Study|Withdrawal by Subject|3|||
25120655|NCT01963611|50233274|FG001|Overall Study|Withdrawal by Subject|2|||
25120656|NCT01963611|50233275|FG002|Overall Study|Withdrawal by Subject|1|||
25120657|NCT01963611|50233276|FG003|Overall Study|Withdrawal by Subject|1|||
25120658|NCT01963611|50233277|FG004|Overall Study|Withdrawal by Subject|3|||
25120659|NCT01963611|50233273|FG000|Overall Study|Other|47|||
25120660|NCT01963611|50233274|FG001|Overall Study|Other|46|||
25120661|NCT01963611|50233275|FG002|Overall Study|Other|48|||
25120662|NCT01963611|50233276|FG003|Overall Study|Other|45|||
25120663|NCT01963611|50233277|FG004|Overall Study|Other|45|||
25120664|NCT01975701|50233290|FG000|Overall Study|Lost to Follow-up|1|||
25120665|NCT01975701|50233290|FG000|Overall Study|Death|23|||
25120666|NCT01975701|50233290|FG000|Overall Study|Physician Decision|1|||
25120667|NCT01962987|50233297|FG000|Overall Study|Adverse Event|4|||
25120668|NCT01962987|50233298|FG001|Overall Study|Adverse Event|4|||
25120669|NCT01962987|50233299|FG002|Overall Study|Adverse Event|0|||
25120670|NCT01962987|50233297|FG000|Overall Study|Lost to Follow-up|0|||
25261707|NCT01300338|50576346|FG001|Overall Study|Lost to Follow-up|0|||
25261708|NCT01300260|50576354|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
25120671|NCT01962987|50233298|FG001|Overall Study|Lost to Follow-up|0|||
25261709|NCT01300260|50576355|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
25120672|NCT01962987|50233299|FG002|Overall Study|Lost to Follow-up|1|||
25120673|NCT01962987|50233297|FG000|Overall Study|Non compliance with dosing requirements|4|||
25120674|NCT01962987|50233298|FG001|Overall Study|Non compliance with dosing requirements|2|||
25120675|NCT01962987|50233299|FG002|Overall Study|Non compliance with dosing requirements|0|||
25120676|NCT01962987|50233297|FG000|Overall Study|Miscellaneous|1|||
25120677|NCT01962987|50233298|FG001|Overall Study|Miscellaneous|9|||
25120678|NCT01962987|50233299|FG002|Overall Study|Miscellaneous|2|||
25120679|NCT01962987|50233297|FG000|Overall Study|Restricted medication|5|||
25120680|NCT01962987|50233298|FG001|Overall Study|Restricted medication|1|||
25120681|NCT01962987|50233299|FG002|Overall Study|Restricted medication|1|||
25120682|NCT01962987|50233297|FG000|Overall Study|Serious Adverse Event|1|||
25120683|NCT01962987|50233298|FG001|Overall Study|Serious Adverse Event|0|||
25120684|NCT01962987|50233299|FG002|Overall Study|Serious Adverse Event|0|||
25120685|NCT01962987|50233297|FG000|Overall Study|Withdrawal by Subject|11|||
25120686|NCT01962987|50233298|FG001|Overall Study|Withdrawal by Subject|10|||
25120687|NCT01962987|50233299|FG002|Overall Study|Withdrawal by Subject|6|||
25120688|NCT01962987|50233297|FG000|Overall Study|Randomized in Error|4|||
25120689|NCT01962987|50233298|FG001|Overall Study|Randomized in Error|2|||
25120690|NCT01962987|50233299|FG002|Overall Study|Randomized in Error|2|||
25120691|NCT01962441|50233310|FG000|Randomized Period|Randomized but Never Treated|4|||
25120692|NCT01962441|50233311|FG001|Randomized Period|Randomized but Never Treated|2|||
25261710|NCT01300260|50576354|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
25261711|NCT01300260|50576355|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
25261712|NCT01300260|50576354|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
25261713|NCT01300260|50576355|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
25261714|NCT01256385|50576374|FG000|Overall Study|Physician Decision|1|||
25261715|NCT01256385|50576375|FG001|Overall Study|Physician Decision|1|||
25261716|NCT01256385|50576374|FG000|Overall Study|Withdrawal by Subject|2|||
25261717|NCT01256385|50576375|FG001|Overall Study|Withdrawal by Subject|2|||
25261718|NCT01298778|50576383|FG000|Overall Study|Lost to Follow-up|2|||
25261719|NCT01298778|50576384|FG001|Overall Study|Lost to Follow-up|3|||
25261720|NCT01298778|50576383|FG000|Overall Study|Incorrect use of VAS|1|||
25261721|NCT01298778|50576384|FG001|Overall Study|Incorrect use of VAS|0|||
25261722|NCT01298778|50576383|FG000|Overall Study|Withdrawal by Subject|0|||
25261723|NCT01298778|50576384|FG001|Overall Study|Withdrawal by Subject|1|||
25261724|NCT01298778|50576383|FG000|Overall Study|Protocol Violation|0|||
25261725|NCT01298778|50576384|FG001|Overall Study|Protocol Violation|1|||
25261726|NCT01298778|50576383|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
25261727|NCT01298778|50576384|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
25261728|NCT01298700|50576394|FG000|Overall Study|Adverse Event|50|||
25261729|NCT01298700|50576395|FG001|Overall Study|Adverse Event|51|||
25261730|NCT01298700|50576394|FG000|Overall Study|Lack of Efficacy|9|||
25261731|NCT01298700|50576395|FG001|Overall Study|Lack of Efficacy|14|||
25261732|NCT01298700|50576394|FG000|Overall Study|Lost to Follow-up|5|||
25261733|NCT01298700|50576395|FG001|Overall Study|Lost to Follow-up|2|||
25261734|NCT01298700|50576394|FG000|Overall Study|Withdrawal by Subject|12|||
25261735|NCT01298700|50576395|FG001|Overall Study|Withdrawal by Subject|9|||
25261736|NCT01298700|50576394|FG000|Overall Study|Protocol Violation|6|||
25261737|NCT01298700|50576395|FG001|Overall Study|Protocol Violation|4|||
25261738|NCT01298700|50576394|FG000|Overall Study|Other Miscellaneous Reasons|16|||
25261739|NCT01298700|50576395|FG001|Overall Study|Other Miscellaneous Reasons|15|||
25261740|NCT01298700|50576394|FG000|Overall Study|Did not Receive Study Drug|3|||
25261741|NCT01298700|50576395|FG001|Overall Study|Did not Receive Study Drug|5|||
25261742|NCT01297920|50576404|FG000|Overall Study|Adverse Event|42|||
25261743|NCT01297920|50576405|FG001|Overall Study|Adverse Event|10|||
25261744|NCT01297920|50576406|FG002|Overall Study|Adverse Event|38|||
25261745|NCT01297920|50576404|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
25261746|NCT01297920|50576405|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
25261747|NCT01297920|50576406|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
25261748|NCT01297920|50576404|FG000|Overall Study|Noncompliance|1|||
25261749|NCT01297920|50576405|FG001|Overall Study|Noncompliance|0|||
25261750|NCT01297920|50576406|FG002|Overall Study|Noncompliance|0|||
25261751|NCT01297920|50576404|FG000|Overall Study|Protocol Violation|1|||
25261752|NCT01297920|50576405|FG001|Overall Study|Protocol Violation|3|||
25261753|NCT01297920|50576406|FG002|Overall Study|Protocol Violation|0|||
25261754|NCT01297920|50576404|FG000|Overall Study|Inadequate Control of IOP|7|||
25261755|NCT01297920|50576405|FG001|Overall Study|Inadequate Control of IOP|9|||
25261756|NCT01297920|50576406|FG002|Overall Study|Inadequate Control of IOP|17|||
25261757|NCT01297920|50576404|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
25261758|NCT01297920|50576405|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
25261759|NCT01297920|50576406|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
25261760|NCT01255761|50576416|FG000|Overall Study|Adverse Event|29|||
25008728|NCT03486834|50101824|FG000|Overall Study|Adverse Event|8|||
25008729|NCT03486834|50101825|FG001|Overall Study|Adverse Event|7|||
25120693|NCT01962441|50233312|FG002|Randomized Period|Randomized but Never Treated|3|||
25120694|NCT01962441|50233310|FG000|Randomized Period|Lost to Follow-up|2|||
25120695|NCT01962441|50233311|FG001|Randomized Period|Lost to Follow-up|4|||
25120696|NCT01962441|50233312|FG002|Randomized Period|Lost to Follow-up|4|||
25261761|NCT01255761|50576417|FG001|Overall Study|Adverse Event|43|||
25261762|NCT01255761|50576416|FG000|Overall Study|Lack of Efficacy|86|||
25261763|NCT01255761|50576417|FG001|Overall Study|Lack of Efficacy|74|||
25261764|NCT01255761|50576416|FG000|Overall Study|Protocol Violation|9|||
25261765|NCT01255761|50576417|FG001|Overall Study|Protocol Violation|5|||
25261766|NCT01255761|50576416|FG000|Overall Study|Lost to Follow-up|10|||
25261767|NCT01255761|50576417|FG001|Overall Study|Lost to Follow-up|8|||
25261768|NCT01255761|50576416|FG000|Overall Study|Withdrawal by Subject|11|||
25261769|NCT01255761|50576417|FG001|Overall Study|Withdrawal by Subject|27|||
25120697|NCT01962441|50233310|FG000|Randomized Period|Withdrew Consent|3|||
25120698|NCT01962441|50233311|FG001|Randomized Period|Withdrew Consent|3|||
25120699|NCT01962441|50233312|FG002|Randomized Period|Withdrew Consent|2|||
25120700|NCT01962441|50233310|FG000|Randomized Period|Adverse Event|1|||
25120701|NCT01962441|50233311|FG001|Randomized Period|Adverse Event|1|||
25120702|NCT01962441|50233312|FG002|Randomized Period|Adverse Event|0|||
25120703|NCT01962441|50233310|FG000|Randomized Period|Death|0|||
25120704|NCT01962441|50233311|FG001|Randomized Period|Death|0|||
25120705|NCT01962441|50233312|FG002|Randomized Period|Death|2|||
25120706|NCT01962441|50233310|FG000|Randomized Period|Protocol Violation|0|||
25120707|NCT01962441|50233311|FG001|Randomized Period|Protocol Violation|1|||
25120708|NCT01962441|50233312|FG002|Randomized Period|Protocol Violation|0|||
25120709|NCT01962441|50233310|FG000|Retreatment Substudy|Lack of Efficacy|1|||
25120710|NCT01962441|50233311|FG001|Retreatment Substudy|Lack of Efficacy|0|||
25120711|NCT01962441|50233312|FG002|Retreatment Substudy|Lack of Efficacy|0|||
25120712|NCT01962441|50233310|FG000|Retreatment Substudy|Lost to Follow-up|1|||
25120713|NCT01962441|50233311|FG001|Retreatment Substudy|Lost to Follow-up|0|||
25120714|NCT01962441|50233312|FG002|Retreatment Substudy|Lost to Follow-up|0|||
25120715|NCT01638013|50233324|FG000|Overall Study|Adverse Event|36|||
25120716|NCT01638013|50233325|FG001|Overall Study|Adverse Event|29|||
25120717|NCT01638013|50233326|FG002|Overall Study|Adverse Event|48|||
25120718|NCT01638013|50233324|FG000|Overall Study|Lack of Efficacy|39|||
25120719|NCT01638013|50233325|FG001|Overall Study|Lack of Efficacy|11|||
25120720|NCT01638013|50233326|FG002|Overall Study|Lack of Efficacy|14|||
25120721|NCT01638013|50233324|FG000|Overall Study|Protocol Violation|10|||
25120722|NCT01638013|50233325|FG001|Overall Study|Protocol Violation|7|||
25120723|NCT01638013|50233326|FG002|Overall Study|Protocol Violation|11|||
25120724|NCT01638013|50233324|FG000|Overall Study|Met discontinuation criteria|4|||
25120725|NCT01638013|50233325|FG001|Overall Study|Met discontinuation criteria|0|||
25120726|NCT01638013|50233326|FG002|Overall Study|Met discontinuation criteria|7|||
25120727|NCT01638013|50233324|FG000|Overall Study|Subject Lost to Follow up|1|||
25120728|NCT01638013|50233325|FG001|Overall Study|Subject Lost to Follow up|0|||
25120729|NCT01638013|50233326|FG002|Overall Study|Subject Lost to Follow up|1|||
25120730|NCT01638013|50233324|FG000|Overall Study|Miscellaneous|25|||
25120731|NCT01638013|50233325|FG001|Overall Study|Miscellaneous|19|||
25120732|NCT01638013|50233326|FG002|Overall Study|Miscellaneous|23|||
25120733|NCT01638013|50233324|FG000|Overall Study|Withdrawal of Consent|16|||
25120734|NCT01638013|50233325|FG001|Overall Study|Withdrawal of Consent|12|||
25120735|NCT01638013|50233326|FG002|Overall Study|Withdrawal of Consent|16|||
25120736|NCT01638013|50233324|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
25120737|NCT01638013|50233325|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
25120738|NCT01638013|50233326|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
25120739|NCT01637623|50233341|FG000|Overall Study|Lost to Follow-up|0|||
25120740|NCT01637623|50233342|FG001|Overall Study|Lost to Follow-up|0|||
25120741|NCT01637623|50233343|FG002|Overall Study|Lost to Follow-up|2|||
25120742|NCT01637623|50233341|FG000|Overall Study|Physician Decision|1|||
25120743|NCT01637623|50233342|FG001|Overall Study|Physician Decision|0|||
25120744|NCT01637623|50233343|FG002|Overall Study|Physician Decision|1|||
25120745|NCT01962207|50233355|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
25120746|NCT01962207|50233356|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
25120747|NCT01962207|50233357|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
25120748|NCT01962207|50233358|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
25120749|NCT01962207|50233355|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
25120750|NCT01962207|50233356|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
25120751|NCT01962207|50233357|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
25120752|NCT01962207|50233358|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
25120753|NCT01962207|50233355|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
25120754|NCT01962207|50233356|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
25120755|NCT01962207|50233357|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
25120756|NCT01962207|50233358|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
25120757|NCT01962207|50233355|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
25120758|NCT01962207|50233356|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
25120759|NCT01962207|50233357|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
25120760|NCT01962207|50233358|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
25120761|NCT01962207|50233355|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
25120762|NCT01962207|50233356|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
25120763|NCT01962207|50233357|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
25120764|NCT01962207|50233358|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
25120765|NCT01962207|50233355|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
25120766|NCT01962207|50233356|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
25120767|NCT01962207|50233357|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
25120768|NCT01962207|50233358|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
25120769|NCT01995825|50233374|FG000|Overall Study|Withdrawal by Subject|1|||
25177458|NCT02754141|50321517|FG010|Overall Study|Other reasons|0|||
25120770|NCT01995825|50233375|FG001|Overall Study|Withdrawal by Subject|0|||
25120771|NCT01995357|50233381|FG000|Period 5|Lack of Efficacy|1|||
25120772|NCT01995357|50233382|FG001|Period 5|Lack of Efficacy|0|||
25120773|NCT01995357|50233383|FG002|Period 5|Lack of Efficacy|0|||
25120774|NCT01995357|50233384|FG003|Period 5|Lack of Efficacy|0|||
25120775|NCT01995357|50233385|FG004|Period 5|Lack of Efficacy|0|||
25120776|NCT01995357|50233386|FG005|Period 5|Lack of Efficacy|0|||
25120777|NCT01995357|50233381|FG000|Period 5|Adverse Event|1|||
25120778|NCT01995357|50233382|FG001|Period 5|Adverse Event|0|||
25120779|NCT01995357|50233383|FG002|Period 5|Adverse Event|1|||
25120780|NCT01995357|50233384|FG003|Period 5|Adverse Event|0|||
25120781|NCT01995357|50233385|FG004|Period 5|Adverse Event|0|||
25120782|NCT01995357|50233386|FG005|Period 5|Adverse Event|0|||
25120783|NCT01638559|50233402|FG000|Overall Study|Lost to Follow-up|1|||
25120784|NCT01638559|50233402|FG000|Overall Study|Withdrawal by Subject|1|||
25120785|NCT01638559|50233402|FG000|Overall Study|Subject declined to travel for biopsy|1|||
25120786|NCT01756456|50233423|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
25120787|NCT01756456|50233424|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
25120788|NCT01756456|50233425|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
25120789|NCT01756456|50233426|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
25120790|NCT01756456|50233427|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
25120791|NCT01756456|50233428|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
25120792|NCT01756456|50233423|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
25120793|NCT01756456|50233424|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
25120794|NCT01756456|50233425|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
25120795|NCT01756456|50233426|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
25120796|NCT01756456|50233427|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
25120797|NCT01756456|50233428|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
25120798|NCT01756456|50233423|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
25120799|NCT01756456|50233424|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
25120800|NCT01756456|50233425|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
25120801|NCT01756456|50233426|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
25120802|NCT01756456|50233427|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
25120803|NCT01756456|50233428|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
25120804|NCT01756456|50233423|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
25120805|NCT01756456|50233424|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
25120806|NCT01756456|50233425|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
25120807|NCT01756456|50233426|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
25120808|NCT01756456|50233427|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
25120809|NCT01756456|50233428|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
25120810|NCT01756456|50233423|FG000|Treatment Period: Phase I/II|Other causes|0|||
25120811|NCT01756456|50233424|FG001|Treatment Period: Phase I/II|Other causes|0|||
25120812|NCT01756456|50233425|FG002|Treatment Period: Phase I/II|Other causes|0|||
25120813|NCT01756456|50233426|FG003|Treatment Period: Phase I/II|Other causes|1|||
25120814|NCT01756456|50233427|FG004|Treatment Period: Phase I/II|Other causes|2|||
25120815|NCT01756456|50233428|FG005|Treatment Period: Phase I/II|Other causes|2|||
25120816|NCT01756456|50233423|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
25120817|NCT01756456|50233424|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
25120818|NCT01756456|50233425|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
25120819|NCT01756456|50233426|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
25120820|NCT01756456|50233427|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
25120821|NCT01756456|50233428|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
25120822|NCT01756456|50233423|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
25120823|NCT01756456|50233424|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
25120824|NCT01756456|50233425|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
25120825|NCT01756456|50233426|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
25120826|NCT01756456|50233427|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
25120827|NCT01756456|50233428|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
25120828|NCT01756456|50233423|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
25120829|NCT01756456|50233424|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
25120830|NCT01756456|50233425|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
25120831|NCT01756456|50233426|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
25120832|NCT01756456|50233427|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
25120833|NCT01756456|50233428|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
25120834|NCT01756456|50233423|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
25120835|NCT01756456|50233424|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
25120836|NCT01756456|50233425|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
25120837|NCT01756456|50233426|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
25120838|NCT01756456|50233427|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
25120839|NCT01756456|50233428|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
25120840|NCT01756456|50233423|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
25120841|NCT01756456|50233424|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
25120842|NCT01756456|50233425|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
25120843|NCT01756456|50233426|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
25120844|NCT01756456|50233427|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
25120845|NCT01756456|50233428|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
25120846|NCT01756456|50233423|FG000|Follow Up Period Phase I/II|Other causes|0|||
25120847|NCT01756456|50233424|FG001|Follow Up Period Phase I/II|Other causes|0|||
25120848|NCT01756456|50233425|FG002|Follow Up Period Phase I/II|Other causes|0|||
25120849|NCT01756456|50233426|FG003|Follow Up Period Phase I/II|Other causes|1|||
25120850|NCT01756456|50233427|FG004|Follow Up Period Phase I/II|Other causes|3|||
25120851|NCT01756456|50233428|FG005|Follow Up Period Phase I/II|Other causes|5|||
25120852|NCT01756300|50233451|FG000|Overall Study|Death|1|||
25120853|NCT01756300|50233451|FG000|Overall Study|Withdrawal by Subject|1|||
25120854|NCT01995201|50233474|FG000|From Baseline Until Week 24|Adverse Event|4|||
25120855|NCT01995201|50233475|FG001|From Baseline Until Week 24|Adverse Event|15|||
25120856|NCT01995201|50233476|FG002|From Baseline Until Week 24|Adverse Event|0|||
25120857|NCT01995201|50233477|FG003|From Baseline Until Week 24|Adverse Event|0|||
25120858|NCT01995201|50233478|FG004|From Baseline Until Week 24|Adverse Event|0|||
25120859|NCT01995201|50233479|FG005|From Baseline Until Week 24|Adverse Event|0|||
25120860|NCT01995201|50233480|FG006|From Baseline Until Week 24|Adverse Event|0|||
25120861|NCT01995201|50233474|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
25120862|NCT01995201|50233475|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
25120863|NCT01995201|50233476|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
25120864|NCT01995201|50233477|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
25120865|NCT01995201|50233478|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
25120866|NCT01995201|50233479|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
25120867|NCT01995201|50233480|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
25120868|NCT01995201|50233474|FG000|From Baseline Until Week 24|Death|0|||
25120869|NCT01995201|50233475|FG001|From Baseline Until Week 24|Death|1|||
25120870|NCT01995201|50233476|FG002|From Baseline Until Week 24|Death|0|||
25120871|NCT01995201|50233477|FG003|From Baseline Until Week 24|Death|0|||
25120872|NCT01995201|50233478|FG004|From Baseline Until Week 24|Death|0|||
25120873|NCT01995201|50233479|FG005|From Baseline Until Week 24|Death|0|||
25120874|NCT01995201|50233480|FG006|From Baseline Until Week 24|Death|0|||
25120875|NCT01995201|50233474|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
25120876|NCT01995201|50233475|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
25120877|NCT01995201|50233476|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
25120878|NCT01995201|50233477|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
25120879|NCT01995201|50233478|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
25120880|NCT01995201|50233479|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
25120881|NCT01995201|50233480|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
25120882|NCT01995201|50233474|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
25120883|NCT01995201|50233475|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
25120884|NCT01995201|50233476|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
25120885|NCT01995201|50233477|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
25120886|NCT01995201|50233478|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
25120887|NCT01995201|50233479|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
25120888|NCT01995201|50233480|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
25120889|NCT01995201|50233474|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
25120890|NCT01995201|50233475|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
25120891|NCT01995201|50233476|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
25120892|NCT01995201|50233477|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
25120893|NCT01995201|50233478|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
25120894|NCT01995201|50233479|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
25120895|NCT01995201|50233480|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
25120896|NCT01995201|50233474|FG000|From Baseline Until Week 24|Physician Decision|0|||
25120897|NCT01995201|50233475|FG001|From Baseline Until Week 24|Physician Decision|2|||
25120898|NCT01995201|50233476|FG002|From Baseline Until Week 24|Physician Decision|0|||
25120899|NCT01995201|50233477|FG003|From Baseline Until Week 24|Physician Decision|0|||
25120900|NCT01995201|50233478|FG004|From Baseline Until Week 24|Physician Decision|0|||
25120901|NCT01995201|50233479|FG005|From Baseline Until Week 24|Physician Decision|0|||
25120902|NCT01995201|50233480|FG006|From Baseline Until Week 24|Physician Decision|0|||
25120903|NCT01995201|50233474|FG000|From Baseline Until Week 24|Protocol Violation|0|||
25120904|NCT01995201|50233475|FG001|From Baseline Until Week 24|Protocol Violation|9|||
25120905|NCT01995201|50233476|FG002|From Baseline Until Week 24|Protocol Violation|0|||
25120906|NCT01995201|50233477|FG003|From Baseline Until Week 24|Protocol Violation|0|||
25120907|NCT01995201|50233478|FG004|From Baseline Until Week 24|Protocol Violation|0|||
25120908|NCT01995201|50233479|FG005|From Baseline Until Week 24|Protocol Violation|0|||
25261770|NCT01255761|50576416|FG000|Overall Study|Other Reasons|37|||
25008730|NCT03486834|50101826|FG002|Overall Study|Adverse Event|0|||
25120909|NCT01995201|50233480|FG006|From Baseline Until Week 24|Protocol Violation|0|||
25120910|NCT01995201|50233474|FG000|From Week 24 Until Week 48|Adverse Event|0|||
25120911|NCT01995201|50233475|FG001|From Week 24 Until Week 48|Adverse Event|0|||
25120912|NCT01995201|50233476|FG002|From Week 24 Until Week 48|Adverse Event|2|||
25120913|NCT01995201|50233477|FG003|From Week 24 Until Week 48|Adverse Event|1|||
25120914|NCT01995201|50233478|FG004|From Week 24 Until Week 48|Adverse Event|1|||
25120915|NCT01995201|50233479|FG005|From Week 24 Until Week 48|Adverse Event|3|||
25120916|NCT01995201|50233480|FG006|From Week 24 Until Week 48|Adverse Event|1|||
25120917|NCT01995201|50233474|FG000|From Week 24 Until Week 48|Death|0|||
25120918|NCT01995201|50233475|FG001|From Week 24 Until Week 48|Death|0|||
25120919|NCT01995201|50233476|FG002|From Week 24 Until Week 48|Death|0|||
25120920|NCT01995201|50233477|FG003|From Week 24 Until Week 48|Death|0|||
25120921|NCT01995201|50233478|FG004|From Week 24 Until Week 48|Death|0|||
25120922|NCT01995201|50233479|FG005|From Week 24 Until Week 48|Death|2|||
25120923|NCT01995201|50233480|FG006|From Week 24 Until Week 48|Death|0|||
25120924|NCT01995201|50233474|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
25120925|NCT01995201|50233475|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
25120926|NCT01995201|50233476|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
25120927|NCT01995201|50233477|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
25120928|NCT01995201|50233478|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
25120929|NCT01995201|50233479|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
25120930|NCT01995201|50233480|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
25120931|NCT01995201|50233474|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
25120932|NCT01995201|50233475|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
25120933|NCT01995201|50233476|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
25120934|NCT01995201|50233477|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
25120935|NCT01995201|50233478|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
25120936|NCT01995201|50233479|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
25120937|NCT01995201|50233480|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
25120938|NCT01995201|50233474|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
25120939|NCT01995201|50233475|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
25120940|NCT01995201|50233476|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
25120941|NCT01995201|50233477|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
25120942|NCT01995201|50233478|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
25120943|NCT01995201|50233479|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
25120944|NCT01995201|50233480|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
25120945|NCT01995201|50233474|FG000|From Week 24 Until Week 48|Physician Decision|0|||
25120946|NCT01995201|50233475|FG001|From Week 24 Until Week 48|Physician Decision|0|||
25120947|NCT01995201|50233476|FG002|From Week 24 Until Week 48|Physician Decision|0|||
25120948|NCT01995201|50233477|FG003|From Week 24 Until Week 48|Physician Decision|0|||
25120949|NCT01995201|50233478|FG004|From Week 24 Until Week 48|Physician Decision|1|||
25120950|NCT01995201|50233479|FG005|From Week 24 Until Week 48|Physician Decision|0|||
25120951|NCT01995201|50233480|FG006|From Week 24 Until Week 48|Physician Decision|0|||
25120952|NCT01995201|50233474|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
25120953|NCT01995201|50233475|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
25120954|NCT01995201|50233476|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
25120955|NCT01995201|50233477|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
25120956|NCT01995201|50233478|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
25120957|NCT01995201|50233479|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
25120958|NCT01995201|50233480|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
25120959|NCT01728454|50233504|FG000|Stage 1 and 2|Pregnancy|1|||
25120960|NCT01728454|50233505|FG001|Stage 1 and 2|Pregnancy|0|||
25120961|NCT01728454|50233506|FG002|Stage 1 and 2|Pregnancy|0|||
25120962|NCT01728454|50233504|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
25120963|NCT01728454|50233505|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
25120964|NCT01728454|50233506|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
25120965|NCT01728454|50233504|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
25120966|NCT01728454|50233505|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
25120967|NCT01728454|50233506|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
25120968|NCT01728454|50233504|FG000|Stage 1 and 2|Lost to Follow-up|1|||
25120969|NCT01728454|50233505|FG001|Stage 1 and 2|Lost to Follow-up|1|||
25120970|NCT01728454|50233506|FG002|Stage 1 and 2|Lost to Follow-up|0|||
25120971|NCT01728454|50233504|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
25177459|NCT02754141|50321518|FG011|Overall Study|Other reasons|0|||
25120972|NCT01728454|50233505|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
25120973|NCT01728454|50233506|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
25120974|NCT01728454|50233504|FG000|Stage 3|Reason Missing|0|||
25120975|NCT01728454|50233505|FG001|Stage 3|Reason Missing|0|||
25120976|NCT01728454|50233506|FG002|Stage 3|Reason Missing|1|||
25120977|NCT01728454|50233504|FG000|Stage 3|Subject Required Other Treatment|0|||
25120978|NCT01728454|50233505|FG001|Stage 3|Subject Required Other Treatment|1|||
25120979|NCT01728454|50233506|FG002|Stage 3|Subject Required Other Treatment|0|||
25120980|NCT01728454|50233504|FG000|Stage 3|Pregnancy|1|||
25120981|NCT01728454|50233505|FG001|Stage 3|Pregnancy|0|||
25177460|NCT02754141|50321519|FG012|Overall Study|Other reasons|2|||
25120982|NCT01728454|50233506|FG002|Stage 3|Pregnancy|0|||
25120983|NCT01728454|50233504|FG000|Stage 3|Withdrew Consent|1|||
25120984|NCT01728454|50233505|FG001|Stage 3|Withdrew Consent|0|||
25120985|NCT01728454|50233506|FG002|Stage 3|Withdrew Consent|1|||
25120986|NCT01728454|50233504|FG000|Stage 3|Non-compliance with Protocol|0|||
25120987|NCT01728454|50233505|FG001|Stage 3|Non-compliance with Protocol|0|||
25120988|NCT01728454|50233506|FG002|Stage 3|Non-compliance with Protocol|1|||
25120989|NCT01728454|50233504|FG000|Stage 3|Lost to Follow-up|0|||
25120990|NCT01728454|50233505|FG001|Stage 3|Lost to Follow-up|3|||
25120991|NCT01728454|50233506|FG002|Stage 3|Lost to Follow-up|1|||
25120992|NCT01728454|50233504|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
25120993|NCT01728454|50233505|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
25120994|NCT01728454|50233506|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
25120995|NCT01636687|50233520|FG000|Induction Period|Withdrawal by Subject|1|||
25120996|NCT01636687|50233521|FG001|Induction Period|Withdrawal by Subject|0|||
25120997|NCT01636687|50233522|FG002|Induction Period|Withdrawal by Subject|0|||
25120998|NCT01636687|50233523|FG003|Induction Period|Withdrawal by Subject|0|||
25120999|NCT01636687|50233524|FG004|Induction Period|Withdrawal by Subject|0|||
25121000|NCT01636687|50233520|FG000|Induction Period|Adverse Event|1|||
25121001|NCT01636687|50233521|FG001|Induction Period|Adverse Event|0|||
25121002|NCT01636687|50233522|FG002|Induction Period|Adverse Event|0|||
25121003|NCT01636687|50233523|FG003|Induction Period|Adverse Event|0|||
25121004|NCT01636687|50233524|FG004|Induction Period|Adverse Event|1|||
25121005|NCT01636687|50233520|FG000|Induction Period|Lack of Efficacy|0|||
25121006|NCT01636687|50233521|FG001|Induction Period|Lack of Efficacy|0|||
25121007|NCT01636687|50233522|FG002|Induction Period|Lack of Efficacy|0|||
25121008|NCT01636687|50233523|FG003|Induction Period|Lack of Efficacy|0|||
25121009|NCT01636687|50233524|FG004|Induction Period|Lack of Efficacy|1|||
25121010|NCT01636687|50233520|FG000|Induction Period|Physician Decision|1|||
25121011|NCT01636687|50233521|FG001|Induction Period|Physician Decision|0|||
25121012|NCT01636687|50233522|FG002|Induction Period|Physician Decision|0|||
25121013|NCT01636687|50233523|FG003|Induction Period|Physician Decision|0|||
25121014|NCT01636687|50233524|FG004|Induction Period|Physician Decision|0|||
25121015|NCT01636687|50233520|FG000|Maintenance Period|Withdrawal by Subject|2|||
25121016|NCT01636687|50233521|FG001|Maintenance Period|Withdrawal by Subject|0|||
25121017|NCT01636687|50233522|FG002|Maintenance Period|Withdrawal by Subject|2|||
25121018|NCT01636687|50233523|FG003|Maintenance Period|Withdrawal by Subject|0|||
25121019|NCT01636687|50233524|FG004|Maintenance Period|Withdrawal by Subject|0|||
25121020|NCT01636687|50233520|FG000|Maintenance Period|Adverse Event|1|||
25121021|NCT01636687|50233521|FG001|Maintenance Period|Adverse Event|0|||
25121022|NCT01636687|50233522|FG002|Maintenance Period|Adverse Event|0|||
25121023|NCT01636687|50233523|FG003|Maintenance Period|Adverse Event|0|||
25121024|NCT01636687|50233524|FG004|Maintenance Period|Adverse Event|0|||
25121025|NCT01636687|50233520|FG000|Maintenance Period|Lack of Efficacy|4|||
25121026|NCT01636687|50233521|FG001|Maintenance Period|Lack of Efficacy|1|||
25121027|NCT01636687|50233522|FG002|Maintenance Period|Lack of Efficacy|0|||
25121028|NCT01636687|50233523|FG003|Maintenance Period|Lack of Efficacy|0|||
25121029|NCT01636687|50233524|FG004|Maintenance Period|Lack of Efficacy|0|||
25121030|NCT01636687|50233520|FG000|Maintenance Period|Lost to Follow-up|1|||
25121031|NCT01636687|50233521|FG001|Maintenance Period|Lost to Follow-up|1|||
25121032|NCT01636687|50233522|FG002|Maintenance Period|Lost to Follow-up|0|||
25121033|NCT01636687|50233523|FG003|Maintenance Period|Lost to Follow-up|0|||
25121034|NCT01636687|50233524|FG004|Maintenance Period|Lost to Follow-up|1|||
25121035|NCT01636687|50233520|FG000|Maintenance Period|Physician Decision|0|||
25121036|NCT01636687|50233521|FG001|Maintenance Period|Physician Decision|0|||
25121037|NCT01636687|50233522|FG002|Maintenance Period|Physician Decision|0|||
25121038|NCT01636687|50233523|FG003|Maintenance Period|Physician Decision|0|||
25121039|NCT01636687|50233524|FG004|Maintenance Period|Physician Decision|1|||
25121040|NCT01636687|50233520|FG000|Extension Period|technical problems|0|||
25121041|NCT01636687|50233521|FG001|Extension Period|technical problems|1|||
25121042|NCT01636687|50233522|FG002|Extension Period|technical problems|2|||
25121043|NCT01636687|50233523|FG003|Extension Period|technical problems|1|||
25121044|NCT01636687|50233524|FG004|Extension Period|technical problems|0|||
25121045|NCT01636687|50233520|FG000|Extension Period|Adverse Event|4|||
25121046|NCT01636687|50233521|FG001|Extension Period|Adverse Event|3|||
25121047|NCT01636687|50233522|FG002|Extension Period|Adverse Event|2|||
25121048|NCT01636687|50233523|FG003|Extension Period|Adverse Event|1|||
25121049|NCT01636687|50233524|FG004|Extension Period|Adverse Event|0|||
25121050|NCT01636687|50233520|FG000|Extension Period|Lack of Efficacy|7|||
25121051|NCT01636687|50233521|FG001|Extension Period|Lack of Efficacy|0|||
25121052|NCT01636687|50233522|FG002|Extension Period|Lack of Efficacy|2|||
25121053|NCT01636687|50233523|FG003|Extension Period|Lack of Efficacy|1|||
25121054|NCT01636687|50233524|FG004|Extension Period|Lack of Efficacy|0|||
25121055|NCT01636687|50233520|FG000|Extension Period|Lost to Follow-up|1|||
25121056|NCT01636687|50233521|FG001|Extension Period|Lost to Follow-up|0|||
25121057|NCT01636687|50233522|FG002|Extension Period|Lost to Follow-up|1|||
25121058|NCT01636687|50233523|FG003|Extension Period|Lost to Follow-up|0|||
25121059|NCT01636687|50233524|FG004|Extension Period|Lost to Follow-up|0|||
25121060|NCT01636687|50233520|FG000|Extension Period|Physician Decision|1|||
25121061|NCT01636687|50233521|FG001|Extension Period|Physician Decision|0|||
25121062|NCT01636687|50233522|FG002|Extension Period|Physician Decision|0|||
25121063|NCT01636687|50233523|FG003|Extension Period|Physician Decision|1|||
25121064|NCT01636687|50233524|FG004|Extension Period|Physician Decision|0|||
25121065|NCT01636687|50233520|FG000|Extension Period|study terminated by sponsor|33|||
25121066|NCT01636687|50233521|FG001|Extension Period|study terminated by sponsor|50|||
25121067|NCT01636687|50233522|FG002|Extension Period|study terminated by sponsor|17|||
25121068|NCT01636687|50233523|FG003|Extension Period|study terminated by sponsor|23|||
25121069|NCT01636687|50233524|FG004|Extension Period|study terminated by sponsor|0|||
25121070|NCT01636687|50233520|FG000|Extension Period|Withdrawal by Subject|1|||
25121071|NCT01636687|50233521|FG001|Extension Period|Withdrawal by Subject|0|||
25121072|NCT01636687|50233522|FG002|Extension Period|Withdrawal by Subject|1|||
25121073|NCT01636687|50233523|FG003|Extension Period|Withdrawal by Subject|1|||
25121074|NCT01636687|50233524|FG004|Extension Period|Withdrawal by Subject|0|||
25261771|NCT01255761|50576417|FG001|Overall Study|Other Reasons|18|||
25261772|NCT01297062|50576429|FG000|Overall Study|Adverse Event|2|||
25261773|NCT01297062|50576430|FG001|Overall Study|Adverse Event|0|||
25261774|NCT01297062|50576431|FG002|Overall Study|Adverse Event|1|||
25261775|NCT01297062|50576432|FG003|Overall Study|Adverse Event|0|||
25261776|NCT01297062|50576433|FG004|Overall Study|Adverse Event|0|||
25261777|NCT01297062|50576434|FG005|Overall Study|Adverse Event|0|||
25261778|NCT01297062|50576435|FG006|Overall Study|Adverse Event|0|||
25261779|NCT01297062|50576429|FG000|Overall Study|Physician Decision|1|||
25121075|NCT01636687|50233520|FG000|Follow-up Period|Withdrawal by Subject|1|||
25121076|NCT01636687|50233521|FG001|Follow-up Period|Withdrawal by Subject|0|||
25121077|NCT01636687|50233522|FG002|Follow-up Period|Withdrawal by Subject|0|||
25121078|NCT01636687|50233523|FG003|Follow-up Period|Withdrawal by Subject|0|||
25121079|NCT01636687|50233524|FG004|Follow-up Period|Withdrawal by Subject|1|||
25121080|NCT01634659|50233544|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
25121081|NCT01634659|50233545|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
25121082|NCT01634659|50233544|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
25121083|NCT01634659|50233545|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
25121084|NCT04863248|50233557|FG000|Overall Study|Sponsor Terminated|4|||
25121085|NCT04863248|50233558|FG001|Overall Study|Sponsor Terminated|1|||
25121086|NCT04863248|50233557|FG000|Overall Study|Death|0|||
25121087|NCT04863248|50233558|FG001|Overall Study|Death|1|||
25121088|NCT04863248|50233557|FG000|Overall Study|Withdrawal by Subject|0|||
25121089|NCT04863248|50233558|FG001|Overall Study|Withdrawal by Subject|1|||
25121090|NCT04498832|50233566|FG000|Overall Study|Adverse Event|1|||
25121091|NCT04498832|50233567|FG001|Overall Study|Adverse Event|3|||
25121092|NCT04498832|50233566|FG000|Overall Study|Withdrawal by Subject|0|||
25121093|NCT04498832|50233567|FG001|Overall Study|Withdrawal by Subject|1|||
25121094|NCT04285229|50233575|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
25121095|NCT04285229|50233576|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
25121096|NCT04285229|50233577|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
25121097|NCT04285229|50233578|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
25121098|NCT04285229|50233579|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
25121099|NCT04285229|50233580|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
25121100|NCT04285229|50233575|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
25121101|NCT04285229|50233576|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
25121102|NCT04285229|50233577|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
25121103|NCT04285229|50233578|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
25121104|NCT04285229|50233579|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
25121105|NCT04285229|50233580|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
25121106|NCT04285229|50233575|FG000|Extended Treatment Period|Adverse Event|0|||
25121107|NCT04285229|50233576|FG001|Extended Treatment Period|Adverse Event|0|||
25121108|NCT04285229|50233577|FG002|Extended Treatment Period|Adverse Event|0|||
25121109|NCT04285229|50233578|FG003|Extended Treatment Period|Adverse Event|1|||
25121110|NCT04285229|50233579|FG004|Extended Treatment Period|Adverse Event|0|||
25121111|NCT04285229|50233580|FG005|Extended Treatment Period|Adverse Event|0|||
25121112|NCT04285229|50233575|FG000|Extended Treatment Period|Physician Decision|0|||
25121113|NCT04285229|50233576|FG001|Extended Treatment Period|Physician Decision|0|||
25121114|NCT04285229|50233577|FG002|Extended Treatment Period|Physician Decision|1|||
25121115|NCT04285229|50233578|FG003|Extended Treatment Period|Physician Decision|0|||
25121116|NCT04285229|50233579|FG004|Extended Treatment Period|Physician Decision|0|||
25121117|NCT04285229|50233580|FG005|Extended Treatment Period|Physician Decision|0|||
25177461|NCT02754141|50321520|FG013|Overall Study|Other reasons|0|||
25121118|NCT04285229|50233575|FG000|Follow-up Period|Adverse Event|0|||
25121119|NCT04285229|50233576|FG001|Follow-up Period|Adverse Event|0|||
25121120|NCT04285229|50233577|FG002|Follow-up Period|Adverse Event|0|||
25261780|NCT01297062|50576430|FG001|Overall Study|Physician Decision|0|||
25261781|NCT01297062|50576431|FG002|Overall Study|Physician Decision|1|||
25261782|NCT01297062|50576432|FG003|Overall Study|Physician Decision|0|||
25121121|NCT04285229|50233578|FG003|Follow-up Period|Adverse Event|0|||
25121122|NCT04285229|50233579|FG004|Follow-up Period|Adverse Event|1|||
25121123|NCT04285229|50233580|FG005|Follow-up Period|Adverse Event|4|||
25121124|NCT04285229|50233575|FG000|Follow-up Period|Withdrawal by Subject|0|||
25121125|NCT04285229|50233576|FG001|Follow-up Period|Withdrawal by Subject|0|||
25121126|NCT04285229|50233577|FG002|Follow-up Period|Withdrawal by Subject|0|||
25121127|NCT04285229|50233578|FG003|Follow-up Period|Withdrawal by Subject|0|||
25121128|NCT04285229|50233579|FG004|Follow-up Period|Withdrawal by Subject|0|||
25121129|NCT04285229|50233580|FG005|Follow-up Period|Withdrawal by Subject|5|||
25121130|NCT04285229|50233575|FG000|Follow-up Period|Covid-19|0|||
25121131|NCT04285229|50233576|FG001|Follow-up Period|Covid-19|0|||
25121132|NCT04285229|50233577|FG002|Follow-up Period|Covid-19|0|||
25121133|NCT04285229|50233578|FG003|Follow-up Period|Covid-19|0|||
25121134|NCT04285229|50233579|FG004|Follow-up Period|Covid-19|0|||
25121135|NCT04285229|50233580|FG005|Follow-up Period|Covid-19|2|||
25121136|NCT04285229|50233575|FG000|Follow-up Period|Physician Decision|0|||
25121137|NCT04285229|50233576|FG001|Follow-up Period|Physician Decision|0|||
25121138|NCT04285229|50233577|FG002|Follow-up Period|Physician Decision|0|||
25121139|NCT04285229|50233578|FG003|Follow-up Period|Physician Decision|0|||
25121140|NCT04285229|50233579|FG004|Follow-up Period|Physician Decision|0|||
25121141|NCT04285229|50233580|FG005|Follow-up Period|Physician Decision|1|||
25121142|NCT04263454|50233597|FG000|Overall Study|Adverse Event|0|||
25121143|NCT04263454|50233598|FG001|Overall Study|Adverse Event|2|||
25121144|NCT04263454|50233597|FG000|Overall Study|Physician Decision|3|||
25121145|NCT04263454|50233598|FG001|Overall Study|Physician Decision|5|||
25121146|NCT04263454|50233597|FG000|Overall Study|Poor Data Quality|0|||
25121147|NCT04263454|50233598|FG001|Overall Study|Poor Data Quality|1|||
25121148|NCT04155463|50233608|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
25121149|NCT04155463|50233609|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
25121150|NCT04056611|50233615|FG000|Overall Study|Physician Decision|1|||
25121151|NCT04024462|50233621|FG000|Overall Study|Withdrawal by Subject|6|||
25261783|NCT01297062|50576433|FG004|Overall Study|Physician Decision|0|||
25261784|NCT01297062|50576434|FG005|Overall Study|Physician Decision|0|||
25261785|NCT01297062|50576435|FG006|Overall Study|Physician Decision|6|||
25261786|NCT01297062|50576429|FG000|Overall Study|Protocol Violation|0|||
25261787|NCT01297062|50576430|FG001|Overall Study|Protocol Violation|0|||
25261788|NCT01297062|50576431|FG002|Overall Study|Protocol Violation|0|||
25261789|NCT01297062|50576432|FG003|Overall Study|Protocol Violation|0|||
25121152|NCT04024462|50233622|FG001|Overall Study|Withdrawal by Subject|7|||
25261790|NCT01297062|50576433|FG004|Overall Study|Protocol Violation|1|||
25261791|NCT01297062|50576434|FG005|Overall Study|Protocol Violation|0|||
25121153|NCT04024462|50233621|FG000|Overall Study|Progressive Disease|0|||
25177462|NCT02754141|50321521|FG014|Overall Study|Other reasons|0|||
25121154|NCT04024462|50233622|FG001|Overall Study|Progressive Disease|1|||
25121155|NCT04024462|50233621|FG000|Overall Study|Adverse Event|0|||
25121156|NCT04024462|50233622|FG001|Overall Study|Adverse Event|1|||
25121157|NCT04024462|50233621|FG000|Overall Study|Death|0|||
25121158|NCT04024462|50233622|FG001|Overall Study|Death|1|||
25121159|NCT04024462|50233621|FG000|Overall Study|Lost to Follow-up|1|||
25121160|NCT04024462|50233622|FG001|Overall Study|Lost to Follow-up|0|||
25121161|NCT04024462|50233621|FG000|Overall Study|Ongoing in the Study|94|||
25121162|NCT04024462|50233622|FG001|Overall Study|Ongoing in the Study|89|||
25121163|NCT04001803|50233628|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
25121164|NCT04001803|50233628|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
25177463|NCT02754141|50321522|FG015|Overall Study|Other reasons|0|||
25177464|NCT02754141|50321523|FG016|Overall Study|Other reasons|0|||
25177465|NCT02754141|50321524|FG017|Overall Study|Other reasons|0|||
25177466|NCT02754141|50321507|FG000|Overall Study|Completed treatment as per protocol|0|||
25177467|NCT02754141|50321508|FG001|Overall Study|Completed treatment as per protocol|1|||
25177468|NCT02754141|50321509|FG002|Overall Study|Completed treatment as per protocol|0|||
25261792|NCT01297062|50576435|FG006|Overall Study|Protocol Violation|0|||
25121165|NCT04001803|50233628|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
25121166|NCT04001803|50233628|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
25121167|NCT04001803|50233628|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
25177469|NCT02754141|50321510|FG003|Overall Study|Completed treatment as per protocol|0|||
25177470|NCT02754141|50321511|FG004|Overall Study|Completed treatment as per protocol|0|||
25121168|NCT04001803|50233628|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
25121169|NCT04001803|50233628|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
25121170|NCT04001803|50233628|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
25121171|NCT04001803|50233628|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
25121172|NCT04001803|50233628|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
25261793|NCT01297062|50576429|FG000|Overall Study|Subject Decision|1|||
25261794|NCT01297062|50576430|FG001|Overall Study|Subject Decision|1|||
25121173|NCT03768427|50233637|FG000|Overall Study|Death|0|||
25121174|NCT03768427|50233638|FG001|Overall Study|Death|0|||
25177471|NCT02754141|50321512|FG005|Overall Study|Completed treatment as per protocol|0|||
25121175|NCT03768427|50233639|FG002|Overall Study|Death|1|||
25121176|NCT03768427|50233640|FG003|Overall Study|Death|0|||
25121177|NCT03768427|50233637|FG000|Overall Study|Lost to Follow-up|2|||
25121178|NCT03768427|50233638|FG001|Overall Study|Lost to Follow-up|0|||
25121179|NCT03768427|50233639|FG002|Overall Study|Lost to Follow-up|0|||
25121180|NCT03768427|50233640|FG003|Overall Study|Lost to Follow-up|0|||
25121181|NCT03768427|50233637|FG000|Overall Study|Physician Decision|3|||
25121182|NCT03768427|50233638|FG001|Overall Study|Physician Decision|2|||
25121183|NCT03768427|50233639|FG002|Overall Study|Physician Decision|4|||
25121184|NCT03768427|50233640|FG003|Overall Study|Physician Decision|4|||
25121185|NCT03768427|50233637|FG000|Overall Study|Withdrawal by Subject|7|||
25121186|NCT03768427|50233638|FG001|Overall Study|Withdrawal by Subject|2|||
25121187|NCT03768427|50233639|FG002|Overall Study|Withdrawal by Subject|6|||
25121188|NCT03768427|50233640|FG003|Overall Study|Withdrawal by Subject|7|||
25121189|NCT03595228|50233654|FG000|Overall Study|Death|2|||
25121190|NCT03595228|50233654|FG000|Overall Study|Lack of Efficacy|13|||
25121191|NCT03595228|50233654|FG000|Overall Study|Withdrawal by Subject|3|||
25121192|NCT03595228|50233654|FG000|Overall Study|Withdrawal by Sponsor|1|||
25121193|NCT03572933|50233660|FG000|Overall Study|Adverse Event|4|||
25121194|NCT03572933|50233661|FG001|Overall Study|Adverse Event|1|||
25121195|NCT03572933|50233660|FG000|Overall Study|Withdrawal by Subject|0|||
25121196|NCT03572933|50233661|FG001|Overall Study|Withdrawal by Subject|1|||
25121197|NCT03558152|50233672|FG000|Overall Study|Adverse Event|0|||
25121198|NCT03558152|50233673|FG001|Overall Study|Adverse Event|0|||
25121199|NCT03558152|50233674|FG002|Overall Study|Adverse Event|1|||
25121200|NCT03558152|50233675|FG003|Overall Study|Adverse Event|1|||
25121201|NCT03558152|50233676|FG004|Overall Study|Adverse Event|2|||
25121202|NCT03558152|50233677|FG005|Overall Study|Adverse Event|1|||
25121203|NCT03558152|50233678|FG006|Overall Study|Adverse Event|1|||
25121204|NCT03558152|50233679|FG007|Overall Study|Adverse Event|0|||
25121205|NCT03558152|50233672|FG000|Overall Study|Death|0|||
25121206|NCT03558152|50233673|FG001|Overall Study|Death|0|||
25121207|NCT03558152|50233674|FG002|Overall Study|Death|0|||
25121208|NCT03558152|50233675|FG003|Overall Study|Death|0|||
25121209|NCT03558152|50233676|FG004|Overall Study|Death|1|||
25121210|NCT03558152|50233677|FG005|Overall Study|Death|0|||
25121211|NCT03558152|50233678|FG006|Overall Study|Death|0|||
25121212|NCT03558152|50233679|FG007|Overall Study|Death|0|||
25121213|NCT03558152|50233672|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
25121214|NCT03558152|50233673|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
25121215|NCT03558152|50233674|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
25121216|NCT03558152|50233675|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
25121217|NCT03558152|50233676|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
25121218|NCT03558152|50233677|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
25121219|NCT03558152|50233678|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
25121220|NCT03558152|50233679|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
25121221|NCT03558152|50233672|FG000|Overall Study|Miscalculation in mmcs|0|||
25121222|NCT03558152|50233673|FG001|Overall Study|Miscalculation in mmcs|0|||
25121223|NCT03558152|50233674|FG002|Overall Study|Miscalculation in mmcs|0|||
25121224|NCT03558152|50233675|FG003|Overall Study|Miscalculation in mmcs|0|||
25121225|NCT03558152|50233676|FG004|Overall Study|Miscalculation in mmcs|0|||
25121226|NCT03558152|50233677|FG005|Overall Study|Miscalculation in mmcs|0|||
25121227|NCT03558152|50233678|FG006|Overall Study|Miscalculation in mmcs|1|||
25121228|NCT03558152|50233679|FG007|Overall Study|Miscalculation in mmcs|0|||
25121229|NCT03558152|50233672|FG000|Overall Study|Mistake in calculation|0|||
25121230|NCT03558152|50233673|FG001|Overall Study|Mistake in calculation|0|||
25121231|NCT03558152|50233674|FG002|Overall Study|Mistake in calculation|0|||
25121232|NCT03558152|50233675|FG003|Overall Study|Mistake in calculation|1|||
25121233|NCT03558152|50233676|FG004|Overall Study|Mistake in calculation|0|||
25121234|NCT03558152|50233677|FG005|Overall Study|Mistake in calculation|0|||
25121235|NCT03558152|50233678|FG006|Overall Study|Mistake in calculation|0|||
25121236|NCT03558152|50233679|FG007|Overall Study|Mistake in calculation|0|||
25121237|NCT03558152|50233672|FG000|Overall Study|Mistake in evaluation of disease status|0|||
25121238|NCT03558152|50233673|FG001|Overall Study|Mistake in evaluation of disease status|0|||
25121239|NCT03558152|50233674|FG002|Overall Study|Mistake in evaluation of disease status|0|||
25121240|NCT03558152|50233675|FG003|Overall Study|Mistake in evaluation of disease status|0|||
25121241|NCT03558152|50233676|FG004|Overall Study|Mistake in evaluation of disease status|0|||
25121242|NCT03558152|50233677|FG005|Overall Study|Mistake in evaluation of disease status|0|||
25121243|NCT03558152|50233678|FG006|Overall Study|Mistake in evaluation of disease status|0|||
25121244|NCT03558152|50233679|FG007|Overall Study|Mistake in evaluation of disease status|1|||
25121245|NCT03558152|50233672|FG000|Overall Study|Physician Decision|0|||
25121246|NCT03558152|50233673|FG001|Overall Study|Physician Decision|0|||
25121247|NCT03558152|50233674|FG002|Overall Study|Physician Decision|0|||
25121248|NCT03558152|50233675|FG003|Overall Study|Physician Decision|0|||
25121249|NCT03558152|50233676|FG004|Overall Study|Physician Decision|0|||
25121250|NCT03558152|50233677|FG005|Overall Study|Physician Decision|0|||
25121251|NCT03558152|50233678|FG006|Overall Study|Physician Decision|1|||
25121252|NCT03558152|50233679|FG007|Overall Study|Physician Decision|0|||
25121253|NCT03558152|50233672|FG000|Overall Study|Withdrawal by Subject|2|||
25121254|NCT03558152|50233673|FG001|Overall Study|Withdrawal by Subject|3|||
25121255|NCT03558152|50233674|FG002|Overall Study|Withdrawal by Subject|2|||
25121256|NCT03558152|50233675|FG003|Overall Study|Withdrawal by Subject|1|||
25121257|NCT03558152|50233676|FG004|Overall Study|Withdrawal by Subject|1|||
25121258|NCT03558152|50233677|FG005|Overall Study|Withdrawal by Subject|1|||
25121259|NCT03558152|50233678|FG006|Overall Study|Withdrawal by Subject|3|||
25121260|NCT03558152|50233679|FG007|Overall Study|Withdrawal by Subject|2|||
25121261|NCT03558152|50233672|FG000|Overall Study|Lack of Efficacy|11|||
25121262|NCT03558152|50233673|FG001|Overall Study|Lack of Efficacy|11|||
25121263|NCT03558152|50233674|FG002|Overall Study|Lack of Efficacy|10|||
25121264|NCT03558152|50233675|FG003|Overall Study|Lack of Efficacy|11|||
25121265|NCT03558152|50233676|FG004|Overall Study|Lack of Efficacy|14|||
25121266|NCT03558152|50233677|FG005|Overall Study|Lack of Efficacy|12|||
25121267|NCT03558152|50233678|FG006|Overall Study|Lack of Efficacy|14|||
25121268|NCT03558152|50233679|FG007|Overall Study|Lack of Efficacy|13|||
25121269|NCT03558152|50233672|FG000|Overall Study|Protocol Violation|1|||
25121270|NCT03558152|50233673|FG001|Overall Study|Protocol Violation|1|||
25121271|NCT03558152|50233674|FG002|Overall Study|Protocol Violation|0|||
25121272|NCT03558152|50233675|FG003|Overall Study|Protocol Violation|1|||
25121273|NCT03558152|50233676|FG004|Overall Study|Protocol Violation|1|||
25121274|NCT03558152|50233677|FG005|Overall Study|Protocol Violation|0|||
25121275|NCT03558152|50233678|FG006|Overall Study|Protocol Violation|2|||
25121276|NCT03558152|50233679|FG007|Overall Study|Protocol Violation|0|||
25121277|NCT03461406|50233719|FG000|Overall Study|Death|1|||
25121278|NCT03461406|50233720|FG001|Overall Study|Death|2|||
25121279|NCT03461406|50233719|FG000|Overall Study|Consent Withdrawn by Participant|0|||
25121280|NCT03461406|50233720|FG001|Overall Study|Consent Withdrawn by Participant|1|||
25121281|NCT03461406|50233719|FG000|Overall Study|Screen Failure|3|||
25121282|NCT03461406|50233720|FG001|Overall Study|Screen Failure|1|||
25121283|NCT03461406|50233719|FG000|Overall Study|Reason not Specified|1|||
25121284|NCT03461406|50233720|FG001|Overall Study|Reason not Specified|3|||
25121285|NCT03461406|50233719|FG000|Overall Study|Lost to Follow-up|3|||
25121286|NCT03461406|50233720|FG001|Overall Study|Lost to Follow-up|0|||
25121287|NCT03408899|50233735|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
25121288|NCT03317496|50233748|FG000|Phase 1b Lead-in: Treatment|Adverse Event|2|||
25121289|NCT03317496|50233749|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
25121290|NCT03317496|50233750|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
25121291|NCT03317496|50233751|FG003|Phase 1b Lead-in: Treatment|Adverse Event|0|||
25121292|NCT03317496|50233752|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
25121293|NCT03317496|50233748|FG000|Phase 1b Lead-in: Treatment|Physician Decision|1|||
25121294|NCT03317496|50233749|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
25121295|NCT03317496|50233750|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
25121296|NCT03317496|50233751|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
25121297|NCT03317496|50233752|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
25121298|NCT03317496|50233748|FG000|Phase 1b Lead-in: Treatment|Death|0|||
25121299|NCT03317496|50233749|FG001|Phase 1b Lead-in: Treatment|Death|0|||
25121300|NCT03317496|50233750|FG002|Phase 1b Lead-in: Treatment|Death|1|||
25121301|NCT03317496|50233751|FG003|Phase 1b Lead-in: Treatment|Death|0|||
25121302|NCT03317496|50233752|FG004|Phase 1b Lead-in: Treatment|Death|0|||
25121303|NCT03317496|50233748|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
25121304|NCT03317496|50233749|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
25121305|NCT03317496|50233750|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
25121306|NCT03317496|50233751|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
25121307|NCT03317496|50233752|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
25121308|NCT03317496|50233748|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
25121309|NCT03317496|50233749|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
25121310|NCT03317496|50233750|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
25121311|NCT03317496|50233751|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
25121312|NCT03317496|50233752|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
25121313|NCT03317496|50233748|FG000|Phase 1b Lead-in: Treatment|Other|0|||
25121314|NCT03317496|50233749|FG001|Phase 1b Lead-in: Treatment|Other|1|||
25121315|NCT03317496|50233750|FG002|Phase 1b Lead-in: Treatment|Other|0|||
25121316|NCT03317496|50233751|FG003|Phase 1b Lead-in: Treatment|Other|0|||
25121317|NCT03317496|50233752|FG004|Phase 1b Lead-in: Treatment|Other|0|||
25121318|NCT03317496|50233748|FG000|Phase 1b Lead-in: Treatment|Ongoing|2|||
25121319|NCT03317496|50233749|FG001|Phase 1b Lead-in: Treatment|Ongoing|1|||
25121320|NCT03317496|50233750|FG002|Phase 1b Lead-in: Treatment|Ongoing|0|||
25121321|NCT03317496|50233751|FG003|Phase 1b Lead-in: Treatment|Ongoing|2|||
25121322|NCT03317496|50233752|FG004|Phase 1b Lead-in: Treatment|Ongoing|0|||
25121323|NCT03317496|50233748|FG000|Phase 1b Lead-in: Follow-up|Death|2|||
25121324|NCT03317496|50233749|FG001|Phase 1b Lead-in: Follow-up|Death|7|||
25121325|NCT03317496|50233750|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
25121326|NCT03317496|50233751|FG003|Phase 1b Lead-in: Follow-up|Death|3|||
25121327|NCT03317496|50233752|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
25121328|NCT03317496|50233748|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
25121329|NCT03317496|50233749|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
25121330|NCT03317496|50233750|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
25121331|NCT03317496|50233751|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
25121332|NCT03317496|50233752|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
25121333|NCT03317496|50233748|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
25121334|NCT03317496|50233749|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
25121335|NCT03317496|50233750|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
25121336|NCT03317496|50233751|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
25121337|NCT03317496|50233752|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
25121338|NCT03317496|50233748|FG000|Phase 1b Lead-in: Follow-up|Other|1|||
25121339|NCT03317496|50233749|FG001|Phase 1b Lead-in: Follow-up|Other|3|||
25121340|NCT03317496|50233750|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
25121341|NCT03317496|50233751|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
25121342|NCT03317496|50233752|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
25261795|NCT01297062|50576431|FG002|Overall Study|Subject Decision|0|||
25121343|NCT03317496|50233748|FG000|Phase 1b Lead-in: Follow-up|Ongoing|0|||
25121344|NCT03317496|50233749|FG001|Phase 1b Lead-in: Follow-up|Ongoing|1|||
25121345|NCT03317496|50233750|FG002|Phase 1b Lead-in: Follow-up|Ongoing|0|||
25121346|NCT03317496|50233751|FG003|Phase 1b Lead-in: Follow-up|Ongoing|0|||
25121347|NCT03317496|50233752|FG004|Phase 1b Lead-in: Follow-up|Ongoing|0|||
25121348|NCT03317496|50233748|FG000|Phase 2: Treatment|Adverse Event|0|||
25121349|NCT03317496|50233749|FG001|Phase 2: Treatment|Adverse Event|0|||
25121350|NCT03317496|50233750|FG002|Phase 2: Treatment|Adverse Event|0|||
25121351|NCT03317496|50233751|FG003|Phase 2: Treatment|Adverse Event|0|||
25121352|NCT03317496|50233752|FG004|Phase 2: Treatment|Adverse Event|4|||
25121353|NCT03317496|50233748|FG000|Phase 2: Treatment|Death|0|||
25121354|NCT03317496|50233749|FG001|Phase 2: Treatment|Death|0|||
25121355|NCT03317496|50233750|FG002|Phase 2: Treatment|Death|0|||
25121356|NCT03317496|50233751|FG003|Phase 2: Treatment|Death|0|||
25121357|NCT03317496|50233752|FG004|Phase 2: Treatment|Death|1|||
25121358|NCT03317496|50233748|FG000|Phase 2: Treatment|Physician Decision|0|||
25121359|NCT03317496|50233749|FG001|Phase 2: Treatment|Physician Decision|0|||
25121360|NCT03317496|50233750|FG002|Phase 2: Treatment|Physician Decision|0|||
25121361|NCT03317496|50233751|FG003|Phase 2: Treatment|Physician Decision|0|||
25121362|NCT03317496|50233752|FG004|Phase 2: Treatment|Physician Decision|1|||
25121363|NCT03317496|50233748|FG000|Phase 2: Treatment|Progressive Disease|0|||
25121364|NCT03317496|50233749|FG001|Phase 2: Treatment|Progressive Disease|0|||
25121365|NCT03317496|50233750|FG002|Phase 2: Treatment|Progressive Disease|0|||
25121366|NCT03317496|50233751|FG003|Phase 2: Treatment|Progressive Disease|0|||
25121367|NCT03317496|50233752|FG004|Phase 2: Treatment|Progressive Disease|18|||
25121368|NCT03317496|50233748|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
25121369|NCT03317496|50233749|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
25121370|NCT03317496|50233750|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
25121371|NCT03317496|50233751|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
25121372|NCT03317496|50233752|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
25121373|NCT03317496|50233748|FG000|Phase 2: Treatment|Other|0|||
25121374|NCT03317496|50233749|FG001|Phase 2: Treatment|Other|0|||
25121375|NCT03317496|50233750|FG002|Phase 2: Treatment|Other|0|||
25121376|NCT03317496|50233751|FG003|Phase 2: Treatment|Other|0|||
25121377|NCT03317496|50233752|FG004|Phase 2: Treatment|Other|2|||
25121378|NCT03317496|50233748|FG000|Phase 2: Treatment|Ongoing|0|||
25121379|NCT03317496|50233749|FG001|Phase 2: Treatment|Ongoing|0|||
25121380|NCT03317496|50233750|FG002|Phase 2: Treatment|Ongoing|0|||
25121381|NCT03317496|50233751|FG003|Phase 2: Treatment|Ongoing|0|||
25121382|NCT03317496|50233752|FG004|Phase 2: Treatment|Ongoing|8|||
25121383|NCT03317496|50233748|FG000|Phase 2: Follow-up|Death|0|||
25121384|NCT03317496|50233749|FG001|Phase 2: Follow-up|Death|0|||
25121385|NCT03317496|50233750|FG002|Phase 2: Follow-up|Death|0|||
25121386|NCT03317496|50233751|FG003|Phase 2: Follow-up|Death|0|||
25121387|NCT03317496|50233752|FG004|Phase 2: Follow-up|Death|16|||
25121388|NCT03317496|50233748|FG000|Phase 2: Follow-up|Withdrawal by Subject|0|||
25121389|NCT03317496|50233749|FG001|Phase 2: Follow-up|Withdrawal by Subject|0|||
25121390|NCT03317496|50233750|FG002|Phase 2: Follow-up|Withdrawal by Subject|0|||
25121391|NCT03317496|50233751|FG003|Phase 2: Follow-up|Withdrawal by Subject|0|||
25261796|NCT01297062|50576432|FG003|Overall Study|Subject Decision|1|||
25121392|NCT03317496|50233752|FG004|Phase 2: Follow-up|Withdrawal by Subject|1|||
25121393|NCT03317496|50233748|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
25121394|NCT03317496|50233749|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
25121395|NCT03317496|50233750|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
25121396|NCT03317496|50233751|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
25121397|NCT03317496|50233752|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
25121398|NCT03317496|50233748|FG000|Phase 2: Follow-up|Other|0|||
25121399|NCT03317496|50233749|FG001|Phase 2: Follow-up|Other|0|||
25121400|NCT03317496|50233750|FG002|Phase 2: Follow-up|Other|0|||
25121401|NCT03317496|50233751|FG003|Phase 2: Follow-up|Other|0|||
25121402|NCT03317496|50233752|FG004|Phase 2: Follow-up|Other|6|||
25121403|NCT03317496|50233748|FG000|Phase 2: Follow-up|Ongoing|0|||
25121404|NCT03317496|50233749|FG001|Phase 2: Follow-up|Ongoing|0|||
25121405|NCT03317496|50233750|FG002|Phase 2: Follow-up|Ongoing|0|||
25121406|NCT03317496|50233751|FG003|Phase 2: Follow-up|Ongoing|0|||
25121407|NCT03317496|50233752|FG004|Phase 2: Follow-up|Ongoing|1|||
25121408|NCT03215810|50233763|FG000|Overall Study|Still responding to nivolumab|1|||
25121409|NCT03215810|50233763|FG000|Overall Study|Insufficient TIL growth|1|||
25121410|NCT03215810|50233763|FG000|Overall Study|Decline in performance status|1|||
25121411|NCT03215810|50233763|FG000|Overall Study|Withdrawal by Subject|1|||
25121412|NCT02528643|50233783|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
25121413|NCT02528643|50233784|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
25121414|NCT02528643|50233783|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
25121415|NCT02528643|50233784|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
25121416|NCT02528643|50233783|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
25121417|NCT02528643|50233784|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
25121418|NCT02528643|50233783|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
25121419|NCT02528643|50233784|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
25121420|NCT02528643|50233783|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
25121421|NCT02528643|50233784|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
25121422|NCT02528643|50233783|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
25121423|NCT02528643|50233784|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
25121424|NCT02528643|50233783|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
25121425|NCT02528643|50233784|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
25121426|NCT02175680|50233827|FG000|Overall Study|non-compliance|1|||
25121427|NCT02175680|50233827|FG000|Overall Study|other non-medical reason|1|||
25121428|NCT01983462|50233841|FG000|Overall Study|Adverse Event|1|||
25121429|NCT01983462|50233842|FG001|Overall Study|Adverse Event|0|||
25121430|NCT01983462|50233843|FG002|Overall Study|Adverse Event|0|||
25121431|NCT01559935|50233874|FG000|Car Phase|Toxicity|4|||
25121432|NCT01559935|50233874|FG000|Car Phase|Death|1|||
25121433|NCT01559935|50233874|FG000|Car Phase|Lack of Efficacy|2|||
25121434|NCT01559935|50233874|FG000|Car Phase|Lost to Follow-up|1|||
25121435|NCT01559935|50233874|FG000|Car Phase|Physician Decision|1|||
25121436|NCT01559935|50233874|FG000|Car Phase|Withdrawal by Subject|2|||
25121437|NCT01559935|50233874|FG000|Car Phase|Per protocol|1|||
25121438|NCT01559935|50233874|FG000|Car Phase|Insurance|1|||
25121439|NCT01559935|50233874|FG000|Car Phase|non-compliance|1|||
25121440|NCT01559935|50233874|FG000|BiRD Phase|Toxicity|1|||
25121441|NCT01559935|50233874|FG000|BiRD Phase|Lack of Efficacy|1|||
25121442|NCT01559935|50233874|FG000|BiRD Phase|Withdrawal by Subject|2|||
25121443|NCT01559935|50233874|FG000|Maintenance Phase|Remains on study|28|||
25121444|NCT01559935|50233874|FG000|Maintenance Phase|Toxicity|1|||
25121445|NCT01559935|50233874|FG000|Maintenance Phase|Lack of Efficacy|18|||
25121446|NCT01559935|50233874|FG000|Maintenance Phase|Withdrawal by Subject|5|||
25121447|NCT01559935|50233874|FG000|Maintenance Phase|Non-compliance|2|||
25121448|NCT01358877|50233880|FG000|Overall Study|Death|80|||
25121449|NCT01358877|50233881|FG001|Overall Study|Death|89|||
25121450|NCT01358877|50233880|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
25121451|NCT01358877|50233881|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
25121452|NCT01358877|50233880|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
25121453|NCT01358877|50233881|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
25121454|NCT01358877|50233880|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
25121455|NCT01358877|50233881|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
25121456|NCT01358877|50233880|FG000|Overall Study|Other|142|||
25121457|NCT01358877|50233881|FG001|Overall Study|Other|129|||
25121458|NCT00981058|50233889|FG000|Overall Study|Adverse Event|1|||
25121459|NCT00981058|50233890|FG001|Overall Study|Adverse Event|1|||
25121460|NCT00981058|50233889|FG000|Overall Study|Progressive Disease|61|||
25121461|NCT00981058|50233890|FG001|Overall Study|Progressive Disease|49|||
25121462|NCT00981058|50233889|FG000|Overall Study|Lost to Follow-up|16|||
25121463|NCT00981058|50233890|FG001|Overall Study|Lost to Follow-up|15|||
25121464|NCT00981058|50233889|FG000|Overall Study|New Anticancer Therapy|6|||
25261797|NCT01297062|50576433|FG004|Overall Study|Subject Decision|1|||
25261798|NCT01297062|50576434|FG005|Overall Study|Subject Decision|1|||
25261799|NCT01297062|50576435|FG006|Overall Study|Subject Decision|2|||
25121465|NCT00981058|50233890|FG001|Overall Study|New Anticancer Therapy|6|||
25121466|NCT00981058|50233889|FG000|Overall Study|Noncompliance|1|||
25121467|NCT00981058|50233890|FG001|Overall Study|Noncompliance|0|||
25121468|NCT00981058|50233889|FG000|Overall Study|Radiologist Error|0|||
25121469|NCT00981058|50233890|FG001|Overall Study|Radiologist Error|1|||
25121470|NCT00981058|50233889|FG000|Overall Study|Randomization Error|1|||
25121471|NCT00981058|50233890|FG001|Overall Study|Randomization Error|2|||
25121472|NCT00981058|50233889|FG000|Overall Study|Withdrawal by Subject|25|||
25121473|NCT00981058|50233890|FG001|Overall Study|Withdrawal by Subject|23|||
25121474|NCT00981058|50233889|FG000|Overall Study|On study treatment at conclusion|9|||
25121475|NCT00981058|50233890|FG001|Overall Study|On study treatment at conclusion|0|||
25168609|NCT00633477|50298172|FG001|Overall Study|Death|0|||
25121476|NCT00565851|50233904|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
25121477|NCT00565851|50233905|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
25121478|NCT00565851|50233906|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
25121479|NCT00565851|50233907|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
25121480|NCT00565851|50233908|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
25121481|NCT00565851|50233909|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
25121482|NCT00565851|50233910|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
25121483|NCT00565851|50233911|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
25121484|NCT00565851|50233904|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
25121485|NCT00565851|50233905|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
25121486|NCT00565851|50233906|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
25121487|NCT00565851|50233907|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
25121488|NCT00565851|50233908|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
25121489|NCT00565851|50233909|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
25121490|NCT00565851|50233910|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
25121491|NCT00565851|50233911|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
25121492|NCT00305227|50233935|FG000|Overall Study|Lost to Follow-up|7|||
25121493|NCT00305227|50233936|FG001|Overall Study|Lost to Follow-up|6|||
25121494|NCT01599793|50233944|FG000|Overall Study|Adverse Event|2|||
25121495|NCT01755598|50233959|FG000|Overall Study|Other|109|||
25121496|NCT01755598|50233960|FG001|Overall Study|Other|109|||
25121497|NCT01755598|50233959|FG000|Overall Study|Lost to Follow-up|32|||
25121498|NCT01755598|50233960|FG001|Overall Study|Lost to Follow-up|43|||
25121499|NCT01755598|50233959|FG000|Overall Study|Migrated/moved from study area|76|||
25121500|NCT01755598|50233960|FG001|Overall Study|Migrated/moved from study area|65|||
25121501|NCT01755598|50233959|FG000|Overall Study|Withdrawal by Subject|22|||
25121502|NCT01755598|50233960|FG001|Overall Study|Withdrawal by Subject|31|||
25121503|NCT01755598|50233959|FG000|Overall Study|Protocol Violation|7|||
25121504|NCT01755598|50233960|FG001|Overall Study|Protocol Violation|7|||
25121505|NCT01755598|50233959|FG000|Overall Study|Adverse Event|19|||
25121506|NCT01755598|50233960|FG001|Overall Study|Adverse Event|28|||
25121507|NCT01606306|50233972|FG000|Overall Study|Lack of Efficacy|2|||
25121508|NCT01606306|50233973|FG001|Overall Study|Lack of Efficacy|1|||
25121509|NCT01606306|50233974|FG002|Overall Study|Lack of Efficacy|4|||
25121510|NCT01606306|50233975|FG003|Overall Study|Lack of Efficacy|4|||
25121511|NCT01606306|50233976|FG004|Overall Study|Lack of Efficacy|1|||
25121512|NCT01606306|50233977|FG005|Overall Study|Lack of Efficacy|2|||
25121513|NCT01606306|50233972|FG000|Overall Study|Adverse Event|1|||
25121514|NCT01606306|50233973|FG001|Overall Study|Adverse Event|0|||
25121515|NCT01606306|50233974|FG002|Overall Study|Adverse Event|1|||
25121516|NCT01606306|50233975|FG003|Overall Study|Adverse Event|1|||
25121517|NCT01606306|50233976|FG004|Overall Study|Adverse Event|2|||
25121518|NCT01606306|50233977|FG005|Overall Study|Adverse Event|0|||
25121519|NCT01606306|50233972|FG000|Overall Study|Lost to Follow-up|7|||
25121520|NCT01606306|50233973|FG001|Overall Study|Lost to Follow-up|4|||
25121521|NCT01606306|50233974|FG002|Overall Study|Lost to Follow-up|5|||
25121522|NCT01606306|50233975|FG003|Overall Study|Lost to Follow-up|4|||
25121523|NCT01606306|50233976|FG004|Overall Study|Lost to Follow-up|3|||
25121524|NCT01606306|50233977|FG005|Overall Study|Lost to Follow-up|5|||
25121525|NCT01606306|50233972|FG000|Overall Study|Withdrawal by Subject|4|||
25121526|NCT01606306|50233973|FG001|Overall Study|Withdrawal by Subject|3|||
25121527|NCT01606306|50233974|FG002|Overall Study|Withdrawal by Subject|4|||
25121528|NCT01606306|50233975|FG003|Overall Study|Withdrawal by Subject|4|||
25121529|NCT01606306|50233976|FG004|Overall Study|Withdrawal by Subject|5|||
25121530|NCT01606306|50233977|FG005|Overall Study|Withdrawal by Subject|4|||
25121531|NCT01606306|50233972|FG000|Overall Study|Physician Decision|1|||
25121532|NCT01606306|50233973|FG001|Overall Study|Physician Decision|2|||
25121533|NCT01606306|50233974|FG002|Overall Study|Physician Decision|0|||
25121534|NCT01606306|50233975|FG003|Overall Study|Physician Decision|0|||
25121535|NCT01606306|50233976|FG004|Overall Study|Physician Decision|0|||
25261800|NCT01254747|50576447|FG000|Overall Study|Unacceptable subjective vision|0|||
25121536|NCT01606306|50233977|FG005|Overall Study|Physician Decision|0|||
25121537|NCT01754194|50233985|FG000|Overall Study|Lost to Follow-up|39|||
25121538|NCT01754194|50233986|FG001|Overall Study|Lost to Follow-up|14|||
25121539|NCT01754194|50233985|FG000|Overall Study|Withdrawal by Subject|4|||
25261801|NCT01254747|50576448|FG001|Overall Study|Unacceptable subjective vision|0|||
25121540|NCT01754194|50233986|FG001|Overall Study|Withdrawal by Subject|5|||
25121541|NCT01754194|50233985|FG000|Overall Study|Other|9|||
25121542|NCT01754194|50233986|FG001|Overall Study|Other|8|||
25121543|NCT01753570|50233997|FG000|Overall Study|Adverse Event|1|||
25121544|NCT01753570|50233998|FG001|Overall Study|Adverse Event|0|||
25121545|NCT01753570|50233999|FG002|Overall Study|Adverse Event|1|||
25121546|NCT01753570|50233997|FG000|Overall Study|Physician Decision|0|||
25121547|NCT01753570|50233998|FG001|Overall Study|Physician Decision|1|||
25121548|NCT01753570|50233999|FG002|Overall Study|Physician Decision|0|||
25121549|NCT01753570|50233997|FG000|Overall Study|Withdrawal by Subject|1|||
25261802|NCT01254747|50576449|FG002|Overall Study|Unacceptable subjective vision|0|||
25121550|NCT01753570|50233998|FG001|Overall Study|Withdrawal by Subject|4|||
25121551|NCT01753570|50233999|FG002|Overall Study|Withdrawal by Subject|0|||
25121552|NCT01753336|50234008|FG000|Overall Study|Patient decision|12|||
25121553|NCT01753336|50234008|FG000|Overall Study|Lost to Follow-up|3|||
25121554|NCT01753336|50234008|FG000|Overall Study|Physician Decision|2|||
25121555|NCT01753336|50234008|FG000|Overall Study|Sponsor's decision|2|||
25121556|NCT01753336|50234008|FG000|Overall Study|Withdrawal by Subject|1|||
25121557|NCT01777282|50234017|FG000|Overall Study|Persistent Hyperglycemia|0|||
25121558|NCT01777282|50234018|FG001|Overall Study|Persistent Hyperglycemia|0|||
25121559|NCT01777282|50234019|FG002|Overall Study|Persistent Hyperglycemia|1|||
25121560|NCT01777282|50234020|FG003|Overall Study|Persistent Hyperglycemia|0|||
25121561|NCT01777282|50234021|FG004|Overall Study|Persistent Hyperglycemia|0|||
25121562|NCT01777282|50234017|FG000|Overall Study|New Antidiabetic Medication|0|||
25121563|NCT01777282|50234018|FG001|Overall Study|New Antidiabetic Medication|0|||
25121564|NCT01777282|50234019|FG002|Overall Study|New Antidiabetic Medication|1|||
25121565|NCT01777282|50234020|FG003|Overall Study|New Antidiabetic Medication|0|||
25121566|NCT01777282|50234021|FG004|Overall Study|New Antidiabetic Medication|0|||
25121567|NCT01777282|50234017|FG000|Overall Study|Adverse Event|4|||
25121568|NCT01777282|50234018|FG001|Overall Study|Adverse Event|4|||
25121569|NCT01777282|50234019|FG002|Overall Study|Adverse Event|2|||
25121570|NCT01777282|50234020|FG003|Overall Study|Adverse Event|1|||
25121571|NCT01777282|50234021|FG004|Overall Study|Adverse Event|3|||
25121572|NCT01777282|50234017|FG000|Overall Study|Withdrawal by Subject|4|||
25121573|NCT01777282|50234018|FG001|Overall Study|Withdrawal by Subject|0|||
25121574|NCT01777282|50234019|FG002|Overall Study|Withdrawal by Subject|0|||
25121575|NCT01777282|50234020|FG003|Overall Study|Withdrawal by Subject|1|||
25121576|NCT01777282|50234021|FG004|Overall Study|Withdrawal by Subject|2|||
25121577|NCT01777282|50234017|FG000|Overall Study|Protocol Violation|2|||
25121578|NCT01777282|50234018|FG001|Overall Study|Protocol Violation|0|||
25121579|NCT01777282|50234019|FG002|Overall Study|Protocol Violation|1|||
25121580|NCT01777282|50234020|FG003|Overall Study|Protocol Violation|0|||
25121581|NCT01777282|50234021|FG004|Overall Study|Protocol Violation|2|||
25121582|NCT01777282|50234017|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
25121583|NCT01777282|50234018|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
25121584|NCT01777282|50234019|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
25121585|NCT01777282|50234020|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
25121586|NCT01777282|50234021|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
25121587|NCT01975389|50234035|FG000|Overall Study|Adverse Event|10|||
25121588|NCT01975389|50234036|FG001|Overall Study|Adverse Event|6|||
25121589|NCT01975389|50234035|FG000|Overall Study|Death|61|||
25121590|NCT01975389|50234036|FG001|Overall Study|Death|54|||
25121591|NCT01975389|50234035|FG000|Overall Study|Lost to Follow-up|81|||
25121592|NCT01975389|50234036|FG001|Overall Study|Lost to Follow-up|86|||
25121593|NCT01975389|50234035|FG000|Overall Study|Withdrawal by Subject|90|||
25121594|NCT01975389|50234036|FG001|Overall Study|Withdrawal by Subject|76|||
25121595|NCT01975389|50234035|FG000|Overall Study|Other|6|||
25121596|NCT01975389|50234036|FG001|Overall Study|Other|9|||
25121597|NCT01975389|50234035|FG000|Overall Study|Randomized, not treated|4|||
25121598|NCT01975389|50234036|FG001|Overall Study|Randomized, not treated|5|||
25121599|NCT01974141|50234044|FG000|Overall Study|Other Reasons|28|||
25121600|NCT01974141|50234045|FG001|Overall Study|Other Reasons|18|||
25121601|NCT01974141|50234044|FG000|Overall Study|Protocol Violation|2|||
25121602|NCT01974141|50234045|FG001|Overall Study|Protocol Violation|6|||
25121603|NCT01974141|50234044|FG000|Overall Study|Personal Reasons|21|||
25261803|NCT01254747|50576450|FG003|Overall Study|Unacceptable subjective vision|2|||
25261804|NCT01254747|50576447|FG000|Overall Study|Difficult removal handling|0|||
25261805|NCT01254747|50576448|FG001|Overall Study|Difficult removal handling|0|||
25121604|NCT01974141|50234045|FG001|Overall Study|Personal Reasons|20|||
25121605|NCT01974141|50234044|FG000|Overall Study|Lost to Follow-up|38|||
25121606|NCT01974141|50234045|FG001|Overall Study|Lost to Follow-up|29|||
25121607|NCT01974141|50234044|FG000|Overall Study|Pregnancy|3|||
25121608|NCT01974141|50234045|FG001|Overall Study|Pregnancy|3|||
25121609|NCT01974141|50234044|FG000|Overall Study|Lack of Efficacy|0|||
25261806|NCT01254747|50576449|FG002|Overall Study|Difficult removal handling|1|||
25121610|NCT01974141|50234045|FG001|Overall Study|Lack of Efficacy|1|||
25121611|NCT01974141|50234044|FG000|Overall Study|Adverse Event|4|||
25121612|NCT01974141|50234045|FG001|Overall Study|Adverse Event|5|||
25121613|NCT01945593|50234055|FG000|Overall Study|Adverse Event|0|||
25121614|NCT01945593|50234056|FG001|Overall Study|Adverse Event|0|||
25121615|NCT01945593|50234057|FG002|Overall Study|Adverse Event|0|||
25121616|NCT01945593|50234058|FG003|Overall Study|Adverse Event|5|||
25121617|NCT01945593|50234055|FG000|Overall Study|Physician Decision|0|||
25121618|NCT01945593|50234056|FG001|Overall Study|Physician Decision|0|||
25261807|NCT01254747|50576450|FG003|Overall Study|Difficult removal handling|0|||
25121619|NCT01945593|50234057|FG002|Overall Study|Physician Decision|1|||
25121620|NCT01945593|50234058|FG003|Overall Study|Physician Decision|1|||
25121621|NCT01945593|50234055|FG000|Overall Study|Withdrawal by Subject|0|||
25121622|NCT01945593|50234056|FG001|Overall Study|Withdrawal by Subject|2|||
25121623|NCT01945593|50234057|FG002|Overall Study|Withdrawal by Subject|0|||
25121624|NCT01945593|50234058|FG003|Overall Study|Withdrawal by Subject|4|||
25121625|NCT01945593|50234055|FG000|Overall Study|Protocol Violation|0|||
25121626|NCT01945593|50234056|FG001|Overall Study|Protocol Violation|2|||
25121627|NCT01945593|50234057|FG002|Overall Study|Protocol Violation|1|||
25121628|NCT01945593|50234058|FG003|Overall Study|Protocol Violation|3|||
25121629|NCT01945593|50234055|FG000|Overall Study|Death|0|||
25121630|NCT01945593|50234056|FG001|Overall Study|Death|0|||
25121631|NCT01945593|50234057|FG002|Overall Study|Death|1|||
25121632|NCT01945593|50234058|FG003|Overall Study|Death|0|||
25121633|NCT01945593|50234055|FG000|Overall Study|Other: Terminated|0|||
25121634|NCT01945593|50234056|FG001|Overall Study|Other: Terminated|0|||
25121635|NCT01945593|50234057|FG002|Overall Study|Other: Terminated|0|||
25121636|NCT01945593|50234058|FG003|Overall Study|Other: Terminated|1|||
25121637|NCT01945593|50234055|FG000|Overall Study|Other: Surgical Procedure|0|||
25121638|NCT01945593|50234056|FG001|Overall Study|Other: Surgical Procedure|2|||
25121639|NCT01945593|50234057|FG002|Overall Study|Other: Surgical Procedure|0|||
25121640|NCT01945593|50234058|FG003|Overall Study|Other: Surgical Procedure|6|||
25121641|NCT01945593|50234055|FG000|Overall Study|Other: Screen Failure|0|||
25121642|NCT01945593|50234056|FG001|Overall Study|Other: Screen Failure|2|||
25121643|NCT01945593|50234057|FG002|Overall Study|Other: Screen Failure|0|||
25121644|NCT01945593|50234058|FG003|Overall Study|Other: Screen Failure|0|||
25121645|NCT01945281|50234075|FG000|Overall Study|Adverse Event|1|||
25121646|NCT01945281|50234076|FG001|Overall Study|Adverse Event|0|||
25121647|NCT01945281|50234075|FG000|Overall Study|Death|3|||
25121648|NCT01945281|50234076|FG001|Overall Study|Death|3|||
25121649|NCT01945281|50234075|FG000|Overall Study|Physician Decision|1|||
25121650|NCT01945281|50234076|FG001|Overall Study|Physician Decision|1|||
25121651|NCT01945281|50234075|FG000|Overall Study|Technical Problems|1|||
25121652|NCT01945281|50234076|FG001|Overall Study|Technical Problems|0|||
25121653|NCT01961349|50234085|FG000|Overall Study|Withdrawal by Subject|1|||
25121654|NCT01961349|50234086|FG001|Overall Study|Withdrawal by Subject|4|||
25121655|NCT01961349|50234087|FG002|Overall Study|Withdrawal by Subject|0|||
25121656|NCT01961349|50234085|FG000|Overall Study|Adverse Event|0|||
25121657|NCT01961349|50234086|FG001|Overall Study|Adverse Event|0|||
25121658|NCT01961349|50234087|FG002|Overall Study|Adverse Event|1|||
25121659|NCT01961349|50234085|FG000|Overall Study|registration error, personal reason etc|2|||
25121660|NCT01961349|50234086|FG001|Overall Study|registration error, personal reason etc|2|||
25121661|NCT01961349|50234087|FG002|Overall Study|registration error, personal reason etc|1|||
25121662|NCT01973595|50234099|FG000|Washout|Withdrawal by Subject|1|||
25121663|NCT01973595|50234100|FG001|Washout|Withdrawal by Subject|0|||
25121664|NCT01973595|50234101|FG002|Washout|Withdrawal by Subject|1|||
25121665|NCT01973595|50234102|FG003|Washout|Withdrawal by Subject|0|||
25121666|NCT01944969|50234113|FG000|Overall Study|Adverse Event|1|||
25121667|NCT01944969|50234113|FG000|Overall Study|Lack of Efficacy|1|||
25121668|NCT01944969|50234113|FG000|Overall Study|Non-compliance with IMP|1|||
25121669|NCT01944969|50234113|FG000|Overall Study|Administrative or other reasons|23|||
25121670|NCT01961115|50234122|FG000|Overall Study|Disease Progression|1|||
25121671|NCT01961115|50234123|FG001|Overall Study|Disease Progression|0|||
25121672|NCT01961115|50234124|FG002|Overall Study|Disease Progression|3|||
25121673|NCT01961115|50234122|FG000|Overall Study|Adverse Event|1|||
25121674|NCT01961115|50234123|FG001|Overall Study|Adverse Event|0|||
25121675|NCT01961115|50234124|FG002|Overall Study|Adverse Event|1|||
25121676|NCT01973439|50234132|FG000|Overall Study|Lost samples from one PK Day|2|||
25121677|NCT01973439|50234132|FG000|Overall Study|Vomiting after commencing once daily|1|||
25121678|NCT01973439|50234132|FG000|Overall Study|PK curve incomplete|2|||
25121679|NCT01973283|50234136|FG000|Overall Study|Lost to Follow-up|4|||
25121680|NCT01943799|50234146|FG000|Overall Study|Lost to Follow-up|0|||
25121681|NCT01943799|50234147|FG001|Overall Study|Lost to Follow-up|1|||
25121682|NCT01943799|50234148|FG002|Overall Study|Lost to Follow-up|1|||
25121683|NCT01943799|50234149|FG003|Overall Study|Lost to Follow-up|0|||
25121684|NCT01943799|50234146|FG000|Overall Study|Protocol Violation|1|||
25121685|NCT01943799|50234147|FG001|Overall Study|Protocol Violation|0|||
25121686|NCT01943799|50234148|FG002|Overall Study|Protocol Violation|0|||
25121687|NCT01943799|50234149|FG003|Overall Study|Protocol Violation|0|||
25121688|NCT01943799|50234146|FG000|Overall Study|Withdrawal by Subject|4|||
25121689|NCT01943799|50234147|FG001|Overall Study|Withdrawal by Subject|2|||
25121690|NCT01943799|50234148|FG002|Overall Study|Withdrawal by Subject|1|||
25121691|NCT01943799|50234149|FG003|Overall Study|Withdrawal by Subject|0|||
25121692|NCT01972659|50234161|FG000|Overall Study|Protocol Violation|2|||
25121693|NCT01972659|50234162|FG001|Overall Study|Protocol Violation|2|||
25121694|NCT01972659|50234161|FG000|Overall Study|problems realted to acceleromyograph|2|||
25121695|NCT01972659|50234162|FG001|Overall Study|problems realted to acceleromyograph|1|||
25121696|NCT01971723|50234170|FG000|Overall Study|Withdrawal by Subject|1|||
25121697|NCT01971723|50234171|FG001|Overall Study|Withdrawal by Subject|1|||
25121698|NCT01971723|50234170|FG000|Overall Study|Protocol Violation|1|||
25121699|NCT01971723|50234171|FG001|Overall Study|Protocol Violation|2|||
25121700|NCT01942785|50234177|FG000|Overall Study|Adverse Event|2|||
25121701|NCT01942785|50234177|FG000|Overall Study|Withdrawal by Subject|1|||
25121702|NCT01942785|50234177|FG000|Overall Study|Protocol Violation|1|||
25121703|NCT01774786|50234185|FG000|Overall Study|Death|300|||
25121704|NCT01774786|50234186|FG001|Overall Study|Death|319|||
25121705|NCT01774786|50234185|FG000|Overall Study|Lost to Follow-up|6|||
25121706|NCT01774786|50234186|FG001|Overall Study|Lost to Follow-up|7|||
25121707|NCT01774786|50234185|FG000|Overall Study|Withdrawal by Subject|18|||
25121708|NCT01774786|50234186|FG001|Overall Study|Withdrawal by Subject|14|||
25121709|NCT01774786|50234185|FG000|Overall Study|Physician Decision|2|||
25121710|NCT01774786|50234186|FG001|Overall Study|Physician Decision|0|||
25121711|NCT01774786|50234185|FG000|Overall Study|Non-compliance|0|||
25121712|NCT01774786|50234186|FG001|Overall Study|Non-compliance|1|||
25121713|NCT01774786|50234185|FG000|Overall Study|Reason Not Specified|2|||
25121714|NCT01774786|50234186|FG001|Overall Study|Reason Not Specified|5|||
25121715|NCT01960725|50234194|FG000|Overall Study|Lost to Follow-up|4|||
25121716|NCT01960725|50234195|FG001|Overall Study|Lost to Follow-up|3|||
25121717|NCT01960725|50234194|FG000|Overall Study|Withdrawal by Subject|1|||
25121718|NCT01960725|50234195|FG001|Overall Study|Withdrawal by Subject|0|||
25121719|NCT01960725|50234194|FG000|Overall Study|unable to obtain blood sample|1|||
25121720|NCT01960725|50234195|FG001|Overall Study|unable to obtain blood sample|2|||
25121721|NCT01942161|50234204|FG000|Overall Study|Adverse Event|1|||
25121722|NCT01942161|50234205|FG001|Overall Study|Adverse Event|2|||
25121723|NCT01942161|50234206|FG002|Overall Study|Adverse Event|5|||
25121724|NCT01942161|50234204|FG000|Overall Study|Physician Decision|3|||
25121725|NCT01942161|50234205|FG001|Overall Study|Physician Decision|1|||
25121726|NCT01942161|50234206|FG002|Overall Study|Physician Decision|0|||
25121727|NCT01942161|50234204|FG000|Overall Study|Protocol Violation|1|||
25121728|NCT01942161|50234205|FG001|Overall Study|Protocol Violation|0|||
25121729|NCT01942161|50234206|FG002|Overall Study|Protocol Violation|0|||
25121730|NCT01942161|50234204|FG000|Overall Study|Withdrawal by Subject|3|||
25121731|NCT01942161|50234205|FG001|Overall Study|Withdrawal by Subject|3|||
25121732|NCT01942161|50234206|FG002|Overall Study|Withdrawal by Subject|1|||
25121733|NCT01971645|50234217|FG000|Overall Study|Adverse Event|1|||
25121734|NCT01971645|50234218|FG001|Overall Study|Adverse Event|0|||
25121735|NCT01971645|50234219|FG002|Overall Study|Adverse Event|0|||
25121736|NCT01971645|50234217|FG000|Overall Study|Lost to Follow-up|1|||
25121737|NCT01971645|50234218|FG001|Overall Study|Lost to Follow-up|0|||
25121738|NCT01971645|50234219|FG002|Overall Study|Lost to Follow-up|1|||
25121739|NCT01971645|50234217|FG000|Overall Study|Protocol Violation|0|||
25121740|NCT01971645|50234218|FG001|Overall Study|Protocol Violation|0|||
25121741|NCT01971645|50234219|FG002|Overall Study|Protocol Violation|1|||
25121742|NCT01941537|50234229|FG000|Overall Study|Lack of Efficacy|1|||
25121743|NCT01941537|50234230|FG001|Overall Study|Lack of Efficacy|2|||
25121744|NCT01941537|50234229|FG000|Overall Study|Lost to Follow-up|1|||
25121745|NCT01941537|50234230|FG001|Overall Study|Lost to Follow-up|0|||
25121746|NCT01941537|50234229|FG000|Overall Study|Pregnancy|1|||
25121747|NCT01941537|50234230|FG001|Overall Study|Pregnancy|0|||
25121748|NCT01941537|50234229|FG000|Overall Study|Adverse Event|1|||
25121749|NCT01941537|50234230|FG001|Overall Study|Adverse Event|0|||
25121750|NCT01941537|50234229|FG000|Overall Study|Withdrawal by Subject|0|||
25121751|NCT01941537|50234230|FG001|Overall Study|Withdrawal by Subject|1|||
25121752|NCT01971567|50234239|FG000|Overall Study|Withdrawal by Subject|3|||
25121753|NCT01971567|50234240|FG001|Overall Study|Withdrawal by Subject|2|||
25121754|NCT01971567|50234239|FG000|Overall Study|Lost to Follow-up|1|||
25121755|NCT01971567|50234240|FG001|Overall Study|Lost to Follow-up|0|||
25121756|NCT01960413|50234248|FG000|Overall Study|Withdrawal by Subject|1|||
25121757|NCT01960413|50234249|FG001|Overall Study|Withdrawal by Subject|1|||
25121758|NCT01960413|50234248|FG000|Overall Study|Physician Decision|1|||
25121759|NCT01960413|50234249|FG001|Overall Study|Physician Decision|0|||
25121760|NCT01960413|50234248|FG000|Overall Study|Lost to Follow-up|2|||
25121761|NCT01960413|50234249|FG001|Overall Study|Lost to Follow-up|0|||
25121762|NCT01970475|50234257|FG000|Overall Study|Withdrawal by Subject|11|||
25121763|NCT01970475|50234258|FG001|Overall Study|Withdrawal by Subject|6|||
25121764|NCT01970475|50234257|FG000|Overall Study|Adverse Event|7|||
25121765|NCT01970475|50234258|FG001|Overall Study|Adverse Event|3|||
25121766|NCT01970475|50234257|FG000|Overall Study|Lost to Follow-up|2|||
25121767|NCT01970475|50234258|FG001|Overall Study|Lost to Follow-up|2|||
25121768|NCT01970475|50234257|FG000|Overall Study|Protocol Violation|1|||
25121769|NCT01970475|50234258|FG001|Overall Study|Protocol Violation|0|||
25121770|NCT01939977|50234266|FG000|Overall Study|Adverse Event|4|||
25121771|NCT01939977|50234267|FG001|Overall Study|Adverse Event|3|||
25121772|NCT01939977|50234266|FG000|Overall Study|Lack of Efficacy|3|||
25121773|NCT01939977|50234267|FG001|Overall Study|Lack of Efficacy|0|||
25121774|NCT01939977|50234266|FG000|Overall Study|Physician Decision|1|||
25121775|NCT01939977|50234267|FG001|Overall Study|Physician Decision|1|||
25121776|NCT01939977|50234266|FG000|Overall Study|Withdrawal by Subject|0|||
25121777|NCT01939977|50234267|FG001|Overall Study|Withdrawal by Subject|2|||
25121778|NCT01939977|50234266|FG000|Overall Study|Did not meet inclusion criteria|1|||
25121779|NCT01939977|50234267|FG001|Overall Study|Did not meet inclusion criteria|0|||
25121780|NCT01939977|50234266|FG000|Overall Study|Did not receive study medication|0|||
25121781|NCT01939977|50234267|FG001|Overall Study|Did not receive study medication|1|||
25177472|NCT02754141|50321513|FG006|Overall Study|Completed treatment as per protocol|0|||
25261808|NCT01254747|50576447|FG000|Overall Study|Symptoms and problems|0|||
25261809|NCT01254747|50576448|FG001|Overall Study|Symptoms and problems|2|||
25261810|NCT01254747|50576449|FG002|Overall Study|Symptoms and problems|1|||
25261811|NCT01254747|50576450|FG003|Overall Study|Symptoms and problems|0|||
25261812|NCT01254747|50576447|FG000|Overall Study|Lost to Follow-up|0|||
25261813|NCT01254747|50576448|FG001|Overall Study|Lost to Follow-up|0|||
25261814|NCT01254747|50576449|FG002|Overall Study|Lost to Follow-up|1|||
25261815|NCT01254747|50576450|FG003|Overall Study|Lost to Follow-up|0|||
25261816|NCT01254747|50576447|FG000|Overall Study|Biomicroscopy|0|||
25261817|NCT01254747|50576448|FG001|Overall Study|Biomicroscopy|0|||
25261818|NCT01254747|50576449|FG002|Overall Study|Biomicroscopy|1|||
25261819|NCT01254747|50576450|FG003|Overall Study|Biomicroscopy|0|||
25261820|NCT01254747|50576447|FG000|Overall Study|Discomfort|0|||
25261821|NCT01254747|50576448|FG001|Overall Study|Discomfort|4|||
25261822|NCT01254747|50576449|FG002|Overall Study|Discomfort|0|||
25261823|NCT01254747|50576450|FG003|Overall Study|Discomfort|0|||
25261824|NCT01296672|50576462|FG000|Overall Study|Lost to Follow-up|73|||
25261825|NCT01296672|50576463|FG001|Overall Study|Lost to Follow-up|18|||
25261826|NCT01254669|50576473|FG000|Overall Study|Withdrawal by Subject|0|||
25261827|NCT01254669|50576474|FG001|Overall Study|Withdrawal by Subject|1|||
25261828|NCT01254669|50576473|FG000|Overall Study|time constraint|2|||
25261829|NCT01254669|50576474|FG001|Overall Study|time constraint|2|||
25261830|NCT01254669|50576473|FG000|Overall Study|called to clinic during intervention|1|||
25261831|NCT01254669|50576474|FG001|Overall Study|called to clinic during intervention|1|||
25261832|NCT01295814|50576484|FG000|Overall Study|Lack of Efficacy|0|||
25261833|NCT01295814|50576485|FG001|Overall Study|Lack of Efficacy|2|||
25261834|NCT01295814|50576484|FG000|Overall Study|Withdrawal by Subject|2|||
25261835|NCT01295814|50576485|FG001|Overall Study|Withdrawal by Subject|0|||
25261836|NCT01254045|50576491|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
25121782|NCT01939899|50234278|FG000|Lead-in Dose Finding Phase|Death|0|||
25121783|NCT01939899|50234279|FG001|Lead-in Dose Finding Phase|Death|3|||
25121784|NCT01939899|50234280|FG002|Lead-in Dose Finding Phase|Death|1|||
25121785|NCT01939899|50234281|FG003|Lead-in Dose Finding Phase|Death|0|||
25121786|NCT01939899|50234282|FG004|Lead-in Dose Finding Phase|Death|0|||
25121787|NCT01939899|50234278|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
25121788|NCT01939899|50234279|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
25121789|NCT01939899|50234280|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
25121790|NCT01939899|50234281|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
25121791|NCT01939899|50234282|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
25177473|NCT02754141|50321514|FG007|Overall Study|Completed treatment as per protocol|0|||
25177474|NCT02754141|50321515|FG008|Overall Study|Completed treatment as per protocol|0|||
25177475|NCT02754141|50321516|FG009|Overall Study|Completed treatment as per protocol|0|||
25177476|NCT02754141|50321517|FG010|Overall Study|Completed treatment as per protocol|0|||
25177477|NCT02754141|50321518|FG011|Overall Study|Completed treatment as per protocol|0|||
25177478|NCT02754141|50321519|FG012|Overall Study|Completed treatment as per protocol|1|||
25177479|NCT02754141|50321520|FG013|Overall Study|Completed treatment as per protocol|0|||
25177480|NCT02754141|50321521|FG014|Overall Study|Completed treatment as per protocol|0|||
25177481|NCT02754141|50321522|FG015|Overall Study|Completed treatment as per protocol|0|||
25177482|NCT02754141|50321523|FG016|Overall Study|Completed treatment as per protocol|0|||
25177483|NCT02754141|50321524|FG017|Overall Study|Completed treatment as per protocol|0|||
25177484|NCT02754141|50321507|FG000|Overall Study|Not completing monotherapy|0|||
25177485|NCT02754141|50321508|FG001|Overall Study|Not completing monotherapy|0|||
25177486|NCT02754141|50321509|FG002|Overall Study|Not completing monotherapy|0|||
25177487|NCT02754141|50321510|FG003|Overall Study|Not completing monotherapy|0|||
25177488|NCT02754141|50321511|FG004|Overall Study|Not completing monotherapy|0|||
25177489|NCT02754141|50321512|FG005|Overall Study|Not completing monotherapy|0|||
25177490|NCT02754141|50321513|FG006|Overall Study|Not completing monotherapy|0|||
25177491|NCT02754141|50321514|FG007|Overall Study|Not completing monotherapy|0|||
25177492|NCT02754141|50321515|FG008|Overall Study|Not completing monotherapy|0|||
25177493|NCT02754141|50321516|FG009|Overall Study|Not completing monotherapy|0|||
25177494|NCT02754141|50321517|FG010|Overall Study|Not completing monotherapy|0|||
25177495|NCT02754141|50321518|FG011|Overall Study|Not completing monotherapy|0|||
25177496|NCT02754141|50321519|FG012|Overall Study|Not completing monotherapy|0|||
25177497|NCT02754141|50321520|FG013|Overall Study|Not completing monotherapy|1|||
25177498|NCT02754141|50321521|FG014|Overall Study|Not completing monotherapy|0|||
25177499|NCT02754141|50321522|FG015|Overall Study|Not completing monotherapy|0|||
25261837|NCT01254045|50576492|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
25261838|NCT01254045|50576493|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
25261839|NCT01254045|50576494|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
25261840|NCT01254045|50576495|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
25261841|NCT01254045|50576496|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
25261842|NCT01075282|50576509|FG000|Overall Study|Withdrawal by Subject|11|||
25121792|NCT01939899|50234278|FG000|Lead-in Dose Finding Phase|Other|0|||
25121793|NCT01939899|50234279|FG001|Lead-in Dose Finding Phase|Other|0|||
25121794|NCT01939899|50234280|FG002|Lead-in Dose Finding Phase|Other|1|||
25121795|NCT01939899|50234281|FG003|Lead-in Dose Finding Phase|Other|0|||
25121796|NCT01939899|50234282|FG004|Lead-in Dose Finding Phase|Other|0|||
25121797|NCT01939899|50234278|FG000|Phase 2|Withdrawal by Subject|0|||
25121798|NCT01939899|50234279|FG001|Phase 2|Withdrawal by Subject|0|||
25121799|NCT01939899|50234280|FG002|Phase 2|Withdrawal by Subject|0|||
25121800|NCT01939899|50234281|FG003|Phase 2|Withdrawal by Subject|2|||
25121801|NCT01939899|50234282|FG004|Phase 2|Withdrawal by Subject|0|||
25121802|NCT01939899|50234278|FG000|Phase 2|Disease Progression|0|||
25121803|NCT01939899|50234279|FG001|Phase 2|Disease Progression|0|||
25121804|NCT01939899|50234280|FG002|Phase 2|Disease Progression|0|||
25261843|NCT01075282|50576510|FG001|Overall Study|Withdrawal by Subject|7|||
25261844|NCT01075282|50576511|FG002|Overall Study|Withdrawal by Subject|11|||
25261845|NCT01075282|50576509|FG000|Overall Study|Adverse Event|9|||
25261846|NCT01075282|50576510|FG001|Overall Study|Adverse Event|8|||
25261847|NCT01075282|50576511|FG002|Overall Study|Adverse Event|5|||
25261848|NCT01075282|50576509|FG000|Overall Study|Entry Criteria Not Met|3|||
25261849|NCT01075282|50576510|FG001|Overall Study|Entry Criteria Not Met|2|||
25261850|NCT01075282|50576511|FG002|Overall Study|Entry Criteria Not Met|0|||
25261851|NCT01075282|50576509|FG000|Overall Study|Lost to Follow-up|3|||
25261852|NCT01075282|50576510|FG001|Overall Study|Lost to Follow-up|3|||
25261853|NCT01075282|50576511|FG002|Overall Study|Lost to Follow-up|3|||
25121805|NCT01939899|50234281|FG003|Phase 2|Disease Progression|9|||
25121806|NCT01939899|50234282|FG004|Phase 2|Disease Progression|1|||
25121807|NCT01970397|50234302|FG000|Overall Study|Adverse Event|0|||
25121808|NCT01970397|50234303|FG001|Overall Study|Adverse Event|1|||
25121809|NCT01970397|50234302|FG000|Overall Study|Lost to Follow-up|0|||
25121810|NCT01970397|50234303|FG001|Overall Study|Lost to Follow-up|1|||
25121811|NCT01970397|50234302|FG000|Overall Study|Personal Reasons|1|||
25121812|NCT01970397|50234303|FG001|Overall Study|Personal Reasons|2|||
25121813|NCT01970397|50234302|FG000|Overall Study|Protocol Violation|1|||
25121814|NCT01970397|50234303|FG001|Overall Study|Protocol Violation|1|||
25121815|NCT01970241|50234311|FG000|Overall Study|Withdrawal by Subject|2|||
25121816|NCT01970241|50234312|FG001|Overall Study|Withdrawal by Subject|0|||
25121817|NCT01970241|50234311|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
25121818|NCT01970241|50234312|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
25121819|NCT01939353|50234320|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
25121820|NCT01939353|50234320|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
25121821|NCT01939353|50234320|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
25121822|NCT01939353|50234320|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
25121823|NCT01939353|50234320|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
25121824|NCT01970007|50234324|FG000|Overall Study|Death|5|||
25121825|NCT01970007|50234324|FG000|Overall Study|Withdrawal by Subject|23|||
25121826|NCT01970007|50234324|FG000|Overall Study|Lost to Follow-up|24|||
25121827|NCT01970007|50234324|FG000|Overall Study|"Other endpoint"|3|||
25121828|NCT01728376|50234334|FG000|Overall Study|Adverse Event|1|||
25121829|NCT01728376|50234335|FG001|Overall Study|Adverse Event|1|||
25121830|NCT01728376|50234336|FG002|Overall Study|Adverse Event|1|||
25121831|NCT01728376|50234337|FG003|Overall Study|Adverse Event|1|||
25121832|NCT01728376|50234338|FG004|Overall Study|Adverse Event|1|||
25121833|NCT01728376|50234339|FG005|Overall Study|Adverse Event|0|||
25121834|NCT01728376|50234334|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
25121835|NCT01728376|50234335|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
25121836|NCT01728376|50234336|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
25121837|NCT01728376|50234337|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
25121838|NCT01728376|50234338|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
25121839|NCT01728376|50234339|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
25121840|NCT01728376|50234334|FG000|Overall Study|No relevant bacteria|2|||
25121841|NCT01728376|50234335|FG001|Overall Study|No relevant bacteria|0|||
25121842|NCT01728376|50234336|FG002|Overall Study|No relevant bacteria|0|||
25121843|NCT01728376|50234337|FG003|Overall Study|No relevant bacteria|0|||
25261854|NCT01075282|50576509|FG000|Overall Study|Physician Decision|3|||
25261855|NCT01075282|50576510|FG001|Overall Study|Physician Decision|3|||
25121844|NCT01728376|50234338|FG004|Overall Study|No relevant bacteria|1|||
25121845|NCT01728376|50234339|FG005|Overall Study|No relevant bacteria|1|||
25121846|NCT01728376|50234334|FG000|Overall Study|Did not receive treatment|0|||
25121847|NCT01728376|50234335|FG001|Overall Study|Did not receive treatment|1|||
25121848|NCT01728376|50234336|FG002|Overall Study|Did not receive treatment|0|||
25121849|NCT01728376|50234337|FG003|Overall Study|Did not receive treatment|0|||
25121850|NCT01728376|50234338|FG004|Overall Study|Did not receive treatment|0|||
25261856|NCT01075282|50576511|FG002|Overall Study|Physician Decision|3|||
25261857|NCT01075282|50576509|FG000|Overall Study|Lack of Efficacy|1|||
25261858|NCT01075282|50576510|FG001|Overall Study|Lack of Efficacy|1|||
25121851|NCT01728376|50234339|FG005|Overall Study|Did not receive treatment|0|||
25121852|NCT01728376|50234334|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
25121853|NCT01728376|50234335|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
25121854|NCT01728376|50234336|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
25121855|NCT01728376|50234337|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
25121856|NCT01728376|50234338|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
25121857|NCT01728376|50234339|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
25121858|NCT01708174|50234356|FG000|Treatment Period|Withdrawal by Subject|1|||
25121859|NCT01708174|50234357|FG001|Treatment Period|Withdrawal by Subject|0|||
25121860|NCT01708174|50234358|FG002|Treatment Period|Withdrawal by Subject|0|||
25121861|NCT01708174|50234356|FG000|Treatment Period|Progressive disease|0|||
25121862|NCT01708174|50234357|FG001|Treatment Period|Progressive disease|1|||
25121863|NCT01708174|50234358|FG002|Treatment Period|Progressive disease|0|||
25121864|NCT01708174|50234356|FG000|Treatment Period|Death|0|||
25121865|NCT01708174|50234357|FG001|Treatment Period|Death|0|||
25121866|NCT01708174|50234358|FG002|Treatment Period|Death|1|||
25121867|NCT01708174|50234356|FG000|Treatment Period|Adverse Event|0|||
25121868|NCT01708174|50234357|FG001|Treatment Period|Adverse Event|1|||
25121869|NCT01708174|50234358|FG002|Treatment Period|Adverse Event|0|||
25121870|NCT02488759|50234373|FG000|Overall Study|Disease progression|74|||
25121871|NCT02488759|50234374|FG001|Overall Study|Disease progression|110|||
25121872|NCT02488759|50234375|FG002|Overall Study|Disease progression|62|||
25121873|NCT02488759|50234376|FG003|Overall Study|Disease progression|7|||
25121874|NCT02488759|50234377|FG004|Overall Study|Disease progression|4|||
25121875|NCT02488759|50234378|FG005|Overall Study|Disease progression|2|||
25121876|NCT02488759|50234373|FG000|Overall Study|Study drug toxicity|11|||
25121877|NCT02488759|50234374|FG001|Overall Study|Study drug toxicity|33|||
25121878|NCT02488759|50234375|FG002|Overall Study|Study drug toxicity|31|||
25121879|NCT02488759|50234376|FG003|Overall Study|Study drug toxicity|0|||
25121880|NCT02488759|50234377|FG004|Overall Study|Study drug toxicity|0|||
25121881|NCT02488759|50234378|FG005|Overall Study|Study drug toxicity|2|||
25121882|NCT02488759|50234373|FG000|Overall Study|Adverse event unrelated to study drug|9|||
25121883|NCT02488759|50234374|FG001|Overall Study|Adverse event unrelated to study drug|11|||
25121884|NCT02488759|50234375|FG002|Overall Study|Adverse event unrelated to study drug|7|||
25121885|NCT02488759|50234376|FG003|Overall Study|Adverse event unrelated to study drug|0|||
25121886|NCT02488759|50234377|FG004|Overall Study|Adverse event unrelated to study drug|1|||
25121887|NCT02488759|50234378|FG005|Overall Study|Adverse event unrelated to study drug|0|||
25121888|NCT02488759|50234373|FG000|Overall Study|Participant request to discontinue study treatment|7|||
25121889|NCT02488759|50234374|FG001|Overall Study|Participant request to discontinue study treatment|8|||
25121890|NCT02488759|50234375|FG002|Overall Study|Participant request to discontinue study treatment|4|||
25121891|NCT02488759|50234376|FG003|Overall Study|Participant request to discontinue study treatment|0|||
25121892|NCT02488759|50234377|FG004|Overall Study|Participant request to discontinue study treatment|0|||
25121893|NCT02488759|50234378|FG005|Overall Study|Participant request to discontinue study treatment|0|||
25121894|NCT02488759|50234373|FG000|Overall Study|Withdrawal by Subject|2|||
25121895|NCT02488759|50234374|FG001|Overall Study|Withdrawal by Subject|0|||
25121896|NCT02488759|50234375|FG002|Overall Study|Withdrawal by Subject|3|||
25121897|NCT02488759|50234376|FG003|Overall Study|Withdrawal by Subject|0|||
25121898|NCT02488759|50234377|FG004|Overall Study|Withdrawal by Subject|0|||
25121899|NCT02488759|50234378|FG005|Overall Study|Withdrawal by Subject|2|||
25121900|NCT02488759|50234373|FG000|Overall Study|Lost to Follow-up|0|||
25121901|NCT02488759|50234374|FG001|Overall Study|Lost to Follow-up|1|||
25121902|NCT02488759|50234375|FG002|Overall Study|Lost to Follow-up|2|||
25121903|NCT02488759|50234376|FG003|Overall Study|Lost to Follow-up|0|||
25121904|NCT02488759|50234377|FG004|Overall Study|Lost to Follow-up|0|||
25121905|NCT02488759|50234378|FG005|Overall Study|Lost to Follow-up|0|||
25121906|NCT02488759|50234373|FG000|Overall Study|Maximum clinical benefit|3|||
25121907|NCT02488759|50234374|FG001|Overall Study|Maximum clinical benefit|0|||
25121908|NCT02488759|50234375|FG002|Overall Study|Maximum clinical benefit|1|||
25121909|NCT02488759|50234376|FG003|Overall Study|Maximum clinical benefit|0|||
25121910|NCT02488759|50234377|FG004|Overall Study|Maximum clinical benefit|0|||
25121911|NCT02488759|50234378|FG005|Overall Study|Maximum clinical benefit|0|||
25121912|NCT02488759|50234373|FG000|Overall Study|Completed treatment|0|||
25121913|NCT02488759|50234374|FG001|Overall Study|Completed treatment|0|||
25121914|NCT02488759|50234375|FG002|Overall Study|Completed treatment|0|||
25121915|NCT02488759|50234376|FG003|Overall Study|Completed treatment|0|||
25121916|NCT02488759|50234377|FG004|Overall Study|Completed treatment|0|||
25121917|NCT02488759|50234378|FG005|Overall Study|Completed treatment|116|||
25121918|NCT02488759|50234373|FG000|Overall Study|Other reasons|5|||
25121919|NCT02488759|50234374|FG001|Overall Study|Other reasons|32|||
25121920|NCT02488759|50234375|FG002|Overall Study|Other reasons|21|||
25121921|NCT02488759|50234376|FG003|Overall Study|Other reasons|1|||
25121922|NCT02488759|50234377|FG004|Overall Study|Other reasons|1|||
25121923|NCT02488759|50234378|FG005|Overall Study|Other reasons|1|||
25121924|NCT01605916|50234397|FG000|Overall Study|Adverse Event|1|||
25121925|NCT01605916|50234398|FG001|Overall Study|Adverse Event|0|||
25121926|NCT01605916|50234399|FG002|Overall Study|Adverse Event|0|||
25121927|NCT01605916|50234400|FG003|Overall Study|Adverse Event|1|||
25121928|NCT01605916|50234401|FG004|Overall Study|Adverse Event|0|||
25121929|NCT01605916|50234397|FG000|Overall Study|Lack of Efficacy|2|||
25121930|NCT01605916|50234398|FG001|Overall Study|Lack of Efficacy|3|||
25121931|NCT01605916|50234399|FG002|Overall Study|Lack of Efficacy|3|||
25121932|NCT01605916|50234400|FG003|Overall Study|Lack of Efficacy|5|||
25121933|NCT01605916|50234401|FG004|Overall Study|Lack of Efficacy|4|||
25121934|NCT01605916|50234397|FG000|Overall Study|Withdrawal by Subject|1|||
25121935|NCT01605916|50234398|FG001|Overall Study|Withdrawal by Subject|1|||
25121936|NCT01605916|50234399|FG002|Overall Study|Withdrawal by Subject|0|||
25121937|NCT01605916|50234400|FG003|Overall Study|Withdrawal by Subject|0|||
25121938|NCT01605916|50234401|FG004|Overall Study|Withdrawal by Subject|2|||
25121939|NCT01635283|50234414|FG000|Overall Study|Tumor Progression|3|||
25121940|NCT01635283|50234414|FG000|Overall Study|Lost to Follow-up|1|||
25121941|NCT01707004|50234421|FG000|Overall Study|Physician Decision|3|||
25121942|NCT01939197|50234433|FG000|Overall Study|Withdrawal by Subject|1|||
25121943|NCT01939197|50234434|FG001|Overall Study|Withdrawal by Subject|0|||
25121944|NCT01939197|50234435|FG002|Overall Study|Withdrawal by Subject|0|||
25121945|NCT01939197|50234436|FG003|Overall Study|Withdrawal by Subject|0|||
25121946|NCT01939197|50234437|FG004|Overall Study|Withdrawal by Subject|1|||
25121947|NCT01939197|50234438|FG005|Overall Study|Withdrawal by Subject|0|||
25121948|NCT01939197|50234439|FG006|Overall Study|Withdrawal by Subject|0|||
25121949|NCT01939197|50234433|FG000|Overall Study|Lost to Follow-up|0|||
25121950|NCT01939197|50234434|FG001|Overall Study|Lost to Follow-up|1|||
25121951|NCT01939197|50234435|FG002|Overall Study|Lost to Follow-up|0|||
25121952|NCT01939197|50234436|FG003|Overall Study|Lost to Follow-up|1|||
25121953|NCT01939197|50234437|FG004|Overall Study|Lost to Follow-up|3|||
25121954|NCT01939197|50234438|FG005|Overall Study|Lost to Follow-up|1|||
25121955|NCT01939197|50234439|FG006|Overall Study|Lost to Follow-up|2|||
25121956|NCT01969851|50234472|FG000|Overall Study|Adverse Event|0|||
25121957|NCT01969851|50234473|FG001|Overall Study|Adverse Event|0|||
25121958|NCT01969851|50234474|FG002|Overall Study|Adverse Event|3|||
25121959|NCT01969851|50234472|FG000|Overall Study|Lack of Efficacy|0|||
25121960|NCT01969851|50234473|FG001|Overall Study|Lack of Efficacy|3|||
25121961|NCT01969851|50234474|FG002|Overall Study|Lack of Efficacy|1|||
25121962|NCT01969851|50234472|FG000|Overall Study|Withdrawal by Subject|1|||
25121963|NCT01969851|50234473|FG001|Overall Study|Withdrawal by Subject|0|||
25121964|NCT01969851|50234474|FG002|Overall Study|Withdrawal by Subject|1|||
25121965|NCT01969851|50234472|FG000|Overall Study|No effective dose in Titration period|0|||
25121966|NCT01969851|50234473|FG001|Overall Study|No effective dose in Titration period|0|||
25121967|NCT01969851|50234474|FG002|Overall Study|No effective dose in Titration period|1|||
25121968|NCT01969851|50234472|FG000|Overall Study|Sponsor decision|0|||
25121969|NCT01969851|50234473|FG001|Overall Study|Sponsor decision|0|||
25121970|NCT01969851|50234474|FG002|Overall Study|Sponsor decision|1|||
25121971|NCT01938573|50234482|FG000|Overall Study|Lack of Efficacy|1|||
25121972|NCT01938573|50234483|FG001|Overall Study|Lack of Efficacy|0|||
25121973|NCT01938573|50234482|FG000|Overall Study|Operation at other hospital|1|||
25121974|NCT01938573|50234483|FG001|Overall Study|Operation at other hospital|0|||
25121975|NCT01937871|50234491|FG000|Overall Study|Adverse Event|6|||
25121976|NCT01937871|50234492|FG001|Overall Study|Adverse Event|6|||
25121977|NCT01937871|50234493|FG002|Overall Study|Adverse Event|2|||
25121978|NCT01937871|50234491|FG000|Overall Study|Lost to Follow-up|8|||
25121979|NCT01937871|50234492|FG001|Overall Study|Lost to Follow-up|2|||
25121980|NCT01937871|50234493|FG002|Overall Study|Lost to Follow-up|4|||
25121981|NCT01937871|50234491|FG000|Overall Study|Withdrawal by Subject|9|||
25121982|NCT01937871|50234492|FG001|Overall Study|Withdrawal by Subject|6|||
25121983|NCT01937871|50234493|FG002|Overall Study|Withdrawal by Subject|4|||
25121984|NCT01937871|50234491|FG000|Overall Study|Physician Decision|0|||
25121985|NCT01937871|50234492|FG001|Overall Study|Physician Decision|1|||
25121986|NCT01937871|50234493|FG002|Overall Study|Physician Decision|0|||
25121987|NCT01937871|50234491|FG000|Overall Study|Entry Criteria Not Met|1|||
25121988|NCT01937871|50234492|FG001|Overall Study|Entry Criteria Not Met|2|||
25121989|NCT01937871|50234493|FG002|Overall Study|Entry Criteria Not Met|1|||
25121990|NCT01269463|50234525|FG000|First Intervention|Withdrawal by Subject|1|||
25121991|NCT01269463|50234526|FG001|First Intervention|Withdrawal by Subject|0|||
25121992|NCT01269463|50234525|FG000|First Intervention|Adverse Event|1|||
25121993|NCT01269463|50234526|FG001|First Intervention|Adverse Event|0|||
25121994|NCT01269463|50234525|FG000|First Intervention|Lack of Efficacy|0|||
25121995|NCT01269463|50234526|FG001|First Intervention|Lack of Efficacy|1|||
25177500|NCT02754141|50321523|FG016|Overall Study|Not completing monotherapy|0|||
25121996|NCT01269463|50234525|FG000|First Intervention|Physician Decision|0|||
25121997|NCT01269463|50234526|FG001|First Intervention|Physician Decision|1|||
25121998|NCT01706926|50234541|FG000|Overall Study|Lost to Follow-up|0|||
25121999|NCT01706926|50234542|FG001|Overall Study|Lost to Follow-up|0|||
25122000|NCT01706926|50234543|FG002|Overall Study|Lost to Follow-up|1|||
25122001|NCT01706926|50234544|FG003|Overall Study|Lost to Follow-up|0|||
25122002|NCT01706926|50234541|FG000|Overall Study|Withdrawal by Subject|2|||
25122003|NCT01706926|50234542|FG001|Overall Study|Withdrawal by Subject|0|||
25122004|NCT01706926|50234543|FG002|Overall Study|Withdrawal by Subject|1|||
25122005|NCT01706926|50234544|FG003|Overall Study|Withdrawal by Subject|2|||
25122006|NCT01706926|50234541|FG000|Overall Study|Other|4|||
25122007|NCT01706926|50234542|FG001|Overall Study|Other|4|||
25122008|NCT01706926|50234543|FG002|Overall Study|Other|4|||
25122009|NCT01706926|50234544|FG003|Overall Study|Other|3|||
25122010|NCT01634113|50234560|FG000|Overall Study|Not treated|0|||
25122011|NCT01634113|50234561|FG001|Overall Study|Not treated|0|||
25122012|NCT01634113|50234562|FG002|Overall Study|Not treated|1|||
25122013|NCT01706770|50234572|FG000|Overall Study|Lost to Follow-up|1|||
25122014|NCT01706770|50234573|FG001|Overall Study|Lost to Follow-up|0|||
25122015|NCT01706770|50234572|FG000|Overall Study|Physician Decision|1|||
25122016|NCT01706770|50234573|FG001|Overall Study|Physician Decision|0|||
25122017|NCT01937715|50234584|FG000|Overall Study|Death|0|||
25122018|NCT01937715|50234585|FG001|Overall Study|Death|0|||
25122019|NCT01937715|50234586|FG002|Overall Study|Death|0|||
25122020|NCT01937715|50234587|FG003|Overall Study|Death|1|||
25122021|NCT01937715|50234588|FG004|Overall Study|Death|0|||
25122022|NCT01937715|50234584|FG000|Overall Study|Withdrawal by Subject|0|||
25122023|NCT01937715|50234585|FG001|Overall Study|Withdrawal by Subject|1|||
25122024|NCT01937715|50234586|FG002|Overall Study|Withdrawal by Subject|0|||
25122025|NCT01937715|50234587|FG003|Overall Study|Withdrawal by Subject|0|||
25122026|NCT01937715|50234588|FG004|Overall Study|Withdrawal by Subject|2|||
25122027|NCT01937715|50234584|FG000|Overall Study|Other|0|||
25122028|NCT01937715|50234585|FG001|Overall Study|Other|0|||
25122029|NCT01937715|50234586|FG002|Overall Study|Other|0|||
25122030|NCT01937715|50234587|FG003|Overall Study|Other|3|||
25122031|NCT01937715|50234588|FG004|Overall Study|Other|0|||
25122032|NCT01937559|50234603|FG000|Overall Study|Physician Decision|3|||
25122033|NCT01937559|50234604|FG001|Overall Study|Physician Decision|3|||
25122034|NCT01937559|50234605|FG002|Overall Study|Physician Decision|0|||
25122035|NCT01937559|50234603|FG000|Overall Study|Withdrawal by Subject|6|||
25122036|NCT01937559|50234604|FG001|Overall Study|Withdrawal by Subject|4|||
25122037|NCT01937559|50234605|FG002|Overall Study|Withdrawal by Subject|0|||
25122038|NCT01937559|50234603|FG000|Overall Study|screen fail|2|||
25122039|NCT01937559|50234604|FG001|Overall Study|screen fail|4|||
25122040|NCT01937559|50234605|FG002|Overall Study|screen fail|0|||
25122041|NCT01960257|50234617|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
25122042|NCT01960257|50234618|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
25122043|NCT01960257|50234619|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
25122044|NCT01960257|50234617|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
25122045|NCT01960257|50234618|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
25122046|NCT01960257|50234619|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
25122047|NCT01960257|50234617|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
25122048|NCT01960257|50234618|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
25122049|NCT01960257|50234619|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
25122050|NCT01918371|50234631|FG000|Overall Study|Missing Data|1|||
25122051|NCT01918371|50234632|FG001|Overall Study|Missing Data|1|||
25122052|NCT01917747|50234640|FG000|Overall Study|Withdrawal by Subject|1|||
25122053|NCT01917747|50234641|FG001|Overall Study|Withdrawal by Subject|2|||
25122054|NCT01917747|50234640|FG000|Overall Study|Lost to Follow-up|18|||
25122055|NCT01917747|50234641|FG001|Overall Study|Lost to Follow-up|9|||
25122056|NCT01597791|50234653|FG000|Overall Study|Physician Decision|2|||
25122057|NCT01597791|50234654|FG001|Overall Study|Physician Decision|1|||
25122058|NCT01597791|50234653|FG000|Overall Study|Cesarean Section|6|||
25122059|NCT01597791|50234654|FG001|Overall Study|Cesarean Section|7|||
25122060|NCT01597791|50234653|FG000|Overall Study|Subject withdrawal|0|||
25122061|NCT01597791|50234654|FG001|Overall Study|Subject withdrawal|1|||
25122062|NCT01597791|50234653|FG000|Overall Study|Protocol Violation|0|||
25122063|NCT01597791|50234654|FG001|Overall Study|Protocol Violation|1|||
25122064|NCT01916967|50234663|FG000|Overall Study|Adverse Event|0|||
25122065|NCT01916967|50234664|FG001|Overall Study|Adverse Event|0|||
25261859|NCT01075282|50576511|FG002|Overall Study|Lack of Efficacy|0|||
25261860|NCT01075282|50576509|FG000|Overall Study|Treatment Non-compliance|1|||
25122066|NCT01916967|50234665|FG002|Overall Study|Adverse Event|2|||
25122067|NCT01916967|50234663|FG000|Overall Study|Lack of Efficacy|0|||
25122068|NCT01916967|50234664|FG001|Overall Study|Lack of Efficacy|0|||
25122069|NCT01916967|50234665|FG002|Overall Study|Lack of Efficacy|6|||
25122070|NCT01916967|50234663|FG000|Overall Study|Physician Decision|0|||
25122071|NCT01916967|50234664|FG001|Overall Study|Physician Decision|0|||
25122072|NCT01916967|50234665|FG002|Overall Study|Physician Decision|1|||
25122073|NCT01916967|50234663|FG000|Overall Study|Protocol Violation|0|||
25122074|NCT01916967|50234664|FG001|Overall Study|Protocol Violation|1|||
25122075|NCT01916967|50234665|FG002|Overall Study|Protocol Violation|0|||
25122076|NCT01936623|50234677|FG000|Overall Study|Lost to Follow-up|0|||
25122077|NCT01936623|50234678|FG001|Overall Study|Lost to Follow-up|5|||
25122078|NCT01959243|50234686|FG000|Overall Study|Investigator Decision|3|||
25122079|NCT01959243|50234687|FG001|Overall Study|Investigator Decision|0|||
25122080|NCT01959243|50234686|FG000|Overall Study|Adverse Event|5|||
25122081|NCT01959243|50234687|FG001|Overall Study|Adverse Event|2|||
25122082|NCT01959243|50234686|FG000|Overall Study|Administrative reasons|2|||
25122083|NCT01959243|50234687|FG001|Overall Study|Administrative reasons|1|||
25122084|NCT01959243|50234686|FG000|Overall Study|Lost to Follow-up|3|||
25122085|NCT01959243|50234687|FG001|Overall Study|Lost to Follow-up|1|||
25122086|NCT01959165|50234697|FG000|Overall Study|Adverse Event|0|||
25122087|NCT01959165|50234698|FG001|Overall Study|Adverse Event|0|||
25122088|NCT01959165|50234699|FG002|Overall Study|Adverse Event|0|||
25122089|NCT01959165|50234700|FG003|Overall Study|Adverse Event|1|||
25122090|NCT01959165|50234697|FG000|Overall Study|Lack of Efficacy|1|||
25122091|NCT01959165|50234698|FG001|Overall Study|Lack of Efficacy|0|||
25122092|NCT01959165|50234699|FG002|Overall Study|Lack of Efficacy|0|||
25122093|NCT01959165|50234700|FG003|Overall Study|Lack of Efficacy|0|||
25122094|NCT01959165|50234697|FG000|Overall Study|overdose|0|||
25122095|NCT01959165|50234698|FG001|Overall Study|overdose|0|||
25122096|NCT01959165|50234699|FG002|Overall Study|overdose|0|||
25122097|NCT01959165|50234700|FG003|Overall Study|overdose|1|||
25122098|NCT01959165|50234697|FG000|Overall Study|Welfare recipient|0|||
25122099|NCT01959165|50234698|FG001|Overall Study|Welfare recipient|1|||
25122100|NCT01959165|50234699|FG002|Overall Study|Welfare recipient|0|||
25122101|NCT01959165|50234700|FG003|Overall Study|Welfare recipient|0|||
25122102|NCT01916109|50234710|FG000|Overall Study|Withdrawal by Subject|1|||
25122103|NCT01915095|50234721|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
25122104|NCT01915095|50234722|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
25122105|NCT01915095|50234723|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
25122106|NCT01915095|50234724|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
25122107|NCT01915095|50234725|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
25122108|NCT01958619|50234750|FG000|Overall Study|Protocol Violation|2|||
25122109|NCT01958619|50234751|FG001|Overall Study|Protocol Violation|0|||
25122110|NCT01958619|50234752|FG002|Overall Study|Protocol Violation|1|||
25122111|NCT01958619|50234753|FG003|Overall Study|Protocol Violation|0|||
25122112|NCT01752634|50234769|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
25122113|NCT01752634|50234770|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
25122114|NCT01752634|50234771|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
25122115|NCT01752634|50234772|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
25122116|NCT01752634|50234773|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
25122117|NCT01752634|50234774|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
25122118|NCT01752634|50234769|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
25122119|NCT01752634|50234770|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
25122120|NCT01752634|50234771|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
25122121|NCT01752634|50234772|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
25122122|NCT01752634|50234773|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
25122123|NCT01752634|50234774|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
25122124|NCT01752634|50234769|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
25122125|NCT01752634|50234770|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
25122126|NCT01752634|50234771|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
25122127|NCT01752634|50234772|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
25122128|NCT01752634|50234773|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
25122129|NCT01752634|50234774|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
25122130|NCT01752634|50234769|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
25122131|NCT01752634|50234770|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
25122132|NCT01752634|50234771|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
25122133|NCT01752634|50234772|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
25122134|NCT01752634|50234773|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
25122135|NCT01752634|50234774|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
25122136|NCT01752634|50234769|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
25122137|NCT01752634|50234770|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
25122138|NCT01752634|50234771|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
25122139|NCT01752634|50234772|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
25122140|NCT01752634|50234773|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
25122141|NCT01752634|50234774|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
25122142|NCT01752634|50234769|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
25122143|NCT01752634|50234770|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
25122144|NCT01752634|50234771|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
25122145|NCT01752634|50234772|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
25122146|NCT01752634|50234773|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
25122147|NCT01752634|50234774|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
25122148|NCT01752634|50234769|FG000|Week 24 to Week 260|Physician Decision|1|||
25008731|NCT03486834|50101824|FG000|Overall Study|Lost to Follow-up|41|||
25122149|NCT01752634|50234770|FG001|Week 24 to Week 260|Physician Decision|2|||
25122150|NCT01752634|50234771|FG002|Week 24 to Week 260|Physician Decision|4|||
25122151|NCT01752634|50234772|FG003|Week 24 to Week 260|Physician Decision|2|||
25122152|NCT01752634|50234773|FG004|Week 24 to Week 260|Physician Decision|1|||
25122153|NCT01752634|50234774|FG005|Week 24 to Week 260|Physician Decision|0|||
25122154|NCT01752634|50234769|FG000|Week 24 to Week 260|Death|0|||
25122155|NCT01752634|50234770|FG001|Week 24 to Week 260|Death|1|||
25122156|NCT01752634|50234771|FG002|Week 24 to Week 260|Death|0|||
25122157|NCT01752634|50234772|FG003|Week 24 to Week 260|Death|0|||
25122158|NCT01752634|50234773|FG004|Week 24 to Week 260|Death|0|||
25122159|NCT01752634|50234774|FG005|Week 24 to Week 260|Death|0|||
25122160|NCT01752634|50234769|FG000|Week 24 to Week 260|Pregnancy|0|||
25122161|NCT01752634|50234770|FG001|Week 24 to Week 260|Pregnancy|0|||
25122162|NCT01752634|50234771|FG002|Week 24 to Week 260|Pregnancy|1|||
25122163|NCT01752634|50234772|FG003|Week 24 to Week 260|Pregnancy|0|||
25122164|NCT01752634|50234773|FG004|Week 24 to Week 260|Pregnancy|0|||
25122165|NCT01752634|50234774|FG005|Week 24 to Week 260|Pregnancy|0|||
25122166|NCT01752634|50234769|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
25122167|NCT01752634|50234770|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
25122168|NCT01752634|50234771|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
25122169|NCT01752634|50234772|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
25122170|NCT01752634|50234773|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
25122171|NCT01752634|50234774|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
25122172|NCT01752634|50234769|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
25122173|NCT01752634|50234770|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
25122174|NCT01752634|50234771|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
25122175|NCT01752634|50234772|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
25122176|NCT01752634|50234773|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
25122177|NCT01752634|50234774|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
25122178|NCT01752634|50234769|FG000|Week 24 to Week 260|Adverse Event|4|||
25122179|NCT01752634|50234770|FG001|Week 24 to Week 260|Adverse Event|8|||
25122180|NCT01752634|50234771|FG002|Week 24 to Week 260|Adverse Event|8|||
25122181|NCT01752634|50234772|FG003|Week 24 to Week 260|Adverse Event|4|||
25122182|NCT01752634|50234773|FG004|Week 24 to Week 260|Adverse Event|2|||
25122183|NCT01752634|50234774|FG005|Week 24 to Week 260|Adverse Event|0|||
25122184|NCT01933113|50234784|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
25122185|NCT01726270|50234788|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
25122186|NCT01726270|50234788|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
25122187|NCT01726270|50234788|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
25122188|NCT01726270|50234788|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
25122189|NCT01726270|50234788|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
25122190|NCT01726270|50234788|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
25122191|NCT00942331|50234796|FG000|Overall Study|Did not start treatment|15|||
25122192|NCT00942331|50234797|FG001|Overall Study|Did not start treatment|22|||
25122193|NCT01914393|50234806|FG000|Overall Study|Protocol Violation|11|||
25122194|NCT01914393|50234807|FG001|Overall Study|Protocol Violation|3|||
25122195|NCT01914393|50234808|FG002|Overall Study|Protocol Violation|19|||
25122196|NCT01914393|50234806|FG000|Overall Study|Lack of Efficacy|11|||
25122197|NCT01914393|50234807|FG001|Overall Study|Lack of Efficacy|16|||
25122198|NCT01914393|50234808|FG002|Overall Study|Lack of Efficacy|5|||
25122199|NCT01914393|50234806|FG000|Overall Study|no reason given|14|||
25122200|NCT01914393|50234807|FG001|Overall Study|no reason given|8|||
25122201|NCT01914393|50234808|FG002|Overall Study|no reason given|16|||
25122202|NCT01914393|50234806|FG000|Overall Study|Adverse Event|29|||
25122203|NCT01914393|50234807|FG001|Overall Study|Adverse Event|18|||
25122204|NCT01914393|50234808|FG002|Overall Study|Adverse Event|31|||
25122205|NCT01914393|50234806|FG000|Overall Study|Withdrawal by Subject|38|||
25122206|NCT01914393|50234807|FG001|Overall Study|Withdrawal by Subject|20|||
25122207|NCT01914393|50234808|FG002|Overall Study|Withdrawal by Subject|47|||
25122208|NCT01914393|50234806|FG000|Overall Study|Lost to Follow-up|12|||
25122209|NCT01914393|50234807|FG001|Overall Study|Lost to Follow-up|6|||
25122210|NCT01914393|50234808|FG002|Overall Study|Lost to Follow-up|19|||
25122211|NCT01914393|50234806|FG000|Overall Study|subject never dosed|0|||
25122212|NCT01914393|50234807|FG001|Overall Study|subject never dosed|0|||
25122213|NCT01914393|50234808|FG002|Overall Study|subject never dosed|1|||
25122214|NCT01931865|50234820|FG000|Overall Study|Lost to Follow-up|2|||
25122215|NCT01931865|50234820|FG000|Overall Study|Withdrawal by Subject|2|||
25122216|NCT01617447|50234827|FG000|Overall Study|Adverse Event|0|||
25122217|NCT01617447|50234828|FG001|Overall Study|Adverse Event|1|||
25122218|NCT01617447|50234827|FG000|Overall Study|Physician Decision|0|||
25122219|NCT01617447|50234828|FG001|Overall Study|Physician Decision|2|||
25122220|NCT00432679|50234836|FG000|Overall Study|Adverse Event|2|||
25122221|NCT00432679|50234837|FG001|Overall Study|Adverse Event|1|||
25122222|NCT00432679|50234836|FG000|Overall Study|Withdrawal by Subject|3|||
25122223|NCT00432679|50234837|FG001|Overall Study|Withdrawal by Subject|2|||
25122224|NCT01600105|50234845|FG000|Total Participants|Withdrawal by Subject|1|||
25122225|NCT01600105|50234846|FG001|Total Participants|Withdrawal by Subject|0|||
25122226|NCT01600105|50234845|FG000|Total Participants|No images in PACS|10|||
25122227|NCT01600105|50234846|FG001|Total Participants|No images in PACS|0|||
25122228|NCT01600105|50234845|FG000|Total Participants|Insufficient image quality|30|||
25122229|NCT01600105|50234846|FG001|Total Participants|Insufficient image quality|10|||
25122230|NCT01600105|50234845|FG000|Sub Study I|Insufficient image quality|0|||
25122231|NCT01600105|50234846|FG001|Sub Study I|Insufficient image quality|10|||
25122232|NCT01600105|50234845|FG000|Sub Study II|Withdrawal by Subject|1|||
25122233|NCT01600105|50234846|FG001|Sub Study II|Withdrawal by Subject|0|||
25122234|NCT01600105|50234845|FG000|Sub Study II|No images in PACS|1|||
25122235|NCT01600105|50234846|FG001|Sub Study II|No images in PACS|0|||
25122236|NCT01600105|50234845|FG000|Sub Study II|Insufficient image quality|3|||
25122237|NCT01600105|50234846|FG001|Sub Study II|Insufficient image quality|0|||
25122238|NCT01600105|50234845|FG000|Sub Study III|Insufficient image quality|5|||
25122239|NCT01600105|50234846|FG001|Sub Study III|Insufficient image quality|0|||
25122240|NCT01600105|50234845|FG000|Sub Study V|Poor Image Quality|2|||
25122241|NCT01600105|50234846|FG001|Sub Study V|Poor Image Quality|0|||
25122242|NCT02246647|50234858|FG000|Overall Study|Withdrawal by Subject|1|||
25122243|NCT02246647|50234859|FG001|Overall Study|Withdrawal by Subject|1|||
25122244|NCT02244619|50234881|FG000|Overall Study|Did not receive study intervention|8|||
25122245|NCT02244619|50234882|FG001|Overall Study|Did not receive study intervention|21|||
25122246|NCT02243371|50234890|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
25122247|NCT02243371|50234891|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
25122248|NCT02243371|50234890|FG000|Overall Study|Death (unrelated)|2|||
25122249|NCT02243371|50234891|FG001|Overall Study|Death (unrelated)|4|||
25122250|NCT02243371|50234890|FG000|Overall Study|Adverse Event (unrelated)|0|||
25122251|NCT02243371|50234891|FG001|Overall Study|Adverse Event (unrelated)|1|||
25122252|NCT02243371|50234890|FG000|Overall Study|Lack of Clinical Benefit|0|||
25122253|NCT02243371|50234891|FG001|Overall Study|Lack of Clinical Benefit|1|||
25122254|NCT02243371|50234890|FG000|Overall Study|Withdrawal by Subject|0|||
25122255|NCT02243371|50234891|FG001|Overall Study|Withdrawal by Subject|2|||
25122256|NCT01931475|50234899|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
25122257|NCT01931475|50234900|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
25122258|NCT01931475|50234899|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
25122259|NCT01931475|50234900|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
25122260|NCT01931475|50234899|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
25122261|NCT01931475|50234900|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
25122262|NCT01931475|50234899|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
25122263|NCT01931475|50234900|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
25122264|NCT01931475|50234899|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
25122265|NCT01931475|50234900|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
25122266|NCT01931475|50234899|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
25122267|NCT01931475|50234900|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
25122268|NCT01931475|50234899|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
25122269|NCT01931475|50234900|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
25122270|NCT01931475|50234899|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
25122271|NCT01931475|50234900|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
25122272|NCT01931475|50234899|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
25122273|NCT01931475|50234900|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
25122274|NCT01931475|50234899|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
25122275|NCT01931475|50234900|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
25122276|NCT01931475|50234899|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
25122277|NCT01931475|50234900|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
25122278|NCT01931397|50234911|FG000|Overall Study|Physician Decision|2|||
25122279|NCT01931397|50234911|FG000|Overall Study|Withdrawal by Subject|8|||
25122280|NCT01931397|50234911|FG000|Overall Study|moved out of state|1|||
25122281|NCT01929993|50234921|FG000|Overall Study|Protocol Violation|4|||
25122282|NCT01929993|50234922|FG001|Overall Study|Protocol Violation|6|||
25122283|NCT01929993|50234921|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
25122284|NCT01929993|50234922|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
25122285|NCT01912599|50234930|FG000|Overall Study|Withdrawal by Subject|0|||
25122286|NCT01912599|50234931|FG001|Overall Study|Withdrawal by Subject|1|||
25122287|NCT01929681|50234939|FG000|Overall Study|Withdrawal by Subject|1|||
25122288|NCT01929681|50234940|FG001|Overall Study|Withdrawal by Subject|0|||
25122289|NCT01929681|50234939|FG000|Overall Study|Physician Decision|1|||
25122290|NCT01929681|50234940|FG001|Overall Study|Physician Decision|1|||
25122291|NCT01646177|50234950|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
25122292|NCT01646177|50234951|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
25122293|NCT01646177|50234952|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
25122294|NCT01646177|50234953|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
25122295|NCT01646177|50234954|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
25122296|NCT01646177|50234955|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
25122297|NCT01646177|50234956|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
25122298|NCT01646177|50234957|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
25122299|NCT01646177|50234958|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
25122300|NCT01646177|50234959|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
25008732|NCT03486834|50101825|FG001|Overall Study|Lost to Follow-up|24|||
25122301|NCT01646177|50234960|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
25122302|NCT01646177|50234961|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
25122303|NCT01646177|50234950|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
25122304|NCT01646177|50234951|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
25122305|NCT01646177|50234952|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
25122306|NCT01646177|50234953|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
25122307|NCT01646177|50234954|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
25122308|NCT01646177|50234955|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
25122309|NCT01646177|50234956|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
25122310|NCT01646177|50234957|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
25122311|NCT01646177|50234958|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
25122312|NCT01646177|50234959|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
25122313|NCT01646177|50234960|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
25122314|NCT01646177|50234961|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
25122315|NCT01646177|50234950|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
25122316|NCT01646177|50234951|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
25122317|NCT01646177|50234952|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
25122318|NCT01646177|50234953|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
25122319|NCT01646177|50234954|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
25122320|NCT01646177|50234955|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
25122321|NCT01646177|50234956|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
25122322|NCT01646177|50234957|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
25122323|NCT01646177|50234958|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
25122324|NCT01646177|50234959|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
25122325|NCT01646177|50234960|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
25122326|NCT01646177|50234961|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
25122327|NCT01646177|50234950|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
25122328|NCT01646177|50234951|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
25122329|NCT01646177|50234952|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
25122330|NCT01646177|50234953|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
25122331|NCT01646177|50234954|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
25122332|NCT01646177|50234955|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
25122333|NCT01646177|50234956|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
25122334|NCT01646177|50234957|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
25122335|NCT01646177|50234958|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
25122336|NCT01646177|50234959|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
25122337|NCT01646177|50234960|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
25122338|NCT01646177|50234961|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
25122339|NCT01646177|50234950|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
25122340|NCT01646177|50234951|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
25122341|NCT01646177|50234952|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
25122342|NCT01646177|50234953|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
25122343|NCT01646177|50234954|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
25122344|NCT01646177|50234955|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
25122345|NCT01646177|50234956|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
25122346|NCT01646177|50234957|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
25122347|NCT01646177|50234958|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
25122348|NCT01646177|50234959|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
25122349|NCT01646177|50234960|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
25122350|NCT01646177|50234961|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
25122351|NCT01646177|50234950|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
25122352|NCT01646177|50234951|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
25122353|NCT01646177|50234952|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
25122354|NCT01646177|50234953|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
25122355|NCT01646177|50234954|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
25122356|NCT01646177|50234955|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
25122357|NCT01646177|50234956|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
25122358|NCT01646177|50234957|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
25122359|NCT01646177|50234958|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
25122360|NCT01646177|50234959|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
25122361|NCT01646177|50234960|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
25122362|NCT01646177|50234961|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
25122363|NCT01646177|50234950|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
25122364|NCT01646177|50234951|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
25122365|NCT01646177|50234952|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
25122366|NCT01646177|50234953|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
25122367|NCT01646177|50234954|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
25122368|NCT01646177|50234955|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
25122369|NCT01646177|50234956|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
25122370|NCT01646177|50234957|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
25122371|NCT01646177|50234958|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
25122372|NCT01646177|50234959|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
25122373|NCT01646177|50234960|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
25122374|NCT01646177|50234961|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
25122375|NCT01646177|50234950|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
25122376|NCT01646177|50234951|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
25122377|NCT01646177|50234952|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
25122378|NCT01646177|50234953|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
25122379|NCT01646177|50234954|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
25122380|NCT01646177|50234955|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
25122381|NCT01646177|50234956|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
25122382|NCT01646177|50234957|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
25122383|NCT01646177|50234958|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
25122384|NCT01646177|50234959|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
25122385|NCT01646177|50234960|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
25122386|NCT01646177|50234961|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
25122387|NCT01646177|50234950|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
25122388|NCT01646177|50234951|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
25122389|NCT01646177|50234952|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
25122390|NCT01646177|50234953|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
25122391|NCT01646177|50234954|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
25122392|NCT01646177|50234955|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
25122393|NCT01646177|50234956|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
25122394|NCT01646177|50234957|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
25122395|NCT01646177|50234958|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
25122396|NCT01646177|50234959|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
25122397|NCT01646177|50234960|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
25122398|NCT01646177|50234961|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
25122399|NCT01646177|50234950|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
25122400|NCT01646177|50234951|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
25122401|NCT01646177|50234952|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
25122402|NCT01646177|50234953|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
25122403|NCT01646177|50234954|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
25122404|NCT01646177|50234955|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
25122405|NCT01646177|50234956|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
25122406|NCT01646177|50234957|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
25122407|NCT01646177|50234958|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
25122408|NCT01646177|50234959|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
25122409|NCT01646177|50234960|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
25122410|NCT01646177|50234961|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
25122411|NCT01646177|50234950|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
25122412|NCT01646177|50234951|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
25122413|NCT01646177|50234952|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
25122414|NCT01646177|50234953|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
25122415|NCT01646177|50234954|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
25122416|NCT01646177|50234955|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
25122417|NCT01646177|50234956|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
25122418|NCT01646177|50234957|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
25122419|NCT01646177|50234958|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
25122420|NCT01646177|50234959|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
25122421|NCT01646177|50234960|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
25122422|NCT01646177|50234961|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
25122423|NCT01646177|50234950|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
25122424|NCT01646177|50234951|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
25122425|NCT01646177|50234952|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
25122426|NCT01646177|50234953|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
25122427|NCT01646177|50234954|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
25122428|NCT01646177|50234955|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
25122429|NCT01646177|50234956|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
25122430|NCT01646177|50234957|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
25122431|NCT01646177|50234958|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
25122432|NCT01646177|50234959|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
25122433|NCT01646177|50234960|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
25122434|NCT01646177|50234961|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
25122435|NCT01646177|50234950|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
25122436|NCT01646177|50234951|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
25122437|NCT01646177|50234952|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
25122438|NCT01646177|50234953|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
25122439|NCT01646177|50234954|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
25122440|NCT01646177|50234955|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
25122441|NCT01646177|50234956|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
25122442|NCT01646177|50234957|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
25122443|NCT01646177|50234958|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
25122444|NCT01646177|50234959|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
25122445|NCT01646177|50234960|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
25122446|NCT01646177|50234961|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
25122447|NCT01646177|50234950|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
25122448|NCT01646177|50234951|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
25122449|NCT01646177|50234952|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
25122450|NCT01646177|50234953|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
25122451|NCT01646177|50234954|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
25122452|NCT01646177|50234955|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
25122453|NCT01646177|50234956|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
25122454|NCT01646177|50234957|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
25122455|NCT01646177|50234958|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
25122456|NCT01646177|50234959|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
25122457|NCT01646177|50234960|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
25122458|NCT01646177|50234961|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
25122459|NCT01646177|50234950|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
25122460|NCT01646177|50234951|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
25122461|NCT01646177|50234952|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
25122462|NCT01646177|50234953|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
25122463|NCT01646177|50234954|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
25122464|NCT01646177|50234955|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
25122465|NCT01646177|50234956|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
25122466|NCT01646177|50234957|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
25122467|NCT01646177|50234958|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
25122468|NCT01646177|50234959|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
25122469|NCT01646177|50234960|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
25122470|NCT01646177|50234961|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
25122471|NCT01646177|50234950|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
25122472|NCT01646177|50234951|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
25122473|NCT01646177|50234952|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
25122474|NCT01646177|50234953|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
25122475|NCT01646177|50234954|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
25122476|NCT01646177|50234955|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
25122477|NCT01646177|50234956|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
25122478|NCT01646177|50234957|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
25122479|NCT01646177|50234958|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
25122480|NCT01646177|50234959|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
25122481|NCT01646177|50234960|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
25122482|NCT01646177|50234961|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
25122483|NCT01646177|50234950|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
25122484|NCT01646177|50234951|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
25122485|NCT01646177|50234952|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
25122486|NCT01646177|50234953|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
25122487|NCT01646177|50234954|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
25122488|NCT01646177|50234955|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
25122489|NCT01646177|50234956|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
25122490|NCT01646177|50234957|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
25122491|NCT01646177|50234958|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
25122492|NCT01646177|50234959|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
25122493|NCT01646177|50234960|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
25122494|NCT01646177|50234961|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
25122495|NCT01646177|50234950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
25122496|NCT01646177|50234951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
25122497|NCT01646177|50234952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
25122498|NCT01646177|50234953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
25122499|NCT01646177|50234954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
25122500|NCT01646177|50234955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
25122501|NCT01646177|50234956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
25122502|NCT01646177|50234957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
25122503|NCT01646177|50234958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
25122504|NCT01646177|50234959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
25122505|NCT01646177|50234960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
25122506|NCT01646177|50234961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
25122507|NCT01646177|50234950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
25122508|NCT01646177|50234951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
25122509|NCT01646177|50234952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
25122510|NCT01646177|50234953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
25122511|NCT01646177|50234954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
25122512|NCT01646177|50234955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
25122513|NCT01646177|50234956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
25122514|NCT01646177|50234957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
25122515|NCT01646177|50234958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
25122516|NCT01646177|50234959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
25122517|NCT01646177|50234960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
25122518|NCT01646177|50234961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
25122519|NCT01646177|50234950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
25122520|NCT01646177|50234951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
25122521|NCT01646177|50234952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
25122522|NCT01646177|50234953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
25122523|NCT01646177|50234954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
25122524|NCT01646177|50234955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
25122525|NCT01646177|50234956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
25122526|NCT01646177|50234957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
25122527|NCT01646177|50234958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
25122528|NCT01646177|50234959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
25122529|NCT01646177|50234960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
25122530|NCT01646177|50234961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
25122531|NCT01646177|50234950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
25122532|NCT01646177|50234951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
25122533|NCT01646177|50234952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
25122534|NCT01646177|50234953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
25122535|NCT01646177|50234954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
25122536|NCT01646177|50234955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
25122537|NCT01646177|50234956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
25122538|NCT01646177|50234957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
25122539|NCT01646177|50234958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
25122540|NCT01646177|50234959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
25122541|NCT01646177|50234960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
25122542|NCT01646177|50234961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
25122543|NCT01646177|50234950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
25122544|NCT01646177|50234951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
25122545|NCT01646177|50234952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
25122546|NCT01646177|50234953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
25122547|NCT01646177|50234954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
25122548|NCT01646177|50234955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
25122549|NCT01646177|50234956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
25122550|NCT01646177|50234957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
25122551|NCT01646177|50234958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
25122552|NCT01646177|50234959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
25122553|NCT01646177|50234960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
25122554|NCT01646177|50234961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
25122555|NCT01646177|50234950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
25261861|NCT01075282|50576510|FG001|Overall Study|Treatment Non-compliance|2|||
25261862|NCT01075282|50576511|FG002|Overall Study|Treatment Non-compliance|2|||
25122556|NCT01646177|50234951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
25122557|NCT01646177|50234952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
25122558|NCT01646177|50234953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
25122559|NCT01646177|50234954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
25122560|NCT01646177|50234955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
25122561|NCT01646177|50234956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
25122562|NCT01646177|50234957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
25122563|NCT01646177|50234958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
25122564|NCT01646177|50234959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
25122565|NCT01646177|50234960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
25122566|NCT01646177|50234961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
25122567|NCT01646177|50234950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
25122568|NCT01646177|50234951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
25122569|NCT01646177|50234952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
25122570|NCT01646177|50234953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
25122571|NCT01646177|50234954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
25122572|NCT01646177|50234955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
25122573|NCT01646177|50234956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
25122574|NCT01646177|50234957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
25122575|NCT01646177|50234958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
25122576|NCT01646177|50234959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
25122577|NCT01646177|50234960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
25122578|NCT01646177|50234961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
25122579|NCT01646177|50234950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
25122580|NCT01646177|50234951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
25122581|NCT01646177|50234952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
25122582|NCT01646177|50234953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
25122583|NCT01646177|50234954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
25122584|NCT01646177|50234955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
25122585|NCT01646177|50234956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
25122586|NCT01646177|50234957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
25122587|NCT01646177|50234958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
25122588|NCT01646177|50234959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
25122589|NCT01646177|50234960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
25122590|NCT01646177|50234961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
25122591|NCT01646177|50234950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
25122592|NCT01646177|50234951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
25122593|NCT01646177|50234952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
25122594|NCT01646177|50234953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
25122595|NCT01646177|50234954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
25122596|NCT01646177|50234955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
25122597|NCT01646177|50234956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
25122598|NCT01646177|50234957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
25122599|NCT01646177|50234958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
25122600|NCT01646177|50234959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
25122601|NCT01646177|50234960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
25122602|NCT01646177|50234961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
25122603|NCT01646177|50234950|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
25122604|NCT01646177|50234951|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
25122605|NCT01646177|50234952|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
25122606|NCT01646177|50234953|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
25122607|NCT01646177|50234954|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
25122608|NCT01646177|50234955|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
25122609|NCT01646177|50234956|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
25122610|NCT01646177|50234957|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
25122611|NCT01646177|50234958|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
25122612|NCT01646177|50234959|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
25122613|NCT01646177|50234960|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
25122614|NCT01646177|50234961|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
25122615|NCT01912287|50234984|FG000|Overall Study|Ineligible|1|||
25122616|NCT01912287|50234985|FG001|Overall Study|Ineligible|0|||
25122617|NCT01912287|50234986|FG002|Overall Study|Ineligible|1|||
25122618|NCT01912287|50234984|FG000|Overall Study|No-show|0|||
25122619|NCT01912287|50234985|FG001|Overall Study|No-show|0|||
25122620|NCT01912287|50234986|FG002|Overall Study|No-show|1|||
25122621|NCT01912287|50234984|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
25122622|NCT01912287|50234985|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
25122623|NCT01912287|50234986|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
25122624|NCT01912287|50234984|FG000|Overall Study|Felt treatment no longer needed|0|||
25122625|NCT01912287|50234985|FG001|Overall Study|Felt treatment no longer needed|1|||
25122626|NCT01912287|50234986|FG002|Overall Study|Felt treatment no longer needed|0|||
25122627|NCT01912287|50234984|FG000|Overall Study|Life circumstances|4|||
25122628|NCT01912287|50234985|FG001|Overall Study|Life circumstances|2|||
25122629|NCT01912287|50234986|FG002|Overall Study|Life circumstances|0|||
25122630|NCT01912287|50234984|FG000|Overall Study|Lost Interest|1|||
25122631|NCT01912287|50234985|FG001|Overall Study|Lost Interest|0|||
25122632|NCT01912287|50234986|FG002|Overall Study|Lost Interest|0|||
25122633|NCT01912287|50234984|FG000|Overall Study|Uknown reason - subject drop out|5|||
25122634|NCT01912287|50234985|FG001|Overall Study|Uknown reason - subject drop out|7|||
25122635|NCT01912287|50234986|FG002|Overall Study|Uknown reason - subject drop out|3|||
25122636|NCT01912287|50234984|FG000|Overall Study|Missed Assesment|1|||
25122637|NCT01912287|50234985|FG001|Overall Study|Missed Assesment|1|||
25122638|NCT01912287|50234986|FG002|Overall Study|Missed Assesment|1|||
25122639|NCT01912287|50234984|FG000|Overall Study|Scheduling/change in availability|17|||
25122640|NCT01912287|50234985|FG001|Overall Study|Scheduling/change in availability|10|||
25122641|NCT01912287|50234986|FG002|Overall Study|Scheduling/change in availability|8|||
25122642|NCT01929135|50234996|FG000|Overall Study|Lost to Follow-up|1|||
25122643|NCT01929135|50234997|FG001|Overall Study|Lost to Follow-up|1|||
25122644|NCT01911819|50235008|FG000|Overall Study|Adverse Event|0|||
25122645|NCT01911819|50235009|FG001|Overall Study|Adverse Event|1|||
25122646|NCT01911819|50235010|FG002|Overall Study|Adverse Event|0|||
25122647|NCT01911819|50235008|FG000|Overall Study|Withdrawal by Subject|1|||
25122648|NCT01911819|50235009|FG001|Overall Study|Withdrawal by Subject|1|||
25122649|NCT01911819|50235010|FG002|Overall Study|Withdrawal by Subject|0|||
25122650|NCT02280863|50235020|FG000|Integrated Platform|Met stopping criteria|0|||
25122651|NCT02280863|50235021|FG001|Integrated Platform|Met stopping criteria|1|||
25122652|NCT01911429|50235034|FG000|Overall Study|Adverse Event|5|||
25122653|NCT01911429|50235035|FG001|Overall Study|Adverse Event|3|||
25122654|NCT01911429|50235036|FG002|Overall Study|Adverse Event|9|||
25122655|NCT01911429|50235034|FG000|Overall Study|Lack of Efficacy|1|||
25122656|NCT01911429|50235035|FG001|Overall Study|Lack of Efficacy|2|||
25122657|NCT01911429|50235036|FG002|Overall Study|Lack of Efficacy|4|||
25122658|NCT01911429|50235034|FG000|Overall Study|Lost to Follow-up|0|||
25122659|NCT01911429|50235035|FG001|Overall Study|Lost to Follow-up|0|||
25122660|NCT01911429|50235036|FG002|Overall Study|Lost to Follow-up|1|||
25122661|NCT01911429|50235034|FG000|Overall Study|Protocol Violation|0|||
25122662|NCT01911429|50235035|FG001|Overall Study|Protocol Violation|0|||
25122663|NCT01911429|50235036|FG002|Overall Study|Protocol Violation|1|||
25122664|NCT01911429|50235034|FG000|Overall Study|Withdrawal by Subject|5|||
25122665|NCT01911429|50235035|FG001|Overall Study|Withdrawal by Subject|5|||
25122666|NCT01911429|50235036|FG002|Overall Study|Withdrawal by Subject|4|||
25122667|NCT01911429|50235034|FG000|Overall Study|Accidental randomization|0|||
25122668|NCT01911429|50235035|FG001|Overall Study|Accidental randomization|0|||
25122669|NCT01911429|50235036|FG002|Overall Study|Accidental randomization|1|||
25122670|NCT01911429|50235034|FG000|Overall Study|subject left study|1|||
25122671|NCT01911429|50235035|FG001|Overall Study|subject left study|0|||
25122672|NCT01911429|50235036|FG002|Overall Study|subject left study|0|||
25122673|NCT02324465|50235046|FG000|Overall Study|device failure|0|||
25122674|NCT02324465|50235047|FG001|Overall Study|device failure|1|||
25122675|NCT02324153|50235055|FG000|Overall Study|Withdrawal by Subject|4|||
25122676|NCT02324153|50235056|FG001|Overall Study|Withdrawal by Subject|1|||
25122677|NCT02324153|50235055|FG000|Overall Study|Surgery postponed after randomization|3|||
25122678|NCT02324153|50235056|FG001|Overall Study|Surgery postponed after randomization|0|||
25122679|NCT02324153|50235055|FG000|Overall Study|Developed delirium preoperatively|1|||
25122680|NCT02324153|50235056|FG001|Overall Study|Developed delirium preoperatively|0|||
25122681|NCT02280473|50235064|FG000|Overall Study|Adverse Event|1|||
25122682|NCT02280473|50235065|FG001|Overall Study|Adverse Event|1|||
25122683|NCT02280473|50235064|FG000|Overall Study|Lack of Efficacy|0|||
25122684|NCT02280473|50235065|FG001|Overall Study|Lack of Efficacy|1|||
25122685|NCT02280473|50235064|FG000|Overall Study|Lost to Follow-up|0|||
25122686|NCT02280473|50235065|FG001|Overall Study|Lost to Follow-up|1|||
25122687|NCT01911273|50235073|FG000|Overall Study|Progression of Disease|1|||
25122688|NCT01911273|50235074|FG001|Overall Study|Progression of Disease|0|||
25122689|NCT01911273|50235073|FG000|Overall Study|Withdrawal by Subject|0|||
25122690|NCT01911273|50235074|FG001|Overall Study|Withdrawal by Subject|2|||
25122691|NCT02308007|50235083|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
25122692|NCT02308007|50235084|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
25122693|NCT02308007|50235085|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
25122694|NCT02308007|50235083|FG000|Overall Study|Positive for STD at Baseline|7|||
25122695|NCT02308007|50235084|FG001|Overall Study|Positive for STD at Baseline|11|||
25122696|NCT02308007|50235085|FG002|Overall Study|Positive for STD at Baseline|7|||
25122697|NCT02308007|50235083|FG000|Overall Study|Lost to Follow-up|3|||
25122698|NCT02308007|50235084|FG001|Overall Study|Lost to Follow-up|0|||
25122699|NCT02308007|50235085|FG002|Overall Study|Lost to Follow-up|1|||
25122700|NCT02278367|50235095|FG000|Overall Study|Physician Decision|5|||
25122701|NCT02278367|50235096|FG001|Overall Study|Physician Decision|0|||
25122702|NCT02278367|50235095|FG000|Overall Study|Withdrawal by Subject|5|||
25122703|NCT02278367|50235096|FG001|Overall Study|Withdrawal by Subject|0|||
25122704|NCT01910181|50235102|FG000|Overall Study|Death|37|||
25122705|NCT01910181|50235102|FG000|Overall Study|Lost to Follow-up|3|||
25122706|NCT01910181|50235102|FG000|Overall Study|Study Terminated by Sponsor|6|||
25122707|NCT01957215|50235109|FG000|Overall Study|Adverse Event|2|||
25122708|NCT01957215|50235110|FG001|Overall Study|Adverse Event|2|||
25122709|NCT01957215|50235109|FG000|Overall Study|Lost to Follow-up|3|||
25122710|NCT01957215|50235110|FG001|Overall Study|Lost to Follow-up|3|||
25122711|NCT01957215|50235109|FG000|Overall Study|Protocol Violation|1|||
25122712|NCT01957215|50235110|FG001|Overall Study|Protocol Violation|2|||
25122713|NCT01957215|50235109|FG000|Overall Study|Withdrawal by Subject|7|||
25122714|NCT01957215|50235110|FG001|Overall Study|Withdrawal by Subject|5|||
25122715|NCT02322749|50235120|FG000|Period 2|Adverse Event|0|||
25122716|NCT02322749|50235121|FG001|Period 2|Adverse Event|0|||
25122717|NCT02322749|50235122|FG002|Period 2|Adverse Event|0|||
25122718|NCT02322749|50235123|FG003|Period 2|Adverse Event|1|||
25122719|NCT02322749|50235124|FG004|Period 2|Adverse Event|0|||
25122720|NCT02322749|50235125|FG005|Period 2|Adverse Event|0|||
25122721|NCT02322749|50235120|FG000|Period 2|Withdrawal by Subject|0|||
25122722|NCT02322749|50235121|FG001|Period 2|Withdrawal by Subject|0|||
25122723|NCT02322749|50235122|FG002|Period 2|Withdrawal by Subject|0|||
25122724|NCT02322749|50235123|FG003|Period 2|Withdrawal by Subject|1|||
25122725|NCT02322749|50235124|FG004|Period 2|Withdrawal by Subject|0|||
25122726|NCT02322749|50235125|FG005|Period 2|Withdrawal by Subject|0|||
25122727|NCT02322749|50235120|FG000|Period 3|Withdrawal by Subject|0|||
25122728|NCT02322749|50235121|FG001|Period 3|Withdrawal by Subject|0|||
25122729|NCT02322749|50235122|FG002|Period 3|Withdrawal by Subject|1|||
25122730|NCT02322749|50235123|FG003|Period 3|Withdrawal by Subject|0|||
25122731|NCT02322749|50235124|FG004|Period 3|Withdrawal by Subject|0|||
25122732|NCT02322749|50235125|FG005|Period 3|Withdrawal by Subject|0|||
25122733|NCT01957137|50235134|FG000|Randomized Portion|Adverse Event|1|||
25122734|NCT01957137|50235134|FG000|Randomized Portion|Withdrawal by Subject|1|||
25122735|NCT01928433|50235149|FG000|Overall Study|Adverse Event|5|||
25122736|NCT01928433|50235150|FG001|Overall Study|Adverse Event|2|||
25122737|NCT01928433|50235151|FG002|Overall Study|Adverse Event|5|||
25122738|NCT01928433|50235149|FG000|Overall Study|Protocol Violation|0|||
25122739|NCT01928433|50235150|FG001|Overall Study|Protocol Violation|0|||
25122740|NCT01928433|50235151|FG002|Overall Study|Protocol Violation|2|||
25122741|NCT01928433|50235149|FG000|Overall Study|Lack of Efficacy|5|||
25122742|NCT01928433|50235150|FG001|Overall Study|Lack of Efficacy|4|||
25122743|NCT01928433|50235151|FG002|Overall Study|Lack of Efficacy|4|||
25122744|NCT01928433|50235149|FG000|Overall Study|Withdrawal by Subject|0|||
25122745|NCT01928433|50235150|FG001|Overall Study|Withdrawal by Subject|4|||
25122746|NCT01928433|50235151|FG002|Overall Study|Withdrawal by Subject|0|||
25122747|NCT01928433|50235149|FG000|Overall Study|Negative screening urine culture|7|||
25122748|NCT01928433|50235150|FG001|Overall Study|Negative screening urine culture|6|||
25122749|NCT01928433|50235151|FG002|Overall Study|Negative screening urine culture|10|||
25122750|NCT01928433|50235149|FG000|Overall Study|Lost to Follow-up|0|||
25122751|NCT01928433|50235150|FG001|Overall Study|Lost to Follow-up|2|||
25122752|NCT01928433|50235151|FG002|Overall Study|Lost to Follow-up|3|||
25122753|NCT01928433|50235149|FG000|Overall Study|Other reasons|3|||
25122754|NCT01928433|50235150|FG001|Overall Study|Other reasons|3|||
25122755|NCT01928433|50235151|FG002|Overall Study|Other reasons|4|||
25122756|NCT02322281|50235165|FG000|Overall Study|Progressive Disease|42|||
25122757|NCT02322281|50235166|FG001|Overall Study|Progressive Disease|14|||
25122758|NCT02322281|50235167|FG002|Overall Study|Progressive Disease|49|||
25122759|NCT02322281|50235165|FG000|Overall Study|Adverse Event|3|||
25122760|NCT02322281|50235166|FG001|Overall Study|Adverse Event|4|||
25122761|NCT02322281|50235167|FG002|Overall Study|Adverse Event|6|||
25122762|NCT02322281|50235165|FG000|Overall Study|Death|3|||
25122763|NCT02322281|50235166|FG001|Overall Study|Death|3|||
25122764|NCT02322281|50235167|FG002|Overall Study|Death|3|||
25122765|NCT02322281|50235165|FG000|Overall Study|Withdrawal by Subject|1|||
25122766|NCT02322281|50235166|FG001|Overall Study|Withdrawal by Subject|1|||
25122767|NCT02322281|50235167|FG002|Overall Study|Withdrawal by Subject|6|||
25122768|NCT02322281|50235165|FG000|Overall Study|Physician Decision|2|||
25122769|NCT02322281|50235166|FG001|Overall Study|Physician Decision|0|||
25122770|NCT02322281|50235167|FG002|Overall Study|Physician Decision|5|||
25122771|NCT02322281|50235165|FG000|Overall Study|Study Terminated by Sponsor|2|||
25122772|NCT02322281|50235166|FG001|Overall Study|Study Terminated by Sponsor|0|||
25122773|NCT02322281|50235167|FG002|Overall Study|Study Terminated by Sponsor|0|||
25122774|NCT02322281|50235165|FG000|Overall Study|Missing|0|||
25122775|NCT02322281|50235166|FG001|Overall Study|Missing|0|||
25122776|NCT02322281|50235167|FG002|Overall Study|Missing|1|||
25122777|NCT02322281|50235165|FG000|Overall Study|Miscellaneous|0|||
25122778|NCT02322281|50235166|FG001|Overall Study|Miscellaneous|0|||
25122779|NCT02322281|50235167|FG002|Overall Study|Miscellaneous|4|||
25122780|NCT02322125|50235177|FG000|Overall Study|Withdrawal by Subject|2|||
25122781|NCT02243293|50235198|FG000|Overall Study|Adverse Event|1|||
25122782|NCT02243293|50235199|FG001|Overall Study|Adverse Event|0|||
25122783|NCT02243293|50235200|FG002|Overall Study|Adverse Event|0|||
25122784|NCT02243293|50235201|FG003|Overall Study|Adverse Event|0|||
25122785|NCT02243293|50235202|FG004|Overall Study|Adverse Event|0|||
25122786|NCT02243293|50235203|FG005|Overall Study|Adverse Event|0|||
25122787|NCT02243293|50235204|FG006|Overall Study|Adverse Event|0|||
25122788|NCT02243293|50235205|FG007|Overall Study|Adverse Event|0|||
25122789|NCT02243293|50235206|FG008|Overall Study|Adverse Event|0|||
25122790|NCT02243293|50235207|FG009|Overall Study|Adverse Event|0|||
25122791|NCT02243293|50235208|FG010|Overall Study|Adverse Event|0|||
25122792|NCT02243293|50235209|FG011|Overall Study|Adverse Event|0|||
25122793|NCT02243293|50235210|FG012|Overall Study|Adverse Event|0|||
25122794|NCT02243293|50235211|FG013|Overall Study|Adverse Event|0|||
25122795|NCT02243293|50235212|FG014|Overall Study|Adverse Event|0|||
25122796|NCT02243293|50235213|FG015|Overall Study|Adverse Event|1|||
25122797|NCT02243293|50235214|FG016|Overall Study|Adverse Event|0|||
25122798|NCT02243293|50235215|FG017|Overall Study|Adverse Event|0|||
25122799|NCT02243293|50235216|FG018|Overall Study|Adverse Event|0|||
25122800|NCT02243293|50235217|FG019|Overall Study|Adverse Event|0|||
25122801|NCT02243293|50235218|FG020|Overall Study|Adverse Event|1|||
25122802|NCT02243293|50235219|FG021|Overall Study|Adverse Event|0|||
25122803|NCT02243293|50235198|FG000|Overall Study|Withdrawal by Subject|1|||
25122804|NCT02243293|50235199|FG001|Overall Study|Withdrawal by Subject|0|||
25122805|NCT02243293|50235200|FG002|Overall Study|Withdrawal by Subject|0|||
25122806|NCT02243293|50235201|FG003|Overall Study|Withdrawal by Subject|0|||
25122807|NCT02243293|50235202|FG004|Overall Study|Withdrawal by Subject|0|||
25122808|NCT02243293|50235203|FG005|Overall Study|Withdrawal by Subject|0|||
25122809|NCT02243293|50235204|FG006|Overall Study|Withdrawal by Subject|0|||
25122810|NCT02243293|50235205|FG007|Overall Study|Withdrawal by Subject|0|||
25122811|NCT02243293|50235206|FG008|Overall Study|Withdrawal by Subject|0|||
25122812|NCT02243293|50235207|FG009|Overall Study|Withdrawal by Subject|1|||
25122813|NCT02243293|50235208|FG010|Overall Study|Withdrawal by Subject|0|||
25122814|NCT02243293|50235209|FG011|Overall Study|Withdrawal by Subject|1|||
25122815|NCT02243293|50235210|FG012|Overall Study|Withdrawal by Subject|0|||
25122816|NCT02243293|50235211|FG013|Overall Study|Withdrawal by Subject|0|||
25122817|NCT02243293|50235212|FG014|Overall Study|Withdrawal by Subject|0|||
25122818|NCT02243293|50235213|FG015|Overall Study|Withdrawal by Subject|0|||
25122819|NCT02243293|50235214|FG016|Overall Study|Withdrawal by Subject|0|||
25122820|NCT02243293|50235215|FG017|Overall Study|Withdrawal by Subject|0|||
25122821|NCT02243293|50235216|FG018|Overall Study|Withdrawal by Subject|0|||
25122822|NCT02243293|50235217|FG019|Overall Study|Withdrawal by Subject|0|||
25122823|NCT02243293|50235218|FG020|Overall Study|Withdrawal by Subject|0|||
25122824|NCT02243293|50235219|FG021|Overall Study|Withdrawal by Subject|1|||
25122825|NCT02243293|50235198|FG000|Overall Study|Lost to Follow-up|0|||
25122826|NCT02243293|50235199|FG001|Overall Study|Lost to Follow-up|1|||
25122827|NCT02243293|50235200|FG002|Overall Study|Lost to Follow-up|1|||
25122828|NCT02243293|50235201|FG003|Overall Study|Lost to Follow-up|1|||
25122829|NCT02243293|50235202|FG004|Overall Study|Lost to Follow-up|0|||
25122830|NCT02243293|50235203|FG005|Overall Study|Lost to Follow-up|0|||
25122831|NCT02243293|50235204|FG006|Overall Study|Lost to Follow-up|3|||
25122832|NCT02243293|50235205|FG007|Overall Study|Lost to Follow-up|0|||
25122833|NCT02243293|50235206|FG008|Overall Study|Lost to Follow-up|0|||
25122834|NCT02243293|50235207|FG009|Overall Study|Lost to Follow-up|0|||
25122835|NCT02243293|50235208|FG010|Overall Study|Lost to Follow-up|0|||
25122836|NCT02243293|50235209|FG011|Overall Study|Lost to Follow-up|2|||
25122837|NCT02243293|50235210|FG012|Overall Study|Lost to Follow-up|0|||
25122838|NCT02243293|50235211|FG013|Overall Study|Lost to Follow-up|0|||
25122839|NCT02243293|50235212|FG014|Overall Study|Lost to Follow-up|0|||
25122840|NCT02243293|50235213|FG015|Overall Study|Lost to Follow-up|0|||
25122841|NCT02243293|50235214|FG016|Overall Study|Lost to Follow-up|3|||
25122842|NCT02243293|50235215|FG017|Overall Study|Lost to Follow-up|1|||
25122843|NCT02243293|50235216|FG018|Overall Study|Lost to Follow-up|0|||
25122844|NCT02243293|50235217|FG019|Overall Study|Lost to Follow-up|0|||
25261863|NCT01075282|50576509|FG000|Overall Study|Protocol Violation|0|||
25122845|NCT02243293|50235218|FG020|Overall Study|Lost to Follow-up|1|||
25122846|NCT02243293|50235219|FG021|Overall Study|Lost to Follow-up|2|||
25122847|NCT02243293|50235198|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
25122848|NCT02243293|50235199|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
25122849|NCT02243293|50235200|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
25122850|NCT02243293|50235201|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
25122851|NCT02243293|50235202|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
25122852|NCT02243293|50235203|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
25122853|NCT02243293|50235204|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
25122854|NCT02243293|50235205|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
25122855|NCT02243293|50235206|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
25122856|NCT02243293|50235207|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
25122857|NCT02243293|50235208|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
25122858|NCT02243293|50235209|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
25122859|NCT02243293|50235210|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
25122860|NCT02243293|50235211|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
25122861|NCT02243293|50235212|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
25122862|NCT02243293|50235213|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
25122863|NCT02243293|50235214|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
25122864|NCT02243293|50235215|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
25122865|NCT02243293|50235216|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
25122866|NCT02243293|50235217|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
25122867|NCT02243293|50235218|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
25122868|NCT02243293|50235219|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
25122869|NCT02243293|50235198|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
25122870|NCT02243293|50235199|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
25122871|NCT02243293|50235200|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
25122872|NCT02243293|50235201|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
25122873|NCT02243293|50235202|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
25122874|NCT02243293|50235203|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
25261864|NCT01075282|50576510|FG001|Overall Study|Protocol Violation|2|||
25261865|NCT01075282|50576511|FG002|Overall Study|Protocol Violation|1|||
25261866|NCT01075282|50576509|FG000|Overall Study|Death|0|||
25261867|NCT01075282|50576510|FG001|Overall Study|Death|1|||
25261868|NCT01075282|50576511|FG002|Overall Study|Death|2|||
25261869|NCT01253811|50576520|FG000|Overall Study|Withdrawal criteria|1|||
25261870|NCT01295580|50576526|FG000|Overall Study|Protocol Violation|4|||
25261871|NCT01295580|50576527|FG001|Overall Study|Protocol Violation|2|||
25261872|NCT01295580|50576526|FG000|Overall Study|Withdrawal by Subject|1|||
25261873|NCT01295580|50576527|FG001|Overall Study|Withdrawal by Subject|4|||
25261874|NCT01295580|50576526|FG000|Overall Study|Adverse Event|2|||
25261875|NCT01295580|50576527|FG001|Overall Study|Adverse Event|1|||
25261876|NCT01295580|50576526|FG000|Overall Study|Lost to Follow-up|1|||
25261877|NCT01295580|50576527|FG001|Overall Study|Lost to Follow-up|0|||
25261878|NCT01295580|50576526|FG000|Overall Study|Lack of Efficacy|1|||
25261879|NCT01295580|50576527|FG001|Overall Study|Lack of Efficacy|0|||
25261880|NCT01295580|50576526|FG000|Overall Study|Other: inconvenience|1|||
25261881|NCT01295580|50576527|FG001|Overall Study|Other: inconvenience|0|||
25261882|NCT01295580|50576526|FG000|Overall Study|Other: family objection|0|||
25261883|NCT01295580|50576527|FG001|Overall Study|Other: family objection|1|||
25261884|NCT01253577|50576533|FG000|Overall Study|Lost to Follow-up|3|||
25261885|NCT01295034|50576541|FG000|Overall Study|Lost to Follow-up|5|||
25261886|NCT01295034|50576542|FG001|Overall Study|Lost to Follow-up|5|||
25261887|NCT01253421|50576553|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
25261888|NCT01253421|50576554|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
25261889|NCT01253421|50576555|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
25261890|NCT01253421|50576556|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
25261891|NCT01253421|50576557|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
25261892|NCT01253421|50576553|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
25261893|NCT01253421|50576554|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
25261894|NCT01253421|50576555|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
25261895|NCT01253421|50576556|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
25261896|NCT01253421|50576557|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
25261897|NCT01253421|50576553|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
25261898|NCT01253421|50576554|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
25261899|NCT01253421|50576555|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
25261900|NCT01253421|50576556|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
25261901|NCT01253421|50576557|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
25261902|NCT01253421|50576553|FG000|Assessment and Scheduling|Physician Decision|1|||
25261903|NCT01253421|50576554|FG001|Assessment and Scheduling|Physician Decision|0|||
25261904|NCT01253421|50576555|FG002|Assessment and Scheduling|Physician Decision|0|||
25261905|NCT01253421|50576556|FG003|Assessment and Scheduling|Physician Decision|0|||
25261906|NCT01253421|50576557|FG004|Assessment and Scheduling|Physician Decision|0|||
25261907|NCT01253421|50576553|FG000|Drug+Scanning Visit|Physician Decision|0|||
25261908|NCT01253421|50576554|FG001|Drug+Scanning Visit|Physician Decision|0|||
25261909|NCT01253421|50576555|FG002|Drug+Scanning Visit|Physician Decision|0|||
25261910|NCT01253421|50576556|FG003|Drug+Scanning Visit|Physician Decision|0|||
25261911|NCT01253421|50576557|FG004|Drug+Scanning Visit|Physician Decision|1|||
25261912|NCT01077076|50576567|FG000|First Intervention|Withdrawal by Subject|1|||
25261913|NCT01077076|50576568|FG001|First Intervention|Withdrawal by Subject|0|||
25261914|NCT01077076|50576569|FG002|First Intervention|Withdrawal by Subject|0|||
25261915|NCT01077076|50576570|FG003|First Intervention|Withdrawal by Subject|0|||
25261916|NCT01077076|50576571|FG004|First Intervention|Withdrawal by Subject|0|||
25261917|NCT01077076|50576572|FG005|First Intervention|Withdrawal by Subject|0|||
25261918|NCT01077076|50576567|FG000|Third Intervention|Death in the participant's family|0|||
25122875|NCT02243293|50235204|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
25122876|NCT02243293|50235205|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
25122877|NCT02243293|50235206|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
25122878|NCT02243293|50235207|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
25122879|NCT02243293|50235208|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
25122880|NCT02243293|50235209|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
25122881|NCT02243293|50235210|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
25122882|NCT02243293|50235211|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
25122883|NCT02243293|50235212|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
25122884|NCT02243293|50235213|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
25122885|NCT02243293|50235214|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
25122886|NCT02243293|50235215|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
25122887|NCT02243293|50235216|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
25122888|NCT02243293|50235217|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
25122889|NCT02243293|50235218|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
25122890|NCT02243293|50235219|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
25122891|NCT02322047|50235260|FG000|Overall Study|Physician Decision|1|||
25122892|NCT02322047|50235261|FG001|Overall Study|Physician Decision|0|||
25122893|NCT02322047|50235262|FG002|Overall Study|Physician Decision|0|||
25122894|NCT02322047|50235263|FG003|Overall Study|Physician Decision|0|||
25122895|NCT02322047|50235260|FG000|Overall Study|Withdrawal by Subject|1|||
25122896|NCT02322047|50235261|FG001|Overall Study|Withdrawal by Subject|0|||
25122897|NCT02322047|50235262|FG002|Overall Study|Withdrawal by Subject|0|||
25122898|NCT02322047|50235263|FG003|Overall Study|Withdrawal by Subject|1|||
25122899|NCT02322047|50235260|FG000|Overall Study|Adverse Event|0|||
25122900|NCT02322047|50235261|FG001|Overall Study|Adverse Event|1|||
25122901|NCT02322047|50235262|FG002|Overall Study|Adverse Event|0|||
25122902|NCT02322047|50235263|FG003|Overall Study|Adverse Event|0|||
25122903|NCT02322047|50235260|FG000|Overall Study|Lost to Follow-up|0|||
25122904|NCT02322047|50235261|FG001|Overall Study|Lost to Follow-up|0|||
25122905|NCT02322047|50235262|FG002|Overall Study|Lost to Follow-up|1|||
25122906|NCT02322047|50235263|FG003|Overall Study|Lost to Follow-up|1|||
25122907|NCT02254291|50235276|FG000|Overall Study|Withdrawal by Subject|0|||
25122908|NCT02254291|50235277|FG001|Overall Study|Withdrawal by Subject|3|||
25122909|NCT02254291|50235278|FG002|Overall Study|Withdrawal by Subject|1|||
25261919|NCT01077076|50576568|FG001|Third Intervention|Death in the participant's family|0|||
25261920|NCT01077076|50576569|FG002|Third Intervention|Death in the participant's family|0|||
25261921|NCT01077076|50576570|FG003|Third Intervention|Death in the participant's family|0|||
25261922|NCT01077076|50576571|FG004|Third Intervention|Death in the participant's family|0|||
25261923|NCT01077076|50576572|FG005|Third Intervention|Death in the participant's family|1|||
25261924|NCT01294800|50576584|FG000|Overall Study|Adverse Event|7|||
25261925|NCT01294800|50576585|FG001|Overall Study|Adverse Event|6|||
25261926|NCT01294800|50576586|FG002|Overall Study|Adverse Event|12|||
25261927|NCT01294800|50576587|FG003|Overall Study|Adverse Event|5|||
25261928|NCT01294800|50576584|FG000|Overall Study|Subject Withdrew Consent|2|||
25261929|NCT01294800|50576585|FG001|Overall Study|Subject Withdrew Consent|2|||
25261930|NCT01294800|50576586|FG002|Overall Study|Subject Withdrew Consent|2|||
25261931|NCT01294800|50576587|FG003|Overall Study|Subject Withdrew Consent|11|||
25261932|NCT01294800|50576584|FG000|Overall Study|Lost to Follow-up|0|||
25261933|NCT01294800|50576585|FG001|Overall Study|Lost to Follow-up|0|||
25261934|NCT01294800|50576586|FG002|Overall Study|Lost to Follow-up|1|||
25261935|NCT01294800|50576587|FG003|Overall Study|Lost to Follow-up|0|||
25261936|NCT01294800|50576584|FG000|Overall Study|Non-compliance With Protocol|0|||
25261937|NCT01294800|50576585|FG001|Overall Study|Non-compliance With Protocol|1|||
25261938|NCT01294800|50576586|FG002|Overall Study|Non-compliance With Protocol|1|||
25261939|NCT01294800|50576587|FG003|Overall Study|Non-compliance With Protocol|0|||
25261940|NCT01294800|50576584|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
25261941|NCT01294800|50576585|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
25261942|NCT01294800|50576586|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
25261943|NCT01294800|50576587|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
25261944|NCT01294644|50576600|FG000|Overall Study|Adverse Event|2|||
25261945|NCT01294644|50576601|FG001|Overall Study|Adverse Event|0|||
25261946|NCT01294644|50576602|FG002|Overall Study|Adverse Event|1|||
25261947|NCT01294644|50576600|FG000|Overall Study|Withdrawal by Subject|3|||
25261948|NCT01294644|50576601|FG001|Overall Study|Withdrawal by Subject|7|||
25261949|NCT01294644|50576602|FG002|Overall Study|Withdrawal by Subject|4|||
25261950|NCT01294644|50576600|FG000|Overall Study|Lost to Follow-up|3|||
25261951|NCT01294644|50576601|FG001|Overall Study|Lost to Follow-up|2|||
25261952|NCT01294644|50576602|FG002|Overall Study|Lost to Follow-up|5|||
25261953|NCT01294644|50576600|FG000|Overall Study|Miscellaneous Reason|2|||
25261954|NCT01294644|50576601|FG001|Overall Study|Miscellaneous Reason|1|||
25261955|NCT01294644|50576602|FG002|Overall Study|Miscellaneous Reason|4|||
25261956|NCT01293240|50576610|FG000|Overall Study|Noncompliance|2|||
25008733|NCT03486834|50101826|FG002|Overall Study|Lost to Follow-up|39|||
25122910|NCT02254291|50235276|FG000|Overall Study|Missing follow-up information|0|||
25122911|NCT02254291|50235277|FG001|Overall Study|Missing follow-up information|0|||
25122912|NCT02254291|50235278|FG002|Overall Study|Missing follow-up information|1|||
25122913|NCT02253433|50235288|FG000|Overall Study|Unable to Contact|9|||
25122914|NCT02253433|50235289|FG001|Overall Study|Unable to Contact|16|||
25122915|NCT02253433|50235288|FG000|Overall Study|Death|1|||
25122916|NCT02253433|50235289|FG001|Overall Study|Death|1|||
25122917|NCT02253433|50235288|FG000|Overall Study|No Longer Interested|3|||
25122918|NCT02253433|50235289|FG001|Overall Study|No Longer Interested|15|||
25122919|NCT02253433|50235288|FG000|Overall Study|Out of Study Area|2|||
25122920|NCT02253433|50235289|FG001|Overall Study|Out of Study Area|7|||
25122921|NCT02253433|50235288|FG000|Overall Study|Uncomfortable with home visitors|0|||
25122922|NCT02253433|50235289|FG001|Overall Study|Uncomfortable with home visitors|3|||
25122923|NCT02253433|50235288|FG000|Overall Study|Unstable Housing/Homeless|0|||
25122924|NCT02253433|50235289|FG001|Overall Study|Unstable Housing/Homeless|7|||
25122925|NCT02253433|50235288|FG000|Overall Study|Too Busy|0|||
25122926|NCT02253433|50235289|FG001|Overall Study|Too Busy|4|||
25122927|NCT02253433|50235288|FG000|Overall Study|Medical or Other Concerns|1|||
25122928|NCT02253433|50235289|FG001|Overall Study|Medical or Other Concerns|2|||
25122929|NCT02242981|50235296|FG000|Overall Study|Withdrawal by Subject|1|||
25122930|NCT02277743|50235303|FG000|Overall Study|Protocol Violation|1|||
25122931|NCT02277743|50235304|FG001|Overall Study|Protocol Violation|1|||
25122932|NCT02277743|50235305|FG002|Overall Study|Protocol Violation|1|||
25122933|NCT02277743|50235303|FG000|Overall Study|Adverse Event|10|||
25122934|NCT02277743|50235304|FG001|Overall Study|Adverse Event|6|||
25122935|NCT02277743|50235305|FG002|Overall Study|Adverse Event|6|||
25122936|NCT02277743|50235303|FG000|Overall Study|Lack of Efficacy|11|||
25122937|NCT02277743|50235304|FG001|Overall Study|Lack of Efficacy|4|||
25122938|NCT02277743|50235305|FG002|Overall Study|Lack of Efficacy|3|||
25122939|NCT02277743|50235303|FG000|Overall Study|Other than specified above|18|||
25122940|NCT02277743|50235304|FG001|Overall Study|Other than specified above|5|||
25122941|NCT02277743|50235305|FG002|Overall Study|Other than specified above|16|||
25122942|NCT02242903|50235320|FG000|Overall Study|Withdrawal by Subject|1|||
25122943|NCT02242903|50235321|FG001|Overall Study|Withdrawal by Subject|0|||
25122944|NCT02242903|50235322|FG002|Overall Study|Withdrawal by Subject|0|||
25122945|NCT02242903|50235323|FG003|Overall Study|Withdrawal by Subject|0|||
25122946|NCT02242903|50235324|FG004|Overall Study|Withdrawal by Subject|0|||
25122947|NCT02242903|50235325|FG005|Overall Study|Withdrawal by Subject|0|||
25122948|NCT02242903|50235326|FG006|Overall Study|Withdrawal by Subject|0|||
25122949|NCT02320721|50235350|FG000|Overall Study|Adverse Event|6|||
25122950|NCT02320721|50235351|FG001|Overall Study|Adverse Event|6|||
25122951|NCT02320721|50235350|FG000|Overall Study|Lack of Efficacy|2|||
25122952|NCT02320721|50235351|FG001|Overall Study|Lack of Efficacy|0|||
25122953|NCT02320721|50235350|FG000|Overall Study|Poor compliance to protocol|3|||
25122954|NCT02320721|50235351|FG001|Overall Study|Poor compliance to protocol|7|||
25122955|NCT02320721|50235350|FG000|Overall Study|Randomized but not treated|0|||
25122956|NCT02320721|50235351|FG001|Overall Study|Randomized but not treated|1|||
25122957|NCT02320721|50235350|FG000|Overall Study|Hypoglycemia|1|||
25122958|NCT02320721|50235351|FG001|Overall Study|Hypoglycemia|0|||
25261957|NCT01253265|50576619|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
25008734|NCT03486834|50101824|FG000|Overall Study|Non-compliance with Study Drug|2|||
25008735|NCT03486834|50101825|FG001|Overall Study|Non-compliance with Study Drug|2|||
25008736|NCT03486834|50101826|FG002|Overall Study|Non-compliance with Study Drug|0|||
25008737|NCT03486834|50101824|FG000|Overall Study|Physician Decision|5|||
25008738|NCT03486834|50101825|FG001|Overall Study|Physician Decision|2|||
25008739|NCT03486834|50101826|FG002|Overall Study|Physician Decision|3|||
25008740|NCT03486834|50101824|FG000|Overall Study|Pregnancy|10|||
25008741|NCT03486834|50101825|FG001|Overall Study|Pregnancy|12|||
25008742|NCT03486834|50101826|FG002|Overall Study|Pregnancy|12|||
25008743|NCT03486834|50101824|FG000|Overall Study|Protocol Deviation|2|||
25008744|NCT03486834|50101825|FG001|Overall Study|Protocol Deviation|3|||
25008745|NCT03486834|50101826|FG002|Overall Study|Protocol Deviation|3|||
25008746|NCT03486834|50101824|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
25008747|NCT03486834|50101825|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
25008748|NCT03486834|50101826|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
25008749|NCT03486834|50101824|FG000|Overall Study|Randomized but not treated|4|||
25122959|NCT02320721|50235350|FG000|Overall Study|Other than specified above|15|||
25122960|NCT02320721|50235351|FG001|Overall Study|Other than specified above|20|||
25122961|NCT02320487|50235357|FG000|Overall Study|Reason not Specified|1|||
25122962|NCT02320487|50235357|FG000|Overall Study|Physician Decision|5|||
25122963|NCT02320487|50235357|FG000|Overall Study|Withdrawal by Subject|1|||
25122964|NCT02320487|50235357|FG000|Overall Study|Death|3|||
25008750|NCT03486834|50101825|FG001|Overall Study|Randomized but not treated|4|||
25008751|NCT03486834|50101826|FG002|Overall Study|Randomized but not treated|1|||
25008752|NCT03522948|50101836|FG000|Overall Study|Lost to Follow-up|1|||
25008753|NCT03406078|50101842|FG000|Overall Study|Death|1|||
25008754|NCT03406078|50101843|FG001|Overall Study|Death|0|||
25122965|NCT02320487|50235357|FG000|Overall Study|Adverse Event|11|||
25122966|NCT02277119|50235364|FG000|Overall Study|Lack of Efficacy|1|||
25122967|NCT02277119|50235365|FG001|Overall Study|Lack of Efficacy|1|||
25122968|NCT02277119|50235366|FG002|Overall Study|Lack of Efficacy|1|||
25122969|NCT02277119|50235364|FG000|Overall Study|Protocol Violation|2|||
25122970|NCT02277119|50235365|FG001|Overall Study|Protocol Violation|3|||
25122971|NCT02277119|50235366|FG002|Overall Study|Protocol Violation|7|||
25122972|NCT02320253|50235377|FG000|Overall Study|Withdrawal by Subject|3|||
25122973|NCT02320253|50235378|FG001|Overall Study|Withdrawal by Subject|0|||
25122974|NCT02320253|50235379|FG002|Overall Study|Withdrawal by Subject|0|||
25122975|NCT02320253|50235377|FG000|Overall Study|Lost to Follow-up|2|||
25122976|NCT02320253|50235378|FG001|Overall Study|Lost to Follow-up|2|||
25122977|NCT02320253|50235379|FG002|Overall Study|Lost to Follow-up|1|||
25122978|NCT02320253|50235377|FG000|Overall Study|Death|1|||
25122979|NCT02320253|50235378|FG001|Overall Study|Death|0|||
25122980|NCT02320253|50235379|FG002|Overall Study|Death|1|||
25122981|NCT02276807|50235389|FG000|Overall Study|Withdrawal by Subject|8|||
25122982|NCT02276807|50235390|FG001|Overall Study|Withdrawal by Subject|7|||
25122983|NCT02276807|50235389|FG000|Overall Study|Lost to Follow-up|10|||
25122984|NCT02276807|50235390|FG001|Overall Study|Lost to Follow-up|10|||
25122985|NCT02252965|50235398|FG000|Overall Study|Adverse Event|9|||
25122986|NCT02252965|50235399|FG001|Overall Study|Adverse Event|14|||
25122987|NCT02252965|50235398|FG000|Overall Study|Lost to Follow-up|16|||
25122988|NCT02252965|50235399|FG001|Overall Study|Lost to Follow-up|8|||
25122989|NCT02252965|50235398|FG000|Overall Study|Protocol Violation|4|||
25122990|NCT02252965|50235399|FG001|Overall Study|Protocol Violation|5|||
25122991|NCT02252965|50235398|FG000|Overall Study|Lack of Efficacy|0|||
25122992|NCT02252965|50235399|FG001|Overall Study|Lack of Efficacy|2|||
25122993|NCT02252965|50235398|FG000|Overall Study|Withdrawal by Subject|7|||
25122994|NCT02252965|50235399|FG001|Overall Study|Withdrawal by Subject|9|||
25122995|NCT02252965|50235398|FG000|Overall Study|Other|4|||
25122996|NCT02252965|50235399|FG001|Overall Study|Other|5|||
25122997|NCT02242435|50235409|FG000|Overall Study|Lost to Follow-up|3|||
25122998|NCT02242435|50235410|FG001|Overall Study|Lost to Follow-up|4|||
25122999|NCT02242435|50235409|FG000|Overall Study|Adverse Event|3|||
25123000|NCT02242435|50235410|FG001|Overall Study|Adverse Event|2|||
25123001|NCT02242435|50235409|FG000|Overall Study|Withdrawal by Subject|13|||
25123002|NCT02242435|50235410|FG001|Overall Study|Withdrawal by Subject|8|||
25123003|NCT02242435|50235409|FG000|Overall Study|Death|0|||
25123004|NCT02242435|50235410|FG001|Overall Study|Death|1|||
25123005|NCT02242435|50235409|FG000|Overall Study|Protocol Violation|1|||
25123006|NCT02242435|50235410|FG001|Overall Study|Protocol Violation|0|||
25123007|NCT02242435|50235409|FG000|Overall Study|Physician Decision|0|||
25123008|NCT02242435|50235410|FG001|Overall Study|Physician Decision|1|||
25123009|NCT02251717|50235418|FG000|Overall Study|Adverse Event|0|||
25123010|NCT02251717|50235419|FG001|Overall Study|Adverse Event|1|||
25123011|NCT02251717|50235418|FG000|Overall Study|Withdrew Consent|1|||
25123012|NCT02251717|50235419|FG001|Overall Study|Withdrew Consent|0|||
25123013|NCT02242201|50235428|FG000|Overall Study|preoperative identified neuropathy|2|||
25123014|NCT02242201|50235429|FG001|Overall Study|preoperative identified neuropathy|0|||
25123015|NCT02242201|50235430|FG002|Overall Study|preoperative identified neuropathy|0|||
25123016|NCT02242201|50235428|FG000|Overall Study|planned post-op anticoagulation|1|||
25123017|NCT02242201|50235429|FG001|Overall Study|planned post-op anticoagulation|0|||
25123018|NCT02242201|50235430|FG002|Overall Study|planned post-op anticoagulation|0|||
25123019|NCT02242201|50235428|FG000|Overall Study|changed surgical procedure|1|||
25123020|NCT02242201|50235429|FG001|Overall Study|changed surgical procedure|0|||
25123021|NCT02242201|50235430|FG002|Overall Study|changed surgical procedure|0|||
25123022|NCT02242201|50235428|FG000|Overall Study|postponed surgery|0|||
25123023|NCT02242201|50235429|FG001|Overall Study|postponed surgery|0|||
25123024|NCT02242201|50235430|FG002|Overall Study|postponed surgery|1|||
25123025|NCT02242201|50235428|FG000|Overall Study|preoperative opioid consumption|0|||
25123026|NCT02242201|50235429|FG001|Overall Study|preoperative opioid consumption|1|||
25123027|NCT02242201|50235430|FG002|Overall Study|preoperative opioid consumption|0|||
25123028|NCT02242045|50235438|FG000|Overall Study|Investigator's Discretion|1|||
25123029|NCT02242045|50235438|FG000|Overall Study|Progressive Disease|2|||
25123030|NCT02242045|50235438|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
25123031|NCT02242045|50235438|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
25008755|NCT03406078|50101842|FG000|Overall Study|Lost to Follow-up|0|||
25008756|NCT03406078|50101843|FG001|Overall Study|Lost to Follow-up|1|||
25008757|NCT03406078|50101842|FG000|Overall Study|Withdrawal by Subject|5|||
25008758|NCT03406078|50101843|FG001|Overall Study|Withdrawal by Subject|2|||
25008759|NCT03634033|50101856|FG000|Overall Study|Did not have a post-assessment|384|||
25123032|NCT02241889|50235442|FG000|Overall Study|device issues|0|||
25123033|NCT02241889|50235443|FG001|Overall Study|device issues|0|||
25123034|NCT02241889|50235444|FG002|Overall Study|device issues|1|||
25123035|NCT02241889|50235445|FG003|Overall Study|device issues|0|||
25123036|NCT02241889|50235446|FG004|Overall Study|device issues|0|||
25008760|NCT03634033|50101857|FG001|Overall Study|Did not have a post-assessment|291|||
25123037|NCT02241889|50235447|FG005|Overall Study|device issues|0|||
25123038|NCT02241889|50235442|FG000|Overall Study|Withdrawal by Subject|0|||
25123039|NCT02241889|50235443|FG001|Overall Study|Withdrawal by Subject|0|||
25123040|NCT02241889|50235444|FG002|Overall Study|Withdrawal by Subject|0|||
25123041|NCT02241889|50235445|FG003|Overall Study|Withdrawal by Subject|0|||
25123042|NCT02241889|50235446|FG004|Overall Study|Withdrawal by Subject|0|||
25123043|NCT02241889|50235447|FG005|Overall Study|Withdrawal by Subject|1|||
25123044|NCT02241733|50235457|FG000|Overall Study|Lost to Follow-up|9|||
25123045|NCT02241733|50235458|FG001|Overall Study|Lost to Follow-up|4|||
25123046|NCT02241733|50235457|FG000|Overall Study|Physician Decision|6|||
25123047|NCT02241733|50235458|FG001|Overall Study|Physician Decision|2|||
25123048|NCT02241733|50235457|FG000|Overall Study|Withdrawal by Subject|0|||
25123049|NCT02241733|50235458|FG001|Overall Study|Withdrawal by Subject|2|||
25123050|NCT02241733|50235457|FG000|Overall Study|Death|0|||
25123051|NCT02241733|50235458|FG001|Overall Study|Death|2|||
25123052|NCT02241343|50235464|FG000|Overall Study|Adverse Event|1|||
25123053|NCT02241187|50235469|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
25123054|NCT02249767|50235476|FG000|Overall Study|Did not use medication|8|||
25123055|NCT02249767|50235477|FG001|Overall Study|Did not use medication|9|||
25123056|NCT02249767|50235478|FG002|Overall Study|Did not use medication|8|||
25123057|NCT02239939|50235488|FG000|Overall Study|Adverse Event|1|||
25123058|NCT02239939|50235489|FG001|Overall Study|Adverse Event|0|||
25123059|NCT02239939|50235488|FG000|Overall Study|Withdrawal by Subject|1|||
25123060|NCT02239939|50235489|FG001|Overall Study|Withdrawal by Subject|1|||
25123061|NCT02239939|50235488|FG000|Overall Study|Lost to Follow-up|0|||
25123062|NCT02239939|50235489|FG001|Overall Study|Lost to Follow-up|1|||
25123063|NCT02248675|50235499|FG000|Overall Study|Lost to Follow-up|3|||
25123064|NCT02248675|50235500|FG001|Overall Study|Lost to Follow-up|1|||
25123065|NCT02207725|50235510|FG000|Overall Study|Did Not Receive Treatment|0|||
25123066|NCT02207725|50235511|FG001|Overall Study|Did Not Receive Treatment|1|||
25123067|NCT02207725|50235512|FG002|Overall Study|Did Not Receive Treatment|1|||
25123068|NCT02207725|50235513|FG003|Overall Study|Did Not Receive Treatment|1|||
25123069|NCT02238379|50235527|FG000|Overall Study|Lost to Follow-up|1|||
25123070|NCT02238379|50235528|FG001|Overall Study|Lost to Follow-up|0|||
25123071|NCT02238067|50235534|FG000|Overall Study|Not completed survey at Month 6|45|||
25123072|NCT02237911|50235541|FG000|Overall Study|Withdrawal by Subject|4|||
25123073|NCT02237911|50235542|FG001|Overall Study|Withdrawal by Subject|7|||
25123074|NCT02237911|50235543|FG002|Overall Study|Withdrawal by Subject|2|||
25123075|NCT02237911|50235541|FG000|Overall Study|Lost to Follow-up|3|||
25123076|NCT02237911|50235542|FG001|Overall Study|Lost to Follow-up|1|||
25123077|NCT02237911|50235543|FG002|Overall Study|Lost to Follow-up|1|||
25123078|NCT02234479|50235553|FG000|Overall Study|Withdrawal by Subject|1|||
25123079|NCT02234479|50235554|FG001|Overall Study|Withdrawal by Subject|3|||
25123080|NCT02207491|50235562|FG000|Overall Study|Adverse Event|20|||
25123081|NCT02207491|50235563|FG001|Overall Study|Adverse Event|4|||
25123082|NCT02207491|50235562|FG000|Overall Study|Withdrawal by Subject|3|||
25123083|NCT02207491|50235563|FG001|Overall Study|Withdrawal by Subject|2|||
25123084|NCT02207491|50235562|FG000|Overall Study|Non-compliant|0|||
25123085|NCT02207491|50235563|FG001|Overall Study|Non-compliant|1|||
25123086|NCT02207491|50235562|FG000|Overall Study|Lost to Follow-up|0|||
25123087|NCT02207491|50235563|FG001|Overall Study|Lost to Follow-up|1|||
25123088|NCT02207491|50235562|FG000|Overall Study|Lack of Efficacy|3|||
25123089|NCT02207491|50235563|FG001|Overall Study|Lack of Efficacy|0|||
25123090|NCT02207491|50235562|FG000|Overall Study|Physician Decision|2|||
25261958|NCT01253265|50576620|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
25261959|NCT01253265|50576621|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
25123091|NCT02207491|50235563|FG001|Overall Study|Physician Decision|0|||
25123092|NCT02207491|50235562|FG000|Overall Study|Protocol Violation|3|||
25123093|NCT02207491|50235563|FG001|Overall Study|Protocol Violation|5|||
25123094|NCT02315066|50235583|FG000|Overall Study|Lost to Follow-up|0|||
25123095|NCT02315066|50235584|FG001|Overall Study|Lost to Follow-up|1|||
25123096|NCT02315066|50235585|FG002|Overall Study|Lost to Follow-up|1|||
25123097|NCT02315066|50235586|FG003|Overall Study|Lost to Follow-up|0|||
25123098|NCT02315066|50235587|FG004|Overall Study|Lost to Follow-up|1|||
25123099|NCT02315066|50235588|FG005|Overall Study|Lost to Follow-up|0|||
25123100|NCT02315066|50235589|FG006|Overall Study|Lost to Follow-up|2|||
25123101|NCT02315066|50235590|FG007|Overall Study|Lost to Follow-up|1|||
25123102|NCT02315066|50235591|FG008|Overall Study|Lost to Follow-up|0|||
25123103|NCT02315066|50235592|FG009|Overall Study|Lost to Follow-up|0|||
25123104|NCT02315066|50235593|FG010|Overall Study|Lost to Follow-up|1|||
25123105|NCT02315066|50235594|FG011|Overall Study|Lost to Follow-up|2|||
25123106|NCT02315066|50235595|FG012|Overall Study|Lost to Follow-up|0|||
25123107|NCT02315066|50235596|FG013|Overall Study|Lost to Follow-up|4|||
25123108|NCT02315066|50235583|FG000|Overall Study|Death|2|||
25123109|NCT02315066|50235584|FG001|Overall Study|Death|7|||
25123110|NCT02315066|50235585|FG002|Overall Study|Death|6|||
25123111|NCT02315066|50235586|FG003|Overall Study|Death|11|||
25261960|NCT01253265|50576622|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
25123112|NCT02315066|50235587|FG004|Overall Study|Death|10|||
25123113|NCT02315066|50235588|FG005|Overall Study|Death|3|||
25123114|NCT02315066|50235589|FG006|Overall Study|Death|9|||
25123115|NCT02315066|50235590|FG007|Overall Study|Death|9|||
25123116|NCT02315066|50235591|FG008|Overall Study|Death|10|||
25123117|NCT02315066|50235592|FG009|Overall Study|Death|8|||
25123118|NCT02315066|50235593|FG010|Overall Study|Death|10|||
25123119|NCT02315066|50235594|FG011|Overall Study|Death|7|||
25123120|NCT02315066|50235595|FG012|Overall Study|Death|8|||
25123121|NCT02315066|50235596|FG013|Overall Study|Death|21|||
25123122|NCT02315066|50235583|FG000|Overall Study|Other|0|||
25123123|NCT02315066|50235584|FG001|Overall Study|Other|0|||
25123124|NCT02315066|50235585|FG002|Overall Study|Other|0|||
25123125|NCT02315066|50235586|FG003|Overall Study|Other|0|||
25123126|NCT02315066|50235587|FG004|Overall Study|Other|0|||
25123127|NCT02315066|50235588|FG005|Overall Study|Other|0|||
25123128|NCT02315066|50235589|FG006|Overall Study|Other|0|||
25123129|NCT02315066|50235590|FG007|Overall Study|Other|1|||
25123130|NCT02315066|50235591|FG008|Overall Study|Other|1|||
25123131|NCT02315066|50235592|FG009|Overall Study|Other|2|||
25008761|NCT03634033|50101858|FG002|Overall Study|Did not have a post-assessment|114|||
25123132|NCT02315066|50235593|FG010|Overall Study|Other|0|||
25123133|NCT02315066|50235594|FG011|Overall Study|Other|0|||
25123134|NCT02315066|50235595|FG012|Overall Study|Other|0|||
25123135|NCT02315066|50235596|FG013|Overall Study|Other|0|||
25123136|NCT02315066|50235583|FG000|Overall Study|Subject refused further follow-up|0|||
25123137|NCT02315066|50235584|FG001|Overall Study|Subject refused further follow-up|2|||
25123138|NCT02315066|50235585|FG002|Overall Study|Subject refused further follow-up|2|||
25123139|NCT02315066|50235586|FG003|Overall Study|Subject refused further follow-up|0|||
25123140|NCT02315066|50235587|FG004|Overall Study|Subject refused further follow-up|0|||
25123141|NCT02315066|50235588|FG005|Overall Study|Subject refused further follow-up|0|||
25123142|NCT02315066|50235589|FG006|Overall Study|Subject refused further follow-up|2|||
25123143|NCT02315066|50235590|FG007|Overall Study|Subject refused further follow-up|3|||
25123144|NCT02315066|50235591|FG008|Overall Study|Subject refused further follow-up|0|||
25123145|NCT02315066|50235592|FG009|Overall Study|Subject refused further follow-up|1|||
25123146|NCT02315066|50235593|FG010|Overall Study|Subject refused further follow-up|1|||
25123147|NCT02315066|50235594|FG011|Overall Study|Subject refused further follow-up|2|||
25123148|NCT02315066|50235595|FG012|Overall Study|Subject refused further follow-up|2|||
25123149|NCT02315066|50235596|FG013|Overall Study|Subject refused further follow-up|4|||
25123150|NCT02315066|50235583|FG000|Overall Study|Study ongoing at date of cut-off|0|||
25123151|NCT02315066|50235584|FG001|Overall Study|Study ongoing at date of cut-off|0|||
25123152|NCT02315066|50235585|FG002|Overall Study|Study ongoing at date of cut-off|0|||
25123153|NCT02315066|50235586|FG003|Overall Study|Study ongoing at date of cut-off|0|||
25123154|NCT02315066|50235587|FG004|Overall Study|Study ongoing at date of cut-off|0|||
25123155|NCT02315066|50235588|FG005|Overall Study|Study ongoing at date of cut-off|0|||
25123156|NCT02315066|50235589|FG006|Overall Study|Study ongoing at date of cut-off|0|||
25123157|NCT02315066|50235590|FG007|Overall Study|Study ongoing at date of cut-off|0|||
25123158|NCT02315066|50235591|FG008|Overall Study|Study ongoing at date of cut-off|0|||
25123159|NCT02315066|50235592|FG009|Overall Study|Study ongoing at date of cut-off|0|||
25123160|NCT02315066|50235593|FG010|Overall Study|Study ongoing at date of cut-off|0|||
25123161|NCT02315066|50235594|FG011|Overall Study|Study ongoing at date of cut-off|0|||
25123162|NCT02315066|50235595|FG012|Overall Study|Study ongoing at date of cut-off|0|||
25123163|NCT02315066|50235596|FG013|Overall Study|Study ongoing at date of cut-off|1|||
25123164|NCT02207413|50235632|FG000|Overall Study|Withdrawal by Subject|1|||
25123165|NCT02207413|50235633|FG001|Overall Study|Withdrawal by Subject|0|||
25123166|NCT02207413|50235634|FG002|Overall Study|Withdrawal by Subject|0|||
25123167|NCT02207413|50235635|FG003|Overall Study|Withdrawal by Subject|0|||
25123168|NCT02207413|50235636|FG004|Overall Study|Withdrawal by Subject|3|||
25123169|NCT02207413|50235637|FG005|Overall Study|Withdrawal by Subject|7|||
25123170|NCT02207413|50235632|FG000|Overall Study|Lost to Follow-up|0|||
25123171|NCT02207413|50235633|FG001|Overall Study|Lost to Follow-up|0|||
25123172|NCT02207413|50235634|FG002|Overall Study|Lost to Follow-up|0|||
25123173|NCT02207413|50235635|FG003|Overall Study|Lost to Follow-up|1|||
25123174|NCT02207413|50235636|FG004|Overall Study|Lost to Follow-up|1|||
25123175|NCT02207413|50235637|FG005|Overall Study|Lost to Follow-up|5|||
25123176|NCT02207413|50235632|FG000|Overall Study|Adverse Event|0|||
25123177|NCT02207413|50235633|FG001|Overall Study|Adverse Event|0|||
25123178|NCT02207413|50235634|FG002|Overall Study|Adverse Event|0|||
25123179|NCT02207413|50235635|FG003|Overall Study|Adverse Event|0|||
25123180|NCT02207413|50235636|FG004|Overall Study|Adverse Event|2|||
25123181|NCT02207413|50235637|FG005|Overall Study|Adverse Event|1|||
25123182|NCT02207413|50235632|FG000|Overall Study|Migrated/moved from study area|0|||
25008762|NCT03634033|50101859|FG003|Overall Study|Did not have a post-assessment|161|||
25123183|NCT02207413|50235633|FG001|Overall Study|Migrated/moved from study area|0|||
25123184|NCT02207413|50235634|FG002|Overall Study|Migrated/moved from study area|0|||
25123185|NCT02207413|50235635|FG003|Overall Study|Migrated/moved from study area|0|||
25123186|NCT02207413|50235636|FG004|Overall Study|Migrated/moved from study area|1|||
25123187|NCT02207413|50235637|FG005|Overall Study|Migrated/moved from study area|0|||
25123188|NCT02309372|50235659|FG000|Overall Study|Lost to Follow-up|3|||
25123189|NCT02309372|50235660|FG001|Overall Study|Lost to Follow-up|2|||
25123190|NCT02276027|50235670|FG000|Overall Study|Death|1|||
25123191|NCT02276027|50235671|FG001|Overall Study|Death|0|||
25123192|NCT02276027|50235672|FG002|Overall Study|Death|0|||
25123193|NCT02276027|50235673|FG003|Overall Study|Death|2|||
25123194|NCT02276027|50235670|FG000|Overall Study|Physician Decision|0|||
25123195|NCT02276027|50235671|FG001|Overall Study|Physician Decision|0|||
25123196|NCT02276027|50235672|FG002|Overall Study|Physician Decision|0|||
25123197|NCT02276027|50235673|FG003|Overall Study|Physician Decision|1|||
25123198|NCT02276027|50235670|FG000|Overall Study|Progressive disease|1|||
25123199|NCT02276027|50235671|FG001|Overall Study|Progressive disease|13|||
25123200|NCT02276027|50235672|FG002|Overall Study|Progressive disease|12|||
25123201|NCT02276027|50235673|FG003|Overall Study|Progressive disease|14|||
25123202|NCT02276027|50235670|FG000|Overall Study|Subject/guardian decision|0|||
25123203|NCT02276027|50235671|FG001|Overall Study|Subject/guardian decision|1|||
25123204|NCT02276027|50235672|FG002|Overall Study|Subject/guardian decision|0|||
25123205|NCT02276027|50235673|FG003|Overall Study|Subject/guardian decision|3|||
25123206|NCT02276027|50235670|FG000|Overall Study|Adverse Event|0|||
25123207|NCT02276027|50235671|FG001|Overall Study|Adverse Event|2|||
25123208|NCT02276027|50235672|FG002|Overall Study|Adverse Event|8|||
25123209|NCT02276027|50235673|FG003|Overall Study|Adverse Event|2|||
25123210|NCT02309294|50235683|FG000|Overall Study|Withdrawal by Subject|2|||
25123211|NCT02233543|50235687|FG000|Period 1|Withdrawal by Subject|1|||
25123212|NCT02233543|50235688|FG001|Period 1|Withdrawal by Subject|0|||
25123213|NCT02233543|50235687|FG000|Period 1|Participants required other treatment.|2|||
25123214|NCT02233543|50235688|FG001|Period 1|Participants required other treatment.|3|||
25123215|NCT02233543|50235687|FG000|Period 2|Adverse Event|1|||
25123216|NCT02233543|50235688|FG001|Period 2|Adverse Event|0|||
25123217|NCT02233543|50235687|FG000|Period 2|Participant required other treatment.|0|||
25123218|NCT02233543|50235688|FG001|Period 2|Participant required other treatment.|1|||
25123219|NCT02233543|50235687|FG000|Period 2|COPD exacerbation|1|||
25123220|NCT02233543|50235688|FG001|Period 2|COPD exacerbation|0|||
25123221|NCT02309138|50235696|FG000|Overall Study|Withdrawal by Subject|44|||
25123222|NCT02309138|50235697|FG001|Overall Study|Withdrawal by Subject|15|||
25123223|NCT02309138|50235696|FG000|Overall Study|Protocol Violation|4|||
25123224|NCT02309138|50235697|FG001|Overall Study|Protocol Violation|2|||
25123225|NCT02309138|50235696|FG000|Overall Study|delivered before visit 2|0|||
25123226|NCT02309138|50235697|FG001|Overall Study|delivered before visit 2|1|||
25123227|NCT02233309|50235713|FG000|Overall Study|Physician Decision|5|||
25123228|NCT02204917|50235717|FG000|Overall Study|Protocol Violation|1|||
25123229|NCT02280044|50235726|FG000|Overall Study|Planned alternate|0|||
25123230|NCT02280044|50235727|FG001|Overall Study|Planned alternate|2|||
25123231|NCT02308748|50235733|FG000|Period 1|Withdrawal by Subject|0|||
25123232|NCT02308748|50235734|FG001|Period 1|Withdrawal by Subject|0|||
25123233|NCT02308748|50235735|FG002|Period 1|Withdrawal by Subject|1|||
25123234|NCT02308748|50235736|FG003|Period 1|Withdrawal by Subject|0|||
25123235|NCT02308748|50235737|FG004|Period 1|Withdrawal by Subject|0|||
25123236|NCT02308748|50235738|FG005|Period 1|Withdrawal by Subject|0|||
25123237|NCT02308748|50235739|FG006|Period 1|Withdrawal by Subject|0|||
25123238|NCT02308748|50235740|FG007|Period 1|Withdrawal by Subject|0|||
25123239|NCT02308748|50235741|FG008|Period 1|Withdrawal by Subject|0|||
25123240|NCT02308748|50235742|FG009|Period 1|Withdrawal by Subject|0|||
25123241|NCT02308748|50235733|FG000|Period 2|Adverse Event|0|||
25123242|NCT02308748|50235734|FG001|Period 2|Adverse Event|0|||
25123243|NCT02308748|50235735|FG002|Period 2|Adverse Event|0|||
25123244|NCT02308748|50235736|FG003|Period 2|Adverse Event|0|||
25123245|NCT02308748|50235737|FG004|Period 2|Adverse Event|0|||
25123246|NCT02308748|50235738|FG005|Period 2|Adverse Event|0|||
25123247|NCT02308748|50235739|FG006|Period 2|Adverse Event|0|||
25123248|NCT02308748|50235740|FG007|Period 2|Adverse Event|1|||
25123249|NCT02308748|50235741|FG008|Period 2|Adverse Event|0|||
25123250|NCT02308748|50235742|FG009|Period 2|Adverse Event|0|||
25123251|NCT02308748|50235733|FG000|Period 3|Protocol Violation|0|||
25123252|NCT02308748|50235734|FG001|Period 3|Protocol Violation|0|||
25123253|NCT02308748|50235735|FG002|Period 3|Protocol Violation|0|||
25123254|NCT02308748|50235736|FG003|Period 3|Protocol Violation|0|||
25123255|NCT02308748|50235737|FG004|Period 3|Protocol Violation|0|||
25123256|NCT02308748|50235738|FG005|Period 3|Protocol Violation|0|||
25123257|NCT02308748|50235739|FG006|Period 3|Protocol Violation|0|||
25123258|NCT02308748|50235740|FG007|Period 3|Protocol Violation|0|||
25123259|NCT02308748|50235741|FG008|Period 3|Protocol Violation|0|||
25123260|NCT02308748|50235742|FG009|Period 3|Protocol Violation|1|||
25123261|NCT02308748|50235733|FG000|Period 5|Adverse Event|1|||
25123262|NCT02308748|50235734|FG001|Period 5|Adverse Event|0|||
25123263|NCT02308748|50235735|FG002|Period 5|Adverse Event|0|||
25123264|NCT02308748|50235736|FG003|Period 5|Adverse Event|0|||
25123265|NCT02308748|50235737|FG004|Period 5|Adverse Event|0|||
25123266|NCT02308748|50235738|FG005|Period 5|Adverse Event|0|||
25123267|NCT02308748|50235739|FG006|Period 5|Adverse Event|0|||
25123268|NCT02308748|50235740|FG007|Period 5|Adverse Event|0|||
25123269|NCT02308748|50235741|FG008|Period 5|Adverse Event|1|||
25123270|NCT02308748|50235742|FG009|Period 5|Adverse Event|0|||
25123271|NCT01646216|50235756|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
25123272|NCT01646216|50235757|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
25123273|NCT01646216|50235756|FG000|Overall Study|Did not complete training|0|||
25123274|NCT01646216|50235757|FG001|Overall Study|Did not complete training|2|||
25123275|NCT01646216|50235756|FG000|Overall Study|Investigator decision|1|||
25123276|NCT01646216|50235757|FG001|Overall Study|Investigator decision|1|||
25123277|NCT02308124|50235770|FG000|Overall Study|Lost to Follow-up|6|||
25123278|NCT02308124|50235771|FG001|Overall Study|Lost to Follow-up|6|||
25123279|NCT02308124|50235772|FG002|Overall Study|Lost to Follow-up|6|||
25123280|NCT02308124|50235770|FG000|Overall Study|Adverse Event|0|||
25123281|NCT02308124|50235771|FG001|Overall Study|Adverse Event|2|||
25123282|NCT02308124|50235772|FG002|Overall Study|Adverse Event|2|||
25123283|NCT02232061|50235780|FG000|Overall Study|Administrative problems|1|||
25123284|NCT02232061|50235780|FG000|Overall Study|Withdrawal by Subject|1|||
25123285|NCT02275481|50235786|FG000|Overall Study|Death|2|||
25123286|NCT02275481|50235787|FG001|Overall Study|Death|1|||
25123287|NCT02275481|50235786|FG000|Overall Study|Lost to Follow-up|2|||
25123288|NCT02275481|50235787|FG001|Overall Study|Lost to Follow-up|0|||
25123289|NCT02275481|50235786|FG000|Overall Study|Withdrawal by Subject|3|||
25123290|NCT02275481|50235787|FG001|Overall Study|Withdrawal by Subject|0|||
25123291|NCT02275481|50235786|FG000|Overall Study|all other reasons combined|2|||
25123292|NCT02275481|50235787|FG001|Overall Study|all other reasons combined|1|||
25008763|NCT03634033|50101860|FG004|Overall Study|Did not have a post-assessment|5|||
25008764|NCT03634033|50101861|FG005|Overall Study|Did not have a post-assessment|0|||
25008765|NCT03634033|50101862|FG006|Overall Study|Did not have a post-assessment|0|||
25008766|NCT03634033|50101856|FG000|Overall Study|Death|0|||
25008767|NCT03634033|50101857|FG001|Overall Study|Death|0|||
25008768|NCT03634033|50101858|FG002|Overall Study|Death|0|||
25008769|NCT03634033|50101859|FG003|Overall Study|Death|0|||
25008770|NCT03634033|50101860|FG004|Overall Study|Death|0|||
25008771|NCT03634033|50101861|FG005|Overall Study|Death|7|||
25008772|NCT03634033|50101862|FG006|Overall Study|Death|7|||
25008773|NCT03634033|50101856|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
25008774|NCT03634033|50101857|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
25008775|NCT03634033|50101858|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
25008776|NCT03634033|50101859|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
25008777|NCT03634033|50101860|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
25008778|NCT03634033|50101861|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
25008779|NCT03634033|50101862|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
25008780|NCT03634033|50101856|FG000|Overall Study|Lost to Follow-up|0|||
25008781|NCT03634033|50101857|FG001|Overall Study|Lost to Follow-up|0|||
25008782|NCT03634033|50101858|FG002|Overall Study|Lost to Follow-up|0|||
25008783|NCT03634033|50101859|FG003|Overall Study|Lost to Follow-up|0|||
25008784|NCT03634033|50101860|FG004|Overall Study|Lost to Follow-up|0|||
25008785|NCT03634033|50101861|FG005|Overall Study|Lost to Follow-up|1|||
25008786|NCT03634033|50101862|FG006|Overall Study|Lost to Follow-up|2|||
25008787|NCT03634033|50101856|FG000|Overall Study|Withdrawal by Subject|0|||
25008788|NCT03634033|50101857|FG001|Overall Study|Withdrawal by Subject|0|||
25008789|NCT03634033|50101858|FG002|Overall Study|Withdrawal by Subject|0|||
25008790|NCT03634033|50101859|FG003|Overall Study|Withdrawal by Subject|0|||
25008791|NCT03634033|50101860|FG004|Overall Study|Withdrawal by Subject|0|||
25008792|NCT03634033|50101861|FG005|Overall Study|Withdrawal by Subject|0|||
25008793|NCT03634033|50101862|FG006|Overall Study|Withdrawal by Subject|1|||
25008794|NCT03103100|50101896|FG000|Overall Study|Adverse Event|1|||
25008795|NCT03103100|50101897|FG001|Overall Study|Adverse Event|0|||
25008796|NCT03103100|50101898|FG002|Overall Study|Adverse Event|0|||
25008797|NCT03103100|50101896|FG000|Overall Study|Physician Decision|1|||
25008798|NCT03103100|50101897|FG001|Overall Study|Physician Decision|0|||
25008799|NCT03103100|50101898|FG002|Overall Study|Physician Decision|2|||
25008800|NCT03438006|50101906|FG000|Overall Study|Adverse Event|1|||
25008801|NCT03438006|50101906|FG000|Overall Study|Lost to Follow-up|67|||
25123293|NCT02275481|50235786|FG000|Overall Study|Physician Decision|0|||
25123294|NCT02275481|50235787|FG001|Overall Study|Physician Decision|1|||
25123295|NCT02204449|50235795|FG000|Overall Study|Lost to Follow-up|7|||
25123296|NCT02204449|50235796|FG001|Overall Study|Lost to Follow-up|9|||
25123297|NCT02204449|50235795|FG000|Overall Study|Death|0|||
25123298|NCT02204449|50235796|FG001|Overall Study|Death|1|||
25008802|NCT03438006|50101906|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
25008803|NCT03438006|50101906|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
25008804|NCT04206020|50101912|FG000|Overall Study|Adverse Event|1|||
25008805|NCT04206020|50101913|FG001|Overall Study|Adverse Event|4|||
25008806|NCT04206020|50101912|FG000|Overall Study|Protocol Violation|2|||
25008807|NCT04206020|50101913|FG001|Overall Study|Protocol Violation|0|||
25008808|NCT04206020|50101912|FG000|Overall Study|Withdrawal by Subject|2|||
25008809|NCT04206020|50101913|FG001|Overall Study|Withdrawal by Subject|0|||
25008810|NCT04206020|50101912|FG000|Overall Study|Lost to Follow-up|2|||
25123299|NCT02204449|50235795|FG000|Overall Study|Withdrawal by Subject|0|||
25123300|NCT02204449|50235796|FG001|Overall Study|Withdrawal by Subject|1|||
25123301|NCT02308046|50235804|FG000|Overall Study|Negative yeast culture at Baseline|32|||
25123302|NCT02308046|50235805|FG001|Overall Study|Negative yeast culture at Baseline|33|||
25261961|NCT01253265|50576623|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
25261962|NCT01253265|50576619|FG000|Overall Study|Withdrawal by Subject|0|||
25261963|NCT01253265|50576620|FG001|Overall Study|Withdrawal by Subject|0|||
25261964|NCT01253265|50576621|FG002|Overall Study|Withdrawal by Subject|0|||
25261965|NCT01253265|50576622|FG003|Overall Study|Withdrawal by Subject|0|||
25261966|NCT01253265|50576623|FG004|Overall Study|Withdrawal by Subject|1|||
25261967|NCT01293084|50576635|FG000|Overall Study|Physician Decision|3|||
25261968|NCT01293084|50576635|FG000|Overall Study|Withdrawal by Subject|2|||
25261969|NCT01293006|50576645|FG000|Period 2|Lost to Follow-up|1|||
25123303|NCT02308046|50235804|FG000|Overall Study|Positive for STD at Baseline|1|||
25123304|NCT02308046|50235805|FG001|Overall Study|Positive for STD at Baseline|2|||
25123305|NCT02308046|50235804|FG000|Overall Study|Lost to Follow-up|1|||
25123306|NCT02308046|50235805|FG001|Overall Study|Lost to Follow-up|3|||
25123307|NCT02318693|50235813|FG000|Overall Study|Protocol Violation|0|||
25123308|NCT02318693|50235814|FG001|Overall Study|Protocol Violation|1|||
25123309|NCT02230891|50235823|FG000|Baseline|Did not meet inclusion|0|||
25123310|NCT02230891|50235824|FG001|Baseline|Did not meet inclusion|1|||
25123311|NCT02230891|50235825|FG002|Baseline|Did not meet inclusion|1|||
25123312|NCT02230891|50235823|FG000|2 Week|Withdrawal by Subject|2|||
25123313|NCT02230891|50235824|FG001|2 Week|Withdrawal by Subject|2|||
25123314|NCT02230891|50235825|FG002|2 Week|Withdrawal by Subject|0|||
25123315|NCT02230891|50235823|FG000|2 Week|Consent withdrawn|1|||
25123316|NCT02230891|50235824|FG001|2 Week|Consent withdrawn|0|||
25123317|NCT02230891|50235825|FG002|2 Week|Consent withdrawn|0|||
25123318|NCT02230891|50235823|FG000|6 Month|Withdrawal by Subject|1|||
25177501|NCT02754141|50321524|FG017|Overall Study|Not completing monotherapy|0|||
25261970|NCT01293006|50576646|FG001|Period 2|Lost to Follow-up|0|||
25261971|NCT01293006|50576647|FG002|Period 2|Lost to Follow-up|0|||
25261972|NCT01293006|50576648|FG003|Period 2|Lost to Follow-up|0|||
25261973|NCT01292928|50576663|FG000|Overall Study|Death|8|||
25261974|NCT01292928|50576663|FG000|Overall Study|Withdrawal by Subject|8|||
25261975|NCT01292928|50576663|FG000|Overall Study|Lost to Follow-up|6|||
25261976|NCT01292928|50576663|FG000|Overall Study|Physician Decision|2|||
25261977|NCT01253187|50576669|FG000|Period 2|Withdrawal by Subject|0|||
25261978|NCT01253187|50576670|FG001|Period 2|Withdrawal by Subject|0|||
25261979|NCT01253187|50576671|FG002|Period 2|Withdrawal by Subject|0|||
25261980|NCT01253187|50576672|FG003|Period 2|Withdrawal by Subject|0|||
25261981|NCT01253187|50576673|FG004|Period 2|Withdrawal by Subject|1|||
25261982|NCT01253187|50576674|FG005|Period 2|Withdrawal by Subject|0|||
25261983|NCT01253187|50576669|FG000|Period 3|Pregnancy|1|||
25261984|NCT01253187|50576670|FG001|Period 3|Pregnancy|0|||
25261985|NCT01253187|50576671|FG002|Period 3|Pregnancy|0|||
25261986|NCT01253187|50576672|FG003|Period 3|Pregnancy|0|||
25261987|NCT01253187|50576673|FG004|Period 3|Pregnancy|0|||
25261988|NCT01253187|50576674|FG005|Period 3|Pregnancy|0|||
25261989|NCT01253187|50576669|FG000|Period 3|difficulty with blood sampling|0|||
25261990|NCT01253187|50576670|FG001|Period 3|difficulty with blood sampling|1|||
25261991|NCT01253187|50576671|FG002|Period 3|difficulty with blood sampling|0|||
25261992|NCT01253187|50576672|FG003|Period 3|difficulty with blood sampling|0|||
25008811|NCT04206020|50101913|FG001|Overall Study|Lost to Follow-up|0|||
25008812|NCT04206020|50101912|FG000|Overall Study|Pregnancy|0|||
25008813|NCT04206020|50101913|FG001|Overall Study|Pregnancy|1|||
25123319|NCT02230891|50235824|FG001|6 Month|Withdrawal by Subject|1|||
25123320|NCT02230891|50235825|FG002|6 Month|Withdrawal by Subject|1|||
25123321|NCT02230891|50235823|FG000|6 Month|Physician Decision|0|||
25123322|NCT02230891|50235824|FG001|6 Month|Physician Decision|2|||
25177502|NCT02659059|50321603|FG000|Overall Study|Other reasons|6|||
25177503|NCT02659059|50321604|FG001|Overall Study|Other reasons|1|||
25177504|NCT02659059|50321603|FG000|Overall Study|Disease Progression|143|||
25177505|NCT02659059|50321604|FG001|Overall Study|Disease Progression|16|||
25177506|NCT02659059|50321603|FG000|Overall Study|Study Drug toxicity|56|||
25177507|NCT02659059|50321604|FG001|Overall Study|Study Drug toxicity|9|||
25177508|NCT02659059|50321603|FG000|Overall Study|Death|3|||
25177509|NCT02659059|50321604|FG001|Overall Study|Death|1|||
25177510|NCT02659059|50321603|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
25261993|NCT01253187|50576673|FG004|Period 3|difficulty with blood sampling|0|||
25261994|NCT01253187|50576674|FG005|Period 3|difficulty with blood sampling|0|||
25261995|NCT01253187|50576669|FG000|Period 3|non-compliance|0|||
25261996|NCT01253187|50576670|FG001|Period 3|non-compliance|0|||
25261997|NCT01253187|50576671|FG002|Period 3|non-compliance|0|||
25261998|NCT01253187|50576672|FG003|Period 3|non-compliance|0|||
25261999|NCT01253187|50576673|FG004|Period 3|non-compliance|1|||
25008814|NCT04206020|50101912|FG000|Overall Study|Unable to attend visits|1|||
25008815|NCT04206020|50101913|FG001|Overall Study|Unable to attend visits|2|||
25262000|NCT01253187|50576674|FG005|Period 3|non-compliance|0|||
25262001|NCT01252563|50576685|FG000|Overall Study|Contract Deviation|41|||
25262002|NCT01252563|50576685|FG000|Overall Study|Centralized Registration Deviation|30|||
25262003|NCT01252563|50576685|FG000|Overall Study|Lost to Follow-up|161|||
25262004|NCT01252563|50576685|FG000|Overall Study|No visit after first day of treatment|194|||
25262005|NCT01252563|50576685|FG000|Overall Study|No drug administration|6|||
25262006|NCT01292226|50576720|FG000|Overall Study|Adverse Event|5|||
25262007|NCT01292226|50576720|FG000|Overall Study|Death|1|||
25262008|NCT01292226|50576720|FG000|Overall Study|Graft loss|1|||
25262009|NCT01292226|50576720|FG000|Overall Study|Protocol Violation|3|||
25262010|NCT01292226|50576720|FG000|Overall Study|Withdrawal by Subject|1|||
25262011|NCT01292226|50576720|FG000|Overall Study|Other|2|||
25262012|NCT01290822|50576724|FG000|Overall Study|Withdrawal by Subject|1|||
25262013|NCT01290822|50576724|FG000|Overall Study|Physician Decision|10|||
25262014|NCT01075048|50576731|FG000|Overall Study|Death|4|||
25262015|NCT01075048|50576732|FG001|Overall Study|Death|17|||
25262016|NCT01075048|50576733|FG002|Overall Study|Death|12|||
25262017|NCT01075048|50576731|FG000|Overall Study|Start of other or new therapy|4|||
25262018|NCT01075048|50576732|FG001|Overall Study|Start of other or new therapy|36|||
25262019|NCT01075048|50576733|FG002|Overall Study|Start of other or new therapy|46|||
25262020|NCT01075048|50576731|FG000|Overall Study|Withdrawal by Subject|1|||
25262021|NCT01075048|50576732|FG001|Overall Study|Withdrawal by Subject|6|||
25262022|NCT01075048|50576733|FG002|Overall Study|Withdrawal by Subject|3|||
25262023|NCT01075048|50576731|FG000|Overall Study|Lost to Follow-up|0|||
25262024|NCT01075048|50576732|FG001|Overall Study|Lost to Follow-up|1|||
25262025|NCT01075048|50576733|FG002|Overall Study|Lost to Follow-up|1|||
25262026|NCT01290666|50576744|FG000|Overall Study|Lost to Follow-up|11|||
25262027|NCT01290666|50576744|FG000|Overall Study|Withdrawal by Subject|23|||
25262028|NCT01290666|50576744|FG000|Overall Study|Early Termination of Study|4|||
25262029|NCT01252251|50576748|FG000|Overall Study|Withdrawal by Subject|1|||
25262030|NCT01289574|50576755|FG000|Overall Study|Lack of Efficacy|4|||
25262031|NCT01289574|50576756|FG001|Overall Study|Lack of Efficacy|0|||
25262032|NCT01289574|50576757|FG002|Overall Study|Lack of Efficacy|1|||
25262033|NCT01289574|50576755|FG000|Overall Study|Lost to Follow-up|2|||
25262034|NCT01289574|50576756|FG001|Overall Study|Lost to Follow-up|0|||
25262035|NCT01289574|50576757|FG002|Overall Study|Lost to Follow-up|1|||
25262036|NCT01289574|50576755|FG000|Overall Study|Withdrawal by Subject|1|||
25262037|NCT01289574|50576756|FG001|Overall Study|Withdrawal by Subject|1|||
25262038|NCT01289574|50576757|FG002|Overall Study|Withdrawal by Subject|1|||
25262039|NCT01289574|50576755|FG000|Overall Study|Adverse Event|0|||
25262040|NCT01289574|50576756|FG001|Overall Study|Adverse Event|1|||
25262041|NCT01289574|50576757|FG002|Overall Study|Adverse Event|0|||
25262042|NCT01289574|50576755|FG000|Overall Study|Subject wanted alternate treatment|0|||
25262043|NCT01289574|50576756|FG001|Overall Study|Subject wanted alternate treatment|1|||
25262044|NCT01289574|50576757|FG002|Overall Study|Subject wanted alternate treatment|0|||
25262045|NCT01252095|50576768|FG000|Overall Study|Disease progression|1|||
25262046|NCT01252095|50576769|FG001|Overall Study|Disease progression|0|||
25262047|NCT01289418|50576778|FG000|Day 8 Survey|email address invalid|283|||
25262048|NCT01289418|50576778|FG000|Day 8 Survey|participants did not complete the survey|1935|||
25262049|NCT01289418|50576778|FG000|Day 29 Survey|email address invalid|283|||
25262050|NCT01289418|50576778|FG000|Day 29 Survey|participants did not complete the survey|2185|||
25262051|NCT01074658|50576784|FG000|Overall Study|No implant attempted|19|||
25262052|NCT01074502|50576788|FG000|Overall Study|Withdrawal by Subject|1|||
25262053|NCT01289028|50576792|FG000|Overall Study|Progressive Disease|49|||
25262054|NCT01289028|50576792|FG000|Overall Study|Adverse Event|14|||
25262055|NCT01289028|50576792|FG000|Overall Study|Withdrawal by Subject|6|||
25262056|NCT01289028|50576792|FG000|Overall Study|Death|4|||
25262057|NCT01289028|50576792|FG000|Overall Study|Lack of Efficacy|2|||
25262058|NCT01289028|50576792|FG000|Overall Study|No longer required|2|||
25262059|NCT01289028|50576792|FG000|Overall Study|Lost to Follow-up|2|||
25262060|NCT01289028|50576792|FG000|Overall Study|New Cancer Therapy|2|||
25262061|NCT01289028|50576792|FG000|Overall Study|Abnormal Lab Value|1|||
25262062|NCT01289028|50576792|FG000|Overall Study|Missing reason for discon|1|||
25262063|NCT01250925|50576801|FG000|Overall Study|Lost to Follow-up|1|||
25262064|NCT01250925|50576802|FG001|Overall Study|Lost to Follow-up|1|||
25262065|NCT01250925|50576803|FG002|Overall Study|Lost to Follow-up|0|||
25262066|NCT01250925|50576801|FG000|Overall Study|Withdrawal by Subject|2|||
25262067|NCT01250925|50576802|FG001|Overall Study|Withdrawal by Subject|0|||
25262068|NCT01250925|50576803|FG002|Overall Study|Withdrawal by Subject|0|||
25262069|NCT01250925|50576801|FG000|Overall Study|Protocol Violation|2|||
25262070|NCT01250925|50576802|FG001|Overall Study|Protocol Violation|0|||
25262071|NCT01250925|50576803|FG002|Overall Study|Protocol Violation|0|||
25262072|NCT01250925|50576801|FG000|Overall Study|Physician Decision|0|||
25262073|NCT01250925|50576802|FG001|Overall Study|Physician Decision|2|||
25262074|NCT01250925|50576803|FG002|Overall Study|Physician Decision|1|||
25262075|NCT01250925|50576801|FG000|Overall Study|Adverse Event|0|||
25262076|NCT01250925|50576802|FG001|Overall Study|Adverse Event|0|||
25262077|NCT01250925|50576803|FG002|Overall Study|Adverse Event|1|||
25262078|NCT01285908|50576811|FG000|Baseline Measurement|unable to insert catheter|1|||
25262079|NCT01285908|50576812|FG001|Baseline Measurement|unable to insert catheter|0|||
25262080|NCT01285908|50576813|FG002|Baseline Measurement|unable to insert catheter|0|||
25262081|NCT01285908|50576811|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
25262082|NCT01285908|50576812|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
25262083|NCT01285908|50576813|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
25262084|NCT01285908|50576811|FG000|Baseline Measurement|unable to tolerate procedure|1|||
25262085|NCT01285908|50576812|FG001|Baseline Measurement|unable to tolerate procedure|0|||
25262086|NCT01285908|50576813|FG002|Baseline Measurement|unable to tolerate procedure|0|||
25262087|NCT01250769|50576847|FG000|Overall Study|Withdrawal by Subject|0|||
25262088|NCT01250769|50576848|FG001|Overall Study|Withdrawal by Subject|1|||
25262089|NCT01250769|50576849|FG002|Overall Study|Withdrawal by Subject|1|||
25262090|NCT01250769|50576850|FG003|Overall Study|Withdrawal by Subject|0|||
25262091|NCT01250769|50576847|FG000|Overall Study|Adverse Event|0|||
25262092|NCT01250769|50576848|FG001|Overall Study|Adverse Event|0|||
25262093|NCT01250769|50576849|FG002|Overall Study|Adverse Event|1|||
25262094|NCT01250769|50576850|FG003|Overall Study|Adverse Event|0|||
25262095|NCT01074268|50576862|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
25262096|NCT01074268|50576863|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
25262097|NCT01074268|50576862|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
25262098|NCT01074268|50576863|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
25262099|NCT01074268|50576862|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
25262100|NCT01074268|50576863|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
25262101|NCT01074268|50576862|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
25262102|NCT01074268|50576863|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
25262103|NCT01074268|50576862|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
25262104|NCT01074268|50576863|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
25262105|NCT01074268|50576862|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
25262106|NCT01074268|50576863|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
25262107|NCT01074268|50576862|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
25262108|NCT01074268|50576863|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
25262109|NCT01074268|50576862|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
25262110|NCT01074268|50576863|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
25262111|NCT01074268|50576862|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
25262112|NCT01074268|50576863|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
25262113|NCT01074190|50576872|FG000|Overall Study|Emergency Cesarean Delivery|1|||
25262114|NCT01074190|50576873|FG001|Overall Study|Emergency Cesarean Delivery|2|||
25262115|NCT01074190|50576874|FG002|Overall Study|Emergency Cesarean Delivery|1|||
25262116|NCT01074190|50576872|FG000|Overall Study|Protocol Violation|2|||
25262117|NCT01074190|50576873|FG001|Overall Study|Protocol Violation|1|||
25262118|NCT01074190|50576874|FG002|Overall Study|Protocol Violation|0|||
25262119|NCT01074190|50576872|FG000|Overall Study|Delivered in under 90 minutes|0|||
25262120|NCT01074190|50576873|FG001|Overall Study|Delivered in under 90 minutes|2|||
25262121|NCT01074190|50576874|FG002|Overall Study|Delivered in under 90 minutes|1|||
25262122|NCT01074190|50576872|FG000|Overall Study|Subject withdrew consent|1|||
25262123|NCT01074190|50576873|FG001|Overall Study|Subject withdrew consent|1|||
25262124|NCT01074190|50576874|FG002|Overall Study|Subject withdrew consent|1|||
25262125|NCT01073566|50576887|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
25262126|NCT01073566|50576888|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
25262127|NCT01072396|50576896|FG000|Period One|Adverse Event|1|||
25262128|NCT01072396|50576897|FG001|Period One|Adverse Event|1|||
25262129|NCT01072396|50576896|FG000|Period One|Protocol Violation|2|||
25262130|NCT01072396|50576897|FG001|Period One|Protocol Violation|1|||
25262131|NCT01072396|50576896|FG000|Period One|Withdrawal by Subject|2|||
25262132|NCT01072396|50576897|FG001|Period One|Withdrawal by Subject|0|||
25262133|NCT01072396|50576896|FG000|Washout Period|Missing termination information|0|||
25262134|NCT01072396|50576897|FG001|Washout Period|Missing termination information|1|||
25262135|NCT01072396|50576896|FG000|Period Two|Adverse Event|0|||
25262136|NCT01072396|50576897|FG001|Period Two|Adverse Event|3|||
25262137|NCT01072396|50576896|FG000|Period Two|Lost to Follow-up|1|||
25262138|NCT01072396|50576897|FG001|Period Two|Lost to Follow-up|0|||
25262139|NCT01045096|50576906|FG000|Overall Study|Withdrawal by Subject|2|||
25262140|NCT01045096|50576907|FG001|Overall Study|Withdrawal by Subject|0|||
25262141|NCT01045096|50576908|FG002|Overall Study|Withdrawal by Subject|0|||
25262142|NCT01045096|50576906|FG000|Overall Study|Other|1|||
25262143|NCT01045096|50576907|FG001|Overall Study|Other|0|||
25262144|NCT01045096|50576908|FG002|Overall Study|Other|0|||
25262145|NCT01285518|50576924|FG000|Overall Study|Lost to Follow-up|0|||
25262146|NCT01285518|50576925|FG001|Overall Study|Lost to Follow-up|0|||
25262147|NCT01285518|50576926|FG002|Overall Study|Lost to Follow-up|0|||
25262148|NCT01285518|50576927|FG003|Overall Study|Lost to Follow-up|0|||
25262149|NCT01285518|50576928|FG004|Overall Study|Lost to Follow-up|0|||
25262150|NCT01285518|50576929|FG005|Overall Study|Lost to Follow-up|1|||
25262151|NCT01285518|50576930|FG006|Overall Study|Lost to Follow-up|0|||
25262152|NCT01285518|50576931|FG007|Overall Study|Lost to Follow-up|0|||
25262153|NCT01073020|50576954|FG000|Overall Study|Withdrawal by Subject|6|||
25262154|NCT01073020|50576955|FG001|Overall Study|Withdrawal by Subject|4|||
25262155|NCT01073020|50576956|FG002|Overall Study|Withdrawal by Subject|1|||
25262156|NCT01073020|50576957|FG003|Overall Study|Withdrawal by Subject|2|||
25262157|NCT01073020|50576954|FG000|Overall Study|Physician Decision|1|||
25262158|NCT01073020|50576955|FG001|Overall Study|Physician Decision|0|||
25262159|NCT01073020|50576956|FG002|Overall Study|Physician Decision|2|||
25262160|NCT01073020|50576957|FG003|Overall Study|Physician Decision|0|||
25262161|NCT01073020|50576954|FG000|Overall Study|Death|0|||
25262162|NCT01073020|50576955|FG001|Overall Study|Death|1|||
25262163|NCT01073020|50576956|FG002|Overall Study|Death|0|||
25262164|NCT01073020|50576957|FG003|Overall Study|Death|0|||
25262165|NCT01284114|50576967|FG000|Overall Study|viral infection|1|||
25262166|NCT01284114|50576967|FG000|Overall Study|From the results of ALLTITUDE study|1|||
25262167|NCT01284114|50576967|FG000|Overall Study|Symptomatic hypotension|1|||
25262168|NCT01284114|50576967|FG000|Overall Study|dizziness|1|||
25262169|NCT01283334|50576972|FG000|Overall Study|Withdrawal by Subject|1|||
25262170|NCT01283334|50576972|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
25262171|NCT01283334|50576972|FG000|Overall Study|Adverse Event|4|||
25262172|NCT01283334|50576972|FG000|Overall Study|Physician Decision|1|||
25262173|NCT01282866|50576978|FG000|Overall Study|Adverse Event|1|||
25262174|NCT01071070|50576984|FG000|Overall Study|Adverse Event|0|||
25262175|NCT01071070|50576985|FG001|Overall Study|Adverse Event|3|||
25262176|NCT01071070|50576984|FG000|Overall Study|Withdrawal by Subject|1|||
25262177|NCT01071070|50576985|FG001|Overall Study|Withdrawal by Subject|0|||
25262178|NCT01071070|50576984|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
25262179|NCT01071070|50576985|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
25262180|NCT01071070|50576984|FG000|Overall Study|Hypercalcemia|1|||
25262181|NCT01071070|50576985|FG001|Overall Study|Hypercalcemia|0|||
25262182|NCT01282476|50576991|FG000|Overall Study|Death|11|||
25262183|NCT01282164|50576997|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
25262184|NCT01282164|50576998|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
25262185|NCT01250379|50577014|FG000|Overall Study|Death|141|||
25262186|NCT01250379|50577015|FG001|Overall Study|Death|148|||
25262187|NCT01250379|50577014|FG000|Overall Study|Withdrawal by Subject|32|||
25262188|NCT01250379|50577015|FG001|Overall Study|Withdrawal by Subject|20|||
25262189|NCT01250379|50577014|FG000|Overall Study|Physician Decision|11|||
25262190|NCT01250379|50577015|FG001|Overall Study|Physician Decision|3|||
25262191|NCT01250379|50577014|FG000|Overall Study|Protocol Violation|2|||
25262192|NCT01250379|50577015|FG001|Overall Study|Protocol Violation|8|||
25262193|NCT01250379|50577014|FG000|Overall Study|Lost to Follow-up|9|||
25262194|NCT01250379|50577015|FG001|Overall Study|Lost to Follow-up|6|||
25262195|NCT01250379|50577014|FG000|Overall Study|Adverse Event|5|||
25262196|NCT01250379|50577015|FG001|Overall Study|Adverse Event|4|||
25262197|NCT01250379|50577014|FG000|Overall Study|Other|0|||
25262198|NCT01250379|50577015|FG001|Overall Study|Other|4|||
25262199|NCT01250379|50577014|FG000|Overall Study|Participant noncompliance|2|||
25262200|NCT01250379|50577015|FG001|Overall Study|Participant noncompliance|0|||
25262201|NCT01072630|50577024|FG000|Overall Study|Adverse Event|11|||
25262202|NCT01072630|50577025|FG001|Overall Study|Adverse Event|19|||
25262203|NCT01072630|50577026|FG002|Overall Study|Adverse Event|2|||
25262204|NCT01072630|50577024|FG000|Overall Study|Lack of Efficacy|10|||
25262205|NCT01072630|50577025|FG001|Overall Study|Lack of Efficacy|10|||
25262206|NCT01072630|50577026|FG002|Overall Study|Lack of Efficacy|1|||
25262207|NCT01072630|50577024|FG000|Overall Study|Withdrawal by Subject|8|||
25262208|NCT01072630|50577025|FG001|Overall Study|Withdrawal by Subject|7|||
25262209|NCT01072630|50577026|FG002|Overall Study|Withdrawal by Subject|2|||
25262210|NCT01072630|50577024|FG000|Overall Study|Protocol Violation|10|||
25262211|NCT01072630|50577025|FG001|Overall Study|Protocol Violation|8|||
25262212|NCT01072630|50577026|FG002|Overall Study|Protocol Violation|4|||
25262213|NCT01072630|50577024|FG000|Overall Study|Lost to Follow-up|11|||
25262214|NCT01072630|50577025|FG001|Overall Study|Lost to Follow-up|11|||
25262215|NCT01072630|50577026|FG002|Overall Study|Lost to Follow-up|1|||
25262216|NCT01072630|50577024|FG000|Overall Study|Noncompliance with study medication|1|||
25262217|NCT01072630|50577025|FG001|Overall Study|Noncompliance with study medication|1|||
25262218|NCT01072630|50577026|FG002|Overall Study|Noncompliance with study medication|1|||
25262219|NCT01072630|50577024|FG000|Overall Study|Noncompliance with study procedures|1|||
25262220|NCT01072630|50577025|FG001|Overall Study|Noncompliance with study procedures|2|||
25262221|NCT01072630|50577026|FG002|Overall Study|Noncompliance with study procedures|1|||
25262222|NCT01072630|50577024|FG000|Overall Study|Other|3|||
25008816|NCT03466086|50101919|FG000|Period 1|Sponsor decision due to study timeline|1|||
25008817|NCT03466086|50101920|FG001|Period 1|Sponsor decision due to study timeline|0|||
25008818|NCT03466086|50101919|FG000|Period 1|Withdrawal by Subject|1|||
25262223|NCT01072630|50577025|FG001|Overall Study|Other|2|||
25262224|NCT01072630|50577026|FG002|Overall Study|Other|1|||
25262225|NCT01281306|50577042|FG000|Overall Study|Lack of Efficacy|0|||
25262226|NCT01281306|50577043|FG001|Overall Study|Lack of Efficacy|1|||
25262227|NCT01281306|50577044|FG002|Overall Study|Lack of Efficacy|3|||
25262228|NCT01281306|50577045|FG003|Overall Study|Lack of Efficacy|0|||
25262229|NCT01281306|50577046|FG004|Overall Study|Lack of Efficacy|2|||
25262230|NCT01281306|50577047|FG005|Overall Study|Lack of Efficacy|0|||
25262231|NCT01281306|50577048|FG006|Overall Study|Lack of Efficacy|1|||
25262232|NCT01281306|50577042|FG000|Overall Study|Withdrawal by Subject|1|||
25262233|NCT01281306|50577043|FG001|Overall Study|Withdrawal by Subject|0|||
25262234|NCT01281306|50577044|FG002|Overall Study|Withdrawal by Subject|2|||
25262235|NCT01281306|50577045|FG003|Overall Study|Withdrawal by Subject|4|||
25262236|NCT01281306|50577046|FG004|Overall Study|Withdrawal by Subject|1|||
25262237|NCT01281306|50577047|FG005|Overall Study|Withdrawal by Subject|3|||
25262238|NCT01281306|50577048|FG006|Overall Study|Withdrawal by Subject|1|||
25262239|NCT01281306|50577042|FG000|Overall Study|Protocol deviation|0|||
25262240|NCT01281306|50577043|FG001|Overall Study|Protocol deviation|1|||
25262241|NCT01281306|50577044|FG002|Overall Study|Protocol deviation|1|||
25262242|NCT01281306|50577045|FG003|Overall Study|Protocol deviation|1|||
25262243|NCT01281306|50577046|FG004|Overall Study|Protocol deviation|1|||
25262244|NCT01281306|50577047|FG005|Overall Study|Protocol deviation|0|||
25262245|NCT01281306|50577048|FG006|Overall Study|Protocol deviation|0|||
25262246|NCT01281306|50577042|FG000|Overall Study|Condition no longer requires study drug|1|||
25262247|NCT01281306|50577043|FG001|Overall Study|Condition no longer requires study drug|0|||
25262248|NCT01281306|50577044|FG002|Overall Study|Condition no longer requires study drug|0|||
25262249|NCT01281306|50577045|FG003|Overall Study|Condition no longer requires study drug|0|||
25262250|NCT01281306|50577046|FG004|Overall Study|Condition no longer requires study drug|0|||
25262251|NCT01281306|50577047|FG005|Overall Study|Condition no longer requires study drug|1|||
25262252|NCT01281306|50577048|FG006|Overall Study|Condition no longer requires study drug|1|||
25262253|NCT01281306|50577042|FG000|Overall Study|Lost to Follow-up|1|||
25262254|NCT01281306|50577043|FG001|Overall Study|Lost to Follow-up|0|||
25262255|NCT01281306|50577044|FG002|Overall Study|Lost to Follow-up|0|||
25262256|NCT01281306|50577045|FG003|Overall Study|Lost to Follow-up|2|||
25262257|NCT01281306|50577046|FG004|Overall Study|Lost to Follow-up|0|||
25008819|NCT03466086|50101920|FG001|Period 1|Withdrawal by Subject|0|||
25008820|NCT03101462|50101928|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
25123323|NCT02230891|50235825|FG002|6 Month|Physician Decision|0|||
25262258|NCT01281306|50577047|FG005|Overall Study|Lost to Follow-up|0|||
25262259|NCT01281306|50577048|FG006|Overall Study|Lost to Follow-up|1|||
25262260|NCT01281306|50577042|FG000|Overall Study|Death|1|||
25262261|NCT01281306|50577043|FG001|Overall Study|Death|0|||
25262262|NCT01281306|50577044|FG002|Overall Study|Death|0|||
25262263|NCT01281306|50577045|FG003|Overall Study|Death|0|||
25262264|NCT01281306|50577046|FG004|Overall Study|Death|0|||
25262265|NCT01281306|50577047|FG005|Overall Study|Death|0|||
25262266|NCT01281306|50577048|FG006|Overall Study|Death|0|||
25262267|NCT01281306|50577042|FG000|Overall Study|Adverse Event|3|||
25262268|NCT01281306|50577043|FG001|Overall Study|Adverse Event|2|||
25262269|NCT01281306|50577044|FG002|Overall Study|Adverse Event|2|||
25262270|NCT01281306|50577045|FG003|Overall Study|Adverse Event|3|||
25262271|NCT01281306|50577046|FG004|Overall Study|Adverse Event|5|||
25262272|NCT01281306|50577047|FG005|Overall Study|Adverse Event|3|||
25262273|NCT01281306|50577048|FG006|Overall Study|Adverse Event|3|||
25262274|NCT01281306|50577042|FG000|Overall Study|Randomized in error|1|||
25262275|NCT01281306|50577043|FG001|Overall Study|Randomized in error|0|||
25262276|NCT01281306|50577044|FG002|Overall Study|Randomized in error|0|||
25262277|NCT01281306|50577045|FG003|Overall Study|Randomized in error|1|||
25262278|NCT01281306|50577046|FG004|Overall Study|Randomized in error|0|||
25262279|NCT01281306|50577047|FG005|Overall Study|Randomized in error|0|||
25262280|NCT01281306|50577048|FG006|Overall Study|Randomized in error|0|||
25262281|NCT01250145|50577066|FG000|Overall Study|Adverse Event|2|||
25262282|NCT01250145|50577067|FG001|Overall Study|Adverse Event|1|||
25262283|NCT01250145|50577066|FG000|Overall Study|Withdrawal by Subject|0|||
25262284|NCT01250145|50577067|FG001|Overall Study|Withdrawal by Subject|4|||
25262285|NCT01067326|50577089|FG000|Overall Study|Adverse Event|0|||
25262286|NCT01067326|50577090|FG001|Overall Study|Adverse Event|2|||
25262287|NCT01067326|50577089|FG000|Overall Study|Withdrawal by Subject|1|||
25262288|NCT01067326|50577090|FG001|Overall Study|Withdrawal by Subject|0|||
25262289|NCT01067326|50577089|FG000|Overall Study|Early Study Termination|1|||
25262290|NCT01067326|50577090|FG001|Overall Study|Early Study Termination|1|||
25262291|NCT01279200|50577098|FG000|Overall Study|Withdrawal by Subject|1|||
25262292|NCT01279200|50577099|FG001|Overall Study|Withdrawal by Subject|3|||
25262293|NCT01279200|50577098|FG000|Overall Study|Patient withdrawal due to high cost|0|||
25262294|NCT01279200|50577099|FG001|Overall Study|Patient withdrawal due to high cost|1|||
25262295|NCT01279200|50577098|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
25262296|NCT01279200|50577099|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
25123324|NCT02230891|50235823|FG000|12 Month|Death|1|||
25123325|NCT02230891|50235824|FG001|12 Month|Death|0|||
25262297|NCT01279200|50577098|FG000|Overall Study|ultrasound screening failure|0|||
25262298|NCT01279200|50577099|FG001|Overall Study|ultrasound screening failure|1|||
25262299|NCT01279200|50577098|FG000|Overall Study|Lost to Follow-up|0|||
25262300|NCT01279200|50577099|FG001|Overall Study|Lost to Follow-up|1|||
25262301|NCT01279200|50577098|FG000|Overall Study|Adverse Event|1|||
25262302|NCT01279200|50577099|FG001|Overall Study|Adverse Event|0|||
25262303|NCT01273818|50577108|FG000|Overall Study|Physician Decision|13|||
25262304|NCT01273818|50577109|FG001|Overall Study|Physician Decision|2|||
25262305|NCT01273818|50577110|FG002|Overall Study|Physician Decision|9|||
25262306|NCT01245387|50577118|FG000|Overall Study|Lost to Follow-up|106|||
25262307|NCT01245387|50577118|FG000|Overall Study|Lack of Efficacy|195|||
25262308|NCT01245387|50577118|FG000|Overall Study|Adverse Event|9|||
25262309|NCT01245387|50577118|FG000|Overall Study|Death|3|||
25262310|NCT01245387|50577118|FG000|Overall Study|Other|131|||
25262311|NCT01245387|50577118|FG000|Overall Study|Missing discontinuation status|369|||
25262312|NCT01037218|50577126|FG000|Overall Study|Adverse Event|4|||
25262313|NCT01037218|50577127|FG001|Overall Study|Adverse Event|2|||
25262314|NCT01037218|50577128|FG002|Overall Study|Adverse Event|2|||
25262315|NCT01037218|50577129|FG003|Overall Study|Adverse Event|1|||
25262316|NCT01037218|50577126|FG000|Overall Study|Lack of Efficacy|0|||
25262317|NCT01037218|50577127|FG001|Overall Study|Lack of Efficacy|2|||
25262318|NCT01037218|50577128|FG002|Overall Study|Lack of Efficacy|1|||
25262319|NCT01037218|50577129|FG003|Overall Study|Lack of Efficacy|5|||
25262320|NCT01037218|50577126|FG000|Overall Study|Lost to Follow-up|3|||
25262321|NCT01037218|50577127|FG001|Overall Study|Lost to Follow-up|5|||
25262322|NCT01037218|50577128|FG002|Overall Study|Lost to Follow-up|4|||
25262323|NCT01037218|50577129|FG003|Overall Study|Lost to Follow-up|2|||
25262324|NCT01037218|50577126|FG000|Overall Study|Withdrawal by Subject|6|||
25262325|NCT01037218|50577127|FG001|Overall Study|Withdrawal by Subject|7|||
25262326|NCT01037218|50577128|FG002|Overall Study|Withdrawal by Subject|7|||
25262327|NCT01037218|50577129|FG003|Overall Study|Withdrawal by Subject|4|||
25262328|NCT01037218|50577126|FG000|Overall Study|Partner Withdrew Consent|0|||
25262329|NCT01037218|50577127|FG001|Overall Study|Partner Withdrew Consent|3|||
25262330|NCT01037218|50577128|FG002|Overall Study|Partner Withdrew Consent|2|||
25262331|NCT01037218|50577129|FG003|Overall Study|Partner Withdrew Consent|1|||
25262332|NCT01037218|50577126|FG000|Overall Study|Protocol Violation|0|||
25262333|NCT01037218|50577127|FG001|Overall Study|Protocol Violation|0|||
25262334|NCT01037218|50577128|FG002|Overall Study|Protocol Violation|2|||
25262335|NCT01037218|50577129|FG003|Overall Study|Protocol Violation|2|||
25262336|NCT01037218|50577126|FG000|Overall Study|Various|3|||
25262337|NCT01037218|50577127|FG001|Overall Study|Various|2|||
25262338|NCT01037218|50577128|FG002|Overall Study|Various|3|||
25262339|NCT01037218|50577129|FG003|Overall Study|Various|1|||
25262340|NCT01038856|50577139|FG000|Overall Study|Adverse Event|2|||
25262341|NCT01066546|50577145|FG000|Overall Study|Study terminated by sponsor|5|||
25262342|NCT01272804|50577155|FG000|Overall Study|Adverse Event|1|||
25262343|NCT01272804|50577156|FG001|Overall Study|Adverse Event|0|||
25262344|NCT01272804|50577157|FG002|Overall Study|Adverse Event|0|||
25262345|NCT01272804|50577158|FG003|Overall Study|Adverse Event|0|||
25262346|NCT01272804|50577159|FG004|Overall Study|Adverse Event|2|||
25262347|NCT01272804|50577160|FG005|Overall Study|Adverse Event|1|||
25262348|NCT01269918|50577176|FG000|Overall Study|Did not receive study drug|0|||
25262349|NCT01269918|50577177|FG001|Overall Study|Did not receive study drug|3|||
25262350|NCT01036594|50577183|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
25262351|NCT01036594|50577184|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
25262352|NCT01036594|50577183|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
25262353|NCT01036594|50577184|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
25262354|NCT01036594|50577183|FG000|Week 12 Evaluation|Adverse Event|5|||
25262355|NCT01036594|50577184|FG001|Week 12 Evaluation|Adverse Event|0|||
25262356|NCT01036594|50577183|FG000|Week 12 Evaluation|Physician Decision|1|||
25262357|NCT01036594|50577184|FG001|Week 12 Evaluation|Physician Decision|0|||
25262358|NCT01036594|50577183|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
25262359|NCT01036594|50577184|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
25262360|NCT01036594|50577183|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
25262361|NCT01036594|50577184|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
25262362|NCT01036594|50577183|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
25262363|NCT01036594|50577184|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
25262364|NCT01036594|50577183|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
25262365|NCT01036594|50577184|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
25262366|NCT01036594|50577183|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
25262367|NCT01036594|50577184|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
25262368|NCT01036438|50577192|FG000|Overall Study|Adverse Event|7|||
25262369|NCT01036438|50577193|FG001|Overall Study|Adverse Event|8|||
25262370|NCT01036438|50577192|FG000|Overall Study|Death|0|||
25262371|NCT01036438|50577193|FG001|Overall Study|Death|1|||
25262372|NCT01036438|50577192|FG000|Overall Study|No effect of study treatment|3|||
25262373|NCT01036438|50577193|FG001|Overall Study|No effect of study treatment|1|||
25262374|NCT01268514|50577199|FG000|Overall Study|Adverse Event|20|||
25262375|NCT01268514|50577199|FG000|Overall Study|Death|8|||
25262376|NCT01268514|50577199|FG000|Overall Study|Lost to Follow-up|5|||
25262377|NCT01268514|50577199|FG000|Overall Study|Withdrawal by Subject|3|||
25262378|NCT01268514|50577199|FG000|Overall Study|Withdrawal by Surgeon|5|||
25262379|NCT01268046|50577209|FG000|Overall Study|Withdrawal by Subject|1|||
25262380|NCT01268046|50577210|FG001|Overall Study|Withdrawal by Subject|0|||
25262381|NCT01268046|50577211|FG002|Overall Study|Withdrawal by Subject|0|||
25262382|NCT01268046|50577212|FG003|Overall Study|Withdrawal by Subject|1|||
25262383|NCT01268046|50577209|FG000|Overall Study|Lost to Follow-up|0|||
25262384|NCT01268046|50577210|FG001|Overall Study|Lost to Follow-up|0|||
25262385|NCT01268046|50577211|FG002|Overall Study|Lost to Follow-up|1|||
25262386|NCT01268046|50577212|FG003|Overall Study|Lost to Follow-up|0|||
25262387|NCT01267266|50577222|FG000|Enrollment Phase|Withdrawal by Subject|2|||
25262388|NCT01267266|50577223|FG001|Enrollment Phase|Withdrawal by Subject|0|||
25262389|NCT01267266|50577222|FG000|Lead-in Phase|Lack of Efficacy|20|||
25262390|NCT01267266|50577223|FG001|Lead-in Phase|Lack of Efficacy|0|||
25262391|NCT01267266|50577222|FG000|Lead-in Phase|Adverse Event|2|||
25262392|NCT01267266|50577223|FG001|Lead-in Phase|Adverse Event|0|||
25262393|NCT01267266|50577222|FG000|Lead-in Phase|Withdrawal by Subject|1|||
25262394|NCT01267266|50577223|FG001|Lead-in Phase|Withdrawal by Subject|0|||
25262395|NCT01034176|50577234|FG000|Overall Study|Physician Decision|2|||
25262396|NCT01034176|50577235|FG001|Overall Study|Physician Decision|0|||
25262397|NCT01034176|50577234|FG000|Overall Study|Withdrawal by Subject|0|||
25262398|NCT01034176|50577235|FG001|Overall Study|Withdrawal by Subject|1|||
25262399|NCT01034176|50577234|FG000|Overall Study|Lost to Follow-up|0|||
25262400|NCT01034176|50577235|FG001|Overall Study|Lost to Follow-up|1|||
25262401|NCT01033942|50577244|FG000|Overall Study|Withdrawal by Subject|1|||
25262402|NCT01033942|50577245|FG001|Overall Study|Withdrawal by Subject|1|||
25262403|NCT01033942|50577246|FG002|Overall Study|Withdrawal by Subject|1|||
25262404|NCT01033942|50577244|FG000|Overall Study|Lost to Follow-up|1|||
25262405|NCT01033942|50577245|FG001|Overall Study|Lost to Follow-up|0|||
25262406|NCT01033942|50577246|FG002|Overall Study|Lost to Follow-up|0|||
25262407|NCT01033942|50577244|FG000|Overall Study|Enrolled in Extension Study|0|||
25262408|NCT01033942|50577245|FG001|Overall Study|Enrolled in Extension Study|3|||
25262409|NCT01033942|50577246|FG002|Overall Study|Enrolled in Extension Study|0|||
25262410|NCT01062256|50577259|FG000|Overall Study|Adverse Event|1|||
25262411|NCT01062256|50577260|FG001|Overall Study|Adverse Event|0|||
25262412|NCT01062256|50577261|FG002|Overall Study|Adverse Event|0|||
25262413|NCT01062256|50577259|FG000|Overall Study|Withdrawal by Subject|1|||
25262414|NCT01062256|50577260|FG001|Overall Study|Withdrawal by Subject|1|||
25262415|NCT01062256|50577261|FG002|Overall Study|Withdrawal by Subject|1|||
25262416|NCT01062256|50577259|FG000|Overall Study|Ineligible|1|||
25262417|NCT01062256|50577260|FG001|Overall Study|Ineligible|4|||
25262418|NCT01062256|50577261|FG002|Overall Study|Ineligible|3|||
25262419|NCT01062256|50577259|FG000|Overall Study|Administrative|0|||
25262420|NCT01062256|50577260|FG001|Overall Study|Administrative|2|||
25262421|NCT01062256|50577261|FG002|Overall Study|Administrative|0|||
25262422|NCT01029886|50577271|FG000|Overall Study|Adverse Event|12|||
25262423|NCT01029886|50577272|FG001|Overall Study|Adverse Event|25|||
25262424|NCT01029886|50577271|FG000|Overall Study|Lost to Follow-up|1|||
25262425|NCT01029886|50577272|FG001|Overall Study|Lost to Follow-up|0|||
25262426|NCT01029886|50577271|FG000|Overall Study|Physician Decision|2|||
25262427|NCT01029886|50577272|FG001|Overall Study|Physician Decision|6|||
25262428|NCT01029886|50577271|FG000|Overall Study|Protocol Violation|17|||
25262429|NCT01029886|50577272|FG001|Overall Study|Protocol Violation|5|||
25262430|NCT01029886|50577271|FG000|Overall Study|Withdrawal by Subject|8|||
25262431|NCT01029886|50577272|FG001|Overall Study|Withdrawal by Subject|18|||
25262432|NCT01029886|50577271|FG000|Overall Study|Entry Criteria Not Met|13|||
25262433|NCT01029886|50577272|FG001|Overall Study|Entry Criteria Not Met|5|||
25262434|NCT01029886|50577271|FG000|Overall Study|Sponsor Decision|1|||
25262435|NCT01029886|50577272|FG001|Overall Study|Sponsor Decision|0|||
25262436|NCT01029886|50577271|FG000|Overall Study|Loss Glucose Control|7|||
25262437|NCT01029886|50577272|FG001|Overall Study|Loss Glucose Control|1|||
25262438|NCT01244763|50577288|FG000|Overall Study|Adverse Event|1|||
25262439|NCT01244763|50577289|FG001|Overall Study|Adverse Event|0|||
25262440|NCT01244763|50577290|FG002|Overall Study|Adverse Event|0|||
25262441|NCT01244763|50577291|FG003|Overall Study|Adverse Event|0|||
25262442|NCT01244763|50577292|FG004|Overall Study|Adverse Event|0|||
25262443|NCT01244763|50577293|FG005|Overall Study|Adverse Event|1|||
25262444|NCT01244763|50577288|FG000|Overall Study|Death|1|||
25262445|NCT01244763|50577289|FG001|Overall Study|Death|0|||
25262446|NCT01244763|50577290|FG002|Overall Study|Death|1|||
25262447|NCT01244763|50577291|FG003|Overall Study|Death|0|||
25262448|NCT01244763|50577292|FG004|Overall Study|Death|2|||
25262449|NCT01244763|50577293|FG005|Overall Study|Death|0|||
25262450|NCT01244763|50577288|FG000|Overall Study|Physician Decision|0|||
25262451|NCT01244763|50577289|FG001|Overall Study|Physician Decision|0|||
25262452|NCT01244763|50577290|FG002|Overall Study|Physician Decision|1|||
25262453|NCT01244763|50577291|FG003|Overall Study|Physician Decision|0|||
25262454|NCT01244763|50577292|FG004|Overall Study|Physician Decision|0|||
25262455|NCT01244763|50577293|FG005|Overall Study|Physician Decision|0|||
25262456|NCT01244763|50577288|FG000|Overall Study|Withdrawal by Subject|1|||
25262457|NCT01244763|50577289|FG001|Overall Study|Withdrawal by Subject|2|||
25262458|NCT01244763|50577290|FG002|Overall Study|Withdrawal by Subject|0|||
25262459|NCT01244763|50577291|FG003|Overall Study|Withdrawal by Subject|1|||
25262460|NCT01244763|50577292|FG004|Overall Study|Withdrawal by Subject|1|||
25008821|NCT03101462|50101929|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
25123326|NCT02230891|50235825|FG002|12 Month|Death|0|||
25123327|NCT02230891|50235823|FG000|12 Month|Lost to Follow-up|0|||
25123328|NCT02230891|50235824|FG001|12 Month|Lost to Follow-up|1|||
25262461|NCT01244763|50577293|FG005|Overall Study|Withdrawal by Subject|2|||
25262462|NCT01244763|50577288|FG000|Overall Study|Lost to Follow-up|0|||
25262463|NCT01244763|50577289|FG001|Overall Study|Lost to Follow-up|1|||
25262464|NCT01244763|50577290|FG002|Overall Study|Lost to Follow-up|0|||
25262465|NCT01244763|50577291|FG003|Overall Study|Lost to Follow-up|0|||
25262466|NCT01244763|50577292|FG004|Overall Study|Lost to Follow-up|0|||
25262467|NCT01244763|50577293|FG005|Overall Study|Lost to Follow-up|0|||
25262468|NCT01244763|50577288|FG000|Overall Study|Enrolled into the Extension Study|0|||
25262469|NCT01244763|50577289|FG001|Overall Study|Enrolled into the Extension Study|0|||
25262470|NCT01244763|50577290|FG002|Overall Study|Enrolled into the Extension Study|0|||
25262471|NCT01244763|50577291|FG003|Overall Study|Enrolled into the Extension Study|0|||
25262472|NCT01244763|50577292|FG004|Overall Study|Enrolled into the Extension Study|0|||
25262473|NCT01244763|50577293|FG005|Overall Study|Enrolled into the Extension Study|1|||
25262474|NCT01244061|50577309|FG000|Overall Study|Death|1|||
25262475|NCT01244061|50577310|FG001|Overall Study|Death|0|||
25262476|NCT01244061|50577309|FG000|Overall Study|Did not meet entrance criteria|1|||
25262477|NCT01244061|50577310|FG001|Overall Study|Did not meet entrance criteria|0|||
25262478|NCT01244061|50577309|FG000|Overall Study|Lack of Efficacy|1|||
25262479|NCT01244061|50577310|FG001|Overall Study|Lack of Efficacy|3|||
25008822|NCT02873936|50101938|FG000|Overall Study|Withdrew Consent|4|||
25262480|NCT01244061|50577309|FG000|Overall Study|Lost to Follow-up|34|||
25262481|NCT01244061|50577310|FG001|Overall Study|Lost to Follow-up|30|||
25262482|NCT01244061|50577309|FG000|Overall Study|Withdrawal by Subject|29|||
25262483|NCT01244061|50577310|FG001|Overall Study|Withdrawal by Subject|46|||
25262484|NCT01244061|50577309|FG000|Overall Study|Other|8|||
25262485|NCT01244061|50577310|FG001|Overall Study|Other|19|||
25262486|NCT01244061|50577309|FG000|Overall Study|Protocol Violation|1|||
25262487|NCT01244061|50577310|FG001|Overall Study|Protocol Violation|1|||
25262488|NCT01244061|50577309|FG000|Overall Study|Adverse Event|5|||
25262489|NCT01244061|50577310|FG001|Overall Study|Adverse Event|2|||
25262490|NCT01244061|50577309|FG000|Overall Study|Randomized but not treated|2|||
25262491|NCT01244061|50577310|FG001|Overall Study|Randomized but not treated|2|||
25262492|NCT01243671|50577316|FG000|Overall Study|Adverse Event|3|||
25262493|NCT01243671|50577316|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
25262494|NCT01243671|50577316|FG000|Overall Study|Other|1|||
25262495|NCT01240785|50577322|FG000|Overall Study|Lost to Follow-up|1|||
25262496|NCT01240785|50577323|FG001|Overall Study|Lost to Follow-up|0|||
25262497|NCT01240785|50577322|FG000|Overall Study|Protocol Violation|0|||
25123329|NCT02230891|50235825|FG002|12 Month|Lost to Follow-up|0|||
25123330|NCT02230891|50235823|FG000|12 Month|Withdrawal by Subject|0|||
25123331|NCT02230891|50235824|FG001|12 Month|Withdrawal by Subject|2|||
25123332|NCT02230891|50235825|FG002|12 Month|Withdrawal by Subject|0|||
25262498|NCT01240785|50577323|FG001|Overall Study|Protocol Violation|3|||
25262499|NCT01240551|50577331|FG000|Overall Study|Refused further treatment|3|||
25262500|NCT01240551|50577332|FG001|Overall Study|Refused further treatment|2|||
25262501|NCT01240551|50577331|FG000|Overall Study|Lost to Follow-up|1|||
25008823|NCT02873936|50101939|FG001|Overall Study|Withdrew Consent|11|||
25008824|NCT02873936|50101940|FG002|Overall Study|Withdrew Consent|20|||
25262502|NCT01240551|50577332|FG001|Overall Study|Lost to Follow-up|1|||
25262503|NCT01239381|50577338|FG000|Overall Study|Protocol Violation|1|||
25262504|NCT01239381|50577338|FG000|Overall Study|Withdrawal by Subject|1|||
25262505|NCT01266876|50577348|FG000|Overall Study|Adverse Event|0|||
25262506|NCT01266876|50577349|FG001|Overall Study|Adverse Event|0|||
25262507|NCT01266876|50577350|FG002|Overall Study|Adverse Event|0|||
25262508|NCT01266876|50577351|FG003|Overall Study|Adverse Event|1|||
25262509|NCT01266876|50577352|FG004|Overall Study|Adverse Event|0|||
25262510|NCT01266642|50577366|FG000|Overall Study|Protocol Violation|0|||
25262511|NCT01266642|50577367|FG001|Overall Study|Protocol Violation|1|||
25262512|NCT01033240|50577376|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
25262513|NCT01033240|50577377|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
25262514|NCT01033240|50577378|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
25262515|NCT01033240|50577376|FG000|Overall Study|Death|2|||
25262516|NCT01033240|50577377|FG001|Overall Study|Death|0|||
25262517|NCT01033240|50577378|FG002|Overall Study|Death|0|||
25262518|NCT01033240|50577376|FG000|Overall Study|Withdrew Consent|2|||
25262519|NCT01033240|50577377|FG001|Overall Study|Withdrew Consent|9|||
25262520|NCT01033240|50577378|FG002|Overall Study|Withdrew Consent|2|||
25262521|NCT01033240|50577376|FG000|Overall Study|Disease Progression|35|||
25262522|NCT01033240|50577377|FG001|Overall Study|Disease Progression|32|||
25262523|NCT01033240|50577378|FG002|Overall Study|Disease Progression|41|||
25262524|NCT01033240|50577376|FG000|Overall Study|Investigator Discretion|0|||
25262525|NCT01033240|50577377|FG001|Overall Study|Investigator Discretion|0|||
25262526|NCT01033240|50577378|FG002|Overall Study|Investigator Discretion|2|||
25262527|NCT01033240|50577376|FG000|Overall Study|Other|0|||
25262528|NCT01033240|50577377|FG001|Overall Study|Other|1|||
25262529|NCT01033240|50577378|FG002|Overall Study|Other|2|||
25262530|NCT01266018|50577386|FG000|Overall Study|Physician Decision|1|||
25262531|NCT01266018|50577387|FG001|Overall Study|Physician Decision|0|||
25262532|NCT01266018|50577386|FG000|Overall Study|Progressive disease|0|||
25262533|NCT01266018|50577387|FG001|Overall Study|Progressive disease|1|||
25262534|NCT01032382|50577395|FG000|Overall Study|Disease dissemination|1|||
25262535|NCT01032382|50577396|FG001|Overall Study|Disease dissemination|1|||
25262536|NCT01032382|50577395|FG000|Overall Study|Treatment failure|3|||
25262537|NCT01032382|50577396|FG001|Overall Study|Treatment failure|1|||
25262538|NCT01032382|50577395|FG000|Overall Study|Index lesion relapse|1|||
25262539|NCT01032382|50577396|FG001|Overall Study|Index lesion relapse|3|||
25262540|NCT01029652|50577404|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
25262541|NCT01029652|50577405|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
25262542|NCT01029652|50577404|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
25262543|NCT01029652|50577405|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
25262544|NCT01029652|50577404|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
25262545|NCT01029652|50577405|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
25262546|NCT01029652|50577404|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
25262547|NCT01029652|50577405|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
25262548|NCT01029652|50577404|FG000|Core Study (0-12 Weeks)|Death|0|||
25262549|NCT01029652|50577405|FG001|Core Study (0-12 Weeks)|Death|1|||
25262550|NCT01029652|50577404|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
25262551|NCT01029652|50577405|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
25262552|NCT01029652|50577404|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
25262553|NCT01029652|50577405|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
25262554|NCT01029652|50577404|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
25262555|NCT01029652|50577405|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
25262556|NCT01029652|50577404|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
25262557|NCT01029652|50577405|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
25262558|NCT01029652|50577404|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
25262559|NCT01029652|50577405|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
25262560|NCT01029652|50577404|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
25262561|NCT01029652|50577405|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
25262562|NCT01029652|50577404|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
25262563|NCT01029652|50577405|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
25262564|NCT01029340|50577434|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
25262565|NCT01029340|50577435|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
25262566|NCT01029340|50577436|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
25262567|NCT01029340|50577437|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
25262568|NCT01029340|50577438|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
25262569|NCT01029340|50577439|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
25123333|NCT02230891|50235823|FG000|18 Month End of Study|Death|0|||
25123334|NCT02230891|50235824|FG001|18 Month End of Study|Death|0|||
25123335|NCT02230891|50235825|FG002|18 Month End of Study|Death|1|||
25123336|NCT02230891|50235823|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
25123337|NCT02230891|50235824|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
25123338|NCT02230891|50235825|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
25123339|NCT01646138|50235840|FG000|Overall Study|Lost to Follow-up|0|||
25123340|NCT01646138|50235841|FG001|Overall Study|Lost to Follow-up|0|||
25123341|NCT01646138|50235842|FG002|Overall Study|Lost to Follow-up|0|||
25123342|NCT01646138|50235843|FG003|Overall Study|Lost to Follow-up|0|||
25123343|NCT01646138|50235844|FG004|Overall Study|Lost to Follow-up|2|||
25262570|NCT01029340|50577434|FG000|Part B Treatment Period|Protocol Violation|0|||
25262571|NCT01029340|50577435|FG001|Part B Treatment Period|Protocol Violation|0|||
25262572|NCT01029340|50577436|FG002|Part B Treatment Period|Protocol Violation|1|||
25262573|NCT01029340|50577437|FG003|Part B Treatment Period|Protocol Violation|0|||
25262574|NCT01029340|50577438|FG004|Part B Treatment Period|Protocol Violation|0|||
25262575|NCT01029340|50577439|FG005|Part B Treatment Period|Protocol Violation|0|||
25262576|NCT01029340|50577434|FG000|Extension Period|Adverse Event|0|||
25262577|NCT01029340|50577435|FG001|Extension Period|Adverse Event|0|||
25262578|NCT01029340|50577436|FG002|Extension Period|Adverse Event|0|||
25262579|NCT01029340|50577437|FG003|Extension Period|Adverse Event|0|||
25262580|NCT01029340|50577438|FG004|Extension Period|Adverse Event|0|||
25262581|NCT01029340|50577439|FG005|Extension Period|Adverse Event|1|||
25262582|NCT01029340|50577434|FG000|Extension Period|starting another study|0|||
25262583|NCT01029340|50577435|FG001|Extension Period|starting another study|0|||
25262584|NCT01029340|50577436|FG002|Extension Period|starting another study|0|||
25262585|NCT01029340|50577437|FG003|Extension Period|starting another study|0|||
25262586|NCT01029340|50577438|FG004|Extension Period|starting another study|0|||
25262587|NCT01029340|50577439|FG005|Extension Period|starting another study|8|||
25262588|NCT01029340|50577434|FG000|Extension Period|non-compliance|0|||
25262589|NCT01029340|50577435|FG001|Extension Period|non-compliance|0|||
25262590|NCT01029340|50577436|FG002|Extension Period|non-compliance|0|||
25262591|NCT01029340|50577437|FG003|Extension Period|non-compliance|0|||
25262592|NCT01029340|50577438|FG004|Extension Period|non-compliance|0|||
25262593|NCT01029340|50577439|FG005|Extension Period|non-compliance|1|||
25262594|NCT01029340|50577434|FG000|Extension Period|Withdrawal by Subject|0|||
25262595|NCT01029340|50577435|FG001|Extension Period|Withdrawal by Subject|0|||
25262596|NCT01029340|50577436|FG002|Extension Period|Withdrawal by Subject|0|||
25262597|NCT01029340|50577437|FG003|Extension Period|Withdrawal by Subject|0|||
25262598|NCT01029340|50577438|FG004|Extension Period|Withdrawal by Subject|0|||
25262599|NCT01029340|50577439|FG005|Extension Period|Withdrawal by Subject|1|||
25262600|NCT01029340|50577434|FG000|Extension Period|Physician Decision|0|||
25262601|NCT01029340|50577435|FG001|Extension Period|Physician Decision|0|||
25262602|NCT01029340|50577436|FG002|Extension Period|Physician Decision|0|||
25262603|NCT01029340|50577437|FG003|Extension Period|Physician Decision|0|||
25262604|NCT01029340|50577438|FG004|Extension Period|Physician Decision|0|||
25262605|NCT01029340|50577439|FG005|Extension Period|Physician Decision|1|||
25262606|NCT01265550|50577456|FG000|Pre Randomization|Withdrawal by Subject|0|||
25262607|NCT01265550|50577457|FG001|Pre Randomization|Withdrawal by Subject|0|||
25262608|NCT01265550|50577458|FG002|Pre Randomization|Withdrawal by Subject|0|||
25262609|NCT01265550|50577459|FG003|Pre Randomization|Withdrawal by Subject|70|||
25262610|NCT01265550|50577456|FG000|Pre Randomization|Technical Exclusions|0|||
25262611|NCT01265550|50577457|FG001|Pre Randomization|Technical Exclusions|0|||
25262612|NCT01265550|50577458|FG002|Pre Randomization|Technical Exclusions|0|||
25262613|NCT01265550|50577459|FG003|Pre Randomization|Technical Exclusions|54|||
25262614|NCT01265550|50577456|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
25262615|NCT01265550|50577457|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
25262616|NCT01265550|50577458|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
25262617|NCT01265550|50577459|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
25262618|NCT01265550|50577456|FG000|Pre Randomization|Non-GERD organic disorders|0|||
25262619|NCT01265550|50577457|FG001|Pre Randomization|Non-GERD organic disorders|0|||
25262620|NCT01265550|50577458|FG002|Pre Randomization|Non-GERD organic disorders|0|||
25262621|NCT01265550|50577459|FG003|Pre Randomization|Non-GERD organic disorders|23|||
25262622|NCT01265550|50577456|FG000|Pre Randomization|Functional heartburn|0|||
25262623|NCT01265550|50577457|FG001|Pre Randomization|Functional heartburn|0|||
25262624|NCT01265550|50577458|FG002|Pre Randomization|Functional heartburn|0|||
25262625|NCT01265550|50577459|FG003|Pre Randomization|Functional heartburn|99|||
25262626|NCT01265394|50577473|FG000|Overall Study|Subjects withdrawn|37|||
25262627|NCT01029262|50577480|FG000|Overall Study|Adverse Event|9|||
25262628|NCT01029262|50577481|FG001|Overall Study|Adverse Event|52|||
25262629|NCT01029262|50577480|FG000|Overall Study|Lack of therapeutic effect|57|||
25262630|NCT01029262|50577481|FG001|Overall Study|Lack of therapeutic effect|76|||
25262631|NCT01029262|50577480|FG000|Overall Study|Withdrawal by Subject|10|||
25262632|NCT01029262|50577481|FG001|Overall Study|Withdrawal by Subject|17|||
25262633|NCT01029262|50577480|FG000|Overall Study|Protocol Violation|2|||
25262634|NCT01029262|50577481|FG001|Overall Study|Protocol Violation|3|||
25262635|NCT01029262|50577480|FG000|Overall Study|Miscellaneous|1|||
25262636|NCT01029262|50577481|FG001|Overall Study|Miscellaneous|9|||
25262637|NCT01029262|50577480|FG000|Overall Study|Death|0|||
25262638|NCT01029262|50577481|FG001|Overall Study|Death|3|||
25262639|NCT01028560|50577494|FG000|Overall Study|Lack of Efficacy|3|||
25262640|NCT01028560|50577495|FG001|Overall Study|Lack of Efficacy|6|||
25262641|NCT01028560|50577494|FG000|Overall Study|Withdrawal by Subject|7|||
25262642|NCT01028560|50577495|FG001|Overall Study|Withdrawal by Subject|12|||
25123344|NCT02204371|50235856|FG000|Overall Study|Adverse Event|1|||
25262643|NCT01061710|50577502|FG000|Overall Study|Protocol Violation|14|||
25262644|NCT01028014|50577512|FG000|Overall Study|Lost to Follow-up|1|||
25262645|NCT01028014|50577513|FG001|Overall Study|Lost to Follow-up|2|||
25262646|NCT01028014|50577514|FG002|Overall Study|Lost to Follow-up|0|||
25262647|NCT01028014|50577515|FG003|Overall Study|Lost to Follow-up|1|||
25262648|NCT01028014|50577516|FG004|Overall Study|Lost to Follow-up|1|||
25262649|NCT01028014|50577517|FG005|Overall Study|Lost to Follow-up|2|||
25262650|NCT01264770|50577537|FG000|Overall Study|Not reported|0|||
25262651|NCT01264770|50577538|FG001|Overall Study|Not reported|0|||
25262652|NCT01264770|50577539|FG002|Overall Study|Not reported|1|||
25262653|NCT01264770|50577540|FG003|Overall Study|Not reported|0|||
25262654|NCT01264770|50577541|FG004|Overall Study|Not reported|0|||
25262655|NCT01264770|50577542|FG005|Overall Study|Not reported|0|||
25262656|NCT01264770|50577537|FG000|Overall Study|e.g., change in circumstances|8|||
25262657|NCT01264770|50577538|FG001|Overall Study|e.g., change in circumstances|3|||
25262658|NCT01264770|50577539|FG002|Overall Study|e.g., change in circumstances|3|||
25262659|NCT01264770|50577540|FG003|Overall Study|e.g., change in circumstances|3|||
25262660|NCT01264770|50577541|FG004|Overall Study|e.g., change in circumstances|4|||
25262661|NCT01264770|50577542|FG005|Overall Study|e.g., change in circumstances|4|||
25262662|NCT01264770|50577537|FG000|Overall Study|Severe non-compliance to protocol|0|||
25262663|NCT01264770|50577538|FG001|Overall Study|Severe non-compliance to protocol|0|||
25262664|NCT01264770|50577539|FG002|Overall Study|Severe non-compliance to protocol|1|||
25262665|NCT01264770|50577540|FG003|Overall Study|Severe non-compliance to protocol|1|||
25262666|NCT01264770|50577541|FG004|Overall Study|Severe non-compliance to protocol|0|||
25262667|NCT01264770|50577542|FG005|Overall Study|Severe non-compliance to protocol|0|||
25262668|NCT01264770|50577537|FG000|Overall Study|Lack of therapeutic response|1|||
25262669|NCT01264770|50577538|FG001|Overall Study|Lack of therapeutic response|0|||
25262670|NCT01264770|50577539|FG002|Overall Study|Lack of therapeutic response|2|||
25262671|NCT01264770|50577540|FG003|Overall Study|Lack of therapeutic response|1|||
25262672|NCT01264770|50577541|FG004|Overall Study|Lack of therapeutic response|1|||
25262673|NCT01264770|50577542|FG005|Overall Study|Lack of therapeutic response|0|||
25262674|NCT01264770|50577537|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
25262675|NCT01264770|50577538|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
25262676|NCT01264770|50577539|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
25262677|NCT01264770|50577540|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
25262678|NCT01264770|50577541|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
25262679|NCT01264770|50577542|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
25262680|NCT01264770|50577537|FG000|Overall Study|Lost to Follow-up|0|||
25262681|NCT01264770|50577538|FG001|Overall Study|Lost to Follow-up|0|||
25262682|NCT01264770|50577539|FG002|Overall Study|Lost to Follow-up|1|||
25262683|NCT01264770|50577540|FG003|Overall Study|Lost to Follow-up|1|||
25262684|NCT01264770|50577541|FG004|Overall Study|Lost to Follow-up|0|||
25262685|NCT01264770|50577542|FG005|Overall Study|Lost to Follow-up|0|||
25262686|NCT01264770|50577537|FG000|Overall Study|Adverse Event|7|||
25262687|NCT01264770|50577538|FG001|Overall Study|Adverse Event|7|||
25262688|NCT01264770|50577539|FG002|Overall Study|Adverse Event|8|||
25262689|NCT01264770|50577540|FG003|Overall Study|Adverse Event|0|||
25262690|NCT01264770|50577541|FG004|Overall Study|Adverse Event|2|||
25262691|NCT01264770|50577542|FG005|Overall Study|Adverse Event|1|||
25262692|NCT01027702|50577562|FG000|Overall Study|Received subsequent therapy|1|||
25262693|NCT01027702|50577563|FG001|Overall Study|Received subsequent therapy|2|||
25262694|NCT01027702|50577564|FG002|Overall Study|Received subsequent therapy|0|||
25262695|NCT01027702|50577565|FG003|Overall Study|Received subsequent therapy|4|||
25262696|NCT01027702|50577566|FG004|Overall Study|Received subsequent therapy|1|||
25262697|NCT01027702|50577567|FG005|Overall Study|Received subsequent therapy|0|||
25262698|NCT01027702|50577568|FG006|Overall Study|Received subsequent therapy|1|||
25262699|NCT01027702|50577562|FG000|Overall Study|Death|0|||
25262700|NCT01027702|50577563|FG001|Overall Study|Death|0|||
25262701|NCT01027702|50577564|FG002|Overall Study|Death|1|||
25262702|NCT01027702|50577565|FG003|Overall Study|Death|0|||
25262703|NCT01027702|50577566|FG004|Overall Study|Death|0|||
25262704|NCT01027702|50577567|FG005|Overall Study|Death|0|||
25262705|NCT01027702|50577568|FG006|Overall Study|Death|0|||
25262706|NCT01302080|50577582|FG000|Overall Study|Withdrew Consent|92|||
25262707|NCT01302080|50577583|FG001|Overall Study|Withdrew Consent|39|||
25262708|NCT01302080|50577582|FG000|Overall Study|Patient/Family Moved|28|||
25262709|NCT01302080|50577583|FG001|Overall Study|Patient/Family Moved|3|||
25262710|NCT01302080|50577582|FG000|Overall Study|Lost to Follow-up|192|||
25262711|NCT01302080|50577583|FG001|Overall Study|Lost to Follow-up|93|||
25262712|NCT01302080|50577582|FG000|Overall Study|Death|1|||
25262713|NCT01302080|50577583|FG001|Overall Study|Death|0|||
25262714|NCT01302080|50577582|FG000|Overall Study|Other|52|||
25262715|NCT01302080|50577583|FG001|Overall Study|Other|8|||
25262716|NCT01302080|50577582|FG000|Overall Study|Reason Missing For Discontinuation|1|||
25262717|NCT01302080|50577583|FG001|Overall Study|Reason Missing For Discontinuation|0|||
25262718|NCT01238991|50577623|FG000|Overall Study|Adverse Event|1|||
25262719|NCT01238991|50577624|FG001|Overall Study|Adverse Event|0|||
25262720|NCT01238991|50577625|FG002|Overall Study|Adverse Event|3|||
25262721|NCT01238991|50577626|FG003|Overall Study|Adverse Event|1|||
25262722|NCT01238991|50577627|FG004|Overall Study|Adverse Event|1|||
25008825|NCT02873936|50101938|FG000|Overall Study|Investigator's Discretion|3|||
25262723|NCT01238991|50577628|FG005|Overall Study|Adverse Event|0|||
25262724|NCT01238991|50577629|FG006|Overall Study|Adverse Event|1|||
25262725|NCT01238991|50577630|FG007|Overall Study|Adverse Event|1|||
25262726|NCT01238991|50577631|FG008|Overall Study|Adverse Event|0|||
25262727|NCT01238991|50577632|FG009|Overall Study|Adverse Event|0|||
25262728|NCT01238991|50577623|FG000|Overall Study|Death|0|||
25262729|NCT01238991|50577624|FG001|Overall Study|Death|0|||
25262730|NCT01238991|50577625|FG002|Overall Study|Death|0|||
25262731|NCT01238991|50577626|FG003|Overall Study|Death|1|||
25262732|NCT01238991|50577627|FG004|Overall Study|Death|0|||
25262733|NCT01238991|50577628|FG005|Overall Study|Death|0|||
25262734|NCT01238991|50577629|FG006|Overall Study|Death|0|||
25262735|NCT01238991|50577630|FG007|Overall Study|Death|0|||
25262736|NCT01238991|50577631|FG008|Overall Study|Death|0|||
25262737|NCT01238991|50577632|FG009|Overall Study|Death|0|||
25262738|NCT01238991|50577623|FG000|Overall Study|Lack of Efficacy|0|||
25262739|NCT01238991|50577624|FG001|Overall Study|Lack of Efficacy|0|||
25262740|NCT01238991|50577625|FG002|Overall Study|Lack of Efficacy|1|||
25262741|NCT01238991|50577626|FG003|Overall Study|Lack of Efficacy|0|||
25262742|NCT01238991|50577627|FG004|Overall Study|Lack of Efficacy|0|||
25262743|NCT01238991|50577628|FG005|Overall Study|Lack of Efficacy|0|||
25262744|NCT01238991|50577629|FG006|Overall Study|Lack of Efficacy|0|||
25262745|NCT01238991|50577630|FG007|Overall Study|Lack of Efficacy|0|||
25262746|NCT01238991|50577631|FG008|Overall Study|Lack of Efficacy|1|||
25262747|NCT01238991|50577632|FG009|Overall Study|Lack of Efficacy|0|||
25262748|NCT01238991|50577623|FG000|Overall Study|Withdrawal by Subject|0|||
25262749|NCT01238991|50577624|FG001|Overall Study|Withdrawal by Subject|0|||
25262750|NCT01238991|50577625|FG002|Overall Study|Withdrawal by Subject|1|||
25262751|NCT01238991|50577626|FG003|Overall Study|Withdrawal by Subject|0|||
25262752|NCT01238991|50577627|FG004|Overall Study|Withdrawal by Subject|0|||
25262753|NCT01238991|50577628|FG005|Overall Study|Withdrawal by Subject|0|||
25262754|NCT01238991|50577629|FG006|Overall Study|Withdrawal by Subject|0|||
25262755|NCT01238991|50577630|FG007|Overall Study|Withdrawal by Subject|0|||
25262756|NCT01238991|50577631|FG008|Overall Study|Withdrawal by Subject|0|||
25262757|NCT01238991|50577632|FG009|Overall Study|Withdrawal by Subject|0|||
25262758|NCT01238991|50577623|FG000|Overall Study|Study Terminated by Sponsor|0|||
25262759|NCT01238991|50577624|FG001|Overall Study|Study Terminated by Sponsor|0|||
25262760|NCT01238991|50577625|FG002|Overall Study|Study Terminated by Sponsor|0|||
25262761|NCT01238991|50577626|FG003|Overall Study|Study Terminated by Sponsor|0|||
25262762|NCT01238991|50577627|FG004|Overall Study|Study Terminated by Sponsor|1|||
25262763|NCT01238991|50577628|FG005|Overall Study|Study Terminated by Sponsor|0|||
25262764|NCT01238991|50577629|FG006|Overall Study|Study Terminated by Sponsor|7|||
25262765|NCT01238991|50577630|FG007|Overall Study|Study Terminated by Sponsor|4|||
25262766|NCT01238991|50577631|FG008|Overall Study|Study Terminated by Sponsor|2|||
25262767|NCT01238991|50577632|FG009|Overall Study|Study Terminated by Sponsor|2|||
25262768|NCT01238991|50577623|FG000|Overall Study|Caregiver's request|0|||
25262769|NCT01238991|50577624|FG001|Overall Study|Caregiver's request|0|||
25262770|NCT01238991|50577625|FG002|Overall Study|Caregiver's request|0|||
25262771|NCT01238991|50577626|FG003|Overall Study|Caregiver's request|0|||
25262772|NCT01238991|50577627|FG004|Overall Study|Caregiver's request|0|||
25262773|NCT01238991|50577628|FG005|Overall Study|Caregiver's request|0|||
25262774|NCT01238991|50577629|FG006|Overall Study|Caregiver's request|0|||
25262775|NCT01238991|50577630|FG007|Overall Study|Caregiver's request|0|||
25262776|NCT01238991|50577631|FG008|Overall Study|Caregiver's request|1|||
25262777|NCT01238991|50577632|FG009|Overall Study|Caregiver's request|0|||
25262778|NCT01238991|50577623|FG000|Overall Study|Admission to a nursing home|1|||
25262779|NCT01238991|50577624|FG001|Overall Study|Admission to a nursing home|0|||
25262780|NCT01238991|50577625|FG002|Overall Study|Admission to a nursing home|1|||
25262781|NCT01238991|50577626|FG003|Overall Study|Admission to a nursing home|0|||
25262782|NCT01238991|50577627|FG004|Overall Study|Admission to a nursing home|0|||
25262783|NCT01238991|50577628|FG005|Overall Study|Admission to a nursing home|0|||
25262784|NCT01238991|50577629|FG006|Overall Study|Admission to a nursing home|0|||
25262785|NCT01238991|50577630|FG007|Overall Study|Admission to a nursing home|0|||
25262786|NCT01238991|50577631|FG008|Overall Study|Admission to a nursing home|0|||
25262787|NCT01238991|50577632|FG009|Overall Study|Admission to a nursing home|0|||
25262788|NCT01238835|50577657|FG000|Overall Study|Death|124|||
25262789|NCT01238835|50577657|FG000|Overall Study|Withdrawal by Subject|9|||
25262790|NCT01238835|50577657|FG000|Overall Study|Lost to Follow-up|1|||
25262791|NCT01238835|50577657|FG000|Overall Study|Site early discontinuation|2|||
25262792|NCT01032070|50577663|FG000|Overall Study|Disease progression|13|||
25262793|NCT01032070|50577664|FG001|Overall Study|Disease progression|8|||
25262794|NCT01032070|50577663|FG000|Overall Study|Medical or ethical reasons|0|||
25262795|NCT01032070|50577664|FG001|Overall Study|Medical or ethical reasons|2|||
25262796|NCT01032070|50577663|FG000|Overall Study|Withdrawal by Subject|0|||
25262797|NCT01032070|50577664|FG001|Overall Study|Withdrawal by Subject|2|||
25262798|NCT01237899|50577681|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
25262799|NCT01237899|50577682|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
25262800|NCT01237899|50577683|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
25262801|NCT01237899|50577684|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
25262802|NCT01237899|50577685|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
25262803|NCT01237899|50577686|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
25262804|NCT01237899|50577687|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
25262805|NCT01237899|50577688|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
25262806|NCT01237899|50577689|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
25262807|NCT01237899|50577690|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
25262808|NCT01237899|50577691|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
25262809|NCT01264380|50577709|FG000|Period C|Disease Progression|0|||
25262810|NCT01264380|50577710|FG001|Period C|Disease Progression|0|||
25262811|NCT01264380|50577711|FG002|Period C|Disease Progression|4|||
25262812|NCT01264380|50577709|FG000|Period C|Death|0|||
25262813|NCT01264380|50577710|FG001|Period C|Death|0|||
25262814|NCT01264380|50577711|FG002|Period C|Death|2|||
25262815|NCT01264380|50577709|FG000|Period C|Follow-up for survival status|0|||
25262816|NCT01264380|50577710|FG001|Period C|Follow-up for survival status|0|||
25262817|NCT01264380|50577711|FG002|Period C|Follow-up for survival status|6|||
25262818|NCT01264380|50577709|FG000|Period C|Withdrawal by Subject|0|||
25262819|NCT01264380|50577710|FG001|Period C|Withdrawal by Subject|0|||
25262820|NCT01264380|50577711|FG002|Period C|Withdrawal by Subject|1|||
25262821|NCT01264380|50577709|FG000|Period C|Adverse Event|0|||
25262822|NCT01264380|50577710|FG001|Period C|Adverse Event|0|||
25262823|NCT01264380|50577711|FG002|Period C|Adverse Event|1|||
25262824|NCT01263444|50577719|FG000|Overall Study|Adverse Event|8|||
25262825|NCT01263444|50577719|FG000|Overall Study|Withdrawal by Subject|1|||
25262826|NCT01263444|50577719|FG000|Overall Study|Protocol Violation|1|||
25262827|NCT01263054|50577725|FG000|Overall Study|Death|1|||
25262828|NCT01263054|50577726|FG001|Overall Study|Death|0|||
25262829|NCT01263054|50577725|FG000|Overall Study|Lost to Follow-up|2|||
25262830|NCT01263054|50577726|FG001|Overall Study|Lost to Follow-up|2|||
25262831|NCT01263054|50577725|FG000|Overall Study|Withdrawal by Subject|1|||
25262832|NCT01263054|50577726|FG001|Overall Study|Withdrawal by Subject|3|||
25262833|NCT01263054|50577725|FG000|Overall Study|Qualification Violation|1|||
25262834|NCT01263054|50577726|FG001|Overall Study|Qualification Violation|0|||
25262835|NCT01263054|50577725|FG000|Overall Study|Other|0|||
25262836|NCT01263054|50577726|FG001|Overall Study|Other|1|||
25262837|NCT01031836|50577738|FG000|Stage I|Adverse Event|1|||
25262838|NCT01031836|50577739|FG001|Stage I|Adverse Event|1|||
25262839|NCT01031836|50577740|FG002|Stage I|Adverse Event|0|||
25262840|NCT01031836|50577741|FG003|Stage I|Adverse Event|0|||
25262841|NCT01031836|50577742|FG004|Stage I|Adverse Event|0|||
25262842|NCT01031836|50577743|FG005|Stage I|Adverse Event|0|||
25262843|NCT01031836|50577738|FG000|Stage I|Other|0|||
25262844|NCT01031836|50577739|FG001|Stage I|Other|1|||
25262845|NCT01031836|50577740|FG002|Stage I|Other|0|||
25262846|NCT01031836|50577741|FG003|Stage I|Other|0|||
25262847|NCT01031836|50577742|FG004|Stage I|Other|0|||
25262848|NCT01031836|50577743|FG005|Stage I|Other|1|||
25262849|NCT01031836|50577738|FG000|Stage II|Adverse Event|0|||
25262850|NCT01031836|50577739|FG001|Stage II|Adverse Event|0|||
25262851|NCT01031836|50577740|FG002|Stage II|Adverse Event|2|||
25262852|NCT01031836|50577741|FG003|Stage II|Adverse Event|2|||
25262853|NCT01031836|50577742|FG004|Stage II|Adverse Event|1|||
25262854|NCT01031836|50577743|FG005|Stage II|Adverse Event|1|||
25262855|NCT01031836|50577738|FG000|Stage II|Other|2|||
25262856|NCT01031836|50577739|FG001|Stage II|Other|0|||
25262857|NCT01031836|50577740|FG002|Stage II|Other|0|||
25262858|NCT01031836|50577741|FG003|Stage II|Other|1|||
25262859|NCT01031836|50577742|FG004|Stage II|Other|1|||
25262860|NCT01031836|50577743|FG005|Stage II|Other|0|||
25262861|NCT01237587|50577759|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
25262862|NCT01237587|50577760|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
25262863|NCT01237587|50577759|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
25262864|NCT01237587|50577760|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
25262865|NCT01237587|50577759|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
25262866|NCT01237587|50577760|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
25262867|NCT01237587|50577759|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
25262868|NCT01237587|50577760|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
25262869|NCT01237587|50577759|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
25262870|NCT01237587|50577760|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
25262871|NCT01237587|50577759|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
25262872|NCT01237587|50577760|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
25262873|NCT01237587|50577759|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
25262874|NCT01237587|50577760|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
25262875|NCT01237587|50577759|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
25262876|NCT01237587|50577760|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
25262877|NCT01237587|50577759|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
25262878|NCT01237587|50577760|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
25262879|NCT01237587|50577759|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
25262880|NCT01237587|50577760|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
25262881|NCT01237587|50577759|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
25262882|NCT01237587|50577760|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
25262883|NCT01237587|50577759|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
25262884|NCT01237587|50577760|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
25262885|NCT01237587|50577759|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
25262886|NCT01237587|50577760|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
25262887|NCT01237587|50577759|FG000|Taper Phase|Adverse Event|0|||
25262888|NCT01237587|50577760|FG001|Taper Phase|Adverse Event|2|||
25262889|NCT01237587|50577759|FG000|Taper Phase|Protocol Violation|2|||
25262890|NCT01237587|50577760|FG001|Taper Phase|Protocol Violation|0|||
25262891|NCT01237587|50577759|FG000|Taper Phase|Lack of Efficacy|2|||
25262892|NCT01237587|50577760|FG001|Taper Phase|Lack of Efficacy|5|||
25262893|NCT01237587|50577759|FG000|Taper Phase|Parent/Guardian Decision|0|||
25262894|NCT01237587|50577760|FG001|Taper Phase|Parent/Guardian Decision|2|||
25262895|NCT01237587|50577759|FG000|Taper Phase|Sponsor Decision|1|||
25262896|NCT01237587|50577760|FG001|Taper Phase|Sponsor Decision|0|||
25262897|NCT01237587|50577759|FG000|Taper Phase|Withdrawal by Subject|0|||
25262898|NCT01237587|50577760|FG001|Taper Phase|Withdrawal by Subject|1|||
25262899|NCT01031680|50577775|FG000|Overall Study|Adverse Event|8|||
25262900|NCT01031680|50577776|FG001|Overall Study|Adverse Event|3|||
25262901|NCT01031680|50577775|FG000|Overall Study|Lost to Follow-up|2|||
25262902|NCT01031680|50577776|FG001|Overall Study|Lost to Follow-up|10|||
25262903|NCT01031680|50577775|FG000|Overall Study|Withdrawal by Subject|12|||
25262904|NCT01031680|50577776|FG001|Overall Study|Withdrawal by Subject|16|||
25262905|NCT01031680|50577775|FG000|Overall Study|Death|2|||
25262906|NCT01031680|50577776|FG001|Overall Study|Death|1|||
25262907|NCT01031680|50577775|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
25262908|NCT01031680|50577776|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
25262909|NCT01031680|50577775|FG000|Overall Study|Poor/Non-compliance|5|||
25262910|NCT01031680|50577776|FG001|Overall Study|Poor/Non-compliance|6|||
25262911|NCT01031680|50577775|FG000|Overall Study|Safety|1|||
25262912|NCT01031680|50577776|FG001|Overall Study|Safety|0|||
25262913|NCT01031680|50577775|FG000|Overall Study|Incorrect Enrolment|1|||
25262914|NCT01031680|50577776|FG001|Overall Study|Incorrect Enrolment|2|||
25262915|NCT01031680|50577775|FG000|Overall Study|Administrative Reason by Sponsor|0|||
25262916|NCT01031680|50577776|FG001|Overall Study|Administrative Reason by Sponsor|1|||
25262917|NCT01031680|50577775|FG000|Overall Study|Various|0|||
25262918|NCT01031680|50577776|FG001|Overall Study|Various|2|||
25262919|NCT01031446|50577782|FG000|Overall Study|Disease Progression|38|||
25262920|NCT01031446|50577782|FG000|Overall Study|Adverse Event|9|||
25262921|NCT01031446|50577782|FG000|Overall Study|Physician Decision|4|||
25262922|NCT01031446|50577782|FG000|Overall Study|Withdrawal by Subject|3|||
25262923|NCT01031446|50577782|FG000|Overall Study|Still on treatment|1|||
25262924|NCT01030900|50577788|FG000|Overall Study|Not treated due to congestive heart failure|1|||
25177511|NCT02659059|50321604|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
25177512|NCT02659059|50321603|FG000|Overall Study|Participant request to discontinue study treatment|5|||
25177513|NCT02659059|50321604|FG001|Overall Study|Participant request to discontinue study treatment|0|||
25177514|NCT02659059|50321603|FG000|Overall Study|Participant withdrew consent|6|||
25177515|NCT02659059|50321604|FG001|Overall Study|Participant withdrew consent|1|||
25177516|NCT01164891|50321619|FG000|Overall Study|Disease Progression|5|||
25177517|NCT01164891|50321619|FG000|Overall Study|Adverse Event|1|||
25177518|NCT01497899|50321628|FG000|Double-Blind Phase|Randomized but not Treated|1|||
25177519|NCT01497899|50321629|FG001|Double-Blind Phase|Randomized but not Treated|0|||
25177520|NCT01497899|50321630|FG002|Double-Blind Phase|Randomized but not Treated|0|||
25177521|NCT01497899|50321631|FG003|Double-Blind Phase|Randomized but not Treated|0|||
25177522|NCT01497899|50321628|FG000|Double-Blind Phase|Adverse Event|1|||
25177523|NCT01497899|50321629|FG001|Double-Blind Phase|Adverse Event|0|||
25262925|NCT01030900|50577788|FG000|Overall Study|Not treated due to rapid disease|1|||
25177524|NCT01497899|50321630|FG002|Double-Blind Phase|Adverse Event|0|||
25177525|NCT01497899|50321631|FG003|Double-Blind Phase|Adverse Event|0|||
25262926|NCT01030822|50577795|FG000|Overall Study|Moved/migrated from study area|6|||
25262927|NCT01030822|50577796|FG001|Overall Study|Moved/migrated from study area|7|||
25262928|NCT01030822|50577797|FG002|Overall Study|Moved/migrated from study area|3|||
25262929|NCT01030822|50577795|FG000|Overall Study|Withdrawal by Subject|16|||
25262930|NCT01030822|50577796|FG001|Overall Study|Withdrawal by Subject|13|||
25262931|NCT01030822|50577797|FG002|Overall Study|Withdrawal by Subject|16|||
25262932|NCT01030822|50577795|FG000|Overall Study|Lost to Follow-up|9|||
25262933|NCT01030822|50577796|FG001|Overall Study|Lost to Follow-up|4|||
25262934|NCT01030822|50577797|FG002|Overall Study|Lost to Follow-up|7|||
25262935|NCT01026454|50577808|FG000|Second Intervention|Pregnancy|1|||
25262936|NCT01026454|50577809|FG001|Second Intervention|Pregnancy|1|||
25262937|NCT01026220|50577815|FG000|Induction|Death|1|||
25262938|NCT01026220|50577816|FG001|Induction|Death|0|||
25262939|NCT01026220|50577817|FG002|Induction|Death|0|||
25262940|NCT01026220|50577815|FG000|Induction|Lack of Efficacy|2|||
25262941|NCT01026220|50577816|FG001|Induction|Lack of Efficacy|0|||
25262942|NCT01026220|50577817|FG002|Induction|Lack of Efficacy|0|||
25262943|NCT01026220|50577815|FG000|Induction|Physician Decision|12|||
25262944|NCT01026220|50577816|FG001|Induction|Physician Decision|0|||
25262945|NCT01026220|50577817|FG002|Induction|Physician Decision|0|||
25262946|NCT01026220|50577815|FG000|Induction|Withdrawal by Subject|9|||
25262947|NCT01026220|50577816|FG001|Induction|Withdrawal by Subject|0|||
25262948|NCT01026220|50577817|FG002|Induction|Withdrawal by Subject|0|||
25262949|NCT01026220|50577815|FG000|Induction|Ineligible|1|||
25262950|NCT01026220|50577816|FG001|Induction|Ineligible|0|||
25262951|NCT01026220|50577817|FG002|Induction|Ineligible|0|||
25262952|NCT01026220|50577815|FG000|Consolidation Maintenance|Death|0|||
25262953|NCT01026220|50577816|FG001|Consolidation Maintenance|Death|1|||
25262954|NCT01026220|50577817|FG002|Consolidation Maintenance|Death|0|||
25262955|NCT01026220|50577815|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
25262956|NCT01026220|50577816|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
25262957|NCT01026220|50577817|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
25262958|NCT01026220|50577815|FG000|Consolidation Maintenance|Physician Decision|0|||
25262959|NCT01026220|50577816|FG001|Consolidation Maintenance|Physician Decision|2|||
25262960|NCT01026220|50577817|FG002|Consolidation Maintenance|Physician Decision|7|||
25262961|NCT01026220|50577815|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
25262962|NCT01026220|50577816|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
25262963|NCT01026220|50577817|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
25262964|NCT01026142|50577834|FG000|Overall Study|Death|136|||
25262965|NCT01026142|50577835|FG001|Overall Study|Death|134|||
25123345|NCT02274857|50235862|FG000|Overall Study|Adverse Event|1|||
25123346|NCT02274857|50235863|FG001|Overall Study|Adverse Event|0|||
25123347|NCT02274857|50235862|FG000|Overall Study|Death|1|||
25123348|NCT02274857|50235863|FG001|Overall Study|Death|2|||
25123349|NCT02274857|50235862|FG000|Overall Study|Lost to Follow-up|3|||
25123350|NCT02274857|50235863|FG001|Overall Study|Lost to Follow-up|0|||
25123351|NCT02274857|50235862|FG000|Overall Study|Physician Decision|2|||
25123352|NCT02274857|50235863|FG001|Overall Study|Physician Decision|0|||
25123353|NCT02274857|50235862|FG000|Overall Study|Trial screen failure|0|||
25123354|NCT02274857|50235863|FG001|Overall Study|Trial screen failure|2|||
25123355|NCT02274857|50235862|FG000|Overall Study|Withdrawal by Subject|11|||
25123356|NCT02274857|50235863|FG001|Overall Study|Withdrawal by Subject|2|||
25123357|NCT02274857|50235862|FG000|Overall Study|Other|2|||
25123358|NCT02274857|50235863|FG001|Overall Study|Other|0|||
25123359|NCT02302859|50235872|FG000|Overall Study|Lost Phone|1|||
25123360|NCT02302859|50235873|FG001|Overall Study|Lost Phone|1|||
25123361|NCT02302859|50235872|FG000|Overall Study|Withdrawal by Subject|0|||
25123362|NCT02302859|50235873|FG001|Overall Study|Withdrawal by Subject|1|||
25123363|NCT02274311|50235879|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
25123364|NCT02316353|50235887|FG000|Overall Study|Pregnancy|1|||
25123365|NCT02316353|50235888|FG001|Overall Study|Pregnancy|3|||
25262966|NCT01026142|50577834|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
25262967|NCT01026142|50577835|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
25262968|NCT01030666|50577843|FG000|Overall Study|Lost to Follow-up|3|||
25262969|NCT01030666|50577844|FG001|Overall Study|Lost to Follow-up|2|||
25262970|NCT01025752|50577853|FG000|Overall Study|Lost to Follow-up|7|||
25262971|NCT01025752|50577854|FG001|Overall Study|Lost to Follow-up|10|||
25262972|NCT01025752|50577853|FG000|Overall Study|Physician Decision|1|||
25123366|NCT02316353|50235887|FG000|Overall Study|Adverse Event|1|||
25123367|NCT02316353|50235888|FG001|Overall Study|Adverse Event|3|||
25123368|NCT02316353|50235887|FG000|Overall Study|Withdrawal by Subject|6|||
25262973|NCT01025752|50577854|FG001|Overall Study|Physician Decision|3|||
25123369|NCT02316353|50235888|FG001|Overall Study|Withdrawal by Subject|2|||
25123370|NCT02273141|50235899|FG000|Overall Study|Adverse Event|0|||
25123371|NCT02273141|50235900|FG001|Overall Study|Adverse Event|1|||
25123372|NCT02273141|50235899|FG000|Overall Study|Lost to Follow-up|1|||
25123373|NCT02273141|50235900|FG001|Overall Study|Lost to Follow-up|3|||
25262974|NCT01030198|50577862|FG000|Overall Study|Could not measure efficacy accurately|0|||
25262975|NCT01030198|50577863|FG001|Overall Study|Could not measure efficacy accurately|7|||
25262976|NCT01301456|50577881|FG000|Stage 1|Withdrawal by Subject|0|||
25262977|NCT01301456|50577882|FG001|Stage 1|Withdrawal by Subject|0|||
25262978|NCT01301456|50577883|FG002|Stage 1|Withdrawal by Subject|1|||
25262979|NCT01301456|50577884|FG003|Stage 1|Withdrawal by Subject|0|||
25262980|NCT01301456|50577885|FG004|Stage 1|Withdrawal by Subject|1|||
25262981|NCT01301456|50577886|FG005|Stage 1|Withdrawal by Subject|0|||
25262982|NCT01301456|50577887|FG006|Stage 1|Withdrawal by Subject|0|||
25262983|NCT01301456|50577888|FG007|Stage 1|Withdrawal by Subject|0|||
25262984|NCT01301456|50577889|FG008|Stage 1|Withdrawal by Subject|0|||
25262985|NCT01301456|50577890|FG009|Stage 1|Withdrawal by Subject|0|||
25262986|NCT01301456|50577891|FG010|Stage 1|Withdrawal by Subject|0|||
25262987|NCT01301456|50577892|FG011|Stage 1|Withdrawal by Subject|0|||
25262988|NCT01301456|50577881|FG000|Stage 1|Randomized but not treated|0|||
25262989|NCT01301456|50577882|FG001|Stage 1|Randomized but not treated|0|||
25262990|NCT01301456|50577883|FG002|Stage 1|Randomized but not treated|0|||
25262991|NCT01301456|50577884|FG003|Stage 1|Randomized but not treated|0|||
25262992|NCT01301456|50577885|FG004|Stage 1|Randomized but not treated|0|||
25262993|NCT01301456|50577886|FG005|Stage 1|Randomized but not treated|0|||
25262994|NCT01301456|50577887|FG006|Stage 1|Randomized but not treated|1|||
25262995|NCT01301456|50577888|FG007|Stage 1|Randomized but not treated|0|||
25262996|NCT01301456|50577889|FG008|Stage 1|Randomized but not treated|0|||
25262997|NCT01301456|50577890|FG009|Stage 1|Randomized but not treated|0|||
25262998|NCT01301456|50577891|FG010|Stage 1|Randomized but not treated|0|||
25262999|NCT01301456|50577892|FG011|Stage 1|Randomized but not treated|0|||
25263000|NCT01301456|50577881|FG000|Stage 2|Adverse Event|0|||
25263001|NCT01301456|50577882|FG001|Stage 2|Adverse Event|0|||
25263002|NCT01301456|50577883|FG002|Stage 2|Adverse Event|0|||
25263003|NCT01301456|50577884|FG003|Stage 2|Adverse Event|0|||
25263004|NCT01301456|50577885|FG004|Stage 2|Adverse Event|0|||
25263005|NCT01301456|50577886|FG005|Stage 2|Adverse Event|0|||
25263006|NCT01301456|50577887|FG006|Stage 2|Adverse Event|0|||
25263007|NCT01301456|50577888|FG007|Stage 2|Adverse Event|0|||
25263008|NCT01301456|50577889|FG008|Stage 2|Adverse Event|0|||
25263009|NCT01301456|50577890|FG009|Stage 2|Adverse Event|0|||
25263010|NCT01301456|50577891|FG010|Stage 2|Adverse Event|1|||
25263011|NCT01301456|50577892|FG011|Stage 2|Adverse Event|0|||
25263012|NCT01023256|50577940|FG000|Overall Study|Protocol Violation|2|||
25263013|NCT01023256|50577941|FG001|Overall Study|Protocol Violation|3|||
25263014|NCT01023256|50577942|FG002|Overall Study|Protocol Violation|0|||
25263015|NCT01023256|50577943|FG003|Overall Study|Protocol Violation|0|||
25263016|NCT01023256|50577940|FG000|Overall Study|Randomized but not treated|1|||
25263017|NCT01023256|50577941|FG001|Overall Study|Randomized but not treated|0|||
25263018|NCT01023256|50577942|FG002|Overall Study|Randomized but not treated|1|||
25263019|NCT01023256|50577943|FG003|Overall Study|Randomized but not treated|0|||
25263020|NCT01023256|50577940|FG000|Overall Study|Other|1|||
25263021|NCT01023256|50577941|FG001|Overall Study|Other|0|||
25263022|NCT01023256|50577942|FG002|Overall Study|Other|0|||
25263023|NCT01023256|50577943|FG003|Overall Study|Other|2|||
25263024|NCT01023256|50577940|FG000|Overall Study|Adverse Event|0|||
25263025|NCT01023256|50577941|FG001|Overall Study|Adverse Event|0|||
25263026|NCT01023256|50577942|FG002|Overall Study|Adverse Event|0|||
25263027|NCT01023256|50577943|FG003|Overall Study|Adverse Event|1|||
25263028|NCT01023256|50577940|FG000|Overall Study|Withdrawal by Subject|0|||
25263029|NCT01023256|50577941|FG001|Overall Study|Withdrawal by Subject|0|||
25263030|NCT01023256|50577942|FG002|Overall Study|Withdrawal by Subject|0|||
25263031|NCT01023256|50577943|FG003|Overall Study|Withdrawal by Subject|2|||
25008826|NCT02873936|50101939|FG001|Overall Study|Investigator's Discretion|5|||
25123374|NCT02273141|50235899|FG000|Overall Study|Withdrawal by Subject|10|||
25123375|NCT02273141|50235900|FG001|Overall Study|Withdrawal by Subject|15|||
25123376|NCT02273141|50235899|FG000|Overall Study|Various|6|||
25263032|NCT01023022|50577956|FG000|Overall Study|Death|5|||
25263033|NCT01023022|50577956|FG000|Overall Study|Lost to Follow-up|7|||
25008827|NCT02873936|50101940|FG002|Overall Study|Investigator's Discretion|4|||
25008828|NCT02873936|50101938|FG000|Overall Study|Adverse Event|3|||
25008829|NCT02873936|50101939|FG001|Overall Study|Adverse Event|5|||
25008830|NCT02873936|50101940|FG002|Overall Study|Adverse Event|3|||
25123377|NCT02273141|50235900|FG001|Overall Study|Various|6|||
25123378|NCT02314052|50235906|FG000|Cycle One|Adverse Event|0|||
25123379|NCT02314052|50235907|FG001|Cycle One|Adverse Event|0|||
25123380|NCT02314052|50235908|FG002|Cycle One|Adverse Event|0|||
25123381|NCT02314052|50235909|FG003|Cycle One|Adverse Event|1|||
25123382|NCT02314052|50235910|FG004|Cycle One|Adverse Event|0|||
25123383|NCT02314052|50235911|FG005|Cycle One|Adverse Event|0|||
25123384|NCT02279732|50235927|FG000|Overall Study|Death|23|||
25123385|NCT02279732|50235928|FG001|Overall Study|Death|20|||
25263034|NCT01023022|50577956|FG000|Overall Study|due to technical issues|2|||
25263035|NCT01058668|50577963|FG000|Double-blind Treatment Phase|Adverse Event|8|||
25263036|NCT01058668|50577964|FG001|Double-blind Treatment Phase|Adverse Event|15|||
25263037|NCT01058668|50577965|FG002|Double-blind Treatment Phase|Adverse Event|25|||
25263038|NCT01058668|50577963|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
25263039|NCT01058668|50577964|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
25263040|NCT01058668|50577965|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
25263041|NCT01058668|50577963|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
25263042|NCT01058668|50577964|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
25263043|NCT01058668|50577965|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
25263044|NCT01058668|50577963|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
25263045|NCT01058668|50577964|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
25263046|NCT01058668|50577965|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
25263047|NCT01058668|50577963|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
25263048|NCT01058668|50577964|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
25263049|NCT01058668|50577965|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
25263050|NCT01058668|50577963|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
25263051|NCT01058668|50577964|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
25263052|NCT01058668|50577965|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
25263053|NCT01301066|50577975|FG000|Overall Study|Lost to Follow-up|5|||
25263054|NCT01301066|50577976|FG001|Overall Study|Lost to Follow-up|11|||
25263055|NCT01301066|50577975|FG000|Overall Study|Protocol Violation|8|||
25263056|NCT01301066|50577976|FG001|Overall Study|Protocol Violation|7|||
25263057|NCT01301066|50577975|FG000|Overall Study|Withdrawal by Subject|4|||
25263058|NCT01301066|50577976|FG001|Overall Study|Withdrawal by Subject|9|||
25263059|NCT01301066|50577975|FG000|Overall Study|Adverse Event|6|||
25263060|NCT01301066|50577976|FG001|Overall Study|Adverse Event|6|||
25263061|NCT01301066|50577975|FG000|Overall Study|Sponsor Decision|2|||
25263062|NCT01301066|50577976|FG001|Overall Study|Sponsor Decision|1|||
25263063|NCT01301066|50577975|FG000|Overall Study|Physician Decision|0|||
25263064|NCT01301066|50577976|FG001|Overall Study|Physician Decision|1|||
25263065|NCT01301066|50577975|FG000|Overall Study|Other|2|||
25263066|NCT01301066|50577976|FG001|Overall Study|Other|0|||
25263067|NCT01022398|50577984|FG000|Overall Study|Study terminated|2|||
25263068|NCT01022398|50577985|FG001|Overall Study|Study terminated|2|||
25263069|NCT01262976|50577996|FG000|Up to Month 2|Serious Adverse Event|0|||
25263070|NCT01262976|50577997|FG001|Up to Month 2|Serious Adverse Event|0|||
25263071|NCT01262976|50577998|FG002|Up to Month 2|Serious Adverse Event|1|||
25008831|NCT02873936|50101938|FG000|Overall Study|Protocol Violation|0|||
25008832|NCT02873936|50101939|FG001|Overall Study|Protocol Violation|1|||
25008833|NCT02873936|50101940|FG002|Overall Study|Protocol Violation|3|||
25008834|NCT02873936|50101938|FG000|Overall Study|Lost to Follow-up|1|||
25008835|NCT02873936|50101939|FG001|Overall Study|Lost to Follow-up|1|||
25008836|NCT02873936|50101940|FG002|Overall Study|Lost to Follow-up|1|||
25008837|NCT02873936|50101938|FG000|Overall Study|Non-compliance With Study Drug|1|||
25008838|NCT02873936|50101939|FG001|Overall Study|Non-compliance With Study Drug|0|||
25008839|NCT02873936|50101940|FG002|Overall Study|Non-compliance With Study Drug|1|||
25008840|NCT02873936|50101938|FG000|Overall Study|Randomized but not Dosed|1|||
25177526|NCT01497899|50321628|FG000|Double-Blind Phase|Lack of Efficacy|0|||
25177527|NCT01497899|50321629|FG001|Double-Blind Phase|Lack of Efficacy|1|||
25263072|NCT01262976|50577999|FG003|Up to Month 2|Serious Adverse Event|0|||
25263073|NCT01262976|50578000|FG004|Up to Month 2|Serious Adverse Event|0|||
25263074|NCT01262976|50578001|FG005|Up to Month 2|Serious Adverse Event|0|||
25263075|NCT01262976|50577996|FG000|Up to Month 2|Withdrawal by Subject|1|||
25263076|NCT01262976|50577997|FG001|Up to Month 2|Withdrawal by Subject|0|||
25263077|NCT01262976|50577998|FG002|Up to Month 2|Withdrawal by Subject|0|||
25263078|NCT01262976|50577999|FG003|Up to Month 2|Withdrawal by Subject|0|||
25263079|NCT01262976|50578000|FG004|Up to Month 2|Withdrawal by Subject|0|||
25263080|NCT01262976|50578001|FG005|Up to Month 2|Withdrawal by Subject|0|||
25263081|NCT01262976|50577996|FG000|Up to Month 2|Migrated/moved from study area|0|||
25263082|NCT01262976|50577997|FG001|Up to Month 2|Migrated/moved from study area|1|||
25008841|NCT02873936|50101939|FG001|Overall Study|Randomized but not Dosed|0|||
25177528|NCT01497899|50321630|FG002|Double-Blind Phase|Lack of Efficacy|0|||
25177529|NCT01497899|50321631|FG003|Double-Blind Phase|Lack of Efficacy|0|||
25177530|NCT01497899|50321628|FG000|Double-Blind Phase|Investigator's Discretion|1|||
25177531|NCT01497899|50321629|FG001|Double-Blind Phase|Investigator's Discretion|0|||
25177532|NCT01497899|50321630|FG002|Double-Blind Phase|Investigator's Discretion|0|||
25177533|NCT01497899|50321631|FG003|Double-Blind Phase|Investigator's Discretion|0|||
25177534|NCT01497899|50321628|FG000|Double-Blind Phase|Withdrew Consent|0|||
25177535|NCT01497899|50321629|FG001|Double-Blind Phase|Withdrew Consent|1|||
25177536|NCT01497899|50321630|FG002|Double-Blind Phase|Withdrew Consent|0|||
25177537|NCT01497899|50321631|FG003|Double-Blind Phase|Withdrew Consent|0|||
25177538|NCT01497899|50321628|FG000|Double-Blind Phase|Lost to Follow-up|3|||
25177539|NCT01497899|50321629|FG001|Double-Blind Phase|Lost to Follow-up|2|||
25177540|NCT01497899|50321630|FG002|Double-Blind Phase|Lost to Follow-up|0|||
25177541|NCT01497899|50321631|FG003|Double-Blind Phase|Lost to Follow-up|0|||
25177542|NCT01497899|50321628|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
25177543|NCT01497899|50321629|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
25263083|NCT01262976|50577998|FG002|Up to Month 2|Migrated/moved from study area|0|||
25263084|NCT01262976|50577999|FG003|Up to Month 2|Migrated/moved from study area|0|||
25263085|NCT01262976|50578000|FG004|Up to Month 2|Migrated/moved from study area|1|||
25263086|NCT01262976|50578001|FG005|Up to Month 2|Migrated/moved from study area|1|||
25263087|NCT01262976|50577996|FG000|Up to Month 2|Lost to Follow-up|1|||
25263088|NCT01262976|50577997|FG001|Up to Month 2|Lost to Follow-up|0|||
25263089|NCT01262976|50577998|FG002|Up to Month 2|Lost to Follow-up|0|||
25263090|NCT01262976|50577999|FG003|Up to Month 2|Lost to Follow-up|1|||
25263091|NCT01262976|50578000|FG004|Up to Month 2|Lost to Follow-up|1|||
25263092|NCT01262976|50578001|FG005|Up to Month 2|Lost to Follow-up|1|||
25263093|NCT01262976|50577996|FG000|Up to Month 2|Other|1|||
25263094|NCT01262976|50577997|FG001|Up to Month 2|Other|0|||
25263095|NCT01262976|50577998|FG002|Up to Month 2|Other|0|||
25263096|NCT01262976|50577999|FG003|Up to Month 2|Other|1|||
25263097|NCT01262976|50578000|FG004|Up to Month 2|Other|0|||
25263098|NCT01262976|50578001|FG005|Up to Month 2|Other|2|||
25263099|NCT01262976|50577996|FG000|Up to Month 7|Serious Adverse Event|0|||
25263100|NCT01262976|50577997|FG001|Up to Month 7|Serious Adverse Event|0|||
25263101|NCT01262976|50577998|FG002|Up to Month 7|Serious Adverse Event|2|||
25263102|NCT01262976|50577999|FG003|Up to Month 7|Serious Adverse Event|0|||
25263103|NCT01262976|50578000|FG004|Up to Month 7|Serious Adverse Event|0|||
25263104|NCT01262976|50578001|FG005|Up to Month 7|Serious Adverse Event|0|||
25263105|NCT01262976|50577996|FG000|Up to Month 7|Withdrawal by Subject|1|||
25263106|NCT01262976|50577997|FG001|Up to Month 7|Withdrawal by Subject|0|||
25263107|NCT01262976|50577998|FG002|Up to Month 7|Withdrawal by Subject|0|||
25263108|NCT01262976|50577999|FG003|Up to Month 7|Withdrawal by Subject|0|||
25263109|NCT01262976|50578000|FG004|Up to Month 7|Withdrawal by Subject|0|||
25263110|NCT01262976|50578001|FG005|Up to Month 7|Withdrawal by Subject|0|||
25263111|NCT01262976|50577996|FG000|Up to Month 7|Migrated/moved from study area|0|||
25263112|NCT01262976|50577997|FG001|Up to Month 7|Migrated/moved from study area|0|||
25263113|NCT01262976|50577998|FG002|Up to Month 7|Migrated/moved from study area|1|||
25263114|NCT01262976|50577999|FG003|Up to Month 7|Migrated/moved from study area|3|||
25263115|NCT01262976|50578000|FG004|Up to Month 7|Migrated/moved from study area|1|||
25263116|NCT01262976|50578001|FG005|Up to Month 7|Migrated/moved from study area|1|||
25263117|NCT01262976|50577996|FG000|Up to Month 7|Lost to Follow-up|1|||
25263118|NCT01262976|50577997|FG001|Up to Month 7|Lost to Follow-up|0|||
25263119|NCT01262976|50577998|FG002|Up to Month 7|Lost to Follow-up|1|||
25263120|NCT01262976|50577999|FG003|Up to Month 7|Lost to Follow-up|3|||
25263121|NCT01262976|50578000|FG004|Up to Month 7|Lost to Follow-up|1|||
25263122|NCT01262976|50578001|FG005|Up to Month 7|Lost to Follow-up|3|||
25263123|NCT01262976|50577996|FG000|Up to Month 7|Other|3|||
25263124|NCT01262976|50577997|FG001|Up to Month 7|Other|0|||
25263125|NCT01262976|50577998|FG002|Up to Month 7|Other|2|||
25263126|NCT01262976|50577999|FG003|Up to Month 7|Other|0|||
25263127|NCT01262976|50578000|FG004|Up to Month 7|Other|0|||
25263128|NCT01262976|50578001|FG005|Up to Month 7|Other|0|||
25263129|NCT01262976|50577996|FG000|Up to Year 1|Serious Adverse Event|0|||
25263130|NCT01262976|50577997|FG001|Up to Year 1|Serious Adverse Event|0|||
25263131|NCT01262976|50577998|FG002|Up to Year 1|Serious Adverse Event|2|||
25263132|NCT01262976|50577999|FG003|Up to Year 1|Serious Adverse Event|0|||
25263133|NCT01262976|50578000|FG004|Up to Year 1|Serious Adverse Event|0|||
25263134|NCT01262976|50578001|FG005|Up to Year 1|Serious Adverse Event|0|||
25263135|NCT01262976|50577996|FG000|Up to Year 1|Withdrawal by Subject|1|||
25263136|NCT01262976|50577997|FG001|Up to Year 1|Withdrawal by Subject|0|||
25263137|NCT01262976|50577998|FG002|Up to Year 1|Withdrawal by Subject|0|||
25263138|NCT01262976|50577999|FG003|Up to Year 1|Withdrawal by Subject|0|||
25263139|NCT01262976|50578000|FG004|Up to Year 1|Withdrawal by Subject|0|||
25263140|NCT01262976|50578001|FG005|Up to Year 1|Withdrawal by Subject|0|||
25263141|NCT01262976|50577996|FG000|Up to Year 1|Migrated/moved from study area|1|||
25263142|NCT01262976|50577997|FG001|Up to Year 1|Migrated/moved from study area|0|||
25263143|NCT01262976|50577998|FG002|Up to Year 1|Migrated/moved from study area|0|||
25263144|NCT01262976|50577999|FG003|Up to Year 1|Migrated/moved from study area|3|||
25263145|NCT01262976|50578000|FG004|Up to Year 1|Migrated/moved from study area|3|||
25263146|NCT01262976|50578001|FG005|Up to Year 1|Migrated/moved from study area|2|||
25263147|NCT01262976|50577996|FG000|Up to Year 1|Lost to Follow-up|4|||
25263148|NCT01262976|50577997|FG001|Up to Year 1|Lost to Follow-up|0|||
25263149|NCT01262976|50577998|FG002|Up to Year 1|Lost to Follow-up|0|||
25263150|NCT01262976|50577999|FG003|Up to Year 1|Lost to Follow-up|1|||
25008842|NCT02873936|50101940|FG002|Overall Study|Randomized but not Dosed|0|||
25008843|NCT02874794|50101950|FG000|Overall Study|Physician Decision|3|||
25008844|NCT02874794|50101951|FG001|Overall Study|Physician Decision|2|||
25008845|NCT02874794|50101950|FG000|Overall Study|Withdrawal by Subject|2|||
25263151|NCT01262976|50578000|FG004|Up to Year 1|Lost to Follow-up|6|||
25263152|NCT01262976|50578001|FG005|Up to Year 1|Lost to Follow-up|5|||
25263153|NCT01262976|50577996|FG000|Up to Year 1|Other|3|||
25263154|NCT01262976|50577997|FG001|Up to Year 1|Other|1|||
25263155|NCT01262976|50577998|FG002|Up to Year 1|Other|0|||
25263156|NCT01262976|50577999|FG003|Up to Year 1|Other|0|||
25263157|NCT01262976|50578000|FG004|Up to Year 1|Other|2|||
25263158|NCT01262976|50578001|FG005|Up to Year 1|Other|1|||
25263159|NCT01262976|50577996|FG000|Up to Year 1|Subjects with unknown completion status|0|||
25263160|NCT01262976|50577997|FG001|Up to Year 1|Subjects with unknown completion status|0|||
25263161|NCT01262976|50577998|FG002|Up to Year 1|Subjects with unknown completion status|1|||
25263162|NCT01262976|50577999|FG003|Up to Year 1|Subjects with unknown completion status|0|||
25263163|NCT01262976|50578000|FG004|Up to Year 1|Subjects with unknown completion status|0|||
25263164|NCT01262976|50578001|FG005|Up to Year 1|Subjects with unknown completion status|1|||
25263165|NCT01262976|50577996|FG000|Up to Year 2|Serious Adverse Event|0|||
25263166|NCT01262976|50577997|FG001|Up to Year 2|Serious Adverse Event|0|||
25263167|NCT01262976|50577998|FG002|Up to Year 2|Serious Adverse Event|2|||
25263168|NCT01262976|50577999|FG003|Up to Year 2|Serious Adverse Event|0|||
25263169|NCT01262976|50578000|FG004|Up to Year 2|Serious Adverse Event|0|||
25263170|NCT01262976|50578001|FG005|Up to Year 2|Serious Adverse Event|0|||
25263171|NCT01262976|50577996|FG000|Up to Year 2|Withdrawal by Subject|1|||
25263172|NCT01262976|50577997|FG001|Up to Year 2|Withdrawal by Subject|0|||
25263173|NCT01262976|50577998|FG002|Up to Year 2|Withdrawal by Subject|0|||
25263174|NCT01262976|50577999|FG003|Up to Year 2|Withdrawal by Subject|0|||
25263175|NCT01262976|50578000|FG004|Up to Year 2|Withdrawal by Subject|0|||
25123386|NCT02279732|50235927|FG000|Overall Study|Disease Progression|13|||
25123387|NCT02279732|50235928|FG001|Overall Study|Disease Progression|3|||
25123388|NCT02279732|50235927|FG000|Overall Study|Withdrawal by Subject|2|||
25263176|NCT01262976|50578001|FG005|Up to Year 2|Withdrawal by Subject|0|||
25263177|NCT01262976|50577996|FG000|Up to Year 2|Migrated/moved from study area|0|||
25263178|NCT01262976|50577997|FG001|Up to Year 2|Migrated/moved from study area|0|||
25263179|NCT01262976|50577998|FG002|Up to Year 2|Migrated/moved from study area|0|||
25263180|NCT01262976|50577999|FG003|Up to Year 2|Migrated/moved from study area|2|||
25263181|NCT01262976|50578000|FG004|Up to Year 2|Migrated/moved from study area|1|||
25263182|NCT01262976|50578001|FG005|Up to Year 2|Migrated/moved from study area|2|||
25263183|NCT01262976|50577996|FG000|Up to Year 2|Lost to Follow-up|1|||
25263184|NCT01262976|50577997|FG001|Up to Year 2|Lost to Follow-up|1|||
25263185|NCT01262976|50577998|FG002|Up to Year 2|Lost to Follow-up|2|||
25263186|NCT01262976|50577999|FG003|Up to Year 2|Lost to Follow-up|2|||
25123389|NCT02279732|50235928|FG001|Overall Study|Withdrawal by Subject|7|||
25123390|NCT02279732|50235927|FG000|Overall Study|Adverse Event|1|||
25123391|NCT02279732|50235928|FG001|Overall Study|Adverse Event|2|||
25123392|NCT02279732|50235927|FG000|Overall Study|Administrative Reason By Sponsor|0|||
25123393|NCT02279732|50235928|FG001|Overall Study|Administrative Reason By Sponsor|2|||
25123394|NCT02279732|50235927|FG000|Overall Study|Study Drug Toxicity|2|||
25123395|NCT02279732|50235928|FG001|Overall Study|Study Drug Toxicity|0|||
25123396|NCT02279732|50235927|FG000|Overall Study|Lost to Follow-up|0|||
25123397|NCT02279732|50235928|FG001|Overall Study|Lost to Follow-up|1|||
25123398|NCT02279732|50235927|FG000|Overall Study|Maximum Clinical Benefit|1|||
25123399|NCT02279732|50235928|FG001|Overall Study|Maximum Clinical Benefit|0|||
25123400|NCT02279732|50235927|FG000|Overall Study|Subject Requested to Discontinue|0|||
25123401|NCT02279732|50235928|FG001|Overall Study|Subject Requested to Discontinue|1|||
25123402|NCT02279732|50235927|FG000|Overall Study|Other|53|||
25123403|NCT02279732|50235928|FG001|Overall Study|Other|67|||
25123404|NCT02279732|50235927|FG000|Overall Study|Other|3|||
25123405|NCT02279732|50235928|FG001|Overall Study|Other|3|||
25123406|NCT02279498|50235936|FG000|Overall Study|Adverse Event|3|||
25123407|NCT02279498|50235937|FG001|Overall Study|Adverse Event|0|||
25123408|NCT02279498|50235936|FG000|Overall Study|Lack of Efficacy|4|||
25123409|NCT02279498|50235937|FG001|Overall Study|Lack of Efficacy|0|||
25123410|NCT02279498|50235936|FG000|Overall Study|Lost to Follow-up|0|||
25123411|NCT02279498|50235937|FG001|Overall Study|Lost to Follow-up|1|||
25123412|NCT02279498|50235936|FG000|Overall Study|Withdrawal by Subject|9|||
25123413|NCT02279498|50235937|FG001|Overall Study|Withdrawal by Subject|2|||
25123414|NCT02279498|50235936|FG000|Overall Study|Undefined|2|||
25123415|NCT02279498|50235937|FG001|Overall Study|Undefined|1|||
25123416|NCT02307266|50235947|FG000|Overall Study|Adverse Event|3|||
25123417|NCT02307266|50235948|FG001|Overall Study|Adverse Event|1|||
25123418|NCT02307266|50235949|FG002|Overall Study|Adverse Event|5|||
25123419|NCT02307266|50235947|FG000|Overall Study|Withdrawal by Subject|2|||
25123420|NCT02307266|50235948|FG001|Overall Study|Withdrawal by Subject|0|||
25123421|NCT02307266|50235949|FG002|Overall Study|Withdrawal by Subject|1|||
25123422|NCT02307266|50235947|FG000|Overall Study|Lost to Follow-up|3|||
25123423|NCT02307266|50235948|FG001|Overall Study|Lost to Follow-up|0|||
25123424|NCT02307266|50235949|FG002|Overall Study|Lost to Follow-up|0|||
25123425|NCT02279420|50235957|FG000|Overall Study|Lost to Follow-up|23|||
25123426|NCT02278952|50235961|FG000|Overall Study|Insufficient Sample|6|||
25123427|NCT02278328|50235971|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
25123428|NCT02278328|50235972|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
25123429|NCT02278328|50235973|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
25123430|NCT02278328|50235971|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
25123431|NCT02278328|50235972|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
25263187|NCT01262976|50578000|FG004|Up to Year 2|Lost to Follow-up|3|||
25263188|NCT01262976|50578001|FG005|Up to Year 2|Lost to Follow-up|3|||
25123432|NCT02278328|50235973|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
25123433|NCT02278328|50235971|FG000|Neuropsych Screening|incomplete consent|0|||
25263189|NCT01262976|50577996|FG000|Up to Year 2|Subjects with unknown completion status|0|||
25263190|NCT01262976|50577997|FG001|Up to Year 2|Subjects with unknown completion status|0|||
25263191|NCT01262976|50577998|FG002|Up to Year 2|Subjects with unknown completion status|1|||
25263192|NCT01262976|50577999|FG003|Up to Year 2|Subjects with unknown completion status|0|||
25263193|NCT01262976|50578000|FG004|Up to Year 2|Subjects with unknown completion status|0|||
25263194|NCT01262976|50578001|FG005|Up to Year 2|Subjects with unknown completion status|0|||
25263195|NCT01262976|50577996|FG000|Up to Year 2|Other|3|||
25263196|NCT01262976|50577997|FG001|Up to Year 2|Other|0|||
25263197|NCT01262976|50577998|FG002|Up to Year 2|Other|0|||
25263198|NCT01262976|50577999|FG003|Up to Year 2|Other|0|||
25263199|NCT01262976|50578000|FG004|Up to Year 2|Other|0|||
25263200|NCT01262976|50578001|FG005|Up to Year 2|Other|0|||
25263201|NCT01262976|50577996|FG000|Up to Year 3|Serious Adverse Event|0|||
25263202|NCT01262976|50577997|FG001|Up to Year 3|Serious Adverse Event|0|||
25263203|NCT01262976|50577998|FG002|Up to Year 3|Serious Adverse Event|2|||
25263204|NCT01262976|50577999|FG003|Up to Year 3|Serious Adverse Event|0|||
25263205|NCT01262976|50578000|FG004|Up to Year 3|Serious Adverse Event|0|||
25263206|NCT01262976|50578001|FG005|Up to Year 3|Serious Adverse Event|0|||
25263207|NCT01262976|50577996|FG000|Up to Year 3|Withdrawal by Subject|1|||
25263208|NCT01262976|50577997|FG001|Up to Year 3|Withdrawal by Subject|0|||
25263209|NCT01262976|50577998|FG002|Up to Year 3|Withdrawal by Subject|0|||
25263210|NCT01262976|50577999|FG003|Up to Year 3|Withdrawal by Subject|0|||
25263211|NCT01262976|50578000|FG004|Up to Year 3|Withdrawal by Subject|0|||
25263212|NCT01262976|50578001|FG005|Up to Year 3|Withdrawal by Subject|0|||
25263213|NCT01262976|50577996|FG000|Up to Year 3|Migrated/moved from study area|0|||
25263214|NCT01262976|50577997|FG001|Up to Year 3|Migrated/moved from study area|0|||
25263215|NCT01262976|50577998|FG002|Up to Year 3|Migrated/moved from study area|0|||
25263216|NCT01262976|50577999|FG003|Up to Year 3|Migrated/moved from study area|2|||
25263217|NCT01262976|50578000|FG004|Up to Year 3|Migrated/moved from study area|1|||
25263218|NCT01262976|50578001|FG005|Up to Year 3|Migrated/moved from study area|1|||
25263219|NCT01262976|50577996|FG000|Up to Year 3|Lost to Follow-up|2|||
25263220|NCT01262976|50577997|FG001|Up to Year 3|Lost to Follow-up|2|||
25263221|NCT01262976|50577998|FG002|Up to Year 3|Lost to Follow-up|4|||
25263222|NCT01262976|50577999|FG003|Up to Year 3|Lost to Follow-up|3|||
25263223|NCT01262976|50578000|FG004|Up to Year 3|Lost to Follow-up|1|||
25263224|NCT01262976|50578001|FG005|Up to Year 3|Lost to Follow-up|3|||
25263225|NCT01262976|50577996|FG000|Up to Year 3|Subjects with unknown completion status|0|||
25263226|NCT01262976|50577997|FG001|Up to Year 3|Subjects with unknown completion status|0|||
25263227|NCT01262976|50577998|FG002|Up to Year 3|Subjects with unknown completion status|1|||
25263228|NCT01262976|50577999|FG003|Up to Year 3|Subjects with unknown completion status|0|||
25263229|NCT01262976|50578000|FG004|Up to Year 3|Subjects with unknown completion status|0|||
25263230|NCT01262976|50578001|FG005|Up to Year 3|Subjects with unknown completion status|0|||
25263231|NCT01262976|50577996|FG000|Up to Year 3|Other|3|||
25263232|NCT01262976|50577997|FG001|Up to Year 3|Other|0|||
25263233|NCT01262976|50577998|FG002|Up to Year 3|Other|0|||
25263234|NCT01262976|50577999|FG003|Up to Year 3|Other|0|||
25263235|NCT01262976|50578000|FG004|Up to Year 3|Other|0|||
25263236|NCT01262976|50578001|FG005|Up to Year 3|Other|0|||
25263237|NCT01300286|50578016|FG000|Overall Study|did not get dosed|1|||
25263238|NCT01300052|50578023|FG000|Overall Study|Adverse Event|3|||
25263239|NCT01300052|50578024|FG001|Overall Study|Adverse Event|0|||
25263240|NCT01300052|50578023|FG000|Overall Study|Withdrawal by Subject|2|||
25263241|NCT01300052|50578024|FG001|Overall Study|Withdrawal by Subject|2|||
25263242|NCT01300052|50578023|FG000|Overall Study|Protocol Violation|1|||
25263243|NCT01300052|50578024|FG001|Overall Study|Protocol Violation|1|||
25263244|NCT01299896|50578032|FG000|Overall Study|Withdrawal by Subject|1|||
25263245|NCT01299896|50578033|FG001|Overall Study|Withdrawal by Subject|7|||
25263246|NCT01299896|50578032|FG000|Overall Study|Lost to Follow-up|0|||
25123434|NCT02278328|50235972|FG001|Neuropsych Screening|incomplete consent|0|||
25123435|NCT02278328|50235973|FG002|Neuropsych Screening|incomplete consent|2|||
25123436|NCT02314637|50235981|FG000|Overall Study|Adverse Event|4|||
25123437|NCT02314637|50235982|FG001|Overall Study|Adverse Event|8|||
25123438|NCT02314637|50235981|FG000|Overall Study|Lack of Efficacy|1|||
25123439|NCT02314637|50235982|FG001|Overall Study|Lack of Efficacy|0|||
25123440|NCT02314637|50235981|FG000|Overall Study|Physician Decision|5|||
25123441|NCT02314637|50235982|FG001|Overall Study|Physician Decision|2|||
25123442|NCT02314637|50235981|FG000|Overall Study|Withdrawal by Subject|5|||
25123443|NCT02314637|50235982|FG001|Overall Study|Withdrawal by Subject|4|||
25263247|NCT01299896|50578033|FG001|Overall Study|Lost to Follow-up|11|||
25263248|NCT01299584|50578039|FG000|Overall Study|Protocol Violation|9|||
25123444|NCT02314637|50235981|FG000|Overall Study|Other Reason|1|||
25263249|NCT01236573|50578054|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
25263250|NCT01236573|50578055|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
25263251|NCT01236573|50578056|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
25263252|NCT01236573|50578057|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
25263253|NCT01236573|50578058|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
25263254|NCT01236573|50578059|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
25123445|NCT02314637|50235982|FG001|Overall Study|Other Reason|0|||
25123446|NCT01646645|50235988|FG000|Overall Study|No Treated|1|||
25123447|NCT01646645|50235988|FG000|Overall Study|Inevaluable Donor|29|||
25123448|NCT02272985|50235992|FG000|Overall Study|Withdrawal by Subject|1|||
25123449|NCT02272985|50235992|FG000|Overall Study|hip fracture|1|||
25123450|NCT02272985|50235992|FG000|Overall Study|kidney transplantation|1|||
25123451|NCT01644149|50235999|FG000|Overall Study|Withdrawal by Subject|1|||
25123452|NCT01644149|50236000|FG001|Overall Study|Withdrawal by Subject|0|||
25123453|NCT01644149|50235999|FG000|Overall Study|Lost to Follow-up|3|||
25123454|NCT01644149|50236000|FG001|Overall Study|Lost to Follow-up|1|||
25123455|NCT02313233|50236009|FG000|Overall Study|Withdrawal by Subject|1|||
25123456|NCT02313233|50236010|FG001|Overall Study|Withdrawal by Subject|2|||
25123457|NCT02313233|50236009|FG000|Overall Study|Administrative reason|1|||
25123458|NCT02313233|50236010|FG001|Overall Study|Administrative reason|1|||
25123459|NCT02305238|50236021|FG000|Overall Study|Death|2|||
25123460|NCT02305238|50236022|FG001|Overall Study|Death|1|||
25123461|NCT02305238|50236023|FG002|Overall Study|Death|0|||
25123462|NCT02305238|50236021|FG000|Overall Study|Progressive disease|4|||
25123463|NCT02305238|50236022|FG001|Overall Study|Progressive disease|4|||
25123464|NCT02305238|50236023|FG002|Overall Study|Progressive disease|0|||
25123465|NCT02305238|50236021|FG000|Overall Study|Logistical difficulties|1|||
25123466|NCT02305238|50236022|FG001|Overall Study|Logistical difficulties|3|||
25123467|NCT02305238|50236023|FG002|Overall Study|Logistical difficulties|0|||
25123468|NCT02305238|50236021|FG000|Overall Study|Protocol Violation|0|||
25123469|NCT02305238|50236022|FG001|Overall Study|Protocol Violation|3|||
25123470|NCT02305238|50236023|FG002|Overall Study|Protocol Violation|0|||
25123471|NCT02305238|50236021|FG000|Overall Study|Physician Decision|2|||
25123472|NCT02305238|50236022|FG001|Overall Study|Physician Decision|1|||
25123473|NCT02305238|50236023|FG002|Overall Study|Physician Decision|0|||
25123474|NCT02305238|50236021|FG000|Overall Study|Adverse Event|4|||
25263255|NCT01236573|50578060|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
25263256|NCT01236573|50578061|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
25263257|NCT01236573|50578062|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
25263258|NCT01236573|50578063|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
25263259|NCT01236573|50578064|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
25263260|NCT01236573|50578054|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
25263261|NCT01236573|50578055|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
25263262|NCT01236573|50578056|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
25263263|NCT01236573|50578057|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
25263264|NCT01236573|50578058|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
25263265|NCT01236573|50578059|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
25263266|NCT01236573|50578060|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
25263267|NCT01236573|50578061|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
25263268|NCT01236573|50578062|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
25263269|NCT01236573|50578063|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
25263270|NCT01236573|50578064|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
25263271|NCT01236573|50578054|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
25263272|NCT01236573|50578055|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
25263273|NCT01236573|50578056|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
25263274|NCT01236573|50578057|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
25263275|NCT01236573|50578058|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
25263276|NCT01236573|50578059|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
25263277|NCT01236573|50578060|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
25263278|NCT01236573|50578061|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
25263279|NCT01236573|50578062|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
25263280|NCT01236573|50578063|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
25263281|NCT01236573|50578064|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
25263282|NCT01236339|50578091|FG000|Overall Study|Termination of study by sponsor|11|||
25263283|NCT01236339|50578092|FG001|Overall Study|Termination of study by sponsor|13|||
25263284|NCT01262898|50578103|FG000|Overall Study|Protocol Violation|1|||
25263285|NCT01262898|50578104|FG001|Overall Study|Protocol Violation|1|||
25263286|NCT01262898|50578105|FG002|Overall Study|Protocol Violation|0|||
25263287|NCT01262898|50578106|FG003|Overall Study|Protocol Violation|0|||
25263288|NCT01262898|50578103|FG000|Overall Study|Lost to Follow-up|1|||
25263289|NCT01262898|50578104|FG001|Overall Study|Lost to Follow-up|0|||
25263290|NCT01262898|50578105|FG002|Overall Study|Lost to Follow-up|0|||
25123475|NCT02305238|50236022|FG001|Overall Study|Adverse Event|2|||
25123476|NCT02305238|50236023|FG002|Overall Study|Adverse Event|0|||
25123477|NCT02305238|50236021|FG000|Overall Study|Withdrawal by Subject|3|||
25123478|NCT02305238|50236022|FG001|Overall Study|Withdrawal by Subject|4|||
25123479|NCT02305238|50236023|FG002|Overall Study|Withdrawal by Subject|0|||
25123480|NCT02305238|50236021|FG000|Overall Study|Randomized failure|0|||
25123481|NCT02305238|50236022|FG001|Overall Study|Randomized failure|0|||
25263291|NCT01262898|50578106|FG003|Overall Study|Lost to Follow-up|0|||
25263292|NCT01262898|50578103|FG000|Overall Study|Withdrawal by Subject|1|||
25263293|NCT01262898|50578104|FG001|Overall Study|Withdrawal by Subject|1|||
25263294|NCT01262898|50578105|FG002|Overall Study|Withdrawal by Subject|0|||
25263295|NCT01262898|50578106|FG003|Overall Study|Withdrawal by Subject|0|||
25263296|NCT01262820|50578119|FG000|Overall Study|Adverse Event|5|||
25263297|NCT01262820|50578119|FG000|Overall Study|Lack of Efficacy|9|||
25263298|NCT01262820|50578119|FG000|Overall Study|Drug held for 21+ days|1|||
25263299|NCT01057810|50578125|FG000|Overall Study|Disease progression|156|||
25263300|NCT01057810|50578126|FG001|Overall Study|Disease progression|197|||
25263301|NCT01057810|50578125|FG000|Overall Study|Study drug toxicity|5|||
25263302|NCT01057810|50578126|FG001|Overall Study|Study drug toxicity|114|||
25263303|NCT01057810|50578125|FG000|Overall Study|Adverse event unrelated to study drug|13|||
25263304|NCT01057810|50578126|FG001|Overall Study|Adverse event unrelated to study drug|29|||
25263305|NCT01057810|50578125|FG000|Overall Study|Withdrawal by Subject|10|||
25263306|NCT01057810|50578126|FG001|Overall Study|Withdrawal by Subject|25|||
25263307|NCT01057810|50578125|FG000|Overall Study|Death|2|||
25263308|NCT01057810|50578126|FG001|Overall Study|Death|12|||
25263309|NCT01057810|50578125|FG000|Overall Study|Maximum clinical benefit|5|||
25263310|NCT01057810|50578126|FG001|Overall Study|Maximum clinical benefit|5|||
25263311|NCT01057810|50578125|FG000|Overall Study|Poor/non-compliance|0|||
25263312|NCT01057810|50578126|FG001|Overall Study|Poor/non-compliance|1|||
25263313|NCT01057810|50578125|FG000|Overall Study|No longer met study criteria|0|||
25263314|NCT01057810|50578126|FG001|Overall Study|No longer met study criteria|1|||
25263315|NCT01057810|50578125|FG000|Overall Study|Other|7|||
25263316|NCT01057810|50578126|FG001|Overall Study|Other|14|||
25263317|NCT01262352|50578134|FG000|Period 1|Illness after randomization|1|||
25263318|NCT01262352|50578135|FG001|Period 1|Illness after randomization|0|||
25263319|NCT01262352|50578134|FG000|Washout|Adverse Event|1|||
25263320|NCT01262352|50578135|FG001|Washout|Adverse Event|1|||
25263321|NCT01262352|50578134|FG000|Washout|Extended Washout|0|||
25263322|NCT01262352|50578135|FG001|Washout|Extended Washout|1|||
25263323|NCT01299272|50578141|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
25263324|NCT01299272|50578142|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
25263325|NCT01299272|50578143|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
25123482|NCT02305238|50236023|FG002|Overall Study|Randomized failure|8|||
25123483|NCT02305238|50236021|FG000|Overall Study|Required procedure failed|0|||
25123484|NCT02305238|50236022|FG001|Overall Study|Required procedure failed|1|||
25123485|NCT02305238|50236023|FG002|Overall Study|Required procedure failed|0|||
25123486|NCT02313155|50236032|FG000|Overall Study|Lost to Follow-up|0|||
25123487|NCT02313155|50236033|FG001|Overall Study|Lost to Follow-up|1|||
25123488|NCT02204293|50236041|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
25123489|NCT02204293|50236042|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
25123490|NCT02204293|50236043|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
25123491|NCT02204293|50236044|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
25123492|NCT02204293|50236045|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
25123493|NCT02204293|50236046|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
25123494|NCT02204293|50236041|FG000|Core Study Part I|Adverse Event|1|||
25123495|NCT02204293|50236042|FG001|Core Study Part I|Adverse Event|0|||
25123496|NCT02204293|50236043|FG002|Core Study Part I|Adverse Event|0|||
25123497|NCT02204293|50236044|FG003|Core Study Part I|Adverse Event|0|||
25123498|NCT02204293|50236045|FG004|Core Study Part I|Adverse Event|0|||
25123499|NCT02204293|50236046|FG005|Core Study Part I|Adverse Event|0|||
25123500|NCT02204293|50236041|FG000|Core Study Part I|Physician Decision|0|||
25123501|NCT02204293|50236042|FG001|Core Study Part I|Physician Decision|3|||
25123502|NCT02204293|50236043|FG002|Core Study Part I|Physician Decision|0|||
25123503|NCT02204293|50236044|FG003|Core Study Part I|Physician Decision|0|||
25123504|NCT02204293|50236045|FG004|Core Study Part I|Physician Decision|0|||
25123505|NCT02204293|50236046|FG005|Core Study Part I|Physician Decision|0|||
25123506|NCT02204293|50236041|FG000|LTE Phase|Study Suspended|0|||
25123507|NCT02204293|50236042|FG001|LTE Phase|Study Suspended|0|||
25263326|NCT01299272|50578144|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
25263327|NCT01299272|50578141|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
25263328|NCT01299272|50578142|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
25263329|NCT01299272|50578143|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
25123508|NCT02204293|50236043|FG002|LTE Phase|Study Suspended|0|||
25123509|NCT02204293|50236044|FG003|LTE Phase|Study Suspended|0|||
25123510|NCT02204293|50236045|FG004|LTE Phase|Study Suspended|0|||
25263330|NCT01299272|50578144|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
25263331|NCT01299272|50578141|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
25123511|NCT02204293|50236046|FG005|LTE Phase|Study Suspended|7|||
25123512|NCT02304926|50236062|FG000|Overall Study|Lost to Follow-up|2|||
25123513|NCT02304926|50236063|FG001|Overall Study|Lost to Follow-up|1|||
25123514|NCT01646255|50236073|FG000|Overall Study|Adverse Event|7|||
25123515|NCT01646255|50236074|FG001|Overall Study|Adverse Event|8|||
25123516|NCT01646255|50236073|FG000|Overall Study|Lack of Efficacy|2|||
25263332|NCT01299272|50578142|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
25263333|NCT01299272|50578143|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
25263334|NCT01299272|50578144|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
25263335|NCT01299272|50578141|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
25263336|NCT01299272|50578142|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
25263337|NCT01299272|50578143|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
25263338|NCT01299272|50578144|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
25263339|NCT01299272|50578141|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
25263340|NCT01299272|50578142|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
25263341|NCT01299272|50578143|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
25263342|NCT01299272|50578144|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
25263343|NCT01299272|50578141|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
25263344|NCT01299272|50578142|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
25263345|NCT01299272|50578143|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
25263346|NCT01299272|50578144|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
25263347|NCT01299272|50578141|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
25263348|NCT01299272|50578142|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
25263349|NCT01299272|50578143|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
25263350|NCT01299272|50578144|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
25263351|NCT01299272|50578141|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
25263352|NCT01299272|50578142|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
25263353|NCT01299272|50578143|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
25123517|NCT01646255|50236074|FG001|Overall Study|Lack of Efficacy|0|||
25123518|NCT01646255|50236073|FG000|Overall Study|Withdrawal by Subject|10|||
25123519|NCT01646255|50236074|FG001|Overall Study|Withdrawal by Subject|6|||
25123520|NCT01646255|50236073|FG000|Overall Study|Compliance is not well|1|||
25123521|NCT01646255|50236074|FG001|Overall Study|Compliance is not well|0|||
25263354|NCT01299272|50578144|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
25263355|NCT01299272|50578141|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
25263356|NCT01299272|50578142|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
25263357|NCT01299272|50578143|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
25263358|NCT01299272|50578144|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
25263359|NCT01299272|50578141|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
25263360|NCT01299272|50578142|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
25263361|NCT01299272|50578143|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
25263362|NCT01299272|50578144|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
25263363|NCT01299272|50578141|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
25263364|NCT01299272|50578142|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
25263365|NCT01299272|50578143|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
25263366|NCT01299272|50578144|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
25263367|NCT01299272|50578141|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
25263368|NCT01299272|50578142|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
25263369|NCT01299272|50578143|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
25123522|NCT01646255|50236073|FG000|Overall Study|Inclusion Criteria Deviation|1|||
25123523|NCT01646255|50236074|FG001|Overall Study|Inclusion Criteria Deviation|0|||
25123524|NCT02304380|50236087|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
25123525|NCT02304380|50236088|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
25123526|NCT02304380|50236089|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
25123527|NCT02304380|50236090|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
25123528|NCT02304380|50236091|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
25123529|NCT02304380|50236092|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
25123530|NCT02203591|50236114|FG000|Overall Study|Did not meet treatment day baseline|147|||
25177544|NCT01497899|50321630|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
25177545|NCT01497899|50321631|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
25177546|NCT01497899|50321628|FG000|Open-Label Extension Phase|Adverse Event|1|||
25177547|NCT01497899|50321629|FG001|Open-Label Extension Phase|Adverse Event|0|||
25177548|NCT01497899|50321630|FG002|Open-Label Extension Phase|Adverse Event|0|||
25177549|NCT01497899|50321631|FG003|Open-Label Extension Phase|Adverse Event|0|||
25177550|NCT01497899|50321628|FG000|Open-Label Extension Phase|Death|1|||
25177551|NCT01497899|50321629|FG001|Open-Label Extension Phase|Death|0|||
25177552|NCT01497899|50321630|FG002|Open-Label Extension Phase|Death|0|||
25177553|NCT01497899|50321631|FG003|Open-Label Extension Phase|Death|0|||
25177554|NCT01497899|50321628|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
25177555|NCT01497899|50321629|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
25177556|NCT01497899|50321630|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
25177557|NCT01497899|50321631|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
25177558|NCT01497899|50321628|FG000|Open-Label Extension Phase|Pregnancy|0|||
25177559|NCT01497899|50321629|FG001|Open-Label Extension Phase|Pregnancy|1|||
25263370|NCT01299272|50578144|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
25263371|NCT01299272|50578141|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
25263372|NCT01299272|50578142|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
25263373|NCT01299272|50578143|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
25263374|NCT01299272|50578144|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
25263375|NCT01299272|50578141|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
25263376|NCT01299272|50578142|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
25263377|NCT01299272|50578143|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
25263378|NCT01299272|50578144|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
25263379|NCT01299272|50578141|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
25263380|NCT01299272|50578142|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
25263381|NCT01299272|50578143|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
25263382|NCT01299272|50578144|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
25263383|NCT01299272|50578141|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
25263384|NCT01299272|50578142|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
25263385|NCT01299272|50578143|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
25263386|NCT01299272|50578144|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
25263387|NCT01299272|50578141|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
25263388|NCT01299272|50578142|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
25263389|NCT01299272|50578143|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
25263390|NCT01299272|50578144|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
25263391|NCT01299272|50578141|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
25123531|NCT02203591|50236115|FG001|Overall Study|Did not meet treatment day baseline|141|||
25123532|NCT02203591|50236116|FG002|Overall Study|Did not meet treatment day baseline|150|||
25123533|NCT02203591|50236117|FG003|Overall Study|Did not meet treatment day baseline|45|||
25123534|NCT02203591|50236118|FG004|Overall Study|Did not meet treatment day baseline|33|||
25123535|NCT02203591|50236119|FG005|Overall Study|Did not meet treatment day baseline|35|||
25123536|NCT02203591|50236120|FG006|Overall Study|Did not meet treatment day baseline|29|||
25263392|NCT01299272|50578142|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
25263393|NCT01299272|50578143|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
25123537|NCT02203591|50236121|FG007|Overall Study|Did not meet treatment day baseline|12|||
25123538|NCT02203591|50236114|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
25123539|NCT02203591|50236115|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
25123540|NCT02203591|50236116|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
25123541|NCT02203591|50236117|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
25123542|NCT02203591|50236118|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
25123543|NCT02203591|50236119|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
25123544|NCT02203591|50236120|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
25123545|NCT02203591|50236121|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
25123546|NCT01642277|50236145|FG000|Overall Study|Adverse Event|10|||
25123547|NCT01642277|50236146|FG001|Overall Study|Adverse Event|0|||
25123548|NCT01642277|50236145|FG000|Overall Study|Physician Decision|2|||
25123549|NCT01642277|50236146|FG001|Overall Study|Physician Decision|0|||
25123550|NCT01642277|50236145|FG000|Overall Study|Protocol Violation|1|||
25123551|NCT01642277|50236146|FG001|Overall Study|Protocol Violation|0|||
25123552|NCT01642277|50236145|FG000|Overall Study|Withdrawal by Subject|11|||
25123553|NCT01642277|50236146|FG001|Overall Study|Withdrawal by Subject|0|||
25123554|NCT02230189|50236156|FG000|Overall Study|Withdrawal by Subject|3|||
25123555|NCT02230189|50236157|FG001|Overall Study|Withdrawal by Subject|0|||
25123556|NCT02230189|50236158|FG002|Overall Study|Withdrawal by Subject|1|||
25123557|NCT02230189|50236156|FG000|Overall Study|Lost to Follow-up|1|||
25123558|NCT02230189|50236157|FG001|Overall Study|Lost to Follow-up|0|||
25123559|NCT02230189|50236158|FG002|Overall Study|Lost to Follow-up|0|||
25123560|NCT02230189|50236156|FG000|Overall Study|Physician Decision|1|||
25177560|NCT01497899|50321630|FG002|Open-Label Extension Phase|Pregnancy|1|||
25177561|NCT01497899|50321631|FG003|Open-Label Extension Phase|Pregnancy|0|||
25123561|NCT02230189|50236157|FG001|Overall Study|Physician Decision|0|||
25123562|NCT02230189|50236158|FG002|Overall Study|Physician Decision|0|||
25123563|NCT02304302|50236169|FG000|Overall Study|Adverse Event|2|||
25177562|NCT01497899|50321628|FG000|Open-Label Extension Phase|Protocol Violation|0|||
25177563|NCT01497899|50321629|FG001|Open-Label Extension Phase|Protocol Violation|0|||
25177564|NCT01497899|50321630|FG002|Open-Label Extension Phase|Protocol Violation|1|||
25177565|NCT01497899|50321631|FG003|Open-Label Extension Phase|Protocol Violation|0|||
25177566|NCT01497899|50321628|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
25177567|NCT01497899|50321629|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
25177568|NCT01497899|50321630|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
25177569|NCT01497899|50321631|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
25177570|NCT01497275|50321638|FG000|Overall Study|Death|1|||
25177571|NCT01497275|50321638|FG000|Overall Study|Adverse Event|1|||
25123564|NCT02304302|50236170|FG001|Overall Study|Adverse Event|3|||
25123565|NCT02304302|50236169|FG000|Overall Study|Lost to Follow-up|1|||
25123566|NCT02304302|50236170|FG001|Overall Study|Lost to Follow-up|4|||
25123567|NCT02304302|50236169|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
25123568|NCT02304302|50236170|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
25123569|NCT02276612|50236182|FG000|Overall Study|Death|1|||
25123570|NCT02276612|50236183|FG001|Overall Study|Death|0|||
25123571|NCT02276612|50236182|FG000|Overall Study|Pregnancy|1|||
25123572|NCT02276612|50236183|FG001|Overall Study|Pregnancy|0|||
25123573|NCT02276612|50236182|FG000|Overall Study|Withdrew Consent|1|||
25123574|NCT02276612|50236183|FG001|Overall Study|Withdrew Consent|0|||
25123575|NCT02276612|50236182|FG000|Overall Study|Lost to Follow-up|1|||
25123576|NCT02276612|50236183|FG001|Overall Study|Lost to Follow-up|0|||
25123577|NCT02301143|50236189|FG000|Induction Period|Enrolled But Not Treated|1|||
25123578|NCT02301143|50236190|FG001|Induction Period|Enrolled But Not Treated|0|||
25123579|NCT02301143|50236189|FG000|Induction Period|Death|1|||
25123580|NCT02301143|50236190|FG001|Induction Period|Death|0|||
25123581|NCT02301143|50236189|FG000|Induction Period|Adverse Event|22|||
25123582|NCT02301143|50236190|FG001|Induction Period|Adverse Event|0|||
25123583|NCT02301143|50236189|FG000|Induction Period|Progressive Disease|8|||
25263394|NCT01299272|50578144|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
25263395|NCT01299272|50578141|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
25263396|NCT01299272|50578142|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
25263397|NCT01299272|50578143|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
25263398|NCT01299272|50578144|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
25263399|NCT01299272|50578141|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
25008846|NCT02874794|50101951|FG001|Overall Study|Withdrawal by Subject|8|||
25008847|NCT02874794|50101950|FG000|Overall Study|Death|2|||
25008848|NCT02874794|50101951|FG001|Overall Study|Death|1|||
25008849|NCT03102710|50101963|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
25008850|NCT03102710|50101964|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
25008851|NCT03102710|50101965|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
25008852|NCT03102710|50101963|FG000|Overall Study|Technical issues during final MRI scan|0|||
25008853|NCT03102710|50101964|FG001|Overall Study|Technical issues during final MRI scan|1|||
25008854|NCT03102710|50101965|FG002|Overall Study|Technical issues during final MRI scan|0|||
25008855|NCT03102710|50101963|FG000|Overall Study|Nausea during MRI scan|0|||
25008856|NCT03102710|50101964|FG001|Overall Study|Nausea during MRI scan|1|||
25008857|NCT03102710|50101965|FG002|Overall Study|Nausea during MRI scan|0|||
25008858|NCT03102710|50101963|FG000|Overall Study|Subject unable to attend final session|0|||
25008859|NCT03102710|50101964|FG001|Overall Study|Subject unable to attend final session|1|||
25008860|NCT03102710|50101965|FG002|Overall Study|Subject unable to attend final session|0|||
25008861|NCT03101150|50101975|FG000|Overall Study|Lost to Follow-up|2|||
25008862|NCT03101150|50101976|FG001|Overall Study|Lost to Follow-up|4|||
25008863|NCT03101150|50101975|FG000|Overall Study|Miscarriage|3|||
25008864|NCT03101150|50101976|FG001|Overall Study|Miscarriage|6|||
25008865|NCT03101930|50101985|FG000|Overall Study|Withdrawal by Subject|2|||
25008866|NCT03101930|50101986|FG001|Overall Study|Withdrawal by Subject|1|||
25008867|NCT03101930|50101987|FG002|Overall Study|Withdrawal by Subject|2|||
25008868|NCT02928848|50101997|FG000|Arm 2|Withdrawal by Subject|1|||
25008869|NCT02928848|50101998|FG001|Arm 2|Withdrawal by Subject|0|||
25008870|NCT02928770|50102006|FG000|Overall Study|Withdrawal by Subject|2|||
25008871|NCT03100838|50102010|FG000|Overall Study|Adverse Event|1|||
25008872|NCT03100838|50102011|FG001|Overall Study|Adverse Event|0|||
25008873|NCT03100838|50102012|FG002|Overall Study|Adverse Event|0|||
25008874|NCT03100838|50102013|FG003|Overall Study|Adverse Event|0|||
25008875|NCT03100838|50102010|FG000|Overall Study|Physician Decision|1|||
25008876|NCT03100838|50102011|FG001|Overall Study|Physician Decision|1|||
25008877|NCT03100838|50102012|FG002|Overall Study|Physician Decision|1|||
25008878|NCT03100838|50102013|FG003|Overall Study|Physician Decision|1|||
25008879|NCT03100838|50102010|FG000|Overall Study|Pregnancy|0|||
25008880|NCT03100838|50102011|FG001|Overall Study|Pregnancy|1|||
25008881|NCT03100838|50102012|FG002|Overall Study|Pregnancy|0|||
25008882|NCT03100838|50102013|FG003|Overall Study|Pregnancy|0|||
25008883|NCT03100838|50102010|FG000|Overall Study|Lost to Follow-up|0|||
25008884|NCT03100838|50102011|FG001|Overall Study|Lost to Follow-up|0|||
25008885|NCT03100838|50102012|FG002|Overall Study|Lost to Follow-up|1|||
25008886|NCT03100838|50102013|FG003|Overall Study|Lost to Follow-up|0|||
25008887|NCT03480750|50102029|FG000|Overall Study|Withdrawal by Subject|0|||
25008888|NCT03480750|50102030|FG001|Overall Study|Withdrawal by Subject|1|||
25123584|NCT02301143|50236190|FG001|Induction Period|Progressive Disease|0|||
25123585|NCT02301143|50236189|FG000|Induction Period|Withdrawal by Subject|3|||
25263400|NCT01299272|50578142|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
25008889|NCT03480750|50102031|FG002|Overall Study|Withdrawal by Subject|0|||
25008890|NCT03480750|50102032|FG003|Overall Study|Withdrawal by Subject|0|||
25123586|NCT02301143|50236190|FG001|Induction Period|Withdrawal by Subject|0|||
25123587|NCT02301143|50236189|FG000|Induction Period|Noncompliance with Study Drug|1|||
25263401|NCT01299272|50578143|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
25263402|NCT01299272|50578144|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
25263403|NCT01299272|50578141|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
25263404|NCT01299272|50578142|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
25263405|NCT01299272|50578143|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
25263406|NCT01299272|50578144|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
25263407|NCT01299272|50578141|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
25263408|NCT01299272|50578142|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
25263409|NCT01299272|50578143|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
25263410|NCT01299272|50578144|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
25263411|NCT01299272|50578141|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
25263412|NCT01299272|50578142|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
25263413|NCT01299272|50578143|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
25263414|NCT01299272|50578144|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
25263415|NCT01299272|50578141|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
25263416|NCT01299272|50578142|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
25263417|NCT01299272|50578143|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
25263418|NCT01299272|50578144|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
25263419|NCT01299272|50578141|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
25263420|NCT01299272|50578142|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
25263421|NCT01299272|50578143|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
25263422|NCT01299272|50578144|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
25263423|NCT01299116|50578161|FG000|Overall Study|Lost to Follow-up|65|||
25263424|NCT01299116|50578162|FG001|Overall Study|Lost to Follow-up|9|||
25263425|NCT01299116|50578163|FG002|Overall Study|Lost to Follow-up|11|||
25263426|NCT01299038|50578176|FG000|Overall Study|Withdrawal by Subject|1|||
25263427|NCT01299038|50578177|FG001|Overall Study|Withdrawal by Subject|0|||
25263428|NCT01298648|50578183|FG000|Overall Study|Withdrawal by Subject|2|||
25263429|NCT01298648|50578183|FG000|Overall Study|Lost to Follow-up|21|||
25263430|NCT01261338|50578189|FG000|Overall Study|Withdrawal by Subject|3|||
25263431|NCT01261338|50578190|FG001|Overall Study|Withdrawal by Subject|2|||
25263432|NCT01260948|50578198|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
25263433|NCT01260948|50578199|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
25263434|NCT01260948|50578198|FG000|Second Intervention|Emesis|0|||
25263435|NCT01260948|50578199|FG001|Second Intervention|Emesis|1|||
25263436|NCT01025284|50578208|FG000|Overall Study|Investigator Decision|0|||
25263437|NCT01025284|50578209|FG001|Overall Study|Investigator Decision|1|||
25263438|NCT01025284|50578210|FG002|Overall Study|Investigator Decision|0|||
25263439|NCT01025284|50578208|FG000|Overall Study|Withdrawal by Subject|0|||
25263440|NCT01025284|50578209|FG001|Overall Study|Withdrawal by Subject|1|||
25263441|NCT01025284|50578210|FG002|Overall Study|Withdrawal by Subject|0|||
25263442|NCT01021852|50578228|FG000|Treatment Period 1|Adverse Event|3|||
25263443|NCT01021852|50578229|FG001|Treatment Period 1|Adverse Event|1|||
25263444|NCT01021852|50578230|FG002|Treatment Period 1|Adverse Event|1|||
25263445|NCT01021852|50578231|FG003|Treatment Period 1|Adverse Event|0|||
25263446|NCT01021852|50578232|FG004|Treatment Period 1|Adverse Event|2|||
25263447|NCT01021852|50578233|FG005|Treatment Period 1|Adverse Event|2|||
25263448|NCT01021852|50578234|FG006|Treatment Period 1|Adverse Event|0|||
25263449|NCT01021852|50578235|FG007|Treatment Period 1|Adverse Event|0|||
25263450|NCT01021852|50578228|FG000|Treatment Period 1|Pregnancy|0|||
25263451|NCT01021852|50578229|FG001|Treatment Period 1|Pregnancy|0|||
25263452|NCT01021852|50578230|FG002|Treatment Period 1|Pregnancy|1|||
25263453|NCT01021852|50578231|FG003|Treatment Period 1|Pregnancy|0|||
25263454|NCT01021852|50578232|FG004|Treatment Period 1|Pregnancy|0|||
25263455|NCT01021852|50578233|FG005|Treatment Period 1|Pregnancy|0|||
25263456|NCT01021852|50578234|FG006|Treatment Period 1|Pregnancy|0|||
25263457|NCT01021852|50578235|FG007|Treatment Period 1|Pregnancy|0|||
25263458|NCT01021852|50578228|FG000|Treatment Period 1|Withdrawal by Subject|0|||
25263459|NCT01021852|50578229|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25263460|NCT01021852|50578230|FG002|Treatment Period 1|Withdrawal by Subject|0|||
25263461|NCT01021852|50578231|FG003|Treatment Period 1|Withdrawal by Subject|0|||
25263462|NCT01021852|50578232|FG004|Treatment Period 1|Withdrawal by Subject|1|||
25263463|NCT01021852|50578233|FG005|Treatment Period 1|Withdrawal by Subject|0|||
25263464|NCT01021852|50578234|FG006|Treatment Period 1|Withdrawal by Subject|0|||
25263465|NCT01021852|50578235|FG007|Treatment Period 1|Withdrawal by Subject|1|||
25263466|NCT01021852|50578228|FG000|Treatment Period 1|Not Treated|0|||
25263467|NCT01021852|50578229|FG001|Treatment Period 1|Not Treated|0|||
25263468|NCT01021852|50578230|FG002|Treatment Period 1|Not Treated|0|||
25263469|NCT01021852|50578231|FG003|Treatment Period 1|Not Treated|2|||
25263470|NCT01021852|50578232|FG004|Treatment Period 1|Not Treated|0|||
25263471|NCT01021852|50578233|FG005|Treatment Period 1|Not Treated|0|||
25263472|NCT01021852|50578234|FG006|Treatment Period 1|Not Treated|0|||
25263473|NCT01021852|50578235|FG007|Treatment Period 1|Not Treated|0|||
25263474|NCT01021852|50578228|FG000|Washout Period-Placebo|Adverse Event|0|||
25263475|NCT01021852|50578229|FG001|Washout Period-Placebo|Adverse Event|0|||
25263476|NCT01021852|50578230|FG002|Washout Period-Placebo|Adverse Event|0|||
25263477|NCT01021852|50578231|FG003|Washout Period-Placebo|Adverse Event|1|||
25263478|NCT01021852|50578232|FG004|Washout Period-Placebo|Adverse Event|0|||
25263479|NCT01021852|50578233|FG005|Washout Period-Placebo|Adverse Event|1|||
25263480|NCT01021852|50578234|FG006|Washout Period-Placebo|Adverse Event|0|||
25263481|NCT01021852|50578235|FG007|Washout Period-Placebo|Adverse Event|0|||
25263482|NCT01021852|50578228|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
25263483|NCT01021852|50578229|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
25263484|NCT01021852|50578230|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
25263485|NCT01021852|50578231|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
25263486|NCT01021852|50578232|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
25263487|NCT01021852|50578233|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
25263488|NCT01021852|50578234|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
25263489|NCT01021852|50578235|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
25263490|NCT01021852|50578228|FG000|Washout Period-Placebo|Protocol Violation|0|||
25263491|NCT01021852|50578229|FG001|Washout Period-Placebo|Protocol Violation|0|||
25263492|NCT01021852|50578230|FG002|Washout Period-Placebo|Protocol Violation|0|||
25263493|NCT01021852|50578231|FG003|Washout Period-Placebo|Protocol Violation|0|||
25263494|NCT01021852|50578232|FG004|Washout Period-Placebo|Protocol Violation|0|||
25263495|NCT01021852|50578233|FG005|Washout Period-Placebo|Protocol Violation|0|||
25263496|NCT01021852|50578234|FG006|Washout Period-Placebo|Protocol Violation|1|||
25263497|NCT01021852|50578235|FG007|Washout Period-Placebo|Protocol Violation|0|||
25263498|NCT01021852|50578228|FG000|Washout Period-No Drug|Adverse Event|1|||
25263499|NCT01021852|50578229|FG001|Washout Period-No Drug|Adverse Event|0|||
25263500|NCT01021852|50578230|FG002|Washout Period-No Drug|Adverse Event|0|||
25263501|NCT01021852|50578231|FG003|Washout Period-No Drug|Adverse Event|0|||
25263502|NCT01021852|50578232|FG004|Washout Period-No Drug|Adverse Event|0|||
25263503|NCT01021852|50578233|FG005|Washout Period-No Drug|Adverse Event|1|||
25263504|NCT01021852|50578234|FG006|Washout Period-No Drug|Adverse Event|0|||
25263505|NCT01021852|50578235|FG007|Washout Period-No Drug|Adverse Event|0|||
25263506|NCT01021852|50578228|FG000|Treatment Period 2|Adverse Event|0|||
25263507|NCT01021852|50578229|FG001|Treatment Period 2|Adverse Event|1|||
25263508|NCT01021852|50578230|FG002|Treatment Period 2|Adverse Event|0|||
25263509|NCT01021852|50578231|FG003|Treatment Period 2|Adverse Event|0|||
25263510|NCT01021852|50578232|FG004|Treatment Period 2|Adverse Event|1|||
25263511|NCT01021852|50578233|FG005|Treatment Period 2|Adverse Event|0|||
25263512|NCT01021852|50578234|FG006|Treatment Period 2|Adverse Event|1|||
25263513|NCT01021852|50578235|FG007|Treatment Period 2|Adverse Event|0|||
25263514|NCT01021852|50578228|FG000|Treatment Period 2|Lack of Efficacy|0|||
25263515|NCT01021852|50578229|FG001|Treatment Period 2|Lack of Efficacy|0|||
25263516|NCT01021852|50578230|FG002|Treatment Period 2|Lack of Efficacy|0|||
25263517|NCT01021852|50578231|FG003|Treatment Period 2|Lack of Efficacy|0|||
25263518|NCT01021852|50578232|FG004|Treatment Period 2|Lack of Efficacy|0|||
25263519|NCT01021852|50578233|FG005|Treatment Period 2|Lack of Efficacy|1|||
25263520|NCT01021852|50578234|FG006|Treatment Period 2|Lack of Efficacy|0|||
25263521|NCT01021852|50578235|FG007|Treatment Period 2|Lack of Efficacy|0|||
25263522|NCT01021852|50578228|FG000|Treatment Period 2|Physician Decision|0|||
25263523|NCT01021852|50578229|FG001|Treatment Period 2|Physician Decision|0|||
25263524|NCT01021852|50578230|FG002|Treatment Period 2|Physician Decision|1|||
25263525|NCT01021852|50578231|FG003|Treatment Period 2|Physician Decision|0|||
25263526|NCT01021852|50578232|FG004|Treatment Period 2|Physician Decision|0|||
25263527|NCT01021852|50578233|FG005|Treatment Period 2|Physician Decision|0|||
25263528|NCT01021852|50578234|FG006|Treatment Period 2|Physician Decision|0|||
25263529|NCT01021852|50578235|FG007|Treatment Period 2|Physician Decision|0|||
25263530|NCT01021852|50578228|FG000|Treatment Period 2|Protocol Violation|0|||
25263531|NCT01021852|50578229|FG001|Treatment Period 2|Protocol Violation|0|||
25263532|NCT01021852|50578230|FG002|Treatment Period 2|Protocol Violation|0|||
25263533|NCT01021852|50578231|FG003|Treatment Period 2|Protocol Violation|0|||
25263534|NCT01021852|50578232|FG004|Treatment Period 2|Protocol Violation|1|||
25263535|NCT01021852|50578233|FG005|Treatment Period 2|Protocol Violation|0|||
25263536|NCT01021852|50578234|FG006|Treatment Period 2|Protocol Violation|1|||
25263537|NCT01021852|50578235|FG007|Treatment Period 2|Protocol Violation|0|||
25263538|NCT01021852|50578228|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25263539|NCT01021852|50578229|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25263540|NCT01021852|50578230|FG002|Treatment Period 2|Withdrawal by Subject|0|||
25263541|NCT01021852|50578231|FG003|Treatment Period 2|Withdrawal by Subject|0|||
25263542|NCT01021852|50578232|FG004|Treatment Period 2|Withdrawal by Subject|0|||
25263543|NCT01021852|50578233|FG005|Treatment Period 2|Withdrawal by Subject|0|||
25263544|NCT01021852|50578234|FG006|Treatment Period 2|Withdrawal by Subject|1|||
25263545|NCT01021852|50578235|FG007|Treatment Period 2|Withdrawal by Subject|2|||
25263546|NCT01056718|50578249|FG000|Overall Study|Withdrawal by Subject|2|||
25263547|NCT01056718|50578249|FG000|Overall Study|Ischemia on baseline stress test|1|||
25263548|NCT01298570|50578256|FG000|Overall Study|Disease progression, relapse during acti|64|||
25263549|NCT01298570|50578257|FG001|Overall Study|Disease progression, relapse during acti|40|||
25263550|NCT01298570|50578256|FG000|Overall Study|Adverse Event|20|||
25263551|NCT01298570|50578257|FG001|Overall Study|Adverse Event|2|||
25263552|NCT01298570|50578256|FG000|Overall Study|Withdrawal by Subject|21|||
25263553|NCT01298570|50578257|FG001|Overall Study|Withdrawal by Subject|6|||
25263554|NCT01298570|50578256|FG000|Overall Study|Treatment delay > 4 weeks|4|||
25263555|NCT01298570|50578257|FG001|Overall Study|Treatment delay > 4 weeks|5|||
25263556|NCT01298570|50578256|FG000|Overall Study|Physician Decision|4|||
25263557|NCT01298570|50578257|FG001|Overall Study|Physician Decision|2|||
25263558|NCT01298570|50578256|FG000|Overall Study|Other complicating disease|2|||
25263559|NCT01298570|50578257|FG001|Overall Study|Other complicating disease|1|||
25263560|NCT01298570|50578256|FG000|Overall Study|Surgery|2|||
25263561|NCT01298570|50578257|FG001|Overall Study|Surgery|1|||
25263562|NCT01298570|50578256|FG000|Overall Study|Symptomatic progression/deterioration|3|||
25263563|NCT01298570|50578257|FG001|Overall Study|Symptomatic progression/deterioration|2|||
25263564|NCT01298570|50578256|FG000|Overall Study|Death|0|||
25263565|NCT01298570|50578257|FG001|Overall Study|Death|1|||
25263566|NCT01298570|50578256|FG000|Overall Study|Ineligibility|0|||
25263567|NCT01298570|50578257|FG001|Overall Study|Ineligibility|1|||
25263568|NCT01259856|50578265|FG000|Overall Study|Adverse Event|12|||
25263569|NCT01259856|50578266|FG001|Overall Study|Adverse Event|9|||
25263570|NCT01259856|50578265|FG000|Overall Study|Death|0|||
25263571|NCT01259856|50578266|FG001|Overall Study|Death|1|||
25263572|NCT01259856|50578265|FG000|Overall Study|Lack of Efficacy|3|||
25263573|NCT01259856|50578266|FG001|Overall Study|Lack of Efficacy|1|||
25263574|NCT01259856|50578265|FG000|Overall Study|Lost to Follow-up|1|||
25263575|NCT01259856|50578266|FG001|Overall Study|Lost to Follow-up|1|||
25263576|NCT01259856|50578265|FG000|Overall Study|Physician Decision|2|||
25263577|NCT01259856|50578266|FG001|Overall Study|Physician Decision|1|||
25263578|NCT01259856|50578265|FG000|Overall Study|Withdrawal by Subject|9|||
25263579|NCT01259856|50578266|FG001|Overall Study|Withdrawal by Subject|10|||
25263580|NCT01259856|50578265|FG000|Overall Study|Treatment never started|0|||
25263581|NCT01259856|50578266|FG001|Overall Study|Treatment never started|6|||
25263582|NCT01259856|50578265|FG000|Overall Study|Study closure by sponsor|40|||
25263583|NCT01259856|50578266|FG001|Overall Study|Study closure by sponsor|41|||
25263584|NCT01259856|50578265|FG000|Overall Study|Patient developed other disease|0|||
25263585|NCT01259856|50578266|FG001|Overall Study|Patient developed other disease|1|||
25263586|NCT01259856|50578265|FG000|Overall Study|Transfer to another study|0|||
25263587|NCT01259856|50578266|FG001|Overall Study|Transfer to another study|1|||
25263588|NCT01259856|50578265|FG000|Overall Study|Unknown/missing|2|||
25263589|NCT01259856|50578266|FG001|Overall Study|Unknown/missing|2|||
25263590|NCT01020838|50578272|FG000|Overall Study|Death|90|||
25263591|NCT01020838|50578272|FG000|Overall Study|Adverse Event|1|||
25263592|NCT01020838|50578272|FG000|Overall Study|Withdrawal by Subject|9|||
25263593|NCT01020838|50578272|FG000|Overall Study|Lost to Follow-up|6|||
25263594|NCT01020838|50578272|FG000|Overall Study|Most common: Study ended by sponsor|77|||
25263595|NCT01259466|50578287|FG000|Overall Study|Withdrawal by Subject|1|||
25263596|NCT01259466|50578288|FG001|Overall Study|Withdrawal by Subject|9|||
25263597|NCT01259388|50578296|FG000|Overall Study|Adverse Event|3|||
25263598|NCT01259388|50578297|FG001|Overall Study|Adverse Event|0|||
25263599|NCT01259388|50578296|FG000|Overall Study|Withdrawal by Subject|1|||
25263600|NCT01259388|50578297|FG001|Overall Study|Withdrawal by Subject|1|||
25263601|NCT01259388|50578296|FG000|Overall Study|Physician Decision|1|||
25263602|NCT01259388|50578297|FG001|Overall Study|Physician Decision|0|||
25263603|NCT01298492|50578303|FG000|Overall Study|Death|2|||
25263604|NCT01298492|50578303|FG000|Overall Study|Insufficient Clinical Response|22|||
25263605|NCT01298492|50578303|FG000|Overall Study|Lost to Follow-up|12|||
25263606|NCT01298492|50578303|FG000|Overall Study|Withdrawal by Subject|47|||
25263607|NCT01298492|50578303|FG000|Overall Study|Other (Unspecified)|7|||
25263608|NCT01298492|50578303|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
25263609|NCT01298492|50578303|FG000|Overall Study|Protocol Violation|2|||
25263610|NCT01298492|50578303|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
25263611|NCT01298492|50578303|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
25263612|NCT01297322|50578309|FG000|Overall Study|Lost to Follow-up|1|||
25263613|NCT01297322|50578310|FG001|Overall Study|Lost to Follow-up|0|||
25263614|NCT01297322|50578309|FG000|Overall Study|Withdrawal by Subject|0|||
25263615|NCT01297322|50578310|FG001|Overall Study|Withdrawal by Subject|1|||
25263616|NCT01297322|50578309|FG000|Overall Study|Protocol Violation|0|||
25263617|NCT01297322|50578310|FG001|Overall Study|Protocol Violation|3|||
25263618|NCT01297244|50578319|FG000|Overall Study|Progressive disease|22|||
25263619|NCT01297244|50578320|FG001|Overall Study|Progressive disease|3|||
25263620|NCT01297244|50578319|FG000|Overall Study|Adverse Event|9|||
25263621|NCT01297244|50578320|FG001|Overall Study|Adverse Event|1|||
25263622|NCT01297244|50578319|FG000|Overall Study|Death|1|||
25263623|NCT01297244|50578320|FG001|Overall Study|Death|1|||
25263624|NCT01297244|50578319|FG000|Overall Study|Clinical progression|1|||
25263625|NCT01297244|50578320|FG001|Overall Study|Clinical progression|1|||
25263626|NCT01297244|50578319|FG000|Overall Study|Withdrawal by Subject|2|||
25263627|NCT01297244|50578320|FG001|Overall Study|Withdrawal by Subject|0|||
25263628|NCT03456726|50578333|FG000|Overall Study|Disease Progression|6|||
25263629|NCT03456726|50578334|FG001|Overall Study|Disease Progression|1|||
25263630|NCT03456726|50578333|FG000|Overall Study|Adverse Event|4|||
25263631|NCT03456726|50578334|FG001|Overall Study|Adverse Event|2|||
25263632|NCT03456726|50578333|FG000|Overall Study|Withdrawal by Subject|1|||
25263633|NCT03456726|50578334|FG001|Overall Study|Withdrawal by Subject|0|||
25263634|NCT03456726|50578333|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
25263635|NCT03456726|50578334|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
25263636|NCT03181932|50578342|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
25263637|NCT03181932|50578343|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
25263638|NCT03181932|50578342|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
25263639|NCT03181932|50578343|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
25263640|NCT03181932|50578342|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
25263641|NCT03181932|50578343|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
25263642|NCT03181932|50578342|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
25263643|NCT03181932|50578343|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
25263644|NCT03181932|50578342|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
25263645|NCT03181932|50578343|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
25263646|NCT03181932|50578342|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
25263647|NCT03181932|50578343|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
25263648|NCT03181932|50578342|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
25263649|NCT03181932|50578343|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
25263650|NCT03181932|50578342|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
25263651|NCT03181932|50578343|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
25263652|NCT03181932|50578342|FG000|Period 2 (Open-label Period)|Reason missing|2|||
25263653|NCT03181932|50578343|FG001|Period 2 (Open-label Period)|Reason missing|0|||
25263654|NCT02864862|50578353|FG000|Overall Study|Lost to Follow-up|1|||
25263655|NCT02864862|50578354|FG001|Overall Study|Lost to Follow-up|0|||
25263656|NCT02864862|50578355|FG002|Overall Study|Lost to Follow-up|1|||
25263657|NCT02864862|50578353|FG000|Overall Study|Protocol Violation|0|||
25263658|NCT02864862|50578354|FG001|Overall Study|Protocol Violation|0|||
25263659|NCT02864862|50578355|FG002|Overall Study|Protocol Violation|1|||
25263660|NCT01598298|50578367|FG000|Overall Study|Not eligible|5|||
25263661|NCT01598298|50578368|FG001|Overall Study|Not eligible|5|||
25263662|NCT01598298|50578367|FG000|Overall Study|Adverse Event|21|||
25263663|NCT01598298|50578368|FG001|Overall Study|Adverse Event|19|||
25263664|NCT01598298|50578367|FG000|Overall Study|Progression/relapse|0|||
25263665|NCT01598298|50578368|FG001|Overall Study|Progression/relapse|2|||
25263666|NCT01598298|50578367|FG000|Overall Study|Withdrawal by Subject|10|||
25263667|NCT01598298|50578368|FG001|Overall Study|Withdrawal by Subject|15|||
25263668|NCT01598298|50578367|FG000|Overall Study|Other reason (not protocol specified)|4|||
25263669|NCT01598298|50578368|FG001|Overall Study|Other reason (not protocol specified)|0|||
25263670|NCT01235949|50578392|FG000|Primary Phase|Migrated/moved from study area|1|||
25263671|NCT01235949|50578393|FG001|Primary Phase|Migrated/moved from study area|1|||
25263672|NCT01235949|50578394|FG002|Primary Phase|Migrated/moved from study area|0|||
25263673|NCT01235949|50578395|FG003|Primary Phase|Migrated/moved from study area|0|||
25263674|NCT01235949|50578396|FG004|Primary Phase|Migrated/moved from study area|1|||
25263675|NCT01235949|50578397|FG005|Primary Phase|Migrated/moved from study area|2|||
25263676|NCT01235949|50578398|FG006|Primary Phase|Migrated/moved from study area|0|||
25263677|NCT01235949|50578399|FG007|Primary Phase|Migrated/moved from study area|0|||
25263678|NCT01235949|50578400|FG008|Primary Phase|Migrated/moved from study area|0|||
25263679|NCT01235949|50578401|FG009|Primary Phase|Migrated/moved from study area|0|||
25263680|NCT01235949|50578402|FG010|Primary Phase|Migrated/moved from study area|0|||
25263681|NCT01235949|50578403|FG011|Primary Phase|Migrated/moved from study area|0|||
25263682|NCT01235949|50578404|FG012|Primary Phase|Migrated/moved from study area|0|||
25263683|NCT01235949|50578405|FG013|Primary Phase|Migrated/moved from study area|0|||
25263684|NCT01235949|50578406|FG014|Primary Phase|Migrated/moved from study area|0|||
25263685|NCT01235949|50578407|FG015|Primary Phase|Migrated/moved from study area|0|||
25263686|NCT01235949|50578408|FG016|Primary Phase|Migrated/moved from study area|0|||
25263687|NCT01235949|50578409|FG017|Primary Phase|Migrated/moved from study area|0|||
25263688|NCT01235949|50578392|FG000|Primary Phase|Adverse Event|0|||
25263689|NCT01235949|50578393|FG001|Primary Phase|Adverse Event|0|||
25263690|NCT01235949|50578394|FG002|Primary Phase|Adverse Event|0|||
25263691|NCT01235949|50578395|FG003|Primary Phase|Adverse Event|1|||
25263692|NCT01235949|50578396|FG004|Primary Phase|Adverse Event|0|||
25008891|NCT03480750|50102033|FG004|Overall Study|Withdrawal by Subject|0|||
25263693|NCT01235949|50578397|FG005|Primary Phase|Adverse Event|0|||
25263694|NCT01235949|50578398|FG006|Primary Phase|Adverse Event|0|||
25263695|NCT01235949|50578399|FG007|Primary Phase|Adverse Event|0|||
25263696|NCT01235949|50578400|FG008|Primary Phase|Adverse Event|0|||
25263697|NCT01235949|50578401|FG009|Primary Phase|Adverse Event|0|||
25263698|NCT01235949|50578402|FG010|Primary Phase|Adverse Event|0|||
25263699|NCT01235949|50578403|FG011|Primary Phase|Adverse Event|0|||
25263700|NCT01235949|50578404|FG012|Primary Phase|Adverse Event|0|||
25263701|NCT01235949|50578405|FG013|Primary Phase|Adverse Event|0|||
25263702|NCT01235949|50578406|FG014|Primary Phase|Adverse Event|0|||
25263703|NCT01235949|50578407|FG015|Primary Phase|Adverse Event|0|||
25263704|NCT01235949|50578408|FG016|Primary Phase|Adverse Event|0|||
25263705|NCT01235949|50578409|FG017|Primary Phase|Adverse Event|0|||
25263706|NCT01235949|50578392|FG000|Primary Phase|Withdrawal by Subject|3|||
25263707|NCT01235949|50578393|FG001|Primary Phase|Withdrawal by Subject|2|||
25263708|NCT01235949|50578394|FG002|Primary Phase|Withdrawal by Subject|2|||
25263709|NCT01235949|50578395|FG003|Primary Phase|Withdrawal by Subject|0|||
25263710|NCT01235949|50578396|FG004|Primary Phase|Withdrawal by Subject|0|||
25263711|NCT01235949|50578397|FG005|Primary Phase|Withdrawal by Subject|3|||
25263712|NCT01235949|50578398|FG006|Primary Phase|Withdrawal by Subject|0|||
25263713|NCT01235949|50578399|FG007|Primary Phase|Withdrawal by Subject|0|||
25263714|NCT01235949|50578400|FG008|Primary Phase|Withdrawal by Subject|0|||
25263715|NCT01235949|50578401|FG009|Primary Phase|Withdrawal by Subject|0|||
25263716|NCT01235949|50578402|FG010|Primary Phase|Withdrawal by Subject|0|||
25263717|NCT01235949|50578403|FG011|Primary Phase|Withdrawal by Subject|0|||
25263718|NCT01235949|50578404|FG012|Primary Phase|Withdrawal by Subject|0|||
25263719|NCT01235949|50578405|FG013|Primary Phase|Withdrawal by Subject|0|||
25263720|NCT01235949|50578406|FG014|Primary Phase|Withdrawal by Subject|0|||
25263721|NCT01235949|50578407|FG015|Primary Phase|Withdrawal by Subject|0|||
25263722|NCT01235949|50578408|FG016|Primary Phase|Withdrawal by Subject|0|||
25263723|NCT01235949|50578409|FG017|Primary Phase|Withdrawal by Subject|0|||
25263724|NCT01235949|50578392|FG000|Primary Phase|Lost to Follow-up|0|||
25263725|NCT01235949|50578393|FG001|Primary Phase|Lost to Follow-up|0|||
25263726|NCT01235949|50578394|FG002|Primary Phase|Lost to Follow-up|1|||
25263727|NCT01235949|50578395|FG003|Primary Phase|Lost to Follow-up|1|||
25263728|NCT01235949|50578396|FG004|Primary Phase|Lost to Follow-up|0|||
25263729|NCT01235949|50578397|FG005|Primary Phase|Lost to Follow-up|2|||
25263730|NCT01235949|50578398|FG006|Primary Phase|Lost to Follow-up|0|||
25263731|NCT01235949|50578399|FG007|Primary Phase|Lost to Follow-up|0|||
25263732|NCT01235949|50578400|FG008|Primary Phase|Lost to Follow-up|0|||
25263733|NCT01235949|50578401|FG009|Primary Phase|Lost to Follow-up|0|||
25263734|NCT01235949|50578402|FG010|Primary Phase|Lost to Follow-up|0|||
25263735|NCT01235949|50578403|FG011|Primary Phase|Lost to Follow-up|0|||
25263736|NCT01235949|50578404|FG012|Primary Phase|Lost to Follow-up|0|||
25263737|NCT01235949|50578405|FG013|Primary Phase|Lost to Follow-up|0|||
25263738|NCT01235949|50578406|FG014|Primary Phase|Lost to Follow-up|0|||
25263739|NCT01235949|50578407|FG015|Primary Phase|Lost to Follow-up|0|||
25263740|NCT01235949|50578408|FG016|Primary Phase|Lost to Follow-up|0|||
25263741|NCT01235949|50578409|FG017|Primary Phase|Lost to Follow-up|0|||
25263742|NCT01235949|50578392|FG000|Booster Phase|Migrated/moved from study area|0|||
25263743|NCT01235949|50578393|FG001|Booster Phase|Migrated/moved from study area|0|||
25263744|NCT01235949|50578394|FG002|Booster Phase|Migrated/moved from study area|0|||
25263745|NCT01235949|50578395|FG003|Booster Phase|Migrated/moved from study area|0|||
25263746|NCT01235949|50578396|FG004|Booster Phase|Migrated/moved from study area|0|||
25263747|NCT01235949|50578397|FG005|Booster Phase|Migrated/moved from study area|0|||
25263748|NCT01235949|50578398|FG006|Booster Phase|Migrated/moved from study area|0|||
25263749|NCT01235949|50578399|FG007|Booster Phase|Migrated/moved from study area|0|||
25263750|NCT01235949|50578400|FG008|Booster Phase|Migrated/moved from study area|0|||
25263751|NCT01235949|50578401|FG009|Booster Phase|Migrated/moved from study area|0|||
25263752|NCT01235949|50578402|FG010|Booster Phase|Migrated/moved from study area|0|||
25263753|NCT01235949|50578403|FG011|Booster Phase|Migrated/moved from study area|1|||
25263754|NCT01235949|50578404|FG012|Booster Phase|Migrated/moved from study area|1|||
25263755|NCT01235949|50578405|FG013|Booster Phase|Migrated/moved from study area|0|||
25263756|NCT01235949|50578406|FG014|Booster Phase|Migrated/moved from study area|0|||
25263757|NCT01235949|50578407|FG015|Booster Phase|Migrated/moved from study area|0|||
25263758|NCT01235949|50578408|FG016|Booster Phase|Migrated/moved from study area|0|||
25263759|NCT01235949|50578409|FG017|Booster Phase|Migrated/moved from study area|1|||
25263760|NCT01235949|50578392|FG000|Booster Phase|Adverse Event|0|||
25263761|NCT01235949|50578393|FG001|Booster Phase|Adverse Event|0|||
25263762|NCT01235949|50578394|FG002|Booster Phase|Adverse Event|0|||
25263763|NCT01235949|50578395|FG003|Booster Phase|Adverse Event|0|||
25263764|NCT01235949|50578396|FG004|Booster Phase|Adverse Event|0|||
25263765|NCT01235949|50578397|FG005|Booster Phase|Adverse Event|0|||
25263766|NCT01235949|50578398|FG006|Booster Phase|Adverse Event|0|||
25263767|NCT01235949|50578399|FG007|Booster Phase|Adverse Event|0|||
25263768|NCT01235949|50578400|FG008|Booster Phase|Adverse Event|0|||
25263769|NCT01235949|50578401|FG009|Booster Phase|Adverse Event|0|||
25263770|NCT01235949|50578402|FG010|Booster Phase|Adverse Event|0|||
25263771|NCT01235949|50578403|FG011|Booster Phase|Adverse Event|0|||
25263772|NCT01235949|50578404|FG012|Booster Phase|Adverse Event|0|||
25263773|NCT01235949|50578405|FG013|Booster Phase|Adverse Event|0|||
25263774|NCT01235949|50578406|FG014|Booster Phase|Adverse Event|0|||
25263775|NCT01235949|50578407|FG015|Booster Phase|Adverse Event|1|||
25263776|NCT01235949|50578408|FG016|Booster Phase|Adverse Event|0|||
25263777|NCT01235949|50578409|FG017|Booster Phase|Adverse Event|0|||
25263778|NCT01235949|50578392|FG000|Booster Phase|Withdrawal by Subject|0|||
25263779|NCT01235949|50578393|FG001|Booster Phase|Withdrawal by Subject|0|||
25263780|NCT01235949|50578394|FG002|Booster Phase|Withdrawal by Subject|0|||
25263781|NCT01235949|50578395|FG003|Booster Phase|Withdrawal by Subject|0|||
25263782|NCT01235949|50578396|FG004|Booster Phase|Withdrawal by Subject|0|||
25263783|NCT01235949|50578397|FG005|Booster Phase|Withdrawal by Subject|0|||
25263784|NCT01235949|50578398|FG006|Booster Phase|Withdrawal by Subject|0|||
25263785|NCT01235949|50578399|FG007|Booster Phase|Withdrawal by Subject|1|||
25263786|NCT01235949|50578400|FG008|Booster Phase|Withdrawal by Subject|1|||
25263787|NCT01235949|50578401|FG009|Booster Phase|Withdrawal by Subject|0|||
25263788|NCT01235949|50578402|FG010|Booster Phase|Withdrawal by Subject|1|||
25263789|NCT01235949|50578403|FG011|Booster Phase|Withdrawal by Subject|1|||
25263790|NCT01235949|50578404|FG012|Booster Phase|Withdrawal by Subject|2|||
25263791|NCT01235949|50578405|FG013|Booster Phase|Withdrawal by Subject|0|||
25263792|NCT01235949|50578406|FG014|Booster Phase|Withdrawal by Subject|2|||
25263793|NCT01235949|50578407|FG015|Booster Phase|Withdrawal by Subject|0|||
25008892|NCT03480750|50102034|FG005|Overall Study|Withdrawal by Subject|0|||
25123588|NCT02301143|50236190|FG001|Induction Period|Noncompliance with Study Drug|0|||
25123589|NCT02301143|50236189|FG000|Induction Period|Physician Decision|4|||
25123590|NCT02301143|50236190|FG001|Induction Period|Physician Decision|0|||
25123591|NCT02301143|50236189|FG000|Induction Period|Symptomatic Deterioration|2|||
25123592|NCT02301143|50236190|FG001|Induction Period|Symptomatic Deterioration|0|||
25123593|NCT02301143|50236189|FG000|Induction Period|Protocol Violation|2|||
25263794|NCT01235949|50578408|FG016|Booster Phase|Withdrawal by Subject|0|||
25263795|NCT01235949|50578409|FG017|Booster Phase|Withdrawal by Subject|0|||
25263796|NCT01235949|50578392|FG000|Booster Phase|Lost to Follow-up|0|||
25263797|NCT01235949|50578393|FG001|Booster Phase|Lost to Follow-up|0|||
25263798|NCT01235949|50578394|FG002|Booster Phase|Lost to Follow-up|0|||
25263799|NCT01235949|50578395|FG003|Booster Phase|Lost to Follow-up|0|||
25263800|NCT01235949|50578396|FG004|Booster Phase|Lost to Follow-up|0|||
25263801|NCT01235949|50578397|FG005|Booster Phase|Lost to Follow-up|0|||
25263802|NCT01235949|50578398|FG006|Booster Phase|Lost to Follow-up|0|||
25263803|NCT01235949|50578399|FG007|Booster Phase|Lost to Follow-up|0|||
25263804|NCT01235949|50578400|FG008|Booster Phase|Lost to Follow-up|1|||
25263805|NCT01235949|50578401|FG009|Booster Phase|Lost to Follow-up|1|||
25263806|NCT01235949|50578402|FG010|Booster Phase|Lost to Follow-up|1|||
25263807|NCT01235949|50578403|FG011|Booster Phase|Lost to Follow-up|1|||
25263808|NCT01235949|50578404|FG012|Booster Phase|Lost to Follow-up|0|||
25263809|NCT01235949|50578405|FG013|Booster Phase|Lost to Follow-up|0|||
25263810|NCT01235949|50578406|FG014|Booster Phase|Lost to Follow-up|0|||
25263811|NCT01235949|50578407|FG015|Booster Phase|Lost to Follow-up|0|||
25263812|NCT01235949|50578408|FG016|Booster Phase|Lost to Follow-up|0|||
25263813|NCT01235949|50578409|FG017|Booster Phase|Lost to Follow-up|1|||
25123594|NCT02301143|50236190|FG001|Induction Period|Protocol Violation|0|||
25123595|NCT02301143|50236189|FG000|Induction Period|Other|1|||
25123596|NCT02301143|50236190|FG001|Induction Period|Other|0|||
25123597|NCT02301143|50236189|FG000|Investigator's Choice|Adverse Event|0|||
25263814|NCT01235793|50578447|FG000|Overall Study|Death|6|||
25263815|NCT01258998|50578452|FG000|Overall Study|Ineligible|1|||
25263816|NCT01235715|50578458|FG000|Overall Study|Physician Decision|0|||
25263817|NCT01235715|50578459|FG001|Overall Study|Physician Decision|2|||
25263818|NCT01235403|50578466|FG000|Overall Study|Adverse Event|14|||
25263819|NCT01235403|50578466|FG000|Overall Study|Lost to Follow-up|2|||
25263820|NCT01235403|50578466|FG000|Overall Study|Withdrawal by Subject|4|||
25263821|NCT01235403|50578466|FG000|Overall Study|Lack of Efficacy|2|||
25263822|NCT01235403|50578466|FG000|Overall Study|Other reasons for premature termination|4|||
25263823|NCT01024036|50578472|FG000|Blinded Treatment|Adverse Event|1|||
25263824|NCT01024036|50578473|FG001|Blinded Treatment|Adverse Event|1|||
25263825|NCT01024036|50578472|FG000|Blinded Treatment|Lack of Efficacy|16|||
25263826|NCT01024036|50578473|FG001|Blinded Treatment|Lack of Efficacy|14|||
25263827|NCT01024036|50578472|FG000|Blinded Treatment|Physician Decision|1|||
25263828|NCT01024036|50578473|FG001|Blinded Treatment|Physician Decision|0|||
25263829|NCT01024036|50578472|FG000|Blinded Treatment|Death|0|||
25263830|NCT01024036|50578473|FG001|Blinded Treatment|Death|2|||
25263831|NCT01024036|50578472|FG000|Blinded Treatment|Withdrawal by Subject|4|||
25263832|NCT01024036|50578473|FG001|Blinded Treatment|Withdrawal by Subject|3|||
25008893|NCT03480750|50102029|FG000|Overall Study|The interruption in Trientine shippment|0|||
25123598|NCT02301143|50236190|FG001|Investigator's Choice|Adverse Event|3|||
25123599|NCT02301143|50236189|FG000|Investigator's Choice|Progressive Disease|0|||
25263833|NCT01024036|50578472|FG000|Unblinded Treatment|Adverse Event|0|||
25263834|NCT01024036|50578473|FG001|Unblinded Treatment|Adverse Event|1|||
25263835|NCT01024036|50578472|FG000|Unblinded Treatment|Lack of Efficacy|0|||
25263836|NCT01024036|50578473|FG001|Unblinded Treatment|Lack of Efficacy|2|||
25263837|NCT01024036|50578472|FG000|Follow-Up Period|Lost to Follow-up|1|||
25263838|NCT01024036|50578473|FG001|Follow-Up Period|Lost to Follow-up|1|||
25263839|NCT01024036|50578472|FG000|Follow-Up Period|Withdrawal by Subject|0|||
25263840|NCT01024036|50578473|FG001|Follow-Up Period|Withdrawal by Subject|1|||
25263841|NCT01024036|50578472|FG000|Follow-Up Period|Adverse Event|4|||
25263842|NCT01024036|50578473|FG001|Follow-Up Period|Adverse Event|1|||
25263843|NCT01234467|50578482|FG000|Overall Study|Adverse Event|3|||
25263844|NCT01234467|50578482|FG000|Overall Study|Death|2|||
25263845|NCT01234467|50578482|FG000|Overall Study|Withdrawal by Subject|2|||
25263846|NCT01234467|50578482|FG000|Overall Study|Disease Progression|2|||
25263847|NCT01234467|50578482|FG000|Overall Study|Clinical deterioration|1|||
25263848|NCT01234467|50578482|FG000|Overall Study|Physician Decision|1|||
25263849|NCT01234467|50578482|FG000|Overall Study|Other complicating disease (stroke)|1|||
25263850|NCT01233999|50578486|FG000|Overall Study|Withdrawal by Subject|1|||
25263851|NCT01233999|50578486|FG000|Overall Study|Lost to Follow-up|1|||
25263852|NCT01233687|50578490|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
25263853|NCT01233687|50578490|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
25263854|NCT01233687|50578490|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
25263855|NCT01023958|50578494|FG000|Overall Study|Progressive disease|48|||
25263856|NCT01023958|50578494|FG000|Overall Study|Other adverse event|1|||
25263857|NCT01023958|50578494|FG000|Overall Study|Refused to continue medication|1|||
25263858|NCT01233609|50578500|FG000|Overall Study|Death|1|||
25263859|NCT01233609|50578501|FG001|Overall Study|Death|0|||
25263860|NCT01233609|50578500|FG000|Overall Study|Lost to Follow-up|3|||
25263861|NCT01233609|50578501|FG001|Overall Study|Lost to Follow-up|1|||
25263862|NCT01233609|50578500|FG000|Overall Study|Adverse Event|2|||
25263863|NCT01233609|50578501|FG001|Overall Study|Adverse Event|1|||
25263864|NCT01233609|50578500|FG000|Overall Study|Withdrawal by Subject|3|||
25263865|NCT01233609|50578501|FG001|Overall Study|Withdrawal by Subject|0|||
25263866|NCT01232283|50578517|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
25263867|NCT01232283|50578518|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
25263868|NCT01232283|50578519|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
25263869|NCT01232283|50578520|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
25263870|NCT01232283|50578521|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
25263871|NCT01232283|50578522|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
25263872|NCT01232283|50578523|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
25263873|NCT01232283|50578524|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
25263874|NCT01232283|50578525|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
25263875|NCT01232283|50578526|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
25263876|NCT01232283|50578517|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
25263877|NCT01232283|50578518|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
25263878|NCT01232283|50578519|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
25263879|NCT01232283|50578520|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
25263880|NCT01232283|50578521|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
25263881|NCT01232283|50578522|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
25263882|NCT01232283|50578523|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
25263883|NCT01232283|50578524|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
25263884|NCT01232283|50578525|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
25263885|NCT01232283|50578526|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
25263886|NCT01232283|50578517|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
25263887|NCT01232283|50578518|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
25177572|NCT01557517|50321644|FG000|Overall Study|Death|1|||
25177573|NCT01557517|50321645|FG001|Overall Study|Death|0|||
25177574|NCT01557517|50321644|FG000|Overall Study|Refused further treatment|0|||
25177575|NCT01557517|50321645|FG001|Overall Study|Refused further treatment|2|||
25177576|NCT01557517|50321644|FG000|Overall Study|Adverse Event|0|||
25177577|NCT01557517|50321645|FG001|Overall Study|Adverse Event|2|||
25177578|NCT01557517|50321644|FG000|Overall Study|Pt declined before treatment started|1|||
25177579|NCT01557517|50321645|FG001|Overall Study|Pt declined before treatment started|0|||
25177580|NCT01497197|50321660|FG000|Overall Study|Lost to Follow-up|1|||
25177581|NCT01497197|50321661|FG001|Overall Study|Lost to Follow-up|0|||
25177582|NCT01497197|50321660|FG000|Overall Study|Protocol Violation|0|||
25177583|NCT01497197|50321661|FG001|Overall Study|Protocol Violation|2|||
25177584|NCT01497197|50321660|FG000|Overall Study|Withdrawal by Subject|2|||
25177585|NCT01497197|50321661|FG001|Overall Study|Withdrawal by Subject|1|||
25177586|NCT01497197|50321660|FG000|Overall Study|Excessive/lack of response to treatment|1|||
25177587|NCT01497197|50321661|FG001|Overall Study|Excessive/lack of response to treatment|0|||
25177588|NCT01497197|50321660|FG000|Overall Study|Risk of OHSS|1|||
25177589|NCT01497197|50321661|FG001|Overall Study|Risk of OHSS|0|||
25177590|NCT01497197|50321660|FG000|Overall Study|No oocytes retrieved|3|||
25177591|NCT01497197|50321661|FG001|Overall Study|No oocytes retrieved|2|||
25177592|NCT01497197|50321660|FG000|Overall Study|No fertilisation|6|||
25177593|NCT01497197|50321661|FG001|Overall Study|No fertilisation|5|||
25177594|NCT01497197|50321660|FG000|Overall Study|Intention to freeze all embryos|0|||
25177595|NCT01497197|50321661|FG001|Overall Study|Intention to freeze all embryos|1|||
25263888|NCT01232283|50578519|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
25263889|NCT01232283|50578520|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
25263890|NCT01232283|50578521|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
25263891|NCT01232283|50578522|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
25263892|NCT01232283|50578523|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
25263893|NCT01232283|50578524|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
25263894|NCT01232283|50578525|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
25263895|NCT01232283|50578526|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
25263896|NCT01232283|50578517|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
25263897|NCT01232283|50578518|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
25263898|NCT01232283|50578519|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
25263899|NCT01232283|50578520|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
25263900|NCT01232283|50578521|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
25263901|NCT01232283|50578522|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
25263902|NCT01232283|50578523|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
25263903|NCT01232283|50578524|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
25263904|NCT01232283|50578525|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
25263905|NCT01232283|50578526|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
25263906|NCT01232283|50578517|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
25263907|NCT01232283|50578518|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
25263908|NCT01232283|50578519|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
25263909|NCT01232283|50578520|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
25263910|NCT01232283|50578521|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
25263911|NCT01232283|50578522|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
25263912|NCT01232283|50578523|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
25263913|NCT01232283|50578524|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
25263914|NCT01232283|50578525|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
25263915|NCT01232283|50578526|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
25263916|NCT01232283|50578517|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
25263917|NCT01232283|50578518|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
25263918|NCT01232283|50578519|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
25263919|NCT01232283|50578520|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
25263920|NCT01232283|50578521|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
25263921|NCT01232283|50578522|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
25263922|NCT01232283|50578523|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
25263923|NCT01232283|50578524|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
25263924|NCT01232283|50578525|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
25263925|NCT01232283|50578526|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
25263926|NCT01232283|50578517|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
25263927|NCT01232283|50578518|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
25263928|NCT01232283|50578519|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
25263929|NCT01232283|50578520|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
25263930|NCT01232283|50578521|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
25263931|NCT01232283|50578522|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
25263932|NCT01232283|50578523|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
25263933|NCT01232283|50578524|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
25263934|NCT01232283|50578525|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
25263935|NCT01232283|50578526|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
25263936|NCT01232283|50578517|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
25263937|NCT01232283|50578518|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
25263938|NCT01232283|50578519|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
25263939|NCT01232283|50578520|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
25263940|NCT01232283|50578521|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
25263941|NCT01232283|50578522|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
25263942|NCT01232283|50578523|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
25263943|NCT01232283|50578524|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
25263944|NCT01232283|50578525|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
25263945|NCT01232283|50578526|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
25263946|NCT01232283|50578517|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
25263947|NCT01232283|50578518|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
25263948|NCT01232283|50578519|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
25263949|NCT01232283|50578520|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
25263950|NCT01232283|50578521|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
25263951|NCT01232283|50578522|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
25263952|NCT01232283|50578523|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
25263953|NCT01232283|50578524|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
25263954|NCT01232283|50578525|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
25263955|NCT01232283|50578526|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
25263956|NCT01232283|50578517|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
25263957|NCT01232283|50578518|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
25263958|NCT01232283|50578519|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
25263959|NCT01232283|50578520|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
25263960|NCT01232283|50578521|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
25263961|NCT01232283|50578522|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
25263962|NCT01232283|50578523|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
25263963|NCT01232283|50578524|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
25263964|NCT01232283|50578525|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
25263965|NCT01232283|50578526|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
25263966|NCT01232283|50578517|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
25263967|NCT01232283|50578518|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
25263968|NCT01232283|50578519|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
25263969|NCT01232283|50578520|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
25263970|NCT01232283|50578521|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
25263971|NCT01232283|50578522|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
25263972|NCT01232283|50578523|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
25263973|NCT01232283|50578524|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
25263974|NCT01232283|50578525|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
25263975|NCT01232283|50578526|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
25263976|NCT01232283|50578517|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
25263977|NCT01232283|50578518|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
25263978|NCT01232283|50578519|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
25263979|NCT01232283|50578520|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
25263980|NCT01232283|50578521|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
25263981|NCT01232283|50578522|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
25263982|NCT01232283|50578523|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
25263983|NCT01232283|50578524|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
25263984|NCT01232283|50578525|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
25263985|NCT01232283|50578526|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
25263986|NCT01232283|50578517|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
25263987|NCT01232283|50578518|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
25263988|NCT01232283|50578519|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
25263989|NCT01232283|50578520|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
25263990|NCT01232283|50578521|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
25263991|NCT01232283|50578522|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
25263992|NCT01232283|50578523|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
25263993|NCT01232283|50578524|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
25263994|NCT01232283|50578525|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
25263995|NCT01232283|50578526|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
25263996|NCT01232283|50578517|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
25263997|NCT01232283|50578518|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
25263998|NCT01232283|50578519|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
25263999|NCT01232283|50578520|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
25264000|NCT01232283|50578521|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
25264001|NCT01232283|50578522|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
25264002|NCT01232283|50578523|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
25264003|NCT01232283|50578524|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
25264004|NCT01232283|50578525|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
25008894|NCT03480750|50102030|FG001|Overall Study|The interruption in Trientine shippment|0|||
25008895|NCT03480750|50102031|FG002|Overall Study|The interruption in Trientine shippment|0|||
25008896|NCT03480750|50102032|FG003|Overall Study|The interruption in Trientine shippment|0|||
25008897|NCT03480750|50102033|FG004|Overall Study|The interruption in Trientine shippment|0|||
25008898|NCT03480750|50102034|FG005|Overall Study|The interruption in Trientine shippment|1|||
25008899|NCT03462030|50102059|FG000|Overall Study|Withdrawal by Subject|1|||
25008900|NCT03462030|50102060|FG001|Overall Study|Withdrawal by Subject|1|||
25008901|NCT03412734|50102068|FG000|Overall Study|Incorrect labeling of samples|2|||
25008902|NCT03412734|50102069|FG001|Overall Study|Incorrect labeling of samples|0|||
25264005|NCT01232283|50578526|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
25264006|NCT01232283|50578517|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
25264007|NCT01232283|50578518|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
25264008|NCT01232283|50578519|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
25264009|NCT01232283|50578520|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
25264010|NCT01232283|50578521|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
25264011|NCT01232283|50578522|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
25264012|NCT01232283|50578523|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
25264013|NCT01232283|50578524|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
25264014|NCT01232283|50578525|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
25264015|NCT01232283|50578526|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
25264016|NCT01232283|50578517|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
25264017|NCT01232283|50578518|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
25264018|NCT01232283|50578519|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
25264019|NCT01232283|50578520|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
25264020|NCT01232283|50578521|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
25264021|NCT01232283|50578522|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
25264022|NCT01232283|50578523|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
25264023|NCT01232283|50578524|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
25264024|NCT01232283|50578525|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
25264025|NCT01232283|50578526|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
25264026|NCT01232283|50578517|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
25264027|NCT01232283|50578518|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
25264028|NCT01232283|50578519|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
25264029|NCT01232283|50578520|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
25264030|NCT01232283|50578521|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
25264031|NCT01232283|50578522|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
25264032|NCT01232283|50578523|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
25264033|NCT01232283|50578524|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
25264034|NCT01232283|50578525|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
25264035|NCT01232283|50578526|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
25264036|NCT01232283|50578517|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
25264037|NCT01232283|50578518|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
25264038|NCT01232283|50578519|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
25264039|NCT01232283|50578520|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
25264040|NCT01232283|50578521|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
25264041|NCT01232283|50578522|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
25264042|NCT01232283|50578523|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
25264043|NCT01232283|50578524|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
25264044|NCT01232283|50578525|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
25264045|NCT01232283|50578526|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
25264046|NCT01232283|50578517|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
25264047|NCT01232283|50578518|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
25264048|NCT01232283|50578519|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
25264049|NCT01232283|50578520|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
25264050|NCT01232283|50578521|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
25264051|NCT01232283|50578522|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
25264052|NCT01232283|50578523|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
25177596|NCT01497197|50321660|FG000|Overall Study|All embryos discarded|0|||
25177597|NCT01497197|50321661|FG001|Overall Study|All embryos discarded|3|||
25177598|NCT01497197|50321660|FG000|Overall Study|Other|3|||
25177599|NCT01497197|50321661|FG001|Overall Study|Other|1|||
25177600|NCT01496885|50321667|FG000|Overall Study|Lost to Follow-up|13|||
25177601|NCT01496885|50321667|FG000|Overall Study|Withdrawal by Subject|7|||
25177602|NCT01496885|50321667|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
25177603|NCT01496885|50321667|FG000|Overall Study|Death|1|||
25177604|NCT01557283|50321671|FG000|Overall Study|Lost to Follow-up|7|||
25177605|NCT01557283|50321671|FG000|Overall Study|Non-responder|19|||
25177606|NCT01557283|50321671|FG000|Overall Study|Adverse Event|7|||
25177607|NCT01557283|50321671|FG000|Overall Study|Lack of Efficacy|1|||
25177608|NCT01557283|50321671|FG000|Overall Study|Non-compliance|1|||
25177609|NCT01557283|50321671|FG000|Overall Study|Withdrawal by Subject|1|||
25177610|NCT01557283|50321671|FG000|Overall Study|Participant's weight too high for dose|1|||
25177611|NCT01557283|50321671|FG000|Overall Study|Worsening of psoriasis|1|||
25177612|NCT01557283|50321671|FG000|Overall Study|Other|6|||
25177613|NCT01523743|50321688|FG000|Period 1|Adverse Event|1|||
25177614|NCT01523743|50321689|FG001|Period 1|Adverse Event|0|||
25177615|NCT01523743|50321688|FG000|Period 1|Withdrawal by Subject|6|||
25177616|NCT01523743|50321689|FG001|Period 1|Withdrawal by Subject|2|||
25177617|NCT01523743|50321688|FG000|Period 1|Lost to Follow-up|1|||
25177618|NCT01523743|50321689|FG001|Period 1|Lost to Follow-up|0|||
25177619|NCT01523743|50321688|FG000|Period 1|Lack of Efficacy|1|||
25177620|NCT01523743|50321689|FG001|Period 1|Lack of Efficacy|0|||
25177621|NCT01523743|50321688|FG000|Period 1|Felt unable to empty bladder|1|||
25264053|NCT01232283|50578524|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
25264054|NCT01232283|50578525|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
25264055|NCT01232283|50578526|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
25264056|NCT01232283|50578517|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
25264057|NCT01232283|50578518|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
25264058|NCT01232283|50578519|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
25264059|NCT01232283|50578520|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
25264060|NCT01232283|50578521|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
25264061|NCT01232283|50578522|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
25264062|NCT01232283|50578523|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
25264063|NCT01232283|50578524|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
25264064|NCT01232283|50578525|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
25264065|NCT01232283|50578526|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
25264066|NCT01232283|50578517|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
25264067|NCT01232283|50578518|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
25264068|NCT01232283|50578519|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
25264069|NCT01232283|50578520|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
25264070|NCT01232283|50578521|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
25264071|NCT01232283|50578522|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
25264072|NCT01232283|50578523|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
25264073|NCT01232283|50578524|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
25264074|NCT01232283|50578525|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
25264075|NCT01232283|50578526|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
25264076|NCT01232283|50578517|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
25264077|NCT01232283|50578518|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
25264078|NCT01232283|50578519|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
25264079|NCT01232283|50578520|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
25264080|NCT01232283|50578521|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
25264081|NCT01232283|50578522|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
25264082|NCT01232283|50578523|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
25264083|NCT01232283|50578524|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
25264084|NCT01232283|50578525|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
25264085|NCT01232283|50578526|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
25264086|NCT01232283|50578517|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
25264087|NCT01232283|50578518|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
25264088|NCT01232283|50578519|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
25264089|NCT01232283|50578520|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
25264090|NCT01232283|50578521|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
25264091|NCT01232283|50578522|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
25264092|NCT01232283|50578523|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
25264093|NCT01232283|50578524|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
25264094|NCT01232283|50578525|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
25264095|NCT01232283|50578526|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
25264096|NCT01232283|50578517|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
25264097|NCT01232283|50578518|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
25264098|NCT01232283|50578519|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
25264099|NCT01232283|50578520|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
25264100|NCT01232283|50578521|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
25264101|NCT01232283|50578522|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
25264102|NCT01232283|50578523|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
25264103|NCT01232283|50578524|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
25264104|NCT01232283|50578525|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
25264105|NCT01232283|50578526|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
25264106|NCT01232283|50578517|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
25264107|NCT01232283|50578518|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
25264108|NCT01232283|50578519|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
25264109|NCT01232283|50578520|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
25264110|NCT01232283|50578521|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
25264111|NCT01232283|50578522|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
25264112|NCT01232283|50578523|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
25264113|NCT01232283|50578524|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
25264114|NCT01232283|50578525|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
25264115|NCT01232283|50578526|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
25264116|NCT01232283|50578517|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
25264117|NCT01232283|50578518|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
25264118|NCT01232283|50578519|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
25264119|NCT01232283|50578520|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
25264120|NCT01232283|50578521|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
25264121|NCT01232283|50578522|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
25264122|NCT01232283|50578523|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
25264123|NCT01232283|50578524|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
25264124|NCT01232283|50578525|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
25264125|NCT01232283|50578526|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
25264126|NCT01232283|50578517|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
25264127|NCT01232283|50578518|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
25264128|NCT01232283|50578519|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
25264129|NCT01232283|50578520|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
25264130|NCT01232283|50578521|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
25264131|NCT01232283|50578522|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
25264132|NCT01232283|50578523|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
25264133|NCT01232283|50578524|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
25264134|NCT01232283|50578525|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
25264135|NCT01232283|50578526|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
25264136|NCT01232283|50578517|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
25264137|NCT01232283|50578518|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
25264138|NCT01232283|50578519|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
25264139|NCT01232283|50578520|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
25264140|NCT01232283|50578521|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
25264141|NCT01232283|50578522|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
25264142|NCT01232283|50578523|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
25264143|NCT01232283|50578524|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
25264144|NCT01232283|50578525|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
25264145|NCT01232283|50578526|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
25264146|NCT01232127|50578548|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
25264147|NCT01232127|50578549|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
25264148|NCT01232127|50578550|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
25264149|NCT01258608|50578564|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
25264150|NCT01258608|50578565|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
25264151|NCT01258608|50578564|FG000|Overall Study|Clinical progression|1|||
25264152|NCT01258608|50578565|FG001|Overall Study|Clinical progression|0|||
25264153|NCT01258608|50578564|FG000|Overall Study|Sponsor decision|0|||
25264154|NCT01258608|50578565|FG001|Overall Study|Sponsor decision|1|||
25264155|NCT01258608|50578564|FG000|Overall Study|Physician Decision|6|||
25264156|NCT01258608|50578565|FG001|Overall Study|Physician Decision|1|||
25264157|NCT01258608|50578564|FG000|Overall Study|Lost to Follow-up|0|||
25264158|NCT01258608|50578565|FG001|Overall Study|Lost to Follow-up|1|||
25264159|NCT01258608|50578564|FG000|Overall Study|Lack of compliance|1|||
25264160|NCT01258608|50578565|FG001|Overall Study|Lack of compliance|0|||
25264161|NCT01258608|50578564|FG000|Overall Study|Lack of Efficacy|0|||
25264162|NCT01258608|50578565|FG001|Overall Study|Lack of Efficacy|1|||
25264163|NCT01258608|50578564|FG000|Overall Study|Adverse Event|6|||
25264164|NCT01258608|50578565|FG001|Overall Study|Adverse Event|10|||
25264165|NCT01258608|50578564|FG000|Overall Study|Withdrawal by Subject|6|||
25264166|NCT01258608|50578565|FG001|Overall Study|Withdrawal by Subject|5|||
25264167|NCT01015612|50578572|FG000|Overall Study|Death|113|||
25264168|NCT01015612|50578572|FG000|Overall Study|Withdrawal by Subject|40|||
25264169|NCT01231659|50578576|FG000|Overall Study|Adverse Event|9|||
25264170|NCT01231659|50578576|FG000|Overall Study|Disease Progression|48|||
25264171|NCT01231659|50578576|FG000|Overall Study|Death|2|||
25264172|NCT01231659|50578576|FG000|Overall Study|Patient refused to complete study visit|1|||
25264173|NCT01231659|50578576|FG000|Overall Study|Other protocol defined criteria|12|||
25264174|NCT01054222|50578580|FG000|Overall Study|Lack of Efficacy|1|||
25264175|NCT01054222|50578580|FG000|Overall Study|Lost to Follow-up|4|||
25264176|NCT01054222|50578580|FG000|Overall Study|Withdrawal by Subject|6|||
25264177|NCT01052428|50578586|FG000|Overall Study|Death|1|||
25264178|NCT01052428|50578587|FG001|Overall Study|Death|0|||
25264179|NCT01052428|50578586|FG000|Overall Study|Withdrawal by Subject|0|||
25264180|NCT01052428|50578587|FG001|Overall Study|Withdrawal by Subject|1|||
25264181|NCT01052272|50578597|FG000|Overall Study|Death|0|||
25264182|NCT01052272|50578598|FG001|Overall Study|Death|0|||
25264183|NCT01052272|50578599|FG002|Overall Study|Death|1|||
25264184|NCT01052272|50578600|FG003|Overall Study|Death|1|||
25264185|NCT01052272|50578597|FG000|Overall Study|Physician Decision|0|||
25264186|NCT01052272|50578598|FG001|Overall Study|Physician Decision|1|||
25264187|NCT01052272|50578599|FG002|Overall Study|Physician Decision|0|||
25264188|NCT01052272|50578600|FG003|Overall Study|Physician Decision|0|||
25264189|NCT01052272|50578597|FG000|Overall Study|patient refuses follow-up|5|||
25264190|NCT01052272|50578598|FG001|Overall Study|patient refuses follow-up|4|||
25264191|NCT01052272|50578599|FG002|Overall Study|patient refuses follow-up|2|||
25264192|NCT01052272|50578600|FG003|Overall Study|patient refuses follow-up|4|||
25264193|NCT01052272|50578597|FG000|Overall Study|Withdrawal by Subject|0|||
25264194|NCT01052272|50578598|FG001|Overall Study|Withdrawal by Subject|2|||
25264195|NCT01052272|50578599|FG002|Overall Study|Withdrawal by Subject|3|||
25264196|NCT01052272|50578600|FG003|Overall Study|Withdrawal by Subject|2|||
25264197|NCT01052272|50578597|FG000|Overall Study|placed in long-term care|0|||
25264198|NCT01052272|50578598|FG001|Overall Study|placed in long-term care|0|||
25264199|NCT01052272|50578599|FG002|Overall Study|placed in long-term care|1|||
25264200|NCT01052272|50578600|FG003|Overall Study|placed in long-term care|0|||
25264201|NCT01052272|50578597|FG000|Overall Study|decline in health|0|||
25264202|NCT01052272|50578598|FG001|Overall Study|decline in health|0|||
25264203|NCT01052272|50578599|FG002|Overall Study|decline in health|1|||
25264204|NCT01052272|50578600|FG003|Overall Study|decline in health|0|||
25264205|NCT01257204|50578613|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
25264206|NCT01257204|50578614|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
25264207|NCT01257204|50578615|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
25264208|NCT01257204|50578613|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
25264209|NCT01257204|50578614|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
25264210|NCT01257204|50578615|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
25264211|NCT01257204|50578613|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
25264212|NCT01257204|50578614|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
25264213|NCT01257204|50578615|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
25264214|NCT01257204|50578613|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
25264215|NCT01257204|50578614|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
25264216|NCT01257204|50578615|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
25123600|NCT02301143|50236190|FG001|Investigator's Choice|Progressive Disease|3|||
25123601|NCT02301143|50236189|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
25123602|NCT02301143|50236190|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
25123603|NCT02301143|50236189|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
25123604|NCT02301143|50236190|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
25123605|NCT02301143|50236189|FG000|Investigator's Choice|Other|0|||
25123606|NCT02301143|50236190|FG001|Investigator's Choice|Other|1|||
25123607|NCT02301143|50236189|FG000|Investigator's Choice|Unresectable Surgery|0|||
25123608|NCT02301143|50236190|FG001|Investigator's Choice|Unresectable Surgery|1|||
25123609|NCT02276222|50236203|FG000|Overall Study|Adverse Event|62|||
25123610|NCT02276222|50236204|FG001|Overall Study|Adverse Event|11|||
25123611|NCT02276222|50236203|FG000|Overall Study|Death|3|||
25123612|NCT02276222|50236204|FG001|Overall Study|Death|4|||
25123613|NCT02276222|50236203|FG000|Overall Study|Lack of Efficacy|13|||
25123614|NCT02276222|50236204|FG001|Overall Study|Lack of Efficacy|3|||
25123615|NCT02276222|50236203|FG000|Overall Study|Protocol Violation|3|||
25123616|NCT02276222|50236204|FG001|Overall Study|Protocol Violation|2|||
25123617|NCT02276222|50236203|FG000|Overall Study|Withdrawal by Subject|79|||
25123618|NCT02276222|50236204|FG001|Overall Study|Withdrawal by Subject|33|||
25123619|NCT02276222|50236203|FG000|Overall Study|non compliance with study medication|6|||
25123620|NCT02276222|50236204|FG001|Overall Study|non compliance with study medication|2|||
25123621|NCT02276222|50236203|FG000|Overall Study|sponsor decision|0|||
25123622|NCT02276222|50236204|FG001|Overall Study|sponsor decision|3|||
25264217|NCT01257204|50578613|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
25264218|NCT01257204|50578614|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
25264219|NCT01257204|50578615|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
25264220|NCT01257204|50578613|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
25264221|NCT01257204|50578614|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
25264222|NCT01257204|50578615|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
25264223|NCT01257204|50578613|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
25264224|NCT01257204|50578614|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
25264225|NCT01257204|50578615|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
25264226|NCT01257204|50578613|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
25264227|NCT01257204|50578614|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
25264228|NCT01257204|50578615|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
25264229|NCT01257204|50578613|FG000|Follow-up Period (up to Week 48)|Other|0|||
25264230|NCT01257204|50578614|FG001|Follow-up Period (up to Week 48)|Other|0|||
25264231|NCT01257204|50578615|FG002|Follow-up Period (up to Week 48)|Other|5|||
25264232|NCT01231581|50578637|FG000|Overall Study|Lost to Follow-up|2|||
25123623|NCT02276222|50236203|FG000|Overall Study|Lost to Follow-up|15|||
25123624|NCT02276222|50236204|FG001|Overall Study|Lost to Follow-up|5|||
25123625|NCT02276222|50236203|FG000|Overall Study|Physician Decision|2|||
25123626|NCT02276222|50236204|FG001|Overall Study|Physician Decision|1|||
25123627|NCT02276222|50236203|FG000|Overall Study|sheduling conflict|1|||
25264233|NCT01231581|50578638|FG001|Overall Study|Lost to Follow-up|2|||
25123628|NCT02276222|50236204|FG001|Overall Study|sheduling conflict|0|||
25264234|NCT01231581|50578637|FG000|Overall Study|Withdrawal by Subject|6|||
25264235|NCT01231581|50578638|FG001|Overall Study|Withdrawal by Subject|9|||
25264236|NCT01231581|50578637|FG000|Overall Study|Study Closed/Terminated|6|||
25264237|NCT01231581|50578638|FG001|Overall Study|Study Closed/Terminated|5|||
25264238|NCT01231581|50578637|FG000|Overall Study|Death|65|||
25264239|NCT01231581|50578638|FG001|Overall Study|Death|64|||
25264240|NCT01231581|50578637|FG000|Overall Study|Ongoing|1|||
25264241|NCT01231581|50578638|FG001|Overall Study|Ongoing|0|||
25264242|NCT01050634|50578644|FG000|Overall Study|Enrolled, but Not Treated|56|||
25264243|NCT01050634|50578644|FG000|Overall Study|Death|2|||
25264244|NCT01050634|50578644|FG000|Overall Study|Adverse Event|42|||
25264245|NCT01050634|50578644|FG000|Overall Study|Lost to Follow-up|2|||
25264246|NCT01050634|50578644|FG000|Overall Study|Other|21|||
25264247|NCT01050634|50578644|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
25264248|NCT01020526|50578648|FG000|Overall Study|Withdrawal by Subject|5|||
25264249|NCT01020526|50578648|FG000|Overall Study|Other reasons|3|||
25264250|NCT01020526|50578648|FG000|Overall Study|Insufficient clinical response|3|||
25264251|NCT01020526|50578648|FG000|Overall Study|Lost to Follow-up|1|||
25264252|NCT01020526|50578648|FG000|Overall Study|Adverse Event|2|||
25264253|NCT01020448|50578652|FG000|Pre-assignment|Adverse Event|6|||
25264254|NCT01020448|50578652|FG000|Pre-assignment|Withdrawal by Subject|5|||
25264255|NCT01020448|50578652|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
25264256|NCT01020448|50578652|FG000|Treatment|Adverse Event|11|||
25264257|NCT01020448|50578652|FG000|Treatment|Consent Withdrawn|3|||
25264258|NCT01020448|50578652|FG000|Treatment|Disease Progression|2|||
25264259|NCT01020448|50578652|FG000|Treatment|Lack of Efficacy|8|||
25264260|NCT01020448|50578652|FG000|Treatment|Lost to Follow-up|2|||
25264261|NCT01256658|50578659|FG000|Period 1|Lost to Follow-up|837|||
25264262|NCT01256658|50578660|FG001|Period 1|Lost to Follow-up|661|||
25264263|NCT01256658|50578659|FG000|Period 1|Withdrawal by Subject|35|||
25264264|NCT01256658|50578660|FG001|Period 1|Withdrawal by Subject|43|||
25264265|NCT01256658|50578659|FG000|Period 1|Death|48|||
25264266|NCT01256658|50578660|FG001|Period 1|Death|44|||
25264267|NCT01256502|50578669|FG000|Overall Study|Had scaffold removed|4|||
25264268|NCT01256502|50578669|FG000|Overall Study|Personal reasons|5|||
25264269|NCT01256502|50578669|FG000|Overall Study|Protocol deviation|1|||
25264270|NCT01256190|50578680|FG000|Overall Study|Lost to Follow-up|2|||
25264271|NCT01256190|50578681|FG001|Overall Study|Lost to Follow-up|0|||
25264272|NCT01255722|50578690|FG000|Overall Study|Adverse Event|0|||
25264273|NCT01255722|50578691|FG001|Overall Study|Adverse Event|1|||
25264274|NCT01255722|50578692|FG002|Overall Study|Adverse Event|1|||
25264275|NCT01255722|50578690|FG000|Overall Study|asymptomatic patient|1|||
25264276|NCT01255722|50578691|FG001|Overall Study|asymptomatic patient|0|||
25264277|NCT01255722|50578692|FG002|Overall Study|asymptomatic patient|0|||
25264278|NCT01255722|50578690|FG000|Overall Study|beta-blocker contraindicated|2|||
25264279|NCT01255722|50578691|FG001|Overall Study|beta-blocker contraindicated|0|||
25264280|NCT01255722|50578692|FG002|Overall Study|beta-blocker contraindicated|0|||
25264281|NCT01231503|50578709|FG000|Overall Study|Adverse Event|0|||
25264282|NCT01231503|50578710|FG001|Overall Study|Adverse Event|0|||
25264283|NCT01231503|50578711|FG002|Overall Study|Adverse Event|0|||
25123629|NCT02276222|50236203|FG000|Overall Study|subject withdrew after randomization|1|||
25123630|NCT02276222|50236204|FG001|Overall Study|subject withdrew after randomization|0|||
25264284|NCT01231503|50578712|FG003|Overall Study|Adverse Event|0|||
25264285|NCT01231503|50578713|FG004|Overall Study|Adverse Event|0|||
25264286|NCT01231503|50578714|FG005|Overall Study|Adverse Event|1|||
25264287|NCT01231503|50578715|FG006|Overall Study|Adverse Event|0|||
25264288|NCT01231503|50578716|FG007|Overall Study|Adverse Event|0|||
25264289|NCT01231503|50578709|FG000|Overall Study|Adverse event, serious fatal|0|||
25264290|NCT01231503|50578710|FG001|Overall Study|Adverse event, serious fatal|0|||
25264291|NCT01231503|50578711|FG002|Overall Study|Adverse event, serious fatal|1|||
25264292|NCT01231503|50578712|FG003|Overall Study|Adverse event, serious fatal|1|||
25264293|NCT01231503|50578713|FG004|Overall Study|Adverse event, serious fatal|0|||
25264294|NCT01231503|50578714|FG005|Overall Study|Adverse event, serious fatal|1|||
25264295|NCT01231503|50578715|FG006|Overall Study|Adverse event, serious fatal|0|||
25264296|NCT01231503|50578716|FG007|Overall Study|Adverse event, serious fatal|0|||
25264297|NCT01231503|50578709|FG000|Overall Study|Withdrawal by Subject|6|||
25264298|NCT01231503|50578710|FG001|Overall Study|Withdrawal by Subject|3|||
25264299|NCT01231503|50578711|FG002|Overall Study|Withdrawal by Subject|3|||
25264300|NCT01231503|50578712|FG003|Overall Study|Withdrawal by Subject|1|||
25264301|NCT01231503|50578713|FG004|Overall Study|Withdrawal by Subject|3|||
25264302|NCT01231503|50578714|FG005|Overall Study|Withdrawal by Subject|5|||
25264303|NCT01231503|50578715|FG006|Overall Study|Withdrawal by Subject|1|||
25264304|NCT01231503|50578716|FG007|Overall Study|Withdrawal by Subject|2|||
25264305|NCT01231503|50578709|FG000|Overall Study|Lost to Follow-up|8|||
25264306|NCT01231503|50578710|FG001|Overall Study|Lost to Follow-up|10|||
25264307|NCT01231503|50578711|FG002|Overall Study|Lost to Follow-up|8|||
25264308|NCT01231503|50578712|FG003|Overall Study|Lost to Follow-up|5|||
25264309|NCT01231503|50578713|FG004|Overall Study|Lost to Follow-up|7|||
25264310|NCT01231503|50578714|FG005|Overall Study|Lost to Follow-up|9|||
25264311|NCT01231503|50578715|FG006|Overall Study|Lost to Follow-up|6|||
25264312|NCT01231503|50578716|FG007|Overall Study|Lost to Follow-up|6|||
25264313|NCT01231503|50578709|FG000|Overall Study|Protocol Violation|0|||
25264314|NCT01231503|50578710|FG001|Overall Study|Protocol Violation|0|||
25264315|NCT01231503|50578711|FG002|Overall Study|Protocol Violation|0|||
25264316|NCT01231503|50578712|FG003|Overall Study|Protocol Violation|1|||
25264317|NCT01231503|50578713|FG004|Overall Study|Protocol Violation|0|||
25264318|NCT01231503|50578714|FG005|Overall Study|Protocol Violation|0|||
25264319|NCT01231503|50578715|FG006|Overall Study|Protocol Violation|0|||
25264320|NCT01231503|50578716|FG007|Overall Study|Protocol Violation|0|||
25264321|NCT01230489|50578744|FG000|Overall Study|Death|2|||
25264322|NCT01230489|50578744|FG000|Overall Study|Adverse Event|2|||
25264323|NCT01230489|50578744|FG000|Overall Study|Treatment modality changed|1|||
25264324|NCT01229397|50578750|FG000|Overall Study|Withdrawal by Subject|3|||
25264325|NCT01229397|50578751|FG001|Overall Study|Withdrawal by Subject|3|||
25264326|NCT01229397|50578750|FG000|Overall Study|Lost to Follow-up|7|||
25264327|NCT01229397|50578751|FG001|Overall Study|Lost to Follow-up|6|||
25264328|NCT01229397|50578750|FG000|Overall Study|Migrated/moved from study area|1|||
25264329|NCT01229397|50578751|FG001|Overall Study|Migrated/moved from study area|0|||
25264330|NCT01228071|50578761|FG000|Overall Study|Protocol Violation|1|||
25264331|NCT01228071|50578761|FG000|Overall Study|Withdrawal by Subject|1|||
25264332|NCT01008475|50578772|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
25264333|NCT01008475|50578773|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
25264334|NCT01008475|50578774|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
25264335|NCT01008475|50578775|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
25264336|NCT01008475|50578776|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
25264337|NCT01008475|50578777|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
25264338|NCT01008475|50578778|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
25264339|NCT01226745|50578800|FG000|Overall Study|Did not complete schedule of assessments|8|||
25264340|NCT01226745|50578801|FG001|Overall Study|Did not complete schedule of assessments|3|||
25264341|NCT01226745|50578802|FG002|Overall Study|Did not complete schedule of assessments|6|||
25264342|NCT01226745|50578803|FG003|Overall Study|Did not complete schedule of assessments|0|||
25264343|NCT01226745|50578804|FG004|Overall Study|Did not complete schedule of assessments|0|||
25264344|NCT01226745|50578805|FG005|Overall Study|Did not complete schedule of assessments|1|||
25264345|NCT01226745|50578800|FG000|Overall Study|Lost to Follow-up|2|||
25264346|NCT01226745|50578801|FG001|Overall Study|Lost to Follow-up|6|||
25264347|NCT01226745|50578802|FG002|Overall Study|Lost to Follow-up|6|||
25264348|NCT01226745|50578803|FG003|Overall Study|Lost to Follow-up|1|||
25264349|NCT01226745|50578804|FG004|Overall Study|Lost to Follow-up|1|||
25264350|NCT01226745|50578805|FG005|Overall Study|Lost to Follow-up|2|||
25264351|NCT01226745|50578800|FG000|Overall Study|Death|1|||
25264352|NCT01226745|50578801|FG001|Overall Study|Death|0|||
25264353|NCT01226745|50578802|FG002|Overall Study|Death|0|||
25264354|NCT01226745|50578803|FG003|Overall Study|Death|0|||
25264355|NCT01226745|50578804|FG004|Overall Study|Death|0|||
25264356|NCT01226745|50578805|FG005|Overall Study|Death|1|||
25264357|NCT01226745|50578800|FG000|Overall Study|Other|6|||
25264358|NCT01226745|50578801|FG001|Overall Study|Other|7|||
25264359|NCT01226745|50578802|FG002|Overall Study|Other|8|||
25264360|NCT01226745|50578803|FG003|Overall Study|Other|4|||
25264361|NCT01226745|50578804|FG004|Overall Study|Other|3|||
25264362|NCT01226745|50578805|FG005|Overall Study|Other|1|||
25264363|NCT01226511|50578822|FG000|Acute Treatment Period|Adverse Event|7|||
25264364|NCT01226511|50578823|FG001|Acute Treatment Period|Adverse Event|6|||
25264365|NCT01226511|50578822|FG000|Acute Treatment Period|Lack of Efficacy|2|||
25264366|NCT01226511|50578823|FG001|Acute Treatment Period|Lack of Efficacy|1|||
25264367|NCT01226511|50578822|FG000|Acute Treatment Period|Lost to Follow-up|3|||
25264368|NCT01226511|50578823|FG001|Acute Treatment Period|Lost to Follow-up|6|||
25264369|NCT01226511|50578822|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
25264370|NCT01226511|50578823|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
25264371|NCT01226511|50578822|FG000|Acute Treatment Period|Protocol Violation|5|||
25264372|NCT01226511|50578823|FG001|Acute Treatment Period|Protocol Violation|5|||
25264373|NCT01226511|50578822|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
25264374|NCT01226511|50578823|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
25264375|NCT01226511|50578822|FG000|Extension Treatment Period|Adverse Event|8|||
25264376|NCT01226511|50578823|FG001|Extension Treatment Period|Adverse Event|8|||
25264377|NCT01226511|50578822|FG000|Extension Treatment Period|Lack of Efficacy|3|||
25264378|NCT01226511|50578823|FG001|Extension Treatment Period|Lack of Efficacy|2|||
25264379|NCT01226511|50578822|FG000|Extension Treatment Period|Lost to Follow-up|4|||
25264380|NCT01226511|50578823|FG001|Extension Treatment Period|Lost to Follow-up|3|||
25264381|NCT01226511|50578822|FG000|Extension Treatment Period|Protocol Violation|2|||
25264382|NCT01226511|50578823|FG001|Extension Treatment Period|Protocol Violation|2|||
25264383|NCT01226511|50578822|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
25264384|NCT01226511|50578823|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
25264385|NCT01226511|50578822|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
25264386|NCT01226511|50578823|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
25264387|NCT01226511|50578822|FG000|Extension Treatment Period|Sponsor Decision|1|||
25264388|NCT01226511|50578823|FG001|Extension Treatment Period|Sponsor Decision|1|||
25264389|NCT01226511|50578822|FG000|Taper Period|Adverse Event|1|||
25264390|NCT01226511|50578823|FG001|Taper Period|Adverse Event|0|||
25264391|NCT01226511|50578822|FG000|Taper Period|Lost to Follow-up|2|||
25264392|NCT01226511|50578823|FG001|Taper Period|Lost to Follow-up|2|||
25264393|NCT01226511|50578822|FG000|Taper Period|Protocol Violation|1|||
25264394|NCT01226511|50578823|FG001|Taper Period|Protocol Violation|0|||
25264395|NCT01226511|50578822|FG000|Taper Period|Parent/Caregiver Decision|1|||
25264396|NCT01226511|50578823|FG001|Taper Period|Parent/Caregiver Decision|1|||
25264397|NCT01226121|50578838|FG000|Overall Study|Lost to Follow-up|2|||
25264398|NCT01226121|50578839|FG001|Overall Study|Lost to Follow-up|0|||
25264399|NCT01226121|50578840|FG002|Overall Study|Lost to Follow-up|1|||
25264400|NCT01226043|50578850|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
25264401|NCT01226043|50578851|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
25264402|NCT01226043|50578852|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
25264403|NCT01226043|50578853|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
25264404|NCT01226043|50578850|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
25264405|NCT01226043|50578851|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
25264406|NCT01226043|50578852|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
25264407|NCT01226043|50578853|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
25264408|NCT01226043|50578850|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
25264409|NCT01226043|50578851|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
25264410|NCT01226043|50578852|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
25264411|NCT01226043|50578853|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
25264412|NCT01226043|50578850|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
25264413|NCT01226043|50578851|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
25264414|NCT01226043|50578852|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
25264415|NCT01226043|50578853|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
25264416|NCT01226043|50578850|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
25264417|NCT01226043|50578851|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
25264418|NCT01226043|50578852|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
25264419|NCT01226043|50578853|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
25264420|NCT01226043|50578850|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
25264421|NCT01226043|50578851|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
25008903|NCT03412734|50102068|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
25008904|NCT03412734|50102069|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
25008905|NCT02374814|50102081|FG000|Overall Study|Lost to Follow-up|1|||
25123631|NCT02275364|50236210|FG000|Period 1|Withdrawal by Subject|1|||
25123632|NCT02275364|50236211|FG001|Period 1|Withdrawal by Subject|0|||
25123633|NCT02275364|50236210|FG000|Period 1|Other reason|1|||
25123634|NCT02275364|50236211|FG001|Period 1|Other reason|0|||
25123635|NCT02275052|50236228|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
25123636|NCT02275052|50236229|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
25123637|NCT02275052|50236230|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
25123638|NCT02275052|50236231|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
25264422|NCT01226043|50578852|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
25264423|NCT01226043|50578853|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
25264424|NCT01226043|50578850|FG000|6-week Re-randomization Phase|Adverse Event|0|||
25123639|NCT02275052|50236228|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
25123640|NCT02275052|50236229|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
25123641|NCT02275052|50236230|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
25123642|NCT02275052|50236231|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
25123643|NCT02275052|50236228|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
25177622|NCT01523743|50321689|FG001|Period 1|Felt unable to empty bladder|0|||
25177623|NCT01523743|50321688|FG000|Period 2|Withdrawal by Subject|0|||
25177624|NCT01523743|50321689|FG001|Period 2|Withdrawal by Subject|2|||
25177625|NCT01523743|50321688|FG000|Period 2|Adverse Event|1|||
25177626|NCT01523743|50321689|FG001|Period 2|Adverse Event|0|||
25177627|NCT01496807|50321704|FG000|Overall Study|Progressive Disease|21|||
25177628|NCT01496807|50321704|FG000|Overall Study|Participant preference/toxicity|8|||
25177629|NCT01496807|50321704|FG000|Overall Study|Change in diagnosis|1|||
25177630|NCT01496183|50321710|FG000|Overall Study|Physician Decision|3|||
25177631|NCT01496183|50321711|FG001|Overall Study|Physician Decision|1|||
25177632|NCT01496183|50321710|FG000|Overall Study|Withdrawal by Subject|0|||
25264425|NCT01226043|50578851|FG001|6-week Re-randomization Phase|Adverse Event|0|||
25264426|NCT01226043|50578852|FG002|6-week Re-randomization Phase|Adverse Event|1|||
25264427|NCT01226043|50578853|FG003|6-week Re-randomization Phase|Adverse Event|1|||
25264428|NCT01226043|50578850|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
25123644|NCT02275052|50236229|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
25123645|NCT02275052|50236230|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
25123646|NCT02275052|50236231|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
25123647|NCT02275052|50236228|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
25123648|NCT02275052|50236229|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
25123649|NCT02275052|50236230|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
25123650|NCT02275052|50236231|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
25123651|NCT02275052|50236228|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
25123652|NCT02275052|50236229|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
25123653|NCT02275052|50236230|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
25123654|NCT02275052|50236231|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
25123655|NCT02275052|50236228|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
25123656|NCT02275052|50236229|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
25123657|NCT02275052|50236230|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
25123658|NCT02275052|50236231|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
25008906|NCT02374814|50102082|FG001|Overall Study|Lost to Follow-up|1|||
25123659|NCT02275052|50236228|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
25123660|NCT02275052|50236229|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
25123661|NCT02275052|50236230|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
25123662|NCT02275052|50236231|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
25123663|NCT02275052|50236228|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
25123664|NCT02275052|50236229|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
25123665|NCT02275052|50236230|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
25123666|NCT02275052|50236231|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
25123667|NCT02275052|50236228|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
25123668|NCT02275052|50236229|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
25123669|NCT02275052|50236230|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
25123670|NCT02275052|50236231|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
25123671|NCT02275052|50236228|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
25123672|NCT02275052|50236229|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
25123673|NCT02275052|50236230|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
25123674|NCT02275052|50236231|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
25123675|NCT02275052|50236228|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
25123676|NCT02275052|50236229|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
25123677|NCT02275052|50236230|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
25123678|NCT02275052|50236231|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
25123679|NCT02274038|50236237|FG000|Overall Study|Death|1|||
25123680|NCT02300558|50236243|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
25264429|NCT01226043|50578851|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
25264430|NCT01226043|50578852|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
25264431|NCT01226043|50578853|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
25264432|NCT01226043|50578850|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
25264433|NCT01226043|50578851|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
25264434|NCT01226043|50578852|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
25123681|NCT02300558|50236243|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
25264435|NCT01226043|50578853|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
25264436|NCT01226043|50578850|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
25264437|NCT01226043|50578851|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
25264438|NCT01226043|50578852|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
25264439|NCT01226043|50578853|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
25264440|NCT01226043|50578850|FG000|6-week Re-randomization Phase|Physician Decision|0|||
25264441|NCT01226043|50578851|FG001|6-week Re-randomization Phase|Physician Decision|0|||
25264442|NCT01226043|50578852|FG002|6-week Re-randomization Phase|Physician Decision|3|||
25264443|NCT01226043|50578853|FG003|6-week Re-randomization Phase|Physician Decision|2|||
25264444|NCT01226043|50578850|FG000|6-week Re-randomization Phase|completed in error|0|||
25264445|NCT01226043|50578851|FG001|6-week Re-randomization Phase|completed in error|0|||
25264446|NCT01226043|50578852|FG002|6-week Re-randomization Phase|completed in error|0|||
25264447|NCT01226043|50578853|FG003|6-week Re-randomization Phase|completed in error|1|||
25264448|NCT01226043|50578850|FG000|30-week Observational Phase|Adverse Event|0|||
25264449|NCT01226043|50578851|FG001|30-week Observational Phase|Adverse Event|0|||
25123682|NCT02300558|50236243|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
25123683|NCT02300558|50236243|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
25123684|NCT02273960|50236255|FG000|Short Term Period|Lost to Follow-up|1|||
25264450|NCT01226043|50578852|FG002|30-week Observational Phase|Adverse Event|1|||
25264451|NCT01226043|50578853|FG003|30-week Observational Phase|Adverse Event|1|||
25008907|NCT02374814|50102083|FG002|Overall Study|Lost to Follow-up|0|||
25264452|NCT01226043|50578850|FG000|30-week Observational Phase|Protocol Violation|0|||
25264453|NCT01226043|50578851|FG001|30-week Observational Phase|Protocol Violation|0|||
25264454|NCT01226043|50578852|FG002|30-week Observational Phase|Protocol Violation|0|||
25264455|NCT01226043|50578853|FG003|30-week Observational Phase|Protocol Violation|1|||
25264456|NCT01226043|50578850|FG000|30-week Observational Phase|Lost to Follow-up|0|||
25264457|NCT01226043|50578851|FG001|30-week Observational Phase|Lost to Follow-up|0|||
25264458|NCT01226043|50578852|FG002|30-week Observational Phase|Lost to Follow-up|2|||
25264459|NCT01226043|50578853|FG003|30-week Observational Phase|Lost to Follow-up|2|||
25264460|NCT01226043|50578850|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
25264461|NCT01226043|50578851|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
25264462|NCT01226043|50578852|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
25264463|NCT01226043|50578853|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
25264464|NCT01226043|50578850|FG000|30-week Observational Phase|Physician Decision|0|||
25264465|NCT01226043|50578851|FG001|30-week Observational Phase|Physician Decision|0|||
25264466|NCT01226043|50578852|FG002|30-week Observational Phase|Physician Decision|2|||
25264467|NCT01226043|50578853|FG003|30-week Observational Phase|Physician Decision|2|||
25264468|NCT01001377|50578885|FG000|Overall Study|Ineligibility determined|2|||
25264469|NCT01001377|50578886|FG001|Overall Study|Ineligibility determined|0|||
25264470|NCT01001377|50578885|FG000|Overall Study|Withdrawal by Subject|19|||
25264471|NCT01001377|50578886|FG001|Overall Study|Withdrawal by Subject|20|||
25264472|NCT01001377|50578885|FG000|Overall Study|Lost to Follow-up|14|||
25264473|NCT01001377|50578886|FG001|Overall Study|Lost to Follow-up|17|||
25264474|NCT01001377|50578885|FG000|Overall Study|Death|391|||
25264475|NCT01001377|50578886|FG001|Overall Study|Death|384|||
25264476|NCT01225887|50578892|FG000|Overall Study|Ineligible:required test not done|2|||
25264477|NCT01225887|50578892|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
25264478|NCT01225887|50578892|FG000|Overall Study|Ineligible:inadequate pathology|2|||
25264479|NCT01001299|50578896|FG000|Overall Study|Insufficient Therapeutic Response|20|||
25264480|NCT01001299|50578896|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
25264481|NCT01001299|50578896|FG000|Overall Study|Death|1|||
25264482|NCT01001299|50578896|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
25264483|NCT01001299|50578896|FG000|Overall Study|Withdrew Consent|1|||
25264484|NCT01296932|50578909|FG000|Overall Study|Dose limiting toxicity|0|||
25264485|NCT01296932|50578910|FG001|Overall Study|Dose limiting toxicity|0|||
25264486|NCT01296932|50578911|FG002|Overall Study|Dose limiting toxicity|0|||
25264487|NCT01296932|50578912|FG003|Overall Study|Dose limiting toxicity|0|||
25264488|NCT01296932|50578913|FG004|Overall Study|Dose limiting toxicity|0|||
25264489|NCT01296932|50578914|FG005|Overall Study|Dose limiting toxicity|0|||
25264490|NCT01296932|50578915|FG006|Overall Study|Dose limiting toxicity|1|||
25123685|NCT02273960|50236256|FG001|Short Term Period|Lost to Follow-up|0|||
25123686|NCT02273960|50236257|FG002|Short Term Period|Lost to Follow-up|0|||
25123687|NCT02273960|50236258|FG003|Short Term Period|Lost to Follow-up|0|||
25123688|NCT02273960|50236255|FG000|Short Term Period|Lack of Efficacy|0|||
25123689|NCT02273960|50236256|FG001|Short Term Period|Lack of Efficacy|0|||
25123690|NCT02273960|50236257|FG002|Short Term Period|Lack of Efficacy|0|||
25123691|NCT02273960|50236258|FG003|Short Term Period|Lack of Efficacy|1|||
25123692|NCT02273960|50236255|FG000|Short Term Period|ST complete, not entering LTE|4|||
25123693|NCT02273960|50236256|FG001|Short Term Period|ST complete, not entering LTE|6|||
25123694|NCT02273960|50236257|FG002|Short Term Period|ST complete, not entering LTE|4|||
25123695|NCT02273960|50236258|FG003|Short Term Period|ST complete, not entering LTE|5|||
25123696|NCT02273960|50236255|FG000|Long Term Extension|Death|0|||
25123697|NCT02273960|50236256|FG001|Long Term Extension|Death|0|||
25123698|NCT02273960|50236257|FG002|Long Term Extension|Death|0|||
25123699|NCT02273960|50236258|FG003|Long Term Extension|Death|1|||
25123700|NCT01646021|50236270|FG000|Overall Study|Death|77|||
25123701|NCT01646021|50236271|FG001|Overall Study|Death|83|||
25123702|NCT01646021|50236270|FG000|Overall Study|Study Terminated by Sponsor|50|||
25264491|NCT01296932|50578916|FG007|Overall Study|Dose limiting toxicity|0|||
25264492|NCT01296932|50578917|FG008|Overall Study|Dose limiting toxicity|1|||
25264493|NCT01296932|50578909|FG000|Overall Study|Progressive disease|2|||
25264494|NCT01296932|50578910|FG001|Overall Study|Progressive disease|0|||
25264495|NCT01296932|50578911|FG002|Overall Study|Progressive disease|1|||
25264496|NCT01296932|50578912|FG003|Overall Study|Progressive disease|1|||
25123703|NCT01646021|50236271|FG001|Overall Study|Study Terminated by Sponsor|41|||
25264497|NCT01296932|50578913|FG004|Overall Study|Progressive disease|2|||
25264498|NCT01296932|50578914|FG005|Overall Study|Progressive disease|3|||
25264499|NCT01296932|50578915|FG006|Overall Study|Progressive disease|1|||
25264500|NCT01296932|50578916|FG007|Overall Study|Progressive disease|0|||
25264501|NCT01296932|50578917|FG008|Overall Study|Progressive disease|0|||
25008908|NCT02374814|50102084|FG003|Overall Study|Lost to Follow-up|1|||
25123704|NCT01646021|50236270|FG000|Overall Study|Lost to Follow-up|2|||
25123705|NCT01646021|50236271|FG001|Overall Study|Lost to Follow-up|2|||
25123706|NCT01646021|50236270|FG000|Overall Study|Withdrawal by Subject|10|||
25264502|NCT01296932|50578909|FG000|Overall Study|Withdrawal by Subject|0|||
25264503|NCT01296932|50578910|FG001|Overall Study|Withdrawal by Subject|0|||
25264504|NCT01296932|50578911|FG002|Overall Study|Withdrawal by Subject|1|||
25264505|NCT01296932|50578912|FG003|Overall Study|Withdrawal by Subject|1|||
25264506|NCT01296932|50578913|FG004|Overall Study|Withdrawal by Subject|0|||
25264507|NCT01296932|50578914|FG005|Overall Study|Withdrawal by Subject|0|||
25264508|NCT01296932|50578915|FG006|Overall Study|Withdrawal by Subject|3|||
25264509|NCT01296932|50578916|FG007|Overall Study|Withdrawal by Subject|0|||
25264510|NCT01296932|50578917|FG008|Overall Study|Withdrawal by Subject|0|||
25264511|NCT01296932|50578909|FG000|Overall Study|Adverse Event|1|||
25264512|NCT01296932|50578910|FG001|Overall Study|Adverse Event|1|||
25264513|NCT01296932|50578911|FG002|Overall Study|Adverse Event|1|||
25264514|NCT01296932|50578912|FG003|Overall Study|Adverse Event|2|||
25264515|NCT01296932|50578913|FG004|Overall Study|Adverse Event|1|||
25264516|NCT01296932|50578914|FG005|Overall Study|Adverse Event|0|||
25264517|NCT01296932|50578915|FG006|Overall Study|Adverse Event|0|||
25264518|NCT01296932|50578916|FG007|Overall Study|Adverse Event|0|||
25264519|NCT01296932|50578917|FG008|Overall Study|Adverse Event|1|||
25264520|NCT01296932|50578909|FG000|Overall Study|Investigator decision|0|||
25264521|NCT01296932|50578910|FG001|Overall Study|Investigator decision|1|||
25264522|NCT01296932|50578911|FG002|Overall Study|Investigator decision|0|||
25264523|NCT01296932|50578912|FG003|Overall Study|Investigator decision|1|||
25264524|NCT01296932|50578913|FG004|Overall Study|Investigator decision|0|||
25264525|NCT01296932|50578914|FG005|Overall Study|Investigator decision|0|||
25264526|NCT01296932|50578915|FG006|Overall Study|Investigator decision|1|||
25264527|NCT01296932|50578916|FG007|Overall Study|Investigator decision|0|||
25264528|NCT01296932|50578917|FG008|Overall Study|Investigator decision|1|||
25264529|NCT01296932|50578909|FG000|Overall Study|No clinical benefit anymore|0|||
25264530|NCT01296932|50578910|FG001|Overall Study|No clinical benefit anymore|1|||
25264531|NCT01296932|50578911|FG002|Overall Study|No clinical benefit anymore|0|||
25264532|NCT01296932|50578912|FG003|Overall Study|No clinical benefit anymore|0|||
25008909|NCT02374814|50102085|FG004|Overall Study|Lost to Follow-up|0|||
25008910|NCT02374814|50102086|FG005|Overall Study|Lost to Follow-up|0|||
25008911|NCT02374814|50102081|FG000|Overall Study|Withdrawal by Subject|0|||
25008912|NCT02374814|50102082|FG001|Overall Study|Withdrawal by Subject|0|||
25008913|NCT02374814|50102083|FG002|Overall Study|Withdrawal by Subject|1|||
25008914|NCT02374814|50102084|FG003|Overall Study|Withdrawal by Subject|1|||
25008915|NCT02374814|50102085|FG004|Overall Study|Withdrawal by Subject|0|||
25008916|NCT02374814|50102086|FG005|Overall Study|Withdrawal by Subject|0|||
25008917|NCT04608344|50102110|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
25008918|NCT04608344|50102111|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
25008919|NCT04608344|50102110|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
25177633|NCT01496183|50321711|FG001|Overall Study|Withdrawal by Subject|1|||
25177634|NCT01495793|50321718|FG000|Overall Study|Lost to Follow-up|1|||
25177635|NCT01495793|50321718|FG000|Overall Study|Violation of inclusion criteria|1|||
25177636|NCT01494467|50321724|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
25264533|NCT01296932|50578913|FG004|Overall Study|No clinical benefit anymore|0|||
25264534|NCT01296932|50578914|FG005|Overall Study|No clinical benefit anymore|0|||
25264535|NCT01296932|50578915|FG006|Overall Study|No clinical benefit anymore|0|||
25264536|NCT01296932|50578916|FG007|Overall Study|No clinical benefit anymore|0|||
25264537|NCT01296932|50578917|FG008|Overall Study|No clinical benefit anymore|0|||
25264538|NCT01296932|50578909|FG000|Overall Study|Physician Decision|0|||
25264539|NCT01296932|50578910|FG001|Overall Study|Physician Decision|0|||
25264540|NCT01296932|50578911|FG002|Overall Study|Physician Decision|1|||
25264541|NCT01296932|50578912|FG003|Overall Study|Physician Decision|0|||
25264542|NCT01296932|50578913|FG004|Overall Study|Physician Decision|0|||
25264543|NCT01296932|50578914|FG005|Overall Study|Physician Decision|0|||
25264544|NCT01296932|50578915|FG006|Overall Study|Physician Decision|0|||
25264545|NCT01296932|50578916|FG007|Overall Study|Physician Decision|0|||
25264546|NCT01296932|50578917|FG008|Overall Study|Physician Decision|0|||
25264547|NCT01296932|50578909|FG000|Overall Study|IV problems, administration not possible|0|||
25264548|NCT01296932|50578910|FG001|Overall Study|IV problems, administration not possible|0|||
25008920|NCT04608344|50102111|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
25008921|NCT03433482|50102129|FG000|Overall Study|Lost to Follow-up|1|||
25008922|NCT03433482|50102130|FG001|Overall Study|Lost to Follow-up|0|||
25177637|NCT01494467|50321725|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
25177638|NCT01494467|50321724|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
25177639|NCT01494467|50321725|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
25177640|NCT01494467|50321724|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
25177641|NCT01494467|50321725|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
25264549|NCT01296932|50578911|FG002|Overall Study|IV problems, administration not possible|1|||
25264550|NCT01296932|50578912|FG003|Overall Study|IV problems, administration not possible|0|||
25264551|NCT01296932|50578913|FG004|Overall Study|IV problems, administration not possible|0|||
25264552|NCT01296932|50578914|FG005|Overall Study|IV problems, administration not possible|0|||
25264553|NCT01296932|50578915|FG006|Overall Study|IV problems, administration not possible|0|||
25123707|NCT01646021|50236271|FG001|Overall Study|Withdrawal by Subject|15|||
25123708|NCT01750918|50236288|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
25123709|NCT01750918|50236289|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
25123710|NCT01750918|50236290|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
25123711|NCT01750918|50236291|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
25123712|NCT01750918|50236292|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
25123713|NCT01750918|50236293|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
25123714|NCT01750918|50236294|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
25123715|NCT01750918|50236295|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
25123716|NCT01750918|50236288|FG000|Overall Study|Lost to Follow-up|0|||
25123717|NCT01750918|50236289|FG001|Overall Study|Lost to Follow-up|0|||
25123718|NCT01750918|50236290|FG002|Overall Study|Lost to Follow-up|2|||
25123719|NCT01750918|50236291|FG003|Overall Study|Lost to Follow-up|2|||
25123720|NCT01750918|50236292|FG004|Overall Study|Lost to Follow-up|0|||
25123721|NCT01750918|50236293|FG005|Overall Study|Lost to Follow-up|0|||
25123722|NCT01750918|50236294|FG006|Overall Study|Lost to Follow-up|0|||
25123723|NCT01750918|50236295|FG007|Overall Study|Lost to Follow-up|1|||
25123724|NCT01750918|50236288|FG000|Overall Study|Withdrawal by Subject|0|||
25123725|NCT01750918|50236289|FG001|Overall Study|Withdrawal by Subject|0|||
25123726|NCT01750918|50236290|FG002|Overall Study|Withdrawal by Subject|1|||
25123727|NCT01750918|50236291|FG003|Overall Study|Withdrawal by Subject|2|||
25123728|NCT01750918|50236292|FG004|Overall Study|Withdrawal by Subject|1|||
25123729|NCT01750918|50236293|FG005|Overall Study|Withdrawal by Subject|1|||
25123730|NCT01750918|50236294|FG006|Overall Study|Withdrawal by Subject|2|||
25123731|NCT01750918|50236295|FG007|Overall Study|Withdrawal by Subject|2|||
25123732|NCT02300987|50236327|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
25123733|NCT02300987|50236328|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
25123734|NCT02300987|50236327|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
25123735|NCT02300987|50236328|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
25123736|NCT02300987|50236327|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
25123737|NCT02300987|50236328|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
25123738|NCT02300987|50236327|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
25123739|NCT02300987|50236328|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
25123740|NCT02300987|50236327|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
25123741|NCT02300987|50236328|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
25123742|NCT01750840|50236335|FG000|Overall Study|Lost to Follow-up|4|||
25123743|NCT01606228|50236340|FG000|Overall Study|Lost to Follow-up|20|||
25123744|NCT01606228|50236340|FG000|Overall Study|Withdrawal by Subject|3|||
25123745|NCT01606228|50236340|FG000|Overall Study|Non-compliant|3|||
25123746|NCT01606228|50236340|FG000|Overall Study|Lack of Efficacy|2|||
25123747|NCT01606228|50236340|FG000|Overall Study|Adverse Event|1|||
25123748|NCT01706536|50236349|FG000|Overall Study|Withdrawal by Subject|1|||
25123749|NCT01706536|50236350|FG001|Overall Study|Withdrawal by Subject|0|||
25123750|NCT01706536|50236351|FG002|Overall Study|Withdrawal by Subject|1|||
25123751|NCT01706536|50236352|FG003|Overall Study|Withdrawal by Subject|0|||
25123752|NCT01706536|50236353|FG004|Overall Study|Withdrawal by Subject|0|||
25123753|NCT01706536|50236349|FG000|Overall Study|Adverse Event|2|||
25123754|NCT01706536|50236350|FG001|Overall Study|Adverse Event|3|||
25123755|NCT01706536|50236351|FG002|Overall Study|Adverse Event|4|||
25177642|NCT01494467|50321724|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
25264554|NCT01296932|50578916|FG007|Overall Study|IV problems, administration not possible|0|||
25264555|NCT01296932|50578917|FG008|Overall Study|IV problems, administration not possible|0|||
25177643|NCT01494467|50321725|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
25177644|NCT01494467|50321724|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
25177645|NCT01494467|50321725|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
25177646|NCT01494467|50321724|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
25177647|NCT01494467|50321725|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
25177648|NCT01494467|50321724|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
25177649|NCT01494467|50321725|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
25177650|NCT01494467|50321724|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
25177651|NCT01494467|50321725|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
25177652|NCT01494467|50321724|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
25177653|NCT01494467|50321725|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
25177654|NCT01494467|50321724|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
25177655|NCT01494467|50321725|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
25177656|NCT01494467|50321724|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
25264556|NCT01296932|50578909|FG000|Overall Study|per protocol|0|||
25123756|NCT01706536|50236352|FG003|Overall Study|Adverse Event|3|||
25123757|NCT01706536|50236353|FG004|Overall Study|Adverse Event|2|||
25123758|NCT01706536|50236349|FG000|Overall Study|Lack of Efficacy|1|||
25123759|NCT01706536|50236350|FG001|Overall Study|Lack of Efficacy|0|||
25264557|NCT01296932|50578910|FG001|Overall Study|per protocol|0|||
25264558|NCT01296932|50578911|FG002|Overall Study|per protocol|1|||
25264559|NCT01296932|50578912|FG003|Overall Study|per protocol|1|||
25264560|NCT01296932|50578913|FG004|Overall Study|per protocol|0|||
25264561|NCT01296932|50578914|FG005|Overall Study|per protocol|0|||
25264562|NCT01296932|50578915|FG006|Overall Study|per protocol|0|||
25264563|NCT01296932|50578916|FG007|Overall Study|per protocol|0|||
25264564|NCT01296932|50578917|FG008|Overall Study|per protocol|0|||
25264565|NCT01296932|50578909|FG000|Overall Study|Low benefit and too many side effects|0|||
25264566|NCT01296932|50578910|FG001|Overall Study|Low benefit and too many side effects|0|||
25264567|NCT01296932|50578911|FG002|Overall Study|Low benefit and too many side effects|0|||
25264568|NCT01296932|50578912|FG003|Overall Study|Low benefit and too many side effects|0|||
25264569|NCT01296932|50578913|FG004|Overall Study|Low benefit and too many side effects|0|||
25264570|NCT01296932|50578914|FG005|Overall Study|Low benefit and too many side effects|0|||
25264571|NCT01296932|50578915|FG006|Overall Study|Low benefit and too many side effects|0|||
25264572|NCT01296932|50578916|FG007|Overall Study|Low benefit and too many side effects|1|||
25264573|NCT01296932|50578917|FG008|Overall Study|Low benefit and too many side effects|0|||
25264574|NCT01296932|50578909|FG000|Overall Study|No adequate treatment response|0|||
25264575|NCT01296932|50578910|FG001|Overall Study|No adequate treatment response|0|||
25264576|NCT01296932|50578911|FG002|Overall Study|No adequate treatment response|0|||
25264577|NCT01296932|50578912|FG003|Overall Study|No adequate treatment response|0|||
25264578|NCT01296932|50578913|FG004|Overall Study|No adequate treatment response|0|||
25264579|NCT01296932|50578914|FG005|Overall Study|No adequate treatment response|0|||
25264580|NCT01296932|50578915|FG006|Overall Study|No adequate treatment response|0|||
25264581|NCT01296932|50578916|FG007|Overall Study|No adequate treatment response|1|||
25264582|NCT01296932|50578917|FG008|Overall Study|No adequate treatment response|0|||
25264583|NCT01296932|50578909|FG000|Overall Study|Dosage already reduced, AE still present|0|||
25264584|NCT01296932|50578910|FG001|Overall Study|Dosage already reduced, AE still present|0|||
25264585|NCT01296932|50578911|FG002|Overall Study|Dosage already reduced, AE still present|0|||
25264586|NCT01296932|50578912|FG003|Overall Study|Dosage already reduced, AE still present|0|||
25264587|NCT01296932|50578913|FG004|Overall Study|Dosage already reduced, AE still present|0|||
25264588|NCT01296932|50578914|FG005|Overall Study|Dosage already reduced, AE still present|0|||
25264589|NCT01296932|50578915|FG006|Overall Study|Dosage already reduced, AE still present|0|||
25264590|NCT01296932|50578916|FG007|Overall Study|Dosage already reduced, AE still present|0|||
25264591|NCT01296932|50578917|FG008|Overall Study|Dosage already reduced, AE still present|1|||
25264592|NCT01296698|50578940|FG000|Overall Study|Adverse Event|1|||
25264593|NCT01296698|50578941|FG001|Overall Study|Adverse Event|0|||
25264594|NCT01296698|50578940|FG000|Overall Study|Death|1|||
25264595|NCT01296698|50578941|FG001|Overall Study|Death|0|||
25264596|NCT01296698|50578940|FG000|Overall Study|Lost to Follow-up|19|||
25264597|NCT01296698|50578941|FG001|Overall Study|Lost to Follow-up|1|||
25264598|NCT01296698|50578940|FG000|Overall Study|Withdrawal by Subject|12|||
25264599|NCT01296698|50578941|FG001|Overall Study|Withdrawal by Subject|0|||
25264600|NCT01296698|50578940|FG000|Overall Study|Difficulty Contacting Subject|2|||
25264601|NCT01296698|50578941|FG001|Overall Study|Difficulty Contacting Subject|0|||
25264602|NCT01296698|50578940|FG000|Overall Study|Study Terminated by Sponsor|209|||
25264603|NCT01296698|50578941|FG001|Overall Study|Study Terminated by Sponsor|12|||
25264604|NCT01001221|50578951|FG000|Overall Study|Adverse Event|1|||
25264605|NCT01001221|50578952|FG001|Overall Study|Adverse Event|2|||
25264606|NCT01001221|50578953|FG002|Overall Study|Adverse Event|0|||
25264607|NCT01001221|50578954|FG003|Overall Study|Adverse Event|2|||
25264608|NCT01001221|50578955|FG004|Overall Study|Adverse Event|0|||
25264609|NCT01001221|50578951|FG000|Overall Study|Disease progression|3|||
25264610|NCT01001221|50578952|FG001|Overall Study|Disease progression|2|||
25264611|NCT01001221|50578953|FG002|Overall Study|Disease progression|2|||
25264612|NCT01001221|50578954|FG003|Overall Study|Disease progression|4|||
25264613|NCT01001221|50578955|FG004|Overall Study|Disease progression|0|||
25264614|NCT01001221|50578951|FG000|Overall Study|Other|1|||
25264615|NCT01001221|50578952|FG001|Overall Study|Other|1|||
25264616|NCT01001221|50578953|FG002|Overall Study|Other|0|||
25264617|NCT01001221|50578954|FG003|Overall Study|Other|0|||
25264618|NCT01001221|50578955|FG004|Overall Study|Other|0|||
25264619|NCT01001221|50578951|FG000|Overall Study|Not treated; protocol exclusion|0|||
25264620|NCT01001221|50578952|FG001|Overall Study|Not treated; protocol exclusion|0|||
25264621|NCT01001221|50578953|FG002|Overall Study|Not treated; protocol exclusion|1|||
25264622|NCT01001221|50578954|FG003|Overall Study|Not treated; protocol exclusion|0|||
25264623|NCT01001221|50578955|FG004|Overall Study|Not treated; protocol exclusion|0|||
25264624|NCT01296152|50578966|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
25264625|NCT01002547|50578973|FG000|Overall Study|Withdrawal by Subject|4|||
25264626|NCT01002547|50578974|FG001|Overall Study|Withdrawal by Subject|0|||
25264627|NCT01002547|50578975|FG002|Overall Study|Withdrawal by Subject|5|||
25264628|NCT01002547|50578973|FG000|Overall Study|Lost to Follow-up|2|||
25264629|NCT01002547|50578974|FG001|Overall Study|Lost to Follow-up|1|||
25264630|NCT01002547|50578975|FG002|Overall Study|Lost to Follow-up|1|||
25264631|NCT01002547|50578973|FG000|Overall Study|Physician Decision|1|||
25264632|NCT01002547|50578974|FG001|Overall Study|Physician Decision|0|||
25264633|NCT01002547|50578975|FG002|Overall Study|Physician Decision|0|||
25264634|NCT01002547|50578973|FG000|Overall Study|Death|0|||
25264635|NCT01002547|50578974|FG001|Overall Study|Death|2|||
25264636|NCT01002547|50578975|FG002|Overall Study|Death|2|||
25264637|NCT01002547|50578973|FG000|Overall Study|Adverse Event|1|||
25264638|NCT01002547|50578974|FG001|Overall Study|Adverse Event|0|||
25264639|NCT01002547|50578975|FG002|Overall Study|Adverse Event|0|||
25264640|NCT01225731|50578988|FG000|Part 1|Did not meet eligibility criteria|1|||
25264641|NCT01225731|50578989|FG001|Part 1|Did not meet eligibility criteria|0|||
25264642|NCT01225731|50578990|FG002|Part 1|Did not meet eligibility criteria|0|||
25264643|NCT01225731|50578991|FG003|Part 1|Did not meet eligibility criteria|0|||
25264644|NCT01225731|50578992|FG004|Part 1|Did not meet eligibility criteria|1|||
25264645|NCT01225731|50578993|FG005|Part 1|Did not meet eligibility criteria|0|||
25264646|NCT01225731|50578994|FG006|Part 1|Did not meet eligibility criteria|0|||
25264647|NCT01225731|50578995|FG007|Part 1|Did not meet eligibility criteria|0|||
25264648|NCT01225731|50578996|FG008|Part 1|Did not meet eligibility criteria|0|||
25264649|NCT01225731|50578997|FG009|Part 1|Did not meet eligibility criteria|0|||
25264650|NCT01225731|50578998|FG010|Part 1|Did not meet eligibility criteria|0|||
25264651|NCT01225731|50578999|FG011|Part 1|Did not meet eligibility criteria|0|||
25264652|NCT01225731|50579000|FG012|Part 1|Did not meet eligibility criteria|0|||
25264653|NCT01225731|50578988|FG000|Part 1|Adverse Event|1|||
25264654|NCT01225731|50578989|FG001|Part 1|Adverse Event|2|||
25264655|NCT01225731|50578990|FG002|Part 1|Adverse Event|1|||
25264656|NCT01225731|50578991|FG003|Part 1|Adverse Event|1|||
25264657|NCT01225731|50578992|FG004|Part 1|Adverse Event|1|||
25264658|NCT01225731|50578993|FG005|Part 1|Adverse Event|0|||
25264659|NCT01225731|50578994|FG006|Part 1|Adverse Event|0|||
25264660|NCT01225731|50578995|FG007|Part 1|Adverse Event|0|||
25264661|NCT01225731|50578996|FG008|Part 1|Adverse Event|0|||
25264662|NCT01225731|50578997|FG009|Part 1|Adverse Event|0|||
25264663|NCT01225731|50578998|FG010|Part 1|Adverse Event|0|||
25264664|NCT01225731|50578999|FG011|Part 1|Adverse Event|0|||
25264665|NCT01225731|50579000|FG012|Part 1|Adverse Event|0|||
25264666|NCT01225731|50578988|FG000|Part 1|Withdrawal by Subject|0|||
25264667|NCT01225731|50578989|FG001|Part 1|Withdrawal by Subject|3|||
25264668|NCT01225731|50578990|FG002|Part 1|Withdrawal by Subject|0|||
25264669|NCT01225731|50578991|FG003|Part 1|Withdrawal by Subject|0|||
25264670|NCT01225731|50578992|FG004|Part 1|Withdrawal by Subject|4|||
25264671|NCT01225731|50578993|FG005|Part 1|Withdrawal by Subject|0|||
25264672|NCT01225731|50578994|FG006|Part 1|Withdrawal by Subject|0|||
25264673|NCT01225731|50578995|FG007|Part 1|Withdrawal by Subject|0|||
25264674|NCT01225731|50578996|FG008|Part 1|Withdrawal by Subject|0|||
25264675|NCT01225731|50578997|FG009|Part 1|Withdrawal by Subject|0|||
25264676|NCT01225731|50578998|FG010|Part 1|Withdrawal by Subject|0|||
25264677|NCT01225731|50578999|FG011|Part 1|Withdrawal by Subject|0|||
25264678|NCT01225731|50579000|FG012|Part 1|Withdrawal by Subject|0|||
25264679|NCT01225731|50578988|FG000|Part 1|Protocol Violation|0|||
25264680|NCT01225731|50578989|FG001|Part 1|Protocol Violation|0|||
25264681|NCT01225731|50578990|FG002|Part 1|Protocol Violation|0|||
25264682|NCT01225731|50578991|FG003|Part 1|Protocol Violation|1|||
25264683|NCT01225731|50578992|FG004|Part 1|Protocol Violation|0|||
25264684|NCT01225731|50578993|FG005|Part 1|Protocol Violation|0|||
25264685|NCT01225731|50578994|FG006|Part 1|Protocol Violation|0|||
25264686|NCT01225731|50578995|FG007|Part 1|Protocol Violation|0|||
25264687|NCT01225731|50578996|FG008|Part 1|Protocol Violation|0|||
25264688|NCT01225731|50578997|FG009|Part 1|Protocol Violation|0|||
25264689|NCT01225731|50578998|FG010|Part 1|Protocol Violation|0|||
25264690|NCT01225731|50578999|FG011|Part 1|Protocol Violation|0|||
25264691|NCT01225731|50579000|FG012|Part 1|Protocol Violation|0|||
25264692|NCT01225731|50578988|FG000|Part 2|Protocol Violation|0|||
25264693|NCT01225731|50578989|FG001|Part 2|Protocol Violation|0|||
25264694|NCT01225731|50578990|FG002|Part 2|Protocol Violation|0|||
25264695|NCT01225731|50578991|FG003|Part 2|Protocol Violation|0|||
25264696|NCT01225731|50578992|FG004|Part 2|Protocol Violation|0|||
25264697|NCT01225731|50578993|FG005|Part 2|Protocol Violation|1|||
25264698|NCT01225731|50578994|FG006|Part 2|Protocol Violation|0|||
25264699|NCT01225731|50578995|FG007|Part 2|Protocol Violation|0|||
25264700|NCT01225731|50578996|FG008|Part 2|Protocol Violation|1|||
25264701|NCT01225731|50578997|FG009|Part 2|Protocol Violation|0|||
25264702|NCT01225731|50578998|FG010|Part 2|Protocol Violation|0|||
25264703|NCT01225731|50578999|FG011|Part 2|Protocol Violation|0|||
25264704|NCT01225731|50579000|FG012|Part 2|Protocol Violation|0|||
25264705|NCT01225731|50578988|FG000|Part 2|Adverse Event|0|||
25264706|NCT01225731|50578989|FG001|Part 2|Adverse Event|0|||
25264707|NCT01225731|50578990|FG002|Part 2|Adverse Event|0|||
25264708|NCT01225731|50578991|FG003|Part 2|Adverse Event|0|||
25264709|NCT01225731|50578992|FG004|Part 2|Adverse Event|0|||
25264710|NCT01225731|50578993|FG005|Part 2|Adverse Event|0|||
25264711|NCT01225731|50578994|FG006|Part 2|Adverse Event|4|||
25264712|NCT01225731|50578995|FG007|Part 2|Adverse Event|4|||
25264713|NCT01225731|50578996|FG008|Part 2|Adverse Event|2|||
25264714|NCT01225731|50578997|FG009|Part 2|Adverse Event|0|||
25264715|NCT01225731|50578998|FG010|Part 2|Adverse Event|0|||
25264716|NCT01225731|50578999|FG011|Part 2|Adverse Event|0|||
25264717|NCT01225731|50579000|FG012|Part 2|Adverse Event|0|||
25264718|NCT01225731|50578988|FG000|Part 2|Lack of Efficacy|0|||
25264719|NCT01225731|50578989|FG001|Part 2|Lack of Efficacy|0|||
25264720|NCT01225731|50578990|FG002|Part 2|Lack of Efficacy|0|||
25264721|NCT01225731|50578991|FG003|Part 2|Lack of Efficacy|0|||
25264722|NCT01225731|50578992|FG004|Part 2|Lack of Efficacy|0|||
25264723|NCT01225731|50578993|FG005|Part 2|Lack of Efficacy|1|||
25264724|NCT01225731|50578994|FG006|Part 2|Lack of Efficacy|0|||
25264725|NCT01225731|50578995|FG007|Part 2|Lack of Efficacy|12|||
25264726|NCT01225731|50578996|FG008|Part 2|Lack of Efficacy|3|||
25264727|NCT01225731|50578997|FG009|Part 2|Lack of Efficacy|0|||
25264728|NCT01225731|50578998|FG010|Part 2|Lack of Efficacy|0|||
25264729|NCT01225731|50578999|FG011|Part 2|Lack of Efficacy|0|||
25264730|NCT01225731|50579000|FG012|Part 2|Lack of Efficacy|0|||
25264731|NCT01225731|50578988|FG000|Part 2|Pregnancy|0|||
25264732|NCT01225731|50578989|FG001|Part 2|Pregnancy|0|||
25264733|NCT01225731|50578990|FG002|Part 2|Pregnancy|0|||
25264734|NCT01225731|50578991|FG003|Part 2|Pregnancy|0|||
25264735|NCT01225731|50578992|FG004|Part 2|Pregnancy|0|||
25264736|NCT01225731|50578993|FG005|Part 2|Pregnancy|0|||
25264737|NCT01225731|50578994|FG006|Part 2|Pregnancy|1|||
25264738|NCT01225731|50578995|FG007|Part 2|Pregnancy|0|||
25264739|NCT01225731|50578996|FG008|Part 2|Pregnancy|1|||
25264740|NCT01225731|50578997|FG009|Part 2|Pregnancy|0|||
25264741|NCT01225731|50578998|FG010|Part 2|Pregnancy|0|||
25264742|NCT01225731|50578999|FG011|Part 2|Pregnancy|0|||
25264743|NCT01225731|50579000|FG012|Part 2|Pregnancy|0|||
25264744|NCT01225731|50578988|FG000|Part 2|Lost to Follow-up|0|||
25264745|NCT01225731|50578989|FG001|Part 2|Lost to Follow-up|0|||
25264746|NCT01225731|50578990|FG002|Part 2|Lost to Follow-up|0|||
25264747|NCT01225731|50578991|FG003|Part 2|Lost to Follow-up|0|||
25264748|NCT01225731|50578992|FG004|Part 2|Lost to Follow-up|0|||
25264749|NCT01225731|50578993|FG005|Part 2|Lost to Follow-up|0|||
25264750|NCT01225731|50578994|FG006|Part 2|Lost to Follow-up|0|||
25264751|NCT01225731|50578995|FG007|Part 2|Lost to Follow-up|3|||
25264752|NCT01225731|50578996|FG008|Part 2|Lost to Follow-up|1|||
25264753|NCT01225731|50578997|FG009|Part 2|Lost to Follow-up|0|||
25264754|NCT01225731|50578998|FG010|Part 2|Lost to Follow-up|0|||
25264755|NCT01225731|50578999|FG011|Part 2|Lost to Follow-up|0|||
25264756|NCT01225731|50579000|FG012|Part 2|Lost to Follow-up|0|||
25264757|NCT01225731|50578988|FG000|Part 2|Physician Decision|0|||
25264758|NCT01225731|50578989|FG001|Part 2|Physician Decision|0|||
25264759|NCT01225731|50578990|FG002|Part 2|Physician Decision|0|||
25264760|NCT01225731|50578991|FG003|Part 2|Physician Decision|0|||
25264761|NCT01225731|50578992|FG004|Part 2|Physician Decision|0|||
25264762|NCT01225731|50578993|FG005|Part 2|Physician Decision|0|||
25264763|NCT01225731|50578994|FG006|Part 2|Physician Decision|0|||
25264764|NCT01225731|50578995|FG007|Part 2|Physician Decision|2|||
25264765|NCT01225731|50578996|FG008|Part 2|Physician Decision|2|||
25264766|NCT01225731|50578997|FG009|Part 2|Physician Decision|0|||
25264767|NCT01225731|50578998|FG010|Part 2|Physician Decision|0|||
25264768|NCT01225731|50578999|FG011|Part 2|Physician Decision|0|||
25264769|NCT01225731|50579000|FG012|Part 2|Physician Decision|0|||
25008923|NCT03433482|50102131|FG002|Overall Study|Lost to Follow-up|1|||
25008924|NCT03433482|50102132|FG003|Overall Study|Lost to Follow-up|1|||
25264770|NCT01225731|50578988|FG000|Part 2|Withdrawal by Subject|0|||
25264771|NCT01225731|50578989|FG001|Part 2|Withdrawal by Subject|0|||
25264772|NCT01225731|50578990|FG002|Part 2|Withdrawal by Subject|0|||
25264773|NCT01225731|50578991|FG003|Part 2|Withdrawal by Subject|0|||
25264774|NCT01225731|50578992|FG004|Part 2|Withdrawal by Subject|0|||
25264775|NCT01225731|50578993|FG005|Part 2|Withdrawal by Subject|1|||
25264776|NCT01225731|50578994|FG006|Part 2|Withdrawal by Subject|3|||
25264777|NCT01225731|50578995|FG007|Part 2|Withdrawal by Subject|4|||
25264778|NCT01225731|50578996|FG008|Part 2|Withdrawal by Subject|1|||
25264779|NCT01225731|50578997|FG009|Part 2|Withdrawal by Subject|0|||
25264780|NCT01225731|50578998|FG010|Part 2|Withdrawal by Subject|0|||
25264781|NCT01225731|50578999|FG011|Part 2|Withdrawal by Subject|0|||
25264782|NCT01225731|50579000|FG012|Part 2|Withdrawal by Subject|0|||
25264783|NCT01225731|50578988|FG000|Part 3|Adverse Event|0|||
25264784|NCT01225731|50578989|FG001|Part 3|Adverse Event|0|||
25264785|NCT01225731|50578990|FG002|Part 3|Adverse Event|0|||
25264786|NCT01225731|50578991|FG003|Part 3|Adverse Event|0|||
25264787|NCT01225731|50578992|FG004|Part 3|Adverse Event|0|||
25264788|NCT01225731|50578993|FG005|Part 3|Adverse Event|0|||
25264789|NCT01225731|50578994|FG006|Part 3|Adverse Event|0|||
25264790|NCT01225731|50578995|FG007|Part 3|Adverse Event|0|||
25264791|NCT01225731|50578996|FG008|Part 3|Adverse Event|0|||
25264792|NCT01225731|50578997|FG009|Part 3|Adverse Event|0|||
25264793|NCT01225731|50578998|FG010|Part 3|Adverse Event|1|||
25264794|NCT01225731|50578999|FG011|Part 3|Adverse Event|1|||
25264795|NCT01225731|50579000|FG012|Part 3|Adverse Event|0|||
25264796|NCT01225731|50578988|FG000|Part 3|Lost to Follow-up|0|||
25264797|NCT01225731|50578989|FG001|Part 3|Lost to Follow-up|0|||
25264798|NCT01225731|50578990|FG002|Part 3|Lost to Follow-up|0|||
25264799|NCT01225731|50578991|FG003|Part 3|Lost to Follow-up|0|||
25264800|NCT01225731|50578992|FG004|Part 3|Lost to Follow-up|0|||
25264801|NCT01225731|50578993|FG005|Part 3|Lost to Follow-up|0|||
25264802|NCT01225731|50578994|FG006|Part 3|Lost to Follow-up|0|||
25264803|NCT01225731|50578995|FG007|Part 3|Lost to Follow-up|0|||
25264804|NCT01225731|50578996|FG008|Part 3|Lost to Follow-up|0|||
25264805|NCT01225731|50578997|FG009|Part 3|Lost to Follow-up|0|||
25264806|NCT01225731|50578998|FG010|Part 3|Lost to Follow-up|1|||
25264807|NCT01225731|50578999|FG011|Part 3|Lost to Follow-up|2|||
25264808|NCT01225731|50579000|FG012|Part 3|Lost to Follow-up|1|||
25264809|NCT01225731|50578988|FG000|Part 3|Physician Decision|0|||
25264810|NCT01225731|50578989|FG001|Part 3|Physician Decision|0|||
25264811|NCT01225731|50578990|FG002|Part 3|Physician Decision|0|||
25264812|NCT01225731|50578991|FG003|Part 3|Physician Decision|0|||
25264813|NCT01225731|50578992|FG004|Part 3|Physician Decision|0|||
25264814|NCT01225731|50578993|FG005|Part 3|Physician Decision|0|||
25264815|NCT01225731|50578994|FG006|Part 3|Physician Decision|0|||
25264816|NCT01225731|50578995|FG007|Part 3|Physician Decision|0|||
25264817|NCT01225731|50578996|FG008|Part 3|Physician Decision|0|||
25264818|NCT01225731|50578997|FG009|Part 3|Physician Decision|0|||
25264819|NCT01225731|50578998|FG010|Part 3|Physician Decision|0|||
25264820|NCT01225731|50578999|FG011|Part 3|Physician Decision|1|||
25264821|NCT01225731|50579000|FG012|Part 3|Physician Decision|2|||
25264822|NCT01225731|50578988|FG000|Part 3|Withdrawal by Subject|0|||
25264823|NCT01225731|50578989|FG001|Part 3|Withdrawal by Subject|0|||
25264824|NCT01225731|50578990|FG002|Part 3|Withdrawal by Subject|0|||
25264825|NCT01225731|50578991|FG003|Part 3|Withdrawal by Subject|0|||
25264826|NCT01225731|50578992|FG004|Part 3|Withdrawal by Subject|0|||
25264827|NCT01225731|50578993|FG005|Part 3|Withdrawal by Subject|0|||
25264828|NCT01225731|50578994|FG006|Part 3|Withdrawal by Subject|0|||
25264829|NCT01225731|50578995|FG007|Part 3|Withdrawal by Subject|0|||
25264830|NCT01225731|50578996|FG008|Part 3|Withdrawal by Subject|0|||
25264831|NCT01225731|50578997|FG009|Part 3|Withdrawal by Subject|0|||
25264832|NCT01225731|50578998|FG010|Part 3|Withdrawal by Subject|4|||
25264833|NCT01225731|50578999|FG011|Part 3|Withdrawal by Subject|6|||
25264834|NCT01225731|50579000|FG012|Part 3|Withdrawal by Subject|4|||
25264835|NCT01007149|50579031|FG000|Overall Study|Administrative problems|0|||
25264836|NCT01007149|50579032|FG001|Overall Study|Administrative problems|1|||
25264837|NCT00998335|50579040|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
25264838|NCT00998335|50579041|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
25264839|NCT01294670|50579058|FG000|Overall Study|Not treated|1|||
25264840|NCT01294670|50579059|FG001|Overall Study|Not treated|0|||
25264841|NCT01294670|50579060|FG002|Overall Study|Not treated|0|||
25264842|NCT01294670|50579061|FG003|Overall Study|Not treated|0|||
25264843|NCT01294670|50579062|FG004|Overall Study|Not treated|0|||
25264844|NCT01006603|50579076|FG000|Overall Study|Withdrawal by Subject|17|||
25264845|NCT01006603|50579077|FG001|Overall Study|Withdrawal by Subject|19|||
25264846|NCT01006603|50579076|FG000|Overall Study|Lost to Follow-up|0|||
25264847|NCT01006603|50579077|FG001|Overall Study|Lost to Follow-up|1|||
25264848|NCT01006603|50579076|FG000|Overall Study|Safety reason|1|||
25264849|NCT01006603|50579077|FG001|Overall Study|Safety reason|1|||
25264850|NCT01006603|50579076|FG000|Overall Study|Protocol Violation|1|||
25264851|NCT01006603|50579077|FG001|Overall Study|Protocol Violation|3|||
25264852|NCT01006603|50579076|FG000|Overall Study|Incorrect enrolment|0|||
25264853|NCT01006603|50579077|FG001|Overall Study|Incorrect enrolment|2|||
25264854|NCT01006603|50579076|FG000|Overall Study|Adverse Event|15|||
25264855|NCT01006603|50579077|FG001|Overall Study|Adverse Event|7|||
25264856|NCT01006603|50579076|FG000|Overall Study|Death|1|||
25264857|NCT01006603|50579077|FG001|Overall Study|Death|1|||
25264858|NCT01006603|50579076|FG000|Overall Study|Study specific discontinuation criteria|33|||
25264859|NCT01006603|50579077|FG001|Overall Study|Study specific discontinuation criteria|34|||
25264860|NCT01006603|50579076|FG000|Overall Study|Other|3|||
25264861|NCT01006603|50579077|FG001|Overall Study|Other|7|||
25264862|NCT00997321|50579085|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
25264863|NCT00997321|50579086|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
25264864|NCT01294592|50579100|FG000|Overall Study|Adverse Event|28|||
25264865|NCT01294592|50579101|FG001|Overall Study|Adverse Event|13|||
25264866|NCT01294592|50579100|FG000|Overall Study|Lack of Efficacy|7|||
25264867|NCT01294592|50579101|FG001|Overall Study|Lack of Efficacy|5|||
25123760|NCT01706536|50236351|FG002|Overall Study|Lack of Efficacy|0|||
25123761|NCT01706536|50236352|FG003|Overall Study|Lack of Efficacy|1|||
25264868|NCT01294592|50579100|FG000|Overall Study|Protocol Violation|1|||
25264869|NCT01294592|50579101|FG001|Overall Study|Protocol Violation|7|||
25264870|NCT01294592|50579100|FG000|Overall Study|Lost to Follow-up|7|||
25264871|NCT01294592|50579101|FG001|Overall Study|Lost to Follow-up|9|||
25264872|NCT01294592|50579100|FG000|Overall Study|Physician Decision|6|||
25264873|NCT01294592|50579101|FG001|Overall Study|Physician Decision|11|||
25264874|NCT01294592|50579100|FG000|Overall Study|Withdrawal by Subject|28|||
25264875|NCT01294592|50579101|FG001|Overall Study|Withdrawal by Subject|28|||
25264876|NCT00997243|50579110|FG000|Overall Study|Early termination of study by sponsor|7|||
25264877|NCT01294514|50579114|FG000|Overall Study|Excluded due to Arrhythmia|1|||
25264878|NCT00999661|50579122|FG000|Overall Study|Lost to Follow-up|59|||
25264879|NCT00999661|50579122|FG000|Overall Study|Adverse Event|1|||
25264880|NCT00999661|50579122|FG000|Overall Study|Withdrawal by Subject|1|||
25264881|NCT00999661|50579122|FG000|Overall Study|Not meeting eligibility criteria|9|||
25264882|NCT01294436|50579128|FG000|Overall Study|Adverse Event|10|||
25264883|NCT01294436|50579129|FG001|Overall Study|Adverse Event|17|||
25264884|NCT01294436|50579128|FG000|Overall Study|Withdrawal by Subject|11|||
25264885|NCT01294436|50579129|FG001|Overall Study|Withdrawal by Subject|28|||
25264886|NCT01294436|50579128|FG000|Overall Study|subject no longer meets study criteria|5|||
25264887|NCT01294436|50579129|FG001|Overall Study|subject no longer meets study criteria|20|||
25264888|NCT01294436|50579128|FG000|Overall Study|poor/non-compliance|2|||
25264889|NCT01294436|50579129|FG001|Overall Study|poor/non-compliance|5|||
25264890|NCT00995371|50579137|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
25264891|NCT00995371|50579138|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
25264892|NCT01294358|50579146|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
25264893|NCT01294358|50579147|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
25264894|NCT01294358|50579148|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
25264895|NCT01294358|50579149|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
25264896|NCT01294358|50579150|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
25264897|NCT01294358|50579146|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
25264898|NCT01294358|50579147|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
25264899|NCT01294358|50579148|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
25264900|NCT01294358|50579149|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
25264901|NCT01294358|50579150|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
25264902|NCT01294358|50579146|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
25264903|NCT01294358|50579147|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
25264904|NCT01294358|50579148|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
25264905|NCT01294358|50579149|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
25264906|NCT01294358|50579150|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
25264907|NCT01294358|50579146|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
25264908|NCT01294358|50579147|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
25264909|NCT01294358|50579148|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
25264910|NCT01294358|50579149|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
25264911|NCT01294358|50579150|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
25264912|NCT00994279|50579169|FG000|Overall Study|Withdrawal by Subject|2|||
25264913|NCT00994279|50579170|FG001|Overall Study|Withdrawal by Subject|2|||
25264914|NCT00994279|50579169|FG000|Overall Study|Toxicity|1|||
25264915|NCT00994279|50579170|FG001|Overall Study|Toxicity|0|||
25264916|NCT00994279|50579169|FG000|Overall Study|Multiple reasons|1|||
25264917|NCT00994279|50579170|FG001|Overall Study|Multiple reasons|3|||
25264918|NCT01294046|50579176|FG000|Overall Study|Infection and surgical explant|1|||
25264919|NCT01294046|50579176|FG000|Overall Study|Eligibility criteria expanded|1|||
25264920|NCT01294046|50579176|FG000|Overall Study|Stimulation response inadqequate|1|||
25264921|NCT01224639|50579191|FG000|Overall Study|Withdrawal by Subject|0|||
25264922|NCT01224639|50579192|FG001|Overall Study|Withdrawal by Subject|0|||
25264923|NCT01224639|50579193|FG002|Overall Study|Withdrawal by Subject|0|||
25264924|NCT01224639|50579194|FG003|Overall Study|Withdrawal by Subject|0|||
25264925|NCT01224639|50579195|FG004|Overall Study|Withdrawal by Subject|2|||
25264926|NCT01224639|50579196|FG005|Overall Study|Withdrawal by Subject|0|||
25264927|NCT01224639|50579197|FG006|Overall Study|Withdrawal by Subject|1|||
25264928|NCT01224639|50579198|FG007|Overall Study|Withdrawal by Subject|1|||
25264929|NCT01224639|50579191|FG000|Overall Study|Adverse Event|0|||
25264930|NCT01224639|50579192|FG001|Overall Study|Adverse Event|0|||
25264931|NCT01224639|50579193|FG002|Overall Study|Adverse Event|0|||
25264932|NCT01224639|50579194|FG003|Overall Study|Adverse Event|0|||
25264933|NCT01224639|50579195|FG004|Overall Study|Adverse Event|0|||
25264934|NCT01224639|50579196|FG005|Overall Study|Adverse Event|0|||
25264935|NCT01224639|50579197|FG006|Overall Study|Adverse Event|0|||
25264936|NCT01224639|50579198|FG007|Overall Study|Adverse Event|1|||
25264937|NCT01293968|50579218|FG000|Overall Study|non-cooperation|3|||
25264938|NCT01293968|50579219|FG001|Overall Study|non-cooperation|3|||
25264939|NCT01293032|50579229|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
25264940|NCT01293032|50579230|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
25264941|NCT01293032|50579231|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
25264942|NCT01293032|50579232|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
25264943|NCT01293032|50579229|FG000|Treatment|Adverse Event|0|||
25264944|NCT01293032|50579230|FG001|Treatment|Adverse Event|0|||
25264945|NCT01293032|50579231|FG002|Treatment|Adverse Event|1|||
25264946|NCT01293032|50579232|FG003|Treatment|Adverse Event|1|||
25264947|NCT01293032|50579229|FG000|Treatment|Withdrawal by Subject|2|||
25264948|NCT01293032|50579230|FG001|Treatment|Withdrawal by Subject|4|||
25264949|NCT01293032|50579231|FG002|Treatment|Withdrawal by Subject|0|||
25264950|NCT01293032|50579232|FG003|Treatment|Withdrawal by Subject|0|||
25264951|NCT01293032|50579229|FG000|Treatment|Disease Progression, relapse|0|||
25264952|NCT01293032|50579230|FG001|Treatment|Disease Progression, relapse|1|||
25264953|NCT01293032|50579231|FG002|Treatment|Disease Progression, relapse|0|||
25264954|NCT01293032|50579232|FG003|Treatment|Disease Progression, relapse|0|||
25264955|NCT01292876|50579239|FG000|Overall Study|Physician Decision|4|||
25264956|NCT01224171|50579247|FG000|Overall Study|Adverse Event|8|||
25264957|NCT01224171|50579248|FG001|Overall Study|Adverse Event|4|||
25264958|NCT01224171|50579247|FG000|Overall Study|Protocol Violation|0|||
25264959|NCT01224171|50579248|FG001|Overall Study|Protocol Violation|1|||
25123762|NCT01706536|50236353|FG004|Overall Study|Lack of Efficacy|0|||
25264960|NCT01224171|50579247|FG000|Overall Study|Lack of Efficacy|5|||
25264961|NCT01224171|50579248|FG001|Overall Study|Lack of Efficacy|1|||
25264962|NCT01224171|50579247|FG000|Overall Study|Withdrawal of Consent|2|||
25264963|NCT01224171|50579248|FG001|Overall Study|Withdrawal of Consent|4|||
25264964|NCT01224171|50579247|FG000|Overall Study|Lost to Follow-up|0|||
25264965|NCT01224171|50579248|FG001|Overall Study|Lost to Follow-up|3|||
25264966|NCT01292486|50579254|FG000|Overall Study|Protocol Violation|2|||
25264967|NCT01292486|50579254|FG000|Overall Study|Did not meet screening criteria|2|||
25264968|NCT01292486|50579254|FG000|Overall Study|Adverse Event|1|||
25123763|NCT01706536|50236349|FG000|Overall Study|non compliance|0|||
25123764|NCT01706536|50236350|FG001|Overall Study|non compliance|1|||
25123765|NCT01706536|50236351|FG002|Overall Study|non compliance|0|||
25264969|NCT01292486|50579254|FG000|Overall Study|Physician Decision|1|||
25264970|NCT01223937|50579261|FG000|Overall Study|Withdrawal by Subject|3|||
25264971|NCT01223937|50579262|FG001|Overall Study|Withdrawal by Subject|2|||
25264972|NCT01223937|50579261|FG000|Overall Study|Lost to Follow-up|1|||
25264973|NCT01223937|50579262|FG001|Overall Study|Lost to Follow-up|4|||
25264974|NCT01223937|50579261|FG000|Overall Study|Adverse Event|1|||
25264975|NCT01223937|50579262|FG001|Overall Study|Adverse Event|4|||
25264976|NCT01223937|50579261|FG000|Overall Study|Protocol Violation|8|||
25264977|NCT01223937|50579262|FG001|Overall Study|Protocol Violation|7|||
25264978|NCT01223937|50579261|FG000|Overall Study|Other|4|||
25264979|NCT01223937|50579262|FG001|Overall Study|Other|1|||
25264980|NCT01290224|50579268|FG000|Overall Study|Adverse Event|1|||
25264981|NCT01290224|50579268|FG000|Overall Study|Refused Further Treatment|4|||
25264982|NCT01223235|50579274|FG000|Overall Study|Withdrawal by Subject|1|||
25264983|NCT01290068|50579280|FG000|Overall Study|Adverse Event|1|||
25264984|NCT01290068|50579281|FG001|Overall Study|Adverse Event|3|||
25264985|NCT01290068|50579280|FG000|Overall Study|Lost to Follow-up|3|||
25264986|NCT01290068|50579281|FG001|Overall Study|Lost to Follow-up|0|||
25264987|NCT01290068|50579280|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
25264988|NCT01290068|50579281|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
25264989|NCT01290068|50579280|FG000|Overall Study|Other|3|||
25264990|NCT01290068|50579281|FG001|Overall Study|Other|1|||
25264991|NCT00998881|50579289|FG000|Overall Study|Adverse Event|2|||
25264992|NCT00998881|50579290|FG001|Overall Study|Adverse Event|2|||
25264993|NCT00998881|50579289|FG000|Overall Study|Lack of Efficacy|1|||
25264994|NCT00998881|50579290|FG001|Overall Study|Lack of Efficacy|0|||
25264995|NCT00998881|50579289|FG000|Overall Study|Physician Decision|3|||
25264996|NCT00998881|50579290|FG001|Overall Study|Physician Decision|0|||
25264997|NCT00998881|50579289|FG000|Overall Study|Withdrawal by Subject|1|||
25264998|NCT00998881|50579290|FG001|Overall Study|Withdrawal by Subject|0|||
25123766|NCT01706536|50236352|FG003|Overall Study|non compliance|0|||
25123767|NCT01706536|50236353|FG004|Overall Study|non compliance|0|||
25264999|NCT00998881|50579289|FG000|Overall Study|Personal matter|1|||
25265000|NCT00998881|50579290|FG001|Overall Study|Personal matter|0|||
25265001|NCT01222767|50579296|FG000|Overall Study|Progressive disease|13|||
25265002|NCT01222767|50579296|FG000|Overall Study|Adverse Event|2|||
25265003|NCT01222767|50579296|FG000|Overall Study|Surgical resection|1|||
25265004|NCT01222767|50579296|FG000|Overall Study|Never treated|1|||
25265005|NCT00993967|50579300|FG000|Overall Study|Adverse Event|8|||
25265006|NCT00993967|50579300|FG000|Overall Study|Death|1|||
25123768|NCT02269943|50236368|FG000|Treatment Period|Death|0|||
25123769|NCT02269943|50236369|FG001|Treatment Period|Death|1|||
25265007|NCT00993967|50579300|FG000|Overall Study|Lost to Follow-up|14|||
25265008|NCT00993967|50579300|FG000|Overall Study|Withdrawal by Subject|36|||
25265009|NCT00993967|50579300|FG000|Overall Study|Protocol Violation|2|||
25265010|NCT01222533|50579304|FG000|Overall Study|Adverse Event|5|||
25265011|NCT01222533|50579304|FG000|Overall Study|Withdrawal by Subject|5|||
25265012|NCT01222533|50579304|FG000|Overall Study|Other|4|||
25265013|NCT01221753|50579316|FG000|Overall Study|Adverse Event|1|||
25265014|NCT01221597|50579322|FG000|Overall Study|Adverse Event|4|||
25265015|NCT01221597|50579323|FG001|Overall Study|Adverse Event|1|||
25265016|NCT01221597|50579322|FG000|Overall Study|Withdrawal by Subject|20|||
25265017|NCT01221597|50579323|FG001|Overall Study|Withdrawal by Subject|6|||
25265018|NCT01221597|50579322|FG000|Overall Study|Lost to Follow-up|6|||
25265019|NCT01221597|50579323|FG001|Overall Study|Lost to Follow-up|5|||
25265020|NCT01221597|50579322|FG000|Overall Study|Protocol Violation|1|||
25265021|NCT01221597|50579323|FG001|Overall Study|Protocol Violation|0|||
25265022|NCT01221597|50579322|FG000|Overall Study|Other|3|||
25008925|NCT03433482|50102129|FG000|Overall Study|Withdrawal by Subject|0|||
25008926|NCT03433482|50102130|FG001|Overall Study|Withdrawal by Subject|0|||
25008927|NCT03433482|50102131|FG002|Overall Study|Withdrawal by Subject|1|||
25008928|NCT03433482|50102132|FG003|Overall Study|Withdrawal by Subject|0|||
25008929|NCT03433482|50102129|FG000|Overall Study|Unknown reason|0|||
25008930|NCT03433482|50102130|FG001|Overall Study|Unknown reason|0|||
25008931|NCT03433482|50102131|FG002|Overall Study|Unknown reason|2|||
25008932|NCT03433482|50102132|FG003|Overall Study|Unknown reason|0|||
25008933|NCT03432858|50102145|FG000|Overall Study|Protocol Violation|2|||
25008934|NCT03432858|50102146|FG001|Overall Study|Protocol Violation|1|||
25008935|NCT03432858|50102147|FG002|Overall Study|Protocol Violation|9|||
25008936|NCT03432858|50102145|FG000|Overall Study|Withdrawal by Subject|0|||
25008937|NCT03432858|50102146|FG001|Overall Study|Withdrawal by Subject|1|||
25008938|NCT03432858|50102147|FG002|Overall Study|Withdrawal by Subject|1|||
25008939|NCT03432858|50102145|FG000|Overall Study|Procedure canceled/rescheduled|0|||
25008940|NCT03432858|50102146|FG001|Overall Study|Procedure canceled/rescheduled|9|||
25008941|NCT03432858|50102147|FG002|Overall Study|Procedure canceled/rescheduled|6|||
25008942|NCT03432858|50102145|FG000|Overall Study|Required postop mobilization with splinting|0|||
25008943|NCT03432858|50102146|FG001|Overall Study|Required postop mobilization with splinting|0|||
25008944|NCT03432858|50102147|FG002|Overall Study|Required postop mobilization with splinting|1|||
25008945|NCT03432390|50102157|FG000|Apnea Period|Protocol Violation|2|||
25008946|NCT03432390|50102158|FG001|Apnea Period|Protocol Violation|2|||
25265023|NCT01221597|50579323|FG001|Overall Study|Other|4|||
25265024|NCT01221597|50579322|FG000|Overall Study|Death|2|||
25265025|NCT01221597|50579323|FG001|Overall Study|Death|0|||
25265026|NCT01221363|50579332|FG000|Overall Study|Pregnancy|1|||
25265027|NCT01221363|50579333|FG001|Overall Study|Pregnancy|0|||
25265028|NCT01221363|50579332|FG000|Overall Study|Withdrawal by Subject|11|||
25265029|NCT01221363|50579333|FG001|Overall Study|Withdrawal by Subject|5|||
25265030|NCT01221285|50579339|FG000|Overall Study|Withdrawal by Subject|1|||
25265031|NCT01014988|50579349|FG000|Overall Study|Adverse Event|20|||
25265032|NCT01014988|50579350|FG001|Overall Study|Adverse Event|0|||
25265033|NCT01014988|50579351|FG002|Overall Study|Adverse Event|1|||
25265034|NCT01014988|50579352|FG003|Overall Study|Adverse Event|0|||
25265035|NCT01014988|50579353|FG004|Overall Study|Adverse Event|1|||
25265036|NCT01014988|50579354|FG005|Overall Study|Adverse Event|3|||
25265037|NCT01014988|50579349|FG000|Overall Study|Lost to Follow-up|1|||
25265038|NCT01014988|50579350|FG001|Overall Study|Lost to Follow-up|0|||
25265039|NCT01014988|50579351|FG002|Overall Study|Lost to Follow-up|1|||
25265040|NCT01014988|50579352|FG003|Overall Study|Lost to Follow-up|0|||
25265041|NCT01014988|50579353|FG004|Overall Study|Lost to Follow-up|0|||
25265042|NCT01014988|50579354|FG005|Overall Study|Lost to Follow-up|0|||
25265043|NCT01014988|50579349|FG000|Overall Study|Physician Decision|1|||
25265044|NCT01014988|50579350|FG001|Overall Study|Physician Decision|0|||
25265045|NCT01014988|50579351|FG002|Overall Study|Physician Decision|0|||
25265046|NCT01014988|50579352|FG003|Overall Study|Physician Decision|0|||
25265047|NCT01014988|50579353|FG004|Overall Study|Physician Decision|0|||
25265048|NCT01014988|50579354|FG005|Overall Study|Physician Decision|0|||
25265049|NCT01014988|50579349|FG000|Overall Study|Withdrawal by Subject|1|||
25265050|NCT01014988|50579350|FG001|Overall Study|Withdrawal by Subject|0|||
25265051|NCT01014988|50579351|FG002|Overall Study|Withdrawal by Subject|0|||
25265052|NCT01014988|50579352|FG003|Overall Study|Withdrawal by Subject|0|||
25265053|NCT01014988|50579353|FG004|Overall Study|Withdrawal by Subject|0|||
25265054|NCT01014988|50579354|FG005|Overall Study|Withdrawal by Subject|0|||
25265055|NCT01014910|50579378|FG000|Overall Study|Withdrawal by Subject|0|||
25265056|NCT01014910|50579379|FG001|Overall Study|Withdrawal by Subject|2|||
25265057|NCT01019980|50579387|FG000|Overall Study|Drug not available.|2|||
25265058|NCT01019980|50579388|FG001|Overall Study|Drug not available.|0|||
25265059|NCT00993499|50579400|FG000|Run-in Period (8 Days)|Adverse Event|0|||
25265060|NCT00993499|50579401|FG001|Run-in Period (8 Days)|Adverse Event|1|||
25008947|NCT03456960|50102170|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
25008948|NCT03456960|50102171|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
25008949|NCT03456960|50102172|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
25008950|NCT03456960|50102173|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
25265061|NCT00993499|50579402|FG002|Run-in Period (8 Days)|Adverse Event|0|||
25265062|NCT00993499|50579403|FG003|Run-in Period (8 Days)|Adverse Event|0|||
25265063|NCT00993499|50579404|FG004|Run-in Period (8 Days)|Adverse Event|0|||
25265064|NCT00993499|50579405|FG005|Run-in Period (8 Days)|Adverse Event|0|||
25265065|NCT00993499|50579400|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
25265066|NCT00993499|50579401|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
25265067|NCT00993499|50579402|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
25265068|NCT00993499|50579403|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
25265069|NCT00993499|50579404|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
25008951|NCT03456960|50102174|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
25265070|NCT00993499|50579405|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
25265071|NCT00993499|50579400|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
25265072|NCT00993499|50579401|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
25265073|NCT00993499|50579402|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
25265074|NCT00993499|50579403|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
25265075|NCT00993499|50579404|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
25265076|NCT00993499|50579405|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
25265077|NCT00993499|50579400|FG000|Run-in Period (8 Days)|Progressive disease|0|||
25265078|NCT00993499|50579401|FG001|Run-in Period (8 Days)|Progressive disease|1|||
25265079|NCT00993499|50579402|FG002|Run-in Period (8 Days)|Progressive disease|1|||
25265080|NCT00993499|50579403|FG003|Run-in Period (8 Days)|Progressive disease|0|||
25265081|NCT00993499|50579404|FG004|Run-in Period (8 Days)|Progressive disease|0|||
25265082|NCT00993499|50579405|FG005|Run-in Period (8 Days)|Progressive disease|0|||
25265083|NCT00993499|50579400|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
25265084|NCT00993499|50579401|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
25265085|NCT00993499|50579402|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
25265086|NCT00993499|50579403|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
25265087|NCT00993499|50579404|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
25123770|NCT02269943|50236368|FG000|Treatment Period|Adverse Event|1|||
25123771|NCT02269943|50236369|FG001|Treatment Period|Adverse Event|10|||
25123772|NCT02269943|50236368|FG000|Treatment Period|Progressive Disease|5|||
25123773|NCT02269943|50236369|FG001|Treatment Period|Progressive Disease|17|||
25123774|NCT02269943|50236368|FG000|Treatment Period|Symptomatic Deterioration|0|||
25123775|NCT02269943|50236369|FG001|Treatment Period|Symptomatic Deterioration|2|||
25265088|NCT00993499|50579405|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
25265089|NCT00993499|50579400|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
25123776|NCT02269943|50236368|FG000|Follow-Up Survival Period|Death|3|||
25123777|NCT02269943|50236369|FG001|Follow-Up Survival Period|Death|16|||
25123778|NCT02269943|50236368|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
25123779|NCT02269943|50236369|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
25123780|NCT02269943|50236368|FG000|Follow-Up Survival Period|Alive|2|||
25123781|NCT02269943|50236369|FG001|Follow-Up Survival Period|Alive|8|||
25123782|NCT01706458|50236377|FG000|Overall Study|Physician Decision|3|||
25123783|NCT01706458|50236378|FG001|Overall Study|Physician Decision|4|||
25123784|NCT02269787|50236386|FG000|Overall Study|Lost to Follow-up|20|||
25123785|NCT02269787|50236387|FG001|Overall Study|Lost to Follow-up|6|||
25123786|NCT02269787|50236386|FG000|Overall Study|Death|2|||
25123787|NCT02269787|50236387|FG001|Overall Study|Death|3|||
25123788|NCT02269787|50236386|FG000|Overall Study|Incapacitated|0|||
25265090|NCT00993499|50579401|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
25265091|NCT00993499|50579402|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
25265092|NCT00993499|50579403|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
25265093|NCT00993499|50579404|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
25265094|NCT00993499|50579405|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
25265095|NCT00993499|50579400|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
25265096|NCT00993499|50579401|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
25265097|NCT00993499|50579402|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
25265098|NCT00993499|50579403|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
25265099|NCT00993499|50579404|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
25265100|NCT00993499|50579405|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
25265101|NCT00993499|50579400|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
25265102|NCT00993499|50579401|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
25265103|NCT00993499|50579402|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
25265104|NCT00993499|50579403|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
25265105|NCT00993499|50579404|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
25265106|NCT00993499|50579405|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
25265107|NCT00993499|50579400|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
25265108|NCT00993499|50579401|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
25265109|NCT00993499|50579402|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
25265110|NCT00993499|50579403|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
25265111|NCT00993499|50579404|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
25265112|NCT00993499|50579405|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
25265113|NCT00993499|50579400|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
25265114|NCT00993499|50579401|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
25123789|NCT02269787|50236387|FG001|Overall Study|Incapacitated|1|||
25123790|NCT01605370|50236395|FG000|Overall Study|Adverse Event|1|||
25123791|NCT01605370|50236396|FG001|Overall Study|Adverse Event|0|||
25123792|NCT02269709|50236402|FG000|Time of Enrollment|Withdrawal by Subject|3|||
25265115|NCT00993499|50579402|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
25265116|NCT00993499|50579403|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
25265117|NCT00993499|50579404|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
25265118|NCT00993499|50579405|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
25265119|NCT00993499|50579400|FG000|Discontinued After Starting Course 3|DLT|1|||
25265120|NCT00993499|50579401|FG001|Discontinued After Starting Course 3|DLT|0|||
25265121|NCT00993499|50579402|FG002|Discontinued After Starting Course 3|DLT|2|||
25265122|NCT00993499|50579403|FG003|Discontinued After Starting Course 3|DLT|1|||
25265123|NCT00993499|50579404|FG004|Discontinued After Starting Course 3|DLT|0|||
25265124|NCT00993499|50579405|FG005|Discontinued After Starting Course 3|DLT|0|||
25265125|NCT00993499|50579400|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
25265126|NCT00993499|50579401|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
25265127|NCT00993499|50579402|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
25265128|NCT00993499|50579403|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
25265129|NCT00993499|50579404|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
25265130|NCT00993499|50579405|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
25265131|NCT01014442|50579421|FG000|Overall Study|Adverse Event|0|||
25265132|NCT01014442|50579422|FG001|Overall Study|Adverse Event|8|||
25265133|NCT01014442|50579421|FG000|Overall Study|Withdrawal by Subject|4|||
25265134|NCT01014442|50579422|FG001|Overall Study|Withdrawal by Subject|4|||
25265135|NCT01014442|50579421|FG000|Overall Study|Protocol Violation|2|||
25265136|NCT01014442|50579422|FG001|Overall Study|Protocol Violation|5|||
25265137|NCT01014442|50579421|FG000|Overall Study|Lack of Compliance|0|||
25265138|NCT01014442|50579422|FG001|Overall Study|Lack of Compliance|1|||
25265139|NCT01014442|50579421|FG000|Overall Study|Unspecified Reason|1|||
25265140|NCT01014442|50579422|FG001|Overall Study|Unspecified Reason|1|||
25265141|NCT00996307|50579436|FG000|Overall Study|Adverse Event|0|||
25008952|NCT03456960|50102175|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
25008953|NCT03456960|50102170|FG000|Period 2 (1 Day)|Adverse Event|1|||
25123793|NCT02269709|50236402|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
25123794|NCT02269709|50236402|FG000|Six Month Follow-up|Lost to Follow-up|12|||
25123795|NCT02269475|50236409|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
25123796|NCT02269475|50236410|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
25123797|NCT02269475|50236409|FG000|Overall Study|Withdrawal by Subject|0|||
25123798|NCT02269475|50236410|FG001|Overall Study|Withdrawal by Subject|1|||
25123799|NCT01605136|50236419|FG000|Study Period|Withdrawal by Subject|2|||
25123800|NCT01605136|50236420|FG001|Study Period|Withdrawal by Subject|0|||
25123801|NCT01605136|50236419|FG000|Study Period|Physician Decision|1|||
25123802|NCT01605136|50236420|FG001|Study Period|Physician Decision|1|||
25123803|NCT01605136|50236419|FG000|Study Period|Lost to Follow-up|0|||
25123804|NCT01605136|50236420|FG001|Study Period|Lost to Follow-up|2|||
25123805|NCT01605136|50236419|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
25123806|NCT01605136|50236420|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
25123807|NCT01706146|50236426|FG000|Overall Study|Withdrawal by Subject|1|||
25123808|NCT01706146|50236426|FG000|Overall Study|Adverse Event|3|||
25123809|NCT01706146|50236426|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
25123810|NCT02269241|50236430|FG000|Overall Study|Lost to Follow-up|269|||
25123811|NCT02269241|50236430|FG000|Overall Study|Withdrawal by Subject|155|||
25123812|NCT02269241|50236430|FG000|Overall Study|Protocol Violation|1|||
25123813|NCT02269241|50236430|FG000|Overall Study|Physician Decision|7|||
25123814|NCT02269241|50236430|FG000|Overall Study|Pregnancy|15|||
25123815|NCT02269241|50236430|FG000|Overall Study|Wish for pregnancy|5|||
25123816|NCT02269241|50236430|FG000|Overall Study|Development of an exclusion criteria|16|||
25123817|NCT02269241|50236430|FG000|Overall Study|Adverse Event|113|||
25123818|NCT02269241|50236430|FG000|Overall Study|At the specific request of the sponsor|20|||
25123819|NCT02269241|50236430|FG000|Overall Study|Several reasons not classified|53|||
25123820|NCT02269241|50236430|FG000|Overall Study|Screening failures|546|||
25123821|NCT01750684|50236437|FG000|Overall Study|Death|1|||
25123822|NCT01750684|50236438|FG001|Overall Study|Death|0|||
25265142|NCT00996307|50579437|FG001|Overall Study|Adverse Event|1|||
25265143|NCT00996307|50579438|FG002|Overall Study|Adverse Event|0|||
25265144|NCT00996307|50579439|FG003|Overall Study|Adverse Event|0|||
25265145|NCT00996307|50579436|FG000|Overall Study|Withdrawal by Subject|3|||
25265146|NCT00996307|50579437|FG001|Overall Study|Withdrawal by Subject|2|||
25265147|NCT00996307|50579438|FG002|Overall Study|Withdrawal by Subject|5|||
25265148|NCT00996307|50579439|FG003|Overall Study|Withdrawal by Subject|5|||
25265149|NCT00996307|50579436|FG000|Overall Study|Lost to Follow-up|13|||
25008954|NCT03456960|50102171|FG001|Period 2 (1 Day)|Adverse Event|0|||
25123823|NCT01750684|50236437|FG000|Overall Study|Non-compliance with Study Drug|0|||
25123824|NCT01750684|50236438|FG001|Overall Study|Non-compliance with Study Drug|1|||
25265150|NCT00996307|50579437|FG001|Overall Study|Lost to Follow-up|13|||
25265151|NCT00996307|50579438|FG002|Overall Study|Lost to Follow-up|7|||
25265152|NCT00996307|50579439|FG003|Overall Study|Lost to Follow-up|15|||
25265153|NCT00996307|50579436|FG000|Overall Study|Administrative reason|0|||
25123825|NCT01750684|50236437|FG000|Overall Study|Withdrawn by Sponsor|0|||
25265154|NCT00996307|50579437|FG001|Overall Study|Administrative reason|1|||
25265155|NCT00996307|50579438|FG002|Overall Study|Administrative reason|0|||
25265156|NCT00996307|50579439|FG003|Overall Study|Administrative reason|0|||
25265157|NCT00996307|50579436|FG000|Overall Study|Unable to classify|4|||
25265158|NCT00996307|50579437|FG001|Overall Study|Unable to classify|0|||
25265159|NCT00996307|50579438|FG002|Overall Study|Unable to classify|2|||
25265160|NCT00996307|50579439|FG003|Overall Study|Unable to classify|1|||
25265161|NCT01219959|50579469|FG000|Overall Study|Adverse Event|6|||
25265162|NCT01219959|50579470|FG001|Overall Study|Adverse Event|14|||
25265163|NCT01219959|50579469|FG000|Overall Study|Physician Decision|0|||
25265164|NCT01219959|50579470|FG001|Overall Study|Physician Decision|4|||
25265165|NCT01219959|50579469|FG000|Overall Study|Withdrawal by Subject|0|||
25265166|NCT01219959|50579470|FG001|Overall Study|Withdrawal by Subject|2|||
25265167|NCT01219959|50579469|FG000|Overall Study|Renal Transplantation|0|||
25265168|NCT01219959|50579470|FG001|Overall Study|Renal Transplantation|3|||
25265169|NCT01219959|50579469|FG000|Overall Study|Other|1|||
25265170|NCT01219959|50579470|FG001|Overall Study|Other|0|||
25265171|NCT00993421|50579483|FG000|Overall Study|Adverse Event|2|||
25265172|NCT00993421|50579484|FG001|Overall Study|Adverse Event|7|||
25265173|NCT00993421|50579485|FG002|Overall Study|Adverse Event|6|||
25265174|NCT00993421|50579486|FG003|Overall Study|Adverse Event|9|||
25265175|NCT00993421|50579487|FG004|Overall Study|Adverse Event|5|||
25265176|NCT00993421|50579488|FG005|Overall Study|Adverse Event|7|||
25265177|NCT00993421|50579489|FG006|Overall Study|Adverse Event|1|||
25265178|NCT00993421|50579483|FG000|Overall Study|Sponsor Decision|36|||
25265179|NCT00993421|50579484|FG001|Overall Study|Sponsor Decision|31|||
25265180|NCT00993421|50579485|FG002|Overall Study|Sponsor Decision|28|||
25265181|NCT00993421|50579486|FG003|Overall Study|Sponsor Decision|30|||
25265182|NCT00993421|50579487|FG004|Overall Study|Sponsor Decision|38|||
25265183|NCT00993421|50579488|FG005|Overall Study|Sponsor Decision|30|||
25265184|NCT00993421|50579489|FG006|Overall Study|Sponsor Decision|29|||
25265185|NCT00993421|50579483|FG000|Overall Study|Lost to Follow-up|3|||
25265186|NCT00993421|50579484|FG001|Overall Study|Lost to Follow-up|5|||
25265187|NCT00993421|50579485|FG002|Overall Study|Lost to Follow-up|5|||
25265188|NCT00993421|50579486|FG003|Overall Study|Lost to Follow-up|0|||
25265189|NCT00993421|50579487|FG004|Overall Study|Lost to Follow-up|0|||
25008955|NCT03456960|50102172|FG002|Period 2 (1 Day)|Adverse Event|0|||
25265190|NCT00993421|50579488|FG005|Overall Study|Lost to Follow-up|0|||
25265191|NCT00993421|50579489|FG006|Overall Study|Lost to Follow-up|6|||
25123826|NCT01750684|50236438|FG001|Overall Study|Withdrawn by Sponsor|1|||
25123827|NCT01750684|50236437|FG000|Overall Study|Protocol Violation|1|||
25123828|NCT01750684|50236438|FG001|Overall Study|Protocol Violation|0|||
25123829|NCT01750294|50236445|FG000|Overall Study|Withdrawal by Subject|1|||
25123830|NCT01750294|50236445|FG000|Overall Study|Safety Endpoint|1|||
25123831|NCT01749982|50236453|FG000|Overall Study|Physician Decision|0|||
25123832|NCT01749982|50236454|FG001|Overall Study|Physician Decision|0|||
25123833|NCT01749982|50236455|FG002|Overall Study|Physician Decision|0|||
25123834|NCT01749982|50236456|FG003|Overall Study|Physician Decision|1|||
25123835|NCT01749982|50236453|FG000|Overall Study|Lost to Follow-up|0|||
25123836|NCT01749982|50236454|FG001|Overall Study|Lost to Follow-up|0|||
25123837|NCT01749982|50236455|FG002|Overall Study|Lost to Follow-up|0|||
25123838|NCT01749982|50236456|FG003|Overall Study|Lost to Follow-up|1|||
25123839|NCT01749982|50236453|FG000|Overall Study|Withdrawal by Subject|0|||
25123840|NCT01749982|50236454|FG001|Overall Study|Withdrawal by Subject|0|||
25123841|NCT01749982|50236455|FG002|Overall Study|Withdrawal by Subject|0|||
25123842|NCT01749982|50236456|FG003|Overall Study|Withdrawal by Subject|1|||
25123843|NCT02269163|50236468|FG000|Overall Study|Lost to Follow-up|1|||
25123844|NCT02269163|50236469|FG001|Overall Study|Lost to Follow-up|0|||
25123845|NCT02269163|50236468|FG000|Overall Study|Major protocol violation|0|||
25123846|NCT02269163|50236469|FG001|Overall Study|Major protocol violation|1|||
25123847|NCT02269163|50236468|FG000|Overall Study|Other|2|||
25123848|NCT02269163|50236469|FG001|Overall Study|Other|2|||
25123849|NCT02269163|50236468|FG000|Overall Study|Withdrawal by Subject|0|||
25123850|NCT02269163|50236469|FG001|Overall Study|Withdrawal by Subject|3|||
25123851|NCT02269163|50236468|FG000|Overall Study|Physician Decision|0|||
25123852|NCT02269163|50236469|FG001|Overall Study|Physician Decision|1|||
25123853|NCT01749826|50236479|FG000|Overall Study|Study Terminated|20|||
25123854|NCT01749826|50236480|FG001|Overall Study|Study Terminated|0|||
25123855|NCT02300129|50236486|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
25123856|NCT02300129|50236487|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
25123857|NCT02300129|50236488|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
25123858|NCT02300129|50236489|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
25123859|NCT02300129|50236486|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
25123860|NCT02300129|50236487|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
25123861|NCT02300129|50236488|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
25123862|NCT02300129|50236489|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
25123863|NCT02300129|50236486|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
25123864|NCT02300129|50236487|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
25123865|NCT02300129|50236488|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
25123866|NCT02300129|50236489|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
25123867|NCT02267135|50236501|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
25123868|NCT02267135|50236502|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
25123869|NCT02267135|50236501|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
25123870|NCT02267135|50236502|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
25123871|NCT02267135|50236501|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
25123872|NCT02267135|50236502|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
25123873|NCT02267135|50236501|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
25123874|NCT02267135|50236502|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
25123875|NCT02267135|50236501|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
25123876|NCT02267135|50236502|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
25123877|NCT02299427|50236513|FG000|Overall Study|Withdrawal by Subject|1|||
25123878|NCT02299427|50236514|FG001|Overall Study|Withdrawal by Subject|0|||
25123879|NCT02299427|50236513|FG000|Overall Study|Lost to Follow-up|1|||
25123880|NCT02299427|50236514|FG001|Overall Study|Lost to Follow-up|3|||
25123881|NCT02299427|50236513|FG000|Overall Study|not adherent to dog website use|21|||
25123882|NCT02299427|50236514|FG001|Overall Study|not adherent to dog website use|0|||
25123883|NCT01724866|50236524|FG000|Overall Study|Adverse Event|0|||
25008956|NCT03456960|50102173|FG003|Period 2 (1 Day)|Adverse Event|1|||
25008957|NCT03456960|50102174|FG004|Period 2 (1 Day)|Adverse Event|0|||
25123884|NCT01724866|50236525|FG001|Overall Study|Adverse Event|0|||
25123885|NCT01724866|50236526|FG002|Overall Study|Adverse Event|1|||
25265192|NCT00993421|50579483|FG000|Overall Study|Withdrawal by Subject|3|||
25265193|NCT00993421|50579484|FG001|Overall Study|Withdrawal by Subject|2|||
25265194|NCT00993421|50579485|FG002|Overall Study|Withdrawal by Subject|3|||
25123886|NCT01724866|50236527|FG003|Overall Study|Adverse Event|1|||
25265195|NCT00993421|50579486|FG003|Overall Study|Withdrawal by Subject|3|||
25265196|NCT00993421|50579487|FG004|Overall Study|Withdrawal by Subject|3|||
25265197|NCT00993421|50579488|FG005|Overall Study|Withdrawal by Subject|5|||
25265198|NCT00993421|50579489|FG006|Overall Study|Withdrawal by Subject|3|||
25265199|NCT00993421|50579483|FG000|Overall Study|Death|0|||
25265200|NCT00993421|50579484|FG001|Overall Study|Death|0|||
25265201|NCT00993421|50579485|FG002|Overall Study|Death|0|||
25123887|NCT01724866|50236524|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
25123888|NCT01724866|50236525|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
25265202|NCT00993421|50579486|FG003|Overall Study|Death|0|||
25265203|NCT00993421|50579487|FG004|Overall Study|Death|0|||
25265204|NCT00993421|50579488|FG005|Overall Study|Death|0|||
25265205|NCT00993421|50579489|FG006|Overall Study|Death|1|||
25265206|NCT00993421|50579483|FG000|Overall Study|Entry Criteria Exclusion|0|||
25265207|NCT00993421|50579484|FG001|Overall Study|Entry Criteria Exclusion|0|||
25265208|NCT00993421|50579485|FG002|Overall Study|Entry Criteria Exclusion|1|||
25265209|NCT00993421|50579486|FG003|Overall Study|Entry Criteria Exclusion|3|||
25265210|NCT00993421|50579487|FG004|Overall Study|Entry Criteria Exclusion|0|||
25265211|NCT00993421|50579488|FG005|Overall Study|Entry Criteria Exclusion|1|||
25265212|NCT00993421|50579489|FG006|Overall Study|Entry Criteria Exclusion|0|||
25265213|NCT00993421|50579483|FG000|Overall Study|Physician Decision|0|||
25265214|NCT00993421|50579484|FG001|Overall Study|Physician Decision|0|||
25265215|NCT00993421|50579485|FG002|Overall Study|Physician Decision|0|||
25265216|NCT00993421|50579486|FG003|Overall Study|Physician Decision|0|||
25265217|NCT00993421|50579487|FG004|Overall Study|Physician Decision|0|||
25265218|NCT00993421|50579488|FG005|Overall Study|Physician Decision|1|||
25265219|NCT00993421|50579489|FG006|Overall Study|Physician Decision|1|||
25265220|NCT00993421|50579483|FG000|Overall Study|Protocol Violation|0|||
25265221|NCT00993421|50579484|FG001|Overall Study|Protocol Violation|0|||
25265222|NCT00993421|50579485|FG002|Overall Study|Protocol Violation|0|||
25265223|NCT00993421|50579486|FG003|Overall Study|Protocol Violation|0|||
25265224|NCT00993421|50579487|FG004|Overall Study|Protocol Violation|0|||
25265225|NCT00993421|50579488|FG005|Overall Study|Protocol Violation|2|||
25265226|NCT00993421|50579489|FG006|Overall Study|Protocol Violation|1|||
25265227|NCT01014208|50579507|FG000|Overall Study|Lost to Follow-up|2|||
25265228|NCT01014208|50579508|FG001|Overall Study|Lost to Follow-up|5|||
25265229|NCT01014208|50579507|FG000|Overall Study|Participant Withdrew Consent|12|||
25265230|NCT01014208|50579508|FG001|Overall Study|Participant Withdrew Consent|12|||
25265231|NCT01014208|50579507|FG000|Overall Study|Did Not Receive Study Drug|2|||
25265232|NCT01014208|50579508|FG001|Overall Study|Did Not Receive Study Drug|0|||
25265233|NCT01014208|50579507|FG000|Overall Study|Study Closed/terminated|78|||
25265234|NCT01014208|50579508|FG001|Overall Study|Study Closed/terminated|83|||
25265235|NCT00991939|50579516|FG000|Overall Study|Lost to Follow-up|0|||
25265236|NCT00991939|50579517|FG001|Overall Study|Lost to Follow-up|1|||
25265237|NCT00991939|50579516|FG000|Overall Study|Withdrawal by Subject|1|||
25265238|NCT00991939|50579517|FG001|Overall Study|Withdrawal by Subject|0|||
25265239|NCT00991939|50579516|FG000|Overall Study|Entire study terminated|4|||
25265240|NCT00991939|50579517|FG001|Overall Study|Entire study terminated|1|||
25008958|NCT03456960|50102175|FG005|Period 2 (1 Day)|Adverse Event|0|||
25008959|NCT03430986|50102193|FG000|24-week Control Period|Adverse Event|1|||
25008960|NCT03430986|50102194|FG001|24-week Control Period|Adverse Event|0|||
25008961|NCT03430986|50102193|FG000|24-week Control Period|Lost to Follow-up|2|||
25008962|NCT03430986|50102194|FG001|24-week Control Period|Lost to Follow-up|2|||
25008963|NCT03430986|50102193|FG000|24-week Control Period|Withdrawal by Participant|5|||
25265241|NCT00993265|50579527|FG000|Overall Study|Adverse Event|1|||
25265242|NCT00993265|50579528|FG001|Overall Study|Adverse Event|0|||
25265243|NCT00993265|50579527|FG000|Overall Study|Changed dose of concomitant drug|2|||
25265244|NCT00993265|50579528|FG001|Overall Study|Changed dose of concomitant drug|0|||
25265245|NCT00993265|50579527|FG000|Overall Study|Non-compliant with study medication|1|||
25265246|NCT00993265|50579528|FG001|Overall Study|Non-compliant with study medication|0|||
25265247|NCT04211389|50579536|FG000|Overall Study|Adverse Event|1|||
25265248|NCT04211389|50579537|FG001|Overall Study|Adverse Event|2|||
25265249|NCT04211389|50579536|FG000|Overall Study|Lost to Follow-up|15|||
25265250|NCT04211389|50579537|FG001|Overall Study|Lost to Follow-up|7|||
25265251|NCT04211389|50579536|FG000|Overall Study|Protocol Violation|0|||
25265252|NCT04211389|50579537|FG001|Overall Study|Protocol Violation|1|||
25008964|NCT03430986|50102194|FG001|24-week Control Period|Withdrawal by Participant|0|||
25008965|NCT03430986|50102193|FG000|24-week Control Period|Protocol Deviation|0|||
25008966|NCT03430986|50102194|FG001|24-week Control Period|Protocol Deviation|2|||
25008967|NCT03430986|50102193|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
25008968|NCT03430986|50102194|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
25123889|NCT01724866|50236526|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
25123890|NCT01724866|50236527|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
25123891|NCT01724866|50236524|FG000|Overall Study|Investigator's Discretion|0|||
25265253|NCT04211389|50579536|FG000|Overall Study|Withdrawal by Subject|10|||
25008969|NCT03430986|50102193|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
25123892|NCT01724866|50236525|FG001|Overall Study|Investigator's Discretion|1|||
25123893|NCT01724866|50236526|FG002|Overall Study|Investigator's Discretion|1|||
25123894|NCT01724866|50236527|FG003|Overall Study|Investigator's Discretion|0|||
25123895|NCT01724866|50236524|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
25123896|NCT01724866|50236525|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
25123897|NCT01724866|50236526|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
25123898|NCT01724866|50236527|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
25123899|NCT01724866|50236524|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
25123900|NCT01724866|50236525|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
25123901|NCT01724866|50236526|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
25123902|NCT01724866|50236527|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
25123903|NCT02266433|50236539|FG000|Overall Study|Lost to Follow-up|54|||
25123904|NCT02266433|50236540|FG001|Overall Study|Lost to Follow-up|46|||
25265254|NCT04211389|50579537|FG001|Overall Study|Withdrawal by Subject|11|||
25265255|NCT00993031|50579545|FG000|Overall Study|Death|0|||
25265256|NCT00993031|50579546|FG001|Overall Study|Death|1|||
25265257|NCT00993031|50579545|FG000|Overall Study|Physician Decision|0|||
25265258|NCT00993031|50579546|FG001|Overall Study|Physician Decision|2|||
25123905|NCT02266433|50236539|FG000|Overall Study|Withdrawal by Subject|5|||
25123906|NCT02266433|50236540|FG001|Overall Study|Withdrawal by Subject|7|||
25123907|NCT01748890|50236547|FG000|Overall Study|Insufficient recruitment for analysis|4|||
25123908|NCT01747876|50236554|FG000|Overall Study|Adverse Event|1|||
25123909|NCT01747876|50236555|FG001|Overall Study|Adverse Event|0|||
25123910|NCT01747876|50236556|FG002|Overall Study|Adverse Event|2|||
25123911|NCT01747876|50236554|FG000|Overall Study|Withdrawal by Subject|0|||
25123912|NCT01747876|50236555|FG001|Overall Study|Withdrawal by Subject|1|||
25123913|NCT01747876|50236556|FG002|Overall Study|Withdrawal by Subject|1|||
25123914|NCT01747876|50236554|FG000|Overall Study|Disease progression|4|||
25123915|NCT01747876|50236555|FG001|Overall Study|Disease progression|13|||
25123916|NCT01747876|50236556|FG002|Overall Study|Disease progression|8|||
25123917|NCT01747876|50236554|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
25123918|NCT01747876|50236555|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
25123919|NCT01747876|50236556|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
25123920|NCT02273726|50236569|FG000|Overall Study|Death|70|||
25123921|NCT02273726|50236570|FG001|Overall Study|Death|62|||
25123922|NCT02273726|50236569|FG000|Overall Study|Withdrawal by Subject|41|||
25123923|NCT02273726|50236570|FG001|Overall Study|Withdrawal by Subject|29|||
25123924|NCT02273726|50236569|FG000|Overall Study|Kidney transplant|31|||
25123925|NCT02273726|50236570|FG001|Overall Study|Kidney transplant|39|||
25123926|NCT02273726|50236569|FG000|Overall Study|Physician Decision|30|||
25123927|NCT02273726|50236570|FG001|Overall Study|Physician Decision|15|||
25123928|NCT02273726|50236569|FG000|Overall Study|Adverse Event|27|||
25123929|NCT02273726|50236570|FG001|Overall Study|Adverse Event|9|||
25123930|NCT02273726|50236569|FG000|Overall Study|Lost to Follow-up|6|||
25123931|NCT02273726|50236570|FG001|Overall Study|Lost to Follow-up|3|||
25123932|NCT02273726|50236569|FG000|Overall Study|Lack of Efficacy|6|||
25123933|NCT02273726|50236570|FG001|Overall Study|Lack of Efficacy|1|||
25123934|NCT02273726|50236569|FG000|Overall Study|Protocol Violation|4|||
25123935|NCT02273726|50236570|FG001|Overall Study|Protocol Violation|0|||
25123936|NCT02273726|50236569|FG000|Overall Study|Other than specified|28|||
25123937|NCT02273726|50236570|FG001|Overall Study|Other than specified|30|||
25123938|NCT01723228|50236578|FG000|Overall Study|Adverse Event|2|||
25123939|NCT01723228|50236579|FG001|Overall Study|Adverse Event|6|||
25123940|NCT01723228|50236578|FG000|Overall Study|Withdrawal by Subject|2|||
25123941|NCT01723228|50236579|FG001|Overall Study|Withdrawal by Subject|1|||
25008970|NCT03430986|50102194|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
25008971|NCT03448536|50102205|FG000|Overall Study|Protocol Violation|2|||
25008972|NCT03448536|50102206|FG001|Overall Study|Protocol Violation|0|||
25123942|NCT01723228|50236578|FG000|Overall Study|Protocol Violation|0|||
25123943|NCT01723228|50236579|FG001|Overall Study|Protocol Violation|2|||
25123944|NCT01723228|50236578|FG000|Overall Study|Lost to Follow-up|2|||
25123945|NCT01723228|50236579|FG001|Overall Study|Lost to Follow-up|1|||
25123946|NCT01723228|50236578|FG000|Overall Study|Other|2|||
25123947|NCT01723228|50236579|FG001|Overall Study|Other|1|||
25123948|NCT02273180|50236587|FG000|Overall Study|Adverse Event|2|||
25123949|NCT02273180|50236588|FG001|Overall Study|Adverse Event|2|||
25123950|NCT02273180|50236587|FG000|Overall Study|Lack of Efficacy|1|||
25123951|NCT02273180|50236588|FG001|Overall Study|Lack of Efficacy|0|||
25123952|NCT02273180|50236587|FG000|Overall Study|Protocol Violation|1|||
25123953|NCT02273180|50236588|FG001|Overall Study|Protocol Violation|7|||
25008973|NCT03448536|50102205|FG000|Overall Study|Pregnancy|1|||
25008974|NCT03448536|50102206|FG001|Overall Study|Pregnancy|0|||
25008975|NCT03448536|50102205|FG000|Overall Study|Withdrawal by Subject|1|||
25008976|NCT03448536|50102206|FG001|Overall Study|Withdrawal by Subject|2|||
25008977|NCT03448536|50102205|FG000|Overall Study|Lost to Follow-up|3|||
25008978|NCT03448536|50102206|FG001|Overall Study|Lost to Follow-up|2|||
25008979|NCT03448536|50102205|FG000|Overall Study|Inadequate pain reporter|1|||
25008980|NCT03448536|50102206|FG001|Overall Study|Inadequate pain reporter|0|||
25008981|NCT03448536|50102205|FG000|Overall Study|Other|3|||
25008982|NCT03448536|50102206|FG001|Overall Study|Other|0|||
25008983|NCT03448536|50102205|FG000|Overall Study|Physician Decision|1|||
25008984|NCT03448536|50102206|FG001|Overall Study|Physician Decision|0|||
25008985|NCT03448224|50102214|FG000|Overall Study|Provided same answer to every question|1|||
25008986|NCT03448224|50102215|FG001|Overall Study|Provided same answer to every question|0|||
25008987|NCT03424044|50102221|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
25008988|NCT03424044|50102222|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
25008989|NCT03424044|50102223|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
25008990|NCT03424044|50102224|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
25008991|NCT03424044|50102225|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
25008992|NCT03424044|50102226|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
25008993|NCT03424044|50102227|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
25265259|NCT00993031|50579545|FG000|Overall Study|Withdrawal by Subject|3|||
25265260|NCT00993031|50579546|FG001|Overall Study|Withdrawal by Subject|3|||
25008994|NCT03424044|50102228|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
25265261|NCT00993031|50579545|FG000|Overall Study|Lost to Follow-up|19|||
25265262|NCT00993031|50579546|FG001|Overall Study|Lost to Follow-up|13|||
25265263|NCT01010776|50579556|FG000|Main Phase|Withdrawal by Subject|14|||
25265264|NCT01010776|50579556|FG000|Main Phase|Lack of Efficacy|8|||
25265265|NCT01010776|50579556|FG000|Main Phase|Adverse Event|7|||
25265266|NCT01010776|50579556|FG000|Main Phase|Lost to Follow-up|6|||
25265267|NCT01010776|50579556|FG000|Main Phase|Non-compliance to study medication|5|||
25265268|NCT01010776|50579556|FG000|Main Phase|Selection failure|2|||
25265269|NCT01010776|50579556|FG000|Main Phase|Inform consent withdrawal|1|||
25265270|NCT01010776|50579556|FG000|Main Phase|Other|1|||
25265271|NCT01010776|50579556|FG000|Main Phase|Did not received study medication|5|||
25265272|NCT01010776|50579556|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
25265273|NCT01010776|50579556|FG000|Extension Phase|Other|3|||
25265274|NCT01018810|50579576|FG000|Overall Study|Withdrawal by Subject|0|||
25265275|NCT01018810|50579577|FG001|Overall Study|Withdrawal by Subject|1|||
25265276|NCT01018810|50579578|FG002|Overall Study|Withdrawal by Subject|0|||
25265277|NCT01018810|50579579|FG003|Overall Study|Withdrawal by Subject|0|||
25265278|NCT01018810|50579580|FG004|Overall Study|Withdrawal by Subject|0|||
25265279|NCT01018810|50579576|FG000|Overall Study|Sponsor Decision|2|||
25265280|NCT01018810|50579577|FG001|Overall Study|Sponsor Decision|0|||
25265281|NCT01018810|50579578|FG002|Overall Study|Sponsor Decision|1|||
25265282|NCT01018810|50579579|FG003|Overall Study|Sponsor Decision|1|||
25265283|NCT01018810|50579580|FG004|Overall Study|Sponsor Decision|1|||
25265284|NCT01018732|50579595|FG000|Overall Study|Lost to Follow-up|0|||
25265285|NCT01018732|50579596|FG001|Overall Study|Lost to Follow-up|0|||
25265286|NCT01018732|50579597|FG002|Overall Study|Lost to Follow-up|3|||
25265287|NCT01018732|50579595|FG000|Overall Study|Protocol Violation|1|||
25265288|NCT01018732|50579596|FG001|Overall Study|Protocol Violation|1|||
25265289|NCT01018732|50579597|FG002|Overall Study|Protocol Violation|0|||
25265290|NCT01018732|50579595|FG000|Overall Study|Inappropriate Enrollment|0|||
25265291|NCT01018732|50579596|FG001|Overall Study|Inappropriate Enrollment|1|||
25265292|NCT01018732|50579597|FG002|Overall Study|Inappropriate Enrollment|0|||
25265293|NCT01018732|50579595|FG000|Overall Study|Unable to Classify|0|||
25008995|NCT03424044|50102229|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
25265294|NCT01018732|50579596|FG001|Overall Study|Unable to Classify|0|||
25265295|NCT01018732|50579597|FG002|Overall Study|Unable to Classify|1|||
25265296|NCT01218867|50579616|FG000|Overall Study|Death during treatment|0|||
25265297|NCT01218867|50579617|FG001|Overall Study|Death during treatment|0|||
25265298|NCT01218867|50579618|FG002|Overall Study|Death during treatment|0|||
25265299|NCT01218867|50579619|FG003|Overall Study|Death during treatment|0|||
25265300|NCT01218867|50579620|FG004|Overall Study|Death during treatment|0|||
25265301|NCT01218867|50579621|FG005|Overall Study|Death during treatment|0|||
25265302|NCT01218867|50579622|FG006|Overall Study|Death during treatment|1|||
25265303|NCT01218867|50579623|FG007|Overall Study|Death during treatment|0|||
25265304|NCT01218867|50579624|FG008|Overall Study|Death during treatment|0|||
25265305|NCT01218867|50579625|FG009|Overall Study|Death during treatment|0|||
25265306|NCT01218867|50579626|FG010|Overall Study|Death during treatment|0|||
25265307|NCT01018264|50579663|FG000|Overall Study|Withdrawal by Subject|1|||
25265308|NCT01018264|50579664|FG001|Overall Study|Withdrawal by Subject|0|||
25265309|NCT01018264|50579663|FG000|Overall Study|Lost to Follow-up|0|||
25265310|NCT01018264|50579664|FG001|Overall Study|Lost to Follow-up|1|||
25265311|NCT01018186|50579673|FG000|2-week Run-in Period|Protocol Violation|1|||
25265312|NCT01018186|50579674|FG001|2-week Run-in Period|Protocol Violation|0|||
25265313|NCT01018186|50579675|FG002|2-week Run-in Period|Protocol Violation|0|||
25265314|NCT01018186|50579676|FG003|2-week Run-in Period|Protocol Violation|0|||
25265315|NCT01018186|50579673|FG000|2-week Run-in Period|Lost to Follow-up|2|||
25265316|NCT01018186|50579674|FG001|2-week Run-in Period|Lost to Follow-up|0|||
25265317|NCT01018186|50579675|FG002|2-week Run-in Period|Lost to Follow-up|0|||
25008996|NCT03424044|50102221|FG000|First Intervention (76 Hours)|Adverse Event|0|||
25008997|NCT03424044|50102222|FG001|First Intervention (76 Hours)|Adverse Event|0|||
25008998|NCT03424044|50102223|FG002|First Intervention (76 Hours)|Adverse Event|0|||
25008999|NCT03424044|50102224|FG003|First Intervention (76 Hours)|Adverse Event|0|||
25009000|NCT03424044|50102225|FG004|First Intervention (76 Hours)|Adverse Event|1|||
25009001|NCT03424044|50102226|FG005|First Intervention (76 Hours)|Adverse Event|0|||
25009002|NCT03424044|50102227|FG006|First Intervention (76 Hours)|Adverse Event|0|||
25009003|NCT03424044|50102228|FG007|First Intervention (76 Hours)|Adverse Event|0|||
25009004|NCT03424044|50102229|FG008|First Intervention (76 Hours)|Adverse Event|0|||
25009005|NCT03424044|50102221|FG000|First Intervention (76 Hours)|device issues|0|||
25009006|NCT03424044|50102222|FG001|First Intervention (76 Hours)|device issues|0|||
25009007|NCT03424044|50102223|FG002|First Intervention (76 Hours)|device issues|0|||
25009008|NCT03424044|50102224|FG003|First Intervention (76 Hours)|device issues|0|||
25265318|NCT01018186|50579676|FG003|2-week Run-in Period|Lost to Follow-up|0|||
25265319|NCT01018186|50579673|FG000|2-week Run-in Period|Physician Decision|3|||
25265320|NCT01018186|50579674|FG001|2-week Run-in Period|Physician Decision|0|||
25265321|NCT01018186|50579675|FG002|2-week Run-in Period|Physician Decision|0|||
25265322|NCT01018186|50579676|FG003|2-week Run-in Period|Physician Decision|0|||
25265323|NCT01018186|50579673|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
25265324|NCT01018186|50579674|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
25265325|NCT01018186|50579675|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
25265326|NCT01018186|50579676|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
25265327|NCT01018186|50579673|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
25265328|NCT01018186|50579674|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
25265329|NCT01018186|50579675|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
25265330|NCT01018186|50579676|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
25265331|NCT01018186|50579673|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
25265332|NCT01018186|50579674|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
25265333|NCT01018186|50579675|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
25265334|NCT01018186|50579676|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
25265335|NCT01018186|50579673|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
25265336|NCT01018186|50579674|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
25265337|NCT01018186|50579675|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
25265338|NCT01018186|50579676|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
25265339|NCT01018186|50579673|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
25265340|NCT01018186|50579674|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
25265341|NCT01018186|50579675|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
25265342|NCT01018186|50579676|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
25265343|NCT01018186|50579673|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
25265344|NCT01018186|50579674|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
25265345|NCT01018186|50579675|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
25265346|NCT01018186|50579676|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
25265347|NCT01018186|50579673|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
25265348|NCT01018186|50579674|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
25265349|NCT01018186|50579675|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
25265350|NCT01018186|50579676|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
25265351|NCT01018186|50579673|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
25265352|NCT01018186|50579674|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
25265353|NCT01018186|50579675|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
25265354|NCT01018186|50579676|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
25265355|NCT01018186|50579673|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
25265356|NCT01018186|50579674|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
25265357|NCT01018186|50579675|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
25265358|NCT01018186|50579676|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
25265359|NCT00987337|50579691|FG000|Overall Study|Adverse Event|10|||
25265360|NCT00987337|50579692|FG001|Overall Study|Adverse Event|9|||
25265361|NCT00987337|50579693|FG002|Overall Study|Adverse Event|8|||
25265362|NCT00987337|50579691|FG000|Overall Study|Insufficient Virologic Response|10|||
25265363|NCT00987337|50579692|FG001|Overall Study|Insufficient Virologic Response|7|||
25265364|NCT00987337|50579693|FG002|Overall Study|Insufficient Virologic Response|12|||
25265365|NCT00987337|50579691|FG000|Overall Study|Virologic Breakthrough|2|||
25265366|NCT00987337|50579692|FG001|Overall Study|Virologic Breakthrough|2|||
25265367|NCT00987337|50579693|FG002|Overall Study|Virologic Breakthrough|8|||
25265368|NCT00987337|50579691|FG000|Overall Study|Lost to Follow-up|10|||
25265369|NCT00987337|50579692|FG001|Overall Study|Lost to Follow-up|6|||
25265370|NCT00987337|50579693|FG002|Overall Study|Lost to Follow-up|2|||
25265371|NCT00987337|50579691|FG000|Overall Study|Withdrawal by Subject|6|||
25265372|NCT00987337|50579692|FG001|Overall Study|Withdrawal by Subject|9|||
25265373|NCT00987337|50579693|FG002|Overall Study|Withdrawal by Subject|9|||
25265374|NCT00987337|50579691|FG000|Overall Study|Other|0|||
25265375|NCT00987337|50579692|FG001|Overall Study|Other|2|||
25265376|NCT00987337|50579693|FG002|Overall Study|Other|5|||
25265377|NCT00987337|50579691|FG000|Overall Study|Protocol Violation|1|||
25265378|NCT00987337|50579692|FG001|Overall Study|Protocol Violation|0|||
25265379|NCT00987337|50579693|FG002|Overall Study|Protocol Violation|2|||
25265380|NCT00987337|50579691|FG000|Overall Study|Participant Relapsed|18|||
25265381|NCT00987337|50579692|FG001|Overall Study|Participant Relapsed|20|||
25265382|NCT00987337|50579693|FG002|Overall Study|Participant Relapsed|5|||
25265383|NCT00992407|50579705|FG000|Overall Study|Protocol Violation|2|||
25265384|NCT00992407|50579706|FG001|Overall Study|Protocol Violation|1|||
25265385|NCT00992407|50579705|FG000|Overall Study|Lost to Follow-up|3|||
25265386|NCT00992407|50579706|FG001|Overall Study|Lost to Follow-up|3|||
25265387|NCT00992407|50579705|FG000|Overall Study|Adverse Event|3|||
25265388|NCT00992407|50579706|FG001|Overall Study|Adverse Event|2|||
25265389|NCT00992407|50579705|FG000|Overall Study|protocol Violation & Adverse events|2|||
25265390|NCT00992407|50579706|FG001|Overall Study|protocol Violation & Adverse events|4|||
25265391|NCT00992407|50579705|FG000|Overall Study|Other|2|||
25265392|NCT00992407|50579706|FG001|Overall Study|Other|0|||
25265393|NCT00992407|50579705|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
25265394|NCT00992407|50579706|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
25265395|NCT00992407|50579705|FG000|Overall Study|Study medication not administered|17|||
25265396|NCT00992407|50579706|FG001|Overall Study|Study medication not administered|13|||
25265397|NCT00986479|50579717|FG000|Period 1|Improved mood|1|||
25265398|NCT00986479|50579718|FG001|Period 1|Improved mood|0|||
25265399|NCT00986479|50579717|FG000|Period 1|Administrative reasons|1|||
25265400|NCT00986479|50579718|FG001|Period 1|Administrative reasons|0|||
25265401|NCT00986245|50579724|FG000|First Intervention|Poor compliance|8|||
25265402|NCT00986245|50579725|FG001|First Intervention|Poor compliance|4|||
25265403|NCT00986245|50579724|FG000|First Intervention|Lack of Efficacy|1|||
25265404|NCT00986245|50579725|FG001|First Intervention|Lack of Efficacy|2|||
25265405|NCT00986245|50579724|FG000|First Intervention|Withdrawal by Subject|0|||
25123954|NCT02273180|50236587|FG000|Overall Study|Randomized but not treated|1|||
25123955|NCT02273180|50236588|FG001|Overall Study|Randomized but not treated|0|||
25123956|NCT02273180|50236587|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
25123957|NCT02273180|50236588|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
25123958|NCT02273180|50236587|FG000|Overall Study|Other than specified above|21|||
25123959|NCT02273180|50236588|FG001|Overall Study|Other than specified above|10|||
25123960|NCT01746862|50236596|FG000|Overall Study|Withdrawal by Subject|1|||
25123961|NCT01746862|50236597|FG001|Overall Study|Withdrawal by Subject|1|||
25123962|NCT01746862|50236596|FG000|Overall Study|Protocol Violation|1|||
25123963|NCT01746862|50236597|FG001|Overall Study|Protocol Violation|0|||
25123964|NCT01746862|50236596|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
25123965|NCT01746862|50236597|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
25123966|NCT01746862|50236596|FG000|Overall Study|Entered puberty during the study|1|||
25123967|NCT01746862|50236597|FG001|Overall Study|Entered puberty during the study|0|||
25123968|NCT01745848|50236604|FG000|Overall Study|Adverse Event|6|||
25123969|NCT01745380|50236610|FG000|Overall Study|Lost to Follow-up|1|||
25123970|NCT01745380|50236611|FG001|Overall Study|Lost to Follow-up|0|||
25123971|NCT01745380|50236610|FG000|Overall Study|Lack of Efficacy|0|||
25123972|NCT01745380|50236611|FG001|Overall Study|Lack of Efficacy|1|||
25123973|NCT01745146|50236619|FG000|Overall Study|Withdrawal by Subject|1|||
25123974|NCT01745146|50236620|FG001|Overall Study|Withdrawal by Subject|3|||
25123975|NCT01745146|50236619|FG000|Overall Study|Lost to Follow-up|2|||
25123976|NCT01745146|50236620|FG001|Overall Study|Lost to Follow-up|0|||
25123977|NCT02272634|50236630|FG000|Overall Study|Adverse Event|1|||
25123978|NCT02272634|50236631|FG001|Overall Study|Adverse Event|0|||
25123979|NCT02272634|50236632|FG002|Overall Study|Adverse Event|0|||
25123980|NCT02272634|50236630|FG000|Overall Study|Protocol Violation|0|||
25123981|NCT02272634|50236631|FG001|Overall Study|Protocol Violation|0|||
25123982|NCT02272634|50236632|FG002|Overall Study|Protocol Violation|1|||
25265406|NCT00986245|50579725|FG001|First Intervention|Withdrawal by Subject|1|||
25265407|NCT00986245|50579724|FG000|First Intervention|Protocol Violation|0|||
25265408|NCT00986245|50579725|FG001|First Intervention|Protocol Violation|1|||
25265409|NCT00986245|50579724|FG000|First Intervention|Out of indication|1|||
25265410|NCT00986245|50579725|FG001|First Intervention|Out of indication|0|||
25265411|NCT00986245|50579724|FG000|Second Intervention|Poor compliance|1|||
25265412|NCT00986245|50579725|FG001|Second Intervention|Poor compliance|0|||
25265413|NCT00986245|50579724|FG000|Second Intervention|Lost to Follow-up|1|||
25265414|NCT00986245|50579725|FG001|Second Intervention|Lost to Follow-up|0|||
25123983|NCT02272634|50236630|FG000|Overall Study|Withdrawal by Subject|0|||
25123984|NCT02272634|50236631|FG001|Overall Study|Withdrawal by Subject|1|||
25123985|NCT02272634|50236632|FG002|Overall Study|Withdrawal by Subject|0|||
25123986|NCT02203513|50236648|FG000|Overall Study|Refused further treatment|2|||
25123987|NCT02203513|50236649|FG001|Overall Study|Refused further treatment|0|||
25123988|NCT02203513|50236650|FG002|Overall Study|Refused further treatment|1|||
25123989|NCT02203513|50236651|FG003|Overall Study|Refused further treatment|0|||
25265415|NCT00986245|50579724|FG000|Second Intervention|Protocol Violation|0|||
25265416|NCT00986245|50579725|FG001|Second Intervention|Protocol Violation|1|||
25265417|NCT00989833|50579739|FG000|Overall Study|Lost to Follow-up|0|||
25265418|NCT00989833|50579740|FG001|Overall Study|Lost to Follow-up|1|||
25123990|NCT02203513|50236652|FG004|Overall Study|Refused further treatment|0|||
25265419|NCT00989833|50579741|FG002|Overall Study|Lost to Follow-up|0|||
25265420|NCT00989833|50579739|FG000|Overall Study|Protocol Violation|1|||
25265421|NCT00989833|50579740|FG001|Overall Study|Protocol Violation|2|||
25265422|NCT00989833|50579741|FG002|Overall Study|Protocol Violation|1|||
25265423|NCT00989833|50579739|FG000|Overall Study|Withdrawal by Subject|0|||
25265424|NCT00989833|50579740|FG001|Overall Study|Withdrawal by Subject|0|||
25265425|NCT00989833|50579741|FG002|Overall Study|Withdrawal by Subject|1|||
25265426|NCT00989833|50579739|FG000|Overall Study|Incorrectly randomized|1|||
25265427|NCT00989833|50579740|FG001|Overall Study|Incorrectly randomized|0|||
25265428|NCT00989833|50579741|FG002|Overall Study|Incorrectly randomized|0|||
25265429|NCT01218477|50579753|FG000|Overall Study|Disease progression|2|||
25265430|NCT01218477|50579754|FG001|Overall Study|Disease progression|3|||
25265431|NCT01218477|50579755|FG002|Overall Study|Disease progression|6|||
25265432|NCT01218477|50579756|FG003|Overall Study|Disease progression|2|||
25265433|NCT01218477|50579753|FG000|Overall Study|Study drug toxicity|0|||
25177657|NCT01494467|50321725|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
25177658|NCT01494467|50321724|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
25177659|NCT01494467|50321725|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
25177660|NCT01494467|50321724|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
25177661|NCT01494467|50321725|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
25177662|NCT01494467|50321724|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
25177663|NCT01494467|50321725|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
25177664|NCT01493687|50321739|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
25177665|NCT01493687|50321740|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
25177666|NCT01493687|50321739|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
25177667|NCT01493687|50321740|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
25177668|NCT01493687|50321739|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
25177669|NCT01493687|50321740|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
25177670|NCT01493687|50321739|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
25177671|NCT01493687|50321740|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
25177672|NCT01493687|50321739|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
25177673|NCT01493687|50321740|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
25177674|NCT01493687|50321739|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
25177675|NCT01493687|50321740|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
25177676|NCT01493687|50321739|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
25177677|NCT01493687|50321740|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
25177678|NCT01493687|50321739|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
25177679|NCT01493687|50321740|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
25177680|NCT01493687|50321739|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
25177681|NCT01493687|50321740|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
25177682|NCT01493687|50321739|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
25177683|NCT01493687|50321740|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
25177684|NCT01493687|50321739|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
25177685|NCT01493687|50321740|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
25177686|NCT01493687|50321739|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
25177687|NCT01493687|50321740|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
25177688|NCT01493687|50321739|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
25009009|NCT03424044|50102225|FG004|First Intervention (76 Hours)|device issues|0|||
25265434|NCT01218477|50579754|FG001|Overall Study|Study drug toxicity|2|||
25265435|NCT01218477|50579755|FG002|Overall Study|Study drug toxicity|5|||
25265436|NCT01218477|50579756|FG003|Overall Study|Study drug toxicity|0|||
25009010|NCT03424044|50102226|FG005|First Intervention (76 Hours)|device issues|0|||
25009011|NCT03424044|50102227|FG006|First Intervention (76 Hours)|device issues|1|||
25009012|NCT03424044|50102228|FG007|First Intervention (76 Hours)|device issues|1|||
25009013|NCT03424044|50102229|FG008|First Intervention (76 Hours)|device issues|1|||
25009014|NCT03424044|50102221|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
25265437|NCT01218477|50579753|FG000|Overall Study|No longer meets study criteria|1|||
25265438|NCT01218477|50579754|FG001|Overall Study|No longer meets study criteria|0|||
25009015|NCT03424044|50102222|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
25009016|NCT03424044|50102223|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
25009017|NCT03424044|50102224|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
25009018|NCT03424044|50102225|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
25265439|NCT01218477|50579755|FG002|Overall Study|No longer meets study criteria|0|||
25265440|NCT01218477|50579756|FG003|Overall Study|No longer meets study criteria|0|||
25265441|NCT01218477|50579753|FG000|Overall Study|Withdrawal by Subject|0|||
25265442|NCT01218477|50579754|FG001|Overall Study|Withdrawal by Subject|0|||
25265443|NCT01218477|50579755|FG002|Overall Study|Withdrawal by Subject|1|||
25265444|NCT01218477|50579756|FG003|Overall Study|Withdrawal by Subject|0|||
25265445|NCT01218477|50579753|FG000|Overall Study|Prepared for cell transplantation|0|||
25009019|NCT03424044|50102226|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
25009020|NCT03424044|50102227|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
25009021|NCT03424044|50102228|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
25009022|NCT03424044|50102229|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
25009023|NCT03424044|50102221|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
25265446|NCT01218477|50579754|FG001|Overall Study|Prepared for cell transplantation|1|||
25265447|NCT01218477|50579755|FG002|Overall Study|Prepared for cell transplantation|1|||
25009024|NCT03424044|50102222|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
25009025|NCT03424044|50102223|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
25009026|NCT03424044|50102224|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
25009027|NCT03424044|50102225|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
25009028|NCT03424044|50102226|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
25009029|NCT03424044|50102227|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
25009030|NCT03424044|50102228|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
25009031|NCT03424044|50102229|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
25009032|NCT03422250|50102243|FG000|Intervention|Adverse Event|0|||
25009033|NCT03422250|50102244|FG001|Intervention|Adverse Event|1|||
25009034|NCT03422250|50102245|FG002|Intervention|Adverse Event|0|||
25009035|NCT03422250|50102246|FG003|Intervention|Adverse Event|1|||
25009036|NCT03422250|50102243|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
25009037|NCT03422250|50102244|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
25009038|NCT03422250|50102245|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
25009039|NCT03422250|50102246|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
25009040|NCT03422250|50102243|FG000|Follow-up|Withdrawal by Subject|0|||
25009041|NCT03422250|50102244|FG001|Follow-up|Withdrawal by Subject|0|||
25009042|NCT03422250|50102245|FG002|Follow-up|Withdrawal by Subject|0|||
25009043|NCT03422250|50102246|FG003|Follow-up|Withdrawal by Subject|1|||
25009044|NCT03422250|50102243|FG000|Follow-up|Adverse Event|0|||
25009045|NCT03422250|50102244|FG001|Follow-up|Adverse Event|0|||
25009046|NCT03422250|50102245|FG002|Follow-up|Adverse Event|0|||
25009047|NCT03422250|50102246|FG003|Follow-up|Adverse Event|1|||
25009048|NCT01266031|50102261|FG000|Overall Study|Not treated|0|||
25009049|NCT01266031|50102262|FG001|Overall Study|Not treated|3|||
25009050|NCT01266031|50102263|FG002|Overall Study|Not treated|2|||
25009051|NCT00075725|50102294|FG000|Overall Study|Adverse Event|6|||
25009052|NCT00075725|50102295|FG001|Overall Study|Adverse Event|6|||
25009053|NCT00075725|50102296|FG002|Overall Study|Adverse Event|20|||
25009054|NCT00075725|50102297|FG003|Overall Study|Adverse Event|8|||
25009055|NCT00075725|50102298|FG004|Overall Study|Adverse Event|4|||
25009056|NCT00075725|50102299|FG005|Overall Study|Adverse Event|38|||
25123991|NCT02203513|50236648|FG000|Overall Study|Switched to alternative treatment|3|||
25123992|NCT02203513|50236649|FG001|Overall Study|Switched to alternative treatment|4|||
25009057|NCT00075725|50102300|FG006|Overall Study|Adverse Event|3|||
25009058|NCT00075725|50102301|FG007|Overall Study|Adverse Event|51|||
25009059|NCT00075725|50102302|FG008|Overall Study|Adverse Event|15|||
25009060|NCT00075725|50102303|FG009|Overall Study|Adverse Event|4|||
25009061|NCT00075725|50102304|FG010|Overall Study|Adverse Event|2|||
25009062|NCT00075725|50102305|FG011|Overall Study|Adverse Event|2|||
25009063|NCT00075725|50102294|FG000|Overall Study|Death|3|||
25009064|NCT00075725|50102295|FG001|Overall Study|Death|5|||
25009065|NCT00075725|50102296|FG002|Overall Study|Death|10|||
25009066|NCT00075725|50102297|FG003|Overall Study|Death|2|||
25009067|NCT00075725|50102298|FG004|Overall Study|Death|3|||
25009068|NCT00075725|50102299|FG005|Overall Study|Death|25|||
25009069|NCT00075725|50102300|FG006|Overall Study|Death|4|||
25009070|NCT00075725|50102301|FG007|Overall Study|Death|22|||
25009071|NCT00075725|50102302|FG008|Overall Study|Death|14|||
25009072|NCT00075725|50102303|FG009|Overall Study|Death|4|||
25009073|NCT00075725|50102304|FG010|Overall Study|Death|3|||
25009074|NCT00075725|50102305|FG011|Overall Study|Death|0|||
25009075|NCT00075725|50102294|FG000|Overall Study|Lost to Follow-up|1|||
25009076|NCT00075725|50102295|FG001|Overall Study|Lost to Follow-up|1|||
25009077|NCT00075725|50102296|FG002|Overall Study|Lost to Follow-up|4|||
25009078|NCT00075725|50102297|FG003|Overall Study|Lost to Follow-up|1|||
25009079|NCT00075725|50102298|FG004|Overall Study|Lost to Follow-up|0|||
25009080|NCT00075725|50102299|FG005|Overall Study|Lost to Follow-up|13|||
25009081|NCT00075725|50102300|FG006|Overall Study|Lost to Follow-up|2|||
25009082|NCT00075725|50102301|FG007|Overall Study|Lost to Follow-up|4|||
25009083|NCT00075725|50102302|FG008|Overall Study|Lost to Follow-up|1|||
25009084|NCT00075725|50102303|FG009|Overall Study|Lost to Follow-up|0|||
25009085|NCT00075725|50102304|FG010|Overall Study|Lost to Follow-up|0|||
25009086|NCT00075725|50102305|FG011|Overall Study|Lost to Follow-up|0|||
25009087|NCT00075725|50102294|FG000|Overall Study|Physician Decision|2|||
25009088|NCT00075725|50102295|FG001|Overall Study|Physician Decision|6|||
25009089|NCT00075725|50102296|FG002|Overall Study|Physician Decision|5|||
25009090|NCT00075725|50102297|FG003|Overall Study|Physician Decision|8|||
25009091|NCT00075725|50102298|FG004|Overall Study|Physician Decision|4|||
25009092|NCT00075725|50102299|FG005|Overall Study|Physician Decision|19|||
25009093|NCT00075725|50102300|FG006|Overall Study|Physician Decision|3|||
25265448|NCT01218477|50579756|FG003|Overall Study|Prepared for cell transplantation|0|||
25265449|NCT01218477|50579753|FG000|Overall Study|Administrative reason by sponsor|0|||
25265450|NCT01218477|50579754|FG001|Overall Study|Administrative reason by sponsor|0|||
25265451|NCT01218477|50579755|FG002|Overall Study|Administrative reason by sponsor|1|||
25265452|NCT01218477|50579756|FG003|Overall Study|Administrative reason by sponsor|0|||
25265453|NCT01218477|50579753|FG000|Overall Study|Maximum clinical benefit|0|||
25265454|NCT01218477|50579754|FG001|Overall Study|Maximum clinical benefit|2|||
25265455|NCT01218477|50579755|FG002|Overall Study|Maximum clinical benefit|0|||
25265456|NCT01218477|50579756|FG003|Overall Study|Maximum clinical benefit|0|||
25265457|NCT01218243|50579772|FG000|Overall Study|Lack of Efficacy|1|||
25265458|NCT01218243|50579773|FG001|Overall Study|Lack of Efficacy|1|||
25265459|NCT01218243|50579772|FG000|Overall Study|Lost to Follow-up|3|||
25265460|NCT01218243|50579773|FG001|Overall Study|Lost to Follow-up|3|||
25265461|NCT01218243|50579772|FG000|Overall Study|Protocol Violation|5|||
25265462|NCT01218243|50579773|FG001|Overall Study|Protocol Violation|10|||
25265463|NCT00989287|50579781|FG000|Overall Study|Adverse Event|1|||
25265464|NCT00989287|50579782|FG001|Overall Study|Adverse Event|0|||
25265465|NCT00989287|50579781|FG000|Overall Study|Lost to Follow-up|0|||
25265466|NCT00989287|50579782|FG001|Overall Study|Lost to Follow-up|1|||
25265467|NCT01218087|50579803|FG000|Overall Study|Death|2|||
25265468|NCT01218087|50579804|FG001|Overall Study|Death|1|||
25265469|NCT01218087|50579803|FG000|Overall Study|Withdrawal by Subject|5|||
25265470|NCT01218087|50579804|FG001|Overall Study|Withdrawal by Subject|0|||
25265471|NCT01218087|50579803|FG000|Overall Study|Transferred|8|||
25265472|NCT01218087|50579804|FG001|Overall Study|Transferred|5|||
25265473|NCT01218009|50579812|FG000|Overall Study|Protocol Violation|2|||
25009094|NCT00075725|50102301|FG007|Overall Study|Physician Decision|17|||
25009095|NCT00075725|50102302|FG008|Overall Study|Physician Decision|5|||
25009096|NCT00075725|50102303|FG009|Overall Study|Physician Decision|0|||
25009097|NCT00075725|50102304|FG010|Overall Study|Physician Decision|1|||
25009098|NCT00075725|50102305|FG011|Overall Study|Physician Decision|0|||
25009099|NCT00075725|50102294|FG000|Overall Study|Pregnancy|0|||
25009100|NCT00075725|50102295|FG001|Overall Study|Pregnancy|0|||
25009101|NCT00075725|50102296|FG002|Overall Study|Pregnancy|0|||
25009102|NCT00075725|50102297|FG003|Overall Study|Pregnancy|0|||
25265474|NCT01218009|50579813|FG001|Overall Study|Protocol Violation|1|||
25265475|NCT01218009|50579812|FG000|Overall Study|Withdrawal by Subject|3|||
25009103|NCT00075725|50102298|FG004|Overall Study|Pregnancy|0|||
25009104|NCT00075725|50102299|FG005|Overall Study|Pregnancy|1|||
25009105|NCT00075725|50102300|FG006|Overall Study|Pregnancy|0|||
25009106|NCT00075725|50102301|FG007|Overall Study|Pregnancy|1|||
25123993|NCT02203513|50236650|FG002|Overall Study|Switched to alternative treatment|0|||
25123994|NCT02203513|50236651|FG003|Overall Study|Switched to alternative treatment|0|||
25123995|NCT02203513|50236652|FG004|Overall Study|Switched to alternative treatment|4|||
25123996|NCT02203513|50236648|FG000|Overall Study|Did not receive investigational product (IP)|0|||
25123997|NCT02203513|50236649|FG001|Overall Study|Did not receive investigational product (IP)|1|||
25123998|NCT02203513|50236650|FG002|Overall Study|Did not receive investigational product (IP)|0|||
25123999|NCT02203513|50236651|FG003|Overall Study|Did not receive investigational product (IP)|0|||
25124000|NCT02203513|50236652|FG004|Overall Study|Did not receive investigational product (IP)|0|||
25124001|NCT02203513|50236648|FG000|Overall Study|Death (unrelated to study therapy)|1|||
25124002|NCT02203513|50236649|FG001|Overall Study|Death (unrelated to study therapy)|3|||
25124003|NCT02203513|50236650|FG002|Overall Study|Death (unrelated to study therapy)|1|||
25124004|NCT02203513|50236651|FG003|Overall Study|Death (unrelated to study therapy)|0|||
25124005|NCT02203513|50236652|FG004|Overall Study|Death (unrelated to study therapy)|2|||
25124006|NCT02203513|50236648|FG000|Overall Study|Lost to Follow-up|0|||
25124007|NCT02203513|50236649|FG001|Overall Study|Lost to Follow-up|0|||
25124008|NCT02203513|50236650|FG002|Overall Study|Lost to Follow-up|1|||
25124009|NCT02203513|50236651|FG003|Overall Study|Lost to Follow-up|1|||
25124010|NCT02203513|50236652|FG004|Overall Study|Lost to Follow-up|0|||
25124011|NCT02299934|50236666|FG000|Overall Study|Termination of study|13|||
25124012|NCT01703260|50236673|FG000|Overall Study|Adverse Event|1|||
25124013|NCT01703260|50236674|FG001|Overall Study|Adverse Event|2|||
25124014|NCT01703260|50236675|FG002|Overall Study|Adverse Event|2|||
25124015|NCT01703260|50236673|FG000|Overall Study|Lost to Follow-up|1|||
25124016|NCT01703260|50236674|FG001|Overall Study|Lost to Follow-up|0|||
25124017|NCT01703260|50236675|FG002|Overall Study|Lost to Follow-up|0|||
25124018|NCT01703260|50236673|FG000|Overall Study|Withdrawal by Subject|0|||
25124019|NCT01703260|50236674|FG001|Overall Study|Withdrawal by Subject|0|||
25124020|NCT01703260|50236675|FG002|Overall Study|Withdrawal by Subject|1|||
25124021|NCT01703260|50236673|FG000|Overall Study|Study Termination|1|||
25124022|NCT01703260|50236674|FG001|Overall Study|Study Termination|2|||
25124023|NCT01703260|50236675|FG002|Overall Study|Study Termination|0|||
25124024|NCT02203357|50236686|FG000|Overall Study|Lost to Follow-up|58|||
25124025|NCT02203357|50236687|FG001|Overall Study|Lost to Follow-up|66|||
25124026|NCT02203357|50236688|FG002|Overall Study|Lost to Follow-up|70|||
25124027|NCT02299388|50236701|FG000|Overall Study|Withdrawal by Subject|0|||
25124028|NCT02299388|50236702|FG001|Overall Study|Withdrawal by Subject|1|||
25124029|NCT02202577|50236710|FG000|Overall Study|Lost to Follow-up|6|||
25124030|NCT02202577|50236711|FG001|Overall Study|Lost to Follow-up|16|||
25124031|NCT02202577|50236710|FG000|Overall Study|Protocol Violation|7|||
25124032|NCT02202577|50236711|FG001|Overall Study|Protocol Violation|3|||
25124033|NCT02299076|50236719|FG000|Overall Study|Fraudulent Entries|20|||
25124034|NCT02299076|50236720|FG001|Overall Study|Fraudulent Entries|14|||
25124035|NCT01723072|50236728|FG000|Overall Study|Withdrawal by Subject|7|||
25124036|NCT01723072|50236729|FG001|Overall Study|Withdrawal by Subject|13|||
25124037|NCT01723072|50236728|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
25124038|NCT01723072|50236729|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
25124039|NCT01723072|50236728|FG000|Overall Study|Other|4|||
25124040|NCT01723072|50236729|FG001|Overall Study|Other|3|||
25124041|NCT01722994|50236737|FG000|Overall Study|Missing data|25|||
25124042|NCT01722994|50236738|FG001|Overall Study|Missing data|17|||
25124043|NCT02228395|50236746|FG000|First Intervention Period|No longer willing to participate|1|||
25124044|NCT02228395|50236747|FG001|First Intervention Period|No longer willing to participate|0|||
25124045|NCT02228395|50236748|FG002|First Intervention Period|No longer willing to participate|0|||
25124046|NCT02228395|50236746|FG000|First Intervention Period|Unable to comply with study dates|0|||
25124047|NCT02228395|50236747|FG001|First Intervention Period|Unable to comply with study dates|1|||
25124048|NCT02228395|50236748|FG002|First Intervention Period|Unable to comply with study dates|1|||
25124049|NCT02170051|50236760|FG000|Overall Study|Withdrawal by Subject|10|||
25124050|NCT02170051|50236761|FG001|Overall Study|Withdrawal by Subject|10|||
25124051|NCT02170051|50236760|FG000|Overall Study|Lost to Follow-up|1|||
25124052|NCT02170051|50236761|FG001|Overall Study|Lost to Follow-up|3|||
25124053|NCT02169739|50236769|FG000|Overall Study|Lost to Follow-up|0|||
25124054|NCT02169739|50236770|FG001|Overall Study|Lost to Follow-up|4|||
25124055|NCT02169505|50236777|FG000|Overall Study|Withdrawal by Subject|1|||
25124056|NCT01909791|50236784|FG000|Overall Study|Death|9|||
25124057|NCT01909791|50236785|FG001|Overall Study|Death|8|||
25124058|NCT01909791|50236786|FG002|Overall Study|Death|4|||
25124059|NCT01909791|50236784|FG000|Overall Study|Withdrawal by Subject|5|||
25124060|NCT01909791|50236785|FG001|Overall Study|Withdrawal by Subject|9|||
25124061|NCT01909791|50236786|FG002|Overall Study|Withdrawal by Subject|13|||
25124062|NCT01909791|50236784|FG000|Overall Study|Lost to Follow-up|5|||
25124063|NCT01909791|50236785|FG001|Overall Study|Lost to Follow-up|11|||
25124064|NCT01909791|50236786|FG002|Overall Study|Lost to Follow-up|10|||
25124065|NCT01909791|50236784|FG000|Overall Study|Missed Visit|2|||
25124066|NCT01909791|50236785|FG001|Overall Study|Missed Visit|0|||
25124067|NCT01909791|50236786|FG002|Overall Study|Missed Visit|1|||
25265476|NCT01218009|50579813|FG001|Overall Study|Withdrawal by Subject|1|||
25265477|NCT01218009|50579812|FG000|Overall Study|Sponsor terminated study|161|||
25265478|NCT01218009|50579813|FG001|Overall Study|Sponsor terminated study|163|||
25265479|NCT00992017|50579819|FG000|Overall Study|Lost to Follow-up|2|||
25265480|NCT00992017|50579819|FG000|Overall Study|Withdrawal by Subject|2|||
25265481|NCT00992017|50579819|FG000|Overall Study|Unable to get to clinic|5|||
25265482|NCT00992017|50579819|FG000|Overall Study|Not adhere to study requirements|1|||
25265483|NCT01217463|50579830|FG000|Overall Study|Adverse Event|8|||
25265484|NCT01217463|50579831|FG001|Overall Study|Adverse Event|5|||
25265485|NCT01217463|50579830|FG000|Overall Study|Physician Decision|0|||
25265486|NCT01217463|50579831|FG001|Overall Study|Physician Decision|1|||
25265487|NCT01217463|50579830|FG000|Overall Study|Withdrawal by Subject|3|||
25265488|NCT01217463|50579831|FG001|Overall Study|Withdrawal by Subject|0|||
25265489|NCT01217463|50579830|FG000|Overall Study|Surgery on the Target Limb|0|||
25265490|NCT01217463|50579831|FG001|Overall Study|Surgery on the Target Limb|1|||
25265491|NCT01217463|50579830|FG000|Overall Study|Patient Non-compliant|1|||
25265492|NCT01217463|50579831|FG001|Overall Study|Patient Non-compliant|0|||
25265493|NCT01217463|50579830|FG000|Overall Study|Other|1|||
25265494|NCT01217463|50579831|FG001|Overall Study|Other|1|||
25265495|NCT01217307|50579841|FG000|Overall Study|Withdrawal by Subject|0|||
25265496|NCT01217307|50579842|FG001|Overall Study|Withdrawal by Subject|1|||
25265497|NCT01217229|50579848|FG000|Overall Study|Adverse Event|1|||
25265498|NCT01217229|50579848|FG000|Overall Study|Disease progression, deterioration|2|||
25265499|NCT01217229|50579848|FG000|Overall Study|Disease progression, Cheson criteria|14|||
25265500|NCT01217229|50579848|FG000|Overall Study|Protocol Violation|1|||
25265501|NCT01217229|50579848|FG000|Overall Study|Disease progression not confirmed|2|||
25265502|NCT01013740|50579854|FG000|Overall Study|Lost to Follow-up|3|||
25265503|NCT01013740|50579855|FG001|Overall Study|Lost to Follow-up|5|||
25265504|NCT01013740|50579854|FG000|Overall Study|Physician Decision|2|||
25009107|NCT00075725|50102302|FG008|Overall Study|Pregnancy|0|||
25009108|NCT00075725|50102303|FG009|Overall Study|Pregnancy|0|||
25009109|NCT00075725|50102304|FG010|Overall Study|Pregnancy|0|||
25009110|NCT00075725|50102305|FG011|Overall Study|Pregnancy|0|||
25009111|NCT00075725|50102294|FG000|Overall Study|Protocol Violation|1|||
25009112|NCT00075725|50102295|FG001|Overall Study|Protocol Violation|1|||
25009113|NCT00075725|50102296|FG002|Overall Study|Protocol Violation|0|||
25009114|NCT00075725|50102297|FG003|Overall Study|Protocol Violation|3|||
25009115|NCT00075725|50102298|FG004|Overall Study|Protocol Violation|3|||
25009116|NCT00075725|50102299|FG005|Overall Study|Protocol Violation|2|||
25009117|NCT00075725|50102300|FG006|Overall Study|Protocol Violation|1|||
25009118|NCT00075725|50102301|FG007|Overall Study|Protocol Violation|2|||
25009119|NCT00075725|50102302|FG008|Overall Study|Protocol Violation|3|||
25009120|NCT00075725|50102303|FG009|Overall Study|Protocol Violation|0|||
25009121|NCT00075725|50102304|FG010|Overall Study|Protocol Violation|0|||
25009122|NCT00075725|50102305|FG011|Overall Study|Protocol Violation|1|||
25009123|NCT00075725|50102294|FG000|Overall Study|Withdrawal by Subject|12|||
25009124|NCT00075725|50102295|FG001|Overall Study|Withdrawal by Subject|3|||
25009125|NCT00075725|50102296|FG002|Overall Study|Withdrawal by Subject|6|||
25009126|NCT00075725|50102297|FG003|Overall Study|Withdrawal by Subject|10|||
25009127|NCT00075725|50102298|FG004|Overall Study|Withdrawal by Subject|6|||
25009128|NCT00075725|50102299|FG005|Overall Study|Withdrawal by Subject|27|||
25009129|NCT00075725|50102300|FG006|Overall Study|Withdrawal by Subject|7|||
25009130|NCT00075725|50102301|FG007|Overall Study|Withdrawal by Subject|31|||
25009131|NCT00075725|50102302|FG008|Overall Study|Withdrawal by Subject|10|||
25009132|NCT00075725|50102303|FG009|Overall Study|Withdrawal by Subject|2|||
25009133|NCT00075725|50102304|FG010|Overall Study|Withdrawal by Subject|0|||
25009134|NCT00075725|50102305|FG011|Overall Study|Withdrawal by Subject|0|||
25009135|NCT00075725|50102294|FG000|Overall Study|Disease Progression, all other reasons|17|||
25009136|NCT00075725|50102295|FG001|Overall Study|Disease Progression, all other reasons|5|||
25009137|NCT00075725|50102296|FG002|Overall Study|Disease Progression, all other reasons|33|||
25009138|NCT00075725|50102297|FG003|Overall Study|Disease Progression, all other reasons|6|||
25009139|NCT00075725|50102298|FG004|Overall Study|Disease Progression, all other reasons|21|||
25009140|NCT00075725|50102299|FG005|Overall Study|Disease Progression, all other reasons|59|||
25009141|NCT00075725|50102300|FG006|Overall Study|Disease Progression, all other reasons|20|||
25009142|NCT00075725|50102301|FG007|Overall Study|Disease Progression, all other reasons|46|||
25009143|NCT00075725|50102302|FG008|Overall Study|Disease Progression, all other reasons|21|||
25009144|NCT00075725|50102303|FG009|Overall Study|Disease Progression, all other reasons|4|||
25009145|NCT00075725|50102304|FG010|Overall Study|Disease Progression, all other reasons|0|||
25009146|NCT00075725|50102305|FG011|Overall Study|Disease Progression, all other reasons|5|||
25265505|NCT01013740|50579855|FG001|Overall Study|Physician Decision|0|||
25265506|NCT01013740|50579854|FG000|Overall Study|Withdrawal by Subject|2|||
25009147|NCT00075725|50102294|FG000|Overall Study|Patient off treatment|0|||
25009148|NCT00075725|50102295|FG001|Overall Study|Patient off treatment|0|||
25009149|NCT00075725|50102296|FG002|Overall Study|Patient off treatment|1|||
25265507|NCT01013740|50579855|FG001|Overall Study|Withdrawal by Subject|10|||
25265508|NCT01013740|50579854|FG000|Overall Study|study close / terminated : done in error|2|||
25265509|NCT01013740|50579855|FG001|Overall Study|study close / terminated : done in error|1|||
25265510|NCT01013740|50579854|FG000|Overall Study|Missing|2|||
25265511|NCT01013740|50579855|FG001|Overall Study|Missing|1|||
25265512|NCT01013740|50579854|FG000|Overall Study|Ongoing: Study records not completed|0|||
25265513|NCT01013740|50579855|FG001|Overall Study|Ongoing: Study records not completed|2|||
25265514|NCT01013350|50579865|FG000|Overall Study|Lost to Follow-up|15|||
25265515|NCT01013350|50579866|FG001|Overall Study|Lost to Follow-up|95|||
25265516|NCT01013350|50579865|FG000|Overall Study|Adverse Event|0|||
25265517|NCT01013350|50579866|FG001|Overall Study|Adverse Event|1|||
25265518|NCT01013350|50579865|FG000|Overall Study|Physician Decision|4|||
25265519|NCT01013350|50579866|FG001|Overall Study|Physician Decision|20|||
25265520|NCT01013350|50579865|FG000|Overall Study|Withdrawal by Subject|15|||
25265521|NCT01013350|50579866|FG001|Overall Study|Withdrawal by Subject|38|||
25265522|NCT01013350|50579865|FG000|Overall Study|Death|3|||
25265523|NCT01013350|50579866|FG001|Overall Study|Death|5|||
25265524|NCT01013350|50579865|FG000|Overall Study|Participant entered interventional study|0|||
25265525|NCT01013350|50579866|FG001|Overall Study|Participant entered interventional study|8|||
25265526|NCT01013350|50579865|FG000|Overall Study|Other|1|||
25265527|NCT01013350|50579866|FG001|Overall Study|Other|25|||
25265528|NCT01018030|50579876|FG000|Overall Study|Adverse Event|10|||
25265529|NCT01018030|50579877|FG001|Overall Study|Adverse Event|5|||
25265530|NCT01018030|50579878|FG002|Overall Study|Adverse Event|5|||
25265531|NCT01018030|50579876|FG000|Overall Study|Withdrawal by Subject|2|||
25265532|NCT01018030|50579877|FG001|Overall Study|Withdrawal by Subject|2|||
25265533|NCT01018030|50579878|FG002|Overall Study|Withdrawal by Subject|4|||
25265534|NCT01018030|50579876|FG000|Overall Study|Lost to Follow-up|2|||
25265535|NCT01018030|50579877|FG001|Overall Study|Lost to Follow-up|0|||
25265536|NCT01018030|50579878|FG002|Overall Study|Lost to Follow-up|3|||
25265537|NCT01018030|50579876|FG000|Overall Study|Protocol Violation|2|||
25265538|NCT01018030|50579877|FG001|Overall Study|Protocol Violation|1|||
25265539|NCT01018030|50579878|FG002|Overall Study|Protocol Violation|0|||
25265540|NCT01018030|50579876|FG000|Overall Study|Physician Decision|1|||
25265541|NCT01018030|50579877|FG001|Overall Study|Physician Decision|0|||
25265542|NCT01018030|50579878|FG002|Overall Study|Physician Decision|1|||
25265543|NCT01018030|50579876|FG000|Overall Study|Lack of Efficacy|1|||
25265544|NCT01018030|50579877|FG001|Overall Study|Lack of Efficacy|0|||
25265545|NCT01018030|50579878|FG002|Overall Study|Lack of Efficacy|0|||
25265546|NCT01018030|50579876|FG000|Overall Study|Did Not Receive Study Drug|1|||
25265547|NCT01018030|50579877|FG001|Overall Study|Did Not Receive Study Drug|3|||
25265548|NCT01018030|50579878|FG002|Overall Study|Did Not Receive Study Drug|0|||
25265549|NCT01217073|50579894|FG000|Base Period|Adverse Event|1|||
25265550|NCT01217073|50579895|FG001|Base Period|Adverse Event|0|||
25265551|NCT01217073|50579896|FG002|Base Period|Adverse Event|1|||
25265552|NCT01217073|50579897|FG003|Base Period|Adverse Event|0|||
25265553|NCT01217073|50579898|FG004|Base Period|Adverse Event|4|||
25265554|NCT01217073|50579899|FG005|Base Period|Adverse Event|1|||
25265555|NCT01217073|50579900|FG006|Base Period|Adverse Event|0|||
25265556|NCT01217073|50579901|FG007|Base Period|Adverse Event|0|||
25265557|NCT01217073|50579894|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
25265558|NCT01217073|50579895|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
25265559|NCT01217073|50579896|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
25265560|NCT01217073|50579897|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
25265561|NCT01217073|50579898|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
25265562|NCT01217073|50579899|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
25265563|NCT01217073|50579900|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
25265564|NCT01217073|50579901|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
25265565|NCT01217073|50579894|FG000|Base Period|Excluded medication|0|||
25265566|NCT01217073|50579895|FG001|Base Period|Excluded medication|0|||
25265567|NCT01217073|50579896|FG002|Base Period|Excluded medication|0|||
25124068|NCT02202499|50236802|FG000|Overall Study|Cancer diagnosis|0|||
25265568|NCT01217073|50579897|FG003|Base Period|Excluded medication|0|||
25265569|NCT01217073|50579898|FG004|Base Period|Excluded medication|1|||
25265570|NCT01217073|50579899|FG005|Base Period|Excluded medication|0|||
25265571|NCT01217073|50579900|FG006|Base Period|Excluded medication|0|||
25265572|NCT01217073|50579901|FG007|Base Period|Excluded medication|0|||
25265573|NCT01217073|50579894|FG000|Base Period|Lack of Efficacy|0|||
25265574|NCT01217073|50579895|FG001|Base Period|Lack of Efficacy|0|||
25265575|NCT01217073|50579896|FG002|Base Period|Lack of Efficacy|0|||
25265576|NCT01217073|50579897|FG003|Base Period|Lack of Efficacy|0|||
25124069|NCT02202499|50236803|FG001|Overall Study|Cancer diagnosis|0|||
25265577|NCT01217073|50579898|FG004|Base Period|Lack of Efficacy|0|||
25265578|NCT01217073|50579899|FG005|Base Period|Lack of Efficacy|1|||
25265579|NCT01217073|50579900|FG006|Base Period|Lack of Efficacy|0|||
25124070|NCT02202499|50236804|FG002|Overall Study|Cancer diagnosis|1|||
25265580|NCT01217073|50579901|FG007|Base Period|Lack of Efficacy|0|||
25265581|NCT01217073|50579894|FG000|Base Period|Lost to Follow-up|0|||
25265582|NCT01217073|50579895|FG001|Base Period|Lost to Follow-up|0|||
25265583|NCT01217073|50579896|FG002|Base Period|Lost to Follow-up|1|||
25265584|NCT01217073|50579897|FG003|Base Period|Lost to Follow-up|1|||
25265585|NCT01217073|50579898|FG004|Base Period|Lost to Follow-up|3|||
25265586|NCT01217073|50579899|FG005|Base Period|Lost to Follow-up|0|||
25265587|NCT01217073|50579900|FG006|Base Period|Lost to Follow-up|0|||
25265588|NCT01217073|50579901|FG007|Base Period|Lost to Follow-up|0|||
25265589|NCT01217073|50579894|FG000|Base Period|Physician Decision|0|||
25265590|NCT01217073|50579895|FG001|Base Period|Physician Decision|0|||
25265591|NCT01217073|50579896|FG002|Base Period|Physician Decision|0|||
25265592|NCT01217073|50579897|FG003|Base Period|Physician Decision|0|||
25265593|NCT01217073|50579898|FG004|Base Period|Physician Decision|1|||
25265594|NCT01217073|50579899|FG005|Base Period|Physician Decision|0|||
25265595|NCT01217073|50579900|FG006|Base Period|Physician Decision|0|||
25265596|NCT01217073|50579901|FG007|Base Period|Physician Decision|0|||
25265597|NCT01217073|50579894|FG000|Base Period|Protocol Violation|1|||
25265598|NCT01217073|50579895|FG001|Base Period|Protocol Violation|0|||
25265599|NCT01217073|50579896|FG002|Base Period|Protocol Violation|0|||
25265600|NCT01217073|50579897|FG003|Base Period|Protocol Violation|0|||
25265601|NCT01217073|50579898|FG004|Base Period|Protocol Violation|1|||
25265602|NCT01217073|50579899|FG005|Base Period|Protocol Violation|2|||
25265603|NCT01217073|50579900|FG006|Base Period|Protocol Violation|0|||
25265604|NCT01217073|50579901|FG007|Base Period|Protocol Violation|0|||
25265605|NCT01217073|50579894|FG000|Base Period|Withdrawal by Subject|4|||
25265606|NCT01217073|50579895|FG001|Base Period|Withdrawal by Subject|5|||
25124071|NCT02202499|50236802|FG000|Overall Study|Moved from area|0|||
25124072|NCT02202499|50236803|FG001|Overall Study|Moved from area|0|||
25124073|NCT02202499|50236804|FG002|Overall Study|Moved from area|1|||
25124074|NCT02202499|50236802|FG000|Overall Study|Declined before randomization|1|||
25124075|NCT02202499|50236803|FG001|Overall Study|Declined before randomization|0|||
25124076|NCT02202499|50236804|FG002|Overall Study|Declined before randomization|0|||
25124077|NCT02202499|50236802|FG000|Overall Study|Auto accident|1|||
25124078|NCT02202499|50236803|FG001|Overall Study|Auto accident|0|||
25124079|NCT02202499|50236804|FG002|Overall Study|Auto accident|0|||
25124080|NCT02202109|50236819|FG000|Overall Study|Lost to Follow-up|88|||
25124081|NCT02202109|50236820|FG001|Overall Study|Lost to Follow-up|87|||
25177689|NCT01493687|50321740|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
25124082|NCT02202109|50236819|FG000|Overall Study|Withdrawal by Subject|2|||
25124083|NCT02202109|50236820|FG001|Overall Study|Withdrawal by Subject|0|||
25124084|NCT02227849|50236826|FG000|Overall Study|Adverse Event|4|||
25124085|NCT02227849|50236826|FG000|Overall Study|Physician Decision|1|||
25124086|NCT02227849|50236826|FG000|Overall Study|Withdrawal by Subject|3|||
25124087|NCT01927497|50236832|FG000|Overall Study|Death|0|||
25124088|NCT01927497|50236833|FG001|Overall Study|Death|1|||
25124089|NCT01927497|50236832|FG000|Overall Study|Protocol Violation|2|||
25124090|NCT01927497|50236833|FG001|Overall Study|Protocol Violation|0|||
25124091|NCT02169271|50236841|FG000|Overall Study|Protocol Violation|1|||
25124092|NCT02169271|50236842|FG001|Overall Study|Protocol Violation|2|||
25124093|NCT02202031|50236850|FG000|Overall Study|Lost to Follow-up|1|||
25124094|NCT02202031|50236851|FG001|Overall Study|Lost to Follow-up|0|||
25124095|NCT02202031|50236850|FG000|Overall Study|Too Busy|1|||
25124096|NCT02202031|50236851|FG001|Overall Study|Too Busy|3|||
25124097|NCT02202031|50236850|FG000|Overall Study|Illness/Medical Reason|0|||
25124098|NCT02202031|50236851|FG001|Overall Study|Illness/Medical Reason|2|||
25124099|NCT02202031|50236850|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
25124100|NCT02202031|50236851|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
25124101|NCT01644188|50236859|FG000|Overall Study|Adverse Event|44|||
25124102|NCT01644188|50236860|FG001|Overall Study|Adverse Event|20|||
25124103|NCT01644188|50236859|FG000|Overall Study|Poor compliance to protocol|26|||
25177690|NCT01493687|50321739|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
25177691|NCT01493687|50321740|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
25177692|NCT01493687|50321739|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
25177693|NCT01493687|50321740|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
25177694|NCT01523587|50321772|FG000|Overall Study|Other than listed|5|||
25177695|NCT01523587|50321773|FG001|Overall Study|Other than listed|5|||
25177696|NCT01523587|50321772|FG000|Overall Study|Worsening of underlying cancer disease|19|||
25177697|NCT01523587|50321773|FG001|Overall Study|Worsening of underlying cancer disease|34|||
25177698|NCT01523587|50321772|FG000|Overall Study|Adverse Event|68|||
25265607|NCT01217073|50579896|FG002|Base Period|Withdrawal by Subject|5|||
25265608|NCT01217073|50579897|FG003|Base Period|Withdrawal by Subject|1|||
25124104|NCT01644188|50236860|FG001|Overall Study|Poor compliance to protocol|14|||
25124105|NCT01644188|50236859|FG000|Overall Study|Physician Decision|1|||
25177699|NCT01523587|50321773|FG001|Overall Study|Adverse Event|52|||
25265609|NCT01217073|50579898|FG004|Base Period|Withdrawal by Subject|5|||
25265610|NCT01217073|50579899|FG005|Base Period|Withdrawal by Subject|5|||
25124106|NCT01644188|50236860|FG001|Overall Study|Physician Decision|3|||
25124107|NCT01644188|50236859|FG000|Overall Study|Participant moved|7|||
25265611|NCT01217073|50579900|FG006|Base Period|Withdrawal by Subject|0|||
25265612|NCT01217073|50579901|FG007|Base Period|Withdrawal by Subject|0|||
25177700|NCT01523587|50321772|FG000|Overall Study|Protocol Violation|5|||
25177701|NCT01523587|50321773|FG001|Overall Study|Protocol Violation|3|||
25177702|NCT01523587|50321772|FG000|Overall Study|Lost to Follow-up|2|||
25177703|NCT01523587|50321773|FG001|Overall Study|Lost to Follow-up|2|||
25177704|NCT01523587|50321772|FG000|Overall Study|Withdrawal by Subject|28|||
25177705|NCT01523587|50321773|FG001|Overall Study|Withdrawal by Subject|20|||
25177706|NCT01523587|50321772|FG000|Overall Study|Withdrew due to Progressive disease|265|||
25177707|NCT01523587|50321773|FG001|Overall Study|Withdrew due to Progressive disease|279|||
25177708|NCT01523587|50321772|FG000|Overall Study|Randomised but bot treated|6|||
25177709|NCT01523587|50321773|FG001|Overall Study|Randomised but bot treated|2|||
25177710|NCT01493531|50321802|FG000|Overall Study|Adverse Event|4|||
25265613|NCT01217073|50579894|FG000|Extension Period|Adverse Event|0|||
25265614|NCT01217073|50579895|FG001|Extension Period|Adverse Event|0|||
25265615|NCT01217073|50579896|FG002|Extension Period|Adverse Event|0|||
25265616|NCT01217073|50579897|FG003|Extension Period|Adverse Event|0|||
25265617|NCT01217073|50579898|FG004|Extension Period|Adverse Event|0|||
25265618|NCT01217073|50579899|FG005|Extension Period|Adverse Event|0|||
25265619|NCT01217073|50579900|FG006|Extension Period|Adverse Event|19|||
25265620|NCT01217073|50579901|FG007|Extension Period|Adverse Event|5|||
25265621|NCT01217073|50579894|FG000|Extension Period|ALT/AST|0|||
25265622|NCT01217073|50579895|FG001|Extension Period|ALT/AST|0|||
25265623|NCT01217073|50579896|FG002|Extension Period|ALT/AST|0|||
25265624|NCT01217073|50579897|FG003|Extension Period|ALT/AST|0|||
25265625|NCT01217073|50579898|FG004|Extension Period|ALT/AST|0|||
25265626|NCT01217073|50579899|FG005|Extension Period|ALT/AST|0|||
25265627|NCT01217073|50579900|FG006|Extension Period|ALT/AST|2|||
25265628|NCT01217073|50579901|FG007|Extension Period|ALT/AST|0|||
25265629|NCT01217073|50579894|FG000|Extension Period|Contraindication to study medication|0|||
25265630|NCT01217073|50579895|FG001|Extension Period|Contraindication to study medication|0|||
25265631|NCT01217073|50579896|FG002|Extension Period|Contraindication to study medication|0|||
25265632|NCT01217073|50579897|FG003|Extension Period|Contraindication to study medication|0|||
25265633|NCT01217073|50579898|FG004|Extension Period|Contraindication to study medication|0|||
25265634|NCT01217073|50579899|FG005|Extension Period|Contraindication to study medication|0|||
25265635|NCT01217073|50579900|FG006|Extension Period|Contraindication to study medication|1|||
25265636|NCT01217073|50579901|FG007|Extension Period|Contraindication to study medication|0|||
25265637|NCT01217073|50579894|FG000|Extension Period|Creatinine/eGFR|0|||
25265638|NCT01217073|50579895|FG001|Extension Period|Creatinine/eGFR|0|||
25265639|NCT01217073|50579896|FG002|Extension Period|Creatinine/eGFR|0|||
25265640|NCT01217073|50579897|FG003|Extension Period|Creatinine/eGFR|0|||
25265641|NCT01217073|50579898|FG004|Extension Period|Creatinine/eGFR|0|||
25265642|NCT01217073|50579899|FG005|Extension Period|Creatinine/eGFR|0|||
25265643|NCT01217073|50579900|FG006|Extension Period|Creatinine/eGFR|11|||
25265644|NCT01217073|50579901|FG007|Extension Period|Creatinine/eGFR|1|||
25265645|NCT01217073|50579894|FG000|Extension Period|Death|0|||
25265646|NCT01217073|50579895|FG001|Extension Period|Death|0|||
25265647|NCT01217073|50579896|FG002|Extension Period|Death|0|||
25265648|NCT01217073|50579897|FG003|Extension Period|Death|0|||
25265649|NCT01217073|50579898|FG004|Extension Period|Death|0|||
25177711|NCT01493531|50321803|FG001|Overall Study|Adverse Event|12|||
25265650|NCT01217073|50579899|FG005|Extension Period|Death|0|||
25265651|NCT01217073|50579900|FG006|Extension Period|Death|1|||
25265652|NCT01217073|50579901|FG007|Extension Period|Death|0|||
25265653|NCT01217073|50579894|FG000|Extension Period|Excluded medication|0|||
25177712|NCT01493531|50321804|FG002|Overall Study|Adverse Event|9|||
25177713|NCT01493531|50321802|FG000|Overall Study|Gout flare|3|||
25265654|NCT01217073|50579895|FG001|Extension Period|Excluded medication|0|||
25265655|NCT01217073|50579896|FG002|Extension Period|Excluded medication|0|||
25265656|NCT01217073|50579897|FG003|Extension Period|Excluded medication|0|||
25265657|NCT01217073|50579898|FG004|Extension Period|Excluded medication|0|||
25265658|NCT01217073|50579899|FG005|Extension Period|Excluded medication|0|||
25124108|NCT01644188|50236860|FG001|Overall Study|Participant moved|2|||
25124109|NCT01644188|50236859|FG000|Overall Study|Related to auto-injector administration|2|||
25124110|NCT01644188|50236860|FG001|Overall Study|Related to auto-injector administration|2|||
25124111|NCT01644188|50236859|FG000|Overall Study|Consent withdrawn by participant|14|||
25124112|NCT01644188|50236860|FG001|Overall Study|Consent withdrawn by participant|7|||
25124113|NCT01644188|50236859|FG000|Overall Study|Selection criteria finally not met|2|||
25124114|NCT01644188|50236860|FG001|Overall Study|Selection criteria finally not met|0|||
25124115|NCT01644188|50236859|FG000|Overall Study|Lost to Follow-up|1|||
25124116|NCT01644188|50236860|FG001|Overall Study|Lost to Follow-up|0|||
25124117|NCT01644188|50236859|FG000|Overall Study|Death|4|||
25124118|NCT01644188|50236860|FG001|Overall Study|Death|3|||
25124119|NCT01644188|50236859|FG000|Overall Study|Last visit outside protocol visit window|14|||
25124120|NCT01644188|50236860|FG001|Overall Study|Last visit outside protocol visit window|16|||
25124121|NCT01644188|50236859|FG000|Overall Study|Site closure|1|||
25124122|NCT01644188|50236860|FG001|Overall Study|Site closure|1|||
25124123|NCT01644188|50236859|FG000|Overall Study|Other than specified above|6|||
25124124|NCT01644188|50236860|FG001|Overall Study|Other than specified above|7|||
25124125|NCT02201953|50236868|FG000|Overall Study|Randomized but Never Treated|1|||
25124126|NCT02201953|50236869|FG001|Overall Study|Randomized but Never Treated|5|||
25124127|NCT02201953|50236868|FG000|Overall Study|Lack of Efficacy|9|||
25124128|NCT02201953|50236869|FG001|Overall Study|Lack of Efficacy|30|||
25124129|NCT02201953|50236868|FG000|Overall Study|Lost to Follow-up|8|||
25265659|NCT01217073|50579900|FG006|Extension Period|Excluded medication|2|||
25009150|NCT00075725|50102297|FG003|Overall Study|Patient off treatment|2|||
25009151|NCT00075725|50102298|FG004|Overall Study|Patient off treatment|1|||
25009152|NCT00075725|50102299|FG005|Overall Study|Patient off treatment|0|||
25009153|NCT00075725|50102300|FG006|Overall Study|Patient off treatment|0|||
25124130|NCT02201953|50236869|FG001|Overall Study|Lost to Follow-up|8|||
25124131|NCT02201953|50236868|FG000|Overall Study|Withdrew Consent|2|||
25124132|NCT02201953|50236869|FG001|Overall Study|Withdrew Consent|5|||
25124133|NCT02201953|50236868|FG000|Overall Study|Adverse Event|0|||
25265660|NCT01217073|50579901|FG007|Extension Period|Excluded medication|0|||
25265661|NCT01217073|50579894|FG000|Extension Period|Lack of Efficacy|0|||
25265662|NCT01217073|50579895|FG001|Extension Period|Lack of Efficacy|0|||
25265663|NCT01217073|50579896|FG002|Extension Period|Lack of Efficacy|0|||
25265664|NCT01217073|50579897|FG003|Extension Period|Lack of Efficacy|0|||
25265665|NCT01217073|50579898|FG004|Extension Period|Lack of Efficacy|0|||
25265666|NCT01217073|50579899|FG005|Extension Period|Lack of Efficacy|0|||
25265667|NCT01217073|50579900|FG006|Extension Period|Lack of Efficacy|3|||
25265668|NCT01217073|50579901|FG007|Extension Period|Lack of Efficacy|0|||
25265669|NCT01217073|50579894|FG000|Extension Period|Lost to Follow-up|0|||
25265670|NCT01217073|50579895|FG001|Extension Period|Lost to Follow-up|0|||
25265671|NCT01217073|50579896|FG002|Extension Period|Lost to Follow-up|0|||
25265672|NCT01217073|50579897|FG003|Extension Period|Lost to Follow-up|0|||
25265673|NCT01217073|50579898|FG004|Extension Period|Lost to Follow-up|0|||
25265674|NCT01217073|50579899|FG005|Extension Period|Lost to Follow-up|0|||
25265675|NCT01217073|50579900|FG006|Extension Period|Lost to Follow-up|9|||
25265676|NCT01217073|50579901|FG007|Extension Period|Lost to Follow-up|1|||
25265677|NCT01217073|50579894|FG000|Extension Period|Non-compliance with study drug|0|||
25265678|NCT01217073|50579895|FG001|Extension Period|Non-compliance with study drug|0|||
25265679|NCT01217073|50579896|FG002|Extension Period|Non-compliance with study drug|0|||
25265680|NCT01217073|50579897|FG003|Extension Period|Non-compliance with study drug|0|||
25265681|NCT01217073|50579898|FG004|Extension Period|Non-compliance with study drug|0|||
25265682|NCT01217073|50579899|FG005|Extension Period|Non-compliance with study drug|0|||
25265683|NCT01217073|50579900|FG006|Extension Period|Non-compliance with study drug|0|||
25265684|NCT01217073|50579901|FG007|Extension Period|Non-compliance with study drug|1|||
25265685|NCT01217073|50579894|FG000|Extension Period|Physician Decision|0|||
25265686|NCT01217073|50579895|FG001|Extension Period|Physician Decision|0|||
25265687|NCT01217073|50579896|FG002|Extension Period|Physician Decision|0|||
25265688|NCT01217073|50579897|FG003|Extension Period|Physician Decision|0|||
25265689|NCT01217073|50579898|FG004|Extension Period|Physician Decision|0|||
25265690|NCT01217073|50579899|FG005|Extension Period|Physician Decision|0|||
25265691|NCT01217073|50579900|FG006|Extension Period|Physician Decision|4|||
25265692|NCT01217073|50579901|FG007|Extension Period|Physician Decision|1|||
25265693|NCT01217073|50579894|FG000|Extension Period|Protocol Violation|0|||
25265694|NCT01217073|50579895|FG001|Extension Period|Protocol Violation|0|||
25265695|NCT01217073|50579896|FG002|Extension Period|Protocol Violation|0|||
25265696|NCT01217073|50579897|FG003|Extension Period|Protocol Violation|0|||
25265697|NCT01217073|50579898|FG004|Extension Period|Protocol Violation|0|||
25265698|NCT01217073|50579899|FG005|Extension Period|Protocol Violation|0|||
25265699|NCT01217073|50579900|FG006|Extension Period|Protocol Violation|2|||
25265700|NCT01217073|50579901|FG007|Extension Period|Protocol Violation|1|||
25265701|NCT01217073|50579894|FG000|Extension Period|Site discontinued study participation|0|||
25265702|NCT01217073|50579895|FG001|Extension Period|Site discontinued study participation|0|||
25265703|NCT01217073|50579896|FG002|Extension Period|Site discontinued study participation|0|||
25265704|NCT01217073|50579897|FG003|Extension Period|Site discontinued study participation|0|||
25265705|NCT01217073|50579898|FG004|Extension Period|Site discontinued study participation|0|||
25265706|NCT01217073|50579899|FG005|Extension Period|Site discontinued study participation|0|||
25265707|NCT01217073|50579900|FG006|Extension Period|Site discontinued study participation|7|||
25124134|NCT02201953|50236869|FG001|Overall Study|Adverse Event|5|||
25124135|NCT02201953|50236868|FG000|Overall Study|Death|0|||
25124136|NCT02201953|50236869|FG001|Overall Study|Death|3|||
25124137|NCT02271854|50236875|FG000|Overall Study|Withdrawal by Subject|2|||
25124138|NCT02271854|50236875|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
25124139|NCT02271854|50236875|FG000|Overall Study|Lost to Follow-up|1|||
25124140|NCT02296892|50236883|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
25124141|NCT02296892|50236884|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
25124142|NCT02296892|50236885|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
25124143|NCT02296892|50236883|FG000|Overall Study|Lost to Follow-up|5|||
25124144|NCT02296892|50236884|FG001|Overall Study|Lost to Follow-up|0|||
25124145|NCT02296892|50236885|FG002|Overall Study|Lost to Follow-up|1|||
25124146|NCT02270684|50236895|FG000|Overall Study|Lost to Follow-up|0|||
25124147|NCT02270684|50236896|FG001|Overall Study|Lost to Follow-up|3|||
25124148|NCT02270684|50236895|FG000|Overall Study|Study terminated|1|||
25124149|NCT02270684|50236896|FG001|Overall Study|Study terminated|0|||
25124150|NCT02168803|50236905|FG000|Overall Study|Lost to Follow-up|1|||
25124151|NCT02168803|50236906|FG001|Overall Study|Lost to Follow-up|0|||
25124152|NCT02168803|50236907|FG002|Overall Study|Lost to Follow-up|1|||
25124153|NCT02168803|50236905|FG000|Overall Study|Withdrawal by Subject|1|||
25124154|NCT02168803|50236906|FG001|Overall Study|Withdrawal by Subject|1|||
25177714|NCT01493531|50321803|FG001|Overall Study|Gout flare|0|||
25177715|NCT01493531|50321804|FG002|Overall Study|Gout flare|2|||
25177716|NCT01493531|50321802|FG000|Overall Study|Protocol Violation|8|||
25177717|NCT01493531|50321803|FG001|Overall Study|Protocol Violation|15|||
25177718|NCT01493531|50321804|FG002|Overall Study|Protocol Violation|12|||
25177719|NCT01493531|50321802|FG000|Overall Study|Sponsor terminated study|5|||
25177720|NCT01493531|50321803|FG001|Overall Study|Sponsor terminated study|2|||
25177721|NCT01493531|50321804|FG002|Overall Study|Sponsor terminated study|3|||
25177722|NCT01493531|50321802|FG000|Overall Study|Lost to Follow-up|5|||
25177723|NCT01493531|50321803|FG001|Overall Study|Lost to Follow-up|7|||
25177724|NCT01493531|50321804|FG002|Overall Study|Lost to Follow-up|11|||
25177725|NCT01493531|50321802|FG000|Overall Study|Withdrawal by Subject|16|||
25177726|NCT01493531|50321803|FG001|Overall Study|Withdrawal by Subject|13|||
25177727|NCT01493531|50321804|FG002|Overall Study|Withdrawal by Subject|11|||
25177728|NCT01493531|50321802|FG000|Overall Study|Death|0|||
25177729|NCT01493531|50321803|FG001|Overall Study|Death|1|||
25177730|NCT01493531|50321804|FG002|Overall Study|Death|0|||
25177731|NCT01523275|50321828|FG000|Overall Study|Lost to Follow-up|1|||
25177732|NCT01523275|50321829|FG001|Overall Study|Lost to Follow-up|2|||
25177733|NCT01523275|50321828|FG000|Overall Study|Withdrawal by Subject|1|||
25265708|NCT01217073|50579901|FG007|Extension Period|Site discontinued study participation|2|||
25265709|NCT01217073|50579894|FG000|Extension Period|Withdrawal by Subject|0|||
25265710|NCT01217073|50579895|FG001|Extension Period|Withdrawal by Subject|0|||
25265711|NCT01217073|50579896|FG002|Extension Period|Withdrawal by Subject|0|||
25265712|NCT01217073|50579897|FG003|Extension Period|Withdrawal by Subject|0|||
25265713|NCT01217073|50579898|FG004|Extension Period|Withdrawal by Subject|0|||
25265714|NCT01217073|50579899|FG005|Extension Period|Withdrawal by Subject|0|||
25265715|NCT01217073|50579900|FG006|Extension Period|Withdrawal by Subject|30|||
25265716|NCT01217073|50579901|FG007|Extension Period|Withdrawal by Subject|8|||
25265717|NCT00985621|50579929|FG000|Overall Study|Adverse Event|2|||
25265718|NCT00985621|50579930|FG001|Overall Study|Adverse Event|3|||
25265719|NCT00985621|50579931|FG002|Overall Study|Adverse Event|4|||
25265720|NCT00985621|50579932|FG003|Overall Study|Adverse Event|16|||
25265721|NCT00985621|50579929|FG000|Overall Study|Lack of Efficacy|10|||
25265722|NCT00985621|50579930|FG001|Overall Study|Lack of Efficacy|6|||
25265723|NCT00985621|50579931|FG002|Overall Study|Lack of Efficacy|5|||
25265724|NCT00985621|50579932|FG003|Overall Study|Lack of Efficacy|12|||
25265725|NCT00985621|50579929|FG000|Overall Study|Lost to Follow-up|2|||
25265726|NCT00985621|50579930|FG001|Overall Study|Lost to Follow-up|3|||
25265727|NCT00985621|50579931|FG002|Overall Study|Lost to Follow-up|4|||
25265728|NCT00985621|50579932|FG003|Overall Study|Lost to Follow-up|4|||
25265729|NCT00985621|50579929|FG000|Overall Study|Study Terminated by Sponsor|89|||
25265730|NCT00985621|50579930|FG001|Overall Study|Study Terminated by Sponsor|108|||
25265731|NCT00985621|50579931|FG002|Overall Study|Study Terminated by Sponsor|99|||
25265732|NCT00985621|50579932|FG003|Overall Study|Study Terminated by Sponsor|92|||
25265733|NCT00985621|50579929|FG000|Overall Study|Protocol Violation|1|||
25265734|NCT00985621|50579930|FG001|Overall Study|Protocol Violation|1|||
25265735|NCT00985621|50579931|FG002|Overall Study|Protocol Violation|1|||
25265736|NCT00985621|50579932|FG003|Overall Study|Protocol Violation|0|||
25265737|NCT00985621|50579929|FG000|Overall Study|Withdrawal by Subject|8|||
25265738|NCT00985621|50579930|FG001|Overall Study|Withdrawal by Subject|10|||
25265739|NCT00985621|50579931|FG002|Overall Study|Withdrawal by Subject|8|||
25265740|NCT00985621|50579932|FG003|Overall Study|Withdrawal by Subject|12|||
25265741|NCT00985621|50579929|FG000|Overall Study|Other|1|||
25265742|NCT00985621|50579930|FG001|Overall Study|Other|0|||
25265743|NCT00985621|50579931|FG002|Overall Study|Other|0|||
25265744|NCT00985621|50579932|FG003|Overall Study|Other|0|||
25265745|NCT00985621|50579929|FG000|Overall Study|Randomized but not Treated|1|||
25265746|NCT00985621|50579930|FG001|Overall Study|Randomized but not Treated|0|||
25265747|NCT00985621|50579931|FG002|Overall Study|Randomized but not Treated|2|||
25265748|NCT00985621|50579932|FG003|Overall Study|Randomized but not Treated|1|||
25265749|NCT01215981|50579946|FG000|Overall Study|Physician Decision|0|||
25265750|NCT01215981|50579947|FG001|Overall Study|Physician Decision|1|||
25265751|NCT01215981|50579946|FG000|Overall Study|Protocol Violation|1|||
25265752|NCT01215981|50579947|FG001|Overall Study|Protocol Violation|0|||
25265753|NCT01215981|50579946|FG000|Overall Study|Withdrawal by Subject|1|||
25265754|NCT01215981|50579947|FG001|Overall Study|Withdrawal by Subject|0|||
25265755|NCT01215513|50579953|FG000|Overall Study|Not completed CS42|9|||
25265756|NCT01215513|50579953|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
25265757|NCT01215513|50579953|FG000|Overall Study|Adverse event (CS42A)|2|||
25265758|NCT01215513|50579953|FG000|Overall Study|Physician decision (CS42A)|6|||
25265759|NCT01215513|50579953|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
25265760|NCT01215513|50579953|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
25265761|NCT01215435|50579960|FG000|Overall Study|Adverse Event|1|||
25265762|NCT01215435|50579961|FG001|Overall Study|Adverse Event|0|||
25265763|NCT01215435|50579960|FG000|Overall Study|Protocol Violation|2|||
25265764|NCT01215435|50579961|FG001|Overall Study|Protocol Violation|0|||
25265765|NCT01215435|50579960|FG000|Overall Study|Withdrawal Criteria|8|||
25265766|NCT01215435|50579961|FG001|Overall Study|Withdrawal Criteria|11|||
25265767|NCT01215435|50579960|FG000|Overall Study|Lost to Follow-up|3|||
25265768|NCT01215435|50579961|FG001|Overall Study|Lost to Follow-up|0|||
25265769|NCT01215435|50579960|FG000|Overall Study|Unclassified|5|||
25265770|NCT01215435|50579961|FG001|Overall Study|Unclassified|5|||
25265771|NCT01215357|50579967|FG000|Overall Study|Withdrawal by Subject|3|||
25265772|NCT01215357|50579967|FG000|Overall Study|Protocol Violation|9|||
25265773|NCT00984295|50579974|FG000|Overall Study|Lost to Follow-up|31|||
25265774|NCT00984295|50579975|FG001|Overall Study|Lost to Follow-up|12|||
25265775|NCT00984295|50579976|FG002|Overall Study|Lost to Follow-up|13|||
25265776|NCT00984295|50579974|FG000|Overall Study|Protocol Violation|2|||
25265777|NCT00984295|50579975|FG001|Overall Study|Protocol Violation|1|||
25265778|NCT00984295|50579976|FG002|Overall Study|Protocol Violation|4|||
25265779|NCT00984295|50579974|FG000|Overall Study|Withdrawal by Subject|18|||
25124155|NCT02168803|50236907|FG002|Overall Study|Withdrawal by Subject|2|||
25124156|NCT02168803|50236905|FG000|Overall Study|Physician Decision|0|||
25124157|NCT02168803|50236906|FG001|Overall Study|Physician Decision|1|||
25124158|NCT02168803|50236907|FG002|Overall Study|Physician Decision|0|||
25124159|NCT02168803|50236905|FG000|Overall Study|Adverse Event|0|||
25124160|NCT02168803|50236906|FG001|Overall Study|Adverse Event|1|||
25124161|NCT02168803|50236907|FG002|Overall Study|Adverse Event|1|||
25124162|NCT02168803|50236905|FG000|Overall Study|Death|0|||
25124163|NCT02168803|50236906|FG001|Overall Study|Death|0|||
25124164|NCT02168803|50236907|FG002|Overall Study|Death|1|||
25124165|NCT02168803|50236905|FG000|Overall Study|Sponsor Decision|0|||
25265780|NCT00984295|50579975|FG001|Overall Study|Withdrawal by Subject|9|||
25265781|NCT00984295|50579976|FG002|Overall Study|Withdrawal by Subject|12|||
25265782|NCT00984295|50579974|FG000|Overall Study|CAE - discontinued test vaccine|0|||
25124166|NCT02168803|50236906|FG001|Overall Study|Sponsor Decision|0|||
25124167|NCT02168803|50236907|FG002|Overall Study|Sponsor Decision|1|||
25265783|NCT00984295|50579975|FG001|Overall Study|CAE - discontinued test vaccine|1|||
25124168|NCT02201329|50236922|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
25124169|NCT02201329|50236922|FG000|Overall Study|Withdrawal by Subject|2|||
25124170|NCT01927419|50236928|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
25265784|NCT00984295|50579976|FG002|Overall Study|CAE - discontinued test vaccine|3|||
25265785|NCT00984295|50579974|FG000|Overall Study|Missed one or more blood samplings|3|||
25265786|NCT00984295|50579975|FG001|Overall Study|Missed one or more blood samplings|7|||
25265787|NCT00984295|50579976|FG002|Overall Study|Missed one or more blood samplings|2|||
25265788|NCT00984295|50579974|FG000|Overall Study|Incomplete safety follow-up|11|||
25265789|NCT00984295|50579975|FG001|Overall Study|Incomplete safety follow-up|2|||
25265790|NCT00984295|50579976|FG002|Overall Study|Incomplete safety follow-up|3|||
25265791|NCT01017952|50579988|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
25265792|NCT01017952|50579989|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
25265793|NCT01017952|50579990|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
25265794|NCT01017952|50579991|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
25265795|NCT01017952|50579992|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
25265796|NCT01017952|50579988|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
25265797|NCT01017952|50579989|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
25265798|NCT01017952|50579990|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
25265799|NCT01017952|50579991|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
25265800|NCT01017952|50579992|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
25265801|NCT01017952|50579988|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
25265802|NCT01017952|50579989|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
25265803|NCT01017952|50579990|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
25265804|NCT01017952|50579991|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
25265805|NCT01017952|50579992|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
25265806|NCT01017952|50579988|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
25265807|NCT01017952|50579989|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
25265808|NCT01017952|50579990|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
25265809|NCT01017952|50579991|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
25265810|NCT01017952|50579992|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
25265811|NCT01017952|50579988|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
25265812|NCT01017952|50579989|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
25124171|NCT01927419|50236929|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
25124172|NCT01927419|50236928|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
25124173|NCT01927419|50236929|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
25124174|NCT01927419|50236928|FG000|Treatment Period|Disease progression|17|||
25124175|NCT01927419|50236929|FG001|Treatment Period|Disease progression|20|||
25124176|NCT01927419|50236928|FG000|Treatment Period|Study drug toxicity|48|||
25124177|NCT01927419|50236929|FG001|Treatment Period|Study drug toxicity|10|||
25124178|NCT01927419|50236928|FG000|Treatment Period|Death|0|||
25124179|NCT01927419|50236929|FG001|Treatment Period|Death|1|||
25124180|NCT01927419|50236928|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
25265813|NCT01017952|50579990|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
25124181|NCT01927419|50236929|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
25124182|NCT01927419|50236928|FG000|Treatment Period|Participant request to discontinue|12|||
25124183|NCT01927419|50236929|FG001|Treatment Period|Participant request to discontinue|4|||
25124184|NCT01927419|50236928|FG000|Treatment Period|Withdrawal by Subject|1|||
25124185|NCT01927419|50236929|FG001|Treatment Period|Withdrawal by Subject|1|||
25124186|NCT01927419|50236928|FG000|Treatment Period|Maximum Clinical Benefit|6|||
25124187|NCT01927419|50236929|FG001|Treatment Period|Maximum Clinical Benefit|2|||
25124188|NCT01927419|50236928|FG000|Treatment Period|Other reasons|3|||
25124189|NCT01927419|50236929|FG001|Treatment Period|Other reasons|4|||
25124190|NCT01927419|50236928|FG000|Treatment Period|Not Reported|1|||
25124191|NCT01927419|50236929|FG001|Treatment Period|Not Reported|1|||
25124192|NCT02168491|50236935|FG000|Overall Study|Withdrawal by Subject|1|||
25124193|NCT02225743|50236939|FG000|Overall Study|Withdrawal by Subject|18|||
25124194|NCT01721746|50236945|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
25124195|NCT01721746|50236946|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
25124196|NCT01721746|50236945|FG000|Pre-Treatment|Withdrawal by Subject|1|||
25124197|NCT01721746|50236946|FG001|Pre-Treatment|Withdrawal by Subject|16|||
25124198|NCT01721746|50236945|FG000|Pre-Treatment|Poor/Non-compliance|1|||
25124199|NCT01721746|50236946|FG001|Pre-Treatment|Poor/Non-compliance|0|||
25124200|NCT01721746|50236945|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
25124201|NCT01721746|50236946|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
25124202|NCT01721746|50236945|FG000|Treatment|Disease Progression|192|||
25124203|NCT01721746|50236946|FG001|Treatment|Disease Progression|74|||
25124204|NCT01721746|50236945|FG000|Treatment|Study Drug Toxicity|19|||
25124205|NCT01721746|50236946|FG001|Treatment|Study Drug Toxicity|11|||
25124206|NCT01721746|50236945|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
25124207|NCT01721746|50236946|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
25124208|NCT01721746|50236945|FG000|Treatment|Participant request to discontinue Study treatment|26|||
25124209|NCT01721746|50236946|FG001|Treatment|Participant request to discontinue Study treatment|7|||
25124210|NCT01721746|50236945|FG000|Treatment|Participant withdrew consent|4|||
25124211|NCT01721746|50236946|FG001|Treatment|Participant withdrew consent|2|||
25124212|NCT01721746|50236945|FG000|Treatment|Maximum Clinical Benefit|9|||
25124213|NCT01721746|50236946|FG001|Treatment|Maximum Clinical Benefit|3|||
25124214|NCT01721746|50236945|FG000|Treatment|Poor/Non-compliance|2|||
25124215|NCT01721746|50236946|FG001|Treatment|Poor/Non-compliance|0|||
25124216|NCT01721746|50236945|FG000|Treatment|Participant no longer met Study criteria|4|||
25265814|NCT01017952|50579991|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
25265815|NCT01017952|50579992|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
25265816|NCT01017952|50579988|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
25265817|NCT01017952|50579989|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
25265818|NCT01017952|50579990|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
25265819|NCT01017952|50579991|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
25265820|NCT01017952|50579992|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
25265821|NCT01017952|50579988|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
25265822|NCT01017952|50579989|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
25265823|NCT01017952|50579990|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
25265824|NCT01017952|50579991|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
25265825|NCT01017952|50579992|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
25265826|NCT01017952|50579988|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
25265827|NCT01017952|50579989|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
25265828|NCT01017952|50579990|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
25265829|NCT01017952|50579991|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
25265830|NCT01017952|50579992|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
25265831|NCT01017952|50579988|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
25265832|NCT01017952|50579989|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
25265833|NCT01017952|50579990|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
25265834|NCT01017952|50579991|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
25265835|NCT01017952|50579992|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
25265836|NCT01017952|50579988|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
25265837|NCT01017952|50579989|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
25265838|NCT01017952|50579990|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
25265839|NCT01017952|50579991|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
25265840|NCT01017952|50579992|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
25124217|NCT01721746|50236946|FG001|Treatment|Participant no longer met Study criteria|0|||
25124218|NCT01721746|50236945|FG000|Treatment|Other reasons|6|||
25124219|NCT01721746|50236946|FG001|Treatment|Other reasons|2|||
25124220|NCT02225665|50236955|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
25124221|NCT02225665|50236956|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
25009154|NCT00075725|50102301|FG007|Overall Study|Patient off treatment|2|||
25009155|NCT00075725|50102302|FG008|Overall Study|Patient off treatment|1|||
25009156|NCT00075725|50102303|FG009|Overall Study|Patient off treatment|0|||
25009157|NCT00075725|50102304|FG010|Overall Study|Patient off treatment|0|||
25009158|NCT00075725|50102305|FG011|Overall Study|Patient off treatment|0|||
25009159|NCT00075725|50102294|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
25009160|NCT00075725|50102295|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
25009161|NCT00075725|50102296|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
25009162|NCT00075725|50102297|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
25009163|NCT00075725|50102298|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
25009164|NCT00075725|50102299|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
25009165|NCT00075725|50102300|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
25009166|NCT00075725|50102301|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
25009167|NCT00075725|50102302|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
25265841|NCT01017952|50579988|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
25265842|NCT01017952|50579989|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
25265843|NCT01017952|50579990|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
25265844|NCT01017952|50579991|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
25265845|NCT01017952|50579992|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
25265846|NCT01017952|50579988|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
25265847|NCT01017952|50579989|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
25265848|NCT01017952|50579990|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
25265849|NCT01017952|50579991|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
25265850|NCT01017952|50579992|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
25265851|NCT01017952|50579988|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
25265852|NCT01017952|50579989|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
25265853|NCT01017952|50579990|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
25265854|NCT01017952|50579991|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
25265855|NCT01017952|50579992|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
25265856|NCT01017952|50579988|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
25265857|NCT01017952|50579989|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
25265858|NCT01017952|50579990|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
25265859|NCT01017952|50579991|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
25265860|NCT01017952|50579992|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
25265861|NCT01214655|50580005|FG000|Part A|Progressive Disease|7|||
25265862|NCT01214655|50580006|FG001|Part A|Progressive Disease|0|||
25265863|NCT01214655|50580007|FG002|Part A|Progressive Disease|0|||
25265864|NCT01214655|50580005|FG000|Part A|Physician Decision|1|||
25265865|NCT01214655|50580006|FG001|Part A|Physician Decision|0|||
25265866|NCT01214655|50580007|FG002|Part A|Physician Decision|0|||
25265867|NCT01214655|50580005|FG000|Part B|Progressive disease|0|||
25265868|NCT01214655|50580006|FG001|Part B|Progressive disease|10|||
25265869|NCT01214655|50580007|FG002|Part B|Progressive disease|0|||
25265870|NCT01214655|50580005|FG000|Part B|Death|0|||
25265871|NCT01214655|50580006|FG001|Part B|Death|1|||
25265872|NCT01214655|50580007|FG002|Part B|Death|0|||
25265873|NCT01214655|50580005|FG000|Part B|Withdrawal by Subject|0|||
25265874|NCT01214655|50580006|FG001|Part B|Withdrawal by Subject|2|||
25265875|NCT01214655|50580007|FG002|Part B|Withdrawal by Subject|0|||
25265876|NCT01214655|50580005|FG000|Part C|Progressive Disease|0|||
25265877|NCT01214655|50580006|FG001|Part C|Progressive Disease|0|||
25265878|NCT01214655|50580007|FG002|Part C|Progressive Disease|5|||
25265879|NCT01214655|50580005|FG000|Part C|Death|0|||
25265880|NCT01214655|50580006|FG001|Part C|Death|0|||
25265881|NCT01214655|50580007|FG002|Part C|Death|1|||
25265882|NCT01214655|50580005|FG000|Part C|Physician Decision|0|||
25265883|NCT01214655|50580006|FG001|Part C|Physician Decision|0|||
25265884|NCT01214655|50580007|FG002|Part C|Physician Decision|1|||
25265885|NCT01017874|50580055|FG000|Overall Study|Withdrawal by Subject|23|||
25265886|NCT01017874|50580056|FG001|Overall Study|Withdrawal by Subject|20|||
25265887|NCT01017874|50580055|FG000|Overall Study|Sponsor decision|3|||
25265888|NCT01017874|50580056|FG001|Overall Study|Sponsor decision|1|||
25265889|NCT01017874|50580055|FG000|Overall Study|Lost to Follow-up|3|||
25265890|NCT01017874|50580056|FG001|Overall Study|Lost to Follow-up|2|||
25265891|NCT01017874|50580055|FG000|Overall Study|Physician Decision|1|||
25265892|NCT01017874|50580056|FG001|Overall Study|Physician Decision|3|||
25009168|NCT00075725|50102303|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
25009169|NCT00075725|50102304|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
25009170|NCT00075725|50102305|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
25265893|NCT01015768|50580062|FG000|Overall Study|Some subject data unuseable|4|||
25265894|NCT01015768|50580063|FG001|Overall Study|Some subject data unuseable|4|||
25265895|NCT04426630|50580071|FG000|Overall Study|Death|4|||
25265896|NCT04426630|50580071|FG000|Overall Study|Lost to Follow-up|2|||
25265897|NCT01010230|50580077|FG000|Overall Study|Withdrawal by Subject|6|||
25265898|NCT01010230|50580078|FG001|Overall Study|Withdrawal by Subject|5|||
25265899|NCT01010230|50580077|FG000|Overall Study|Lost to Follow-up|4|||
25265900|NCT01010230|50580078|FG001|Overall Study|Lost to Follow-up|2|||
25265901|NCT01009840|50580084|FG000|Overall Study|Lost to Follow-up|1|||
25265902|NCT01009840|50580084|FG000|Overall Study|Adverse Event|4|||
25265903|NCT01009840|50580084|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
25265904|NCT01009840|50580084|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
25265905|NCT01009840|50580084|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
25265906|NCT00982657|50580092|FG000|Overall Study|Death|1|||
25265907|NCT00982657|50580093|FG001|Overall Study|Death|0|||
25265908|NCT00982657|50580094|FG002|Overall Study|Death|1|||
25265909|NCT00982657|50580095|FG003|Overall Study|Death|1|||
25265910|NCT00982657|50580092|FG000|Overall Study|Withdrawal by Subject|0|||
25265911|NCT00982657|50580093|FG001|Overall Study|Withdrawal by Subject|0|||
25265912|NCT00982657|50580094|FG002|Overall Study|Withdrawal by Subject|1|||
25265913|NCT00982657|50580095|FG003|Overall Study|Withdrawal by Subject|3|||
25265914|NCT00982657|50580092|FG000|Overall Study|Other|0|||
25009171|NCT00075725|50102294|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
25009172|NCT00075725|50102295|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
25009173|NCT00075725|50102296|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
25009174|NCT00075725|50102297|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
25009175|NCT00075725|50102298|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
25009176|NCT00075725|50102299|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
25009177|NCT00075725|50102300|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
25009178|NCT00075725|50102301|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
25009179|NCT00075725|50102302|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
25009180|NCT00075725|50102303|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
25009181|NCT00075725|50102304|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
25009182|NCT00075725|50102305|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
25009183|NCT00075725|50102294|FG000|Overall Study|Pt non compliant with therapy|2|||
25009184|NCT00075725|50102295|FG001|Overall Study|Pt non compliant with therapy|1|||
25009185|NCT00075725|50102296|FG002|Overall Study|Pt non compliant with therapy|1|||
25009186|NCT00075725|50102297|FG003|Overall Study|Pt non compliant with therapy|0|||
25009187|NCT00075725|50102298|FG004|Overall Study|Pt non compliant with therapy|2|||
25009188|NCT00075725|50102299|FG005|Overall Study|Pt non compliant with therapy|14|||
25009189|NCT00075725|50102300|FG006|Overall Study|Pt non compliant with therapy|2|||
25265915|NCT00982657|50580093|FG001|Overall Study|Other|0|||
25009190|NCT00075725|50102301|FG007|Overall Study|Pt non compliant with therapy|5|||
25009191|NCT00075725|50102302|FG008|Overall Study|Pt non compliant with therapy|3|||
25009192|NCT00075725|50102303|FG009|Overall Study|Pt non compliant with therapy|0|||
25265916|NCT00982657|50580094|FG002|Overall Study|Other|0|||
25265917|NCT00982657|50580095|FG003|Overall Study|Other|4|||
25265918|NCT00982657|50580092|FG000|Overall Study|On going at date of cut-off|0|||
25009193|NCT00075725|50102304|FG010|Overall Study|Pt non compliant with therapy|0|||
25009194|NCT00075725|50102305|FG011|Overall Study|Pt non compliant with therapy|0|||
25009195|NCT00075725|50102294|FG000|Overall Study|Pt age out of range for treatment|0|||
25009196|NCT00075725|50102295|FG001|Overall Study|Pt age out of range for treatment|1|||
25009197|NCT00075725|50102296|FG002|Overall Study|Pt age out of range for treatment|0|||
25124222|NCT02225665|50236955|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
25124223|NCT02225665|50236956|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
25124224|NCT01721200|50236964|FG000|Overall Study|Lost to Follow-up|3|||
25124225|NCT01721200|50236965|FG001|Overall Study|Lost to Follow-up|5|||
25124226|NCT02225587|50236978|FG000|Overall Study|Adverse Event|5|||
25124227|NCT02225587|50236979|FG001|Overall Study|Adverse Event|5|||
25124228|NCT02225587|50236978|FG000|Overall Study|Lost to Follow-up|5|||
25124229|NCT02225587|50236979|FG001|Overall Study|Lost to Follow-up|5|||
25124230|NCT02225587|50236978|FG000|Overall Study|Non-Compliance With Study Drug|1|||
25124231|NCT02225587|50236979|FG001|Overall Study|Non-Compliance With Study Drug|0|||
25124232|NCT02225587|50236978|FG000|Overall Study|Physician Decision|2|||
25124233|NCT02225587|50236979|FG001|Overall Study|Physician Decision|0|||
25124234|NCT02225587|50236978|FG000|Overall Study|Protocol Violation|1|||
25124235|NCT02225587|50236979|FG001|Overall Study|Protocol Violation|0|||
25124236|NCT02225587|50236978|FG000|Overall Study|Participant Moved|1|||
25124237|NCT02225587|50236979|FG001|Overall Study|Participant Moved|0|||
25124238|NCT02225587|50236978|FG000|Overall Study|Withdrawal by Subject|13|||
25124239|NCT02225587|50236979|FG001|Overall Study|Withdrawal by Subject|28|||
25124240|NCT02296424|50236987|FG000|Part 1|New therapy for study indication|0|||
25124241|NCT02296424|50236988|FG001|Part 1|New therapy for study indication|1|||
25124242|NCT02296424|50236989|FG002|Part 1|New therapy for study indication|0|||
25124243|NCT02296424|50236990|FG003|Part 1|New therapy for study indication|0|||
25124244|NCT02296424|50236987|FG000|Part 1|Protocol Violation|0|||
25124245|NCT02296424|50236988|FG001|Part 1|Protocol Violation|1|||
25124246|NCT02296424|50236989|FG002|Part 1|Protocol Violation|0|||
25124247|NCT02296424|50236990|FG003|Part 1|Protocol Violation|0|||
25124248|NCT02296424|50236987|FG000|Part 1|Withdrawal by Subject|0|||
25124249|NCT02296424|50236988|FG001|Part 1|Withdrawal by Subject|2|||
25124250|NCT02296424|50236989|FG002|Part 1|Withdrawal by Subject|0|||
25124251|NCT02296424|50236990|FG003|Part 1|Withdrawal by Subject|0|||
25124252|NCT02296424|50236987|FG000|Part 1|Study terminated by sponsor|0|||
25124253|NCT02296424|50236988|FG001|Part 1|Study terminated by sponsor|1|||
25124254|NCT02296424|50236989|FG002|Part 1|Study terminated by sponsor|0|||
25124255|NCT02296424|50236990|FG003|Part 1|Study terminated by sponsor|0|||
25124256|NCT02296424|50236987|FG000|Part 1|Adverse Event|2|||
25265919|NCT00982657|50580093|FG001|Overall Study|On going at date of cut-off|0|||
25265920|NCT00982657|50580094|FG002|Overall Study|On going at date of cut-off|0|||
25265921|NCT00982657|50580095|FG003|Overall Study|On going at date of cut-off|1|||
25265922|NCT01005316|50580118|FG000|Overall Study|Adverse Event|0|||
25265923|NCT01005316|50580119|FG001|Overall Study|Adverse Event|0|||
25265924|NCT01005316|50580120|FG002|Overall Study|Adverse Event|0|||
25265925|NCT01005316|50580121|FG003|Overall Study|Adverse Event|1|||
25265926|NCT01005316|50580118|FG000|Overall Study|Death|20|||
25265927|NCT01005316|50580119|FG001|Overall Study|Death|5|||
25265928|NCT01005316|50580120|FG002|Overall Study|Death|1|||
25265929|NCT01005316|50580121|FG003|Overall Study|Death|15|||
25265930|NCT01005316|50580118|FG000|Overall Study|Study Termination|5|||
25265931|NCT01005316|50580119|FG001|Overall Study|Study Termination|63|||
25265932|NCT01005316|50580120|FG002|Overall Study|Study Termination|9|||
25265933|NCT01005316|50580121|FG003|Overall Study|Study Termination|85|||
25265934|NCT01005316|50580118|FG000|Overall Study|Lost to Follow-up|1|||
25265935|NCT01005316|50580119|FG001|Overall Study|Lost to Follow-up|3|||
25265936|NCT01005316|50580120|FG002|Overall Study|Lost to Follow-up|0|||
25265937|NCT01005316|50580121|FG003|Overall Study|Lost to Follow-up|2|||
25124257|NCT02296424|50236988|FG001|Part 1|Adverse Event|11|||
25124258|NCT02296424|50236989|FG002|Part 1|Adverse Event|0|||
25124259|NCT02296424|50236990|FG003|Part 1|Adverse Event|0|||
25124260|NCT02296424|50236987|FG000|Part 1|Lack of Efficacy|5|||
25124261|NCT02296424|50236988|FG001|Part 1|Lack of Efficacy|17|||
25124262|NCT02296424|50236989|FG002|Part 1|Lack of Efficacy|0|||
25124263|NCT02296424|50236990|FG003|Part 1|Lack of Efficacy|0|||
25124264|NCT02296424|50236987|FG000|Part 1|16 directly started part II|16|||
25265938|NCT01005316|50580118|FG000|Overall Study|Physician Decision|6|||
25265939|NCT01005316|50580119|FG001|Overall Study|Physician Decision|0|||
25265940|NCT01005316|50580120|FG002|Overall Study|Physician Decision|0|||
25265941|NCT01005316|50580121|FG003|Overall Study|Physician Decision|0|||
25265942|NCT01005316|50580118|FG000|Overall Study|Sponsor Decision|6|||
25124265|NCT02296424|50236988|FG001|Part 1|16 directly started part II|0|||
25124266|NCT02296424|50236989|FG002|Part 1|16 directly started part II|0|||
25265943|NCT01005316|50580119|FG001|Overall Study|Sponsor Decision|3|||
25265944|NCT01005316|50580120|FG002|Overall Study|Sponsor Decision|0|||
25265945|NCT01005316|50580121|FG003|Overall Study|Sponsor Decision|0|||
25265946|NCT01005316|50580118|FG000|Overall Study|Withdrawal by Subject|1|||
25265947|NCT01005316|50580119|FG001|Overall Study|Withdrawal by Subject|1|||
25265948|NCT01005316|50580120|FG002|Overall Study|Withdrawal by Subject|0|||
25265949|NCT01005316|50580121|FG003|Overall Study|Withdrawal by Subject|2|||
25265950|NCT01005316|50580118|FG000|Overall Study|Consented to Another Study|2|||
25265951|NCT01005316|50580119|FG001|Overall Study|Consented to Another Study|0|||
25265952|NCT01005316|50580120|FG002|Overall Study|Consented to Another Study|0|||
25265953|NCT01005316|50580121|FG003|Overall Study|Consented to Another Study|0|||
25265954|NCT01005316|50580118|FG000|Overall Study|Delisted|8|||
25265955|NCT01005316|50580119|FG001|Overall Study|Delisted|0|||
25265956|NCT01005316|50580120|FG002|Overall Study|Delisted|0|||
25265957|NCT01005316|50580121|FG003|Overall Study|Delisted|0|||
25265958|NCT01005316|50580118|FG000|Overall Study|Transferred Care|1|||
25265959|NCT01005316|50580119|FG001|Overall Study|Transferred Care|0|||
25265960|NCT01005316|50580120|FG002|Overall Study|Transferred Care|1|||
25265961|NCT01005316|50580121|FG003|Overall Study|Transferred Care|3|||
25265962|NCT01005316|50580118|FG000|Overall Study|Retransplanted|0|||
25265963|NCT01005316|50580119|FG001|Overall Study|Retransplanted|1|||
25265964|NCT01005316|50580120|FG002|Overall Study|Retransplanted|0|||
25265965|NCT01005316|50580121|FG003|Overall Study|Retransplanted|0|||
25265966|NCT01004848|50580134|FG000|Overall Study|Lost to Follow-up|55|||
25265967|NCT01004848|50580135|FG001|Overall Study|Lost to Follow-up|45|||
25265968|NCT01009294|50580143|FG000|Overall Study|Study discontinued by Sponsor|6|||
25265969|NCT01009060|50580149|FG000|Overall Study|Adverse Event|1|||
25265970|NCT01009060|50580150|FG001|Overall Study|Adverse Event|2|||
25265971|NCT01009060|50580149|FG000|Overall Study|Protocol Violation|0|||
25265972|NCT01009060|50580150|FG001|Overall Study|Protocol Violation|1|||
25265973|NCT01009060|50580149|FG000|Overall Study|Lost to Follow-up|1|||
25265974|NCT01009060|50580150|FG001|Overall Study|Lost to Follow-up|0|||
25265975|NCT01009060|50580149|FG000|Overall Study|Physician Decision|1|||
25265976|NCT01009060|50580150|FG001|Overall Study|Physician Decision|1|||
25265977|NCT01009060|50580149|FG000|Overall Study|Withdrawal by Subject|1|||
25265978|NCT01009060|50580150|FG001|Overall Study|Withdrawal by Subject|1|||
25265979|NCT00988429|50580163|FG000|Overall Study|Adverse Event|9|||
25265980|NCT00988429|50580164|FG001|Overall Study|Adverse Event|21|||
25265981|NCT00988429|50580165|FG002|Overall Study|Adverse Event|45|||
25265982|NCT00988429|50580163|FG000|Overall Study|Lack of Efficacy|0|||
25265983|NCT00988429|50580164|FG001|Overall Study|Lack of Efficacy|0|||
25265984|NCT00988429|50580165|FG002|Overall Study|Lack of Efficacy|1|||
25009198|NCT00075725|50102297|FG003|Overall Study|Pt age out of range for treatment|0|||
25265985|NCT00988429|50580163|FG000|Overall Study|Non-Compliance with Study Drug|5|||
25265986|NCT00988429|50580164|FG001|Overall Study|Non-Compliance with Study Drug|1|||
25265987|NCT00988429|50580165|FG002|Overall Study|Non-Compliance with Study Drug|3|||
25265988|NCT00988429|50580163|FG000|Overall Study|Physician Decision|1|||
25265989|NCT00988429|50580164|FG001|Overall Study|Physician Decision|0|||
25265990|NCT00988429|50580165|FG002|Overall Study|Physician Decision|3|||
25265991|NCT00988429|50580163|FG000|Overall Study|Pregnancy|2|||
25265992|NCT00988429|50580164|FG001|Overall Study|Pregnancy|1|||
25265993|NCT00988429|50580165|FG002|Overall Study|Pregnancy|0|||
25265994|NCT00988429|50580163|FG000|Overall Study|Protocol Violation|4|||
25265995|NCT00988429|50580164|FG001|Overall Study|Protocol Violation|3|||
25265996|NCT00988429|50580165|FG002|Overall Study|Protocol Violation|3|||
25265997|NCT00988429|50580163|FG000|Overall Study|Withdrawal by Subject|7|||
25265998|NCT00988429|50580164|FG001|Overall Study|Withdrawal by Subject|7|||
25265999|NCT00988429|50580165|FG002|Overall Study|Withdrawal by Subject|12|||
25266000|NCT00988429|50580163|FG000|Overall Study|Administrative Reasons|1|||
25266001|NCT00988429|50580164|FG001|Overall Study|Administrative Reasons|2|||
25266002|NCT00988429|50580165|FG002|Overall Study|Administrative Reasons|1|||
25009199|NCT00075725|50102298|FG004|Overall Study|Pt age out of range for treatment|0|||
25009200|NCT00075725|50102299|FG005|Overall Study|Pt age out of range for treatment|1|||
25266003|NCT00988429|50580163|FG000|Overall Study|other reasons|8|||
25009201|NCT00075725|50102300|FG006|Overall Study|Pt age out of range for treatment|0|||
25009202|NCT00075725|50102301|FG007|Overall Study|Pt age out of range for treatment|1|||
25009203|NCT00075725|50102302|FG008|Overall Study|Pt age out of range for treatment|0|||
25009204|NCT00075725|50102303|FG009|Overall Study|Pt age out of range for treatment|0|||
25266004|NCT00988429|50580164|FG001|Overall Study|other reasons|8|||
25009205|NCT00075725|50102304|FG010|Overall Study|Pt age out of range for treatment|0|||
25009206|NCT00075725|50102305|FG011|Overall Study|Pt age out of range for treatment|0|||
25009207|NCT00075725|50102294|FG000|Overall Study|Insurance issues|0|||
25009208|NCT00075725|50102295|FG001|Overall Study|Insurance issues|1|||
25266005|NCT00988429|50580165|FG002|Overall Study|other reasons|1|||
25266006|NCT01008904|50580174|FG000|Overall Study|Lost to Follow-up|1|||
25266007|NCT01008904|50580174|FG000|Overall Study|Adverse Event|2|||
25266008|NCT01008904|50580174|FG000|Overall Study|unexpected unrelated surgery|1|||
25266009|NCT01004614|50580182|FG000|Washout|Withdrawal by Subject|0|||
25266010|NCT01004614|50580183|FG001|Washout|Withdrawal by Subject|1|||
25266011|NCT01004614|50580184|FG002|Washout|Withdrawal by Subject|0|||
25266012|NCT01004614|50580185|FG003|Washout|Withdrawal by Subject|0|||
25266013|NCT00981409|50580197|FG000|Overall Study|Adverse Event|4|||
25266014|NCT00981409|50580198|FG001|Overall Study|Adverse Event|0|||
25266015|NCT00981409|50580197|FG000|Overall Study|Protocol Violation|0|||
25266016|NCT00981409|50580198|FG001|Overall Study|Protocol Violation|1|||
25266017|NCT00981409|50580197|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
25266018|NCT00981409|50580198|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
25266019|NCT01008748|50580204|FG000|Overall Study|Lost to Follow-up|80|||
25266020|NCT01008748|50580204|FG000|Overall Study|Other|1|||
25266021|NCT01004146|50580210|FG000|Overall Study|Withdrawal by Subject|4|||
25266022|NCT01004146|50580211|FG001|Overall Study|Withdrawal by Subject|5|||
25266023|NCT01012414|50580217|FG000|Overall Study|Withdrawal by Subject|2|||
25266024|NCT01012414|50580217|FG000|Overall Study|Lost to Follow-up|1|||
25266025|NCT01012414|50580217|FG000|Overall Study|Trial was stopped before completed|7|||
25266026|NCT00975715|50580225|FG000|Titration Period|Adverse Event|6|||
25266027|NCT00975715|50580226|FG001|Titration Period|Adverse Event|0|||
25266028|NCT00975715|50580225|FG000|Titration Period|Protocol Violation|1|||
25266029|NCT00975715|50580226|FG001|Titration Period|Protocol Violation|0|||
25266030|NCT00975715|50580225|FG000|Maintenance Period|Adverse Event|2|||
25266031|NCT00975715|50580226|FG001|Maintenance Period|Adverse Event|1|||
25266032|NCT03962491|50580234|FG000|Overall Study|Lost to Follow-up|4|||
25266033|NCT03962491|50580235|FG001|Overall Study|Lost to Follow-up|5|||
25266034|NCT00978757|50580243|FG000|Overall Study|Physician Decision|1|||
25266035|NCT00978757|50580244|FG001|Overall Study|Physician Decision|3|||
25266036|NCT01214421|50580254|FG000|Overall Study|Lost to Follow-up|7|||
25266037|NCT01214421|50580255|FG001|Overall Study|Lost to Follow-up|3|||
25266038|NCT01214421|50580256|FG002|Overall Study|Lost to Follow-up|7|||
25266039|NCT01214421|50580257|FG003|Overall Study|Lost to Follow-up|3|||
25266040|NCT01214421|50580254|FG000|Overall Study|Adverse Event|16|||
25266041|NCT01214421|50580255|FG001|Overall Study|Adverse Event|35|||
25266042|NCT01214421|50580256|FG002|Overall Study|Adverse Event|14|||
25266043|NCT01214421|50580257|FG003|Overall Study|Adverse Event|3|||
25266044|NCT01214421|50580254|FG000|Overall Study|Sponsor Discontinued Site|1|||
25266045|NCT01214421|50580255|FG001|Overall Study|Sponsor Discontinued Site|2|||
25266046|NCT01214421|50580256|FG002|Overall Study|Sponsor Discontinued Site|0|||
25266047|NCT01214421|50580257|FG003|Overall Study|Sponsor Discontinued Site|0|||
25266048|NCT01214421|50580254|FG000|Overall Study|Withdrawal Criteria Met|3|||
25266049|NCT01214421|50580255|FG001|Overall Study|Withdrawal Criteria Met|0|||
25009209|NCT00075725|50102296|FG002|Overall Study|Insurance issues|0|||
25266050|NCT01214421|50580256|FG002|Overall Study|Withdrawal Criteria Met|2|||
25266051|NCT01214421|50580257|FG003|Overall Study|Withdrawal Criteria Met|1|||
25266052|NCT01214421|50580254|FG000|Overall Study|Physician Decision|2|||
25266053|NCT01214421|50580255|FG001|Overall Study|Physician Decision|0|||
25266054|NCT01214421|50580256|FG002|Overall Study|Physician Decision|4|||
25266055|NCT01214421|50580257|FG003|Overall Study|Physician Decision|0|||
25266056|NCT01214421|50580254|FG000|Overall Study|Withdrawal by Subject|21|||
25266057|NCT01214421|50580255|FG001|Overall Study|Withdrawal by Subject|18|||
25266058|NCT01214421|50580256|FG002|Overall Study|Withdrawal by Subject|11|||
25266059|NCT01214421|50580257|FG003|Overall Study|Withdrawal by Subject|2|||
25266060|NCT04102111|50580269|FG000|Overall Study|Withdrawal by Subject|2|||
25009210|NCT00075725|50102297|FG003|Overall Study|Insurance issues|1|||
25009211|NCT00075725|50102298|FG004|Overall Study|Insurance issues|1|||
25009212|NCT00075725|50102299|FG005|Overall Study|Insurance issues|1|||
25124267|NCT02296424|50236990|FG003|Part 1|16 directly started part II|0|||
25124268|NCT02296424|50236987|FG000|Part 2|Lack of Efficacy|0|||
25124269|NCT02296424|50236988|FG001|Part 2|Lack of Efficacy|0|||
25124270|NCT02296424|50236989|FG002|Part 2|Lack of Efficacy|1|||
25124271|NCT02296424|50236990|FG003|Part 2|Lack of Efficacy|0|||
25124272|NCT02296424|50236987|FG000|Part 2|Adverse Event|0|||
25124273|NCT02296424|50236988|FG001|Part 2|Adverse Event|0|||
25124274|NCT02296424|50236989|FG002|Part 2|Adverse Event|1|||
25124275|NCT02296424|50236990|FG003|Part 2|Adverse Event|0|||
25124276|NCT02296424|50236987|FG000|Part 2|Lost to Follow-up|0|||
25124277|NCT02296424|50236988|FG001|Part 2|Lost to Follow-up|0|||
25124278|NCT02296424|50236989|FG002|Part 2|Lost to Follow-up|1|||
25124279|NCT02296424|50236990|FG003|Part 2|Lost to Follow-up|0|||
25124280|NCT02296190|50237004|FG000|Overall Study|Lost to Follow-up|0|||
25124281|NCT02296190|50237005|FG001|Overall Study|Lost to Follow-up|0|||
25124282|NCT02296190|50237006|FG002|Overall Study|Lost to Follow-up|0|||
25124283|NCT02296190|50237007|FG003|Overall Study|Lost to Follow-up|0|||
25124284|NCT02296190|50237008|FG004|Overall Study|Lost to Follow-up|1|||
25124285|NCT02296190|50237009|FG005|Overall Study|Lost to Follow-up|0|||
25124286|NCT02296190|50237004|FG000|Overall Study|Failure to induce PSVT|6|||
25124287|NCT02296190|50237005|FG001|Overall Study|Failure to induce PSVT|10|||
25124288|NCT02296190|50237006|FG002|Overall Study|Failure to induce PSVT|5|||
25124289|NCT02296190|50237007|FG003|Overall Study|Failure to induce PSVT|13|||
25124290|NCT02296190|50237008|FG004|Overall Study|Failure to induce PSVT|8|||
25124291|NCT02296190|50237009|FG005|Overall Study|Failure to induce PSVT|0|||
25124292|NCT02296190|50237004|FG000|Overall Study|Physician Decision|1|||
25124293|NCT02296190|50237005|FG001|Overall Study|Physician Decision|1|||
25124294|NCT02296190|50237006|FG002|Overall Study|Physician Decision|0|||
25124295|NCT02296190|50237007|FG003|Overall Study|Physician Decision|1|||
25124296|NCT02296190|50237008|FG004|Overall Study|Physician Decision|2|||
25124297|NCT02296190|50237009|FG005|Overall Study|Physician Decision|0|||
25124298|NCT02296190|50237004|FG000|Overall Study|Withdrawal by Subject|0|||
25124299|NCT02296190|50237005|FG001|Overall Study|Withdrawal by Subject|1|||
25124300|NCT02296190|50237006|FG002|Overall Study|Withdrawal by Subject|0|||
25124301|NCT02296190|50237007|FG003|Overall Study|Withdrawal by Subject|0|||
25124302|NCT02296190|50237008|FG004|Overall Study|Withdrawal by Subject|0|||
25124303|NCT02296190|50237009|FG005|Overall Study|Withdrawal by Subject|0|||
25124304|NCT02296190|50237004|FG000|Overall Study|PSVT < 5 minutes|5|||
25124305|NCT02296190|50237005|FG001|Overall Study|PSVT < 5 minutes|6|||
25124306|NCT02296190|50237006|FG002|Overall Study|PSVT < 5 minutes|6|||
25124307|NCT02296190|50237007|FG003|Overall Study|PSVT < 5 minutes|6|||
25124308|NCT02296190|50237008|FG004|Overall Study|PSVT < 5 minutes|5|||
25124309|NCT02296190|50237009|FG005|Overall Study|PSVT < 5 minutes|0|||
25124310|NCT02296190|50237004|FG000|Overall Study|Patient was given Propofol|0|||
25124311|NCT02296190|50237005|FG001|Overall Study|Patient was given Propofol|1|||
25124312|NCT02296190|50237006|FG002|Overall Study|Patient was given Propofol|0|||
25124313|NCT02296190|50237007|FG003|Overall Study|Patient was given Propofol|1|||
25124314|NCT02296190|50237008|FG004|Overall Study|Patient was given Propofol|0|||
25124315|NCT02296190|50237009|FG005|Overall Study|Patient was given Propofol|0|||
25124316|NCT02296190|50237004|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
25124317|NCT02296190|50237005|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
25124318|NCT02296190|50237006|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
25124319|NCT02296190|50237007|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
25124320|NCT02296190|50237008|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
25124321|NCT02296190|50237009|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
25124322|NCT02296190|50237004|FG000|Overall Study|Blood pressure <100 after sedation|0|||
25124323|NCT02296190|50237005|FG001|Overall Study|Blood pressure <100 after sedation|0|||
25124324|NCT02296190|50237006|FG002|Overall Study|Blood pressure <100 after sedation|0|||
25124325|NCT02296190|50237007|FG003|Overall Study|Blood pressure <100 after sedation|1|||
25124326|NCT02296190|50237008|FG004|Overall Study|Blood pressure <100 after sedation|0|||
25124327|NCT02296190|50237009|FG005|Overall Study|Blood pressure <100 after sedation|0|||
25009213|NCT00075725|50102300|FG006|Overall Study|Insurance issues|0|||
25124328|NCT02296190|50237004|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
25124329|NCT02296190|50237005|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
25124330|NCT02296190|50237006|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
25124331|NCT02296190|50237007|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
25124332|NCT02296190|50237008|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
25124333|NCT02296190|50237009|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
25009214|NCT00075725|50102301|FG007|Overall Study|Insurance issues|1|||
25124334|NCT02296190|50237004|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
25124335|NCT02296190|50237005|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
25124336|NCT02296190|50237006|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
25124337|NCT02296190|50237007|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
25124338|NCT02296190|50237008|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
25124339|NCT02296190|50237009|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
25124340|NCT02296190|50237004|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
25124341|NCT02296190|50237005|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
25124342|NCT02296190|50237006|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
25124343|NCT02296190|50237007|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
25124344|NCT02296190|50237008|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
25124345|NCT02296190|50237009|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
25124346|NCT02296190|50237004|FG000|Overall Study|Lab result not available in time|1|||
25124347|NCT02296190|50237005|FG001|Overall Study|Lab result not available in time|0|||
25124348|NCT02296190|50237006|FG002|Overall Study|Lab result not available in time|0|||
25124349|NCT02296190|50237007|FG003|Overall Study|Lab result not available in time|0|||
25124350|NCT02296190|50237008|FG004|Overall Study|Lab result not available in time|0|||
25124351|NCT02296190|50237009|FG005|Overall Study|Lab result not available in time|0|||
25124352|NCT02296112|50237022|FG000|Overall Study|Disease progression|7|||
25124353|NCT02296112|50237022|FG000|Overall Study|Toxicity|1|||
25124354|NCT02296112|50237022|FG000|Overall Study|Began an alternate therapy|1|||
25124355|NCT02295644|50237035|FG000|Overall Study|Did not meet inclusion criterion|0|||
25124356|NCT02295644|50237036|FG001|Overall Study|Did not meet inclusion criterion|0|||
25124357|NCT02295644|50237037|FG002|Overall Study|Did not meet inclusion criterion|1|||
25124358|NCT02295644|50237038|FG003|Overall Study|Did not meet inclusion criterion|2|||
25124359|NCT02269670|50237048|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
25124360|NCT02225353|50237055|FG000|Overall Study|Lost to Follow-up|0|||
25124361|NCT02225353|50237056|FG001|Overall Study|Lost to Follow-up|1|||
25124362|NCT02225353|50237057|FG002|Overall Study|Lost to Follow-up|3|||
25124363|NCT02225353|50237055|FG000|Overall Study|Protocol Violation|4|||
25124364|NCT02225353|50237056|FG001|Overall Study|Protocol Violation|5|||
25124365|NCT02225353|50237057|FG002|Overall Study|Protocol Violation|12|||
25124366|NCT01641926|50237072|FG000|Overall Study|Adverse Event|5|||
25124367|NCT01641926|50237073|FG001|Overall Study|Adverse Event|2|||
25124368|NCT01641926|50237074|FG002|Overall Study|Adverse Event|3|||
25124369|NCT01641926|50237075|FG003|Overall Study|Adverse Event|1|||
25124370|NCT01641926|50237072|FG000|Overall Study|Lost to Follow-up|2|||
25124371|NCT01641926|50237073|FG001|Overall Study|Lost to Follow-up|2|||
25124372|NCT01641926|50237074|FG002|Overall Study|Lost to Follow-up|1|||
25124373|NCT01641926|50237075|FG003|Overall Study|Lost to Follow-up|0|||
25124374|NCT01641926|50237072|FG000|Overall Study|Physician Decision|6|||
25124375|NCT01641926|50237073|FG001|Overall Study|Physician Decision|5|||
25124376|NCT01641926|50237074|FG002|Overall Study|Physician Decision|0|||
25124377|NCT01641926|50237075|FG003|Overall Study|Physician Decision|1|||
25124378|NCT01641926|50237072|FG000|Overall Study|Protocol Violation|1|||
25124379|NCT01641926|50237073|FG001|Overall Study|Protocol Violation|0|||
25124380|NCT01641926|50237074|FG002|Overall Study|Protocol Violation|0|||
25124381|NCT01641926|50237075|FG003|Overall Study|Protocol Violation|1|||
25124382|NCT01641926|50237072|FG000|Overall Study|Withdrawal by Subject|13|||
25124383|NCT01641926|50237073|FG001|Overall Study|Withdrawal by Subject|5|||
25124384|NCT01641926|50237074|FG002|Overall Study|Withdrawal by Subject|6|||
25124385|NCT01641926|50237075|FG003|Overall Study|Withdrawal by Subject|1|||
25124386|NCT01641926|50237072|FG000|Overall Study|Not Treated|1|||
25124387|NCT01641926|50237073|FG001|Overall Study|Not Treated|1|||
25124388|NCT01641926|50237074|FG002|Overall Study|Not Treated|1|||
25124389|NCT01641926|50237075|FG003|Overall Study|Not Treated|0|||
25124390|NCT02295020|50237087|FG000|Overall Study|Adverse Event|0|||
25124391|NCT02295020|50237088|FG001|Overall Study|Adverse Event|1|||
25124392|NCT02295020|50237087|FG000|Overall Study|Withdrawal by Subject|3|||
25124393|NCT02295020|50237088|FG001|Overall Study|Withdrawal by Subject|2|||
25124394|NCT02200939|50237102|FG000|Overall Study|Participant withdrew consent|0|||
25124395|NCT02200939|50237103|FG001|Overall Study|Participant withdrew consent|1|||
25124396|NCT02200939|50237102|FG000|Overall Study|Lost to Follow-up|2|||
25124397|NCT02200939|50237103|FG001|Overall Study|Lost to Follow-up|9|||
25124398|NCT02200939|50237102|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
25124399|NCT02200939|50237103|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
25124400|NCT02294786|50237115|FG000|Overall Study|Withdrawal by Subject|0|||
25124401|NCT02294786|50237116|FG001|Overall Study|Withdrawal by Subject|1|||
25124402|NCT02294786|50237115|FG000|Overall Study|Physician Decision|6|||
25124403|NCT02294786|50237116|FG001|Overall Study|Physician Decision|7|||
25124404|NCT02294786|50237115|FG000|Overall Study|Lost to Follow-up|1|||
25124405|NCT02294786|50237116|FG001|Overall Study|Lost to Follow-up|2|||
25124406|NCT02294786|50237115|FG000|Overall Study|Protocol Violation|1|||
25124407|NCT02294786|50237116|FG001|Overall Study|Protocol Violation|0|||
25124408|NCT02294786|50237115|FG000|Overall Study|Adverse Event|1|||
25124409|NCT02294786|50237116|FG001|Overall Study|Adverse Event|1|||
25124410|NCT02294786|50237115|FG000|Overall Study|Death|2|||
25124411|NCT02294786|50237116|FG001|Overall Study|Death|3|||
25124412|NCT02269124|50237125|FG000|Overall Study|Lost to Follow-up|1|||
25124413|NCT02269124|50237126|FG001|Overall Study|Lost to Follow-up|0|||
25124414|NCT02269124|50237125|FG000|Overall Study|Withdrawal by Subject|0|||
25124415|NCT02269124|50237126|FG001|Overall Study|Withdrawal by Subject|2|||
25124416|NCT01927341|50237138|FG000|Phase 1b|Lost to Follow-up|1|||
25124417|NCT01927341|50237139|FG001|Phase 1b|Lost to Follow-up|0|||
25124418|NCT01927341|50237140|FG002|Phase 1b|Lost to Follow-up|0|||
25124419|NCT01927341|50237141|FG003|Phase 1b|Lost to Follow-up|0|||
25124420|NCT01927341|50237142|FG004|Phase 1b|Lost to Follow-up|0|||
25124421|NCT01927341|50237138|FG000|Phase 1b|Death|2|||
25124422|NCT01927341|50237139|FG001|Phase 1b|Death|0|||
25124423|NCT01927341|50237140|FG002|Phase 1b|Death|0|||
25124424|NCT01927341|50237141|FG003|Phase 1b|Death|0|||
25124425|NCT01927341|50237142|FG004|Phase 1b|Death|0|||
25124426|NCT01927341|50237138|FG000|Phase 1b|Follow-up completed|7|||
25124427|NCT01927341|50237139|FG001|Phase 1b|Follow-up completed|0|||
25124428|NCT01927341|50237140|FG002|Phase 1b|Follow-up completed|0|||
25124429|NCT01927341|50237141|FG003|Phase 1b|Follow-up completed|0|||
25124430|NCT01927341|50237142|FG004|Phase 1b|Follow-up completed|0|||
25124431|NCT01927341|50237138|FG000|Phase 2|Lost to Follow-up|0|||
25124432|NCT01927341|50237139|FG001|Phase 2|Lost to Follow-up|1|||
25124433|NCT01927341|50237140|FG002|Phase 2|Lost to Follow-up|0|||
25124434|NCT01927341|50237141|FG003|Phase 2|Lost to Follow-up|0|||
25124435|NCT01927341|50237142|FG004|Phase 2|Lost to Follow-up|0|||
25124436|NCT01927341|50237138|FG000|Phase 2|Participant withdrew consent|0|||
25124437|NCT01927341|50237139|FG001|Phase 2|Participant withdrew consent|2|||
25124438|NCT01927341|50237140|FG002|Phase 2|Participant withdrew consent|1|||
25124439|NCT01927341|50237141|FG003|Phase 2|Participant withdrew consent|2|||
25124440|NCT01927341|50237142|FG004|Phase 2|Participant withdrew consent|3|||
25124441|NCT01927341|50237138|FG000|Phase 2|Death|0|||
25124442|NCT01927341|50237139|FG001|Phase 2|Death|4|||
25124443|NCT01927341|50237140|FG002|Phase 2|Death|0|||
25124444|NCT01927341|50237141|FG003|Phase 2|Death|3|||
25124445|NCT01927341|50237142|FG004|Phase 2|Death|2|||
25124446|NCT01927341|50237138|FG000|Phase 2|New cancer therapy|0|||
25266061|NCT04102111|50580270|FG001|Overall Study|Withdrawal by Subject|3|||
25266062|NCT04102111|50580269|FG000|Overall Study|Adverse Event|1|||
25266063|NCT04102111|50580270|FG001|Overall Study|Adverse Event|1|||
25266064|NCT04102111|50580269|FG000|Overall Study|Study terminated by sponsor|1|||
25266065|NCT04102111|50580270|FG001|Overall Study|Study terminated by sponsor|3|||
25266066|NCT01214187|50580278|FG000|Overall Study|Adverse Event|6|||
25266067|NCT01214187|50580279|FG001|Overall Study|Adverse Event|2|||
25266068|NCT01214187|50580278|FG000|Overall Study|Death|1|||
25266069|NCT01214187|50580279|FG001|Overall Study|Death|1|||
25266070|NCT01214187|50580278|FG000|Overall Study|Withdrawal by Subject|0|||
25266071|NCT01214187|50580279|FG001|Overall Study|Withdrawal by Subject|3|||
25266072|NCT01003990|50580288|FG000|Overall Study|Adverse Event|8|||
25266073|NCT01003990|50580289|FG001|Overall Study|Adverse Event|5|||
25266074|NCT01003990|50580290|FG002|Overall Study|Adverse Event|11|||
25266075|NCT01003990|50580288|FG000|Overall Study|Death|0|||
25266076|NCT01003990|50580289|FG001|Overall Study|Death|8|||
25266077|NCT01003990|50580290|FG002|Overall Study|Death|1|||
25266078|NCT01003990|50580288|FG000|Overall Study|Lack of Efficacy|10|||
25266079|NCT01003990|50580289|FG001|Overall Study|Lack of Efficacy|2|||
25266080|NCT01003990|50580290|FG002|Overall Study|Lack of Efficacy|3|||
25266081|NCT01003990|50580288|FG000|Overall Study|Lost to Follow-up|30|||
25266082|NCT01003990|50580289|FG001|Overall Study|Lost to Follow-up|12|||
25266083|NCT01003990|50580290|FG002|Overall Study|Lost to Follow-up|7|||
25266084|NCT01003990|50580288|FG000|Overall Study|Reasons Not Identified|14|||
25266085|NCT01003990|50580289|FG001|Overall Study|Reasons Not Identified|13|||
25266086|NCT01003990|50580290|FG002|Overall Study|Reasons Not Identified|8|||
25266087|NCT01003990|50580288|FG000|Overall Study|Poor/Non-compliance|4|||
25266088|NCT01003990|50580289|FG001|Overall Study|Poor/Non-compliance|3|||
25266089|NCT01003990|50580290|FG002|Overall Study|Poor/Non-compliance|2|||
25266090|NCT01003990|50580288|FG000|Overall Study|Pregnancy|10|||
25266091|NCT01003990|50580289|FG001|Overall Study|Pregnancy|2|||
25124447|NCT01927341|50237139|FG001|Phase 2|New cancer therapy|1|||
25124448|NCT01927341|50237140|FG002|Phase 2|New cancer therapy|0|||
25124449|NCT01927341|50237141|FG003|Phase 2|New cancer therapy|4|||
25124450|NCT01927341|50237142|FG004|Phase 2|New cancer therapy|1|||
25124451|NCT01927341|50237138|FG000|Phase 2|Disease progression|0|||
25266092|NCT01003990|50580290|FG002|Overall Study|Pregnancy|4|||
25266093|NCT01003990|50580288|FG000|Overall Study|No Longer Met Study Criteria|4|||
25266094|NCT01003990|50580289|FG001|Overall Study|No Longer Met Study Criteria|1|||
25266095|NCT01003990|50580290|FG002|Overall Study|No Longer Met Study Criteria|0|||
25266096|NCT01003990|50580288|FG000|Overall Study|Subject Withdrew Consent|12|||
25266097|NCT01003990|50580289|FG001|Overall Study|Subject Withdrew Consent|5|||
25124452|NCT01927341|50237139|FG001|Phase 2|Disease progression|1|||
25124453|NCT01927341|50237140|FG002|Phase 2|Disease progression|1|||
25124454|NCT01927341|50237141|FG003|Phase 2|Disease progression|1|||
25124455|NCT01927341|50237142|FG004|Phase 2|Disease progression|0|||
25124456|NCT01927341|50237138|FG000|Phase 2|Follow-up completed|0|||
25124457|NCT01927341|50237139|FG001|Phase 2|Follow-up completed|6|||
25124458|NCT01927341|50237140|FG002|Phase 2|Follow-up completed|3|||
25124459|NCT01927341|50237141|FG003|Phase 2|Follow-up completed|5|||
25124460|NCT01927341|50237142|FG004|Phase 2|Follow-up completed|2|||
25124461|NCT02294474|50237160|FG000|Overall Study|Adverse Event|7|||
25124462|NCT02294474|50237161|FG001|Overall Study|Adverse Event|7|||
25124463|NCT02294474|50237160|FG000|Overall Study|Lack of Efficacy|2|||
25124464|NCT02294474|50237161|FG001|Overall Study|Lack of Efficacy|1|||
25124465|NCT02294474|50237160|FG000|Overall Study|Protocol Violation|4|||
25124466|NCT02294474|50237161|FG001|Overall Study|Protocol Violation|2|||
25124467|NCT02294474|50237160|FG000|Overall Study|Other than specified above|12|||
25124468|NCT02294474|50237161|FG001|Overall Study|Other than specified above|12|||
25124469|NCT02168101|50237171|FG000|Overall Study|Death|2|||
25124470|NCT02168101|50237172|FG001|Overall Study|Death|2|||
25124471|NCT02168101|50237173|FG002|Overall Study|Death|1|||
25124472|NCT01956123|50237184|FG000|COS Cycle 2|Protocol Violation|8|||
25124473|NCT01956123|50237185|FG001|COS Cycle 2|Protocol Violation|3|||
25124474|NCT01956123|50237186|FG002|COS Cycle 2|Protocol Violation|0|||
25124475|NCT01956123|50237187|FG003|COS Cycle 2|Protocol Violation|0|||
25124476|NCT01956123|50237184|FG000|COS Cycle 2|Adverse Event|3|||
25124477|NCT01956123|50237185|FG001|COS Cycle 2|Adverse Event|4|||
25124478|NCT01956123|50237186|FG002|COS Cycle 2|Adverse Event|0|||
25124479|NCT01956123|50237187|FG003|COS Cycle 2|Adverse Event|0|||
25124480|NCT01956123|50237184|FG000|COS Cycle 2|Personal Reasons|2|||
25124481|NCT01956123|50237185|FG001|COS Cycle 2|Personal Reasons|0|||
25124482|NCT01956123|50237186|FG002|COS Cycle 2|Personal Reasons|0|||
25124483|NCT01956123|50237187|FG003|COS Cycle 2|Personal Reasons|0|||
25124484|NCT01956123|50237184|FG000|COS Cycle 2|Withdrawal by Subject|1|||
25124485|NCT01956123|50237185|FG001|COS Cycle 2|Withdrawal by Subject|0|||
25124486|NCT01956123|50237186|FG002|COS Cycle 2|Withdrawal by Subject|0|||
25124487|NCT01956123|50237187|FG003|COS Cycle 2|Withdrawal by Subject|0|||
25124488|NCT01956123|50237184|FG000|COS Cycle 3|Protocol Violation|0|||
25124489|NCT01956123|50237185|FG001|COS Cycle 3|Protocol Violation|0|||
25124490|NCT01956123|50237186|FG002|COS Cycle 3|Protocol Violation|2|||
25124491|NCT01956123|50237187|FG003|COS Cycle 3|Protocol Violation|1|||
25124492|NCT01956123|50237184|FG000|COS Cycle 3|Adverse Event|0|||
25124493|NCT01956123|50237185|FG001|COS Cycle 3|Adverse Event|0|||
25124494|NCT01956123|50237186|FG002|COS Cycle 3|Adverse Event|3|||
25124495|NCT01956123|50237187|FG003|COS Cycle 3|Adverse Event|0|||
25266098|NCT01003990|50580290|FG002|Overall Study|Subject Withdrew Consent|7|||
25266099|NCT01003210|50580300|FG000|Overall Study|Lost to Follow-up|1|||
25266100|NCT01003210|50580301|FG001|Overall Study|Lost to Follow-up|3|||
25266101|NCT01002820|50580307|FG000|Overall Study|Adverse Event|1|||
25266102|NCT01002820|50580307|FG000|Overall Study|Withdrawal by Subject|2|||
25266103|NCT01002820|50580307|FG000|Overall Study|Lack of Efficacy|1|||
25266104|NCT01012258|50580311|FG000|Overall Study|Death|14|||
25266105|NCT01012258|50580311|FG000|Overall Study|Lost to Follow-up|1|||
25266106|NCT01012258|50580311|FG000|Overall Study|Adverse Event|1|||
25266107|NCT01012258|50580311|FG000|Overall Study|Progressive Disease (PD)|18|||
25124496|NCT01956123|50237184|FG000|COS Cycle 3|Personal Reasons|0|||
25124497|NCT01956123|50237185|FG001|COS Cycle 3|Personal Reasons|0|||
25266108|NCT01012258|50580311|FG000|Overall Study|Symptomatic Deterioration|1|||
25124498|NCT01956123|50237186|FG002|COS Cycle 3|Personal Reasons|1|||
25266109|NCT01012258|50580311|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
25124499|NCT01956123|50237187|FG003|COS Cycle 3|Personal Reasons|0|||
25124500|NCT01956123|50237184|FG000|COS Cycle 3|Withdrawal by Subject|0|||
25124501|NCT01956123|50237185|FG001|COS Cycle 3|Withdrawal by Subject|0|||
25124502|NCT01956123|50237186|FG002|COS Cycle 3|Withdrawal by Subject|0|||
25124503|NCT01956123|50237187|FG003|COS Cycle 3|Withdrawal by Subject|1|||
25266110|NCT01012258|50580311|FG000|Overall Study|Another Tumor Discovered|1|||
25124504|NCT02298179|50237210|FG000|Overall Study|Lost to Follow-up|0|||
25124505|NCT02298179|50237211|FG001|Overall Study|Lost to Follow-up|0|||
25124506|NCT02298179|50237212|FG002|Overall Study|Lost to Follow-up|1|||
25124507|NCT02298179|50237213|FG003|Overall Study|Lost to Follow-up|0|||
25124508|NCT02298179|50237214|FG004|Overall Study|Lost to Follow-up|0|||
25124509|NCT02298179|50237215|FG005|Overall Study|Lost to Follow-up|0|||
25124510|NCT02298179|50237216|FG006|Overall Study|Lost to Follow-up|0|||
25124511|NCT02298179|50237217|FG007|Overall Study|Lost to Follow-up|1|||
25124512|NCT02298179|50237218|FG008|Overall Study|Lost to Follow-up|0|||
25124513|NCT02298179|50237219|FG009|Overall Study|Lost to Follow-up|0|||
25124514|NCT02298179|50237220|FG010|Overall Study|Lost to Follow-up|0|||
25124515|NCT02298179|50237221|FG011|Overall Study|Lost to Follow-up|0|||
25124516|NCT02298023|50237250|FG000|Overall Study|Withdrawal by Subject|1|||
25124517|NCT02298023|50237251|FG001|Overall Study|Withdrawal by Subject|0|||
25124518|NCT02298023|50237252|FG002|Overall Study|Withdrawal by Subject|0|||
25124519|NCT02296931|50237265|FG000|Overall Study|Protocol Violation|0|||
25124520|NCT02296931|50237266|FG001|Overall Study|Protocol Violation|2|||
25124521|NCT02166697|50237272|FG000|Overall Study|Protocol Violation|347|||
25124522|NCT01909479|50237278|FG000|From Baseline to Week 26|Adverse Event|3|||
25124523|NCT01909479|50237279|FG001|From Baseline to Week 26|Adverse Event|2|||
25124524|NCT01909479|50237278|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
25124525|NCT01909479|50237279|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
25124526|NCT01909479|50237278|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
25124527|NCT01909479|50237279|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
25124528|NCT01909479|50237278|FG000|26 - 52 Weeks|Adverse Event|0|||
25124529|NCT01909479|50237279|FG001|26 - 52 Weeks|Adverse Event|1|||
25124530|NCT01909479|50237278|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
25124531|NCT01909479|50237279|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
25124532|NCT01909479|50237278|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
25124533|NCT01909479|50237279|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
25124534|NCT01909479|50237278|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
25124535|NCT01909479|50237279|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
25124536|NCT01909479|50237278|FG000|52 Weeks to End of Study|Adverse Event|2|||
25124537|NCT01909479|50237279|FG001|52 Weeks to End of Study|Adverse Event|1|||
25124538|NCT01909479|50237278|FG000|52 Weeks to End of Study|Death|0|||
25124539|NCT01909479|50237279|FG001|52 Weeks to End of Study|Death|1|||
25124540|NCT01909479|50237278|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
25124541|NCT01909479|50237279|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
25124542|NCT01909479|50237278|FG000|52 Weeks to End of Study|Protocol Violation|1|||
25124543|NCT01909479|50237279|FG001|52 Weeks to End of Study|Protocol Violation|0|||
25124544|NCT01909479|50237278|FG000|52 Weeks to End of Study|Progressive disease|1|||
25124545|NCT01909479|50237279|FG001|52 Weeks to End of Study|Progressive disease|1|||
25124546|NCT01909479|50237278|FG000|52 Weeks to End of Study|Personal reasons|2|||
25124547|NCT01909479|50237279|FG001|52 Weeks to End of Study|Personal reasons|1|||
25124548|NCT01909479|50237278|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
25124549|NCT01909479|50237279|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
25124550|NCT01909479|50237278|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
25124551|NCT01909479|50237279|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
25124552|NCT01909479|50237278|FG000|52 Weeks to End of Study|Lack of contact|1|||
25124553|NCT01909479|50237279|FG001|52 Weeks to End of Study|Lack of contact|0|||
25124554|NCT01909479|50237278|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
25266111|NCT01012258|50580311|FG000|Overall Study|Ongoing|29|||
25266112|NCT01011946|50580316|FG000|Overall Study|Transferred to another hospital|2|||
25266113|NCT01011946|50580316|FG000|Overall Study|No pathological lab value|1|||
25266114|NCT00975481|50580320|FG000|Second Intervention Period|Adverse Event|2|||
25266115|NCT00975481|50580321|FG001|Second Intervention Period|Adverse Event|1|||
25266116|NCT00975481|50580322|FG002|Second Intervention Period|Adverse Event|0|||
25266117|NCT00975481|50580323|FG003|Second Intervention Period|Adverse Event|0|||
25266118|NCT00975481|50580324|FG004|Second Intervention Period|Adverse Event|0|||
25266119|NCT00975481|50580325|FG005|Second Intervention Period|Adverse Event|0|||
25266120|NCT00975481|50580320|FG000|Second Intervention Period|Withdrawal by Subject|0|||
25266121|NCT00975481|50580321|FG001|Second Intervention Period|Withdrawal by Subject|0|||
25266122|NCT00975481|50580322|FG002|Second Intervention Period|Withdrawal by Subject|1|||
25124555|NCT01909479|50237279|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
25124556|NCT01909479|50237278|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
25124557|NCT01909479|50237279|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
25124558|NCT01955733|50237292|FG000|Period 1|Lost to Follow-up|1|||
25124559|NCT01955733|50237293|FG001|Period 1|Lost to Follow-up|0|||
25124560|NCT01955733|50237294|FG002|Period 1|Lost to Follow-up|0|||
25124561|NCT01955733|50237292|FG000|Period 2|Adverse Event|1|||
25124562|NCT01955733|50237293|FG001|Period 2|Adverse Event|0|||
25124563|NCT01955733|50237294|FG002|Period 2|Adverse Event|0|||
25124564|NCT01955733|50237292|FG000|Period 2|Physician Decision|0|||
25124565|NCT01955733|50237293|FG001|Period 2|Physician Decision|0|||
25124566|NCT01955733|50237294|FG002|Period 2|Physician Decision|1|||
25124567|NCT01955733|50237292|FG000|Period 2|Withdrawal by Subject|1|||
25124568|NCT01955733|50237293|FG001|Period 2|Withdrawal by Subject|3|||
25124569|NCT01955733|50237294|FG002|Period 2|Withdrawal by Subject|2|||
25124570|NCT01955733|50237292|FG000|Period 2|Study terminated by sponsor|8|||
25124571|NCT01955733|50237293|FG001|Period 2|Study terminated by sponsor|14|||
25124572|NCT01955733|50237294|FG002|Period 2|Study terminated by sponsor|16|||
25124573|NCT01955733|50237292|FG000|Period 2|Lost to Follow-up|2|||
25124574|NCT01955733|50237293|FG001|Period 2|Lost to Follow-up|0|||
25124575|NCT01955733|50237294|FG002|Period 2|Lost to Follow-up|0|||
25124576|NCT01955733|50237292|FG000|Period 2|Other not defined above|0|||
25124577|NCT01955733|50237293|FG001|Period 2|Other not defined above|2|||
25124578|NCT01955733|50237294|FG002|Period 2|Other not defined above|2|||
25124579|NCT02197897|50237302|FG000|Overall Study|not eligible|1|||
25124580|NCT02223793|50237309|FG000|Overall Study|Lost to Follow-up|10|||
25124581|NCT02223793|50237310|FG001|Overall Study|Lost to Follow-up|1|||
25124582|NCT02223793|50237311|FG002|Overall Study|Lost to Follow-up|2|||
25124583|NCT02223793|50237309|FG000|Overall Study|Withdrawal by Subject|3|||
25124584|NCT02223793|50237310|FG001|Overall Study|Withdrawal by Subject|2|||
25124585|NCT02223793|50237311|FG002|Overall Study|Withdrawal by Subject|3|||
25124586|NCT02223793|50237309|FG000|Overall Study|Moved/studycenter unable to participate|4|||
25124587|NCT02223793|50237310|FG001|Overall Study|Moved/studycenter unable to participate|6|||
25124588|NCT02223793|50237311|FG002|Overall Study|Moved/studycenter unable to participate|8|||
25124589|NCT01926015|50237321|FG000|Overall Study|Withdrawal by parent/guardian|0|||
25124590|NCT01926015|50237322|FG001|Overall Study|Withdrawal by parent/guardian|1|||
25124591|NCT01926015|50237321|FG000|Overall Study|Randomized not treated|2|||
25124592|NCT01926015|50237322|FG001|Overall Study|Randomized not treated|0|||
25124593|NCT02223715|50237328|FG000|Overall Study|Death|31|||
25124594|NCT02223715|50237328|FG000|Overall Study|Lost to Follow-up|73|||
25124595|NCT02196259|50237338|FG000|Overall Study|Researcher choice|0|||
25124596|NCT02196259|50237339|FG001|Overall Study|Researcher choice|0|||
25124597|NCT02196259|50237340|FG002|Overall Study|Researcher choice|1|||
25124598|NCT02196259|50237338|FG000|Overall Study|Partial data analysis|0|||
25124599|NCT02196259|50237339|FG001|Overall Study|Partial data analysis|3|||
25266123|NCT00975481|50580323|FG003|Second Intervention Period|Withdrawal by Subject|0|||
25266124|NCT00975481|50580324|FG004|Second Intervention Period|Withdrawal by Subject|0|||
25266125|NCT00975481|50580325|FG005|Second Intervention Period|Withdrawal by Subject|0|||
25266126|NCT00975481|50580320|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
25266127|NCT00975481|50580321|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
25266128|NCT00975481|50580322|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
25266129|NCT00975481|50580323|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
25266130|NCT00975481|50580324|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
25266131|NCT00975481|50580325|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
25266132|NCT00975481|50580320|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
25266133|NCT00975481|50580321|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
25266134|NCT00975481|50580322|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
25266135|NCT00975481|50580323|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
25266136|NCT00975481|50580324|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
25266137|NCT00975481|50580325|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
25266138|NCT01011868|50580346|FG000|After Week 18 Follow-up|Adverse Event|8|||
25266139|NCT01011868|50580347|FG001|After Week 18 Follow-up|Adverse Event|6|||
25266140|NCT01011868|50580348|FG002|After Week 18 Follow-up|Adverse Event|13|||
25266141|NCT01011868|50580346|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
25124600|NCT02196259|50237340|FG002|Overall Study|Partial data analysis|0|||
25124601|NCT02294396|50237351|FG000|Overall Study|Adverse Event|26|||
25124602|NCT02294396|50237352|FG001|Overall Study|Adverse Event|25|||
25124603|NCT02294396|50237353|FG002|Overall Study|Adverse Event|21|||
25124604|NCT02294396|50237354|FG003|Overall Study|Adverse Event|24|||
25124605|NCT02294396|50237351|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
25124606|NCT02294396|50237352|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
25266142|NCT01011868|50580347|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
25266143|NCT01011868|50580348|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
25009215|NCT00075725|50102302|FG008|Overall Study|Insurance issues|0|||
25124607|NCT02294396|50237353|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
25124608|NCT02294396|50237354|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
25124609|NCT02294396|50237351|FG000|Overall Study|Withdrawal by Subject|8|||
25124610|NCT02294396|50237352|FG001|Overall Study|Withdrawal by Subject|6|||
25124611|NCT02294396|50237353|FG002|Overall Study|Withdrawal by Subject|6|||
25124612|NCT02294396|50237354|FG003|Overall Study|Withdrawal by Subject|8|||
25124613|NCT02294396|50237351|FG000|Overall Study|Lost to Follow-up|0|||
25124614|NCT02294396|50237352|FG001|Overall Study|Lost to Follow-up|0|||
25124615|NCT02294396|50237353|FG002|Overall Study|Lost to Follow-up|1|||
25124616|NCT02294396|50237354|FG003|Overall Study|Lost to Follow-up|1|||
25124617|NCT02294396|50237351|FG000|Overall Study|Protocol Deviation|3|||
25124618|NCT02294396|50237352|FG001|Overall Study|Protocol Deviation|2|||
25124619|NCT02294396|50237353|FG002|Overall Study|Protocol Deviation|2|||
25124620|NCT02294396|50237354|FG003|Overall Study|Protocol Deviation|1|||
25124621|NCT02294396|50237351|FG000|Overall Study|Miscellaneous|2|||
25124622|NCT02294396|50237352|FG001|Overall Study|Miscellaneous|0|||
25124623|NCT02294396|50237353|FG002|Overall Study|Miscellaneous|5|||
25124624|NCT02294396|50237354|FG003|Overall Study|Miscellaneous|2|||
25124625|NCT01721044|50237367|FG000|Treatment Period|Adverse Event|7|||
25124626|NCT01721044|50237368|FG001|Treatment Period|Adverse Event|7|||
25124627|NCT01721044|50237369|FG002|Treatment Period|Adverse Event|10|||
25124628|NCT01721044|50237367|FG000|Treatment Period|Death|0|||
25124629|NCT01721044|50237368|FG001|Treatment Period|Death|0|||
25124630|NCT01721044|50237369|FG002|Treatment Period|Death|1|||
25124631|NCT01721044|50237367|FG000|Treatment Period|Lack of Efficacy|16|||
25124632|NCT01721044|50237368|FG001|Treatment Period|Lack of Efficacy|4|||
25124633|NCT01721044|50237369|FG002|Treatment Period|Lack of Efficacy|4|||
25124634|NCT01721044|50237367|FG000|Treatment Period|Lost to Follow-up|0|||
25124635|NCT01721044|50237368|FG001|Treatment Period|Lost to Follow-up|0|||
25124636|NCT01721044|50237369|FG002|Treatment Period|Lost to Follow-up|1|||
25124637|NCT01721044|50237367|FG000|Treatment Period|Physician Decision|1|||
25124638|NCT01721044|50237368|FG001|Treatment Period|Physician Decision|0|||
25124639|NCT01721044|50237369|FG002|Treatment Period|Physician Decision|2|||
25124640|NCT01721044|50237367|FG000|Treatment Period|Protocol Violation|1|||
25124641|NCT01721044|50237368|FG001|Treatment Period|Protocol Violation|0|||
25124642|NCT01721044|50237369|FG002|Treatment Period|Protocol Violation|0|||
25124643|NCT01721044|50237367|FG000|Treatment Period|Withdrawal by Subject|7|||
25124644|NCT01721044|50237368|FG001|Treatment Period|Withdrawal by Subject|6|||
25124645|NCT01721044|50237369|FG002|Treatment Period|Withdrawal by Subject|1|||
25124646|NCT02164981|50237391|FG000|Started|Withdrawal by Subject|2|||
25124647|NCT02164981|50237392|FG001|Started|Withdrawal by Subject|1|||
25124648|NCT02164981|50237393|FG002|Started|Withdrawal by Subject|0|||
25124649|NCT02164981|50237391|FG000|Started|Protocol Violation|2|||
25124650|NCT02164981|50237392|FG001|Started|Protocol Violation|0|||
25124651|NCT02164981|50237393|FG002|Started|Protocol Violation|0|||
25124652|NCT02164981|50237391|FG000|Started|Adverse Event|1|||
25124653|NCT02164981|50237392|FG001|Started|Adverse Event|2|||
25124654|NCT02164981|50237393|FG002|Started|Adverse Event|0|||
25124655|NCT02164981|50237391|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
25124656|NCT02164981|50237392|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
25124657|NCT02164981|50237393|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
25124658|NCT02164981|50237391|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
25124659|NCT02164981|50237392|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
25124660|NCT02164981|50237393|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
25124661|NCT02164981|50237391|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
25124662|NCT02164981|50237392|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
25009216|NCT00075725|50102303|FG009|Overall Study|Insurance issues|0|||
25009217|NCT00075725|50102304|FG010|Overall Study|Insurance issues|0|||
25009218|NCT00075725|50102305|FG011|Overall Study|Insurance issues|0|||
25124663|NCT02164981|50237393|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
25124664|NCT02195869|50237414|FG000|Overall Study|cGVHD Progression|5|||
25124665|NCT02195869|50237414|FG000|Overall Study|Malignancy Progression/relapse|2|||
25124666|NCT02195869|50237414|FG000|Overall Study|Adverse Event|15|||
25124667|NCT02195869|50237414|FG000|Overall Study|Withdrawal by Subject|7|||
25124668|NCT02195869|50237414|FG000|Overall Study|Physician Decision|4|||
25124669|NCT02195869|50237414|FG000|Overall Study|Study Terminated by Sponsor|7|||
25124670|NCT02195869|50237414|FG000|Overall Study|Noncompliance with study drug|2|||
25124671|NCT01908699|50237423|FG000|Overall Study|Adverse Event|8|||
25124672|NCT01908699|50237424|FG001|Overall Study|Adverse Event|12|||
25124673|NCT01908699|50237423|FG000|Overall Study|Lack of Efficacy|2|||
25124674|NCT01908699|50237424|FG001|Overall Study|Lack of Efficacy|2|||
25124675|NCT01908699|50237423|FG000|Overall Study|Lost to Follow-up|2|||
25124676|NCT01908699|50237424|FG001|Overall Study|Lost to Follow-up|4|||
25124677|NCT01908699|50237423|FG000|Overall Study|Physician Decision|8|||
25124678|NCT01908699|50237424|FG001|Overall Study|Physician Decision|8|||
25124679|NCT01908699|50237423|FG000|Overall Study|Withdrawal by Subject|15|||
25124680|NCT01908699|50237424|FG001|Overall Study|Withdrawal by Subject|10|||
25124681|NCT01908699|50237423|FG000|Overall Study|Pregnancy|0|||
25124682|NCT01908699|50237424|FG001|Overall Study|Pregnancy|1|||
25124683|NCT01908699|50237423|FG000|Overall Study|Randomized in Error|1|||
25124684|NCT01908699|50237424|FG001|Overall Study|Randomized in Error|0|||
25124685|NCT01908699|50237423|FG000|Overall Study|Death|9|||
25124686|NCT01908699|50237424|FG001|Overall Study|Death|12|||
25124687|NCT01908699|50237423|FG000|Overall Study|Progressive Disease|30|||
25124688|NCT01908699|50237424|FG001|Overall Study|Progressive Disease|29|||
25124689|NCT01599637|50237433|FG000|Overall Study|administrative problems|0|||
25124690|NCT01599637|50237434|FG001|Overall Study|administrative problems|2|||
25124691|NCT01599637|50237435|FG002|Overall Study|administrative problems|0|||
25124692|NCT01599637|50237433|FG000|Overall Study|Adverse Event|1|||
25124693|NCT01599637|50237434|FG001|Overall Study|Adverse Event|0|||
25124694|NCT01599637|50237435|FG002|Overall Study|Adverse Event|0|||
25124695|NCT02264639|50237450|FG000|Overall Study|Death (after completing single-dose phase)|1|||
25124696|NCT02264639|50237451|FG001|Overall Study|Death (after completing single-dose phase)|0|||
25124697|NCT02264639|50237452|FG002|Overall Study|Death (after completing single-dose phase)|0|||
25124698|NCT02264639|50237453|FG003|Overall Study|Death (after completing single-dose phase)|0|||
25124699|NCT02264639|50237454|FG004|Overall Study|Death (after completing single-dose phase)|0|||
25124700|NCT02264639|50237450|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
25124701|NCT02264639|50237451|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
25124702|NCT02264639|50237452|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
25124703|NCT02264639|50237453|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
25124704|NCT02264639|50237454|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
25124705|NCT02264639|50237450|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
25124706|NCT02264639|50237451|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
25124707|NCT02264639|50237452|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
25124708|NCT02264639|50237453|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
25124709|NCT02264639|50237454|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
25124710|NCT02264639|50237450|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
25124711|NCT02264639|50237451|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
25124712|NCT02264639|50237452|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
25124713|NCT02264639|50237453|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
25124714|NCT02264639|50237454|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
25124715|NCT01363011|50237471|FG000|Main Study|Adverse Event|2|||
25124716|NCT01363011|50237472|FG001|Main Study|Adverse Event|3|||
25124717|NCT01363011|50237471|FG000|Main Study|Investigator's Discretion|1|||
25124718|NCT01363011|50237472|FG001|Main Study|Investigator's Discretion|1|||
25124719|NCT01363011|50237471|FG000|Main Study|Withdrew Consent|1|||
25124720|NCT01363011|50237472|FG001|Main Study|Withdrew Consent|4|||
25124721|NCT01363011|50237471|FG000|Main Study|Protocol Violation|0|||
25124722|NCT01363011|50237472|FG001|Main Study|Protocol Violation|1|||
25124723|NCT01363011|50237471|FG000|Extension Phase|Adverse Event|1|||
25124724|NCT01363011|50237472|FG001|Extension Phase|Adverse Event|1|||
25124725|NCT01363011|50237471|FG000|Extension Phase|Lack of Efficacy|0|||
25124726|NCT01363011|50237472|FG001|Extension Phase|Lack of Efficacy|1|||
25124727|NCT01363011|50237471|FG000|Extension Phase|Investigator's Discretion|2|||
25124728|NCT01363011|50237472|FG001|Extension Phase|Investigator's Discretion|2|||
25124729|NCT01363011|50237471|FG000|Extension Phase|Withdrew Consent|0|||
25124730|NCT01363011|50237472|FG001|Extension Phase|Withdrew Consent|1|||
25124731|NCT01363011|50237471|FG000|Extension Phase|Lost to Follow-up|0|||
25124732|NCT01363011|50237472|FG001|Extension Phase|Lost to Follow-up|2|||
25124733|NCT01363011|50237471|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
25266144|NCT01011868|50580346|FG000|After Week 18 Follow-up|Protocol Violation|1|||
25266145|NCT01011868|50580347|FG001|After Week 18 Follow-up|Protocol Violation|1|||
25266146|NCT01011868|50580348|FG002|After Week 18 Follow-up|Protocol Violation|1|||
25266147|NCT01011868|50580346|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
25266148|NCT01011868|50580347|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
25266149|NCT01011868|50580348|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
25266150|NCT01011868|50580346|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
25266151|NCT01011868|50580347|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
25124734|NCT01363011|50237472|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
25124735|NCT02263547|50237478|FG000|Overall Study|Adverse Event|1|||
25124736|NCT02263547|50237478|FG000|Overall Study|Lost to Follow-up|2|||
25124737|NCT01925703|50237482|FG000|Overall Study|Physician Decision|1|||
25124738|NCT01925703|50237482|FG000|Overall Study|Lost to Follow-up|2|||
25124739|NCT01925703|50237482|FG000|Overall Study|Discharge prior to full iron repletion|1|||
25177734|NCT01523275|50321829|FG001|Overall Study|Withdrawal by Subject|0|||
25177735|NCT01492439|50321846|FG000|Overall Study|Withdrew from RTE|4|||
25124740|NCT02195011|50237488|FG000|Overall Study|Adverse Event|4|||
25124741|NCT02195011|50237489|FG001|Overall Study|Adverse Event|0|||
25124742|NCT02195011|50237488|FG000|Overall Study|Progressive Disease|18|||
25124743|NCT02195011|50237489|FG001|Overall Study|Progressive Disease|1|||
25124744|NCT02195011|50237488|FG000|Overall Study|Withdrawal by Subject|3|||
25124745|NCT02195011|50237489|FG001|Overall Study|Withdrawal by Subject|0|||
25124746|NCT01617681|50237499|FG000|Period 1 Double Blind|Adverse Event|2|||
25124747|NCT01617681|50237500|FG001|Period 1 Double Blind|Adverse Event|0|||
25124748|NCT01617681|50237501|FG002|Period 1 Double Blind|Adverse Event|0|||
25124749|NCT01617681|50237502|FG003|Period 1 Double Blind|Adverse Event|2|||
25124750|NCT01617681|50237503|FG004|Period 1 Double Blind|Adverse Event|0|||
25124751|NCT01617681|50237499|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
25124752|NCT01617681|50237500|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
25124753|NCT01617681|50237501|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
25124754|NCT01617681|50237502|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
25124755|NCT01617681|50237503|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
25124756|NCT01617681|50237499|FG000|Period 2 Open Label|Adverse Event|0|||
25124757|NCT01617681|50237500|FG001|Period 2 Open Label|Adverse Event|0|||
25124758|NCT01617681|50237501|FG002|Period 2 Open Label|Adverse Event|0|||
25124759|NCT01617681|50237502|FG003|Period 2 Open Label|Adverse Event|0|||
25124760|NCT01617681|50237503|FG004|Period 2 Open Label|Adverse Event|3|||
25124761|NCT01617681|50237499|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
25124762|NCT01617681|50237500|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
25124763|NCT01617681|50237501|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
25124764|NCT01617681|50237502|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
25124765|NCT01617681|50237503|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
25124766|NCT02263079|50237515|FG000|Overall Study|Physician Decision|1|||
25124767|NCT02263079|50237516|FG001|Overall Study|Physician Decision|0|||
25124768|NCT02263079|50237517|FG002|Overall Study|Physician Decision|0|||
25124769|NCT02263079|50237515|FG000|Overall Study|Withdrawal by Subject|2|||
25124770|NCT02263079|50237516|FG001|Overall Study|Withdrawal by Subject|8|||
25124771|NCT02263079|50237517|FG002|Overall Study|Withdrawal by Subject|0|||
25124772|NCT02295995|50237527|FG000|Overall Study|Lost to Follow-up|5|||
25124773|NCT02295995|50237528|FG001|Overall Study|Lost to Follow-up|1|||
25124774|NCT02294981|50237535|FG000|Overall Study|Lost to Follow-up|1|||
25124775|NCT02262377|50237541|FG000|Overall Study|Lost to Follow-up|5|||
25124776|NCT02262377|50237542|FG001|Overall Study|Lost to Follow-up|6|||
25124777|NCT02262377|50237541|FG000|Overall Study|Found ineligible after enrollment|3|||
25124778|NCT02262377|50237542|FG001|Overall Study|Found ineligible after enrollment|0|||
25124779|NCT02262377|50237541|FG000|Overall Study|Withdrawal by Subject|4|||
25177736|NCT01492439|50321847|FG001|Overall Study|Withdrew from RTE|9|||
25177737|NCT01572727|50321882|FG000|Overall Study|Adverse Event|43|||
25177738|NCT01572727|50321883|FG001|Overall Study|Adverse Event|15|||
25177739|NCT01572727|50321882|FG000|Overall Study|Lost to Follow-up|1|||
25177740|NCT01572727|50321883|FG001|Overall Study|Lost to Follow-up|1|||
25177741|NCT01572727|50321882|FG000|Overall Study|Physician Decision|23|||
25177742|NCT01572727|50321883|FG001|Overall Study|Physician Decision|9|||
25177743|NCT01572727|50321882|FG000|Overall Study|Progressive disease|59|||
25124780|NCT02262377|50237542|FG001|Overall Study|Withdrawal by Subject|0|||
25124781|NCT02260817|50237551|FG000|Overall Study|Lost to Follow-up|0|||
25124782|NCT02260817|50237552|FG001|Overall Study|Lost to Follow-up|14|||
25124783|NCT02260817|50237551|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
25124784|NCT02260817|50237552|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
25124785|NCT02260817|50237551|FG000|Overall Study|Observation, no biopsy|0|||
25124786|NCT02260817|50237552|FG001|Overall Study|Observation, no biopsy|1|||
25124787|NCT02260817|50237551|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
25124788|NCT02260817|50237552|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
25124789|NCT02260817|50237551|FG000|Overall Study|Protocol Violation|0|||
25124790|NCT02260817|50237552|FG001|Overall Study|Protocol Violation|14|||
25124791|NCT01642589|50237560|FG000|Overall Study|Withdrawal by Subject|1|||
25124792|NCT01642589|50237561|FG001|Overall Study|Withdrawal by Subject|1|||
25124793|NCT02268812|50237571|FG000|Overall Study|Adverse Event|8|||
25124794|NCT02268812|50237572|FG001|Overall Study|Adverse Event|26|||
25124795|NCT02268812|50237573|FG002|Overall Study|Adverse Event|7|||
25124796|NCT02268812|50237574|FG003|Overall Study|Adverse Event|10|||
25124797|NCT02268812|50237571|FG000|Overall Study|Protocol deviation|0|||
25124798|NCT02268812|50237572|FG001|Overall Study|Protocol deviation|0|||
25124799|NCT02268812|50237573|FG002|Overall Study|Protocol deviation|1|||
25124800|NCT02268812|50237574|FG003|Overall Study|Protocol deviation|0|||
25124801|NCT02268812|50237571|FG000|Overall Study|Withdrawal by Subject|0|||
25124802|NCT02268812|50237572|FG001|Overall Study|Withdrawal by Subject|1|||
25124803|NCT02268812|50237573|FG002|Overall Study|Withdrawal by Subject|0|||
25177744|NCT01572727|50321883|FG001|Overall Study|Progressive disease|82|||
25177745|NCT01572727|50321882|FG000|Overall Study|Protocol Violation|0|||
25177746|NCT01572727|50321883|FG001|Overall Study|Protocol Violation|1|||
25124804|NCT02268812|50237574|FG003|Overall Study|Withdrawal by Subject|0|||
25124805|NCT02268812|50237571|FG000|Overall Study|Physician Decision|3|||
25124806|NCT02268812|50237572|FG001|Overall Study|Physician Decision|1|||
25124807|NCT02268812|50237573|FG002|Overall Study|Physician Decision|0|||
25124808|NCT02268812|50237574|FG003|Overall Study|Physician Decision|1|||
25124809|NCT02268812|50237571|FG000|Overall Study|Other|5|||
25124810|NCT02268812|50237572|FG001|Overall Study|Other|4|||
25124811|NCT02268812|50237573|FG002|Overall Study|Other|1|||
25124812|NCT02268812|50237574|FG003|Overall Study|Other|3|||
25124813|NCT01954251|50237586|FG000|Overall Study|Adverse Event|5|||
25124814|NCT01954251|50237587|FG001|Overall Study|Adverse Event|7|||
25124815|NCT01954251|50237586|FG000|Overall Study|Lost to Follow-up|6|||
25124816|NCT01954251|50237587|FG001|Overall Study|Lost to Follow-up|6|||
25124817|NCT01954251|50237586|FG000|Overall Study|Withdrawal by Subject|2|||
25124818|NCT01954251|50237587|FG001|Overall Study|Withdrawal by Subject|6|||
25124819|NCT01644617|50237597|FG000|Overall Study|Withdrawal by Subject|3|||
25124820|NCT01644617|50237598|FG001|Overall Study|Withdrawal by Subject|4|||
25124821|NCT01644617|50237599|FG002|Overall Study|Withdrawal by Subject|1|||
25124822|NCT01644617|50237597|FG000|Overall Study|Lost to Follow-up|0|||
25124823|NCT01644617|50237598|FG001|Overall Study|Lost to Follow-up|1|||
25124824|NCT01644617|50237599|FG002|Overall Study|Lost to Follow-up|0|||
25124825|NCT01644617|50237597|FG000|Overall Study|Adverse Event|3|||
25124826|NCT01644617|50237598|FG001|Overall Study|Adverse Event|0|||
25124827|NCT01644617|50237599|FG002|Overall Study|Adverse Event|6|||
25124828|NCT02294318|50237609|FG000|Overall Study|Worsening of drinking|3|||
25124829|NCT02294318|50237610|FG001|Overall Study|Worsening of drinking|0|||
25124830|NCT02294318|50237609|FG000|Overall Study|Not exposed to intervention|0|||
25177747|NCT01572727|50321882|FG000|Overall Study|Study terminated by sponsor|61|||
25177748|NCT01572727|50321883|FG001|Overall Study|Study terminated by sponsor|83|||
25177749|NCT01572727|50321882|FG000|Overall Study|Parent/guardian decision|14|||
25177750|NCT01572727|50321883|FG001|Overall Study|Parent/guardian decision|9|||
25177751|NCT01572727|50321882|FG000|Overall Study|Death|2|||
25177752|NCT01572727|50321883|FG001|Overall Study|Death|2|||
25177753|NCT01572727|50321882|FG000|Overall Study|Untreated|4|||
25266152|NCT01011868|50580348|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
25266153|NCT01011868|50580346|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
25266154|NCT01011868|50580347|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
25266155|NCT01011868|50580348|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
25266156|NCT01011868|50580346|FG000|After Week 78 Follow-up|Adverse Event|14|||
25266157|NCT01011868|50580347|FG001|After Week 78 Follow-up|Adverse Event|18|||
25266158|NCT01011868|50580348|FG002|After Week 78 Follow-up|Adverse Event|21|||
25266159|NCT01011868|50580346|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
25266160|NCT01011868|50580347|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
25266161|NCT01011868|50580348|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
25266162|NCT01011868|50580346|FG000|After Week 78 Follow-up|Protocol Violation|9|||
25266163|NCT01011868|50580347|FG001|After Week 78 Follow-up|Protocol Violation|1|||
25266164|NCT01011868|50580348|FG002|After Week 78 Follow-up|Protocol Violation|2|||
25266165|NCT01011868|50580346|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
25266166|NCT01011868|50580347|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
25266167|NCT01011868|50580348|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
25266168|NCT01011868|50580346|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
25266169|NCT01011868|50580347|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
25266170|NCT01011868|50580348|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
25266171|NCT01011868|50580346|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
25266172|NCT01011868|50580347|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
25266173|NCT01011868|50580348|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
25266174|NCT01213251|50580359|FG000|Overall Study|Death|2|||
25266175|NCT01213251|50580360|FG001|Overall Study|Death|1|||
25266176|NCT01213251|50580361|FG002|Overall Study|Death|2|||
25124831|NCT02294318|50237610|FG001|Overall Study|Not exposed to intervention|2|||
25124832|NCT02293499|50237619|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
25124833|NCT02293499|50237620|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
25124834|NCT02293499|50237621|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
25124835|NCT02293499|50237619|FG000|Intervention - Camp|Withdrawal by Subject|3|||
25124836|NCT02293499|50237620|FG001|Intervention - Camp|Withdrawal by Subject|6|||
25177754|NCT01572727|50321883|FG001|Overall Study|Untreated|7|||
25177755|NCT01522651|50321930|FG000|Overall Study|Adverse Event|3|||
25124837|NCT02293499|50237621|FG002|Intervention - Camp|Withdrawal by Subject|2|||
25177756|NCT01522651|50321931|FG001|Overall Study|Adverse Event|4|||
25177757|NCT01522651|50321932|FG002|Overall Study|Adverse Event|4|||
25266177|NCT01213251|50580359|FG000|Overall Study|Exit|3|||
25266178|NCT01213251|50580360|FG001|Overall Study|Exit|2|||
25266179|NCT01213251|50580361|FG002|Overall Study|Exit|8|||
25266180|NCT01213251|50580359|FG000|Overall Study|Protocol Violation|1|||
25177758|NCT01522651|50321933|FG003|Overall Study|Adverse Event|5|||
25177759|NCT01522651|50321934|FG004|Overall Study|Adverse Event|4|||
25177760|NCT01522651|50321930|FG000|Overall Study|Cardioversion|1|||
25177761|NCT01522651|50321931|FG001|Overall Study|Cardioversion|0|||
25177762|NCT01522651|50321932|FG002|Overall Study|Cardioversion|0|||
25177763|NCT01522651|50321933|FG003|Overall Study|Cardioversion|0|||
25177764|NCT01522651|50321934|FG004|Overall Study|Cardioversion|0|||
25177765|NCT01522651|50321930|FG000|Overall Study|Device Malfunction|0|||
25124838|NCT02293499|50237619|FG000|Intervention - Camp|these are those not showing up at camp|24|||
25124839|NCT02293499|50237620|FG001|Intervention - Camp|these are those not showing up at camp|28|||
25124840|NCT02293499|50237621|FG002|Intervention - Camp|these are those not showing up at camp|4|||
25124841|NCT02293499|50237619|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
25124842|NCT02293499|50237620|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
25124843|NCT02293499|50237621|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
25124844|NCT02293499|50237619|FG000|3 Month Follow Up|Lost to Follow-up|14|||
25124845|NCT02293499|50237620|FG001|3 Month Follow Up|Lost to Follow-up|15|||
25124846|NCT02293499|50237621|FG002|3 Month Follow Up|Lost to Follow-up|6|||
25124847|NCT02293499|50237619|FG000|6 Month Follow Up|Lost to Follow-up|17|||
25124848|NCT02293499|50237620|FG001|6 Month Follow Up|Lost to Follow-up|27|||
25124849|NCT02293499|50237621|FG002|6 Month Follow Up|Lost to Follow-up|6|||
25124850|NCT02293499|50237619|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
25124851|NCT02293499|50237620|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
25009219|NCT00075725|50102294|FG000|Overall Study|MRD positive after extended ind|0|||
25177766|NCT01522651|50321931|FG001|Overall Study|Device Malfunction|1|||
25177767|NCT01522651|50321932|FG002|Overall Study|Device Malfunction|0|||
25177768|NCT01522651|50321933|FG003|Overall Study|Device Malfunction|0|||
25177769|NCT01522651|50321934|FG004|Overall Study|Device Malfunction|0|||
25177770|NCT01522651|50321930|FG000|Overall Study|Investigator's Discretion|0|||
25177771|NCT01522651|50321931|FG001|Overall Study|Investigator's Discretion|1|||
25177772|NCT01522651|50321932|FG002|Overall Study|Investigator's Discretion|0|||
25177773|NCT01522651|50321933|FG003|Overall Study|Investigator's Discretion|0|||
25177774|NCT01522651|50321934|FG004|Overall Study|Investigator's Discretion|0|||
25177775|NCT01522651|50321930|FG000|Overall Study|Protocol Violation|3|||
25177776|NCT01522651|50321931|FG001|Overall Study|Protocol Violation|0|||
25177777|NCT01522651|50321932|FG002|Overall Study|Protocol Violation|0|||
25177778|NCT01522651|50321933|FG003|Overall Study|Protocol Violation|0|||
25177779|NCT01522651|50321934|FG004|Overall Study|Protocol Violation|0|||
25177780|NCT01522651|50321930|FG000|Overall Study|Reason Not Specified|0|||
25177781|NCT01522651|50321931|FG001|Overall Study|Reason Not Specified|0|||
25177782|NCT01522651|50321932|FG002|Overall Study|Reason Not Specified|0|||
25177783|NCT01522651|50321933|FG003|Overall Study|Reason Not Specified|1|||
25266181|NCT01213251|50580360|FG001|Overall Study|Protocol Violation|1|||
25266182|NCT01213251|50580361|FG002|Overall Study|Protocol Violation|0|||
25266183|NCT01213251|50580359|FG000|Overall Study|Missed 18-Month Follow-up|0|||
25266184|NCT01213251|50580360|FG001|Overall Study|Missed 18-Month Follow-up|0|||
25266185|NCT01213251|50580361|FG002|Overall Study|Missed 18-Month Follow-up|1|||
25266186|NCT01213173|50580376|FG000|Overall Study|Protocol Violation|2|||
25266187|NCT01213173|50580377|FG001|Overall Study|Protocol Violation|0|||
25266188|NCT01213173|50580376|FG000|Overall Study|Adverse Event|4|||
25266189|NCT01213173|50580377|FG001|Overall Study|Adverse Event|8|||
25266190|NCT01213173|50580376|FG000|Overall Study|Withdrawal by Subject|5|||
25266191|NCT01213173|50580377|FG001|Overall Study|Withdrawal by Subject|5|||
25266192|NCT01213173|50580376|FG000|Overall Study|Incorrect Enrollment|1|||
25266193|NCT01213173|50580377|FG001|Overall Study|Incorrect Enrollment|3|||
25266194|NCT01212159|50580385|FG000|Overall Study|Withdrawal by Subject|12|||
25266195|NCT01212159|50580386|FG001|Overall Study|Withdrawal by Subject|12|||
25266196|NCT00973765|50580394|FG000|Overall Study|Lost to Follow-up|8|||
25266197|NCT00973765|50580395|FG001|Overall Study|Lost to Follow-up|14|||
25266198|NCT01211769|50580405|FG000|Overall Study|Lost to Follow-up|7|||
25009220|NCT00075725|50102295|FG001|Overall Study|MRD positive after extended ind|1|||
25009221|NCT00075725|50102296|FG002|Overall Study|MRD positive after extended ind|1|||
25009222|NCT00075725|50102297|FG003|Overall Study|MRD positive after extended ind|0|||
25009223|NCT00075725|50102298|FG004|Overall Study|MRD positive after extended ind|1|||
25009224|NCT00075725|50102299|FG005|Overall Study|MRD positive after extended ind|2|||
25009225|NCT00075725|50102300|FG006|Overall Study|MRD positive after extended ind|0|||
25124852|NCT02293499|50237621|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
25124853|NCT02293499|50237619|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
25177784|NCT01522651|50321934|FG004|Overall Study|Reason Not Specified|0|||
25177785|NCT01522651|50321930|FG000|Overall Study|Participant Non-Compliance|1|||
25177786|NCT01522651|50321931|FG001|Overall Study|Participant Non-Compliance|0|||
25177787|NCT01522651|50321932|FG002|Overall Study|Participant Non-Compliance|0|||
25177788|NCT01522651|50321933|FG003|Overall Study|Participant Non-Compliance|0|||
25266199|NCT01211769|50580406|FG001|Overall Study|Lost to Follow-up|9|||
25266200|NCT01211769|50580407|FG002|Overall Study|Lost to Follow-up|5|||
25266201|NCT01211769|50580408|FG003|Overall Study|Lost to Follow-up|9|||
25266202|NCT01211769|50580405|FG000|Overall Study|Physician Decision|2|||
25124854|NCT02293499|50237620|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
25124855|NCT02293499|50237621|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
25124856|NCT02293499|50237619|FG000|9 Month Follow Up|Lost to Follow-up|24|||
25124857|NCT02293499|50237620|FG001|9 Month Follow Up|Lost to Follow-up|28|||
25124858|NCT02293499|50237621|FG002|9 Month Follow Up|Lost to Follow-up|4|||
25124859|NCT02293499|50237619|FG000|12 Month Follow Up|Lost to Follow-up|26|||
25124860|NCT02293499|50237620|FG001|12 Month Follow Up|Lost to Follow-up|25|||
25124861|NCT02293499|50237621|FG002|12 Month Follow Up|Lost to Follow-up|6|||
25124862|NCT02293499|50237619|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
25124863|NCT02293499|50237620|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
25124864|NCT02293499|50237621|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
25124865|NCT02293499|50237619|FG000|15 Month Follow Up|Lost to Follow-up|22|||
25124866|NCT02293499|50237620|FG001|15 Month Follow Up|Lost to Follow-up|22|||
25124867|NCT02293499|50237621|FG002|15 Month Follow Up|Lost to Follow-up|7|||
25124868|NCT02257385|50237632|FG000|Overall Study|Adverse Event|12|||
25124869|NCT02257385|50237633|FG001|Overall Study|Adverse Event|8|||
25124870|NCT02257385|50237632|FG000|Overall Study|Lack of Efficacy|1|||
25124871|NCT02257385|50237633|FG001|Overall Study|Lack of Efficacy|2|||
25124872|NCT02257385|50237632|FG000|Overall Study|Protocol Violation|5|||
25124873|NCT02257385|50237633|FG001|Overall Study|Protocol Violation|7|||
25124874|NCT02257385|50237632|FG000|Overall Study|Lost to Follow-up|0|||
25124875|NCT02257385|50237633|FG001|Overall Study|Lost to Follow-up|1|||
25124876|NCT02257385|50237632|FG000|Overall Study|Withdrawal by Subject|4|||
25124877|NCT02257385|50237633|FG001|Overall Study|Withdrawal by Subject|4|||
25124878|NCT01629667|50237642|FG000|Overall Study|Lost to Follow-up|0|||
25124879|NCT01629667|50237643|FG001|Overall Study|Lost to Follow-up|1|||
25124880|NCT01629667|50237644|FG002|Overall Study|Lost to Follow-up|1|||
25124881|NCT01629667|50237642|FG000|Overall Study|Withdrawal by Subject|31|||
25124882|NCT01629667|50237643|FG001|Overall Study|Withdrawal by Subject|20|||
25124883|NCT01629667|50237644|FG002|Overall Study|Withdrawal by Subject|28|||
25124884|NCT01629667|50237642|FG000|Overall Study|Death|1|||
25124885|NCT01629667|50237643|FG001|Overall Study|Death|5|||
25124886|NCT01629667|50237644|FG002|Overall Study|Death|3|||
25124887|NCT01629667|50237642|FG000|Overall Study|Randomized, not treated|2|||
25124888|NCT01629667|50237643|FG001|Overall Study|Randomized, not treated|1|||
25124889|NCT01629667|50237644|FG002|Overall Study|Randomized, not treated|0|||
25124890|NCT01629667|50237642|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
25124891|NCT01629667|50237643|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
25124892|NCT01629667|50237644|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
25124893|NCT01629667|50237642|FG000|Overall Study|Requiring lung transplant|2|||
25124894|NCT01629667|50237643|FG001|Overall Study|Requiring lung transplant|1|||
25124895|NCT01629667|50237644|FG002|Overall Study|Requiring lung transplant|3|||
25124896|NCT01629667|50237642|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
25124897|NCT01629667|50237643|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
25124898|NCT01629667|50237644|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
25124899|NCT01629667|50237642|FG000|Overall Study|Started other medicine|1|||
25124900|NCT01629667|50237643|FG001|Overall Study|Started other medicine|0|||
25124901|NCT01629667|50237644|FG002|Overall Study|Started other medicine|1|||
25124902|NCT01629667|50237642|FG000|Overall Study|Site error in safety follow-up|0|||
25124903|NCT01629667|50237643|FG001|Overall Study|Site error in safety follow-up|0|||
25124904|NCT01629667|50237644|FG002|Overall Study|Site error in safety follow-up|1|||
25124905|NCT01629667|50237642|FG000|Overall Study|Enrolled in another clinical study|0|||
25124906|NCT01629667|50237643|FG001|Overall Study|Enrolled in another clinical study|1|||
25124907|NCT01629667|50237644|FG002|Overall Study|Enrolled in another clinical study|0|||
25124908|NCT01629667|50237642|FG000|Overall Study|Code break|1|||
25124909|NCT01629667|50237643|FG001|Overall Study|Code break|0|||
25124910|NCT01629667|50237644|FG002|Overall Study|Code break|0|||
25124911|NCT01645280|50237659|FG000|Overall Study|Death|0|||
25124912|NCT01645280|50237660|FG001|Overall Study|Death|1|||
25124913|NCT01645280|50237661|FG002|Overall Study|Death|0|||
25124914|NCT01645280|50237662|FG003|Overall Study|Death|0|||
25124915|NCT01645280|50237663|FG004|Overall Study|Death|0|||
25124916|NCT01645280|50237659|FG000|Overall Study|Withdrawal by Subject|4|||
25124917|NCT01645280|50237660|FG001|Overall Study|Withdrawal by Subject|0|||
25124918|NCT01645280|50237661|FG002|Overall Study|Withdrawal by Subject|2|||
25124919|NCT01645280|50237662|FG003|Overall Study|Withdrawal by Subject|4|||
25124920|NCT01645280|50237663|FG004|Overall Study|Withdrawal by Subject|5|||
25124921|NCT01645280|50237659|FG000|Overall Study|Lost to Follow-up|0|||
25124922|NCT01645280|50237660|FG001|Overall Study|Lost to Follow-up|0|||
25124923|NCT01645280|50237661|FG002|Overall Study|Lost to Follow-up|0|||
25124924|NCT01645280|50237662|FG003|Overall Study|Lost to Follow-up|2|||
25124925|NCT01645280|50237663|FG004|Overall Study|Lost to Follow-up|1|||
25124926|NCT01645280|50237659|FG000|Overall Study|Other|1|||
25124927|NCT01645280|50237660|FG001|Overall Study|Other|1|||
25124928|NCT01645280|50237661|FG002|Overall Study|Other|2|||
25124929|NCT01645280|50237662|FG003|Overall Study|Other|0|||
25177789|NCT01522651|50321934|FG004|Overall Study|Participant Non-Compliance|0|||
25177790|NCT01522651|50321930|FG000|Overall Study|Withdrew Consent|1|||
25177791|NCT01522651|50321931|FG001|Overall Study|Withdrew Consent|1|||
25177792|NCT01522651|50321932|FG002|Overall Study|Withdrew Consent|0|||
25177793|NCT01522651|50321933|FG003|Overall Study|Withdrew Consent|1|||
25177794|NCT01522651|50321934|FG004|Overall Study|Withdrew Consent|1|||
25177795|NCT01522651|50321930|FG000|Overall Study|Randomized but Never Treated|0|||
25177796|NCT01522651|50321931|FG001|Overall Study|Randomized but Never Treated|1|||
25177797|NCT01522651|50321932|FG002|Overall Study|Randomized but Never Treated|0|||
25177798|NCT01522651|50321933|FG003|Overall Study|Randomized but Never Treated|1|||
25177799|NCT01522651|50321934|FG004|Overall Study|Randomized but Never Treated|1|||
25177800|NCT01554241|50321961|FG000|Overall Study|Death|3|||
25177801|NCT01554241|50321962|FG001|Overall Study|Death|1|||
25177802|NCT01554241|50321963|FG002|Overall Study|Death|1|||
25177803|NCT01554241|50321964|FG003|Overall Study|Death|0|||
25177804|NCT01554241|50321961|FG000|Overall Study|protocol specified renal stone|0|||
25177805|NCT01554241|50321962|FG001|Overall Study|protocol specified renal stone|0|||
25177806|NCT01554241|50321963|FG002|Overall Study|protocol specified renal stone|0|||
25177807|NCT01554241|50321964|FG003|Overall Study|protocol specified renal stone|1|||
25177808|NCT01554241|50321961|FG000|Overall Study|protocol specified change in eGFR|0|||
25177809|NCT01554241|50321962|FG001|Overall Study|protocol specified change in eGFR|0|||
25124930|NCT01645280|50237663|FG004|Overall Study|Other|0|||
25124931|NCT01645280|50237659|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
25124932|NCT01645280|50237660|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
25124933|NCT01645280|50237661|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
25124934|NCT01645280|50237662|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
25124935|NCT01645280|50237663|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
25124936|NCT02256917|50237676|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
25124937|NCT02256917|50237676|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
25124938|NCT02256917|50237676|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
25124939|NCT02256917|50237676|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
25124940|NCT02256917|50237676|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
25124941|NCT01629589|50237689|FG000|Overall Study|Protocol Violation|4|||
25124942|NCT01629589|50237690|FG001|Overall Study|Protocol Violation|2|||
25124943|NCT01629589|50237689|FG000|Overall Study|Lost to Follow-up|2|||
25124944|NCT01629589|50237690|FG001|Overall Study|Lost to Follow-up|1|||
25124945|NCT01629589|50237689|FG000|Overall Study|Withdrawal by Subject|2|||
25124946|NCT01629589|50237690|FG001|Overall Study|Withdrawal by Subject|3|||
25124947|NCT01629589|50237689|FG000|Overall Study|Did not receive study vaccine|0|||
25124948|NCT01629589|50237690|FG001|Overall Study|Did not receive study vaccine|1|||
25124949|NCT02256839|50237698|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
25124950|NCT02256839|50237699|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
25124951|NCT02220907|50237705|FG000|Overall Study|Adverse Event|7|||
25124952|NCT02220907|50237705|FG000|Overall Study|Physician Decision|1|||
25124953|NCT02220907|50237705|FG000|Overall Study|Withdrawal by Subject|2|||
25124954|NCT02220907|50237705|FG000|Overall Study|Conflict with the stopping criteria|1|||
25124955|NCT02255981|50237709|FG000|Overall Study|Lost to Follow-up|3|||
25124956|NCT02255981|50237709|FG000|Overall Study|Withdrawal by Subject|1|||
25124957|NCT01601873|50237721|FG000|Overall Study|Lost to Follow-up|2|||
25177810|NCT01554241|50321963|FG002|Overall Study|protocol specified change in eGFR|1|||
25177811|NCT01554241|50321964|FG003|Overall Study|protocol specified change in eGFR|0|||
25177812|NCT01554241|50321961|FG000|Overall Study|Withdrawal by Subject|0|||
25177813|NCT01554241|50321962|FG001|Overall Study|Withdrawal by Subject|0|||
25177814|NCT01554241|50321963|FG002|Overall Study|Withdrawal by Subject|2|||
25124958|NCT01601873|50237722|FG001|Overall Study|Lost to Follow-up|3|||
25124959|NCT02194933|50237730|FG000|Overall Study|Lost to Follow-up|1|||
25124960|NCT02194933|50237731|FG001|Overall Study|Lost to Follow-up|2|||
25124961|NCT02194933|50237730|FG000|Overall Study|Participant met withdrawal criteria|1|||
25124962|NCT02194933|50237731|FG001|Overall Study|Participant met withdrawal criteria|3|||
25124963|NCT02194933|50237730|FG000|Overall Study|Withdrawal by Subject|0|||
25124964|NCT02194933|50237731|FG001|Overall Study|Withdrawal by Subject|2|||
25124965|NCT02194933|50237730|FG000|Overall Study|Lack of Efficacy|1|||
25124966|NCT02194933|50237731|FG001|Overall Study|Lack of Efficacy|2|||
25124967|NCT01644890|50237741|FG000|Overall Study|Adverse Event|7|||
25124968|NCT01644890|50237742|FG001|Overall Study|Adverse Event|20|||
25124969|NCT01644890|50237741|FG000|Overall Study|Death|1|||
25177815|NCT01554241|50321964|FG003|Overall Study|Withdrawal by Subject|0|||
25177816|NCT01521559|50321976|FG000|Overall Study|Adverse Event|0|||
25124970|NCT01644890|50237742|FG001|Overall Study|Death|3|||
25124971|NCT01644890|50237741|FG000|Overall Study|Physician Decision|3|||
25124972|NCT01644890|50237742|FG001|Overall Study|Physician Decision|9|||
25124973|NCT01644890|50237741|FG000|Overall Study|Protocol Violation|6|||
25177817|NCT01521559|50321977|FG001|Overall Study|Adverse Event|4|||
25177818|NCT01521559|50321976|FG000|Overall Study|Death|1|||
25177819|NCT01521559|50321977|FG001|Overall Study|Death|0|||
25266203|NCT01211769|50580406|FG001|Overall Study|Physician Decision|0|||
25177820|NCT01521559|50321976|FG000|Overall Study|Withdrawal by Subject|9|||
25177821|NCT01521559|50321977|FG001|Overall Study|Withdrawal by Subject|11|||
25177822|NCT01521559|50321976|FG000|Overall Study|Lost to Follow-up|3|||
25177823|NCT01521559|50321977|FG001|Overall Study|Lost to Follow-up|1|||
25177824|NCT01521559|50321976|FG000|Overall Study|Protocol Violation|1|||
25177825|NCT01521559|50321977|FG001|Overall Study|Protocol Violation|0|||
25177826|NCT01521559|50321976|FG000|Overall Study|Other|1|||
25177827|NCT01521559|50321977|FG001|Overall Study|Other|2|||
25177828|NCT01554163|50321986|FG000|Overall Study|Adverse Event|3|||
25177829|NCT01554163|50321987|FG001|Overall Study|Adverse Event|0|||
25177830|NCT01554163|50321986|FG000|Overall Study|Lack of Efficacy|1|||
25177831|NCT01554163|50321987|FG001|Overall Study|Lack of Efficacy|0|||
25177832|NCT01554163|50321986|FG000|Overall Study|Lost to Follow-up|1|||
25177833|NCT01554163|50321987|FG001|Overall Study|Lost to Follow-up|0|||
25177834|NCT01554163|50321986|FG000|Overall Study|Non-Compliance With Study Drug|1|||
25177835|NCT01554163|50321987|FG001|Overall Study|Non-Compliance With Study Drug|1|||
25177836|NCT01554163|50321986|FG000|Overall Study|Protocol Violation|0|||
25177837|NCT01554163|50321987|FG001|Overall Study|Protocol Violation|4|||
25177838|NCT01554163|50321986|FG000|Overall Study|Withdrawal by Subject|1|||
25177839|NCT01554163|50321987|FG001|Overall Study|Withdrawal by Subject|5|||
25177840|NCT01554163|50321986|FG000|Overall Study|Not Treated|1|||
25177841|NCT01554163|50321987|FG001|Overall Study|Not Treated|0|||
25177842|NCT01553851|50321993|FG000|Overall Study|Adverse Event|2|||
25177843|NCT01553851|50321993|FG000|Overall Study|constipation|1|||
25177844|NCT01552915|50322013|FG000|Overall Study|Adverse Event|3|||
25177845|NCT01552915|50322014|FG001|Overall Study|Adverse Event|14|||
25177846|NCT01552915|50322015|FG002|Overall Study|Adverse Event|3|||
25177847|NCT01552915|50322013|FG000|Overall Study|Lost to Follow-up|4|||
25177848|NCT01552915|50322014|FG001|Overall Study|Lost to Follow-up|6|||
25177849|NCT01552915|50322015|FG002|Overall Study|Lost to Follow-up|5|||
25177850|NCT01552915|50322013|FG000|Overall Study|Withdrawal by Subject|6|||
25177851|NCT01552915|50322014|FG001|Overall Study|Withdrawal by Subject|4|||
25177852|NCT01552915|50322015|FG002|Overall Study|Withdrawal by Subject|5|||
25177853|NCT01552915|50322013|FG000|Overall Study|Protocol Violation|0|||
25177854|NCT01552915|50322014|FG001|Overall Study|Protocol Violation|4|||
25124974|NCT01644890|50237742|FG001|Overall Study|Protocol Violation|7|||
25124975|NCT01644890|50237741|FG000|Overall Study|Withdrawal by Subject|19|||
25124976|NCT01644890|50237742|FG001|Overall Study|Withdrawal by Subject|27|||
25124977|NCT01644890|50237741|FG000|Overall Study|Progression Disease|160|||
25124978|NCT01644890|50237742|FG001|Overall Study|Progression Disease|131|||
25124979|NCT01644890|50237741|FG000|Overall Study|Clinical Progression|6|||
25124980|NCT01644890|50237742|FG001|Overall Study|Clinical Progression|6|||
25124981|NCT01644890|50237741|FG000|Overall Study|> 28 days since last dose of study drug|6|||
25124982|NCT01644890|50237742|FG001|Overall Study|> 28 days since last dose of study drug|3|||
25124983|NCT01644890|50237741|FG000|Overall Study|Other|8|||
25124984|NCT01644890|50237742|FG001|Overall Study|Other|9|||
25124985|NCT01628965|50237748|FG000|Overall Study|Adverse Event|30|||
25124986|NCT01628965|50237748|FG000|Overall Study|Lack of Efficacy|7|||
25124987|NCT01628965|50237748|FG000|Overall Study|Withdrawal by Subject|3|||
25124988|NCT01628965|50237748|FG000|Overall Study|Lost to Follow-up|1|||
25124989|NCT01628965|50237748|FG000|Overall Study|Discontinuation criteria|8|||
25124990|NCT01644734|50237752|FG000|Overall Study|Adverse Event|4|||
25124991|NCT01644734|50237752|FG000|Overall Study|Lost to Follow-up|17|||
25124992|NCT01644734|50237752|FG000|Overall Study|Reasons other than stated above|7|||
25124993|NCT01644734|50237752|FG000|Overall Study|Missing documentation|238|||
25124994|NCT02255279|50237758|FG000|Overall Study|Lost to Follow-up|2|||
25124995|NCT02255279|50237759|FG001|Overall Study|Lost to Follow-up|2|||
25124996|NCT02255279|50237758|FG000|Overall Study|Protocol Violation|0|||
25124997|NCT02255279|50237759|FG001|Overall Study|Protocol Violation|1|||
25124998|NCT02255279|50237758|FG000|Overall Study|Withdrawal by Subject|3|||
25124999|NCT02255279|50237759|FG001|Overall Study|Withdrawal by Subject|6|||
25125000|NCT01643798|50237779|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
25125001|NCT01643798|50237780|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
25125002|NCT02194699|50237793|FG000|Randomised|Did not receive treatment|1|||
25125003|NCT02194699|50237794|FG001|Randomised|Did not receive treatment|5|||
25177855|NCT01552915|50322015|FG002|Overall Study|Protocol Violation|4|||
25177856|NCT01552915|50322013|FG000|Overall Study|Lack of Efficacy|8|||
25177857|NCT01552915|50322014|FG001|Overall Study|Lack of Efficacy|1|||
25177858|NCT01552915|50322015|FG002|Overall Study|Lack of Efficacy|4|||
25177859|NCT01552915|50322013|FG000|Overall Study|Other|2|||
25177860|NCT01552915|50322014|FG001|Overall Study|Other|0|||
25177861|NCT01552915|50322015|FG002|Overall Study|Other|6|||
25177862|NCT01552681|50322044|FG000|Overall Study|Withdrawal by Subject|4|||
25125004|NCT02194699|50237793|FG000|Randomised|Without potential for 52 weeks of IP|5|||
25125005|NCT02194699|50237794|FG001|Randomised|Without potential for 52 weeks of IP|5|||
25177863|NCT01552681|50322045|FG001|Overall Study|Withdrawal by Subject|0|||
25177864|NCT01552681|50322044|FG000|Overall Study|Physician Decision|1|||
25125006|NCT02194699|50237793|FG000|Randomised|Duplicate patient|2|||
25177865|NCT01552681|50322045|FG001|Overall Study|Physician Decision|0|||
25125007|NCT02194699|50237794|FG001|Randomised|Duplicate patient|1|||
25125008|NCT02194699|50237793|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
25125009|NCT02194699|50237794|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
25177866|NCT01552681|50322044|FG000|Overall Study|Subject moved away|0|||
25177867|NCT01552681|50322045|FG001|Overall Study|Subject moved away|1|||
25177868|NCT01570387|50322077|FG000|Overall Study|Adverse Event|1|||
25177869|NCT01570387|50322078|FG001|Overall Study|Adverse Event|0|||
25177870|NCT01570387|50322079|FG002|Overall Study|Adverse Event|0|||
25177871|NCT01570387|50322080|FG003|Overall Study|Adverse Event|0|||
25177872|NCT01570387|50322077|FG000|Overall Study|Death|0|||
25177873|NCT01570387|50322078|FG001|Overall Study|Death|0|||
25177874|NCT01570387|50322079|FG002|Overall Study|Death|0|||
25177875|NCT01570387|50322080|FG003|Overall Study|Death|1|||
25177876|NCT01570387|50322077|FG000|Overall Study|Withdrawal by Subject|0|||
25177877|NCT01570387|50322078|FG001|Overall Study|Withdrawal by Subject|0|||
25177878|NCT01570387|50322079|FG002|Overall Study|Withdrawal by Subject|0|||
25177879|NCT01570387|50322080|FG003|Overall Study|Withdrawal by Subject|1|||
25177880|NCT01570309|50322089|FG000|Overall Study|Withdrawal by Subject|3|||
25125010|NCT02194699|50237793|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
25177881|NCT01570309|50322090|FG001|Overall Study|Withdrawal by Subject|3|||
25177882|NCT01519921|50322102|FG000|Overall Study|Adverse Event|10|||
25177883|NCT01519921|50322103|FG001|Overall Study|Adverse Event|9|||
25177884|NCT01519921|50322102|FG000|Overall Study|Lack of Efficacy|4|||
25177885|NCT01519921|50322103|FG001|Overall Study|Lack of Efficacy|3|||
25177886|NCT01519921|50322102|FG000|Overall Study|Withdrawal by Subject|3|||
25177887|NCT01519921|50322103|FG001|Overall Study|Withdrawal by Subject|0|||
25177888|NCT01519921|50322102|FG000|Overall Study|Lost to Follow-up|2|||
25177889|NCT01519921|50322103|FG001|Overall Study|Lost to Follow-up|1|||
25177890|NCT01519921|50322102|FG000|Overall Study|Treatment refusal|2|||
25177891|NCT01519921|50322103|FG001|Overall Study|Treatment refusal|1|||
25177892|NCT01519921|50322102|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
25177893|NCT01519921|50322103|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
25177894|NCT01519765|50322111|FG000|Overall Study|Adverse Event|0|||
25177895|NCT01519765|50322112|FG001|Overall Study|Adverse Event|1|||
25177896|NCT01519765|50322111|FG000|Overall Study|Lack of Efficacy|2|||
25177897|NCT01519765|50322112|FG001|Overall Study|Lack of Efficacy|0|||
25177898|NCT01519765|50322111|FG000|Overall Study|Protocol Violation|1|||
25177899|NCT01519765|50322112|FG001|Overall Study|Protocol Violation|0|||
25177900|NCT01519765|50322111|FG000|Overall Study|Withdrawal by Subject|0|||
25177901|NCT01519765|50322112|FG001|Overall Study|Withdrawal by Subject|1|||
25125011|NCT02194699|50237794|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
25125012|NCT02194699|50237793|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
25125013|NCT02194699|50237794|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
25125014|NCT02194699|50237793|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
25125015|NCT02194699|50237794|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
25125016|NCT02194699|50237793|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
25125017|NCT02194699|50237794|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
25125018|NCT02194699|50237793|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
25125019|NCT02194699|50237794|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
25125020|NCT02293538|50237810|FG000|Overall Study|Adverse Event|0|||
25125021|NCT02293538|50237811|FG001|Overall Study|Adverse Event|1|||
25125022|NCT02293538|50237810|FG000|Overall Study|Lost to Follow-up|1|||
25125023|NCT02293538|50237811|FG001|Overall Study|Lost to Follow-up|0|||
25125024|NCT02293538|50237810|FG000|Overall Study|Withdrawal by Subject|0|||
25125025|NCT02293538|50237811|FG001|Overall Study|Withdrawal by Subject|1|||
25125026|NCT02194621|50237821|FG000|Overall Study|6 withdrew prior to randomization|2|||
25125027|NCT02194621|50237822|FG001|Overall Study|6 withdrew prior to randomization|2|||
25177902|NCT01552603|50322119|FG000|Overall Study|Physician Decision|1|||
25177903|NCT01552369|50322125|FG000|Overall Study|Did not consent to extended follow up|8|||
25125028|NCT02194621|50237823|FG002|Overall Study|6 withdrew prior to randomization|2|||
25125029|NCT02194621|50237821|FG000|Overall Study|Withdrawal by Subject|4|||
25177904|NCT01552369|50322126|FG001|Overall Study|Did not consent to extended follow up|9|||
25177905|NCT01552057|50322136|FG000|Overall Study|Adverse Event|14|||
25177906|NCT01552057|50322137|FG001|Overall Study|Adverse Event|15|||
25177907|NCT01552057|50322136|FG000|Overall Study|Lack of Efficacy|8|||
25125030|NCT02194621|50237822|FG001|Overall Study|Withdrawal by Subject|4|||
25177908|NCT01552057|50322137|FG001|Overall Study|Lack of Efficacy|23|||
25177909|NCT01552057|50322136|FG000|Overall Study|Withdrawal by Subject|5|||
25177910|NCT01552057|50322137|FG001|Overall Study|Withdrawal by Subject|8|||
25177911|NCT01552057|50322136|FG000|Overall Study|Entry Criteria Not Met|2|||
25177912|NCT01552057|50322137|FG001|Overall Study|Entry Criteria Not Met|2|||
25177913|NCT01552057|50322136|FG000|Overall Study|Physician Decision|1|||
25177914|NCT01552057|50322137|FG001|Overall Study|Physician Decision|0|||
25177915|NCT01551745|50322143|FG000|Overall Study|Withdrawal by Subject|1|||
25177916|NCT01551745|50322143|FG000|Overall Study|Disease Progression|2|||
25177917|NCT01551355|50322153|FG000|Overall Study|Lost to Follow-up|51|||
25177918|NCT01551355|50322154|FG001|Overall Study|Lost to Follow-up|49|||
25177919|NCT01551355|50322155|FG002|Overall Study|Lost to Follow-up|34|||
25177920|NCT01551355|50322156|FG003|Overall Study|Lost to Follow-up|24|||
25177921|NCT01551355|50322157|FG004|Overall Study|Lost to Follow-up|9|||
25177922|NCT01551355|50322158|FG005|Overall Study|Lost to Follow-up|6|||
25177923|NCT01569841|50322166|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
25177924|NCT01569841|50322167|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
25177925|NCT01569763|50322177|FG000|Overall Study|Lack of Efficacy|2|||
25177926|NCT01569763|50322178|FG001|Overall Study|Lack of Efficacy|7|||
25177927|NCT01569763|50322177|FG000|Overall Study|Adverse Event|1|||
25177928|NCT01569763|50322178|FG001|Overall Study|Adverse Event|0|||
25177929|NCT01550965|50322184|FG000|Overall Study|Adverse Event|26|||
25125031|NCT02194621|50237823|FG002|Overall Study|Withdrawal by Subject|7|||
25125032|NCT02220205|50237833|FG000|Overall Study|Withdrawal by Subject|1|||
25125033|NCT02220205|50237834|FG001|Overall Study|Withdrawal by Subject|0|||
25125034|NCT02266706|50237849|FG000|Overall Study|Withdrawal by Subject|0|||
25125035|NCT02266706|50237850|FG001|Overall Study|Withdrawal by Subject|1|||
25125036|NCT02266706|50237851|FG002|Overall Study|Withdrawal by Subject|1|||
25177930|NCT01550965|50322184|FG000|Overall Study|Withdrawal by Subject|10|||
25177931|NCT01550965|50322184|FG000|Overall Study|Lost to Follow-up|2|||
25177932|NCT01550965|50322184|FG000|Overall Study|Lack of Efficacy|59|||
25177933|NCT01550965|50322184|FG000|Overall Study|Other|13|||
25177934|NCT01569295|50322305|FG000|Overall Study|Progressive Disease|75|||
25177935|NCT01569295|50322306|FG001|Overall Study|Progressive Disease|139|||
25177936|NCT01569295|50322305|FG000|Overall Study|Adverse Event|39|||
25177937|NCT01569295|50322306|FG001|Overall Study|Adverse Event|14|||
25177938|NCT01569295|50322305|FG000|Overall Study|Withdrawal by Subject|25|||
25177939|NCT01569295|50322306|FG001|Overall Study|Withdrawal by Subject|12|||
25177940|NCT01569295|50322305|FG000|Overall Study|Death|19|||
25177941|NCT01569295|50322306|FG001|Overall Study|Death|15|||
25177942|NCT01569295|50322305|FG000|Overall Study|Physician Decision|13|||
25177943|NCT01569295|50322306|FG001|Overall Study|Physician Decision|18|||
25177944|NCT01569295|50322305|FG000|Overall Study|Study Terminated by Sponsor|24|||
25177945|NCT01569295|50322306|FG001|Overall Study|Study Terminated by Sponsor|2|||
25177946|NCT01569295|50322305|FG000|Overall Study|Other Reason not Specified|3|||
25177947|NCT01569295|50322306|FG001|Overall Study|Other Reason not Specified|5|||
25177948|NCT01569295|50322305|FG000|Overall Study|Non-Compliance with Study Drug|6|||
25177949|NCT01569295|50322306|FG001|Overall Study|Non-Compliance with Study Drug|1|||
25177950|NCT01569295|50322305|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
25177951|NCT01569295|50322306|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
25125037|NCT02266706|50237852|FG003|Overall Study|Withdrawal by Subject|0|||
25125038|NCT02266706|50237853|FG004|Overall Study|Withdrawal by Subject|0|||
25125039|NCT02266706|50237854|FG005|Overall Study|Withdrawal by Subject|1|||
25125040|NCT02266706|50237855|FG006|Overall Study|Withdrawal by Subject|0|||
25125041|NCT02266706|50237856|FG007|Overall Study|Withdrawal by Subject|0|||
25125042|NCT02266706|50237857|FG008|Overall Study|Withdrawal by Subject|0|||
25125043|NCT02266706|50237849|FG000|Overall Study|Screen failure|0|||
25125044|NCT02266706|50237850|FG001|Overall Study|Screen failure|0|||
25125045|NCT02266706|50237851|FG002|Overall Study|Screen failure|0|||
25125046|NCT02266706|50237852|FG003|Overall Study|Screen failure|0|||
25125047|NCT02266706|50237853|FG004|Overall Study|Screen failure|0|||
25125048|NCT02266706|50237854|FG005|Overall Study|Screen failure|1|||
25125049|NCT02266706|50237855|FG006|Overall Study|Screen failure|1|||
25125050|NCT02266706|50237856|FG007|Overall Study|Screen failure|0|||
25125051|NCT02266706|50237857|FG008|Overall Study|Screen failure|0|||
25125052|NCT02266706|50237849|FG000|Overall Study|Enrollment in another study|0|||
25125053|NCT02266706|50237850|FG001|Overall Study|Enrollment in another study|0|||
25125054|NCT02266706|50237851|FG002|Overall Study|Enrollment in another study|0|||
25125055|NCT02266706|50237852|FG003|Overall Study|Enrollment in another study|1|||
25125056|NCT02266706|50237853|FG004|Overall Study|Enrollment in another study|0|||
25125057|NCT02266706|50237854|FG005|Overall Study|Enrollment in another study|0|||
25125058|NCT02266706|50237855|FG006|Overall Study|Enrollment in another study|0|||
25177952|NCT01569295|50322305|FG000|Overall Study|Lost to Follow-up|1|||
25177953|NCT01569295|50322306|FG001|Overall Study|Lost to Follow-up|1|||
25177954|NCT01549951|50322363|FG000|Overall Study|Adverse Event|15|||
25177955|NCT01549951|50322363|FG000|Overall Study|Withdrawal by Subject|2|||
25177956|NCT01549951|50322363|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
25177957|NCT01549951|50322363|FG000|Overall Study|Progressive disease|29|||
25177958|NCT01549951|50322363|FG000|Overall Study|Symptomatic deterioration|1|||
25177959|NCT01549951|50322363|FG000|Overall Study|Other|2|||
25177960|NCT01517893|50322369|FG000|Overall Study|Withdrawal by Subject|3|||
25125059|NCT02266706|50237856|FG007|Overall Study|Enrollment in another study|0|||
25125060|NCT02266706|50237857|FG008|Overall Study|Enrollment in another study|0|||
25125061|NCT02293460|50237877|FG000|Overall Study|Protocol Violation|1|||
25125062|NCT02293460|50237877|FG000|Overall Study|Lack of Efficacy|2|||
25125063|NCT02293460|50237877|FG000|Overall Study|Adverse Event|2|||
25125064|NCT02293460|50237877|FG000|Overall Study|Withdrawal by Subject|1|||
25168610|NCT00633477|50298171|FG000|Overall Study|Randomized but not treated|1|||
25177961|NCT01517893|50322370|FG001|Overall Study|Withdrawal by Subject|0|||
25177962|NCT01489891|50322378|FG000|Overall Study|Endoscopy failure|1|||
25266204|NCT01211769|50580407|FG002|Overall Study|Physician Decision|2|||
25266205|NCT01211769|50580408|FG003|Overall Study|Physician Decision|1|||
25266206|NCT01211769|50580405|FG000|Overall Study|Adverse Event|0|||
25266207|NCT01211769|50580406|FG001|Overall Study|Adverse Event|1|||
25266208|NCT01211769|50580407|FG002|Overall Study|Adverse Event|1|||
25266209|NCT01211769|50580408|FG003|Overall Study|Adverse Event|1|||
25266210|NCT01211613|50580421|FG000|Overall Study|Lost to Follow-up|2|||
25266211|NCT01211613|50580422|FG001|Overall Study|Lost to Follow-up|2|||
25266212|NCT01211613|50580423|FG002|Overall Study|Lost to Follow-up|2|||
25266213|NCT01211613|50580421|FG000|Overall Study|Withdrawal by Subject|1|||
25266214|NCT01211613|50580422|FG001|Overall Study|Withdrawal by Subject|0|||
25266215|NCT01211613|50580423|FG002|Overall Study|Withdrawal by Subject|0|||
25266216|NCT01211535|50580433|FG000|Overall Study|Adverse Event|0|||
25266217|NCT01211535|50580434|FG001|Overall Study|Adverse Event|1|||
25266218|NCT01011556|50580444|FG000|Overall Study|Adverse Event|1|||
25266219|NCT01011556|50580445|FG001|Overall Study|Adverse Event|3|||
25266220|NCT01011556|50580446|FG002|Overall Study|Adverse Event|2|||
25266221|NCT01011556|50580447|FG003|Overall Study|Adverse Event|1|||
25266222|NCT01011556|50580444|FG000|Overall Study|Lost to Follow-up|1|||
25266223|NCT01011556|50580445|FG001|Overall Study|Lost to Follow-up|0|||
25266224|NCT01011556|50580446|FG002|Overall Study|Lost to Follow-up|0|||
25266225|NCT01011556|50580447|FG003|Overall Study|Lost to Follow-up|0|||
25266226|NCT01011556|50580444|FG000|Overall Study|Physician Decision|1|||
25266227|NCT01011556|50580445|FG001|Overall Study|Physician Decision|0|||
25266228|NCT01011556|50580446|FG002|Overall Study|Physician Decision|0|||
25266229|NCT01011556|50580447|FG003|Overall Study|Physician Decision|1|||
25266230|NCT01011556|50580444|FG000|Overall Study|Protocol Violation|0|||
25266231|NCT01011556|50580445|FG001|Overall Study|Protocol Violation|1|||
25266232|NCT01011556|50580446|FG002|Overall Study|Protocol Violation|0|||
25266233|NCT01011556|50580447|FG003|Overall Study|Protocol Violation|0|||
25266234|NCT01011556|50580444|FG000|Overall Study|Withdrawal by Subject|1|||
25266235|NCT01011556|50580445|FG001|Overall Study|Withdrawal by Subject|2|||
25266236|NCT01011556|50580446|FG002|Overall Study|Withdrawal by Subject|4|||
25266237|NCT01011556|50580447|FG003|Overall Study|Withdrawal by Subject|4|||
25266238|NCT01011556|50580444|FG000|Overall Study|Sponsor decision|0|||
25266239|NCT01011556|50580445|FG001|Overall Study|Sponsor decision|1|||
25266240|NCT01011556|50580446|FG002|Overall Study|Sponsor decision|1|||
25266241|NCT01011556|50580447|FG003|Overall Study|Sponsor decision|2|||
25266242|NCT01011556|50580444|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
25266243|NCT01011556|50580445|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
25266244|NCT01011556|50580446|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
25266245|NCT01011556|50580447|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
25266246|NCT01211145|50580464|FG000|Overall Study|Reason not specified|3|||
25266247|NCT01211145|50580465|FG001|Overall Study|Reason not specified|2|||
25168611|NCT00633477|50298172|FG001|Overall Study|Randomized but not treated|0|||
25168612|NCT00331773|50298197|FG000|Overall Study|Withdrawal by Subject|6|||
25168613|NCT00331773|50298198|FG001|Overall Study|Withdrawal by Subject|4|||
25168614|NCT00331773|50298197|FG000|Overall Study|Protocol Violation|10|||
25168615|NCT00331773|50298198|FG001|Overall Study|Protocol Violation|3|||
25177963|NCT01489891|50322379|FG001|Overall Study|Endoscopy failure|0|||
25177964|NCT04062240|50322461|FG000|Overall Study|equipment malfunction|1|||
25177965|NCT02790138|50322467|FG000|Overall Study|Adverse Event|5|||
25177966|NCT02790138|50322468|FG001|Overall Study|Adverse Event|2|||
25177967|NCT02790138|50322467|FG000|Overall Study|Significant Protocol Deviation|0|||
25177968|NCT02790138|50322468|FG001|Overall Study|Significant Protocol Deviation|1|||
25266248|NCT01211145|50580466|FG002|Overall Study|Reason not specified|2|||
25266249|NCT01211145|50580467|FG003|Overall Study|Reason not specified|1|||
25168616|NCT00633243|50298231|FG000|Overall Study|Withdrawal by Subject|0|||
25168617|NCT00633243|50298232|FG001|Overall Study|Withdrawal by Subject|1|||
25168618|NCT00633243|50298231|FG000|Overall Study|incarceration|0|||
25168619|NCT00633243|50298232|FG001|Overall Study|incarceration|2|||
25266250|NCT01211145|50580464|FG000|Overall Study|Lost to Follow-up|3|||
25168620|NCT00633243|50298231|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
25168621|NCT00633243|50298232|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
25168622|NCT00633243|50298231|FG000|Overall Study|Not comfortable with self-injecting|0|||
25177969|NCT02790138|50322467|FG000|Overall Study|Lost to Follow-up|1|||
25177970|NCT02790138|50322468|FG001|Overall Study|Lost to Follow-up|0|||
25266251|NCT01211145|50580465|FG001|Overall Study|Lost to Follow-up|2|||
25266252|NCT01211145|50580466|FG002|Overall Study|Lost to Follow-up|1|||
25266253|NCT01211145|50580467|FG003|Overall Study|Lost to Follow-up|2|||
25266254|NCT01211145|50580464|FG000|Overall Study|Study-specific withdrawal criteria|1|||
25177971|NCT02790138|50322467|FG000|Overall Study|Voluntary Withdrawal|8|||
25266255|NCT01211145|50580465|FG001|Overall Study|Study-specific withdrawal criteria|0|||
25266256|NCT01211145|50580466|FG002|Overall Study|Study-specific withdrawal criteria|0|||
25266257|NCT01211145|50580467|FG003|Overall Study|Study-specific withdrawal criteria|0|||
25266258|NCT01211145|50580464|FG000|Overall Study|Severe noncompliance to protocol|1|||
25266259|NCT01211145|50580465|FG001|Overall Study|Severe noncompliance to protocol|0|||
25266260|NCT01211145|50580466|FG002|Overall Study|Severe noncompliance to protocol|0|||
25266261|NCT01211145|50580467|FG003|Overall Study|Severe noncompliance to protocol|0|||
25266262|NCT01211145|50580464|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
25266263|NCT01211145|50580465|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
25266264|NCT01211145|50580466|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
25266265|NCT01211145|50580467|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
25266266|NCT01211145|50580464|FG000|Overall Study|Patient decision|2|||
25266267|NCT01211145|50580465|FG001|Overall Study|Patient decision|1|||
25266268|NCT01211145|50580466|FG002|Overall Study|Patient decision|0|||
25266269|NCT01211145|50580467|FG003|Overall Study|Patient decision|2|||
25266270|NCT00977665|50580479|FG000|Overall Study|Withdrawal by Subject|1|||
25266271|NCT00977665|50580480|FG001|Overall Study|Withdrawal by Subject|3|||
25266272|NCT00977665|50580479|FG000|Overall Study|Physician Decision|2|||
25266273|NCT00977665|50580480|FG001|Overall Study|Physician Decision|1|||
25266274|NCT00977665|50580479|FG000|Overall Study|Sponsor requested withdrawal|0|||
25177972|NCT02790138|50322468|FG001|Overall Study|Voluntary Withdrawal|9|||
25177973|NCT02790138|50322467|FG000|Overall Study|Lack of Efficacy|6|||
25177974|NCT02790138|50322468|FG001|Overall Study|Lack of Efficacy|7|||
25177975|NCT02790138|50322467|FG000|Overall Study|Reason not Specified|1|||
25177976|NCT02790138|50322468|FG001|Overall Study|Reason not Specified|0|||
25177977|NCT01489189|50322623|FG000|Overall Study|Withdrawal by Subject|20|||
25177978|NCT01489189|50322624|FG001|Overall Study|Withdrawal by Subject|23|||
25177979|NCT01489189|50322623|FG000|Overall Study|Death|10|||
25177980|NCT01489189|50322624|FG001|Overall Study|Death|8|||
25177981|NCT01489189|50322623|FG000|Overall Study|Missed Visit|1|||
25177982|NCT01489189|50322624|FG001|Overall Study|Missed Visit|4|||
25177983|NCT01549873|50322633|FG000|Overall Study|Physician Decision|0|||
25177984|NCT01549873|50322634|FG001|Overall Study|Physician Decision|1|||
25177985|NCT01489111|50322640|FG000|Overall Study|Withdrawal criterion|1|||
25177986|NCT01488487|50322644|FG000|Overall Study|Adverse Event|6|||
25177987|NCT01488487|50322644|FG000|Overall Study|Death|1|||
25177988|NCT01488487|50322644|FG000|Overall Study|Withdrawal by Subject|2|||
25177989|NCT01488097|50322648|FG000|Overall Study|Lost to Follow-up|1|||
25177990|NCT01516879|50322654|FG000|Overall Study|Withdrawal by Subject|9|||
25177991|NCT01516879|50322655|FG001|Overall Study|Withdrawal by Subject|11|||
25177992|NCT01516879|50322654|FG000|Overall Study|Death|0|||
25177993|NCT01516879|50322655|FG001|Overall Study|Death|2|||
25177994|NCT01516879|50322654|FG000|Overall Study|Lost to Follow-up|2|||
25177995|NCT01516879|50322655|FG001|Overall Study|Lost to Follow-up|11|||
25177996|NCT01516879|50322654|FG000|Overall Study|Other|5|||
25177997|NCT01516879|50322655|FG001|Overall Study|Other|10|||
25177998|NCT01515865|50322661|FG000|Part A (Open-label)|Other|3|||
25177999|NCT01515865|50322662|FG001|Part A (Open-label)|Other|0|||
25178000|NCT01515865|50322663|FG002|Part A (Open-label)|Other|0|||
25178001|NCT01515865|50322661|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
25178002|NCT01515865|50322662|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
25178003|NCT01515865|50322663|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
25178004|NCT01515865|50322661|FG000|Part B (Open-label)|Other|1|||
25178005|NCT01515865|50322662|FG001|Part B (Open-label)|Other|0|||
25178006|NCT01515865|50322663|FG002|Part B (Open-label)|Other|0|||
25178007|NCT01547299|50322673|FG000|Overall Study|Withdrawal by Subject|2|||
25178008|NCT01547299|50322674|FG001|Overall Study|Withdrawal by Subject|2|||
25266275|NCT00977665|50580480|FG001|Overall Study|Sponsor requested withdrawal|1|||
25266276|NCT00977665|50580479|FG000|Overall Study|Lost to Follow-up|1|||
25266277|NCT00977665|50580480|FG001|Overall Study|Lost to Follow-up|0|||
25266278|NCT00977665|50580479|FG000|Overall Study|Death|3|||
25266279|NCT00977665|50580480|FG001|Overall Study|Death|2|||
25266280|NCT00977665|50580479|FG000|Overall Study|Adverse Event|14|||
25266281|NCT00977665|50580480|FG001|Overall Study|Adverse Event|7|||
25266282|NCT00977665|50580479|FG000|Overall Study|Treatment failure|0|||
25178009|NCT01515475|50322684|FG000|Overall Study|Lost to Follow-up|20|||
25266283|NCT00977665|50580480|FG001|Overall Study|Treatment failure|1|||
25266284|NCT01210443|50580486|FG000|Overall Study|Study terminated by sponsor|2|||
25266285|NCT01007812|50580490|FG000|Period 1, One Week|Lost to Follow-up|0|||
25178010|NCT01515475|50322685|FG001|Overall Study|Lost to Follow-up|15|||
25178011|NCT01515475|50322686|FG002|Overall Study|Lost to Follow-up|12|||
25178012|NCT01515475|50322687|FG003|Overall Study|Lost to Follow-up|12|||
25178013|NCT01515319|50322773|FG000|Overall Study|Withdrawal by Subject|0|||
25178014|NCT01515319|50322774|FG001|Overall Study|Withdrawal by Subject|0|||
25178015|NCT01515319|50322775|FG002|Overall Study|Withdrawal by Subject|0|||
25178016|NCT01515319|50322776|FG003|Overall Study|Withdrawal by Subject|0|||
25178017|NCT01515319|50322777|FG004|Overall Study|Withdrawal by Subject|0|||
25266286|NCT01007812|50580491|FG001|Period 1, One Week|Lost to Follow-up|1|||
25266287|NCT01007812|50580490|FG000|Period 1, One Week|Discomfort|1|||
25266288|NCT01007812|50580491|FG001|Period 1, One Week|Discomfort|0|||
25266289|NCT01208961|50580497|FG000|High-Fat Period III|Protocol Violation|1|||
25266290|NCT01208961|50580498|FG001|High-Fat Period III|Protocol Violation|0|||
25266291|NCT01001572|50580505|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
25266292|NCT01001572|50580506|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
25266293|NCT01001572|50580507|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
25266294|NCT01001572|50580505|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
25266295|NCT01001572|50580506|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
25266296|NCT01001572|50580507|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
25266297|NCT01001572|50580505|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
25266298|NCT01001572|50580506|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
25266299|NCT01001572|50580507|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
25266300|NCT01001572|50580505|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
25266301|NCT01001572|50580506|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
25266302|NCT01001572|50580507|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
25266303|NCT01001572|50580505|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
25266304|NCT01001572|50580506|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
25266305|NCT01001572|50580507|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
25266306|NCT01001572|50580505|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
25266307|NCT01001572|50580506|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
25266308|NCT01001572|50580507|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
25266309|NCT01001572|50580505|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
25266310|NCT01001572|50580506|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
25266311|NCT01001572|50580507|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
25266312|NCT01001572|50580505|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
25266313|NCT01001572|50580506|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
25266314|NCT01001572|50580507|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
25266315|NCT01001572|50580505|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
25266316|NCT01001572|50580506|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
25266317|NCT01001572|50580507|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
25266318|NCT01001572|50580505|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
25266319|NCT01001572|50580506|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
25266320|NCT01001572|50580507|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
25266321|NCT01001572|50580505|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
25266322|NCT01001572|50580506|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
25266323|NCT01001572|50580507|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
25266324|NCT01001572|50580505|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
25266325|NCT01001572|50580506|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
25266326|NCT01001572|50580507|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
25266327|NCT01001572|50580505|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
25266328|NCT01001572|50580506|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
25266329|NCT01001572|50580507|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
25266330|NCT01001572|50580505|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
25266331|NCT01001572|50580506|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
25266332|NCT01001572|50580507|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
25266333|NCT01208415|50580513|FG000|Overall Study|Death|1|||
25125065|NCT02266004|50237881|FG000|Overall Study|unrelated adverse event|1|||
25125066|NCT02266004|50237881|FG000|Overall Study|Physician Decision|1|||
25125067|NCT02292719|50237891|FG000|Overall Study|Withdrawal by Subject|0|||
25178018|NCT01515319|50322778|FG005|Overall Study|Withdrawal by Subject|0|||
25178019|NCT01515319|50322779|FG006|Overall Study|Withdrawal by Subject|1|||
25178020|NCT01515319|50322780|FG007|Overall Study|Withdrawal by Subject|0|||
25178021|NCT01515319|50322781|FG008|Overall Study|Withdrawal by Subject|0|||
25178022|NCT01515319|50322782|FG009|Overall Study|Withdrawal by Subject|0|||
25178023|NCT01515319|50322773|FG000|Overall Study|Adverse Event|0|||
25178024|NCT01515319|50322774|FG001|Overall Study|Adverse Event|0|||
25178025|NCT01515319|50322775|FG002|Overall Study|Adverse Event|0|||
25178026|NCT01515319|50322776|FG003|Overall Study|Adverse Event|0|||
25125068|NCT02292719|50237892|FG001|Overall Study|Withdrawal by Subject|0|||
25125069|NCT02292719|50237893|FG002|Overall Study|Withdrawal by Subject|0|||
25125070|NCT02292719|50237894|FG003|Overall Study|Withdrawal by Subject|1|||
25125071|NCT02292719|50237895|FG004|Overall Study|Withdrawal by Subject|1|||
25125072|NCT02292719|50237896|FG005|Overall Study|Withdrawal by Subject|0|||
25125073|NCT02292719|50237891|FG000|Overall Study|Subject enrolled in new study.|0|||
25178027|NCT01515319|50322777|FG004|Overall Study|Adverse Event|0|||
25125074|NCT02292719|50237892|FG001|Overall Study|Subject enrolled in new study.|0|||
25178028|NCT01515319|50322778|FG005|Overall Study|Adverse Event|0|||
25266334|NCT01208415|50580513|FG000|Overall Study|Lost to Follow-up|2|||
25266335|NCT01208415|50580513|FG000|Overall Study|Withdrawal by Subject|3|||
25266336|NCT01208415|50580513|FG000|Overall Study|Device not placed|1|||
25266337|NCT01208415|50580513|FG000|Overall Study|Still be eligible for follow-up|33|||
25266338|NCT01208337|50580517|FG000|Overall Study|Death|3|||
25266339|NCT01208181|50580533|FG000|Part 1|Withdrawal by Subject|11|||
25266340|NCT01208181|50580534|FG001|Part 1|Withdrawal by Subject|10|||
25266341|NCT01208181|50580535|FG002|Part 1|Withdrawal by Subject|0|||
25266342|NCT01208181|50580536|FG003|Part 1|Withdrawal by Subject|0|||
25266343|NCT01208181|50580537|FG004|Part 1|Withdrawal by Subject|0|||
25266344|NCT01208181|50580533|FG000|Part 1|Technical problem|5|||
25266345|NCT01208181|50580534|FG001|Part 1|Technical problem|0|||
25266346|NCT01208181|50580535|FG002|Part 1|Technical problem|0|||
25266347|NCT01208181|50580536|FG003|Part 1|Technical problem|0|||
25266348|NCT01208181|50580537|FG004|Part 1|Technical problem|0|||
25266349|NCT01208181|50580533|FG000|Part 1|Protocol Violation|10|||
25266350|NCT01208181|50580534|FG001|Part 1|Protocol Violation|5|||
25266351|NCT01208181|50580535|FG002|Part 1|Protocol Violation|0|||
25266352|NCT01208181|50580536|FG003|Part 1|Protocol Violation|0|||
25266353|NCT01208181|50580537|FG004|Part 1|Protocol Violation|0|||
25266354|NCT01208181|50580533|FG000|Part 1|Physician Decision|4|||
25266355|NCT01208181|50580534|FG001|Part 1|Physician Decision|0|||
25266356|NCT01208181|50580535|FG002|Part 1|Physician Decision|0|||
25266357|NCT01208181|50580536|FG003|Part 1|Physician Decision|0|||
25266358|NCT01208181|50580537|FG004|Part 1|Physician Decision|0|||
25266359|NCT01208181|50580533|FG000|Part 1|Non-compliance with study drug|1|||
25266360|NCT01208181|50580534|FG001|Part 1|Non-compliance with study drug|1|||
25266361|NCT01208181|50580535|FG002|Part 1|Non-compliance with study drug|0|||
25266362|NCT01208181|50580536|FG003|Part 1|Non-compliance with study drug|0|||
25266363|NCT01208181|50580537|FG004|Part 1|Non-compliance with study drug|0|||
25266364|NCT01208181|50580533|FG000|Part 1|Lost to Follow-up|5|||
25266365|NCT01208181|50580534|FG001|Part 1|Lost to Follow-up|3|||
25266366|NCT01208181|50580535|FG002|Part 1|Lost to Follow-up|0|||
25266367|NCT01208181|50580536|FG003|Part 1|Lost to Follow-up|0|||
25266368|NCT01208181|50580537|FG004|Part 1|Lost to Follow-up|1|||
25266369|NCT01208181|50580533|FG000|Part 1|Lack of Efficacy|37|||
25266370|NCT01208181|50580534|FG001|Part 1|Lack of Efficacy|12|||
25266371|NCT01208181|50580535|FG002|Part 1|Lack of Efficacy|0|||
25266372|NCT01208181|50580536|FG003|Part 1|Lack of Efficacy|0|||
25266373|NCT01208181|50580537|FG004|Part 1|Lack of Efficacy|17|||
25266374|NCT01208181|50580533|FG000|Part 1|Adverse Event|26|||
25266375|NCT01208181|50580534|FG001|Part 1|Adverse Event|24|||
25266376|NCT01208181|50580535|FG002|Part 1|Adverse Event|0|||
25266377|NCT01208181|50580536|FG003|Part 1|Adverse Event|0|||
25266378|NCT01208181|50580537|FG004|Part 1|Adverse Event|4|||
25266379|NCT01208181|50580533|FG000|Part 2|Adverse Event|0|||
25266380|NCT01208181|50580534|FG001|Part 2|Adverse Event|0|||
25266381|NCT01208181|50580535|FG002|Part 2|Adverse Event|6|||
25266382|NCT01208181|50580536|FG003|Part 2|Adverse Event|7|||
25266383|NCT01208181|50580537|FG004|Part 2|Adverse Event|0|||
25266384|NCT01208181|50580533|FG000|Part 2|Withdrawal by Subject|0|||
25266385|NCT01208181|50580534|FG001|Part 2|Withdrawal by Subject|0|||
25266386|NCT01208181|50580535|FG002|Part 2|Withdrawal by Subject|1|||
25266387|NCT01208181|50580536|FG003|Part 2|Withdrawal by Subject|1|||
25266388|NCT01208181|50580537|FG004|Part 2|Withdrawal by Subject|0|||
25266389|NCT01208181|50580533|FG000|Part 2|Protocol Violation|0|||
25266390|NCT01208181|50580534|FG001|Part 2|Protocol Violation|0|||
25266391|NCT01208181|50580535|FG002|Part 2|Protocol Violation|1|||
25266392|NCT01208181|50580536|FG003|Part 2|Protocol Violation|0|||
25266393|NCT01208181|50580537|FG004|Part 2|Protocol Violation|0|||
25266394|NCT01208181|50580533|FG000|Part 2|Physician Decision|0|||
25266395|NCT01208181|50580534|FG001|Part 2|Physician Decision|0|||
25266396|NCT01208181|50580535|FG002|Part 2|Physician Decision|1|||
25266397|NCT01208181|50580536|FG003|Part 2|Physician Decision|2|||
25266398|NCT01208181|50580537|FG004|Part 2|Physician Decision|0|||
25266399|NCT01208181|50580533|FG000|Part 2|Non-compliance with study drug|0|||
25266400|NCT01208181|50580534|FG001|Part 2|Non-compliance with study drug|0|||
25266401|NCT01208181|50580535|FG002|Part 2|Non-compliance with study drug|1|||
25266402|NCT01208181|50580536|FG003|Part 2|Non-compliance with study drug|1|||
25266403|NCT01208181|50580537|FG004|Part 2|Non-compliance with study drug|0|||
25266404|NCT01208181|50580533|FG000|Part 2|Lost to Follow-up|0|||
25266405|NCT01208181|50580534|FG001|Part 2|Lost to Follow-up|0|||
25266406|NCT01208181|50580535|FG002|Part 2|Lost to Follow-up|1|||
25266407|NCT01208181|50580536|FG003|Part 2|Lost to Follow-up|2|||
25266408|NCT01208181|50580537|FG004|Part 2|Lost to Follow-up|0|||
25266409|NCT01208181|50580533|FG000|Part 2|Lack of Efficacy|0|||
25266410|NCT01208181|50580534|FG001|Part 2|Lack of Efficacy|0|||
25266411|NCT01208181|50580535|FG002|Part 2|Lack of Efficacy|5|||
25266412|NCT01208181|50580536|FG003|Part 2|Lack of Efficacy|7|||
25266413|NCT01208181|50580537|FG004|Part 2|Lack of Efficacy|0|||
25266414|NCT01208103|50580554|FG000|Overall Study|Adverse Event|1|||
25266415|NCT01208103|50580554|FG000|Overall Study|Withdrawal by Subject|1|||
25266416|NCT01206777|50580559|FG000|Overall Study|Death|1|||
25266417|NCT01206777|50580559|FG000|Overall Study|Adverse Event|1|||
25266418|NCT01001494|50580566|FG000|Overall Study|Adverse Event|8|||
25266419|NCT01001494|50580567|FG001|Overall Study|Adverse Event|4|||
25266420|NCT01001494|50580568|FG002|Overall Study|Adverse Event|6|||
25266421|NCT01001494|50580566|FG000|Overall Study|Protocol Violation|0|||
25266422|NCT01001494|50580567|FG001|Overall Study|Protocol Violation|1|||
25266423|NCT01001494|50580568|FG002|Overall Study|Protocol Violation|1|||
25266424|NCT01001494|50580566|FG000|Overall Study|Lost to Follow-up|2|||
25266425|NCT01001494|50580567|FG001|Overall Study|Lost to Follow-up|0|||
25266426|NCT01001494|50580568|FG002|Overall Study|Lost to Follow-up|1|||
25266427|NCT01001494|50580566|FG000|Overall Study|Withdrawal by Subject|9|||
25266428|NCT01001494|50580567|FG001|Overall Study|Withdrawal by Subject|7|||
25266429|NCT01001494|50580568|FG002|Overall Study|Withdrawal by Subject|17|||
25266430|NCT01001494|50580566|FG000|Overall Study|COPD exacerbation|3|||
25266431|NCT01001494|50580567|FG001|Overall Study|COPD exacerbation|4|||
25266432|NCT01001494|50580568|FG002|Overall Study|COPD exacerbation|5|||
25266433|NCT01001494|50580566|FG000|Overall Study|Lack of Efficacy|2|||
25266434|NCT01001494|50580567|FG001|Overall Study|Lack of Efficacy|0|||
25125075|NCT02292719|50237893|FG002|Overall Study|Subject enrolled in new study.|1|||
25125076|NCT02292719|50237894|FG003|Overall Study|Subject enrolled in new study.|0|||
25125077|NCT02292719|50237895|FG004|Overall Study|Subject enrolled in new study.|0|||
25125078|NCT02292719|50237896|FG005|Overall Study|Subject enrolled in new study.|0|||
25125079|NCT02291861|50237914|FG000|Overall Study|Adverse Event|2|||
25125080|NCT02291861|50237915|FG001|Overall Study|Adverse Event|4|||
25125081|NCT02291861|50237916|FG002|Overall Study|Adverse Event|1|||
25266435|NCT01001494|50580568|FG002|Overall Study|Lack of Efficacy|8|||
25266436|NCT01001494|50580566|FG000|Overall Study|Other|0|||
25266437|NCT01001494|50580567|FG001|Overall Study|Other|1|||
25266438|NCT01001494|50580568|FG002|Overall Study|Other|3|||
25266439|NCT01205685|50580576|FG000|Overall Study|Disease Progression|10|||
25266440|NCT01205685|50580576|FG000|Overall Study|Withdrawal by Subject|1|||
25266441|NCT01205529|50580580|FG000|Overall Study|Procedure Cancelled|4|||
25266442|NCT01205529|50580580|FG000|Overall Study|Withdrawal by Subject|2|||
25266443|NCT01205529|50580580|FG000|Overall Study|Physician Decision|4|||
25125082|NCT02291861|50237917|FG003|Overall Study|Adverse Event|2|||
25125083|NCT02291861|50237914|FG000|Overall Study|Death|0|||
25125084|NCT02291861|50237915|FG001|Overall Study|Death|0|||
25178029|NCT01515319|50322779|FG006|Overall Study|Adverse Event|0|||
25178030|NCT01515319|50322780|FG007|Overall Study|Adverse Event|0|||
25178031|NCT01515319|50322781|FG008|Overall Study|Adverse Event|3|||
25178032|NCT01515319|50322782|FG009|Overall Study|Adverse Event|0|||
25178033|NCT01515319|50322773|FG000|Overall Study|Protocol Violation|0|||
25178034|NCT01515319|50322774|FG001|Overall Study|Protocol Violation|0|||
25178035|NCT01515319|50322775|FG002|Overall Study|Protocol Violation|0|||
25178036|NCT01515319|50322776|FG003|Overall Study|Protocol Violation|0|||
25178037|NCT01515319|50322777|FG004|Overall Study|Protocol Violation|0|||
25178038|NCT01515319|50322778|FG005|Overall Study|Protocol Violation|0|||
25178039|NCT01515319|50322779|FG006|Overall Study|Protocol Violation|0|||
25178040|NCT01515319|50322780|FG007|Overall Study|Protocol Violation|0|||
25178041|NCT01515319|50322781|FG008|Overall Study|Protocol Violation|2|||
25178042|NCT01515319|50322782|FG009|Overall Study|Protocol Violation|0|||
25178043|NCT01492361|50322819|FG000|Overall Study|Withdrawal by Subject|281|||
25178044|NCT01492361|50322820|FG001|Overall Study|Withdrawal by Subject|297|||
25178045|NCT01492361|50322819|FG000|Overall Study|Physician Decision|12|||
25178046|NCT01492361|50322820|FG001|Overall Study|Physician Decision|12|||
25178047|NCT01492361|50322819|FG000|Overall Study|Lost to Follow-up|6|||
25178048|NCT01492361|50322820|FG001|Overall Study|Lost to Follow-up|13|||
25178049|NCT01492361|50322819|FG000|Overall Study|Other than specified above|106|||
25178050|NCT01492361|50322820|FG001|Overall Study|Other than specified above|138|||
25178051|NCT01514461|50322899|FG000|Overall Study|Adverse Event|2|||
25178052|NCT01514461|50322900|FG001|Overall Study|Adverse Event|1|||
25178053|NCT01514461|50322901|FG002|Overall Study|Adverse Event|3|||
25178054|NCT01514461|50322899|FG000|Overall Study|Physician Decision|1|||
25178055|NCT01514461|50322900|FG001|Overall Study|Physician Decision|1|||
25178056|NCT01514461|50322901|FG002|Overall Study|Physician Decision|0|||
25178057|NCT01514461|50322899|FG000|Overall Study|Patient/guardian decision|1|||
25178058|NCT01514461|50322900|FG001|Overall Study|Patient/guardian decision|1|||
25178059|NCT01514461|50322901|FG002|Overall Study|Patient/guardian decision|1|||
25178060|NCT01514461|50322899|FG000|Overall Study|Death|1|||
25178061|NCT01514461|50322900|FG001|Overall Study|Death|0|||
25178062|NCT01514461|50322901|FG002|Overall Study|Death|0|||
25178063|NCT01491737|50322947|FG000|Overall Study|Withdrawal by Subject|20|||
25178064|NCT01491737|50322948|FG001|Overall Study|Withdrawal by Subject|17|||
25178065|NCT01491737|50322947|FG000|Overall Study|Lost to Follow-up|2|||
25178066|NCT01491737|50322948|FG001|Overall Study|Lost to Follow-up|10|||
25178067|NCT01491737|50322947|FG000|Overall Study|Death|63|||
25178068|NCT01491737|50322948|FG001|Overall Study|Death|57|||
25178069|NCT01491737|50322947|FG000|Overall Study|Study Termination by Sponsor|36|||
25178070|NCT01491737|50322948|FG001|Overall Study|Study Termination by Sponsor|36|||
25266444|NCT01205529|50580580|FG000|Overall Study|Unstable post op|15|||
25266445|NCT01205529|50580580|FG000|Overall Study|No longer met criteria|30|||
25178071|NCT01491737|50322947|FG000|Overall Study|Reason Not Specified|8|||
25178072|NCT01491737|50322948|FG001|Overall Study|Reason Not Specified|9|||
25266446|NCT01205451|50580586|FG000|Overall Study|Lost to Follow-up|1|||
25266447|NCT01205451|50580587|FG001|Overall Study|Lost to Follow-up|1|||
25266448|NCT01205451|50580586|FG000|Overall Study|Withdrawal by Subject|5|||
25266449|NCT01205451|50580587|FG001|Overall Study|Withdrawal by Subject|9|||
25266450|NCT01001104|50580597|FG000|Overall Study|Adverse Event|2|||
25266451|NCT01001104|50580598|FG001|Overall Study|Adverse Event|1|||
25266452|NCT01001104|50580599|FG002|Overall Study|Adverse Event|0|||
25266453|NCT01001104|50580600|FG003|Overall Study|Adverse Event|0|||
25266454|NCT01001104|50580597|FG000|Overall Study|Lost to Follow-up|0|||
25266455|NCT01001104|50580598|FG001|Overall Study|Lost to Follow-up|0|||
25125085|NCT02291861|50237916|FG002|Overall Study|Death|1|||
25125086|NCT02291861|50237917|FG003|Overall Study|Death|1|||
25125087|NCT02291861|50237914|FG000|Overall Study|Protocol Violation|1|||
25125088|NCT02291861|50237915|FG001|Overall Study|Protocol Violation|0|||
25125089|NCT02291861|50237916|FG002|Overall Study|Protocol Violation|0|||
25125090|NCT02291861|50237917|FG003|Overall Study|Protocol Violation|1|||
25125091|NCT02291861|50237914|FG000|Overall Study|Withdrawal by Subject|1|||
25125092|NCT02291861|50237915|FG001|Overall Study|Withdrawal by Subject|2|||
25125093|NCT02291861|50237916|FG002|Overall Study|Withdrawal by Subject|1|||
25125094|NCT02291861|50237917|FG003|Overall Study|Withdrawal by Subject|4|||
25125095|NCT02291861|50237914|FG000|Overall Study|Noncompliance|1|||
25125096|NCT02291861|50237915|FG001|Overall Study|Noncompliance|1|||
25125097|NCT02291861|50237916|FG002|Overall Study|Noncompliance|2|||
25125098|NCT02291861|50237917|FG003|Overall Study|Noncompliance|1|||
25125099|NCT02291861|50237914|FG000|Overall Study|Lost to Follow-up|2|||
25125100|NCT02291861|50237915|FG001|Overall Study|Lost to Follow-up|1|||
25125101|NCT02291861|50237916|FG002|Overall Study|Lost to Follow-up|4|||
25125102|NCT02291861|50237917|FG003|Overall Study|Lost to Follow-up|0|||
25125103|NCT02291861|50237914|FG000|Overall Study|Other|0|||
25125104|NCT02291861|50237915|FG001|Overall Study|Other|0|||
25125105|NCT02291861|50237916|FG002|Overall Study|Other|0|||
25125106|NCT02291861|50237917|FG003|Overall Study|Other|1|||
25125107|NCT02291549|50237929|FG000|Overall Study|Lost to Follow-up|1|||
25125108|NCT02291549|50237930|FG001|Overall Study|Lost to Follow-up|0|||
25125109|NCT02291549|50237929|FG000|Overall Study|Withdrawal by Subject|0|||
25125110|NCT02291549|50237930|FG001|Overall Study|Withdrawal by Subject|1|||
25125111|NCT02264990|50237940|FG000|Overall Study|Death|255|||
25125112|NCT02264990|50237941|FG001|Overall Study|Death|250|||
25125113|NCT02264990|50237940|FG000|Overall Study|Withdrawal by Subject|4|||
25125114|NCT02264990|50237941|FG001|Overall Study|Withdrawal by Subject|5|||
25125115|NCT02264990|50237940|FG000|Overall Study|Lost to Follow-up|1|||
25125116|NCT02264990|50237941|FG001|Overall Study|Lost to Follow-up|3|||
25125117|NCT02264990|50237940|FG000|Overall Study|Other|0|||
25125118|NCT02264990|50237941|FG001|Overall Study|Other|1|||
25125119|NCT02291237|50237950|FG000|Overall Study|Study Terminated by Sponsor|72|||
25125120|NCT02291237|50237951|FG001|Overall Study|Study Terminated by Sponsor|67|||
25125121|NCT02291237|50237950|FG000|Overall Study|Adverse Event|1|||
25125122|NCT02291237|50237951|FG001|Overall Study|Adverse Event|3|||
25125123|NCT02291237|50237950|FG000|Overall Study|Investigator's Discretion|0|||
25125124|NCT02291237|50237951|FG001|Overall Study|Investigator's Discretion|3|||
25125125|NCT02291237|50237950|FG000|Overall Study|Withdrew Consent|11|||
25125126|NCT02291237|50237951|FG001|Overall Study|Withdrew Consent|11|||
25125127|NCT02291237|50237950|FG000|Overall Study|Lost to Follow-up|0|||
25125128|NCT02291237|50237951|FG001|Overall Study|Lost to Follow-up|2|||
25125129|NCT02291237|50237950|FG000|Overall Study|Subject Required Prohibited Medication|2|||
25125130|NCT02291237|50237951|FG001|Overall Study|Subject Required Prohibited Medication|0|||
25178073|NCT01487863|50322960|FG000|Overall Study|Death|19|||
25178074|NCT01487863|50322961|FG001|Overall Study|Death|19|||
25178075|NCT01487161|50322980|FG000|Overall Study|Adverse Event|1|||
25178076|NCT01487161|50322981|FG001|Overall Study|Adverse Event|0|||
25178077|NCT01487161|50322982|FG002|Overall Study|Adverse Event|0|||
25125131|NCT02292446|50237957|FG000|Overall Study|Adverse Event|12|||
25125132|NCT02292446|50237957|FG000|Overall Study|Death|1|||
25125133|NCT02292446|50237957|FG000|Overall Study|Disease progression|2|||
25125134|NCT02292446|50237957|FG000|Overall Study|Subject/guardian decision|2|||
25125135|NCT02292446|50237957|FG000|Overall Study|Withdrawal by Subject|3|||
25125136|NCT02290925|50237966|FG000|First Period of Three Months|Lost to Follow-up|2|||
25125137|NCT02290925|50237967|FG001|First Period of Three Months|Lost to Follow-up|1|||
25125138|NCT02290925|50237966|FG000|First Period of Three Months|Death|1|||
25178078|NCT01487161|50322983|FG003|Overall Study|Adverse Event|0|||
25125139|NCT02290925|50237967|FG001|First Period of Three Months|Death|0|||
25178079|NCT01487161|50322980|FG000|Overall Study|Withdrawal by Subject|1|||
25178080|NCT01487161|50322981|FG001|Overall Study|Withdrawal by Subject|1|||
25125140|NCT02290925|50237966|FG000|First Period of Three Months|Insulin Started|1|||
25125141|NCT02290925|50237967|FG001|First Period of Three Months|Insulin Started|1|||
25125142|NCT02290925|50237966|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
25178081|NCT01487161|50322982|FG002|Overall Study|Withdrawal by Subject|1|||
25125143|NCT02290925|50237967|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
25125144|NCT02290925|50237966|FG000|Second Period of 3 Months|insulin started|0|||
25125145|NCT02290925|50237967|FG001|Second Period of 3 Months|insulin started|1|||
25125146|NCT02290691|50237977|FG000|Overall Study|Noncompliance|0|||
25125147|NCT02290691|50237978|FG001|Overall Study|Noncompliance|1|||
25125148|NCT02290691|50237977|FG000|Overall Study|Withdrawal by Subject|1|||
25125149|NCT02290691|50237978|FG001|Overall Study|Withdrawal by Subject|1|||
25125150|NCT02290691|50237977|FG000|Overall Study|Lost to Follow-up|7|||
25125151|NCT02290691|50237978|FG001|Overall Study|Lost to Follow-up|7|||
25125152|NCT02292212|50237984|FG000|ViE Phase|Withdrawal by Subject|1|||
25125153|NCT02292212|50237984|FG000|ViE Phase|Protocol Violation|2|||
25125154|NCT02291510|50237999|FG000|Overall Study|Adverse Event|0|||
25125155|NCT02291510|50238000|FG001|Overall Study|Adverse Event|0|||
25125156|NCT02291510|50238001|FG002|Overall Study|Adverse Event|0|||
25125157|NCT02291510|50238002|FG003|Overall Study|Adverse Event|1|||
25125158|NCT02290223|50238014|FG000|6 Months|Lost to Follow-up|9|||
25125159|NCT02290223|50238015|FG001|6 Months|Lost to Follow-up|6|||
25125160|NCT02290223|50238014|FG000|6 Months|Withdrawal by Subject|5|||
25125161|NCT02290223|50238015|FG001|6 Months|Withdrawal by Subject|0|||
25125162|NCT02290223|50238014|FG000|6 Months|deceased (not related to study)|2|||
25125163|NCT02290223|50238015|FG001|6 Months|deceased (not related to study)|0|||
25125164|NCT02290223|50238014|FG000|12 Months|Lost to Follow-up|16|||
25125165|NCT02290223|50238015|FG001|12 Months|Lost to Follow-up|10|||
25125166|NCT02290223|50238014|FG000|12 Months|Refusal|0|||
25125167|NCT02290223|50238015|FG001|12 Months|Refusal|1|||
25125168|NCT02289833|50238023|FG000|Overall Study|Study discontinuation|0|||
25125169|NCT02289833|50238024|FG001|Overall Study|Study discontinuation|1|||
25125170|NCT02289833|50238023|FG000|Overall Study|Lost to Follow-up|4|||
25125171|NCT02289833|50238024|FG001|Overall Study|Lost to Follow-up|0|||
25125172|NCT02289833|50238023|FG000|Overall Study|Death|23|||
25125173|NCT02289833|50238024|FG001|Overall Study|Death|16|||
25125174|NCT01702558|50238037|FG000|Overall Study|Withdrawal by Subject|0|||
25125175|NCT01702558|50238038|FG001|Overall Study|Withdrawal by Subject|0|||
25125176|NCT01702558|50238039|FG002|Overall Study|Withdrawal by Subject|0|||
25125177|NCT01702558|50238040|FG003|Overall Study|Withdrawal by Subject|12|||
25125178|NCT01702558|50238041|FG004|Overall Study|Withdrawal by Subject|4|||
25125179|NCT01702558|50238037|FG000|Overall Study|Lost to Follow-up|0|||
25125180|NCT01702558|50238038|FG001|Overall Study|Lost to Follow-up|0|||
25125181|NCT01702558|50238039|FG002|Overall Study|Lost to Follow-up|0|||
25125182|NCT01702558|50238040|FG003|Overall Study|Lost to Follow-up|3|||
25125183|NCT01702558|50238041|FG004|Overall Study|Lost to Follow-up|0|||
25125184|NCT01702558|50238037|FG000|Overall Study|Death|4|||
25125185|NCT01702558|50238038|FG001|Overall Study|Death|3|||
25125186|NCT01702558|50238039|FG002|Overall Study|Death|3|||
25125187|NCT01702558|50238040|FG003|Overall Study|Death|16|||
25125188|NCT01702558|50238041|FG004|Overall Study|Death|20|||
25125189|NCT01702558|50238037|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
25125190|NCT01702558|50238038|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
25125191|NCT01702558|50238039|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
25125192|NCT01702558|50238040|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
25125193|NCT01702558|50238041|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
25125194|NCT01702558|50238037|FG000|Overall Study|Study Terminated by Sponsor|0|||
25125195|NCT01702558|50238038|FG001|Overall Study|Study Terminated by Sponsor|1|||
25125196|NCT01702558|50238039|FG002|Overall Study|Study Terminated by Sponsor|0|||
25125197|NCT01702558|50238040|FG003|Overall Study|Study Terminated by Sponsor|0|||
25125198|NCT01702558|50238041|FG004|Overall Study|Study Terminated by Sponsor|1|||
25125199|NCT01702558|50238037|FG000|Overall Study|Other|0|||
25125200|NCT01702558|50238038|FG001|Overall Study|Other|0|||
25125201|NCT01702558|50238039|FG002|Overall Study|Other|0|||
25125202|NCT01702558|50238040|FG003|Overall Study|Other|16|||
25125203|NCT01702558|50238041|FG004|Overall Study|Other|17|||
25125204|NCT02287883|50238056|FG000|Overall Study|Death|8|||
25125205|NCT02287883|50238057|FG001|Overall Study|Death|7|||
25125206|NCT02287883|50238056|FG000|Overall Study|No longer eligible|222|||
25125207|NCT02287883|50238057|FG001|Overall Study|No longer eligible|182|||
25125208|NCT02287883|50238056|FG000|Overall Study|Non-response to survey|229|||
25125209|NCT02287883|50238057|FG001|Overall Study|Non-response to survey|237|||
25125210|NCT01743040|50238063|FG000|Overall Study|Death|1|||
25178082|NCT01487161|50322983|FG003|Overall Study|Withdrawal by Subject|2|||
25125211|NCT01743040|50238063|FG000|Overall Study|Lost to Follow-up|66|||
25125212|NCT01743040|50238063|FG000|Overall Study|Physician Decision|40|||
25125213|NCT01743040|50238063|FG000|Overall Study|Protocol Violation|1|||
25125214|NCT01743040|50238063|FG000|Overall Study|Withdrawal by Subject|121|||
25125215|NCT02194465|50238074|FG000|Overall Study|Adverse Event|6|||
25125216|NCT02194465|50238075|FG001|Overall Study|Adverse Event|1|||
25125217|NCT02194465|50238076|FG002|Overall Study|Adverse Event|4|||
25125218|NCT02194465|50238077|FG003|Overall Study|Adverse Event|4|||
25125219|NCT02194465|50238078|FG004|Overall Study|Adverse Event|4|||
25125220|NCT02194465|50238079|FG005|Overall Study|Adverse Event|2|||
25125221|NCT02194465|50238080|FG006|Overall Study|Adverse Event|0|||
25125222|NCT02194465|50238074|FG000|Overall Study|Lost to Follow-up|0|||
25125223|NCT02194465|50238075|FG001|Overall Study|Lost to Follow-up|0|||
25125224|NCT02194465|50238076|FG002|Overall Study|Lost to Follow-up|0|||
25125225|NCT02194465|50238077|FG003|Overall Study|Lost to Follow-up|1|||
25125226|NCT02194465|50238078|FG004|Overall Study|Lost to Follow-up|0|||
25125227|NCT02194465|50238079|FG005|Overall Study|Lost to Follow-up|1|||
25125228|NCT02194465|50238080|FG006|Overall Study|Lost to Follow-up|0|||
25125229|NCT02194465|50238074|FG000|Overall Study|Physician Decision|1|||
25125230|NCT02194465|50238075|FG001|Overall Study|Physician Decision|0|||
25125231|NCT02194465|50238076|FG002|Overall Study|Physician Decision|0|||
25125232|NCT02194465|50238077|FG003|Overall Study|Physician Decision|0|||
25125233|NCT02194465|50238078|FG004|Overall Study|Physician Decision|0|||
25125234|NCT02194465|50238079|FG005|Overall Study|Physician Decision|0|||
25125235|NCT02194465|50238080|FG006|Overall Study|Physician Decision|0|||
25125236|NCT02194465|50238074|FG000|Overall Study|Protocol Violation|1|||
25125237|NCT02194465|50238075|FG001|Overall Study|Protocol Violation|1|||
25125238|NCT02194465|50238076|FG002|Overall Study|Protocol Violation|2|||
25266456|NCT01001104|50580599|FG002|Overall Study|Lost to Follow-up|1|||
25266457|NCT01001104|50580600|FG003|Overall Study|Lost to Follow-up|0|||
25266458|NCT01001104|50580597|FG000|Overall Study|Entry Criteria Not Met|0|||
25266459|NCT01001104|50580598|FG001|Overall Study|Entry Criteria Not Met|0|||
25266460|NCT01001104|50580599|FG002|Overall Study|Entry Criteria Not Met|0|||
25266461|NCT01001104|50580600|FG003|Overall Study|Entry Criteria Not Met|1|||
25266462|NCT01001104|50580597|FG000|Overall Study|Withdrawal by Subject|0|||
25266463|NCT01001104|50580598|FG001|Overall Study|Withdrawal by Subject|0|||
25266464|NCT01001104|50580599|FG002|Overall Study|Withdrawal by Subject|0|||
25266465|NCT01001104|50580600|FG003|Overall Study|Withdrawal by Subject|2|||
25266466|NCT00998764|50580615|FG000|Overall Study|Lack of Efficacy|3|||
25266467|NCT00998764|50580616|FG001|Overall Study|Lack of Efficacy|6|||
25266468|NCT00998764|50580615|FG000|Overall Study|Adverse Event|17|||
25266469|NCT00998764|50580616|FG001|Overall Study|Adverse Event|12|||
25266470|NCT00998764|50580615|FG000|Overall Study|Withdrawal by Subject|19|||
25266471|NCT00998764|50580616|FG001|Overall Study|Withdrawal by Subject|25|||
25266472|NCT00998764|50580615|FG000|Overall Study|Physician Decision|3|||
25266473|NCT00998764|50580616|FG001|Overall Study|Physician Decision|3|||
25266474|NCT00998764|50580615|FG000|Overall Study|Death|3|||
25266475|NCT00998764|50580616|FG001|Overall Study|Death|1|||
25266476|NCT00998764|50580615|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
25178083|NCT01487161|50322980|FG000|Overall Study|missing data|0|||
25178084|NCT01487161|50322981|FG001|Overall Study|missing data|1|||
25178085|NCT01487161|50322982|FG002|Overall Study|missing data|0|||
25178086|NCT01487161|50322983|FG003|Overall Study|missing data|0|||
25178087|NCT01491035|50323038|FG000|Overall Study|Lost to Follow-up|0|||
25178088|NCT01491035|50323039|FG001|Overall Study|Lost to Follow-up|0|||
25178089|NCT01491035|50323040|FG002|Overall Study|Lost to Follow-up|0|||
25178090|NCT01491035|50323041|FG003|Overall Study|Lost to Follow-up|0|||
25178091|NCT01491035|50323042|FG004|Overall Study|Lost to Follow-up|1|||
25178092|NCT01491035|50323043|FG005|Overall Study|Lost to Follow-up|0|||
25178093|NCT01491035|50323044|FG006|Overall Study|Lost to Follow-up|0|||
25266477|NCT00998764|50580616|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
25266478|NCT00998764|50580615|FG000|Overall Study|Protocol Violation|0|||
25266479|NCT00998764|50580616|FG001|Overall Study|Protocol Violation|1|||
25266480|NCT00998764|50580615|FG000|Overall Study|Failed to Return|1|||
25266481|NCT00998764|50580616|FG001|Overall Study|Failed to Return|1|||
25266482|NCT00998764|50580615|FG000|Overall Study|Lost to Follow-up|1|||
25266483|NCT00998764|50580616|FG001|Overall Study|Lost to Follow-up|1|||
25266484|NCT00998764|50580615|FG000|Overall Study|Loss of Caregiver|0|||
25266485|NCT00998764|50580616|FG001|Overall Study|Loss of Caregiver|3|||
25266486|NCT00998764|50580615|FG000|Overall Study|Other|4|||
25266487|NCT00998764|50580616|FG001|Overall Study|Other|4|||
25266488|NCT00998764|50580615|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
25266489|NCT00998764|50580616|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
25266490|NCT01204671|50580629|FG000|Overall Study|Adverse Event|4|||
25125239|NCT02194465|50238077|FG003|Overall Study|Protocol Violation|1|||
25266491|NCT01204671|50580630|FG001|Overall Study|Adverse Event|3|||
25125240|NCT02194465|50238078|FG004|Overall Study|Protocol Violation|1|||
25125241|NCT02194465|50238079|FG005|Overall Study|Protocol Violation|0|||
25125242|NCT02194465|50238080|FG006|Overall Study|Protocol Violation|0|||
25125243|NCT02194465|50238074|FG000|Overall Study|Withdrawal by Subject|1|||
25125244|NCT02194465|50238075|FG001|Overall Study|Withdrawal by Subject|3|||
25178094|NCT01491035|50323045|FG007|Overall Study|Lost to Follow-up|0|||
25178095|NCT01488071|50323069|FG000|Overall Study|Adverse Event|15|||
25266492|NCT01204671|50580631|FG002|Overall Study|Adverse Event|3|||
25266493|NCT01204671|50580632|FG003|Overall Study|Adverse Event|3|||
25266494|NCT01204671|50580633|FG004|Overall Study|Adverse Event|1|||
25266495|NCT01204671|50580629|FG000|Overall Study|Withdrawal by Subject|2|||
25266496|NCT01204671|50580630|FG001|Overall Study|Withdrawal by Subject|3|||
25178096|NCT01488071|50323070|FG001|Overall Study|Adverse Event|23|||
25266497|NCT01204671|50580631|FG002|Overall Study|Withdrawal by Subject|4|||
25266498|NCT01204671|50580632|FG003|Overall Study|Withdrawal by Subject|5|||
25266499|NCT01204671|50580633|FG004|Overall Study|Withdrawal by Subject|3|||
25266500|NCT01204671|50580629|FG000|Overall Study|Lost to Follow-up|7|||
25125245|NCT02194465|50238076|FG002|Overall Study|Withdrawal by Subject|1|||
25125246|NCT02194465|50238077|FG003|Overall Study|Withdrawal by Subject|2|||
25125247|NCT02194465|50238078|FG004|Overall Study|Withdrawal by Subject|2|||
25125248|NCT02194465|50238079|FG005|Overall Study|Withdrawal by Subject|1|||
25125249|NCT02194465|50238080|FG006|Overall Study|Withdrawal by Subject|2|||
25125250|NCT02194465|50238074|FG000|Overall Study|Discontinued follow-up period|0|||
25125251|NCT02194465|50238075|FG001|Overall Study|Discontinued follow-up period|2|||
25125252|NCT02194465|50238076|FG002|Overall Study|Discontinued follow-up period|1|||
25125253|NCT02194465|50238077|FG003|Overall Study|Discontinued follow-up period|0|||
25178097|NCT01488071|50323069|FG000|Overall Study|Lack of Efficacy|11|||
25178098|NCT01488071|50323070|FG001|Overall Study|Lack of Efficacy|17|||
25178099|NCT01488071|50323069|FG000|Overall Study|Non-compliance with study drug|2|||
25178100|NCT01488071|50323070|FG001|Overall Study|Non-compliance with study drug|0|||
25178101|NCT01488071|50323069|FG000|Overall Study|Protocol Violation|5|||
25178102|NCT01488071|50323070|FG001|Overall Study|Protocol Violation|7|||
25178103|NCT01488071|50323069|FG000|Overall Study|Withdrawal of Consent|14|||
25178104|NCT01488071|50323070|FG001|Overall Study|Withdrawal of Consent|12|||
25178105|NCT01488071|50323069|FG000|Overall Study|Lost to Follow-up|1|||
25178106|NCT01488071|50323070|FG001|Overall Study|Lost to Follow-up|0|||
25178107|NCT01488071|50323069|FG000|Overall Study|Administrative or Other Reason(s)|5|||
25178108|NCT01488071|50323070|FG001|Overall Study|Administrative or Other Reason(s)|4|||
25178109|NCT01487525|50323078|FG000|Overall Study|Withdrawal by Subject|0|||
25178110|NCT01487525|50323079|FG001|Overall Study|Withdrawal by Subject|1|||
25178111|NCT01486199|50323087|FG000|Two Year Period Between Study Days|Physician Decision|1|||
25178112|NCT01486199|50323088|FG001|Two Year Period Between Study Days|Physician Decision|0|||
25178113|NCT01485887|50323094|FG000|Overall Study|Withdrawal by Subject|2|||
25178114|NCT01485887|50323094|FG000|Overall Study|Adverse Event|8|||
25178115|NCT01485887|50323094|FG000|Overall Study|Deterioration of primary disease|1|||
25178116|NCT01485887|50323094|FG000|Overall Study|Primary disease markedly improved|1|||
25178117|NCT01546519|50323102|FG000|Overall Study|Adverse Event|0|||
25178118|NCT01546519|50323103|FG001|Overall Study|Adverse Event|0|||
25178119|NCT01546519|50323104|FG002|Overall Study|Adverse Event|1|||
25178120|NCT01546519|50323105|FG003|Overall Study|Adverse Event|1|||
25178121|NCT01546519|50323102|FG000|Overall Study|Death|0|||
25178122|NCT01546519|50323103|FG001|Overall Study|Death|1|||
25178123|NCT01546519|50323104|FG002|Overall Study|Death|3|||
25178124|NCT01546519|50323105|FG003|Overall Study|Death|1|||
25178125|NCT01546519|50323102|FG000|Overall Study|related to disease progression|2|||
25178126|NCT01546519|50323103|FG001|Overall Study|related to disease progression|2|||
25178127|NCT01546519|50323104|FG002|Overall Study|related to disease progression|2|||
25178128|NCT01546519|50323105|FG003|Overall Study|related to disease progression|1|||
25178129|NCT01546519|50323102|FG000|Overall Study|Physician Decision|6|||
25178130|NCT01546519|50323103|FG001|Overall Study|Physician Decision|5|||
25178131|NCT01546519|50323104|FG002|Overall Study|Physician Decision|2|||
25178132|NCT01546519|50323105|FG003|Overall Study|Physician Decision|3|||
25178133|NCT01546519|50323102|FG000|Overall Study|Withdrawal by Subject|1|||
25178134|NCT01546519|50323103|FG001|Overall Study|Withdrawal by Subject|0|||
25178135|NCT01546519|50323104|FG002|Overall Study|Withdrawal by Subject|0|||
25178136|NCT01546519|50323105|FG003|Overall Study|Withdrawal by Subject|0|||
25178137|NCT01484951|50323119|FG000|Overall Study|Adverse Event|3|||
25178138|NCT01484951|50323119|FG000|Overall Study|Personal Reasons|1|||
25178139|NCT01484951|50323119|FG000|Overall Study|Non-Compliance|1|||
25178140|NCT01484873|50323123|FG000|Overall Study|Withdrawal by Subject|2|||
25178141|NCT01486927|50323128|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
25178142|NCT01486927|50323128|FG000|Overall Study|Physician Decision|1|||
25178143|NCT01486927|50323128|FG000|Overall Study|50 Exposure days not reached|2|||
25178144|NCT01486927|50323128|FG000|Overall Study|Withdrawal by Subject|8|||
25178145|NCT01486927|50323128|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
25178146|NCT01513759|50323161|FG000|Overall Study|Protocol Violation|4|||
25178147|NCT01513759|50323161|FG000|Overall Study|Death during catheter placement|1|||
25178148|NCT01484561|50323167|FG000|Overall Study|Lack of Efficacy|3|||
25178149|NCT01484561|50323168|FG001|Overall Study|Lack of Efficacy|1|||
25178150|NCT01484561|50323167|FG000|Overall Study|Lost to Follow-up|1|||
25178151|NCT01484561|50323168|FG001|Overall Study|Lost to Follow-up|0|||
25178152|NCT01484561|50323167|FG000|Overall Study|Withdrawal by Subject|3|||
25178153|NCT01484561|50323168|FG001|Overall Study|Withdrawal by Subject|0|||
25178154|NCT01484561|50323167|FG000|Overall Study|Other|1|||
25178155|NCT01484561|50323168|FG001|Overall Study|Other|1|||
25178156|NCT01484561|50323167|FG000|Overall Study|Adverse Event|1|||
25178157|NCT01484561|50323168|FG001|Overall Study|Adverse Event|4|||
25178158|NCT01546207|50323174|FG000|Overall Study|Death|1|||
25266501|NCT01204671|50580630|FG001|Overall Study|Lost to Follow-up|8|||
25266502|NCT01204671|50580631|FG002|Overall Study|Lost to Follow-up|6|||
25178159|NCT01513291|50323180|FG000|Treatment Period|Adverse Event|8|||
25178160|NCT01513291|50323181|FG001|Treatment Period|Adverse Event|4|||
25178161|NCT01513291|50323182|FG002|Treatment Period|Adverse Event|0|||
25178162|NCT01513291|50323183|FG003|Treatment Period|Adverse Event|0|||
25178163|NCT01513291|50323184|FG004|Treatment Period|Adverse Event|0|||
25178164|NCT01513291|50323180|FG000|Treatment Period|Lack of Efficacy|3|||
25178165|NCT01513291|50323181|FG001|Treatment Period|Lack of Efficacy|0|||
25178166|NCT01513291|50323182|FG002|Treatment Period|Lack of Efficacy|0|||
25178167|NCT01513291|50323183|FG003|Treatment Period|Lack of Efficacy|0|||
25178168|NCT01513291|50323184|FG004|Treatment Period|Lack of Efficacy|0|||
25178169|NCT01513291|50323180|FG000|Treatment Period|Lost to Follow-up|2|||
25178170|NCT01513291|50323181|FG001|Treatment Period|Lost to Follow-up|3|||
25178171|NCT01513291|50323182|FG002|Treatment Period|Lost to Follow-up|0|||
25178172|NCT01513291|50323183|FG003|Treatment Period|Lost to Follow-up|0|||
25178173|NCT01513291|50323184|FG004|Treatment Period|Lost to Follow-up|0|||
25178174|NCT01513291|50323180|FG000|Treatment Period|Physician Decision|1|||
25178175|NCT01513291|50323181|FG001|Treatment Period|Physician Decision|0|||
25178176|NCT01513291|50323182|FG002|Treatment Period|Physician Decision|0|||
25178177|NCT01513291|50323183|FG003|Treatment Period|Physician Decision|0|||
25178178|NCT01513291|50323184|FG004|Treatment Period|Physician Decision|0|||
25178179|NCT01513291|50323180|FG000|Treatment Period|Protocol Violation|1|||
25178180|NCT01513291|50323181|FG001|Treatment Period|Protocol Violation|2|||
25178181|NCT01513291|50323182|FG002|Treatment Period|Protocol Violation|0|||
25178182|NCT01513291|50323183|FG003|Treatment Period|Protocol Violation|0|||
25178183|NCT01513291|50323184|FG004|Treatment Period|Protocol Violation|0|||
25178184|NCT01513291|50323180|FG000|Treatment Period|Withdrawal by Subject|8|||
25178185|NCT01513291|50323181|FG001|Treatment Period|Withdrawal by Subject|5|||
25178186|NCT01513291|50323182|FG002|Treatment Period|Withdrawal by Subject|0|||
25178187|NCT01513291|50323183|FG003|Treatment Period|Withdrawal by Subject|0|||
25178188|NCT01513291|50323184|FG004|Treatment Period|Withdrawal by Subject|0|||
25178189|NCT01513291|50323180|FG000|Treatment Period|Randomized not treated|0|||
25178190|NCT01513291|50323181|FG001|Treatment Period|Randomized not treated|2|||
25178191|NCT01513291|50323182|FG002|Treatment Period|Randomized not treated|0|||
25178192|NCT01513291|50323183|FG003|Treatment Period|Randomized not treated|0|||
25178193|NCT01513291|50323184|FG004|Treatment Period|Randomized not treated|0|||
25178194|NCT01513291|50323180|FG000|Run-out Period|Lost to Follow-up|0|||
25178195|NCT01513291|50323181|FG001|Run-out Period|Lost to Follow-up|0|||
25178196|NCT01513291|50323182|FG002|Run-out Period|Lost to Follow-up|0|||
25178197|NCT01513291|50323183|FG003|Run-out Period|Lost to Follow-up|1|||
25178198|NCT01513291|50323184|FG004|Run-out Period|Lost to Follow-up|0|||
25178199|NCT01513291|50323180|FG000|Run-out Period|Withdrawal by Subject|0|||
25178200|NCT01513291|50323181|FG001|Run-out Period|Withdrawal by Subject|0|||
25178201|NCT01513291|50323182|FG002|Run-out Period|Withdrawal by Subject|0|||
25178202|NCT01513291|50323183|FG003|Run-out Period|Withdrawal by Subject|1|||
25178203|NCT01513291|50323184|FG004|Run-out Period|Withdrawal by Subject|0|||
25178204|NCT01483937|50323198|FG000|Overall Study|Withdrawal by Subject|4|||
25178205|NCT01483937|50323199|FG001|Overall Study|Withdrawal by Subject|3|||
25178206|NCT01483625|50323210|FG000|Overall Study|Adverse Event|1|||
25178207|NCT01483625|50323211|FG001|Overall Study|Adverse Event|1|||
25178208|NCT01483625|50323210|FG000|Overall Study|Refused to continue medication|2|||
25178209|NCT01483625|50323211|FG001|Overall Study|Refused to continue medication|1|||
25178210|NCT01483625|50323210|FG000|Overall Study|Due to other reason|1|||
25178211|NCT01483625|50323211|FG001|Overall Study|Due to other reason|0|||
25178212|NCT01485991|50323219|FG000|Overall Study|Adverse Event|0|||
25178213|NCT01485991|50323220|FG001|Overall Study|Adverse Event|4|||
25178214|NCT01485991|50323219|FG000|Overall Study|Lost to Follow-up|13|||
25178215|NCT01485991|50323220|FG001|Overall Study|Lost to Follow-up|10|||
25178216|NCT01485991|50323219|FG000|Overall Study|Withdrawal by Subject|13|||
25178217|NCT01485991|50323220|FG001|Overall Study|Withdrawal by Subject|20|||
25266503|NCT01204671|50580632|FG003|Overall Study|Lost to Follow-up|4|||
25266504|NCT01204671|50580633|FG004|Overall Study|Lost to Follow-up|0|||
25266505|NCT01204671|50580629|FG000|Overall Study|Unknown Completion Status|1|||
25178218|NCT01485991|50323219|FG000|Overall Study|randomized but not treated|6|||
25178219|NCT01485991|50323220|FG001|Overall Study|randomized but not treated|2|||
25178220|NCT01482767|50323252|FG000|Overall Study|Death|1|||
25178221|NCT01482767|50323253|FG001|Overall Study|Death|1|||
25178222|NCT01482767|50323252|FG000|Overall Study|Withdrawal by Subject|7|||
25178223|NCT01482767|50323253|FG001|Overall Study|Withdrawal by Subject|5|||
25178224|NCT01482767|50323252|FG000|Overall Study|Lost to Follow-up|12|||
25266506|NCT01204671|50580630|FG001|Overall Study|Unknown Completion Status|1|||
25178225|NCT01482767|50323253|FG001|Overall Study|Lost to Follow-up|6|||
25178226|NCT01482767|50323252|FG000|Overall Study|Adverse Event|0|||
25178227|NCT01482767|50323253|FG001|Overall Study|Adverse Event|3|||
25178228|NCT01482767|50323252|FG000|Overall Study|Site closure|22|||
25178229|NCT01482767|50323253|FG001|Overall Study|Site closure|14|||
25266507|NCT01204671|50580631|FG002|Overall Study|Unknown Completion Status|0|||
25266508|NCT01204671|50580632|FG003|Overall Study|Unknown Completion Status|0|||
25266509|NCT01204671|50580633|FG004|Overall Study|Unknown Completion Status|0|||
25266510|NCT01204671|50580629|FG000|Overall Study|Physician Decision|0|||
25266511|NCT01204671|50580630|FG001|Overall Study|Physician Decision|0|||
25266512|NCT01204671|50580631|FG002|Overall Study|Physician Decision|0|||
25266513|NCT01204671|50580632|FG003|Overall Study|Physician Decision|1|||
25266514|NCT01204671|50580633|FG004|Overall Study|Physician Decision|0|||
25266515|NCT01202955|50580651|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
25266516|NCT01202955|50580652|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
25266517|NCT01202877|50580661|FG000|Overall Study|Disease Progression|0|||
25266518|NCT01202877|50580662|FG001|Overall Study|Disease Progression|1|||
25266519|NCT01202877|50580663|FG002|Overall Study|Disease Progression|2|||
25266520|NCT01202877|50580661|FG000|Overall Study|Adverse Event|0|||
25266521|NCT01202877|50580662|FG001|Overall Study|Adverse Event|0|||
25266522|NCT01202877|50580663|FG002|Overall Study|Adverse Event|2|||
25266523|NCT01202877|50580661|FG000|Overall Study|Withdrawal by Subject|0|||
25266524|NCT01202877|50580662|FG001|Overall Study|Withdrawal by Subject|0|||
25266525|NCT01202877|50580663|FG002|Overall Study|Withdrawal by Subject|1|||
25266526|NCT01202877|50580661|FG000|Overall Study|Death|0|||
25266527|NCT01202877|50580662|FG001|Overall Study|Death|0|||
25266528|NCT01202877|50580663|FG002|Overall Study|Death|1|||
25125254|NCT02194465|50238078|FG004|Overall Study|Discontinued follow-up period|2|||
25125255|NCT02194465|50238079|FG005|Overall Study|Discontinued follow-up period|0|||
25125256|NCT02194465|50238080|FG006|Overall Study|Discontinued follow-up period|0|||
25125257|NCT02287025|50238102|FG000|Overall Study|Not treated|2|||
25125258|NCT02287025|50238103|FG001|Overall Study|Not treated|0|||
25125259|NCT02287025|50238102|FG000|Overall Study|Progression of disease|3|||
25125260|NCT02287025|50238103|FG001|Overall Study|Progression of disease|2|||
25125261|NCT02287025|50238102|FG000|Overall Study|Adverse Event|2|||
25125262|NCT02287025|50238103|FG001|Overall Study|Adverse Event|4|||
25125263|NCT02287025|50238102|FG000|Overall Study|Withdrawal by Subject|2|||
25125264|NCT02287025|50238103|FG001|Overall Study|Withdrawal by Subject|2|||
25125265|NCT02287025|50238102|FG000|Overall Study|Screening failed|1|||
25125266|NCT02287025|50238103|FG001|Overall Study|Screening failed|1|||
25125267|NCT01720264|50238107|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
25125268|NCT01720264|50238107|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
25125269|NCT01720264|50238107|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
25125270|NCT01702246|50238111|FG000|Overall Study|Lost to Follow-up|2|||
25125271|NCT01702246|50238111|FG000|Overall Study|Withdrawal by Subject|2|||
25125272|NCT01702246|50238111|FG000|Overall Study|Physician Decision|1|||
25125273|NCT01631227|50238120|FG000|Overall Study|withdrawn consent|27|||
25125274|NCT01631227|50238121|FG001|Overall Study|withdrawn consent|21|||
25125275|NCT01631227|50238120|FG000|Overall Study|Adverse Event|1|||
25125276|NCT01631227|50238121|FG001|Overall Study|Adverse Event|0|||
25125277|NCT01631227|50238120|FG000|Overall Study|administrative|2|||
25125278|NCT01631227|50238121|FG001|Overall Study|administrative|1|||
25125279|NCT01719172|50238127|FG000|Overall Study|Lost to Follow-up|1|||
25125280|NCT01719172|50238127|FG000|Overall Study|Death|1|||
25125281|NCT02286947|50238131|FG000|Overall Study|Withdrawal by Subject|2|||
25125282|NCT02286713|50238139|FG000|One Week Follow-Up|Death|1|||
25125283|NCT02286713|50238140|FG001|One Week Follow-Up|Death|0|||
25125284|NCT02286713|50238139|FG000|One Week Follow-Up|Lost to Follow-up|17|||
25125285|NCT02286713|50238140|FG001|One Week Follow-Up|Lost to Follow-up|21|||
25125286|NCT02286713|50238139|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
25125287|NCT02286713|50238140|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
25125288|NCT02286713|50238139|FG000|Three Month Follow-Up|Death|1|||
25125289|NCT02286713|50238140|FG001|Three Month Follow-Up|Death|1|||
25266529|NCT01202409|50580671|FG000|Overall Study|Adverse Event|1|||
25125290|NCT02286713|50238139|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
25125291|NCT02286713|50238140|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
25266530|NCT01202409|50580671|FG000|Overall Study|Ineligible - KRAS mutants|7|||
25266531|NCT01202175|50580677|FG000|Overall Study|Lost to Follow-up|2|||
25266532|NCT01202175|50580677|FG000|Overall Study|Withdrawal by Subject|1|||
25009226|NCT00075725|50102301|FG007|Overall Study|MRD positive after extended ind|1|||
25125292|NCT02286713|50238139|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
25125293|NCT02286713|50238140|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
25125294|NCT02286713|50238139|FG000|Six Month Follow-Up|Death|2|||
25125295|NCT02286713|50238140|FG001|Six Month Follow-Up|Death|0|||
25125296|NCT02286713|50238139|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
25125297|NCT02286713|50238140|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
25125298|NCT02285855|50238148|FG000|Overall Study|Withdrawal by Subject|2|||
25125299|NCT02285855|50238149|FG001|Overall Study|Withdrawal by Subject|1|||
25266533|NCT01202175|50580677|FG000|Overall Study|Adverse Event|2|||
25266534|NCT01201785|50580682|FG000|Overall Study|Lost to Follow-up|16|||
25125300|NCT02285777|50238157|FG000|Overall Study|Withdrawal by Subject|1|||
25266535|NCT01201317|50580689|FG000|Overall Study|Withdrawal by Subject|5|||
25266536|NCT01201317|50580690|FG001|Overall Study|Withdrawal by Subject|0|||
25125301|NCT02285777|50238158|FG001|Overall Study|Withdrawal by Subject|1|||
25125302|NCT02285777|50238157|FG000|Overall Study|Lost to Follow-up|4|||
25125303|NCT02285777|50238158|FG001|Overall Study|Lost to Follow-up|2|||
25125304|NCT02285153|50238166|FG000|Overall Study|Adverse Event|1|||
25125305|NCT02285153|50238167|FG001|Overall Study|Adverse Event|0|||
25125306|NCT02284373|50238176|FG000|Overall Study|Withdrawal by Subject|0|||
25125307|NCT02284373|50238177|FG001|Overall Study|Withdrawal by Subject|1|||
25125308|NCT02284373|50238178|FG002|Overall Study|Withdrawal by Subject|0|||
25125309|NCT02284373|50238176|FG000|Overall Study|Other|0|||
25125310|NCT02284373|50238177|FG001|Overall Study|Other|1|||
25125311|NCT02284373|50238178|FG002|Overall Study|Other|0|||
25125312|NCT02284373|50238176|FG000|Overall Study|Lost to Follow-up|0|||
25266537|NCT01201317|50580691|FG002|Overall Study|Withdrawal by Subject|3|||
25266538|NCT01201317|50580689|FG000|Overall Study|Adverse Event|2|||
25266539|NCT01201317|50580690|FG001|Overall Study|Adverse Event|2|||
25266540|NCT01201317|50580691|FG002|Overall Study|Adverse Event|2|||
25266541|NCT01201317|50580689|FG000|Overall Study|Screen failure|1|||
25266542|NCT01201317|50580690|FG001|Overall Study|Screen failure|1|||
25266543|NCT01201317|50580691|FG002|Overall Study|Screen failure|0|||
25266544|NCT01201317|50580689|FG000|Overall Study|Protocol Violation|0|||
25266545|NCT01201317|50580690|FG001|Overall Study|Protocol Violation|1|||
25266546|NCT01201317|50580691|FG002|Overall Study|Protocol Violation|1|||
25266547|NCT01201317|50580689|FG000|Overall Study|Death|0|||
25266548|NCT01201317|50580690|FG001|Overall Study|Death|1|||
25266549|NCT01201317|50580691|FG002|Overall Study|Death|0|||
25266550|NCT01201317|50580689|FG000|Overall Study|Study-specific withdrawal criteria|0|||
25266551|NCT01201317|50580690|FG001|Overall Study|Study-specific withdrawal criteria|0|||
25266552|NCT01201317|50580691|FG002|Overall Study|Study-specific withdrawal criteria|1|||
25266553|NCT01201317|50580689|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
25266554|NCT01201317|50580690|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
25266555|NCT01201317|50580691|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
25266556|NCT01201317|50580689|FG000|Overall Study|Decrease in renal function|0|||
25266557|NCT01201317|50580690|FG001|Overall Study|Decrease in renal function|1|||
25266558|NCT01201317|50580691|FG002|Overall Study|Decrease in renal function|0|||
25266559|NCT01201317|50580689|FG000|Overall Study|Lack of Efficacy|1|||
25266560|NCT01201317|50580690|FG001|Overall Study|Lack of Efficacy|0|||
25266561|NCT01201317|50580691|FG002|Overall Study|Lack of Efficacy|0|||
25266562|NCT01201317|50580689|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
25266563|NCT01201317|50580690|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
25266564|NCT01201317|50580691|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
25266565|NCT01200069|50580701|FG000|Overall Study|Withdrawal by Subject|0|||
25266566|NCT01200069|50580702|FG001|Overall Study|Withdrawal by Subject|1|||
25266567|NCT01199601|50580753|FG000|Overall Study|Lost to Follow-up|47|||
25266568|NCT01199601|50580754|FG001|Overall Study|Lost to Follow-up|66|||
25266569|NCT01199601|50580753|FG000|Overall Study|Withdrawal by Subject|15|||
25266570|NCT01199601|50580754|FG001|Overall Study|Withdrawal by Subject|3|||
25266571|NCT01199601|50580753|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
25266572|NCT01199601|50580754|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
25266573|NCT01199289|50580764|FG000|Overall Study|Ineligibility determined|2|||
25266574|NCT01199289|50580765|FG001|Overall Study|Ineligibility determined|1|||
25266575|NCT01199289|50580766|FG002|Overall Study|Ineligibility determined|0|||
25266576|NCT01199289|50580767|FG003|Overall Study|Ineligibility determined|0|||
25266577|NCT01199289|50580764|FG000|Overall Study|Protocol Violation|1|||
25266578|NCT01199289|50580765|FG001|Overall Study|Protocol Violation|0|||
25266579|NCT01199289|50580766|FG002|Overall Study|Protocol Violation|0|||
25266580|NCT01199289|50580767|FG003|Overall Study|Protocol Violation|1|||
25266581|NCT01199289|50580764|FG000|Overall Study|Noncompliance|1|||
25266582|NCT01199289|50580765|FG001|Overall Study|Noncompliance|0|||
25266583|NCT01199289|50580766|FG002|Overall Study|Noncompliance|2|||
25266584|NCT01199289|50580767|FG003|Overall Study|Noncompliance|0|||
25266585|NCT01199289|50580764|FG000|Overall Study|Adverse Event|0|||
25266586|NCT01199289|50580765|FG001|Overall Study|Adverse Event|3|||
25266587|NCT01199289|50580766|FG002|Overall Study|Adverse Event|1|||
25266588|NCT01199289|50580767|FG003|Overall Study|Adverse Event|4|||
25266589|NCT01199289|50580764|FG000|Overall Study|Full consent withdrawn|2|||
25009227|NCT00075725|50102302|FG008|Overall Study|MRD positive after extended ind|0|||
25266590|NCT01199289|50580765|FG001|Overall Study|Full consent withdrawn|2|||
25125313|NCT02284373|50238177|FG001|Overall Study|Lost to Follow-up|1|||
25266591|NCT01199289|50580766|FG002|Overall Study|Full consent withdrawn|2|||
25266592|NCT01199289|50580767|FG003|Overall Study|Full consent withdrawn|3|||
25266593|NCT01199289|50580764|FG000|Overall Study|Administrative decision|0|||
25266594|NCT01199289|50580765|FG001|Overall Study|Administrative decision|0|||
25266595|NCT01199289|50580766|FG002|Overall Study|Administrative decision|0|||
25266596|NCT01199289|50580767|FG003|Overall Study|Administrative decision|1|||
25125314|NCT02284373|50238178|FG002|Overall Study|Lost to Follow-up|0|||
25125315|NCT01632241|50238188|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
25266597|NCT01199289|50580764|FG000|Overall Study|Lost to Follow-up|0|||
25266598|NCT01199289|50580765|FG001|Overall Study|Lost to Follow-up|0|||
25266599|NCT01199289|50580766|FG002|Overall Study|Lost to Follow-up|0|||
25266600|NCT01199289|50580767|FG003|Overall Study|Lost to Follow-up|1|||
25266601|NCT01199289|50580764|FG000|Overall Study|Protocol-specified criteria|3|||
25266602|NCT01199289|50580765|FG001|Overall Study|Protocol-specified criteria|0|||
25266603|NCT01199289|50580766|FG002|Overall Study|Protocol-specified criteria|0|||
25266604|NCT01199289|50580767|FG003|Overall Study|Protocol-specified criteria|1|||
25266605|NCT01199289|50580764|FG000|Overall Study|Pregnancy|0|||
25266606|NCT01199289|50580765|FG001|Overall Study|Pregnancy|1|||
25266607|NCT01199289|50580766|FG002|Overall Study|Pregnancy|0|||
25266608|NCT01199289|50580767|FG003|Overall Study|Pregnancy|1|||
25266609|NCT01199055|50580783|FG000|Overall Study|Death|0|||
25266610|NCT01199055|50580784|FG001|Overall Study|Death|1|||
25266611|NCT01199055|50580785|FG002|Overall Study|Death|0|||
25266612|NCT01199055|50580783|FG000|Overall Study|Physician Decision|0|||
25266613|NCT01199055|50580784|FG001|Overall Study|Physician Decision|1|||
25266614|NCT01199055|50580785|FG002|Overall Study|Physician Decision|1|||
25266615|NCT01199055|50580783|FG000|Overall Study|Progressive disease|2|||
25266616|NCT01199055|50580784|FG001|Overall Study|Progressive disease|1|||
25178230|NCT01482767|50323252|FG000|Overall Study|Non-adherence to study requirements|4|||
25178231|NCT01482767|50323253|FG001|Overall Study|Non-adherence to study requirements|7|||
25178232|NCT01482767|50323252|FG000|Overall Study|Alternate HCV treatment|7|||
25178233|NCT01482767|50323253|FG001|Overall Study|Alternate HCV treatment|8|||
25178234|NCT01482767|50323252|FG000|Overall Study|Ineligible|0|||
25178235|NCT01482767|50323253|FG001|Overall Study|Ineligible|5|||
25178236|NCT01482767|50323252|FG000|Overall Study|Nurse error|1|||
25178237|NCT01482767|50323253|FG001|Overall Study|Nurse error|0|||
25178238|NCT01482221|50323282|FG000|Overall Study|Lack of Efficacy|1|||
25178239|NCT01482221|50323283|FG001|Overall Study|Lack of Efficacy|0|||
25178240|NCT01482221|50323284|FG002|Overall Study|Lack of Efficacy|1|||
25266617|NCT01199055|50580785|FG002|Overall Study|Progressive disease|2|||
25266618|NCT01199055|50580783|FG000|Overall Study|Withdrawal by Subject|0|||
25266619|NCT01199055|50580784|FG001|Overall Study|Withdrawal by Subject|0|||
25266620|NCT01199055|50580785|FG002|Overall Study|Withdrawal by Subject|1|||
25266621|NCT01198977|50580797|FG000|Overall Study|Lost to Follow-up|1|||
25266622|NCT01198977|50580798|FG001|Overall Study|Lost to Follow-up|0|||
25266623|NCT01198587|50580810|FG000|Overall Study|Lost to Follow-up|8|||
25178241|NCT01482221|50323282|FG000|Overall Study|Lost to Follow-up|3|||
25178242|NCT01482221|50323283|FG001|Overall Study|Lost to Follow-up|2|||
25178243|NCT01482221|50323284|FG002|Overall Study|Lost to Follow-up|1|||
25178244|NCT01482221|50323282|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
25178245|NCT01482221|50323283|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
25178246|NCT01482221|50323284|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
25178247|NCT01482221|50323282|FG000|Overall Study|Condition under Investigation Worsened|3|||
25178248|NCT01482221|50323283|FG001|Overall Study|Condition under Investigation Worsened|2|||
25178249|NCT01482221|50323284|FG002|Overall Study|Condition under Investigation Worsened|4|||
25178250|NCT01482221|50323282|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
25178251|NCT01482221|50323283|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
25178252|NCT01482221|50323284|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
25178253|NCT01482221|50323282|FG000|Overall Study|Adverse Event|1|||
25178254|NCT01482221|50323283|FG001|Overall Study|Adverse Event|7|||
25178255|NCT01482221|50323284|FG002|Overall Study|Adverse Event|3|||
25178256|NCT01482221|50323282|FG000|Overall Study|Withdrawal by Subject|10|||
25178257|NCT01482221|50323283|FG001|Overall Study|Withdrawal by Subject|7|||
25178258|NCT01482221|50323284|FG002|Overall Study|Withdrawal by Subject|12|||
25178259|NCT01482221|50323282|FG000|Overall Study|Incorrect randomization|0|||
25178260|NCT01482221|50323283|FG001|Overall Study|Incorrect randomization|1|||
25178261|NCT01482221|50323284|FG002|Overall Study|Incorrect randomization|0|||
25178262|NCT01482221|50323282|FG000|Overall Study|Physician Decision|0|||
25178263|NCT01482221|50323283|FG001|Overall Study|Physician Decision|1|||
25178264|NCT01482221|50323284|FG002|Overall Study|Physician Decision|0|||
25178265|NCT01482065|50323294|FG000|Overall Study|Withdrawal by Subject|0|||
25178266|NCT01482065|50323295|FG001|Overall Study|Withdrawal by Subject|1|||
25178267|NCT01545817|50323310|FG000|Pazopanib|Disease progression|51|||
25266624|NCT01198587|50580811|FG001|Overall Study|Lost to Follow-up|0|||
25266625|NCT01198587|50580812|FG002|Overall Study|Lost to Follow-up|9|||
25266626|NCT01198587|50580813|FG003|Overall Study|Lost to Follow-up|0|||
25266627|NCT01198509|50580834|FG000|Overall Study|Withdrawal by Subject|1|||
25266628|NCT01198509|50580835|FG001|Overall Study|Withdrawal by Subject|0|||
25178268|NCT01545817|50323311|FG001|Pazopanib|Disease progression|0|||
25178269|NCT01545817|50323310|FG000|Pazopanib|Adverse Event|19|||
25178270|NCT01545817|50323311|FG001|Pazopanib|Adverse Event|0|||
25178271|NCT01545817|50323310|FG000|Pazopanib|Other reason|4|||
25178272|NCT01545817|50323311|FG001|Pazopanib|Other reason|0|||
25178273|NCT01545817|50323310|FG000|Everolimus|Other reason|0|||
25178274|NCT01545817|50323311|FG001|Everolimus|Other reason|7|||
25178275|NCT01545817|50323310|FG000|Everolimus|Disease progression|0|||
25266629|NCT01198509|50580836|FG002|Overall Study|Withdrawal by Subject|0|||
25266630|NCT01198509|50580837|FG003|Overall Study|Withdrawal by Subject|0|||
25266631|NCT01198509|50580838|FG004|Overall Study|Withdrawal by Subject|0|||
25266632|NCT01198509|50580839|FG005|Overall Study|Withdrawal by Subject|0|||
25266633|NCT01198275|50580853|FG000|Overall Study|Adverse Event|2|||
25266634|NCT01198275|50580854|FG001|Overall Study|Adverse Event|3|||
25266635|NCT01198275|50580853|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
25266636|NCT01198275|50580854|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
25266637|NCT01197417|50580862|FG000|Overall Study|Physician Decision|3|||
25266638|NCT01197417|50580863|FG001|Overall Study|Physician Decision|2|||
25266639|NCT01197417|50580862|FG000|Overall Study|Withdrawal by Subject|2|||
25266640|NCT01197417|50580863|FG001|Overall Study|Withdrawal by Subject|4|||
25266641|NCT01197417|50580862|FG000|Overall Study|Site miscommunication|0|||
25266642|NCT01197417|50580863|FG001|Overall Study|Site miscommunication|1|||
25266643|NCT01197417|50580862|FG000|Overall Study|Subject transferred to intensive care|0|||
25266644|NCT01197417|50580863|FG001|Overall Study|Subject transferred to intensive care|1|||
25266645|NCT01197417|50580862|FG000|Overall Study|Not consented in time to receive drug|0|||
25266646|NCT01197417|50580863|FG001|Overall Study|Not consented in time to receive drug|1|||
25266647|NCT01197417|50580862|FG000|Overall Study|Hypotension|1|||
25125316|NCT01632241|50238189|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
25266648|NCT01197417|50580863|FG001|Overall Study|Hypotension|2|||
25266649|NCT01197417|50580862|FG000|Overall Study|Found to be ineligible|2|||
25266650|NCT01197417|50580863|FG001|Overall Study|Found to be ineligible|5|||
25266651|NCT01197417|50580862|FG000|Overall Study|No 25-hour magnesium level|0|||
25125317|NCT01632241|50238188|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
25125318|NCT01632241|50238189|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
25125319|NCT01632241|50238188|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
25125320|NCT01632241|50238189|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
25125321|NCT01632241|50238188|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
25125322|NCT01632241|50238189|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
25125323|NCT01632241|50238188|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
25125324|NCT01632241|50238189|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
25125325|NCT01632241|50238188|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
25125326|NCT01632241|50238189|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
25125327|NCT01632241|50238188|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
25125328|NCT01632241|50238189|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
25125329|NCT01632241|50238188|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
25125330|NCT01632241|50238189|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
25125331|NCT01632241|50238188|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
25125332|NCT01632241|50238189|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
25125333|NCT01632241|50238188|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
25178276|NCT01545817|50323311|FG001|Everolimus|Disease progression|25|||
25178277|NCT01545817|50323310|FG000|Everolimus|Adverse Event|0|||
25178278|NCT01545817|50323311|FG001|Everolimus|Adverse Event|6|||
25178279|NCT01512979|50323330|FG000|Overall Study|Adverse Event|2|||
25178280|NCT01512979|50323331|FG001|Overall Study|Adverse Event|2|||
25178281|NCT01512979|50323330|FG000|Overall Study|Protocol Violation|1|||
25178282|NCT01512979|50323331|FG001|Overall Study|Protocol Violation|4|||
25178283|NCT01512979|50323330|FG000|Overall Study|Lost to Follow-up|2|||
25178284|NCT01512979|50323331|FG001|Overall Study|Lost to Follow-up|5|||
25178285|NCT01512979|50323330|FG000|Overall Study|Withdrawal by Subject|1|||
25178286|NCT01512979|50323331|FG001|Overall Study|Withdrawal by Subject|2|||
25178287|NCT01512979|50323330|FG000|Overall Study|Reason other than stated above|13|||
25178288|NCT01512979|50323331|FG001|Overall Study|Reason other than stated above|9|||
25178289|NCT01512745|50323343|FG000|Overall Study|Adverse Event|22|||
25178290|NCT01512745|50323344|FG001|Overall Study|Adverse Event|3|||
25178291|NCT01512745|50323343|FG000|Overall Study|Death|9|||
25178292|NCT01512745|50323344|FG001|Overall Study|Death|13|||
25178293|NCT01512745|50323343|FG000|Overall Study|Withdrawal by Subject|2|||
25178294|NCT01512745|50323344|FG001|Overall Study|Withdrawal by Subject|2|||
25178295|NCT01512745|50323343|FG000|Overall Study|Lost to Follow-up|4|||
25178296|NCT01512745|50323344|FG001|Overall Study|Lost to Follow-up|0|||
25178297|NCT01512745|50323343|FG000|Overall Study|Lack of Efficacy|2|||
25178298|NCT01512745|50323344|FG001|Overall Study|Lack of Efficacy|2|||
25178299|NCT01512745|50323343|FG000|Overall Study|Protocol Violation|1|||
25178300|NCT01512745|50323344|FG001|Overall Study|Protocol Violation|0|||
25178301|NCT01478321|50323350|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
25178302|NCT01478321|50323350|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
25178303|NCT01478321|50323350|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
25178304|NCT01478321|50323350|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
25266652|NCT01197417|50580863|FG001|Overall Study|No 25-hour magnesium level|2|||
25266653|NCT00977431|50580874|FG000|Overall Study|Other than listed|1|||
25125334|NCT01632241|50238189|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
25178305|NCT01478321|50323350|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
25266654|NCT00977431|50580875|FG001|Overall Study|Other than listed|0|||
25266655|NCT00977431|50580876|FG002|Overall Study|Other than listed|0|||
25266656|NCT00977431|50580877|FG003|Overall Study|Other than listed|0|||
25125335|NCT01632241|50238188|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
25125336|NCT01632241|50238189|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
25125337|NCT01632241|50238188|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
25125338|NCT01632241|50238189|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
25266657|NCT00977431|50580878|FG004|Overall Study|Other than listed|2|||
25125339|NCT01632241|50238188|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
25125340|NCT01632241|50238189|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
25125341|NCT01632241|50238188|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
25125342|NCT01632241|50238189|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
25178306|NCT01478321|50323350|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
25178307|NCT01478321|50323350|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
25178308|NCT01478321|50323350|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
25178309|NCT01544491|50323356|FG000|Overall Study|Withdrawal by Subject|3|||
25125343|NCT02263508|50238204|FG000|Overall Study|Withdrawal by Subject|1|||
25125344|NCT02263508|50238205|FG001|Overall Study|Withdrawal by Subject|23|||
25178310|NCT01544491|50323357|FG001|Overall Study|Withdrawal by Subject|2|||
25178311|NCT01544491|50323356|FG000|Overall Study|Lost to Follow-up|0|||
25178312|NCT01544491|50323357|FG001|Overall Study|Lost to Follow-up|1|||
25178313|NCT01544491|50323356|FG000|Overall Study|administrative problems|2|||
25178314|NCT01544491|50323357|FG001|Overall Study|administrative problems|0|||
25178315|NCT01478087|50323376|FG000|Overall Study|due to sponsor closing study|1|||
25178316|NCT01477853|50323394|FG000|Phase A|Adverse Event|1|||
25178317|NCT01477853|50323395|FG001|Phase A|Adverse Event|2|||
25178318|NCT01477853|50323396|FG002|Phase A|Adverse Event|2|||
25178319|NCT01477853|50323394|FG000|Phase A|Lost to Follow-up|4|||
25178320|NCT01477853|50323395|FG001|Phase A|Lost to Follow-up|3|||
25178321|NCT01477853|50323396|FG002|Phase A|Lost to Follow-up|2|||
25178322|NCT01477853|50323394|FG000|Phase A|Physician Decision|1|||
25178323|NCT01477853|50323395|FG001|Phase A|Physician Decision|0|||
25178324|NCT01477853|50323396|FG002|Phase A|Physician Decision|1|||
25178325|NCT01477853|50323394|FG000|Phase A|Study terminated by sponsor|37|||
25178326|NCT01477853|50323395|FG001|Phase A|Study terminated by sponsor|40|||
25178327|NCT01477853|50323396|FG002|Phase A|Study terminated by sponsor|39|||
25178328|NCT01477853|50323394|FG000|Phase B|Lost to Follow-up|0|||
25178329|NCT01477853|50323395|FG001|Phase B|Lost to Follow-up|1|||
25178330|NCT01477853|50323396|FG002|Phase B|Lost to Follow-up|0|||
25178331|NCT01477853|50323394|FG000|Phase B|Study terminated by sponsor|12|||
25178332|NCT01477853|50323395|FG001|Phase B|Study terminated by sponsor|10|||
25178333|NCT01477853|50323396|FG002|Phase B|Study terminated by sponsor|11|||
25178334|NCT01511419|50323428|FG000|Dose 2|Physician Decision|1|||
25178335|NCT01511419|50323429|FG001|Dose 2|Physician Decision|0|||
25178336|NCT01511107|50323491|FG000|Overall Study|Ineligible|3|||
25178337|NCT01511107|50323492|FG001|Overall Study|Ineligible|2|||
25178338|NCT01511107|50323491|FG000|Overall Study|Lost to Follow-up|10|||
25178339|NCT01511107|50323492|FG001|Overall Study|Lost to Follow-up|19|||
25178340|NCT01511107|50323491|FG000|Overall Study|Withdrawal by Subject|9|||
25178341|NCT01511107|50323492|FG001|Overall Study|Withdrawal by Subject|20|||
25178342|NCT01484977|50323527|FG000|Overall Study|Adverse Event|8|||
25178343|NCT01484977|50323527|FG000|Overall Study|Lack of Efficacy|4|||
25178344|NCT01484977|50323527|FG000|Overall Study|Protocol Violation|6|||
25178345|NCT01484977|50323527|FG000|Overall Study|Lost to Follow-up|1|||
25178346|NCT01484977|50323527|FG000|Overall Study|Withdrawal by Subject|4|||
25178347|NCT01484977|50323527|FG000|Overall Study|Subject Protocol Non-compliant|1|||
25178348|NCT01484977|50323527|FG000|Overall Study|Moving Overseas|1|||
25178349|NCT01484977|50323527|FG000|Overall Study|Low White Blood Cell Count|1|||
25178350|NCT01484977|50323527|FG000|Overall Study|Lack of Compliance|1|||
25178351|NCT01475825|50323607|FG000|Overall Study|Adverse Event|41|||
25178352|NCT01475825|50323608|FG001|Overall Study|Adverse Event|15|||
25178353|NCT01475825|50323609|FG002|Overall Study|Adverse Event|27|||
25178354|NCT01475825|50323610|FG003|Overall Study|Adverse Event|11|||
25178355|NCT01475825|50323607|FG000|Overall Study|Death|1|||
25178356|NCT01475825|50323608|FG001|Overall Study|Death|0|||
25178357|NCT01475825|50323609|FG002|Overall Study|Death|1|||
25178358|NCT01475825|50323610|FG003|Overall Study|Death|0|||
25178359|NCT01475825|50323607|FG000|Overall Study|Lack of Efficacy|0|||
25178360|NCT01475825|50323608|FG001|Overall Study|Lack of Efficacy|0|||
25125345|NCT02263508|50238206|FG002|Overall Study|Withdrawal by Subject|17|||
25178361|NCT01475825|50323609|FG002|Overall Study|Lack of Efficacy|1|||
25178362|NCT01475825|50323610|FG003|Overall Study|Lack of Efficacy|0|||
25178363|NCT01475825|50323607|FG000|Overall Study|Lost to Follow-up|0|||
25178364|NCT01475825|50323608|FG001|Overall Study|Lost to Follow-up|0|||
25178365|NCT01475825|50323609|FG002|Overall Study|Lost to Follow-up|3|||
25178366|NCT01475825|50323610|FG003|Overall Study|Lost to Follow-up|1|||
25178367|NCT01475825|50323607|FG000|Overall Study|Non-compliance with Study Drug|1|||
25178368|NCT01475825|50323608|FG001|Overall Study|Non-compliance with Study Drug|2|||
25178369|NCT01475825|50323609|FG002|Overall Study|Non-compliance with Study Drug|4|||
25178370|NCT01475825|50323610|FG003|Overall Study|Non-compliance with Study Drug|0|||
25178371|NCT01475825|50323607|FG000|Overall Study|Other: Not available|0|||
25178372|NCT01475825|50323608|FG001|Overall Study|Other: Not available|0|||
25178373|NCT01475825|50323609|FG002|Overall Study|Other: Not available|2|||
25178374|NCT01475825|50323610|FG003|Overall Study|Other: Not available|0|||
25178375|NCT01475825|50323607|FG000|Overall Study|Protocol Violation|1|||
25178376|NCT01475825|50323608|FG001|Overall Study|Protocol Violation|0|||
25178377|NCT01475825|50323609|FG002|Overall Study|Protocol Violation|0|||
25178378|NCT01475825|50323610|FG003|Overall Study|Protocol Violation|0|||
25178379|NCT01475825|50323607|FG000|Overall Study|Physician Decision|0|||
25178380|NCT01475825|50323608|FG001|Overall Study|Physician Decision|1|||
25178381|NCT01475825|50323609|FG002|Overall Study|Physician Decision|0|||
25178382|NCT01475825|50323610|FG003|Overall Study|Physician Decision|0|||
25178383|NCT01475825|50323607|FG000|Overall Study|Withdrawal by Subject|8|||
25178384|NCT01475825|50323608|FG001|Overall Study|Withdrawal by Subject|3|||
25178385|NCT01475825|50323609|FG002|Overall Study|Withdrawal by Subject|11|||
25178386|NCT01475825|50323610|FG003|Overall Study|Withdrawal by Subject|7|||
25178387|NCT01475825|50323607|FG000|Overall Study|Did not enter OLC|15|||
25178388|NCT01475825|50323608|FG001|Overall Study|Did not enter OLC|11|||
25178389|NCT01475825|50323609|FG002|Overall Study|Did not enter OLC|15|||
25178390|NCT01475825|50323610|FG003|Overall Study|Did not enter OLC|11|||
25178391|NCT01484431|50323632|FG000|Period 1: High Dose|Physician Decision|0|||
25178392|NCT01484431|50323633|FG001|Period 1: High Dose|Physician Decision|1|||
25266658|NCT00977431|50580874|FG000|Overall Study|Protocol Violation|0|||
25266659|NCT00977431|50580875|FG001|Overall Study|Protocol Violation|0|||
25266660|NCT00977431|50580876|FG002|Overall Study|Protocol Violation|1|||
25266661|NCT00977431|50580877|FG003|Overall Study|Protocol Violation|0|||
25266662|NCT00977431|50580878|FG004|Overall Study|Protocol Violation|0|||
25266663|NCT00977431|50580874|FG000|Overall Study|Adverse Event|3|||
25266664|NCT00977431|50580875|FG001|Overall Study|Adverse Event|0|||
25266665|NCT00977431|50580876|FG002|Overall Study|Adverse Event|4|||
25266666|NCT00977431|50580877|FG003|Overall Study|Adverse Event|0|||
25266667|NCT00977431|50580878|FG004|Overall Study|Adverse Event|6|||
25266668|NCT00977431|50580874|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
25266669|NCT00977431|50580875|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
25266670|NCT00977431|50580876|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
25266671|NCT00977431|50580877|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
25266672|NCT00977431|50580878|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
25266673|NCT00977431|50580874|FG000|Overall Study|Progressive disease|2|||
25266674|NCT00977431|50580875|FG001|Overall Study|Progressive disease|6|||
25266675|NCT00977431|50580876|FG002|Overall Study|Progressive disease|1|||
25266676|NCT00977431|50580877|FG003|Overall Study|Progressive disease|3|||
25266677|NCT00977431|50580878|FG004|Overall Study|Progressive disease|5|||
25266678|NCT00977197|50580896|FG000|Overall Study|Withdrawal by Subject|3|||
25266679|NCT00977197|50580897|FG001|Overall Study|Withdrawal by Subject|4|||
25266680|NCT00977197|50580896|FG000|Overall Study|Adverse Event|3|||
25266681|NCT00977197|50580897|FG001|Overall Study|Adverse Event|1|||
25266682|NCT00977197|50580896|FG000|Overall Study|Lack of Efficacy|1|||
25266683|NCT00977197|50580897|FG001|Overall Study|Lack of Efficacy|0|||
25266684|NCT00977197|50580896|FG000|Overall Study|Lost to Follow-up|1|||
25266685|NCT00977197|50580897|FG001|Overall Study|Lost to Follow-up|3|||
25266686|NCT00977197|50580896|FG000|Overall Study|Nonadherence|1|||
25266687|NCT00977197|50580897|FG001|Overall Study|Nonadherence|1|||
25266688|NCT00974311|50580905|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
25266689|NCT00974311|50580906|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
25266690|NCT00974311|50580905|FG000|DB Phase (up to 24 Months)|Death|561|||
25266691|NCT00974311|50580906|FG001|DB Phase (up to 24 Months)|Death|298|||
25266692|NCT00974311|50580905|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
25266693|NCT00974311|50580906|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
25266694|NCT00974311|50580905|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
25266695|NCT00974311|50580906|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
25266696|NCT00974311|50580905|FG000|DB Phase (up to 24 Months)|Other|1|||
25266697|NCT00974311|50580906|FG001|DB Phase (up to 24 Months)|Other|0|||
25266698|NCT00974311|50580905|FG000|OLE Phase (up to 77 Months)|Death|14|||
25266699|NCT00974311|50580906|FG001|OLE Phase (up to 77 Months)|Death|21|||
25266700|NCT00974311|50580905|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
25009228|NCT00075725|50102303|FG009|Overall Study|MRD positive after extended ind|0|||
25178393|NCT01484431|50323634|FG002|Period 1: High Dose|Physician Decision|0|||
25178394|NCT01484431|50323632|FG000|Period 2|Death|0|||
25178395|NCT01484431|50323633|FG001|Period 2|Death|1|||
25178396|NCT01484431|50323634|FG002|Period 2|Death|1|||
25178397|NCT01484431|50323632|FG000|Period 2|Physician Decision|0|||
25266701|NCT00974311|50580906|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
25266702|NCT00974311|50580905|FG000|OLE Phase (up to 77 Months)|Other|15|||
25266703|NCT00974311|50580906|FG001|OLE Phase (up to 77 Months)|Other|2|||
25266704|NCT00974311|50580905|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
25266705|NCT00974311|50580906|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
25266706|NCT00974233|50580915|FG000|Induction Chemoimmunotherapy|Death|2|||
25266707|NCT00974233|50580915|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
25266708|NCT00974233|50580915|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
25266709|NCT00974233|50580915|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
25266710|NCT00974233|50580915|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
25266711|NCT00974233|50580915|FG000|Maintenance Lenalidomide|Adverse Event|8|||
25266712|NCT00973921|50580927|FG000|Overall Study|IVUS results were not available|9|||
25266713|NCT00972595|50580931|FG000|Period 1|Adverse Event|1|||
25266714|NCT00972595|50580932|FG001|Period 1|Adverse Event|0|||
25266715|NCT01196091|50580941|FG000|Overall Study|Adverse Event|22|||
25266716|NCT01196091|50580942|FG001|Overall Study|Adverse Event|27|||
25266717|NCT01196091|50580943|FG002|Overall Study|Adverse Event|26|||
25266718|NCT01196091|50580941|FG000|Overall Study|Death|3|||
25266719|NCT01196091|50580942|FG001|Overall Study|Death|2|||
25266720|NCT01196091|50580943|FG002|Overall Study|Death|2|||
25266721|NCT01196091|50580941|FG000|Overall Study|Entry Criteria Not Met|11|||
25266722|NCT01196091|50580942|FG001|Overall Study|Entry Criteria Not Met|11|||
25266723|NCT01196091|50580943|FG002|Overall Study|Entry Criteria Not Met|10|||
25266724|NCT01196091|50580941|FG000|Overall Study|Lack of Efficacy|15|||
25266725|NCT01196091|50580942|FG001|Overall Study|Lack of Efficacy|12|||
25266726|NCT01196091|50580943|FG002|Overall Study|Lack of Efficacy|17|||
25266727|NCT01196091|50580941|FG000|Overall Study|Lost to Follow-up|5|||
25266728|NCT01196091|50580942|FG001|Overall Study|Lost to Follow-up|5|||
25266729|NCT01196091|50580943|FG002|Overall Study|Lost to Follow-up|6|||
25266730|NCT01196091|50580941|FG000|Overall Study|Parent/Caregiver Decision|0|||
25266731|NCT01196091|50580942|FG001|Overall Study|Parent/Caregiver Decision|0|||
25266732|NCT01196091|50580943|FG002|Overall Study|Parent/Caregiver Decision|1|||
25266733|NCT01196091|50580941|FG000|Overall Study|Withdrawal by Subject|16|||
25266734|NCT01196091|50580942|FG001|Overall Study|Withdrawal by Subject|19|||
25266735|NCT01196091|50580943|FG002|Overall Study|Withdrawal by Subject|22|||
25266736|NCT01196091|50580941|FG000|Overall Study|Physician Decision|3|||
25266737|NCT01196091|50580942|FG001|Overall Study|Physician Decision|3|||
25266738|NCT01196091|50580943|FG002|Overall Study|Physician Decision|4|||
25266739|NCT01196091|50580941|FG000|Overall Study|Protocol Violation|1|||
25266740|NCT01196091|50580942|FG001|Overall Study|Protocol Violation|3|||
25266741|NCT01196091|50580943|FG002|Overall Study|Protocol Violation|3|||
25266742|NCT01196091|50580941|FG000|Overall Study|Sponsor Decision|6|||
25266743|NCT01196091|50580942|FG001|Overall Study|Sponsor Decision|5|||
25266744|NCT01196091|50580943|FG002|Overall Study|Sponsor Decision|4|||
25266745|NCT01196091|50580941|FG000|Overall Study|Excluded Site|5|||
25266746|NCT01196091|50580942|FG001|Overall Study|Excluded Site|11|||
25266747|NCT01196091|50580943|FG002|Overall Study|Excluded Site|8|||
25266748|NCT01196091|50580941|FG000|Overall Study|Randomized, No Study Drug Received|1|||
25266749|NCT01196091|50580942|FG001|Overall Study|Randomized, No Study Drug Received|0|||
25266750|NCT01196091|50580943|FG002|Overall Study|Randomized, No Study Drug Received|1|||
25266751|NCT01195623|50580958|FG000|Overall Study|Lost to Follow-up|35|||
25266752|NCT01195623|50580959|FG001|Overall Study|Lost to Follow-up|37|||
25266753|NCT01195545|50580965|FG000|Overall Study|Protocol Violation|4|||
25266754|NCT01194999|50580969|FG000|Overall Study|Lost to Follow-up|17|||
25266755|NCT01194531|50580975|FG000|Overall Study|Withdrawal by Subject|1|||
25266756|NCT01194531|50580976|FG001|Overall Study|Withdrawal by Subject|0|||
25266757|NCT01194531|50580975|FG000|Overall Study|Protocol Violation|4|||
25266758|NCT01194531|50580976|FG001|Overall Study|Protocol Violation|1|||
25266759|NCT01194531|50580975|FG000|Overall Study|Physician Decision|0|||
25266760|NCT01194531|50580976|FG001|Overall Study|Physician Decision|2|||
25266761|NCT00972517|50580982|FG000|Overall Study|Adverse Event|0|||
25266762|NCT00972517|50580983|FG001|Overall Study|Adverse Event|0|||
25266763|NCT00972517|50580984|FG002|Overall Study|Adverse Event|0|||
25266764|NCT00972517|50580985|FG003|Overall Study|Adverse Event|1|||
25266765|NCT00972517|50580986|FG004|Overall Study|Adverse Event|0|||
25266766|NCT00972517|50580987|FG005|Overall Study|Adverse Event|0|||
25266767|NCT00972517|50580982|FG000|Overall Study|Withdrawal by Subject|0|||
25266768|NCT00972517|50580983|FG001|Overall Study|Withdrawal by Subject|1|||
25266769|NCT00972517|50580984|FG002|Overall Study|Withdrawal by Subject|0|||
25266770|NCT00972517|50580985|FG003|Overall Study|Withdrawal by Subject|2|||
25266771|NCT00972517|50580986|FG004|Overall Study|Withdrawal by Subject|1|||
25266772|NCT00972517|50580987|FG005|Overall Study|Withdrawal by Subject|0|||
25266773|NCT00972283|50581009|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
25266774|NCT00972283|50581010|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
25266775|NCT00972283|50581009|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
25266776|NCT00972283|50581010|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
25125346|NCT02263508|50238204|FG000|Overall Study|Sponsor Decision|12|||
25266777|NCT00972283|50581009|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
25266778|NCT00972283|50581010|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
25266779|NCT00972283|50581009|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
25266780|NCT00972283|50581010|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
25266781|NCT00972283|50581009|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
25266782|NCT00972283|50581010|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
25266783|NCT00972283|50581009|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
25266784|NCT00972283|50581010|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
25266785|NCT00972283|50581009|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
25266786|NCT00972283|50581010|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
25266787|NCT00972283|50581009|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
25266788|NCT00972283|50581010|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
25266789|NCT00972283|50581009|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
25266790|NCT00972283|50581010|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
25266791|NCT00972283|50581009|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
25266792|NCT00972283|50581010|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
25266793|NCT00969709|50581020|FG000|Overall Study|Adverse Event|3|||
25266794|NCT00969709|50581021|FG001|Overall Study|Adverse Event|13|||
25266795|NCT00969709|50581022|FG002|Overall Study|Adverse Event|26|||
25266796|NCT00969709|50581023|FG003|Overall Study|Adverse Event|12|||
25266797|NCT00969709|50581020|FG000|Overall Study|Lack of Efficacy|7|||
25266798|NCT00969709|50581021|FG001|Overall Study|Lack of Efficacy|4|||
25266799|NCT00969709|50581022|FG002|Overall Study|Lack of Efficacy|1|||
25266800|NCT00969709|50581023|FG003|Overall Study|Lack of Efficacy|3|||
25266801|NCT00969709|50581020|FG000|Overall Study|Protocol Violation|9|||
25266802|NCT00969709|50581021|FG001|Overall Study|Protocol Violation|5|||
25266803|NCT00969709|50581022|FG002|Overall Study|Protocol Violation|9|||
25178398|NCT01484431|50323633|FG001|Period 2|Physician Decision|0|||
25178399|NCT01484431|50323634|FG002|Period 2|Physician Decision|1|||
25178400|NCT01484431|50323632|FG000|Period 2|Non-Compliance with Study Drug|1|||
25178401|NCT01484431|50323633|FG001|Period 2|Non-Compliance with Study Drug|0|||
25178402|NCT01484431|50323634|FG002|Period 2|Non-Compliance with Study Drug|0|||
25178403|NCT01473953|50323682|FG000|Overall Study|Other|1|||
25178404|NCT01473953|50323683|FG001|Overall Study|Other|0|||
25178405|NCT01473953|50323684|FG002|Overall Study|Other|0|||
25178406|NCT01473953|50323685|FG003|Overall Study|Other|0|||
25178407|NCT01473953|50323686|FG004|Overall Study|Other|0|||
25178408|NCT01510717|50323700|FG000|Overall Study|Adverse Event|1|||
25178409|NCT01510717|50323701|FG001|Overall Study|Adverse Event|2|||
25178410|NCT01510717|50323700|FG000|Overall Study|Death|1|||
25178411|NCT01510717|50323701|FG001|Overall Study|Death|0|||
25178412|NCT01510717|50323700|FG000|Overall Study|Lost to Follow-up|0|||
25178413|NCT01510717|50323701|FG001|Overall Study|Lost to Follow-up|1|||
25178414|NCT01510717|50323700|FG000|Overall Study|Withdrawal by Subject|0|||
25178415|NCT01510717|50323701|FG001|Overall Study|Withdrawal by Subject|2|||
25178416|NCT01473563|50323717|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
25178417|NCT01484275|50323735|FG000|Overall Study|Study terminated by sponsor|28|||
25178418|NCT01484275|50323736|FG001|Overall Study|Study terminated by sponsor|32|||
25178419|NCT01484275|50323735|FG000|Overall Study|Other|10|||
25178420|NCT01484275|50323736|FG001|Overall Study|Other|0|||
25178421|NCT01484275|50323735|FG000|Overall Study|Death|3|||
25178422|NCT01484275|50323736|FG001|Overall Study|Death|4|||
25178423|NCT01484275|50323735|FG000|Overall Study|Withdrawal by Subject|1|||
25178424|NCT01484275|50323736|FG001|Overall Study|Withdrawal by Subject|5|||
25178425|NCT01484275|50323735|FG000|Overall Study|Lost to Follow-up|1|||
25266804|NCT00969709|50581023|FG003|Overall Study|Protocol Violation|10|||
25266805|NCT00969709|50581020|FG000|Overall Study|Withdrawal by Subject|9|||
25266806|NCT00969709|50581021|FG001|Overall Study|Withdrawal by Subject|12|||
25266807|NCT00969709|50581022|FG002|Overall Study|Withdrawal by Subject|11|||
25266808|NCT00969709|50581023|FG003|Overall Study|Withdrawal by Subject|23|||
25266809|NCT00969709|50581020|FG000|Overall Study|Lost to Follow-up|10|||
25266810|NCT00969709|50581021|FG001|Overall Study|Lost to Follow-up|14|||
25266811|NCT00969709|50581022|FG002|Overall Study|Lost to Follow-up|8|||
25266812|NCT00969709|50581023|FG003|Overall Study|Lost to Follow-up|15|||
25266813|NCT00969709|50581020|FG000|Overall Study|Other reasons|0|||
25266814|NCT00969709|50581021|FG001|Overall Study|Other reasons|0|||
25266815|NCT00969709|50581022|FG002|Overall Study|Other reasons|3|||
25266816|NCT00969709|50581023|FG003|Overall Study|Other reasons|0|||
25266817|NCT01193517|50581040|FG000|Overall Study|Early Progression|1|||
25266818|NCT01193517|50581041|FG001|Overall Study|Early Progression|0|||
25266819|NCT01193517|50581042|FG002|Overall Study|Early Progression|0|||
25266820|NCT01193283|50581051|FG000|Overall Study|Death|1|||
25266821|NCT00971425|50581057|FG000|Overall Study|Adverse Event|1|||
25178426|NCT01484275|50323736|FG001|Overall Study|Lost to Follow-up|1|||
25266822|NCT00971425|50581058|FG001|Overall Study|Adverse Event|1|||
25178427|NCT01544335|50323742|FG000|Overall Study|Lost to Follow-up|27|||
25178428|NCT01544335|50323742|FG000|Overall Study|Death|4|||
25178429|NCT01544335|50323742|FG000|Overall Study|Disease progression|3|||
25178430|NCT01544335|50323742|FG000|Overall Study|Baseline Measurements not Available|19|||
25178431|NCT01484197|50323746|FG000|Treatment Period 1|Adverse Event|1|||
25178432|NCT01484197|50323747|FG001|Treatment Period 1|Adverse Event|0|||
25266823|NCT00971425|50581057|FG000|Overall Study|Withdrawal by Subject|0|||
25266824|NCT00971425|50581058|FG001|Overall Study|Withdrawal by Subject|1|||
25266825|NCT01193127|50581068|FG000|Randomized|Surgery Cancelled|0|||
25266826|NCT01193127|50581069|FG001|Randomized|Surgery Cancelled|0|||
25266827|NCT01193127|50581070|FG002|Randomized|Surgery Cancelled|0|||
25266828|NCT01193127|50581071|FG003|Randomized|Surgery Cancelled|1|||
25266829|NCT01193127|50581068|FG000|Treated|Withdrawal by Subject|0|||
25266830|NCT01193127|50581069|FG001|Treated|Withdrawal by Subject|0|||
25266831|NCT01193127|50581070|FG002|Treated|Withdrawal by Subject|0|||
25266832|NCT01193127|50581071|FG003|Treated|Withdrawal by Subject|1|||
25266833|NCT01192815|50581083|FG000|Overall Study|Withdrawal by Subject|1|||
25266834|NCT01192815|50581083|FG000|Overall Study|Lack of Efficacy|1|||
25266835|NCT01192347|50581087|FG000|Overall Study|Death|3|||
25266836|NCT01192347|50581087|FG000|Overall Study|Lost to Follow-up|3|||
25266837|NCT01192347|50581087|FG000|Overall Study|Withdrawal by Subject|1|||
25266838|NCT01192347|50581087|FG000|Overall Study|Adverse Event|1|||
25266839|NCT01192347|50581087|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
25266840|NCT01192347|50581087|FG000|Overall Study|Patient seen in different hospital|1|||
25266841|NCT01192347|50581087|FG000|Overall Study|Patient not visiting hospital regularly|1|||
25266842|NCT01192347|50581087|FG000|Overall Study|Patient did not show up for visits|1|||
25266843|NCT01192191|50581093|FG000|Overall Study|Adverse Event|7|||
25266844|NCT01192191|50581094|FG001|Overall Study|Adverse Event|12|||
25266845|NCT01192191|50581093|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
25266846|NCT01192191|50581094|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
25266847|NCT01192191|50581093|FG000|Overall Study|Lost to Follow-up|0|||
25266848|NCT01192191|50581094|FG001|Overall Study|Lost to Follow-up|1|||
25266849|NCT01192191|50581093|FG000|Overall Study|Withdrawal by Subject|1|||
25266850|NCT01192191|50581094|FG001|Overall Study|Withdrawal by Subject|6|||
25266851|NCT01307267|50581123|FG000|Overall Study|Death|4|||
25266852|NCT01307267|50581124|FG001|Overall Study|Death|3|||
25125347|NCT02263508|50238205|FG001|Overall Study|Sponsor Decision|165|||
25125348|NCT02263508|50238206|FG002|Overall Study|Sponsor Decision|182|||
25125349|NCT02263508|50238204|FG000|Overall Study|Lost to Follow-up|2|||
25125350|NCT02263508|50238205|FG001|Overall Study|Lost to Follow-up|7|||
25125351|NCT02263508|50238206|FG002|Overall Study|Lost to Follow-up|7|||
25125352|NCT02263508|50238204|FG000|Overall Study|Death|6|||
25125353|NCT02263508|50238205|FG001|Overall Study|Death|151|||
25125354|NCT02263508|50238206|FG002|Overall Study|Death|140|||
25125355|NCT02291432|50238217|FG000|Overall Study|Withdrawal by Subject|2|||
25125356|NCT02290340|50238225|FG000|Overall Study|Lost to Follow-up|0|||
25125357|NCT02290340|50238226|FG001|Overall Study|Lost to Follow-up|0|||
25125358|NCT02290340|50238227|FG002|Overall Study|Lost to Follow-up|0|||
25125359|NCT02290340|50238228|FG003|Overall Study|Lost to Follow-up|1|||
25125360|NCT02290340|50238225|FG000|Overall Study|Withdrawal by Subject|1|||
25125361|NCT02290340|50238226|FG001|Overall Study|Withdrawal by Subject|0|||
25125362|NCT02290340|50238227|FG002|Overall Study|Withdrawal by Subject|0|||
25125363|NCT02290340|50238228|FG003|Overall Study|Withdrawal by Subject|0|||
25125364|NCT02290340|50238225|FG000|Overall Study|Other|1|||
25125365|NCT02290340|50238226|FG001|Overall Study|Other|0|||
25125366|NCT02290340|50238227|FG002|Overall Study|Other|0|||
25125367|NCT02290340|50238228|FG003|Overall Study|Other|1|||
25125368|NCT02290028|50238241|FG000|Overall Study|Death|217|||
25125369|NCT02290028|50238241|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
25125370|NCT02290028|50238241|FG000|Overall Study|No longer under care of study physician|76|||
25125371|NCT02290028|50238241|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
25125372|NCT02290028|50238241|FG000|Overall Study|Withdrawal by Subject|52|||
25125373|NCT02290028|50238241|FG000|Overall Study|Study site closure|44|||
25125374|NCT02290028|50238241|FG000|Overall Study|Lost to Follow-up|34|||
25125375|NCT02290028|50238241|FG000|Overall Study|Miscellaneous|10|||
25125376|NCT02290028|50238241|FG000|Overall Study|Transition to EP PASSION|1295|||
25125377|NCT02290028|50238241|FG000|Overall Study|Planned study completion at 12 months|257|||
25125378|NCT01741792|50238251|FG000|Overall Study|Death|6|||
25266853|NCT01307267|50581125|FG002|Overall Study|Death|5|||
25266854|NCT01307267|50581126|FG003|Overall Study|Death|3|||
25266855|NCT01307267|50581127|FG004|Overall Study|Death|1|||
25266856|NCT01307267|50581128|FG005|Overall Study|Death|26|||
25266857|NCT01307267|50581129|FG006|Overall Study|Death|2|||
25266858|NCT01307267|50581130|FG007|Overall Study|Death|2|||
25125379|NCT01741792|50238252|FG001|Overall Study|Death|1|||
25125380|NCT01741792|50238253|FG002|Overall Study|Death|12|||
25125381|NCT02289950|50238269|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
25125382|NCT02289950|50238270|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
25266859|NCT01307267|50581131|FG008|Overall Study|Death|21|||
25125383|NCT02289950|50238269|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
25125384|NCT02289950|50238270|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
25266860|NCT01307267|50581132|FG009|Overall Study|Death|2|||
25266861|NCT01307267|50581133|FG010|Overall Study|Death|3|||
25125385|NCT02289950|50238269|FG000|Overall Study|Lost to Follow-up|1|||
25125386|NCT02289950|50238270|FG001|Overall Study|Lost to Follow-up|0|||
25125387|NCT02289950|50238269|FG000|Overall Study|Physician Decision|9|||
25125388|NCT02289950|50238270|FG001|Overall Study|Physician Decision|3|||
25125389|NCT02289950|50238269|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
25125390|NCT02289950|50238270|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
25125391|NCT02289950|50238269|FG000|Overall Study|Withdrawal by Subject|1|||
25125392|NCT02289950|50238270|FG001|Overall Study|Withdrawal by Subject|3|||
25125393|NCT02289950|50238269|FG000|Overall Study|Test article held for greater than 28 days|0|||
25125394|NCT02289950|50238270|FG001|Overall Study|Test article held for greater than 28 days|1|||
25125395|NCT02289950|50238269|FG000|Overall Study|Adverse Event|11|||
25125396|NCT02289950|50238270|FG001|Overall Study|Adverse Event|3|||
25266862|NCT01307267|50581134|FG011|Overall Study|Death|9|||
25266863|NCT01307267|50581135|FG012|Overall Study|Death|0|||
25266864|NCT01307267|50581136|FG013|Overall Study|Death|0|||
25266865|NCT01307267|50581137|FG014|Overall Study|Death|0|||
25266866|NCT01307267|50581138|FG015|Overall Study|Death|0|||
25266867|NCT01307267|50581139|FG016|Overall Study|Death|1|||
25266868|NCT01307267|50581140|FG017|Overall Study|Death|1|||
25266869|NCT01307267|50581141|FG018|Overall Study|Death|2|||
25266870|NCT01307267|50581142|FG019|Overall Study|Death|8|||
25266871|NCT01307267|50581143|FG020|Overall Study|Death|1|||
25266872|NCT01307267|50581144|FG021|Overall Study|Death|2|||
25266873|NCT01307267|50581145|FG022|Overall Study|Death|2|||
25266874|NCT01307267|50581123|FG000|Overall Study|Lost to Follow-up|0|||
25266875|NCT01307267|50581124|FG001|Overall Study|Lost to Follow-up|0|||
25266876|NCT01307267|50581125|FG002|Overall Study|Lost to Follow-up|0|||
25266877|NCT01307267|50581126|FG003|Overall Study|Lost to Follow-up|0|||
25266878|NCT01307267|50581127|FG004|Overall Study|Lost to Follow-up|0|||
25266879|NCT01307267|50581128|FG005|Overall Study|Lost to Follow-up|7|||
25266880|NCT01307267|50581129|FG006|Overall Study|Lost to Follow-up|0|||
25266881|NCT01307267|50581130|FG007|Overall Study|Lost to Follow-up|0|||
25266882|NCT01307267|50581131|FG008|Overall Study|Lost to Follow-up|1|||
25266883|NCT01307267|50581132|FG009|Overall Study|Lost to Follow-up|2|||
25266884|NCT01307267|50581133|FG010|Overall Study|Lost to Follow-up|1|||
25266885|NCT01307267|50581134|FG011|Overall Study|Lost to Follow-up|0|||
25266886|NCT01307267|50581135|FG012|Overall Study|Lost to Follow-up|0|||
25266887|NCT01307267|50581136|FG013|Overall Study|Lost to Follow-up|0|||
25266888|NCT01307267|50581137|FG014|Overall Study|Lost to Follow-up|0|||
25266889|NCT01307267|50581138|FG015|Overall Study|Lost to Follow-up|0|||
25266890|NCT01307267|50581139|FG016|Overall Study|Lost to Follow-up|0|||
25266891|NCT01307267|50581140|FG017|Overall Study|Lost to Follow-up|0|||
25266892|NCT01307267|50581141|FG018|Overall Study|Lost to Follow-up|0|||
25266893|NCT01307267|50581142|FG019|Overall Study|Lost to Follow-up|2|||
25266894|NCT01307267|50581143|FG020|Overall Study|Lost to Follow-up|0|||
25266895|NCT01307267|50581144|FG021|Overall Study|Lost to Follow-up|0|||
25266896|NCT01307267|50581145|FG022|Overall Study|Lost to Follow-up|0|||
25266897|NCT01307267|50581123|FG000|Overall Study|Withdrawal by Subject|0|||
25266898|NCT01307267|50581124|FG001|Overall Study|Withdrawal by Subject|0|||
25266899|NCT01307267|50581125|FG002|Overall Study|Withdrawal by Subject|0|||
25266900|NCT01307267|50581126|FG003|Overall Study|Withdrawal by Subject|0|||
25266901|NCT01307267|50581127|FG004|Overall Study|Withdrawal by Subject|0|||
25266902|NCT01307267|50581128|FG005|Overall Study|Withdrawal by Subject|1|||
25266903|NCT01307267|50581129|FG006|Overall Study|Withdrawal by Subject|0|||
25266904|NCT01307267|50581130|FG007|Overall Study|Withdrawal by Subject|1|||
25266905|NCT01307267|50581131|FG008|Overall Study|Withdrawal by Subject|5|||
25266906|NCT01307267|50581132|FG009|Overall Study|Withdrawal by Subject|1|||
25125397|NCT02289950|50238269|FG000|Overall Study|Death|1|||
25125398|NCT02289950|50238270|FG001|Overall Study|Death|1|||
25178433|NCT01484197|50323748|FG002|Treatment Period 1|Adverse Event|0|||
25178434|NCT01484197|50323749|FG003|Treatment Period 1|Adverse Event|0|||
25178435|NCT01484197|50323746|FG000|Treatment Period 2|Subject withdrew consent|0|||
25178436|NCT01484197|50323747|FG001|Treatment Period 2|Subject withdrew consent|0|||
25178437|NCT01484197|50323748|FG002|Treatment Period 2|Subject withdrew consent|0|||
25178438|NCT01484197|50323749|FG003|Treatment Period 2|Subject withdrew consent|1|||
25266907|NCT01307267|50581133|FG010|Overall Study|Withdrawal by Subject|1|||
25266908|NCT01307267|50581134|FG011|Overall Study|Withdrawal by Subject|1|||
25266909|NCT01307267|50581135|FG012|Overall Study|Withdrawal by Subject|0|||
25266910|NCT01307267|50581136|FG013|Overall Study|Withdrawal by Subject|0|||
25125399|NCT02289950|50238269|FG000|Overall Study|Other|5|||
25266911|NCT01307267|50581137|FG014|Overall Study|Withdrawal by Subject|0|||
25266912|NCT01307267|50581138|FG015|Overall Study|Withdrawal by Subject|0|||
25266913|NCT01307267|50581139|FG016|Overall Study|Withdrawal by Subject|0|||
25266914|NCT01307267|50581140|FG017|Overall Study|Withdrawal by Subject|0|||
25266915|NCT01307267|50581141|FG018|Overall Study|Withdrawal by Subject|0|||
25266916|NCT01307267|50581142|FG019|Overall Study|Withdrawal by Subject|3|||
25178439|NCT01473407|50323761|FG000|Overall Study|Physician Decision|1|||
25266917|NCT01307267|50581143|FG020|Overall Study|Withdrawal by Subject|0|||
25266918|NCT01307267|50581144|FG021|Overall Study|Withdrawal by Subject|0|||
25266919|NCT01307267|50581145|FG022|Overall Study|Withdrawal by Subject|0|||
25266920|NCT01307267|50581123|FG000|Overall Study|Other|0|||
25266921|NCT01307267|50581124|FG001|Overall Study|Other|0|||
25266922|NCT01307267|50581125|FG002|Overall Study|Other|0|||
25266923|NCT01307267|50581126|FG003|Overall Study|Other|0|||
25178440|NCT01473407|50323762|FG001|Overall Study|Physician Decision|4|||
25178441|NCT01473407|50323761|FG000|Overall Study|Lost to Follow-up|10|||
25178442|NCT01473407|50323762|FG001|Overall Study|Lost to Follow-up|4|||
25266924|NCT01307267|50581127|FG004|Overall Study|Other|0|||
25266925|NCT01307267|50581128|FG005|Overall Study|Other|7|||
25266926|NCT01307267|50581129|FG006|Overall Study|Other|0|||
25266927|NCT01307267|50581130|FG007|Overall Study|Other|1|||
25266928|NCT01307267|50581131|FG008|Overall Study|Other|3|||
25266929|NCT01307267|50581132|FG009|Overall Study|Other|0|||
25266930|NCT01307267|50581133|FG010|Overall Study|Other|1|||
25266931|NCT01307267|50581134|FG011|Overall Study|Other|1|||
25266932|NCT01307267|50581135|FG012|Overall Study|Other|1|||
25266933|NCT01307267|50581136|FG013|Overall Study|Other|0|||
25266934|NCT01307267|50581137|FG014|Overall Study|Other|2|||
25266935|NCT01307267|50581138|FG015|Overall Study|Other|1|||
25266936|NCT01307267|50581139|FG016|Overall Study|Other|0|||
25266937|NCT01307267|50581140|FG017|Overall Study|Other|0|||
25266938|NCT01307267|50581141|FG018|Overall Study|Other|0|||
25266939|NCT01307267|50581142|FG019|Overall Study|Other|19|||
25266940|NCT01307267|50581143|FG020|Overall Study|Other|2|||
25266941|NCT01307267|50581144|FG021|Overall Study|Other|3|||
25266942|NCT01307267|50581145|FG022|Overall Study|Other|2|||
25266943|NCT01307111|50581207|FG000|IUD Insertion|Lost to Follow-up|2|||
25266944|NCT01307111|50581208|FG001|IUD Insertion|Lost to Follow-up|0|||
25266945|NCT01307111|50581207|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
25266946|NCT01307111|50581208|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
25266947|NCT01306877|50581216|FG000|Overall Study|Lost to Follow-up|3|||
25266948|NCT01306877|50581217|FG001|Overall Study|Lost to Follow-up|3|||
25266949|NCT01306877|50581216|FG000|Overall Study|Physician Decision|0|||
25266950|NCT01306877|50581217|FG001|Overall Study|Physician Decision|1|||
25266951|NCT01191801|50581225|FG000|Overall Study|Death|36|||
25266952|NCT01191801|50581226|FG001|Overall Study|Death|12|||
25266953|NCT01191801|50581225|FG000|Overall Study|Lack of Efficacy|176|||
25266954|NCT01191801|50581226|FG001|Overall Study|Lack of Efficacy|258|||
25266955|NCT01191801|50581225|FG000|Overall Study|Adverse Event|9|||
25266956|NCT01191801|50581226|FG001|Overall Study|Adverse Event|8|||
25266957|NCT01191801|50581225|FG000|Overall Study|Protocol Violation|2|||
25266958|NCT01191801|50581226|FG001|Overall Study|Protocol Violation|4|||
25266959|NCT01191801|50581225|FG000|Overall Study|Physician Decision|47|||
25266960|NCT01191801|50581226|FG001|Overall Study|Physician Decision|24|||
25266961|NCT01191801|50581225|FG000|Overall Study|Withdrawal by Subject|1|||
25266962|NCT01191801|50581226|FG001|Overall Study|Withdrawal by Subject|4|||
25266963|NCT01191801|50581225|FG000|Overall Study|Not Provided|45|||
25266964|NCT01191801|50581226|FG001|Overall Study|Not Provided|27|||
25266965|NCT01306643|50581232|FG000|Overall Study|Adverse Event|5|||
25266966|NCT01306643|50581232|FG000|Overall Study|Disease Progression|7|||
25266967|NCT01306643|50581232|FG000|Overall Study|Other: Change in Eligibility Status|1|||
25266968|NCT01306331|50581238|FG000|Overall Study|Adverse Event|28|||
25266969|NCT01306331|50581239|FG001|Overall Study|Adverse Event|25|||
25266970|NCT01306331|50581238|FG000|Overall Study|Lost to Follow-up|321|||
25266971|NCT01306331|50581239|FG001|Overall Study|Lost to Follow-up|323|||
25009229|NCT00075725|50102304|FG010|Overall Study|MRD positive after extended ind|0|||
25009230|NCT00075725|50102305|FG011|Overall Study|MRD positive after extended ind|0|||
25009231|NCT00075725|50102294|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
25009232|NCT00075725|50102295|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
25009233|NCT00075725|50102296|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
25009234|NCT00075725|50102297|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
25009235|NCT00075725|50102298|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
25009236|NCT00075725|50102299|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
25125400|NCT02289950|50238270|FG001|Overall Study|Other|2|||
25178443|NCT01473407|50323761|FG000|Overall Study|Adverse Event|8|||
25178444|NCT01473407|50323762|FG001|Overall Study|Adverse Event|8|||
25178445|NCT01473407|50323761|FG000|Overall Study|Randomization Error|3|||
25266972|NCT01306331|50581238|FG000|Overall Study|Physician Decision|26|||
25178446|NCT01473407|50323762|FG001|Overall Study|Randomization Error|1|||
25178447|NCT01473407|50323761|FG000|Overall Study|Withdrawal by Subject|4|||
25178448|NCT01473407|50323762|FG001|Overall Study|Withdrawal by Subject|7|||
25178449|NCT01473407|50323761|FG000|Overall Study|Kidney Transplant|7|||
25266973|NCT01306331|50581239|FG001|Overall Study|Physician Decision|22|||
25266974|NCT01306331|50581238|FG000|Overall Study|Pregnancy|136|||
25266975|NCT01306331|50581239|FG001|Overall Study|Pregnancy|151|||
25266976|NCT01306331|50581238|FG000|Overall Study|Protocol Violation|154|||
25266977|NCT01306331|50581239|FG001|Overall Study|Protocol Violation|124|||
25266978|NCT01306331|50581238|FG000|Overall Study|Withdrawal by Subject|163|||
25266979|NCT01306331|50581239|FG001|Overall Study|Withdrawal by Subject|152|||
25266980|NCT01306331|50581238|FG000|Overall Study|Not sexually active|29|||
25266981|NCT01306331|50581239|FG001|Overall Study|Not sexually active|28|||
25266982|NCT01306331|50581238|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
25266983|NCT01306331|50581239|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
25266984|NCT01306331|50581238|FG000|Overall Study|Other|34|||
25266985|NCT01306331|50581239|FG001|Overall Study|Other|32|||
25266986|NCT01306253|50581247|FG000|Overall Study|Lost to Follow-up|1|||
25125401|NCT02289950|50238269|FG000|Overall Study|Not Treated|2|||
25125402|NCT02289950|50238270|FG001|Overall Study|Not Treated|1|||
25125403|NCT01741012|50238276|FG000|Overall Study|Lost to Follow-up|1|||
25125404|NCT01741012|50238276|FG000|Overall Study|Withdrawal by Subject|2|||
25125405|NCT02288312|50238284|FG000|Overall Study|Pregnancy|1|||
25125406|NCT02288312|50238285|FG001|Overall Study|Pregnancy|0|||
25125407|NCT02288312|50238286|FG002|Overall Study|Pregnancy|0|||
25125408|NCT01740388|50238296|FG000|Overall Study|Withdrawal by Subject|1|||
25125409|NCT01740388|50238297|FG001|Overall Study|Withdrawal by Subject|2|||
25125410|NCT01740388|50238296|FG000|Overall Study|Lost to Follow-up|2|||
25125411|NCT01740388|50238297|FG001|Overall Study|Lost to Follow-up|0|||
25125412|NCT01740388|50238296|FG000|Overall Study|Physician Decision|2|||
25125413|NCT01740388|50238297|FG001|Overall Study|Physician Decision|6|||
25125414|NCT01740388|50238296|FG000|Overall Study|Subjects missing data, completed|41|||
25125415|NCT01740388|50238297|FG001|Overall Study|Subjects missing data, completed|36|||
25125416|NCT01740154|50238303|FG000|Overall Study|Adverse Event|1|||
25125417|NCT02287922|50238311|FG000|Overall Study|Adverse Event|1|||
25125418|NCT02287922|50238312|FG001|Overall Study|Adverse Event|1|||
25125419|NCT02287922|50238313|FG002|Overall Study|Adverse Event|3|||
25125420|NCT02287922|50238314|FG003|Overall Study|Adverse Event|4|||
25125421|NCT02287922|50238311|FG000|Overall Study|Withdrawal by Subject|1|||
25125422|NCT02287922|50238312|FG001|Overall Study|Withdrawal by Subject|1|||
25125423|NCT02287922|50238313|FG002|Overall Study|Withdrawal by Subject|1|||
25125424|NCT02287922|50238314|FG003|Overall Study|Withdrawal by Subject|2|||
25125425|NCT02287922|50238311|FG000|Overall Study|Lost to Follow-up|0|||
25125426|NCT02287922|50238312|FG001|Overall Study|Lost to Follow-up|0|||
25125427|NCT02287922|50238313|FG002|Overall Study|Lost to Follow-up|1|||
25125428|NCT02287922|50238314|FG003|Overall Study|Lost to Follow-up|0|||
25125429|NCT02287922|50238311|FG000|Overall Study|Sponsor's decision|0|||
25125430|NCT02287922|50238312|FG001|Overall Study|Sponsor's decision|0|||
25125431|NCT02287922|50238313|FG002|Overall Study|Sponsor's decision|0|||
25125432|NCT02287922|50238314|FG003|Overall Study|Sponsor's decision|1|||
25125433|NCT02287922|50238311|FG000|Overall Study|Other|1|||
25125434|NCT02287922|50238312|FG001|Overall Study|Other|0|||
25125435|NCT02287922|50238313|FG002|Overall Study|Other|2|||
25125436|NCT02287922|50238314|FG003|Overall Study|Other|0|||
25125437|NCT02287610|50238325|FG000|Overall Study|Lost to Follow-up|3|||
25125438|NCT02287610|50238325|FG000|Overall Study|Withdrawal by Subject|8|||
25125439|NCT02287610|50238325|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
25125440|NCT02262728|50238331|FG000|Follow-up Phase (3 Years)|Death|0|||
25125441|NCT02262728|50238332|FG001|Follow-up Phase (3 Years)|Death|1|||
25125442|NCT02262728|50238331|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
25125443|NCT02262728|50238332|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
25125444|NCT02262728|50238331|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
25125445|NCT02262728|50238332|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
25125446|NCT02262260|50238340|FG000|Overall Study|Adverse Event|4|||
25125447|NCT02262260|50238341|FG001|Overall Study|Adverse Event|1|||
25125448|NCT02262260|50238340|FG000|Overall Study|Withdrawal of consent|4|||
25125449|NCT02262260|50238341|FG001|Overall Study|Withdrawal of consent|2|||
25125450|NCT02262260|50238340|FG000|Overall Study|Lost to Follow-up|1|||
25125451|NCT02262260|50238341|FG001|Overall Study|Lost to Follow-up|2|||
25125452|NCT02262260|50238340|FG000|Overall Study|Protocol deviation|2|||
25125453|NCT02262260|50238341|FG001|Overall Study|Protocol deviation|5|||
25125454|NCT02285270|50238347|FG000|Overall Study|Lost to Follow-up|1|||
25125455|NCT02285270|50238347|FG000|Overall Study|Physician Decision|3|||
25125456|NCT02285270|50238347|FG000|Overall Study|Determined to be ineligible|1|||
25125457|NCT01717768|50238361|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
25178450|NCT01473407|50323762|FG001|Overall Study|Kidney Transplant|6|||
25125458|NCT01717768|50238362|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
25125459|NCT01717768|50238363|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
25125460|NCT01717768|50238364|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
25178451|NCT01473407|50323761|FG000|Overall Study|Vacation/Travel|1|||
25178452|NCT01473407|50323762|FG001|Overall Study|Vacation/Travel|1|||
25178453|NCT01473407|50323761|FG000|Overall Study|Elevated Hemoglobin|1|||
25178454|NCT01473407|50323762|FG001|Overall Study|Elevated Hemoglobin|0|||
25178455|NCT01473407|50323761|FG000|Overall Study|Patient Received Aranesp|1|||
25178456|NCT01473407|50323762|FG001|Overall Study|Patient Received Aranesp|0|||
25178457|NCT01473407|50323761|FG000|Overall Study|Patient Lost Green Card Status|1|||
25125461|NCT01717768|50238365|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
25125462|NCT01717768|50238366|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
25178458|NCT01473407|50323762|FG001|Overall Study|Patient Lost Green Card Status|0|||
25178459|NCT01473407|50323761|FG000|Overall Study|Temperature Excursion|2|||
25266987|NCT01306253|50581248|FG001|Overall Study|Lost to Follow-up|1|||
25266988|NCT01305941|50581254|FG000|Overall Study|Adverse Event|6|||
25266989|NCT01305941|50581254|FG000|Overall Study|Clinical decline|2|||
25266990|NCT01305941|50581254|FG000|Overall Study|Withdrawal by Subject|1|||
25266991|NCT01305941|50581254|FG000|Overall Study|Death|1|||
25266992|NCT01305239|50581258|FG000|Overall Study|Adverse Event|22|||
25266993|NCT01305239|50581258|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
25266994|NCT01194219|50581264|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
25266995|NCT01194219|50581265|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
25266996|NCT01194219|50581266|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
25266997|NCT01194219|50581267|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
25266998|NCT01194219|50581268|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
25266999|NCT01194219|50581269|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
25267000|NCT01194219|50581270|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
25267001|NCT01194219|50581271|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
25267002|NCT01194219|50581272|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
25267003|NCT01194219|50581273|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
25267004|NCT01194219|50581264|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
25267005|NCT01194219|50581265|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
25267006|NCT01194219|50581266|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
25267007|NCT01194219|50581267|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
25267008|NCT01194219|50581268|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
25267009|NCT01194219|50581269|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
25267010|NCT01194219|50581270|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
25267011|NCT01194219|50581271|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
25267012|NCT01194219|50581272|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
25267013|NCT01194219|50581273|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
25267014|NCT01194219|50581264|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
25267015|NCT01194219|50581265|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
25267016|NCT01194219|50581266|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
25267017|NCT01194219|50581267|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
25267018|NCT01194219|50581268|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
25267019|NCT01194219|50581269|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
25267020|NCT01194219|50581270|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
25267021|NCT01194219|50581271|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
25267022|NCT01194219|50581272|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
25267023|NCT01194219|50581273|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
25267024|NCT01194219|50581264|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
25267025|NCT01194219|50581265|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
25267026|NCT01194219|50581266|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
25267027|NCT01194219|50581267|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
25267028|NCT01194219|50581268|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
25267029|NCT01194219|50581269|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
25267030|NCT01194219|50581270|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
25267031|NCT01194219|50581271|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
25267032|NCT01194219|50581272|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
25267033|NCT01194219|50581273|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
25267034|NCT01194219|50581264|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
25267035|NCT01194219|50581265|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
25267036|NCT01194219|50581266|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
25267037|NCT01194219|50581267|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
25267038|NCT01194219|50581268|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
25267039|NCT01194219|50581269|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
25267040|NCT01194219|50581270|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
25267041|NCT01194219|50581271|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
25267042|NCT01194219|50581272|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
25267043|NCT01194219|50581273|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
25267044|NCT01194219|50581264|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
25267045|NCT01194219|50581265|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
25267046|NCT01194219|50581266|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
25267047|NCT01194219|50581267|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
25267048|NCT01194219|50581268|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
25267049|NCT01194219|50581269|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
25267050|NCT01194219|50581270|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
25267051|NCT01194219|50581271|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
25267052|NCT01194219|50581272|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
25267053|NCT01194219|50581273|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
25267054|NCT01194219|50581264|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
25267055|NCT01194219|50581265|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
25267056|NCT01194219|50581266|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
25267057|NCT01194219|50581267|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
25267058|NCT01194219|50581268|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
25267059|NCT01194219|50581269|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
25267060|NCT01194219|50581270|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
25267061|NCT01194219|50581271|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
25267062|NCT01194219|50581272|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
25267063|NCT01194219|50581273|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
25267064|NCT01194219|50581264|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
25267065|NCT01194219|50581265|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
25267066|NCT01194219|50581266|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
25267067|NCT01194219|50581267|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
25267068|NCT01194219|50581268|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
25267069|NCT01194219|50581269|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
25267070|NCT01194219|50581270|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
25267071|NCT01194219|50581271|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
25267072|NCT01194219|50581272|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
25267073|NCT01194219|50581273|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
25267074|NCT01194219|50581264|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
25267075|NCT01194219|50581265|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
25267076|NCT01194219|50581266|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
25267077|NCT01194219|50581267|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
25267078|NCT01194219|50581268|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
25267079|NCT01194219|50581269|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
25267080|NCT01194219|50581270|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
25267081|NCT01194219|50581271|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
25267082|NCT01194219|50581272|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
25267083|NCT01194219|50581273|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
25267084|NCT01194219|50581264|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
25267085|NCT01194219|50581265|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
25267086|NCT01194219|50581266|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
25267087|NCT01194219|50581267|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
25267088|NCT01194219|50581268|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
25267089|NCT01194219|50581269|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
25267090|NCT01194219|50581270|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
25267091|NCT01194219|50581271|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
25267092|NCT01194219|50581272|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
25267093|NCT01194219|50581273|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
25267094|NCT01194219|50581264|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
25267095|NCT01194219|50581265|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
25267096|NCT01194219|50581266|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
25267097|NCT01194219|50581267|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
25267098|NCT01194219|50581268|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
25267099|NCT01194219|50581269|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
25267100|NCT01194219|50581270|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
25267101|NCT01194219|50581271|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
25267102|NCT01194219|50581272|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
25267103|NCT01194219|50581273|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
25267104|NCT01194219|50581264|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
25267105|NCT01194219|50581265|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
25267106|NCT01194219|50581266|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
25267107|NCT01194219|50581267|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
25267108|NCT01194219|50581268|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
25267109|NCT01194219|50581269|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
25267110|NCT01194219|50581270|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
25267111|NCT01194219|50581271|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
25267112|NCT01194219|50581272|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
25267113|NCT01194219|50581273|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
25267114|NCT01194219|50581264|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
25267115|NCT01194219|50581265|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
25267116|NCT01194219|50581266|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
25267117|NCT01194219|50581267|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
25267118|NCT01194219|50581268|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
25267119|NCT01194219|50581269|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
25267120|NCT01194219|50581270|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
25267121|NCT01194219|50581271|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
25267122|NCT01194219|50581272|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
25267123|NCT01194219|50581273|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
25267124|NCT01194219|50581264|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
25267125|NCT01194219|50581265|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
25267126|NCT01194219|50581266|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
25267127|NCT01194219|50581267|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
25267128|NCT01194219|50581268|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
25267129|NCT01194219|50581269|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
25267130|NCT01194219|50581270|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
25267131|NCT01194219|50581271|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
25267132|NCT01194219|50581272|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
25267133|NCT01194219|50581273|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
25267134|NCT01194219|50581264|FG000|Maintenance Phase Weeks16-32|Other|0|||
25267135|NCT01194219|50581265|FG001|Maintenance Phase Weeks16-32|Other|0|||
25267136|NCT01194219|50581266|FG002|Maintenance Phase Weeks16-32|Other|2|||
25267137|NCT01194219|50581267|FG003|Maintenance Phase Weeks16-32|Other|1|||
25267138|NCT01194219|50581268|FG004|Maintenance Phase Weeks16-32|Other|0|||
25267139|NCT01194219|50581269|FG005|Maintenance Phase Weeks16-32|Other|0|||
25267140|NCT01194219|50581270|FG006|Maintenance Phase Weeks16-32|Other|0|||
25267141|NCT01194219|50581271|FG007|Maintenance Phase Weeks16-32|Other|0|||
25125463|NCT01717768|50238367|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
25125464|NCT01717768|50238368|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
25125465|NCT01717768|50238369|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
25125466|NCT01717768|50238370|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
25125467|NCT01717768|50238371|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
25125468|NCT01717768|50238372|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
25125469|NCT01717768|50238361|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
25125470|NCT01717768|50238362|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
25125471|NCT01717768|50238363|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
25125472|NCT01717768|50238364|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
25125473|NCT01717768|50238365|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
25125474|NCT01717768|50238366|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
25125475|NCT01717768|50238367|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
25125476|NCT01717768|50238368|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
25125477|NCT01717768|50238369|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
25125478|NCT01717768|50238370|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
25125479|NCT01717768|50238371|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
25125480|NCT01717768|50238372|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
25125481|NCT01717768|50238361|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
25125482|NCT01717768|50238362|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
25125483|NCT01717768|50238363|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
25125484|NCT01717768|50238364|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
25125485|NCT01717768|50238365|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
25125486|NCT01717768|50238366|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
25125487|NCT01717768|50238367|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
25125488|NCT01717768|50238368|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
25125489|NCT01717768|50238369|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
25125490|NCT01717768|50238370|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
25125491|NCT01717768|50238371|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
25178460|NCT01473407|50323762|FG001|Overall Study|Temperature Excursion|3|||
25178461|NCT01473407|50323761|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
25178462|NCT01473407|50323762|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
25178463|NCT01473407|50323761|FG000|Overall Study|Sponsor's Decision|10|||
25178464|NCT01473407|50323762|FG001|Overall Study|Sponsor's Decision|10|||
25178465|NCT01473407|50323761|FG000|Overall Study|Site Closure|1|||
25178466|NCT01473407|50323762|FG001|Overall Study|Site Closure|0|||
25178467|NCT01472939|50323772|FG000|Overall Study|Adverse Event|3|||
25178468|NCT01472939|50323773|FG001|Overall Study|Adverse Event|7|||
25178469|NCT01472939|50323774|FG002|Overall Study|Adverse Event|7|||
25267142|NCT01194219|50581272|FG008|Maintenance Phase Weeks16-32|Other|0|||
25267143|NCT01194219|50581273|FG009|Maintenance Phase Weeks16-32|Other|0|||
25267144|NCT01194219|50581264|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
25267145|NCT01194219|50581265|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
25267146|NCT01194219|50581266|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
25267147|NCT01194219|50581267|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
25267148|NCT01194219|50581268|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
25267149|NCT01194219|50581269|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
25267150|NCT01194219|50581270|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
25267151|NCT01194219|50581271|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
25267152|NCT01194219|50581272|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
25267153|NCT01194219|50581273|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
25267154|NCT01194219|50581264|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
25267155|NCT01194219|50581265|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
25267156|NCT01194219|50581266|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
25267157|NCT01194219|50581267|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
25267158|NCT01194219|50581268|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
25267159|NCT01194219|50581269|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
25267160|NCT01194219|50581270|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
25267161|NCT01194219|50581271|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
25267162|NCT01194219|50581272|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
25267163|NCT01194219|50581273|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
25267164|NCT01194219|50581264|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
25267165|NCT01194219|50581265|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
25267166|NCT01194219|50581266|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
25267167|NCT01194219|50581267|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
25267168|NCT01194219|50581268|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
25267169|NCT01194219|50581269|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
25267170|NCT01194219|50581270|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
25267171|NCT01194219|50581271|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
25267172|NCT01194219|50581272|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
25267173|NCT01194219|50581273|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
25267174|NCT01194219|50581264|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
25267175|NCT01194219|50581265|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
25267176|NCT01194219|50581266|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
25267177|NCT01194219|50581267|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
25267178|NCT01194219|50581268|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
25267179|NCT01194219|50581269|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
25267180|NCT01194219|50581270|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
25267181|NCT01194219|50581271|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
25267182|NCT01194219|50581272|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
25267183|NCT01194219|50581273|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
25267184|NCT01194219|50581264|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
25267185|NCT01194219|50581265|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
25267186|NCT01194219|50581266|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
25267187|NCT01194219|50581267|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
25267188|NCT01194219|50581268|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
25267189|NCT01194219|50581269|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
25267190|NCT01194219|50581270|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
25267191|NCT01194219|50581271|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
25267192|NCT01194219|50581272|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
25267193|NCT01194219|50581273|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
25267194|NCT01194219|50581264|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
25267195|NCT01194219|50581265|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
25125492|NCT01717768|50238372|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
25009237|NCT00075725|50102300|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
25267196|NCT01194219|50581266|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
25267197|NCT01194219|50581267|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
25267198|NCT01194219|50581268|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
25267199|NCT01194219|50581269|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
25267200|NCT01194219|50581270|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
25267201|NCT01194219|50581271|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
25267202|NCT01194219|50581272|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
25267203|NCT01194219|50581273|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
25267204|NCT01194219|50581264|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
25267205|NCT01194219|50581265|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
25267206|NCT01194219|50581266|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
25267207|NCT01194219|50581267|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
25267208|NCT01194219|50581268|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
25267209|NCT01194219|50581269|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
25267210|NCT01194219|50581270|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
25267211|NCT01194219|50581271|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
25267212|NCT01194219|50581272|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
25267213|NCT01194219|50581273|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
25267214|NCT01194219|50581264|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
25267215|NCT01194219|50581265|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
25267216|NCT01194219|50581266|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
25267217|NCT01194219|50581267|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
25267218|NCT01194219|50581268|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
25267219|NCT01194219|50581269|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
25267220|NCT01194219|50581270|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
25267221|NCT01194219|50581271|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
25267222|NCT01194219|50581272|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
25125493|NCT01717768|50238361|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
25125494|NCT01717768|50238362|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
25125495|NCT01717768|50238363|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
25125496|NCT01717768|50238364|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
25125497|NCT01717768|50238365|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
25125498|NCT01717768|50238366|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
25125499|NCT01717768|50238367|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
25125500|NCT01717768|50238368|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
25125501|NCT01717768|50238369|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
25125502|NCT01717768|50238370|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
25125503|NCT01717768|50238371|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
25125504|NCT01717768|50238372|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
25125505|NCT02260934|50238400|FG000|Overall Study|Lost to Follow-up|2|||
25125506|NCT02260934|50238401|FG001|Overall Study|Lost to Follow-up|1|||
25267223|NCT01194219|50581273|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
25267224|NCT01194219|50581264|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
25267225|NCT01194219|50581265|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
25267226|NCT01194219|50581266|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
25267227|NCT01194219|50581267|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
25267228|NCT01194219|50581268|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
25267229|NCT01194219|50581269|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
25267230|NCT01194219|50581270|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
25267231|NCT01194219|50581271|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
25267232|NCT01194219|50581272|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
25267233|NCT01194219|50581273|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
25267234|NCT01194219|50581264|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
25267235|NCT01194219|50581265|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
25267236|NCT01194219|50581266|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
25267237|NCT01194219|50581267|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
25267238|NCT01194219|50581268|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
25267239|NCT01194219|50581269|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
25267240|NCT01194219|50581270|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
25267241|NCT01194219|50581271|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
25267242|NCT01194219|50581272|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
25267243|NCT01194219|50581273|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
25267244|NCT01194219|50581264|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
25125507|NCT02260934|50238400|FG000|Overall Study|Withdrawal by Subject|0|||
25267245|NCT01194219|50581265|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
25267246|NCT01194219|50581266|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
25267247|NCT01194219|50581267|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
25267248|NCT01194219|50581268|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
25267249|NCT01194219|50581269|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
25267250|NCT01194219|50581270|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
25267251|NCT01194219|50581271|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
25267252|NCT01194219|50581272|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
25267253|NCT01194219|50581273|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
25267254|NCT01194219|50581264|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
25267255|NCT01194219|50581265|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
25267256|NCT01194219|50581266|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
25267257|NCT01194219|50581267|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
25267258|NCT01194219|50581268|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
25267259|NCT01194219|50581269|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
25267260|NCT01194219|50581270|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
25267261|NCT01194219|50581271|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
25267262|NCT01194219|50581272|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
25267263|NCT01194219|50581273|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
25267264|NCT01194219|50581264|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
25267265|NCT01194219|50581265|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
25267266|NCT01194219|50581266|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
25267267|NCT01194219|50581267|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
25267268|NCT01194219|50581268|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
25267269|NCT01194219|50581269|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
25267270|NCT01194219|50581270|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
25267271|NCT01194219|50581271|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
25267272|NCT01194219|50581272|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
25267273|NCT01194219|50581273|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
25267274|NCT01194219|50581264|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
25267275|NCT01194219|50581265|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
25267276|NCT01194219|50581266|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
25267277|NCT01194219|50581267|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
25267278|NCT01194219|50581268|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
25267279|NCT01194219|50581269|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
25125508|NCT02260934|50238401|FG001|Overall Study|Withdrawal by Subject|2|||
25125509|NCT02260934|50238400|FG000|Overall Study|Participant Relocated|1|||
25125510|NCT02260934|50238401|FG001|Overall Study|Participant Relocated|0|||
25125511|NCT02260934|50238400|FG000|Overall Study|Site error|0|||
25125512|NCT02260934|50238401|FG001|Overall Study|Site error|1|||
25125513|NCT02260388|50238418|FG000|Overall Study|Lost to Follow-up|2|||
25125514|NCT02260388|50238419|FG001|Overall Study|Lost to Follow-up|8|||
25125515|NCT02260388|50238420|FG002|Overall Study|Lost to Follow-up|3|||
25125516|NCT02260388|50238421|FG003|Overall Study|Lost to Follow-up|4|||
25125517|NCT02260154|50238431|FG000|Overall Study|Screening failure|2|||
25125518|NCT02284178|50238438|FG000|Overall Study|Met exclusion criteria|49|||
25125519|NCT02284178|50238439|FG001|Overall Study|Met exclusion criteria|54|||
25125520|NCT01643408|50238445|FG000|Overall Study|Adverse Event|12|||
25125521|NCT01643408|50238445|FG000|Overall Study|Other|2|||
25125522|NCT02283788|50238453|FG000|Overall Study|Adverse Event|1|||
25125523|NCT02283788|50238454|FG001|Overall Study|Adverse Event|3|||
25125524|NCT02283788|50238455|FG002|Overall Study|Adverse Event|5|||
25125525|NCT02283788|50238456|FG003|Overall Study|Adverse Event|1|||
25125526|NCT02283788|50238453|FG000|Overall Study|Withdrawal by Subject|0|||
25125527|NCT02283788|50238454|FG001|Overall Study|Withdrawal by Subject|1|||
25125528|NCT02283788|50238455|FG002|Overall Study|Withdrawal by Subject|0|||
25125529|NCT02283788|50238456|FG003|Overall Study|Withdrawal by Subject|1|||
25125530|NCT01739764|50238469|FG000|Overall Study|Adverse Event|0|||
25125531|NCT01739764|50238470|FG001|Overall Study|Adverse Event|3|||
25125532|NCT01739764|50238471|FG002|Overall Study|Adverse Event|4|||
25125533|NCT01739764|50238469|FG000|Overall Study|Death|4|||
25125534|NCT01739764|50238470|FG001|Overall Study|Death|6|||
25125535|NCT01739764|50238471|FG002|Overall Study|Death|38|||
25125536|NCT01739764|50238469|FG000|Overall Study|Lost to Follow-up|0|||
25267280|NCT01194219|50581270|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
25267281|NCT01194219|50581271|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
25267282|NCT01194219|50581272|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
25125537|NCT01739764|50238470|FG001|Overall Study|Lost to Follow-up|0|||
25125538|NCT01739764|50238471|FG002|Overall Study|Lost to Follow-up|5|||
25125539|NCT01739764|50238469|FG000|Overall Study|Non-Compliance|0|||
25125540|NCT01739764|50238470|FG001|Overall Study|Non-Compliance|0|||
25125541|NCT01739764|50238471|FG002|Overall Study|Non-Compliance|1|||
25125542|NCT01739764|50238469|FG000|Overall Study|Multiple Reasons|3|||
25125543|NCT01739764|50238470|FG001|Overall Study|Multiple Reasons|2|||
25125544|NCT01739764|50238471|FG002|Overall Study|Multiple Reasons|3|||
25125545|NCT01739764|50238469|FG000|Overall Study|Physician Decision|2|||
25125546|NCT01739764|50238470|FG001|Overall Study|Physician Decision|2|||
25125547|NCT01739764|50238471|FG002|Overall Study|Physician Decision|4|||
25125548|NCT01739764|50238469|FG000|Overall Study|Progressive Disease|3|||
25125549|NCT01739764|50238470|FG001|Overall Study|Progressive Disease|5|||
25267283|NCT01194219|50581273|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
25267284|NCT01194219|50581264|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
25267285|NCT01194219|50581265|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
25267286|NCT01194219|50581266|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
25267287|NCT01194219|50581267|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
25267288|NCT01194219|50581268|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
25267289|NCT01194219|50581269|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
25267290|NCT01194219|50581270|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
25267291|NCT01194219|50581271|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
25267292|NCT01194219|50581272|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
25267293|NCT01194219|50581273|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
25267294|NCT01304693|50581301|FG000|Overall Study|Adverse Event|0|||
25267295|NCT01304693|50581302|FG001|Overall Study|Adverse Event|0|||
25267296|NCT01304693|50581303|FG002|Overall Study|Adverse Event|0|||
25267297|NCT01304693|50581304|FG003|Overall Study|Adverse Event|0|||
25267298|NCT01304693|50581305|FG004|Overall Study|Adverse Event|1|||
25267299|NCT01304693|50581301|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
25267300|NCT01304693|50581302|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
25267301|NCT01304693|50581303|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
25267302|NCT01304693|50581304|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
25267303|NCT01304693|50581305|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
25267304|NCT01304147|50581317|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
25267305|NCT01304147|50581318|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
25267306|NCT01303445|50581324|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
25267307|NCT01303445|50581325|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
25267308|NCT01303445|50581324|FG000|Second Intervention (7 Days)|Adverse Event|0|||
25267309|NCT01303445|50581325|FG001|Second Intervention (7 Days)|Adverse Event|2|||
25267310|NCT01303445|50581324|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
25267311|NCT01303445|50581325|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
25267312|NCT01303445|50581324|FG000|Washout (14 Days)|Protocol Violation|1|||
25267313|NCT01303445|50581325|FG001|Washout (14 Days)|Protocol Violation|0|||
25267314|NCT01303445|50581324|FG000|Washout (14 Days)|Lost to Follow-up|0|||
25267315|NCT01303445|50581325|FG001|Washout (14 Days)|Lost to Follow-up|2|||
25267316|NCT01303445|50581324|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
25267317|NCT01303445|50581325|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
25267318|NCT01303445|50581324|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
25125550|NCT01739764|50238471|FG002|Overall Study|Progressive Disease|16|||
25125551|NCT01739764|50238469|FG000|Overall Study|Protocol Violation|0|||
25125552|NCT01739764|50238470|FG001|Overall Study|Protocol Violation|0|||
25125553|NCT01739764|50238471|FG002|Overall Study|Protocol Violation|2|||
25125554|NCT01739764|50238469|FG000|Overall Study|Study Terminated by Sponsor|8|||
25125555|NCT01739764|50238470|FG001|Overall Study|Study Terminated by Sponsor|13|||
25125556|NCT01739764|50238471|FG002|Overall Study|Study Terminated by Sponsor|26|||
25125557|NCT01739764|50238469|FG000|Overall Study|Withdrawal by Subject|6|||
25125558|NCT01739764|50238470|FG001|Overall Study|Withdrawal by Subject|5|||
25125559|NCT01739764|50238471|FG002|Overall Study|Withdrawal by Subject|27|||
25125560|NCT01700530|50238482|FG000|Overall Study|Withdrawal by Subject|0|||
25125561|NCT01700530|50238483|FG001|Overall Study|Withdrawal by Subject|3|||
25125562|NCT01700530|50238484|FG002|Overall Study|Withdrawal by Subject|1|||
25125563|NCT01700140|50238495|FG000|Overall Study|Use of rescue drugs|3|||
25125564|NCT01700140|50238496|FG001|Overall Study|Use of rescue drugs|3|||
25125565|NCT01700140|50238497|FG002|Overall Study|Use of rescue drugs|1|||
25125566|NCT01700140|50238495|FG000|Overall Study|Discontinuation of radiotherapy|1|||
25125567|NCT01700140|50238496|FG001|Overall Study|Discontinuation of radiotherapy|0|||
25125568|NCT01700140|50238497|FG002|Overall Study|Discontinuation of radiotherapy|0|||
25125569|NCT01700140|50238495|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
25125570|NCT01700140|50238496|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
25125571|NCT01700140|50238497|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
25125572|NCT01700140|50238495|FG000|Overall Study|Aggravation of symptoms|1|||
25125573|NCT01700140|50238496|FG001|Overall Study|Aggravation of symptoms|0|||
25267319|NCT01303445|50581325|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
25125574|NCT01700140|50238497|FG002|Overall Study|Aggravation of symptoms|0|||
25125575|NCT01700140|50238495|FG000|Overall Study|Adverse Event|0|||
25125576|NCT01700140|50238496|FG001|Overall Study|Adverse Event|1|||
25267320|NCT01188681|50581339|FG000|Overall Study|bladder cancer|0|||
25125577|NCT01700140|50238497|FG002|Overall Study|Adverse Event|0|||
25125578|NCT01700140|50238495|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
25125579|NCT01700140|50238496|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
25125580|NCT01700140|50238497|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
25125581|NCT01717456|50238510|FG000|End of Treatment|Physician Decision|0|||
25125582|NCT01717456|50238511|FG001|End of Treatment|Physician Decision|1|||
25125583|NCT01717456|50238510|FG000|End of Treatment|Lost to Follow-up|0|||
25267321|NCT01188681|50581340|FG001|Overall Study|bladder cancer|0|||
25267322|NCT01188681|50581341|FG002|Overall Study|bladder cancer|1|||
25267323|NCT01188681|50581342|FG003|Overall Study|bladder cancer|0|||
25267324|NCT01188681|50581339|FG000|Overall Study|Withdrawal by Subject|0|||
25267325|NCT01188681|50581340|FG001|Overall Study|Withdrawal by Subject|0|||
25267326|NCT01188681|50581341|FG002|Overall Study|Withdrawal by Subject|0|||
25267327|NCT01188681|50581342|FG003|Overall Study|Withdrawal by Subject|1|||
25267328|NCT01302899|50581358|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
25267329|NCT01302899|50581359|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
25267330|NCT01302899|50581358|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
25267331|NCT01302899|50581359|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
25267332|NCT01187901|50581371|FG000|Overall Study|Protocol Violation|1|||
25267333|NCT01187901|50581372|FG001|Overall Study|Protocol Violation|0|||
25267334|NCT01187901|50581371|FG000|Overall Study|Lost to Follow-up|1|||
25267335|NCT01187901|50581372|FG001|Overall Study|Lost to Follow-up|2|||
25267336|NCT01187901|50581371|FG000|Overall Study|Unrelated Health Reasons|1|||
25267337|NCT01187901|50581372|FG001|Overall Study|Unrelated Health Reasons|2|||
25267338|NCT01187901|50581371|FG000|Overall Study|Suspected Allergic Reaction|1|||
25267339|NCT01187901|50581372|FG001|Overall Study|Suspected Allergic Reaction|1|||
25267340|NCT01187901|50581371|FG000|Overall Study|Adverse Event|3|||
25267341|NCT01187901|50581372|FG001|Overall Study|Adverse Event|0|||
25267342|NCT01187901|50581371|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
25267343|NCT01187901|50581372|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
25267344|NCT01187901|50581371|FG000|Overall Study|Pregnancy|0|||
25267345|NCT01187901|50581372|FG001|Overall Study|Pregnancy|2|||
25267346|NCT01302119|50581380|FG000|Overall Study|Withdrawal by Subject|30|||
25267347|NCT01302119|50581381|FG001|Overall Study|Withdrawal by Subject|20|||
25267348|NCT01302119|50581380|FG000|Overall Study|Lost to Follow-up|10|||
25267349|NCT01302119|50581381|FG001|Overall Study|Lost to Follow-up|4|||
25267350|NCT01302119|50581380|FG000|Overall Study|Adverse Event|2|||
25267351|NCT01302119|50581381|FG001|Overall Study|Adverse Event|1|||
25267352|NCT01302119|50581380|FG000|Overall Study|Non-compliance|4|||
25267353|NCT01302119|50581381|FG001|Overall Study|Non-compliance|2|||
25267354|NCT01302119|50581380|FG000|Overall Study|Non-specific|4|||
25267355|NCT01302119|50581381|FG001|Overall Study|Non-specific|1|||
25267356|NCT01302041|50581387|FG000|Overall Study|Death|5|||
25267357|NCT01302041|50581387|FG000|Overall Study|Withdrawal by Subject|4|||
25267358|NCT01302041|50581387|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
25267359|NCT01302041|50581387|FG000|Overall Study|Other-Miscellaneous Reason|2|||
25267360|NCT01301729|50581392|FG000|Overall Study|Withdrawal by Subject|2|||
25267361|NCT01301729|50581392|FG000|Overall Study|Participant did not Return for Treatment|1|||
25267362|NCT01301729|50581392|FG000|Overall Study|Violated Selection Criteria|1|||
25267363|NCT01187043|50581402|FG000|Overall Study|Adverse Event|0|||
25267364|NCT01187043|50581403|FG001|Overall Study|Adverse Event|0|||
25267365|NCT01187043|50581404|FG002|Overall Study|Adverse Event|0|||
25267366|NCT01187043|50581405|FG003|Overall Study|Adverse Event|0|||
25267367|NCT01187043|50581406|FG004|Overall Study|Adverse Event|1|||
25267368|NCT01187043|50581402|FG000|Overall Study|Unable to make scheduled visits|1|||
25267369|NCT01187043|50581403|FG001|Overall Study|Unable to make scheduled visits|0|||
25267370|NCT01187043|50581404|FG002|Overall Study|Unable to make scheduled visits|4|||
25267371|NCT01187043|50581405|FG003|Overall Study|Unable to make scheduled visits|0|||
25267372|NCT01187043|50581406|FG004|Overall Study|Unable to make scheduled visits|1|||
25267373|NCT01186809|50581418|FG000|Overall Study|Death|30|||
25267374|NCT01186419|50581424|FG000|Overall Study|Withdrawal by Subject|5|||
25267375|NCT01186419|50581425|FG001|Overall Study|Withdrawal by Subject|3|||
25267376|NCT01186419|50581424|FG000|Overall Study|Adverse Event|1|||
25267377|NCT01186419|50581425|FG001|Overall Study|Adverse Event|2|||
25267378|NCT01186419|50581424|FG000|Overall Study|Physician Decision|0|||
25267379|NCT01186419|50581425|FG001|Overall Study|Physician Decision|3|||
25267380|NCT01186419|50581424|FG000|Overall Study|Other|1|||
25267381|NCT01186419|50581425|FG001|Overall Study|Other|1|||
25267382|NCT01301027|50581432|FG000|Overall Study|Physician Decision|2|||
25267383|NCT01301027|50581433|FG001|Overall Study|Physician Decision|0|||
25267384|NCT01301027|50581432|FG000|Overall Study|Withdrawal by Subject|2|||
25267385|NCT01301027|50581433|FG001|Overall Study|Withdrawal by Subject|3|||
25267386|NCT01301027|50581432|FG000|Overall Study|Adverse Event|0|||
25267387|NCT01301027|50581433|FG001|Overall Study|Adverse Event|2|||
25267388|NCT01301027|50581432|FG000|Overall Study|Fracture|1|||
25267389|NCT01301027|50581433|FG001|Overall Study|Fracture|3|||
25267390|NCT01301027|50581432|FG000|Overall Study|Transplant|0|||
25267391|NCT01301027|50581433|FG001|Overall Study|Transplant|2|||
25267392|NCT01301027|50581432|FG000|Overall Study|Volume Overload|3|||
25267393|NCT01301027|50581433|FG001|Overall Study|Volume Overload|0|||
25267394|NCT01185639|50581439|FG000|Overall Study|Progressed and didn't receive therapy|2|||
25267395|NCT01185561|50581445|FG000|Overall Study|Lost to Follow-up|0|||
25267396|NCT01185561|50581446|FG001|Overall Study|Lost to Follow-up|4|||
25267397|NCT01185561|50581445|FG000|Overall Study|Withdrawal by Subject|2|||
25267398|NCT01185561|50581446|FG001|Overall Study|Withdrawal by Subject|8|||
25267399|NCT01185249|50581452|FG000|Overall Study|Patients discharged or change in status|42|||
25267400|NCT01184859|50581462|FG000|Period 1: Single Dose|Insufficient urine production|0|||
25267401|NCT01184859|50581463|FG001|Period 1: Single Dose|Insufficient urine production|1|||
25267402|NCT01184859|50581464|FG002|Period 1: Single Dose|Insufficient urine production|0|||
25267403|NCT01184859|50581465|FG003|Period 1: Single Dose|Insufficient urine production|0|||
25267404|NCT01184859|50581466|FG004|Period 1: Single Dose|Insufficient urine production|0|||
25267405|NCT01184859|50581462|FG000|Period 1: Single Dose|Protocol Violation|0|||
25267406|NCT01184859|50581463|FG001|Period 1: Single Dose|Protocol Violation|1|||
25267407|NCT01184859|50581464|FG002|Period 1: Single Dose|Protocol Violation|0|||
25267408|NCT01184859|50581465|FG003|Period 1: Single Dose|Protocol Violation|0|||
25267409|NCT01184859|50581466|FG004|Period 1: Single Dose|Protocol Violation|0|||
25267410|NCT01184859|50581462|FG000|Period 1: Single Dose|Adverse Event|0|||
25267411|NCT01184859|50581463|FG001|Period 1: Single Dose|Adverse Event|0|||
25267412|NCT01184859|50581464|FG002|Period 1: Single Dose|Adverse Event|0|||
25125584|NCT01717456|50238511|FG001|End of Treatment|Lost to Follow-up|1|||
25125585|NCT01717456|50238510|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
25125586|NCT01717456|50238511|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
25125587|NCT01699750|50238520|FG000|Overall Study|Withdrew Consent|0|||
25125588|NCT01699750|50238521|FG001|Overall Study|Withdrew Consent|1|||
25125589|NCT01699750|50238520|FG000|Overall Study|Other|0|||
25125590|NCT01699750|50238521|FG001|Overall Study|Other|2|||
25125591|NCT01716754|50238535|FG000|Overall Study|Death|0|||
25125592|NCT01716754|50238536|FG001|Overall Study|Death|0|||
25125593|NCT01716754|50238537|FG002|Overall Study|Death|0|||
25125594|NCT01716754|50238538|FG003|Overall Study|Death|1|||
25125595|NCT01716754|50238535|FG000|Overall Study|Protocol deviation|0|||
25125596|NCT01716754|50238536|FG001|Overall Study|Protocol deviation|2|||
25125597|NCT01716754|50238537|FG002|Overall Study|Protocol deviation|7|||
25125598|NCT01716754|50238538|FG003|Overall Study|Protocol deviation|2|||
25125599|NCT01716754|50238535|FG000|Overall Study|Non-compliance with study treatment|0|||
25125600|NCT01716754|50238536|FG001|Overall Study|Non-compliance with study treatment|0|||
25125601|NCT01716754|50238537|FG002|Overall Study|Non-compliance with study treatment|1|||
25125602|NCT01716754|50238538|FG003|Overall Study|Non-compliance with study treatment|0|||
25125603|NCT01716754|50238535|FG000|Overall Study|Physician Decision|1|||
25125604|NCT01716754|50238536|FG001|Overall Study|Physician Decision|0|||
25125605|NCT01716754|50238537|FG002|Overall Study|Physician Decision|0|||
25125606|NCT01716754|50238538|FG003|Overall Study|Physician Decision|0|||
25125607|NCT01716754|50238535|FG000|Overall Study|Lost to Follow-up|1|||
25125608|NCT01716754|50238536|FG001|Overall Study|Lost to Follow-up|0|||
25125609|NCT01716754|50238537|FG002|Overall Study|Lost to Follow-up|0|||
25125610|NCT01716754|50238538|FG003|Overall Study|Lost to Follow-up|1|||
25125611|NCT01716754|50238535|FG000|Overall Study|Adverse Event|4|||
25125612|NCT01716754|50238536|FG001|Overall Study|Adverse Event|2|||
25125613|NCT01716754|50238537|FG002|Overall Study|Adverse Event|2|||
25125614|NCT01716754|50238538|FG003|Overall Study|Adverse Event|1|||
25267413|NCT01184859|50581465|FG003|Period 1: Single Dose|Adverse Event|0|||
25267414|NCT01184859|50581466|FG004|Period 1: Single Dose|Adverse Event|1|||
25009238|NCT00075725|50102301|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
25125615|NCT01716754|50238535|FG000|Overall Study|Withdrawal by Subject|5|||
25125616|NCT01716754|50238536|FG001|Overall Study|Withdrawal by Subject|0|||
25125617|NCT01716754|50238537|FG002|Overall Study|Withdrawal by Subject|4|||
25178470|NCT01472939|50323775|FG003|Overall Study|Adverse Event|14|||
25267415|NCT01184859|50581462|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
25267416|NCT01184859|50581463|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
25267417|NCT01184859|50581464|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
25267418|NCT01184859|50581465|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
25267419|NCT01184859|50581466|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
25267420|NCT01184859|50581462|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
25267421|NCT01184859|50581463|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
25267422|NCT01184859|50581464|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
25267423|NCT01184859|50581465|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
25267424|NCT01184859|50581466|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
25267425|NCT01184079|50581485|FG000|Overall Study|Lost to Follow-up|14|||
25267426|NCT01184079|50581486|FG001|Overall Study|Lost to Follow-up|2|||
25267427|NCT01190865|50581494|FG000|Overall Study|Withdrawal by Subject|1|||
25267428|NCT01190865|50581494|FG000|Overall Study|Non-compliance|2|||
25267429|NCT01190475|50581501|FG000|Overall Study|Withdrawal by Subject|0|||
25267430|NCT01190475|50581502|FG001|Overall Study|Withdrawal by Subject|0|||
25267431|NCT01190475|50581503|FG002|Overall Study|Withdrawal by Subject|1|||
25267432|NCT01289990|50581526|FG000|Overall Study|Death|0|||
25267433|NCT01289990|50581527|FG001|Overall Study|Death|0|||
25267434|NCT01289990|50581528|FG002|Overall Study|Death|0|||
25267435|NCT01289990|50581529|FG003|Overall Study|Death|1|||
25267436|NCT01289990|50581530|FG004|Overall Study|Death|2|||
25267437|NCT01289990|50581531|FG005|Overall Study|Death|1|||
25267438|NCT01289990|50581532|FG006|Overall Study|Death|0|||
25267439|NCT01289990|50581533|FG007|Overall Study|Death|0|||
25267440|NCT01289990|50581534|FG008|Overall Study|Death|0|||
25267441|NCT01289990|50581535|FG009|Overall Study|Death|0|||
25267442|NCT01289990|50581536|FG010|Overall Study|Death|0|||
25267443|NCT01289990|50581537|FG011|Overall Study|Death|1|||
25267444|NCT01289990|50581538|FG012|Overall Study|Death|0|||
25267445|NCT01289990|50581526|FG000|Overall Study|Lost to Follow-up|3|||
25267446|NCT01289990|50581527|FG001|Overall Study|Lost to Follow-up|2|||
25267447|NCT01289990|50581528|FG002|Overall Study|Lost to Follow-up|5|||
25267448|NCT01289990|50581529|FG003|Overall Study|Lost to Follow-up|5|||
25267449|NCT01289990|50581530|FG004|Overall Study|Lost to Follow-up|3|||
25267450|NCT01289990|50581531|FG005|Overall Study|Lost to Follow-up|4|||
25267451|NCT01289990|50581532|FG006|Overall Study|Lost to Follow-up|2|||
25267452|NCT01289990|50581533|FG007|Overall Study|Lost to Follow-up|2|||
25267453|NCT01289990|50581534|FG008|Overall Study|Lost to Follow-up|1|||
25267454|NCT01289990|50581535|FG009|Overall Study|Lost to Follow-up|4|||
25267455|NCT01289990|50581536|FG010|Overall Study|Lost to Follow-up|2|||
25267456|NCT01289990|50581537|FG011|Overall Study|Lost to Follow-up|1|||
25267457|NCT01289990|50581538|FG012|Overall Study|Lost to Follow-up|2|||
25267458|NCT01289990|50581526|FG000|Overall Study|Withdrawal by Subject|15|||
25267459|NCT01289990|50581527|FG001|Overall Study|Withdrawal by Subject|14|||
25267460|NCT01289990|50581528|FG002|Overall Study|Withdrawal by Subject|12|||
25267461|NCT01289990|50581529|FG003|Overall Study|Withdrawal by Subject|13|||
25267462|NCT01289990|50581530|FG004|Overall Study|Withdrawal by Subject|8|||
25267463|NCT01289990|50581531|FG005|Overall Study|Withdrawal by Subject|7|||
25267464|NCT01289990|50581532|FG006|Overall Study|Withdrawal by Subject|13|||
25267465|NCT01289990|50581533|FG007|Overall Study|Withdrawal by Subject|9|||
25267466|NCT01289990|50581534|FG008|Overall Study|Withdrawal by Subject|12|||
25267467|NCT01289990|50581535|FG009|Overall Study|Withdrawal by Subject|13|||
25267468|NCT01289990|50581536|FG010|Overall Study|Withdrawal by Subject|11|||
25267469|NCT01289990|50581537|FG011|Overall Study|Withdrawal by Subject|13|||
25267470|NCT01289990|50581538|FG012|Overall Study|Withdrawal by Subject|16|||
25267471|NCT01289990|50581526|FG000|Overall Study|discontinued in preceding trial|18|||
25267472|NCT01289990|50581527|FG001|Overall Study|discontinued in preceding trial|20|||
25178471|NCT01472939|50323772|FG000|Overall Study|Lack of Efficacy|1|||
25178472|NCT01472939|50323773|FG001|Overall Study|Lack of Efficacy|0|||
25178473|NCT01472939|50323774|FG002|Overall Study|Lack of Efficacy|0|||
25178474|NCT01472939|50323775|FG003|Overall Study|Lack of Efficacy|1|||
25178475|NCT01472939|50323772|FG000|Overall Study|Lost to Follow-up|3|||
25178476|NCT01472939|50323773|FG001|Overall Study|Lost to Follow-up|0|||
25178477|NCT01472939|50323774|FG002|Overall Study|Lost to Follow-up|2|||
25178478|NCT01472939|50323775|FG003|Overall Study|Lost to Follow-up|0|||
25178479|NCT01472939|50323772|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
25178480|NCT01472939|50323773|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
25267473|NCT01289990|50581528|FG002|Overall Study|discontinued in preceding trial|41|||
25267474|NCT01289990|50581529|FG003|Overall Study|discontinued in preceding trial|17|||
25267475|NCT01289990|50581530|FG004|Overall Study|discontinued in preceding trial|11|||
25178481|NCT01472939|50323774|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
25178482|NCT01472939|50323775|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
25267476|NCT01289990|50581531|FG005|Overall Study|discontinued in preceding trial|12|||
25267477|NCT01289990|50581532|FG006|Overall Study|discontinued in preceding trial|18|||
25267478|NCT01289990|50581533|FG007|Overall Study|discontinued in preceding trial|8|||
25267479|NCT01289990|50581534|FG008|Overall Study|discontinued in preceding trial|17|||
25267480|NCT01289990|50581535|FG009|Overall Study|discontinued in preceding trial|21|||
25267481|NCT01289990|50581536|FG010|Overall Study|discontinued in preceding trial|17|||
25267482|NCT01289990|50581537|FG011|Overall Study|discontinued in preceding trial|17|||
25267483|NCT01289990|50581538|FG012|Overall Study|discontinued in preceding trial|24|||
25267484|NCT01289990|50581526|FG000|Overall Study|did not continue in extension|41|||
25267485|NCT01289990|50581527|FG001|Overall Study|did not continue in extension|45|||
25267486|NCT01289990|50581528|FG002|Overall Study|did not continue in extension|51|||
25267487|NCT01289990|50581529|FG003|Overall Study|did not continue in extension|51|||
25267488|NCT01289990|50581530|FG004|Overall Study|did not continue in extension|48|||
25267489|NCT01289990|50581531|FG005|Overall Study|did not continue in extension|50|||
25267490|NCT01289990|50581532|FG006|Overall Study|did not continue in extension|54|||
25267491|NCT01289990|50581533|FG007|Overall Study|did not continue in extension|36|||
25267492|NCT01289990|50581534|FG008|Overall Study|did not continue in extension|44|||
25267493|NCT01289990|50581535|FG009|Overall Study|did not continue in extension|48|||
25267494|NCT01289990|50581536|FG010|Overall Study|did not continue in extension|45|||
25267495|NCT01289990|50581537|FG011|Overall Study|did not continue in extension|34|||
25267496|NCT01289990|50581538|FG012|Overall Study|did not continue in extension|56|||
25267497|NCT01289990|50581526|FG000|Overall Study|Not treated|0|||
25267498|NCT01289990|50581527|FG001|Overall Study|Not treated|0|||
25267499|NCT01289990|50581528|FG002|Overall Study|Not treated|0|||
25267500|NCT01289990|50581529|FG003|Overall Study|Not treated|0|||
25267501|NCT01289990|50581530|FG004|Overall Study|Not treated|0|||
25267502|NCT01289990|50581531|FG005|Overall Study|Not treated|0|||
25267503|NCT01289990|50581532|FG006|Overall Study|Not treated|1|||
25267504|NCT01289990|50581533|FG007|Overall Study|Not treated|0|||
25267505|NCT01289990|50581534|FG008|Overall Study|Not treated|1|||
25267506|NCT01289990|50581535|FG009|Overall Study|Not treated|0|||
25267507|NCT01289990|50581536|FG010|Overall Study|Not treated|1|||
25267508|NCT01289990|50581537|FG011|Overall Study|Not treated|2|||
25267509|NCT01289990|50581538|FG012|Overall Study|Not treated|0|||
25267510|NCT01190007|50581566|FG000|Overall Study|Withdrawal by Subject|4|||
25267511|NCT01190007|50581566|FG000|Overall Study|Adverse Event|8|||
25267512|NCT01190007|50581566|FG000|Overall Study|Difficulty of visit for complications|1|||
25267513|NCT01190007|50581566|FG000|Overall Study|Participant was arrested|1|||
25267514|NCT01189461|50581570|FG000|Overall Study|Lack of Efficacy|13|||
25267515|NCT01189461|50581570|FG000|Overall Study|Lost to Follow-up|1|||
25267516|NCT01189461|50581570|FG000|Overall Study|Withdrawal by Subject|6|||
25267517|NCT01189461|50581570|FG000|Overall Study|Protocol Violation|1|||
25267518|NCT01189461|50581570|FG000|Overall Study|Adverse Event|2|||
25267519|NCT01189461|50581570|FG000|Overall Study|Did not meet entrance criteria|3|||
25267520|NCT01189461|50581570|FG000|Overall Study|Other|8|||
25267521|NCT01189227|50581576|FG000|Overall Study|Study terminated due to low accrual|6|||
25267522|NCT01189227|50581577|FG001|Overall Study|Study terminated due to low accrual|3|||
25267523|NCT01300247|50581585|FG000|Overall Study|Death|1|||
25267524|NCT01300247|50581586|FG001|Overall Study|Death|1|||
25267525|NCT01300247|50581585|FG000|Overall Study|Lost to Follow-up|2|||
25267526|NCT01300247|50581586|FG001|Overall Study|Lost to Follow-up|0|||
25267527|NCT01300247|50581585|FG000|Overall Study|Withdrawal by Subject|1|||
25267528|NCT01300247|50581586|FG001|Overall Study|Withdrawal by Subject|0|||
25267529|NCT01300247|50581585|FG000|Overall Study|Non-Compliance|0|||
25267530|NCT01300247|50581586|FG001|Overall Study|Non-Compliance|1|||
25267531|NCT01289678|50581592|FG000|Overall Study|Physician Decision|6|||
25267532|NCT01289210|50581596|FG000|Overall Study|Adverse Event|1|||
25267533|NCT01183221|50581602|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
25267534|NCT01183221|50581603|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
25267535|NCT01183143|50581609|FG000|Overall Study|Protocol Violation|115|||
25267536|NCT01183143|50581609|FG000|Overall Study|Withdrawal by Subject|19|||
25267537|NCT01183143|50581609|FG000|Overall Study|Subject Questionnaires not returned|5|||
25267538|NCT01183143|50581609|FG000|Overall Study|Subjects enrolled, but not treated|11|||
25267539|NCT01183065|50581613|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
25267540|NCT01182441|50581619|FG000|Overall Study|Patient Still in Follow-up|152|||
25267541|NCT01182441|50581620|FG001|Overall Study|Patient Still in Follow-up|72|||
25267542|NCT01182441|50581619|FG000|Overall Study|Death|37|||
25267543|NCT01182441|50581620|FG001|Overall Study|Death|25|||
25267544|NCT01182441|50581619|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
25267545|NCT01182441|50581620|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
25267546|NCT01182441|50581619|FG000|Overall Study|Lost to Follow-up|5|||
25267547|NCT01182441|50581620|FG001|Overall Study|Lost to Follow-up|8|||
25267548|NCT01182441|50581619|FG000|Overall Study|Withdrawal by Subject|6|||
25267549|NCT01182441|50581620|FG001|Overall Study|Withdrawal by Subject|13|||
25267550|NCT01182441|50581619|FG000|Overall Study|Implant Not Attempted|4|||
25267551|NCT01182441|50581620|FG001|Overall Study|Implant Not Attempted|0|||
25267552|NCT01182441|50581619|FG000|Overall Study|Adverse Event|2|||
25267553|NCT01182441|50581620|FG001|Overall Study|Adverse Event|0|||
25267554|NCT01182441|50581619|FG000|Overall Study|Physician Decision|1|||
25267555|NCT01182441|50581620|FG001|Overall Study|Physician Decision|1|||
25125618|NCT01716754|50238538|FG003|Overall Study|Withdrawal by Subject|3|||
25125619|NCT01698814|50238549|FG000|Overall Study|Adverse Event|0|||
25125620|NCT01698814|50238550|FG001|Overall Study|Adverse Event|2|||
25125621|NCT01698814|50238549|FG000|Overall Study|Lost to Follow-up|0|||
25125622|NCT01698814|50238550|FG001|Overall Study|Lost to Follow-up|1|||
25125623|NCT01698814|50238549|FG000|Overall Study|Pregnancy|1|||
25125624|NCT01698814|50238550|FG001|Overall Study|Pregnancy|0|||
25125625|NCT01698814|50238549|FG000|Overall Study|Randomized in error|1|||
25125626|NCT01698814|50238550|FG001|Overall Study|Randomized in error|0|||
25125627|NCT01738984|50238558|FG000|Overall Study|Pregnancy|4|||
25125628|NCT01738984|50238559|FG001|Overall Study|Pregnancy|0|||
25125629|NCT01738984|50238558|FG000|Overall Study|Withdrawal by Subject|1|||
25125630|NCT01738984|50238559|FG001|Overall Study|Withdrawal by Subject|0|||
25125631|NCT01738984|50238558|FG000|Overall Study|Lost to Follow-up|59|||
25125632|NCT01738984|50238559|FG001|Overall Study|Lost to Follow-up|39|||
25125633|NCT01738594|50238568|FG000|Registration and Treatment Start|Adverse Event|0|||
25125634|NCT01738594|50238569|FG001|Registration and Treatment Start|Adverse Event|1|||
25125635|NCT01738594|50238570|FG002|Registration and Treatment Start|Adverse Event|0|||
25125636|NCT01738594|50238571|FG003|Registration and Treatment Start|Adverse Event|0|||
25125637|NCT01738594|50238572|FG004|Registration and Treatment Start|Adverse Event|0|||
25125638|NCT01738594|50238573|FG005|Registration and Treatment Start|Adverse Event|0|||
25125639|NCT01738594|50238574|FG006|Registration and Treatment Start|Adverse Event|0|||
25125640|NCT01738594|50238575|FG007|Registration and Treatment Start|Adverse Event|0|||
25125641|NCT01738594|50238568|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
25125642|NCT01738594|50238569|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
25125643|NCT01738594|50238570|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
25125644|NCT01738594|50238571|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
25125645|NCT01738594|50238572|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
25125646|NCT01738594|50238573|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
25125647|NCT01738594|50238574|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
25125648|NCT01738594|50238575|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
25125649|NCT01738594|50238568|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
25125650|NCT01738594|50238569|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
25125651|NCT01738594|50238570|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
25125652|NCT01738594|50238571|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
25125653|NCT01738594|50238572|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
25125654|NCT01738594|50238573|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
25125655|NCT01738594|50238574|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
25125656|NCT01738594|50238575|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
25125657|NCT01738594|50238568|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
25125658|NCT01738594|50238569|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
25125659|NCT01738594|50238570|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
25125660|NCT01738594|50238571|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
25125661|NCT01738594|50238572|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
25125662|NCT01738594|50238573|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
25125663|NCT01738594|50238574|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
25125664|NCT01738594|50238575|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
25125665|NCT01738594|50238568|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
25125666|NCT01738594|50238569|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
25125667|NCT01738594|50238570|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
25125668|NCT01738594|50238571|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
25125669|NCT01738594|50238572|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
25125670|NCT01738594|50238573|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
25125671|NCT01738594|50238574|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
25125672|NCT01738594|50238575|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
25125673|NCT01738594|50238568|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
25125674|NCT01738594|50238569|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
25125675|NCT01738594|50238570|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
25125676|NCT01738594|50238571|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
25125677|NCT01738594|50238572|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
25125678|NCT01738594|50238573|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
25125679|NCT01738594|50238574|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
25125680|NCT01738594|50238575|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
25125681|NCT01738594|50238568|FG000|Follow up for 1 Year|Death|0|||
25267556|NCT01182285|50581626|FG000|First Intervention Week 1-10|Disease progression|1|||
25267557|NCT01182285|50581627|FG001|First Intervention Week 1-10|Disease progression|0|||
25267558|NCT01182285|50581628|FG002|First Intervention Week 1-10|Disease progression|0|||
25267559|NCT01182285|50581626|FG000|First Intervention Week 1-10|Adverse Event|1|||
25125682|NCT01738594|50238569|FG001|Follow up for 1 Year|Death|0|||
25125683|NCT01738594|50238570|FG002|Follow up for 1 Year|Death|0|||
25125684|NCT01738594|50238571|FG003|Follow up for 1 Year|Death|0|||
25125685|NCT01738594|50238572|FG004|Follow up for 1 Year|Death|0|||
25125686|NCT01738594|50238573|FG005|Follow up for 1 Year|Death|1|||
25125687|NCT01738594|50238574|FG006|Follow up for 1 Year|Death|0|||
25267560|NCT01182285|50581627|FG001|First Intervention Week 1-10|Adverse Event|0|||
25267561|NCT01182285|50581628|FG002|First Intervention Week 1-10|Adverse Event|0|||
25267562|NCT01182285|50581626|FG000|First Intervention Week 1-10|Non-compliance|1|||
25267563|NCT01182285|50581627|FG001|First Intervention Week 1-10|Non-compliance|0|||
25267564|NCT01182285|50581628|FG002|First Intervention Week 1-10|Non-compliance|0|||
25267565|NCT01182285|50581626|FG000|Third Intervention Week 11-52|Disease Progression|0|||
25267566|NCT01182285|50581627|FG001|Third Intervention Week 11-52|Disease Progression|0|||
25267567|NCT01182285|50581628|FG002|Third Intervention Week 11-52|Disease Progression|6|||
25267568|NCT01182285|50581626|FG000|Third Intervention Week 11-52|Other|0|||
25267569|NCT01182285|50581627|FG001|Third Intervention Week 11-52|Other|0|||
25267570|NCT01182285|50581628|FG002|Third Intervention Week 11-52|Other|2|||
25267571|NCT01182207|50581637|FG000|First Intervention|Positive Hepatitis Results|0|||
25267572|NCT01182207|50581638|FG001|First Intervention|Positive Hepatitis Results|1|||
25267573|NCT01182207|50581637|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
25267574|NCT01182207|50581638|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
25267575|NCT01181895|50581647|FG000|Overall Study|Adverse Event|3|||
25267576|NCT01181895|50581648|FG001|Overall Study|Adverse Event|1|||
25267577|NCT01181895|50581649|FG002|Overall Study|Adverse Event|1|||
25267578|NCT01181895|50581647|FG000|Overall Study|Lack of Efficacy|8|||
25267579|NCT01181895|50581648|FG001|Overall Study|Lack of Efficacy|9|||
25267580|NCT01181895|50581649|FG002|Overall Study|Lack of Efficacy|9|||
25267581|NCT01181895|50581647|FG000|Overall Study|Protocol Violation|2|||
25267582|NCT01181895|50581648|FG001|Overall Study|Protocol Violation|1|||
25267583|NCT01181895|50581649|FG002|Overall Study|Protocol Violation|0|||
25267584|NCT01181895|50581647|FG000|Overall Study|Lost to Follow-up|0|||
25267585|NCT01181895|50581648|FG001|Overall Study|Lost to Follow-up|1|||
25267586|NCT01181895|50581649|FG002|Overall Study|Lost to Follow-up|2|||
25267587|NCT01181895|50581647|FG000|Overall Study|Investigator Discretion|1|||
25267588|NCT01181895|50581648|FG001|Overall Study|Investigator Discretion|2|||
25267589|NCT01181895|50581649|FG002|Overall Study|Investigator Discretion|1|||
25267590|NCT01181895|50581647|FG000|Overall Study|Withdrawal by Subject|3|||
25267591|NCT01181895|50581648|FG001|Overall Study|Withdrawal by Subject|0|||
25267592|NCT01181895|50581649|FG002|Overall Study|Withdrawal by Subject|5|||
25267593|NCT01181271|50581657|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
25267594|NCT01181271|50581657|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
25267595|NCT01181271|50581657|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
25267596|NCT01181271|50581657|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
25267597|NCT01180647|50581663|FG000|Overall Study|Lost to Follow-up|5|||
25267598|NCT01180647|50581664|FG001|Overall Study|Lost to Follow-up|6|||
25267599|NCT00969553|50581679|FG000|Overall Study|Progressive disease (PD)|2|||
25267600|NCT00969553|50581680|FG001|Overall Study|Progressive disease (PD)|2|||
25267601|NCT00969553|50581681|FG002|Overall Study|Progressive disease (PD)|6|||
25267602|NCT00969553|50581682|FG003|Overall Study|Progressive disease (PD)|9|||
25125688|NCT01738594|50238575|FG007|Follow up for 1 Year|Death|0|||
25125689|NCT01738594|50238568|FG000|Follow up for 1 Year|Other|0|||
25178483|NCT01472939|50323772|FG000|Overall Study|Prohibited Medication|0|||
25178484|NCT01472939|50323773|FG001|Overall Study|Prohibited Medication|1|||
25178485|NCT01472939|50323774|FG002|Overall Study|Prohibited Medication|0|||
25267603|NCT00969553|50581683|FG004|Overall Study|Progressive disease (PD)|2|||
25267604|NCT00969553|50581684|FG005|Overall Study|Progressive disease (PD)|4|||
25267605|NCT00969553|50581685|FG006|Overall Study|Progressive disease (PD)|2|||
25267606|NCT00969553|50581686|FG007|Overall Study|Progressive disease (PD)|12|||
25267607|NCT00969553|50581687|FG008|Overall Study|Progressive disease (PD)|3|||
25125690|NCT01738594|50238569|FG001|Follow up for 1 Year|Other|0|||
25178486|NCT01472939|50323775|FG003|Overall Study|Prohibited Medication|0|||
25178487|NCT01472939|50323772|FG000|Overall Study|Withdrawal By PI|1|||
25178488|NCT01472939|50323773|FG001|Overall Study|Withdrawal By PI|0|||
25178489|NCT01472939|50323774|FG002|Overall Study|Withdrawal By PI|0|||
25178490|NCT01472939|50323775|FG003|Overall Study|Withdrawal By PI|0|||
25178491|NCT01472939|50323772|FG000|Overall Study|Protocol Violation|3|||
25178492|NCT01472939|50323773|FG001|Overall Study|Protocol Violation|3|||
25178493|NCT01472939|50323774|FG002|Overall Study|Protocol Violation|0|||
25125691|NCT01738594|50238570|FG002|Follow up for 1 Year|Other|0|||
25125692|NCT01738594|50238571|FG003|Follow up for 1 Year|Other|0|||
25178494|NCT01472939|50323775|FG003|Overall Study|Protocol Violation|1|||
25178495|NCT01472939|50323772|FG000|Overall Study|Withdrawal by Subject|9|||
25267608|NCT00969553|50581679|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
25267609|NCT00969553|50581680|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
25267610|NCT00969553|50581681|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
25267611|NCT00969553|50581682|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
25267612|NCT00969553|50581683|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
25267613|NCT00969553|50581684|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
25267614|NCT00969553|50581685|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
25267615|NCT00969553|50581686|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
25267616|NCT00969553|50581687|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
25267617|NCT00969553|50581679|FG000|Overall Study|Other Adverse Event|0|||
25267618|NCT00969553|50581680|FG001|Overall Study|Other Adverse Event|0|||
25267619|NCT00969553|50581681|FG002|Overall Study|Other Adverse Event|0|||
25267620|NCT00969553|50581682|FG003|Overall Study|Other Adverse Event|1|||
25267621|NCT00969553|50581683|FG004|Overall Study|Other Adverse Event|0|||
25267622|NCT00969553|50581684|FG005|Overall Study|Other Adverse Event|0|||
25267623|NCT00969553|50581685|FG006|Overall Study|Other Adverse Event|1|||
25267624|NCT00969553|50581686|FG007|Overall Study|Other Adverse Event|0|||
25267625|NCT00969553|50581687|FG008|Overall Study|Other Adverse Event|0|||
25267626|NCT00969553|50581679|FG000|Overall Study|Refused cont. medication|1|||
25267627|NCT00969553|50581680|FG001|Overall Study|Refused cont. medication|1|||
25267628|NCT00969553|50581681|FG002|Overall Study|Refused cont. medication|0|||
25267629|NCT00969553|50581682|FG003|Overall Study|Refused cont. medication|2|||
25267630|NCT00969553|50581683|FG004|Overall Study|Refused cont. medication|0|||
25267631|NCT00969553|50581684|FG005|Overall Study|Refused cont. medication|0|||
25267632|NCT00969553|50581685|FG006|Overall Study|Refused cont. medication|0|||
25267633|NCT00969553|50581686|FG007|Overall Study|Refused cont. medication|1|||
25267634|NCT00969553|50581687|FG008|Overall Study|Refused cont. medication|0|||
25267635|NCT00969553|50581679|FG000|Overall Study|Not specified above|0|||
25267636|NCT00969553|50581680|FG001|Overall Study|Not specified above|0|||
25267637|NCT00969553|50581681|FG002|Overall Study|Not specified above|0|||
25267638|NCT00969553|50581682|FG003|Overall Study|Not specified above|4|||
25267639|NCT00969553|50581683|FG004|Overall Study|Not specified above|0|||
25267640|NCT00969553|50581684|FG005|Overall Study|Not specified above|0|||
25267641|NCT00969553|50581685|FG006|Overall Study|Not specified above|1|||
25267642|NCT00969553|50581686|FG007|Overall Study|Not specified above|1|||
25267643|NCT00969553|50581687|FG008|Overall Study|Not specified above|0|||
25267644|NCT01179477|50581715|FG000|Overall Study|Death|542|||
25267645|NCT01179477|50581715|FG000|Overall Study|Unsuccessful implant|80|||
25267646|NCT01179477|50581715|FG000|Overall Study|Non-death withdrawal|438|||
25267647|NCT01179477|50581715|FG000|Overall Study|Did not complete final visit|27|||
25267648|NCT01179399|50581719|FG000|Overall Study|Adverse Event|1|||
25267649|NCT01179399|50581719|FG000|Overall Study|Lack of Efficacy|30|||
25267650|NCT01179399|50581719|FG000|Overall Study|Withdrawal by Subject|1|||
25267651|NCT01178853|50581725|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
25267652|NCT01178853|50581726|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
25267653|NCT01178853|50581725|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
25267654|NCT01178853|50581726|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
25267655|NCT01178853|50581725|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
25267656|NCT01178853|50581726|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
25267657|NCT01178853|50581725|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
25267658|NCT01178853|50581726|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
25267659|NCT01178853|50581725|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
25267660|NCT01178853|50581726|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
25267661|NCT01178385|50581734|FG000|Overall Study|Withdrawal by Subject|2|||
25267662|NCT01178385|50581735|FG001|Overall Study|Withdrawal by Subject|0|||
25267663|NCT01288976|50581744|FG000|Overall Study|Withdrawal by Subject|58|||
25267664|NCT01288976|50581745|FG001|Overall Study|Withdrawal by Subject|12|||
25267665|NCT01288976|50581746|FG002|Overall Study|Withdrawal by Subject|9|||
25267666|NCT01288976|50581744|FG000|Overall Study|Death|98|||
25267667|NCT01288976|50581745|FG001|Overall Study|Death|6|||
25267668|NCT01288976|50581746|FG002|Overall Study|Death|4|||
25267669|NCT01288976|50581744|FG000|Overall Study|Data unavailable|22|||
25267670|NCT01288976|50581745|FG001|Overall Study|Data unavailable|9|||
25267671|NCT01288976|50581746|FG002|Overall Study|Data unavailable|7|||
25267672|NCT00970489|50581754|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
25267673|NCT00970489|50581755|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
25267674|NCT00968617|50581761|FG000|Overall Study|Study terminated by sponsor|6|||
25267675|NCT00968539|50581767|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
25267676|NCT00968539|50581768|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
25267677|NCT00976573|50581777|FG000|Overall Study|Ineligible|0|||
25267678|NCT00976573|50581778|FG001|Overall Study|Ineligible|1|||
25267679|NCT00976573|50581777|FG000|Overall Study|Cancel prior to receiving treatment|4|||
25267680|NCT00976573|50581778|FG001|Overall Study|Cancel prior to receiving treatment|2|||
25267681|NCT03661723|50581786|FG000|Overall Study|Disease Progression|4|||
25267682|NCT03661723|50581787|FG001|Overall Study|Disease Progression|24|||
25267683|NCT03661723|50581788|FG002|Overall Study|Disease Progression|4|||
25267684|NCT03661723|50581789|FG003|Overall Study|Disease Progression|19|||
25267685|NCT03661723|50581786|FG000|Overall Study|Withdrawal by Subject|1|||
25267686|NCT03661723|50581787|FG001|Overall Study|Withdrawal by Subject|0|||
25267687|NCT03661723|50581788|FG002|Overall Study|Withdrawal by Subject|2|||
25267688|NCT03661723|50581789|FG003|Overall Study|Withdrawal by Subject|4|||
25267689|NCT03661723|50581786|FG000|Overall Study|Physician Decision|1|||
25267690|NCT03661723|50581787|FG001|Overall Study|Physician Decision|0|||
25267691|NCT03661723|50581788|FG002|Overall Study|Physician Decision|0|||
25267692|NCT03661723|50581789|FG003|Overall Study|Physician Decision|0|||
25267693|NCT03661723|50581786|FG000|Overall Study|Clinical Deterioration|0|||
25267694|NCT03661723|50581787|FG001|Overall Study|Clinical Deterioration|0|||
25267695|NCT03661723|50581788|FG002|Overall Study|Clinical Deterioration|0|||
25267696|NCT03661723|50581789|FG003|Overall Study|Clinical Deterioration|1|||
25267697|NCT00976495|50581798|FG000|Overall Study|Withdrawal by Subject|0|||
25267698|NCT00976495|50581799|FG001|Overall Study|Withdrawal by Subject|1|||
25267699|NCT00976495|50581800|FG002|Overall Study|Withdrawal by Subject|0|||
25267700|NCT01288430|50581818|FG000|Part 1|Progressive disease|2|||
25267701|NCT01288430|50581819|FG001|Part 1|Progressive disease|1|||
25267702|NCT01288430|50581820|FG002|Part 1|Progressive disease|1|||
25267703|NCT01288430|50581821|FG003|Part 1|Progressive disease|6|||
25267704|NCT01288430|50581822|FG004|Part 1|Progressive disease|2|||
25267705|NCT01288430|50581823|FG005|Part 1|Progressive disease|4|||
25267706|NCT01288430|50581824|FG006|Part 1|Progressive disease|2|||
25267707|NCT01288430|50581825|FG007|Part 1|Progressive disease|0|||
25267708|NCT01288430|50581826|FG008|Part 1|Progressive disease|0|||
25267709|NCT01288430|50581827|FG009|Part 1|Progressive disease|0|||
25267710|NCT01288430|50581818|FG000|Part 1|Clinical disease progression|0|||
25267711|NCT01288430|50581819|FG001|Part 1|Clinical disease progression|0|||
25267712|NCT01288430|50581820|FG002|Part 1|Clinical disease progression|1|||
25267713|NCT01288430|50581821|FG003|Part 1|Clinical disease progression|0|||
25267714|NCT01288430|50581822|FG004|Part 1|Clinical disease progression|0|||
25267715|NCT01288430|50581823|FG005|Part 1|Clinical disease progression|2|||
25267716|NCT01288430|50581824|FG006|Part 1|Clinical disease progression|2|||
25267717|NCT01288430|50581825|FG007|Part 1|Clinical disease progression|0|||
25267718|NCT01288430|50581826|FG008|Part 1|Clinical disease progression|0|||
25267719|NCT01288430|50581827|FG009|Part 1|Clinical disease progression|0|||
25267720|NCT01288430|50581818|FG000|Part 1|Death due to disease progression|0|||
25267721|NCT01288430|50581819|FG001|Part 1|Death due to disease progression|0|||
25267722|NCT01288430|50581820|FG002|Part 1|Death due to disease progression|0|||
25267723|NCT01288430|50581821|FG003|Part 1|Death due to disease progression|0|||
25267724|NCT01288430|50581822|FG004|Part 1|Death due to disease progression|1|||
25267725|NCT01288430|50581823|FG005|Part 1|Death due to disease progression|0|||
25267726|NCT01288430|50581824|FG006|Part 1|Death due to disease progression|0|||
25267727|NCT01288430|50581825|FG007|Part 1|Death due to disease progression|0|||
25267728|NCT01288430|50581826|FG008|Part 1|Death due to disease progression|0|||
25267729|NCT01288430|50581827|FG009|Part 1|Death due to disease progression|0|||
25267730|NCT01288430|50581818|FG000|Part 1|Adverse Event|0|||
25267731|NCT01288430|50581819|FG001|Part 1|Adverse Event|0|||
25267732|NCT01288430|50581820|FG002|Part 1|Adverse Event|3|||
25267733|NCT01288430|50581821|FG003|Part 1|Adverse Event|1|||
25267734|NCT01288430|50581822|FG004|Part 1|Adverse Event|0|||
25267735|NCT01288430|50581823|FG005|Part 1|Adverse Event|0|||
25267736|NCT01288430|50581824|FG006|Part 1|Adverse Event|2|||
25267737|NCT01288430|50581825|FG007|Part 1|Adverse Event|0|||
25267738|NCT01288430|50581826|FG008|Part 1|Adverse Event|0|||
25267739|NCT01288430|50581827|FG009|Part 1|Adverse Event|0|||
25267740|NCT01288430|50581818|FG000|Part 1|Other|0|||
25267741|NCT01288430|50581819|FG001|Part 1|Other|2|||
25267742|NCT01288430|50581820|FG002|Part 1|Other|0|||
25267743|NCT01288430|50581821|FG003|Part 1|Other|0|||
25267744|NCT01288430|50581822|FG004|Part 1|Other|0|||
25267745|NCT01288430|50581823|FG005|Part 1|Other|0|||
25267746|NCT01288430|50581824|FG006|Part 1|Other|1|||
25267747|NCT01288430|50581825|FG007|Part 1|Other|0|||
25267748|NCT01288430|50581826|FG008|Part 1|Other|0|||
25267749|NCT01288430|50581827|FG009|Part 1|Other|0|||
25267750|NCT01288430|50581818|FG000|Part 2|Progressive disease|0|||
25267751|NCT01288430|50581819|FG001|Part 2|Progressive disease|0|||
25267752|NCT01288430|50581820|FG002|Part 2|Progressive disease|0|||
25267753|NCT01288430|50581821|FG003|Part 2|Progressive disease|0|||
25267754|NCT01288430|50581822|FG004|Part 2|Progressive disease|0|||
25267755|NCT01288430|50581823|FG005|Part 2|Progressive disease|0|||
25267756|NCT01288430|50581824|FG006|Part 2|Progressive disease|0|||
25267757|NCT01288430|50581825|FG007|Part 2|Progressive disease|8|||
25267758|NCT01288430|50581826|FG008|Part 2|Progressive disease|7|||
25267759|NCT01288430|50581827|FG009|Part 2|Progressive disease|2|||
25267760|NCT01288430|50581818|FG000|Part 2|Clinical disease progression|0|||
25267761|NCT01288430|50581819|FG001|Part 2|Clinical disease progression|0|||
25267762|NCT01288430|50581820|FG002|Part 2|Clinical disease progression|0|||
25267763|NCT01288430|50581821|FG003|Part 2|Clinical disease progression|0|||
25267764|NCT01288430|50581822|FG004|Part 2|Clinical disease progression|0|||
25267765|NCT01288430|50581823|FG005|Part 2|Clinical disease progression|0|||
25267766|NCT01288430|50581824|FG006|Part 2|Clinical disease progression|0|||
25267767|NCT01288430|50581825|FG007|Part 2|Clinical disease progression|2|||
25267768|NCT01288430|50581826|FG008|Part 2|Clinical disease progression|0|||
25267769|NCT01288430|50581827|FG009|Part 2|Clinical disease progression|0|||
25267770|NCT01288430|50581818|FG000|Part 2|Withdrawal by Subject|0|||
25267771|NCT01288430|50581819|FG001|Part 2|Withdrawal by Subject|0|||
25267772|NCT01288430|50581820|FG002|Part 2|Withdrawal by Subject|0|||
25267773|NCT01288430|50581821|FG003|Part 2|Withdrawal by Subject|0|||
25267774|NCT01288430|50581822|FG004|Part 2|Withdrawal by Subject|0|||
25267775|NCT01288430|50581823|FG005|Part 2|Withdrawal by Subject|0|||
25267776|NCT01288430|50581824|FG006|Part 2|Withdrawal by Subject|0|||
25267777|NCT01288430|50581825|FG007|Part 2|Withdrawal by Subject|1|||
25267778|NCT01288430|50581826|FG008|Part 2|Withdrawal by Subject|4|||
25267779|NCT01288430|50581827|FG009|Part 2|Withdrawal by Subject|0|||
25125693|NCT01738594|50238572|FG004|Follow up for 1 Year|Other|0|||
25125694|NCT01738594|50238573|FG005|Follow up for 1 Year|Other|2|||
25125695|NCT01738594|50238574|FG006|Follow up for 1 Year|Other|0|||
25125696|NCT01738594|50238575|FG007|Follow up for 1 Year|Other|0|||
25125697|NCT01738438|50238585|FG000|Overall Study|Disease Progression|32|||
25125698|NCT01738438|50238585|FG000|Overall Study|Adverse Event|3|||
25125699|NCT01716520|50238589|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
25125700|NCT01716520|50238590|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
25125701|NCT01716520|50238591|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
25125702|NCT01716520|50238592|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
25125703|NCT01716520|50238593|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
25125704|NCT01716520|50238594|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
25125705|NCT01716520|50238589|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
25125706|NCT01716520|50238590|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
25125707|NCT01716520|50238591|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
25125708|NCT01716520|50238592|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
25125709|NCT01716520|50238593|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
25125710|NCT01716520|50238594|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
25125711|NCT01716520|50238589|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
25125712|NCT01716520|50238590|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
25125713|NCT01716520|50238591|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
25125714|NCT01716520|50238592|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
25125715|NCT01716520|50238593|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
25125716|NCT01716520|50238594|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
25125717|NCT01716520|50238589|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
25125718|NCT01716520|50238590|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
25125719|NCT01716520|50238591|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
25125720|NCT01716520|50238592|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
25125721|NCT01716520|50238593|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
25125722|NCT01716520|50238594|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
25125723|NCT01716520|50238589|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
25125724|NCT01716520|50238590|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
25125725|NCT01716520|50238591|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
25125726|NCT01716520|50238592|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
25125727|NCT01716520|50238593|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
25125728|NCT01716520|50238594|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
25125729|NCT01716520|50238589|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
25125730|NCT01716520|50238590|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
25125731|NCT01716520|50238591|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
25125732|NCT01716520|50238592|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
25125733|NCT01716520|50238593|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
25125734|NCT01716520|50238594|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
25125735|NCT01716520|50238589|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
25267780|NCT01288430|50581818|FG000|Part 2|Adverse Event|0|||
25267781|NCT01288430|50581819|FG001|Part 2|Adverse Event|0|||
25267782|NCT01288430|50581820|FG002|Part 2|Adverse Event|0|||
25267783|NCT01288430|50581821|FG003|Part 2|Adverse Event|0|||
25267784|NCT01288430|50581822|FG004|Part 2|Adverse Event|0|||
25267785|NCT01288430|50581823|FG005|Part 2|Adverse Event|0|||
25267786|NCT01288430|50581824|FG006|Part 2|Adverse Event|0|||
25267787|NCT01288430|50581825|FG007|Part 2|Adverse Event|1|||
25267788|NCT01288430|50581826|FG008|Part 2|Adverse Event|1|||
25267789|NCT01288430|50581827|FG009|Part 2|Adverse Event|0|||
25267790|NCT01288430|50581818|FG000|Part 2|Other|0|||
25267791|NCT01288430|50581819|FG001|Part 2|Other|0|||
25267792|NCT01288430|50581820|FG002|Part 2|Other|0|||
25267793|NCT01288430|50581821|FG003|Part 2|Other|0|||
25267794|NCT01288430|50581822|FG004|Part 2|Other|0|||
25267795|NCT01288430|50581823|FG005|Part 2|Other|0|||
25267796|NCT01288430|50581824|FG006|Part 2|Other|0|||
25125736|NCT01716520|50238590|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
25267797|NCT01288430|50581825|FG007|Part 2|Other|0|||
25267798|NCT01288430|50581826|FG008|Part 2|Other|0|||
25267799|NCT01288430|50581827|FG009|Part 2|Other|1|||
25267800|NCT01287416|50581856|FG000|Pre-post Training|Withdrawal by Subject|17|||
25267801|NCT01287416|50581857|FG001|Pre-post Training|Withdrawal by Subject|24|||
25267802|NCT01287416|50581856|FG000|Pre-post Training|Lost to Follow-up|5|||
25267803|NCT01287416|50581857|FG001|Pre-post Training|Lost to Follow-up|1|||
25267804|NCT01287416|50581856|FG000|6 Month Follow-up|Lost to Follow-up|3|||
25267805|NCT01287416|50581857|FG001|6 Month Follow-up|Lost to Follow-up|2|||
25267806|NCT00998296|50581874|FG000|Overall Study|Progressive disease|0|||
25267807|NCT00998296|50581875|FG001|Overall Study|Progressive disease|1|||
25267808|NCT00998296|50581876|FG002|Overall Study|Progressive disease|0|||
25267809|NCT00998296|50581877|FG003|Overall Study|Progressive disease|0|||
25267810|NCT00998296|50581878|FG004|Overall Study|Progressive disease|0|||
25267811|NCT00998296|50581879|FG005|Overall Study|Progressive disease|0|||
25267812|NCT00998296|50581880|FG006|Overall Study|Progressive disease|1|||
25267813|NCT00998296|50581881|FG007|Overall Study|Progressive disease|0|||
25267814|NCT00998296|50581882|FG008|Overall Study|Progressive disease|0|||
25267815|NCT00998296|50581883|FG009|Overall Study|Progressive disease|14|||
25267816|NCT00998296|50581884|FG010|Overall Study|Progressive disease|5|||
25267817|NCT00998296|50581874|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
25267818|NCT00998296|50581875|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
25267819|NCT00998296|50581876|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
25267820|NCT00998296|50581877|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
25267821|NCT00998296|50581878|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
25267822|NCT00998296|50581879|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
25267823|NCT00998296|50581880|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
25267824|NCT00998296|50581881|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
25267825|NCT00998296|50581882|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
25267826|NCT00998296|50581883|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
25267827|NCT00998296|50581884|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
25267828|NCT00998296|50581874|FG000|Overall Study|Other adverse event|0|||
25267829|NCT00998296|50581875|FG001|Overall Study|Other adverse event|0|||
25267830|NCT00998296|50581876|FG002|Overall Study|Other adverse event|0|||
25267831|NCT00998296|50581877|FG003|Overall Study|Other adverse event|0|||
25267832|NCT00998296|50581878|FG004|Overall Study|Other adverse event|1|||
25267833|NCT00998296|50581879|FG005|Overall Study|Other adverse event|0|||
25267834|NCT00998296|50581880|FG006|Overall Study|Other adverse event|0|||
25125737|NCT01716520|50238591|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
25125738|NCT01716520|50238592|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
25125739|NCT01716520|50238593|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
25125740|NCT01716520|50238594|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
25125741|NCT01716520|50238589|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
25125742|NCT01716520|50238590|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
25267835|NCT00998296|50581881|FG007|Overall Study|Other adverse event|0|||
25267836|NCT00998296|50581882|FG008|Overall Study|Other adverse event|0|||
25267837|NCT00998296|50581883|FG009|Overall Study|Other adverse event|1|||
25267838|NCT00998296|50581884|FG010|Overall Study|Other adverse event|2|||
25267839|NCT00998296|50581874|FG000|Overall Study|Refused to continue taking trial med.|0|||
25267840|NCT00998296|50581875|FG001|Overall Study|Refused to continue taking trial med.|0|||
25267841|NCT00998296|50581876|FG002|Overall Study|Refused to continue taking trial med.|0|||
25267842|NCT00998296|50581877|FG003|Overall Study|Refused to continue taking trial med.|0|||
25267843|NCT00998296|50581878|FG004|Overall Study|Refused to continue taking trial med.|0|||
25267844|NCT00998296|50581879|FG005|Overall Study|Refused to continue taking trial med.|0|||
25267845|NCT00998296|50581880|FG006|Overall Study|Refused to continue taking trial med.|0|||
25267846|NCT00998296|50581881|FG007|Overall Study|Refused to continue taking trial med.|0|||
25267847|NCT00998296|50581882|FG008|Overall Study|Refused to continue taking trial med.|0|||
25267848|NCT00998296|50581883|FG009|Overall Study|Refused to continue taking trial med.|2|||
25267849|NCT00998296|50581884|FG010|Overall Study|Refused to continue taking trial med.|0|||
25267850|NCT00998296|50581874|FG000|Overall Study|Reason other than those specified above|0|||
25267851|NCT00998296|50581875|FG001|Overall Study|Reason other than those specified above|0|||
25267852|NCT00998296|50581876|FG002|Overall Study|Reason other than those specified above|0|||
25267853|NCT00998296|50581877|FG003|Overall Study|Reason other than those specified above|0|||
25267854|NCT00998296|50581878|FG004|Overall Study|Reason other than those specified above|0|||
25267855|NCT00998296|50581879|FG005|Overall Study|Reason other than those specified above|0|||
25267856|NCT00998296|50581880|FG006|Overall Study|Reason other than those specified above|0|||
25267857|NCT00998296|50581881|FG007|Overall Study|Reason other than those specified above|0|||
25267858|NCT00998296|50581882|FG008|Overall Study|Reason other than those specified above|0|||
25267859|NCT00998296|50581883|FG009|Overall Study|Reason other than those specified above|1|||
25267860|NCT00998296|50581884|FG010|Overall Study|Reason other than those specified above|0|||
25267861|NCT01178073|50581916|FG000|Overall Study|Adverse Event|34|||
25267862|NCT01178073|50581917|FG001|Overall Study|Adverse Event|27|||
25267863|NCT01178073|50581918|FG002|Overall Study|Adverse Event|24|||
25267864|NCT01178073|50581916|FG000|Overall Study|Protocol Violation|1|||
25267865|NCT01178073|50581917|FG001|Overall Study|Protocol Violation|1|||
25267866|NCT01178073|50581918|FG002|Overall Study|Protocol Violation|1|||
25267867|NCT01178073|50581916|FG000|Overall Study|Lost to Follow-up|2|||
25267868|NCT01178073|50581917|FG001|Overall Study|Lost to Follow-up|0|||
25267869|NCT01178073|50581918|FG002|Overall Study|Lost to Follow-up|3|||
25267870|NCT01178073|50581916|FG000|Overall Study|Physician Decision|14|||
25267871|NCT01178073|50581917|FG001|Overall Study|Physician Decision|10|||
25267872|NCT01178073|50581918|FG002|Overall Study|Physician Decision|10|||
25267873|NCT01178073|50581916|FG000|Overall Study|Withdrawal by Subject|10|||
25267874|NCT01178073|50581917|FG001|Overall Study|Withdrawal by Subject|6|||
25267875|NCT01178073|50581918|FG002|Overall Study|Withdrawal by Subject|8|||
25267876|NCT01178073|50581916|FG000|Overall Study|Missing Completion Status|1|||
25267877|NCT01178073|50581917|FG001|Overall Study|Missing Completion Status|0|||
25267878|NCT01178073|50581918|FG002|Overall Study|Missing Completion Status|0|||
25267879|NCT00997984|50581930|FG000|Overall Study|Adverse Event|1|||
25267880|NCT00997984|50581931|FG001|Overall Study|Adverse Event|8|||
25267881|NCT00997984|50581932|FG002|Overall Study|Adverse Event|8|||
25267882|NCT00997984|50581930|FG000|Overall Study|Protocol Violation|1|||
25267883|NCT00997984|50581931|FG001|Overall Study|Protocol Violation|3|||
25267884|NCT00997984|50581932|FG002|Overall Study|Protocol Violation|0|||
25267885|NCT00997984|50581930|FG000|Overall Study|Withdrawal by Subject|6|||
25267886|NCT00997984|50581931|FG001|Overall Study|Withdrawal by Subject|9|||
25267887|NCT00997984|50581932|FG002|Overall Study|Withdrawal by Subject|5|||
25267888|NCT00997984|50581930|FG000|Overall Study|Lost to Follow-up|8|||
25267889|NCT00997984|50581931|FG001|Overall Study|Lost to Follow-up|5|||
25267890|NCT00997984|50581932|FG002|Overall Study|Lost to Follow-up|4|||
25267891|NCT00997984|50581930|FG000|Overall Study|Lack of Efficacy|20|||
25267892|NCT00997984|50581931|FG001|Overall Study|Lack of Efficacy|6|||
25267893|NCT00997984|50581932|FG002|Overall Study|Lack of Efficacy|3|||
25267894|NCT00997984|50581930|FG000|Overall Study|Met exclusion criteria|1|||
25267895|NCT00997984|50581931|FG001|Overall Study|Met exclusion criteria|0|||
25267896|NCT00997984|50581932|FG002|Overall Study|Met exclusion criteria|0|||
25267897|NCT00997984|50581930|FG000|Overall Study|non-compliance|0|||
25267898|NCT00997984|50581931|FG001|Overall Study|non-compliance|2|||
25267899|NCT00997984|50581932|FG002|Overall Study|non-compliance|3|||
25267900|NCT00997984|50581930|FG000|Overall Study|Wrong medication dispensed|0|||
25267901|NCT00997984|50581931|FG001|Overall Study|Wrong medication dispensed|1|||
25267902|NCT00997984|50581932|FG002|Overall Study|Wrong medication dispensed|0|||
25267903|NCT00997984|50581930|FG000|Overall Study|Suicidal ideation|0|||
25267904|NCT00997984|50581931|FG001|Overall Study|Suicidal ideation|0|||
25267905|NCT00997984|50581932|FG002|Overall Study|Suicidal ideation|1|||
25267906|NCT00997984|50581930|FG000|Overall Study|Work schedule|0|||
25267907|NCT00997984|50581931|FG001|Overall Study|Work schedule|0|||
25267908|NCT00997984|50581932|FG002|Overall Study|Work schedule|2|||
25267909|NCT01177293|50581942|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
25267910|NCT01177293|50581943|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
25267911|NCT01177137|50581952|FG000|Overall Study|Withdrawal by Subject|10|||
25267912|NCT01177137|50581953|FG001|Overall Study|Withdrawal by Subject|10|||
25267913|NCT01177137|50581954|FG002|Overall Study|Withdrawal by Subject|2|||
25267914|NCT01177059|50581965|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
25267915|NCT01177059|50581965|FG000|Overall Study|Withdrew consent|2|||
25267916|NCT01177059|50581965|FG000|Overall Study|Lost to Follow-up|18|||
25267917|NCT01176513|50581969|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
25267918|NCT01299389|50581975|FG000|Double-blind|Adverse Event|45|||
25267919|NCT01299389|50581976|FG001|Double-blind|Adverse Event|27|||
25267920|NCT01299389|50581977|FG002|Double-blind|Adverse Event|0|||
25267921|NCT01299389|50581978|FG003|Double-blind|Adverse Event|0|||
25267922|NCT01299389|50581975|FG000|Double-blind|Lack of Efficacy|45|||
25267923|NCT01299389|50581976|FG001|Double-blind|Lack of Efficacy|21|||
25267924|NCT01299389|50581977|FG002|Double-blind|Lack of Efficacy|0|||
25267925|NCT01299389|50581978|FG003|Double-blind|Lack of Efficacy|0|||
25267926|NCT01299389|50581975|FG000|Double-blind|Lost to Follow-up|2|||
25267927|NCT01299389|50581976|FG001|Double-blind|Lost to Follow-up|1|||
25267928|NCT01299389|50581977|FG002|Double-blind|Lost to Follow-up|0|||
25267929|NCT01299389|50581978|FG003|Double-blind|Lost to Follow-up|0|||
25267930|NCT01299389|50581975|FG000|Double-blind|Withdrawal by Subject|16|||
25267931|NCT01299389|50581976|FG001|Double-blind|Withdrawal by Subject|13|||
25267932|NCT01299389|50581977|FG002|Double-blind|Withdrawal by Subject|0|||
25267933|NCT01299389|50581978|FG003|Double-blind|Withdrawal by Subject|0|||
25267934|NCT01299389|50581975|FG000|Double-blind|Other|1|||
25267935|NCT01299389|50581976|FG001|Double-blind|Other|1|||
25267936|NCT01299389|50581977|FG002|Double-blind|Other|0|||
25267937|NCT01299389|50581978|FG003|Double-blind|Other|0|||
25267938|NCT01299389|50581975|FG000|Double-blind|"fail to meet study population criteria"|0|||
25267939|NCT01299389|50581976|FG001|Double-blind|"fail to meet study population criteria"|1|||
25267940|NCT01299389|50581977|FG002|Double-blind|"fail to meet study population criteria"|0|||
25267941|NCT01299389|50581978|FG003|Double-blind|"fail to meet study population criteria"|0|||
25267942|NCT01299389|50581975|FG000|Post-observational|Other|0|||
25125743|NCT01716520|50238591|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
25125744|NCT01716520|50238592|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
25125745|NCT01716520|50238593|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
25125746|NCT01716520|50238594|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
25125747|NCT01716520|50238589|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
25125748|NCT01716520|50238590|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
25125749|NCT01716520|50238591|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
25125750|NCT01716520|50238592|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
25125751|NCT01716520|50238593|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
25125752|NCT01716520|50238594|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
25125753|NCT01716520|50238589|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
25125754|NCT01716520|50238590|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
25267943|NCT01299389|50581976|FG001|Post-observational|Other|0|||
25267944|NCT01299389|50581977|FG002|Post-observational|Other|12|||
25267945|NCT01299389|50581978|FG003|Post-observational|Other|6|||
25267946|NCT01298999|50581989|FG000|Overall Study|Physician Decision|0|||
25267947|NCT01298999|50581990|FG001|Overall Study|Physician Decision|1|||
25267948|NCT01298999|50581989|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
25267949|NCT01298999|50581990|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
25267950|NCT01007032|50582000|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
25267951|NCT01007032|50582001|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
25267952|NCT01007032|50582002|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
25267953|NCT01007032|50582003|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
25267954|NCT01007032|50582000|FG000|Overall Study|Withdrawal by Subject|0|||
25267955|NCT01007032|50582001|FG001|Overall Study|Withdrawal by Subject|0|||
25267956|NCT01007032|50582002|FG002|Overall Study|Withdrawal by Subject|0|||
25267957|NCT01007032|50582003|FG003|Overall Study|Withdrawal by Subject|1|||
25267958|NCT00976027|50582020|FG000|Overall Study|Serious Adverse Event|36|||
25267959|NCT00976027|50582021|FG001|Overall Study|Serious Adverse Event|17|||
25267960|NCT00976027|50582020|FG000|Overall Study|Adverse Event|0|||
25267961|NCT00976027|50582021|FG001|Overall Study|Adverse Event|2|||
25267962|NCT00976027|50582020|FG000|Overall Study|Protocol Violation|60|||
25267963|NCT00976027|50582021|FG001|Overall Study|Protocol Violation|27|||
25267964|NCT00976027|50582020|FG000|Overall Study|Lost to Follow-up|208|||
25267965|NCT00976027|50582021|FG001|Overall Study|Lost to Follow-up|103|||
25267966|NCT00976027|50582020|FG000|Overall Study|Withdrawal by Subject|107|||
25267967|NCT00976027|50582021|FG001|Overall Study|Withdrawal by Subject|66|||
25267968|NCT01298765|50582027|FG000|Titration Period|Adverse Event|26|||
25267969|NCT01298765|50582027|FG000|Titration Period|Death|1|||
25267970|NCT01298765|50582027|FG000|Titration Period|Lack of Efficacy|21|||
25267971|NCT01298765|50582027|FG000|Titration Period|Lost to Follow-up|9|||
25267972|NCT01298765|50582027|FG000|Titration Period|Physician Decision|1|||
25267973|NCT01298765|50582027|FG000|Titration Period|Withdrawal by Subject|10|||
25267974|NCT01298765|50582027|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
25267975|NCT01298765|50582027|FG000|Long-Term Treatment Period|Adverse Event|19|||
25267976|NCT01298765|50582027|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
25267977|NCT01298765|50582027|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
25267978|NCT01298765|50582027|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
25267979|NCT01298765|50582027|FG000|Long-Term Treatment Period|Physician Decision|1|||
25125755|NCT01716520|50238591|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
25125756|NCT01716520|50238592|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
25267980|NCT01298765|50582027|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
25267981|NCT00997438|50582034|FG000|Overall Study|Blood draw difficulty|2|||
25267982|NCT00997438|50582035|FG001|Overall Study|Blood draw difficulty|0|||
25267983|NCT00997438|50582036|FG002|Overall Study|Blood draw difficulty|1|||
25267984|NCT00997438|50582034|FG000|Overall Study|Withdrawal by Subject|1|||
25267985|NCT00997438|50582035|FG001|Overall Study|Withdrawal by Subject|1|||
25267986|NCT00997438|50582036|FG002|Overall Study|Withdrawal by Subject|0|||
25267987|NCT00997438|50582034|FG000|Overall Study|Exclusion criteria at visit 1|2|||
25267988|NCT00997438|50582035|FG001|Overall Study|Exclusion criteria at visit 1|2|||
25267989|NCT00997438|50582036|FG002|Overall Study|Exclusion criteria at visit 1|3|||
25267990|NCT00997126|50582047|FG000|Overall Study|Physician Decision|7|||
25267991|NCT00997126|50582048|FG001|Overall Study|Physician Decision|11|||
25267992|NCT01000636|50582054|FG000|Overall Study|Withdrawal by Subject|1|||
25267993|NCT01000636|50582054|FG000|Overall Study|Adverse Event|1|||
25267994|NCT00965419|50582058|FG000|Open Label Treatment for Responders|Adverse Event|33|||
25267995|NCT00965419|50582058|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
25267996|NCT00965419|50582058|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
25267997|NCT00965419|50582058|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
25267998|NCT00965419|50582058|FG000|Open Label Treatment for Responders|Physician Decision|6|||
25267999|NCT00965419|50582058|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
25268000|NCT00965419|50582058|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
25268001|NCT00965419|50582058|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
25268002|NCT00965419|50582058|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
25268003|NCT00965419|50582058|FG000|Follow-up Phase|Adverse Event|9|||
25268004|NCT00965419|50582058|FG000|Follow-up Phase|Protocol Violation|4|||
25268005|NCT00965419|50582058|FG000|Follow-up Phase|Withdrawal by Subject|8|||
25268006|NCT00965419|50582058|FG000|Follow-up Phase|Physician Decision|4|||
25268007|NCT00965419|50582058|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
25268008|NCT00965419|50582058|FG000|Follow-up Phase|Lack of Efficacy|28|||
25268009|NCT01000480|50582063|FG000|Induction Phase|Adverse Event|2|||
25268010|NCT01000480|50582063|FG000|Induction Phase|Lost to Follow-up|1|||
25268011|NCT01000480|50582063|FG000|Induction Phase|Physician Decision|1|||
25268012|NCT01000480|50582063|FG000|Induction Phase|Entry Criteria Not Met|3|||
25268013|NCT01000480|50582063|FG000|Concurrent Therapy Phase|Adverse Event|4|||
25268014|NCT01000480|50582063|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
25268015|NCT01000480|50582063|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
25268016|NCT01000480|50582063|FG000|Concurrent Therapy Phase|Physician Decision|1|||
25268017|NCT00965341|50582069|FG000|Overall Study|Withdrew consent|1|||
25268018|NCT00965341|50582070|FG001|Overall Study|Withdrew consent|5|||
25268019|NCT00965341|50582069|FG000|Overall Study|Lost to Follow-up|1|||
25268020|NCT00965341|50582070|FG001|Overall Study|Lost to Follow-up|0|||
25268021|NCT00965341|50582069|FG000|Overall Study|Transportation issues|4|||
25268022|NCT00965341|50582070|FG001|Overall Study|Transportation issues|3|||
25268023|NCT01175811|50582078|FG000|Overall Study|Adverse Event|1|||
25268024|NCT01175811|50582079|FG001|Overall Study|Adverse Event|1|||
25268025|NCT01175811|50582078|FG000|Overall Study|Entry criteria not met|3|||
25268026|NCT01175811|50582079|FG001|Overall Study|Entry criteria not met|1|||
25268027|NCT01175811|50582078|FG000|Overall Study|Lack of Efficacy|1|||
25268028|NCT01175811|50582079|FG001|Overall Study|Lack of Efficacy|0|||
25268029|NCT01175811|50582078|FG000|Overall Study|Lost to Follow-up|3|||
25268030|NCT01175811|50582079|FG001|Overall Study|Lost to Follow-up|2|||
25268031|NCT01175811|50582078|FG000|Overall Study|Physician Decision|1|||
25268032|NCT01175811|50582079|FG001|Overall Study|Physician Decision|1|||
25268033|NCT01175811|50582078|FG000|Overall Study|Protocol Violation|1|||
25268034|NCT01175811|50582079|FG001|Overall Study|Protocol Violation|2|||
25268035|NCT01175811|50582078|FG000|Overall Study|Withdrawal by Subject|6|||
25268036|NCT01175811|50582079|FG001|Overall Study|Withdrawal by Subject|7|||
25268037|NCT00965263|50582087|FG000|Overall Study|Physician Decision|2|||
25268038|NCT00965263|50582088|FG001|Overall Study|Physician Decision|0|||
25268039|NCT00965263|50582087|FG000|Overall Study|Family emergency|0|||
25268040|NCT00965263|50582088|FG001|Overall Study|Family emergency|1|||
25268041|NCT00965263|50582087|FG000|Overall Study|Protocol Violation|0|||
25268042|NCT00965263|50582088|FG001|Overall Study|Protocol Violation|2|||
25268043|NCT00965185|50582114|FG000|Overall Study|Lost to Follow-up|2|||
25178496|NCT01472939|50323773|FG001|Overall Study|Withdrawal by Subject|3|||
25178497|NCT01472939|50323774|FG002|Overall Study|Withdrawal by Subject|1|||
25268044|NCT00965185|50582115|FG001|Overall Study|Lost to Follow-up|0|||
25268045|NCT00965185|50582114|FG000|Overall Study|Withdrawal by Subject|0|||
25268046|NCT00965185|50582115|FG001|Overall Study|Withdrawal by Subject|1|||
25268047|NCT01174563|50582123|FG000|Overall Study|Progressive Disease|45|||
25268048|NCT01174563|50582123|FG000|Overall Study|Death|5|||
25268049|NCT01174563|50582123|FG000|Overall Study|Investigator's Discretion|5|||
25268050|NCT01174563|50582123|FG000|Overall Study|Participant Withdrew Consent|3|||
25268051|NCT01174563|50582123|FG000|Overall Study|Rash Adverse Event|1|||
25268052|NCT01174563|50582123|FG000|Overall Study|Sponsor's decision|1|||
25268053|NCT01298531|50582129|FG000|Overall Study|Lack of Efficacy|0|||
25268054|NCT01298531|50582130|FG001|Overall Study|Lack of Efficacy|1|||
25268055|NCT01298531|50582129|FG000|Overall Study|Lost to Follow-up|2|||
25125757|NCT01716520|50238593|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
25125758|NCT01716520|50238594|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
25125759|NCT01716520|50238589|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
25125760|NCT01716520|50238590|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
25125761|NCT01716520|50238591|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
25125762|NCT01716520|50238592|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
25125763|NCT01716520|50238593|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
25125764|NCT01716520|50238594|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
25125765|NCT01716520|50238589|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
25125766|NCT01716520|50238590|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
25125767|NCT01716520|50238591|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
25125768|NCT01716520|50238592|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
25125769|NCT01716520|50238593|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
25125770|NCT01716520|50238594|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
25125771|NCT01716520|50238589|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
25125772|NCT01716520|50238590|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
25125773|NCT01716520|50238591|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
25125774|NCT01716520|50238592|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
25125775|NCT01716520|50238593|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
25125776|NCT01716520|50238594|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
25125777|NCT01716520|50238589|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
25125778|NCT01716520|50238590|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
25125779|NCT01716520|50238591|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
25125780|NCT01716520|50238592|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
25125781|NCT01716520|50238593|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
25125782|NCT01716520|50238594|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
25125783|NCT01716520|50238589|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
25125784|NCT01716520|50238590|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
25125785|NCT01716520|50238591|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
25125786|NCT01716520|50238592|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
25125787|NCT01716520|50238593|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
25125788|NCT01716520|50238594|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
25125789|NCT01698268|50238604|FG000|Overall Study|Physician Decision|2|||
25125790|NCT01698268|50238605|FG001|Overall Study|Physician Decision|1|||
25125791|NCT01697956|50238613|FG000|Overall Study|Protocol Violation|1|||
25125792|NCT01697956|50238614|FG001|Overall Study|Protocol Violation|1|||
25125793|NCT01697800|50238628|FG000|Overall Study|Death|0|||
25125794|NCT01697800|50238629|FG001|Overall Study|Death|1|||
25125795|NCT01644500|50238638|FG000|Overall Study|Adverse Event|6|||
25125796|NCT01644500|50238639|FG001|Overall Study|Adverse Event|1|||
25125797|NCT01644500|50238640|FG002|Overall Study|Adverse Event|2|||
25125798|NCT01644500|50238638|FG000|Overall Study|Death|0|||
25125799|NCT01644500|50238639|FG001|Overall Study|Death|1|||
25125800|NCT01644500|50238640|FG002|Overall Study|Death|0|||
25125801|NCT01644500|50238638|FG000|Overall Study|Lost to Follow-up|3|||
25125802|NCT01644500|50238639|FG001|Overall Study|Lost to Follow-up|8|||
25125803|NCT01644500|50238640|FG002|Overall Study|Lost to Follow-up|0|||
25125804|NCT01644500|50238638|FG000|Overall Study|Protocol Violation|1|||
25125805|NCT01644500|50238639|FG001|Overall Study|Protocol Violation|1|||
25125806|NCT01644500|50238640|FG002|Overall Study|Protocol Violation|0|||
25125807|NCT01644500|50238638|FG000|Overall Study|Withdrawal by Subject|11|||
25125808|NCT01644500|50238639|FG001|Overall Study|Withdrawal by Subject|12|||
25125809|NCT01644500|50238640|FG002|Overall Study|Withdrawal by Subject|12|||
25125810|NCT01644500|50238638|FG000|Overall Study|Physician Decision|1|||
25125811|NCT01644500|50238639|FG001|Overall Study|Physician Decision|1|||
25125812|NCT01644500|50238640|FG002|Overall Study|Physician Decision|1|||
25125813|NCT01604824|50238652|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
25125814|NCT01604824|50238653|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
25125815|NCT01604824|50238654|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
25125816|NCT01604824|50238655|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
25125817|NCT01604824|50238656|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
25125818|NCT01604824|50238657|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
25125819|NCT01604824|50238652|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
25125820|NCT01604824|50238653|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
25125821|NCT01604824|50238654|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
25125822|NCT01604824|50238655|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
25125823|NCT01604824|50238656|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
25125824|NCT01604824|50238657|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
25268056|NCT01298531|50582130|FG001|Overall Study|Lost to Follow-up|0|||
25125825|NCT01716052|50238671|FG000|Overall Study|Withdrawal of funding|1|||
25125826|NCT01716052|50238672|FG001|Overall Study|Withdrawal of funding|1|||
25125827|NCT01641692|50238678|FG000|Treatment Period 1|Adverse Event|1|||
25268057|NCT01298531|50582129|FG000|Overall Study|Protocol Violation|1|||
25268058|NCT01298531|50582130|FG001|Overall Study|Protocol Violation|1|||
25268059|NCT01298531|50582129|FG000|Overall Study|Adverse Event|4|||
25268060|NCT01298531|50582130|FG001|Overall Study|Adverse Event|3|||
25268061|NCT01298531|50582129|FG000|Overall Study|Does not meet entrance criteria|0|||
25268062|NCT01298531|50582130|FG001|Overall Study|Does not meet entrance criteria|1|||
25268063|NCT01298531|50582129|FG000|Overall Study|Other|2|||
25268064|NCT01298531|50582130|FG001|Overall Study|Other|1|||
25125828|NCT01641692|50238679|FG001|Treatment Period 1|Adverse Event|0|||
25125829|NCT01641692|50238680|FG002|Treatment Period 1|Adverse Event|0|||
25125830|NCT01641692|50238681|FG003|Treatment Period 1|Adverse Event|0|||
25125831|NCT01641692|50238682|FG004|Treatment Period 1|Adverse Event|0|||
25125832|NCT01641692|50238683|FG005|Treatment Period 1|Adverse Event|0|||
25125833|NCT01641692|50238684|FG006|Treatment Period 1|Adverse Event|0|||
25125834|NCT01641692|50238685|FG007|Treatment Period 1|Adverse Event|0|||
25125835|NCT01641692|50238678|FG000|Treatment Period 1|Lack of Efficacy|0|||
25125836|NCT01641692|50238679|FG001|Treatment Period 1|Lack of Efficacy|0|||
25125837|NCT01641692|50238680|FG002|Treatment Period 1|Lack of Efficacy|0|||
25125838|NCT01641692|50238681|FG003|Treatment Period 1|Lack of Efficacy|0|||
25125839|NCT01641692|50238682|FG004|Treatment Period 1|Lack of Efficacy|0|||
25125840|NCT01641692|50238683|FG005|Treatment Period 1|Lack of Efficacy|0|||
25125841|NCT01641692|50238684|FG006|Treatment Period 1|Lack of Efficacy|0|||
25125842|NCT01641692|50238685|FG007|Treatment Period 1|Lack of Efficacy|1|||
25125843|NCT01641692|50238678|FG000|Treatment Period 1|Protocol Violation|1|||
25125844|NCT01641692|50238679|FG001|Treatment Period 1|Protocol Violation|0|||
25125845|NCT01641692|50238680|FG002|Treatment Period 1|Protocol Violation|0|||
25125846|NCT01641692|50238681|FG003|Treatment Period 1|Protocol Violation|0|||
25125847|NCT01641692|50238682|FG004|Treatment Period 1|Protocol Violation|2|||
25125848|NCT01641692|50238683|FG005|Treatment Period 1|Protocol Violation|0|||
25125849|NCT01641692|50238684|FG006|Treatment Period 1|Protocol Violation|0|||
25125850|NCT01641692|50238685|FG007|Treatment Period 1|Protocol Violation|0|||
25125851|NCT01641692|50238678|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
25125852|NCT01641692|50238679|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
25125853|NCT01641692|50238680|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
25125854|NCT01641692|50238681|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
25125855|NCT01641692|50238682|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
25125856|NCT01641692|50238683|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
25125857|NCT01641692|50238684|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
25125858|NCT01641692|50238685|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
25125859|NCT01641692|50238678|FG000|Treatment Period 1|Lost to Follow-up|0|||
25125860|NCT01641692|50238679|FG001|Treatment Period 1|Lost to Follow-up|0|||
25125861|NCT01641692|50238680|FG002|Treatment Period 1|Lost to Follow-up|1|||
25125862|NCT01641692|50238681|FG003|Treatment Period 1|Lost to Follow-up|0|||
25125863|NCT01641692|50238682|FG004|Treatment Period 1|Lost to Follow-up|0|||
25125864|NCT01641692|50238683|FG005|Treatment Period 1|Lost to Follow-up|0|||
25125865|NCT01641692|50238684|FG006|Treatment Period 1|Lost to Follow-up|0|||
25268065|NCT01174173|50582137|FG000|Overall Study|drug-drug interaction|1|||
25268066|NCT00964795|50582142|FG000|Overall Study|Withdrawal by Subject|79|||
25268067|NCT00964795|50582142|FG000|Overall Study|Adverse Event|12|||
25268068|NCT00964795|50582142|FG000|Overall Study|Death|14|||
25268069|NCT00964795|50582142|FG000|Overall Study|Lost to Follow-up|7|||
25268070|NCT00964795|50582142|FG000|Overall Study|Termination of Study by Sponsor|169|||
25268071|NCT00964795|50582142|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
25268072|NCT00964795|50582142|FG000|Overall Study|Other|23|||
25268073|NCT01173471|50582151|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
25268074|NCT01173471|50582152|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
25268075|NCT01173471|50582153|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
25268076|NCT01173471|50582154|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
25125866|NCT01641692|50238685|FG007|Treatment Period 1|Lost to Follow-up|0|||
25268077|NCT01173471|50582151|FG000|Overall Study|Condition under investigation worsened|2|||
25268078|NCT01173471|50582152|FG001|Overall Study|Condition under investigation worsened|0|||
25268079|NCT01173471|50582153|FG002|Overall Study|Condition under investigation worsened|0|||
25268080|NCT01173471|50582154|FG003|Overall Study|Condition under investigation worsened|0|||
25268081|NCT01173471|50582151|FG000|Overall Study|Lost to Follow-up|0|||
25125867|NCT01641692|50238678|FG000|Treatment Period 1|Physician Decision|0|||
25125868|NCT01641692|50238679|FG001|Treatment Period 1|Physician Decision|0|||
25125869|NCT01641692|50238680|FG002|Treatment Period 1|Physician Decision|0|||
25125870|NCT01641692|50238681|FG003|Treatment Period 1|Physician Decision|0|||
25125871|NCT01641692|50238682|FG004|Treatment Period 1|Physician Decision|1|||
25268082|NCT01173471|50582152|FG001|Overall Study|Lost to Follow-up|0|||
25268083|NCT01173471|50582153|FG002|Overall Study|Lost to Follow-up|1|||
25268084|NCT01173471|50582154|FG003|Overall Study|Lost to Follow-up|0|||
25268085|NCT01173471|50582151|FG000|Overall Study|Reason given as Other|0|||
25268086|NCT01173471|50582152|FG001|Overall Study|Reason given as Other|0|||
25268087|NCT01173471|50582153|FG002|Overall Study|Reason given as Other|1|||
25268088|NCT01173471|50582154|FG003|Overall Study|Reason given as Other|0|||
25268089|NCT01172847|50582164|FG000|Overall Study|Withdrawal by Subject|3|||
25125872|NCT01641692|50238683|FG005|Treatment Period 1|Physician Decision|0|||
25125873|NCT01641692|50238684|FG006|Treatment Period 1|Physician Decision|0|||
25125874|NCT01641692|50238685|FG007|Treatment Period 1|Physician Decision|0|||
25125875|NCT01641692|50238678|FG000|Treatment Period 1|Withdrawal by Subject|0|||
25125876|NCT01641692|50238679|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25125877|NCT01641692|50238680|FG002|Treatment Period 1|Withdrawal by Subject|0|||
25125878|NCT01641692|50238681|FG003|Treatment Period 1|Withdrawal by Subject|0|||
25125879|NCT01641692|50238682|FG004|Treatment Period 1|Withdrawal by Subject|0|||
25125880|NCT01641692|50238683|FG005|Treatment Period 1|Withdrawal by Subject|2|||
25125881|NCT01641692|50238684|FG006|Treatment Period 1|Withdrawal by Subject|0|||
25125882|NCT01641692|50238685|FG007|Treatment Period 1|Withdrawal by Subject|1|||
25125883|NCT01641692|50238678|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
25125884|NCT01641692|50238679|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
25125885|NCT01641692|50238680|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
25125886|NCT01641692|50238681|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
25125887|NCT01641692|50238682|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
25125888|NCT01641692|50238683|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
25125889|NCT01641692|50238684|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
25125890|NCT01641692|50238685|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
25125891|NCT01641692|50238678|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
25125892|NCT01641692|50238679|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
25125893|NCT01641692|50238680|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
25125894|NCT01641692|50238681|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
25125895|NCT01641692|50238682|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
25125896|NCT01641692|50238683|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
25125897|NCT01641692|50238684|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
25125898|NCT01641692|50238685|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
25125899|NCT01641692|50238678|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
25125900|NCT01641692|50238679|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
25125901|NCT01641692|50238680|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
25125902|NCT01641692|50238681|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
25125903|NCT01641692|50238682|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
25125904|NCT01641692|50238683|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
25125905|NCT01641692|50238684|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
25125906|NCT01641692|50238685|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
25125907|NCT01641692|50238678|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
25125908|NCT01641692|50238679|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
25125909|NCT01641692|50238680|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
25125910|NCT01641692|50238681|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
25125911|NCT01641692|50238682|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
25125912|NCT01641692|50238683|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
25125913|NCT01641692|50238684|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
25125914|NCT01641692|50238685|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
25125915|NCT01641692|50238678|FG000|Treatment Period 2|Lack of Efficacy|1|||
25125916|NCT01641692|50238679|FG001|Treatment Period 2|Lack of Efficacy|0|||
25125917|NCT01641692|50238680|FG002|Treatment Period 2|Lack of Efficacy|0|||
25125918|NCT01641692|50238681|FG003|Treatment Period 2|Lack of Efficacy|0|||
25125919|NCT01641692|50238682|FG004|Treatment Period 2|Lack of Efficacy|0|||
25125920|NCT01641692|50238683|FG005|Treatment Period 2|Lack of Efficacy|0|||
25125921|NCT01641692|50238684|FG006|Treatment Period 2|Lack of Efficacy|0|||
25125922|NCT01641692|50238685|FG007|Treatment Period 2|Lack of Efficacy|0|||
25125923|NCT01641692|50238678|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
25125924|NCT01641692|50238679|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
25125925|NCT01641692|50238680|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
25125926|NCT01641692|50238681|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
25125927|NCT01641692|50238682|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
25125928|NCT01641692|50238683|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
25125929|NCT01641692|50238684|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
25125930|NCT01641692|50238685|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
25125931|NCT01641692|50238678|FG000|Treatment Period 2|Lost to Follow-up|0|||
25125932|NCT01641692|50238679|FG001|Treatment Period 2|Lost to Follow-up|0|||
25125933|NCT01641692|50238680|FG002|Treatment Period 2|Lost to Follow-up|0|||
25125934|NCT01641692|50238681|FG003|Treatment Period 2|Lost to Follow-up|0|||
25125935|NCT01641692|50238682|FG004|Treatment Period 2|Lost to Follow-up|0|||
25268090|NCT00966355|50582177|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
25125936|NCT01641692|50238683|FG005|Treatment Period 2|Lost to Follow-up|1|||
25268091|NCT00966355|50582178|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
25268092|NCT00966355|50582179|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
25268093|NCT00966355|50582177|FG000|Overall Study|newly diagnosed advanced HCC|11|||
25268094|NCT00966355|50582178|FG001|Overall Study|newly diagnosed advanced HCC|12|||
25268095|NCT00966355|50582179|FG002|Overall Study|newly diagnosed advanced HCC|10|||
25268096|NCT00966355|50582177|FG000|Overall Study|Lost to Follow-up|5|||
25125937|NCT01641692|50238684|FG006|Treatment Period 2|Lost to Follow-up|0|||
25125938|NCT01641692|50238685|FG007|Treatment Period 2|Lost to Follow-up|0|||
25125939|NCT01641692|50238678|FG000|Treatment Period 2|Withdrawal by Subject|1|||
25125940|NCT01641692|50238679|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25125941|NCT01641692|50238680|FG002|Treatment Period 2|Withdrawal by Subject|0|||
25125942|NCT01641692|50238681|FG003|Treatment Period 2|Withdrawal by Subject|0|||
25125943|NCT01641692|50238682|FG004|Treatment Period 2|Withdrawal by Subject|0|||
25125944|NCT01641692|50238683|FG005|Treatment Period 2|Withdrawal by Subject|1|||
25125945|NCT01641692|50238684|FG006|Treatment Period 2|Withdrawal by Subject|0|||
25125946|NCT01641692|50238685|FG007|Treatment Period 2|Withdrawal by Subject|1|||
25125947|NCT01641692|50238678|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
25125948|NCT01641692|50238679|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
25125949|NCT01641692|50238680|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
25125950|NCT01641692|50238681|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
25125951|NCT01641692|50238682|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
25125952|NCT01641692|50238683|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
25125953|NCT01641692|50238684|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
25125954|NCT01641692|50238685|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
25125955|NCT01641692|50238678|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
25125956|NCT01641692|50238679|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
25125957|NCT01641692|50238680|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
25125958|NCT01641692|50238681|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
25125959|NCT01641692|50238682|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
25125960|NCT01641692|50238683|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
25125961|NCT01641692|50238684|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
25125962|NCT01641692|50238685|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
25125963|NCT01641692|50238678|FG000|Treatment Period 3|Adverse Event|0|||
25125964|NCT01641692|50238679|FG001|Treatment Period 3|Adverse Event|0|||
25125965|NCT01641692|50238680|FG002|Treatment Period 3|Adverse Event|0|||
25125966|NCT01641692|50238681|FG003|Treatment Period 3|Adverse Event|0|||
25125967|NCT01641692|50238682|FG004|Treatment Period 3|Adverse Event|0|||
25125968|NCT01641692|50238683|FG005|Treatment Period 3|Adverse Event|0|||
25125969|NCT01641692|50238684|FG006|Treatment Period 3|Adverse Event|1|||
25125970|NCT01641692|50238685|FG007|Treatment Period 3|Adverse Event|0|||
25125971|NCT01641692|50238678|FG000|Treatment Period 3|Protocol Violation|0|||
25125972|NCT01641692|50238679|FG001|Treatment Period 3|Protocol Violation|0|||
25125973|NCT01641692|50238680|FG002|Treatment Period 3|Protocol Violation|1|||
25125974|NCT01641692|50238681|FG003|Treatment Period 3|Protocol Violation|0|||
25125975|NCT01641692|50238682|FG004|Treatment Period 3|Protocol Violation|0|||
25125976|NCT01641692|50238683|FG005|Treatment Period 3|Protocol Violation|0|||
25125977|NCT01641692|50238684|FG006|Treatment Period 3|Protocol Violation|0|||
25125978|NCT01641692|50238685|FG007|Treatment Period 3|Protocol Violation|0|||
25125979|NCT01641692|50238678|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
25125980|NCT01641692|50238679|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
25125981|NCT01641692|50238680|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
25125982|NCT01641692|50238681|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
25125983|NCT01641692|50238682|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
25125984|NCT01641692|50238683|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
25125985|NCT01641692|50238684|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
25125986|NCT01641692|50238685|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
25125987|NCT01641692|50238678|FG000|Treatment Period 3|Lost to Follow-up|0|||
25125988|NCT01641692|50238679|FG001|Treatment Period 3|Lost to Follow-up|1|||
25125989|NCT01641692|50238680|FG002|Treatment Period 3|Lost to Follow-up|0|||
25125990|NCT01641692|50238681|FG003|Treatment Period 3|Lost to Follow-up|0|||
25125991|NCT01641692|50238682|FG004|Treatment Period 3|Lost to Follow-up|0|||
25125992|NCT01641692|50238683|FG005|Treatment Period 3|Lost to Follow-up|0|||
25125993|NCT01641692|50238684|FG006|Treatment Period 3|Lost to Follow-up|0|||
25125994|NCT01641692|50238685|FG007|Treatment Period 3|Lost to Follow-up|0|||
25268097|NCT00966355|50582178|FG001|Overall Study|Lost to Follow-up|4|||
25268098|NCT00966355|50582179|FG002|Overall Study|Lost to Follow-up|3|||
25125995|NCT01641692|50238678|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
25125996|NCT01641692|50238679|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
25268099|NCT01172535|50582187|FG000|Overall Study|Death|3|||
25125997|NCT01641692|50238680|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
25268100|NCT01172535|50582187|FG000|Overall Study|Withdrawal by Subject|2|||
25268101|NCT01172535|50582187|FG000|Overall Study|Lost to Follow-up|1|||
25268102|NCT01172535|50582187|FG000|Overall Study|Ineligible at study entry|1|||
25268103|NCT01172535|50582187|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
25268104|NCT00966277|50582196|FG000|Overall Study|Withdrawal by Subject|3|||
25268105|NCT00966277|50582197|FG001|Overall Study|Withdrawal by Subject|0|||
25268106|NCT00966277|50582196|FG000|Overall Study|Ineligible|1|||
25268107|NCT00966277|50582197|FG001|Overall Study|Ineligible|3|||
25268108|NCT00966277|50582196|FG000|Overall Study|Treatment Plan Changed|0|||
25268109|NCT00966277|50582197|FG001|Overall Study|Treatment Plan Changed|1|||
25268110|NCT01298141|50582203|FG000|Overall Study|Adverse Event|3|||
25268111|NCT01298141|50582203|FG000|Overall Study|Refusal of Required Study Procedures|1|||
25268112|NCT01298141|50582203|FG000|Overall Study|Withdrawal by Subject|6|||
25268113|NCT01298141|50582203|FG000|Overall Study|Termination of Study by the Investigator|5|||
25268114|NCT01298141|50582203|FG000|Overall Study|Other|5|||
25268115|NCT01298141|50582203|FG000|Overall Study|Lost to Follow-up|1|||
25268116|NCT01298141|50582203|FG000|Overall Study|Death|6|||
25268117|NCT01298141|50582203|FG000|Overall Study|Not treated|4|||
25268118|NCT01171989|50582210|FG000|Overall Study|Lost to Follow-up|0|||
25268119|NCT01171989|50582211|FG001|Overall Study|Lost to Follow-up|0|||
25268120|NCT01171989|50582212|FG002|Overall Study|Lost to Follow-up|1|||
25268121|NCT01297517|50582223|FG000|Overall Study|Adverse Event|21|||
25125998|NCT01641692|50238681|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
25125999|NCT01641692|50238682|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
25126000|NCT01641692|50238683|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
25126001|NCT01641692|50238684|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
25126002|NCT01641692|50238685|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
25126003|NCT01641692|50238678|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
25126004|NCT01641692|50238679|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
25126005|NCT01641692|50238680|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
25126006|NCT01641692|50238681|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
25126007|NCT01641692|50238682|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
25126008|NCT01641692|50238683|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
25126009|NCT01641692|50238684|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
25126010|NCT01641692|50238685|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
25126011|NCT01682512|50238707|FG000|Overall Study|Adverse Event|6|||
25126012|NCT01682512|50238708|FG001|Overall Study|Adverse Event|5|||
25126013|NCT01682512|50238709|FG002|Overall Study|Adverse Event|2|||
25126014|NCT01682512|50238707|FG000|Overall Study|Withdrawal by Subject|2|||
25126015|NCT01682512|50238708|FG001|Overall Study|Withdrawal by Subject|6|||
25126016|NCT01682512|50238709|FG002|Overall Study|Withdrawal by Subject|3|||
25126017|NCT01682512|50238707|FG000|Overall Study|Physician Decision|0|||
25126018|NCT01682512|50238708|FG001|Overall Study|Physician Decision|2|||
25126019|NCT01682512|50238709|FG002|Overall Study|Physician Decision|0|||
25126020|NCT01682512|50238707|FG000|Overall Study|Study terminated by sponsor|46|||
25126021|NCT01682512|50238708|FG001|Overall Study|Study terminated by sponsor|43|||
25126022|NCT01682512|50238709|FG002|Overall Study|Study terminated by sponsor|0|||
25126023|NCT01682512|50238707|FG000|Overall Study|Lost to Follow-up|3|||
25126024|NCT01682512|50238708|FG001|Overall Study|Lost to Follow-up|0|||
25126025|NCT01682512|50238709|FG002|Overall Study|Lost to Follow-up|2|||
25126026|NCT01682512|50238707|FG000|Overall Study|Protocol Violation|2|||
25126027|NCT01682512|50238708|FG001|Overall Study|Protocol Violation|3|||
25126028|NCT01682512|50238709|FG002|Overall Study|Protocol Violation|2|||
25126029|NCT01682512|50238707|FG000|Overall Study|Primary lack of efficacy|10|||
25126030|NCT01682512|50238708|FG001|Overall Study|Primary lack of efficacy|7|||
25126031|NCT01682512|50238709|FG002|Overall Study|Primary lack of efficacy|7|||
25126032|NCT01682512|50238707|FG000|Overall Study|Secondary lack of efficacy|1|||
25126033|NCT01682512|50238708|FG001|Overall Study|Secondary lack of efficacy|1|||
25126034|NCT01682512|50238709|FG002|Overall Study|Secondary lack of efficacy|0|||
25126035|NCT01682512|50238707|FG000|Overall Study|Other than stated above|2|||
25126036|NCT01682512|50238708|FG001|Overall Study|Other than stated above|4|||
25126037|NCT01682512|50238709|FG002|Overall Study|Other than stated above|2|||
25126038|NCT02256488|50238721|FG000|Overall Study|Lost to Follow-up|6|||
25126039|NCT02256488|50238722|FG001|Overall Study|Lost to Follow-up|6|||
25268122|NCT01297517|50582224|FG001|Overall Study|Adverse Event|7|||
25268123|NCT01297517|50582225|FG002|Overall Study|Adverse Event|16|||
25268124|NCT01297517|50582223|FG000|Overall Study|Lost to Follow-up|1|||
25268125|NCT01297517|50582224|FG001|Overall Study|Lost to Follow-up|0|||
25268126|NCT01297517|50582225|FG002|Overall Study|Lost to Follow-up|1|||
25126040|NCT02256488|50238723|FG002|Overall Study|Lost to Follow-up|9|||
25126041|NCT02256488|50238724|FG003|Overall Study|Lost to Follow-up|3|||
25126042|NCT02256488|50238721|FG000|Overall Study|OTHER|1|||
25126043|NCT02256488|50238722|FG001|Overall Study|OTHER|0|||
25126044|NCT02256488|50238723|FG002|Overall Study|OTHER|1|||
25268127|NCT01297517|50582223|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
25268128|NCT01297517|50582224|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
25268129|NCT01297517|50582225|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
25268130|NCT01297517|50582223|FG000|Overall Study|Noncompliance|1|||
25268131|NCT01297517|50582224|FG001|Overall Study|Noncompliance|0|||
25268132|NCT01297517|50582225|FG002|Overall Study|Noncompliance|0|||
25268133|NCT01297517|50582223|FG000|Overall Study|Protocol Violation|1|||
25268134|NCT01297517|50582224|FG001|Overall Study|Protocol Violation|1|||
25268135|NCT01297517|50582225|FG002|Overall Study|Protocol Violation|1|||
25268136|NCT01297517|50582223|FG000|Overall Study|Inadequate Control of IOP|1|||
25268137|NCT01297517|50582224|FG001|Overall Study|Inadequate Control of IOP|1|||
25268138|NCT01297517|50582225|FG002|Overall Study|Inadequate Control of IOP|2|||
25268139|NCT01171677|50582235|FG000|Overall Study|Withdrawal by Subject|0|||
25268140|NCT01171677|50582236|FG001|Overall Study|Withdrawal by Subject|3|||
25268141|NCT01171677|50582235|FG000|Overall Study|Adverse Event|1|||
25268142|NCT01171677|50582236|FG001|Overall Study|Adverse Event|0|||
25268143|NCT01171677|50582235|FG000|Overall Study|completed <70% IntenSati classes|5|||
25268144|NCT01171677|50582236|FG001|Overall Study|completed <70% IntenSati classes|0|||
25268145|NCT01171521|50582242|FG000|Overall Study|Lost to Follow-up|5|||
25268146|NCT01171521|50582242|FG000|Overall Study|screen failure|1|||
25268147|NCT01296347|50582248|FG000|Allocation|Withdrawal by Subject|1|||
25268148|NCT01296347|50582249|FG001|Allocation|Withdrawal by Subject|2|||
25268149|NCT01296347|50582248|FG000|Allocation|Lack of Efficacy|1|||
25268150|NCT01296347|50582249|FG001|Allocation|Lack of Efficacy|2|||
25268151|NCT01296347|50582248|FG000|Allocation|not received infusion|1|||
25268152|NCT01296347|50582249|FG001|Allocation|not received infusion|0|||
25268153|NCT01296347|50582248|FG000|6 Week Follow up|Death|0|||
25268154|NCT01296347|50582249|FG001|6 Week Follow up|Death|1|||
25268155|NCT01296347|50582248|FG000|3 Month Follow up|Death|1|||
25268156|NCT01296347|50582249|FG001|3 Month Follow up|Death|0|||
25268157|NCT01296347|50582248|FG000|3 Month Follow up|Lost to Follow-up|0|||
25268158|NCT01296347|50582249|FG001|3 Month Follow up|Lost to Follow-up|1|||
25268159|NCT01296347|50582248|FG000|6 Month Follow up|Death|2|||
25268160|NCT01296347|50582249|FG001|6 Month Follow up|Death|1|||
25268161|NCT01296347|50582248|FG000|6 Month Follow up|Lost to Follow-up|0|||
25268162|NCT01296347|50582249|FG001|6 Month Follow up|Lost to Follow-up|1|||
25268163|NCT01296347|50582248|FG000|12 Month Follow up|Lost to Follow-up|3|||
25268164|NCT01296347|50582249|FG001|12 Month Follow up|Lost to Follow-up|1|||
25268165|NCT01296347|50582248|FG000|12 Month Follow up|Death|1|||
25268166|NCT01296347|50582249|FG001|12 Month Follow up|Death|1|||
25268167|NCT01296347|50582248|FG000|12 Month Follow up|Withdrawal by Subject|0|||
25268168|NCT01296347|50582249|FG001|12 Month Follow up|Withdrawal by Subject|1|||
25268169|NCT01296035|50582258|FG000|Overall Study|Withdrawal by Subject|1|||
25268170|NCT01294787|50582262|FG000|Period 1|Adverse Event|0|||
25268171|NCT01294787|50582263|FG001|Period 1|Adverse Event|0|||
25268172|NCT01294787|50582264|FG002|Period 1|Adverse Event|0|||
25268173|NCT01294787|50582265|FG003|Period 1|Adverse Event|0|||
25268174|NCT01294787|50582266|FG004|Period 1|Adverse Event|1|||
25268175|NCT01294787|50582267|FG005|Period 1|Adverse Event|0|||
25268176|NCT01294787|50582262|FG000|Period 1|Withdrawal by Subject|0|||
25268177|NCT01294787|50582263|FG001|Period 1|Withdrawal by Subject|0|||
25268178|NCT01294787|50582264|FG002|Period 1|Withdrawal by Subject|0|||
25268179|NCT01294787|50582265|FG003|Period 1|Withdrawal by Subject|1|||
25268180|NCT01294787|50582266|FG004|Period 1|Withdrawal by Subject|1|||
25268181|NCT01294787|50582267|FG005|Period 1|Withdrawal by Subject|1|||
25268182|NCT01294787|50582262|FG000|Period 1|Administrative problem|0|||
25268183|NCT01294787|50582263|FG001|Period 1|Administrative problem|0|||
25268184|NCT01294787|50582264|FG002|Period 1|Administrative problem|1|||
25268185|NCT01294787|50582265|FG003|Period 1|Administrative problem|0|||
25268186|NCT01294787|50582266|FG004|Period 1|Administrative problem|0|||
25268187|NCT01294787|50582267|FG005|Period 1|Administrative problem|1|||
25268188|NCT01294787|50582262|FG000|Period 2|Adverse Event|0|||
25268189|NCT01294787|50582263|FG001|Period 2|Adverse Event|3|||
25268190|NCT01294787|50582264|FG002|Period 2|Adverse Event|0|||
25268191|NCT01294787|50582265|FG003|Period 2|Adverse Event|1|||
25268192|NCT01294787|50582266|FG004|Period 2|Adverse Event|0|||
25268193|NCT01294787|50582267|FG005|Period 2|Adverse Event|0|||
25268194|NCT01294787|50582262|FG000|Period 2|No longer needs study drug|0|||
25268195|NCT01294787|50582263|FG001|Period 2|No longer needs study drug|0|||
25268196|NCT01294787|50582264|FG002|Period 2|No longer needs study drug|0|||
25268197|NCT01294787|50582265|FG003|Period 2|No longer needs study drug|1|||
25268198|NCT01294787|50582266|FG004|Period 2|No longer needs study drug|0|||
25268199|NCT01294787|50582267|FG005|Period 2|No longer needs study drug|0|||
25268200|NCT01294787|50582262|FG000|Period 3|Adverse Event|0|||
25268201|NCT01294787|50582263|FG001|Period 3|Adverse Event|0|||
25268202|NCT01294787|50582264|FG002|Period 3|Adverse Event|0|||
25268203|NCT01294787|50582265|FG003|Period 3|Adverse Event|0|||
25268204|NCT01294787|50582266|FG004|Period 3|Adverse Event|1|||
25268205|NCT01294787|50582267|FG005|Period 3|Adverse Event|0|||
25268206|NCT01294553|50582278|FG000|Overall Study|Duplicated Participants|1|||
25268207|NCT01294553|50582278|FG000|Overall Study|Protocol Violation|268|||
25268208|NCT01294397|50582283|FG000|Overall Study|Withdrawal by Subject|1|||
25268209|NCT01294397|50582283|FG000|Overall Study|Administrative Decision|1|||
25268210|NCT01293695|50582291|FG000|Overall Study|Withdrawal by Subject|7|||
25268211|NCT01293695|50582292|FG001|Overall Study|Withdrawal by Subject|1|||
25268212|NCT01293695|50582291|FG000|Overall Study|Lost to Follow-up|8|||
25268213|NCT01293695|50582292|FG001|Overall Study|Lost to Follow-up|6|||
25268214|NCT01293539|50582301|FG000|Overall Study|Physician Decision|1|||
25268215|NCT01292837|50582305|FG000|Overall Study|Adverse Event|1|||
25268216|NCT01292837|50582305|FG000|Overall Study|Further treatment determined|1|||
25268217|NCT00965731|50582311|FG000|Overall Study|Death|0|||
25268218|NCT00965731|50582312|FG001|Overall Study|Death|4|||
25268219|NCT00965731|50582311|FG000|Overall Study|Withdrawal by Subject|0|||
25268220|NCT00965731|50582312|FG001|Overall Study|Withdrawal by Subject|1|||
25268221|NCT00965731|50582311|FG000|Overall Study|Other|7|||
25268222|NCT00965731|50582312|FG001|Overall Study|Other|15|||
25268223|NCT00965575|50582325|FG000|Overall Study|subject unwillingness to swallow study c|1|||
25268224|NCT00965575|50582326|FG001|Overall Study|subject unwillingness to swallow study c|0|||
25268225|NCT00965497|50582334|FG000|Overall Study|Physician Decision|1|||
25268226|NCT00963937|50582341|FG000|Overall Study|Protocol Violation|1|||
25268227|NCT00963937|50582342|FG001|Overall Study|Protocol Violation|1|||
25126045|NCT02256488|50238724|FG003|Overall Study|OTHER|1|||
25126046|NCT02256488|50238721|FG000|Overall Study|Withdrawal by Subject|1|||
25126047|NCT02256488|50238722|FG001|Overall Study|Withdrawal by Subject|0|||
25126048|NCT02256488|50238723|FG002|Overall Study|Withdrawal by Subject|0|||
25126049|NCT02256488|50238724|FG003|Overall Study|Withdrawal by Subject|2|||
25126050|NCT01715896|50238737|FG000|Overall Study|Lost to Follow-up|0|||
25126051|NCT01715896|50238738|FG001|Overall Study|Lost to Follow-up|2|||
25126052|NCT01715896|50238737|FG000|Overall Study|Withdrawal by Subject|1|||
25126053|NCT01715896|50238738|FG001|Overall Study|Withdrawal by Subject|4|||
25126054|NCT01715896|50238737|FG000|Overall Study|Other|2|||
25126055|NCT01715896|50238738|FG001|Overall Study|Other|5|||
25126056|NCT02255552|50238747|FG000|Overall Study|Participants enrolled into another study|0|||
25126057|NCT02255552|50238748|FG001|Overall Study|Participants enrolled into another study|11|||
25126058|NCT02255552|50238747|FG000|Overall Study|Withdrawal by Subject|1|||
25126059|NCT02255552|50238748|FG001|Overall Study|Withdrawal by Subject|4|||
25126060|NCT01714726|50238756|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
25126061|NCT01714726|50238757|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
25126062|NCT01714726|50238758|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
25126063|NCT01714726|50238759|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
25126064|NCT01714726|50238756|FG000|Double-Blinded Induction Period|Adverse Event|0|||
25126065|NCT01714726|50238757|FG001|Double-Blinded Induction Period|Adverse Event|1|||
25126066|NCT01714726|50238758|FG002|Double-Blinded Induction Period|Adverse Event|0|||
25126067|NCT01714726|50238759|FG003|Double-Blinded Induction Period|Adverse Event|0|||
25126068|NCT01714726|50238756|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
25126069|NCT01714726|50238757|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
25126070|NCT01714726|50238758|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
25126071|NCT01714726|50238759|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
25126072|NCT01714726|50238756|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
25126073|NCT01714726|50238757|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
25126074|NCT01714726|50238758|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
25126075|NCT01714726|50238759|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
25126076|NCT01714726|50238756|FG000|Open-Label Period|Other|0|||
25126077|NCT01714726|50238757|FG001|Open-Label Period|Other|0|||
25126078|NCT01714726|50238758|FG002|Open-Label Period|Other|1|||
25126079|NCT01714726|50238759|FG003|Open-Label Period|Other|3|||
25126080|NCT01714726|50238756|FG000|Open-Label Period|Adverse Event|0|||
25126081|NCT01714726|50238757|FG001|Open-Label Period|Adverse Event|0|||
25126082|NCT01714726|50238758|FG002|Open-Label Period|Adverse Event|1|||
25126083|NCT01714726|50238759|FG003|Open-Label Period|Adverse Event|0|||
25126084|NCT01714726|50238756|FG000|Open-Label Period|Withdrawal by Subject|0|||
25126085|NCT01714726|50238757|FG001|Open-Label Period|Withdrawal by Subject|0|||
25126086|NCT01714726|50238758|FG002|Open-Label Period|Withdrawal by Subject|9|||
25126087|NCT01714726|50238759|FG003|Open-Label Period|Withdrawal by Subject|19|||
25268228|NCT00963937|50582343|FG002|Overall Study|Protocol Violation|0|||
25126088|NCT01714726|50238756|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
25126089|NCT01714726|50238757|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
25126090|NCT01714726|50238758|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
25126091|NCT01714726|50238759|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
25178498|NCT01472939|50323775|FG003|Overall Study|Withdrawal by Subject|4|||
25268229|NCT00963937|50582341|FG000|Overall Study|Physician Decision|18|||
25126092|NCT01714726|50238756|FG000|Open-Label Period|Lost to Follow-up|0|||
25268230|NCT00963937|50582342|FG001|Overall Study|Physician Decision|10|||
25268231|NCT00963937|50582343|FG002|Overall Study|Physician Decision|4|||
25268232|NCT01170663|50582356|FG000|Overall Study|Lost to Follow-up|3|||
25268233|NCT01170663|50582357|FG001|Overall Study|Lost to Follow-up|9|||
25268234|NCT01170663|50582356|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
25268235|NCT01170663|50582357|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
25268236|NCT01170273|50582365|FG000|Overall Study|Lost to Follow-up|6|||
25268237|NCT01170273|50582366|FG001|Overall Study|Lost to Follow-up|8|||
25268238|NCT01170273|50582365|FG000|Overall Study|Protocol Violation|1|||
25268239|NCT01170273|50582366|FG001|Overall Study|Protocol Violation|0|||
25268240|NCT01170273|50582365|FG000|Overall Study|Death|1|||
25268241|NCT01170273|50582366|FG001|Overall Study|Death|0|||
25268242|NCT01170273|50582365|FG000|Overall Study|Adverse Event|0|||
25268243|NCT01170273|50582366|FG001|Overall Study|Adverse Event|1|||
25268244|NCT01170039|50582374|FG000|Overall Study|Withdrawal by Subject|5|||
25268245|NCT01170039|50582375|FG001|Overall Study|Withdrawal by Subject|3|||
25268246|NCT01170039|50582374|FG000|Overall Study|Lack of funding, drug not available|3|||
25268247|NCT01170039|50582375|FG001|Overall Study|Lack of funding, drug not available|3|||
25268248|NCT01169649|50582381|FG000|Overall Study|Patient Not Treated|3|||
25268249|NCT01169493|50582391|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
25268250|NCT01169493|50582392|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
25268251|NCT01169493|50582393|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
25268252|NCT01169493|50582394|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
25268253|NCT01169493|50582395|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
25268254|NCT01169493|50582396|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
25268255|NCT01169493|50582391|FG000|Period 3 (6 Months)|Adverse Event|0|||
25268256|NCT01169493|50582392|FG001|Period 3 (6 Months)|Adverse Event|1|||
25268257|NCT01169493|50582393|FG002|Period 3 (6 Months)|Adverse Event|0|||
25268258|NCT01169493|50582394|FG003|Period 3 (6 Months)|Adverse Event|0|||
25268259|NCT01169493|50582395|FG004|Period 3 (6 Months)|Adverse Event|0|||
25009239|NCT00075725|50102302|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
25009240|NCT00075725|50102303|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
25009241|NCT00075725|50102304|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
25009242|NCT00075725|50102305|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
25009243|NCT00075725|50102294|FG000|Overall Study|Inevaluable|1|||
25009244|NCT00075725|50102295|FG001|Overall Study|Inevaluable|1|||
25009245|NCT00075725|50102296|FG002|Overall Study|Inevaluable|4|||
25009246|NCT00075725|50102297|FG003|Overall Study|Inevaluable|2|||
25009247|NCT00075725|50102298|FG004|Overall Study|Inevaluable|2|||
25009248|NCT00075725|50102299|FG005|Overall Study|Inevaluable|9|||
25009249|NCT00075725|50102300|FG006|Overall Study|Inevaluable|1|||
25009250|NCT00075725|50102301|FG007|Overall Study|Inevaluable|11|||
25009251|NCT00075725|50102302|FG008|Overall Study|Inevaluable|2|||
25009252|NCT00075725|50102303|FG009|Overall Study|Inevaluable|0|||
25126093|NCT01714726|50238757|FG001|Open-Label Period|Lost to Follow-up|0|||
25126094|NCT01714726|50238758|FG002|Open-Label Period|Lost to Follow-up|3|||
25126095|NCT01714726|50238759|FG003|Open-Label Period|Lost to Follow-up|4|||
25126096|NCT02255474|50238772|FG000|Overall Study|Lost to Follow-up|1|||
25126097|NCT02255474|50238773|FG001|Overall Study|Lost to Follow-up|1|||
25126098|NCT02255474|50238774|FG002|Overall Study|Lost to Follow-up|3|||
25126099|NCT02255474|50238772|FG000|Overall Study|Withdrawal by Subject|1|||
25126100|NCT02255474|50238773|FG001|Overall Study|Withdrawal by Subject|1|||
25126101|NCT02255474|50238774|FG002|Overall Study|Withdrawal by Subject|0|||
25126102|NCT02254772|50238783|FG000|Overall Study|Ineligible|1|||
25126103|NCT02254772|50238783|FG000|Overall Study|Withdrawal by Subject|1|||
25126104|NCT02254460|50238787|FG000|Overall Study|Adverse Event|1|||
25126105|NCT02254460|50238788|FG001|Overall Study|Adverse Event|0|||
25126106|NCT01682044|50238794|FG000|Overall Study|Death|1|||
25126107|NCT01682044|50238794|FG000|Overall Study|Progression|3|||
25126108|NCT01696942|50238800|FG000|Overall Study|Withdrawal by Subject|1|||
25126109|NCT01696942|50238801|FG001|Overall Study|Withdrawal by Subject|0|||
25126110|NCT01696942|50238800|FG000|Overall Study|Protocol Violation|1|||
25126111|NCT01696942|50238801|FG001|Overall Study|Protocol Violation|2|||
25126112|NCT01696942|50238800|FG000|Overall Study|screen failure|0|||
25126113|NCT01696942|50238801|FG001|Overall Study|screen failure|1|||
25126114|NCT01640366|50238807|FG000|Overall Study|Withdrawal by Subject|1|||
25268260|NCT01169493|50582396|FG005|Period 3 (6 Months)|Adverse Event|0|||
25268261|NCT01169493|50582391|FG000|Period 3 (6 Months)|Physician Decision|0|||
25268262|NCT01169493|50582392|FG001|Period 3 (6 Months)|Physician Decision|1|||
25268263|NCT01169493|50582393|FG002|Period 3 (6 Months)|Physician Decision|1|||
25009253|NCT00075725|50102304|FG010|Overall Study|Inevaluable|1|||
25126115|NCT01640366|50238807|FG000|Overall Study|Protocol Violation|16|||
25178499|NCT01544179|50323790|FG000|Overall Study|Death|50|||
25009254|NCT00075725|50102305|FG011|Overall Study|Inevaluable|0|||
25009255|NCT00075725|50102294|FG000|Overall Study|Other|4|||
25126116|NCT01640366|50238807|FG000|Overall Study|Lost to Follow-up|5|||
25126117|NCT01640288|50238815|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
25178500|NCT01544179|50323791|FG001|Overall Study|Death|37|||
25268264|NCT01169493|50582394|FG003|Period 3 (6 Months)|Physician Decision|0|||
25268265|NCT01169493|50582395|FG004|Period 3 (6 Months)|Physician Decision|0|||
25268266|NCT01169493|50582396|FG005|Period 3 (6 Months)|Physician Decision|0|||
25009256|NCT00075725|50102295|FG001|Overall Study|Other|2|||
25009257|NCT00075725|50102296|FG002|Overall Study|Other|1|||
25268267|NCT01287104|50582408|FG000|Overall Study|Patient developed progressive disease|1|||
25268268|NCT01287104|50582409|FG001|Overall Study|Patient developed progressive disease|1|||
25268269|NCT01287104|50582410|FG002|Overall Study|Patient developed progressive disease|3|||
25268270|NCT01287104|50582411|FG003|Overall Study|Patient developed progressive disease|2|||
25268271|NCT01287104|50582408|FG000|Overall Study|Donor anaphylaxis|0|||
25268272|NCT01287104|50582409|FG001|Overall Study|Donor anaphylaxis|1|||
25268273|NCT01287104|50582410|FG002|Overall Study|Donor anaphylaxis|0|||
25268274|NCT01287104|50582411|FG003|Overall Study|Donor anaphylaxis|1|||
25268275|NCT01287104|50582408|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
25268276|NCT01287104|50582409|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
25268277|NCT01287104|50582410|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
25268278|NCT01287104|50582411|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
25268279|NCT01287104|50582408|FG000|Overall Study|Low donor chimerism|0|||
25268280|NCT01287104|50582409|FG001|Overall Study|Low donor chimerism|1|||
25268281|NCT01287104|50582410|FG002|Overall Study|Low donor chimerism|0|||
25268282|NCT01287104|50582411|FG003|Overall Study|Low donor chimerism|0|||
25268283|NCT01287104|50582408|FG000|Overall Study|NK cells did not meet release criteria|0|||
25268284|NCT01287104|50582409|FG001|Overall Study|NK cells did not meet release criteria|1|||
25268285|NCT01287104|50582410|FG002|Overall Study|NK cells did not meet release criteria|0|||
25268286|NCT01287104|50582411|FG003|Overall Study|NK cells did not meet release criteria|0|||
25268287|NCT01286558|50582430|FG000|Overall Study|Adverse Event|1|||
25268288|NCT01286558|50582431|FG001|Overall Study|Adverse Event|1|||
25268289|NCT01286558|50582430|FG000|Overall Study|Withdrawal by Subject|0|||
25268290|NCT01286558|50582431|FG001|Overall Study|Withdrawal by Subject|1|||
25268291|NCT01169103|50582439|FG000|Overall Study|Lost to Follow-up|3|||
25268292|NCT01169103|50582440|FG001|Overall Study|Lost to Follow-up|3|||
25268293|NCT01169103|50582439|FG000|Overall Study|Withdrawal by Subject|3|||
25268294|NCT01169103|50582440|FG001|Overall Study|Withdrawal by Subject|1|||
25268295|NCT01286480|50582448|FG000|Overall Study|Withdrawal by Subject|5|||
25268296|NCT01286480|50582449|FG001|Overall Study|Withdrawal by Subject|3|||
25268297|NCT01286168|50582455|FG000|Overall Study|Withdrawal by Subject|1|||
25268298|NCT01286168|50582455|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
25268299|NCT01286012|50582462|FG000|Overall Study|Adverse Event|3|||
25268300|NCT01286012|50582463|FG001|Overall Study|Adverse Event|3|||
25268301|NCT01286012|50582462|FG000|Overall Study|Death|2|||
25268302|NCT01286012|50582463|FG001|Overall Study|Death|3|||
25268303|NCT01286012|50582462|FG000|Overall Study|Protocol Violation|1|||
25268304|NCT01286012|50582463|FG001|Overall Study|Protocol Violation|1|||
25268305|NCT01286012|50582462|FG000|Overall Study|Withdrawal by Subject|4|||
25268306|NCT01286012|50582463|FG001|Overall Study|Withdrawal by Subject|4|||
25268307|NCT01286012|50582462|FG000|Overall Study|Physician Decision|2|||
25268308|NCT01286012|50582463|FG001|Overall Study|Physician Decision|0|||
25268309|NCT01286012|50582462|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
25268310|NCT01286012|50582463|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
25268311|NCT00963547|50582474|FG000|Overall Study|Adverse Event|0|||
25268312|NCT00963547|50582475|FG001|Overall Study|Adverse Event|1|||
25268313|NCT00963547|50582476|FG002|Overall Study|Adverse Event|0|||
25268314|NCT00963547|50582477|FG003|Overall Study|Adverse Event|1|||
25268315|NCT00963547|50582478|FG004|Overall Study|Adverse Event|0|||
25268316|NCT00963547|50582479|FG005|Overall Study|Adverse Event|0|||
25268317|NCT00963547|50582480|FG006|Overall Study|Adverse Event|0|||
25268318|NCT00963547|50582474|FG000|Overall Study|Physician Decision|1|||
25268319|NCT00963547|50582475|FG001|Overall Study|Physician Decision|1|||
25268320|NCT00963547|50582476|FG002|Overall Study|Physician Decision|0|||
25268321|NCT00963547|50582477|FG003|Overall Study|Physician Decision|0|||
25268322|NCT00963547|50582478|FG004|Overall Study|Physician Decision|0|||
25268323|NCT00963547|50582479|FG005|Overall Study|Physician Decision|0|||
25268324|NCT00963547|50582480|FG006|Overall Study|Physician Decision|0|||
25268325|NCT00963547|50582474|FG000|Overall Study|Progressive Disease|3|||
25268326|NCT00963547|50582475|FG001|Overall Study|Progressive Disease|8|||
25268327|NCT00963547|50582476|FG002|Overall Study|Progressive Disease|9|||
25268328|NCT00963547|50582477|FG003|Overall Study|Progressive Disease|5|||
25268329|NCT00963547|50582478|FG004|Overall Study|Progressive Disease|0|||
25268330|NCT00963547|50582479|FG005|Overall Study|Progressive Disease|0|||
25268331|NCT00963547|50582480|FG006|Overall Study|Progressive Disease|0|||
25268332|NCT00963547|50582474|FG000|Overall Study|Withdrawal by Subject|0|||
25268333|NCT00963547|50582475|FG001|Overall Study|Withdrawal by Subject|0|||
25268334|NCT00963547|50582476|FG002|Overall Study|Withdrawal by Subject|3|||
25268335|NCT00963547|50582477|FG003|Overall Study|Withdrawal by Subject|0|||
25268336|NCT00963547|50582478|FG004|Overall Study|Withdrawal by Subject|0|||
25268337|NCT00963547|50582479|FG005|Overall Study|Withdrawal by Subject|0|||
25009258|NCT00075725|50102297|FG003|Overall Study|Other|1|||
25009259|NCT00075725|50102298|FG004|Overall Study|Other|1|||
25268338|NCT00963547|50582480|FG006|Overall Study|Withdrawal by Subject|0|||
25268339|NCT00963547|50582474|FG000|Overall Study|Reason Unknown|0|||
25268340|NCT00963547|50582475|FG001|Overall Study|Reason Unknown|1|||
25268341|NCT00963547|50582476|FG002|Overall Study|Reason Unknown|0|||
25268342|NCT00963547|50582477|FG003|Overall Study|Reason Unknown|0|||
25268343|NCT00963547|50582478|FG004|Overall Study|Reason Unknown|0|||
25268344|NCT00963547|50582479|FG005|Overall Study|Reason Unknown|0|||
25126118|NCT01640288|50238816|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
25126119|NCT01640288|50238815|FG000|Overall Study|Screen Failure|20|||
25126120|NCT01640288|50238816|FG001|Overall Study|Screen Failure|18|||
25126121|NCT01640288|50238815|FG000|Overall Study|Withdrawn by PI|5|||
25126122|NCT01640288|50238816|FG001|Overall Study|Withdrawn by PI|0|||
25126123|NCT01640288|50238815|FG000|Overall Study|Withdrawal by Subject|1|||
25126124|NCT01640288|50238816|FG001|Overall Study|Withdrawal by Subject|0|||
25126125|NCT01639040|50238825|FG000|Overall Study|Adverse Event|1|||
25126126|NCT01639040|50238826|FG001|Overall Study|Adverse Event|0|||
25126127|NCT01640054|50238835|FG000|Overall Study|Study-specific disc criteria|1|||
25126128|NCT01640054|50238835|FG000|Overall Study|Lack of Efficacy|3|||
25126129|NCT01640054|50238835|FG000|Overall Study|Adverse Event|2|||
25126130|NCT01600586|50238841|FG000|Overall Study|Physician Decision|3|||
25126131|NCT01600586|50238842|FG001|Overall Study|Physician Decision|3|||
25126132|NCT01639742|50238855|FG000|Overall Study|Study Ongoing|17|||
25126133|NCT01639742|50238855|FG000|Overall Study|Lost to Follow-up|1|||
25126134|NCT02164513|50238862|FG000|Overall Study|Adverse Event|162|||
25126135|NCT02164513|50238863|FG001|Overall Study|Adverse Event|180|||
25126136|NCT02164513|50238864|FG002|Overall Study|Adverse Event|111|||
25126137|NCT02164513|50238862|FG000|Overall Study|Other: Study Closed or terminated|5|||
25126138|NCT02164513|50238863|FG001|Overall Study|Other: Study Closed or terminated|2|||
25126139|NCT02164513|50238864|FG002|Overall Study|Other: Study Closed or terminated|4|||
25126140|NCT02164513|50238862|FG000|Overall Study|Lost to Follow-up|30|||
25126141|NCT02164513|50238863|FG001|Overall Study|Lost to Follow-up|36|||
25126142|NCT02164513|50238864|FG002|Overall Study|Lost to Follow-up|22|||
25126143|NCT02164513|50238862|FG000|Overall Study|Physician Decision|47|||
25126144|NCT02164513|50238863|FG001|Overall Study|Physician Decision|57|||
25126145|NCT02164513|50238864|FG002|Overall Study|Physician Decision|28|||
25126146|NCT02164513|50238862|FG000|Overall Study|Withdrawal by Subject|192|||
25126147|NCT02164513|50238863|FG001|Overall Study|Withdrawal by Subject|261|||
25126148|NCT02164513|50238864|FG002|Overall Study|Withdrawal by Subject|130|||
25126149|NCT02164513|50238862|FG000|Overall Study|Other: Reason not provided by site|1|||
25126150|NCT02164513|50238863|FG001|Overall Study|Other: Reason not provided by site|0|||
25126151|NCT02164513|50238864|FG002|Overall Study|Other: Reason not provided by site|0|||
25126152|NCT02218489|50238884|FG000|Overall Study|Withdrawal by Subject|4|||
25126153|NCT02218489|50238885|FG001|Overall Study|Withdrawal by Subject|3|||
25126154|NCT02218489|50238884|FG000|Overall Study|Lost to Follow-up|1|||
25126155|NCT02218489|50238885|FG001|Overall Study|Lost to Follow-up|0|||
25126156|NCT02192905|50238892|FG000|Overall Study|Lost to Follow-up|1|||
25126157|NCT01713946|50238900|FG000|Overall Study|Death|0|||
25126158|NCT01713946|50238901|FG001|Overall Study|Death|2|||
25126159|NCT01713946|50238902|FG002|Overall Study|Death|2|||
25126160|NCT01713946|50238900|FG000|Overall Study|Adverse Event|19|||
25126161|NCT01713946|50238901|FG001|Overall Study|Adverse Event|14|||
25126162|NCT01713946|50238902|FG002|Overall Study|Adverse Event|13|||
25126163|NCT01713946|50238900|FG000|Overall Study|Withdrawal by Subject|12|||
25126164|NCT01713946|50238901|FG001|Overall Study|Withdrawal by Subject|12|||
25126165|NCT01713946|50238902|FG002|Overall Study|Withdrawal by Subject|8|||
25126166|NCT01713946|50238900|FG000|Overall Study|Lack of Efficacy|8|||
25126167|NCT01713946|50238901|FG001|Overall Study|Lack of Efficacy|8|||
25126168|NCT01713946|50238902|FG002|Overall Study|Lack of Efficacy|14|||
25126169|NCT01713946|50238900|FG000|Overall Study|Protocol Violation|2|||
25268345|NCT00963547|50582480|FG006|Overall Study|Reason Unknown|0|||
25268346|NCT01285310|50582496|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
25268347|NCT01285310|50582497|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
25268348|NCT01285310|50582498|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
25268349|NCT01285310|50582499|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
25268350|NCT01285310|50582500|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
25268351|NCT01285310|50582496|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
25268352|NCT01285310|50582497|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
25268353|NCT01285310|50582498|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
25268354|NCT01285310|50582499|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
25268355|NCT01285310|50582500|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
25268356|NCT01285310|50582496|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
25268357|NCT01285310|50582497|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
25268358|NCT01285310|50582498|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
25126170|NCT01713946|50238901|FG001|Overall Study|Protocol Violation|4|||
25126171|NCT01713946|50238902|FG002|Overall Study|Protocol Violation|1|||
25126172|NCT01713946|50238900|FG000|Overall Study|Lost to Follow-up|0|||
25126173|NCT01713946|50238901|FG001|Overall Study|Lost to Follow-up|0|||
25126174|NCT01713946|50238902|FG002|Overall Study|Lost to Follow-up|1|||
25126175|NCT01713946|50238900|FG000|Overall Study|Administrative problems|1|||
25126176|NCT01713946|50238901|FG001|Overall Study|Administrative problems|0|||
25268359|NCT01285310|50582499|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
25268360|NCT01285310|50582500|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
25268361|NCT01285310|50582496|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
25268362|NCT01285310|50582497|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
25268363|NCT01285310|50582498|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
25268364|NCT01285310|50582499|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
25268365|NCT01285310|50582500|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
25268366|NCT01285310|50582496|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
25268367|NCT01285310|50582497|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
25268368|NCT01285310|50582498|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
25268369|NCT01285310|50582499|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
25268370|NCT01285310|50582500|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
25268371|NCT01285310|50582496|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
25268372|NCT01285310|50582497|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
25268373|NCT01285310|50582498|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
25268374|NCT01285310|50582499|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
25268375|NCT01285310|50582500|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
25268376|NCT01285310|50582496|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
25268377|NCT01285310|50582497|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
25268378|NCT01285310|50582498|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
25268379|NCT01285310|50582499|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
25268380|NCT01285310|50582500|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
25268381|NCT01285310|50582496|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
25268382|NCT01285310|50582497|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
25268383|NCT01285310|50582498|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
25268384|NCT01285310|50582499|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
25268385|NCT01285310|50582500|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
25268386|NCT01285310|50582496|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
25268387|NCT01285310|50582497|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
25268388|NCT01285310|50582498|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
25268389|NCT01285310|50582499|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
25268390|NCT01285310|50582500|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
25268391|NCT01285310|50582496|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
25268392|NCT01285310|50582497|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
25268393|NCT01285310|50582498|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
25268394|NCT01285310|50582499|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
25268395|NCT01285310|50582500|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
25268396|NCT01285310|50582496|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
25268397|NCT01285310|50582497|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
25268398|NCT01285310|50582498|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
25268399|NCT01285310|50582499|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
25268400|NCT01285310|50582500|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
25268401|NCT01285310|50582496|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
25268402|NCT01285310|50582497|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
25268403|NCT01285310|50582498|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
25268404|NCT01285310|50582499|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
25268405|NCT01285310|50582500|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
25268406|NCT01254630|50582542|FG000|Overall Study|Adverse Event|36|||
25268407|NCT01254630|50582543|FG001|Overall Study|Adverse Event|15|||
25268408|NCT01254630|50582544|FG002|Overall Study|Adverse Event|40|||
25268409|NCT01254630|50582545|FG003|Overall Study|Adverse Event|8|||
25268410|NCT01254630|50582542|FG000|Overall Study|Death|461|||
25268411|NCT01254630|50582543|FG001|Overall Study|Death|151|||
25268412|NCT01254630|50582544|FG002|Overall Study|Death|478|||
25268413|NCT01254630|50582545|FG003|Overall Study|Death|139|||
25268414|NCT01254630|50582542|FG000|Overall Study|Lost to Follow-up|80|||
25268415|NCT01254630|50582543|FG001|Overall Study|Lost to Follow-up|26|||
25268416|NCT01254630|50582544|FG002|Overall Study|Lost to Follow-up|89|||
25268417|NCT01254630|50582545|FG003|Overall Study|Lost to Follow-up|32|||
25268418|NCT01254630|50582542|FG000|Overall Study|Physician Decision|24|||
25268419|NCT01254630|50582543|FG001|Overall Study|Physician Decision|8|||
25268420|NCT01254630|50582544|FG002|Overall Study|Physician Decision|16|||
25268421|NCT01254630|50582545|FG003|Overall Study|Physician Decision|7|||
25268422|NCT01254630|50582542|FG000|Overall Study|Withdrawal by Subject|201|||
25268423|NCT01254630|50582543|FG001|Overall Study|Withdrawal by Subject|94|||
25268424|NCT01254630|50582544|FG002|Overall Study|Withdrawal by Subject|188|||
25268425|NCT01254630|50582545|FG003|Overall Study|Withdrawal by Subject|89|||
25268426|NCT01254630|50582542|FG000|Overall Study|Study terminated by sponsor|0|||
25268427|NCT01254630|50582543|FG001|Overall Study|Study terminated by sponsor|994|||
25009260|NCT00075725|50102299|FG005|Overall Study|Other|4|||
25268428|NCT01254630|50582544|FG002|Overall Study|Study terminated by sponsor|0|||
25268429|NCT01254630|50582545|FG003|Overall Study|Study terminated by sponsor|1010|||
25268430|NCT01254630|50582542|FG000|Overall Study|Status not recorded|0|||
25268431|NCT01254630|50582543|FG001|Overall Study|Status not recorded|0|||
25268432|NCT01254630|50582544|FG002|Overall Study|Status not recorded|1|||
25268433|NCT01254630|50582545|FG003|Overall Study|Status not recorded|0|||
25268434|NCT01284140|50582555|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
25268435|NCT01284140|50582556|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
25268436|NCT01284140|50582555|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
25268437|NCT01284140|50582556|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
25268438|NCT01254318|50582562|FG000|Overall Study|Lost to Follow-up|5|||
25268439|NCT01254318|50582562|FG000|Overall Study|Death|47|||
25268440|NCT01284062|50582570|FG000|Overall Study|Adverse Event|4|||
25268441|NCT01284062|50582571|FG001|Overall Study|Adverse Event|5|||
25268442|NCT01284062|50582572|FG002|Overall Study|Adverse Event|0|||
25268443|NCT01284062|50582573|FG003|Overall Study|Adverse Event|5|||
25268444|NCT01284062|50582570|FG000|Overall Study|Lack of Efficacy|3|||
25268445|NCT01284062|50582571|FG001|Overall Study|Lack of Efficacy|2|||
25268446|NCT01284062|50582572|FG002|Overall Study|Lack of Efficacy|2|||
25268447|NCT01284062|50582573|FG003|Overall Study|Lack of Efficacy|1|||
25268448|NCT01284062|50582570|FG000|Overall Study|Medication error without adverse event|0|||
25268449|NCT01284062|50582571|FG001|Overall Study|Medication error without adverse event|0|||
25268450|NCT01284062|50582572|FG002|Overall Study|Medication error without adverse event|1|||
25268451|NCT01284062|50582573|FG003|Overall Study|Medication error without adverse event|0|||
25268452|NCT01284062|50582570|FG000|Overall Study|Protocol Violation|1|||
25268453|NCT01284062|50582571|FG001|Overall Study|Protocol Violation|0|||
25268454|NCT01284062|50582572|FG002|Overall Study|Protocol Violation|0|||
25268455|NCT01284062|50582573|FG003|Overall Study|Protocol Violation|2|||
25268456|NCT01284062|50582570|FG000|Overall Study|Withdrawal by Subject|3|||
25268457|NCT01284062|50582571|FG001|Overall Study|Withdrawal by Subject|1|||
25268458|NCT01284062|50582572|FG002|Overall Study|Withdrawal by Subject|2|||
25268459|NCT01284062|50582573|FG003|Overall Study|Withdrawal by Subject|5|||
25268460|NCT01284062|50582570|FG000|Overall Study|Other|0|||
25268461|NCT01284062|50582571|FG001|Overall Study|Other|0|||
25268462|NCT01284062|50582572|FG002|Overall Study|Other|0|||
25268463|NCT01284062|50582573|FG003|Overall Study|Other|1|||
25268464|NCT01284062|50582570|FG000|Overall Study|Site Closed|0|||
25268465|NCT01284062|50582571|FG001|Overall Study|Site Closed|0|||
25268466|NCT01284062|50582572|FG002|Overall Study|Site Closed|1|||
25268467|NCT01284062|50582573|FG003|Overall Study|Site Closed|0|||
25268468|NCT01253304|50582590|FG000|Overall Study|Adverse Event|0|||
25268469|NCT01253304|50582591|FG001|Overall Study|Adverse Event|0|||
25268470|NCT01253304|50582592|FG002|Overall Study|Adverse Event|0|||
25268471|NCT01253304|50582593|FG003|Overall Study|Adverse Event|1|||
25268472|NCT01253226|50582608|FG000|Overall Study|Adverse Event|0|||
25268473|NCT01253226|50582609|FG001|Overall Study|Adverse Event|0|||
25268474|NCT01253226|50582610|FG002|Overall Study|Adverse Event|1|||
25268475|NCT01253226|50582611|FG003|Overall Study|Adverse Event|0|||
25268476|NCT01253226|50582612|FG004|Overall Study|Adverse Event|0|||
25268477|NCT01253226|50582608|FG000|Overall Study|Death|0|||
25268478|NCT01253226|50582609|FG001|Overall Study|Death|1|||
25268479|NCT01253226|50582610|FG002|Overall Study|Death|0|||
25268480|NCT01253226|50582611|FG003|Overall Study|Death|0|||
25268481|NCT01253226|50582612|FG004|Overall Study|Death|0|||
25268482|NCT01253226|50582608|FG000|Overall Study|Physician Decision|0|||
25268483|NCT01253226|50582609|FG001|Overall Study|Physician Decision|0|||
25268484|NCT01253226|50582610|FG002|Overall Study|Physician Decision|0|||
25268485|NCT01253226|50582611|FG003|Overall Study|Physician Decision|0|||
25268486|NCT01253226|50582612|FG004|Overall Study|Physician Decision|2|||
25268487|NCT01253226|50582608|FG000|Overall Study|Withdrawal by Subject|0|||
25268488|NCT01253226|50582609|FG001|Overall Study|Withdrawal by Subject|0|||
25268489|NCT01253226|50582610|FG002|Overall Study|Withdrawal by Subject|0|||
25268490|NCT01253226|50582611|FG003|Overall Study|Withdrawal by Subject|1|||
25268491|NCT01253226|50582612|FG004|Overall Study|Withdrawal by Subject|0|||
25268492|NCT01252290|50582624|FG000|Overall Study|Withdrawal by Subject|1|||
25268493|NCT01252134|50582628|FG000|Period 1, 8 Hours|Personal Reasons|0|||
25268494|NCT01252134|50582629|FG001|Period 1, 8 Hours|Personal Reasons|1|||
25268495|NCT01252134|50582630|FG002|Period 1, 8 Hours|Personal Reasons|1|||
25268496|NCT01252134|50582631|FG003|Period 1, 8 Hours|Personal Reasons|0|||
25268497|NCT01252134|50582632|FG004|Period 1, 8 Hours|Personal Reasons|0|||
25268498|NCT01252134|50582633|FG005|Period 1, 8 Hours|Personal Reasons|0|||
25268499|NCT01251744|50582643|FG000|Overall Study|Lost to Follow-up|1|||
25268500|NCT01251744|50582644|FG001|Overall Study|Lost to Follow-up|0|||
25268501|NCT01251354|50582657|FG000|Overall Study|Adverse Event|1|||
25268502|NCT01251354|50582657|FG000|Overall Study|Investigator's Decision|1|||
25268503|NCT01251354|50582657|FG000|Overall Study|Disease Progression|4|||
25268504|NCT01251276|50582663|FG000|Overall Study|Protocol Violation|1|||
25009261|NCT00075725|50102300|FG006|Overall Study|Other|2|||
25268505|NCT01251276|50582664|FG001|Overall Study|Protocol Violation|0|||
25268506|NCT01251276|50582663|FG000|Overall Study|Lost to Follow-up|0|||
25268507|NCT01251276|50582664|FG001|Overall Study|Lost to Follow-up|1|||
25268508|NCT01251120|50582672|FG000|Overall Study|Lack of Efficacy|0|||
25268509|NCT01251120|50582673|FG001|Overall Study|Lack of Efficacy|1|||
25268510|NCT01250418|50582681|FG000|Overall Study|monitor data failure|1|||
25268511|NCT01250418|50582682|FG001|Overall Study|monitor data failure|1|||
25268512|NCT01292603|50582693|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
25268513|NCT01292603|50582694|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
25268514|NCT01292603|50582695|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
25268515|NCT01292603|50582696|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
25268516|NCT01292603|50582697|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
25268517|NCT01292603|50582698|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
25268518|NCT01292603|50582693|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
25268519|NCT01292603|50582694|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
25268520|NCT01292603|50582695|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
25268521|NCT01292603|50582696|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
25268522|NCT01292603|50582697|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
25268523|NCT01292603|50582698|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
25268524|NCT01292603|50582693|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
25268525|NCT01292603|50582694|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
25268526|NCT01292603|50582695|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
25268527|NCT01292603|50582696|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
25268528|NCT01292603|50582697|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
25268529|NCT01292603|50582698|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
25268530|NCT01292603|50582693|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
25268531|NCT01292603|50582694|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
25268532|NCT01292603|50582695|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
25268533|NCT01292603|50582696|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
25268534|NCT01292603|50582697|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
25268535|NCT01292603|50582698|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
25268536|NCT01292603|50582693|FG000|Part 1: Regular Follow-Up Period|Death|3|||
25268537|NCT01292603|50582694|FG001|Part 1: Regular Follow-Up Period|Death|1|||
25268538|NCT01292603|50582695|FG002|Part 1: Regular Follow-Up Period|Death|3|||
25268539|NCT01292603|50582696|FG003|Part 1: Regular Follow-Up Period|Death|1|||
25268540|NCT01292603|50582697|FG004|Part 1: Regular Follow-Up Period|Death|0|||
25268541|NCT01292603|50582698|FG005|Part 1: Regular Follow-Up Period|Death|0|||
25268542|NCT01292603|50582693|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
25268543|NCT01292603|50582694|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
25268544|NCT01292603|50582695|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
25268545|NCT01292603|50582696|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
25268546|NCT01292603|50582697|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
25268547|NCT01292603|50582698|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
25268548|NCT01292603|50582693|FG000|Part 2: Dose Confirmation Period|Death|0|||
25268549|NCT01292603|50582694|FG001|Part 2: Dose Confirmation Period|Death|0|||
25268550|NCT01292603|50582695|FG002|Part 2: Dose Confirmation Period|Death|0|||
25268551|NCT01292603|50582696|FG003|Part 2: Dose Confirmation Period|Death|0|||
25268552|NCT01292603|50582697|FG004|Part 2: Dose Confirmation Period|Death|1|||
25268553|NCT01292603|50582698|FG005|Part 2: Dose Confirmation Period|Death|0|||
25268554|NCT01292603|50582693|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
25268555|NCT01292603|50582694|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
25268556|NCT01292603|50582695|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
25268557|NCT01292603|50582696|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
25268558|NCT01292603|50582697|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
25268559|NCT01292603|50582698|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
25268560|NCT01292603|50582693|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
25268561|NCT01292603|50582694|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
25268562|NCT01292603|50582695|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
25268563|NCT01292603|50582696|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
25268564|NCT01292603|50582697|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
25268565|NCT01292603|50582698|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
25268566|NCT01292603|50582693|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
25268567|NCT01292603|50582694|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
25268568|NCT01292603|50582695|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
25268569|NCT01292603|50582696|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
25009262|NCT00075725|50102301|FG007|Overall Study|Other|9|||
25268570|NCT01292603|50582697|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
25268571|NCT01292603|50582698|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
25009263|NCT00075725|50102302|FG008|Overall Study|Other|2|||
25268572|NCT01292603|50582693|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
25268573|NCT01292603|50582694|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
25268574|NCT01292603|50582695|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
25268575|NCT01292603|50582696|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
25268576|NCT01292603|50582697|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
25268577|NCT01292603|50582698|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
25268578|NCT01292603|50582693|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
25268579|NCT01292603|50582694|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
25268580|NCT01292603|50582695|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
25268581|NCT01292603|50582696|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
25268582|NCT01292603|50582697|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
25268583|NCT01292603|50582698|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
25268584|NCT01292603|50582693|FG000|Part 2: Regular Follow-Up|Death|0|||
25268585|NCT01292603|50582694|FG001|Part 2: Regular Follow-Up|Death|0|||
25268586|NCT01292603|50582695|FG002|Part 2: Regular Follow-Up|Death|0|||
25268587|NCT01292603|50582696|FG003|Part 2: Regular Follow-Up|Death|0|||
25268588|NCT01292603|50582697|FG004|Part 2: Regular Follow-Up|Death|6|||
25268589|NCT01292603|50582698|FG005|Part 2: Regular Follow-Up|Death|3|||
25268590|NCT01292603|50582693|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
25268591|NCT01292603|50582694|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
25268592|NCT01292603|50582695|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
25268593|NCT01292603|50582696|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
25268594|NCT01292603|50582697|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
25268595|NCT01292603|50582698|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
25268596|NCT01292603|50582693|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
25268597|NCT01292603|50582694|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
25268598|NCT01292603|50582695|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
25268599|NCT01292603|50582696|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
25268600|NCT01292603|50582697|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
25268601|NCT01292603|50582698|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
25268602|NCT01292603|50582693|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
25268603|NCT01292603|50582694|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
25268604|NCT01292603|50582695|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
25268605|NCT01292603|50582696|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
25268606|NCT01292603|50582697|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
25268607|NCT01292603|50582698|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
25268608|NCT01292603|50582693|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
25268609|NCT01292603|50582694|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
25268610|NCT01292603|50582695|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
25268611|NCT01292603|50582696|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
25268612|NCT01292603|50582697|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
25268613|NCT01292603|50582698|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
25268614|NCT01292603|50582693|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
25268615|NCT01292603|50582694|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
25268616|NCT01292603|50582695|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
25268617|NCT01292603|50582696|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
25268618|NCT01292603|50582697|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
25268619|NCT01292603|50582698|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
25268620|NCT01292603|50582693|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
25268621|NCT01292603|50582694|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
25268622|NCT01292603|50582695|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
25268623|NCT01292603|50582696|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
25268624|NCT01292603|50582697|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
25268625|NCT01292603|50582698|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
25268626|NCT01292603|50582693|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
25268627|NCT01292603|50582694|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
25268628|NCT01292603|50582695|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
25268629|NCT01292603|50582696|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
25268630|NCT01292603|50582697|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
25268631|NCT01292603|50582698|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
25268632|NCT01292603|50582693|FG000|Overall Survival Status|Death|3|||
25268633|NCT01292603|50582694|FG001|Overall Survival Status|Death|1|||
25268634|NCT01292603|50582695|FG002|Overall Survival Status|Death|3|||
25268635|NCT01292603|50582696|FG003|Overall Survival Status|Death|1|||
25268636|NCT01292603|50582697|FG004|Overall Survival Status|Death|16|||
25268637|NCT01292603|50582698|FG005|Overall Survival Status|Death|10|||
25268638|NCT01292057|50582721|FG000|Overall Study|Protocol Violation|1|||
25268639|NCT01292057|50582722|FG001|Overall Study|Protocol Violation|1|||
25268640|NCT01292057|50582721|FG000|Overall Study|Lost to Follow-up|1|||
25268641|NCT01292057|50582722|FG001|Overall Study|Lost to Follow-up|1|||
25268642|NCT01291277|50582730|FG000|Overall Study|Death|2|||
25268643|NCT01291277|50582731|FG001|Overall Study|Death|2|||
25268644|NCT01291277|50582730|FG000|Overall Study|Lost to Follow-up|3|||
25268645|NCT01291277|50582731|FG001|Overall Study|Lost to Follow-up|1|||
25268646|NCT01290887|50582739|FG000|Overall Study|Adverse Event|6|||
25268647|NCT01290887|50582740|FG001|Overall Study|Adverse Event|11|||
25268648|NCT01290887|50582739|FG000|Overall Study|Lack of Efficacy|4|||
25268649|NCT01290887|50582740|FG001|Overall Study|Lack of Efficacy|5|||
25268650|NCT01290887|50582739|FG000|Overall Study|Withdrawal by Subject|26|||
25268651|NCT01290887|50582740|FG001|Overall Study|Withdrawal by Subject|32|||
25268652|NCT01290887|50582739|FG000|Overall Study|Protocol Violation|2|||
25268653|NCT01290887|50582740|FG001|Overall Study|Protocol Violation|1|||
25268654|NCT01290887|50582739|FG000|Overall Study|Lost to Follow-up|4|||
25268655|NCT01290887|50582740|FG001|Overall Study|Lost to Follow-up|4|||
25268656|NCT01290887|50582739|FG000|Overall Study|Non-compliance to study procedures|0|||
25268657|NCT01290887|50582740|FG001|Overall Study|Non-compliance to study procedures|1|||
25268658|NCT01290887|50582739|FG000|Overall Study|Non-compliance to study medications|1|||
25268659|NCT01290887|50582740|FG001|Overall Study|Non-compliance to study medications|0|||
25268660|NCT01290887|50582739|FG000|Overall Study|Sponsor closure of study|420|||
25268661|NCT01290887|50582740|FG001|Overall Study|Sponsor closure of study|476|||
25268662|NCT01290887|50582739|FG000|Overall Study|Other|3|||
25268663|NCT01290887|50582740|FG001|Overall Study|Other|6|||
25268664|NCT01290731|50582746|FG000|Overall Study|Withdrawal by Subject|1|||
25268665|NCT01290341|50582752|FG000|Overall Study|Protocol Violation|7|||
25268666|NCT01290341|50582753|FG001|Overall Study|Protocol Violation|3|||
25268667|NCT01290341|50582752|FG000|Overall Study|Adverse Event|1|||
25268668|NCT01290341|50582753|FG001|Overall Study|Adverse Event|0|||
25268669|NCT01290341|50582752|FG000|Overall Study|Lost to Follow-up|21|||
25268670|NCT01290341|50582753|FG001|Overall Study|Lost to Follow-up|10|||
25268671|NCT01290341|50582752|FG000|Overall Study|Withdrawal by Subject|19|||
25268672|NCT01290341|50582753|FG001|Overall Study|Withdrawal by Subject|5|||
25268673|NCT01290341|50582752|FG000|Overall Study|Negative baseline culture and others|44|||
25268674|NCT01290341|50582753|FG001|Overall Study|Negative baseline culture and others|11|||
25268675|NCT01290263|50582761|FG000|Overall Study|Adverse Event|0|||
25268676|NCT01290263|50582762|FG001|Overall Study|Adverse Event|0|||
25268677|NCT01290263|50582763|FG002|Overall Study|Adverse Event|0|||
25268678|NCT01290263|50582764|FG003|Overall Study|Adverse Event|1|||
25268679|NCT01290263|50582765|FG004|Overall Study|Adverse Event|1|||
25268680|NCT01290263|50582761|FG000|Overall Study|Lack of Efficacy|8|||
25268681|NCT01290263|50582762|FG001|Overall Study|Lack of Efficacy|2|||
25268682|NCT01290263|50582763|FG002|Overall Study|Lack of Efficacy|7|||
25268683|NCT01290263|50582764|FG003|Overall Study|Lack of Efficacy|24|||
25268684|NCT01290263|50582765|FG004|Overall Study|Lack of Efficacy|33|||
25268685|NCT01290263|50582761|FG000|Overall Study|Withdrawal by Subject|3|||
25268686|NCT01290263|50582762|FG001|Overall Study|Withdrawal by Subject|1|||
25268687|NCT01290263|50582763|FG002|Overall Study|Withdrawal by Subject|0|||
25268688|NCT01290263|50582764|FG003|Overall Study|Withdrawal by Subject|1|||
25268689|NCT01290263|50582765|FG004|Overall Study|Withdrawal by Subject|2|||
25268690|NCT01290263|50582761|FG000|Overall Study|Participant Non-Compliance|0|||
25268691|NCT01290263|50582762|FG001|Overall Study|Participant Non-Compliance|0|||
25268692|NCT01290263|50582763|FG002|Overall Study|Participant Non-Compliance|0|||
25268693|NCT01290263|50582764|FG003|Overall Study|Participant Non-Compliance|1|||
25268694|NCT01290263|50582765|FG004|Overall Study|Participant Non-Compliance|1|||
25268695|NCT01290029|50582773|FG000|Overall Study|Other|2|||
25268696|NCT01289639|50582780|FG000|Overall Study|Lost to Follow-up|1|||
25268697|NCT01289639|50582781|FG001|Overall Study|Lost to Follow-up|0|||
25268698|NCT01289639|50582782|FG002|Overall Study|Lost to Follow-up|0|||
25268699|NCT01289015|50582792|FG000|Overall Study|Protocol Violation|12|||
25268700|NCT01289015|50582793|FG001|Overall Study|Protocol Violation|9|||
25268701|NCT01289015|50582792|FG000|Overall Study|Adverse Event|3|||
25268702|NCT01289015|50582793|FG001|Overall Study|Adverse Event|0|||
25268703|NCT01289015|50582792|FG000|Overall Study|Lost to Follow-up|33|||
25268704|NCT01289015|50582793|FG001|Overall Study|Lost to Follow-up|17|||
25268705|NCT01289015|50582792|FG000|Overall Study|Withdrawal by Subject|17|||
25268706|NCT01289015|50582793|FG001|Overall Study|Withdrawal by Subject|8|||
25268707|NCT01289015|50582792|FG000|Overall Study|Disease progression|1|||
25268708|NCT01289015|50582793|FG001|Overall Study|Disease progression|0|||
25268709|NCT01289015|50582792|FG000|Overall Study|Negative baseline culture and others|33|||
25268710|NCT01289015|50582793|FG001|Overall Study|Negative baseline culture and others|20|||
25268711|NCT01288937|50582801|FG000|Overall Study|Adverse Event|1|||
25268712|NCT01288937|50582802|FG001|Overall Study|Adverse Event|0|||
25268713|NCT01288469|50582811|FG000|Overall Study|Adverse Event|4|||
25268714|NCT01288469|50582812|FG001|Overall Study|Adverse Event|1|||
25268715|NCT01288469|50582813|FG002|Overall Study|Adverse Event|1|||
25268716|NCT01288469|50582811|FG000|Overall Study|Poor compliance to protocol|0|||
25268717|NCT01288469|50582812|FG001|Overall Study|Poor compliance to protocol|1|||
25268718|NCT01288469|50582813|FG002|Overall Study|Poor compliance to protocol|0|||
25268719|NCT01288469|50582811|FG000|Overall Study|Participant Moved|1|||
25268720|NCT01288469|50582812|FG001|Overall Study|Participant Moved|0|||
25268721|NCT01288469|50582813|FG002|Overall Study|Participant Moved|0|||
25268722|NCT01288469|50582811|FG000|Overall Study|Consent withdrawn by subject|1|||
25268723|NCT01288469|50582812|FG001|Overall Study|Consent withdrawn by subject|1|||
25268724|NCT01288469|50582813|FG002|Overall Study|Consent withdrawn by subject|1|||
25268725|NCT01288469|50582811|FG000|Overall Study|Exclusion criteria finally met|1|||
25268726|NCT01288469|50582812|FG001|Overall Study|Exclusion criteria finally met|0|||
25268727|NCT01288469|50582813|FG002|Overall Study|Exclusion criteria finally met|0|||
25268728|NCT01288079|50582825|FG000|Overall Study|Withdrawal by Subject|2|||
25268729|NCT01288079|50582826|FG001|Overall Study|Withdrawal by Subject|4|||
25268730|NCT01288079|50582827|FG002|Overall Study|Withdrawal by Subject|1|||
25268731|NCT01288079|50582828|FG003|Overall Study|Withdrawal by Subject|0|||
25268732|NCT01288079|50582825|FG000|Overall Study|Adverse Event|2|||
25268733|NCT01288079|50582826|FG001|Overall Study|Adverse Event|1|||
25268734|NCT01288079|50582827|FG002|Overall Study|Adverse Event|2|||
25268735|NCT01288079|50582828|FG003|Overall Study|Adverse Event|3|||
25268736|NCT01288079|50582825|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
25268737|NCT01288079|50582826|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
25268738|NCT01288079|50582827|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
25268739|NCT01288079|50582828|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
25268740|NCT01288079|50582825|FG000|Overall Study|Condition under Investigation Worsened|0|||
25268741|NCT01288079|50582826|FG001|Overall Study|Condition under Investigation Worsened|0|||
25268742|NCT01288079|50582827|FG002|Overall Study|Condition under Investigation Worsened|0|||
25268743|NCT01288079|50582828|FG003|Overall Study|Condition under Investigation Worsened|1|||
25268744|NCT01288079|50582825|FG000|Overall Study|Lack of Efficacy|2|||
25268745|NCT01288079|50582826|FG001|Overall Study|Lack of Efficacy|2|||
25268746|NCT01288079|50582827|FG002|Overall Study|Lack of Efficacy|0|||
25268747|NCT01288079|50582828|FG003|Overall Study|Lack of Efficacy|2|||
25268748|NCT01288079|50582825|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
25268749|NCT01288079|50582826|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
25268750|NCT01288079|50582827|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
25268751|NCT01288079|50582828|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
25268752|NCT01288079|50582825|FG000|Overall Study|Lost to Follow-up|1|||
25268753|NCT01288079|50582826|FG001|Overall Study|Lost to Follow-up|1|||
25268754|NCT01288079|50582827|FG002|Overall Study|Lost to Follow-up|1|||
25268755|NCT01288079|50582828|FG003|Overall Study|Lost to Follow-up|0|||
25268756|NCT01288079|50582825|FG000|Overall Study|Other or Study Termination|11|||
25268757|NCT01288079|50582826|FG001|Overall Study|Other or Study Termination|15|||
25268758|NCT01288079|50582827|FG002|Overall Study|Other or Study Termination|14|||
25268759|NCT01288079|50582828|FG003|Overall Study|Other or Study Termination|8|||
25268760|NCT01287221|50582840|FG000|Overall Study|Lack of Perceived Benefit|1|||
25268761|NCT01287221|50582841|FG001|Overall Study|Lack of Perceived Benefit|1|||
25268762|NCT01287221|50582840|FG000|Overall Study|Adverse Event|3|||
25126177|NCT01713946|50238902|FG002|Overall Study|Administrative problems|0|||
25126178|NCT01713946|50238900|FG000|Overall Study|Did not continue in Ext|0|||
25126179|NCT01713946|50238901|FG001|Overall Study|Did not continue in Ext|3|||
25126180|NCT01713946|50238902|FG002|Overall Study|Did not continue in Ext|0|||
25126181|NCT01713946|50238900|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
25126182|NCT01713946|50238901|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
25126183|NCT01713946|50238902|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
25268763|NCT01287221|50582841|FG001|Overall Study|Adverse Event|3|||
25268764|NCT01287221|50582840|FG000|Overall Study|Withdrawal by Subject|0|||
25268765|NCT01287221|50582841|FG001|Overall Study|Withdrawal by Subject|1|||
25268766|NCT01168401|50582858|FG000|Overall Study|Lost to Follow-up|1|||
25268767|NCT01168401|50582859|FG001|Overall Study|Lost to Follow-up|1|||
25268768|NCT01168401|50582860|FG002|Overall Study|Lost to Follow-up|2|||
25268769|NCT01168401|50582861|FG003|Overall Study|Lost to Follow-up|1|||
25268770|NCT01168401|50582862|FG004|Overall Study|Lost to Follow-up|0|||
25268771|NCT01168401|50582863|FG005|Overall Study|Lost to Follow-up|0|||
25268772|NCT01168401|50582864|FG006|Overall Study|Lost to Follow-up|0|||
25268773|NCT01168401|50582865|FG007|Overall Study|Lost to Follow-up|0|||
25268774|NCT01168401|50582866|FG008|Overall Study|Lost to Follow-up|0|||
25268775|NCT01168401|50582867|FG009|Overall Study|Lost to Follow-up|0|||
25268776|NCT01168401|50582868|FG010|Overall Study|Lost to Follow-up|0|||
25268777|NCT01168401|50582858|FG000|Overall Study|Withdrawal by Subject|0|||
25268778|NCT01168401|50582859|FG001|Overall Study|Withdrawal by Subject|0|||
25268779|NCT01168401|50582860|FG002|Overall Study|Withdrawal by Subject|0|||
25268780|NCT01168401|50582861|FG003|Overall Study|Withdrawal by Subject|1|||
25268781|NCT01168401|50582862|FG004|Overall Study|Withdrawal by Subject|0|||
25268782|NCT01168401|50582863|FG005|Overall Study|Withdrawal by Subject|0|||
25268783|NCT01168401|50582864|FG006|Overall Study|Withdrawal by Subject|0|||
25268784|NCT01168401|50582865|FG007|Overall Study|Withdrawal by Subject|0|||
25268785|NCT01168401|50582866|FG008|Overall Study|Withdrawal by Subject|0|||
25268786|NCT01168401|50582867|FG009|Overall Study|Withdrawal by Subject|0|||
25268787|NCT01168401|50582868|FG010|Overall Study|Withdrawal by Subject|0|||
25268788|NCT01287065|50582892|FG000|Treatment Period 1|Adverse Event|0|||
24907540|NCT00623805|50001588|FG000|Overall Study|Lack of Efficacy|3|||
25268789|NCT01287065|50582893|FG001|Treatment Period 1|Adverse Event|0|||
25268790|NCT01287065|50582894|FG002|Treatment Period 1|Adverse Event|0|||
25268791|NCT01287065|50582895|FG003|Treatment Period 1|Adverse Event|0|||
25268792|NCT01287065|50582896|FG004|Treatment Period 1|Adverse Event|1|||
25268793|NCT01287065|50582897|FG005|Treatment Period 1|Adverse Event|0|||
25268794|NCT01287065|50582892|FG000|Treatment Period 1|Withdrawal by Subject|0|||
25268795|NCT01287065|50582893|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25268796|NCT01287065|50582894|FG002|Treatment Period 1|Withdrawal by Subject|0|||
25268797|NCT01287065|50582895|FG003|Treatment Period 1|Withdrawal by Subject|0|||
25268798|NCT01287065|50582896|FG004|Treatment Period 1|Withdrawal by Subject|0|||
25268799|NCT01287065|50582897|FG005|Treatment Period 1|Withdrawal by Subject|1|||
25268800|NCT01167153|50582907|FG000|Overall Study|Non-effective therapy|1|||
25268801|NCT01167153|50582908|FG001|Overall Study|Non-effective therapy|4|||
25268802|NCT01167153|50582907|FG000|Overall Study|AE including clinical laboratory AE|2|||
25268803|NCT01167153|50582908|FG001|Overall Study|AE including clinical laboratory AE|8|||
25268804|NCT01167153|50582907|FG000|Overall Study|Hypotension|1|||
25268805|NCT01167153|50582908|FG001|Overall Study|Hypotension|0|||
25268806|NCT01167153|50582907|FG000|Overall Study|Lost to Follow-up|7|||
25268807|NCT01167153|50582908|FG001|Overall Study|Lost to Follow-up|9|||
25268808|NCT01167153|50582907|FG000|Overall Study|Non-compliance to concomitant medication|0|||
25268809|NCT01167153|50582908|FG001|Overall Study|Non-compliance to concomitant medication|2|||
25268810|NCT01167153|50582907|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
25268811|NCT01167153|50582908|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
25268812|NCT01167153|50582907|FG000|Overall Study|Withdrawal consent|1|||
25126184|NCT01713946|50238900|FG000|Overall Study|Patients never switched to everolimus|0|||
25126185|NCT01713946|50238901|FG001|Overall Study|Patients never switched to everolimus|0|||
25126186|NCT01713946|50238902|FG002|Overall Study|Patients never switched to everolimus|5|||
25126187|NCT02163499|50238928|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
25126188|NCT02163499|50238928|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
25126189|NCT02163499|50238928|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
25126190|NCT02163499|50238928|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
25126191|NCT02163499|50238928|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
25126192|NCT02163499|50238928|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
25126193|NCT02163499|50238928|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
25126194|NCT02163499|50238928|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
25126195|NCT02163499|50238928|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
25126196|NCT02163499|50238928|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
25126197|NCT02163499|50238928|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
25126198|NCT02163499|50238928|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
25126199|NCT02163499|50238928|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
25126200|NCT02163499|50238928|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
25126201|NCT02163499|50238928|FG000|Extended Dosing Phase: ZS|Death|8|||
25126202|NCT02163499|50238928|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
25126203|NCT02163499|50238928|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
25126204|NCT02163499|50238928|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
25126205|NCT02163187|50238938|FG000|Overall Study|Device removed|1|||
25126206|NCT02163187|50238939|FG001|Overall Study|Device removed|0|||
25126207|NCT02163187|50238938|FG000|Overall Study|Progressive disease|1|||
25126208|NCT02163187|50238939|FG001|Overall Study|Progressive disease|0|||
25126209|NCT02191579|50238947|FG000|Treatment 1|Multiple Reasons Specified|27|||
25126210|NCT02191579|50238948|FG001|Treatment 1|Multiple Reasons Specified|58|||
25126211|NCT02191579|50238947|FG000|Treatment 2|Multiple Reasons Specified|0|||
25126212|NCT02191579|50238948|FG001|Treatment 2|Multiple Reasons Specified|25|||
25126213|NCT01363700|50238957|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
25126214|NCT01363700|50238958|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
25126215|NCT01363700|50238959|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
25126216|NCT01363700|50238960|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
25126217|NCT01363700|50238961|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
25126218|NCT01637402|50238972|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
25126219|NCT01637402|50238973|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
25126220|NCT01637402|50238972|FG000|Standard Dose Regimen|Adverse Event|1|||
25126221|NCT01637402|50238973|FG001|Standard Dose Regimen|Adverse Event|0|||
25126222|NCT01637402|50238972|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
25126223|NCT01637402|50238973|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
25126224|NCT01637402|50238972|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
25126225|NCT01637402|50238973|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
25268813|NCT01167153|50582908|FG001|Overall Study|Withdrawal consent|1|||
25126226|NCT01637402|50238972|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
25178501|NCT01544179|50323790|FG000|Overall Study|Lost to Follow-up|0|||
25268814|NCT01167153|50582907|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
25268815|NCT01167153|50582908|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
25268816|NCT01166763|50582914|FG000|Overall Study|Withdrawal by Subject|3|||
25268817|NCT01166373|50582922|FG000|Overall Study|Lost to Follow-up|3|||
25268818|NCT01166373|50582923|FG001|Overall Study|Lost to Follow-up|2|||
25268819|NCT01166373|50582924|FG002|Overall Study|Lost to Follow-up|2|||
25268820|NCT01166373|50582925|FG003|Overall Study|Lost to Follow-up|2|||
25268821|NCT01166373|50582922|FG000|Overall Study|Withdrawal by Subject|1|||
25268822|NCT01166373|50582923|FG001|Overall Study|Withdrawal by Subject|2|||
25268823|NCT01166373|50582924|FG002|Overall Study|Withdrawal by Subject|2|||
25268824|NCT01166373|50582925|FG003|Overall Study|Withdrawal by Subject|3|||
25268825|NCT01166373|50582922|FG000|Overall Study|Physician Decision|1|||
25268826|NCT01166373|50582923|FG001|Overall Study|Physician Decision|0|||
25268827|NCT01166373|50582924|FG002|Overall Study|Physician Decision|0|||
25268828|NCT01166373|50582925|FG003|Overall Study|Physician Decision|0|||
25268829|NCT00963235|50582937|FG000|Overall Study|Withdrawal by Subject|22|||
25268830|NCT00963235|50582937|FG000|Overall Study|Lost to Follow-up|14|||
25268831|NCT00963235|50582937|FG000|Overall Study|Failed to return|9|||
25268832|NCT00963235|50582937|FG000|Overall Study|Protocol Violation|7|||
25268833|NCT00963235|50582937|FG000|Overall Study|Adverse Event|5|||
25268834|NCT00963235|50582937|FG000|Overall Study|Physician Decision|2|||
25268835|NCT00963235|50582937|FG000|Overall Study|Other|1|||
25268836|NCT01165281|50582946|FG000|Overall Study|Adverse Event|12|||
25268837|NCT01165281|50582947|FG001|Overall Study|Adverse Event|14|||
25268838|NCT01165281|50582946|FG000|Overall Study|Death|3|||
25268839|NCT01165281|50582947|FG001|Overall Study|Death|4|||
25268840|NCT01165281|50582946|FG000|Overall Study|Lack of Efficacy|4|||
25268841|NCT01165281|50582947|FG001|Overall Study|Lack of Efficacy|1|||
25268842|NCT01165281|50582946|FG000|Overall Study|Lost to Follow-up|0|||
25268843|NCT01165281|50582947|FG001|Overall Study|Lost to Follow-up|1|||
25268844|NCT01165281|50582946|FG000|Overall Study|Physician Decision|8|||
25268845|NCT01165281|50582947|FG001|Overall Study|Physician Decision|1|||
25268846|NCT01165281|50582946|FG000|Overall Study|Protocol Violation|6|||
25268847|NCT01165281|50582947|FG001|Overall Study|Protocol Violation|5|||
25268848|NCT01165281|50582946|FG000|Overall Study|Withdrawal by Subject|8|||
25268849|NCT01165281|50582947|FG001|Overall Study|Withdrawal by Subject|7|||
25268850|NCT01165281|50582946|FG000|Overall Study|Noncompliance with Study Drug|1|||
25268851|NCT01165281|50582947|FG001|Overall Study|Noncompliance with Study Drug|4|||
25268852|NCT01165281|50582946|FG000|Overall Study|Progressive Disease|10|||
25268853|NCT01165281|50582947|FG001|Overall Study|Progressive Disease|14|||
25268854|NCT01165281|50582946|FG000|Overall Study|Other|6|||
25268855|NCT01165281|50582947|FG001|Overall Study|Other|0|||
25268856|NCT01165203|50582955|FG000|Active Phase|Serious Adverse Event|1|||
25268857|NCT01165203|50582956|FG001|Active Phase|Serious Adverse Event|0|||
25268858|NCT01165203|50582955|FG000|Active Phase|Withdrawal by Subject|2|||
25268859|NCT01165203|50582956|FG001|Active Phase|Withdrawal by Subject|1|||
25268860|NCT01165203|50582955|FG000|Active Phase|Migrated/moved from study area|0|||
25268861|NCT01165203|50582956|FG001|Active Phase|Migrated/moved from study area|1|||
25268862|NCT01165203|50582955|FG000|Active Phase|Lost to Follow-up|2|||
25268863|NCT01165203|50582956|FG001|Active Phase|Lost to Follow-up|0|||
25268864|NCT01165203|50582955|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
25268865|NCT01165203|50582956|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
25268866|NCT01165203|50582955|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
25268867|NCT01165203|50582956|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
25268868|NCT01165203|50582955|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
25268869|NCT01165203|50582956|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
25268870|NCT01165203|50582955|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
25268871|NCT01165203|50582956|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
25268872|NCT01165203|50582955|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
25268873|NCT01165203|50582956|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
25268874|NCT00960661|50582971|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
25268875|NCT00960661|50582972|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
25268876|NCT00960661|50582973|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
25268877|NCT00960661|50582971|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
25268878|NCT00960661|50582972|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
25268879|NCT00960661|50582973|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
25268880|NCT00960661|50582971|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
25268881|NCT00960661|50582972|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
25268882|NCT00960661|50582973|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
25268883|NCT00960661|50582971|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
25268884|NCT00960661|50582972|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
25268885|NCT00960661|50582973|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
25268886|NCT00960661|50582971|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
25268887|NCT00960661|50582972|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
25268888|NCT00960661|50582973|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
25268889|NCT00960661|50582971|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
25268890|NCT00960661|50582972|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
25009264|NCT00075725|50102303|FG009|Overall Study|Other|1|||
25009265|NCT00075725|50102304|FG010|Overall Study|Other|0|||
25009266|NCT00075725|50102305|FG011|Overall Study|Other|3|||
25009267|NCT00075725|50102294|FG000|Overall Study|Pt trying to find a BM donor|0|||
25009268|NCT00075725|50102295|FG001|Overall Study|Pt trying to find a BM donor|1|||
25009269|NCT00075725|50102296|FG002|Overall Study|Pt trying to find a BM donor|0|||
25009270|NCT00075725|50102297|FG003|Overall Study|Pt trying to find a BM donor|0|||
25009271|NCT00075725|50102298|FG004|Overall Study|Pt trying to find a BM donor|0|||
25009272|NCT00075725|50102299|FG005|Overall Study|Pt trying to find a BM donor|0|||
25009273|NCT00075725|50102300|FG006|Overall Study|Pt trying to find a BM donor|0|||
25009274|NCT00075725|50102301|FG007|Overall Study|Pt trying to find a BM donor|0|||
25009275|NCT00075725|50102302|FG008|Overall Study|Pt trying to find a BM donor|0|||
25009276|NCT00075725|50102303|FG009|Overall Study|Pt trying to find a BM donor|0|||
25009277|NCT00075725|50102304|FG010|Overall Study|Pt trying to find a BM donor|0|||
25009278|NCT00075725|50102305|FG011|Overall Study|Pt trying to find a BM donor|0|||
25009279|NCT00075725|50102294|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
25009280|NCT00075725|50102295|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
25009281|NCT00075725|50102296|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
25009282|NCT00075725|50102297|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
25009283|NCT00075725|50102298|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
25009284|NCT00075725|50102299|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
25009285|NCT00075725|50102300|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
25009286|NCT00075725|50102301|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
25009287|NCT00075725|50102302|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
25126227|NCT01637402|50238973|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
25126228|NCT01637402|50238972|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
25126229|NCT01637402|50238973|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
25126230|NCT02217475|50239001|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
25126231|NCT02217475|50239002|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
25126232|NCT02217475|50239003|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
25126233|NCT02217475|50239001|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
25268891|NCT00960661|50582973|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
25268892|NCT00960661|50582971|FG000|Interventional Phase|Adverse Event|0|||
25268893|NCT00960661|50582972|FG001|Interventional Phase|Adverse Event|17|||
25268894|NCT00960661|50582973|FG002|Interventional Phase|Adverse Event|8|||
25268895|NCT00960661|50582971|FG000|Interventional Phase|Death|0|||
25268896|NCT00960661|50582972|FG001|Interventional Phase|Death|1|||
25268897|NCT00960661|50582973|FG002|Interventional Phase|Death|0|||
25268898|NCT00960661|50582971|FG000|Interventional Phase|Lost to Follow-up|0|||
25268899|NCT00960661|50582972|FG001|Interventional Phase|Lost to Follow-up|0|||
25268900|NCT00960661|50582973|FG002|Interventional Phase|Lost to Follow-up|2|||
25268901|NCT00960661|50582971|FG000|Interventional Phase|entry criteria not met|0|||
25268902|NCT00960661|50582972|FG001|Interventional Phase|entry criteria not met|3|||
25268903|NCT00960661|50582973|FG002|Interventional Phase|entry criteria not met|0|||
25268904|NCT00960661|50582971|FG000|Interventional Phase|Protocol Violation|0|||
25268905|NCT00960661|50582972|FG001|Interventional Phase|Protocol Violation|7|||
25268906|NCT00960661|50582973|FG002|Interventional Phase|Protocol Violation|2|||
25268907|NCT00960661|50582971|FG000|Interventional Phase|Withdrawal by Subject|0|||
25268908|NCT00960661|50582972|FG001|Interventional Phase|Withdrawal by Subject|18|||
25268909|NCT00960661|50582973|FG002|Interventional Phase|Withdrawal by Subject|29|||
25268910|NCT00960661|50582971|FG000|Interventional Phase|Physician Decision|0|||
25268911|NCT00960661|50582972|FG001|Interventional Phase|Physician Decision|3|||
25268912|NCT00960661|50582973|FG002|Interventional Phase|Physician Decision|5|||
25268913|NCT00960661|50582971|FG000|Interventional Phase|sponsor decision|0|||
25268914|NCT00960661|50582972|FG001|Interventional Phase|sponsor decision|1|||
25268915|NCT00960661|50582973|FG002|Interventional Phase|sponsor decision|0|||
25268916|NCT00960661|50582971|FG000|Interventional Phase|Lack of Efficacy|0|||
25268917|NCT00960661|50582972|FG001|Interventional Phase|Lack of Efficacy|2|||
25268918|NCT00960661|50582973|FG002|Interventional Phase|Lack of Efficacy|0|||
25268919|NCT00960193|50582979|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
25268920|NCT00960115|50582988|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
25268921|NCT00960115|50582989|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
25009288|NCT00075725|50102303|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
25009289|NCT00075725|50102304|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
25009290|NCT00075725|50102305|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
25268922|NCT00959647|50582995|FG000|Overall Study|Adverse Event|2|||
25268923|NCT00959647|50582995|FG000|Overall Study|Progressive disease|6|||
25268924|NCT00959647|50582995|FG000|Overall Study|Study terminated by sponsor|4|||
25268925|NCT00959647|50582995|FG000|Overall Study|Withdrawal by Subject|7|||
25268926|NCT00957931|50582999|FG000|Overall Study|Death|4|||
25268927|NCT00957853|50583006|FG000|Overall Study|Withdrawal by Subject|1|||
25126234|NCT02217475|50239002|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
25126235|NCT02217475|50239003|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
25126236|NCT02217475|50239001|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
25126237|NCT02217475|50239002|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
25126238|NCT02217475|50239003|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
25126239|NCT02217475|50239001|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
25126240|NCT02217475|50239002|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
25126241|NCT02217475|50239003|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
25126242|NCT02217475|50239001|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
25126243|NCT02217475|50239002|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
25126244|NCT02217475|50239003|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
25126245|NCT02217475|50239001|FG000|Discontinued After Period 1|Adverse Event|1|||
25126246|NCT02217475|50239002|FG001|Discontinued After Period 1|Adverse Event|2|||
25126247|NCT02217475|50239003|FG002|Discontinued After Period 1|Adverse Event|0|||
25126248|NCT02217475|50239001|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
25126249|NCT02217475|50239002|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
25126250|NCT02217475|50239003|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
25126251|NCT02217475|50239001|FG000|Discontinued After Period 1|Physician Decision|0|||
25126252|NCT02217475|50239002|FG001|Discontinued After Period 1|Physician Decision|0|||
25126253|NCT02217475|50239003|FG002|Discontinued After Period 1|Physician Decision|1|||
25126254|NCT02217475|50239001|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
25126255|NCT02217475|50239002|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
25126256|NCT02217475|50239003|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
25126257|NCT02217475|50239001|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
25126258|NCT02217475|50239002|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
25126259|NCT02217475|50239003|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
25126260|NCT02217475|50239001|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
25126261|NCT02217475|50239002|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
25126262|NCT02217475|50239003|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
25126263|NCT02217475|50239001|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
25126264|NCT02217475|50239002|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
25126265|NCT02217475|50239003|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
25126266|NCT02217475|50239001|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
25126267|NCT02217475|50239002|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
25126268|NCT02217475|50239003|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
25126269|NCT02191267|50239023|FG000|Overall Study|Withdrawal by Subject|1|||
25126270|NCT02191267|50239024|FG001|Overall Study|Withdrawal by Subject|0|||
25126271|NCT02191267|50239025|FG002|Overall Study|Withdrawal by Subject|0|||
25126272|NCT02189941|50239033|FG000|Overall Study|Non-compliance|0|||
25126273|NCT02189941|50239034|FG001|Overall Study|Non-compliance|0|||
25126274|NCT02189941|50239035|FG002|Overall Study|Non-compliance|1|||
25126275|NCT02216773|50239045|FG000|Overall Study|Disease progression|4|||
25126276|NCT02216773|50239046|FG001|Overall Study|Disease progression|2|||
25126277|NCT02216773|50239045|FG000|Overall Study|Insufficient FLRV|4|||
25126278|NCT02216773|50239046|FG001|Overall Study|Insufficient FLRV|0|||
25126279|NCT02216773|50239045|FG000|Overall Study|Abandoned|4|||
25126280|NCT02216773|50239046|FG001|Overall Study|Abandoned|3|||
25126281|NCT01601132|50239052|FG000|Overall Study|Patient withdrew consent|1|||
25126282|NCT01601132|50239052|FG000|Overall Study|Protocol deviation|1|||
25126283|NCT02162719|50239061|FG000|Overall Study|Death|41|||
25126284|NCT02162719|50239062|FG001|Overall Study|Death|46|||
25126285|NCT02162719|50239061|FG000|Overall Study|Lost to Follow-up|1|||
25126286|NCT02162719|50239062|FG001|Overall Study|Lost to Follow-up|3|||
25126287|NCT02162719|50239061|FG000|Overall Study|Disease Progression|2|||
25126288|NCT02162719|50239062|FG001|Overall Study|Disease Progression|1|||
25126289|NCT02162719|50239061|FG000|Overall Study|Withdrawal by Subject|8|||
25178502|NCT01544179|50323791|FG001|Overall Study|Lost to Follow-up|1|||
25178503|NCT01544179|50323790|FG000|Overall Study|Adverse Event|0|||
25126290|NCT02162719|50239062|FG001|Overall Study|Withdrawal by Subject|2|||
25126291|NCT02162719|50239061|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
25126292|NCT02162719|50239062|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
25126293|NCT02161549|50239070|FG000|Overall Study|Physician Decision|6|||
25126294|NCT02161549|50239071|FG001|Overall Study|Physician Decision|2|||
25178504|NCT01544179|50323791|FG001|Overall Study|Adverse Event|1|||
24907541|NCT00623805|50001589|FG001|Overall Study|Lack of Efficacy|7|||
25126295|NCT02189863|50239077|FG000|First 2 Weeks|Motion Sickness|4|||
25126296|NCT02189863|50239078|FG001|First 2 Weeks|Motion Sickness|2|||
25126297|NCT02189473|50239089|FG000|Overall Study|Death|22|||
25126298|NCT02189473|50239090|FG001|Overall Study|Death|23|||
25126299|NCT02189473|50239089|FG000|Overall Study|Lost to Follow-up|1|||
25126300|NCT02189473|50239090|FG001|Overall Study|Lost to Follow-up|2|||
25126301|NCT02188849|50239098|FG000|Overall Study|Lost to Follow-up|3|||
25126302|NCT02188849|50239099|FG001|Overall Study|Lost to Follow-up|8|||
25126303|NCT01636076|50239107|FG000|Overall Study|Terminated by sponsor|1|||
25126304|NCT01636076|50239108|FG001|Overall Study|Terminated by sponsor|1|||
25126305|NCT01636076|50239107|FG000|Overall Study|Lack of Efficacy|0|||
25126306|NCT01636076|50239108|FG001|Overall Study|Lack of Efficacy|1|||
25126307|NCT01636076|50239107|FG000|Overall Study|Lost to Follow-up|1|||
25126308|NCT01636076|50239108|FG001|Overall Study|Lost to Follow-up|0|||
25126309|NCT01636076|50239107|FG000|Overall Study|Physician Decision|1|||
25126310|NCT01636076|50239108|FG001|Overall Study|Physician Decision|1|||
25126311|NCT01636076|50239107|FG000|Overall Study|Non-compliance with study treatment|1|||
25126312|NCT01636076|50239108|FG001|Overall Study|Non-compliance with study treatment|1|||
25126313|NCT01636076|50239107|FG000|Overall Study|Adverse Event|6|||
25126314|NCT01636076|50239108|FG001|Overall Study|Adverse Event|11|||
25126315|NCT01636076|50239107|FG000|Overall Study|Withdrawal by Subject|7|||
25126316|NCT01636076|50239108|FG001|Overall Study|Withdrawal by Subject|10|||
25126317|NCT01635998|50239123|FG000|Overall Study|Death|1|||
25126318|NCT01635998|50239124|FG001|Overall Study|Death|1|||
25126319|NCT01635998|50239123|FG000|Overall Study|Lost to Follow-up|2|||
25126320|NCT01635998|50239124|FG001|Overall Study|Lost to Follow-up|1|||
25126321|NCT01635998|50239123|FG000|Overall Study|Withdrawal by Subject|1|||
25126322|NCT01635998|50239124|FG001|Overall Study|Withdrawal by Subject|5|||
25126323|NCT01635920|50239132|FG000|Overall Study|Adverse Event|1|||
25126324|NCT01635920|50239133|FG001|Overall Study|Adverse Event|0|||
25126325|NCT01635920|50239132|FG000|Overall Study|Lost to Follow-up|0|||
25126326|NCT01635920|50239133|FG001|Overall Study|Lost to Follow-up|1|||
25126327|NCT01635920|50239132|FG000|Overall Study|Subject decision|2|||
25126328|NCT01635920|50239133|FG001|Overall Study|Subject decision|0|||
25126329|NCT02160145|50239150|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
25126330|NCT02160145|50239151|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
25126331|NCT02160145|50239152|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
25126332|NCT02160145|50239150|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
25126333|NCT02160145|50239151|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
25126334|NCT02160145|50239152|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
25126335|NCT02160145|50239150|FG000|Randomized Double-blind Period|Subject decision|0|||
25126336|NCT02160145|50239151|FG001|Randomized Double-blind Period|Subject decision|21|||
25126337|NCT02160145|50239152|FG002|Randomized Double-blind Period|Subject decision|20|||
25126338|NCT02160145|50239150|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
25126339|NCT02160145|50239151|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
25126340|NCT02160145|50239152|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
25126341|NCT02160145|50239150|FG000|Randomized Double-blind Period|Physician Decision|0|||
25126342|NCT02160145|50239151|FG001|Randomized Double-blind Period|Physician Decision|7|||
25126343|NCT02160145|50239152|FG002|Randomized Double-blind Period|Physician Decision|5|||
25126344|NCT01696396|50239163|FG000|Overall Study|Withdrawal by Subject|19|||
25126345|NCT01696396|50239164|FG001|Overall Study|Withdrawal by Subject|5|||
25126346|NCT01696396|50239165|FG002|Overall Study|Withdrawal by Subject|19|||
25126347|NCT01696396|50239166|FG003|Overall Study|Withdrawal by Subject|11|||
25126348|NCT01696396|50239163|FG000|Overall Study|Decision by Sponsor|3|||
25126349|NCT01696396|50239164|FG001|Overall Study|Decision by Sponsor|1|||
25126350|NCT01696396|50239165|FG002|Overall Study|Decision by Sponsor|2|||
25126351|NCT01696396|50239166|FG003|Overall Study|Decision by Sponsor|2|||
25126352|NCT01696396|50239163|FG000|Overall Study|Lost to Follow-up|9|||
25126353|NCT01696396|50239164|FG001|Overall Study|Lost to Follow-up|1|||
25126354|NCT01696396|50239165|FG002|Overall Study|Lost to Follow-up|4|||
25126355|NCT01696396|50239166|FG003|Overall Study|Lost to Follow-up|1|||
25126356|NCT01696396|50239163|FG000|Overall Study|Death|0|||
25126357|NCT01696396|50239164|FG001|Overall Study|Death|0|||
25126358|NCT01696396|50239165|FG002|Overall Study|Death|1|||
25126359|NCT01696396|50239166|FG003|Overall Study|Death|0|||
25126360|NCT02216071|50239182|FG000|Overall Study|Withdrawal by Subject|7|||
25126361|NCT02216071|50239183|FG001|Overall Study|Withdrawal by Subject|2|||
25268928|NCT00957853|50583007|FG001|Overall Study|Withdrawal by Subject|0|||
25268929|NCT00957853|50583008|FG002|Overall Study|Withdrawal by Subject|0|||
25268930|NCT00957229|50583018|FG000|Study Start|Adverse Event|0|||
25126362|NCT02216071|50239182|FG000|Overall Study|Lost to Follow-up|3|||
25126363|NCT02216071|50239183|FG001|Overall Study|Lost to Follow-up|3|||
25126364|NCT02216071|50239182|FG000|Overall Study|Protocol Violation|3|||
25126365|NCT02216071|50239183|FG001|Overall Study|Protocol Violation|5|||
25126366|NCT02216071|50239182|FG000|Overall Study|Other|2|||
25126367|NCT02216071|50239183|FG001|Overall Study|Other|2|||
25126368|NCT01681576|50239191|FG000|Period 1|Adverse Event|1|||
25126369|NCT01681576|50239192|FG001|Period 1|Adverse Event|0|||
25126370|NCT01681576|50239191|FG000|Period 1|Protocol Deviation|1|||
25126371|NCT01681576|50239192|FG001|Period 1|Protocol Deviation|0|||
25126372|NCT01681576|50239191|FG000|Period 2|subject/guardian decision|3|||
25126373|NCT01681576|50239192|FG001|Period 2|subject/guardian decision|1|||
25126374|NCT01681576|50239191|FG000|Period 2|Non-compliance with study treatment|1|||
25126375|NCT01681576|50239192|FG001|Period 2|Non-compliance with study treatment|0|||
25126376|NCT02188459|50239202|FG000|Overall Study|Lost to Follow-up|3|||
25126377|NCT02188459|50239203|FG001|Overall Study|Lost to Follow-up|4|||
25126378|NCT02188459|50239202|FG000|Overall Study|Early Termination|0|||
25126379|NCT02188459|50239203|FG001|Overall Study|Early Termination|3|||
25126380|NCT02214121|50239225|FG000|Part A|Patient decision|2|||
25126381|NCT02214121|50239226|FG001|Part A|Patient decision|0|||
25126382|NCT02214121|50239227|FG002|Part A|Patient decision|0|||
25126383|NCT02214121|50239225|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
25126384|NCT02214121|50239226|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
25126385|NCT02214121|50239227|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
25126386|NCT02214121|50239225|FG000|Part A|Other|1|||
25126387|NCT02214121|50239226|FG001|Part A|Other|0|||
25126388|NCT02214121|50239227|FG002|Part A|Other|0|||
25126389|NCT02214121|50239225|FG000|Part B|Patient decision|0|||
25126390|NCT02214121|50239226|FG001|Part B|Patient decision|1|||
25126391|NCT02214121|50239227|FG002|Part B|Patient decision|0|||
25126392|NCT02214121|50239225|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
25126393|NCT02214121|50239226|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
25126394|NCT02214121|50239227|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
25126395|NCT02214121|50239225|FG000|Part B|Lost to Follow-up|0|||
25126396|NCT02214121|50239226|FG001|Part B|Lost to Follow-up|0|||
25126397|NCT02214121|50239227|FG002|Part B|Lost to Follow-up|1|||
25126398|NCT01681186|50239255|FG000|Washout Period From Second Intervention|Adverse Event|0|||
25126399|NCT01681186|50239256|FG001|Washout Period From Second Intervention|Adverse Event|0|||
25126400|NCT01681186|50239257|FG002|Washout Period From Second Intervention|Adverse Event|0|||
25126401|NCT01681186|50239258|FG003|Washout Period From Second Intervention|Adverse Event|0|||
25126402|NCT01681186|50239259|FG004|Washout Period From Second Intervention|Adverse Event|0|||
25126403|NCT01681186|50239260|FG005|Washout Period From Second Intervention|Adverse Event|0|||
25126404|NCT01681186|50239261|FG006|Washout Period From Second Intervention|Adverse Event|1|||
25126405|NCT01681186|50239262|FG007|Washout Period From Second Intervention|Adverse Event|0|||
25126406|NCT01681186|50239255|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
25126407|NCT01681186|50239256|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
25126408|NCT01681186|50239257|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
25126409|NCT01681186|50239258|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
25126410|NCT01681186|50239259|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
25126411|NCT01681186|50239260|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
25126412|NCT01681186|50239261|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
25126413|NCT01681186|50239262|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
25126414|NCT01681186|50239255|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
25126415|NCT01681186|50239256|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
25126416|NCT01681186|50239257|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
25126417|NCT01681186|50239258|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
25126418|NCT01681186|50239259|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
25126419|NCT01681186|50239260|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
25126420|NCT01681186|50239261|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
25126421|NCT01681186|50239262|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
25126422|NCT01681186|50239255|FG000|Fourth Intervention|Protocol Violation|0|||
25126423|NCT01681186|50239256|FG001|Fourth Intervention|Protocol Violation|0|||
25126424|NCT01681186|50239257|FG002|Fourth Intervention|Protocol Violation|0|||
25126425|NCT01681186|50239258|FG003|Fourth Intervention|Protocol Violation|0|||
25126426|NCT01681186|50239259|FG004|Fourth Intervention|Protocol Violation|0|||
25126427|NCT01681186|50239260|FG005|Fourth Intervention|Protocol Violation|0|||
25126428|NCT01681186|50239261|FG006|Fourth Intervention|Protocol Violation|0|||
25268931|NCT00957229|50583019|FG001|Study Start|Adverse Event|3|||
25268932|NCT00957229|50583018|FG000|Study Start|Disease Progression|1|||
25268933|NCT00957229|50583019|FG001|Study Start|Disease Progression|0|||
25126429|NCT01681186|50239262|FG007|Fourth Intervention|Protocol Violation|1|||
25268934|NCT00957229|50583018|FG000|Reallocated to or Continued Vismodegib|Death|1|||
25268935|NCT00957229|50583019|FG001|Reallocated to or Continued Vismodegib|Death|1|||
25126430|NCT03597464|50239294|FG000|Overall Study|Withdrawal by Subject|4|||
25126431|NCT03597464|50239295|FG001|Overall Study|Withdrawal by Subject|5|||
25126432|NCT03597464|50239294|FG000|Overall Study|Lost to Follow-up|3|||
25126433|NCT03597464|50239295|FG001|Overall Study|Lost to Follow-up|1|||
25126434|NCT03597464|50239294|FG000|Overall Study|Pregnancy|3|||
25126435|NCT03597464|50239295|FG001|Overall Study|Pregnancy|1|||
25126436|NCT03597464|50239294|FG000|Overall Study|Lack of Efficacy|2|||
25268936|NCT00957229|50583018|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
25268937|NCT00957229|50583019|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
25268938|NCT02604511|50583025|FG000|Overall Study|Adverse Event|3|||
25268939|NCT02604511|50583025|FG000|Overall Study|Disease Progression|4|||
25268940|NCT02604511|50583025|FG000|Overall Study|Withdrawal by Subject|3|||
25268941|NCT02604511|50583025|FG000|Overall Study|Participant ineligible|1|||
25268942|NCT02604511|50583025|FG000|Overall Study|Intercurrent illness|1|||
25268943|NCT00956839|50583033|FG000|Overall Study|Lost to Follow-up|3|||
25268944|NCT00956839|50583034|FG001|Overall Study|Lost to Follow-up|0|||
25268945|NCT00956839|50583035|FG002|Overall Study|Lost to Follow-up|3|||
25268946|NCT00956293|50583045|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
25268947|NCT00956293|50583046|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
25268948|NCT00956293|50583047|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
25268949|NCT00956293|50583045|FG000|Main Period (Pre-randomization)|Death|0|||
25268950|NCT00956293|50583046|FG001|Main Period (Pre-randomization)|Death|0|||
25268951|NCT00956293|50583047|FG002|Main Period (Pre-randomization)|Death|1|||
25268952|NCT00956293|50583045|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
25268953|NCT00956293|50583046|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
25268954|NCT00956293|50583047|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
25268955|NCT00956293|50583045|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
25268956|NCT00956293|50583046|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
25268957|NCT00956293|50583047|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
25268958|NCT00956293|50583045|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
25268959|NCT00956293|50583046|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
25268960|NCT00956293|50583047|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
25268961|NCT00956293|50583045|FG000|Main Period (Pre-randomization)|Graft loss|0|||
25268962|NCT00956293|50583046|FG001|Main Period (Pre-randomization)|Graft loss|0|||
25268963|NCT00956293|50583047|FG002|Main Period (Pre-randomization)|Graft loss|7|||
25268964|NCT00956293|50583045|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
25268965|NCT00956293|50583046|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
25268966|NCT00956293|50583047|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
25268967|NCT00956293|50583045|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
25268968|NCT00956293|50583046|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
25268969|NCT00956293|50583047|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
25268970|NCT00956293|50583045|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
25268971|NCT00956293|50583046|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
25268972|NCT00956293|50583047|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
25268973|NCT00956293|50583045|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
25268974|NCT00956293|50583046|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
25268975|NCT00956293|50583047|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
25268976|NCT00956293|50583045|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
25268977|NCT00956293|50583046|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
25268978|NCT00956293|50583047|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
25268979|NCT00956293|50583045|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
25268980|NCT00956293|50583046|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
25268981|NCT00956293|50583047|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
25268982|NCT00956293|50583045|FG000|Main Period (Randomization)|Adverse Event|0|||
25268983|NCT00956293|50583046|FG001|Main Period (Randomization)|Adverse Event|15|||
25268984|NCT00956293|50583047|FG002|Main Period (Randomization)|Adverse Event|0|||
25268985|NCT00956293|50583045|FG000|Follow-up Period|Follow-up period was terminated.|20|||
25268986|NCT00956293|50583046|FG001|Follow-up Period|Follow-up period was terminated.|32|||
25268987|NCT00956293|50583047|FG002|Follow-up Period|Follow-up period was terminated.|0|||
25268988|NCT00955825|50583055|FG000|Overall Study|Adverse Event|15|||
25268989|NCT00955825|50583056|FG001|Overall Study|Adverse Event|2|||
25268990|NCT00955825|50583055|FG000|Overall Study|Withdrawal by Subject|4|||
25268991|NCT00955825|50583056|FG001|Overall Study|Withdrawal by Subject|6|||
25268992|NCT00955825|50583055|FG000|Overall Study|Any other reason not above-mentioned|7|||
25268993|NCT00955825|50583056|FG001|Overall Study|Any other reason not above-mentioned|9|||
25268994|NCT01164579|50583065|FG000|Overall Study|Lack of Efficacy|0|||
25268995|NCT01164579|50583066|FG001|Overall Study|Lack of Efficacy|0|||
25268996|NCT01164579|50583067|FG002|Overall Study|Lack of Efficacy|6|||
25268997|NCT01164579|50583065|FG000|Overall Study|Lost to Follow-up|1|||
25268998|NCT01164579|50583066|FG001|Overall Study|Lost to Follow-up|1|||
25268999|NCT01164579|50583067|FG002|Overall Study|Lost to Follow-up|0|||
25269000|NCT01164579|50583065|FG000|Overall Study|Withdrawal by Subject|2|||
25269001|NCT01164579|50583066|FG001|Overall Study|Withdrawal by Subject|5|||
25269002|NCT01164579|50583067|FG002|Overall Study|Withdrawal by Subject|3|||
25269003|NCT01164579|50583065|FG000|Overall Study|Protocol Violation|0|||
25269004|NCT01164579|50583066|FG001|Overall Study|Protocol Violation|1|||
25009291|NCT00075725|50102294|FG000|Overall Study|Unsuccessful institutional transfer|0|||
25009292|NCT00075725|50102295|FG001|Overall Study|Unsuccessful institutional transfer|0|||
25269005|NCT01164579|50583067|FG002|Overall Study|Protocol Violation|2|||
25269006|NCT01164579|50583065|FG000|Overall Study|Adverse Event|4|||
25269007|NCT01164579|50583066|FG001|Overall Study|Adverse Event|2|||
25269008|NCT01164579|50583067|FG002|Overall Study|Adverse Event|5|||
25269009|NCT01164579|50583065|FG000|Overall Study|Reason not specified|1|||
25269010|NCT01164579|50583066|FG001|Overall Study|Reason not specified|0|||
25269011|NCT01164579|50583067|FG002|Overall Study|Reason not specified|0|||
25269012|NCT00958789|50583076|FG000|Overall Study|Death|5|||
25269013|NCT00958789|50583076|FG000|Overall Study|Lost to Follow-up|14|||
25269014|NCT00958789|50583076|FG000|Overall Study|Withdrawal by Subject|17|||
25269015|NCT00958789|50583076|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
25269016|NCT00958789|50583076|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
25009293|NCT00075725|50102296|FG002|Overall Study|Unsuccessful institutional transfer|2|||
25009294|NCT00075725|50102297|FG003|Overall Study|Unsuccessful institutional transfer|0|||
25009295|NCT00075725|50102298|FG004|Overall Study|Unsuccessful institutional transfer|0|||
25009296|NCT00075725|50102299|FG005|Overall Study|Unsuccessful institutional transfer|0|||
25009297|NCT00075725|50102300|FG006|Overall Study|Unsuccessful institutional transfer|0|||
25009298|NCT00075725|50102301|FG007|Overall Study|Unsuccessful institutional transfer|0|||
25009299|NCT00075725|50102302|FG008|Overall Study|Unsuccessful institutional transfer|0|||
25009300|NCT00075725|50102303|FG009|Overall Study|Unsuccessful institutional transfer|1|||
25009301|NCT00075725|50102304|FG010|Overall Study|Unsuccessful institutional transfer|0|||
25009302|NCT00075725|50102305|FG011|Overall Study|Unsuccessful institutional transfer|0|||
25009303|NCT00075725|50102294|FG000|Overall Study|specimen(s) not submitted|0|||
25009304|NCT00075725|50102295|FG001|Overall Study|specimen(s) not submitted|0|||
25009305|NCT00075725|50102296|FG002|Overall Study|specimen(s) not submitted|2|||
25009306|NCT00075725|50102297|FG003|Overall Study|specimen(s) not submitted|0|||
25009307|NCT00075725|50102298|FG004|Overall Study|specimen(s) not submitted|0|||
25009308|NCT00075725|50102299|FG005|Overall Study|specimen(s) not submitted|0|||
25009309|NCT00075725|50102300|FG006|Overall Study|specimen(s) not submitted|0|||
25009310|NCT00075725|50102301|FG007|Overall Study|specimen(s) not submitted|0|||
25009311|NCT00075725|50102302|FG008|Overall Study|specimen(s) not submitted|0|||
25009312|NCT00075725|50102303|FG009|Overall Study|specimen(s) not submitted|0|||
25009313|NCT00075725|50102304|FG010|Overall Study|specimen(s) not submitted|0|||
25009314|NCT00075725|50102305|FG011|Overall Study|specimen(s) not submitted|0|||
25009315|NCT00075725|50102294|FG000|Overall Study|Pt went to transplant|0|||
25009316|NCT00075725|50102295|FG001|Overall Study|Pt went to transplant|0|||
25009317|NCT00075725|50102296|FG002|Overall Study|Pt went to transplant|0|||
25009318|NCT00075725|50102297|FG003|Overall Study|Pt went to transplant|1|||
25269017|NCT00958789|50583076|FG000|Overall Study|Subject terminated|2|||
25269018|NCT00958789|50583076|FG000|Overall Study|Revision|7|||
25269019|NCT02445391|50583087|FG000|Overall Study|No active protocol treatment|3|||
25269020|NCT02445391|50583088|FG001|Overall Study|No active protocol treatment|0|||
25269021|NCT02445391|50583089|FG002|Overall Study|No active protocol treatment|0|||
25269022|NCT02445391|50583087|FG000|Overall Study|Adverse Event|0|||
25269023|NCT02445391|50583088|FG001|Overall Study|Adverse Event|21|||
25269024|NCT02445391|50583089|FG002|Overall Study|Adverse Event|12|||
25269025|NCT02445391|50583087|FG000|Overall Study|Alternative therapy|0|||
25269026|NCT02445391|50583088|FG001|Overall Study|Alternative therapy|0|||
25269027|NCT02445391|50583089|FG002|Overall Study|Alternative therapy|1|||
25269028|NCT02445391|50583087|FG000|Overall Study|Disease progression|0|||
25269029|NCT02445391|50583088|FG001|Overall Study|Disease progression|7|||
25269030|NCT02445391|50583089|FG002|Overall Study|Disease progression|22|||
25269031|NCT02445391|50583087|FG000|Overall Study|Complicating disease|0|||
25269032|NCT02445391|50583088|FG001|Overall Study|Complicating disease|2|||
25269033|NCT02445391|50583089|FG002|Overall Study|Complicating disease|1|||
25269034|NCT02445391|50583087|FG000|Overall Study|Withdrawal by Subject|0|||
25269035|NCT02445391|50583088|FG001|Overall Study|Withdrawal by Subject|4|||
25269036|NCT02445391|50583089|FG002|Overall Study|Withdrawal by Subject|9|||
25269037|NCT02445391|50583087|FG000|Overall Study|Financial issue|0|||
25269038|NCT02445391|50583088|FG001|Overall Study|Financial issue|0|||
25269039|NCT02445391|50583089|FG002|Overall Study|Financial issue|2|||
25269040|NCT02445391|50583087|FG000|Overall Study|Still on treatment|0|||
25269041|NCT02445391|50583088|FG001|Overall Study|Still on treatment|7|||
25269042|NCT02445391|50583089|FG002|Overall Study|Still on treatment|16|||
25269043|NCT02445391|50583087|FG000|Overall Study|Not start protocol therapy|0|||
25269044|NCT02445391|50583088|FG001|Overall Study|Not start protocol therapy|12|||
25269045|NCT02445391|50583089|FG002|Overall Study|Not start protocol therapy|9|||
25009319|NCT00075725|50102298|FG004|Overall Study|Pt went to transplant|0|||
25126437|NCT03597464|50239295|FG001|Overall Study|Lack of Efficacy|0|||
25269046|NCT01246986|50583105|FG000|Overall Study|Lost to Follow-up|0|||
25269047|NCT01246986|50583106|FG001|Overall Study|Lost to Follow-up|1|||
25269048|NCT01246986|50583107|FG002|Overall Study|Lost to Follow-up|3|||
25269049|NCT01246986|50583108|FG003|Overall Study|Lost to Follow-up|0|||
25009320|NCT00075725|50102299|FG005|Overall Study|Pt went to transplant|1|||
25009321|NCT00075725|50102300|FG006|Overall Study|Pt went to transplant|0|||
25009322|NCT00075725|50102301|FG007|Overall Study|Pt went to transplant|0|||
25269050|NCT01246986|50583109|FG004|Overall Study|Lost to Follow-up|0|||
25269051|NCT01246986|50583110|FG005|Overall Study|Lost to Follow-up|1|||
25269052|NCT01246986|50583111|FG006|Overall Study|Lost to Follow-up|0|||
25269053|NCT01246986|50583105|FG000|Overall Study|Withdrawal by Subject|3|||
25269054|NCT01246986|50583106|FG001|Overall Study|Withdrawal by Subject|4|||
25269055|NCT01246986|50583107|FG002|Overall Study|Withdrawal by Subject|3|||
25269056|NCT01246986|50583108|FG003|Overall Study|Withdrawal by Subject|0|||
25269057|NCT01246986|50583109|FG004|Overall Study|Withdrawal by Subject|4|||
25269058|NCT01246986|50583110|FG005|Overall Study|Withdrawal by Subject|0|||
25269059|NCT01246986|50583111|FG006|Overall Study|Withdrawal by Subject|0|||
25269060|NCT01164501|50583145|FG000|Overall Study|Not treated|2|||
25269061|NCT01164501|50583146|FG001|Overall Study|Not treated|0|||
25269062|NCT01164501|50583147|FG002|Overall Study|Not treated|1|||
25269063|NCT01164501|50583145|FG000|Overall Study|Adverse Event|18|||
25269064|NCT01164501|50583146|FG001|Overall Study|Adverse Event|4|||
25269065|NCT01164501|50583147|FG002|Overall Study|Adverse Event|21|||
25126438|NCT03597464|50239294|FG000|Overall Study|Physician Decision|2|||
25126439|NCT03597464|50239295|FG001|Overall Study|Physician Decision|2|||
25126440|NCT03597464|50239294|FG000|Overall Study|Protocol Violation|1|||
25126441|NCT03597464|50239295|FG001|Overall Study|Protocol Violation|1|||
25126442|NCT03597464|50239294|FG000|Overall Study|Adverse Event|0|||
25126443|NCT03597464|50239295|FG001|Overall Study|Adverse Event|2|||
25126444|NCT03597464|50239294|FG000|Overall Study|Death|0|||
25126445|NCT03597464|50239295|FG001|Overall Study|Death|3|||
25126446|NCT01695772|50239303|FG000|Overall Study|Withdrawal by Subject|18|||
25126447|NCT01695772|50239303|FG000|Overall Study|Progressive Disease|8|||
25126448|NCT01695772|50239303|FG000|Overall Study|Investigator Decision|5|||
25126449|NCT01695772|50239303|FG000|Overall Study|Lost to Follow-up|4|||
25126450|NCT01695772|50239303|FG000|Overall Study|Protocol Violation|2|||
25126451|NCT01695772|50239303|FG000|Overall Study|Unspecified Reason|1|||
25126452|NCT02159521|50239307|FG000|Overall Study|Enrolled but not treated|3|||
25126453|NCT02159521|50239307|FG000|Overall Study|Withdrawal by Subject|7|||
25126454|NCT02159521|50239307|FG000|Overall Study|Lost to Follow-up|6|||
25126455|NCT02159521|50239307|FG000|Overall Study|Death|1|||
25126456|NCT02159521|50239307|FG000|Overall Study|Other than specified|1|||
25269066|NCT01164501|50583145|FG000|Overall Study|Lack of Efficacy|0|||
25269067|NCT01164501|50583146|FG001|Overall Study|Lack of Efficacy|0|||
25269068|NCT01164501|50583147|FG002|Overall Study|Lack of Efficacy|1|||
25269069|NCT01164501|50583145|FG000|Overall Study|Non compliant with protocol|1|||
25269070|NCT01164501|50583146|FG001|Overall Study|Non compliant with protocol|1|||
25269071|NCT01164501|50583147|FG002|Overall Study|Non compliant with protocol|4|||
25269072|NCT01164501|50583145|FG000|Overall Study|Lost to Follow-up|3|||
25269073|NCT01164501|50583146|FG001|Overall Study|Lost to Follow-up|0|||
25269074|NCT01164501|50583147|FG002|Overall Study|Lost to Follow-up|3|||
25269075|NCT01164501|50583145|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
25269076|NCT01164501|50583146|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
25269077|NCT01164501|50583147|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
25269078|NCT01164501|50583145|FG000|Overall Study|Other reason not defined above|9|||
25269079|NCT01164501|50583146|FG001|Overall Study|Other reason not defined above|1|||
25269080|NCT01164501|50583147|FG002|Overall Study|Other reason not defined above|4|||
25269081|NCT00958711|50583159|FG000|Overall Study|Withdrawal by Subject|0|||
25269082|NCT00958711|50583160|FG001|Overall Study|Withdrawal by Subject|4|||
25269083|NCT00958711|50583159|FG000|Overall Study|Physician Decision|5|||
25269084|NCT00958711|50583160|FG001|Overall Study|Physician Decision|7|||
25269085|NCT00958711|50583159|FG000|Overall Study|Lost to Follow-up|4|||
25269086|NCT00958711|50583160|FG001|Overall Study|Lost to Follow-up|1|||
25269087|NCT00958711|50583159|FG000|Overall Study|Other|2|||
25269088|NCT00958711|50583160|FG001|Overall Study|Other|5|||
25269089|NCT00958711|50583159|FG000|Overall Study|Death|1|||
25269090|NCT00958711|50583160|FG001|Overall Study|Death|2|||
25126457|NCT01636934|50239313|FG000|Overall Study|Withdrawal by Subject|3|||
25126458|NCT01636934|50239314|FG001|Overall Study|Withdrawal by Subject|2|||
25126459|NCT01636934|50239313|FG000|Overall Study|Chemo cancel|1|||
25269091|NCT00958711|50583159|FG000|Overall Study|Adverse Event|1|||
25269092|NCT00958711|50583160|FG001|Overall Study|Adverse Event|2|||
25269093|NCT01163721|50583168|FG000|Overall Study|Adverse Event|5|||
25269094|NCT01163721|50583169|FG001|Overall Study|Adverse Event|6|||
25269095|NCT01163721|50583168|FG000|Overall Study|Withdrawal by Subject|3|||
25269096|NCT01163721|50583169|FG001|Overall Study|Withdrawal by Subject|4|||
25269097|NCT01163721|50583168|FG000|Overall Study|Lost to Follow-up|0|||
25126460|NCT01636934|50239314|FG001|Overall Study|Chemo cancel|0|||
25126461|NCT01636934|50239313|FG000|Overall Study|Too ill to continue|1|||
25126462|NCT01636934|50239314|FG001|Overall Study|Too ill to continue|0|||
25126463|NCT01636934|50239313|FG000|Overall Study|Never started study medication|1|||
25126464|NCT01636934|50239314|FG001|Overall Study|Never started study medication|1|||
25269098|NCT01163721|50583169|FG001|Overall Study|Lost to Follow-up|1|||
25269099|NCT01163721|50583168|FG000|Overall Study|Physician Decision|0|||
25269100|NCT01163721|50583169|FG001|Overall Study|Physician Decision|1|||
25269101|NCT00958243|50583181|FG000|Overall Study|Withdrawal by Subject|0|||
25269102|NCT00958243|50583182|FG001|Overall Study|Withdrawal by Subject|1|||
25269103|NCT00958243|50583183|FG002|Overall Study|Withdrawal by Subject|3|||
25269104|NCT00958243|50583184|FG003|Overall Study|Withdrawal by Subject|1|||
25269105|NCT00958243|50583185|FG004|Overall Study|Withdrawal by Subject|1|||
25269106|NCT00958243|50583186|FG005|Overall Study|Withdrawal by Subject|5|||
25269107|NCT00958243|50583181|FG000|Overall Study|Lost to Follow-up|2|||
25269108|NCT00958243|50583182|FG001|Overall Study|Lost to Follow-up|5|||
25269109|NCT00958243|50583183|FG002|Overall Study|Lost to Follow-up|11|||
25269110|NCT00958243|50583184|FG003|Overall Study|Lost to Follow-up|2|||
25269111|NCT00958243|50583185|FG004|Overall Study|Lost to Follow-up|8|||
25269112|NCT00958243|50583186|FG005|Overall Study|Lost to Follow-up|5|||
25269113|NCT01241760|50583208|FG000|Overall Study|Adverse Event|1|||
25269114|NCT01241760|50583209|FG001|Overall Study|Adverse Event|0|||
25269115|NCT01241760|50583208|FG000|Overall Study|Lost to Follow-up|18|||
25269116|NCT01241760|50583209|FG001|Overall Study|Lost to Follow-up|22|||
25269117|NCT01241760|50583208|FG000|Overall Study|Withdrawal by Subject|13|||
25269118|NCT01241760|50583209|FG001|Overall Study|Withdrawal by Subject|13|||
25269119|NCT01241760|50583208|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
25269120|NCT01241760|50583209|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
25269121|NCT01241760|50583208|FG000|Overall Study|Other|1|||
25269122|NCT01241760|50583209|FG001|Overall Study|Other|1|||
25269123|NCT00958165|50583216|FG000|Overall Study|Lost to Follow-up|5|||
25269124|NCT00958165|50583216|FG000|Overall Study|Not eligible|9|||
25269125|NCT00958009|50583220|FG000|Overall Study|Adverse Event|1|||
25269126|NCT00958009|50583220|FG000|Overall Study|Subject found device difficult to use|1|||
25269127|NCT00953407|50583229|FG000|Overall Study|Failed inclusion criteria|1|||
25269128|NCT00953407|50583230|FG001|Overall Study|Failed inclusion criteria|1|||
25269129|NCT00953407|50583231|FG002|Overall Study|Failed inclusion criteria|1|||
25269130|NCT00953407|50583232|FG003|Overall Study|Failed inclusion criteria|1|||
25269131|NCT00953407|50583233|FG004|Overall Study|Failed inclusion criteria|1|||
25269132|NCT00953407|50583229|FG000|Overall Study|Lost to Follow-up|0|||
25269133|NCT00953407|50583230|FG001|Overall Study|Lost to Follow-up|0|||
25269134|NCT00953407|50583231|FG002|Overall Study|Lost to Follow-up|0|||
25269135|NCT00953407|50583232|FG003|Overall Study|Lost to Follow-up|1|||
25269136|NCT00953407|50583233|FG004|Overall Study|Lost to Follow-up|0|||
25269137|NCT00953329|50583245|FG000|Overall Study|Lack of Efficacy|1|||
25269138|NCT00953017|50583253|FG000|Overall Study|DId not show up for colonoscopy|4|||
25269139|NCT00953017|50583254|FG001|Overall Study|DId not show up for colonoscopy|4|||
25269140|NCT00953017|50583255|FG002|Overall Study|DId not show up for colonoscopy|5|||
25269141|NCT00953017|50583256|FG003|Overall Study|DId not show up for colonoscopy|4|||
25269142|NCT00953017|50583253|FG000|Overall Study|Incomplete data|1|||
25269143|NCT00953017|50583254|FG001|Overall Study|Incomplete data|1|||
25269144|NCT00953017|50583255|FG002|Overall Study|Incomplete data|0|||
25269145|NCT00953017|50583256|FG003|Overall Study|Incomplete data|0|||
25269146|NCT00953017|50583253|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
25269147|NCT00953017|50583254|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
25269148|NCT00953017|50583255|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
25269149|NCT00953017|50583256|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
25269150|NCT00953017|50583253|FG000|Overall Study|Brown stool prior to procedure|0|||
25269151|NCT00953017|50583254|FG001|Overall Study|Brown stool prior to procedure|0|||
25269152|NCT00953017|50583255|FG002|Overall Study|Brown stool prior to procedure|1|||
25269153|NCT00953017|50583256|FG003|Overall Study|Brown stool prior to procedure|0|||
25269154|NCT00952705|50583269|FG000|Overall Study|Lost to Follow-up|24|||
25269155|NCT00952705|50583270|FG001|Overall Study|Lost to Follow-up|8|||
25269156|NCT00952705|50583271|FG002|Overall Study|Lost to Follow-up|9|||
25269157|NCT00952705|50583269|FG000|Overall Study|Withdrawal by Subject|2|||
25269158|NCT00952705|50583270|FG001|Overall Study|Withdrawal by Subject|1|||
25269159|NCT00952705|50583271|FG002|Overall Study|Withdrawal by Subject|1|||
25269160|NCT00952705|50583269|FG000|Overall Study|Death|2|||
25269161|NCT00952705|50583270|FG001|Overall Study|Death|0|||
25269162|NCT00952705|50583271|FG002|Overall Study|Death|0|||
25269163|NCT00952705|50583269|FG000|Overall Study|Incarcerated post dose|5|||
25269164|NCT00952705|50583270|FG001|Overall Study|Incarcerated post dose|0|||
25269165|NCT00952705|50583271|FG002|Overall Study|Incarcerated post dose|0|||
25269166|NCT00952705|50583269|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
25269167|NCT00952705|50583270|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
25269168|NCT00952705|50583271|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
25269169|NCT00955357|50583285|FG000|Titration Phase|Adverse Event|9|||
25269170|NCT00955357|50583286|FG001|Titration Phase|Adverse Event|46|||
25269171|NCT00955357|50583285|FG000|Titration Phase|Lack of Efficacy|0|||
25178505|NCT01544179|50323790|FG000|Overall Study|Withdrawal by Subject|12|||
25269172|NCT00955357|50583286|FG001|Titration Phase|Lack of Efficacy|2|||
25269173|NCT00955357|50583285|FG000|Titration Phase|Protocol Violation|3|||
25269174|NCT00955357|50583286|FG001|Titration Phase|Protocol Violation|7|||
25269175|NCT00955357|50583285|FG000|Titration Phase|Lost to Follow-up|1|||
25269176|NCT00955357|50583286|FG001|Titration Phase|Lost to Follow-up|3|||
25269177|NCT00955357|50583285|FG000|Titration Phase|Withdrawal by Subject|3|||
25269178|NCT00955357|50583286|FG001|Titration Phase|Withdrawal by Subject|5|||
25269179|NCT00955357|50583285|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
25269180|NCT00955357|50583286|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
25269181|NCT00955357|50583285|FG000|Titration Phase|Study medication not tolerated|0|||
25269182|NCT00955357|50583286|FG001|Titration Phase|Study medication not tolerated|1|||
25269183|NCT00955357|50583285|FG000|Titration Phase|Non compliance to study procedures|0|||
25269184|NCT00955357|50583286|FG001|Titration Phase|Non compliance to study procedures|1|||
25269185|NCT00955357|50583285|FG000|Maintenance Phase|Adverse Event|3|||
25269186|NCT00955357|50583286|FG001|Maintenance Phase|Adverse Event|23|||
25269187|NCT00955357|50583285|FG000|Maintenance Phase|Lack of Efficacy|0|||
25269188|NCT00955357|50583286|FG001|Maintenance Phase|Lack of Efficacy|4|||
25269189|NCT00955357|50583285|FG000|Maintenance Phase|Protocol Violation|2|||
25269190|NCT00955357|50583286|FG001|Maintenance Phase|Protocol Violation|6|||
25269191|NCT00955357|50583285|FG000|Maintenance Phase|Lost to Follow-up|2|||
25269192|NCT00955357|50583286|FG001|Maintenance Phase|Lost to Follow-up|7|||
25269193|NCT00955357|50583285|FG000|Maintenance Phase|Withdrawal by Subject|4|||
25269194|NCT00955357|50583286|FG001|Maintenance Phase|Withdrawal by Subject|4|||
25269195|NCT00955357|50583285|FG000|Maintenance Phase|Patient moving out of area|0|||
25269196|NCT00955357|50583286|FG001|Maintenance Phase|Patient moving out of area|1|||
25269197|NCT00955357|50583285|FG000|Maintenance Phase|Non compliance to study procedures|1|||
25269198|NCT00955357|50583286|FG001|Maintenance Phase|Non compliance to study procedures|0|||
25269199|NCT00955279|50583295|FG000|Overall Study|Other|0|||
25269200|NCT00955279|50583296|FG001|Overall Study|Other|0|||
25269201|NCT00955279|50583297|FG002|Overall Study|Other|3|||
25269202|NCT00955279|50583295|FG000|Overall Study|Death|1|||
25269203|NCT00955279|50583296|FG001|Overall Study|Death|1|||
25269204|NCT00955279|50583297|FG002|Overall Study|Death|1|||
25269205|NCT00955279|50583295|FG000|Overall Study|Lost to Follow-up|0|||
25269206|NCT00955279|50583296|FG001|Overall Study|Lost to Follow-up|3|||
25269207|NCT00955279|50583297|FG002|Overall Study|Lost to Follow-up|1|||
25269208|NCT00955279|50583295|FG000|Overall Study|Withdrawal by Subject|2|||
25269209|NCT00955279|50583296|FG001|Overall Study|Withdrawal by Subject|0|||
25269210|NCT00955279|50583297|FG002|Overall Study|Withdrawal by Subject|3|||
25269211|NCT00954733|50583305|FG000|Overall Study|blood gas machine did not work|1|||
25269212|NCT00954421|50583309|FG000|Screening|screen failures|3|||
25269213|NCT00954421|50583309|FG000|6 Months of DBS|Withdrawal by Subject|1|||
25269214|NCT00954421|50583309|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
25269215|NCT01241448|50583319|FG000|Overall Study|Adverse Event|1|||
25269216|NCT01241448|50583320|FG001|Overall Study|Adverse Event|0|||
25269217|NCT01241448|50583321|FG002|Overall Study|Adverse Event|2|||
25269218|NCT01241448|50583322|FG003|Overall Study|Adverse Event|2|||
25269219|NCT01241448|50583319|FG000|Overall Study|Lost to Follow-up|2|||
25269220|NCT01241448|50583320|FG001|Overall Study|Lost to Follow-up|1|||
25269221|NCT01241448|50583321|FG002|Overall Study|Lost to Follow-up|1|||
25269222|NCT01241448|50583322|FG003|Overall Study|Lost to Follow-up|1|||
25269223|NCT01241448|50583319|FG000|Overall Study|Physician Decision|0|||
25269224|NCT01241448|50583320|FG001|Overall Study|Physician Decision|2|||
25269225|NCT01241448|50583321|FG002|Overall Study|Physician Decision|0|||
25269226|NCT01241448|50583322|FG003|Overall Study|Physician Decision|0|||
25269227|NCT01241448|50583319|FG000|Overall Study|Protocol Violation|10|||
25269228|NCT01241448|50583320|FG001|Overall Study|Protocol Violation|5|||
25269229|NCT01241448|50583321|FG002|Overall Study|Protocol Violation|3|||
25269230|NCT01241448|50583322|FG003|Overall Study|Protocol Violation|6|||
25269231|NCT01241448|50583319|FG000|Overall Study|Sponsor Decision|17|||
25269232|NCT01241448|50583320|FG001|Overall Study|Sponsor Decision|14|||
25269233|NCT01241448|50583321|FG002|Overall Study|Sponsor Decision|12|||
25269234|NCT01241448|50583322|FG003|Overall Study|Sponsor Decision|6|||
25269235|NCT01241448|50583319|FG000|Overall Study|Withdrawal by Subject|4|||
25269236|NCT01241448|50583320|FG001|Overall Study|Withdrawal by Subject|5|||
25009323|NCT00075725|50102302|FG008|Overall Study|Pt went to transplant|0|||
25269237|NCT01241448|50583321|FG002|Overall Study|Withdrawal by Subject|3|||
25269238|NCT01241448|50583322|FG003|Overall Study|Withdrawal by Subject|6|||
25269239|NCT01241448|50583319|FG000|Overall Study|Excluded due to data integrity issues|3|||
25269240|NCT01241448|50583320|FG001|Overall Study|Excluded due to data integrity issues|2|||
25269241|NCT01241448|50583321|FG002|Overall Study|Excluded due to data integrity issues|2|||
25009324|NCT00075725|50102303|FG009|Overall Study|Pt went to transplant|0|||
25269242|NCT01241448|50583322|FG003|Overall Study|Excluded due to data integrity issues|2|||
25269243|NCT01240356|50583335|FG000|Overall Study|Withdrawal by Subject|2|||
25269244|NCT01240356|50583336|FG001|Overall Study|Withdrawal by Subject|0|||
25269245|NCT01240356|50583335|FG000|Overall Study|MRI contraindication|1|||
25269246|NCT01240356|50583336|FG001|Overall Study|MRI contraindication|0|||
25269247|NCT01239732|50583345|FG000|Overall Study|Termination of study per protocol|667|||
25269248|NCT01239732|50583345|FG000|Overall Study|Death|226|||
25269249|NCT01239732|50583345|FG000|Overall Study|Withdrawal by Subject|87|||
25269250|NCT01239732|50583345|FG000|Overall Study|Adverse Event|6|||
25269251|NCT01239732|50583345|FG000|Overall Study|Protocol Violation|3|||
25269252|NCT01239732|50583345|FG000|Overall Study|Participant non compliance|5|||
25269253|NCT01239732|50583345|FG000|Overall Study|Study termination by sponsor|2|||
25269254|NCT01239732|50583345|FG000|Overall Study|Investigator's decision|4|||
25269255|NCT01239732|50583345|FG000|Overall Study|Treatment failure|2|||
25269256|NCT01239732|50583345|FG000|Overall Study|Other|19|||
25269257|NCT02227147|50583351|FG000|Controlled Treatment Period|Adverse Event|4|||
25269258|NCT02227147|50583352|FG001|Controlled Treatment Period|Adverse Event|3|||
25269259|NCT02227147|50583351|FG000|Controlled Treatment Period|Other|2|||
25269260|NCT02227147|50583352|FG001|Controlled Treatment Period|Other|0|||
25269261|NCT02227147|50583351|FG000|Follow-up Period|Other|3|||
25269262|NCT02227147|50583352|FG001|Follow-up Period|Other|5|||
25269263|NCT00948025|50583364|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
25269264|NCT00948025|50583365|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
25269265|NCT00948025|50583364|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
25269266|NCT00948025|50583365|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
25269267|NCT00948025|50583364|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
25269268|NCT00948025|50583365|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
25269269|NCT00947011|50583372|FG000|Overall Study|Study was terminated,PI left institution|12|||
25269270|NCT01239342|50583380|FG000|Overall Study|Adverse Event|1|||
25269271|NCT01239342|50583381|FG001|Overall Study|Adverse Event|0|||
25269272|NCT01239342|50583380|FG000|Overall Study|Withdrawal by Subject|1|||
25269273|NCT01239342|50583381|FG001|Overall Study|Withdrawal by Subject|5|||
25269274|NCT01239342|50583380|FG000|Overall Study|Reason Unknown|1|||
25269275|NCT01239342|50583381|FG001|Overall Study|Reason Unknown|1|||
25269276|NCT00946309|50583389|FG000|Overall Study|Protocol Violation|1|||
25269277|NCT00946309|50583390|FG001|Overall Study|Protocol Violation|0|||
25269278|NCT00946309|50583389|FG000|Overall Study|Lost to Follow-up|0|||
25269279|NCT00946309|50583390|FG001|Overall Study|Lost to Follow-up|1|||
25269280|NCT00946309|50583389|FG000|Overall Study|Procedure cancelled/discontinued|0|||
25269281|NCT00946309|50583390|FG001|Overall Study|Procedure cancelled/discontinued|3|||
25269282|NCT01236534|50583399|FG000|Overall Study|Adverse Event|3|||
25269283|NCT01236534|50583400|FG001|Overall Study|Adverse Event|0|||
25269284|NCT01235598|50583408|FG000|Overall Study|Adverse Event|0|||
25269285|NCT01235598|50583409|FG001|Overall Study|Adverse Event|3|||
25269286|NCT01235598|50583408|FG000|Overall Study|Lack of Efficacy|0|||
25126465|NCT01712854|50239320|FG000|Overall Study|Physician Decision|1|||
25126466|NCT01693120|50239324|FG000|Enrollment|Lost to Follow-up|1|||
25126467|NCT01693120|50239324|FG000|Enrollment|Withdrawal by Subject|10|||
25126468|NCT01693120|50239324|FG000|Enrollment|Protocol Violation|46|||
25126469|NCT01693120|50239324|FG000|Enrollment|Physician Decision|3|||
25126470|NCT01693120|50239324|FG000|Enrollment|Adverse Event|1|||
25126471|NCT01693120|50239324|FG000|Enrollment|Study closed|8|||
25126472|NCT01693120|50239324|FG000|Enrollment|Other|1|||
25126473|NCT01693120|50239324|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
25126474|NCT01693120|50239324|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
25126475|NCT01693120|50239324|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
25126476|NCT01693120|50239324|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
25126477|NCT01693120|50239324|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
25126478|NCT02159365|50239328|FG000|Overall Study|Disease Progression|23|||
25126479|NCT02159365|50239328|FG000|Overall Study|Other reasons|11|||
25126480|NCT02159365|50239328|FG000|Overall Study|Administrative reason by Sponsor|9|||
25126481|NCT02159365|50239328|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
25126482|NCT02159365|50239328|FG000|Overall Study|Study drug toxicity|7|||
25269287|NCT01235598|50583409|FG001|Overall Study|Lack of Efficacy|1|||
25269288|NCT01235598|50583408|FG000|Overall Study|Withdrawal by Subject|1|||
25269289|NCT01235598|50583409|FG001|Overall Study|Withdrawal by Subject|0|||
25269290|NCT01235442|50583418|FG000|Overall Study|Lost to Follow-up|12|||
25269291|NCT01235442|50583419|FG001|Overall Study|Lost to Follow-up|10|||
25269292|NCT01235442|50583418|FG000|Overall Study|Death|0|||
25269293|NCT01235442|50583419|FG001|Overall Study|Death|2|||
25009325|NCT00075725|50102304|FG010|Overall Study|Pt went to transplant|0|||
25009326|NCT00075725|50102305|FG011|Overall Study|Pt went to transplant|0|||
25269294|NCT01235442|50583418|FG000|Overall Study|Pregnancy|1|||
25126483|NCT02159365|50239328|FG000|Overall Study|Maximum clinical benefit|3|||
25126484|NCT02159365|50239328|FG000|Overall Study|Subject request to discontinue treatment|3|||
25126485|NCT02159365|50239328|FG000|Overall Study|Subject withdrew consent|3|||
25126486|NCT02159365|50239328|FG000|Overall Study|Death|1|||
25269295|NCT01235442|50583419|FG001|Overall Study|Pregnancy|1|||
25009327|NCT00075725|50102294|FG000|Overall Study|Pt received additional steroids|0|||
25269296|NCT01235442|50583418|FG000|Overall Study|Ineligibility determined|5|||
25269297|NCT01235442|50583419|FG001|Overall Study|Ineligibility determined|4|||
25269298|NCT01235442|50583418|FG000|Overall Study|Protocol Violation|3|||
25269299|NCT01235442|50583419|FG001|Overall Study|Protocol Violation|3|||
25269300|NCT01235442|50583418|FG000|Overall Study|Adverse Event|4|||
25269301|NCT01235442|50583419|FG001|Overall Study|Adverse Event|6|||
25269302|NCT01235442|50583418|FG000|Overall Study|Withdrawal by Subject|15|||
25269303|NCT01235442|50583419|FG001|Overall Study|Withdrawal by Subject|9|||
25269304|NCT01235442|50583418|FG000|Overall Study|Lack of Efficacy|1|||
25269305|NCT01235442|50583419|FG001|Overall Study|Lack of Efficacy|3|||
25269306|NCT01235442|50583418|FG000|Overall Study|Noncompliance|1|||
25269307|NCT01235442|50583419|FG001|Overall Study|Noncompliance|2|||
25269308|NCT01235442|50583418|FG000|Overall Study|Administrative decision|1|||
25269309|NCT01235442|50583419|FG001|Overall Study|Administrative decision|2|||
25269310|NCT01235442|50583418|FG000|Overall Study|Other unspecified|1|||
25269311|NCT01235442|50583419|FG001|Overall Study|Other unspecified|2|||
25269312|NCT01163253|50583427|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
25269313|NCT01163253|50583428|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
25269314|NCT01163253|50583427|FG000|Overall Study|Study Terminated by Sponsor|978|||
25269315|NCT01163253|50583428|FG001|Overall Study|Study Terminated by Sponsor|349|||
25269316|NCT01163253|50583427|FG000|Overall Study|Protocol Violation|43|||
25269317|NCT01163253|50583428|FG001|Overall Study|Protocol Violation|12|||
25269318|NCT01163253|50583427|FG000|Overall Study|Withdrawal by Subject|199|||
25269319|NCT01163253|50583428|FG001|Overall Study|Withdrawal by Subject|50|||
25269320|NCT01163253|50583427|FG000|Overall Study|Medication Error|1|||
25269321|NCT01163253|50583428|FG001|Overall Study|Medication Error|0|||
25269322|NCT01163253|50583427|FG000|Overall Study|Lost to Follow-up|125|||
25269323|NCT01163253|50583428|FG001|Overall Study|Lost to Follow-up|23|||
25269324|NCT01163253|50583427|FG000|Overall Study|Insufficient Clinical Response|423|||
25269325|NCT01163253|50583428|FG001|Overall Study|Insufficient Clinical Response|29|||
25269326|NCT01163253|50583427|FG000|Overall Study|Adverse Event|300|||
25269327|NCT01163253|50583428|FG001|Overall Study|Adverse Event|78|||
25269328|NCT01163253|50583427|FG000|Overall Study|Death|17|||
25269329|NCT01163253|50583428|FG001|Overall Study|Death|5|||
25269330|NCT01163253|50583427|FG000|Overall Study|Ongoing|13|||
25269331|NCT01163253|50583428|FG001|Overall Study|Ongoing|4|||
25269332|NCT01163253|50583427|FG000|Overall Study|Other Unspecified|170|||
25269333|NCT01163253|50583428|FG001|Overall Study|Other Unspecified|34|||
25269334|NCT01162863|50583437|FG000|Overall Study|Lack of Efficacy|1|||
25269335|NCT01162863|50583438|FG001|Overall Study|Lack of Efficacy|0|||
25269336|NCT01162863|50583439|FG002|Overall Study|Lack of Efficacy|0|||
25269337|NCT01162863|50583437|FG000|Overall Study|Adverse Event|0|||
25269338|NCT01162863|50583438|FG001|Overall Study|Adverse Event|1|||
25269339|NCT01162863|50583439|FG002|Overall Study|Adverse Event|0|||
25269340|NCT01162473|50583449|FG000|Overall Study|Adverse Event|2|||
25269341|NCT01162473|50583450|FG001|Overall Study|Adverse Event|1|||
25269342|NCT01162473|50583449|FG000|Overall Study|Withdrawal by Subject|0|||
25269343|NCT01162473|50583450|FG001|Overall Study|Withdrawal by Subject|4|||
25269344|NCT01162239|50583460|FG000|Treatment Phase|Withdrawal by Subject|1|||
25269345|NCT01162239|50583461|FG001|Treatment Phase|Withdrawal by Subject|3|||
25269346|NCT01162239|50583462|FG002|Treatment Phase|Withdrawal by Subject|2|||
25269347|NCT01162239|50583463|FG003|Treatment Phase|Withdrawal by Subject|3|||
25269348|NCT01162239|50583460|FG000|Treatment Phase|Death|0|||
25269349|NCT01162239|50583461|FG001|Treatment Phase|Death|0|||
25269350|NCT01162239|50583462|FG002|Treatment Phase|Death|0|||
25269351|NCT01162239|50583463|FG003|Treatment Phase|Death|1|||
25269352|NCT01162239|50583460|FG000|Treatment Phase|Lost to Follow-up|5|||
25269353|NCT01162239|50583461|FG001|Treatment Phase|Lost to Follow-up|4|||
25269354|NCT01162239|50583462|FG002|Treatment Phase|Lost to Follow-up|2|||
25269355|NCT01162239|50583463|FG003|Treatment Phase|Lost to Follow-up|1|||
25269356|NCT01162239|50583460|FG000|Extended Follow-up|Lost to Follow-up|8|||
25269357|NCT01162239|50583461|FG001|Extended Follow-up|Lost to Follow-up|13|||
25269358|NCT01162239|50583462|FG002|Extended Follow-up|Lost to Follow-up|8|||
25269359|NCT01162239|50583463|FG003|Extended Follow-up|Lost to Follow-up|6|||
25269360|NCT01161537|50583474|FG000|Part B|Withdrawal by Subject|2|||
25269361|NCT01234350|50583485|FG000|Overall Study|Adverse Event|277|||
25269362|NCT01234350|50583486|FG001|Overall Study|Adverse Event|92|||
25269363|NCT01234350|50583485|FG000|Overall Study|Withdrawal by Subject|61|||
25126487|NCT02159365|50239328|FG000|Overall Study|Lost to Follow-up|1|||
25269364|NCT01234350|50583486|FG001|Overall Study|Withdrawal by Subject|36|||
25269365|NCT01234350|50583485|FG000|Overall Study|Lost to Follow-up|115|||
25269366|NCT01234350|50583486|FG001|Overall Study|Lost to Follow-up|47|||
25269367|NCT01234350|50583485|FG000|Overall Study|Covers a diverse set of reasons|234|||
25269368|NCT01234350|50583486|FG001|Overall Study|Covers a diverse set of reasons|92|||
25269369|NCT01233258|50583497|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
25269370|NCT01233258|50583498|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
25269371|NCT01233258|50583499|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
25269372|NCT01233258|50583500|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
25269373|NCT01233258|50583501|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
25269374|NCT01233258|50583502|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
25269375|NCT01233258|50583497|FG000|First Intervention (6 Months)|Protocol Violation|0|||
25269376|NCT01233258|50583498|FG001|First Intervention (6 Months)|Protocol Violation|0|||
25269377|NCT01233258|50583499|FG002|First Intervention (6 Months)|Protocol Violation|1|||
25269378|NCT01233258|50583500|FG003|First Intervention (6 Months)|Protocol Violation|0|||
25269379|NCT01233258|50583501|FG004|First Intervention (6 Months)|Protocol Violation|0|||
25269380|NCT01233258|50583502|FG005|First Intervention (6 Months)|Protocol Violation|0|||
25269381|NCT01233258|50583497|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
25269382|NCT01233258|50583498|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
25269383|NCT01233258|50583499|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
25269384|NCT01233258|50583500|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
25269385|NCT01233258|50583501|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
25269386|NCT01233258|50583502|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
25269387|NCT01232868|50583519|FG000|Overall Study|Lost to Follow-up|2|||
25269388|NCT01232868|50583520|FG001|Overall Study|Lost to Follow-up|4|||
25269389|NCT01232790|50583526|FG000|Randomization|Withdrawal by Subject|2|||
25269390|NCT01232790|50583527|FG001|Randomization|Withdrawal by Subject|0|||
25269391|NCT01232790|50583526|FG000|Randomization|Protocol Violation|0|||
25269392|NCT01232790|50583527|FG001|Randomization|Protocol Violation|1|||
25269393|NCT01232790|50583526|FG000|Randomization|Physician Decision|0|||
25269394|NCT01232790|50583527|FG001|Randomization|Physician Decision|1|||
25269395|NCT01232790|50583526|FG000|Initial Assessment|Withdrawal by Subject|0|||
25269396|NCT01232790|50583527|FG001|Initial Assessment|Withdrawal by Subject|1|||
25269397|NCT01232790|50583526|FG000|First Crossover|Withdrawal by Subject|1|||
25269398|NCT01232790|50583527|FG001|First Crossover|Withdrawal by Subject|0|||
25269399|NCT01232790|50583526|FG000|Second Crossover|Withdrawal by Subject|1|||
25269400|NCT01232790|50583527|FG001|Second Crossover|Withdrawal by Subject|2|||
25269401|NCT01232556|50583545|FG000|Overall Study|Withdrawal by Subject|21|||
25269402|NCT01232556|50583546|FG001|Overall Study|Withdrawal by Subject|17|||
25269403|NCT01232556|50583545|FG000|Overall Study|Death|97|||
25269404|NCT01232556|50583546|FG001|Overall Study|Death|97|||
25269405|NCT01232556|50583545|FG000|Overall Study|Lost to Follow-up|0|||
25269406|NCT01232556|50583546|FG001|Overall Study|Lost to Follow-up|2|||
25269407|NCT01232556|50583545|FG000|Overall Study|Terminated by Sponsor|35|||
25269408|NCT01232556|50583546|FG001|Overall Study|Terminated by Sponsor|51|||
25269409|NCT01232556|50583545|FG000|Overall Study|Other|6|||
25269410|NCT01232556|50583546|FG001|Overall Study|Other|4|||
25269411|NCT00946153|50583557|FG000|Phase 2|Adverse Event|0|||
25269412|NCT00946153|50583558|FG001|Phase 2|Adverse Event|0|||
25269413|NCT00946153|50583559|FG002|Phase 2|Adverse Event|0|||
25269414|NCT00946153|50583560|FG003|Phase 2|Adverse Event|0|||
25269415|NCT00946153|50583561|FG004|Phase 2|Adverse Event|6|||
25269416|NCT00946153|50583557|FG000|Phase 2|Need more reduction of dose|0|||
25269417|NCT00946153|50583558|FG001|Phase 2|Need more reduction of dose|0|||
25269418|NCT00946153|50583559|FG002|Phase 2|Need more reduction of dose|0|||
25269419|NCT00946153|50583560|FG003|Phase 2|Need more reduction of dose|0|||
25269420|NCT00946153|50583561|FG004|Phase 2|Need more reduction of dose|2|||
25269421|NCT00946153|50583557|FG000|Phase 2|Physician Decision|0|||
25269422|NCT00946153|50583558|FG001|Phase 2|Physician Decision|0|||
25126488|NCT01712074|50239335|FG000|Placebo Run-in Period|Adverse Event|2|||
25126489|NCT01712074|50239336|FG001|Placebo Run-in Period|Adverse Event|0|||
25126490|NCT01712074|50239337|FG002|Placebo Run-in Period|Adverse Event|0|||
25126491|NCT01712074|50239335|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
25126492|NCT01712074|50239336|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
25126493|NCT01712074|50239337|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
25126494|NCT01712074|50239335|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
25126495|NCT01712074|50239336|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
25126496|NCT01712074|50239337|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
25126497|NCT01712074|50239335|FG000|Placebo Run-in Period|Other|1|||
25126498|NCT01712074|50239336|FG001|Placebo Run-in Period|Other|0|||
25126499|NCT01712074|50239337|FG002|Placebo Run-in Period|Other|0|||
25126500|NCT01712074|50239335|FG000|Placebo Run-in Period|No longer willing to participate|1|||
25269423|NCT00946153|50583559|FG002|Phase 2|Physician Decision|0|||
25269424|NCT00946153|50583560|FG003|Phase 2|Physician Decision|0|||
25269425|NCT00946153|50583561|FG004|Phase 2|Physician Decision|1|||
25269426|NCT00946153|50583557|FG000|Phase 2|14 days washout for recovery due to AE|0|||
25269427|NCT00946153|50583558|FG001|Phase 2|14 days washout for recovery due to AE|0|||
25269428|NCT00946153|50583559|FG002|Phase 2|14 days washout for recovery due to AE|0|||
25269429|NCT00946153|50583560|FG003|Phase 2|14 days washout for recovery due to AE|0|||
25269430|NCT00946153|50583561|FG004|Phase 2|14 days washout for recovery due to AE|4|||
25269431|NCT01160289|50583583|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
25126501|NCT01712074|50239336|FG001|Placebo Run-in Period|No longer willing to participate|0|||
25269432|NCT01160289|50583584|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
25269433|NCT01160289|50583585|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
25269434|NCT01160289|50583586|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
25269435|NCT01160289|50583587|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
25269436|NCT01160289|50583588|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
25269437|NCT01160289|50583583|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
25269438|NCT01160289|50583584|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
25269439|NCT01160289|50583585|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
25269440|NCT01160289|50583586|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
25269441|NCT01160289|50583587|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
25269442|NCT01160289|50583588|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
25269443|NCT01160289|50583583|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
25269444|NCT01160289|50583584|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
25269445|NCT01160289|50583585|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
25269446|NCT01160289|50583586|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
25269447|NCT01160289|50583587|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
25269448|NCT01160289|50583588|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
25269449|NCT01160289|50583583|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
25269450|NCT01160289|50583584|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
25269451|NCT01160289|50583585|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
25269452|NCT01160289|50583586|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
25269453|NCT01160289|50583587|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
25269454|NCT01160289|50583588|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
25269455|NCT01160289|50583583|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
25269456|NCT01160289|50583584|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
25269457|NCT01160289|50583585|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
25269458|NCT01160289|50583586|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
25269459|NCT01160289|50583587|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
25269460|NCT01160289|50583588|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
25269461|NCT01160289|50583583|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
25269462|NCT01160289|50583584|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
25269463|NCT01160289|50583585|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
25269464|NCT01160289|50583586|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
25269465|NCT01160289|50583587|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
25269466|NCT01160289|50583588|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
25269467|NCT01160289|50583583|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
25269468|NCT01160289|50583584|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
25269469|NCT01160289|50583585|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
25269470|NCT01160289|50583586|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
25269471|NCT01160289|50583587|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
25269472|NCT01160289|50583588|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
25269473|NCT01160289|50583583|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
25269474|NCT01160289|50583584|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
25269475|NCT01160289|50583585|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
25269476|NCT01160289|50583586|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
25269477|NCT01160289|50583587|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
25269478|NCT01160289|50583588|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
25269479|NCT01160289|50583583|FG000|Post-Randomization Period|Adverse Event|0|||
25269480|NCT01160289|50583584|FG001|Post-Randomization Period|Adverse Event|4|||
25269481|NCT01160289|50583585|FG002|Post-Randomization Period|Adverse Event|4|||
25269482|NCT01160289|50583586|FG003|Post-Randomization Period|Adverse Event|2|||
25269483|NCT01160289|50583587|FG004|Post-Randomization Period|Adverse Event|0|||
25269484|NCT01160289|50583588|FG005|Post-Randomization Period|Adverse Event|0|||
25269485|NCT01160289|50583583|FG000|Post-Randomization Period|Death|0|||
25269486|NCT01160289|50583584|FG001|Post-Randomization Period|Death|0|||
25269487|NCT01160289|50583585|FG002|Post-Randomization Period|Death|0|||
25269488|NCT01160289|50583586|FG003|Post-Randomization Period|Death|1|||
25269489|NCT01160289|50583587|FG004|Post-Randomization Period|Death|0|||
25269490|NCT01160289|50583588|FG005|Post-Randomization Period|Death|0|||
25269491|NCT01160289|50583583|FG000|Post-Randomization Period|Lack of Efficacy|0|||
25269492|NCT01160289|50583584|FG001|Post-Randomization Period|Lack of Efficacy|1|||
25269493|NCT01160289|50583585|FG002|Post-Randomization Period|Lack of Efficacy|0|||
25126502|NCT01712074|50239337|FG002|Placebo Run-in Period|No longer willing to participate|0|||
25269494|NCT01160289|50583586|FG003|Post-Randomization Period|Lack of Efficacy|3|||
25269495|NCT01160289|50583587|FG004|Post-Randomization Period|Lack of Efficacy|0|||
25126503|NCT01712074|50239335|FG000|Double Blind Period|Adverse Event|0|||
25269496|NCT01160289|50583588|FG005|Post-Randomization Period|Lack of Efficacy|0|||
25269497|NCT01160289|50583583|FG000|Post-Randomization Period|Lost to Follow-up|0|||
25269498|NCT01160289|50583584|FG001|Post-Randomization Period|Lost to Follow-up|3|||
25269499|NCT01160289|50583585|FG002|Post-Randomization Period|Lost to Follow-up|2|||
25269500|NCT01160289|50583586|FG003|Post-Randomization Period|Lost to Follow-up|5|||
25269501|NCT01160289|50583587|FG004|Post-Randomization Period|Lost to Follow-up|3|||
25269502|NCT01160289|50583588|FG005|Post-Randomization Period|Lost to Follow-up|4|||
25269503|NCT01160289|50583583|FG000|Post-Randomization Period|Physician Decision|0|||
25269504|NCT01160289|50583584|FG001|Post-Randomization Period|Physician Decision|0|||
25269505|NCT01160289|50583585|FG002|Post-Randomization Period|Physician Decision|1|||
25269506|NCT01160289|50583586|FG003|Post-Randomization Period|Physician Decision|0|||
25269507|NCT01160289|50583587|FG004|Post-Randomization Period|Physician Decision|0|||
25269508|NCT01160289|50583588|FG005|Post-Randomization Period|Physician Decision|0|||
25269509|NCT01160289|50583583|FG000|Post-Randomization Period|Protocol Violation|0|||
25269510|NCT01160289|50583584|FG001|Post-Randomization Period|Protocol Violation|4|||
25269511|NCT01160289|50583585|FG002|Post-Randomization Period|Protocol Violation|2|||
25269512|NCT01160289|50583586|FG003|Post-Randomization Period|Protocol Violation|0|||
25269513|NCT01160289|50583587|FG004|Post-Randomization Period|Protocol Violation|1|||
25269514|NCT01160289|50583588|FG005|Post-Randomization Period|Protocol Violation|3|||
25269515|NCT01160289|50583583|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
25126504|NCT01712074|50239336|FG001|Double Blind Period|Adverse Event|2|||
25269516|NCT01160289|50583584|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
25269517|NCT01160289|50583585|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
25269518|NCT01160289|50583586|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
25269519|NCT01160289|50583587|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
25269520|NCT01160289|50583588|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
25269521|NCT01160289|50583583|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
25269522|NCT01160289|50583584|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
25269523|NCT01160289|50583585|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
25269524|NCT01160289|50583586|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
25269525|NCT01160289|50583587|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
25269526|NCT01160289|50583588|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
25269527|NCT01160289|50583583|FG000|Post-Randomization Period|Sponsor Decision|0|||
25269528|NCT01160289|50583584|FG001|Post-Randomization Period|Sponsor Decision|1|||
25269529|NCT01160289|50583585|FG002|Post-Randomization Period|Sponsor Decision|0|||
25269530|NCT01160289|50583586|FG003|Post-Randomization Period|Sponsor Decision|0|||
25269531|NCT01160289|50583587|FG004|Post-Randomization Period|Sponsor Decision|0|||
25126505|NCT01712074|50239337|FG002|Double Blind Period|Adverse Event|1|||
25126506|NCT01712074|50239335|FG000|Double Blind Period|No longer willing to participate|0|||
25126507|NCT01712074|50239336|FG001|Double Blind Period|No longer willing to participate|2|||
25126508|NCT01712074|50239337|FG002|Double Blind Period|No longer willing to participate|4|||
25126509|NCT01712074|50239335|FG000|Double Blind Period|Death|0|||
25126510|NCT01712074|50239336|FG001|Double Blind Period|Death|1|||
25126511|NCT01712074|50239337|FG002|Double Blind Period|Death|0|||
25126512|NCT01712074|50239335|FG000|Double Blind Period|Lost to Follow-up|0|||
25126513|NCT01712074|50239336|FG001|Double Blind Period|Lost to Follow-up|2|||
25126514|NCT01712074|50239337|FG002|Double Blind Period|Lost to Follow-up|1|||
25126515|NCT01712074|50239335|FG000|Double Blind Period|Other|0|||
25126516|NCT01712074|50239336|FG001|Double Blind Period|Other|4|||
25126517|NCT01712074|50239337|FG002|Double Blind Period|Other|1|||
25126518|NCT01712074|50239335|FG000|Double Blind Period|Protocol Violation|0|||
25126519|NCT01712074|50239336|FG001|Double Blind Period|Protocol Violation|0|||
25126520|NCT01712074|50239337|FG002|Double Blind Period|Protocol Violation|1|||
25126521|NCT01712074|50239335|FG000|Double Blind Period|No longer met eligibility criteria|0|||
25126522|NCT01712074|50239336|FG001|Double Blind Period|No longer met eligibility criteria|3|||
25126523|NCT01712074|50239337|FG002|Double Blind Period|No longer met eligibility criteria|0|||
25126524|NCT01711216|50239352|FG000|Overall Study|Adverse Event|4|||
25126525|NCT01711216|50239352|FG000|Overall Study|Pregnancy|56|||
25269532|NCT01160289|50583588|FG005|Post-Randomization Period|Sponsor Decision|0|||
25269533|NCT01159665|50583607|FG000|Overall Study|Withdrawal by Subject|0|||
25269534|NCT01159665|50583608|FG001|Overall Study|Withdrawal by Subject|1|||
25269535|NCT01159665|50583609|FG002|Overall Study|Withdrawal by Subject|0|||
25269536|NCT01159665|50583610|FG003|Overall Study|Withdrawal by Subject|0|||
25269537|NCT01159665|50583611|FG004|Overall Study|Withdrawal by Subject|0|||
25269538|NCT01159665|50583612|FG005|Overall Study|Withdrawal by Subject|0|||
25269539|NCT01159431|50583628|FG000|Overall Study|Adverse Event|1|||
25269540|NCT01159431|50583629|FG001|Overall Study|Adverse Event|2|||
25269541|NCT01159431|50583628|FG000|Overall Study|non-compliance|1|||
25269542|NCT01159431|50583629|FG001|Overall Study|non-compliance|1|||
25269543|NCT01159431|50583628|FG000|Overall Study|Lack of Efficacy|0|||
25126526|NCT01711216|50239352|FG000|Overall Study|Withdrawal by Subject|6|||
25126527|NCT01711216|50239352|FG000|Overall Study|Lost to Follow-up|46|||
25126528|NCT01711216|50239352|FG000|Overall Study|variety of other minor reasons|83|||
25269544|NCT01159431|50583629|FG001|Overall Study|Lack of Efficacy|3|||
25269545|NCT01158261|50583642|FG000|Overall Study|Lost to Follow-up|9|||
25269546|NCT01158261|50583642|FG000|Overall Study|Death|7|||
25269547|NCT01158261|50583642|FG000|Overall Study|Withdrawal by Subject|1|||
25269548|NCT01157169|50583648|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
25269549|NCT01157169|50583649|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
25269550|NCT01157169|50583648|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
25269551|NCT01157169|50583649|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
25269552|NCT01231620|50583658|FG000|Overall Study|Physician Decision|3|||
25269553|NCT01231620|50583659|FG001|Overall Study|Physician Decision|5|||
25269554|NCT01231620|50583660|FG002|Overall Study|Physician Decision|10|||
25269555|NCT01231620|50583658|FG000|Overall Study|Death|12|||
25269556|NCT01231620|50583659|FG001|Overall Study|Death|14|||
25269557|NCT01231620|50583660|FG002|Overall Study|Death|11|||
25269558|NCT01231620|50583658|FG000|Overall Study|Adverse Event|2|||
25269559|NCT01231620|50583659|FG001|Overall Study|Adverse Event|2|||
25269560|NCT01231620|50583660|FG002|Overall Study|Adverse Event|1|||
25269561|NCT01231620|50583658|FG000|Overall Study|Withdrawal by Subject|6|||
25269562|NCT01231620|50583659|FG001|Overall Study|Withdrawal by Subject|6|||
25269563|NCT01231620|50583660|FG002|Overall Study|Withdrawal by Subject|8|||
25269564|NCT01231620|50583658|FG000|Overall Study|Lost to Follow-up|3|||
25269565|NCT01231620|50583659|FG001|Overall Study|Lost to Follow-up|4|||
25269566|NCT01231620|50583660|FG002|Overall Study|Lost to Follow-up|9|||
25269567|NCT01231464|50583670|FG000|Overall Study|Adverse Event|0|||
25269568|NCT01231464|50583671|FG001|Overall Study|Adverse Event|1|||
25269569|NCT01231464|50583670|FG000|Overall Study|Protocol Violation|1|||
25269570|NCT01231464|50583671|FG001|Overall Study|Protocol Violation|2|||
25269571|NCT01231464|50583670|FG000|Overall Study|Lost to Follow-up|1|||
25269572|NCT01231464|50583671|FG001|Overall Study|Lost to Follow-up|2|||
25269573|NCT01231464|50583670|FG000|Overall Study|Withdrawal by Subject|3|||
25269574|NCT01231464|50583671|FG001|Overall Study|Withdrawal by Subject|2|||
25269575|NCT01156311|50583681|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
25269576|NCT01156311|50583682|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
25269577|NCT01156311|50583683|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
25269578|NCT01156311|50583684|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
25269579|NCT01156311|50583681|FG000|2-Month Monotherapy Period|Physician Decision|0|||
25269580|NCT01156311|50583682|FG001|2-Month Monotherapy Period|Physician Decision|1|||
25269581|NCT01156311|50583683|FG002|2-Month Monotherapy Period|Physician Decision|0|||
25269582|NCT01156311|50583684|FG003|2-Month Monotherapy Period|Physician Decision|0|||
25269583|NCT01156311|50583681|FG000|2-Month Monotherapy Period|Other|1|||
25269584|NCT01156311|50583682|FG001|2-Month Monotherapy Period|Other|0|||
25269585|NCT01156311|50583683|FG002|2-Month Monotherapy Period|Other|0|||
25269586|NCT01156311|50583684|FG003|2-Month Monotherapy Period|Other|0|||
25269587|NCT01156311|50583681|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
25269588|NCT01156311|50583682|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
25269589|NCT01156311|50583683|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
25269590|NCT01156311|50583684|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
25269591|NCT01156311|50583681|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
25269592|NCT01156311|50583682|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
25126529|NCT01711216|50239352|FG000|Overall Study|no reason specified|22|||
25269593|NCT01156311|50583683|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
25269594|NCT01156311|50583684|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
25269595|NCT01156311|50583681|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
25269596|NCT01156311|50583682|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
25269597|NCT01156311|50583683|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
25269598|NCT01156311|50583684|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
25126530|NCT01692730|50239362|FG000|Overall Study|Lost to Follow-up|225|||
25126531|NCT01692730|50239363|FG001|Overall Study|Lost to Follow-up|227|||
25126532|NCT01691794|50239372|FG000|Overall Study|Poor/Non-Compliance|1|||
25126533|NCT01691794|50239373|FG001|Overall Study|Poor/Non-Compliance|4|||
25126534|NCT01691794|50239374|FG002|Overall Study|Poor/Non-Compliance|1|||
25126535|NCT01691794|50239372|FG000|Overall Study|Death|0|||
25126536|NCT01691794|50239373|FG001|Overall Study|Death|0|||
25126537|NCT01691794|50239374|FG002|Overall Study|Death|1|||
25126538|NCT01691794|50239372|FG000|Overall Study|Lack of Efficacy|0|||
25126539|NCT01691794|50239373|FG001|Overall Study|Lack of Efficacy|7|||
25126540|NCT01691794|50239374|FG002|Overall Study|Lack of Efficacy|1|||
25269599|NCT01156311|50583681|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
25269600|NCT01156311|50583682|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
25269601|NCT01156311|50583683|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
25269602|NCT01156311|50583684|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
25269603|NCT01156311|50583681|FG000|6-month Add-on Therapy Period|Other|0|||
25269604|NCT01156311|50583682|FG001|6-month Add-on Therapy Period|Other|0|||
25269605|NCT01156311|50583683|FG002|6-month Add-on Therapy Period|Other|1|||
25126541|NCT01691794|50239372|FG000|Overall Study|Participant request to discontinue|0|||
25269606|NCT01156311|50583684|FG003|6-month Add-on Therapy Period|Other|2|||
25126542|NCT01691794|50239373|FG001|Overall Study|Participant request to discontinue|1|||
25126543|NCT01691794|50239374|FG002|Overall Study|Participant request to discontinue|0|||
25126544|NCT01691794|50239372|FG000|Overall Study|Adverse Event|0|||
25126545|NCT01691794|50239373|FG001|Overall Study|Adverse Event|1|||
25126546|NCT01691794|50239374|FG002|Overall Study|Adverse Event|1|||
25269607|NCT01230060|50583695|FG000|Overall Study|Withdrawal by Subject|1|||
25269608|NCT01155531|50583703|FG000|Overall Study|Adverse Event|0|||
25269609|NCT01155531|50583704|FG001|Overall Study|Adverse Event|0|||
25269610|NCT01155531|50583705|FG002|Overall Study|Adverse Event|1|||
25269611|NCT01155531|50583706|FG003|Overall Study|Adverse Event|0|||
25269612|NCT01155531|50583703|FG000|Overall Study|Lost to Follow-up|0|||
25269613|NCT01155531|50583704|FG001|Overall Study|Lost to Follow-up|0|||
25269614|NCT01155531|50583705|FG002|Overall Study|Lost to Follow-up|0|||
25269615|NCT01155531|50583706|FG003|Overall Study|Lost to Follow-up|1|||
25269616|NCT01155531|50583703|FG000|Overall Study|Withdrawal by Subject|1|||
25269617|NCT01155531|50583704|FG001|Overall Study|Withdrawal by Subject|0|||
25269618|NCT01155531|50583705|FG002|Overall Study|Withdrawal by Subject|1|||
25269619|NCT01155531|50583706|FG003|Overall Study|Withdrawal by Subject|0|||
25269620|NCT01155219|50583718|FG000|Overall Study|Adverse Event|3|||
25269621|NCT01155219|50583719|FG001|Overall Study|Adverse Event|1|||
25269622|NCT01155219|50583718|FG000|Overall Study|non-medical reason|1|||
25269623|NCT01155219|50583719|FG001|Overall Study|non-medical reason|2|||
25269624|NCT01229436|50583725|FG000|Overall Study|Withdrawal by Subject|2|||
25269625|NCT01229436|50583725|FG000|Overall Study|Lost to Follow-up|3|||
25269626|NCT01155141|50583729|FG000|Overall Study|Withdrawal by Subject|1|||
25269627|NCT01155141|50583729|FG000|Overall Study|Screen Failure|1|||
25269628|NCT01155063|50583733|FG000|Overall Study|Adverse Event|1|||
25269629|NCT01155063|50583733|FG000|Overall Study|Withdrawal by Subject|1|||
25269630|NCT01155063|50583733|FG000|Overall Study|Study terminated by sponsor|87|||
25269631|NCT01154673|50583739|FG000|Overall Study|Lost to Follow-up|1|||
25269632|NCT01154673|50583740|FG001|Overall Study|Lost to Follow-up|0|||
25126547|NCT01691794|50239372|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
25126548|NCT01691794|50239373|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
25126549|NCT01691794|50239374|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
25126550|NCT01691794|50239372|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
25126551|NCT01691794|50239373|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
25269633|NCT01154673|50583739|FG000|Overall Study|moved out of province|1|||
25269634|NCT01154673|50583740|FG001|Overall Study|moved out of province|0|||
25269635|NCT01154283|50583748|FG000|0-6 Weeks|Withdrawal by Subject|7|||
25269636|NCT01154283|50583749|FG001|0-6 Weeks|Withdrawal by Subject|2|||
25269637|NCT01154283|50583748|FG000|0-6 Weeks|Death|0|||
25269638|NCT01154283|50583749|FG001|0-6 Weeks|Death|1|||
25269639|NCT01154283|50583748|FG000|7-12 Weeks|Death|1|||
25269640|NCT01154283|50583749|FG001|7-12 Weeks|Death|0|||
25269641|NCT01154283|50583748|FG000|7-12 Weeks|Withdrawal by Subject|0|||
25269642|NCT01154283|50583749|FG001|7-12 Weeks|Withdrawal by Subject|1|||
25269643|NCT00944125|50583755|FG000|3 to 6 Months|Withdrawal by Subject|0|||
25269644|NCT00944125|50583756|FG001|3 to 6 Months|Withdrawal by Subject|2|||
25269645|NCT00944125|50583755|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
25269646|NCT00944125|50583756|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
25269647|NCT00912223|50583762|FG000|Overall Study|Withdrawal by Subject|1|||
25269648|NCT00912223|50583762|FG000|Overall Study|Not transplanted|1|||
25269649|NCT00912223|50583762|FG000|Overall Study|Transformed disease|1|||
25269650|NCT01154127|50583768|FG000|Period 1 (21 Days)|Adverse Event|3|||
25178506|NCT01544179|50323791|FG001|Overall Study|Withdrawal by Subject|7|||
25178507|NCT01544179|50323790|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
25178508|NCT01544179|50323791|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
25178509|NCT01483651|50323797|FG000|Overall Study|Withdrawal by Subject|0|||
25178510|NCT01483651|50323798|FG001|Overall Study|Withdrawal by Subject|1|||
25178511|NCT01483651|50323799|FG002|Overall Study|Withdrawal by Subject|1|||
25178512|NCT01483651|50323800|FG003|Overall Study|Withdrawal by Subject|0|||
25178513|NCT01483651|50323801|FG004|Overall Study|Withdrawal by Subject|0|||
25178514|NCT01483651|50323802|FG005|Overall Study|Withdrawal by Subject|1|||
25269651|NCT01154127|50583769|FG001|Period 1 (21 Days)|Adverse Event|4|||
25269652|NCT01154127|50583768|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
25269653|NCT01154127|50583769|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
25126552|NCT01691794|50239374|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
25126553|NCT01710514|50239384|FG000|Overall Study|Adverse Event|6|||
25269654|NCT01154127|50583768|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
25269655|NCT01154127|50583769|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
25269656|NCT01154127|50583768|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
25269657|NCT01154127|50583769|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
25269658|NCT01154127|50583768|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
25178515|NCT01464307|50323812|FG000|Main Period|Death|0|||
25178516|NCT01464307|50323813|FG001|Main Period|Death|1|||
25269659|NCT01154127|50583769|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
25269660|NCT01228734|50583777|FG000|Overall Study|Randomized, but not treated|0|||
25269661|NCT01228734|50583778|FG001|Overall Study|Randomized, but not treated|4|||
25269662|NCT01227954|50583784|FG000|Overall Study|Protocol Violation|6|||
25269663|NCT01227954|50583784|FG000|Overall Study|No protocol treatment|7|||
25269664|NCT01153971|50583788|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
25269665|NCT01153971|50583788|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
25269666|NCT01153971|50583788|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
25269667|NCT01153971|50583788|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
25269668|NCT01153971|50583788|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
25269669|NCT01153971|50583788|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
25269670|NCT01153971|50583788|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
25269671|NCT01153893|50583794|FG000|Overall Study|Adverse Event|1|||
25269672|NCT01153893|50583795|FG001|Overall Study|Adverse Event|0|||
25269673|NCT00951379|50583803|FG000|Overall Study|Adverse Event|4|||
25269674|NCT00951379|50583804|FG001|Overall Study|Adverse Event|1|||
25269675|NCT00951379|50583803|FG000|Overall Study|Withdrawal by Subject|1|||
25269676|NCT00951379|50583804|FG001|Overall Study|Withdrawal by Subject|0|||
25269677|NCT00951379|50583803|FG000|Overall Study|Noncompliance|1|||
25269678|NCT00951379|50583804|FG001|Overall Study|Noncompliance|0|||
25269679|NCT00951379|50583803|FG000|Overall Study|Disease Progression|0|||
25269680|NCT00951379|50583804|FG001|Overall Study|Disease Progression|1|||
25269681|NCT01153815|50583820|FG000|Overall Study|Adverse Event|3|||
25269682|NCT01153815|50583821|FG001|Overall Study|Adverse Event|1|||
25269683|NCT01153815|50583820|FG000|Overall Study|Withdrawal by Subject|6|||
25269684|NCT01153815|50583821|FG001|Overall Study|Withdrawal by Subject|4|||
25269685|NCT01153425|50583829|FG000|Overall Study|Withdrawal by Subject|3|||
25269686|NCT01153425|50583830|FG001|Overall Study|Withdrawal by Subject|3|||
25269687|NCT01153347|50583841|FG000|Overall Study|Withdrawal by Subject|7|||
25269688|NCT01153347|50583842|FG001|Overall Study|Withdrawal by Subject|7|||
25269689|NCT01153347|50583843|FG002|Overall Study|Withdrawal by Subject|7|||
25269690|NCT01153347|50583844|FG003|Overall Study|Withdrawal by Subject|7|||
25269691|NCT01153347|50583841|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
25269692|NCT01153347|50583842|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
25269693|NCT01153347|50583843|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
25269694|NCT01153347|50583844|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
25269695|NCT01153347|50583841|FG000|Overall Study|Adverse Event|3|||
25269696|NCT01153347|50583842|FG001|Overall Study|Adverse Event|9|||
25269697|NCT01153347|50583843|FG002|Overall Study|Adverse Event|21|||
25269698|NCT01153347|50583844|FG003|Overall Study|Adverse Event|7|||
25269699|NCT01153347|50583841|FG000|Overall Study|Severe non-compliance to protocol|6|||
25269700|NCT01153347|50583842|FG001|Overall Study|Severe non-compliance to protocol|7|||
25269701|NCT01153347|50583843|FG002|Overall Study|Severe non-compliance to protocol|4|||
25269702|NCT01153347|50583844|FG003|Overall Study|Severe non-compliance to protocol|3|||
25269703|NCT01153347|50583841|FG000|Overall Study|Condition under investigation worsened|1|||
25269704|NCT01153347|50583842|FG001|Overall Study|Condition under investigation worsened|1|||
25269705|NCT01153347|50583843|FG002|Overall Study|Condition under investigation worsened|0|||
25269706|NCT01153347|50583844|FG003|Overall Study|Condition under investigation worsened|0|||
25269707|NCT01153347|50583841|FG000|Overall Study|Lack of Efficacy|2|||
25269708|NCT01153347|50583842|FG001|Overall Study|Lack of Efficacy|2|||
25269709|NCT01153347|50583843|FG002|Overall Study|Lack of Efficacy|0|||
25126554|NCT01710514|50239385|FG001|Overall Study|Adverse Event|7|||
25126555|NCT01710514|50239384|FG000|Overall Study|Withdrawal by Subject|1|||
25126556|NCT01710514|50239385|FG001|Overall Study|Withdrawal by Subject|0|||
25126557|NCT01592344|50239396|FG000|Overall Study|Adverse Event|1|||
25126558|NCT01592344|50239397|FG001|Overall Study|Adverse Event|1|||
25126559|NCT01592344|50239396|FG000|Overall Study|Lack of Efficacy|1|||
25126560|NCT01592344|50239397|FG001|Overall Study|Lack of Efficacy|0|||
25126561|NCT01592344|50239396|FG000|Overall Study|not available at primary outcome visit|2|||
25126562|NCT01592344|50239397|FG001|Overall Study|not available at primary outcome visit|4|||
25126563|NCT01636778|50239403|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
25126564|NCT01636778|50239404|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
25126565|NCT01636778|50239405|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
25178517|NCT01464307|50323812|FG000|Main Period|Adverse Event|6|||
25178518|NCT01464307|50323813|FG001|Main Period|Adverse Event|1|||
25269710|NCT01153347|50583844|FG003|Overall Study|Lack of Efficacy|4|||
25269711|NCT01153347|50583841|FG000|Overall Study|Study-specific withdrawal criteria|4|||
25269712|NCT01153347|50583842|FG001|Overall Study|Study-specific withdrawal criteria|3|||
25269713|NCT01153347|50583843|FG002|Overall Study|Study-specific withdrawal criteria|1|||
25269714|NCT01153347|50583844|FG003|Overall Study|Study-specific withdrawal criteria|2|||
25269715|NCT01153347|50583841|FG000|Overall Study|Lost to Follow-up|4|||
25126566|NCT01636778|50239403|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
25178519|NCT01464307|50323812|FG000|Main Period|Lack of Efficacy|2|||
25126567|NCT01636778|50239404|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
25126568|NCT01636778|50239405|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
25126569|NCT01636778|50239403|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
25126570|NCT01636778|50239404|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
25126571|NCT01636778|50239405|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
25126572|NCT01636778|50239403|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
25126573|NCT01636778|50239404|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
25126574|NCT01636778|50239405|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
25126575|NCT01636778|50239403|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
25126576|NCT01636778|50239404|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
25126577|NCT01636778|50239405|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
25126578|NCT01636778|50239403|FG000|Follow-up Period After Part 2|Other|0|||
25126579|NCT01636778|50239404|FG001|Follow-up Period After Part 2|Other|0|||
25126580|NCT01636778|50239405|FG002|Follow-up Period After Part 2|Other|1|||
25126581|NCT01636778|50239403|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
25126582|NCT01636778|50239404|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
25126583|NCT01636778|50239405|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
25126584|NCT01636778|50239403|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
25126585|NCT01636778|50239404|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
25126586|NCT01636778|50239405|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
25126587|NCT02159053|50239416|FG000|Overall Study|Death|2|||
25126588|NCT02159053|50239417|FG001|Overall Study|Death|0|||
25126589|NCT02159053|50239418|FG002|Overall Study|Death|1|||
25126590|NCT02159053|50239416|FG000|Overall Study|Physician Decision|0|||
25126591|NCT02159053|50239417|FG001|Overall Study|Physician Decision|1|||
25126592|NCT02159053|50239418|FG002|Overall Study|Physician Decision|1|||
25126593|NCT02159053|50239416|FG000|Overall Study|Lack of Efficacy|3|||
25126594|NCT02159053|50239417|FG001|Overall Study|Lack of Efficacy|4|||
25126595|NCT02159053|50239418|FG002|Overall Study|Lack of Efficacy|7|||
25126596|NCT02159053|50239416|FG000|Overall Study|Adverse Event|7|||
25126597|NCT02159053|50239417|FG001|Overall Study|Adverse Event|6|||
25126598|NCT02159053|50239418|FG002|Overall Study|Adverse Event|5|||
25126599|NCT02159053|50239416|FG000|Overall Study|Participants/guardian decision|8|||
25126600|NCT02159053|50239417|FG001|Overall Study|Participants/guardian decision|10|||
25126601|NCT02159053|50239418|FG002|Overall Study|Participants/guardian decision|6|||
25126602|NCT02158975|50239428|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
25126603|NCT02158663|50239435|FG000|Overall Study|Withdrawal by Subject|5|||
25126604|NCT02158663|50239436|FG001|Overall Study|Withdrawal by Subject|4|||
25126605|NCT02158039|50239444|FG000|Overall Study|Withdrawal by Subject|1|||
25126606|NCT02158039|50239444|FG000|Overall Study|Screen Failure|9|||
25126607|NCT01635764|50239462|FG000|Overall Study|Adverse Event|46|||
25126608|NCT01635764|50239462|FG000|Overall Study|Lack of Efficacy|76|||
25126609|NCT01635764|50239462|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
25126610|NCT01635764|50239462|FG000|Overall Study|Protocol Deviation|1|||
25126611|NCT01635764|50239462|FG000|Overall Study|Withdrew Consent|67|||
25126612|NCT01635764|50239462|FG000|Overall Study|Lost to Follow-up|53|||
25126613|NCT01635764|50239462|FG000|Overall Study|Other|28|||
25126614|NCT03432260|50239478|FG000|Overall Study|Lost to Follow-up|1|||
25126615|NCT03432260|50239479|FG001|Overall Study|Lost to Follow-up|1|||
25126616|NCT03432260|50239480|FG002|Overall Study|Lost to Follow-up|0|||
25126617|NCT03432260|50239481|FG003|Overall Study|Lost to Follow-up|0|||
25126618|NCT03432260|50239482|FG004|Overall Study|Lost to Follow-up|1|||
25126619|NCT01634360|50239496|FG000|Overall Study|Adverse Event|10|||
25126620|NCT01634360|50239497|FG001|Overall Study|Adverse Event|34|||
25126621|NCT01634360|50239496|FG000|Overall Study|subject withdrew consent|13|||
25269716|NCT01153347|50583842|FG001|Overall Study|Lost to Follow-up|9|||
25269717|NCT01153347|50583843|FG002|Overall Study|Lost to Follow-up|11|||
25269718|NCT01153347|50583844|FG003|Overall Study|Lost to Follow-up|8|||
25269719|NCT01153347|50583841|FG000|Overall Study|Other|5|||
25269720|NCT01153347|50583842|FG001|Overall Study|Other|5|||
25269721|NCT01153347|50583843|FG002|Overall Study|Other|4|||
25269722|NCT01153347|50583844|FG003|Overall Study|Other|0|||
25269723|NCT01153347|50583841|FG000|Overall Study|Death|1|||
25269724|NCT01153347|50583842|FG001|Overall Study|Death|0|||
25269725|NCT01153347|50583843|FG002|Overall Study|Death|0|||
25126622|NCT01634360|50239497|FG001|Overall Study|subject withdrew consent|23|||
25126623|NCT01634360|50239496|FG000|Overall Study|Protocol Violation|1|||
25126624|NCT01634360|50239497|FG001|Overall Study|Protocol Violation|1|||
25126625|NCT01634360|50239496|FG000|Overall Study|Lack of Efficacy|4|||
25126626|NCT01634360|50239497|FG001|Overall Study|Lack of Efficacy|14|||
25126627|NCT01634360|50239496|FG000|Overall Study|Other|3|||
25126628|NCT01634360|50239497|FG001|Overall Study|Other|20|||
25126629|NCT01634360|50239496|FG000|Overall Study|Study termination by sponsor|18|||
25126630|NCT01634360|50239497|FG001|Overall Study|Study termination by sponsor|44|||
25126631|NCT01635218|50239514|FG000|Overall Study|Lost to Follow-up|3|||
25269726|NCT01153347|50583844|FG003|Overall Study|Death|0|||
25269727|NCT01153269|50583854|FG000|Overall Study|Withdrawal by Subject|1|||
25269728|NCT01153269|50583854|FG000|Overall Study|Antiretroviral therapy break|1|||
25269729|NCT01152021|50583863|FG000|Overall Study|Adverse Event|4|||
25269730|NCT01152021|50583864|FG001|Overall Study|Adverse Event|4|||
25269731|NCT01152021|50583863|FG000|Overall Study|Study drug had expired|1|||
25269732|NCT01152021|50583864|FG001|Overall Study|Study drug had expired|0|||
25269733|NCT01152021|50583863|FG000|Overall Study|Physician Decision|1|||
25269734|NCT01152021|50583864|FG001|Overall Study|Physician Decision|1|||
25269735|NCT01152021|50583863|FG000|Overall Study|No access to study drug in Pharmacy|0|||
25269736|NCT01152021|50583864|FG001|Overall Study|No access to study drug in Pharmacy|1|||
25269737|NCT01151085|50583872|FG000|Overall Study|Lost to Follow-up|31|||
25269738|NCT01151085|50583872|FG000|Overall Study|Protocol Violation|25|||
25269739|NCT01149681|50583883|FG000|Overall Study|Withdrawal by Subject|7|||
25269740|NCT01149681|50583883|FG000|Overall Study|Progressive disease|1|||
25269741|NCT01149681|50583883|FG000|Overall Study|Physician Decision|2|||
25269742|NCT01149681|50583883|FG000|Overall Study|adverse events nonrelated study drug|2|||
25269743|NCT01149369|50583890|FG000|Overall Study|Adverse Event|6|||
25269744|NCT01149369|50583891|FG001|Overall Study|Adverse Event|3|||
25269745|NCT01740427|50583899|FG000|Overall Study|Ongoing|45|||
25269746|NCT01740427|50583900|FG001|Overall Study|Ongoing|5|||
25269747|NCT01740427|50583899|FG000|Overall Study|Objective Progression or Relapse|281|||
25269748|NCT01740427|50583900|FG001|Overall Study|Objective Progression or Relapse|171|||
25269749|NCT01740427|50583899|FG000|Overall Study|Adverse Event|31|||
25269750|NCT01740427|50583900|FG001|Overall Study|Adverse Event|9|||
25269751|NCT01740427|50583899|FG000|Overall Study|Global Deterioration of Health Status|28|||
25269752|NCT01740427|50583900|FG001|Overall Study|Global Deterioration of Health Status|12|||
25126632|NCT01635218|50239515|FG001|Overall Study|Lost to Follow-up|7|||
25126633|NCT01635218|50239516|FG002|Overall Study|Lost to Follow-up|6|||
25126634|NCT02049866|50239524|FG000|Overall Study|Withdrawal by Subject|1|||
25126635|NCT04274894|50239528|FG000|Overall Study|Adverse Event|7|||
25126636|NCT04274894|50239528|FG000|Overall Study|Withdrew consent|5|||
25126637|NCT04274894|50239528|FG000|Overall Study|Lost to Follow-up|9|||
25126638|NCT04274894|50239528|FG000|Overall Study|COVID-19 infection|1|||
25126639|NCT04274894|50239528|FG000|Overall Study|Other, not specified|20|||
25126640|NCT02213263|50239534|FG000|Overall Study|Insufficient clinical response|4|||
25126641|NCT02213263|50239535|FG001|Overall Study|Insufficient clinical response|3|||
25126642|NCT02213263|50239534|FG000|Overall Study|Lost to Follow-up|0|||
25126643|NCT02213263|50239535|FG001|Overall Study|Lost to Follow-up|1|||
25126644|NCT02213263|50239534|FG000|Overall Study|No longer willing to participate|3|||
25126645|NCT02213263|50239535|FG001|Overall Study|No longer willing to participate|4|||
25126646|NCT02213263|50239534|FG000|Overall Study|Progressive disease|20|||
25126647|NCT02213263|50239535|FG001|Overall Study|Progressive disease|14|||
25126648|NCT02213263|50239534|FG000|Overall Study|Protocol Violation|0|||
25126649|NCT02213263|50239535|FG001|Overall Study|Protocol Violation|1|||
25126650|NCT02213263|50239534|FG000|Overall Study|Adverse Event|1|||
25126651|NCT02213263|50239535|FG001|Overall Study|Adverse Event|3|||
25126652|NCT02211313|50239543|FG000|Overall Study|Treatment Failure|5|||
25126653|NCT02211313|50239544|FG001|Overall Study|Treatment Failure|2|||
25126654|NCT02211313|50239543|FG000|Overall Study|No Follow up Questionnaires|1|||
25126655|NCT02211313|50239544|FG001|Overall Study|No Follow up Questionnaires|1|||
25126656|NCT02210689|50239553|FG000|Overall Study|Withdrawal by Subject|7|||
25126657|NCT02210689|50239554|FG001|Overall Study|Withdrawal by Subject|4|||
25126658|NCT02210689|50239555|FG002|Overall Study|Withdrawal by Subject|2|||
25126659|NCT02210689|50239553|FG000|Overall Study|Adverse Event|0|||
25126660|NCT02210689|50239554|FG001|Overall Study|Adverse Event|1|||
25126661|NCT02210689|50239555|FG002|Overall Study|Adverse Event|0|||
25126662|NCT02210689|50239553|FG000|Overall Study|Protocol Violation|1|||
25126663|NCT02210689|50239554|FG001|Overall Study|Protocol Violation|0|||
25126664|NCT02210689|50239555|FG002|Overall Study|Protocol Violation|0|||
25126665|NCT02210689|50239553|FG000|Overall Study|Lost to Follow-up|11|||
25126666|NCT02210689|50239554|FG001|Overall Study|Lost to Follow-up|9|||
25126667|NCT02210689|50239555|FG002|Overall Study|Lost to Follow-up|5|||
25126668|NCT02210689|50239553|FG000|Overall Study|Pregnancy|0|||
25269753|NCT01740427|50583899|FG000|Overall Study|Participant Refused Continued Treatment|26|||
25269754|NCT01740427|50583900|FG001|Overall Study|Participant Refused Continued Treatment|15|||
25269755|NCT01740427|50583899|FG000|Overall Study|Unspecified reasons|15|||
25269756|NCT01740427|50583900|FG001|Overall Study|Unspecified reasons|4|||
25269757|NCT01740427|50583899|FG000|Overall Study|Death|10|||
25126669|NCT02210689|50239554|FG001|Overall Study|Pregnancy|1|||
25126670|NCT02210689|50239555|FG002|Overall Study|Pregnancy|0|||
25126671|NCT02210689|50239553|FG000|Overall Study|Lack of Efficacy|0|||
25126672|NCT02210689|50239554|FG001|Overall Study|Lack of Efficacy|1|||
25126673|NCT02210689|50239555|FG002|Overall Study|Lack of Efficacy|5|||
25126674|NCT02210689|50239553|FG000|Overall Study|Prohibited medication|2|||
25126675|NCT02210689|50239554|FG001|Overall Study|Prohibited medication|8|||
25126676|NCT02210689|50239555|FG002|Overall Study|Prohibited medication|1|||
25126677|NCT02210689|50239553|FG000|Overall Study|Negative Nugent score at baseline|6|||
25269758|NCT01740427|50583900|FG001|Overall Study|Death|3|||
25269759|NCT01740427|50583899|FG000|Overall Study|Protocol Violation|5|||
25269760|NCT01740427|50583900|FG001|Overall Study|Protocol Violation|3|||
25269761|NCT01740427|50583899|FG000|Overall Study|Lost to Follow-up|2|||
25269762|NCT01740427|50583900|FG001|Overall Study|Lost to Follow-up|0|||
25269763|NCT01740427|50583899|FG000|Overall Study|Site Terminated by Sponsor|1|||
25269764|NCT01740427|50583900|FG001|Overall Study|Site Terminated by Sponsor|0|||
25269765|NCT01149057|50583906|FG000|Overall Study|Lack of Efficacy|16|||
25269766|NCT01149057|50583906|FG000|Overall Study|Adverse Event|13|||
25269767|NCT01149057|50583906|FG000|Overall Study|Withdrawal by Subject|9|||
25269768|NCT01149057|50583906|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
25269769|NCT01149057|50583906|FG000|Overall Study|B Cell Depletion|4|||
25269770|NCT01149057|50583906|FG000|Overall Study|Participant Non-Compliance|2|||
25269771|NCT01149057|50583906|FG000|Overall Study|Lost to Follow-up|1|||
25269772|NCT01149057|50583906|FG000|Overall Study|High Parathyroid Hormone Value|1|||
25269773|NCT01149057|50583906|FG000|Overall Study|Other|6|||
25269774|NCT01227564|50583913|FG000|Overall Study|No Longer Willing to Participate|4|||
25269775|NCT01227564|50583914|FG001|Overall Study|No Longer Willing to Participate|2|||
25269776|NCT01227564|50583915|FG002|Overall Study|No Longer Willing to Participate|5|||
25269777|NCT01227564|50583913|FG000|Overall Study|Participant moved to another town|0|||
25269778|NCT01227564|50583914|FG001|Overall Study|Participant moved to another town|0|||
25269779|NCT01227564|50583915|FG002|Overall Study|Participant moved to another town|1|||
25269780|NCT01148979|50583931|FG000|Overall Study|Lost to Follow-up|0|||
25269781|NCT01148979|50583932|FG001|Overall Study|Lost to Follow-up|1|||
25269782|NCT01148511|50583940|FG000|Exposed to Study Drug|Protocol Violation|2|||
25269783|NCT01148511|50583941|FG001|Exposed to Study Drug|Protocol Violation|0|||
25269784|NCT01148511|50583942|FG002|Exposed to Study Drug|Protocol Violation|0|||
25269785|NCT01148511|50583940|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
25269786|NCT01148511|50583941|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
25269787|NCT01148511|50583942|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
25269788|NCT01148511|50583940|FG000|Randomized|Adverse Event|0|||
25269789|NCT01148511|50583941|FG001|Randomized|Adverse Event|1|||
25269790|NCT01148511|50583942|FG002|Randomized|Adverse Event|0|||
25269791|NCT01148511|50583940|FG000|Randomized|Protocol Violation|0|||
25269792|NCT01148511|50583941|FG001|Randomized|Protocol Violation|2|||
25269793|NCT01148511|50583942|FG002|Randomized|Protocol Violation|1|||
25269794|NCT01148511|50583940|FG000|Randomized|Lost to Follow-up|0|||
25269795|NCT01148511|50583941|FG001|Randomized|Lost to Follow-up|1|||
25269796|NCT01148511|50583942|FG002|Randomized|Lost to Follow-up|1|||
25269797|NCT01148511|50583940|FG000|Randomized|Consent withdrawal|0|||
25269798|NCT01148511|50583941|FG001|Randomized|Consent withdrawal|5|||
25269799|NCT01148511|50583942|FG002|Randomized|Consent withdrawal|3|||
25269800|NCT01148511|50583940|FG000|Randomized|Other|0|||
25269801|NCT01148511|50583941|FG001|Randomized|Other|1|||
25269802|NCT01148511|50583942|FG002|Randomized|Other|1|||
25269803|NCT00547339|50583953|FG000|Overall Study|Physician Decision|0|||
25269804|NCT00547339|50583954|FG001|Overall Study|Physician Decision|0|||
25269805|NCT00547339|50583955|FG002|Overall Study|Physician Decision|1|||
25269806|NCT00547339|50583956|FG003|Overall Study|Physician Decision|0|||
25269807|NCT01227252|50583979|FG000|Overall Study|Sponsor Decision|0|||
25269808|NCT01227252|50583980|FG001|Overall Study|Sponsor Decision|1|||
25269809|NCT01227252|50583981|FG002|Overall Study|Sponsor Decision|0|||
25269810|NCT01227252|50583982|FG003|Overall Study|Sponsor Decision|0|||
25269811|NCT01227252|50583979|FG000|Overall Study|Lost to Follow-up|0|||
25269812|NCT01227252|50583980|FG001|Overall Study|Lost to Follow-up|1|||
25269813|NCT01227252|50583981|FG002|Overall Study|Lost to Follow-up|0|||
25269814|NCT01227252|50583982|FG003|Overall Study|Lost to Follow-up|0|||
25269815|NCT01227252|50583979|FG000|Overall Study|Withdrawal by Subject|0|||
25269816|NCT01227252|50583980|FG001|Overall Study|Withdrawal by Subject|1|||
25269817|NCT01227252|50583981|FG002|Overall Study|Withdrawal by Subject|0|||
25269818|NCT01227252|50583982|FG003|Overall Study|Withdrawal by Subject|0|||
25269819|NCT01227018|50583995|FG000|Overall Study|Disease progression|9|||
25269820|NCT01227018|50583995|FG000|Overall Study|Toxicity|2|||
25269821|NCT01227018|50583995|FG000|Overall Study|Withdrew after beginning treatment|4|||
25269822|NCT01226472|50584009|FG000|Overall Study|Progressive Disease|1|||
25269823|NCT01225146|50584015|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
25269824|NCT01225146|50584016|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
25269825|NCT01223196|50584026|FG000|Overall Study|Lost to Follow-up|2|||
25269826|NCT01223196|50584027|FG001|Overall Study|Lost to Follow-up|0|||
25269827|NCT01223196|50584026|FG000|Overall Study|Physician Decision|1|||
25269828|NCT01223196|50584027|FG001|Overall Study|Physician Decision|0|||
25269829|NCT01223196|50584026|FG000|Overall Study|Withdrawal by Subject|1|||
25269830|NCT01223196|50584027|FG001|Overall Study|Withdrawal by Subject|0|||
25269831|NCT01222416|50584037|FG000|Overall Study|ineligible;metastasis|3|||
25269832|NCT01222416|50584038|FG001|Overall Study|ineligible;metastasis|0|||
25269833|NCT01222416|50584037|FG000|Overall Study|Adverse Event|4|||
25269834|NCT01222416|50584038|FG001|Overall Study|Adverse Event|0|||
25269835|NCT01222416|50584037|FG000|Overall Study|Withdrawal by Subject|5|||
25269836|NCT01222416|50584038|FG001|Overall Study|Withdrawal by Subject|0|||
25269837|NCT01222416|50584037|FG000|Overall Study|scheduling|6|||
25269838|NCT01222416|50584038|FG001|Overall Study|scheduling|0|||
25269839|NCT01222416|50584037|FG000|Overall Study|missed view/scan|1|||
25269840|NCT01222416|50584038|FG001|Overall Study|missed view/scan|0|||
25269841|NCT01222416|50584037|FG000|Overall Study|Death|1|||
25269842|NCT01222416|50584038|FG001|Overall Study|Death|0|||
25269843|NCT01222104|50584044|FG000|Overall Study|Lost to Follow-up|37|||
25269844|NCT01222104|50584044|FG000|Overall Study|Death|10|||
25269845|NCT01221948|50584054|FG000|Overall Study|Physician Decision|5|||
25269846|NCT01221948|50584054|FG000|Overall Study|Withdrawal by Subject|2|||
25269847|NCT01221948|50584054|FG000|Overall Study|not disclosed|2|||
25126678|NCT02210689|50239554|FG001|Overall Study|Negative Nugent score at baseline|2|||
25126679|NCT02210689|50239555|FG002|Overall Study|Negative Nugent score at baseline|2|||
25126680|NCT02210689|50239553|FG000|Overall Study|Other|25|||
25126681|NCT02210689|50239554|FG001|Overall Study|Other|21|||
25126682|NCT02210689|50239555|FG002|Overall Study|Other|8|||
25126683|NCT02209597|50239563|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
25126684|NCT02209597|50239563|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
25126685|NCT02209597|50239563|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
25126686|NCT02209597|50239563|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
25126687|NCT02188303|50239592|FG000|Overall Study|Adverse Event|0|||
25126688|NCT02188303|50239593|FG001|Overall Study|Adverse Event|0|||
25126689|NCT02188303|50239594|FG002|Overall Study|Adverse Event|0|||
25126690|NCT02188303|50239595|FG003|Overall Study|Adverse Event|0|||
25126691|NCT02188303|50239596|FG004|Overall Study|Adverse Event|0|||
25126692|NCT02188303|50239597|FG005|Overall Study|Adverse Event|2|||
25126693|NCT02188303|50239598|FG006|Overall Study|Adverse Event|0|||
25269848|NCT01221948|50584054|FG000|Overall Study|Death|1|||
25269849|NCT01221948|50584054|FG000|Overall Study|Protocol Violation|4|||
25269850|NCT01221090|50584062|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
25269851|NCT01221090|50584063|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
25269852|NCT01221090|50584064|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
25269853|NCT01221090|50584065|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
25269854|NCT01221090|50584062|FG000|Overall Study|Withdrawal by Subject|0|||
25269855|NCT01221090|50584063|FG001|Overall Study|Withdrawal by Subject|22|||
25269856|NCT01221090|50584064|FG002|Overall Study|Withdrawal by Subject|27|||
25269857|NCT01221090|50584065|FG003|Overall Study|Withdrawal by Subject|2|||
25269858|NCT00950911|50584077|FG000|Overall Study|Adverse Event|0|||
25269859|NCT00950911|50584078|FG001|Overall Study|Adverse Event|2|||
25269860|NCT00950911|50584077|FG000|Overall Study|Death|4|||
25269861|NCT00950911|50584078|FG001|Overall Study|Death|6|||
25269862|NCT00950911|50584077|FG000|Overall Study|Disease progression|2|||
25269863|NCT00950911|50584078|FG001|Overall Study|Disease progression|2|||
25269864|NCT00950911|50584077|FG000|Overall Study|Consent withdrawn|1|||
25269865|NCT00950911|50584078|FG001|Overall Study|Consent withdrawn|3|||
25269866|NCT00950911|50584077|FG000|Overall Study|Administrative decision|3|||
25269867|NCT00950911|50584078|FG001|Overall Study|Administrative decision|1|||
25269868|NCT00950911|50584077|FG000|Overall Study|Ineligibility determined|1|||
25269869|NCT00950911|50584078|FG001|Overall Study|Ineligibility determined|0|||
25269870|NCT00950911|50584077|FG000|Overall Study|Noncompliance|1|||
25269871|NCT00950911|50584078|FG001|Overall Study|Noncompliance|0|||
25269872|NCT00950911|50584077|FG000|Overall Study|Poor performance status|0|||
25269873|NCT00950911|50584078|FG001|Overall Study|Poor performance status|1|||
25269874|NCT01220856|50584086|FG000|Overall Study|graft loss|3|||
25269875|NCT01220856|50584087|FG001|Overall Study|graft loss|3|||
25269876|NCT01220856|50584086|FG000|Overall Study|Lost to Follow-up|1|||
25269877|NCT01220856|50584087|FG001|Overall Study|Lost to Follow-up|0|||
25269878|NCT01218594|50584096|FG000|Overall Study|Death|1|||
25269879|NCT01218594|50584096|FG000|Overall Study|Withdrawal by Subject|3|||
25269880|NCT01218594|50584096|FG000|Overall Study|Adverse Event|2|||
25269881|NCT01218594|50584096|FG000|Overall Study|Physician Decision|6|||
25269882|NCT01610557|50584104|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
25126694|NCT02188303|50239599|FG007|Overall Study|Adverse Event|2|||
25126695|NCT02188303|50239592|FG000|Overall Study|Dose Termination Criteria Met|0|||
25126696|NCT02188303|50239593|FG001|Overall Study|Dose Termination Criteria Met|0|||
25126697|NCT02188303|50239594|FG002|Overall Study|Dose Termination Criteria Met|0|||
25178520|NCT01464307|50323813|FG001|Main Period|Lack of Efficacy|0|||
25269883|NCT01610557|50584105|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
25269884|NCT01610557|50584106|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
25269885|NCT01610557|50584107|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
25269886|NCT01610557|50584108|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
25269887|NCT01610557|50584104|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
25269888|NCT01610557|50584105|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
25269889|NCT01610557|50584106|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
25269890|NCT01610557|50584107|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
25269891|NCT01610557|50584108|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
25269892|NCT00943735|50584119|FG000|Overall Study|Adverse Event|12|||
25269893|NCT00943735|50584119|FG000|Overall Study|Withdrawal by Subject|8|||
25269894|NCT00943735|50584119|FG000|Overall Study|Death|1|||
25269895|NCT00943735|50584119|FG000|Overall Study|Other|8|||
25269896|NCT00943735|50584119|FG000|Overall Study|Other|3|||
25269897|NCT00943579|50584125|FG000|Overall Study|Adverse Event|4|||
25269898|NCT00943579|50584126|FG001|Overall Study|Adverse Event|3|||
25269899|NCT00943579|50584125|FG000|Overall Study|Lack of Efficacy|2|||
25269900|NCT00943579|50584126|FG001|Overall Study|Lack of Efficacy|2|||
25269901|NCT00489307|50584137|FG000|Overall Study|Death|1|||
25269902|NCT00489307|50584138|FG001|Overall Study|Death|1|||
25269903|NCT00489307|50584137|FG000|Overall Study|Lost to Follow-up|2|||
25269904|NCT00489307|50584138|FG001|Overall Study|Lost to Follow-up|2|||
25269905|NCT00489307|50584137|FG000|Overall Study|Physician Decision|1|||
25269906|NCT00489307|50584138|FG001|Overall Study|Physician Decision|0|||
25269907|NCT00489307|50584137|FG000|Overall Study|Withdrawal by Subject|2|||
25269908|NCT00489307|50584138|FG001|Overall Study|Withdrawal by Subject|4|||
25269909|NCT00489307|50584137|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
25269910|NCT00489307|50584138|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
25269911|NCT00489307|50584137|FG000|Overall Study|Surgery after assignment|1|||
25269912|NCT00489307|50584138|FG001|Overall Study|Surgery after assignment|0|||
25269913|NCT00489307|50584137|FG000|Overall Study|Did not fill up the forms|2|||
25269914|NCT00489307|50584138|FG001|Overall Study|Did not fill up the forms|1|||
25269915|NCT00489307|50584137|FG000|Overall Study|Patient or family refusal|5|||
25269916|NCT00489307|50584138|FG001|Overall Study|Patient or family refusal|9|||
25269917|NCT01147809|50584150|FG000|Phase I (168 Days)|Adverse Event|0|||
25269918|NCT01147809|50584151|FG001|Phase I (168 Days)|Adverse Event|0|||
25269919|NCT01147809|50584152|FG002|Phase I (168 Days)|Adverse Event|0|||
25269920|NCT01147809|50584153|FG003|Phase I (168 Days)|Adverse Event|1|||
25269921|NCT01147809|50584154|FG004|Phase I (168 Days)|Adverse Event|0|||
25269922|NCT01147809|50584155|FG005|Phase I (168 Days)|Adverse Event|0|||
25269923|NCT01147809|50584150|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
25269924|NCT01147809|50584151|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
25269925|NCT01147809|50584152|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
25269926|NCT01147809|50584153|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
25269927|NCT01147809|50584154|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
25269928|NCT01147809|50584155|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
25269929|NCT01147809|50584150|FG000|Phase I (168 Days)|Physician Decision|0|||
25269930|NCT01147809|50584151|FG001|Phase I (168 Days)|Physician Decision|1|||
25269931|NCT01147809|50584152|FG002|Phase I (168 Days)|Physician Decision|2|||
25269932|NCT01147809|50584153|FG003|Phase I (168 Days)|Physician Decision|0|||
25269933|NCT01147809|50584154|FG004|Phase I (168 Days)|Physician Decision|0|||
25269934|NCT01147809|50584155|FG005|Phase I (168 Days)|Physician Decision|0|||
25269935|NCT01147809|50584150|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
25126698|NCT02188303|50239595|FG003|Overall Study|Dose Termination Criteria Met|0|||
25126699|NCT02188303|50239596|FG004|Overall Study|Dose Termination Criteria Met|0|||
25126700|NCT02188303|50239597|FG005|Overall Study|Dose Termination Criteria Met|0|||
25126701|NCT02188303|50239598|FG006|Overall Study|Dose Termination Criteria Met|2|||
25126702|NCT02188303|50239599|FG007|Overall Study|Dose Termination Criteria Met|4|||
25126703|NCT04867382|50239635|FG000|Overall Study|Did not complete the survey|2|||
25126704|NCT04867382|50239636|FG001|Overall Study|Did not complete the survey|1|||
25126705|NCT02187055|50239645|FG000|Overall Study|Lack of Efficacy|10|||
25126706|NCT02187055|50239646|FG001|Overall Study|Lack of Efficacy|3|||
25126707|NCT02187055|50239647|FG002|Overall Study|Lack of Efficacy|7|||
25126708|NCT02187055|50239645|FG000|Overall Study|Lost to Follow-up|2|||
25269936|NCT01147809|50584151|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
25269937|NCT01147809|50584152|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
25269938|NCT01147809|50584153|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
25269939|NCT01147809|50584154|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
25269940|NCT01147809|50584155|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
25269941|NCT01147809|50584150|FG000|Phase II (168 Days)|Adverse Event|0|||
25269942|NCT01147809|50584151|FG001|Phase II (168 Days)|Adverse Event|0|||
25269943|NCT01147809|50584152|FG002|Phase II (168 Days)|Adverse Event|0|||
25269944|NCT01147809|50584153|FG003|Phase II (168 Days)|Adverse Event|0|||
25269945|NCT01147809|50584154|FG004|Phase II (168 Days)|Adverse Event|3|||
25269946|NCT01147809|50584155|FG005|Phase II (168 Days)|Adverse Event|6|||
25269947|NCT01147809|50584150|FG000|Phase II (168 Days)|Protocol Violation|0|||
25269948|NCT01147809|50584151|FG001|Phase II (168 Days)|Protocol Violation|0|||
25269949|NCT01147809|50584152|FG002|Phase II (168 Days)|Protocol Violation|0|||
25269950|NCT01147809|50584153|FG003|Phase II (168 Days)|Protocol Violation|0|||
25126709|NCT02187055|50239646|FG001|Overall Study|Lost to Follow-up|7|||
25126710|NCT02187055|50239647|FG002|Overall Study|Lost to Follow-up|3|||
25269951|NCT01147809|50584154|FG004|Phase II (168 Days)|Protocol Violation|0|||
25269952|NCT01147809|50584155|FG005|Phase II (168 Days)|Protocol Violation|1|||
25269953|NCT01147809|50584150|FG000|Phase II (168 Days)|Physician Decision|0|||
25269954|NCT01147809|50584151|FG001|Phase II (168 Days)|Physician Decision|0|||
25269955|NCT01147809|50584152|FG002|Phase II (168 Days)|Physician Decision|0|||
25269956|NCT01147809|50584153|FG003|Phase II (168 Days)|Physician Decision|0|||
25269957|NCT01147809|50584154|FG004|Phase II (168 Days)|Physician Decision|5|||
25269958|NCT01147809|50584155|FG005|Phase II (168 Days)|Physician Decision|11|||
25269959|NCT01147809|50584150|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
25269960|NCT01147809|50584151|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
25269961|NCT01147809|50584152|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
25269962|NCT01147809|50584153|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
25269963|NCT01147809|50584154|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
25269964|NCT01147809|50584155|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
25269965|NCT01147809|50584150|FG000|Phase II (168 Days)|Ongoing|0|||
25269966|NCT01147809|50584151|FG001|Phase II (168 Days)|Ongoing|0|||
25269967|NCT01147809|50584152|FG002|Phase II (168 Days)|Ongoing|0|||
25269968|NCT01147809|50584153|FG003|Phase II (168 Days)|Ongoing|0|||
25269969|NCT01147809|50584154|FG004|Phase II (168 Days)|Ongoing|1|||
25269970|NCT01147809|50584155|FG005|Phase II (168 Days)|Ongoing|0|||
25269971|NCT00943111|50584172|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
25269972|NCT00943111|50584173|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
25269973|NCT00943111|50584174|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
25269974|NCT00943111|50584172|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
25269975|NCT00943111|50584173|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
25269976|NCT00943111|50584174|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
25269977|NCT00943111|50584172|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
25269978|NCT00943111|50584173|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
25269979|NCT00943111|50584174|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
25269980|NCT00943111|50584172|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
25269981|NCT00943111|50584173|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
25269982|NCT00943111|50584174|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
25269983|NCT00943111|50584172|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
25269984|NCT00943111|50584173|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
25269985|NCT00943111|50584174|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
25269986|NCT00943111|50584172|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
25269987|NCT00943111|50584173|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
25269988|NCT00943111|50584174|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
25269989|NCT00943111|50584172|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
25269990|NCT00943111|50584173|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
25269991|NCT00943111|50584174|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
25269992|NCT00943111|50584172|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
25269993|NCT00943111|50584173|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
25269994|NCT00943111|50584174|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
25126711|NCT02187055|50239645|FG000|Overall Study|No longer meets eligibility criteria|0|||
25126712|NCT02187055|50239646|FG001|Overall Study|No longer meets eligibility criteria|2|||
25126713|NCT02187055|50239647|FG002|Overall Study|No longer meets eligibility criteria|0|||
25126714|NCT02187055|50239645|FG000|Overall Study|No longer willing to participate|6|||
25126715|NCT02187055|50239646|FG001|Overall Study|No longer willing to participate|8|||
25126716|NCT02187055|50239647|FG002|Overall Study|No longer willing to participate|10|||
25126717|NCT02187055|50239645|FG000|Overall Study|Other|5|||
25126718|NCT02187055|50239646|FG001|Overall Study|Other|6|||
25126719|NCT02187055|50239647|FG002|Overall Study|Other|3|||
25126720|NCT02187055|50239645|FG000|Overall Study|Protocol Violation|9|||
25126721|NCT02187055|50239646|FG001|Overall Study|Protocol Violation|9|||
25126722|NCT02187055|50239647|FG002|Overall Study|Protocol Violation|4|||
25269995|NCT01147497|50584183|FG000|Overall Study|failed insertion|2|||
25269996|NCT01147497|50584184|FG001|Overall Study|failed insertion|0|||
25269997|NCT01147341|50584192|FG000|Double Blind Period|Lack of Efficacy|1|||
25269998|NCT01147341|50584193|FG001|Double Blind Period|Lack of Efficacy|1|||
25009328|NCT00075725|50102295|FG001|Overall Study|Pt received additional steroids|0|||
25009329|NCT00075725|50102296|FG002|Overall Study|Pt received additional steroids|0|||
25009330|NCT00075725|50102297|FG003|Overall Study|Pt received additional steroids|1|||
25009331|NCT00075725|50102298|FG004|Overall Study|Pt received additional steroids|0|||
25009332|NCT00075725|50102299|FG005|Overall Study|Pt received additional steroids|0|||
25009333|NCT00075725|50102300|FG006|Overall Study|Pt received additional steroids|0|||
25269999|NCT01147341|50584192|FG000|Double Blind Period|Withdrawal by Subject|0|||
25270000|NCT01147341|50584193|FG001|Double Blind Period|Withdrawal by Subject|1|||
25270001|NCT01147341|50584192|FG000|Open Label Period|Lack of Efficacy|3|||
25270002|NCT01147341|50584193|FG001|Open Label Period|Lack of Efficacy|0|||
25270003|NCT01147341|50584192|FG000|Open Label Period|Subject moved|1|||
25270004|NCT01147341|50584193|FG001|Open Label Period|Subject moved|0|||
25126723|NCT02187055|50239645|FG000|Overall Study|Pregnancy|3|||
25126724|NCT02187055|50239646|FG001|Overall Study|Pregnancy|1|||
25126725|NCT02187055|50239647|FG002|Overall Study|Pregnancy|0|||
25126726|NCT02187055|50239645|FG000|Overall Study|Withdrawal by Subject|11|||
25009334|NCT00075725|50102301|FG007|Overall Study|Pt received additional steroids|0|||
25009335|NCT00075725|50102302|FG008|Overall Study|Pt received additional steroids|0|||
25009336|NCT00075725|50102303|FG009|Overall Study|Pt received additional steroids|0|||
25009337|NCT00075725|50102304|FG010|Overall Study|Pt received additional steroids|0|||
25009338|NCT00075725|50102305|FG011|Overall Study|Pt received additional steroids|0|||
25009339|NCT00075725|50102294|FG000|Overall Study|Pt relocated|0|||
25009340|NCT00075725|50102295|FG001|Overall Study|Pt relocated|0|||
25009341|NCT00075725|50102296|FG002|Overall Study|Pt relocated|0|||
25009342|NCT00075725|50102297|FG003|Overall Study|Pt relocated|2|||
25270005|NCT00950755|50584199|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
25270006|NCT00950755|50584199|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
25270007|NCT00950755|50584199|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
25270008|NCT00950755|50584199|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
25270009|NCT00950755|50584199|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
25270010|NCT00950755|50584199|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
25270011|NCT00950755|50584199|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
25270012|NCT00950755|50584199|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
25270013|NCT00950755|50584199|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
25270014|NCT00950755|50584199|FG000|Long-Term Follow-Up|Death|8|||
25270015|NCT01147107|50584205|FG000|Overall Study|Lack of Efficacy|5|||
25270016|NCT01147107|50584206|FG001|Overall Study|Lack of Efficacy|0|||
25270017|NCT01147107|50584205|FG000|Overall Study|Withdrawal by Subject|1|||
25270018|NCT01147107|50584206|FG001|Overall Study|Withdrawal by Subject|1|||
25270019|NCT00942409|50584212|FG000|Overall Study|Lack of Efficacy|1|||
25270020|NCT00942409|50584212|FG000|Overall Study|study drug unavailable|2|||
25270021|NCT01146951|50584218|FG000|Overall Study|Adverse Event|4|||
25270022|NCT01146951|50584219|FG001|Overall Study|Adverse Event|1|||
25270023|NCT01146873|50584227|FG000|Overall Study|Transfer out|0|||
25270024|NCT01146873|50584228|FG001|Overall Study|Transfer out|6|||
25270025|NCT01146795|50584234|FG000|Overall Study|Withdrawal by Subject|4|||
25270026|NCT01146795|50584234|FG000|Overall Study|Adverse Event|6|||
25270027|NCT01146795|50584234|FG000|Overall Study|Still in treatment at study closure|10|||
25270028|NCT01146561|50584238|FG000|Overall Study|Withdrawal by Subject|1|||
25270029|NCT01146561|50584238|FG000|Overall Study|Lost to Follow-up|1|||
25270030|NCT00942175|50584246|FG000|Overall Study|Adverse Event|2|||
25270031|NCT00942175|50584247|FG001|Overall Study|Adverse Event|1|||
25270032|NCT00942175|50584248|FG002|Overall Study|Adverse Event|0|||
25270033|NCT00942175|50584249|FG003|Overall Study|Adverse Event|0|||
25270034|NCT00942175|50584246|FG000|Overall Study|Protocol Violation|0|||
25270035|NCT00942175|50584247|FG001|Overall Study|Protocol Violation|1|||
25270036|NCT00942175|50584248|FG002|Overall Study|Protocol Violation|2|||
25270037|NCT00942175|50584249|FG003|Overall Study|Protocol Violation|0|||
25270038|NCT00942175|50584246|FG000|Overall Study|Pregnancy|0|||
25270039|NCT00942175|50584247|FG001|Overall Study|Pregnancy|0|||
25270040|NCT00942175|50584248|FG002|Overall Study|Pregnancy|0|||
25270041|NCT00942175|50584249|FG003|Overall Study|Pregnancy|1|||
25270042|NCT00942175|50584246|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
25270043|NCT00942175|50584247|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
25270044|NCT00942175|50584248|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
25270045|NCT00942175|50584249|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
25270046|NCT00942175|50584246|FG000|Overall Study|Low Platelet Count|0|||
25270047|NCT00942175|50584247|FG001|Overall Study|Low Platelet Count|2|||
25270048|NCT00942175|50584248|FG002|Overall Study|Low Platelet Count|0|||
25270049|NCT00942175|50584249|FG003|Overall Study|Low Platelet Count|0|||
25270050|NCT01145625|50584269|FG000|Overall Study|Lost to Follow-up|8|||
25270051|NCT01145625|50584270|FG001|Overall Study|Lost to Follow-up|9|||
25270052|NCT01145625|50584269|FG000|Overall Study|Adverse Event|6|||
25270053|NCT01145625|50584270|FG001|Overall Study|Adverse Event|4|||
25270054|NCT01145625|50584269|FG000|Overall Study|Protocol Violation|3|||
25270055|NCT01145625|50584270|FG001|Overall Study|Protocol Violation|1|||
25270056|NCT01145625|50584269|FG000|Overall Study|Withdrawal by Subject|7|||
25270057|NCT01145625|50584270|FG001|Overall Study|Withdrawal by Subject|16|||
25270058|NCT01145625|50584269|FG000|Overall Study|Pregnancy|0|||
25270059|NCT01145625|50584270|FG001|Overall Study|Pregnancy|1|||
25270060|NCT01144377|50584281|FG000|52 Week Treatment Period|Adverse Event|0|||
25270061|NCT01144377|50584282|FG001|52 Week Treatment Period|Adverse Event|0|||
25270062|NCT01144377|50584283|FG002|52 Week Treatment Period|Adverse Event|3|||
25270063|NCT01144377|50584284|FG003|52 Week Treatment Period|Adverse Event|2|||
25270064|NCT01144377|50584285|FG004|52 Week Treatment Period|Adverse Event|1|||
25270065|NCT01144377|50584281|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
25009343|NCT00075725|50102298|FG004|Overall Study|Pt relocated|0|||
25270066|NCT01144377|50584282|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
25270067|NCT01144377|50584283|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
25009344|NCT00075725|50102299|FG005|Overall Study|Pt relocated|1|||
25009345|NCT00075725|50102300|FG006|Overall Study|Pt relocated|1|||
25270068|NCT01144377|50584284|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
25270069|NCT01144377|50584285|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
25270070|NCT01144377|50584281|FG000|52 Week Treatment Period|Protocol Violation|0|||
25270071|NCT01144377|50584282|FG001|52 Week Treatment Period|Protocol Violation|0|||
25270072|NCT01144377|50584283|FG002|52 Week Treatment Period|Protocol Violation|0|||
25270073|NCT01144377|50584284|FG003|52 Week Treatment Period|Protocol Violation|0|||
25270074|NCT01144377|50584285|FG004|52 Week Treatment Period|Protocol Violation|1|||
25270075|NCT01144377|50584281|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
25270076|NCT01144377|50584282|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
25270077|NCT01144377|50584283|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
25270078|NCT01144377|50584284|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
25270079|NCT01144377|50584285|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
25270080|NCT01144377|50584281|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
25270081|NCT01144377|50584282|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
25270082|NCT01144377|50584283|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
25270083|NCT01144377|50584284|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
25270084|NCT01144377|50584285|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
25270085|NCT01144377|50584281|FG000|52 Week Treatment Period|Sponsor Decision|0|||
25270086|NCT01144377|50584282|FG001|52 Week Treatment Period|Sponsor Decision|0|||
25270087|NCT01144377|50584283|FG002|52 Week Treatment Period|Sponsor Decision|0|||
25270088|NCT01144377|50584284|FG003|52 Week Treatment Period|Sponsor Decision|0|||
25270089|NCT01144377|50584285|FG004|52 Week Treatment Period|Sponsor Decision|1|||
25270090|NCT01144377|50584281|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
25270091|NCT01144377|50584282|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
25270092|NCT01144377|50584283|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
25270093|NCT01144377|50584284|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
25270094|NCT01144377|50584285|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
25270095|NCT01144377|50584281|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
25270096|NCT01144377|50584282|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
25270097|NCT01144377|50584283|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
25270098|NCT01144377|50584284|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
25270099|NCT01144377|50584285|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
25270100|NCT01144377|50584281|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
25270101|NCT01144377|50584282|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
25270102|NCT01144377|50584283|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
25270103|NCT01144377|50584284|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
25270104|NCT01144377|50584285|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
25270105|NCT00950599|50584307|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
25270106|NCT00950599|50584308|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
25270107|NCT00950599|50584309|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
25270108|NCT00950599|50584310|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
25270109|NCT00950599|50584311|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
25270110|NCT00950599|50584312|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
25270111|NCT00950599|50584313|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
25270112|NCT00950599|50584314|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
25270113|NCT00950599|50584315|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
25270114|NCT00950599|50584316|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
25126727|NCT02187055|50239646|FG001|Overall Study|Withdrawal by Subject|11|||
25126728|NCT02187055|50239647|FG002|Overall Study|Withdrawal by Subject|11|||
25126729|NCT02187055|50239645|FG000|Overall Study|Adverse Event|21|||
25126730|NCT02187055|50239646|FG001|Overall Study|Adverse Event|26|||
25126731|NCT02187055|50239647|FG002|Overall Study|Adverse Event|36|||
25270115|NCT00950599|50584307|FG000|Double-Blind Treatment Period|Adverse Event|0|||
25270116|NCT00950599|50584308|FG001|Double-Blind Treatment Period|Adverse Event|1|||
25270117|NCT00950599|50584309|FG002|Double-Blind Treatment Period|Adverse Event|1|||
25270118|NCT00950599|50584310|FG003|Double-Blind Treatment Period|Adverse Event|1|||
25270119|NCT00950599|50584311|FG004|Double-Blind Treatment Period|Adverse Event|1|||
25270120|NCT00950599|50584312|FG005|Double-Blind Treatment Period|Adverse Event|1|||
25270121|NCT00950599|50584313|FG006|Double-Blind Treatment Period|Adverse Event|0|||
25270122|NCT00950599|50584314|FG007|Double-Blind Treatment Period|Adverse Event|0|||
25270123|NCT00950599|50584315|FG008|Double-Blind Treatment Period|Adverse Event|0|||
25270124|NCT00950599|50584316|FG009|Double-Blind Treatment Period|Adverse Event|0|||
25270125|NCT00950599|50584307|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
25270126|NCT00950599|50584308|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
25270127|NCT00950599|50584309|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
25270128|NCT00950599|50584310|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
25270129|NCT00950599|50584311|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
25270130|NCT00950599|50584312|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
25270131|NCT00950599|50584313|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
25270132|NCT00950599|50584314|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
25270133|NCT00950599|50584315|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
25270134|NCT00950599|50584316|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
25270135|NCT00950599|50584307|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
25270136|NCT00950599|50584308|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
25270137|NCT00950599|50584309|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
25270138|NCT00950599|50584310|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
25270139|NCT00950599|50584311|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
25270140|NCT00950599|50584312|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
25270141|NCT00950599|50584313|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
25270142|NCT00950599|50584314|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
25270143|NCT00950599|50584315|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
25270144|NCT00950599|50584316|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
25270145|NCT00950599|50584307|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
25270146|NCT00950599|50584308|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
25270147|NCT00950599|50584309|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
25270148|NCT00950599|50584310|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
25270149|NCT00950599|50584311|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
25270150|NCT00950599|50584312|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
25270151|NCT00950599|50584313|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
25270152|NCT00950599|50584314|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
25270153|NCT00950599|50584315|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
25270154|NCT00950599|50584316|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
25270155|NCT00950599|50584307|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
25270156|NCT00950599|50584308|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
25270157|NCT00950599|50584309|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
25270158|NCT00950599|50584310|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
25270159|NCT00950599|50584311|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
25270160|NCT00950599|50584312|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
25270161|NCT00950599|50584313|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
25270162|NCT00950599|50584314|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
25270163|NCT00950599|50584315|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
25270164|NCT00950599|50584316|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
25270165|NCT00950599|50584307|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
25270166|NCT00950599|50584308|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
25270167|NCT00950599|50584309|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
25126732|NCT02187055|50239645|FG000|Overall Study|Death|2|||
25126733|NCT02187055|50239646|FG001|Overall Study|Death|0|||
25126734|NCT02187055|50239647|FG002|Overall Study|Death|0|||
25126735|NCT02246660|50239687|FG000|Overall Study|Withdrawal by Subject|0|||
25126736|NCT02246660|50239688|FG001|Overall Study|Withdrawal by Subject|1|||
25126737|NCT02246660|50239689|FG002|Overall Study|Withdrawal by Subject|0|||
25126738|NCT02246660|50239687|FG000|Overall Study|Death|0|||
25126739|NCT02246660|50239688|FG001|Overall Study|Death|0|||
25126740|NCT02246660|50239689|FG002|Overall Study|Death|1|||
25126741|NCT02246582|50239697|FG000|Overall Study|Withdrawal by Subject|3|||
25126742|NCT02246582|50239698|FG001|Overall Study|Withdrawal by Subject|4|||
25126743|NCT02137369|50239704|FG000|Overall Study|Withdrawal by Subject|3|||
25126744|NCT02137369|50239705|FG001|Overall Study|Withdrawal by Subject|2|||
25126745|NCT02137369|50239704|FG000|Overall Study|Adverse Event|2|||
25126746|NCT02137369|50239705|FG001|Overall Study|Adverse Event|0|||
25126747|NCT02137369|50239704|FG000|Overall Study|Lost to Follow-up|1|||
25270168|NCT00950599|50584310|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
25126748|NCT02137369|50239705|FG001|Overall Study|Lost to Follow-up|0|||
25126749|NCT02137369|50239704|FG000|Overall Study|Moved away|2|||
25126750|NCT02137369|50239705|FG001|Overall Study|Moved away|0|||
25126751|NCT02155309|50239714|FG000|Overall Study|Protocol Violation|0|||
25126752|NCT02155309|50239715|FG001|Overall Study|Protocol Violation|0|||
25126753|NCT02155309|50239716|FG002|Overall Study|Protocol Violation|1|||
25126754|NCT02186821|50239723|FG000|Overall Study|Adverse Event|9|||
25126755|NCT02186821|50239723|FG000|Overall Study|Death|2|||
25126756|NCT02186821|50239723|FG000|Overall Study|Disease progression|32|||
25126757|NCT02186821|50239723|FG000|Overall Study|Protocol Violation|1|||
25126758|NCT02186821|50239723|FG000|Overall Study|Physician Decision|1|||
25270169|NCT00950599|50584311|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
25126759|NCT02186821|50239723|FG000|Overall Study|Study terminated by sponsor|2|||
25126760|NCT01710358|50239730|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
25270170|NCT00950599|50584312|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
25126761|NCT01710358|50239731|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
25126762|NCT01710358|50239732|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
25126763|NCT01710358|50239730|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
25126764|NCT01710358|50239731|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
25126765|NCT01710358|50239732|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
25126766|NCT01710358|50239730|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
25126767|NCT01710358|50239731|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
25126768|NCT01710358|50239732|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
25126769|NCT01710358|50239730|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
25126770|NCT01710358|50239731|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
25126771|NCT01710358|50239732|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
25126772|NCT01710358|50239730|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
25126773|NCT01710358|50239731|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
25126774|NCT01710358|50239732|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
25126775|NCT01710358|50239730|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
25126776|NCT01710358|50239731|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
25126777|NCT01710358|50239732|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
25126778|NCT01710358|50239730|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
25126779|NCT01710358|50239731|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
25126780|NCT01710358|50239732|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
25126781|NCT01710358|50239730|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
25126782|NCT01710358|50239731|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
25126783|NCT01710358|50239732|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
25126784|NCT01710358|50239730|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
25126785|NCT01710358|50239731|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
25126786|NCT01710358|50239732|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
25126787|NCT01710358|50239730|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
25126788|NCT01710358|50239731|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
25126789|NCT01710358|50239732|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
25126790|NCT01710358|50239730|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
25126791|NCT01710358|50239731|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
25126792|NCT01710358|50239732|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
25126793|NCT01710358|50239730|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
25126794|NCT01710358|50239731|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
25126795|NCT01710358|50239732|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
25126796|NCT01710358|50239730|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
25126797|NCT01710358|50239731|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
25126798|NCT01710358|50239732|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
25126799|NCT01710358|50239730|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
25126800|NCT01710358|50239731|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
25126801|NCT01710358|50239732|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
25126802|NCT01710358|50239730|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
25126803|NCT01710358|50239731|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
25126804|NCT01710358|50239732|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
25126805|NCT01710358|50239730|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
25126806|NCT01710358|50239731|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
25126807|NCT01710358|50239732|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
25270171|NCT00950599|50584313|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
25270172|NCT00950599|50584314|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
25270173|NCT00950599|50584315|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
25270174|NCT00950599|50584316|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
25270175|NCT00950599|50584307|FG000|Follow-Up Period|Adverse Event|0|||
25270176|NCT00950599|50584308|FG001|Follow-Up Period|Adverse Event|0|||
25270177|NCT00950599|50584309|FG002|Follow-Up Period|Adverse Event|0|||
25270178|NCT00950599|50584310|FG003|Follow-Up Period|Adverse Event|0|||
25270179|NCT00950599|50584311|FG004|Follow-Up Period|Adverse Event|0|||
25270180|NCT00950599|50584312|FG005|Follow-Up Period|Adverse Event|0|||
25270181|NCT00950599|50584313|FG006|Follow-Up Period|Adverse Event|0|||
25270182|NCT00950599|50584314|FG007|Follow-Up Period|Adverse Event|0|||
25270183|NCT00950599|50584315|FG008|Follow-Up Period|Adverse Event|1|||
25270184|NCT00950599|50584316|FG009|Follow-Up Period|Adverse Event|0|||
25270185|NCT00950599|50584307|FG000|Follow-Up Period|Lack of Efficacy|0|||
25270186|NCT00950599|50584308|FG001|Follow-Up Period|Lack of Efficacy|0|||
25270187|NCT00950599|50584309|FG002|Follow-Up Period|Lack of Efficacy|0|||
25126808|NCT01710358|50239730|FG000|Rescue Period|Adverse Event|0|||
25178521|NCT01464307|50323812|FG000|Main Period|Withdrawal by Subject|5|||
25178522|NCT01464307|50323813|FG001|Main Period|Withdrawal by Subject|2|||
25270188|NCT00950599|50584310|FG003|Follow-Up Period|Lack of Efficacy|0|||
25270189|NCT00950599|50584311|FG004|Follow-Up Period|Lack of Efficacy|0|||
25009346|NCT00075725|50102301|FG007|Overall Study|Pt relocated|2|||
25270190|NCT00950599|50584312|FG005|Follow-Up Period|Lack of Efficacy|0|||
25270191|NCT00950599|50584313|FG006|Follow-Up Period|Lack of Efficacy|0|||
25270192|NCT00950599|50584314|FG007|Follow-Up Period|Lack of Efficacy|0|||
25270193|NCT00950599|50584315|FG008|Follow-Up Period|Lack of Efficacy|3|||
25270194|NCT00950599|50584316|FG009|Follow-Up Period|Lack of Efficacy|0|||
25270195|NCT00950599|50584307|FG000|Follow-Up Period|Lost to Follow-up|0|||
25270196|NCT00950599|50584308|FG001|Follow-Up Period|Lost to Follow-up|0|||
25270197|NCT00950599|50584309|FG002|Follow-Up Period|Lost to Follow-up|0|||
25270198|NCT00950599|50584310|FG003|Follow-Up Period|Lost to Follow-up|0|||
25270199|NCT00950599|50584311|FG004|Follow-Up Period|Lost to Follow-up|0|||
25270200|NCT00950599|50584312|FG005|Follow-Up Period|Lost to Follow-up|0|||
25270201|NCT00950599|50584313|FG006|Follow-Up Period|Lost to Follow-up|0|||
25270202|NCT00950599|50584314|FG007|Follow-Up Period|Lost to Follow-up|0|||
25126809|NCT01710358|50239731|FG001|Rescue Period|Adverse Event|15|||
25126810|NCT01710358|50239732|FG002|Rescue Period|Adverse Event|0|||
25126811|NCT01710358|50239730|FG000|Rescue Period|Death|0|||
25126812|NCT01710358|50239731|FG001|Rescue Period|Death|1|||
25126813|NCT01710358|50239732|FG002|Rescue Period|Death|0|||
25126814|NCT01710358|50239730|FG000|Rescue Period|Lack of Efficacy|0|||
25126815|NCT01710358|50239731|FG001|Rescue Period|Lack of Efficacy|7|||
25126816|NCT01710358|50239732|FG002|Rescue Period|Lack of Efficacy|0|||
25126817|NCT01710358|50239730|FG000|Rescue Period|Withdrawal by Subject|0|||
25126818|NCT01710358|50239731|FG001|Rescue Period|Withdrawal by Subject|8|||
25126819|NCT01710358|50239732|FG002|Rescue Period|Withdrawal by Subject|0|||
25126820|NCT01633112|50239756|FG000|Overall Study|Lack of Efficacy|1|||
25126821|NCT01633112|50239757|FG001|Overall Study|Lack of Efficacy|6|||
25126822|NCT01633112|50239758|FG002|Overall Study|Lack of Efficacy|13|||
25126823|NCT01633112|50239756|FG000|Overall Study|Abnormal laboratory value(s)|3|||
25126824|NCT01633112|50239757|FG001|Overall Study|Abnormal laboratory value(s)|1|||
25126825|NCT01633112|50239758|FG002|Overall Study|Abnormal laboratory value(s)|0|||
25126826|NCT01633112|50239756|FG000|Overall Study|Abnormal test procedure result(s)|0|||
25126827|NCT01633112|50239757|FG001|Overall Study|Abnormal test procedure result(s)|1|||
25126828|NCT01633112|50239758|FG002|Overall Study|Abnormal test procedure result(s)|0|||
25126829|NCT01633112|50239756|FG000|Overall Study|Administrative problems|1|||
25126830|NCT01633112|50239757|FG001|Overall Study|Administrative problems|2|||
25126831|NCT01633112|50239758|FG002|Overall Study|Administrative problems|5|||
25126832|NCT01633112|50239756|FG000|Overall Study|Adverse Event|16|||
25126833|NCT01633112|50239757|FG001|Overall Study|Adverse Event|18|||
25126834|NCT01633112|50239758|FG002|Overall Study|Adverse Event|20|||
25126835|NCT01633112|50239756|FG000|Overall Study|Lost to Follow-up|7|||
25126836|NCT01633112|50239757|FG001|Overall Study|Lost to Follow-up|19|||
25126837|NCT01633112|50239758|FG002|Overall Study|Lost to Follow-up|6|||
25126838|NCT01633112|50239756|FG000|Overall Study|Protocol Violation|4|||
25126839|NCT01633112|50239757|FG001|Overall Study|Protocol Violation|0|||
25126840|NCT01633112|50239758|FG002|Overall Study|Protocol Violation|2|||
25126841|NCT01633112|50239756|FG000|Overall Study|Subject no longer requires study drug|0|||
25126842|NCT01633112|50239757|FG001|Overall Study|Subject no longer requires study drug|0|||
25126843|NCT01633112|50239758|FG002|Overall Study|Subject no longer requires study drug|1|||
25126844|NCT01633112|50239756|FG000|Overall Study|Withdrawal by Subject|20|||
25126845|NCT01633112|50239757|FG001|Overall Study|Withdrawal by Subject|12|||
25126846|NCT01633112|50239758|FG002|Overall Study|Withdrawal by Subject|41|||
25270203|NCT00950599|50584315|FG008|Follow-Up Period|Lost to Follow-up|5|||
25270204|NCT00950599|50584316|FG009|Follow-Up Period|Lost to Follow-up|1|||
25270205|NCT00950599|50584307|FG000|Follow-Up Period|Physician Decision|0|||
25270206|NCT00950599|50584308|FG001|Follow-Up Period|Physician Decision|0|||
25270207|NCT00950599|50584309|FG002|Follow-Up Period|Physician Decision|0|||
25270208|NCT00950599|50584310|FG003|Follow-Up Period|Physician Decision|0|||
25270209|NCT00950599|50584311|FG004|Follow-Up Period|Physician Decision|0|||
25270210|NCT00950599|50584312|FG005|Follow-Up Period|Physician Decision|0|||
25270211|NCT00950599|50584313|FG006|Follow-Up Period|Physician Decision|0|||
25270212|NCT00950599|50584314|FG007|Follow-Up Period|Physician Decision|0|||
25270213|NCT00950599|50584315|FG008|Follow-Up Period|Physician Decision|1|||
25270214|NCT00950599|50584316|FG009|Follow-Up Period|Physician Decision|0|||
25270215|NCT00950599|50584307|FG000|Follow-Up Period|Poor/Noncompliance|0|||
25270216|NCT00950599|50584308|FG001|Follow-Up Period|Poor/Noncompliance|0|||
25270217|NCT00950599|50584309|FG002|Follow-Up Period|Poor/Noncompliance|0|||
25126847|NCT01633112|50239756|FG000|Overall Study|missing Study Completion CRF|1|||
25126848|NCT01633112|50239757|FG001|Overall Study|missing Study Completion CRF|1|||
25126849|NCT01633112|50239758|FG002|Overall Study|missing Study Completion CRF|4|||
25270218|NCT00950599|50584310|FG003|Follow-Up Period|Poor/Noncompliance|0|||
25270219|NCT00950599|50584311|FG004|Follow-Up Period|Poor/Noncompliance|0|||
25270220|NCT00950599|50584312|FG005|Follow-Up Period|Poor/Noncompliance|0|||
25126850|NCT01691482|50239767|FG000|Treatment Period 2|Adverse Event|0|||
25126851|NCT01691482|50239768|FG001|Treatment Period 2|Adverse Event|1|||
25126852|NCT01691482|50239767|FG000|Treatment Period 2|Protocol Violation|1|||
25270221|NCT00950599|50584313|FG006|Follow-Up Period|Poor/Noncompliance|0|||
25270222|NCT00950599|50584314|FG007|Follow-Up Period|Poor/Noncompliance|0|||
25270223|NCT00950599|50584315|FG008|Follow-Up Period|Poor/Noncompliance|1|||
25270224|NCT00950599|50584316|FG009|Follow-Up Period|Poor/Noncompliance|0|||
25270225|NCT00950599|50584307|FG000|Follow-Up Period|Subject withdrew Consent|0|||
25270226|NCT00950599|50584308|FG001|Follow-Up Period|Subject withdrew Consent|0|||
25270227|NCT00950599|50584309|FG002|Follow-Up Period|Subject withdrew Consent|0|||
25270228|NCT00950599|50584310|FG003|Follow-Up Period|Subject withdrew Consent|0|||
25270229|NCT00950599|50584311|FG004|Follow-Up Period|Subject withdrew Consent|0|||
25270230|NCT00950599|50584312|FG005|Follow-Up Period|Subject withdrew Consent|0|||
25270231|NCT00950599|50584313|FG006|Follow-Up Period|Subject withdrew Consent|0|||
25126853|NCT01691482|50239768|FG001|Treatment Period 2|Protocol Violation|1|||
25126854|NCT02246114|50239777|FG000|Overall Study|miscarriage|1|||
25126855|NCT02246114|50239778|FG001|Overall Study|miscarriage|0|||
25126856|NCT01710046|50239786|FG000|Overall Study|Lost to Follow-up|1|||
25126857|NCT01710046|50239787|FG001|Overall Study|Lost to Follow-up|0|||
25126858|NCT02154529|50239797|FG000|Overall Study|Death|1|||
25126859|NCT02154529|50239798|FG001|Overall Study|Death|1|||
25126860|NCT02154529|50239799|FG002|Overall Study|Death|5|||
25126861|NCT02154529|50239800|FG003|Overall Study|Death|1|||
25126862|NCT02154529|50239797|FG000|Overall Study|Termination of study by sponsor|2|||
25126863|NCT02154529|50239798|FG001|Overall Study|Termination of study by sponsor|2|||
25126864|NCT02154529|50239799|FG002|Overall Study|Termination of study by sponsor|3|||
25126865|NCT02154529|50239800|FG003|Overall Study|Termination of study by sponsor|1|||
25126866|NCT02154529|50239797|FG000|Overall Study|Lost to Follow-up|1|||
25126867|NCT02154529|50239798|FG001|Overall Study|Lost to Follow-up|0|||
25126868|NCT02154529|50239799|FG002|Overall Study|Lost to Follow-up|0|||
25126869|NCT02154529|50239800|FG003|Overall Study|Lost to Follow-up|0|||
25126870|NCT01954017|50239815|FG000|Overall Study|Adverse Event|0|||
25126871|NCT01954017|50239816|FG001|Overall Study|Adverse Event|0|||
25126872|NCT01954017|50239817|FG002|Overall Study|Adverse Event|1|||
25126873|NCT01954017|50239815|FG000|Overall Study|Death|2|||
25126874|NCT01954017|50239816|FG001|Overall Study|Death|1|||
25126875|NCT01954017|50239817|FG002|Overall Study|Death|1|||
25126876|NCT01954017|50239815|FG000|Overall Study|Withdrawal by Subject|0|||
25126877|NCT01954017|50239816|FG001|Overall Study|Withdrawal by Subject|1|||
25126878|NCT01954017|50239817|FG002|Overall Study|Withdrawal by Subject|0|||
25126879|NCT01954017|50239815|FG000|Overall Study|Protocol Violation|0|||
25126880|NCT01954017|50239816|FG001|Overall Study|Protocol Violation|3|||
25126881|NCT01954017|50239817|FG002|Overall Study|Protocol Violation|2|||
25126882|NCT01954017|50239815|FG000|Overall Study|Necrotizing enterocolitis|1|||
25126883|NCT01954017|50239816|FG001|Overall Study|Necrotizing enterocolitis|0|||
25126884|NCT01954017|50239817|FG002|Overall Study|Necrotizing enterocolitis|1|||
25126885|NCT01954017|50239815|FG000|Overall Study|Enteral intake stopped >7 days|0|||
25126886|NCT01954017|50239816|FG001|Overall Study|Enteral intake stopped >7 days|1|||
25126887|NCT01954017|50239817|FG002|Overall Study|Enteral intake stopped >7 days|1|||
25126888|NCT01954017|50239815|FG000|Overall Study|All other reasons|2|||
25126889|NCT01954017|50239816|FG001|Overall Study|All other reasons|2|||
25126890|NCT01954017|50239817|FG002|Overall Study|All other reasons|7|||
25126891|NCT02154139|50239851|FG000|Overall Study|Injection not administered|2|||
25126892|NCT02154139|50239851|FG000|Overall Study|Other|2|||
25270232|NCT00950599|50584314|FG007|Follow-Up Period|Subject withdrew Consent|0|||
25270233|NCT00950599|50584315|FG008|Follow-Up Period|Subject withdrew Consent|2|||
25270234|NCT00950599|50584316|FG009|Follow-Up Period|Subject withdrew Consent|1|||
25270235|NCT01144299|50584341|FG000|Overall Study|Lost to Follow-up|1|||
25270236|NCT01144299|50584342|FG001|Overall Study|Lost to Follow-up|0|||
25270237|NCT01144299|50584341|FG000|Overall Study|Withdrawal by Subject|1|||
25270238|NCT01144299|50584342|FG001|Overall Study|Withdrawal by Subject|0|||
25270239|NCT01143207|50584348|FG000|Overall Study|Lost to Follow-up|2|||
25270240|NCT01143051|50584358|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
25270241|NCT01143051|50584359|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
25270242|NCT01143051|50584360|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
25270243|NCT01143051|50584361|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
25270244|NCT01143051|50584362|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
25126893|NCT02154139|50239851|FG000|Overall Study|Investigator transferred|3|||
25126894|NCT02245568|50239855|FG000|Overall Study|Study terminated by Sponsor|346|||
25126895|NCT02245568|50239855|FG000|Overall Study|Adverse Event|144|||
25126896|NCT02245568|50239855|FG000|Overall Study|Lack of Efficacy|98|||
25126897|NCT02245568|50239855|FG000|Overall Study|Withdrawal by Caregiver|85|||
25126898|NCT02245568|50239855|FG000|Overall Study|Withdrawal by Subject|77|||
25270245|NCT01143051|50584363|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
25270246|NCT01143051|50584358|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
25270247|NCT01143051|50584359|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
25270248|NCT01143051|50584360|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
25270249|NCT01143051|50584361|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
25126899|NCT02245568|50239855|FG000|Overall Study|Withdrawal by Legal Representative|31|||
25126900|NCT02245568|50239855|FG000|Overall Study|Missing (Site closure)|16|||
25126901|NCT02245568|50239855|FG000|Overall Study|Physician Decision|14|||
25126902|NCT02245568|50239855|FG000|Overall Study|Non-compliance with study drug|11|||
25126903|NCT02245568|50239855|FG000|Overall Study|Death|9|||
25126904|NCT02245568|50239855|FG000|Overall Study|Blue staining|6|||
25126905|NCT02245568|50239855|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
25126906|NCT02245568|50239855|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
25126907|NCT02245568|50239855|FG000|Overall Study|Lost to Follow-up|5|||
25126908|NCT02154061|50239861|FG000|Overall Study|Pregnancy|1|||
25126909|NCT02154061|50239862|FG001|Overall Study|Pregnancy|0|||
25126910|NCT02154061|50239861|FG000|Overall Study|enrolled but not vaccinated|1|||
25126911|NCT02154061|50239862|FG001|Overall Study|enrolled but not vaccinated|0|||
25126912|NCT01907217|50239870|FG000|Overall Study|Withdrawal by Subject|0|||
25126913|NCT01907217|50239871|FG001|Overall Study|Withdrawal by Subject|2|||
25126914|NCT01953783|50239879|FG000|Overall Study|Progressive disease|2|||
25126915|NCT02134015|50239885|FG000|Overall Study|Protocol Violation|0|||
25126916|NCT02134015|50239886|FG001|Overall Study|Protocol Violation|1|||
25126917|NCT02134015|50239885|FG000|Overall Study|Death|2|||
25126918|NCT02134015|50239886|FG001|Overall Study|Death|1|||
25126919|NCT02134015|50239885|FG000|Overall Study|Reason not provided|1|||
25126920|NCT02134015|50239886|FG001|Overall Study|Reason not provided|2|||
25126921|NCT02134015|50239885|FG000|Overall Study|Clinical progression|14|||
25126922|NCT02134015|50239886|FG001|Overall Study|Clinical progression|7|||
25126923|NCT02134015|50239885|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
25126924|NCT02134015|50239886|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
25126925|NCT02134015|50239885|FG000|Overall Study|Study terminated by sponsor|2|||
25126926|NCT02134015|50239886|FG001|Overall Study|Study terminated by sponsor|3|||
25126927|NCT02134015|50239885|FG000|Overall Study|Adverse Event|9|||
25126928|NCT02134015|50239886|FG001|Overall Study|Adverse Event|10|||
25126929|NCT02134015|50239885|FG000|Overall Study|Withdrawal by Subject|3|||
25126930|NCT02134015|50239886|FG001|Overall Study|Withdrawal by Subject|7|||
25126931|NCT01924845|50239892|FG000|Overall Study|Adverse Event|3|||
25126932|NCT01924845|50239892|FG000|Overall Study|Withdrawal by Subject|2|||
25126933|NCT01924845|50239892|FG000|Overall Study|Protocol Violation|1|||
25126934|NCT01630135|50239898|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
25126935|NCT01630135|50239899|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
25126936|NCT01691248|50239907|FG000|Overall Study|Protocol Violation|43|||
25126937|NCT01691248|50239908|FG001|Overall Study|Protocol Violation|27|||
25126938|NCT01691248|50239907|FG000|Overall Study|Adverse Event|24|||
25126939|NCT01691248|50239908|FG001|Overall Study|Adverse Event|22|||
25126940|NCT01691248|50239907|FG000|Overall Study|Withdrawal by Subject|20|||
25126941|NCT01691248|50239908|FG001|Overall Study|Withdrawal by Subject|18|||
25126942|NCT01691248|50239907|FG000|Overall Study|Confirmed CDAD|14|||
25126943|NCT01691248|50239908|FG001|Overall Study|Confirmed CDAD|31|||
25126944|NCT01691248|50239907|FG000|Overall Study|Lost to Follow-up|2|||
25126945|NCT01691248|50239908|FG001|Overall Study|Lost to Follow-up|5|||
25126946|NCT01691248|50239907|FG000|Overall Study|Reason not provided|4|||
25126947|NCT01691248|50239908|FG001|Overall Study|Reason not provided|4|||
25126948|NCT01691248|50239907|FG000|Overall Study|Not Treated|4|||
25126949|NCT01691248|50239908|FG001|Overall Study|Not Treated|7|||
25126950|NCT01924767|50239919|FG000|Overall Study|Adverse Event|1|||
25126951|NCT01924767|50239920|FG001|Overall Study|Adverse Event|0|||
25126952|NCT01924767|50239921|FG002|Overall Study|Adverse Event|1|||
25126953|NCT01924767|50239922|FG003|Overall Study|Adverse Event|0|||
25126954|NCT01924767|50239923|FG004|Overall Study|Adverse Event|0|||
25126955|NCT01691092|50239940|FG000|Overall Study|Lost to Follow-up|10|||
25126956|NCT01691092|50239940|FG000|Overall Study|Physician Decision|4|||
25270250|NCT01143051|50584362|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
25270251|NCT01143051|50584363|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
25270252|NCT01142661|50584373|FG000|Overall Study|Adverse Event|2|||
25270253|NCT01142661|50584373|FG000|Overall Study|Withdrawal by Subject|1|||
25270254|NCT01142661|50584373|FG000|Overall Study|Physician Decision|1|||
25270255|NCT01142193|50584379|FG000|Overall Study|Adverse Event|12|||
25270256|NCT01142193|50584380|FG001|Overall Study|Adverse Event|4|||
25270257|NCT01142193|50584379|FG000|Overall Study|Lack of Efficacy|2|||
25270258|NCT01142193|50584380|FG001|Overall Study|Lack of Efficacy|1|||
25126957|NCT01691092|50239940|FG000|Overall Study|Withdrawal by Subject|3|||
25126958|NCT01691092|50239940|FG000|Overall Study|non-compliance|3|||
25126959|NCT01691092|50239940|FG000|Overall Study|used for different study|2|||
25126960|NCT01691092|50239940|FG000|Overall Study|screen fail|19|||
25126961|NCT02133001|50239946|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
25270259|NCT01142193|50584379|FG000|Overall Study|Physician Decision|1|||
25270260|NCT01142193|50584380|FG001|Overall Study|Physician Decision|1|||
25126962|NCT02133001|50239947|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
25126963|NCT02133001|50239946|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
25126964|NCT02133001|50239947|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
25126965|NCT02133001|50239946|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
25270261|NCT01142193|50584379|FG000|Overall Study|Withdrawal by Subject|4|||
25126966|NCT02133001|50239947|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
25270262|NCT01142193|50584380|FG001|Overall Study|Withdrawal by Subject|3|||
25126967|NCT02133001|50239946|FG000|Double Blind (Day 1-25)|Other|2|||
25126968|NCT02133001|50239947|FG001|Double Blind (Day 1-25)|Other|2|||
25126969|NCT02133001|50239946|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
25126970|NCT02133001|50239947|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
25126971|NCT02133001|50239946|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
25126972|NCT02133001|50239947|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
25126973|NCT02133001|50239946|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
25126974|NCT02133001|50239947|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
25126975|NCT02133001|50239946|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
25126976|NCT02133001|50239947|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
25126977|NCT01709578|50239958|FG000|Overall Study|Rescued and entered in long term safety|63|||
25126978|NCT01709578|50239959|FG001|Overall Study|Rescued and entered in long term safety|25|||
25126979|NCT01709578|50239960|FG002|Overall Study|Rescued and entered in long term safety|26|||
25126980|NCT01709578|50239958|FG000|Overall Study|Adverse Event|9|||
25126981|NCT01709578|50239959|FG001|Overall Study|Adverse Event|18|||
25126982|NCT01709578|50239960|FG002|Overall Study|Adverse Event|17|||
25126983|NCT01709578|50239958|FG000|Overall Study|Lack of Efficacy|5|||
25126984|NCT01709578|50239959|FG001|Overall Study|Lack of Efficacy|4|||
25126985|NCT01709578|50239960|FG002|Overall Study|Lack of Efficacy|2|||
25126986|NCT01709578|50239958|FG000|Overall Study|Poor compliance to protocol|1|||
25126987|NCT01709578|50239959|FG001|Overall Study|Poor compliance to protocol|2|||
25126988|NCT01709578|50239960|FG002|Overall Study|Poor compliance to protocol|1|||
25126989|NCT01709578|50239958|FG000|Overall Study|Other, not related to safety or efficacy|2|||
25126990|NCT01709578|50239959|FG001|Overall Study|Other, not related to safety or efficacy|7|||
25126991|NCT01709578|50239960|FG002|Overall Study|Other, not related to safety or efficacy|5|||
25126992|NCT02132767|50239970|FG000|Overall Study|Death|3|||
25126993|NCT02132767|50239971|FG001|Overall Study|Death|2|||
25126994|NCT02132767|50239970|FG000|Overall Study|Withdrawal by Subject|10|||
25126995|NCT02132767|50239971|FG001|Overall Study|Withdrawal by Subject|9|||
25126996|NCT02132767|50239970|FG000|Overall Study|Lost to Follow-up|4|||
25126997|NCT02132767|50239971|FG001|Overall Study|Lost to Follow-up|4|||
25126998|NCT02153905|50239979|FG000|Overall Study|Death|1|||
25126999|NCT02153905|50239980|FG001|Overall Study|Death|0|||
25127000|NCT02153827|50239988|FG000|Overall Study|Lost to Follow-up|3|||
25127001|NCT02153827|50239989|FG001|Overall Study|Lost to Follow-up|9|||
25127002|NCT02153359|50239995|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
25127003|NCT02153359|50239996|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
25127004|NCT01691014|50240009|FG000|Overall Study|Premature Termination|1|||
25127005|NCT01691014|50240010|FG001|Overall Study|Premature Termination|6|||
25127006|NCT01691014|50240011|FG002|Overall Study|Premature Termination|0|||
25127007|NCT01691014|50240012|FG003|Overall Study|Premature Termination|3|||
25127008|NCT01691014|50240009|FG000|Overall Study|Other|0|||
25127009|NCT01691014|50240010|FG001|Overall Study|Other|0|||
25127010|NCT01691014|50240011|FG002|Overall Study|Other|2|||
25127011|NCT01691014|50240012|FG003|Overall Study|Other|0|||
25270263|NCT01142193|50584379|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
25270264|NCT01142193|50584380|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
25270265|NCT01142193|50584379|FG000|Overall Study|Other|1|||
25270266|NCT01142193|50584380|FG001|Overall Study|Other|2|||
25270267|NCT01142115|50584386|FG000|First Intervention|Lack of Efficacy|1|||
25270268|NCT01142115|50584387|FG001|First Intervention|Lack of Efficacy|1|||
25270269|NCT01142115|50584386|FG000|First Intervention|Adverse Event|1|||
25270270|NCT01142115|50584387|FG001|First Intervention|Adverse Event|0|||
25270271|NCT01140477|50584394|FG000|Overall Study|Lost to Follow-up|4|||
25270272|NCT01140477|50584395|FG001|Overall Study|Lost to Follow-up|0|||
25270273|NCT01140477|50584394|FG000|Overall Study|Withdrawal by Subject|1|||
25270274|NCT01140477|50584395|FG001|Overall Study|Withdrawal by Subject|4|||
25270275|NCT01140477|50584394|FG000|Overall Study|Surgical complication preventing implant|2|||
25270276|NCT01140477|50584395|FG001|Overall Study|Surgical complication preventing implant|0|||
25270277|NCT01140477|50584394|FG000|Overall Study|Death|1|||
25270278|NCT01140477|50584395|FG001|Overall Study|Death|1|||
25270279|NCT01140477|50584394|FG000|Overall Study|Subject explanted|0|||
25270280|NCT01140477|50584395|FG001|Overall Study|Subject explanted|1|||
25270281|NCT01139775|50584404|FG000|Overall Study|Adverse Event|0|||
25127012|NCT01691014|50240009|FG000|Overall Study|Withdrawal by Subject|0|||
25127013|NCT01691014|50240010|FG001|Overall Study|Withdrawal by Subject|1|||
25127014|NCT01691014|50240011|FG002|Overall Study|Withdrawal by Subject|1|||
25127015|NCT01691014|50240012|FG003|Overall Study|Withdrawal by Subject|1|||
25127016|NCT01691014|50240009|FG000|Overall Study|Adverse Event|0|||
25270282|NCT01139775|50584405|FG001|Overall Study|Adverse Event|6|||
25270283|NCT01139775|50584406|FG002|Overall Study|Adverse Event|2|||
25270284|NCT01139775|50584404|FG000|Overall Study|Protocol Violation|0|||
25127017|NCT01691014|50240010|FG001|Overall Study|Adverse Event|5|||
25127018|NCT01691014|50240011|FG002|Overall Study|Adverse Event|1|||
25127019|NCT01691014|50240012|FG003|Overall Study|Adverse Event|1|||
25270285|NCT01139775|50584405|FG001|Overall Study|Protocol Violation|5|||
25127020|NCT01691014|50240009|FG000|Overall Study|Lack of Efficacy|2|||
25270286|NCT01139775|50584406|FG002|Overall Study|Protocol Violation|0|||
25270287|NCT01139775|50584404|FG000|Overall Study|Withdrawal by Subject|1|||
25270288|NCT01139775|50584405|FG001|Overall Study|Withdrawal by Subject|0|||
25270289|NCT01139775|50584406|FG002|Overall Study|Withdrawal by Subject|2|||
25270290|NCT01139775|50584404|FG000|Overall Study|Physician Decision|0|||
25270291|NCT01139775|50584405|FG001|Overall Study|Physician Decision|2|||
25270292|NCT01139775|50584406|FG002|Overall Study|Physician Decision|2|||
25127021|NCT01691014|50240010|FG001|Overall Study|Lack of Efficacy|3|||
25127022|NCT01691014|50240011|FG002|Overall Study|Lack of Efficacy|7|||
25127023|NCT01691014|50240012|FG003|Overall Study|Lack of Efficacy|0|||
25127024|NCT02245412|50240025|FG000|Treatment Period|Death|1|||
25127025|NCT02245412|50240026|FG001|Treatment Period|Death|1|||
25127026|NCT02245412|50240027|FG002|Treatment Period|Death|0|||
25127027|NCT02245412|50240025|FG000|Treatment Period|Physician Decision|1|||
25127028|NCT02245412|50240026|FG001|Treatment Period|Physician Decision|1|||
25127029|NCT02245412|50240027|FG002|Treatment Period|Physician Decision|0|||
25127030|NCT02245412|50240025|FG000|Treatment Period|Withdrawal by Subject|2|||
25127031|NCT02245412|50240026|FG001|Treatment Period|Withdrawal by Subject|1|||
25127032|NCT02245412|50240027|FG002|Treatment Period|Withdrawal by Subject|0|||
25127033|NCT02245412|50240025|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
25127034|NCT02245412|50240026|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
25127035|NCT02245412|50240027|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
25127036|NCT02245412|50240025|FG000|Follow-Up Period|Death|4|||
25127037|NCT02245412|50240026|FG001|Follow-Up Period|Death|2|||
25127038|NCT02245412|50240027|FG002|Follow-Up Period|Death|1|||
25127039|NCT02245412|50240025|FG000|Follow-Up Period|Physician Decision|1|||
25127040|NCT02245412|50240026|FG001|Follow-Up Period|Physician Decision|0|||
25127041|NCT02245412|50240027|FG002|Follow-Up Period|Physician Decision|0|||
25127042|NCT02245412|50240025|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
25127043|NCT02245412|50240026|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
25127044|NCT02245412|50240027|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
25127045|NCT02244944|50240035|FG000|Overall Study|Withdrawal by Subject|1|||
25127046|NCT02244944|50240035|FG000|Overall Study|Study Terminated|1|||
25127047|NCT01689532|50240041|FG000|Overall Study|Adverse Event|9|||
25127048|NCT01689532|50240042|FG001|Overall Study|Adverse Event|5|||
25127049|NCT01689532|50240041|FG000|Overall Study|Lack of Efficacy|2|||
25127050|NCT01689532|50240042|FG001|Overall Study|Lack of Efficacy|2|||
25127051|NCT01689532|50240041|FG000|Overall Study|Withdrawal by Subject|1|||
25127052|NCT01689532|50240042|FG001|Overall Study|Withdrawal by Subject|2|||
25127053|NCT01689532|50240041|FG000|Overall Study|Physician Decision|2|||
25127054|NCT01689532|50240042|FG001|Overall Study|Physician Decision|0|||
25127055|NCT01924689|50240054|FG000|Overall Study|Death|0|||
25127056|NCT01924689|50240055|FG001|Overall Study|Death|1|||
25127057|NCT01924689|50240056|FG002|Overall Study|Death|0|||
25127058|NCT01924689|50240057|FG003|Overall Study|Death|1|||
25127059|NCT01924689|50240058|FG004|Overall Study|Death|0|||
25270293|NCT01283516|50584425|FG000|Overall Study|Adverse Event|0|||
25270294|NCT01283516|50584426|FG001|Overall Study|Adverse Event|0|||
25270295|NCT01283516|50584427|FG002|Overall Study|Adverse Event|0|||
25270296|NCT01283516|50584428|FG003|Overall Study|Adverse Event|0|||
25270297|NCT01283516|50584429|FG004|Overall Study|Adverse Event|0|||
25270298|NCT01283516|50584430|FG005|Overall Study|Adverse Event|0|||
25270299|NCT01283516|50584431|FG006|Overall Study|Adverse Event|2|||
25270300|NCT01283516|50584432|FG007|Overall Study|Adverse Event|0|||
25270301|NCT01283516|50584433|FG008|Overall Study|Adverse Event|28|||
25270302|NCT01283516|50584425|FG000|Overall Study|Death|0|||
25270303|NCT01283516|50584426|FG001|Overall Study|Death|0|||
25270304|NCT01283516|50584427|FG002|Overall Study|Death|0|||
25270305|NCT01283516|50584428|FG003|Overall Study|Death|0|||
25270306|NCT01283516|50584429|FG004|Overall Study|Death|0|||
25270307|NCT01283516|50584430|FG005|Overall Study|Death|1|||
25270308|NCT01283516|50584431|FG006|Overall Study|Death|0|||
25127060|NCT01924689|50240059|FG005|Overall Study|Death|0|||
25127061|NCT01924689|50240054|FG000|Overall Study|Disease progression|0|||
25127062|NCT01924689|50240055|FG001|Overall Study|Disease progression|0|||
25127063|NCT01924689|50240056|FG002|Overall Study|Disease progression|2|||
25127064|NCT01924689|50240057|FG003|Overall Study|Disease progression|0|||
25127065|NCT01924689|50240058|FG004|Overall Study|Disease progression|3|||
25127066|NCT01924689|50240059|FG005|Overall Study|Disease progression|2|||
25127067|NCT01924689|50240054|FG000|Overall Study|New therapy or study|3|||
25127068|NCT01924689|50240055|FG001|Overall Study|New therapy or study|2|||
25127069|NCT01924689|50240056|FG002|Overall Study|New therapy or study|1|||
25270309|NCT01283516|50584432|FG007|Overall Study|Death|1|||
25270310|NCT01283516|50584433|FG008|Overall Study|Death|12|||
25270311|NCT01283516|50584425|FG000|Overall Study|Disease Progression|2|||
25270312|NCT01283516|50584426|FG001|Overall Study|Disease Progression|2|||
25270313|NCT01283516|50584427|FG002|Overall Study|Disease Progression|3|||
25270314|NCT01283516|50584428|FG003|Overall Study|Disease Progression|3|||
25127070|NCT01924689|50240057|FG003|Overall Study|New therapy or study|4|||
25270315|NCT01283516|50584429|FG004|Overall Study|Disease Progression|13|||
25270316|NCT01283516|50584430|FG005|Overall Study|Disease Progression|8|||
25270317|NCT01283516|50584431|FG006|Overall Study|Disease Progression|6|||
25270318|NCT01283516|50584432|FG007|Overall Study|Disease Progression|3|||
25270319|NCT01283516|50584433|FG008|Overall Study|Disease Progression|139|||
25270320|NCT01283516|50584425|FG000|Overall Study|Withdrawal by Subject|0|||
25270321|NCT01283516|50584426|FG001|Overall Study|Withdrawal by Subject|0|||
25270322|NCT01283516|50584427|FG002|Overall Study|Withdrawal by Subject|0|||
25270323|NCT01283516|50584428|FG003|Overall Study|Withdrawal by Subject|0|||
25270324|NCT01283516|50584429|FG004|Overall Study|Withdrawal by Subject|1|||
25270325|NCT01283516|50584430|FG005|Overall Study|Withdrawal by Subject|0|||
25270326|NCT01283516|50584431|FG006|Overall Study|Withdrawal by Subject|1|||
25270327|NCT01283516|50584432|FG007|Overall Study|Withdrawal by Subject|0|||
25270328|NCT01283516|50584433|FG008|Overall Study|Withdrawal by Subject|36|||
25270329|NCT01283516|50584425|FG000|Overall Study|Administrative problems|0|||
25270330|NCT01283516|50584426|FG001|Overall Study|Administrative problems|0|||
25270331|NCT01283516|50584427|FG002|Overall Study|Administrative problems|0|||
25127071|NCT01924689|50240058|FG004|Overall Study|New therapy or study|2|||
25127072|NCT01924689|50240059|FG005|Overall Study|New therapy or study|0|||
25127073|NCT01924689|50240054|FG000|Overall Study|Withdrawal of consent|0|||
25127074|NCT01924689|50240055|FG001|Overall Study|Withdrawal of consent|0|||
25127075|NCT01924689|50240056|FG002|Overall Study|Withdrawal of consent|1|||
25127076|NCT01924689|50240057|FG003|Overall Study|Withdrawal of consent|1|||
25127077|NCT01924689|50240058|FG004|Overall Study|Withdrawal of consent|0|||
25127078|NCT01924689|50240059|FG005|Overall Study|Withdrawal of consent|0|||
25127079|NCT01924689|50240054|FG000|Overall Study|Other|0|||
25127080|NCT01924689|50240055|FG001|Overall Study|Other|0|||
25127081|NCT01924689|50240056|FG002|Overall Study|Other|0|||
25127082|NCT01924689|50240057|FG003|Overall Study|Other|0|||
25127083|NCT01924689|50240058|FG004|Overall Study|Other|1|||
25127084|NCT01924689|50240059|FG005|Overall Study|Other|0|||
25127085|NCT01591330|50240077|FG000|Period 1|Adverse Event|1|||
25127086|NCT01591330|50240078|FG001|Period 1|Adverse Event|0|||
25127087|NCT01591330|50240079|FG002|Period 1|Adverse Event|0|||
25127088|NCT01591330|50240080|FG003|Period 1|Adverse Event|0|||
25127089|NCT01591330|50240077|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
25127090|NCT01591330|50240078|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
25127091|NCT01591330|50240079|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
25127092|NCT01591330|50240080|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
25127093|NCT01591330|50240077|FG000|Period 2|Adverse Event|1|||
25127094|NCT01591330|50240078|FG001|Period 2|Adverse Event|0|||
25127095|NCT01591330|50240079|FG002|Period 2|Adverse Event|0|||
25127096|NCT01591330|50240080|FG003|Period 2|Adverse Event|0|||
25127097|NCT01591096|50240090|FG000|Overall Study|Adverse Event|1|||
25127098|NCT01953003|50240096|FG000|Overall Study|Not treated|0|||
25127099|NCT01953003|50240097|FG001|Overall Study|Not treated|1|||
25127100|NCT01953003|50240096|FG000|Overall Study|Progressive disease|35|||
25270332|NCT01283516|50584428|FG003|Overall Study|Administrative problems|0|||
25270333|NCT01283516|50584429|FG004|Overall Study|Administrative problems|0|||
25270334|NCT01283516|50584430|FG005|Overall Study|Administrative problems|1|||
25270335|NCT01283516|50584431|FG006|Overall Study|Administrative problems|1|||
25270336|NCT01283516|50584432|FG007|Overall Study|Administrative problems|1|||
25270337|NCT01283516|50584433|FG008|Overall Study|Administrative problems|39|||
25270338|NCT01283516|50584425|FG000|Overall Study|Lost to Follow-up|0|||
25270339|NCT01283516|50584426|FG001|Overall Study|Lost to Follow-up|0|||
25270340|NCT01283516|50584427|FG002|Overall Study|Lost to Follow-up|0|||
25270341|NCT01283516|50584428|FG003|Overall Study|Lost to Follow-up|0|||
25270342|NCT01283516|50584429|FG004|Overall Study|Lost to Follow-up|0|||
25270343|NCT01283516|50584430|FG005|Overall Study|Lost to Follow-up|0|||
25270344|NCT01283516|50584431|FG006|Overall Study|Lost to Follow-up|0|||
25270345|NCT01283516|50584432|FG007|Overall Study|Lost to Follow-up|0|||
25270346|NCT01283516|50584433|FG008|Overall Study|Lost to Follow-up|1|||
25270347|NCT01137435|50584461|FG000|Overall Study|Lost to Follow-up|24|||
25270348|NCT01137435|50584461|FG000|Overall Study|Off label usage|4|||
25127101|NCT01953003|50240097|FG001|Overall Study|Progressive disease|45|||
25127102|NCT01953003|50240096|FG000|Overall Study|Related Adverse events|7|||
25127103|NCT01953003|50240097|FG001|Overall Study|Related Adverse events|2|||
25270349|NCT01283282|50584465|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
25270350|NCT01283282|50584466|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
25270351|NCT01283282|50584465|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
25270352|NCT01283282|50584466|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
25270353|NCT01283282|50584465|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
25009347|NCT00075725|50102302|FG008|Overall Study|Pt relocated|1|||
25127104|NCT01953003|50240096|FG000|Overall Study|Non-related adverse events|0|||
25127105|NCT01953003|50240097|FG001|Overall Study|Non-related adverse events|2|||
25127106|NCT01953003|50240096|FG000|Overall Study|Protocol Violation|0|||
25127107|NCT01953003|50240097|FG001|Overall Study|Protocol Violation|1|||
25127108|NCT01953003|50240096|FG000|Overall Study|Withdrawal by Subject|14|||
25270354|NCT01283282|50584466|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
25270355|NCT01282814|50584475|FG000|First Intervention|Emesis During Dosing Interval|0|||
25270356|NCT01282814|50584476|FG001|First Intervention|Emesis During Dosing Interval|3|||
25270357|NCT01282814|50584475|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
25270358|NCT01282814|50584476|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
25270359|NCT00941863|50584487|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
25270360|NCT00941863|50584488|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
25270361|NCT00941863|50584489|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
25270362|NCT00941863|50584490|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
25270363|NCT00941863|50584491|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
25270364|NCT00941863|50584487|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
25270365|NCT00941863|50584488|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
25270366|NCT00941863|50584489|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
25270367|NCT00941863|50584490|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
25270368|NCT00941863|50584491|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
25270369|NCT00941863|50584487|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
25270370|NCT00941863|50584488|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
25270371|NCT00941863|50584489|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
25270372|NCT00941863|50584490|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
25270373|NCT00941863|50584491|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
25270374|NCT00941863|50584487|FG000|Until Primary Completion Date (PCD)|Death|0|||
25270375|NCT00941863|50584488|FG001|Until Primary Completion Date (PCD)|Death|0|||
25270376|NCT00941863|50584489|FG002|Until Primary Completion Date (PCD)|Death|1|||
25270377|NCT00941863|50584490|FG003|Until Primary Completion Date (PCD)|Death|2|||
25270378|NCT00941863|50584491|FG004|Until Primary Completion Date (PCD)|Death|7|||
25270379|NCT00941863|50584487|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
25270380|NCT00941863|50584488|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
25270381|NCT00941863|50584489|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
25270382|NCT00941863|50584490|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
25270383|NCT00941863|50584491|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
25270384|NCT00941863|50584487|FG000|Continued After PCD|Withdrawal by Subject|0|||
25270385|NCT00941863|50584488|FG001|Continued After PCD|Withdrawal by Subject|0|||
25270386|NCT00941863|50584489|FG002|Continued After PCD|Withdrawal by Subject|0|||
25270387|NCT00941863|50584490|FG003|Continued After PCD|Withdrawal by Subject|0|||
25270388|NCT00941863|50584491|FG004|Continued After PCD|Withdrawal by Subject|1|||
25270389|NCT00941863|50584487|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
25270390|NCT00941863|50584488|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
25270391|NCT00941863|50584489|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
25270392|NCT00941863|50584490|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
25270393|NCT00941863|50584491|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
25270394|NCT01282424|50584507|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
25270395|NCT01282424|50584507|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
25270396|NCT01282424|50584507|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
25270397|NCT01282424|50584507|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
25270398|NCT01282424|50584507|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
25270399|NCT01282424|50584507|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
25270400|NCT01282424|50584507|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
25270401|NCT01282424|50584507|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
25270402|NCT01281956|50584511|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
25270403|NCT01281956|50584512|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
25270404|NCT01279850|50584521|FG000|Overall Study|Protocol Violation|50|||
25270405|NCT01279850|50584521|FG000|Overall Study|No Drug Administration Information|7|||
25270406|NCT01279850|50584521|FG000|Overall Study|No Visit After Treatment|34|||
25270407|NCT00949975|50584529|FG000|Overall Study|Voluntary discontinuation|6|||
25270408|NCT00949975|50584530|FG001|Overall Study|Voluntary discontinuation|5|||
25270409|NCT00949975|50584531|FG002|Overall Study|Voluntary discontinuation|3|||
25270410|NCT00949975|50584532|FG003|Overall Study|Voluntary discontinuation|6|||
25270411|NCT00949975|50584529|FG000|Overall Study|Adverse Event|11|||
25270412|NCT00949975|50584530|FG001|Overall Study|Adverse Event|11|||
25270413|NCT00949975|50584531|FG002|Overall Study|Adverse Event|10|||
25270414|NCT00949975|50584532|FG003|Overall Study|Adverse Event|10|||
25270415|NCT00949975|50584529|FG000|Overall Study|Safety reason|0|||
25270416|NCT00949975|50584530|FG001|Overall Study|Safety reason|1|||
25270417|NCT00949975|50584531|FG002|Overall Study|Safety reason|0|||
25270418|NCT00949975|50584532|FG003|Overall Study|Safety reason|0|||
25270419|NCT00949975|50584529|FG000|Overall Study|Study-specific criteria|0|||
25270420|NCT00949975|50584530|FG001|Overall Study|Study-specific criteria|1|||
25270421|NCT00949975|50584531|FG002|Overall Study|Study-specific criteria|1|||
25270422|NCT00949975|50584532|FG003|Overall Study|Study-specific criteria|0|||
25270423|NCT00949975|50584529|FG000|Overall Study|Incorrect enrolment|5|||
25270424|NCT00949975|50584530|FG001|Overall Study|Incorrect enrolment|10|||
25270425|NCT00949975|50584531|FG002|Overall Study|Incorrect enrolment|4|||
25270426|NCT00949975|50584532|FG003|Overall Study|Incorrect enrolment|7|||
25270427|NCT00949975|50584529|FG000|Overall Study|Severe non-compliance|3|||
25270428|NCT00949975|50584530|FG001|Overall Study|Severe non-compliance|1|||
25270429|NCT00949975|50584531|FG002|Overall Study|Severe non-compliance|0|||
25270430|NCT00949975|50584532|FG003|Overall Study|Severe non-compliance|2|||
25270431|NCT00949975|50584529|FG000|Overall Study|Lost to Follow-up|1|||
25270432|NCT00949975|50584530|FG001|Overall Study|Lost to Follow-up|0|||
25270433|NCT00949975|50584531|FG002|Overall Study|Lost to Follow-up|1|||
25270434|NCT00949975|50584532|FG003|Overall Study|Lost to Follow-up|3|||
25270435|NCT00949975|50584529|FG000|Overall Study|Other|1|||
25270436|NCT00949975|50584530|FG001|Overall Study|Other|0|||
25270437|NCT00949975|50584531|FG002|Overall Study|Other|0|||
25270438|NCT00949975|50584532|FG003|Overall Study|Other|0|||
25270439|NCT00939055|50584544|FG000|Overall Study|Discontinuation prior to procedure|4|||
25270440|NCT00939055|50584545|FG001|Overall Study|Discontinuation prior to procedure|0|||
25270441|NCT01136967|50584554|FG000|Overall Study|Adverse Event|9|||
25270442|NCT01136967|50584555|FG001|Overall Study|Adverse Event|12|||
25270443|NCT01136967|50584554|FG000|Overall Study|Participant Choice|8|||
25270444|NCT01136967|50584555|FG001|Overall Study|Participant Choice|3|||
25270445|NCT01136967|50584554|FG000|Overall Study|Lost to Follow-up|0|||
25270446|NCT01136967|50584555|FG001|Overall Study|Lost to Follow-up|1|||
25127109|NCT01953003|50240097|FG001|Overall Study|Withdrawal by Subject|4|||
25127110|NCT01952691|50240103|FG000|Overall Study|Lost to Follow-up|2|||
25127111|NCT01709500|50240109|FG000|Overall Study|Randomized but not treated|0|||
25127112|NCT01709500|50240110|FG001|Overall Study|Randomized but not treated|1|||
25127113|NCT01709500|50240109|FG000|Overall Study|Adverse Event|5|||
25127114|NCT01709500|50240110|FG001|Overall Study|Adverse Event|1|||
25127115|NCT01709500|50240109|FG000|Overall Study|Poor compliance to protocol|2|||
25127116|NCT01709500|50240110|FG001|Overall Study|Poor compliance to protocol|1|||
25127117|NCT01709500|50240109|FG000|Overall Study|Other|3|||
25127118|NCT01709500|50240110|FG001|Overall Study|Other|1|||
25127119|NCT01709500|50240109|FG000|Overall Study|Related to IMP administration|1|||
25127120|NCT01709500|50240110|FG001|Overall Study|Related to IMP administration|0|||
25127121|NCT01709500|50240109|FG000|Overall Study|Treatment ongoing|156|||
25127122|NCT01709500|50240110|FG001|Overall Study|Treatment ongoing|78|||
25127123|NCT01599806|50240118|FG000|Overall Study|Lost to Follow-up|20|||
25127124|NCT01599806|50240119|FG001|Overall Study|Lost to Follow-up|20|||
25127125|NCT01599806|50240118|FG000|Overall Study|Withdrawal by Subject|12|||
25127126|NCT01599806|50240119|FG001|Overall Study|Withdrawal by Subject|12|||
25127127|NCT01599806|50240118|FG000|Overall Study|Other Eligibility criteria|11|||
25127128|NCT01599806|50240119|FG001|Overall Study|Other Eligibility criteria|9|||
25127129|NCT01599325|50240125|FG000|Primary Parent Phase|Adverse Event|5|||
25270447|NCT01136967|50584554|FG000|Overall Study|Withdrawal by Subject|1|||
25270448|NCT01136967|50584555|FG001|Overall Study|Withdrawal by Subject|2|||
25270449|NCT01136967|50584554|FG000|Overall Study|Clinical Progression|3|||
25270450|NCT01136967|50584555|FG001|Overall Study|Clinical Progression|5|||
25270451|NCT01136967|50584554|FG000|Overall Study|Radiation|1|||
25270452|NCT01136967|50584555|FG001|Overall Study|Radiation|0|||
25270453|NCT01136967|50584554|FG000|Overall Study|Non-compliance|1|||
25270454|NCT01136967|50584555|FG001|Overall Study|Non-compliance|0|||
25270455|NCT01136967|50584554|FG000|Overall Study|Investigator's Choice|1|||
25127130|NCT01599325|50240125|FG000|Primary Parent Phase|Disease Progression|7|||
25127131|NCT01599325|50240125|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
25127132|NCT01599325|50240125|FG000|Primary Parent Phase|Death|13|||
25127133|NCT01599325|50240125|FG000|Primary Parent Phase|Protocol Violation|1|||
25127134|NCT01599325|50240125|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
25127135|NCT01599325|50240125|FG000|Primary Parent Phase|Other|2|||
25127136|NCT01599325|50240125|FG000|Extension Phase|Study Closure|1|||
25127137|NCT01599325|50240125|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
25127138|NCT01599325|50240125|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
25127139|NCT01599325|50240125|FG000|Extension Phase|Disease Progression|1|||
25127140|NCT01599325|50240125|FG000|Extension Phase|Withdrawal by Subject|8|||
25270456|NCT01136967|50584555|FG001|Overall Study|Investigator's Choice|1|||
25127141|NCT01924299|50240132|FG000|Period 2|Withdrawal by Subject|1|||
25127142|NCT01924299|50240133|FG001|Period 2|Withdrawal by Subject|0|||
25270457|NCT01136967|50584554|FG000|Overall Study|Increase in Lesion Size|0|||
25270458|NCT01136967|50584555|FG001|Overall Study|Increase in Lesion Size|2|||
25270459|NCT01136967|50584554|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
25127143|NCT01924299|50240132|FG000|Period 2|Adverse Event|0|||
25127144|NCT01924299|50240133|FG001|Period 2|Adverse Event|1|||
25127145|NCT02182999|50240147|FG000|Overall Study|Adverse Event|4|||
25127146|NCT02182999|50240148|FG001|Overall Study|Adverse Event|3|||
25127147|NCT02182999|50240147|FG000|Overall Study|Physician Decision|1|||
25127148|NCT02182999|50240148|FG001|Overall Study|Physician Decision|0|||
25270460|NCT01136967|50584555|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
25270461|NCT01218516|50584563|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
25270462|NCT01218516|50584564|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
25127149|NCT02243696|50240154|FG000|Overall Study|Death|282|||
25127150|NCT02243696|50240154|FG000|Overall Study|Withdrawal by Subject|79|||
25127151|NCT02243696|50240154|FG000|Overall Study|Lost to Follow-up|57|||
25127152|NCT02243696|50240154|FG000|Overall Study|Subject No Longer has Study System|42|||
25127153|NCT02243696|50240154|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
25127154|NCT02243696|50240154|FG000|Overall Study|Study Terminated for EP PASSION|961|||
25127155|NCT01598311|50240160|FG000|Overall Study|Physician Decision|4|||
25127156|NCT01598311|50240161|FG001|Overall Study|Physician Decision|5|||
25127157|NCT01598311|50240160|FG000|Overall Study|Adverse Event|9|||
25127158|NCT01598311|50240161|FG001|Overall Study|Adverse Event|13|||
25127159|NCT01598311|50240160|FG000|Overall Study|Lost to Follow-up|7|||
25127160|NCT01598311|50240161|FG001|Overall Study|Lost to Follow-up|12|||
25127161|NCT01598311|50240160|FG000|Overall Study|Withdrawal by Subject|9|||
25127162|NCT01598311|50240161|FG001|Overall Study|Withdrawal by Subject|13|||
25127163|NCT01598311|50240160|FG000|Overall Study|No reason provided.|0|||
25127164|NCT01598311|50240161|FG001|Overall Study|No reason provided.|5|||
25127165|NCT01598311|50240160|FG000|Overall Study|Randomized but never treated|8|||
25127166|NCT01598311|50240161|FG001|Overall Study|Randomized but never treated|5|||
25127167|NCT01598311|50240160|FG000|Overall Study|Treated but no confirmed CDAD|9|||
25127168|NCT01598311|50240161|FG001|Overall Study|Treated but no confirmed CDAD|8|||
25127169|NCT01598311|50240160|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
25127170|NCT01598311|50240161|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
25127171|NCT02182843|50240167|FG000|Overall Study|Withdrawal by Subject|7|||
25127172|NCT02182843|50240167|FG000|Overall Study|Lost to Follow-up|2|||
25127173|NCT02182843|50240167|FG000|Overall Study|Adverse Event|1|||
25127174|NCT02208050|50240173|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
25127175|NCT02208050|50240174|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
25127176|NCT02978222|50240196|FG000|Overall Study|Withdrawal by Subject|2|||
25127177|NCT02978222|50240197|FG001|Overall Study|Withdrawal by Subject|2|||
25127178|NCT02978222|50240196|FG000|Overall Study|Physician Decision|2|||
25127179|NCT02978222|50240197|FG001|Overall Study|Physician Decision|0|||
25127180|NCT02978222|50240196|FG000|Overall Study|Adverse Event|0|||
25127181|NCT02978222|50240197|FG001|Overall Study|Adverse Event|1|||
25127182|NCT02978222|50240196|FG000|Overall Study|Death|1|||
25127183|NCT02978222|50240197|FG001|Overall Study|Death|0|||
25127184|NCT02978222|50240196|FG000|Overall Study|Disease Progression|32|||
25127185|NCT02978222|50240197|FG001|Overall Study|Disease Progression|32|||
25127186|NCT02978222|50240196|FG000|Overall Study|Early Study Termination|24|||
25127187|NCT02978222|50240197|FG001|Overall Study|Early Study Termination|21|||
25270463|NCT01218516|50584565|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
25270464|NCT01218516|50584566|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
25270465|NCT01218516|50584563|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
25270466|NCT01218516|50584564|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
25270467|NCT01218516|50584565|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
25270468|NCT01218516|50584566|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
25270469|NCT01218516|50584563|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
25270470|NCT01218516|50584564|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
25270471|NCT01218516|50584565|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
25270472|NCT01218516|50584566|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
25270473|NCT01218516|50584563|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
25270474|NCT01218516|50584564|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
25270475|NCT01218516|50584565|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
25270476|NCT01218516|50584566|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
25270477|NCT01218516|50584563|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
25270478|NCT01218516|50584564|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
25270479|NCT01218516|50584565|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
25270480|NCT01218516|50584566|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
25270481|NCT01218516|50584563|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
25270482|NCT01218516|50584564|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
25270483|NCT01218516|50584565|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
25270484|NCT01218516|50584566|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
25270485|NCT01218516|50584563|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
25127188|NCT02181673|50240205|FG000|Up to Week 24|Adverse Event|2|||
25127189|NCT02181673|50240206|FG001|Up to Week 24|Adverse Event|0|||
25127190|NCT02181673|50240207|FG002|Up to Week 24|Adverse Event|3|||
25127191|NCT02181673|50240205|FG000|Up to Week 24|Death|1|||
25127192|NCT02181673|50240206|FG001|Up to Week 24|Death|0|||
25127193|NCT02181673|50240207|FG002|Up to Week 24|Death|0|||
25127194|NCT02181673|50240205|FG000|Up to Week 24|Lack of Efficacy|1|||
25127195|NCT02181673|50240206|FG001|Up to Week 24|Lack of Efficacy|0|||
25127196|NCT02181673|50240207|FG002|Up to Week 24|Lack of Efficacy|0|||
25270486|NCT01218516|50584564|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
25270487|NCT01218516|50584565|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
25270488|NCT01218516|50584566|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
25270489|NCT01218516|50584563|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
25270490|NCT01218516|50584564|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
25270491|NCT01218516|50584565|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
25270492|NCT01218516|50584566|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
25270493|NCT01218516|50584563|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
25270494|NCT01218516|50584564|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
25270495|NCT01218516|50584565|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
25270496|NCT01218516|50584566|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
25270497|NCT01218516|50584563|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
25270498|NCT01218516|50584564|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
25270499|NCT01218516|50584565|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
25270500|NCT01218516|50584566|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
25270501|NCT01218516|50584563|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
25270502|NCT01218516|50584564|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
25270503|NCT01218516|50584565|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
25270504|NCT01218516|50584566|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
25270505|NCT01218516|50584563|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
25270506|NCT01218516|50584564|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
25270507|NCT01218516|50584565|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
25270508|NCT01218516|50584566|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
25270509|NCT00938431|50584579|FG000|Overall Study|Adverse Event|5|||
25270510|NCT00938431|50584580|FG001|Overall Study|Adverse Event|8|||
25270511|NCT00938431|50584581|FG002|Overall Study|Adverse Event|6|||
25270512|NCT00938431|50584579|FG000|Overall Study|Lack of Efficacy|0|||
25270513|NCT00938431|50584580|FG001|Overall Study|Lack of Efficacy|1|||
25270514|NCT00938431|50584581|FG002|Overall Study|Lack of Efficacy|0|||
25270515|NCT00938431|50584579|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
25270516|NCT00938431|50584580|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
25270517|NCT00938431|50584581|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
25270518|NCT00938431|50584579|FG000|Overall Study|Dosing compliance issue|0|||
25270519|NCT00938431|50584580|FG001|Overall Study|Dosing compliance issue|0|||
25270520|NCT00938431|50584581|FG002|Overall Study|Dosing compliance issue|1|||
25270521|NCT00938431|50584579|FG000|Overall Study|Reached maximum dose early|0|||
25270522|NCT00938431|50584580|FG001|Overall Study|Reached maximum dose early|0|||
25270523|NCT00938431|50584581|FG002|Overall Study|Reached maximum dose early|1|||
25270524|NCT01136811|50584593|FG000|Overall Study|Physician Decision|11|||
25270525|NCT00949117|50584599|FG000|Overall Study|Lack of Efficacy|2|||
25270526|NCT00949117|50584600|FG001|Overall Study|Lack of Efficacy|3|||
25270527|NCT00949117|50584599|FG000|Overall Study|Protocol Violation|1|||
25270528|NCT00949117|50584600|FG001|Overall Study|Protocol Violation|1|||
25270529|NCT00949117|50584599|FG000|Overall Study|Adverse Event|0|||
25270530|NCT00949117|50584600|FG001|Overall Study|Adverse Event|1|||
25270531|NCT00938041|50584608|FG000|Overall Study|Lost to Follow-up|6|||
25270532|NCT00938041|50584608|FG000|Overall Study|Received Alternative Therapy|1|||
25270533|NCT00938041|50584608|FG000|Overall Study|Progressive Disease|5|||
25270534|NCT00938041|50584608|FG000|Overall Study|Death|12|||
25270535|NCT00938041|50584608|FG000|Overall Study|Adrenal Insufficiency|3|||
25270536|NCT01218438|50584612|FG000|Epoch 1|Physician Decision|2|||
25270537|NCT01218438|50584612|FG000|Epoch 1|Adverse Event|1|||
25270538|NCT01218438|50584612|FG000|Epoch 3|Withdrawal by Subject|3|||
25270539|NCT01218438|50584612|FG000|Epoch 3|Adverse Event|1|||
25270540|NCT01218438|50584612|FG000|Epoch 4|Physician Decision|1|||
25270541|NCT01218438|50584612|FG000|Epoch 4|Withdrawal by Subject|2|||
25270542|NCT00935701|50584686|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
25270543|NCT01277510|50584693|FG000|Double-blind Phase|Non-compliance|0|||
25270544|NCT01277510|50584694|FG001|Double-blind Phase|Non-compliance|1|||
25270545|NCT01277510|50584693|FG000|Double-blind Phase|Adverse Event|1|||
25270546|NCT01277510|50584694|FG001|Double-blind Phase|Adverse Event|0|||
25270547|NCT01277510|50584693|FG000|Double-blind Phase|Withdrawal by Subject|2|||
25270548|NCT01277510|50584694|FG001|Double-blind Phase|Withdrawal by Subject|0|||
25270549|NCT01277510|50584693|FG000|Double-blind Phase|Administrative decision|7|||
25270550|NCT01277510|50584694|FG001|Double-blind Phase|Administrative decision|9|||
25270551|NCT01277510|50584693|FG000|Double-blind Phase|Death|0|||
25270552|NCT01277510|50584694|FG001|Double-blind Phase|Death|1|||
25270553|NCT01277510|50584693|FG000|Double-blind Phase|Protocol-specified criteria|2|||
25270554|NCT01277510|50584694|FG001|Double-blind Phase|Protocol-specified criteria|6|||
25178523|NCT01464307|50323812|FG000|Main Period|Predefined discontinuation criteria|2|||
25178524|NCT01464307|50323813|FG001|Main Period|Predefined discontinuation criteria|1|||
25270555|NCT01277510|50584693|FG000|Double-blind Phase|Other|1|||
25270556|NCT01277510|50584694|FG001|Double-blind Phase|Other|1|||
25270557|NCT01277510|50584693|FG000|Open-label Phase|Administrative decision|4|||
25270558|NCT01277510|50584694|FG001|Open-label Phase|Administrative decision|3|||
25270559|NCT01277510|50584693|FG000|Open-label Phase|Protocol-specified criteria|1|||
25270560|NCT01277510|50584694|FG001|Open-label Phase|Protocol-specified criteria|0|||
25270561|NCT01277510|50584693|FG000|Open-label Phase|Never received investigational product|2|||
25270562|NCT01277510|50584694|FG001|Open-label Phase|Never received investigational product|0|||
25270563|NCT00937495|50584702|FG000|Overall Study|Protocol Violation|2|||
25270564|NCT01268306|50584706|FG000|Overall Study|Lost to Follow-up|1|||
25270565|NCT00936715|50584710|FG000|Overall Study|Investigators Discretion|1|||
25270566|NCT00936715|50584710|FG000|Overall Study|Protocol Violation|1|||
25270567|NCT00936715|50584710|FG000|Overall Study|Safety or Tolerability Reasons|4|||
25270568|NCT01267994|50584714|FG000|Overall Study|Adverse Event|2|||
25270569|NCT00934843|50584721|FG000|Overall Study|Protocol Violation|0|||
25127197|NCT02181673|50240205|FG000|Up to Week 24|Lost to Follow-up|1|||
25127198|NCT02181673|50240206|FG001|Up to Week 24|Lost to Follow-up|0|||
25127199|NCT02181673|50240207|FG002|Up to Week 24|Lost to Follow-up|0|||
25127200|NCT02181673|50240205|FG000|Up to Week 24|Physician Decision|0|||
25127201|NCT02181673|50240206|FG001|Up to Week 24|Physician Decision|0|||
25127202|NCT02181673|50240207|FG002|Up to Week 24|Physician Decision|3|||
25127203|NCT02181673|50240205|FG000|Up to Week 24|Withdrawal by Subject|10|||
25127204|NCT02181673|50240206|FG001|Up to Week 24|Withdrawal by Subject|0|||
25127205|NCT02181673|50240207|FG002|Up to Week 24|Withdrawal by Subject|1|||
25127206|NCT02181673|50240205|FG000|Up to Week 24|Other|2|||
25127207|NCT02181673|50240206|FG001|Up to Week 24|Other|0|||
25127208|NCT02181673|50240207|FG002|Up to Week 24|Other|3|||
25127209|NCT02181673|50240205|FG000|Up to Week 24|Randomized not Treated|0|||
25127210|NCT02181673|50240206|FG001|Up to Week 24|Randomized not Treated|0|||
25127211|NCT02181673|50240207|FG002|Up to Week 24|Randomized not Treated|1|||
25127212|NCT02181673|50240205|FG000|Week 24-Week 60|Adverse Event|0|||
25127213|NCT02181673|50240206|FG001|Week 24-Week 60|Adverse Event|4|||
25127214|NCT02181673|50240207|FG002|Week 24-Week 60|Adverse Event|10|||
25127215|NCT02181673|50240205|FG000|Week 24-Week 60|Other|0|||
25127216|NCT02181673|50240206|FG001|Week 24-Week 60|Other|2|||
25127217|NCT02181673|50240207|FG002|Week 24-Week 60|Other|1|||
25127218|NCT02181673|50240205|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
25127219|NCT02181673|50240206|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
25127220|NCT02181673|50240207|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
25127221|NCT02181673|50240205|FG000|Week 24-Week 60|Pregnancy|0|||
25127222|NCT02181673|50240206|FG001|Week 24-Week 60|Pregnancy|0|||
25127223|NCT02181673|50240207|FG002|Week 24-Week 60|Pregnancy|1|||
25270570|NCT00934843|50584722|FG001|Overall Study|Protocol Violation|1|||
25270571|NCT01266902|50584730|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
25270572|NCT01266902|50584731|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
25270573|NCT01266902|50584732|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
25270574|NCT01266902|50584730|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
25270575|NCT01266902|50584731|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
25270576|NCT01266902|50584732|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
25270577|NCT01266902|50584730|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
25270578|NCT01266902|50584731|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
25270579|NCT01266902|50584732|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
25270580|NCT01266902|50584730|FG000|Period 1 (Main Study)|Adverse Event|3|||
25270581|NCT01266902|50584731|FG001|Period 1 (Main Study)|Adverse Event|11|||
25270582|NCT01266902|50584732|FG002|Period 1 (Main Study)|Adverse Event|0|||
25270583|NCT01266902|50584730|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
25270584|NCT01266902|50584731|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
25270585|NCT01266902|50584732|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
25270586|NCT01266902|50584730|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
25270587|NCT01266902|50584731|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
25270588|NCT01266902|50584732|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
25270589|NCT01266902|50584730|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
25270590|NCT01266902|50584731|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
25127224|NCT02181673|50240205|FG000|Week 24-Week 60|Lack of Efficacy|0|||
25127225|NCT02181673|50240206|FG001|Week 24-Week 60|Lack of Efficacy|0|||
25270591|NCT01266902|50584732|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
25270592|NCT01266902|50584730|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
25127226|NCT02181673|50240207|FG002|Week 24-Week 60|Lack of Efficacy|1|||
25127227|NCT02181673|50240205|FG000|Week 24-Week 60|Lost to Follow-up|0|||
25127228|NCT02181673|50240206|FG001|Week 24-Week 60|Lost to Follow-up|0|||
25127229|NCT02181673|50240207|FG002|Week 24-Week 60|Lost to Follow-up|1|||
25127230|NCT02181673|50240205|FG000|Week 24-Week 60|Physician Decision|0|||
25127231|NCT02181673|50240206|FG001|Week 24-Week 60|Physician Decision|0|||
25127232|NCT02181673|50240207|FG002|Week 24-Week 60|Physician Decision|1|||
25270593|NCT01266902|50584731|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
25270594|NCT01266902|50584732|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
25270595|NCT01266902|50584730|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
25270596|NCT01266902|50584731|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
25270597|NCT01266902|50584732|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
25270598|NCT01266902|50584730|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
25270599|NCT01266902|50584731|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
25270600|NCT01266902|50584732|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
25270601|NCT01266824|50584742|FG000|Overall Study|Study terminated prior to completion|2|||
25270602|NCT01266824|50584743|FG001|Overall Study|Study terminated prior to completion|3|||
25270603|NCT01266590|50584749|FG000|Overall Study|Adverse Event|3|||
25270604|NCT01266590|50584749|FG000|Overall Study|Lost to Follow-up|1|||
25270605|NCT01266590|50584749|FG000|Overall Study|Withdrawal by Subject|1|||
25270606|NCT01266590|50584749|FG000|Overall Study|Physician Decision|1|||
25270607|NCT01266122|50584758|FG000|Overall Study|Lost to Follow-up|6|||
25270608|NCT01266122|50584759|FG001|Overall Study|Lost to Follow-up|6|||
25270609|NCT01265498|50584767|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
25270610|NCT01265498|50584768|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
25270611|NCT01265420|50584774|FG000|Overall Study|Lost to Follow-up|1|||
25270612|NCT01264718|50584780|FG000|Overall Study|Lost to Follow-up|3|||
25270613|NCT01264718|50584781|FG001|Overall Study|Lost to Follow-up|2|||
25270614|NCT01264718|50584780|FG000|Overall Study|Withdrawal by Subject|9|||
25270615|NCT01264718|50584781|FG001|Overall Study|Withdrawal by Subject|15|||
25270616|NCT01264718|50584780|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
25270617|NCT01264718|50584781|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
25270618|NCT01264016|50584787|FG000|Overall Study|Withdrawal by Subject|1|||
25270619|NCT01264016|50584787|FG000|Overall Study|Felt faint at sight of blood|1|||
25270620|NCT01263782|50584796|FG000|Overall Study|Death|0|||
25270621|NCT01263782|50584797|FG001|Overall Study|Death|0|||
25270622|NCT01263782|50584798|FG002|Overall Study|Death|1|||
25270623|NCT01263782|50584799|FG003|Overall Study|Death|0|||
25270624|NCT01263782|50584796|FG000|Overall Study|Progressive disease|0|||
25270625|NCT01263782|50584797|FG001|Overall Study|Progressive disease|0|||
25270626|NCT01263782|50584798|FG002|Overall Study|Progressive disease|0|||
25270627|NCT01263782|50584799|FG003|Overall Study|Progressive disease|1|||
25270628|NCT01263782|50584796|FG000|Overall Study|Too early|0|||
25270629|NCT01263782|50584797|FG001|Overall Study|Too early|0|||
25270630|NCT01263782|50584798|FG002|Overall Study|Too early|1|||
25270631|NCT01263782|50584799|FG003|Overall Study|Too early|0|||
25270632|NCT01263782|50584796|FG000|Overall Study|Inevaluable|0|||
25270633|NCT01263782|50584797|FG001|Overall Study|Inevaluable|0|||
25270634|NCT01263782|50584798|FG002|Overall Study|Inevaluable|1|||
25270635|NCT01263782|50584799|FG003|Overall Study|Inevaluable|0|||
25270636|NCT01263704|50584809|FG000|Overall Study|Progressive disease|18|||
25270637|NCT01263704|50584809|FG000|Overall Study|Adverse Event|3|||
25270638|NCT01263704|50584809|FG000|Overall Study|Death|2|||
25270639|NCT01263704|50584809|FG000|Overall Study|Patient withdrew consent|2|||
25270640|NCT01263704|50584809|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
25270641|NCT01263704|50584809|FG000|Overall Study|Lost to Follow-up|1|||
25270642|NCT01263704|50584809|FG000|Overall Study|Colon metastases|1|||
25270643|NCT01263704|50584809|FG000|Overall Study|Principal Investigator (PI) decision|1|||
25270644|NCT01263470|50584819|FG000|Overall Study|Adverse Event|2|||
25270645|NCT01263470|50584820|FG001|Overall Study|Adverse Event|2|||
25270646|NCT01263470|50584821|FG002|Overall Study|Adverse Event|1|||
25270647|NCT01263470|50584822|FG003|Overall Study|Adverse Event|1|||
25270648|NCT01263470|50584823|FG004|Overall Study|Adverse Event|2|||
25270649|NCT01263470|50584824|FG005|Overall Study|Adverse Event|2|||
25270650|NCT01263470|50584819|FG000|Overall Study|Protocol Violation|0|||
25270651|NCT01263470|50584820|FG001|Overall Study|Protocol Violation|1|||
25270652|NCT01263470|50584821|FG002|Overall Study|Protocol Violation|0|||
25270653|NCT01263470|50584822|FG003|Overall Study|Protocol Violation|0|||
25270654|NCT01263470|50584823|FG004|Overall Study|Protocol Violation|0|||
25270655|NCT01263470|50584824|FG005|Overall Study|Protocol Violation|1|||
25270656|NCT01263470|50584819|FG000|Overall Study|Withdrawal by Subject|0|||
25270657|NCT01263470|50584820|FG001|Overall Study|Withdrawal by Subject|1|||
25270658|NCT01263470|50584821|FG002|Overall Study|Withdrawal by Subject|1|||
25270659|NCT01263470|50584822|FG003|Overall Study|Withdrawal by Subject|2|||
25270660|NCT01263470|50584823|FG004|Overall Study|Withdrawal by Subject|0|||
25270661|NCT01263470|50584824|FG005|Overall Study|Withdrawal by Subject|2|||
25270662|NCT01263470|50584819|FG000|Overall Study|Lack of Efficacy|0|||
25270663|NCT01263470|50584820|FG001|Overall Study|Lack of Efficacy|0|||
25270664|NCT01263470|50584821|FG002|Overall Study|Lack of Efficacy|2|||
25270665|NCT01263470|50584822|FG003|Overall Study|Lack of Efficacy|0|||
25270666|NCT01263470|50584823|FG004|Overall Study|Lack of Efficacy|0|||
25270667|NCT01263470|50584824|FG005|Overall Study|Lack of Efficacy|0|||
25270668|NCT01263470|50584819|FG000|Overall Study|Participant Unavailability|0|||
25270669|NCT01263470|50584820|FG001|Overall Study|Participant Unavailability|1|||
25127233|NCT02131129|50240216|FG000|Overall Study|Withdrawal by Subject|1|||
25127234|NCT02131129|50240217|FG001|Overall Study|Withdrawal by Subject|0|||
25127235|NCT02152345|50240225|FG000|Overall Study|Case Cancellations|2|||
25127236|NCT02152345|50240226|FG001|Overall Study|Case Cancellations|4|||
25127237|NCT02152345|50240225|FG000|Overall Study|Withdrawal by Subject|2|||
25127238|NCT02152345|50240226|FG001|Overall Study|Withdrawal by Subject|1|||
25127239|NCT02180659|50240234|FG000|Overall Study|Adverse Event|1|||
25127240|NCT02180659|50240235|FG001|Overall Study|Adverse Event|0|||
25127241|NCT02180659|50240234|FG000|Overall Study|Lost to Follow-up|4|||
25127242|NCT02180659|50240235|FG001|Overall Study|Lost to Follow-up|2|||
25127243|NCT02180659|50240234|FG000|Overall Study|Subject incarcerated during conduct|1|||
25127244|NCT02180659|50240235|FG001|Overall Study|Subject incarcerated during conduct|0|||
25127245|NCT02180659|50240234|FG000|Overall Study|Withdrawal by Subject|0|||
25127246|NCT02180659|50240235|FG001|Overall Study|Withdrawal by Subject|2|||
25127247|NCT02180659|50240234|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
25127248|NCT02180659|50240235|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
25127249|NCT02130427|50240241|FG000|Overall Study|Imaging results not interpretable|30|||
25127250|NCT02207816|50240248|FG000|Overall Study|Serious Adverse Event|0|||
25127251|NCT02207816|50240249|FG001|Overall Study|Serious Adverse Event|5|||
25127252|NCT02207816|50240250|FG002|Overall Study|Serious Adverse Event|2|||
25127253|NCT02207816|50240248|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
25127254|NCT02207816|50240249|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
25127255|NCT02207816|50240250|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
25127256|NCT02207816|50240248|FG000|Overall Study|Withdrawal by Subject|4|||
25127257|NCT02207816|50240249|FG001|Overall Study|Withdrawal by Subject|9|||
25127258|NCT02207816|50240250|FG002|Overall Study|Withdrawal by Subject|7|||
25127259|NCT02207816|50240248|FG000|Overall Study|Migrated/Moved From Study Area|41|||
25127260|NCT02207816|50240249|FG001|Overall Study|Migrated/Moved From Study Area|60|||
25127261|NCT02207816|50240250|FG002|Overall Study|Migrated/Moved From Study Area|51|||
25127262|NCT02207816|50240248|FG000|Overall Study|Lost to Follow-up|3|||
25127263|NCT02207816|50240249|FG001|Overall Study|Lost to Follow-up|9|||
25127264|NCT02207816|50240250|FG002|Overall Study|Lost to Follow-up|1|||
25127265|NCT02207816|50240248|FG000|Overall Study|Other|1|||
25127266|NCT02207816|50240249|FG001|Overall Study|Other|2|||
25127267|NCT02207816|50240250|FG002|Overall Study|Other|4|||
25127268|NCT02241512|50240263|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
25127269|NCT02241512|50240264|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
25127270|NCT02205476|50240272|FG000|Overall Study|Study termination by Sponsor|7|||
25127271|NCT02205476|50240273|FG001|Overall Study|Study termination by Sponsor|3|||
25127272|NCT01709110|50240287|FG000|Overall Study|Adverse Event|56|||
25127273|NCT01709110|50240288|FG001|Overall Study|Adverse Event|48|||
25127274|NCT01709110|50240287|FG000|Overall Study|Death|14|||
25127275|NCT01709110|50240288|FG001|Overall Study|Death|6|||
25127276|NCT01709110|50240287|FG000|Overall Study|Lost to Follow-up|7|||
25127277|NCT01709110|50240288|FG001|Overall Study|Lost to Follow-up|5|||
25127278|NCT01709110|50240287|FG000|Overall Study|Protocol Violation|4|||
25127279|NCT01709110|50240288|FG001|Overall Study|Protocol Violation|6|||
25127280|NCT01709110|50240287|FG000|Overall Study|Withdrawal by Subject|96|||
25127281|NCT01709110|50240288|FG001|Overall Study|Withdrawal by Subject|89|||
25127282|NCT01709110|50240287|FG000|Overall Study|Physician Decision|4|||
25127283|NCT01709110|50240288|FG001|Overall Study|Physician Decision|10|||
25127284|NCT01709110|50240287|FG000|Overall Study|Sponsor Decision|2|||
25127285|NCT01709110|50240288|FG001|Overall Study|Sponsor Decision|2|||
25127286|NCT01709110|50240287|FG000|Overall Study|Lack of Efficacy|1|||
25127287|NCT01709110|50240288|FG001|Overall Study|Lack of Efficacy|1|||
25127288|NCT01709110|50240287|FG000|Overall Study|Caregiver Decision|1|||
25127289|NCT01709110|50240288|FG001|Overall Study|Caregiver Decision|1|||
25127290|NCT02240108|50240296|FG000|Overall Study|Other than specified|8|||
25127291|NCT02240108|50240297|FG001|Overall Study|Other than specified|6|||
25127292|NCT02240108|50240296|FG000|Overall Study|Adverse Event|1|||
25127293|NCT02240108|50240297|FG001|Overall Study|Adverse Event|9|||
25127294|NCT02240108|50240296|FG000|Overall Study|Pregnancy|1|||
25127295|NCT02240108|50240297|FG001|Overall Study|Pregnancy|0|||
25127296|NCT02240108|50240296|FG000|Overall Study|Withdrawal by Subject|4|||
25270670|NCT01263470|50584821|FG002|Overall Study|Participant Unavailability|0|||
25127297|NCT02240108|50240297|FG001|Overall Study|Withdrawal by Subject|9|||
25127298|NCT02240108|50240296|FG000|Overall Study|StudyTerminated by Sponsor|0|||
25127299|NCT02240108|50240297|FG001|Overall Study|StudyTerminated by Sponsor|1|||
25127300|NCT02239640|50240303|FG000|Overall Study|Withdrawal by Subject|3|||
25127301|NCT02239640|50240303|FG000|Overall Study|Lost to Follow-up|72|||
25127302|NCT02239640|50240303|FG000|Overall Study|Death|142|||
25127303|NCT01590628|50240315|FG000|Overall Study|Death|2|||
25127304|NCT01590628|50240316|FG001|Overall Study|Death|0|||
25127305|NCT02130193|50240328|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
25127306|NCT02130193|50240329|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
25127307|NCT02130193|50240330|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
25127308|NCT02130193|50240328|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
25127309|NCT02130193|50240329|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
25127310|NCT02130193|50240330|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
25127311|NCT02130193|50240328|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
25127312|NCT02130193|50240329|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
25127313|NCT02130193|50240330|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
25127314|NCT02130193|50240328|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
25127315|NCT02130193|50240329|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
25127316|NCT02130193|50240330|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
25127317|NCT01590082|50240341|FG000|Overall Study|Withdrawal by Subject|1|||
25127318|NCT01590082|50240342|FG001|Overall Study|Withdrawal by Subject|0|||
25127319|NCT01590082|50240341|FG000|Overall Study|Ineligible|1|||
25127320|NCT01590082|50240342|FG001|Overall Study|Ineligible|0|||
25127321|NCT01631474|50240353|FG000|Overall Study|Lost to Follow-up|8|||
25127322|NCT01631474|50240354|FG001|Overall Study|Lost to Follow-up|5|||
25127323|NCT01631474|50240355|FG002|Overall Study|Lost to Follow-up|7|||
25127324|NCT01631474|50240356|FG003|Overall Study|Lost to Follow-up|5|||
25127325|NCT01631474|50240357|FG004|Overall Study|Lost to Follow-up|5|||
25127326|NCT01631474|50240353|FG000|Overall Study|Withdrawal by Subject|4|||
25127327|NCT01631474|50240354|FG001|Overall Study|Withdrawal by Subject|4|||
25127328|NCT01631474|50240355|FG002|Overall Study|Withdrawal by Subject|2|||
25127329|NCT01631474|50240356|FG003|Overall Study|Withdrawal by Subject|6|||
25009348|NCT00075725|50102303|FG009|Overall Study|Pt relocated|0|||
25009349|NCT00075725|50102304|FG010|Overall Study|Pt relocated|0|||
25009350|NCT00075725|50102305|FG011|Overall Study|Pt relocated|0|||
25009351|NCT00075725|50102294|FG000|Overall Study|Institution Terminated|0|||
25127330|NCT01631474|50240357|FG004|Overall Study|Withdrawal by Subject|5|||
25127331|NCT01631474|50240353|FG000|Overall Study|Lack of Efficacy|2|||
25270671|NCT01263470|50584822|FG003|Overall Study|Participant Unavailability|0|||
25270672|NCT01263470|50584823|FG004|Overall Study|Participant Unavailability|0|||
25270673|NCT01263470|50584824|FG005|Overall Study|Participant Unavailability|0|||
25270674|NCT01263470|50584819|FG000|Overall Study|Study Drug Non-compliance|0|||
25270675|NCT01263470|50584820|FG001|Overall Study|Study Drug Non-compliance|0|||
25270676|NCT01263470|50584821|FG002|Overall Study|Study Drug Non-compliance|0|||
25270677|NCT01263470|50584822|FG003|Overall Study|Study Drug Non-compliance|0|||
25270678|NCT01263470|50584823|FG004|Overall Study|Study Drug Non-compliance|1|||
25270679|NCT01263470|50584824|FG005|Overall Study|Study Drug Non-compliance|0|||
25270680|NCT01262456|50584841|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
25270681|NCT01262456|50584842|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
25270682|NCT01262456|50584843|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
25270683|NCT01262456|50584841|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
25127332|NCT01631474|50240354|FG001|Overall Study|Lack of Efficacy|2|||
25127333|NCT01631474|50240355|FG002|Overall Study|Lack of Efficacy|0|||
25127334|NCT01631474|50240356|FG003|Overall Study|Lack of Efficacy|0|||
25127335|NCT01631474|50240357|FG004|Overall Study|Lack of Efficacy|2|||
25127336|NCT01631474|50240353|FG000|Overall Study|Noncompliance with Study Drug|0|||
25127337|NCT01631474|50240354|FG001|Overall Study|Noncompliance with Study Drug|0|||
25127338|NCT01631474|50240355|FG002|Overall Study|Noncompliance with Study Drug|0|||
25127339|NCT01631474|50240356|FG003|Overall Study|Noncompliance with Study Drug|0|||
25127340|NCT01631474|50240357|FG004|Overall Study|Noncompliance with Study Drug|1|||
25127341|NCT01631474|50240353|FG000|Overall Study|Adverse Event|0|||
25270684|NCT01262456|50584842|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
25270685|NCT01262456|50584843|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
25270686|NCT01262456|50584841|FG000|3-Month Double-Blind Period|Adverse Event|6|||
25127342|NCT01631474|50240354|FG001|Overall Study|Adverse Event|1|||
25127343|NCT01631474|50240355|FG002|Overall Study|Adverse Event|0|||
25127344|NCT01631474|50240356|FG003|Overall Study|Adverse Event|0|||
25127345|NCT01631474|50240357|FG004|Overall Study|Adverse Event|0|||
25127346|NCT02203916|50240372|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
25127347|NCT02203916|50240373|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
25270687|NCT01262456|50584842|FG001|3-Month Double-Blind Period|Adverse Event|4|||
25127348|NCT02203916|50240374|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
25127349|NCT02203916|50240372|FG000|Overall Study|Major Protocol Deviation|1|||
25127350|NCT02203916|50240373|FG001|Overall Study|Major Protocol Deviation|1|||
25127351|NCT02203916|50240374|FG002|Overall Study|Major Protocol Deviation|0|||
25127352|NCT02203916|50240372|FG000|Overall Study|Lost to Follow-up|0|||
25127353|NCT02203916|50240373|FG001|Overall Study|Lost to Follow-up|1|||
25127354|NCT02203916|50240374|FG002|Overall Study|Lost to Follow-up|0|||
25127355|NCT02203916|50240372|FG000|Overall Study|Voluntary Withdrawal|3|||
25127356|NCT02203916|50240373|FG001|Overall Study|Voluntary Withdrawal|3|||
25127357|NCT02203916|50240374|FG002|Overall Study|Voluntary Withdrawal|8|||
25127358|NCT02203916|50240372|FG000|Overall Study|Lack of Efficacy|3|||
25127359|NCT02203916|50240373|FG001|Overall Study|Lack of Efficacy|0|||
25127360|NCT02203916|50240374|FG002|Overall Study|Lack of Efficacy|0|||
25127361|NCT02203916|50240372|FG000|Overall Study|Reason Not Specified|0|||
25127362|NCT02203916|50240373|FG001|Overall Study|Reason Not Specified|2|||
25127363|NCT02203916|50240374|FG002|Overall Study|Reason Not Specified|1|||
25127364|NCT02179177|50240398|FG000|Overall Study|Lost to Follow-up|1|||
25127365|NCT02179177|50240399|FG001|Overall Study|Lost to Follow-up|1|||
25127366|NCT02179177|50240398|FG000|Overall Study|Withdrawal by Subject|1|||
25127367|NCT02179177|50240399|FG001|Overall Study|Withdrawal by Subject|1|||
25127368|NCT02239328|50240405|FG000|Overall Study|Benign disease noted at time of surgery|6|||
25127369|NCT02239328|50240405|FG000|Overall Study|Equipment or website malfunction|2|||
25127370|NCT02129803|50240411|FG000|Overall Study|Protocol Violation|4|||
25127371|NCT02129803|50240412|FG001|Overall Study|Protocol Violation|0|||
25127372|NCT02129803|50240411|FG000|Overall Study|Physician Decision|0|||
25127373|NCT02129803|50240412|FG001|Overall Study|Physician Decision|1|||
25127374|NCT02129803|50240411|FG000|Overall Study|Difficulty sleeping|1|||
25127375|NCT02129803|50240412|FG001|Overall Study|Difficulty sleeping|0|||
25127376|NCT02129803|50240411|FG000|Overall Study|Morning headache|0|||
25127377|NCT02129803|50240412|FG001|Overall Study|Morning headache|1|||
25127378|NCT02129803|50240411|FG000|Overall Study|Withdrawal by Subject|1|||
25127379|NCT02129803|50240412|FG001|Overall Study|Withdrawal by Subject|1|||
25127380|NCT02239094|50240418|FG000|Overall Study|Withdrawal by Subject|1|||
25270688|NCT01262456|50584843|FG002|3-Month Double-Blind Period|Adverse Event|8|||
25270689|NCT01262456|50584841|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
25270690|NCT01262456|50584842|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
25270691|NCT01262456|50584843|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
25270692|NCT01262456|50584841|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
25270693|NCT01262456|50584842|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
25270694|NCT01262456|50584843|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
25270695|NCT01262456|50584841|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
25270696|NCT01262456|50584842|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
25270697|NCT01262456|50584843|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
25270698|NCT01262456|50584841|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
25270699|NCT01262456|50584842|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
25270700|NCT01262456|50584843|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
25270701|NCT01262456|50584841|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
25270702|NCT01262456|50584842|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
25127381|NCT02239094|50240418|FG000|Overall Study|Remitted before started|1|||
25127382|NCT02129647|50240422|FG000|Overall Study|Adverse Event|2|||
25127383|NCT02129647|50240422|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
25127384|NCT02238626|50240430|FG000|Overall Study|Adverse Event|3|||
25127385|NCT02238626|50240431|FG001|Overall Study|Adverse Event|5|||
25127386|NCT02238626|50240432|FG002|Overall Study|Adverse Event|0|||
25127387|NCT02238626|50240433|FG003|Overall Study|Adverse Event|3|||
25127388|NCT02238626|50240430|FG000|Overall Study|Lost to Follow-up|2|||
25127389|NCT02238626|50240431|FG001|Overall Study|Lost to Follow-up|4|||
25127390|NCT02238626|50240432|FG002|Overall Study|Lost to Follow-up|2|||
25127391|NCT02238626|50240433|FG003|Overall Study|Lost to Follow-up|2|||
25127392|NCT02238626|50240430|FG000|Overall Study|Withdrawal by Subject|0|||
25127393|NCT02238626|50240431|FG001|Overall Study|Withdrawal by Subject|3|||
25127394|NCT02238626|50240432|FG002|Overall Study|Withdrawal by Subject|0|||
25127395|NCT02238626|50240433|FG003|Overall Study|Withdrawal by Subject|1|||
25127396|NCT02238626|50240430|FG000|Overall Study|Death|0|||
25127397|NCT02238626|50240431|FG001|Overall Study|Death|0|||
25127398|NCT02238626|50240432|FG002|Overall Study|Death|1|||
25127399|NCT02238626|50240433|FG003|Overall Study|Death|1|||
25270703|NCT01262456|50584843|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
25270704|NCT01262456|50584841|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
25127400|NCT02238626|50240430|FG000|Overall Study|Other|0|||
25127401|NCT02238626|50240431|FG001|Overall Study|Other|2|||
25270705|NCT01262456|50584842|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
25127402|NCT02238626|50240432|FG002|Overall Study|Other|0|||
25127403|NCT02238626|50240433|FG003|Overall Study|Other|0|||
25127404|NCT02151643|50240459|FG000|Overall Study|Adverse Event|2|||
25127405|NCT02151643|50240460|FG001|Overall Study|Adverse Event|0|||
25127406|NCT02151643|50240461|FG002|Overall Study|Adverse Event|1|||
25127407|NCT02151643|50240462|FG003|Overall Study|Adverse Event|4|||
25127408|NCT02151643|50240463|FG004|Overall Study|Adverse Event|0|||
25127409|NCT02151643|50240459|FG000|Overall Study|Withdrawal by Subject|0|||
25127410|NCT02151643|50240460|FG001|Overall Study|Withdrawal by Subject|1|||
25127411|NCT02151643|50240461|FG002|Overall Study|Withdrawal by Subject|1|||
25127412|NCT02151643|50240462|FG003|Overall Study|Withdrawal by Subject|1|||
25127413|NCT02151643|50240463|FG004|Overall Study|Withdrawal by Subject|1|||
25127414|NCT02151643|50240459|FG000|Overall Study|Hyperphosphataemia|1|||
25127415|NCT02151643|50240460|FG001|Overall Study|Hyperphosphataemia|0|||
25127416|NCT02151643|50240461|FG002|Overall Study|Hyperphosphataemia|0|||
25127417|NCT02151643|50240462|FG003|Overall Study|Hyperphosphataemia|0|||
25127418|NCT02151643|50240463|FG004|Overall Study|Hyperphosphataemia|1|||
25127419|NCT02151643|50240459|FG000|Overall Study|High Ferritin levels|3|||
25127420|NCT02151643|50240460|FG001|Overall Study|High Ferritin levels|3|||
25127421|NCT02151643|50240461|FG002|Overall Study|High Ferritin levels|2|||
25127422|NCT02151643|50240462|FG003|Overall Study|High Ferritin levels|2|||
25127423|NCT02151643|50240463|FG004|Overall Study|High Ferritin levels|1|||
25127424|NCT02203838|50240479|FG000|Overall Study|Lack of Efficacy|7|||
25127425|NCT02203838|50240480|FG001|Overall Study|Lack of Efficacy|0|||
25127426|NCT02203838|50240481|FG002|Overall Study|Lack of Efficacy|1|||
25127427|NCT02203838|50240482|FG003|Overall Study|Lack of Efficacy|1|||
25127428|NCT02203838|50240479|FG000|Overall Study|Adverse Event|46|||
25127429|NCT02203838|50240480|FG001|Overall Study|Adverse Event|6|||
25127430|NCT02203838|50240481|FG002|Overall Study|Adverse Event|3|||
25127431|NCT02203838|50240482|FG003|Overall Study|Adverse Event|2|||
25270706|NCT01262456|50584843|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
25270707|NCT00932893|50584861|FG000|Overall Study|Death|115|||
25270708|NCT00932893|50584862|FG001|Overall Study|Death|24|||
25270709|NCT00932893|50584861|FG000|Overall Study|Lost to Follow-up|8|||
25270710|NCT00932893|50584862|FG001|Overall Study|Lost to Follow-up|0|||
25270711|NCT00932893|50584861|FG000|Overall Study|Withdrawal by Subject|5|||
25270712|NCT00932893|50584862|FG001|Overall Study|Withdrawal by Subject|2|||
25270713|NCT00932893|50584861|FG000|Overall Study|Other|5|||
25270714|NCT00932893|50584862|FG001|Overall Study|Other|144|||
25270715|NCT01260896|50584871|FG000|First Intervention|Withdrawn Due to Emesis|2|||
25127432|NCT02203838|50240479|FG000|Overall Study|Lost to Follow-up|39|||
25127433|NCT02203838|50240480|FG001|Overall Study|Lost to Follow-up|3|||
25127434|NCT02203838|50240481|FG002|Overall Study|Lost to Follow-up|2|||
25127435|NCT02203838|50240482|FG003|Overall Study|Lost to Follow-up|1|||
25127436|NCT02203838|50240479|FG000|Overall Study|Protocol Violation|7|||
25127437|NCT02203838|50240480|FG001|Overall Study|Protocol Violation|3|||
25127438|NCT02203838|50240481|FG002|Overall Study|Protocol Violation|0|||
25127439|NCT02203838|50240482|FG003|Overall Study|Protocol Violation|0|||
25270716|NCT01260896|50584872|FG001|First Intervention|Withdrawn Due to Emesis|0|||
25270717|NCT00932737|50584880|FG000|Overall Study|Not treated in second episode|1|||
25270718|NCT00932737|50584881|FG001|Overall Study|Not treated in second episode|0|||
25127440|NCT02203838|50240479|FG000|Overall Study|Withdrawal by Subject|83|||
25127441|NCT02203838|50240480|FG001|Overall Study|Withdrawal by Subject|10|||
25127442|NCT02203838|50240481|FG002|Overall Study|Withdrawal by Subject|8|||
25127443|NCT02203838|50240482|FG003|Overall Study|Withdrawal by Subject|11|||
25270719|NCT00932737|50584880|FG000|Overall Study|Adverse Event|0|||
25270720|NCT00932737|50584881|FG001|Overall Study|Adverse Event|1|||
25127444|NCT02203838|50240479|FG000|Overall Study|Physician Decision|27|||
25127445|NCT02203838|50240480|FG001|Overall Study|Physician Decision|0|||
25127446|NCT02203838|50240481|FG002|Overall Study|Physician Decision|2|||
25127447|NCT02203838|50240482|FG003|Overall Study|Physician Decision|3|||
25127448|NCT02203838|50240479|FG000|Overall Study|Other|1|||
25127449|NCT02203838|50240480|FG001|Overall Study|Other|0|||
25127450|NCT02203838|50240481|FG002|Overall Study|Other|0|||
25127451|NCT02203838|50240482|FG003|Overall Study|Other|0|||
25127452|NCT02178787|50240494|FG000|Overall Study|Lost to Follow-up|1|||
25127453|NCT02178787|50240495|FG001|Overall Study|Lost to Follow-up|0|||
25127454|NCT02178787|50240494|FG000|Overall Study|Withdrawal by Subject|0|||
25127455|NCT02178787|50240495|FG001|Overall Study|Withdrawal by Subject|2|||
25127456|NCT02178787|50240494|FG000|Overall Study|No TCD window|3|||
25127457|NCT02178787|50240495|FG001|Overall Study|No TCD window|7|||
25127458|NCT02178787|50240494|FG000|Overall Study|Physician Decision|1|||
25127459|NCT02178787|50240495|FG001|Overall Study|Physician Decision|0|||
25127460|NCT02178709|50240503|FG000|Overall Study|Adverse Event|5|||
25127461|NCT02178709|50240503|FG000|Overall Study|Death|2|||
25127462|NCT02178709|50240503|FG000|Overall Study|Withdrawal by Subject|2|||
25127463|NCT02178709|50240503|FG000|Overall Study|Physician Decision|2|||
25127464|NCT02178709|50240503|FG000|Overall Study|Disease Progression|5|||
25127465|NCT02238080|50240507|FG000|Overall Study|Death|13|||
25127466|NCT02238080|50240507|FG000|Overall Study|Treatment interrupted|6|||
25127467|NCT02238080|50240507|FG000|Overall Study|Withdrawal by Subject|2|||
25127468|NCT02238080|50240507|FG000|Overall Study|Other|4|||
25127469|NCT02150863|50240514|FG000|Overall Study|Lost to Follow-up|0|||
25127470|NCT02150863|50240515|FG001|Overall Study|Lost to Follow-up|1|||
25270721|NCT00939523|50584887|FG000|Overall Study|Lack of Efficacy|1|||
25270722|NCT00939523|50584887|FG000|Overall Study|Physician Decision|2|||
25270723|NCT01260584|50584895|FG000|Period 1|Protocol Violation|0|||
25270724|NCT01260584|50584896|FG001|Period 1|Protocol Violation|0|||
25270725|NCT01260584|50584897|FG002|Period 1|Protocol Violation|1|||
25270726|NCT01260584|50584898|FG003|Period 1|Protocol Violation|1|||
25270727|NCT01260584|50584895|FG000|Period 1|Adverse Event|0|||
25270728|NCT01260584|50584896|FG001|Period 1|Adverse Event|0|||
25270729|NCT01260584|50584897|FG002|Period 1|Adverse Event|1|||
25270730|NCT01260584|50584898|FG003|Period 1|Adverse Event|0|||
25270731|NCT01260584|50584895|FG000|Period 2|Protocol Violation|0|||
25270732|NCT01260584|50584896|FG001|Period 2|Protocol Violation|2|||
25270733|NCT01260584|50584897|FG002|Period 2|Protocol Violation|3|||
25270734|NCT01260584|50584898|FG003|Period 2|Protocol Violation|1|||
25270735|NCT01260584|50584895|FG000|Period 2|Adverse Event|1|||
25270736|NCT01260584|50584896|FG001|Period 2|Adverse Event|0|||
25270737|NCT01260584|50584897|FG002|Period 2|Adverse Event|2|||
25270738|NCT01260584|50584898|FG003|Period 2|Adverse Event|0|||
25270739|NCT01260584|50584895|FG000|Period 2|Withdrawal by Subject|0|||
25270740|NCT01260584|50584896|FG001|Period 2|Withdrawal by Subject|1|||
25270741|NCT01260584|50584897|FG002|Period 2|Withdrawal by Subject|0|||
25270742|NCT01260584|50584898|FG003|Period 2|Withdrawal by Subject|0|||
25270743|NCT00927589|50584908|FG000|Overall Study|Death|1|||
25270744|NCT00927589|50584908|FG000|Overall Study|Physician Decision|1|||
25127471|NCT02150863|50240516|FG002|Overall Study|Lost to Follow-up|0|||
25127472|NCT02178553|50240526|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
25127473|NCT02178553|50240527|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
25270745|NCT00927589|50584908|FG000|Overall Study|Withdrawal by Subject|3|||
25270746|NCT00927589|50584908|FG000|Overall Study|Adverse Event|2|||
25127474|NCT02178553|50240526|FG000|Overall Study|Physician Decision|0|||
25127475|NCT02178553|50240527|FG001|Overall Study|Physician Decision|4|||
25270747|NCT00927589|50584908|FG000|Overall Study|Disease Progression|8|||
25270748|NCT00927589|50584908|FG000|Overall Study|Non-compliance|1|||
25127476|NCT02178553|50240526|FG000|Overall Study|Technical problem with injection|1|||
25127477|NCT02178553|50240527|FG001|Overall Study|Technical problem with injection|3|||
25270749|NCT00932425|50584914|FG000|Overall Study|Lost to Follow-up|0|||
25270750|NCT00932425|50584915|FG001|Overall Study|Lost to Follow-up|1|||
25270751|NCT00932425|50584914|FG000|Overall Study|Withdrawal by Subject|0|||
25270752|NCT00932425|50584915|FG001|Overall Study|Withdrawal by Subject|1|||
25270753|NCT00932113|50584923|FG000|Overall Study|Lost to Follow-up|1|||
25270754|NCT00932113|50584924|FG001|Overall Study|Lost to Follow-up|0|||
25270755|NCT00931801|50584933|FG000|Overall Study|Adverse Event|0|||
25270756|NCT00931801|50584934|FG001|Overall Study|Adverse Event|0|||
25270757|NCT00931801|50584935|FG002|Overall Study|Adverse Event|1|||
25270758|NCT00931801|50584933|FG000|Overall Study|Lost to Follow-up|0|||
25270759|NCT00931801|50584934|FG001|Overall Study|Lost to Follow-up|1|||
25270760|NCT00931801|50584935|FG002|Overall Study|Lost to Follow-up|0|||
25270761|NCT00931801|50584933|FG000|Overall Study|Withdrawal by Subject|1|||
25270762|NCT00931801|50584934|FG001|Overall Study|Withdrawal by Subject|0|||
25270763|NCT00931801|50584935|FG002|Overall Study|Withdrawal by Subject|0|||
25270764|NCT00931801|50584933|FG000|Overall Study|Confirmed Virologic Failure|0|||
25270765|NCT00931801|50584934|FG001|Overall Study|Confirmed Virologic Failure|0|||
25270766|NCT00931801|50584935|FG002|Overall Study|Confirmed Virologic Failure|3|||
25270767|NCT00931723|50584949|FG000|Overall Study|Withdrawal by Subject|11|||
25270768|NCT00931723|50584950|FG001|Overall Study|Withdrawal by Subject|13|||
25270769|NCT00931723|50584949|FG000|Overall Study|Adverse Event|6|||
25270770|NCT00931723|50584950|FG001|Overall Study|Adverse Event|13|||
25270771|NCT00931723|50584949|FG000|Overall Study|Lithium found in blood|0|||
25270772|NCT00931723|50584950|FG001|Overall Study|Lithium found in blood|1|||
25270773|NCT00931723|50584949|FG000|Overall Study|Condition under investigation worsened|1|||
25270774|NCT00931723|50584950|FG001|Overall Study|Condition under investigation worsened|2|||
25270775|NCT00931723|50584949|FG000|Overall Study|Lost to Follow-up|1|||
25270776|NCT00931723|50584950|FG001|Overall Study|Lost to Follow-up|2|||
25270777|NCT00931723|50584949|FG000|Overall Study|Study-specific discontinuation criteria|1|||
25270778|NCT00931723|50584950|FG001|Overall Study|Study-specific discontinuation criteria|1|||
25270779|NCT00931723|50584949|FG000|Overall Study|Severe non-compliance to protocol|2|||
25270780|NCT00931723|50584950|FG001|Overall Study|Severe non-compliance to protocol|0|||
25270781|NCT00931723|50584949|FG000|Overall Study|Safety reasons|0|||
25270782|NCT00931723|50584950|FG001|Overall Study|Safety reasons|1|||
25270783|NCT00931723|50584949|FG000|Overall Study|Took prohibited concomitant medication|0|||
25270784|NCT00931723|50584950|FG001|Overall Study|Took prohibited concomitant medication|1|||
25270785|NCT00931723|50584949|FG000|Overall Study|Lack or insufficient theraputic response|2|||
25270786|NCT00931723|50584950|FG001|Overall Study|Lack or insufficient theraputic response|5|||
25270787|NCT00931723|50584949|FG000|Overall Study|Sponsor decision|1|||
25270788|NCT00931723|50584950|FG001|Overall Study|Sponsor decision|0|||
25270789|NCT00931723|50584949|FG000|Overall Study|Late hospital discharge|1|||
25270790|NCT00931723|50584950|FG001|Overall Study|Late hospital discharge|0|||
25270791|NCT00931411|50584958|FG000|First Intervention - 42 Days|Adverse Event|2|||
25270792|NCT00931411|50584959|FG001|First Intervention - 42 Days|Adverse Event|3|||
25270793|NCT00931411|50584958|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
25270794|NCT00931411|50584959|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
25270795|NCT00931411|50584958|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
25270796|NCT00931411|50584959|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
25270797|NCT00931255|50584971|FG000|Overall Study|Follow up biopsy not done|2|||
25270798|NCT00931255|50584972|FG001|Overall Study|Follow up biopsy not done|3|||
25127478|NCT01627327|50240535|FG000|Overall Study|Adverse Event|6|||
25127479|NCT01627327|50240536|FG001|Overall Study|Adverse Event|12|||
25127480|NCT01627327|50240535|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
25127481|NCT01627327|50240536|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
25127482|NCT01627327|50240535|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
25127483|NCT01627327|50240536|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
25127484|NCT01627327|50240535|FG000|Overall Study|Protocol Violation|4|||
25127485|NCT01627327|50240536|FG001|Overall Study|Protocol Violation|10|||
25127486|NCT01627327|50240535|FG000|Overall Study|Lost to Follow-up|1|||
25127487|NCT01627327|50240536|FG001|Overall Study|Lost to Follow-up|3|||
25127488|NCT01627327|50240535|FG000|Overall Study|Physician Decision|1|||
25127489|NCT01627327|50240536|FG001|Overall Study|Physician Decision|0|||
25270799|NCT00930553|50584978|FG000|Overall Study|Adverse Event|1|||
25270800|NCT00930553|50584978|FG000|Overall Study|Lack of Efficacy|7|||
25270801|NCT00930553|50584978|FG000|Overall Study|Physician Decision|39|||
25270802|NCT00930553|50584978|FG000|Overall Study|Protocol Violation|1|||
25270803|NCT00930553|50584978|FG000|Overall Study|Pregnancy|1|||
25270804|NCT00930553|50584978|FG000|Overall Study|Withdrawal by Subject|88|||
25270805|NCT00930553|50584978|FG000|Overall Study|Lost to Follow-up|25|||
25270806|NCT00930553|50584978|FG000|Overall Study|Death|9|||
25270807|NCT00930553|50584978|FG000|Overall Study|Study terminated by sponsor|24|||
25270808|NCT00930553|50584978|FG000|Overall Study|Other than specified above|28|||
25270809|NCT00929695|50585002|FG000|Overall Study|Death|2|||
25270810|NCT00929695|50585003|FG001|Overall Study|Death|1|||
25270811|NCT00929695|50585002|FG000|Overall Study|Withdrawal by Subject|0|||
25127490|NCT01627327|50240535|FG000|Overall Study|Withdrawal by Subject|3|||
25270812|NCT00929695|50585003|FG001|Overall Study|Withdrawal by Subject|2|||
25270813|NCT00929695|50585002|FG000|Overall Study|discharge home|4|||
25270814|NCT00929695|50585003|FG001|Overall Study|discharge home|3|||
25270815|NCT00929695|50585002|FG000|Overall Study|incorrect stratification|2|||
25270816|NCT00929695|50585003|FG001|Overall Study|incorrect stratification|0|||
25270817|NCT00927355|50585016|FG000|Overall Study|Adverse Event|1|||
25270818|NCT00927355|50585017|FG001|Overall Study|Adverse Event|1|||
25127491|NCT01627327|50240536|FG001|Overall Study|Withdrawal by Subject|3|||
25127492|NCT01627249|50240545|FG000|Overall Study|Death|3|||
25127493|NCT01627249|50240546|FG001|Overall Study|Death|5|||
25127494|NCT01627249|50240547|FG002|Overall Study|Death|3|||
25127495|NCT01627249|50240545|FG000|Overall Study|Withdrawal by Subject|12|||
25127496|NCT01627249|50240546|FG001|Overall Study|Withdrawal by Subject|6|||
25127497|NCT01627249|50240547|FG002|Overall Study|Withdrawal by Subject|9|||
25127498|NCT01627249|50240545|FG000|Overall Study|Missed Visit|1|||
25127499|NCT01627249|50240546|FG001|Overall Study|Missed Visit|1|||
25127500|NCT01627249|50240547|FG002|Overall Study|Missed Visit|0|||
25127501|NCT01688830|50240576|FG000|Overall Study|Lost to Follow-up|0|||
25127502|NCT01688830|50240577|FG001|Overall Study|Lost to Follow-up|0|||
25127503|NCT01688830|50240578|FG002|Overall Study|Lost to Follow-up|0|||
25127504|NCT01688830|50240579|FG003|Overall Study|Lost to Follow-up|0|||
25127505|NCT01688830|50240580|FG004|Overall Study|Lost to Follow-up|0|||
25127506|NCT01688830|50240581|FG005|Overall Study|Lost to Follow-up|0|||
25127507|NCT01688830|50240582|FG006|Overall Study|Lost to Follow-up|0|||
25127508|NCT01688830|50240583|FG007|Overall Study|Lost to Follow-up|0|||
25127509|NCT01688830|50240584|FG008|Overall Study|Lost to Follow-up|0|||
25127510|NCT01688830|50240585|FG009|Overall Study|Lost to Follow-up|0|||
25127511|NCT01688830|50240586|FG010|Overall Study|Lost to Follow-up|1|||
25127512|NCT01688830|50240587|FG011|Overall Study|Lost to Follow-up|0|||
25127513|NCT01688830|50240588|FG012|Overall Study|Lost to Follow-up|0|||
25127514|NCT01688830|50240589|FG013|Overall Study|Lost to Follow-up|0|||
25127515|NCT01688830|50240590|FG014|Overall Study|Lost to Follow-up|0|||
25127516|NCT01688830|50240591|FG015|Overall Study|Lost to Follow-up|0|||
25127517|NCT01688830|50240592|FG016|Overall Study|Lost to Follow-up|0|||
25127518|NCT01688830|50240593|FG017|Overall Study|Lost to Follow-up|0|||
25270819|NCT00923845|50585037|FG000|Induction Therapy|Poor performance status|0|||
25270820|NCT00923845|50585038|FG001|Induction Therapy|Poor performance status|2|||
25270821|NCT00922987|50585045|FG000|Overall Study|Insufficient clinical response|1|||
25270822|NCT00922987|50585045|FG000|Overall Study|Protocol Violation|2|||
25270823|NCT00922987|50585045|FG000|Overall Study|Adverse Event|1|||
25270824|NCT00928135|50585051|FG000|Overall Study|Withdrawal by Subject|1|||
25270825|NCT00928135|50585052|FG001|Overall Study|Withdrawal by Subject|0|||
25270826|NCT00928057|50585060|FG000|Overall Study|Adverse Event|1|||
25270827|NCT00928057|50585061|FG001|Overall Study|Adverse Event|2|||
25270828|NCT00928057|50585060|FG000|Overall Study|Withdrawal by Subject|1|||
25270829|NCT00928057|50585061|FG001|Overall Study|Withdrawal by Subject|0|||
25270830|NCT00928057|50585060|FG000|Overall Study|Lost to Follow-up|0|||
25270831|NCT00928057|50585061|FG001|Overall Study|Lost to Follow-up|1|||
25270832|NCT00928057|50585060|FG000|Overall Study|Protocol Violation|0|||
25270833|NCT00928057|50585061|FG001|Overall Study|Protocol Violation|1|||
25270834|NCT00927901|50585077|FG000|Treatment Period 1|Subject withdrew consent|0|||
25270835|NCT00927901|50585078|FG001|Treatment Period 1|Subject withdrew consent|0|||
25270836|NCT00927901|50585079|FG002|Treatment Period 1|Subject withdrew consent|1|||
25270837|NCT00927901|50585080|FG003|Treatment Period 1|Subject withdrew consent|0|||
25270838|NCT00927901|50585077|FG000|Treatment Period 4|Adverse Event|0|||
25270839|NCT00927901|50585078|FG001|Treatment Period 4|Adverse Event|0|||
25270840|NCT00927901|50585079|FG002|Treatment Period 4|Adverse Event|0|||
25270841|NCT00927901|50585080|FG003|Treatment Period 4|Adverse Event|1|||
25270842|NCT00927901|50585077|FG000|Treatment Period 4|Subject withdrew consent|0|||
25270843|NCT00927901|50585078|FG001|Treatment Period 4|Subject withdrew consent|0|||
25270844|NCT00927901|50585079|FG002|Treatment Period 4|Subject withdrew consent|1|||
25270845|NCT00927901|50585080|FG003|Treatment Period 4|Subject withdrew consent|0|||
25270846|NCT01218204|50585095|FG000|Part B Washout|Adverse Event|0|||
25270847|NCT01218204|50585096|FG001|Part B Washout|Adverse Event|1|||
25127519|NCT01688830|50240594|FG018|Overall Study|Lost to Follow-up|0|||
25127520|NCT01688830|50240595|FG019|Overall Study|Lost to Follow-up|0|||
25127521|NCT01688830|50240596|FG020|Overall Study|Lost to Follow-up|0|||
25270848|NCT01218204|50585097|FG002|Part B Washout|Adverse Event|0|||
25127522|NCT02178475|50240680|FG000|Overall Study|Withdrawal by Subject|7|||
25127523|NCT02178475|50240680|FG000|Overall Study|Lost to Follow-up|10|||
25127524|NCT02178475|50240680|FG000|Overall Study|Death|13|||
25127525|NCT02178475|50240680|FG000|Overall Study|Protocol-specified Criteria|99|||
25127526|NCT01569022|50240684|FG000|First Intervention|Lost to Follow-up|2|||
25127527|NCT01569022|50240685|FG001|First Intervention|Lost to Follow-up|1|||
25270849|NCT01218204|50585098|FG003|Part B Washout|Adverse Event|0|||
25270850|NCT01218204|50585095|FG000|Part B Washout|Lost to Follow-up|0|||
25270851|NCT01218204|50585096|FG001|Part B Washout|Lost to Follow-up|2|||
25270852|NCT01218204|50585097|FG002|Part B Washout|Lost to Follow-up|0|||
25127528|NCT01569022|50240684|FG000|Second Intervention|Lost to Follow-up|2|||
25127529|NCT01569022|50240685|FG001|Second Intervention|Lost to Follow-up|2|||
25127530|NCT01629823|50240696|FG000|Trial Period|Missed visit|11|||
25127531|NCT01629823|50240697|FG001|Trial Period|Missed visit|9|||
25270853|NCT01218204|50585098|FG003|Part B Washout|Lost to Follow-up|0|||
25270854|NCT01218204|50585095|FG000|Part B Washout|Physician Decision|0|||
25270855|NCT01218204|50585096|FG001|Part B Washout|Physician Decision|14|||
25270856|NCT01218204|50585097|FG002|Part B Washout|Physician Decision|0|||
25270857|NCT01218204|50585098|FG003|Part B Washout|Physician Decision|0|||
25270858|NCT01218204|50585095|FG000|Part B Washout|Withdrawal by Subject|0|||
25270859|NCT01218204|50585096|FG001|Part B Washout|Withdrawal by Subject|14|||
25270860|NCT01218204|50585097|FG002|Part B Washout|Withdrawal by Subject|0|||
25270861|NCT01218204|50585098|FG003|Part B Washout|Withdrawal by Subject|0|||
25270862|NCT01218204|50585095|FG000|Part B Washout|Reached defined stopping criteria|0|||
25270863|NCT01218204|50585096|FG001|Part B Washout|Reached defined stopping criteria|2|||
25270864|NCT01218204|50585097|FG002|Part B Washout|Reached defined stopping criteria|0|||
25270865|NCT01218204|50585098|FG003|Part B Washout|Reached defined stopping criteria|0|||
25270866|NCT01218204|50585095|FG000|Part B Washout|Did not meet continuation criteria|0|||
25270867|NCT01218204|50585096|FG001|Part B Washout|Did not meet continuation criteria|112|||
25270868|NCT01218204|50585097|FG002|Part B Washout|Did not meet continuation criteria|0|||
25270869|NCT01218204|50585098|FG003|Part B Washout|Did not meet continuation criteria|0|||
25270870|NCT01218204|50585095|FG000|Part B Run-in|Adverse Event|0|||
25270871|NCT01218204|50585096|FG001|Part B Run-in|Adverse Event|0|||
25270872|NCT01218204|50585097|FG002|Part B Run-in|Adverse Event|1|||
25270873|NCT01218204|50585098|FG003|Part B Run-in|Adverse Event|0|||
25270874|NCT01218204|50585095|FG000|Part B Run-in|Protocol Violation|0|||
25270875|NCT01218204|50585096|FG001|Part B Run-in|Protocol Violation|0|||
25270876|NCT01218204|50585097|FG002|Part B Run-in|Protocol Violation|2|||
25270877|NCT01218204|50585098|FG003|Part B Run-in|Protocol Violation|0|||
25270878|NCT01218204|50585095|FG000|Part B Run-in|Withdrawal by Subject|0|||
25270879|NCT01218204|50585096|FG001|Part B Run-in|Withdrawal by Subject|0|||
25270880|NCT01218204|50585097|FG002|Part B Run-in|Withdrawal by Subject|3|||
25270881|NCT01218204|50585098|FG003|Part B Run-in|Withdrawal by Subject|0|||
25270882|NCT01218204|50585095|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
25270883|NCT01218204|50585096|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
25270884|NCT01218204|50585097|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
25270885|NCT01218204|50585098|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
25270886|NCT01218204|50585095|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
25270887|NCT01218204|50585096|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
25270888|NCT01218204|50585097|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
25270889|NCT01218204|50585098|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
25270890|NCT00926575|50585147|FG000|Overall Study|Adverse Event|1|||
25270891|NCT00926575|50585148|FG001|Overall Study|Adverse Event|1|||
25270892|NCT00926575|50585147|FG000|Overall Study|Death|4|||
25270893|NCT00926575|50585148|FG001|Overall Study|Death|4|||
25270894|NCT00926575|50585147|FG000|Overall Study|Lost to Follow-up|1|||
25270895|NCT00926575|50585148|FG001|Overall Study|Lost to Follow-up|1|||
25127532|NCT01629823|50240698|FG002|Trial Period|Missed visit|8|||
25127533|NCT01629823|50240696|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
25127534|NCT01629823|50240697|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
25127535|NCT01629823|50240698|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
25127536|NCT01629823|50240696|FG000|Trial Period|Pregnancy|1|||
25127537|NCT01629823|50240697|FG001|Trial Period|Pregnancy|0|||
25127538|NCT01629823|50240698|FG002|Trial Period|Pregnancy|0|||
25127539|NCT01629823|50240696|FG000|Trial Period|Adverse Event|0|||
25127540|NCT01629823|50240697|FG001|Trial Period|Adverse Event|1|||
25127541|NCT01629823|50240698|FG002|Trial Period|Adverse Event|0|||
25270896|NCT00926575|50585147|FG000|Overall Study|Physician Decision|1|||
25270897|NCT00926575|50585148|FG001|Overall Study|Physician Decision|2|||
25270898|NCT00926575|50585147|FG000|Overall Study|Protocol Violation|1|||
25270899|NCT00926575|50585148|FG001|Overall Study|Protocol Violation|0|||
25270900|NCT00926575|50585147|FG000|Overall Study|Withdrawal by Subject|8|||
25270901|NCT00926575|50585148|FG001|Overall Study|Withdrawal by Subject|9|||
25270902|NCT01218126|50585158|FG000|Overall Study|Adverse Event|8|||
25270903|NCT01218126|50585159|FG001|Overall Study|Adverse Event|10|||
25270904|NCT01218126|50585160|FG002|Overall Study|Adverse Event|12|||
25270905|NCT01218126|50585161|FG003|Overall Study|Adverse Event|16|||
25270906|NCT01218126|50585158|FG000|Overall Study|Lack of Efficacy|7|||
25127542|NCT01629823|50240696|FG000|Trial Period|Out-of-window visit|0|||
25127543|NCT01629823|50240697|FG001|Trial Period|Out-of-window visit|2|||
25127544|NCT01629823|50240698|FG002|Trial Period|Out-of-window visit|0|||
25270907|NCT01218126|50585159|FG001|Overall Study|Lack of Efficacy|2|||
25127545|NCT01629823|50240696|FG000|Trial Period|Failed to hold medication|0|||
25127546|NCT01629823|50240697|FG001|Trial Period|Failed to hold medication|0|||
25127547|NCT01629823|50240698|FG002|Trial Period|Failed to hold medication|1|||
25127548|NCT01629823|50240696|FG000|Washout Period|Safety|2|||
25127549|NCT01629823|50240697|FG001|Washout Period|Safety|5|||
25127550|NCT01629823|50240698|FG002|Washout Period|Safety|0|||
25127551|NCT01629823|50240696|FG000|Washout Period|Pregnancy|1|||
25127552|NCT01629823|50240697|FG001|Washout Period|Pregnancy|0|||
25127553|NCT01629823|50240698|FG002|Washout Period|Pregnancy|0|||
25127554|NCT01629823|50240696|FG000|Washout Period|Protocol Violation|0|||
25127555|NCT01629823|50240697|FG001|Washout Period|Protocol Violation|1|||
25127556|NCT01629823|50240698|FG002|Washout Period|Protocol Violation|0|||
25127557|NCT01688050|50240706|FG000|Overall Study|Death|7|||
25127558|NCT01688050|50240706|FG000|Overall Study|Conversion to open repair|1|||
25127559|NCT01688050|50240706|FG000|Overall Study|Lost to Follow-up|13|||
25127560|NCT01688050|50240706|FG000|Overall Study|Withdrawal by Subject|10|||
25127561|NCT01604278|50240712|FG000|Overall Study|Lack of Efficacy|0|||
25127562|NCT01604278|50240713|FG001|Overall Study|Lack of Efficacy|1|||
25127563|NCT01604278|50240712|FG000|Overall Study|Lost to Follow-up|1|||
25127564|NCT01604278|50240713|FG001|Overall Study|Lost to Follow-up|0|||
25127565|NCT01604278|50240712|FG000|Overall Study|Administrative problems|2|||
25127566|NCT01604278|50240713|FG001|Overall Study|Administrative problems|1|||
25127567|NCT01604278|50240712|FG000|Overall Study|Withdrawal by Subject|3|||
25127568|NCT01604278|50240713|FG001|Overall Study|Withdrawal by Subject|3|||
25127569|NCT01604278|50240712|FG000|Overall Study|Adverse Event|3|||
25127570|NCT01604278|50240713|FG001|Overall Study|Adverse Event|5|||
25127571|NCT01604278|50240712|FG000|Overall Study|Protocol Deviation|5|||
25127572|NCT01604278|50240713|FG001|Overall Study|Protocol Deviation|3|||
25127573|NCT01687270|50240719|FG000|Overall Study|Lack of Efficacy|11|||
25127574|NCT01687270|50240719|FG000|Overall Study|Lost to Follow-up|1|||
25127575|NCT01589770|50240725|FG000|Overall Study|EGFR <60ml/min|6|||
25127576|NCT01589770|50240726|FG001|Overall Study|EGFR <60ml/min|4|||
25127577|NCT01589770|50240725|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
25127578|NCT01589770|50240726|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
25127579|NCT01588990|50240732|FG000|Phase A|Withdrawal by Subject|5|||
25127580|NCT01588990|50240732|FG000|Phase A|Physician Decision|11|||
25127581|NCT01588990|50240732|FG000|Phase A|Other|14|||
25127582|NCT01588990|50240732|FG000|Phase A|Lost to Follow-up|1|||
25127583|NCT01588990|50240732|FG000|Phase A|Death|5|||
25127584|NCT01588990|50240732|FG000|Phase A|Adverse Event|28|||
25127585|NCT01588990|50240732|FG000|Phase A|Still on therapy at end of study|6|||
25127586|NCT01588990|50240732|FG000|Phase B|Adverse Event|2|||
25127587|NCT01588990|50240732|FG000|Phase B|Still on therapy at end of study|5|||
25127588|NCT01588990|50240732|FG000|Phase B|Withdrawal by Subject|3|||
25127589|NCT01588990|50240732|FG000|Phase B|Physician Decision|4|||
25127590|NCT01588990|50240732|FG000|Phase B|Other|2|||
25127591|NCT02176525|50240748|FG000|Overall Study|Adverse Event|0|||
25127592|NCT02176525|50240749|FG001|Overall Study|Adverse Event|0|||
25127593|NCT02176525|50240750|FG002|Overall Study|Adverse Event|0|||
25127594|NCT02176525|50240751|FG003|Overall Study|Adverse Event|1|||
25127595|NCT02176525|50240752|FG004|Overall Study|Adverse Event|1|||
25127596|NCT02176525|50240753|FG005|Overall Study|Adverse Event|0|||
25127597|NCT02176525|50240754|FG006|Overall Study|Adverse Event|1|||
25127598|NCT02176525|50240755|FG007|Overall Study|Adverse Event|0|||
25127599|NCT02176525|50240748|FG000|Overall Study|not treated|1|||
25127600|NCT02176525|50240749|FG001|Overall Study|not treated|0|||
25127601|NCT02176525|50240750|FG002|Overall Study|not treated|0|||
25127602|NCT02176525|50240751|FG003|Overall Study|not treated|0|||
25127603|NCT02176525|50240752|FG004|Overall Study|not treated|0|||
25127604|NCT02176525|50240753|FG005|Overall Study|not treated|1|||
25127605|NCT02176525|50240754|FG006|Overall Study|not treated|0|||
25127606|NCT02176525|50240755|FG007|Overall Study|not treated|0|||
25127607|NCT02127931|50240781|FG000|Overall Study|Glitch in Game|1|||
25127608|NCT02127307|50240786|FG000|Overall Study|Protocol Violation|36|||
25127609|NCT02127307|50240786|FG000|Overall Study|Lost to Follow-up|2|||
25127610|NCT02127307|50240786|FG000|Overall Study|Death|101|||
25127611|NCT02127307|50240786|FG000|Overall Study|Other than specified above|169|||
25270908|NCT01218126|50585160|FG002|Overall Study|Lack of Efficacy|2|||
25127612|NCT02126839|50240792|FG000|Overall Study|Adverse Event|0|||
25127613|NCT02126839|50240793|FG001|Overall Study|Adverse Event|1|||
25127614|NCT02126839|50240792|FG000|Overall Study|Withdrawal by Subject|1|||
25127615|NCT02126839|50240793|FG001|Overall Study|Withdrawal by Subject|0|||
25127616|NCT02126839|50240792|FG000|Overall Study|Withdrawal by parent/guardian|1|||
25127617|NCT02126839|50240793|FG001|Overall Study|Withdrawal by parent/guardian|0|||
25127618|NCT02126839|50240792|FG000|Overall Study|Protocol Violation|2|||
25127619|NCT02126839|50240793|FG001|Overall Study|Protocol Violation|3|||
25127620|NCT02126839|50240792|FG000|Overall Study|Sponsor request|0|||
25127621|NCT02126839|50240793|FG001|Overall Study|Sponsor request|1|||
25127622|NCT02126839|50240792|FG000|Overall Study|Lost to Follow-up|1|||
25127623|NCT02126839|50240793|FG001|Overall Study|Lost to Follow-up|4|||
25127624|NCT02126839|50240792|FG000|Overall Study|Other|5|||
25127625|NCT02126839|50240793|FG001|Overall Study|Other|5|||
25127626|NCT02125279|50240799|FG000|Overall Study|Lack of Efficacy|2|||
25127627|NCT02125279|50240799|FG000|Overall Study|Withdrawal by Subject|6|||
25127628|NCT02125279|50240799|FG000|Overall Study|Protocol Violation|1|||
25127629|NCT02125279|50240799|FG000|Overall Study|Lost to Follow-up|4|||
25127630|NCT02124811|50240807|FG000|Overall Study|Early termination|2|||
25127631|NCT02124811|50240808|FG001|Overall Study|Early termination|2|||
25127632|NCT02124811|50240807|FG000|Overall Study|Withdrawal by Subject|1|||
25127633|NCT02124811|50240808|FG001|Overall Study|Withdrawal by Subject|0|||
25127634|NCT02148445|50240816|FG000|Overall Study|Death|1|||
25127635|NCT02148445|50240817|FG001|Overall Study|Death|3|||
25127636|NCT02148211|50240825|FG000|Overall Study|Lost to Follow-up|352|||
25127637|NCT02147587|50240831|FG000|Overall Study|Adverse Event|9|||
25127638|NCT02147587|50240832|FG001|Overall Study|Adverse Event|4|||
25127639|NCT02147587|50240831|FG000|Overall Study|Lack of Efficacy|2|||
25127640|NCT02147587|50240832|FG001|Overall Study|Lack of Efficacy|1|||
25127641|NCT02147353|50240840|FG000|Overall Study|Lost to Follow-up|2|||
25127642|NCT02147353|50240841|FG001|Overall Study|Lost to Follow-up|0|||
25127643|NCT02147353|50240840|FG000|Overall Study|unable to make visits|4|||
25127644|NCT02147353|50240841|FG001|Overall Study|unable to make visits|0|||
25127645|NCT02147353|50240840|FG000|Overall Study|medication noncompliance|3|||
25127646|NCT02147353|50240841|FG001|Overall Study|medication noncompliance|0|||
25127647|NCT02147197|50240850|FG000|Overall Study|Adverse Event|1|||
25127648|NCT02147197|50240851|FG001|Overall Study|Adverse Event|0|||
25127649|NCT02147197|50240852|FG002|Overall Study|Adverse Event|0|||
25127650|NCT02147197|50240850|FG000|Overall Study|Withdrawal of Consent|4|||
25127651|NCT02147197|50240851|FG001|Overall Study|Withdrawal of Consent|3|||
25127652|NCT02147197|50240852|FG002|Overall Study|Withdrawal of Consent|2|||
25127653|NCT02147197|50240850|FG000|Overall Study|Lost to Follow-up|2|||
25127654|NCT02147197|50240851|FG001|Overall Study|Lost to Follow-up|3|||
25127655|NCT02147197|50240852|FG002|Overall Study|Lost to Follow-up|1|||
25127656|NCT02147197|50240850|FG000|Overall Study|Protocol Violation|1|||
25127657|NCT02147197|50240851|FG001|Overall Study|Protocol Violation|0|||
25127658|NCT02147197|50240852|FG002|Overall Study|Protocol Violation|3|||
25127659|NCT02147197|50240850|FG000|Overall Study|Other Miscellaneous Reasons|1|||
25127660|NCT02147197|50240851|FG001|Overall Study|Other Miscellaneous Reasons|0|||
25127661|NCT02147197|50240852|FG002|Overall Study|Other Miscellaneous Reasons|3|||
25127662|NCT02176291|50240862|FG000|Overall Study|Death|1|||
25270909|NCT01218126|50585161|FG003|Overall Study|Lack of Efficacy|6|||
25270910|NCT01218126|50585158|FG000|Overall Study|Protocol Violation|5|||
25270911|NCT01218126|50585159|FG001|Overall Study|Protocol Violation|2|||
25270912|NCT01218126|50585160|FG002|Overall Study|Protocol Violation|2|||
25270913|NCT01218126|50585161|FG003|Overall Study|Protocol Violation|3|||
25270914|NCT01218126|50585158|FG000|Overall Study|Protocol-defined stopping criteria|1|||
25270915|NCT01218126|50585159|FG001|Overall Study|Protocol-defined stopping criteria|1|||
25270916|NCT01218126|50585160|FG002|Overall Study|Protocol-defined stopping criteria|0|||
25270917|NCT01218126|50585161|FG003|Overall Study|Protocol-defined stopping criteria|0|||
25270918|NCT01218126|50585158|FG000|Overall Study|Lost to Follow-up|0|||
25270919|NCT01218126|50585159|FG001|Overall Study|Lost to Follow-up|0|||
25270920|NCT01218126|50585160|FG002|Overall Study|Lost to Follow-up|0|||
25270921|NCT01218126|50585161|FG003|Overall Study|Lost to Follow-up|2|||
25270922|NCT01218126|50585158|FG000|Overall Study|Physician Decision|1|||
25270923|NCT01218126|50585159|FG001|Overall Study|Physician Decision|2|||
25270924|NCT01218126|50585160|FG002|Overall Study|Physician Decision|4|||
25270925|NCT01218126|50585161|FG003|Overall Study|Physician Decision|2|||
25270926|NCT01218126|50585158|FG000|Overall Study|Withdrawal by Subject|2|||
25270927|NCT01218126|50585159|FG001|Overall Study|Withdrawal by Subject|5|||
25270928|NCT01218126|50585160|FG002|Overall Study|Withdrawal by Subject|4|||
25270929|NCT01218126|50585161|FG003|Overall Study|Withdrawal by Subject|6|||
25270930|NCT01217892|50585175|FG000|Overall Study|Adverse Event|1|||
25270931|NCT01217892|50585176|FG001|Overall Study|Adverse Event|1|||
25270932|NCT01217892|50585177|FG002|Overall Study|Adverse Event|1|||
25270933|NCT01217892|50585178|FG003|Overall Study|Adverse Event|0|||
25127663|NCT02176291|50240863|FG001|Overall Study|Death|0|||
25127664|NCT02176291|50240862|FG000|Overall Study|non compliance with protocol|2|||
25127665|NCT02176291|50240863|FG001|Overall Study|non compliance with protocol|0|||
25127666|NCT02176291|50240862|FG000|Overall Study|Withdrawal by Subject|2|||
25270934|NCT01217892|50585175|FG000|Overall Study|Withdrawal by Subject|0|||
25127667|NCT02176291|50240863|FG001|Overall Study|Withdrawal by Subject|0|||
25127668|NCT02175745|50240869|FG000|Overall Study|Not Eligible|1|||
25127669|NCT02175277|50240873|FG000|Overall Study|Protocol-specified Criteria|1|||
25127670|NCT02124265|50240877|FG000|Overall Study|Adverse Event|1|||
25270935|NCT01217892|50585176|FG001|Overall Study|Withdrawal by Subject|2|||
25270936|NCT01217892|50585177|FG002|Overall Study|Withdrawal by Subject|1|||
25127671|NCT02146105|50240881|FG000|Overall Study|Adverse Event|1|||
25127672|NCT02146105|50240881|FG000|Overall Study|Withdrawal by Subject|5|||
25127673|NCT02175199|50240887|FG000|Overall Study|Withdrawal by Subject|1|||
25270937|NCT01217892|50585178|FG003|Overall Study|Withdrawal by Subject|0|||
25270938|NCT01217892|50585175|FG000|Overall Study|Lab value|1|||
25127674|NCT02175199|50240888|FG001|Overall Study|Withdrawal by Subject|5|||
25127675|NCT02175199|50240887|FG000|Overall Study|Randomized in Error|1|||
25127676|NCT02175199|50240888|FG001|Overall Study|Randomized in Error|0|||
25127677|NCT02175199|50240887|FG000|Overall Study|Sponsor Decision|1|||
25127678|NCT02175199|50240888|FG001|Overall Study|Sponsor Decision|0|||
25127679|NCT02123797|50240897|FG000|Baseline Intervention|Death|9|||
25127680|NCT02123797|50240898|FG001|Baseline Intervention|Death|16|||
25127681|NCT02123797|50240899|FG002|Baseline Intervention|Death|0|||
25127682|NCT02123797|50240900|FG003|Baseline Intervention|Death|0|||
25127683|NCT02123797|50240901|FG004|Baseline Intervention|Death|0|||
25127684|NCT02123797|50240897|FG000|Baseline Intervention|Withdrawal by Subject|2|||
25127685|NCT02123797|50240898|FG001|Baseline Intervention|Withdrawal by Subject|8|||
25127686|NCT02123797|50240899|FG002|Baseline Intervention|Withdrawal by Subject|0|||
25127687|NCT02123797|50240900|FG003|Baseline Intervention|Withdrawal by Subject|0|||
25127688|NCT02123797|50240901|FG004|Baseline Intervention|Withdrawal by Subject|0|||
25127689|NCT02123797|50240897|FG000|Baseline Intervention|Relocation|2|||
25127690|NCT02123797|50240898|FG001|Baseline Intervention|Relocation|0|||
25127691|NCT02123797|50240899|FG002|Baseline Intervention|Relocation|0|||
25127692|NCT02123797|50240900|FG003|Baseline Intervention|Relocation|0|||
25127693|NCT02123797|50240901|FG004|Baseline Intervention|Relocation|0|||
25127694|NCT02123797|50240897|FG000|Baseline Intervention|Out of window for initial survey|6|||
25127695|NCT02123797|50240898|FG001|Baseline Intervention|Out of window for initial survey|13|||
25127696|NCT02123797|50240899|FG002|Baseline Intervention|Out of window for initial survey|0|||
25127697|NCT02123797|50240900|FG003|Baseline Intervention|Out of window for initial survey|0|||
25127698|NCT02123797|50240901|FG004|Baseline Intervention|Out of window for initial survey|0|||
25127699|NCT02123797|50240897|FG000|Baseline Intervention|Lost to Follow-up|0|||
25127700|NCT02123797|50240898|FG001|Baseline Intervention|Lost to Follow-up|5|||
25127701|NCT02123797|50240899|FG002|Baseline Intervention|Lost to Follow-up|0|||
25127702|NCT02123797|50240900|FG003|Baseline Intervention|Lost to Follow-up|0|||
25270939|NCT01217892|50585176|FG001|Overall Study|Lab value|0|||
25270940|NCT01217892|50585177|FG002|Overall Study|Lab value|1|||
25270941|NCT01217892|50585178|FG003|Overall Study|Lab value|0|||
25270942|NCT01217892|50585175|FG000|Overall Study|Subject no longer meets study criteria|5|||
25270943|NCT01217892|50585176|FG001|Overall Study|Subject no longer meets study criteria|2|||
25270944|NCT01217892|50585177|FG002|Overall Study|Subject no longer meets study criteria|4|||
25270945|NCT01217892|50585178|FG003|Overall Study|Subject no longer meets study criteria|8|||
25270946|NCT01217892|50585175|FG000|Overall Study|Incorrect enrollment|0|||
25270947|NCT01217892|50585176|FG001|Overall Study|Incorrect enrollment|1|||
25270948|NCT01217892|50585177|FG002|Overall Study|Incorrect enrollment|1|||
25270949|NCT01217892|50585178|FG003|Overall Study|Incorrect enrollment|0|||
25270950|NCT01217892|50585175|FG000|Overall Study|Poor/Non-Compliance|0|||
25270951|NCT01217892|50585176|FG001|Overall Study|Poor/Non-Compliance|0|||
25270952|NCT01217892|50585177|FG002|Overall Study|Poor/Non-Compliance|1|||
25270953|NCT01217892|50585178|FG003|Overall Study|Poor/Non-Compliance|0|||
25270954|NCT01217814|50585191|FG000|Overall Study|Adverse Event|1|||
25270955|NCT01217814|50585192|FG001|Overall Study|Adverse Event|1|||
25270956|NCT01217814|50585193|FG002|Overall Study|Adverse Event|0|||
25270957|NCT01217814|50585191|FG000|Overall Study|Lack of Efficacy|0|||
25270958|NCT01217814|50585192|FG001|Overall Study|Lack of Efficacy|0|||
25270959|NCT01217814|50585193|FG002|Overall Study|Lack of Efficacy|1|||
25270960|NCT01217190|50585204|FG000|Second Dosing|Withdrawal by Subject|0|||
25270961|NCT01217190|50585205|FG001|Second Dosing|Withdrawal by Subject|2|||
25270962|NCT01136733|50585221|FG000|Phase 1b|Adverse Event|0|||
25270963|NCT01136733|50585222|FG001|Phase 1b|Adverse Event|3|||
25270964|NCT01136733|50585223|FG002|Phase 1b|Adverse Event|1|||
25270965|NCT01136733|50585224|FG003|Phase 1b|Adverse Event|0|||
25270966|NCT01136733|50585225|FG004|Phase 1b|Adverse Event|0|||
25270967|NCT01136733|50585226|FG005|Phase 1b|Adverse Event|0|||
25270968|NCT01136733|50585227|FG006|Phase 1b|Adverse Event|0|||
25270969|NCT01136733|50585221|FG000|Phase 1b|Participant Choice|0|||
25127703|NCT02123797|50240901|FG004|Baseline Intervention|Lost to Follow-up|0|||
25127704|NCT02123797|50240897|FG000|Baseline Intervention|Other Disease|3|||
25127705|NCT02123797|50240898|FG001|Baseline Intervention|Other Disease|0|||
25127706|NCT02123797|50240899|FG002|Baseline Intervention|Other Disease|0|||
25127707|NCT02123797|50240900|FG003|Baseline Intervention|Other Disease|0|||
25270970|NCT01136733|50585222|FG001|Phase 1b|Participant Choice|0|||
25270971|NCT01136733|50585223|FG002|Phase 1b|Participant Choice|1|||
25270972|NCT01136733|50585224|FG003|Phase 1b|Participant Choice|0|||
25270973|NCT01136733|50585225|FG004|Phase 1b|Participant Choice|0|||
25270974|NCT01136733|50585226|FG005|Phase 1b|Participant Choice|0|||
25127708|NCT02123797|50240901|FG004|Baseline Intervention|Other Disease|0|||
25270975|NCT01136733|50585227|FG006|Phase 1b|Participant Choice|0|||
25270976|NCT01136733|50585221|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
25270977|NCT01136733|50585222|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
25127709|NCT02123797|50240897|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
25127710|NCT02123797|50240898|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
25270978|NCT01136733|50585223|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
25270979|NCT01136733|50585224|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
25270980|NCT01136733|50585225|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
25270981|NCT01136733|50585226|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
25270982|NCT01136733|50585227|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
25270983|NCT01136733|50585221|FG000|Phase 1b|Clinical Progression|1|||
25270984|NCT01136733|50585222|FG001|Phase 1b|Clinical Progression|1|||
25270985|NCT01136733|50585223|FG002|Phase 1b|Clinical Progression|0|||
25270986|NCT01136733|50585224|FG003|Phase 1b|Clinical Progression|0|||
25270987|NCT01136733|50585225|FG004|Phase 1b|Clinical Progression|0|||
25270988|NCT01136733|50585226|FG005|Phase 1b|Clinical Progression|0|||
25270989|NCT01136733|50585227|FG006|Phase 1b|Clinical Progression|0|||
25270990|NCT01136733|50585221|FG000|Phase 2|Disease Progression|0|||
25270991|NCT01136733|50585222|FG001|Phase 2|Disease Progression|0|||
25270992|NCT01136733|50585223|FG002|Phase 2|Disease Progression|0|||
25270993|NCT01136733|50585224|FG003|Phase 2|Disease Progression|0|||
25270994|NCT01136733|50585225|FG004|Phase 2|Disease Progression|30|||
25270995|NCT01136733|50585226|FG005|Phase 2|Disease Progression|32|||
25270996|NCT01136733|50585227|FG006|Phase 2|Disease Progression|38|||
25270997|NCT01136733|50585221|FG000|Phase 2|Adverse Event|0|||
25270998|NCT01136733|50585222|FG001|Phase 2|Adverse Event|0|||
25270999|NCT01136733|50585223|FG002|Phase 2|Adverse Event|0|||
25271000|NCT01136733|50585224|FG003|Phase 2|Adverse Event|0|||
25127711|NCT02123797|50240899|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
25127712|NCT02123797|50240900|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
25127713|NCT02123797|50240901|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
25127714|NCT02123797|50240897|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
25127715|NCT02123797|50240898|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
25127716|NCT02123797|50240899|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
25127717|NCT02123797|50240900|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
25127718|NCT02123797|50240901|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
25127719|NCT02123797|50240897|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
25127720|NCT02123797|50240898|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
25127721|NCT02123797|50240899|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
25127722|NCT02123797|50240900|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
25127723|NCT02123797|50240901|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
25127724|NCT02123797|50240897|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
25127725|NCT02123797|50240898|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
25127726|NCT02123797|50240899|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
25127727|NCT02123797|50240900|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
25127728|NCT02123797|50240901|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
25127729|NCT02123797|50240897|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
25127730|NCT02123797|50240898|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
25127731|NCT02123797|50240899|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
25127732|NCT02123797|50240900|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
25127733|NCT02123797|50240901|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
25127734|NCT02123797|50240897|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
25127735|NCT02123797|50240898|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
25127736|NCT02123797|50240899|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
25127737|NCT02123797|50240900|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
25127738|NCT02123797|50240901|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
25127739|NCT02123797|50240897|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
25127740|NCT02123797|50240898|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
25127741|NCT02123797|50240899|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
25127742|NCT02123797|50240900|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
25127743|NCT02123797|50240901|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
25127744|NCT02123797|50240897|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
25127745|NCT02123797|50240898|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
25127746|NCT02123797|50240899|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
25127747|NCT02123797|50240900|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
25127748|NCT02123797|50240901|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
25127749|NCT02123797|50240897|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
25127750|NCT02123797|50240898|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
25127751|NCT02123797|50240899|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
25127752|NCT02123797|50240900|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
25127753|NCT02123797|50240901|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
25271001|NCT01136733|50585225|FG004|Phase 2|Adverse Event|11|||
25271002|NCT01136733|50585226|FG005|Phase 2|Adverse Event|13|||
25271003|NCT01136733|50585227|FG006|Phase 2|Adverse Event|5|||
25271004|NCT01136733|50585221|FG000|Phase 2|Participant Choice|0|||
25271005|NCT01136733|50585222|FG001|Phase 2|Participant Choice|0|||
25271006|NCT01136733|50585223|FG002|Phase 2|Participant Choice|0|||
25127754|NCT02175121|50240926|FG000|Overall Study|Lack of Efficacy|1|||
25127755|NCT02175121|50240927|FG001|Overall Study|Lack of Efficacy|0|||
25127756|NCT02175121|50240928|FG002|Overall Study|Lack of Efficacy|0|||
25127757|NCT02175121|50240929|FG003|Overall Study|Lack of Efficacy|0|||
25127758|NCT02175121|50240930|FG004|Overall Study|Lack of Efficacy|0|||
25127759|NCT02175121|50240926|FG000|Overall Study|Lost to Follow-up|0|||
25127760|NCT02175121|50240927|FG001|Overall Study|Lost to Follow-up|1|||
25127761|NCT02175121|50240928|FG002|Overall Study|Lost to Follow-up|0|||
25127762|NCT02175121|50240929|FG003|Overall Study|Lost to Follow-up|1|||
25127763|NCT02175121|50240930|FG004|Overall Study|Lost to Follow-up|0|||
25127764|NCT02175121|50240926|FG000|Overall Study|Personal emergency|0|||
25127765|NCT02175121|50240927|FG001|Overall Study|Personal emergency|0|||
25127766|NCT02175121|50240928|FG002|Overall Study|Personal emergency|0|||
25127767|NCT02175121|50240929|FG003|Overall Study|Personal emergency|0|||
25127768|NCT02175121|50240930|FG004|Overall Study|Personal emergency|1|||
25127769|NCT02175121|50240926|FG000|Overall Study|Schedule conflict|0|||
25127770|NCT02175121|50240927|FG001|Overall Study|Schedule conflict|0|||
25127771|NCT02175121|50240928|FG002|Overall Study|Schedule conflict|1|||
25127772|NCT02175121|50240929|FG003|Overall Study|Schedule conflict|0|||
25127773|NCT02175121|50240930|FG004|Overall Study|Schedule conflict|0|||
25127774|NCT02175121|50240926|FG000|Overall Study|Time issues|0|||
25127775|NCT02175121|50240927|FG001|Overall Study|Time issues|0|||
25127776|NCT02175121|50240928|FG002|Overall Study|Time issues|1|||
25127777|NCT02175121|50240929|FG003|Overall Study|Time issues|0|||
25127778|NCT02175121|50240930|FG004|Overall Study|Time issues|0|||
25127779|NCT01568866|50240948|FG000|Overall Study|Disease Progression|208|||
25127780|NCT01568866|50240949|FG001|Overall Study|Disease Progression|183|||
25127781|NCT01568866|50240948|FG000|Overall Study|Adverse Event|94|||
25271007|NCT01136733|50585224|FG003|Phase 2|Participant Choice|0|||
25271008|NCT01136733|50585225|FG004|Phase 2|Participant Choice|3|||
25127782|NCT01568866|50240949|FG001|Overall Study|Adverse Event|96|||
25127783|NCT01568866|50240948|FG000|Overall Study|Patient Request|55|||
25127784|NCT01568866|50240949|FG001|Overall Study|Patient Request|71|||
25127785|NCT01568866|50240948|FG000|Overall Study|Physician Decision|40|||
25127786|NCT01568866|50240949|FG001|Overall Study|Physician Decision|32|||
25127787|NCT01568866|50240948|FG000|Overall Study|Withdrawal by Subject|19|||
25127788|NCT01568866|50240949|FG001|Overall Study|Withdrawal by Subject|11|||
25127789|NCT01568866|50240948|FG000|Overall Study|Death|10|||
25271009|NCT01136733|50585226|FG005|Phase 2|Participant Choice|0|||
25271010|NCT01136733|50585227|FG006|Phase 2|Participant Choice|1|||
25271011|NCT01136733|50585221|FG000|Phase 2|Administrative-Withdrew Consent|0|||
25271012|NCT01136733|50585222|FG001|Phase 2|Administrative-Withdrew Consent|0|||
25271013|NCT01136733|50585223|FG002|Phase 2|Administrative-Withdrew Consent|0|||
25271014|NCT01136733|50585224|FG003|Phase 2|Administrative-Withdrew Consent|0|||
25271015|NCT01136733|50585225|FG004|Phase 2|Administrative-Withdrew Consent|1|||
25271016|NCT01136733|50585226|FG005|Phase 2|Administrative-Withdrew Consent|0|||
25271017|NCT01136733|50585227|FG006|Phase 2|Administrative-Withdrew Consent|0|||
25271018|NCT01136733|50585221|FG000|Phase 2|Other|0|||
25271019|NCT01136733|50585222|FG001|Phase 2|Other|0|||
25271020|NCT01136733|50585223|FG002|Phase 2|Other|0|||
25271021|NCT01136733|50585224|FG003|Phase 2|Other|0|||
25271022|NCT01136733|50585225|FG004|Phase 2|Other|6|||
25271023|NCT01136733|50585226|FG005|Phase 2|Other|7|||
25271024|NCT01136733|50585227|FG006|Phase 2|Other|6|||
25271025|NCT01136655|50585257|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
25271026|NCT01136655|50585257|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
25271027|NCT01136655|50585257|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
25271028|NCT01136655|50585257|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
25271029|NCT01135017|50585272|FG000|Overall Study|Adverse Event|3|||
25271030|NCT01135017|50585273|FG001|Overall Study|Adverse Event|8|||
25271031|NCT01135017|50585272|FG000|Overall Study|Other than above|3|||
25271032|NCT01135017|50585273|FG001|Overall Study|Other than above|4|||
25271033|NCT01134939|50585287|FG000|Overall Study|Adverse Event|9|||
25127790|NCT01568866|50240949|FG001|Overall Study|Death|18|||
25127791|NCT01568866|50240948|FG000|Overall Study|Protocol Non-compliance|2|||
25271034|NCT01134939|50585288|FG001|Overall Study|Adverse Event|3|||
25271035|NCT01134939|50585289|FG002|Overall Study|Adverse Event|4|||
25271036|NCT01134939|50585290|FG003|Overall Study|Adverse Event|5|||
25271037|NCT01134939|50585291|FG004|Overall Study|Adverse Event|5|||
25271038|NCT01134939|50585292|FG005|Overall Study|Adverse Event|5|||
25271039|NCT01134939|50585293|FG006|Overall Study|Adverse Event|1|||
25127792|NCT01568866|50240949|FG001|Overall Study|Protocol Non-compliance|4|||
25127793|NCT01568866|50240948|FG000|Overall Study|Lost to Follow-up|1|||
25127794|NCT01568866|50240949|FG001|Overall Study|Lost to Follow-up|0|||
25127795|NCT01568866|50240948|FG000|Overall Study|Randomized but Not Dosed|9|||
25271040|NCT01134939|50585294|FG007|Overall Study|Adverse Event|0|||
25271041|NCT01134939|50585287|FG000|Overall Study|Lack of Efficacy|2|||
25271042|NCT01134939|50585288|FG001|Overall Study|Lack of Efficacy|5|||
25271043|NCT01134939|50585289|FG002|Overall Study|Lack of Efficacy|1|||
25271044|NCT01134939|50585290|FG003|Overall Study|Lack of Efficacy|0|||
25127796|NCT01568866|50240949|FG001|Overall Study|Randomized but Not Dosed|1|||
25271045|NCT01134939|50585291|FG004|Overall Study|Lack of Efficacy|3|||
25271046|NCT01134939|50585292|FG005|Overall Study|Lack of Efficacy|0|||
25271047|NCT01134939|50585293|FG006|Overall Study|Lack of Efficacy|1|||
25271048|NCT01134939|50585294|FG007|Overall Study|Lack of Efficacy|0|||
25271049|NCT01134939|50585287|FG000|Overall Study|Lost to Follow-up|2|||
25271050|NCT01134939|50585288|FG001|Overall Study|Lost to Follow-up|3|||
25271051|NCT01134939|50585289|FG002|Overall Study|Lost to Follow-up|0|||
25271052|NCT01134939|50585290|FG003|Overall Study|Lost to Follow-up|1|||
25271053|NCT01134939|50585291|FG004|Overall Study|Lost to Follow-up|2|||
25271054|NCT01134939|50585292|FG005|Overall Study|Lost to Follow-up|1|||
25271055|NCT01134939|50585293|FG006|Overall Study|Lost to Follow-up|0|||
25271056|NCT01134939|50585294|FG007|Overall Study|Lost to Follow-up|0|||
25271057|NCT01134939|50585287|FG000|Overall Study|Death|0|||
25271058|NCT01134939|50585288|FG001|Overall Study|Death|1|||
25271059|NCT01134939|50585289|FG002|Overall Study|Death|0|||
25271060|NCT01134939|50585290|FG003|Overall Study|Death|0|||
25271061|NCT01134939|50585291|FG004|Overall Study|Death|0|||
25271062|NCT01134939|50585292|FG005|Overall Study|Death|0|||
25271063|NCT01134939|50585293|FG006|Overall Study|Death|0|||
25271064|NCT01134939|50585294|FG007|Overall Study|Death|0|||
25271065|NCT01134939|50585287|FG000|Overall Study|Termination page not available|4|||
25271066|NCT01134939|50585288|FG001|Overall Study|Termination page not available|6|||
25271067|NCT01134939|50585289|FG002|Overall Study|Termination page not available|5|||
25271068|NCT01134939|50585290|FG003|Overall Study|Termination page not available|8|||
25271069|NCT01134939|50585291|FG004|Overall Study|Termination page not available|0|||
25271070|NCT01134939|50585292|FG005|Overall Study|Termination page not available|3|||
25271071|NCT01134939|50585293|FG006|Overall Study|Termination page not available|7|||
25271072|NCT01134939|50585294|FG007|Overall Study|Termination page not available|0|||
25271073|NCT01134783|50585310|FG000|Overall Study|Pregnancy|16|||
25271074|NCT01134783|50585311|FG001|Overall Study|Pregnancy|8|||
25271075|NCT01134783|50585310|FG000|Overall Study|Withdrawal by Subject|15|||
25271076|NCT01134783|50585311|FG001|Overall Study|Withdrawal by Subject|9|||
25271077|NCT01134783|50585310|FG000|Overall Study|Lost to Follow-up|5|||
25271078|NCT01134783|50585311|FG001|Overall Study|Lost to Follow-up|20|||
25271079|NCT01134705|50585323|FG000|Overall Study|Adverse Event|1|||
25271080|NCT01134705|50585324|FG001|Overall Study|Adverse Event|7|||
25271081|NCT01134705|50585323|FG000|Overall Study|Withdrawal by Subject|6|||
25271082|NCT01134705|50585324|FG001|Overall Study|Withdrawal by Subject|6|||
25271083|NCT01134705|50585323|FG000|Overall Study|Pregnancy|1|||
25271084|NCT01134705|50585324|FG001|Overall Study|Pregnancy|0|||
25127797|NCT01568320|50240955|FG000|Overall Study|Death|20|||
25127798|NCT01568320|50240955|FG000|Overall Study|Lost to Follow-up|9|||
25127799|NCT01568320|50240955|FG000|Overall Study|Withdrawal by Subject|10|||
25127800|NCT01568320|50240955|FG000|Overall Study|Conversion to open repair|1|||
25127801|NCT01568320|50240955|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
25127802|NCT01567852|50240961|FG000|Overall Study|Withdrawal by Subject|3|||
25127803|NCT01567852|50240962|FG001|Overall Study|Withdrawal by Subject|6|||
25271085|NCT01134705|50585323|FG000|Overall Study|Lost to Follow-up|5|||
25271086|NCT01134705|50585324|FG001|Overall Study|Lost to Follow-up|2|||
25271087|NCT01134705|50585323|FG000|Overall Study|Protocol Violation|1|||
25271088|NCT01134705|50585324|FG001|Overall Study|Protocol Violation|1|||
25271089|NCT01134705|50585323|FG000|Overall Study|Other|1|||
25271090|NCT01134705|50585324|FG001|Overall Study|Other|6|||
25271091|NCT00927823|50585330|FG000|Continuous Dosing Period|Death|0|||
25271092|NCT00927823|50585331|FG001|Continuous Dosing Period|Death|0|||
25271093|NCT00927823|50585332|FG002|Continuous Dosing Period|Death|6|||
25271094|NCT00927823|50585333|FG003|Continuous Dosing Period|Death|0|||
25271095|NCT00927823|50585330|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
25271096|NCT00927823|50585331|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
25271097|NCT00927823|50585332|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
25271098|NCT00927823|50585333|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
25271099|NCT00927823|50585330|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
25271100|NCT00927823|50585331|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
25271101|NCT00927823|50585332|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
25271102|NCT00927823|50585333|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
25271103|NCT00927823|50585330|FG000|Continuous Dosing Period|Other|1|||
25271104|NCT00927823|50585331|FG001|Continuous Dosing Period|Other|2|||
25271105|NCT00927823|50585332|FG002|Continuous Dosing Period|Other|9|||
25271106|NCT00927823|50585333|FG003|Continuous Dosing Period|Other|3|||
25271107|NCT01134627|50585352|FG000|Overall Study|Adverse Event|47|||
25127804|NCT01567852|50240961|FG000|Overall Study|ECT discontinued|1|||
25271108|NCT01134627|50585353|FG001|Overall Study|Adverse Event|31|||
25271109|NCT01134627|50585352|FG000|Overall Study|Lost to Follow-up|1|||
25271110|NCT01134627|50585353|FG001|Overall Study|Lost to Follow-up|2|||
25271111|NCT01134627|50585352|FG000|Overall Study|Protocol Violation|3|||
25271112|NCT01134627|50585353|FG001|Overall Study|Protocol Violation|5|||
25271113|NCT01134627|50585352|FG000|Overall Study|Lack of Efficacy|2|||
25271114|NCT01134627|50585353|FG001|Overall Study|Lack of Efficacy|12|||
25271115|NCT01134627|50585352|FG000|Overall Study|Withdrawal by Subject|4|||
25271116|NCT01134627|50585353|FG001|Overall Study|Withdrawal by Subject|3|||
25271117|NCT01134627|50585352|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
25271118|NCT01134627|50585353|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
25271119|NCT01134627|50585352|FG000|Overall Study|Other|11|||
25271120|NCT01134627|50585353|FG001|Overall Study|Other|14|||
25271121|NCT01134393|50585359|FG000|Overall Study|Adverse Event|18|||
25271122|NCT01134393|50585359|FG000|Overall Study|Lack of Efficacy|2|||
25271123|NCT01134393|50585359|FG000|Overall Study|Protocol Violation|12|||
25271124|NCT01134393|50585359|FG000|Overall Study|Lost to Follow-up|3|||
25271125|NCT01134393|50585359|FG000|Overall Study|Withdrawal by Subject|11|||
25271126|NCT01134393|50585359|FG000|Overall Study|Other|6|||
25271127|NCT00922441|50585367|FG000|Overall Study|Protocol Violation|0|||
25271128|NCT00922441|50585368|FG001|Overall Study|Protocol Violation|0|||
25271129|NCT00922441|50585369|FG002|Overall Study|Protocol Violation|2|||
25271130|NCT00922441|50585367|FG000|Overall Study|Withdrawal by Subject|0|||
25271131|NCT00922441|50585368|FG001|Overall Study|Withdrawal by Subject|0|||
25271132|NCT00922441|50585369|FG002|Overall Study|Withdrawal by Subject|1|||
25271133|NCT01217112|50585382|FG000|Overall Study|Adverse Event|0|||
25271134|NCT01217112|50585383|FG001|Overall Study|Adverse Event|2|||
25271135|NCT01217112|50585384|FG002|Overall Study|Adverse Event|0|||
25271136|NCT01217112|50585385|FG003|Overall Study|Adverse Event|2|||
25271137|NCT01217112|50585386|FG004|Overall Study|Adverse Event|0|||
25271138|NCT01217112|50585382|FG000|Overall Study|Withdrawal by Subject|0|||
25271139|NCT01217112|50585383|FG001|Overall Study|Withdrawal by Subject|0|||
25271140|NCT01217112|50585384|FG002|Overall Study|Withdrawal by Subject|1|||
25271141|NCT01217112|50585385|FG003|Overall Study|Withdrawal by Subject|0|||
25271142|NCT01217112|50585386|FG004|Overall Study|Withdrawal by Subject|0|||
25271143|NCT01217112|50585382|FG000|Overall Study|Physician Decision|0|||
25271144|NCT01217112|50585383|FG001|Overall Study|Physician Decision|0|||
25271145|NCT01217112|50585384|FG002|Overall Study|Physician Decision|0|||
25271146|NCT01217112|50585385|FG003|Overall Study|Physician Decision|0|||
25271147|NCT01217112|50585386|FG004|Overall Study|Physician Decision|1|||
25271148|NCT01216332|50585400|FG000|Overall Study|Withdrawal by Subject|4|||
25271149|NCT01216332|50585401|FG001|Overall Study|Withdrawal by Subject|0|||
25271150|NCT00922207|50585410|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
25271151|NCT00922207|50585411|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
25271152|NCT00922207|50585412|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
25271153|NCT00922207|50585410|FG000|Overall Study|Insufficient Therapeutic Response|0|||
25271154|NCT00922207|50585411|FG001|Overall Study|Insufficient Therapeutic Response|0|||
25271155|NCT00922207|50585412|FG002|Overall Study|Insufficient Therapeutic Response|1|||
25271156|NCT00922207|50585410|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
25271157|NCT00922207|50585411|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
25271158|NCT00922207|50585412|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
25271159|NCT00922207|50585410|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
25271160|NCT00922207|50585411|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
25271161|NCT00922207|50585412|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
25271162|NCT00922207|50585410|FG000|Overall Study|Withdrew Consent|2|||
25271163|NCT00922207|50585411|FG001|Overall Study|Withdrew Consent|5|||
25271164|NCT00922207|50585412|FG002|Overall Study|Withdrew Consent|2|||
25127805|NCT01567852|50240962|FG001|Overall Study|ECT discontinued|1|||
25127806|NCT01588366|50240973|FG000|Overall Study|Adverse Event|0|||
25127807|NCT01588366|50240974|FG001|Overall Study|Adverse Event|1|||
25127808|NCT01588366|50240975|FG002|Overall Study|Adverse Event|0|||
25127809|NCT01588366|50240976|FG003|Overall Study|Adverse Event|1|||
25127810|NCT01588366|50240977|FG004|Overall Study|Adverse Event|0|||
25127811|NCT01588366|50240978|FG005|Overall Study|Adverse Event|2|||
25127812|NCT01686958|50240994|FG000|Overall Study|Withdrawal by Subject|1|||
25127813|NCT01686568|50241001|FG000|Main Study|Withdrawal by Subject|1|||
25127814|NCT01686568|50241002|FG001|Main Study|Withdrawal by Subject|3|||
25271165|NCT00922207|50585410|FG000|Overall Study|Abnormality of Laboratory Test|0|||
25271166|NCT00922207|50585411|FG001|Overall Study|Abnormality of Laboratory Test|1|||
25271167|NCT00922207|50585412|FG002|Overall Study|Abnormality of Laboratory Test|1|||
25271168|NCT01134315|50585422|FG000|Overall Study|Adverse Event|1|||
25271169|NCT01134315|50585423|FG001|Overall Study|Adverse Event|2|||
25271170|NCT01134315|50585422|FG000|Overall Study|Other Reason|8|||
25271171|NCT01134315|50585423|FG001|Overall Study|Other Reason|17|||
25271172|NCT01216176|50585432|FG000|Overall Study|Adverse Event|0|||
25271173|NCT01216176|50585433|FG001|Overall Study|Adverse Event|8|||
25271174|NCT01216176|50585434|FG002|Overall Study|Adverse Event|0|||
25271175|NCT01216176|50585432|FG000|Overall Study|Physician Decision|0|||
25271176|NCT01216176|50585433|FG001|Overall Study|Physician Decision|0|||
25127815|NCT01686568|50241001|FG000|Main Study|Noncompliance with protocol|0|||
25271177|NCT01216176|50585434|FG002|Overall Study|Physician Decision|1|||
25271178|NCT01133847|50585446|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
25127816|NCT01686568|50241002|FG001|Main Study|Noncompliance with protocol|1|||
25127817|NCT01686568|50241001|FG000|Main Study|Liver enzymes above range of exclusion|1|||
25127818|NCT01686568|50241002|FG001|Main Study|Liver enzymes above range of exclusion|0|||
25127819|NCT01686568|50241001|FG000|Sub-Study|Not consented for sub-study|2|||
25127820|NCT01686568|50241002|FG001|Sub-Study|Not consented for sub-study|2|||
25127821|NCT01567462|50241010|FG000|Overall Study|Withdrawal by Subject|4|||
25127822|NCT01567462|50241011|FG001|Overall Study|Withdrawal by Subject|7|||
25127823|NCT01587898|50241021|FG000|Overall Study|Adverse Event|1|||
25127824|NCT01587898|50241022|FG001|Overall Study|Adverse Event|1|||
25127825|NCT01587898|50241023|FG002|Overall Study|Adverse Event|0|||
25127826|NCT01587898|50241024|FG003|Overall Study|Adverse Event|0|||
25127827|NCT01587898|50241021|FG000|Overall Study|Protocol Violation|0|||
25271179|NCT01133847|50585447|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
25271180|NCT01133847|50585448|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
25271181|NCT01133847|50585446|FG000|Follow-Up Phase|Lost to Follow-up|1|||
25271182|NCT01133847|50585447|FG001|Follow-Up Phase|Lost to Follow-up|3|||
25271183|NCT01133847|50585448|FG002|Follow-Up Phase|Lost to Follow-up|7|||
25271184|NCT01133379|50585460|FG000|Overall Study|Withdrawal by Subject|0|||
25271185|NCT01133379|50585461|FG001|Overall Study|Withdrawal by Subject|1|||
25271186|NCT01133379|50585462|FG002|Overall Study|Withdrawal by Subject|1|||
25271187|NCT01133379|50585460|FG000|Overall Study|Lost to Follow-up|1|||
25271188|NCT01133379|50585461|FG001|Overall Study|Lost to Follow-up|1|||
25271189|NCT01133379|50585462|FG002|Overall Study|Lost to Follow-up|1|||
25271190|NCT01133067|50585470|FG000|Overall Study|Death|136|||
25271191|NCT01133067|50585470|FG000|Overall Study|Lost to Follow-up|3|||
25127828|NCT01587898|50241022|FG001|Overall Study|Protocol Violation|2|||
25127829|NCT01587898|50241023|FG002|Overall Study|Protocol Violation|1|||
25127830|NCT01587898|50241024|FG003|Overall Study|Protocol Violation|1|||
25127831|NCT01587898|50241021|FG000|Overall Study|Lost to Follow-up|0|||
25127832|NCT01587898|50241022|FG001|Overall Study|Lost to Follow-up|0|||
25127833|NCT01587898|50241023|FG002|Overall Study|Lost to Follow-up|0|||
25127834|NCT01587898|50241024|FG003|Overall Study|Lost to Follow-up|1|||
25127835|NCT01587898|50241021|FG000|Overall Study|Withdrawal by Subject|2|||
25127836|NCT01587898|50241022|FG001|Overall Study|Withdrawal by Subject|1|||
25127837|NCT01587898|50241023|FG002|Overall Study|Withdrawal by Subject|0|||
25127838|NCT01587898|50241024|FG003|Overall Study|Withdrawal by Subject|0|||
25127839|NCT01587898|50241021|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
25127840|NCT01587898|50241022|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
25127841|NCT01587898|50241023|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
25127842|NCT01587898|50241024|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
25127843|NCT01567306|50241043|FG000|Overall Study|Protocol Violation|2|||
25127844|NCT01567306|50241044|FG001|Overall Study|Protocol Violation|2|||
25127845|NCT01567306|50241045|FG002|Overall Study|Protocol Violation|0|||
25127846|NCT01567306|50241046|FG003|Overall Study|Protocol Violation|3|||
25127847|NCT01567306|50241047|FG004|Overall Study|Protocol Violation|1|||
25127848|NCT01567306|50241048|FG005|Overall Study|Protocol Violation|1|||
25127849|NCT01567306|50241043|FG000|Overall Study|Change site living|1|||
25127850|NCT01567306|50241044|FG001|Overall Study|Change site living|0|||
25127851|NCT01567306|50241045|FG002|Overall Study|Change site living|0|||
25127852|NCT01567306|50241046|FG003|Overall Study|Change site living|0|||
25127853|NCT01567306|50241047|FG004|Overall Study|Change site living|0|||
25127854|NCT01567306|50241048|FG005|Overall Study|Change site living|0|||
25127855|NCT01567306|50241043|FG000|Overall Study|Adverse Event|0|||
25127856|NCT01567306|50241044|FG001|Overall Study|Adverse Event|0|||
25127857|NCT01567306|50241045|FG002|Overall Study|Adverse Event|0|||
25127858|NCT01567306|50241046|FG003|Overall Study|Adverse Event|2|||
25127859|NCT01567306|50241047|FG004|Overall Study|Adverse Event|4|||
25127860|NCT01567306|50241048|FG005|Overall Study|Adverse Event|1|||
25127861|NCT01567306|50241043|FG000|Overall Study|Lost to Follow-up|0|||
25127862|NCT01567306|50241044|FG001|Overall Study|Lost to Follow-up|0|||
25127863|NCT01567306|50241045|FG002|Overall Study|Lost to Follow-up|0|||
25127864|NCT01567306|50241046|FG003|Overall Study|Lost to Follow-up|0|||
25127865|NCT01567306|50241047|FG004|Overall Study|Lost to Follow-up|2|||
25127866|NCT01567306|50241048|FG005|Overall Study|Lost to Follow-up|0|||
25127867|NCT01567306|50241043|FG000|Overall Study|Withdrawal by Subject|0|||
25127868|NCT01567306|50241044|FG001|Overall Study|Withdrawal by Subject|0|||
25271192|NCT01132755|50585474|FG000|Overall Study|Procedure not done due to medical reason|23|||
25271193|NCT01132755|50585474|FG000|Overall Study|Protocol Violation|15|||
25271194|NCT01132755|50585474|FG000|Overall Study|Withdrawal by Subject|4|||
25127869|NCT01567306|50241045|FG002|Overall Study|Withdrawal by Subject|0|||
25127870|NCT01567306|50241046|FG003|Overall Study|Withdrawal by Subject|0|||
25127871|NCT01567306|50241047|FG004|Overall Study|Withdrawal by Subject|0|||
25271195|NCT00919711|50585480|FG000|Overall Study|Withdrawal by Subject|15|||
25127872|NCT01567306|50241048|FG005|Overall Study|Withdrawal by Subject|1|||
25127873|NCT01587274|50241065|FG000|Overall Study|Lost to Follow-up|4|||
25127874|NCT01587274|50241066|FG001|Overall Study|Lost to Follow-up|5|||
25271196|NCT00919711|50585481|FG001|Overall Study|Withdrawal by Subject|7|||
25271197|NCT00919711|50585480|FG000|Overall Study|Adverse Event|13|||
25127875|NCT01587274|50241067|FG002|Overall Study|Lost to Follow-up|3|||
25127876|NCT01587118|50241075|FG000|Overall Study|Adverse Event|3|||
25127877|NCT01587118|50241075|FG000|Overall Study|Lost to Follow-up|2|||
25127878|NCT01587118|50241075|FG000|Overall Study|Relocation|1|||
25127879|NCT01587118|50241075|FG000|Overall Study|nonresponse|1|||
25127880|NCT01905657|50241082|FG000|Overall Study|Adverse Event|23|||
25127881|NCT01905657|50241083|FG001|Overall Study|Adverse Event|17|||
25127882|NCT01905657|50241084|FG002|Overall Study|Adverse Event|18|||
25127883|NCT01905657|50241082|FG000|Overall Study|Clinical Progression|103|||
25127884|NCT01905657|50241083|FG001|Overall Study|Clinical Progression|78|||
25127885|NCT01905657|50241084|FG002|Overall Study|Clinical Progression|59|||
25127886|NCT01905657|50241082|FG000|Overall Study|Death|40|||
25127887|NCT01905657|50241083|FG001|Overall Study|Death|43|||
25127888|NCT01905657|50241084|FG002|Overall Study|Death|47|||
25127889|NCT01905657|50241082|FG000|Overall Study|Excluded Medication|13|||
25127890|NCT01905657|50241083|FG001|Overall Study|Excluded Medication|16|||
25127891|NCT01905657|50241084|FG002|Overall Study|Excluded Medication|9|||
25127892|NCT01905657|50241082|FG000|Overall Study|Lost to Follow-up|1|||
25127893|NCT01905657|50241083|FG001|Overall Study|Lost to Follow-up|2|||
25127894|NCT01905657|50241084|FG002|Overall Study|Lost to Follow-up|1|||
25127895|NCT01905657|50241082|FG000|Overall Study|Physician Decision|5|||
25127896|NCT01905657|50241083|FG001|Overall Study|Physician Decision|8|||
25127897|NCT01905657|50241084|FG002|Overall Study|Physician Decision|12|||
25127898|NCT01905657|50241082|FG000|Overall Study|Protocol Violation|2|||
25127899|NCT01905657|50241083|FG001|Overall Study|Protocol Violation|1|||
25271198|NCT00919711|50585481|FG001|Overall Study|Adverse Event|3|||
25271199|NCT00919711|50585480|FG000|Overall Study|Other|1|||
25271200|NCT00919711|50585481|FG001|Overall Study|Other|2|||
25271201|NCT00919711|50585480|FG000|Overall Study|Administrative Decision|0|||
25271202|NCT00919711|50585481|FG001|Overall Study|Administrative Decision|1|||
25271203|NCT00919711|50585480|FG000|Overall Study|Lost to Follow-up|2|||
25271204|NCT00919711|50585481|FG001|Overall Study|Lost to Follow-up|0|||
25271205|NCT00919711|50585480|FG000|Overall Study|Death|1|||
25271206|NCT00919711|50585481|FG001|Overall Study|Death|0|||
25271207|NCT00919711|50585480|FG000|Overall Study|Noncompliance|1|||
25271208|NCT00919711|50585481|FG001|Overall Study|Noncompliance|0|||
25271209|NCT01131585|50585489|FG000|Overall Study|Adverse Event|0|||
25271210|NCT01131585|50585490|FG001|Overall Study|Adverse Event|2|||
25271211|NCT01131585|50585489|FG000|Overall Study|Abnormal laboratory value|1|||
25271212|NCT01131585|50585490|FG001|Overall Study|Abnormal laboratory value|0|||
25271213|NCT01131585|50585489|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25271214|NCT01131585|50585490|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
25271215|NCT01131585|50585489|FG000|Overall Study|Protocol Violation|2|||
25271216|NCT01131585|50585490|FG001|Overall Study|Protocol Violation|1|||
25271217|NCT01131585|50585489|FG000|Overall Study|Withdrawal by Subject|3|||
25271218|NCT01131585|50585490|FG001|Overall Study|Withdrawal by Subject|3|||
25271219|NCT01131585|50585489|FG000|Overall Study|Lost to Follow-up|0|||
25271220|NCT01131585|50585490|FG001|Overall Study|Lost to Follow-up|1|||
25271221|NCT01131585|50585489|FG000|Overall Study|Administrative problems|1|||
25271222|NCT01131585|50585490|FG001|Overall Study|Administrative problems|1|||
25271223|NCT01131585|50585489|FG000|Overall Study|Study termination|78|||
25271224|NCT01131585|50585490|FG001|Overall Study|Study termination|32|||
25271225|NCT01131507|50585496|FG000|Overall Study|Adverse Event|1|||
25271226|NCT01131507|50585496|FG000|Overall Study|Lost to Follow-up|1|||
25271227|NCT01131507|50585496|FG000|Overall Study|Withdrawal by Subject|1|||
25271228|NCT01131351|50585502|FG000|Overall Study|Adverse Event|0|||
25271229|NCT01131351|50585503|FG001|Overall Study|Adverse Event|2|||
25271230|NCT01131351|50585502|FG000|Overall Study|Protocol Deviation|0|||
25271231|NCT01131351|50585503|FG001|Overall Study|Protocol Deviation|1|||
25271232|NCT00919633|50585513|FG000|Overall Study|Adverse Event|1|||
25271233|NCT00919633|50585514|FG001|Overall Study|Adverse Event|9|||
25271234|NCT00919633|50585515|FG002|Overall Study|Adverse Event|12|||
25271235|NCT00919633|50585516|FG003|Overall Study|Adverse Event|10|||
25271236|NCT00919633|50585513|FG000|Overall Study|Death|0|||
25271237|NCT00919633|50585514|FG001|Overall Study|Death|0|||
25271238|NCT00919633|50585515|FG002|Overall Study|Death|2|||
25271239|NCT00919633|50585516|FG003|Overall Study|Death|0|||
25271240|NCT00919633|50585513|FG000|Overall Study|Lack of Efficacy|17|||
25271241|NCT00919633|50585514|FG001|Overall Study|Lack of Efficacy|3|||
25271242|NCT00919633|50585515|FG002|Overall Study|Lack of Efficacy|2|||
25127900|NCT01905657|50241084|FG002|Overall Study|Protocol Violation|1|||
25127901|NCT01905657|50241082|FG000|Overall Study|Screen Failure|0|||
25127902|NCT01905657|50241083|FG001|Overall Study|Screen Failure|1|||
25127903|NCT01905657|50241084|FG002|Overall Study|Screen Failure|0|||
25127904|NCT01905657|50241082|FG000|Overall Study|Withdrawal by Subject|15|||
25127905|NCT01905657|50241083|FG001|Overall Study|Withdrawal by Subject|21|||
25127906|NCT01905657|50241084|FG002|Overall Study|Withdrawal by Subject|53|||
25127907|NCT01905657|50241082|FG000|Overall Study|Sponsor Decision|1|||
25271243|NCT00919633|50585516|FG003|Overall Study|Lack of Efficacy|3|||
25271244|NCT00919633|50585513|FG000|Overall Study|Withdrawal by Subject|1|||
25271245|NCT00919633|50585514|FG001|Overall Study|Withdrawal by Subject|2|||
25271246|NCT00919633|50585515|FG002|Overall Study|Withdrawal by Subject|4|||
25271247|NCT00919633|50585516|FG003|Overall Study|Withdrawal by Subject|3|||
25271248|NCT00919633|50585513|FG000|Overall Study|Lost to Follow-up|3|||
25271249|NCT00919633|50585514|FG001|Overall Study|Lost to Follow-up|1|||
25271250|NCT00919633|50585515|FG002|Overall Study|Lost to Follow-up|0|||
25271251|NCT00919633|50585516|FG003|Overall Study|Lost to Follow-up|2|||
25271252|NCT00919633|50585513|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
25271253|NCT00919633|50585514|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
25271254|NCT00919633|50585515|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
25271255|NCT00919633|50585516|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
25271256|NCT00919633|50585513|FG000|Overall Study|Protocol Violation|0|||
25271257|NCT00919633|50585514|FG001|Overall Study|Protocol Violation|0|||
25271258|NCT00919633|50585515|FG002|Overall Study|Protocol Violation|0|||
25271259|NCT00919633|50585516|FG003|Overall Study|Protocol Violation|1|||
25271260|NCT00919633|50585513|FG000|Overall Study|Physician Decision|0|||
25271261|NCT00919633|50585514|FG001|Overall Study|Physician Decision|0|||
25271262|NCT00919633|50585515|FG002|Overall Study|Physician Decision|0|||
25271263|NCT00919633|50585516|FG003|Overall Study|Physician Decision|1|||
25271264|NCT00919633|50585513|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
25271265|NCT00919633|50585514|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
25271266|NCT00919633|50585515|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
25271267|NCT00919633|50585516|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
25271268|NCT00919633|50585513|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
25271269|NCT00919633|50585514|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
25271270|NCT00919633|50585515|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
25271271|NCT00919633|50585516|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
25271272|NCT01130883|50585526|FG000|Overall Study|Patient Noncompliance|6|||
25271273|NCT01130883|50585526|FG000|Overall Study|Reason Unknown|1|||
25271274|NCT01130883|50585526|FG000|Overall Study|Adverse Event|3|||
25271275|NCT00926029|50585533|FG000|Overall Study|Lost to Follow-up|2|||
25271276|NCT00926029|50585534|FG001|Overall Study|Lost to Follow-up|1|||
25271277|NCT00926029|50585535|FG002|Overall Study|Lost to Follow-up|1|||
25271278|NCT01130493|50585545|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
25271279|NCT01130493|50585546|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
25271280|NCT01130493|50585547|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
25271281|NCT01130493|50585545|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
25271282|NCT01130493|50585546|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
25271283|NCT01130493|50585547|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
25127908|NCT01905657|50241083|FG001|Overall Study|Sponsor Decision|0|||
25127909|NCT01905657|50241084|FG002|Overall Study|Sponsor Decision|0|||
25127910|NCT02202980|50241109|FG000|Overall Study|Lack of Efficacy|1|||
25127911|NCT02202980|50241110|FG001|Overall Study|Lack of Efficacy|0|||
25127912|NCT02202980|50241111|FG002|Overall Study|Lack of Efficacy|7|||
25127913|NCT02202980|50241112|FG003|Overall Study|Lack of Efficacy|0|||
25127914|NCT02202980|50241113|FG004|Overall Study|Lack of Efficacy|3|||
25127915|NCT02202980|50241114|FG005|Overall Study|Lack of Efficacy|1|||
25127916|NCT02202980|50241115|FG006|Overall Study|Lack of Efficacy|11|||
25127917|NCT02202980|50241116|FG007|Overall Study|Lack of Efficacy|2|||
25127918|NCT02202980|50241117|FG008|Overall Study|Lack of Efficacy|2|||
25127919|NCT02202980|50241118|FG009|Overall Study|Lack of Efficacy|0|||
25127920|NCT02202980|50241119|FG010|Overall Study|Lack of Efficacy|0|||
25127921|NCT02202980|50241120|FG011|Overall Study|Lack of Efficacy|3|||
25127922|NCT02202980|50241121|FG012|Overall Study|Lack of Efficacy|10|||
25127923|NCT02202980|50241122|FG013|Overall Study|Lack of Efficacy|0|||
25127924|NCT02202980|50241109|FG000|Overall Study|Protocol Violation|0|||
25127925|NCT02202980|50241110|FG001|Overall Study|Protocol Violation|0|||
25127926|NCT02202980|50241111|FG002|Overall Study|Protocol Violation|0|||
25127927|NCT02202980|50241112|FG003|Overall Study|Protocol Violation|3|||
25127928|NCT02202980|50241113|FG004|Overall Study|Protocol Violation|3|||
25127929|NCT02202980|50241114|FG005|Overall Study|Protocol Violation|0|||
25127930|NCT02202980|50241115|FG006|Overall Study|Protocol Violation|0|||
25127931|NCT02202980|50241116|FG007|Overall Study|Protocol Violation|0|||
25127932|NCT02202980|50241117|FG008|Overall Study|Protocol Violation|0|||
25271284|NCT01130493|50585545|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
25271285|NCT01130493|50585546|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
25127933|NCT02202980|50241118|FG009|Overall Study|Protocol Violation|0|||
25271286|NCT01130493|50585547|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
25271287|NCT01130493|50585545|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
25271288|NCT01130493|50585546|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
25271289|NCT01130493|50585547|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
25271290|NCT01130493|50585545|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
25127934|NCT02202980|50241119|FG010|Overall Study|Protocol Violation|0|||
25127935|NCT02202980|50241120|FG011|Overall Study|Protocol Violation|0|||
25127936|NCT02202980|50241121|FG012|Overall Study|Protocol Violation|0|||
25127937|NCT02202980|50241122|FG013|Overall Study|Protocol Violation|0|||
25127938|NCT02202980|50241109|FG000|Overall Study|Lost to Follow-up|0|||
25127939|NCT02202980|50241110|FG001|Overall Study|Lost to Follow-up|1|||
25127940|NCT02202980|50241111|FG002|Overall Study|Lost to Follow-up|1|||
25127941|NCT02202980|50241112|FG003|Overall Study|Lost to Follow-up|1|||
25127942|NCT02202980|50241113|FG004|Overall Study|Lost to Follow-up|0|||
25127943|NCT02202980|50241114|FG005|Overall Study|Lost to Follow-up|0|||
25127944|NCT02202980|50241115|FG006|Overall Study|Lost to Follow-up|0|||
25127945|NCT02202980|50241116|FG007|Overall Study|Lost to Follow-up|1|||
25127946|NCT02202980|50241117|FG008|Overall Study|Lost to Follow-up|1|||
25127947|NCT02202980|50241118|FG009|Overall Study|Lost to Follow-up|0|||
25271291|NCT01130493|50585546|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
25271292|NCT01130493|50585547|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
25271293|NCT01130493|50585545|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
25271294|NCT01130493|50585546|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
25271295|NCT01130493|50585547|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
25271296|NCT01130493|50585545|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
25271297|NCT01130493|50585546|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
25271298|NCT01130493|50585547|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
25271299|NCT01130493|50585545|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
25271300|NCT01130493|50585546|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
25271301|NCT01130493|50585547|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
25271302|NCT01130493|50585545|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
25271303|NCT01130493|50585546|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
25271304|NCT01130493|50585547|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
25271305|NCT01130493|50585545|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
25271306|NCT01130493|50585546|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
25271307|NCT01130493|50585547|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
25271308|NCT01130493|50585545|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
25271309|NCT01130493|50585546|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
25271310|NCT01130493|50585547|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
25271311|NCT01130493|50585545|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
25271312|NCT01130493|50585546|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
25271313|NCT01130493|50585547|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
25271314|NCT01130493|50585545|FG000|Part 2: OLE|Adverse Event|0|||
25271315|NCT01130493|50585546|FG001|Part 2: OLE|Adverse Event|2|||
25271316|NCT01130493|50585547|FG002|Part 2: OLE|Adverse Event|1|||
25271317|NCT01130493|50585545|FG000|Part 2: OLE|Withdrawal by Subject|0|||
25271318|NCT01130493|50585546|FG001|Part 2: OLE|Withdrawal by Subject|1|||
25271319|NCT01130493|50585547|FG002|Part 2: OLE|Withdrawal by Subject|4|||
25271320|NCT01130337|50585558|FG000|Overall Study|Withdrawal by Subject|3|||
25271321|NCT01130337|50585558|FG000|Overall Study|Principal investigator decision|1|||
25271322|NCT01130337|50585558|FG000|Overall Study|Death|1|||
25271323|NCT01130337|50585558|FG000|Overall Study|Disease progression|1|||
25271324|NCT01130337|50585558|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
25271325|NCT01130337|50585558|FG000|Overall Study|Surgical resection (R2)|1|||
25271326|NCT01130103|50585564|FG000|Randomized Treatment|Adverse Event|1|||
25271327|NCT01130103|50585565|FG001|Randomized Treatment|Adverse Event|1|||
25271328|NCT01130103|50585564|FG000|Randomized Treatment|Lost to Follow-up|1|||
25271329|NCT01130103|50585565|FG001|Randomized Treatment|Lost to Follow-up|0|||
25271330|NCT01130103|50585564|FG000|Randomized Treatment|Protocol Violation|3|||
25271331|NCT01130103|50585565|FG001|Randomized Treatment|Protocol Violation|2|||
25271332|NCT01130103|50585564|FG000|Randomized Treatment|Withdrawal by Subject|1|||
25271333|NCT01130103|50585565|FG001|Randomized Treatment|Withdrawal by Subject|2|||
25271334|NCT01130103|50585564|FG000|Maintenance Treatment|Lack of Efficacy|0|||
25271335|NCT01130103|50585565|FG001|Maintenance Treatment|Lack of Efficacy|1|||
25271336|NCT01130103|50585564|FG000|Maintenance Treatment|Lost to Follow-up|1|||
25271337|NCT01130103|50585565|FG001|Maintenance Treatment|Lost to Follow-up|1|||
25271338|NCT01130103|50585564|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
25271339|NCT01130103|50585565|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
25271340|NCT01129557|50585574|FG000|Overall Study|Adverse Event|1|||
25271341|NCT01129557|50585575|FG001|Overall Study|Adverse Event|2|||
25127948|NCT02202980|50241119|FG010|Overall Study|Lost to Follow-up|0|||
25127949|NCT02202980|50241120|FG011|Overall Study|Lost to Follow-up|0|||
25127950|NCT02202980|50241121|FG012|Overall Study|Lost to Follow-up|1|||
25271342|NCT01129557|50585576|FG002|Overall Study|Adverse Event|2|||
25271343|NCT01129557|50585574|FG000|Overall Study|Novartis terminated study early|3|||
25271344|NCT01129557|50585575|FG001|Overall Study|Novartis terminated study early|3|||
25271345|NCT01129557|50585576|FG002|Overall Study|Novartis terminated study early|2|||
25127951|NCT02202980|50241122|FG013|Overall Study|Lost to Follow-up|0|||
25127952|NCT02202980|50241109|FG000|Overall Study|Withdrew Consent|0|||
25127953|NCT02202980|50241110|FG001|Overall Study|Withdrew Consent|1|||
25127954|NCT02202980|50241111|FG002|Overall Study|Withdrew Consent|2|||
25271346|NCT01129011|50585597|FG000|Overall Study|Adverse Event|20|||
25271347|NCT01129011|50585598|FG001|Overall Study|Adverse Event|30|||
25271348|NCT01129011|50585597|FG000|Overall Study|Withdrawal by Subject|24|||
25271349|NCT01129011|50585598|FG001|Overall Study|Withdrawal by Subject|8|||
25271350|NCT01129011|50585597|FG000|Overall Study|Lost to Follow-up|6|||
25271351|NCT01129011|50585598|FG001|Overall Study|Lost to Follow-up|7|||
25271352|NCT01129011|50585597|FG000|Overall Study|Duodenal Ulcer|2|||
25271353|NCT01129011|50585598|FG001|Overall Study|Duodenal Ulcer|8|||
25271354|NCT01129011|50585597|FG000|Overall Study|misc|7|||
25271355|NCT01129011|50585598|FG001|Overall Study|misc|4|||
25271356|NCT00919867|50585610|FG000|First Intervention|Withdrawal by Subject|0|||
25271357|NCT00919867|50585611|FG001|First Intervention|Withdrawal by Subject|0|||
25271358|NCT00919867|50585612|FG002|First Intervention|Withdrawal by Subject|1|||
25271359|NCT00919867|50585613|FG003|First Intervention|Withdrawal by Subject|0|||
25271360|NCT00919867|50585614|FG004|First Intervention|Withdrawal by Subject|0|||
25271361|NCT00919867|50585615|FG005|First Intervention|Withdrawal by Subject|0|||
25271362|NCT00919867|50585610|FG000|First Intervention|Physician Decision|0|||
25271363|NCT00919867|50585611|FG001|First Intervention|Physician Decision|0|||
25127955|NCT02202980|50241112|FG003|Overall Study|Withdrew Consent|0|||
25127956|NCT02202980|50241113|FG004|Overall Study|Withdrew Consent|0|||
25127957|NCT02202980|50241114|FG005|Overall Study|Withdrew Consent|0|||
25127958|NCT02202980|50241115|FG006|Overall Study|Withdrew Consent|0|||
25127959|NCT02202980|50241116|FG007|Overall Study|Withdrew Consent|0|||
25127960|NCT02202980|50241117|FG008|Overall Study|Withdrew Consent|1|||
25127961|NCT02202980|50241118|FG009|Overall Study|Withdrew Consent|0|||
25127962|NCT02202980|50241119|FG010|Overall Study|Withdrew Consent|0|||
25127963|NCT02202980|50241120|FG011|Overall Study|Withdrew Consent|0|||
25127964|NCT02202980|50241121|FG012|Overall Study|Withdrew Consent|0|||
25127965|NCT02202980|50241122|FG013|Overall Study|Withdrew Consent|0|||
25127966|NCT01952145|50241154|FG000|Overall Study|Protocol Violation|2|||
25127967|NCT01952145|50241155|FG001|Overall Study|Protocol Violation|1|||
25127968|NCT01952145|50241154|FG000|Overall Study|Death|0|||
25127969|NCT01952145|50241155|FG001|Overall Study|Death|1|||
25127970|NCT01952145|50241154|FG000|Overall Study|Adverse Event|9|||
25127971|NCT01952145|50241155|FG001|Overall Study|Adverse Event|0|||
25127972|NCT01952145|50241154|FG000|Overall Study|Withdrawal Criteria|16|||
25127973|NCT01952145|50241155|FG001|Overall Study|Withdrawal Criteria|11|||
25127974|NCT01952145|50241154|FG000|Overall Study|Unclassified|1|||
25127975|NCT01952145|50241155|FG001|Overall Study|Unclassified|1|||
25127976|NCT01923363|50241161|FG000|Overall Study|Protocol Violation|1|||
25127977|NCT01905267|50241167|FG000|Overall Study|Physician Decision|2|||
25127978|NCT01905267|50241168|FG001|Overall Study|Physician Decision|2|||
25127979|NCT01923285|50241176|FG000|Overall Study|Withdrawal by Subject|7|||
25127980|NCT01923285|50241177|FG001|Overall Study|Withdrawal by Subject|6|||
25127981|NCT01904721|50241190|FG000|Overall Study|Other Reasons|0|||
25127982|NCT01904721|50241191|FG001|Overall Study|Other Reasons|0|||
25127983|NCT01904721|50241192|FG002|Overall Study|Other Reasons|1|||
25127984|NCT01904721|50241193|FG003|Overall Study|Other Reasons|1|||
25127985|NCT01904721|50241194|FG004|Overall Study|Other Reasons|2|||
25127986|NCT01904721|50241195|FG005|Overall Study|Other Reasons|2|||
25127987|NCT01904721|50241196|FG006|Overall Study|Other Reasons|2|||
25127988|NCT01904721|50241190|FG000|Overall Study|Personal Reasons|0|||
25127989|NCT01904721|50241191|FG001|Overall Study|Personal Reasons|0|||
25127990|NCT01904721|50241192|FG002|Overall Study|Personal Reasons|0|||
25127991|NCT01904721|50241193|FG003|Overall Study|Personal Reasons|0|||
25127992|NCT01904721|50241194|FG004|Overall Study|Personal Reasons|2|||
25127993|NCT01904721|50241195|FG005|Overall Study|Personal Reasons|3|||
25127994|NCT01904721|50241196|FG006|Overall Study|Personal Reasons|3|||
25127995|NCT01904721|50241190|FG000|Overall Study|Lost to Follow-up|0|||
25127996|NCT01904721|50241191|FG001|Overall Study|Lost to Follow-up|0|||
25127997|NCT01904721|50241192|FG002|Overall Study|Lost to Follow-up|0|||
25127998|NCT01904721|50241193|FG003|Overall Study|Lost to Follow-up|0|||
25271364|NCT00919867|50585612|FG002|First Intervention|Physician Decision|0|||
25127999|NCT01904721|50241194|FG004|Overall Study|Lost to Follow-up|1|||
25128000|NCT01904721|50241195|FG005|Overall Study|Lost to Follow-up|3|||
25128001|NCT01904721|50241196|FG006|Overall Study|Lost to Follow-up|1|||
25128002|NCT01904721|50241190|FG000|Overall Study|Lack of Efficacy|0|||
25128003|NCT01904721|50241191|FG001|Overall Study|Lack of Efficacy|0|||
25128004|NCT01904721|50241192|FG002|Overall Study|Lack of Efficacy|0|||
25128005|NCT01904721|50241193|FG003|Overall Study|Lack of Efficacy|0|||
25128006|NCT01904721|50241194|FG004|Overall Study|Lack of Efficacy|0|||
25128007|NCT01904721|50241195|FG005|Overall Study|Lack of Efficacy|0|||
25271365|NCT00919867|50585613|FG003|First Intervention|Physician Decision|0|||
25009352|NCT00075725|50102295|FG001|Overall Study|Institution Terminated|0|||
25128008|NCT01904721|50241196|FG006|Overall Study|Lack of Efficacy|1|||
25128009|NCT01904721|50241190|FG000|Overall Study|Adverse Event|0|||
25128010|NCT01904721|50241191|FG001|Overall Study|Adverse Event|0|||
25128011|NCT01904721|50241192|FG002|Overall Study|Adverse Event|0|||
25128012|NCT01904721|50241193|FG003|Overall Study|Adverse Event|0|||
25271366|NCT00919867|50585614|FG004|First Intervention|Physician Decision|0|||
25128013|NCT01904721|50241194|FG004|Overall Study|Adverse Event|3|||
25128014|NCT01904721|50241195|FG005|Overall Study|Adverse Event|1|||
25128015|NCT01904721|50241196|FG006|Overall Study|Adverse Event|0|||
25128016|NCT01904019|50241208|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
25128017|NCT01904019|50241208|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
25128018|NCT01904019|50241208|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
25128019|NCT01904019|50241208|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
25128020|NCT01904019|50241208|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
25128021|NCT01904019|50241208|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
25128022|NCT01922895|50241214|FG000|Overall Study|Death|0|||
25128023|NCT01922895|50241215|FG001|Overall Study|Death|1|||
25128024|NCT01922895|50241214|FG000|Overall Study|Withdrawal by Subject|1|||
25128025|NCT01922895|50241215|FG001|Overall Study|Withdrawal by Subject|2|||
25128026|NCT01922895|50241214|FG000|Overall Study|Lost to Follow-up|5|||
25128027|NCT01922895|50241215|FG001|Overall Study|Lost to Follow-up|11|||
25128028|NCT01922739|50241223|FG000|Titration/Adjustment Period|Adverse Event|3|||
25128029|NCT01922739|50241223|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
25128030|NCT01922739|50241223|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
25128031|NCT01922739|50241223|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
25128032|NCT01922739|50241223|FG000|Open-label Treatment Period|Adverse Event|6|||
25128033|NCT01922739|50241223|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
25128034|NCT01922739|50241223|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
25128035|NCT01922739|50241223|FG000|Open-label Treatment Period|Protocol Violation|5|||
25128036|NCT01922739|50241223|FG000|Open-label Treatment Period|Pregnancy|1|||
25128037|NCT01922739|50241223|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
25128038|NCT01922739|50241223|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
25128039|NCT01922739|50241223|FG000|Open-label Treatment Period|Physician Decision|1|||
25128040|NCT01922739|50241223|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
25271367|NCT00919867|50585615|FG005|First Intervention|Physician Decision|1|||
25271368|NCT01215942|50585625|FG000|Treatment Period|Adverse Event|15|||
25271369|NCT01215942|50585626|FG001|Treatment Period|Adverse Event|26|||
25271370|NCT01215942|50585625|FG000|Treatment Period|Death|2|||
25271371|NCT01215942|50585626|FG001|Treatment Period|Death|4|||
25271372|NCT01215942|50585625|FG000|Treatment Period|Lack of Efficacy|23|||
25271373|NCT01215942|50585626|FG001|Treatment Period|Lack of Efficacy|62|||
25271374|NCT01215942|50585625|FG000|Treatment Period|Lost to Follow-up|3|||
25271375|NCT01215942|50585626|FG001|Treatment Period|Lost to Follow-up|4|||
25271376|NCT01215942|50585625|FG000|Treatment Period|Withdrawal by Subject|17|||
25271377|NCT01215942|50585626|FG001|Treatment Period|Withdrawal by Subject|40|||
25271378|NCT01215942|50585625|FG000|Treatment Period|Physician Decision|5|||
25128041|NCT02236988|50241243|FG000|Overall Study|Lost to Follow-up|0|||
25128042|NCT02236988|50241244|FG001|Overall Study|Lost to Follow-up|0|||
25128043|NCT02236988|50241245|FG002|Overall Study|Lost to Follow-up|0|||
25128044|NCT02236988|50241246|FG003|Overall Study|Lost to Follow-up|1|||
25271379|NCT01215942|50585626|FG001|Treatment Period|Physician Decision|5|||
25271380|NCT01215942|50585625|FG000|Treatment Period|Protocol Violation|0|||
25271381|NCT01215942|50585626|FG001|Treatment Period|Protocol Violation|1|||
25271382|NCT01215942|50585625|FG000|Treatment Period|Sponsor Decision|349|||
25271383|NCT01215942|50585626|FG001|Treatment Period|Sponsor Decision|530|||
25271384|NCT01215942|50585625|FG000|Post-Treatment Follow-Up Period|Death|0|||
25271385|NCT01215942|50585626|FG001|Post-Treatment Follow-Up Period|Death|1|||
25271386|NCT01215942|50585625|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
25128045|NCT02236988|50241243|FG000|Overall Study|Unable to Comply with Study Visits|0|||
25128046|NCT02236988|50241244|FG001|Overall Study|Unable to Comply with Study Visits|0|||
25128047|NCT02236988|50241245|FG002|Overall Study|Unable to Comply with Study Visits|0|||
25128048|NCT02236988|50241246|FG003|Overall Study|Unable to Comply with Study Visits|2|||
25128049|NCT02236598|50241299|FG000|Overall Study|Adverse Event|0|||
25128050|NCT02236598|50241300|FG001|Overall Study|Adverse Event|1|||
25128051|NCT02236598|50241299|FG000|Overall Study|Withdrawal by Subject|0|||
25128052|NCT02236598|50241300|FG001|Overall Study|Withdrawal by Subject|1|||
25128053|NCT01922349|50241310|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
25128054|NCT01922349|50241311|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
25128055|NCT01922349|50241312|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
25178525|NCT01464307|50323812|FG000|Open-Label Extension Period|Adverse Event|15|||
25271387|NCT01215942|50585626|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
25128056|NCT01922349|50241313|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
25128057|NCT02236520|50241351|FG000|Overall Study|Physician Decision|0|||
25128058|NCT02236520|50241352|FG001|Overall Study|Physician Decision|5|||
25128059|NCT02236520|50241353|FG002|Overall Study|Physician Decision|0|||
25178526|NCT01464307|50323813|FG001|Open-Label Extension Period|Adverse Event|0|||
25271388|NCT01215942|50585625|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
25271389|NCT01215942|50585626|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
25271390|NCT01215942|50585625|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
25271391|NCT01215942|50585626|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
25128060|NCT02236520|50241354|FG003|Overall Study|Physician Decision|0|||
25128061|NCT02236520|50241351|FG000|Overall Study|Withdrawal by Subject|1|||
25128062|NCT02236520|50241352|FG001|Overall Study|Withdrawal by Subject|0|||
25128063|NCT02236520|50241353|FG002|Overall Study|Withdrawal by Subject|0|||
25128064|NCT02236520|50241354|FG003|Overall Study|Withdrawal by Subject|1|||
25128065|NCT02236520|50241351|FG000|Overall Study|Pregnancy|1|||
25128066|NCT02236520|50241352|FG001|Overall Study|Pregnancy|0|||
25128067|NCT02236520|50241353|FG002|Overall Study|Pregnancy|0|||
25128068|NCT02236520|50241354|FG003|Overall Study|Pregnancy|0|||
25128069|NCT01922271|50241366|FG000|WASHOUT Period|Withdrawal by Subject|1|||
25128070|NCT01922271|50241367|FG001|WASHOUT Period|Withdrawal by Subject|0|||
25128071|NCT02236130|50241375|FG000|Overall Study|Lost to Follow-up|7|||
25128072|NCT02236130|50241376|FG001|Overall Study|Lost to Follow-up|12|||
25128073|NCT02233946|50241384|FG000|Baseline|Withdrawal by Subject|2|||
25128074|NCT02233946|50241385|FG001|Baseline|Withdrawal by Subject|0|||
25128075|NCT02233946|50241384|FG000|3-months Follow-up|Lost to Follow-up|53|||
25128076|NCT02233946|50241385|FG001|3-months Follow-up|Lost to Follow-up|29|||
25128077|NCT02233946|50241384|FG000|6-months Follow-up|Lost to Follow-up|21|||
25128078|NCT02233946|50241385|FG001|6-months Follow-up|Lost to Follow-up|2|||
25128079|NCT02233946|50241384|FG000|9-month Follow-up|Lost to Follow-up|20|||
25128080|NCT02233946|50241385|FG001|9-month Follow-up|Lost to Follow-up|11|||
25128081|NCT02233946|50241384|FG000|12-month Follow-up|Lost to Follow-up|28|||
25128082|NCT02233946|50241385|FG001|12-month Follow-up|Lost to Follow-up|11|||
25128083|NCT02232698|50241393|FG000|Overall Study|Pregnancy|1|||
25128084|NCT02232698|50241394|FG001|Overall Study|Pregnancy|1|||
25128085|NCT02232698|50241393|FG000|Overall Study|Met exclusion criteria|1|||
25128086|NCT02232698|50241394|FG001|Overall Study|Met exclusion criteria|1|||
25271392|NCT01215942|50585625|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
25271393|NCT01215942|50585626|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
25271394|NCT01128621|50585645|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
25271395|NCT01128621|50585646|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
25271396|NCT00918463|50585668|FG000|Overall Study|Death|1|||
25271397|NCT00918463|50585668|FG000|Overall Study|Lack of Efficacy|1|||
25271398|NCT01128543|50585672|FG000|Overall Study|Withdrawal by Subject|3|||
25271399|NCT01128543|50585672|FG000|Overall Study|Protocol Violation|1|||
25271400|NCT01128387|50585678|FG000|Overall Study|Physician Decision|0|||
25271401|NCT01128387|50585679|FG001|Overall Study|Physician Decision|1|||
25128087|NCT02232698|50241393|FG000|Overall Study|Had device-associated symptoms|7|||
25128088|NCT02232698|50241394|FG001|Overall Study|Had device-associated symptoms|0|||
25128089|NCT02232698|50241393|FG000|Overall Study|Non-compliance with study device|1|||
25128090|NCT02232698|50241394|FG001|Overall Study|Non-compliance with study device|4|||
25128091|NCT02232698|50241393|FG000|Overall Study|Allocated to control group|0|||
25128092|NCT02232698|50241394|FG001|Overall Study|Allocated to control group|3|||
25128093|NCT02232698|50241393|FG000|Overall Study|Withdrawal by Subject|0|||
25128094|NCT02232698|50241394|FG001|Overall Study|Withdrawal by Subject|11|||
25128095|NCT01632878|50241402|FG000|Screening|Physician Decision|268|||
25128096|NCT01632878|50241402|FG000|Treatment|Lost to Follow-up|41|||
25128097|NCT01632878|50241402|FG000|Treatment|Withdrawal by Subject|36|||
25128098|NCT01632878|50241402|FG000|Treatment|Physician Decision|34|||
25128099|NCT01632878|50241402|FG000|Treatment|missing information|4|||
25128100|NCT01632878|50241402|FG000|Treatment|no information on study completion|43|||
25128101|NCT01632800|50241406|FG000|Overall Study|Subject did not fit in apparatus|1|||
25128102|NCT01641809|50241414|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
25128103|NCT01641809|50241415|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
25128104|NCT01641809|50241416|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
25128105|NCT01641809|50241417|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
25128106|NCT01641809|50241414|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
25128107|NCT01641809|50241415|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
25128108|NCT01641809|50241416|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
25128109|NCT01641809|50241417|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
25128110|NCT01641809|50241414|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
25271402|NCT01214850|50585688|FG000|Overall Study|Withdrawal by Subject|38|||
25128111|NCT01641809|50241415|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
25271403|NCT01214850|50585689|FG001|Overall Study|Withdrawal by Subject|31|||
25128112|NCT01641809|50241416|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
25128113|NCT01641809|50241417|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
25128114|NCT01641809|50241414|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
25128115|NCT01641809|50241415|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
25128116|NCT01641809|50241416|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
25128117|NCT01641809|50241417|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
25128118|NCT01641809|50241414|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
25128119|NCT01641809|50241415|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
25271404|NCT01214850|50585690|FG002|Overall Study|Withdrawal by Subject|28|||
25128120|NCT01641809|50241416|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
25128121|NCT01641809|50241417|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
25128122|NCT01641809|50241414|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
25128123|NCT01641809|50241415|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
25128124|NCT01641809|50241416|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
25128125|NCT01641809|50241417|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
25128126|NCT01641809|50241414|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
25128127|NCT01641809|50241415|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
25128128|NCT01641809|50241416|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
25128129|NCT01641809|50241417|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
25128130|NCT01641809|50241414|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
25271405|NCT01214850|50585688|FG000|Overall Study|Lost to Follow-up|124|||
25271406|NCT01214850|50585689|FG001|Overall Study|Lost to Follow-up|98|||
25271407|NCT01214850|50585690|FG002|Overall Study|Lost to Follow-up|123|||
25271408|NCT01214850|50585688|FG000|Overall Study|Protocol Violation|5|||
25271409|NCT01214850|50585689|FG001|Overall Study|Protocol Violation|5|||
25271410|NCT01214850|50585690|FG002|Overall Study|Protocol Violation|6|||
25271411|NCT01214850|50585688|FG000|Overall Study|Adverse event or death|11|||
25271412|NCT01214850|50585689|FG001|Overall Study|Adverse event or death|8|||
25271413|NCT01214850|50585690|FG002|Overall Study|Adverse event or death|3|||
25271414|NCT01214850|50585688|FG000|Overall Study|Inappropriate enrollment|2|||
25271415|NCT01214850|50585689|FG001|Overall Study|Inappropriate enrollment|1|||
25271416|NCT01214850|50585690|FG002|Overall Study|Inappropriate enrollment|0|||
25271417|NCT01214850|50585688|FG000|Overall Study|Administrative reason|1|||
25271418|NCT01214850|50585689|FG001|Overall Study|Administrative reason|0|||
25271419|NCT01214850|50585690|FG002|Overall Study|Administrative reason|0|||
25271420|NCT01214850|50585688|FG000|Overall Study|Unable to classify|2|||
25128131|NCT01641809|50241415|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
25128132|NCT01641809|50241416|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
25128133|NCT01641809|50241417|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
25128134|NCT01641809|50241414|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
25128135|NCT01641809|50241415|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
25128136|NCT01641809|50241416|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
25128137|NCT01641809|50241417|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
25128138|NCT01641809|50241414|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
25128139|NCT01641809|50241415|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
25128140|NCT01641809|50241416|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
25128141|NCT01641809|50241417|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
25128142|NCT01641809|50241414|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
25128143|NCT01641809|50241415|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
25128144|NCT01641809|50241416|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
25128145|NCT01641809|50241417|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
25128146|NCT01641809|50241414|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
25128147|NCT01641809|50241415|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
25271421|NCT01214850|50585689|FG001|Overall Study|Unable to classify|1|||
25271422|NCT01214850|50585690|FG002|Overall Study|Unable to classify|1|||
25271423|NCT01128153|50585703|FG000|Overall Study|Adverse Event|1|||
25271424|NCT01128153|50585704|FG001|Overall Study|Adverse Event|3|||
25271425|NCT01128153|50585703|FG000|Overall Study|Condition under investigation worsened|8|||
25271426|NCT01128153|50585704|FG001|Overall Study|Condition under investigation worsened|7|||
25271427|NCT01128153|50585703|FG000|Overall Study|Withdrawal by Subject|2|||
25271428|NCT01128153|50585704|FG001|Overall Study|Withdrawal by Subject|3|||
25271429|NCT01128153|50585703|FG000|Overall Study|Incorrect enrolment to study|2|||
25271430|NCT01128153|50585704|FG001|Overall Study|Incorrect enrolment to study|1|||
25271431|NCT01128153|50585703|FG000|Overall Study|Protocol Violation|2|||
25271432|NCT01128153|50585704|FG001|Overall Study|Protocol Violation|0|||
25271433|NCT01128153|50585703|FG000|Overall Study|Developed discontinuation criteria|1|||
25271434|NCT01128153|50585704|FG001|Overall Study|Developed discontinuation criteria|1|||
25271435|NCT00925015|50585713|FG000|Overall Study|Adverse Event|1|||
25009353|NCT00075725|50102296|FG002|Overall Study|Institution Terminated|0|||
25009354|NCT00075725|50102297|FG003|Overall Study|Institution Terminated|0|||
25128148|NCT01641809|50241416|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
25128149|NCT01641809|50241417|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
25128150|NCT01641809|50241414|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
25271436|NCT00925015|50585714|FG001|Overall Study|Adverse Event|2|||
25271437|NCT00925015|50585715|FG002|Overall Study|Adverse Event|1|||
25271438|NCT00925015|50585713|FG000|Overall Study|Physician Decision|0|||
25271439|NCT00925015|50585714|FG001|Overall Study|Physician Decision|1|||
25271440|NCT00925015|50585715|FG002|Overall Study|Physician Decision|0|||
25271441|NCT00925015|50585713|FG000|Overall Study|Progressive Disease|7|||
25271442|NCT00925015|50585714|FG001|Overall Study|Progressive Disease|3|||
25271443|NCT00925015|50585715|FG002|Overall Study|Progressive Disease|4|||
25128151|NCT01641809|50241415|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
25128152|NCT01641809|50241416|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
25128153|NCT01641809|50241417|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
25128154|NCT01641809|50241414|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
25128155|NCT01641809|50241415|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
25128156|NCT01641809|50241416|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
25271444|NCT00925015|50585713|FG000|Overall Study|Withdrawal by Subject|0|||
25271445|NCT00925015|50585714|FG001|Overall Study|Withdrawal by Subject|0|||
25271446|NCT00925015|50585715|FG002|Overall Study|Withdrawal by Subject|1|||
25271447|NCT01127763|50585727|FG000|Overall Study|Adverse Event|2|||
25271448|NCT01127763|50585727|FG000|Overall Study|Withdrawal by Subject|1|||
25271449|NCT01127763|50585727|FG000|Overall Study|Physician Decision|2|||
25271450|NCT01127607|50585737|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
25271451|NCT01127607|50585738|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
25271452|NCT01127607|50585737|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
25271453|NCT01127607|50585738|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
25271454|NCT00924781|50585765|FG000|Overall Study|Study terminated by sponsor|12|||
25271455|NCT00924781|50585766|FG001|Overall Study|Study terminated by sponsor|10|||
25271456|NCT01127451|50585784|FG000|Overall Study|Other|2|||
25271457|NCT01127451|50585785|FG001|Overall Study|Other|1|||
25271458|NCT01127451|50585784|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
25128157|NCT01641809|50241417|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
25128158|NCT01641809|50241414|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
25128159|NCT01641809|50241415|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
25271459|NCT01127451|50585785|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
25271460|NCT01127451|50585784|FG000|Overall Study|Death|22|||
25271461|NCT01127451|50585785|FG001|Overall Study|Death|17|||
25271462|NCT01127451|50585784|FG000|Overall Study|Lost to Follow-up|3|||
25271463|NCT01127451|50585785|FG001|Overall Study|Lost to Follow-up|0|||
25271464|NCT01127451|50585784|FG000|Overall Study|Administrative Reason by Sponsor|2|||
25271465|NCT01127451|50585785|FG001|Overall Study|Administrative Reason by Sponsor|2|||
25271466|NCT01127373|50585791|FG000|Overall Study|Not Treated|3|||
25271467|NCT01127373|50585791|FG000|Overall Study|Lost to Follow-up|7|||
25271468|NCT01127373|50585791|FG000|Overall Study|Withdrawal by Subject|1|||
25271469|NCT01127373|50585791|FG000|Overall Study|Disease progression|1|||
25271470|NCT01127139|50585795|FG000|Overall Study|Adverse Event|40|||
25271471|NCT01127139|50585795|FG000|Overall Study|Incompliance|12|||
25271472|NCT01127139|50585795|FG000|Overall Study|Lack of Efficacy|4|||
25271473|NCT01127139|50585795|FG000|Overall Study|Reason not specified|1|||
25271474|NCT01214616|50585806|FG000|Overall Study|Progressive disease|2|||
25271475|NCT01214616|50585807|FG001|Overall Study|Progressive disease|2|||
25271476|NCT01214616|50585808|FG002|Overall Study|Progressive disease|2|||
25271477|NCT01214616|50585809|FG003|Overall Study|Progressive disease|4|||
25271478|NCT01214616|50585806|FG000|Overall Study|Dose limiting toxicity|0|||
25271479|NCT01214616|50585807|FG001|Overall Study|Dose limiting toxicity|2|||
25271480|NCT01214616|50585808|FG002|Overall Study|Dose limiting toxicity|0|||
25271481|NCT01214616|50585809|FG003|Overall Study|Dose limiting toxicity|0|||
25271482|NCT01214616|50585806|FG000|Overall Study|Other adverse events|0|||
25271483|NCT01214616|50585807|FG001|Overall Study|Other adverse events|1|||
25128160|NCT01641809|50241416|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
25128161|NCT01641809|50241417|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
25128162|NCT01641809|50241414|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
25128163|NCT01641809|50241415|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
25128164|NCT01641809|50241416|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
25128165|NCT01641809|50241417|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
25128166|NCT01641809|50241414|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
25128167|NCT01641809|50241415|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
25128168|NCT01641809|50241416|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
25128169|NCT01641809|50241417|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
25128170|NCT01641809|50241414|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
25128171|NCT01641809|50241415|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
25128172|NCT01641809|50241416|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
25271484|NCT01214616|50585808|FG002|Overall Study|Other adverse events|1|||
25271485|NCT01214616|50585809|FG003|Overall Study|Other adverse events|1|||
25271486|NCT01214616|50585806|FG000|Overall Study|Withdrawal by Subject|1|||
25271487|NCT01214616|50585807|FG001|Overall Study|Withdrawal by Subject|0|||
25271488|NCT01214616|50585808|FG002|Overall Study|Withdrawal by Subject|0|||
25271489|NCT01214616|50585809|FG003|Overall Study|Withdrawal by Subject|1|||
25271490|NCT01213836|50585829|FG000|Period 1, First Intervention|Adverse Event|2|||
25271491|NCT01213836|50585830|FG001|Period 1, First Intervention|Adverse Event|1|||
25271492|NCT01213836|50585829|FG000|Period 1, First Intervention|Protocol Violation|0|||
25271493|NCT01213836|50585830|FG001|Period 1, First Intervention|Protocol Violation|1|||
25271494|NCT01213836|50585829|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
25128173|NCT01641809|50241417|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
25128174|NCT01632566|50241440|FG000|Overall Study|Withdrawal by Subject|0|||
25128175|NCT01632566|50241441|FG001|Overall Study|Withdrawal by Subject|1|||
25128176|NCT01632566|50241442|FG002|Overall Study|Withdrawal by Subject|0|||
25128177|NCT01632566|50241443|FG003|Overall Study|Withdrawal by Subject|0|||
25128178|NCT01632566|50241444|FG004|Overall Study|Withdrawal by Subject|0|||
25128179|NCT01632566|50241440|FG000|Overall Study|Sponsor Decision|0|||
25128180|NCT01632566|50241441|FG001|Overall Study|Sponsor Decision|2|||
25128181|NCT01632566|50241442|FG002|Overall Study|Sponsor Decision|9|||
25128182|NCT01632566|50241443|FG003|Overall Study|Sponsor Decision|2|||
25128183|NCT01632566|50241444|FG004|Overall Study|Sponsor Decision|2|||
25128184|NCT02254304|50241462|FG000|Overall Study|Adverse Event|2|||
25128185|NCT02254304|50241463|FG001|Overall Study|Adverse Event|1|||
25128186|NCT02254304|50241462|FG000|Overall Study|Lost to Follow-up|2|||
25128187|NCT02254304|50241463|FG001|Overall Study|Lost to Follow-up|2|||
25128188|NCT02254304|50241462|FG000|Overall Study|Protocol Violation|1|||
25128189|NCT02254304|50241463|FG001|Overall Study|Protocol Violation|0|||
25128190|NCT02254304|50241462|FG000|Overall Study|Withdrawal by Subject|3|||
25128191|NCT02254304|50241463|FG001|Overall Study|Withdrawal by Subject|0|||
25128192|NCT02254304|50241462|FG000|Overall Study|Injection site pain and Injection fear|1|||
25128193|NCT02254304|50241463|FG001|Overall Study|Injection site pain and Injection fear|0|||
25128194|NCT02254304|50241462|FG000|Overall Study|Personal causes|4|||
25128195|NCT02254304|50241463|FG001|Overall Study|Personal causes|1|||
25128196|NCT02254304|50241462|FG000|Overall Study|Personal decision|1|||
25128197|NCT02254304|50241463|FG001|Overall Study|Personal decision|0|||
25128198|NCT02174731|50241473|FG000|Overall Study|Participant decision|67|||
25271495|NCT01213836|50585830|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
25271496|NCT01127061|50585841|FG000|Overall Study|Lost to Follow-up|7|||
25271497|NCT01127061|50585842|FG001|Overall Study|Lost to Follow-up|10|||
25271498|NCT01127061|50585841|FG000|Overall Study|Physician Decision|3|||
25271499|NCT01127061|50585842|FG001|Overall Study|Physician Decision|3|||
25271500|NCT00924703|50585848|FG000|Overall Study|Withdrawal by Subject|11|||
25271501|NCT00924703|50585848|FG000|Overall Study|Physician Decision|5|||
25271502|NCT00924703|50585848|FG000|Overall Study|Lost to Follow-up|3|||
25271503|NCT00924703|50585848|FG000|Overall Study|Adverse Event|2|||
25271504|NCT00924703|50585848|FG000|Overall Study|Withdrawal by Sponsor|1|||
25271505|NCT01213524|50585854|FG000|Baseline|Withdrawal by Subject|5|||
25271506|NCT01213524|50585854|FG000|Baseline|high breath alcohol levels|1|||
25271507|NCT01213524|50585854|FG000|Baseline|Physician Decision|1|||
25271508|NCT01213524|50585854|FG000|Session 2|Withdrawal by Subject|5|||
25271509|NCT01213524|50585854|FG000|Session 3|Withdrawal by Subject|4|||
25271510|NCT01213524|50585854|FG000|Session 4|Physician Decision|1|||
25128199|NCT02174731|50241474|FG001|Overall Study|Participant decision|64|||
25128200|NCT02174731|50241473|FG000|Overall Study|Incorrect enrolment before randomization|0|||
25128201|NCT02174731|50241474|FG001|Overall Study|Incorrect enrolment before randomization|1|||
25128202|NCT02174731|50241473|FG000|Overall Study|Missing|2|||
25128203|NCT02174731|50241474|FG001|Overall Study|Missing|0|||
25271511|NCT01213524|50585854|FG000|Session 4|Withdrawal by Subject|2|||
25271512|NCT01212744|50585865|FG000|Overall Study|Withdrawal by Subject|1|||
25271513|NCT01212588|50585873|FG000|Overall Study|Physician Decision|0|||
25271514|NCT01212588|50585874|FG001|Overall Study|Physician Decision|1|||
25271515|NCT01212588|50585873|FG000|Overall Study|Protocol Violation|1|||
25271516|NCT01212588|50585874|FG001|Overall Study|Protocol Violation|1|||
25271517|NCT00918385|50585882|FG000|Monotherapy|Adverse Event|1|||
25271518|NCT00918385|50585883|FG001|Monotherapy|Adverse Event|6|||
25271519|NCT00918385|50585882|FG000|Monotherapy|Complicating illness|1|||
25271520|NCT00918385|50585883|FG001|Monotherapy|Complicating illness|0|||
25271521|NCT00918385|50585882|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
25271522|NCT00918385|50585883|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
25271523|NCT00918385|50585882|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
25271524|NCT00918385|50585883|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
25271525|NCT00918385|50585882|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
25271526|NCT00918385|50585883|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
25271527|NCT00918385|50585882|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
25271528|NCT00918385|50585883|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
25009355|NCT00075725|50102298|FG004|Overall Study|Institution Terminated|1|||
25128204|NCT01922037|50241482|FG000|Overall Study|Withdrawal by Subject|2|||
25128205|NCT01922037|50241483|FG001|Overall Study|Withdrawal by Subject|44|||
25128206|NCT01922037|50241482|FG000|Overall Study|Adverse Event|1|||
25271529|NCT01211262|50585893|FG000|Overall Study|Progressive Disease|18|||
25271530|NCT01211262|50585894|FG001|Overall Study|Progressive Disease|9|||
25128207|NCT01922037|50241483|FG001|Overall Study|Adverse Event|7|||
25128208|NCT01922037|50241482|FG000|Overall Study|Death|0|||
25128209|NCT01922037|50241483|FG001|Overall Study|Death|5|||
25128210|NCT01922037|50241482|FG000|Overall Study|Pregnancy|0|||
25128211|NCT01922037|50241483|FG001|Overall Study|Pregnancy|2|||
25128212|NCT01922037|50241482|FG000|Overall Study|Participant non-compliance|4|||
25271531|NCT01211262|50585893|FG000|Overall Study|Adverse Event|4|||
25271532|NCT01211262|50585894|FG001|Overall Study|Adverse Event|0|||
25271533|NCT01211262|50585893|FG000|Overall Study|Withdrawal of Consent|1|||
25271534|NCT01211262|50585894|FG001|Overall Study|Withdrawal of Consent|0|||
25271535|NCT01211262|50585893|FG000|Overall Study|Other|0|||
25271536|NCT01211262|50585894|FG001|Overall Study|Other|1|||
25271537|NCT01211184|50585906|FG000|Overall Study|Withdrawal by Subject|0|||
25271538|NCT01211184|50585907|FG001|Overall Study|Withdrawal by Subject|2|||
25271539|NCT01211184|50585908|FG002|Overall Study|Withdrawal by Subject|1|||
25271540|NCT00924469|50585921|FG000|Overall Study|Adverse Event|2|||
25271541|NCT00924469|50585922|FG001|Overall Study|Adverse Event|0|||
25271542|NCT00924469|50585921|FG000|Overall Study|Withdrawal by Subject|0|||
25271543|NCT00924469|50585922|FG001|Overall Study|Withdrawal by Subject|1|||
25271544|NCT00924469|50585921|FG000|Overall Study|Lost to Follow-up|0|||
25271545|NCT00924469|50585922|FG001|Overall Study|Lost to Follow-up|1|||
25271546|NCT00924313|50585928|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
25271547|NCT01209780|50585936|FG000|Overall Study|Adverse Event|0|||
25271548|NCT01209780|50585937|FG001|Overall Study|Adverse Event|1|||
25271549|NCT01209780|50585938|FG002|Overall Study|Adverse Event|0|||
25271550|NCT01209780|50585939|FG003|Overall Study|Adverse Event|0|||
25271551|NCT01209780|50585940|FG004|Overall Study|Adverse Event|0|||
25271552|NCT01209780|50585936|FG000|Overall Study|Withdrawal by Subject|9|||
25271553|NCT01209780|50585937|FG001|Overall Study|Withdrawal by Subject|2|||
25271554|NCT01209780|50585938|FG002|Overall Study|Withdrawal by Subject|1|||
25271555|NCT01209780|50585939|FG003|Overall Study|Withdrawal by Subject|1|||
25271556|NCT01209780|50585940|FG004|Overall Study|Withdrawal by Subject|0|||
25271557|NCT01209780|50585936|FG000|Overall Study|Lost to Follow-up|17|||
25271558|NCT01209780|50585937|FG001|Overall Study|Lost to Follow-up|12|||
25271559|NCT01209780|50585938|FG002|Overall Study|Lost to Follow-up|3|||
25271560|NCT01209780|50585939|FG003|Overall Study|Lost to Follow-up|9|||
25271561|NCT01209780|50585940|FG004|Overall Study|Lost to Follow-up|4|||
25271562|NCT01209780|50585936|FG000|Overall Study|Protocol Violation|0|||
25271563|NCT01209780|50585937|FG001|Overall Study|Protocol Violation|1|||
25271564|NCT01209780|50585938|FG002|Overall Study|Protocol Violation|0|||
25271565|NCT01209780|50585939|FG003|Overall Study|Protocol Violation|0|||
25271566|NCT01209780|50585940|FG004|Overall Study|Protocol Violation|0|||
25271567|NCT01209780|50585936|FG000|Overall Study|Inappropriate enrollment|0|||
25271568|NCT01209780|50585937|FG001|Overall Study|Inappropriate enrollment|2|||
25271569|NCT01209780|50585938|FG002|Overall Study|Inappropriate enrollment|0|||
25271570|NCT01209780|50585939|FG003|Overall Study|Inappropriate enrollment|0|||
25271571|NCT01209780|50585940|FG004|Overall Study|Inappropriate enrollment|1|||
25271572|NCT00916357|50585953|FG000|Period 1|Withdrawal by Subject|1|||
25271573|NCT00916357|50585954|FG001|Period 1|Withdrawal by Subject|0|||
25271574|NCT00916357|50585955|FG002|Period 1|Withdrawal by Subject|0|||
25271575|NCT00916357|50585956|FG003|Period 1|Withdrawal by Subject|0|||
25271576|NCT00916357|50585957|FG004|Period 1|Withdrawal by Subject|0|||
25271577|NCT00916357|50585958|FG005|Period 1|Withdrawal by Subject|0|||
25271578|NCT00916357|50585953|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
25271579|NCT00916357|50585954|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
25271580|NCT00916357|50585955|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
25128213|NCT01922037|50241483|FG001|Overall Study|Participant non-compliance|46|||
25128214|NCT01922037|50241482|FG000|Overall Study|Investigator/Sponsor decision|1|||
25128215|NCT01922037|50241483|FG001|Overall Study|Investigator/Sponsor decision|4|||
25128216|NCT01922037|50241482|FG000|Overall Study|Other unspecified|2|||
25271581|NCT00916357|50585956|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
25271582|NCT00916357|50585957|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
25271583|NCT00916357|50585958|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
25271584|NCT01209624|50585967|FG000|Overall Study|Death|2|||
25271585|NCT01209624|50585967|FG000|Overall Study|Adverse Event|13|||
25271586|NCT01209624|50585967|FG000|Overall Study|Lack of Efficacy|17|||
25271587|NCT01209624|50585967|FG000|Overall Study|Lost to Follow-up|290|||
25271588|NCT01209624|50585967|FG000|Overall Study|Other|4|||
25271589|NCT00916279|50585971|FG000|Overall Study|Death|2|||
25271590|NCT00916279|50585971|FG000|Overall Study|Lost to Follow-up|2|||
25271591|NCT01209078|50585980|FG000|Overall Study|Adverse Event|5|||
25271592|NCT01209078|50585981|FG001|Overall Study|Adverse Event|0|||
25271593|NCT01209078|50585980|FG000|Overall Study|Lost to Follow-up|4|||
25271594|NCT01209078|50585981|FG001|Overall Study|Lost to Follow-up|0|||
25271595|NCT01209078|50585980|FG000|Overall Study|Physician Decision|5|||
25271596|NCT01209078|50585981|FG001|Overall Study|Physician Decision|2|||
25271597|NCT01209078|50585980|FG000|Overall Study|Withdrawal by Subject|2|||
25271598|NCT01209078|50585981|FG001|Overall Study|Withdrawal by Subject|1|||
25271599|NCT01207596|50585989|FG000|Overall Study|Physician Decision|4|||
25271600|NCT01207596|50585989|FG000|Overall Study|Lack of Efficacy|1|||
25271601|NCT01207596|50585989|FG000|Overall Study|Adverse Event|3|||
25271602|NCT01207596|50585989|FG000|Overall Study|Withdrawal by Subject|1|||
25128217|NCT01922037|50241483|FG001|Overall Study|Other unspecified|66|||
25271603|NCT00915343|50585993|FG000|Part B - Open Label Period|Treatment switch|0|||
25271604|NCT00915343|50585994|FG001|Part B - Open Label Period|Treatment switch|0|||
25271605|NCT00915343|50585995|FG002|Part B - Open Label Period|Treatment switch|1|||
25271606|NCT00915343|50585993|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
25271607|NCT00915343|50585994|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
25271608|NCT00915343|50585995|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
25271609|NCT00911989|50586007|FG000|Overall Study|Adverse Event|1|||
25271610|NCT00910273|50586013|FG000|Overall Study|Lack of Efficacy|6|||
25271611|NCT00910273|50586014|FG001|Overall Study|Lack of Efficacy|9|||
25271612|NCT00910273|50586013|FG000|Overall Study|Adverse Event|1|||
25271613|NCT00910273|50586014|FG001|Overall Study|Adverse Event|1|||
25271614|NCT00910273|50586013|FG000|Overall Study|Withdrawal by Subject|1|||
25271615|NCT00910273|50586014|FG001|Overall Study|Withdrawal by Subject|0|||
25271616|NCT00910273|50586013|FG000|Overall Study|Discontinuation of study by sponsor|8|||
25271617|NCT00910273|50586014|FG001|Overall Study|Discontinuation of study by sponsor|2|||
25271618|NCT00910273|50586013|FG000|Overall Study|Protocol Violation|1|||
25271619|NCT00910273|50586014|FG001|Overall Study|Protocol Violation|0|||
25271620|NCT00910273|50586013|FG000|Overall Study|Lost to Follow-up|1|||
25271621|NCT00910273|50586014|FG001|Overall Study|Lost to Follow-up|1|||
25271622|NCT00910039|50586020|FG000|Overall Study|Physician Decision|1|||
25271623|NCT00909181|50586028|FG000|Overall Study|Lost to Follow-up|39|||
25271624|NCT00909181|50586029|FG001|Overall Study|Lost to Follow-up|18|||
25271625|NCT00909181|50586030|FG002|Overall Study|Lost to Follow-up|33|||
25271626|NCT01286987|50586053|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
25271627|NCT01286987|50586054|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
25271628|NCT01286987|50586055|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
25271629|NCT01286987|50586056|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
25271630|NCT01286987|50586057|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
25271631|NCT01286987|50586058|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
25271632|NCT01286987|50586059|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
25271633|NCT01286987|50586060|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
25271634|NCT01286987|50586061|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
25271635|NCT01286987|50586062|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
25271636|NCT01286987|50586063|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
25271637|NCT01286987|50586064|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
25271638|NCT01286987|50586065|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
25271639|NCT01286987|50586066|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
25271640|NCT01286987|50586067|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
25271641|NCT01286987|50586053|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
25271642|NCT01286987|50586054|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
25271643|NCT01286987|50586055|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
25271644|NCT01286987|50586056|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
25271645|NCT01286987|50586057|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
25271646|NCT01286987|50586058|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
25271647|NCT01286987|50586059|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
25271648|NCT01286987|50586060|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
25271649|NCT01286987|50586061|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
25271650|NCT01286987|50586062|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
25271651|NCT01286987|50586063|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
25271652|NCT01286987|50586064|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
25271653|NCT01286987|50586065|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
25271654|NCT01286987|50586066|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
25271655|NCT01286987|50586067|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
25271656|NCT01286987|50586053|FG000|Part 1: Dose Escalation|Physician Decision|0|||
25271657|NCT01286987|50586054|FG001|Part 1: Dose Escalation|Physician Decision|0|||
25271658|NCT01286987|50586055|FG002|Part 1: Dose Escalation|Physician Decision|0|||
25271659|NCT01286987|50586056|FG003|Part 1: Dose Escalation|Physician Decision|0|||
25271660|NCT01286987|50586057|FG004|Part 1: Dose Escalation|Physician Decision|1|||
25271661|NCT01286987|50586058|FG005|Part 1: Dose Escalation|Physician Decision|0|||
25271662|NCT01286987|50586059|FG006|Part 1: Dose Escalation|Physician Decision|0|||
25271663|NCT01286987|50586060|FG007|Part 1: Dose Escalation|Physician Decision|0|||
25271664|NCT01286987|50586061|FG008|Part 1: Dose Escalation|Physician Decision|0|||
25271665|NCT01286987|50586062|FG009|Part 1: Dose Escalation|Physician Decision|0|||
25271666|NCT01286987|50586063|FG010|Part 1: Dose Escalation|Physician Decision|0|||
25271667|NCT01286987|50586064|FG011|Part 1: Dose Escalation|Physician Decision|0|||
25271668|NCT01286987|50586065|FG012|Part 1: Dose Escalation|Physician Decision|0|||
25271669|NCT01286987|50586066|FG013|Part 1: Dose Escalation|Physician Decision|0|||
25271670|NCT01286987|50586067|FG014|Part 1: Dose Escalation|Physician Decision|0|||
25271671|NCT01286987|50586053|FG000|Part 2: Dose Expansion|Death|0|||
25271672|NCT01286987|50586054|FG001|Part 2: Dose Expansion|Death|0|||
25271673|NCT01286987|50586055|FG002|Part 2: Dose Expansion|Death|0|||
25271674|NCT01286987|50586056|FG003|Part 2: Dose Expansion|Death|0|||
25271675|NCT01286987|50586057|FG004|Part 2: Dose Expansion|Death|0|||
25271676|NCT01286987|50586058|FG005|Part 2: Dose Expansion|Death|0|||
25271677|NCT01286987|50586059|FG006|Part 2: Dose Expansion|Death|0|||
25271678|NCT01286987|50586060|FG007|Part 2: Dose Expansion|Death|0|||
25271679|NCT01286987|50586061|FG008|Part 2: Dose Expansion|Death|0|||
25271680|NCT01286987|50586062|FG009|Part 2: Dose Expansion|Death|0|||
25271681|NCT01286987|50586063|FG010|Part 2: Dose Expansion|Death|0|||
25271682|NCT01286987|50586064|FG011|Part 2: Dose Expansion|Death|0|||
25271683|NCT01286987|50586065|FG012|Part 2: Dose Expansion|Death|1|||
25271684|NCT01286987|50586066|FG013|Part 2: Dose Expansion|Death|1|||
25271685|NCT01286987|50586067|FG014|Part 2: Dose Expansion|Death|0|||
25271686|NCT01286987|50586053|FG000|Part 2: Dose Expansion|Physician Decision|0|||
25271687|NCT01286987|50586054|FG001|Part 2: Dose Expansion|Physician Decision|0|||
25271688|NCT01286987|50586055|FG002|Part 2: Dose Expansion|Physician Decision|0|||
25271689|NCT01286987|50586056|FG003|Part 2: Dose Expansion|Physician Decision|0|||
25271690|NCT01286987|50586057|FG004|Part 2: Dose Expansion|Physician Decision|0|||
25271691|NCT01286987|50586058|FG005|Part 2: Dose Expansion|Physician Decision|0|||
25271692|NCT01286987|50586059|FG006|Part 2: Dose Expansion|Physician Decision|0|||
25271693|NCT01286987|50586060|FG007|Part 2: Dose Expansion|Physician Decision|0|||
25271694|NCT01286987|50586061|FG008|Part 2: Dose Expansion|Physician Decision|0|||
25271695|NCT01286987|50586062|FG009|Part 2: Dose Expansion|Physician Decision|0|||
25271696|NCT01286987|50586063|FG010|Part 2: Dose Expansion|Physician Decision|1|||
25271697|NCT01286987|50586064|FG011|Part 2: Dose Expansion|Physician Decision|1|||
25271698|NCT01286987|50586065|FG012|Part 2: Dose Expansion|Physician Decision|0|||
25271699|NCT01286987|50586066|FG013|Part 2: Dose Expansion|Physician Decision|1|||
25271700|NCT01286987|50586067|FG014|Part 2: Dose Expansion|Physician Decision|0|||
25271701|NCT01286987|50586053|FG000|Part 2: Dose Expansion|Other|0|||
25271702|NCT01286987|50586054|FG001|Part 2: Dose Expansion|Other|0|||
25271703|NCT01286987|50586055|FG002|Part 2: Dose Expansion|Other|0|||
25128218|NCT02282813|50241494|FG000|Overall Study|Withdrawal by Subject|4|||
25128219|NCT02282813|50241495|FG001|Overall Study|Withdrawal by Subject|5|||
25128220|NCT02282813|50241496|FG002|Overall Study|Withdrawal by Subject|0|||
25128221|NCT02282813|50241494|FG000|Overall Study|Adverse Event|3|||
25128222|NCT02282813|50241495|FG001|Overall Study|Adverse Event|10|||
25128223|NCT02282813|50241496|FG002|Overall Study|Adverse Event|1|||
25128224|NCT02282813|50241494|FG000|Overall Study|Subject non-compliance|1|||
25128225|NCT02282813|50241495|FG001|Overall Study|Subject non-compliance|4|||
25128226|NCT02282813|50241496|FG002|Overall Study|Subject non-compliance|0|||
25128227|NCT02282813|50241494|FG000|Overall Study|Physician Decision|0|||
25128228|NCT02282813|50241495|FG001|Overall Study|Physician Decision|3|||
25128229|NCT02282813|50241496|FG002|Overall Study|Physician Decision|1|||
25128230|NCT02282813|50241494|FG000|Overall Study|Lost to Follow-up|2|||
25128231|NCT02282813|50241495|FG001|Overall Study|Lost to Follow-up|0|||
25128232|NCT02282813|50241496|FG002|Overall Study|Lost to Follow-up|1|||
25128233|NCT02282813|50241494|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
25128234|NCT02282813|50241495|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
25128235|NCT02282813|50241496|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
25128236|NCT02282813|50241494|FG000|Overall Study|Lack of Efficacy|1|||
25128237|NCT02282813|50241495|FG001|Overall Study|Lack of Efficacy|0|||
25128238|NCT02282813|50241496|FG002|Overall Study|Lack of Efficacy|0|||
25128239|NCT02282813|50241494|FG000|Overall Study|Administrative reasons|0|||
25128240|NCT02282813|50241495|FG001|Overall Study|Administrative reasons|1|||
25128241|NCT02282813|50241496|FG002|Overall Study|Administrative reasons|0|||
25128242|NCT01903863|50241508|FG000|Overall Study|Physician Decision|2|||
25128243|NCT01903863|50241509|FG001|Overall Study|Physician Decision|0|||
25128244|NCT02123251|50241517|FG000|Overall Study|Death|1|||
25128245|NCT02123251|50241518|FG001|Overall Study|Death|1|||
25128246|NCT02123251|50241517|FG000|Overall Study|Withdrawal by Subject|0|||
25128247|NCT02123251|50241518|FG001|Overall Study|Withdrawal by Subject|3|||
25128248|NCT02123251|50241517|FG000|Overall Study|Lost Medicaid eligibility|29|||
25128249|NCT02123251|50241518|FG001|Overall Study|Lost Medicaid eligibility|22|||
25128250|NCT02123251|50241517|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
25128251|NCT02123251|50241518|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
25128252|NCT01902303|50241527|FG000|Overall Study|Adverse Event|0|||
25009356|NCT00075725|50102299|FG005|Overall Study|Institution Terminated|0|||
25128253|NCT01902303|50241528|FG001|Overall Study|Adverse Event|1|||
25128254|NCT01902303|50241527|FG000|Overall Study|Lost to Follow-up|0|||
25128255|NCT01902303|50241528|FG001|Overall Study|Lost to Follow-up|1|||
25128256|NCT01902303|50241527|FG000|Overall Study|Protocol Violation|2|||
25271704|NCT01286987|50586056|FG003|Part 2: Dose Expansion|Other|0|||
25271705|NCT01286987|50586057|FG004|Part 2: Dose Expansion|Other|0|||
25271706|NCT01286987|50586058|FG005|Part 2: Dose Expansion|Other|0|||
25271707|NCT01286987|50586059|FG006|Part 2: Dose Expansion|Other|0|||
25271708|NCT01286987|50586060|FG007|Part 2: Dose Expansion|Other|0|||
25271709|NCT01286987|50586061|FG008|Part 2: Dose Expansion|Other|0|||
25128257|NCT01902303|50241528|FG001|Overall Study|Protocol Violation|2|||
25128258|NCT01902303|50241527|FG000|Overall Study|subject lost investigational product|0|||
25128259|NCT01902303|50241528|FG001|Overall Study|subject lost investigational product|1|||
25128260|NCT01902303|50241527|FG000|Overall Study|Did not develop a cold sore|21|||
25271710|NCT01286987|50586062|FG009|Part 2: Dose Expansion|Other|0|||
25271711|NCT01286987|50586063|FG010|Part 2: Dose Expansion|Other|0|||
25128261|NCT01902303|50241528|FG001|Overall Study|Did not develop a cold sore|19|||
25128262|NCT02122783|50241538|FG000|Overall Study|Adverse Event|0|||
25128263|NCT02122783|50241539|FG001|Overall Study|Adverse Event|1|||
25128264|NCT01921257|50241548|FG000|Overall Study|Adverse Event|1|||
25128265|NCT01921257|50241548|FG000|Overall Study|Protocol Violation|1|||
25128266|NCT01921257|50241548|FG000|Overall Study|Withdrawal by Subject|1|||
25128267|NCT02121847|50241553|FG000|Overall Study|Administrative Reasons|1|||
25128268|NCT02121847|50241553|FG000|Overall Study|Adverse Event|2|||
25128269|NCT01921179|50241559|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
25128270|NCT01921179|50241560|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
25128271|NCT01921179|50241559|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
25128272|NCT01921179|50241560|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
25128273|NCT01587040|50241571|FG000|Overall Study|Protocol Violation|0|||
25128274|NCT01587040|50241572|FG001|Overall Study|Protocol Violation|0|||
25128275|NCT01587040|50241573|FG002|Overall Study|Protocol Violation|1|||
25128276|NCT01587040|50241574|FG003|Overall Study|Protocol Violation|0|||
25128277|NCT01587040|50241571|FG000|Overall Study|Adverse Event|0|||
25128278|NCT01587040|50241572|FG001|Overall Study|Adverse Event|1|||
25128279|NCT01587040|50241573|FG002|Overall Study|Adverse Event|10|||
25128280|NCT01587040|50241574|FG003|Overall Study|Adverse Event|0|||
25128281|NCT01587040|50241571|FG000|Overall Study|Disease progression|12|||
25128282|NCT01587040|50241572|FG001|Overall Study|Disease progression|1|||
25128283|NCT01587040|50241573|FG002|Overall Study|Disease progression|15|||
25128284|NCT01587040|50241574|FG003|Overall Study|Disease progression|3|||
25128285|NCT01587040|50241571|FG000|Overall Study|Other than specified|5|||
25271712|NCT01286987|50586064|FG011|Part 2: Dose Expansion|Other|0|||
25271713|NCT01286987|50586065|FG012|Part 2: Dose Expansion|Other|0|||
25128286|NCT01587040|50241572|FG001|Overall Study|Other than specified|1|||
25128287|NCT01587040|50241573|FG002|Overall Study|Other than specified|11|||
25128288|NCT01587040|50241574|FG003|Overall Study|Other than specified|1|||
25128289|NCT02144701|50241586|FG000|Overall Study|development of relapse, GVHD or death|9|||
25128290|NCT02144701|50241587|FG001|Overall Study|development of relapse, GVHD or death|3|||
25128291|NCT01921101|50241595|FG000|Overall Study|Death|16|||
25128292|NCT01921101|50241596|FG001|Overall Study|Death|6|||
25128293|NCT01586806|50241605|FG000|Overall Study|Protocol Violation|0|||
25128294|NCT01586806|50241606|FG001|Overall Study|Protocol Violation|1|||
25128295|NCT01586806|50241607|FG002|Overall Study|Protocol Violation|0|||
25128296|NCT01586806|50241605|FG000|Overall Study|Withdrawal by Subject|1|||
25128297|NCT01586806|50241606|FG001|Overall Study|Withdrawal by Subject|0|||
25128298|NCT01586806|50241607|FG002|Overall Study|Withdrawal by Subject|0|||
25128299|NCT01586806|50241605|FG000|Overall Study|Lost to Follow-up|2|||
25128300|NCT01586806|50241606|FG001|Overall Study|Lost to Follow-up|3|||
25128301|NCT01586806|50241607|FG002|Overall Study|Lost to Follow-up|2|||
25128302|NCT02144077|50241617|FG000|Overall Study|Withdrawal by Subject|3|||
25128303|NCT02144077|50241618|FG001|Overall Study|Withdrawal by Subject|3|||
25128304|NCT02144077|50241617|FG000|Overall Study|Adverse Event|2|||
25128305|NCT02144077|50241618|FG001|Overall Study|Adverse Event|3|||
25128306|NCT02144077|50241617|FG000|Overall Study|Lost to Follow-up|2|||
25128307|NCT02144077|50241618|FG001|Overall Study|Lost to Follow-up|2|||
25128308|NCT02144077|50241617|FG000|Overall Study|Protocol Violation|1|||
25128309|NCT02144077|50241618|FG001|Overall Study|Protocol Violation|2|||
25128310|NCT02144077|50241617|FG000|Overall Study|Death|0|||
25128311|NCT02144077|50241618|FG001|Overall Study|Death|1|||
25128312|NCT02144077|50241617|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
25128313|NCT02144077|50241618|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
25128314|NCT02172625|50241626|FG000|Overall Study|Adverse Event|0|||
25128315|NCT02172625|50241627|FG001|Overall Study|Adverse Event|1|||
25128316|NCT02172625|50241626|FG000|Overall Study|Pregnancy|0|||
25128317|NCT02172625|50241627|FG001|Overall Study|Pregnancy|1|||
25128318|NCT02172625|50241626|FG000|Overall Study|car accident|0|||
25128319|NCT02172625|50241627|FG001|Overall Study|car accident|1|||
25128320|NCT02143843|50241637|FG000|Overall Study|Adverse Event|8|||
25128321|NCT02143843|50241637|FG000|Overall Study|Lack of Efficacy|2|||
25128322|NCT02143843|50241637|FG000|Overall Study|Withdrawal by Subject|2|||
25128323|NCT02121535|50241643|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
25128324|NCT02121535|50241644|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
25128325|NCT02121535|50241643|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
25128326|NCT02121535|50241644|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
25128327|NCT01586338|50241651|FG000|Overall Study|Adverse Event|3|||
25128328|NCT01586338|50241651|FG000|Overall Study|Lost to Follow-up|1|||
25128329|NCT01586338|50241651|FG000|Overall Study|Withdrawal by participant|3|||
25128330|NCT01586338|50241651|FG000|Overall Study|Other|1|||
25128331|NCT02143141|50241657|FG000|Overall Study|pain scores at 24 hours not collected|1|||
25128332|NCT02143141|50241658|FG001|Overall Study|pain scores at 24 hours not collected|0|||
25128333|NCT02171065|50241667|FG000|Overall Study|Withdrawal by Subject|1|||
25128334|NCT02171065|50241668|FG001|Overall Study|Withdrawal by Subject|0|||
25128335|NCT02171065|50241669|FG002|Overall Study|Withdrawal by Subject|0|||
25271714|NCT01286987|50586066|FG013|Part 2: Dose Expansion|Other|1|||
25271715|NCT01286987|50586067|FG014|Part 2: Dose Expansion|Other|0|||
25271716|NCT01286987|50586053|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
25271717|NCT01286987|50586054|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
25271718|NCT01286987|50586055|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
25271719|NCT01286987|50586056|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
25271720|NCT01286987|50586057|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
25271721|NCT01286987|50586058|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
25271722|NCT01286987|50586059|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
25271723|NCT01286987|50586060|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
25271724|NCT01286987|50586061|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
25271725|NCT01286987|50586062|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
25271726|NCT01286987|50586063|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
25271727|NCT01286987|50586064|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
25271728|NCT01286987|50586065|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
25128336|NCT02171065|50241667|FG000|Overall Study|Lost to Follow-up|0|||
25128337|NCT02171065|50241668|FG001|Overall Study|Lost to Follow-up|0|||
25128338|NCT02171065|50241669|FG002|Overall Study|Lost to Follow-up|1|||
25128339|NCT01566604|50241681|FG000|Overall Study|Patient's inability to use the device|1|||
25128340|NCT01566604|50241682|FG001|Overall Study|Patient's inability to use the device|0|||
25128341|NCT01566604|50241681|FG000|Overall Study|Administrative problems|1|||
25128342|NCT01566604|50241682|FG001|Overall Study|Administrative problems|0|||
25128343|NCT01566604|50241681|FG000|Overall Study|Lack of Efficacy|1|||
25128344|NCT01566604|50241682|FG001|Overall Study|Lack of Efficacy|2|||
25128345|NCT01566604|50241681|FG000|Overall Study|Protocol deviation|2|||
25128346|NCT01566604|50241682|FG001|Overall Study|Protocol deviation|0|||
25128347|NCT01566604|50241681|FG000|Overall Study|Abnormal laboratory value|2|||
25128348|NCT01566604|50241682|FG001|Overall Study|Abnormal laboratory value|0|||
25128349|NCT01566604|50241681|FG000|Overall Study|Death|4|||
25128350|NCT01566604|50241682|FG001|Overall Study|Death|1|||
25128351|NCT01566604|50241681|FG000|Overall Study|Adverse Event|4|||
25128352|NCT01566604|50241682|FG001|Overall Study|Adverse Event|2|||
25128353|NCT01566604|50241681|FG000|Overall Study|Withdrawal by Subject|9|||
25128354|NCT01566604|50241682|FG001|Overall Study|Withdrawal by Subject|6|||
25128355|NCT01684930|50241690|FG000|Overall Study|Withdrawal by Subject|3|||
25128356|NCT01684930|50241691|FG001|Overall Study|Withdrawal by Subject|1|||
25128357|NCT01566214|50241699|FG000|Overall Study|Lost to Follow-up|3|||
25128358|NCT01566214|50241700|FG001|Overall Study|Lost to Follow-up|0|||
25128359|NCT02253992|50241709|FG000|Overall Study|Study drug toxicity|1|||
25128360|NCT02253992|50241710|FG001|Overall Study|Study drug toxicity|0|||
25128361|NCT02253992|50241711|FG002|Overall Study|Study drug toxicity|10|||
25128362|NCT02253992|50241709|FG000|Overall Study|Disease progression|4|||
25128363|NCT02253992|50241710|FG001|Overall Study|Disease progression|3|||
25128364|NCT02253992|50241711|FG002|Overall Study|Disease progression|98|||
25128365|NCT02253992|50241709|FG000|Overall Study|Withdrawal by Subject|0|||
25128366|NCT02253992|50241710|FG001|Overall Study|Withdrawal by Subject|0|||
25128367|NCT02253992|50241711|FG002|Overall Study|Withdrawal by Subject|3|||
25128368|NCT02253992|50241709|FG000|Overall Study|Adverse Event|0|||
25128369|NCT02253992|50241710|FG001|Overall Study|Adverse Event|0|||
25128370|NCT02253992|50241711|FG002|Overall Study|Adverse Event|8|||
25128371|NCT02253992|50241709|FG000|Overall Study|Death|0|||
25128372|NCT02253992|50241710|FG001|Overall Study|Death|0|||
25128373|NCT02253992|50241711|FG002|Overall Study|Death|1|||
25128374|NCT02253992|50241709|FG000|Overall Study|Subject discontinued study drug|1|||
25128375|NCT02253992|50241710|FG001|Overall Study|Subject discontinued study drug|0|||
25128376|NCT02253992|50241711|FG002|Overall Study|Subject discontinued study drug|1|||
25128377|NCT02253992|50241709|FG000|Overall Study|Completed treatment as per protocol|0|||
25128378|NCT02253992|50241710|FG001|Overall Study|Completed treatment as per protocol|1|||
25128379|NCT02253992|50241711|FG002|Overall Study|Completed treatment as per protocol|22|||
25128380|NCT02253992|50241709|FG000|Overall Study|Other|0|||
25128381|NCT02253992|50241710|FG001|Overall Study|Other|0|||
25128382|NCT02253992|50241711|FG002|Overall Study|Other|1|||
25128383|NCT02252588|50241735|FG000|Overall Study|Withdrawal by Subject|4|||
25128384|NCT02252588|50241736|FG001|Overall Study|Withdrawal by Subject|0|||
25128385|NCT01585558|50241745|FG000|Overall Study|Withdrawal by Subject|4|||
25128386|NCT01585558|50241746|FG001|Overall Study|Withdrawal by Subject|5|||
25271729|NCT01286987|50586066|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
25128387|NCT01585558|50241747|FG002|Overall Study|Withdrawal by Subject|8|||
25271730|NCT01286987|50586067|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
25271731|NCT01286987|50586053|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
25128388|NCT01585558|50241745|FG000|Overall Study|Lost to Follow-up|2|||
25128389|NCT01585558|50241746|FG001|Overall Study|Lost to Follow-up|0|||
25128390|NCT01585558|50241747|FG002|Overall Study|Lost to Follow-up|3|||
25128391|NCT01585558|50241745|FG000|Overall Study|Adverse Event|3|||
25128392|NCT01585558|50241746|FG001|Overall Study|Adverse Event|4|||
25128393|NCT01585558|50241747|FG002|Overall Study|Adverse Event|1|||
25128394|NCT01585558|50241745|FG000|Overall Study|Protocol Violation|4|||
25128395|NCT01585558|50241746|FG001|Overall Study|Protocol Violation|3|||
25128396|NCT01585558|50241747|FG002|Overall Study|Protocol Violation|2|||
25128397|NCT01585558|50241745|FG000|Overall Study|Lack of Efficacy|0|||
25128398|NCT01585558|50241746|FG001|Overall Study|Lack of Efficacy|0|||
25128399|NCT01585558|50241747|FG002|Overall Study|Lack of Efficacy|1|||
25128400|NCT01565980|50241757|FG000|Overall Study|Death|1|||
25128401|NCT01565980|50241758|FG001|Overall Study|Death|0|||
25128402|NCT01565980|50241757|FG000|Overall Study|Lost to Follow-up|1|||
25128403|NCT01565980|50241758|FG001|Overall Study|Lost to Follow-up|0|||
25128404|NCT01565980|50241757|FG000|Overall Study|health complications|1|||
25128405|NCT01565980|50241758|FG001|Overall Study|health complications|1|||
25128406|NCT01565980|50241757|FG000|Overall Study|stopped medical treatment|1|||
25128407|NCT01565980|50241758|FG001|Overall Study|stopped medical treatment|0|||
25128408|NCT01565980|50241757|FG000|Overall Study|Withdrawal by Subject|0|||
25128409|NCT01565980|50241758|FG001|Overall Study|Withdrawal by Subject|3|||
25128410|NCT01585246|50241773|FG000|Overall Study|Lost to Follow-up|0|||
25128411|NCT01585246|50241774|FG001|Overall Study|Lost to Follow-up|0|||
25128412|NCT01585246|50241775|FG002|Overall Study|Lost to Follow-up|2|||
25128413|NCT01585246|50241776|FG003|Overall Study|Lost to Follow-up|1|||
25128414|NCT01585246|50241777|FG004|Overall Study|Lost to Follow-up|0|||
25128415|NCT01585246|50241773|FG000|Overall Study|Protocol Violation|0|||
25128416|NCT01585246|50241774|FG001|Overall Study|Protocol Violation|0|||
25128417|NCT01585246|50241775|FG002|Overall Study|Protocol Violation|0|||
25128418|NCT01585246|50241776|FG003|Overall Study|Protocol Violation|0|||
25128419|NCT01585246|50241777|FG004|Overall Study|Protocol Violation|1|||
25128420|NCT01585246|50241773|FG000|Overall Study|Withdrawal by Subject|0|||
25128421|NCT01585246|50241774|FG001|Overall Study|Withdrawal by Subject|0|||
25128422|NCT01585246|50241775|FG002|Overall Study|Withdrawal by Subject|1|||
25128423|NCT01585246|50241776|FG003|Overall Study|Withdrawal by Subject|2|||
25128424|NCT01585246|50241777|FG004|Overall Study|Withdrawal by Subject|1|||
25128425|NCT01585246|50241773|FG000|Overall Study|Other|0|||
25128426|NCT01585246|50241774|FG001|Overall Study|Other|1|||
25128427|NCT01585246|50241775|FG002|Overall Study|Other|1|||
25128428|NCT01585246|50241776|FG003|Overall Study|Other|1|||
25128429|NCT01585246|50241777|FG004|Overall Study|Other|0|||
25128430|NCT01585168|50241794|FG000|Overall Study|Lost to Follow-up|3|||
25128431|NCT01585168|50241795|FG001|Overall Study|Lost to Follow-up|1|||
25128432|NCT01585168|50241796|FG002|Overall Study|Lost to Follow-up|1|||
25128433|NCT01585168|50241797|FG003|Overall Study|Lost to Follow-up|1|||
25128434|NCT02252042|50241807|FG000|Overall Study|Death|170|||
25128435|NCT02252042|50241808|FG001|Overall Study|Death|192|||
25128436|NCT02252042|50241807|FG000|Overall Study|Physician Decision|0|||
25128437|NCT02252042|50241808|FG001|Overall Study|Physician Decision|1|||
25128438|NCT02252042|50241807|FG000|Overall Study|Withdrawal by Subject|13|||
25128439|NCT02252042|50241808|FG001|Overall Study|Withdrawal by Subject|20|||
25128440|NCT02252042|50241807|FG000|Overall Study|Ongoing in study|64|||
25128441|NCT02252042|50241808|FG001|Overall Study|Ongoing in study|35|||
25128442|NCT02232074|50241816|FG000|Overall Study|Withdrawal by Subject|5|||
25128443|NCT02232074|50241817|FG001|Overall Study|Withdrawal by Subject|3|||
25128444|NCT02232074|50241816|FG000|Overall Study|No legal concerns at baseline|36|||
25128445|NCT02232074|50241817|FG001|Overall Study|No legal concerns at baseline|41|||
25128446|NCT02232074|50241816|FG000|Overall Study|deemed ineligible|0|||
25128447|NCT02232074|50241817|FG001|Overall Study|deemed ineligible|1|||
25128448|NCT02142283|50241831|FG000|Overall Study|Death|20|||
25128449|NCT02142283|50241832|FG001|Overall Study|Death|18|||
25128450|NCT02142283|50241831|FG000|Overall Study|Withdrawal by Subject|1|||
25128451|NCT02142283|50241832|FG001|Overall Study|Withdrawal by Subject|3|||
25128452|NCT02231918|50241841|FG000|Overall Study|Withdrawal by Subject|0|||
25128453|NCT02231918|50241842|FG001|Overall Study|Withdrawal by Subject|1|||
25128454|NCT02231918|50241843|FG002|Overall Study|Withdrawal by Subject|0|||
25128455|NCT02231918|50241841|FG000|Overall Study|Adverse Event|0|||
25128456|NCT02231918|50241842|FG001|Overall Study|Adverse Event|0|||
25128457|NCT02231918|50241843|FG002|Overall Study|Adverse Event|1|||
25128458|NCT02199314|50241851|FG000|Overall Study|Withdrawal by Subject|6|||
25128459|NCT02199314|50241851|FG000|Overall Study|Physician Decision|10|||
25128460|NCT02199080|50241855|FG000|Overall Study|Protocol Violation|12|||
25128461|NCT02251652|50241861|FG000|Overall Study|Withdrawal by Subject|1|||
25128462|NCT02197520|50241867|FG000|Period 1|Withdrawal by Subject|1|||
25128463|NCT02197520|50241868|FG001|Period 1|Withdrawal by Subject|0|||
25128464|NCT02197520|50241867|FG000|Period 2|Adverse Event|0|||
25128465|NCT02197520|50241868|FG001|Period 2|Adverse Event|2|||
25128466|NCT02197520|50241867|FG000|Period 2|Withdrawal by Subject|1|||
25128467|NCT02197520|50241868|FG001|Period 2|Withdrawal by Subject|0|||
25128468|NCT02230904|50241878|FG000|Overall Study|Safety follow up could not take place|0|||
25128469|NCT02230904|50241879|FG001|Overall Study|Safety follow up could not take place|1|||
25128470|NCT02230670|50241889|FG000|Overall Study|Adverse Event|1|||
25128471|NCT02230670|50241890|FG001|Overall Study|Adverse Event|2|||
25128472|NCT02230670|50241889|FG000|Overall Study|Withdrawal by Subject|2|||
25128473|NCT02230670|50241890|FG001|Overall Study|Withdrawal by Subject|2|||
25128474|NCT02230670|50241889|FG000|Overall Study|Physician Decision|0|||
25128475|NCT02230670|50241890|FG001|Overall Study|Physician Decision|1|||
25128476|NCT02230670|50241889|FG000|Overall Study|Protocol Violation|0|||
25128477|NCT02230670|50241890|FG001|Overall Study|Protocol Violation|1|||
25128478|NCT02230670|50241889|FG000|Overall Study|Progression to Child-Pugh C|1|||
25128479|NCT02230670|50241890|FG001|Overall Study|Progression to Child-Pugh C|2|||
25128480|NCT02197130|50241899|FG000|Overall Study|Adverse Event|13|||
25128481|NCT02197130|50241900|FG001|Overall Study|Adverse Event|4|||
25128482|NCT02197130|50241901|FG002|Overall Study|Adverse Event|23|||
25128483|NCT02197130|50241899|FG000|Overall Study|Death|0|||
25128484|NCT02197130|50241900|FG001|Overall Study|Death|1|||
25128485|NCT02197130|50241901|FG002|Overall Study|Death|0|||
25128486|NCT02197130|50241899|FG000|Overall Study|Lost to Follow-up|2|||
25128487|NCT02197130|50241900|FG001|Overall Study|Lost to Follow-up|0|||
25128488|NCT02197130|50241901|FG002|Overall Study|Lost to Follow-up|1|||
25128489|NCT02197130|50241899|FG000|Overall Study|Does not meet entrance criteria|0|||
25128490|NCT02197130|50241900|FG001|Overall Study|Does not meet entrance criteria|0|||
25128491|NCT02197130|50241901|FG002|Overall Study|Does not meet entrance criteria|1|||
25128492|NCT02197130|50241899|FG000|Overall Study|Withdrawal by Subject|0|||
25271732|NCT01286987|50586054|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
25271733|NCT01286987|50586055|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
25271734|NCT01286987|50586056|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
25271735|NCT01286987|50586057|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
25271736|NCT01286987|50586058|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
25271737|NCT01286987|50586059|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
25271738|NCT01286987|50586060|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
25271739|NCT01286987|50586061|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
25271740|NCT01286987|50586062|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
25271741|NCT01286987|50586063|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
25271742|NCT01286987|50586064|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
25271743|NCT01286987|50586065|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
25271744|NCT01286987|50586066|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
25271745|NCT01286987|50586067|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
25128493|NCT02197130|50241900|FG001|Overall Study|Withdrawal by Subject|3|||
25128494|NCT02197130|50241901|FG002|Overall Study|Withdrawal by Subject|4|||
25128495|NCT02197130|50241899|FG000|Overall Study|Other|1|||
25128496|NCT02197130|50241900|FG001|Overall Study|Other|0|||
25128497|NCT02197130|50241901|FG002|Overall Study|Other|3|||
25128498|NCT02196506|50241911|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
25128499|NCT02196506|50241912|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
25128500|NCT02196506|50241913|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
25128501|NCT02196506|50241914|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
25128502|NCT02196506|50241911|FG000|Phase A|Withdrawal by Subject|34|||
25128503|NCT02196506|50241912|FG001|Phase A|Withdrawal by Subject|0|||
25128504|NCT02196506|50241913|FG002|Phase A|Withdrawal by Subject|0|||
25128505|NCT02196506|50241914|FG003|Phase A|Withdrawal by Subject|0|||
25128506|NCT02196506|50241911|FG000|Phase A|Adverse Event|22|||
25128507|NCT02196506|50241912|FG001|Phase A|Adverse Event|0|||
25128508|NCT02196506|50241913|FG002|Phase A|Adverse Event|0|||
25128509|NCT02196506|50241914|FG003|Phase A|Adverse Event|0|||
25128510|NCT02196506|50241911|FG000|Phase A|Lost to Follow-up|9|||
25128511|NCT02196506|50241912|FG001|Phase A|Lost to Follow-up|0|||
25128512|NCT02196506|50241913|FG002|Phase A|Lost to Follow-up|0|||
25128513|NCT02196506|50241914|FG003|Phase A|Lost to Follow-up|0|||
25128514|NCT02196506|50241911|FG000|Phase A|Protocol deviation|12|||
25128515|NCT02196506|50241912|FG001|Phase A|Protocol deviation|0|||
25128516|NCT02196506|50241913|FG002|Phase A|Protocol deviation|0|||
25128517|NCT02196506|50241914|FG003|Phase A|Protocol deviation|0|||
25128518|NCT02196506|50241911|FG000|Phase A|Participant withdrawn by investigator|10|||
25128519|NCT02196506|50241912|FG001|Phase A|Participant withdrawn by investigator|0|||
25128520|NCT02196506|50241913|FG002|Phase A|Participant withdrawn by investigator|0|||
25128521|NCT02196506|50241914|FG003|Phase A|Participant withdrawn by investigator|0|||
25128522|NCT02196506|50241911|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
25128523|NCT02196506|50241912|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
25128524|NCT02196506|50241913|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
25128525|NCT02196506|50241914|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
25128526|NCT02196506|50241911|FG000|Phase B|Lack of Efficacy|0|||
25128527|NCT02196506|50241912|FG001|Phase B|Lack of Efficacy|1|||
25128528|NCT02196506|50241913|FG002|Phase B|Lack of Efficacy|2|||
25128529|NCT02196506|50241914|FG003|Phase B|Lack of Efficacy|0|||
25128530|NCT02196506|50241911|FG000|Phase B|Withdrawal by Participant|0|||
25128531|NCT02196506|50241912|FG001|Phase B|Withdrawal by Participant|8|||
25128532|NCT02196506|50241913|FG002|Phase B|Withdrawal by Participant|1|||
25128533|NCT02196506|50241914|FG003|Phase B|Withdrawal by Participant|0|||
25271746|NCT01286987|50586053|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
25271747|NCT01286987|50586054|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
25128534|NCT02196506|50241911|FG000|Phase B|Adverse Event|0|||
25271748|NCT01286987|50586055|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
25271749|NCT01286987|50586056|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
25271750|NCT01286987|50586057|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
25271751|NCT01286987|50586058|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
25271752|NCT01286987|50586059|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
25271753|NCT01286987|50586060|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
25271754|NCT01286987|50586061|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
25271755|NCT01286987|50586062|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
25271756|NCT01286987|50586063|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
25271757|NCT01286987|50586064|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
25271758|NCT01286987|50586065|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
25271759|NCT01286987|50586066|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
25271760|NCT01286987|50586067|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
25271761|NCT01286753|50586110|FG000|Overall Study|Adverse Event|7|||
25271762|NCT01286753|50586111|FG001|Overall Study|Adverse Event|6|||
25271763|NCT01286753|50586110|FG000|Overall Study|Progression|11|||
25271764|NCT01286753|50586111|FG001|Overall Study|Progression|13|||
25271765|NCT01286753|50586110|FG000|Overall Study|Refused Treatment|1|||
25271766|NCT01286753|50586111|FG001|Overall Study|Refused Treatment|0|||
25271767|NCT01286753|50586110|FG000|Overall Study|Withdrawal of Consent|0|||
25271768|NCT01286753|50586111|FG001|Overall Study|Withdrawal of Consent|2|||
25271769|NCT01286753|50586110|FG000|Overall Study|Discontinued to Join Extension Study|6|||
25271770|NCT01286753|50586111|FG001|Overall Study|Discontinued to Join Extension Study|4|||
25271771|NCT01286753|50586110|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
25271772|NCT01286753|50586111|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
25271773|NCT01286129|50586120|FG000|Overall Study|Withdrawal by Subject|4|||
25271774|NCT01286129|50586121|FG001|Overall Study|Withdrawal by Subject|1|||
25271775|NCT01286129|50586120|FG000|Overall Study|Could not comply with study requirements|4|||
25271776|NCT01286129|50586121|FG001|Overall Study|Could not comply with study requirements|4|||
25271777|NCT01285349|50586132|FG000|Overall Study|Lost to Follow-up|27|||
25128535|NCT02196506|50241912|FG001|Phase B|Adverse Event|4|||
25128536|NCT02196506|50241913|FG002|Phase B|Adverse Event|1|||
25128537|NCT02196506|50241914|FG003|Phase B|Adverse Event|0|||
25128538|NCT02196506|50241911|FG000|Phase B|Lost to Follow-up|0|||
25128539|NCT02196506|50241912|FG001|Phase B|Lost to Follow-up|2|||
25128540|NCT02196506|50241913|FG002|Phase B|Lost to Follow-up|1|||
25128541|NCT02196506|50241914|FG003|Phase B|Lost to Follow-up|0|||
25128542|NCT02196506|50241911|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
25128543|NCT02196506|50241912|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
25128544|NCT02196506|50241913|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
25128545|NCT02196506|50241914|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
25128546|NCT02196506|50241911|FG000|Phase A+|Withdrawal by Participant|0|||
25128547|NCT02196506|50241912|FG001|Phase A+|Withdrawal by Participant|0|||
25128548|NCT02196506|50241913|FG002|Phase A+|Withdrawal by Participant|0|||
25128549|NCT02196506|50241914|FG003|Phase A+|Withdrawal by Participant|5|||
25128550|NCT02196506|50241911|FG000|Phase A+|Adverse Event|0|||
25128551|NCT02196506|50241912|FG001|Phase A+|Adverse Event|0|||
25128552|NCT02196506|50241913|FG002|Phase A+|Adverse Event|0|||
25128553|NCT02196506|50241914|FG003|Phase A+|Adverse Event|1|||
25128554|NCT02196506|50241911|FG000|Phase A+|Lost to Follow-up|0|||
25128555|NCT02196506|50241912|FG001|Phase A+|Lost to Follow-up|0|||
25128556|NCT02196506|50241913|FG002|Phase A+|Lost to Follow-up|0|||
25128557|NCT02196506|50241914|FG003|Phase A+|Lost to Follow-up|6|||
25128558|NCT02196506|50241911|FG000|Phase A+|Participant withdrawn by investigator|0|||
25128559|NCT02196506|50241912|FG001|Phase A+|Participant withdrawn by investigator|0|||
25128560|NCT02196506|50241913|FG002|Phase A+|Participant withdrawn by investigator|0|||
25128561|NCT02196506|50241914|FG003|Phase A+|Participant withdrawn by investigator|1|||
25128562|NCT02228720|50241920|FG000|Open Label - Day 30|Lost to Follow-up|1|||
25128563|NCT02228564|50241924|FG000|Overall Study|Withdrawal by Subject|10|||
25128564|NCT02228564|50241924|FG000|Overall Study|Death|11|||
25128565|NCT02228564|50241924|FG000|Overall Study|Physician Decision|5|||
25271778|NCT01285349|50586133|FG001|Overall Study|Lost to Follow-up|20|||
25271779|NCT01285349|50586134|FG002|Overall Study|Lost to Follow-up|27|||
25271780|NCT01284959|50586146|FG000|Overall Study|Withdrawal by Subject|1|||
25271781|NCT01284959|50586147|FG001|Overall Study|Withdrawal by Subject|0|||
25271782|NCT01284959|50586148|FG002|Overall Study|Withdrawal by Subject|0|||
25128566|NCT02228564|50241924|FG000|Overall Study|Lost to Follow-up|17|||
25128567|NCT02228564|50241924|FG000|Overall Study|Other|6|||
25128568|NCT01640951|50241936|FG000|Overall Study|Adverse Event|8|||
25128569|NCT01640951|50241937|FG001|Overall Study|Adverse Event|3|||
25128570|NCT01640951|50241938|FG002|Overall Study|Adverse Event|10|||
25128571|NCT01640951|50241939|FG003|Overall Study|Adverse Event|6|||
25128572|NCT01640951|50241940|FG004|Overall Study|Adverse Event|1|||
25128573|NCT01640951|50241941|FG005|Overall Study|Adverse Event|11|||
25128574|NCT01640951|50241942|FG006|Overall Study|Adverse Event|1|||
25128575|NCT01640951|50241943|FG007|Overall Study|Adverse Event|3|||
25128576|NCT01640951|50241936|FG000|Overall Study|Lack of Efficacy|20|||
25128577|NCT01640951|50241937|FG001|Overall Study|Lack of Efficacy|1|||
25128578|NCT01640951|50241938|FG002|Overall Study|Lack of Efficacy|7|||
25128579|NCT01640951|50241939|FG003|Overall Study|Lack of Efficacy|14|||
25128580|NCT01640951|50241940|FG004|Overall Study|Lack of Efficacy|0|||
25128581|NCT01640951|50241941|FG005|Overall Study|Lack of Efficacy|6|||
25271783|NCT01284959|50586146|FG000|Overall Study|Adverse Event|0|||
25271784|NCT01284959|50586147|FG001|Overall Study|Adverse Event|0|||
25271785|NCT01284959|50586148|FG002|Overall Study|Adverse Event|1|||
25271786|NCT01284491|50586156|FG000|Overall Study|Study termination|13|||
25271787|NCT01283009|50586164|FG000|Overall Study|Death|83|||
25271788|NCT01283009|50586165|FG001|Overall Study|Death|78|||
25271789|NCT01283009|50586164|FG000|Overall Study|Study ended early|23|||
25271790|NCT01283009|50586165|FG001|Overall Study|Study ended early|26|||
25271791|NCT01283009|50586164|FG000|Overall Study|Withdrawal by Subject|10|||
25271792|NCT01283009|50586165|FG001|Overall Study|Withdrawal by Subject|8|||
25271793|NCT01283009|50586164|FG000|Overall Study|Physician Decision|1|||
25271794|NCT01283009|50586165|FG001|Overall Study|Physician Decision|1|||
25128582|NCT01640951|50241942|FG006|Overall Study|Lack of Efficacy|5|||
25128583|NCT01640951|50241943|FG007|Overall Study|Lack of Efficacy|6|||
25128584|NCT01640951|50241936|FG000|Overall Study|Lost to Follow-up|1|||
25128585|NCT01640951|50241937|FG001|Overall Study|Lost to Follow-up|0|||
25128586|NCT01640951|50241938|FG002|Overall Study|Lost to Follow-up|6|||
25128587|NCT01640951|50241939|FG003|Overall Study|Lost to Follow-up|2|||
25128588|NCT01640951|50241940|FG004|Overall Study|Lost to Follow-up|2|||
25128589|NCT01640951|50241941|FG005|Overall Study|Lost to Follow-up|3|||
25128590|NCT01640951|50241942|FG006|Overall Study|Lost to Follow-up|1|||
25128591|NCT01640951|50241943|FG007|Overall Study|Lost to Follow-up|1|||
25128592|NCT01640951|50241936|FG000|Overall Study|Non-compliance with study treatment|0|||
25128593|NCT01640951|50241937|FG001|Overall Study|Non-compliance with study treatment|0|||
25128594|NCT01640951|50241938|FG002|Overall Study|Non-compliance with study treatment|1|||
25128595|NCT01640951|50241939|FG003|Overall Study|Non-compliance with study treatment|1|||
25128596|NCT01640951|50241940|FG004|Overall Study|Non-compliance with study treatment|1|||
25128597|NCT01640951|50241941|FG005|Overall Study|Non-compliance with study treatment|4|||
25128598|NCT01640951|50241942|FG006|Overall Study|Non-compliance with study treatment|1|||
25128599|NCT01640951|50241943|FG007|Overall Study|Non-compliance with study treatment|0|||
25128600|NCT01640951|50241936|FG000|Overall Study|Physician Decision|2|||
25128601|NCT01640951|50241937|FG001|Overall Study|Physician Decision|5|||
25128602|NCT01640951|50241938|FG002|Overall Study|Physician Decision|2|||
25128603|NCT01640951|50241939|FG003|Overall Study|Physician Decision|2|||
25128604|NCT01640951|50241940|FG004|Overall Study|Physician Decision|2|||
25128605|NCT01640951|50241941|FG005|Overall Study|Physician Decision|3|||
25128606|NCT01640951|50241942|FG006|Overall Study|Physician Decision|3|||
25128607|NCT01640951|50241943|FG007|Overall Study|Physician Decision|0|||
25128608|NCT01640951|50241936|FG000|Overall Study|Pregnancy|3|||
25128609|NCT01640951|50241937|FG001|Overall Study|Pregnancy|0|||
25128610|NCT01640951|50241938|FG002|Overall Study|Pregnancy|0|||
25128611|NCT01640951|50241939|FG003|Overall Study|Pregnancy|4|||
25128612|NCT01640951|50241940|FG004|Overall Study|Pregnancy|0|||
25128613|NCT01640951|50241941|FG005|Overall Study|Pregnancy|0|||
25128614|NCT01640951|50241942|FG006|Overall Study|Pregnancy|2|||
25128615|NCT01640951|50241943|FG007|Overall Study|Pregnancy|0|||
25128616|NCT01640951|50241936|FG000|Overall Study|Protocol Deviation|0|||
25128617|NCT01640951|50241937|FG001|Overall Study|Protocol Deviation|1|||
25271795|NCT01283009|50586164|FG000|Overall Study|Lost to Follow-up|1|||
25271796|NCT01283009|50586165|FG001|Overall Study|Lost to Follow-up|0|||
25271797|NCT01283009|50586164|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
25271798|NCT01283009|50586165|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
25128618|NCT01640951|50241938|FG002|Overall Study|Protocol Deviation|2|||
25128619|NCT01640951|50241939|FG003|Overall Study|Protocol Deviation|1|||
25128620|NCT01640951|50241940|FG004|Overall Study|Protocol Deviation|0|||
25128621|NCT01640951|50241941|FG005|Overall Study|Protocol Deviation|1|||
25128622|NCT01640951|50241942|FG006|Overall Study|Protocol Deviation|0|||
25128623|NCT01640951|50241943|FG007|Overall Study|Protocol Deviation|0|||
25128624|NCT01640951|50241936|FG000|Overall Study|Subject/Guardian decision|12|||
25128625|NCT01640951|50241937|FG001|Overall Study|Subject/Guardian decision|4|||
25128626|NCT01640951|50241938|FG002|Overall Study|Subject/Guardian decision|13|||
25128627|NCT01640951|50241939|FG003|Overall Study|Subject/Guardian decision|15|||
25128628|NCT01640951|50241940|FG004|Overall Study|Subject/Guardian decision|7|||
25128629|NCT01640951|50241941|FG005|Overall Study|Subject/Guardian decision|19|||
25128630|NCT01640951|50241942|FG006|Overall Study|Subject/Guardian decision|5|||
25128631|NCT01640951|50241943|FG007|Overall Study|Subject/Guardian decision|4|||
25128632|NCT01640951|50241936|FG000|Overall Study|Death|0|||
25128633|NCT01640951|50241937|FG001|Overall Study|Death|1|||
25128634|NCT01640951|50241938|FG002|Overall Study|Death|1|||
25128635|NCT01640951|50241939|FG003|Overall Study|Death|0|||
25128636|NCT01640951|50241940|FG004|Overall Study|Death|0|||
25128637|NCT01640951|50241941|FG005|Overall Study|Death|0|||
25128638|NCT01640951|50241942|FG006|Overall Study|Death|0|||
25128639|NCT01640951|50241943|FG007|Overall Study|Death|2|||
25271799|NCT01282463|50586174|FG000|Overall Study|Lost to Follow-up|1|||
25271800|NCT01282463|50586175|FG001|Overall Study|Lost to Follow-up|0|||
25271801|NCT01282463|50586176|FG002|Overall Study|Lost to Follow-up|0|||
25271802|NCT01282463|50586174|FG000|Overall Study|Withdrawal by Subject|6|||
25271803|NCT01282463|50586175|FG001|Overall Study|Withdrawal by Subject|2|||
25271804|NCT01282463|50586176|FG002|Overall Study|Withdrawal by Subject|3|||
25271805|NCT01282463|50586174|FG000|Overall Study|"Never Treated Death"|0|||
25271806|NCT01282463|50586175|FG001|Overall Study|"Never Treated Death"|1|||
25271807|NCT01282463|50586176|FG002|Overall Study|"Never Treated Death"|0|||
25271808|NCT01282463|50586174|FG000|Overall Study|"Never Treated PD"|0|||
25271809|NCT01282463|50586175|FG001|Overall Study|"Never Treated PD"|1|||
25271810|NCT01282463|50586176|FG002|Overall Study|"Never Treated PD"|0|||
25271811|NCT01282463|50586174|FG000|Overall Study|Protocol Violation|0|||
25271812|NCT01282463|50586175|FG001|Overall Study|Protocol Violation|0|||
25271813|NCT01282463|50586176|FG002|Overall Study|Protocol Violation|1|||
25271814|NCT01282463|50586174|FG000|Overall Study|Physician Decision|1|||
25271815|NCT01282463|50586175|FG001|Overall Study|Physician Decision|0|||
25271816|NCT01282463|50586176|FG002|Overall Study|Physician Decision|0|||
25271817|NCT01282229|50586192|FG000|Overall Study|Protocol Violation|2|||
25271818|NCT01281917|50586210|FG000|Overall Study|Withdrawal by Subject|1|||
25271819|NCT01281839|50586216|FG000|Overall Study|Lost to Follow-up|6|||
25271820|NCT01281839|50586217|FG001|Overall Study|Lost to Follow-up|3|||
25271821|NCT01281839|50586216|FG000|Overall Study|Withdrawal by Subject|4|||
25271822|NCT01281839|50586217|FG001|Overall Study|Withdrawal by Subject|10|||
25271823|NCT01281839|50586216|FG000|Overall Study|Reason not specified|0|||
25271824|NCT01281839|50586217|FG001|Overall Study|Reason not specified|1|||
25271825|NCT01281137|50586225|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
25271826|NCT01281137|50586226|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
25271827|NCT01281137|50586225|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
25271828|NCT01281137|50586226|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
25271829|NCT01281137|50586225|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
25271830|NCT01281137|50586226|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
25271831|NCT01281137|50586225|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
25271832|NCT01281137|50586226|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
25271833|NCT01281137|50586225|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
25271834|NCT01281137|50586226|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
25271835|NCT01280981|50586250|FG000|Overall Study|Withdrawal by Subject|11|||
25271836|NCT01280981|50586250|FG000|Overall Study|Protocol Violation|2|||
25271837|NCT01280981|50586250|FG000|Overall Study|Lack of Efficacy|13|||
25271838|NCT01280981|50586250|FG000|Overall Study|Lost to Follow-up|3|||
25271839|NCT01280981|50586250|FG000|Overall Study|Adverse Event|6|||
25271840|NCT01280981|50586250|FG000|Overall Study|Irregular or discontinued menses|3|||
25271841|NCT01280981|50586250|FG000|Overall Study|Failed to return|45|||
25271842|NCT01280981|50586250|FG000|Overall Study|Non-compliance with protocol|3|||
25271843|NCT01280981|50586250|FG000|Overall Study|Withdrawal of consent|3|||
25271844|NCT01280981|50586250|FG000|Overall Study|Elective surgery|2|||
25271845|NCT01280981|50586250|FG000|Overall Study|Study site closure|1|||
25271846|NCT01280903|50586256|FG000|Overall Study|Lost to Follow-up|23|||
25271847|NCT01280903|50586257|FG001|Overall Study|Lost to Follow-up|16|||
25128640|NCT02228096|50241965|FG000|Overall Study|Study terminated by Sponsor|24|||
25128641|NCT02228096|50241965|FG000|Overall Study|Lack of Efficacy|18|||
25128642|NCT02228096|50241965|FG000|Overall Study|Death|12|||
25128643|NCT02228096|50241965|FG000|Overall Study|Physician Decision|3|||
25271848|NCT01280591|50586267|FG000|Overall Study|Withdrawal by Subject|0|||
25271849|NCT01280591|50586268|FG001|Overall Study|Withdrawal by Subject|0|||
25128644|NCT02228096|50241965|FG000|Overall Study|Subject/guardian decision|2|||
25271850|NCT01280591|50586269|FG002|Overall Study|Withdrawal by Subject|0|||
25271851|NCT01280591|50586270|FG003|Overall Study|Withdrawal by Subject|2|||
25271852|NCT01280591|50586267|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
25271853|NCT01280591|50586268|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
25271854|NCT01280591|50586269|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
25271855|NCT01280591|50586270|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
25271856|NCT01280357|50586280|FG000|Overall Study|Excluded no internal monitoring|14|||
25271857|NCT01280357|50586280|FG000|Overall Study|IInsufficient data/No data supplied|12|||
25271858|NCT01274351|50586287|FG000|Overall Study|Lost to Follow-up|1|||
25271859|NCT01274351|50586287|FG000|Overall Study|patient not compliant with the protocol|1|||
25271860|NCT01274351|50586287|FG000|Overall Study|Pregnancy|1|||
25271861|NCT01274351|50586287|FG000|Overall Study|Death|2|||
25271862|NCT01274351|50586287|FG000|Overall Study|Withdrawal by Subject|3|||
25271863|NCT01274351|50586287|FG000|Overall Study|Adverse Event|8|||
25271864|NCT01274351|50586287|FG000|Overall Study|progression of disease|3|||
25271865|NCT01274351|50586287|FG000|Overall Study|hospitalization|1|||
25271866|NCT01271933|50586291|FG000|Single-Blind Phase|Lack of Efficacy|37|||
25271867|NCT01271933|50586292|FG001|Single-Blind Phase|Lack of Efficacy|0|||
25271868|NCT01271933|50586293|FG002|Single-Blind Phase|Lack of Efficacy|0|||
25271869|NCT01271933|50586291|FG000|Single-Blind Phase|Lost to Follow-up|10|||
25271870|NCT01271933|50586292|FG001|Single-Blind Phase|Lost to Follow-up|0|||
25271871|NCT01271933|50586293|FG002|Single-Blind Phase|Lost to Follow-up|0|||
25271872|NCT01271933|50586291|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
25271873|NCT01271933|50586292|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
25271874|NCT01271933|50586293|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
25271875|NCT01271933|50586291|FG000|Single-Blind Phase|Protocol Violation|3|||
25271876|NCT01271933|50586292|FG001|Single-Blind Phase|Protocol Violation|0|||
25178527|NCT01464307|50323812|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
25178528|NCT01464307|50323813|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
25178529|NCT01464307|50323812|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
25178530|NCT01464307|50323813|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
25178531|NCT01464307|50323812|FG000|Open-Label Extension Period|Death|1|||
25178532|NCT01464307|50323813|FG001|Open-Label Extension Period|Death|0|||
25178533|NCT01464307|50323812|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
25178534|NCT01464307|50323813|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
25178535|NCT01464307|50323812|FG000|Open-Label Extension Period|Non-compliance|9|||
25178536|NCT01464307|50323813|FG001|Open-Label Extension Period|Non-compliance|0|||
25178537|NCT01464307|50323812|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
25178538|NCT01464307|50323813|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
25178539|NCT01483183|50323830|FG000|Overall Study|Physician Decision|0|||
25178540|NCT01483183|50323831|FG001|Overall Study|Physician Decision|0|||
25178541|NCT01483183|50323832|FG002|Overall Study|Physician Decision|0|||
25178542|NCT01483183|50323833|FG003|Overall Study|Physician Decision|0|||
25178543|NCT01483183|50323834|FG004|Overall Study|Physician Decision|0|||
25178544|NCT01483183|50323835|FG005|Overall Study|Physician Decision|0|||
25178545|NCT01483183|50323836|FG006|Overall Study|Physician Decision|2|||
25178546|NCT01483183|50323837|FG007|Overall Study|Physician Decision|0|||
25178547|NCT01483183|50323838|FG008|Overall Study|Physician Decision|0|||
25178548|NCT01483183|50323839|FG009|Overall Study|Physician Decision|0|||
25271877|NCT01271933|50586293|FG002|Single-Blind Phase|Protocol Violation|0|||
25271878|NCT01271933|50586291|FG000|Single-Blind Phase|Adverse Event|52|||
25271879|NCT01271933|50586292|FG001|Single-Blind Phase|Adverse Event|0|||
25271880|NCT01271933|50586293|FG002|Single-Blind Phase|Adverse Event|0|||
25271881|NCT01271933|50586291|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
25271882|NCT01271933|50586292|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
25128645|NCT02228096|50241965|FG000|Overall Study|New therapy for study indication|1|||
25128646|NCT02228096|50241965|FG000|Overall Study|Enrolled, not infused|11|||
25128647|NCT01640873|50241985|FG000|Overall Study|Protocol Violation|2|||
25128648|NCT01640873|50241986|FG001|Overall Study|Protocol Violation|1|||
25128649|NCT01683994|50241997|FG000|Overall Study|Withdrawal by Subject|1|||
25128650|NCT01683994|50241998|FG001|Overall Study|Withdrawal by Subject|0|||
25128651|NCT01683994|50241999|FG002|Overall Study|Withdrawal by Subject|0|||
25271883|NCT01271933|50586293|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
25271884|NCT01271933|50586291|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
25271885|NCT01271933|50586292|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
25271886|NCT01271933|50586293|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
25271887|NCT01271933|50586291|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
25128652|NCT01683994|50242000|FG003|Overall Study|Withdrawal by Subject|1|||
25178549|NCT01483183|50323830|FG000|Overall Study|Withdrawal by Subject|0|||
25178550|NCT01483183|50323831|FG001|Overall Study|Withdrawal by Subject|0|||
25178551|NCT01483183|50323832|FG002|Overall Study|Withdrawal by Subject|0|||
25178552|NCT01483183|50323833|FG003|Overall Study|Withdrawal by Subject|0|||
25178553|NCT01483183|50323834|FG004|Overall Study|Withdrawal by Subject|0|||
25178554|NCT01483183|50323835|FG005|Overall Study|Withdrawal by Subject|0|||
25271888|NCT01271933|50586292|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
25271889|NCT01271933|50586293|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
25271890|NCT01271933|50586291|FG000|Double-Blind Phase|Randomized but not treated|0|||
25271891|NCT01271933|50586292|FG001|Double-Blind Phase|Randomized but not treated|0|||
25271892|NCT01271933|50586293|FG002|Double-Blind Phase|Randomized but not treated|1|||
25271893|NCT01271933|50586291|FG000|Double-Blind Phase|Lack of Efficacy|0|||
25271894|NCT01271933|50586292|FG001|Double-Blind Phase|Lack of Efficacy|6|||
25271895|NCT01271933|50586293|FG002|Double-Blind Phase|Lack of Efficacy|9|||
25271896|NCT01271933|50586291|FG000|Double-Blind Phase|Lost to Follow-up|0|||
25271897|NCT01271933|50586292|FG001|Double-Blind Phase|Lost to Follow-up|1|||
25271898|NCT01271933|50586293|FG002|Double-Blind Phase|Lost to Follow-up|1|||
25271899|NCT01271933|50586291|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
25271900|NCT01271933|50586292|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
25271901|NCT01271933|50586293|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
25271902|NCT01271933|50586291|FG000|Double-Blind Phase|Adverse Event|0|||
25271903|NCT01271933|50586292|FG001|Double-Blind Phase|Adverse Event|3|||
25271904|NCT01271933|50586293|FG002|Double-Blind Phase|Adverse Event|0|||
25271905|NCT01271933|50586291|FG000|Double-Blind Phase|Participant request-personal reason|0|||
25271906|NCT01271933|50586292|FG001|Double-Blind Phase|Participant request-personal reason|1|||
25271907|NCT01271933|50586293|FG002|Double-Blind Phase|Participant request-personal reason|0|||
25271908|NCT01269125|50586306|FG000|Overall Study|Adverse Event|3|||
25271909|NCT01269125|50586307|FG001|Overall Study|Adverse Event|5|||
25271910|NCT01269125|50586308|FG002|Overall Study|Adverse Event|0|||
25271911|NCT01269125|50586306|FG000|Overall Study|Lost to Follow-up|4|||
25271912|NCT01269125|50586307|FG001|Overall Study|Lost to Follow-up|0|||
25271913|NCT01269125|50586308|FG002|Overall Study|Lost to Follow-up|0|||
25271914|NCT01268891|50586318|FG000|Overall Study|Adverse Event|3|||
25271915|NCT01268891|50586319|FG001|Overall Study|Adverse Event|7|||
25271916|NCT01268891|50586318|FG000|Overall Study|Lack of Efficacy|1|||
25271917|NCT01268891|50586319|FG001|Overall Study|Lack of Efficacy|0|||
25271918|NCT01268891|50586318|FG000|Overall Study|Withdrawal of Consent|3|||
25271919|NCT01268891|50586319|FG001|Overall Study|Withdrawal of Consent|1|||
25271920|NCT01268891|50586318|FG000|Overall Study|Administrative or other reason(s)|1|||
25271921|NCT01268891|50586319|FG001|Overall Study|Administrative or other reason(s)|0|||
25271922|NCT01268501|50586325|FG000|Overall Study|Lost to Follow-up|1|||
25271923|NCT01268501|50586325|FG000|Overall Study|Withdrawal by Subject|3|||
25271924|NCT01268501|50586325|FG000|Overall Study|Unacceptable Subjective Vision|3|||
25271925|NCT01268501|50586325|FG000|Overall Study|Handling Difficulties|2|||
25271926|NCT01268267|50586329|FG000|Overall Study|Protocol Violation|1|||
25271927|NCT01267253|50586334|FG000|Overall Study|Ineligible - required test not done|1|||
25271928|NCT01267253|50586334|FG000|Overall Study|Inevaluable-never received study treatme|2|||
25271929|NCT01266317|50586338|FG000|Overall Study|Withdrawal by Subject|2|||
25271930|NCT01266161|50586344|FG000|Overall Study|Ineligible|1|||
25271931|NCT01266161|50586345|FG001|Overall Study|Ineligible|0|||
25271932|NCT01266161|50586344|FG000|Overall Study|Lack of Efficacy|0|||
25271933|NCT01266161|50586345|FG001|Overall Study|Lack of Efficacy|1|||
25271934|NCT01266161|50586344|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
25271935|NCT01266161|50586345|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
25271936|NCT01265849|50586354|FG000|Overall Study|Randomized//Treatment not initiated|1|||
25271937|NCT01265849|50586355|FG001|Overall Study|Randomized//Treatment not initiated|4|||
25271938|NCT01265849|50586356|FG002|Overall Study|Randomized//Treatment not initiated|0|||
25271939|NCT01265849|50586354|FG000|Overall Study|Physician Decision|1|||
25271940|NCT01265849|50586355|FG001|Overall Study|Physician Decision|2|||
25271941|NCT01265849|50586356|FG002|Overall Study|Physician Decision|0|||
25271942|NCT01265849|50586354|FG000|Overall Study|Lost to Follow-up|18|||
25271943|NCT01265849|50586355|FG001|Overall Study|Lost to Follow-up|15|||
25271944|NCT01265849|50586356|FG002|Overall Study|Lost to Follow-up|5|||
25271945|NCT01265849|50586354|FG000|Overall Study|Not otherwise specified|1|||
25271946|NCT01265849|50586355|FG001|Overall Study|Not otherwise specified|6|||
25271947|NCT01265849|50586356|FG002|Overall Study|Not otherwise specified|1|||
25271948|NCT01265849|50586354|FG000|Overall Study|Withdrawal by Subject|25|||
25271949|NCT01265849|50586355|FG001|Overall Study|Withdrawal by Subject|34|||
25271950|NCT01265849|50586356|FG002|Overall Study|Withdrawal by Subject|13|||
25271951|NCT01265615|50586372|FG000|Overall Study|Protocol Violation|2|||
25271952|NCT01265615|50586373|FG001|Overall Study|Protocol Violation|2|||
25271953|NCT01265615|50586374|FG002|Overall Study|Protocol Violation|4|||
25271954|NCT01265615|50586375|FG003|Overall Study|Protocol Violation|3|||
25271955|NCT01264835|50586385|FG000|Overall Study|Lost to Follow-up|1|||
25271956|NCT01264679|50586389|FG000|Overall Study|Participation in Another Clinical Trial|1|||
25271957|NCT01264679|50586389|FG000|Overall Study|Physician Decision|1|||
25271958|NCT01264679|50586389|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
25271959|NCT01264679|50586389|FG000|Overall Study|Withdrawal by Subject|1|||
25271960|NCT01263665|50586394|FG000|Overall Study|Withdrew Consent|1|||
25271961|NCT01263665|50586394|FG000|Overall Study|Lost to Follow-up|3|||
25271962|NCT01263665|50586394|FG000|Overall Study|Death|2|||
25271963|NCT01263665|50586394|FG000|Overall Study|Amputation above the ankle|1|||
25271964|NCT01263665|50586394|FG000|Overall Study|Surgical Bypass|2|||
25271965|NCT01263509|50586400|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
25271966|NCT01263509|50586401|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
25271967|NCT01263509|50586402|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
25271968|NCT01263509|50586403|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
25271969|NCT01263509|50586400|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
25271970|NCT01263509|50586401|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
25271971|NCT01263509|50586402|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
25271972|NCT01263509|50586403|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
25271973|NCT01263509|50586400|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
25271974|NCT01263509|50586401|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
25271975|NCT01263509|50586402|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
25271976|NCT01263509|50586403|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
25271977|NCT01263509|50586400|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
25271978|NCT01263509|50586401|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
25271979|NCT01263509|50586402|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
25271980|NCT01263509|50586403|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
25271981|NCT01263509|50586400|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
25271982|NCT01263509|50586401|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
25271983|NCT01263509|50586402|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
25271984|NCT01263509|50586403|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
25271985|NCT01263197|50586411|FG000|First Intervention (Period 1)|Adverse Event|0|||
25271986|NCT01263197|50586412|FG001|First Intervention (Period 1)|Adverse Event|0|||
25271987|NCT01263197|50586413|FG002|First Intervention (Period 1)|Adverse Event|0|||
25271988|NCT01263197|50586414|FG003|First Intervention (Period 1)|Adverse Event|0|||
25271989|NCT01263197|50586415|FG004|First Intervention (Period 1)|Adverse Event|0|||
25271990|NCT01263197|50586416|FG005|First Intervention (Period 1)|Adverse Event|1|||
25271991|NCT01263197|50586411|FG000|Washout Period 1|Protocol Violation|0|||
25271992|NCT01263197|50586412|FG001|Washout Period 1|Protocol Violation|0|||
25271993|NCT01263197|50586413|FG002|Washout Period 1|Protocol Violation|0|||
25271994|NCT01263197|50586414|FG003|Washout Period 1|Protocol Violation|0|||
25271995|NCT01263197|50586415|FG004|Washout Period 1|Protocol Violation|1|||
25271996|NCT01263197|50586416|FG005|Washout Period 1|Protocol Violation|0|||
25271997|NCT01263197|50586411|FG000|Washout Period 2|Physician Decision|0|||
25271998|NCT01263197|50586412|FG001|Washout Period 2|Physician Decision|0|||
25271999|NCT01263197|50586413|FG002|Washout Period 2|Physician Decision|0|||
25272000|NCT01263197|50586414|FG003|Washout Period 2|Physician Decision|0|||
25272001|NCT01263197|50586415|FG004|Washout Period 2|Physician Decision|0|||
25272002|NCT01263197|50586416|FG005|Washout Period 2|Physician Decision|1|||
25272003|NCT01263197|50586411|FG000|Washout Period 2|Protocol Violation|0|||
25272004|NCT01263197|50586412|FG001|Washout Period 2|Protocol Violation|0|||
25272005|NCT01263197|50586413|FG002|Washout Period 2|Protocol Violation|0|||
25272006|NCT01263197|50586414|FG003|Washout Period 2|Protocol Violation|1|||
25272007|NCT01263197|50586415|FG004|Washout Period 2|Protocol Violation|0|||
25272008|NCT01263197|50586416|FG005|Washout Period 2|Protocol Violation|0|||
25272009|NCT01263197|50586411|FG000|Third Intervention (Period 3)|Adverse Event|0|||
25272010|NCT01263197|50586412|FG001|Third Intervention (Period 3)|Adverse Event|1|||
25272011|NCT01263197|50586413|FG002|Third Intervention (Period 3)|Adverse Event|0|||
25272012|NCT01263197|50586414|FG003|Third Intervention (Period 3)|Adverse Event|0|||
25272013|NCT01263197|50586415|FG004|Third Intervention (Period 3)|Adverse Event|0|||
25272014|NCT01263197|50586416|FG005|Third Intervention (Period 3)|Adverse Event|0|||
25128653|NCT01683994|50242001|FG004|Overall Study|Withdrawal by Subject|0|||
25128654|NCT01683994|50241997|FG000|Overall Study|Intercurrent illness|0|||
25128655|NCT01683994|50241998|FG001|Overall Study|Intercurrent illness|0|||
25128656|NCT01683994|50241999|FG002|Overall Study|Intercurrent illness|0|||
25128657|NCT01683994|50242000|FG003|Overall Study|Intercurrent illness|2|||
25128658|NCT01683994|50242001|FG004|Overall Study|Intercurrent illness|1|||
25128659|NCT02247440|50242019|FG000|Overall Study|Withdrawal by Subject|1|||
25128660|NCT02247440|50242019|FG000|Overall Study|Lack of Efficacy|3|||
25128661|NCT01683838|50242025|FG000|Overall Study|Adverse Event|12|||
25128662|NCT01683838|50242026|FG001|Overall Study|Adverse Event|2|||
25128663|NCT01683838|50242025|FG000|Overall Study|Protocol Violation|3|||
25128664|NCT01683838|50242026|FG001|Overall Study|Protocol Violation|1|||
25128665|NCT01683838|50242025|FG000|Overall Study|Withdrawal by Subject|6|||
25128666|NCT01683838|50242026|FG001|Overall Study|Withdrawal by Subject|5|||
25128667|NCT01683838|50242025|FG000|Overall Study|Lost to Follow-up|1|||
25272015|NCT01263119|50586430|FG000|Period 1|Protocol Violation|2|||
25272016|NCT01263119|50586430|FG000|Period 2|Adverse Event|2|||
25272017|NCT01262651|50586440|FG000|Overall Study|Adverse Event|40|||
25272018|NCT01262651|50586441|FG001|Overall Study|Adverse Event|35|||
25128668|NCT01683838|50242026|FG001|Overall Study|Lost to Follow-up|1|||
25128669|NCT01683838|50242025|FG000|Overall Study|Other|4|||
25128670|NCT01683838|50242026|FG001|Overall Study|Other|3|||
25128671|NCT01683604|50242032|FG000|Overall Study|Adverse Event|2|||
25128672|NCT01683604|50242032|FG000|Overall Study|Lack of Efficacy|1|||
25128673|NCT01683604|50242032|FG000|Overall Study|Other|2|||
25128674|NCT02196038|50242043|FG000|Overall Study|Death|16|||
25128675|NCT02196038|50242044|FG001|Overall Study|Death|21|||
25128676|NCT02196038|50242043|FG000|Overall Study|Withdrawal by Subject|0|||
25128677|NCT02196038|50242044|FG001|Overall Study|Withdrawal by Subject|1|||
25128678|NCT02196038|50242043|FG000|Overall Study|Lost to Follow-up|1|||
25128679|NCT02196038|50242044|FG001|Overall Study|Lost to Follow-up|0|||
25128680|NCT02141659|50242056|FG000|Overall Study|Major Protocol Deviation|0|||
25128681|NCT02141659|50242057|FG001|Overall Study|Major Protocol Deviation|1|||
25128682|NCT02141659|50242058|FG002|Overall Study|Major Protocol Deviation|0|||
25128683|NCT02141659|50242059|FG003|Overall Study|Major Protocol Deviation|0|||
25128684|NCT02141659|50242060|FG004|Overall Study|Major Protocol Deviation|0|||
25272019|NCT01262651|50586440|FG000|Overall Study|Withdrawal by Subject|15|||
25272020|NCT01262651|50586441|FG001|Overall Study|Withdrawal by Subject|11|||
25128685|NCT02141659|50242061|FG005|Overall Study|Major Protocol Deviation|0|||
25128686|NCT02141659|50242056|FG000|Overall Study|Lack of Efficacy|0|||
25128687|NCT02141659|50242057|FG001|Overall Study|Lack of Efficacy|0|||
25128688|NCT02141659|50242058|FG002|Overall Study|Lack of Efficacy|0|||
25128689|NCT02141659|50242059|FG003|Overall Study|Lack of Efficacy|0|||
25128690|NCT02141659|50242060|FG004|Overall Study|Lack of Efficacy|0|||
25128691|NCT02141659|50242061|FG005|Overall Study|Lack of Efficacy|1|||
25128692|NCT02141659|50242056|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
25128693|NCT02141659|50242057|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
25128694|NCT02141659|50242058|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
25128695|NCT02141659|50242059|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
25128696|NCT02141659|50242060|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
25128697|NCT02141659|50242061|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
25128698|NCT01640249|50242082|FG000|Period 1|Withdrawal by Subject|1|||
25128699|NCT01640249|50242083|FG001|Period 1|Withdrawal by Subject|0|||
25128700|NCT01640249|50242084|FG002|Period 1|Withdrawal by Subject|0|||
25128701|NCT01640249|50242085|FG003|Period 1|Withdrawal by Subject|0|||
25128702|NCT01640249|50242086|FG004|Period 1|Withdrawal by Subject|0|||
25128703|NCT01640249|50242087|FG005|Period 1|Withdrawal by Subject|1|||
25128704|NCT01640249|50242088|FG006|Period 1|Withdrawal by Subject|0|||
25128705|NCT02121301|50242110|FG000|Overall Study|Protocol Violation|1|||
25128706|NCT02121301|50242111|FG001|Overall Study|Protocol Violation|4|||
25128707|NCT02121301|50242112|FG002|Overall Study|Protocol Violation|1|||
25128708|NCT02227862|50242122|FG000|Overall Study|Protocol Violation|7|||
25128709|NCT02227862|50242123|FG001|Overall Study|Protocol Violation|9|||
25128710|NCT02227862|50242122|FG000|Overall Study|Other|0|||
25128711|NCT02227862|50242123|FG001|Overall Study|Other|2|||
25128712|NCT02227862|50242122|FG000|Overall Study|Adverse Event|4|||
25128713|NCT02227862|50242123|FG001|Overall Study|Adverse Event|3|||
25128714|NCT02227862|50242122|FG000|Overall Study|Withdrawal by Subject|7|||
25128715|NCT02227862|50242123|FG001|Overall Study|Withdrawal by Subject|6|||
25128716|NCT02227862|50242122|FG000|Overall Study|Lost to Follow-up|1|||
25128717|NCT02227862|50242123|FG001|Overall Study|Lost to Follow-up|2|||
25128718|NCT02120833|50242131|FG000|Overall Study|Adverse Event|1|||
25128719|NCT02120833|50242132|FG001|Overall Study|Adverse Event|0|||
25128720|NCT02120833|50242131|FG000|Overall Study|Withdrawal by Subject|2|||
25128721|NCT02120833|50242132|FG001|Overall Study|Withdrawal by Subject|0|||
25128722|NCT02120833|50242131|FG000|Overall Study|Lost to Follow-up|1|||
25128723|NCT02120833|50242132|FG001|Overall Study|Lost to Follow-up|1|||
25128724|NCT02170207|50242138|FG000|Overall Study|Case report forms unavailable|5|||
25128725|NCT02227784|50242146|FG000|Double-Blind Phase|Adverse Event|3|||
25128726|NCT02227784|50242147|FG001|Double-Blind Phase|Adverse Event|2|||
25128727|NCT02227784|50242148|FG002|Double-Blind Phase|Adverse Event|1|||
25272021|NCT01262651|50586440|FG000|Overall Study|Withdrawal by Investigator|2|||
25128728|NCT02227784|50242149|FG003|Double-Blind Phase|Adverse Event|3|||
25128729|NCT02227784|50242150|FG004|Double-Blind Phase|Adverse Event|0|||
25128730|NCT02227784|50242146|FG000|Double-Blind Phase|Physician Decision|1|||
25128731|NCT02227784|50242147|FG001|Double-Blind Phase|Physician Decision|0|||
25128732|NCT02227784|50242148|FG002|Double-Blind Phase|Physician Decision|0|||
25128733|NCT02227784|50242149|FG003|Double-Blind Phase|Physician Decision|1|||
25128734|NCT02227784|50242150|FG004|Double-Blind Phase|Physician Decision|0|||
25128735|NCT02227784|50242146|FG000|Double-Blind Phase|Protocol Violation|0|||
25128736|NCT02227784|50242147|FG001|Double-Blind Phase|Protocol Violation|0|||
25128737|NCT02227784|50242148|FG002|Double-Blind Phase|Protocol Violation|1|||
25128738|NCT02227784|50242149|FG003|Double-Blind Phase|Protocol Violation|1|||
25128739|NCT02227784|50242150|FG004|Double-Blind Phase|Protocol Violation|0|||
25128740|NCT02227784|50242146|FG000|Double-Blind Phase|Sponsor Decision|34|||
25128741|NCT02227784|50242147|FG001|Double-Blind Phase|Sponsor Decision|15|||
25128742|NCT02227784|50242148|FG002|Double-Blind Phase|Sponsor Decision|14|||
25128743|NCT02227784|50242149|FG003|Double-Blind Phase|Sponsor Decision|32|||
25128744|NCT02227784|50242150|FG004|Double-Blind Phase|Sponsor Decision|0|||
25128745|NCT02227784|50242146|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
25128746|NCT02227784|50242147|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
25272022|NCT01262651|50586441|FG001|Overall Study|Withdrawal by Investigator|2|||
25272023|NCT01262651|50586440|FG000|Overall Study|Met Withdrawal Criteria|1|||
25272024|NCT01262651|50586441|FG001|Overall Study|Met Withdrawal Criteria|0|||
25272025|NCT01262573|50586449|FG000|Overall Study|Withdrawal by Subject|0|||
25272026|NCT01262573|50586450|FG001|Overall Study|Withdrawal by Subject|1|||
25272027|NCT01262027|50586456|FG000|Overall Study|Adverse Event|1|||
25272028|NCT01262027|50586456|FG000|Overall Study|Withdrawal by Subject|3|||
25272029|NCT01262027|50586456|FG000|Overall Study|Protocol Violation|1|||
25272030|NCT01261793|50586463|FG000|Overall Study|Lack of Efficacy|44|||
25272031|NCT01261793|50586464|FG001|Overall Study|Lack of Efficacy|37|||
25272032|NCT01261793|50586465|FG002|Overall Study|Lack of Efficacy|32|||
25128747|NCT02227784|50242148|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
25128748|NCT02227784|50242149|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
25128749|NCT02227784|50242150|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
25128750|NCT02227784|50242146|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
25128751|NCT02227784|50242147|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
25128752|NCT02227784|50242148|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
25128753|NCT02227784|50242149|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
25128754|NCT02227784|50242150|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
25128755|NCT02227784|50242146|FG000|Open-Label Extension Phase (OLE)|Death|0|||
25128756|NCT02227784|50242147|FG001|Open-Label Extension Phase (OLE)|Death|0|||
25128757|NCT02227784|50242148|FG002|Open-Label Extension Phase (OLE)|Death|0|||
25128758|NCT02227784|50242149|FG003|Open-Label Extension Phase (OLE)|Death|0|||
25128759|NCT02227784|50242150|FG004|Open-Label Extension Phase (OLE)|Death|1|||
25128760|NCT02227784|50242146|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
25128761|NCT02227784|50242147|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
25128762|NCT02227784|50242148|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
25128763|NCT02227784|50242149|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
25128764|NCT02227784|50242150|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
25178555|NCT01483183|50323836|FG006|Overall Study|Withdrawal by Subject|0|||
25178556|NCT01483183|50323837|FG007|Overall Study|Withdrawal by Subject|0|||
25178557|NCT01483183|50323838|FG008|Overall Study|Withdrawal by Subject|0|||
25178558|NCT01483183|50323839|FG009|Overall Study|Withdrawal by Subject|1|||
25178559|NCT01483027|50323869|FG000|Overall Study|Administrative Reasons|2|||
25178560|NCT01483027|50323870|FG001|Overall Study|Administrative Reasons|1|||
25178561|NCT01483027|50323869|FG000|Overall Study|Withdrawal by Subject|21|||
25178562|NCT01483027|50323870|FG001|Overall Study|Withdrawal by Subject|32|||
25178563|NCT01483027|50323869|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
25178564|NCT01483027|50323870|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
25178565|NCT01483027|50323869|FG000|Overall Study|Lost to Follow-up|1|||
25178566|NCT01483027|50323870|FG001|Overall Study|Lost to Follow-up|1|||
25178567|NCT01483027|50323869|FG000|Overall Study|Adverse Event|0|||
25178568|NCT01483027|50323870|FG001|Overall Study|Adverse Event|1|||
25178569|NCT01483027|50323869|FG000|Overall Study|Withdrawal by Subject|0|||
25178570|NCT01483027|50323870|FG001|Overall Study|Withdrawal by Subject|1|||
25178571|NCT01463683|50323879|FG000|Overall Study|Adverse Event|2|||
25178572|NCT01463683|50323880|FG001|Overall Study|Adverse Event|0|||
25178573|NCT01463683|50323881|FG002|Overall Study|Adverse Event|0|||
25178574|NCT01463683|50323879|FG000|Overall Study|Lost to Follow-up|10|||
25178575|NCT01463683|50323880|FG001|Overall Study|Lost to Follow-up|9|||
25178576|NCT01463683|50323881|FG002|Overall Study|Lost to Follow-up|7|||
25178577|NCT01463683|50323879|FG000|Overall Study|Physician Decision|0|||
25178578|NCT01463683|50323880|FG001|Overall Study|Physician Decision|3|||
25178579|NCT01463683|50323881|FG002|Overall Study|Physician Decision|1|||
25178580|NCT01463683|50323879|FG000|Overall Study|Pregnancy|2|||
25178581|NCT01463683|50323880|FG001|Overall Study|Pregnancy|2|||
25178582|NCT01463683|50323881|FG002|Overall Study|Pregnancy|1|||
25178583|NCT01463683|50323879|FG000|Overall Study|Withdrawal by Subject|5|||
25128765|NCT02227784|50242146|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
25128766|NCT02227784|50242147|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
25128767|NCT02227784|50242148|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
25178584|NCT01463683|50323880|FG001|Overall Study|Withdrawal by Subject|17|||
25178585|NCT01463683|50323881|FG002|Overall Study|Withdrawal by Subject|2|||
25178586|NCT01482169|50323889|FG000|Overall Study|Physician Decision|2|||
25178587|NCT01481779|50323898|FG000|Overall Study|Adverse Event|23|||
25178588|NCT01481779|50323899|FG001|Overall Study|Adverse Event|5|||
25178589|NCT01481779|50323898|FG000|Overall Study|Lost to Follow-up|3|||
25178590|NCT01481779|50323899|FG001|Overall Study|Lost to Follow-up|2|||
25178591|NCT01481779|50323898|FG000|Overall Study|Protocol Violation|2|||
25178592|NCT01481779|50323899|FG001|Overall Study|Protocol Violation|3|||
25178593|NCT01481779|50323898|FG000|Overall Study|Withdrawal by Subject|26|||
25272033|NCT01261793|50586463|FG000|Overall Study|Protocol Violation|3|||
25272034|NCT01261793|50586464|FG001|Overall Study|Protocol Violation|5|||
25272035|NCT01261793|50586465|FG002|Overall Study|Protocol Violation|6|||
25272036|NCT01261793|50586463|FG000|Overall Study|Lost to Follow-up|10|||
25272037|NCT01261793|50586464|FG001|Overall Study|Lost to Follow-up|3|||
25272038|NCT01261793|50586465|FG002|Overall Study|Lost to Follow-up|7|||
25272039|NCT01261793|50586463|FG000|Overall Study|Withdrawal by Subject|12|||
25272040|NCT01261793|50586464|FG001|Overall Study|Withdrawal by Subject|14|||
25272041|NCT01261793|50586465|FG002|Overall Study|Withdrawal by Subject|14|||
25272042|NCT01261793|50586463|FG000|Overall Study|Death|3|||
25272043|NCT01261793|50586464|FG001|Overall Study|Death|1|||
25272044|NCT01261793|50586465|FG002|Overall Study|Death|0|||
25272045|NCT01261793|50586463|FG000|Overall Study|Adverse Event|9|||
25272046|NCT01261793|50586464|FG001|Overall Study|Adverse Event|24|||
25272047|NCT01261793|50586465|FG002|Overall Study|Adverse Event|19|||
25272048|NCT01261793|50586463|FG000|Overall Study|Patient non-availability|1|||
25272049|NCT01261793|50586464|FG001|Overall Study|Patient non-availability|1|||
25272050|NCT01261793|50586465|FG002|Overall Study|Patient non-availability|1|||
25128768|NCT02227784|50242149|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
25128769|NCT02227784|50242150|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
25128770|NCT01565668|50242165|FG000|Overall Study|Death|2|||
25128771|NCT01565668|50242166|FG001|Overall Study|Death|1|||
25128772|NCT01565668|50242165|FG000|Overall Study|Lack of Efficacy|4|||
25128773|NCT01565668|50242166|FG001|Overall Study|Lack of Efficacy|2|||
25128774|NCT01565668|50242165|FG000|Overall Study|Participant went on Hospice Care|1|||
25128775|NCT01565668|50242166|FG001|Overall Study|Participant went on Hospice Care|0|||
25128776|NCT01565668|50242165|FG000|Overall Study|Adverse Event|6|||
25128777|NCT01565668|50242166|FG001|Overall Study|Adverse Event|1|||
25128778|NCT01565668|50242165|FG000|Overall Study|Randomized, but never received drug|0|||
25128779|NCT01565668|50242166|FG001|Overall Study|Randomized, but never received drug|2|||
25128780|NCT01565668|50242165|FG000|Overall Study|Progressive disease|13|||
25128781|NCT01565668|50242166|FG001|Overall Study|Progressive disease|14|||
25272051|NCT01261793|50586463|FG000|Overall Study|Suspected pregnancy|1|||
25272052|NCT01261793|50586464|FG001|Overall Study|Suspected pregnancy|1|||
25272053|NCT01261793|50586465|FG002|Overall Study|Suspected pregnancy|0|||
25272054|NCT01261793|50586463|FG000|Overall Study|Patient non-compliance|1|||
25272055|NCT01261793|50586464|FG001|Overall Study|Patient non-compliance|0|||
25272056|NCT01261793|50586465|FG002|Overall Study|Patient non-compliance|1|||
25272057|NCT01261793|50586463|FG000|Overall Study|Patient pregnant|1|||
25272058|NCT01261793|50586464|FG001|Overall Study|Patient pregnant|0|||
25272059|NCT01261793|50586465|FG002|Overall Study|Patient pregnant|0|||
25272060|NCT01261793|50586463|FG000|Overall Study|Outside the study area|0|||
25272061|NCT01261793|50586464|FG001|Overall Study|Outside the study area|2|||
25272062|NCT01261793|50586465|FG002|Overall Study|Outside the study area|1|||
25272063|NCT01261793|50586463|FG000|Overall Study|Lack of efficacy & patient not available|0|||
25272064|NCT01261793|50586464|FG001|Overall Study|Lack of efficacy & patient not available|1|||
25272065|NCT01261793|50586465|FG002|Overall Study|Lack of efficacy & patient not available|0|||
25272066|NCT01261793|50586463|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
25272067|NCT01261793|50586464|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
25272068|NCT01261793|50586465|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
25272069|NCT01261793|50586463|FG000|Overall Study|Randomization error|0|||
25272070|NCT01261793|50586464|FG001|Overall Study|Randomization error|1|||
25272071|NCT01261793|50586465|FG002|Overall Study|Randomization error|0|||
25272072|NCT01261793|50586463|FG000|Overall Study|Patient unable to start IV line|0|||
25272073|NCT01261793|50586464|FG001|Overall Study|Patient unable to start IV line|0|||
25272074|NCT01261793|50586465|FG002|Overall Study|Patient unable to start IV line|1|||
25272075|NCT01261325|50586476|FG000|Overall Study|Lack of Efficacy|1|||
25272076|NCT01261325|50586477|FG001|Overall Study|Lack of Efficacy|1|||
25272077|NCT01261325|50586478|FG002|Overall Study|Lack of Efficacy|0|||
25272078|NCT01261325|50586476|FG000|Overall Study|Withdrawal by Subject|2|||
25272079|NCT01261325|50586477|FG001|Overall Study|Withdrawal by Subject|2|||
25272080|NCT01261325|50586478|FG002|Overall Study|Withdrawal by Subject|4|||
25272081|NCT01261325|50586476|FG000|Overall Study|SAE, non-fatal|1|||
25272082|NCT01261325|50586477|FG001|Overall Study|SAE, non-fatal|5|||
25272083|NCT01261325|50586478|FG002|Overall Study|SAE, non-fatal|1|||
25128782|NCT01565668|50242165|FG000|Overall Study|Withdrawal by Subject|1|||
25128783|NCT01565668|50242166|FG001|Overall Study|Withdrawal by Subject|3|||
25128784|NCT01565668|50242165|FG000|Overall Study|HSCT Transplant|11|||
25272084|NCT01261325|50586476|FG000|Overall Study|AE, non-serious non-fatal|9|||
25128785|NCT01565668|50242166|FG001|Overall Study|HSCT Transplant|15|||
25128786|NCT01683058|50242172|FG000|Overall Study|Lost to Follow-up|9|||
25178594|NCT01481779|50323899|FG001|Overall Study|Withdrawal by Subject|13|||
25178595|NCT01481779|50323898|FG000|Overall Study|Physician Decision|13|||
25272085|NCT01261325|50586477|FG001|Overall Study|AE, non-serious non-fatal|15|||
25272086|NCT01261325|50586478|FG002|Overall Study|AE, non-serious non-fatal|13|||
25272087|NCT01261325|50586476|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
25272088|NCT01261325|50586477|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
25272089|NCT01261325|50586478|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
25272090|NCT01261325|50586476|FG000|Overall Study|Non Compliance|2|||
25272091|NCT01261325|50586477|FG001|Overall Study|Non Compliance|0|||
25128787|NCT01683058|50242172|FG000|Overall Study|Adverse Event|6|||
25128788|NCT01683058|50242172|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
25128789|NCT01683058|50242172|FG000|Overall Study|Withdrawal by Subject|7|||
25128790|NCT01683058|50242172|FG000|Overall Study|Lack of Efficacy|2|||
25128791|NCT01626859|50242180|FG000|Overall Study|Adverse Event|1|||
25128792|NCT01626859|50242181|FG001|Overall Study|Adverse Event|3|||
25128793|NCT01626859|50242182|FG002|Overall Study|Adverse Event|2|||
25128794|NCT01626859|50242180|FG000|Overall Study|Physician Decision|0|||
25128795|NCT01626859|50242181|FG001|Overall Study|Physician Decision|1|||
25128796|NCT01626859|50242182|FG002|Overall Study|Physician Decision|0|||
25128797|NCT01626859|50242180|FG000|Overall Study|Withdrawal by Subject|1|||
25128798|NCT01626859|50242181|FG001|Overall Study|Withdrawal by Subject|4|||
25128799|NCT01626859|50242182|FG002|Overall Study|Withdrawal by Subject|2|||
25128800|NCT02193776|50242194|FG000|Overall Study|Consent withdrawn|1|||
25128801|NCT02193776|50242195|FG001|Overall Study|Consent withdrawn|0|||
25128802|NCT02193776|50242196|FG002|Overall Study|Consent withdrawn|0|||
25128803|NCT02193776|50242197|FG003|Overall Study|Consent withdrawn|0|||
25128804|NCT02193776|50242194|FG000|Overall Study|Failure to comply with protocol|0|||
25128805|NCT02193776|50242195|FG001|Overall Study|Failure to comply with protocol|1|||
25128806|NCT02193776|50242196|FG002|Overall Study|Failure to comply with protocol|0|||
25128807|NCT02193776|50242197|FG003|Overall Study|Failure to comply with protocol|0|||
25128808|NCT02193776|50242194|FG000|Overall Study|Investigator/Sponsor decision|1|||
25128809|NCT02193776|50242195|FG001|Overall Study|Investigator/Sponsor decision|1|||
25128810|NCT02193776|50242196|FG002|Overall Study|Investigator/Sponsor decision|0|||
25128811|NCT02193776|50242197|FG003|Overall Study|Investigator/Sponsor decision|0|||
25128812|NCT02193776|50242194|FG000|Overall Study|Death|1|||
25128813|NCT02193776|50242195|FG001|Overall Study|Death|0|||
25128814|NCT02193776|50242196|FG002|Overall Study|Death|0|||
25128815|NCT02193776|50242197|FG003|Overall Study|Death|0|||
25128816|NCT02193776|50242194|FG000|Overall Study|Adverse event/Specific toxicity|5|||
25128817|NCT02193776|50242195|FG001|Overall Study|Adverse event/Specific toxicity|5|||
25128818|NCT02193776|50242196|FG002|Overall Study|Adverse event/Specific toxicity|2|||
25128819|NCT02193776|50242197|FG003|Overall Study|Adverse event/Specific toxicity|2|||
25128820|NCT02170064|50242210|FG000|Overall Study|Withdrawal by Subject|5|||
25128821|NCT02170064|50242211|FG001|Overall Study|Withdrawal by Subject|1|||
25128822|NCT02170064|50242212|FG002|Overall Study|Withdrawal by Subject|1|||
25128823|NCT02170064|50242210|FG000|Overall Study|Physician Decision|1|||
25128824|NCT02170064|50242211|FG001|Overall Study|Physician Decision|1|||
25128825|NCT02170064|50242212|FG002|Overall Study|Physician Decision|0|||
25128826|NCT02169830|50242223|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
25128827|NCT02169830|50242224|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
25128828|NCT02169830|50242225|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
25128829|NCT02169830|50242223|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
25128830|NCT02169830|50242224|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
25128831|NCT02169830|50242225|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
25128832|NCT02169830|50242223|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
25128833|NCT02169830|50242224|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
25128834|NCT02169830|50242225|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
25128835|NCT02169830|50242223|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
25128836|NCT02169830|50242224|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
25128837|NCT02169830|50242225|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
25128838|NCT02169830|50242223|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
25128839|NCT02169830|50242224|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
25128840|NCT02169830|50242225|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
25128841|NCT02169674|50242235|FG000|Overall Study|Withdrawal by Subject|2|||
25128842|NCT02169674|50242236|FG001|Overall Study|Withdrawal by Subject|1|||
25128843|NCT02169674|50242235|FG000|Overall Study|Seroprotected|30|||
25128844|NCT02169674|50242236|FG001|Overall Study|Seroprotected|76|||
25128845|NCT02169674|50242235|FG000|Overall Study|Lost to Follow-up|0|||
25128846|NCT02169674|50242236|FG001|Overall Study|Lost to Follow-up|1|||
25128847|NCT02169284|50242244|FG000|Overall Study|Physician Decision|0|||
25128848|NCT02169284|50242245|FG001|Overall Study|Physician Decision|1|||
25128849|NCT02119819|50242259|FG000|Overall Study|Adverse Event|3|||
25128850|NCT02119819|50242260|FG001|Overall Study|Adverse Event|1|||
25128851|NCT02119819|50242261|FG002|Overall Study|Adverse Event|2|||
25128852|NCT02119819|50242262|FG003|Overall Study|Adverse Event|3|||
25128853|NCT02119819|50242263|FG004|Overall Study|Adverse Event|0|||
25128854|NCT02119819|50242264|FG005|Overall Study|Adverse Event|1|||
25128855|NCT02119819|50242259|FG000|Overall Study|Lack of Efficacy|0|||
25272092|NCT01261325|50586478|FG002|Overall Study|Non Compliance|0|||
25272093|NCT01261325|50586476|FG000|Overall Study|Patient Randomized by Mistake|0|||
25128856|NCT02119819|50242260|FG001|Overall Study|Lack of Efficacy|0|||
25128857|NCT02119819|50242261|FG002|Overall Study|Lack of Efficacy|0|||
25128858|NCT02119819|50242262|FG003|Overall Study|Lack of Efficacy|0|||
25128859|NCT02119819|50242263|FG004|Overall Study|Lack of Efficacy|0|||
25128860|NCT02119819|50242264|FG005|Overall Study|Lack of Efficacy|1|||
25128861|NCT02119819|50242259|FG000|Overall Study|Lost to Follow-up|0|||
25128862|NCT02119819|50242260|FG001|Overall Study|Lost to Follow-up|0|||
25128863|NCT02119819|50242261|FG002|Overall Study|Lost to Follow-up|1|||
25128864|NCT02119819|50242262|FG003|Overall Study|Lost to Follow-up|2|||
25128865|NCT02119819|50242263|FG004|Overall Study|Lost to Follow-up|1|||
25128866|NCT02119819|50242264|FG005|Overall Study|Lost to Follow-up|2|||
25128867|NCT02119819|50242259|FG000|Overall Study|Physician Decision|1|||
25128868|NCT02119819|50242260|FG001|Overall Study|Physician Decision|1|||
25128869|NCT02119819|50242261|FG002|Overall Study|Physician Decision|0|||
25128870|NCT02119819|50242262|FG003|Overall Study|Physician Decision|0|||
25128871|NCT02119819|50242263|FG004|Overall Study|Physician Decision|0|||
25128872|NCT02119819|50242264|FG005|Overall Study|Physician Decision|1|||
25128873|NCT02119819|50242259|FG000|Overall Study|Withdrawal by Subject|5|||
25128874|NCT02119819|50242260|FG001|Overall Study|Withdrawal by Subject|3|||
25178596|NCT01481779|50323899|FG001|Overall Study|Physician Decision|4|||
25178597|NCT01481779|50323898|FG000|Overall Study|Sponsor Decision|3|||
25178598|NCT01481779|50323899|FG001|Overall Study|Sponsor Decision|1|||
25178599|NCT01463527|50323907|FG000|Overall Study|Protocol Violation|1|||
25178600|NCT01463527|50323908|FG001|Overall Study|Protocol Violation|1|||
25178601|NCT01463527|50323907|FG000|Overall Study|Crying >20% of sedation|5|||
25178602|NCT01463527|50323908|FG001|Overall Study|Crying >20% of sedation|6|||
25178603|NCT01509547|50323916|FG000|Overall Study|Lost to Follow-up|24|||
25128875|NCT02119819|50242261|FG002|Overall Study|Withdrawal by Subject|0|||
25128876|NCT02119819|50242262|FG003|Overall Study|Withdrawal by Subject|0|||
25128877|NCT02119819|50242263|FG004|Overall Study|Withdrawal by Subject|6|||
25128878|NCT02119819|50242264|FG005|Overall Study|Withdrawal by Subject|10|||
25128879|NCT02119819|50242259|FG000|Overall Study|Jury Duty|0|||
25128880|NCT02119819|50242260|FG001|Overall Study|Jury Duty|0|||
25128881|NCT02119819|50242261|FG002|Overall Study|Jury Duty|1|||
25128882|NCT02119819|50242262|FG003|Overall Study|Jury Duty|0|||
25128883|NCT02119819|50242263|FG004|Overall Study|Jury Duty|0|||
25128884|NCT02119819|50242264|FG005|Overall Study|Jury Duty|0|||
25128885|NCT02119819|50242259|FG000|Overall Study|Protocol Violation|0|||
25128886|NCT02119819|50242260|FG001|Overall Study|Protocol Violation|0|||
25128887|NCT02119819|50242261|FG002|Overall Study|Protocol Violation|0|||
25128888|NCT02119819|50242262|FG003|Overall Study|Protocol Violation|1|||
25128889|NCT02119819|50242263|FG004|Overall Study|Protocol Violation|0|||
25128890|NCT02119819|50242264|FG005|Overall Study|Protocol Violation|0|||
25128891|NCT02119819|50242259|FG000|Overall Study|Left the city to get a job|0|||
25128892|NCT02119819|50242260|FG001|Overall Study|Left the city to get a job|0|||
25128893|NCT02119819|50242261|FG002|Overall Study|Left the city to get a job|0|||
25128894|NCT02119819|50242262|FG003|Overall Study|Left the city to get a job|1|||
25128895|NCT02119819|50242263|FG004|Overall Study|Left the city to get a job|0|||
25128896|NCT02119819|50242264|FG005|Overall Study|Left the city to get a job|0|||
25128897|NCT02168816|50242280|FG000|Overall Study|Lost to Follow-up|2|||
25128898|NCT02168816|50242281|FG001|Overall Study|Lost to Follow-up|2|||
25128899|NCT01584232|50242289|FG000|Overall Study|Adverse Event|3|||
25128900|NCT01584232|50242290|FG001|Overall Study|Adverse Event|1|||
25128901|NCT01584232|50242289|FG000|Overall Study|Withdrawal by Subject|2|||
25128902|NCT01584232|50242290|FG001|Overall Study|Withdrawal by Subject|1|||
25128903|NCT01584232|50242289|FG000|Overall Study|Physician Decision|2|||
25128904|NCT01584232|50242290|FG001|Overall Study|Physician Decision|1|||
25128905|NCT01584232|50242289|FG000|Overall Study|Lost to Follow-up|1|||
25128906|NCT01584232|50242290|FG001|Overall Study|Lost to Follow-up|0|||
25128907|NCT01639703|50242296|FG000|Overall Study|Withdrawal by Subject|5|||
25128908|NCT01639703|50242296|FG000|Overall Study|Other reason|7|||
25128909|NCT02119663|50242314|FG000|Overall Study|Disease progression|26|||
25128910|NCT02119663|50242315|FG001|Overall Study|Disease progression|27|||
25128911|NCT02119663|50242314|FG000|Overall Study|Adverse Event|5|||
25128912|NCT02119663|50242315|FG001|Overall Study|Adverse Event|5|||
25128913|NCT02119663|50242314|FG000|Overall Study|Death|3|||
25128914|NCT02119663|50242315|FG001|Overall Study|Death|2|||
25128915|NCT02119663|50242314|FG000|Overall Study|Physician Decision|1|||
25128916|NCT02119663|50242315|FG001|Overall Study|Physician Decision|2|||
25128917|NCT02119663|50242314|FG000|Overall Study|Other unspecified|2|||
25128918|NCT02119663|50242315|FG001|Overall Study|Other unspecified|0|||
25128919|NCT02119663|50242314|FG000|Overall Study|Subject decision|0|||
25128920|NCT02119663|50242315|FG001|Overall Study|Subject decision|1|||
25128921|NCT02119663|50242314|FG000|Overall Study|Study Terminated by the Sponsor|3|||
25272094|NCT01261325|50586477|FG001|Overall Study|Patient Randomized by Mistake|1|||
25128922|NCT02119663|50242315|FG001|Overall Study|Study Terminated by the Sponsor|4|||
25178604|NCT01509547|50323917|FG001|Overall Study|Lost to Follow-up|14|||
25178605|NCT01509547|50323916|FG000|Overall Study|Withdrawal by Subject|11|||
25178606|NCT01509547|50323917|FG001|Overall Study|Withdrawal by Subject|24|||
25178607|NCT01509547|50323916|FG000|Overall Study|Physician Decision|0|||
25128923|NCT01639469|50242323|FG000|Overall Study|Death|4|||
25128924|NCT01639469|50242324|FG001|Overall Study|Death|2|||
25128925|NCT01639469|50242323|FG000|Overall Study|Lost to Follow-up|1|||
25128926|NCT01639469|50242324|FG001|Overall Study|Lost to Follow-up|1|||
25128927|NCT02193074|50242332|FG000|Overall Study|Withdrawal by Subject|1|||
25272095|NCT01261325|50586478|FG002|Overall Study|Patient Randomized by Mistake|0|||
25272096|NCT01261325|50586476|FG000|Overall Study|Erroneously Randomized|1|||
25272097|NCT01261325|50586477|FG001|Overall Study|Erroneously Randomized|0|||
25272098|NCT01261325|50586478|FG002|Overall Study|Erroneously Randomized|0|||
25272099|NCT01261325|50586476|FG000|Overall Study|Screen Failure|1|||
25272100|NCT01261325|50586477|FG001|Overall Study|Screen Failure|0|||
25128928|NCT02193074|50242333|FG001|Overall Study|Withdrawal by Subject|2|||
25128929|NCT02193074|50242332|FG000|Overall Study|Adverse Event|16|||
25128930|NCT02193074|50242333|FG001|Overall Study|Adverse Event|13|||
25128931|NCT02192606|50242341|FG000|Overall Study|surgery type was changed|1|||
25128932|NCT02192606|50242342|FG001|Overall Study|surgery type was changed|1|||
25128933|NCT02192606|50242341|FG000|Overall Study|Physician Decision|1|||
25128934|NCT02192606|50242342|FG001|Overall Study|Physician Decision|2|||
25128935|NCT02192606|50242341|FG000|Overall Study|3D equipment rep unable to join|0|||
25128936|NCT02192606|50242342|FG001|Overall Study|3D equipment rep unable to join|1|||
25128937|NCT01628107|50242348|FG000|Overall Study|Withdrawal by Subject|17|||
25128938|NCT01628107|50242348|FG000|Overall Study|Lost to Follow-up|4|||
25128939|NCT01628107|50242348|FG000|Overall Study|Adverse Event|33|||
25128940|NCT01628107|50242348|FG000|Overall Study|Physician Decision|2|||
25128941|NCT01628107|50242348|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
25128942|NCT01628107|50242348|FG000|Overall Study|Non-compliant with Study Procedures|10|||
25128943|NCT01628107|50242348|FG000|Overall Study|Not Treated|8|||
25128944|NCT01628107|50242348|FG000|Overall Study|Sponsor Decision|11|||
25128945|NCT01628107|50242348|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
25128946|NCT01628107|50242348|FG000|Overall Study|Relocated|8|||
25128947|NCT01628107|50242348|FG000|Overall Study|Kidney Transplant|9|||
25128948|NCT01628107|50242348|FG000|Overall Study|Use of Standard of Care|9|||
25128949|NCT01583530|50242358|FG000|Overall Study|Adverse Event|0|||
25128950|NCT01583530|50242359|FG001|Overall Study|Adverse Event|0|||
25128951|NCT01583530|50242360|FG002|Overall Study|Adverse Event|0|||
25128952|NCT01583530|50242361|FG003|Overall Study|Adverse Event|0|||
25128953|NCT01583530|50242362|FG004|Overall Study|Adverse Event|0|||
25128954|NCT01583530|50242363|FG005|Overall Study|Adverse Event|1|||
25128955|NCT01583530|50242358|FG000|Overall Study|Withdrawal by Subject|0|||
25128956|NCT01583530|50242359|FG001|Overall Study|Withdrawal by Subject|3|||
25128957|NCT01583530|50242360|FG002|Overall Study|Withdrawal by Subject|0|||
25128958|NCT01583530|50242361|FG003|Overall Study|Withdrawal by Subject|1|||
25128959|NCT01583530|50242362|FG004|Overall Study|Withdrawal by Subject|1|||
25128960|NCT01583530|50242363|FG005|Overall Study|Withdrawal by Subject|2|||
25128961|NCT01583530|50242358|FG000|Overall Study|Lost to Follow-up|0|||
25128962|NCT01583530|50242359|FG001|Overall Study|Lost to Follow-up|0|||
25128963|NCT01583530|50242360|FG002|Overall Study|Lost to Follow-up|0|||
25128964|NCT01583530|50242361|FG003|Overall Study|Lost to Follow-up|0|||
25128965|NCT01583530|50242362|FG004|Overall Study|Lost to Follow-up|3|||
25128966|NCT01583530|50242363|FG005|Overall Study|Lost to Follow-up|0|||
25128967|NCT01583530|50242358|FG000|Overall Study|Lack of compliance|0|||
25128968|NCT01583530|50242359|FG001|Overall Study|Lack of compliance|0|||
25128969|NCT01583530|50242360|FG002|Overall Study|Lack of compliance|0|||
25128970|NCT01583530|50242361|FG003|Overall Study|Lack of compliance|0|||
25128971|NCT01583530|50242362|FG004|Overall Study|Lack of compliance|1|||
25128972|NCT01583530|50242363|FG005|Overall Study|Lack of compliance|0|||
25128973|NCT01639001|50242382|FG000|Overall Study|Refused further follow-up|9|||
25128974|NCT01639001|50242383|FG001|Overall Study|Refused further follow-up|12|||
25128975|NCT01639001|50242382|FG000|Overall Study|Lost to Follow-up|3|||
25128976|NCT01639001|50242383|FG001|Overall Study|Lost to Follow-up|0|||
25128977|NCT01639001|50242382|FG000|Overall Study|Death|62|||
25128978|NCT01639001|50242383|FG001|Overall Study|Death|61|||
25128979|NCT01639001|50242382|FG000|Overall Study|Randomized but not treated|0|||
25128980|NCT01639001|50242383|FG001|Overall Study|Randomized but not treated|2|||
25128981|NCT01639001|50242382|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
25128982|NCT01639001|50242383|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
25128983|NCT02224664|50242391|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
25128984|NCT02224664|50242392|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
25128985|NCT02224664|50242393|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
25128986|NCT02224664|50242394|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
25128987|NCT02224664|50242395|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
25128988|NCT02224664|50242391|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
25128989|NCT02224664|50242392|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
25128990|NCT02224664|50242393|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
25128991|NCT02224664|50242394|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
25128992|NCT02224664|50242395|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
25128993|NCT02224664|50242391|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
25272101|NCT01261325|50586478|FG002|Overall Study|Screen Failure|0|||
25128994|NCT02224664|50242392|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
25128995|NCT02224664|50242393|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
25128996|NCT02224664|50242394|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
25128997|NCT02224664|50242395|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
25128998|NCT02168270|50242411|FG000|Overall Study|Lack of Efficacy|4|||
25128999|NCT02167256|50242417|FG000|Overall Study|Adverse Event|13|||
25129000|NCT02167256|50242418|FG001|Overall Study|Adverse Event|6|||
25129001|NCT02167256|50242417|FG000|Overall Study|Withdrawal by Subject|4|||
25129002|NCT02167256|50242418|FG001|Overall Study|Withdrawal by Subject|4|||
25129003|NCT02167256|50242417|FG000|Overall Study|non-compliance|3|||
25129004|NCT02167256|50242418|FG001|Overall Study|non-compliance|0|||
25129005|NCT02167256|50242417|FG000|Overall Study|Study partner unable to participate|1|||
25129006|NCT02167256|50242418|FG001|Overall Study|Study partner unable to participate|0|||
25129007|NCT02191046|50242426|FG000|Overall Study|low compliance|5|||
25129008|NCT02191046|50242427|FG001|Overall Study|low compliance|1|||
25129009|NCT02166476|50242435|FG000|Overall Study|Withdrawal by Subject|5|||
25129010|NCT02166476|50242436|FG001|Overall Study|Withdrawal by Subject|7|||
25129011|NCT02166476|50242435|FG000|Overall Study|Adverse Event|3|||
25129012|NCT02166476|50242436|FG001|Overall Study|Adverse Event|3|||
25129013|NCT02166476|50242435|FG000|Overall Study|Lost to Follow-up|5|||
25129014|NCT02166476|50242436|FG001|Overall Study|Lost to Follow-up|10|||
25129015|NCT02166476|50242435|FG000|Overall Study|Physician Decision|1|||
25129016|NCT02166476|50242436|FG001|Overall Study|Physician Decision|0|||
25129017|NCT02166476|50242435|FG000|Overall Study|Unable to Come for Visit|0|||
25129018|NCT02166476|50242436|FG001|Overall Study|Unable to Come for Visit|3|||
25129019|NCT02224274|50242447|FG000|Overall Study|Death|1|||
25129020|NCT02224274|50242448|FG001|Overall Study|Death|0|||
25129021|NCT02189252|50242462|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
25129022|NCT02189252|50242463|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
25129023|NCT02189252|50242464|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
25129024|NCT02189252|50242465|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
25129025|NCT02189252|50242462|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
25129026|NCT02189252|50242463|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
25129027|NCT02189252|50242464|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
25129028|NCT02189252|50242465|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
25129029|NCT01583374|50242479|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
25129030|NCT01583374|50242480|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
25129031|NCT01583374|50242481|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
25129032|NCT01583374|50242482|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
25129033|NCT01583374|50242483|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
25129034|NCT01583374|50242484|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
25129035|NCT01583374|50242485|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
25129036|NCT01583374|50242486|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
25129037|NCT01583374|50242487|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
25129038|NCT01583374|50242479|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
25129039|NCT01583374|50242480|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
25129040|NCT01583374|50242481|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
25129041|NCT01583374|50242482|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
25129042|NCT01583374|50242483|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
25129043|NCT01583374|50242484|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
25129044|NCT01583374|50242485|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
25129045|NCT01583374|50242486|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
25129046|NCT01583374|50242487|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
25129047|NCT01583374|50242479|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
25129048|NCT01583374|50242480|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
25129049|NCT01583374|50242481|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
25129050|NCT01583374|50242482|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
25129051|NCT01583374|50242483|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
25129052|NCT01583374|50242484|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
25129053|NCT01583374|50242485|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
25129054|NCT01583374|50242486|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
25129055|NCT01583374|50242487|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
25129056|NCT01583374|50242479|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
25129057|NCT01583374|50242480|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
25129058|NCT01583374|50242481|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
25129059|NCT01583374|50242482|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
25129060|NCT01583374|50242483|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
25129061|NCT01583374|50242484|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
25178608|NCT01509547|50323917|FG001|Overall Study|Physician Decision|1|||
25129062|NCT01583374|50242485|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
25129063|NCT01583374|50242486|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
25129064|NCT01583374|50242487|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
25129065|NCT01583374|50242479|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
25129066|NCT01583374|50242480|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
25129067|NCT01583374|50242481|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
25129068|NCT01583374|50242482|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
25129069|NCT01583374|50242483|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
25129070|NCT01583374|50242484|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
25129071|NCT01583374|50242485|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
25129072|NCT01583374|50242486|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
25129073|NCT01583374|50242487|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
25129074|NCT01583374|50242479|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
25129075|NCT01583374|50242480|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
25129076|NCT01583374|50242481|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
25129077|NCT01583374|50242482|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
25129078|NCT01583374|50242483|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
25129079|NCT01583374|50242484|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
25129080|NCT01583374|50242485|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
25129081|NCT01583374|50242486|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
25129082|NCT01583374|50242487|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
25129083|NCT01583374|50242479|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
25129084|NCT01583374|50242480|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
25129085|NCT01583374|50242481|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
25129086|NCT01583374|50242482|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
25129087|NCT01583374|50242483|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
25129088|NCT01583374|50242484|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
25129089|NCT01583374|50242485|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
25129090|NCT01583374|50242486|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
25129091|NCT01583374|50242487|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
25129092|NCT01583374|50242479|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
25129093|NCT01583374|50242480|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
25129094|NCT01583374|50242481|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
25129095|NCT01583374|50242482|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
25129096|NCT01583374|50242483|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
25129097|NCT01583374|50242484|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
25129098|NCT01583374|50242485|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
25129099|NCT01583374|50242486|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
25129100|NCT01583374|50242487|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
25129101|NCT01583374|50242479|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
25129102|NCT01583374|50242480|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
25129103|NCT01583374|50242481|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
25129104|NCT01583374|50242482|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
25129105|NCT01583374|50242483|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
25129106|NCT01583374|50242484|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
25129107|NCT01583374|50242485|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
25129108|NCT01583374|50242486|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
25129109|NCT01583374|50242487|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
25129110|NCT01583374|50242479|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
25129111|NCT01583374|50242480|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
25129112|NCT01583374|50242481|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
25129113|NCT01583374|50242482|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
25129114|NCT01583374|50242483|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
25129115|NCT01583374|50242484|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
25129116|NCT01583374|50242485|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
25129117|NCT01583374|50242486|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
25129118|NCT01583374|50242487|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
25129119|NCT01583374|50242479|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
25129120|NCT01583374|50242480|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
25129121|NCT01583374|50242481|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
25129122|NCT01583374|50242482|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
25129123|NCT01583374|50242483|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
25129124|NCT01583374|50242484|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
25129125|NCT01583374|50242485|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
25129126|NCT01583374|50242486|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
25129127|NCT01583374|50242487|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
25178609|NCT01509079|50323925|FG000|Overall Study|Lack of Efficacy|0|||
25129128|NCT01583374|50242479|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
25129129|NCT01583374|50242480|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
25129130|NCT01583374|50242481|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
25129131|NCT01583374|50242482|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
25129132|NCT01583374|50242483|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
25129133|NCT01583374|50242484|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
25129134|NCT01583374|50242485|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
25129135|NCT01583374|50242486|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
25129136|NCT01583374|50242487|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
25129137|NCT01583374|50242479|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
25129138|NCT01583374|50242480|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
25129139|NCT01583374|50242481|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
25129140|NCT01583374|50242482|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
25129141|NCT01583374|50242483|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
25129142|NCT01583374|50242484|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
25129143|NCT01583374|50242485|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
25129144|NCT01583374|50242486|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
25129145|NCT01583374|50242487|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
25129146|NCT01583374|50242479|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
25129147|NCT01583374|50242480|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
25129148|NCT01583374|50242481|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
25129149|NCT01583374|50242482|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
25129150|NCT01583374|50242483|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
25129151|NCT01583374|50242484|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
25129152|NCT01583374|50242485|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
25129153|NCT01583374|50242486|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
25129154|NCT01583374|50242487|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
25129155|NCT01583374|50242479|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
25129156|NCT01583374|50242480|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
25129157|NCT01583374|50242481|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
25129158|NCT01583374|50242482|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
25129159|NCT01583374|50242483|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
25129160|NCT01583374|50242484|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
25129161|NCT01583374|50242485|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
25129162|NCT01583374|50242486|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
25129163|NCT01583374|50242487|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
25129164|NCT01583374|50242479|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
25129165|NCT01583374|50242480|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
25129166|NCT01583374|50242481|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
25129167|NCT01583374|50242482|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
25272102|NCT01261325|50586476|FG000|Overall Study|Randomized in Error|0|||
25272103|NCT01261325|50586477|FG001|Overall Study|Randomized in Error|0|||
25272104|NCT01261325|50586478|FG002|Overall Study|Randomized in Error|1|||
25272105|NCT01261325|50586476|FG000|Overall Study|Protocol Violation|0|||
25129168|NCT01583374|50242483|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
25129169|NCT01583374|50242484|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
25129170|NCT01583374|50242485|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
25129171|NCT01583374|50242486|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
25129172|NCT01583374|50242487|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
25129173|NCT01583374|50242479|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
25129174|NCT01583374|50242480|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
25272106|NCT01261325|50586477|FG001|Overall Study|Protocol Violation|3|||
25272107|NCT01261325|50586478|FG002|Overall Study|Protocol Violation|1|||
25272108|NCT01261325|50586476|FG000|Overall Study|Lost to Follow-up|0|||
25272109|NCT01261325|50586477|FG001|Overall Study|Lost to Follow-up|1|||
25272110|NCT01261325|50586478|FG002|Overall Study|Lost to Follow-up|3|||
25272111|NCT01261325|50586476|FG000|Overall Study|AE, serious fatal|0|||
25272112|NCT01261325|50586477|FG001|Overall Study|AE, serious fatal|0|||
25272113|NCT01261325|50586478|FG002|Overall Study|AE, serious fatal|2|||
25272114|NCT01260701|50586489|FG000|Overall Study|Adverse Event|9|||
25272115|NCT01260701|50586489|FG000|Overall Study|Withdrawal by Subject|2|||
25272116|NCT01260701|50586489|FG000|Overall Study|Progression|53|||
25272117|NCT01260701|50586489|FG000|Overall Study|Death|2|||
25272118|NCT01260701|50586489|FG000|Overall Study|Not protocol specified|3|||
25272119|NCT01260701|50586489|FG000|Overall Study|Under review|1|||
25272120|NCT01260701|50586489|FG000|Overall Study|Ineligible|4|||
25272121|NCT01260701|50586489|FG000|Overall Study|Did not begin protocol therapy|1|||
25272122|NCT01260467|50586493|FG000|Overall Study|Withdrawal by Subject|2|||
25272123|NCT01260311|50586499|FG000|Overall Study|Adverse Event|11|||
25272124|NCT01260311|50586499|FG000|Overall Study|Lack of Efficacy|4|||
25272125|NCT01260311|50586499|FG000|Overall Study|Lost to Follow-up|25|||
25272126|NCT01260311|50586499|FG000|Overall Study|Withdrawal by Subject|6|||
25272127|NCT01260311|50586499|FG000|Overall Study|Financial Constraints|77|||
25272128|NCT01260311|50586499|FG000|Overall Study|Gone to Province|2|||
25272129|NCT01260311|50586499|FG000|Overall Study|Medication Stopped|1|||
25272130|NCT01260311|50586499|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
25129175|NCT01583374|50242481|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
25129176|NCT01583374|50242482|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
25129177|NCT01583374|50242483|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
25129178|NCT01583374|50242484|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
25129179|NCT01583374|50242485|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
25129180|NCT01583374|50242486|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
25129181|NCT01583374|50242487|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
25129182|NCT01583374|50242479|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
25129183|NCT01583374|50242480|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
25129184|NCT01583374|50242481|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
25129185|NCT01583374|50242482|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
25129186|NCT01583374|50242483|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
25129187|NCT01583374|50242484|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
25129188|NCT01583374|50242485|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
25129189|NCT01583374|50242486|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
25129190|NCT01583374|50242487|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
25129191|NCT01583374|50242479|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
25129192|NCT01583374|50242480|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
25129193|NCT01583374|50242481|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
25129194|NCT01583374|50242482|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
25129195|NCT01583374|50242483|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
25129196|NCT01583374|50242484|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
25129197|NCT01583374|50242485|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
25129198|NCT01583374|50242486|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
25129199|NCT01583374|50242487|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
25129200|NCT01583296|50242508|FG000|Overall Study|Withdrawal by Subject|11|||
25129201|NCT01583296|50242509|FG001|Overall Study|Withdrawal by Subject|10|||
25129202|NCT02222714|50242520|FG000|Overall Study|Death|0|||
25129203|NCT02222714|50242521|FG001|Overall Study|Death|2|||
25129204|NCT02222714|50242522|FG002|Overall Study|Death|3|||
25129205|NCT02222714|50242523|FG003|Overall Study|Death|4|||
25129206|NCT02222714|50242524|FG004|Overall Study|Death|6|||
25129207|NCT02222714|50242520|FG000|Overall Study|Withdrawal by Subject|0|||
25129208|NCT02222714|50242521|FG001|Overall Study|Withdrawal by Subject|0|||
25272131|NCT01259375|50586503|FG000|Overall Study|Adverse Event|1|||
25272132|NCT01940471|50586520|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
25272133|NCT01940471|50586521|FG001|Double-Blind Phase|Randomized but Never Treated|1|||
25272134|NCT01940471|50586520|FG000|Double-Blind Phase|Withdrew Consent|13|||
25272135|NCT01940471|50586521|FG001|Double-Blind Phase|Withdrew Consent|7|||
25272136|NCT01940471|50586520|FG000|Double-Blind Phase|Adverse Event|1|||
25272137|NCT01940471|50586521|FG001|Double-Blind Phase|Adverse Event|2|||
25272138|NCT01940471|50586520|FG000|Double-Blind Phase|Lost to Follow-up|3|||
25272139|NCT01940471|50586521|FG001|Double-Blind Phase|Lost to Follow-up|2|||
25272140|NCT01940471|50586520|FG000|Double-Blind Phase|Pregnancy|2|||
25272141|NCT01940471|50586521|FG001|Double-Blind Phase|Pregnancy|1|||
25272142|NCT01940471|50586520|FG000|Double-Blind Phase|Investigator's Discretion|5|||
25272143|NCT01940471|50586521|FG001|Double-Blind Phase|Investigator's Discretion|0|||
25272144|NCT01940471|50586520|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
25272145|NCT01940471|50586521|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
25272146|NCT01940471|50586520|FG000|Double-Blind Phase|Protocol-Specified Criteria|1|||
25272147|NCT01940471|50586521|FG001|Double-Blind Phase|Protocol-Specified Criteria|0|||
25272148|NCT01940471|50586520|FG000|Double-Blind Phase|Death|1|||
25272149|NCT01940471|50586521|FG001|Double-Blind Phase|Death|0|||
25272150|NCT01940471|50586520|FG000|Double-Blind Phase|Lack of Efficacy|1|||
25272151|NCT01940471|50586521|FG001|Double-Blind Phase|Lack of Efficacy|0|||
25272152|NCT01940471|50586520|FG000|Double-Blind Phase|Protocol Violation|0|||
25272153|NCT01940471|50586521|FG001|Double-Blind Phase|Protocol Violation|1|||
25272154|NCT01940471|50586520|FG000|Double-Blind Phase|Still in Double-Blind Phase|539|||
25272155|NCT01940471|50586521|FG001|Double-Blind Phase|Still in Double-Blind Phase|270|||
25272156|NCT01940471|50586520|FG000|Open-Label Extension|Still in Open-Label Extension Phase|14|||
25129209|NCT02222714|50242522|FG002|Overall Study|Withdrawal by Subject|1|||
25272157|NCT01940471|50586521|FG001|Open-Label Extension|Still in Open-Label Extension Phase|8|||
25272158|NCT01321073|50586528|FG000|Overall Study|Did not attempt implant|4|||
25272159|NCT01321073|50586528|FG000|Overall Study|Death|3|||
25272160|NCT01259297|50586540|FG000|Double Blind Randomized Period|Death|1|||
25272161|NCT01259297|50586541|FG001|Double Blind Randomized Period|Death|1|||
25272162|NCT01259297|50586542|FG002|Double Blind Randomized Period|Death|1|||
25272163|NCT01259297|50586543|FG003|Double Blind Randomized Period|Death|2|||
25272164|NCT01259297|50586544|FG004|Double Blind Randomized Period|Death|1|||
25272165|NCT01259297|50586545|FG005|Double Blind Randomized Period|Death|5|||
25272166|NCT01259297|50586546|FG006|Double Blind Randomized Period|Death|2|||
25272167|NCT01259297|50586547|FG007|Double Blind Randomized Period|Death|1|||
25129210|NCT02222714|50242523|FG003|Overall Study|Withdrawal by Subject|0|||
25129211|NCT02222714|50242524|FG004|Overall Study|Withdrawal by Subject|1|||
25129212|NCT02164916|50242541|FG000|Overall Study|Adverse Event|3|||
25129213|NCT02164916|50242542|FG001|Overall Study|Adverse Event|8|||
25129214|NCT02164916|50242541|FG000|Overall Study|Death|1|||
25129215|NCT02164916|50242542|FG001|Overall Study|Death|1|||
25129216|NCT02164916|50242541|FG000|Overall Study|Refusal unrelated to adverse event|3|||
25129217|NCT02164916|50242542|FG001|Overall Study|Refusal unrelated to adverse event|7|||
25129218|NCT02164916|50242541|FG000|Overall Study|Progression|37|||
25129219|NCT02164916|50242542|FG001|Overall Study|Progression|26|||
25129220|NCT02164916|50242541|FG000|Overall Study|Not protocol specified|5|||
25129221|NCT02164916|50242542|FG001|Overall Study|Not protocol specified|1|||
25129222|NCT02164916|50242541|FG000|Overall Study|Reason under review|1|||
25129223|NCT02164916|50242542|FG001|Overall Study|Reason under review|6|||
25129224|NCT02164916|50242541|FG000|Overall Study|Not eligible|2|||
25129225|NCT02164916|50242542|FG001|Overall Study|Not eligible|5|||
25129226|NCT02222558|50242553|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
25129227|NCT02222558|50242554|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
25129228|NCT02222558|50242555|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
25129229|NCT02222558|50242556|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
25129230|NCT02222558|50242557|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
25129231|NCT02222558|50242558|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
25129232|NCT02222558|50242553|FG000|Period 3|Withdrawal by Subject|0|||
25129233|NCT02222558|50242554|FG001|Period 3|Withdrawal by Subject|0|||
25129234|NCT02222558|50242555|FG002|Period 3|Withdrawal by Subject|0|||
25129235|NCT02222558|50242556|FG003|Period 3|Withdrawal by Subject|0|||
25129236|NCT02222558|50242557|FG004|Period 3|Withdrawal by Subject|0|||
25129237|NCT02222558|50242558|FG005|Period 3|Withdrawal by Subject|1|||
25129238|NCT02188784|50242574|FG000|Overall Study|Death|3|||
25129239|NCT02188784|50242575|FG001|Overall Study|Death|1|||
25129240|NCT02188784|50242574|FG000|Overall Study|Lost to Follow-up|1|||
25129241|NCT02188784|50242575|FG001|Overall Study|Lost to Follow-up|0|||
25129242|NCT02188784|50242574|FG000|Overall Study|Withdrawal by Subject|3|||
25129243|NCT02188784|50242575|FG001|Overall Study|Withdrawal by Subject|9|||
25129244|NCT02188784|50242574|FG000|Overall Study|Physician Decision|2|||
25129245|NCT02188784|50242575|FG001|Overall Study|Physician Decision|3|||
25129246|NCT02222246|50242598|FG000|Overall Study|No Emergency Department Visits|27|||
25129247|NCT02222246|50242599|FG001|Overall Study|No Emergency Department Visits|26|||
25129248|NCT02222246|50242598|FG000|Overall Study|Physician Decision|0|||
25129249|NCT02222246|50242599|FG001|Overall Study|Physician Decision|1|||
25129250|NCT02188160|50242609|FG000|Overall Study|Adverse Event|1|||
25129251|NCT02188160|50242610|FG001|Overall Study|Adverse Event|0|||
25129252|NCT02188160|50242609|FG000|Overall Study|Use of an excluded medication|0|||
25129253|NCT02188160|50242610|FG001|Overall Study|Use of an excluded medication|1|||
25129254|NCT02220998|50242618|FG000|Overall Study|Randomized but Never Treated|1|||
25129255|NCT02220998|50242619|FG001|Overall Study|Randomized but Never Treated|2|||
25129256|NCT02220998|50242618|FG000|Overall Study|Death|2|||
25129257|NCT02220998|50242619|FG001|Overall Study|Death|0|||
25129258|NCT02220998|50242618|FG000|Overall Study|Lack of Efficacy|0|||
25129259|NCT02220998|50242619|FG001|Overall Study|Lack of Efficacy|5|||
25129260|NCT02220998|50242618|FG000|Overall Study|Lost to Follow-up|4|||
25129261|NCT02220998|50242619|FG001|Overall Study|Lost to Follow-up|4|||
25129262|NCT02220920|50242627|FG000|Overall Study|Adverse Event|1|||
25129263|NCT02220920|50242628|FG001|Overall Study|Adverse Event|0|||
25129264|NCT02220920|50242627|FG000|Overall Study|Lack of Efficacy|0|||
25129265|NCT02220920|50242628|FG001|Overall Study|Lack of Efficacy|1|||
25129266|NCT02220920|50242627|FG000|Overall Study|Withdrawal by Subject|1|||
25129267|NCT02220920|50242628|FG001|Overall Study|Withdrawal by Subject|0|||
25129268|NCT02220920|50242627|FG000|Overall Study|Conflict with the stopping criteria|1|||
25129269|NCT02220920|50242628|FG001|Overall Study|Conflict with the stopping criteria|2|||
25272168|NCT01259297|50586540|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
25272169|NCT01259297|50586541|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
25129270|NCT03966053|50242634|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
25129271|NCT01583218|50242649|FG000|Overall Study|Withdrawal by Subject|43|||
25272170|NCT01259297|50586542|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
25129272|NCT01583218|50242650|FG001|Overall Study|Withdrawal by Subject|29|||
25129273|NCT01583218|50242649|FG000|Overall Study|Death|206|||
25129274|NCT01583218|50242650|FG001|Overall Study|Death|211|||
25129275|NCT01583218|50242649|FG000|Overall Study|Lost to Follow-up|11|||
25129276|NCT01583218|50242650|FG001|Overall Study|Lost to Follow-up|17|||
25129277|NCT01583218|50242649|FG000|Overall Study|Adverse event or serious adverse event|3|||
25129278|NCT01583218|50242650|FG001|Overall Study|Adverse event or serious adverse event|3|||
25129279|NCT01583218|50242649|FG000|Overall Study|Patient /Family decision|3|||
25129280|NCT01583218|50242650|FG001|Overall Study|Patient /Family decision|0|||
25129281|NCT01583218|50242649|FG000|Overall Study|Cannot contact patient directly|1|||
25129282|NCT01583218|50242650|FG001|Overall Study|Cannot contact patient directly|2|||
25129283|NCT01583218|50242649|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
25129284|NCT01583218|50242650|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
25129285|NCT01583218|50242649|FG000|Overall Study|Patient did not wish to attend visits|0|||
25129286|NCT01583218|50242650|FG001|Overall Study|Patient did not wish to attend visits|1|||
25129287|NCT01583218|50242649|FG000|Overall Study|Patient randomized but not dosed|17|||
25129288|NCT01583218|50242650|FG001|Overall Study|Patient randomized but not dosed|16|||
25129289|NCT01583218|50242649|FG000|Overall Study|Patient was assessed via phone in person|1|||
25129290|NCT01583218|50242650|FG001|Overall Study|Patient was assessed via phone in person|0|||
25129291|NCT01583218|50242649|FG000|Overall Study|Patient deemed ineligible after random|2|||
25129292|NCT01583218|50242650|FG001|Overall Study|Patient deemed ineligible after random|0|||
25129293|NCT01583218|50242649|FG000|Overall Study|Patient was early terminated from study|0|||
25129294|NCT01583218|50242650|FG001|Overall Study|Patient was early terminated from study|1|||
25129295|NCT01583218|50242649|FG000|Overall Study|Patient was randomized due to mistake|1|||
25129296|NCT01583218|50242650|FG001|Overall Study|Patient was randomized due to mistake|0|||
25129297|NCT01583218|50242649|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
25129298|NCT01583218|50242650|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
25129299|NCT01583218|50242649|FG000|Overall Study|Withdraw of consent on day of random|1|||
25129300|NCT01583218|50242650|FG001|Overall Study|Withdraw of consent on day of random|0|||
25129301|NCT01634555|50242656|FG000|Overall Study|Adverse Event|3|||
25129302|NCT01634555|50242656|FG000|Overall Study|Physician Decision|1|||
25129303|NCT01634243|50242663|FG000|Overall Study|Adverse Event|5|||
25129304|NCT01634243|50242664|FG001|Overall Study|Adverse Event|5|||
25129305|NCT01634243|50242663|FG000|Overall Study|Lack of Efficacy|1|||
25129306|NCT01634243|50242664|FG001|Overall Study|Lack of Efficacy|0|||
25129307|NCT01542034|50242681|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
25129308|NCT01542034|50242682|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
25272171|NCT01259297|50586543|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
25272172|NCT01259297|50586544|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
25272173|NCT01259297|50586545|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
25272174|NCT01259297|50586546|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
25272175|NCT01259297|50586547|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
25272176|NCT01259297|50586540|FG000|Double Blind Randomized Period|Other reasons|0|||
25272177|NCT01259297|50586541|FG001|Double Blind Randomized Period|Other reasons|1|||
25272178|NCT01259297|50586542|FG002|Double Blind Randomized Period|Other reasons|0|||
25272179|NCT01259297|50586543|FG003|Double Blind Randomized Period|Other reasons|0|||
25272180|NCT01259297|50586544|FG004|Double Blind Randomized Period|Other reasons|1|||
25272181|NCT01259297|50586545|FG005|Double Blind Randomized Period|Other reasons|2|||
25272182|NCT01259297|50586546|FG006|Double Blind Randomized Period|Other reasons|3|||
25272183|NCT01259297|50586547|FG007|Double Blind Randomized Period|Other reasons|1|||
25272184|NCT01126437|50586567|FG000|Overall Study|Not treated|11|||
25272185|NCT01126437|50586568|FG001|Overall Study|Not treated|18|||
25272186|NCT01126437|50586569|FG002|Overall Study|Not treated|19|||
25272187|NCT01126437|50586567|FG000|Overall Study|Sites with data irregularities/fraud|6|||
25272188|NCT01126437|50586568|FG001|Overall Study|Sites with data irregularities/fraud|6|||
25272189|NCT01126437|50586569|FG002|Overall Study|Sites with data irregularities/fraud|7|||
25272190|NCT01126437|50586567|FG000|Overall Study|Adverse Event|602|||
25272191|NCT01126437|50586568|FG001|Overall Study|Adverse Event|606|||
25272192|NCT01126437|50586569|FG002|Overall Study|Adverse Event|635|||
25272193|NCT01126437|50586567|FG000|Overall Study|Lack of Efficacy|65|||
25272194|NCT01126437|50586568|FG001|Overall Study|Lack of Efficacy|60|||
25272195|NCT01126437|50586569|FG002|Overall Study|Lack of Efficacy|59|||
25129309|NCT01542034|50242681|FG000|Overall Study|Administrative decision|0|||
25129310|NCT01542034|50242682|FG001|Overall Study|Administrative decision|3|||
25129311|NCT01542034|50242681|FG000|Overall Study|Subject Noncompliance|1|||
25129312|NCT01542034|50242682|FG001|Overall Study|Subject Noncompliance|0|||
25129313|NCT01542034|50242681|FG000|Overall Study|Adverse Event|2|||
25129314|NCT01542034|50242682|FG001|Overall Study|Adverse Event|2|||
25272196|NCT01126437|50586567|FG000|Overall Study|Protocol Violation|64|||
25272197|NCT01126437|50586568|FG001|Overall Study|Protocol Violation|66|||
25272198|NCT01126437|50586569|FG002|Overall Study|Protocol Violation|41|||
25272199|NCT01126437|50586567|FG000|Overall Study|Lost to Follow-up|52|||
25272200|NCT01126437|50586568|FG001|Overall Study|Lost to Follow-up|63|||
25272201|NCT01126437|50586569|FG002|Overall Study|Lost to Follow-up|55|||
25272202|NCT01126437|50586567|FG000|Overall Study|Withdrawal by Subject|331|||
25272203|NCT01126437|50586568|FG001|Overall Study|Withdrawal by Subject|335|||
25272204|NCT01126437|50586569|FG002|Overall Study|Withdrawal by Subject|319|||
25272205|NCT01126437|50586567|FG000|Overall Study|Other reason not specified|210|||
25272206|NCT01126437|50586568|FG001|Overall Study|Other reason not specified|176|||
25272207|NCT01126437|50586569|FG002|Overall Study|Other reason not specified|178|||
25272208|NCT01258595|50586579|FG000|Overall Study|Lost to Follow-up|1|||
25272209|NCT01258595|50586580|FG001|Overall Study|Lost to Follow-up|0|||
25272210|NCT01258595|50586579|FG000|Overall Study|Withdrawal by Subject|0|||
25129315|NCT01542034|50242681|FG000|Overall Study|Lost to Follow-up|7|||
25129316|NCT01542034|50242682|FG001|Overall Study|Lost to Follow-up|6|||
25129317|NCT01564732|50242690|FG000|Overall Study|Early termination by the study sponsor|6|||
25129318|NCT01564732|50242691|FG001|Overall Study|Early termination by the study sponsor|5|||
25129319|NCT01541644|50242697|FG000|Overall Study|Withdrawal by Subject|3|||
25129320|NCT01582282|50242704|FG000|Overall Study|Adverse Event|1|||
25129321|NCT01582282|50242705|FG001|Overall Study|Adverse Event|1|||
25129322|NCT01582282|50242706|FG002|Overall Study|Adverse Event|0|||
25129323|NCT01582282|50242704|FG000|Overall Study|Lost to Follow-up|1|||
25129324|NCT01582282|50242705|FG001|Overall Study|Lost to Follow-up|0|||
25129325|NCT01582282|50242706|FG002|Overall Study|Lost to Follow-up|0|||
25129326|NCT01582282|50242704|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
25129327|NCT01582282|50242705|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
25129328|NCT01582282|50242706|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
25129329|NCT01599650|50242717|FG000|Overall Study|Administrative issue|1|||
25129330|NCT01599650|50242718|FG001|Overall Study|Administrative issue|0|||
25129331|NCT01599650|50242719|FG002|Overall Study|Administrative issue|1|||
25129332|NCT01599650|50242717|FG000|Overall Study|Physician Decision|2|||
25129333|NCT01599650|50242718|FG001|Overall Study|Physician Decision|0|||
25129334|NCT01599650|50242719|FG002|Overall Study|Physician Decision|7|||
25129335|NCT01599650|50242717|FG000|Overall Study|Protocol Violation|0|||
25129336|NCT01599650|50242718|FG001|Overall Study|Protocol Violation|3|||
25129337|NCT01599650|50242719|FG002|Overall Study|Protocol Violation|0|||
25129338|NCT01599650|50242717|FG000|Overall Study|Death|2|||
25129339|NCT01599650|50242718|FG001|Overall Study|Death|1|||
25129340|NCT01599650|50242719|FG002|Overall Study|Death|2|||
25129341|NCT01599650|50242717|FG000|Overall Study|Lost to Follow-up|3|||
25129342|NCT01599650|50242718|FG001|Overall Study|Lost to Follow-up|3|||
25129343|NCT01599650|50242719|FG002|Overall Study|Lost to Follow-up|3|||
25129344|NCT01599650|50242717|FG000|Overall Study|Withdrawal by Subject|11|||
25129345|NCT01599650|50242718|FG001|Overall Study|Withdrawal by Subject|11|||
25129346|NCT01599650|50242719|FG002|Overall Study|Withdrawal by Subject|10|||
25129347|NCT01599650|50242717|FG000|Overall Study|Adverse Event|3|||
25129348|NCT01599650|50242718|FG001|Overall Study|Adverse Event|8|||
25129349|NCT01599650|50242719|FG002|Overall Study|Adverse Event|4|||
25129350|NCT01541254|50242729|FG000|Overall Study|Withdrawal by Subject|1|||
25129351|NCT01541254|50242729|FG000|Overall Study|excluded - metal allergy|1|||
25129352|NCT01541254|50242729|FG000|Overall Study|enrolled after study closed|1|||
25129353|NCT01541254|50242729|FG000|Overall Study|GI bleed prior to procedure|1|||
25129354|NCT01541254|50242729|FG000|Overall Study|stent not required|1|||
25129355|NCT01541254|50242729|FG000|Overall Study|alternate stent used|1|||
25129356|NCT02163902|50242735|FG000|Overall Study|Subject's Request|3|||
25129357|NCT02163902|50242736|FG001|Overall Study|Subject's Request|4|||
25129358|NCT02163902|50242735|FG000|Overall Study|Lost to Follow-up|6|||
25129359|NCT02163902|50242736|FG001|Overall Study|Lost to Follow-up|7|||
25129360|NCT02163902|50242735|FG000|Overall Study|Administrative Decision|2|||
25129361|NCT02163902|50242736|FG001|Overall Study|Administrative Decision|2|||
25129362|NCT01630616|50242748|FG000|Overall Study|Adverse Event|0|||
25129363|NCT01630616|50242749|FG001|Overall Study|Adverse Event|0|||
25129364|NCT01630616|50242750|FG002|Overall Study|Adverse Event|0|||
25129365|NCT01630616|50242751|FG003|Overall Study|Adverse Event|1|||
25129366|NCT01630616|50242752|FG004|Overall Study|Adverse Event|0|||
25129367|NCT01630616|50242753|FG005|Overall Study|Adverse Event|0|||
25129368|NCT01630616|50242748|FG000|Overall Study|Withdrawal by Subject|0|||
25129369|NCT01630616|50242749|FG001|Overall Study|Withdrawal by Subject|0|||
25129370|NCT01630616|50242750|FG002|Overall Study|Withdrawal by Subject|0|||
25129371|NCT01630616|50242751|FG003|Overall Study|Withdrawal by Subject|2|||
25129372|NCT01630616|50242752|FG004|Overall Study|Withdrawal by Subject|0|||
25129373|NCT01630616|50242753|FG005|Overall Study|Withdrawal by Subject|0|||
25129374|NCT03774875|50242772|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
25129375|NCT03774875|50242773|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
25129376|NCT03774875|50242772|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
25129377|NCT03774875|50242773|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
25129378|NCT03774875|50242772|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
25129379|NCT03774875|50242773|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
25129380|NCT03774875|50242772|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
25272211|NCT01258595|50586580|FG001|Overall Study|Withdrawal by Subject|1|||
25129381|NCT03774875|50242773|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
25129382|NCT03774875|50242772|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
25129383|NCT03774875|50242773|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
25129384|NCT03774875|50242772|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
25129385|NCT03774875|50242773|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
25129386|NCT03774875|50242772|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
25129387|NCT03774875|50242773|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
25129388|NCT03774875|50242772|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
25129389|NCT03774875|50242773|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
25129390|NCT03774875|50242772|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
25129391|NCT03774875|50242773|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
25129392|NCT03774875|50242772|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
25129393|NCT03774875|50242773|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
25129394|NCT03774875|50242772|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
25129395|NCT03774875|50242773|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
25129396|NCT03774875|50242772|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
25129397|NCT03774875|50242773|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
25129398|NCT03774875|50242772|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
25129399|NCT03774875|50242773|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
25272212|NCT01257737|50586588|FG000|Overall Study|Lost to Follow-up|1|||
25272213|NCT01257737|50586589|FG001|Overall Study|Lost to Follow-up|2|||
25272214|NCT01257737|50586588|FG000|Overall Study|Liver transplant|1|||
25272215|NCT01257737|50586589|FG001|Overall Study|Liver transplant|0|||
25272216|NCT01257737|50586588|FG000|Overall Study|Relocation out of the country|0|||
25272217|NCT01257737|50586589|FG001|Overall Study|Relocation out of the country|1|||
25272218|NCT01257737|50586588|FG000|Overall Study|Withdrew from study|0|||
25272219|NCT01257737|50586589|FG001|Overall Study|Withdrew from study|1|||
25272220|NCT01126359|50586596|FG000|First Intervention (20-minutes)|Physician Decision|0|||
25272221|NCT01126359|50586597|FG001|First Intervention (20-minutes)|Physician Decision|1|||
25272222|NCT01125813|50586607|FG000|Overall Study|Death|1|||
25272223|NCT01125813|50586607|FG000|Overall Study|Withdrawal by Subject|1|||
25272224|NCT01125813|50586607|FG000|Overall Study|Screen Failures|4|||
25272225|NCT00996892|50586611|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
25272226|NCT00996892|50586612|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
25272227|NCT00996892|50586613|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
25272228|NCT00996892|50586614|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
25272229|NCT00996892|50586615|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
25272230|NCT00996892|50586616|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
25272231|NCT00996892|50586617|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
25272232|NCT00996892|50586618|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
25272233|NCT00996892|50586619|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
25272234|NCT00996892|50586620|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
25272235|NCT00996892|50586621|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
25272236|NCT00996892|50586622|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
25272237|NCT00996892|50586623|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
25272238|NCT00996892|50586624|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
25272239|NCT00996892|50586625|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
25272240|NCT00996892|50586626|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
25272241|NCT00996892|50586627|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
25272242|NCT00996892|50586628|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
25272243|NCT00996892|50586629|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
25272244|NCT00996892|50586630|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
25272245|NCT00996892|50586611|FG000|Dose-Escalation Stage 1|Death|1|||
25272246|NCT00996892|50586612|FG001|Dose-Escalation Stage 1|Death|0|||
25272247|NCT00996892|50586613|FG002|Dose-Escalation Stage 1|Death|0|||
25272248|NCT00996892|50586614|FG003|Dose-Escalation Stage 1|Death|0|||
25272249|NCT00996892|50586615|FG004|Dose-Escalation Stage 1|Death|0|||
25272250|NCT00996892|50586616|FG005|Dose-Escalation Stage 1|Death|1|||
25272251|NCT00996892|50586617|FG006|Dose-Escalation Stage 1|Death|0|||
25272252|NCT00996892|50586618|FG007|Dose-Escalation Stage 1|Death|0|||
25272253|NCT00996892|50586619|FG008|Dose-Escalation Stage 1|Death|0|||
25272254|NCT00996892|50586620|FG009|Dose-Escalation Stage 1|Death|0|||
25272255|NCT00996892|50586621|FG010|Dose-Escalation Stage 1|Death|0|||
25272256|NCT00996892|50586622|FG011|Dose-Escalation Stage 1|Death|0|||
25272257|NCT00996892|50586623|FG012|Dose-Escalation Stage 1|Death|0|||
25272258|NCT00996892|50586624|FG013|Dose-Escalation Stage 1|Death|0|||
25272259|NCT00996892|50586625|FG014|Dose-Escalation Stage 1|Death|0|||
25272260|NCT00996892|50586626|FG015|Dose-Escalation Stage 1|Death|0|||
25272261|NCT00996892|50586627|FG016|Dose-Escalation Stage 1|Death|0|||
25272262|NCT00996892|50586628|FG017|Dose-Escalation Stage 1|Death|0|||
25272263|NCT00996892|50586629|FG018|Dose-Escalation Stage 1|Death|0|||
25272264|NCT00996892|50586630|FG019|Dose-Escalation Stage 1|Death|0|||
25272265|NCT00996892|50586611|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
25272266|NCT00996892|50586612|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
25272267|NCT00996892|50586613|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
25272268|NCT00996892|50586614|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
25272269|NCT00996892|50586615|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
25272270|NCT00996892|50586616|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
25272271|NCT00996892|50586617|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
25272272|NCT00996892|50586618|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
25129400|NCT02220764|50242786|FG000|Overall Study|Lost to Follow-up|3|||
25129401|NCT02220764|50242787|FG001|Overall Study|Lost to Follow-up|1|||
25129402|NCT02220764|50242786|FG000|Overall Study|Death|1|||
25129403|NCT02220764|50242787|FG001|Overall Study|Death|0|||
25129404|NCT01563172|50242793|FG000|Overall Study|Adverse Event|5|||
25129405|NCT01563172|50242793|FG000|Overall Study|Lost to Follow-up|2|||
25129406|NCT01563172|50242793|FG000|Overall Study|Other (Protocol deviation)|5|||
25129407|NCT01563172|50242793|FG000|Overall Study|Other (Not specified)|1|||
25129408|NCT02161718|50242810|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
25129409|NCT02161718|50242811|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
25129410|NCT02161718|50242812|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
25129411|NCT02161718|50242810|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
25129412|NCT02161718|50242811|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
25129413|NCT02161718|50242812|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
25129414|NCT02161718|50242810|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
25129415|NCT02161718|50242811|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
25129416|NCT02161718|50242812|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
25129417|NCT02161718|50242810|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
25129418|NCT02161718|50242811|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
25129419|NCT02161718|50242812|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
25129420|NCT02161718|50242810|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
25129421|NCT02161718|50242811|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
25129422|NCT02161718|50242812|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
25129423|NCT02161718|50242810|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
25129424|NCT02161718|50242811|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
25129425|NCT02161718|50242812|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
25129426|NCT02161718|50242810|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
25129427|NCT02161718|50242811|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
25129428|NCT02161718|50242812|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
25129429|NCT02161718|50242810|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
25129430|NCT02161718|50242811|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
25129431|NCT02161718|50242812|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
25129432|NCT02161718|50242810|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
25272273|NCT00996892|50586619|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
25272274|NCT00996892|50586620|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
25272275|NCT00996892|50586621|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
25272276|NCT00996892|50586622|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
25272277|NCT00996892|50586623|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
25272278|NCT00996892|50586624|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
25272279|NCT00996892|50586625|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
25272280|NCT00996892|50586626|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
25272281|NCT00996892|50586627|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
25272282|NCT00996892|50586628|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
25272283|NCT00996892|50586629|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
25272284|NCT00996892|50586630|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
25272285|NCT00996892|50586611|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
25272286|NCT00996892|50586612|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
25272287|NCT00996892|50586613|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
25272288|NCT00996892|50586614|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
25272289|NCT00996892|50586615|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
25129433|NCT02161718|50242811|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
25129434|NCT02161718|50242812|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
25272290|NCT00996892|50586616|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
25272291|NCT00996892|50586617|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
25272292|NCT00996892|50586618|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
25272293|NCT00996892|50586619|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
25272294|NCT00996892|50586620|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
25272295|NCT00996892|50586621|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
25272296|NCT00996892|50586622|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
25272297|NCT00996892|50586623|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
25272298|NCT00996892|50586624|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
25272299|NCT00996892|50586625|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
25272300|NCT00996892|50586626|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
25272301|NCT00996892|50586627|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
25272302|NCT00996892|50586628|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
25272303|NCT00996892|50586629|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
25272304|NCT00996892|50586630|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
25129435|NCT02161718|50242810|FG000|Post- Randomization Period|Lost to Follow-up|0|||
25129436|NCT02161718|50242811|FG001|Post- Randomization Period|Lost to Follow-up|9|||
25129437|NCT02161718|50242812|FG002|Post- Randomization Period|Lost to Follow-up|15|||
25129438|NCT02161718|50242810|FG000|Post- Randomization Period|Adverse Event|0|||
25129439|NCT02161718|50242811|FG001|Post- Randomization Period|Adverse Event|9|||
25129440|NCT02161718|50242812|FG002|Post- Randomization Period|Adverse Event|10|||
25129441|NCT02161718|50242810|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
25129442|NCT02161718|50242811|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
25129443|NCT02161718|50242812|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
25129444|NCT02161718|50242810|FG000|Post- Randomization Period|Physician Decision|0|||
25129445|NCT02161718|50242811|FG001|Post- Randomization Period|Physician Decision|2|||
25129446|NCT02161718|50242812|FG002|Post- Randomization Period|Physician Decision|4|||
25129447|NCT02161718|50242810|FG000|Post- Randomization Period|Protocol Violation|0|||
25129448|NCT02161718|50242811|FG001|Post- Randomization Period|Protocol Violation|2|||
25129449|NCT02161718|50242812|FG002|Post- Randomization Period|Protocol Violation|3|||
25129450|NCT02161718|50242810|FG000|Post- Randomization Period|Lack of Efficacy|0|||
25129451|NCT02161718|50242811|FG001|Post- Randomization Period|Lack of Efficacy|0|||
25129452|NCT02161718|50242812|FG002|Post- Randomization Period|Lack of Efficacy|1|||
25129453|NCT02161718|50242810|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
25129454|NCT02161718|50242811|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
25129455|NCT02161718|50242812|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
25129456|NCT02161718|50242810|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
25129457|NCT02161718|50242811|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
25129458|NCT02161718|50242812|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
25129459|NCT02161718|50242810|FG000|Post- Randomization Period|Relocation|0|||
25129460|NCT02161718|50242811|FG001|Post- Randomization Period|Relocation|3|||
25129461|NCT02161718|50242812|FG002|Post- Randomization Period|Relocation|0|||
25129462|NCT02219048|50242821|FG000|Overall Study|Adverse Event|2|||
25129463|NCT02219048|50242822|FG001|Overall Study|Adverse Event|5|||
25129464|NCT02219048|50242821|FG000|Overall Study|No longer meets eligibility criteria|1|||
25129465|NCT02219048|50242822|FG001|Overall Study|No longer meets eligibility criteria|0|||
25129466|NCT02219048|50242821|FG000|Overall Study|Study terminated by sponsor|16|||
25129467|NCT02219048|50242822|FG001|Overall Study|Study terminated by sponsor|15|||
25129468|NCT02219048|50242821|FG000|Overall Study|Withdrawal by Subject|2|||
25129469|NCT02219048|50242822|FG001|Overall Study|Withdrawal by Subject|0|||
25129470|NCT02219048|50242821|FG000|Overall Study|Other|0|||
25129471|NCT02219048|50242822|FG001|Overall Study|Other|1|||
25129472|NCT02218736|50242830|FG000|Overall Study|Withdrawal by Subject|10|||
25129473|NCT02218736|50242831|FG001|Overall Study|Withdrawal by Subject|9|||
25129474|NCT02218736|50242830|FG000|Overall Study|Protocol Violation|2|||
25129475|NCT02218736|50242831|FG001|Overall Study|Protocol Violation|0|||
25129476|NCT01540474|50242841|FG000|Vaccination Period|Lost to Follow-up|0|||
25129477|NCT01540474|50242842|FG001|Vaccination Period|Lost to Follow-up|1|||
25129478|NCT01540474|50242843|FG002|Vaccination Period|Lost to Follow-up|0|||
25272305|NCT00996892|50586611|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
25272306|NCT00996892|50586612|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
25272307|NCT00996892|50586613|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
25272308|NCT00996892|50586614|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
25272309|NCT00996892|50586615|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
25272310|NCT00996892|50586616|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
25272311|NCT00996892|50586617|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
25272312|NCT00996892|50586618|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
25272313|NCT00996892|50586619|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
25272314|NCT00996892|50586620|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
25129479|NCT01540474|50242844|FG003|Vaccination Period|Lost to Follow-up|0|||
25129480|NCT01580488|50242855|FG000|Overall Study|Withdrawal by Subject|1|||
25272315|NCT00996892|50586621|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
25272316|NCT00996892|50586622|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
25129481|NCT01580020|50242871|FG000|Overall Study|Lack of Efficacy|0|||
25129482|NCT01580020|50242872|FG001|Overall Study|Lack of Efficacy|5|||
25129483|NCT01580020|50242873|FG002|Overall Study|Lack of Efficacy|0|||
25129484|NCT01580020|50242874|FG003|Overall Study|Lack of Efficacy|1|||
25129485|NCT01580020|50242871|FG000|Overall Study|Withdrawal by Subject|0|||
25272317|NCT00996892|50586623|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
25272318|NCT00996892|50586624|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
25272319|NCT00996892|50586625|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
25272320|NCT00996892|50586626|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
25272321|NCT00996892|50586627|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
25272322|NCT00996892|50586628|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
25129486|NCT01580020|50242872|FG001|Overall Study|Withdrawal by Subject|1|||
25129487|NCT01580020|50242873|FG002|Overall Study|Withdrawal by Subject|1|||
25129488|NCT01580020|50242874|FG003|Overall Study|Withdrawal by Subject|0|||
25129489|NCT01580020|50242871|FG000|Overall Study|Adverse Event|1|||
25129490|NCT01580020|50242872|FG001|Overall Study|Adverse Event|1|||
25129491|NCT01580020|50242873|FG002|Overall Study|Adverse Event|1|||
25129492|NCT01580020|50242874|FG003|Overall Study|Adverse Event|1|||
25129493|NCT01580020|50242871|FG000|Overall Study|Administrative Problems|0|||
25129494|NCT01580020|50242872|FG001|Overall Study|Administrative Problems|0|||
25129495|NCT01580020|50242873|FG002|Overall Study|Administrative Problems|1|||
25129496|NCT01580020|50242874|FG003|Overall Study|Administrative Problems|0|||
25129497|NCT01580020|50242871|FG000|Overall Study|Lost to Follow-up|0|||
25129498|NCT01580020|50242872|FG001|Overall Study|Lost to Follow-up|0|||
25129499|NCT01580020|50242873|FG002|Overall Study|Lost to Follow-up|1|||
25129500|NCT01580020|50242874|FG003|Overall Study|Lost to Follow-up|0|||
25129501|NCT01579474|50242890|FG000|Overall Study|Adverse Event|1|||
25129502|NCT01579474|50242891|FG001|Overall Study|Adverse Event|13|||
25129503|NCT01579474|50242892|FG002|Overall Study|Adverse Event|2|||
25129504|NCT01579474|50242893|FG003|Overall Study|Adverse Event|0|||
25129505|NCT01579474|50242894|FG004|Overall Study|Adverse Event|0|||
25129506|NCT01579474|50242895|FG005|Overall Study|Adverse Event|1|||
25129507|NCT01579474|50242890|FG000|Overall Study|Lack of Efficacy|1|||
25129508|NCT01579474|50242891|FG001|Overall Study|Lack of Efficacy|0|||
25129509|NCT01579474|50242892|FG002|Overall Study|Lack of Efficacy|0|||
25129510|NCT01579474|50242893|FG003|Overall Study|Lack of Efficacy|0|||
25129511|NCT01579474|50242894|FG004|Overall Study|Lack of Efficacy|1|||
25129512|NCT01579474|50242895|FG005|Overall Study|Lack of Efficacy|0|||
25129513|NCT01579474|50242890|FG000|Overall Study|Withdrawal by Subject|1|||
25129514|NCT01579474|50242891|FG001|Overall Study|Withdrawal by Subject|0|||
25129515|NCT01579474|50242892|FG002|Overall Study|Withdrawal by Subject|0|||
25129516|NCT01579474|50242893|FG003|Overall Study|Withdrawal by Subject|0|||
25129517|NCT01579474|50242894|FG004|Overall Study|Withdrawal by Subject|0|||
25129518|NCT01579474|50242895|FG005|Overall Study|Withdrawal by Subject|0|||
25129519|NCT01579318|50242908|FG000|Overall Study|Disease Progression|1|||
25129520|NCT01562782|50242914|FG000|Overall Study|Withdrawal by Subject|3|||
25129521|NCT01562782|50242915|FG001|Overall Study|Withdrawal by Subject|3|||
25129522|NCT01562782|50242914|FG000|Overall Study|screen failure|1|||
25129523|NCT01562782|50242915|FG001|Overall Study|screen failure|2|||
25129524|NCT01579006|50242921|FG000|Overall Study|Lack of Efficacy|10|||
25129525|NCT01579006|50242921|FG000|Overall Study|Adverse Event|13|||
25129526|NCT01579006|50242921|FG000|Overall Study|Withdrawal by Subject|5|||
25129527|NCT01579006|50242921|FG000|Overall Study|Non-compliance|3|||
25129528|NCT01579006|50242921|FG000|Overall Study|Due to participant's health fund|1|||
25129529|NCT01579006|50242921|FG000|Overall Study|Scheduled surgery|1|||
25129530|NCT01578850|50242927|FG000|Period 1|Insufficient Clinical Response|1|||
25129531|NCT01578850|50242928|FG001|Period 1|Insufficient Clinical Response|0|||
25129532|NCT01578850|50242929|FG002|Period 1|Insufficient Clinical Response|0|||
25129533|NCT01578850|50242927|FG000|Period 1|Adverse Event|11|||
25129534|NCT01578850|50242928|FG001|Period 1|Adverse Event|0|||
25129535|NCT01578850|50242929|FG002|Period 1|Adverse Event|0|||
25129536|NCT01578850|50242927|FG000|Period 1|Death|1|||
25129537|NCT01578850|50242928|FG001|Period 1|Death|0|||
25129538|NCT01578850|50242929|FG002|Period 1|Death|0|||
25129539|NCT01578850|50242927|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
25129540|NCT01578850|50242928|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
25272323|NCT00996892|50586629|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
25129541|NCT01578850|50242929|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
25129542|NCT01578850|50242927|FG000|Period 1|Withdrawal by Subject|9|||
25129543|NCT01578850|50242928|FG001|Period 1|Withdrawal by Subject|0|||
25129544|NCT01578850|50242929|FG002|Period 1|Withdrawal by Subject|0|||
25272324|NCT00996892|50586630|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
25129545|NCT01578850|50242927|FG000|Period 1|Study Terminated by Sponsor|3|||
25129546|NCT01578850|50242928|FG001|Period 1|Study Terminated by Sponsor|0|||
25129547|NCT01578850|50242929|FG002|Period 1|Study Terminated by Sponsor|0|||
25129548|NCT01578850|50242927|FG000|Period 2|Insufficient Clinical Response|0|||
25129549|NCT01578850|50242928|FG001|Period 2|Insufficient Clinical Response|1|||
25129550|NCT01578850|50242929|FG002|Period 2|Insufficient Clinical Response|0|||
25129551|NCT01578850|50242927|FG000|Period 2|Adverse Event|0|||
25272325|NCT00996892|50586611|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
25129552|NCT01578850|50242928|FG001|Period 2|Adverse Event|3|||
25129553|NCT01578850|50242929|FG002|Period 2|Adverse Event|6|||
25129554|NCT01578850|50242927|FG000|Period 2|Lost to Follow-up|0|||
25129555|NCT01578850|50242928|FG001|Period 2|Lost to Follow-up|1|||
25129556|NCT01578850|50242929|FG002|Period 2|Lost to Follow-up|2|||
25129557|NCT01578850|50242927|FG000|Period 2|Withdrawal by Subject|0|||
25129558|NCT01578850|50242928|FG001|Period 2|Withdrawal by Subject|2|||
25129559|NCT01578850|50242929|FG002|Period 2|Withdrawal by Subject|2|||
25129560|NCT01578850|50242927|FG000|Period 2|Study Terminated by Sponsor|0|||
25129561|NCT01578850|50242928|FG001|Period 2|Study Terminated by Sponsor|5|||
25129562|NCT01578850|50242929|FG002|Period 2|Study Terminated by Sponsor|4|||
25129563|NCT01578850|50242927|FG000|Period 2|Unspecified Reasons|0|||
25129564|NCT01578850|50242928|FG001|Period 2|Unspecified Reasons|1|||
25129565|NCT01578850|50242929|FG002|Period 2|Unspecified Reasons|0|||
25129566|NCT01539538|50242939|FG000|Overall Study|Adverse Event|13|||
25129567|NCT01539538|50242940|FG001|Overall Study|Adverse Event|18|||
25129568|NCT01539538|50242939|FG000|Overall Study|Lack of Efficacy|13|||
25129569|NCT01539538|50242940|FG001|Overall Study|Lack of Efficacy|16|||
25129570|NCT01539538|50242939|FG000|Overall Study|Withdrawal by Subject|2|||
25129571|NCT01539538|50242940|FG001|Overall Study|Withdrawal by Subject|3|||
25129572|NCT01539538|50242939|FG000|Overall Study|PCA no longer required or PCA problem|3|||
25129573|NCT01539538|50242940|FG001|Overall Study|PCA no longer required or PCA problem|7|||
25129574|NCT01562548|50242950|FG000|Overall Study|Lost to Follow-up|0|||
25129575|NCT01562548|50242951|FG001|Overall Study|Lost to Follow-up|0|||
25129576|NCT01562548|50242952|FG002|Overall Study|Lost to Follow-up|1|||
25129577|NCT01562548|50242953|FG003|Overall Study|Lost to Follow-up|0|||
25129578|NCT01562314|50242967|FG000|Overall Study|Adverse Event|10|||
25129579|NCT01562314|50242968|FG001|Overall Study|Adverse Event|5|||
25129580|NCT01562314|50242967|FG000|Overall Study|Met Withdrawal Criteria|3|||
25129581|NCT01562314|50242968|FG001|Overall Study|Met Withdrawal Criteria|2|||
25129582|NCT01562314|50242967|FG000|Overall Study|Withdrawal by Subject|0|||
25129583|NCT01562314|50242968|FG001|Overall Study|Withdrawal by Subject|1|||
25129584|NCT01539226|50242976|FG000|Overall Study|Withdrawal by Subject|24|||
25129585|NCT01539226|50242977|FG001|Overall Study|Withdrawal by Subject|54|||
25129586|NCT01539226|50242976|FG000|Overall Study|Lost to Follow-up|20|||
25129587|NCT01539226|50242977|FG001|Overall Study|Lost to Follow-up|54|||
25129588|NCT01539226|50242976|FG000|Overall Study|Death|1|||
25129589|NCT01539226|50242977|FG001|Overall Study|Death|2|||
25129590|NCT01539226|50242976|FG000|Overall Study|Adverse Event|2|||
25129591|NCT01539226|50242977|FG001|Overall Study|Adverse Event|0|||
25129592|NCT01539226|50242976|FG000|Overall Study|Pregnancy|13|||
25129593|NCT01539226|50242977|FG001|Overall Study|Pregnancy|29|||
25129594|NCT01539226|50242976|FG000|Overall Study|inappropriate enrollment|0|||
25129595|NCT01539226|50242977|FG001|Overall Study|inappropriate enrollment|1|||
25129596|NCT01539226|50242976|FG000|Overall Study|Multiple Reasons|3|||
25129597|NCT01539226|50242977|FG001|Overall Study|Multiple Reasons|1|||
25129598|NCT01539226|50242976|FG000|Overall Study|not HIV seroconversion-related|93|||
25129599|NCT01539226|50242977|FG001|Overall Study|not HIV seroconversion-related|176|||
25129600|NCT01539226|50242976|FG000|Overall Study|HIV seroconversion-related|55|||
25129601|NCT01539226|50242977|FG001|Overall Study|HIV seroconversion-related|80|||
25129602|NCT01539226|50242976|FG000|Overall Study|Non-compliance|6|||
25129603|NCT01539226|50242977|FG001|Overall Study|Non-compliance|8|||
25129604|NCT01577758|50242983|FG000|Dose Escalation Phase|Adverse Event|0|||
25129605|NCT01577758|50242984|FG001|Dose Escalation Phase|Adverse Event|0|||
25129606|NCT01577758|50242985|FG002|Dose Escalation Phase|Adverse Event|0|||
25129607|NCT01577758|50242986|FG003|Dose Escalation Phase|Adverse Event|0|||
25129608|NCT01577758|50242987|FG004|Dose Escalation Phase|Adverse Event|0|||
25129609|NCT01577758|50242988|FG005|Dose Escalation Phase|Adverse Event|2|||
25129610|NCT01577758|50242989|FG006|Dose Escalation Phase|Adverse Event|1|||
25129611|NCT01577758|50242990|FG007|Dose Escalation Phase|Adverse Event|0|||
25129612|NCT01577758|50242983|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
25129613|NCT01577758|50242984|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
25129614|NCT01577758|50242985|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
25129615|NCT01577758|50242986|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
25129616|NCT01577758|50242987|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
25129617|NCT01577758|50242988|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
25129618|NCT01577758|50242989|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
25272326|NCT00996892|50586612|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
25272327|NCT00996892|50586613|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
25129619|NCT01577758|50242990|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
25129620|NCT01577758|50242983|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
25129621|NCT01577758|50242984|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
25129622|NCT01577758|50242985|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
25129623|NCT01577758|50242986|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
25129624|NCT01577758|50242987|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
25129625|NCT01577758|50242988|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
25129626|NCT01577758|50242989|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
25129627|NCT01577758|50242990|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
25129628|NCT01577758|50242983|FG000|Dose Escalation Phase|Progression Disease|2|||
25129629|NCT01577758|50242984|FG001|Dose Escalation Phase|Progression Disease|2|||
25129630|NCT01577758|50242985|FG002|Dose Escalation Phase|Progression Disease|1|||
25129631|NCT01577758|50242986|FG003|Dose Escalation Phase|Progression Disease|2|||
25129632|NCT01577758|50242987|FG004|Dose Escalation Phase|Progression Disease|5|||
25129633|NCT01577758|50242988|FG005|Dose Escalation Phase|Progression Disease|0|||
25129634|NCT01577758|50242989|FG006|Dose Escalation Phase|Progression Disease|0|||
25129635|NCT01577758|50242990|FG007|Dose Escalation Phase|Progression Disease|0|||
25129636|NCT01577758|50242983|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
25129637|NCT01577758|50242984|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
25129638|NCT01577758|50242985|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
25129639|NCT01577758|50242986|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
25129640|NCT01577758|50242987|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
25129641|NCT01577758|50242988|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
25129642|NCT01577758|50242989|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
25129643|NCT01577758|50242990|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
25129644|NCT01577758|50242983|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
25129645|NCT01577758|50242984|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
25129646|NCT01577758|50242985|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
25129647|NCT01577758|50242986|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
25129648|NCT01577758|50242987|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
25129649|NCT01577758|50242988|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
25129650|NCT01577758|50242989|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
25129651|NCT01577758|50242990|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
25129652|NCT01577758|50242983|FG000|mCRC Expansion Phase|Progression Disease|0|||
25129653|NCT01577758|50242984|FG001|mCRC Expansion Phase|Progression Disease|0|||
25129654|NCT01577758|50242985|FG002|mCRC Expansion Phase|Progression Disease|0|||
25129655|NCT01577758|50242986|FG003|mCRC Expansion Phase|Progression Disease|0|||
25129656|NCT01577758|50242987|FG004|mCRC Expansion Phase|Progression Disease|0|||
25129657|NCT01577758|50242988|FG005|mCRC Expansion Phase|Progression Disease|0|||
25129658|NCT01577758|50242989|FG006|mCRC Expansion Phase|Progression Disease|0|||
25129659|NCT01577758|50242990|FG007|mCRC Expansion Phase|Progression Disease|19|||
25129660|NCT01537432|50243012|FG000|Overall Study|Lost to Follow-up|3|||
25129661|NCT01537432|50243013|FG001|Overall Study|Lost to Follow-up|1|||
25129662|NCT01537432|50243012|FG000|Overall Study|Withdrawal by Subject|0|||
25129663|NCT01537432|50243013|FG001|Overall Study|Withdrawal by Subject|1|||
25129664|NCT01537432|50243012|FG000|Overall Study|Administrative problems|1|||
25129665|NCT01537432|50243013|FG001|Overall Study|Administrative problems|0|||
25129666|NCT01537432|50243012|FG000|Overall Study|Adverse Event|1|||
25129667|NCT01537432|50243013|FG001|Overall Study|Adverse Event|0|||
25129668|NCT01537432|50243012|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25129669|NCT01537432|50243013|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
25129670|NCT01537198|50243019|FG000|Overall Study|RSV infection|2|||
25129671|NCT01537198|50243019|FG000|Overall Study|Adverse Event|4|||
25129672|NCT01537198|50243019|FG000|Overall Study|No Further Visits to the Clinic|37|||
25129673|NCT01537198|50243019|FG000|Overall Study|Other|111|||
25129674|NCT01537120|50243023|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
25129675|NCT01537120|50243023|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
25129676|NCT01537042|50243031|FG000|Overall Study|Adverse Event|0|||
25129677|NCT01537042|50243032|FG001|Overall Study|Adverse Event|2|||
25129678|NCT01537042|50243031|FG000|Overall Study|Lack of Efficacy|0|||
25129679|NCT01537042|50243032|FG001|Overall Study|Lack of Efficacy|1|||
25129680|NCT01537042|50243031|FG000|Overall Study|Protocol Violation|0|||
25129681|NCT01537042|50243032|FG001|Overall Study|Protocol Violation|1|||
25129682|NCT01537042|50243031|FG000|Overall Study|Other|0|||
25129683|NCT01537042|50243032|FG001|Overall Study|Other|1|||
25129684|NCT01536574|50243053|FG000|Overall Study|Adverse Event|4|||
25129685|NCT01536574|50243054|FG001|Overall Study|Adverse Event|5|||
25129686|NCT01536574|50243053|FG000|Overall Study|Withdrawal by Subject|1|||
25129687|NCT01536574|50243054|FG001|Overall Study|Withdrawal by Subject|2|||
25129688|NCT01536574|50243053|FG000|Overall Study|Lack of Efficacy|1|||
25129689|NCT01536574|50243054|FG001|Overall Study|Lack of Efficacy|0|||
25129690|NCT01536418|50243062|FG000|Overall Study|Protocol Violation|2|||
25272328|NCT00996892|50586614|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
25272329|NCT00996892|50586615|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
25272330|NCT00996892|50586616|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
25272331|NCT00996892|50586617|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
25129691|NCT01536418|50243063|FG001|Overall Study|Protocol Violation|3|||
25129692|NCT01536418|50243062|FG000|Overall Study|Physician Decision|1|||
25129693|NCT01536418|50243063|FG001|Overall Study|Physician Decision|3|||
25129694|NCT01536418|50243062|FG000|Overall Study|Study closed/terminated|41|||
25129695|NCT01536418|50243063|FG001|Overall Study|Study closed/terminated|37|||
25129696|NCT01536418|50243062|FG000|Overall Study|Lack of Efficacy|10|||
25129697|NCT01536418|50243063|FG001|Overall Study|Lack of Efficacy|16|||
25129698|NCT01536418|50243062|FG000|Overall Study|Adverse Event|9|||
25129699|NCT01536418|50243063|FG001|Overall Study|Adverse Event|4|||
25272332|NCT00996892|50586618|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
25272333|NCT00996892|50586619|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
25272334|NCT00996892|50586620|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
25272335|NCT00996892|50586621|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
25272336|NCT00996892|50586622|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
25272337|NCT00996892|50586623|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
25272338|NCT00996892|50586624|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
25272339|NCT00996892|50586625|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
25272340|NCT00996892|50586626|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
25272341|NCT00996892|50586627|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
25129700|NCT01536418|50243062|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
25129701|NCT01536418|50243063|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
25129702|NCT01536418|50243062|FG000|Overall Study|Withdrawal by Subject|5|||
25129703|NCT01536418|50243063|FG001|Overall Study|Withdrawal by Subject|3|||
25129704|NCT01576042|50243072|FG000|Overall Study|Physician Decision|2|||
25129705|NCT01576042|50243073|FG001|Overall Study|Physician Decision|0|||
25129706|NCT01561300|50243079|FG000|Run in on Placebo|Adverse Event|1|||
25272342|NCT00996892|50586628|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
25272343|NCT00996892|50586629|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
25272344|NCT00996892|50586630|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
25272345|NCT00996892|50586611|FG000|Dose-Escalation Stage 1A|Death|0|||
25272346|NCT00996892|50586612|FG001|Dose-Escalation Stage 1A|Death|0|||
25272347|NCT00996892|50586613|FG002|Dose-Escalation Stage 1A|Death|0|||
25272348|NCT00996892|50586614|FG003|Dose-Escalation Stage 1A|Death|0|||
25272349|NCT00996892|50586615|FG004|Dose-Escalation Stage 1A|Death|0|||
25272350|NCT00996892|50586616|FG005|Dose-Escalation Stage 1A|Death|0|||
25272351|NCT00996892|50586617|FG006|Dose-Escalation Stage 1A|Death|0|||
25272352|NCT00996892|50586618|FG007|Dose-Escalation Stage 1A|Death|0|||
25272353|NCT00996892|50586619|FG008|Dose-Escalation Stage 1A|Death|0|||
25272354|NCT00996892|50586620|FG009|Dose-Escalation Stage 1A|Death|2|||
25272355|NCT00996892|50586621|FG010|Dose-Escalation Stage 1A|Death|0|||
25272356|NCT00996892|50586622|FG011|Dose-Escalation Stage 1A|Death|1|||
25272357|NCT00996892|50586623|FG012|Dose-Escalation Stage 1A|Death|1|||
25272358|NCT00996892|50586624|FG013|Dose-Escalation Stage 1A|Death|0|||
25272359|NCT00996892|50586625|FG014|Dose-Escalation Stage 1A|Death|0|||
25272360|NCT00996892|50586626|FG015|Dose-Escalation Stage 1A|Death|0|||
25272361|NCT00996892|50586627|FG016|Dose-Escalation Stage 1A|Death|0|||
25272362|NCT00996892|50586628|FG017|Dose-Escalation Stage 1A|Death|0|||
25272363|NCT00996892|50586629|FG018|Dose-Escalation Stage 1A|Death|0|||
25272364|NCT00996892|50586630|FG019|Dose-Escalation Stage 1A|Death|0|||
25272365|NCT00996892|50586611|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
25272366|NCT00996892|50586612|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
25272367|NCT00996892|50586613|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
25272368|NCT00996892|50586614|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
25272369|NCT00996892|50586615|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
25272370|NCT00996892|50586616|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
25272371|NCT00996892|50586617|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
25272372|NCT00996892|50586618|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
25272373|NCT00996892|50586619|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
25272374|NCT00996892|50586620|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
25272375|NCT00996892|50586621|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
25272376|NCT00996892|50586622|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
25272377|NCT00996892|50586623|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
25272378|NCT00996892|50586624|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
25272379|NCT00996892|50586625|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
25272380|NCT00996892|50586626|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
25272381|NCT00996892|50586627|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
25272382|NCT00996892|50586628|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
25272383|NCT00996892|50586629|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
25272384|NCT00996892|50586630|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
25272385|NCT00996892|50586611|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
25272386|NCT00996892|50586612|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
25272387|NCT00996892|50586613|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
25272388|NCT00996892|50586614|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
25272389|NCT00996892|50586615|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
25272390|NCT00996892|50586616|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
25272391|NCT00996892|50586617|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
25272392|NCT00996892|50586618|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
25272393|NCT00996892|50586619|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
25272394|NCT00996892|50586620|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
25272395|NCT00996892|50586621|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
25272396|NCT00996892|50586622|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
25272397|NCT00996892|50586623|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
25272398|NCT00996892|50586624|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
25129707|NCT01561300|50243080|FG001|Run in on Placebo|Adverse Event|0|||
25272399|NCT00996892|50586625|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
25272400|NCT00996892|50586626|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
25272401|NCT00996892|50586627|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
25272402|NCT00996892|50586628|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
25272403|NCT00996892|50586629|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
25272404|NCT00996892|50586630|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
25129708|NCT01536262|50243090|FG000|Overall Study|Adverse Event|6|||
25129709|NCT01536262|50243091|FG001|Overall Study|Adverse Event|1|||
25129710|NCT01536262|50243092|FG002|Overall Study|Adverse Event|2|||
25129711|NCT01536262|50243090|FG000|Overall Study|Withdrawal by Subject|1|||
25129712|NCT01536262|50243091|FG001|Overall Study|Withdrawal by Subject|1|||
25129713|NCT01536262|50243092|FG002|Overall Study|Withdrawal by Subject|0|||
25129714|NCT01536262|50243090|FG000|Overall Study|Other than stated above|1|||
25129715|NCT01536262|50243091|FG001|Overall Study|Other than stated above|0|||
25129716|NCT01536262|50243092|FG002|Overall Study|Other than stated above|0|||
25129717|NCT01560988|50243101|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
25129718|NCT01560988|50243102|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
25129719|NCT01560988|50243101|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
25129720|NCT01560988|50243102|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
25129721|NCT01560988|50243101|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
25129722|NCT01560988|50243102|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
25129723|NCT01535638|50243113|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
25129724|NCT01535638|50243114|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
25129725|NCT01535638|50243115|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
25129726|NCT01535638|50243116|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
25129727|NCT01535638|50243117|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
25129728|NCT01535638|50243118|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
25129729|NCT01535638|50243113|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
25129730|NCT01535638|50243114|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
25129731|NCT01535638|50243115|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
25129732|NCT01535638|50243116|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
25129733|NCT01535638|50243117|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
25129734|NCT01535638|50243118|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
25129735|NCT01535560|50243129|FG000|Overall Study|Adverse Event|12|||
25129736|NCT01535560|50243130|FG001|Overall Study|Adverse Event|7|||
25129737|NCT01535560|50243129|FG000|Overall Study|Lost to Follow-up|1|||
25129738|NCT01535560|50243130|FG001|Overall Study|Lost to Follow-up|3|||
25129739|NCT01535560|50243129|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
25129740|NCT01535560|50243130|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
25129741|NCT01535560|50243129|FG000|Overall Study|Treatment Failure|21|||
25129742|NCT01535560|50243130|FG001|Overall Study|Treatment Failure|83|||
25129743|NCT01535560|50243129|FG000|Overall Study|Other|0|||
25129744|NCT01535560|50243130|FG001|Overall Study|Other|1|||
25129745|NCT01535560|50243129|FG000|Overall Study|Randomized in Error|0|||
25129746|NCT01535560|50243130|FG001|Overall Study|Randomized in Error|1|||
25129747|NCT01575028|50243138|FG000|Overall Study|Physician Decision|0|||
25129748|NCT01575028|50243139|FG001|Overall Study|Physician Decision|1|||
25129749|NCT03576131|50243153|FG000|Overall Study|Investigator decision|0|||
25129750|NCT03576131|50243154|FG001|Overall Study|Investigator decision|0|||
25129751|NCT03576131|50243155|FG002|Overall Study|Investigator decision|0|||
25129752|NCT03576131|50243156|FG003|Overall Study|Investigator decision|1|||
25129753|NCT03576131|50243157|FG004|Overall Study|Investigator decision|0|||
25129754|NCT03576131|50243158|FG005|Overall Study|Investigator decision|1|||
25129755|NCT03576131|50243159|FG006|Overall Study|Investigator decision|0|||
25129756|NCT03576131|50243160|FG007|Overall Study|Investigator decision|0|||
25129757|NCT03576131|50243153|FG000|Overall Study|Withdrawal by Subject|1|||
25129758|NCT03576131|50243154|FG001|Overall Study|Withdrawal by Subject|1|||
25129759|NCT03576131|50243155|FG002|Overall Study|Withdrawal by Subject|0|||
25129760|NCT03576131|50243156|FG003|Overall Study|Withdrawal by Subject|1|||
25129761|NCT03576131|50243157|FG004|Overall Study|Withdrawal by Subject|2|||
25129762|NCT03576131|50243158|FG005|Overall Study|Withdrawal by Subject|3|||
25129763|NCT03576131|50243159|FG006|Overall Study|Withdrawal by Subject|1|||
25129764|NCT03576131|50243160|FG007|Overall Study|Withdrawal by Subject|0|||
25129765|NCT03576131|50243153|FG000|Overall Study|Death|3|||
25129766|NCT03576131|50243154|FG001|Overall Study|Death|3|||
25129767|NCT03576131|50243155|FG002|Overall Study|Death|1|||
25129768|NCT03576131|50243156|FG003|Overall Study|Death|5|||
25129769|NCT03576131|50243157|FG004|Overall Study|Death|4|||
25272405|NCT00996892|50586611|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
25129770|NCT03576131|50243158|FG005|Overall Study|Death|1|||
25129771|NCT03576131|50243159|FG006|Overall Study|Death|0|||
25129772|NCT03576131|50243160|FG007|Overall Study|Death|1|||
25129773|NCT03576131|50243153|FG000|Overall Study|New anti-cancer treatment|5|||
25129774|NCT03576131|50243154|FG001|Overall Study|New anti-cancer treatment|1|||
25129775|NCT03576131|50243155|FG002|Overall Study|New anti-cancer treatment|2|||
25129776|NCT03576131|50243156|FG003|Overall Study|New anti-cancer treatment|3|||
25129777|NCT03576131|50243157|FG004|Overall Study|New anti-cancer treatment|0|||
25129778|NCT03576131|50243158|FG005|Overall Study|New anti-cancer treatment|0|||
25129779|NCT03576131|50243159|FG006|Overall Study|New anti-cancer treatment|0|||
25129780|NCT03576131|50243160|FG007|Overall Study|New anti-cancer treatment|0|||
25129781|NCT03576131|50243153|FG000|Overall Study|Unspecified reason|0|||
25129782|NCT03576131|50243154|FG001|Overall Study|Unspecified reason|0|||
25129783|NCT03576131|50243155|FG002|Overall Study|Unspecified reason|1|||
25129784|NCT03576131|50243156|FG003|Overall Study|Unspecified reason|1|||
25129785|NCT03576131|50243157|FG004|Overall Study|Unspecified reason|1|||
25129786|NCT03576131|50243158|FG005|Overall Study|Unspecified reason|1|||
25129787|NCT03576131|50243159|FG006|Overall Study|Unspecified reason|0|||
25129788|NCT03576131|50243160|FG007|Overall Study|Unspecified reason|0|||
25272406|NCT00996892|50586612|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
25272407|NCT00996892|50586613|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
25272408|NCT00996892|50586614|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
25272409|NCT00996892|50586615|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
25272410|NCT00996892|50586616|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
25272411|NCT00996892|50586617|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
25272412|NCT00996892|50586618|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
25272413|NCT00996892|50586619|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
25272414|NCT00996892|50586620|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
25272415|NCT00996892|50586621|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
25272416|NCT00996892|50586622|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
25272417|NCT00996892|50586623|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
25272418|NCT00996892|50586624|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
25272419|NCT00996892|50586625|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
25272420|NCT00996892|50586626|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
25272421|NCT00996892|50586627|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
25272422|NCT00996892|50586628|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
25272423|NCT00996892|50586629|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
25272424|NCT00996892|50586630|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
25272425|NCT00996892|50586611|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
25272426|NCT00996892|50586612|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
25272427|NCT00996892|50586613|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
25272428|NCT00996892|50586614|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
25272429|NCT00996892|50586615|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
25272430|NCT00996892|50586616|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
25272431|NCT00996892|50586617|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
25272432|NCT00996892|50586618|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
25272433|NCT00996892|50586619|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
25272434|NCT00996892|50586620|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
25272435|NCT00996892|50586621|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
25272436|NCT00996892|50586622|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
25272437|NCT00996892|50586623|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
25272438|NCT00996892|50586624|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
25272439|NCT00996892|50586625|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
25272440|NCT00996892|50586626|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
25272441|NCT00996892|50586627|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
25272442|NCT00996892|50586628|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
25272443|NCT00996892|50586629|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
25272444|NCT00996892|50586630|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
25272445|NCT00996892|50586611|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
25272446|NCT00996892|50586612|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
25272447|NCT00996892|50586613|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
25272448|NCT00996892|50586614|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
25129789|NCT03576131|50243153|FG000|Overall Study|Subject non-compliance|0|||
25129790|NCT03576131|50243154|FG001|Overall Study|Subject non-compliance|0|||
25129791|NCT03576131|50243155|FG002|Overall Study|Subject non-compliance|0|||
25129792|NCT03576131|50243156|FG003|Overall Study|Subject non-compliance|0|||
25129793|NCT03576131|50243157|FG004|Overall Study|Subject non-compliance|0|||
25129794|NCT03576131|50243158|FG005|Overall Study|Subject non-compliance|1|||
25129795|NCT03576131|50243159|FG006|Overall Study|Subject non-compliance|0|||
25129796|NCT03576131|50243160|FG007|Overall Study|Subject non-compliance|0|||
25129797|NCT01574716|50243192|FG000|Part 1|Death|3|||
25129798|NCT01574716|50243193|FG001|Part 1|Death|1|||
25272449|NCT00996892|50586615|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
25272450|NCT00996892|50586616|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
25272451|NCT00996892|50586617|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
25129799|NCT01574716|50243194|FG002|Part 1|Death|8|||
25129800|NCT01574716|50243195|FG003|Part 1|Death|0|||
25129801|NCT01574716|50243196|FG004|Part 1|Death|0|||
25129802|NCT01574716|50243192|FG000|Part 1|Discontinuation of study by sponsor|0|||
25129803|NCT01574716|50243193|FG001|Part 1|Discontinuation of study by sponsor|0|||
25129804|NCT01574716|50243194|FG002|Part 1|Discontinuation of study by sponsor|1|||
25129805|NCT01574716|50243195|FG003|Part 1|Discontinuation of study by sponsor|0|||
25129806|NCT01574716|50243196|FG004|Part 1|Discontinuation of study by sponsor|0|||
25129807|NCT01574716|50243192|FG000|Part 1|Withdrawal by Subject|0|||
25129808|NCT01574716|50243193|FG001|Part 1|Withdrawal by Subject|2|||
25129809|NCT01574716|50243194|FG002|Part 1|Withdrawal by Subject|0|||
25129810|NCT01574716|50243195|FG003|Part 1|Withdrawal by Subject|0|||
25129811|NCT01574716|50243196|FG004|Part 1|Withdrawal by Subject|0|||
25129812|NCT01574716|50243192|FG000|Part 1|Lost to Follow-up|0|||
25129813|NCT01574716|50243193|FG001|Part 1|Lost to Follow-up|1|||
25129814|NCT01574716|50243194|FG002|Part 1|Lost to Follow-up|0|||
25129815|NCT01574716|50243195|FG003|Part 1|Lost to Follow-up|0|||
25129816|NCT01574716|50243196|FG004|Part 1|Lost to Follow-up|0|||
25129817|NCT01574716|50243192|FG000|Part 2|Progressive disease|0|||
25129818|NCT01574716|50243193|FG001|Part 2|Progressive disease|0|||
25129819|NCT01574716|50243194|FG002|Part 2|Progressive disease|0|||
25129820|NCT01574716|50243195|FG003|Part 2|Progressive disease|1|||
25129821|NCT01574716|50243196|FG004|Part 2|Progressive disease|0|||
25129822|NCT01574716|50243192|FG000|Part 2|Death|0|||
25129823|NCT01574716|50243193|FG001|Part 2|Death|0|||
25129824|NCT01574716|50243194|FG002|Part 2|Death|0|||
25129825|NCT01574716|50243195|FG003|Part 2|Death|76|||
25129826|NCT01574716|50243196|FG004|Part 2|Death|35|||
25129827|NCT01574716|50243192|FG000|Part 2|Discontinuation of study by sponsor|0|||
25129828|NCT01574716|50243193|FG001|Part 2|Discontinuation of study by sponsor|0|||
25129829|NCT01574716|50243194|FG002|Part 2|Discontinuation of study by sponsor|0|||
25129830|NCT01574716|50243195|FG003|Part 2|Discontinuation of study by sponsor|51|||
25129831|NCT01574716|50243196|FG004|Part 2|Discontinuation of study by sponsor|31|||
25129832|NCT01574716|50243192|FG000|Part 2|Withdrawal by Subject|0|||
25129833|NCT01574716|50243193|FG001|Part 2|Withdrawal by Subject|0|||
25129834|NCT01574716|50243194|FG002|Part 2|Withdrawal by Subject|0|||
25129835|NCT01574716|50243195|FG003|Part 2|Withdrawal by Subject|5|||
25129836|NCT01574716|50243196|FG004|Part 2|Withdrawal by Subject|4|||
25129837|NCT01574716|50243192|FG000|Part 2|Brain metastases|0|||
25129838|NCT01574716|50243193|FG001|Part 2|Brain metastases|0|||
25129839|NCT01574716|50243194|FG002|Part 2|Brain metastases|0|||
25129840|NCT01574716|50243195|FG003|Part 2|Brain metastases|1|||
25129841|NCT01574716|50243196|FG004|Part 2|Brain metastases|0|||
25272452|NCT00996892|50586618|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
25272453|NCT00996892|50586619|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
25272454|NCT00996892|50586620|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
25272455|NCT00996892|50586621|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
25272456|NCT00996892|50586622|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
25272457|NCT00996892|50586623|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
25272458|NCT00996892|50586624|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
25272459|NCT00996892|50586625|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
25272460|NCT00996892|50586626|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
25272461|NCT00996892|50586627|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
25272462|NCT00996892|50586628|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
25272463|NCT00996892|50586629|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
25272464|NCT00996892|50586630|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
25272465|NCT00996892|50586611|FG000|Expansion Stage 2|Adverse Event|0|||
25272466|NCT00996892|50586612|FG001|Expansion Stage 2|Adverse Event|0|||
25272467|NCT00996892|50586613|FG002|Expansion Stage 2|Adverse Event|0|||
25272468|NCT00996892|50586614|FG003|Expansion Stage 2|Adverse Event|0|||
25272469|NCT00996892|50586615|FG004|Expansion Stage 2|Adverse Event|0|||
25272470|NCT00996892|50586616|FG005|Expansion Stage 2|Adverse Event|0|||
25272471|NCT00996892|50586617|FG006|Expansion Stage 2|Adverse Event|0|||
25272472|NCT00996892|50586618|FG007|Expansion Stage 2|Adverse Event|0|||
25272473|NCT00996892|50586619|FG008|Expansion Stage 2|Adverse Event|0|||
25272474|NCT00996892|50586620|FG009|Expansion Stage 2|Adverse Event|0|||
25272475|NCT00996892|50586621|FG010|Expansion Stage 2|Adverse Event|0|||
25272476|NCT00996892|50586622|FG011|Expansion Stage 2|Adverse Event|0|||
25272477|NCT00996892|50586623|FG012|Expansion Stage 2|Adverse Event|0|||
25272478|NCT00996892|50586624|FG013|Expansion Stage 2|Adverse Event|0|||
25272479|NCT00996892|50586625|FG014|Expansion Stage 2|Adverse Event|0|||
25272480|NCT00996892|50586626|FG015|Expansion Stage 2|Adverse Event|0|||
25129842|NCT01574716|50243192|FG000|Part 2|Lost to Follow-up|0|||
25129843|NCT01574716|50243193|FG001|Part 2|Lost to Follow-up|0|||
25129844|NCT01574716|50243194|FG002|Part 2|Lost to Follow-up|0|||
25129845|NCT01574716|50243195|FG003|Part 2|Lost to Follow-up|3|||
25129846|NCT01574716|50243196|FG004|Part 2|Lost to Follow-up|0|||
25129847|NCT02161562|50243207|FG000|Overall Study|Withdrawal by Subject|5|||
25129848|NCT02161562|50243208|FG001|Overall Study|Withdrawal by Subject|8|||
25129849|NCT02161562|50243207|FG000|Overall Study|Protocol Violation|9|||
25129850|NCT02161562|50243208|FG001|Overall Study|Protocol Violation|4|||
25129851|NCT02161562|50243207|FG000|Overall Study|Pregnancy|1|||
25129852|NCT02161562|50243208|FG001|Overall Study|Pregnancy|2|||
25129853|NCT02161562|50243207|FG000|Overall Study|Lost to Follow-up|3|||
25272481|NCT00996892|50586627|FG016|Expansion Stage 2|Adverse Event|0|||
25272482|NCT00996892|50586628|FG017|Expansion Stage 2|Adverse Event|0|||
25272483|NCT00996892|50586629|FG018|Expansion Stage 2|Adverse Event|3|||
25272484|NCT00996892|50586630|FG019|Expansion Stage 2|Adverse Event|0|||
25272485|NCT00996892|50586611|FG000|Expansion Stage 2|Death|0|||
25272486|NCT00996892|50586612|FG001|Expansion Stage 2|Death|0|||
25129854|NCT02161562|50243208|FG001|Overall Study|Lost to Follow-up|1|||
25129855|NCT02161562|50243207|FG000|Overall Study|Lack of Efficacy|4|||
25129856|NCT02161562|50243208|FG001|Overall Study|Lack of Efficacy|1|||
25129857|NCT02161562|50243207|FG000|Overall Study|Adverse Event|1|||
25129858|NCT02161562|50243208|FG001|Overall Study|Adverse Event|1|||
25129859|NCT02161562|50243207|FG000|Overall Study|Participant moved back to home country|1|||
25129860|NCT02161562|50243208|FG001|Overall Study|Participant moved back to home country|0|||
25129861|NCT02161562|50243207|FG000|Overall Study|Withdrew due to being out of the country|1|||
25129862|NCT02161562|50243208|FG001|Overall Study|Withdrew due to being out of the country|0|||
25129863|NCT02161562|50243207|FG000|Overall Study|Participant moved out of province|1|||
25129864|NCT02161562|50243208|FG001|Overall Study|Participant moved out of province|0|||
25129865|NCT01559116|50243227|FG000|Overall Study|Adverse Event|10|||
25129866|NCT01559116|50243227|FG000|Overall Study|Lack of Efficacy|1|||
25129867|NCT01559116|50243227|FG000|Overall Study|Lost to Follow-up|1|||
25129868|NCT01559116|50243227|FG000|Overall Study|Protocol Violation|1|||
25129869|NCT01559116|50243227|FG000|Overall Study|Withdrawal by Subject|4|||
25129870|NCT01559116|50243227|FG000|Overall Study|other than stated above|9|||
25129871|NCT01574326|50243246|FG000|Overall Study|Randomized but not treated|0|||
25129872|NCT01574326|50243247|FG001|Overall Study|Randomized but not treated|1|||
25129873|NCT01574326|50243246|FG000|Overall Study|Withdrawal by Participant|2|||
25129874|NCT01574326|50243247|FG001|Overall Study|Withdrawal by Participant|4|||
25129875|NCT01574326|50243246|FG000|Overall Study|Physician Decision|5|||
25129876|NCT01574326|50243247|FG001|Overall Study|Physician Decision|3|||
25129877|NCT01574326|50243246|FG000|Overall Study|Adverse Event|1|||
25129878|NCT01574326|50243247|FG001|Overall Study|Adverse Event|3|||
25129879|NCT01574326|50243246|FG000|Overall Study|Other: Mainly kidney transplant|8|||
25129880|NCT01574326|50243247|FG001|Overall Study|Other: Mainly kidney transplant|8|||
25129881|NCT01574248|50243260|FG000|Overall Study|Withdrawal by Subject|2|||
25129882|NCT01574248|50243261|FG001|Overall Study|Withdrawal by Subject|0|||
25129883|NCT01574248|50243260|FG000|Overall Study|Missing primary endpoint data|1|||
25129884|NCT01574248|50243261|FG001|Overall Study|Missing primary endpoint data|0|||
25129885|NCT01573624|50243267|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
25129886|NCT01573624|50243268|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
25129887|NCT01573624|50243269|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
25129888|NCT01573624|50243270|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
25129889|NCT01573624|50243271|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
25129890|NCT01573624|50243272|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
25129891|NCT01573624|50243273|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
25129892|NCT01573624|50243267|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
25129893|NCT01573624|50243268|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
25129894|NCT01573624|50243269|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
25129895|NCT01573624|50243270|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
25129896|NCT01573624|50243271|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
25129897|NCT01573624|50243272|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
25129898|NCT01573624|50243273|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
25129899|NCT01573624|50243267|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
25129900|NCT01573624|50243268|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
25129901|NCT01573624|50243269|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
25129902|NCT01573624|50243270|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
25129903|NCT01573624|50243271|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
25129904|NCT01573624|50243272|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
25129905|NCT01573624|50243273|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
25129906|NCT01573624|50243267|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
25129907|NCT01573624|50243268|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
25129908|NCT01573624|50243269|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
25129909|NCT01573624|50243270|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
25129910|NCT01573624|50243271|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
25272487|NCT00996892|50586613|FG002|Expansion Stage 2|Death|0|||
25272488|NCT00996892|50586614|FG003|Expansion Stage 2|Death|0|||
25272489|NCT00996892|50586615|FG004|Expansion Stage 2|Death|0|||
25129911|NCT01573624|50243272|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
25129912|NCT01573624|50243273|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
25168623|NCT00633243|50298232|FG001|Overall Study|Not comfortable with self-injecting|1|||
25272490|NCT00996892|50586616|FG005|Expansion Stage 2|Death|0|||
25272491|NCT00996892|50586617|FG006|Expansion Stage 2|Death|0|||
25178610|NCT01509079|50323926|FG001|Overall Study|Lack of Efficacy|2|||
25178611|NCT01509079|50323925|FG000|Overall Study|started an excluded medication|0|||
25178612|NCT01509079|50323926|FG001|Overall Study|started an excluded medication|1|||
25178613|NCT01463293|50323935|FG000|Overall Study|Lost to Follow-up|1|||
25178614|NCT01463293|50323936|FG001|Overall Study|Lost to Follow-up|4|||
25178615|NCT01463293|50323937|FG002|Overall Study|Lost to Follow-up|5|||
25178616|NCT01463293|50323935|FG000|Overall Study|Adverse Event|1|||
25178617|NCT01463293|50323936|FG001|Overall Study|Adverse Event|2|||
25178618|NCT01463293|50323937|FG002|Overall Study|Adverse Event|0|||
25178619|NCT01463293|50323935|FG000|Overall Study|Withdrawal by Subject|4|||
25178620|NCT01463293|50323936|FG001|Overall Study|Withdrawal by Subject|10|||
25129913|NCT01573624|50243267|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
25129914|NCT01573624|50243268|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
25129915|NCT01573624|50243269|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
25129916|NCT01573624|50243270|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
25129917|NCT01573624|50243271|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
25129918|NCT01573624|50243272|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
25129919|NCT01573624|50243273|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
25129920|NCT01573624|50243267|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
25129921|NCT01573624|50243268|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
25129922|NCT01573624|50243269|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
25129923|NCT01573624|50243270|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
25129924|NCT01573624|50243271|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
25129925|NCT01573624|50243272|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
25129926|NCT01573624|50243273|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
25129927|NCT01573624|50243267|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
25129928|NCT01573624|50243268|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
25129929|NCT01573624|50243269|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
25129930|NCT01573624|50243270|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
25129931|NCT01573624|50243271|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
25129932|NCT01573624|50243272|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
25129933|NCT01573624|50243273|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
25129934|NCT01573624|50243267|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
25129935|NCT01573624|50243268|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
25129936|NCT01573624|50243269|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
25129937|NCT01573624|50243270|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
25129938|NCT01573624|50243271|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
25129939|NCT01573624|50243272|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
25129940|NCT01573624|50243273|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
25129941|NCT01573624|50243267|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
25129942|NCT01573624|50243268|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
25129943|NCT01573624|50243269|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
25129944|NCT01573624|50243270|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
25129945|NCT01573624|50243271|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
25129946|NCT01573624|50243272|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
25129947|NCT01573624|50243273|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
25129948|NCT01573624|50243267|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
25129949|NCT01573624|50243268|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
25129950|NCT01573624|50243269|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
25129951|NCT01573624|50243270|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
25129952|NCT01573624|50243271|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
25129953|NCT01573624|50243272|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
25129954|NCT01573624|50243273|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
25129955|NCT01573624|50243267|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
25129956|NCT01573624|50243268|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
25129957|NCT01573624|50243269|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
25129958|NCT01573624|50243270|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
25129959|NCT01573624|50243271|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
25178621|NCT01463293|50323937|FG002|Overall Study|Withdrawal by Subject|5|||
25178622|NCT01463293|50323935|FG000|Overall Study|Other|0|||
25178623|NCT01463293|50323936|FG001|Overall Study|Other|0|||
25178624|NCT01463293|50323937|FG002|Overall Study|Other|2|||
25178625|NCT01479985|50323968|FG000|Overall Study|Tablet malfunction, no data saved|1|||
25178626|NCT01479985|50323969|FG001|Overall Study|Tablet malfunction, no data saved|1|||
25272492|NCT00996892|50586618|FG007|Expansion Stage 2|Death|0|||
25129960|NCT01573624|50243272|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
25129961|NCT01573624|50243273|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
25129962|NCT01573624|50243267|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
25129963|NCT01573624|50243268|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
25129964|NCT01573624|50243269|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
25129965|NCT01573624|50243270|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
25129966|NCT01573624|50243271|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
25129967|NCT01573624|50243272|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
25129968|NCT01573624|50243273|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
25129969|NCT01573624|50243267|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
25129970|NCT01573624|50243268|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
25129971|NCT01573624|50243269|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
25129972|NCT01573624|50243270|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
25129973|NCT01573624|50243271|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
25129974|NCT01573624|50243272|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
25129975|NCT01573624|50243273|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
25129976|NCT01573624|50243267|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
25272493|NCT00996892|50586619|FG008|Expansion Stage 2|Death|0|||
25272494|NCT00996892|50586620|FG009|Expansion Stage 2|Death|0|||
25272495|NCT00996892|50586621|FG010|Expansion Stage 2|Death|0|||
25272496|NCT00996892|50586622|FG011|Expansion Stage 2|Death|0|||
25272497|NCT00996892|50586623|FG012|Expansion Stage 2|Death|0|||
25272498|NCT00996892|50586624|FG013|Expansion Stage 2|Death|0|||
25272499|NCT00996892|50586625|FG014|Expansion Stage 2|Death|0|||
25272500|NCT00996892|50586626|FG015|Expansion Stage 2|Death|0|||
25272501|NCT00996892|50586627|FG016|Expansion Stage 2|Death|0|||
25129977|NCT01573624|50243268|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
25129978|NCT01573624|50243269|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
25129979|NCT01573624|50243270|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
25129980|NCT01573624|50243271|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
25129981|NCT01573624|50243272|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
25129982|NCT01573624|50243273|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
25129983|NCT01573624|50243267|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
25129984|NCT01573624|50243268|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
25129985|NCT01573624|50243269|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
25129986|NCT01573624|50243270|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
25129987|NCT01573624|50243271|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
25129988|NCT01573624|50243272|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
25129989|NCT01573624|50243273|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
25129990|NCT01573624|50243267|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
25129991|NCT01573624|50243268|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
25129992|NCT01573624|50243269|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
25129993|NCT01573624|50243270|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
25129994|NCT01573624|50243271|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
25129995|NCT01573624|50243272|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
25129996|NCT01573624|50243273|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
25129997|NCT01573624|50243267|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
25129998|NCT01573624|50243268|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
25129999|NCT01573624|50243269|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
25130000|NCT01573624|50243270|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
25130001|NCT01573624|50243271|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
25130002|NCT01573624|50243272|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
25130003|NCT01573624|50243273|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
25272502|NCT00996892|50586628|FG017|Expansion Stage 2|Death|0|||
25272503|NCT00996892|50586629|FG018|Expansion Stage 2|Death|2|||
25272504|NCT00996892|50586630|FG019|Expansion Stage 2|Death|0|||
25272505|NCT00996892|50586611|FG000|Expansion Stage 2|Physician Decision|0|||
25272506|NCT00996892|50586612|FG001|Expansion Stage 2|Physician Decision|0|||
25272507|NCT00996892|50586613|FG002|Expansion Stage 2|Physician Decision|0|||
25272508|NCT00996892|50586614|FG003|Expansion Stage 2|Physician Decision|0|||
25130004|NCT01573624|50243267|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
25130005|NCT01573624|50243268|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
25130006|NCT01573624|50243269|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
25130007|NCT01573624|50243270|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
25130008|NCT01573624|50243271|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
25130009|NCT01573624|50243272|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
25130010|NCT01573624|50243273|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
25130011|NCT01573624|50243267|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
25130012|NCT01573624|50243268|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
25130013|NCT01573624|50243269|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
25130014|NCT01573624|50243270|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
25130015|NCT01573624|50243271|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
25130016|NCT01573624|50243272|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
25130017|NCT01573624|50243273|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
25130018|NCT01573624|50243267|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
25130019|NCT01573624|50243268|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
25130020|NCT01573624|50243269|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
25130021|NCT01573624|50243270|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
25130022|NCT01573624|50243271|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
25130023|NCT01573624|50243272|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
25130024|NCT01573624|50243273|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
25130025|NCT01573624|50243267|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
25130026|NCT01573624|50243268|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
25130027|NCT01573624|50243269|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
25130028|NCT01573624|50243270|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
25130029|NCT01573624|50243271|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
25130030|NCT01573624|50243272|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
25130031|NCT01573624|50243273|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
25130032|NCT01573624|50243267|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
25130033|NCT01573624|50243268|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
25130034|NCT01573624|50243269|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
25130035|NCT01573624|50243270|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
25130036|NCT01573624|50243271|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
25130037|NCT01573624|50243272|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
25130038|NCT01573624|50243273|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
25130039|NCT01573624|50243267|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
25130040|NCT01573624|50243268|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
25130041|NCT01573624|50243269|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
25130042|NCT01573624|50243270|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
25130043|NCT01573624|50243271|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
25130044|NCT01573624|50243272|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
25130045|NCT01573624|50243273|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
25130046|NCT01573624|50243267|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
25130047|NCT01573624|50243268|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
25130048|NCT01573624|50243269|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
25130049|NCT01573624|50243270|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
25130050|NCT01573624|50243271|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
25130051|NCT01573624|50243272|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
25130052|NCT01573624|50243273|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
25130053|NCT01573624|50243267|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
25130054|NCT01573624|50243268|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
25130055|NCT01573624|50243269|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
25130056|NCT01573624|50243270|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
25130057|NCT01573624|50243271|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
25130058|NCT01573624|50243272|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
25130059|NCT01573624|50243273|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
25130060|NCT01573624|50243267|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
25130061|NCT01573624|50243268|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
25130062|NCT01573624|50243269|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
25272509|NCT00996892|50586615|FG004|Expansion Stage 2|Physician Decision|0|||
25272510|NCT00996892|50586616|FG005|Expansion Stage 2|Physician Decision|0|||
25272511|NCT00996892|50586617|FG006|Expansion Stage 2|Physician Decision|0|||
25130063|NCT01573624|50243270|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
25130064|NCT01573624|50243271|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
25130065|NCT01573624|50243272|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
25130066|NCT01573624|50243273|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
25130067|NCT01573624|50243267|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
25130068|NCT01573624|50243268|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
25130069|NCT01573624|50243269|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
25130070|NCT01573624|50243270|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
25130071|NCT01573624|50243271|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
25130072|NCT01573624|50243272|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
25130073|NCT01573624|50243273|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
25130074|NCT01557946|50243297|FG000|Overall Study|Adverse Event|3|||
25130075|NCT01557946|50243298|FG001|Overall Study|Adverse Event|0|||
25130076|NCT01534078|50243303|FG000|Overall Study|Death|1|||
25130077|NCT01534078|50243303|FG000|Overall Study|Withdrawal by Subject|1|||
25130078|NCT02185040|50243312|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
25130079|NCT02185040|50243313|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
25130080|NCT02185040|50243314|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
25130081|NCT02185040|50243315|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
25130082|NCT02185040|50243316|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
25130083|NCT02185040|50243317|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
25130084|NCT02185040|50243318|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
25130085|NCT02185040|50243312|FG000|Part 1 Treatment Phase|Adverse Event|1|||
25130086|NCT02185040|50243313|FG001|Part 1 Treatment Phase|Adverse Event|0|||
25130087|NCT02185040|50243314|FG002|Part 1 Treatment Phase|Adverse Event|0|||
25130088|NCT02185040|50243315|FG003|Part 1 Treatment Phase|Adverse Event|2|||
25130089|NCT02185040|50243316|FG004|Part 1 Treatment Phase|Adverse Event|3|||
25130090|NCT02185040|50243317|FG005|Part 1 Treatment Phase|Adverse Event|0|||
25130091|NCT02185040|50243318|FG006|Part 1 Treatment Phase|Adverse Event|0|||
25130092|NCT02185040|50243312|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
25130093|NCT02185040|50243313|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
25130094|NCT02185040|50243314|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
25130095|NCT02185040|50243315|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
25130096|NCT02185040|50243316|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
25130097|NCT02185040|50243317|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
25130098|NCT02185040|50243318|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
25130099|NCT02185040|50243312|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
25130100|NCT02185040|50243313|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
25130101|NCT02185040|50243314|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
25130102|NCT02185040|50243315|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
25130103|NCT02185040|50243316|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
25130104|NCT02185040|50243317|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
25130105|NCT02185040|50243318|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
25130106|NCT02185040|50243312|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
25130107|NCT02185040|50243313|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
25130108|NCT02185040|50243314|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
25130109|NCT02185040|50243315|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
25130110|NCT02185040|50243316|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
25130111|NCT02185040|50243317|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
25130112|NCT02185040|50243318|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
25130113|NCT02185040|50243312|FG000|Active Treatment Extension Phase|Adverse Event|0|||
25130114|NCT02185040|50243313|FG001|Active Treatment Extension Phase|Adverse Event|0|||
25130115|NCT02185040|50243314|FG002|Active Treatment Extension Phase|Adverse Event|0|||
25130116|NCT02185040|50243315|FG003|Active Treatment Extension Phase|Adverse Event|0|||
25130117|NCT02185040|50243316|FG004|Active Treatment Extension Phase|Adverse Event|0|||
25130118|NCT02185040|50243317|FG005|Active Treatment Extension Phase|Adverse Event|1|||
25130119|NCT02185040|50243318|FG006|Active Treatment Extension Phase|Adverse Event|4|||
25130120|NCT02185040|50243312|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
25130121|NCT02185040|50243313|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
25130122|NCT02185040|50243314|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
25130123|NCT02185040|50243315|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
25130124|NCT02185040|50243316|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
25130125|NCT02185040|50243317|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
25130126|NCT02185040|50243318|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
25130127|NCT02185040|50243312|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
25130128|NCT02185040|50243313|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
25130129|NCT02185040|50243314|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
25009357|NCT00075725|50102300|FG006|Overall Study|Institution Terminated|0|||
25130130|NCT02185040|50243315|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
25130131|NCT02185040|50243316|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
25130132|NCT02185040|50243317|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
25130133|NCT02185040|50243318|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
25130134|NCT02161406|50243340|FG000|Overall Study|Death|2|||
25130135|NCT02161406|50243341|FG001|Overall Study|Death|1|||
25130136|NCT02161406|50243340|FG000|Overall Study|Lost to Follow-up|2|||
25130137|NCT02161406|50243341|FG001|Overall Study|Lost to Follow-up|1|||
25130138|NCT02161406|50243340|FG000|Overall Study|Withdrawal by Subject|2|||
25130139|NCT02161406|50243341|FG001|Overall Study|Withdrawal by Subject|4|||
25130140|NCT02161406|50243340|FG000|Overall Study|investigator withdrew subject|3|||
25130141|NCT02161406|50243341|FG001|Overall Study|investigator withdrew subject|1|||
25130142|NCT02161406|50243340|FG000|Overall Study|Lack of Efficacy|1|||
25130143|NCT02161406|50243341|FG001|Overall Study|Lack of Efficacy|1|||
25130144|NCT02161406|50243340|FG000|Overall Study|relocation|0|||
25130145|NCT02161406|50243341|FG001|Overall Study|relocation|1|||
25130146|NCT02161016|50243347|FG000|Overall Study|withdrawn by IRB|1|||
25130147|NCT01573000|50243353|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
25130148|NCT01573000|50243354|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
25130149|NCT01573000|50243353|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
25130150|NCT01573000|50243354|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
25130151|NCT01573000|50243353|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
25130152|NCT01573000|50243354|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
25130153|NCT01573000|50243353|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
25130154|NCT01573000|50243354|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
25130155|NCT01573000|50243353|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
25130156|NCT01573000|50243354|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
25130157|NCT01573000|50243353|FG000|Crossover Phase|Lack of Efficacy|0|||
25130158|NCT01573000|50243354|FG001|Crossover Phase|Lack of Efficacy|13|||
25130159|NCT01573000|50243353|FG000|Crossover Phase|Lost to Follow-up|0|||
25130160|NCT01573000|50243354|FG001|Crossover Phase|Lost to Follow-up|2|||
25272512|NCT00996892|50586618|FG007|Expansion Stage 2|Physician Decision|0|||
25272513|NCT00996892|50586619|FG008|Expansion Stage 2|Physician Decision|0|||
25272514|NCT00996892|50586620|FG009|Expansion Stage 2|Physician Decision|0|||
25272515|NCT00996892|50586621|FG010|Expansion Stage 2|Physician Decision|0|||
25272516|NCT00996892|50586622|FG011|Expansion Stage 2|Physician Decision|0|||
25272517|NCT00996892|50586623|FG012|Expansion Stage 2|Physician Decision|0|||
25272518|NCT00996892|50586624|FG013|Expansion Stage 2|Physician Decision|0|||
25272519|NCT00996892|50586625|FG014|Expansion Stage 2|Physician Decision|0|||
25272520|NCT00996892|50586626|FG015|Expansion Stage 2|Physician Decision|0|||
25272521|NCT00996892|50586627|FG016|Expansion Stage 2|Physician Decision|0|||
25272522|NCT00996892|50586628|FG017|Expansion Stage 2|Physician Decision|0|||
25272523|NCT00996892|50586629|FG018|Expansion Stage 2|Physician Decision|1|||
25272524|NCT00996892|50586630|FG019|Expansion Stage 2|Physician Decision|0|||
25272525|NCT00996892|50586611|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
25272526|NCT00996892|50586612|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
25272527|NCT00996892|50586613|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
25272528|NCT00996892|50586614|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
25272529|NCT00996892|50586615|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
25272530|NCT00996892|50586616|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
25272531|NCT00996892|50586617|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
25272532|NCT00996892|50586618|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
25272533|NCT00996892|50586619|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
25272534|NCT00996892|50586620|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
25272535|NCT00996892|50586621|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
25272536|NCT00996892|50586622|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
25272537|NCT00996892|50586623|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
25272538|NCT00996892|50586624|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
25272539|NCT00996892|50586625|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
25272540|NCT00996892|50586626|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
25272541|NCT00996892|50586627|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
25272542|NCT00996892|50586628|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
25272543|NCT00996892|50586629|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
25272544|NCT00996892|50586630|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
25272545|NCT00996892|50586611|FG000|Expansion Stage 2|Disease Progression|0|||
25272546|NCT00996892|50586612|FG001|Expansion Stage 2|Disease Progression|0|||
25272547|NCT00996892|50586613|FG002|Expansion Stage 2|Disease Progression|0|||
25272548|NCT00996892|50586614|FG003|Expansion Stage 2|Disease Progression|0|||
25272549|NCT00996892|50586615|FG004|Expansion Stage 2|Disease Progression|0|||
25272550|NCT00996892|50586616|FG005|Expansion Stage 2|Disease Progression|0|||
25272551|NCT00996892|50586617|FG006|Expansion Stage 2|Disease Progression|0|||
25272552|NCT00996892|50586618|FG007|Expansion Stage 2|Disease Progression|0|||
25272553|NCT00996892|50586619|FG008|Expansion Stage 2|Disease Progression|0|||
25272554|NCT00996892|50586620|FG009|Expansion Stage 2|Disease Progression|0|||
25130161|NCT01573000|50243353|FG000|Crossover Phase|Death|0|||
25130162|NCT01573000|50243354|FG001|Crossover Phase|Death|3|||
25130163|NCT01573000|50243353|FG000|Long-Term Follow-Up|Death|3|||
25130164|NCT01573000|50243354|FG001|Long-Term Follow-Up|Death|0|||
25130165|NCT01573000|50243353|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
25130166|NCT01573000|50243354|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
25130167|NCT01572922|50243364|FG000|Overall Study|Adverse Event|1|||
25130168|NCT01572922|50243364|FG000|Overall Study|Protocol Violation|1|||
25130169|NCT01572922|50243364|FG000|Overall Study|Death|1|||
25130170|NCT01572844|50243373|FG000|Overall Study|Physician Decision|1|||
25130171|NCT01572844|50243374|FG001|Overall Study|Physician Decision|1|||
25130172|NCT01557400|50243383|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
25130173|NCT01557400|50243383|FG000|Overall Study|Adverse Event|3|||
25130174|NCT01557400|50243383|FG000|Overall Study|Lost to Follow-up|5|||
25130175|NCT01557400|50243383|FG000|Overall Study|Withdrawal by Subject|9|||
25130176|NCT01533922|50243387|FG000|Overall Study|Adverse Event|5|||
25130177|NCT01533922|50243388|FG001|Overall Study|Adverse Event|8|||
25130178|NCT01533922|50243389|FG002|Overall Study|Adverse Event|6|||
25130179|NCT01533922|50243390|FG003|Overall Study|Adverse Event|3|||
25130180|NCT01533922|50243391|FG004|Overall Study|Adverse Event|4|||
25130181|NCT01533922|50243387|FG000|Overall Study|Lack of Efficacy|0|||
25130182|NCT01533922|50243388|FG001|Overall Study|Lack of Efficacy|0|||
25130183|NCT01533922|50243389|FG002|Overall Study|Lack of Efficacy|1|||
25130184|NCT01533922|50243390|FG003|Overall Study|Lack of Efficacy|0|||
25130185|NCT01533922|50243391|FG004|Overall Study|Lack of Efficacy|0|||
25130186|NCT01533922|50243387|FG000|Overall Study|Protocol Violation|0|||
25130187|NCT01533922|50243388|FG001|Overall Study|Protocol Violation|3|||
25130188|NCT01533922|50243389|FG002|Overall Study|Protocol Violation|0|||
25130189|NCT01533922|50243390|FG003|Overall Study|Protocol Violation|0|||
25130190|NCT01533922|50243391|FG004|Overall Study|Protocol Violation|1|||
25130191|NCT01533922|50243387|FG000|Overall Study|Withdrawal by Subject|3|||
25130192|NCT01533922|50243388|FG001|Overall Study|Withdrawal by Subject|1|||
25130193|NCT01533922|50243389|FG002|Overall Study|Withdrawal by Subject|2|||
25130194|NCT01533922|50243390|FG003|Overall Study|Withdrawal by Subject|2|||
25130195|NCT01533922|50243391|FG004|Overall Study|Withdrawal by Subject|1|||
25130196|NCT01533922|50243387|FG000|Overall Study|Other reason not defined above|2|||
25130197|NCT01533922|50243388|FG001|Overall Study|Other reason not defined above|0|||
25130198|NCT01533922|50243389|FG002|Overall Study|Other reason not defined above|1|||
25130199|NCT01533922|50243390|FG003|Overall Study|Other reason not defined above|0|||
25130200|NCT01533922|50243391|FG004|Overall Study|Other reason not defined above|0|||
25130201|NCT01533688|50243406|FG000|Overall Study|Withdrawal by Subject|5|||
25130202|NCT01533688|50243407|FG001|Overall Study|Withdrawal by Subject|4|||
25130203|NCT01533688|50243408|FG002|Overall Study|Withdrawal by Subject|3|||
25130204|NCT01533688|50243406|FG000|Overall Study|Medically unstable|1|||
25130205|NCT01533688|50243407|FG001|Overall Study|Medically unstable|3|||
25130206|NCT01533688|50243408|FG002|Overall Study|Medically unstable|3|||
25130207|NCT01533688|50243406|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
25130208|NCT01533688|50243407|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
25130209|NCT01533688|50243408|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
25130210|NCT01532986|50243420|FG000|Overall Study|Death|9|||
25130211|NCT01532986|50243421|FG001|Overall Study|Death|9|||
25272555|NCT00996892|50586621|FG010|Expansion Stage 2|Disease Progression|0|||
25272556|NCT00996892|50586622|FG011|Expansion Stage 2|Disease Progression|0|||
25272557|NCT00996892|50586623|FG012|Expansion Stage 2|Disease Progression|0|||
25272558|NCT00996892|50586624|FG013|Expansion Stage 2|Disease Progression|0|||
25272559|NCT00996892|50586625|FG014|Expansion Stage 2|Disease Progression|0|||
25272560|NCT00996892|50586626|FG015|Expansion Stage 2|Disease Progression|0|||
25272561|NCT00996892|50586627|FG016|Expansion Stage 2|Disease Progression|0|||
25272562|NCT00996892|50586628|FG017|Expansion Stage 2|Disease Progression|0|||
25272563|NCT00996892|50586629|FG018|Expansion Stage 2|Disease Progression|28|||
25272564|NCT00996892|50586630|FG019|Expansion Stage 2|Disease Progression|0|||
25272565|NCT00996892|50586611|FG000|Expansion Stage 2A|Adverse Event|0|||
25130212|NCT01532986|50243420|FG000|Overall Study|Withdrawal by Subject|7|||
25130213|NCT01532986|50243421|FG001|Overall Study|Withdrawal by Subject|10|||
25130214|NCT01532986|50243420|FG000|Overall Study|Physician Decision|7|||
25130215|NCT01532986|50243421|FG001|Overall Study|Physician Decision|5|||
25130216|NCT01532908|50243430|FG000|Overall Study|Not Transplanted|1|||
25178627|NCT01479985|50323968|FG000|Overall Study|No decisional conflict scale responses|0|||
25272566|NCT00996892|50586612|FG001|Expansion Stage 2A|Adverse Event|0|||
25272567|NCT00996892|50586613|FG002|Expansion Stage 2A|Adverse Event|0|||
25272568|NCT00996892|50586614|FG003|Expansion Stage 2A|Adverse Event|0|||
25272569|NCT00996892|50586615|FG004|Expansion Stage 2A|Adverse Event|0|||
25130217|NCT01532908|50243431|FG001|Overall Study|Not Transplanted|0|||
25130218|NCT02160782|50243437|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
25130219|NCT02160782|50243438|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
25130220|NCT02160782|50243439|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
25272570|NCT00996892|50586616|FG005|Expansion Stage 2A|Adverse Event|0|||
25272571|NCT00996892|50586617|FG006|Expansion Stage 2A|Adverse Event|0|||
25130221|NCT02160782|50243440|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
25130222|NCT02160782|50243441|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
25130223|NCT02160782|50243437|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
25130224|NCT02160782|50243438|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
25130225|NCT02160782|50243439|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
25130226|NCT02160782|50243440|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
25130227|NCT02160782|50243441|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
25130228|NCT02160782|50243437|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
25130229|NCT02160782|50243438|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
25130230|NCT02160782|50243439|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
25130231|NCT02160782|50243440|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
25130232|NCT02160782|50243441|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
25130233|NCT02160782|50243437|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
25130234|NCT02160782|50243438|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
25272572|NCT00996892|50586618|FG007|Expansion Stage 2A|Adverse Event|0|||
25130235|NCT02160782|50243439|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
25130236|NCT02160782|50243440|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
25130237|NCT02160782|50243441|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
25130238|NCT02160782|50243437|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
25130239|NCT02160782|50243438|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
25130240|NCT02160782|50243439|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
25130241|NCT02160782|50243440|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
25130242|NCT02160782|50243441|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
25130243|NCT02160782|50243437|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
25272573|NCT00996892|50586619|FG008|Expansion Stage 2A|Adverse Event|0|||
25130244|NCT02160782|50243438|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
25130245|NCT02160782|50243439|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
25130246|NCT02160782|50243440|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
25130247|NCT02160782|50243441|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
25130248|NCT02160782|50243437|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
25130249|NCT02160782|50243438|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
25130250|NCT02160782|50243439|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
25130251|NCT02160782|50243440|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
25130252|NCT02160782|50243441|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
25130253|NCT02160626|50243468|FG000|Overall Study|Adverse Event|1|||
25130254|NCT02160626|50243469|FG001|Overall Study|Adverse Event|0|||
25130255|NCT02160626|50243470|FG002|Overall Study|Adverse Event|0|||
25130256|NCT02160626|50243468|FG000|Overall Study|Schedule not conducive to study visits|0|||
25130257|NCT02160626|50243469|FG001|Overall Study|Schedule not conducive to study visits|0|||
25130258|NCT02160626|50243470|FG002|Overall Study|Schedule not conducive to study visits|1|||
25130259|NCT02160626|50243468|FG000|Overall Study|Withdrawal by Subject|0|||
25130260|NCT02160626|50243469|FG001|Overall Study|Withdrawal by Subject|1|||
25130261|NCT02160626|50243470|FG002|Overall Study|Withdrawal by Subject|0|||
25130262|NCT02160314|50243482|FG000|Overall Study|Adverse Event|0|||
25130263|NCT02160314|50243483|FG001|Overall Study|Adverse Event|6|||
25130264|NCT02160314|50243482|FG000|Overall Study|Protocol Violation|0|||
25130265|NCT02160314|50243483|FG001|Overall Study|Protocol Violation|4|||
25130266|NCT02160314|50243482|FG000|Overall Study|Withdrawal by Subject|1|||
25130267|NCT02160314|50243483|FG001|Overall Study|Withdrawal by Subject|2|||
25130268|NCT02160314|50243482|FG000|Overall Study|Lost to Follow-up|0|||
25130269|NCT02160314|50243483|FG001|Overall Study|Lost to Follow-up|1|||
25130270|NCT02160002|50243491|FG000|Overall Study|Withdrawal by Subject|2|||
25272574|NCT00996892|50586620|FG009|Expansion Stage 2A|Adverse Event|0|||
25272575|NCT00996892|50586621|FG010|Expansion Stage 2A|Adverse Event|0|||
25272576|NCT00996892|50586622|FG011|Expansion Stage 2A|Adverse Event|0|||
25272577|NCT00996892|50586623|FG012|Expansion Stage 2A|Adverse Event|0|||
25272578|NCT00996892|50586624|FG013|Expansion Stage 2A|Adverse Event|0|||
25272579|NCT00996892|50586625|FG014|Expansion Stage 2A|Adverse Event|0|||
25272580|NCT00996892|50586626|FG015|Expansion Stage 2A|Adverse Event|0|||
25272581|NCT00996892|50586627|FG016|Expansion Stage 2A|Adverse Event|0|||
25272582|NCT00996892|50586628|FG017|Expansion Stage 2A|Adverse Event|0|||
25130271|NCT02160002|50243492|FG001|Overall Study|Withdrawal by Subject|1|||
25130272|NCT02218268|50243498|FG000|24 Hour Washout|Physician Decision|11|||
25272583|NCT00996892|50586629|FG018|Expansion Stage 2A|Adverse Event|0|||
25272584|NCT00996892|50586630|FG019|Expansion Stage 2A|Adverse Event|8|||
25272585|NCT00996892|50586611|FG000|Expansion Stage 2A|Physician Decision|0|||
25272586|NCT00996892|50586612|FG001|Expansion Stage 2A|Physician Decision|0|||
25009358|NCT00075725|50102301|FG007|Overall Study|Institution Terminated|3|||
25272587|NCT00996892|50586613|FG002|Expansion Stage 2A|Physician Decision|0|||
25272588|NCT00996892|50586614|FG003|Expansion Stage 2A|Physician Decision|0|||
25130273|NCT02218268|50243499|FG001|24 Hour Washout|Physician Decision|9|||
25130274|NCT02217878|50243507|FG000|Overall Study|required morphine due to chest pain|1|||
25130275|NCT02217878|50243508|FG001|Overall Study|required morphine due to chest pain|2|||
25130276|NCT02217878|50243507|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
25130277|NCT02217878|50243508|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
25130278|NCT02217566|50243514|FG000|Overall Study|Lost to Follow-up|2|||
25130279|NCT02217566|50243514|FG000|Overall Study|Death|3|||
25130280|NCT02217566|50243514|FG000|Overall Study|Early study termination|6|||
25130281|NCT02217410|50243521|FG000|Overall Study|Graft Loss|0|||
25130282|NCT02217410|50243522|FG001|Overall Study|Graft Loss|0|||
25130283|NCT02217410|50243523|FG002|Overall Study|Graft Loss|2|||
25130284|NCT02217410|50243521|FG000|Overall Study|Withdrawal by Subject|0|||
25130285|NCT02217410|50243522|FG001|Overall Study|Withdrawal by Subject|0|||
25130286|NCT02217410|50243523|FG002|Overall Study|Withdrawal by Subject|2|||
25130287|NCT02217410|50243521|FG000|Overall Study|Lost to Follow-up|0|||
25130288|NCT02217410|50243522|FG001|Overall Study|Lost to Follow-up|0|||
25130289|NCT02217410|50243523|FG002|Overall Study|Lost to Follow-up|1|||
25130290|NCT02217410|50243521|FG000|Overall Study|Lack of Efficacy|0|||
25130291|NCT02217410|50243522|FG001|Overall Study|Lack of Efficacy|1|||
25130292|NCT02217410|50243523|FG002|Overall Study|Lack of Efficacy|0|||
25130293|NCT02217410|50243521|FG000|Overall Study|Physician Decision|1|||
25130294|NCT02217410|50243522|FG001|Overall Study|Physician Decision|3|||
25130295|NCT02217410|50243523|FG002|Overall Study|Physician Decision|0|||
25130296|NCT02217332|50243536|FG000|Overall Study|Adverse Event|3|||
25130297|NCT02217332|50243536|FG000|Overall Study|Dose interruption >1 month|1|||
25130298|NCT02217332|50243536|FG000|Overall Study|Protocol Violation (eligibility)|1|||
25130299|NCT02217332|50243536|FG000|Overall Study|Withdrawal by Subject|1|||
25130300|NCT02217332|50243536|FG000|Overall Study|Lost to Follow-up|1|||
25130301|NCT02184572|50243542|FG000|Overall Study|Lost to Follow-up|29|||
25130302|NCT02184572|50243543|FG001|Overall Study|Lost to Follow-up|21|||
25130303|NCT02184572|50243542|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
25130304|NCT02184572|50243543|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
25130305|NCT02184572|50243542|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
25130306|NCT02184572|50243543|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
25130307|NCT02184572|50243542|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
25130308|NCT02184572|50243543|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
25130309|NCT02184572|50243542|FG000|Overall Study|Traveling Outside The Country|1|||
25130310|NCT02184572|50243543|FG001|Overall Study|Traveling Outside The Country|0|||
25130311|NCT02184572|50243542|FG000|Overall Study|Withdrawal by Subject|14|||
25130312|NCT02184572|50243543|FG001|Overall Study|Withdrawal by Subject|9|||
25130313|NCT02181842|50243551|FG000|Overall Study|Case Report Forms Uncollected|2|||
25130314|NCT01632020|50243557|FG000|Overall Study|Withdrawal by Subject|1|||
25130315|NCT01632020|50243558|FG001|Overall Study|Withdrawal by Subject|0|||
25130316|NCT01632020|50243557|FG000|Overall Study|Adverse Event|1|||
25130317|NCT01632020|50243558|FG001|Overall Study|Adverse Event|0|||
25130318|NCT02181296|50243566|FG000|Overall Study|Lost to Follow-up|7|||
25130319|NCT02181296|50243567|FG001|Overall Study|Lost to Follow-up|6|||
25130320|NCT02215616|50243577|FG000|Overall Study|Sponsor requested to stop study drug|0|||
25130321|NCT02215616|50243578|FG001|Overall Study|Sponsor requested to stop study drug|0|||
25130322|NCT02215616|50243579|FG002|Overall Study|Sponsor requested to stop study drug|1|||
25130323|NCT02215616|50243580|FG003|Overall Study|Sponsor requested to stop study drug|4|||
25130324|NCT02215616|50243577|FG000|Overall Study|Death|1|||
25130325|NCT02215616|50243578|FG001|Overall Study|Death|0|||
25130326|NCT02215616|50243579|FG002|Overall Study|Death|0|||
25130327|NCT02215616|50243580|FG003|Overall Study|Death|0|||
25130328|NCT02215616|50243577|FG000|Overall Study|Adverse Event|7|||
25130329|NCT02215616|50243578|FG001|Overall Study|Adverse Event|4|||
25130330|NCT02215616|50243579|FG002|Overall Study|Adverse Event|9|||
25130331|NCT02215616|50243580|FG003|Overall Study|Adverse Event|2|||
25130332|NCT02215616|50243577|FG000|Overall Study|Withdrawal by Subject|1|||
25130333|NCT02215616|50243578|FG001|Overall Study|Withdrawal by Subject|8|||
25130334|NCT02215616|50243579|FG002|Overall Study|Withdrawal by Subject|2|||
25130335|NCT02215616|50243580|FG003|Overall Study|Withdrawal by Subject|5|||
25130336|NCT02215616|50243577|FG000|Overall Study|Non-compliance|0|||
25130337|NCT02215616|50243578|FG001|Overall Study|Non-compliance|2|||
25130338|NCT02215616|50243579|FG002|Overall Study|Non-compliance|1|||
25130339|NCT02215616|50243580|FG003|Overall Study|Non-compliance|0|||
25130340|NCT02215616|50243577|FG000|Overall Study|Protocol Violation|0|||
25130341|NCT02215616|50243578|FG001|Overall Study|Protocol Violation|2|||
25130342|NCT02215616|50243579|FG002|Overall Study|Protocol Violation|0|||
25130343|NCT02215616|50243580|FG003|Overall Study|Protocol Violation|0|||
25130344|NCT02215616|50243577|FG000|Overall Study|Lost to Follow-up|1|||
25130345|NCT02215616|50243578|FG001|Overall Study|Lost to Follow-up|1|||
25130346|NCT02215616|50243579|FG002|Overall Study|Lost to Follow-up|0|||
25130347|NCT02215616|50243580|FG003|Overall Study|Lost to Follow-up|1|||
25130348|NCT02215616|50243577|FG000|Overall Study|Other than specified|1|||
25130349|NCT02215616|50243578|FG001|Overall Study|Other than specified|0|||
25130350|NCT02215616|50243579|FG002|Overall Study|Other than specified|1|||
25130351|NCT02215616|50243580|FG003|Overall Study|Other than specified|1|||
25130352|NCT02213666|50243590|FG000|Overall Study|Withdrawal by Subject|1|||
25130353|NCT02213510|50243596|FG000|Overall Study|Death|0|||
25130354|NCT02213510|50243597|FG001|Overall Study|Death|1|||
25130355|NCT02213510|50243596|FG000|Overall Study|Lost to Follow-up|1|||
25130356|NCT02213510|50243597|FG001|Overall Study|Lost to Follow-up|0|||
25130357|NCT02158442|50243605|FG000|Overall Study|Withdrawal by Subject|1|||
25130358|NCT02158442|50243606|FG001|Overall Study|Withdrawal by Subject|0|||
25130359|NCT02158442|50243605|FG000|Overall Study|Perfusion staff not available|1|||
25130360|NCT02158442|50243606|FG001|Overall Study|Perfusion staff not available|0|||
25130361|NCT02158364|50243612|FG000|Overall Study|Case report forms uncollected|10|||
25130362|NCT02158364|50243612|FG000|Overall Study|Protocol Deviation|50|||
25130363|NCT02180672|50243618|FG000|Overall Study|Lost to Follow-up|5|||
25130364|NCT02180672|50243619|FG001|Overall Study|Lost to Follow-up|7|||
25130365|NCT02213198|50243627|FG000|Baseline|No show for intake|7|||
25130366|NCT02213198|50243628|FG001|Baseline|No show for intake|9|||
25130367|NCT02213198|50243627|FG000|Baseline|Withdrawal by Subject|34|||
25130368|NCT02213198|50243628|FG001|Baseline|Withdrawal by Subject|11|||
25130369|NCT02213198|50243627|FG000|Baseline|transferred out of clinic|7|||
25130370|NCT02213198|50243628|FG001|Baseline|transferred out of clinic|9|||
25130371|NCT02213198|50243627|FG000|Baseline|Lost to Follow-up|40|||
25130372|NCT02213198|50243628|FG001|Baseline|Lost to Follow-up|21|||
25130373|NCT02213198|50243627|FG000|Baseline|incarcerated,violent|0|||
25130374|NCT02213198|50243628|FG001|Baseline|incarcerated,violent|1|||
25130375|NCT02213198|50243627|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
25130376|NCT02213198|50243628|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
25130377|NCT02213198|50243627|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
25130378|NCT02213198|50243628|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
25130379|NCT02213198|50243627|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
25130380|NCT02213198|50243628|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
25130381|NCT02213198|50243627|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
25130382|NCT02213198|50243628|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
25130383|NCT02213198|50243627|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
25130384|NCT02213198|50243628|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
25130385|NCT02213198|50243627|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
25130386|NCT02213198|50243628|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
25130387|NCT02157506|50243639|FG000|Overall Study|Adverse Event|0|||
25130388|NCT02157506|50243640|FG001|Overall Study|Adverse Event|1|||
25130389|NCT02157506|50243641|FG002|Overall Study|Adverse Event|0|||
25130390|NCT02157506|50243642|FG003|Overall Study|Adverse Event|0|||
25130391|NCT02157506|50243643|FG004|Overall Study|Adverse Event|0|||
25130392|NCT02157506|50243639|FG000|Overall Study|Lost to Follow-up|0|||
25130393|NCT02157506|50243640|FG001|Overall Study|Lost to Follow-up|0|||
25130394|NCT02157506|50243641|FG002|Overall Study|Lost to Follow-up|1|||
25130395|NCT02157506|50243642|FG003|Overall Study|Lost to Follow-up|0|||
25130396|NCT02157506|50243643|FG004|Overall Study|Lost to Follow-up|0|||
25130397|NCT01920711|50243657|FG000|Overall Study|Death|347|||
25130398|NCT01920711|50243658|FG001|Overall Study|Death|356|||
25130399|NCT01920711|50243657|FG000|Overall Study|Lost to Follow-up|13|||
25130400|NCT01920711|50243658|FG001|Overall Study|Lost to Follow-up|14|||
25272589|NCT00996892|50586615|FG004|Expansion Stage 2A|Physician Decision|0|||
25272590|NCT00996892|50586616|FG005|Expansion Stage 2A|Physician Decision|0|||
25272591|NCT00996892|50586617|FG006|Expansion Stage 2A|Physician Decision|0|||
25272592|NCT00996892|50586618|FG007|Expansion Stage 2A|Physician Decision|0|||
25272593|NCT00996892|50586619|FG008|Expansion Stage 2A|Physician Decision|0|||
25272594|NCT00996892|50586620|FG009|Expansion Stage 2A|Physician Decision|0|||
25272595|NCT00996892|50586621|FG010|Expansion Stage 2A|Physician Decision|0|||
25130401|NCT01920711|50243657|FG000|Overall Study|Withdrawal by Subject|4|||
25130402|NCT01920711|50243658|FG001|Overall Study|Withdrawal by Subject|3|||
25130403|NCT02180438|50243665|FG000|Overall Study|Lost to Follow-up|1|||
25130404|NCT02179190|50243669|FG000|Enrollment|Exit Prior to Device Attempt|11|||
25130405|NCT02179190|50243669|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
25130406|NCT02179190|50243669|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
25130407|NCT02179190|50243669|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
25130408|NCT02179190|50243669|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
25130409|NCT02179190|50243669|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
25130410|NCT02157116|50243673|FG000|Overall Study|Withdrawal by Subject|4|||
25130411|NCT02157116|50243673|FG000|Overall Study|Physician Decision|3|||
25130412|NCT02157116|50243673|FG000|Overall Study|Failed Screening|2|||
25130413|NCT01920555|50243682|FG000|Overall Study|Physician Decision|1|||
25130414|NCT01920555|50243683|FG001|Overall Study|Physician Decision|2|||
25130415|NCT01920555|50243684|FG002|Overall Study|Physician Decision|1|||
25272596|NCT00996892|50586622|FG011|Expansion Stage 2A|Physician Decision|0|||
25272597|NCT00996892|50586623|FG012|Expansion Stage 2A|Physician Decision|0|||
25130416|NCT01920555|50243685|FG003|Overall Study|Physician Decision|2|||
25130417|NCT01920555|50243686|FG004|Overall Study|Physician Decision|0|||
25130418|NCT01920555|50243682|FG000|Overall Study|Lack of Efficacy|2|||
25130419|NCT01920555|50243683|FG001|Overall Study|Lack of Efficacy|0|||
25130420|NCT01920555|50243684|FG002|Overall Study|Lack of Efficacy|0|||
25130421|NCT01920555|50243685|FG003|Overall Study|Lack of Efficacy|0|||
25130422|NCT01920555|50243686|FG004|Overall Study|Lack of Efficacy|0|||
25130423|NCT01920555|50243682|FG000|Overall Study|Travel Difficulties|1|||
25130424|NCT01920555|50243683|FG001|Overall Study|Travel Difficulties|1|||
25130425|NCT01920555|50243684|FG002|Overall Study|Travel Difficulties|0|||
25130426|NCT01920555|50243685|FG003|Overall Study|Travel Difficulties|0|||
25130427|NCT01920555|50243686|FG004|Overall Study|Travel Difficulties|1|||
25130428|NCT01920555|50243682|FG000|Overall Study|Lost to Follow-up|0|||
25130429|NCT01920555|50243683|FG001|Overall Study|Lost to Follow-up|1|||
25130430|NCT01920555|50243684|FG002|Overall Study|Lost to Follow-up|0|||
25130431|NCT01920555|50243685|FG003|Overall Study|Lost to Follow-up|1|||
25130432|NCT01920555|50243686|FG004|Overall Study|Lost to Follow-up|0|||
25130433|NCT02156804|50243698|FG000|Overall Study|Withdrawal by Subject|1|||
25130434|NCT02156492|50243705|FG000|Period 1|No Reason Given|0|||
25130435|NCT02156492|50243706|FG001|Period 1|No Reason Given|1|||
25130436|NCT02156492|50243707|FG002|Period 1|No Reason Given|0|||
25130437|NCT02156492|50243705|FG000|Period 3|Adverse Event|0|||
25130438|NCT02156492|50243706|FG001|Period 3|Adverse Event|1|||
25130439|NCT02156492|50243707|FG002|Period 3|Adverse Event|0|||
25130440|NCT01920477|50243727|FG000|Overall Study|Adverse Event|0|||
25130441|NCT01920477|50243728|FG001|Overall Study|Adverse Event|1|||
25130442|NCT01920477|50243727|FG000|Overall Study|Lack of Efficacy|1|||
25130443|NCT01920477|50243728|FG001|Overall Study|Lack of Efficacy|0|||
25130444|NCT01920477|50243727|FG000|Overall Study|Study closed/terminated|14|||
25130445|NCT01920477|50243728|FG001|Overall Study|Study closed/terminated|15|||
25272598|NCT00996892|50586624|FG013|Expansion Stage 2A|Physician Decision|0|||
25272599|NCT00996892|50586625|FG014|Expansion Stage 2A|Physician Decision|0|||
25272600|NCT00996892|50586626|FG015|Expansion Stage 2A|Physician Decision|0|||
25272601|NCT00996892|50586627|FG016|Expansion Stage 2A|Physician Decision|0|||
25272602|NCT00996892|50586628|FG017|Expansion Stage 2A|Physician Decision|0|||
25272603|NCT00996892|50586629|FG018|Expansion Stage 2A|Physician Decision|0|||
25272604|NCT00996892|50586630|FG019|Expansion Stage 2A|Physician Decision|2|||
25272605|NCT00996892|50586611|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
25272606|NCT00996892|50586612|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
25272607|NCT00996892|50586613|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
25272608|NCT00996892|50586614|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
25272609|NCT00996892|50586615|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
25272610|NCT00996892|50586616|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
25272611|NCT00996892|50586617|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
25272612|NCT00996892|50586618|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
25272613|NCT00996892|50586619|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
25272614|NCT00996892|50586620|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
25272615|NCT00996892|50586621|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
25272616|NCT00996892|50586622|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
25272617|NCT00996892|50586623|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
25272618|NCT00996892|50586624|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
25272619|NCT00996892|50586625|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
25272620|NCT00996892|50586626|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
25272621|NCT00996892|50586627|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
25272622|NCT00996892|50586628|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
25272623|NCT00996892|50586629|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
25272624|NCT00996892|50586630|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
25272625|NCT00996892|50586611|FG000|Expansion Stage 2A|Disease Progression|0|||
25272626|NCT00996892|50586612|FG001|Expansion Stage 2A|Disease Progression|0|||
25272627|NCT00996892|50586613|FG002|Expansion Stage 2A|Disease Progression|0|||
25130446|NCT01920477|50243727|FG000|Overall Study|Withdrawal by Subject|0|||
25130447|NCT01920477|50243728|FG001|Overall Study|Withdrawal by Subject|1|||
25130448|NCT02213042|50243737|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
25130449|NCT02213042|50243738|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
25272628|NCT00996892|50586614|FG003|Expansion Stage 2A|Disease Progression|0|||
25130450|NCT02213042|50243739|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
25130451|NCT02213042|50243737|FG000|Overall Study|Adverse Event|2|||
25130452|NCT02213042|50243738|FG001|Overall Study|Adverse Event|1|||
25130453|NCT02213042|50243739|FG002|Overall Study|Adverse Event|0|||
25130454|NCT02213042|50243737|FG000|Overall Study|Withdrawal by Subject|0|||
25178628|NCT01479985|50323969|FG001|Overall Study|No decisional conflict scale responses|2|||
25178629|NCT01479985|50323968|FG000|Overall Study|No post-visit survey|5|||
25272629|NCT00996892|50586615|FG004|Expansion Stage 2A|Disease Progression|0|||
25272630|NCT00996892|50586616|FG005|Expansion Stage 2A|Disease Progression|0|||
25272631|NCT00996892|50586617|FG006|Expansion Stage 2A|Disease Progression|0|||
25272632|NCT00996892|50586618|FG007|Expansion Stage 2A|Disease Progression|0|||
25272633|NCT00996892|50586619|FG008|Expansion Stage 2A|Disease Progression|0|||
25130455|NCT02213042|50243738|FG001|Overall Study|Withdrawal by Subject|1|||
25130456|NCT02213042|50243739|FG002|Overall Study|Withdrawal by Subject|1|||
25130457|NCT02213042|50243737|FG000|Overall Study|Protocol Violation|1|||
25130458|NCT02213042|50243738|FG001|Overall Study|Protocol Violation|0|||
25130459|NCT02213042|50243739|FG002|Overall Study|Protocol Violation|0|||
25130460|NCT02213042|50243737|FG000|Overall Study|Investigator discretion|0|||
25272634|NCT00996892|50586620|FG009|Expansion Stage 2A|Disease Progression|0|||
25272635|NCT00996892|50586621|FG010|Expansion Stage 2A|Disease Progression|0|||
25272636|NCT00996892|50586622|FG011|Expansion Stage 2A|Disease Progression|0|||
25272637|NCT00996892|50586623|FG012|Expansion Stage 2A|Disease Progression|0|||
25272638|NCT00996892|50586624|FG013|Expansion Stage 2A|Disease Progression|0|||
25272639|NCT00996892|50586625|FG014|Expansion Stage 2A|Disease Progression|0|||
25272640|NCT00996892|50586626|FG015|Expansion Stage 2A|Disease Progression|0|||
25272641|NCT00996892|50586627|FG016|Expansion Stage 2A|Disease Progression|0|||
25272642|NCT00996892|50586628|FG017|Expansion Stage 2A|Disease Progression|0|||
25272643|NCT00996892|50586629|FG018|Expansion Stage 2A|Disease Progression|0|||
25272644|NCT00996892|50586630|FG019|Expansion Stage 2A|Disease Progression|31|||
25272645|NCT01257581|50586694|FG000|Overall Study|Early Termination|3|||
25272646|NCT01257581|50586695|FG001|Overall Study|Early Termination|1|||
25272647|NCT01257581|50586696|FG002|Overall Study|Early Termination|2|||
25272648|NCT01257581|50586694|FG000|Overall Study|Death|2|||
25272649|NCT01257581|50586695|FG001|Overall Study|Death|2|||
25272650|NCT01257581|50586696|FG002|Overall Study|Death|4|||
25272651|NCT01257503|50586706|FG000|Overall Study|Lost to Follow-up|7|||
25272652|NCT01257503|50586707|FG001|Overall Study|Lost to Follow-up|10|||
25272653|NCT01257503|50586706|FG000|Overall Study|Over 5 years old at enrollment|0|||
25272654|NCT01257503|50586707|FG001|Overall Study|Over 5 years old at enrollment|1|||
25272655|NCT01257503|50586706|FG000|Overall Study|strep culture positive at enrollment|1|||
25272656|NCT01257503|50586707|FG001|Overall Study|strep culture positive at enrollment|0|||
25272657|NCT00995566|50586713|FG000|Overall Study|Adverse Event|2|||
25272658|NCT00995566|50586713|FG000|Overall Study|Early study termination|52|||
25272659|NCT01257425|50586719|FG000|Overall Study|Lack of Efficacy|3|||
25272660|NCT01257425|50586720|FG001|Overall Study|Lack of Efficacy|3|||
25272661|NCT01257425|50586719|FG000|Overall Study|Adverse Event|1|||
25272662|NCT01257425|50586720|FG001|Overall Study|Adverse Event|1|||
25272663|NCT01257425|50586719|FG000|Overall Study|Protocol Violation|1|||
25272664|NCT01257425|50586720|FG001|Overall Study|Protocol Violation|1|||
25272665|NCT01257425|50586719|FG000|Overall Study|Withdrawal by Subject|0|||
25272666|NCT01257425|50586720|FG001|Overall Study|Withdrawal by Subject|1|||
25272667|NCT01257425|50586719|FG000|Overall Study|Death|1|||
25272668|NCT01257425|50586720|FG001|Overall Study|Death|0|||
25272669|NCT00995488|50586726|FG000|Overall Study|Withdrawal by Subject|1|||
25272670|NCT01256879|50586730|FG000|Overall Study|Withdrawal by Subject|1|||
25272671|NCT01125189|50586743|FG000|Treatment Period|Lack of Efficacy|15|||
25272672|NCT01125189|50586744|FG001|Treatment Period|Lack of Efficacy|18|||
25272673|NCT01125189|50586745|FG002|Treatment Period|Lack of Efficacy|25|||
25272674|NCT01125189|50586743|FG000|Treatment Period|Adverse Event|7|||
25272675|NCT01125189|50586744|FG001|Treatment Period|Adverse Event|8|||
25272676|NCT01125189|50586745|FG002|Treatment Period|Adverse Event|8|||
25272677|NCT01125189|50586743|FG000|Treatment Period|Withdrawal by Subject|3|||
25272678|NCT01125189|50586744|FG001|Treatment Period|Withdrawal by Subject|1|||
25272679|NCT01125189|50586745|FG002|Treatment Period|Withdrawal by Subject|1|||
25272680|NCT01125189|50586743|FG000|Treatment Period|Death|1|||
25272681|NCT01125189|50586744|FG001|Treatment Period|Death|0|||
25272682|NCT01125189|50586745|FG002|Treatment Period|Death|0|||
25272683|NCT01125189|50586743|FG000|Treatment Period|Lost to Follow-up|1|||
25272684|NCT01125189|50586744|FG001|Treatment Period|Lost to Follow-up|2|||
25130461|NCT02213042|50243738|FG001|Overall Study|Investigator discretion|0|||
25130462|NCT02213042|50243739|FG002|Overall Study|Investigator discretion|1|||
25130463|NCT02212730|50243751|FG000|Overall Study|Tumor not of the required cell histology|1|||
25130464|NCT02212730|50243752|FG001|Overall Study|Tumor not of the required cell histology|0|||
25130465|NCT02212730|50243751|FG000|Overall Study|Withdrawal by Subject|1|||
25130466|NCT02212730|50243752|FG001|Overall Study|Withdrawal by Subject|0|||
25130467|NCT02212730|50243751|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
25130468|NCT02212730|50243752|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
25130469|NCT02178956|50243762|FG000|Overall Study|Lost to Follow-up|4|||
25272685|NCT01125189|50586745|FG002|Treatment Period|Lost to Follow-up|1|||
25272686|NCT01125189|50586743|FG000|Treatment Period|Poor compliance/noncompliance|0|||
25272687|NCT01125189|50586744|FG001|Treatment Period|Poor compliance/noncompliance|1|||
25272688|NCT01125189|50586745|FG002|Treatment Period|Poor compliance/noncompliance|0|||
25272689|NCT01125189|50586743|FG000|Treatment Period|Participants requested to discontinue|1|||
25272690|NCT01125189|50586744|FG001|Treatment Period|Participants requested to discontinue|3|||
25272691|NCT01125189|50586745|FG002|Treatment Period|Participants requested to discontinue|4|||
25272692|NCT01125189|50586743|FG000|Treatment Period|Other reasons|1|||
25272693|NCT01125189|50586744|FG001|Treatment Period|Other reasons|1|||
25272694|NCT01125189|50586745|FG002|Treatment Period|Other reasons|0|||
25130470|NCT02178956|50243763|FG001|Overall Study|Lost to Follow-up|4|||
25130471|NCT02178956|50243762|FG000|Overall Study|Sponsor terminated study|49|||
25130472|NCT02178956|50243763|FG001|Overall Study|Sponsor terminated study|58|||
25130473|NCT02178956|50243762|FG000|Overall Study|Withdrawal by Subject|15|||
25130474|NCT02178956|50243763|FG001|Overall Study|Withdrawal by Subject|11|||
25130475|NCT02178956|50243762|FG000|Overall Study|Various Reasons|3|||
25130476|NCT02178956|50243763|FG001|Overall Study|Various Reasons|5|||
25130477|NCT02211638|50243773|FG000|Overall Study|Case Report Forms Uncollected|291|||
25130478|NCT02211638|50243773|FG000|Overall Study|Protocol Violation|692|||
25130479|NCT02178566|50243779|FG000|Overall Study|patient did not complete due to noncompliance|0|||
25130480|NCT02178566|50243780|FG001|Overall Study|patient did not complete due to noncompliance|1|||
25130481|NCT02211014|50243788|FG000|Overall Study|Adverse Event|0|||
25130482|NCT02211014|50243789|FG001|Overall Study|Adverse Event|2|||
25130483|NCT02211014|50243788|FG000|Overall Study|Physician Decision|1|||
25130484|NCT02211014|50243789|FG001|Overall Study|Physician Decision|2|||
25130485|NCT02211014|50243788|FG000|Overall Study|Started another cancer therapy|1|||
25130486|NCT02211014|50243789|FG001|Overall Study|Started another cancer therapy|0|||
25130487|NCT02211014|50243788|FG000|Overall Study|Withdrawal by Subject|0|||
25130488|NCT02211014|50243789|FG001|Overall Study|Withdrawal by Subject|1|||
25130489|NCT02211014|50243788|FG000|Overall Study|In agreement with patient, no benefit|0|||
25130490|NCT02211014|50243789|FG001|Overall Study|In agreement with patient, no benefit|1|||
25130491|NCT01631864|50243813|FG000|Overall Study|Withdrawal by Subject|0|||
25130492|NCT01631864|50243814|FG001|Overall Study|Withdrawal by Subject|1|||
25130493|NCT01631864|50243813|FG000|Overall Study|Adverse Event|2|||
25130494|NCT01631864|50243814|FG001|Overall Study|Adverse Event|3|||
25130495|NCT02210780|50243822|FG000|Overall Study|Adverse Event|0|||
25130496|NCT02210780|50243823|FG001|Overall Study|Adverse Event|5|||
25130497|NCT02210780|50243822|FG000|Overall Study|Lost to Follow-up|2|||
25130498|NCT02210780|50243823|FG001|Overall Study|Lost to Follow-up|1|||
25130499|NCT02210780|50243822|FG000|Overall Study|Withdrawal by Subject|1|||
25130500|NCT02210780|50243823|FG001|Overall Study|Withdrawal by Subject|1|||
25130501|NCT02210780|50243822|FG000|Overall Study|Physician Decision|1|||
25130502|NCT02210780|50243823|FG001|Overall Study|Physician Decision|0|||
25130503|NCT02210780|50243822|FG000|Overall Study|Protocol Violation|1|||
25130504|NCT02210780|50243823|FG001|Overall Study|Protocol Violation|0|||
25130505|NCT02210780|50243822|FG000|Overall Study|Other than specified above|0|||
25130506|NCT02210780|50243823|FG001|Overall Study|Other than specified above|1|||
25130507|NCT01557244|50243834|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
25130508|NCT01557244|50243835|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
25130509|NCT01557244|50243836|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
25130510|NCT01557244|50243837|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
25130511|NCT01557244|50243838|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
25130512|NCT01557244|50243839|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
25130513|NCT01557244|50243840|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
25130514|NCT01557244|50243834|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
25130515|NCT01557244|50243835|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
25130516|NCT01557244|50243836|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
25130517|NCT01557244|50243837|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
25130518|NCT01557244|50243838|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
25130519|NCT01557244|50243839|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
25130520|NCT01557244|50243840|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
25130521|NCT01557244|50243834|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
25130522|NCT01557244|50243835|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
25130523|NCT01557244|50243836|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
25130524|NCT01557244|50243837|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
25130525|NCT01557244|50243838|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
25130526|NCT01557244|50243839|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
25130527|NCT01557244|50243840|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
25130528|NCT01557244|50243834|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
25130529|NCT01557244|50243835|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
25130530|NCT01557244|50243836|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
25130531|NCT01557244|50243837|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
25130532|NCT01557244|50243838|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
25130533|NCT01557244|50243839|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
25130534|NCT01557244|50243840|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
25178630|NCT01479985|50323969|FG001|Overall Study|No post-visit survey|3|||
25130535|NCT01557244|50243834|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
25130536|NCT01557244|50243835|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
25178631|NCT01462435|50323983|FG000|Overall Study|Lack of Efficacy|1|||
25130537|NCT01557244|50243836|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
25130538|NCT01557244|50243837|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
25130539|NCT01557244|50243838|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
25130540|NCT01557244|50243839|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
25130541|NCT01557244|50243840|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
25130542|NCT01557244|50243834|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
25130543|NCT01557244|50243835|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
25130544|NCT01557244|50243836|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
25130545|NCT01557244|50243837|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
25178632|NCT01462435|50323984|FG001|Overall Study|Lack of Efficacy|0|||
25272695|NCT01125189|50586743|FG000|Treatment Period|Completed 24 week treatment period only|2|||
25272696|NCT01125189|50586744|FG001|Treatment Period|Completed 24 week treatment period only|1|||
25272697|NCT01125189|50586745|FG002|Treatment Period|Completed 24 week treatment period only|2|||
25272698|NCT01125189|50586743|FG000|Follow up Period|Withdrawal by Subject|3|||
25272699|NCT01125189|50586744|FG001|Follow up Period|Withdrawal by Subject|2|||
25272700|NCT01125189|50586745|FG002|Follow up Period|Withdrawal by Subject|5|||
25272701|NCT01125189|50586743|FG000|Follow up Period|Death|1|||
25272702|NCT01125189|50586744|FG001|Follow up Period|Death|0|||
25272703|NCT01125189|50586745|FG002|Follow up Period|Death|0|||
25272704|NCT01125189|50586743|FG000|Follow up Period|Lost to Follow-up|12|||
25272705|NCT01125189|50586744|FG001|Follow up Period|Lost to Follow-up|9|||
25272706|NCT01125189|50586745|FG002|Follow up Period|Lost to Follow-up|6|||
25272707|NCT01125189|50586743|FG000|Follow up Period|Other reasons|4|||
25272708|NCT01125189|50586744|FG001|Follow up Period|Other reasons|4|||
25272709|NCT01125189|50586745|FG002|Follow up Period|Other reasons|5|||
25272710|NCT01256567|50586756|FG000|Overall Study|Withdrawal by Subject|1|||
25272711|NCT00996736|50586763|FG000|Overall Study|Death|1|||
25272712|NCT00996736|50586764|FG001|Overall Study|Death|1|||
25272713|NCT00996736|50586763|FG000|Overall Study|Lost to Follow-up|15|||
25272714|NCT00996736|50586764|FG001|Overall Study|Lost to Follow-up|14|||
25272715|NCT00996736|50586763|FG000|Overall Study|Visit not within 3-month window|5|||
25272716|NCT00996736|50586764|FG001|Overall Study|Visit not within 3-month window|3|||
25272717|NCT00996658|50586772|FG000|Overall Study|Adverse Event|2|||
25272718|NCT00996658|50586773|FG001|Overall Study|Adverse Event|5|||
25272719|NCT00996658|50586772|FG000|Overall Study|Protocol Violation|0|||
25272720|NCT00996658|50586773|FG001|Overall Study|Protocol Violation|1|||
25272721|NCT00996658|50586772|FG000|Overall Study|Lost to Follow-up|2|||
25272722|NCT00996658|50586773|FG001|Overall Study|Lost to Follow-up|5|||
25272723|NCT00996658|50586772|FG000|Overall Study|Non-compliance issues|3|||
25272724|NCT00996658|50586773|FG001|Overall Study|Non-compliance issues|3|||
25272725|NCT00996658|50586772|FG000|Overall Study|Other|9|||
25272726|NCT00996658|50586773|FG001|Overall Study|Other|7|||
25272727|NCT01124643|50586779|FG000|Overall Study|Death|1|||
25272728|NCT01256411|50586787|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
25272729|NCT01256411|50586788|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
25272730|NCT01256411|50586789|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
25272731|NCT01256411|50586790|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
25272732|NCT01256411|50586791|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
25272733|NCT01256411|50586792|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
25272734|NCT01256411|50586787|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
25272735|NCT01256411|50586788|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
25272736|NCT01256411|50586789|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
25272737|NCT01256411|50586790|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
25272738|NCT01256411|50586791|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
25272739|NCT01256411|50586792|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
25272740|NCT01256411|50586787|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
25272741|NCT01256411|50586788|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
25272742|NCT01256411|50586789|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
25272743|NCT01256411|50586790|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
25272744|NCT01256411|50586791|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
25272745|NCT01256411|50586792|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
25272746|NCT01256411|50586787|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
25272747|NCT01256411|50586788|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
25272748|NCT01256411|50586789|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
25272749|NCT01256411|50586790|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
25272750|NCT01256411|50586791|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
25178633|NCT01462435|50323985|FG002|Overall Study|Lack of Efficacy|0|||
25272751|NCT01256411|50586792|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
25272752|NCT01256411|50586787|FG000|Extension by Maximum Treatment|Adverse Event|4|||
25272753|NCT01256411|50586788|FG001|Extension by Maximum Treatment|Adverse Event|2|||
24907542|NCT00623805|50001588|FG000|Overall Study|Lost to Follow-up|2|||
25272754|NCT01256411|50586789|FG002|Extension by Maximum Treatment|Adverse Event|1|||
25272755|NCT01256411|50586790|FG003|Extension by Maximum Treatment|Adverse Event|0|||
25272756|NCT01256411|50586791|FG004|Extension by Maximum Treatment|Adverse Event|0|||
25272757|NCT01256411|50586792|FG005|Extension by Maximum Treatment|Adverse Event|0|||
25272758|NCT01256411|50586787|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
25272759|NCT01256411|50586788|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
25272760|NCT01256411|50586789|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
25272761|NCT01256411|50586790|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
25272762|NCT01256411|50586791|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
25272763|NCT01256411|50586792|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
25272764|NCT01256411|50586787|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
25272765|NCT01256411|50586788|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
25272766|NCT01256411|50586789|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
25272767|NCT01256411|50586790|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
25272768|NCT01256411|50586791|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
25272769|NCT01256411|50586792|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
25272770|NCT01256411|50586787|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
25272771|NCT01256411|50586788|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
25272772|NCT01256411|50586789|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
25272773|NCT01256411|50586790|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
25272774|NCT01256411|50586791|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
25272775|NCT01256411|50586792|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
25272776|NCT01256411|50586787|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
25272777|NCT01256411|50586788|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
25272778|NCT01256411|50586789|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
25272779|NCT01256411|50586790|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
25272780|NCT01256411|50586791|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
25272781|NCT01256411|50586792|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
25272782|NCT01256411|50586787|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
25272783|NCT01256411|50586788|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
25272784|NCT01256411|50586789|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
25272785|NCT01256411|50586790|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
25272786|NCT01256411|50586791|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
25272787|NCT01256411|50586792|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
25272788|NCT00996580|50586806|FG000|Overall Study|Adverse Event|466|||
25272789|NCT00996580|50586806|FG000|Overall Study|Lost to Follow-up|480|||
25272790|NCT00996580|50586806|FG000|Overall Study|Noncompliance with the protocol|137|||
25272791|NCT00996580|50586806|FG000|Overall Study|Physician Decision|5|||
25272792|NCT00996580|50586806|FG000|Overall Study|Pregnancy|68|||
25272793|NCT00996580|50586806|FG000|Overall Study|Protocol Violation|16|||
25272794|NCT00996580|50586806|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
25272795|NCT00996580|50586806|FG000|Overall Study|Withdrawal by Subject|217|||
25272796|NCT00996580|50586806|FG000|Overall Study|Other|29|||
25272797|NCT01124175|50586815|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
25272798|NCT01124175|50586816|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
25272799|NCT01256177|50586824|FG000|Overall Study|Withdrawal by Subject|23|||
25272800|NCT01256177|50586825|FG001|Overall Study|Withdrawal by Subject|22|||
25272801|NCT01256177|50586824|FG000|Overall Study|Lost to Follow-up|2|||
25272802|NCT01256177|50586825|FG001|Overall Study|Lost to Follow-up|2|||
25272803|NCT01256177|50586824|FG000|Overall Study|Adverse Event|8|||
25272804|NCT01256177|50586825|FG001|Overall Study|Adverse Event|9|||
25272805|NCT01256177|50586824|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
25272806|NCT01256177|50586825|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
25272807|NCT01256177|50586824|FG000|Overall Study|Condition under Investigation Worsened|1|||
25272808|NCT01256177|50586825|FG001|Overall Study|Condition under Investigation Worsened|0|||
25272809|NCT01256177|50586824|FG000|Overall Study|Lack of Efficacy|11|||
25272810|NCT01256177|50586825|FG001|Overall Study|Lack of Efficacy|2|||
25272811|NCT01256177|50586824|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
25272812|NCT01256177|50586825|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
25272813|NCT00999544|50586831|FG000|Overall Study|Withdrawal by Subject|1|||
25272814|NCT01124097|50586868|FG000|Overall Study|Withdrawal by Subject|4|||
25272815|NCT01124097|50586869|FG001|Overall Study|Withdrawal by Subject|3|||
25272816|NCT01124097|50586870|FG002|Overall Study|Withdrawal by Subject|2|||
25272817|NCT01124097|50586871|FG003|Overall Study|Withdrawal by Subject|3|||
25272818|NCT01124097|50586868|FG000|Overall Study|Lack of Efficacy|2|||
25272819|NCT01124097|50586869|FG001|Overall Study|Lack of Efficacy|3|||
25272820|NCT01124097|50586870|FG002|Overall Study|Lack of Efficacy|1|||
25272821|NCT01124097|50586871|FG003|Overall Study|Lack of Efficacy|3|||
25272822|NCT01124097|50586868|FG000|Overall Study|Adverse Event|24|||
25272823|NCT01124097|50586869|FG001|Overall Study|Adverse Event|15|||
25272824|NCT01124097|50586870|FG002|Overall Study|Adverse Event|15|||
25272825|NCT01124097|50586871|FG003|Overall Study|Adverse Event|7|||
25272826|NCT01124097|50586868|FG000|Overall Study|Protocol Violation|2|||
25272827|NCT01124097|50586869|FG001|Overall Study|Protocol Violation|0|||
25272828|NCT01124097|50586870|FG002|Overall Study|Protocol Violation|2|||
25272829|NCT01124097|50586871|FG003|Overall Study|Protocol Violation|1|||
25272830|NCT01124097|50586868|FG000|Overall Study|Physician Decision|2|||
25272831|NCT01124097|50586869|FG001|Overall Study|Physician Decision|1|||
25272832|NCT01124097|50586870|FG002|Overall Study|Physician Decision|0|||
25272833|NCT01124097|50586871|FG003|Overall Study|Physician Decision|0|||
25272834|NCT01123941|50586883|FG000|Overall Study|Lost to Follow-up|2|||
25272835|NCT01123941|50586884|FG001|Overall Study|Lost to Follow-up|1|||
25272836|NCT01123395|50586890|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
25272837|NCT01123395|50586891|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
25272838|NCT01255787|50586901|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
25272839|NCT01255787|50586902|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
25272840|NCT01255787|50586903|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
25272841|NCT01255787|50586904|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
25272842|NCT01255787|50586901|FG000|Overall Study|Major Protocol Deviation|1|||
25272843|NCT01255787|50586902|FG001|Overall Study|Major Protocol Deviation|1|||
25272844|NCT01255787|50586903|FG002|Overall Study|Major Protocol Deviation|0|||
25272845|NCT01255787|50586904|FG003|Overall Study|Major Protocol Deviation|4|||
25130546|NCT01557244|50243838|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
25130547|NCT01557244|50243839|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
25130548|NCT01557244|50243840|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
25130549|NCT01557244|50243834|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
25130550|NCT01557244|50243835|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
25130551|NCT01557244|50243836|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
25130552|NCT01557244|50243837|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
25130553|NCT01557244|50243838|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
25130554|NCT01557244|50243839|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
25130555|NCT01557244|50243840|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
25130556|NCT01557244|50243834|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
25130557|NCT01557244|50243835|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
25130558|NCT01557244|50243836|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
25130559|NCT01557244|50243837|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
25130560|NCT01557244|50243838|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
25130561|NCT01557244|50243839|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
25130562|NCT01557244|50243840|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
25130563|NCT01557244|50243834|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
25130564|NCT01557244|50243835|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
25130565|NCT01557244|50243836|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
25178634|NCT01462435|50323986|FG003|Overall Study|Lack of Efficacy|3|||
25178635|NCT01462435|50323983|FG000|Overall Study|Physician Decision|0|||
25178636|NCT01462435|50323984|FG001|Overall Study|Physician Decision|0|||
25178637|NCT01462435|50323985|FG002|Overall Study|Physician Decision|1|||
25178638|NCT01462435|50323986|FG003|Overall Study|Physician Decision|0|||
25178639|NCT01462435|50323983|FG000|Overall Study|Withdrawal by Subject|0|||
25178640|NCT01462435|50323984|FG001|Overall Study|Withdrawal by Subject|0|||
25178641|NCT01462435|50323985|FG002|Overall Study|Withdrawal by Subject|0|||
25178642|NCT01462435|50323986|FG003|Overall Study|Withdrawal by Subject|1|||
25178643|NCT01462435|50323983|FG000|Overall Study|Lost to Follow-up|0|||
25178644|NCT01462435|50323984|FG001|Overall Study|Lost to Follow-up|0|||
25178645|NCT01462435|50323985|FG002|Overall Study|Lost to Follow-up|0|||
25178646|NCT01462435|50323986|FG003|Overall Study|Lost to Follow-up|1|||
25178647|NCT01472081|50324002|FG000|Overall Study|Continuing treatment at time of analysis|1|||
25178648|NCT01472081|50324003|FG001|Overall Study|Continuing treatment at time of analysis|4|||
25130566|NCT01557244|50243837|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
25130567|NCT01557244|50243838|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
25130568|NCT01557244|50243839|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
25130569|NCT01557244|50243840|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
25130570|NCT01557244|50243834|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
25130571|NCT01557244|50243835|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
25178649|NCT01472081|50324004|FG002|Overall Study|Continuing treatment at time of analysis|1|||
25272846|NCT01255787|50586901|FG000|Overall Study|Lost to Follow-up|1|||
25272847|NCT01255787|50586902|FG001|Overall Study|Lost to Follow-up|2|||
25272848|NCT01255787|50586903|FG002|Overall Study|Lost to Follow-up|4|||
25272849|NCT01255787|50586904|FG003|Overall Study|Lost to Follow-up|2|||
25178650|NCT01472081|50324005|FG003|Overall Study|Continuing treatment at time of analysis|8|||
25178651|NCT01472081|50324006|FG004|Overall Study|Continuing treatment at time of analysis|9|||
25272850|NCT01255787|50586901|FG000|Overall Study|Withdrawal of Consent|3|||
25130572|NCT01557244|50243836|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
25130573|NCT01557244|50243837|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
25130574|NCT01557244|50243838|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
25130575|NCT01557244|50243839|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
25130576|NCT01557244|50243840|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
25130577|NCT01557244|50243834|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
25130578|NCT01557244|50243835|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
25130579|NCT01557244|50243836|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
25130580|NCT01557244|50243837|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
25130581|NCT01557244|50243838|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
25130582|NCT01557244|50243839|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
25130583|NCT01557244|50243840|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
25130584|NCT01557244|50243834|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
25130585|NCT01557244|50243835|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
25130586|NCT01557244|50243836|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
25130587|NCT01557244|50243837|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
25130588|NCT01557244|50243838|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
25130589|NCT01557244|50243839|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
25130590|NCT01557244|50243840|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
25130591|NCT02155712|50243870|FG000|Primary Objective|Death|3|||
25130592|NCT02155712|50243871|FG001|Primary Objective|Death|0|||
25130593|NCT02155712|50243870|FG000|Primary Objective|Lost to Follow-up|22|||
25130594|NCT02155712|50243871|FG001|Primary Objective|Lost to Follow-up|0|||
25130595|NCT02155712|50243870|FG000|Primary Objective|No 2-Year Forms but not Terminated|13|||
25130596|NCT02155712|50243871|FG001|Primary Objective|No 2-Year Forms but not Terminated|0|||
25130597|NCT02155712|50243870|FG000|Primary Objective|Revision/Removal of Tibial Baseplate|1|||
25130598|NCT02155712|50243871|FG001|Primary Objective|Revision/Removal of Tibial Baseplate|0|||
25130599|NCT02155712|50243870|FG000|Primary Objective|Withdrawal by Subject|21|||
25130600|NCT02155712|50243871|FG001|Primary Objective|Withdrawal by Subject|0|||
25130601|NCT02177942|50243879|FG000|Overall Study|Adverse Event|1|||
25130602|NCT02177942|50243880|FG001|Overall Study|Adverse Event|0|||
25130603|NCT02177942|50243879|FG000|Overall Study|Lost to Follow-up|1|||
25130604|NCT02177942|50243880|FG001|Overall Study|Lost to Follow-up|1|||
25130605|NCT02177942|50243879|FG000|Overall Study|Protocol Violation|4|||
25130606|NCT02177942|50243880|FG001|Overall Study|Protocol Violation|6|||
25130607|NCT02177942|50243879|FG000|Overall Study|Withdrawal by Subject|71|||
25130608|NCT02177942|50243880|FG001|Overall Study|Withdrawal by Subject|81|||
25130609|NCT02155322|50243890|FG000|Overall Study|Adverse Event|1|||
25130610|NCT02155322|50243890|FG000|Overall Study|Physician Decision|1|||
25130611|NCT02155322|50243890|FG000|Overall Study|Relapse/Recurrence|8|||
25130612|NCT02155322|50243890|FG000|Overall Study|Withdrawal by Subject|4|||
25130613|NCT02210000|50243896|FG000|Overall Study|Study Terminated|11|||
25130614|NCT02210000|50243897|FG001|Overall Study|Study Terminated|12|||
25130615|NCT02210000|50243896|FG000|Overall Study|Withdrawal by Subject|7|||
25130616|NCT02210000|50243897|FG001|Overall Study|Withdrawal by Subject|1|||
25130617|NCT02210000|50243896|FG000|Overall Study|Adverse Event|1|||
25130618|NCT02210000|50243897|FG001|Overall Study|Adverse Event|5|||
25130619|NCT02210000|50243896|FG000|Overall Study|Lost to Follow-up|0|||
25130620|NCT02210000|50243897|FG001|Overall Study|Lost to Follow-up|2|||
25130621|NCT02210000|50243896|FG000|Overall Study|Physician Decision|0|||
25130622|NCT02210000|50243897|FG001|Overall Study|Physician Decision|1|||
25130623|NCT01531894|50243903|FG000|Overall Study|Physician Decision|8|||
25130624|NCT01531894|50243903|FG000|Overall Study|Death|1|||
25130625|NCT02209766|50243911|FG000|Overall Study|Withdrawal by Subject|0|||
25130626|NCT02209766|50243912|FG001|Overall Study|Withdrawal by Subject|0|||
25130627|NCT02209766|50243913|FG002|Overall Study|Withdrawal by Subject|0|||
25130628|NCT02209766|50243914|FG003|Overall Study|Withdrawal by Subject|1|||
25130629|NCT02209766|50243915|FG004|Overall Study|Withdrawal by Subject|0|||
25130630|NCT02209454|50243925|FG000|Second Period|Adverse Event|1|||
25130631|NCT02209454|50243926|FG001|Second Period|Adverse Event|0|||
25130632|NCT01571596|50243935|FG000|Overall Study|Adverse Event|2|||
25130633|NCT01571596|50243936|FG001|Overall Study|Adverse Event|0|||
25130634|NCT01571596|50243937|FG002|Overall Study|Adverse Event|0|||
25130635|NCT01571596|50243935|FG000|Overall Study|Study Terminated by the Sponsor|0|||
25130636|NCT01571596|50243936|FG001|Overall Study|Study Terminated by the Sponsor|1|||
25130637|NCT01571596|50243937|FG002|Overall Study|Study Terminated by the Sponsor|1|||
25130638|NCT01557166|50243949|FG000|Overall Study|Adverse Event|20|||
25130639|NCT01557166|50243950|FG001|Overall Study|Adverse Event|6|||
25130640|NCT01557166|50243949|FG000|Overall Study|Lack of Efficacy|2|||
25130641|NCT01557166|50243950|FG001|Overall Study|Lack of Efficacy|1|||
25130642|NCT01557166|50243949|FG000|Overall Study|Protocol Violation|8|||
25272851|NCT01255787|50586902|FG001|Overall Study|Withdrawal of Consent|9|||
25130643|NCT01557166|50243950|FG001|Overall Study|Protocol Violation|5|||
25130644|NCT01557166|50243949|FG000|Overall Study|Withdrawn consent|12|||
25130645|NCT01557166|50243950|FG001|Overall Study|Withdrawn consent|20|||
25130646|NCT01557166|50243949|FG000|Overall Study|Target dose not tolerated|1|||
25130647|NCT01557166|50243950|FG001|Overall Study|Target dose not tolerated|0|||
25130648|NCT01557166|50243949|FG000|Overall Study|Psychiatric disorder|1|||
25130649|NCT01557166|50243950|FG001|Overall Study|Psychiatric disorder|0|||
25130650|NCT01557166|50243949|FG000|Overall Study|Unclassified|2|||
25130651|NCT01557166|50243950|FG001|Overall Study|Unclassified|5|||
25130652|NCT01556932|50243956|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
25178652|NCT01472081|50324007|FG005|Overall Study|Continuing treatment at time of analysis|0|||
25178653|NCT01472081|50324002|FG000|Overall Study|Disease Progression|4|||
25178654|NCT01472081|50324003|FG001|Overall Study|Disease Progression|10|||
25178655|NCT01472081|50324004|FG002|Overall Study|Disease Progression|12|||
25178656|NCT01472081|50324005|FG003|Overall Study|Disease Progression|31|||
25178657|NCT01472081|50324006|FG004|Overall Study|Disease Progression|22|||
25130653|NCT01556932|50243957|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
25130654|NCT02177786|50243966|FG000|Overall Study|Withdrew Consent|2|||
25130655|NCT02177786|50243967|FG001|Overall Study|Withdrew Consent|6|||
25130656|NCT02177786|50243968|FG002|Overall Study|Withdrew Consent|9|||
25130657|NCT02177786|50243969|FG003|Overall Study|Withdrew Consent|5|||
25130658|NCT02177786|50243966|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
25130659|NCT02177786|50243967|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
25130660|NCT02177786|50243968|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
25130661|NCT02177786|50243969|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
25130662|NCT02177786|50243966|FG000|Overall Study|Adverse Event|1|||
25130663|NCT02177786|50243967|FG001|Overall Study|Adverse Event|1|||
25130664|NCT02177786|50243968|FG002|Overall Study|Adverse Event|2|||
25130665|NCT02177786|50243969|FG003|Overall Study|Adverse Event|3|||
25130666|NCT02177786|50243966|FG000|Overall Study|Death|1|||
25130667|NCT02177786|50243967|FG001|Overall Study|Death|1|||
25130668|NCT02177786|50243968|FG002|Overall Study|Death|1|||
25130669|NCT02177786|50243969|FG003|Overall Study|Death|1|||
25130670|NCT02177786|50243966|FG000|Overall Study|Lost to Follow-up|0|||
25130671|NCT02177786|50243967|FG001|Overall Study|Lost to Follow-up|0|||
25130672|NCT02177786|50243968|FG002|Overall Study|Lost to Follow-up|2|||
25130673|NCT02177786|50243969|FG003|Overall Study|Lost to Follow-up|2|||
25130674|NCT02177786|50243966|FG000|Overall Study|Non-Compliance with Study Drug|0|||
25130675|NCT02177786|50243967|FG001|Overall Study|Non-Compliance with Study Drug|1|||
25130676|NCT02177786|50243968|FG002|Overall Study|Non-Compliance with Study Drug|0|||
25130677|NCT02177786|50243969|FG003|Overall Study|Non-Compliance with Study Drug|1|||
25130678|NCT02177786|50243966|FG000|Overall Study|Protocol Violation|0|||
25130679|NCT02177786|50243967|FG001|Overall Study|Protocol Violation|0|||
25130680|NCT02177786|50243968|FG002|Overall Study|Protocol Violation|2|||
25130681|NCT02177786|50243969|FG003|Overall Study|Protocol Violation|0|||
25130682|NCT02177786|50243966|FG000|Overall Study|Progressive Disease|0|||
25130683|NCT02177786|50243967|FG001|Overall Study|Progressive Disease|1|||
25130684|NCT02177786|50243968|FG002|Overall Study|Progressive Disease|0|||
25130685|NCT02177786|50243969|FG003|Overall Study|Progressive Disease|0|||
25130686|NCT02177786|50243966|FG000|Overall Study|Missing study completion status|0|||
25130687|NCT02177786|50243967|FG001|Overall Study|Missing study completion status|1|||
25130688|NCT02177786|50243968|FG002|Overall Study|Missing study completion status|0|||
25130689|NCT02177786|50243969|FG003|Overall Study|Missing study completion status|0|||
25130690|NCT01555762|50243979|FG000|Overall Study|No information on Bevacizumab intake|11|||
25130691|NCT01555762|50243979|FG000|Overall Study|Missing start date of infusion|8|||
25130692|NCT01555762|50243979|FG000|Overall Study|75 years old or more ticked No|1|||
25130693|NCT01555762|50243979|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
25130694|NCT01555762|50243979|FG000|Overall Study|Death linked to progression of disease|165|||
25130695|NCT01555762|50243979|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
25130696|NCT01555762|50243979|FG000|Overall Study|Investigator's decision|10|||
25130697|NCT01555762|50243979|FG000|Overall Study|Participant not wishing to continue|5|||
25130698|NCT01555762|50243979|FG000|Overall Study|Missing data|1|||
25130699|NCT01555762|50243979|FG000|Overall Study|Death linked to an adverse event|14|||
25130700|NCT02153918|50243983|FG000|Overall Study|Refused further treatment|1|||
25130701|NCT02176928|50243989|FG000|Overall Study|Lost to Follow-up|2|||
25130702|NCT02176928|50243990|FG001|Overall Study|Lost to Follow-up|4|||
25130703|NCT01628510|50243998|FG000|Overall Study|Withdrawal by Subject|0|||
25130704|NCT01628510|50243999|FG001|Overall Study|Withdrawal by Subject|4|||
25130705|NCT01628510|50243998|FG000|Overall Study|Death|3|||
25130706|NCT01628510|50243999|FG001|Overall Study|Death|1|||
25130707|NCT01571362|50244007|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
25130708|NCT01571362|50244008|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
25130709|NCT01571362|50244009|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
25178658|NCT01472081|50324007|FG005|Overall Study|Disease Progression|3|||
25178659|NCT01472081|50324002|FG000|Overall Study|Study drug toxicity|2|||
25130710|NCT01571362|50244007|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
25130711|NCT01571362|50244008|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
25130712|NCT01571362|50244009|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
25130713|NCT01571362|50244007|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
25130714|NCT01571362|50244008|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
25130715|NCT01571362|50244009|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
25130716|NCT01571362|50244007|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
25130717|NCT01571362|50244008|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
25130718|NCT01571362|50244009|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
25130719|NCT01571362|50244007|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
25130720|NCT01571362|50244008|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
25130721|NCT01571362|50244009|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
25130722|NCT01571362|50244007|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
25130723|NCT01571362|50244008|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
25130724|NCT01571362|50244009|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
25130725|NCT01571362|50244007|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
25130726|NCT01571362|50244008|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
25130727|NCT01571362|50244009|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
25130728|NCT01571362|50244007|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
25130729|NCT01571362|50244008|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
25130730|NCT01571362|50244009|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
25130731|NCT01571362|50244007|FG000|Double-Blind Treatment Period|Adverse Event|0|||
25130732|NCT01571362|50244008|FG001|Double-Blind Treatment Period|Adverse Event|9|||
25130733|NCT01571362|50244009|FG002|Double-Blind Treatment Period|Adverse Event|14|||
25130734|NCT01571362|50244007|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
25130735|NCT01571362|50244008|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
25130736|NCT01571362|50244009|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
25130737|NCT01571362|50244007|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
25130738|NCT01571362|50244008|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
25130739|NCT01571362|50244009|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
25130740|NCT01571362|50244007|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
25130741|NCT01571362|50244008|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
25130742|NCT01571362|50244009|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
25130743|NCT01571284|50244017|FG000|Overall Study|Participant's decision|84|||
25130744|NCT01571284|50244017|FG000|Overall Study|Lost to Follow-up|3|||
25130745|NCT01571284|50244017|FG000|Overall Study|Enrolled but not treated|2|||
25130746|NCT01571284|50244017|FG000|Overall Study|Other than specified above|80|||
25130747|NCT02137772|50244023|FG000|Overall Study|Adverse Event|6|||
25130748|NCT02137772|50244024|FG001|Overall Study|Adverse Event|3|||
25130749|NCT02137772|50244023|FG000|Overall Study|Death|71|||
25130750|NCT02137772|50244024|FG001|Overall Study|Death|44|||
25130751|NCT02137772|50244023|FG000|Overall Study|Lost to Follow-up|8|||
25130752|NCT02137772|50244024|FG001|Overall Study|Lost to Follow-up|4|||
25130753|NCT02137772|50244023|FG000|Overall Study|Physician Decision|15|||
25130754|NCT02137772|50244024|FG001|Overall Study|Physician Decision|5|||
25130755|NCT02137772|50244023|FG000|Overall Study|Withdrawal by Subject|28|||
25130756|NCT02137772|50244024|FG001|Overall Study|Withdrawal by Subject|17|||
25130757|NCT02137772|50244023|FG000|Overall Study|Non-compliance with study drug|1|||
25130758|NCT02137772|50244024|FG001|Overall Study|Non-compliance with study drug|0|||
25130759|NCT02137772|50244023|FG000|Overall Study|Not treated|3|||
25130760|NCT02137772|50244024|FG001|Overall Study|Not treated|2|||
25130761|NCT01555138|50244032|FG000|Overall Study|Death|0|||
25130762|NCT01555138|50244033|FG001|Overall Study|Death|1|||
25130763|NCT01555138|50244032|FG000|Overall Study|Lost to Follow-up|1|||
25130764|NCT01555138|50244033|FG001|Overall Study|Lost to Follow-up|0|||
25130765|NCT01555138|50244032|FG000|Overall Study|Abnormal Lab reults|1|||
25130766|NCT01555138|50244033|FG001|Overall Study|Abnormal Lab reults|3|||
25130767|NCT01555138|50244032|FG000|Overall Study|Lack of Efficacy|2|||
25130768|NCT01555138|50244033|FG001|Overall Study|Lack of Efficacy|2|||
25130769|NCT01555138|50244032|FG000|Overall Study|Protocol Violation|5|||
25130770|NCT01555138|50244033|FG001|Overall Study|Protocol Violation|3|||
25130771|NCT01555138|50244032|FG000|Overall Study|Administrative problems|8|||
25130772|NCT01555138|50244033|FG001|Overall Study|Administrative problems|0|||
25130773|NCT01555138|50244032|FG000|Overall Study|Withdrawal by Subject|16|||
25130774|NCT01555138|50244033|FG001|Overall Study|Withdrawal by Subject|15|||
25130775|NCT01555138|50244032|FG000|Overall Study|Adverse Event|14|||
25130776|NCT01555138|50244033|FG001|Overall Study|Adverse Event|14|||
25130777|NCT02137226|50244041|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
25272852|NCT01255787|50586903|FG002|Overall Study|Withdrawal of Consent|3|||
25272853|NCT01255787|50586904|FG003|Overall Study|Withdrawal of Consent|4|||
25130778|NCT02137226|50244042|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
25130779|NCT02137226|50244043|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
25130780|NCT02137226|50244044|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
25130781|NCT02137226|50244045|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
25130782|NCT02137226|50244041|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
25130783|NCT02137226|50244042|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
25130784|NCT02137226|50244043|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
25130785|NCT02137226|50244044|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
25130786|NCT02137226|50244045|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
25130787|NCT02137226|50244041|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
25130788|NCT02137226|50244042|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
25130789|NCT02137226|50244043|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
25130790|NCT02137226|50244044|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
25130791|NCT02137226|50244045|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
25130792|NCT02137226|50244041|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
25130793|NCT02137226|50244042|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
25130794|NCT02137226|50244043|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
25130795|NCT02137226|50244044|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
25130796|NCT02137226|50244045|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
25130797|NCT02137226|50244041|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
25130798|NCT02137226|50244042|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
25130799|NCT02137226|50244043|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
25130800|NCT02137226|50244044|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
25130801|NCT02137226|50244045|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
25130802|NCT02137226|50244041|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
25130803|NCT02137226|50244042|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
25130804|NCT02137226|50244043|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
25130805|NCT02137226|50244044|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
25130806|NCT02137226|50244045|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
25130807|NCT02137226|50244041|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
25130808|NCT02137226|50244042|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
25130809|NCT02137226|50244043|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
25130810|NCT02137226|50244044|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
25130811|NCT02137226|50244045|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
25130812|NCT02137226|50244041|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
25130813|NCT02137226|50244042|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
25130814|NCT02137226|50244043|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
25130815|NCT02137226|50244044|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
25130816|NCT02137226|50244045|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
25130817|NCT02137226|50244041|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
25130818|NCT02137226|50244042|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
25130819|NCT02137226|50244043|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
25130820|NCT02137226|50244044|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
25272854|NCT01255787|50586901|FG000|Overall Study|Pregnancy|0|||
25272855|NCT01255787|50586902|FG001|Overall Study|Pregnancy|0|||
25272856|NCT01255787|50586903|FG002|Overall Study|Pregnancy|0|||
25272857|NCT01255787|50586904|FG003|Overall Study|Pregnancy|1|||
25272858|NCT01255787|50586901|FG000|Overall Study|Lack of Efficacy|2|||
25272859|NCT01255787|50586902|FG001|Overall Study|Lack of Efficacy|2|||
25272860|NCT01255787|50586903|FG002|Overall Study|Lack of Efficacy|2|||
25272861|NCT01255787|50586904|FG003|Overall Study|Lack of Efficacy|2|||
25272862|NCT01255787|50586901|FG000|Overall Study|Noncompliance with Study Drug|3|||
25272863|NCT01255787|50586902|FG001|Overall Study|Noncompliance with Study Drug|1|||
25272864|NCT01255787|50586903|FG002|Overall Study|Noncompliance with Study Drug|0|||
25272865|NCT01255787|50586904|FG003|Overall Study|Noncompliance with Study Drug|0|||
25272866|NCT01123161|50586916|FG000|Overall Study|Lost to Follow-up|1|||
25272867|NCT01123161|50586917|FG001|Overall Study|Lost to Follow-up|0|||
25272868|NCT01123161|50586916|FG000|Overall Study|Withdrawal by Subject|1|||
25272869|NCT01123161|50586917|FG001|Overall Study|Withdrawal by Subject|0|||
25272870|NCT01255631|50586928|FG000|Overall Study|poor enrollment, no data analyzed|9|||
25272871|NCT01255631|50586929|FG001|Overall Study|poor enrollment, no data analyzed|6|||
25130821|NCT02137226|50244045|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
25130822|NCT02137226|50244041|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
25130823|NCT02137226|50244042|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
25130824|NCT02137226|50244043|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
25130825|NCT02137226|50244044|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
25272872|NCT00999466|50586938|FG000|Main Part|Withdrawal by Subject|0|||
25272873|NCT00999466|50586939|FG001|Main Part|Withdrawal by Subject|0|||
25272874|NCT00999466|50586940|FG002|Main Part|Withdrawal by Subject|2|||
25272875|NCT00999466|50586938|FG000|Main Part|Adverse Event|0|||
25272876|NCT00999466|50586939|FG001|Main Part|Adverse Event|4|||
25178660|NCT01472081|50324003|FG001|Overall Study|Study drug toxicity|9|||
25178661|NCT01472081|50324004|FG002|Overall Study|Study drug toxicity|4|||
25272877|NCT00999466|50586940|FG002|Main Part|Adverse Event|2|||
25130826|NCT02137226|50244045|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
25130827|NCT02137226|50244041|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
25130828|NCT02137226|50244042|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
25130829|NCT02137226|50244043|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
25130830|NCT02137226|50244044|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
25130831|NCT02137226|50244045|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
25130832|NCT02137226|50244041|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
25130833|NCT02137226|50244042|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
25130834|NCT02137226|50244043|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
25130835|NCT02137226|50244044|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
25130836|NCT02137226|50244045|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
25130837|NCT01530334|50244053|FG000|Overall Study|Adverse Event|3|||
25130838|NCT01530334|50244053|FG000|Overall Study|unknown reason|1|||
25130839|NCT01530334|50244053|FG000|Overall Study|Progressive disease|47|||
25130840|NCT01570192|50244059|FG000|Overall Study|no qualifying organism|6|||
25130841|NCT01570192|50244060|FG001|Overall Study|no qualifying organism|12|||
25130842|NCT01570192|50244059|FG000|Overall Study|changed to palliative care|1|||
25130843|NCT01570192|50244060|FG001|Overall Study|changed to palliative care|0|||
25130844|NCT01570192|50244059|FG000|Overall Study|Physician Decision|0|||
25130845|NCT01570192|50244060|FG001|Overall Study|Physician Decision|1|||
25130846|NCT02136914|50244073|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
25130847|NCT02136914|50244074|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
25130848|NCT02136914|50244073|FG000|Overall Study|Withdrawal by Subject|3|||
25130849|NCT02136914|50244074|FG001|Overall Study|Withdrawal by Subject|10|||
25130850|NCT02136914|50244073|FG000|Overall Study|Subject Unwilling to Proceed|7|||
25130851|NCT02136914|50244074|FG001|Overall Study|Subject Unwilling to Proceed|2|||
25130852|NCT02136914|50244073|FG000|Overall Study|Lost to Follow-up|1|||
25130853|NCT02136914|50244074|FG001|Overall Study|Lost to Follow-up|1|||
25130854|NCT02136914|50244073|FG000|Overall Study|Did Not Receive Study Drug|2|||
25130855|NCT02136914|50244074|FG001|Overall Study|Did Not Receive Study Drug|0|||
25130856|NCT02136914|50244073|FG000|Overall Study|Lack of Efficacy|1|||
25130857|NCT02136914|50244074|FG001|Overall Study|Lack of Efficacy|0|||
25130858|NCT02136914|50244073|FG000|Overall Study|Death|0|||
25130859|NCT02136914|50244074|FG001|Overall Study|Death|1|||
25130860|NCT01530256|50244080|FG000|Overall Study|Death|2|||
25130861|NCT01554904|50244084|FG000|Overall Study|Withdrawal by Subject|3|||
25130862|NCT01554904|50244084|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
25130863|NCT01529632|50244090|FG000|Overall Study|Administrative problem|2|||
25130864|NCT01529632|50244091|FG001|Overall Study|Administrative problem|1|||
25130865|NCT01529632|50244090|FG000|Overall Study|Protocol Violation|0|||
25130866|NCT01529632|50244091|FG001|Overall Study|Protocol Violation|1|||
25130867|NCT01529632|50244090|FG000|Overall Study|Adverse Event|1|||
25130868|NCT01529632|50244091|FG001|Overall Study|Adverse Event|1|||
25130869|NCT01554514|50244097|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
25130870|NCT01554514|50244097|FG000|Overall Study|Physician Decision|1|||
25130871|NCT01553188|50244105|FG000|Overall Study|Patient choice|1|||
25130872|NCT01553188|50244106|FG001|Overall Study|Patient choice|0|||
25130873|NCT01553188|50244107|FG002|Overall Study|Patient choice|0|||
25130874|NCT01553188|50244108|FG003|Overall Study|Patient choice|0|||
25130875|NCT01553188|50244105|FG000|Overall Study|Intercurrent illness and adverse event|0|||
25130876|NCT01553188|50244106|FG001|Overall Study|Intercurrent illness and adverse event|1|||
25130877|NCT01553188|50244107|FG002|Overall Study|Intercurrent illness and adverse event|2|||
25130878|NCT01553188|50244108|FG003|Overall Study|Intercurrent illness and adverse event|0|||
25130879|NCT02175758|50244127|FG000|Treatment Phase|Lost to Follow-up|0|||
25130880|NCT02175758|50244128|FG001|Treatment Phase|Lost to Follow-up|1|||
25130881|NCT02175758|50244129|FG002|Treatment Phase|Lost to Follow-up|0|||
25130882|NCT02175758|50244130|FG003|Treatment Phase|Lost to Follow-up|0|||
25130883|NCT02175758|50244131|FG004|Treatment Phase|Lost to Follow-up|0|||
25130884|NCT02175758|50244132|FG005|Treatment Phase|Lost to Follow-up|0|||
25130885|NCT02175758|50244127|FG000|Treatment Phase|Adverse Event|0|||
25130886|NCT02175758|50244128|FG001|Treatment Phase|Adverse Event|0|||
25130887|NCT02175758|50244129|FG002|Treatment Phase|Adverse Event|0|||
25130888|NCT02175758|50244130|FG003|Treatment Phase|Adverse Event|0|||
25130889|NCT02175758|50244131|FG004|Treatment Phase|Adverse Event|1|||
25130890|NCT02175758|50244132|FG005|Treatment Phase|Adverse Event|0|||
25130891|NCT01529008|50244174|FG000|Bone Marrow Harvesting|Physician Decision|1|||
25130892|NCT01529008|50244175|FG001|Bone Marrow Harvesting|Physician Decision|1|||
25130893|NCT01529008|50244174|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
25130894|NCT01529008|50244175|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
25130895|NCT01529008|50244174|FG000|Treatment|Adverse Event|6|||
25130896|NCT01529008|50244175|FG001|Treatment|Adverse Event|0|||
25130897|NCT01529008|50244174|FG000|Treatment|Other|3|||
25130898|NCT01529008|50244175|FG001|Treatment|Other|1|||
25130899|NCT01529008|50244174|FG000|Efficacy Analysis|Protocol Violation|2|||
25130900|NCT01529008|50244175|FG001|Efficacy Analysis|Protocol Violation|0|||
25130901|NCT01529008|50244174|FG000|Efficacy Analysis|Physician Decision|0|||
25130902|NCT01529008|50244175|FG001|Efficacy Analysis|Physician Decision|1|||
25130903|NCT01529008|50244174|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
25130904|NCT01529008|50244175|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
25130905|NCT01599104|50244184|FG000|Overall Study|Withdrawal by Subject|1|||
25130906|NCT01599104|50244185|FG001|Overall Study|Withdrawal by Subject|1|||
25130907|NCT01599104|50244186|FG002|Overall Study|Withdrawal by Subject|2|||
25130908|NCT01599104|50244184|FG000|Overall Study|Technical Problems|1|||
25130909|NCT01599104|50244185|FG001|Overall Study|Technical Problems|0|||
25130910|NCT01599104|50244186|FG002|Overall Study|Technical Problems|0|||
25130911|NCT01599104|50244184|FG000|Overall Study|Physician Decision|3|||
25130912|NCT01599104|50244185|FG001|Overall Study|Physician Decision|2|||
25130913|NCT01599104|50244186|FG002|Overall Study|Physician Decision|2|||
25130914|NCT01599104|50244184|FG000|Overall Study|Non-compliance with study treatment|0|||
25130915|NCT01599104|50244185|FG001|Overall Study|Non-compliance with study treatment|1|||
25130916|NCT01599104|50244186|FG002|Overall Study|Non-compliance with study treatment|0|||
25130917|NCT01599104|50244184|FG000|Overall Study|Lack of Efficacy|4|||
25130918|NCT01599104|50244185|FG001|Overall Study|Lack of Efficacy|4|||
25130919|NCT01599104|50244186|FG002|Overall Study|Lack of Efficacy|10|||
25130920|NCT01599104|50244184|FG000|Overall Study|Adverse Event|7|||
25130921|NCT01599104|50244185|FG001|Overall Study|Adverse Event|6|||
25130922|NCT01599104|50244186|FG002|Overall Study|Adverse Event|12|||
25130923|NCT01569568|50244196|FG000|Overall Study|Physician Decision|0|||
25130924|NCT01569568|50244197|FG001|Overall Study|Physician Decision|2|||
25130925|NCT02136680|50244205|FG000|Overall Study|No Longer Interested|1|||
25130926|NCT02136680|50244206|FG001|Overall Study|No Longer Interested|1|||
25130927|NCT02136680|50244205|FG000|Overall Study|No longer receiving care at clinic|3|||
25130928|NCT02136680|50244206|FG001|Overall Study|No longer receiving care at clinic|5|||
25130929|NCT02136680|50244205|FG000|Overall Study|Moved away|5|||
25130930|NCT02136680|50244206|FG001|Overall Study|Moved away|4|||
25130931|NCT02136680|50244205|FG000|Overall Study|Unable to schedule|17|||
25130932|NCT02136680|50244206|FG001|Overall Study|Unable to schedule|16|||
25130933|NCT02136680|50244205|FG000|Overall Study|Study ended before interview due|6|||
25130934|NCT02136680|50244206|FG001|Overall Study|Study ended before interview due|3|||
25130935|NCT01552954|50244214|FG000|Overall Study|Adverse Event|1|||
25130936|NCT01552954|50244215|FG001|Overall Study|Adverse Event|2|||
25130937|NCT01552954|50244214|FG000|Overall Study|Lost to Follow-up|1|||
25130938|NCT01552954|50244215|FG001|Overall Study|Lost to Follow-up|1|||
25130939|NCT01552954|50244214|FG000|Overall Study|Withdrawal by Subject|1|||
25130940|NCT01552954|50244215|FG001|Overall Study|Withdrawal by Subject|1|||
25130941|NCT01552954|50244214|FG000|Overall Study|Protocol Violation|1|||
25130942|NCT01552954|50244215|FG001|Overall Study|Protocol Violation|2|||
25130943|NCT01552954|50244214|FG000|Overall Study|diagnosed DM|1|||
25130944|NCT01552954|50244215|FG001|Overall Study|diagnosed DM|0|||
25130945|NCT02175368|50244221|FG000|Overall Study|Lost to Follow-up|1|||
25130946|NCT01518244|50244225|FG000|Overall Study|Adverse Event|3|||
25130947|NCT01552408|50244231|FG000|Overall Study|Lost to Follow-up|2|||
25130948|NCT01552408|50244232|FG001|Overall Study|Lost to Follow-up|0|||
25130949|NCT01552408|50244231|FG000|Overall Study|Relocation|0|||
25130950|NCT01552408|50244232|FG001|Overall Study|Relocation|1|||
25130951|NCT01552408|50244231|FG000|Overall Study|Withdrawal by Subject|2|||
25130952|NCT01552408|50244232|FG001|Overall Study|Withdrawal by Subject|1|||
25130953|NCT01528696|50244241|FG000|Overall Study|See detailed description|18|||
25130954|NCT01528696|50244242|FG001|Overall Study|See detailed description|19|||
25130955|NCT02174276|50244252|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
25130956|NCT02174276|50244253|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
25130957|NCT02174276|50244254|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
25130958|NCT02174276|50244255|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
25130959|NCT02174276|50244252|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
25130960|NCT02174276|50244253|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
25130961|NCT02174276|50244254|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
25130962|NCT02174276|50244255|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
25130963|NCT02174276|50244252|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
25130964|NCT02174276|50244253|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
25130965|NCT02174276|50244254|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
25130966|NCT02174276|50244255|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
25130967|NCT02174276|50244252|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
25130968|NCT02174276|50244253|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
25130969|NCT02174276|50244254|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
25130970|NCT02174276|50244255|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
25130971|NCT02174276|50244252|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
25130972|NCT02174276|50244253|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
25130973|NCT02174276|50244254|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
25130974|NCT02174276|50244255|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
25130975|NCT02174276|50244252|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
25130976|NCT02174276|50244253|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
25272878|NCT01255163|50586950|FG000|Overall Study|Withdrawal by Subject|1|||
25130977|NCT02174276|50244254|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
25130978|NCT02174276|50244255|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
25130979|NCT01528072|50244265|FG000|Overall Study|Withdrawal by Subject|5|||
25272879|NCT01255163|50586951|FG001|Overall Study|Withdrawal by Subject|0|||
25272880|NCT01255163|50586950|FG000|Overall Study|Lost to Follow-up|2|||
25272881|NCT01255163|50586951|FG001|Overall Study|Lost to Follow-up|0|||
25130980|NCT01528072|50244265|FG000|Overall Study|Physician Decision|1|||
25130981|NCT01528072|50244265|FG000|Overall Study|Determined not eligible by AEAC|1|||
25130982|NCT01528072|50244265|FG000|Overall Study|Missed Visit|2|||
25130983|NCT01528072|50244265|FG000|Overall Study|Lost to Follow-up|5|||
25130984|NCT01528072|50244265|FG000|Overall Study|Explanted|2|||
25130985|NCT01528072|50244265|FG000|Overall Study|Site Closure|4|||
25130986|NCT01528072|50244265|FG000|Overall Study|Death|2|||
25130987|NCT01528072|50244265|FG000|Overall Study|Early Termination of Study|52|||
25130988|NCT01527682|50244269|FG000|Overall Study|Protocol Violation|8|||
25130989|NCT01527370|50244273|FG000|Overall Study|Withdrawal by Subject|4|||
25130990|NCT01527370|50244273|FG000|Overall Study|Physician Decision|1|||
25130991|NCT01527370|50244273|FG000|Overall Study|Death|1|||
25130992|NCT01527292|50244279|FG000|Overall Study|Physician Decision|0|||
25130993|NCT01527292|50244280|FG001|Overall Study|Physician Decision|3|||
25130994|NCT01516216|50244288|FG000|Overall Study|Adverse Event|2|||
25130995|NCT01516216|50244289|FG001|Overall Study|Adverse Event|4|||
25130996|NCT01516216|50244288|FG000|Overall Study|Disease Progression|38|||
25130997|NCT01516216|50244289|FG001|Overall Study|Disease Progression|34|||
25130998|NCT01516216|50244288|FG000|Overall Study|Withdrawal by Subject|9|||
25130999|NCT01516216|50244289|FG001|Overall Study|Withdrawal by Subject|11|||
25131000|NCT01516216|50244288|FG000|Overall Study|Potentially Curative Resection|6|||
25131001|NCT01516216|50244289|FG001|Overall Study|Potentially Curative Resection|12|||
25131002|NCT01516216|50244288|FG000|Overall Study|Nonadherence|2|||
25131003|NCT01516216|50244289|FG001|Overall Study|Nonadherence|3|||
25131004|NCT01516216|50244288|FG000|Overall Study|Physician Decision|6|||
25131005|NCT01516216|50244289|FG001|Overall Study|Physician Decision|3|||
25131006|NCT01516216|50244288|FG000|Overall Study|Prolonged Treatment Delay|5|||
25131007|NCT01516216|50244289|FG001|Overall Study|Prolonged Treatment Delay|1|||
25131008|NCT01516216|50244288|FG000|Overall Study|Intercurrent Illness|1|||
25131009|NCT01516216|50244289|FG001|Overall Study|Intercurrent Illness|0|||
25131010|NCT01516216|50244288|FG000|Overall Study|Death|1|||
25131011|NCT01516216|50244289|FG001|Overall Study|Death|1|||
25131012|NCT01950819|50244299|FG000|Overall Study|Graft Loss|35|||
25131013|NCT01950819|50244300|FG001|Overall Study|Graft Loss|30|||
25131014|NCT01950819|50244299|FG000|Overall Study|Death|29|||
25131015|NCT01950819|50244300|FG001|Overall Study|Death|34|||
25131016|NCT01950819|50244299|FG000|Overall Study|Subject / Gardian decision|54|||
25131017|NCT01950819|50244300|FG001|Overall Study|Subject / Gardian decision|51|||
25131018|NCT01950819|50244299|FG000|Overall Study|technical problems|2|||
25131019|NCT01950819|50244300|FG001|Overall Study|technical problems|0|||
25131020|NCT01950819|50244299|FG000|Overall Study|Pregnancy|0|||
25131021|NCT01950819|50244300|FG001|Overall Study|Pregnancy|2|||
25131022|NCT01950819|50244299|FG000|Overall Study|Lost to Follow-up|9|||
25131023|NCT01950819|50244300|FG001|Overall Study|Lost to Follow-up|17|||
25131024|NCT01514422|50244306|FG000|Overall Study|Lost to Follow-up|1|||
25131025|NCT01513330|50244310|FG000|SenSura Mio First,|Adverse Event|2|||
25131026|NCT01513330|50244311|FG001|SenSura Mio First,|Adverse Event|0|||
25131027|NCT01513330|50244310|FG000|SenSura Mio First,|Lack of Efficacy|0|||
25131028|NCT01513330|50244311|FG001|SenSura Mio First,|Lack of Efficacy|1|||
25131029|NCT01513330|50244310|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
25131030|NCT01513330|50244311|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
25131031|NCT01513330|50244310|FG000|SenSura Mio First,|Other|1|||
25131032|NCT01513330|50244311|FG001|SenSura Mio First,|Other|0|||
25131033|NCT01513330|50244310|FG000|Standard Care First,|Lack of Efficacy|2|||
25131034|NCT01513330|50244311|FG001|Standard Care First,|Lack of Efficacy|2|||
25131035|NCT01513330|50244310|FG000|Standard Care First,|Withdrawal by Subject|1|||
25131036|NCT01513330|50244311|FG001|Standard Care First,|Withdrawal by Subject|2|||
25131037|NCT01513330|50244310|FG000|Standard Care First,|Other|1|||
25131038|NCT01513330|50244311|FG001|Standard Care First,|Other|0|||
25131039|NCT01524796|50244317|FG000|Overall Study|Adverse Event|13|||
25131040|NCT01524796|50244317|FG000|Overall Study|Lack of Efficacy|3|||
25131041|NCT01524796|50244317|FG000|Overall Study|Lost to Follow-up|1|||
25131042|NCT01524796|50244317|FG000|Overall Study|The price|1|||
25131043|NCT01524796|50244317|FG000|Overall Study|Withdrawal by Subject|4|||
25131044|NCT01524796|50244317|FG000|Overall Study|Move|1|||
25131045|NCT01524796|50244317|FG000|Overall Study|Deterioration of pains|1|||
25131046|NCT01524796|50244317|FG000|Overall Study|Gall stone surgery|1|||
25272882|NCT01255163|50586950|FG000|Overall Study|Adverse Event|0|||
25131047|NCT01524796|50244317|FG000|Overall Study|Nervous about confidentiality|1|||
25131048|NCT01524796|50244317|FG000|Overall Study|Switch to carbamazapine|1|||
25131049|NCT01524796|50244317|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
25131050|NCT01547728|50244321|FG000|Overall Study|Change in procedure and equipment|1|||
25131051|NCT01547728|50244321|FG000|Overall Study|Drug not ready for subject|1|||
25131052|NCT01547728|50244321|FG000|Overall Study|Screen failure|39|||
25131053|NCT01523392|50244327|FG000|Treatment Period 1|Withdrawal by Subject|2|||
25131054|NCT01523392|50244328|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25131055|NCT01523392|50244327|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
25131056|NCT01523392|50244328|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
25131057|NCT01523392|50244327|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
25131058|NCT01523392|50244328|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
25131059|NCT01512160|50244340|FG000|Overall Study|Lost to Follow-up|1|||
25131060|NCT01512160|50244341|FG001|Overall Study|Lost to Follow-up|0|||
25131061|NCT01512160|50244342|FG002|Overall Study|Lost to Follow-up|0|||
25131062|NCT01512160|50244343|FG003|Overall Study|Lost to Follow-up|0|||
25131063|NCT01512160|50244340|FG000|Overall Study|Withdrawal by Subject|1|||
25131064|NCT01512160|50244341|FG001|Overall Study|Withdrawal by Subject|0|||
25131065|NCT01512160|50244342|FG002|Overall Study|Withdrawal by Subject|0|||
25131066|NCT01512160|50244343|FG003|Overall Study|Withdrawal by Subject|1|||
25131067|NCT01546168|50244356|FG000|Overall Study|Lost to Follow-up|1|||
25131068|NCT01546168|50244357|FG001|Overall Study|Lost to Follow-up|0|||
25131069|NCT01546168|50244356|FG000|Overall Study|Withdrawal by Subject|1|||
25131070|NCT01546168|50244357|FG001|Overall Study|Withdrawal by Subject|0|||
25131071|NCT01546168|50244356|FG000|Overall Study|ineligible after signing consent|2|||
25131072|NCT01546168|50244357|FG001|Overall Study|ineligible after signing consent|0|||
25131073|NCT01901289|50244363|FG000|Overall Study|Death|32|||
25131074|NCT01901289|50244363|FG000|Overall Study|Lost to Follow-up|16|||
25131075|NCT01901289|50244363|FG000|Overall Study|Withdrawal by Subject|35|||
25131076|NCT01901289|50244363|FG000|Overall Study|Other type of endpoint met|2|||
25131077|NCT01950741|50244367|FG000|Overall Study|Lost to Follow-up|1|||
25131078|NCT01950741|50244367|FG000|Overall Study|Death|1|||
25131079|NCT01950741|50244367|FG000|Overall Study|Withdrawal by Subject|1|||
25131080|NCT01950273|50244373|FG000|Overall Study|Protocol Violation|1|||
25131081|NCT01950273|50244374|FG001|Overall Study|Protocol Violation|0|||
25131082|NCT01950273|50244373|FG000|Overall Study|Withdrawal by Subject|2|||
25131083|NCT01950273|50244374|FG001|Overall Study|Withdrawal by Subject|0|||
25131084|NCT01950273|50244373|FG000|Overall Study|Other not defined above|1|||
25131085|NCT01950273|50244374|FG001|Overall Study|Other not defined above|0|||
25131086|NCT01919307|50244380|FG000|Overall Study|Withdrawal by Subject|9|||
25131087|NCT01919229|50244387|FG000|Overall Study|Subject/guardian decision|0|||
25131088|NCT01919229|50244388|FG001|Overall Study|Subject/guardian decision|0|||
25131089|NCT01919229|50244389|FG002|Overall Study|Subject/guardian decision|1|||
25131090|NCT01901055|50244399|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
25131091|NCT01901055|50244400|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
25131092|NCT01901055|50244399|FG000|Randomization But Not Titrated|Physician Decision|0|||
25131093|NCT01901055|50244400|FG001|Randomization But Not Titrated|Physician Decision|1|||
25131094|NCT01901055|50244399|FG000|Started Protocol to Week 6|Physician Decision|2|||
25131095|NCT01901055|50244400|FG001|Started Protocol to Week 6|Physician Decision|1|||
25131096|NCT01901055|50244399|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
25131097|NCT01901055|50244400|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
25131098|NCT01901055|50244399|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
25131099|NCT01901055|50244400|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
25131100|NCT01901055|50244399|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
25131101|NCT01901055|50244400|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
25131102|NCT01901055|50244399|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
25131103|NCT01901055|50244400|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
25131104|NCT01901055|50244399|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
25131105|NCT01901055|50244400|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
25131106|NCT01901055|50244399|FG000|Week 24|Withdrawal by Subject|13|||
25131107|NCT01901055|50244400|FG001|Week 24|Withdrawal by Subject|19|||
25131108|NCT01901055|50244399|FG000|Week 24|Physician Decision|1|||
25131109|NCT01901055|50244400|FG001|Week 24|Physician Decision|0|||
25131110|NCT01901055|50244399|FG000|Week 36|Withdrawal by Subject|0|||
25131111|NCT01901055|50244400|FG001|Week 36|Withdrawal by Subject|5|||
25131112|NCT01511536|50244412|FG000|Phase 1|Other|0|||
25131113|NCT01511536|50244413|FG001|Phase 1|Other|1|||
25131114|NCT01511536|50244414|FG002|Phase 1|Other|0|||
25131115|NCT01511536|50244412|FG000|Phase 2|Other|0|||
25131116|NCT01511536|50244413|FG001|Phase 2|Other|0|||
25131117|NCT01511536|50244414|FG002|Phase 2|Other|9|||
25131118|NCT01890759|50244424|FG000|Overall Study|Protocol Violation|0|||
25131119|NCT01890759|50244425|FG001|Overall Study|Protocol Violation|2|||
25131120|NCT01890759|50244424|FG000|Overall Study|Lost to Follow-up|0|||
25131121|NCT01890759|50244425|FG001|Overall Study|Lost to Follow-up|2|||
25131122|NCT01890759|50244424|FG000|Overall Study|Withdrawal by Subject|2|||
25131123|NCT01890759|50244425|FG001|Overall Study|Withdrawal by Subject|8|||
25131124|NCT01900899|50244433|FG000|Overall Study|Withdrawal by Subject|7|||
25178662|NCT01472081|50324005|FG003|Overall Study|Study drug toxicity|6|||
25131125|NCT01900899|50244434|FG001|Overall Study|Withdrawal by Subject|1|||
25131126|NCT01900899|50244433|FG000|Overall Study|Migrated from study area|2|||
25131127|NCT01900899|50244434|FG001|Overall Study|Migrated from study area|0|||
25131128|NCT01510912|50244440|FG000|Overall Study|Adverse Event|99|||
25131129|NCT01510912|50244440|FG000|Overall Study|Lack of Efficacy|12|||
25131130|NCT01510912|50244440|FG000|Overall Study|Non-compliance with trial drug|23|||
25131131|NCT01510912|50244440|FG000|Overall Study|Withdrawal by Subject|49|||
25178663|NCT01472081|50324006|FG004|Overall Study|Study drug toxicity|13|||
25178664|NCT01472081|50324007|FG005|Overall Study|Study drug toxicity|2|||
25178665|NCT01472081|50324002|FG000|Overall Study|Death|0|||
25178666|NCT01472081|50324003|FG001|Overall Study|Death|0|||
25178667|NCT01472081|50324004|FG002|Overall Study|Death|0|||
25178668|NCT01472081|50324005|FG003|Overall Study|Death|0|||
25178669|NCT01472081|50324006|FG004|Overall Study|Death|1|||
25178670|NCT01472081|50324007|FG005|Overall Study|Death|0|||
25178671|NCT01472081|50324002|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
25178672|NCT01472081|50324003|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
25178673|NCT01472081|50324004|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
25178674|NCT01472081|50324005|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
25178675|NCT01472081|50324006|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
25178676|NCT01472081|50324007|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
25009359|NCT00075725|50102302|FG008|Overall Study|Institution Terminated|0|||
25131132|NCT01510912|50244440|FG000|Overall Study|Physician Decision|1|||
25131133|NCT01510912|50244440|FG000|Overall Study|Protocol Violation|27|||
25131134|NCT01510912|50244440|FG000|Overall Study|Lost to Follow-up|26|||
25131135|NCT01510912|50244440|FG000|Overall Study|Other, including joint replacement|5|||
25131136|NCT01510756|50244444|FG000|Overall Study|Death|1|||
25131137|NCT01510756|50244444|FG000|Overall Study|Lack of Efficacy|2|||
25131138|NCT01510756|50244444|FG000|Overall Study|Physician Decision|1|||
25131139|NCT01522456|50244448|FG000|Overall Study|Adverse Event|2|||
25131140|NCT01522456|50244448|FG000|Overall Study|Lost to Follow-up|2|||
25131141|NCT01522456|50244448|FG000|Overall Study|Withdrawal by Subject|2|||
25131142|NCT01522456|50244448|FG000|Overall Study|Pregnancy|1|||
25131143|NCT01522456|50244448|FG000|Overall Study|Tolerability Assessment|1|||
25131144|NCT01545934|50244461|FG000|Overall Study|Withdrawal by Subject|4|||
25131145|NCT01545934|50244462|FG001|Overall Study|Withdrawal by Subject|3|||
25131146|NCT01545934|50244461|FG000|Overall Study|Lost to Follow-up|1|||
25131147|NCT01545934|50244462|FG001|Overall Study|Lost to Follow-up|0|||
25131148|NCT01521364|50244469|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
25131149|NCT01521364|50244469|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
25131150|NCT01545388|50244483|FG000|Overall Study|Adverse Event|2|||
25131151|NCT01545388|50244484|FG001|Overall Study|Adverse Event|4|||
25131152|NCT01545388|50244485|FG002|Overall Study|Adverse Event|1|||
25131153|NCT01545388|50244483|FG000|Overall Study|Lack of Efficacy|3|||
25131154|NCT01545388|50244484|FG001|Overall Study|Lack of Efficacy|2|||
25131155|NCT01545388|50244485|FG002|Overall Study|Lack of Efficacy|5|||
25131156|NCT01545388|50244483|FG000|Overall Study|Participant moved or relocated|1|||
25131157|NCT01545388|50244484|FG001|Overall Study|Participant moved or relocated|0|||
25131158|NCT01545388|50244485|FG002|Overall Study|Participant moved or relocated|0|||
25131159|NCT01545388|50244483|FG000|Overall Study|Withdrawal by Subject|1|||
25131160|NCT01545388|50244484|FG001|Overall Study|Withdrawal by Subject|4|||
25131161|NCT01545388|50244485|FG002|Overall Study|Withdrawal by Subject|2|||
25131162|NCT01545388|50244483|FG000|Overall Study|Other|1|||
25131163|NCT01545388|50244484|FG001|Overall Study|Other|1|||
25131164|NCT01545388|50244485|FG002|Overall Study|Other|0|||
25131165|NCT01545076|50244493|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
25131166|NCT01545076|50244494|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
25131167|NCT01545076|50244495|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
25131168|NCT01545076|50244496|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
25131169|NCT01545076|50244497|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
25131170|NCT01545076|50244493|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
25131171|NCT01545076|50244494|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
25131172|NCT01545076|50244495|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
25131173|NCT01545076|50244496|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
25131174|NCT01545076|50244497|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
25131175|NCT01545076|50244493|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
25131176|NCT01545076|50244494|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
25131177|NCT01545076|50244495|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
25131178|NCT01545076|50244496|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
25131179|NCT01545076|50244497|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
25131180|NCT01545076|50244493|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
25131181|NCT01545076|50244494|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
25178677|NCT01472081|50324002|FG000|Overall Study|Withdrawal by Subject|0|||
25178678|NCT01472081|50324003|FG001|Overall Study|Withdrawal by Subject|0|||
25178679|NCT01472081|50324004|FG002|Overall Study|Withdrawal by Subject|0|||
25131182|NCT01545076|50244495|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
25131183|NCT01545076|50244496|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
25131184|NCT01545076|50244497|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
25131185|NCT01545076|50244493|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
25131186|NCT01545076|50244494|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
25131187|NCT01545076|50244495|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
25131188|NCT01545076|50244496|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
25131189|NCT01545076|50244497|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
25131190|NCT01545076|50244493|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
25131191|NCT01545076|50244494|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
25131192|NCT01545076|50244495|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
25131193|NCT01545076|50244496|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
25131194|NCT01545076|50244497|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
25131195|NCT01545076|50244493|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
25131196|NCT01545076|50244494|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
25131197|NCT01545076|50244495|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
25131198|NCT01545076|50244496|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
25131199|NCT01545076|50244497|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
25131200|NCT01545076|50244493|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
25131201|NCT01545076|50244494|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
25131202|NCT01545076|50244495|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
25131203|NCT01545076|50244496|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
25131204|NCT01545076|50244497|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
25131205|NCT01545076|50244493|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
25131206|NCT01545076|50244494|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
25131207|NCT01545076|50244495|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
25131208|NCT01545076|50244496|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
25131209|NCT01545076|50244497|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
25131210|NCT01544920|50244512|FG000|Overall Study|Adverse Event|0|||
25131211|NCT01544920|50244513|FG001|Overall Study|Adverse Event|3|||
25131212|NCT01544920|50244512|FG000|Overall Study|Death|0|||
25131213|NCT01544920|50244513|FG001|Overall Study|Death|1|||
25131214|NCT01544920|50244512|FG000|Overall Study|Lost to Follow-up|11|||
25131215|NCT01544920|50244513|FG001|Overall Study|Lost to Follow-up|12|||
25131216|NCT01544920|50244512|FG000|Overall Study|Protocol Violation|0|||
25131217|NCT01544920|50244513|FG001|Overall Study|Protocol Violation|2|||
25131218|NCT01544920|50244512|FG000|Overall Study|Physician Decision|4|||
25131219|NCT01544920|50244513|FG001|Overall Study|Physician Decision|1|||
25131220|NCT01544920|50244512|FG000|Overall Study|Withdrawal by Subject|4|||
25131221|NCT01544920|50244513|FG001|Overall Study|Withdrawal by Subject|4|||
25131222|NCT01509664|50244523|FG000|Overall Study|Lost to Follow-up|15|||
25131223|NCT01509664|50244524|FG001|Overall Study|Lost to Follow-up|21|||
25131224|NCT01543828|50244532|FG000|Treatment 2|Lost to Follow-up|1|||
25131225|NCT01543828|50244533|FG001|Treatment 2|Lost to Follow-up|0|||
25131226|NCT01520506|50244541|FG000|Overall Study|Missed Visit|4|||
25131227|NCT01520506|50244541|FG000|Overall Study|Lost to Follow-up|1|||
25178680|NCT01472081|50324005|FG003|Overall Study|Withdrawal by Subject|0|||
25178681|NCT01472081|50324006|FG004|Overall Study|Withdrawal by Subject|0|||
25178682|NCT01472081|50324007|FG005|Overall Study|Withdrawal by Subject|1|||
25178683|NCT01472081|50324002|FG000|Overall Study|Poor/non-compliance|0|||
25178684|NCT01472081|50324003|FG001|Overall Study|Poor/non-compliance|0|||
25178685|NCT01472081|50324004|FG002|Overall Study|Poor/non-compliance|1|||
25178686|NCT01472081|50324005|FG003|Overall Study|Poor/non-compliance|0|||
25178687|NCT01472081|50324006|FG004|Overall Study|Poor/non-compliance|1|||
25178688|NCT01472081|50324007|FG005|Overall Study|Poor/non-compliance|0|||
25178689|NCT01472081|50324002|FG000|Overall Study|No longer meets study criteria|0|||
25178690|NCT01472081|50324003|FG001|Overall Study|No longer meets study criteria|0|||
25178691|NCT01472081|50324004|FG002|Overall Study|No longer meets study criteria|1|||
25131228|NCT01520506|50244541|FG000|Overall Study|Withdrawal by Subject|1|||
25131229|NCT01519960|50244548|FG000|Overall Study|Withdrawal from the study|26|||
25131230|NCT01519960|50244549|FG001|Overall Study|Withdrawal from the study|22|||
25131231|NCT01519960|50244550|FG002|Overall Study|Withdrawal from the study|5|||
25131232|NCT01543204|50244566|FG000|Overall Study|Non-compliance|1|||
25131233|NCT01543204|50244566|FG000|Overall Study|Adverse Event|1|||
25131234|NCT01543204|50244566|FG000|Overall Study|Withdrawal by Subject|4|||
25131235|NCT01543204|50244566|FG000|Overall Study|Requirement for Alternative Therapy|1|||
25178692|NCT01472081|50324005|FG003|Overall Study|No longer meets study criteria|0|||
25178693|NCT01472081|50324006|FG004|Overall Study|No longer meets study criteria|0|||
25178694|NCT01472081|50324007|FG005|Overall Study|No longer meets study criteria|0|||
25178695|NCT01472081|50324002|FG000|Overall Study|Subject request to discontinue treatment|0|||
25178696|NCT01472081|50324003|FG001|Overall Study|Subject request to discontinue treatment|3|||
25131236|NCT01543204|50244566|FG000|Overall Study|Lost to Follow-up|1|||
25131237|NCT01488994|50244576|FG000|Overall Study|Withdrawal by Subject|0|||
25131238|NCT01488994|50244577|FG001|Overall Study|Withdrawal by Subject|1|||
25131239|NCT01508650|50244590|FG000|Overall Study|Lost to Follow-up|0|||
25131240|NCT01508650|50244591|FG001|Overall Study|Lost to Follow-up|3|||
25131241|NCT01488448|50244599|FG000|Overall Study|Withdrawal by Subject|3|||
25131242|NCT01488448|50244600|FG001|Overall Study|Withdrawal by Subject|1|||
25131243|NCT01488448|50244599|FG000|Overall Study|Adverse Event|9|||
25131244|NCT01488448|50244600|FG001|Overall Study|Adverse Event|4|||
25131245|NCT01488448|50244599|FG000|Overall Study|Physician Decision|4|||
25131246|NCT01488448|50244600|FG001|Overall Study|Physician Decision|9|||
25131247|NCT01488448|50244599|FG000|Overall Study|Protocol Violation|4|||
25131248|NCT01488448|50244600|FG001|Overall Study|Protocol Violation|3|||
25131249|NCT01518946|50244610|FG000|Open-label Phase|Other|4|||
25131250|NCT01518946|50244611|FG001|Open-label Phase|Other|0|||
25131251|NCT01518946|50244612|FG002|Open-label Phase|Other|0|||
25131252|NCT01518946|50244610|FG000|Randomized Phase (First Intervention)|Other|0|||
25131253|NCT01518946|50244611|FG001|Randomized Phase (First Intervention)|Other|1|||
25131254|NCT01518946|50244612|FG002|Randomized Phase (First Intervention)|Other|0|||
25131255|NCT01488370|50244622|FG000|Overall Study|Protocol Violation|0|||
25131256|NCT01488370|50244623|FG001|Overall Study|Protocol Violation|1|||
25131257|NCT01488370|50244624|FG002|Overall Study|Protocol Violation|1|||
25131258|NCT01518322|50244632|FG000|Overall Study|FeNO measurement was missing|13|||
25131259|NCT01507246|50244643|FG000|Overall Study|Required different surgical procedures|2|||
25131260|NCT01507246|50244644|FG001|Overall Study|Required different surgical procedures|1|||
25131261|NCT01507090|50244653|FG000|Overall Study|incomplete dataset|18|||
25131262|NCT01464346|50244667|FG000|Overall Study|Withdrawal by Subject|0|||
25131263|NCT01464346|50244668|FG001|Overall Study|Withdrawal by Subject|0|||
25131264|NCT01464346|50244669|FG002|Overall Study|Withdrawal by Subject|1|||
25131265|NCT01487200|50244696|FG000|Overall Study|Withdrawal by Subject|0|||
25131266|NCT01487200|50244697|FG001|Overall Study|Withdrawal by Subject|1|||
25131267|NCT01487200|50244698|FG002|Overall Study|Withdrawal by Subject|0|||
25131268|NCT01487200|50244699|FG003|Overall Study|Withdrawal by Subject|0|||
25131269|NCT01463878|50244712|FG000|Overall Study|no longer met criteria for tube feed|2|||
25131270|NCT01463878|50244713|FG001|Overall Study|no longer met criteria for tube feed|2|||
25131271|NCT01505608|50244721|FG000|Phase I|Lack of Efficacy|0|||
25131272|NCT01505608|50244722|FG001|Phase I|Lack of Efficacy|4|||
25131273|NCT01505608|50244721|FG000|Phase I|Adverse Event|0|||
25131274|NCT01505608|50244722|FG001|Phase I|Adverse Event|1|||
25131275|NCT01505608|50244721|FG000|Phase I|Withdrawal by Subject|0|||
25131276|NCT01505608|50244722|FG001|Phase I|Withdrawal by Subject|1|||
25131277|NCT01505608|50244721|FG000|Phase II|Lack of Efficacy|2|||
25131278|NCT01505608|50244722|FG001|Phase II|Lack of Efficacy|1|||
25131279|NCT01505608|50244721|FG000|Phase II|Protocol Violation|0|||
25131280|NCT01505608|50244722|FG001|Phase II|Protocol Violation|1|||
25131281|NCT01486966|50244733|FG000|Overall Study|Adverse Event|0|||
25131282|NCT01486966|50244734|FG001|Overall Study|Adverse Event|1|||
25131283|NCT01486966|50244733|FG000|Overall Study|Withdrawal by Subject|0|||
25131284|NCT01486966|50244734|FG001|Overall Study|Withdrawal by Subject|1|||
25131285|NCT01900665|50244742|FG000|Placebo Controlled Period|Death|9|||
25131286|NCT01900665|50244743|FG001|Placebo Controlled Period|Death|16|||
25131287|NCT01900665|50244742|FG000|Placebo Controlled Period|Adverse Event|48|||
25131288|NCT01900665|50244743|FG001|Placebo Controlled Period|Adverse Event|39|||
25131289|NCT01900665|50244742|FG000|Placebo Controlled Period|Protocol Violation|1|||
25131290|NCT01900665|50244743|FG001|Placebo Controlled Period|Protocol Violation|7|||
25131291|NCT01900665|50244742|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
25131292|NCT01900665|50244743|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
25131293|NCT01900665|50244742|FG000|Placebo Controlled Period|Physician Decision|11|||
25131294|NCT01900665|50244743|FG001|Placebo Controlled Period|Physician Decision|7|||
25131295|NCT01900665|50244742|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
25131296|NCT01900665|50244743|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
25131297|NCT01900665|50244742|FG000|Placebo Controlled Period|Caregiver Decision|33|||
25131298|NCT01900665|50244743|FG001|Placebo Controlled Period|Caregiver Decision|41|||
25131299|NCT01900665|50244742|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
25131300|NCT01900665|50244743|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
25131301|NCT01900665|50244742|FG000|Open Label Period|Adverse Event|16|||
25131302|NCT01900665|50244743|FG001|Open Label Period|Adverse Event|20|||
25131303|NCT01900665|50244742|FG000|Open Label Period|Death|5|||
25131304|NCT01900665|50244743|FG001|Open Label Period|Death|6|||
25131305|NCT01900665|50244742|FG000|Open Label Period|Lost to Follow-up|1|||
25131306|NCT01900665|50244743|FG001|Open Label Period|Lost to Follow-up|1|||
25131307|NCT01900665|50244742|FG000|Open Label Period|Parent/Caregiver Decision|33|||
25131308|NCT01900665|50244743|FG001|Open Label Period|Parent/Caregiver Decision|34|||
25131309|NCT01900665|50244742|FG000|Open Label Period|Physician Decision|4|||
25131310|NCT01900665|50244743|FG001|Open Label Period|Physician Decision|4|||
25131311|NCT01900665|50244742|FG000|Open Label Period|Protocol Violation|0|||
25131312|NCT01900665|50244743|FG001|Open Label Period|Protocol Violation|1|||
25131313|NCT01900665|50244742|FG000|Open Label Period|Sponsor Decision|802|||
25131314|NCT01900665|50244743|FG001|Open Label Period|Sponsor Decision|765|||
25131315|NCT01900665|50244742|FG000|Open Label Period|Withdrawal by Subject|20|||
25131316|NCT01900665|50244743|FG001|Open Label Period|Withdrawal by Subject|28|||
25131317|NCT01900431|50244754|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
25131318|NCT01900431|50244755|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
25131319|NCT01900431|50244756|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
25131320|NCT01900431|50244754|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
25131321|NCT01900431|50244755|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
25131322|NCT01900431|50244756|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
25131323|NCT01900431|50244754|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
25131324|NCT01900431|50244755|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
25131325|NCT01900431|50244756|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
25131326|NCT01900431|50244754|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
25131327|NCT01900431|50244755|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
25131328|NCT01900431|50244756|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
25131329|NCT01900431|50244754|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
25131330|NCT01900431|50244755|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
25131331|NCT01900431|50244756|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
25131332|NCT01900431|50244754|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
25131333|NCT01900431|50244755|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
25131334|NCT01900431|50244756|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
25131335|NCT01900431|50244754|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
25131336|NCT01900431|50244755|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
25131337|NCT01900431|50244756|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
25131338|NCT01900431|50244754|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
25131339|NCT01900431|50244755|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
25131340|NCT01900431|50244756|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
25131341|NCT01900431|50244754|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
25131342|NCT01900431|50244755|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
25131343|NCT01900431|50244756|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
25131344|NCT01948791|50244764|FG000|Overall Study|Adverse Event|12|||
25131345|NCT01948791|50244764|FG000|Overall Study|Lack of Efficacy|3|||
25131346|NCT01948791|50244764|FG000|Overall Study|Protocol Violation|2|||
25131347|NCT01948791|50244764|FG000|Overall Study|Withdrawal by Subject|5|||
25131348|NCT01948791|50244764|FG000|Overall Study|Lost to Follow-up|6|||
25131349|NCT01948791|50244764|FG000|Overall Study|Management issues|1|||
25131350|NCT01948791|50244764|FG000|Overall Study|Others|7|||
25131351|NCT01948791|50244764|FG000|Overall Study|Screening failure|35|||
25131352|NCT01899729|50244773|FG000|Overall Study|Adverse Event|1|||
25131353|NCT01899729|50244774|FG001|Overall Study|Adverse Event|0|||
25131354|NCT01899729|50244775|FG002|Overall Study|Adverse Event|0|||
25131355|NCT01899729|50244776|FG003|Overall Study|Adverse Event|0|||
25131356|NCT01899729|50244777|FG004|Overall Study|Adverse Event|1|||
25131357|NCT01899729|50244773|FG000|Overall Study|Withdrawal by Subject|1|||
25131358|NCT01899729|50244774|FG001|Overall Study|Withdrawal by Subject|2|||
25131359|NCT01899729|50244775|FG002|Overall Study|Withdrawal by Subject|0|||
25131360|NCT01899729|50244776|FG003|Overall Study|Withdrawal by Subject|0|||
25131361|NCT01899729|50244777|FG004|Overall Study|Withdrawal by Subject|0|||
25131362|NCT01899729|50244773|FG000|Overall Study|Lack of Efficacy|0|||
25131363|NCT01899729|50244774|FG001|Overall Study|Lack of Efficacy|0|||
25131364|NCT01899729|50244775|FG002|Overall Study|Lack of Efficacy|2|||
25178697|NCT01472081|50324004|FG002|Overall Study|Subject request to discontinue treatment|1|||
25178698|NCT01472081|50324005|FG003|Overall Study|Subject request to discontinue treatment|1|||
25272883|NCT01255163|50586951|FG001|Overall Study|Adverse Event|2|||
25272884|NCT01255163|50586950|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
25272885|NCT01255163|50586951|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
25272886|NCT01123083|50586961|FG000|Overall Study|Investigator recommendation|1|||
25131365|NCT01899729|50244776|FG003|Overall Study|Lack of Efficacy|0|||
25131366|NCT01899729|50244777|FG004|Overall Study|Lack of Efficacy|1|||
25272887|NCT01123083|50586962|FG001|Overall Study|Investigator recommendation|1|||
25272888|NCT01123083|50586961|FG000|Overall Study|Administrative reasons|0|||
25272889|NCT01123083|50586962|FG001|Overall Study|Administrative reasons|4|||
25272890|NCT01123083|50586961|FG000|Overall Study|Lost to Follow-up|2|||
25131367|NCT01898091|50244791|FG000|Overall Study|Lost to Follow-up|1|||
25131368|NCT01898091|50244792|FG001|Overall Study|Lost to Follow-up|1|||
25131369|NCT01898091|50244791|FG000|Overall Study|Withdrawal by Subject|1|||
25131370|NCT01898091|50244792|FG001|Overall Study|Withdrawal by Subject|5|||
25131371|NCT01947855|50244801|FG000|Overall Study|Withdrawal by Subject|1|||
25131372|NCT01947855|50244802|FG001|Overall Study|Withdrawal by Subject|0|||
25131373|NCT01947855|50244803|FG002|Overall Study|Withdrawal by Subject|0|||
25131374|NCT01888965|50244811|FG000|Overall Study|Adverse Event|5|||
25131375|NCT01888965|50244811|FG000|Overall Study|Lack of Efficacy|4|||
25131376|NCT01888497|50244815|FG000|Washout Period 1|Withdrawal by Subject|0|||
25131377|NCT01888497|50244816|FG001|Washout Period 1|Withdrawal by Subject|0|||
25131378|NCT01888497|50244817|FG002|Washout Period 1|Withdrawal by Subject|1|||
25131379|NCT01888497|50244818|FG003|Washout Period 1|Withdrawal by Subject|1|||
25131380|NCT01888497|50244815|FG000|Washout Period 2|Adverse Event|0|||
25131381|NCT01888497|50244816|FG001|Washout Period 2|Adverse Event|0|||
25131382|NCT01888497|50244817|FG002|Washout Period 2|Adverse Event|0|||
25131383|NCT01888497|50244818|FG003|Washout Period 2|Adverse Event|1|||
25131384|NCT01888497|50244815|FG000|Washout Period 2|Withdrawal by Subject|0|||
25131385|NCT01888497|50244816|FG001|Washout Period 2|Withdrawal by Subject|0|||
25131386|NCT01888497|50244817|FG002|Washout Period 2|Withdrawal by Subject|0|||
25131387|NCT01888497|50244818|FG003|Washout Period 2|Withdrawal by Subject|1|||
25131388|NCT01505530|50244831|FG000|Overall Study|Progressive Disease|19|||
25131389|NCT01505530|50244832|FG001|Overall Study|Progressive Disease|17|||
25131390|NCT01505530|50244833|FG002|Overall Study|Progressive Disease|18|||
25131391|NCT01505530|50244831|FG000|Overall Study|Adverse Event|1|||
25131392|NCT01505530|50244832|FG001|Overall Study|Adverse Event|1|||
25131393|NCT01505530|50244833|FG002|Overall Study|Adverse Event|0|||
25131394|NCT01505530|50244831|FG000|Overall Study|Withdrawal by Subject|7|||
25131395|NCT01505530|50244832|FG001|Overall Study|Withdrawal by Subject|8|||
25131396|NCT01505530|50244833|FG002|Overall Study|Withdrawal by Subject|6|||
25131397|NCT01505530|50244831|FG000|Overall Study|Physician Decision|6|||
25131398|NCT01505530|50244832|FG001|Overall Study|Physician Decision|2|||
25131399|NCT01505530|50244833|FG002|Overall Study|Physician Decision|5|||
25131400|NCT01505530|50244831|FG000|Overall Study|Sponsor Decision|1|||
25131401|NCT01505530|50244832|FG001|Overall Study|Sponsor Decision|8|||
25131402|NCT01505530|50244833|FG002|Overall Study|Sponsor Decision|7|||
25131403|NCT01505530|50244831|FG000|Overall Study|Death|7|||
25131404|NCT01505530|50244832|FG001|Overall Study|Death|6|||
25131405|NCT01505530|50244833|FG002|Overall Study|Death|5|||
25131406|NCT01505530|50244831|FG000|Overall Study|entry criteria not met|0|||
25131407|NCT01505530|50244832|FG001|Overall Study|entry criteria not met|1|||
25131408|NCT01505530|50244833|FG002|Overall Study|entry criteria not met|0|||
25131409|NCT01485796|50244841|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
25131410|NCT01485796|50244841|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
25131411|NCT01485796|50244841|FG000|Period 2: Epoch 2|Adverse Event|3|||
25131412|NCT01485796|50244841|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
25131413|NCT01485796|50244841|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
25131414|NCT01485796|50244841|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
25131415|NCT01485796|50244841|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
25131416|NCT01485796|50244841|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
25131417|NCT01505374|50244849|FG000|Overall Study|Lost to Follow-up|1|||
25131418|NCT01505374|50244850|FG001|Overall Study|Lost to Follow-up|0|||
25131419|NCT01897233|50244857|FG000|Part B (24 Weeks)|Adverse Event|1|||
25131420|NCT01897233|50244857|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
25131421|NCT01897233|50244857|FG000|Part B (24 Weeks)|Physician Decision|1|||
25131422|NCT01887717|50244867|FG000|Overall Study|Withdrawal by Subject|1|||
25131423|NCT01887717|50244868|FG001|Overall Study|Withdrawal by Subject|7|||
25131424|NCT01887717|50244867|FG000|Overall Study|Physician Decision|0|||
25131425|NCT01887717|50244868|FG001|Overall Study|Physician Decision|2|||
25131426|NCT01887717|50244867|FG000|Overall Study|Administrative reasons|5|||
25178699|NCT01472081|50324006|FG004|Overall Study|Subject request to discontinue treatment|0|||
25178700|NCT01472081|50324007|FG005|Overall Study|Subject request to discontinue treatment|0|||
25131427|NCT01887717|50244868|FG001|Overall Study|Administrative reasons|2|||
25131428|NCT01886781|50244876|FG000|Overall Study|Protocol Violation|5|||
25131429|NCT01886781|50244877|FG001|Overall Study|Protocol Violation|0|||
25131430|NCT01886781|50244876|FG000|Overall Study|Adverse Event|1|||
25131431|NCT01886781|50244877|FG001|Overall Study|Adverse Event|0|||
25131432|NCT01886781|50244876|FG000|Overall Study|Lost to Follow-up|5|||
25131433|NCT01886781|50244877|FG001|Overall Study|Lost to Follow-up|0|||
25131434|NCT01886781|50244876|FG000|Overall Study|Withdrawal by Subject|2|||
25131435|NCT01886781|50244877|FG001|Overall Study|Withdrawal by Subject|1|||
25131436|NCT01886781|50244876|FG000|Overall Study|Worsening of symptoms|1|||
25131437|NCT01886781|50244877|FG001|Overall Study|Worsening of symptoms|1|||
25131438|NCT01946529|50244886|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
25131439|NCT01946529|50244887|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
25131440|NCT01946529|50244888|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
25131441|NCT01946529|50244886|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
25131442|NCT01946529|50244887|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
25131443|NCT01946529|50244888|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
25131444|NCT01463098|50244909|FG000|Part A (11 Days)|Participant Choice|2|||
25131445|NCT01463098|50244910|FG001|Part A (11 Days)|Participant Choice|0|||
25131446|NCT01463098|50244911|FG002|Part A (11 Days)|Participant Choice|0|||
25131447|NCT01463098|50244912|FG003|Part A (11 Days)|Participant Choice|0|||
25131448|NCT01463098|50244913|FG004|Part A (11 Days)|Participant Choice|0|||
25131449|NCT01463098|50244914|FG005|Part A (11 Days)|Participant Choice|0|||
25131450|NCT01463098|50244915|FG006|Part A (11 Days)|Participant Choice|0|||
25131451|NCT01463098|50244916|FG007|Part A (11 Days)|Participant Choice|0|||
25131452|NCT01463098|50244917|FG008|Part A (11 Days)|Participant Choice|1|||
25131453|NCT01463098|50244918|FG009|Part A (11 Days)|Participant Choice|0|||
25131454|NCT01463098|50244919|FG010|Part A (11 Days)|Participant Choice|0|||
25131455|NCT01463098|50244920|FG011|Part A (11 Days)|Participant Choice|0|||
25131456|NCT01463098|50244921|FG012|Part A (11 Days)|Participant Choice|0|||
25272891|NCT01123083|50586962|FG001|Overall Study|Lost to Follow-up|6|||
25272892|NCT01123083|50586961|FG000|Overall Study|Adverse Event|1|||
25272893|NCT01123083|50586962|FG001|Overall Study|Adverse Event|0|||
25272894|NCT01123083|50586961|FG000|Overall Study|Withdrew for another reason not covered|0|||
25272895|NCT01123083|50586962|FG001|Overall Study|Withdrew for another reason not covered|1|||
25272896|NCT01123083|50586961|FG000|Overall Study|Participant/legal representative request|7|||
25131457|NCT01463098|50244922|FG013|Part A (11 Days)|Participant Choice|0|||
25131458|NCT01463098|50244909|FG000|Part A (11 Days)|Lost to Follow-up|0|||
25131459|NCT01463098|50244910|FG001|Part A (11 Days)|Lost to Follow-up|0|||
25131460|NCT01463098|50244911|FG002|Part A (11 Days)|Lost to Follow-up|0|||
25131461|NCT01463098|50244912|FG003|Part A (11 Days)|Lost to Follow-up|0|||
25178701|NCT01471691|50324022|FG000|Overall Study|Lack of Efficacy|0|||
25178702|NCT01471691|50324023|FG001|Overall Study|Lack of Efficacy|1|||
25178703|NCT01471379|50324032|FG000|Overall Study|Adverse Event|1|||
25178704|NCT01471379|50324033|FG001|Overall Study|Adverse Event|0|||
25178705|NCT01471379|50324034|FG002|Overall Study|Adverse Event|0|||
25178706|NCT01471379|50324032|FG000|Overall Study|Study terminated|0|||
25178707|NCT01471379|50324033|FG001|Overall Study|Study terminated|1|||
25272897|NCT01123083|50586962|FG001|Overall Study|Participant/legal representative request|3|||
25131462|NCT01463098|50244913|FG004|Part A (11 Days)|Lost to Follow-up|1|||
25272898|NCT01254305|50586971|FG000|Overall Study|Adverse Event|6|||
25131463|NCT01463098|50244914|FG005|Part A (11 Days)|Lost to Follow-up|0|||
25131464|NCT01463098|50244915|FG006|Part A (11 Days)|Lost to Follow-up|0|||
25131465|NCT01463098|50244916|FG007|Part A (11 Days)|Lost to Follow-up|0|||
25178708|NCT01471379|50324034|FG002|Overall Study|Study terminated|0|||
25178709|NCT01470989|50324045|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
25178710|NCT01470989|50324046|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
25272899|NCT01254305|50586972|FG001|Overall Study|Adverse Event|3|||
25131466|NCT01463098|50244917|FG008|Part A (11 Days)|Lost to Follow-up|0|||
25131467|NCT01463098|50244918|FG009|Part A (11 Days)|Lost to Follow-up|0|||
25131468|NCT01463098|50244919|FG010|Part A (11 Days)|Lost to Follow-up|0|||
25131469|NCT01463098|50244920|FG011|Part A (11 Days)|Lost to Follow-up|0|||
25131470|NCT01463098|50244921|FG012|Part A (11 Days)|Lost to Follow-up|0|||
25131471|NCT01463098|50244922|FG013|Part A (11 Days)|Lost to Follow-up|0|||
25131472|NCT01463098|50244909|FG000|Part B (11 Days)|Participant Choice|0|||
25131473|NCT01463098|50244910|FG001|Part B (11 Days)|Participant Choice|0|||
25131474|NCT01463098|50244911|FG002|Part B (11 Days)|Participant Choice|0|||
25131475|NCT01463098|50244912|FG003|Part B (11 Days)|Participant Choice|0|||
25131476|NCT01463098|50244913|FG004|Part B (11 Days)|Participant Choice|0|||
25131477|NCT01463098|50244914|FG005|Part B (11 Days)|Participant Choice|0|||
25131478|NCT01463098|50244915|FG006|Part B (11 Days)|Participant Choice|0|||
25131479|NCT01463098|50244916|FG007|Part B (11 Days)|Participant Choice|0|||
25131480|NCT01463098|50244917|FG008|Part B (11 Days)|Participant Choice|0|||
25131481|NCT01463098|50244918|FG009|Part B (11 Days)|Participant Choice|0|||
25131482|NCT01463098|50244919|FG010|Part B (11 Days)|Participant Choice|0|||
25131483|NCT01463098|50244920|FG011|Part B (11 Days)|Participant Choice|1|||
25131484|NCT01463098|50244921|FG012|Part B (11 Days)|Participant Choice|0|||
25131485|NCT01463098|50244922|FG013|Part B (11 Days)|Participant Choice|0|||
25131486|NCT01626079|50244974|FG000|Overall Study|Death|117|||
25131487|NCT01626079|50244975|FG001|Overall Study|Death|153|||
25131488|NCT01626079|50244976|FG002|Overall Study|Death|39|||
25131489|NCT01626079|50244974|FG000|Overall Study|Withdrawal by Subject|15|||
25131490|NCT01626079|50244975|FG001|Overall Study|Withdrawal by Subject|39|||
25131491|NCT01626079|50244976|FG002|Overall Study|Withdrawal by Subject|5|||
25131492|NCT01626079|50244974|FG000|Overall Study|Lost to Follow-up|5|||
25131493|NCT01626079|50244975|FG001|Overall Study|Lost to Follow-up|4|||
25131494|NCT01626079|50244976|FG002|Overall Study|Lost to Follow-up|2|||
25131495|NCT01626079|50244974|FG000|Overall Study|Missed Visits|13|||
25131496|NCT01626079|50244975|FG001|Overall Study|Missed Visits|5|||
25131497|NCT01626079|50244976|FG002|Overall Study|Missed Visits|6|||
25131498|NCT01462942|50244992|FG000|Overall Study|Adverse Event|7|||
25131499|NCT01462942|50244993|FG001|Overall Study|Adverse Event|12|||
25131500|NCT01462942|50244994|FG002|Overall Study|Adverse Event|10|||
25131501|NCT01462942|50244995|FG003|Overall Study|Adverse Event|11|||
25131502|NCT01462942|50244996|FG004|Overall Study|Adverse Event|11|||
25131503|NCT01462942|50244992|FG000|Overall Study|Other, including COPD exacerbation|3|||
25131504|NCT01462942|50244993|FG001|Overall Study|Other, including COPD exacerbation|5|||
25131505|NCT01462942|50244994|FG002|Overall Study|Other, including COPD exacerbation|2|||
25131506|NCT01462942|50244995|FG003|Overall Study|Other, including COPD exacerbation|8|||
25131507|NCT01462942|50244996|FG004|Overall Study|Other, including COPD exacerbation|5|||
25131508|NCT01462942|50244992|FG000|Overall Study|Withdrawal by Subject|14|||
25131509|NCT01462942|50244993|FG001|Overall Study|Withdrawal by Subject|10|||
25131510|NCT01462942|50244994|FG002|Overall Study|Withdrawal by Subject|14|||
25131511|NCT01462942|50244995|FG003|Overall Study|Withdrawal by Subject|16|||
25131512|NCT01462942|50244996|FG004|Overall Study|Withdrawal by Subject|19|||
25131513|NCT01462942|50244992|FG000|Overall Study|Lack of Efficacy|6|||
25131514|NCT01462942|50244993|FG001|Overall Study|Lack of Efficacy|0|||
25131515|NCT01462942|50244994|FG002|Overall Study|Lack of Efficacy|4|||
25131516|NCT01462942|50244995|FG003|Overall Study|Lack of Efficacy|5|||
25131517|NCT01462942|50244996|FG004|Overall Study|Lack of Efficacy|3|||
25131518|NCT01462942|50244992|FG000|Overall Study|Lost to Follow-up|0|||
25131519|NCT01462942|50244993|FG001|Overall Study|Lost to Follow-up|1|||
25131520|NCT01462942|50244994|FG002|Overall Study|Lost to Follow-up|1|||
25131521|NCT01462942|50244995|FG003|Overall Study|Lost to Follow-up|1|||
25131522|NCT01462942|50244996|FG004|Overall Study|Lost to Follow-up|1|||
25131523|NCT01462942|50244992|FG000|Overall Study|Protocol Violation|4|||
25131524|NCT01462942|50244993|FG001|Overall Study|Protocol Violation|6|||
25131525|NCT01462942|50244994|FG002|Overall Study|Protocol Violation|9|||
25131526|NCT01462942|50244995|FG003|Overall Study|Protocol Violation|9|||
25131527|NCT01462942|50244996|FG004|Overall Study|Protocol Violation|6|||
25131528|NCT01462630|50245008|FG000|Overall Study|Did not initiate therapy|3|||
25131529|NCT01462630|50245008|FG000|Overall Study|Death|1|||
25131530|NCT01462630|50245008|FG000|Overall Study|Protocol Violation|2|||
25131531|NCT01462630|50245008|FG000|Overall Study|Adverse Event|1|||
25131532|NCT01504204|50245014|FG000|Overall Study|Lost to Follow-up|1|||
25131533|NCT01504204|50245015|FG001|Overall Study|Lost to Follow-up|1|||
25131534|NCT01485640|50245021|FG000|Overall Study|Adverse Event|10|||
25131535|NCT01485640|50245021|FG000|Overall Study|Lack of Efficacy|2|||
25131536|NCT01485640|50245021|FG000|Overall Study|Protocol Violation|1|||
25131537|NCT01485640|50245021|FG000|Overall Study|Withdrawal by Subject|14|||
25131538|NCT01485640|50245021|FG000|Overall Study|Terminated by Sponsor|95|||
25131539|NCT02118961|50245027|FG000|Overall Study|Withdrawal by Subject|1|||
25131540|NCT02118961|50245028|FG001|Overall Study|Withdrawal by Subject|0|||
25131541|NCT02140645|50245040|FG000|Overall Study|Not linked|5489|||
25131542|NCT02140645|50245041|FG001|Overall Study|Not linked|61654|||
25131543|NCT02140645|50245042|FG002|Overall Study|Not linked|4236|||
25131544|NCT02140645|50245043|FG003|Overall Study|Not linked|13833|||
25131545|NCT02140645|50245044|FG004|Overall Study|Not linked|3286|||
25131546|NCT02140645|50245045|FG005|Overall Study|Not linked|70896|||
25131547|NCT02140567|50245054|FG000|Overall Study|Problems with recording equipment|6|||
25131548|NCT02140411|50245059|FG000|Overall Study|Adverse Event|1|||
25131549|NCT02139943|50245066|FG000|Overall Study|Adverse Event|0|||
25131550|NCT02139943|50245067|FG001|Overall Study|Adverse Event|1|||
25131551|NCT02139943|50245068|FG002|Overall Study|Adverse Event|2|||
25131552|NCT02139943|50245066|FG000|Overall Study|Lost to Follow-up|3|||
25131553|NCT02139943|50245067|FG001|Overall Study|Lost to Follow-up|2|||
25131554|NCT02139943|50245068|FG002|Overall Study|Lost to Follow-up|2|||
25131555|NCT02139943|50245066|FG000|Overall Study|Withdrawal by Subject|4|||
25131556|NCT02139943|50245067|FG001|Overall Study|Withdrawal by Subject|3|||
25131557|NCT02139943|50245068|FG002|Overall Study|Withdrawal by Subject|0|||
25131558|NCT02139943|50245066|FG000|Overall Study|Other|0|||
25131559|NCT02139943|50245067|FG001|Overall Study|Other|0|||
25131560|NCT02139943|50245068|FG002|Overall Study|Other|1|||
25131561|NCT02139943|50245066|FG000|Overall Study|Participant wishes to discontinue|2|||
25131562|NCT02139943|50245067|FG001|Overall Study|Participant wishes to discontinue|0|||
25131563|NCT02139943|50245068|FG002|Overall Study|Participant wishes to discontinue|0|||
25131564|NCT02139943|50245066|FG000|Overall Study|Participant in Poor Compliance|1|||
25131565|NCT02139943|50245067|FG001|Overall Study|Participant in Poor Compliance|0|||
25131566|NCT02139943|50245068|FG002|Overall Study|Participant in Poor Compliance|1|||
25131567|NCT02139943|50245066|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
25131568|NCT02139943|50245067|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
25131569|NCT02139943|50245068|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
25131570|NCT01485172|50245082|FG000|Overall Study|Adverse Event|2|||
25131571|NCT01485172|50245083|FG001|Overall Study|Adverse Event|1|||
25131572|NCT01485172|50245084|FG002|Overall Study|Adverse Event|2|||
25131573|NCT01485172|50245085|FG003|Overall Study|Adverse Event|2|||
25131574|NCT01485172|50245086|FG004|Overall Study|Adverse Event|1|||
25131575|NCT01485172|50245087|FG005|Overall Study|Adverse Event|2|||
25131576|NCT01485172|50245082|FG000|Overall Study|Lack of Efficacy|2|||
25131577|NCT01485172|50245083|FG001|Overall Study|Lack of Efficacy|0|||
25131578|NCT01485172|50245084|FG002|Overall Study|Lack of Efficacy|0|||
25131579|NCT01485172|50245085|FG003|Overall Study|Lack of Efficacy|0|||
25131580|NCT01485172|50245086|FG004|Overall Study|Lack of Efficacy|0|||
25131581|NCT01485172|50245087|FG005|Overall Study|Lack of Efficacy|0|||
25131582|NCT01485172|50245082|FG000|Overall Study|Protocol Violation|0|||
25131583|NCT01485172|50245083|FG001|Overall Study|Protocol Violation|0|||
25131584|NCT01485172|50245084|FG002|Overall Study|Protocol Violation|4|||
25131585|NCT01485172|50245085|FG003|Overall Study|Protocol Violation|5|||
25131586|NCT01485172|50245086|FG004|Overall Study|Protocol Violation|1|||
25131587|NCT01485172|50245087|FG005|Overall Study|Protocol Violation|0|||
25131588|NCT01485172|50245082|FG000|Overall Study|Protocol defined stopping criteria|1|||
25131589|NCT01485172|50245083|FG001|Overall Study|Protocol defined stopping criteria|0|||
25131590|NCT01485172|50245084|FG002|Overall Study|Protocol defined stopping criteria|0|||
25131591|NCT01485172|50245085|FG003|Overall Study|Protocol defined stopping criteria|0|||
25131592|NCT01485172|50245086|FG004|Overall Study|Protocol defined stopping criteria|1|||
25131593|NCT01485172|50245087|FG005|Overall Study|Protocol defined stopping criteria|0|||
25131594|NCT01485172|50245082|FG000|Overall Study|Lost to Follow-up|0|||
25131595|NCT01485172|50245083|FG001|Overall Study|Lost to Follow-up|0|||
25131596|NCT01485172|50245084|FG002|Overall Study|Lost to Follow-up|1|||
25131597|NCT01485172|50245085|FG003|Overall Study|Lost to Follow-up|0|||
25131598|NCT01485172|50245086|FG004|Overall Study|Lost to Follow-up|0|||
25131599|NCT01485172|50245087|FG005|Overall Study|Lost to Follow-up|1|||
25131600|NCT01485172|50245082|FG000|Overall Study|Physician Decision|0|||
25131601|NCT01485172|50245083|FG001|Overall Study|Physician Decision|0|||
25131602|NCT01485172|50245084|FG002|Overall Study|Physician Decision|0|||
25131603|NCT01485172|50245085|FG003|Overall Study|Physician Decision|0|||
25131604|NCT01485172|50245086|FG004|Overall Study|Physician Decision|1|||
25131605|NCT01485172|50245087|FG005|Overall Study|Physician Decision|0|||
25131606|NCT01485172|50245082|FG000|Overall Study|Withdrawal by Subject|2|||
25131607|NCT01485172|50245083|FG001|Overall Study|Withdrawal by Subject|0|||
25131608|NCT01485172|50245084|FG002|Overall Study|Withdrawal by Subject|0|||
25131609|NCT01485172|50245085|FG003|Overall Study|Withdrawal by Subject|1|||
25131610|NCT01485172|50245086|FG004|Overall Study|Withdrawal by Subject|1|||
25131611|NCT01485172|50245087|FG005|Overall Study|Withdrawal by Subject|1|||
25009360|NCT00075725|50102303|FG009|Overall Study|Institution Terminated|0|||
25009361|NCT00075725|50102304|FG010|Overall Study|Institution Terminated|0|||
25009362|NCT00075725|50102305|FG011|Overall Study|Institution Terminated|0|||
25131612|NCT02105701|50245105|FG000|Overall Study|Lost to Follow-up|1|||
25131613|NCT02105701|50245106|FG001|Overall Study|Lost to Follow-up|0|||
25009363|NCT00075725|50102294|FG000|Overall Study|Study Closure|1|||
25131614|NCT02105701|50245107|FG002|Overall Study|Lost to Follow-up|2|||
25131615|NCT02105701|50245108|FG003|Overall Study|Lost to Follow-up|1|||
25131616|NCT02105701|50245105|FG000|Overall Study|Protocol Violation|0|||
25131617|NCT02105701|50245106|FG001|Overall Study|Protocol Violation|0|||
25131618|NCT02105701|50245107|FG002|Overall Study|Protocol Violation|1|||
25131619|NCT02105701|50245108|FG003|Overall Study|Protocol Violation|0|||
25131620|NCT02105701|50245105|FG000|Overall Study|Withdrawal by Subject|2|||
25131621|NCT02105701|50245106|FG001|Overall Study|Withdrawal by Subject|1|||
25131622|NCT02105701|50245107|FG002|Overall Study|Withdrawal by Subject|0|||
25131623|NCT02105701|50245108|FG003|Overall Study|Withdrawal by Subject|1|||
25131624|NCT02105701|50245105|FG000|Overall Study|Death|1|||
25131625|NCT02105701|50245106|FG001|Overall Study|Death|0|||
25131626|NCT02105701|50245107|FG002|Overall Study|Death|0|||
25131627|NCT02105701|50245108|FG003|Overall Study|Death|0|||
25131628|NCT01502956|50245120|FG000|Overall Study|Death|0|||
25131629|NCT01502956|50245121|FG001|Overall Study|Death|2|||
25131630|NCT01502956|50245120|FG000|Overall Study|Lost to Follow-up|14|||
25131631|NCT01502956|50245121|FG001|Overall Study|Lost to Follow-up|11|||
25131632|NCT01502956|50245120|FG000|Overall Study|Physician Decision|2|||
25131633|NCT01502956|50245121|FG001|Overall Study|Physician Decision|3|||
25131634|NCT01502956|50245120|FG000|Overall Study|Withdrawal by Subject|8|||
25131635|NCT01502956|50245121|FG001|Overall Study|Withdrawal by Subject|10|||
25131636|NCT01502644|50245130|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
25131637|NCT01502644|50245131|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
25131638|NCT01502644|50245132|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
25131639|NCT01502644|50245133|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
25131640|NCT01502644|50245130|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
25131641|NCT01502644|50245131|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
25131642|NCT01502644|50245132|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
25131643|NCT01502644|50245133|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
25131644|NCT01502644|50245130|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
25131645|NCT01502644|50245131|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
25131646|NCT01502644|50245132|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
25131647|NCT01502644|50245133|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
25131648|NCT01502644|50245130|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
25131649|NCT01502644|50245131|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
25131650|NCT01502644|50245132|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
25131651|NCT01502644|50245133|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
25131652|NCT01502644|50245130|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
25131653|NCT01502644|50245131|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
25131654|NCT01502644|50245132|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
25131655|NCT01502644|50245133|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
25131656|NCT01462318|50245143|FG000|Main Study / TP-DI Study|Other|2|||
25131657|NCT01462318|50245144|FG001|Main Study / TP-DI Study|Other|0|||
25131658|NCT01462318|50245145|FG002|Main Study / TP-DI Study|Other|0|||
25131659|NCT01462318|50245143|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
25131660|NCT01462318|50245144|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
25131661|NCT01462318|50245145|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
25131662|NCT01462318|50245143|FG000|Main Study / TP-DI Study|Adverse Event|4|||
25131663|NCT01462318|50245144|FG001|Main Study / TP-DI Study|Adverse Event|0|||
25131664|NCT01462318|50245145|FG002|Main Study / TP-DI Study|Adverse Event|0|||
25131665|NCT01462318|50245143|FG000|Extension Phase|Lost to Follow-up|0|||
25131666|NCT01462318|50245144|FG001|Extension Phase|Lost to Follow-up|0|||
25131667|NCT01462318|50245145|FG002|Extension Phase|Lost to Follow-up|1|||
25131668|NCT01462318|50245143|FG000|Extension Phase|Other|0|||
25131669|NCT01462318|50245144|FG001|Extension Phase|Other|0|||
25131670|NCT01462318|50245145|FG002|Extension Phase|Other|1|||
25131671|NCT01462318|50245143|FG000|Extension Phase|Disease Progression|0|||
25131672|NCT01462318|50245144|FG001|Extension Phase|Disease Progression|0|||
25131673|NCT01462318|50245145|FG002|Extension Phase|Disease Progression|1|||
25131674|NCT01462318|50245143|FG000|Extension Phase|Withdrawal by Subject|0|||
25131675|NCT01462318|50245144|FG001|Extension Phase|Withdrawal by Subject|0|||
25131676|NCT01462318|50245145|FG002|Extension Phase|Withdrawal by Subject|15|||
25131677|NCT01462318|50245143|FG000|Extension Phase|Investigator Decision|0|||
25131678|NCT01462318|50245144|FG001|Extension Phase|Investigator Decision|0|||
25131679|NCT01462318|50245145|FG002|Extension Phase|Investigator Decision|5|||
25131680|NCT01462318|50245143|FG000|Extension Phase|Adverse Event|0|||
25131681|NCT01462318|50245144|FG001|Extension Phase|Adverse Event|0|||
25131682|NCT01462318|50245145|FG002|Extension Phase|Adverse Event|22|||
25131683|NCT01485094|50245153|FG000|Overall Study|Adverse Event|1|||
25131684|NCT01485094|50245154|FG001|Overall Study|Adverse Event|1|||
25131685|NCT01485094|50245155|FG002|Overall Study|Adverse Event|1|||
25131686|NCT01485094|50245153|FG000|Overall Study|Lost to Follow-up|1|||
25131687|NCT01485094|50245154|FG001|Overall Study|Lost to Follow-up|0|||
25131688|NCT01485094|50245155|FG002|Overall Study|Lost to Follow-up|0|||
25131689|NCT01485094|50245153|FG000|Overall Study|Withdrawal by Subject|1|||
25131690|NCT01485094|50245154|FG001|Overall Study|Withdrawal by Subject|1|||
25131691|NCT01485094|50245155|FG002|Overall Study|Withdrawal by Subject|0|||
25131692|NCT01484938|50245163|FG000|Overall Study|Adverse Event|2|||
25131693|NCT01484938|50245163|FG000|Overall Study|Lost to Follow-up|1|||
25131694|NCT01484938|50245163|FG000|Overall Study|Noncompliance|1|||
25131695|NCT01502410|50245171|FG000|Overall Study|Adverse Event|1|||
25131696|NCT01502410|50245172|FG001|Overall Study|Adverse Event|2|||
25131697|NCT01502410|50245173|FG002|Overall Study|Adverse Event|0|||
25131698|NCT01502410|50245174|FG003|Overall Study|Adverse Event|0|||
25131699|NCT01502410|50245171|FG000|Overall Study|Lack of Efficacy|7|||
25131700|NCT01502410|50245172|FG001|Overall Study|Lack of Efficacy|7|||
25131701|NCT01502410|50245173|FG002|Overall Study|Lack of Efficacy|0|||
25131702|NCT01502410|50245174|FG003|Overall Study|Lack of Efficacy|0|||
25131703|NCT01502410|50245171|FG000|Overall Study|Physician Decision|0|||
25131704|NCT01502410|50245172|FG001|Overall Study|Physician Decision|1|||
25131705|NCT01502410|50245173|FG002|Overall Study|Physician Decision|0|||
25131706|NCT01502410|50245174|FG003|Overall Study|Physician Decision|0|||
25131707|NCT01502410|50245171|FG000|Overall Study|Withdrawal by Subject|2|||
25131708|NCT01502410|50245172|FG001|Overall Study|Withdrawal by Subject|0|||
25131709|NCT01502410|50245173|FG002|Overall Study|Withdrawal by Subject|0|||
25131710|NCT01502410|50245174|FG003|Overall Study|Withdrawal by Subject|0|||
25131711|NCT01462162|50245183|FG000|Overall Study|Adverse Event|5|||
25131712|NCT01462162|50245183|FG000|Overall Study|Lack of Efficacy|4|||
25131713|NCT01462162|50245183|FG000|Overall Study|Abnormal laboratory parameters|1|||
25131714|NCT01462162|50245183|FG000|Overall Study|Other|2|||
25131715|NCT01483924|50245193|FG000|Overall Study|Withdrawal by Subject|2|||
25272900|NCT01254305|50586973|FG002|Overall Study|Adverse Event|2|||
25272901|NCT01254305|50586971|FG000|Overall Study|Lack of Efficacy|1|||
25272902|NCT01254305|50586972|FG001|Overall Study|Lack of Efficacy|0|||
25272903|NCT01254305|50586973|FG002|Overall Study|Lack of Efficacy|1|||
25272904|NCT01254305|50586971|FG000|Overall Study|Protocol Violation|1|||
25272905|NCT01254305|50586972|FG001|Overall Study|Protocol Violation|7|||
25272906|NCT01254305|50586973|FG002|Overall Study|Protocol Violation|3|||
25272907|NCT01254305|50586971|FG000|Overall Study|Withdrawal by Subject|4|||
25272908|NCT01254305|50586972|FG001|Overall Study|Withdrawal by Subject|2|||
25272909|NCT01254305|50586973|FG002|Overall Study|Withdrawal by Subject|4|||
25272910|NCT01254305|50586971|FG000|Overall Study|Lost to Follow-up|10|||
25272911|NCT01254305|50586972|FG001|Overall Study|Lost to Follow-up|6|||
25272912|NCT01254305|50586973|FG002|Overall Study|Lost to Follow-up|5|||
25272913|NCT01254305|50586971|FG000|Overall Study|Other Reasons|0|||
25272914|NCT01254305|50586972|FG001|Overall Study|Other Reasons|0|||
25272915|NCT01254305|50586973|FG002|Overall Study|Other Reasons|2|||
25272916|NCT01122927|50586984|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
25272917|NCT01122927|50586985|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
25272918|NCT01122927|50586984|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
25272919|NCT01122927|50586985|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
25272920|NCT01122927|50586984|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
25272921|NCT01122927|50586985|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
25272922|NCT01122927|50586984|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
25272923|NCT01122927|50586985|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
25272924|NCT01122927|50586984|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
25272925|NCT01122927|50586985|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
25272926|NCT01122927|50586984|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
25131716|NCT01483924|50245194|FG001|Overall Study|Withdrawal by Subject|0|||
25178711|NCT01470989|50324045|FG000|Overall Study|Adverse Event|2|||
25178712|NCT01470989|50324046|FG001|Overall Study|Adverse Event|5|||
25178713|NCT01470989|50324045|FG000|Overall Study|Abnormal laboratory value|1|||
25131717|NCT01483924|50245195|FG002|Overall Study|Withdrawal by Subject|0|||
25131718|NCT01483924|50245196|FG003|Overall Study|Withdrawal by Subject|1|||
25131719|NCT01483924|50245197|FG004|Overall Study|Withdrawal by Subject|1|||
25131720|NCT01483924|50245193|FG000|Overall Study|Adverse Event|0|||
25131721|NCT01483924|50245194|FG001|Overall Study|Adverse Event|0|||
25131722|NCT01483924|50245195|FG002|Overall Study|Adverse Event|1|||
25131723|NCT01483924|50245196|FG003|Overall Study|Adverse Event|1|||
25131724|NCT01483924|50245197|FG004|Overall Study|Adverse Event|0|||
25131725|NCT01483924|50245193|FG000|Overall Study|Non-compliance|0|||
25131726|NCT01483924|50245194|FG001|Overall Study|Non-compliance|0|||
25131727|NCT01483924|50245195|FG002|Overall Study|Non-compliance|0|||
25131728|NCT01483924|50245196|FG003|Overall Study|Non-compliance|1|||
25178714|NCT01470989|50324046|FG001|Overall Study|Abnormal laboratory value|1|||
25178715|NCT01470989|50324045|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25178716|NCT01470989|50324046|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
25178717|NCT01470989|50324045|FG000|Overall Study|Withdrawal by Subject|19|||
25178718|NCT01470989|50324046|FG001|Overall Study|Withdrawal by Subject|17|||
25272927|NCT01122927|50586985|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
25272928|NCT01122927|50586984|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
25272929|NCT01122927|50586985|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
25272930|NCT01122927|50586984|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
25272931|NCT01122927|50586985|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
25131729|NCT01483924|50245197|FG004|Overall Study|Non-compliance|1|||
25131730|NCT01483924|50245193|FG000|Overall Study|Sponsor concern over ECG result|0|||
25131731|NCT01483924|50245194|FG001|Overall Study|Sponsor concern over ECG result|0|||
25131732|NCT01483924|50245195|FG002|Overall Study|Sponsor concern over ECG result|0|||
25178719|NCT01470989|50324045|FG000|Overall Study|Lost to Follow-up|18|||
25178720|NCT01470989|50324046|FG001|Overall Study|Lost to Follow-up|13|||
25178721|NCT01470989|50324045|FG000|Overall Study|Administrative problems|2|||
25178722|NCT01470989|50324046|FG001|Overall Study|Administrative problems|4|||
25178723|NCT01470989|50324045|FG000|Overall Study|Death|2|||
25009364|NCT00075725|50102295|FG001|Overall Study|Study Closure|0|||
25131733|NCT01483924|50245196|FG003|Overall Study|Sponsor concern over ECG result|1|||
25131734|NCT01483924|50245197|FG004|Overall Study|Sponsor concern over ECG result|0|||
25131735|NCT01462084|50245218|FG000|Overall Study|Withdrawal by Subject|1|||
25131736|NCT01462084|50245219|FG001|Overall Study|Withdrawal by Subject|0|||
25131737|NCT01462084|50245218|FG000|Overall Study|Protocol Violation|1|||
25131738|NCT01462084|50245219|FG001|Overall Study|Protocol Violation|1|||
25131739|NCT02134028|50245234|FG000|Overall Study|Lack of Efficacy|1|||
25131740|NCT02134028|50245235|FG001|Overall Study|Lack of Efficacy|0|||
25131741|NCT02134028|50245236|FG002|Overall Study|Lack of Efficacy|3|||
25131742|NCT02134028|50245237|FG003|Overall Study|Lack of Efficacy|2|||
25131743|NCT02134028|50245238|FG004|Overall Study|Lack of Efficacy|1|||
25131744|NCT02134028|50245239|FG005|Overall Study|Lack of Efficacy|2|||
25131745|NCT02134028|50245240|FG006|Overall Study|Lack of Efficacy|1|||
25131746|NCT02134028|50245241|FG007|Overall Study|Lack of Efficacy|0|||
25131747|NCT02134028|50245234|FG000|Overall Study|Poor compliance to protocol|1|||
25131748|NCT02134028|50245235|FG001|Overall Study|Poor compliance to protocol|1|||
25131749|NCT02134028|50245236|FG002|Overall Study|Poor compliance to protocol|3|||
25131750|NCT02134028|50245237|FG003|Overall Study|Poor compliance to protocol|7|||
25131751|NCT02134028|50245238|FG004|Overall Study|Poor compliance to protocol|1|||
25131752|NCT02134028|50245239|FG005|Overall Study|Poor compliance to protocol|1|||
25131753|NCT02134028|50245240|FG006|Overall Study|Poor compliance to protocol|0|||
25131754|NCT02134028|50245241|FG007|Overall Study|Poor compliance to protocol|0|||
25131755|NCT02134028|50245234|FG000|Overall Study|Other unspecified|4|||
25131756|NCT02134028|50245235|FG001|Overall Study|Other unspecified|22|||
25131757|NCT02134028|50245236|FG002|Overall Study|Other unspecified|33|||
25131758|NCT02134028|50245237|FG003|Overall Study|Other unspecified|64|||
25131759|NCT02134028|50245238|FG004|Overall Study|Other unspecified|8|||
25009365|NCT00075725|50102296|FG002|Overall Study|Study Closure|0|||
25009366|NCT00075725|50102297|FG003|Overall Study|Study Closure|0|||
25009367|NCT00075725|50102298|FG004|Overall Study|Study Closure|1|||
25009368|NCT00075725|50102299|FG005|Overall Study|Study Closure|3|||
25009369|NCT00075725|50102300|FG006|Overall Study|Study Closure|0|||
25009370|NCT00075725|50102301|FG007|Overall Study|Study Closure|1|||
25009371|NCT00075725|50102302|FG008|Overall Study|Study Closure|0|||
25009372|NCT00075725|50102303|FG009|Overall Study|Study Closure|0|||
25009373|NCT00075725|50102304|FG010|Overall Study|Study Closure|0|||
25009374|NCT00075725|50102305|FG011|Overall Study|Study Closure|0|||
25009375|NCT00075725|50102294|FG000|Overall Study|Other complications|0|||
25009376|NCT00075725|50102295|FG001|Overall Study|Other complications|0|||
25131760|NCT02134028|50245239|FG005|Overall Study|Other unspecified|6|||
25131761|NCT02134028|50245240|FG006|Overall Study|Other unspecified|2|||
25131762|NCT02134028|50245241|FG007|Overall Study|Other unspecified|1|||
25131763|NCT02134028|50245234|FG000|Overall Study|Adverse Event|3|||
25131764|NCT02134028|50245235|FG001|Overall Study|Adverse Event|19|||
25131765|NCT02134028|50245236|FG002|Overall Study|Adverse Event|13|||
25131766|NCT02134028|50245237|FG003|Overall Study|Adverse Event|32|||
25131767|NCT02134028|50245238|FG004|Overall Study|Adverse Event|4|||
25131768|NCT02134028|50245239|FG005|Overall Study|Adverse Event|5|||
25131769|NCT02134028|50245240|FG006|Overall Study|Adverse Event|1|||
25131770|NCT02134028|50245241|FG007|Overall Study|Adverse Event|2|||
25131771|NCT02172950|50245263|FG000|Overall Study|Physician Decision|3|||
25131772|NCT02172950|50245264|FG001|Overall Study|Physician Decision|3|||
25131773|NCT02172950|50245263|FG000|Overall Study|Lack of Efficacy|1|||
25131774|NCT02172950|50245264|FG001|Overall Study|Lack of Efficacy|0|||
25131775|NCT02172950|50245263|FG000|Overall Study|Adverse Event|4|||
25131776|NCT02172950|50245264|FG001|Overall Study|Adverse Event|1|||
25131777|NCT02172950|50245263|FG000|Overall Study|Withdrawal by Subject|10|||
25131778|NCT02172950|50245264|FG001|Overall Study|Withdrawal by Subject|0|||
25131779|NCT02172950|50245263|FG000|Overall Study|Protocol Violation|1|||
25131780|NCT02172950|50245264|FG001|Overall Study|Protocol Violation|0|||
25131781|NCT02172950|50245263|FG000|Overall Study|Lost to Follow-up|1|||
25178724|NCT01470989|50324046|FG001|Overall Study|Death|2|||
25178725|NCT01470989|50324045|FG000|Overall Study|Protocol deviation|1|||
25009377|NCT00075725|50102296|FG002|Overall Study|Other complications|0|||
25009378|NCT00075725|50102297|FG003|Overall Study|Other complications|0|||
25009379|NCT00075725|50102298|FG004|Overall Study|Other complications|0|||
25009380|NCT00075725|50102299|FG005|Overall Study|Other complications|1|||
25131782|NCT02172950|50245264|FG001|Overall Study|Lost to Follow-up|0|||
25131783|NCT02172950|50245263|FG000|Overall Study|Death|1|||
25131784|NCT02172950|50245264|FG001|Overall Study|Death|0|||
25131785|NCT02172950|50245263|FG000|Overall Study|Patient traveling|1|||
25131786|NCT02172950|50245264|FG001|Overall Study|Patient traveling|0|||
25131787|NCT02172950|50245263|FG000|Overall Study|Patient went to other country|1|||
25131788|NCT02172950|50245264|FG001|Overall Study|Patient went to other country|0|||
25131789|NCT02172950|50245263|FG000|Overall Study|Patient relocated overseas|1|||
25131790|NCT02172950|50245264|FG001|Overall Study|Patient relocated overseas|1|||
25131791|NCT02172950|50245263|FG000|Overall Study|Patient moving|1|||
25131792|NCT02172950|50245264|FG001|Overall Study|Patient moving|0|||
25131793|NCT02151266|50245274|FG000|Overall Study|Lost to Follow-up|1|||
25131794|NCT02151266|50245275|FG001|Overall Study|Lost to Follow-up|4|||
25131795|NCT02151266|50245276|FG002|Overall Study|Lost to Follow-up|1|||
25131796|NCT02151266|50245274|FG000|Overall Study|Did NOT receive intervention|3|||
25131797|NCT02151266|50245275|FG001|Overall Study|Did NOT receive intervention|6|||
25131798|NCT02151266|50245276|FG002|Overall Study|Did NOT receive intervention|2|||
25131799|NCT02151266|50245274|FG000|Overall Study|Not able to exercise|4|||
25131800|NCT02151266|50245275|FG001|Overall Study|Not able to exercise|5|||
25131801|NCT02151266|50245276|FG002|Overall Study|Not able to exercise|4|||
25131802|NCT02151110|50245292|FG000|Overall Study|Withdrawal by Subject|0|||
25131803|NCT02151110|50245293|FG001|Overall Study|Withdrawal by Subject|0|||
25131804|NCT02151110|50245294|FG002|Overall Study|Withdrawal by Subject|0|||
25131805|NCT02151110|50245295|FG003|Overall Study|Withdrawal by Subject|0|||
25131806|NCT02151110|50245296|FG004|Overall Study|Withdrawal by Subject|0|||
25131807|NCT02151110|50245297|FG005|Overall Study|Withdrawal by Subject|0|||
25131808|NCT02151110|50245298|FG006|Overall Study|Withdrawal by Subject|0|||
25131809|NCT02151110|50245299|FG007|Overall Study|Withdrawal by Subject|1|||
25131810|NCT02151110|50245292|FG000|Overall Study|Lost to Follow-up|0|||
25131811|NCT02151110|50245293|FG001|Overall Study|Lost to Follow-up|0|||
25131812|NCT02151110|50245294|FG002|Overall Study|Lost to Follow-up|0|||
25131813|NCT02151110|50245295|FG003|Overall Study|Lost to Follow-up|0|||
25131814|NCT02151110|50245296|FG004|Overall Study|Lost to Follow-up|0|||
25131815|NCT02151110|50245297|FG005|Overall Study|Lost to Follow-up|0|||
25131816|NCT02151110|50245298|FG006|Overall Study|Lost to Follow-up|0|||
25131817|NCT02151110|50245299|FG007|Overall Study|Lost to Follow-up|2|||
25131818|NCT02132312|50245326|FG000|Overall Study|Adverse Event|2|||
25131819|NCT02132312|50245327|FG001|Overall Study|Adverse Event|0|||
25131820|NCT02132312|50245326|FG000|Overall Study|Physician Decision|1|||
25131821|NCT02132312|50245327|FG001|Overall Study|Physician Decision|1|||
25131822|NCT02132312|50245326|FG000|Overall Study|Protocol Violation|0|||
25131823|NCT02132312|50245327|FG001|Overall Study|Protocol Violation|1|||
25131824|NCT02132312|50245326|FG000|Overall Study|Withdrawal by Subject|1|||
25131825|NCT02132312|50245327|FG001|Overall Study|Withdrawal by Subject|0|||
25131826|NCT02132312|50245326|FG000|Overall Study|Lost to Follow-up|2|||
25131827|NCT02132312|50245327|FG001|Overall Study|Lost to Follow-up|1|||
25131828|NCT02131766|50245333|FG000|Overall Study|Withdrawal by Subject|4|||
25131829|NCT02150954|50245342|FG000|Overall Study|Protocol Violation|1|||
25131830|NCT02150954|50245343|FG001|Overall Study|Protocol Violation|0|||
25131831|NCT02131532|50245349|FG000|Overall Study|Withdrawal by Subject|1|||
25131832|NCT02131532|50245349|FG000|Overall Study|Physician Decision|1|||
25131833|NCT02131532|50245349|FG000|Overall Study|Other health conditions|2|||
25131834|NCT02170688|50245363|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
25131835|NCT02170688|50245364|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
25131836|NCT02170688|50245365|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
25131837|NCT02170688|50245366|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
25131838|NCT02170688|50245367|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
25131839|NCT02170688|50245363|FG000|Overall Study|Full dose not received|0|||
25131840|NCT02170688|50245364|FG001|Overall Study|Full dose not received|1|||
25131841|NCT02170688|50245365|FG002|Overall Study|Full dose not received|0|||
25131842|NCT02170688|50245366|FG003|Overall Study|Full dose not received|0|||
25131843|NCT02170688|50245367|FG004|Overall Study|Full dose not received|0|||
25131844|NCT02170688|50245363|FG000|Overall Study|Physician Decision|0|||
25131845|NCT02170688|50245364|FG001|Overall Study|Physician Decision|0|||
25131846|NCT02170688|50245365|FG002|Overall Study|Physician Decision|1|||
25131847|NCT02170688|50245366|FG003|Overall Study|Physician Decision|0|||
25131848|NCT02170688|50245367|FG004|Overall Study|Physician Decision|0|||
25131849|NCT02170298|50245381|FG000|Overall Study|Withdrawal by Subject|0|||
25131850|NCT02170298|50245382|FG001|Overall Study|Withdrawal by Subject|1|||
25131851|NCT02170298|50245381|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
25178726|NCT01470989|50324046|FG001|Overall Study|Protocol deviation|2|||
25178727|NCT01470599|50324056|FG000|Overall Study|Did not meet entrance criteria|1|||
25178728|NCT01470599|50324057|FG001|Overall Study|Did not meet entrance criteria|0|||
25131852|NCT02170298|50245382|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
25131853|NCT02131064|50245390|FG000|Overall Study|Death|5|||
25131854|NCT02131064|50245391|FG001|Overall Study|Death|6|||
25131855|NCT02131064|50245390|FG000|Overall Study|Lost to Follow-up|4|||
25131856|NCT02131064|50245391|FG001|Overall Study|Lost to Follow-up|8|||
25131857|NCT02131064|50245390|FG000|Overall Study|Withdrawal by Subject|14|||
25178729|NCT01470599|50324056|FG000|Overall Study|Lost to Follow-up|2|||
25131858|NCT02131064|50245391|FG001|Overall Study|Withdrawal by Subject|18|||
25131859|NCT02131064|50245390|FG000|Overall Study|Other|2|||
25131860|NCT02131064|50245391|FG001|Overall Study|Other|2|||
25131861|NCT02130986|50245400|FG000|Overall Study|Withdrawal by Subject|4|||
25131862|NCT02130986|50245401|FG001|Overall Study|Withdrawal by Subject|4|||
25131863|NCT02130986|50245400|FG000|Overall Study|Lost to Follow-up|151|||
25131864|NCT02130986|50245401|FG001|Overall Study|Lost to Follow-up|160|||
25131865|NCT02130284|50245409|FG000|Overall Study|Withdrawal by Subject|3|||
25131866|NCT02130284|50245409|FG000|Overall Study|Subject Withdrew Consent|1|||
25131867|NCT02130284|50245409|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
25131868|NCT02130284|50245409|FG000|Overall Study|Subject was screened as backup for study|3|||
25131869|NCT02130284|50245409|FG000|Overall Study|Screen Failure|1|||
25131870|NCT02147288|50245415|FG000|Overall Study|post-operative hematoma|1|||
25131871|NCT02147288|50245416|FG001|Overall Study|post-operative hematoma|1|||
25131872|NCT02147288|50245417|FG002|Overall Study|post-operative hematoma|0|||
25131873|NCT02147288|50245418|FG003|Overall Study|post-operative hematoma|0|||
25131874|NCT02147288|50245419|FG004|Overall Study|post-operative hematoma|0|||
25131875|NCT02147288|50245420|FG005|Overall Study|post-operative hematoma|0|||
25131876|NCT02147288|50245421|FG006|Overall Study|post-operative hematoma|0|||
25131877|NCT02147288|50245422|FG007|Overall Study|post-operative hematoma|0|||
25131878|NCT02147288|50245423|FG008|Overall Study|post-operative hematoma|0|||
25131879|NCT02147288|50245424|FG009|Overall Study|post-operative hematoma|0|||
25131880|NCT02147288|50245415|FG000|Overall Study|complications from concurrent hernia rep|0|||
25131881|NCT02147288|50245416|FG001|Overall Study|complications from concurrent hernia rep|1|||
25131882|NCT02147288|50245417|FG002|Overall Study|complications from concurrent hernia rep|0|||
25131883|NCT02147288|50245418|FG003|Overall Study|complications from concurrent hernia rep|0|||
25131884|NCT02147288|50245419|FG004|Overall Study|complications from concurrent hernia rep|0|||
25131885|NCT02147288|50245420|FG005|Overall Study|complications from concurrent hernia rep|0|||
25131886|NCT02147288|50245421|FG006|Overall Study|complications from concurrent hernia rep|0|||
25131887|NCT02147288|50245422|FG007|Overall Study|complications from concurrent hernia rep|0|||
25131888|NCT02147288|50245423|FG008|Overall Study|complications from concurrent hernia rep|0|||
25131889|NCT02147288|50245424|FG009|Overall Study|complications from concurrent hernia rep|0|||
25131890|NCT02147132|50245430|FG000|Overall Study|Lost to Follow-up|1|||
25131891|NCT02147132|50245431|FG001|Overall Study|Lost to Follow-up|0|||
25131892|NCT02147132|50245432|FG002|Overall Study|Lost to Follow-up|0|||
25131893|NCT02147132|50245433|FG003|Overall Study|Lost to Follow-up|0|||
25131894|NCT02146430|50245447|FG000|Overall Study|Protocol Violation|5|||
25131895|NCT02146430|50245448|FG001|Overall Study|Protocol Violation|4|||
25131896|NCT02146430|50245449|FG002|Overall Study|Protocol Violation|8|||
25131897|NCT02146430|50245450|FG003|Overall Study|Protocol Violation|6|||
25131898|NCT02146430|50245447|FG000|Overall Study|Lack of Efficacy|13|||
25131899|NCT02146430|50245448|FG001|Overall Study|Lack of Efficacy|11|||
25131900|NCT02146430|50245449|FG002|Overall Study|Lack of Efficacy|8|||
25131901|NCT02146430|50245450|FG003|Overall Study|Lack of Efficacy|5|||
25131902|NCT02146430|50245447|FG000|Overall Study|Adverse Event|20|||
25131903|NCT02146430|50245448|FG001|Overall Study|Adverse Event|40|||
25131904|NCT02146430|50245449|FG002|Overall Study|Adverse Event|32|||
25131905|NCT02146430|50245450|FG003|Overall Study|Adverse Event|49|||
25131906|NCT02146430|50245447|FG000|Overall Study|Reason missing or not reported|2|||
25131907|NCT02146430|50245448|FG001|Overall Study|Reason missing or not reported|3|||
25131908|NCT02146430|50245449|FG002|Overall Study|Reason missing or not reported|4|||
25131909|NCT02146430|50245450|FG003|Overall Study|Reason missing or not reported|5|||
25131910|NCT02146430|50245447|FG000|Overall Study|Withdrawal by Subject|27|||
25131911|NCT02146430|50245448|FG001|Overall Study|Withdrawal by Subject|29|||
25131912|NCT02146430|50245449|FG002|Overall Study|Withdrawal by Subject|30|||
25131913|NCT02146430|50245450|FG003|Overall Study|Withdrawal by Subject|34|||
25131914|NCT02129192|50245466|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
25131915|NCT02129192|50245467|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
25131916|NCT02105948|50245480|FG000|Overall Study|Adverse Event|10|||
25131917|NCT02105948|50245481|FG001|Overall Study|Adverse Event|7|||
25131918|NCT02105948|50245482|FG002|Overall Study|Adverse Event|11|||
25272932|NCT01122927|50586984|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
25272933|NCT01122927|50586985|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
25272934|NCT01122927|50586984|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
25272935|NCT01122927|50586985|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
25272936|NCT01122927|50586984|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
25131919|NCT02105948|50245483|FG003|Overall Study|Adverse Event|11|||
25131920|NCT02105948|50245480|FG000|Overall Study|Lack of Efficacy|0|||
25131921|NCT02105948|50245481|FG001|Overall Study|Lack of Efficacy|1|||
25131922|NCT02105948|50245482|FG002|Overall Study|Lack of Efficacy|3|||
25131923|NCT02105948|50245483|FG003|Overall Study|Lack of Efficacy|2|||
25131924|NCT02105948|50245480|FG000|Overall Study|Lost to Follow-up|0|||
25131925|NCT02105948|50245481|FG001|Overall Study|Lost to Follow-up|0|||
25131926|NCT02105948|50245482|FG002|Overall Study|Lost to Follow-up|2|||
25131927|NCT02105948|50245483|FG003|Overall Study|Lost to Follow-up|1|||
25131928|NCT02105948|50245480|FG000|Overall Study|Physician Decision|2|||
25131929|NCT02105948|50245481|FG001|Overall Study|Physician Decision|2|||
25131930|NCT02105948|50245482|FG002|Overall Study|Physician Decision|2|||
25272937|NCT01122927|50586985|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
25272938|NCT01122927|50586984|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
25272939|NCT01122927|50586985|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
25272940|NCT01254227|50586995|FG000|Overall Study|Withdrawal by Subject|6|||
25272941|NCT01254227|50586995|FG000|Overall Study|Lost to Follow-up|6|||
25272942|NCT01254227|50586995|FG000|Overall Study|Adverse Event|5|||
25272943|NCT01254227|50586995|FG000|Overall Study|Abnormal test procedure result|5|||
25272944|NCT01254227|50586995|FG000|Overall Study|Administrative problems|2|||
25272945|NCT01254227|50586995|FG000|Overall Study|Death|1|||
25272946|NCT01254227|50586995|FG000|Overall Study|Protocol deviation|1|||
25272947|NCT00995410|50586999|FG000|Overall Study|Adverse Event|51|||
25272948|NCT00995410|50586999|FG000|Overall Study|Withdrawal by Subject|7|||
25272949|NCT00995410|50586999|FG000|Overall Study|Lost to Follow-up|2|||
25272950|NCT00995410|50586999|FG000|Overall Study|Misc|28|||
25272951|NCT00995020|50587005|FG000|Overall Study|margin analysis not performed|2|||
25272952|NCT00995020|50587006|FG001|Overall Study|margin analysis not performed|5|||
25272953|NCT00995020|50587005|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
25272954|NCT00995020|50587006|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
25272955|NCT01122381|50587016|FG000|Overall Study|study terminated early|0|||
25272956|NCT01122381|50587017|FG001|Overall Study|study terminated early|1|||
25272957|NCT00996034|50587023|FG000|Overall Study|Lost to Follow-up|2|||
25272958|NCT00996034|50587023|FG000|Overall Study|withdrawn by PI|1|||
25272959|NCT01253447|50587027|FG000|Overall Study|Adverse Event|2|||
25272960|NCT01121991|50587032|FG000|Overall Study|Lack of Ovarian Response|2|||
25272961|NCT01121991|50587032|FG000|Overall Study|No Oocytes Retrieved|3|||
25272962|NCT01121991|50587032|FG000|Overall Study|No Fertilization|1|||
25272963|NCT00994240|50587038|FG000|Overall Study|Lost to Follow-up|3|||
25272964|NCT00994240|50587039|FG001|Overall Study|Lost to Follow-up|2|||
25272965|NCT00994240|50587038|FG000|Overall Study|Withdrawal by Subject|1|||
25272966|NCT00994240|50587039|FG001|Overall Study|Withdrawal by Subject|0|||
25272967|NCT00994240|50587038|FG000|Overall Study|study termination|2|||
25272968|NCT00994240|50587039|FG001|Overall Study|study termination|3|||
25272969|NCT01253369|50587045|FG000|Overall Study|Adverse Event|4|||
25272970|NCT01253369|50587045|FG000|Overall Study|Withdrawal by Subject|2|||
25272971|NCT01253369|50587045|FG000|Overall Study|Death|1|||
25272972|NCT01253369|50587045|FG000|Overall Study|Progressive disease|23|||
25272973|NCT01253369|50587045|FG000|Overall Study|Not Evaluable|3|||
25272974|NCT01121913|50587049|FG000|First Intervention Period|Adverse Event|0|||
25272975|NCT01121913|50587050|FG001|First Intervention Period|Adverse Event|0|||
25272976|NCT01121913|50587051|FG002|First Intervention Period|Adverse Event|1|||
25272977|NCT01121913|50587052|FG003|First Intervention Period|Adverse Event|0|||
25272978|NCT01121913|50587049|FG000|First Washout Period|Withdrawal by Subject|1|||
25272979|NCT01121913|50587050|FG001|First Washout Period|Withdrawal by Subject|0|||
25272980|NCT01121913|50587051|FG002|First Washout Period|Withdrawal by Subject|0|||
25272981|NCT01121913|50587052|FG003|First Washout Period|Withdrawal by Subject|0|||
25272982|NCT01121913|50587049|FG000|Second Intervention Period|Adverse Event|0|||
25272983|NCT01121913|50587050|FG001|Second Intervention Period|Adverse Event|0|||
25131931|NCT02105948|50245483|FG003|Overall Study|Physician Decision|2|||
25131932|NCT02105948|50245480|FG000|Overall Study|Withdrawal by Subject|15|||
25131933|NCT02105948|50245481|FG001|Overall Study|Withdrawal by Subject|10|||
25131934|NCT02105948|50245482|FG002|Overall Study|Withdrawal by Subject|10|||
25131935|NCT02105948|50245483|FG003|Overall Study|Withdrawal by Subject|11|||
25131936|NCT02128724|50245498|FG000|Overall Study|Death|1|||
25131937|NCT02128724|50245499|FG001|Overall Study|Death|0|||
25131938|NCT02128724|50245500|FG002|Overall Study|Death|0|||
25272984|NCT01121913|50587051|FG002|Second Intervention Period|Adverse Event|1|||
25272985|NCT01121913|50587052|FG003|Second Intervention Period|Adverse Event|0|||
25272986|NCT01121913|50587049|FG000|Second Washout Period|Withdrawal by Subject|0|||
25272987|NCT01121913|50587050|FG001|Second Washout Period|Withdrawal by Subject|0|||
25272988|NCT01121913|50587051|FG002|Second Washout Period|Withdrawal by Subject|1|||
25272989|NCT01121913|50587052|FG003|Second Washout Period|Withdrawal by Subject|0|||
25272990|NCT01121913|50587049|FG000|Third Washout Period|Adverse Event|1|||
25272991|NCT01121913|50587050|FG001|Third Washout Period|Adverse Event|0|||
25272992|NCT01121913|50587051|FG002|Third Washout Period|Adverse Event|0|||
25131939|NCT02128724|50245501|FG003|Overall Study|Death|0|||
25131940|NCT02128724|50245498|FG000|Overall Study|Adverse Event|0|||
25131941|NCT02128724|50245499|FG001|Overall Study|Adverse Event|1|||
25131942|NCT02128724|50245500|FG002|Overall Study|Adverse Event|0|||
25131943|NCT02128724|50245501|FG003|Overall Study|Adverse Event|0|||
25131944|NCT02128724|50245498|FG000|Overall Study|Physician Decision|0|||
25272993|NCT01121913|50587052|FG003|Third Washout Period|Adverse Event|0|||
25272994|NCT00994162|50587064|FG000|Overall Study|Withdrawal by Subject|1|||
25272995|NCT00994162|50587064|FG000|Overall Study|Lost to Follow-up|2|||
25272996|NCT00994162|50587064|FG000|Overall Study|Product Complaint|1|||
25272997|NCT00994162|50587064|FG000|Overall Study|Poor Compliance|5|||
25131945|NCT02128724|50245499|FG001|Overall Study|Physician Decision|0|||
25272998|NCT00994162|50587064|FG000|Overall Study|Lack of Response|3|||
25272999|NCT00994162|50587064|FG000|Overall Study|Discharged from Hospital|4|||
25273000|NCT00994162|50587064|FG000|Overall Study|Death|2|||
25273001|NCT00994162|50587064|FG000|Overall Study|Care Transferred to Another Physician|2|||
25273002|NCT00994162|50587064|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
25273003|NCT00994162|50587064|FG000|Overall Study|Physician Decision|2|||
25273004|NCT00994162|50587064|FG000|Overall Study|Surrounding Wound Erythematous|1|||
25273005|NCT00994162|50587064|FG000|Overall Study|Machine Losing Vaccum|1|||
25273006|NCT00994162|50587064|FG000|Overall Study|Patient Lived Too Far Away|1|||
25273007|NCT00994162|50587064|FG000|Overall Study|Above Knee Amputation|1|||
25273008|NCT00994162|50587064|FG000|Overall Study|Reason Not Reported By Site|1|||
25273009|NCT00993928|50587071|FG000|Overall Study|Withdrawal by Subject|4|||
25273010|NCT00993928|50587072|FG001|Overall Study|Withdrawal by Subject|7|||
25273011|NCT00993928|50587071|FG000|Overall Study|ineligible|1|||
25273012|NCT00993928|50587072|FG001|Overall Study|ineligible|0|||
25273013|NCT01253291|50587087|FG000|Overall Study|Withdrawal by Subject|1|||
25273014|NCT01253291|50587088|FG001|Overall Study|Withdrawal by Subject|1|||
25273015|NCT01253291|50587089|FG002|Overall Study|Withdrawal by Subject|0|||
25273016|NCT01253291|50587090|FG003|Overall Study|Withdrawal by Subject|0|||
25273017|NCT01253291|50587091|FG004|Overall Study|Withdrawal by Subject|0|||
25273018|NCT01253291|50587087|FG000|Overall Study|Adverse Event|0|||
25273019|NCT01253291|50587088|FG001|Overall Study|Adverse Event|1|||
25273020|NCT01253291|50587089|FG002|Overall Study|Adverse Event|0|||
25273021|NCT01253291|50587090|FG003|Overall Study|Adverse Event|0|||
25273022|NCT01253291|50587091|FG004|Overall Study|Adverse Event|0|||
25273023|NCT01253291|50587087|FG000|Overall Study|Lack of Efficacy|1|||
25273024|NCT01253291|50587088|FG001|Overall Study|Lack of Efficacy|0|||
25273025|NCT01253291|50587089|FG002|Overall Study|Lack of Efficacy|0|||
25273026|NCT01253291|50587090|FG003|Overall Study|Lack of Efficacy|0|||
25273027|NCT01253291|50587091|FG004|Overall Study|Lack of Efficacy|0|||
25273028|NCT01253291|50587087|FG000|Overall Study|Physician Decision|2|||
25273029|NCT01253291|50587088|FG001|Overall Study|Physician Decision|0|||
25273030|NCT01253291|50587089|FG002|Overall Study|Physician Decision|0|||
25273031|NCT01253291|50587090|FG003|Overall Study|Physician Decision|0|||
25273032|NCT01253291|50587091|FG004|Overall Study|Physician Decision|2|||
25273033|NCT01121757|50587106|FG000|First Drug|Death|1|||
25273034|NCT01121757|50587107|FG001|First Drug|Death|0|||
25273035|NCT01121757|50587106|FG000|First Drug|Disease Progression|0|||
25273036|NCT01121757|50587107|FG001|First Drug|Disease Progression|2|||
25273037|NCT01121757|50587106|FG000|Combination|Physician Decision|0|||
25273038|NCT01121757|50587107|FG001|Combination|Physician Decision|1|||
25273039|NCT01121757|50587106|FG000|Combination|Disease Progression|2|||
25273040|NCT01121757|50587107|FG001|Combination|Disease Progression|0|||
25178730|NCT01470599|50324057|FG001|Overall Study|Lost to Follow-up|1|||
25178731|NCT01470599|50324056|FG000|Overall Study|Withdrawal by Subject|3|||
25273041|NCT01253135|50587115|FG000|Original Protocol|Protocol Amendment|15|||
25273042|NCT01253135|50587115|FG000|Amended Protocol|Non-compliance|1|||
25273043|NCT00993616|50587123|FG000|Overall Study|No tumor at entry|1|||
25273044|NCT00993616|50587123|FG000|Overall Study|Never treated|1|||
25273045|NCT01120899|50587133|FG000|Overall Study|Withdrawal by Subject|3|||
25273046|NCT01120275|50587137|FG000|Overall Study|Adverse Event|3|||
25273047|NCT01120275|50587137|FG000|Overall Study|Progression|27|||
25273048|NCT01120275|50587137|FG000|Overall Study|Ineligible|3|||
25273049|NCT01120275|50587137|FG000|Overall Study|Withdrawal by Subject|1|||
25273050|NCT01120275|50587137|FG000|Overall Study|Refusal|1|||
25009381|NCT00075725|50102300|FG006|Overall Study|Other complications|0|||
25009382|NCT00075725|50102301|FG007|Overall Study|Other complications|0|||
25009383|NCT00075725|50102302|FG008|Overall Study|Other complications|0|||
25009384|NCT00075725|50102303|FG009|Overall Study|Other complications|0|||
25009385|NCT00075725|50102304|FG010|Overall Study|Other complications|0|||
25009386|NCT00075725|50102305|FG011|Overall Study|Other complications|0|||
25009387|NCT00075725|50102294|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
25009388|NCT00075725|50102295|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
25009389|NCT00075725|50102296|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
25009390|NCT00075725|50102297|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
25009391|NCT00075725|50102298|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
25009392|NCT00075725|50102299|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
25009393|NCT00075725|50102300|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
25009394|NCT00075725|50102301|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
25009395|NCT00075725|50102302|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
25009396|NCT00075725|50102303|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
25009397|NCT00075725|50102304|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
25009398|NCT00075725|50102305|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
25273051|NCT01120275|50587137|FG000|Overall Study|Not specific|1|||
25273052|NCT00991510|50587144|FG000|Period I (Days 1-14)|Adverse Event|1|||
25273053|NCT00991510|50587145|FG001|Period I (Days 1-14)|Adverse Event|0|||
25273054|NCT00991510|50587144|FG000|Period III (Days 29-112)|Adverse Event|1|||
25131946|NCT02128724|50245500|FG002|Overall Study|Physician Decision|0|||
25131947|NCT02128724|50245501|FG003|Overall Study|Physician Decision|2|||
25131948|NCT02128724|50245498|FG000|Overall Study|Withdrawal by Subject|0|||
25131949|NCT02128724|50245499|FG001|Overall Study|Withdrawal by Subject|0|||
25131950|NCT02128724|50245500|FG002|Overall Study|Withdrawal by Subject|0|||
25131951|NCT02128724|50245501|FG003|Overall Study|Withdrawal by Subject|1|||
25131952|NCT02128490|50245515|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
25131953|NCT02128490|50245516|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
25131954|NCT02128490|50245517|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
25131955|NCT02128490|50245518|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
25131956|NCT02128490|50245519|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
25131957|NCT02128490|50245515|FG000|Overall Study|Major Protocol Deviation|1|||
25131958|NCT02128490|50245516|FG001|Overall Study|Major Protocol Deviation|2|||
25131959|NCT02128490|50245517|FG002|Overall Study|Major Protocol Deviation|0|||
25273055|NCT00991510|50587145|FG001|Period III (Days 29-112)|Adverse Event|1|||
25273056|NCT01119963|50587157|FG000|Overall Study|Lost to Follow-up|1|||
25273057|NCT01119963|50587158|FG001|Overall Study|Lost to Follow-up|1|||
25273058|NCT01252667|50587172|FG000|Overall Study|Transplant aborted post-conditioning|0|||
25273059|NCT01252667|50587173|FG001|Overall Study|Transplant aborted post-conditioning|0|||
25273060|NCT01252667|50587174|FG002|Overall Study|Transplant aborted post-conditioning|0|||
25273061|NCT01252667|50587175|FG003|Overall Study|Transplant aborted post-conditioning|0|||
25273062|NCT01252667|50587176|FG004|Overall Study|Transplant aborted post-conditioning|0|||
25273063|NCT01252667|50587177|FG005|Overall Study|Transplant aborted post-conditioning|1|||
25273064|NCT01119105|50587194|FG000|Overall Study|Withdrawal by Subject|1|||
25273065|NCT01119105|50587195|FG001|Overall Study|Withdrawal by Subject|1|||
25273066|NCT01119105|50587196|FG002|Overall Study|Withdrawal by Subject|1|||
25273067|NCT01119105|50587194|FG000|Overall Study|Lost to Follow-up|0|||
25273068|NCT01119105|50587195|FG001|Overall Study|Lost to Follow-up|2|||
25273069|NCT01119105|50587196|FG002|Overall Study|Lost to Follow-up|5|||
25273070|NCT01119105|50587194|FG000|Overall Study|Adverse Event|1|||
25273071|NCT01119105|50587195|FG001|Overall Study|Adverse Event|0|||
25131960|NCT02128490|50245518|FG003|Overall Study|Major Protocol Deviation|2|||
25131961|NCT02128490|50245519|FG004|Overall Study|Major Protocol Deviation|2|||
25131962|NCT02128490|50245515|FG000|Overall Study|Lost to Follow-up|0|||
25131963|NCT02128490|50245516|FG001|Overall Study|Lost to Follow-up|0|||
25273072|NCT01119105|50587196|FG002|Overall Study|Adverse Event|1|||
25131964|NCT02128490|50245517|FG002|Overall Study|Lost to Follow-up|1|||
25131965|NCT02128490|50245518|FG003|Overall Study|Lost to Follow-up|1|||
25131966|NCT02128490|50245519|FG004|Overall Study|Lost to Follow-up|1|||
25131967|NCT02128490|50245515|FG000|Overall Study|Voluntary Withdrawal|3|||
25131968|NCT02128490|50245516|FG001|Overall Study|Voluntary Withdrawal|3|||
25131969|NCT02128490|50245517|FG002|Overall Study|Voluntary Withdrawal|1|||
25131970|NCT02128490|50245518|FG003|Overall Study|Voluntary Withdrawal|1|||
25131971|NCT02128490|50245519|FG004|Overall Study|Voluntary Withdrawal|2|||
25131972|NCT02128490|50245515|FG000|Overall Study|Lack of Efficacy|0|||
25131973|NCT02128490|50245516|FG001|Overall Study|Lack of Efficacy|1|||
25131974|NCT02128490|50245517|FG002|Overall Study|Lack of Efficacy|0|||
25131975|NCT02128490|50245518|FG003|Overall Study|Lack of Efficacy|0|||
25131976|NCT02128490|50245519|FG004|Overall Study|Lack of Efficacy|0|||
25131977|NCT02128490|50245515|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
25131978|NCT02128490|50245516|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
25131979|NCT02128490|50245517|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
25131980|NCT02128490|50245518|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
25131981|NCT02128490|50245519|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
25131982|NCT02128490|50245515|FG000|Overall Study|Other Miscellaneous Reasons|0|||
25273073|NCT01119105|50587194|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
25273074|NCT01119105|50587195|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
25273075|NCT01119105|50587196|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
25273076|NCT01119105|50587194|FG000|Overall Study|Other|1|||
25273077|NCT01119105|50587195|FG001|Overall Study|Other|1|||
25273078|NCT01119105|50587196|FG002|Overall Study|Other|0|||
25273079|NCT01118949|50587204|FG000|Overall Study|Adverse Event|5|||
25273080|NCT01118949|50587204|FG000|Overall Study|Withdrawal by Subject|4|||
25273081|NCT01252355|50587211|FG000|Overall Study|Adverse Event|9|||
25273082|NCT01252355|50587212|FG001|Overall Study|Adverse Event|17|||
25273083|NCT01252355|50587213|FG002|Overall Study|Adverse Event|22|||
25273084|NCT01252355|50587211|FG000|Overall Study|Lack of Efficacy|6|||
25273085|NCT01252355|50587212|FG001|Overall Study|Lack of Efficacy|4|||
25273086|NCT01252355|50587213|FG002|Overall Study|Lack of Efficacy|2|||
25273087|NCT01252355|50587211|FG000|Overall Study|Lost to Follow-up|0|||
25273088|NCT01252355|50587212|FG001|Overall Study|Lost to Follow-up|0|||
25273089|NCT01252355|50587213|FG002|Overall Study|Lost to Follow-up|1|||
25273090|NCT01252355|50587211|FG000|Overall Study|Poor Compliance to Protocol|1|||
25273091|NCT01252355|50587212|FG001|Overall Study|Poor Compliance to Protocol|1|||
25273092|NCT01252355|50587213|FG002|Overall Study|Poor Compliance to Protocol|1|||
25273093|NCT01252355|50587211|FG000|Overall Study|Progressive Disease|2|||
25273094|NCT01252355|50587212|FG001|Overall Study|Progressive Disease|0|||
25273095|NCT01252355|50587213|FG002|Overall Study|Progressive Disease|0|||
25273096|NCT01252355|50587211|FG000|Overall Study|Sponsor Early Termination of Study|149|||
25273097|NCT01252355|50587212|FG001|Overall Study|Sponsor Early Termination of Study|149|||
25273098|NCT01252355|50587213|FG002|Overall Study|Sponsor Early Termination of Study|146|||
25273099|NCT01252355|50587211|FG000|Overall Study|Randomized but not Treated|2|||
25273100|NCT01252355|50587212|FG001|Overall Study|Randomized but not Treated|0|||
25273101|NCT01252355|50587213|FG002|Overall Study|Randomized but not Treated|0|||
25273102|NCT01252355|50587211|FG000|Overall Study|Other Than Above|8|||
25273103|NCT01252355|50587212|FG001|Overall Study|Other Than Above|7|||
25273104|NCT01252355|50587213|FG002|Overall Study|Other Than Above|7|||
25131983|NCT02128490|50245516|FG001|Overall Study|Other Miscellaneous Reasons|0|||
25131984|NCT02128490|50245517|FG002|Overall Study|Other Miscellaneous Reasons|2|||
25131985|NCT02128490|50245518|FG003|Overall Study|Other Miscellaneous Reasons|1|||
25131986|NCT02128490|50245519|FG004|Overall Study|Other Miscellaneous Reasons|1|||
25131987|NCT02146352|50245531|FG000|Overall Study|Death|1|||
25131988|NCT02146352|50245531|FG000|Overall Study|Patient entered hospice care|1|||
25131989|NCT02146274|50245535|FG000|Overall Study|Protocol Violation|73|||
25131990|NCT02105636|50245544|FG000|Pre-Treatment|Disease Progression|1|||
25131991|NCT02105636|50245545|FG001|Pre-Treatment|Disease Progression|0|||
25131992|NCT02105636|50245544|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
25131993|NCT02105636|50245545|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
25131994|NCT02105636|50245544|FG000|Pre-Treatment|Participant withdrew consent|0|||
25131995|NCT02105636|50245545|FG001|Pre-Treatment|Participant withdrew consent|6|||
25131996|NCT02105636|50245544|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
25131997|NCT02105636|50245545|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
25131998|NCT02105636|50245544|FG000|Treatment|Study Drug Toxicity|14|||
25131999|NCT02105636|50245545|FG001|Treatment|Study Drug Toxicity|10|||
25132000|NCT02105636|50245544|FG000|Treatment|Adverse event unrelated to study drug|19|||
25132001|NCT02105636|50245545|FG001|Treatment|Adverse event unrelated to study drug|3|||
25132002|NCT02105636|50245544|FG000|Treatment|Participant request to discontinue study treatment|8|||
25132003|NCT02105636|50245545|FG001|Treatment|Participant request to discontinue study treatment|6|||
25132004|NCT02105636|50245544|FG000|Treatment|Participant withdrew consent|5|||
25132005|NCT02105636|50245545|FG001|Treatment|Participant withdrew consent|1|||
25273105|NCT01118325|50587224|FG000|Overall Study|Adverse Event|1|||
25273106|NCT01118325|50587225|FG001|Overall Study|Adverse Event|0|||
25132006|NCT02105636|50245544|FG000|Treatment|Lost to Follow-up|1|||
25132007|NCT02105636|50245545|FG001|Treatment|Lost to Follow-up|0|||
25273107|NCT01118325|50587226|FG002|Overall Study|Adverse Event|1|||
25273108|NCT01117857|50587247|FG000|Overall Study|Lost to Follow-up|4|||
25132008|NCT02105636|50245544|FG000|Treatment|Maximum Clinical Benefit|1|||
25132009|NCT02105636|50245545|FG001|Treatment|Maximum Clinical Benefit|3|||
25132010|NCT02105636|50245544|FG000|Treatment|Poor/Non-compliance|0|||
25132011|NCT02105636|50245545|FG001|Treatment|Poor/Non-compliance|1|||
25132012|NCT02105636|50245544|FG000|Treatment|Participant no longer meets study criteria|1|||
25132013|NCT02105636|50245545|FG001|Treatment|Participant no longer meets study criteria|0|||
25132014|NCT02105636|50245544|FG000|Treatment|Other reasons|1|||
25132015|NCT02105636|50245545|FG001|Treatment|Other reasons|0|||
25132016|NCT02105636|50245544|FG000|Treatment|Disease Progression|185|||
25132017|NCT02105636|50245545|FG001|Treatment|Disease Progression|87|||
25132018|NCT01626872|50245554|FG000|Overall Study|Physician Decision|13|||
25132019|NCT01626872|50245555|FG001|Overall Study|Physician Decision|9|||
25132020|NCT01626872|50245556|FG002|Overall Study|Physician Decision|6|||
25132021|NCT01626872|50245554|FG000|Overall Study|Withdrawal by Subject|19|||
25132022|NCT01626872|50245555|FG001|Overall Study|Withdrawal by Subject|27|||
25132023|NCT01626872|50245556|FG002|Overall Study|Withdrawal by Subject|8|||
25132024|NCT01626872|50245554|FG000|Overall Study|Adverse Event (including Death)|20|||
25132025|NCT01626872|50245555|FG001|Overall Study|Adverse Event (including Death)|28|||
25132026|NCT01626872|50245556|FG002|Overall Study|Adverse Event (including Death)|8|||
25132027|NCT01626872|50245554|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
25132028|NCT01626872|50245555|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
25132029|NCT01626872|50245556|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
25132030|NCT01598090|50245567|FG000|Treatment Period|Poor/non-compliance|0|||
25132031|NCT01598090|50245568|FG001|Treatment Period|Poor/non-compliance|2|||
25132032|NCT01598090|50245569|FG002|Treatment Period|Poor/non-compliance|0|||
25132033|NCT01598090|50245567|FG000|Treatment Period|No longer meet study criteria|0|||
25132034|NCT01598090|50245568|FG001|Treatment Period|No longer meet study criteria|1|||
25273109|NCT01117857|50587247|FG000|Overall Study|Withdrawal by Subject|4|||
25273110|NCT01117857|50587247|FG000|Overall Study|Physician Decision|1|||
25273111|NCT01251887|50587254|FG000|Overall Study|Scheduling conflict|1|||
25273112|NCT01251887|50587255|FG001|Overall Study|Scheduling conflict|2|||
25273113|NCT01251887|50587256|FG002|Overall Study|Scheduling conflict|2|||
25273114|NCT01251887|50587254|FG000|Overall Study|Physician Decision|0|||
25273115|NCT01251887|50587255|FG001|Overall Study|Physician Decision|1|||
25273116|NCT01251887|50587256|FG002|Overall Study|Physician Decision|0|||
25273117|NCT00991276|50587270|FG000|First Intervention Period|Adverse Event|0|||
25273118|NCT00991276|50587271|FG001|First Intervention Period|Adverse Event|1|||
25273119|NCT00991276|50587272|FG002|First Intervention Period|Adverse Event|0|||
25273120|NCT00991276|50587273|FG003|First Intervention Period|Adverse Event|1|||
25273121|NCT00991276|50587274|FG004|First Intervention Period|Adverse Event|0|||
25132035|NCT01598090|50245569|FG002|Treatment Period|No longer meet study criteria|0|||
25132036|NCT01598090|50245567|FG000|Treatment Period|Lack of Efficacy|5|||
25132037|NCT01598090|50245568|FG001|Treatment Period|Lack of Efficacy|14|||
25132038|NCT01598090|50245569|FG002|Treatment Period|Lack of Efficacy|6|||
25132039|NCT01598090|50245567|FG000|Treatment Period|Adverse Event|2|||
25132040|NCT01598090|50245568|FG001|Treatment Period|Adverse Event|33|||
25132041|NCT01598090|50245569|FG002|Treatment Period|Adverse Event|17|||
25132042|NCT01598090|50245567|FG000|Treatment Period|Other reasons|0|||
25132043|NCT01598090|50245568|FG001|Treatment Period|Other reasons|4|||
25132044|NCT01598090|50245569|FG002|Treatment Period|Other reasons|1|||
25132045|NCT01598090|50245567|FG000|Treatment Period|Withdrawal by Subject|3|||
25132046|NCT01598090|50245568|FG001|Treatment Period|Withdrawal by Subject|13|||
25132047|NCT01598090|50245569|FG002|Treatment Period|Withdrawal by Subject|10|||
25132048|NCT01598090|50245567|FG000|Treatment Period|Lost to Follow-up|1|||
25132049|NCT01598090|50245568|FG001|Treatment Period|Lost to Follow-up|5|||
25132050|NCT01598090|50245569|FG002|Treatment Period|Lost to Follow-up|1|||
25132051|NCT01598090|50245567|FG000|Follow-up Period|Death|0|||
25132052|NCT01598090|50245568|FG001|Follow-up Period|Death|1|||
25132053|NCT01598090|50245569|FG002|Follow-up Period|Death|0|||
25132054|NCT01598090|50245567|FG000|Follow-up Period|No longer required per protocol|1|||
25273122|NCT00991276|50587275|FG005|First Intervention Period|Adverse Event|0|||
25273123|NCT00991276|50587270|FG000|First Intervention Period|Protocol Violation|0|||
25132055|NCT01598090|50245568|FG001|Follow-up Period|No longer required per protocol|3|||
25132056|NCT01598090|50245569|FG002|Follow-up Period|No longer required per protocol|2|||
25273124|NCT00991276|50587271|FG001|First Intervention Period|Protocol Violation|0|||
25273125|NCT00991276|50587272|FG002|First Intervention Period|Protocol Violation|0|||
25273126|NCT00991276|50587273|FG003|First Intervention Period|Protocol Violation|0|||
25273127|NCT00991276|50587274|FG004|First Intervention Period|Protocol Violation|2|||
25132057|NCT01598090|50245567|FG000|Follow-up Period|Not reported|0|||
25132058|NCT01598090|50245568|FG001|Follow-up Period|Not reported|10|||
25132059|NCT01598090|50245569|FG002|Follow-up Period|Not reported|4|||
25132060|NCT01598090|50245567|FG000|Follow-up Period|Withdrawal by Subject|0|||
25132061|NCT01598090|50245568|FG001|Follow-up Period|Withdrawal by Subject|3|||
25132062|NCT01598090|50245569|FG002|Follow-up Period|Withdrawal by Subject|2|||
25132063|NCT01598090|50245567|FG000|Follow-up Period|Other reasons|2|||
25132064|NCT01598090|50245568|FG001|Follow-up Period|Other reasons|8|||
25132065|NCT01598090|50245569|FG002|Follow-up Period|Other reasons|8|||
25132066|NCT01598090|50245567|FG000|Follow-up Period|Lost to Follow-up|2|||
25132067|NCT01598090|50245568|FG001|Follow-up Period|Lost to Follow-up|10|||
25132068|NCT01598090|50245569|FG002|Follow-up Period|Lost to Follow-up|12|||
25132069|NCT02105012|50245580|FG000|Overall Study|Withdrawal by Subject|11|||
25132070|NCT02105012|50245580|FG000|Overall Study|Protocol Specified Criteria|9|||
25132071|NCT02105012|50245580|FG000|Overall Study|Lost to Follow-up|4|||
25132072|NCT02105012|50245580|FG000|Overall Study|Protocol Violation|4|||
25132073|NCT02105012|50245580|FG000|Overall Study|Physician Decision|3|||
25132074|NCT02105012|50245580|FG000|Overall Study|Adverse Event|1|||
25132075|NCT02105012|50245580|FG000|Overall Study|Lack of Efficacy|1|||
25132076|NCT02145182|50245594|FG000|Overall Study|Adverse Event|4|||
25132077|NCT02145182|50245595|FG001|Overall Study|Adverse Event|1|||
25132078|NCT02145182|50245594|FG000|Overall Study|Death|7|||
25132079|NCT02145182|50245595|FG001|Overall Study|Death|7|||
25273128|NCT00991276|50587275|FG005|First Intervention Period|Protocol Violation|0|||
25273129|NCT00991276|50587270|FG000|First Intervention Period|Insufficient clinical response|0|||
25132080|NCT02145182|50245594|FG000|Overall Study|Lost to Follow-up|2|||
25132081|NCT02145182|50245595|FG001|Overall Study|Lost to Follow-up|2|||
25132082|NCT02145182|50245594|FG000|Overall Study|Pre-transplant Withdrawal|0|||
25132083|NCT02145182|50245595|FG001|Overall Study|Pre-transplant Withdrawal|2|||
25132084|NCT02145182|50245594|FG000|Overall Study|Withdrawal by Subject|5|||
25132085|NCT02145182|50245595|FG001|Overall Study|Withdrawal by Subject|4|||
25132086|NCT02145026|50245601|FG000|Overall Study|Adverse Event|2|||
25132087|NCT02145026|50245601|FG000|Overall Study|Death|4|||
25132088|NCT02145026|50245601|FG000|Overall Study|Withdrawal by Subject|2|||
25132089|NCT02145026|50245601|FG000|Overall Study|Physician Decision|4|||
25132090|NCT02144012|50245607|FG000|Overall Study|Adverse Event|1|||
25132091|NCT02144012|50245608|FG001|Overall Study|Adverse Event|0|||
25132092|NCT02144012|50245607|FG000|Overall Study|Death|1|||
25132093|NCT02144012|50245608|FG001|Overall Study|Death|0|||
25132094|NCT02144012|50245607|FG000|Overall Study|Withdrawal by Subject|11|||
25132095|NCT02144012|50245608|FG001|Overall Study|Withdrawal by Subject|3|||
25132096|NCT02144012|50245607|FG000|Overall Study|Study Terminated by Sponsor|18|||
25132097|NCT02144012|50245608|FG001|Overall Study|Study Terminated by Sponsor|12|||
25132098|NCT02144012|50245607|FG000|Overall Study|Other|3|||
25132099|NCT02144012|50245608|FG001|Overall Study|Other|0|||
25132100|NCT02103062|50245616|FG000|Overall Study|Adverse Event|1|||
25132101|NCT02103062|50245617|FG001|Overall Study|Adverse Event|2|||
25132102|NCT02103062|50245616|FG000|Overall Study|Progressive Disease|17|||
25132103|NCT02103062|50245617|FG001|Overall Study|Progressive Disease|20|||
25273130|NCT00991276|50587271|FG001|First Intervention Period|Insufficient clinical response|0|||
25273131|NCT00991276|50587272|FG002|First Intervention Period|Insufficient clinical response|0|||
25273132|NCT00991276|50587273|FG003|First Intervention Period|Insufficient clinical response|0|||
25273133|NCT00991276|50587274|FG004|First Intervention Period|Insufficient clinical response|1|||
25132104|NCT02103062|50245616|FG000|Overall Study|Death|0|||
25132105|NCT02103062|50245617|FG001|Overall Study|Death|1|||
25132106|NCT02141984|50245625|FG000|Overall Study|Lack of Efficacy|2|||
25132107|NCT02141672|50245632|FG000|Overall Study|Adverse Event|0|||
25132108|NCT02141672|50245633|FG001|Overall Study|Adverse Event|1|||
25132109|NCT02141672|50245634|FG002|Overall Study|Adverse Event|0|||
25132110|NCT02141672|50245632|FG000|Overall Study|Death|10|||
25132111|NCT02141672|50245633|FG001|Overall Study|Death|2|||
25132112|NCT02141672|50245634|FG002|Overall Study|Death|1|||
25132113|NCT02141672|50245632|FG000|Overall Study|Lack of Efficacy|0|||
25132114|NCT02141672|50245633|FG001|Overall Study|Lack of Efficacy|0|||
25132115|NCT02141672|50245634|FG002|Overall Study|Lack of Efficacy|2|||
25132116|NCT02141672|50245632|FG000|Overall Study|Lost to Follow-up|1|||
25273134|NCT00991276|50587275|FG005|First Intervention Period|Insufficient clinical response|0|||
25132117|NCT02141672|50245633|FG001|Overall Study|Lost to Follow-up|1|||
25132118|NCT02141672|50245634|FG002|Overall Study|Lost to Follow-up|3|||
25132119|NCT02141672|50245632|FG000|Overall Study|Physician Decision|1|||
25132120|NCT02141672|50245633|FG001|Overall Study|Physician Decision|2|||
25132121|NCT02141672|50245634|FG002|Overall Study|Physician Decision|5|||
25132122|NCT02141672|50245632|FG000|Overall Study|Protocol Violation|0|||
25132123|NCT02141672|50245633|FG001|Overall Study|Protocol Violation|0|||
25132124|NCT02141672|50245634|FG002|Overall Study|Protocol Violation|1|||
25132125|NCT02141672|50245632|FG000|Overall Study|Withdrawal by Subject|3|||
25132126|NCT02141672|50245633|FG001|Overall Study|Withdrawal by Subject|2|||
25132127|NCT02141672|50245634|FG002|Overall Study|Withdrawal by Subject|5|||
25132128|NCT02141672|50245632|FG000|Overall Study|refused to follow-up|1|||
25132129|NCT02141672|50245633|FG001|Overall Study|refused to follow-up|0|||
25132130|NCT02141672|50245634|FG002|Overall Study|refused to follow-up|1|||
25132131|NCT02141516|50245645|FG000|Overall Study|Adverse Event|0|||
25132132|NCT02141516|50245646|FG001|Overall Study|Adverse Event|1|||
25132133|NCT02141516|50245647|FG002|Overall Study|Adverse Event|0|||
25132134|NCT02141516|50245645|FG000|Overall Study|Lost to Follow-up|0|||
25132135|NCT02141516|50245646|FG001|Overall Study|Lost to Follow-up|1|||
25132136|NCT02141516|50245647|FG002|Overall Study|Lost to Follow-up|0|||
25132137|NCT02141516|50245645|FG000|Overall Study|Other|0|||
25132138|NCT02141516|50245646|FG001|Overall Study|Other|3|||
25132139|NCT02141516|50245647|FG002|Overall Study|Other|0|||
25132140|NCT02141360|50245661|FG000|Overall Study|Withdrawal by Subject|6|||
25273135|NCT00991276|50587270|FG000|First Intervention Period|Other|0|||
25273136|NCT00991276|50587271|FG001|First Intervention Period|Other|0|||
25273137|NCT00991276|50587272|FG002|First Intervention Period|Other|0|||
25273138|NCT00991276|50587273|FG003|First Intervention Period|Other|1|||
25273139|NCT00991276|50587274|FG004|First Intervention Period|Other|1|||
25273140|NCT00991276|50587275|FG005|First Intervention Period|Other|0|||
25273141|NCT00991276|50587270|FG000|First Intervention Period|Withdrawal by Subject|0|||
25273142|NCT00991276|50587271|FG001|First Intervention Period|Withdrawal by Subject|1|||
25273143|NCT00991276|50587272|FG002|First Intervention Period|Withdrawal by Subject|0|||
25273144|NCT00991276|50587273|FG003|First Intervention Period|Withdrawal by Subject|1|||
25273145|NCT00991276|50587274|FG004|First Intervention Period|Withdrawal by Subject|0|||
25273146|NCT00991276|50587275|FG005|First Intervention Period|Withdrawal by Subject|1|||
25273147|NCT00991276|50587270|FG000|First Intervention Period|Lost to Follow-up|0|||
25273148|NCT00991276|50587271|FG001|First Intervention Period|Lost to Follow-up|1|||
25273149|NCT00991276|50587272|FG002|First Intervention Period|Lost to Follow-up|0|||
25273150|NCT00991276|50587273|FG003|First Intervention Period|Lost to Follow-up|1|||
25273151|NCT00991276|50587274|FG004|First Intervention Period|Lost to Follow-up|0|||
25273152|NCT00991276|50587275|FG005|First Intervention Period|Lost to Follow-up|0|||
25273153|NCT00991276|50587270|FG000|Second Intervention Period|Adverse Event|0|||
25273154|NCT00991276|50587271|FG001|Second Intervention Period|Adverse Event|2|||
25273155|NCT00991276|50587272|FG002|Second Intervention Period|Adverse Event|0|||
25273156|NCT00991276|50587273|FG003|Second Intervention Period|Adverse Event|1|||
25273157|NCT00991276|50587274|FG004|Second Intervention Period|Adverse Event|1|||
25273158|NCT00991276|50587275|FG005|Second Intervention Period|Adverse Event|0|||
25273159|NCT00991276|50587270|FG000|Second Intervention Period|Protocol Violation|1|||
25273160|NCT00991276|50587271|FG001|Second Intervention Period|Protocol Violation|0|||
25273161|NCT00991276|50587272|FG002|Second Intervention Period|Protocol Violation|0|||
25273162|NCT00991276|50587273|FG003|Second Intervention Period|Protocol Violation|0|||
25273163|NCT00991276|50587274|FG004|Second Intervention Period|Protocol Violation|0|||
25273164|NCT00991276|50587275|FG005|Second Intervention Period|Protocol Violation|0|||
25273165|NCT00991276|50587270|FG000|Second Intervention Period|Other|0|||
25273166|NCT00991276|50587271|FG001|Second Intervention Period|Other|0|||
25132141|NCT02141360|50245662|FG001|Overall Study|Withdrawal by Subject|0|||
25132142|NCT02141360|50245663|FG002|Overall Study|Withdrawal by Subject|0|||
25132143|NCT02141360|50245661|FG000|Overall Study|Study Terminated before Visit|1|||
25132144|NCT02141360|50245662|FG001|Overall Study|Study Terminated before Visit|0|||
25132145|NCT02141360|50245663|FG002|Overall Study|Study Terminated before Visit|0|||
25132146|NCT01628198|50245671|FG000|Overall Study|Lost to Follow-up|7|||
25132147|NCT01628198|50245671|FG000|Overall Study|Withdrawal by Subject|10|||
25132148|NCT01628198|50245671|FG000|Overall Study|Screen failure|1|||
25132149|NCT01628120|50245675|FG000|Overall Study|Withdrawal by Subject|7|||
25132150|NCT01628120|50245675|FG000|Overall Study|Adverse Event|12|||
25132151|NCT01628120|50245675|FG000|Overall Study|Lost to Follow-up|1|||
25132152|NCT01628120|50245675|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
25132153|NCT01628120|50245675|FG000|Overall Study|Non-compliant with Study Procedures|1|||
25132154|NCT01628120|50245675|FG000|Overall Study|Not Treated|3|||
25132155|NCT01628120|50245675|FG000|Overall Study|Sponsor Decision|5|||
25132156|NCT01628120|50245675|FG000|Overall Study|Switched Dialysis Method|2|||
25132157|NCT01628120|50245675|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
25132158|NCT01628120|50245675|FG000|Overall Study|Moved or Relocated|5|||
25273167|NCT00991276|50587272|FG002|Second Intervention Period|Other|0|||
25273168|NCT00991276|50587273|FG003|Second Intervention Period|Other|1|||
25273169|NCT00991276|50587274|FG004|Second Intervention Period|Other|0|||
25273170|NCT00991276|50587275|FG005|Second Intervention Period|Other|1|||
25273171|NCT00991276|50587270|FG000|Third Intervention Period|Protocol Violation|1|||
25273172|NCT00991276|50587271|FG001|Third Intervention Period|Protocol Violation|0|||
25273173|NCT00991276|50587272|FG002|Third Intervention Period|Protocol Violation|0|||
25273174|NCT00991276|50587273|FG003|Third Intervention Period|Protocol Violation|0|||
25273175|NCT00991276|50587274|FG004|Third Intervention Period|Protocol Violation|0|||
25273176|NCT00991276|50587275|FG005|Third Intervention Period|Protocol Violation|0|||
25132159|NCT01628120|50245675|FG000|Overall Study|Kidney Transplant|2|||
25132160|NCT01628120|50245675|FG000|Overall Study|Use of Standard of Care|1|||
25132161|NCT01627340|50245681|FG000|Overall Study|Adverse Event|1|||
25132162|NCT01627340|50245682|FG001|Overall Study|Adverse Event|0|||
25132163|NCT01627340|50245681|FG000|Overall Study|Lost to Follow-up|8|||
25132164|NCT01627340|50245682|FG001|Overall Study|Lost to Follow-up|4|||
25132165|NCT01627340|50245681|FG000|Overall Study|Pregnancy|1|||
25132166|NCT01627340|50245682|FG001|Overall Study|Pregnancy|0|||
25132167|NCT01627340|50245681|FG000|Overall Study|Withdrawal by Subject|2|||
25132168|NCT01627340|50245682|FG001|Overall Study|Withdrawal by Subject|0|||
25132169|NCT02125838|50245692|FG000|Overall Study|Lost to Follow-up|4|||
25132170|NCT02125838|50245693|FG001|Overall Study|Lost to Follow-up|4|||
25132171|NCT02125604|50245699|FG000|Overall Study|Other|4|||
25132172|NCT02125604|50245699|FG000|Overall Study|Investigator Decision|1|||
25132173|NCT02125604|50245699|FG000|Overall Study|Lost to Follow-up|2|||
25132174|NCT02125604|50245699|FG000|Overall Study|Consent Withdrawn|4|||
25132175|NCT02125604|50245699|FG000|Overall Study|Adverse Event|20|||
25132176|NCT02124746|50245706|FG000|Overall Study|Adverse Event|2|||
25132177|NCT02124746|50245707|FG001|Overall Study|Adverse Event|1|||
25132178|NCT02124746|50245708|FG002|Overall Study|Adverse Event|2|||
25132179|NCT02124746|50245706|FG000|Overall Study|Death|2|||
25132180|NCT02124746|50245707|FG001|Overall Study|Death|1|||
25132181|NCT02124746|50245708|FG002|Overall Study|Death|3|||
25132182|NCT02124746|50245706|FG000|Overall Study|Lack of Efficacy|3|||
25132183|NCT02124746|50245707|FG001|Overall Study|Lack of Efficacy|2|||
25132184|NCT02124746|50245708|FG002|Overall Study|Lack of Efficacy|2|||
25132185|NCT02124746|50245706|FG000|Overall Study|Physician Decision|6|||
25132186|NCT02124746|50245707|FG001|Overall Study|Physician Decision|4|||
25132187|NCT02124746|50245708|FG002|Overall Study|Physician Decision|5|||
25132188|NCT02124746|50245706|FG000|Overall Study|Non-Compliance with Study Drug|0|||
25132189|NCT02124746|50245707|FG001|Overall Study|Non-Compliance with Study Drug|1|||
25132190|NCT02124746|50245708|FG002|Overall Study|Non-Compliance with Study Drug|0|||
25132191|NCT02124746|50245706|FG000|Overall Study|Withdrawal by Subject|3|||
25132192|NCT02124746|50245707|FG001|Overall Study|Withdrawal by Subject|3|||
25132193|NCT02124746|50245708|FG002|Overall Study|Withdrawal by Subject|0|||
25132194|NCT02124746|50245706|FG000|Overall Study|Study Terminated by Sponsor|0|||
25132195|NCT02124746|50245707|FG001|Overall Study|Study Terminated by Sponsor|0|||
25132196|NCT02124746|50245708|FG002|Overall Study|Study Terminated by Sponsor|6|||
25132197|NCT02124746|50245706|FG000|Overall Study|Disease Progression|3|||
25132198|NCT02124746|50245707|FG001|Overall Study|Disease Progression|6|||
25132199|NCT02124746|50245708|FG002|Overall Study|Disease Progression|4|||
25132200|NCT02123966|50245716|FG000|Overall Study|Intercurrent Illness|1|||
25273177|NCT00991276|50587270|FG000|Third Intervention Period|Other|0|||
25273178|NCT00991276|50587271|FG001|Third Intervention Period|Other|0|||
25273179|NCT00991276|50587272|FG002|Third Intervention Period|Other|0|||
25273180|NCT00991276|50587273|FG003|Third Intervention Period|Other|0|||
25273181|NCT00991276|50587274|FG004|Third Intervention Period|Other|0|||
25273182|NCT00991276|50587275|FG005|Third Intervention Period|Other|1|||
25273183|NCT00991276|50587270|FG000|Third Intervention Period|Adverse Event|0|||
25273184|NCT00991276|50587271|FG001|Third Intervention Period|Adverse Event|0|||
25273185|NCT00991276|50587272|FG002|Third Intervention Period|Adverse Event|1|||
25132201|NCT02123576|50245722|FG000|Overall Study|Adverse Event|1|||
25132202|NCT02123576|50245723|FG001|Overall Study|Adverse Event|0|||
25132203|NCT01177397|50245741|FG000|Overall Study|Protocol Violation|0|||
25132204|NCT01177397|50245742|FG001|Overall Study|Protocol Violation|0|||
25132205|NCT01177397|50245743|FG002|Overall Study|Protocol Violation|0|||
25132206|NCT01177397|50245744|FG003|Overall Study|Protocol Violation|0|||
25132207|NCT01177397|50245745|FG004|Overall Study|Protocol Violation|0|||
25132208|NCT01177397|50245746|FG005|Overall Study|Protocol Violation|1|||
25132209|NCT01177397|50245747|FG006|Overall Study|Protocol Violation|0|||
25132210|NCT01177397|50245748|FG007|Overall Study|Protocol Violation|0|||
25132211|NCT01177397|50245749|FG008|Overall Study|Protocol Violation|0|||
25132212|NCT01177397|50245750|FG009|Overall Study|Protocol Violation|0|||
25132213|NCT01177397|50245751|FG010|Overall Study|Protocol Violation|0|||
25132214|NCT01177397|50245752|FG011|Overall Study|Protocol Violation|0|||
25132215|NCT01177397|50245741|FG000|Overall Study|Lost to Follow-up|0|||
25132216|NCT01177397|50245742|FG001|Overall Study|Lost to Follow-up|0|||
25132217|NCT01177397|50245743|FG002|Overall Study|Lost to Follow-up|0|||
25273186|NCT00991276|50587273|FG003|Third Intervention Period|Adverse Event|0|||
25273187|NCT00991276|50587274|FG004|Third Intervention Period|Adverse Event|0|||
25273188|NCT00991276|50587275|FG005|Third Intervention Period|Adverse Event|0|||
25132218|NCT01177397|50245744|FG003|Overall Study|Lost to Follow-up|0|||
25132219|NCT01177397|50245745|FG004|Overall Study|Lost to Follow-up|1|||
25132220|NCT01177397|50245746|FG005|Overall Study|Lost to Follow-up|0|||
25132221|NCT01177397|50245747|FG006|Overall Study|Lost to Follow-up|0|||
25132222|NCT01177397|50245748|FG007|Overall Study|Lost to Follow-up|2|||
25132223|NCT01177397|50245749|FG008|Overall Study|Lost to Follow-up|0|||
25132224|NCT01177397|50245750|FG009|Overall Study|Lost to Follow-up|0|||
25273189|NCT00991276|50587270|FG000|Third Intervention Period|Withdrawal by Subject|0|||
25273190|NCT00991276|50587271|FG001|Third Intervention Period|Withdrawal by Subject|0|||
25132225|NCT01177397|50245751|FG010|Overall Study|Lost to Follow-up|0|||
25132226|NCT01177397|50245752|FG011|Overall Study|Lost to Follow-up|0|||
25132227|NCT01177397|50245741|FG000|Overall Study|Death|0|||
25132228|NCT01177397|50245742|FG001|Overall Study|Death|0|||
25132229|NCT01177397|50245743|FG002|Overall Study|Death|1|||
25132230|NCT01177397|50245744|FG003|Overall Study|Death|1|||
25132231|NCT01177397|50245745|FG004|Overall Study|Death|0|||
25132232|NCT01177397|50245746|FG005|Overall Study|Death|0|||
25132233|NCT01177397|50245747|FG006|Overall Study|Death|0|||
25132234|NCT01177397|50245748|FG007|Overall Study|Death|5|||
25132235|NCT01177397|50245749|FG008|Overall Study|Death|2|||
25132236|NCT01177397|50245750|FG009|Overall Study|Death|1|||
25132237|NCT01177397|50245751|FG010|Overall Study|Death|0|||
25132238|NCT01177397|50245752|FG011|Overall Study|Death|0|||
25132239|NCT01177397|50245741|FG000|Overall Study|Withdrawal by Subject|0|||
25132240|NCT01177397|50245742|FG001|Overall Study|Withdrawal by Subject|0|||
25132241|NCT01177397|50245743|FG002|Overall Study|Withdrawal by Subject|1|||
25132242|NCT01177397|50245744|FG003|Overall Study|Withdrawal by Subject|1|||
25132243|NCT01177397|50245745|FG004|Overall Study|Withdrawal by Subject|1|||
25132244|NCT01177397|50245746|FG005|Overall Study|Withdrawal by Subject|2|||
25132245|NCT01177397|50245747|FG006|Overall Study|Withdrawal by Subject|0|||
25132246|NCT01177397|50245748|FG007|Overall Study|Withdrawal by Subject|5|||
25132247|NCT01177397|50245749|FG008|Overall Study|Withdrawal by Subject|9|||
25132248|NCT01177397|50245750|FG009|Overall Study|Withdrawal by Subject|1|||
25132249|NCT01177397|50245751|FG010|Overall Study|Withdrawal by Subject|1|||
25132250|NCT01177397|50245752|FG011|Overall Study|Withdrawal by Subject|0|||
25132251|NCT01177397|50245741|FG000|Overall Study|Adverse Event|0|||
25132252|NCT01177397|50245742|FG001|Overall Study|Adverse Event|0|||
25132253|NCT01177397|50245743|FG002|Overall Study|Adverse Event|1|||
25132254|NCT01177397|50245744|FG003|Overall Study|Adverse Event|2|||
25132255|NCT01177397|50245745|FG004|Overall Study|Adverse Event|0|||
25132256|NCT01177397|50245746|FG005|Overall Study|Adverse Event|12|||
25132257|NCT01177397|50245747|FG006|Overall Study|Adverse Event|1|||
25132258|NCT01177397|50245748|FG007|Overall Study|Adverse Event|14|||
25132259|NCT01177397|50245749|FG008|Overall Study|Adverse Event|8|||
25132260|NCT01177397|50245750|FG009|Overall Study|Adverse Event|6|||
25132261|NCT01177397|50245751|FG010|Overall Study|Adverse Event|3|||
25132262|NCT01177397|50245752|FG011|Overall Study|Adverse Event|7|||
25132263|NCT01177397|50245741|FG000|Overall Study|Disease progression|1|||
25132264|NCT01177397|50245742|FG001|Overall Study|Disease progression|2|||
25132265|NCT01177397|50245743|FG002|Overall Study|Disease progression|5|||
25132266|NCT01177397|50245744|FG003|Overall Study|Disease progression|5|||
25132267|NCT01177397|50245745|FG004|Overall Study|Disease progression|4|||
25132268|NCT01177397|50245746|FG005|Overall Study|Disease progression|10|||
25132269|NCT01177397|50245747|FG006|Overall Study|Disease progression|10|||
25132270|NCT01177397|50245748|FG007|Overall Study|Disease progression|21|||
25132271|NCT01177397|50245749|FG008|Overall Study|Disease progression|18|||
25132272|NCT01177397|50245750|FG009|Overall Study|Disease progression|12|||
25132273|NCT01177397|50245751|FG010|Overall Study|Disease progression|10|||
25132274|NCT01177397|50245752|FG011|Overall Study|Disease progression|8|||
25132275|NCT01177397|50245741|FG000|Overall Study|Other reasons|0|||
25132276|NCT01177397|50245742|FG001|Overall Study|Other reasons|0|||
25132277|NCT01177397|50245743|FG002|Overall Study|Other reasons|1|||
25273191|NCT00991276|50587272|FG002|Third Intervention Period|Withdrawal by Subject|0|||
25273192|NCT00991276|50587273|FG003|Third Intervention Period|Withdrawal by Subject|1|||
25273193|NCT00991276|50587274|FG004|Third Intervention Period|Withdrawal by Subject|0|||
25273194|NCT00991276|50587275|FG005|Third Intervention Period|Withdrawal by Subject|0|||
25273195|NCT00990652|50587284|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
25273196|NCT00990652|50587284|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
25273197|NCT00990340|50587291|FG000|First 14-day Treatment|Not Compliant|2|||
25273198|NCT00990340|50587292|FG001|First 14-day Treatment|Not Compliant|1|||
25132278|NCT01177397|50245744|FG003|Overall Study|Other reasons|0|||
25132279|NCT01177397|50245745|FG004|Overall Study|Other reasons|1|||
25132280|NCT01177397|50245746|FG005|Overall Study|Other reasons|1|||
25132281|NCT01177397|50245747|FG006|Overall Study|Other reasons|2|||
25132282|NCT01177397|50245748|FG007|Overall Study|Other reasons|6|||
25132283|NCT01177397|50245749|FG008|Overall Study|Other reasons|10|||
25132284|NCT01177397|50245750|FG009|Overall Study|Other reasons|8|||
25132285|NCT01177397|50245751|FG010|Overall Study|Other reasons|0|||
25132286|NCT01177397|50245752|FG011|Overall Study|Other reasons|2|||
25132287|NCT00864227|50245793|FG000|Overall Study|Withdrawal by Subject|1|||
25132288|NCT00864227|50245793|FG000|Overall Study|Disease Relapse/Progression|3|||
25132289|NCT02102204|50245797|FG000|Overall Study|Withdrawal by Subject|137|||
25132290|NCT02102204|50245797|FG000|Overall Study|Death|92|||
24907543|NCT00623805|50001589|FG001|Overall Study|Lost to Follow-up|2|||
25132291|NCT02102204|50245797|FG000|Overall Study|Lost to Follow-up|65|||
25132292|NCT02102204|50245797|FG000|Overall Study|Sponsor Decision|5|||
25132293|NCT02102204|50245797|FG000|Overall Study|Ongoing|5|||
25132294|NCT02141204|50245803|FG000|Overall Study|Lost to Follow-up|2|||
25132295|NCT02141204|50245804|FG001|Overall Study|Lost to Follow-up|1|||
25132296|NCT02141204|50245803|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
25132297|NCT02141204|50245804|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
25132298|NCT02141204|50245803|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
25132299|NCT02141204|50245804|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
25132300|NCT02141204|50245803|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
25132301|NCT02141204|50245804|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
25132302|NCT02140970|50245812|FG000|Overall Study|Lost to Follow-up|1|||
25132303|NCT02140970|50245813|FG001|Overall Study|Lost to Follow-up|2|||
25132304|NCT02140970|50245812|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
25132305|NCT02140970|50245813|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
25132306|NCT02140970|50245812|FG000|Overall Study|Did not meet inclusion criteria|0|||
25132307|NCT02140970|50245813|FG001|Overall Study|Did not meet inclusion criteria|1|||
25132308|NCT02101112|50245819|FG000|Overall Study|Adverse Event|0|||
25132309|NCT02101112|50245820|FG001|Overall Study|Adverse Event|0|||
25132310|NCT02101112|50245821|FG002|Overall Study|Adverse Event|1|||
25132311|NCT02101112|50245822|FG003|Overall Study|Adverse Event|0|||
25132312|NCT02101112|50245823|FG004|Overall Study|Adverse Event|0|||
25132313|NCT02101112|50245824|FG005|Overall Study|Adverse Event|0|||
25132314|NCT02101112|50245819|FG000|Overall Study|Withdrawal by Subject|0|||
25132315|NCT02101112|50245820|FG001|Overall Study|Withdrawal by Subject|0|||
25132316|NCT02101112|50245821|FG002|Overall Study|Withdrawal by Subject|0|||
25132317|NCT02101112|50245822|FG003|Overall Study|Withdrawal by Subject|0|||
25132318|NCT02101112|50245823|FG004|Overall Study|Withdrawal by Subject|1|||
25132319|NCT02101112|50245824|FG005|Overall Study|Withdrawal by Subject|0|||
25132320|NCT02139644|50245839|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
25132321|NCT02139644|50245840|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25132322|NCT02139644|50245841|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25132323|NCT02139644|50245842|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25132324|NCT02139644|50245843|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25132325|NCT02139644|50245844|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
25132326|NCT02139644|50245839|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
25132327|NCT02139644|50245840|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25132328|NCT02139644|50245841|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25132329|NCT02139644|50245842|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25132330|NCT02139644|50245843|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25132331|NCT02139644|50245844|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
25132332|NCT02139644|50245839|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
25132333|NCT02139644|50245840|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25132334|NCT02139644|50245841|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25132335|NCT02139644|50245842|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25132336|NCT02139644|50245843|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25132337|NCT02139644|50245844|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
25132338|NCT02139644|50245839|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
25132339|NCT02139644|50245840|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25132340|NCT02139644|50245841|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25132341|NCT02139644|50245842|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25132342|NCT02139644|50245843|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25132343|NCT02139644|50245844|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
25132344|NCT02139644|50245839|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
25132345|NCT02139644|50245840|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25132346|NCT02139644|50245841|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25132347|NCT02139644|50245842|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25132348|NCT02139644|50245843|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25132349|NCT02139644|50245844|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
25132350|NCT02139644|50245839|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
25132351|NCT02139644|50245840|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
25132352|NCT02139644|50245841|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
25132353|NCT02139644|50245842|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
25132354|NCT02139644|50245843|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
25132355|NCT02139644|50245844|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
25132356|NCT02139644|50245839|FG000|Run-In Period (Pre-assignment)|Other|6|||
25132357|NCT02139644|50245840|FG001|Run-In Period (Pre-assignment)|Other|0|||
25132358|NCT02139644|50245841|FG002|Run-In Period (Pre-assignment)|Other|0|||
25273199|NCT00990340|50587291|FG000|First 14-day Treatment|Lost to Follow-up|2|||
25132359|NCT02139644|50245842|FG003|Run-In Period (Pre-assignment)|Other|0|||
25132360|NCT02139644|50245843|FG004|Run-In Period (Pre-assignment)|Other|0|||
25132361|NCT02139644|50245844|FG005|Run-In Period (Pre-assignment)|Other|0|||
25132362|NCT02139644|50245839|FG000|Treatment Period|Adverse Event|0|||
25132363|NCT02139644|50245840|FG001|Treatment Period|Adverse Event|0|||
25132364|NCT02139644|50245841|FG002|Treatment Period|Adverse Event|3|||
25273200|NCT00990340|50587292|FG001|First 14-day Treatment|Lost to Follow-up|1|||
25273201|NCT00990340|50587291|FG000|First 14-day Treatment|Protocol Violation|2|||
25132365|NCT02139644|50245842|FG003|Treatment Period|Adverse Event|2|||
25132366|NCT02139644|50245843|FG004|Treatment Period|Adverse Event|1|||
25132367|NCT02139644|50245844|FG005|Treatment Period|Adverse Event|6|||
25132368|NCT02139644|50245839|FG000|Treatment Period|Withdrawal by Subject|0|||
25132369|NCT02139644|50245840|FG001|Treatment Period|Withdrawal by Subject|0|||
25132370|NCT02139644|50245841|FG002|Treatment Period|Withdrawal by Subject|2|||
25132371|NCT02139644|50245842|FG003|Treatment Period|Withdrawal by Subject|2|||
25132372|NCT02139644|50245843|FG004|Treatment Period|Withdrawal by Subject|3|||
25132373|NCT02139644|50245844|FG005|Treatment Period|Withdrawal by Subject|2|||
25132374|NCT02139644|50245839|FG000|Treatment Period|Non-compliance|0|||
25132375|NCT02139644|50245840|FG001|Treatment Period|Non-compliance|0|||
25132376|NCT02139644|50245841|FG002|Treatment Period|Non-compliance|0|||
25132377|NCT02139644|50245842|FG003|Treatment Period|Non-compliance|1|||
25132378|NCT02139644|50245843|FG004|Treatment Period|Non-compliance|0|||
25132379|NCT02139644|50245844|FG005|Treatment Period|Non-compliance|0|||
25132380|NCT02139644|50245839|FG000|Treatment Period|Protocol Violation|0|||
25132381|NCT02139644|50245840|FG001|Treatment Period|Protocol Violation|0|||
25132382|NCT02139644|50245841|FG002|Treatment Period|Protocol Violation|0|||
25132383|NCT02139644|50245842|FG003|Treatment Period|Protocol Violation|1|||
25132384|NCT02139644|50245843|FG004|Treatment Period|Protocol Violation|1|||
25178732|NCT01470599|50324057|FG001|Overall Study|Withdrawal by Subject|4|||
25178733|NCT01470599|50324056|FG000|Overall Study|Other|1|||
25273202|NCT00990340|50587292|FG001|First 14-day Treatment|Protocol Violation|2|||
25009399|NCT00075725|50102294|FG000|Overall Study|Pt incarcerated|0|||
25178734|NCT01470599|50324057|FG001|Overall Study|Other|0|||
25178735|NCT01470599|50324056|FG000|Overall Study|Protocol Violation|3|||
25178736|NCT01470599|50324057|FG001|Overall Study|Protocol Violation|1|||
25178737|NCT01470599|50324056|FG000|Overall Study|Adverse event related to study drug|2|||
25178738|NCT01470599|50324057|FG001|Overall Study|Adverse event related to study drug|5|||
25178739|NCT01470599|50324056|FG000|Overall Study|Insufficient clinical response|6|||
25273203|NCT01207440|50587307|FG000|Overall Study|Adverse Event|46|||
25009400|NCT00075725|50102295|FG001|Overall Study|Pt incarcerated|0|||
25009401|NCT00075725|50102296|FG002|Overall Study|Pt incarcerated|0|||
25009402|NCT00075725|50102297|FG003|Overall Study|Pt incarcerated|0|||
25009403|NCT00075725|50102298|FG004|Overall Study|Pt incarcerated|0|||
25009404|NCT00075725|50102299|FG005|Overall Study|Pt incarcerated|0|||
25009405|NCT00075725|50102300|FG006|Overall Study|Pt incarcerated|0|||
25009406|NCT00075725|50102301|FG007|Overall Study|Pt incarcerated|1|||
25009407|NCT00075725|50102302|FG008|Overall Study|Pt incarcerated|0|||
25009408|NCT00075725|50102303|FG009|Overall Study|Pt incarcerated|0|||
25009409|NCT00075725|50102304|FG010|Overall Study|Pt incarcerated|0|||
25009410|NCT00075725|50102305|FG011|Overall Study|Pt incarcerated|0|||
25009411|NCT02953782|50102344|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
25009412|NCT02953782|50102345|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
25009413|NCT02953782|50102346|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
25009414|NCT02953782|50102347|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
25009415|NCT02953782|50102348|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
25009416|NCT02953782|50102349|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
25009417|NCT02953782|50102350|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
25009418|NCT02953782|50102351|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
25009419|NCT02953782|50102344|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
25009420|NCT02953782|50102345|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
25009421|NCT02953782|50102346|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
25009422|NCT02953782|50102347|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
25009423|NCT02953782|50102348|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
25009424|NCT02953782|50102349|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
25009425|NCT02953782|50102350|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
25009426|NCT02953782|50102351|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
25009427|NCT02953782|50102344|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
25009428|NCT02953782|50102345|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
25009429|NCT02953782|50102346|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
25009430|NCT02953782|50102347|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
25009431|NCT02953782|50102348|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
25009432|NCT02953782|50102349|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
25009433|NCT02953782|50102350|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
25132385|NCT02139644|50245844|FG005|Treatment Period|Protocol Violation|1|||
25132386|NCT02139644|50245839|FG000|Treatment Period|Disease progression|0|||
25132387|NCT02139644|50245840|FG001|Treatment Period|Disease progression|0|||
25132388|NCT02139644|50245841|FG002|Treatment Period|Disease progression|0|||
25132389|NCT02139644|50245842|FG003|Treatment Period|Disease progression|1|||
25132390|NCT02139644|50245843|FG004|Treatment Period|Disease progression|1|||
25178740|NCT01470599|50324057|FG001|Overall Study|Insufficient clinical response|27|||
25273204|NCT01207440|50587308|FG001|Overall Study|Adverse Event|11|||
25132391|NCT02139644|50245844|FG005|Treatment Period|Disease progression|2|||
25132392|NCT02139644|50245839|FG000|Treatment Period|Lost to Follow-up|0|||
25132393|NCT02139644|50245840|FG001|Treatment Period|Lost to Follow-up|0|||
25132394|NCT02139644|50245841|FG002|Treatment Period|Lost to Follow-up|1|||
25132395|NCT02139644|50245842|FG003|Treatment Period|Lost to Follow-up|1|||
25132396|NCT02139644|50245843|FG004|Treatment Period|Lost to Follow-up|1|||
25132397|NCT02139644|50245844|FG005|Treatment Period|Lost to Follow-up|1|||
25132398|NCT02139644|50245839|FG000|Treatment Period|Lack of Efficacy|0|||
25132399|NCT02139644|50245840|FG001|Treatment Period|Lack of Efficacy|0|||
25132400|NCT02139644|50245841|FG002|Treatment Period|Lack of Efficacy|1|||
25132401|NCT02139644|50245842|FG003|Treatment Period|Lack of Efficacy|0|||
25132402|NCT02139644|50245843|FG004|Treatment Period|Lack of Efficacy|1|||
25132403|NCT02139644|50245844|FG005|Treatment Period|Lack of Efficacy|4|||
25132404|NCT02139644|50245839|FG000|Treatment Period|Other|0|||
25132405|NCT02139644|50245840|FG001|Treatment Period|Other|3|||
25132406|NCT02139644|50245841|FG002|Treatment Period|Other|1|||
25132407|NCT02139644|50245842|FG003|Treatment Period|Other|1|||
25132408|NCT02139644|50245843|FG004|Treatment Period|Other|0|||
25132409|NCT02139644|50245844|FG005|Treatment Period|Other|1|||
25132410|NCT02100644|50245856|FG000|LTG Escalation Phase|Adverse Event|9|||
25132411|NCT02100644|50245857|FG001|LTG Escalation Phase|Adverse Event|0|||
25132412|NCT02100644|50245858|FG002|LTG Escalation Phase|Adverse Event|0|||
25132413|NCT02100644|50245856|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
25132414|NCT02100644|50245857|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
25132415|NCT02100644|50245858|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
25132416|NCT02100644|50245856|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
25132417|NCT02100644|50245857|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
25273205|NCT01207440|50587309|FG002|Overall Study|Adverse Event|7|||
25273206|NCT01207440|50587310|FG003|Overall Study|Adverse Event|2|||
25273207|NCT01207440|50587311|FG004|Overall Study|Adverse Event|6|||
25273208|NCT01207440|50587312|FG005|Overall Study|Adverse Event|6|||
25273209|NCT01207440|50587313|FG006|Overall Study|Adverse Event|2|||
25273210|NCT01207440|50587307|FG000|Overall Study|Death|6|||
25273211|NCT01207440|50587308|FG001|Overall Study|Death|3|||
25273212|NCT01207440|50587309|FG002|Overall Study|Death|2|||
25273213|NCT01207440|50587310|FG003|Overall Study|Death|2|||
25273214|NCT01207440|50587311|FG004|Overall Study|Death|7|||
25273215|NCT01207440|50587312|FG005|Overall Study|Death|5|||
25273216|NCT01207440|50587313|FG006|Overall Study|Death|1|||
25273217|NCT01207440|50587307|FG000|Overall Study|Lack of Efficacy|13|||
25273218|NCT01207440|50587308|FG001|Overall Study|Lack of Efficacy|2|||
25132418|NCT02100644|50245858|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
25132419|NCT02074982|50245864|FG000|Overall Study|Adverse Event|15|||
25132420|NCT02074982|50245865|FG001|Overall Study|Adverse Event|7|||
25132421|NCT02074982|50245864|FG000|Overall Study|Lack of Efficacy|6|||
25132422|NCT02074982|50245865|FG001|Overall Study|Lack of Efficacy|1|||
25132423|NCT02074982|50245864|FG000|Overall Study|Lost to Follow-up|9|||
25132424|NCT02074982|50245865|FG001|Overall Study|Lost to Follow-up|10|||
25132425|NCT02074982|50245864|FG000|Overall Study|Non-compliance with study treatment|0|||
25132426|NCT02074982|50245865|FG001|Overall Study|Non-compliance with study treatment|2|||
25132427|NCT02074982|50245864|FG000|Overall Study|Physician Decision|1|||
25178741|NCT01470599|50324056|FG000|Overall Study|Adverse event not related to study drug|1|||
25178742|NCT01470599|50324057|FG001|Overall Study|Adverse event not related to study drug|5|||
25178743|NCT01469819|50324063|FG000|Overall Study|Withdrawal by Subject|1|||
25132428|NCT02074982|50245865|FG001|Overall Study|Physician Decision|1|||
25132429|NCT02074982|50245864|FG000|Overall Study|Pregnancy|1|||
25132430|NCT02074982|50245865|FG001|Overall Study|Pregnancy|2|||
25132431|NCT02074982|50245864|FG000|Overall Study|Protocol deviation|4|||
25132432|NCT02074982|50245865|FG001|Overall Study|Protocol deviation|3|||
25132433|NCT02074982|50245864|FG000|Overall Study|Technical problems|0|||
25273219|NCT01207440|50587309|FG002|Overall Study|Lack of Efficacy|5|||
25273220|NCT01207440|50587310|FG003|Overall Study|Lack of Efficacy|1|||
25273221|NCT01207440|50587311|FG004|Overall Study|Lack of Efficacy|2|||
25273222|NCT01207440|50587312|FG005|Overall Study|Lack of Efficacy|3|||
25273223|NCT01207440|50587313|FG006|Overall Study|Lack of Efficacy|0|||
25273224|NCT01207440|50587307|FG000|Overall Study|Lost to Follow-up|0|||
25132434|NCT02074982|50245865|FG001|Overall Study|Technical problems|2|||
25132435|NCT02074982|50245864|FG000|Overall Study|Subject/guardian decision|15|||
25132436|NCT02074982|50245865|FG001|Overall Study|Subject/guardian decision|24|||
25132437|NCT02074982|50245864|FG000|Overall Study|Death|0|||
25132438|NCT02074982|50245865|FG001|Overall Study|Death|2|||
25132439|NCT02074514|50245875|FG000|Overall Study|Lack of Efficacy|3|||
25132440|NCT02074514|50245876|FG001|Overall Study|Lack of Efficacy|2|||
25132441|NCT02074514|50245875|FG000|Overall Study|Lost to Follow-up|0|||
25132442|NCT02074514|50245876|FG001|Overall Study|Lost to Follow-up|1|||
25132443|NCT02074514|50245875|FG000|Overall Study|Withdrew Consent|0|||
25132444|NCT02074514|50245876|FG001|Overall Study|Withdrew Consent|1|||
25132445|NCT02099708|50245886|FG000|Overall Study|Data Not Available|30|||
25132446|NCT02099708|50245886|FG000|Overall Study|Lost to Follow-up|141|||
25132447|NCT02099708|50245886|FG000|Overall Study|Other|29|||
25132448|NCT02073656|50245890|FG000|Primary Study|Lost to Follow-up|6|||
25132449|NCT02073656|50245890|FG000|Primary Study|Death|1|||
25132450|NCT02073656|50245890|FG000|Primary Study|Withdrew Consent|1|||
25132451|NCT02242643|50245898|FG000|Overall Study|Protocol Violation|1|||
25132452|NCT02242643|50245899|FG001|Overall Study|Protocol Violation|2|||
25132453|NCT02242643|50245898|FG000|Overall Study|Withdrawal by Subject|15|||
25132454|NCT02242643|50245899|FG001|Overall Study|Withdrawal by Subject|10|||
25132455|NCT02242643|50245898|FG000|Overall Study|Migrated/moved from study area|1|||
25132456|NCT02242643|50245899|FG001|Overall Study|Migrated/moved from study area|3|||
25132457|NCT02242643|50245898|FG000|Overall Study|Lost to Follow-up|54|||
25132458|NCT02242643|50245899|FG001|Overall Study|Lost to Follow-up|61|||
25132459|NCT02242643|50245898|FG000|Overall Study|Child placed in foster care by family|0|||
25132460|NCT02242643|50245899|FG001|Overall Study|Child placed in foster care by family|1|||
25132461|NCT02242643|50245898|FG000|Overall Study|Non-compliance|1|||
25132462|NCT02242643|50245899|FG001|Overall Study|Non-compliance|0|||
25132463|NCT02242643|50245898|FG000|Overall Study|Consent withdrawal by parent|1|||
25132464|NCT02242643|50245899|FG001|Overall Study|Consent withdrawal by parent|0|||
25132465|NCT02242643|50245898|FG000|Overall Study|Protocol requirements not followed|1|||
25132466|NCT02242643|50245899|FG001|Overall Study|Protocol requirements not followed|0|||
25132467|NCT02242643|50245898|FG000|Overall Study|Language barrier|1|||
25132468|NCT02242643|50245899|FG001|Overall Study|Language barrier|0|||
25132469|NCT02242643|50245898|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
25132470|NCT02242643|50245899|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
25132471|NCT02097290|50245907|FG000|Overall Study|Death|6|||
25132472|NCT02097290|50245907|FG000|Overall Study|Total Withdrawals|3|||
25132473|NCT02097290|50245907|FG000|Overall Study|Attempt|8|||
25132474|NCT02072174|50245913|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
25132475|NCT02072174|50245914|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
25132476|NCT02072174|50245913|FG000|Overall Study|Protocol Violation|16|||
25132477|NCT02072174|50245914|FG001|Overall Study|Protocol Violation|23|||
25132478|NCT02072174|50245913|FG000|Overall Study|Physician Decision|0|||
25132479|NCT02072174|50245914|FG001|Overall Study|Physician Decision|1|||
25132480|NCT02072174|50245913|FG000|Overall Study|Non-compliance with protocol requirement|2|||
25132481|NCT02072174|50245914|FG001|Overall Study|Non-compliance with protocol requirement|0|||
25132482|NCT02209181|50245926|FG000|Overall Study|Adverse Event|1|||
25132483|NCT02209181|50245927|FG001|Overall Study|Adverse Event|0|||
25132484|NCT02209181|50245928|FG002|Overall Study|Adverse Event|1|||
25132485|NCT02209181|50245929|FG003|Overall Study|Adverse Event|0|||
25132486|NCT02209181|50245926|FG000|Overall Study|Withdrawal by Subject|0|||
25132487|NCT02209181|50245927|FG001|Overall Study|Withdrawal by Subject|1|||
25132488|NCT02209181|50245928|FG002|Overall Study|Withdrawal by Subject|0|||
25132489|NCT02209181|50245929|FG003|Overall Study|Withdrawal by Subject|0|||
25132490|NCT02208089|50245941|FG000|Overall Study|Withdrawal by Subject|1|||
25132491|NCT02208089|50245942|FG001|Overall Study|Withdrawal by Subject|0|||
25132492|NCT02208089|50245941|FG000|Overall Study|Lost to Follow-up|6|||
25132493|NCT02208089|50245942|FG001|Overall Study|Lost to Follow-up|0|||
25132494|NCT02242487|50245951|FG000|Overall Study|Adverse Event|13|||
25132495|NCT02242487|50245952|FG001|Overall Study|Adverse Event|15|||
25132496|NCT02242487|50245951|FG000|Overall Study|Lack of Efficacy|4|||
25132497|NCT02242487|50245952|FG001|Overall Study|Lack of Efficacy|6|||
25132498|NCT02242487|50245951|FG000|Overall Study|Protocol Violation|2|||
25132499|NCT02242487|50245952|FG001|Overall Study|Protocol Violation|0|||
25132500|NCT02242487|50245951|FG000|Overall Study|Lost to Follow-up|2|||
25132501|NCT02242487|50245952|FG001|Overall Study|Lost to Follow-up|1|||
25132502|NCT02242487|50245951|FG000|Overall Study|Other - Miscellaneous|4|||
25132503|NCT02242487|50245952|FG001|Overall Study|Other - Miscellaneous|6|||
25132504|NCT02242487|50245951|FG000|Overall Study|Withdrawal by Subject|37|||
25132505|NCT02242487|50245952|FG001|Overall Study|Withdrawal by Subject|19|||
25132506|NCT02241785|50245960|FG000|Overall Study|Sponsor Termination|43|||
25132507|NCT02241785|50245960|FG000|Overall Study|Withdrawal by Subject|1|||
25132508|NCT02241785|50245960|FG000|Overall Study|Lost to Follow-up|2|||
25178744|NCT01469819|50324063|FG000|Overall Study|Did not meet inclusionary criteria|2|||
24907544|NCT00623805|50001588|FG000|Overall Study|Protocol Violation|1|||
25132509|NCT02241785|50245960|FG000|Overall Study|Adverse Event|1|||
25132510|NCT02241551|50245966|FG000|Overall Study|Adverse Event|1|||
25132511|NCT02241551|50245967|FG001|Overall Study|Adverse Event|0|||
25132512|NCT02207621|50245978|FG000|Overall Study|Adverse Event|71|||
25132513|NCT02207621|50245979|FG001|Overall Study|Adverse Event|15|||
25132514|NCT02207621|50245980|FG002|Overall Study|Adverse Event|132|||
25132515|NCT02207621|50245978|FG000|Overall Study|Withdrawal by Subject|9|||
25132516|NCT02207621|50245979|FG001|Overall Study|Withdrawal by Subject|9|||
25273225|NCT01207440|50587308|FG001|Overall Study|Lost to Follow-up|0|||
25273226|NCT01207440|50587309|FG002|Overall Study|Lost to Follow-up|2|||
25273227|NCT01207440|50587310|FG003|Overall Study|Lost to Follow-up|1|||
25273228|NCT01207440|50587311|FG004|Overall Study|Lost to Follow-up|0|||
25273229|NCT01207440|50587312|FG005|Overall Study|Lost to Follow-up|0|||
25273230|NCT01207440|50587313|FG006|Overall Study|Lost to Follow-up|0|||
25273231|NCT01207440|50587307|FG000|Overall Study|Non-compliance with Study Drug|3|||
25273232|NCT01207440|50587308|FG001|Overall Study|Non-compliance with Study Drug|0|||
25273233|NCT01207440|50587309|FG002|Overall Study|Non-compliance with Study Drug|1|||
25273234|NCT01207440|50587310|FG003|Overall Study|Non-compliance with Study Drug|0|||
25273235|NCT01207440|50587311|FG004|Overall Study|Non-compliance with Study Drug|0|||
25273236|NCT01207440|50587312|FG005|Overall Study|Non-compliance with Study Drug|0|||
25273237|NCT01207440|50587313|FG006|Overall Study|Non-compliance with Study Drug|0|||
25273238|NCT01207440|50587307|FG000|Overall Study|Physician Decision|6|||
25273239|NCT01207440|50587308|FG001|Overall Study|Physician Decision|5|||
25273240|NCT01207440|50587309|FG002|Overall Study|Physician Decision|5|||
25273241|NCT01207440|50587310|FG003|Overall Study|Physician Decision|0|||
25273242|NCT01207440|50587311|FG004|Overall Study|Physician Decision|1|||
25273243|NCT01207440|50587312|FG005|Overall Study|Physician Decision|0|||
25273244|NCT01207440|50587313|FG006|Overall Study|Physician Decision|0|||
25273245|NCT01207440|50587307|FG000|Overall Study|Progressive Disease|19|||
25273246|NCT01207440|50587308|FG001|Overall Study|Progressive Disease|10|||
25273247|NCT01207440|50587309|FG002|Overall Study|Progressive Disease|19|||
25273248|NCT01207440|50587310|FG003|Overall Study|Progressive Disease|7|||
25273249|NCT01207440|50587311|FG004|Overall Study|Progressive Disease|23|||
25273250|NCT01207440|50587312|FG005|Overall Study|Progressive Disease|27|||
25273251|NCT01207440|50587313|FG006|Overall Study|Progressive Disease|0|||
25273252|NCT01207440|50587307|FG000|Overall Study|Protocol Violation|2|||
25273253|NCT01207440|50587308|FG001|Overall Study|Protocol Violation|0|||
25273254|NCT01207440|50587309|FG002|Overall Study|Protocol Violation|0|||
25273255|NCT01207440|50587310|FG003|Overall Study|Protocol Violation|0|||
25132517|NCT02207621|50245980|FG002|Overall Study|Withdrawal by Subject|13|||
25132518|NCT02207621|50245978|FG000|Overall Study|Non-Compliant|3|||
25132519|NCT02207621|50245979|FG001|Overall Study|Non-Compliant|3|||
25132520|NCT02207621|50245980|FG002|Overall Study|Non-Compliant|1|||
25132521|NCT02207621|50245978|FG000|Overall Study|Lost to Follow-up|1|||
25132522|NCT02207621|50245979|FG001|Overall Study|Lost to Follow-up|0|||
25132523|NCT02207621|50245980|FG002|Overall Study|Lost to Follow-up|3|||
25132524|NCT02207621|50245978|FG000|Overall Study|Lack of Efficacy|10|||
25132525|NCT02207621|50245979|FG001|Overall Study|Lack of Efficacy|2|||
25132526|NCT02207621|50245980|FG002|Overall Study|Lack of Efficacy|4|||
25132527|NCT02207621|50245978|FG000|Overall Study|Disallowed Concurrent Medication|2|||
25132528|NCT02207621|50245979|FG001|Overall Study|Disallowed Concurrent Medication|5|||
25132529|NCT02207621|50245980|FG002|Overall Study|Disallowed Concurrent Medication|2|||
25132530|NCT02207621|50245978|FG000|Overall Study|Physician Decision|1|||
25132531|NCT02207621|50245979|FG001|Overall Study|Physician Decision|2|||
25132532|NCT02207621|50245980|FG002|Overall Study|Physician Decision|2|||
25132533|NCT02207621|50245978|FG000|Overall Study|Protocol Violation|4|||
25132534|NCT02207621|50245979|FG001|Overall Study|Protocol Violation|10|||
25132535|NCT02207621|50245980|FG002|Overall Study|Protocol Violation|6|||
25132536|NCT02207621|50245978|FG000|Overall Study|Death|2|||
25132537|NCT02207621|50245979|FG001|Overall Study|Death|0|||
25132538|NCT02207621|50245980|FG002|Overall Study|Death|0|||
25132539|NCT02207621|50245978|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
25132540|NCT02207621|50245979|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
25132541|NCT02207621|50245980|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
25132542|NCT02240693|50245994|FG000|Overall Study|Adverse Event|0|||
25132543|NCT02240693|50245995|FG001|Overall Study|Adverse Event|0|||
25132544|NCT02240693|50245996|FG002|Overall Study|Adverse Event|0|||
25132545|NCT02240693|50245997|FG003|Overall Study|Adverse Event|0|||
25132546|NCT02240693|50245998|FG004|Overall Study|Adverse Event|1|||
25273256|NCT01207440|50587311|FG004|Overall Study|Protocol Violation|0|||
25273257|NCT01207440|50587312|FG005|Overall Study|Protocol Violation|0|||
25132547|NCT02240693|50245994|FG000|Overall Study|Withdrawal by Subject|0|||
25132548|NCT02240693|50245995|FG001|Overall Study|Withdrawal by Subject|0|||
25132549|NCT02240693|50245996|FG002|Overall Study|Withdrawal by Subject|2|||
25273258|NCT01207440|50587313|FG006|Overall Study|Protocol Violation|0|||
25273259|NCT01207440|50587307|FG000|Overall Study|Site Terminated by Sponsor|69|||
25273260|NCT01207440|50587308|FG001|Overall Study|Site Terminated by Sponsor|19|||
25273261|NCT01207440|50587309|FG002|Overall Study|Site Terminated by Sponsor|12|||
25273262|NCT01207440|50587310|FG003|Overall Study|Site Terminated by Sponsor|2|||
25132550|NCT02240693|50245997|FG003|Overall Study|Withdrawal by Subject|1|||
25132551|NCT02240693|50245998|FG004|Overall Study|Withdrawal by Subject|0|||
25132552|NCT02240693|50245994|FG000|Overall Study|Other than specified|0|||
25132553|NCT02240693|50245995|FG001|Overall Study|Other than specified|0|||
25132554|NCT02240693|50245996|FG002|Overall Study|Other than specified|2|||
25132555|NCT02240693|50245997|FG003|Overall Study|Other than specified|0|||
25132556|NCT02240693|50245998|FG004|Overall Study|Other than specified|0|||
25132557|NCT02239679|50246015|FG000|Overall Study|Lost to Follow-up|1|||
25132558|NCT02239679|50246016|FG001|Overall Study|Lost to Follow-up|0|||
25132559|NCT02239679|50246017|FG002|Overall Study|Lost to Follow-up|0|||
25132560|NCT02239679|50246015|FG000|Overall Study|Withdrawal by Subject|2|||
25132561|NCT02239679|50246016|FG001|Overall Study|Withdrawal by Subject|3|||
25132562|NCT02239679|50246017|FG002|Overall Study|Withdrawal by Subject|1|||
25132563|NCT02072096|50246027|FG000|Overall Study|Lack of Efficacy|18|||
25132564|NCT02072096|50246028|FG001|Overall Study|Lack of Efficacy|29|||
25132565|NCT02072096|50246027|FG000|Overall Study|Protocol Violation|7|||
25132566|NCT02072096|50246028|FG001|Overall Study|Protocol Violation|7|||
25132567|NCT02072096|50246027|FG000|Overall Study|Withdrawal by Subject|5|||
25132568|NCT02072096|50246028|FG001|Overall Study|Withdrawal by Subject|7|||
25132569|NCT02072096|50246027|FG000|Overall Study|Adverse Event|5|||
25132570|NCT02072096|50246028|FG001|Overall Study|Adverse Event|2|||
25132571|NCT02072096|50246027|FG000|Overall Study|No Reason Provided|4|||
25132572|NCT02072096|50246028|FG001|Overall Study|No Reason Provided|2|||
25273263|NCT01207440|50587311|FG004|Overall Study|Site Terminated by Sponsor|3|||
25273264|NCT01207440|50587312|FG005|Overall Study|Site Terminated by Sponsor|0|||
25132573|NCT02072096|50246027|FG000|Overall Study|Death|2|||
25132574|NCT02072096|50246028|FG001|Overall Study|Death|0|||
25132575|NCT02072096|50246027|FG000|Overall Study|Physician Decision|0|||
25132576|NCT02072096|50246028|FG001|Overall Study|Physician Decision|1|||
25132577|NCT02072096|50246027|FG000|Overall Study|Study Terminated by Sponsor|43|||
25132578|NCT02072096|50246028|FG001|Overall Study|Study Terminated by Sponsor|30|||
25132579|NCT02072096|50246027|FG000|Overall Study|Lost to Follow-up|1|||
25132580|NCT02072096|50246028|FG001|Overall Study|Lost to Follow-up|0|||
25273265|NCT01207440|50587313|FG006|Overall Study|Site Terminated by Sponsor|2|||
25273266|NCT01207440|50587307|FG000|Overall Study|Withdrawal by Subject|29|||
25273267|NCT01207440|50587308|FG001|Overall Study|Withdrawal by Subject|4|||
25132581|NCT02071706|50246035|FG000|Overall Study|Adverse Event|1|||
25273268|NCT01207440|50587309|FG002|Overall Study|Withdrawal by Subject|5|||
25273269|NCT01207440|50587310|FG003|Overall Study|Withdrawal by Subject|3|||
25273270|NCT01207440|50587311|FG004|Overall Study|Withdrawal by Subject|2|||
25273271|NCT01207440|50587312|FG005|Overall Study|Withdrawal by Subject|2|||
25132582|NCT02071706|50246035|FG000|Overall Study|Withdrawal by Subject|2|||
25132583|NCT01631825|50246039|FG000|Overall Study|Adverse Event|42|||
25132584|NCT01631825|50246039|FG000|Overall Study|Lack of Efficacy|7|||
25132585|NCT01631825|50246039|FG000|Overall Study|Withdrawal by Subject|9|||
25132586|NCT01631825|50246039|FG000|Overall Study|Protocol Violation|4|||
25132587|NCT01631825|50246039|FG000|Overall Study|Discontinuation criteria|1|||
25273272|NCT01207440|50587313|FG006|Overall Study|Withdrawal by Subject|0|||
25273273|NCT01207440|50587307|FG000|Overall Study|Reason Not Specified|10|||
25009434|NCT02953782|50102351|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
25009435|NCT02953782|50102344|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
25132588|NCT01631825|50246039|FG000|Overall Study|Physician Decision|2|||
25132589|NCT02071082|50246045|FG000|Overall Study|Enrolled and Never Treated|1|||
25132590|NCT02071082|50246046|FG001|Overall Study|Enrolled and Never Treated|1|||
25132591|NCT02071082|50246045|FG000|Overall Study|Adverse Event|0|||
25132592|NCT02071082|50246046|FG001|Overall Study|Adverse Event|1|||
25132593|NCT02071082|50246045|FG000|Overall Study|Withdrew Consent|0|||
25132594|NCT02071082|50246046|FG001|Overall Study|Withdrew Consent|4|||
25132595|NCT02071082|50246045|FG000|Overall Study|Lost to Follow-up|1|||
25132596|NCT02071082|50246046|FG001|Overall Study|Lost to Follow-up|1|||
25132597|NCT02123108|50246054|FG000|Overall Study|Death|2|||
25132598|NCT02123108|50246055|FG001|Overall Study|Death|3|||
25132599|NCT02121392|50246063|FG000|Prior to Intervention|Protocol Violation|40|||
25132600|NCT02121392|50246064|FG001|Prior to Intervention|Protocol Violation|35|||
25132601|NCT02121392|50246063|FG000|Prior to Intervention|Withdrawal by Subject|8|||
25132602|NCT02121392|50246064|FG001|Prior to Intervention|Withdrawal by Subject|6|||
25132603|NCT02121392|50246063|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
25132604|NCT02121392|50246064|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
25132605|NCT02121392|50246063|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
25132606|NCT02121392|50246064|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
25132607|NCT02097056|50246070|FG000|Overall Study|Protocol Violation|2|||
25132608|NCT02097056|50246070|FG000|Overall Study|Withdrawal by Subject|15|||
25132609|NCT02097056|50246070|FG000|Overall Study|Lost to Follow-up|2|||
25132610|NCT02097056|50246070|FG000|Overall Study|Adverse Event|37|||
25132611|NCT02097056|50246070|FG000|Overall Study|Other|2|||
25132612|NCT02121002|50246077|FG000|Overall Study|Physician Decision|2|||
25132613|NCT02121002|50246078|FG001|Overall Study|Physician Decision|0|||
25132614|NCT02121002|50246079|FG002|Overall Study|Physician Decision|0|||
25132615|NCT02121002|50246077|FG000|Overall Study|Withdrawal by Subject|3|||
25132616|NCT02121002|50246078|FG001|Overall Study|Withdrawal by Subject|1|||
25132617|NCT02121002|50246079|FG002|Overall Study|Withdrawal by Subject|4|||
25132618|NCT02121002|50246077|FG000|Overall Study|Protocol Violation|1|||
25132619|NCT02121002|50246078|FG001|Overall Study|Protocol Violation|2|||
25132620|NCT02121002|50246079|FG002|Overall Study|Protocol Violation|4|||
25132621|NCT02121002|50246077|FG000|Overall Study|Concomitant therapy|0|||
25132622|NCT02121002|50246078|FG001|Overall Study|Concomitant therapy|1|||
25132623|NCT02121002|50246079|FG002|Overall Study|Concomitant therapy|1|||
25132624|NCT02121002|50246077|FG000|Overall Study|Others|1|||
25132625|NCT02121002|50246078|FG001|Overall Study|Others|0|||
25132626|NCT02121002|50246079|FG002|Overall Study|Others|1|||
25132627|NCT02096900|50246089|FG000|Overall Study|Did not receive medication|3|||
25132628|NCT02096900|50246090|FG001|Overall Study|Did not receive medication|1|||
25132629|NCT02096900|50246089|FG000|Overall Study|Surgery cancelled- medication received|1|||
25132630|NCT02096900|50246090|FG001|Overall Study|Surgery cancelled- medication received|1|||
25132631|NCT02120924|50246099|FG000|Overall Study|Lack of Efficacy|1|||
25132632|NCT02120924|50246100|FG001|Overall Study|Lack of Efficacy|2|||
25132633|NCT02120924|50246101|FG002|Overall Study|Lack of Efficacy|3|||
25132634|NCT02120924|50246099|FG000|Overall Study|Adverse Event|0|||
25132635|NCT02120924|50246100|FG001|Overall Study|Adverse Event|1|||
25132636|NCT02120924|50246101|FG002|Overall Study|Adverse Event|3|||
25132637|NCT02120924|50246099|FG000|Overall Study|Withdrawal by Subject|16|||
25132638|NCT02120924|50246100|FG001|Overall Study|Withdrawal by Subject|20|||
25132639|NCT02120924|50246101|FG002|Overall Study|Withdrawal by Subject|8|||
25132640|NCT02120924|50246099|FG000|Overall Study|Lost to Follow-up|14|||
25132641|NCT02120924|50246100|FG001|Overall Study|Lost to Follow-up|14|||
25132642|NCT02120924|50246101|FG002|Overall Study|Lost to Follow-up|11|||
25132643|NCT02120924|50246099|FG000|Overall Study|Pregnancy|2|||
25132644|NCT02120924|50246100|FG001|Overall Study|Pregnancy|0|||
25132645|NCT02120924|50246101|FG002|Overall Study|Pregnancy|0|||
25132646|NCT02120924|50246099|FG000|Overall Study|Protocol Violation|3|||
25132647|NCT02120924|50246100|FG001|Overall Study|Protocol Violation|7|||
25132648|NCT02120924|50246101|FG002|Overall Study|Protocol Violation|2|||
25132649|NCT02120924|50246099|FG000|Overall Study|Physician Decision|0|||
25132650|NCT02120924|50246100|FG001|Overall Study|Physician Decision|1|||
25132651|NCT02120924|50246101|FG002|Overall Study|Physician Decision|1|||
25132652|NCT02120924|50246099|FG000|Overall Study|Death|1|||
25178745|NCT01469819|50324063|FG000|Overall Study|Could not swallow SmartPill|2|||
25132653|NCT02120924|50246100|FG001|Overall Study|Death|0|||
25132654|NCT02120924|50246101|FG002|Overall Study|Death|0|||
25132655|NCT02120924|50246099|FG000|Overall Study|Compliance with IP|5|||
25132656|NCT02120924|50246100|FG001|Overall Study|Compliance with IP|1|||
25132657|NCT02120924|50246101|FG002|Overall Study|Compliance with IP|1|||
25132658|NCT02096744|50246110|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
25132659|NCT02096744|50246111|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
25132660|NCT02096744|50246110|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
25132661|NCT02096744|50246111|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
25132662|NCT02096744|50246110|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
25178746|NCT01469819|50324063|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
25132663|NCT02096744|50246111|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
25132664|NCT02096042|50246119|FG000|Overall Study|Disease Progression|1|||
25132665|NCT02096042|50246120|FG001|Overall Study|Disease Progression|0|||
25132666|NCT02096042|50246121|FG002|Overall Study|Disease Progression|0|||
25132667|NCT02120456|50246137|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
25132668|NCT02120456|50246138|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
25132669|NCT02120456|50246139|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
25132670|NCT02120456|50246140|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
25132671|NCT02120456|50246141|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
25132672|NCT02120456|50246142|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
25132673|NCT02120456|50246143|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
25132674|NCT02120456|50246144|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
25132675|NCT02120456|50246145|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
25132676|NCT02120456|50246137|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
25132677|NCT02120456|50246138|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
25132678|NCT02120456|50246139|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
25132679|NCT02120456|50246140|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
25132680|NCT02120456|50246141|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
25132681|NCT02120456|50246142|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
25132682|NCT02120456|50246143|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
25132683|NCT02120456|50246144|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
25132684|NCT02120456|50246145|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
25132685|NCT02120456|50246137|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
25132686|NCT02120456|50246138|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
25132687|NCT02120456|50246139|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
25132688|NCT02120456|50246140|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
25132689|NCT02120456|50246141|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
25132690|NCT02120456|50246142|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
25132691|NCT02120456|50246143|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
25132692|NCT02120456|50246144|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
25067298|NCT02842853|50172900|FG001|Overall Study|Non-compliance with the protocol|7|||
25178747|NCT01507831|50324075|FG000|Overall Study|Randomized but not treated|0|||
25178748|NCT01507831|50324076|FG001|Overall Study|Randomized but not treated|3|||
25178749|NCT01507831|50324075|FG000|Overall Study|Adverse Event|48|||
25178750|NCT01507831|50324076|FG001|Overall Study|Adverse Event|113|||
25178751|NCT01507831|50324075|FG000|Overall Study|Death|6|||
25178752|NCT01507831|50324076|FG001|Overall Study|Death|2|||
25178753|NCT01507831|50324075|FG000|Overall Study|Poor compliance to protocol|38|||
25178754|NCT01507831|50324076|FG001|Overall Study|Poor compliance to protocol|60|||
25132693|NCT02120456|50246145|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
25132694|NCT02120300|50246169|FG000|Overall Study|Enrolled but Never Treated|2|||
25132695|NCT02120300|50246170|FG001|Overall Study|Enrolled but Never Treated|0|||
25132696|NCT02120300|50246171|FG002|Overall Study|Enrolled but Never Treated|0|||
25132697|NCT02120300|50246172|FG003|Overall Study|Enrolled but Never Treated|0|||
25132698|NCT02120300|50246169|FG000|Overall Study|Lack of Efficacy|0|||
25132699|NCT02120300|50246170|FG001|Overall Study|Lack of Efficacy|0|||
25132700|NCT02120300|50246171|FG002|Overall Study|Lack of Efficacy|0|||
25132701|NCT02120300|50246172|FG003|Overall Study|Lack of Efficacy|1|||
25132702|NCT02120300|50246169|FG000|Overall Study|Lost to Follow-up|1|||
25132703|NCT02120300|50246170|FG001|Overall Study|Lost to Follow-up|0|||
25132704|NCT02120300|50246171|FG002|Overall Study|Lost to Follow-up|0|||
25132705|NCT02120300|50246172|FG003|Overall Study|Lost to Follow-up|0|||
25132706|NCT02070380|50246188|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
25132707|NCT02070380|50246189|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
25132708|NCT02070380|50246190|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
25178755|NCT01507831|50324075|FG000|Overall Study|Physician Decision|0|||
25178756|NCT01507831|50324076|FG001|Overall Study|Physician Decision|4|||
25178757|NCT01507831|50324075|FG000|Overall Study|Participant moved|5|||
25178758|NCT01507831|50324076|FG001|Overall Study|Participant moved|19|||
25178759|NCT01507831|50324075|FG000|Overall Study|Consent withdrawn by participant|34|||
25178760|NCT01507831|50324076|FG001|Overall Study|Consent withdrawn by participant|72|||
25178761|NCT01507831|50324075|FG000|Overall Study|Related to study drug administration|5|||
25067299|NCT02842853|50172901|FG002|Overall Study|Non-compliance with the protocol|2|||
25067300|NCT02842853|50172902|FG003|Overall Study|Non-compliance with the protocol|5|||
25067301|NCT02842853|50172899|FG000|Overall Study|Subject met exclusion criteria|0|||
25067302|NCT02842853|50172900|FG001|Overall Study|Subject met exclusion criteria|1|||
25067303|NCT02842853|50172901|FG002|Overall Study|Subject met exclusion criteria|0|||
25067304|NCT02842853|50172902|FG003|Overall Study|Subject met exclusion criteria|0|||
25067305|NCT02842853|50172899|FG000|Overall Study|Withdrawal by Subject|11|||
25067306|NCT02842853|50172900|FG001|Overall Study|Withdrawal by Subject|13|||
25067307|NCT02842853|50172901|FG002|Overall Study|Withdrawal by Subject|9|||
25067308|NCT02842853|50172902|FG003|Overall Study|Withdrawal by Subject|8|||
25067309|NCT02842853|50172899|FG000|Overall Study|Lost to Follow-up|9|||
25132709|NCT02070380|50246191|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
25132710|NCT02070380|50246188|FG000|Second Injection|Image sets missing or technically inadeq|0|||
25132711|NCT02070380|50246189|FG001|Second Injection|Image sets missing or technically inadeq|1|||
25132712|NCT02070380|50246190|FG002|Second Injection|Image sets missing or technically inadeq|0|||
25132713|NCT02070380|50246191|FG003|Second Injection|Image sets missing or technically inadeq|0|||
25132714|NCT02070380|50246188|FG000|Second Injection|Protocol Violation|0|||
25132715|NCT02070380|50246189|FG001|Second Injection|Protocol Violation|1|||
25132716|NCT02070380|50246190|FG002|Second Injection|Protocol Violation|1|||
25132717|NCT02070380|50246191|FG003|Second Injection|Protocol Violation|5|||
25132718|NCT02069366|50246209|FG000|Overall Study|Lost to Follow-up|0|||
25132719|NCT02069366|50246210|FG001|Overall Study|Lost to Follow-up|0|||
25132720|NCT02069366|50246211|FG002|Overall Study|Lost to Follow-up|1|||
25132721|NCT02069366|50246212|FG003|Overall Study|Lost to Follow-up|0|||
25132722|NCT02069366|50246213|FG004|Overall Study|Lost to Follow-up|0|||
25132723|NCT02069366|50246214|FG005|Overall Study|Lost to Follow-up|2|||
25132724|NCT02069366|50246209|FG000|Overall Study|Protocol Violation|0|||
25178762|NCT01507831|50324076|FG001|Overall Study|Related to study drug administration|14|||
25178763|NCT01507831|50324075|FG000|Overall Study|Last visit outside protocol visit window|51|||
25178764|NCT01507831|50324076|FG001|Overall Study|Last visit outside protocol visit window|143|||
25178765|NCT01507831|50324075|FG000|Overall Study|Selection criteria finally not met|0|||
25178766|NCT01507831|50324076|FG001|Overall Study|Selection criteria finally not met|1|||
25178767|NCT01507831|50324075|FG000|Overall Study|Site closure|0|||
25178768|NCT01507831|50324076|FG001|Overall Study|Site closure|3|||
25178769|NCT01507831|50324075|FG000|Overall Study|Potential lost to follow-up|3|||
25178770|NCT01507831|50324076|FG001|Overall Study|Potential lost to follow-up|0|||
25178771|NCT01507831|50324075|FG000|Overall Study|Other|3|||
25178772|NCT01507831|50324076|FG001|Overall Study|Other|6|||
25178773|NCT01479595|50324084|FG000|Overall Study|Protocol deviation|0|||
25178774|NCT01479595|50324085|FG001|Overall Study|Protocol deviation|1|||
25178775|NCT01479595|50324084|FG000|Overall Study|Adverse Event|2|||
25178776|NCT01479595|50324085|FG001|Overall Study|Adverse Event|1|||
25178777|NCT01462357|50324094|FG000|Overall Study|Death|0|||
25178778|NCT01462357|50324095|FG001|Overall Study|Death|0|||
25178779|NCT01462357|50324096|FG002|Overall Study|Death|1|||
25178780|NCT01462357|50324094|FG000|Overall Study|Withdrawal by Subject|3|||
25178781|NCT01462357|50324095|FG001|Overall Study|Withdrawal by Subject|11|||
25132725|NCT02069366|50246210|FG001|Overall Study|Protocol Violation|0|||
25132726|NCT02069366|50246211|FG002|Overall Study|Protocol Violation|1|||
25132727|NCT02069366|50246212|FG003|Overall Study|Protocol Violation|0|||
25132728|NCT02069366|50246213|FG004|Overall Study|Protocol Violation|0|||
25132729|NCT02069366|50246214|FG005|Overall Study|Protocol Violation|0|||
25132730|NCT02069366|50246209|FG000|Overall Study|Withdrawal by Subject|1|||
25132731|NCT02069366|50246210|FG001|Overall Study|Withdrawal by Subject|0|||
25132732|NCT02069366|50246211|FG002|Overall Study|Withdrawal by Subject|1|||
25132733|NCT02069366|50246212|FG003|Overall Study|Withdrawal by Subject|2|||
25132734|NCT02069366|50246213|FG004|Overall Study|Withdrawal by Subject|0|||
25132735|NCT02069366|50246214|FG005|Overall Study|Withdrawal by Subject|0|||
25132736|NCT02068508|50246229|FG000|Overall Study|Case report forms uncollected|27|||
25132737|NCT02068508|50246229|FG000|Overall Study|Patient did not visit the study site|1|||
25132738|NCT02068508|50246229|FG000|Overall Study|Protocol Violation|4|||
25132739|NCT02068352|50246236|FG000|Overall Study|Lost to Follow-up|0|||
25132740|NCT02068352|50246237|FG001|Overall Study|Lost to Follow-up|2|||
25132741|NCT02068352|50246238|FG002|Overall Study|Lost to Follow-up|0|||
25132742|NCT02068352|50246236|FG000|Overall Study|Adverse Event|4|||
25132743|NCT02068352|50246237|FG001|Overall Study|Adverse Event|2|||
25132744|NCT02068352|50246238|FG002|Overall Study|Adverse Event|7|||
25132745|NCT02068352|50246236|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
25132746|NCT02068352|50246237|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
25132747|NCT02068352|50246238|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
25132748|NCT02068352|50246236|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
25178782|NCT01462357|50324096|FG002|Overall Study|Withdrawal by Subject|3|||
25178783|NCT01462357|50324094|FG000|Overall Study|Migrated/moved from study area|2|||
25132749|NCT02068352|50246237|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
25178784|NCT01462357|50324095|FG001|Overall Study|Migrated/moved from study area|3|||
25178785|NCT01462357|50324096|FG002|Overall Study|Migrated/moved from study area|1|||
25178786|NCT01462357|50324094|FG000|Overall Study|Lost to Follow-up|3|||
25178787|NCT01462357|50324095|FG001|Overall Study|Lost to Follow-up|5|||
25178788|NCT01462357|50324096|FG002|Overall Study|Lost to Follow-up|7|||
25132750|NCT02068352|50246238|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
25132751|NCT02068352|50246236|FG000|Overall Study|Protocol Deviation|0|||
25132752|NCT02068352|50246237|FG001|Overall Study|Protocol Deviation|0|||
25132753|NCT02068352|50246238|FG002|Overall Study|Protocol Deviation|1|||
25132754|NCT02207231|50246249|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
25178789|NCT01479439|50324107|FG000|Overall Study|Adverse Event|1|||
25132755|NCT02207231|50246250|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
25132756|NCT02207231|50246251|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
25132757|NCT02207231|50246252|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
25132758|NCT02207231|50246249|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
25132759|NCT02207231|50246250|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
25132760|NCT02207231|50246251|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
25132761|NCT02207231|50246252|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
25132762|NCT02207231|50246249|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
25132763|NCT02207231|50246250|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
25132764|NCT02207231|50246251|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
25132765|NCT02207231|50246252|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
25132766|NCT02207231|50246249|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
25132767|NCT02207231|50246250|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
25132768|NCT02207231|50246251|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
25132769|NCT02207231|50246252|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
25132770|NCT02207231|50246249|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
25132771|NCT02207231|50246250|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
25132772|NCT02207231|50246251|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
25132773|NCT02207231|50246252|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
25132774|NCT02207231|50246249|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
25132775|NCT02207231|50246250|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
25132776|NCT02207231|50246251|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
25132777|NCT02207231|50246252|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
25132778|NCT02207231|50246249|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
25132779|NCT02207231|50246250|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
25132780|NCT02207231|50246251|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
25132781|NCT02207231|50246252|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
25132782|NCT02207231|50246249|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
25132783|NCT02207231|50246250|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
25132784|NCT02207231|50246251|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
25132785|NCT02207231|50246252|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
25132786|NCT02207231|50246249|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
25132787|NCT02207231|50246250|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
25132788|NCT02207231|50246251|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
25132789|NCT02207231|50246252|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
25132790|NCT02207231|50246249|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
25132791|NCT02207231|50246250|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
25132792|NCT02207231|50246251|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
25132793|NCT02207231|50246252|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
25132794|NCT02207231|50246249|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
25132795|NCT02207231|50246250|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
25132796|NCT02207231|50246251|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
25132797|NCT02207231|50246252|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
25178790|NCT01479439|50324108|FG001|Overall Study|Adverse Event|0|||
25178791|NCT01479439|50324109|FG002|Overall Study|Adverse Event|0|||
25132798|NCT02207231|50246249|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
25132799|NCT02207231|50246250|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
25132800|NCT02207231|50246251|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
25132801|NCT02207231|50246252|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
25132802|NCT02207231|50246249|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
25132803|NCT02207231|50246250|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
25132804|NCT02207231|50246251|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
25132805|NCT02207231|50246252|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
25132806|NCT02207231|50246249|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
25132807|NCT02207231|50246250|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
25132808|NCT02207231|50246251|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
25132809|NCT02207231|50246252|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
25132810|NCT02207231|50246249|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
25132811|NCT02207231|50246250|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
25132812|NCT02207231|50246251|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
25132813|NCT02207231|50246252|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
25132814|NCT02207231|50246249|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
25132815|NCT02207231|50246250|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
25132816|NCT02207231|50246251|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
25178792|NCT01479439|50324107|FG000|Overall Study|Lost to Follow-up|0|||
24907545|NCT00623805|50001589|FG001|Overall Study|Protocol Violation|1|||
25132817|NCT02207231|50246252|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
25178793|NCT01479439|50324108|FG001|Overall Study|Lost to Follow-up|1|||
25178794|NCT01479439|50324109|FG002|Overall Study|Lost to Follow-up|0|||
25178795|NCT01479439|50324107|FG000|Overall Study|Protocol Violation|0|||
25178796|NCT01479439|50324108|FG001|Overall Study|Protocol Violation|0|||
25178797|NCT01479439|50324109|FG002|Overall Study|Protocol Violation|2|||
25178798|NCT01478971|50324120|FG000|Standard of Care Period|Adverse Event|1|||
25178799|NCT01478971|50324120|FG000|Standard of Care Period|Withdrawal by Subject|3|||
25178800|NCT01478971|50324120|FG000|Standard of Care Period|Death|8|||
25178801|NCT01478971|50324120|FG000|Standard of Care Period|Lost to Follow-up|9|||
25178802|NCT01478971|50324120|FG000|Standard of Care Period|Other|4|||
25178803|NCT01478971|50324120|FG000|Peginesatide Treatment Period|Adverse Event|1|||
25178804|NCT01478971|50324120|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
25178805|NCT01478971|50324120|FG000|Peginesatide Treatment Period|Death|4|||
25178806|NCT01478971|50324120|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
25178807|NCT01478971|50324120|FG000|Peginesatide Treatment Period|Other|4|||
25178808|NCT01507051|50324132|FG000|Overall Study|Withdrawal by Subject|1|||
25178809|NCT01507051|50324133|FG001|Overall Study|Withdrawal by Subject|3|||
25178810|NCT01507051|50324134|FG002|Overall Study|Withdrawal by Subject|1|||
25178811|NCT01507051|50324135|FG003|Overall Study|Withdrawal by Subject|6|||
25132818|NCT02207231|50246249|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
25132819|NCT02207231|50246250|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
25132820|NCT02207231|50246251|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
25132821|NCT02207231|50246252|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
25132822|NCT02207231|50246249|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
25132823|NCT02207231|50246250|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
25132824|NCT02207231|50246251|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
25132825|NCT02207231|50246252|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
25132826|NCT02207231|50246249|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
25132827|NCT02207231|50246250|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
25132828|NCT02207231|50246251|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
25132829|NCT02207231|50246252|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
25132830|NCT02207231|50246249|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
25132831|NCT02207231|50246250|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
25132832|NCT02207231|50246251|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
25132833|NCT02207231|50246252|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
25132834|NCT02207231|50246249|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
25132835|NCT02207231|50246250|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
25132836|NCT02207231|50246251|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
25132837|NCT02207231|50246252|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
25132838|NCT02239601|50246272|FG000|Overall Study|Withdrawal by Subject|3|||
25132839|NCT02239601|50246273|FG001|Overall Study|Withdrawal by Subject|4|||
25132840|NCT02239601|50246272|FG000|Overall Study|Protocol Violation|4|||
25132841|NCT02239601|50246273|FG001|Overall Study|Protocol Violation|2|||
25132842|NCT02236559|50246286|FG000|Overall Study|Met Exclusion|3|||
25132843|NCT02236559|50246287|FG001|Overall Study|Met Exclusion|6|||
25132844|NCT02236559|50246286|FG000|Overall Study|Did not Meet Inclusion|3|||
25132845|NCT02236559|50246287|FG001|Overall Study|Did not Meet Inclusion|3|||
25132846|NCT02236559|50246286|FG000|Overall Study|Subject Did Not Consent|4|||
25178812|NCT01507051|50324132|FG000|Overall Study|Physician Decision|0|||
25178813|NCT01507051|50324133|FG001|Overall Study|Physician Decision|0|||
25178814|NCT01507051|50324134|FG002|Overall Study|Physician Decision|0|||
25178815|NCT01507051|50324135|FG003|Overall Study|Physician Decision|1|||
25067310|NCT02842853|50172900|FG001|Overall Study|Lost to Follow-up|13|||
25132847|NCT02236559|50246287|FG001|Overall Study|Subject Did Not Consent|2|||
25132848|NCT02236559|50246286|FG000|Overall Study|Physician Decision|1|||
25132849|NCT02236559|50246287|FG001|Overall Study|Physician Decision|1|||
25132850|NCT02236559|50246286|FG000|Overall Study|Withdrawal by Subject|1|||
25132851|NCT02236559|50246287|FG001|Overall Study|Withdrawal by Subject|0|||
25132852|NCT02206685|50246295|FG000|Overall Study|Surgery cancelled/changed|2|||
25132853|NCT02206685|50246296|FG001|Overall Study|Surgery cancelled/changed|3|||
25132854|NCT02206685|50246295|FG000|Overall Study|Withdrawal by Subject|1|||
25132855|NCT02206685|50246296|FG001|Overall Study|Withdrawal by Subject|2|||
25132856|NCT02206685|50246295|FG000|Overall Study|Protocol Violation|2|||
25132857|NCT02206685|50246296|FG001|Overall Study|Protocol Violation|2|||
25132858|NCT02206607|50246302|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
25132859|NCT02206607|50246303|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
25132860|NCT02206607|50246304|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
25132861|NCT02206607|50246305|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
25132862|NCT02206607|50246306|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
25132863|NCT02206607|50246302|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
25132864|NCT02206607|50246303|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
25132865|NCT02206607|50246304|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
25132866|NCT02206607|50246305|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
25132867|NCT02206607|50246306|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
25132868|NCT02119676|50246326|FG000|Overall Study|Adverse Event|9|||
25132869|NCT02119676|50246327|FG001|Overall Study|Adverse Event|17|||
25132870|NCT02119676|50246328|FG002|Overall Study|Adverse Event|10|||
25132871|NCT02119676|50246329|FG003|Overall Study|Adverse Event|10|||
25132872|NCT02119676|50246326|FG000|Overall Study|Disease progression|53|||
25132873|NCT02119676|50246327|FG001|Overall Study|Disease progression|55|||
25132874|NCT02119676|50246328|FG002|Overall Study|Disease progression|68|||
25132875|NCT02119676|50246329|FG003|Overall Study|Disease progression|73|||
25132876|NCT02119676|50246326|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
25132877|NCT02119676|50246327|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
25132878|NCT02119676|50246328|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
25132879|NCT02119676|50246329|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
25132880|NCT02119676|50246326|FG000|Overall Study|Physician Decision|4|||
25132881|NCT02119676|50246327|FG001|Overall Study|Physician Decision|2|||
25132882|NCT02119676|50246328|FG002|Overall Study|Physician Decision|3|||
25132883|NCT02119676|50246329|FG003|Overall Study|Physician Decision|2|||
25132884|NCT02119676|50246326|FG000|Overall Study|Death|9|||
25132885|NCT02119676|50246327|FG001|Overall Study|Death|3|||
25132886|NCT02119676|50246328|FG002|Overall Study|Death|2|||
25132887|NCT02119676|50246329|FG003|Overall Study|Death|1|||
25132888|NCT02119676|50246326|FG000|Overall Study|Noncompliance|0|||
25132889|NCT02119676|50246327|FG001|Overall Study|Noncompliance|1|||
25132890|NCT02119676|50246328|FG002|Overall Study|Noncompliance|0|||
25132891|NCT02119676|50246329|FG003|Overall Study|Noncompliance|0|||
25132892|NCT02119676|50246326|FG000|Overall Study|Lost to Follow-up|0|||
25132893|NCT02119676|50246327|FG001|Overall Study|Lost to Follow-up|0|||
25132894|NCT02119676|50246328|FG002|Overall Study|Lost to Follow-up|1|||
25132895|NCT02119676|50246329|FG003|Overall Study|Lost to Follow-up|0|||
25132896|NCT02119676|50246326|FG000|Overall Study|Protocol deviation|0|||
25132897|NCT02119676|50246327|FG001|Overall Study|Protocol deviation|0|||
25132898|NCT02119676|50246328|FG002|Overall Study|Protocol deviation|1|||
25132899|NCT02119676|50246329|FG003|Overall Study|Protocol deviation|0|||
25132900|NCT02119676|50246326|FG000|Overall Study|Other, unspecified|2|||
25132901|NCT02119676|50246327|FG001|Overall Study|Other, unspecified|1|||
25132902|NCT02119676|50246328|FG002|Overall Study|Other, unspecified|3|||
25132903|NCT02119676|50246329|FG003|Overall Study|Other, unspecified|4|||
25132904|NCT02119676|50246326|FG000|Overall Study|Did not receive study med|2|||
25132905|NCT02119676|50246327|FG001|Overall Study|Did not receive study med|2|||
25067311|NCT02842853|50172901|FG002|Overall Study|Lost to Follow-up|10|||
25067312|NCT02842853|50172902|FG003|Overall Study|Lost to Follow-up|11|||
25067313|NCT02433340|50172918|FG000|Overall Study|Adverse Event|0|||
25067314|NCT02433340|50172919|FG001|Overall Study|Adverse Event|0|||
25067315|NCT02433340|50172920|FG002|Overall Study|Adverse Event|1|||
25067316|NCT02433340|50172921|FG003|Overall Study|Adverse Event|0|||
25067317|NCT02433340|50172918|FG000|Overall Study|Withdrawal by Subject|1|||
25067318|NCT02433340|50172919|FG001|Overall Study|Withdrawal by Subject|0|||
25067319|NCT02433340|50172920|FG002|Overall Study|Withdrawal by Subject|1|||
25067320|NCT02433340|50172921|FG003|Overall Study|Withdrawal by Subject|2|||
25067321|NCT02433340|50172918|FG000|Overall Study|Lost to Follow-up|0|||
25067322|NCT02433340|50172919|FG001|Overall Study|Lost to Follow-up|1|||
25067323|NCT02433340|50172920|FG002|Overall Study|Lost to Follow-up|0|||
25067324|NCT02433340|50172921|FG003|Overall Study|Lost to Follow-up|0|||
25067325|NCT02433340|50172918|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
25067326|NCT02433340|50172919|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
25067327|NCT02433340|50172920|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
25132906|NCT02119676|50246328|FG002|Overall Study|Did not receive study med|4|||
25132907|NCT02119676|50246329|FG003|Overall Study|Did not receive study med|5|||
25132908|NCT02206061|50246342|FG000|Overall Study|Withdrawal by Subject|4|||
25132909|NCT02206061|50246343|FG001|Overall Study|Withdrawal by Subject|7|||
25132910|NCT02206061|50246344|FG002|Overall Study|Withdrawal by Subject|1|||
25132911|NCT02206061|50246342|FG000|Overall Study|Lost to Follow-up|14|||
25132912|NCT02206061|50246343|FG001|Overall Study|Lost to Follow-up|7|||
25132913|NCT02206061|50246344|FG002|Overall Study|Lost to Follow-up|20|||
25132914|NCT02095106|50246354|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
25132915|NCT02095106|50246355|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
25132916|NCT01631747|50246367|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
25132917|NCT01631747|50246368|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
25132918|NCT01631747|50246367|FG000|Live Birth|Pregnancy Termination|1|||
25132919|NCT01631747|50246368|FG001|Live Birth|Pregnancy Termination|0|||
25132920|NCT01631747|50246367|FG000|Live Birth|MIscarriage|2|||
25132921|NCT01631747|50246368|FG001|Live Birth|MIscarriage|0|||
25132922|NCT01631747|50246367|FG000|Live Birth|Stillbirth|1|||
25132923|NCT01631747|50246368|FG001|Live Birth|Stillbirth|1|||
25132924|NCT01631747|50246367|FG000|One Year Infant Outcomes|Patient Refused|13|||
25132925|NCT01631747|50246368|FG001|One Year Infant Outcomes|Patient Refused|9|||
25132926|NCT02068118|50246377|FG000|18-month Comparative Study Period|Death|90|||
25132927|NCT02068118|50246378|FG001|18-month Comparative Study Period|Death|97|||
25132928|NCT02068118|50246377|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
25132929|NCT02068118|50246378|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
25132930|NCT02068118|50246377|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
25132931|NCT02068118|50246378|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
25132932|NCT02068118|50246377|FG000|18-month Comparative Study Period|Heart transplant|9|||
25132933|NCT02068118|50246378|FG001|18-month Comparative Study Period|Heart transplant|15|||
25132934|NCT02068118|50246377|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
25132935|NCT02068118|50246378|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
25132936|NCT02068118|50246377|FG000|18-month Comparative Study Period|Hemiplegia|0|||
25132937|NCT02068118|50246378|FG001|18-month Comparative Study Period|Hemiplegia|1|||
25132938|NCT02068118|50246377|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
25132939|NCT02068118|50246378|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
25132940|NCT02068118|50246377|FG000|18-month Comparative Study Period|Move|0|||
25132941|NCT02068118|50246378|FG001|18-month Comparative Study Period|Move|1|||
25132942|NCT02068118|50246377|FG000|18-month Comparative Study Period|Hearing loss|0|||
25132943|NCT02068118|50246378|FG001|18-month Comparative Study Period|Hearing loss|1|||
25132944|NCT02068118|50246377|FG000|Extension Period|Death|0|||
25132945|NCT02068118|50246378|FG001|Extension Period|Death|2|||
25132946|NCT02068118|50246377|FG000|Extension Period|Withdrawal by Subject|1|||
25132947|NCT02068118|50246378|FG001|Extension Period|Withdrawal by Subject|0|||
25132948|NCT02068118|50246377|FG000|Extension Period|Heart transplant|1|||
25132949|NCT02068118|50246378|FG001|Extension Period|Heart transplant|0|||
25132950|NCT02068118|50246377|FG000|Extension Period|Wrong device use|0|||
25132951|NCT02068118|50246378|FG001|Extension Period|Wrong device use|1|||
25132952|NCT01623830|50246388|FG000|Overall Study|Withdrawal by Subject|6|||
25273274|NCT01207440|50587308|FG001|Overall Study|Reason Not Specified|10|||
25273275|NCT01207440|50587309|FG002|Overall Study|Reason Not Specified|7|||
25273276|NCT01207440|50587310|FG003|Overall Study|Reason Not Specified|0|||
25273277|NCT01207440|50587311|FG004|Overall Study|Reason Not Specified|4|||
25273278|NCT01207440|50587312|FG005|Overall Study|Reason Not Specified|3|||
25273279|NCT01207440|50587313|FG006|Overall Study|Reason Not Specified|0|||
25273280|NCT00990184|50587335|FG000|Overall Study|Physician Decision|1|||
25273281|NCT00986830|50587341|FG000|Overall Study|Death|1|||
25273282|NCT00986830|50587341|FG000|Overall Study|Lost to Follow-up|1|||
25273283|NCT00986830|50587341|FG000|Overall Study|Lack of Efficacy|1|||
25273284|NCT00986830|50587341|FG000|Overall Study|Unable to access sinus with device|5|||
25273285|NCT00990106|50587347|FG000|Overall Study|"too busy to continue"|1|||
25273286|NCT00990106|50587348|FG001|Overall Study|"too busy to continue"|2|||
25273287|NCT00990106|50587347|FG000|Overall Study|Lost to Follow-up|1|||
25273288|NCT00990106|50587348|FG001|Overall Study|Lost to Follow-up|3|||
25273289|NCT00990106|50587347|FG000|Overall Study|Withdrawal by Subject|2|||
25273290|NCT00990106|50587348|FG001|Overall Study|Withdrawal by Subject|1|||
25273291|NCT00990106|50587347|FG000|Overall Study|opted for open label prazosin|1|||
25273292|NCT00990106|50587348|FG001|Overall Study|opted for open label prazosin|1|||
25273293|NCT00990106|50587347|FG000|Overall Study|relocation/deployment|4|||
25273294|NCT00990106|50587348|FG001|Overall Study|relocation/deployment|1|||
25132953|NCT01623830|50246389|FG001|Overall Study|Withdrawal by Subject|7|||
25132954|NCT01623830|50246388|FG000|Overall Study|Exclusion from Study|1|||
25132955|NCT01623830|50246389|FG001|Overall Study|Exclusion from Study|2|||
25273295|NCT00990106|50587347|FG000|Overall Study|started exclusionary medication|0|||
25273296|NCT00990106|50587348|FG001|Overall Study|started exclusionary medication|1|||
25273297|NCT00990106|50587347|FG000|Overall Study|planned major surgery|0|||
25132956|NCT01634165|50246395|FG000|Period 2|Adverse Event|0|||
25132957|NCT01634165|50246396|FG001|Period 2|Adverse Event|1|||
25132958|NCT01634165|50246397|FG002|Period 2|Adverse Event|0|||
25132959|NCT01634165|50246398|FG003|Period 2|Adverse Event|0|||
25132960|NCT03575897|50246410|FG000|Overall Study|Lost to Follow-up|12|||
25132961|NCT03575897|50246411|FG001|Overall Study|Lost to Follow-up|13|||
25132962|NCT02235311|50246419|FG000|Overall Study|Lost to Follow-up|0|||
25132963|NCT02235311|50246420|FG001|Overall Study|Lost to Follow-up|1|||
25132964|NCT02235311|50246419|FG000|Overall Study|Protocol Violation|0|||
25132965|NCT02235311|50246420|FG001|Overall Study|Protocol Violation|1|||
25132966|NCT02204579|50246426|FG000|Overall Study|Screen failures|2|||
25132967|NCT02235077|50246437|FG000|Overall Study|Death|5|||
25132968|NCT02235077|50246438|FG001|Overall Study|Death|7|||
25132969|NCT02235077|50246437|FG000|Overall Study|Lost to Follow-up|5|||
25132970|NCT02235077|50246438|FG001|Overall Study|Lost to Follow-up|6|||
25132971|NCT02235077|50246437|FG000|Overall Study|Withdrawal by Subject|8|||
25132972|NCT02235077|50246438|FG001|Overall Study|Withdrawal by Subject|5|||
25132973|NCT02235077|50246437|FG000|Overall Study|Physician Decision|0|||
25132974|NCT02235077|50246438|FG001|Overall Study|Physician Decision|1|||
25273298|NCT00990106|50587348|FG001|Overall Study|planned major surgery|1|||
25273299|NCT00990106|50587347|FG000|Overall Study|scheduling conflicts|0|||
25273300|NCT00990106|50587348|FG001|Overall Study|scheduling conflicts|2|||
25273301|NCT00983476|50587357|FG000|Overall Study|Did not receive intervention|17|||
25273302|NCT00983476|50587358|FG001|Overall Study|Did not receive intervention|22|||
25273303|NCT00983476|50587359|FG002|Overall Study|Did not receive intervention|0|||
25273304|NCT00982228|50587403|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
25273305|NCT00982228|50587404|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
25273306|NCT00982228|50587403|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
25273307|NCT00982228|50587404|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
25273308|NCT00982228|50587403|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
25132975|NCT02234141|50246448|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
25132976|NCT02234141|50246449|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
25132977|NCT02234141|50246450|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
25132978|NCT02234141|50246451|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
25132979|NCT02234141|50246452|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
25132980|NCT02234141|50246453|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
25132981|NCT02234141|50246454|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
25132982|NCT02234141|50246448|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
25132983|NCT02234141|50246449|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
25132984|NCT02234141|50246450|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
25132985|NCT02234141|50246451|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
25132986|NCT02234141|50246452|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
25132987|NCT02234141|50246453|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
25132988|NCT02234141|50246454|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
25132989|NCT02234141|50246448|FG000|Treatment Period (24 Weeks)|Death|1|||
25132990|NCT02234141|50246449|FG001|Treatment Period (24 Weeks)|Death|2|||
25132991|NCT02234141|50246450|FG002|Treatment Period (24 Weeks)|Death|0|||
25132992|NCT02234141|50246451|FG003|Treatment Period (24 Weeks)|Death|1|||
25132993|NCT02234141|50246452|FG004|Treatment Period (24 Weeks)|Death|0|||
25132994|NCT02234141|50246453|FG005|Treatment Period (24 Weeks)|Death|0|||
25132995|NCT02234141|50246454|FG006|Treatment Period (24 Weeks)|Death|0|||
25132996|NCT02234141|50246448|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
25132997|NCT02234141|50246449|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
25132998|NCT02234141|50246450|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
25132999|NCT02234141|50246451|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
25133000|NCT02234141|50246452|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
25133001|NCT02234141|50246453|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
25133002|NCT02234141|50246454|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
25133003|NCT02234141|50246448|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
25133004|NCT02234141|50246449|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
25133005|NCT02234141|50246450|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
25133006|NCT02234141|50246451|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
25178816|NCT01507051|50324132|FG000|Overall Study|Adverse Event|1|||
25133007|NCT02234141|50246452|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
25133008|NCT02234141|50246453|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
25133009|NCT02234141|50246454|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
25133010|NCT02234141|50246448|FG000|Long-Term Treatment Period|Death|0|||
25133011|NCT02234141|50246449|FG001|Long-Term Treatment Period|Death|0|||
25133012|NCT02234141|50246450|FG002|Long-Term Treatment Period|Death|0|||
25133013|NCT02234141|50246451|FG003|Long-Term Treatment Period|Death|0|||
25133014|NCT02234141|50246452|FG004|Long-Term Treatment Period|Death|0|||
25133015|NCT02234141|50246453|FG005|Long-Term Treatment Period|Death|1|||
25133016|NCT02234141|50246454|FG006|Long-Term Treatment Period|Death|0|||
25133017|NCT02234141|50246448|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
25133018|NCT02234141|50246449|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
25133019|NCT02234141|50246450|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
25133020|NCT02234141|50246451|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
25133021|NCT02234141|50246452|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
25133022|NCT02234141|50246453|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
25133023|NCT02234141|50246454|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
25133024|NCT02234141|50246448|FG000|Long-Term Treatment Period|Adverse Event|4|||
25133025|NCT02234141|50246449|FG001|Long-Term Treatment Period|Adverse Event|0|||
25133026|NCT02234141|50246450|FG002|Long-Term Treatment Period|Adverse Event|5|||
25133027|NCT02234141|50246451|FG003|Long-Term Treatment Period|Adverse Event|0|||
25133028|NCT02234141|50246452|FG004|Long-Term Treatment Period|Adverse Event|1|||
25133029|NCT02234141|50246453|FG005|Long-Term Treatment Period|Adverse Event|1|||
25133030|NCT02234141|50246454|FG006|Long-Term Treatment Period|Adverse Event|1|||
25133031|NCT02234141|50246448|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
25133032|NCT02234141|50246449|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
25133033|NCT02234141|50246450|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
25133034|NCT02234141|50246451|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
25133035|NCT02234141|50246452|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
25133036|NCT02234141|50246453|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
25133037|NCT02234141|50246454|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
25133038|NCT02234141|50246448|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
25133039|NCT02234141|50246449|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
25133040|NCT02234141|50246450|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
25133041|NCT02234141|50246451|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
25133042|NCT02234141|50246452|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
25133043|NCT02234141|50246453|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
25133044|NCT02234141|50246454|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
25133045|NCT02234063|50246467|FG000|Overall Study|Lost to Follow-up|235|||
25133046|NCT02234063|50246468|FG001|Overall Study|Lost to Follow-up|42|||
25133047|NCT02234063|50246467|FG000|Overall Study|Withdrawal by Subject|20|||
25133048|NCT02234063|50246468|FG001|Overall Study|Withdrawal by Subject|1|||
25133049|NCT02232893|50246481|FG000|Overall Study|Withdrawal by Subject|4|||
25133050|NCT02232893|50246482|FG001|Overall Study|Withdrawal by Subject|1|||
25133051|NCT02232893|50246481|FG000|Overall Study|Adverse Event|0|||
25133052|NCT02232893|50246482|FG001|Overall Study|Adverse Event|1|||
25133053|NCT02232893|50246481|FG000|Overall Study|Sponsor request early termination|0|||
25133054|NCT02232893|50246482|FG001|Overall Study|Sponsor request early termination|1|||
25133055|NCT02232893|50246481|FG000|Overall Study|Developed exclusion criteria|0|||
25133056|NCT02232893|50246482|FG001|Overall Study|Developed exclusion criteria|1|||
25133057|NCT02232893|50246481|FG000|Overall Study|Other|0|||
25133058|NCT02232893|50246482|FG001|Overall Study|Other|3|||
25133059|NCT02203721|50246490|FG000|Overall Study|Lost to Follow-up|1|||
25133060|NCT02203721|50246491|FG001|Overall Study|Lost to Follow-up|0|||
25133061|NCT02203721|50246490|FG000|Overall Study|Death|0|||
25133062|NCT02203721|50246491|FG001|Overall Study|Death|2|||
25133063|NCT02203721|50246490|FG000|Overall Study|Illness|0|||
25133064|NCT02203721|50246491|FG001|Overall Study|Illness|1|||
25133065|NCT01618695|50246501|FG000|Core Phase|Adverse Event|4|||
25133066|NCT01618695|50246502|FG001|Core Phase|Adverse Event|5|||
25133067|NCT01618695|50246503|FG002|Core Phase|Adverse Event|15|||
25133068|NCT01618695|50246504|FG003|Core Phase|Adverse Event|20|||
25133069|NCT01618695|50246501|FG000|Core Phase|Lost to Follow-up|0|||
25133070|NCT01618695|50246502|FG001|Core Phase|Lost to Follow-up|0|||
25133071|NCT01618695|50246503|FG002|Core Phase|Lost to Follow-up|1|||
25133072|NCT01618695|50246504|FG003|Core Phase|Lost to Follow-up|0|||
25133073|NCT01618695|50246501|FG000|Core Phase|Withdrawal by Subject|16|||
25133074|NCT01618695|50246502|FG001|Core Phase|Withdrawal by Subject|11|||
25133075|NCT01618695|50246503|FG002|Core Phase|Withdrawal by Subject|9|||
25133076|NCT01618695|50246504|FG003|Core Phase|Withdrawal by Subject|13|||
25133077|NCT01618695|50246501|FG000|Core Phase|Pregnancy|2|||
25133078|NCT01618695|50246502|FG001|Core Phase|Pregnancy|0|||
25133079|NCT01618695|50246503|FG002|Core Phase|Pregnancy|0|||
25133080|NCT01618695|50246504|FG003|Core Phase|Pregnancy|0|||
25133081|NCT01618695|50246501|FG000|Core Phase|Lack of Efficacy|1|||
25133082|NCT01618695|50246502|FG001|Core Phase|Lack of Efficacy|2|||
25133083|NCT01618695|50246503|FG002|Core Phase|Lack of Efficacy|1|||
25133084|NCT01618695|50246504|FG003|Core Phase|Lack of Efficacy|1|||
25133085|NCT01618695|50246501|FG000|Core Phase|Other than specified|1|||
25133086|NCT01618695|50246502|FG001|Core Phase|Other than specified|2|||
25133087|NCT01618695|50246503|FG002|Core Phase|Other than specified|2|||
25133088|NCT01618695|50246504|FG003|Core Phase|Other than specified|2|||
25133089|NCT01618695|50246501|FG000|Core Phase|Not treated|1|||
25133090|NCT01618695|50246502|FG001|Core Phase|Not treated|0|||
25133091|NCT01618695|50246503|FG002|Core Phase|Not treated|2|||
25133092|NCT01618695|50246504|FG003|Core Phase|Not treated|0|||
25133093|NCT01618695|50246501|FG000|Extension Phase|Lack of Efficacy|17|||
25133094|NCT01618695|50246502|FG001|Extension Phase|Lack of Efficacy|33|||
25133095|NCT01618695|50246503|FG002|Extension Phase|Lack of Efficacy|26|||
25133096|NCT01618695|50246504|FG003|Extension Phase|Lack of Efficacy|24|||
25133097|NCT01618695|50246501|FG000|Extension Phase|Pregnancy|2|||
25133098|NCT01618695|50246502|FG001|Extension Phase|Pregnancy|0|||
25133099|NCT01618695|50246503|FG002|Extension Phase|Pregnancy|1|||
25133100|NCT01618695|50246504|FG003|Extension Phase|Pregnancy|1|||
25133101|NCT01618695|50246501|FG000|Extension Phase|Withdrawal by Subject|43|||
25133102|NCT01618695|50246502|FG001|Extension Phase|Withdrawal by Subject|48|||
25133103|NCT01618695|50246503|FG002|Extension Phase|Withdrawal by Subject|42|||
25133104|NCT01618695|50246504|FG003|Extension Phase|Withdrawal by Subject|33|||
25133105|NCT01618695|50246501|FG000|Extension Phase|Adverse Event|18|||
25133106|NCT01618695|50246502|FG001|Extension Phase|Adverse Event|16|||
25133107|NCT01618695|50246503|FG002|Extension Phase|Adverse Event|9|||
25133108|NCT01618695|50246504|FG003|Extension Phase|Adverse Event|20|||
25133109|NCT01618695|50246501|FG000|Extension Phase|Lost to Follow-up|2|||
25133110|NCT01618695|50246502|FG001|Extension Phase|Lost to Follow-up|1|||
25133111|NCT01618695|50246503|FG002|Extension Phase|Lost to Follow-up|1|||
25133112|NCT01618695|50246504|FG003|Extension Phase|Lost to Follow-up|1|||
25133113|NCT01618695|50246501|FG000|Extension Phase|Other than specified|13|||
25133114|NCT01618695|50246502|FG001|Extension Phase|Other than specified|18|||
25133115|NCT01618695|50246503|FG002|Extension Phase|Other than specified|13|||
25133116|NCT01618695|50246504|FG003|Extension Phase|Other than specified|18|||
25133117|NCT01896531|50246517|FG000|Overall Study|Death|57|||
25133118|NCT01896531|50246518|FG001|Overall Study|Death|59|||
25273309|NCT00982228|50587404|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
25273310|NCT00982228|50587403|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
25273311|NCT00982228|50587404|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
25273312|NCT00982228|50587403|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
25273313|NCT00982228|50587404|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
25273314|NCT00982228|50587403|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
25273315|NCT00982228|50587404|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
25273316|NCT00982228|50587403|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
25133119|NCT01896531|50246517|FG000|Overall Study|Lost to Follow-up|3|||
25133120|NCT01896531|50246518|FG001|Overall Study|Lost to Follow-up|0|||
25133121|NCT01896531|50246517|FG000|Overall Study|Non-compliance|0|||
25133122|NCT01896531|50246518|FG001|Overall Study|Non-compliance|1|||
25133123|NCT01896531|50246517|FG000|Overall Study|Study Ended by Sponsor|7|||
25133124|NCT01896531|50246518|FG001|Overall Study|Study Ended by Sponsor|20|||
25133125|NCT01896531|50246517|FG000|Overall Study|Withdrawal by Subject|3|||
25133126|NCT01896531|50246518|FG001|Overall Study|Withdrawal by Subject|2|||
25133127|NCT01896531|50246517|FG000|Overall Study|Death Prior to Treatment|1|||
25133128|NCT01896531|50246518|FG001|Overall Study|Death Prior to Treatment|0|||
25133129|NCT01618305|50246526|FG000|Overall Study|Death|0|||
25133130|NCT01618305|50246527|FG001|Overall Study|Death|1|||
25133131|NCT01618305|50246526|FG000|Overall Study|Lost to Follow-up|11|||
25133132|NCT01618305|50246527|FG001|Overall Study|Lost to Follow-up|7|||
25133133|NCT01618305|50246526|FG000|Overall Study|Protocol Violation|1|||
25133134|NCT01618305|50246527|FG001|Overall Study|Protocol Violation|0|||
25133135|NCT01618305|50246526|FG000|Overall Study|Withdrawal by Subject|3|||
25133136|NCT01618305|50246527|FG001|Overall Study|Withdrawal by Subject|2|||
25133137|NCT01886313|50246539|FG000|Overall Study|Adverse Event|1|||
25133138|NCT01886313|50246540|FG001|Overall Study|Adverse Event|1|||
25133139|NCT01896297|50246546|FG000|Overall Study|Died in post treatment phase|1|||
25133140|NCT01884675|50246552|FG000|Overall Study|Study closed/terminated|3|||
25133141|NCT01884675|50246553|FG001|Overall Study|Study closed/terminated|2|||
25133142|NCT01884597|50246564|FG000|Overall Study|Adverse Event|0|||
25133143|NCT01884597|50246565|FG001|Overall Study|Adverse Event|0|||
25133144|NCT01884597|50246566|FG002|Overall Study|Adverse Event|1|||
25133145|NCT01884597|50246564|FG000|Overall Study|Lack of Efficacy|1|||
25133146|NCT01884597|50246565|FG001|Overall Study|Lack of Efficacy|0|||
25133147|NCT01884597|50246566|FG002|Overall Study|Lack of Efficacy|0|||
25133148|NCT01884597|50246564|FG000|Overall Study|Death|0|||
25133149|NCT01884597|50246565|FG001|Overall Study|Death|1|||
25133150|NCT01884597|50246566|FG002|Overall Study|Death|0|||
25133151|NCT01895361|50246583|FG000|Overall Study|Adverse Event|1|||
25133152|NCT01895361|50246584|FG001|Overall Study|Adverse Event|1|||
25133153|NCT01895361|50246585|FG002|Overall Study|Adverse Event|3|||
25133154|NCT01895361|50246583|FG000|Overall Study|Death|2|||
25133155|NCT01895361|50246584|FG001|Overall Study|Death|1|||
25133156|NCT01895361|50246585|FG002|Overall Study|Death|2|||
25133157|NCT01895361|50246583|FG000|Overall Study|Lost to Follow-up|4|||
25133158|NCT01895361|50246584|FG001|Overall Study|Lost to Follow-up|4|||
25133159|NCT01895361|50246585|FG002|Overall Study|Lost to Follow-up|6|||
25133160|NCT01895361|50246583|FG000|Overall Study|Non-compliance with study|1|||
25133161|NCT01895361|50246584|FG001|Overall Study|Non-compliance with study|3|||
25133162|NCT01895361|50246585|FG002|Overall Study|Non-compliance with study|1|||
25133163|NCT01895361|50246583|FG000|Overall Study|Physician Decision|2|||
25133164|NCT01895361|50246584|FG001|Overall Study|Physician Decision|2|||
25133165|NCT01895361|50246585|FG002|Overall Study|Physician Decision|2|||
25133166|NCT01895361|50246583|FG000|Overall Study|Withdrawal by Subject|7|||
25133167|NCT01895361|50246584|FG001|Overall Study|Withdrawal by Subject|6|||
25133168|NCT01895361|50246585|FG002|Overall Study|Withdrawal by Subject|6|||
25133169|NCT01895361|50246583|FG000|Overall Study|Lack of Efficacy|0|||
25133170|NCT01895361|50246584|FG001|Overall Study|Lack of Efficacy|1|||
25133171|NCT01895361|50246585|FG002|Overall Study|Lack of Efficacy|0|||
25133172|NCT01895361|50246583|FG000|Overall Study|Reasons different from categories above|7|||
25133173|NCT01895361|50246584|FG001|Overall Study|Reasons different from categories above|3|||
25133174|NCT01895361|50246585|FG002|Overall Study|Reasons different from categories above|4|||
25133175|NCT01883895|50246593|FG000|Overall Study|Lost to Follow-up|2|||
25133176|NCT01864005|50246599|FG000|Overall Study|Protocol Violation|0|||
25133177|NCT01864005|50246600|FG001|Overall Study|Protocol Violation|1|||
25133178|NCT01864005|50246599|FG000|Overall Study|Withdrawal by Subject|0|||
25133179|NCT01864005|50246600|FG001|Overall Study|Withdrawal by Subject|1|||
25133180|NCT01864005|50246599|FG000|Overall Study|Incorrect enrolment|1|||
25133181|NCT01864005|50246600|FG001|Overall Study|Incorrect enrolment|0|||
25133182|NCT01864005|50246599|FG000|Overall Study|Disease need|1|||
25133183|NCT01864005|50246600|FG001|Overall Study|Disease need|1|||
25133184|NCT01864005|50246599|FG000|Overall Study|Need GP IIb/IIIa|1|||
25133185|NCT01864005|50246600|FG001|Overall Study|Need GP IIb/IIIa|3|||
25133186|NCT01863849|50246608|FG000|Overall Study|Lost to Follow-up|1|||
25133187|NCT01863849|50246609|FG001|Overall Study|Lost to Follow-up|0|||
25133188|NCT01863771|50246616|FG000|Induction Phase|Adverse Event|9|||
25133189|NCT01863771|50246617|FG001|Induction Phase|Adverse Event|0|||
25133190|NCT01863771|50246618|FG002|Induction Phase|Adverse Event|0|||
25133191|NCT01863771|50246619|FG003|Induction Phase|Adverse Event|0|||
25133192|NCT01863771|50246616|FG000|Induction Phase|Lack of Efficacy|10|||
25133193|NCT01863771|50246617|FG001|Induction Phase|Lack of Efficacy|0|||
25133194|NCT01863771|50246618|FG002|Induction Phase|Lack of Efficacy|0|||
25133195|NCT01863771|50246619|FG003|Induction Phase|Lack of Efficacy|0|||
25178817|NCT01507051|50324133|FG001|Overall Study|Adverse Event|0|||
25178818|NCT01507051|50324134|FG002|Overall Study|Adverse Event|0|||
25178819|NCT01507051|50324135|FG003|Overall Study|Adverse Event|0|||
25133196|NCT01863771|50246616|FG000|Induction Phase|Withdrawal by Subject|2|||
25133197|NCT01863771|50246617|FG001|Induction Phase|Withdrawal by Subject|0|||
25133198|NCT01863771|50246618|FG002|Induction Phase|Withdrawal by Subject|0|||
25133199|NCT01863771|50246619|FG003|Induction Phase|Withdrawal by Subject|0|||
25133200|NCT01863771|50246616|FG000|Maintenance Phase|Adverse Event|0|||
25133201|NCT01863771|50246617|FG001|Maintenance Phase|Adverse Event|0|||
25133202|NCT01863771|50246618|FG002|Maintenance Phase|Adverse Event|1|||
25133203|NCT01863771|50246619|FG003|Maintenance Phase|Adverse Event|1|||
25133204|NCT01863771|50246616|FG000|Maintenance Phase|Lack of Efficacy|0|||
25133205|NCT01863771|50246617|FG001|Maintenance Phase|Lack of Efficacy|3|||
25133206|NCT01863771|50246618|FG002|Maintenance Phase|Lack of Efficacy|7|||
25133207|NCT01863771|50246619|FG003|Maintenance Phase|Lack of Efficacy|38|||
25133208|NCT01863771|50246616|FG000|Maintenance Phase|Physician Decision|0|||
25133209|NCT01863771|50246617|FG001|Maintenance Phase|Physician Decision|0|||
25133210|NCT01863771|50246618|FG002|Maintenance Phase|Physician Decision|2|||
25133211|NCT01863771|50246619|FG003|Maintenance Phase|Physician Decision|1|||
25133212|NCT01863771|50246616|FG000|Maintenance Phase|Pregnancy|0|||
25133213|NCT01863771|50246617|FG001|Maintenance Phase|Pregnancy|1|||
25133214|NCT01863771|50246618|FG002|Maintenance Phase|Pregnancy|0|||
25133215|NCT01863771|50246619|FG003|Maintenance Phase|Pregnancy|0|||
25133216|NCT01863771|50246616|FG000|Maintenance Phase|Withdrawal by Subject|0|||
25133217|NCT01863771|50246617|FG001|Maintenance Phase|Withdrawal by Subject|1|||
25133218|NCT01863771|50246618|FG002|Maintenance Phase|Withdrawal by Subject|2|||
25133219|NCT01863771|50246619|FG003|Maintenance Phase|Withdrawal by Subject|3|||
25133220|NCT01894581|50246629|FG000|Overall Study|Withdrawal by Subject|2|||
25133221|NCT01894581|50246630|FG001|Overall Study|Withdrawal by Subject|3|||
25133222|NCT01894581|50246629|FG000|Overall Study|Screen Failure|3|||
25133223|NCT01894581|50246630|FG001|Overall Study|Screen Failure|4|||
25133224|NCT02203331|50246642|FG000|Overall Study|Pregnancy|1|||
25133225|NCT02203331|50246643|FG001|Overall Study|Pregnancy|0|||
25133226|NCT02203331|50246644|FG002|Overall Study|Pregnancy|0|||
25133227|NCT02203331|50246645|FG003|Overall Study|Pregnancy|0|||
25133228|NCT02203331|50246646|FG004|Overall Study|Pregnancy|2|||
25133229|NCT02203331|50246647|FG005|Overall Study|Pregnancy|0|||
25133230|NCT02203331|50246642|FG000|Overall Study|Withdrawal by Subject|1|||
25133231|NCT02203331|50246643|FG001|Overall Study|Withdrawal by Subject|0|||
25133232|NCT02203331|50246644|FG002|Overall Study|Withdrawal by Subject|1|||
25133233|NCT02203331|50246645|FG003|Overall Study|Withdrawal by Subject|0|||
25133234|NCT02203331|50246646|FG004|Overall Study|Withdrawal by Subject|0|||
25133235|NCT02203331|50246647|FG005|Overall Study|Withdrawal by Subject|3|||
25133236|NCT02203331|50246642|FG000|Overall Study|Adverse Event|4|||
25133237|NCT02203331|50246643|FG001|Overall Study|Adverse Event|8|||
25133238|NCT02203331|50246644|FG002|Overall Study|Adverse Event|3|||
25133239|NCT02203331|50246645|FG003|Overall Study|Adverse Event|4|||
25133240|NCT02203331|50246646|FG004|Overall Study|Adverse Event|3|||
25133241|NCT02203331|50246647|FG005|Overall Study|Adverse Event|3|||
25133242|NCT02203331|50246642|FG000|Overall Study|Other Reasons|1|||
25133243|NCT02203331|50246643|FG001|Overall Study|Other Reasons|2|||
25133244|NCT02203331|50246644|FG002|Overall Study|Other Reasons|0|||
25133245|NCT02203331|50246645|FG003|Overall Study|Other Reasons|2|||
25133246|NCT02203331|50246646|FG004|Overall Study|Other Reasons|0|||
25133247|NCT02203331|50246647|FG005|Overall Study|Other Reasons|0|||
25133248|NCT02203331|50246642|FG000|Overall Study|Lack of Efficacy|0|||
25133249|NCT02203331|50246643|FG001|Overall Study|Lack of Efficacy|2|||
25133250|NCT02203331|50246644|FG002|Overall Study|Lack of Efficacy|1|||
25133251|NCT02203331|50246645|FG003|Overall Study|Lack of Efficacy|0|||
25133252|NCT02203331|50246646|FG004|Overall Study|Lack of Efficacy|0|||
25133253|NCT02203331|50246647|FG005|Overall Study|Lack of Efficacy|1|||
25133254|NCT02203331|50246642|FG000|Overall Study|Protocol Violation|0|||
25133255|NCT02203331|50246643|FG001|Overall Study|Protocol Violation|2|||
25133256|NCT02203331|50246644|FG002|Overall Study|Protocol Violation|0|||
25133257|NCT02203331|50246645|FG003|Overall Study|Protocol Violation|1|||
25133258|NCT02203331|50246646|FG004|Overall Study|Protocol Violation|1|||
25133259|NCT02203331|50246647|FG005|Overall Study|Protocol Violation|0|||
25133260|NCT02203331|50246642|FG000|Overall Study|Lost to Follow-up|0|||
25133261|NCT02203331|50246643|FG001|Overall Study|Lost to Follow-up|0|||
25133262|NCT02203331|50246644|FG002|Overall Study|Lost to Follow-up|0|||
25133263|NCT02203331|50246645|FG003|Overall Study|Lost to Follow-up|0|||
25133264|NCT02203331|50246646|FG004|Overall Study|Lost to Follow-up|1|||
25133265|NCT02203331|50246647|FG005|Overall Study|Lost to Follow-up|0|||
25133266|NCT01893411|50246664|FG000|Overall Study|Protocol Violation|1|||
25133267|NCT01893411|50246665|FG001|Overall Study|Protocol Violation|0|||
25133268|NCT01893411|50246666|FG002|Overall Study|Protocol Violation|0|||
25133269|NCT01893411|50246664|FG000|Overall Study|Physician Decision|1|||
25178820|NCT01478347|50324145|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
25178821|NCT01478347|50324145|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
25178822|NCT01478347|50324145|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
25133270|NCT01893411|50246665|FG001|Overall Study|Physician Decision|1|||
25133271|NCT01893411|50246666|FG002|Overall Study|Physician Decision|2|||
25133272|NCT01893411|50246664|FG000|Overall Study|Lack of Efficacy|2|||
25133273|NCT01893411|50246665|FG001|Overall Study|Lack of Efficacy|1|||
25133274|NCT01893411|50246666|FG002|Overall Study|Lack of Efficacy|0|||
25133275|NCT01893411|50246664|FG000|Overall Study|Other|3|||
25133276|NCT01893411|50246665|FG001|Overall Study|Other|1|||
25133277|NCT01893411|50246666|FG002|Overall Study|Other|3|||
25133278|NCT01893411|50246664|FG000|Overall Study|Adverse Event|1|||
25133279|NCT01893411|50246665|FG001|Overall Study|Adverse Event|0|||
25133280|NCT01893411|50246666|FG002|Overall Study|Adverse Event|0|||
25133281|NCT01893411|50246664|FG000|Overall Study|Withdrawal by Subject|7|||
25133282|NCT01893411|50246665|FG001|Overall Study|Withdrawal by Subject|4|||
25133283|NCT01893411|50246666|FG002|Overall Study|Withdrawal by Subject|3|||
25133284|NCT01893411|50246664|FG000|Overall Study|Lost to Follow-up|2|||
25133285|NCT01893411|50246665|FG001|Overall Study|Lost to Follow-up|0|||
25133286|NCT01893411|50246666|FG002|Overall Study|Lost to Follow-up|1|||
25133287|NCT02232425|50246676|FG000|Overall Study|Lost to Follow-up|6|||
25133288|NCT02232425|50246677|FG001|Overall Study|Lost to Follow-up|2|||
25133289|NCT02232425|50246676|FG000|Overall Study|Adverse Event|2|||
25133290|NCT02232425|50246677|FG001|Overall Study|Adverse Event|0|||
25133291|NCT02232425|50246676|FG000|Overall Study|Withdrawal by Subject|5|||
25133292|NCT02232425|50246677|FG001|Overall Study|Withdrawal by Subject|6|||
25133293|NCT02232425|50246676|FG000|Overall Study|Lack of Efficacy|1|||
25133294|NCT02232425|50246677|FG001|Overall Study|Lack of Efficacy|0|||
25133295|NCT01631435|50246683|FG000|Overall Study|Adverse Event|2|||
25133296|NCT01631435|50246683|FG000|Overall Study|Withdrawal by Subject|2|||
25133297|NCT01631435|50246683|FG000|Overall Study|incomplete study procedure|5|||
25133298|NCT02230085|50246688|FG000|Overall Study|Physician Decision|1|||
25133299|NCT02230085|50246688|FG000|Overall Study|Withdrawal by Subject|3|||
25133300|NCT01882803|50246692|FG000|Overall Study|Disease Progression|53|||
25133301|NCT01882803|50246692|FG000|Overall Study|Adverse Event|22|||
25133302|NCT01882803|50246692|FG000|Overall Study|Death|7|||
25133303|NCT01882803|50246692|FG000|Overall Study|Physician Decision|7|||
25133304|NCT01882803|50246692|FG000|Overall Study|Protocol Violation|1|||
25133305|NCT01882803|50246692|FG000|Overall Study|Withdrawal by Subject|4|||
25133306|NCT02202785|50246700|FG000|Overall Study|Study Terminated by Sponsor|1|||
25133307|NCT02202785|50246701|FG001|Overall Study|Study Terminated by Sponsor|6|||
25133308|NCT02202785|50246702|FG002|Overall Study|Study Terminated by Sponsor|4|||
25133309|NCT02202785|50246700|FG000|Overall Study|Withdrawal by Subject|0|||
25133310|NCT02202785|50246701|FG001|Overall Study|Withdrawal by Subject|1|||
25133311|NCT02202785|50246702|FG002|Overall Study|Withdrawal by Subject|0|||
25133312|NCT02202785|50246700|FG000|Overall Study|Lost to Follow-up|0|||
25133313|NCT02202785|50246701|FG001|Overall Study|Lost to Follow-up|1|||
25133314|NCT02202785|50246702|FG002|Overall Study|Lost to Follow-up|0|||
25133315|NCT02202785|50246700|FG000|Overall Study|Reason not Specified|10|||
25133316|NCT02202785|50246701|FG001|Overall Study|Reason not Specified|7|||
25133317|NCT02202785|50246702|FG002|Overall Study|Reason not Specified|13|||
25133318|NCT01882647|50246712|FG000|Overall Study|Lost to Follow-up|2|||
25009436|NCT02953782|50102345|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
25009437|NCT02953782|50102346|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
25273317|NCT00982228|50587404|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
25273318|NCT00982228|50587403|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
25273319|NCT00982228|50587404|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
25273320|NCT00982228|50587403|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
25273321|NCT00982228|50587404|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
25273322|NCT00982228|50587403|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
25273323|NCT00982228|50587404|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
25273324|NCT01260350|50587430|FG000|Overall Study|Lack of Efficacy|0|||
25273325|NCT01260350|50587431|FG001|Overall Study|Lack of Efficacy|0|||
25273326|NCT01260350|50587432|FG002|Overall Study|Lack of Efficacy|0|||
25273327|NCT01260350|50587433|FG003|Overall Study|Lack of Efficacy|0|||
25273328|NCT01260350|50587434|FG004|Overall Study|Lack of Efficacy|0|||
25009438|NCT02953782|50102347|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
25009439|NCT02953782|50102348|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
25273329|NCT01260350|50587435|FG005|Overall Study|Lack of Efficacy|0|||
25273330|NCT01260350|50587436|FG006|Overall Study|Lack of Efficacy|0|||
25273331|NCT01260350|50587437|FG007|Overall Study|Lack of Efficacy|0|||
25273332|NCT01260350|50587438|FG008|Overall Study|Lack of Efficacy|0|||
25273333|NCT01260350|50587439|FG009|Overall Study|Lack of Efficacy|0|||
25273334|NCT01260350|50587440|FG010|Overall Study|Lack of Efficacy|0|||
25273335|NCT01260350|50587441|FG011|Overall Study|Lack of Efficacy|0|||
25273336|NCT01260350|50587442|FG012|Overall Study|Lack of Efficacy|0|||
25273337|NCT01260350|50587443|FG013|Overall Study|Lack of Efficacy|0|||
25273338|NCT01260350|50587444|FG014|Overall Study|Lack of Efficacy|0|||
25273339|NCT01260350|50587445|FG015|Overall Study|Lack of Efficacy|0|||
25273340|NCT01260350|50587446|FG016|Overall Study|Lack of Efficacy|0|||
25273341|NCT01260350|50587447|FG017|Overall Study|Lack of Efficacy|1|||
25273342|NCT01260350|50587448|FG018|Overall Study|Lack of Efficacy|0|||
25273343|NCT01260350|50587449|FG019|Overall Study|Lack of Efficacy|0|||
25273344|NCT01260350|50587450|FG020|Overall Study|Lack of Efficacy|3|||
25009440|NCT02953782|50102349|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
25009441|NCT02953782|50102350|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
25009442|NCT02953782|50102351|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
25009443|NCT02953782|50102344|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
25009444|NCT02953782|50102345|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
25009445|NCT02953782|50102346|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
25009446|NCT02953782|50102347|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
25009447|NCT02953782|50102348|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
25009448|NCT02953782|50102349|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
25133319|NCT01882647|50246713|FG001|Overall Study|Lost to Follow-up|2|||
25133320|NCT01882647|50246712|FG000|Overall Study|Withdrawal by Subject|0|||
25133321|NCT01882647|50246713|FG001|Overall Study|Withdrawal by Subject|4|||
25133322|NCT01882257|50246722|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
25133323|NCT01882257|50246723|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
25133324|NCT01882257|50246724|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
25133325|NCT01882257|50246722|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
25133326|NCT01882257|50246723|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
25133327|NCT01882257|50246724|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
25273345|NCT01260350|50587451|FG021|Overall Study|Lack of Efficacy|0|||
25133328|NCT01862991|50246734|FG000|Overall Study|Lost to Follow-up|2|||
25133329|NCT01862991|50246735|FG001|Overall Study|Lost to Follow-up|1|||
25273346|NCT01260350|50587430|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273347|NCT01260350|50587431|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273348|NCT01260350|50587432|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273349|NCT01260350|50587433|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273350|NCT01260350|50587434|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273351|NCT01260350|50587435|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273352|NCT01260350|50587436|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273353|NCT01260350|50587437|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273354|NCT01260350|50587438|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
25133330|NCT01862991|50246736|FG002|Overall Study|Lost to Follow-up|1|||
25133331|NCT01862991|50246734|FG000|Overall Study|Protocol Violation|1|||
25133332|NCT01862991|50246735|FG001|Overall Study|Protocol Violation|0|||
25133333|NCT01862991|50246736|FG002|Overall Study|Protocol Violation|0|||
25133334|NCT02202551|50246748|FG000|Overall Study|Adverse Event|8|||
25133335|NCT02202551|50246749|FG001|Overall Study|Adverse Event|19|||
25133336|NCT02202551|50246750|FG002|Overall Study|Adverse Event|5|||
25133337|NCT02202551|50246751|FG003|Overall Study|Adverse Event|9|||
25133338|NCT02202551|50246748|FG000|Overall Study|Death|3|||
25133339|NCT02202551|50246749|FG001|Overall Study|Death|2|||
25133340|NCT02202551|50246750|FG002|Overall Study|Death|1|||
25133341|NCT02202551|50246751|FG003|Overall Study|Death|1|||
25133342|NCT02202551|50246748|FG000|Overall Study|Lost to Follow-up|0|||
25133343|NCT02202551|50246749|FG001|Overall Study|Lost to Follow-up|1|||
25133344|NCT02202551|50246750|FG002|Overall Study|Lost to Follow-up|0|||
25133345|NCT02202551|50246751|FG003|Overall Study|Lost to Follow-up|1|||
25133346|NCT02202551|50246748|FG000|Overall Study|Needed to take excluded medication|0|||
25133347|NCT02202551|50246749|FG001|Overall Study|Needed to take excluded medication|2|||
25133348|NCT02202551|50246750|FG002|Overall Study|Needed to take excluded medication|0|||
25133349|NCT02202551|50246751|FG003|Overall Study|Needed to take excluded medication|1|||
25133350|NCT02202551|50246748|FG000|Overall Study|Subject moved away|0|||
25133351|NCT02202551|50246749|FG001|Overall Study|Subject moved away|1|||
25133352|NCT02202551|50246750|FG002|Overall Study|Subject moved away|0|||
25133353|NCT02202551|50246751|FG003|Overall Study|Subject moved away|0|||
25133354|NCT02202551|50246748|FG000|Overall Study|DBS surgery|3|||
25133355|NCT02202551|50246749|FG001|Overall Study|DBS surgery|0|||
25133356|NCT02202551|50246750|FG002|Overall Study|DBS surgery|0|||
25133357|NCT02202551|50246751|FG003|Overall Study|DBS surgery|0|||
25273355|NCT01260350|50587439|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25133358|NCT02202551|50246748|FG000|Overall Study|Dyskinesia upon taper|1|||
25133359|NCT02202551|50246749|FG001|Overall Study|Dyskinesia upon taper|0|||
25273356|NCT01260350|50587440|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273357|NCT01260350|50587441|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273358|NCT01260350|50587442|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273359|NCT01260350|50587443|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273360|NCT01260350|50587444|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273361|NCT01260350|50587445|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273362|NCT01260350|50587446|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273363|NCT01260350|50587447|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25133360|NCT02202551|50246750|FG002|Overall Study|Dyskinesia upon taper|0|||
25133361|NCT02202551|50246751|FG003|Overall Study|Dyskinesia upon taper|0|||
25133362|NCT02202551|50246748|FG000|Overall Study|Lack of Efficacy|0|||
25133363|NCT02202551|50246749|FG001|Overall Study|Lack of Efficacy|1|||
25133364|NCT02202551|50246750|FG002|Overall Study|Lack of Efficacy|0|||
25133365|NCT02202551|50246751|FG003|Overall Study|Lack of Efficacy|0|||
25133366|NCT02202551|50246748|FG000|Overall Study|Physician Decision|1|||
25133367|NCT02202551|50246749|FG001|Overall Study|Physician Decision|0|||
25133368|NCT02202551|50246750|FG002|Overall Study|Physician Decision|0|||
25133369|NCT02202551|50246751|FG003|Overall Study|Physician Decision|0|||
25133370|NCT02202551|50246748|FG000|Overall Study|Site closure|3|||
25133371|NCT02202551|50246749|FG001|Overall Study|Site closure|0|||
25133372|NCT02202551|50246750|FG002|Overall Study|Site closure|0|||
25133373|NCT02202551|50246751|FG003|Overall Study|Site closure|1|||
25133374|NCT02202551|50246748|FG000|Overall Study|Unable to complete visits per protocol|1|||
25133375|NCT02202551|50246749|FG001|Overall Study|Unable to complete visits per protocol|0|||
25133376|NCT02202551|50246750|FG002|Overall Study|Unable to complete visits per protocol|0|||
25133377|NCT02202551|50246751|FG003|Overall Study|Unable to complete visits per protocol|0|||
25133378|NCT02202551|50246748|FG000|Overall Study|Worsening Dyskinesia|0|||
25133379|NCT02202551|50246749|FG001|Overall Study|Worsening Dyskinesia|0|||
25133380|NCT02202551|50246750|FG002|Overall Study|Worsening Dyskinesia|0|||
25133381|NCT02202551|50246751|FG003|Overall Study|Worsening Dyskinesia|1|||
25133382|NCT02202551|50246748|FG000|Overall Study|Protocol Violation|0|||
25133383|NCT02202551|50246749|FG001|Overall Study|Protocol Violation|1|||
25133384|NCT02202551|50246750|FG002|Overall Study|Protocol Violation|0|||
25133385|NCT02202551|50246751|FG003|Overall Study|Protocol Violation|0|||
25133386|NCT02202551|50246748|FG000|Overall Study|Sponsor's decision|2|||
25133387|NCT02202551|50246749|FG001|Overall Study|Sponsor's decision|0|||
25133388|NCT02202551|50246750|FG002|Overall Study|Sponsor's decision|0|||
25133389|NCT02202551|50246751|FG003|Overall Study|Sponsor's decision|0|||
25133390|NCT02202551|50246748|FG000|Overall Study|Subject unwilling to proceed|1|||
25133391|NCT02202551|50246749|FG001|Overall Study|Subject unwilling to proceed|5|||
25133392|NCT02202551|50246750|FG002|Overall Study|Subject unwilling to proceed|3|||
25133393|NCT02202551|50246751|FG003|Overall Study|Subject unwilling to proceed|5|||
25133394|NCT02202551|50246748|FG000|Overall Study|Subject consent withdrawn|0|||
25133395|NCT02202551|50246749|FG001|Overall Study|Subject consent withdrawn|3|||
25133396|NCT02202551|50246750|FG002|Overall Study|Subject consent withdrawn|1|||
25133397|NCT02202551|50246751|FG003|Overall Study|Subject consent withdrawn|2|||
25133398|NCT02202551|50246748|FG000|Overall Study|eGFR<50mL/min/m2|2|||
25133399|NCT02202551|50246749|FG001|Overall Study|eGFR<50mL/min/m2|2|||
25133400|NCT02202551|50246750|FG002|Overall Study|eGFR<50mL/min/m2|0|||
25133401|NCT02202551|50246751|FG003|Overall Study|eGFR<50mL/min/m2|1|||
25133402|NCT02202317|50246765|FG000|Overall Study|Lost to Follow-up|1|||
25133403|NCT02118337|50246778|FG000|Overall Study|Other|1|||
25133404|NCT02118337|50246779|FG001|Overall Study|Other|0|||
25133405|NCT02118337|50246780|FG002|Overall Study|Other|0|||
25133406|NCT02118337|50246781|FG003|Overall Study|Other|0|||
25133407|NCT02118337|50246782|FG004|Overall Study|Other|2|||
25133408|NCT02118337|50246783|FG005|Overall Study|Other|3|||
25133409|NCT02118337|50246784|FG006|Overall Study|Other|1|||
25133410|NCT02118337|50246785|FG007|Overall Study|Other|28|||
25133411|NCT02118337|50246786|FG008|Overall Study|Other|15|||
25133412|NCT02118337|50246778|FG000|Overall Study|Lost to Follow-up|0|||
25133413|NCT02118337|50246779|FG001|Overall Study|Lost to Follow-up|0|||
25133414|NCT02118337|50246780|FG002|Overall Study|Lost to Follow-up|0|||
25133415|NCT02118337|50246781|FG003|Overall Study|Lost to Follow-up|0|||
25133416|NCT02118337|50246782|FG004|Overall Study|Lost to Follow-up|0|||
25133417|NCT02118337|50246783|FG005|Overall Study|Lost to Follow-up|0|||
25133418|NCT02118337|50246784|FG006|Overall Study|Lost to Follow-up|0|||
25133419|NCT02118337|50246785|FG007|Overall Study|Lost to Follow-up|1|||
25133420|NCT02118337|50246786|FG008|Overall Study|Lost to Follow-up|0|||
25133421|NCT02118337|50246778|FG000|Overall Study|Withdrawal by Subject|1|||
25133422|NCT02118337|50246779|FG001|Overall Study|Withdrawal by Subject|3|||
25133423|NCT02118337|50246780|FG002|Overall Study|Withdrawal by Subject|2|||
25133424|NCT02118337|50246781|FG003|Overall Study|Withdrawal by Subject|1|||
25133425|NCT02118337|50246782|FG004|Overall Study|Withdrawal by Subject|2|||
25133426|NCT02118337|50246783|FG005|Overall Study|Withdrawal by Subject|2|||
25133427|NCT02118337|50246784|FG006|Overall Study|Withdrawal by Subject|1|||
25133428|NCT02118337|50246785|FG007|Overall Study|Withdrawal by Subject|4|||
25133429|NCT02118337|50246786|FG008|Overall Study|Withdrawal by Subject|2|||
25133430|NCT02118337|50246778|FG000|Overall Study|Death|2|||
25133431|NCT02118337|50246779|FG001|Overall Study|Death|2|||
25133432|NCT02118337|50246780|FG002|Overall Study|Death|1|||
25133433|NCT02118337|50246781|FG003|Overall Study|Death|2|||
25133434|NCT02118337|50246782|FG004|Overall Study|Death|5|||
25133435|NCT02118337|50246783|FG005|Overall Study|Death|1|||
25133436|NCT02118337|50246784|FG006|Overall Study|Death|2|||
25133437|NCT02118337|50246785|FG007|Overall Study|Death|9|||
25133438|NCT02118337|50246786|FG008|Overall Study|Death|4|||
25133439|NCT02117713|50246810|FG000|Week 48|Adverse Event|4|||
25133440|NCT02117713|50246810|FG000|Week 48|Withdrawal by caregiver|2|||
25133441|NCT02117713|50246810|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
25133442|NCT02117713|50246810|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
25009449|NCT02953782|50102350|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
25009450|NCT02953782|50102351|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
25009451|NCT02953782|50102344|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
25133443|NCT02117713|50246810|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
25133444|NCT02117713|50246810|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
25133445|NCT02105467|50246824|FG000|Period 1|Lost to Follow-up|1|||
25133446|NCT02105467|50246825|FG001|Period 1|Lost to Follow-up|0|||
25133447|NCT02105467|50246824|FG000|Period 1|Death|1|||
25133448|NCT02105467|50246825|FG001|Period 1|Death|0|||
25133449|NCT02105467|50246824|FG000|Period 2|Lost to Follow-up|1|||
25133450|NCT02105467|50246825|FG001|Period 2|Lost to Follow-up|0|||
25133451|NCT02105467|50246824|FG000|Period 2|Death|1|||
25133452|NCT02105467|50246825|FG001|Period 2|Death|0|||
25133453|NCT02105467|50246824|FG000|Period 2|Withdrawal by Subject|0|||
25133454|NCT02105467|50246825|FG001|Period 2|Withdrawal by Subject|2|||
25133455|NCT02105467|50246824|FG000|Period 3|Lost to Follow-up|0|||
25133456|NCT02105467|50246825|FG001|Period 3|Lost to Follow-up|1|||
25133457|NCT02202161|50246840|FG000|Overall Study|Adverse Event|1|||
25133458|NCT02202161|50246841|FG001|Overall Study|Adverse Event|1|||
25133459|NCT02202161|50246842|FG002|Overall Study|Adverse Event|0|||
25133460|NCT02202161|50246843|FG003|Overall Study|Adverse Event|0|||
25133461|NCT02202161|50246844|FG004|Overall Study|Adverse Event|0|||
25133462|NCT02202161|50246845|FG005|Overall Study|Adverse Event|1|||
25133463|NCT02202161|50246846|FG006|Overall Study|Adverse Event|0|||
25133464|NCT02202161|50246847|FG007|Overall Study|Adverse Event|0|||
25133465|NCT02202161|50246840|FG000|Overall Study|Did not meet continuation criteria|0|||
25133466|NCT02202161|50246841|FG001|Overall Study|Did not meet continuation criteria|0|||
25133467|NCT02202161|50246842|FG002|Overall Study|Did not meet continuation criteria|0|||
25133468|NCT02202161|50246843|FG003|Overall Study|Did not meet continuation criteria|0|||
25133469|NCT02202161|50246844|FG004|Overall Study|Did not meet continuation criteria|0|||
25133470|NCT02202161|50246845|FG005|Overall Study|Did not meet continuation criteria|0|||
25133471|NCT02202161|50246846|FG006|Overall Study|Did not meet continuation criteria|0|||
25133472|NCT02202161|50246847|FG007|Overall Study|Did not meet continuation criteria|3|||
25133473|NCT02202161|50246840|FG000|Overall Study|Physician Decision|0|||
25133474|NCT02202161|50246841|FG001|Overall Study|Physician Decision|0|||
25133475|NCT02202161|50246842|FG002|Overall Study|Physician Decision|0|||
25133476|NCT02202161|50246843|FG003|Overall Study|Physician Decision|0|||
25133477|NCT02202161|50246844|FG004|Overall Study|Physician Decision|0|||
25133478|NCT02202161|50246845|FG005|Overall Study|Physician Decision|0|||
25133479|NCT02202161|50246846|FG006|Overall Study|Physician Decision|0|||
25133480|NCT02202161|50246847|FG007|Overall Study|Physician Decision|3|||
25133481|NCT02202161|50246840|FG000|Overall Study|Withdrawal by Subject|0|||
25133482|NCT02202161|50246841|FG001|Overall Study|Withdrawal by Subject|0|||
25133483|NCT02202161|50246842|FG002|Overall Study|Withdrawal by Subject|0|||
25133484|NCT02202161|50246843|FG003|Overall Study|Withdrawal by Subject|0|||
25133485|NCT02202161|50246844|FG004|Overall Study|Withdrawal by Subject|1|||
25133486|NCT02202161|50246845|FG005|Overall Study|Withdrawal by Subject|0|||
25133487|NCT02202161|50246846|FG006|Overall Study|Withdrawal by Subject|0|||
25133488|NCT02202161|50246847|FG007|Overall Study|Withdrawal by Subject|0|||
25133489|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Adverse Event|76|||
25133490|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Adverse Event|0|||
25133491|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Adverse Event|0|||
25133492|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Death|3|||
25133493|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Death|0|||
25133494|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Death|0|||
25133495|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
25133496|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
25133497|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
25133498|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Physician Decision|9|||
25133499|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Physician Decision|0|||
25133500|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Physician Decision|0|||
25133501|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
25133502|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
25133503|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
25133504|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Disease progression|45|||
25133505|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Disease progression|0|||
25133506|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Disease progression|0|||
25133507|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
25133508|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
25133509|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
25133510|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
25133511|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
25133512|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
25133513|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
25133514|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
25133515|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
25133516|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
25133517|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
25133518|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
25133519|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
25133520|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
25133521|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
25133522|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
25133523|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
25133524|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
25133525|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
25133526|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
25133527|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
25133528|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
25133529|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
25133530|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
25133531|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
25133532|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
25133533|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
25133534|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Promotor request|1|||
25133535|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Promotor request|0|||
25133536|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Promotor request|0|||
25133537|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
25133538|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
25133539|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
25133540|NCT01461928|50246866|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
25133541|NCT01461928|50246867|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
25133542|NCT01461928|50246868|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
25133543|NCT01461928|50246866|FG000|Maintenance I (24 Months)|Death|3|||
25133544|NCT01461928|50246867|FG001|Maintenance I (24 Months)|Death|0|||
25133545|NCT01461928|50246868|FG002|Maintenance I (24 Months)|Death|0|||
25133546|NCT01461928|50246866|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
25133547|NCT01461928|50246867|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
25133548|NCT01461928|50246868|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
25133549|NCT01461928|50246866|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
25133550|NCT01461928|50246867|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
25133551|NCT01461928|50246868|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
25133552|NCT01461928|50246866|FG000|Maintenance I (24 Months)|Diseases progression|91|||
25133553|NCT01461928|50246867|FG001|Maintenance I (24 Months)|Diseases progression|0|||
25133554|NCT01461928|50246868|FG002|Maintenance I (24 Months)|Diseases progression|0|||
25133555|NCT01461928|50246866|FG000|Maintenance I (24 Months)|Adverse Event|70|||
25133556|NCT01461928|50246867|FG001|Maintenance I (24 Months)|Adverse Event|0|||
25133557|NCT01461928|50246868|FG002|Maintenance I (24 Months)|Adverse Event|0|||
25133558|NCT01461928|50246866|FG000|Maintenance I (24 Months)|Physician Decision|9|||
25133559|NCT01461928|50246867|FG001|Maintenance I (24 Months)|Physician Decision|0|||
25133560|NCT01461928|50246868|FG002|Maintenance I (24 Months)|Physician Decision|0|||
25133561|NCT01461928|50246866|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
25133562|NCT01461928|50246867|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
25133563|NCT01461928|50246868|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
25133564|NCT01461928|50246866|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
25133565|NCT01461928|50246867|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
25133566|NCT01461928|50246868|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
25133567|NCT01461928|50246866|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
25133568|NCT01461928|50246867|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
25133569|NCT01461928|50246868|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
25133570|NCT01461928|50246866|FG000|Maintenance I (24 Months)|Not compliant|1|||
25133571|NCT01461928|50246867|FG001|Maintenance I (24 Months)|Not compliant|0|||
25133572|NCT01461928|50246868|FG002|Maintenance I (24 Months)|Not compliant|0|||
25133573|NCT01461928|50246866|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
25133574|NCT01461928|50246867|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
25133575|NCT01461928|50246868|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
25133576|NCT01461928|50246866|FG000|Maintenance II (15 Months)|Adverse Event|0|||
25133577|NCT01461928|50246867|FG001|Maintenance II (15 Months)|Adverse Event|2|||
25133578|NCT01461928|50246868|FG002|Maintenance II (15 Months)|Adverse Event|0|||
25133579|NCT01461928|50246866|FG000|Maintenance II (15 Months)|Death|0|||
25133580|NCT01461928|50246867|FG001|Maintenance II (15 Months)|Death|10|||
25133581|NCT01461928|50246868|FG002|Maintenance II (15 Months)|Death|8|||
25133582|NCT01461928|50246866|FG000|Maintenance II (15 Months)|Physician Decision|0|||
25133583|NCT01461928|50246867|FG001|Maintenance II (15 Months)|Physician Decision|0|||
25133584|NCT01461928|50246868|FG002|Maintenance II (15 Months)|Physician Decision|4|||
25133585|NCT01461928|50246866|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
25133586|NCT01461928|50246867|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
25133587|NCT01461928|50246868|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
25133588|NCT01461928|50246866|FG000|Maintenance II (15 Months)|Moved to another town|0|||
25133589|NCT01461928|50246867|FG001|Maintenance II (15 Months)|Moved to another town|1|||
25133590|NCT01461928|50246868|FG002|Maintenance II (15 Months)|Moved to another town|0|||
25133591|NCT01461928|50246866|FG000|Maintenance II (15 Months)|Disease progression|0|||
25133592|NCT01461928|50246867|FG001|Maintenance II (15 Months)|Disease progression|0|||
25133593|NCT01461928|50246868|FG002|Maintenance II (15 Months)|Disease progression|3|||
25133594|NCT01461928|50246866|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
25133595|NCT01461928|50246867|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
25133596|NCT01461928|50246868|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
25133597|NCT01461928|50246866|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
25133598|NCT01461928|50246867|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
25133599|NCT01461928|50246868|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
25133600|NCT01461928|50246866|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
25133601|NCT01461928|50246867|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
25133602|NCT01461928|50246868|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
25133603|NCT01461928|50246866|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
25133604|NCT01461928|50246867|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
25133605|NCT01461928|50246868|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
25133606|NCT01461928|50246866|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
25133607|NCT01461928|50246867|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
25133608|NCT01461928|50246868|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
25133609|NCT03097991|50246881|FG000|Overall Study|Didn't meet study criteria|8|||
25178823|NCT01478113|50324151|FG000|Overall Study|Withdrawal by Subject|0|||
25133610|NCT03097991|50246882|FG001|Overall Study|Didn't meet study criteria|0|||
25133611|NCT03097991|50246881|FG000|Overall Study|Withdrawal by Subject|12|||
25133612|NCT03097991|50246882|FG001|Overall Study|Withdrawal by Subject|6|||
25133613|NCT03097991|50246881|FG000|Overall Study|Death of Baby|3|||
25133614|NCT03097991|50246882|FG001|Overall Study|Death of Baby|1|||
25133615|NCT03097991|50246881|FG000|Overall Study|Lost to Follow-up|24|||
25133616|NCT03097991|50246882|FG001|Overall Study|Lost to Follow-up|38|||
25133617|NCT03097991|50246881|FG000|Overall Study|Adverse Event|3|||
25133618|NCT03097991|50246882|FG001|Overall Study|Adverse Event|5|||
25133619|NCT02623205|50246894|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
25133620|NCT02623205|50246895|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
25133621|NCT01500694|50246904|FG000|Overall Study|Adverse Event|4|||
25133622|NCT01500694|50246905|FG001|Overall Study|Adverse Event|3|||
25133623|NCT01500694|50246904|FG000|Overall Study|Protocol Violation|0|||
25133624|NCT01500694|50246905|FG001|Overall Study|Protocol Violation|1|||
25133625|NCT01500694|50246904|FG000|Overall Study|Withdrawal by Subject|23|||
25133626|NCT01500694|50246905|FG001|Overall Study|Withdrawal by Subject|14|||
25133627|NCT01500694|50246904|FG000|Overall Study|Lost to Follow-up|2|||
25133628|NCT01500694|50246905|FG001|Overall Study|Lost to Follow-up|3|||
25133629|NCT01500694|50246904|FG000|Overall Study|Lack of Efficacy|14|||
25133630|NCT01500694|50246905|FG001|Overall Study|Lack of Efficacy|5|||
25133631|NCT01500694|50246904|FG000|Overall Study|Other|9|||
25133632|NCT01500694|50246905|FG001|Overall Study|Other|3|||
25133633|NCT01500382|50246915|FG000|Washout Period|Study site went out of business|0|||
25133634|NCT01500382|50246916|FG001|Washout Period|Study site went out of business|0|||
25133635|NCT01500382|50246917|FG002|Washout Period|Study site went out of business|1|||
25133636|NCT01500382|50246918|FG003|Washout Period|Study site went out of business|0|||
25133637|NCT02137837|50246931|FG000|Overall Study|Adverse Event|0|||
25133638|NCT02137837|50246932|FG001|Overall Study|Adverse Event|2|||
25133639|NCT02137837|50246933|FG002|Overall Study|Adverse Event|1|||
25133640|NCT02137837|50246931|FG000|Overall Study|Refusal unrelated to adverse event|2|||
25133641|NCT02137837|50246932|FG001|Overall Study|Refusal unrelated to adverse event|2|||
25133642|NCT02137837|50246933|FG002|Overall Study|Refusal unrelated to adverse event|1|||
25133643|NCT02137837|50246931|FG000|Overall Study|Progression/relapse|9|||
25133644|NCT02137837|50246932|FG001|Overall Study|Progression/relapse|7|||
25133645|NCT02137837|50246933|FG002|Overall Study|Progression/relapse|7|||
25133646|NCT02137837|50246931|FG000|Overall Study|Not protocol specified|2|||
25133647|NCT02137837|50246932|FG001|Overall Study|Not protocol specified|1|||
25133648|NCT02137837|50246933|FG002|Overall Study|Not protocol specified|3|||
25133649|NCT01483690|50246948|FG000|Overall Study|Adverse Event|1|||
25133650|NCT01483690|50246949|FG001|Overall Study|Adverse Event|2|||
25133651|NCT01483690|50246948|FG000|Overall Study|clinical deterioration|1|||
25133652|NCT01483690|50246949|FG001|Overall Study|clinical deterioration|0|||
25133653|NCT01483690|50246948|FG000|Overall Study|Physician Decision|0|||
25133654|NCT01483690|50246949|FG001|Overall Study|Physician Decision|2|||
25133655|NCT01483690|50246948|FG000|Overall Study|exclusionary procedure|0|||
25133656|NCT01483690|50246949|FG001|Overall Study|exclusionary procedure|1|||
25133657|NCT02104765|50246962|FG000|Overall Study|Lost to Follow-up|0|||
25133658|NCT02104765|50246963|FG001|Overall Study|Lost to Follow-up|0|||
25133659|NCT02104765|50246964|FG002|Overall Study|Lost to Follow-up|1|||
25133660|NCT02104765|50246965|FG003|Overall Study|Lost to Follow-up|0|||
25133661|NCT02104765|50246966|FG004|Overall Study|Lost to Follow-up|0|||
25133662|NCT02104765|50246967|FG005|Overall Study|Lost to Follow-up|0|||
25133663|NCT02104765|50246968|FG006|Overall Study|Lost to Follow-up|0|||
25133664|NCT02104765|50246962|FG000|Overall Study|Withdrawal by Subject|0|||
25133665|NCT02104765|50246963|FG001|Overall Study|Withdrawal by Subject|0|||
25133666|NCT02104765|50246964|FG002|Overall Study|Withdrawal by Subject|0|||
25133667|NCT02104765|50246965|FG003|Overall Study|Withdrawal by Subject|1|||
25133668|NCT02104765|50246966|FG004|Overall Study|Withdrawal by Subject|1|||
25133669|NCT02104765|50246967|FG005|Overall Study|Withdrawal by Subject|0|||
25133670|NCT02104765|50246968|FG006|Overall Study|Withdrawal by Subject|1|||
25133671|NCT01483144|50246993|FG000|Overall Study|Adverse Event|9|||
25133672|NCT01483144|50246994|FG001|Overall Study|Adverse Event|4|||
25133673|NCT01483144|50246995|FG002|Overall Study|Adverse Event|6|||
25133674|NCT01483144|50246993|FG000|Overall Study|Withdrawal by Subject|0|||
25133675|NCT01483144|50246994|FG001|Overall Study|Withdrawal by Subject|2|||
25133676|NCT01483144|50246995|FG002|Overall Study|Withdrawal by Subject|5|||
25133677|NCT01483144|50246993|FG000|Overall Study|Physician Decision|1|||
25133678|NCT01483144|50246994|FG001|Overall Study|Physician Decision|0|||
25133679|NCT01483144|50246995|FG002|Overall Study|Physician Decision|0|||
25133680|NCT01483144|50246993|FG000|Overall Study|Lost to Follow-up|2|||
25133681|NCT01483144|50246994|FG001|Overall Study|Lost to Follow-up|4|||
25133682|NCT01483144|50246995|FG002|Overall Study|Lost to Follow-up|1|||
25133683|NCT01483144|50246993|FG000|Overall Study|Protocol Violation|3|||
25133684|NCT01483144|50246994|FG001|Overall Study|Protocol Violation|3|||
25133685|NCT01483144|50246995|FG002|Overall Study|Protocol Violation|3|||
25133686|NCT01881789|50247009|FG000|Overall Study|Withdrawal by Subject|0|||
25133687|NCT01881789|50247010|FG001|Overall Study|Withdrawal by Subject|2|||
25133688|NCT01881789|50247011|FG002|Overall Study|Withdrawal by Subject|1|||
25133689|NCT01881789|50247012|FG003|Overall Study|Withdrawal by Subject|0|||
25133690|NCT01881789|50247013|FG004|Overall Study|Withdrawal by Subject|1|||
25133691|NCT01881789|50247014|FG005|Overall Study|Withdrawal by Subject|1|||
25133692|NCT01881789|50247009|FG000|Overall Study|Study Terminated by Sponsor|0|||
25133693|NCT01881789|50247010|FG001|Overall Study|Study Terminated by Sponsor|0|||
25133694|NCT01881789|50247011|FG002|Overall Study|Study Terminated by Sponsor|0|||
25133695|NCT01881789|50247012|FG003|Overall Study|Study Terminated by Sponsor|0|||
25133696|NCT01881789|50247013|FG004|Overall Study|Study Terminated by Sponsor|0|||
25133697|NCT01881789|50247014|FG005|Overall Study|Study Terminated by Sponsor|1|||
25133698|NCT01881789|50247009|FG000|Overall Study|Other|3|||
25133699|NCT01881789|50247010|FG001|Overall Study|Other|5|||
25133700|NCT01881789|50247011|FG002|Overall Study|Other|2|||
25133701|NCT01881789|50247012|FG003|Overall Study|Other|3|||
25133702|NCT01881789|50247013|FG004|Overall Study|Other|1|||
25133703|NCT01881789|50247014|FG005|Overall Study|Other|1|||
25133704|NCT02075203|50247032|FG000|Overall Study|Withdrawal by Subject|1|||
25133705|NCT02075203|50247033|FG001|Overall Study|Withdrawal by Subject|0|||
25133706|NCT02075203|50247034|FG002|Overall Study|Withdrawal by Subject|1|||
25133707|NCT02075203|50247032|FG000|Overall Study|Adverse Event|1|||
25133708|NCT02075203|50247033|FG001|Overall Study|Adverse Event|0|||
25133709|NCT02075203|50247034|FG002|Overall Study|Adverse Event|0|||
25133710|NCT02075203|50247032|FG000|Overall Study|participant refused to use contraception|1|||
25133711|NCT02075203|50247033|FG001|Overall Study|participant refused to use contraception|0|||
25133712|NCT02075203|50247034|FG002|Overall Study|participant refused to use contraception|0|||
25133713|NCT01892163|50247044|FG000|Overall Study|Death|1|||
25133714|NCT01892163|50247045|FG001|Overall Study|Death|1|||
25133715|NCT01892163|50247044|FG000|Overall Study|Lost to Follow-up|1|||
25133716|NCT01892163|50247045|FG001|Overall Study|Lost to Follow-up|0|||
25133717|NCT01881009|50247053|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
25133718|NCT01881009|50247054|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
25133719|NCT01500226|50247063|FG000|Overall Study|Adverse Event|31|||
25133720|NCT01500226|50247064|FG001|Overall Study|Adverse Event|38|||
25133721|NCT01500226|50247063|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
25133722|NCT01500226|50247064|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
25133723|NCT01500226|50247063|FG000|Overall Study|Withdrawal by Subject|93|||
25133724|NCT01500226|50247064|FG001|Overall Study|Withdrawal by Subject|96|||
25133725|NCT01500226|50247063|FG000|Overall Study|Death|12|||
25133726|NCT01500226|50247064|FG001|Overall Study|Death|4|||
25133727|NCT01500226|50247063|FG000|Overall Study|Disease Progression|16|||
25133728|NCT01500226|50247064|FG001|Overall Study|Disease Progression|14|||
25133729|NCT01500226|50247063|FG000|Overall Study|Protocol Violation|53|||
25133730|NCT01500226|50247064|FG001|Overall Study|Protocol Violation|39|||
25133731|NCT01500226|50247063|FG000|Overall Study|Physician Decision|17|||
25133732|NCT01500226|50247064|FG001|Overall Study|Physician Decision|15|||
25133733|NCT01500226|50247063|FG000|Overall Study|Lack of Efficacy|14|||
25133734|NCT01500226|50247064|FG001|Overall Study|Lack of Efficacy|30|||
25133735|NCT01500226|50247063|FG000|Overall Study|Lost to Follow-up|9|||
25133736|NCT01500226|50247064|FG001|Overall Study|Lost to Follow-up|5|||
25133737|NCT01500226|50247063|FG000|Overall Study|Other Reasons|19|||
25133738|NCT01500226|50247064|FG001|Overall Study|Other Reasons|16|||
25133739|NCT02075047|50247072|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
25133740|NCT02075047|50247073|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
25133741|NCT02075047|50247072|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
25133742|NCT02075047|50247073|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
25133743|NCT02075047|50247072|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
25133744|NCT02075047|50247073|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
25133745|NCT02075047|50247072|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
25133746|NCT02075047|50247073|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
25133747|NCT02075047|50247072|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
25133748|NCT02075047|50247073|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
25133749|NCT02075047|50247072|FG000|Treatment Phase (4 Weeks)|Other|1|||
25133750|NCT02075047|50247073|FG001|Treatment Phase (4 Weeks)|Other|1|||
25133751|NCT02075047|50247072|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
25133752|NCT02075047|50247073|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
25133753|NCT02075047|50247072|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
25133754|NCT02075047|50247073|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
25133755|NCT02075047|50247072|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
25133756|NCT02075047|50247073|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
25133757|NCT02075047|50247072|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
25133758|NCT02075047|50247073|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
25133759|NCT02075047|50247072|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
25133760|NCT02075047|50247073|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
25133761|NCT02075047|50247072|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
25133762|NCT02075047|50247073|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
25133763|NCT02075047|50247072|FG000|Follow up Phase (5 Weeks)|Other|1|||
25133764|NCT02075047|50247073|FG001|Follow up Phase (5 Weeks)|Other|2|||
25133765|NCT02075047|50247072|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
25133766|NCT02075047|50247073|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
25133767|NCT01859949|50247081|FG000|Overall Study|Family Matters|0|||
25133768|NCT01859949|50247082|FG001|Overall Study|Family Matters|1|||
25133769|NCT01859949|50247081|FG000|Overall Study|Physician Decision|2|||
25133770|NCT01859949|50247082|FG001|Overall Study|Physician Decision|4|||
25133771|NCT01859949|50247081|FG000|Overall Study|Withdrawal by Subject|11|||
25133772|NCT01859949|50247082|FG001|Overall Study|Withdrawal by Subject|10|||
25133773|NCT01859949|50247081|FG000|Overall Study|Protocol Violation|1|||
25133774|NCT01859949|50247082|FG001|Overall Study|Protocol Violation|1|||
25133775|NCT01859949|50247081|FG000|Overall Study|Adverse Event|0|||
25133776|NCT01859949|50247082|FG001|Overall Study|Adverse Event|1|||
25133777|NCT01859793|50247090|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
25133778|NCT01859793|50247091|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
25133779|NCT01859793|50247090|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
25133780|NCT01859793|50247091|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
25133781|NCT01859793|50247090|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
25133782|NCT01859793|50247091|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
25133783|NCT01859793|50247090|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
25133784|NCT01859793|50247091|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
25133785|NCT01859715|50247100|FG000|Overall Study|No 2nd VAS|16|||
25133786|NCT01859715|50247101|FG001|Overall Study|No 2nd VAS|8|||
25133787|NCT01859715|50247102|FG002|Overall Study|No 2nd VAS|23|||
25133788|NCT01890915|50247114|FG000|Overall Study|Adverse Event|1|||
25133789|NCT01890915|50247115|FG001|Overall Study|Adverse Event|0|||
25133790|NCT01890915|50247114|FG000|Overall Study|Protocol Violation|2|||
25133791|NCT01890915|50247115|FG001|Overall Study|Protocol Violation|0|||
25133792|NCT01890915|50247114|FG000|Overall Study|Equipment Malfunction|0|||
25133793|NCT01890915|50247115|FG001|Overall Study|Equipment Malfunction|1|||
25133794|NCT01615263|50247123|FG000|Overall Study|Post-randomization exclusion|0|||
25133795|NCT01615263|50247124|FG001|Overall Study|Post-randomization exclusion|2|||
25133796|NCT01859403|50247141|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
25133797|NCT01859403|50247142|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
25133798|NCT01859403|50247141|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
25133799|NCT01859403|50247142|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
25133800|NCT01859403|50247141|FG000|Primary Endpoint Measure|Physician Decision|0|||
25133801|NCT01859403|50247142|FG001|Primary Endpoint Measure|Physician Decision|1|||
25133802|NCT01859403|50247141|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
25133803|NCT01859403|50247142|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
25133804|NCT01858701|50247148|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
25133805|NCT01858701|50247149|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
25133806|NCT01858701|50247148|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
25133807|NCT01858701|50247149|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
25133808|NCT01858701|50247148|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
25133809|NCT01858701|50247149|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
25133810|NCT01858701|50247148|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
25133811|NCT01858701|50247149|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
25133812|NCT01461538|50247158|FG000|Overall Study|Death|15|||
25133813|NCT01461538|50247159|FG001|Overall Study|Death|6|||
25133814|NCT01461538|50247160|FG002|Overall Study|Death|2|||
25133815|NCT01461538|50247158|FG000|Overall Study|Study Stopped by Sponsor|2|||
25133816|NCT01461538|50247159|FG001|Overall Study|Study Stopped by Sponsor|1|||
25133817|NCT01461538|50247160|FG002|Overall Study|Study Stopped by Sponsor|0|||
25133818|NCT01461538|50247158|FG000|Overall Study|Withdrawal by Subject|1|||
25133819|NCT01461538|50247159|FG001|Overall Study|Withdrawal by Subject|1|||
25133820|NCT01461538|50247160|FG002|Overall Study|Withdrawal by Subject|0|||
25133821|NCT02117479|50247172|FG000|Overall Study|Death|13|||
25133822|NCT02117479|50247173|FG001|Overall Study|Death|8|||
25133823|NCT02117479|50247172|FG000|Overall Study|Adverse Event|8|||
25133824|NCT02117479|50247173|FG001|Overall Study|Adverse Event|16|||
25133825|NCT02117479|50247172|FG000|Overall Study|Subject decision|8|||
25133826|NCT02117479|50247173|FG001|Overall Study|Subject decision|9|||
25133827|NCT02117479|50247172|FG000|Overall Study|Disease progression|104|||
25133828|NCT02117479|50247173|FG001|Overall Study|Disease progression|108|||
25133829|NCT02117479|50247172|FG000|Overall Study|Noncompliance with study treatment|1|||
25133830|NCT02117479|50247173|FG001|Overall Study|Noncompliance with study treatment|0|||
25133831|NCT02117479|50247172|FG000|Overall Study|Study terminated by the sponsor|4|||
25133832|NCT02117479|50247173|FG001|Overall Study|Study terminated by the sponsor|6|||
25133833|NCT02117479|50247172|FG000|Overall Study|Physician Decision|7|||
25133834|NCT02117479|50247173|FG001|Overall Study|Physician Decision|2|||
25133835|NCT02117479|50247172|FG000|Overall Study|Other unspecified|11|||
25133836|NCT02117479|50247173|FG001|Overall Study|Other unspecified|7|||
25133837|NCT02229851|50247182|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
25133838|NCT02229851|50247183|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
25133839|NCT02229851|50247184|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
25133840|NCT02229851|50247185|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
25133841|NCT02229851|50247186|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
25133842|NCT02229851|50247187|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
25133843|NCT02229851|50247188|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
25133844|NCT02229851|50247182|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
25133845|NCT02229851|50247183|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
25133846|NCT02229851|50247184|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
25133847|NCT02229851|50247185|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
25133848|NCT02229851|50247186|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
25133849|NCT02229851|50247187|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
25133850|NCT02229851|50247188|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
25133851|NCT02229851|50247182|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
25133852|NCT02229851|50247183|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
25133853|NCT02229851|50247184|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
25133854|NCT02229851|50247185|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
25133855|NCT02229851|50247186|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
25133856|NCT02229851|50247187|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
25133857|NCT02229851|50247188|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
25133858|NCT02229851|50247182|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
25133859|NCT02229851|50247183|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
25133860|NCT02229851|50247184|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
25133861|NCT02229851|50247185|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
25133862|NCT02229851|50247186|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
25133863|NCT02229851|50247187|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
25133864|NCT02229851|50247188|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
25133865|NCT02229851|50247182|FG000|Main Phase (Double-blind Phase)|Death|1|||
25133866|NCT02229851|50247183|FG001|Main Phase (Double-blind Phase)|Death|1|||
25133867|NCT02229851|50247184|FG002|Main Phase (Double-blind Phase)|Death|0|||
25133868|NCT02229851|50247185|FG003|Main Phase (Double-blind Phase)|Death|0|||
25133869|NCT02229851|50247186|FG004|Main Phase (Double-blind Phase)|Death|0|||
25133870|NCT02229851|50247187|FG005|Main Phase (Double-blind Phase)|Death|0|||
25133871|NCT02229851|50247188|FG006|Main Phase (Double-blind Phase)|Death|0|||
25133872|NCT02229851|50247182|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
25133873|NCT02229851|50247183|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
25133874|NCT02229851|50247184|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
25133875|NCT02229851|50247185|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
25133876|NCT02229851|50247186|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
25133877|NCT02229851|50247187|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
25133878|NCT02229851|50247188|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
25133879|NCT02229851|50247182|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
25133880|NCT02229851|50247183|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
25133881|NCT02229851|50247184|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
25133882|NCT02229851|50247185|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
25133883|NCT02229851|50247186|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
25133884|NCT02229851|50247187|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
25133885|NCT02229851|50247188|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
25133886|NCT02229851|50247182|FG000|Extension Phase (Open-label Phase)|Death|0|||
25133887|NCT02229851|50247183|FG001|Extension Phase (Open-label Phase)|Death|0|||
25009452|NCT02953782|50102345|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
25133888|NCT02229851|50247184|FG002|Extension Phase (Open-label Phase)|Death|0|||
25133889|NCT02229851|50247185|FG003|Extension Phase (Open-label Phase)|Death|1|||
25133890|NCT02229851|50247186|FG004|Extension Phase (Open-label Phase)|Death|0|||
25133891|NCT02229851|50247187|FG005|Extension Phase (Open-label Phase)|Death|1|||
25133892|NCT02229851|50247188|FG006|Extension Phase (Open-label Phase)|Death|1|||
25133893|NCT01482910|50247205|FG000|Overall Study|Adverse Event|6|||
25133894|NCT01482910|50247206|FG001|Overall Study|Adverse Event|5|||
25133895|NCT01482910|50247205|FG000|Overall Study|Lost to Follow-up|0|||
25133896|NCT01482910|50247206|FG001|Overall Study|Lost to Follow-up|1|||
25133897|NCT01482910|50247205|FG000|Overall Study|Protocol Violation|1|||
25133898|NCT01482910|50247206|FG001|Overall Study|Protocol Violation|1|||
25133899|NCT01482910|50247205|FG000|Overall Study|Withdrawal by Subject|7|||
25133900|NCT01482910|50247206|FG001|Overall Study|Withdrawal by Subject|2|||
25133901|NCT01482910|50247205|FG000|Overall Study|Death|1|||
25133902|NCT01482910|50247206|FG001|Overall Study|Death|0|||
25133903|NCT01626391|50247216|FG000|Overall Study|Physician Decision|1|||
25133904|NCT01626391|50247217|FG001|Overall Study|Physician Decision|0|||
25133905|NCT01626391|50247216|FG000|Overall Study|Withdrawal by Subject|1|||
25133906|NCT01626391|50247217|FG001|Overall Study|Withdrawal by Subject|0|||
25133907|NCT02103439|50247225|FG000|Overall Study|Adverse Event|0|||
25133908|NCT02103439|50247226|FG001|Overall Study|Adverse Event|2|||
25133909|NCT02103439|50247225|FG000|Overall Study|Withdrawal by Subject|3|||
25133910|NCT02103439|50247226|FG001|Overall Study|Withdrawal by Subject|1|||
25133911|NCT02229539|50247239|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
25133912|NCT02229539|50247240|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
25133913|NCT02229539|50247241|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
25133914|NCT02229539|50247239|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
25133915|NCT02229539|50247240|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
25133916|NCT02229539|50247241|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
25133917|NCT02229539|50247239|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
25133918|NCT02229539|50247240|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
25133919|NCT02229539|50247241|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
25133920|NCT02229539|50247239|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
25133921|NCT02229539|50247240|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
25133922|NCT02229539|50247241|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
25133923|NCT02229539|50247239|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
25133924|NCT02229539|50247240|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
25273364|NCT01260350|50587448|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273365|NCT01260350|50587449|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273366|NCT01260350|50587450|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273367|NCT01260350|50587451|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
25273368|NCT01260194|50587505|FG000|Overall Study|Withdrawal of Consent|1|||
25273369|NCT01259726|50587513|FG000|Overall Study|Death|1|||
25273370|NCT01259726|50587514|FG001|Overall Study|Death|0|||
25273371|NCT01259726|50587515|FG002|Overall Study|Death|0|||
25273372|NCT01259726|50587516|FG003|Overall Study|Death|0|||
25273373|NCT01259726|50587513|FG000|Overall Study|Physician Decision|2|||
25273374|NCT01259726|50587514|FG001|Overall Study|Physician Decision|0|||
25273375|NCT01259726|50587515|FG002|Overall Study|Physician Decision|1|||
25133925|NCT02229539|50247241|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
25133926|NCT02229539|50247239|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
25133927|NCT02229539|50247240|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
25133928|NCT02229539|50247241|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
25133929|NCT02229539|50247239|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
25133930|NCT02229539|50247240|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
25133931|NCT02229539|50247241|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
25133932|NCT02229539|50247239|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
25133933|NCT02229539|50247240|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
25133934|NCT02229539|50247241|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
25133935|NCT02229539|50247239|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
25133936|NCT02229539|50247240|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
25133937|NCT02229539|50247241|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
25133938|NCT01835223|50247251|FG000|Overall Study|Adverse Event|1|||
25133939|NCT01835223|50247252|FG001|Overall Study|Adverse Event|0|||
25133940|NCT01835223|50247251|FG000|Overall Study|Withdrawal by Subject|2|||
25133941|NCT01835223|50247252|FG001|Overall Study|Withdrawal by Subject|0|||
25133942|NCT01835223|50247251|FG000|Overall Study|Disease progression|2|||
25133943|NCT01835223|50247252|FG001|Overall Study|Disease progression|1|||
25133944|NCT01835223|50247251|FG000|Overall Study|Became Inelligible|4|||
25133945|NCT01835223|50247252|FG001|Overall Study|Became Inelligible|0|||
25133946|NCT01482598|50247262|FG000|Overall Study|Death|7|||
25133947|NCT01482598|50247263|FG001|Overall Study|Death|10|||
25133948|NCT01482598|50247262|FG000|Overall Study|Physician Decision|0|||
25133949|NCT01482598|50247263|FG001|Overall Study|Physician Decision|3|||
25178824|NCT01478113|50324152|FG001|Overall Study|Withdrawal by Subject|1|||
25178825|NCT01478113|50324151|FG000|Overall Study|Physician Decision|1|||
25133950|NCT01482598|50247262|FG000|Overall Study|Withdrawal by Subject|4|||
25133951|NCT01482598|50247263|FG001|Overall Study|Withdrawal by Subject|5|||
25133952|NCT01482598|50247262|FG000|Overall Study|Lost to Follow-up|5|||
25178826|NCT01478113|50324152|FG001|Overall Study|Physician Decision|0|||
25133953|NCT01482598|50247263|FG001|Overall Study|Lost to Follow-up|4|||
25133954|NCT01460446|50247271|FG000|Overall Study|Non-compliance|2|||
25133955|NCT01460446|50247272|FG001|Overall Study|Non-compliance|9|||
25133956|NCT01460446|50247271|FG000|Overall Study|Consent Withdrawn|0|||
25133957|NCT01460446|50247272|FG001|Overall Study|Consent Withdrawn|4|||
25133958|NCT01460446|50247271|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
25133959|NCT01460446|50247272|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
25133960|NCT01460446|50247271|FG000|Overall Study|Surgery/Illness|1|||
25133961|NCT01460446|50247272|FG001|Overall Study|Surgery/Illness|1|||
25133962|NCT01460446|50247271|FG000|Overall Study|Pregnancy|1|||
25133963|NCT01460446|50247272|FG001|Overall Study|Pregnancy|0|||
25133964|NCT01460446|50247271|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
25133965|NCT01460446|50247272|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
25133966|NCT02229383|50247281|FG000|Overall Study|Adverse Event|7|||
25133967|NCT02229383|50247282|FG001|Overall Study|Adverse Event|4|||
25133968|NCT02229383|50247281|FG000|Overall Study|Death|0|||
25133969|NCT02229383|50247282|FG001|Overall Study|Death|1|||
25133970|NCT02229383|50247281|FG000|Overall Study|Lost to Follow-up|5|||
25133971|NCT02229383|50247282|FG001|Overall Study|Lost to Follow-up|3|||
25133972|NCT02229383|50247281|FG000|Overall Study|Withdrawal by Subject|4|||
25133973|NCT02229383|50247282|FG001|Overall Study|Withdrawal by Subject|6|||
25133974|NCT02229383|50247281|FG000|Overall Study|Did not receive treatment|1|||
25133975|NCT02229383|50247282|FG001|Overall Study|Did not receive treatment|0|||
25133976|NCT02229383|50247281|FG000|Overall Study|Other|3|||
25133977|NCT02229383|50247282|FG001|Overall Study|Other|8|||
25133978|NCT01499368|50247291|FG000|Overall Study|Did not meet I/E criteria|8|||
25133979|NCT01499368|50247292|FG001|Overall Study|Did not meet I/E criteria|4|||
25133980|NCT01499368|50247293|FG002|Overall Study|Did not meet I/E criteria|4|||
25133981|NCT01499368|50247291|FG000|Overall Study|Prohibited Concomitant medication|1|||
25133982|NCT01499368|50247292|FG001|Overall Study|Prohibited Concomitant medication|1|||
25133983|NCT01499368|50247293|FG002|Overall Study|Prohibited Concomitant medication|0|||
25133984|NCT01499368|50247291|FG000|Overall Study|Withdrawal by Subject|11|||
25133985|NCT01499368|50247292|FG001|Overall Study|Withdrawal by Subject|10|||
25133986|NCT01499368|50247293|FG002|Overall Study|Withdrawal by Subject|8|||
25133987|NCT01499368|50247291|FG000|Overall Study|Lost to Follow-up|3|||
25133988|NCT01499368|50247292|FG001|Overall Study|Lost to Follow-up|2|||
25133989|NCT01499368|50247293|FG002|Overall Study|Lost to Follow-up|5|||
25133990|NCT01499368|50247291|FG000|Overall Study|Adverse Event|4|||
25133991|NCT01499368|50247292|FG001|Overall Study|Adverse Event|0|||
25133992|NCT01499368|50247293|FG002|Overall Study|Adverse Event|2|||
25133993|NCT01499368|50247291|FG000|Overall Study|Physician Decision|0|||
25133994|NCT01499368|50247292|FG001|Overall Study|Physician Decision|1|||
25133995|NCT01499368|50247293|FG002|Overall Study|Physician Decision|0|||
25133996|NCT01499368|50247291|FG000|Overall Study|Deviation from visit window|0|||
25133997|NCT01499368|50247292|FG001|Overall Study|Deviation from visit window|0|||
25133998|NCT01499368|50247293|FG002|Overall Study|Deviation from visit window|1|||
25133999|NCT01499368|50247291|FG000|Overall Study|Error of Prescriptions|0|||
25134000|NCT01499368|50247292|FG001|Overall Study|Error of Prescriptions|0|||
25134001|NCT01499368|50247293|FG002|Overall Study|Error of Prescriptions|1|||
25134002|NCT01835145|50247303|FG000|Overall Study|Ineligible prior to treatment|1|||
25134003|NCT01835145|50247304|FG001|Overall Study|Ineligible prior to treatment|0|||
25134004|NCT02229227|50247314|FG000|Overall Study|Adverse Event|14|||
25134005|NCT02229227|50247315|FG001|Overall Study|Adverse Event|9|||
25134006|NCT02229227|50247314|FG000|Overall Study|Lack of Efficacy|3|||
25134007|NCT02229227|50247315|FG001|Overall Study|Lack of Efficacy|3|||
25134008|NCT02229227|50247314|FG000|Overall Study|Protocol Violation|6|||
25134009|NCT02229227|50247315|FG001|Overall Study|Protocol Violation|8|||
25134010|NCT02229227|50247314|FG000|Overall Study|Protocol defined stopping criteria|1|||
25134011|NCT02229227|50247315|FG001|Overall Study|Protocol defined stopping criteria|3|||
25134012|NCT02229227|50247314|FG000|Overall Study|Lost to Follow-up|3|||
25134013|NCT02229227|50247315|FG001|Overall Study|Lost to Follow-up|3|||
25134014|NCT02229227|50247314|FG000|Overall Study|Study terminated by sponsor|11|||
25134015|NCT02229227|50247315|FG001|Overall Study|Study terminated by sponsor|11|||
25134016|NCT02229227|50247314|FG000|Overall Study|Withdrawal by Subject|8|||
25134017|NCT02229227|50247315|FG001|Overall Study|Withdrawal by Subject|12|||
25134018|NCT02229227|50247314|FG000|Overall Study|Other|0|||
25134019|NCT02229227|50247315|FG001|Overall Study|Other|1|||
25134020|NCT02229227|50247314|FG000|Overall Study|Physician Decision|5|||
25134021|NCT02229227|50247315|FG001|Overall Study|Physician Decision|12|||
25134022|NCT01499290|50247323|FG000|Overall Study|Withdrawal by Subject|22|||
25134023|NCT01499290|50247324|FG001|Overall Study|Withdrawal by Subject|15|||
25134024|NCT01499290|50247323|FG000|Overall Study|Not specified in study report|11|||
25134025|NCT01499290|50247324|FG001|Overall Study|Not specified in study report|5|||
25134026|NCT01499290|50247323|FG000|Overall Study|Condition improved/subject recovered|1|||
25134027|NCT01499290|50247324|FG001|Overall Study|Condition improved/subject recovered|0|||
25134028|NCT01499290|50247323|FG000|Overall Study|Lack of Efficacy|7|||
25134029|NCT01499290|50247324|FG001|Overall Study|Lack of Efficacy|8|||
25134030|NCT01499290|50247323|FG000|Overall Study|Adverse Event|14|||
25134031|NCT01499290|50247324|FG001|Overall Study|Adverse Event|7|||
25134032|NCT01833897|50247349|FG000|Overall Study|Lack of Efficacy|1|||
25134033|NCT01481896|50247353|FG000|Overall Study|Lost to Follow-up|12|||
25134034|NCT02226653|50247369|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
25134035|NCT02226653|50247370|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
25134036|NCT02226653|50247369|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
25134037|NCT02226653|50247370|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
25134038|NCT02201771|50247386|FG000|Overall Study|Death|3|||
25134039|NCT02201771|50247387|FG001|Overall Study|Death|2|||
25134040|NCT02201771|50247388|FG002|Overall Study|Death|0|||
25134041|NCT02201771|50247386|FG000|Overall Study|Protocol Violation|10|||
25134042|NCT02201771|50247387|FG001|Overall Study|Protocol Violation|8|||
25134043|NCT02201771|50247388|FG002|Overall Study|Protocol Violation|10|||
25134044|NCT01460368|50247398|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
25134045|NCT01460368|50247399|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
25134046|NCT01460368|50247400|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
25134047|NCT01460368|50247401|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
25134048|NCT01460368|50247402|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
25134049|NCT01460368|50247403|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
25134050|NCT01460368|50247404|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
25134051|NCT01460368|50247398|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
25134052|NCT01460368|50247399|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
25134053|NCT01460368|50247400|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
25134054|NCT01460368|50247401|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
25134055|NCT01460368|50247402|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
25134056|NCT01460368|50247403|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
25134057|NCT01460368|50247404|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
25134058|NCT01460368|50247398|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
25134059|NCT01460368|50247399|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
25134060|NCT01460368|50247400|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
25134061|NCT01460368|50247401|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
25134062|NCT01460368|50247402|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
25134063|NCT01460368|50247403|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
25134064|NCT01460368|50247404|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
25134065|NCT01460368|50247398|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
25134066|NCT01460368|50247399|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
25134067|NCT01460368|50247400|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
25134068|NCT01460368|50247401|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
25134069|NCT01460368|50247402|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
25134070|NCT01460368|50247403|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
25134071|NCT01460368|50247404|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
25134072|NCT01460368|50247398|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
25134073|NCT01460368|50247399|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
25134074|NCT01460368|50247400|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
25134075|NCT01460368|50247401|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
25134076|NCT01460368|50247402|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
25134077|NCT01460368|50247403|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
25134078|NCT01460368|50247404|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
25134079|NCT01460290|50247413|FG000|Overall Study|Adverse Event|3|||
25134080|NCT01460290|50247413|FG000|Overall Study|Elevated liver function|1|||
25134081|NCT02200211|50247422|FG000|Overall Study|Lost to Follow-up|7|||
25134082|NCT02200211|50247423|FG001|Overall Study|Lost to Follow-up|7|||
25134083|NCT02200211|50247424|FG002|Overall Study|Lost to Follow-up|1|||
25134084|NCT02200211|50247425|FG003|Overall Study|Lost to Follow-up|2|||
25134085|NCT02200211|50247422|FG000|Overall Study|Withdrawal by Subject|1|||
25134086|NCT02200211|50247423|FG001|Overall Study|Withdrawal by Subject|0|||
25134087|NCT02200211|50247424|FG002|Overall Study|Withdrawal by Subject|0|||
25134088|NCT02200211|50247425|FG003|Overall Study|Withdrawal by Subject|0|||
25134089|NCT01459666|50247445|FG000|Overall Study|PI left institution|5|||
25134090|NCT01459666|50247446|FG001|Overall Study|PI left institution|4|||
25134091|NCT01858389|50247454|FG000|Overall Study|Death|1|||
25134092|NCT01858389|50247455|FG001|Overall Study|Death|3|||
25134093|NCT01858389|50247454|FG000|Overall Study|Study terminated by sponsor|0|||
25134094|NCT01858389|50247455|FG001|Overall Study|Study terminated by sponsor|2|||
25134095|NCT01858389|50247454|FG000|Overall Study|Withdrawal by Subject|0|||
25134096|NCT01858389|50247455|FG001|Overall Study|Withdrawal by Subject|1|||
25134097|NCT01858389|50247454|FG000|Overall Study|Progressive disease|10|||
25134098|NCT01858389|50247455|FG001|Overall Study|Progressive disease|11|||
25134099|NCT01858389|50247454|FG000|Overall Study|Other|2|||
25134100|NCT01858389|50247455|FG001|Overall Study|Other|4|||
25134101|NCT01858389|50247454|FG000|Overall Study|Adverse Event|3|||
25134102|NCT01858389|50247455|FG001|Overall Study|Adverse Event|1|||
25134103|NCT01858389|50247454|FG000|Overall Study|Did not receive treatment|0|||
25134104|NCT01858389|50247455|FG001|Overall Study|Did not receive treatment|3|||
25134105|NCT02199509|50247463|FG000|Overall Study|Suicidal Ideation|0|||
25134106|NCT02199509|50247464|FG001|Overall Study|Suicidal Ideation|1|||
25134107|NCT02199509|50247463|FG000|Overall Study|Misunderstood titration schedule|1|||
25134108|NCT02199509|50247464|FG001|Overall Study|Misunderstood titration schedule|0|||
25134109|NCT01458574|50247477|FG000|Overall Study|Adverse Event|5|||
25134110|NCT01458574|50247478|FG001|Overall Study|Adverse Event|9|||
25134111|NCT01458574|50247479|FG002|Overall Study|Adverse Event|7|||
25134112|NCT01458574|50247477|FG000|Overall Study|Lack of Efficacy|70|||
25134113|NCT01458574|50247478|FG001|Overall Study|Lack of Efficacy|53|||
25134114|NCT01458574|50247479|FG002|Overall Study|Lack of Efficacy|132|||
25134115|NCT01458574|50247477|FG000|Overall Study|Lost to Follow-up|3|||
25134116|NCT01458574|50247478|FG001|Overall Study|Lost to Follow-up|2|||
25134117|NCT01458574|50247479|FG002|Overall Study|Lost to Follow-up|1|||
25134118|NCT01458574|50247477|FG000|Overall Study|Pregnancy|1|||
25134119|NCT01458574|50247478|FG001|Overall Study|Pregnancy|1|||
25134120|NCT01458574|50247479|FG002|Overall Study|Pregnancy|0|||
25134121|NCT01458574|50247477|FG000|Overall Study|Protocol Violation|0|||
25134122|NCT01458574|50247478|FG001|Overall Study|Protocol Violation|1|||
25134123|NCT01458574|50247479|FG002|Overall Study|Protocol Violation|0|||
25134124|NCT01458574|50247477|FG000|Overall Study|Withdrawal by Subject|6|||
25134125|NCT01458574|50247478|FG001|Overall Study|Withdrawal by Subject|3|||
25134126|NCT01458574|50247479|FG002|Overall Study|Withdrawal by Subject|5|||
25134127|NCT01458574|50247477|FG000|Overall Study|Other|2|||
25134128|NCT01458574|50247478|FG001|Overall Study|Other|1|||
25134129|NCT01458574|50247479|FG002|Overall Study|Other|0|||
25134130|NCT01458574|50247477|FG000|Overall Study|Randomized but not treated|0|||
25134131|NCT01458574|50247478|FG001|Overall Study|Randomized but not treated|1|||
25134132|NCT01458574|50247479|FG002|Overall Study|Randomized but not treated|0|||
25134133|NCT02224703|50247490|FG000|Overall Study|Adverse Event|0|||
25134134|NCT02224703|50247491|FG001|Overall Study|Adverse Event|5|||
25134135|NCT02224703|50247492|FG002|Overall Study|Adverse Event|0|||
25134136|NCT02224703|50247490|FG000|Overall Study|Withdrawn by investigator|1|||
25134137|NCT02224703|50247491|FG001|Overall Study|Withdrawn by investigator|0|||
25134138|NCT02224703|50247492|FG002|Overall Study|Withdrawn by investigator|0|||
25134139|NCT02224703|50247490|FG000|Overall Study|Advised by medical monitor|1|||
25134140|NCT02224703|50247491|FG001|Overall Study|Advised by medical monitor|0|||
25134141|NCT02224703|50247492|FG002|Overall Study|Advised by medical monitor|0|||
25134142|NCT02224703|50247490|FG000|Overall Study|Withdrawn by parent/guardian|0|||
25134143|NCT02224703|50247491|FG001|Overall Study|Withdrawn by parent/guardian|1|||
25134144|NCT02224703|50247492|FG002|Overall Study|Withdrawn by parent/guardian|0|||
25134145|NCT02224703|50247490|FG000|Overall Study|Lack of Efficacy|1|||
25134146|NCT02224703|50247491|FG001|Overall Study|Lack of Efficacy|0|||
25134147|NCT02224703|50247492|FG002|Overall Study|Lack of Efficacy|0|||
25134148|NCT02198963|50247501|FG000|Overall Study|Adverse Event|1|||
25134149|NCT02198963|50247501|FG000|Overall Study|Withdrawal by Subject|6|||
25134150|NCT01458106|50247525|FG000|Overall Study|Withdrawal by Subject|2|||
25134151|NCT01458106|50247526|FG001|Overall Study|Withdrawal by Subject|0|||
25134152|NCT01458106|50247525|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
25134153|NCT01458106|50247526|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
25273376|NCT01259726|50587516|FG003|Overall Study|Physician Decision|1|||
25273377|NCT01259726|50587513|FG000|Overall Study|Withdrawal by Subject|1|||
25134154|NCT01458106|50247525|FG000|Overall Study|Withdrawn Per Protocol|0|||
25134155|NCT01458106|50247526|FG001|Overall Study|Withdrawn Per Protocol|1|||
25134156|NCT01457950|50247537|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
25134157|NCT01457950|50247538|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
25134158|NCT01457950|50247539|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
25273378|NCT01259726|50587514|FG001|Overall Study|Withdrawal by Subject|3|||
25273379|NCT01259726|50587515|FG002|Overall Study|Withdrawal by Subject|2|||
25273380|NCT01259726|50587516|FG003|Overall Study|Withdrawal by Subject|1|||
25273381|NCT01259726|50587513|FG000|Overall Study|Lost to Follow-up|1|||
25273382|NCT01259726|50587514|FG001|Overall Study|Lost to Follow-up|1|||
25273383|NCT01259726|50587515|FG002|Overall Study|Lost to Follow-up|1|||
25273384|NCT01259726|50587516|FG003|Overall Study|Lost to Follow-up|3|||
25273385|NCT01259492|50587530|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
25273386|NCT01259492|50587531|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
25273387|NCT01259492|50587532|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
25273388|NCT01259492|50587533|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
25273389|NCT01259492|50587530|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
25134159|NCT01457950|50247540|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
25273390|NCT01259492|50587531|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
25273391|NCT01259492|50587532|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
25273392|NCT01259492|50587533|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
25134160|NCT01457950|50247537|FG000|Double-Blind Phase|Protocol Violation|2|||
25134161|NCT01457950|50247538|FG001|Double-Blind Phase|Protocol Violation|1|||
25134162|NCT01457950|50247539|FG002|Double-Blind Phase|Protocol Violation|0|||
25134163|NCT01457950|50247540|FG003|Double-Blind Phase|Protocol Violation|0|||
25134164|NCT01457950|50247537|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
25134165|NCT01457950|50247538|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
25134166|NCT01457950|50247539|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
25134167|NCT01457950|50247540|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
25134168|NCT01457950|50247537|FG000|Open-Label Phase|Adverse Event|0|||
25134169|NCT01457950|50247538|FG001|Open-Label Phase|Adverse Event|0|||
25134170|NCT01457950|50247539|FG002|Open-Label Phase|Adverse Event|0|||
25134171|NCT01457950|50247540|FG003|Open-Label Phase|Adverse Event|1|||
25134172|NCT01457950|50247537|FG000|Open-Label Phase|Protocol Violation|0|||
25134173|NCT01457950|50247538|FG001|Open-Label Phase|Protocol Violation|0|||
25134174|NCT01457950|50247539|FG002|Open-Label Phase|Protocol Violation|0|||
25134175|NCT01457950|50247540|FG003|Open-Label Phase|Protocol Violation|1|||
25134176|NCT01457950|50247537|FG000|Open-Label Phase|Withdrawal by Subject|0|||
25134177|NCT01457950|50247538|FG001|Open-Label Phase|Withdrawal by Subject|0|||
25134178|NCT01457950|50247539|FG002|Open-Label Phase|Withdrawal by Subject|2|||
25134179|NCT01457950|50247540|FG003|Open-Label Phase|Withdrawal by Subject|0|||
25134180|NCT01499134|50247553|FG000|Overall Study|Withdrawal by Subject|0|||
25134181|NCT01499134|50247554|FG001|Overall Study|Withdrawal by Subject|1|||
25134182|NCT02198651|50247560|FG000|Lead-in Period|Withdrew consent|13|||
25134183|NCT02198651|50247561|FG001|Lead-in Period|Withdrew consent|0|||
25134184|NCT02198651|50247562|FG002|Lead-in Period|Withdrew consent|0|||
25134185|NCT02198651|50247563|FG003|Lead-in Period|Withdrew consent|0|||
25134186|NCT02198651|50247564|FG004|Lead-in Period|Withdrew consent|0|||
25134187|NCT02198651|50247560|FG000|Lead-in Period|Adverse Event|2|||
25134188|NCT02198651|50247561|FG001|Lead-in Period|Adverse Event|0|||
25134189|NCT02198651|50247562|FG002|Lead-in Period|Adverse Event|0|||
25134190|NCT02198651|50247563|FG003|Lead-in Period|Adverse Event|0|||
25134191|NCT02198651|50247564|FG004|Lead-in Period|Adverse Event|0|||
25134192|NCT02198651|50247560|FG000|Lead-in Period|Other, not specified|22|||
25134193|NCT02198651|50247561|FG001|Lead-in Period|Other, not specified|0|||
25134194|NCT02198651|50247562|FG002|Lead-in Period|Other, not specified|0|||
25134195|NCT02198651|50247563|FG003|Lead-in Period|Other, not specified|0|||
25134196|NCT02198651|50247564|FG004|Lead-in Period|Other, not specified|0|||
25134197|NCT02198651|50247560|FG000|Double-blind Period|Withdrew consent|0|||
25134198|NCT02198651|50247561|FG001|Double-blind Period|Withdrew consent|4|||
25134199|NCT02198651|50247562|FG002|Double-blind Period|Withdrew consent|0|||
25134200|NCT02198651|50247563|FG003|Double-blind Period|Withdrew consent|0|||
25134201|NCT02198651|50247564|FG004|Double-blind Period|Withdrew consent|0|||
25134202|NCT02198651|50247560|FG000|Double-blind Period|Adverse Event|0|||
25134203|NCT02198651|50247561|FG001|Double-blind Period|Adverse Event|1|||
25134204|NCT02198651|50247562|FG002|Double-blind Period|Adverse Event|0|||
25134205|NCT02198651|50247563|FG003|Double-blind Period|Adverse Event|0|||
25134206|NCT02198651|50247564|FG004|Double-blind Period|Adverse Event|0|||
25134207|NCT02198651|50247560|FG000|Double-blind Period|Other, not specified|0|||
25134208|NCT02198651|50247561|FG001|Double-blind Period|Other, not specified|4|||
25134209|NCT02198651|50247562|FG002|Double-blind Period|Other, not specified|1|||
25134210|NCT02198651|50247563|FG003|Double-blind Period|Other, not specified|0|||
25134211|NCT02198651|50247564|FG004|Double-blind Period|Other, not specified|0|||
25134212|NCT02198651|50247560|FG000|Open-label Rescue Period|Withdrew consent|0|||
25134213|NCT02198651|50247561|FG001|Open-label Rescue Period|Withdrew consent|0|||
25134214|NCT02198651|50247562|FG002|Open-label Rescue Period|Withdrew consent|0|||
25134215|NCT02198651|50247563|FG003|Open-label Rescue Period|Withdrew consent|2|||
25134216|NCT02198651|50247564|FG004|Open-label Rescue Period|Withdrew consent|0|||
25134217|NCT02198651|50247560|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
25134218|NCT02198651|50247561|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
25134219|NCT02198651|50247562|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
25134220|NCT02198651|50247563|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
25134221|NCT02198651|50247564|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
25134222|NCT01498822|50247579|FG000|Overall Study|Protocol Violation|8|||
25134223|NCT01498822|50247580|FG001|Overall Study|Protocol Violation|4|||
25134224|NCT01498822|50247579|FG000|Overall Study|Other Reason|5|||
25134225|NCT01498822|50247580|FG001|Overall Study|Other Reason|2|||
25134226|NCT01498822|50247579|FG000|Overall Study|Lack of Efficacy|7|||
25134227|NCT01498822|50247580|FG001|Overall Study|Lack of Efficacy|2|||
25134228|NCT01498822|50247579|FG000|Overall Study|AE, non-serious non-fatal|8|||
25134229|NCT01498822|50247580|FG001|Overall Study|AE, non-serious non-fatal|17|||
25134230|NCT01498822|50247579|FG000|Overall Study|SAE, non-fatal|2|||
25134231|NCT01498822|50247580|FG001|Overall Study|SAE, non-fatal|2|||
25134232|NCT01498822|50247579|FG000|Overall Study|Adverse Event, serious fatal|1|||
25134233|NCT01498822|50247580|FG001|Overall Study|Adverse Event, serious fatal|1|||
25273393|NCT01259492|50587530|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
25134234|NCT01498822|50247579|FG000|Overall Study|Withdrawal by Subject|15|||
25134235|NCT01498822|50247580|FG001|Overall Study|Withdrawal by Subject|25|||
25134236|NCT01498822|50247579|FG000|Overall Study|Lost to Follow-up|8|||
25134237|NCT01498822|50247580|FG001|Overall Study|Lost to Follow-up|3|||
25134238|NCT01498120|50247588|FG000|Overall Study|Lost to Follow-up|1|||
25134239|NCT01498120|50247588|FG000|Overall Study|Withdrawal by Subject|5|||
25134240|NCT01498120|50247588|FG000|Overall Study|AE, non-serious non-fatal|3|||
25134241|NCT01498120|50247588|FG000|Overall Study|Other|4|||
25134242|NCT01497262|50247592|FG000|Overall Study|Abnormal Lab Values|4|||
25134243|NCT01497262|50247592|FG000|Overall Study|Abnormal Test Procedure Result|1|||
25134244|NCT01497262|50247592|FG000|Overall Study|Physician Decision|1|||
25134245|NCT01497262|50247592|FG000|Overall Study|Withdrawal by Subject|2|||
25134246|NCT01497262|50247592|FG000|Overall Study|Adverse Event|2|||
25134247|NCT01497262|50247592|FG000|Overall Study|Protocol Violation|1|||
25134248|NCT02224625|50247596|FG000|Irritation|Adverse Event|6|||
25134249|NCT02224625|50247596|FG000|Sensitization|Adverse Event|55|||
25134250|NCT02197247|50247608|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
25134251|NCT02197247|50247608|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
25134252|NCT02197247|50247608|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
25134253|NCT02197247|50247608|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
25134254|NCT02197247|50247608|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
25134255|NCT02197247|50247608|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
25134256|NCT02197247|50247608|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
25134257|NCT02197247|50247608|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
25134258|NCT02224157|50247620|FG000|Overall Study|Severe non-compliance to protocol|2|||
25134259|NCT02224157|50247621|FG001|Overall Study|Severe non-compliance to protocol|2|||
25134260|NCT02224157|50247620|FG000|Overall Study|Other|13|||
25134261|NCT02224157|50247621|FG001|Overall Study|Other|10|||
25134262|NCT02224157|50247620|FG000|Overall Study|Subject decision|58|||
25134263|NCT02224157|50247621|FG001|Overall Study|Subject decision|50|||
25134264|NCT02224157|50247620|FG000|Overall Study|Prematurely closed site|4|||
25134265|NCT02224157|50247621|FG001|Overall Study|Prematurely closed site|2|||
25134266|NCT02224157|50247620|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
25134267|NCT02224157|50247621|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
25134268|NCT02224157|50247620|FG000|Overall Study|Lost to Follow-up|27|||
25134269|NCT02224157|50247621|FG001|Overall Study|Lost to Follow-up|35|||
25134270|NCT02224157|50247620|FG000|Overall Study|Death|1|||
25134271|NCT02224157|50247621|FG001|Overall Study|Death|1|||
25134272|NCT02224157|50247620|FG000|Overall Study|Adverse Event|1|||
25134273|NCT02224157|50247621|FG001|Overall Study|Adverse Event|3|||
25134274|NCT02196701|50247629|FG000|Overall Study|Adverse Event|1|||
25134275|NCT02196701|50247629|FG000|Overall Study|Lost to Follow-up|1|||
25134276|NCT02196701|50247629|FG000|Overall Study|Non-adherence to Protocol|1|||
25134277|NCT01481116|50247639|FG000|Overall Study|Adverse Event|26|||
25134278|NCT01481116|50247640|FG001|Overall Study|Adverse Event|26|||
25134279|NCT01481116|50247641|FG002|Overall Study|Adverse Event|42|||
25134280|NCT01481116|50247639|FG000|Overall Study|Major Protocol Deviation|3|||
25134281|NCT01481116|50247640|FG001|Overall Study|Major Protocol Deviation|7|||
25134282|NCT01481116|50247641|FG002|Overall Study|Major Protocol Deviation|1|||
25134283|NCT01481116|50247639|FG000|Overall Study|Lost to Follow-up|8|||
25134284|NCT01481116|50247640|FG001|Overall Study|Lost to Follow-up|12|||
25134285|NCT01481116|50247641|FG002|Overall Study|Lost to Follow-up|11|||
25134286|NCT01481116|50247639|FG000|Overall Study|Withdrawal by Subject|37|||
25134287|NCT01481116|50247640|FG001|Overall Study|Withdrawal by Subject|33|||
25134288|NCT01481116|50247641|FG002|Overall Study|Withdrawal by Subject|37|||
25134289|NCT01481116|50247639|FG000|Overall Study|Study Termination|730|||
25134290|NCT01481116|50247640|FG001|Overall Study|Study Termination|729|||
25134291|NCT01481116|50247641|FG002|Overall Study|Study Termination|713|||
25134292|NCT01481116|50247639|FG000|Overall Study|Pregnancy|0|||
25134293|NCT01481116|50247640|FG001|Overall Study|Pregnancy|0|||
25134294|NCT01481116|50247641|FG002|Overall Study|Pregnancy|1|||
25134295|NCT01481116|50247639|FG000|Overall Study|Lack of Efficacy|3|||
25134296|NCT01481116|50247640|FG001|Overall Study|Lack of Efficacy|3|||
25134297|NCT01481116|50247641|FG002|Overall Study|Lack of Efficacy|1|||
25134298|NCT01481116|50247639|FG000|Overall Study|Contraindications|1|||
25134299|NCT01481116|50247640|FG001|Overall Study|Contraindications|1|||
25134300|NCT01481116|50247641|FG002|Overall Study|Contraindications|0|||
25134301|NCT01481116|50247639|FG000|Overall Study|Other|1|||
25134302|NCT01481116|50247640|FG001|Overall Study|Other|1|||
25134303|NCT01481116|50247641|FG002|Overall Study|Other|0|||
25134304|NCT01481116|50247639|FG000|Overall Study|Participant Started Taking Glipizide|1|||
25134305|NCT01481116|50247640|FG001|Overall Study|Participant Started Taking Glipizide|0|||
25134306|NCT01481116|50247641|FG002|Overall Study|Participant Started Taking Glipizide|0|||
25134307|NCT01481116|50247639|FG000|Overall Study|Participant Moved Out of Area|2|||
25134308|NCT01481116|50247640|FG001|Overall Study|Participant Moved Out of Area|0|||
25134309|NCT01481116|50247641|FG002|Overall Study|Participant Moved Out of Area|1|||
25134310|NCT01481116|50247639|FG000|Overall Study|Participant Moved Out of Country|1|||
25134311|NCT01481116|50247640|FG001|Overall Study|Participant Moved Out of Country|0|||
25134312|NCT01481116|50247641|FG002|Overall Study|Participant Moved Out of Country|1|||
25134313|NCT01481116|50247639|FG000|Overall Study|Investigator Decision|3|||
25134314|NCT01481116|50247640|FG001|Overall Study|Investigator Decision|2|||
25134315|NCT01481116|50247641|FG002|Overall Study|Investigator Decision|1|||
25134316|NCT01481116|50247639|FG000|Overall Study|Sponsor Decision|0|||
25134317|NCT01481116|50247640|FG001|Overall Study|Sponsor Decision|1|||
25134318|NCT01481116|50247641|FG002|Overall Study|Sponsor Decision|3|||
25134319|NCT01481116|50247639|FG000|Overall Study|Non-Compliant With Study Drug|0|||
25134320|NCT01481116|50247640|FG001|Overall Study|Non-Compliant With Study Drug|1|||
25134321|NCT01481116|50247641|FG002|Overall Study|Non-Compliant With Study Drug|1|||
25134322|NCT01481116|50247639|FG000|Overall Study|Investigator's Discretion|2|||
25134323|NCT01481116|50247640|FG001|Overall Study|Investigator's Discretion|0|||
25134324|NCT01481116|50247641|FG002|Overall Study|Investigator's Discretion|0|||
25134325|NCT01481116|50247639|FG000|Overall Study|Death|2|||
25134326|NCT01481116|50247640|FG001|Overall Study|Death|1|||
25134327|NCT01481116|50247641|FG002|Overall Study|Death|0|||
25134328|NCT01481116|50247639|FG000|Overall Study|Hypoglycemic Event|4|||
25134329|NCT01481116|50247640|FG001|Overall Study|Hypoglycemic Event|0|||
25134330|NCT01481116|50247641|FG002|Overall Study|Hypoglycemic Event|0|||
25134331|NCT02222207|50247649|FG000|Overall Study|Death|1|||
25134332|NCT02222207|50247649|FG000|Overall Study|Other reasons|2|||
25134333|NCT02222207|50247649|FG000|Overall Study|Adverse Event|1|||
25134334|NCT01457014|50247653|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
25134335|NCT01457014|50247654|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
25134336|NCT01457014|50247655|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
25134337|NCT01457014|50247656|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
25009453|NCT02953782|50102346|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
25009454|NCT02953782|50102347|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
25009455|NCT02953782|50102348|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
25009456|NCT02953782|50102349|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
25009457|NCT02953782|50102350|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
25009458|NCT02953782|50102351|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
25009459|NCT02953782|50102344|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
25009460|NCT02953782|50102345|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
25134338|NCT01457014|50247653|FG000|First Night|Withdrawal by Subject|3|||
25134339|NCT01457014|50247654|FG001|First Night|Withdrawal by Subject|0|||
25134340|NCT01457014|50247655|FG002|First Night|Withdrawal by Subject|0|||
25134341|NCT01457014|50247656|FG003|First Night|Withdrawal by Subject|0|||
25134342|NCT02254421|50247666|FG000|Overall Study|Randomized but Not Treated|1|||
25134343|NCT02254421|50247667|FG001|Overall Study|Randomized but Not Treated|0|||
25134344|NCT02254421|50247666|FG000|Overall Study|Death|0|||
25134345|NCT02254421|50247667|FG001|Overall Study|Death|2|||
25134346|NCT02254421|50247666|FG000|Overall Study|Withdrew Consent|1|||
25134347|NCT02254421|50247667|FG001|Overall Study|Withdrew Consent|1|||
25134348|NCT02252939|50247673|FG000|Overall Study|Lost to Follow-up|3|||
25134349|NCT02196077|50247682|FG000|Overall Study|Adverse Event|4|||
25134350|NCT02196077|50247682|FG000|Overall Study|Lack of Efficacy|1|||
25134351|NCT02196077|50247682|FG000|Overall Study|Withdrawal by Subject|14|||
25134352|NCT02196077|50247682|FG000|Overall Study|Physician Decision|1|||
25134353|NCT02196077|50247682|FG000|Overall Study|Lost to Follow-up|3|||
25134354|NCT02196077|50247682|FG000|Overall Study|Protocol Violation|24|||
25134355|NCT02195687|50247696|FG000|Overall Study|Personal Reasons|1|||
25134356|NCT02195687|50247697|FG001|Overall Study|Personal Reasons|1|||
25134357|NCT02195687|50247696|FG000|Overall Study|Lost to Follow-up|4|||
25134358|NCT02195687|50247697|FG001|Overall Study|Lost to Follow-up|1|||
25134359|NCT02195531|50247706|FG000|Overall Study|Withdrawal by Subject|1|||
25134360|NCT02195531|50247707|FG001|Overall Study|Withdrawal by Subject|1|||
25134361|NCT02195531|50247708|FG002|Overall Study|Withdrawal by Subject|1|||
25134362|NCT02252081|50247718|FG000|Overall Study|Withdrawal by Subject|2|||
25134363|NCT02252081|50247719|FG001|Overall Study|Withdrawal by Subject|1|||
25134364|NCT02252081|50247718|FG000|Overall Study|Adverse Event|4|||
25009461|NCT02953782|50102346|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
25009462|NCT02953782|50102347|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
25009463|NCT02953782|50102348|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
25134365|NCT02252081|50247719|FG001|Overall Study|Adverse Event|1|||
25134366|NCT02252081|50247718|FG000|Overall Study|non compliance & others|0|||
25134367|NCT02252081|50247719|FG001|Overall Study|non compliance & others|2|||
25134368|NCT01623752|50247733|FG000|Phase 1 (78 Weeks)|No Data|249|||
25134369|NCT01623752|50247734|FG001|Phase 1 (78 Weeks)|No Data|66|||
25134370|NCT01623752|50247735|FG002|Phase 1 (78 Weeks)|No Data|2|||
25134371|NCT01623752|50247733|FG000|Phase 1 (78 Weeks)|Other|33|||
25134372|NCT01623752|50247734|FG001|Phase 1 (78 Weeks)|Other|20|||
25134373|NCT01623752|50247735|FG002|Phase 1 (78 Weeks)|Other|0|||
25134374|NCT01623752|50247733|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
25134375|NCT01623752|50247734|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
25134376|NCT01623752|50247735|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
25134377|NCT01623752|50247733|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
25134378|NCT01623752|50247734|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
25134379|NCT01623752|50247735|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
25134380|NCT01623752|50247733|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
25134381|NCT01623752|50247734|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
25009464|NCT02953782|50102349|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
25009465|NCT02953782|50102350|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
25134382|NCT01623752|50247735|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
25009466|NCT02953782|50102351|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
25134383|NCT01623752|50247733|FG000|Phase 2 (78 Weeks)|Other|5|||
25134384|NCT01623752|50247734|FG001|Phase 2 (78 Weeks)|Other|1|||
25134385|NCT01623752|50247735|FG002|Phase 2 (78 Weeks)|Other|0|||
25134386|NCT01623752|50247733|FG000|Phase 2 (78 Weeks)|No Data|43|||
25134387|NCT01623752|50247734|FG001|Phase 2 (78 Weeks)|No Data|11|||
25134388|NCT01623752|50247735|FG002|Phase 2 (78 Weeks)|No Data|0|||
25134389|NCT01623752|50247733|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
25134390|NCT01623752|50247734|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
25134391|NCT01623752|50247735|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
25134392|NCT01623596|50247746|FG000|Overall Study|Abnormal laboratory values|2|||
25134393|NCT01623596|50247747|FG001|Overall Study|Abnormal laboratory values|0|||
25134394|NCT01623596|50247746|FG000|Overall Study|Administrative problems|9|||
25134395|NCT01623596|50247747|FG001|Overall Study|Administrative problems|13|||
25134396|NCT01623596|50247746|FG000|Overall Study|Adverse Event|20|||
25134397|NCT01623596|50247747|FG001|Overall Study|Adverse Event|29|||
25134398|NCT01623596|50247746|FG000|Overall Study|Death|0|||
25134399|NCT01623596|50247747|FG001|Overall Study|Death|2|||
25134400|NCT01623596|50247746|FG000|Overall Study|Lost to Follow-up|12|||
25134401|NCT01623596|50247747|FG001|Overall Study|Lost to Follow-up|16|||
25134402|NCT01623596|50247746|FG000|Overall Study|Withdrawal by Subject|13|||
25134403|NCT01623596|50247747|FG001|Overall Study|Withdrawal by Subject|31|||
25134404|NCT01623596|50247746|FG000|Overall Study|Patient no longer requires study drug|1|||
25134405|NCT01623596|50247747|FG001|Overall Study|Patient no longer requires study drug|0|||
25134406|NCT01623596|50247746|FG000|Overall Study|Protocol Violation|0|||
25134407|NCT01623596|50247747|FG001|Overall Study|Protocol Violation|6|||
25134408|NCT01623596|50247746|FG000|Overall Study|Lack of Efficacy|5|||
25134409|NCT01623596|50247747|FG001|Overall Study|Lack of Efficacy|3|||
25134410|NCT02219477|50247758|FG000|Overall Study|Adverse Event|0|||
25134411|NCT02219477|50247759|FG001|Overall Study|Adverse Event|1|||
25134412|NCT02219477|50247760|FG002|Overall Study|Adverse Event|1|||
25134413|NCT02219477|50247758|FG000|Overall Study|Withdrawal by Subject|0|||
25134414|NCT02219477|50247759|FG001|Overall Study|Withdrawal by Subject|1|||
25134415|NCT02219477|50247760|FG002|Overall Study|Withdrawal by Subject|0|||
25134416|NCT02119286|50247772|FG000|Overall Study|Adverse Event|9|||
25009467|NCT02953782|50102344|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
25009468|NCT02953782|50102345|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
25009469|NCT02953782|50102346|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
25009470|NCT02953782|50102347|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
25009471|NCT02953782|50102348|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
25009472|NCT02953782|50102349|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
25009473|NCT02953782|50102350|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
25009474|NCT02953782|50102351|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
25009475|NCT03760081|50102374|FG000|Overall Study|Miscellaneous|0|||
25009476|NCT03760081|50102375|FG001|Overall Study|Miscellaneous|1|||
25009477|NCT03760081|50102374|FG000|Overall Study|Progressive Disease|5|||
25009478|NCT03760081|50102375|FG001|Overall Study|Progressive Disease|10|||
25134417|NCT02119286|50247773|FG001|Overall Study|Adverse Event|7|||
25134418|NCT02119286|50247774|FG002|Overall Study|Adverse Event|2|||
25134419|NCT02119286|50247772|FG000|Overall Study|Lack of Efficacy|11|||
25134420|NCT02119286|50247773|FG001|Overall Study|Lack of Efficacy|3|||
25134421|NCT02119286|50247774|FG002|Overall Study|Lack of Efficacy|4|||
25134422|NCT02119286|50247772|FG000|Overall Study|Lost to Follow-up|2|||
25134423|NCT02119286|50247773|FG001|Overall Study|Lost to Follow-up|0|||
25134424|NCT02119286|50247774|FG002|Overall Study|Lost to Follow-up|1|||
25273394|NCT01259492|50587531|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
25273395|NCT01259492|50587532|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
25273396|NCT01259492|50587533|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
25273397|NCT01259492|50587530|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
25273398|NCT01259492|50587531|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
25273399|NCT01259492|50587532|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
25273400|NCT01259492|50587533|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
25273401|NCT01259492|50587530|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
25273402|NCT01259492|50587531|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
25273403|NCT01259492|50587532|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
25134425|NCT02119286|50247772|FG000|Overall Study|Withdrawal by Subject|4|||
25134426|NCT02119286|50247773|FG001|Overall Study|Withdrawal by Subject|1|||
25134427|NCT02119286|50247774|FG002|Overall Study|Withdrawal by Subject|0|||
25009479|NCT03760081|50102374|FG000|Overall Study|Death|1|||
25134428|NCT02250443|50247782|FG000|Overall Study|Administrative problems|7|||
25134429|NCT02250443|50247782|FG000|Overall Study|Adverse Event|3|||
25134430|NCT02093390|50247788|FG000|Overall Study|Withdrawal by Subject|0|||
25134431|NCT02093390|50247789|FG001|Overall Study|Withdrawal by Subject|1|||
25134432|NCT02194985|50247796|FG000|Overall Study|Adverse Event|1|||
25134433|NCT02194985|50247796|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
25134434|NCT02194985|50247796|FG000|Overall Study|Physician Decision|4|||
25134435|NCT02194985|50247796|FG000|Overall Study|Lost to Follow-up|1|||
25134436|NCT02194985|50247796|FG000|Overall Study|Withdrawal by Subject|2|||
25134437|NCT02219087|50247802|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
25134438|NCT02219087|50247803|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
25134439|NCT02248961|50247811|FG000|Overall Study|Adverse Event|1|||
25134440|NCT02248961|50247812|FG001|Overall Study|Adverse Event|0|||
25134441|NCT02248961|50247811|FG000|Overall Study|Withdrawal by Subject|1|||
25134442|NCT02248961|50247812|FG001|Overall Study|Withdrawal by Subject|2|||
25134443|NCT02248961|50247811|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
25134444|NCT02248961|50247812|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
25134445|NCT02219009|50247820|FG000|Overall Study|Withdrawal by Subject|5|||
25134446|NCT02219009|50247821|FG001|Overall Study|Withdrawal by Subject|1|||
25134447|NCT02219009|50247820|FG000|Overall Study|Adverse Event|2|||
25134448|NCT02219009|50247821|FG001|Overall Study|Adverse Event|4|||
25134449|NCT02219009|50247820|FG000|Overall Study|Lost to Follow-up|2|||
25134450|NCT02219009|50247821|FG001|Overall Study|Lost to Follow-up|2|||
25134451|NCT02219009|50247820|FG000|Overall Study|Protocol deviation|1|||
25134452|NCT02219009|50247821|FG001|Overall Study|Protocol deviation|0|||
25134453|NCT02219009|50247820|FG000|Overall Study|Physician Decision|0|||
25134454|NCT02219009|50247821|FG001|Overall Study|Physician Decision|1|||
25134455|NCT02248649|50247829|FG000|Overall Study|Death|7|||
25134456|NCT02248649|50247830|FG001|Overall Study|Death|11|||
25134457|NCT02248649|50247829|FG000|Overall Study|Lost to Follow-up|14|||
25134458|NCT02248649|50247830|FG001|Overall Study|Lost to Follow-up|10|||
25134459|NCT02218541|50247838|FG000|Overall Study|Lost to Follow-up|2|||
25134460|NCT02218541|50247839|FG001|Overall Study|Lost to Follow-up|1|||
25134461|NCT02218541|50247838|FG000|Overall Study|Implant Failure|4|||
25134462|NCT02218541|50247839|FG001|Overall Study|Implant Failure|1|||
25134463|NCT02217527|50247848|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
25134464|NCT02217527|50247849|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
25134465|NCT02217527|50247848|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
25134466|NCT02217527|50247849|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
25134467|NCT01456936|50247859|FG000|Overall Study|Other reason|41|||
25134468|NCT01456936|50247860|FG001|Overall Study|Other reason|30|||
25134469|NCT01456936|50247861|FG002|Overall Study|Other reason|36|||
25134470|NCT01456936|50247862|FG003|Overall Study|Other reason|33|||
25134471|NCT01456936|50247859|FG000|Overall Study|No longer meets eligibility criteria|4|||
25134472|NCT01456936|50247860|FG001|Overall Study|No longer meets eligibility criteria|8|||
25134473|NCT01456936|50247861|FG002|Overall Study|No longer meets eligibility criteria|6|||
25134474|NCT01456936|50247862|FG003|Overall Study|No longer meets eligibility criteria|5|||
25134475|NCT01456936|50247859|FG000|Overall Study|Protocol Violation|4|||
25134476|NCT01456936|50247860|FG001|Overall Study|Protocol Violation|2|||
25134477|NCT01456936|50247861|FG002|Overall Study|Protocol Violation|5|||
25134478|NCT01456936|50247862|FG003|Overall Study|Protocol Violation|5|||
25273404|NCT01259492|50587533|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
25273405|NCT01259492|50587530|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
25273406|NCT01259492|50587531|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
25273407|NCT01259492|50587532|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
25273408|NCT01259492|50587533|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
25273409|NCT01259492|50587530|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
25273410|NCT01259492|50587531|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
25273411|NCT01259492|50587532|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
25273412|NCT01259492|50587533|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
25009480|NCT03760081|50102375|FG001|Overall Study|Death|1|||
25134479|NCT01456936|50247859|FG000|Overall Study|Pregnancy|1|||
25134480|NCT01456936|50247860|FG001|Overall Study|Pregnancy|0|||
25134481|NCT01456936|50247861|FG002|Overall Study|Pregnancy|0|||
25134482|NCT01456936|50247862|FG003|Overall Study|Pregnancy|1|||
25134483|NCT01456936|50247859|FG000|Overall Study|Insufficient clinical response|4|||
25134484|NCT01456936|50247860|FG001|Overall Study|Insufficient clinical response|4|||
25134485|NCT01456936|50247861|FG002|Overall Study|Insufficient clinical response|14|||
25134486|NCT01456936|50247862|FG003|Overall Study|Insufficient clinical response|13|||
25273413|NCT01259492|50587530|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
25134487|NCT01456936|50247859|FG000|Overall Study|No longer willing to participate|195|||
25134488|NCT01456936|50247860|FG001|Overall Study|No longer willing to participate|218|||
25134489|NCT01456936|50247861|FG002|Overall Study|No longer willing to participate|224|||
25134490|NCT01456936|50247862|FG003|Overall Study|No longer willing to participate|248|||
25134491|NCT01456936|50247859|FG000|Overall Study|Lost to Follow-up|135|||
25134492|NCT01456936|50247860|FG001|Overall Study|Lost to Follow-up|126|||
25134493|NCT01456936|50247861|FG002|Overall Study|Lost to Follow-up|144|||
25134494|NCT01456936|50247862|FG003|Overall Study|Lost to Follow-up|127|||
25134495|NCT01456936|50247859|FG000|Overall Study|Medication error|0|||
25134496|NCT01456936|50247860|FG001|Overall Study|Medication error|1|||
25134497|NCT01456936|50247861|FG002|Overall Study|Medication error|0|||
25134498|NCT01456936|50247862|FG003|Overall Study|Medication error|1|||
25134499|NCT01456936|50247859|FG000|Overall Study|Adverse event (study drug)|25|||
25134500|NCT01456936|50247860|FG001|Overall Study|Adverse event (study drug)|21|||
25134501|NCT01456936|50247861|FG002|Overall Study|Adverse event (study drug)|26|||
25134502|NCT01456936|50247862|FG003|Overall Study|Adverse event (study drug)|17|||
25134503|NCT01456936|50247859|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
25134504|NCT01456936|50247860|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
25134505|NCT01456936|50247861|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
25134506|NCT01456936|50247862|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
25134507|NCT01456936|50247859|FG000|Overall Study|Death|0|||
25134508|NCT01456936|50247860|FG001|Overall Study|Death|3|||
25134509|NCT01456936|50247861|FG002|Overall Study|Death|1|||
25134510|NCT01456936|50247862|FG003|Overall Study|Death|3|||
25134511|NCT01456936|50247859|FG000|Overall Study|Randomized but not treated|21|||
25134512|NCT01456936|50247860|FG001|Overall Study|Randomized but not treated|28|||
25134513|NCT01456936|50247861|FG002|Overall Study|Randomized but not treated|16|||
25134514|NCT01456936|50247862|FG003|Overall Study|Randomized but not treated|21|||
25134515|NCT01456780|50247875|FG000|Overall Study|Lost to Follow-up|3|||
25134516|NCT01456780|50247876|FG001|Overall Study|Lost to Follow-up|3|||
25134517|NCT01456780|50247877|FG002|Overall Study|Lost to Follow-up|0|||
25134518|NCT01480258|50247887|FG000|Infant Series|Protocol Violation|2|||
25134519|NCT01480258|50247888|FG001|Infant Series|Protocol Violation|0|||
25134520|NCT01480258|50247887|FG000|Infant Series|Physician Decision|0|||
25134521|NCT01480258|50247888|FG001|Infant Series|Physician Decision|1|||
25134522|NCT01480258|50247887|FG000|Infant Series|Not Vaccinated|3|||
25134523|NCT01480258|50247888|FG001|Infant Series|Not Vaccinated|0|||
25134524|NCT01480258|50247887|FG000|Infant Series|Adverse Event|1|||
25134525|NCT01480258|50247888|FG001|Infant Series|Adverse Event|1|||
25134526|NCT01480258|50247887|FG000|Infant Series|Withdrawal by Subject|1|||
25134527|NCT01480258|50247888|FG001|Infant Series|Withdrawal by Subject|6|||
25134528|NCT01480258|50247887|FG000|Interim Period|Lost to Follow-up|0|||
25134529|NCT01480258|50247888|FG001|Interim Period|Lost to Follow-up|2|||
25134530|NCT01480258|50247887|FG000|Interim Period|Physician Decision|1|||
25134531|NCT01480258|50247888|FG001|Interim Period|Physician Decision|0|||
25134532|NCT01480258|50247887|FG000|Interim Period|Protocol Violation|0|||
25134533|NCT01480258|50247888|FG001|Interim Period|Protocol Violation|1|||
25134534|NCT01480258|50247887|FG000|Interim Period|Withdrawal by Subject|9|||
25134535|NCT01480258|50247888|FG001|Interim Period|Withdrawal by Subject|6|||
25134536|NCT01479868|50247894|FG000|Overall Study|Adverse Event|1|||
25134537|NCT01479868|50247894|FG000|Overall Study|Lost to Follow-up|4|||
25134538|NCT01479868|50247894|FG000|Overall Study|Protocol Violation|1|||
25134539|NCT01479868|50247894|FG000|Overall Study|Withdrawal by Subject|1|||
25134540|NCT01479868|50247894|FG000|Overall Study|Sponsor's Decision|1|||
25134541|NCT01479868|50247894|FG000|Overall Study|Initiation of new HCV Therapy|1|||
25134542|NCT01478620|50247898|FG000|Overall Study|Lost to Follow-up|6|||
25134543|NCT01455220|50247902|FG000|Overall Study|screen fail|30|||
25134544|NCT01454830|50247911|FG000|Overall Study|Withdrawal by Subject|4|||
25134545|NCT01454830|50247912|FG001|Overall Study|Withdrawal by Subject|4|||
25134546|NCT01454830|50247911|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
25134547|NCT01454830|50247912|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
25134548|NCT01454830|50247911|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
25134549|NCT01454830|50247912|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
25134550|NCT01454830|50247911|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
25134551|NCT01454830|50247912|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
25134552|NCT01454830|50247911|FG000|Overall Study|Withdrawal - no polysomnography|3|||
25134553|NCT01454830|50247912|FG001|Overall Study|Withdrawal - no polysomnography|2|||
25134554|NCT01454596|50247930|FG000|Overall Study|Death|0|||
25273414|NCT01259492|50587531|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
25134555|NCT01454596|50247931|FG001|Overall Study|Death|0|||
25134556|NCT01454596|50247932|FG002|Overall Study|Death|0|||
25134557|NCT01454596|50247933|FG003|Overall Study|Death|0|||
25134558|NCT01454596|50247934|FG004|Overall Study|Death|0|||
25134559|NCT01454596|50247935|FG005|Overall Study|Death|0|||
25134560|NCT01454596|50247936|FG006|Overall Study|Death|0|||
25134561|NCT01454596|50247937|FG007|Overall Study|Death|0|||
25134562|NCT01454596|50247938|FG008|Overall Study|Death|0|||
25134563|NCT01454596|50247939|FG009|Overall Study|Death|1|||
25134564|NCT01454596|50247940|FG010|Overall Study|Death|1|||
25134565|NCT01454596|50247941|FG011|Overall Study|Death|0|||
25134566|NCT02247479|50247970|FG000|Overall Study|Adverse Event|8|||
25134567|NCT02247479|50247971|FG001|Overall Study|Adverse Event|9|||
25134568|NCT02247479|50247972|FG002|Overall Study|Adverse Event|8|||
25134569|NCT02247479|50247970|FG000|Overall Study|Death|5|||
25134570|NCT02247479|50247971|FG001|Overall Study|Death|4|||
25134571|NCT02247479|50247972|FG002|Overall Study|Death|6|||
25134572|NCT02247479|50247970|FG000|Overall Study|Lost to Follow-up|3|||
25134573|NCT02247479|50247971|FG001|Overall Study|Lost to Follow-up|3|||
25134574|NCT02247479|50247972|FG002|Overall Study|Lost to Follow-up|1|||
25134575|NCT02247479|50247970|FG000|Overall Study|Non-compliance|0|||
25134576|NCT02247479|50247971|FG001|Overall Study|Non-compliance|0|||
25134577|NCT02247479|50247972|FG002|Overall Study|Non-compliance|1|||
25134578|NCT02247479|50247970|FG000|Overall Study|Withdrawal by Subject|25|||
25134579|NCT02247479|50247971|FG001|Overall Study|Withdrawal by Subject|29|||
25134580|NCT02247479|50247972|FG002|Overall Study|Withdrawal by Subject|24|||
25134581|NCT02247479|50247970|FG000|Overall Study|Study Terminated by Sponsor|98|||
25134582|NCT02247479|50247971|FG001|Overall Study|Study Terminated by Sponsor|88|||
25134583|NCT02247479|50247972|FG002|Overall Study|Study Terminated by Sponsor|94|||
25134584|NCT02247479|50247970|FG000|Overall Study|Physician Decision|1|||
25134585|NCT02247479|50247971|FG001|Overall Study|Physician Decision|0|||
25134586|NCT02247479|50247972|FG002|Overall Study|Physician Decision|2|||
25134587|NCT02247479|50247970|FG000|Overall Study|Unspecified Reason|2|||
25134588|NCT02247479|50247971|FG001|Overall Study|Unspecified Reason|5|||
25134589|NCT02247479|50247972|FG002|Overall Study|Unspecified Reason|2|||
25134590|NCT01454284|50247982|FG000|Overall Study|Adverse Event|20|||
25134591|NCT01454284|50247983|FG001|Overall Study|Adverse Event|7|||
25134592|NCT01454284|50247982|FG000|Overall Study|Death|0|||
25134593|NCT01454284|50247983|FG001|Overall Study|Death|3|||
25134594|NCT01454284|50247982|FG000|Overall Study|Lost to Follow-up|13|||
25134595|NCT01454284|50247983|FG001|Overall Study|Lost to Follow-up|8|||
25134596|NCT01454284|50247982|FG000|Overall Study|Protocol Violation|9|||
25134597|NCT01454284|50247983|FG001|Overall Study|Protocol Violation|6|||
25134598|NCT01454284|50247982|FG000|Overall Study|Withdrawal by Subject|58|||
25134599|NCT01454284|50247983|FG001|Overall Study|Withdrawal by Subject|36|||
25134600|NCT01454284|50247982|FG000|Overall Study|Physician Decision|16|||
25134601|NCT01454284|50247983|FG001|Overall Study|Physician Decision|11|||
25134602|NCT01454284|50247982|FG000|Overall Study|Sponsor Decision|0|||
25134603|NCT01454284|50247983|FG001|Overall Study|Sponsor Decision|2|||
25134604|NCT02247401|50247992|FG000|Overall Study|Adverse Event|1|||
25134605|NCT02247401|50247993|FG001|Overall Study|Adverse Event|0|||
25134606|NCT02247401|50247994|FG002|Overall Study|Adverse Event|0|||
25134607|NCT02247401|50247992|FG000|Overall Study|Withdrawal by Subject|4|||
25134608|NCT02247401|50247993|FG001|Overall Study|Withdrawal by Subject|1|||
25134609|NCT02247401|50247994|FG002|Overall Study|Withdrawal by Subject|1|||
25134610|NCT02247401|50247992|FG000|Overall Study|Lost to Follow-up|1|||
25134611|NCT02247401|50247993|FG001|Overall Study|Lost to Follow-up|1|||
25134612|NCT02247401|50247994|FG002|Overall Study|Lost to Follow-up|1|||
25134613|NCT02247011|50248005|FG000|Overall Study|Poor quality of radiological results|125|||
25134614|NCT02246777|50248012|FG000|Overall Study|Adverse Event|2|||
25134615|NCT02246777|50248012|FG000|Overall Study|Change of residence|1|||
25134616|NCT01495702|50248023|FG000|Randomized Phase|Randomized But Not Treated|1|||
25134617|NCT01495702|50248024|FG001|Randomized Phase|Randomized But Not Treated|4|||
25134618|NCT01495702|50248023|FG000|Randomized Phase|Adverse Event|2|||
25134619|NCT01495702|50248024|FG001|Randomized Phase|Adverse Event|2|||
25134620|NCT01495702|50248023|FG000|Randomized Phase|Death|1|||
25134621|NCT01495702|50248024|FG001|Randomized Phase|Death|0|||
25134622|NCT01495702|50248023|FG000|Randomized Phase|Lack of Efficacy|2|||
25134623|NCT01495702|50248024|FG001|Randomized Phase|Lack of Efficacy|0|||
25134624|NCT01495702|50248023|FG000|Randomized Phase|Investigators Discretion|2|||
25134625|NCT01495702|50248024|FG001|Randomized Phase|Investigators Discretion|0|||
25134626|NCT01495702|50248023|FG000|Randomized Phase|Withdrew Consent|10|||
25134627|NCT01495702|50248024|FG001|Randomized Phase|Withdrew Consent|18|||
25134628|NCT01495702|50248023|FG000|Randomized Phase|Lost to Follow-up|4|||
25134629|NCT01495702|50248024|FG001|Randomized Phase|Lost to Follow-up|3|||
25134630|NCT01495702|50248023|FG000|Randomized Phase|Participant Noncompliance|1|||
25134631|NCT01495702|50248024|FG001|Randomized Phase|Participant Noncompliance|0|||
25134632|NCT01495702|50248023|FG000|Randomized Phase|Protocol Violation|3|||
25134633|NCT01495702|50248024|FG001|Randomized Phase|Protocol Violation|1|||
25134634|NCT01630889|50248031|FG000|Overall Study|Death|2|||
25134635|NCT01630889|50248031|FG000|Overall Study|Withdrawal by Subject|1|||
25134636|NCT01630889|50248031|FG000|Overall Study|Other than Specified|2|||
25134637|NCT01630889|50248031|FG000|Overall Study|Lost to Follow-up|4|||
25134638|NCT01630889|50248031|FG000|Overall Study|Other|1|||
25134639|NCT01495000|50248037|FG000|Overall Study|Lost to Follow-up|2|||
25134640|NCT01495000|50248038|FG001|Overall Study|Lost to Follow-up|2|||
25134641|NCT01495000|50248037|FG000|Overall Study|Protocol Violation|1|||
25134642|NCT01495000|50248038|FG001|Overall Study|Protocol Violation|0|||
25134643|NCT01495000|50248037|FG000|Overall Study|Withdrawal by Subject|10|||
25134644|NCT01495000|50248038|FG001|Overall Study|Withdrawal by Subject|10|||
25134645|NCT01494922|50248044|FG000|Overall Study|Adverse Event|1|||
25134646|NCT02192099|50248048|FG000|Overall Study|Adverse Event|1|||
25134647|NCT02192099|50248048|FG000|Overall Study|Lost to Follow-up|2|||
25134648|NCT02192099|50248048|FG000|Overall Study|Physician Decision|1|||
25134649|NCT02192099|50248048|FG000|Overall Study|Pregnancy|1|||
25134650|NCT02192099|50248048|FG000|Overall Study|Protocol Violation|8|||
25134651|NCT02192099|50248048|FG000|Overall Study|Study Terminated by Sponsor|32|||
25134652|NCT02192099|50248048|FG000|Overall Study|Withdrawal by Subject|11|||
25134653|NCT02192099|50248048|FG000|Overall Study|Miscellaneous Reasons|5|||
25134654|NCT01494610|50248052|FG000|Period 1|Withdrawal by Subject|1|||
25134655|NCT01494610|50248053|FG001|Period 1|Withdrawal by Subject|1|||
25134656|NCT01494610|50248052|FG000|Period 3|Adverse Event|1|||
25134657|NCT01494610|50248053|FG001|Period 3|Adverse Event|0|||
25134658|NCT01494610|50248052|FG000|Period 3|Withdrawal by Subject|1|||
25134659|NCT01494610|50248053|FG001|Period 3|Withdrawal by Subject|0|||
25134660|NCT01494610|50248052|FG000|Period 4|Protocol Violation|1|||
25134661|NCT01494610|50248053|FG001|Period 4|Protocol Violation|0|||
25134662|NCT02116777|50248072|FG000|Overall Study|Adverse Event|0|||
25134663|NCT02116777|50248073|FG001|Overall Study|Adverse Event|0|||
25134664|NCT02116777|50248074|FG002|Overall Study|Adverse Event|0|||
25134665|NCT02116777|50248075|FG003|Overall Study|Adverse Event|0|||
25134666|NCT02116777|50248076|FG004|Overall Study|Adverse Event|2|||
25134667|NCT02116777|50248077|FG005|Overall Study|Adverse Event|2|||
25134668|NCT02116777|50248078|FG006|Overall Study|Adverse Event|0|||
25134669|NCT02116777|50248072|FG000|Overall Study|Death|0|||
25134670|NCT02116777|50248073|FG001|Overall Study|Death|0|||
25134671|NCT02116777|50248074|FG002|Overall Study|Death|0|||
25134672|NCT02116777|50248075|FG003|Overall Study|Death|1|||
25134673|NCT02116777|50248076|FG004|Overall Study|Death|0|||
25134674|NCT02116777|50248077|FG005|Overall Study|Death|0|||
25134675|NCT02116777|50248078|FG006|Overall Study|Death|0|||
25134676|NCT02116777|50248072|FG000|Overall Study|Lack of Efficacy|3|||
25134677|NCT02116777|50248073|FG001|Overall Study|Lack of Efficacy|3|||
25134678|NCT02116777|50248074|FG002|Overall Study|Lack of Efficacy|3|||
25134679|NCT02116777|50248075|FG003|Overall Study|Lack of Efficacy|8|||
25134680|NCT02116777|50248076|FG004|Overall Study|Lack of Efficacy|4|||
25134681|NCT02116777|50248077|FG005|Overall Study|Lack of Efficacy|1|||
25134682|NCT02116777|50248078|FG006|Overall Study|Lack of Efficacy|9|||
25134683|NCT02116777|50248072|FG000|Overall Study|Physician Decision|0|||
25134684|NCT02116777|50248073|FG001|Overall Study|Physician Decision|0|||
25134685|NCT02116777|50248074|FG002|Overall Study|Physician Decision|0|||
25134686|NCT02116777|50248075|FG003|Overall Study|Physician Decision|2|||
25134687|NCT02116777|50248076|FG004|Overall Study|Physician Decision|0|||
25134688|NCT02116777|50248077|FG005|Overall Study|Physician Decision|0|||
25134689|NCT02116777|50248078|FG006|Overall Study|Physician Decision|0|||
25134690|NCT02116777|50248072|FG000|Overall Study|Protocol Violation|0|||
25134691|NCT02116777|50248073|FG001|Overall Study|Protocol Violation|0|||
25134692|NCT02116777|50248074|FG002|Overall Study|Protocol Violation|0|||
25134693|NCT02116777|50248075|FG003|Overall Study|Protocol Violation|1|||
25134694|NCT02116777|50248076|FG004|Overall Study|Protocol Violation|0|||
25134695|NCT02116777|50248077|FG005|Overall Study|Protocol Violation|0|||
25134696|NCT02116777|50248078|FG006|Overall Study|Protocol Violation|0|||
25134697|NCT02116777|50248072|FG000|Overall Study|Withdrawal by Subject|0|||
25134698|NCT02116777|50248073|FG001|Overall Study|Withdrawal by Subject|0|||
25134699|NCT02116777|50248074|FG002|Overall Study|Withdrawal by Subject|0|||
25134700|NCT02116777|50248075|FG003|Overall Study|Withdrawal by Subject|1|||
25134701|NCT02116777|50248076|FG004|Overall Study|Withdrawal by Subject|0|||
25134702|NCT02116777|50248077|FG005|Overall Study|Withdrawal by Subject|0|||
25134703|NCT02116777|50248078|FG006|Overall Study|Withdrawal by Subject|0|||
25134704|NCT01494532|50248103|FG000|Overall Study|Adverse Event|4|||
25134705|NCT01494532|50248104|FG001|Overall Study|Adverse Event|1|||
25134706|NCT01494532|50248105|FG002|Overall Study|Adverse Event|8|||
25134707|NCT01494532|50248106|FG003|Overall Study|Adverse Event|6|||
25273415|NCT01259492|50587532|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
25134708|NCT01494532|50248107|FG004|Overall Study|Adverse Event|5|||
25134709|NCT01494532|50248108|FG005|Overall Study|Adverse Event|0|||
25134710|NCT01494532|50248103|FG000|Overall Study|Lack of Efficacy|0|||
25134711|NCT01494532|50248104|FG001|Overall Study|Lack of Efficacy|0|||
25134712|NCT01494532|50248105|FG002|Overall Study|Lack of Efficacy|0|||
25134713|NCT01494532|50248106|FG003|Overall Study|Lack of Efficacy|0|||
25273416|NCT01259492|50587533|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
25134714|NCT01494532|50248107|FG004|Overall Study|Lack of Efficacy|2|||
25134715|NCT01494532|50248108|FG005|Overall Study|Lack of Efficacy|0|||
25134716|NCT01494532|50248103|FG000|Overall Study|Protocol deviation|2|||
25134717|NCT01494532|50248104|FG001|Overall Study|Protocol deviation|1|||
25134718|NCT01494532|50248105|FG002|Overall Study|Protocol deviation|3|||
25134719|NCT01494532|50248106|FG003|Overall Study|Protocol deviation|2|||
25134720|NCT01494532|50248107|FG004|Overall Study|Protocol deviation|3|||
25134721|NCT01494532|50248108|FG005|Overall Study|Protocol deviation|0|||
25134722|NCT01494532|50248103|FG000|Overall Study|Protocol-defined stopping criteria|0|||
25134723|NCT01494532|50248104|FG001|Overall Study|Protocol-defined stopping criteria|0|||
25134724|NCT01494532|50248105|FG002|Overall Study|Protocol-defined stopping criteria|1|||
25134725|NCT01494532|50248106|FG003|Overall Study|Protocol-defined stopping criteria|0|||
25134726|NCT01494532|50248107|FG004|Overall Study|Protocol-defined stopping criteria|0|||
25134727|NCT01494532|50248108|FG005|Overall Study|Protocol-defined stopping criteria|0|||
25134728|NCT01494532|50248103|FG000|Overall Study|Lost to Follow-up|1|||
25134729|NCT01494532|50248104|FG001|Overall Study|Lost to Follow-up|0|||
25134730|NCT01494532|50248105|FG002|Overall Study|Lost to Follow-up|0|||
25134731|NCT01494532|50248106|FG003|Overall Study|Lost to Follow-up|2|||
25134732|NCT01494532|50248107|FG004|Overall Study|Lost to Follow-up|0|||
25134733|NCT01494532|50248108|FG005|Overall Study|Lost to Follow-up|0|||
25134734|NCT01494532|50248103|FG000|Overall Study|Physician Decision|0|||
25134735|NCT01494532|50248104|FG001|Overall Study|Physician Decision|1|||
25134736|NCT01494532|50248105|FG002|Overall Study|Physician Decision|1|||
25134737|NCT01494532|50248106|FG003|Overall Study|Physician Decision|2|||
25134738|NCT01494532|50248107|FG004|Overall Study|Physician Decision|0|||
25134739|NCT01494532|50248108|FG005|Overall Study|Physician Decision|0|||
25134740|NCT01494532|50248103|FG000|Overall Study|Withdrawal by Subject|3|||
25134741|NCT01494532|50248104|FG001|Overall Study|Withdrawal by Subject|1|||
25134742|NCT01494532|50248105|FG002|Overall Study|Withdrawal by Subject|4|||
25134743|NCT01494532|50248106|FG003|Overall Study|Withdrawal by Subject|3|||
25134744|NCT01494532|50248107|FG004|Overall Study|Withdrawal by Subject|2|||
25134745|NCT01494532|50248108|FG005|Overall Study|Withdrawal by Subject|0|||
25134746|NCT02191397|50248125|FG000|Overall Study|Adverse Event|28|||
25273417|NCT01259492|50587530|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
25273418|NCT01259492|50587531|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
25273419|NCT01259492|50587532|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
25273420|NCT01259492|50587533|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
25273421|NCT01259492|50587530|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
25273422|NCT01259492|50587531|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
25273423|NCT01259492|50587532|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
25273424|NCT01259492|50587533|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
25273425|NCT01259492|50587530|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
25273426|NCT01259492|50587531|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
25273427|NCT01259492|50587532|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
25273428|NCT01259492|50587533|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
25273429|NCT01259492|50587530|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
25273430|NCT01259492|50587531|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
25273431|NCT01259492|50587532|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
25273432|NCT01259492|50587533|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
25273433|NCT01259492|50587530|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
25273434|NCT01259492|50587531|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
25273435|NCT01259492|50587532|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
25273436|NCT01259492|50587533|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
25273437|NCT01259492|50587530|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
25273438|NCT01259492|50587531|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
25273439|NCT01259492|50587532|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
25273440|NCT01259492|50587533|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
25273441|NCT01259492|50587530|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
25178827|NCT01506271|50324163|FG000|Overall Study|Progressive disease|0|||
25134747|NCT02191397|50248126|FG001|Overall Study|Adverse Event|17|||
25134748|NCT02191397|50248125|FG000|Overall Study|Lack of Efficacy|10|||
25134749|NCT02191397|50248126|FG001|Overall Study|Lack of Efficacy|5|||
25134750|NCT02191397|50248125|FG000|Overall Study|Protocol Violation|0|||
25134751|NCT02191397|50248126|FG001|Overall Study|Protocol Violation|3|||
25134752|NCT02191397|50248125|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
25134753|NCT02191397|50248126|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
25134754|NCT02191397|50248125|FG000|Overall Study|Lost to Follow-up|10|||
25134755|NCT02191397|50248126|FG001|Overall Study|Lost to Follow-up|11|||
25134756|NCT02191397|50248125|FG000|Overall Study|Physician Decision|8|||
25134757|NCT02191397|50248126|FG001|Overall Study|Physician Decision|3|||
25134758|NCT02191397|50248125|FG000|Overall Study|Withdrawal by Subject|22|||
25134759|NCT02191397|50248126|FG001|Overall Study|Withdrawal by Subject|27|||
25134760|NCT01630811|50248132|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
25134761|NCT01630811|50248133|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
25134762|NCT01494298|50248143|FG000|Overall Study|Protocol Violation|2|||
25134763|NCT01494298|50248144|FG001|Overall Study|Protocol Violation|8|||
25134764|NCT02170025|50248154|FG000|Overall Study|Adverse Event|2|||
25134765|NCT02170025|50248155|FG001|Overall Study|Adverse Event|0|||
25134766|NCT02169791|50248161|FG000|Overall Study|Death|6|||
25134767|NCT02169791|50248161|FG000|Overall Study|patient withdrew consent|1|||
25134768|NCT02216591|50248167|FG000|Overall Study|Lost to Follow-up|0|||
25134769|NCT02216591|50248168|FG001|Overall Study|Lost to Follow-up|1|||
25134770|NCT02216357|50248176|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
25134771|NCT02216357|50248177|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
25134772|NCT01492426|50248185|FG000|Treatment|Death|0|||
25134773|NCT01492426|50248186|FG001|Treatment|Death|1|||
25134774|NCT01492426|50248185|FG000|Treatment|Other|1|||
25134775|NCT01492426|50248186|FG001|Treatment|Other|0|||
25134776|NCT01492426|50248185|FG000|Treatment|Adverse Event|25|||
25134777|NCT01492426|50248186|FG001|Treatment|Adverse Event|25|||
25134778|NCT01492426|50248185|FG000|Treatment|Lack of Efficacy|38|||
25134779|NCT01492426|50248186|FG001|Treatment|Lack of Efficacy|5|||
25134780|NCT01492426|50248185|FG000|Treatment|Participant withdrew consent|1|||
25134781|NCT01492426|50248186|FG001|Treatment|Participant withdrew consent|2|||
25134782|NCT01492426|50248185|FG000|Treatment|Poor compliance/noncompliance|1|||
25134783|NCT01492426|50248186|FG001|Treatment|Poor compliance/noncompliance|0|||
25134784|NCT01492426|50248185|FG000|Treatment|Subject requested discontinue study drug|7|||
25134785|NCT01492426|50248186|FG001|Treatment|Subject requested discontinue study drug|3|||
25134786|NCT01492426|50248185|FG000|Treatment|Lost to Follow-up|9|||
25134787|NCT01492426|50248186|FG001|Treatment|Lost to Follow-up|4|||
25134788|NCT01492426|50248185|FG000|Treatment|Participant does not meet study criteria|1|||
25134789|NCT01492426|50248186|FG001|Treatment|Participant does not meet study criteria|0|||
25134790|NCT01492426|50248185|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
25134791|NCT01492426|50248186|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
25134792|NCT01492426|50248185|FG000|Follow-Up|Death|1|||
25134793|NCT01492426|50248186|FG001|Follow-Up|Death|0|||
25134794|NCT01492426|50248185|FG000|Follow-Up|Other|4|||
25134795|NCT01492426|50248186|FG001|Follow-Up|Other|2|||
25134796|NCT01492426|50248185|FG000|Follow-Up|Participant Withdrew Consent|6|||
25134797|NCT01492426|50248186|FG001|Follow-Up|Participant Withdrew Consent|1|||
25134798|NCT01492426|50248185|FG000|Follow-Up|Lost to Follow-up|12|||
25134799|NCT01492426|50248186|FG001|Follow-Up|Lost to Follow-up|6|||
25134800|NCT01453348|50248199|FG000|Overall Study|Death|0|||
25134801|NCT01453348|50248200|FG001|Overall Study|Death|0|||
25134802|NCT01453348|50248201|FG002|Overall Study|Death|1|||
25134803|NCT01453348|50248199|FG000|Overall Study|Withdrawal by Subject|0|||
25273442|NCT01259492|50587531|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
25273443|NCT01259492|50587532|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
25273444|NCT01259492|50587533|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
25273445|NCT01259492|50587530|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
25273446|NCT01259492|50587531|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
25273447|NCT01259492|50587532|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
25273448|NCT01259492|50587533|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
25273449|NCT01259492|50587530|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
25273450|NCT01259492|50587531|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
25273451|NCT01259492|50587532|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
25273452|NCT01259492|50587533|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
25134804|NCT01453348|50248200|FG001|Overall Study|Withdrawal by Subject|1|||
25134805|NCT01453348|50248201|FG002|Overall Study|Withdrawal by Subject|0|||
25134806|NCT01453348|50248199|FG000|Overall Study|Protocol Violation|1|||
25134807|NCT01453348|50248200|FG001|Overall Study|Protocol Violation|0|||
25134808|NCT01453348|50248201|FG002|Overall Study|Protocol Violation|0|||
25134809|NCT01453036|50248215|FG000|Overall Study|Lost to Follow-up|26|||
25134810|NCT01453036|50248216|FG001|Overall Study|Lost to Follow-up|115|||
25134811|NCT01453036|50248217|FG002|Overall Study|Lost to Follow-up|31|||
25134812|NCT01475734|50248227|FG000|Overall Study|Withdrawal by Subject|1|||
25134813|NCT01475734|50248228|FG001|Overall Study|Withdrawal by Subject|0|||
25134814|NCT01475734|50248227|FG000|Overall Study|Protocol Violation|1|||
25134815|NCT01475734|50248228|FG001|Overall Study|Protocol Violation|0|||
25134816|NCT01475734|50248227|FG000|Overall Study|Physician Decision|0|||
25134817|NCT01475734|50248228|FG001|Overall Study|Physician Decision|1|||
25134818|NCT01452412|50248236|FG000|Overall Study|Withdrawal by Subject|15|||
25134819|NCT01452412|50248237|FG001|Overall Study|Withdrawal by Subject|11|||
25134820|NCT01452412|50248236|FG000|Overall Study|Adverse Event|4|||
25134821|NCT01452412|50248237|FG001|Overall Study|Adverse Event|3|||
25134822|NCT01452412|50248236|FG000|Overall Study|Lost to Follow-up|5|||
25134823|NCT01452412|50248237|FG001|Overall Study|Lost to Follow-up|3|||
25134824|NCT01452412|50248236|FG000|Overall Study|Death|1|||
25134825|NCT01452412|50248237|FG001|Overall Study|Death|0|||
25134826|NCT01452412|50248236|FG000|Overall Study|Initiated dialysis|1|||
25134827|NCT01452412|50248237|FG001|Overall Study|Initiated dialysis|0|||
25134828|NCT01452412|50248236|FG000|Overall Study|Other|2|||
25134829|NCT01452412|50248237|FG001|Overall Study|Other|0|||
25134830|NCT01474876|50248246|FG000|Overall Study|Adverse Event|11|||
25134831|NCT01474876|50248247|FG001|Overall Study|Adverse Event|5|||
25134832|NCT01474876|50248248|FG002|Overall Study|Adverse Event|0|||
25134833|NCT01474876|50248246|FG000|Overall Study|Serious Adverse Event|2|||
25134834|NCT01474876|50248247|FG001|Overall Study|Serious Adverse Event|3|||
25134835|NCT01474876|50248248|FG002|Overall Study|Serious Adverse Event|0|||
25134836|NCT01474876|50248246|FG000|Overall Study|Lost to Follow-up|5|||
25134837|NCT01474876|50248247|FG001|Overall Study|Lost to Follow-up|4|||
25134838|NCT01474876|50248248|FG002|Overall Study|Lost to Follow-up|0|||
25134839|NCT01474876|50248246|FG000|Overall Study|Investigator's decision|28|||
25134840|NCT01474876|50248247|FG001|Overall Study|Investigator's decision|6|||
25134841|NCT01474876|50248248|FG002|Overall Study|Investigator's decision|0|||
25134842|NCT01474876|50248246|FG000|Overall Study|Patient's request|19|||
25134843|NCT01474876|50248247|FG001|Overall Study|Patient's request|5|||
25134844|NCT01474876|50248248|FG002|Overall Study|Patient's request|0|||
25134845|NCT01474876|50248246|FG000|Overall Study|Investigator's decision and pt request|1|||
25134846|NCT01474876|50248247|FG001|Overall Study|Investigator's decision and pt request|0|||
25134847|NCT01474876|50248248|FG002|Overall Study|Investigator's decision and pt request|0|||
25134848|NCT01491802|50248254|FG000|Overall Study|Adverse Event|1|||
25134849|NCT01491802|50248255|FG001|Overall Study|Adverse Event|1|||
25134850|NCT01491802|50248254|FG000|Overall Study|Withdrawal by Subject|0|||
25134851|NCT01491802|50248255|FG001|Overall Study|Withdrawal by Subject|1|||
25134852|NCT02168777|50248265|FG000|Overall Study|Withdrawal by Subject|1|||
25134853|NCT02168777|50248266|FG001|Overall Study|Withdrawal by Subject|0|||
25134854|NCT02168777|50248267|FG002|Overall Study|Withdrawal by Subject|2|||
25134855|NCT02168777|50248265|FG000|Overall Study|Adverse Event|1|||
25134856|NCT02168777|50248266|FG001|Overall Study|Adverse Event|0|||
25134857|NCT02168777|50248267|FG002|Overall Study|Adverse Event|1|||
25134858|NCT02168777|50248265|FG000|Overall Study|Disease recurrence|0|||
25134859|NCT02168777|50248266|FG001|Overall Study|Disease recurrence|0|||
25134860|NCT02168777|50248267|FG002|Overall Study|Disease recurrence|1|||
25134861|NCT02168777|50248265|FG000|Overall Study|Radiological disease progression|0|||
25134862|NCT02168777|50248266|FG001|Overall Study|Radiological disease progression|5|||
25134863|NCT02168777|50248267|FG002|Overall Study|Radiological disease progression|5|||
25134864|NCT02168777|50248265|FG000|Overall Study|Clinical disease progression|0|||
25134865|NCT02168777|50248266|FG001|Overall Study|Clinical disease progression|1|||
25273453|NCT01259492|50587530|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
25273454|NCT01259492|50587531|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
25273455|NCT01259492|50587532|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
25273456|NCT01259492|50587533|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
25273457|NCT01259492|50587530|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
25273458|NCT01259492|50587531|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
25273459|NCT01259492|50587532|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
25273460|NCT01259492|50587533|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
25273461|NCT01259492|50587530|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
25273462|NCT01259492|50587531|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
25273463|NCT01259492|50587532|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
25273464|NCT01259492|50587533|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
25273465|NCT01117623|50587550|FG000|Overall Study|Adverse Event|0|||
25134866|NCT02168777|50248267|FG002|Overall Study|Clinical disease progression|2|||
25134867|NCT02168777|50248265|FG000|Overall Study|Other reason|0|||
25134868|NCT02168777|50248266|FG001|Overall Study|Other reason|1|||
25134869|NCT02168777|50248267|FG002|Overall Study|Other reason|0|||
25134870|NCT01491178|50248278|FG000|Overall Study|Adverse Event|1016|||
25134871|NCT01491178|50248278|FG000|Overall Study|Improvement of NVAF|210|||
25134872|NCT01491178|50248278|FG000|Overall Study|To conduct invasive treatment|59|||
25134873|NCT01491178|50248278|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
25134874|NCT01491178|50248278|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
25134875|NCT01491178|50248278|FG000|Overall Study|To take a contraindication|20|||
25134876|NCT01491178|50248278|FG000|Overall Study|Other than specified above|657|||
25134877|NCT02189837|50248286|FG000|Overall Study|Withdrawal by Subject|2|||
25134878|NCT02189837|50248287|FG001|Overall Study|Withdrawal by Subject|1|||
25134879|NCT02189837|50248288|FG002|Overall Study|Withdrawal by Subject|3|||
25178828|NCT01506271|50324164|FG001|Overall Study|Progressive disease|1|||
25178829|NCT01506271|50324165|FG002|Overall Study|Progressive disease|0|||
25178830|NCT01506271|50324163|FG000|Overall Study|Protocol Violation|3|||
25178831|NCT01506271|50324164|FG001|Overall Study|Protocol Violation|1|||
25178832|NCT01506271|50324165|FG002|Overall Study|Protocol Violation|0|||
25178833|NCT01506271|50324163|FG000|Overall Study|Death|0|||
25178834|NCT01506271|50324164|FG001|Overall Study|Death|1|||
25178835|NCT01506271|50324165|FG002|Overall Study|Death|0|||
25178836|NCT01506271|50324163|FG000|Overall Study|Adverse Event|0|||
25178837|NCT01506271|50324164|FG001|Overall Study|Adverse Event|2|||
25178838|NCT01506271|50324165|FG002|Overall Study|Adverse Event|0|||
25178839|NCT01506271|50324163|FG000|Overall Study|Insufficient supply of study drug|1|||
25178840|NCT01506271|50324164|FG001|Overall Study|Insufficient supply of study drug|0|||
25178841|NCT01506271|50324165|FG002|Overall Study|Insufficient supply of study drug|0|||
25178842|NCT01506271|50324163|FG000|Overall Study|Withdrawal by Subject|0|||
25178843|NCT01506271|50324164|FG001|Overall Study|Withdrawal by Subject|1|||
25178844|NCT01506271|50324165|FG002|Overall Study|Withdrawal by Subject|1|||
25178845|NCT01506271|50324163|FG000|Overall Study|Lost to Follow-up|0|||
25178846|NCT01506271|50324164|FG001|Overall Study|Lost to Follow-up|1|||
25178847|NCT01506271|50324165|FG002|Overall Study|Lost to Follow-up|2|||
25134880|NCT02189837|50248289|FG003|Overall Study|Withdrawal by Subject|1|||
25178848|NCT01506193|50324176|FG000|Overall Study|Protocol Violation|1|||
25273466|NCT01117623|50587551|FG001|Overall Study|Adverse Event|2|||
25273467|NCT01117623|50587552|FG002|Overall Study|Adverse Event|4|||
25273468|NCT01117623|50587553|FG003|Overall Study|Adverse Event|0|||
25273469|NCT01117623|50587554|FG004|Overall Study|Adverse Event|2|||
25273470|NCT01117623|50587555|FG005|Overall Study|Adverse Event|0|||
25273471|NCT01117623|50587556|FG006|Overall Study|Adverse Event|0|||
25273472|NCT01117623|50587557|FG007|Overall Study|Adverse Event|2|||
25273473|NCT01117623|50587550|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
25273474|NCT01117623|50587551|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
25273475|NCT01117623|50587552|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
25273476|NCT01117623|50587553|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
25178849|NCT01506193|50324177|FG001|Overall Study|Protocol Violation|0|||
25178850|NCT01506193|50324178|FG002|Overall Study|Protocol Violation|1|||
25178851|NCT01506193|50324176|FG000|Overall Study|Migrated/moved from study area|0|||
25009481|NCT03422172|50102383|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
25134881|NCT02189837|50248286|FG000|Overall Study|Sponsor Decision|0|||
25134882|NCT02189837|50248287|FG001|Overall Study|Sponsor Decision|0|||
25134883|NCT02189837|50248288|FG002|Overall Study|Sponsor Decision|0|||
25134884|NCT02189837|50248289|FG003|Overall Study|Sponsor Decision|1|||
25134885|NCT02216123|50248301|FG000|Overall Study|Lost to Follow-up|4|||
25134886|NCT02216123|50248302|FG001|Overall Study|Lost to Follow-up|2|||
25134887|NCT02216123|50248301|FG000|Overall Study|Withdrawal by Subject|2|||
25134888|NCT02216123|50248302|FG001|Overall Study|Withdrawal by Subject|0|||
25134889|NCT02189759|50248316|FG000|Overall Study|Lost to Follow-up|0|||
25134890|NCT02189759|50248317|FG001|Overall Study|Lost to Follow-up|0|||
25134891|NCT02189759|50248318|FG002|Overall Study|Lost to Follow-up|2|||
25134892|NCT02189759|50248319|FG003|Overall Study|Lost to Follow-up|5|||
25134893|NCT01490866|50248331|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
25134894|NCT01490866|50248331|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
25134895|NCT01490866|50248331|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
25134896|NCT01490866|50248331|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
25134897|NCT01490866|50248331|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
25134898|NCT01490866|50248331|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
25134899|NCT01490866|50248331|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
25134900|NCT01490866|50248331|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
25134901|NCT01490866|50248331|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
25134902|NCT01490866|50248331|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
25134903|NCT01490866|50248331|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
25134904|NCT02215967|50248342|FG000|Overall Study|Patient became ineligible for treatment|0|||
25134905|NCT02215967|50248343|FG001|Overall Study|Patient became ineligible for treatment|0|||
25134906|NCT02215967|50248344|FG002|Overall Study|Patient became ineligible for treatment|0|||
25134907|NCT02215967|50248345|FG003|Overall Study|Patient became ineligible for treatment|3|||
25134908|NCT02215967|50248342|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
25134909|NCT02215967|50248343|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
25134910|NCT02215967|50248344|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
25134911|NCT02215967|50248345|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
25134912|NCT02168387|50248357|FG000|Overall Study|Planned exubation|6|||
25134913|NCT02168387|50248358|FG001|Overall Study|Planned exubation|3|||
25134914|NCT02168387|50248357|FG000|Overall Study|Death|1|||
25134915|NCT02168387|50248358|FG001|Overall Study|Death|0|||
25134916|NCT02188589|50248364|FG000|Overall Study|Withdrawal by Subject|5|||
25134917|NCT02167451|50248369|FG000|Overall Study|Withdrawal by Subject|1|||
25134918|NCT02167139|50248375|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
25134919|NCT02167139|50248376|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
25134920|NCT02167139|50248377|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
25134921|NCT02167139|50248378|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
25134922|NCT02167139|50248375|FG000|Randomised, Double-blind|Adverse Event|2|||
25134923|NCT02167139|50248376|FG001|Randomised, Double-blind|Adverse Event|9|||
25134924|NCT02167139|50248377|FG002|Randomised, Double-blind|Adverse Event|0|||
25134925|NCT02167139|50248378|FG003|Randomised, Double-blind|Adverse Event|0|||
25134926|NCT02167139|50248375|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
25134927|NCT02167139|50248376|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
25134928|NCT02167139|50248377|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
25134929|NCT02167139|50248378|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
25134930|NCT02167139|50248375|FG000|Randomised, Double-blind|Other|3|||
25134931|NCT02167139|50248376|FG001|Randomised, Double-blind|Other|0|||
25134932|NCT02167139|50248377|FG002|Randomised, Double-blind|Other|0|||
25134933|NCT02167139|50248378|FG003|Randomised, Double-blind|Other|0|||
25134934|NCT02167139|50248375|FG000|Transition-extension|Adverse Event|2|||
25134935|NCT02167139|50248376|FG001|Transition-extension|Adverse Event|0|||
25134936|NCT02167139|50248377|FG002|Transition-extension|Adverse Event|2|||
25134937|NCT02167139|50248378|FG003|Transition-extension|Adverse Event|3|||
25134938|NCT02167139|50248375|FG000|Transition-extension|Withdrawal by Subject|2|||
25134939|NCT02167139|50248376|FG001|Transition-extension|Withdrawal by Subject|0|||
25134940|NCT02167139|50248377|FG002|Transition-extension|Withdrawal by Subject|4|||
25134941|NCT02167139|50248378|FG003|Transition-extension|Withdrawal by Subject|1|||
25134942|NCT02167139|50248375|FG000|Transition-extension|Lack of Efficacy|0|||
25134943|NCT02167139|50248376|FG001|Transition-extension|Lack of Efficacy|0|||
25134944|NCT02167139|50248377|FG002|Transition-extension|Lack of Efficacy|1|||
25134945|NCT02167139|50248378|FG003|Transition-extension|Lack of Efficacy|1|||
25134946|NCT02167139|50248375|FG000|Transition-extension|Other|1|||
25134947|NCT02167139|50248376|FG001|Transition-extension|Other|0|||
25134948|NCT02167139|50248377|FG002|Transition-extension|Other|1|||
25134949|NCT02167139|50248378|FG003|Transition-extension|Other|0|||
25134950|NCT02167139|50248375|FG000|Transition-extension|Lost to Follow-up|1|||
25134951|NCT02167139|50248376|FG001|Transition-extension|Lost to Follow-up|0|||
25134952|NCT02167139|50248377|FG002|Transition-extension|Lost to Follow-up|0|||
25134953|NCT02167139|50248378|FG003|Transition-extension|Lost to Follow-up|0|||
25273477|NCT01117623|50587554|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
25273478|NCT01117623|50587555|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
25273479|NCT01117623|50587556|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
25273480|NCT01117623|50587557|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
25273481|NCT01117623|50587550|FG000|Overall Study|Withdrawal by Subject|0|||
25273482|NCT01117623|50587551|FG001|Overall Study|Withdrawal by Subject|0|||
25273483|NCT01117623|50587552|FG002|Overall Study|Withdrawal by Subject|2|||
25273484|NCT01117623|50587553|FG003|Overall Study|Withdrawal by Subject|0|||
25273485|NCT01117623|50587554|FG004|Overall Study|Withdrawal by Subject|0|||
25273486|NCT01117623|50587555|FG005|Overall Study|Withdrawal by Subject|1|||
25273487|NCT01117623|50587556|FG006|Overall Study|Withdrawal by Subject|1|||
25273488|NCT01117623|50587557|FG007|Overall Study|Withdrawal by Subject|1|||
25273489|NCT01117623|50587550|FG000|Overall Study|Non-compliance with study medication|0|||
25273490|NCT01117623|50587551|FG001|Overall Study|Non-compliance with study medication|0|||
25273491|NCT01117623|50587552|FG002|Overall Study|Non-compliance with study medication|0|||
25273492|NCT01117623|50587553|FG003|Overall Study|Non-compliance with study medication|0|||
25273493|NCT01117623|50587554|FG004|Overall Study|Non-compliance with study medication|0|||
25134974|NCT02116621|50248415|FG000|Baseline|Withdrawal by Subject|0|||
25134975|NCT02116621|50248416|FG001|Baseline|Withdrawal by Subject|4|||
25134976|NCT02116621|50248415|FG000|Three Month Follow-up|Death|1|||
25134977|NCT02116621|50248416|FG001|Three Month Follow-up|Death|1|||
25134978|NCT02116621|50248415|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
25134979|NCT02116621|50248416|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
25134980|NCT02116621|50248415|FG000|Three Month Follow-up|Lost to Follow-up|0|||
25134981|NCT02116621|50248416|FG001|Three Month Follow-up|Lost to Follow-up|1|||
25134982|NCT02116621|50248415|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
25134983|NCT02116621|50248416|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
25134984|NCT02116621|50248415|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
25134985|NCT02116621|50248416|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
25134986|NCT02116621|50248415|FG000|Six Month Follow-up|Lost to Follow-up|2|||
25134987|NCT02116621|50248416|FG001|Six Month Follow-up|Lost to Follow-up|1|||
25134988|NCT02116621|50248415|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
25134989|NCT02116621|50248416|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
25134990|NCT02116621|50248415|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
25134991|NCT02116621|50248416|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
25134992|NCT02116621|50248415|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
25134993|NCT02116621|50248416|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
25134994|NCT02116621|50248415|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
25134995|NCT02116621|50248416|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
25134996|NCT02116621|50248415|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
25134997|NCT02116621|50248416|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
25134998|NCT02116309|50248424|FG000|Overall Study|Lost to Follow-up|0|||
25134999|NCT02116309|50248425|FG001|Overall Study|Lost to Follow-up|1|||
25135000|NCT02115607|50248431|FG000|Overall Study|Withdrawal by Subject|1|||
25135001|NCT01490632|50248440|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
25135002|NCT01490632|50248441|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
25135003|NCT01490632|50248442|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
25135004|NCT01490632|50248443|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
25135005|NCT01490632|50248444|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
25135006|NCT01490632|50248445|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
25135007|NCT01490632|50248446|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
25135008|NCT01490632|50248447|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
25135009|NCT01490632|50248448|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
25135010|NCT01490632|50248449|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
25135011|NCT01490632|50248450|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
25135012|NCT01490632|50248451|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
25135013|NCT01490632|50248452|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
25135014|NCT01490632|50248453|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
25135015|NCT01490632|50248454|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
25135016|NCT01490632|50248455|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
25135017|NCT01490632|50248456|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
25135018|NCT01490632|50248457|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
25135019|NCT01490632|50248458|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
25135020|NCT01490632|50248459|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
25135021|NCT01490632|50248440|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
25135022|NCT01490632|50248441|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
25135023|NCT01490632|50248442|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
25135024|NCT01490632|50248443|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
25135025|NCT01490632|50248444|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
25135026|NCT01490632|50248445|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
25135027|NCT01490632|50248446|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
25135028|NCT01490632|50248447|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
25135029|NCT01490632|50248448|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
25135030|NCT01490632|50248449|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
25135031|NCT01490632|50248450|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
25135032|NCT01490632|50248451|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
25135033|NCT01490632|50248452|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
25135034|NCT01490632|50248453|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
25135035|NCT01490632|50248454|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
25135036|NCT01490632|50248455|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
25135037|NCT01490632|50248456|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
25135038|NCT01490632|50248457|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
25135039|NCT01490632|50248458|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
25135040|NCT01490632|50248459|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
25135041|NCT01490632|50248440|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
25135042|NCT01490632|50248441|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
25135043|NCT01490632|50248442|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
25135044|NCT01490632|50248443|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
25135045|NCT01490632|50248444|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
25135046|NCT01490632|50248445|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
25135047|NCT01490632|50248446|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
25135048|NCT01490632|50248447|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
25135049|NCT01490632|50248448|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
25135050|NCT01490632|50248449|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
25135051|NCT01490632|50248450|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
25135052|NCT01490632|50248451|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
25135053|NCT01490632|50248452|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
25135054|NCT01490632|50248453|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
25135055|NCT01490632|50248454|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
25135056|NCT01490632|50248455|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
25135057|NCT01490632|50248456|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
25135058|NCT01490632|50248457|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
25135059|NCT01490632|50248458|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
25135060|NCT01490632|50248459|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
25135061|NCT01490632|50248440|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
25135062|NCT01490632|50248441|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
25135063|NCT01490632|50248442|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
25135064|NCT01490632|50248443|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
25135065|NCT01490632|50248444|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
25135066|NCT01490632|50248445|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
25135067|NCT01490632|50248446|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
25135068|NCT01490632|50248447|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
25135069|NCT01490632|50248448|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
25135070|NCT01490632|50248449|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
25135071|NCT01490632|50248450|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
25135072|NCT01490632|50248451|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
25135073|NCT01490632|50248452|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
25135074|NCT01490632|50248453|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
25135075|NCT01490632|50248454|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
25135076|NCT01490632|50248455|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
25135077|NCT01490632|50248456|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
25135078|NCT01490632|50248457|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
25135079|NCT01490632|50248458|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
25135080|NCT01490632|50248459|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
25135081|NCT01490632|50248440|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
25135082|NCT01490632|50248441|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135083|NCT01490632|50248442|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135084|NCT01490632|50248443|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135085|NCT01490632|50248444|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135086|NCT01490632|50248445|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135087|NCT01490632|50248446|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135088|NCT01490632|50248447|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135089|NCT01490632|50248448|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135090|NCT01490632|50248449|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135091|NCT01490632|50248450|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135092|NCT01490632|50248451|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135093|NCT01490632|50248452|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135094|NCT01490632|50248453|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135095|NCT01490632|50248454|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135096|NCT01490632|50248455|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135097|NCT01490632|50248456|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135098|NCT01490632|50248457|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135099|NCT01490632|50248458|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135100|NCT01490632|50248459|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
25135101|NCT01490632|50248440|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
25135102|NCT01490632|50248441|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
25135103|NCT01490632|50248442|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
25135104|NCT01490632|50248443|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
25135105|NCT01490632|50248444|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
25135106|NCT01490632|50248445|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
25135107|NCT01490632|50248446|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
25135108|NCT01490632|50248447|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
25135109|NCT01490632|50248448|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
25135110|NCT01490632|50248449|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
25135111|NCT01490632|50248450|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
25135112|NCT01490632|50248451|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
25135113|NCT01490632|50248452|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
25135114|NCT01490632|50248453|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
25135115|NCT01490632|50248454|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
25135116|NCT01490632|50248455|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
25135117|NCT01490632|50248456|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
25135118|NCT01490632|50248457|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
25135119|NCT01490632|50248458|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
25135120|NCT01490632|50248459|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
25135121|NCT01490632|50248440|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135122|NCT01490632|50248441|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135123|NCT01490632|50248442|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135124|NCT01490632|50248443|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135125|NCT01490632|50248444|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
25135126|NCT01490632|50248445|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135127|NCT01490632|50248446|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135128|NCT01490632|50248447|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135129|NCT01490632|50248448|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135130|NCT01490632|50248449|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135131|NCT01490632|50248450|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135132|NCT01490632|50248451|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135133|NCT01490632|50248452|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135134|NCT01490632|50248453|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135135|NCT01490632|50248454|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135136|NCT01490632|50248455|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135137|NCT01490632|50248456|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135138|NCT01490632|50248457|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135139|NCT01490632|50248458|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135140|NCT01490632|50248459|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
25135141|NCT01490632|50248440|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
25135142|NCT01490632|50248441|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
25135143|NCT01490632|50248442|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
25135144|NCT01490632|50248443|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
25135145|NCT01490632|50248444|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
25135146|NCT01490632|50248445|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
25135147|NCT01490632|50248446|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
25135148|NCT01490632|50248447|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
25135149|NCT01490632|50248448|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
25135150|NCT01490632|50248449|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
25135151|NCT01490632|50248450|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
25135152|NCT01490632|50248451|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
25135153|NCT01490632|50248452|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
25135154|NCT01490632|50248453|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
25135155|NCT01490632|50248454|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
25135156|NCT01490632|50248455|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
25135157|NCT01490632|50248456|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
25135158|NCT01490632|50248457|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
25135159|NCT01490632|50248458|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
25135160|NCT01490632|50248459|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
25135161|NCT01490632|50248440|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
25135162|NCT01490632|50248441|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
25135163|NCT01490632|50248442|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
25135164|NCT01490632|50248443|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
25135165|NCT01490632|50248444|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
25135166|NCT01490632|50248445|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
25135167|NCT01490632|50248446|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
25135168|NCT01490632|50248447|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
25135169|NCT01490632|50248448|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
25135170|NCT01490632|50248449|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
25135171|NCT01490632|50248450|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
25135172|NCT01490632|50248451|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
25135173|NCT01490632|50248452|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
25135174|NCT01490632|50248453|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
25135175|NCT01490632|50248454|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
25135176|NCT01490632|50248455|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
25135177|NCT01490632|50248456|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
25135178|NCT01490632|50248457|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
25135179|NCT01490632|50248458|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
25135180|NCT01490632|50248459|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
25135181|NCT01490632|50248440|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135182|NCT01490632|50248441|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135183|NCT01490632|50248442|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135184|NCT01490632|50248443|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135185|NCT01490632|50248444|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135186|NCT01490632|50248445|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135187|NCT01490632|50248446|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
25135188|NCT01490632|50248447|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135189|NCT01490632|50248448|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135190|NCT01490632|50248449|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
25135191|NCT01490632|50248450|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135192|NCT01490632|50248451|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135193|NCT01490632|50248452|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135194|NCT01490632|50248453|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135195|NCT01490632|50248454|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135196|NCT01490632|50248455|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135197|NCT01490632|50248456|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135198|NCT01490632|50248457|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135199|NCT01490632|50248458|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135200|NCT01490632|50248459|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
25135201|NCT01490632|50248440|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135202|NCT01490632|50248441|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135203|NCT01490632|50248442|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135204|NCT01490632|50248443|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135205|NCT01490632|50248444|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135206|NCT01490632|50248445|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135207|NCT01490632|50248446|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
25135208|NCT01490632|50248447|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135209|NCT01490632|50248448|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135210|NCT01490632|50248449|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135211|NCT01490632|50248450|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135212|NCT01490632|50248451|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135213|NCT01490632|50248452|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135214|NCT01490632|50248453|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135215|NCT01490632|50248454|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
25178852|NCT01506193|50324177|FG001|Overall Study|Migrated/moved from study area|0|||
25135216|NCT01490632|50248455|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135217|NCT01490632|50248456|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135218|NCT01490632|50248457|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135219|NCT01490632|50248458|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135220|NCT01490632|50248459|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
25135221|NCT01490632|50248440|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135222|NCT01490632|50248441|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135223|NCT01490632|50248442|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135224|NCT01490632|50248443|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135225|NCT01490632|50248444|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135226|NCT01490632|50248445|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
25135227|NCT01490632|50248446|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135228|NCT01490632|50248447|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135229|NCT01490632|50248448|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135230|NCT01490632|50248449|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135231|NCT01490632|50248450|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135232|NCT01490632|50248451|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135233|NCT01490632|50248452|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135234|NCT01490632|50248453|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135235|NCT01490632|50248454|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135236|NCT01490632|50248455|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135237|NCT01490632|50248456|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135238|NCT01490632|50248457|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135239|NCT01490632|50248458|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135240|NCT01490632|50248459|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
25135241|NCT01490632|50248440|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
25135242|NCT01490632|50248441|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
25135243|NCT01490632|50248442|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
25135244|NCT01490632|50248443|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
25135245|NCT01490632|50248444|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
25135246|NCT01490632|50248445|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
25135247|NCT01490632|50248446|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
25135248|NCT01490632|50248447|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
25135249|NCT01490632|50248448|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
25135250|NCT01490632|50248449|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
25135251|NCT01490632|50248450|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
25135252|NCT01490632|50248451|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
25135253|NCT01490632|50248452|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
25135254|NCT01490632|50248453|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
25135255|NCT01490632|50248454|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
25135256|NCT01490632|50248455|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
25135257|NCT01490632|50248456|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
25135258|NCT01490632|50248457|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
25135259|NCT01490632|50248458|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
25135260|NCT01490632|50248459|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
25135261|NCT01490632|50248440|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
25135262|NCT01490632|50248441|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
25135263|NCT01490632|50248442|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
25135264|NCT01490632|50248443|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
25135265|NCT01490632|50248444|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
25135266|NCT01490632|50248445|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
25135267|NCT01490632|50248446|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
25135268|NCT01490632|50248447|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
25135269|NCT01490632|50248448|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
25178853|NCT01506193|50324178|FG002|Overall Study|Migrated/moved from study area|1|||
25273494|NCT01117623|50587555|FG005|Overall Study|Non-compliance with study medication|0|||
25273495|NCT01117623|50587556|FG006|Overall Study|Non-compliance with study medication|0|||
25273496|NCT01117623|50587557|FG007|Overall Study|Non-compliance with study medication|1|||
25273497|NCT01117623|50587550|FG000|Overall Study|Invest. text: completed all planned txs|0|||
25273498|NCT01117623|50587551|FG001|Overall Study|Invest. text: completed all planned txs|0|||
25273499|NCT01117623|50587552|FG002|Overall Study|Invest. text: completed all planned txs|0|||
25273500|NCT01117623|50587553|FG003|Overall Study|Invest. text: completed all planned txs|0|||
25273501|NCT01117623|50587554|FG004|Overall Study|Invest. text: completed all planned txs|0|||
25273502|NCT01117623|50587555|FG005|Overall Study|Invest. text: completed all planned txs|1|||
25135270|NCT01490632|50248449|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
25135271|NCT01490632|50248450|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
25135272|NCT01490632|50248451|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
25135273|NCT01490632|50248452|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
25135274|NCT01490632|50248453|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
25135275|NCT01490632|50248454|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
25135276|NCT01490632|50248455|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
25135277|NCT01490632|50248456|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
25135278|NCT01490632|50248457|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
25135279|NCT01490632|50248458|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
25135280|NCT01490632|50248459|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
25135281|NCT01490632|50248440|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135282|NCT01490632|50248441|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135283|NCT01490632|50248442|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135284|NCT01490632|50248443|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135285|NCT01490632|50248444|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135286|NCT01490632|50248445|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135287|NCT01490632|50248446|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135288|NCT01490632|50248447|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135289|NCT01490632|50248448|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135290|NCT01490632|50248449|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135291|NCT01490632|50248450|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135292|NCT01490632|50248451|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135293|NCT01490632|50248452|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135294|NCT01490632|50248453|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135295|NCT01490632|50248454|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
25135296|NCT01490632|50248455|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
25135297|NCT01490632|50248456|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135298|NCT01490632|50248457|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135299|NCT01490632|50248458|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135300|NCT01490632|50248459|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
25135301|NCT01490632|50248440|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135302|NCT01490632|50248441|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135303|NCT01490632|50248442|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135304|NCT01490632|50248443|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135305|NCT01490632|50248444|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135306|NCT01490632|50248445|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135307|NCT01490632|50248446|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135308|NCT01490632|50248447|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135309|NCT01490632|50248448|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135310|NCT01490632|50248449|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135311|NCT01490632|50248450|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135312|NCT01490632|50248451|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135313|NCT01490632|50248452|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135314|NCT01490632|50248453|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
25135315|NCT01490632|50248454|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135316|NCT01490632|50248455|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135317|NCT01490632|50248456|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135318|NCT01490632|50248457|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135319|NCT01490632|50248458|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135320|NCT01490632|50248459|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
25135321|NCT01490632|50248440|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25135322|NCT01490632|50248441|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25135323|NCT01490632|50248442|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25135324|NCT01490632|50248443|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25135325|NCT01490632|50248444|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25135326|NCT01490632|50248445|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25135327|NCT01490632|50248446|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25135328|NCT01490632|50248447|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25135329|NCT01490632|50248448|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25135330|NCT01490632|50248449|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25135331|NCT01490632|50248450|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25273503|NCT01117623|50587556|FG006|Overall Study|Invest. text: completed all planned txs|0|||
25273504|NCT01117623|50587557|FG007|Overall Study|Invest. text: completed all planned txs|0|||
25273505|NCT01116687|50587577|FG000|Overall Study|Withdrawal by Subject|4|||
25273506|NCT01114737|50587583|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
25273507|NCT01114737|50587584|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
25273508|NCT01114737|50587583|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
25273509|NCT01114737|50587584|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
25273510|NCT01114737|50587583|FG000|Randomized Treatment Period|Pregnancy|1|||
25273511|NCT01114737|50587584|FG001|Randomized Treatment Period|Pregnancy|0|||
25273512|NCT01114737|50587583|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
25273513|NCT01114737|50587584|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
25273514|NCT01114737|50587583|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
25135332|NCT01490632|50248451|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25135333|NCT01490632|50248452|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25135334|NCT01490632|50248453|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25135335|NCT01490632|50248454|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
25135336|NCT01490632|50248455|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
25135337|NCT01490632|50248456|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25135338|NCT01490632|50248457|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25135339|NCT01490632|50248458|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25135340|NCT01490632|50248459|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
25178854|NCT01506193|50324176|FG000|Overall Study|Adverse event, non-fatal|0|||
25178855|NCT01506193|50324177|FG001|Overall Study|Adverse event, non-fatal|0|||
25135341|NCT01490632|50248440|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
25135342|NCT01490632|50248441|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
25135343|NCT01490632|50248442|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
25135344|NCT01490632|50248443|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
25135345|NCT01490632|50248444|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
25135346|NCT01490632|50248445|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
25135347|NCT01490632|50248446|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
25135348|NCT01490632|50248447|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
25135349|NCT01490632|50248448|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
25135350|NCT01490632|50248449|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
25135351|NCT01490632|50248450|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
25135352|NCT01490632|50248451|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
25135353|NCT01490632|50248452|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
25135354|NCT01490632|50248453|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
25135355|NCT01490632|50248454|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
25135356|NCT01490632|50248455|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
25135357|NCT01490632|50248456|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
25135358|NCT01490632|50248457|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
25135359|NCT01490632|50248458|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
25135360|NCT01490632|50248459|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
25135361|NCT01490632|50248440|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
25135362|NCT01490632|50248441|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
25273515|NCT01114737|50587584|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
25273516|NCT01114737|50587583|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
25273517|NCT01114737|50587584|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
25273518|NCT01113879|50587607|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
25273519|NCT01113879|50587608|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
25273520|NCT00979576|50587619|FG000|Combination Treatment Phase|Progressive disease|3|||
25273521|NCT00979576|50587620|FG001|Combination Treatment Phase|Progressive disease|1|||
25273522|NCT00979576|50587621|FG002|Combination Treatment Phase|Progressive disease|5|||
25273523|NCT00979576|50587619|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
25273524|NCT00979576|50587620|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
25273525|NCT00979576|50587621|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
25273526|NCT00979576|50587619|FG000|Combination Treatment Phase|Adverse Event|0|||
25273527|NCT00979576|50587620|FG001|Combination Treatment Phase|Adverse Event|2|||
25273528|NCT00979576|50587621|FG002|Combination Treatment Phase|Adverse Event|2|||
25273529|NCT00979576|50587619|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
25135363|NCT01490632|50248442|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
25135364|NCT01490632|50248443|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
25135365|NCT01490632|50248444|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
25135366|NCT01490632|50248445|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
25135367|NCT01490632|50248446|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
25135368|NCT01490632|50248447|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
25135369|NCT01490632|50248448|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
25135370|NCT01490632|50248449|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
25135371|NCT01490632|50248450|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
25135372|NCT01490632|50248451|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
25135373|NCT01490632|50248452|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
25135374|NCT01490632|50248453|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
25135375|NCT01490632|50248454|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
25135376|NCT01490632|50248455|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
25135377|NCT01490632|50248456|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
25135378|NCT01490632|50248457|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
25135379|NCT01490632|50248458|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
25135380|NCT01490632|50248459|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
25135381|NCT01490632|50248440|FG000|Part D: Re-Treatment Period|Death|0|||
25135382|NCT01490632|50248441|FG001|Part D: Re-Treatment Period|Death|0|||
25135383|NCT01490632|50248442|FG002|Part D: Re-Treatment Period|Death|0|||
25135384|NCT01490632|50248443|FG003|Part D: Re-Treatment Period|Death|0|||
25135385|NCT01490632|50248444|FG004|Part D: Re-Treatment Period|Death|0|||
25135386|NCT01490632|50248445|FG005|Part D: Re-Treatment Period|Death|0|||
25135387|NCT01490632|50248446|FG006|Part D: Re-Treatment Period|Death|0|||
25135388|NCT01490632|50248447|FG007|Part D: Re-Treatment Period|Death|0|||
25135389|NCT01490632|50248448|FG008|Part D: Re-Treatment Period|Death|0|||
25135390|NCT01490632|50248449|FG009|Part D: Re-Treatment Period|Death|0|||
25135391|NCT01490632|50248450|FG010|Part D: Re-Treatment Period|Death|0|||
25135392|NCT01490632|50248451|FG011|Part D: Re-Treatment Period|Death|0|||
25135393|NCT01490632|50248452|FG012|Part D: Re-Treatment Period|Death|0|||
25135394|NCT01490632|50248453|FG013|Part D: Re-Treatment Period|Death|0|||
25135395|NCT01490632|50248454|FG014|Part D: Re-Treatment Period|Death|0|||
25135396|NCT01490632|50248455|FG015|Part D: Re-Treatment Period|Death|0|||
25135397|NCT01490632|50248456|FG016|Part D: Re-Treatment Period|Death|0|||
25135398|NCT01490632|50248457|FG017|Part D: Re-Treatment Period|Death|0|||
25135399|NCT01490632|50248458|FG018|Part D: Re-Treatment Period|Death|1|||
25135400|NCT01490632|50248459|FG019|Part D: Re-Treatment Period|Death|0|||
25135401|NCT01490632|50248440|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
25135402|NCT01490632|50248441|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
25135403|NCT01490632|50248442|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
25135404|NCT01490632|50248443|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
25135405|NCT01490632|50248444|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
25135406|NCT01490632|50248445|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
25135407|NCT01490632|50248446|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
25135408|NCT01490632|50248447|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
25135409|NCT01490632|50248448|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
25135410|NCT01490632|50248449|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
25135411|NCT01490632|50248450|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
25135412|NCT01490632|50248451|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
25135413|NCT01490632|50248452|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
25135414|NCT01490632|50248453|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
25135415|NCT01490632|50248454|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
25135416|NCT01490632|50248455|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
25135417|NCT01490632|50248456|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
25135418|NCT01490632|50248457|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
25135419|NCT01490632|50248458|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
25135420|NCT01490632|50248459|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
25135421|NCT01490632|50248440|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135422|NCT01490632|50248441|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135423|NCT01490632|50248442|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135424|NCT01490632|50248443|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135425|NCT01490632|50248444|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135426|NCT01490632|50248445|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135427|NCT01490632|50248446|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135428|NCT01490632|50248447|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135429|NCT01490632|50248448|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25273530|NCT00979576|50587620|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
25273531|NCT00979576|50587621|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
25273532|NCT00979420|50587634|FG000|Overall Study|Adverse Event|1|||
25135430|NCT01490632|50248449|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135431|NCT01490632|50248450|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135432|NCT01490632|50248451|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135433|NCT01490632|50248452|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135434|NCT01490632|50248453|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135435|NCT01490632|50248454|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135436|NCT01490632|50248455|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135437|NCT01490632|50248456|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135438|NCT01490632|50248457|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135439|NCT01490632|50248458|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
25135440|NCT01490632|50248459|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
25135441|NCT01490632|50248440|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
25178856|NCT01506193|50324178|FG002|Overall Study|Adverse event, non-fatal|1|||
25273533|NCT00979420|50587635|FG001|Overall Study|Adverse Event|0|||
25273534|NCT00979420|50587636|FG002|Overall Study|Adverse Event|0|||
25273535|NCT00979420|50587637|FG003|Overall Study|Adverse Event|0|||
25273536|NCT00979420|50587634|FG000|Overall Study|Lack of Efficacy|3|||
25273537|NCT00979420|50587635|FG001|Overall Study|Lack of Efficacy|0|||
25273538|NCT00979420|50587636|FG002|Overall Study|Lack of Efficacy|1|||
25273539|NCT00979420|50587637|FG003|Overall Study|Lack of Efficacy|1|||
25273540|NCT00979420|50587634|FG000|Overall Study|Other reasons not related to Viramune|3|||
25273541|NCT00979420|50587635|FG001|Overall Study|Other reasons not related to Viramune|0|||
25273542|NCT00979420|50587636|FG002|Overall Study|Other reasons not related to Viramune|0|||
25135442|NCT01490632|50248441|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
25135443|NCT01490632|50248442|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
25135444|NCT01490632|50248443|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
25135445|NCT01490632|50248444|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
25135446|NCT01490632|50248445|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
25135447|NCT01490632|50248446|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
25135448|NCT01490632|50248447|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
25135449|NCT01490632|50248448|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
25135450|NCT01490632|50248449|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
25135451|NCT01490632|50248450|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
25135452|NCT01490632|50248451|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
25135453|NCT01490632|50248452|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
25135454|NCT01490632|50248453|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
25135455|NCT01490632|50248454|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
25135456|NCT01490632|50248455|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
25135457|NCT01490632|50248456|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
25135458|NCT01490632|50248457|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
25135459|NCT01490632|50248458|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
25135460|NCT01490632|50248459|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
25135461|NCT01490632|50248440|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
25135462|NCT01490632|50248441|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
25135463|NCT01490632|50248442|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
25135464|NCT01490632|50248443|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
25135465|NCT01490632|50248444|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
25135466|NCT01490632|50248445|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
25135467|NCT01490632|50248446|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
25135468|NCT01490632|50248447|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
25135469|NCT01490632|50248448|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
25135470|NCT01490632|50248449|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
25135471|NCT01490632|50248450|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
25135472|NCT01490632|50248451|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
25135473|NCT01490632|50248452|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
25135474|NCT01490632|50248453|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
25135475|NCT01490632|50248454|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
25135476|NCT01490632|50248455|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
25135477|NCT01490632|50248456|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
25135478|NCT01490632|50248457|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
25135479|NCT01490632|50248458|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
25135480|NCT01490632|50248459|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
25135481|NCT01490632|50248440|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
25135482|NCT01490632|50248441|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
25135483|NCT01490632|50248442|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
25135484|NCT01490632|50248443|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
25135485|NCT01490632|50248444|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
25273543|NCT00979420|50587637|FG003|Overall Study|Other reasons not related to Viramune|1|||
25273544|NCT02702180|50587648|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
25273545|NCT02702180|50587649|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
25273546|NCT02702180|50587650|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
25273547|NCT02702180|50587648|FG000|Double-blind Treatment Period|Adverse Event|0|||
25273548|NCT02702180|50587649|FG001|Double-blind Treatment Period|Adverse Event|0|||
25273549|NCT02702180|50587650|FG002|Double-blind Treatment Period|Adverse Event|1|||
25273550|NCT02702180|50587648|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
25273551|NCT02702180|50587649|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
25273552|NCT02702180|50587650|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
25273553|NCT02702180|50587648|FG000|Double-blind Treatment Period|Protocol Violation|0|||
25273554|NCT02702180|50587649|FG001|Double-blind Treatment Period|Protocol Violation|0|||
25273555|NCT02702180|50587650|FG002|Double-blind Treatment Period|Protocol Violation|2|||
25273556|NCT02702180|50587648|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
25273557|NCT02702180|50587649|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
25273558|NCT02702180|50587650|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
25273559|NCT02702180|50587648|FG000|Open-label Treatment Period|Withdrawn in error|0|||
25273560|NCT02702180|50587649|FG001|Open-label Treatment Period|Withdrawn in error|0|||
25273561|NCT02702180|50587650|FG002|Open-label Treatment Period|Withdrawn in error|1|||
25135486|NCT01490632|50248445|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
25135487|NCT01490632|50248446|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
25135488|NCT01490632|50248447|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
25135489|NCT01490632|50248448|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
25135490|NCT01490632|50248449|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
25135491|NCT01490632|50248450|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
25135492|NCT01490632|50248451|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
25135493|NCT01490632|50248452|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
25135494|NCT01490632|50248453|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
25135495|NCT01490632|50248454|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
25135496|NCT01490632|50248455|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
25135497|NCT01490632|50248456|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
25135498|NCT01490632|50248457|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
25135499|NCT01490632|50248458|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
25135500|NCT01490632|50248459|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
25135501|NCT02073643|50248502|FG000|Overall Study|Lost to Follow-up|24|||
25135502|NCT01451554|50248508|FG000|Overall Study|Withdrawal by Subject|14|||
25135503|NCT01451554|50248509|FG001|Overall Study|Withdrawal by Subject|9|||
25135504|NCT01474486|50248515|FG000|Overall Study|Death|2|||
25135505|NCT01474486|50248515|FG000|Overall Study|Withdrawal by Subject|4|||
25135506|NCT01474486|50248515|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
25135507|NCT01451398|50248525|FG000|Overall Study|Adverse Event|7|||
25135508|NCT01451398|50248526|FG001|Overall Study|Adverse Event|9|||
25135509|NCT01451398|50248525|FG000|Overall Study|Protocol Violation|1|||
25135510|NCT01451398|50248526|FG001|Overall Study|Protocol Violation|2|||
25135511|NCT01451398|50248525|FG000|Overall Study|Physician Decision|1|||
25135512|NCT01451398|50248526|FG001|Overall Study|Physician Decision|1|||
25135513|NCT01451398|50248525|FG000|Overall Study|Withdrawal by Subject|10|||
25135514|NCT01451398|50248526|FG001|Overall Study|Withdrawal by Subject|14|||
25135515|NCT01451398|50248525|FG000|Overall Study|Lost to Follow-up|6|||
25135516|NCT01451398|50248526|FG001|Overall Study|Lost to Follow-up|4|||
25135517|NCT01451398|50248525|FG000|Overall Study|Non-compliance with study drug|1|||
25135518|NCT01451398|50248526|FG001|Overall Study|Non-compliance with study drug|3|||
25135519|NCT01451398|50248525|FG000|Overall Study|Non-compliance with protocol|1|||
25135520|NCT01451398|50248526|FG001|Overall Study|Non-compliance with protocol|1|||
25135521|NCT01451398|50248525|FG000|Overall Study|Moved out of country|0|||
25135522|NCT01451398|50248526|FG001|Overall Study|Moved out of country|1|||
25135523|NCT01451398|50248525|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
25135524|NCT01451398|50248526|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
25135525|NCT01451398|50248525|FG000|Overall Study|Lack of Efficacy|0|||
25135526|NCT01451398|50248526|FG001|Overall Study|Lack of Efficacy|1|||
25135527|NCT02073565|50248534|FG000|Cohort A|Withdrawal by Subject|1|||
25135528|NCT02073565|50248535|FG001|Cohort A|Withdrawal by Subject|0|||
25135529|NCT02073565|50248534|FG000|Cohort B|Withdrawal by Subject|1|||
25135530|NCT02073565|50248535|FG001|Cohort B|Withdrawal by Subject|2|||
25135531|NCT02073565|50248534|FG000|Cohort C|Withdrawal by Subject|0|||
25135532|NCT02073565|50248535|FG001|Cohort C|Withdrawal by Subject|2|||
25135533|NCT02073565|50248534|FG000|Cohort C|Lost to Follow-up|0|||
25135534|NCT02073565|50248535|FG001|Cohort C|Lost to Follow-up|2|||
25135535|NCT02072941|50248543|FG000|Overall Study|Withdrawal by Subject|29|||
25135536|NCT02072941|50248544|FG001|Overall Study|Withdrawal by Subject|21|||
25135537|NCT02072941|50248543|FG000|Overall Study|Lost to Follow-up|4|||
25135538|NCT02072941|50248544|FG001|Overall Study|Lost to Follow-up|4|||
25135539|NCT02072941|50248543|FG000|Overall Study|Death|3|||
25135540|NCT02072941|50248544|FG001|Overall Study|Death|2|||
25135541|NCT02072941|50248543|FG000|Overall Study|Removed by Study Staff|2|||
25135542|NCT02072941|50248544|FG001|Overall Study|Removed by Study Staff|2|||
25135543|NCT02100631|50248553|FG000|Overall Study|Withdrawal by Subject|1|||
25135544|NCT02100631|50248554|FG001|Overall Study|Withdrawal by Subject|0|||
25135545|NCT02100631|50248555|FG002|Overall Study|Withdrawal by Subject|0|||
25135546|NCT02100631|50248553|FG000|Overall Study|Lost to Follow-up|3|||
25135547|NCT02100631|50248554|FG001|Overall Study|Lost to Follow-up|4|||
25135548|NCT02100631|50248555|FG002|Overall Study|Lost to Follow-up|0|||
25135549|NCT02100631|50248553|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
25135550|NCT02100631|50248554|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
25135551|NCT02100631|50248555|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
25135552|NCT01451164|50248567|FG000|Overall Study|Adverse Event|19|||
25135553|NCT01451164|50248568|FG001|Overall Study|Adverse Event|12|||
25135554|NCT01451164|50248569|FG002|Overall Study|Adverse Event|18|||
25135555|NCT01451164|50248570|FG003|Overall Study|Adverse Event|21|||
25135556|NCT01451164|50248567|FG000|Overall Study|Withdrawal Criteria|1|||
25135557|NCT01451164|50248568|FG001|Overall Study|Withdrawal Criteria|1|||
25135558|NCT01451164|50248569|FG002|Overall Study|Withdrawal Criteria|1|||
25135559|NCT01451164|50248570|FG003|Overall Study|Withdrawal Criteria|1|||
25135560|NCT01451164|50248567|FG000|Overall Study|Physician Decision|2|||
25135561|NCT01451164|50248568|FG001|Overall Study|Physician Decision|0|||
25135562|NCT01451164|50248569|FG002|Overall Study|Physician Decision|1|||
25135563|NCT01451164|50248570|FG003|Overall Study|Physician Decision|0|||
25135564|NCT01451164|50248567|FG000|Overall Study|Withdrawal by Subject|14|||
25135565|NCT01451164|50248568|FG001|Overall Study|Withdrawal by Subject|11|||
25135566|NCT01451164|50248569|FG002|Overall Study|Withdrawal by Subject|16|||
25135567|NCT01451164|50248570|FG003|Overall Study|Withdrawal by Subject|17|||
25135568|NCT01451164|50248567|FG000|Overall Study|Protocol Violation|0|||
25135569|NCT01451164|50248568|FG001|Overall Study|Protocol Violation|1|||
25135570|NCT01451164|50248569|FG002|Overall Study|Protocol Violation|0|||
25135571|NCT01451164|50248570|FG003|Overall Study|Protocol Violation|0|||
25135572|NCT01451164|50248567|FG000|Overall Study|Lack of Efficacy|7|||
25135573|NCT01451164|50248568|FG001|Overall Study|Lack of Efficacy|9|||
25135574|NCT01451164|50248569|FG002|Overall Study|Lack of Efficacy|9|||
25135575|NCT01451164|50248570|FG003|Overall Study|Lack of Efficacy|7|||
25135576|NCT02071849|50248580|FG000|6-month Primary Endpoint|Did not receive device|4|||
25135577|NCT02071849|50248580|FG000|6-month Primary Endpoint|Adverse Event|1|||
25135578|NCT02071849|50248580|FG000|2-year Extended Follow-up|Adverse Event|1|||
25135579|NCT02071771|50248584|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
25135580|NCT02071771|50248585|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
25135581|NCT02071771|50248584|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
25135582|NCT02071771|50248585|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
25135583|NCT02071225|50248591|FG000|Overall Study|Withdrawal of Consent|2|||
25135584|NCT02071225|50248591|FG000|Overall Study|Protocol Deviation|1|||
25135585|NCT02071225|50248591|FG000|Overall Study|Lost to Follow-up|2|||
25135586|NCT02071225|50248591|FG000|Overall Study|Death|25|||
25135587|NCT01450696|50248597|FG000|Overall Study|Never Treated|1|||
25135588|NCT01450696|50248598|FG001|Overall Study|Never Treated|1|||
25135589|NCT01450696|50248597|FG000|Overall Study|Death|77|||
25135590|NCT01450696|50248598|FG001|Overall Study|Death|84|||
25135591|NCT01450696|50248597|FG000|Overall Study|Lost to Follow-up|3|||
25135592|NCT01450696|50248598|FG001|Overall Study|Lost to Follow-up|3|||
25135593|NCT01450696|50248597|FG000|Overall Study|Non-Compliance|1|||
25135594|NCT01450696|50248598|FG001|Overall Study|Non-Compliance|0|||
25135595|NCT01450696|50248597|FG000|Overall Study|Withdrawal by Subject|13|||
25135596|NCT01450696|50248598|FG001|Overall Study|Withdrawal by Subject|2|||
25135597|NCT01450696|50248597|FG000|Overall Study|Study Terminated by Sponsor|53|||
25135598|NCT01450696|50248598|FG001|Overall Study|Study Terminated by Sponsor|58|||
25135599|NCT02070991|50248606|FG000|Overall Study|Death|2|||
25135600|NCT02070991|50248607|FG001|Overall Study|Death|0|||
25135601|NCT02070991|50248606|FG000|Overall Study|Withdrawal by Subject|1|||
25135602|NCT02070991|50248607|FG001|Overall Study|Withdrawal by Subject|0|||
25135603|NCT02114515|50248615|FG000|Overall Study|Lost to Follow-up|52|||
25135604|NCT02114515|50248616|FG001|Overall Study|Lost to Follow-up|55|||
25135605|NCT02114515|50248615|FG000|Overall Study|Death|12|||
25135606|NCT02114515|50248616|FG001|Overall Study|Death|12|||
25135607|NCT02114515|50248615|FG000|Overall Study|Withdrawal by Subject|4|||
25135608|NCT02114515|50248616|FG001|Overall Study|Withdrawal by Subject|22|||
25135609|NCT02114515|50248615|FG000|Overall Study|Other|65|||
25135610|NCT02114515|50248616|FG001|Overall Study|Other|61|||
25135611|NCT01490086|50248627|FG000|Overall Study|Consent withdrawn|4|||
25135612|NCT01490086|50248628|FG001|Overall Study|Consent withdrawn|4|||
25135613|NCT01490086|50248629|FG002|Overall Study|Consent withdrawn|3|||
25135614|NCT01490086|50248630|FG003|Overall Study|Consent withdrawn|0|||
25135615|NCT01490086|50248631|FG004|Overall Study|Consent withdrawn|1|||
25135616|NCT01490086|50248627|FG000|Overall Study|Non-compliance|0|||
25135617|NCT01490086|50248628|FG001|Overall Study|Non-compliance|1|||
25135618|NCT01490086|50248629|FG002|Overall Study|Non-compliance|0|||
25135619|NCT01490086|50248630|FG003|Overall Study|Non-compliance|0|||
25135620|NCT01490086|50248631|FG004|Overall Study|Non-compliance|0|||
25135621|NCT01490086|50248627|FG000|Overall Study|Abnormal laboratory findings|1|||
25135622|NCT01490086|50248628|FG001|Overall Study|Abnormal laboratory findings|0|||
25135623|NCT01490086|50248629|FG002|Overall Study|Abnormal laboratory findings|0|||
25135624|NCT01490086|50248630|FG003|Overall Study|Abnormal laboratory findings|0|||
25135625|NCT01490086|50248631|FG004|Overall Study|Abnormal laboratory findings|0|||
25135626|NCT01490086|50248627|FG000|Overall Study|Lost to Follow-up|0|||
25135627|NCT01490086|50248628|FG001|Overall Study|Lost to Follow-up|0|||
25135628|NCT01490086|50248629|FG002|Overall Study|Lost to Follow-up|0|||
25135629|NCT01490086|50248630|FG003|Overall Study|Lost to Follow-up|0|||
25135630|NCT01490086|50248631|FG004|Overall Study|Lost to Follow-up|1|||
25135631|NCT01490086|50248627|FG000|Overall Study|Physician Decision|3|||
25135632|NCT01490086|50248628|FG001|Overall Study|Physician Decision|4|||
25135633|NCT01490086|50248629|FG002|Overall Study|Physician Decision|2|||
25135634|NCT01490086|50248630|FG003|Overall Study|Physician Decision|3|||
25135635|NCT01490086|50248631|FG004|Overall Study|Physician Decision|1|||
25135636|NCT01490086|50248627|FG000|Overall Study|Adverse Event|0|||
25135637|NCT01490086|50248628|FG001|Overall Study|Adverse Event|0|||
25135638|NCT01490086|50248629|FG002|Overall Study|Adverse Event|1|||
25135639|NCT01490086|50248630|FG003|Overall Study|Adverse Event|2|||
25135640|NCT01490086|50248631|FG004|Overall Study|Adverse Event|0|||
25135641|NCT01490086|50248627|FG000|Overall Study|Lack of Efficacy|0|||
25135642|NCT01490086|50248628|FG001|Overall Study|Lack of Efficacy|3|||
25135643|NCT01490086|50248629|FG002|Overall Study|Lack of Efficacy|1|||
25135644|NCT01490086|50248630|FG003|Overall Study|Lack of Efficacy|0|||
25135645|NCT01490086|50248631|FG004|Overall Study|Lack of Efficacy|8|||
25135646|NCT01490086|50248627|FG000|Overall Study|Worsening of symptoms|0|||
25135647|NCT01490086|50248628|FG001|Overall Study|Worsening of symptoms|1|||
25135648|NCT01490086|50248629|FG002|Overall Study|Worsening of symptoms|0|||
25135649|NCT01490086|50248630|FG003|Overall Study|Worsening of symptoms|1|||
25135650|NCT01490086|50248631|FG004|Overall Study|Worsening of symptoms|0|||
25135651|NCT01490086|50248627|FG000|Overall Study|Subject uncontrollable and abusive|0|||
25135652|NCT01490086|50248628|FG001|Overall Study|Subject uncontrollable and abusive|1|||
25135653|NCT01490086|50248629|FG002|Overall Study|Subject uncontrollable and abusive|0|||
25135654|NCT01490086|50248630|FG003|Overall Study|Subject uncontrollable and abusive|0|||
25135655|NCT01490086|50248631|FG004|Overall Study|Subject uncontrollable and abusive|0|||
25135656|NCT01490086|50248627|FG000|Overall Study|Subject left hospital|0|||
25135657|NCT01490086|50248628|FG001|Overall Study|Subject left hospital|1|||
25135658|NCT01490086|50248629|FG002|Overall Study|Subject left hospital|0|||
25135659|NCT01490086|50248630|FG003|Overall Study|Subject left hospital|1|||
25135660|NCT01490086|50248631|FG004|Overall Study|Subject left hospital|0|||
25135661|NCT02114203|50248646|FG000|Overall Study|Adverse Event|0|||
25273562|NCT00980980|50587662|FG000|Overall Study|Withdrawal by Hospital|0|||
25273563|NCT00980980|50587663|FG001|Overall Study|Withdrawal by Hospital|1|||
25273564|NCT00980980|50587664|FG002|Overall Study|Withdrawal by Hospital|0|||
25273565|NCT00980200|50587675|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
25273566|NCT00980200|50587676|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
25273567|NCT00980200|50587677|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
25273568|NCT00980200|50587678|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
25273569|NCT00980200|50587679|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
25273570|NCT00980200|50587675|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
25273571|NCT00980200|50587676|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
25273572|NCT00980200|50587677|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
25273573|NCT00980200|50587678|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
25273574|NCT00980200|50587679|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
25273575|NCT00979654|50587691|FG000|Overall Study|Lost to Follow-up|1|||
25273576|NCT00979654|50587691|FG000|Overall Study|Withdrawal by Subject|22|||
25273577|NCT00979654|50587691|FG000|Overall Study|Death|1|||
25273578|NCT00979654|50587691|FG000|Overall Study|Lack of Efficacy|6|||
25273579|NCT00979654|50587691|FG000|Overall Study|Adverse Event|1|||
25273580|NCT00979654|50587691|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
25273581|NCT00979654|50587691|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
25273582|NCT00979654|50587691|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
25273583|NCT00979654|50587691|FG000|Overall Study|Serious Adverse Event|1|||
25273584|NCT00979654|50587691|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
25273585|NCT00978562|50587695|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
25273586|NCT02865460|50587703|FG000|Overall Study|Adverse Event|1|||
25273587|NCT02865460|50587704|FG001|Overall Study|Adverse Event|0|||
25273588|NCT02865460|50587703|FG000|Overall Study|Withdrawal by Subject|1|||
25273589|NCT02865460|50587704|FG001|Overall Study|Withdrawal by Subject|1|||
25273590|NCT02865460|50587703|FG000|Overall Study|Lost to Follow-up|7|||
25273591|NCT02865460|50587704|FG001|Overall Study|Lost to Follow-up|4|||
25273592|NCT02865460|50587703|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
25273593|NCT02865460|50587704|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
25273594|NCT01206816|50587717|FG000|Overall Study|Protocol Violation|0|||
25273595|NCT01206816|50587718|FG001|Overall Study|Protocol Violation|0|||
25273596|NCT01206816|50587719|FG002|Overall Study|Protocol Violation|1|||
25135662|NCT02114203|50248647|FG001|Overall Study|Adverse Event|1|||
25135663|NCT02114203|50248648|FG002|Overall Study|Adverse Event|0|||
25135664|NCT02114203|50248646|FG000|Overall Study|Withdrawal by Subject|0|||
25135665|NCT02114203|50248647|FG001|Overall Study|Withdrawal by Subject|1|||
25135666|NCT02114203|50248648|FG002|Overall Study|Withdrawal by Subject|0|||
25135667|NCT02113579|50248658|FG000|Overall Study|Adverse Event|1|||
25135668|NCT02113579|50248659|FG001|Overall Study|Adverse Event|0|||
25135669|NCT02113579|50248658|FG000|Overall Study|Withdrawal by Subject|3|||
25135670|NCT02113579|50248659|FG001|Overall Study|Withdrawal by Subject|2|||
25135671|NCT02113579|50248658|FG000|Overall Study|Lost to Follow-up|6|||
25135672|NCT02113579|50248659|FG001|Overall Study|Lost to Follow-up|2|||
25135673|NCT01474018|50248667|FG000|Overall Study|Lost to Follow-up|0|||
25135674|NCT01474018|50248668|FG001|Overall Study|Lost to Follow-up|1|||
25135675|NCT01474018|50248667|FG000|Overall Study|Withdrawal by Subject|0|||
25135676|NCT01474018|50248668|FG001|Overall Study|Withdrawal by Subject|2|||
25135677|NCT02100475|50248676|FG000|Overall Study|Unclassified|1|||
25273597|NCT01206816|50587720|FG003|Overall Study|Protocol Violation|0|||
25273598|NCT01206816|50587721|FG004|Overall Study|Protocol Violation|0|||
25273599|NCT01206816|50587722|FG005|Overall Study|Protocol Violation|0|||
25273600|NCT01206816|50587723|FG006|Overall Study|Protocol Violation|0|||
25273601|NCT01206816|50587717|FG000|Overall Study|Withdrawal by Subject|0|||
25273602|NCT01206816|50587718|FG001|Overall Study|Withdrawal by Subject|0|||
25273603|NCT01206816|50587719|FG002|Overall Study|Withdrawal by Subject|1|||
25273604|NCT01206816|50587720|FG003|Overall Study|Withdrawal by Subject|0|||
25273605|NCT01206816|50587721|FG004|Overall Study|Withdrawal by Subject|0|||
25273606|NCT01206816|50587722|FG005|Overall Study|Withdrawal by Subject|0|||
25273607|NCT01206816|50587723|FG006|Overall Study|Withdrawal by Subject|0|||
25273608|NCT01206816|50587717|FG000|Overall Study|Progressive disease|3|||
25273609|NCT01206816|50587718|FG001|Overall Study|Progressive disease|3|||
25273610|NCT01206816|50587719|FG002|Overall Study|Progressive disease|13|||
25273611|NCT01206816|50587720|FG003|Overall Study|Progressive disease|3|||
25273612|NCT01206816|50587721|FG004|Overall Study|Progressive disease|3|||
25273613|NCT01206816|50587722|FG005|Overall Study|Progressive disease|16|||
25273614|NCT01206816|50587723|FG006|Overall Study|Progressive disease|3|||
25273615|NCT01206816|50587717|FG000|Overall Study|Other AE|0|||
25273616|NCT01206816|50587718|FG001|Overall Study|Other AE|0|||
25273617|NCT01206816|50587719|FG002|Overall Study|Other AE|4|||
25273618|NCT01206816|50587720|FG003|Overall Study|Other AE|0|||
25273619|NCT01206816|50587721|FG004|Overall Study|Other AE|0|||
25273620|NCT01206816|50587722|FG005|Overall Study|Other AE|3|||
25273621|NCT01206816|50587723|FG006|Overall Study|Other AE|2|||
25273622|NCT01206816|50587717|FG000|Overall Study|other than stated above|0|||
25273623|NCT01206816|50587718|FG001|Overall Study|other than stated above|0|||
25273624|NCT01206816|50587719|FG002|Overall Study|other than stated above|1|||
25273625|NCT01206816|50587720|FG003|Overall Study|other than stated above|0|||
25273626|NCT01206816|50587721|FG004|Overall Study|other than stated above|0|||
25273627|NCT01206816|50587722|FG005|Overall Study|other than stated above|0|||
25273628|NCT01206816|50587723|FG006|Overall Study|other than stated above|1|||
25273629|NCT01206582|50587745|FG000|Overall Study|Withdrew prior to study|1|||
25273630|NCT01206582|50587746|FG001|Overall Study|Withdrew prior to study|0|||
25273631|NCT01206582|50587745|FG000|Overall Study|Discontinued intervention before week 8|1|||
25273632|NCT01206582|50587746|FG001|Overall Study|Discontinued intervention before week 8|2|||
25273633|NCT01259102|50587757|FG000|Overall Study|Adverse Event|1|||
25273634|NCT01259102|50587758|FG001|Overall Study|Adverse Event|0|||
25135678|NCT02100475|50248677|FG001|Overall Study|Unclassified|2|||
25273635|NCT01259102|50587759|FG002|Overall Study|Adverse Event|1|||
25273636|NCT01259102|50587760|FG003|Overall Study|Adverse Event|1|||
25135679|NCT02100475|50248676|FG000|Overall Study|Withdrawal criteria|1|||
25135680|NCT02100475|50248677|FG001|Overall Study|Withdrawal criteria|0|||
25135681|NCT02113189|50248686|FG000|Overall Study|Lost to follow up|2|||
25135682|NCT02113189|50248687|FG001|Overall Study|Lost to follow up|1|||
25135683|NCT02113189|50248688|FG002|Overall Study|Lost to follow up|3|||
25135684|NCT01440946|50248701|FG000|Overall Study|Lost to Follow-up|1|||
25135685|NCT01440946|50248702|FG001|Overall Study|Lost to Follow-up|1|||
25135686|NCT01440946|50248701|FG000|Overall Study|Physician Decision|1|||
25135687|NCT01440946|50248702|FG001|Overall Study|Physician Decision|0|||
25135688|NCT01450540|50248711|FG000|Overall Study|Withdrawal by Subject|19|||
25135689|NCT01450540|50248712|FG001|Overall Study|Withdrawal by Subject|13|||
25135690|NCT01450540|50248711|FG000|Overall Study|protocol deviation|3|||
25135691|NCT01450540|50248712|FG001|Overall Study|protocol deviation|23|||
25135692|NCT02070757|50248722|FG000|Overall Study|Adverse Event|107|||
25135693|NCT02070757|50248723|FG001|Overall Study|Adverse Event|99|||
25135694|NCT02070757|50248722|FG000|Overall Study|Lost to Follow-up|7|||
25135695|NCT02070757|50248723|FG001|Overall Study|Lost to Follow-up|4|||
25135696|NCT02070757|50248722|FG000|Overall Study|Protocol Violation|0|||
25135697|NCT02070757|50248723|FG001|Overall Study|Protocol Violation|4|||
25135698|NCT02070757|50248722|FG000|Overall Study|Withdrawal by Subject|1|||
25135699|NCT02070757|50248723|FG001|Overall Study|Withdrawal by Subject|3|||
25135700|NCT02070757|50248722|FG000|Overall Study|Investigator Decision|0|||
25135701|NCT02070757|50248723|FG001|Overall Study|Investigator Decision|2|||
25135702|NCT02070757|50248722|FG000|Overall Study|Discharged from Study Hospital|2|||
25135703|NCT02070757|50248723|FG001|Overall Study|Discharged from Study Hospital|2|||
25135704|NCT02100319|50248729|FG000|Overall Study|Case Report Forms Uncollected|11|||
25135705|NCT02100319|50248729|FG000|Overall Study|Protocol Deviation|5|||
25135706|NCT01625845|50248735|FG000|Overall Study|Adverse Event|1|||
25135707|NCT01625845|50248736|FG001|Overall Study|Adverse Event|2|||
25135708|NCT01625845|50248735|FG000|Overall Study|Lost to Follow-up|2|||
25135709|NCT01625845|50248736|FG001|Overall Study|Lost to Follow-up|1|||
25135710|NCT01625845|50248735|FG000|Overall Study|Withdrawal by Subject|2|||
25135711|NCT01625845|50248736|FG001|Overall Study|Withdrawal by Subject|0|||
25135712|NCT01473940|50248746|FG000|Induction Therapy|Death|0|||
25135713|NCT01473940|50248747|FG001|Induction Therapy|Death|0|||
25135714|NCT01473940|50248748|FG002|Induction Therapy|Death|1|||
25135715|NCT01473940|50248749|FG003|Induction Therapy|Death|1|||
25135716|NCT01473940|50248746|FG000|Induction Therapy|Progressive Disease|0|||
25135717|NCT01473940|50248747|FG001|Induction Therapy|Progressive Disease|1|||
25135718|NCT01473940|50248748|FG002|Induction Therapy|Progressive Disease|1|||
25135719|NCT01473940|50248749|FG003|Induction Therapy|Progressive Disease|0|||
25135720|NCT01473940|50248746|FG000|Maintenance Therapy|Progressive Disease|1|||
25135721|NCT01473940|50248747|FG001|Maintenance Therapy|Progressive Disease|2|||
25135722|NCT01473940|50248748|FG002|Maintenance Therapy|Progressive Disease|1|||
25135723|NCT01473940|50248749|FG003|Maintenance Therapy|Progressive Disease|4|||
25135724|NCT01832727|50248771|FG000|Overall Study|Adverse Event|4|||
25135725|NCT01832727|50248772|FG001|Overall Study|Adverse Event|6|||
25135726|NCT01832727|50248773|FG002|Overall Study|Adverse Event|1|||
25135727|NCT01832727|50248774|FG003|Overall Study|Adverse Event|0|||
25135728|NCT01832727|50248775|FG004|Overall Study|Adverse Event|1|||
25135729|NCT01832727|50248776|FG005|Overall Study|Adverse Event|1|||
25135730|NCT01832727|50248777|FG006|Overall Study|Adverse Event|2|||
25135731|NCT01832727|50248778|FG007|Overall Study|Adverse Event|1|||
25135732|NCT01832727|50248779|FG008|Overall Study|Adverse Event|9|||
25135733|NCT01832727|50248771|FG000|Overall Study|Disease progression|3|||
25135734|NCT01832727|50248772|FG001|Overall Study|Disease progression|0|||
25135735|NCT01832727|50248773|FG002|Overall Study|Disease progression|2|||
25135736|NCT01832727|50248774|FG003|Overall Study|Disease progression|1|||
25135737|NCT01832727|50248775|FG004|Overall Study|Disease progression|3|||
25135738|NCT01832727|50248776|FG005|Overall Study|Disease progression|3|||
25135739|NCT01832727|50248777|FG006|Overall Study|Disease progression|6|||
25135740|NCT01832727|50248778|FG007|Overall Study|Disease progression|2|||
25135741|NCT01832727|50248779|FG008|Overall Study|Disease progression|7|||
25135742|NCT01832727|50248771|FG000|Overall Study|Lost to Follow-up|0|||
25135743|NCT01832727|50248772|FG001|Overall Study|Lost to Follow-up|0|||
25135744|NCT01832727|50248773|FG002|Overall Study|Lost to Follow-up|0|||
25135745|NCT01832727|50248774|FG003|Overall Study|Lost to Follow-up|1|||
25135746|NCT01832727|50248775|FG004|Overall Study|Lost to Follow-up|0|||
25135747|NCT01832727|50248776|FG005|Overall Study|Lost to Follow-up|0|||
25135748|NCT01832727|50248777|FG006|Overall Study|Lost to Follow-up|0|||
25135749|NCT01832727|50248778|FG007|Overall Study|Lost to Follow-up|0|||
25135750|NCT01832727|50248779|FG008|Overall Study|Lost to Follow-up|0|||
25135751|NCT01832727|50248771|FG000|Overall Study|Physician Decision|1|||
25135752|NCT01832727|50248772|FG001|Overall Study|Physician Decision|0|||
25135753|NCT01832727|50248773|FG002|Overall Study|Physician Decision|0|||
25135754|NCT01832727|50248774|FG003|Overall Study|Physician Decision|1|||
25135755|NCT01832727|50248775|FG004|Overall Study|Physician Decision|0|||
25178857|NCT01506193|50324176|FG000|Overall Study|Withdrawal by Subject|5|||
25178858|NCT01506193|50324177|FG001|Overall Study|Withdrawal by Subject|1|||
25273637|NCT01259102|50587761|FG004|Overall Study|Adverse Event|0|||
25273638|NCT01259102|50587757|FG000|Overall Study|Other|0|||
25273639|NCT01259102|50587758|FG001|Overall Study|Other|0|||
25273640|NCT01259102|50587759|FG002|Overall Study|Other|1|||
25273641|NCT01259102|50587760|FG003|Overall Study|Other|1|||
25273642|NCT01259102|50587761|FG004|Overall Study|Other|1|||
25273643|NCT00978250|50587777|FG000|Overall Study|Late determination of ineligibility|0|||
25273644|NCT00978250|50587778|FG001|Overall Study|Late determination of ineligibility|1|||
25273645|NCT00978250|50587779|FG002|Overall Study|Late determination of ineligibility|0|||
25273646|NCT00978250|50587780|FG003|Overall Study|Late determination of ineligibility|1|||
25135756|NCT01832727|50248776|FG005|Overall Study|Physician Decision|1|||
25135757|NCT01832727|50248777|FG006|Overall Study|Physician Decision|0|||
25135758|NCT01832727|50248778|FG007|Overall Study|Physician Decision|0|||
25135759|NCT01832727|50248779|FG008|Overall Study|Physician Decision|0|||
25135760|NCT01832727|50248771|FG000|Overall Study|Withdrawal by Subject|1|||
25135761|NCT01832727|50248772|FG001|Overall Study|Withdrawal by Subject|1|||
25135762|NCT01832727|50248773|FG002|Overall Study|Withdrawal by Subject|0|||
25135763|NCT01832727|50248774|FG003|Overall Study|Withdrawal by Subject|1|||
25135764|NCT01832727|50248775|FG004|Overall Study|Withdrawal by Subject|0|||
25135765|NCT01832727|50248776|FG005|Overall Study|Withdrawal by Subject|1|||
25135766|NCT01832727|50248777|FG006|Overall Study|Withdrawal by Subject|0|||
25135767|NCT01832727|50248778|FG007|Overall Study|Withdrawal by Subject|2|||
25135768|NCT01832727|50248779|FG008|Overall Study|Withdrawal by Subject|1|||
25135769|NCT01832727|50248771|FG000|Overall Study|Study terminated by sponsor|0|||
25135770|NCT01832727|50248772|FG001|Overall Study|Study terminated by sponsor|0|||
25135771|NCT01832727|50248773|FG002|Overall Study|Study terminated by sponsor|0|||
25135772|NCT01832727|50248774|FG003|Overall Study|Study terminated by sponsor|0|||
25135773|NCT01832727|50248775|FG004|Overall Study|Study terminated by sponsor|0|||
25135774|NCT01832727|50248776|FG005|Overall Study|Study terminated by sponsor|0|||
25135775|NCT01832727|50248777|FG006|Overall Study|Study terminated by sponsor|0|||
25135776|NCT01832727|50248778|FG007|Overall Study|Study terminated by sponsor|1|||
25135777|NCT01832727|50248779|FG008|Overall Study|Study terminated by sponsor|1|||
25135778|NCT01473394|50248810|FG000|Overall Study|Adverse Event|13|||
25135779|NCT01473394|50248811|FG001|Overall Study|Adverse Event|16|||
25135780|NCT01473394|50248810|FG000|Overall Study|Insufficient Therapeutic Response|4|||
25135781|NCT01473394|50248811|FG001|Overall Study|Insufficient Therapeutic Response|1|||
25135782|NCT01473394|50248810|FG000|Overall Study|Protocol Violation|7|||
25135783|NCT01473394|50248811|FG001|Overall Study|Protocol Violation|5|||
25135784|NCT01473394|50248810|FG000|Overall Study|Withdrew Consent|12|||
25135785|NCT01473394|50248811|FG001|Overall Study|Withdrew Consent|10|||
25135786|NCT01473394|50248810|FG000|Overall Study|Lost to Follow-up|9|||
25135787|NCT01473394|50248811|FG001|Overall Study|Lost to Follow-up|11|||
25135788|NCT01449682|50248819|FG000|Overall Study|Death|0|||
25135789|NCT01449682|50248820|FG001|Overall Study|Death|1|||
25135790|NCT01449682|50248819|FG000|Overall Study|Adverse Event|1|||
25135791|NCT01449682|50248820|FG001|Overall Study|Adverse Event|0|||
25135792|NCT01449526|50248828|FG000|Overall Study|Lost to Follow-up|1|||
25135793|NCT01449526|50248829|FG001|Overall Study|Lost to Follow-up|2|||
25135794|NCT01449526|50248828|FG000|Overall Study|Withdrawal by Subject|1|||
25135795|NCT01449526|50248829|FG001|Overall Study|Withdrawal by Subject|1|||
25135796|NCT01449526|50248828|FG000|Overall Study|Symptoms/complaints|0|||
25135797|NCT01449526|50248829|FG001|Overall Study|Symptoms/complaints|1|||
25135798|NCT01449526|50248828|FG000|Overall Study|Lack of Motivation|0|||
25135799|NCT01449526|50248829|FG001|Overall Study|Lack of Motivation|1|||
25135800|NCT01449526|50248828|FG000|Overall Study|Cannot maintain visits|0|||
25135801|NCT01449526|50248829|FG001|Overall Study|Cannot maintain visits|1|||
25135802|NCT01440322|50248837|FG000|Overall Study|Discomfort|2|||
25135803|NCT01440322|50248838|FG001|Overall Study|Discomfort|0|||
25135804|NCT01440322|50248837|FG000|Overall Study|Biomicroscopy|1|||
25135805|NCT01440322|50248838|FG001|Overall Study|Biomicroscopy|0|||
25135806|NCT01440322|50248837|FG000|Overall Study|Symptoms and Problems|1|||
25135807|NCT01440322|50248838|FG001|Overall Study|Symptoms and Problems|0|||
25135808|NCT01440322|50248837|FG000|Overall Study|Unacceptable Subjective Vision|1|||
25135809|NCT01440322|50248838|FG001|Overall Study|Unacceptable Subjective Vision|0|||
25135810|NCT01440322|50248837|FG000|Overall Study|Other Product Related|1|||
25135811|NCT01440322|50248838|FG001|Overall Study|Other Product Related|0|||
25135812|NCT01440322|50248837|FG000|Overall Study|Unrelated Medical Problem|0|||
25135813|NCT01440322|50248838|FG001|Overall Study|Unrelated Medical Problem|1|||
25135814|NCT01440322|50248837|FG000|Overall Study|Other Non-Product Related|1|||
25135815|NCT01440322|50248838|FG001|Overall Study|Other Non-Product Related|0|||
25135816|NCT01832493|50248844|FG000|Overall Study|Physician Decision|2|||
25135817|NCT01832493|50248844|FG000|Overall Study|Protocol Violation|4|||
25135818|NCT01832493|50248844|FG000|Overall Study|Unable to place LV lead|2|||
25135819|NCT01831791|50248848|FG000|Overall Study|Withdrawal by Subject|10|||
25135820|NCT01857531|50248852|FG000|Overall Study|Withdrawal by Subject|4|||
25135821|NCT02166047|50248868|FG000|Overall Study|Withdrawal by Participant|0|||
25135822|NCT02166047|50248869|FG001|Overall Study|Withdrawal by Participant|1|||
25135823|NCT02166047|50248870|FG002|Overall Study|Withdrawal by Participant|2|||
25135824|NCT02166047|50248871|FG003|Overall Study|Withdrawal by Participant|0|||
25135825|NCT02166047|50248872|FG004|Overall Study|Withdrawal by Participant|0|||
25135826|NCT02166047|50248873|FG005|Overall Study|Withdrawal by Participant|0|||
25135827|NCT02166047|50248874|FG006|Overall Study|Withdrawal by Participant|1|||
25135828|NCT02166047|50248875|FG007|Overall Study|Withdrawal by Participant|0|||
25135829|NCT02166047|50248876|FG008|Overall Study|Withdrawal by Participant|0|||
25135830|NCT02166047|50248877|FG009|Overall Study|Withdrawal by Participant|0|||
25135831|NCT02166047|50248878|FG010|Overall Study|Withdrawal by Participant|0|||
25135832|NCT02166047|50248879|FG011|Overall Study|Withdrawal by Participant|0|||
25135833|NCT02166047|50248868|FG000|Overall Study|Adverse Event|0|||
25135834|NCT02166047|50248869|FG001|Overall Study|Adverse Event|0|||
25135835|NCT02166047|50248870|FG002|Overall Study|Adverse Event|0|||
25135836|NCT02166047|50248871|FG003|Overall Study|Adverse Event|0|||
25135837|NCT02166047|50248872|FG004|Overall Study|Adverse Event|1|||
25135838|NCT02166047|50248873|FG005|Overall Study|Adverse Event|0|||
25273647|NCT01259024|50587792|FG000|Overall Study|Physician Decision|1|||
25273648|NCT01257698|50587798|FG000|Overall Study|Protocol Violation|4|||
25135839|NCT02166047|50248874|FG006|Overall Study|Adverse Event|1|||
25135840|NCT02166047|50248875|FG007|Overall Study|Adverse Event|0|||
25135841|NCT02166047|50248876|FG008|Overall Study|Adverse Event|0|||
25135842|NCT02166047|50248877|FG009|Overall Study|Adverse Event|0|||
25135843|NCT02166047|50248878|FG010|Overall Study|Adverse Event|2|||
25135844|NCT02166047|50248879|FG011|Overall Study|Adverse Event|0|||
25135845|NCT01493284|50248905|FG000|Overall Study|Death|29|||
25135846|NCT01493284|50248905|FG000|Overall Study|Withdrawal by Subject|32|||
25273649|NCT01257698|50587799|FG001|Overall Study|Protocol Violation|0|||
25273650|NCT01257542|50587807|FG000|Overall Study|Protocol Violation|3|||
25273651|NCT01257542|50587808|FG001|Overall Study|Protocol Violation|5|||
25273652|NCT01257542|50587807|FG000|Overall Study|Withdrawal by Subject|0|||
25273653|NCT01257542|50587808|FG001|Overall Study|Withdrawal by Subject|2|||
25273654|NCT01257230|50587817|FG000|Overall Study|Not Treated|0|||
25273655|NCT01257230|50587818|FG001|Overall Study|Not Treated|0|||
25273656|NCT01257230|50587819|FG002|Overall Study|Not Treated|1|||
25273657|NCT01257230|50587817|FG000|Overall Study|Adverse Event|2|||
25273658|NCT01257230|50587818|FG001|Overall Study|Adverse Event|0|||
25273659|NCT01257230|50587819|FG002|Overall Study|Adverse Event|0|||
25273660|NCT01257230|50587817|FG000|Overall Study|Lack of Efficacy|0|||
25273661|NCT01257230|50587818|FG001|Overall Study|Lack of Efficacy|1|||
25135847|NCT02165735|50248911|FG000|Overall Study|Lost to Follow-up|12|||
25135848|NCT02165735|50248912|FG001|Overall Study|Lost to Follow-up|10|||
25135849|NCT02165735|50248911|FG000|Overall Study|Withdrawal by Subject|3|||
25135850|NCT02165735|50248912|FG001|Overall Study|Withdrawal by Subject|0|||
25135851|NCT02165735|50248911|FG000|Overall Study|Participant indicated lack of time|1|||
25135852|NCT02165735|50248912|FG001|Overall Study|Participant indicated lack of time|3|||
25135853|NCT02165735|50248911|FG000|Overall Study|Protocol Violation|0|||
25135854|NCT02165735|50248912|FG001|Overall Study|Protocol Violation|1|||
25135855|NCT02069899|50248921|FG000|Overall Study|Adverse Event|6|||
25135856|NCT02069899|50248922|FG001|Overall Study|Adverse Event|0|||
25135857|NCT02069899|50248923|FG002|Overall Study|Adverse Event|1|||
25135858|NCT02069899|50248921|FG000|Overall Study|Withdrawal by Participant|2|||
25135859|NCT02069899|50248922|FG001|Overall Study|Withdrawal by Participant|0|||
25135860|NCT02069899|50248923|FG002|Overall Study|Withdrawal by Participant|0|||
25135861|NCT02069899|50248921|FG000|Overall Study|Lost to Follow-up|1|||
25135862|NCT02069899|50248922|FG001|Overall Study|Lost to Follow-up|0|||
25135863|NCT02069899|50248923|FG002|Overall Study|Lost to Follow-up|1|||
25135864|NCT02069899|50248921|FG000|Overall Study|Other|4|||
25135865|NCT02069899|50248922|FG001|Overall Study|Other|0|||
25135866|NCT02069899|50248923|FG002|Overall Study|Other|0|||
25135867|NCT02069899|50248921|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
25135868|NCT02069899|50248922|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
25135869|NCT02069899|50248923|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
25135870|NCT02069899|50248921|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
25135871|NCT02069899|50248922|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
25135872|NCT02069899|50248923|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
25135873|NCT01831089|50248938|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
25135874|NCT01831089|50248939|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
25135875|NCT01831089|50248940|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
25135876|NCT01831089|50248941|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
25135877|NCT01831089|50248942|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
25135878|NCT01831089|50248943|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
25135879|NCT01831089|50248938|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
25135880|NCT01831089|50248939|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
25135881|NCT01831089|50248940|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
25135882|NCT01831089|50248941|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
25135883|NCT01831089|50248942|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
25135884|NCT01831089|50248943|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
25135885|NCT01831089|50248938|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
25135886|NCT01831089|50248939|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
25135887|NCT01831089|50248940|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
25135888|NCT01831089|50248941|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
25135889|NCT01831089|50248942|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
25135890|NCT01831089|50248943|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
25135891|NCT01831089|50248938|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
25135892|NCT01831089|50248939|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
25135893|NCT01831089|50248940|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
25135894|NCT01831089|50248941|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
25135895|NCT01831089|50248942|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
25135896|NCT01831089|50248943|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
25135897|NCT01831089|50248938|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
25135898|NCT01831089|50248939|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
25135899|NCT01831089|50248940|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
25135900|NCT01831089|50248941|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
25135901|NCT01831089|50248942|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
25135902|NCT01831089|50248943|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
25135903|NCT01831089|50248938|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
25135904|NCT01831089|50248939|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
25135905|NCT01831089|50248940|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
25135906|NCT01831089|50248941|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
25135907|NCT01831089|50248942|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
25135908|NCT01831089|50248943|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
25135909|NCT01831089|50248938|FG000|Cohort III: Dose Level 3|Global end of study|0|||
25135910|NCT01831089|50248939|FG001|Cohort III: Dose Level 3|Global end of study|0|||
25135911|NCT01831089|50248940|FG002|Cohort III: Dose Level 3|Global end of study|1|||
25273662|NCT01257230|50587819|FG002|Overall Study|Lack of Efficacy|0|||
25273663|NCT01257230|50587817|FG000|Overall Study|Protocol Violation|3|||
25273664|NCT01257230|50587818|FG001|Overall Study|Protocol Violation|0|||
25135912|NCT01831089|50248941|FG003|Cohort III: Dose Level 3|Global end of study|0|||
25135913|NCT01831089|50248942|FG004|Cohort III: Dose Level 3|Global end of study|0|||
25135914|NCT01831089|50248943|FG005|Cohort III: Dose Level 3|Global end of study|0|||
25135915|NCT01831089|50248938|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
25135916|NCT01831089|50248939|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
25135917|NCT01831089|50248940|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
25135918|NCT01831089|50248941|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
25135919|NCT01831089|50248942|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
25135920|NCT01831089|50248943|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
25135921|NCT01831089|50248938|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
25135922|NCT01831089|50248939|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
25135923|NCT01831089|50248940|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
25135924|NCT01831089|50248941|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
25135925|NCT01831089|50248942|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
25135926|NCT01831089|50248943|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
25135927|NCT01831089|50248938|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
25135928|NCT01831089|50248939|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
25135929|NCT01831089|50248940|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
25135930|NCT01831089|50248941|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
25135931|NCT01831089|50248942|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
25135932|NCT01831089|50248943|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
25135933|NCT01831089|50248938|FG000|Cohort V: Dose Level 5|Death|0|||
25135934|NCT01831089|50248939|FG001|Cohort V: Dose Level 5|Death|0|||
25135935|NCT01831089|50248940|FG002|Cohort V: Dose Level 5|Death|0|||
25135936|NCT01831089|50248941|FG003|Cohort V: Dose Level 5|Death|0|||
25135937|NCT01831089|50248942|FG004|Cohort V: Dose Level 5|Death|1|||
25273665|NCT01257230|50587819|FG002|Overall Study|Protocol Violation|1|||
25273666|NCT01257230|50587817|FG000|Overall Study|Withdrawal by Subject|0|||
25273667|NCT01257230|50587818|FG001|Overall Study|Withdrawal by Subject|4|||
25273668|NCT01257230|50587819|FG002|Overall Study|Withdrawal by Subject|1|||
25273669|NCT01257230|50587817|FG000|Overall Study|Other reason not defined above|1|||
25273670|NCT01257230|50587818|FG001|Overall Study|Other reason not defined above|5|||
25273671|NCT01257230|50587819|FG002|Overall Study|Other reason not defined above|3|||
25273672|NCT01113801|50587832|FG000|Overall Study|Adverse Event|4|||
25273673|NCT01113801|50587833|FG001|Overall Study|Adverse Event|0|||
25273674|NCT01113801|50587834|FG002|Overall Study|Adverse Event|2|||
25135938|NCT01831089|50248943|FG005|Cohort V: Dose Level 5|Death|0|||
25135939|NCT01831089|50248938|FG000|Cohort V: Dose Level 5|Global end of study|0|||
25135940|NCT01831089|50248939|FG001|Cohort V: Dose Level 5|Global end of study|0|||
25135941|NCT01831089|50248940|FG002|Cohort V: Dose Level 5|Global end of study|0|||
25135942|NCT01831089|50248941|FG003|Cohort V: Dose Level 5|Global end of study|0|||
25135943|NCT01831089|50248942|FG004|Cohort V: Dose Level 5|Global end of study|2|||
25135944|NCT01831089|50248943|FG005|Cohort V: Dose Level 5|Global end of study|0|||
25135945|NCT01831089|50248938|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
25135946|NCT01831089|50248939|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
25135947|NCT01831089|50248940|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
25135948|NCT01831089|50248941|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
25135949|NCT01831089|50248942|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
25135950|NCT01831089|50248943|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
25135951|NCT01831089|50248938|FG000|Cohort B: Arm B|Progressive disease|0|||
25135952|NCT01831089|50248939|FG001|Cohort B: Arm B|Progressive disease|0|||
25135953|NCT01831089|50248940|FG002|Cohort B: Arm B|Progressive disease|0|||
25135954|NCT01831089|50248941|FG003|Cohort B: Arm B|Progressive disease|0|||
25135955|NCT01831089|50248942|FG004|Cohort B: Arm B|Progressive disease|0|||
25135956|NCT01831089|50248943|FG005|Cohort B: Arm B|Progressive disease|8|||
25135957|NCT01831089|50248938|FG000|Cohort B: Arm B|Physician Decision|0|||
25135958|NCT01831089|50248939|FG001|Cohort B: Arm B|Physician Decision|0|||
25135959|NCT01831089|50248940|FG002|Cohort B: Arm B|Physician Decision|0|||
25135960|NCT01831089|50248941|FG003|Cohort B: Arm B|Physician Decision|0|||
25135961|NCT01831089|50248942|FG004|Cohort B: Arm B|Physician Decision|0|||
25135962|NCT01831089|50248943|FG005|Cohort B: Arm B|Physician Decision|2|||
25135963|NCT01831089|50248938|FG000|Cohort B: Arm B|Never treated|0|||
25135964|NCT01831089|50248939|FG001|Cohort B: Arm B|Never treated|0|||
25135965|NCT01831089|50248940|FG002|Cohort B: Arm B|Never treated|0|||
25135966|NCT01831089|50248941|FG003|Cohort B: Arm B|Never treated|0|||
25135967|NCT01831089|50248942|FG004|Cohort B: Arm B|Never treated|0|||
25135968|NCT01831089|50248943|FG005|Cohort B: Arm B|Never treated|2|||
25135969|NCT01831089|50248938|FG000|Cohort B: Arm B|Adverse Event|0|||
25135970|NCT01831089|50248939|FG001|Cohort B: Arm B|Adverse Event|0|||
25135971|NCT01831089|50248940|FG002|Cohort B: Arm B|Adverse Event|0|||
25135972|NCT01831089|50248941|FG003|Cohort B: Arm B|Adverse Event|0|||
25135973|NCT01831089|50248942|FG004|Cohort B: Arm B|Adverse Event|0|||
25135974|NCT01831089|50248943|FG005|Cohort B: Arm B|Adverse Event|1|||
25135975|NCT01831089|50248938|FG000|Cohort B: Arm B|Global end of study|0|||
25135976|NCT01831089|50248939|FG001|Cohort B: Arm B|Global end of study|0|||
25135977|NCT01831089|50248940|FG002|Cohort B: Arm B|Global end of study|0|||
25135978|NCT01831089|50248941|FG003|Cohort B: Arm B|Global end of study|0|||
25135979|NCT01831089|50248942|FG004|Cohort B: Arm B|Global end of study|0|||
25135980|NCT01831089|50248943|FG005|Cohort B: Arm B|Global end of study|1|||
25135981|NCT02112877|50248960|FG000|Overall Study|Withdrawal by Subject|1|||
25135982|NCT02112877|50248961|FG001|Overall Study|Withdrawal by Subject|7|||
25135983|NCT02112877|50248960|FG000|Overall Study|Visit Missed|1|||
25135984|NCT02112877|50248961|FG001|Overall Study|Visit Missed|6|||
25135985|NCT02098369|50248972|FG000|Overall Study|Withdrawal by Subject|1|||
25135986|NCT02098369|50248973|FG001|Overall Study|Withdrawal by Subject|5|||
25135987|NCT02098369|50248974|FG002|Overall Study|Withdrawal by Subject|0|||
25135988|NCT02098369|50248972|FG000|Overall Study|Lost to Follow-up|5|||
25135989|NCT02098369|50248973|FG001|Overall Study|Lost to Follow-up|1|||
25135990|NCT02098369|50248974|FG002|Overall Study|Lost to Follow-up|3|||
25135991|NCT02098369|50248972|FG000|Overall Study|Death|1|||
25135992|NCT02098369|50248973|FG001|Overall Study|Death|1|||
25135993|NCT02098369|50248974|FG002|Overall Study|Death|1|||
25135994|NCT02098369|50248972|FG000|Overall Study|Other|0|||
25135995|NCT02098369|50248973|FG001|Overall Study|Other|2|||
25135996|NCT02098369|50248974|FG002|Overall Study|Other|1|||
25135997|NCT02111785|50248986|FG000|Overall Study|Death|0|||
25135998|NCT02111785|50248987|FG001|Overall Study|Death|1|||
25135999|NCT02111785|50248988|FG002|Overall Study|Death|0|||
25136000|NCT02111785|50248989|FG003|Overall Study|Death|0|||
25136001|NCT02068885|50249006|FG000|Overall Study|Withdrew|3|||
25136002|NCT02068885|50249007|FG001|Overall Study|Withdrew|5|||
25136003|NCT02068885|50249008|FG002|Overall Study|Withdrew|8|||
25136004|NCT02068495|50249017|FG000|Overall Study|Case Report Forms Uncollected|60|||
25136005|NCT02068495|50249017|FG000|Overall Study|Protocol Deviation|49|||
25136006|NCT02097823|50249023|FG000|Overall Study|Withdrawal by Subject|1|||
25136007|NCT02097823|50249024|FG001|Overall Study|Withdrawal by Subject|1|||
25136008|NCT01830855|50249035|FG000|Overall Study|Other|7|||
25136009|NCT01830855|50249036|FG001|Overall Study|Other|1|||
25136010|NCT01830855|50249037|FG002|Overall Study|Other|4|||
25136011|NCT01830855|50249038|FG003|Overall Study|Other|4|||
25136012|NCT01830855|50249035|FG000|Overall Study|Medication error without associated AE|1|||
25136013|NCT01830855|50249036|FG001|Overall Study|Medication error without associated AE|0|||
25136014|NCT01830855|50249037|FG002|Overall Study|Medication error without associated AE|0|||
25136015|NCT01830855|50249038|FG003|Overall Study|Medication error without associated AE|1|||
25136016|NCT01830855|50249035|FG000|Overall Study|Pregnancy|3|||
25136017|NCT01830855|50249036|FG001|Overall Study|Pregnancy|1|||
25136018|NCT01830855|50249037|FG002|Overall Study|Pregnancy|2|||
25136019|NCT01830855|50249038|FG003|Overall Study|Pregnancy|1|||
25136020|NCT01830855|50249035|FG000|Overall Study|No longer meets eligibility criteria|11|||
25136021|NCT01830855|50249036|FG001|Overall Study|No longer meets eligibility criteria|2|||
25136022|NCT01830855|50249037|FG002|Overall Study|No longer meets eligibility criteria|3|||
25136023|NCT01830855|50249038|FG003|Overall Study|No longer meets eligibility criteria|5|||
25136024|NCT01830855|50249035|FG000|Overall Study|Adverse Event|11|||
25136025|NCT01830855|50249036|FG001|Overall Study|Adverse Event|5|||
25136026|NCT01830855|50249037|FG002|Overall Study|Adverse Event|6|||
25136027|NCT01830855|50249038|FG003|Overall Study|Adverse Event|3|||
25136028|NCT01830855|50249035|FG000|Overall Study|Protocol deviation|10|||
25136029|NCT01830855|50249036|FG001|Overall Study|Protocol deviation|5|||
25136030|NCT01830855|50249037|FG002|Overall Study|Protocol deviation|6|||
25136031|NCT01830855|50249038|FG003|Overall Study|Protocol deviation|6|||
25136032|NCT01830855|50249035|FG000|Overall Study|Withdrawal by Subject|33|||
25136033|NCT01830855|50249036|FG001|Overall Study|Withdrawal by Subject|14|||
25136034|NCT01830855|50249037|FG002|Overall Study|Withdrawal by Subject|10|||
25136035|NCT01830855|50249038|FG003|Overall Study|Withdrawal by Subject|12|||
25136036|NCT01830855|50249035|FG000|Overall Study|No longer willing to participate|32|||
25136037|NCT01830855|50249036|FG001|Overall Study|No longer willing to participate|13|||
25136038|NCT01830855|50249037|FG002|Overall Study|No longer willing to participate|12|||
25136039|NCT01830855|50249038|FG003|Overall Study|No longer willing to participate|17|||
25136040|NCT01830855|50249035|FG000|Overall Study|Lost to Follow-up|47|||
25136041|NCT01830855|50249036|FG001|Overall Study|Lost to Follow-up|20|||
25136042|NCT01830855|50249037|FG002|Overall Study|Lost to Follow-up|23|||
25136043|NCT01830855|50249038|FG003|Overall Study|Lost to Follow-up|33|||
25136044|NCT01857063|50249055|FG000|Period 1 (7 Days)|Adverse Event|0|||
25136045|NCT01857063|50249056|FG001|Period 1 (7 Days)|Adverse Event|1|||
25136046|NCT01857063|50249055|FG000|Period 1 (7 Days)|Physician Decision|1|||
25136047|NCT01857063|50249056|FG001|Period 1 (7 Days)|Physician Decision|0|||
25136048|NCT01857063|50249055|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
25136049|NCT01857063|50249056|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
25136050|NCT01857063|50249055|FG000|Period 2 (7 Days)|Adverse Event|2|||
25136051|NCT01857063|50249056|FG001|Period 2 (7 Days)|Adverse Event|1|||
25136052|NCT01857063|50249055|FG000|Period 2 (7 Days)|Physician Decision|1|||
25136053|NCT01857063|50249056|FG001|Period 2 (7 Days)|Physician Decision|1|||
25136054|NCT01857063|50249055|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
25136055|NCT01857063|50249056|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
25136056|NCT01856907|50249065|FG000|Overall Study|Pregnancy|0|||
25136057|NCT01856907|50249066|FG001|Overall Study|Pregnancy|1|||
25136058|NCT01856907|50249067|FG002|Overall Study|Pregnancy|0|||
25136059|NCT01856907|50249065|FG000|Overall Study|Pregnancy|0|||
25136060|NCT01856907|50249066|FG001|Overall Study|Pregnancy|1|||
25136061|NCT01856907|50249067|FG002|Overall Study|Pregnancy|0|||
25136062|NCT01856907|50249065|FG000|Overall Study|Withdrawal by Subject|0|||
25136063|NCT01856907|50249066|FG001|Overall Study|Withdrawal by Subject|1|||
25136064|NCT01856907|50249067|FG002|Overall Study|Withdrawal by Subject|0|||
25136065|NCT02212457|50249084|FG000|Overall Study|Adverse Event|1|||
25136066|NCT02212457|50249085|FG001|Overall Study|Adverse Event|2|||
25136067|NCT02212457|50249086|FG002|Overall Study|Adverse Event|2|||
25136068|NCT02212457|50249087|FG003|Overall Study|Adverse Event|2|||
25136069|NCT02212457|50249088|FG004|Overall Study|Adverse Event|0|||
25136070|NCT02212457|50249089|FG005|Overall Study|Adverse Event|1|||
25136071|NCT02212457|50249084|FG000|Overall Study|Withdrawal by Subject|8|||
25136072|NCT02212457|50249085|FG001|Overall Study|Withdrawal by Subject|10|||
25136073|NCT02212457|50249086|FG002|Overall Study|Withdrawal by Subject|8|||
25136074|NCT02212457|50249087|FG003|Overall Study|Withdrawal by Subject|6|||
25136075|NCT02212457|50249088|FG004|Overall Study|Withdrawal by Subject|5|||
25136076|NCT02212457|50249089|FG005|Overall Study|Withdrawal by Subject|4|||
25136077|NCT02212457|50249084|FG000|Overall Study|Lost to Follow-up|6|||
25136078|NCT02212457|50249085|FG001|Overall Study|Lost to Follow-up|7|||
25136079|NCT02212457|50249086|FG002|Overall Study|Lost to Follow-up|4|||
25136080|NCT02212457|50249087|FG003|Overall Study|Lost to Follow-up|1|||
25136081|NCT02212457|50249088|FG004|Overall Study|Lost to Follow-up|8|||
25136082|NCT02212457|50249089|FG005|Overall Study|Lost to Follow-up|4|||
25136083|NCT02212457|50249084|FG000|Overall Study|Protocol Violation|2|||
25136084|NCT02212457|50249085|FG001|Overall Study|Protocol Violation|1|||
25136085|NCT02212457|50249086|FG002|Overall Study|Protocol Violation|0|||
25136086|NCT02212457|50249087|FG003|Overall Study|Protocol Violation|1|||
25136087|NCT02212457|50249088|FG004|Overall Study|Protocol Violation|2|||
25136088|NCT02212457|50249089|FG005|Overall Study|Protocol Violation|3|||
25136089|NCT02212457|50249084|FG000|Overall Study|Other|2|||
25136090|NCT02212457|50249085|FG001|Overall Study|Other|1|||
25136091|NCT02212457|50249086|FG002|Overall Study|Other|2|||
25136092|NCT02212457|50249087|FG003|Overall Study|Other|1|||
25136093|NCT02212457|50249088|FG004|Overall Study|Other|0|||
25136094|NCT02212457|50249089|FG005|Overall Study|Other|1|||
25136095|NCT02097745|50249110|FG000|Overall Study|Adverse Event|25|||
25136096|NCT02097745|50249110|FG000|Overall Study|Death|16|||
25136097|NCT02097745|50249110|FG000|Overall Study|Failure to Return|14|||
25136098|NCT02097745|50249110|FG000|Overall Study|Administrative/Other|27|||
25136099|NCT02097745|50249110|FG000|Overall Study|Reason Not Specified|96|||
25136100|NCT02111083|50249119|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
25136101|NCT02111083|50249120|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
25136102|NCT01629563|50249128|FG000|Overall Study|Adverse Event|16|||
25136103|NCT01629563|50249129|FG001|Overall Study|Adverse Event|16|||
25136104|NCT01629563|50249128|FG000|Overall Study|Death|2|||
25136105|NCT01629563|50249129|FG001|Overall Study|Death|0|||
25136106|NCT01629563|50249128|FG000|Overall Study|Lack of Efficacy|2|||
25136107|NCT01629563|50249129|FG001|Overall Study|Lack of Efficacy|3|||
25136108|NCT01629563|50249128|FG000|Overall Study|Lost to Follow-up|1|||
25136109|NCT01629563|50249129|FG001|Overall Study|Lost to Follow-up|0|||
25136110|NCT01629563|50249128|FG000|Overall Study|Pregnancy|1|||
25136111|NCT01629563|50249129|FG001|Overall Study|Pregnancy|2|||
25136112|NCT01629563|50249128|FG000|Overall Study|Protocol Violation|0|||
25136113|NCT01629563|50249129|FG001|Overall Study|Protocol Violation|1|||
25136114|NCT01629563|50249128|FG000|Overall Study|Withdrawal by Subject|27|||
25136115|NCT01629563|50249129|FG001|Overall Study|Withdrawal by Subject|20|||
25136116|NCT01629563|50249128|FG000|Overall Study|surgery|0|||
25136117|NCT01629563|50249129|FG001|Overall Study|surgery|3|||
25136118|NCT01629563|50249128|FG000|Overall Study|Lack of return of menses|12|||
25136119|NCT01629563|50249129|FG001|Overall Study|Lack of return of menses|7|||
25136120|NCT01629563|50249128|FG000|Overall Study|Protocol Violation|0|||
25136121|NCT01629563|50249129|FG001|Overall Study|Protocol Violation|1|||
25136122|NCT02097277|50249140|FG000|Overall Study|Subject no longer meets study criteria|0|||
25136123|NCT02097277|50249141|FG001|Overall Study|Subject no longer meets study criteria|1|||
25136124|NCT02097277|50249142|FG002|Overall Study|Subject no longer meets study criteria|0|||
25136125|NCT02097277|50249143|FG003|Overall Study|Subject no longer meets study criteria|1|||
25136126|NCT02097277|50249144|FG004|Overall Study|Subject no longer meets study criteria|0|||
25136127|NCT02097277|50249140|FG000|Overall Study|Subject request to discontinue treatment|0|||
25136128|NCT02097277|50249141|FG001|Overall Study|Subject request to discontinue treatment|0|||
25136129|NCT02097277|50249142|FG002|Overall Study|Subject request to discontinue treatment|0|||
25136130|NCT02097277|50249143|FG003|Overall Study|Subject request to discontinue treatment|0|||
25136131|NCT02097277|50249144|FG004|Overall Study|Subject request to discontinue treatment|1|||
25136132|NCT02097277|50249140|FG000|Overall Study|Lost to Follow-up|0|||
25136133|NCT02097277|50249141|FG001|Overall Study|Lost to Follow-up|1|||
25136134|NCT02097277|50249142|FG002|Overall Study|Lost to Follow-up|1|||
25136135|NCT02097277|50249143|FG003|Overall Study|Lost to Follow-up|0|||
25136136|NCT02097277|50249144|FG004|Overall Study|Lost to Follow-up|0|||
25136137|NCT02097277|50249140|FG000|Overall Study|Withdrawal by Subject|2|||
25136138|NCT02097277|50249141|FG001|Overall Study|Withdrawal by Subject|1|||
25136139|NCT02097277|50249142|FG002|Overall Study|Withdrawal by Subject|0|||
25136140|NCT02097277|50249143|FG003|Overall Study|Withdrawal by Subject|1|||
25136141|NCT02097277|50249144|FG004|Overall Study|Withdrawal by Subject|0|||
25273675|NCT01113801|50587835|FG003|Overall Study|Adverse Event|6|||
25273676|NCT01113801|50587832|FG000|Overall Study|Death|4|||
25273677|NCT01113801|50587833|FG001|Overall Study|Death|5|||
25273678|NCT01113801|50587834|FG002|Overall Study|Death|3|||
25273679|NCT01113801|50587835|FG003|Overall Study|Death|4|||
25273680|NCT01113801|50587832|FG000|Overall Study|Protocol Violation|0|||
25273681|NCT01113801|50587833|FG001|Overall Study|Protocol Violation|1|||
25273682|NCT01113801|50587834|FG002|Overall Study|Protocol Violation|0|||
25273683|NCT01113801|50587835|FG003|Overall Study|Protocol Violation|0|||
25273684|NCT01113801|50587832|FG000|Overall Study|Withdrawal by Subject|9|||
25273685|NCT01113801|50587833|FG001|Overall Study|Withdrawal by Subject|7|||
25273686|NCT01113801|50587834|FG002|Overall Study|Withdrawal by Subject|7|||
25273687|NCT01113801|50587835|FG003|Overall Study|Withdrawal by Subject|8|||
25273688|NCT01113801|50587832|FG000|Overall Study|Physician Decision|2|||
25273689|NCT01113801|50587833|FG001|Overall Study|Physician Decision|2|||
25136142|NCT02097277|50249140|FG000|Overall Study|Adverse Event|0|||
25136143|NCT02097277|50249141|FG001|Overall Study|Adverse Event|0|||
25136144|NCT02097277|50249142|FG002|Overall Study|Adverse Event|1|||
25136145|NCT02097277|50249143|FG003|Overall Study|Adverse Event|2|||
25136146|NCT02097277|50249144|FG004|Overall Study|Adverse Event|0|||
25136147|NCT02212379|50249160|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
25136148|NCT02212379|50249160|FG000|From Baseline to Week 48|Adverse Event|7|||
25136149|NCT02212379|50249160|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
25136150|NCT02212379|50249160|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
25136151|NCT02212379|50249160|FG000|From Week 48 to Week 96|Adverse Event|1|||
25136152|NCT02212379|50249160|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
25136153|NCT02110693|50249167|FG000|Overall Study|Withdrawal by Subject|6|||
25136154|NCT02110693|50249168|FG001|Overall Study|Withdrawal by Subject|7|||
25136155|NCT02110693|50249167|FG000|Overall Study|skipped assessment|15|||
25136156|NCT02110693|50249168|FG001|Overall Study|skipped assessment|18|||
25136157|NCT02110693|50249167|FG000|Overall Study|technical difficulties|6|||
25136158|NCT02110693|50249168|FG001|Overall Study|technical difficulties|4|||
25136159|NCT02110693|50249167|FG000|Overall Study|Other|1|||
25136160|NCT02110693|50249168|FG001|Overall Study|Other|0|||
25136161|NCT02212301|50249188|FG000|Period 1|Lost to Follow-up|0|||
25136162|NCT02212301|50249189|FG001|Period 1|Lost to Follow-up|1|||
25136163|NCT02211209|50249198|FG000|Overall Study|Investigator judgment|0|||
25136164|NCT02211209|50249199|FG001|Overall Study|Investigator judgment|1|||
25136165|NCT02211209|50249198|FG000|Overall Study|Voluntary withdrawal|1|||
25136166|NCT02211209|50249199|FG001|Overall Study|Voluntary withdrawal|4|||
25136167|NCT02211209|50249198|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
25136168|NCT02211209|50249199|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
25136169|NCT02211209|50249198|FG000|Overall Study|Reason Not Specified|1|||
25136170|NCT02211209|50249199|FG001|Overall Study|Reason Not Specified|0|||
25136171|NCT02187809|50249205|FG000|Overall Study|The study was terminated|3|||
25136172|NCT02110225|50249212|FG000|Overall Study|Lost to Follow-up|0|||
25136173|NCT02110225|50249213|FG001|Overall Study|Lost to Follow-up|1|||
25136174|NCT02110225|50249214|FG002|Overall Study|Lost to Follow-up|0|||
25136175|NCT02187029|50249227|FG000|Overall Study|Adverse Event|0|||
25136176|NCT02187029|50249228|FG001|Overall Study|Adverse Event|1|||
25136177|NCT02187029|50249229|FG002|Overall Study|Adverse Event|1|||
25136178|NCT02187029|50249230|FG003|Overall Study|Adverse Event|0|||
25136179|NCT02187029|50249227|FG000|Overall Study|Study Terminated by Sponsor|0|||
25136180|NCT02187029|50249228|FG001|Overall Study|Study Terminated by Sponsor|0|||
25136181|NCT02187029|50249229|FG002|Overall Study|Study Terminated by Sponsor|10|||
25136182|NCT02187029|50249230|FG003|Overall Study|Study Terminated by Sponsor|3|||
25136183|NCT02187029|50249227|FG000|Overall Study|Withdrawal by Subject|1|||
25136184|NCT02187029|50249228|FG001|Overall Study|Withdrawal by Subject|0|||
25136185|NCT02187029|50249229|FG002|Overall Study|Withdrawal by Subject|0|||
25136186|NCT02187029|50249230|FG003|Overall Study|Withdrawal by Subject|0|||
25136187|NCT02163395|50249240|FG000|Overall Study|Withdrawal by Subject|1|||
25136188|NCT02163395|50249240|FG000|Overall Study|Lost to Follow-up|3|||
25136189|NCT02163395|50249240|FG000|Overall Study|Adverse Event|1|||
25136190|NCT02162771|50249246|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
25136191|NCT02162771|50249247|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
25136192|NCT02162771|50249246|FG000|Core Study Period (Part 2)|Adverse Event|4|||
25136193|NCT02162771|50249247|FG001|Core Study Period (Part 2)|Adverse Event|1|||
25136194|NCT02162771|50249246|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
25136195|NCT02162771|50249247|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
25136196|NCT02162771|50249246|FG000|Core Study Period (Part 2)|Physician Decision|0|||
25136197|NCT02162771|50249247|FG001|Core Study Period (Part 2)|Physician Decision|2|||
25136198|NCT02162771|50249246|FG000|Core Study Period (Part 2)|Death|1|||
25136199|NCT02162771|50249247|FG001|Core Study Period (Part 2)|Death|0|||
25136200|NCT02162771|50249246|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
25136201|NCT02162771|50249247|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
25136202|NCT02162771|50249246|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
25136203|NCT02162771|50249247|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
25136204|NCT02162771|50249246|FG000|Maintenance Study Period (Part 2)|Death|2|||
25136205|NCT02162771|50249247|FG001|Maintenance Study Period (Part 2)|Death|1|||
25136206|NCT02162771|50249246|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
25136207|NCT02162771|50249247|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
25136208|NCT02162771|50249246|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
25136209|NCT02162771|50249247|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
25136210|NCT02162771|50249246|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
25136211|NCT02162771|50249247|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
25136212|NCT02161757|50249256|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
25136213|NCT02161757|50249257|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
25136214|NCT02161757|50249258|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
25273690|NCT01113801|50587834|FG002|Overall Study|Physician Decision|3|||
25273691|NCT01113801|50587835|FG003|Overall Study|Physician Decision|3|||
25273692|NCT01113801|50587832|FG000|Overall Study|Sponsor Decision|15|||
25273693|NCT01113801|50587833|FG001|Overall Study|Sponsor Decision|21|||
25273694|NCT01113801|50587834|FG002|Overall Study|Sponsor Decision|20|||
25273695|NCT01113801|50587835|FG003|Overall Study|Sponsor Decision|15|||
25273696|NCT01113801|50587832|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
25273697|NCT01113801|50587833|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
25273698|NCT01113801|50587834|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
25273699|NCT01113801|50587835|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
25273700|NCT01256684|50587848|FG000|Overall Study|Adverse Event|1|||
25136215|NCT02161757|50249256|FG000|Treatment Through Study Completion|Adverse Event|1|||
25136216|NCT02161757|50249257|FG001|Treatment Through Study Completion|Adverse Event|1|||
25136217|NCT02161757|50249258|FG002|Treatment Through Study Completion|Adverse Event|0|||
25136218|NCT02161757|50249256|FG000|Treatment Through Study Completion|Protocol Violation|0|||
25136219|NCT02161757|50249257|FG001|Treatment Through Study Completion|Protocol Violation|1|||
25136220|NCT02161757|50249258|FG002|Treatment Through Study Completion|Protocol Violation|2|||
25136221|NCT02161757|50249256|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
25136222|NCT02161757|50249257|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
25136223|NCT02161757|50249258|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
25136224|NCT02161757|50249256|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
25136225|NCT02161757|50249257|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
25136226|NCT02161757|50249258|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
25136227|NCT02161757|50249256|FG000|Treatment Through Study Completion|Other|20|||
25136228|NCT02161757|50249257|FG001|Treatment Through Study Completion|Other|19|||
25136229|NCT02161757|50249258|FG002|Treatment Through Study Completion|Other|12|||
25136230|NCT02161757|50249256|FG000|Treatment Through Study Completion|Death|2|||
25136231|NCT02161757|50249257|FG001|Treatment Through Study Completion|Death|1|||
25136232|NCT02161757|50249258|FG002|Treatment Through Study Completion|Death|1|||
25136233|NCT02160977|50249268|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
25136234|NCT02160977|50249269|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
25136235|NCT02160977|50249268|FG000|Three Months After Surgery|Lost to Follow-up|0|||
25136236|NCT02160977|50249269|FG001|Three Months After Surgery|Lost to Follow-up|2|||
25136237|NCT02160977|50249268|FG000|Six Months After Surgery|Lost to Follow-up|2|||
25136238|NCT02160977|50249269|FG001|Six Months After Surgery|Lost to Follow-up|1|||
25136239|NCT02160899|50249281|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
25136240|NCT02160899|50249282|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
25136241|NCT02160899|50249283|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
25136242|NCT02160899|50249284|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
25136243|NCT02160899|50249285|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
25136244|NCT02160899|50249286|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
25136245|NCT02160041|50249300|FG000|Overall Study|Adverse Event|11|||
25136246|NCT02160041|50249300|FG000|Overall Study|Death|2|||
25136247|NCT02160041|50249300|FG000|Overall Study|disease progression|57|||
25136248|NCT02160041|50249300|FG000|Overall Study|Protocol Violation|1|||
25136249|NCT02160041|50249300|FG000|Overall Study|non-compliance with study|1|||
25136250|NCT02160041|50249300|FG000|Overall Study|Physician Decision|3|||
25136251|NCT02160041|50249300|FG000|Overall Study|Withdrawal by Subject|8|||
25136252|NCT02160041|50249300|FG000|Overall Study|study terminated by by sponsor|1|||
25136253|NCT02186873|50249306|FG000|Overall Study|Adverse Event|1|||
25136254|NCT02186873|50249307|FG001|Overall Study|Adverse Event|3|||
25136255|NCT02186873|50249306|FG000|Overall Study|Lack of Efficacy|0|||
25136256|NCT02186873|50249307|FG001|Overall Study|Lack of Efficacy|1|||
25136257|NCT02186873|50249306|FG000|Overall Study|Lost to Follow-up|1|||
25136258|NCT02186873|50249307|FG001|Overall Study|Lost to Follow-up|2|||
25136259|NCT02186873|50249306|FG000|Overall Study|Withdrawal by Subject|7|||
25136260|NCT02186873|50249307|FG001|Overall Study|Withdrawal by Subject|2|||
25136261|NCT02096263|50249317|FG000|Overall Study|Adverse Event|1|||
25136262|NCT02096263|50249318|FG001|Overall Study|Adverse Event|0|||
25136263|NCT02096263|50249319|FG002|Overall Study|Adverse Event|1|||
25136264|NCT02096263|50249317|FG000|Overall Study|Lost to Follow-up|14|||
25136265|NCT02096263|50249318|FG001|Overall Study|Lost to Follow-up|18|||
25136266|NCT02096263|50249319|FG002|Overall Study|Lost to Follow-up|15|||
25136267|NCT02096263|50249317|FG000|Overall Study|Other|7|||
25136268|NCT02096263|50249318|FG001|Overall Study|Other|9|||
25136269|NCT02096263|50249319|FG002|Overall Study|Other|6|||
25136270|NCT02096263|50249317|FG000|Overall Study|Sponsor study termination|0|||
25136271|NCT02096263|50249318|FG001|Overall Study|Sponsor study termination|0|||
25136272|NCT02096263|50249319|FG002|Overall Study|Sponsor study termination|1|||
25136273|NCT02096263|50249317|FG000|Overall Study|Protocol Violation|7|||
25136274|NCT02096263|50249318|FG001|Overall Study|Protocol Violation|2|||
25136275|NCT02096263|50249319|FG002|Overall Study|Protocol Violation|8|||
25136276|NCT02096263|50249317|FG000|Overall Study|Withdrawal by Subject|5|||
25136277|NCT02096263|50249318|FG001|Overall Study|Withdrawal by Subject|7|||
25136278|NCT02096263|50249319|FG002|Overall Study|Withdrawal by Subject|8|||
25136279|NCT01830543|50249330|FG000|Overall Study|Subject Decision|19|||
25136280|NCT01830543|50249331|FG001|Overall Study|Subject Decision|21|||
25136281|NCT01830543|50249332|FG002|Overall Study|Subject Decision|57|||
25136282|NCT01830543|50249330|FG000|Overall Study|Adverse Event|91|||
25136283|NCT01830543|50249331|FG001|Overall Study|Adverse Event|77|||
25136284|NCT01830543|50249332|FG002|Overall Study|Adverse Event|76|||
25136285|NCT01830543|50249330|FG000|Overall Study|Death|20|||
25136286|NCT01830543|50249331|FG001|Overall Study|Death|22|||
25136287|NCT01830543|50249332|FG002|Overall Study|Death|22|||
25136288|NCT01830543|50249330|FG000|Overall Study|Protocol Violation|3|||
25136289|NCT01830543|50249331|FG001|Overall Study|Protocol Violation|7|||
25136290|NCT01830543|50249332|FG002|Overall Study|Protocol Violation|7|||
25136291|NCT01830543|50249330|FG000|Overall Study|Physician Decision|11|||
25136292|NCT01830543|50249331|FG001|Overall Study|Physician Decision|5|||
25136293|NCT01830543|50249332|FG002|Overall Study|Physician Decision|12|||
25136294|NCT01830543|50249330|FG000|Overall Study|Withdrawal by consent|3|||
25136295|NCT01830543|50249331|FG001|Overall Study|Withdrawal by consent|3|||
25136296|NCT01830543|50249332|FG002|Overall Study|Withdrawal by consent|3|||
25136297|NCT01830543|50249330|FG000|Overall Study|Other|12|||
25136298|NCT01830543|50249331|FG001|Overall Study|Other|17|||
25136299|NCT01830543|50249332|FG002|Overall Study|Other|37|||
25136300|NCT02109445|50249340|FG000|Overall Study|Symptomatic deterioration|2|||
25136301|NCT02109445|50249340|FG000|Overall Study|Adverse Event|1|||
25136302|NCT02109133|50249346|FG000|Overall Study|Lost to Follow-up|1|||
25136303|NCT02109133|50249347|FG001|Overall Study|Lost to Follow-up|0|||
25136304|NCT01623271|50249355|FG000|Overall Study|Withdrawal by Subject|2|||
25136305|NCT01856673|50249362|FG000|Overall Study|Withdrawal by Subject|44|||
25136306|NCT01856673|50249363|FG001|Overall Study|Withdrawal by Subject|50|||
25136307|NCT01856673|50249364|FG002|Overall Study|Withdrawal by Subject|33|||
25136308|NCT01856673|50249362|FG000|Overall Study|Lost to Follow-up|31|||
25136309|NCT01856673|50249363|FG001|Overall Study|Lost to Follow-up|34|||
25136310|NCT01856673|50249364|FG002|Overall Study|Lost to Follow-up|0|||
25136311|NCT01856673|50249362|FG000|Overall Study|Unknown reasons|9|||
25136312|NCT01856673|50249363|FG001|Overall Study|Unknown reasons|0|||
25136313|NCT01856673|50249364|FG002|Overall Study|Unknown reasons|0|||
25136314|NCT01856673|50249362|FG000|Overall Study|Psychologist decision|1|||
25136315|NCT01856673|50249363|FG001|Overall Study|Psychologist decision|0|||
25136316|NCT01856673|50249364|FG002|Overall Study|Psychologist decision|0|||
25136317|NCT01856673|50249362|FG000|Overall Study|Paperwork errors|8|||
25136318|NCT01856673|50249363|FG001|Overall Study|Paperwork errors|0|||
25136319|NCT01856673|50249364|FG002|Overall Study|Paperwork errors|0|||
25136320|NCT01856673|50249362|FG000|Overall Study|Death|1|||
25136321|NCT01856673|50249363|FG001|Overall Study|Death|1|||
25136322|NCT01856673|50249364|FG002|Overall Study|Death|0|||
25136323|NCT01856673|50249362|FG000|Overall Study|Protocol Violation|1|||
25136324|NCT01856673|50249363|FG001|Overall Study|Protocol Violation|0|||
25136325|NCT01856673|50249364|FG002|Overall Study|Protocol Violation|1|||
25136326|NCT02095951|50249374|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
25136327|NCT02095951|50249375|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
25136328|NCT02095873|50249387|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
25136329|NCT02095873|50249388|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
25136330|NCT02095873|50249387|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
25136331|NCT02095873|50249388|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
25136332|NCT02095873|50249387|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
25136333|NCT02095873|50249388|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
25136334|NCT02094937|50249396|FG000|8 Weeks in Period 1|Adverse Event|9|||
25136335|NCT02094937|50249397|FG001|8 Weeks in Period 1|Adverse Event|0|||
25136336|NCT02094937|50249398|FG002|8 Weeks in Period 1|Adverse Event|0|||
25136337|NCT02094937|50249399|FG003|8 Weeks in Period 1|Adverse Event|0|||
25136338|NCT02094937|50249396|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
25136339|NCT02094937|50249397|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
25136340|NCT02094937|50249398|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
25136341|NCT02094937|50249399|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
25136342|NCT02094937|50249396|FG000|8 Weeks in Period 1|Protocol Violation|2|||
25136343|NCT02094937|50249397|FG001|8 Weeks in Period 1|Protocol Violation|0|||
25136344|NCT02094937|50249398|FG002|8 Weeks in Period 1|Protocol Violation|0|||
25136345|NCT02094937|50249399|FG003|8 Weeks in Period 1|Protocol Violation|0|||
25136346|NCT02094937|50249396|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
25136347|NCT02094937|50249397|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
25136348|NCT02094937|50249398|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
25136349|NCT02094937|50249399|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
25136350|NCT02094937|50249396|FG000|8 Weeks in Period 1|Physician Decision|1|||
25136351|NCT02094937|50249397|FG001|8 Weeks in Period 1|Physician Decision|0|||
25136352|NCT02094937|50249398|FG002|8 Weeks in Period 1|Physician Decision|0|||
25136353|NCT02094937|50249399|FG003|8 Weeks in Period 1|Physician Decision|0|||
25136354|NCT02094937|50249396|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
25136355|NCT02094937|50249397|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
25136356|NCT02094937|50249398|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
25136357|NCT02094937|50249399|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
25136358|NCT02094937|50249396|FG000|12 Weeks in Period 2|Adverse Event|0|||
25136359|NCT02094937|50249397|FG001|12 Weeks in Period 2|Adverse Event|2|||
25136360|NCT02094937|50249398|FG002|12 Weeks in Period 2|Adverse Event|4|||
25136361|NCT02094937|50249399|FG003|12 Weeks in Period 2|Adverse Event|1|||
25136362|NCT02094937|50249396|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
25136363|NCT02094937|50249397|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
25136364|NCT02094937|50249398|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
25136365|NCT02094937|50249399|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
25136366|NCT02094937|50249396|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
25136367|NCT02094937|50249397|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
25136368|NCT02094937|50249398|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
25136369|NCT02094937|50249399|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
25136370|NCT02094937|50249396|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
25136371|NCT02094937|50249397|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
25136372|NCT02094937|50249398|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
25136373|NCT02094937|50249399|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
25136374|NCT02094937|50249396|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
25136375|NCT02094937|50249397|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
25136376|NCT02094937|50249398|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
25136377|NCT02094937|50249399|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
25136378|NCT02093923|50249413|FG000|Overall Study|Lost to Follow-up|0|||
25136379|NCT02093923|50249414|FG001|Overall Study|Lost to Follow-up|0|||
25136380|NCT02093923|50249415|FG002|Overall Study|Lost to Follow-up|0|||
25136381|NCT02093923|50249416|FG003|Overall Study|Lost to Follow-up|1|||
25136382|NCT02093923|50249417|FG004|Overall Study|Lost to Follow-up|0|||
25136383|NCT02093923|50249413|FG000|Overall Study|Screen failure after randomization|0|||
25136384|NCT02093923|50249414|FG001|Overall Study|Screen failure after randomization|0|||
25136385|NCT02093923|50249415|FG002|Overall Study|Screen failure after randomization|0|||
25136386|NCT02093923|50249416|FG003|Overall Study|Screen failure after randomization|1|||
25136387|NCT02093923|50249417|FG004|Overall Study|Screen failure after randomization|0|||
25136388|NCT02186561|50249433|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
25136389|NCT02186561|50249433|FG000|Enrollment|Enrollment Cap Reached|5|||
25136390|NCT02186561|50249433|FG000|Enrollment|Insurance Denial|2|||
25136391|NCT02186561|50249433|FG000|Enrollment|Withdrawal by Subject|2|||
25136392|NCT02186561|50249433|FG000|Enrollment|Investigator Withdrew Consent|1|||
25136393|NCT02186561|50249433|FG000|30-Day Post Index Procedure Visit|Death|1|||
25136394|NCT02186561|50249433|FG000|1- Year Post Index Procedure Visit|Death|1|||
25136395|NCT02186561|50249433|FG000|1- Year Post Index Procedure Visit|Missed|1|||
25136396|NCT02066467|50249439|FG000|Overall Study|Did not undergo implant procedure|24|||
25136397|NCT02066467|50249439|FG000|Overall Study|Attempted to implant withoput success|43|||
25136398|NCT02066467|50249439|FG000|Overall Study|Consent ineligible|1|||
25136399|NCT02066467|50249439|FG000|Overall Study|Death|54|||
25136400|NCT02066467|50249439|FG000|Overall Study|Lost to Follow-up|51|||
25136401|NCT02066467|50249439|FG000|Overall Study|Adverse Event|20|||
25136402|NCT02066467|50249439|FG000|Overall Study|Withdrawal by Subject|16|||
25136403|NCT02066467|50249439|FG000|Overall Study|Physician Decision|2|||
25136404|NCT02066467|50249439|FG000|Overall Study|Not defined|4|||
25136405|NCT02186171|50249445|FG000|Overall Study|Withdrawal by Subject|1|||
25136406|NCT02186171|50249446|FG001|Overall Study|Withdrawal by Subject|9|||
25136407|NCT02186171|50249445|FG000|Overall Study|Lost to Follow-up|2|||
25136408|NCT02186171|50249446|FG001|Overall Study|Lost to Follow-up|2|||
25136409|NCT02186171|50249445|FG000|Overall Study|Death|1|||
25136410|NCT02186171|50249446|FG001|Overall Study|Death|2|||
25136411|NCT02186171|50249445|FG000|Overall Study|Protocol-specified Criteria|0|||
25136412|NCT02186171|50249446|FG001|Overall Study|Protocol-specified Criteria|2|||
25136413|NCT02186015|50249454|FG000|Overall Study|Physician Decision|1|||
25136414|NCT02186015|50249455|FG001|Overall Study|Physician Decision|0|||
25136415|NCT02066389|50249468|FG000|Overall Study|Adverse Event|1|||
25136416|NCT02066389|50249469|FG001|Overall Study|Adverse Event|1|||
25136417|NCT02066389|50249470|FG002|Overall Study|Adverse Event|1|||
25136418|NCT02066389|50249471|FG003|Overall Study|Adverse Event|1|||
25136419|NCT02066389|50249472|FG004|Overall Study|Adverse Event|5|||
25136420|NCT02066389|50249473|FG005|Overall Study|Adverse Event|1|||
25136421|NCT02066389|50249468|FG000|Overall Study|Withdrawal by Subject|4|||
25136422|NCT02066389|50249469|FG001|Overall Study|Withdrawal by Subject|0|||
25136423|NCT02066389|50249470|FG002|Overall Study|Withdrawal by Subject|5|||
25136424|NCT02066389|50249471|FG003|Overall Study|Withdrawal by Subject|1|||
25136425|NCT02066389|50249472|FG004|Overall Study|Withdrawal by Subject|1|||
25136426|NCT02066389|50249473|FG005|Overall Study|Withdrawal by Subject|2|||
25136427|NCT02066389|50249468|FG000|Overall Study|Lost to Follow-up|0|||
25136428|NCT02066389|50249469|FG001|Overall Study|Lost to Follow-up|0|||
25136429|NCT02066389|50249470|FG002|Overall Study|Lost to Follow-up|0|||
25136430|NCT02066389|50249471|FG003|Overall Study|Lost to Follow-up|1|||
25136431|NCT02066389|50249472|FG004|Overall Study|Lost to Follow-up|1|||
25136432|NCT02066389|50249473|FG005|Overall Study|Lost to Follow-up|1|||
25136433|NCT02066389|50249468|FG000|Overall Study|Randomized in Error|0|||
25136434|NCT02066389|50249469|FG001|Overall Study|Randomized in Error|0|||
25136435|NCT02066389|50249470|FG002|Overall Study|Randomized in Error|0|||
25136436|NCT02066389|50249471|FG003|Overall Study|Randomized in Error|0|||
25136437|NCT02066389|50249472|FG004|Overall Study|Randomized in Error|0|||
25136438|NCT02066389|50249473|FG005|Overall Study|Randomized in Error|1|||
25136439|NCT02106403|50249487|FG000|Follow-Up Visit 3|Other Reason|0|||
25136440|NCT02106403|50249488|FG001|Follow-Up Visit 3|Other Reason|0|||
25136441|NCT02106403|50249489|FG002|Follow-Up Visit 3|Other Reason|0|||
25136442|NCT02106403|50249490|FG003|Follow-Up Visit 3|Other Reason|0|||
25136443|NCT02106403|50249491|FG004|Follow-Up Visit 3|Other Reason|0|||
25136444|NCT02106403|50249492|FG005|Follow-Up Visit 3|Other Reason|1|||
25136445|NCT02133131|50249509|FG000|Overall Study|Adverse Event|0|||
25136446|NCT02133131|50249510|FG001|Overall Study|Adverse Event|0|||
25136447|NCT02133131|50249511|FG002|Overall Study|Adverse Event|0|||
25136448|NCT02133131|50249512|FG003|Overall Study|Adverse Event|1|||
25136449|NCT02133131|50249513|FG004|Overall Study|Adverse Event|0|||
25136450|NCT02133131|50249514|FG005|Overall Study|Adverse Event|0|||
25136451|NCT02133131|50249515|FG006|Overall Study|Adverse Event|0|||
25136452|NCT02133131|50249509|FG000|Overall Study|Lost to Follow-up|1|||
25136453|NCT02133131|50249510|FG001|Overall Study|Lost to Follow-up|0|||
25136454|NCT02133131|50249511|FG002|Overall Study|Lost to Follow-up|0|||
25136455|NCT02133131|50249512|FG003|Overall Study|Lost to Follow-up|1|||
25136456|NCT02133131|50249513|FG004|Overall Study|Lost to Follow-up|0|||
25136457|NCT02133131|50249514|FG005|Overall Study|Lost to Follow-up|0|||
25136458|NCT02133131|50249515|FG006|Overall Study|Lost to Follow-up|0|||
25136459|NCT02133131|50249509|FG000|Overall Study|Status not recorded|4|||
25136460|NCT02133131|50249510|FG001|Overall Study|Status not recorded|5|||
25136461|NCT02133131|50249511|FG002|Overall Study|Status not recorded|1|||
25136462|NCT02133131|50249512|FG003|Overall Study|Status not recorded|4|||
25136463|NCT02133131|50249513|FG004|Overall Study|Status not recorded|0|||
25136464|NCT02133131|50249514|FG005|Overall Study|Status not recorded|0|||
25136465|NCT02133131|50249515|FG006|Overall Study|Status not recorded|0|||
25136466|NCT02133131|50249509|FG000|Overall Study|Ongoing in study|0|||
25136467|NCT02133131|50249510|FG001|Overall Study|Ongoing in study|0|||
25136468|NCT02133131|50249511|FG002|Overall Study|Ongoing in study|0|||
25136469|NCT02133131|50249512|FG003|Overall Study|Ongoing in study|0|||
25136470|NCT02133131|50249513|FG004|Overall Study|Ongoing in study|15|||
25136471|NCT02133131|50249514|FG005|Overall Study|Ongoing in study|14|||
25136472|NCT02133131|50249515|FG006|Overall Study|Ongoing in study|11|||
25136473|NCT02133131|50249509|FG000|Overall Study|Protocol Violation|0|||
25136474|NCT02133131|50249510|FG001|Overall Study|Protocol Violation|0|||
25136475|NCT02133131|50249511|FG002|Overall Study|Protocol Violation|0|||
25136476|NCT02133131|50249512|FG003|Overall Study|Protocol Violation|0|||
25136477|NCT02133131|50249513|FG004|Overall Study|Protocol Violation|0|||
25136478|NCT02133131|50249514|FG005|Overall Study|Protocol Violation|0|||
25136479|NCT02133131|50249515|FG006|Overall Study|Protocol Violation|1|||
25136480|NCT02106325|50249533|FG000|Phase 1|Lost to Follow-up|2|||
25136481|NCT02106325|50249534|FG001|Phase 1|Lost to Follow-up|2|||
25136482|NCT02106325|50249533|FG000|Phase 2|Lost to Follow-up|2|||
25136483|NCT02106325|50249534|FG001|Phase 2|Lost to Follow-up|3|||
25136484|NCT02106325|50249533|FG000|Phase 3|Lost to Follow-up|2|||
25136485|NCT02106325|50249534|FG001|Phase 3|Lost to Follow-up|1|||
25136486|NCT01625689|50249542|FG000|Overall Study|Migration|2|||
25136487|NCT01625689|50249543|FG001|Overall Study|Migration|1|||
25136488|NCT02184611|50249551|FG000|Overall Study|Lack of Efficacy|11|||
25136489|NCT02184611|50249552|FG001|Overall Study|Lack of Efficacy|15|||
25136490|NCT02184611|50249551|FG000|Overall Study|Withdrawal by Subject|5|||
25136491|NCT02184611|50249552|FG001|Overall Study|Withdrawal by Subject|6|||
25136492|NCT02184611|50249551|FG000|Overall Study|Adverse Event|4|||
25136493|NCT02184611|50249552|FG001|Overall Study|Adverse Event|5|||
25136494|NCT02184611|50249551|FG000|Overall Study|Protocol Violation|1|||
25136495|NCT02184611|50249552|FG001|Overall Study|Protocol Violation|1|||
25136496|NCT02184611|50249551|FG000|Overall Study|Protocol defined stopping criteria|0|||
25136497|NCT02184611|50249552|FG001|Overall Study|Protocol defined stopping criteria|1|||
25136498|NCT02066311|50249558|FG000|Overall Study|Adverse Event|4|||
25136499|NCT02066311|50249558|FG000|Overall Study|Withdrawal by Subject|1|||
25136500|NCT02184455|50249562|FG000|Overall Study|Lost to Follow-up|1|||
25136501|NCT02184143|50249568|FG000|Overall Study|Withdrawal by Subject|4|||
25136502|NCT02184143|50249569|FG001|Overall Study|Withdrawal by Subject|4|||
25136503|NCT02184143|50249568|FG000|Overall Study|Lost to Follow-up|5|||
25136504|NCT02184143|50249569|FG001|Overall Study|Lost to Follow-up|3|||
25136505|NCT02184143|50249568|FG000|Overall Study|Death|1|||
25136506|NCT02184143|50249569|FG001|Overall Study|Death|0|||
25136507|NCT01625611|50249579|FG000|Overall Study|No adlib drinks Lab 1|3|||
25136508|NCT01625611|50249580|FG001|Overall Study|No adlib drinks Lab 1|0|||
25136509|NCT01625611|50249579|FG000|Overall Study|Technical issues with PET|1|||
25136510|NCT01625611|50249580|FG001|Overall Study|Technical issues with PET|0|||
25136511|NCT01625611|50249579|FG000|Overall Study|Unable to complete study procedures|1|||
25136512|NCT01625611|50249580|FG001|Overall Study|Unable to complete study procedures|0|||
25136513|NCT01625611|50249579|FG000|Overall Study|Withdrawal by Subject|3|||
25136514|NCT01625611|50249580|FG001|Overall Study|Withdrawal by Subject|0|||
25136515|NCT02159807|50249590|FG000|Overall Study|Adverse Event|0|||
25136516|NCT02159807|50249591|FG001|Overall Study|Adverse Event|0|||
25136517|NCT02159807|50249592|FG002|Overall Study|Adverse Event|1|||
25136518|NCT02159807|50249590|FG000|Overall Study|No CSF|1|||
25136519|NCT02159807|50249591|FG001|Overall Study|No CSF|1|||
25136520|NCT02159807|50249592|FG002|Overall Study|No CSF|1|||
25136521|NCT02159807|50249590|FG000|Overall Study|elevated blood pressure|0|||
25136522|NCT02159807|50249591|FG001|Overall Study|elevated blood pressure|0|||
25136523|NCT02159807|50249592|FG002|Overall Study|elevated blood pressure|1|||
25136524|NCT02066233|50249602|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
25136525|NCT02066233|50249603|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
25136526|NCT02159729|50249611|FG000|Overall Study|Adverse Event|0|||
25136527|NCT02159729|50249612|FG001|Overall Study|Adverse Event|1|||
25136528|NCT02159729|50249611|FG000|Overall Study|Subject's Request|13|||
25136529|NCT02159729|50249612|FG001|Overall Study|Subject's Request|10|||
25136530|NCT02159729|50249611|FG000|Overall Study|Lost to Follow-up|24|||
25136531|NCT02159729|50249612|FG001|Overall Study|Lost to Follow-up|9|||
25136532|NCT02159729|50249611|FG000|Overall Study|Non compliance|2|||
25136533|NCT02159729|50249612|FG001|Overall Study|Non compliance|0|||
25136534|NCT02159729|50249611|FG000|Overall Study|Other Unspecified|3|||
25136535|NCT02159729|50249612|FG001|Overall Study|Other Unspecified|1|||
25136536|NCT02159183|50249620|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
25136537|NCT02159183|50249621|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
25273701|NCT01256684|50587849|FG001|Overall Study|Adverse Event|4|||
25136538|NCT02159183|50249620|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
25178859|NCT01506193|50324178|FG002|Overall Study|Withdrawal by Subject|8|||
25136539|NCT02159183|50249621|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
25136540|NCT02159183|50249620|FG000|Analysis After the 36 Months Follow-up|Death|0|||
25136541|NCT02159183|50249621|FG001|Analysis After the 36 Months Follow-up|Death|1|||
25136542|NCT02159183|50249620|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
25136543|NCT02159183|50249621|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
25136544|NCT02159183|50249620|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
25136545|NCT02159183|50249621|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
25136546|NCT02183675|50249633|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
25136547|NCT02183675|50249634|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
25136548|NCT02183675|50249635|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
25136549|NCT02183675|50249636|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
25136550|NCT02183675|50249637|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
25136551|NCT02183675|50249638|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
25136552|NCT02183519|50249650|FG000|Overall Study|computer error|3|||
25136553|NCT02183519|50249651|FG001|Overall Study|computer error|0|||
25136554|NCT02183519|50249650|FG000|Overall Study|Did not respond to cough inducter|0|||
25136555|NCT02183519|50249651|FG001|Overall Study|Did not respond to cough inducter|3|||
25136556|NCT02132195|50249660|FG000|Initial Assignment|Relapsed|14|||
25136557|NCT02132195|50249661|FG001|Initial Assignment|Relapsed|0|||
25136558|NCT02132195|50249662|FG002|Initial Assignment|Relapsed|0|||
25136559|NCT02132195|50249660|FG000|Rescue Therapy|Relapsed|0|||
25136560|NCT02132195|50249661|FG001|Rescue Therapy|Relapsed|0|||
25136561|NCT02132195|50249662|FG002|Rescue Therapy|Relapsed|7|||
25136562|NCT02132195|50249660|FG000|Rescue Therapy|Physician Decision|0|||
25136563|NCT02132195|50249661|FG001|Rescue Therapy|Physician Decision|0|||
25136564|NCT02132195|50249662|FG002|Rescue Therapy|Physician Decision|1|||
25136565|NCT02132195|50249660|FG000|Rescue Therapy|Withdrawal by Subject|0|||
25136566|NCT02132195|50249661|FG001|Rescue Therapy|Withdrawal by Subject|0|||
25136567|NCT02132195|50249662|FG002|Rescue Therapy|Withdrawal by Subject|1|||
25136568|NCT02132195|50249660|FG000|Rescue Therapy|Adverse Event|0|||
25136569|NCT02132195|50249661|FG001|Rescue Therapy|Adverse Event|0|||
25136570|NCT02132195|50249662|FG002|Rescue Therapy|Adverse Event|2|||
25136571|NCT02182973|50249672|FG000|Overall Study|Withdrawal by Subject|3|||
25136572|NCT02182973|50249673|FG001|Overall Study|Withdrawal by Subject|0|||
25136573|NCT02182895|50249682|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
25136574|NCT02182895|50249683|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
25136575|NCT01625377|50249691|FG000|Overall Study|Death|1|||
25136576|NCT01625377|50249692|FG001|Overall Study|Death|1|||
25136577|NCT01625377|50249691|FG000|Overall Study|Administrative Problem|1|||
25136578|NCT01625377|50249692|FG001|Overall Study|Administrative Problem|1|||
25136579|NCT01625377|50249691|FG000|Overall Study|Protocol Violation|0|||
25136580|NCT01625377|50249692|FG001|Overall Study|Protocol Violation|3|||
25136581|NCT01625377|50249691|FG000|Overall Study|Adverse Event|3|||
25136582|NCT01625377|50249692|FG001|Overall Study|Adverse Event|16|||
25136583|NCT01625377|50249691|FG000|Overall Study|Graft loss|1|||
25136584|NCT01625377|50249692|FG001|Overall Study|Graft loss|0|||
25136585|NCT01625377|50249691|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25136586|NCT01625377|50249692|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
25136587|NCT01625377|50249691|FG000|Overall Study|Abnormal laboratory values|1|||
25136588|NCT01625377|50249692|FG001|Overall Study|Abnormal laboratory values|0|||
25136589|NCT02158949|50249700|FG000|Overall Study|Withdrawal by Subject|1|||
25136590|NCT02158949|50249701|FG001|Overall Study|Withdrawal by Subject|0|||
25136591|NCT02158949|50249700|FG000|Overall Study|Lost to Follow-up|5|||
25178860|NCT01506193|50324176|FG000|Overall Study|Lost to Follow-up|8|||
25136592|NCT02158949|50249701|FG001|Overall Study|Lost to Follow-up|11|||
25136593|NCT02132117|50249709|FG000|Overall Study|Adverse Event|6|||
25136594|NCT02132117|50249710|FG001|Overall Study|Adverse Event|1|||
25136595|NCT02132117|50249709|FG000|Overall Study|Lost to Follow-up|2|||
25136596|NCT02132117|50249710|FG001|Overall Study|Lost to Follow-up|2|||
25136597|NCT02132117|50249709|FG000|Overall Study|Personal Reasons|1|||
25136598|NCT02132117|50249710|FG001|Overall Study|Personal Reasons|2|||
25136599|NCT02132117|50249709|FG000|Overall Study|Other Miscellaneous Reasons|2|||
25136600|NCT02132117|50249710|FG001|Overall Study|Other Miscellaneous Reasons|0|||
25136601|NCT02093689|50249719|FG000|Overall Study|Physician Decision|4|||
25136602|NCT02093689|50249720|FG001|Overall Study|Physician Decision|0|||
25136603|NCT02093689|50249721|FG002|Overall Study|Physician Decision|0|||
25136604|NCT02047045|50249729|FG000|Baseline|Withdrawal by Subject|3|||
25136605|NCT02047045|50249730|FG001|Baseline|Withdrawal by Subject|2|||
25136606|NCT02047045|50249729|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
25136607|NCT02047045|50249730|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
25136608|NCT02047045|50249729|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
25136609|NCT02047045|50249730|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
25136610|NCT02047045|50249729|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
25136611|NCT02047045|50249730|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
25136612|NCT02047045|50249729|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
25136613|NCT02047045|50249730|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
25136614|NCT02047045|50249729|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
25136615|NCT02047045|50249730|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
25136616|NCT02047045|50249729|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
25136617|NCT02047045|50249730|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
25136618|NCT02047045|50249729|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
25136619|NCT02047045|50249730|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
25136620|NCT02047045|50249729|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
25136621|NCT02047045|50249730|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
25009482|NCT03422172|50102383|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
25009483|NCT03422172|50102383|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
25136622|NCT02131259|50249736|FG000|Overall Study|Progressive disease|751|||
25136623|NCT02131259|50249736|FG000|Overall Study|Adverse Event|341|||
25136624|NCT02131259|50249736|FG000|Overall Study|Lost to Follow-up|7|||
25136625|NCT02131259|50249736|FG000|Overall Study|Relocation|32|||
25136626|NCT02131259|50249736|FG000|Overall Study|Other|63|||
25136627|NCT02131259|50249736|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
25136628|NCT02131259|50249736|FG000|Overall Study|Progressive disease/relocation|1|||
25136629|NCT02131259|50249736|FG000|Overall Study|Progressive disease/other|2|||
25136630|NCT02131259|50249736|FG000|Overall Study|AE/lost to follow-up|1|||
25136631|NCT02131259|50249736|FG000|Overall Study|AE/other|1|||
25136632|NCT02131259|50249736|FG000|Overall Study|Progressive disease/AE/other|1|||
25136633|NCT02131259|50249736|FG000|Overall Study|Missing|3|||
25136634|NCT01856595|50249749|FG000|Overall Study|Withdrawal by Subject|0|||
25136635|NCT01856595|50249750|FG001|Overall Study|Withdrawal by Subject|1|||
25136636|NCT01856595|50249751|FG002|Overall Study|Withdrawal by Subject|0|||
25136637|NCT01856595|50249752|FG003|Overall Study|Withdrawal by Subject|0|||
25136638|NCT01856595|50249753|FG004|Overall Study|Withdrawal by Subject|0|||
25136639|NCT01856595|50249754|FG005|Overall Study|Withdrawal by Subject|0|||
25136640|NCT01856595|50249755|FG006|Overall Study|Withdrawal by Subject|1|||
25136641|NCT01856595|50249756|FG007|Overall Study|Withdrawal by Subject|0|||
25136642|NCT01856595|50249757|FG008|Overall Study|Withdrawal by Subject|0|||
25136643|NCT02158247|50249794|FG000|Overall Study|Invisible vocal cords|5|||
25136644|NCT01829295|50249816|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
25136645|NCT01829295|50249817|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
25136646|NCT01829295|50249818|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
25136647|NCT01829295|50249819|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
25136648|NCT01829295|50249816|FG000|6-12 Months|Adverse Event|0|||
25136649|NCT01829295|50249817|FG001|6-12 Months|Adverse Event|0|||
25136650|NCT01829295|50249818|FG002|6-12 Months|Adverse Event|3|||
25136651|NCT01829295|50249819|FG003|6-12 Months|Adverse Event|2|||
25136652|NCT01829295|50249816|FG000|6-12 Months|Lost to Follow-up|2|||
25136653|NCT01829295|50249817|FG001|6-12 Months|Lost to Follow-up|0|||
25136654|NCT01829295|50249818|FG002|6-12 Months|Lost to Follow-up|0|||
25136655|NCT01829295|50249819|FG003|6-12 Months|Lost to Follow-up|0|||
25136656|NCT01829295|50249816|FG000|6-12 Months|Withdrawal by Subject|2|||
25136657|NCT01829295|50249817|FG001|6-12 Months|Withdrawal by Subject|2|||
25136658|NCT01829295|50249818|FG002|6-12 Months|Withdrawal by Subject|0|||
25136659|NCT01829295|50249819|FG003|6-12 Months|Withdrawal by Subject|0|||
25136660|NCT02157935|50249831|FG000|Overall Study|Withdrawal by Subject|25|||
25136661|NCT02157935|50249832|FG001|Overall Study|Withdrawal by Subject|39|||
25136662|NCT02157935|50249831|FG000|Overall Study|Screen failure|1|||
25136663|NCT02157935|50249832|FG001|Overall Study|Screen failure|2|||
25136664|NCT02157935|50249831|FG000|Overall Study|Protocol Violation|1|||
25136665|NCT02157935|50249832|FG001|Overall Study|Protocol Violation|0|||
25136666|NCT02157935|50249831|FG000|Overall Study|Progressive disease|0|||
25136667|NCT02157935|50249832|FG001|Overall Study|Progressive disease|2|||
25136668|NCT02157935|50249831|FG000|Overall Study|Other|5|||
25136669|NCT02157935|50249832|FG001|Overall Study|Other|12|||
25136670|NCT02157935|50249831|FG000|Overall Study|Lack of Efficacy|0|||
25136671|NCT02157935|50249832|FG001|Overall Study|Lack of Efficacy|1|||
25136672|NCT02157935|50249831|FG000|Overall Study|Death|4|||
25136673|NCT02157935|50249832|FG001|Overall Study|Death|4|||
25136674|NCT02157935|50249831|FG000|Overall Study|Adverse Event|3|||
25136675|NCT02157935|50249832|FG001|Overall Study|Adverse Event|5|||
25136676|NCT02157779|50249840|FG000|Overall Study|Logistical|9|||
25136677|NCT02157779|50249841|FG001|Overall Study|Logistical|3|||
25136678|NCT02157779|50249840|FG000|Overall Study|Stopped attending, reason unknown|11|||
25178861|NCT01506193|50324177|FG001|Overall Study|Lost to Follow-up|3|||
25136679|NCT02157779|50249841|FG001|Overall Study|Stopped attending, reason unknown|7|||
25136680|NCT02157779|50249840|FG000|Overall Study|No response to outreach after Baseline|1|||
25136681|NCT02157779|50249841|FG001|Overall Study|No response to outreach after Baseline|1|||
25136682|NCT02157779|50249840|FG000|Overall Study|Moved|1|||
25136683|NCT02157779|50249841|FG001|Overall Study|Moved|0|||
25136684|NCT02157779|50249840|FG000|Overall Study|Medical|1|||
25136685|NCT02157779|50249841|FG001|Overall Study|Medical|0|||
25136686|NCT02157779|50249840|FG000|Overall Study|Legal issue|1|||
25136687|NCT02157779|50249841|FG001|Overall Study|Legal issue|0|||
25136688|NCT02093221|50249855|FG000|Overall Study|Adverse Event|1|||
25136689|NCT02093221|50249856|FG001|Overall Study|Adverse Event|0|||
25136690|NCT02093221|50249857|FG002|Overall Study|Adverse Event|0|||
25136691|NCT02093221|50249858|FG003|Overall Study|Adverse Event|0|||
25136692|NCT02093221|50249859|FG004|Overall Study|Adverse Event|0|||
25136693|NCT02093221|50249855|FG000|Overall Study|Withdrawal by Subject|1|||
25136694|NCT02093221|50249856|FG001|Overall Study|Withdrawal by Subject|1|||
25136695|NCT02093221|50249857|FG002|Overall Study|Withdrawal by Subject|4|||
25136696|NCT02093221|50249858|FG003|Overall Study|Withdrawal by Subject|1|||
25136697|NCT02093221|50249859|FG004|Overall Study|Withdrawal by Subject|1|||
25136698|NCT02093221|50249855|FG000|Overall Study|Lost to Follow-up|2|||
25136699|NCT02093221|50249856|FG001|Overall Study|Lost to Follow-up|0|||
25136700|NCT02093221|50249857|FG002|Overall Study|Lost to Follow-up|1|||
25136701|NCT02093221|50249858|FG003|Overall Study|Lost to Follow-up|1|||
25136702|NCT02093221|50249859|FG004|Overall Study|Lost to Follow-up|0|||
25136703|NCT02093221|50249855|FG000|Overall Study|Death|0|||
25136704|NCT02093221|50249856|FG001|Overall Study|Death|1|||
25136705|NCT02093221|50249857|FG002|Overall Study|Death|0|||
25136706|NCT02093221|50249858|FG003|Overall Study|Death|0|||
25009484|NCT00057863|50102392|FG000|Overall Study|Death|1|||
25009485|NCT00057863|50102392|FG000|Overall Study|Withdrawal by Subject|2|||
25136707|NCT02093221|50249859|FG004|Overall Study|Death|0|||
25136708|NCT02093221|50249855|FG000|Overall Study|Protocol Violation|0|||
25136709|NCT02093221|50249856|FG001|Overall Study|Protocol Violation|1|||
25136710|NCT02093221|50249857|FG002|Overall Study|Protocol Violation|0|||
25136711|NCT02093221|50249858|FG003|Overall Study|Protocol Violation|0|||
25136712|NCT02093221|50249859|FG004|Overall Study|Protocol Violation|0|||
25136713|NCT02093221|50249855|FG000|Overall Study|Study termination|6|||
25136714|NCT02093221|50249856|FG001|Overall Study|Study termination|5|||
25136715|NCT02093221|50249857|FG002|Overall Study|Study termination|4|||
25136716|NCT02093221|50249858|FG003|Overall Study|Study termination|6|||
25136717|NCT02093221|50249859|FG004|Overall Study|Study termination|7|||
25136718|NCT02092909|50249875|FG000|Overall Study|Adverse Event|0|||
25136719|NCT02092909|50249876|FG001|Overall Study|Adverse Event|0|||
25136720|NCT02092909|50249877|FG002|Overall Study|Adverse Event|4|||
25136721|NCT02092909|50249878|FG003|Overall Study|Adverse Event|2|||
25136722|NCT02092909|50249875|FG000|Overall Study|Lack of Efficacy|0|||
25136723|NCT02092909|50249876|FG001|Overall Study|Lack of Efficacy|2|||
25136724|NCT02092909|50249877|FG002|Overall Study|Lack of Efficacy|1|||
25136725|NCT02092909|50249878|FG003|Overall Study|Lack of Efficacy|0|||
25136726|NCT02092909|50249875|FG000|Overall Study|Withdrawal by Subject|0|||
25136727|NCT02092909|50249876|FG001|Overall Study|Withdrawal by Subject|0|||
25136728|NCT02092909|50249877|FG002|Overall Study|Withdrawal by Subject|2|||
25136729|NCT02092909|50249878|FG003|Overall Study|Withdrawal by Subject|1|||
25136730|NCT02092909|50249875|FG000|Overall Study|Study terminated by Sponsor|0|||
25136731|NCT02092909|50249876|FG001|Overall Study|Study terminated by Sponsor|0|||
25136732|NCT02092909|50249877|FG002|Overall Study|Study terminated by Sponsor|0|||
25136733|NCT02092909|50249878|FG003|Overall Study|Study terminated by Sponsor|2|||
25136734|NCT02092909|50249875|FG000|Overall Study|Miscellaneous|1|||
25136735|NCT02092909|50249876|FG001|Overall Study|Miscellaneous|1|||
25136736|NCT02092909|50249877|FG002|Overall Study|Miscellaneous|2|||
25136737|NCT02092909|50249878|FG003|Overall Study|Miscellaneous|1|||
25136738|NCT01623115|50249890|FG000|Overall Study|Randomized but not treated|0|||
25136739|NCT01623115|50249891|FG001|Overall Study|Randomized but not treated|1|||
25136740|NCT01623115|50249890|FG000|Overall Study|Physician Decision|1|||
25136741|NCT01623115|50249891|FG001|Overall Study|Physician Decision|0|||
25136742|NCT01623115|50249890|FG000|Overall Study|Participants moved|1|||
25136743|NCT01623115|50249891|FG001|Overall Study|Participants moved|5|||
25136744|NCT01623115|50249890|FG000|Overall Study|Adverse Event|10|||
25136745|NCT01623115|50249891|FG001|Overall Study|Adverse Event|13|||
25136746|NCT01623115|50249890|FG000|Overall Study|Poor compliance to protocol|4|||
25136747|NCT01623115|50249891|FG001|Overall Study|Poor compliance to protocol|10|||
25136748|NCT01623115|50249890|FG000|Overall Study|Consent withdrawn by participant|2|||
25136749|NCT01623115|50249891|FG001|Overall Study|Consent withdrawn by participant|6|||
25136750|NCT01623115|50249890|FG000|Overall Study|Related to study drug administration|0|||
25136751|NCT01623115|50249891|FG001|Overall Study|Related to study drug administration|2|||
25136752|NCT01623115|50249890|FG000|Overall Study|Last visit outside protocol visit window|14|||
25136753|NCT01623115|50249891|FG001|Overall Study|Last visit outside protocol visit window|26|||
25136754|NCT01623115|50249890|FG000|Overall Study|Site closure|1|||
25136755|NCT01623115|50249891|FG001|Overall Study|Site closure|7|||
25136756|NCT01623115|50249890|FG000|Overall Study|Death|0|||
25136757|NCT01623115|50249891|FG001|Overall Study|Death|4|||
25136758|NCT01623115|50249890|FG000|Overall Study|Other than specified above|0|||
25136759|NCT01623115|50249891|FG001|Overall Study|Other than specified above|3|||
25136760|NCT02092285|50249897|FG000|Induction Phase|Adverse Event|7|||
25136761|NCT02092285|50249897|FG000|Induction Phase|Physician Decision|4|||
25136762|NCT02092285|50249897|FG000|Induction Phase|Pregnancy|1|||
25136763|NCT02092285|50249897|FG000|Induction Phase|Relapse/Recurrence|7|||
25136764|NCT02092285|50249897|FG000|Induction Phase|Withdrawal by Subject|2|||
25136765|NCT02092285|50249897|FG000|Induction Phase|Lack of Efficacy|14|||
25136766|NCT02092285|50249897|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
25136767|NCT02092285|50249897|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
25136768|NCT02092285|50249897|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
25136769|NCT02092285|50249897|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
25136770|NCT02092285|50249897|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
25136771|NCT02092285|50249897|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
25136772|NCT02092285|50249897|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
25136773|NCT02092285|50249897|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
25136774|NCT02092285|50249897|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
25136775|NCT02091739|50249904|FG000|MP: 16 Weeks|Adverse Event|1|||
25136776|NCT02091739|50249905|FG001|MP: 16 Weeks|Adverse Event|1|||
25136777|NCT02091739|50249906|FG002|MP: 16 Weeks|Adverse Event|1|||
25136778|NCT02091739|50249907|FG003|MP: 16 Weeks|Adverse Event|0|||
25136779|NCT02091739|50249908|FG004|MP: 16 Weeks|Adverse Event|0|||
25136780|NCT02091739|50249904|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
25136781|NCT02091739|50249905|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
25136782|NCT02091739|50249906|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
25136783|NCT02091739|50249907|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
25136784|NCT02091739|50249908|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
25136785|NCT02091739|50249904|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
25136786|NCT02091739|50249905|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
25136787|NCT02091739|50249906|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
25136788|NCT02091739|50249907|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
25136789|NCT02091739|50249908|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
25136790|NCT02091739|50249904|FG000|EP: 48 Weeks|Other|0|||
25136791|NCT02091739|50249905|FG001|EP: 48 Weeks|Other|0|||
25136792|NCT02091739|50249906|FG002|EP: 48 Weeks|Other|0|||
25136793|NCT02091739|50249907|FG003|EP: 48 Weeks|Other|1|||
25136794|NCT02091739|50249908|FG004|EP: 48 Weeks|Other|0|||
25136795|NCT02091739|50249904|FG000|EP: 48 Weeks|Death|0|||
25136796|NCT02091739|50249905|FG001|EP: 48 Weeks|Death|0|||
25136797|NCT02091739|50249906|FG002|EP: 48 Weeks|Death|0|||
25136798|NCT02091739|50249907|FG003|EP: 48 Weeks|Death|3|||
25136799|NCT02091739|50249908|FG004|EP: 48 Weeks|Death|2|||
25136800|NCT02091739|50249904|FG000|EP: 48 Weeks|Adverse Event|0|||
25136801|NCT02091739|50249905|FG001|EP: 48 Weeks|Adverse Event|0|||
25136802|NCT02091739|50249906|FG002|EP: 48 Weeks|Adverse Event|0|||
25136803|NCT02091739|50249907|FG003|EP: 48 Weeks|Adverse Event|2|||
25136804|NCT02091739|50249908|FG004|EP: 48 Weeks|Adverse Event|6|||
25136805|NCT02091739|50249904|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
25136806|NCT02091739|50249905|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
25136807|NCT02091739|50249906|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
25136808|NCT02091739|50249907|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
25136809|NCT02091739|50249908|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
25136810|NCT02045875|50249920|FG000|Overall Study|Lost to Follow-up|3|||
25136811|NCT02045875|50249921|FG001|Overall Study|Lost to Follow-up|0|||
25136812|NCT02045875|50249920|FG000|Overall Study|Withdrawal by Subject|4|||
25136813|NCT02045875|50249921|FG001|Overall Study|Withdrawal by Subject|3|||
25136814|NCT01597635|50249930|FG000|Part A|Adverse Event|3|||
25136815|NCT01597635|50249931|FG001|Part A|Adverse Event|0|||
25136816|NCT01597635|50249932|FG002|Part A|Adverse Event|0|||
25136817|NCT01597635|50249930|FG000|Part B|Adverse Event|0|||
25136818|NCT01597635|50249931|FG001|Part B|Adverse Event|0|||
25136819|NCT01597635|50249932|FG002|Part B|Adverse Event|1|||
25136820|NCT01597635|50249930|FG000|Part B|Protocol Violation|0|||
25136821|NCT01597635|50249931|FG001|Part B|Protocol Violation|1|||
25136822|NCT01597635|50249932|FG002|Part B|Protocol Violation|0|||
25136823|NCT01597635|50249930|FG000|Part B|Protocol-defined stopping criteria|0|||
25136824|NCT01597635|50249931|FG001|Part B|Protocol-defined stopping criteria|4|||
25136825|NCT01597635|50249932|FG002|Part B|Protocol-defined stopping criteria|3|||
25136826|NCT01597635|50249930|FG000|Part B|Withdrawal by Subject|0|||
25136827|NCT01597635|50249931|FG001|Part B|Withdrawal by Subject|1|||
25136828|NCT01597635|50249932|FG002|Part B|Withdrawal by Subject|0|||
25136829|NCT01828281|50249943|FG000|Overall Study|Withdrawal by Subject|1|||
25136830|NCT01828281|50249944|FG001|Overall Study|Withdrawal by Subject|0|||
25136831|NCT01827267|50249953|FG000|Overall Study|Did not receive study drug|1|||
25136832|NCT01827267|50249954|FG001|Overall Study|Did not receive study drug|1|||
25136833|NCT01827267|50249953|FG000|Overall Study|Physician Decision|1|||
25136834|NCT01827267|50249954|FG001|Overall Study|Physician Decision|0|||
25136835|NCT01827267|50249953|FG000|Overall Study|Disease Progression|1|||
25136836|NCT01827267|50249954|FG001|Overall Study|Disease Progression|1|||
25136837|NCT01827267|50249953|FG000|Overall Study|Sponsor Discontinued Study|2|||
25136838|NCT01827267|50249954|FG001|Overall Study|Sponsor Discontinued Study|8|||
25136839|NCT01827267|50249953|FG000|Overall Study|Still on study|0|||
25136840|NCT01827267|50249954|FG001|Overall Study|Still on study|2|||
25136841|NCT01855425|50249961|FG000|Overall Study|Physician Decision|20|||
25136842|NCT01854879|50249965|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
25136843|NCT01854879|50249965|FG000|Overall Study|screen fail|3|||
25136844|NCT01854879|50249965|FG000|Overall Study|incomplete data set|1|||
25136845|NCT01827111|50249969|FG000|Overall Study|Disease Progression|1|||
25136846|NCT02045095|50249973|FG000|Overall Study|Other|0|||
25136847|NCT02045095|50249974|FG001|Overall Study|Other|0|||
25136848|NCT02045095|50249975|FG002|Overall Study|Other|1|||
25136849|NCT02045095|50249976|FG003|Overall Study|Other|0|||
25136850|NCT02045095|50249977|FG004|Overall Study|Other|0|||
25136851|NCT02045095|50249978|FG005|Overall Study|Other|2|||
25136852|NCT02045095|50249979|FG006|Overall Study|Other|0|||
25136853|NCT02045095|50249973|FG000|Overall Study|Progressive Disease|3|||
25136854|NCT02045095|50249974|FG001|Overall Study|Progressive Disease|3|||
25136855|NCT02045095|50249975|FG002|Overall Study|Progressive Disease|2|||
25136856|NCT02045095|50249976|FG003|Overall Study|Progressive Disease|4|||
25136857|NCT02045095|50249977|FG004|Overall Study|Progressive Disease|2|||
25136858|NCT02045095|50249978|FG005|Overall Study|Progressive Disease|4|||
25136859|NCT02045095|50249979|FG006|Overall Study|Progressive Disease|1|||
25136860|NCT02045095|50249973|FG000|Overall Study|Withdrawal by Subject|0|||
25136861|NCT02045095|50249974|FG001|Overall Study|Withdrawal by Subject|0|||
25136862|NCT02045095|50249975|FG002|Overall Study|Withdrawal by Subject|0|||
25136863|NCT02045095|50249976|FG003|Overall Study|Withdrawal by Subject|0|||
25136864|NCT02045095|50249977|FG004|Overall Study|Withdrawal by Subject|3|||
25136865|NCT02045095|50249978|FG005|Overall Study|Withdrawal by Subject|0|||
25136866|NCT02045095|50249979|FG006|Overall Study|Withdrawal by Subject|0|||
25136867|NCT02045095|50249973|FG000|Overall Study|Adverse Event|0|||
25136868|NCT02045095|50249974|FG001|Overall Study|Adverse Event|1|||
25136869|NCT02045095|50249975|FG002|Overall Study|Adverse Event|1|||
25136870|NCT02045095|50249976|FG003|Overall Study|Adverse Event|0|||
25136871|NCT02045095|50249977|FG004|Overall Study|Adverse Event|0|||
25136872|NCT02045095|50249978|FG005|Overall Study|Adverse Event|2|||
25136873|NCT02045095|50249979|FG006|Overall Study|Adverse Event|0|||
25136874|NCT02181803|50250004|FG000|Overall Study|Withdrawal by Subject|0|||
25136875|NCT02181803|50250005|FG001|Overall Study|Withdrawal by Subject|2|||
25136876|NCT02181803|50250006|FG002|Overall Study|Withdrawal by Subject|0|||
25136877|NCT02181803|50250007|FG003|Overall Study|Withdrawal by Subject|0|||
25136878|NCT02181803|50250008|FG004|Overall Study|Withdrawal by Subject|0|||
25136879|NCT02181803|50250009|FG005|Overall Study|Withdrawal by Subject|0|||
25136880|NCT02181803|50250010|FG006|Overall Study|Withdrawal by Subject|0|||
25136881|NCT02181803|50250011|FG007|Overall Study|Withdrawal by Subject|0|||
25136882|NCT02181803|50250012|FG008|Overall Study|Withdrawal by Subject|0|||
25136883|NCT02181803|50250004|FG000|Overall Study|Physician Decision|0|||
25136884|NCT02181803|50250005|FG001|Overall Study|Physician Decision|0|||
25136885|NCT02181803|50250006|FG002|Overall Study|Physician Decision|0|||
25136886|NCT02181803|50250007|FG003|Overall Study|Physician Decision|1|||
25136887|NCT02181803|50250008|FG004|Overall Study|Physician Decision|0|||
25136888|NCT02181803|50250009|FG005|Overall Study|Physician Decision|0|||
25136889|NCT02181803|50250010|FG006|Overall Study|Physician Decision|0|||
25136890|NCT02181803|50250011|FG007|Overall Study|Physician Decision|1|||
25136891|NCT02181803|50250012|FG008|Overall Study|Physician Decision|0|||
25136892|NCT02181803|50250004|FG000|Overall Study|Adverse Event|0|||
25136893|NCT02181803|50250005|FG001|Overall Study|Adverse Event|2|||
25136894|NCT02181803|50250006|FG002|Overall Study|Adverse Event|0|||
25136895|NCT02181803|50250007|FG003|Overall Study|Adverse Event|1|||
25136896|NCT02181803|50250008|FG004|Overall Study|Adverse Event|0|||
25136897|NCT02181803|50250009|FG005|Overall Study|Adverse Event|0|||
25136898|NCT02181803|50250010|FG006|Overall Study|Adverse Event|1|||
25009486|NCT00075023|50102398|FG000|Pilot Study|Physician Decision|1|||
25009487|NCT00075023|50102399|FG001|Pilot Study|Physician Decision|2|||
25136899|NCT02181803|50250011|FG007|Overall Study|Adverse Event|0|||
25136900|NCT02181803|50250012|FG008|Overall Study|Adverse Event|0|||
25136901|NCT01826487|50250059|FG000|Overall Study|Adverse Event|1|||
25136902|NCT01826487|50250060|FG001|Overall Study|Adverse Event|1|||
25136903|NCT01826487|50250059|FG000|Overall Study|Lost to Follow-up|1|||
25136904|NCT01826487|50250060|FG001|Overall Study|Lost to Follow-up|0|||
25136905|NCT01826487|50250059|FG000|Overall Study|Withdrawal by Subject|1|||
25136906|NCT01826487|50250060|FG001|Overall Study|Withdrawal by Subject|3|||
25136907|NCT01826487|50250059|FG000|Overall Study|Protocol Violation|1|||
25136908|NCT01826487|50250060|FG001|Overall Study|Protocol Violation|1|||
25136909|NCT02064439|50250070|FG000|Overall Study|Adverse Event|51|||
25136910|NCT02064439|50250071|FG001|Overall Study|Adverse Event|47|||
25136911|NCT02064439|50250072|FG002|Overall Study|Adverse Event|46|||
25136912|NCT02064439|50250070|FG000|Overall Study|Death|0|||
25136913|NCT02064439|50250071|FG001|Overall Study|Death|2|||
25136914|NCT02064439|50250072|FG002|Overall Study|Death|3|||
25136915|NCT02064439|50250070|FG000|Overall Study|Withdrawal by Subject|29|||
25136916|NCT02064439|50250071|FG001|Overall Study|Withdrawal by Subject|18|||
25136917|NCT02064439|50250072|FG002|Overall Study|Withdrawal by Subject|26|||
25136918|NCT02064439|50250070|FG000|Overall Study|Protocol Violation|3|||
25136919|NCT02064439|50250071|FG001|Overall Study|Protocol Violation|5|||
25136920|NCT02064439|50250072|FG002|Overall Study|Protocol Violation|3|||
25136921|NCT02064439|50250070|FG000|Overall Study|Lost to Follow-up|1|||
25136922|NCT02064439|50250071|FG001|Overall Study|Lost to Follow-up|3|||
25136923|NCT02064439|50250072|FG002|Overall Study|Lost to Follow-up|4|||
25136924|NCT02064439|50250070|FG000|Overall Study|Non-compliance with study medication|21|||
25136925|NCT02064439|50250071|FG001|Overall Study|Non-compliance with study medication|19|||
25136926|NCT02064439|50250072|FG002|Overall Study|Non-compliance with study medication|23|||
25009488|NCT00075023|50102398|FG000|Pilot Study|Withdrawal by Subject|1|||
25178862|NCT01506193|50324178|FG002|Overall Study|Lost to Follow-up|3|||
25178863|NCT01505881|50324189|FG000|Overall Study|Adverse Event|0|||
25136927|NCT02064439|50250070|FG000|Overall Study|Physician Decision|0|||
25136928|NCT02064439|50250071|FG001|Overall Study|Physician Decision|1|||
25136929|NCT02064439|50250072|FG002|Overall Study|Physician Decision|1|||
25136930|NCT02064439|50250070|FG000|Overall Study|Logistical difficulties|6|||
25009489|NCT00075023|50102399|FG001|Pilot Study|Withdrawal by Subject|0|||
25009490|NCT00074711|50102408|FG000|Overall Study|Withdrawal by Subject|1|||
25009491|NCT00074711|50102409|FG001|Overall Study|Withdrawal by Subject|1|||
25009492|NCT00074711|50102408|FG000|Overall Study|Lost to Follow-up|10|||
25136931|NCT02064439|50250071|FG001|Overall Study|Logistical difficulties|5|||
25136932|NCT02064439|50250072|FG002|Overall Study|Logistical difficulties|2|||
25136933|NCT02064439|50250070|FG000|Overall Study|Efficacy outcome reached|18|||
25136934|NCT02064439|50250071|FG001|Overall Study|Efficacy outcome reached|16|||
25136935|NCT02064439|50250072|FG002|Overall Study|Efficacy outcome reached|57|||
25136936|NCT02064439|50250070|FG000|Overall Study|Safety outcome reached|12|||
25136937|NCT02064439|50250071|FG001|Overall Study|Safety outcome reached|20|||
25136938|NCT02064439|50250072|FG002|Overall Study|Safety outcome reached|10|||
25136939|NCT02064439|50250070|FG000|Overall Study|Other|2|||
25136940|NCT02064439|50250071|FG001|Overall Study|Other|2|||
25136941|NCT02064439|50250072|FG002|Overall Study|Other|7|||
25136942|NCT02130557|50250082|FG000|Overall Study|Withdrawal by Subject|12|||
25136943|NCT02130557|50250083|FG001|Overall Study|Withdrawal by Subject|12|||
25136944|NCT02130557|50250082|FG000|Overall Study|Investigator Request|0|||
25136945|NCT02130557|50250083|FG001|Overall Study|Investigator Request|2|||
25136946|NCT02130557|50250082|FG000|Overall Study|Deceased|14|||
25136947|NCT02130557|50250083|FG001|Overall Study|Deceased|14|||
25136948|NCT02130557|50250082|FG000|Overall Study|Lost to Follow-up|6|||
25136949|NCT02130557|50250083|FG001|Overall Study|Lost to Follow-up|7|||
25136950|NCT02130557|50250082|FG000|Overall Study|Other|2|||
25136951|NCT02130557|50250083|FG001|Overall Study|Other|1|||
25136952|NCT02130557|50250082|FG000|Overall Study|Missing|2|||
25009493|NCT00074711|50102409|FG001|Overall Study|Lost to Follow-up|8|||
25009494|NCT00074711|50102408|FG000|Overall Study|Participant stopped study drug|4|||
25136953|NCT02130557|50250083|FG001|Overall Study|Missing|1|||
25136954|NCT01854645|50250094|FG000|Overall Study|Protocol-Specified Criteria|13|||
25136955|NCT01854645|50250095|FG001|Overall Study|Protocol-Specified Criteria|10|||
25136956|NCT01854645|50250096|FG002|Overall Study|Protocol-Specified Criteria|8|||
25136957|NCT01854645|50250097|FG003|Overall Study|Protocol-Specified Criteria|5|||
25136958|NCT01854645|50250098|FG004|Overall Study|Protocol-Specified Criteria|7|||
25136959|NCT01854645|50250094|FG000|Overall Study|Administrative Reasons / Missing|0|||
25136960|NCT01854645|50250095|FG001|Overall Study|Administrative Reasons / Missing|0|||
25136961|NCT01854645|50250096|FG002|Overall Study|Administrative Reasons / Missing|0|||
25136962|NCT01854645|50250097|FG003|Overall Study|Administrative Reasons / Missing|1|||
25136963|NCT01854645|50250098|FG004|Overall Study|Administrative Reasons / Missing|1|||
25136964|NCT01854645|50250094|FG000|Overall Study|Protocol Violation|3|||
25136965|NCT01854645|50250095|FG001|Overall Study|Protocol Violation|0|||
25136966|NCT01854645|50250096|FG002|Overall Study|Protocol Violation|5|||
25136967|NCT01854645|50250097|FG003|Overall Study|Protocol Violation|4|||
25136968|NCT01854645|50250098|FG004|Overall Study|Protocol Violation|1|||
25136969|NCT01854645|50250094|FG000|Overall Study|Lost to Follow-up|10|||
25136970|NCT01854645|50250095|FG001|Overall Study|Lost to Follow-up|7|||
25136971|NCT01854645|50250096|FG002|Overall Study|Lost to Follow-up|8|||
25136972|NCT01854645|50250097|FG003|Overall Study|Lost to Follow-up|5|||
25136973|NCT01854645|50250098|FG004|Overall Study|Lost to Follow-up|0|||
25136974|NCT01854645|50250094|FG000|Overall Study|Physician Decision|1|||
25136975|NCT01854645|50250095|FG001|Overall Study|Physician Decision|5|||
25136976|NCT01854645|50250096|FG002|Overall Study|Physician Decision|3|||
25136977|NCT01854645|50250097|FG003|Overall Study|Physician Decision|3|||
25136978|NCT01854645|50250098|FG004|Overall Study|Physician Decision|7|||
25136979|NCT01854645|50250094|FG000|Overall Study|Withdrawal by Subject|31|||
25136980|NCT01854645|50250095|FG001|Overall Study|Withdrawal by Subject|41|||
25136981|NCT01854645|50250096|FG002|Overall Study|Withdrawal by Subject|30|||
25136982|NCT01854645|50250097|FG003|Overall Study|Withdrawal by Subject|21|||
25136983|NCT01854645|50250098|FG004|Overall Study|Withdrawal by Subject|24|||
25136984|NCT01854645|50250094|FG000|Overall Study|Lack of Efficacy|7|||
25136985|NCT01854645|50250095|FG001|Overall Study|Lack of Efficacy|12|||
25136986|NCT01854645|50250096|FG002|Overall Study|Lack of Efficacy|9|||
25136987|NCT01854645|50250097|FG003|Overall Study|Lack of Efficacy|3|||
25136988|NCT01854645|50250098|FG004|Overall Study|Lack of Efficacy|9|||
25136989|NCT01854645|50250094|FG000|Overall Study|Adverse Event|33|||
25178864|NCT01505881|50324190|FG001|Overall Study|Adverse Event|1|||
25136990|NCT01854645|50250095|FG001|Overall Study|Adverse Event|31|||
25136991|NCT01854645|50250096|FG002|Overall Study|Adverse Event|19|||
25136992|NCT01854645|50250097|FG003|Overall Study|Adverse Event|20|||
25178865|NCT01505881|50324189|FG000|Overall Study|Lost to Follow-up|2|||
25136993|NCT01854645|50250098|FG004|Overall Study|Adverse Event|11|||
25136994|NCT01825941|50250112|FG000|Overall Study|Lost to Follow-up|4|||
25136995|NCT01825941|50250113|FG001|Overall Study|Lost to Follow-up|1|||
25136996|NCT02064205|50250119|FG000|Overall Study|Withdrawal by Subject|1|||
25136997|NCT02090959|50250135|FG000|Overall Study|Withdrawal by Subject|10|||
25136998|NCT02090959|50250135|FG000|Overall Study|Adverse Event|1|||
25136999|NCT02090959|50250135|FG000|Overall Study|Investigator decision|2|||
25137000|NCT02090959|50250135|FG000|Overall Study|Study termination|6|||
25137001|NCT02090959|50250135|FG000|Overall Study|Enrolled but not treated|1|||
25137002|NCT02090959|50250135|FG000|Overall Study|Transfer for compassionate use medicine|4|||
25137003|NCT02090959|50250135|FG000|Overall Study|Move to medical need program|3|||
25137004|NCT02090959|50250135|FG000|Overall Study|Entered in to other study|34|||
25137005|NCT02090959|50250135|FG000|Overall Study|Switched to commercial supply|88|||
25137006|NCT02090959|50250135|FG000|Overall Study|Other than specified|2|||
25137007|NCT02044159|50250141|FG000|Overall Study|Consent declined (deferred consent)|2|||
25137008|NCT02044159|50250142|FG001|Overall Study|Consent declined (deferred consent)|4|||
25137009|NCT02044159|50250141|FG000|Overall Study|No longer eligible, drug not given|1|||
25137010|NCT02044159|50250142|FG001|Overall Study|No longer eligible, drug not given|0|||
25137011|NCT02044159|50250141|FG000|Overall Study|Nurse declined to give study drug|1|||
25137012|NCT02044159|50250142|FG001|Overall Study|Nurse declined to give study drug|0|||
25137013|NCT02090725|50250151|FG000|Overall Study|Withdrawal by Subject|1|||
25137014|NCT02090725|50250151|FG000|Overall Study|participants moved from area|3|||
25137015|NCT02180165|50250159|FG000|Overall Study|Not Treated|0|||
25137016|NCT02180165|50250160|FG001|Overall Study|Not Treated|0|||
25137017|NCT02180165|50250161|FG002|Overall Study|Not Treated|1|||
25137018|NCT02180165|50250162|FG003|Overall Study|Not Treated|0|||
25137019|NCT02180165|50250159|FG000|Overall Study|Adverse Event|7|||
25137020|NCT02180165|50250160|FG001|Overall Study|Adverse Event|0|||
25137021|NCT02180165|50250161|FG002|Overall Study|Adverse Event|18|||
25137022|NCT02180165|50250162|FG003|Overall Study|Adverse Event|3|||
25137023|NCT02180165|50250159|FG000|Overall Study|Lack of Efficacy|0|||
25137024|NCT02180165|50250160|FG001|Overall Study|Lack of Efficacy|1|||
25137025|NCT02180165|50250161|FG002|Overall Study|Lack of Efficacy|3|||
25137026|NCT02180165|50250162|FG003|Overall Study|Lack of Efficacy|2|||
25137027|NCT02180165|50250159|FG000|Overall Study|Physician Decision|1|||
25137028|NCT02180165|50250160|FG001|Overall Study|Physician Decision|0|||
25137029|NCT02180165|50250161|FG002|Overall Study|Physician Decision|5|||
25137030|NCT02180165|50250162|FG003|Overall Study|Physician Decision|0|||
25137031|NCT02180165|50250159|FG000|Overall Study|Withdrawal by Subject|3|||
25137032|NCT02180165|50250160|FG001|Overall Study|Withdrawal by Subject|0|||
25137033|NCT02180165|50250161|FG002|Overall Study|Withdrawal by Subject|2|||
25137034|NCT02180165|50250162|FG003|Overall Study|Withdrawal by Subject|1|||
25137035|NCT02155985|50250177|FG000|Overall Study|Withdrawal by Subject|0|||
25137036|NCT02155985|50250178|FG001|Overall Study|Withdrawal by Subject|0|||
25137037|NCT02155985|50250179|FG002|Overall Study|Withdrawal by Subject|1|||
25137038|NCT02155985|50250177|FG000|Overall Study|Lost to Follow-up|1|||
25137039|NCT02155985|50250178|FG001|Overall Study|Lost to Follow-up|0|||
25137040|NCT02155985|50250179|FG002|Overall Study|Lost to Follow-up|0|||
25137041|NCT02155829|50250189|FG000|Overall Study|Adverse Event|1|||
25137042|NCT02155829|50250190|FG001|Overall Study|Adverse Event|0|||
25137043|NCT02155829|50250189|FG000|Overall Study|Withdrawal by Subject|3|||
25137044|NCT02155829|50250190|FG001|Overall Study|Withdrawal by Subject|3|||
25137045|NCT02155829|50250189|FG000|Overall Study|Protocol Violation|2|||
25137046|NCT02155829|50250190|FG001|Overall Study|Protocol Violation|0|||
25137047|NCT02129777|50250202|FG000|Double-Blind Period|Adverse Event|0|||
25137048|NCT02129777|50250203|FG001|Double-Blind Period|Adverse Event|0|||
25137049|NCT02129777|50250204|FG002|Double-Blind Period|Adverse Event|0|||
25137050|NCT02129777|50250205|FG003|Double-Blind Period|Adverse Event|0|||
25137051|NCT02129777|50250206|FG004|Double-Blind Period|Adverse Event|1|||
25137052|NCT02129777|50250207|FG005|Double-Blind Period|Adverse Event|0|||
25137053|NCT02129777|50250208|FG006|Double-Blind Period|Adverse Event|0|||
25137054|NCT02129777|50250202|FG000|Double-Blind Period|Lost to Follow-up|1|||
25137055|NCT02129777|50250203|FG001|Double-Blind Period|Lost to Follow-up|1|||
25137056|NCT02129777|50250204|FG002|Double-Blind Period|Lost to Follow-up|1|||
25137057|NCT02129777|50250205|FG003|Double-Blind Period|Lost to Follow-up|2|||
25137058|NCT02129777|50250206|FG004|Double-Blind Period|Lost to Follow-up|0|||
25137059|NCT02129777|50250207|FG005|Double-Blind Period|Lost to Follow-up|0|||
25137060|NCT02129777|50250208|FG006|Double-Blind Period|Lost to Follow-up|0|||
25137061|NCT02129777|50250202|FG000|Double-Blind Period|Withdrawal by Subject|2|||
25137062|NCT02129777|50250203|FG001|Double-Blind Period|Withdrawal by Subject|4|||
25137063|NCT02129777|50250204|FG002|Double-Blind Period|Withdrawal by Subject|3|||
25137064|NCT02129777|50250205|FG003|Double-Blind Period|Withdrawal by Subject|2|||
25137065|NCT02129777|50250206|FG004|Double-Blind Period|Withdrawal by Subject|3|||
25137066|NCT02129777|50250207|FG005|Double-Blind Period|Withdrawal by Subject|0|||
25137067|NCT02129777|50250208|FG006|Double-Blind Period|Withdrawal by Subject|0|||
25137068|NCT02129777|50250202|FG000|Double-Blind Period|Pregnancy|0|||
25137069|NCT02129777|50250203|FG001|Double-Blind Period|Pregnancy|0|||
25137070|NCT02129777|50250204|FG002|Double-Blind Period|Pregnancy|0|||
25137071|NCT02129777|50250205|FG003|Double-Blind Period|Pregnancy|0|||
25137072|NCT02129777|50250206|FG004|Double-Blind Period|Pregnancy|1|||
25137073|NCT02129777|50250207|FG005|Double-Blind Period|Pregnancy|0|||
25137074|NCT02129777|50250208|FG006|Double-Blind Period|Pregnancy|0|||
25137075|NCT02129777|50250202|FG000|Double-Blind Period|Lack of Efficacy|3|||
25137076|NCT02129777|50250203|FG001|Double-Blind Period|Lack of Efficacy|1|||
25137077|NCT02129777|50250204|FG002|Double-Blind Period|Lack of Efficacy|0|||
25137078|NCT02129777|50250205|FG003|Double-Blind Period|Lack of Efficacy|3|||
25137079|NCT02129777|50250206|FG004|Double-Blind Period|Lack of Efficacy|2|||
25137080|NCT02129777|50250207|FG005|Double-Blind Period|Lack of Efficacy|0|||
25137081|NCT02129777|50250208|FG006|Double-Blind Period|Lack of Efficacy|0|||
25137082|NCT02129777|50250202|FG000|Double-Blind Period|Other|1|||
25137083|NCT02129777|50250203|FG001|Double-Blind Period|Other|2|||
25137084|NCT02129777|50250204|FG002|Double-Blind Period|Other|0|||
25137085|NCT02129777|50250205|FG003|Double-Blind Period|Other|0|||
25137086|NCT02129777|50250206|FG004|Double-Blind Period|Other|0|||
25137087|NCT02129777|50250207|FG005|Double-Blind Period|Other|0|||
25137088|NCT02129777|50250208|FG006|Double-Blind Period|Other|0|||
25137089|NCT02129777|50250202|FG000|Open-Label Period|Lack of Efficacy|0|||
25137090|NCT02129777|50250203|FG001|Open-Label Period|Lack of Efficacy|0|||
25137091|NCT02129777|50250204|FG002|Open-Label Period|Lack of Efficacy|0|||
25137092|NCT02129777|50250205|FG003|Open-Label Period|Lack of Efficacy|0|||
25137093|NCT02129777|50250206|FG004|Open-Label Period|Lack of Efficacy|0|||
25137094|NCT02129777|50250207|FG005|Open-Label Period|Lack of Efficacy|0|||
25137095|NCT02129777|50250208|FG006|Open-Label Period|Lack of Efficacy|5|||
25137096|NCT02129777|50250202|FG000|Open-Label Period|Lost to Follow-up|0|||
25137097|NCT02129777|50250203|FG001|Open-Label Period|Lost to Follow-up|0|||
25137098|NCT02129777|50250204|FG002|Open-Label Period|Lost to Follow-up|0|||
25137099|NCT02129777|50250205|FG003|Open-Label Period|Lost to Follow-up|0|||
25137100|NCT02129777|50250206|FG004|Open-Label Period|Lost to Follow-up|0|||
25137101|NCT02129777|50250207|FG005|Open-Label Period|Lost to Follow-up|1|||
25137102|NCT02129777|50250208|FG006|Open-Label Period|Lost to Follow-up|1|||
25137103|NCT02129777|50250202|FG000|Open-Label Period|Withdrawal by Subject|0|||
25137104|NCT02129777|50250203|FG001|Open-Label Period|Withdrawal by Subject|0|||
25137105|NCT02129777|50250204|FG002|Open-Label Period|Withdrawal by Subject|0|||
25137106|NCT02129777|50250205|FG003|Open-Label Period|Withdrawal by Subject|0|||
25137107|NCT02129777|50250206|FG004|Open-Label Period|Withdrawal by Subject|0|||
25137108|NCT02129777|50250207|FG005|Open-Label Period|Withdrawal by Subject|1|||
25137109|NCT02129777|50250208|FG006|Open-Label Period|Withdrawal by Subject|3|||
25137110|NCT02129777|50250202|FG000|Open-Label Period|Study Termination|0|||
25137111|NCT02129777|50250203|FG001|Open-Label Period|Study Termination|0|||
25137112|NCT02129777|50250204|FG002|Open-Label Period|Study Termination|0|||
25137113|NCT02129777|50250205|FG003|Open-Label Period|Study Termination|0|||
25137114|NCT02129777|50250206|FG004|Open-Label Period|Study Termination|0|||
25137115|NCT02129777|50250207|FG005|Open-Label Period|Study Termination|10|||
25137116|NCT02129777|50250208|FG006|Open-Label Period|Study Termination|39|||
25137117|NCT02178995|50250229|FG000|Double Blind|Adverse Event|0|||
25137118|NCT02178995|50250230|FG001|Double Blind|Adverse Event|0|||
25137119|NCT02178995|50250231|FG002|Double Blind|Adverse Event|0|||
25137120|NCT02178995|50250232|FG003|Double Blind|Adverse Event|0|||
25137121|NCT02178995|50250233|FG004|Double Blind|Adverse Event|0|||
25137122|NCT02178995|50250234|FG005|Double Blind|Adverse Event|1|||
25137123|NCT02178995|50250235|FG006|Double Blind|Adverse Event|0|||
25137124|NCT02178995|50250236|FG007|Double Blind|Adverse Event|1|||
25137125|NCT02178995|50250237|FG008|Double Blind|Adverse Event|1|||
25137126|NCT02178995|50250229|FG000|Double Blind|Lost to Follow-up|0|||
25137127|NCT02178995|50250230|FG001|Double Blind|Lost to Follow-up|1|||
25137128|NCT02178995|50250231|FG002|Double Blind|Lost to Follow-up|0|||
25137129|NCT02178995|50250232|FG003|Double Blind|Lost to Follow-up|0|||
25137130|NCT02178995|50250233|FG004|Double Blind|Lost to Follow-up|0|||
25137131|NCT02178995|50250234|FG005|Double Blind|Lost to Follow-up|0|||
25137132|NCT02178995|50250235|FG006|Double Blind|Lost to Follow-up|0|||
25137133|NCT02178995|50250236|FG007|Double Blind|Lost to Follow-up|1|||
25137134|NCT02178995|50250237|FG008|Double Blind|Lost to Follow-up|0|||
25137135|NCT02178995|50250229|FG000|Open Label|Adverse Event|2|||
25137136|NCT02178995|50250230|FG001|Open Label|Adverse Event|0|||
25137137|NCT02178995|50250231|FG002|Open Label|Adverse Event|0|||
25137138|NCT02178995|50250232|FG003|Open Label|Adverse Event|0|||
25137139|NCT02178995|50250233|FG004|Open Label|Adverse Event|0|||
25137140|NCT02178995|50250234|FG005|Open Label|Adverse Event|0|||
25137141|NCT02178995|50250235|FG006|Open Label|Adverse Event|0|||
25137142|NCT02178995|50250236|FG007|Open Label|Adverse Event|0|||
25137143|NCT02178995|50250237|FG008|Open Label|Adverse Event|0|||
25137144|NCT02128997|50250263|FG000|Overall Study|Lost to Follow-up|6|||
25137145|NCT02128997|50250264|FG001|Overall Study|Lost to Follow-up|11|||
25137146|NCT02155283|50250270|FG000|Overall Study|Lost to Follow-up|3|||
25137147|NCT02155283|50250270|FG000|Overall Study|Withdrawal by Subject|1|||
25137148|NCT02155283|50250270|FG000|Overall Study|Protocol Violation|3|||
25137149|NCT02154581|50250276|FG000|Overall Study|Lost to Follow-up|7|||
25137150|NCT02154581|50250277|FG001|Overall Study|Lost to Follow-up|8|||
25137151|NCT02154425|50250285|FG000|Screening Period|Adverse Event|1|||
25137152|NCT02154347|50250295|FG000|Double-blind Period|Adverse Event|1|||
25137153|NCT02154347|50250296|FG001|Double-blind Period|Adverse Event|2|||
25137154|NCT02154347|50250295|FG000|Double-blind Period|Lack of Efficacy|1|||
25137155|NCT02154347|50250296|FG001|Double-blind Period|Lack of Efficacy|0|||
25137156|NCT02154347|50250295|FG000|Double-blind Period|Physician Decision|0|||
25137157|NCT02154347|50250296|FG001|Double-blind Period|Physician Decision|1|||
25137158|NCT02154347|50250295|FG000|Double-blind Period|Withdrawal by Subject|1|||
25137159|NCT02154347|50250296|FG001|Double-blind Period|Withdrawal by Subject|1|||
25137160|NCT02154347|50250295|FG000|Open-label Period|Adverse Event|3|||
25137161|NCT02154347|50250296|FG001|Open-label Period|Adverse Event|4|||
25137162|NCT02154347|50250295|FG000|Open-label Period|Lack of Efficacy|4|||
25137163|NCT02154347|50250296|FG001|Open-label Period|Lack of Efficacy|19|||
25137164|NCT02154347|50250295|FG000|Open-label Period|Protocol Violation|0|||
25137165|NCT02154347|50250296|FG001|Open-label Period|Protocol Violation|1|||
25137166|NCT02154347|50250295|FG000|Open-label Period|Withdrawal by Subject|0|||
25137167|NCT02154347|50250296|FG001|Open-label Period|Withdrawal by Subject|1|||
25137168|NCT01627067|50250303|FG000|Overall Study|Screen Failure|1|||
25137169|NCT02178059|50250309|FG000|Washout|Physician Decision|1|||
25137170|NCT02178059|50250310|FG001|Washout|Physician Decision|0|||
25137171|NCT01626989|50250316|FG000|Screening Period|Screen Failure|15|||
25137172|NCT01626989|50250317|FG001|Screening Period|Screen Failure|0|||
25137173|NCT01626989|50250318|FG002|Screening Period|Screen Failure|0|||
25137174|NCT01626989|50250316|FG000|Screening Period|Withdrawal by Subject|2|||
25137175|NCT01626989|50250317|FG001|Screening Period|Withdrawal by Subject|0|||
25137176|NCT01626989|50250318|FG002|Screening Period|Withdrawal by Subject|0|||
25137177|NCT02128217|50250329|FG000|Overall Study|Lost to Follow-up|0|||
25137178|NCT02128217|50250330|FG001|Overall Study|Lost to Follow-up|1|||
25137179|NCT01629953|50250343|FG000|Overall Study|Death|3|||
25137180|NCT01629953|50250344|FG001|Overall Study|Death|1|||
25137181|NCT01629953|50250343|FG000|Overall Study|Lost to Follow-up|10|||
25137182|NCT01629953|50250344|FG001|Overall Study|Lost to Follow-up|14|||
25137183|NCT02127281|50250352|FG000|Overall Study|Lost to Follow-up|1|||
25137184|NCT02127281|50250353|FG001|Overall Study|Lost to Follow-up|0|||
25137185|NCT01628549|50250363|FG000|Overall Study|Adverse Event|1|||
25137186|NCT01628549|50250364|FG001|Overall Study|Adverse Event|1|||
25137187|NCT01628549|50250365|FG002|Overall Study|Adverse Event|0|||
25137188|NCT01628549|50250366|FG003|Overall Study|Adverse Event|4|||
25137189|NCT01628549|50250363|FG000|Overall Study|Lost to Follow-up|3|||
25137190|NCT01628549|50250364|FG001|Overall Study|Lost to Follow-up|4|||
25137191|NCT01628549|50250365|FG002|Overall Study|Lost to Follow-up|3|||
25137192|NCT01628549|50250366|FG003|Overall Study|Lost to Follow-up|3|||
25137193|NCT01628549|50250363|FG000|Overall Study|Withdrawal by Subject|3|||
25137194|NCT01628549|50250364|FG001|Overall Study|Withdrawal by Subject|4|||
25137195|NCT01628549|50250365|FG002|Overall Study|Withdrawal by Subject|4|||
25137196|NCT01628549|50250366|FG003|Overall Study|Withdrawal by Subject|1|||
25137197|NCT01628549|50250363|FG000|Overall Study|Protocol Violation|2|||
25137198|NCT01628549|50250364|FG001|Overall Study|Protocol Violation|1|||
25137199|NCT01628549|50250365|FG002|Overall Study|Protocol Violation|1|||
25137200|NCT01628549|50250366|FG003|Overall Study|Protocol Violation|0|||
25137201|NCT01628549|50250363|FG000|Overall Study|withdrawn for noncompliance|0|||
25009495|NCT00074711|50102409|FG001|Overall Study|Participant stopped study drug|6|||
25009496|NCT03420300|50102415|FG000|Overall Study|Death|2|||
25067328|NCT02433340|50172921|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
25067329|NCT02433340|50172918|FG000|Overall Study|Other|0|||
25067330|NCT02433340|50172919|FG001|Overall Study|Other|1|||
25067331|NCT02433340|50172920|FG002|Overall Study|Other|0|||
25067332|NCT02433340|50172921|FG003|Overall Study|Other|0|||
25067333|NCT02400346|50172933|FG000|Overall Study|Adverse Event|24|||
25067334|NCT02400346|50172933|FG000|Overall Study|Lack of Efficacy|9|||
25067335|NCT02400346|50172933|FG000|Overall Study|Non-compliance with IMP|1|||
25067336|NCT02400346|50172933|FG000|Overall Study|Withdrawal by Subject|7|||
25067337|NCT02400346|50172933|FG000|Overall Study|Administrative or other reason(s)|2|||
25067338|NCT02400346|50172933|FG000|Overall Study|Lost to Follow-up|1|||
25067339|NCT02399254|50172937|FG000|Overall Study|Physician Decision|2|||
25067340|NCT02456662|50172944|FG000|Overall Study|Lost to Follow-up|2|||
25067341|NCT02456662|50172945|FG001|Overall Study|Lost to Follow-up|1|||
25067342|NCT01653262|50172951|FG000|Overall Study|Lack of Efficacy|1|||
25067343|NCT01653262|50172951|FG000|Overall Study|SAE, non-fatal|1|||
25067344|NCT01653262|50172951|FG000|Overall Study|AE, non-serious non-fatal|1|||
25067345|NCT02455336|50172957|FG000|Overall Study|Withdrawal by Subject|0|||
25067346|NCT02455336|50172958|FG001|Overall Study|Withdrawal by Subject|2|||
25067347|NCT02455336|50172957|FG000|Overall Study|Adverse Event|3|||
25067348|NCT02455336|50172958|FG001|Overall Study|Adverse Event|0|||
25067349|NCT02455336|50172957|FG000|Overall Study|Non-responder to treatment|2|||
25067350|NCT02455336|50172958|FG001|Overall Study|Non-responder to treatment|0|||
25067351|NCT02397694|50172966|FG000|Double-Blinded Phase|Adverse Event|1|||
25067352|NCT02397694|50172967|FG001|Double-Blinded Phase|Adverse Event|0|||
25067353|NCT02397694|50172966|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
25067354|NCT02397694|50172967|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
25067355|NCT02397694|50172966|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
25067356|NCT02397694|50172967|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
25067357|NCT02397694|50172966|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
25067358|NCT02397694|50172967|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
25067359|NCT02397694|50172966|FG000|Open Label Extension Phase|Protocol Violation|1|||
25067360|NCT02397694|50172967|FG001|Open Label Extension Phase|Protocol Violation|0|||
25137202|NCT01628549|50250364|FG001|Overall Study|withdrawn for noncompliance|2|||
25137203|NCT01628549|50250365|FG002|Overall Study|withdrawn for noncompliance|1|||
25137204|NCT01628549|50250366|FG003|Overall Study|withdrawn for noncompliance|0|||
25137205|NCT01628549|50250363|FG000|Overall Study|abnormal laboratory test results|0|||
25137206|NCT01628549|50250364|FG001|Overall Study|abnormal laboratory test results|0|||
25137207|NCT01628549|50250365|FG002|Overall Study|abnormal laboratory test results|1|||
25137208|NCT01628549|50250366|FG003|Overall Study|abnormal laboratory test results|0|||
25137209|NCT01628549|50250363|FG000|Overall Study|positive pregnancy test|0|||
25137210|NCT01628549|50250364|FG001|Overall Study|positive pregnancy test|0|||
25137211|NCT01628549|50250365|FG002|Overall Study|positive pregnancy test|0|||
25137212|NCT01628549|50250366|FG003|Overall Study|positive pregnancy test|1|||
25137213|NCT02127125|50250385|FG000|Overall Study|Lost to Follow-up|0|||
25137214|NCT02127125|50250386|FG001|Overall Study|Lost to Follow-up|0|||
25137215|NCT02127125|50250387|FG002|Overall Study|Lost to Follow-up|0|||
25137216|NCT02127125|50250388|FG003|Overall Study|Lost to Follow-up|0|||
25137217|NCT02127125|50250389|FG004|Overall Study|Lost to Follow-up|2|||
25137218|NCT02127125|50250390|FG005|Overall Study|Lost to Follow-up|1|||
25137219|NCT02127125|50250391|FG006|Overall Study|Lost to Follow-up|0|||
25137220|NCT02127125|50250392|FG007|Overall Study|Lost to Follow-up|0|||
25137221|NCT02127125|50250393|FG008|Overall Study|Lost to Follow-up|0|||
25137222|NCT02127125|50250385|FG000|Overall Study|Withdrawal by Subject|0|||
25009497|NCT03419598|50102419|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
25009498|NCT03407430|50102427|FG000|Washout|Protocol Violation|1|||
25137223|NCT02127125|50250386|FG001|Overall Study|Withdrawal by Subject|0|||
25137224|NCT02127125|50250387|FG002|Overall Study|Withdrawal by Subject|0|||
25137225|NCT02127125|50250388|FG003|Overall Study|Withdrawal by Subject|1|||
25178866|NCT01505881|50324190|FG001|Overall Study|Lost to Follow-up|0|||
25137226|NCT02127125|50250389|FG004|Overall Study|Withdrawal by Subject|0|||
25137227|NCT02127125|50250390|FG005|Overall Study|Withdrawal by Subject|0|||
25137228|NCT02127125|50250391|FG006|Overall Study|Withdrawal by Subject|0|||
25137229|NCT02127125|50250392|FG007|Overall Study|Withdrawal by Subject|0|||
25137230|NCT02127125|50250393|FG008|Overall Study|Withdrawal by Subject|0|||
25137231|NCT02127125|50250385|FG000|Overall Study|Physician Decision|0|||
25137232|NCT02127125|50250386|FG001|Overall Study|Physician Decision|0|||
25137233|NCT02127125|50250387|FG002|Overall Study|Physician Decision|1|||
25137234|NCT02127125|50250388|FG003|Overall Study|Physician Decision|0|||
25137235|NCT02127125|50250389|FG004|Overall Study|Physician Decision|1|||
25137236|NCT02127125|50250390|FG005|Overall Study|Physician Decision|2|||
25137237|NCT02127125|50250391|FG006|Overall Study|Physician Decision|0|||
25137238|NCT02127125|50250392|FG007|Overall Study|Physician Decision|0|||
25137239|NCT02127125|50250393|FG008|Overall Study|Physician Decision|0|||
25137240|NCT02090413|50250416|FG000|Overall Study|Adverse Event|11|||
25137241|NCT02090413|50250417|FG001|Overall Study|Adverse Event|15|||
25137242|NCT02090413|50250418|FG002|Overall Study|Adverse Event|20|||
25009499|NCT03407430|50102428|FG001|Washout|Protocol Violation|0|||
25009500|NCT03407118|50102441|FG000|Period 2|Withdrawal by Subject|1|||
25137243|NCT02090413|50250416|FG000|Overall Study|Flushing event|2|||
25137244|NCT02090413|50250417|FG001|Overall Study|Flushing event|0|||
25137245|NCT02090413|50250418|FG002|Overall Study|Flushing event|1|||
25137246|NCT02090413|50250416|FG000|Overall Study|Withdrawal by Subject|2|||
25137247|NCT02090413|50250417|FG001|Overall Study|Withdrawal by Subject|2|||
25137248|NCT02090413|50250418|FG002|Overall Study|Withdrawal by Subject|2|||
25137249|NCT02090413|50250416|FG000|Overall Study|Investigator Decision|1|||
25137250|NCT02090413|50250417|FG001|Overall Study|Investigator Decision|1|||
25137251|NCT02090413|50250418|FG002|Overall Study|Investigator Decision|0|||
25137252|NCT02090413|50250416|FG000|Overall Study|Other|2|||
25137253|NCT02090413|50250417|FG001|Overall Study|Other|1|||
25137254|NCT02090413|50250418|FG002|Overall Study|Other|0|||
25137255|NCT02090413|50250416|FG000|Overall Study|Lost to Follow-up|1|||
25137256|NCT02090413|50250417|FG001|Overall Study|Lost to Follow-up|1|||
25137257|NCT02090413|50250418|FG002|Overall Study|Lost to Follow-up|0|||
25137258|NCT02063737|50250429|FG000|Overall Study|Lost to Follow-up|11|||
25137259|NCT02063737|50250430|FG001|Overall Study|Lost to Follow-up|4|||
25137260|NCT02125877|50250438|FG000|Overall Study|Physician Decision|1|||
25137261|NCT02125877|50250439|FG001|Overall Study|Physician Decision|0|||
25137262|NCT02125877|50250438|FG000|Overall Study|Death|0|||
25137263|NCT02125877|50250439|FG001|Overall Study|Death|1|||
25137264|NCT02125877|50250438|FG000|Overall Study|Administrative problems|0|||
25137265|NCT02125877|50250439|FG001|Overall Study|Administrative problems|1|||
25137266|NCT02125877|50250438|FG000|Overall Study|Participant/guardian decision|0|||
25137267|NCT02125877|50250439|FG001|Overall Study|Participant/guardian decision|2|||
25137268|NCT02125877|50250438|FG000|Overall Study|Withdrawal by Subject|2|||
25137269|NCT02125877|50250439|FG001|Overall Study|Withdrawal by Subject|1|||
25137270|NCT02125877|50250438|FG000|Overall Study|Protocol deviation|4|||
25137271|NCT02125877|50250439|FG001|Overall Study|Protocol deviation|1|||
25178867|NCT01505881|50324189|FG000|Overall Study|Withdrawal by Subject|2|||
25178868|NCT01505881|50324190|FG001|Overall Study|Withdrawal by Subject|0|||
25178869|NCT01462045|50324200|FG000|Overall Study|Family matter|0|||
25178870|NCT01462045|50324201|FG001|Overall Study|Family matter|1|||
25178871|NCT01462045|50324202|FG002|Overall Study|Family matter|0|||
25178872|NCT01505647|50324212|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
25178873|NCT01505647|50324213|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
25178874|NCT01505647|50324212|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
25178875|NCT01505647|50324213|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
25178876|NCT01505647|50324212|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
25137272|NCT02125877|50250438|FG000|Overall Study|Adverse Event|6|||
25137273|NCT02125877|50250439|FG001|Overall Study|Adverse Event|4|||
25273702|NCT01256684|50587850|FG002|Overall Study|Adverse Event|2|||
25273703|NCT01256684|50587848|FG000|Overall Study|Withdrawal by Subject|4|||
25273704|NCT01256684|50587849|FG001|Overall Study|Withdrawal by Subject|0|||
25273705|NCT01256684|50587850|FG002|Overall Study|Withdrawal by Subject|2|||
25273706|NCT01256684|50587848|FG000|Overall Study|Physician Decision|0|||
25273707|NCT01256684|50587849|FG001|Overall Study|Physician Decision|1|||
25273708|NCT01256684|50587850|FG002|Overall Study|Physician Decision|0|||
25273709|NCT01256684|50587848|FG000|Overall Study|Lack of Efficacy|0|||
25273710|NCT01256684|50587849|FG001|Overall Study|Lack of Efficacy|1|||
25137274|NCT01598987|50250445|FG000|Baseline to Month 12|Administrative problems|2|||
25137275|NCT01598987|50250445|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
25137276|NCT01598987|50250445|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
25137277|NCT01598987|50250445|FG000|Baseline to 24 Month|Administrative problems|2|||
25137278|NCT01598987|50250445|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
25137279|NCT02063659|50250459|FG000|Double-Blind Treatment Period|Adverse Event|1|||
25137280|NCT02063659|50250460|FG001|Double-Blind Treatment Period|Adverse Event|2|||
25137281|NCT02063659|50250461|FG002|Double-Blind Treatment Period|Adverse Event|0|||
25178877|NCT01505647|50324213|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
25178878|NCT01505647|50324212|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
25178879|NCT01505647|50324213|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
25178880|NCT01505647|50324212|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
25178881|NCT01505647|50324213|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
25178882|NCT01477333|50324219|FG000|Overall Study|Adverse Event|1|||
25178883|NCT01477333|50324219|FG000|Overall Study|Withdrawal by Subject|1|||
25178884|NCT01477333|50324219|FG000|Overall Study|Clinical Deterioration|1|||
25178885|NCT01461811|50324229|FG000|Overall Study|Adverse Event|2|||
25178886|NCT01461811|50324230|FG001|Overall Study|Adverse Event|1|||
25178887|NCT01461811|50324229|FG000|Overall Study|Subject decision unrelated to an AE|1|||
25178888|NCT01461811|50324230|FG001|Overall Study|Subject decision unrelated to an AE|1|||
25178889|NCT01461811|50324229|FG000|Overall Study|Noncompliance|1|||
25178890|NCT01461811|50324230|FG001|Overall Study|Noncompliance|1|||
25178891|NCT01505491|50324239|FG000|Overall Study|Other reason not listed|1|||
25137282|NCT02063659|50250462|FG003|Double-Blind Treatment Period|Adverse Event|0|||
25137283|NCT02063659|50250459|FG000|Double-Blind Treatment Period|Physician Decision|1|||
25137284|NCT02063659|50250460|FG001|Double-Blind Treatment Period|Physician Decision|0|||
25137285|NCT02063659|50250461|FG002|Double-Blind Treatment Period|Physician Decision|0|||
25137286|NCT02063659|50250462|FG003|Double-Blind Treatment Period|Physician Decision|0|||
25178892|NCT01505491|50324240|FG001|Overall Study|Other reason not listed|0|||
25178893|NCT01505491|50324241|FG002|Overall Study|Other reason not listed|0|||
25178894|NCT01505491|50324239|FG000|Overall Study|Withdrawal by Subject|1|||
25137287|NCT02063659|50250459|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
25137288|NCT02063659|50250460|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
25137289|NCT02063659|50250461|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
25137290|NCT02063659|50250462|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
25137291|NCT02063659|50250459|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
25137292|NCT02063659|50250460|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
25137293|NCT02063659|50250461|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
25137294|NCT02063659|50250462|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
25137295|NCT02063659|50250459|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
25137296|NCT02063659|50250460|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
25137297|NCT02063659|50250461|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
25137298|NCT02063659|50250462|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
25137299|NCT02063659|50250459|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
25137300|NCT02063659|50250460|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
25137301|NCT02063659|50250461|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
25137302|NCT02063659|50250462|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
25137303|NCT02063659|50250459|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
25137304|NCT02063659|50250460|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
25137305|NCT02063659|50250461|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
25137306|NCT02063659|50250462|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
25137307|NCT02063659|50250459|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
25137308|NCT02063659|50250460|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
25137309|NCT02063659|50250461|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
25178895|NCT01505491|50324240|FG001|Overall Study|Withdrawal by Subject|1|||
25178896|NCT01505491|50324241|FG002|Overall Study|Withdrawal by Subject|4|||
25178897|NCT01505491|50324239|FG000|Overall Study|Lost to Follow-up|0|||
25178898|NCT01505491|50324240|FG001|Overall Study|Lost to Follow-up|0|||
25178899|NCT01505491|50324241|FG002|Overall Study|Lost to Follow-up|1|||
25178900|NCT01504867|50324251|FG000|Overall Study|Inclusion criteria not met|2|||
25178901|NCT01504867|50324252|FG001|Overall Study|Inclusion criteria not met|2|||
25178902|NCT01504867|50324251|FG000|Overall Study|Consent revoked|5|||
25178903|NCT01504867|50324252|FG001|Overall Study|Consent revoked|1|||
25178904|NCT01476475|50324260|FG000|Overall Study|Adverse Event|6|||
25178905|NCT01476475|50324261|FG001|Overall Study|Adverse Event|0|||
25178906|NCT01476475|50324260|FG000|Overall Study|Poor compliance to protocol|1|||
25178907|NCT01476475|50324261|FG001|Overall Study|Poor compliance to protocol|1|||
25178908|NCT01476475|50324260|FG000|Overall Study|Other reasons|4|||
25178909|NCT01476475|50324261|FG001|Overall Study|Other reasons|2|||
25178910|NCT01475851|50324270|FG000|Overall Study|Protocol defined stopping criteria|1|||
25178911|NCT01475851|50324271|FG001|Overall Study|Protocol defined stopping criteria|0|||
25178912|NCT01460719|50324277|FG000|Overall Study|Adverse Event|1|||
25178913|NCT01460719|50324277|FG000|Overall Study|Withdrawal by Subject|1|||
25178914|NCT01468181|50324347|FG000|Overall Study|Adverse Event|8|||
25137310|NCT02063659|50250462|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
25137311|NCT02062879|50250478|FG000|Overall Study|Withdrawal by Subject|4|||
25137312|NCT02062879|50250479|FG001|Overall Study|Withdrawal by Subject|1|||
25137313|NCT02062645|50250485|FG000|Overall Study|Adverse Event|2|||
25137314|NCT02062645|50250485|FG000|Overall Study|Protocol Violation|8|||
25137315|NCT02062645|50250485|FG000|Overall Study|Lost to Follow-up|5|||
25137316|NCT02088697|50250491|FG000|Period I|Physician Decision|1|||
25137317|NCT02088697|50250492|FG001|Period I|Physician Decision|4|||
25137318|NCT02088697|50250491|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
25137319|NCT02088697|50250492|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
25137320|NCT01825785|50250505|FG000|Overall Study|Adverse Event|0|||
25137321|NCT01825785|50250506|FG001|Overall Study|Adverse Event|0|||
25137322|NCT01825785|50250507|FG002|Overall Study|Adverse Event|0|||
25178915|NCT01468181|50324348|FG001|Overall Study|Adverse Event|1|||
25178916|NCT01468181|50324349|FG002|Overall Study|Adverse Event|6|||
25178917|NCT01468181|50324350|FG003|Overall Study|Adverse Event|2|||
25137323|NCT01825785|50250508|FG003|Overall Study|Adverse Event|0|||
25137324|NCT01825785|50250509|FG004|Overall Study|Adverse Event|1|||
25137325|NCT01825785|50250510|FG005|Overall Study|Adverse Event|0|||
25178918|NCT01468181|50324351|FG004|Overall Study|Adverse Event|2|||
25178919|NCT01468181|50324347|FG000|Overall Study|Protocol Violation|2|||
25137326|NCT01825785|50250511|FG006|Overall Study|Adverse Event|0|||
25137327|NCT01825785|50250505|FG000|Overall Study|Withdrawal by Subject|0|||
25137328|NCT01825785|50250506|FG001|Overall Study|Withdrawal by Subject|0|||
25137329|NCT01825785|50250507|FG002|Overall Study|Withdrawal by Subject|0|||
25137330|NCT01825785|50250508|FG003|Overall Study|Withdrawal by Subject|0|||
25137331|NCT01825785|50250509|FG004|Overall Study|Withdrawal by Subject|1|||
25137332|NCT01825785|50250510|FG005|Overall Study|Withdrawal by Subject|1|||
25137333|NCT01825785|50250511|FG006|Overall Study|Withdrawal by Subject|0|||
25137334|NCT02043301|50250536|FG000|Overall Study|Discontinued|0|||
25137335|NCT02043301|50250537|FG001|Overall Study|Discontinued|1|||
25137336|NCT02043301|50250538|FG002|Overall Study|Discontinued|0|||
25137337|NCT01598753|50250550|FG000|Overall Study|Adverse Event|1|||
25137338|NCT01598753|50250551|FG001|Overall Study|Adverse Event|9|||
25137339|NCT01598753|50250552|FG002|Overall Study|Adverse Event|1|||
25137340|NCT01598753|50250553|FG003|Overall Study|Adverse Event|7|||
25137341|NCT01598753|50250550|FG000|Overall Study|Lost to Follow-up|4|||
25137342|NCT01598753|50250551|FG001|Overall Study|Lost to Follow-up|3|||
25137343|NCT01598753|50250552|FG002|Overall Study|Lost to Follow-up|7|||
25137344|NCT01598753|50250553|FG003|Overall Study|Lost to Follow-up|5|||
25137345|NCT01598753|50250550|FG000|Overall Study|Physician Decision|0|||
25137346|NCT01598753|50250551|FG001|Overall Study|Physician Decision|1|||
25137347|NCT01598753|50250552|FG002|Overall Study|Physician Decision|0|||
25137348|NCT01598753|50250553|FG003|Overall Study|Physician Decision|2|||
25137349|NCT01598753|50250550|FG000|Overall Study|Withdrawal by Subject|7|||
25137350|NCT01598753|50250551|FG001|Overall Study|Withdrawal by Subject|2|||
25137351|NCT01598753|50250552|FG002|Overall Study|Withdrawal by Subject|0|||
25137352|NCT01598753|50250553|FG003|Overall Study|Withdrawal by Subject|1|||
25137353|NCT02177123|50250563|FG000|Overall Study|Lost to Follow-up|6|||
25137354|NCT02177123|50250563|FG000|Overall Study|Withdrawal by Subject|4|||
25137355|NCT02177123|50250563|FG000|Overall Study|Adverse Event|4|||
25137356|NCT02177123|50250563|FG000|Overall Study|Physician Decision|3|||
25137357|NCT02177123|50250563|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
25137358|NCT02177123|50250563|FG000|Overall Study|Excluded for medical reasons|2|||
25137359|NCT02177123|50250563|FG000|Overall Study|Death|1|||
25137360|NCT02177123|50250563|FG000|Overall Study|Other|1|||
25137361|NCT02177123|50250563|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
25137362|NCT01824693|50250573|FG000|Overall Study|Death|0|||
25137363|NCT01824693|50250574|FG001|Overall Study|Death|1|||
25137364|NCT01824693|50250575|FG002|Overall Study|Death|0|||
25137365|NCT01824693|50250573|FG000|Overall Study|Physician Decision|1|||
25137366|NCT01824693|50250574|FG001|Overall Study|Physician Decision|1|||
25137367|NCT01824693|50250575|FG002|Overall Study|Physician Decision|1|||
25137368|NCT01824693|50250573|FG000|Overall Study|Withdrawal by Subject|0|||
25137369|NCT01824693|50250574|FG001|Overall Study|Withdrawal by Subject|0|||
25137370|NCT01824693|50250575|FG002|Overall Study|Withdrawal by Subject|1|||
25137371|NCT01824693|50250573|FG000|Overall Study|Progressive Disease|0|||
25137372|NCT01824693|50250574|FG001|Overall Study|Progressive Disease|5|||
25137373|NCT01824693|50250575|FG002|Overall Study|Progressive Disease|0|||
25137374|NCT01824693|50250573|FG000|Overall Study|Ineligible|0|||
25137375|NCT01824693|50250574|FG001|Overall Study|Ineligible|0|||
25137376|NCT01824693|50250575|FG002|Overall Study|Ineligible|3|||
25137377|NCT01824693|50250573|FG000|Overall Study|No Transplant Planned|0|||
25137378|NCT01824693|50250574|FG001|Overall Study|No Transplant Planned|0|||
25137379|NCT01824693|50250575|FG002|Overall Study|No Transplant Planned|10|||
25137380|NCT02176655|50250582|FG000|Overall Study|Subjects did not treat|6|||
25137381|NCT02125331|50250589|FG000|Overall Study|Protocol Violation|1|||
25137382|NCT02125331|50250590|FG001|Overall Study|Protocol Violation|0|||
25137383|NCT02125331|50250589|FG000|Overall Study|technical problem|2|||
25137384|NCT02125331|50250590|FG001|Overall Study|technical problem|0|||
25137385|NCT02125331|50250589|FG000|Overall Study|screen failure|2|||
25137386|NCT02125331|50250590|FG001|Overall Study|screen failure|0|||
25137387|NCT01622569|50250600|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
25137388|NCT01622569|50250601|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
25137389|NCT01622569|50250602|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
25137390|NCT01622569|50250603|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
25137391|NCT01622569|50250600|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
25137392|NCT01622569|50250601|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
25137393|NCT01622569|50250602|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
25137394|NCT01622569|50250603|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
25137395|NCT01622569|50250600|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
25137396|NCT01622569|50250601|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
25137397|NCT01622569|50250602|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
25137398|NCT01622569|50250603|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
25137399|NCT01622569|50250600|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
25137400|NCT01622569|50250601|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
25137401|NCT01622569|50250602|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
25137402|NCT01622569|50250603|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
25137403|NCT01622569|50250600|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
25137404|NCT01622569|50250601|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
25137405|NCT01622569|50250602|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
25137406|NCT01622569|50250603|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
25137407|NCT01622569|50250600|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
25137408|NCT01622569|50250601|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
25137409|NCT01622569|50250602|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
25137410|NCT01622569|50250603|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
25137411|NCT01622569|50250600|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
25178920|NCT01468181|50324348|FG001|Overall Study|Protocol Violation|0|||
25178921|NCT01468181|50324349|FG002|Overall Study|Protocol Violation|1|||
25137412|NCT01622569|50250601|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
25137413|NCT01622569|50250602|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
25137414|NCT01622569|50250603|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
25137415|NCT01622569|50250600|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
25137416|NCT01622569|50250601|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
25137417|NCT01622569|50250602|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
25137418|NCT01622569|50250603|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
25137419|NCT01824303|50250625|FG000|Randomized Study|Withdrawal by Subject|1|||
25137420|NCT01824303|50250626|FG001|Randomized Study|Withdrawal by Subject|1|||
25137421|NCT01824303|50250625|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
25137422|NCT01824303|50250626|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
25137423|NCT01853397|50250638|FG000|Overall Study|Withdrawal by Subject|0|||
25137424|NCT01853397|50250639|FG001|Overall Study|Withdrawal by Subject|0|||
25137425|NCT01853397|50250640|FG002|Overall Study|Withdrawal by Subject|0|||
25137426|NCT01853397|50250641|FG003|Overall Study|Withdrawal by Subject|1|||
25137427|NCT01853397|50250638|FG000|Overall Study|Subject Noncompliance|0|||
25178922|NCT01468181|50324350|FG003|Overall Study|Protocol Violation|0|||
25137428|NCT01853397|50250639|FG001|Overall Study|Subject Noncompliance|0|||
25137429|NCT01853397|50250640|FG002|Overall Study|Subject Noncompliance|0|||
25137430|NCT01853397|50250641|FG003|Overall Study|Subject Noncompliance|1|||
25137431|NCT02088073|50250656|FG000|Acute Phase|Withdrawal by Subject|5|||
25137432|NCT02088073|50250657|FG001|Acute Phase|Withdrawal by Subject|0|||
25137433|NCT02088073|50250658|FG002|Acute Phase|Withdrawal by Subject|0|||
25137434|NCT02088073|50250659|FG003|Acute Phase|Withdrawal by Subject|0|||
25137435|NCT02088073|50250660|FG004|Acute Phase|Withdrawal by Subject|0|||
25137436|NCT02088073|50250656|FG000|Acute Phase|Hyperkalemia|2|||
25137437|NCT02088073|50250657|FG001|Acute Phase|Hyperkalemia|0|||
25137438|NCT02088073|50250658|FG002|Acute Phase|Hyperkalemia|0|||
25137439|NCT02088073|50250659|FG003|Acute Phase|Hyperkalemia|0|||
25137440|NCT02088073|50250660|FG004|Acute Phase|Hyperkalemia|0|||
25137441|NCT02088073|50250656|FG000|Maintanance Phase|Withdrawal by Subject|0|||
25137442|NCT02088073|50250657|FG001|Maintanance Phase|Withdrawal by Subject|2|||
25137443|NCT02088073|50250658|FG002|Maintanance Phase|Withdrawal by Subject|0|||
25137444|NCT02088073|50250659|FG003|Maintanance Phase|Withdrawal by Subject|0|||
25137445|NCT02088073|50250660|FG004|Maintanance Phase|Withdrawal by Subject|0|||
25137446|NCT02088073|50250656|FG000|Maintanance Phase|Adverse Event|0|||
25137447|NCT02088073|50250657|FG001|Maintanance Phase|Adverse Event|0|||
25137448|NCT02088073|50250658|FG002|Maintanance Phase|Adverse Event|3|||
25137449|NCT02088073|50250659|FG003|Maintanance Phase|Adverse Event|0|||
25137450|NCT02088073|50250660|FG004|Maintanance Phase|Adverse Event|1|||
25137451|NCT02088073|50250656|FG000|Maintanance Phase|Physician Decision|0|||
25137452|NCT02088073|50250657|FG001|Maintanance Phase|Physician Decision|0|||
25137453|NCT02088073|50250658|FG002|Maintanance Phase|Physician Decision|0|||
25137454|NCT02088073|50250659|FG003|Maintanance Phase|Physician Decision|0|||
25137455|NCT02088073|50250660|FG004|Maintanance Phase|Physician Decision|1|||
25137456|NCT02088073|50250656|FG000|Maintanance Phase|Sponsor's decision|0|||
25137457|NCT02088073|50250657|FG001|Maintanance Phase|Sponsor's decision|2|||
25137458|NCT02088073|50250658|FG002|Maintanance Phase|Sponsor's decision|0|||
25137459|NCT02088073|50250659|FG003|Maintanance Phase|Sponsor's decision|2|||
25137460|NCT02088073|50250660|FG004|Maintanance Phase|Sponsor's decision|1|||
25137461|NCT02088073|50250656|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
25137462|NCT02088073|50250657|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
25137463|NCT02088073|50250658|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
25137464|NCT02088073|50250659|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
25137465|NCT02088073|50250660|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
25009501|NCT03407118|50102442|FG001|Period 2|Withdrawal by Subject|0|||
25009502|NCT03406962|50102448|FG000|Overall Study|Death|2|||
25137466|NCT02088073|50250656|FG000|Maintanance Phase|Miscellaneous|0|||
25137467|NCT02088073|50250657|FG001|Maintanance Phase|Miscellaneous|2|||
25137468|NCT02088073|50250658|FG002|Maintanance Phase|Miscellaneous|1|||
25137469|NCT02088073|50250659|FG003|Maintanance Phase|Miscellaneous|2|||
25137470|NCT02088073|50250660|FG004|Maintanance Phase|Miscellaneous|1|||
25137471|NCT02088073|50250656|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
25178923|NCT01468181|50324351|FG004|Overall Study|Protocol Violation|1|||
25137472|NCT02088073|50250657|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
25137473|NCT02088073|50250658|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
25137474|NCT02088073|50250659|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
25178924|NCT01468181|50324347|FG000|Overall Study|Physician Decision|0|||
25178925|NCT01468181|50324348|FG001|Overall Study|Physician Decision|0|||
25137475|NCT02088073|50250660|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
25137476|NCT02088073|50250656|FG000|Maintanance Phase|Subject compliance|0|||
25137477|NCT02088073|50250657|FG001|Maintanance Phase|Subject compliance|1|||
25137478|NCT02088073|50250658|FG002|Maintanance Phase|Subject compliance|0|||
25137479|NCT02088073|50250659|FG003|Maintanance Phase|Subject compliance|0|||
25137480|NCT02088073|50250660|FG004|Maintanance Phase|Subject compliance|0|||
25137481|NCT01823991|50250675|FG000|Overall Study|Withdrawal by Subject|8|||
25137482|NCT01823991|50250676|FG001|Overall Study|Withdrawal by Subject|5|||
25137483|NCT02087059|50250686|FG000|Overall Study|Disease Progression|1|||
25137484|NCT02087059|50250686|FG000|Overall Study|Adverse Event|5|||
25137485|NCT02087059|50250686|FG000|Overall Study|Lost to Follow-up|1|||
25137486|NCT02152631|50250692|FG000|Overall Study|Adverse Event|32|||
25137487|NCT02152631|50250693|FG001|Overall Study|Adverse Event|4|||
25009503|NCT03406962|50102448|FG000|Overall Study|Adverse Event|1|||
25009504|NCT03406260|50102459|FG000|Period 1|Adverse Event|0|||
25009505|NCT03406260|50102460|FG001|Period 1|Adverse Event|0|||
25009506|NCT03406260|50102461|FG002|Period 1|Adverse Event|0|||
25009507|NCT03406260|50102462|FG003|Period 1|Adverse Event|0|||
25009508|NCT03406260|50102463|FG004|Period 1|Adverse Event|1|||
25009509|NCT03406260|50102464|FG005|Period 1|Adverse Event|0|||
25009510|NCT03419364|50102477|FG000|Overall Study|Delivery due to maternal condition|2|||
25178926|NCT01468181|50324349|FG002|Overall Study|Physician Decision|0|||
25137488|NCT02152631|50250692|FG000|Overall Study|Withdrawal by Subject|13|||
25137489|NCT02152631|50250693|FG001|Overall Study|Withdrawal by Subject|16|||
25137490|NCT02152631|50250692|FG000|Overall Study|Noncompliance with study drug|1|||
25137491|NCT02152631|50250693|FG001|Overall Study|Noncompliance with study drug|0|||
25137492|NCT02152631|50250692|FG000|Overall Study|Physician Decision|1|||
25137493|NCT02152631|50250693|FG001|Overall Study|Physician Decision|2|||
25273711|NCT01256684|50587850|FG002|Overall Study|Lack of Efficacy|1|||
25273712|NCT01256684|50587848|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
25273713|NCT01256684|50587849|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
25273714|NCT01256684|50587850|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
25273715|NCT01204710|50587860|FG000|Randomization Treatment|Lost to Follow-up|1|||
25273716|NCT01204710|50587861|FG001|Randomization Treatment|Lost to Follow-up|0|||
25273717|NCT01204710|50587860|FG000|Randomization Treatment|Withdrawal by Subject|6|||
25273718|NCT01204710|50587861|FG001|Randomization Treatment|Withdrawal by Subject|5|||
25273719|NCT01204710|50587860|FG000|Randomization Treatment|Physician Decision|3|||
25273720|NCT01204710|50587861|FG001|Randomization Treatment|Physician Decision|2|||
25273721|NCT01204710|50587860|FG000|Randomization Treatment|Entry criteria not met|0|||
25137494|NCT02152631|50250692|FG000|Overall Study|Lost to Follow-up|0|||
25137495|NCT02152631|50250693|FG001|Overall Study|Lost to Follow-up|1|||
25137496|NCT02152631|50250692|FG000|Overall Study|On Treatment|19|||
25137497|NCT02152631|50250693|FG001|Overall Study|On Treatment|3|||
25137498|NCT02152163|50250701|FG000|Overall Study|Physician Decision|12|||
25137499|NCT02152163|50250702|FG001|Overall Study|Physician Decision|13|||
25137500|NCT02152007|50250708|FG000|Overall Study|Withdrawal by Subject|1|||
25137501|NCT02151851|50250715|FG000|Overall Study|Lack of Efficacy|67|||
25137502|NCT02151851|50250716|FG001|Overall Study|Lack of Efficacy|94|||
25137503|NCT02151851|50250715|FG000|Overall Study|Protocol Violation|0|||
25137504|NCT02151851|50250716|FG001|Overall Study|Protocol Violation|1|||
25137505|NCT02151851|50250715|FG000|Overall Study|Withdrawal by Subject|2|||
25137506|NCT02151851|50250716|FG001|Overall Study|Withdrawal by Subject|5|||
25137507|NCT02151851|50250715|FG000|Overall Study|Medical impairment|1|||
25137508|NCT02151851|50250716|FG001|Overall Study|Medical impairment|0|||
25137509|NCT02151851|50250715|FG000|Overall Study|Low compliance to study visits|0|||
25137510|NCT02151851|50250716|FG001|Overall Study|Low compliance to study visits|1|||
25137511|NCT02151851|50250715|FG000|Overall Study|Subject entered into study in error|0|||
25137512|NCT02151851|50250716|FG001|Overall Study|Subject entered into study in error|1|||
25137513|NCT02151851|50250715|FG000|Overall Study|Adverse Event|6|||
25137514|NCT02151851|50250716|FG001|Overall Study|Adverse Event|28|||
25137515|NCT02176421|50250722|FG000|Overall Study|Lost to Follow-up|4|||
25137516|NCT02176421|50250722|FG000|Overall Study|Adverse Event|1|||
25137517|NCT02042443|50250728|FG000|Overall Study|Adverse Event|2|||
25137518|NCT02042443|50250729|FG001|Overall Study|Adverse Event|1|||
25137519|NCT02042443|50250728|FG000|Overall Study|Withdrawal by Subject|0|||
25137520|NCT02042443|50250729|FG001|Overall Study|Withdrawal by Subject|1|||
25137521|NCT02042443|50250728|FG000|Overall Study|Progression|21|||
25137522|NCT02042443|50250729|FG001|Overall Study|Progression|17|||
25137523|NCT02042443|50250728|FG000|Overall Study|not protocol specified|1|||
25137524|NCT02042443|50250729|FG001|Overall Study|not protocol specified|1|||
25178927|NCT01468181|50324350|FG003|Overall Study|Physician Decision|1|||
25137525|NCT02042443|50250728|FG000|Overall Study|Not eligible/not analyzable|3|||
25137526|NCT02042443|50250729|FG001|Overall Study|Not eligible/not analyzable|6|||
25137527|NCT02118896|50250746|FG000|Overall Study|Death|4|||
25178928|NCT01468181|50324351|FG004|Overall Study|Physician Decision|1|||
25137528|NCT02118896|50250747|FG001|Overall Study|Death|0|||
25137529|NCT02118896|50250748|FG002|Overall Study|Death|4|||
25137530|NCT02118896|50250749|FG003|Overall Study|Death|6|||
25137531|NCT02118896|50250750|FG004|Overall Study|Death|3|||
25137532|NCT02118896|50250751|FG005|Overall Study|Death|1|||
25137533|NCT02118896|50250752|FG006|Overall Study|Death|0|||
25137534|NCT02118896|50250753|FG007|Overall Study|Death|0|||
25137535|NCT02118896|50250754|FG008|Overall Study|Death|0|||
25137536|NCT02118896|50250755|FG009|Overall Study|Death|0|||
25137537|NCT02118896|50250746|FG000|Overall Study|Adverse Event|5|||
25137538|NCT02118896|50250747|FG001|Overall Study|Adverse Event|4|||
25137539|NCT02118896|50250748|FG002|Overall Study|Adverse Event|4|||
25137540|NCT02118896|50250749|FG003|Overall Study|Adverse Event|5|||
25137541|NCT02118896|50250750|FG004|Overall Study|Adverse Event|5|||
25137542|NCT02118896|50250751|FG005|Overall Study|Adverse Event|9|||
25137543|NCT02118896|50250752|FG006|Overall Study|Adverse Event|1|||
25137544|NCT02118896|50250753|FG007|Overall Study|Adverse Event|1|||
25137545|NCT02118896|50250754|FG008|Overall Study|Adverse Event|4|||
25137546|NCT02118896|50250755|FG009|Overall Study|Adverse Event|0|||
25137547|NCT02118896|50250746|FG000|Overall Study|Consent withdrawn|2|||
25137548|NCT02118896|50250747|FG001|Overall Study|Consent withdrawn|0|||
25137549|NCT02118896|50250748|FG002|Overall Study|Consent withdrawn|3|||
25137550|NCT02118896|50250749|FG003|Overall Study|Consent withdrawn|4|||
25137551|NCT02118896|50250750|FG004|Overall Study|Consent withdrawn|1|||
25137552|NCT02118896|50250751|FG005|Overall Study|Consent withdrawn|4|||
25137553|NCT02118896|50250752|FG006|Overall Study|Consent withdrawn|0|||
25137554|NCT02118896|50250753|FG007|Overall Study|Consent withdrawn|0|||
25137555|NCT02118896|50250754|FG008|Overall Study|Consent withdrawn|0|||
25137556|NCT02118896|50250755|FG009|Overall Study|Consent withdrawn|0|||
25137557|NCT02118896|50250746|FG000|Overall Study|Non-compliance|2|||
25137558|NCT02118896|50250747|FG001|Overall Study|Non-compliance|1|||
25137559|NCT02118896|50250748|FG002|Overall Study|Non-compliance|1|||
25137560|NCT02118896|50250749|FG003|Overall Study|Non-compliance|5|||
25137561|NCT02118896|50250750|FG004|Overall Study|Non-compliance|0|||
25137562|NCT02118896|50250751|FG005|Overall Study|Non-compliance|1|||
25137563|NCT02118896|50250752|FG006|Overall Study|Non-compliance|0|||
25137564|NCT02118896|50250753|FG007|Overall Study|Non-compliance|1|||
25137565|NCT02118896|50250754|FG008|Overall Study|Non-compliance|0|||
25137566|NCT02118896|50250755|FG009|Overall Study|Non-compliance|0|||
25137567|NCT02118896|50250746|FG000|Overall Study|Pregnancy|1|||
25137568|NCT02118896|50250747|FG001|Overall Study|Pregnancy|1|||
25137569|NCT02118896|50250748|FG002|Overall Study|Pregnancy|0|||
25137570|NCT02118896|50250749|FG003|Overall Study|Pregnancy|0|||
25137571|NCT02118896|50250750|FG004|Overall Study|Pregnancy|1|||
25137572|NCT02118896|50250751|FG005|Overall Study|Pregnancy|3|||
25137573|NCT02118896|50250752|FG006|Overall Study|Pregnancy|1|||
25137574|NCT02118896|50250753|FG007|Overall Study|Pregnancy|0|||
25137575|NCT02118896|50250754|FG008|Overall Study|Pregnancy|0|||
25137576|NCT02118896|50250755|FG009|Overall Study|Pregnancy|0|||
25137577|NCT02118896|50250746|FG000|Overall Study|Lost to Follow-up|1|||
25137578|NCT02118896|50250747|FG001|Overall Study|Lost to Follow-up|2|||
25137579|NCT02118896|50250748|FG002|Overall Study|Lost to Follow-up|1|||
25137580|NCT02118896|50250749|FG003|Overall Study|Lost to Follow-up|0|||
25137581|NCT02118896|50250750|FG004|Overall Study|Lost to Follow-up|2|||
25137582|NCT02118896|50250751|FG005|Overall Study|Lost to Follow-up|1|||
25137583|NCT02118896|50250752|FG006|Overall Study|Lost to Follow-up|0|||
25137584|NCT02118896|50250753|FG007|Overall Study|Lost to Follow-up|0|||
25137585|NCT02118896|50250754|FG008|Overall Study|Lost to Follow-up|0|||
25137586|NCT02118896|50250755|FG009|Overall Study|Lost to Follow-up|0|||
25137587|NCT02118896|50250746|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
25137588|NCT02118896|50250747|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
25137589|NCT02118896|50250748|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
25137590|NCT02118896|50250749|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
25137591|NCT02118896|50250750|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
25178929|NCT01468181|50324347|FG000|Overall Study|Lost to Follow-up|0|||
25137592|NCT02118896|50250751|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
25137593|NCT02118896|50250752|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
25137594|NCT02118896|50250753|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
25137595|NCT02118896|50250754|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
25137596|NCT02118896|50250755|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
25137597|NCT02118896|50250746|FG000|Overall Study|Prohibited medication|0|||
25137598|NCT02118896|50250747|FG001|Overall Study|Prohibited medication|0|||
25137599|NCT02118896|50250748|FG002|Overall Study|Prohibited medication|0|||
25137600|NCT02118896|50250749|FG003|Overall Study|Prohibited medication|0|||
25137601|NCT02118896|50250750|FG004|Overall Study|Prohibited medication|1|||
25137602|NCT02118896|50250751|FG005|Overall Study|Prohibited medication|3|||
25137603|NCT02118896|50250752|FG006|Overall Study|Prohibited medication|0|||
25178930|NCT01468181|50324348|FG001|Overall Study|Lost to Follow-up|0|||
25009511|NCT03419364|50102478|FG001|Overall Study|Delivery due to maternal condition|0|||
25009512|NCT03419364|50102479|FG002|Overall Study|Delivery due to maternal condition|0|||
25009513|NCT02954172|50102489|FG000|Overall Study|Protocol Violation|3|||
25009514|NCT02954172|50102490|FG001|Overall Study|Protocol Violation|0|||
25009515|NCT02954172|50102489|FG000|Overall Study|allergic reaction|2|||
25009516|NCT02954172|50102490|FG001|Overall Study|allergic reaction|1|||
25009517|NCT02954172|50102489|FG000|Overall Study|non-measurable lesions at baseline|1|||
25009518|NCT02954172|50102490|FG001|Overall Study|non-measurable lesions at baseline|2|||
25009519|NCT02953938|50102499|FG000|Overall Study|Adverse Event|0|||
25009520|NCT02953938|50102500|FG001|Overall Study|Adverse Event|1|||
25137604|NCT02118896|50250753|FG007|Overall Study|Prohibited medication|0|||
25137605|NCT02118896|50250754|FG008|Overall Study|Prohibited medication|0|||
25137606|NCT02118896|50250755|FG009|Overall Study|Prohibited medication|0|||
25137607|NCT02118896|50250746|FG000|Overall Study|Miscellaneous|1|||
25137608|NCT02118896|50250747|FG001|Overall Study|Miscellaneous|2|||
25137609|NCT02118896|50250748|FG002|Overall Study|Miscellaneous|0|||
25137610|NCT02118896|50250749|FG003|Overall Study|Miscellaneous|2|||
25137611|NCT02118896|50250750|FG004|Overall Study|Miscellaneous|0|||
25137612|NCT02118896|50250751|FG005|Overall Study|Miscellaneous|4|||
25137613|NCT02118896|50250752|FG006|Overall Study|Miscellaneous|0|||
25137614|NCT02118896|50250753|FG007|Overall Study|Miscellaneous|0|||
25137615|NCT02118896|50250754|FG008|Overall Study|Miscellaneous|0|||
25137616|NCT02118896|50250755|FG009|Overall Study|Miscellaneous|0|||
25137617|NCT02124707|50250778|FG000|Overall Study|Adverse Event|5|||
25137618|NCT02124707|50250778|FG000|Overall Study|Physician Decision|1|||
25137619|NCT02124707|50250778|FG000|Overall Study|Death|1|||
25137620|NCT02067728|50250785|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
25137621|NCT02067728|50250786|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
25137622|NCT02067728|50250785|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
25137623|NCT02067728|50250786|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
25137624|NCT02067728|50250785|FG000|6 Month Measurements|Unable to attend|114|||
25137625|NCT02067728|50250786|FG001|6 Month Measurements|Unable to attend|97|||
25137626|NCT02118428|50250794|FG000|Overall Study|Physician Decision|0|||
25137627|NCT02118428|50250795|FG001|Overall Study|Physician Decision|1|||
25137628|NCT02118428|50250796|FG002|Overall Study|Physician Decision|0|||
25137629|NCT02118428|50250794|FG000|Overall Study|Withdrawal by Subject|2|||
25137630|NCT02118428|50250795|FG001|Overall Study|Withdrawal by Subject|2|||
25137631|NCT02118428|50250796|FG002|Overall Study|Withdrawal by Subject|0|||
25009521|NCT02953938|50102499|FG000|Overall Study|Withdrawal by Subject|1|||
25009522|NCT02953938|50102500|FG001|Overall Study|Withdrawal by Subject|1|||
25137632|NCT02118428|50250794|FG000|Overall Study|Death|7|||
25009523|NCT03758443|50102511|FG000|Induction Period|Adverse Event|2|||
25137633|NCT02118428|50250795|FG001|Overall Study|Death|5|||
25137634|NCT02118428|50250796|FG002|Overall Study|Death|0|||
25137635|NCT02118428|50250794|FG000|Overall Study|Lost to Follow-up|3|||
25137636|NCT02118428|50250795|FG001|Overall Study|Lost to Follow-up|1|||
25137637|NCT02118428|50250796|FG002|Overall Study|Lost to Follow-up|0|||
25137638|NCT02118428|50250794|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
25137639|NCT02118428|50250795|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
25137640|NCT02118428|50250796|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
25137641|NCT02067104|50250804|FG000|Overall Study|Study termination due to low accrual|4|||
25137642|NCT02067104|50250805|FG001|Overall Study|Study termination due to low accrual|5|||
25137643|NCT02092220|50250811|FG000|Period 1|Unrelated Illness|0|||
25137644|NCT02092220|50250812|FG001|Period 1|Unrelated Illness|2|||
25137645|NCT02092220|50250811|FG000|Period 2|Severe Hypoglycaemia|1|||
25137646|NCT02092220|50250812|FG001|Period 2|Severe Hypoglycaemia|0|||
25137647|NCT02092220|50250811|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
25137648|NCT02092220|50250812|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
25137649|NCT02066402|50250822|FG000|Overall Study|Adverse Event|1|||
25137650|NCT02066402|50250823|FG001|Overall Study|Adverse Event|2|||
25137651|NCT02066402|50250822|FG000|Overall Study|Lost to Follow-up|11|||
25137652|NCT02066402|50250823|FG001|Overall Study|Lost to Follow-up|8|||
25137653|NCT02066402|50250822|FG000|Overall Study|Withdrawal by Subject|14|||
25137654|NCT02066402|50250823|FG001|Overall Study|Withdrawal by Subject|11|||
25137655|NCT02066402|50250822|FG000|Overall Study|Progressive disease-clinical progression|0|||
25137656|NCT02066402|50250823|FG001|Overall Study|Progressive disease-clinical progression|1|||
25137657|NCT02066402|50250822|FG000|Overall Study|Protocol driven decision point|0|||
25137658|NCT02066402|50250823|FG001|Overall Study|Protocol driven decision point|1|||
25137659|NCT02060383|50250834|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
25137660|NCT02060383|50250835|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
25137661|NCT02060383|50250836|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
25137662|NCT02060383|50250837|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
25137663|NCT02060383|50250838|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
25137664|NCT02060383|50250834|FG000|Core Phase|Adverse Event|2|||
25137665|NCT02060383|50250835|FG001|Core Phase|Adverse Event|0|||
25137666|NCT02060383|50250836|FG002|Core Phase|Adverse Event|0|||
25137667|NCT02060383|50250837|FG003|Core Phase|Adverse Event|2|||
25137668|NCT02060383|50250838|FG004|Core Phase|Adverse Event|6|||
25137669|NCT02060383|50250834|FG000|Core Phase|Administrative problems|0|||
25137670|NCT02060383|50250835|FG001|Core Phase|Administrative problems|1|||
25137671|NCT02060383|50250836|FG002|Core Phase|Administrative problems|0|||
25137672|NCT02060383|50250837|FG003|Core Phase|Administrative problems|0|||
25137673|NCT02060383|50250838|FG004|Core Phase|Administrative problems|0|||
25137674|NCT02060383|50250834|FG000|Core Phase|Protocol Violation|0|||
25137675|NCT02060383|50250835|FG001|Core Phase|Protocol Violation|0|||
25137676|NCT02060383|50250836|FG002|Core Phase|Protocol Violation|0|||
25137677|NCT02060383|50250837|FG003|Core Phase|Protocol Violation|1|||
25137678|NCT02060383|50250838|FG004|Core Phase|Protocol Violation|0|||
25137679|NCT02060383|50250834|FG000|Core Phase|Withdrawal by Subject|0|||
25137680|NCT02060383|50250835|FG001|Core Phase|Withdrawal by Subject|0|||
25137681|NCT02060383|50250836|FG002|Core Phase|Withdrawal by Subject|0|||
25137682|NCT02060383|50250837|FG003|Core Phase|Withdrawal by Subject|4|||
25137683|NCT02060383|50250838|FG004|Core Phase|Withdrawal by Subject|2|||
25137684|NCT02060383|50250834|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
25137685|NCT02060383|50250835|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
25137686|NCT02060383|50250836|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
25137687|NCT02060383|50250837|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
25137688|NCT02060383|50250838|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
25137689|NCT02060383|50250834|FG000|Extension Phase|Adverse Event|1|||
25137690|NCT02060383|50250835|FG001|Extension Phase|Adverse Event|1|||
25137691|NCT02060383|50250836|FG002|Extension Phase|Adverse Event|2|||
25137692|NCT02060383|50250837|FG003|Extension Phase|Adverse Event|0|||
25137693|NCT02060383|50250838|FG004|Extension Phase|Adverse Event|1|||
25137694|NCT02060383|50250834|FG000|Extension Phase|Withdrawal by Subject|0|||
25137695|NCT02060383|50250835|FG001|Extension Phase|Withdrawal by Subject|1|||
25137696|NCT02060383|50250836|FG002|Extension Phase|Withdrawal by Subject|0|||
25137697|NCT02060383|50250837|FG003|Extension Phase|Withdrawal by Subject|0|||
25137698|NCT02060383|50250838|FG004|Extension Phase|Withdrawal by Subject|2|||
25137699|NCT02060383|50250834|FG000|Extension Phase|Administrative problems|1|||
25137700|NCT02060383|50250835|FG001|Extension Phase|Administrative problems|0|||
25137701|NCT02060383|50250836|FG002|Extension Phase|Administrative problems|0|||
25137702|NCT02060383|50250837|FG003|Extension Phase|Administrative problems|0|||
25137703|NCT02060383|50250838|FG004|Extension Phase|Administrative problems|0|||
25137704|NCT02060383|50250834|FG000|Extension Phase|Death|0|||
25137705|NCT02060383|50250835|FG001|Extension Phase|Death|0|||
25137706|NCT02060383|50250836|FG002|Extension Phase|Death|1|||
25137707|NCT02060383|50250837|FG003|Extension Phase|Death|0|||
25137708|NCT02060383|50250838|FG004|Extension Phase|Death|1|||
25137709|NCT02060383|50250834|FG000|Extension Phase|Protocol Violation|0|||
25137710|NCT02060383|50250835|FG001|Extension Phase|Protocol Violation|0|||
25137711|NCT02060383|50250836|FG002|Extension Phase|Protocol Violation|0|||
25137712|NCT02060383|50250837|FG003|Extension Phase|Protocol Violation|0|||
25137713|NCT02060383|50250838|FG004|Extension Phase|Protocol Violation|1|||
25137714|NCT02086591|50250850|FG000|Overall Study|Adverse Event|1|||
25137715|NCT02086591|50250850|FG000|Overall Study|Withdrawal by Subject|1|||
25137716|NCT02086591|50250850|FG000|Overall Study|protocol terminated|3|||
25137717|NCT02065622|50250856|FG000|Induction Study|Adverse Event|13|||
25137718|NCT02065622|50250857|FG001|Induction Study|Adverse Event|19|||
25137719|NCT02065622|50250858|FG002|Induction Study|Adverse Event|0|||
25137720|NCT02065622|50250859|FG003|Induction Study|Adverse Event|0|||
25137721|NCT02065622|50250860|FG004|Induction Study|Adverse Event|0|||
25137722|NCT02065622|50250856|FG000|Induction Study|Withdrawal by Subject|3|||
25137723|NCT02065622|50250857|FG001|Induction Study|Withdrawal by Subject|5|||
25137724|NCT02065622|50250858|FG002|Induction Study|Withdrawal by Subject|0|||
25137725|NCT02065622|50250859|FG003|Induction Study|Withdrawal by Subject|0|||
25137726|NCT02065622|50250860|FG004|Induction Study|Withdrawal by Subject|0|||
25137727|NCT02065622|50250856|FG000|Induction Study|Lost to Follow-up|1|||
25137728|NCT02065622|50250857|FG001|Induction Study|Lost to Follow-up|0|||
25137729|NCT02065622|50250858|FG002|Induction Study|Lost to Follow-up|0|||
25137730|NCT02065622|50250859|FG003|Induction Study|Lost to Follow-up|0|||
25137731|NCT02065622|50250860|FG004|Induction Study|Lost to Follow-up|0|||
25137732|NCT02065622|50250856|FG000|Induction Study|Lack of Efficacy|22|||
25137733|NCT02065622|50250857|FG001|Induction Study|Lack of Efficacy|27|||
25137734|NCT02065622|50250858|FG002|Induction Study|Lack of Efficacy|0|||
25137735|NCT02065622|50250859|FG003|Induction Study|Lack of Efficacy|0|||
25137736|NCT02065622|50250860|FG004|Induction Study|Lack of Efficacy|0|||
25137737|NCT02065622|50250856|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
25137738|NCT02065622|50250857|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
25137739|NCT02065622|50250858|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
25137740|NCT02065622|50250859|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
25137741|NCT02065622|50250860|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
25137742|NCT02065622|50250856|FG000|Induction Study|Subject Noncompliance|1|||
25137743|NCT02065622|50250857|FG001|Induction Study|Subject Noncompliance|1|||
25137744|NCT02065622|50250858|FG002|Induction Study|Subject Noncompliance|0|||
25137745|NCT02065622|50250859|FG003|Induction Study|Subject Noncompliance|0|||
25137746|NCT02065622|50250860|FG004|Induction Study|Subject Noncompliance|0|||
25137747|NCT02065622|50250856|FG000|Induction Study|Other, Not Specified|3|||
25137748|NCT02065622|50250857|FG001|Induction Study|Other, Not Specified|2|||
25137749|NCT02065622|50250858|FG002|Induction Study|Other, Not Specified|0|||
25137750|NCT02065622|50250859|FG003|Induction Study|Other, Not Specified|0|||
25137751|NCT02065622|50250860|FG004|Induction Study|Other, Not Specified|0|||
25137752|NCT02065622|50250856|FG000|Maintenance Study|Adverse Event|0|||
25137753|NCT02065622|50250857|FG001|Maintenance Study|Adverse Event|0|||
25137754|NCT02065622|50250858|FG002|Maintenance Study|Adverse Event|25|||
25137755|NCT02065622|50250859|FG003|Maintenance Study|Adverse Event|22|||
25137756|NCT02065622|50250860|FG004|Maintenance Study|Adverse Event|11|||
25137757|NCT02065622|50250856|FG000|Maintenance Study|Withdrawal by Subject|0|||
25137758|NCT02065622|50250857|FG001|Maintenance Study|Withdrawal by Subject|0|||
25137759|NCT02065622|50250858|FG002|Maintenance Study|Withdrawal by Subject|11|||
25137760|NCT02065622|50250859|FG003|Maintenance Study|Withdrawal by Subject|5|||
25137761|NCT02065622|50250860|FG004|Maintenance Study|Withdrawal by Subject|7|||
25137762|NCT02065622|50250856|FG000|Maintenance Study|Lost to Follow-up|0|||
25137763|NCT02065622|50250857|FG001|Maintenance Study|Lost to Follow-up|0|||
25137764|NCT02065622|50250858|FG002|Maintenance Study|Lost to Follow-up|4|||
25137765|NCT02065622|50250859|FG003|Maintenance Study|Lost to Follow-up|1|||
25137766|NCT02065622|50250860|FG004|Maintenance Study|Lost to Follow-up|1|||
25137767|NCT02065622|50250856|FG000|Maintenance Study|Lack of Efficacy|0|||
25137768|NCT02065622|50250857|FG001|Maintenance Study|Lack of Efficacy|0|||
25137769|NCT02065622|50250858|FG002|Maintenance Study|Lack of Efficacy|70|||
25137770|NCT02065622|50250859|FG003|Maintenance Study|Lack of Efficacy|55|||
25137771|NCT02065622|50250860|FG004|Maintenance Study|Lack of Efficacy|19|||
25137772|NCT02065622|50250856|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
25137773|NCT02065622|50250857|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
25137774|NCT02065622|50250858|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
25137775|NCT02065622|50250859|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
25137776|NCT02065622|50250860|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
25137777|NCT02065622|50250856|FG000|Maintenance Study|Subject Non-Compliance|0|||
25137778|NCT02065622|50250857|FG001|Maintenance Study|Subject Non-Compliance|0|||
25137779|NCT02065622|50250858|FG002|Maintenance Study|Subject Non-Compliance|1|||
25137780|NCT02065622|50250859|FG003|Maintenance Study|Subject Non-Compliance|3|||
25137781|NCT02065622|50250860|FG004|Maintenance Study|Subject Non-Compliance|2|||
25137782|NCT02065622|50250856|FG000|Maintenance Study|Other, Not Specified|0|||
25137783|NCT02065622|50250857|FG001|Maintenance Study|Other, Not Specified|0|||
25137784|NCT02065622|50250858|FG002|Maintenance Study|Other, Not Specified|6|||
25137785|NCT02065622|50250859|FG003|Maintenance Study|Other, Not Specified|14|||
25137786|NCT02065622|50250860|FG004|Maintenance Study|Other, Not Specified|2|||
25137787|NCT02065622|50250856|FG000|Maintenance Study|Unknown Reason|0|||
25137788|NCT02065622|50250857|FG001|Maintenance Study|Unknown Reason|0|||
25137789|NCT02065622|50250858|FG002|Maintenance Study|Unknown Reason|0|||
25137790|NCT02065622|50250859|FG003|Maintenance Study|Unknown Reason|1|||
25137791|NCT02065622|50250860|FG004|Maintenance Study|Unknown Reason|0|||
25137792|NCT02117648|50250875|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
25137793|NCT02117648|50250875|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
25137794|NCT02117648|50250875|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
25137795|NCT02117648|50250875|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
25137796|NCT02117648|50250875|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
25137797|NCT02117648|50250875|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
25137798|NCT02117648|50250875|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
25009524|NCT03758443|50102512|FG001|Induction Period|Adverse Event|4|||
25009525|NCT03758443|50102513|FG002|Induction Period|Adverse Event|2|||
25009526|NCT03758443|50102514|FG003|Induction Period|Adverse Event|3|||
25009527|NCT03758443|50102511|FG000|Induction Period|Physician Decision|1|||
25009528|NCT03758443|50102512|FG001|Induction Period|Physician Decision|1|||
25009529|NCT03758443|50102513|FG002|Induction Period|Physician Decision|3|||
25009530|NCT03758443|50102514|FG003|Induction Period|Physician Decision|0|||
25009531|NCT03758443|50102511|FG000|Induction Period|Protocol Violation|0|||
25009532|NCT03758443|50102512|FG001|Induction Period|Protocol Violation|0|||
25009533|NCT03758443|50102513|FG002|Induction Period|Protocol Violation|0|||
25009534|NCT03758443|50102514|FG003|Induction Period|Protocol Violation|1|||
25009535|NCT03758443|50102511|FG000|Induction Period|Withdrawal by Subject|3|||
25009536|NCT03758443|50102512|FG001|Induction Period|Withdrawal by Subject|2|||
25009537|NCT03758443|50102513|FG002|Induction Period|Withdrawal by Subject|2|||
25009538|NCT03758443|50102514|FG003|Induction Period|Withdrawal by Subject|4|||
25009539|NCT03758443|50102511|FG000|Extended Induction Period|Adverse Event|1|||
25009540|NCT03758443|50102512|FG001|Extended Induction Period|Adverse Event|1|||
25009541|NCT03758443|50102513|FG002|Extended Induction Period|Adverse Event|0|||
25009542|NCT03758443|50102514|FG003|Extended Induction Period|Adverse Event|1|||
25009543|NCT03758443|50102511|FG000|Extended Induction Period|Lost to Follow-up|1|||
25137799|NCT02117648|50250875|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
25137800|NCT02117648|50250875|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
25137801|NCT02117648|50250875|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
25137802|NCT02117648|50250875|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
25137803|NCT02124161|50250885|FG000|Overall Study|Other unspecified|0|||
25137804|NCT02124161|50250886|FG001|Overall Study|Other unspecified|1|||
25137805|NCT02124161|50250885|FG000|Overall Study|Death|1|||
25137806|NCT02124161|50250886|FG001|Overall Study|Death|0|||
25137807|NCT02124161|50250885|FG000|Overall Study|Protocol Violation|2|||
25137808|NCT02124161|50250886|FG001|Overall Study|Protocol Violation|1|||
25137809|NCT02124161|50250885|FG000|Overall Study|Withdrawal by Subject|1|||
25137810|NCT02124161|50250886|FG001|Overall Study|Withdrawal by Subject|2|||
25137811|NCT02124161|50250885|FG000|Overall Study|Adverse Event|2|||
25137812|NCT02124161|50250886|FG001|Overall Study|Adverse Event|0|||
25137813|NCT02124161|50250885|FG000|Overall Study|Does not meet entrance criteria|2|||
25178931|NCT01468181|50324349|FG002|Overall Study|Lost to Follow-up|1|||
25178932|NCT01468181|50324350|FG003|Overall Study|Lost to Follow-up|0|||
25137814|NCT02124161|50250886|FG001|Overall Study|Does not meet entrance criteria|3|||
25137815|NCT02124161|50250885|FG000|Overall Study|No longer meets eligibility criteria|5|||
25137816|NCT02124161|50250886|FG001|Overall Study|No longer meets eligibility criteria|4|||
25137817|NCT02124161|50250885|FG000|Overall Study|Lost to Follow-up|3|||
25137818|NCT02124161|50250886|FG001|Overall Study|Lost to Follow-up|4|||
25137819|NCT02175641|50250901|FG000|Overall Study|Death|3|||
25137820|NCT02175641|50250902|FG001|Overall Study|Death|4|||
25137821|NCT02175641|50250901|FG000|Overall Study|Lost to Follow-up|4|||
25137822|NCT02175641|50250902|FG001|Overall Study|Lost to Follow-up|4|||
25137823|NCT02175641|50250901|FG000|Overall Study|Withdrawal by Subject|7|||
25137824|NCT02175641|50250902|FG001|Overall Study|Withdrawal by Subject|4|||
25137825|NCT02175641|50250901|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
25137826|NCT02175641|50250902|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
25137827|NCT02175641|50250901|FG000|Overall Study|Developed Contraindicated Condition|8|||
25137828|NCT02175641|50250902|FG001|Overall Study|Developed Contraindicated Condition|0|||
25137829|NCT02117570|50250911|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
25137830|NCT02117570|50250912|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
25137831|NCT02117570|50250913|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
25137832|NCT02117570|50250911|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
25137833|NCT02117570|50250912|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
25137834|NCT02117570|50250913|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
25137835|NCT02117570|50250911|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
25137836|NCT02117570|50250912|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
25137837|NCT02117570|50250913|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
25137838|NCT02117570|50250911|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
25137839|NCT02117570|50250912|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
25137840|NCT02117570|50250913|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
25137841|NCT02117570|50250911|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
25137842|NCT02117570|50250912|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
25137843|NCT02117570|50250913|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
25137844|NCT02117570|50250911|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
25137845|NCT02117570|50250912|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
25137846|NCT02117570|50250913|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
25137847|NCT02117570|50250911|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
25137848|NCT02117570|50250912|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
25178933|NCT01468181|50324351|FG004|Overall Study|Lost to Follow-up|1|||
25178934|NCT01468181|50324347|FG000|Overall Study|Withdrawal by Subject|0|||
25178935|NCT01468181|50324348|FG001|Overall Study|Withdrawal by Subject|1|||
25137849|NCT02117570|50250913|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
25137850|NCT02123459|50250924|FG000|Washout Period (1 Day)|Adverse Event|1|||
25137851|NCT02123459|50250925|FG001|Washout Period (1 Day)|Adverse Event|0|||
25137852|NCT01853475|50250934|FG000|Overall Study|Withdrawal by Subject|0|||
25137853|NCT01853475|50250935|FG001|Overall Study|Withdrawal by Subject|1|||
25137854|NCT01853475|50250936|FG002|Overall Study|Withdrawal by Subject|0|||
25137855|NCT02151773|50250944|FG000|Overall Study|Protocol Deviation|64|||
25137856|NCT02151461|50250952|FG000|Overall Study|Adverse Event|5|||
25137857|NCT02151461|50250953|FG001|Overall Study|Adverse Event|1|||
25137858|NCT02151461|50250954|FG002|Overall Study|Adverse Event|0|||
25137859|NCT02151461|50250955|FG003|Overall Study|Adverse Event|2|||
25137860|NCT02151461|50250952|FG000|Overall Study|Lost to Follow-up|0|||
25137861|NCT02151461|50250953|FG001|Overall Study|Lost to Follow-up|0|||
25137862|NCT02151461|50250954|FG002|Overall Study|Lost to Follow-up|1|||
25137863|NCT02151461|50250955|FG003|Overall Study|Lost to Follow-up|1|||
25137864|NCT02151461|50250952|FG000|Overall Study|Withdrawal by Subject|1|||
25137865|NCT02151461|50250953|FG001|Overall Study|Withdrawal by Subject|0|||
25137866|NCT02151461|50250954|FG002|Overall Study|Withdrawal by Subject|1|||
25137867|NCT02151461|50250955|FG003|Overall Study|Withdrawal by Subject|1|||
25137868|NCT02151461|50250952|FG000|Overall Study|Treatment discontinuation|0|||
25137869|NCT02151461|50250953|FG001|Overall Study|Treatment discontinuation|0|||
25137870|NCT02151461|50250954|FG002|Overall Study|Treatment discontinuation|1|||
25137871|NCT02151461|50250955|FG003|Overall Study|Treatment discontinuation|0|||
25137872|NCT02117414|50250967|FG000|Overall Study|Death|5|||
25137873|NCT02117414|50250968|FG001|Overall Study|Death|2|||
25137874|NCT02117414|50250967|FG000|Overall Study|Withdrawal by Subject|10|||
25137875|NCT02117414|50250968|FG001|Overall Study|Withdrawal by Subject|4|||
25137876|NCT02091986|50250979|FG000|Overall Study|7 rand in error 1 patient decision|2|||
25137877|NCT02091986|50250980|FG001|Overall Study|7 rand in error 1 patient decision|3|||
25137878|NCT02091986|50250981|FG002|Overall Study|7 rand in error 1 patient decision|3|||
25137879|NCT02091986|50250979|FG000|Overall Study|Lost to Follow-up|1|||
25137880|NCT02091986|50250980|FG001|Overall Study|Lost to Follow-up|0|||
25137881|NCT02091986|50250981|FG002|Overall Study|Lost to Follow-up|0|||
25137882|NCT02091986|50250979|FG000|Overall Study|Withdrawal by Subject|4|||
25137883|NCT02091986|50250980|FG001|Overall Study|Withdrawal by Subject|8|||
25137884|NCT02091986|50250981|FG002|Overall Study|Withdrawal by Subject|3|||
25137885|NCT02091986|50250979|FG000|Overall Study|Adverse Event|0|||
25137886|NCT02091986|50250980|FG001|Overall Study|Adverse Event|0|||
25137887|NCT02091986|50250981|FG002|Overall Study|Adverse Event|2|||
25137888|NCT02091752|50250989|FG000|Overall Study|Study terminated by Sponsor|2|||
25137889|NCT02091752|50250989|FG000|Overall Study|Adverse Event|1|||
25137890|NCT02117024|50250995|FG000|Overall Study|Progressive Disease|26|||
25137891|NCT02117024|50250996|FG001|Overall Study|Progressive Disease|9|||
25137892|NCT02117024|50250995|FG000|Overall Study|Significant Clinical Progression|7|||
25137893|NCT02117024|50250996|FG001|Overall Study|Significant Clinical Progression|4|||
25137894|NCT02117024|50250995|FG000|Overall Study|Death|5|||
25137895|NCT02117024|50250996|FG001|Overall Study|Death|0|||
25137896|NCT02117024|50250995|FG000|Overall Study|Withdrawal by Subject|3|||
25137897|NCT02117024|50250996|FG001|Overall Study|Withdrawal by Subject|1|||
25137898|NCT02117024|50250995|FG000|Overall Study|Protocol Violation|1|||
25137899|NCT02117024|50250996|FG001|Overall Study|Protocol Violation|0|||
25137900|NCT02117024|50250995|FG000|Overall Study|Adverse Event|1|||
25137901|NCT02117024|50250996|FG001|Overall Study|Adverse Event|2|||
25137902|NCT02117024|50250995|FG000|Overall Study|Randomized in Error|1|||
25137903|NCT02117024|50250996|FG001|Overall Study|Randomized in Error|0|||
25137904|NCT02117024|50250995|FG000|Overall Study|Patient returned to primary oncologist|0|||
25137905|NCT02117024|50250996|FG001|Overall Study|Patient returned to primary oncologist|1|||
25137906|NCT02117024|50250995|FG000|Overall Study|Patient took treatment break|0|||
25137907|NCT02117024|50250996|FG001|Overall Study|Patient took treatment break|1|||
25137908|NCT02117024|50250995|FG000|Overall Study|Physician Decision|0|||
25137909|NCT02117024|50250996|FG001|Overall Study|Physician Decision|2|||
25137910|NCT02091440|50251002|FG000|Overall Study|Death|2|||
25137911|NCT02064920|50251008|FG000|Overall Study|Adverse Event|0|||
25137912|NCT02064920|50251009|FG001|Overall Study|Adverse Event|4|||
25137913|NCT02064920|50251008|FG000|Overall Study|Physician Decision|0|||
25137914|NCT02064920|50251009|FG001|Overall Study|Physician Decision|1|||
25137915|NCT02064920|50251008|FG000|Overall Study|Technical Problems|0|||
25137916|NCT02064920|50251009|FG001|Overall Study|Technical Problems|1|||
25137917|NCT02064920|50251008|FG000|Overall Study|Withdrawal by Subject|1|||
25137918|NCT02064920|50251009|FG001|Overall Study|Withdrawal by Subject|3|||
25137919|NCT02151149|50251017|FG000|Treatment Period|Death|2|||
25137920|NCT02151149|50251018|FG001|Treatment Period|Death|3|||
25137921|NCT02151149|50251017|FG000|Treatment Period|Adverse Event|17|||
25137922|NCT02151149|50251018|FG001|Treatment Period|Adverse Event|14|||
25137923|NCT02151149|50251017|FG000|Treatment Period|Progressive Disease|25|||
25137924|NCT02151149|50251018|FG001|Treatment Period|Progressive Disease|24|||
25137925|NCT02151149|50251017|FG000|Treatment Period|Symptomatic Deterioration|2|||
25137926|NCT02151149|50251018|FG001|Treatment Period|Symptomatic Deterioration|10|||
25137927|NCT02151149|50251017|FG000|Treatment Period|Withdrawal by Subject|13|||
25137928|NCT02151149|50251018|FG001|Treatment Period|Withdrawal by Subject|11|||
25137929|NCT02151149|50251017|FG000|Treatment Period|Miscellaneous|8|||
25137930|NCT02151149|50251018|FG001|Treatment Period|Miscellaneous|7|||
25137931|NCT02151149|50251017|FG000|Treatment Period|Participants randomized but not treated|3|||
25137932|NCT02151149|50251018|FG001|Treatment Period|Participants randomized but not treated|2|||
25178936|NCT01468181|50324349|FG002|Overall Study|Withdrawal by Subject|0|||
25178937|NCT01468181|50324350|FG003|Overall Study|Withdrawal by Subject|0|||
25137933|NCT02151149|50251017|FG000|Follow-Up Period|Lost to Follow-up|2|||
25137934|NCT02151149|50251018|FG001|Follow-Up Period|Lost to Follow-up|3|||
25137935|NCT02151149|50251017|FG000|Follow-Up Period|Death|37|||
25137936|NCT02151149|50251018|FG001|Follow-Up Period|Death|34|||
25137937|NCT02150213|50251024|FG000|Overall Study|Lost to Follow-up|1|||
25137938|NCT02150213|50251024|FG000|Overall Study|Withdrawal by Subject|1|||
25137939|NCT02091362|50251030|FG000|Period 1|Protocol Violation|1|||
25137940|NCT02091362|50251031|FG001|Period 1|Protocol Violation|0|||
25137941|NCT02091362|50251030|FG000|Period 1|Withdrawal by Subject|2|||
25137942|NCT02091362|50251031|FG001|Period 1|Withdrawal by Subject|3|||
25137943|NCT02091362|50251030|FG000|Period 1|Lost to Follow-up|0|||
25137944|NCT02091362|50251031|FG001|Period 1|Lost to Follow-up|1|||
25137945|NCT02091362|50251030|FG000|Period 1|Adverse Event|2|||
25137946|NCT02091362|50251031|FG001|Period 1|Adverse Event|0|||
25137947|NCT02091362|50251030|FG000|Wash-out|Lost to Follow-up|1|||
25137948|NCT02091362|50251031|FG001|Wash-out|Lost to Follow-up|1|||
25137949|NCT02091362|50251030|FG000|Wash-out|Withdrawal by Subject|0|||
25137950|NCT02091362|50251031|FG001|Wash-out|Withdrawal by Subject|2|||
25137951|NCT02091362|50251030|FG000|Period 2|Adverse Event|1|||
25137952|NCT02091362|50251031|FG001|Period 2|Adverse Event|0|||
25137953|NCT02091362|50251030|FG000|Period 2|Lost to Follow-up|0|||
25137954|NCT02091362|50251031|FG001|Period 2|Lost to Follow-up|1|||
25137955|NCT02091362|50251030|FG000|Period 2|Withdrawal by Subject|1|||
25137956|NCT02091362|50251031|FG001|Period 2|Withdrawal by Subject|1|||
25137957|NCT02150057|50251043|FG000|Overall Study|Lost to Follow-up|6|||
25137958|NCT02150057|50251044|FG001|Overall Study|Lost to Follow-up|4|||
25137959|NCT02064296|50251053|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
25137960|NCT02064296|50251054|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
25137961|NCT02064296|50251055|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
25137962|NCT02064296|50251053|FG000|Intervention|Withdrawal by Subject|0|||
25137963|NCT02064296|50251054|FG001|Intervention|Withdrawal by Subject|1|||
25137964|NCT02064296|50251055|FG002|Intervention|Withdrawal by Subject|2|||
25137965|NCT02063984|50251067|FG000|Overall Study|Lost to Follow-up|6|||
25137966|NCT02063984|50251068|FG001|Overall Study|Lost to Follow-up|5|||
25137967|NCT02091284|50251080|FG000|Overall Study|Withdrawal by Subject|2|||
25137968|NCT02091284|50251081|FG001|Overall Study|Withdrawal by Subject|1|||
25137969|NCT02091284|50251080|FG000|Overall Study|unreliable data|1|||
25137970|NCT02091284|50251081|FG001|Overall Study|unreliable data|0|||
25137971|NCT02115386|50251089|FG000|Overall Study|Protocol Violation|1|||
25137972|NCT02115386|50251089|FG000|Overall Study|Administrative - trial was terminated|6|||
25137973|NCT02091206|50251097|FG000|Treatment Period|Adverse Event|0|||
25137974|NCT02091206|50251098|FG001|Treatment Period|Adverse Event|1|||
25137975|NCT02091206|50251099|FG002|Treatment Period|Adverse Event|0|||
25137976|NCT02091206|50251100|FG003|Treatment Period|Adverse Event|0|||
25137977|NCT02091206|50251097|FG000|Treatment Period|Met withdrawal criteria|0|||
25137978|NCT02091206|50251098|FG001|Treatment Period|Met withdrawal criteria|0|||
25137979|NCT02091206|50251099|FG002|Treatment Period|Met withdrawal criteria|1|||
25137980|NCT02091206|50251100|FG003|Treatment Period|Met withdrawal criteria|0|||
25137981|NCT02091206|50251097|FG000|Taper Period|Participant refused study drug|1|||
25137982|NCT02091206|50251098|FG001|Taper Period|Participant refused study drug|0|||
25137983|NCT02091206|50251099|FG002|Taper Period|Participant refused study drug|0|||
25137984|NCT02091206|50251100|FG003|Taper Period|Participant refused study drug|1|||
25137985|NCT02091206|50251097|FG000|Taper Period|Lost to Follow-up|0|||
25137986|NCT02091206|50251098|FG001|Taper Period|Lost to Follow-up|0|||
25137987|NCT02091206|50251099|FG002|Taper Period|Lost to Follow-up|0|||
25137988|NCT02091206|50251100|FG003|Taper Period|Lost to Follow-up|1|||
25137989|NCT02090426|50251112|FG000|Overall Study|Lost to Follow-up|12|||
25137990|NCT02090426|50251113|FG001|Overall Study|Lost to Follow-up|6|||
25137991|NCT02063828|50251122|FG000|Overall Study|Withdrawal by Subject|4|||
25137992|NCT02063828|50251123|FG001|Overall Study|Withdrawal by Subject|6|||
25137993|NCT02063828|50251124|FG002|Overall Study|Withdrawal by Subject|3|||
25137994|NCT02063828|50251122|FG000|Overall Study|Death|0|||
25137995|NCT02063828|50251123|FG001|Overall Study|Death|0|||
25137996|NCT02063828|50251124|FG002|Overall Study|Death|1|||
25137997|NCT02063672|50251134|FG000|Overall Study|Ongoing Follow-up|27|||
25137998|NCT02063672|50251135|FG001|Overall Study|Ongoing Follow-up|14|||
25137999|NCT02063672|50251134|FG000|Overall Study|Death|5|||
25138000|NCT02063672|50251135|FG001|Overall Study|Death|3|||
25009544|NCT03758443|50102512|FG001|Extended Induction Period|Lost to Follow-up|0|||
25138001|NCT02063672|50251134|FG000|Overall Study|Lost to Follow-up|1|||
25138002|NCT02063672|50251135|FG001|Overall Study|Lost to Follow-up|3|||
25138003|NCT02063672|50251134|FG000|Overall Study|Withdrawal by Subject|2|||
25138004|NCT02063672|50251135|FG001|Overall Study|Withdrawal by Subject|2|||
25138005|NCT02062658|50251141|FG000|Overall Study|Withdrawal by Subject|1|||
25138006|NCT02062658|50251141|FG000|Overall Study|Lack of Efficacy|1|||
25138007|NCT02115308|50251147|FG000|Overall Study|Safety Screening|2|||
25138008|NCT02115308|50251148|FG001|Overall Study|Safety Screening|2|||
25138009|NCT02114684|50251160|FG000|Overall Study|Death|6|||
25138010|NCT02114684|50251161|FG001|Overall Study|Death|4|||
25138011|NCT02114684|50251160|FG000|Overall Study|Lost to Follow-up|1|||
25138012|NCT02114684|50251161|FG001|Overall Study|Lost to Follow-up|2|||
25138013|NCT02114684|50251160|FG000|Overall Study|Withdrawal by Subject|1|||
25138014|NCT02114684|50251161|FG001|Overall Study|Withdrawal by Subject|2|||
25138015|NCT02114684|50251160|FG000|Overall Study|Relocation|3|||
25138016|NCT02114684|50251161|FG001|Overall Study|Relocation|1|||
25138017|NCT02114684|50251160|FG000|Overall Study|Rifampicin resistant on culture|0|||
25138018|NCT02114684|50251161|FG001|Overall Study|Rifampicin resistant on culture|1|||
25138019|NCT02114684|50251160|FG000|Overall Study|Patient Incarcerated|1|||
25138020|NCT02114684|50251161|FG001|Overall Study|Patient Incarcerated|0|||
25138021|NCT02090114|50251175|FG000|Overall Study|Withdrawal by Subject|3|||
25138022|NCT02090114|50251176|FG001|Overall Study|Withdrawal by Subject|6|||
25138023|NCT02090114|50251177|FG002|Overall Study|Withdrawal by Subject|2|||
25138024|NCT02090114|50251178|FG003|Overall Study|Withdrawal by Subject|1|||
25138025|NCT02090114|50251175|FG000|Overall Study|Physician Decision|5|||
25138026|NCT02090114|50251176|FG001|Overall Study|Physician Decision|0|||
25138027|NCT02090114|50251177|FG002|Overall Study|Physician Decision|1|||
25138028|NCT02090114|50251178|FG003|Overall Study|Physician Decision|1|||
25138029|NCT02090114|50251175|FG000|Overall Study|Adverse Event|1|||
25138030|NCT02090114|50251176|FG001|Overall Study|Adverse Event|2|||
25138031|NCT02090114|50251177|FG002|Overall Study|Adverse Event|2|||
25138032|NCT02090114|50251178|FG003|Overall Study|Adverse Event|0|||
25138033|NCT02090114|50251175|FG000|Overall Study|Progressive Disease|20|||
25138034|NCT02090114|50251176|FG001|Overall Study|Progressive Disease|21|||
25138035|NCT02090114|50251177|FG002|Overall Study|Progressive Disease|23|||
25138036|NCT02090114|50251178|FG003|Overall Study|Progressive Disease|6|||
25138037|NCT02090114|50251175|FG000|Overall Study|Death|1|||
25138038|NCT02090114|50251176|FG001|Overall Study|Death|0|||
25138039|NCT02090114|50251177|FG002|Overall Study|Death|1|||
25138040|NCT02090114|50251178|FG003|Overall Study|Death|0|||
25138041|NCT01623050|50251188|FG000|Overall Study|Lost to Follow-up|9|||
25138042|NCT02089334|50251196|FG000|Overall Study|Withdrawal by Subject|0|||
25138043|NCT02089334|50251197|FG001|Overall Study|Withdrawal by Subject|0|||
25138044|NCT02089334|50251198|FG002|Overall Study|Withdrawal by Subject|0|||
25138045|NCT02089334|50251199|FG003|Overall Study|Withdrawal by Subject|2|||
25138046|NCT02089334|50251196|FG000|Overall Study|Adverse Event|0|||
25138047|NCT02089334|50251197|FG001|Overall Study|Adverse Event|0|||
25138048|NCT02089334|50251198|FG002|Overall Study|Adverse Event|0|||
25138049|NCT02089334|50251199|FG003|Overall Study|Adverse Event|2|||
25138050|NCT02089334|50251196|FG000|Overall Study|Progressive disease|0|||
25138051|NCT02089334|50251197|FG001|Overall Study|Progressive disease|0|||
25138052|NCT02089334|50251198|FG002|Overall Study|Progressive disease|0|||
25138053|NCT02089334|50251199|FG003|Overall Study|Progressive disease|2|||
25138054|NCT02089334|50251196|FG000|Overall Study|Physician Decision|0|||
25138055|NCT02089334|50251197|FG001|Overall Study|Physician Decision|0|||
25138056|NCT02089334|50251198|FG002|Overall Study|Physician Decision|1|||
25138057|NCT02089334|50251199|FG003|Overall Study|Physician Decision|1|||
25138058|NCT02114606|50251212|FG000|Overall Study|Unable to swallow Cytosponge|6|||
25138059|NCT02113436|50251218|FG000|Period 1: 8 Weeks|Adverse Event|1|||
25138060|NCT02113436|50251219|FG001|Period 1: 8 Weeks|Adverse Event|0|||
25138061|NCT02113436|50251220|FG002|Period 1: 8 Weeks|Adverse Event|0|||
25138062|NCT02113436|50251221|FG003|Period 1: 8 Weeks|Adverse Event|0|||
25138063|NCT02113436|50251218|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
25138064|NCT02113436|50251219|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
25138065|NCT02113436|50251220|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
25138066|NCT02113436|50251221|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
25138067|NCT02113436|50251218|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
25138068|NCT02113436|50251219|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
25138069|NCT02113436|50251220|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
25138070|NCT02113436|50251221|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
25138071|NCT02113436|50251218|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
25138072|NCT02113436|50251219|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
25138073|NCT02113436|50251220|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
25138074|NCT02113436|50251221|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
25138075|NCT02113436|50251218|FG000|Period 2: 16 Weeks|Adverse Event|0|||
25138076|NCT02113436|50251219|FG001|Period 2: 16 Weeks|Adverse Event|0|||
25138077|NCT02113436|50251220|FG002|Period 2: 16 Weeks|Adverse Event|4|||
25138078|NCT02113436|50251221|FG003|Period 2: 16 Weeks|Adverse Event|5|||
25138079|NCT02113436|50251218|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
25138080|NCT02113436|50251219|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
25138081|NCT02113436|50251220|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
25138082|NCT02113436|50251221|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
25138083|NCT02113436|50251218|FG000|Period 2: 16 Weeks|Physician Decision|0|||
25273722|NCT01204710|50587861|FG001|Randomization Treatment|Entry criteria not met|1|||
25273723|NCT01204710|50587860|FG000|Randomization Treatment|Adverse Event|4|||
25273724|NCT01204710|50587861|FG001|Randomization Treatment|Adverse Event|2|||
25273725|NCT01204710|50587860|FG000|Randomization Treatment|Sponsor Decision|0|||
25273726|NCT01204710|50587861|FG001|Randomization Treatment|Sponsor Decision|1|||
25273727|NCT01204710|50587860|FG000|Randomization Treatment|Worsening of General condition|0|||
25273728|NCT01204710|50587861|FG001|Randomization Treatment|Worsening of General condition|1|||
25138084|NCT02113436|50251219|FG001|Period 2: 16 Weeks|Physician Decision|0|||
25273729|NCT01204710|50587860|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
25138085|NCT02113436|50251220|FG002|Period 2: 16 Weeks|Physician Decision|2|||
25138086|NCT02113436|50251221|FG003|Period 2: 16 Weeks|Physician Decision|0|||
25273730|NCT01204710|50587861|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
25138087|NCT02113436|50251218|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
25138088|NCT02113436|50251219|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
25138089|NCT02113436|50251220|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
25138090|NCT02113436|50251221|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
25138091|NCT02113124|50251232|FG000|Overall Study|Unable to retrieve blood sample|1|||
25138092|NCT02113124|50251233|FG001|Overall Study|Unable to retrieve blood sample|1|||
25138093|NCT02087774|50251241|FG000|Overall Study|Were absent day of data collection|8|||
25138094|NCT02087774|50251242|FG001|Overall Study|Were absent day of data collection|20|||
25138095|NCT02111564|50251250|FG000|Overall Study|Death|109|||
25138096|NCT02111564|50251251|FG001|Overall Study|Death|120|||
25138097|NCT02111564|50251250|FG000|Overall Study|Lost to Follow-up|2|||
25138098|NCT02111564|50251251|FG001|Overall Study|Lost to Follow-up|3|||
25138099|NCT02111564|50251250|FG000|Overall Study|Withdrawal by Subject|20|||
25273731|NCT01204710|50587860|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
25138100|NCT02111564|50251251|FG001|Overall Study|Withdrawal by Subject|20|||
25138101|NCT02087150|50251260|FG000|Overall Study|Death|0|||
25138102|NCT02087150|50251261|FG001|Overall Study|Death|1|||
25138103|NCT02087150|50251262|FG002|Overall Study|Death|0|||
25138104|NCT02087150|50251260|FG000|Overall Study|Lost to Follow-up|6|||
25138105|NCT02087150|50251261|FG001|Overall Study|Lost to Follow-up|13|||
25138106|NCT02087150|50251262|FG002|Overall Study|Lost to Follow-up|7|||
25138107|NCT02087150|50251260|FG000|Overall Study|Withdrawal by Subject|2|||
25138108|NCT02087150|50251261|FG001|Overall Study|Withdrawal by Subject|5|||
25138109|NCT02087150|50251262|FG002|Overall Study|Withdrawal by Subject|3|||
25138110|NCT02087150|50251260|FG000|Overall Study|Physician Decision|0|||
25138111|NCT02087150|50251261|FG001|Overall Study|Physician Decision|1|||
25138112|NCT02087150|50251262|FG002|Overall Study|Physician Decision|0|||
25138113|NCT02087150|50251260|FG000|Overall Study|Procedure not done|1|||
25138114|NCT02087150|50251261|FG001|Overall Study|Procedure not done|13|||
25178938|NCT01468181|50324351|FG004|Overall Study|Withdrawal by Subject|0|||
25178939|NCT01693562|50324386|FG000|Escalation Phase|Withdrawal by Subject|0|||
25178940|NCT01693562|50324387|FG001|Escalation Phase|Withdrawal by Subject|1|||
25178941|NCT01693562|50324388|FG002|Escalation Phase|Withdrawal by Subject|0|||
25178942|NCT01693562|50324389|FG003|Escalation Phase|Withdrawal by Subject|0|||
25138115|NCT02087150|50251262|FG002|Overall Study|Procedure not done|0|||
25138116|NCT02087150|50251260|FG000|Overall Study|F/U not completed w/in study window|0|||
25138117|NCT02087150|50251261|FG001|Overall Study|F/U not completed w/in study window|0|||
25138118|NCT02087150|50251262|FG002|Overall Study|F/U not completed w/in study window|1|||
25138119|NCT02087150|50251260|FG000|Overall Study|Other|1|||
25138120|NCT02087150|50251261|FG001|Overall Study|Other|0|||
25178943|NCT01693562|50324390|FG004|Escalation Phase|Withdrawal by Subject|0|||
25178944|NCT01693562|50324391|FG005|Escalation Phase|Withdrawal by Subject|2|||
25178945|NCT01693562|50324392|FG006|Escalation Phase|Withdrawal by Subject|0|||
25138121|NCT02087150|50251262|FG002|Overall Study|Other|0|||
25138122|NCT02087150|50251260|FG000|Overall Study|Pt moved out of town|0|||
25138123|NCT02087150|50251261|FG001|Overall Study|Pt moved out of town|1|||
25178946|NCT01693562|50324393|FG007|Escalation Phase|Withdrawal by Subject|0|||
25178947|NCT01693562|50324394|FG008|Escalation Phase|Withdrawal by Subject|0|||
25178948|NCT01693562|50324395|FG009|Escalation Phase|Withdrawal by Subject|0|||
25178949|NCT01693562|50324396|FG010|Escalation Phase|Withdrawal by Subject|0|||
25178950|NCT01693562|50324397|FG011|Escalation Phase|Withdrawal by Subject|0|||
25178951|NCT01693562|50324398|FG012|Escalation Phase|Withdrawal by Subject|0|||
25178952|NCT01693562|50324399|FG013|Escalation Phase|Withdrawal by Subject|0|||
25178953|NCT01693562|50324400|FG014|Escalation Phase|Withdrawal by Subject|0|||
25178954|NCT01693562|50324401|FG015|Escalation Phase|Withdrawal by Subject|0|||
25178955|NCT01693562|50324402|FG016|Escalation Phase|Withdrawal by Subject|0|||
25178956|NCT01693562|50324403|FG017|Escalation Phase|Withdrawal by Subject|0|||
25178957|NCT01693562|50324404|FG018|Escalation Phase|Withdrawal by Subject|0|||
25178958|NCT01693562|50324405|FG019|Escalation Phase|Withdrawal by Subject|0|||
25178959|NCT01693562|50324406|FG020|Escalation Phase|Withdrawal by Subject|0|||
25178960|NCT01693562|50324407|FG021|Escalation Phase|Withdrawal by Subject|0|||
25178961|NCT01693562|50324408|FG022|Escalation Phase|Withdrawal by Subject|0|||
25178962|NCT01693562|50324386|FG000|Escalation Phase|Death|4|||
25178963|NCT01693562|50324387|FG001|Escalation Phase|Death|2|||
25178964|NCT01693562|50324388|FG002|Escalation Phase|Death|0|||
25138124|NCT02087150|50251262|FG002|Overall Study|Pt moved out of town|0|||
25138125|NCT02111174|50251273|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
25138126|NCT02111174|50251274|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
25138127|NCT02111174|50251273|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
25138128|NCT02111174|50251274|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
25138129|NCT02111174|50251273|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
25138130|NCT02111174|50251274|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
25138131|NCT02111174|50251273|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
25138132|NCT02111174|50251274|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
25138133|NCT02111096|50251283|FG000|Overall Study|Adverse Event|4|||
25138134|NCT02111096|50251284|FG001|Overall Study|Adverse Event|1|||
25138135|NCT02111096|50251285|FG002|Overall Study|Adverse Event|2|||
25138136|NCT02111096|50251283|FG000|Overall Study|Non-Compliance with Study Drug|1|||
25138137|NCT02111096|50251284|FG001|Overall Study|Non-Compliance with Study Drug|1|||
25138138|NCT02111096|50251285|FG002|Overall Study|Non-Compliance with Study Drug|0|||
25138139|NCT02111096|50251283|FG000|Overall Study|Lost to Follow Up|1|||
25138140|NCT02111096|50251284|FG001|Overall Study|Lost to Follow Up|1|||
25138141|NCT02111096|50251285|FG002|Overall Study|Lost to Follow Up|1|||
25138142|NCT02111096|50251283|FG000|Overall Study|Physician Decision|0|||
25138143|NCT02111096|50251284|FG001|Overall Study|Physician Decision|1|||
25138144|NCT02111096|50251285|FG002|Overall Study|Physician Decision|0|||
25138145|NCT02111096|50251283|FG000|Overall Study|Protocol Violation|1|||
25138146|NCT02111096|50251284|FG001|Overall Study|Protocol Violation|0|||
25138147|NCT02111096|50251285|FG002|Overall Study|Protocol Violation|1|||
25138148|NCT02111096|50251283|FG000|Overall Study|Terminated by Sponsor|53|||
25138149|NCT02111096|50251284|FG001|Overall Study|Terminated by Sponsor|35|||
25138150|NCT02111096|50251285|FG002|Overall Study|Terminated by Sponsor|54|||
25138151|NCT02111096|50251283|FG000|Overall Study|Withdrawal by Subject|4|||
25138152|NCT02111096|50251284|FG001|Overall Study|Withdrawal by Subject|2|||
25138153|NCT02111096|50251285|FG002|Overall Study|Withdrawal by Subject|8|||
25138154|NCT02110706|50251298|FG000|Overall Study|Adverse Event|2|||
25138155|NCT02110706|50251299|FG001|Overall Study|Adverse Event|3|||
25178965|NCT01693562|50324389|FG003|Escalation Phase|Death|3|||
25138156|NCT02110706|50251298|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
25138157|NCT02110706|50251299|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
25138158|NCT02110238|50251309|FG000|12 Week Pivotal Phase|Adverse Event|3|||
25138159|NCT02110238|50251310|FG001|12 Week Pivotal Phase|Adverse Event|0|||
25138160|NCT02110238|50251309|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
25138161|NCT02110238|50251310|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
25138162|NCT02110238|50251309|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
25138163|NCT02110238|50251310|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
25138164|NCT02110238|50251309|FG000|12 Week Pivotal Phase|Physician Decision|0|||
25009545|NCT03758443|50102513|FG002|Extended Induction Period|Lost to Follow-up|0|||
25138165|NCT02110238|50251310|FG001|12 Week Pivotal Phase|Physician Decision|2|||
25138166|NCT02110238|50251309|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
25138167|NCT02110238|50251310|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
25138168|NCT02110238|50251309|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
25178966|NCT01693562|50324390|FG004|Escalation Phase|Death|6|||
25178967|NCT01693562|50324391|FG005|Escalation Phase|Death|4|||
25178968|NCT01693562|50324392|FG006|Escalation Phase|Death|0|||
25178969|NCT01693562|50324393|FG007|Escalation Phase|Death|0|||
25178970|NCT01693562|50324394|FG008|Escalation Phase|Death|0|||
25138169|NCT02110238|50251310|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
25138170|NCT02110238|50251309|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
25138171|NCT02110238|50251310|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
25138172|NCT02110238|50251309|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
25138173|NCT02110238|50251310|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
25138174|NCT02110238|50251309|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
25138175|NCT02110238|50251310|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
25138176|NCT02110238|50251309|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
25138177|NCT02110238|50251310|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
25138178|NCT02110238|50251309|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
25138179|NCT02110238|50251310|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
25138180|NCT02108912|50251318|FG000|Overall Study|Lost to Follow-up|1|||
25138181|NCT02108912|50251319|FG001|Overall Study|Lost to Follow-up|1|||
25138182|NCT02108912|50251318|FG000|Overall Study|lack of transportation|1|||
25138183|NCT02108912|50251319|FG001|Overall Study|lack of transportation|0|||
25138184|NCT02108912|50251318|FG000|Overall Study|high blood pressure|1|||
25138185|NCT02108912|50251319|FG001|Overall Study|high blood pressure|0|||
25138186|NCT02108600|50251327|FG000|Overall Study|Withdrawal by Subject|2|||
25138187|NCT02108600|50251328|FG001|Overall Study|Withdrawal by Subject|0|||
25138188|NCT02108600|50251327|FG000|Overall Study|Lost to Follow-up|1|||
25138189|NCT02108600|50251328|FG001|Overall Study|Lost to Follow-up|1|||
25138190|NCT02107898|50251336|FG000|Overall Study|Adverse Event|4|||
25138191|NCT02107898|50251337|FG001|Overall Study|Adverse Event|7|||
25138192|NCT02107898|50251336|FG000|Overall Study|Poor compliance to protocol|0|||
25138193|NCT02107898|50251337|FG001|Overall Study|Poor compliance to protocol|1|||
25138194|NCT02107898|50251336|FG000|Overall Study|Participant moved|0|||
25138195|NCT02107898|50251337|FG001|Overall Study|Participant moved|2|||
25138196|NCT02107898|50251336|FG000|Overall Study|Consent withdrawn by participant|2|||
25138197|NCT02107898|50251337|FG001|Overall Study|Consent withdrawn by participant|1|||
25138198|NCT02107898|50251336|FG000|Overall Study|Randomized but not treated|0|||
25138199|NCT02107898|50251337|FG001|Overall Study|Randomized but not treated|1|||
25138200|NCT02059148|50251343|FG000|Treatment 1|Protocol Violation|0|||
25138201|NCT02059148|50251344|FG001|Treatment 1|Protocol Violation|0|||
25138202|NCT02059148|50251345|FG002|Treatment 1|Protocol Violation|0|||
25138203|NCT02059148|50251346|FG003|Treatment 1|Protocol Violation|0|||
25138204|NCT02059148|50251347|FG004|Treatment 1|Protocol Violation|0|||
25138205|NCT02059148|50251348|FG005|Treatment 1|Protocol Violation|1|||
25178971|NCT01693562|50324395|FG009|Escalation Phase|Death|0|||
25138206|NCT02058992|50251359|FG000|Overall Study|Lost to Follow-up|4|||
25138207|NCT02058992|50251359|FG000|Overall Study|Protocol Violation|92|||
25138208|NCT02058992|50251359|FG000|Overall Study|CRF Uncollected|20|||
25138209|NCT02058836|50251365|FG000|Overall Study|Withdrawal by Subject|1|||
25138210|NCT02058836|50251366|FG001|Overall Study|Withdrawal by Subject|1|||
25009546|NCT03758443|50102514|FG003|Extended Induction Period|Lost to Follow-up|0|||
25009547|NCT03758443|50102511|FG000|Extended Induction Period|Physician Decision|2|||
25009548|NCT03758443|50102512|FG001|Extended Induction Period|Physician Decision|1|||
25009549|NCT03758443|50102513|FG002|Extended Induction Period|Physician Decision|2|||
25009550|NCT03758443|50102514|FG003|Extended Induction Period|Physician Decision|2|||
25009551|NCT03758443|50102511|FG000|Extended Induction Period|Protocol Violation|0|||
25009552|NCT03758443|50102512|FG001|Extended Induction Period|Protocol Violation|0|||
25009553|NCT03758443|50102513|FG002|Extended Induction Period|Protocol Violation|0|||
25009554|NCT03758443|50102514|FG003|Extended Induction Period|Protocol Violation|1|||
25009555|NCT03758443|50102511|FG000|Extended Induction Period|Withdrawal by Subject|8|||
25009556|NCT03758443|50102512|FG001|Extended Induction Period|Withdrawal by Subject|1|||
25009557|NCT03758443|50102513|FG002|Extended Induction Period|Withdrawal by Subject|7|||
25009558|NCT03758443|50102514|FG003|Extended Induction Period|Withdrawal by Subject|3|||
25009559|NCT03758443|50102511|FG000|Extended Induction Period|Miscellaneous|1|||
25009560|NCT03758443|50102512|FG001|Extended Induction Period|Miscellaneous|0|||
25009561|NCT03758443|50102513|FG002|Extended Induction Period|Miscellaneous|0|||
25009562|NCT03758443|50102514|FG003|Extended Induction Period|Miscellaneous|0|||
25009563|NCT03758443|50102511|FG000|Maintenance Period|Adverse Event|1|||
25009564|NCT03758443|50102512|FG001|Maintenance Period|Adverse Event|2|||
25009565|NCT03758443|50102513|FG002|Maintenance Period|Adverse Event|0|||
25009566|NCT03758443|50102514|FG003|Maintenance Period|Adverse Event|0|||
25009567|NCT03758443|50102511|FG000|Maintenance Period|Lost to Follow-up|0|||
25009568|NCT03758443|50102512|FG001|Maintenance Period|Lost to Follow-up|0|||
25009569|NCT03758443|50102513|FG002|Maintenance Period|Lost to Follow-up|0|||
25009570|NCT03758443|50102514|FG003|Maintenance Period|Lost to Follow-up|1|||
25009571|NCT03758443|50102511|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
25009572|NCT03758443|50102512|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
25009573|NCT03758443|50102513|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
25009574|NCT03758443|50102514|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
25009575|NCT03758443|50102511|FG000|Maintenance Period|Protocol Violation|0|||
25009576|NCT03758443|50102512|FG001|Maintenance Period|Protocol Violation|1|||
25009577|NCT03758443|50102513|FG002|Maintenance Period|Protocol Violation|0|||
25009578|NCT03758443|50102514|FG003|Maintenance Period|Protocol Violation|0|||
25009579|NCT03758443|50102511|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
25009580|NCT03758443|50102512|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
25009581|NCT03758443|50102513|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
25009582|NCT03758443|50102514|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
25009583|NCT03758443|50102511|FG000|Maintenance Period|Withdrawal by Subject|1|||
25009584|NCT03758443|50102512|FG001|Maintenance Period|Withdrawal by Subject|0|||
25009585|NCT03758443|50102513|FG002|Maintenance Period|Withdrawal by Subject|1|||
25009586|NCT03758443|50102514|FG003|Maintenance Period|Withdrawal by Subject|1|||
25009587|NCT03758443|50102511|FG000|Maintenance Period|Miscellaneous|0|||
25273732|NCT01204710|50587861|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
25273733|NCT01204710|50587860|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
25273734|NCT01204710|50587861|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
25273735|NCT01204710|50587860|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
25273736|NCT01204710|50587861|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
25273737|NCT01256450|50587876|FG000|Open-label Titration|Adverse Event|39|||
25273738|NCT01256450|50587877|FG001|Open-label Titration|Adverse Event|0|||
25273739|NCT01256450|50587878|FG002|Open-label Titration|Adverse Event|0|||
25273740|NCT01256450|50587876|FG000|Open-label Titration|Lost to Follow-up|7|||
25273741|NCT01256450|50587877|FG001|Open-label Titration|Lost to Follow-up|0|||
25273742|NCT01256450|50587878|FG002|Open-label Titration|Lost to Follow-up|0|||
25273743|NCT01256450|50587876|FG000|Open-label Titration|Lack of analgesic effect|30|||
25273744|NCT01256450|50587877|FG001|Open-label Titration|Lack of analgesic effect|0|||
25273745|NCT01256450|50587878|FG002|Open-label Titration|Lack of analgesic effect|0|||
25273746|NCT01256450|50587876|FG000|Open-label Titration|Non-compliance|9|||
25273747|NCT01256450|50587877|FG001|Open-label Titration|Non-compliance|0|||
25273748|NCT01256450|50587878|FG002|Open-label Titration|Non-compliance|0|||
25273749|NCT01256450|50587876|FG000|Open-label Titration|Screen failure|1|||
25273750|NCT01256450|50587877|FG001|Open-label Titration|Screen failure|0|||
25009588|NCT03758443|50102512|FG001|Maintenance Period|Miscellaneous|0|||
25009589|NCT03758443|50102513|FG002|Maintenance Period|Miscellaneous|1|||
25273751|NCT01256450|50587878|FG002|Open-label Titration|Screen failure|0|||
25273752|NCT01256450|50587876|FG000|Open-label Titration|Other|13|||
25009590|NCT03758443|50102514|FG003|Maintenance Period|Miscellaneous|0|||
25009591|NCT03442764|50102536|FG000|Overall Study|Adverse Event|1|||
25009592|NCT03442764|50102537|FG001|Overall Study|Adverse Event|0|||
25009593|NCT03442764|50102538|FG002|Overall Study|Adverse Event|0|||
25009594|NCT03442296|50102549|FG000|3 Month Follow-up|Death|3|||
25009595|NCT03442296|50102550|FG001|3 Month Follow-up|Death|1|||
25178972|NCT01693562|50324396|FG010|Escalation Phase|Death|0|||
25009596|NCT03442296|50102549|FG000|3 Month Follow-up|Lost to Follow-up|1|||
25009597|NCT03442296|50102550|FG001|3 Month Follow-up|Lost to Follow-up|1|||
25009598|NCT03442296|50102549|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
25009599|NCT03442296|50102550|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
25009600|NCT03442296|50102549|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
25009601|NCT03442296|50102550|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
25009602|NCT03442296|50102549|FG000|12 Month Follow-up|Incomplete measurement|1|||
25009603|NCT03442296|50102550|FG001|12 Month Follow-up|Incomplete measurement|1|||
25009604|NCT03441984|50102558|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
25009605|NCT03441984|50102559|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
25009606|NCT03441984|50102560|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
25009607|NCT03441984|50102561|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
25178973|NCT01693562|50324397|FG011|Escalation Phase|Death|0|||
25138211|NCT02107274|50251374|FG000|Treatment vs. Placebo|Adverse Event|3|||
25138212|NCT02107274|50251375|FG001|Treatment vs. Placebo|Adverse Event|0|||
25138213|NCT02107274|50251374|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
25138214|NCT02107274|50251375|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
25138215|NCT02107274|50251374|FG000|Control Phase|Lost to Follow-up|1|||
25138216|NCT02107274|50251375|FG001|Control Phase|Lost to Follow-up|1|||
25138217|NCT02107274|50251374|FG000|Control Phase|Death|2|||
25138218|NCT02107274|50251375|FG001|Control Phase|Death|0|||
25138219|NCT02107274|50251374|FG000|Control Phase|Adverse Event|0|||
25138220|NCT02107274|50251375|FG001|Control Phase|Adverse Event|1|||
25138221|NCT02174627|50251383|FG000|Overall Study|Missing|0|||
25138222|NCT02174627|50251384|FG001|Overall Study|Missing|1|||
25138223|NCT02174627|50251383|FG000|Overall Study|Incorrect enrolment before randomization|0|||
25138224|NCT02174627|50251384|FG001|Overall Study|Incorrect enrolment before randomization|1|||
25138225|NCT02174627|50251383|FG000|Overall Study|Participant decision|84|||
25138226|NCT02174627|50251384|FG001|Overall Study|Participant decision|128|||
25273753|NCT01256450|50587877|FG001|Open-label Titration|Other|0|||
25273754|NCT01256450|50587878|FG002|Open-label Titration|Other|0|||
25273755|NCT01256450|50587876|FG000|Double-blind Treatment|Adverse Event|0|||
25273756|NCT01256450|50587877|FG001|Double-blind Treatment|Adverse Event|8|||
25273757|NCT01256450|50587878|FG002|Double-blind Treatment|Adverse Event|6|||
25273758|NCT01256450|50587876|FG000|Double-blind Treatment|Lost to Follow-up|0|||
25273759|NCT01256450|50587877|FG001|Double-blind Treatment|Lost to Follow-up|1|||
25273760|NCT01256450|50587878|FG002|Double-blind Treatment|Lost to Follow-up|7|||
25138227|NCT02173769|50251390|FG000|Overall Study|Protocol Violation|4|||
25273761|NCT01256450|50587876|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
25273762|NCT01256450|50587877|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
25138228|NCT02121509|50251397|FG000|Washout Period (35 Days)|Adverse Event|1|||
25178974|NCT01693562|50324398|FG012|Escalation Phase|Death|0|||
25178975|NCT01693562|50324399|FG013|Escalation Phase|Death|0|||
25178976|NCT01693562|50324400|FG014|Escalation Phase|Death|0|||
25178977|NCT01693562|50324401|FG015|Escalation Phase|Death|0|||
25138229|NCT02121509|50251398|FG001|Washout Period (35 Days)|Adverse Event|1|||
25138230|NCT02121509|50251399|FG002|Washout Period (35 Days)|Adverse Event|0|||
25138231|NCT02121509|50251400|FG003|Washout Period (35 Days)|Adverse Event|0|||
25138232|NCT02121509|50251397|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
25138233|NCT02121509|50251398|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
25138234|NCT02121509|50251399|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
25138235|NCT02121509|50251400|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
25138236|NCT02121509|50251397|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
25138237|NCT02121509|50251398|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
25138238|NCT02121509|50251399|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
25138239|NCT02121509|50251400|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
25138240|NCT02149199|50251413|FG000|Overall Study|Study specific withdrawal criteria|4|||
25138241|NCT02149199|50251414|FG001|Overall Study|Study specific withdrawal criteria|21|||
25138242|NCT02149199|50251415|FG002|Overall Study|Study specific withdrawal criteria|6|||
25138243|NCT02149199|50251413|FG000|Overall Study|Other|20|||
25138244|NCT02149199|50251414|FG001|Overall Study|Other|25|||
25138245|NCT02149199|50251415|FG002|Overall Study|Other|20|||
25138246|NCT02149199|50251413|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
25138247|NCT02149199|50251414|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
25138248|NCT02149199|50251415|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
25138249|NCT02149199|50251413|FG000|Overall Study|Withdrawal by Subject|75|||
25138250|NCT02149199|50251414|FG001|Overall Study|Withdrawal by Subject|93|||
25178978|NCT01693562|50324402|FG016|Escalation Phase|Death|0|||
25178979|NCT01693562|50324403|FG017|Escalation Phase|Death|0|||
25178980|NCT01693562|50324404|FG018|Escalation Phase|Death|0|||
25178981|NCT01693562|50324405|FG019|Escalation Phase|Death|0|||
25178982|NCT01693562|50324406|FG020|Escalation Phase|Death|0|||
25178983|NCT01693562|50324407|FG021|Escalation Phase|Death|0|||
25178984|NCT01693562|50324408|FG022|Escalation Phase|Death|0|||
25178985|NCT01693562|50324386|FG000|Escalation Phase|Lost to Follow-up|0|||
25178986|NCT01693562|50324387|FG001|Escalation Phase|Lost to Follow-up|1|||
25178987|NCT01693562|50324388|FG002|Escalation Phase|Lost to Follow-up|1|||
25178988|NCT01693562|50324389|FG003|Escalation Phase|Lost to Follow-up|0|||
25178989|NCT01693562|50324390|FG004|Escalation Phase|Lost to Follow-up|0|||
25178990|NCT01693562|50324391|FG005|Escalation Phase|Lost to Follow-up|0|||
25178991|NCT01693562|50324392|FG006|Escalation Phase|Lost to Follow-up|0|||
25178992|NCT01693562|50324393|FG007|Escalation Phase|Lost to Follow-up|0|||
25178993|NCT01693562|50324394|FG008|Escalation Phase|Lost to Follow-up|0|||
25138251|NCT02149199|50251415|FG002|Overall Study|Withdrawal by Subject|77|||
25138252|NCT02149199|50251413|FG000|Overall Study|Protocol Violation|16|||
25138253|NCT02149199|50251414|FG001|Overall Study|Protocol Violation|13|||
25178994|NCT01693562|50324395|FG009|Escalation Phase|Lost to Follow-up|0|||
25178995|NCT01693562|50324396|FG010|Escalation Phase|Lost to Follow-up|0|||
25178996|NCT01693562|50324397|FG011|Escalation Phase|Lost to Follow-up|0|||
25178997|NCT01693562|50324398|FG012|Escalation Phase|Lost to Follow-up|0|||
25178998|NCT01693562|50324399|FG013|Escalation Phase|Lost to Follow-up|0|||
25138254|NCT02149199|50251415|FG002|Overall Study|Protocol Violation|15|||
25009608|NCT03441984|50102562|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
25138255|NCT02149199|50251413|FG000|Overall Study|Lost to Follow-up|3|||
25138256|NCT02149199|50251414|FG001|Overall Study|Lost to Follow-up|12|||
25138257|NCT02149199|50251415|FG002|Overall Study|Lost to Follow-up|11|||
25138258|NCT02149199|50251413|FG000|Overall Study|Death|0|||
25138259|NCT02149199|50251414|FG001|Overall Study|Death|0|||
25138260|NCT02149199|50251415|FG002|Overall Study|Death|1|||
25138261|NCT02149199|50251413|FG000|Overall Study|Adverse Event|6|||
25138262|NCT02149199|50251414|FG001|Overall Study|Adverse Event|15|||
25138263|NCT02149199|50251415|FG002|Overall Study|Adverse Event|9|||
25138264|NCT02120417|50251425|FG000|Overall Study|Death|5|||
25138265|NCT02120417|50251426|FG001|Overall Study|Death|1|||
25138266|NCT02120417|50251425|FG000|Overall Study|Adverse Event|3|||
25138267|NCT02120417|50251426|FG001|Overall Study|Adverse Event|9|||
25009609|NCT03441984|50102563|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
25009610|NCT03441984|50102564|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
25009611|NCT03441984|50102565|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
25009612|NCT03441984|50102566|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
25138268|NCT02120417|50251425|FG000|Overall Study|Participant decision|4|||
25138269|NCT02120417|50251426|FG001|Overall Study|Participant decision|4|||
25138270|NCT02120417|50251425|FG000|Overall Study|Disease progression|41|||
25138271|NCT02120417|50251426|FG001|Overall Study|Disease progression|45|||
25138272|NCT02120417|50251425|FG000|Overall Study|Noncompliance with study treatment|0|||
25138273|NCT02120417|50251426|FG001|Overall Study|Noncompliance with study treatment|2|||
25138274|NCT02120417|50251425|FG000|Overall Study|Physician Decision|2|||
25138275|NCT02120417|50251426|FG001|Overall Study|Physician Decision|3|||
25138276|NCT02120417|50251425|FG000|Overall Study|Other unspecified|5|||
25138277|NCT02120417|50251426|FG001|Overall Study|Other unspecified|4|||
25138278|NCT02148263|50251434|FG000|Overall Study|Withdrawal by Subject|3|||
25009613|NCT03441984|50102567|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
25009614|NCT03441984|50102568|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
25067361|NCT02397694|50172966|FG000|Open Label Extension Phase|Withdrew Consent|3|||
25138279|NCT02148263|50251435|FG001|Overall Study|Withdrawal by Subject|2|||
25138280|NCT02147561|50251441|FG000|Overall Study|Lost to Follow-up|3|||
25138281|NCT02147561|50251441|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
25138282|NCT02058368|50251447|FG000|Overall Study|Adverse Event|15|||
25138283|NCT02058368|50251448|FG001|Overall Study|Adverse Event|20|||
25138284|NCT02058368|50251447|FG000|Overall Study|Lack of Efficacy|0|||
25138285|NCT02058368|50251448|FG001|Overall Study|Lack of Efficacy|1|||
25138286|NCT02058368|50251447|FG000|Overall Study|Protocol Violation|0|||
25138287|NCT02058368|50251448|FG001|Overall Study|Protocol Violation|4|||
25138288|NCT02058368|50251447|FG000|Overall Study|Lost to Follow-up|2|||
25138289|NCT02058368|50251448|FG001|Overall Study|Lost to Follow-up|0|||
25138290|NCT02058368|50251447|FG000|Overall Study|Physician Decision|2|||
25138291|NCT02058368|50251448|FG001|Overall Study|Physician Decision|3|||
25138292|NCT02058368|50251447|FG000|Overall Study|Withdrawal by Subject|22|||
25138293|NCT02058368|50251448|FG001|Overall Study|Withdrawal by Subject|26|||
25138294|NCT02107196|50251456|FG000|12-week Treatment Period|Adverse Event|6|||
25138295|NCT02107196|50251457|FG001|12-week Treatment Period|Adverse Event|3|||
25138296|NCT02107196|50251456|FG000|12-week Treatment Period|Lack of Efficacy|2|||
25138297|NCT02107196|50251457|FG001|12-week Treatment Period|Lack of Efficacy|1|||
25138298|NCT02107196|50251456|FG000|12-week Treatment Period|Lost to Follow-up|3|||
25138299|NCT02107196|50251457|FG001|12-week Treatment Period|Lost to Follow-up|6|||
25138300|NCT02107196|50251456|FG000|12-week Treatment Period|Physician Decision|0|||
25138301|NCT02107196|50251457|FG001|12-week Treatment Period|Physician Decision|1|||
25138302|NCT02107196|50251456|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
25138303|NCT02107196|50251457|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
25138304|NCT02107196|50251456|FG000|12-week Treatment Period|Protocol Violation|7|||
25138305|NCT02107196|50251457|FG001|12-week Treatment Period|Protocol Violation|8|||
25138306|NCT02107196|50251456|FG000|12-week Treatment Period|Reason Missing|11|||
25138307|NCT02107196|50251457|FG001|12-week Treatment Period|Reason Missing|8|||
25138308|NCT02107196|50251456|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
25138309|NCT02107196|50251457|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
25138310|NCT02107196|50251456|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
25138311|NCT02107196|50251457|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
25138312|NCT02107196|50251456|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
25138313|NCT02107196|50251457|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
25138314|NCT02107196|50251456|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
25138315|NCT02107196|50251457|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
25138316|NCT02058290|50251465|FG000|Overall Study|Protocol Violation|2|||
25138317|NCT02058290|50251466|FG001|Overall Study|Protocol Violation|1|||
25138318|NCT02058290|50251465|FG000|Overall Study|Physician Decision|1|||
25138319|NCT02058290|50251466|FG001|Overall Study|Physician Decision|0|||
25138320|NCT02058290|50251465|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
25138321|NCT02058290|50251466|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
25138322|NCT02058290|50251465|FG000|Overall Study|Withdrawal by Subject|0|||
25138323|NCT02058290|50251466|FG001|Overall Study|Withdrawal by Subject|1|||
25138324|NCT02082158|50251478|FG000|Overall Study|Withdrawal by Subject|0|||
25138325|NCT02082158|50251479|FG001|Overall Study|Withdrawal by Subject|0|||
25138326|NCT02082158|50251480|FG002|Overall Study|Withdrawal by Subject|0|||
25138327|NCT02082158|50251481|FG003|Overall Study|Withdrawal by Subject|0|||
25138328|NCT02082158|50251482|FG004|Overall Study|Withdrawal by Subject|1|||
25138329|NCT02082158|50251483|FG005|Overall Study|Withdrawal by Subject|0|||
25138330|NCT02082158|50251478|FG000|Overall Study|Failed Fit-testing|8|||
25138331|NCT02082158|50251479|FG001|Overall Study|Failed Fit-testing|8|||
25138332|NCT02082158|50251480|FG002|Overall Study|Failed Fit-testing|14|||
25138333|NCT02082158|50251481|FG003|Overall Study|Failed Fit-testing|4|||
25138334|NCT02082158|50251482|FG004|Overall Study|Failed Fit-testing|3|||
25138335|NCT02082158|50251483|FG005|Overall Study|Failed Fit-testing|7|||
25138336|NCT02106884|50251505|FG000|Overall Study|Change of diagnosis/exclusion|0|||
25138337|NCT02106884|50251506|FG001|Overall Study|Change of diagnosis/exclusion|1|||
25138338|NCT02081846|50251517|FG000|Overall Study|Withdrawal by Subject|1|||
25138339|NCT02081846|50251518|FG001|Overall Study|Withdrawal by Subject|0|||
25138340|NCT02081846|50251517|FG000|Overall Study|invalid consent|1|||
25138341|NCT02081846|50251518|FG001|Overall Study|invalid consent|0|||
25138342|NCT02081690|50251524|FG000|Overall Study|Death|3|||
25138343|NCT02081690|50251524|FG000|Overall Study|Physician Decision|3|||
25138344|NCT02081690|50251524|FG000|Overall Study|Withdrawal by Subject|1|||
25138345|NCT02057666|50251530|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
25138346|NCT02057666|50251531|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
25138347|NCT02057666|50251530|FG000|Double Blind Treatment Period|Poor tolerability|7|||
25138348|NCT02057666|50251531|FG001|Double Blind Treatment Period|Poor tolerability|2|||
25138349|NCT02057666|50251530|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
25138350|NCT02057666|50251531|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
25138351|NCT02057666|50251530|FG000|Double Blind Treatment Period|Physician Decision|1|||
25138352|NCT02057666|50251531|FG001|Double Blind Treatment Period|Physician Decision|0|||
25138353|NCT02057666|50251530|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
25138354|NCT02057666|50251531|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
25138355|NCT02057666|50251530|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
25138356|NCT02057666|50251531|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
25138357|NCT02057666|50251530|FG000|Double Blind Treatment Period|Sponsor's request|70|||
25138358|NCT02057666|50251531|FG001|Double Blind Treatment Period|Sponsor's request|34|||
25138359|NCT02057666|50251530|FG000|Open-Label Treatment Period|Poor tolerability|0|||
25138360|NCT02057666|50251531|FG001|Open-Label Treatment Period|Poor tolerability|1|||
25138361|NCT02057666|50251530|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
25138362|NCT02057666|50251531|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
25138363|NCT02057666|50251530|FG000|Open-Label Treatment Period|Sponsor's request|0|||
25138364|NCT02057666|50251531|FG001|Open-Label Treatment Period|Sponsor's request|4|||
25138365|NCT01625000|50251542|FG000|Overall Study|Physician Decision|15|||
25138366|NCT01625000|50251543|FG001|Overall Study|Physician Decision|7|||
25138367|NCT01625000|50251544|FG002|Overall Study|Physician Decision|7|||
25138368|NCT01625000|50251545|FG003|Overall Study|Physician Decision|2|||
25138369|NCT01625000|50251546|FG004|Overall Study|Physician Decision|15|||
25138370|NCT01625000|50251542|FG000|Overall Study|Protocol Violation|3|||
25138371|NCT01625000|50251543|FG001|Overall Study|Protocol Violation|10|||
25138372|NCT01625000|50251544|FG002|Overall Study|Protocol Violation|4|||
25138373|NCT01625000|50251545|FG003|Overall Study|Protocol Violation|1|||
25138374|NCT01625000|50251546|FG004|Overall Study|Protocol Violation|2|||
25138375|NCT01625000|50251542|FG000|Overall Study|Withdrawal by Subject|19|||
25138376|NCT01625000|50251543|FG001|Overall Study|Withdrawal by Subject|16|||
25138377|NCT01625000|50251544|FG002|Overall Study|Withdrawal by Subject|11|||
25138378|NCT01625000|50251545|FG003|Overall Study|Withdrawal by Subject|9|||
25138379|NCT01625000|50251546|FG004|Overall Study|Withdrawal by Subject|17|||
25138380|NCT01625000|50251542|FG000|Overall Study|Adverse Event (including Death)|15|||
25138381|NCT01625000|50251543|FG001|Overall Study|Adverse Event (including Death)|19|||
25138382|NCT01625000|50251544|FG002|Overall Study|Adverse Event (including Death)|11|||
25138383|NCT01625000|50251545|FG003|Overall Study|Adverse Event (including Death)|7|||
25138384|NCT01625000|50251546|FG004|Overall Study|Adverse Event (including Death)|21|||
25138385|NCT02081534|50251565|FG000|Overall Study|Adverse Event|5|||
25138386|NCT02081534|50251566|FG001|Overall Study|Adverse Event|4|||
25138387|NCT02081534|50251567|FG002|Overall Study|Adverse Event|3|||
25138388|NCT02081534|50251568|FG003|Overall Study|Adverse Event|10|||
25178999|NCT01693562|50324400|FG014|Escalation Phase|Lost to Follow-up|0|||
25179000|NCT01693562|50324401|FG015|Escalation Phase|Lost to Follow-up|0|||
25179001|NCT01693562|50324402|FG016|Escalation Phase|Lost to Follow-up|0|||
25138389|NCT02081534|50251569|FG004|Overall Study|Adverse Event|2|||
25179002|NCT01693562|50324403|FG017|Escalation Phase|Lost to Follow-up|0|||
25138390|NCT02081534|50251570|FG005|Overall Study|Adverse Event|8|||
25138391|NCT02081534|50251571|FG006|Overall Study|Adverse Event|2|||
25138392|NCT02081534|50251565|FG000|Overall Study|Withdrawal by Subject|0|||
25138393|NCT02081534|50251566|FG001|Overall Study|Withdrawal by Subject|1|||
25179003|NCT01693562|50324404|FG018|Escalation Phase|Lost to Follow-up|0|||
25009615|NCT03441984|50102569|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
25009616|NCT03441360|50102587|FG000|Overall Study|Radiological disease progression|5|||
25009617|NCT03441360|50102588|FG001|Overall Study|Radiological disease progression|6|||
25009618|NCT03441360|50102589|FG002|Overall Study|Radiological disease progression|4|||
25009619|NCT03441360|50102587|FG000|Overall Study|Clinical disease progression|2|||
25138394|NCT02081534|50251567|FG002|Overall Study|Withdrawal by Subject|1|||
25138395|NCT02081534|50251568|FG003|Overall Study|Withdrawal by Subject|1|||
25273763|NCT01256450|50587878|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
25273764|NCT01256450|50587876|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
25273765|NCT01256450|50587877|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
25273766|NCT01256450|50587878|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
25273767|NCT01256450|50587876|FG000|Double-blind Treatment|Non-compliance|0|||
25273768|NCT01256450|50587877|FG001|Double-blind Treatment|Non-compliance|5|||
25273769|NCT01256450|50587878|FG002|Double-blind Treatment|Non-compliance|4|||
25273770|NCT01256450|50587876|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
25273771|NCT01256450|50587877|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
25273772|NCT01256450|50587878|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
25273773|NCT01256450|50587876|FG000|Double-blind Treatment|Other|0|||
25273774|NCT01256450|50587877|FG001|Double-blind Treatment|Other|9|||
25273775|NCT01256450|50587878|FG002|Double-blind Treatment|Other|12|||
25009620|NCT03441360|50102588|FG001|Overall Study|Clinical disease progression|2|||
25009621|NCT03441360|50102589|FG002|Overall Study|Clinical disease progression|0|||
25009622|NCT03441360|50102587|FG000|Overall Study|Adverse Event|1|||
25009623|NCT03441360|50102588|FG001|Overall Study|Adverse Event|0|||
25009624|NCT03441360|50102589|FG002|Overall Study|Adverse Event|1|||
25009625|NCT01347840|50102597|FG000|Overall Study|Withdrawal by Subject|1|||
25009626|NCT01347762|50102605|FG000|Overall Study|Lost to Follow-up|0|||
25009627|NCT01347762|50102606|FG001|Overall Study|Lost to Follow-up|1|||
25009628|NCT01347762|50102607|FG002|Overall Study|Lost to Follow-up|6|||
25009629|NCT01347762|50102608|FG003|Overall Study|Lost to Follow-up|5|||
25009630|NCT01347762|50102605|FG000|Overall Study|Withdrawal by Subject|4|||
25009631|NCT01347762|50102606|FG001|Overall Study|Withdrawal by Subject|1|||
25009632|NCT01347762|50102607|FG002|Overall Study|Withdrawal by Subject|3|||
25009633|NCT01347762|50102608|FG003|Overall Study|Withdrawal by Subject|3|||
25009634|NCT03438396|50102618|FG000|Overall Study|Ongoing on study treatment|4|||
25009635|NCT03438396|50102618|FG000|Overall Study|Ongoing in survival follow-up|33|||
25009636|NCT03438396|50102618|FG000|Overall Study|Withdrawal by Subject|4|||
25009637|NCT03438396|50102618|FG000|Overall Study|Lost to Follow-up|2|||
25009638|NCT03438396|50102618|FG000|Overall Study|Death|58|||
25009639|NCT03438396|50102618|FG000|Overall Study|Not treated|1|||
25009640|NCT00073307|50102624|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
25009641|NCT00073307|50102625|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
25009642|NCT00073307|50102626|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
25009643|NCT00073307|50102624|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
25009644|NCT00073307|50102625|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
25009645|NCT00073307|50102626|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
25009646|NCT00073307|50102624|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
25009647|NCT00073307|50102625|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
25009648|NCT00073307|50102626|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
25009649|NCT00073307|50102624|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
25009650|NCT00073307|50102625|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
25138396|NCT02081534|50251569|FG004|Overall Study|Withdrawal by Subject|1|||
25009651|NCT00073307|50102626|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
25009652|NCT00073307|50102624|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
25009653|NCT00073307|50102625|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
25009654|NCT00073307|50102626|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
25009655|NCT00073307|50102624|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
25009656|NCT00073307|50102625|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
25009657|NCT00073307|50102626|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
25009658|NCT00073307|50102624|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
25009659|NCT00073307|50102625|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
25009660|NCT00073307|50102626|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
25009661|NCT00073307|50102624|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
25009662|NCT00073307|50102625|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
25009663|NCT00073307|50102626|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
25009664|NCT00073307|50102624|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
25009665|NCT00073307|50102625|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
25009666|NCT00073307|50102626|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
25009667|NCT00073307|50102624|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
25009668|NCT00073307|50102625|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
25009669|NCT00073307|50102626|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
25009670|NCT00073307|50102624|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
25009671|NCT00073307|50102625|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
25009672|NCT00073307|50102626|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
25009673|NCT00073307|50102624|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
25009674|NCT00073307|50102625|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
25009675|NCT00073307|50102626|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
25009676|NCT00073307|50102624|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
25009677|NCT00073307|50102625|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
25009678|NCT00073307|50102626|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
25009679|NCT00073307|50102624|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
25009680|NCT00073307|50102625|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
25009681|NCT00073307|50102626|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
25009682|NCT00073307|50102624|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
25009683|NCT00073307|50102625|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
25009684|NCT00073307|50102626|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
25009685|NCT00073307|50102624|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
25009686|NCT00073307|50102625|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
25009687|NCT00073307|50102626|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
25009688|NCT00073307|50102624|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
25009689|NCT00073307|50102625|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
25009690|NCT00073307|50102626|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
25009691|NCT00073307|50102624|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
25009692|NCT00073307|50102625|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
25009693|NCT00073307|50102626|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
25009694|NCT00073307|50102624|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
25009695|NCT00073307|50102625|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
25009696|NCT00073307|50102626|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
25009697|NCT03388164|50102637|FG000|Overall Study|Withdrawal by Subject|3|||
25009698|NCT03388164|50102638|FG001|Overall Study|Withdrawal by Subject|1|||
25009699|NCT03403374|50102644|FG000|Overall Study|Lost to Follow-up|1|||
25009700|NCT03387462|50102648|FG000|Overall Study|Lost to Follow-up|1|||
25009701|NCT03756883|50102655|FG000|Overall Study|Adverse Event|2|||
25009702|NCT03756883|50102656|FG001|Overall Study|Adverse Event|2|||
25138397|NCT02081534|50251570|FG005|Overall Study|Withdrawal by Subject|0|||
25138398|NCT02081534|50251571|FG006|Overall Study|Withdrawal by Subject|1|||
25273776|NCT01204398|50587885|FG000|Overall Study|Adverse Event|1|||
25273777|NCT01111851|50587891|FG000|Overall Study|All planned PET scans were not obtained.|2|||
25273778|NCT01111851|50587892|FG001|Overall Study|All planned PET scans were not obtained.|0|||
25273779|NCT01256294|50587898|FG000|Overall Study|Adverse Event|1|||
25273780|NCT01256294|50587899|FG001|Overall Study|Adverse Event|0|||
25273781|NCT01256294|50587898|FG000|Overall Study|Withdrawal by Subject|1|||
25273782|NCT01256294|50587899|FG001|Overall Study|Withdrawal by Subject|1|||
25273783|NCT01256294|50587898|FG000|Overall Study|Protocol deviation|2|||
25273784|NCT01256294|50587899|FG001|Overall Study|Protocol deviation|1|||
25273785|NCT01256060|50587905|FG000|Overall Study|Lost to Follow-up|0|||
25273786|NCT01256060|50587906|FG001|Overall Study|Lost to Follow-up|1|||
25273787|NCT01256060|50587907|FG002|Overall Study|Lost to Follow-up|0|||
25273788|NCT01256060|50587908|FG003|Overall Study|Lost to Follow-up|0|||
25273789|NCT01255904|50587916|FG000|Overall Study|Physician Decision|1|||
25273790|NCT01255904|50587917|FG001|Overall Study|Physician Decision|4|||
25273791|NCT01255670|50587925|FG000|Overall Study|Adverse Event|10|||
25273792|NCT01255670|50587926|FG001|Overall Study|Adverse Event|10|||
25273793|NCT01255670|50587925|FG000|Overall Study|Lost to Follow-up|16|||
25273794|NCT01255670|50587926|FG001|Overall Study|Lost to Follow-up|10|||
25273795|NCT01255592|50587934|FG000|Overall Study|Adverse Event|5|||
25273796|NCT01255592|50587935|FG001|Overall Study|Adverse Event|0|||
25273797|NCT01255592|50587934|FG000|Overall Study|Withdrawal by Subject|1|||
25273798|NCT01255592|50587935|FG001|Overall Study|Withdrawal by Subject|0|||
25273799|NCT01255592|50587934|FG000|Overall Study|Other|0|||
25273800|NCT01255592|50587935|FG001|Overall Study|Other|1|||
25273801|NCT01255436|50587944|FG000|Overall Study|Lost to Follow-up|178|||
25273802|NCT01255436|50587945|FG001|Overall Study|Lost to Follow-up|191|||
25009703|NCT03756883|50102657|FG002|Overall Study|Adverse Event|2|||
25138399|NCT02081534|50251565|FG000|Overall Study|Protocol Violation|0|||
25009704|NCT03756883|50102655|FG000|Overall Study|Lack of Efficacy|0|||
25009705|NCT03756883|50102656|FG001|Overall Study|Lack of Efficacy|1|||
25138400|NCT02081534|50251566|FG001|Overall Study|Protocol Violation|3|||
25138401|NCT02081534|50251567|FG002|Overall Study|Protocol Violation|0|||
25138402|NCT02081534|50251568|FG003|Overall Study|Protocol Violation|0|||
25138403|NCT02081534|50251569|FG004|Overall Study|Protocol Violation|0|||
25138404|NCT02081534|50251570|FG005|Overall Study|Protocol Violation|0|||
25138405|NCT02081534|50251571|FG006|Overall Study|Protocol Violation|1|||
25138406|NCT02081534|50251565|FG000|Overall Study|Lost to Follow-up|0|||
25138407|NCT02081534|50251566|FG001|Overall Study|Lost to Follow-up|0|||
25273803|NCT01255436|50587944|FG000|Overall Study|Death, stroke, or MI|4|||
25273804|NCT01255436|50587945|FG001|Overall Study|Death, stroke, or MI|3|||
25273805|NCT01203930|50587953|FG000|Overall Study|Disease Progression|0|||
25273806|NCT01203930|50587954|FG001|Overall Study|Disease Progression|4|||
25273807|NCT01203930|50587953|FG000|Overall Study|Death|3|||
25273808|NCT01203930|50587954|FG001|Overall Study|Death|1|||
25273809|NCT01203930|50587953|FG000|Overall Study|Withdrew Consent|1|||
25273810|NCT01203930|50587954|FG001|Overall Study|Withdrew Consent|10|||
25273811|NCT01203930|50587953|FG000|Overall Study|Investigator Request|0|||
25273812|NCT01203930|50587954|FG001|Overall Study|Investigator Request|8|||
25009706|NCT03756883|50102657|FG002|Overall Study|Lack of Efficacy|2|||
25138408|NCT02081534|50251567|FG002|Overall Study|Lost to Follow-up|0|||
25138409|NCT02081534|50251568|FG003|Overall Study|Lost to Follow-up|2|||
25273813|NCT01203930|50587953|FG000|Overall Study|Study Terminated by Sponsor|0|||
25273814|NCT01203930|50587954|FG001|Overall Study|Study Terminated by Sponsor|12|||
25009707|NCT03756883|50102655|FG000|Overall Study|Lost to Follow-up|3|||
25138410|NCT02081534|50251569|FG004|Overall Study|Lost to Follow-up|1|||
25138411|NCT02081534|50251570|FG005|Overall Study|Lost to Follow-up|1|||
25138412|NCT02081534|50251571|FG006|Overall Study|Lost to Follow-up|0|||
25138413|NCT02057198|50251590|FG000|Overall Study|Death|0|||
25138414|NCT02057198|50251591|FG001|Overall Study|Death|0|||
25138415|NCT02057198|50251592|FG002|Overall Study|Death|1|||
25138416|NCT02057198|50251590|FG000|Overall Study|Discharged early; lost to followup|0|||
25138417|NCT02057198|50251591|FG001|Overall Study|Discharged early; lost to followup|1|||
25138418|NCT02057198|50251592|FG002|Overall Study|Discharged early; lost to followup|0|||
25138419|NCT02056652|50251602|FG000|Overall Study|Withdrawal by Subject|1|||
25138420|NCT02056652|50251603|FG001|Overall Study|Withdrawal by Subject|0|||
25138421|NCT02056652|50251602|FG000|Overall Study|Lost to Follow-up|0|||
25138422|NCT02056652|50251603|FG001|Overall Study|Lost to Follow-up|3|||
25138423|NCT02056340|50251611|FG000|Overall Study|Lost to Follow-up|5|||
25179004|NCT01693562|50324405|FG019|Escalation Phase|Lost to Follow-up|0|||
25273815|NCT01203930|50587953|FG000|Overall Study|Poor tolerance of study drug|0|||
25273816|NCT01203930|50587954|FG001|Overall Study|Poor tolerance of study drug|1|||
25273817|NCT01203930|50587953|FG000|Overall Study|Adverse Event|17|||
25273818|NCT01203930|50587954|FG001|Overall Study|Adverse Event|5|||
25273819|NCT01254890|50587964|FG000|Overall Study|Ineligible|0|||
25273820|NCT01254890|50587965|FG001|Overall Study|Ineligible|3|||
25273821|NCT01254890|50587964|FG000|Overall Study|Withdrawal by Subject|1|||
25273822|NCT01254890|50587965|FG001|Overall Study|Withdrawal by Subject|2|||
25273823|NCT01254890|50587964|FG000|Overall Study|Disease Progression|0|||
25273824|NCT01254890|50587965|FG001|Overall Study|Disease Progression|5|||
25138424|NCT02056340|50251612|FG001|Overall Study|Lost to Follow-up|5|||
25138425|NCT02056340|50251611|FG000|Overall Study|Withdrawal by Subject|2|||
25138426|NCT02056340|50251612|FG001|Overall Study|Withdrawal by Subject|6|||
25138427|NCT02046122|50251618|FG000|Overall Study|Physician Decision|8|||
25273825|NCT01203852|50587970|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
25273826|NCT01203852|50587970|FG000|Washout 2 Weeks|Physician Decision|46|||
25009708|NCT03756883|50102656|FG001|Overall Study|Lost to Follow-up|3|||
25009709|NCT03756883|50102657|FG002|Overall Study|Lost to Follow-up|0|||
25009710|NCT03756883|50102655|FG000|Overall Study|Protocol Violation|2|||
25009711|NCT03756883|50102656|FG001|Overall Study|Protocol Violation|0|||
25009712|NCT03756883|50102657|FG002|Overall Study|Protocol Violation|1|||
25009713|NCT03756883|50102655|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
25009714|NCT03756883|50102656|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
25009715|NCT03756883|50102657|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
25138428|NCT02046122|50251618|FG000|Overall Study|Withdrawal by Subject|1|||
25138429|NCT02080832|50251625|FG000|Overall Study|Excluded from analysis by MRI|9|||
25138430|NCT02080832|50251626|FG001|Overall Study|Excluded from analysis by MRI|10|||
25138431|NCT02080832|50251627|FG002|Overall Study|Excluded from analysis by MRI|14|||
25138432|NCT02080832|50251625|FG000|Overall Study|Lost to Follow-up|0|||
25138433|NCT02080832|50251626|FG001|Overall Study|Lost to Follow-up|2|||
25138434|NCT02080832|50251627|FG002|Overall Study|Lost to Follow-up|2|||
25138435|NCT02080364|50251641|FG000|Baseline Period|Protocol Violation|2|||
25138436|NCT02080364|50251642|FG001|Baseline Period|Protocol Violation|1|||
25138437|NCT02080364|50251643|FG002|Baseline Period|Protocol Violation|0|||
25138438|NCT02080364|50251644|FG003|Baseline Period|Protocol Violation|0|||
25138439|NCT02080364|50251641|FG000|Baseline Period|Other|0|||
25138440|NCT02080364|50251642|FG001|Baseline Period|Other|1|||
25138441|NCT02080364|50251643|FG002|Baseline Period|Other|1|||
25138442|NCT02080364|50251644|FG003|Baseline Period|Other|0|||
25138443|NCT02080364|50251641|FG000|Treatment Period|Adverse Event|10|||
25138444|NCT02080364|50251642|FG001|Treatment Period|Adverse Event|15|||
25138445|NCT02080364|50251643|FG002|Treatment Period|Adverse Event|11|||
25138446|NCT02080364|50251644|FG003|Treatment Period|Adverse Event|14|||
25138447|NCT02080364|50251641|FG000|Treatment Period|Lost to Follow-up|2|||
25138448|NCT02080364|50251642|FG001|Treatment Period|Lost to Follow-up|3|||
25138449|NCT02080364|50251643|FG002|Treatment Period|Lost to Follow-up|5|||
25138450|NCT02080364|50251644|FG003|Treatment Period|Lost to Follow-up|0|||
25138451|NCT02080364|50251641|FG000|Treatment Period|Protocol Violation|5|||
25138452|NCT02080364|50251642|FG001|Treatment Period|Protocol Violation|3|||
25179005|NCT01693562|50324406|FG020|Escalation Phase|Lost to Follow-up|0|||
25179006|NCT01693562|50324407|FG021|Escalation Phase|Lost to Follow-up|0|||
25179007|NCT01693562|50324408|FG022|Escalation Phase|Lost to Follow-up|0|||
25138453|NCT02080364|50251643|FG002|Treatment Period|Protocol Violation|5|||
25138454|NCT02080364|50251644|FG003|Treatment Period|Protocol Violation|1|||
25138455|NCT02080364|50251641|FG000|Treatment Period|Withdrawal by Subject|16|||
25138456|NCT02080364|50251642|FG001|Treatment Period|Withdrawal by Subject|16|||
25138457|NCT02080364|50251643|FG002|Treatment Period|Withdrawal by Subject|15|||
25009716|NCT03756883|50102655|FG000|Overall Study|Withdrawal by Subject|4|||
25009717|NCT03756883|50102656|FG001|Overall Study|Withdrawal by Subject|1|||
25009718|NCT03756883|50102657|FG002|Overall Study|Withdrawal by Subject|0|||
25009719|NCT03756883|50102655|FG000|Overall Study|Other Reasons|2|||
25009720|NCT03756883|50102656|FG001|Overall Study|Other Reasons|4|||
25009721|NCT03756883|50102657|FG002|Overall Study|Other Reasons|0|||
25009722|NCT03386994|50102668|FG000|Overall Study|Lung transplant|1|||
25009723|NCT03386994|50102668|FG000|Overall Study|Adverse Event|14|||
25009724|NCT03386994|50102668|FG000|Overall Study|Lost to Follow-up|4|||
25179008|NCT01693562|50324386|FG000|Escalation Phase|Other|0|||
25009725|NCT03386994|50102668|FG000|Overall Study|Withdrawal by Subject|3|||
25009726|NCT03386994|50102668|FG000|Overall Study|Death|16|||
25009727|NCT03756571|50102685|FG000|Overall Study|Lost to Follow-up|1|||
25179009|NCT01693562|50324387|FG001|Escalation Phase|Other|0|||
25179010|NCT01693562|50324388|FG002|Escalation Phase|Other|2|||
25179011|NCT01693562|50324389|FG003|Escalation Phase|Other|0|||
25179012|NCT01693562|50324390|FG004|Escalation Phase|Other|0|||
25179013|NCT01693562|50324391|FG005|Escalation Phase|Other|1|||
25179014|NCT01693562|50324392|FG006|Escalation Phase|Other|0|||
25179015|NCT01693562|50324393|FG007|Escalation Phase|Other|0|||
25179016|NCT01693562|50324394|FG008|Escalation Phase|Other|0|||
25179017|NCT01693562|50324395|FG009|Escalation Phase|Other|0|||
25179018|NCT01693562|50324396|FG010|Escalation Phase|Other|0|||
25179019|NCT01693562|50324397|FG011|Escalation Phase|Other|0|||
25009728|NCT03756571|50102686|FG001|Overall Study|Lost to Follow-up|1|||
25009729|NCT03386448|50102694|FG000|Overall Study|Adverse Event|0|||
25009730|NCT03386448|50102695|FG001|Overall Study|Adverse Event|2|||
25009731|NCT02951988|50102704|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
25179020|NCT01693562|50324398|FG012|Escalation Phase|Other|0|||
25179021|NCT01693562|50324399|FG013|Escalation Phase|Other|0|||
25179022|NCT01693562|50324400|FG014|Escalation Phase|Other|0|||
25179023|NCT01693562|50324401|FG015|Escalation Phase|Other|0|||
25179024|NCT01693562|50324402|FG016|Escalation Phase|Other|0|||
25179025|NCT01693562|50324403|FG017|Escalation Phase|Other|0|||
25179026|NCT01693562|50324404|FG018|Escalation Phase|Other|0|||
25179027|NCT01693562|50324405|FG019|Escalation Phase|Other|0|||
25179028|NCT01693562|50324406|FG020|Escalation Phase|Other|0|||
25138458|NCT02080364|50251644|FG003|Treatment Period|Withdrawal by Subject|10|||
25138459|NCT02080364|50251641|FG000|Treatment Period|Study Terminated by Sponsor|0|||
25138460|NCT02080364|50251642|FG001|Treatment Period|Study Terminated by Sponsor|0|||
25138461|NCT02080364|50251643|FG002|Treatment Period|Study Terminated by Sponsor|180|||
25138462|NCT02080364|50251644|FG003|Treatment Period|Study Terminated by Sponsor|183|||
25138463|NCT02080364|50251641|FG000|Treatment Period|Other|14|||
25138464|NCT02080364|50251642|FG001|Treatment Period|Other|12|||
25179029|NCT01693562|50324407|FG021|Escalation Phase|Other|0|||
25179030|NCT01693562|50324408|FG022|Escalation Phase|Other|0|||
25179031|NCT01693562|50324386|FG000|Exploration Phase|Withdrawal by Subject|0|||
25179032|NCT01693562|50324387|FG001|Exploration Phase|Withdrawal by Subject|0|||
25179033|NCT01693562|50324388|FG002|Exploration Phase|Withdrawal by Subject|0|||
25179034|NCT01693562|50324389|FG003|Exploration Phase|Withdrawal by Subject|0|||
25179035|NCT01693562|50324390|FG004|Exploration Phase|Withdrawal by Subject|0|||
25179036|NCT01693562|50324391|FG005|Exploration Phase|Withdrawal by Subject|0|||
25179037|NCT01693562|50324392|FG006|Exploration Phase|Withdrawal by Subject|2|||
25179038|NCT01693562|50324393|FG007|Exploration Phase|Withdrawal by Subject|0|||
25179039|NCT01693562|50324394|FG008|Exploration Phase|Withdrawal by Subject|0|||
25179040|NCT01693562|50324395|FG009|Exploration Phase|Withdrawal by Subject|0|||
25138465|NCT02080364|50251643|FG002|Treatment Period|Other|21|||
25179041|NCT01693562|50324396|FG010|Exploration Phase|Withdrawal by Subject|0|||
25179042|NCT01693562|50324397|FG011|Exploration Phase|Withdrawal by Subject|0|||
25138466|NCT02080364|50251644|FG003|Treatment Period|Other|16|||
25179043|NCT01693562|50324398|FG012|Exploration Phase|Withdrawal by Subject|0|||
25179044|NCT01693562|50324399|FG013|Exploration Phase|Withdrawal by Subject|0|||
25179045|NCT01693562|50324400|FG014|Exploration Phase|Withdrawal by Subject|0|||
25179046|NCT01693562|50324401|FG015|Exploration Phase|Withdrawal by Subject|0|||
25273827|NCT01105533|50587977|FG000|Overall Study|Death|0|||
25273828|NCT01105533|50587978|FG001|Overall Study|Death|0|||
25273829|NCT01105533|50587979|FG002|Overall Study|Death|0|||
25273830|NCT01105533|50587980|FG003|Overall Study|Death|0|||
25273831|NCT01105533|50587981|FG004|Overall Study|Death|1|||
25273832|NCT01105533|50587982|FG005|Overall Study|Death|0|||
25273833|NCT01105533|50587983|FG006|Overall Study|Death|0|||
25273834|NCT01105533|50587984|FG007|Overall Study|Death|0|||
25273835|NCT01105533|50587985|FG008|Overall Study|Death|0|||
25273836|NCT01105533|50587977|FG000|Overall Study|Lack of Efficacy|1|||
25273837|NCT01105533|50587978|FG001|Overall Study|Lack of Efficacy|1|||
25273838|NCT01105533|50587979|FG002|Overall Study|Lack of Efficacy|3|||
25273839|NCT01105533|50587980|FG003|Overall Study|Lack of Efficacy|3|||
25273840|NCT01105533|50587981|FG004|Overall Study|Lack of Efficacy|4|||
25273841|NCT01105533|50587982|FG005|Overall Study|Lack of Efficacy|5|||
25273842|NCT01105533|50587983|FG006|Overall Study|Lack of Efficacy|3|||
25273843|NCT01105533|50587984|FG007|Overall Study|Lack of Efficacy|2|||
25273844|NCT01105533|50587985|FG008|Overall Study|Lack of Efficacy|9|||
25273845|NCT01105533|50587977|FG000|Overall Study|Adverse Event|0|||
25273846|NCT01105533|50587978|FG001|Overall Study|Adverse Event|0|||
25273847|NCT01105533|50587979|FG002|Overall Study|Adverse Event|0|||
25273848|NCT01105533|50587980|FG003|Overall Study|Adverse Event|0|||
25273849|NCT01105533|50587981|FG004|Overall Study|Adverse Event|1|||
25273850|NCT01105533|50587982|FG005|Overall Study|Adverse Event|2|||
25273851|NCT01105533|50587983|FG006|Overall Study|Adverse Event|2|||
25273852|NCT01105533|50587984|FG007|Overall Study|Adverse Event|0|||
25273853|NCT01105533|50587985|FG008|Overall Study|Adverse Event|1|||
25138467|NCT02079038|50251656|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
25138468|NCT02079038|50251657|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
25138469|NCT02079038|50251656|FG000|Modified Intent to Treat Population|Death|1|||
25138470|NCT02079038|50251657|FG001|Modified Intent to Treat Population|Death|0|||
25138471|NCT02079038|50251656|FG000|Completed 6 Months|Lost to Follow-up|2|||
25138472|NCT02079038|50251657|FG001|Completed 6 Months|Lost to Follow-up|1|||
25138473|NCT02045732|50251665|FG000|Overall Study|At the discretion of the investigator|1|||
25138474|NCT02045732|50251666|FG001|Overall Study|At the discretion of the investigator|1|||
25138475|NCT02044874|50251675|FG000|Overall Study|Adverse Event|5|||
25273854|NCT01105533|50587977|FG000|Overall Study|Other|0|||
25273855|NCT01105533|50587978|FG001|Overall Study|Other|0|||
25273856|NCT01105533|50587979|FG002|Overall Study|Other|0|||
25273857|NCT01105533|50587980|FG003|Overall Study|Other|0|||
25273858|NCT01105533|50587981|FG004|Overall Study|Other|1|||
25273859|NCT01105533|50587982|FG005|Overall Study|Other|0|||
25273860|NCT01105533|50587983|FG006|Overall Study|Other|3|||
25273861|NCT01105533|50587984|FG007|Overall Study|Other|1|||
25273862|NCT01105533|50587985|FG008|Overall Study|Other|2|||
25273863|NCT01105533|50587977|FG000|Overall Study|Physician Decision|0|||
25273864|NCT01105533|50587978|FG001|Overall Study|Physician Decision|0|||
25273865|NCT01105533|50587979|FG002|Overall Study|Physician Decision|0|||
25273866|NCT01105533|50587980|FG003|Overall Study|Physician Decision|0|||
25273867|NCT01105533|50587981|FG004|Overall Study|Physician Decision|0|||
25273868|NCT01105533|50587982|FG005|Overall Study|Physician Decision|0|||
25273869|NCT01105533|50587983|FG006|Overall Study|Physician Decision|0|||
25273870|NCT01105533|50587984|FG007|Overall Study|Physician Decision|1|||
25273871|NCT01105533|50587985|FG008|Overall Study|Physician Decision|0|||
25138476|NCT02044874|50251676|FG001|Overall Study|Adverse Event|6|||
25138477|NCT02044874|50251677|FG002|Overall Study|Adverse Event|6|||
25138478|NCT02044874|50251675|FG000|Overall Study|Withdrawal by Subject|8|||
25138479|NCT02044874|50251676|FG001|Overall Study|Withdrawal by Subject|16|||
25138480|NCT02044874|50251677|FG002|Overall Study|Withdrawal by Subject|23|||
25138481|NCT02044874|50251675|FG000|Overall Study|Physician Decision|0|||
25138482|NCT02044874|50251676|FG001|Overall Study|Physician Decision|2|||
25138483|NCT02044874|50251677|FG002|Overall Study|Physician Decision|1|||
25138484|NCT02044874|50251675|FG000|Overall Study|Lost to Follow-up|10|||
25138485|NCT02044874|50251676|FG001|Overall Study|Lost to Follow-up|27|||
25138486|NCT02044874|50251677|FG002|Overall Study|Lost to Follow-up|21|||
25138487|NCT02044874|50251675|FG000|Overall Study|Sponsor Decision|0|||
25138488|NCT02044874|50251676|FG001|Overall Study|Sponsor Decision|1|||
25138489|NCT02044874|50251677|FG002|Overall Study|Sponsor Decision|1|||
25138490|NCT02044874|50251675|FG000|Overall Study|Other|7|||
25138491|NCT02044874|50251676|FG001|Overall Study|Other|3|||
25138492|NCT02044874|50251677|FG002|Overall Study|Other|8|||
25138493|NCT02078960|50251690|FG000|Treatment Period|Other|0|||
25138494|NCT02078960|50251691|FG001|Treatment Period|Other|0|||
25138495|NCT02078960|50251692|FG002|Treatment Period|Other|1|||
25138496|NCT02078960|50251690|FG000|Treatment Period|Lack of Efficacy|0|||
25138497|NCT02078960|50251691|FG001|Treatment Period|Lack of Efficacy|1|||
25138498|NCT02078960|50251692|FG002|Treatment Period|Lack of Efficacy|0|||
25138499|NCT02078960|50251690|FG000|Treatment Period|Disease progression - accelerated phase|0|||
25138500|NCT02078960|50251691|FG001|Treatment Period|Disease progression - accelerated phase|1|||
25138501|NCT02078960|50251692|FG002|Treatment Period|Disease progression - accelerated phase|0|||
25138502|NCT02078960|50251690|FG000|Treatment Period|Disease progression - blast phase|1|||
25138503|NCT02078960|50251691|FG001|Treatment Period|Disease progression - blast phase|0|||
25138504|NCT02078960|50251692|FG002|Treatment Period|Disease progression - blast phase|0|||
25138505|NCT02078960|50251690|FG000|Treatment Period|Withdrawal by Subject|0|||
25138506|NCT02078960|50251691|FG001|Treatment Period|Withdrawal by Subject|1|||
25138507|NCT02078960|50251692|FG002|Treatment Period|Withdrawal by Subject|1|||
25138508|NCT02078960|50251690|FG000|Treatment Period|Adverse Event|1|||
25138509|NCT02078960|50251691|FG001|Treatment Period|Adverse Event|0|||
25138510|NCT02078960|50251692|FG002|Treatment Period|Adverse Event|0|||
25138511|NCT02078960|50251690|FG000|Treatment Period|Death|0|||
25138512|NCT02078960|50251691|FG001|Treatment Period|Death|0|||
25138513|NCT02078960|50251692|FG002|Treatment Period|Death|1|||
25138514|NCT02078960|50251690|FG000|Follow-up Period|Death|2|||
25138515|NCT02078960|50251691|FG001|Follow-up Period|Death|0|||
25138516|NCT02078960|50251692|FG002|Follow-up Period|Death|0|||
25138517|NCT02078960|50251690|FG000|Follow-up Period|Lost to Follow-up|0|||
25138518|NCT02078960|50251691|FG001|Follow-up Period|Lost to Follow-up|1|||
25138519|NCT02078960|50251692|FG002|Follow-up Period|Lost to Follow-up|0|||
25138520|NCT02078102|50251704|FG000|Overall Study|Adverse Event|1|||
25138521|NCT02078102|50251705|FG001|Overall Study|Adverse Event|0|||
25138522|NCT02078102|50251704|FG000|Overall Study|Withdrawal by Subject|1|||
25009732|NCT02951988|50102705|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
25138523|NCT02078102|50251705|FG001|Overall Study|Withdrawal by Subject|0|||
25138524|NCT02078102|50251704|FG000|Overall Study|Physician Decision|0|||
25138525|NCT02078102|50251705|FG001|Overall Study|Physician Decision|1|||
25138526|NCT02054702|50251714|FG000|Overall Study|Lost to Follow-up|3|||
25138527|NCT02054702|50251715|FG001|Overall Study|Lost to Follow-up|5|||
25138528|NCT02054702|50251714|FG000|Overall Study|Adverse Event|3|||
25138529|NCT02054702|50251715|FG001|Overall Study|Adverse Event|1|||
25138530|NCT02054702|50251714|FG000|Overall Study|Met Withdrawal Criteria|4|||
25009733|NCT02951988|50102706|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
25009734|NCT02951988|50102707|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
25009735|NCT02951988|50102704|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
25009736|NCT02951988|50102705|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
25009737|NCT02951988|50102706|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
25009738|NCT02951988|50102707|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
25009739|NCT02951988|50102704|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
25009740|NCT02951988|50102705|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
25009741|NCT02951988|50102706|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
25009742|NCT02951988|50102707|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
25009743|NCT02951988|50102704|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
25009744|NCT02951988|50102705|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
25009745|NCT02951988|50102706|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
25009746|NCT02951988|50102707|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
25009747|NCT02951988|50102704|FG000|Open-Label Treatment Period|Protocol Violation|22|||
25009748|NCT02951988|50102705|FG001|Open-Label Treatment Period|Protocol Violation|0|||
25009749|NCT02951988|50102706|FG002|Open-Label Treatment Period|Protocol Violation|0|||
25009750|NCT02951988|50102707|FG003|Open-Label Treatment Period|Protocol Violation|0|||
25009751|NCT02951988|50102704|FG000|Open-Label Treatment Period|Pregnancy|2|||
25009752|NCT02951988|50102705|FG001|Open-Label Treatment Period|Pregnancy|0|||
25009753|NCT02951988|50102706|FG002|Open-Label Treatment Period|Pregnancy|0|||
25009754|NCT02951988|50102707|FG003|Open-Label Treatment Period|Pregnancy|0|||
25009755|NCT02951988|50102704|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
25009756|NCT02951988|50102705|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
25009757|NCT02951988|50102706|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
25009758|NCT02951988|50102707|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
25009759|NCT02951988|50102704|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
25009760|NCT02951988|50102705|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
25138531|NCT02054702|50251715|FG001|Overall Study|Met Withdrawal Criteria|1|||
25138532|NCT02054702|50251714|FG000|Overall Study|Physician Decision|0|||
25138533|NCT02054702|50251715|FG001|Overall Study|Physician Decision|1|||
25138534|NCT02054702|50251714|FG000|Overall Study|Withdrawal by Subject|14|||
25009761|NCT02951988|50102706|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
25179047|NCT01693562|50324402|FG016|Exploration Phase|Withdrawal by Subject|0|||
25138535|NCT02054702|50251715|FG001|Overall Study|Withdrawal by Subject|4|||
25138536|NCT02044094|50251721|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
25138537|NCT02044094|50251721|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
25138538|NCT02044094|50251721|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
25138539|NCT02044094|50251721|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
25138540|NCT02044094|50251721|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
25138541|NCT02044094|50251721|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
25138542|NCT02044094|50251721|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
25138543|NCT02044094|50251721|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
25138544|NCT02043938|50251736|FG000|Overall Study|Withdrawal by Subject|7|||
25138545|NCT02043938|50251736|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
25138546|NCT02043938|50251736|FG000|Overall Study|No show by subject|1|||
25138547|NCT02043938|50251736|FG000|Overall Study|Investigator decision|1|||
25138548|NCT02053610|50251745|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
25138549|NCT02053610|50251746|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
25138550|NCT02053610|50251745|FG000|Overall Study|Withdrew Consent|2|||
25138551|NCT02053610|50251746|FG001|Overall Study|Withdrew Consent|9|||
25138552|NCT02053610|50251745|FG000|Overall Study|Death|5|||
25138553|NCT02053610|50251746|FG001|Overall Study|Death|5|||
25138554|NCT02053610|50251745|FG000|Overall Study|Administrative/Other|1|||
25138555|NCT02053610|50251746|FG001|Overall Study|Administrative/Other|1|||
25138556|NCT02053610|50251745|FG000|Overall Study|Disease Progression|2|||
25138557|NCT02053610|50251746|FG001|Overall Study|Disease Progression|3|||
25138558|NCT02053610|50251745|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
25138559|NCT02053610|50251746|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
25138560|NCT02053610|50251745|FG000|Overall Study|Did not Receive Treatment|4|||
25138561|NCT02053610|50251746|FG001|Overall Study|Did not Receive Treatment|2|||
25138562|NCT02053610|50251745|FG000|Overall Study|Insufficient Therapeutic Response|1|||
25138563|NCT02053610|50251746|FG001|Overall Study|Insufficient Therapeutic Response|1|||
25138564|NCT02053610|50251745|FG000|Overall Study|Violation of Selection Criteria|1|||
25138565|NCT02053610|50251746|FG001|Overall Study|Violation of Selection Criteria|0|||
25138566|NCT02075606|50251752|FG000|Overall Study|Adverse Event|5|||
25138567|NCT02075606|50251752|FG000|Overall Study|Withdrawal by Subject|1|||
25179048|NCT01693562|50324403|FG017|Exploration Phase|Withdrawal by Subject|0|||
25179049|NCT01693562|50324404|FG018|Exploration Phase|Withdrawal by Subject|0|||
25009762|NCT02951988|50102707|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
25009763|NCT02951988|50102704|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
25009764|NCT02951988|50102705|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
25009765|NCT02951988|50102706|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
25009766|NCT02951988|50102707|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
25009767|NCT02951988|50102704|FG000|Open-Label Treatment Period|Adverse Event|45|||
25009768|NCT02951988|50102705|FG001|Open-Label Treatment Period|Adverse Event|0|||
25009769|NCT02951988|50102706|FG002|Open-Label Treatment Period|Adverse Event|0|||
25009770|NCT02951988|50102707|FG003|Open-Label Treatment Period|Adverse Event|0|||
25138568|NCT02075606|50251752|FG000|Overall Study|Death|1|||
25138569|NCT02075606|50251752|FG000|Overall Study|Investigator's decision|1|||
25179050|NCT01693562|50324405|FG019|Exploration Phase|Withdrawal by Subject|0|||
25179051|NCT01693562|50324406|FG020|Exploration Phase|Withdrawal by Subject|0|||
25179052|NCT01693562|50324407|FG021|Exploration Phase|Withdrawal by Subject|0|||
25179053|NCT01693562|50324408|FG022|Exploration Phase|Withdrawal by Subject|0|||
25179054|NCT01693562|50324386|FG000|Exploration Phase|Death|0|||
25179055|NCT01693562|50324387|FG001|Exploration Phase|Death|0|||
25179056|NCT01693562|50324388|FG002|Exploration Phase|Death|0|||
25179057|NCT01693562|50324389|FG003|Exploration Phase|Death|0|||
25179058|NCT01693562|50324390|FG004|Exploration Phase|Death|0|||
25179059|NCT01693562|50324391|FG005|Exploration Phase|Death|0|||
25179060|NCT01693562|50324392|FG006|Exploration Phase|Death|17|||
25179061|NCT01693562|50324393|FG007|Exploration Phase|Death|0|||
25179062|NCT01693562|50324394|FG008|Exploration Phase|Death|0|||
25138570|NCT02075606|50251752|FG000|Overall Study|Symptom management|1|||
25138571|NCT02075606|50251752|FG000|Overall Study|Increasing Symptoms|1|||
25138572|NCT02043782|50251761|FG000|Period 1|Adverse Event|0|||
25138573|NCT02043782|50251762|FG001|Period 1|Adverse Event|0|||
25138574|NCT02043782|50251763|FG002|Period 1|Adverse Event|1|||
25138575|NCT02043782|50251764|FG003|Period 1|Adverse Event|0|||
25138576|NCT02043782|50251765|FG004|Period 1|Adverse Event|0|||
25138577|NCT02043782|50251766|FG005|Period 1|Adverse Event|0|||
25138578|NCT02052596|50251776|FG000|Active Phase|Adverse Event|3|||
25138579|NCT02052596|50251777|FG001|Active Phase|Adverse Event|2|||
25138580|NCT02052596|50251776|FG000|Active Phase|Lost to Follow-up|8|||
25138581|NCT02052596|50251777|FG001|Active Phase|Lost to Follow-up|11|||
25009771|NCT02951988|50102704|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
25009772|NCT02951988|50102705|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
25009773|NCT02951988|50102706|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
25009774|NCT02951988|50102707|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
25009775|NCT02951988|50102704|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
25009776|NCT02951988|50102705|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
25009777|NCT02951988|50102706|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
25009778|NCT02951988|50102707|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
25009779|NCT02951988|50102704|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
25009780|NCT02951988|50102705|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
25009781|NCT02951988|50102706|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
25009782|NCT02951988|50102707|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
25138582|NCT02052596|50251776|FG000|Active Phase|Protocol Violation|1|||
25138583|NCT02052596|50251777|FG001|Active Phase|Protocol Violation|2|||
25138584|NCT02052596|50251776|FG000|Active Phase|Withdrawal by Subject|3|||
25138585|NCT02052596|50251777|FG001|Active Phase|Withdrawal by Subject|4|||
25138586|NCT02052596|50251776|FG000|Active Phase|Enrolled in error|1|||
25138587|NCT02052596|50251777|FG001|Active Phase|Enrolled in error|0|||
25138588|NCT02052596|50251776|FG000|Active Phase|Lost due to Crohn's disease|0|||
25138589|NCT02052596|50251777|FG001|Active Phase|Lost due to Crohn's disease|1|||
25138590|NCT02052596|50251776|FG000|Safety Phase|Adverse Event|6|||
25138591|NCT02052596|50251777|FG001|Safety Phase|Adverse Event|3|||
25179063|NCT01693562|50324395|FG009|Exploration Phase|Death|0|||
25179064|NCT01693562|50324396|FG010|Exploration Phase|Death|0|||
25179065|NCT01693562|50324397|FG011|Exploration Phase|Death|0|||
25179066|NCT01693562|50324398|FG012|Exploration Phase|Death|0|||
25179067|NCT01693562|50324399|FG013|Exploration Phase|Death|0|||
25179068|NCT01693562|50324400|FG014|Exploration Phase|Death|0|||
25179069|NCT01693562|50324401|FG015|Exploration Phase|Death|0|||
25179070|NCT01693562|50324402|FG016|Exploration Phase|Death|0|||
25179071|NCT01693562|50324403|FG017|Exploration Phase|Death|0|||
25179072|NCT01693562|50324404|FG018|Exploration Phase|Death|0|||
25138592|NCT02052596|50251776|FG000|Safety Phase|Lost to Follow-up|11|||
25138593|NCT02052596|50251777|FG001|Safety Phase|Lost to Follow-up|18|||
25138594|NCT02052596|50251776|FG000|Safety Phase|Protocol Violation|1|||
25138595|NCT02052596|50251777|FG001|Safety Phase|Protocol Violation|2|||
25138596|NCT02052596|50251776|FG000|Safety Phase|Withdrawal by Subject|8|||
25138597|NCT02052596|50251777|FG001|Safety Phase|Withdrawal by Subject|11|||
25138598|NCT02052596|50251776|FG000|Safety Phase|Enrolled in error|1|||
25138599|NCT02052596|50251777|FG001|Safety Phase|Enrolled in error|0|||
25138600|NCT02052596|50251776|FG000|Safety Phase|Lost due to Crohn's disease|0|||
25138601|NCT02052596|50251777|FG001|Safety Phase|Lost due to Crohn's disease|1|||
25138602|NCT02052440|50251785|FG000|Overall Study|Withdrawal by Subject|0|||
25138603|NCT02052440|50251786|FG001|Overall Study|Withdrawal by Subject|1|||
25138604|NCT02049944|50251792|FG000|Overall Study|Protocol Violation|2|||
25138605|NCT02043548|50251798|FG000|Overall Study|Lack of Efficacy|1|||
25138606|NCT02043548|50251799|FG001|Overall Study|Lack of Efficacy|0|||
25138607|NCT02043548|50251798|FG000|Overall Study|Adverse Event|0|||
25138608|NCT02043548|50251799|FG001|Overall Study|Adverse Event|1|||
25138609|NCT01622348|50251808|FG000|Overall Study|Withdrawal by Subject|1|||
25138610|NCT01622348|50251809|FG001|Overall Study|Withdrawal by Subject|0|||
25138611|NCT01622348|50251810|FG002|Overall Study|Withdrawal by Subject|1|||
25138612|NCT01621880|50251820|FG000|Overall Study|Adverse Event|5|||
25138613|NCT01621880|50251821|FG001|Overall Study|Adverse Event|1|||
25138614|NCT01621880|50251820|FG000|Overall Study|Withdrawal by Subject|5|||
25138615|NCT01621880|50251821|FG001|Overall Study|Withdrawal by Subject|4|||
25138616|NCT01621802|50251834|FG000|Overall Study|Protocol Violation|0|||
25138617|NCT01621802|50251835|FG001|Overall Study|Protocol Violation|0|||
25138618|NCT01621802|50251836|FG002|Overall Study|Protocol Violation|0|||
25138619|NCT01621802|50251837|FG003|Overall Study|Protocol Violation|0|||
25138620|NCT01621802|50251838|FG004|Overall Study|Protocol Violation|0|||
25138621|NCT01621802|50251839|FG005|Overall Study|Protocol Violation|1|||
25138622|NCT01621802|50251834|FG000|Overall Study|Withdrawal by Subject|8|||
25179073|NCT01693562|50324405|FG019|Exploration Phase|Death|0|||
25179074|NCT01693562|50324406|FG020|Exploration Phase|Death|0|||
25273872|NCT01203072|50588003|FG000|Overall Study|Adverse Event|5|||
25273873|NCT01203072|50588004|FG001|Overall Study|Adverse Event|3|||
25273874|NCT01203072|50588005|FG002|Overall Study|Adverse Event|2|||
25273875|NCT01203072|50588006|FG003|Overall Study|Adverse Event|4|||
25273876|NCT01203072|50588007|FG004|Overall Study|Adverse Event|2|||
25273877|NCT01203072|50588003|FG000|Overall Study|Lack of Efficacy|1|||
25273878|NCT01203072|50588004|FG001|Overall Study|Lack of Efficacy|0|||
25273879|NCT01203072|50588005|FG002|Overall Study|Lack of Efficacy|0|||
25273880|NCT01203072|50588006|FG003|Overall Study|Lack of Efficacy|0|||
25138623|NCT01621802|50251835|FG001|Overall Study|Withdrawal by Subject|4|||
25179075|NCT01693562|50324407|FG021|Exploration Phase|Death|0|||
25179076|NCT01693562|50324408|FG022|Exploration Phase|Death|0|||
25273881|NCT01203072|50588007|FG004|Overall Study|Lack of Efficacy|0|||
25273882|NCT01203072|50588003|FG000|Overall Study|Lost to Follow-up|0|||
25273883|NCT01203072|50588004|FG001|Overall Study|Lost to Follow-up|1|||
25179077|NCT01693562|50324386|FG000|Exploration Phase|Other|0|||
25138624|NCT01621802|50251836|FG002|Overall Study|Withdrawal by Subject|4|||
25138625|NCT01621802|50251837|FG003|Overall Study|Withdrawal by Subject|2|||
25138626|NCT01621802|50251838|FG004|Overall Study|Withdrawal by Subject|2|||
25138627|NCT01621802|50251839|FG005|Overall Study|Withdrawal by Subject|0|||
25138628|NCT01621802|50251834|FG000|Overall Study|Migrated/moved from study area|0|||
25138629|NCT01621802|50251835|FG001|Overall Study|Migrated/moved from study area|0|||
25138630|NCT01621802|50251836|FG002|Overall Study|Migrated/moved from study area|2|||
25138631|NCT01621802|50251837|FG003|Overall Study|Migrated/moved from study area|0|||
25138632|NCT01621802|50251838|FG004|Overall Study|Migrated/moved from study area|1|||
25138633|NCT01621802|50251839|FG005|Overall Study|Migrated/moved from study area|0|||
25138634|NCT01621802|50251834|FG000|Overall Study|Others|3|||
25138635|NCT01621802|50251835|FG001|Overall Study|Others|3|||
25138636|NCT01621802|50251836|FG002|Overall Study|Others|3|||
25138637|NCT01621802|50251837|FG003|Overall Study|Others|2|||
25138638|NCT01621802|50251838|FG004|Overall Study|Others|1|||
25138639|NCT01621802|50251839|FG005|Overall Study|Others|0|||
25138640|NCT01621802|50251834|FG000|Overall Study|Lost to Follow-up|36|||
25138641|NCT01621802|50251835|FG001|Overall Study|Lost to Follow-up|16|||
25179078|NCT01693562|50324387|FG001|Exploration Phase|Other|0|||
25138642|NCT01621802|50251836|FG002|Overall Study|Lost to Follow-up|24|||
25138643|NCT01621802|50251837|FG003|Overall Study|Lost to Follow-up|7|||
25138644|NCT01621802|50251838|FG004|Overall Study|Lost to Follow-up|31|||
25138645|NCT01621802|50251839|FG005|Overall Study|Lost to Follow-up|11|||
25138646|NCT02059291|50251865|FG000|Epoch 2|Lack of Efficacy|0|||
25138647|NCT02059291|50251866|FG001|Epoch 2|Lack of Efficacy|0|||
25138648|NCT02059291|50251867|FG002|Epoch 2|Lack of Efficacy|0|||
25179079|NCT01693562|50324388|FG002|Exploration Phase|Other|0|||
25179080|NCT01693562|50324389|FG003|Exploration Phase|Other|0|||
25138649|NCT02059291|50251868|FG003|Epoch 2|Lack of Efficacy|1|||
25138650|NCT02059291|50251869|FG004|Epoch 2|Lack of Efficacy|0|||
25138651|NCT02059291|50251870|FG005|Epoch 2|Lack of Efficacy|1|||
25138652|NCT02059291|50251871|FG006|Epoch 2|Lack of Efficacy|0|||
25138653|NCT02059291|50251872|FG007|Epoch 2|Lack of Efficacy|0|||
25138654|NCT02059291|50251873|FG008|Epoch 2|Lack of Efficacy|0|||
25138655|NCT02059291|50251874|FG009|Epoch 2|Lack of Efficacy|0|||
25138656|NCT02059291|50251875|FG010|Epoch 2|Lack of Efficacy|0|||
25138657|NCT02059291|50251876|FG011|Epoch 2|Lack of Efficacy|0|||
25138658|NCT02059291|50251877|FG012|Epoch 2|Lack of Efficacy|0|||
25138659|NCT02059291|50251878|FG013|Epoch 2|Lack of Efficacy|0|||
25138660|NCT02059291|50251879|FG014|Epoch 2|Lack of Efficacy|0|||
25138661|NCT02059291|50251880|FG015|Epoch 2|Lack of Efficacy|0|||
25138662|NCT02059291|50251881|FG016|Epoch 2|Lack of Efficacy|0|||
25138663|NCT02059291|50251882|FG017|Epoch 2|Lack of Efficacy|0|||
25138664|NCT02059291|50251883|FG018|Epoch 2|Lack of Efficacy|0|||
25138665|NCT02059291|50251884|FG019|Epoch 2|Lack of Efficacy|0|||
25138666|NCT02059291|50251885|FG020|Epoch 2|Lack of Efficacy|0|||
25138667|NCT02059291|50251886|FG021|Epoch 2|Lack of Efficacy|0|||
25138668|NCT02059291|50251887|FG022|Epoch 2|Lack of Efficacy|0|||
25138669|NCT02059291|50251888|FG023|Epoch 2|Lack of Efficacy|0|||
25138670|NCT02059291|50251889|FG024|Epoch 2|Lack of Efficacy|0|||
25138671|NCT02059291|50251865|FG000|Epoch 2|Adverse Event|0|||
25138672|NCT02059291|50251866|FG001|Epoch 2|Adverse Event|0|||
25138673|NCT02059291|50251867|FG002|Epoch 2|Adverse Event|1|||
25138674|NCT02059291|50251868|FG003|Epoch 2|Adverse Event|1|||
25138675|NCT02059291|50251869|FG004|Epoch 2|Adverse Event|0|||
25138676|NCT02059291|50251870|FG005|Epoch 2|Adverse Event|0|||
25138677|NCT02059291|50251871|FG006|Epoch 2|Adverse Event|0|||
25138678|NCT02059291|50251872|FG007|Epoch 2|Adverse Event|1|||
25138679|NCT02059291|50251873|FG008|Epoch 2|Adverse Event|1|||
25138680|NCT02059291|50251874|FG009|Epoch 2|Adverse Event|0|||
25138681|NCT02059291|50251875|FG010|Epoch 2|Adverse Event|0|||
25138682|NCT02059291|50251876|FG011|Epoch 2|Adverse Event|0|||
25138683|NCT02059291|50251877|FG012|Epoch 2|Adverse Event|0|||
25138684|NCT02059291|50251878|FG013|Epoch 2|Adverse Event|0|||
25009783|NCT02951988|50102704|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
25138685|NCT02059291|50251879|FG014|Epoch 2|Adverse Event|0|||
25138686|NCT02059291|50251880|FG015|Epoch 2|Adverse Event|0|||
25138687|NCT02059291|50251881|FG016|Epoch 2|Adverse Event|0|||
25009784|NCT02951988|50102705|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
25009785|NCT02951988|50102706|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
25009786|NCT02951988|50102707|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
25009787|NCT02951988|50102704|FG000|Double-Blind Treatment Period|Pregnancy|0|||
25009788|NCT02951988|50102705|FG001|Double-Blind Treatment Period|Pregnancy|1|||
25009789|NCT02951988|50102706|FG002|Double-Blind Treatment Period|Pregnancy|1|||
25009790|NCT02951988|50102707|FG003|Double-Blind Treatment Period|Pregnancy|0|||
25009791|NCT02951988|50102704|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
25009792|NCT02951988|50102705|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
25009793|NCT02951988|50102706|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
25009794|NCT02951988|50102707|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
25009795|NCT02951988|50102704|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
25009796|NCT02951988|50102705|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
25009797|NCT02951988|50102706|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
25009798|NCT02951988|50102707|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
25009799|NCT02951988|50102704|FG000|Double-Blind Treatment Period|Adverse Event|0|||
25009800|NCT02951988|50102705|FG001|Double-Blind Treatment Period|Adverse Event|8|||
25009801|NCT02951988|50102706|FG002|Double-Blind Treatment Period|Adverse Event|3|||
25009802|NCT02951988|50102707|FG003|Double-Blind Treatment Period|Adverse Event|6|||
25009803|NCT02951988|50102704|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
25009804|NCT02951988|50102705|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
25009805|NCT02951988|50102706|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
25009806|NCT02951988|50102707|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
25009807|NCT00009737|50102719|FG000|Overall Study|Adverse Event|112|||
25009808|NCT00009737|50102720|FG001|Overall Study|Adverse Event|75|||
25009809|NCT00009737|50102719|FG000|Overall Study|Death|4|||
25009810|NCT00009737|50102720|FG001|Overall Study|Death|6|||
25009811|NCT00009737|50102719|FG000|Overall Study|Lack of Efficacy|17|||
25009812|NCT00009737|50102720|FG001|Overall Study|Lack of Efficacy|15|||
25009813|NCT00009737|50102719|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
25009814|NCT00009737|50102720|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
25009815|NCT00009737|50102719|FG000|Overall Study|Other Protocol Violation|1|||
25009816|NCT00009737|50102720|FG001|Overall Study|Other Protocol Violation|0|||
25009817|NCT00009737|50102719|FG000|Overall Study|Refused Treatment|15|||
25009818|NCT00009737|50102720|FG001|Overall Study|Refused Treatment|16|||
25009819|NCT00009737|50102719|FG000|Overall Study|Lost to Follow-up|1|||
25009820|NCT00009737|50102720|FG001|Overall Study|Lost to Follow-up|1|||
25009821|NCT00009737|50102719|FG000|Overall Study|Administrative/Other Reasons|7|||
25009822|NCT00009737|50102720|FG001|Overall Study|Administrative/Other Reasons|1|||
25009823|NCT03417102|50102728|FG000|Overall Study|Adverse Event|0|||
25009824|NCT03417102|50102729|FG001|Overall Study|Adverse Event|1|||
25009825|NCT03417102|50102728|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
25009826|NCT03417102|50102729|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
25179081|NCT01693562|50324390|FG004|Exploration Phase|Other|0|||
25179082|NCT01693562|50324391|FG005|Exploration Phase|Other|0|||
25009827|NCT03417102|50102728|FG000|Overall Study|Other|0|||
25179083|NCT01693562|50324392|FG006|Exploration Phase|Other|2|||
25009828|NCT03417102|50102729|FG001|Overall Study|Other|1|||
25009829|NCT03417024|50102735|FG000|Overall Study|Study Termination prior to follow-up|11|||
25009830|NCT03417024|50102735|FG000|Overall Study|Physician Decision|2|||
25009831|NCT00028769|50102739|FG000|Overall Study|Adverse Event|2|||
25138688|NCT02059291|50251882|FG017|Epoch 2|Adverse Event|0|||
25138689|NCT02059291|50251883|FG018|Epoch 2|Adverse Event|0|||
25138690|NCT02059291|50251884|FG019|Epoch 2|Adverse Event|0|||
25138691|NCT02059291|50251885|FG020|Epoch 2|Adverse Event|0|||
25138692|NCT02059291|50251886|FG021|Epoch 2|Adverse Event|0|||
25009832|NCT00028769|50102739|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
25009833|NCT00028769|50102739|FG000|Overall Study|Progression or Death|31|||
25009834|NCT00028769|50102739|FG000|Overall Study|Other - Not Protocol Specified|1|||
25009835|NCT00028769|50102739|FG000|Overall Study|Ineligible|5|||
25009836|NCT00028769|50102739|FG000|Overall Study|Not Analyzable|1|||
25009837|NCT02953314|50102745|FG000|Overall Study|Adverse Event|0|||
25009838|NCT02953314|50102746|FG001|Overall Study|Adverse Event|1|||
25009839|NCT02953314|50102745|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
25009840|NCT02953314|50102746|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
25009841|NCT03402750|50102754|FG000|Overall Study|Lost to Follow-up|2|||
25009842|NCT03402750|50102755|FG001|Overall Study|Lost to Follow-up|1|||
25009843|NCT00007475|50102764|FG000|Overall Study|Withdrawal by Subject|1|||
25009844|NCT00007475|50102765|FG001|Overall Study|Withdrawal by Subject|0|||
25009845|NCT00007475|50102766|FG002|Overall Study|Withdrawal by Subject|0|||
25009846|NCT00007475|50102767|FG003|Overall Study|Withdrawal by Subject|0|||
25138693|NCT02059291|50251887|FG022|Epoch 2|Adverse Event|0|||
25138694|NCT02059291|50251888|FG023|Epoch 2|Adverse Event|0|||
25138695|NCT02059291|50251889|FG024|Epoch 2|Adverse Event|0|||
25138696|NCT02059291|50251865|FG000|Epoch 2|Withdrawal by Subject|0|||
25138697|NCT02059291|50251866|FG001|Epoch 2|Withdrawal by Subject|1|||
25138698|NCT02059291|50251867|FG002|Epoch 2|Withdrawal by Subject|0|||
25138699|NCT02059291|50251868|FG003|Epoch 2|Withdrawal by Subject|0|||
25138700|NCT02059291|50251869|FG004|Epoch 2|Withdrawal by Subject|0|||
25138701|NCT02059291|50251870|FG005|Epoch 2|Withdrawal by Subject|1|||
25138702|NCT02059291|50251871|FG006|Epoch 2|Withdrawal by Subject|0|||
25138703|NCT02059291|50251872|FG007|Epoch 2|Withdrawal by Subject|0|||
25138704|NCT02059291|50251873|FG008|Epoch 2|Withdrawal by Subject|1|||
25009847|NCT00007475|50102764|FG000|Overall Study|Adverse Event|3|||
25009848|NCT00007475|50102765|FG001|Overall Study|Adverse Event|0|||
25138705|NCT02059291|50251874|FG009|Epoch 2|Withdrawal by Subject|0|||
25138706|NCT02059291|50251875|FG010|Epoch 2|Withdrawal by Subject|0|||
25138707|NCT02059291|50251876|FG011|Epoch 2|Withdrawal by Subject|0|||
25138708|NCT02059291|50251877|FG012|Epoch 2|Withdrawal by Subject|0|||
25138709|NCT02059291|50251878|FG013|Epoch 2|Withdrawal by Subject|0|||
25138710|NCT02059291|50251879|FG014|Epoch 2|Withdrawal by Subject|0|||
25138711|NCT02059291|50251880|FG015|Epoch 2|Withdrawal by Subject|0|||
25138712|NCT02059291|50251881|FG016|Epoch 2|Withdrawal by Subject|0|||
25138713|NCT02059291|50251882|FG017|Epoch 2|Withdrawal by Subject|0|||
25138714|NCT02059291|50251883|FG018|Epoch 2|Withdrawal by Subject|0|||
25138715|NCT02059291|50251884|FG019|Epoch 2|Withdrawal by Subject|0|||
25138716|NCT02059291|50251885|FG020|Epoch 2|Withdrawal by Subject|0|||
25138717|NCT02059291|50251886|FG021|Epoch 2|Withdrawal by Subject|0|||
25138718|NCT02059291|50251887|FG022|Epoch 2|Withdrawal by Subject|0|||
25138719|NCT02059291|50251888|FG023|Epoch 2|Withdrawal by Subject|0|||
25138720|NCT02059291|50251889|FG024|Epoch 2|Withdrawal by Subject|0|||
25138721|NCT02059291|50251865|FG000|Epoch 3|Physician Decision|0|||
25138722|NCT02059291|50251866|FG001|Epoch 3|Physician Decision|0|||
25138723|NCT02059291|50251867|FG002|Epoch 3|Physician Decision|0|||
25138724|NCT02059291|50251868|FG003|Epoch 3|Physician Decision|0|||
25138725|NCT02059291|50251869|FG004|Epoch 3|Physician Decision|0|||
25138726|NCT02059291|50251870|FG005|Epoch 3|Physician Decision|0|||
25138727|NCT02059291|50251871|FG006|Epoch 3|Physician Decision|0|||
25138728|NCT02059291|50251872|FG007|Epoch 3|Physician Decision|0|||
25138729|NCT02059291|50251873|FG008|Epoch 3|Physician Decision|0|||
25138730|NCT02059291|50251874|FG009|Epoch 3|Physician Decision|0|||
25138731|NCT02059291|50251875|FG010|Epoch 3|Physician Decision|0|||
25138732|NCT02059291|50251876|FG011|Epoch 3|Physician Decision|0|||
25138733|NCT02059291|50251877|FG012|Epoch 3|Physician Decision|0|||
25138734|NCT02059291|50251878|FG013|Epoch 3|Physician Decision|1|||
25138735|NCT02059291|50251879|FG014|Epoch 3|Physician Decision|0|||
25138736|NCT02059291|50251880|FG015|Epoch 3|Physician Decision|1|||
25138737|NCT02059291|50251881|FG016|Epoch 3|Physician Decision|0|||
25138738|NCT02059291|50251882|FG017|Epoch 3|Physician Decision|0|||
25138739|NCT02059291|50251883|FG018|Epoch 3|Physician Decision|0|||
25138740|NCT02059291|50251884|FG019|Epoch 3|Physician Decision|0|||
25138741|NCT02059291|50251885|FG020|Epoch 3|Physician Decision|0|||
25138742|NCT02059291|50251886|FG021|Epoch 3|Physician Decision|0|||
25138743|NCT02059291|50251887|FG022|Epoch 3|Physician Decision|0|||
25138744|NCT02059291|50251888|FG023|Epoch 3|Physician Decision|0|||
25138745|NCT02059291|50251889|FG024|Epoch 3|Physician Decision|0|||
25138746|NCT02059291|50251865|FG000|Epoch 3|Adverse Event|0|||
25138747|NCT02059291|50251866|FG001|Epoch 3|Adverse Event|0|||
25138748|NCT02059291|50251867|FG002|Epoch 3|Adverse Event|0|||
25138749|NCT02059291|50251868|FG003|Epoch 3|Adverse Event|0|||
25138750|NCT02059291|50251869|FG004|Epoch 3|Adverse Event|0|||
25138751|NCT02059291|50251870|FG005|Epoch 3|Adverse Event|0|||
25138752|NCT02059291|50251871|FG006|Epoch 3|Adverse Event|0|||
25138753|NCT02059291|50251872|FG007|Epoch 3|Adverse Event|0|||
25138754|NCT02059291|50251873|FG008|Epoch 3|Adverse Event|0|||
25138755|NCT02059291|50251874|FG009|Epoch 3|Adverse Event|0|||
25138756|NCT02059291|50251875|FG010|Epoch 3|Adverse Event|0|||
25138757|NCT02059291|50251876|FG011|Epoch 3|Adverse Event|0|||
25138758|NCT02059291|50251877|FG012|Epoch 3|Adverse Event|0|||
25138759|NCT02059291|50251878|FG013|Epoch 3|Adverse Event|0|||
25138760|NCT02059291|50251879|FG014|Epoch 3|Adverse Event|0|||
25138761|NCT02059291|50251880|FG015|Epoch 3|Adverse Event|1|||
25138762|NCT02059291|50251881|FG016|Epoch 3|Adverse Event|0|||
25138763|NCT02059291|50251882|FG017|Epoch 3|Adverse Event|0|||
25138764|NCT02059291|50251883|FG018|Epoch 3|Adverse Event|0|||
25138765|NCT02059291|50251884|FG019|Epoch 3|Adverse Event|0|||
25138766|NCT02059291|50251885|FG020|Epoch 3|Adverse Event|0|||
25138767|NCT02059291|50251886|FG021|Epoch 3|Adverse Event|0|||
25138768|NCT02059291|50251887|FG022|Epoch 3|Adverse Event|0|||
25138769|NCT02059291|50251888|FG023|Epoch 3|Adverse Event|0|||
25138770|NCT02059291|50251889|FG024|Epoch 3|Adverse Event|0|||
25138771|NCT02059291|50251865|FG000|Epoch 3|Lack of Efficacy|0|||
25138772|NCT02059291|50251866|FG001|Epoch 3|Lack of Efficacy|0|||
25138773|NCT02059291|50251867|FG002|Epoch 3|Lack of Efficacy|0|||
25009849|NCT00007475|50102766|FG002|Overall Study|Adverse Event|0|||
25138774|NCT02059291|50251868|FG003|Epoch 3|Lack of Efficacy|0|||
25138775|NCT02059291|50251869|FG004|Epoch 3|Lack of Efficacy|0|||
25138776|NCT02059291|50251870|FG005|Epoch 3|Lack of Efficacy|0|||
25138777|NCT02059291|50251871|FG006|Epoch 3|Lack of Efficacy|0|||
25138778|NCT02059291|50251872|FG007|Epoch 3|Lack of Efficacy|0|||
25138779|NCT02059291|50251873|FG008|Epoch 3|Lack of Efficacy|0|||
25138780|NCT02059291|50251874|FG009|Epoch 3|Lack of Efficacy|0|||
25138781|NCT02059291|50251875|FG010|Epoch 3|Lack of Efficacy|0|||
25138782|NCT02059291|50251876|FG011|Epoch 3|Lack of Efficacy|0|||
25138783|NCT02059291|50251877|FG012|Epoch 3|Lack of Efficacy|0|||
25138784|NCT02059291|50251878|FG013|Epoch 3|Lack of Efficacy|0|||
25138785|NCT02059291|50251879|FG014|Epoch 3|Lack of Efficacy|0|||
25138786|NCT02059291|50251880|FG015|Epoch 3|Lack of Efficacy|3|||
25138787|NCT02059291|50251881|FG016|Epoch 3|Lack of Efficacy|0|||
25138788|NCT02059291|50251882|FG017|Epoch 3|Lack of Efficacy|0|||
25138789|NCT02059291|50251883|FG018|Epoch 3|Lack of Efficacy|0|||
25138790|NCT02059291|50251884|FG019|Epoch 3|Lack of Efficacy|0|||
25138791|NCT02059291|50251885|FG020|Epoch 3|Lack of Efficacy|0|||
25138792|NCT02059291|50251886|FG021|Epoch 3|Lack of Efficacy|0|||
25138793|NCT02059291|50251887|FG022|Epoch 3|Lack of Efficacy|0|||
25138794|NCT02059291|50251888|FG023|Epoch 3|Lack of Efficacy|0|||
25138795|NCT02059291|50251889|FG024|Epoch 3|Lack of Efficacy|0|||
25138796|NCT02059291|50251865|FG000|Epoch 3|Withdrawal by Subject|0|||
25138797|NCT02059291|50251866|FG001|Epoch 3|Withdrawal by Subject|0|||
25138798|NCT02059291|50251867|FG002|Epoch 3|Withdrawal by Subject|0|||
25138799|NCT02059291|50251868|FG003|Epoch 3|Withdrawal by Subject|0|||
25138800|NCT02059291|50251869|FG004|Epoch 3|Withdrawal by Subject|0|||
25138801|NCT02059291|50251870|FG005|Epoch 3|Withdrawal by Subject|0|||
25138802|NCT02059291|50251871|FG006|Epoch 3|Withdrawal by Subject|0|||
25138803|NCT02059291|50251872|FG007|Epoch 3|Withdrawal by Subject|0|||
25138804|NCT02059291|50251873|FG008|Epoch 3|Withdrawal by Subject|0|||
25138805|NCT02059291|50251874|FG009|Epoch 3|Withdrawal by Subject|0|||
25138806|NCT02059291|50251875|FG010|Epoch 3|Withdrawal by Subject|0|||
25138807|NCT02059291|50251876|FG011|Epoch 3|Withdrawal by Subject|0|||
25138808|NCT02059291|50251877|FG012|Epoch 3|Withdrawal by Subject|0|||
25138809|NCT02059291|50251878|FG013|Epoch 3|Withdrawal by Subject|0|||
25138810|NCT02059291|50251879|FG014|Epoch 3|Withdrawal by Subject|0|||
25138811|NCT02059291|50251880|FG015|Epoch 3|Withdrawal by Subject|1|||
25138812|NCT02059291|50251881|FG016|Epoch 3|Withdrawal by Subject|0|||
25138813|NCT02059291|50251882|FG017|Epoch 3|Withdrawal by Subject|0|||
25138814|NCT02059291|50251883|FG018|Epoch 3|Withdrawal by Subject|0|||
25138815|NCT02059291|50251884|FG019|Epoch 3|Withdrawal by Subject|0|||
25138816|NCT02059291|50251885|FG020|Epoch 3|Withdrawal by Subject|0|||
25138817|NCT02059291|50251886|FG021|Epoch 3|Withdrawal by Subject|0|||
25138818|NCT02059291|50251887|FG022|Epoch 3|Withdrawal by Subject|0|||
25138819|NCT02059291|50251888|FG023|Epoch 3|Withdrawal by Subject|0|||
25138820|NCT02059291|50251889|FG024|Epoch 3|Withdrawal by Subject|0|||
25138821|NCT02059291|50251865|FG000|Epoch 4|Adverse Event|0|||
25138822|NCT02059291|50251866|FG001|Epoch 4|Adverse Event|0|||
25138823|NCT02059291|50251867|FG002|Epoch 4|Adverse Event|0|||
25138824|NCT02059291|50251868|FG003|Epoch 4|Adverse Event|0|||
25138825|NCT02059291|50251869|FG004|Epoch 4|Adverse Event|0|||
25138826|NCT02059291|50251870|FG005|Epoch 4|Adverse Event|0|||
25138827|NCT02059291|50251871|FG006|Epoch 4|Adverse Event|0|||
25138828|NCT02059291|50251872|FG007|Epoch 4|Adverse Event|0|||
25138829|NCT02059291|50251873|FG008|Epoch 4|Adverse Event|0|||
25138830|NCT02059291|50251874|FG009|Epoch 4|Adverse Event|0|||
25179084|NCT01693562|50324393|FG007|Exploration Phase|Other|0|||
25179085|NCT01693562|50324394|FG008|Exploration Phase|Other|0|||
25179086|NCT01693562|50324395|FG009|Exploration Phase|Other|0|||
25179087|NCT01693562|50324396|FG010|Exploration Phase|Other|0|||
25179088|NCT01693562|50324397|FG011|Exploration Phase|Other|0|||
25179089|NCT01693562|50324398|FG012|Exploration Phase|Other|0|||
25179090|NCT01693562|50324399|FG013|Exploration Phase|Other|0|||
25179091|NCT01693562|50324400|FG014|Exploration Phase|Other|0|||
25179092|NCT01693562|50324401|FG015|Exploration Phase|Other|0|||
25009850|NCT00007475|50102767|FG003|Overall Study|Adverse Event|0|||
25009851|NCT00025883|50102779|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
25009852|NCT00025883|50102779|FG000|Overall Study|no baseline data|1|||
25009853|NCT00025883|50102779|FG000|Overall Study|Death|1|||
25009854|NCT00025883|50102779|FG000|Overall Study|Adverse Event|1|||
25009855|NCT00025883|50102779|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
25009856|NCT00072293|50102786|FG000|Overall Study|Lost to Follow-up|1|||
25009857|NCT00072293|50102787|FG001|Overall Study|Lost to Follow-up|1|||
25009858|NCT00072293|50102786|FG000|Overall Study|Withdrawal by Subject|0|||
25009859|NCT00072293|50102787|FG001|Overall Study|Withdrawal by Subject|1|||
25009860|NCT03753763|50102795|FG000|Overall Study|Adverse Event|2|||
25138831|NCT02059291|50251875|FG010|Epoch 4|Adverse Event|0|||
25179093|NCT01693562|50324402|FG016|Exploration Phase|Other|0|||
25179094|NCT01693562|50324403|FG017|Exploration Phase|Other|0|||
25179095|NCT01693562|50324404|FG018|Exploration Phase|Other|0|||
25138832|NCT02059291|50251876|FG011|Epoch 4|Adverse Event|0|||
25179096|NCT01693562|50324405|FG019|Exploration Phase|Other|0|||
25179097|NCT01693562|50324406|FG020|Exploration Phase|Other|0|||
25138833|NCT02059291|50251877|FG012|Epoch 4|Adverse Event|0|||
25138834|NCT02059291|50251878|FG013|Epoch 4|Adverse Event|0|||
25138835|NCT02059291|50251879|FG014|Epoch 4|Adverse Event|0|||
25138836|NCT02059291|50251880|FG015|Epoch 4|Adverse Event|0|||
25138837|NCT02059291|50251881|FG016|Epoch 4|Adverse Event|1|||
25009861|NCT03753763|50102796|FG001|Overall Study|Adverse Event|0|||
25009862|NCT03753763|50102795|FG000|Overall Study|Withdrawal by Subject|3|||
25009863|NCT03753763|50102796|FG001|Overall Study|Withdrawal by Subject|1|||
25009864|NCT03753763|50102795|FG000|Overall Study|clinical deterioration|1|||
25009865|NCT03753763|50102796|FG001|Overall Study|clinical deterioration|0|||
25138838|NCT02059291|50251882|FG017|Epoch 4|Adverse Event|0|||
25138839|NCT02059291|50251883|FG018|Epoch 4|Adverse Event|0|||
25138840|NCT02059291|50251884|FG019|Epoch 4|Adverse Event|0|||
25138841|NCT02059291|50251885|FG020|Epoch 4|Adverse Event|0|||
25138842|NCT02059291|50251886|FG021|Epoch 4|Adverse Event|0|||
25138843|NCT02059291|50251887|FG022|Epoch 4|Adverse Event|1|||
25273884|NCT01203072|50588005|FG002|Overall Study|Lost to Follow-up|0|||
25273885|NCT01203072|50588006|FG003|Overall Study|Lost to Follow-up|0|||
25273886|NCT01203072|50588007|FG004|Overall Study|Lost to Follow-up|0|||
25273887|NCT01203072|50588003|FG000|Overall Study|Protocol Violation|2|||
25273888|NCT01203072|50588004|FG001|Overall Study|Protocol Violation|0|||
25273889|NCT01203072|50588005|FG002|Overall Study|Protocol Violation|0|||
25273890|NCT01203072|50588006|FG003|Overall Study|Protocol Violation|0|||
25273891|NCT01203072|50588007|FG004|Overall Study|Protocol Violation|1|||
25273892|NCT01203072|50588003|FG000|Overall Study|Withdrawal by Subject|2|||
25273893|NCT01203072|50588004|FG001|Overall Study|Withdrawal by Subject|2|||
25273894|NCT01203072|50588005|FG002|Overall Study|Withdrawal by Subject|1|||
25273895|NCT01203072|50588006|FG003|Overall Study|Withdrawal by Subject|2|||
25273896|NCT01203072|50588007|FG004|Overall Study|Withdrawal by Subject|3|||
25138844|NCT02059291|50251888|FG023|Epoch 4|Adverse Event|0|||
25138845|NCT02059291|50251889|FG024|Epoch 4|Adverse Event|0|||
25273897|NCT01105377|50588021|FG000|Overall Study|Withdrawal by Subject|0|||
25273898|NCT01105377|50588022|FG001|Overall Study|Withdrawal by Subject|1|||
25273899|NCT01105065|50588028|FG000|Overall Study|Adverse Event|5|||
25273900|NCT01105065|50588028|FG000|Overall Study|Technical Problems|1|||
25138846|NCT02059291|50251865|FG000|Epoch 4|Pregnancy|0|||
25138847|NCT02059291|50251866|FG001|Epoch 4|Pregnancy|0|||
25138848|NCT02059291|50251867|FG002|Epoch 4|Pregnancy|0|||
25138849|NCT02059291|50251868|FG003|Epoch 4|Pregnancy|0|||
25138850|NCT02059291|50251869|FG004|Epoch 4|Pregnancy|0|||
25138851|NCT02059291|50251870|FG005|Epoch 4|Pregnancy|0|||
25138852|NCT02059291|50251871|FG006|Epoch 4|Pregnancy|0|||
25138853|NCT02059291|50251872|FG007|Epoch 4|Pregnancy|0|||
25138854|NCT02059291|50251873|FG008|Epoch 4|Pregnancy|0|||
25138855|NCT02059291|50251874|FG009|Epoch 4|Pregnancy|0|||
25138856|NCT02059291|50251875|FG010|Epoch 4|Pregnancy|0|||
25138857|NCT02059291|50251876|FG011|Epoch 4|Pregnancy|0|||
25138858|NCT02059291|50251877|FG012|Epoch 4|Pregnancy|0|||
25138859|NCT02059291|50251878|FG013|Epoch 4|Pregnancy|0|||
25009866|NCT03384966|50102805|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
25009867|NCT03384966|50102806|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
25009868|NCT03384966|50102807|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
25009869|NCT03384966|50102805|FG000|Follow-up Period|Adverse Event|1|||
25009870|NCT03384966|50102806|FG001|Follow-up Period|Adverse Event|0|||
25009871|NCT03384966|50102807|FG002|Follow-up Period|Adverse Event|0|||
25009872|NCT03402126|50102824|FG000|Overall Study|Lost to Follow-up|6|||
25009873|NCT03402126|50102824|FG000|Overall Study|Protocol Violation|10|||
25009874|NCT03402126|50102824|FG000|Overall Study|Sponsor request/Study termination|29|||
25009875|NCT03402126|50102824|FG000|Overall Study|Study product no longer in use|1|||
25009876|NCT03402126|50102824|FG000|Overall Study|Technical problems|1|||
25009877|NCT03402126|50102824|FG000|Overall Study|Withdrawal by Subject|6|||
25009878|NCT03402126|50102824|FG000|Overall Study|Physician Decision|2|||
25009879|NCT03402126|50102824|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
25009880|NCT03402126|50102824|FG000|Overall Study|Death|4|||
25009881|NCT03355326|50102830|FG000|Overall Study|Protocol Violation|3|||
25009882|NCT03355326|50102831|FG001|Overall Study|Protocol Violation|3|||
25009883|NCT03353220|50102837|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
25009884|NCT03353220|50102838|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
25009885|NCT03751657|50102846|FG000|Overall Study|Physician Decision|0|||
25009886|NCT03751657|50102847|FG001|Overall Study|Physician Decision|1|||
25009887|NCT03751657|50102846|FG000|Overall Study|Withdrawal by Subject|1|||
25138860|NCT02059291|50251879|FG014|Epoch 4|Pregnancy|0|||
25009888|NCT03751657|50102847|FG001|Overall Study|Withdrawal by Subject|1|||
25009889|NCT03751657|50102846|FG000|Overall Study|Lost to Follow-up|2|||
25009890|NCT03751657|50102847|FG001|Overall Study|Lost to Follow-up|1|||
25138861|NCT02059291|50251880|FG015|Epoch 4|Pregnancy|0|||
25138862|NCT02059291|50251881|FG016|Epoch 4|Pregnancy|1|||
25138863|NCT02059291|50251882|FG017|Epoch 4|Pregnancy|0|||
25138864|NCT02059291|50251883|FG018|Epoch 4|Pregnancy|0|||
25138865|NCT02059291|50251884|FG019|Epoch 4|Pregnancy|0|||
25138866|NCT02059291|50251885|FG020|Epoch 4|Pregnancy|0|||
25138867|NCT02059291|50251886|FG021|Epoch 4|Pregnancy|0|||
25138868|NCT02059291|50251887|FG022|Epoch 4|Pregnancy|0|||
25138869|NCT02059291|50251888|FG023|Epoch 4|Pregnancy|0|||
25138870|NCT02059291|50251889|FG024|Epoch 4|Pregnancy|0|||
25138871|NCT02059291|50251865|FG000|Epoch 4|Withdrawal by Subject|0|||
25138872|NCT02059291|50251866|FG001|Epoch 4|Withdrawal by Subject|0|||
25138873|NCT02059291|50251867|FG002|Epoch 4|Withdrawal by Subject|0|||
25138874|NCT02059291|50251868|FG003|Epoch 4|Withdrawal by Subject|0|||
25138875|NCT02059291|50251869|FG004|Epoch 4|Withdrawal by Subject|0|||
25138876|NCT02059291|50251870|FG005|Epoch 4|Withdrawal by Subject|0|||
25138877|NCT02059291|50251871|FG006|Epoch 4|Withdrawal by Subject|0|||
25138878|NCT02059291|50251872|FG007|Epoch 4|Withdrawal by Subject|0|||
25138879|NCT02059291|50251873|FG008|Epoch 4|Withdrawal by Subject|0|||
25138880|NCT02059291|50251874|FG009|Epoch 4|Withdrawal by Subject|0|||
25138881|NCT02059291|50251875|FG010|Epoch 4|Withdrawal by Subject|0|||
25138882|NCT02059291|50251876|FG011|Epoch 4|Withdrawal by Subject|0|||
25138883|NCT02059291|50251877|FG012|Epoch 4|Withdrawal by Subject|0|||
25138884|NCT02059291|50251878|FG013|Epoch 4|Withdrawal by Subject|0|||
25138885|NCT02059291|50251879|FG014|Epoch 4|Withdrawal by Subject|0|||
25138886|NCT02059291|50251880|FG015|Epoch 4|Withdrawal by Subject|0|||
25138887|NCT02059291|50251881|FG016|Epoch 4|Withdrawal by Subject|0|||
25138888|NCT02059291|50251882|FG017|Epoch 4|Withdrawal by Subject|0|||
25138889|NCT02059291|50251883|FG018|Epoch 4|Withdrawal by Subject|0|||
25138890|NCT02059291|50251884|FG019|Epoch 4|Withdrawal by Subject|0|||
25138891|NCT02059291|50251885|FG020|Epoch 4|Withdrawal by Subject|1|||
25138892|NCT02059291|50251886|FG021|Epoch 4|Withdrawal by Subject|0|||
25138893|NCT02059291|50251887|FG022|Epoch 4|Withdrawal by Subject|0|||
25138894|NCT02059291|50251888|FG023|Epoch 4|Withdrawal by Subject|0|||
25138895|NCT02059291|50251889|FG024|Epoch 4|Withdrawal by Subject|0|||
25138896|NCT02059291|50251865|FG000|Epoch 4|Lack of Efficacy|0|||
25138897|NCT02059291|50251866|FG001|Epoch 4|Lack of Efficacy|0|||
25138898|NCT02059291|50251867|FG002|Epoch 4|Lack of Efficacy|0|||
25138899|NCT02059291|50251868|FG003|Epoch 4|Lack of Efficacy|0|||
25138900|NCT02059291|50251869|FG004|Epoch 4|Lack of Efficacy|0|||
25138901|NCT02059291|50251870|FG005|Epoch 4|Lack of Efficacy|0|||
25138902|NCT02059291|50251871|FG006|Epoch 4|Lack of Efficacy|0|||
25138903|NCT02059291|50251872|FG007|Epoch 4|Lack of Efficacy|0|||
25138904|NCT02059291|50251873|FG008|Epoch 4|Lack of Efficacy|0|||
25138905|NCT02059291|50251874|FG009|Epoch 4|Lack of Efficacy|0|||
25138906|NCT02059291|50251875|FG010|Epoch 4|Lack of Efficacy|0|||
25138907|NCT02059291|50251876|FG011|Epoch 4|Lack of Efficacy|0|||
25138908|NCT02059291|50251877|FG012|Epoch 4|Lack of Efficacy|0|||
25138909|NCT02059291|50251878|FG013|Epoch 4|Lack of Efficacy|0|||
25138910|NCT02059291|50251879|FG014|Epoch 4|Lack of Efficacy|0|||
25138911|NCT02059291|50251880|FG015|Epoch 4|Lack of Efficacy|0|||
25138912|NCT02059291|50251881|FG016|Epoch 4|Lack of Efficacy|0|||
25138913|NCT02059291|50251882|FG017|Epoch 4|Lack of Efficacy|0|||
25138914|NCT02059291|50251883|FG018|Epoch 4|Lack of Efficacy|0|||
25138915|NCT02059291|50251884|FG019|Epoch 4|Lack of Efficacy|0|||
25138916|NCT02059291|50251885|FG020|Epoch 4|Lack of Efficacy|0|||
25138917|NCT02059291|50251886|FG021|Epoch 4|Lack of Efficacy|0|||
25138918|NCT02059291|50251887|FG022|Epoch 4|Lack of Efficacy|0|||
25138919|NCT02059291|50251888|FG023|Epoch 4|Lack of Efficacy|1|||
25138920|NCT02059291|50251889|FG024|Epoch 4|Lack of Efficacy|0|||
25138921|NCT02042924|50251917|FG000|Overall Study|Early Death|1|||
25138922|NCT02041520|50251923|FG000|Overall Study|Adverse Event|2|||
25138923|NCT02041520|50251924|FG001|Overall Study|Adverse Event|1|||
25138924|NCT02041520|50251923|FG000|Overall Study|Withdrawal by Subject|3|||
25138925|NCT02041520|50251924|FG001|Overall Study|Withdrawal by Subject|4|||
25138926|NCT02041520|50251923|FG000|Overall Study|Protocol Violation|1|||
25138927|NCT02041520|50251924|FG001|Overall Study|Protocol Violation|0|||
25138928|NCT02041520|50251923|FG000|Overall Study|Lost to Follow-up|0|||
25138929|NCT02041520|50251924|FG001|Overall Study|Lost to Follow-up|1|||
25138930|NCT02041520|50251923|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
25138931|NCT02041520|50251924|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
25138932|NCT02041429|50251936|FG000|Overall Study|Progressive Disease|2|||
25138933|NCT02041429|50251937|FG001|Overall Study|Progressive Disease|2|||
25138934|NCT02041429|50251938|FG002|Overall Study|Progressive Disease|3|||
25138935|NCT02041429|50251939|FG003|Overall Study|Progressive Disease|2|||
25138936|NCT02041429|50251936|FG000|Overall Study|Toxicity|0|||
25138937|NCT02041429|50251937|FG001|Overall Study|Toxicity|1|||
25138938|NCT02041429|50251938|FG002|Overall Study|Toxicity|4|||
25138939|NCT02041429|50251939|FG003|Overall Study|Toxicity|2|||
25138940|NCT02041429|50251936|FG000|Overall Study|Withdrawal by Subject|0|||
25138941|NCT02041429|50251937|FG001|Overall Study|Withdrawal by Subject|1|||
25138942|NCT02041429|50251938|FG002|Overall Study|Withdrawal by Subject|0|||
25138943|NCT02041429|50251939|FG003|Overall Study|Withdrawal by Subject|0|||
25138944|NCT02041429|50251936|FG000|Overall Study|On Maintenance Therapy|1|||
25138945|NCT02041429|50251937|FG001|Overall Study|On Maintenance Therapy|0|||
25138946|NCT02041429|50251938|FG002|Overall Study|On Maintenance Therapy|0|||
25138947|NCT02041429|50251939|FG003|Overall Study|On Maintenance Therapy|2|||
25138948|NCT02083783|50251956|FG000|Overall Study|Withdrawal by Subject|1|||
25138949|NCT02083783|50251957|FG001|Overall Study|Withdrawal by Subject|0|||
25138950|NCT02083081|50251967|FG000|Overall Study|Lost to Follow-up|31|||
25138951|NCT02083081|50251968|FG001|Overall Study|Lost to Follow-up|9|||
25138952|NCT02040805|50251976|FG000|Overall Study|Lost to Follow-up|14|||
25138953|NCT02040805|50251977|FG001|Overall Study|Lost to Follow-up|9|||
25009891|NCT00025259|50102860|FG000|Overall Study|Death|1|||
25009892|NCT00025259|50102861|FG001|Overall Study|Death|3|||
25009893|NCT00025259|50102862|FG002|Overall Study|Death|0|||
25009894|NCT00025259|50102863|FG003|Overall Study|Death|3|||
25009895|NCT00025259|50102864|FG004|Overall Study|Death|0|||
25009896|NCT00025259|50102865|FG005|Overall Study|Death|1|||
25009897|NCT00025259|50102866|FG006|Overall Study|Death|2|||
25009898|NCT00025259|50102860|FG000|Overall Study|Lack of Efficacy|2|||
25009899|NCT00025259|50102861|FG001|Overall Study|Lack of Efficacy|46|||
25138954|NCT02040805|50251976|FG000|Overall Study|Withdrawal by Subject|28|||
25138955|NCT02040805|50251977|FG001|Overall Study|Withdrawal by Subject|41|||
25138956|NCT02040259|50251983|FG000|Overall Study|Death|280|||
25009900|NCT00025259|50102862|FG002|Overall Study|Lack of Efficacy|60|||
25009901|NCT00025259|50102863|FG003|Overall Study|Lack of Efficacy|78|||
25138957|NCT02040259|50251983|FG000|Overall Study|Lost to Follow-up|76|||
25138958|NCT02040259|50251983|FG000|Overall Study|Assessment not completed|3|||
25138959|NCT02040259|50251983|FG000|Overall Study|Withdrawal by Subject|4|||
25138960|NCT02059135|50251991|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
25138961|NCT02059135|50251992|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
25138962|NCT02059135|50251991|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
25138963|NCT02059135|50251992|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
25138964|NCT02059135|50251991|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
25138965|NCT02059135|50251992|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
25138966|NCT02059135|50251991|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
25138967|NCT02059135|50251992|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
25273901|NCT01111539|50588034|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
25273902|NCT01111539|50588035|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
25273903|NCT01111539|50588036|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
25273904|NCT01111539|50588037|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
25273905|NCT01111539|50588038|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
25273906|NCT01111539|50588034|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
25273907|NCT01111539|50588035|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
25273908|NCT01111539|50588036|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
25273909|NCT01111539|50588037|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
25273910|NCT01111539|50588038|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
25273911|NCT01111539|50588034|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
25273912|NCT01111539|50588035|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
25273913|NCT01111539|50588036|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
25273914|NCT01111539|50588037|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
25273915|NCT01111539|50588038|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
25273916|NCT01111539|50588034|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
25009902|NCT00025259|50102864|FG004|Overall Study|Lack of Efficacy|11|||
25138968|NCT02059135|50251991|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
25138969|NCT02059135|50251992|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
25138970|NCT02059135|50251991|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
25138971|NCT02059135|50251992|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
25138972|NCT02059135|50251991|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
25179098|NCT01693562|50324407|FG021|Exploration Phase|Other|0|||
25273917|NCT01111539|50588035|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
25273918|NCT01111539|50588036|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
25273919|NCT01111539|50588037|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
25138973|NCT02059135|50251992|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
25138974|NCT02059135|50251991|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
25138975|NCT02059135|50251992|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
25138976|NCT02081677|50252004|FG000|Overall Study|Adverse Event|0|||
25138977|NCT02081677|50252005|FG001|Overall Study|Adverse Event|0|||
25138978|NCT02081677|50252006|FG002|Overall Study|Adverse Event|1|||
25138979|NCT02081677|50252007|FG003|Overall Study|Adverse Event|0|||
25138980|NCT02081677|50252004|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
25138981|NCT02081677|50252005|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
25138982|NCT02081677|50252006|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
25138983|NCT02081677|50252007|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
25009903|NCT00025259|50102865|FG005|Overall Study|Lack of Efficacy|30|||
25009904|NCT00025259|50102866|FG006|Overall Study|Lack of Efficacy|38|||
25009905|NCT00025259|50102860|FG000|Overall Study|Lost to Follow-up|2|||
25009906|NCT00025259|50102861|FG001|Overall Study|Lost to Follow-up|9|||
25009907|NCT00025259|50102862|FG002|Overall Study|Lost to Follow-up|13|||
25009908|NCT00025259|50102863|FG003|Overall Study|Lost to Follow-up|13|||
25138984|NCT02081677|50252004|FG000|Overall Study|Not comfortable with lens care system|1|||
25009909|NCT00025259|50102864|FG004|Overall Study|Lost to Follow-up|1|||
25009910|NCT00025259|50102865|FG005|Overall Study|Lost to Follow-up|3|||
25009911|NCT00025259|50102866|FG006|Overall Study|Lost to Follow-up|1|||
25009912|NCT00025259|50102860|FG000|Overall Study|Physician Decision|12|||
25009913|NCT00025259|50102861|FG001|Overall Study|Physician Decision|1|||
25138985|NCT02081677|50252005|FG001|Overall Study|Not comfortable with lens care system|0|||
25009914|NCT00025259|50102862|FG002|Overall Study|Physician Decision|0|||
25009915|NCT00025259|50102863|FG003|Overall Study|Physician Decision|5|||
25009916|NCT00025259|50102864|FG004|Overall Study|Physician Decision|4|||
25009917|NCT00025259|50102865|FG005|Overall Study|Physician Decision|2|||
25138986|NCT02081677|50252006|FG002|Overall Study|Not comfortable with lens care system|0|||
25138987|NCT02081677|50252007|FG003|Overall Study|Not comfortable with lens care system|0|||
25138988|NCT02081677|50252004|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
25138989|NCT02081677|50252005|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
25138990|NCT02081677|50252006|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
25138991|NCT02081677|50252007|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
25009918|NCT00025259|50102866|FG006|Overall Study|Physician Decision|1|||
25009919|NCT00025259|50102860|FG000|Overall Study|Protocol Violation|3|||
25009920|NCT00025259|50102861|FG001|Overall Study|Protocol Violation|2|||
25009921|NCT00025259|50102862|FG002|Overall Study|Protocol Violation|2|||
25009922|NCT00025259|50102863|FG003|Overall Study|Protocol Violation|1|||
25009923|NCT00025259|50102864|FG004|Overall Study|Protocol Violation|2|||
25009924|NCT00025259|50102865|FG005|Overall Study|Protocol Violation|1|||
25009925|NCT00025259|50102866|FG006|Overall Study|Protocol Violation|3|||
25009926|NCT00025259|50102860|FG000|Overall Study|Withdrawal by Subject|9|||
25009927|NCT00025259|50102861|FG001|Overall Study|Withdrawal by Subject|27|||
25009928|NCT00025259|50102862|FG002|Overall Study|Withdrawal by Subject|6|||
25009929|NCT00025259|50102863|FG003|Overall Study|Withdrawal by Subject|14|||
25009930|NCT00025259|50102864|FG004|Overall Study|Withdrawal by Subject|11|||
25009931|NCT00025259|50102865|FG005|Overall Study|Withdrawal by Subject|8|||
25009932|NCT00025259|50102866|FG006|Overall Study|Withdrawal by Subject|3|||
25009933|NCT00025259|50102860|FG000|Overall Study|Ineligible|14|||
25009934|NCT00025259|50102861|FG001|Overall Study|Ineligible|1|||
25009935|NCT00025259|50102862|FG002|Overall Study|Ineligible|0|||
25009936|NCT00025259|50102863|FG003|Overall Study|Ineligible|0|||
25009937|NCT00025259|50102864|FG004|Overall Study|Ineligible|6|||
25138992|NCT02038933|50252019|FG000|Overall Study|Disease progression|104|||
25009938|NCT00025259|50102865|FG005|Overall Study|Ineligible|0|||
25138993|NCT02038933|50252019|FG000|Overall Study|Study drug toxicity|6|||
25138994|NCT02038933|50252019|FG000|Overall Study|Adverse event unrelated to study drug|6|||
25009939|NCT00025259|50102866|FG006|Overall Study|Ineligible|1|||
25009940|NCT00025259|50102860|FG000|Overall Study|Randomization error|1|||
25009941|NCT00025259|50102861|FG001|Overall Study|Randomization error|0|||
25009942|NCT00025259|50102862|FG002|Overall Study|Randomization error|0|||
25138995|NCT02038933|50252019|FG000|Overall Study|Participant request to discontinue treatment|2|||
25138996|NCT02038933|50252019|FG000|Overall Study|Lost to Follow-up|1|||
25138997|NCT02038933|50252019|FG000|Overall Study|Other reasons|2|||
25138998|NCT02081599|50252026|FG000|Period 1：Double-blind Period|Adverse Event|3|||
25138999|NCT02081599|50252027|FG001|Period 1：Double-blind Period|Adverse Event|0|||
25009943|NCT00025259|50102863|FG003|Overall Study|Randomization error|0|||
25139000|NCT02081599|50252026|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
25139001|NCT02081599|50252027|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
25139002|NCT02081599|50252026|FG000|Period 1：Double-blind Period|Physician Decision|1|||
25009944|NCT00025259|50102864|FG004|Overall Study|Randomization error|1|||
25009945|NCT00025259|50102865|FG005|Overall Study|Randomization error|7|||
25009946|NCT00025259|50102866|FG006|Overall Study|Randomization error|2|||
25139003|NCT02081599|50252027|FG001|Period 1：Double-blind Period|Physician Decision|0|||
25139004|NCT02081599|50252026|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
25139005|NCT02081599|50252027|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
25139006|NCT02081599|50252026|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
25139007|NCT02081599|50252027|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
25139008|NCT02081599|50252026|FG000|Period 1：Double-blind Period|stopping criteria|1|||
25139009|NCT02081599|50252027|FG001|Period 1：Double-blind Period|stopping criteria|0|||
25139010|NCT02081599|50252026|FG000|Period 2：Open-label Period|Adverse Event|1|||
25139011|NCT02081599|50252027|FG001|Period 2：Open-label Period|Adverse Event|0|||
25139012|NCT02081599|50252026|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
25139013|NCT02081599|50252027|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
25139014|NCT02081599|50252026|FG000|Period 2：Open-label Period|Physician Decision|1|||
25139015|NCT02081599|50252027|FG001|Period 2：Open-label Period|Physician Decision|0|||
25139016|NCT02081599|50252026|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
25139017|NCT02081599|50252027|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
25139018|NCT02038543|50252039|FG000|Overall Study|Screen Failure|0|||
25139019|NCT02038543|50252040|FG001|Overall Study|Screen Failure|0|||
25009947|NCT00025259|50102860|FG000|Overall Study|Adverse Event|1|||
25009948|NCT00025259|50102861|FG001|Overall Study|Adverse Event|0|||
25139020|NCT02038543|50252041|FG002|Overall Study|Screen Failure|0|||
25139021|NCT02038543|50252042|FG003|Overall Study|Screen Failure|1|||
25139022|NCT02038543|50252039|FG000|Overall Study|Withdrawal by Subject|0|||
25139023|NCT02038543|50252040|FG001|Overall Study|Withdrawal by Subject|0|||
25139024|NCT02038543|50252041|FG002|Overall Study|Withdrawal by Subject|0|||
25139025|NCT02038543|50252042|FG003|Overall Study|Withdrawal by Subject|1|||
25139026|NCT02038153|50252052|FG000|Overall Study|Withdrawal by Subject|1|||
25139027|NCT02038075|50252058|FG000|Overall Study|Withdrawal by Subject|3|||
25009949|NCT00025259|50102862|FG002|Overall Study|Adverse Event|0|||
25009950|NCT00025259|50102863|FG003|Overall Study|Adverse Event|0|||
25009951|NCT00025259|50102864|FG004|Overall Study|Adverse Event|0|||
25009952|NCT00025259|50102865|FG005|Overall Study|Adverse Event|0|||
25009953|NCT00025259|50102866|FG006|Overall Study|Adverse Event|0|||
25139028|NCT02038075|50252059|FG001|Overall Study|Withdrawal by Subject|0|||
25139029|NCT02058589|50252067|FG000|Overall Study|Serious Adverse Event|1|||
25139030|NCT02058589|50252068|FG001|Overall Study|Serious Adverse Event|1|||
25139031|NCT02058589|50252067|FG000|Overall Study|Non-Serious Adverse Event|1|||
25009954|NCT03351738|50102891|FG000|Overall Study|Withdrawal by Subject|0|||
25009955|NCT03351738|50102892|FG001|Overall Study|Withdrawal by Subject|1|||
25009956|NCT03351738|50102893|FG002|Overall Study|Withdrawal by Subject|0|||
25009957|NCT03351738|50102894|FG003|Overall Study|Withdrawal by Subject|1|||
25009958|NCT03351738|50102895|FG004|Overall Study|Withdrawal by Subject|0|||
25009959|NCT03351738|50102896|FG005|Overall Study|Withdrawal by Subject|0|||
25009960|NCT03351114|50102915|FG000|Overall Study|Withdrawal by Subject|1|||
25009961|NCT03350256|50102919|FG000|Overall Study|Inclusion/exclusion violation|4|||
25009962|NCT03350256|50102919|FG000|Overall Study|Recommended for other therapies|2|||
25009963|NCT03350256|50102919|FG000|Overall Study|Protocol Violation|3|||
25009964|NCT03350256|50102919|FG000|Overall Study|Non compliance|2|||
25009965|NCT03350256|50102919|FG000|Overall Study|Denial by insurance|1|||
25009966|NCT03350256|50102919|FG000|Overall Study|Adverse Event|2|||
25009967|NCT03350256|50102919|FG000|Overall Study|Trial failure|12|||
25009968|NCT03350256|50102919|FG000|Overall Study|Did not proceed to permanent implant|3|||
25009969|NCT03350256|50102919|FG000|Overall Study|Withdrawal by Subject|3|||
25139032|NCT02058589|50252068|FG001|Overall Study|Non-Serious Adverse Event|0|||
25139033|NCT02058589|50252067|FG000|Overall Study|Withdrawal by Subject|0|||
25139034|NCT02058589|50252068|FG001|Overall Study|Withdrawal by Subject|1|||
25139035|NCT02079805|50252078|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
25009970|NCT03350256|50102919|FG000|Overall Study|Subject moving out of state|1|||
25009971|NCT03350256|50102919|FG000|Overall Study|Lost to Follow-up|1|||
25009972|NCT03350256|50102919|FG000|Overall Study|Lack of Efficacy|2|||
25009973|NCT00024167|50102926|FG000|Overall Study|Death|53|||
25009974|NCT00024167|50102927|FG001|Overall Study|Death|47|||
25009975|NCT00022763|50102936|FG000|Overall Study|Adverse Event|1|||
25009976|NCT00022763|50102937|FG001|Overall Study|Adverse Event|2|||
25009977|NCT00022763|50102936|FG000|Overall Study|Injection Site Reactions|0|||
25139036|NCT02079805|50252079|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
25139037|NCT02079805|50252078|FG000|Overall Study|Voluntary Withdrawal|0|||
25179099|NCT01693562|50324408|FG022|Exploration Phase|Other|0|||
25139038|NCT02079805|50252079|FG001|Overall Study|Voluntary Withdrawal|1|||
25139039|NCT02037295|50252089|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
25139040|NCT02037295|50252090|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
25139041|NCT02037295|50252091|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
25139042|NCT02037295|50252092|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
25139043|NCT02079649|50252108|FG000|Overall Study|Lost to Follow-up|0|||
25009978|NCT00022763|50102937|FG001|Overall Study|Injection Site Reactions|2|||
25009979|NCT00022763|50102936|FG000|Overall Study|Death|0|||
25009980|NCT00022763|50102937|FG001|Overall Study|Death|1|||
25009981|NCT00022763|50102936|FG000|Overall Study|Lost to Follow-up|0|||
25009982|NCT00022763|50102937|FG001|Overall Study|Lost to Follow-up|3|||
25009983|NCT00022763|50102936|FG000|Overall Study|Withdrawal by Subject|4|||
25009984|NCT00022763|50102937|FG001|Overall Study|Withdrawal by Subject|7|||
25009985|NCT00022763|50102936|FG000|Overall Study|Insufficient Therapy|1|||
25009986|NCT00022763|50102937|FG001|Overall Study|Insufficient Therapy|0|||
25009987|NCT00022763|50102936|FG000|Overall Study|Admin|3|||
25009988|NCT00022763|50102937|FG001|Overall Study|Admin|2|||
25273920|NCT01111539|50588038|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
25273921|NCT01111539|50588034|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
25273922|NCT01111539|50588035|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
25273923|NCT01111539|50588036|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
25273924|NCT01111539|50588037|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
25273925|NCT01111539|50588038|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
25273926|NCT01111539|50588034|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
25273927|NCT01111539|50588035|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
25273928|NCT01111539|50588036|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
25273929|NCT01111539|50588037|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
25273930|NCT01111539|50588038|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
25273931|NCT01111539|50588034|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
25273932|NCT01111539|50588035|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
25139044|NCT02079649|50252109|FG001|Overall Study|Lost to Follow-up|0|||
25139045|NCT02079649|50252110|FG002|Overall Study|Lost to Follow-up|0|||
25273933|NCT01111539|50588036|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
25273934|NCT01111539|50588037|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
25273935|NCT01111539|50588038|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
25273936|NCT01111539|50588034|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
25273937|NCT01111539|50588035|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
25273938|NCT01111539|50588036|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
25273939|NCT01111539|50588037|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
25273940|NCT01111539|50588038|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
25273941|NCT01111539|50588034|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
25273942|NCT01111539|50588035|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
25273943|NCT01111539|50588036|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
25273944|NCT01111539|50588037|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
25273945|NCT01111539|50588038|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
25010013|NCT00071513|50102961|FG000|Intervention Component|Withdrawal by Subject|2|||
25010014|NCT00071513|50102962|FG001|Intervention Component|Withdrawal by Subject|3|||
25010015|NCT00071513|50102961|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
25010016|NCT00071513|50102962|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
25010017|NCT00006389|50102970|FG000|Overall Study|Adverse Event|1|||
25010018|NCT00006305|50102979|FG000|Overall Study|Withdrawal by Subject|17|||
25010019|NCT00006305|50102980|FG001|Overall Study|Withdrawal by Subject|10|||
25010020|NCT00006305|50102981|FG002|Overall Study|Withdrawal by Subject|15|||
25010021|NCT00006305|50102982|FG003|Overall Study|Withdrawal by Subject|14|||
25010022|NCT03529773|50103032|FG000|Overall Study|Adverse Event|0|||
25010023|NCT03529773|50103033|FG001|Overall Study|Adverse Event|0|||
25010024|NCT03529773|50103034|FG002|Overall Study|Adverse Event|0|||
25010025|NCT03529773|50103035|FG003|Overall Study|Adverse Event|0|||
25010026|NCT03529773|50103036|FG004|Overall Study|Adverse Event|0|||
25010027|NCT03529773|50103037|FG005|Overall Study|Adverse Event|0|||
25010028|NCT03529773|50103038|FG006|Overall Study|Adverse Event|0|||
25010029|NCT03529773|50103039|FG007|Overall Study|Adverse Event|0|||
25010030|NCT03529773|50103040|FG008|Overall Study|Adverse Event|0|||
25010031|NCT03529773|50103041|FG009|Overall Study|Adverse Event|0|||
25010032|NCT03529773|50103042|FG010|Overall Study|Adverse Event|0|||
25010033|NCT03529773|50103043|FG011|Overall Study|Adverse Event|0|||
25010034|NCT03529773|50103044|FG012|Overall Study|Adverse Event|0|||
25010035|NCT03529773|50103045|FG013|Overall Study|Adverse Event|0|||
25010036|NCT03529773|50103046|FG014|Overall Study|Adverse Event|0|||
25179100|NCT01693562|50324386|FG000|Expansion Phase|Withdrawal by Subject|0|||
25179101|NCT01693562|50324387|FG001|Expansion Phase|Withdrawal by Subject|0|||
25010037|NCT03529773|50103047|FG015|Overall Study|Adverse Event|0|||
25010038|NCT03529773|50103048|FG016|Overall Study|Adverse Event|0|||
25010039|NCT03529773|50103049|FG017|Overall Study|Adverse Event|0|||
25273946|NCT01111539|50588034|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
25273947|NCT01111539|50588035|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
25273948|NCT01111539|50588036|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
25273949|NCT01111539|50588037|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
25273950|NCT01111539|50588038|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
25010040|NCT03529773|50103050|FG018|Overall Study|Adverse Event|0|||
25010041|NCT03529773|50103051|FG019|Overall Study|Adverse Event|0|||
25010042|NCT03529773|50103052|FG020|Overall Study|Adverse Event|0|||
25010043|NCT03529773|50103053|FG021|Overall Study|Adverse Event|0|||
25010044|NCT03529773|50103054|FG022|Overall Study|Adverse Event|0|||
25010045|NCT03529773|50103055|FG023|Overall Study|Adverse Event|0|||
25010046|NCT03529773|50103056|FG024|Overall Study|Adverse Event|0|||
25010047|NCT03529773|50103057|FG025|Overall Study|Adverse Event|0|||
25010048|NCT03529773|50103058|FG026|Overall Study|Adverse Event|0|||
25010049|NCT03529773|50103059|FG027|Overall Study|Adverse Event|0|||
25010050|NCT03529773|50103060|FG028|Overall Study|Adverse Event|0|||
25010051|NCT03529773|50103061|FG029|Overall Study|Adverse Event|0|||
25010052|NCT03529773|50103062|FG030|Overall Study|Adverse Event|1|||
25010053|NCT03529773|50103063|FG031|Overall Study|Adverse Event|0|||
25010054|NCT03529773|50103064|FG032|Overall Study|Adverse Event|0|||
25010055|NCT03529773|50103065|FG033|Overall Study|Adverse Event|0|||
25010056|NCT03529773|50103066|FG034|Overall Study|Adverse Event|0|||
25010057|NCT03529773|50103067|FG035|Overall Study|Adverse Event|1|||
25010058|NCT03529773|50103068|FG036|Overall Study|Adverse Event|0|||
25010059|NCT03529773|50103069|FG037|Overall Study|Adverse Event|0|||
25010060|NCT03529773|50103070|FG038|Overall Study|Adverse Event|1|||
25010061|NCT03529773|50103071|FG039|Overall Study|Adverse Event|1|||
25010062|NCT03529773|50103032|FG000|Overall Study|Death|0|||
25010063|NCT03529773|50103033|FG001|Overall Study|Death|0|||
25010064|NCT03529773|50103034|FG002|Overall Study|Death|0|||
25010065|NCT03529773|50103035|FG003|Overall Study|Death|0|||
25010066|NCT03529773|50103036|FG004|Overall Study|Death|0|||
25010067|NCT03529773|50103037|FG005|Overall Study|Death|0|||
25010068|NCT03529773|50103038|FG006|Overall Study|Death|0|||
25010069|NCT03529773|50103039|FG007|Overall Study|Death|0|||
25010070|NCT03529773|50103040|FG008|Overall Study|Death|0|||
25010071|NCT03529773|50103041|FG009|Overall Study|Death|0|||
25010072|NCT03529773|50103042|FG010|Overall Study|Death|0|||
25010073|NCT03529773|50103043|FG011|Overall Study|Death|0|||
25010074|NCT03529773|50103044|FG012|Overall Study|Death|1|||
25010075|NCT03529773|50103045|FG013|Overall Study|Death|0|||
25010076|NCT03529773|50103046|FG014|Overall Study|Death|0|||
25010077|NCT03529773|50103047|FG015|Overall Study|Death|0|||
25010078|NCT03529773|50103048|FG016|Overall Study|Death|0|||
25010079|NCT03529773|50103049|FG017|Overall Study|Death|0|||
25010080|NCT03529773|50103050|FG018|Overall Study|Death|0|||
25010081|NCT03529773|50103051|FG019|Overall Study|Death|1|||
25010082|NCT03529773|50103052|FG020|Overall Study|Death|0|||
25010083|NCT03529773|50103053|FG021|Overall Study|Death|0|||
25010084|NCT03529773|50103054|FG022|Overall Study|Death|1|||
25010085|NCT03529773|50103055|FG023|Overall Study|Death|0|||
25010086|NCT03529773|50103056|FG024|Overall Study|Death|0|||
25010087|NCT03529773|50103057|FG025|Overall Study|Death|0|||
25010088|NCT03529773|50103058|FG026|Overall Study|Death|0|||
25139046|NCT02079649|50252111|FG003|Overall Study|Lost to Follow-up|1|||
25010089|NCT03529773|50103059|FG027|Overall Study|Death|0|||
25010090|NCT03529773|50103060|FG028|Overall Study|Death|0|||
25010091|NCT03529773|50103061|FG029|Overall Study|Death|0|||
25010092|NCT03529773|50103062|FG030|Overall Study|Death|0|||
25010093|NCT03529773|50103063|FG031|Overall Study|Death|0|||
25010094|NCT03529773|50103064|FG032|Overall Study|Death|0|||
25010095|NCT03529773|50103065|FG033|Overall Study|Death|1|||
25010096|NCT03529773|50103066|FG034|Overall Study|Death|1|||
25010097|NCT03529773|50103067|FG035|Overall Study|Death|0|||
25010098|NCT03529773|50103068|FG036|Overall Study|Death|1|||
25010099|NCT03529773|50103069|FG037|Overall Study|Death|0|||
25010100|NCT03529773|50103070|FG038|Overall Study|Death|0|||
25010101|NCT03529773|50103071|FG039|Overall Study|Death|0|||
25139047|NCT02079649|50252108|FG000|Overall Study|Withdrawal by Subject|0|||
25139048|NCT02079649|50252109|FG001|Overall Study|Withdrawal by Subject|0|||
25139049|NCT02079649|50252110|FG002|Overall Study|Withdrawal by Subject|0|||
25139050|NCT02079649|50252111|FG003|Overall Study|Withdrawal by Subject|1|||
25139051|NCT02079649|50252108|FG000|Overall Study|Randomization error (prior to treatment)|1|||
25139052|NCT02079649|50252109|FG001|Overall Study|Randomization error (prior to treatment)|0|||
25139053|NCT02079649|50252110|FG002|Overall Study|Randomization error (prior to treatment)|1|||
25139054|NCT02079649|50252111|FG003|Overall Study|Randomization error (prior to treatment)|0|||
25139055|NCT02036515|50252125|FG000|Overall Study|Adverse Event|1|||
25139056|NCT02036515|50252126|FG001|Overall Study|Adverse Event|1|||
25139057|NCT02036515|50252127|FG002|Overall Study|Adverse Event|2|||
25139058|NCT02036515|50252125|FG000|Overall Study|Lost to Follow-up|0|||
25139059|NCT02036515|50252126|FG001|Overall Study|Lost to Follow-up|2|||
25139060|NCT02036515|50252127|FG002|Overall Study|Lost to Follow-up|0|||
25139061|NCT02036515|50252125|FG000|Overall Study|Non-compliance with study drug|0|||
25139062|NCT02036515|50252126|FG001|Overall Study|Non-compliance with study drug|0|||
25139063|NCT02036515|50252127|FG002|Overall Study|Non-compliance with study drug|2|||
25139064|NCT02036515|50252125|FG000|Overall Study|Screen failure|0|||
25139065|NCT02036515|50252126|FG001|Overall Study|Screen failure|2|||
25139066|NCT02036515|50252127|FG002|Overall Study|Screen failure|0|||
25139067|NCT02036515|50252125|FG000|Overall Study|Withdrawal by Subject|4|||
25139068|NCT02036515|50252126|FG001|Overall Study|Withdrawal by Subject|7|||
25139069|NCT02036515|50252127|FG002|Overall Study|Withdrawal by Subject|9|||
25139070|NCT02036515|50252125|FG000|Overall Study|Hyperglycemia|0|||
25139071|NCT02036515|50252126|FG001|Overall Study|Hyperglycemia|0|||
25139072|NCT02036515|50252127|FG002|Overall Study|Hyperglycemia|1|||
25139073|NCT02078713|50252139|FG000|Overall Study|Lost to Follow-up|49|||
25139074|NCT02078713|50252140|FG001|Overall Study|Lost to Follow-up|55|||
25139075|NCT02078713|50252141|FG002|Overall Study|Lost to Follow-up|0|||
25139076|NCT02078713|50252142|FG003|Overall Study|Lost to Follow-up|0|||
25139077|NCT02078713|50252139|FG000|Overall Study|Pregnant at baseline|3|||
25139078|NCT02078713|50252140|FG001|Overall Study|Pregnant at baseline|5|||
25139079|NCT02078713|50252141|FG002|Overall Study|Pregnant at baseline|0|||
25139080|NCT02078713|50252142|FG003|Overall Study|Pregnant at baseline|0|||
25139081|NCT02078713|50252139|FG000|Overall Study|Enrolled twice|0|||
25139082|NCT02078713|50252140|FG001|Overall Study|Enrolled twice|1|||
25139083|NCT02078713|50252141|FG002|Overall Study|Enrolled twice|0|||
25139084|NCT02078713|50252142|FG003|Overall Study|Enrolled twice|0|||
25139085|NCT02035267|50252158|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
25139086|NCT02035267|50252159|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
25139087|NCT02035267|50252160|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
25139088|NCT02035267|50252161|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
25139089|NCT02035267|50252158|FG000|Overall Study|Adverse Event|0|||
25139090|NCT02035267|50252159|FG001|Overall Study|Adverse Event|0|||
25139091|NCT02035267|50252160|FG002|Overall Study|Adverse Event|1|||
25139092|NCT02035267|50252161|FG003|Overall Study|Adverse Event|0|||
25139093|NCT02035267|50252158|FG000|Overall Study|Lost to Follow-up|0|||
25139094|NCT02035267|50252159|FG001|Overall Study|Lost to Follow-up|0|||
25139095|NCT02035267|50252160|FG002|Overall Study|Lost to Follow-up|0|||
25139096|NCT02035267|50252161|FG003|Overall Study|Lost to Follow-up|1|||
25139097|NCT02035267|50252158|FG000|Overall Study|Other unspecified|0|||
25139098|NCT02035267|50252159|FG001|Overall Study|Other unspecified|1|||
25139099|NCT02035267|50252160|FG002|Overall Study|Other unspecified|0|||
25139100|NCT02035267|50252161|FG003|Overall Study|Other unspecified|0|||
25139101|NCT04373460|50252195|FG000|Overall Study|Did not receive tranfusion|18|||
25139102|NCT04373460|50252196|FG001|Overall Study|Did not receive tranfusion|26|||
25139103|NCT04280081|50252206|FG000|Overall Study|Adverse Event|4|||
25139104|NCT04280081|50252206|FG000|Overall Study|Death|2|||
25139105|NCT04280081|50252206|FG000|Overall Study|Progressive Disease|6|||
25139106|NCT04159805|50252222|FG000|Overall Study|Withdrawal by Subject|0|||
25139107|NCT04159805|50252223|FG001|Overall Study|Withdrawal by Subject|2|||
25139108|NCT04159805|50252224|FG002|Overall Study|Withdrawal by Subject|2|||
25139109|NCT03901456|50252239|FG000|Overall Study|Withdrawal by Subject|0|||
25139110|NCT03901456|50252240|FG001|Overall Study|Withdrawal by Subject|0|||
25139111|NCT03901456|50252241|FG002|Overall Study|Withdrawal by Subject|1|||
25139112|NCT03901456|50252239|FG000|Overall Study|Lost to Follow-up|0|||
25139113|NCT03901456|50252240|FG001|Overall Study|Lost to Follow-up|1|||
25139114|NCT03901456|50252241|FG002|Overall Study|Lost to Follow-up|0|||
25139115|NCT03848845|50252254|FG000|Overall Study|Lost to Follow-up|0|||
25139116|NCT03848845|50252255|FG001|Overall Study|Lost to Follow-up|1|||
25139117|NCT03848845|50252256|FG002|Overall Study|Lost to Follow-up|0|||
25139118|NCT03848845|50252254|FG000|Overall Study|Withdrawal by Subject|3|||
25139119|NCT03848845|50252255|FG001|Overall Study|Withdrawal by Subject|2|||
25139120|NCT03848845|50252256|FG002|Overall Study|Withdrawal by Subject|6|||
25139121|NCT03848845|50252254|FG000|Overall Study|In Follow-up|0|||
25139122|NCT03848845|50252255|FG001|Overall Study|In Follow-up|1|||
25139123|NCT03848845|50252256|FG002|Overall Study|In Follow-up|12|||
25010102|NCT03529773|50103032|FG000|Overall Study|Lost to Follow-up|0|||
25010103|NCT03529773|50103033|FG001|Overall Study|Lost to Follow-up|0|||
25010104|NCT03529773|50103034|FG002|Overall Study|Lost to Follow-up|1|||
25010105|NCT03529773|50103035|FG003|Overall Study|Lost to Follow-up|0|||
25010106|NCT03529773|50103036|FG004|Overall Study|Lost to Follow-up|1|||
25139124|NCT03848845|50252254|FG000|Overall Study|On Study Treatment|0|||
25010107|NCT03529773|50103037|FG005|Overall Study|Lost to Follow-up|1|||
25010108|NCT03529773|50103038|FG006|Overall Study|Lost to Follow-up|0|||
25010109|NCT03529773|50103039|FG007|Overall Study|Lost to Follow-up|0|||
25010110|NCT03529773|50103040|FG008|Overall Study|Lost to Follow-up|0|||
25010111|NCT03529773|50103041|FG009|Overall Study|Lost to Follow-up|0|||
25010112|NCT03529773|50103042|FG010|Overall Study|Lost to Follow-up|0|||
25010113|NCT03529773|50103043|FG011|Overall Study|Lost to Follow-up|0|||
25010114|NCT03529773|50103044|FG012|Overall Study|Lost to Follow-up|0|||
25010115|NCT03529773|50103045|FG013|Overall Study|Lost to Follow-up|1|||
25010116|NCT03529773|50103046|FG014|Overall Study|Lost to Follow-up|4|||
25010117|NCT03529773|50103047|FG015|Overall Study|Lost to Follow-up|1|||
25010118|NCT03529773|50103048|FG016|Overall Study|Lost to Follow-up|1|||
25010119|NCT03529773|50103049|FG017|Overall Study|Lost to Follow-up|0|||
25139125|NCT03848845|50252255|FG001|Overall Study|On Study Treatment|0|||
25139126|NCT03848845|50252256|FG002|Overall Study|On Study Treatment|4|||
25139127|NCT03848845|50252254|FG000|Overall Study|Physician Decision|0|||
25139128|NCT03848845|50252255|FG001|Overall Study|Physician Decision|0|||
25139129|NCT03848845|50252256|FG002|Overall Study|Physician Decision|1|||
25139130|NCT03299166|50252307|FG000|Overall Study|Adverse Event|9|||
25139131|NCT03299166|50252308|FG001|Overall Study|Adverse Event|4|||
25139132|NCT03299166|50252307|FG000|Overall Study|Withdrawal by Subject|6|||
25139133|NCT03299166|50252308|FG001|Overall Study|Withdrawal by Subject|5|||
25139134|NCT03299166|50252307|FG000|Overall Study|Physician Decision|1|||
25139135|NCT03299166|50252308|FG001|Overall Study|Physician Decision|1|||
25139136|NCT03299166|50252307|FG000|Overall Study|Sponsor Decision|3|||
25139137|NCT03299166|50252308|FG001|Overall Study|Sponsor Decision|0|||
25010120|NCT03529773|50103050|FG018|Overall Study|Lost to Follow-up|1|||
25010121|NCT03529773|50103051|FG019|Overall Study|Lost to Follow-up|1|||
25010122|NCT03529773|50103052|FG020|Overall Study|Lost to Follow-up|2|||
25010123|NCT03529773|50103053|FG021|Overall Study|Lost to Follow-up|4|||
25010124|NCT03529773|50103054|FG022|Overall Study|Lost to Follow-up|3|||
25179102|NCT01693562|50324388|FG002|Expansion Phase|Withdrawal by Subject|0|||
25010125|NCT03529773|50103055|FG023|Overall Study|Lost to Follow-up|4|||
25010126|NCT03529773|50103056|FG024|Overall Study|Lost to Follow-up|3|||
25139138|NCT03299166|50252307|FG000|Overall Study|Lost to Follow-up|2|||
25139139|NCT03299166|50252308|FG001|Overall Study|Lost to Follow-up|4|||
25139140|NCT03299166|50252307|FG000|Overall Study|Randomization Error|0|||
25139141|NCT03299166|50252308|FG001|Overall Study|Randomization Error|1|||
25010127|NCT03529773|50103057|FG025|Overall Study|Lost to Follow-up|5|||
25010128|NCT03529773|50103058|FG026|Overall Study|Lost to Follow-up|5|||
25010129|NCT03529773|50103059|FG027|Overall Study|Lost to Follow-up|0|||
25010130|NCT03529773|50103060|FG028|Overall Study|Lost to Follow-up|0|||
25010131|NCT03529773|50103061|FG029|Overall Study|Lost to Follow-up|0|||
25010132|NCT03529773|50103062|FG030|Overall Study|Lost to Follow-up|1|||
25139142|NCT03299166|50252307|FG000|Overall Study|Subject unable to return due to COVID|1|||
25139143|NCT03299166|50252308|FG001|Overall Study|Subject unable to return due to COVID|0|||
25139144|NCT03299166|50252307|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
25139145|NCT03299166|50252308|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
25139146|NCT03286504|50252316|FG000|Overall Study|Lost to Follow-up|19|||
25139147|NCT03286504|50252317|FG001|Overall Study|Lost to Follow-up|16|||
25139148|NCT03226249|50252323|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
25010133|NCT03529773|50103063|FG031|Overall Study|Lost to Follow-up|0|||
25010134|NCT03529773|50103064|FG032|Overall Study|Lost to Follow-up|0|||
25010135|NCT03529773|50103065|FG033|Overall Study|Lost to Follow-up|1|||
25010136|NCT03529773|50103066|FG034|Overall Study|Lost to Follow-up|1|||
25010137|NCT03529773|50103067|FG035|Overall Study|Lost to Follow-up|0|||
25010138|NCT03529773|50103068|FG036|Overall Study|Lost to Follow-up|0|||
25010139|NCT03529773|50103069|FG037|Overall Study|Lost to Follow-up|3|||
25010140|NCT03529773|50103070|FG038|Overall Study|Lost to Follow-up|1|||
25010141|NCT03529773|50103071|FG039|Overall Study|Lost to Follow-up|1|||
25010142|NCT03529773|50103032|FG000|Overall Study|No longer meets eligibility criteria|0|||
25139149|NCT03226249|50252323|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
25139150|NCT03226249|50252323|FG000|Survival Follow-up|Patients still in follow-up.|30|||
25139151|NCT02941926|50252327|FG000|Overall Study|Progressive disease|1109|||
25139152|NCT02941926|50252327|FG000|Overall Study|Adverse Event|504|||
25139153|NCT02941926|50252327|FG000|Overall Study|Subject/guardian decision|127|||
25010143|NCT03529773|50103033|FG001|Overall Study|No longer meets eligibility criteria|0|||
25139154|NCT02941926|50252327|FG000|Overall Study|Physician Decision|112|||
25139155|NCT02941926|50252327|FG000|Overall Study|Death|46|||
25139156|NCT02941926|50252327|FG000|Overall Study|Protocol deviation|34|||
25139157|NCT02941926|50252327|FG000|Overall Study|Lost to Follow-up|8|||
25139158|NCT02941926|50252327|FG000|Overall Study|Technical problems|5|||
25139159|NCT02849548|50252335|FG000|Overall Study|Lost to Follow-up|1|||
25139160|NCT02849548|50252336|FG001|Overall Study|Lost to Follow-up|2|||
25010144|NCT03529773|50103034|FG002|Overall Study|No longer meets eligibility criteria|0|||
25139161|NCT02849548|50252335|FG000|Overall Study|Protocol Violation|1|||
25139162|NCT02849548|50252336|FG001|Overall Study|Protocol Violation|0|||
25010145|NCT03529773|50103035|FG003|Overall Study|No longer meets eligibility criteria|0|||
25139163|NCT02411448|50252354|FG000|Overall Study|Withdrawal by Subject|1|||
25139164|NCT02411448|50252355|FG001|Overall Study|Withdrawal by Subject|14|||
25139165|NCT02411448|50252356|FG002|Overall Study|Withdrawal by Subject|9|||
25139166|NCT02411448|50252354|FG000|Overall Study|Other|0|||
25139167|NCT02411448|50252355|FG001|Overall Study|Other|2|||
25139168|NCT02411448|50252356|FG002|Overall Study|Other|0|||
25139169|NCT02411448|50252354|FG000|Overall Study|Did not receive study treatment|0|||
25010146|NCT03529773|50103036|FG004|Overall Study|No longer meets eligibility criteria|0|||
25139170|NCT02411448|50252355|FG001|Overall Study|Did not receive study treatment|3|||
25139171|NCT02411448|50252356|FG002|Overall Study|Did not receive study treatment|0|||
25139172|NCT02411448|50252354|FG000|Overall Study|Alive on study treatment|3|||
25139173|NCT02411448|50252355|FG001|Overall Study|Alive on study treatment|64|||
25139174|NCT02411448|50252356|FG002|Overall Study|Alive on study treatment|43|||
25139175|NCT02321514|50252368|FG000|Overall Study|Death|15|||
25139176|NCT02321514|50252368|FG000|Overall Study|Missed Visit|7|||
25139177|NCT02321514|50252368|FG000|Overall Study|Study Exit|3|||
25139178|NCT02266134|50252376|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
25010147|NCT03529773|50103037|FG005|Overall Study|No longer meets eligibility criteria|0|||
25010148|NCT03529773|50103038|FG006|Overall Study|No longer meets eligibility criteria|0|||
25010149|NCT03529773|50103039|FG007|Overall Study|No longer meets eligibility criteria|0|||
25010150|NCT03529773|50103040|FG008|Overall Study|No longer meets eligibility criteria|0|||
25010151|NCT03529773|50103041|FG009|Overall Study|No longer meets eligibility criteria|0|||
25010152|NCT03529773|50103042|FG010|Overall Study|No longer meets eligibility criteria|0|||
25010153|NCT03529773|50103043|FG011|Overall Study|No longer meets eligibility criteria|0|||
25010154|NCT03529773|50103044|FG012|Overall Study|No longer meets eligibility criteria|0|||
25010155|NCT03529773|50103045|FG013|Overall Study|No longer meets eligibility criteria|0|||
25010156|NCT03529773|50103046|FG014|Overall Study|No longer meets eligibility criteria|0|||
25010157|NCT03529773|50103047|FG015|Overall Study|No longer meets eligibility criteria|0|||
25010158|NCT03529773|50103048|FG016|Overall Study|No longer meets eligibility criteria|0|||
25010159|NCT03529773|50103049|FG017|Overall Study|No longer meets eligibility criteria|0|||
25010160|NCT03529773|50103050|FG018|Overall Study|No longer meets eligibility criteria|0|||
25010161|NCT03529773|50103051|FG019|Overall Study|No longer meets eligibility criteria|0|||
25010162|NCT03529773|50103052|FG020|Overall Study|No longer meets eligibility criteria|0|||
25010163|NCT03529773|50103053|FG021|Overall Study|No longer meets eligibility criteria|0|||
25010164|NCT03529773|50103054|FG022|Overall Study|No longer meets eligibility criteria|1|||
25010165|NCT03529773|50103055|FG023|Overall Study|No longer meets eligibility criteria|0|||
25010166|NCT03529773|50103056|FG024|Overall Study|No longer meets eligibility criteria|0|||
25010167|NCT03529773|50103057|FG025|Overall Study|No longer meets eligibility criteria|0|||
25010168|NCT03529773|50103058|FG026|Overall Study|No longer meets eligibility criteria|0|||
25139179|NCT02266134|50252377|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
25179103|NCT01693562|50324389|FG003|Expansion Phase|Withdrawal by Subject|0|||
25139180|NCT02266134|50252378|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
25139181|NCT02266134|50252379|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
25010169|NCT03529773|50103059|FG027|Overall Study|No longer meets eligibility criteria|0|||
25010170|NCT03529773|50103060|FG028|Overall Study|No longer meets eligibility criteria|0|||
25010171|NCT03529773|50103061|FG029|Overall Study|No longer meets eligibility criteria|0|||
25010172|NCT03529773|50103062|FG030|Overall Study|No longer meets eligibility criteria|0|||
25139182|NCT02266134|50252376|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
25010173|NCT03529773|50103063|FG031|Overall Study|No longer meets eligibility criteria|0|||
25139183|NCT02266134|50252377|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
25139184|NCT02266134|50252378|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
25139185|NCT02266134|50252379|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
25139186|NCT02266134|50252376|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
25139187|NCT02266134|50252377|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
25139188|NCT02266134|50252378|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
25139189|NCT02266134|50252379|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
25139190|NCT02266134|50252376|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
25139191|NCT02266134|50252377|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
25139192|NCT02266134|50252378|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
25139193|NCT02266134|50252379|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
25139194|NCT02266134|50252376|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
25139195|NCT02266134|50252377|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
25179104|NCT01693562|50324390|FG004|Expansion Phase|Withdrawal by Subject|0|||
25010174|NCT03529773|50103064|FG032|Overall Study|No longer meets eligibility criteria|0|||
25010175|NCT03529773|50103065|FG033|Overall Study|No longer meets eligibility criteria|0|||
25010176|NCT03529773|50103066|FG034|Overall Study|No longer meets eligibility criteria|0|||
25139196|NCT02266134|50252378|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
25139197|NCT02266134|50252379|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
25139198|NCT02266134|50252376|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
25139199|NCT02266134|50252377|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
25139200|NCT02266134|50252378|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
25139201|NCT02266134|50252379|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
25139202|NCT01847274|50252407|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
25139203|NCT01847274|50252408|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
25139204|NCT01847274|50252409|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
25139205|NCT01847274|50252410|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
25139206|NCT01847274|50252411|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
25139207|NCT01847274|50252412|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
25139208|NCT01847274|50252413|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
25139209|NCT01847274|50252414|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
25139210|NCT01847274|50252415|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
25139211|NCT01847274|50252416|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
25139212|NCT01847274|50252417|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
25139213|NCT01847274|50252407|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
25139214|NCT01847274|50252408|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
25139215|NCT01847274|50252409|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
25139216|NCT01847274|50252410|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
25139217|NCT01847274|50252411|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
25139218|NCT01847274|50252412|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
25139219|NCT01847274|50252413|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
25139220|NCT01847274|50252414|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
25139221|NCT01847274|50252415|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
25139222|NCT01847274|50252416|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
25139223|NCT01847274|50252417|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
25139224|NCT01847274|50252407|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
25139225|NCT01847274|50252408|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
25139226|NCT01847274|50252409|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
25139227|NCT01847274|50252410|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
25139228|NCT01847274|50252411|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
25139229|NCT01847274|50252412|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
25139230|NCT01847274|50252413|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
25139231|NCT01847274|50252414|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
25139232|NCT01847274|50252415|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
25139233|NCT01847274|50252416|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
25139234|NCT01847274|50252417|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
25139235|NCT01847274|50252407|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
25139236|NCT01847274|50252408|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
25139237|NCT01847274|50252409|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
25139238|NCT01847274|50252410|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
25139239|NCT01847274|50252411|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
25139240|NCT01847274|50252412|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
25139241|NCT01847274|50252413|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
25139242|NCT01847274|50252414|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
25139243|NCT01847274|50252415|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
25139244|NCT01847274|50252416|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
25139245|NCT01847274|50252417|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
25139246|NCT01847274|50252407|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
25139247|NCT01847274|50252408|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
25139248|NCT01847274|50252409|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
25139249|NCT01847274|50252410|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
25139250|NCT01847274|50252411|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
25139251|NCT01847274|50252412|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
25139252|NCT01847274|50252413|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
25139253|NCT01847274|50252414|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
25139254|NCT01847274|50252415|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
25139255|NCT01847274|50252416|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
25139256|NCT01847274|50252417|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
25139257|NCT01847274|50252407|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
25139258|NCT01847274|50252408|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
25139259|NCT01847274|50252409|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
25179105|NCT01693562|50324391|FG005|Expansion Phase|Withdrawal by Subject|0|||
25179106|NCT01693562|50324392|FG006|Expansion Phase|Withdrawal by Subject|0|||
25179107|NCT01693562|50324393|FG007|Expansion Phase|Withdrawal by Subject|16|||
25139260|NCT01847274|50252410|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
25139261|NCT01847274|50252411|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
25139262|NCT01847274|50252412|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
25139263|NCT01847274|50252413|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
25139264|NCT01847274|50252414|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
25139265|NCT01847274|50252415|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
25179108|NCT01693562|50324394|FG008|Expansion Phase|Withdrawal by Subject|2|||
25179109|NCT01693562|50324395|FG009|Expansion Phase|Withdrawal by Subject|54|||
25139266|NCT01847274|50252416|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
25139267|NCT01847274|50252417|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
25139268|NCT01847274|50252407|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
25139269|NCT01847274|50252408|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
25139270|NCT01847274|50252409|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
25139271|NCT01847274|50252410|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
25139272|NCT01847274|50252411|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
25139273|NCT01847274|50252412|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
25139274|NCT01847274|50252413|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
25139275|NCT01847274|50252414|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
25139276|NCT01847274|50252415|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
25139277|NCT01847274|50252416|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
25139278|NCT01847274|50252417|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
25139279|NCT01847274|50252407|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
25139280|NCT01847274|50252408|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
25139281|NCT01847274|50252409|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
25139282|NCT01847274|50252410|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
25139283|NCT01847274|50252411|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
25139284|NCT01847274|50252412|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
25139285|NCT01847274|50252413|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
25139286|NCT01847274|50252414|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
25139287|NCT01847274|50252415|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
25139288|NCT01847274|50252416|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
25139289|NCT01847274|50252417|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
25139290|NCT01847274|50252407|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
25139291|NCT01847274|50252408|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
25139292|NCT01847274|50252409|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
25139293|NCT01847274|50252410|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
25139294|NCT01847274|50252411|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
25139295|NCT01847274|50252412|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
25139296|NCT01847274|50252413|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
25139297|NCT01847274|50252414|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
25139298|NCT01847274|50252415|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
25139299|NCT01847274|50252416|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
25139300|NCT01847274|50252417|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
25139301|NCT01847274|50252407|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
25139302|NCT01847274|50252408|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
25139303|NCT01847274|50252409|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
25139304|NCT01847274|50252410|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
25139305|NCT01847274|50252411|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
25139306|NCT01847274|50252412|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
25139307|NCT01847274|50252413|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
25139308|NCT01847274|50252414|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
25139309|NCT01847274|50252415|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
25139310|NCT01847274|50252416|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
25139311|NCT01847274|50252417|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
25139312|NCT01847274|50252407|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
25139313|NCT01847274|50252408|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
25139314|NCT01847274|50252409|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
25139315|NCT01847274|50252410|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
25139316|NCT01847274|50252411|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
25139317|NCT01847274|50252412|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
25139318|NCT01847274|50252413|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
25139319|NCT01847274|50252414|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
25139320|NCT01847274|50252415|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
25139321|NCT01847274|50252416|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
25139322|NCT01847274|50252417|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
25139323|NCT01847274|50252407|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
25139324|NCT01847274|50252408|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
25139325|NCT01847274|50252409|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
25139326|NCT01847274|50252410|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
25179110|NCT01693562|50324396|FG010|Expansion Phase|Withdrawal by Subject|2|||
25179111|NCT01693562|50324397|FG011|Expansion Phase|Withdrawal by Subject|2|||
25273951|NCT01111539|50588034|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
25273952|NCT01111539|50588035|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
25139327|NCT01847274|50252411|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
25139328|NCT01847274|50252412|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
25139329|NCT01847274|50252413|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
25139330|NCT01847274|50252414|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
25139331|NCT01847274|50252415|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
25139332|NCT01847274|50252416|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
25139333|NCT01847274|50252417|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
25139334|NCT01847274|50252407|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
25139335|NCT01847274|50252408|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
25139336|NCT01847274|50252409|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
25139337|NCT01847274|50252410|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
25139338|NCT01847274|50252411|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
25139339|NCT01847274|50252412|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
25139340|NCT01847274|50252413|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
25139341|NCT01847274|50252414|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
25139342|NCT01847274|50252415|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
25139343|NCT01847274|50252416|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
25139344|NCT01847274|50252417|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
25139345|NCT01847274|50252407|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
25139346|NCT01847274|50252408|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
25139347|NCT01847274|50252409|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
25139348|NCT01847274|50252410|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
25139349|NCT01847274|50252411|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
25139350|NCT01847274|50252412|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
25139351|NCT01847274|50252413|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
25139352|NCT01847274|50252414|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
25139353|NCT01847274|50252415|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
25139354|NCT01847274|50252416|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
25139355|NCT01847274|50252417|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
25139356|NCT01847274|50252407|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
25273953|NCT01111539|50588036|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
25273954|NCT01111539|50588037|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
25273955|NCT01111539|50588038|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
25273956|NCT01111539|50588034|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
25273957|NCT01111539|50588035|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
25273958|NCT01111539|50588036|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
25273959|NCT01111539|50588037|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
25273960|NCT01111539|50588038|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
25273961|NCT01111539|50588034|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
25273962|NCT01111539|50588035|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
25139357|NCT01847274|50252408|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
25139358|NCT01847274|50252409|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
25139359|NCT01847274|50252410|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
25139360|NCT01847274|50252411|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
25139361|NCT01847274|50252412|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
25139362|NCT01847274|50252413|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
25139363|NCT01847274|50252414|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
25139364|NCT01847274|50252415|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
25139365|NCT01847274|50252416|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
25139366|NCT01847274|50252417|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
25139367|NCT01847274|50252407|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
25139368|NCT01847274|50252408|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
25139369|NCT01847274|50252409|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
25139370|NCT01847274|50252410|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
25139371|NCT01847274|50252411|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
25139372|NCT01847274|50252412|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
25139373|NCT01847274|50252413|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
25139374|NCT01847274|50252414|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
25139375|NCT01847274|50252415|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
25139376|NCT01847274|50252416|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
25139377|NCT01847274|50252417|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
25139378|NCT01566695|50252456|FG000|Overall Study|Lack of Efficacy|18|||
25139379|NCT01566695|50252457|FG001|Overall Study|Lack of Efficacy|45|||
25139380|NCT01566695|50252456|FG000|Overall Study|Adverse Event|28|||
25139381|NCT01566695|50252457|FG001|Overall Study|Adverse Event|27|||
25273963|NCT01111539|50588036|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
25273964|NCT01111539|50588037|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
25273965|NCT01111539|50588038|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
25273966|NCT01111539|50588034|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
25273967|NCT01111539|50588035|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
25273968|NCT01111539|50588036|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
25273969|NCT01111539|50588037|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
25273970|NCT01111539|50588038|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
25273971|NCT01111149|50588051|FG000|Overall Study|Protocol Violation|1|||
25273972|NCT01111149|50588052|FG001|Overall Study|Protocol Violation|1|||
25273973|NCT01111149|50588053|FG002|Overall Study|Protocol Violation|2|||
25273974|NCT01111149|50588051|FG000|Overall Study|Withdrawal by Subject|1|||
25273975|NCT01111149|50588052|FG001|Overall Study|Withdrawal by Subject|0|||
25273976|NCT01111149|50588053|FG002|Overall Study|Withdrawal by Subject|2|||
25273977|NCT01254656|50588064|FG000|Overall Study|Discontinued due to termination of study|40|||
25273978|NCT01254656|50588065|FG001|Overall Study|Discontinued due to termination of study|39|||
25273979|NCT01254656|50588066|FG002|Overall Study|Discontinued due to termination of study|13|||
25273980|NCT01254656|50588064|FG000|Overall Study|Lack of Efficacy|3|||
25273981|NCT01254656|50588065|FG001|Overall Study|Lack of Efficacy|0|||
25273982|NCT01254656|50588066|FG002|Overall Study|Lack of Efficacy|0|||
25273983|NCT01254656|50588064|FG000|Overall Study|Lost to Follow-up|1|||
25273984|NCT01254656|50588065|FG001|Overall Study|Lost to Follow-up|0|||
25273985|NCT01254656|50588066|FG002|Overall Study|Lost to Follow-up|2|||
25273986|NCT01254656|50588064|FG000|Overall Study|Withdrawal by Subject|2|||
25273987|NCT01254656|50588065|FG001|Overall Study|Withdrawal by Subject|2|||
25273988|NCT01254656|50588066|FG002|Overall Study|Withdrawal by Subject|1|||
25273989|NCT01254656|50588064|FG000|Overall Study|Pregnancy|0|||
25273990|NCT01254656|50588065|FG001|Overall Study|Pregnancy|0|||
25273991|NCT01254656|50588066|FG002|Overall Study|Pregnancy|2|||
25273992|NCT01254656|50588064|FG000|Overall Study|Adverse Event|1|||
25273993|NCT01254656|50588065|FG001|Overall Study|Adverse Event|1|||
25273994|NCT01254656|50588066|FG002|Overall Study|Adverse Event|0|||
25273995|NCT01254656|50588064|FG000|Overall Study|Death|0|||
25273996|NCT01254656|50588065|FG001|Overall Study|Death|1|||
25273997|NCT01254656|50588066|FG002|Overall Study|Death|0|||
25273998|NCT01110915|50588076|FG000|Overall Study|Death|2|||
25273999|NCT01110915|50588077|FG001|Overall Study|Death|1|||
25274000|NCT01110915|50588076|FG000|Overall Study|Lost to Follow-up|1|||
25274001|NCT01110915|50588077|FG001|Overall Study|Lost to Follow-up|0|||
25274002|NCT01110915|50588076|FG000|Overall Study|Withdrawal by Subject|7|||
25274003|NCT01110915|50588077|FG001|Overall Study|Withdrawal by Subject|1|||
25274004|NCT01254344|50588086|FG000|Overall Study|Adverse Event|2|||
25139382|NCT01566695|50252456|FG000|Overall Study|Death|20|||
25139383|NCT01566695|50252457|FG001|Overall Study|Death|8|||
25139384|NCT01566695|50252456|FG000|Overall Study|Withdrawal by Subject|14|||
25139385|NCT01566695|50252457|FG001|Overall Study|Withdrawal by Subject|7|||
25139386|NCT01566695|50252456|FG000|Overall Study|Progressive Disease|11|||
25139387|NCT01566695|50252457|FG001|Overall Study|Progressive Disease|6|||
25139388|NCT01566695|50252456|FG000|Overall Study|Miscellaneous|4|||
25139389|NCT01566695|50252457|FG001|Overall Study|Miscellaneous|6|||
25139390|NCT01560819|50252465|FG000|Overall Study|Physician Decision|1|||
25139391|NCT01560819|50252466|FG001|Overall Study|Physician Decision|0|||
25139392|NCT01425528|50252472|FG000|Overall Study|Withdrawal by Subject|1|||
25139393|NCT01425528|50252473|FG001|Overall Study|Withdrawal by Subject|1|||
25139394|NCT00442104|50252479|FG000|Overall Study|Adverse Event|5|||
25139395|NCT00442104|50252479|FG000|Overall Study|Death|2|||
25139396|NCT00442104|50252479|FG000|Overall Study|Lost to Follow-up|3|||
25139397|NCT00442104|50252479|FG000|Overall Study|Withdrawal by Subject|5|||
25139398|NCT00442104|50252479|FG000|Overall Study|Insufficient Clinical Response|10|||
25139399|NCT00442104|50252479|FG000|Overall Study|Other|21|||
25139400|NCT00442104|50252479|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
25139401|NCT00441896|50252493|FG000|Overall Study|Withdrawal by Subject|0|||
25139402|NCT00441896|50252494|FG001|Overall Study|Withdrawal by Subject|0|||
25139403|NCT00441896|50252495|FG002|Overall Study|Withdrawal by Subject|0|||
25139404|NCT00441896|50252496|FG003|Overall Study|Withdrawal by Subject|1|||
25139405|NCT00441896|50252497|FG004|Overall Study|Withdrawal by Subject|0|||
25139406|NCT00441896|50252498|FG005|Overall Study|Withdrawal by Subject|0|||
25139407|NCT00441896|50252499|FG006|Overall Study|Withdrawal by Subject|0|||
25139408|NCT00441896|50252500|FG007|Overall Study|Withdrawal by Subject|0|||
25139409|NCT00441896|50252501|FG008|Overall Study|Withdrawal by Subject|0|||
25179112|NCT01693562|50324398|FG012|Expansion Phase|Withdrawal by Subject|3|||
25139410|NCT00441896|50252502|FG009|Overall Study|Withdrawal by Subject|0|||
25139411|NCT00441896|50252493|FG000|Overall Study|Other|0|||
25139412|NCT00441896|50252494|FG001|Overall Study|Other|0|||
25139413|NCT00441896|50252495|FG002|Overall Study|Other|0|||
25139414|NCT00441896|50252496|FG003|Overall Study|Other|0|||
25139415|NCT00441896|50252497|FG004|Overall Study|Other|1|||
25139416|NCT00441896|50252498|FG005|Overall Study|Other|0|||
25139417|NCT00441896|50252499|FG006|Overall Study|Other|0|||
25139418|NCT00441896|50252500|FG007|Overall Study|Other|0|||
25139419|NCT00441896|50252501|FG008|Overall Study|Other|0|||
25139420|NCT00441896|50252502|FG009|Overall Study|Other|0|||
25139421|NCT02034877|50252530|FG000|Overall Study|Lost to Follow-up|0|||
25139422|NCT02034877|50252531|FG001|Overall Study|Lost to Follow-up|3|||
25139423|NCT02034877|50252530|FG000|Overall Study|No Longer Willing to Participate|0|||
25139424|NCT02034877|50252531|FG001|Overall Study|No Longer Willing to Participate|3|||
25139425|NCT02034799|50252539|FG000|Overall Study|Withdrawal by Subject|0|||
25139426|NCT02034799|50252540|FG001|Overall Study|Withdrawal by Subject|2|||
25139427|NCT02034799|50252539|FG000|Overall Study|Lost to Follow-up|0|||
25139428|NCT02034799|50252540|FG001|Overall Study|Lost to Follow-up|1|||
25139429|NCT02034799|50252539|FG000|Overall Study|Death|2|||
25139430|NCT02034799|50252540|FG001|Overall Study|Death|1|||
25139431|NCT02057575|50252550|FG000|Overall Study|Adverse Event|0|||
25139432|NCT02057575|50252551|FG001|Overall Study|Adverse Event|2|||
25139433|NCT02057575|50252552|FG002|Overall Study|Adverse Event|0|||
25139434|NCT02057575|50252553|FG003|Overall Study|Adverse Event|1|||
25139435|NCT02057575|50252550|FG000|Overall Study|Withdrawal by Subject|1|||
25139436|NCT02057575|50252551|FG001|Overall Study|Withdrawal by Subject|0|||
25139437|NCT02057575|50252552|FG002|Overall Study|Withdrawal by Subject|0|||
25139438|NCT02057575|50252553|FG003|Overall Study|Withdrawal by Subject|0|||
25139439|NCT02057575|50252550|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
25139440|NCT02057575|50252551|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
25139441|NCT02057575|50252552|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
25139442|NCT02057575|50252553|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
25139443|NCT02057575|50252550|FG000|Overall Study|Protocol Violation|0|||
25139444|NCT02057575|50252551|FG001|Overall Study|Protocol Violation|1|||
25139445|NCT02057575|50252552|FG002|Overall Study|Protocol Violation|0|||
25139446|NCT02057575|50252553|FG003|Overall Study|Protocol Violation|0|||
25139447|NCT02077465|50252565|FG000|Overall Study|Withdrew Consent|0|||
25139448|NCT02077465|50252566|FG001|Overall Study|Withdrew Consent|1|||
25139449|NCT02077465|50252565|FG000|Overall Study|Lost to Follow-up|1|||
25139450|NCT02077465|50252566|FG001|Overall Study|Lost to Follow-up|0|||
25139451|NCT02034565|50252572|FG000|Overall Study|Adverse Event|1|||
25139452|NCT02034565|50252573|FG001|Overall Study|Adverse Event|0|||
25139453|NCT02075515|50252584|FG000|Overall Study|Serious Adverse Event|1|||
25139454|NCT02075515|50252585|FG001|Overall Study|Serious Adverse Event|1|||
25139455|NCT02075515|50252586|FG002|Overall Study|Serious Adverse Event|1|||
25139456|NCT02075515|50252584|FG000|Overall Study|Non-Serious Adverse Event|0|||
25139457|NCT02075515|50252585|FG001|Overall Study|Non-Serious Adverse Event|1|||
25139458|NCT02075515|50252586|FG002|Overall Study|Non-Serious Adverse Event|0|||
25139459|NCT02075515|50252584|FG000|Overall Study|Withdrawal by Subject|2|||
25139460|NCT02075515|50252585|FG001|Overall Study|Withdrawal by Subject|0|||
25139461|NCT02075515|50252586|FG002|Overall Study|Withdrawal by Subject|1|||
25139462|NCT02075515|50252584|FG000|Overall Study|Lost to Follow-up|1|||
25139463|NCT02075515|50252585|FG001|Overall Study|Lost to Follow-up|3|||
25139464|NCT02075515|50252586|FG002|Overall Study|Lost to Follow-up|6|||
25139465|NCT02034409|50252597|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
25139466|NCT02034409|50252598|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
25139467|NCT02034409|50252597|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
25139468|NCT02034409|50252598|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
25139469|NCT02034409|50252597|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
25139470|NCT02034409|50252598|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
25139471|NCT02034409|50252597|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
25179113|NCT01693562|50324399|FG013|Expansion Phase|Withdrawal by Subject|5|||
25139472|NCT02034409|50252598|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
25139473|NCT02034409|50252597|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
25139474|NCT02034409|50252598|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
25139475|NCT02034409|50252597|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
25139476|NCT02034409|50252598|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
25139477|NCT02021318|50252606|FG000|Overall Study|Adverse Event|2|||
25139478|NCT02021318|50252607|FG001|Overall Study|Adverse Event|1|||
25139479|NCT02021318|50252606|FG000|Overall Study|Death|33|||
25139480|NCT02021318|50252607|FG001|Overall Study|Death|34|||
25139481|NCT02021318|50252606|FG000|Overall Study|Lost to Follow-up|3|||
25139482|NCT02021318|50252607|FG001|Overall Study|Lost to Follow-up|3|||
25139483|NCT02021318|50252606|FG000|Overall Study|Progressive Disease|0|||
25139484|NCT02021318|50252607|FG001|Overall Study|Progressive Disease|1|||
25139485|NCT02021318|50252606|FG000|Overall Study|Withdrawal by Subject|30|||
25139486|NCT02021318|50252607|FG001|Overall Study|Withdrawal by Subject|18|||
25139487|NCT02021318|50252606|FG000|Overall Study|Physician Decision|3|||
25139488|NCT02021318|50252607|FG001|Overall Study|Physician Decision|3|||
25139489|NCT02021318|50252606|FG000|Overall Study|Miscellaneous|2|||
25139490|NCT02021318|50252607|FG001|Overall Study|Miscellaneous|3|||
25139491|NCT02041286|50252614|FG000|Overall Study|Adverse Event|1|||
25139492|NCT02020616|50252627|FG000|Overall Study|Adverse Event|0|||
25139493|NCT02020616|50252628|FG001|Overall Study|Adverse Event|0|||
25139494|NCT02020616|50252629|FG002|Overall Study|Adverse Event|0|||
25139495|NCT02020616|50252630|FG003|Overall Study|Adverse Event|0|||
25139496|NCT02020616|50252631|FG004|Overall Study|Adverse Event|0|||
25139497|NCT02020616|50252632|FG005|Overall Study|Adverse Event|1|||
25139498|NCT02020616|50252633|FG006|Overall Study|Adverse Event|1|||
25139499|NCT02020616|50252627|FG000|Overall Study|Physician Decision|0|||
25139500|NCT02020616|50252628|FG001|Overall Study|Physician Decision|0|||
25139501|NCT02020616|50252629|FG002|Overall Study|Physician Decision|0|||
25139502|NCT02020616|50252630|FG003|Overall Study|Physician Decision|0|||
25139503|NCT02020616|50252631|FG004|Overall Study|Physician Decision|0|||
25139504|NCT02020616|50252632|FG005|Overall Study|Physician Decision|1|||
25139505|NCT02020616|50252633|FG006|Overall Study|Physician Decision|2|||
25139506|NCT02020616|50252627|FG000|Overall Study|Withdrawal by Subject|0|||
25139507|NCT02020616|50252628|FG001|Overall Study|Withdrawal by Subject|0|||
25139508|NCT02020616|50252629|FG002|Overall Study|Withdrawal by Subject|1|||
25139509|NCT02020616|50252630|FG003|Overall Study|Withdrawal by Subject|0|||
25139510|NCT02020616|50252631|FG004|Overall Study|Withdrawal by Subject|0|||
25139511|NCT02020616|50252632|FG005|Overall Study|Withdrawal by Subject|1|||
25139512|NCT02020616|50252633|FG006|Overall Study|Withdrawal by Subject|1|||
25139513|NCT02020616|50252627|FG000|Overall Study|Lost to Follow-up|0|||
25139514|NCT02020616|50252628|FG001|Overall Study|Lost to Follow-up|1|||
25139515|NCT02020616|50252629|FG002|Overall Study|Lost to Follow-up|0|||
25139516|NCT02020616|50252630|FG003|Overall Study|Lost to Follow-up|1|||
25139517|NCT02020616|50252631|FG004|Overall Study|Lost to Follow-up|1|||
25139518|NCT02020616|50252632|FG005|Overall Study|Lost to Follow-up|1|||
25139519|NCT02020616|50252633|FG006|Overall Study|Lost to Follow-up|0|||
25139520|NCT02020616|50252627|FG000|Overall Study|Early Termination Criteria Met|0|||
25139521|NCT02020616|50252628|FG001|Overall Study|Early Termination Criteria Met|0|||
25139522|NCT02020616|50252629|FG002|Overall Study|Early Termination Criteria Met|1|||
25139523|NCT02020616|50252630|FG003|Overall Study|Early Termination Criteria Met|0|||
25139524|NCT02020616|50252631|FG004|Overall Study|Early Termination Criteria Met|0|||
25139525|NCT02020616|50252632|FG005|Overall Study|Early Termination Criteria Met|1|||
25139526|NCT02020616|50252633|FG006|Overall Study|Early Termination Criteria Met|0|||
25139527|NCT02020616|50252627|FG000|Overall Study|Randomized in Error|0|||
25139528|NCT02020616|50252628|FG001|Overall Study|Randomized in Error|0|||
25139529|NCT02020616|50252629|FG002|Overall Study|Randomized in Error|0|||
25139530|NCT02020616|50252630|FG003|Overall Study|Randomized in Error|1|||
25139531|NCT02020616|50252631|FG004|Overall Study|Randomized in Error|0|||
25139532|NCT02020616|50252632|FG005|Overall Study|Randomized in Error|0|||
25274005|NCT01254344|50588087|FG001|Overall Study|Adverse Event|5|||
25139533|NCT02020616|50252633|FG006|Overall Study|Randomized in Error|0|||
25139534|NCT02020616|50252627|FG000|Overall Study|Lack of Efficacy|0|||
25139535|NCT02020616|50252628|FG001|Overall Study|Lack of Efficacy|0|||
25139536|NCT02020616|50252629|FG002|Overall Study|Lack of Efficacy|0|||
25139537|NCT02020616|50252630|FG003|Overall Study|Lack of Efficacy|0|||
25139538|NCT02020616|50252631|FG004|Overall Study|Lack of Efficacy|1|||
25139539|NCT02020616|50252632|FG005|Overall Study|Lack of Efficacy|0|||
25139540|NCT02020616|50252633|FG006|Overall Study|Lack of Efficacy|0|||
25139541|NCT02048072|50252663|FG000|Overall Study|Adverse Event|3|||
25139542|NCT02048072|50252663|FG000|Overall Study|Lost to Follow-up|1|||
25139543|NCT02047604|50252673|FG000|Overall Study|Withdrawal by Subject|0|||
25139544|NCT02047604|50252674|FG001|Overall Study|Withdrawal by Subject|0|||
25139545|NCT02047604|50252675|FG002|Overall Study|Withdrawal by Subject|0|||
25139546|NCT02047604|50252676|FG003|Overall Study|Withdrawal by Subject|0|||
25139547|NCT02047604|50252677|FG004|Overall Study|Withdrawal by Subject|1|||
25139548|NCT02047604|50252678|FG005|Overall Study|Withdrawal by Subject|1|||
25139549|NCT01622660|50252692|FG000|Overall Study|Adverse Event|1|||
25139550|NCT02019602|50252698|FG000|Screening Period|Ineligibility|4|||
25139551|NCT02019602|50252699|FG001|Screening Period|Ineligibility|0|||
25139552|NCT02019602|50252698|FG000|Screening Period|Adverse Event|1|||
25139553|NCT02019602|50252699|FG001|Screening Period|Adverse Event|0|||
25139554|NCT01994876|50252706|FG000|Test Period 1|Withdrawal by Subject|0|||
25139555|NCT01994876|50252707|FG001|Test Period 1|Withdrawal by Subject|1|||
25139556|NCT01994876|50252706|FG000|Test Period 1|Adverse Event|0|||
25139557|NCT01994876|50252707|FG001|Test Period 1|Adverse Event|1|||
25139558|NCT01994876|50252706|FG000|Test Period 2|Adverse Event|1|||
25139559|NCT01994876|50252707|FG001|Test Period 2|Adverse Event|0|||
25139560|NCT01994876|50252706|FG000|Test Period 2|Protocol Violation|0|||
25139561|NCT01994876|50252707|FG001|Test Period 2|Protocol Violation|1|||
25139562|NCT02040428|50252717|FG000|Overall Study|Death|4|||
25139563|NCT02040428|50252718|FG001|Overall Study|Death|3|||
25139564|NCT02040428|50252717|FG000|Overall Study|Withdrawal by Subject|1|||
25179114|NCT01693562|50324400|FG014|Expansion Phase|Withdrawal by Subject|16|||
25139565|NCT02040428|50252718|FG001|Overall Study|Withdrawal by Subject|1|||
25139566|NCT02018822|50252726|FG000|Overall Study|filling replaced by crown|0|||
25139567|NCT02018822|50252727|FG001|Overall Study|filling replaced by crown|1|||
25139568|NCT02018822|50252728|FG002|Overall Study|filling replaced by crown|0|||
25139569|NCT02018822|50252726|FG000|Overall Study|Physician Decision|0|||
25139570|NCT02018822|50252727|FG001|Overall Study|Physician Decision|1|||
25179115|NCT01693562|50324401|FG015|Expansion Phase|Withdrawal by Subject|7|||
25139571|NCT02018822|50252728|FG002|Overall Study|Physician Decision|1|||
25139572|NCT02018822|50252726|FG000|Overall Study|Lost to Follow-up|6|||
25139573|NCT02018822|50252727|FG001|Overall Study|Lost to Follow-up|6|||
25139574|NCT02018822|50252728|FG002|Overall Study|Lost to Follow-up|5|||
25139575|NCT02055157|50252743|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
25139576|NCT02055157|50252744|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
25139577|NCT02055157|50252745|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
25139578|NCT02055157|50252746|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
25139579|NCT02055157|50252743|FG000|Initial 6 Months|Adverse Event|0|||
25139580|NCT02055157|50252744|FG001|Initial 6 Months|Adverse Event|0|||
25139581|NCT02055157|50252745|FG002|Initial 6 Months|Adverse Event|0|||
25139582|NCT02055157|50252746|FG003|Initial 6 Months|Adverse Event|1|||
25139583|NCT02055157|50252743|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
25139584|NCT02055157|50252744|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
25139585|NCT02055157|50252745|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
25139586|NCT02055157|50252746|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
25139587|NCT02055157|50252743|FG000|18-month Extension|Investigator decision|0|||
25139588|NCT02055157|50252744|FG001|18-month Extension|Investigator decision|1|||
25139589|NCT02055157|50252745|FG002|18-month Extension|Investigator decision|0|||
25139590|NCT02055157|50252746|FG003|18-month Extension|Investigator decision|0|||
25139591|NCT02055157|50252743|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
25139592|NCT02055157|50252744|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
25139593|NCT02055157|50252745|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
25139594|NCT02055157|50252746|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
25139595|NCT02022007|50252770|FG000|Overall Study|Withdrawal by Subject|1|||
25139596|NCT02022007|50252771|FG001|Overall Study|Withdrawal by Subject|1|||
25139597|NCT02022007|50252772|FG002|Overall Study|Withdrawal by Subject|1|||
25139598|NCT02022007|50252770|FG000|Overall Study|Noncompliant|0|||
25139599|NCT02022007|50252771|FG001|Overall Study|Noncompliant|0|||
25139600|NCT02022007|50252772|FG002|Overall Study|Noncompliant|1|||
25139601|NCT02031679|50252782|FG000|Overall Study|Protocol Violation|0|||
25139602|NCT02031679|50252783|FG001|Overall Study|Protocol Violation|1|||
25139603|NCT02031679|50252782|FG000|Overall Study|Lack of Efficacy|0|||
25139604|NCT02031679|50252783|FG001|Overall Study|Lack of Efficacy|1|||
25139605|NCT02053753|50252791|FG000|Overall Study|Withdrawal by Subject|2|||
25139606|NCT02053753|50252792|FG001|Overall Study|Withdrawal by Subject|4|||
25139607|NCT02053753|50252791|FG000|Overall Study|Decision by Sponsor|1|||
25139608|NCT02053753|50252792|FG001|Overall Study|Decision by Sponsor|1|||
25139609|NCT02053753|50252791|FG000|Overall Study|Lost to Follow-up|4|||
25139610|NCT02053753|50252792|FG001|Overall Study|Lost to Follow-up|3|||
25139611|NCT02019979|50252798|FG000|Overall Study|study terminated|14|||
25139612|NCT02019667|50252802|FG000|First Intervention (6 Months)|Adverse Event|0|||
25139613|NCT02019667|50252803|FG001|First Intervention (6 Months)|Adverse Event|1|||
25139614|NCT02019667|50252802|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
25139615|NCT02019667|50252803|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
25139616|NCT02019667|50252802|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
25139617|NCT02019667|50252803|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
25139618|NCT02030821|50252815|FG000|Overall Study|Physician Decision|2|||
25139619|NCT02030821|50252816|FG001|Overall Study|Physician Decision|2|||
25139620|NCT02030821|50252817|FG002|Overall Study|Physician Decision|5|||
25139621|NCT02030821|50252818|FG003|Overall Study|Physician Decision|2|||
25139622|NCT02052739|50252830|FG000|Overall Study|Withdrew due to Adverse Event|3|||
25139623|NCT02052739|50252831|FG001|Overall Study|Withdrew due to Adverse Event|0|||
25139624|NCT02052739|50252830|FG000|Overall Study|Participant Died|2|||
25139625|NCT02052739|50252831|FG001|Overall Study|Participant Died|1|||
25139626|NCT02019277|50252839|FG000|Overall Study|Withdrawal by Subject|3|||
25139627|NCT02019277|50252839|FG000|Overall Study|Death|7|||
25139628|NCT02019277|50252839|FG000|Overall Study|Did no Cooperate|1|||
25139629|NCT02019277|50252839|FG000|Overall Study|Adverse Event|1|||
25139630|NCT02030119|50252847|FG000|Overall Study|Withdrawal by Subject|3|||
25139631|NCT02030119|50252848|FG001|Overall Study|Withdrawal by Subject|1|||
25139632|NCT02030119|50252849|FG002|Overall Study|Withdrawal by Subject|5|||
25139633|NCT02030119|50252850|FG003|Overall Study|Withdrawal by Subject|3|||
25139634|NCT02030119|50252847|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
25139635|NCT02030119|50252848|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
25139636|NCT02030119|50252849|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
25139637|NCT02030119|50252850|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
25139638|NCT01823835|50252875|FG000|Overall Study|Adverse Event|0|||
25139639|NCT01823835|50252876|FG001|Overall Study|Adverse Event|0|||
25139640|NCT01823835|50252877|FG002|Overall Study|Adverse Event|0|||
25139641|NCT01823835|50252878|FG003|Overall Study|Adverse Event|0|||
25139642|NCT01823835|50252879|FG004|Overall Study|Adverse Event|1|||
25139643|NCT01823835|50252880|FG005|Overall Study|Adverse Event|0|||
25139644|NCT01823835|50252881|FG006|Overall Study|Adverse Event|1|||
25139645|NCT01823835|50252882|FG007|Overall Study|Adverse Event|0|||
25139646|NCT01823835|50252883|FG008|Overall Study|Adverse Event|0|||
25139647|NCT01823835|50252884|FG009|Overall Study|Adverse Event|0|||
25139648|NCT01823835|50252885|FG010|Overall Study|Adverse Event|1|||
25139649|NCT01823835|50252886|FG011|Overall Study|Adverse Event|2|||
25139650|NCT01823835|50252887|FG012|Overall Study|Adverse Event|0|||
25139651|NCT01823835|50252888|FG013|Overall Study|Adverse Event|0|||
25139652|NCT01823835|50252889|FG014|Overall Study|Adverse Event|0|||
25139653|NCT01823835|50252875|FG000|Overall Study|Physician Decision|0|||
25139654|NCT01823835|50252876|FG001|Overall Study|Physician Decision|0|||
25139655|NCT01823835|50252877|FG002|Overall Study|Physician Decision|0|||
25139656|NCT01823835|50252878|FG003|Overall Study|Physician Decision|0|||
25139657|NCT01823835|50252879|FG004|Overall Study|Physician Decision|0|||
25139658|NCT01823835|50252880|FG005|Overall Study|Physician Decision|0|||
25139659|NCT01823835|50252881|FG006|Overall Study|Physician Decision|0|||
25139660|NCT01823835|50252882|FG007|Overall Study|Physician Decision|0|||
25139661|NCT01823835|50252883|FG008|Overall Study|Physician Decision|0|||
25139662|NCT01823835|50252884|FG009|Overall Study|Physician Decision|0|||
25139663|NCT01823835|50252885|FG010|Overall Study|Physician Decision|0|||
25139664|NCT01823835|50252886|FG011|Overall Study|Physician Decision|2|||
25139665|NCT01823835|50252887|FG012|Overall Study|Physician Decision|0|||
25139666|NCT01823835|50252888|FG013|Overall Study|Physician Decision|0|||
25139667|NCT01823835|50252889|FG014|Overall Study|Physician Decision|0|||
25139668|NCT01823835|50252875|FG000|Overall Study|Progressive Disease|3|||
25139669|NCT01823835|50252876|FG001|Overall Study|Progressive Disease|4|||
25139670|NCT01823835|50252877|FG002|Overall Study|Progressive Disease|3|||
25139671|NCT01823835|50252878|FG003|Overall Study|Progressive Disease|6|||
25139672|NCT01823835|50252879|FG004|Overall Study|Progressive Disease|4|||
25139673|NCT01823835|50252880|FG005|Overall Study|Progressive Disease|6|||
25139674|NCT01823835|50252881|FG006|Overall Study|Progressive Disease|5|||
25139675|NCT01823835|50252882|FG007|Overall Study|Progressive Disease|3|||
25139676|NCT01823835|50252883|FG008|Overall Study|Progressive Disease|3|||
25139677|NCT01823835|50252884|FG009|Overall Study|Progressive Disease|18|||
25139678|NCT01823835|50252885|FG010|Overall Study|Progressive Disease|8|||
25139679|NCT01823835|50252886|FG011|Overall Study|Progressive Disease|46|||
25139680|NCT01823835|50252887|FG012|Overall Study|Progressive Disease|18|||
25179116|NCT01693562|50324402|FG016|Expansion Phase|Withdrawal by Subject|40|||
25139681|NCT01823835|50252888|FG013|Overall Study|Progressive Disease|4|||
25139682|NCT01823835|50252889|FG014|Overall Study|Progressive Disease|6|||
25139683|NCT01823835|50252875|FG000|Overall Study|Study Termination|0|||
25139684|NCT01823835|50252876|FG001|Overall Study|Study Termination|0|||
25139685|NCT01823835|50252877|FG002|Overall Study|Study Termination|0|||
25139686|NCT01823835|50252878|FG003|Overall Study|Study Termination|0|||
25139687|NCT01823835|50252879|FG004|Overall Study|Study Termination|1|||
25139688|NCT01823835|50252880|FG005|Overall Study|Study Termination|0|||
25139689|NCT01823835|50252881|FG006|Overall Study|Study Termination|0|||
25139690|NCT01823835|50252882|FG007|Overall Study|Study Termination|0|||
25139691|NCT01823835|50252883|FG008|Overall Study|Study Termination|0|||
25139692|NCT01823835|50252884|FG009|Overall Study|Study Termination|0|||
25139693|NCT01823835|50252885|FG010|Overall Study|Study Termination|0|||
25139694|NCT01823835|50252886|FG011|Overall Study|Study Termination|1|||
25139695|NCT01823835|50252887|FG012|Overall Study|Study Termination|0|||
25139696|NCT01823835|50252888|FG013|Overall Study|Study Termination|0|||
25139697|NCT01823835|50252889|FG014|Overall Study|Study Termination|0|||
25139698|NCT01823835|50252875|FG000|Overall Study|Withdrawal by Subject|0|||
25139699|NCT01823835|50252876|FG001|Overall Study|Withdrawal by Subject|0|||
25179117|NCT01693562|50324403|FG017|Expansion Phase|Withdrawal by Subject|4|||
25274006|NCT01254344|50588086|FG000|Overall Study|Physician Decision|7|||
25139700|NCT01823835|50252877|FG002|Overall Study|Withdrawal by Subject|1|||
25139701|NCT01823835|50252878|FG003|Overall Study|Withdrawal by Subject|0|||
25274007|NCT01254344|50588087|FG001|Overall Study|Physician Decision|4|||
25274008|NCT01254344|50588086|FG000|Overall Study|Protocol Violation|1|||
25274009|NCT01254344|50588087|FG001|Overall Study|Protocol Violation|4|||
25274010|NCT01254344|50588086|FG000|Overall Study|Withdrawal by Subject|3|||
25274011|NCT01254344|50588087|FG001|Overall Study|Withdrawal by Subject|6|||
25274012|NCT01102803|50588095|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
25274013|NCT01102803|50588096|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
25274014|NCT01102803|50588095|FG000|Post to Follow-Up|Lost to Follow-up|1|||
25274015|NCT01102803|50588096|FG001|Post to Follow-Up|Lost to Follow-up|3|||
25274016|NCT01254188|50588104|FG000|Overall Study|Disease Progression|6|||
25274017|NCT01254188|50588104|FG000|Overall Study|Protocol Violation|6|||
25274018|NCT01254188|50588104|FG000|Overall Study|Pregnancy|2|||
25274019|NCT01254188|50588104|FG000|Overall Study|Death|4|||
25274020|NCT01254188|50588104|FG000|Overall Study|Lost to Follow-up|5|||
25274021|NCT01254188|50588104|FG000|Overall Study|Withdrawal by Subject|7|||
25274022|NCT01254188|50588104|FG000|Overall Study|Adverse Event|43|||
25274023|NCT01254188|50588104|FG000|Overall Study|per investigator discretion|20|||
25274024|NCT01109979|50588110|FG000|Overall Study|Physician Decision|2|||
25274025|NCT01109979|50588111|FG001|Overall Study|Physician Decision|0|||
25274026|NCT01109979|50588110|FG000|Overall Study|Withdrawal by Subject|0|||
25274027|NCT01109979|50588111|FG001|Overall Study|Withdrawal by Subject|1|||
25139702|NCT01823835|50252879|FG004|Overall Study|Withdrawal by Subject|0|||
25139703|NCT01823835|50252880|FG005|Overall Study|Withdrawal by Subject|0|||
25139704|NCT01823835|50252881|FG006|Overall Study|Withdrawal by Subject|0|||
25139705|NCT01823835|50252882|FG007|Overall Study|Withdrawal by Subject|0|||
25139706|NCT01823835|50252883|FG008|Overall Study|Withdrawal by Subject|0|||
25139707|NCT01823835|50252884|FG009|Overall Study|Withdrawal by Subject|1|||
25139708|NCT01823835|50252885|FG010|Overall Study|Withdrawal by Subject|1|||
25139709|NCT01823835|50252886|FG011|Overall Study|Withdrawal by Subject|2|||
25139710|NCT01823835|50252887|FG012|Overall Study|Withdrawal by Subject|1|||
25179118|NCT01693562|50324404|FG018|Expansion Phase|Withdrawal by Subject|8|||
25139711|NCT01823835|50252888|FG013|Overall Study|Withdrawal by Subject|0|||
25139712|NCT01823835|50252889|FG014|Overall Study|Withdrawal by Subject|0|||
25139713|NCT02173379|50252931|FG000|Overall Study|Lost to Follow-up|48|||
25139714|NCT02173379|50252932|FG001|Overall Study|Lost to Follow-up|34|||
25139715|NCT02173379|50252931|FG000|Overall Study|Withdrawal by Subject|14|||
25139716|NCT02173379|50252932|FG001|Overall Study|Withdrawal by Subject|17|||
25139717|NCT02173379|50252931|FG000|Overall Study|Physician Decision|7|||
25139718|NCT02173379|50252932|FG001|Overall Study|Physician Decision|4|||
25139719|NCT02173379|50252931|FG000|Overall Study|Death|22|||
25139720|NCT02173379|50252932|FG001|Overall Study|Death|22|||
25139721|NCT01823679|50252939|FG000|Overall Study|Death|1|||
25139722|NCT01823289|50252944|FG000|Overall Study|Lost to Follow-up|5|||
25139723|NCT01823289|50252944|FG000|Overall Study|Adverse Event|5|||
25139724|NCT01823289|50252944|FG000|Overall Study|Lack of Efficacy|1|||
25139725|NCT01823289|50252944|FG000|Overall Study|Physician Decision|9|||
25139726|NCT01823289|50252944|FG000|Overall Study|Administered contraindicated medicine|1|||
25139727|NCT01823289|50252944|FG000|Overall Study|Transaminase increased more than 3 times|1|||
25139728|NCT01823289|50252944|FG000|Overall Study|Drug affected efficacy and safety|1|||
25139729|NCT01823289|50252944|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
25139730|NCT01822899|50252950|FG000|Overall Study|Adverse Event|6|||
25139731|NCT01822899|50252951|FG001|Overall Study|Adverse Event|5|||
25139732|NCT01822899|50252950|FG000|Overall Study|Lack of Efficacy|6|||
25139733|NCT01822899|50252951|FG001|Overall Study|Lack of Efficacy|3|||
25139734|NCT01822899|50252950|FG000|Overall Study|Protocol Violation|6|||
25139735|NCT01822899|50252951|FG001|Overall Study|Protocol Violation|3|||
25139736|NCT01822899|50252950|FG000|Overall Study|Lost to Follow-up|1|||
25139737|NCT01822899|50252951|FG001|Overall Study|Lost to Follow-up|0|||
25139738|NCT01822899|50252950|FG000|Overall Study|Withdrawal by Subject|5|||
25010177|NCT03529773|50103067|FG035|Overall Study|No longer meets eligibility criteria|0|||
25139739|NCT01822899|50252951|FG001|Overall Study|Withdrawal by Subject|7|||
25139740|NCT01822821|50252959|FG000|Overall Study|Eligible surgery cancelled|1|||
25139741|NCT01822821|50252960|FG001|Overall Study|Eligible surgery cancelled|1|||
25139742|NCT01822821|50252959|FG000|Overall Study|Other reasons|1|||
25139743|NCT01822821|50252960|FG001|Overall Study|Other reasons|0|||
25139744|NCT01822665|50252966|FG000|Overall Study|Adverse Event|3|||
25139745|NCT01822665|50252966|FG000|Overall Study|Other Reason|5|||
25139746|NCT02173301|50252988|FG000|Overall Study|Adverse Event|7|||
25139747|NCT02173301|50252989|FG001|Overall Study|Adverse Event|8|||
25139748|NCT02173301|50252990|FG002|Overall Study|Adverse Event|13|||
25139749|NCT02173301|50252991|FG003|Overall Study|Adverse Event|5|||
25139750|NCT02173301|50252988|FG000|Overall Study|Withdrawal by Subject|8|||
25139751|NCT02173301|50252989|FG001|Overall Study|Withdrawal by Subject|10|||
25139752|NCT02173301|50252990|FG002|Overall Study|Withdrawal by Subject|4|||
25139753|NCT02173301|50252991|FG003|Overall Study|Withdrawal by Subject|8|||
25139754|NCT02173301|50252988|FG000|Overall Study|Lost to Follow-up|4|||
25139755|NCT02173301|50252989|FG001|Overall Study|Lost to Follow-up|4|||
25139756|NCT02173301|50252990|FG002|Overall Study|Lost to Follow-up|2|||
25139757|NCT02173301|50252991|FG003|Overall Study|Lost to Follow-up|2|||
25139758|NCT02173301|50252988|FG000|Overall Study|Protocol Violation|0|||
25139759|NCT02173301|50252989|FG001|Overall Study|Protocol Violation|1|||
25139760|NCT02173301|50252990|FG002|Overall Study|Protocol Violation|0|||
25139761|NCT02173301|50252991|FG003|Overall Study|Protocol Violation|0|||
25139762|NCT02173301|50252988|FG000|Overall Study|Physician Decision|0|||
25139763|NCT02173301|50252989|FG001|Overall Study|Physician Decision|0|||
25139764|NCT02173301|50252990|FG002|Overall Study|Physician Decision|1|||
25139765|NCT02173301|50252991|FG003|Overall Study|Physician Decision|0|||
25139766|NCT02173301|50252988|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
25274028|NCT01102491|50588119|FG000|Overall Study|Protocol Violation|11|||
25274029|NCT01102491|50588120|FG001|Overall Study|Protocol Violation|12|||
25274030|NCT01102257|50588128|FG000|Overall Study|Adverse Event|1|||
25274031|NCT01102257|50588129|FG001|Overall Study|Adverse Event|0|||
25274032|NCT01102257|50588128|FG000|Overall Study|Adverse Event|1|||
25274033|NCT01102257|50588129|FG001|Overall Study|Adverse Event|0|||
25274034|NCT01253564|50588135|FG000|Overall Study|Disease Progression|22|||
25274035|NCT01253564|50588135|FG000|Overall Study|Withdrawal by Subject|1|||
25274036|NCT01253564|50588135|FG000|Overall Study|Serious Adverse Event|1|||
25010178|NCT03529773|50103068|FG036|Overall Study|No longer meets eligibility criteria|0|||
25010179|NCT03529773|50103069|FG037|Overall Study|No longer meets eligibility criteria|0|||
25010180|NCT03529773|50103070|FG038|Overall Study|No longer meets eligibility criteria|1|||
25010181|NCT03529773|50103071|FG039|Overall Study|No longer meets eligibility criteria|0|||
25010182|NCT03529773|50103032|FG000|Overall Study|Other|0|||
25010183|NCT03529773|50103033|FG001|Overall Study|Other|0|||
25010184|NCT03529773|50103034|FG002|Overall Study|Other|0|||
25010185|NCT03529773|50103035|FG003|Overall Study|Other|0|||
25010186|NCT03529773|50103036|FG004|Overall Study|Other|0|||
25010187|NCT03529773|50103037|FG005|Overall Study|Other|0|||
25010188|NCT03529773|50103038|FG006|Overall Study|Other|0|||
25010189|NCT03529773|50103039|FG007|Overall Study|Other|0|||
25010190|NCT03529773|50103040|FG008|Overall Study|Other|0|||
25010191|NCT03529773|50103041|FG009|Overall Study|Other|0|||
25010192|NCT03529773|50103042|FG010|Overall Study|Other|0|||
25010193|NCT03529773|50103043|FG011|Overall Study|Other|0|||
25010194|NCT03529773|50103044|FG012|Overall Study|Other|1|||
25168624|NCT00633243|50298231|FG000|Overall Study|Mental Health--Depression|0|||
25010195|NCT03529773|50103045|FG013|Overall Study|Other|0|||
25010196|NCT03529773|50103046|FG014|Overall Study|Other|2|||
25010197|NCT03529773|50103047|FG015|Overall Study|Other|0|||
25010198|NCT03529773|50103048|FG016|Overall Study|Other|0|||
25010199|NCT03529773|50103049|FG017|Overall Study|Other|3|||
25010200|NCT03529773|50103050|FG018|Overall Study|Other|0|||
25010201|NCT03529773|50103051|FG019|Overall Study|Other|0|||
25010202|NCT03529773|50103052|FG020|Overall Study|Other|1|||
25010203|NCT03529773|50103053|FG021|Overall Study|Other|0|||
25010204|NCT03529773|50103054|FG022|Overall Study|Other|1|||
25010205|NCT03529773|50103055|FG023|Overall Study|Other|0|||
25010206|NCT03529773|50103056|FG024|Overall Study|Other|3|||
25010207|NCT03529773|50103057|FG025|Overall Study|Other|2|||
25010208|NCT03529773|50103058|FG026|Overall Study|Other|2|||
25010209|NCT03529773|50103059|FG027|Overall Study|Other|0|||
25010210|NCT03529773|50103060|FG028|Overall Study|Other|0|||
25010211|NCT03529773|50103061|FG029|Overall Study|Other|0|||
25010212|NCT03529773|50103062|FG030|Overall Study|Other|0|||
25010213|NCT03529773|50103063|FG031|Overall Study|Other|0|||
25010214|NCT03529773|50103064|FG032|Overall Study|Other|0|||
25010215|NCT03529773|50103065|FG033|Overall Study|Other|0|||
25010216|NCT03529773|50103066|FG034|Overall Study|Other|1|||
25010217|NCT03529773|50103067|FG035|Overall Study|Other|1|||
25010218|NCT03529773|50103068|FG036|Overall Study|Other|0|||
25010219|NCT03529773|50103069|FG037|Overall Study|Other|0|||
25010220|NCT03529773|50103070|FG038|Overall Study|Other|0|||
25010221|NCT03529773|50103071|FG039|Overall Study|Other|0|||
25010222|NCT03529773|50103032|FG000|Overall Study|Physician Decision|0|||
25010223|NCT03529773|50103033|FG001|Overall Study|Physician Decision|0|||
25010224|NCT03529773|50103034|FG002|Overall Study|Physician Decision|0|||
25010225|NCT03529773|50103035|FG003|Overall Study|Physician Decision|0|||
25010226|NCT03529773|50103036|FG004|Overall Study|Physician Decision|0|||
25010227|NCT03529773|50103037|FG005|Overall Study|Physician Decision|0|||
25010228|NCT03529773|50103038|FG006|Overall Study|Physician Decision|0|||
25010229|NCT03529773|50103039|FG007|Overall Study|Physician Decision|0|||
25010230|NCT03529773|50103040|FG008|Overall Study|Physician Decision|0|||
25010231|NCT03529773|50103041|FG009|Overall Study|Physician Decision|0|||
25010232|NCT03529773|50103042|FG010|Overall Study|Physician Decision|0|||
25010233|NCT03529773|50103043|FG011|Overall Study|Physician Decision|0|||
25010234|NCT03529773|50103044|FG012|Overall Study|Physician Decision|0|||
25010235|NCT03529773|50103045|FG013|Overall Study|Physician Decision|0|||
25010236|NCT03529773|50103046|FG014|Overall Study|Physician Decision|0|||
25010237|NCT03529773|50103047|FG015|Overall Study|Physician Decision|0|||
25010238|NCT03529773|50103048|FG016|Overall Study|Physician Decision|0|||
25010239|NCT03529773|50103049|FG017|Overall Study|Physician Decision|0|||
25010240|NCT03529773|50103050|FG018|Overall Study|Physician Decision|0|||
25010241|NCT03529773|50103051|FG019|Overall Study|Physician Decision|1|||
25010242|NCT03529773|50103052|FG020|Overall Study|Physician Decision|1|||
25010243|NCT03529773|50103053|FG021|Overall Study|Physician Decision|0|||
25010244|NCT03529773|50103054|FG022|Overall Study|Physician Decision|0|||
25010245|NCT03529773|50103055|FG023|Overall Study|Physician Decision|0|||
25274037|NCT01108809|50588139|FG000|Overall Study|Adverse Event|3|||
25274038|NCT01108809|50588139|FG000|Overall Study|Lost to Follow-up|1|||
25274039|NCT01253408|50588147|FG000|Overall Study|Adverse Event|0|||
25274040|NCT01253408|50588148|FG001|Overall Study|Adverse Event|1|||
25274041|NCT01253408|50588149|FG002|Overall Study|Adverse Event|0|||
25274042|NCT01253174|50588157|FG000|Period 1|Randomized but not treated|0|||
25274043|NCT01253174|50588158|FG001|Period 1|Randomized but not treated|1|||
25274044|NCT01253174|50588159|FG002|Period 1|Randomized but not treated|1|||
25274045|NCT01253174|50588160|FG003|Period 1|Randomized but not treated|0|||
25274046|NCT01253174|50588161|FG004|Period 1|Randomized but not treated|1|||
25274047|NCT01253174|50588162|FG005|Period 1|Randomized but not treated|0|||
25274048|NCT01253174|50588157|FG000|Period 2|Adverse Event|0|||
25274049|NCT01253174|50588158|FG001|Period 2|Adverse Event|0|||
25274050|NCT01253174|50588159|FG002|Period 2|Adverse Event|1|||
25274051|NCT01253174|50588160|FG003|Period 2|Adverse Event|0|||
25274052|NCT01253174|50588161|FG004|Period 2|Adverse Event|0|||
25274053|NCT01253174|50588162|FG005|Period 2|Adverse Event|0|||
25274054|NCT01253174|50588157|FG000|Period 3|Withdrawal by Subject|0|||
25274055|NCT01253174|50588158|FG001|Period 3|Withdrawal by Subject|1|||
25274056|NCT01253174|50588159|FG002|Period 3|Withdrawal by Subject|0|||
25274057|NCT01253174|50588160|FG003|Period 3|Withdrawal by Subject|0|||
25274058|NCT01253174|50588161|FG004|Period 3|Withdrawal by Subject|1|||
25274059|NCT01253174|50588162|FG005|Period 3|Withdrawal by Subject|0|||
25274060|NCT01253174|50588157|FG000|Period 3|Pregnancy|0|||
25274061|NCT01253174|50588158|FG001|Period 3|Pregnancy|0|||
25010246|NCT03529773|50103056|FG024|Overall Study|Physician Decision|0|||
25010247|NCT03529773|50103057|FG025|Overall Study|Physician Decision|0|||
25010248|NCT03529773|50103058|FG026|Overall Study|Physician Decision|0|||
25010249|NCT03529773|50103059|FG027|Overall Study|Physician Decision|0|||
25010250|NCT03529773|50103060|FG028|Overall Study|Physician Decision|0|||
25274062|NCT01253174|50588159|FG002|Period 3|Pregnancy|1|||
25274063|NCT01253174|50588160|FG003|Period 3|Pregnancy|0|||
25274064|NCT01253174|50588161|FG004|Period 3|Pregnancy|0|||
25139767|NCT02173301|50252989|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
25010251|NCT03529773|50103061|FG029|Overall Study|Physician Decision|0|||
25010252|NCT03529773|50103062|FG030|Overall Study|Physician Decision|0|||
25010253|NCT03529773|50103063|FG031|Overall Study|Physician Decision|0|||
25010254|NCT03529773|50103064|FG032|Overall Study|Physician Decision|0|||
25010255|NCT03529773|50103065|FG033|Overall Study|Physician Decision|0|||
25010256|NCT03529773|50103066|FG034|Overall Study|Physician Decision|0|||
25010257|NCT03529773|50103067|FG035|Overall Study|Physician Decision|0|||
25010258|NCT03529773|50103068|FG036|Overall Study|Physician Decision|0|||
25010259|NCT03529773|50103069|FG037|Overall Study|Physician Decision|0|||
25274065|NCT01253174|50588162|FG005|Period 3|Pregnancy|0|||
25274066|NCT01108731|50588173|FG000|Overall Study|Withdrawal by Subject|1|||
25274067|NCT01108731|50588174|FG001|Overall Study|Withdrawal by Subject|1|||
25274068|NCT01108731|50588173|FG000|Overall Study|Adverse Event|3|||
25274069|NCT01108731|50588174|FG001|Overall Study|Adverse Event|3|||
25274070|NCT01253018|50588182|FG000|Overall Study|Lost to Follow-up|1|||
25168625|NCT00633243|50298232|FG001|Overall Study|Mental Health--Depression|1|||
25274071|NCT01253018|50588183|FG001|Overall Study|Lost to Follow-up|1|||
25274072|NCT01253018|50588182|FG000|Overall Study|Robot Repair Issues|2|||
25274073|NCT01253018|50588183|FG001|Overall Study|Robot Repair Issues|0|||
25274074|NCT01253018|50588182|FG000|Overall Study|Withdrawal by Subject|1|||
25010260|NCT03529773|50103070|FG038|Overall Study|Physician Decision|0|||
25010261|NCT03529773|50103071|FG039|Overall Study|Physician Decision|0|||
25010262|NCT03529773|50103032|FG000|Overall Study|Protocol Violation|0|||
25010263|NCT03529773|50103033|FG001|Overall Study|Protocol Violation|0|||
25010264|NCT03529773|50103034|FG002|Overall Study|Protocol Violation|0|||
25010265|NCT03529773|50103035|FG003|Overall Study|Protocol Violation|0|||
25010266|NCT03529773|50103036|FG004|Overall Study|Protocol Violation|0|||
25010267|NCT03529773|50103037|FG005|Overall Study|Protocol Violation|0|||
25010268|NCT03529773|50103038|FG006|Overall Study|Protocol Violation|0|||
25274075|NCT01253018|50588183|FG001|Overall Study|Withdrawal by Subject|1|||
25274076|NCT01108341|50588190|FG000|Overall Study|Death|2|||
25274077|NCT01108341|50588190|FG000|Overall Study|Withdrawal by Subject|1|||
25274078|NCT01108341|50588190|FG000|Overall Study|Lost to Follow-up|1|||
25274079|NCT01108341|50588190|FG000|Overall Study|Other|1|||
25274080|NCT01108263|50588196|FG000|Overall Study|Adverse Event|0|||
25274081|NCT01108263|50588197|FG001|Overall Study|Adverse Event|1|||
25274082|NCT01108185|50588203|FG000|Overall Study|Non-compliance|15|||
25274083|NCT01108185|50588203|FG000|Overall Study|Lost to Follow-up|12|||
25274084|NCT01252940|50588209|FG000|Main Study Phase|Randomized but not treated|4|||
25274085|NCT01252940|50588210|FG001|Main Study Phase|Randomized but not treated|2|||
25274086|NCT01252940|50588209|FG000|Main Study Phase|Adverse Event|3|||
25274087|NCT01252940|50588210|FG001|Main Study Phase|Adverse Event|1|||
25274088|NCT01252940|50588209|FG000|Main Study Phase|Lack of Efficacy|1|||
25274089|NCT01252940|50588210|FG001|Main Study Phase|Lack of Efficacy|0|||
25274090|NCT01252940|50588209|FG000|Main Study Phase|Lost to Follow-up|6|||
25274091|NCT01252940|50588210|FG001|Main Study Phase|Lost to Follow-up|1|||
25274092|NCT01252940|50588209|FG000|Main Study Phase|Physician Decision|1|||
25274093|NCT01252940|50588210|FG001|Main Study Phase|Physician Decision|0|||
25274094|NCT01252940|50588209|FG000|Main Study Phase|Protocol Violation|4|||
25274095|NCT01252940|50588210|FG001|Main Study Phase|Protocol Violation|2|||
25274096|NCT01252940|50588209|FG000|Main Study Phase|Withdrawal by Subject|6|||
25274097|NCT01252940|50588210|FG001|Main Study Phase|Withdrawal by Subject|5|||
25274098|NCT01252940|50588209|FG000|Main Study Phase|Subject Non-compliance|1|||
25274099|NCT01252940|50588210|FG001|Main Study Phase|Subject Non-compliance|1|||
25274100|NCT01252940|50588209|FG000|Extension Phase|Adverse Event|2|||
25274101|NCT01252940|50588210|FG001|Extension Phase|Adverse Event|1|||
25274102|NCT01252940|50588209|FG000|Extension Phase|Lack of Efficacy|1|||
25274103|NCT01252940|50588210|FG001|Extension Phase|Lack of Efficacy|0|||
25274104|NCT01252940|50588209|FG000|Extension Phase|Lost to Follow-up|5|||
25274105|NCT01252940|50588210|FG001|Extension Phase|Lost to Follow-up|0|||
25274106|NCT01252940|50588209|FG000|Extension Phase|Physician Decision|0|||
25274107|NCT01252940|50588210|FG001|Extension Phase|Physician Decision|1|||
25274108|NCT01252940|50588209|FG000|Extension Phase|Subject Non-compliance|1|||
25274109|NCT01252940|50588210|FG001|Extension Phase|Subject Non-compliance|0|||
25274110|NCT01252940|50588209|FG000|Extension Phase|Withdrawal by Subject|1|||
25274111|NCT01252940|50588210|FG001|Extension Phase|Withdrawal by Subject|1|||
25274112|NCT01252238|50588220|FG000|Overall Study|Sponsor terminated study|4|||
25274113|NCT01252238|50588221|FG001|Overall Study|Sponsor terminated study|4|||
25274114|NCT01252238|50588222|FG002|Overall Study|Sponsor terminated study|4|||
25274115|NCT01101477|50588236|FG000|Overall Study|Protocol Violation|5|||
25274116|NCT01101477|50588237|FG001|Overall Study|Protocol Violation|3|||
25274117|NCT01101477|50588238|FG002|Overall Study|Protocol Violation|1|||
25274118|NCT01251770|50588248|FG000|Overall Study|Protocol Violation|13|||
25274119|NCT01251770|50588249|FG001|Overall Study|Protocol Violation|7|||
25274120|NCT01101321|50588255|FG000|Period 1|Withdrawal by Subject|1|||
25274121|NCT01101321|50588256|FG001|Period 1|Withdrawal by Subject|1|||
25274122|NCT01101321|50588255|FG000|Period 1|Adverse Event|3|||
25274123|NCT01101321|50588256|FG001|Period 1|Adverse Event|3|||
25274124|NCT01101165|50588262|FG000|Period 1|Adverse Event|1|||
25274125|NCT01101165|50588263|FG001|Period 1|Adverse Event|2|||
25274126|NCT01101165|50588262|FG000|Period 1|Withdrawal by Subject|0|||
25274127|NCT01101165|50588263|FG001|Period 1|Withdrawal by Subject|2|||
25274128|NCT01101165|50588262|FG000|Period 1|Positive Drug Screen|0|||
25274129|NCT01101165|50588263|FG001|Period 1|Positive Drug Screen|1|||
25274130|NCT01101165|50588262|FG000|Period 1|Lost to Follow-up|1|||
25274131|NCT01101165|50588263|FG001|Period 1|Lost to Follow-up|0|||
25274132|NCT01101165|50588262|FG000|Period 2|Withdrawal by Subject|3|||
25274133|NCT01101165|50588263|FG001|Period 2|Withdrawal by Subject|1|||
25274134|NCT01101165|50588262|FG000|Period 2|Adverse Event|1|||
25274135|NCT01101165|50588263|FG001|Period 2|Adverse Event|0|||
25274136|NCT01100853|50588271|FG000|Overall Study|Lost to Follow-up|11|||
25274137|NCT01100853|50588272|FG001|Overall Study|Lost to Follow-up|6|||
25274138|NCT01100853|50588271|FG000|Overall Study|Received <4 study injections|10|||
25274139|NCT01100853|50588272|FG001|Overall Study|Received <4 study injections|13|||
25274140|NCT01100853|50588271|FG000|Overall Study|Withdrawal by Subject|6|||
25274141|NCT01100853|50588272|FG001|Overall Study|Withdrawal by Subject|4|||
25274142|NCT01100307|50588280|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
25274143|NCT01100307|50588281|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
25274144|NCT01100307|50588280|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
25274145|NCT01100307|50588281|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
25274146|NCT01100307|50588280|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
25274147|NCT01100307|50588281|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
25274148|NCT01100307|50588280|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
25274149|NCT01100307|50588281|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
25010269|NCT03529773|50103039|FG007|Overall Study|Protocol Violation|0|||
25010270|NCT03529773|50103040|FG008|Overall Study|Protocol Violation|0|||
25010271|NCT03529773|50103041|FG009|Overall Study|Protocol Violation|0|||
25139768|NCT02173301|50252990|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
25139769|NCT02173301|50252991|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
25139770|NCT01822587|50253004|FG000|Overall Study|Lost to Follow-up|7|||
25139771|NCT01822587|50253005|FG001|Overall Study|Lost to Follow-up|9|||
25139772|NCT01822587|50253006|FG002|Overall Study|Lost to Follow-up|12|||
25139773|NCT01822587|50253004|FG000|Overall Study|Physician Decision|9|||
25010272|NCT03529773|50103042|FG010|Overall Study|Protocol Violation|0|||
25010273|NCT03529773|50103043|FG011|Overall Study|Protocol Violation|0|||
25010274|NCT03529773|50103044|FG012|Overall Study|Protocol Violation|0|||
25010275|NCT03529773|50103045|FG013|Overall Study|Protocol Violation|0|||
25010276|NCT03529773|50103046|FG014|Overall Study|Protocol Violation|0|||
25010277|NCT03529773|50103047|FG015|Overall Study|Protocol Violation|0|||
25010278|NCT03529773|50103048|FG016|Overall Study|Protocol Violation|0|||
25010279|NCT03529773|50103049|FG017|Overall Study|Protocol Violation|0|||
25010280|NCT03529773|50103050|FG018|Overall Study|Protocol Violation|0|||
25010281|NCT03529773|50103051|FG019|Overall Study|Protocol Violation|0|||
25010282|NCT03529773|50103052|FG020|Overall Study|Protocol Violation|0|||
25010283|NCT03529773|50103053|FG021|Overall Study|Protocol Violation|0|||
25010284|NCT03529773|50103054|FG022|Overall Study|Protocol Violation|0|||
25010285|NCT03529773|50103055|FG023|Overall Study|Protocol Violation|0|||
25010286|NCT03529773|50103056|FG024|Overall Study|Protocol Violation|0|||
25010287|NCT03529773|50103057|FG025|Overall Study|Protocol Violation|0|||
25010288|NCT03529773|50103058|FG026|Overall Study|Protocol Violation|0|||
25010289|NCT03529773|50103059|FG027|Overall Study|Protocol Violation|0|||
25010290|NCT03529773|50103060|FG028|Overall Study|Protocol Violation|0|||
25010291|NCT03529773|50103061|FG029|Overall Study|Protocol Violation|0|||
25010292|NCT03529773|50103062|FG030|Overall Study|Protocol Violation|1|||
25010293|NCT03529773|50103063|FG031|Overall Study|Protocol Violation|0|||
25010294|NCT03529773|50103064|FG032|Overall Study|Protocol Violation|0|||
25010295|NCT03529773|50103065|FG033|Overall Study|Protocol Violation|0|||
25139774|NCT01822587|50253005|FG001|Overall Study|Physician Decision|6|||
25139775|NCT01822587|50253006|FG002|Overall Study|Physician Decision|6|||
25139776|NCT01822353|50253017|FG000|Overall Study|Adverse Event|1|||
25139777|NCT01822353|50253018|FG001|Overall Study|Adverse Event|3|||
25139778|NCT01822353|50253019|FG002|Overall Study|Adverse Event|1|||
25139779|NCT01822353|50253017|FG000|Overall Study|Pregnancy|0|||
25139780|NCT01822353|50253018|FG001|Overall Study|Pregnancy|1|||
25139781|NCT01822353|50253019|FG002|Overall Study|Pregnancy|0|||
25139782|NCT01822353|50253017|FG000|Overall Study|Withdrawal by Subject|3|||
25139783|NCT01822353|50253018|FG001|Overall Study|Withdrawal by Subject|1|||
25139784|NCT01822353|50253019|FG002|Overall Study|Withdrawal by Subject|0|||
25139785|NCT01821963|50253030|FG000|Overall Study|Adverse Event|1|||
25139786|NCT01821807|50253036|FG000|Overall Study|Lost to Follow-up|3|||
25139787|NCT01821807|50253037|FG001|Overall Study|Lost to Follow-up|1|||
25139788|NCT01821729|50253043|FG000|Overall Study|Withdrawal by Subject|1|||
25139789|NCT01820637|50253047|FG000|Overall Study|Death|2|||
25139790|NCT01820637|50253047|FG000|Overall Study|Withdrawal by Subject|1|||
25139791|NCT02172911|50253053|FG000|Overall Study|Serious Adverse Event|0|||
25139792|NCT02172911|50253054|FG001|Overall Study|Serious Adverse Event|1|||
25139793|NCT02172911|50253053|FG000|Overall Study|Progression of Disease|0|||
25139794|NCT02172911|50253054|FG001|Overall Study|Progression of Disease|1|||
25139795|NCT02172911|50253053|FG000|Overall Study|Loss of insurance coverage|1|||
25139796|NCT02172911|50253054|FG001|Overall Study|Loss of insurance coverage|0|||
25139797|NCT02120027|50253062|FG000|Overall Study|Adverse Event|4|||
25139798|NCT02120027|50253063|FG001|Overall Study|Adverse Event|5|||
25139799|NCT02120027|50253062|FG000|Overall Study|Lack of Efficacy|3|||
25139800|NCT02120027|50253063|FG001|Overall Study|Lack of Efficacy|5|||
25139801|NCT02120027|50253062|FG000|Overall Study|Lost to Follow-up|5|||
25139802|NCT02120027|50253063|FG001|Overall Study|Lost to Follow-up|13|||
25139803|NCT02120027|50253062|FG000|Overall Study|Other|4|||
25139804|NCT02120027|50253063|FG001|Overall Study|Other|0|||
25139805|NCT02120027|50253062|FG000|Overall Study|Physician Decision|4|||
25139806|NCT02120027|50253063|FG001|Overall Study|Physician Decision|3|||
25139807|NCT02120027|50253062|FG000|Overall Study|Protocol Violation|18|||
25139808|NCT02120027|50253063|FG001|Overall Study|Protocol Violation|21|||
25139809|NCT02120027|50253062|FG000|Overall Study|Study terminated by Sponsor|45|||
25139810|NCT02120027|50253063|FG001|Overall Study|Study terminated by Sponsor|47|||
25139811|NCT02120027|50253062|FG000|Overall Study|Withdrawal by Subject|33|||
25139812|NCT02120027|50253063|FG001|Overall Study|Withdrawal by Subject|25|||
25139813|NCT01850823|50253072|FG000|Overall Study|Early Visit Window|0|||
25139814|NCT01850823|50253073|FG001|Overall Study|Early Visit Window|1|||
25139815|NCT01850823|50253074|FG002|Overall Study|Early Visit Window|4|||
25139816|NCT01850823|50253072|FG000|Overall Study|Enrolled in Error|0|||
25139817|NCT01850823|50253073|FG001|Overall Study|Enrolled in Error|1|||
25139818|NCT01850823|50253074|FG002|Overall Study|Enrolled in Error|2|||
25139819|NCT01850823|50253072|FG000|Overall Study|Lack of Efficacy|1|||
25139820|NCT01850823|50253073|FG001|Overall Study|Lack of Efficacy|0|||
25139821|NCT01850823|50253074|FG002|Overall Study|Lack of Efficacy|0|||
25139822|NCT01850823|50253072|FG000|Overall Study|Lost to Follow-up|0|||
25139823|NCT01850823|50253073|FG001|Overall Study|Lost to Follow-up|0|||
25139824|NCT01850823|50253074|FG002|Overall Study|Lost to Follow-up|1|||
25139825|NCT01850823|50253072|FG000|Overall Study|Restricted Medication|0|||
25010296|NCT03529773|50103066|FG034|Overall Study|Protocol Violation|0|||
25010297|NCT03529773|50103067|FG035|Overall Study|Protocol Violation|0|||
25010298|NCT03529773|50103068|FG036|Overall Study|Protocol Violation|0|||
25010299|NCT03529773|50103069|FG037|Overall Study|Protocol Violation|0|||
25010300|NCT03529773|50103070|FG038|Overall Study|Protocol Violation|0|||
25139826|NCT01850823|50253073|FG001|Overall Study|Restricted Medication|0|||
25139827|NCT01850823|50253074|FG002|Overall Study|Restricted Medication|2|||
25139828|NCT01850823|50253072|FG000|Overall Study|Significant worstening of SAR|0|||
25139829|NCT01850823|50253073|FG001|Overall Study|Significant worstening of SAR|1|||
25139830|NCT01850823|50253074|FG002|Overall Study|Significant worstening of SAR|0|||
25139831|NCT01850823|50253072|FG000|Overall Study|Withdrawal by Subject|2|||
25139832|NCT01850823|50253073|FG001|Overall Study|Withdrawal by Subject|0|||
25139833|NCT01850823|50253074|FG002|Overall Study|Withdrawal by Subject|1|||
25139834|NCT01820559|50253087|FG000|Overall Study|Adverse Event|4|||
25139835|NCT01820559|50253088|FG001|Overall Study|Adverse Event|6|||
25139836|NCT01820559|50253089|FG002|Overall Study|Adverse Event|13|||
25139837|NCT01820559|50253087|FG000|Overall Study|Withdrawal by Subject|1|||
25139838|NCT01820559|50253088|FG001|Overall Study|Withdrawal by Subject|2|||
25139839|NCT01820559|50253089|FG002|Overall Study|Withdrawal by Subject|5|||
25139840|NCT01820559|50253087|FG000|Overall Study|Protocol Violation|2|||
25139841|NCT01820559|50253088|FG001|Overall Study|Protocol Violation|1|||
25139842|NCT01820559|50253089|FG002|Overall Study|Protocol Violation|3|||
25139843|NCT01820559|50253087|FG000|Overall Study|Subject's non-compliance|1|||
25139844|NCT01820559|50253088|FG001|Overall Study|Subject's non-compliance|0|||
25139845|NCT01820559|50253089|FG002|Overall Study|Subject's non-compliance|2|||
25139846|NCT01820559|50253087|FG000|Overall Study|Lost to Follow-up|3|||
25139847|NCT01820559|50253088|FG001|Overall Study|Lost to Follow-up|2|||
25139848|NCT01820559|50253089|FG002|Overall Study|Lost to Follow-up|2|||
25139849|NCT01820559|50253087|FG000|Overall Study|At sponsor request|0|||
25139850|NCT01820559|50253088|FG001|Overall Study|At sponsor request|0|||
25139851|NCT01820559|50253089|FG002|Overall Study|At sponsor request|1|||
25139852|NCT01820559|50253087|FG000|Overall Study|Lack of Efficacy|3|||
25139853|NCT01820559|50253088|FG001|Overall Study|Lack of Efficacy|2|||
25139854|NCT01820559|50253089|FG002|Overall Study|Lack of Efficacy|3|||
25139855|NCT01818765|50253097|FG000|Overall Study|Death|2|||
25139856|NCT01850589|50253104|FG000|Overall Study|Withdrawal by Subject|8|||
25139857|NCT01850589|50253105|FG001|Overall Study|Withdrawal by Subject|0|||
25139858|NCT01818531|50253113|FG000|Overall Study|Withdrawn for case delay after block|1|||
25139859|NCT01818531|50253114|FG001|Overall Study|Withdrawn for case delay after block|0|||
25139860|NCT01818531|50253113|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
25139861|NCT01818531|50253114|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
25139862|NCT01818531|50253113|FG000|Overall Study|Withdrawn for failure to place block|0|||
25139863|NCT01818531|50253114|FG001|Overall Study|Withdrawn for failure to place block|1|||
25139864|NCT02171429|50253123|FG000|Overall Study|Other|0|||
25139865|NCT02171429|50253124|FG001|Overall Study|Other|1|||
25139866|NCT02171429|50253125|FG002|Overall Study|Other|1|||
25139867|NCT02171429|50253123|FG000|Overall Study|Non-Compliance|0|||
25139868|NCT02171429|50253124|FG001|Overall Study|Non-Compliance|0|||
25139869|NCT02171429|50253125|FG002|Overall Study|Non-Compliance|1|||
25139870|NCT02171429|50253123|FG000|Overall Study|Physician Decision|0|||
25139871|NCT02171429|50253124|FG001|Overall Study|Physician Decision|0|||
25139872|NCT02171429|50253125|FG002|Overall Study|Physician Decision|1|||
25139873|NCT02171429|50253123|FG000|Overall Study|Withdrawal by Subject|1|||
25139874|NCT02171429|50253124|FG001|Overall Study|Withdrawal by Subject|1|||
25139875|NCT02171429|50253125|FG002|Overall Study|Withdrawal by Subject|1|||
25139876|NCT02171429|50253123|FG000|Overall Study|Lost to Follow-up|0|||
25139877|NCT02171429|50253124|FG001|Overall Study|Lost to Follow-up|1|||
25139878|NCT02171429|50253125|FG002|Overall Study|Lost to Follow-up|0|||
25139879|NCT02171429|50253123|FG000|Overall Study|Death|0|||
25139880|NCT02171429|50253124|FG001|Overall Study|Death|0|||
25139881|NCT02171429|50253125|FG002|Overall Study|Death|1|||
25139882|NCT01818297|50253138|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
25139883|NCT01818297|50253139|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
25139884|NCT01818297|50253138|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
25139885|NCT01818297|50253139|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
25139886|NCT01818297|50253138|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
25139887|NCT01818297|50253139|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
25139888|NCT01818141|50253147|FG000|Overall Study|Withdrawal by Subject|2|||
25139889|NCT01818141|50253148|FG001|Overall Study|Withdrawal by Subject|0|||
25139890|NCT01818141|50253147|FG000|Overall Study|No baseline C.diff colonies|1|||
25139891|NCT01818141|50253148|FG001|Overall Study|No baseline C.diff colonies|1|||
25139892|NCT01818141|50253147|FG000|Overall Study|Lost to Follow-up|0|||
25139893|NCT01818141|50253148|FG001|Overall Study|Lost to Follow-up|2|||
25139894|NCT01849497|50253156|FG000|Overall Study|Withdrawal by Subject|1|||
25139895|NCT01849497|50253157|FG001|Overall Study|Withdrawal by Subject|2|||
25139896|NCT01849497|50253156|FG000|Overall Study|Sponsor Decision|0|||
25139897|NCT01849497|50253157|FG001|Overall Study|Sponsor Decision|1|||
25139898|NCT01849497|50253156|FG000|Overall Study|Lost to Follow-up|0|||
25139899|NCT01849497|50253157|FG001|Overall Study|Lost to Follow-up|1|||
25139900|NCT02147093|50253165|FG000|Period 1|Lost to Follow-up|0|||
25139901|NCT02147093|50253166|FG001|Period 1|Lost to Follow-up|1|||
25139902|NCT02147093|50253165|FG000|Period 2|Protocol Violation|2|||
25139903|NCT02147093|50253166|FG001|Period 2|Protocol Violation|0|||
25139904|NCT02119325|50253172|FG000|Washout Period 1|Adverse Event|0|||
25139905|NCT02119325|50253173|FG001|Washout Period 1|Adverse Event|1|||
25139906|NCT01816893|50253183|FG000|Washout Period|Withdrawal by Subject|2|||
25139907|NCT01816893|50253184|FG001|Washout Period|Withdrawal by Subject|0|||
25139908|NCT01848483|50253192|FG000|Overall Study|Death|2|||
25139909|NCT01848483|50253193|FG001|Overall Study|Death|1|||
25139910|NCT01848483|50253192|FG000|Overall Study|Lost to Follow-up|6|||
25139911|NCT01848483|50253193|FG001|Overall Study|Lost to Follow-up|8|||
25139912|NCT01848483|50253192|FG000|Overall Study|Withdrawal by Subject|1|||
25139913|NCT01848483|50253193|FG001|Overall Study|Withdrawal by Subject|0|||
25139914|NCT01848483|50253192|FG000|Overall Study|Incarceration|2|||
25139915|NCT01848483|50253193|FG001|Overall Study|Incarceration|2|||
25139916|NCT01610271|50253202|FG000|Overall Study|Surgery not complete|0|||
25139917|NCT01610271|50253203|FG001|Overall Study|Surgery not complete|1|||
25139918|NCT01610271|50253202|FG000|Overall Study|Prosthesis not implanted|2|||
25139919|NCT01610271|50253203|FG001|Overall Study|Prosthesis not implanted|3|||
25139920|NCT02170727|50253213|FG000|Overall Study|Lost to Follow-up|1|||
25139921|NCT02170727|50253214|FG001|Overall Study|Lost to Follow-up|0|||
25139922|NCT02170727|50253213|FG000|Overall Study|Withdrawal by Subject|2|||
25139923|NCT02170727|50253214|FG001|Overall Study|Withdrawal by Subject|0|||
25139924|NCT01847313|50253225|FG000|Overall Study|Death|0|||
25139925|NCT01847313|50253226|FG001|Overall Study|Death|1|||
25139926|NCT01847313|50253225|FG000|Overall Study|Withdrawal by Subject|0|||
25139927|NCT01847313|50253226|FG001|Overall Study|Withdrawal by Subject|1|||
25139928|NCT02144285|50253242|FG000|Overall Study|Withdrawal by Subject|0|||
25139929|NCT02144285|50253243|FG001|Overall Study|Withdrawal by Subject|0|||
25139930|NCT02144285|50253244|FG002|Overall Study|Withdrawal by Subject|0|||
25139931|NCT02144285|50253245|FG003|Overall Study|Withdrawal by Subject|0|||
25139932|NCT02144285|50253246|FG004|Overall Study|Withdrawal by Subject|1|||
25139933|NCT02144285|50253247|FG005|Overall Study|Withdrawal by Subject|0|||
25139934|NCT02144285|50253248|FG006|Overall Study|Withdrawal by Subject|0|||
25139935|NCT02144285|50253249|FG007|Overall Study|Withdrawal by Subject|0|||
25139936|NCT02144285|50253250|FG008|Overall Study|Withdrawal by Subject|0|||
25139937|NCT02144285|50253251|FG009|Overall Study|Withdrawal by Subject|0|||
25139938|NCT02117687|50253289|FG000|Overall Study|Lost to Follow-up|0|||
25139939|NCT02117687|50253290|FG001|Overall Study|Lost to Follow-up|1|||
25139940|NCT02117687|50253289|FG000|Overall Study|Adverse Event|0|||
25139941|NCT02117687|50253290|FG001|Overall Study|Adverse Event|2|||
25139942|NCT02117687|50253289|FG000|Overall Study|Other Reasons|1|||
25139943|NCT02117687|50253290|FG001|Overall Study|Other Reasons|1|||
25139944|NCT02143583|50253299|FG000|Overall Study|Withdrawal by Subject|1|||
25139945|NCT02143583|50253300|FG001|Overall Study|Withdrawal by Subject|0|||
25139946|NCT02143583|50253301|FG002|Overall Study|Withdrawal by Subject|1|||
25139947|NCT02143583|50253299|FG000|Overall Study|husband illness|0|||
25139948|NCT02143583|50253300|FG001|Overall Study|husband illness|0|||
25139949|NCT02143583|50253301|FG002|Overall Study|husband illness|1|||
25139950|NCT02105987|50253311|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
25139951|NCT02105987|50253312|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
25139952|NCT02105987|50253313|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
25139953|NCT02105987|50253314|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
25139954|NCT02105987|50253315|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
25139955|NCT02105987|50253316|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
25139956|NCT02105987|50253311|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
25139957|NCT02105987|50253312|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
25010301|NCT03529773|50103071|FG039|Overall Study|Protocol Violation|0|||
25139958|NCT02105987|50253313|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
25139959|NCT02105987|50253314|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
25139960|NCT02105987|50253315|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
25139961|NCT02105987|50253316|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
25139962|NCT02105987|50253311|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
25139963|NCT02105987|50253312|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
25139964|NCT02105987|50253313|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
25139965|NCT02105987|50253314|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
25139966|NCT02105987|50253315|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
25139967|NCT02105987|50253316|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
25139968|NCT02105987|50253311|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
25139969|NCT02105987|50253312|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
25139970|NCT02105987|50253313|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
25139971|NCT02105987|50253314|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
25139972|NCT02105987|50253315|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
25139973|NCT02105987|50253316|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
25139974|NCT02105987|50253311|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
25139975|NCT02105987|50253312|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
25139976|NCT02105987|50253313|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
25139977|NCT02105987|50253314|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
25139978|NCT02105987|50253315|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
25139979|NCT02105987|50253316|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
25139980|NCT02105987|50253311|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
25139981|NCT02105987|50253312|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
25139982|NCT02105987|50253313|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
25139983|NCT02105987|50253314|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
25139984|NCT02105987|50253315|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
25139985|NCT02105987|50253316|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
25139986|NCT02105987|50253311|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
25139987|NCT02105987|50253312|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
25139988|NCT02105987|50253313|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
25139989|NCT02105987|50253314|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
25139990|NCT02105987|50253315|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
25139991|NCT02105987|50253316|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
25139992|NCT02105987|50253311|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
25139993|NCT02105987|50253312|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
25139994|NCT02105987|50253313|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
25139995|NCT02105987|50253314|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
25139996|NCT02105987|50253315|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
25139997|NCT02105987|50253316|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
25139998|NCT02105987|50253311|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
25274150|NCT01100307|50588280|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
25274151|NCT01100307|50588281|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
25274152|NCT01100307|50588280|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
25274153|NCT01100307|50588281|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
25274154|NCT01100073|50588289|FG000|Overall Study|Lack of Efficacy|4|||
25274155|NCT01100073|50588289|FG000|Overall Study|Insufficient Tolerability|21|||
25274156|NCT01100073|50588289|FG000|Overall Study|Withdrawal by Subject|13|||
25274157|NCT01100073|50588289|FG000|Overall Study|Lost to Follow-up|39|||
25274158|NCT01100073|50588289|FG000|Overall Study|Lack of effect + patient's wish|2|||
25274159|NCT01100073|50588289|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
25274160|NCT01100073|50588289|FG000|Overall Study|Other|8|||
25274161|NCT01100073|50588289|FG000|Overall Study|Missing|5|||
25274162|NCT01099917|50588293|FG000|Overall Study|Adverse Event|3|||
25274163|NCT01099917|50588293|FG000|Overall Study|Not Treated|24|||
25274164|NCT01099215|50588299|FG000|Overall Study|Withdrawal by Subject|1|||
25274165|NCT01099215|50588300|FG001|Overall Study|Withdrawal by Subject|0|||
25274166|NCT01099215|50588299|FG000|Overall Study|Adverse Event|0|||
25139999|NCT02105987|50253312|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
25140000|NCT02105987|50253313|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
25140001|NCT02105987|50253314|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
25140002|NCT02105987|50253315|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
25140003|NCT02105987|50253316|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
25140004|NCT02105987|50253311|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
25140005|NCT02105987|50253312|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
25140006|NCT02105987|50253313|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
25140007|NCT02105987|50253314|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
25140008|NCT02105987|50253315|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
25140009|NCT02105987|50253316|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
25140010|NCT02105987|50253311|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
25140011|NCT02105987|50253312|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
25140012|NCT02105987|50253313|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
25140013|NCT02105987|50253314|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
25140014|NCT02105987|50253315|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
25140015|NCT02105987|50253316|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
25140016|NCT02105987|50253311|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
25140017|NCT02105987|50253312|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
25140018|NCT02105987|50253313|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
25140019|NCT02105987|50253314|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
25140020|NCT02105987|50253315|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
25140021|NCT02105987|50253316|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
25140022|NCT02105987|50253311|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
25140023|NCT02105987|50253312|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
25140024|NCT02105987|50253313|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
25140025|NCT02105987|50253314|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
25140026|NCT02105987|50253315|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
25140027|NCT02105987|50253316|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
25010302|NCT03529773|50103032|FG000|Overall Study|Withdrawal by Subject|0|||
25010303|NCT03529773|50103033|FG001|Overall Study|Withdrawal by Subject|0|||
25010304|NCT03529773|50103034|FG002|Overall Study|Withdrawal by Subject|0|||
25010305|NCT03529773|50103035|FG003|Overall Study|Withdrawal by Subject|0|||
25010306|NCT03529773|50103036|FG004|Overall Study|Withdrawal by Subject|0|||
25010307|NCT03529773|50103037|FG005|Overall Study|Withdrawal by Subject|0|||
25010308|NCT03529773|50103038|FG006|Overall Study|Withdrawal by Subject|0|||
25140028|NCT02105987|50253311|FG000|Continuation Phase|Protocol Violation|0|||
25140029|NCT02105987|50253312|FG001|Continuation Phase|Protocol Violation|0|||
25140030|NCT02105987|50253313|FG002|Continuation Phase|Protocol Violation|0|||
25140031|NCT02105987|50253314|FG003|Continuation Phase|Protocol Violation|0|||
25140032|NCT02105987|50253315|FG004|Continuation Phase|Protocol Violation|1|||
25140033|NCT02105987|50253316|FG005|Continuation Phase|Protocol Violation|0|||
25140034|NCT02141633|50253324|FG000|Overall Study|Physician Decision|1|||
25140035|NCT02141633|50253325|FG001|Overall Study|Physician Decision|0|||
25140036|NCT01846611|50253333|FG000|Overall Study|Lost to Follow-up|4|||
25140037|NCT01846611|50253334|FG001|Overall Study|Lost to Follow-up|6|||
25140038|NCT01846611|50253333|FG000|Overall Study|Withdrawal by Subject|15|||
25274167|NCT01099215|50588300|FG001|Overall Study|Adverse Event|1|||
25274168|NCT01097655|50588306|FG000|Overall Study|Withdrawal by Subject|1|||
25274169|NCT01097655|50588306|FG000|Overall Study|Subject Documented Twice|1|||
25274170|NCT01097655|50588306|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
25274171|NCT01107405|50588315|FG000|Overall Study|Adverse Event|1|||
25274172|NCT01107405|50588316|FG001|Overall Study|Adverse Event|1|||
25274173|NCT01107405|50588317|FG002|Overall Study|Adverse Event|0|||
25274174|NCT01107405|50588318|FG003|Overall Study|Adverse Event|0|||
25274175|NCT01107405|50588319|FG004|Overall Study|Adverse Event|2|||
25274176|NCT01107405|50588315|FG000|Overall Study|Withdrawal by Subject|1|||
25274177|NCT01107405|50588316|FG001|Overall Study|Withdrawal by Subject|0|||
25274178|NCT01107405|50588317|FG002|Overall Study|Withdrawal by Subject|1|||
25274179|NCT01107405|50588318|FG003|Overall Study|Withdrawal by Subject|2|||
25274180|NCT01107405|50588319|FG004|Overall Study|Withdrawal by Subject|1|||
25274181|NCT01107405|50588315|FG000|Overall Study|Protocol Violation|0|||
25274182|NCT01107405|50588316|FG001|Overall Study|Protocol Violation|0|||
25274183|NCT01107405|50588317|FG002|Overall Study|Protocol Violation|1|||
25274184|NCT01107405|50588318|FG003|Overall Study|Protocol Violation|1|||
25274185|NCT01107405|50588319|FG004|Overall Study|Protocol Violation|0|||
25274186|NCT01097577|50588333|FG000|Overall Study|Adverse Event|0|||
25274187|NCT01097577|50588334|FG001|Overall Study|Adverse Event|1|||
25274188|NCT01097421|50588340|FG000|Overall Study|Adverse Event|8|||
25274189|NCT01097421|50588340|FG000|Overall Study|Protocol Violation|2|||
25274190|NCT01097421|50588340|FG000|Overall Study|Lost to Follow-up|1|||
25274191|NCT01097421|50588340|FG000|Overall Study|Withdrawal by Subject|3|||
25274192|NCT01251614|50588347|FG000|Overall Study|Adverse Event|1|||
25274193|NCT01251614|50588348|FG001|Overall Study|Adverse Event|0|||
25274194|NCT01251614|50588349|FG002|Overall Study|Adverse Event|1|||
25274195|NCT01251614|50588347|FG000|Overall Study|Lack of Efficacy|1|||
25274196|NCT01251614|50588348|FG001|Overall Study|Lack of Efficacy|9|||
25274197|NCT01251614|50588349|FG002|Overall Study|Lack of Efficacy|4|||
25274198|NCT01251614|50588347|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
25274199|NCT01251614|50588348|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
25274200|NCT01251614|50588349|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
25274201|NCT01251614|50588347|FG000|Overall Study|Pregnancy|0|||
25274202|NCT01251614|50588348|FG001|Overall Study|Pregnancy|0|||
25010309|NCT03529773|50103039|FG007|Overall Study|Withdrawal by Subject|1|||
25010310|NCT03529773|50103040|FG008|Overall Study|Withdrawal by Subject|0|||
25010311|NCT03529773|50103041|FG009|Overall Study|Withdrawal by Subject|1|||
25010312|NCT03529773|50103042|FG010|Overall Study|Withdrawal by Subject|1|||
25010313|NCT03529773|50103043|FG011|Overall Study|Withdrawal by Subject|0|||
25010314|NCT03529773|50103044|FG012|Overall Study|Withdrawal by Subject|0|||
25010315|NCT03529773|50103045|FG013|Overall Study|Withdrawal by Subject|0|||
25010316|NCT03529773|50103046|FG014|Overall Study|Withdrawal by Subject|0|||
25010317|NCT03529773|50103047|FG015|Overall Study|Withdrawal by Subject|3|||
25010318|NCT03529773|50103048|FG016|Overall Study|Withdrawal by Subject|0|||
25010319|NCT03529773|50103049|FG017|Overall Study|Withdrawal by Subject|2|||
25010320|NCT03529773|50103050|FG018|Overall Study|Withdrawal by Subject|3|||
25010321|NCT03529773|50103051|FG019|Overall Study|Withdrawal by Subject|1|||
25010322|NCT03529773|50103052|FG020|Overall Study|Withdrawal by Subject|3|||
25010323|NCT03529773|50103053|FG021|Overall Study|Withdrawal by Subject|1|||
25010324|NCT03529773|50103054|FG022|Overall Study|Withdrawal by Subject|1|||
25010325|NCT03529773|50103055|FG023|Overall Study|Withdrawal by Subject|2|||
25010326|NCT03529773|50103056|FG024|Overall Study|Withdrawal by Subject|2|||
25010327|NCT03529773|50103057|FG025|Overall Study|Withdrawal by Subject|4|||
25010328|NCT03529773|50103058|FG026|Overall Study|Withdrawal by Subject|2|||
25010329|NCT03529773|50103059|FG027|Overall Study|Withdrawal by Subject|1|||
25010330|NCT03529773|50103060|FG028|Overall Study|Withdrawal by Subject|1|||
25010331|NCT03529773|50103061|FG029|Overall Study|Withdrawal by Subject|0|||
25010332|NCT03529773|50103062|FG030|Overall Study|Withdrawal by Subject|0|||
25010333|NCT03529773|50103063|FG031|Overall Study|Withdrawal by Subject|0|||
25010334|NCT03529773|50103064|FG032|Overall Study|Withdrawal by Subject|0|||
25010335|NCT03529773|50103065|FG033|Overall Study|Withdrawal by Subject|0|||
25010336|NCT03529773|50103066|FG034|Overall Study|Withdrawal by Subject|1|||
25010337|NCT03529773|50103067|FG035|Overall Study|Withdrawal by Subject|2|||
25010338|NCT03529773|50103068|FG036|Overall Study|Withdrawal by Subject|0|||
25010339|NCT03529773|50103069|FG037|Overall Study|Withdrawal by Subject|2|||
25010340|NCT03529773|50103070|FG038|Overall Study|Withdrawal by Subject|1|||
25010341|NCT03529773|50103071|FG039|Overall Study|Withdrawal by Subject|1|||
25010342|NCT03529773|50103032|FG000|Overall Study|Screen Failure|0|||
25010343|NCT03529773|50103033|FG001|Overall Study|Screen Failure|0|||
25010344|NCT03529773|50103034|FG002|Overall Study|Screen Failure|0|||
25010345|NCT03529773|50103035|FG003|Overall Study|Screen Failure|0|||
25010346|NCT03529773|50103036|FG004|Overall Study|Screen Failure|0|||
25010347|NCT03529773|50103037|FG005|Overall Study|Screen Failure|0|||
25010348|NCT03529773|50103038|FG006|Overall Study|Screen Failure|0|||
25010349|NCT03529773|50103039|FG007|Overall Study|Screen Failure|0|||
25010350|NCT03529773|50103040|FG008|Overall Study|Screen Failure|0|||
25010351|NCT03529773|50103041|FG009|Overall Study|Screen Failure|0|||
25010352|NCT03529773|50103042|FG010|Overall Study|Screen Failure|0|||
25010353|NCT03529773|50103043|FG011|Overall Study|Screen Failure|0|||
25010354|NCT03529773|50103044|FG012|Overall Study|Screen Failure|0|||
25010355|NCT03529773|50103045|FG013|Overall Study|Screen Failure|0|||
25010356|NCT03529773|50103046|FG014|Overall Study|Screen Failure|0|||
25010357|NCT03529773|50103047|FG015|Overall Study|Screen Failure|0|||
25010358|NCT03529773|50103048|FG016|Overall Study|Screen Failure|0|||
25010359|NCT03529773|50103049|FG017|Overall Study|Screen Failure|0|||
25010360|NCT03529773|50103050|FG018|Overall Study|Screen Failure|0|||
25010361|NCT03529773|50103051|FG019|Overall Study|Screen Failure|0|||
25010362|NCT03529773|50103052|FG020|Overall Study|Screen Failure|0|||
25140039|NCT01846611|50253334|FG001|Overall Study|Withdrawal by Subject|19|||
25140040|NCT01846611|50253333|FG000|Overall Study|Other|19|||
25010363|NCT03529773|50103053|FG021|Overall Study|Screen Failure|0|||
25010364|NCT03529773|50103054|FG022|Overall Study|Screen Failure|0|||
25140041|NCT01846611|50253334|FG001|Overall Study|Other|18|||
25140042|NCT02141399|50253340|FG000|Overall Study|Adverse Event|158|||
25140043|NCT02141399|50253340|FG000|Overall Study|Lack of Efficacy|62|||
25140044|NCT02141399|50253340|FG000|Overall Study|Lost to Follow-up|151|||
25140045|NCT02141399|50253340|FG000|Overall Study|Non-compliance with study drug|18|||
25140046|NCT02141399|50253340|FG000|Overall Study|Other|45|||
25140047|NCT02141399|50253340|FG000|Overall Study|Physician Decision|17|||
25140048|NCT02141399|50253340|FG000|Overall Study|Pregnancy|3|||
25179119|NCT01693562|50324405|FG019|Expansion Phase|Withdrawal by Subject|3|||
25179120|NCT01693562|50324406|FG020|Expansion Phase|Withdrawal by Subject|1|||
25179121|NCT01693562|50324407|FG021|Expansion Phase|Withdrawal by Subject|8|||
25274203|NCT01251614|50588349|FG002|Overall Study|Pregnancy|2|||
25274204|NCT01251614|50588347|FG000|Overall Study|Loss of Disease Control|0|||
25274205|NCT01251614|50588348|FG001|Overall Study|Loss of Disease Control|1|||
25274206|NCT01251614|50588349|FG002|Overall Study|Loss of Disease Control|0|||
25274207|NCT01251614|50588347|FG000|Overall Study|Withdrawal by Subject|0|||
25274208|NCT01251614|50588348|FG001|Overall Study|Withdrawal by Subject|2|||
25274209|NCT01251614|50588349|FG002|Overall Study|Withdrawal by Subject|1|||
25274210|NCT01251614|50588347|FG000|Overall Study|Lost to Follow-up|0|||
25274211|NCT01251614|50588348|FG001|Overall Study|Lost to Follow-up|1|||
25010365|NCT03529773|50103055|FG023|Overall Study|Screen Failure|0|||
25010366|NCT03529773|50103056|FG024|Overall Study|Screen Failure|0|||
25010367|NCT03529773|50103057|FG025|Overall Study|Screen Failure|0|||
25010368|NCT03529773|50103058|FG026|Overall Study|Screen Failure|0|||
25010369|NCT03529773|50103059|FG027|Overall Study|Screen Failure|0|||
25010370|NCT03529773|50103060|FG028|Overall Study|Screen Failure|0|||
25010371|NCT03529773|50103061|FG029|Overall Study|Screen Failure|0|||
25010372|NCT03529773|50103062|FG030|Overall Study|Screen Failure|0|||
25010373|NCT03529773|50103063|FG031|Overall Study|Screen Failure|0|||
25010374|NCT03529773|50103064|FG032|Overall Study|Screen Failure|0|||
25010375|NCT03529773|50103065|FG033|Overall Study|Screen Failure|0|||
25010376|NCT03529773|50103066|FG034|Overall Study|Screen Failure|0|||
25010377|NCT03529773|50103067|FG035|Overall Study|Screen Failure|0|||
25010378|NCT03529773|50103068|FG036|Overall Study|Screen Failure|1|||
25010379|NCT03529773|50103069|FG037|Overall Study|Screen Failure|1|||
25010380|NCT03529773|50103070|FG038|Overall Study|Screen Failure|0|||
25010381|NCT03529773|50103071|FG039|Overall Study|Screen Failure|1|||
25010382|NCT03529773|50103032|FG000|Overall Study|Randomized but not vaccinated|0|||
25010383|NCT03529773|50103033|FG001|Overall Study|Randomized but not vaccinated|0|||
25010384|NCT03529773|50103034|FG002|Overall Study|Randomized but not vaccinated|0|||
25010385|NCT03529773|50103035|FG003|Overall Study|Randomized but not vaccinated|0|||
25010386|NCT03529773|50103036|FG004|Overall Study|Randomized but not vaccinated|0|||
25010387|NCT03529773|50103037|FG005|Overall Study|Randomized but not vaccinated|0|||
25010388|NCT03529773|50103038|FG006|Overall Study|Randomized but not vaccinated|0|||
25274212|NCT01251614|50588349|FG002|Overall Study|Lost to Follow-up|0|||
25274213|NCT01106625|50588370|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
25274214|NCT01106625|50588371|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
25274215|NCT01106625|50588372|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
25274216|NCT01106625|50588370|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
25274217|NCT01106625|50588371|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
25274218|NCT01106625|50588372|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
25274219|NCT01106625|50588370|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
25274220|NCT01106625|50588371|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
25274221|NCT01106625|50588372|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
25274222|NCT01106625|50588370|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
25274223|NCT01106625|50588371|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
25274224|NCT01106625|50588372|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
25274225|NCT01106625|50588370|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
25274226|NCT01106625|50588371|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
25274227|NCT01106625|50588372|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
25274228|NCT01106625|50588370|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
25274229|NCT01106625|50588371|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
25274230|NCT01106625|50588372|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
25274231|NCT01106625|50588370|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
25274232|NCT01106625|50588371|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
25274233|NCT01106625|50588372|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
25274234|NCT01106625|50588370|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
25274235|NCT01106625|50588371|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
25274236|NCT01106625|50588372|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
25274237|NCT01106625|50588370|FG000|Core Period: Baseline to Week 26|Other|8|||
25274238|NCT01106625|50588371|FG001|Core Period: Baseline to Week 26|Other|7|||
25274239|NCT01106625|50588372|FG002|Core Period: Baseline to Week 26|Other|4|||
25274240|NCT01106625|50588370|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
25274241|NCT01106625|50588371|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
25010389|NCT03529773|50103039|FG007|Overall Study|Randomized but not vaccinated|0|||
25010390|NCT03529773|50103040|FG008|Overall Study|Randomized but not vaccinated|0|||
25010391|NCT03529773|50103041|FG009|Overall Study|Randomized but not vaccinated|0|||
25010392|NCT03529773|50103042|FG010|Overall Study|Randomized but not vaccinated|0|||
25010393|NCT03529773|50103043|FG011|Overall Study|Randomized but not vaccinated|0|||
25010394|NCT03529773|50103044|FG012|Overall Study|Randomized but not vaccinated|0|||
25010395|NCT03529773|50103045|FG013|Overall Study|Randomized but not vaccinated|0|||
25010396|NCT03529773|50103046|FG014|Overall Study|Randomized but not vaccinated|0|||
25010397|NCT03529773|50103047|FG015|Overall Study|Randomized but not vaccinated|0|||
25010398|NCT03529773|50103048|FG016|Overall Study|Randomized but not vaccinated|0|||
25010399|NCT03529773|50103049|FG017|Overall Study|Randomized but not vaccinated|1|||
25010400|NCT03529773|50103050|FG018|Overall Study|Randomized but not vaccinated|0|||
25010401|NCT03529773|50103051|FG019|Overall Study|Randomized but not vaccinated|0|||
25010402|NCT03529773|50103052|FG020|Overall Study|Randomized but not vaccinated|0|||
25010403|NCT03529773|50103053|FG021|Overall Study|Randomized but not vaccinated|0|||
25010404|NCT03529773|50103054|FG022|Overall Study|Randomized but not vaccinated|0|||
25010405|NCT03529773|50103055|FG023|Overall Study|Randomized but not vaccinated|0|||
25010406|NCT03529773|50103056|FG024|Overall Study|Randomized but not vaccinated|0|||
25010407|NCT03529773|50103057|FG025|Overall Study|Randomized but not vaccinated|0|||
25010408|NCT03529773|50103058|FG026|Overall Study|Randomized but not vaccinated|0|||
25010409|NCT03529773|50103059|FG027|Overall Study|Randomized but not vaccinated|1|||
25010410|NCT03529773|50103060|FG028|Overall Study|Randomized but not vaccinated|0|||
25140049|NCT02141399|50253340|FG000|Overall Study|Protocol Violation|38|||
25140050|NCT02141399|50253340|FG000|Overall Study|Withdrawal by Subject|238|||
25010411|NCT03529773|50103061|FG029|Overall Study|Randomized but not vaccinated|0|||
25010412|NCT03529773|50103062|FG030|Overall Study|Randomized but not vaccinated|0|||
25010413|NCT03529773|50103063|FG031|Overall Study|Randomized but not vaccinated|0|||
25010414|NCT03529773|50103064|FG032|Overall Study|Randomized but not vaccinated|0|||
25010415|NCT03529773|50103065|FG033|Overall Study|Randomized but not vaccinated|0|||
25010416|NCT03529773|50103066|FG034|Overall Study|Randomized but not vaccinated|0|||
25010417|NCT03529773|50103067|FG035|Overall Study|Randomized but not vaccinated|0|||
25010418|NCT03529773|50103068|FG036|Overall Study|Randomized but not vaccinated|0|||
25010419|NCT03529773|50103069|FG037|Overall Study|Randomized but not vaccinated|0|||
25010420|NCT03529773|50103070|FG038|Overall Study|Randomized but not vaccinated|0|||
25010421|NCT03529773|50103071|FG039|Overall Study|Randomized but not vaccinated|0|||
25010422|NCT03799211|50103176|FG000|Overall Study|Lost to Follow-up|2|||
25010423|NCT03799211|50103177|FG001|Overall Study|Lost to Follow-up|13|||
25010424|NCT03799211|50103176|FG000|Overall Study|Withdrawal by Subject|2|||
25010425|NCT03799211|50103177|FG001|Overall Study|Withdrawal by Subject|0|||
25010426|NCT03349710|50103189|FG000|Treatment Period|Death|0|||
25010427|NCT03349710|50103190|FG001|Treatment Period|Death|0|||
25010428|NCT03349710|50103191|FG002|Treatment Period|Death|1|||
25010429|NCT03349710|50103192|FG003|Treatment Period|Death|0|||
25010430|NCT03349710|50103189|FG000|Treatment Period|Disease Progression|0|||
25010431|NCT03349710|50103190|FG001|Treatment Period|Disease Progression|2|||
25010432|NCT03349710|50103191|FG002|Treatment Period|Disease Progression|0|||
25010433|NCT03349710|50103192|FG003|Treatment Period|Disease Progression|1|||
25010434|NCT03349710|50103189|FG000|Treatment Period|Study Drug Toxicity|1|||
25010435|NCT03349710|50103190|FG001|Treatment Period|Study Drug Toxicity|0|||
25010436|NCT03349710|50103191|FG002|Treatment Period|Study Drug Toxicity|1|||
25010437|NCT03349710|50103192|FG003|Treatment Period|Study Drug Toxicity|1|||
25010438|NCT03349710|50103189|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
25010439|NCT03349710|50103190|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
25010440|NCT03349710|50103191|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
25010441|NCT03349710|50103192|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
25010442|NCT03349710|50103189|FG000|Treatment Period|admin reason by sponsor|0|||
25010443|NCT03349710|50103190|FG001|Treatment Period|admin reason by sponsor|7|||
25179122|NCT01693562|50324408|FG022|Expansion Phase|Withdrawal by Subject|1|||
25179123|NCT01693562|50324386|FG000|Expansion Phase|Death|0|||
25179124|NCT01693562|50324387|FG001|Expansion Phase|Death|0|||
25179125|NCT01693562|50324388|FG002|Expansion Phase|Death|0|||
25179126|NCT01693562|50324389|FG003|Expansion Phase|Death|0|||
25179127|NCT01693562|50324390|FG004|Expansion Phase|Death|0|||
25179128|NCT01693562|50324391|FG005|Expansion Phase|Death|0|||
25179129|NCT01693562|50324392|FG006|Expansion Phase|Death|0|||
25179130|NCT01693562|50324393|FG007|Expansion Phase|Death|42|||
25179131|NCT01693562|50324394|FG008|Expansion Phase|Death|17|||
25179132|NCT01693562|50324395|FG009|Expansion Phase|Death|208|||
25179133|NCT01693562|50324396|FG010|Expansion Phase|Death|30|||
25140051|NCT02141399|50253340|FG000|Overall Study|Failure to meet eligibility criteria|14|||
25140052|NCT01846299|50253346|FG000|Overall Study|Physician Decision|4|||
25140053|NCT01846299|50253347|FG001|Overall Study|Physician Decision|2|||
25140054|NCT01846299|50253346|FG000|Overall Study|Protocol deviation|1|||
25140055|NCT01846299|50253347|FG001|Overall Study|Protocol deviation|0|||
25140056|NCT01846299|50253346|FG000|Overall Study|Death|1|||
25140057|NCT01846299|50253347|FG001|Overall Study|Death|2|||
25179134|NCT01693562|50324397|FG011|Expansion Phase|Death|8|||
25179135|NCT01693562|50324398|FG012|Expansion Phase|Death|19|||
25179136|NCT01693562|50324399|FG013|Expansion Phase|Death|42|||
25179137|NCT01693562|50324400|FG014|Expansion Phase|Death|23|||
25179138|NCT01693562|50324401|FG015|Expansion Phase|Death|23|||
25179139|NCT01693562|50324402|FG016|Expansion Phase|Death|128|||
25179140|NCT01693562|50324403|FG017|Expansion Phase|Death|16|||
25179141|NCT01693562|50324404|FG018|Expansion Phase|Death|36|||
25179142|NCT01693562|50324405|FG019|Expansion Phase|Death|16|||
25179143|NCT01693562|50324406|FG020|Expansion Phase|Death|17|||
25179144|NCT01693562|50324407|FG021|Expansion Phase|Death|35|||
25140058|NCT01846299|50253346|FG000|Overall Study|Lost to Follow-up|3|||
25140059|NCT01846299|50253347|FG001|Overall Study|Lost to Follow-up|0|||
25140060|NCT01846299|50253346|FG000|Overall Study|Withdrawal by Subject|1|||
25140061|NCT01846299|50253347|FG001|Overall Study|Withdrawal by Subject|6|||
25140062|NCT01846299|50253346|FG000|Overall Study|Adverse Event|2|||
25140063|NCT01846299|50253347|FG001|Overall Study|Adverse Event|0|||
25179145|NCT01693562|50324408|FG022|Expansion Phase|Death|7|||
25179146|NCT01693562|50324386|FG000|Expansion Phase|Lost to Follow-up|0|||
25010444|NCT03349710|50103191|FG002|Treatment Period|admin reason by sponsor|0|||
25010445|NCT03349710|50103192|FG003|Treatment Period|admin reason by sponsor|19|||
25010446|NCT03349710|50103189|FG000|Treatment Period|Other Reason|2|||
25010447|NCT03349710|50103190|FG001|Treatment Period|Other Reason|0|||
25010448|NCT03349710|50103191|FG002|Treatment Period|Other Reason|2|||
25010449|NCT03349710|50103192|FG003|Treatment Period|Other Reason|1|||
25140064|NCT01628393|50253358|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
25179147|NCT01693562|50324387|FG001|Expansion Phase|Lost to Follow-up|0|||
25179148|NCT01693562|50324388|FG002|Expansion Phase|Lost to Follow-up|0|||
25179149|NCT01693562|50324389|FG003|Expansion Phase|Lost to Follow-up|0|||
25179150|NCT01693562|50324390|FG004|Expansion Phase|Lost to Follow-up|0|||
25179151|NCT01693562|50324391|FG005|Expansion Phase|Lost to Follow-up|0|||
25179152|NCT01693562|50324392|FG006|Expansion Phase|Lost to Follow-up|0|||
25179153|NCT01693562|50324393|FG007|Expansion Phase|Lost to Follow-up|1|||
25140065|NCT01628393|50253359|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
25140066|NCT01628393|50253360|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
25140067|NCT01628393|50253361|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
25140068|NCT01628393|50253362|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
25140069|NCT01628393|50253358|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
25140070|NCT01628393|50253359|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
25140071|NCT01628393|50253360|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
25140072|NCT01628393|50253361|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
25140073|NCT01628393|50253362|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
25140074|NCT01628393|50253358|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
25140075|NCT01628393|50253359|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
25140076|NCT01628393|50253360|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
25140077|NCT01628393|50253361|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
25140078|NCT01628393|50253362|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
25140079|NCT01628393|50253358|FG000|Blinded Active Extension Period|Adverse Event|0|||
25140080|NCT01628393|50253359|FG001|Blinded Active Extension Period|Adverse Event|1|||
25140081|NCT01628393|50253360|FG002|Blinded Active Extension Period|Adverse Event|0|||
25140082|NCT01628393|50253361|FG003|Blinded Active Extension Period|Adverse Event|2|||
25140083|NCT01628393|50253362|FG004|Blinded Active Extension Period|Adverse Event|2|||
25140084|NCT01628393|50253358|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
25140085|NCT01628393|50253359|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
25140086|NCT01628393|50253360|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
25140087|NCT01628393|50253361|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
25140088|NCT01628393|50253362|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
25140089|NCT01628393|50253358|FG000|Blinded Active Extension Period|Physician Decision|0|||
25140090|NCT01628393|50253359|FG001|Blinded Active Extension Period|Physician Decision|3|||
25140091|NCT01628393|50253360|FG002|Blinded Active Extension Period|Physician Decision|0|||
25140092|NCT01628393|50253361|FG003|Blinded Active Extension Period|Physician Decision|1|||
25140093|NCT01628393|50253362|FG004|Blinded Active Extension Period|Physician Decision|0|||
25140094|NCT01628393|50253358|FG000|Blinded Active Extension Period|Protocol Violation|0|||
25140095|NCT01628393|50253359|FG001|Blinded Active Extension Period|Protocol Violation|0|||
25179154|NCT01693562|50324394|FG008|Expansion Phase|Lost to Follow-up|2|||
25179155|NCT01693562|50324395|FG009|Expansion Phase|Lost to Follow-up|10|||
25010450|NCT03349710|50103189|FG000|Treatment Period|completed|6|||
25010451|NCT03349710|50103190|FG001|Treatment Period|completed|0|||
25010452|NCT03349710|50103191|FG002|Treatment Period|completed|18|||
25179156|NCT01693562|50324396|FG010|Expansion Phase|Lost to Follow-up|4|||
25179157|NCT01693562|50324397|FG011|Expansion Phase|Lost to Follow-up|4|||
25179158|NCT01693562|50324398|FG012|Expansion Phase|Lost to Follow-up|1|||
25179159|NCT01693562|50324399|FG013|Expansion Phase|Lost to Follow-up|3|||
25179160|NCT01693562|50324400|FG014|Expansion Phase|Lost to Follow-up|0|||
25179161|NCT01693562|50324401|FG015|Expansion Phase|Lost to Follow-up|1|||
25179162|NCT01693562|50324402|FG016|Expansion Phase|Lost to Follow-up|1|||
25179163|NCT01693562|50324403|FG017|Expansion Phase|Lost to Follow-up|0|||
25010453|NCT03349710|50103192|FG003|Treatment Period|completed|1|||
25010454|NCT03349710|50103189|FG000|Treatment Period|participant request to discontinue|0|||
25010455|NCT03349710|50103190|FG001|Treatment Period|participant request to discontinue|0|||
25010456|NCT03349710|50103191|FG002|Treatment Period|participant request to discontinue|4|||
25010457|NCT03349710|50103192|FG003|Treatment Period|participant request to discontinue|0|||
25010458|NCT03349710|50103189|FG000|Treatment Period|participant withdrew consent|1|||
25010459|NCT03349710|50103190|FG001|Treatment Period|participant withdrew consent|0|||
25010460|NCT03349710|50103191|FG002|Treatment Period|participant withdrew consent|0|||
25010461|NCT03349710|50103192|FG003|Treatment Period|participant withdrew consent|0|||
25010462|NCT03511053|50103202|FG000|Overall Study|Withdrawal by Subject|1|||
25010463|NCT03377634|50103208|FG000|Study Period|Adverse Event|1|||
25010464|NCT03377634|50103209|FG001|Study Period|Adverse Event|0|||
25010465|NCT03377634|50103208|FG000|Study Period|Withdrawal by Subject|1|||
25010466|NCT03377634|50103209|FG001|Study Period|Withdrawal by Subject|0|||
25010467|NCT03528369|50103218|FG000|Overall Study|Withdrawal by Subject|2|||
25010468|NCT03528369|50103219|FG001|Overall Study|Withdrawal by Subject|0|||
25010469|NCT03528369|50103220|FG002|Overall Study|Withdrawal by Subject|0|||
25010470|NCT03528369|50103218|FG000|Overall Study|Lost to Follow-up|1|||
25140096|NCT01628393|50253360|FG002|Blinded Active Extension Period|Protocol Violation|2|||
25140097|NCT01628393|50253361|FG003|Blinded Active Extension Period|Protocol Violation|1|||
25179164|NCT01693562|50324404|FG018|Expansion Phase|Lost to Follow-up|2|||
25010471|NCT03528369|50103219|FG001|Overall Study|Lost to Follow-up|0|||
25179165|NCT01693562|50324405|FG019|Expansion Phase|Lost to Follow-up|1|||
25179166|NCT01693562|50324406|FG020|Expansion Phase|Lost to Follow-up|2|||
25010472|NCT03528369|50103220|FG002|Overall Study|Lost to Follow-up|0|||
25010473|NCT03528369|50103218|FG000|Overall Study|Adverse Event|0|||
25010474|NCT03528369|50103219|FG001|Overall Study|Adverse Event|1|||
25010475|NCT03528369|50103220|FG002|Overall Study|Adverse Event|0|||
25140098|NCT01628393|50253362|FG004|Blinded Active Extension Period|Protocol Violation|0|||
25140099|NCT01628393|50253358|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
25140100|NCT01628393|50253359|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
25140101|NCT01628393|50253360|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
25140102|NCT01628393|50253361|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
25140103|NCT01628393|50253362|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
25140104|NCT01846221|50253378|FG000|Overall Study|Catheter Failure|2|||
25140105|NCT01846221|50253379|FG001|Overall Study|Catheter Failure|0|||
25140106|NCT01846221|50253378|FG000|Overall Study|Age Exclusion|1|||
25140107|NCT01846221|50253379|FG001|Overall Study|Age Exclusion|0|||
25140108|NCT01815099|50253385|FG000|Overall Study|Lack of Efficacy|1|||
25140109|NCT01815099|50253385|FG000|Overall Study|unable to attend study visits|1|||
25140110|NCT01845831|50253392|FG000|Inpatient Phase|Withdrawal by Subject|1|||
25140111|NCT01845831|50253393|FG001|Inpatient Phase|Withdrawal by Subject|1|||
25140112|NCT01845831|50253394|FG002|Inpatient Phase|Withdrawal by Subject|0|||
25140113|NCT01845831|50253395|FG003|Inpatient Phase|Withdrawal by Subject|0|||
25140114|NCT01845831|50253396|FG004|Inpatient Phase|Withdrawal by Subject|0|||
25140115|NCT01627691|50253407|FG000|Overall Study|Death|11|||
25140116|NCT01627691|50253407|FG000|Overall Study|Lost to Follow-up|3|||
25140117|NCT01627691|50253407|FG000|Overall Study|Withdrawal by Subject|1|||
25140118|NCT01627691|50253407|FG000|Overall Study|Missed the visit|3|||
25140119|NCT01844895|50253411|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
25140120|NCT01844895|50253411|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
25140121|NCT01844895|50253411|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
25140122|NCT01844895|50253411|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
25140123|NCT01844895|50253411|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
25140124|NCT01844895|50253411|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
25140125|NCT01844895|50253411|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
25140126|NCT02116361|50253428|FG000|Overall Study|Pregnancy|0|||
25140127|NCT02116361|50253429|FG001|Overall Study|Pregnancy|0|||
25140128|NCT02116361|50253430|FG002|Overall Study|Pregnancy|0|||
25140129|NCT02116361|50253431|FG003|Overall Study|Pregnancy|1|||
25010476|NCT00006011|50103231|FG000|Overall Study|Disease progression|13|||
25010477|NCT00006011|50103232|FG001|Overall Study|Disease progression|6|||
25010478|NCT00006011|50103233|FG002|Overall Study|Disease progression|26|||
25010479|NCT00006011|50103231|FG000|Overall Study|Refused further treatment|15|||
25010480|NCT00006011|50103232|FG001|Overall Study|Refused further treatment|13|||
25010481|NCT00006011|50103233|FG002|Overall Study|Refused further treatment|26|||
25010482|NCT00006011|50103231|FG000|Overall Study|Adverse Event|15|||
25010483|NCT00006011|50103232|FG001|Overall Study|Adverse Event|39|||
25010484|NCT00006011|50103233|FG002|Overall Study|Adverse Event|5|||
25010485|NCT00006011|50103231|FG000|Overall Study|Death|0|||
25010486|NCT00006011|50103232|FG001|Overall Study|Death|1|||
25010487|NCT00006011|50103233|FG002|Overall Study|Death|2|||
25010488|NCT00006011|50103231|FG000|Overall Study|Other|4|||
25010489|NCT00006011|50103232|FG001|Overall Study|Other|2|||
25010490|NCT00006011|50103233|FG002|Overall Study|Other|5|||
25010491|NCT00006011|50103231|FG000|Overall Study|Ineligible|18|||
25010492|NCT00006011|50103232|FG001|Overall Study|Ineligible|16|||
25010493|NCT00006011|50103233|FG002|Overall Study|Ineligible|9|||
25010494|NCT03377556|50103239|FG000|Overall Study|Adverse Event|5|||
25010495|NCT03377556|50103239|FG000|Overall Study|Refusal unrelated to adverse events|1|||
25010496|NCT03377556|50103239|FG000|Overall Study|Progression/relapse|38|||
25010497|NCT03377556|50103239|FG000|Overall Study|Death|3|||
25010498|NCT03750955|50103245|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
25010499|NCT03750955|50103246|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
25010500|NCT03750955|50103245|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
25010501|NCT03750955|50103246|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
25010502|NCT00005957|50103256|FG000|Overall Study|No treated|3|||
25010503|NCT00005957|50103257|FG001|Overall Study|No treated|9|||
25010504|NCT00005957|50103256|FG000|Overall Study|Crossover to the other arm|5|||
25010505|NCT00005957|50103257|FG001|Overall Study|Crossover to the other arm|19|||
25140130|NCT02116361|50253428|FG000|Overall Study|Protocol Violation|1|||
25010506|NCT00005879|50103265|FG000|Overall Study|Withdrawal by Subject|8|||
25010507|NCT00005879|50103266|FG001|Overall Study|Withdrawal by Subject|10|||
25010508|NCT03583359|50103274|FG000|Overall Study|Withdrawal by Subject|15|||
25010509|NCT03583359|50103275|FG001|Overall Study|Withdrawal by Subject|6|||
25010510|NCT03583359|50103274|FG000|Overall Study|Lost to Follow-up|12|||
25010511|NCT03583359|50103275|FG001|Overall Study|Lost to Follow-up|3|||
25140131|NCT02116361|50253429|FG001|Overall Study|Protocol Violation|0|||
25140132|NCT02116361|50253430|FG002|Overall Study|Protocol Violation|0|||
25140133|NCT02116361|50253431|FG003|Overall Study|Protocol Violation|2|||
25140134|NCT02116361|50253428|FG000|Overall Study|Physician Decision|2|||
25179167|NCT01693562|50324407|FG021|Expansion Phase|Lost to Follow-up|2|||
25010512|NCT03583359|50103274|FG000|Overall Study|Adverse Event|0|||
25010513|NCT03583359|50103275|FG001|Overall Study|Adverse Event|1|||
25010514|NCT03583359|50103274|FG000|Overall Study|Protocol Violation|0|||
25010515|NCT03583359|50103275|FG001|Overall Study|Protocol Violation|1|||
25010516|NCT03583359|50103274|FG000|Overall Study|Other|2|||
25010517|NCT03583359|50103275|FG001|Overall Study|Other|1|||
25010518|NCT03510663|50103289|FG000|Overall Study|Withdrawal by Subject|0|||
25010519|NCT03510663|50103290|FG001|Overall Study|Withdrawal by Subject|1|||
25010520|NCT03510663|50103291|FG002|Overall Study|Withdrawal by Subject|0|||
25010521|NCT03510663|50103292|FG003|Overall Study|Withdrawal by Subject|0|||
25010522|NCT03510663|50103293|FG004|Overall Study|Withdrawal by Subject|0|||
25010523|NCT03510663|50103294|FG005|Overall Study|Withdrawal by Subject|0|||
25010524|NCT03510663|50103295|FG006|Overall Study|Withdrawal by Subject|0|||
25010525|NCT03510663|50103296|FG007|Overall Study|Withdrawal by Subject|0|||
25010526|NCT03510273|50103306|FG000|Overall Study|Withdrawal by Subject|2|||
25010527|NCT03510273|50103306|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
25010528|NCT03510273|50103306|FG000|Overall Study|Moved away from study area|4|||
25010529|NCT03582813|50103316|FG000|Overall Study|Lost to Follow-up|18|||
25010530|NCT03582813|50103317|FG001|Overall Study|Lost to Follow-up|21|||
25010531|NCT03582813|50103316|FG000|Overall Study|Withdrawal by Subject|1|||
25010532|NCT03582813|50103317|FG001|Overall Study|Withdrawal by Subject|0|||
25140135|NCT02116361|50253429|FG001|Overall Study|Physician Decision|3|||
25140136|NCT02116361|50253430|FG002|Overall Study|Physician Decision|0|||
25140137|NCT02116361|50253431|FG003|Overall Study|Physician Decision|0|||
25140138|NCT02116361|50253428|FG000|Overall Study|Adverse Event|1|||
25140139|NCT02116361|50253429|FG001|Overall Study|Adverse Event|0|||
25140140|NCT02116361|50253430|FG002|Overall Study|Adverse Event|0|||
25140141|NCT02116361|50253431|FG003|Overall Study|Adverse Event|3|||
25140142|NCT02116361|50253428|FG000|Overall Study|Other Reasons|3|||
25140143|NCT02116361|50253429|FG001|Overall Study|Other Reasons|3|||
25140144|NCT02116361|50253430|FG002|Overall Study|Other Reasons|3|||
25140145|NCT02116361|50253431|FG003|Overall Study|Other Reasons|3|||
25010533|NCT03480009|50103327|FG000|Overall Study|Lost to Follow-up|4|||
25010534|NCT03480009|50103328|FG001|Overall Study|Lost to Follow-up|5|||
25010535|NCT03480009|50103329|FG002|Overall Study|Lost to Follow-up|4|||
25010536|NCT03480009|50103330|FG003|Overall Study|Lost to Follow-up|0|||
25010537|NCT03399786|50103345|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
25010538|NCT03399786|50103346|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
25010539|NCT03399786|50103347|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
25010540|NCT03399786|50103348|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
25010541|NCT03399786|50103345|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
25010542|NCT03399786|50103346|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
25010543|NCT03399786|50103347|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
25010544|NCT03399786|50103348|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
25010545|NCT03399786|50103345|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
25010546|NCT03399786|50103346|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
25010547|NCT03399786|50103347|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
25010548|NCT03399786|50103348|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
25010549|NCT03505593|50103356|FG000|Overall Study|Withdrawal by Subject|1|||
25010550|NCT03505593|50103356|FG000|Overall Study|Died before procedure|1|||
25010551|NCT03505593|50103356|FG000|Overall Study|Anatomical abnormality|1|||
25010552|NCT03505593|50103356|FG000|Overall Study|Unable to pass through esophagus|1|||
25010553|NCT03505593|50103356|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
25010554|NCT03504189|50103360|FG000|Overall Study|Withdrawal by Subject|1|||
25010555|NCT03504189|50103360|FG000|Overall Study|Screening Failure|1|||
25010556|NCT03504189|50103360|FG000|Overall Study|Device Failure|2|||
25010557|NCT03374358|50103371|FG000|Overall Study|Withdrawal by Subject|0|||
25010558|NCT03374358|50103372|FG001|Overall Study|Withdrawal by Subject|2|||
25010559|NCT03372096|50103378|FG000|Overall Study|Study Closed|8|||
25010560|NCT00004859|50103387|FG000|Overall Study|Lack of Efficacy|43|||
25010561|NCT00004859|50103388|FG001|Overall Study|Lack of Efficacy|113|||
25010562|NCT00004859|50103387|FG000|Overall Study|Adverse Event|31|||
25010563|NCT00004859|50103388|FG001|Overall Study|Adverse Event|93|||
25010564|NCT00004859|50103387|FG000|Overall Study|Death|5|||
25010565|NCT00004859|50103388|FG001|Overall Study|Death|5|||
25010566|NCT00004859|50103387|FG000|Overall Study|Withdrawal by Subject|7|||
25010567|NCT00004859|50103388|FG001|Overall Study|Withdrawal by Subject|33|||
25140146|NCT02116361|50253428|FG000|Overall Study|Lack of Efficacy|5|||
25010568|NCT00004859|50103387|FG000|Overall Study|Protocol Violation|2|||
25010569|NCT00004859|50103388|FG001|Overall Study|Protocol Violation|2|||
25010570|NCT00004859|50103387|FG000|Overall Study|other disease|0|||
25010571|NCT00004859|50103388|FG001|Overall Study|other disease|3|||
25010572|NCT00004859|50103387|FG000|Overall Study|error|3|||
25010573|NCT00004859|50103388|FG001|Overall Study|error|1|||
25010574|NCT00004859|50103387|FG000|Overall Study|missing data|14|||
25010575|NCT00004859|50103388|FG001|Overall Study|missing data|11|||
25010576|NCT00004859|50103387|FG000|Overall Study|Other|13|||
25140147|NCT02116361|50253429|FG001|Overall Study|Lack of Efficacy|7|||
25010577|NCT00004859|50103388|FG001|Overall Study|Other|21|||
25010578|NCT03500679|50103398|FG000|Overall Study|Lost to Follow-up|6|||
25010579|NCT03500679|50103399|FG001|Overall Study|Lost to Follow-up|3|||
25010580|NCT03500679|50103398|FG000|Overall Study|Withdrawal by Subject|3|||
25010581|NCT03500679|50103399|FG001|Overall Study|Withdrawal by Subject|0|||
25140148|NCT02116361|50253430|FG002|Overall Study|Lack of Efficacy|4|||
25140149|NCT02116361|50253431|FG003|Overall Study|Lack of Efficacy|3|||
25140150|NCT02116361|50253428|FG000|Overall Study|Lost to Follow-up|4|||
25010582|NCT03348930|50103405|FG000|Washout (1 Week)|Lost to Follow-up|1|||
25274242|NCT01106625|50588372|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
25274243|NCT01106625|50588370|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
25274244|NCT01106625|50588371|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
25274245|NCT01106625|50588372|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
25274246|NCT01106625|50588370|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
25274247|NCT01106625|50588371|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
25274248|NCT01106625|50588372|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
25274249|NCT01106625|50588370|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
25274250|NCT01106625|50588371|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
25010583|NCT03348930|50103406|FG001|Washout (1 Week)|Lost to Follow-up|1|||
25010584|NCT03500211|50103414|FG000|Overall Study|Withdrawal by Subject|1|||
25010585|NCT03500211|50103415|FG001|Overall Study|Withdrawal by Subject|1|||
25010586|NCT03478683|50103423|FG000|Overall Study|Adverse Event|5|||
25010587|NCT03478683|50103424|FG001|Overall Study|Adverse Event|3|||
25010588|NCT03478683|50103423|FG000|Overall Study|Lost to Follow-up|0|||
25010589|NCT03478683|50103424|FG001|Overall Study|Lost to Follow-up|5|||
25010590|NCT03478683|50103423|FG000|Overall Study|Physician Decision|1|||
25010591|NCT03478683|50103424|FG001|Overall Study|Physician Decision|3|||
25010592|NCT03478683|50103423|FG000|Overall Study|Withdrawal by Subject|7|||
25010593|NCT03478683|50103424|FG001|Overall Study|Withdrawal by Subject|7|||
25010594|NCT03478371|50103430|FG000|Overall Study|non-compliance|1|||
25010595|NCT03478371|50103430|FG000|Overall Study|Lost to Follow-up|4|||
25010596|NCT03477903|50103440|FG000|Overall Study|Study Terminated by Sponsor|1|||
25010597|NCT03475875|50103444|FG000|Period 1|Lost to Follow-up|1|||
25010598|NCT03475875|50103445|FG001|Period 1|Lost to Follow-up|0|||
25140151|NCT02116361|50253429|FG001|Overall Study|Lost to Follow-up|5|||
25140152|NCT02116361|50253430|FG002|Overall Study|Lost to Follow-up|7|||
25140153|NCT02116361|50253431|FG003|Overall Study|Lost to Follow-up|5|||
25140154|NCT02116361|50253428|FG000|Overall Study|Personal Reasons|6|||
25140155|NCT02116361|50253429|FG001|Overall Study|Personal Reasons|6|||
25140156|NCT02116361|50253430|FG002|Overall Study|Personal Reasons|4|||
25140157|NCT02116361|50253431|FG003|Overall Study|Personal Reasons|9|||
25140158|NCT02116361|50253428|FG000|Overall Study|Investigator Decision - Relapse|9|||
25140159|NCT02116361|50253429|FG001|Overall Study|Investigator Decision - Relapse|7|||
25140160|NCT02116361|50253430|FG002|Overall Study|Investigator Decision - Relapse|8|||
25140161|NCT02116361|50253431|FG003|Overall Study|Investigator Decision - Relapse|5|||
25140162|NCT02140775|50253443|FG000|Overall Study|Withdrawal by Subject|30|||
25140163|NCT02140775|50253444|FG001|Overall Study|Withdrawal by Subject|7|||
25140164|NCT01844817|50253454|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
25140165|NCT01844817|50253455|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
25140166|NCT01844817|50253454|FG000|Treatment|Progressive Disease|27|||
25140167|NCT01844817|50253455|FG001|Treatment|Progressive Disease|36|||
25140168|NCT01844817|50253454|FG000|Treatment|Adverse Event|17|||
25140169|NCT01844817|50253455|FG001|Treatment|Adverse Event|9|||
25140170|NCT01844817|50253454|FG000|Treatment|Withdrawal by Subject|10|||
25140171|NCT01844817|50253455|FG001|Treatment|Withdrawal by Subject|6|||
25140172|NCT01844817|50253454|FG000|Treatment|Death|10|||
25140173|NCT01844817|50253455|FG001|Treatment|Death|8|||
25140174|NCT01844817|50253454|FG000|Treatment|Lost to Follow-up|0|||
25140175|NCT01844817|50253455|FG001|Treatment|Lost to Follow-up|1|||
25140176|NCT01844817|50253454|FG000|Treatment|Other|0|||
25140177|NCT01844817|50253455|FG001|Treatment|Other|3|||
25140178|NCT01814553|50253464|FG000|Overall Study|PD per clinical progression|6|||
25140179|NCT01814553|50253465|FG001|Overall Study|PD per clinical progression|8|||
25140180|NCT01814553|50253464|FG000|Overall Study|Other Adverse Event|4|||
25140181|NCT01814553|50253465|FG001|Overall Study|Other Adverse Event|5|||
25140182|NCT01814553|50253464|FG000|Overall Study|Withdrawal by Subject|1|||
25140183|NCT01814553|50253465|FG001|Overall Study|Withdrawal by Subject|1|||
25140184|NCT01814553|50253464|FG000|Overall Study|Other than stated|7|||
25140185|NCT01814553|50253465|FG001|Overall Study|Other than stated|8|||
25140186|NCT02116205|50253475|FG000|Overall Study|Withdrawal by Subject|2|||
25140187|NCT02116205|50253476|FG001|Overall Study|Withdrawal by Subject|4|||
25140188|NCT02116205|50253477|FG002|Overall Study|Withdrawal by Subject|1|||
25140189|NCT02116205|50253478|FG003|Overall Study|Withdrawal by Subject|3|||
25140190|NCT02116205|50253475|FG000|Overall Study|Lost to Follow-up|0|||
25140191|NCT02116205|50253476|FG001|Overall Study|Lost to Follow-up|2|||
25274251|NCT01106625|50588372|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
25274252|NCT01106625|50588370|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
25274253|NCT01106625|50588371|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
25274254|NCT01106625|50588372|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
25274255|NCT01106625|50588370|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
25274256|NCT01106625|50588371|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
25274257|NCT01106625|50588372|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
25274258|NCT01106625|50588370|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
25274259|NCT01106625|50588371|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
25274260|NCT01106625|50588372|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
25274261|NCT01106625|50588370|FG000|Extension Period: Week 26 to Week 52|Other|5|||
25274262|NCT01106625|50588371|FG001|Extension Period: Week 26 to Week 52|Other|5|||
25140192|NCT02116205|50253477|FG002|Overall Study|Lost to Follow-up|1|||
25140193|NCT02116205|50253478|FG003|Overall Study|Lost to Follow-up|2|||
25140194|NCT02116205|50253475|FG000|Overall Study|Physician Decision|0|||
25140195|NCT02116205|50253476|FG001|Overall Study|Physician Decision|1|||
25140196|NCT02116205|50253477|FG002|Overall Study|Physician Decision|1|||
25140197|NCT02116205|50253478|FG003|Overall Study|Physician Decision|1|||
25140198|NCT02116205|50253475|FG000|Overall Study|Exclusion criteria|0|||
25140199|NCT02116205|50253476|FG001|Overall Study|Exclusion criteria|0|||
25140200|NCT02116205|50253477|FG002|Overall Study|Exclusion criteria|1|||
25140201|NCT02116205|50253478|FG003|Overall Study|Exclusion criteria|0|||
25140202|NCT01844583|50253490|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
25140203|NCT01844583|50253491|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
25140204|NCT02115815|50253509|FG000|Overall Study|Withdrawal by Subject|2|||
25140205|NCT02115815|50253510|FG001|Overall Study|Withdrawal by Subject|0|||
25140206|NCT02115815|50253511|FG002|Overall Study|Withdrawal by Subject|0|||
25140207|NCT02115815|50253512|FG003|Overall Study|Withdrawal by Subject|0|||
25140208|NCT02115815|50253513|FG004|Overall Study|Withdrawal by Subject|0|||
25140209|NCT02115815|50253514|FG005|Overall Study|Withdrawal by Subject|0|||
25140210|NCT02115815|50253515|FG006|Overall Study|Withdrawal by Subject|0|||
25140211|NCT02115815|50253509|FG000|Overall Study|Not enough drug to dose participant|0|||
25140212|NCT02115815|50253510|FG001|Overall Study|Not enough drug to dose participant|0|||
25140213|NCT02115815|50253511|FG002|Overall Study|Not enough drug to dose participant|0|||
25140214|NCT02115815|50253512|FG003|Overall Study|Not enough drug to dose participant|0|||
25140215|NCT02115815|50253513|FG004|Overall Study|Not enough drug to dose participant|0|||
25140216|NCT02115815|50253514|FG005|Overall Study|Not enough drug to dose participant|1|||
25140217|NCT02115815|50253515|FG006|Overall Study|Not enough drug to dose participant|0|||
25140218|NCT02115815|50253509|FG000|Overall Study|Missed appointment, randomized in error|0|||
25140219|NCT02115815|50253510|FG001|Overall Study|Missed appointment, randomized in error|0|||
25140220|NCT02115815|50253511|FG002|Overall Study|Missed appointment, randomized in error|0|||
25140221|NCT02115815|50253512|FG003|Overall Study|Missed appointment, randomized in error|0|||
25140222|NCT02115815|50253513|FG004|Overall Study|Missed appointment, randomized in error|0|||
25140223|NCT02115815|50253514|FG005|Overall Study|Missed appointment, randomized in error|1|||
25140224|NCT02115815|50253515|FG006|Overall Study|Missed appointment, randomized in error|0|||
25140225|NCT02115269|50253531|FG000|Overall Study|Lost to Follow-up|43|||
25140226|NCT02115269|50253531|FG000|Overall Study|Did not complete patient diary|3|||
25140227|NCT02115269|50253531|FG000|Overall Study|Moved to another city|7|||
25140228|NCT02115269|50253531|FG000|Overall Study|Withdrawal by Subject|2|||
25010599|NCT03475875|50103444|FG000|Period 1|Adverse Event|2|||
25010600|NCT03475875|50103445|FG001|Period 1|Adverse Event|1|||
25010601|NCT03475875|50103444|FG000|Period 2|Adverse Event|3|||
25010602|NCT03475875|50103445|FG001|Period 2|Adverse Event|0|||
25010603|NCT03475875|50103444|FG000|Period 2|Protocol Violation|0|||
25010604|NCT03475875|50103445|FG001|Period 2|Protocol Violation|1|||
25010605|NCT03474081|50103453|FG000|Overall Study|Adverse Event|6|||
25010606|NCT03474081|50103454|FG001|Overall Study|Adverse Event|3|||
25010607|NCT03474081|50103453|FG000|Overall Study|Lost to Follow-up|2|||
25010608|NCT03474081|50103454|FG001|Overall Study|Lost to Follow-up|1|||
25010609|NCT03474081|50103453|FG000|Overall Study|Physician Decision|3|||
25010610|NCT03474081|50103454|FG001|Overall Study|Physician Decision|2|||
25010611|NCT03474081|50103453|FG000|Overall Study|Withdrawal by Subject|5|||
25010612|NCT03474081|50103454|FG001|Overall Study|Withdrawal by Subject|7|||
25010613|NCT03474081|50103453|FG000|Overall Study|Investigator site closed|1|||
25010614|NCT03474081|50103454|FG001|Overall Study|Investigator site closed|0|||
25010615|NCT03346434|50103466|FG000|Overall Study|Randomized in Error|0|||
25010616|NCT03346434|50103467|FG001|Overall Study|Randomized in Error|0|||
25010617|NCT03346434|50103468|FG002|Overall Study|Randomized in Error|0|||
25010618|NCT03346434|50103469|FG003|Overall Study|Randomized in Error|0|||
25010619|NCT03346434|50103470|FG004|Overall Study|Randomized in Error|1|||
25010620|NCT03346434|50103471|FG005|Overall Study|Randomized in Error|0|||
25010621|NCT03346434|50103466|FG000|Overall Study|Withdrawal by Subject|0|||
25010622|NCT03346434|50103467|FG001|Overall Study|Withdrawal by Subject|0|||
25010623|NCT03346434|50103468|FG002|Overall Study|Withdrawal by Subject|1|||
25010624|NCT03346434|50103469|FG003|Overall Study|Withdrawal by Subject|0|||
25010625|NCT03346434|50103470|FG004|Overall Study|Withdrawal by Subject|1|||
25010626|NCT03346434|50103471|FG005|Overall Study|Withdrawal by Subject|0|||
25010627|NCT03346434|50103466|FG000|Overall Study|Lost to Follow-up|0|||
25010628|NCT03346434|50103467|FG001|Overall Study|Lost to Follow-up|0|||
25010629|NCT03346434|50103468|FG002|Overall Study|Lost to Follow-up|0|||
25010630|NCT03346434|50103469|FG003|Overall Study|Lost to Follow-up|0|||
25010631|NCT03346434|50103470|FG004|Overall Study|Lost to Follow-up|1|||
25010632|NCT03346434|50103471|FG005|Overall Study|Lost to Follow-up|1|||
25010633|NCT03346434|50103466|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
25010634|NCT03346434|50103467|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
25010635|NCT03346434|50103468|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
25010636|NCT03346434|50103469|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
25010637|NCT03346434|50103470|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
25140229|NCT02115269|50253531|FG000|Overall Study|Didn't take study drug|2|||
25140230|NCT02115113|50253546|FG000|Participants in Run-in Period|Death|0|||
25140231|NCT02115113|50253547|FG001|Participants in Run-in Period|Death|0|||
25140232|NCT02115113|50253548|FG002|Participants in Run-in Period|Death|1|||
25140233|NCT02115113|50253546|FG000|Participants in Run-in Period|Administrative problems|0|||
25140234|NCT02115113|50253547|FG001|Participants in Run-in Period|Administrative problems|0|||
25140235|NCT02115113|50253548|FG002|Participants in Run-in Period|Administrative problems|1|||
25140236|NCT02115113|50253546|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
25140237|NCT02115113|50253547|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
25140238|NCT02115113|50253548|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
25140239|NCT02115113|50253546|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
25140240|NCT02115113|50253547|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
25140241|NCT02115113|50253548|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
25140242|NCT02115113|50253546|FG000|Participants Randomized|Lost to Follow-up|1|||
25140243|NCT02115113|50253547|FG001|Participants Randomized|Lost to Follow-up|0|||
25140244|NCT02115113|50253548|FG002|Participants Randomized|Lost to Follow-up|0|||
25140245|NCT02115113|50253546|FG000|Participants Randomized|Death|1|||
25140246|NCT02115113|50253547|FG001|Participants Randomized|Death|0|||
25140247|NCT02115113|50253548|FG002|Participants Randomized|Death|0|||
25140248|NCT02114879|50253559|FG000|Overall Study|Withdrawal by Subject|9|||
25140249|NCT02114879|50253560|FG001|Overall Study|Withdrawal by Subject|5|||
25140250|NCT02114879|50253559|FG000|Overall Study|Death|6|||
25140251|NCT02114879|50253560|FG001|Overall Study|Death|11|||
25140252|NCT02114879|50253559|FG000|Overall Study|Lost to Follow-up|4|||
25140253|NCT02114879|50253560|FG001|Overall Study|Lost to Follow-up|6|||
25140254|NCT02114879|50253559|FG000|Overall Study|Physician Decision|0|||
25274263|NCT01106625|50588372|FG002|Extension Period: Week 26 to Week 52|Other|4|||
25274264|NCT01251380|50588383|FG000|Overall Study|Other (Not otherwise specified)|12|||
25274265|NCT01251380|50588383|FG000|Overall Study|Withdrawal by Subject|6|||
25274266|NCT01251380|50588383|FG000|Overall Study|Lack of Efficacy|1|||
25274267|NCT01251380|50588383|FG000|Overall Study|Adverse Event|1|||
25274268|NCT01251380|50588383|FG000|Overall Study|Lost to Follow-up|2|||
25274269|NCT01251146|50588394|FG000|Overall Study|Lost to Follow-up|3|||
25274270|NCT01251146|50588395|FG001|Overall Study|Lost to Follow-up|10|||
25010638|NCT03346434|50103471|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
25010639|NCT03393000|50103489|FG000|Overall Study|Death|11|||
25010640|NCT03393000|50103489|FG000|Overall Study|Withdrawal by Subject|2|||
25010641|NCT03393000|50103489|FG000|Overall Study|Physician Decision|1|||
25010642|NCT03370770|50103493|FG000|Overall Study|Patient was followed in another hospital center|1|||
25010643|NCT03370770|50103493|FG000|Overall Study|Progressive Disease|98|||
25010644|NCT03370770|50103493|FG000|Overall Study|Adverse Event|2|||
25010645|NCT03370770|50103493|FG000|Overall Study|Death|5|||
25010646|NCT03473301|50103500|FG000|Overall Study|Protocol Violation|4|||
25010647|NCT03473301|50103501|FG001|Overall Study|Protocol Violation|0|||
25010648|NCT03473301|50103502|FG002|Overall Study|Protocol Violation|0|||
25140255|NCT02114879|50253560|FG001|Overall Study|Physician Decision|2|||
25140256|NCT02114177|50253568|FG000|Overall Study|Lost to Follow-up|1|||
25140257|NCT02114177|50253569|FG001|Overall Study|Lost to Follow-up|2|||
25140258|NCT02114177|50253568|FG000|Overall Study|Withdrawal by Subject|6|||
25140259|NCT02114177|50253569|FG001|Overall Study|Withdrawal by Subject|1|||
25140260|NCT02114177|50253568|FG000|Overall Study|Other|2|||
25140261|NCT02114177|50253569|FG001|Overall Study|Other|1|||
25140262|NCT02138825|50253577|FG000|Main Study Treatment|Adverse Event|11|||
25140263|NCT02138825|50253578|FG001|Main Study Treatment|Adverse Event|3|||
25140264|NCT02138825|50253577|FG000|Main Study Treatment|Death|1|||
25140265|NCT02138825|50253578|FG001|Main Study Treatment|Death|2|||
25140266|NCT02138825|50253577|FG000|Main Study Treatment|Protocol Violation|2|||
25140267|NCT02138825|50253578|FG001|Main Study Treatment|Protocol Violation|2|||
25140268|NCT02138825|50253577|FG000|Main Study Treatment|Sponsor decision|12|||
25140269|NCT02138825|50253578|FG001|Main Study Treatment|Sponsor decision|18|||
25140270|NCT02138825|50253577|FG000|Main Study Treatment|Study terminated by sponsor|10|||
25140271|NCT02138825|50253578|FG001|Main Study Treatment|Study terminated by sponsor|9|||
25140272|NCT02138825|50253577|FG000|Main Study Treatment|Withdrawal by Subject|3|||
25140273|NCT02138825|50253578|FG001|Main Study Treatment|Withdrawal by Subject|1|||
25010649|NCT03473301|50103500|FG000|Overall Study|Withdrawal by Subject|0|||
25010650|NCT03473301|50103501|FG001|Overall Study|Withdrawal by Subject|1|||
25010651|NCT03473301|50103502|FG002|Overall Study|Withdrawal by Subject|0|||
25010652|NCT03473301|50103500|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
25010653|NCT03473301|50103501|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
25010654|NCT03473301|50103502|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
25010655|NCT03390426|50103514|FG000|Overall Study|Protocol Violation|0|||
25010656|NCT03390426|50103515|FG001|Overall Study|Protocol Violation|1|||
25010657|NCT03472521|50103523|FG000|Overall Study|Lost to Follow-up|3|||
25010658|NCT03472521|50103524|FG001|Overall Study|Lost to Follow-up|2|||
25010659|NCT03472521|50103523|FG000|Overall Study|Discontinued intervention|3|||
25010660|NCT03472521|50103524|FG001|Overall Study|Discontinued intervention|1|||
25010661|NCT02906020|50103540|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
25010662|NCT02906020|50103541|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
25010663|NCT02906020|50103542|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
25010664|NCT02906020|50103543|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
25010665|NCT02906020|50103544|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
25010666|NCT02906020|50103545|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
25010667|NCT02906020|50103546|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
25010668|NCT02906020|50103547|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
25140274|NCT02138825|50253577|FG000|Main Study Treatment|Medical decision|1|||
25140275|NCT02138825|50253578|FG001|Main Study Treatment|Medical decision|0|||
25140276|NCT02138825|50253577|FG000|Long-term Extension|Study termination by sponsor|32|||
25140277|NCT02138825|50253578|FG001|Long-term Extension|Study termination by sponsor|38|||
25140278|NCT02138825|50253577|FG000|Safety Follow-up|Adverse Event|4|||
25140279|NCT02138825|50253578|FG001|Safety Follow-up|Adverse Event|3|||
25140280|NCT02138825|50253577|FG000|Safety Follow-up|Death|11|||
25140281|NCT02138825|50253578|FG001|Safety Follow-up|Death|5|||
25140282|NCT02138825|50253577|FG000|Safety Follow-up|Withdrawal by Subject|5|||
25140283|NCT02138825|50253578|FG001|Safety Follow-up|Withdrawal by Subject|3|||
25140284|NCT02138825|50253577|FG000|Safety Follow-up|clinic worsening|1|||
25140285|NCT02138825|50253578|FG001|Safety Follow-up|clinic worsening|0|||
25140286|NCT02138825|50253577|FG000|Safety Follow-up|withdrawal by PI|1|||
25140287|NCT02138825|50253578|FG001|Safety Follow-up|withdrawal by PI|0|||
25140288|NCT02138825|50253577|FG000|Safety Follow-up|logistical difficulties|0|||
25140289|NCT02138825|50253578|FG001|Safety Follow-up|logistical difficulties|1|||
25140290|NCT02138825|50253577|FG000|Safety Follow-up|progressive disease|0|||
25140291|NCT02138825|50253578|FG001|Safety Follow-up|progressive disease|2|||
25010669|NCT02906020|50103548|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
25010670|NCT02906020|50103549|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
25010671|NCT02906020|50103550|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
25010672|NCT02906020|50103551|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
25010673|NCT02906020|50103552|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
25140292|NCT02138825|50253577|FG000|Safety Follow-up|too unwell to attend the visit|0|||
25140293|NCT02138825|50253578|FG001|Safety Follow-up|too unwell to attend the visit|1|||
25140294|NCT02138825|50253577|FG000|Safety Follow-up|treatment unblinded|0|||
25140295|NCT02138825|50253578|FG001|Safety Follow-up|treatment unblinded|1|||
25140296|NCT02138825|50253577|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
25140297|NCT02138825|50253578|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
25140298|NCT02138747|50253593|FG000|Treatment Period 1|Adverse Event|10|||
25140299|NCT02138747|50253594|FG001|Treatment Period 1|Adverse Event|14|||
25140300|NCT02138747|50253595|FG002|Treatment Period 1|Adverse Event|2|||
25140301|NCT02138747|50253596|FG003|Treatment Period 1|Adverse Event|1|||
25140302|NCT02138747|50253593|FG000|Treatment Period 1|Lost to Follow-up|0|||
25140303|NCT02138747|50253594|FG001|Treatment Period 1|Lost to Follow-up|1|||
25140304|NCT02138747|50253595|FG002|Treatment Period 1|Lost to Follow-up|1|||
25140305|NCT02138747|50253596|FG003|Treatment Period 1|Lost to Follow-up|0|||
25140306|NCT02138747|50253593|FG000|Treatment Period 1|Protocol Violation|0|||
25140307|NCT02138747|50253594|FG001|Treatment Period 1|Protocol Violation|2|||
25140308|NCT02138747|50253595|FG002|Treatment Period 1|Protocol Violation|0|||
25140309|NCT02138747|50253596|FG003|Treatment Period 1|Protocol Violation|0|||
25140310|NCT02138747|50253593|FG000|Treatment Period 1|Withdrawal by Subject|8|||
25140311|NCT02138747|50253594|FG001|Treatment Period 1|Withdrawal by Subject|4|||
25140312|NCT02138747|50253595|FG002|Treatment Period 1|Withdrawal by Subject|1|||
25140313|NCT02138747|50253596|FG003|Treatment Period 1|Withdrawal by Subject|3|||
25140314|NCT02138747|50253593|FG000|Treatment Period 1|Other - Miscellaneous|2|||
25140315|NCT02138747|50253594|FG001|Treatment Period 1|Other - Miscellaneous|4|||
25140316|NCT02138747|50253595|FG002|Treatment Period 1|Other - Miscellaneous|0|||
25140317|NCT02138747|50253596|FG003|Treatment Period 1|Other - Miscellaneous|0|||
25140318|NCT02138747|50253593|FG000|Treatment Period 2|Adverse Event|6|||
25140319|NCT02138747|50253594|FG001|Treatment Period 2|Adverse Event|3|||
25140320|NCT02138747|50253595|FG002|Treatment Period 2|Adverse Event|1|||
25140321|NCT02138747|50253596|FG003|Treatment Period 2|Adverse Event|1|||
25140322|NCT02138747|50253593|FG000|Treatment Period 2|Lost to Follow-up|2|||
25140323|NCT02138747|50253594|FG001|Treatment Period 2|Lost to Follow-up|0|||
25140324|NCT02138747|50253595|FG002|Treatment Period 2|Lost to Follow-up|0|||
25140325|NCT02138747|50253596|FG003|Treatment Period 2|Lost to Follow-up|0|||
25140326|NCT02138747|50253593|FG000|Treatment Period 2|Protocol Violation|1|||
25140327|NCT02138747|50253594|FG001|Treatment Period 2|Protocol Violation|0|||
25140328|NCT02138747|50253595|FG002|Treatment Period 2|Protocol Violation|0|||
25140329|NCT02138747|50253596|FG003|Treatment Period 2|Protocol Violation|0|||
25140330|NCT02138747|50253593|FG000|Treatment Period 2|Withdrawal by Subject|5|||
25140331|NCT02138747|50253594|FG001|Treatment Period 2|Withdrawal by Subject|4|||
25140332|NCT02138747|50253595|FG002|Treatment Period 2|Withdrawal by Subject|1|||
25140333|NCT02138747|50253596|FG003|Treatment Period 2|Withdrawal by Subject|2|||
25140334|NCT02138747|50253593|FG000|Treatment Period 2|Other - Miscellaneous|3|||
25140335|NCT02138747|50253594|FG001|Treatment Period 2|Other - Miscellaneous|0|||
25140336|NCT02138747|50253595|FG002|Treatment Period 2|Other - Miscellaneous|0|||
25140337|NCT02138747|50253596|FG003|Treatment Period 2|Other - Miscellaneous|0|||
25140338|NCT02105285|50253609|FG000|Overall Study|Adverse Event|1|||
25140339|NCT02105285|50253610|FG001|Overall Study|Adverse Event|1|||
25140340|NCT02105285|50253611|FG002|Overall Study|Adverse Event|0|||
25140341|NCT02105285|50253609|FG000|Overall Study|Protocol Violation|0|||
25140342|NCT02105285|50253610|FG001|Overall Study|Protocol Violation|1|||
25140343|NCT02105285|50253611|FG002|Overall Study|Protocol Violation|0|||
25140344|NCT02105285|50253609|FG000|Overall Study|Withdrawal by Subject|1|||
25140345|NCT02105285|50253610|FG001|Overall Study|Withdrawal by Subject|0|||
25140346|NCT02105285|50253611|FG002|Overall Study|Withdrawal by Subject|0|||
25140347|NCT02104895|50253620|FG000|Overall Study|Withdrawal by Subject|0|||
25010674|NCT02906020|50103553|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
25010675|NCT02906020|50103554|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
25010676|NCT02906020|50103555|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
25010677|NCT02906020|50103540|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
25010678|NCT02906020|50103541|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
25010679|NCT02906020|50103542|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
25010680|NCT02906020|50103543|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
25010681|NCT02906020|50103544|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
25010682|NCT02906020|50103545|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
25010683|NCT02906020|50103546|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
25140348|NCT02104895|50253621|FG001|Overall Study|Withdrawal by Subject|14|||
25140349|NCT01621490|50253636|FG000|Overall Study|Participant completed treatment|4|||
25140350|NCT01621490|50253637|FG001|Overall Study|Participant completed treatment|4|||
25140351|NCT01621490|50253638|FG002|Overall Study|Participant completed treatment|1|||
25140352|NCT01621490|50253639|FG003|Overall Study|Participant completed treatment|0|||
25140353|NCT01621490|50253640|FG004|Overall Study|Participant completed treatment|0|||
25140354|NCT01621490|50253641|FG005|Overall Study|Participant completed treatment|0|||
25140355|NCT01621490|50253642|FG006|Overall Study|Participant completed treatment|0|||
25140356|NCT01621490|50253643|FG007|Overall Study|Participant completed treatment|1|||
25140357|NCT01621490|50253644|FG008|Overall Study|Participant completed treatment|0|||
25010684|NCT02906020|50103547|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
25010685|NCT02906020|50103548|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
25010686|NCT02906020|50103549|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
25010687|NCT02906020|50103550|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
25010688|NCT02906020|50103551|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
25010689|NCT02906020|50103552|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
25010690|NCT02906020|50103553|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
25010691|NCT02906020|50103554|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
25010692|NCT02906020|50103555|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
25010693|NCT02906020|50103540|FG000|Part 2: Double-blind Treatment Period|Other|0|||
25010694|NCT02906020|50103541|FG001|Part 2: Double-blind Treatment Period|Other|0|||
25010695|NCT02906020|50103542|FG002|Part 2: Double-blind Treatment Period|Other|0|||
25010696|NCT02906020|50103543|FG003|Part 2: Double-blind Treatment Period|Other|0|||
25010697|NCT02906020|50103544|FG004|Part 2: Double-blind Treatment Period|Other|0|||
25010698|NCT02906020|50103545|FG005|Part 2: Double-blind Treatment Period|Other|0|||
25010699|NCT02906020|50103546|FG006|Part 2: Double-blind Treatment Period|Other|0|||
25010700|NCT02906020|50103547|FG007|Part 2: Double-blind Treatment Period|Other|0|||
25140358|NCT01621490|50253636|FG000|Overall Study|Patient could not travel|1|||
25140359|NCT01621490|50253637|FG001|Overall Study|Patient could not travel|0|||
25140360|NCT01621490|50253638|FG002|Overall Study|Patient could not travel|0|||
25140361|NCT01621490|50253639|FG003|Overall Study|Patient could not travel|0|||
25140362|NCT01621490|50253640|FG004|Overall Study|Patient could not travel|0|||
25140363|NCT01621490|50253641|FG005|Overall Study|Patient could not travel|0|||
25140364|NCT01621490|50253642|FG006|Overall Study|Patient could not travel|0|||
25140365|NCT01621490|50253643|FG007|Overall Study|Patient could not travel|0|||
25140366|NCT01621490|50253644|FG008|Overall Study|Patient could not travel|0|||
25010701|NCT02906020|50103548|FG008|Part 2: Double-blind Treatment Period|Other|6|||
25010702|NCT02906020|50103549|FG009|Part 2: Double-blind Treatment Period|Other|10|||
25010703|NCT02906020|50103550|FG010|Part 2: Double-blind Treatment Period|Other|0|||
25010704|NCT02906020|50103551|FG011|Part 2: Double-blind Treatment Period|Other|0|||
25010705|NCT02906020|50103552|FG012|Part 2: Double-blind Treatment Period|Other|0|||
25010706|NCT02906020|50103553|FG013|Part 2: Double-blind Treatment Period|Other|0|||
25010707|NCT02906020|50103554|FG014|Part 2: Double-blind Treatment Period|Other|0|||
25010708|NCT02906020|50103555|FG015|Part 2: Double-blind Treatment Period|Other|0|||
25010709|NCT02906020|50103540|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
25010710|NCT02906020|50103541|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
25010711|NCT02906020|50103542|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
25010712|NCT02906020|50103543|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
25010713|NCT02906020|50103544|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
25010714|NCT02906020|50103545|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
25010715|NCT02906020|50103546|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
25010716|NCT02906020|50103547|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
25010717|NCT02906020|50103548|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
25010718|NCT02906020|50103549|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
25140367|NCT01621490|50253636|FG000|Overall Study|Subject no longer meets study criteria|0|||
25140368|NCT01621490|50253637|FG001|Overall Study|Subject no longer meets study criteria|0|||
25010719|NCT02906020|50103550|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
25010720|NCT02906020|50103551|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
25010721|NCT02906020|50103552|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
25010722|NCT02906020|50103553|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
25010723|NCT02906020|50103554|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
25010724|NCT02906020|50103555|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
25010725|NCT02906020|50103540|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
25010726|NCT02906020|50103541|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
25010727|NCT02906020|50103542|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
25010728|NCT02906020|50103543|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
25010729|NCT02906020|50103544|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
25010730|NCT02906020|50103545|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
25010731|NCT02906020|50103546|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
25010732|NCT02906020|50103547|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
25010733|NCT02906020|50103548|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
25140369|NCT01621490|50253638|FG002|Overall Study|Subject no longer meets study criteria|0|||
25140370|NCT01621490|50253639|FG003|Overall Study|Subject no longer meets study criteria|0|||
25140371|NCT01621490|50253640|FG004|Overall Study|Subject no longer meets study criteria|1|||
25140372|NCT01621490|50253641|FG005|Overall Study|Subject no longer meets study criteria|0|||
25140373|NCT01621490|50253642|FG006|Overall Study|Subject no longer meets study criteria|0|||
25140374|NCT01621490|50253643|FG007|Overall Study|Subject no longer meets study criteria|0|||
25140375|NCT01621490|50253644|FG008|Overall Study|Subject no longer meets study criteria|0|||
25140376|NCT01621490|50253636|FG000|Overall Study|Maximum clinical benefit|3|||
25140377|NCT01621490|50253637|FG001|Overall Study|Maximum clinical benefit|2|||
25140378|NCT01621490|50253638|FG002|Overall Study|Maximum clinical benefit|0|||
25010734|NCT02906020|50103549|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
25010735|NCT02906020|50103550|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
25010736|NCT02906020|50103551|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
25010737|NCT02906020|50103552|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
25010738|NCT02906020|50103553|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
25010739|NCT02906020|50103554|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
25010740|NCT02906020|50103555|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
25010741|NCT02906020|50103540|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
25010742|NCT02906020|50103541|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
25010743|NCT02906020|50103542|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
25010744|NCT02906020|50103543|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
25010745|NCT02906020|50103544|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
25010746|NCT02906020|50103545|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
25010747|NCT02906020|50103546|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
25010748|NCT02906020|50103547|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
25010749|NCT02906020|50103548|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
25010750|NCT02906020|50103549|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
25010751|NCT02906020|50103550|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
25010752|NCT02906020|50103551|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
25010753|NCT02906020|50103552|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
25010754|NCT02906020|50103553|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
25010755|NCT02906020|50103554|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
25010756|NCT02906020|50103555|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
25010757|NCT02906020|50103540|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
25010758|NCT02906020|50103541|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
25010759|NCT02906020|50103542|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
25010760|NCT02906020|50103543|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
25010761|NCT02906020|50103544|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
25010762|NCT02906020|50103545|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
25010763|NCT02906020|50103546|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
25010764|NCT02906020|50103547|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
25010765|NCT02906020|50103548|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
25010766|NCT02906020|50103549|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
25010767|NCT02906020|50103550|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
25010768|NCT02906020|50103551|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
25010769|NCT02906020|50103552|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
25140379|NCT01621490|50253639|FG003|Overall Study|Maximum clinical benefit|0|||
25140380|NCT01621490|50253640|FG004|Overall Study|Maximum clinical benefit|0|||
25140381|NCT01621490|50253641|FG005|Overall Study|Maximum clinical benefit|0|||
25140382|NCT01621490|50253642|FG006|Overall Study|Maximum clinical benefit|1|||
25140383|NCT01621490|50253643|FG007|Overall Study|Maximum clinical benefit|2|||
25010770|NCT02906020|50103553|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
25010771|NCT02906020|50103554|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
25010772|NCT02906020|50103555|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
25010773|NCT02906020|50103540|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
25010774|NCT02906020|50103541|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
25010775|NCT02906020|50103542|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
25010776|NCT02906020|50103543|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
25010777|NCT02906020|50103544|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
25010778|NCT02906020|50103545|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
25010779|NCT02906020|50103546|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
25010780|NCT02906020|50103547|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
25010781|NCT02906020|50103548|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
25010782|NCT02906020|50103549|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
25010783|NCT02906020|50103550|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
25140384|NCT01621490|50253644|FG008|Overall Study|Maximum clinical benefit|0|||
25140385|NCT01621490|50253636|FG000|Overall Study|Withdrawal by Subject|1|||
25140386|NCT01621490|50253637|FG001|Overall Study|Withdrawal by Subject|0|||
25140387|NCT01621490|50253638|FG002|Overall Study|Withdrawal by Subject|0|||
25140388|NCT01621490|50253639|FG003|Overall Study|Withdrawal by Subject|0|||
25140389|NCT01621490|50253640|FG004|Overall Study|Withdrawal by Subject|0|||
25140390|NCT01621490|50253641|FG005|Overall Study|Withdrawal by Subject|3|||
25140391|NCT01621490|50253642|FG006|Overall Study|Withdrawal by Subject|0|||
25140392|NCT01621490|50253643|FG007|Overall Study|Withdrawal by Subject|0|||
25179168|NCT01693562|50324408|FG022|Expansion Phase|Lost to Follow-up|1|||
25010784|NCT02906020|50103551|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
25010785|NCT02906020|50103552|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
25010786|NCT02906020|50103553|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
25010787|NCT02906020|50103554|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
25010788|NCT02906020|50103555|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
25010789|NCT02906020|50103540|FG000|Part 2: Long-term Follow-up Period|Other|0|||
25010790|NCT02906020|50103541|FG001|Part 2: Long-term Follow-up Period|Other|0|||
25010791|NCT02906020|50103542|FG002|Part 2: Long-term Follow-up Period|Other|0|||
25010792|NCT02906020|50103543|FG003|Part 2: Long-term Follow-up Period|Other|0|||
25010793|NCT02906020|50103544|FG004|Part 2: Long-term Follow-up Period|Other|0|||
25010794|NCT02906020|50103545|FG005|Part 2: Long-term Follow-up Period|Other|0|||
25010795|NCT02906020|50103546|FG006|Part 2: Long-term Follow-up Period|Other|0|||
25010796|NCT02906020|50103547|FG007|Part 2: Long-term Follow-up Period|Other|0|||
25010797|NCT02906020|50103548|FG008|Part 2: Long-term Follow-up Period|Other|0|||
25010798|NCT02906020|50103549|FG009|Part 2: Long-term Follow-up Period|Other|0|||
25010799|NCT02906020|50103550|FG010|Part 2: Long-term Follow-up Period|Other|0|||
25010800|NCT02906020|50103551|FG011|Part 2: Long-term Follow-up Period|Other|0|||
25010801|NCT02906020|50103552|FG012|Part 2: Long-term Follow-up Period|Other|13|||
25010802|NCT02906020|50103553|FG013|Part 2: Long-term Follow-up Period|Other|8|||
25010803|NCT02906020|50103554|FG014|Part 2: Long-term Follow-up Period|Other|3|||
25010804|NCT02906020|50103555|FG015|Part 2: Long-term Follow-up Period|Other|2|||
25010805|NCT03499353|50103583|FG000|Treatment|Adverse Event|3|||
25010806|NCT03499353|50103583|FG000|Treatment|Progressive Disease|10|||
25010807|NCT03499353|50103583|FG000|Treatment|Other|1|||
25010808|NCT03499353|50103583|FG000|Treatment|Withdrawal by Subject|2|||
25010809|NCT03499353|50103583|FG000|Long-Term Follow-up|Death|2|||
25010810|NCT03499353|50103583|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
25010811|NCT03499353|50103583|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
25010812|NCT03368664|50103587|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
25010813|NCT03368664|50103587|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
25010814|NCT03368664|50103587|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
25067362|NCT02397694|50172967|FG001|Open Label Extension Phase|Withdrew Consent|1|||
25067363|NCT02397694|50172966|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
25067364|NCT02397694|50172967|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
25067365|NCT02783599|50172977|FG000|Overall Study|Progressive disease|23|||
25067366|NCT02783599|50172977|FG000|Overall Study|Surgical Resection|10|||
25067367|NCT02783599|50172977|FG000|Overall Study|Adverse Event|4|||
25067368|NCT02783599|50172977|FG000|Overall Study|Physician Decision|2|||
25067369|NCT02783599|50172977|FG000|Overall Study|Death|1|||
25067370|NCT02838017|50172990|FG000|Overall Study|Lost to Follow-up|14|||
25010815|NCT03368664|50103587|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
25010816|NCT00004259|50103599|FG000|Overall Study|Protocol Violation|1|||
25010817|NCT00004259|50103600|FG001|Overall Study|Protocol Violation|2|||
25010818|NCT00004259|50103601|FG002|Overall Study|Protocol Violation|0|||
25010819|NCT00004259|50103602|FG003|Overall Study|Protocol Violation|0|||
25010820|NCT00004259|50103599|FG000|Overall Study|Withdrawal by Subject|0|||
25010821|NCT00004259|50103600|FG001|Overall Study|Withdrawal by Subject|2|||
25010822|NCT00004259|50103601|FG002|Overall Study|Withdrawal by Subject|0|||
25010823|NCT00004259|50103602|FG003|Overall Study|Withdrawal by Subject|0|||
25010824|NCT03365934|50103626|FG000|Overall Study|Adverse Event|1|||
25010825|NCT03365934|50103626|FG000|Overall Study|Withdrawal by Subject|1|||
25010826|NCT03468855|50103635|FG000|Overall Study|Adverse Event|2|||
25010827|NCT03468855|50103635|FG000|Overall Study|Lost to Follow-up|5|||
25140393|NCT01621490|50253644|FG008|Overall Study|Withdrawal by Subject|0|||
25140394|NCT01621490|50253636|FG000|Overall Study|Subject request to discontinue study|1|||
25140395|NCT01621490|50253637|FG001|Overall Study|Subject request to discontinue study|3|||
25140396|NCT01621490|50253638|FG002|Overall Study|Subject request to discontinue study|1|||
25140397|NCT01621490|50253639|FG003|Overall Study|Subject request to discontinue study|1|||
25010828|NCT03468855|50103635|FG000|Overall Study|Withdrawal by Subject|3|||
25010829|NCT03468855|50103635|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
25010830|NCT03738865|50103641|FG000|Overall Study|Withdrawal by Subject|3|||
25010831|NCT03738865|50103642|FG001|Overall Study|Withdrawal by Subject|3|||
25010832|NCT03738865|50103641|FG000|Overall Study|Adverse Event|2|||
25010833|NCT03738865|50103642|FG001|Overall Study|Adverse Event|0|||
25010834|NCT03738865|50103641|FG000|Overall Study|Physician Decision|0|||
25010835|NCT03738865|50103642|FG001|Overall Study|Physician Decision|1|||
25010836|NCT03524157|50103651|FG000|Overall Study|cytology not readable|0|||
25010837|NCT03524157|50103652|FG001|Overall Study|cytology not readable|0|||
25140398|NCT01621490|50253640|FG004|Overall Study|Subject request to discontinue study|0|||
25140399|NCT01621490|50253641|FG005|Overall Study|Subject request to discontinue study|2|||
25140400|NCT01621490|50253642|FG006|Overall Study|Subject request to discontinue study|1|||
25140401|NCT01621490|50253643|FG007|Overall Study|Subject request to discontinue study|0|||
25140402|NCT01621490|50253644|FG008|Overall Study|Subject request to discontinue study|1|||
25140403|NCT01621490|50253636|FG000|Overall Study|Adverse event unrelated to study drug|2|||
25140404|NCT01621490|50253637|FG001|Overall Study|Adverse event unrelated to study drug|1|||
25140405|NCT01621490|50253638|FG002|Overall Study|Adverse event unrelated to study drug|0|||
25140406|NCT01621490|50253639|FG003|Overall Study|Adverse event unrelated to study drug|0|||
25010838|NCT03524157|50103653|FG002|Overall Study|cytology not readable|1|||
25010839|NCT03437733|50103667|FG000|Overall Study|Eligibility criteria not met|0|||
25010840|NCT03437733|50103668|FG001|Overall Study|Eligibility criteria not met|3|||
25010841|NCT03468543|50103676|FG000|Overall Study|Protocol stopping rules met|3|||
25010842|NCT03467763|50103680|FG000|Overall Study|Lost to Follow-up|1|||
25010843|NCT03467763|50103680|FG000|Overall Study|Protocol Violation|2|||
25010844|NCT00004031|50103688|FG000|Overall Study|Adverse Event|5|||
25010845|NCT00004031|50103689|FG001|Overall Study|Adverse Event|0|||
25010846|NCT00004031|50103688|FG000|Overall Study|Refusal unrelated to adverse events|2|||
25010847|NCT00004031|50103689|FG001|Overall Study|Refusal unrelated to adverse events|11|||
25010848|NCT00004031|50103688|FG000|Overall Study|Progression/relapse|9|||
25010849|NCT00004031|50103689|FG001|Overall Study|Progression/relapse|4|||
25010850|NCT00004031|50103688|FG000|Overall Study|Death|3|||
25010851|NCT00004031|50103689|FG001|Overall Study|Death|1|||
25010852|NCT00004031|50103688|FG000|Overall Study|Other- not protocol specified|3|||
25010853|NCT00004031|50103689|FG001|Overall Study|Other- not protocol specified|3|||
25010854|NCT00004031|50103688|FG000|Overall Study|Reason under review|3|||
25010855|NCT00004031|50103689|FG001|Overall Study|Reason under review|2|||
25010856|NCT03467217|50103699|FG000|Overall Study|Trial stopped early|5|||
25010857|NCT03467217|50103700|FG001|Overall Study|Trial stopped early|2|||
25010858|NCT03467217|50103699|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
25010859|NCT03467217|50103700|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
25010860|NCT03467217|50103699|FG000|Overall Study|Lost to Follow-up|0|||
25010861|NCT03467217|50103700|FG001|Overall Study|Lost to Follow-up|2|||
25010862|NCT00003875|50103706|FG000|Overall Study|Screen Failed|1|||
25010863|NCT03495453|50103712|FG000|Overall Study|Withdrawal by Subject|0|||
25010864|NCT03495453|50103713|FG001|Overall Study|Withdrawal by Subject|1|||
25010865|NCT03364686|50103719|FG000|Overall Study|Physician Decision|2|||
25010866|NCT03437577|50103726|FG000|Pre-Randomization|Withdrawal by Subject|0|||
25010867|NCT03437577|50103727|FG001|Pre-Randomization|Withdrawal by Subject|0|||
25010868|NCT03437577|50103728|FG002|Pre-Randomization|Withdrawal by Subject|10|||
25010869|NCT03437577|50103726|FG000|Post-Randomization|Physician Decision|0|||
25274271|NCT01096017|50588401|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
25010870|NCT03437577|50103727|FG001|Post-Randomization|Physician Decision|2|||
25010871|NCT03437577|50103728|FG002|Post-Randomization|Physician Decision|0|||
25010872|NCT03336528|50103736|FG000|Overall Study|Protocol Violation|1|||
25010873|NCT03336528|50103737|FG001|Overall Study|Protocol Violation|1|||
25140407|NCT01621490|50253640|FG004|Overall Study|Adverse event unrelated to study drug|0|||
25140408|NCT01621490|50253641|FG005|Overall Study|Adverse event unrelated to study drug|0|||
25140409|NCT01621490|50253642|FG006|Overall Study|Adverse event unrelated to study drug|0|||
25140410|NCT01621490|50253643|FG007|Overall Study|Adverse event unrelated to study drug|2|||
25140411|NCT01621490|50253644|FG008|Overall Study|Adverse event unrelated to study drug|1|||
25140412|NCT01621490|50253636|FG000|Overall Study|Disease progression|27|||
25140413|NCT01621490|50253637|FG001|Overall Study|Disease progression|28|||
25140414|NCT01621490|50253638|FG002|Overall Study|Disease progression|1|||
25140415|NCT01621490|50253639|FG003|Overall Study|Disease progression|5|||
25140416|NCT01621490|50253640|FG004|Overall Study|Disease progression|3|||
25140417|NCT01621490|50253641|FG005|Overall Study|Disease progression|8|||
25140418|NCT01621490|50253642|FG006|Overall Study|Disease progression|7|||
25140419|NCT01621490|50253643|FG007|Overall Study|Disease progression|0|||
25140420|NCT01621490|50253644|FG008|Overall Study|Disease progression|4|||
25140421|NCT01621490|50253636|FG000|Overall Study|Study drug toxicity|1|||
25140422|NCT01621490|50253637|FG001|Overall Study|Study drug toxicity|4|||
25140423|NCT01621490|50253638|FG002|Overall Study|Study drug toxicity|5|||
25140424|NCT01621490|50253639|FG003|Overall Study|Study drug toxicity|3|||
25140425|NCT01621490|50253640|FG004|Overall Study|Study drug toxicity|1|||
25140426|NCT01621490|50253641|FG005|Overall Study|Study drug toxicity|10|||
25140427|NCT01621490|50253642|FG006|Overall Study|Study drug toxicity|1|||
25140428|NCT01621490|50253643|FG007|Overall Study|Study drug toxicity|4|||
25140429|NCT01621490|50253644|FG008|Overall Study|Study drug toxicity|1|||
25140430|NCT01621490|50253636|FG000|Overall Study|Death|0|||
25140431|NCT01621490|50253637|FG001|Overall Study|Death|0|||
25140432|NCT01621490|50253638|FG002|Overall Study|Death|0|||
25140433|NCT01621490|50253639|FG003|Overall Study|Death|0|||
25140434|NCT01621490|50253640|FG004|Overall Study|Death|0|||
25140435|NCT01621490|50253641|FG005|Overall Study|Death|0|||
25140436|NCT01621490|50253642|FG006|Overall Study|Death|0|||
25140437|NCT01621490|50253643|FG007|Overall Study|Death|1|||
25140438|NCT01621490|50253644|FG008|Overall Study|Death|0|||
25140439|NCT01621490|50253636|FG000|Overall Study|Grade 4 Lipase elevation|1|||
25140440|NCT01621490|50253637|FG001|Overall Study|Grade 4 Lipase elevation|0|||
25140441|NCT01621490|50253638|FG002|Overall Study|Grade 4 Lipase elevation|0|||
25140442|NCT01621490|50253639|FG003|Overall Study|Grade 4 Lipase elevation|0|||
25140443|NCT01621490|50253640|FG004|Overall Study|Grade 4 Lipase elevation|0|||
25140444|NCT01621490|50253641|FG005|Overall Study|Grade 4 Lipase elevation|0|||
25140445|NCT01621490|50253642|FG006|Overall Study|Grade 4 Lipase elevation|0|||
25140446|NCT01621490|50253643|FG007|Overall Study|Grade 4 Lipase elevation|0|||
25140447|NCT01621490|50253644|FG008|Overall Study|Grade 4 Lipase elevation|0|||
25140448|NCT01621490|50253636|FG000|Overall Study|BMS informed of patient status|0|||
25140449|NCT01621490|50253637|FG001|Overall Study|BMS informed of patient status|0|||
25140450|NCT01621490|50253638|FG002|Overall Study|BMS informed of patient status|1|||
25140451|NCT01621490|50253639|FG003|Overall Study|BMS informed of patient status|0|||
25140452|NCT01621490|50253640|FG004|Overall Study|BMS informed of patient status|0|||
25140453|NCT01621490|50253641|FG005|Overall Study|BMS informed of patient status|0|||
25140454|NCT01621490|50253642|FG006|Overall Study|BMS informed of patient status|0|||
25140455|NCT01621490|50253643|FG007|Overall Study|BMS informed of patient status|0|||
25140456|NCT01621490|50253644|FG008|Overall Study|BMS informed of patient status|0|||
25140457|NCT01621490|50253636|FG000|Overall Study|Investigator decision|0|||
25140458|NCT01621490|50253637|FG001|Overall Study|Investigator decision|0|||
25140459|NCT01621490|50253638|FG002|Overall Study|Investigator decision|1|||
25140460|NCT01621490|50253639|FG003|Overall Study|Investigator decision|0|||
25140461|NCT01621490|50253640|FG004|Overall Study|Investigator decision|1|||
25140462|NCT01621490|50253641|FG005|Overall Study|Investigator decision|0|||
25140463|NCT01621490|50253642|FG006|Overall Study|Investigator decision|1|||
25140464|NCT01621490|50253643|FG007|Overall Study|Investigator decision|0|||
25140465|NCT01621490|50253644|FG008|Overall Study|Investigator decision|0|||
25140466|NCT01621490|50253636|FG000|Overall Study|Documented disease progression|0|||
25140467|NCT01621490|50253637|FG001|Overall Study|Documented disease progression|0|||
25140468|NCT01621490|50253638|FG002|Overall Study|Documented disease progression|1|||
25140469|NCT01621490|50253639|FG003|Overall Study|Documented disease progression|0|||
25140470|NCT01621490|50253640|FG004|Overall Study|Documented disease progression|0|||
25140471|NCT01621490|50253641|FG005|Overall Study|Documented disease progression|0|||
25140472|NCT01621490|50253642|FG006|Overall Study|Documented disease progression|0|||
25140473|NCT01621490|50253643|FG007|Overall Study|Documented disease progression|0|||
25140474|NCT01621490|50253644|FG008|Overall Study|Documented disease progression|0|||
25140475|NCT01621490|50253636|FG000|Overall Study|Patient reached treatment 2 yr limit|0|||
25140476|NCT01621490|50253637|FG001|Overall Study|Patient reached treatment 2 yr limit|1|||
25140477|NCT01621490|50253638|FG002|Overall Study|Patient reached treatment 2 yr limit|0|||
25140478|NCT01621490|50253639|FG003|Overall Study|Patient reached treatment 2 yr limit|0|||
25140479|NCT01621490|50253640|FG004|Overall Study|Patient reached treatment 2 yr limit|0|||
25140480|NCT01621490|50253641|FG005|Overall Study|Patient reached treatment 2 yr limit|0|||
25140481|NCT01621490|50253642|FG006|Overall Study|Patient reached treatment 2 yr limit|0|||
25010874|NCT03336528|50103736|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
25010875|NCT03336528|50103737|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
25140482|NCT01621490|50253643|FG007|Overall Study|Patient reached treatment 2 yr limit|0|||
25140483|NCT01621490|50253644|FG008|Overall Study|Patient reached treatment 2 yr limit|0|||
25140484|NCT01621490|50253636|FG000|Overall Study|Clinical deterioration|0|||
25140485|NCT01621490|50253637|FG001|Overall Study|Clinical deterioration|1|||
25140486|NCT01621490|50253638|FG002|Overall Study|Clinical deterioration|0|||
25140487|NCT01621490|50253639|FG003|Overall Study|Clinical deterioration|0|||
25140488|NCT01621490|50253640|FG004|Overall Study|Clinical deterioration|0|||
25140489|NCT01621490|50253641|FG005|Overall Study|Clinical deterioration|0|||
25140490|NCT01621490|50253642|FG006|Overall Study|Clinical deterioration|0|||
25140491|NCT01621490|50253643|FG007|Overall Study|Clinical deterioration|0|||
25140492|NCT01621490|50253644|FG008|Overall Study|Clinical deterioration|0|||
25140493|NCT01621490|50253636|FG000|Overall Study|Complete response|0|||
25140494|NCT01621490|50253637|FG001|Overall Study|Complete response|0|||
25140495|NCT01621490|50253638|FG002|Overall Study|Complete response|0|||
25140496|NCT01621490|50253639|FG003|Overall Study|Complete response|0|||
25140497|NCT01621490|50253640|FG004|Overall Study|Complete response|0|||
25140498|NCT01621490|50253641|FG005|Overall Study|Complete response|0|||
25140499|NCT01621490|50253642|FG006|Overall Study|Complete response|0|||
25140500|NCT01621490|50253643|FG007|Overall Study|Complete response|0|||
25140501|NCT01621490|50253644|FG008|Overall Study|Complete response|1|||
25010876|NCT03336528|50103736|FG000|Overall Study|Did not receive study medication|1|||
25010877|NCT03336528|50103737|FG001|Overall Study|Did not receive study medication|2|||
25010878|NCT03364608|50103745|FG000|Overall Study|Withdrawal by Subject|4|||
25010879|NCT03364608|50103745|FG000|Overall Study|Protocol Violation|2|||
25010880|NCT03364608|50103745|FG000|Overall Study|Lost to Follow-up|2|||
25010881|NCT00003869|50103759|FG000|Overall Study|Adverse Event|14|||
25010882|NCT00003869|50103760|FG001|Overall Study|Adverse Event|3|||
25010883|NCT00003869|50103759|FG000|Overall Study|Withdrawal by Subject|21|||
25010884|NCT00003869|50103760|FG001|Overall Study|Withdrawal by Subject|3|||
25010885|NCT00003869|50103759|FG000|Overall Study|Death|1|||
25010886|NCT00003869|50103760|FG001|Overall Study|Death|2|||
25010887|NCT00003869|50103759|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
25010888|NCT00003869|50103760|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
25010889|NCT03344640|50103768|FG000|Overall Study|Adverse Event|1|||
25010890|NCT03344640|50103769|FG001|Overall Study|Adverse Event|0|||
25010891|NCT03344640|50103768|FG000|Overall Study|Physician Decision|1|||
25010892|NCT03344640|50103769|FG001|Overall Study|Physician Decision|1|||
25010893|NCT03344640|50103768|FG000|Overall Study|Withdrawal by Subject|1|||
25010894|NCT03344640|50103769|FG001|Overall Study|Withdrawal by Subject|2|||
25010895|NCT03344640|50103768|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
25010896|NCT03344640|50103769|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
25010897|NCT03344562|50103777|FG000|Overall Study|Withdrawal by Subject|2|||
25010898|NCT03344562|50103778|FG001|Overall Study|Withdrawal by Subject|0|||
25010899|NCT00003659|50103784|FG000|Overall Study|Withdrawal by Subject|3|||
25010900|NCT03494985|50103792|FG000|Overall Study|Adverse Event|3|||
25010901|NCT03494985|50103793|FG001|Overall Study|Adverse Event|2|||
25010902|NCT03494985|50103794|FG002|Overall Study|Adverse Event|3|||
25010903|NCT03494985|50103795|FG003|Overall Study|Adverse Event|0|||
25010904|NCT03494985|50103792|FG000|Overall Study|Other (Withdrawal of consent)|2|||
25010905|NCT03494985|50103793|FG001|Overall Study|Other (Withdrawal of consent)|3|||
25010906|NCT03494985|50103794|FG002|Overall Study|Other (Withdrawal of consent)|2|||
25010907|NCT03494985|50103795|FG003|Overall Study|Other (Withdrawal of consent)|5|||
25010908|NCT03494985|50103792|FG000|Overall Study|Other (Not specified)|0|||
25010909|NCT03494985|50103793|FG001|Overall Study|Other (Not specified)|1|||
25010910|NCT03494985|50103794|FG002|Overall Study|Other (Not specified)|1|||
25010911|NCT03494985|50103795|FG003|Overall Study|Other (Not specified)|0|||
25010912|NCT03437265|50103805|FG000|Overall Study|Protocol Violation|6|||
25010913|NCT00003509|50103809|FG000|Overall Study|Not evaluable|5|||
25010914|NCT03344172|50103815|FG000|Overall Study|Received <1 dose of treatment|1|||
25010915|NCT03344172|50103816|FG001|Overall Study|Received <1 dose of treatment|0|||
25010916|NCT03465891|50103824|FG000|Overall Study|Withdrawal by Subject|0|||
25010917|NCT03465891|50103825|FG001|Overall Study|Withdrawal by Subject|1|||
25010918|NCT03465891|50103824|FG000|Overall Study|Disease progression|1|||
25140502|NCT01621490|50253636|FG000|Overall Study|Patient delayed due to toxicity|0|||
25010919|NCT03465891|50103825|FG001|Overall Study|Disease progression|0|||
25010920|NCT03363906|50103831|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
25010921|NCT03363906|50103832|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
25010922|NCT03363906|50103831|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
25010923|NCT03363906|50103832|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
25010924|NCT03363906|50103831|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
25010925|NCT03363906|50103832|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
25010926|NCT03363906|50103831|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
25140503|NCT01621490|50253637|FG001|Overall Study|Patient delayed due to toxicity|0|||
25010927|NCT03363906|50103832|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
25010928|NCT00003473|50103838|FG000|Overall Study|Three patients were not evaluable.|3|||
25010929|NCT03343626|50103850|FG000|Overall Study|Lost to Follow-up|4|||
25010930|NCT03343626|50103851|FG001|Overall Study|Lost to Follow-up|3|||
25010931|NCT03343626|50103852|FG002|Overall Study|Lost to Follow-up|2|||
25010932|NCT03343626|50103853|FG003|Overall Study|Lost to Follow-up|5|||
25010933|NCT03343626|50103854|FG004|Overall Study|Lost to Follow-up|4|||
25010934|NCT03343626|50103855|FG005|Overall Study|Lost to Follow-up|4|||
25010935|NCT03343626|50103856|FG006|Overall Study|Lost to Follow-up|4|||
25010936|NCT03343626|50103857|FG007|Overall Study|Lost to Follow-up|7|||
25010937|NCT03343626|50103850|FG000|Overall Study|Withdrawal of Consent|2|||
25010938|NCT03343626|50103851|FG001|Overall Study|Withdrawal of Consent|1|||
25010939|NCT03343626|50103852|FG002|Overall Study|Withdrawal of Consent|0|||
25010940|NCT03343626|50103853|FG003|Overall Study|Withdrawal of Consent|3|||
25010941|NCT03343626|50103854|FG004|Overall Study|Withdrawal of Consent|3|||
25010942|NCT03343626|50103855|FG005|Overall Study|Withdrawal of Consent|1|||
25010943|NCT03343626|50103856|FG006|Overall Study|Withdrawal of Consent|1|||
25010944|NCT03343626|50103857|FG007|Overall Study|Withdrawal of Consent|2|||
25010945|NCT03343626|50103850|FG000|Overall Study|Reason not Specified|0|||
25010946|NCT03343626|50103851|FG001|Overall Study|Reason not Specified|1|||
25010947|NCT03343626|50103852|FG002|Overall Study|Reason not Specified|0|||
25010948|NCT03343626|50103853|FG003|Overall Study|Reason not Specified|0|||
25010949|NCT03343626|50103854|FG004|Overall Study|Reason not Specified|0|||
25010950|NCT03343626|50103855|FG005|Overall Study|Reason not Specified|0|||
25010951|NCT03343626|50103856|FG006|Overall Study|Reason not Specified|0|||
25010952|NCT03343626|50103857|FG007|Overall Study|Reason not Specified|1|||
25010953|NCT03343626|50103850|FG000|Overall Study|Data Entry Error|0|||
25010954|NCT03343626|50103851|FG001|Overall Study|Data Entry Error|0|||
25010955|NCT03343626|50103852|FG002|Overall Study|Data Entry Error|0|||
25010956|NCT03343626|50103853|FG003|Overall Study|Data Entry Error|0|||
25010957|NCT03343626|50103854|FG004|Overall Study|Data Entry Error|0|||
25010958|NCT03343626|50103855|FG005|Overall Study|Data Entry Error|0|||
25010959|NCT03343626|50103856|FG006|Overall Study|Data Entry Error|0|||
25010960|NCT03343626|50103857|FG007|Overall Study|Data Entry Error|1|||
25010961|NCT03334422|50103882|FG000|Overall Study|Adverse Event|1|||
25010962|NCT03334422|50103883|FG001|Overall Study|Adverse Event|3|||
25010963|NCT03334422|50103884|FG002|Overall Study|Adverse Event|2|||
25010964|NCT03334422|50103885|FG003|Overall Study|Adverse Event|2|||
25010965|NCT03334422|50103882|FG000|Overall Study|Lack of Efficacy|10|||
25010966|NCT03334422|50103883|FG001|Overall Study|Lack of Efficacy|2|||
25010967|NCT03334422|50103884|FG002|Overall Study|Lack of Efficacy|7|||
25010968|NCT03334422|50103885|FG003|Overall Study|Lack of Efficacy|3|||
25010969|NCT03334422|50103882|FG000|Overall Study|Withdrawal by Subject|8|||
25010970|NCT03334422|50103883|FG001|Overall Study|Withdrawal by Subject|3|||
25010971|NCT03334422|50103884|FG002|Overall Study|Withdrawal by Subject|1|||
25010972|NCT03334422|50103885|FG003|Overall Study|Withdrawal by Subject|0|||
25010973|NCT03334422|50103882|FG000|Overall Study|Lost to Follow-up|0|||
25010974|NCT03334422|50103883|FG001|Overall Study|Lost to Follow-up|0|||
25010975|NCT03334422|50103884|FG002|Overall Study|Lost to Follow-up|0|||
25010976|NCT03334422|50103885|FG003|Overall Study|Lost to Follow-up|1|||
25010977|NCT03334422|50103882|FG000|Overall Study|Inability to obtain laboratory samples|0|||
25010978|NCT03334422|50103883|FG001|Overall Study|Inability to obtain laboratory samples|1|||
25010979|NCT03334422|50103884|FG002|Overall Study|Inability to obtain laboratory samples|0|||
25010980|NCT03334422|50103885|FG003|Overall Study|Inability to obtain laboratory samples|0|||
25010981|NCT03334422|50103882|FG000|Overall Study|Pregnancy|0|||
25010982|NCT03334422|50103883|FG001|Overall Study|Pregnancy|1|||
25010983|NCT03334422|50103884|FG002|Overall Study|Pregnancy|0|||
25010984|NCT03334422|50103885|FG003|Overall Study|Pregnancy|0|||
25274272|NCT01096017|50588402|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
25274273|NCT01106157|50588410|FG000|Overall Study|Withdrawal by Subject|1|||
25274274|NCT01106157|50588411|FG001|Overall Study|Withdrawal by Subject|0|||
25274275|NCT01094301|50588417|FG000|Trial Stage|Withdrawal by Subject|1|||
25274276|NCT01094301|50588417|FG000|Implant Stage|Adverse Event|1|||
25274277|NCT01094301|50588417|FG000|Implant Stage|Protocol Violation|1|||
25274278|NCT01094301|50588417|FG000|Implant Stage|Withdrawal by Subject|2|||
25274279|NCT01094301|50588417|FG000|Implant Stage|No return of pain|4|||
25274280|NCT01093755|50588425|FG000|Overall Study|Withdrawal by Subject|3|||
25274281|NCT01093755|50588426|FG001|Overall Study|Withdrawal by Subject|4|||
25274282|NCT01093599|50588434|FG000|Overall Study|Lost to Follow-up|32|||
25274283|NCT01093599|50588435|FG001|Overall Study|Lost to Follow-up|46|||
25274284|NCT01092663|50588443|FG000|Overall Study|Withdrawal by Subject|3|||
25274285|NCT01092663|50588444|FG001|Overall Study|Withdrawal by Subject|2|||
25274286|NCT01092663|50588443|FG000|Overall Study|Glucose >300mg/dL|1|||
25274287|NCT01092663|50588444|FG001|Overall Study|Glucose >300mg/dL|0|||
25011001|NCT03362190|50103913|FG000|Overall Study|Adverse Event|0|||
25011002|NCT03362190|50103914|FG001|Overall Study|Adverse Event|0|||
25140504|NCT01621490|50253638|FG002|Overall Study|Patient delayed due to toxicity|0|||
25011003|NCT03362190|50103915|FG002|Overall Study|Adverse Event|0|||
25011004|NCT03362190|50103916|FG003|Overall Study|Adverse Event|1|||
25011005|NCT03362190|50103913|FG000|Overall Study|Withdrawal by Subject|0|||
25179169|NCT01693562|50324386|FG000|Expansion Phase|Other|0|||
25274288|NCT01092663|50588443|FG000|Overall Study|High fasting triglyceride|2|||
25274289|NCT01092663|50588444|FG001|Overall Study|High fasting triglyceride|0|||
25274290|NCT01092663|50588443|FG000|Overall Study|Adverse Event|1|||
25274291|NCT01092663|50588444|FG001|Overall Study|Adverse Event|1|||
25274292|NCT01092663|50588443|FG000|Overall Study|Protocol Violation|0|||
25274293|NCT01092663|50588444|FG001|Overall Study|Protocol Violation|1|||
25274294|NCT01078623|50588455|FG000|Treatment Period 1|Adverse Event|1|||
25274295|NCT01078623|50588456|FG001|Treatment Period 1|Adverse Event|1|||
25274296|NCT01078623|50588457|FG002|Treatment Period 1|Adverse Event|1|||
25011006|NCT03362190|50103914|FG001|Overall Study|Withdrawal by Subject|0|||
25011007|NCT03362190|50103915|FG002|Overall Study|Withdrawal by Subject|0|||
25011008|NCT03362190|50103916|FG003|Overall Study|Withdrawal by Subject|1|||
25011009|NCT02323126|50103932|FG000|Overall Study|Patient / guardian decision|0|||
25011010|NCT02323126|50103933|FG001|Overall Study|Patient / guardian decision|1|||
25011011|NCT02323126|50103934|FG002|Overall Study|Patient / guardian decision|2|||
25011012|NCT02323126|50103932|FG000|Overall Study|Progressive disease|14|||
25011013|NCT02323126|50103933|FG001|Overall Study|Progressive disease|8|||
25011014|NCT02323126|50103934|FG002|Overall Study|Progressive disease|14|||
25011015|NCT02323126|50103932|FG000|Overall Study|Physician Decision|0|||
25011016|NCT02323126|50103933|FG001|Overall Study|Physician Decision|1|||
25011017|NCT02323126|50103934|FG002|Overall Study|Physician Decision|3|||
25011018|NCT02323126|50103932|FG000|Overall Study|Death|1|||
25011019|NCT02323126|50103933|FG001|Overall Study|Death|1|||
25011020|NCT02323126|50103934|FG002|Overall Study|Death|4|||
25011021|NCT02323126|50103932|FG000|Overall Study|Adverse Event|3|||
25011022|NCT02323126|50103933|FG001|Overall Study|Adverse Event|5|||
25011023|NCT02323126|50103934|FG002|Overall Study|Adverse Event|7|||
25011024|NCT03491553|50103951|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
25011025|NCT03491553|50103952|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
25011026|NCT03491553|50103953|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
25011027|NCT03491553|50103954|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
25011028|NCT03491553|50103955|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
25011029|NCT03491553|50103956|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
25011030|NCT03491553|50103951|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
25011031|NCT03491553|50103952|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
25011032|NCT03491553|50103953|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
25011033|NCT03491553|50103954|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
25011034|NCT03491553|50103955|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
25011035|NCT03491553|50103956|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
25011036|NCT00003377|50103977|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
25011037|NCT00003377|50103978|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
25011038|NCT00003377|50103979|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
25011039|NCT00003377|50103980|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
25011040|NCT00003377|50103981|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
25011041|NCT00003377|50103977|FG000|Period II|Ureteral stent complications|0|||
25011042|NCT00003377|50103978|FG001|Period II|Ureteral stent complications|0|||
25011043|NCT00003377|50103979|FG002|Period II|Ureteral stent complications|0|||
25011044|NCT00003377|50103980|FG003|Period II|Ureteral stent complications|0|||
25011045|NCT00003377|50103981|FG004|Period II|Ureteral stent complications|1|||
25011046|NCT00651742|50103994|FG000|Overall Study|Objective Disease Progression|22|||
25011047|NCT00651742|50103994|FG000|Overall Study|Toxicity|3|||
25011048|NCT00651742|50103994|FG000|Overall Study|Investigator Judgment|1|||
25011049|NCT00651742|50103994|FG000|Overall Study|Withdrawal of Consent|1|||
25011050|NCT00651742|50103994|FG000|Overall Study|Enrolled but not treated|1|||
25011051|NCT00002651|50104000|FG000|Induction|Adverse Event|44|||
25011052|NCT00002651|50104001|FG001|Induction|Adverse Event|0|||
25011053|NCT00002651|50104002|FG002|Induction|Adverse Event|0|||
25011054|NCT00002651|50104000|FG000|Induction|Refusal unrelated to adverse event|50|||
25011055|NCT00002651|50104001|FG001|Induction|Refusal unrelated to adverse event|0|||
25011056|NCT00002651|50104002|FG002|Induction|Refusal unrelated to adverse event|0|||
25011057|NCT00002651|50104000|FG000|Induction|Progression/relapse|274|||
25011058|NCT00002651|50104001|FG001|Induction|Progression/relapse|0|||
25011059|NCT00002651|50104002|FG002|Induction|Progression/relapse|0|||
25011060|NCT00002651|50104000|FG000|Induction|Death|62|||
25011061|NCT00002651|50104001|FG001|Induction|Death|0|||
25011062|NCT00002651|50104002|FG002|Induction|Death|0|||
25011063|NCT00002651|50104000|FG000|Induction|Other|823|||
25011064|NCT00002651|50104001|FG001|Induction|Other|0|||
25011065|NCT00002651|50104002|FG002|Induction|Other|0|||
25011066|NCT00002651|50104000|FG000|Induction|not eligible|90|||
25011067|NCT00002651|50104001|FG001|Induction|not eligible|0|||
25011068|NCT00002651|50104002|FG002|Induction|not eligible|0|||
25011069|NCT00002651|50104000|FG000|Consolidation and Randomization|Adverse Event|0|||
25011070|NCT00002651|50104001|FG001|Consolidation and Randomization|Adverse Event|36|||
25011071|NCT00002651|50104002|FG002|Consolidation and Randomization|Adverse Event|14|||
25011072|NCT00002651|50104000|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
25011073|NCT00002651|50104001|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
25011074|NCT00002651|50104002|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
25011075|NCT00002651|50104000|FG000|Consolidation and Randomization|Progression/relapse|0|||
25011076|NCT00002651|50104001|FG001|Consolidation and Randomization|Progression/relapse|295|||
25011077|NCT00002651|50104002|FG002|Consolidation and Randomization|Progression/relapse|298|||
25011078|NCT00002651|50104000|FG000|Consolidation and Randomization|Death|0|||
25011079|NCT00002651|50104001|FG001|Consolidation and Randomization|Death|38|||
25011080|NCT00002651|50104002|FG002|Consolidation and Randomization|Death|48|||
25011081|NCT00002651|50104000|FG000|Consolidation and Randomization|Other|0|||
25011082|NCT00002651|50104001|FG001|Consolidation and Randomization|Other|314|||
25011083|NCT00002651|50104002|FG002|Consolidation and Randomization|Other|313|||
25011084|NCT00002651|50104000|FG000|Consolidation and Randomization|not eligible|0|||
25011085|NCT00002651|50104001|FG001|Consolidation and Randomization|not eligible|102|||
25011086|NCT00002651|50104002|FG002|Consolidation and Randomization|not eligible|112|||
25011087|NCT00002597|50104012|FG000|Overall Study|Protocol Violation|19|||
25011088|NCT00002597|50104013|FG001|Overall Study|Protocol Violation|17|||
25011089|NCT00002597|50104012|FG000|Overall Study|Withdrawal by Subject|7|||
25011090|NCT00002597|50104013|FG001|Overall Study|Withdrawal by Subject|6|||
25011091|NCT03435081|50104022|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
25011092|NCT03435081|50104023|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
25011093|NCT03435081|50104024|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
25011094|NCT03435081|50104022|FG000|Week 0 to Week 16|Adverse Event|2|||
25011095|NCT03435081|50104023|FG001|Week 0 to Week 16|Adverse Event|2|||
25011096|NCT03435081|50104024|FG002|Week 0 to Week 16|Adverse Event|2|||
25011097|NCT03435081|50104022|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
25011098|NCT03435081|50104023|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
25011099|NCT03435081|50104024|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
25011100|NCT03435081|50104022|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
25011101|NCT03435081|50104023|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
25011102|NCT03435081|50104024|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
25011103|NCT03435081|50104022|FG000|Week 0 to Week 16|Pregnancy|1|||
25011104|NCT03435081|50104023|FG001|Week 0 to Week 16|Pregnancy|0|||
25011105|NCT03435081|50104024|FG002|Week 0 to Week 16|Pregnancy|0|||
25011106|NCT03435081|50104022|FG000|Week 0 to Week 16|Non-compliance|1|||
25011107|NCT03435081|50104023|FG001|Week 0 to Week 16|Non-compliance|0|||
25011108|NCT03435081|50104024|FG002|Week 0 to Week 16|Non-compliance|2|||
25011109|NCT03435081|50104022|FG000|Week 0 to Week 16|Inadequate Response|0|||
25011110|NCT03435081|50104023|FG001|Week 0 to Week 16|Inadequate Response|1|||
25011111|NCT03435081|50104024|FG002|Week 0 to Week 16|Inadequate Response|0|||
25011112|NCT03435081|50104022|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
25011113|NCT03435081|50104023|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
25011114|NCT03435081|50104024|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
25011115|NCT03435081|50104022|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
25011116|NCT03435081|50104023|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
25011117|NCT03435081|50104024|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
25011118|NCT03435081|50104022|FG000|Week 16 to Week 104|Adverse Event|1|||
25011119|NCT03435081|50104023|FG001|Week 16 to Week 104|Adverse Event|0|||
25011120|NCT03435081|50104024|FG002|Week 16 to Week 104|Adverse Event|2|||
25011121|NCT03435081|50104022|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
25011122|NCT03435081|50104023|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
25011123|NCT03435081|50104024|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
25011124|NCT03435081|50104022|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
25011125|NCT03435081|50104023|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
25011126|NCT03435081|50104024|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
25011127|NCT03435081|50104022|FG000|Week 16 to Week 104|Non--Compliance|0|||
25011128|NCT03435081|50104023|FG001|Week 16 to Week 104|Non--Compliance|0|||
25011129|NCT03435081|50104024|FG002|Week 16 to Week 104|Non--Compliance|1|||
25011130|NCT02738008|50104039|FG000|Overall Study|Study Terminated by Sponsor|1|||
25011131|NCT02738008|50104040|FG001|Overall Study|Study Terminated by Sponsor|5|||
25274297|NCT01078623|50588458|FG003|Treatment Period 1|Adverse Event|0|||
25011132|NCT02738008|50104041|FG002|Overall Study|Study Terminated by Sponsor|3|||
25011133|NCT02738008|50104039|FG000|Overall Study|Adverse Event|0|||
25011134|NCT02738008|50104040|FG001|Overall Study|Adverse Event|1|||
25011135|NCT02738008|50104041|FG002|Overall Study|Adverse Event|2|||
25274298|NCT01078623|50588459|FG004|Treatment Period 1|Adverse Event|0|||
25274299|NCT01078623|50588460|FG005|Treatment Period 1|Adverse Event|0|||
25274300|NCT01078623|50588461|FG006|Treatment Period 1|Adverse Event|1|||
25140505|NCT01621490|50253639|FG003|Overall Study|Patient delayed due to toxicity|0|||
25140506|NCT01621490|50253640|FG004|Overall Study|Patient delayed due to toxicity|0|||
25140507|NCT01621490|50253641|FG005|Overall Study|Patient delayed due to toxicity|1|||
25140508|NCT01621490|50253642|FG006|Overall Study|Patient delayed due to toxicity|0|||
25140509|NCT01621490|50253643|FG007|Overall Study|Patient delayed due to toxicity|0|||
25140510|NCT01621490|50253644|FG008|Overall Study|Patient delayed due to toxicity|0|||
25140511|NCT02018887|50253765|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
25140512|NCT02018887|50253766|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
25140513|NCT02018887|50253767|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
25140514|NCT02018887|50253768|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
25140515|NCT02018887|50253769|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
25140516|NCT02018887|50253770|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
25140517|NCT02018887|50253771|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
25140518|NCT02018887|50253772|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
25140519|NCT02018887|50253773|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
25140520|NCT02018887|50253774|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
25140521|NCT02018887|50253775|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
25140522|NCT02018887|50253765|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
25140523|NCT02018887|50253766|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
25140524|NCT02018887|50253767|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
25140525|NCT02018887|50253768|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
25140526|NCT02018887|50253769|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
25140527|NCT02018887|50253770|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
25140528|NCT02018887|50253771|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
25140529|NCT02018887|50253772|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
25140530|NCT02018887|50253773|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
25140531|NCT02018887|50253774|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
25140532|NCT02018887|50253775|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
25140533|NCT02018887|50253765|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
25140534|NCT02018887|50253766|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
25140535|NCT02018887|50253767|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
25140536|NCT02018887|50253768|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
25140537|NCT02018887|50253769|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
25140538|NCT02018887|50253770|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
25140539|NCT02018887|50253771|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
25140540|NCT02018887|50253772|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
25274301|NCT01078623|50588462|FG007|Treatment Period 1|Adverse Event|0|||
25274302|NCT01078623|50588463|FG008|Treatment Period 1|Adverse Event|1|||
25274303|NCT01078623|50588464|FG009|Treatment Period 1|Adverse Event|1|||
25274304|NCT01078623|50588465|FG010|Treatment Period 1|Adverse Event|0|||
25274305|NCT01078623|50588466|FG011|Treatment Period 1|Adverse Event|0|||
25274306|NCT01078623|50588467|FG012|Treatment Period 1|Adverse Event|0|||
25274307|NCT01078623|50588468|FG013|Treatment Period 1|Adverse Event|0|||
25140541|NCT02018887|50253773|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
25140542|NCT02018887|50253774|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
25140543|NCT02018887|50253775|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
25274308|NCT01078623|50588469|FG014|Treatment Period 1|Adverse Event|0|||
25274309|NCT01078623|50588470|FG015|Treatment Period 1|Adverse Event|0|||
25274310|NCT01078623|50588471|FG016|Treatment Period 1|Adverse Event|0|||
25274311|NCT01078623|50588472|FG017|Treatment Period 1|Adverse Event|0|||
25274312|NCT01078623|50588473|FG018|Treatment Period 1|Adverse Event|0|||
25274313|NCT01078623|50588474|FG019|Treatment Period 1|Adverse Event|0|||
25274314|NCT01078623|50588455|FG000|Treatment Period 1|Withdrawal by Subject|0|||
25274315|NCT01078623|50588456|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25274316|NCT01078623|50588457|FG002|Treatment Period 1|Withdrawal by Subject|0|||
25274317|NCT01078623|50588458|FG003|Treatment Period 1|Withdrawal by Subject|0|||
25274318|NCT01078623|50588459|FG004|Treatment Period 1|Withdrawal by Subject|0|||
25274319|NCT01078623|50588460|FG005|Treatment Period 1|Withdrawal by Subject|0|||
25274320|NCT01078623|50588461|FG006|Treatment Period 1|Withdrawal by Subject|0|||
25274321|NCT01078623|50588462|FG007|Treatment Period 1|Withdrawal by Subject|1|||
25274322|NCT01078623|50588463|FG008|Treatment Period 1|Withdrawal by Subject|0|||
25011154|NCT03489369|50104064|FG000|Overall Study|Documented Progressive Disease|3|||
25011155|NCT03489369|50104065|FG001|Overall Study|Documented Progressive Disease|2|||
25011156|NCT03489369|50104066|FG002|Overall Study|Documented Progressive Disease|3|||
25011157|NCT03489369|50104067|FG003|Overall Study|Documented Progressive Disease|6|||
25011158|NCT03489369|50104064|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
25011159|NCT03489369|50104065|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
25011160|NCT03489369|50104066|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
25011161|NCT03489369|50104067|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
25011162|NCT03257254|50104077|FG000|Overall Study|Withdrawal by Subject|7|||
25011163|NCT03257254|50104077|FG000|Overall Study|Lost to Follow-up|9|||
25011164|NCT03257254|50104077|FG000|Overall Study|Study discontinued by sponsor|5|||
25011165|NCT03738475|50104083|FG000|Overall Study|Participant Non-Compliance|1|||
25011166|NCT03738475|50104084|FG001|Overall Study|Participant Non-Compliance|0|||
25011167|NCT03084718|50104095|FG000|Overall Study|Withdrawal by Subject|4|||
25011168|NCT03084718|50104096|FG001|Overall Study|Withdrawal by Subject|3|||
25011169|NCT03084718|50104097|FG002|Overall Study|Withdrawal by Subject|4|||
25011170|NCT03084718|50104098|FG003|Overall Study|Withdrawal by Subject|0|||
25011171|NCT03084718|50104099|FG004|Overall Study|Withdrawal by Subject|0|||
25011172|NCT03084718|50104095|FG000|Overall Study|Physician Decision|1|||
25011173|NCT03084718|50104096|FG001|Overall Study|Physician Decision|0|||
25011174|NCT03084718|50104097|FG002|Overall Study|Physician Decision|0|||
25011175|NCT03084718|50104098|FG003|Overall Study|Physician Decision|0|||
25011176|NCT03084718|50104099|FG004|Overall Study|Physician Decision|0|||
25011177|NCT03084718|50104095|FG000|Overall Study|Adverse Event|3|||
25011178|NCT03084718|50104096|FG001|Overall Study|Adverse Event|5|||
25011179|NCT03084718|50104097|FG002|Overall Study|Adverse Event|5|||
25011180|NCT03084718|50104098|FG003|Overall Study|Adverse Event|8|||
25011181|NCT03084718|50104099|FG004|Overall Study|Adverse Event|2|||
25011182|NCT03084718|50104095|FG000|Overall Study|Lack of Efficacy|2|||
25011183|NCT03084718|50104096|FG001|Overall Study|Lack of Efficacy|0|||
25011184|NCT03084718|50104097|FG002|Overall Study|Lack of Efficacy|1|||
25011185|NCT03084718|50104098|FG003|Overall Study|Lack of Efficacy|4|||
25011186|NCT03084718|50104099|FG004|Overall Study|Lack of Efficacy|0|||
25011187|NCT03084718|50104095|FG000|Overall Study|Lost to Follow-up|0|||
25011188|NCT03084718|50104096|FG001|Overall Study|Lost to Follow-up|1|||
25011189|NCT03084718|50104097|FG002|Overall Study|Lost to Follow-up|0|||
25011190|NCT03084718|50104098|FG003|Overall Study|Lost to Follow-up|0|||
25011191|NCT03084718|50104099|FG004|Overall Study|Lost to Follow-up|2|||
25011192|NCT03084718|50104095|FG000|Overall Study|Protocol Violation|0|||
25011193|NCT03084718|50104096|FG001|Overall Study|Protocol Violation|0|||
25011194|NCT03084718|50104097|FG002|Overall Study|Protocol Violation|1|||
25011195|NCT03084718|50104098|FG003|Overall Study|Protocol Violation|0|||
25011196|NCT03084718|50104099|FG004|Overall Study|Protocol Violation|0|||
25011197|NCT03084718|50104095|FG000|Overall Study|Death|0|||
25011198|NCT03084718|50104096|FG001|Overall Study|Death|1|||
25011199|NCT03084718|50104097|FG002|Overall Study|Death|0|||
25011200|NCT03084718|50104098|FG003|Overall Study|Death|0|||
25011201|NCT03084718|50104099|FG004|Overall Study|Death|0|||
25011202|NCT03084718|50104095|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
25011203|NCT03084718|50104096|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
25011204|NCT03084718|50104097|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
25011205|NCT03084718|50104098|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
25011206|NCT03084718|50104099|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
25011207|NCT04321252|50104123|FG000|Overall Study|Withdrawal by Subject|0|||
25011208|NCT04321252|50104124|FG001|Overall Study|Withdrawal by Subject|0|||
25011209|NCT04321252|50104125|FG002|Overall Study|Withdrawal by Subject|0|||
25011210|NCT04321252|50104126|FG003|Overall Study|Withdrawal by Subject|0|||
25011211|NCT04321252|50104127|FG004|Overall Study|Withdrawal by Subject|0|||
25011212|NCT04321252|50104128|FG005|Overall Study|Withdrawal by Subject|1|||
25011213|NCT04321252|50104129|FG006|Overall Study|Withdrawal by Subject|0|||
25011214|NCT04321252|50104130|FG007|Overall Study|Withdrawal by Subject|0|||
25011215|NCT04321252|50104131|FG008|Overall Study|Withdrawal by Subject|0|||
25011216|NCT03433677|50104163|FG000|Period 1|Protocol Violation|1|||
25011217|NCT03433677|50104164|FG001|Period 1|Protocol Violation|0|||
25011218|NCT03433677|50104163|FG000|Period 2|Withdrawal by Subject|1|||
25011219|NCT03433677|50104164|FG001|Period 2|Withdrawal by Subject|1|||
25011220|NCT02492711|50104174|FG000|Overall Study|Adverse Event|9|||
25011221|NCT02492711|50104175|FG001|Overall Study|Adverse Event|9|||
25011222|NCT02492711|50104176|FG002|Overall Study|Adverse Event|2|||
25011223|NCT02492711|50104174|FG000|Overall Study|Death|3|||
25011224|NCT02492711|50104175|FG001|Overall Study|Death|3|||
25011225|NCT02492711|50104176|FG002|Overall Study|Death|0|||
25011226|NCT02492711|50104174|FG000|Overall Study|Withdrawal by Subject|10|||
25011227|NCT02492711|50104175|FG001|Overall Study|Withdrawal by Subject|16|||
25011228|NCT02492711|50104176|FG002|Overall Study|Withdrawal by Subject|5|||
25011229|NCT02492711|50104174|FG000|Overall Study|Physician Decision|10|||
25011230|NCT02492711|50104175|FG001|Overall Study|Physician Decision|6|||
25011231|NCT02492711|50104176|FG002|Overall Study|Physician Decision|4|||
25011232|NCT02492711|50104174|FG000|Overall Study|Lost to Follow-up|0|||
25011233|NCT02492711|50104175|FG001|Overall Study|Lost to Follow-up|0|||
25011234|NCT02492711|50104176|FG002|Overall Study|Lost to Follow-up|1|||
25011235|NCT02492711|50104174|FG000|Overall Study|study treatment delay|2|||
25011236|NCT02492711|50104175|FG001|Overall Study|study treatment delay|1|||
25011237|NCT02492711|50104176|FG002|Overall Study|study treatment delay|0|||
25011238|NCT02492711|50104174|FG000|Overall Study|change in chemotherapy|0|||
25011239|NCT02492711|50104175|FG001|Overall Study|change in chemotherapy|1|||
25011240|NCT02492711|50104176|FG002|Overall Study|change in chemotherapy|0|||
25011241|NCT02492711|50104174|FG000|Overall Study|never treated|2|||
25011242|NCT02492711|50104175|FG001|Overall Study|never treated|4|||
25011243|NCT02492711|50104176|FG002|Overall Study|never treated|0|||
25011244|NCT02492711|50104174|FG000|Overall Study|Other|0|||
25011245|NCT02492711|50104175|FG001|Overall Study|Other|0|||
25011246|NCT02492711|50104176|FG002|Overall Study|Other|1|||
25011247|NCT01147822|50104191|FG000|Overall Study|Death|66|||
25011248|NCT01147822|50104192|FG001|Overall Study|Death|59|||
25011249|NCT01147822|50104191|FG000|Overall Study|Protocol Violation|0|||
25011250|NCT01147822|50104192|FG001|Overall Study|Protocol Violation|1|||
25011251|NCT01147822|50104191|FG000|Overall Study|Lost to Follow-up|3|||
25011252|NCT01147822|50104192|FG001|Overall Study|Lost to Follow-up|2|||
25011253|NCT01147822|50104191|FG000|Overall Study|Physician Decision|0|||
25011254|NCT01147822|50104192|FG001|Overall Study|Physician Decision|2|||
25011255|NCT01147822|50104191|FG000|Overall Study|Withdrawal by Subject|8|||
25011256|NCT01147822|50104192|FG001|Overall Study|Withdrawal by Subject|13|||
25011257|NCT01147822|50104191|FG000|Overall Study|Not Completed/Ongoing|111|||
25011258|NCT01147822|50104192|FG001|Overall Study|Not Completed/Ongoing|102|||
25011259|NCT03431337|50104200|FG000|Overall Study|Lost to Follow-up|21|||
25011260|NCT03431337|50104201|FG001|Overall Study|Lost to Follow-up|19|||
25011261|NCT03431337|50104200|FG000|Overall Study|Withdrawal by Subject|8|||
25011262|NCT03431337|50104201|FG001|Overall Study|Withdrawal by Subject|3|||
25011263|NCT03738241|50104221|FG000|Overall Study|Withdrawal by Subject|0|||
25011264|NCT03738241|50104222|FG001|Overall Study|Withdrawal by Subject|0|||
25011265|NCT03738241|50104223|FG002|Overall Study|Withdrawal by Subject|0|||
25011266|NCT03738241|50104224|FG003|Overall Study|Withdrawal by Subject|0|||
25011267|NCT03738241|50104225|FG004|Overall Study|Withdrawal by Subject|0|||
25011268|NCT03738241|50104226|FG005|Overall Study|Withdrawal by Subject|0|||
25011269|NCT03738241|50104227|FG006|Overall Study|Withdrawal by Subject|0|||
25011270|NCT03738241|50104228|FG007|Overall Study|Withdrawal by Subject|0|||
25011271|NCT03738241|50104229|FG008|Overall Study|Withdrawal by Subject|0|||
25011272|NCT03738241|50104230|FG009|Overall Study|Withdrawal by Subject|1|||
25011273|NCT03738241|50104221|FG000|Overall Study|Physician Decision|0|||
25011274|NCT03738241|50104222|FG001|Overall Study|Physician Decision|0|||
25011275|NCT03738241|50104223|FG002|Overall Study|Physician Decision|0|||
25011276|NCT03738241|50104224|FG003|Overall Study|Physician Decision|0|||
25011277|NCT03738241|50104225|FG004|Overall Study|Physician Decision|0|||
25011278|NCT03738241|50104226|FG005|Overall Study|Physician Decision|0|||
25011279|NCT03738241|50104227|FG006|Overall Study|Physician Decision|0|||
25011280|NCT03738241|50104228|FG007|Overall Study|Physician Decision|0|||
25011281|NCT03738241|50104229|FG008|Overall Study|Physician Decision|1|||
25011282|NCT03738241|50104230|FG009|Overall Study|Physician Decision|0|||
25011283|NCT03738241|50104221|FG000|Overall Study|Adverse Event|1|||
25011284|NCT03738241|50104222|FG001|Overall Study|Adverse Event|0|||
25140544|NCT02018887|50253765|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
25140545|NCT02018887|50253766|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
25140546|NCT02018887|50253767|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
25140547|NCT02018887|50253768|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
25140548|NCT02018887|50253769|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
25140549|NCT02018887|50253770|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
25140550|NCT02018887|50253771|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
25140551|NCT02018887|50253772|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
25140552|NCT02018887|50253773|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
25140553|NCT02018887|50253774|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
25140554|NCT02018887|50253775|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
25140555|NCT02030041|50253844|FG000|Overall Study|Withdrawal by Subject|2|||
25140556|NCT02030041|50253845|FG001|Overall Study|Withdrawal by Subject|2|||
25140557|NCT02030041|50253846|FG002|Overall Study|Withdrawal by Subject|1|||
25140558|NCT01844505|50253857|FG000|Overall Study|Disease progression|170|||
25140559|NCT01844505|50253858|FG001|Overall Study|Disease progression|88|||
25140560|NCT01844505|50253859|FG002|Overall Study|Disease progression|224|||
25140561|NCT01844505|50253857|FG000|Overall Study|Study drug toxicity|40|||
25140562|NCT01844505|50253858|FG001|Overall Study|Study drug toxicity|131|||
25140563|NCT01844505|50253859|FG002|Overall Study|Study drug toxicity|50|||
25140564|NCT01844505|50253857|FG000|Overall Study|Death|1|||
25140565|NCT01844505|50253858|FG001|Overall Study|Death|3|||
25140566|NCT01844505|50253859|FG002|Overall Study|Death|1|||
25140567|NCT01844505|50253857|FG000|Overall Study|Adverse event unrelated to study drug|7|||
25140568|NCT01844505|50253858|FG001|Overall Study|Adverse event unrelated to study drug|15|||
25140569|NCT01844505|50253859|FG002|Overall Study|Adverse event unrelated to study drug|6|||
25140570|NCT01844505|50253857|FG000|Overall Study|Subject request discontinue treatment|17|||
25140571|NCT01844505|50253858|FG001|Overall Study|Subject request discontinue treatment|14|||
25011285|NCT03738241|50104223|FG002|Overall Study|Adverse Event|0|||
25011286|NCT03738241|50104224|FG003|Overall Study|Adverse Event|0|||
25011287|NCT03738241|50104225|FG004|Overall Study|Adverse Event|0|||
25011288|NCT03738241|50104226|FG005|Overall Study|Adverse Event|0|||
25011289|NCT03738241|50104227|FG006|Overall Study|Adverse Event|0|||
25011290|NCT03738241|50104228|FG007|Overall Study|Adverse Event|0|||
25011291|NCT03738241|50104229|FG008|Overall Study|Adverse Event|0|||
25011292|NCT03738241|50104230|FG009|Overall Study|Adverse Event|0|||
25011293|NCT03430245|50104252|FG000|Overall Study|Withdrawal by Subject|6|||
25011294|NCT03430245|50104252|FG000|Overall Study|Lost to Follow-up|1|||
25011295|NCT03461289|50104256|FG000|Overall Study|Death|1|||
25011296|NCT03428997|50104260|FG000|Overall Study|Sponsor decision.|1|||
25011297|NCT03428997|50104260|FG000|Overall Study|Withdrawal by Subject|3|||
25011298|NCT03428997|50104260|FG000|Overall Study|Lost to Follow-up|4|||
25011299|NCT03452943|50104268|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
25011300|NCT03452943|50104269|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
25011301|NCT03452943|50104268|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
25011302|NCT03452943|50104269|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
25011303|NCT03452943|50104268|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
25011304|NCT03452943|50104269|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
25011305|NCT03452943|50104268|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
25011306|NCT03452943|50104269|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
25011307|NCT03452943|50104268|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
25011308|NCT03452943|50104269|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
25011309|NCT03452943|50104268|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
25011310|NCT03452943|50104269|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
25011311|NCT03481725|50104277|FG000|Overall Study|Withdrawal by Subject|1|||
25011312|NCT03481725|50104278|FG001|Overall Study|Withdrawal by Subject|0|||
25011313|NCT03480243|50104286|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
25011314|NCT03480243|50104286|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
25011315|NCT03426345|50104301|FG000|Overall Study|Adverse Event|4|||
25011316|NCT03426345|50104302|FG001|Overall Study|Adverse Event|4|||
25011317|NCT03426345|50104301|FG000|Overall Study|Lack of Efficacy|1|||
25011318|NCT03426345|50104302|FG001|Overall Study|Lack of Efficacy|0|||
25011319|NCT03426345|50104301|FG000|Overall Study|Withdrawal by Subject|5|||
25011320|NCT03426345|50104302|FG001|Overall Study|Withdrawal by Subject|6|||
25140572|NCT01844505|50253859|FG002|Overall Study|Subject request discontinue treatment|8|||
25274323|NCT01078623|50588464|FG009|Treatment Period 1|Withdrawal by Subject|0|||
25274324|NCT01078623|50588465|FG010|Treatment Period 1|Withdrawal by Subject|1|||
25011321|NCT03426345|50104301|FG000|Overall Study|Lost to Follow-up|3|||
25274325|NCT01078623|50588466|FG011|Treatment Period 1|Withdrawal by Subject|0|||
25011322|NCT03426345|50104302|FG001|Overall Study|Lost to Follow-up|1|||
25011323|NCT03426345|50104301|FG000|Overall Study|Protocol Deviation|3|||
25011324|NCT03426345|50104302|FG001|Overall Study|Protocol Deviation|4|||
25011325|NCT03426345|50104301|FG000|Overall Study|Reason Not Specified|1|||
25011326|NCT03426345|50104302|FG001|Overall Study|Reason Not Specified|2|||
25011327|NCT03426345|50104301|FG000|Overall Study|Missing Completion Status|1|||
25140573|NCT01844505|50253857|FG000|Overall Study|Withdrawal by Subject|0|||
25140574|NCT01844505|50253858|FG001|Overall Study|Withdrawal by Subject|3|||
25140575|NCT01844505|50253859|FG002|Overall Study|Withdrawal by Subject|0|||
25140576|NCT01844505|50253857|FG000|Overall Study|Lost to Follow-up|1|||
25140577|NCT01844505|50253858|FG001|Overall Study|Lost to Follow-up|0|||
25140578|NCT01844505|50253859|FG002|Overall Study|Lost to Follow-up|0|||
25140579|NCT01844505|50253857|FG000|Overall Study|Maximum clinical benefit|8|||
25140580|NCT01844505|50253858|FG001|Overall Study|Maximum clinical benefit|11|||
25140581|NCT01844505|50253859|FG002|Overall Study|Maximum clinical benefit|2|||
25140582|NCT01844505|50253857|FG000|Overall Study|Poor/non-compliance|1|||
25140583|NCT01844505|50253858|FG001|Overall Study|Poor/non-compliance|1|||
25140584|NCT01844505|50253859|FG002|Overall Study|Poor/non-compliance|1|||
25140585|NCT01844505|50253857|FG000|Overall Study|Subject no longer meets criteria|0|||
25011328|NCT03426345|50104302|FG001|Overall Study|Missing Completion Status|0|||
25011329|NCT03426267|50104311|FG000|Overall Study|Physician Decision|1|||
25011330|NCT03426267|50104312|FG001|Overall Study|Physician Decision|4|||
25140586|NCT01844505|50253858|FG001|Overall Study|Subject no longer meets criteria|1|||
25011331|NCT03426267|50104311|FG000|Overall Study|Lost to Follow-up|1|||
25140587|NCT01844505|50253859|FG002|Overall Study|Subject no longer meets criteria|0|||
25140588|NCT01844505|50253857|FG000|Overall Study|Other Reasons|4|||
25140589|NCT01844505|50253858|FG001|Overall Study|Other Reasons|2|||
25140590|NCT01844505|50253859|FG002|Overall Study|Other Reasons|2|||
25140591|NCT01844505|50253857|FG000|Overall Study|Not Reported|0|||
25140592|NCT01844505|50253858|FG001|Overall Study|Not Reported|0|||
25140593|NCT01844505|50253859|FG002|Overall Study|Not Reported|1|||
25140594|NCT01994720|50253869|FG000|Overall Study|Withdrawal by Subject|46|||
25140595|NCT01994720|50253870|FG001|Overall Study|Withdrawal by Subject|56|||
25140596|NCT01814397|50253876|FG000|Overall Study|Adverse Event|7|||
25140597|NCT01814397|50253876|FG000|Overall Study|Withdrawal by Subject|7|||
25140598|NCT01814007|50253880|FG000|Overall Study|Withdrawal by Subject|1|||
25140599|NCT01844115|50253887|FG000|Overall Study|Adverse Event|4|||
25140600|NCT01844115|50253888|FG001|Overall Study|Adverse Event|22|||
25140601|NCT01844115|50253887|FG000|Overall Study|Lack of Efficacy|1|||
25140602|NCT01844115|50253888|FG001|Overall Study|Lack of Efficacy|4|||
25140603|NCT01844115|50253887|FG000|Overall Study|Protocol Violation|12|||
25140604|NCT01844115|50253888|FG001|Overall Study|Protocol Violation|10|||
25140605|NCT01844115|50253887|FG000|Overall Study|Withdrawal by Subject|11|||
25140606|NCT01844115|50253888|FG001|Overall Study|Withdrawal by Subject|11|||
25179170|NCT01693562|50324387|FG001|Expansion Phase|Other|0|||
25140607|NCT01844115|50253887|FG000|Overall Study|Lost to Follow-up|11|||
25179171|NCT01693562|50324388|FG002|Expansion Phase|Other|0|||
25011332|NCT03426267|50104312|FG001|Overall Study|Lost to Follow-up|0|||
25140608|NCT01844115|50253888|FG001|Overall Study|Lost to Follow-up|10|||
25140609|NCT01844115|50253887|FG000|Overall Study|Pregnancy|0|||
25140610|NCT01844115|50253888|FG001|Overall Study|Pregnancy|1|||
25140611|NCT02018042|50253894|FG000|Overall Study|Withdrawal by Subject|1|||
25140612|NCT01813305|50253900|FG000|Overall Study|Withdrawal by Subject|12|||
25140613|NCT01813305|50253901|FG001|Overall Study|Withdrawal by Subject|5|||
25140614|NCT01813305|50253900|FG000|Overall Study|Safety Concern|4|||
25140615|NCT01813305|50253901|FG001|Overall Study|Safety Concern|0|||
25140616|NCT01813305|50253900|FG000|Overall Study|Ulcer became worse|4|||
25140617|NCT01813305|50253901|FG001|Overall Study|Ulcer became worse|0|||
25140618|NCT01813305|50253900|FG000|Overall Study|Physician Decision|4|||
25140619|NCT01813305|50253901|FG001|Overall Study|Physician Decision|0|||
25140620|NCT01813305|50253900|FG000|Overall Study|Lost to Follow-up|3|||
25140621|NCT01813305|50253901|FG001|Overall Study|Lost to Follow-up|1|||
25140622|NCT01813305|50253900|FG000|Overall Study|Protocol Violation|1|||
25140623|NCT01813305|50253901|FG001|Overall Study|Protocol Violation|0|||
25011333|NCT03426267|50104311|FG000|Overall Study|Withdrawal by Subject|4|||
25011334|NCT03426267|50104312|FG001|Overall Study|Withdrawal by Subject|10|||
25011335|NCT03426267|50104311|FG000|Overall Study|Protocol Violation|1|||
25011336|NCT03426267|50104312|FG001|Overall Study|Protocol Violation|3|||
25011337|NCT03426267|50104311|FG000|Overall Study|Adverse Event|9|||
25011338|NCT03426267|50104312|FG001|Overall Study|Adverse Event|27|||
25011339|NCT03426267|50104311|FG000|Overall Study|Prohibited Treatment Intake|2|||
25011340|NCT03426267|50104312|FG001|Overall Study|Prohibited Treatment Intake|3|||
25011341|NCT03426267|50104311|FG000|Overall Study|Lack of Efficacy|0|||
25011342|NCT03426267|50104312|FG001|Overall Study|Lack of Efficacy|25|||
25011343|NCT03426267|50104311|FG000|Overall Study|other|3|||
25011344|NCT03426267|50104312|FG001|Overall Study|other|0|||
25011345|NCT03412929|50104318|FG000|Overall Study|Protocol Violation|3|||
25011346|NCT03451773|50104324|FG000|Overall Study|Death on study|1|||
25011347|NCT03451773|50104325|FG001|Overall Study|Death on study|5|||
25011348|NCT03451773|50104324|FG000|Overall Study|Death during follow-up period|0|||
25011349|NCT03451773|50104325|FG001|Overall Study|Death during follow-up period|1|||
25011350|NCT03425253|50104332|FG000|Overall Study|Adverse Event|2|||
25011351|NCT03425253|50104332|FG000|Overall Study|Lost to Follow-up|3|||
25011352|NCT03425253|50104332|FG000|Overall Study|Withdrew Consent|6|||
25140624|NCT01813305|50253900|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
25140625|NCT01813305|50253901|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
25140626|NCT01993940|50253911|FG000|Overall Study|Adverse Event|16|||
25140627|NCT01993940|50253912|FG001|Overall Study|Adverse Event|11|||
25140628|NCT01993940|50253911|FG000|Overall Study|Withdrawal by Subject|15|||
25140629|NCT01993940|50253912|FG001|Overall Study|Withdrawal by Subject|19|||
25140630|NCT01993940|50253911|FG000|Overall Study|Lost to Follow-up|2|||
25140631|NCT01993940|50253912|FG001|Overall Study|Lost to Follow-up|5|||
25140632|NCT01993940|50253911|FG000|Overall Study|Protocol Violation|5|||
25140633|NCT01993940|50253912|FG001|Overall Study|Protocol Violation|8|||
25140634|NCT01993940|50253911|FG000|Overall Study|Death|1|||
25140635|NCT01993940|50253912|FG001|Overall Study|Death|0|||
25140636|NCT01993940|50253911|FG000|Overall Study|Other - Miscellaneous|1|||
25140637|NCT01993940|50253912|FG001|Overall Study|Other - Miscellaneous|1|||
25140638|NCT01843803|50253920|FG000|Overall Study|not a Veteran, did not see provider|1|||
25140639|NCT01843803|50253921|FG001|Overall Study|not a Veteran, did not see provider|3|||
25140640|NCT02017171|50253929|FG000|Overall Study|Death|10|||
25140641|NCT02017171|50253930|FG001|Overall Study|Death|4|||
25140642|NCT02017171|50253929|FG000|Overall Study|Withdrawal by Subject|23|||
25140643|NCT02017171|50253930|FG001|Overall Study|Withdrawal by Subject|17|||
25140644|NCT02017171|50253929|FG000|Overall Study|Lost to Follow-up|21|||
25140645|NCT02017171|50253930|FG001|Overall Study|Lost to Follow-up|20|||
25140646|NCT02017171|50253929|FG000|Overall Study|ESKD|6|||
25140647|NCT02017171|50253930|FG001|Overall Study|ESKD|2|||
25140648|NCT02017171|50253929|FG000|Overall Study|Miscellaneous|2|||
25140649|NCT02017171|50253930|FG001|Overall Study|Miscellaneous|3|||
25140650|NCT02029417|50253937|FG000|Overall Study|Death|1|||
25140651|NCT02029417|50253937|FG000|Overall Study|Adverse Event|1|||
25140652|NCT02016716|50253944|FG000|Overall Study|Withdrawal by Subject|5|||
25140653|NCT02016716|50253945|FG001|Overall Study|Withdrawal by Subject|5|||
25140654|NCT02016716|50253946|FG002|Overall Study|Withdrawal by Subject|5|||
25140655|NCT02016716|50253944|FG000|Overall Study|Protocol-specified Criteria|0|||
25140656|NCT02016716|50253945|FG001|Overall Study|Protocol-specified Criteria|1|||
25011353|NCT03425253|50104332|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
25140657|NCT02016716|50253946|FG002|Overall Study|Protocol-specified Criteria|0|||
25140658|NCT02016716|50253944|FG000|Overall Study|Lost to Follow-up|1|||
25179172|NCT01693562|50324389|FG003|Expansion Phase|Other|0|||
25011354|NCT03424239|50104337|FG000|Overall Study|Withdrawal by Subject|2|||
25011355|NCT03451071|50104341|FG000|First Vaccine|Withdrawal by Subject|1|||
25011356|NCT03451071|50104341|FG000|Second Vaccine|Lost to Follow-up|19|||
25140659|NCT02016716|50253945|FG001|Overall Study|Lost to Follow-up|2|||
25140660|NCT02016716|50253946|FG002|Overall Study|Lost to Follow-up|1|||
25140661|NCT02050321|50253955|FG000|Overall Study|Withdrawal by Subject|1|||
25140662|NCT02050321|50253955|FG000|Overall Study|Adverse Event|1|||
25140663|NCT02039414|50253961|FG000|Overall Study|Delivered|1|||
25140664|NCT02039414|50253962|FG001|Overall Study|Delivered|1|||
25140665|NCT02039414|50253961|FG000|Overall Study|Lost to Follow-up|2|||
25140666|NCT02039414|50253962|FG001|Overall Study|Lost to Follow-up|0|||
25140667|NCT02039414|50253961|FG000|Overall Study|Protocol Violation|3|||
25140668|NCT02039414|50253962|FG001|Overall Study|Protocol Violation|1|||
25140669|NCT02017015|50253968|FG000|Overall Study|Adverse Event|9|||
25140670|NCT02017015|50253968|FG000|Overall Study|Withdrawal by Subject|21|||
25140671|NCT02017015|50253968|FG000|Overall Study|Death|4|||
25179173|NCT01693562|50324390|FG004|Expansion Phase|Other|0|||
25011357|NCT03451071|50104341|FG000|Third Vaccine|Lost to Follow-up|22|||
25011358|NCT03451071|50104341|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
25011359|NCT03449979|50104349|FG000|Overall Study|Technical difficulty|0|||
25011360|NCT03449979|50104350|FG001|Overall Study|Technical difficulty|0|||
25011361|NCT03449979|50104351|FG002|Overall Study|Technical difficulty|0|||
25011362|NCT03449979|50104352|FG003|Overall Study|Technical difficulty|1|||
25011363|NCT03449199|50104365|FG000|Overall Study|Lost to Follow-up|1|||
25011364|NCT03449199|50104366|FG001|Overall Study|Lost to Follow-up|1|||
25140672|NCT02017015|50253968|FG000|Overall Study|Progressive Disease|31|||
25140673|NCT02017015|50253968|FG000|Overall Study|Non-compliance with study drug|2|||
25011365|NCT03449199|50104367|FG002|Overall Study|Lost to Follow-up|0|||
25140674|NCT02017015|50253968|FG000|Overall Study|Physician Decision|2|||
25140675|NCT02016625|50253975|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
25140676|NCT02016625|50253976|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
25140677|NCT02016625|50253975|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
25140678|NCT02016625|50253976|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
25140679|NCT02016625|50253975|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
25140680|NCT02016625|50253976|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
25011366|NCT03449199|50104365|FG000|Overall Study|Protocol Deviation|0|||
25011367|NCT03449199|50104366|FG001|Overall Study|Protocol Deviation|0|||
25011368|NCT03449199|50104367|FG002|Overall Study|Protocol Deviation|1|||
25011369|NCT03449199|50104365|FG000|Overall Study|Withdrawal by Subject|0|||
25011370|NCT03449199|50104366|FG001|Overall Study|Withdrawal by Subject|0|||
25011371|NCT03449199|50104367|FG002|Overall Study|Withdrawal by Subject|1|||
25011372|NCT03421431|50104381|FG000|Overall Study|Adverse Event|2|||
25011373|NCT03421431|50104382|FG001|Overall Study|Adverse Event|1|||
25011374|NCT03421431|50104383|FG002|Overall Study|Adverse Event|12|||
25011375|NCT03421431|50104381|FG000|Overall Study|Lost to Follow-up|1|||
25011376|NCT03421431|50104382|FG001|Overall Study|Lost to Follow-up|1|||
25011377|NCT03421431|50104383|FG002|Overall Study|Lost to Follow-up|1|||
25011378|NCT03421431|50104381|FG000|Overall Study|Withdrawal by Subject|3|||
25011379|NCT03421431|50104382|FG001|Overall Study|Withdrawal by Subject|2|||
25011380|NCT03421431|50104383|FG002|Overall Study|Withdrawal by Subject|1|||
25011381|NCT03421431|50104381|FG000|Overall Study|Protocol Violation|0|||
25011382|NCT03421431|50104382|FG001|Overall Study|Protocol Violation|1|||
25011383|NCT03421431|50104383|FG002|Overall Study|Protocol Violation|0|||
25011384|NCT03421431|50104381|FG000|Overall Study|Participant met Stopping Rules|0|||
25011385|NCT03421431|50104382|FG001|Overall Study|Participant met Stopping Rules|1|||
25011386|NCT03421431|50104383|FG002|Overall Study|Participant met Stopping Rules|0|||
25011387|NCT03448419|50104395|FG000|Overall Study|Adverse Event|10|||
25011388|NCT03448419|50104396|FG001|Overall Study|Adverse Event|9|||
25011389|NCT03448419|50104395|FG000|Overall Study|Lost to Follow-up|0|||
25011390|NCT03448419|50104396|FG001|Overall Study|Lost to Follow-up|2|||
25011391|NCT03448419|50104395|FG000|Overall Study|Withdrawal by Subject|3|||
25011392|NCT03448419|50104396|FG001|Overall Study|Withdrawal by Subject|1|||
25011393|NCT03448419|50104395|FG000|Overall Study|Not treated|0|||
25011394|NCT03448419|50104396|FG001|Overall Study|Not treated|1|||
25011395|NCT03448419|50104395|FG000|Overall Study|Patient did not attend all visits|0|||
25011396|NCT03448419|50104396|FG001|Overall Study|Patient did not attend all visits|2|||
25011397|NCT03448419|50104395|FG000|Overall Study|Withdrawn by Sponsor|0|||
25140681|NCT02016482|50253994|FG000|Period A|Adverse Event|3|||
25011398|NCT03448419|50104396|FG001|Overall Study|Withdrawn by Sponsor|1|||
25011399|NCT03419403|50104407|FG000|Overall Study|Withdrawal by Subject|5|||
25011400|NCT03419403|50104408|FG001|Overall Study|Withdrawal by Subject|2|||
25011401|NCT03419403|50104409|FG002|Overall Study|Withdrawal by Subject|5|||
25011402|NCT03419403|50104410|FG003|Overall Study|Withdrawal by Subject|1|||
25011403|NCT03419403|50104407|FG000|Overall Study|Progressive disease (per protocol)|0|||
25011404|NCT03419403|50104408|FG001|Overall Study|Progressive disease (per protocol)|2|||
25011405|NCT03419403|50104409|FG002|Overall Study|Progressive disease (per protocol)|2|||
25011406|NCT03419403|50104410|FG003|Overall Study|Progressive disease (per protocol)|0|||
25011407|NCT03419403|50104407|FG000|Overall Study|Other, not specified|6|||
25011408|NCT03419403|50104408|FG001|Overall Study|Other, not specified|4|||
25011409|NCT03419403|50104409|FG002|Overall Study|Other, not specified|5|||
25011410|NCT03419403|50104410|FG003|Overall Study|Other, not specified|1|||
25011411|NCT03419403|50104407|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
25011412|NCT03419403|50104408|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
25011413|NCT03419403|50104409|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
25011414|NCT03419403|50104410|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
25011415|NCT03447249|50104420|FG000|Overall Study|Adverse Event|1|||
25011416|NCT03447249|50104421|FG001|Overall Study|Adverse Event|0|||
25011417|NCT03447249|50104420|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
25011418|NCT03447249|50104421|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
25011419|NCT03447249|50104420|FG000|Overall Study|Other|3|||
25011420|NCT03447249|50104421|FG001|Overall Study|Other|0|||
25011421|NCT03418545|50104431|FG000|Overall Study|Withdrawal by Participant|2|||
25011422|NCT03418545|50104432|FG001|Overall Study|Withdrawal by Participant|4|||
25140682|NCT02016482|50253995|FG001|Period A|Adverse Event|5|||
25011423|NCT03418545|50104431|FG000|Overall Study|Lost to Follow-up|3|||
25011424|NCT03418545|50104432|FG001|Overall Study|Lost to Follow-up|5|||
25011425|NCT03418545|50104431|FG000|Overall Study|Reason Not Specified|0|||
25011426|NCT03418545|50104432|FG001|Overall Study|Reason Not Specified|1|||
25011427|NCT03418545|50104431|FG000|Overall Study|Missing Completion Status|0|||
25011428|NCT03418545|50104432|FG001|Overall Study|Missing Completion Status|1|||
25011429|NCT03409731|50104441|FG000|Overall Study|Withdrawal by Subject|1|||
25011430|NCT03409731|50104441|FG000|Overall Study|Death|2|||
25140683|NCT02016482|50253994|FG000|Period A|Withdrawal by Subject|3|||
25140684|NCT02016482|50253995|FG001|Period A|Withdrawal by Subject|4|||
25140685|NCT02016482|50253994|FG000|Period A|Lost to Follow-up|3|||
25140686|NCT02016482|50253995|FG001|Period A|Lost to Follow-up|3|||
25140687|NCT02016482|50253994|FG000|Period A|Lack of Efficacy|2|||
25140688|NCT02016482|50253995|FG001|Period A|Lack of Efficacy|1|||
25140689|NCT02016482|50253994|FG000|Period A|Other|3|||
25011431|NCT03446781|50104447|FG000|Overall Study|Lost to Follow-up|11|||
25011432|NCT03446781|50104448|FG001|Overall Study|Lost to Follow-up|5|||
25011433|NCT03446781|50104447|FG000|Overall Study|Withdrawal by Subject|9|||
25011434|NCT03446781|50104448|FG001|Overall Study|Withdrawal by Subject|7|||
25011435|NCT03446781|50104447|FG000|Overall Study|Adverse Event|8|||
25011436|NCT03446781|50104448|FG001|Overall Study|Adverse Event|2|||
25011437|NCT03446781|50104447|FG000|Overall Study|Protocol Violation|0|||
25011438|NCT03446781|50104448|FG001|Overall Study|Protocol Violation|3|||
25011439|NCT03445065|50104480|FG000|Overall Study|Withdrawal by Subject|3|||
25011440|NCT03445065|50104481|FG001|Overall Study|Withdrawal by Subject|6|||
25011441|NCT03445065|50104482|FG002|Overall Study|Withdrawal by Subject|2|||
25140690|NCT02016482|50253995|FG001|Period A|Other|0|||
25140691|NCT02016482|50253994|FG000|Period A|Protocol Violation|0|||
25140692|NCT02016482|50253995|FG001|Period A|Protocol Violation|1|||
25140693|NCT02016482|50253994|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
25140694|NCT02016482|50253995|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
25140695|NCT02016482|50253994|FG000|Period B|Withdrawal by Subject|1|||
25011442|NCT03445065|50104483|FG003|Overall Study|Withdrawal by Subject|2|||
25140696|NCT02016482|50253995|FG001|Period B|Withdrawal by Subject|1|||
25140697|NCT02016482|50253994|FG000|Period B|Lost to Follow-up|2|||
25140698|NCT02016482|50253995|FG001|Period B|Lost to Follow-up|0|||
25140699|NCT02016482|50253994|FG000|Period B|Lack of Efficacy|6|||
25140700|NCT02016482|50253995|FG001|Period B|Lack of Efficacy|4|||
25140701|NCT02016482|50253994|FG000|Period B|Other|4|||
25140702|NCT02016482|50253995|FG001|Period B|Other|0|||
25140703|NCT02016482|50253994|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
25140704|NCT02016482|50253995|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
25011443|NCT03445065|50104480|FG000|Overall Study|Other|4|||
25011444|NCT03445065|50104481|FG001|Overall Study|Other|3|||
25011445|NCT03445065|50104482|FG002|Overall Study|Other|3|||
25011446|NCT03445065|50104483|FG003|Overall Study|Other|1|||
25011447|NCT01224106|50104508|FG000|Double-Blind Treatment Phase|Death|3|||
25011448|NCT01224106|50104509|FG001|Double-Blind Treatment Phase|Death|0|||
25011449|NCT01224106|50104510|FG002|Double-Blind Treatment Phase|Death|0|||
25011450|NCT01224106|50104511|FG003|Double-Blind Treatment Phase|Death|0|||
25011451|NCT01224106|50104512|FG004|Double-Blind Treatment Phase|Death|0|||
25011452|NCT01224106|50104508|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
25011453|NCT01224106|50104509|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
25011454|NCT01224106|50104510|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
25011455|NCT01224106|50104511|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
25011456|NCT01224106|50104512|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
25011457|NCT01224106|50104508|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
25011458|NCT01224106|50104509|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
25011459|NCT01224106|50104510|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
25011460|NCT01224106|50104511|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
25011461|NCT01224106|50104512|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
25011462|NCT01224106|50104508|FG000|Double-Blind Treatment Phase|Other|0|||
25011463|NCT01224106|50104509|FG001|Double-Blind Treatment Phase|Other|0|||
25011464|NCT01224106|50104510|FG002|Double-Blind Treatment Phase|Other|1|||
25011465|NCT01224106|50104511|FG003|Double-Blind Treatment Phase|Other|0|||
25011466|NCT01224106|50104512|FG004|Double-Blind Treatment Phase|Other|0|||
25011467|NCT01224106|50104508|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
25011468|NCT01224106|50104509|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
25011469|NCT01224106|50104510|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
25011470|NCT01224106|50104511|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
25011471|NCT01224106|50104512|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
25011472|NCT01224106|50104508|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
25011473|NCT01224106|50104509|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
25011474|NCT01224106|50104510|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
25140705|NCT02028871|50254005|FG000|Overall Study|Positive urine drug screen|1|||
25140706|NCT02028871|50254006|FG001|Overall Study|Positive urine drug screen|1|||
25140707|NCT02028871|50254005|FG000|Overall Study|Withdrawal by Subject|1|||
25140708|NCT02028871|50254006|FG001|Overall Study|Withdrawal by Subject|2|||
25140709|NCT02028871|50254005|FG000|Overall Study|IV placement difficulty|1|||
25140710|NCT02028871|50254006|FG001|Overall Study|IV placement difficulty|0|||
25140711|NCT02028871|50254005|FG000|Overall Study|Current Illness|1|||
25140712|NCT02028871|50254006|FG001|Overall Study|Current Illness|0|||
25140713|NCT02028715|50254017|FG000|Overall Study|Adverse Event|2|||
25140714|NCT02028715|50254018|FG001|Overall Study|Adverse Event|2|||
25140715|NCT02028715|50254017|FG000|Overall Study|Physician Decision|1|||
25140716|NCT02028715|50254018|FG001|Overall Study|Physician Decision|0|||
25140717|NCT02028715|50254017|FG000|Overall Study|Did not complete satisfaction surveys|2|||
25140718|NCT02028715|50254018|FG001|Overall Study|Did not complete satisfaction surveys|2|||
25140719|NCT02016170|50254027|FG000|Overall Study|Adverse Event|1|||
25140720|NCT02016170|50254028|FG001|Overall Study|Adverse Event|1|||
25140721|NCT02016170|50254029|FG002|Overall Study|Adverse Event|0|||
25140722|NCT02016170|50254027|FG000|Overall Study|Protocol Violation|1|||
25140723|NCT02016170|50254028|FG001|Overall Study|Protocol Violation|0|||
25140724|NCT02016170|50254029|FG002|Overall Study|Protocol Violation|0|||
25140725|NCT02028169|50254036|FG000|Overall Study|Lost to Follow-up|21|||
25140726|NCT02028169|50254036|FG000|Overall Study|Lack of Efficacy|2|||
25140727|NCT02028169|50254036|FG000|Overall Study|Withdrawal by Subject|2|||
25140728|NCT02028169|50254036|FG000|Overall Study|Adverse Event|1|||
25140729|NCT02028169|50254036|FG000|Overall Study|Cessation of Drug|1|||
25140730|NCT02028169|50254036|FG000|Overall Study|Concomitant Medication Usage|1|||
25140731|NCT02015546|50254043|FG000|Overall Study|Withdrawal by Subject|1|||
25140732|NCT02015546|50254044|FG001|Overall Study|Withdrawal by Subject|1|||
25140733|NCT02015546|50254045|FG002|Overall Study|Withdrawal by Subject|1|||
25011475|NCT01224106|50104511|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
25140734|NCT02015546|50254043|FG000|Overall Study|Screem Failure|2|||
25140735|NCT02015546|50254044|FG001|Overall Study|Screem Failure|1|||
25140736|NCT02015546|50254045|FG002|Overall Study|Screem Failure|3|||
25140737|NCT02027701|50254053|FG000|Overall Study|Adverse Event|3|||
25140738|NCT02027701|50254053|FG000|Overall Study|Lack of Efficacy|8|||
25011476|NCT01224106|50104512|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
25011477|NCT01224106|50104508|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
25011478|NCT01224106|50104509|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
25011479|NCT01224106|50104510|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
25011480|NCT01224106|50104511|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
25011481|NCT01224106|50104512|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
25011482|NCT01224106|50104508|FG000|Open-Label Extension (OLE) Phase|Death|0|||
25011483|NCT01224106|50104509|FG001|Open-Label Extension (OLE) Phase|Death|0|||
25011484|NCT01224106|50104510|FG002|Open-Label Extension (OLE) Phase|Death|0|||
25011485|NCT01224106|50104511|FG003|Open-Label Extension (OLE) Phase|Death|1|||
25011486|NCT01224106|50104512|FG004|Open-Label Extension (OLE) Phase|Death|3|||
25011487|NCT01224106|50104508|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
25011488|NCT01224106|50104509|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
25011489|NCT01224106|50104510|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
25011490|NCT01224106|50104511|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
25011491|NCT01224106|50104512|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
25011492|NCT01224106|50104508|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
25011493|NCT01224106|50104509|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
25011494|NCT01224106|50104510|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
25011495|NCT01224106|50104511|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
25011496|NCT01224106|50104512|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
25011497|NCT01224106|50104508|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
25011498|NCT01224106|50104509|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
25011499|NCT01224106|50104510|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
25011500|NCT01224106|50104511|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
25011501|NCT01224106|50104512|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
25011502|NCT01224106|50104508|FG000|Open-Label Extension (OLE) Phase|Other|0|||
25011503|NCT01224106|50104509|FG001|Open-Label Extension (OLE) Phase|Other|0|||
25011504|NCT01224106|50104510|FG002|Open-Label Extension (OLE) Phase|Other|0|||
25011505|NCT01224106|50104511|FG003|Open-Label Extension (OLE) Phase|Other|5|||
25011506|NCT01224106|50104512|FG004|Open-Label Extension (OLE) Phase|Other|3|||
25011507|NCT03409107|50104532|FG000|Overall Study|Withdrawal by Subject|4|||
25011508|NCT03409107|50104533|FG001|Overall Study|Withdrawal by Subject|2|||
25011509|NCT03409107|50104532|FG000|Overall Study|Physician Decision|1|||
25011510|NCT03409107|50104533|FG001|Overall Study|Physician Decision|0|||
25011511|NCT03409107|50104532|FG000|Overall Study|Lost to Follow-up|7|||
25011512|NCT03409107|50104533|FG001|Overall Study|Lost to Follow-up|2|||
25011513|NCT03409107|50104532|FG000|Overall Study|Adverse Event|5|||
25011514|NCT03409107|50104533|FG001|Overall Study|Adverse Event|3|||
25011515|NCT03408873|50104547|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
25011516|NCT03408873|50104547|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
25011517|NCT03408873|50104547|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
25011518|NCT03408873|50104547|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
25011519|NCT03408873|50104547|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
25011520|NCT03408873|50104547|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
25011521|NCT03780959|50104554|FG000|Part 1|Adverse Event|1|||
25011522|NCT03780959|50104555|FG001|Part 1|Adverse Event|0|||
25011523|NCT03780959|50104556|FG002|Part 1|Adverse Event|0|||
25011524|NCT03780959|50104554|FG000|Part 1|Withdrawal by Subject|1|||
25011525|NCT03780959|50104555|FG001|Part 1|Withdrawal by Subject|0|||
25011526|NCT03780959|50104556|FG002|Part 1|Withdrawal by Subject|0|||
25011527|NCT03780959|50104554|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
25011528|NCT03780959|50104555|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
25011529|NCT03780959|50104556|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
25011530|NCT03780959|50104554|FG000|Part 1|Response Status|2|||
25011531|NCT03780959|50104555|FG001|Part 1|Response Status|0|||
25011532|NCT03780959|50104556|FG002|Part 1|Response Status|0|||
25011533|NCT03780959|50104554|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
25011534|NCT03780959|50104555|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
25011535|NCT03780959|50104556|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
25011536|NCT03780959|50104554|FG000|Part 2|Response Status|0|||
25011537|NCT03780959|50104555|FG001|Part 2|Response Status|18|||
25011538|NCT03780959|50104556|FG002|Part 2|Response Status|6|||
25011539|NCT03408639|50104568|FG000|Overall Study|Death|5|||
25011540|NCT03408639|50104569|FG001|Overall Study|Death|5|||
25011541|NCT03408639|50104568|FG000|Overall Study|Lost to Follow-up|1|||
25011542|NCT03408639|50104569|FG001|Overall Study|Lost to Follow-up|4|||
25011543|NCT03408639|50104568|FG000|Overall Study|Withdrawal by Subject|2|||
25011544|NCT03408639|50104569|FG001|Overall Study|Withdrawal by Subject|7|||
25011545|NCT03408639|50104568|FG000|Overall Study|Physician Decision|3|||
25011546|NCT03408639|50104569|FG001|Overall Study|Physician Decision|6|||
25011547|NCT03810235|50104577|FG000|Overall Study|Withdrawal by Subject|2|||
25011548|NCT03810235|50104578|FG001|Overall Study|Withdrawal by Subject|0|||
25011549|NCT03408483|50104587|FG000|Overall Study|Physician Decision|3|||
25011550|NCT03408483|50104588|FG001|Overall Study|Physician Decision|3|||
25011551|NCT03408483|50104587|FG000|Overall Study|Lost to Follow-up|3|||
25011552|NCT03408483|50104588|FG001|Overall Study|Lost to Follow-up|0|||
25011553|NCT03777917|50104596|FG000|Overall Study|Withdrawal by Subject|1|||
25011554|NCT03777917|50104597|FG001|Overall Study|Withdrawal by Subject|0|||
25011555|NCT03777917|50104596|FG000|Overall Study|Physician Decision|1|||
25011556|NCT03777917|50104597|FG001|Overall Study|Physician Decision|0|||
25140739|NCT02027701|50254053|FG000|Overall Study|Physician Decision|2|||
25140740|NCT02027701|50254053|FG000|Overall Study|Withdrawal by Subject|3|||
25011557|NCT03777917|50104596|FG000|Overall Study|Lost to Follow-up|6|||
25011558|NCT03777917|50104597|FG001|Overall Study|Lost to Follow-up|2|||
25011559|NCT03777917|50104596|FG000|Overall Study|Other|1|||
25011560|NCT03777917|50104597|FG001|Overall Study|Other|0|||
25011561|NCT03777059|50104608|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
25011562|NCT03777059|50104609|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
25011563|NCT03777059|50104610|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
25140741|NCT02038790|50254059|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
25140742|NCT02038790|50254060|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
25140743|NCT02027623|50254069|FG000|Overall Study|Lost to Follow-up|3|||
25140744|NCT02027623|50254070|FG001|Overall Study|Lost to Follow-up|3|||
25140745|NCT02027623|50254069|FG000|Overall Study|Withdrawal by Subject|6|||
25140746|NCT02027623|50254070|FG001|Overall Study|Withdrawal by Subject|9|||
25140747|NCT02015221|50254079|FG000|Overall Study|Withdrawal by Subject|8|||
25140748|NCT02015221|50254080|FG001|Overall Study|Withdrawal by Subject|6|||
25140749|NCT02015221|50254079|FG000|Overall Study|Lost to Follow-up|1|||
25140750|NCT02015221|50254080|FG001|Overall Study|Lost to Follow-up|0|||
25140751|NCT02027311|50254088|FG000|Overall Study|Protocol Violation|3|||
25140752|NCT02027311|50254089|FG001|Overall Study|Protocol Violation|2|||
25140753|NCT02047903|50254097|FG000|Overall Study|Adverse Event|14|||
25140754|NCT02047903|50254097|FG000|Overall Study|Serious adverse event|10|||
25140755|NCT02047903|50254097|FG000|Overall Study|Withdrawal by Subject|16|||
25140756|NCT02047903|50254097|FG000|Overall Study|Lost to Follow-up|4|||
25011564|NCT03777059|50104611|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
25011565|NCT03777059|50104608|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
25011566|NCT03777059|50104609|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
25011567|NCT03777059|50104610|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
25011568|NCT03777059|50104611|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
25011569|NCT03777059|50104608|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
25011570|NCT03777059|50104609|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
25011571|NCT03777059|50104610|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
25011572|NCT03777059|50104611|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
25011573|NCT03777059|50104608|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
25011574|NCT03777059|50104609|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
25011575|NCT03777059|50104610|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
25011576|NCT03777059|50104611|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
25011577|NCT03777059|50104608|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
25011578|NCT03777059|50104609|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
25011579|NCT03777059|50104610|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
25011580|NCT03777059|50104611|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
25011581|NCT03777059|50104608|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
25011582|NCT03777059|50104609|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
25011583|NCT03777059|50104610|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
25011584|NCT03777059|50104611|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
25011585|NCT03777059|50104608|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
25011586|NCT03777059|50104609|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
25011587|NCT03777059|50104610|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
25011588|NCT03777059|50104611|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
25140757|NCT02047903|50254097|FG000|Overall Study|Reason not listed|6|||
25011589|NCT03777059|50104608|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
25011590|NCT03777059|50104609|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
25011591|NCT03777059|50104610|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
25011592|NCT03777059|50104611|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
25011593|NCT03777059|50104608|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
25011594|NCT03777059|50104609|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
25140758|NCT02047903|50254097|FG000|Overall Study|Not Treated|9|||
25140759|NCT02015065|50254104|FG000|Overall Study|Death on study|1|||
25140760|NCT02015065|50254105|FG001|Overall Study|Death on study|2|||
25140761|NCT02015065|50254106|FG002|Overall Study|Death on study|1|||
25011595|NCT03777059|50104610|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
25011596|NCT03777059|50104611|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
25179174|NCT01693562|50324391|FG005|Expansion Phase|Other|0|||
25274326|NCT01078623|50588467|FG012|Treatment Period 1|Withdrawal by Subject|0|||
25274327|NCT01078623|50588468|FG013|Treatment Period 1|Withdrawal by Subject|0|||
25274328|NCT01078623|50588469|FG014|Treatment Period 1|Withdrawal by Subject|0|||
25274329|NCT01078623|50588470|FG015|Treatment Period 1|Withdrawal by Subject|0|||
25274330|NCT01078623|50588471|FG016|Treatment Period 1|Withdrawal by Subject|0|||
25274331|NCT01078623|50588472|FG017|Treatment Period 1|Withdrawal by Subject|0|||
25274332|NCT01078623|50588473|FG018|Treatment Period 1|Withdrawal by Subject|0|||
25274333|NCT01078623|50588474|FG019|Treatment Period 1|Withdrawal by Subject|0|||
25274334|NCT01078623|50588455|FG000|Treatment Period 1|Protocol Violation|0|||
25274335|NCT01078623|50588456|FG001|Treatment Period 1|Protocol Violation|0|||
25274336|NCT01078623|50588457|FG002|Treatment Period 1|Protocol Violation|0|||
25274337|NCT01078623|50588458|FG003|Treatment Period 1|Protocol Violation|0|||
25274338|NCT01078623|50588459|FG004|Treatment Period 1|Protocol Violation|0|||
25274339|NCT01078623|50588460|FG005|Treatment Period 1|Protocol Violation|1|||
25274340|NCT01078623|50588461|FG006|Treatment Period 1|Protocol Violation|0|||
25274341|NCT01078623|50588462|FG007|Treatment Period 1|Protocol Violation|0|||
25274342|NCT01078623|50588463|FG008|Treatment Period 1|Protocol Violation|0|||
25274343|NCT01078623|50588464|FG009|Treatment Period 1|Protocol Violation|0|||
25274344|NCT01078623|50588465|FG010|Treatment Period 1|Protocol Violation|0|||
25274345|NCT01078623|50588466|FG011|Treatment Period 1|Protocol Violation|0|||
25274346|NCT01078623|50588467|FG012|Treatment Period 1|Protocol Violation|0|||
25274347|NCT01078623|50588468|FG013|Treatment Period 1|Protocol Violation|0|||
25274348|NCT01078623|50588469|FG014|Treatment Period 1|Protocol Violation|0|||
25274349|NCT01078623|50588470|FG015|Treatment Period 1|Protocol Violation|0|||
25274350|NCT01078623|50588471|FG016|Treatment Period 1|Protocol Violation|0|||
25274351|NCT01078623|50588472|FG017|Treatment Period 1|Protocol Violation|0|||
25274352|NCT01078623|50588473|FG018|Treatment Period 1|Protocol Violation|0|||
25274353|NCT01078623|50588474|FG019|Treatment Period 1|Protocol Violation|0|||
25274354|NCT01078623|50588455|FG000|Treatment Period 2|Adverse Event|0|||
25274355|NCT01078623|50588456|FG001|Treatment Period 2|Adverse Event|0|||
25274356|NCT01078623|50588457|FG002|Treatment Period 2|Adverse Event|0|||
25274357|NCT01078623|50588458|FG003|Treatment Period 2|Adverse Event|0|||
25274358|NCT01078623|50588459|FG004|Treatment Period 2|Adverse Event|0|||
25274359|NCT01078623|50588460|FG005|Treatment Period 2|Adverse Event|0|||
25011597|NCT03777059|50104608|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
25011598|NCT03777059|50104609|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
25011599|NCT03777059|50104610|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
25011600|NCT03777059|50104611|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
25011601|NCT03777059|50104608|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
25011602|NCT03777059|50104609|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
25011603|NCT03777059|50104610|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
25011604|NCT03777059|50104611|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
25011605|NCT03100058|50104630|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
25011606|NCT03100058|50104631|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
25011607|NCT03100058|50104632|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
25011608|NCT03100058|50104633|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
25011609|NCT03100058|50104634|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
25011610|NCT03100058|50104635|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
25011611|NCT03100058|50104636|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
25011612|NCT03100058|50104637|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
25011613|NCT03100058|50104638|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
25011614|NCT03100058|50104639|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
25011615|NCT03100058|50104640|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
25011616|NCT03100058|50104641|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
25011617|NCT03100058|50104642|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
25011618|NCT03100058|50104630|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
25011619|NCT03100058|50104631|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
25011620|NCT03100058|50104632|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
25011621|NCT03100058|50104633|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
25011622|NCT03100058|50104634|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
25011623|NCT03100058|50104635|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
25011624|NCT03100058|50104636|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
25011625|NCT03100058|50104637|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
25011626|NCT03100058|50104638|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
25011627|NCT03100058|50104639|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
25011628|NCT03100058|50104640|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
25011629|NCT03100058|50104641|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
25011630|NCT03100058|50104642|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
25011631|NCT03100058|50104630|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
25011632|NCT03100058|50104631|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
25011633|NCT03100058|50104632|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
25011634|NCT03100058|50104633|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
25011635|NCT03100058|50104634|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
25011636|NCT03100058|50104635|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
25011637|NCT03100058|50104636|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
25011638|NCT03100058|50104637|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
25011639|NCT03100058|50104638|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
25011640|NCT03100058|50104639|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
25011641|NCT03100058|50104640|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
25011642|NCT03100058|50104641|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
25011643|NCT03100058|50104642|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
25011644|NCT03100058|50104630|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
25011645|NCT03100058|50104631|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
25011646|NCT03100058|50104632|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
25011647|NCT03100058|50104633|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
25011648|NCT03100058|50104634|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
25011649|NCT03100058|50104635|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
25011650|NCT03100058|50104636|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
25140762|NCT02026141|50254116|FG000|Overall Study|Protocol Violation|0|||
25140763|NCT02026141|50254117|FG001|Overall Study|Protocol Violation|1|||
25140764|NCT02026063|50254125|FG000|Overall Study|Physician Decision|0|||
25140765|NCT02026063|50254126|FG001|Overall Study|Physician Decision|10|||
25140766|NCT02026063|50254125|FG000|Overall Study|Noncompliance with Study Drug|1|||
25140767|NCT02026063|50254126|FG001|Overall Study|Noncompliance with Study Drug|1|||
25140768|NCT02026063|50254125|FG000|Overall Study|Withdrawal of Consent|1|||
25140769|NCT02026063|50254126|FG001|Overall Study|Withdrawal of Consent|6|||
25140770|NCT02026063|50254125|FG000|Overall Study|Adverse Event|5|||
25140771|NCT02026063|50254126|FG001|Overall Study|Adverse Event|20|||
25140772|NCT02026063|50254125|FG000|Overall Study|Lack of Efficacy|0|||
25140773|NCT02026063|50254126|FG001|Overall Study|Lack of Efficacy|4|||
25140774|NCT02026063|50254125|FG000|Overall Study|Lost to Follow-up|0|||
25140775|NCT02026063|50254126|FG001|Overall Study|Lost to Follow-up|1|||
25179175|NCT01693562|50324392|FG006|Expansion Phase|Other|0|||
25011651|NCT03100058|50104637|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
25011652|NCT03100058|50104638|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
25011653|NCT03100058|50104639|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
25011654|NCT03100058|50104640|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
25011655|NCT03100058|50104641|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
25011656|NCT03100058|50104642|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
25011657|NCT03100058|50104630|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
25011658|NCT03100058|50104631|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
25011659|NCT03100058|50104632|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
25011660|NCT03100058|50104633|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
25011661|NCT03100058|50104634|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
25011662|NCT03100058|50104635|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
25011663|NCT03100058|50104636|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
25011664|NCT03100058|50104637|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
25011665|NCT03100058|50104638|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
25011666|NCT03100058|50104639|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
25011667|NCT03100058|50104640|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
25011668|NCT03100058|50104641|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
25011669|NCT03100058|50104642|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
25011670|NCT03100058|50104630|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
25011671|NCT03100058|50104631|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
25011672|NCT03100058|50104632|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
25011673|NCT03100058|50104633|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
25011674|NCT03100058|50104634|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
25011675|NCT03100058|50104635|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
25011676|NCT03100058|50104636|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
25011677|NCT03100058|50104637|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
25011678|NCT03100058|50104638|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
25011679|NCT03100058|50104639|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
25011680|NCT03100058|50104640|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
25011681|NCT03100058|50104641|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
25011682|NCT03100058|50104642|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
25011683|NCT03100058|50104630|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
25011684|NCT03100058|50104631|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
25011685|NCT03100058|50104632|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
25011686|NCT03100058|50104633|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
25011687|NCT03100058|50104634|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
25011688|NCT03100058|50104635|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
25011689|NCT03100058|50104636|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
25011690|NCT03100058|50104637|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
25011691|NCT03100058|50104638|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
25011692|NCT03100058|50104639|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
25011693|NCT03100058|50104640|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
25011694|NCT03100058|50104641|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
25011695|NCT03100058|50104642|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
25011696|NCT03100058|50104630|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
25011697|NCT03100058|50104631|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
25011698|NCT03100058|50104632|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
25011699|NCT03100058|50104633|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
25011700|NCT03100058|50104634|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
25011701|NCT03100058|50104635|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
25011702|NCT03100058|50104636|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
25140776|NCT02026063|50254125|FG000|Overall Study|Reason not Specified|2|||
25140777|NCT02026063|50254126|FG001|Overall Study|Reason not Specified|7|||
25140778|NCT02025907|50254135|FG000|Overall Study|Lack of Efficacy|1|||
25140779|NCT02025907|50254136|FG001|Overall Study|Lack of Efficacy|0|||
25140780|NCT02025907|50254135|FG000|Overall Study|Withdrawal by Subject|15|||
25140781|NCT02025907|50254136|FG001|Overall Study|Withdrawal by Subject|8|||
25140782|NCT02025907|50254135|FG000|Overall Study|Protocol Violation|2|||
25011703|NCT03100058|50104637|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
25011704|NCT03100058|50104638|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
25011705|NCT03100058|50104639|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
25011706|NCT03100058|50104640|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
25011707|NCT03100058|50104641|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
25011708|NCT03100058|50104642|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
25140783|NCT02025907|50254136|FG001|Overall Study|Protocol Violation|0|||
25140784|NCT02025907|50254135|FG000|Overall Study|Physician Decision|2|||
25011709|NCT03100058|50104630|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
25011710|NCT03100058|50104631|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
25011711|NCT03100058|50104632|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
25011712|NCT03100058|50104633|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
25011713|NCT03100058|50104634|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
25011714|NCT03100058|50104635|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
25011715|NCT03100058|50104636|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
25011716|NCT03100058|50104637|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
25011717|NCT03100058|50104638|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
25011718|NCT03100058|50104639|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
25011719|NCT03100058|50104640|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
25011720|NCT03100058|50104641|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
25011721|NCT03100058|50104642|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
25011722|NCT03100058|50104630|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
25011723|NCT03100058|50104631|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
25011724|NCT03100058|50104632|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
25011725|NCT03100058|50104633|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
25011726|NCT03100058|50104634|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
25011727|NCT03100058|50104635|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
25011728|NCT03100058|50104636|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
25011729|NCT03100058|50104637|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
25011730|NCT03100058|50104638|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
25011731|NCT03100058|50104639|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
25011732|NCT03100058|50104640|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
25011733|NCT03100058|50104641|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
25011734|NCT03100058|50104642|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
25011735|NCT03100058|50104630|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
25011736|NCT03100058|50104631|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
25011737|NCT03100058|50104632|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
25011738|NCT03100058|50104633|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
25011739|NCT03100058|50104634|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
25011740|NCT03100058|50104635|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
25011741|NCT03100058|50104636|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
25011742|NCT03100058|50104637|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
25011743|NCT03100058|50104638|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
25011744|NCT03100058|50104639|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
25011745|NCT03100058|50104640|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
25011746|NCT03100058|50104641|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
25011747|NCT03100058|50104642|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
25011748|NCT03100058|50104630|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
25011749|NCT03100058|50104631|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
25011750|NCT03100058|50104632|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
25011751|NCT03100058|50104633|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
25011752|NCT03100058|50104634|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
25011753|NCT03100058|50104635|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
25011754|NCT03100058|50104636|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
25011755|NCT03100058|50104637|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
25011756|NCT03100058|50104638|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
25011757|NCT03100058|50104639|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
25011758|NCT03100058|50104640|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
25011759|NCT03100058|50104641|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
25011760|NCT03100058|50104642|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
25011761|NCT03100058|50104630|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
25011762|NCT03100058|50104631|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
25011763|NCT03100058|50104632|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
25011764|NCT03100058|50104633|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
25011765|NCT03100058|50104634|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
25011766|NCT03100058|50104635|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
25011767|NCT03100058|50104636|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
25011768|NCT03100058|50104637|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
25011769|NCT03100058|50104638|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
25011770|NCT03100058|50104639|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
25011771|NCT03100058|50104640|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
25011772|NCT03100058|50104641|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
25011773|NCT03100058|50104642|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
25011774|NCT03100058|50104630|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
25011775|NCT03100058|50104631|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
25011776|NCT03100058|50104632|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
25011777|NCT03100058|50104633|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
25011778|NCT03100058|50104634|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
25011779|NCT03100058|50104635|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
25011780|NCT03100058|50104636|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
25011781|NCT03100058|50104637|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
25011782|NCT03100058|50104638|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
25011783|NCT03100058|50104639|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
25011784|NCT03100058|50104640|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
25011785|NCT03100058|50104641|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
25011786|NCT03100058|50104642|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
25011787|NCT03100058|50104630|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
25011788|NCT03100058|50104631|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
25011789|NCT03100058|50104632|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
25011790|NCT03100058|50104633|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
25011791|NCT03100058|50104634|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
25011792|NCT03100058|50104635|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
25011793|NCT03100058|50104636|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
25011794|NCT03100058|50104637|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
25011795|NCT03100058|50104638|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
25011796|NCT03100058|50104639|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
25011797|NCT03100058|50104640|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
25011798|NCT03100058|50104641|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
25011799|NCT03100058|50104642|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
25011800|NCT02871778|50104688|FG000|Part A: Treatment Period 1|Adverse Event|1|||
25011801|NCT02871778|50104689|FG001|Part A: Treatment Period 1|Adverse Event|1|||
25011802|NCT02871778|50104690|FG002|Part A: Treatment Period 1|Adverse Event|1|||
25011803|NCT02871778|50104691|FG003|Part A: Treatment Period 1|Adverse Event|0|||
25011804|NCT02871778|50104692|FG004|Part A: Treatment Period 1|Adverse Event|0|||
25011805|NCT02871778|50104693|FG005|Part A: Treatment Period 1|Adverse Event|0|||
25011806|NCT02871778|50104694|FG006|Part A: Treatment Period 1|Adverse Event|0|||
25011807|NCT02871778|50104695|FG007|Part A: Treatment Period 1|Adverse Event|0|||
25011808|NCT02871778|50104688|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
25011809|NCT02871778|50104689|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
25011810|NCT02871778|50104690|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
25011811|NCT02871778|50104691|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
25011812|NCT02871778|50104692|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
25011813|NCT02871778|50104693|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
25011814|NCT02871778|50104694|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
25011815|NCT02871778|50104695|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
25011816|NCT02871778|50104688|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
25011817|NCT02871778|50104689|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
25011818|NCT02871778|50104690|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
25011819|NCT02871778|50104691|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
25011820|NCT02871778|50104692|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
25011821|NCT02871778|50104693|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
25011822|NCT02871778|50104694|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
25011823|NCT02871778|50104695|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
25011824|NCT02871778|50104688|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
25011825|NCT02871778|50104689|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
25011826|NCT02871778|50104690|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
25011827|NCT02871778|50104691|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
25011828|NCT02871778|50104692|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
25011829|NCT02871778|50104693|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
25011830|NCT02871778|50104694|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
25011831|NCT02871778|50104695|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
25011832|NCT02871778|50104688|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
25011833|NCT02871778|50104689|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
25011834|NCT02871778|50104690|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
25011835|NCT02871778|50104691|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
25011836|NCT02871778|50104692|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
25011837|NCT02871778|50104693|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
25067371|NCT02838017|50172991|FG001|Overall Study|Lost to Follow-up|11|||
25011838|NCT02871778|50104694|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
25011839|NCT02871778|50104695|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
25011840|NCT02871778|50104688|FG000|Part A: Treatment Period 2|Adverse Event|2|||
25011841|NCT02871778|50104689|FG001|Part A: Treatment Period 2|Adverse Event|2|||
25011842|NCT02871778|50104690|FG002|Part A: Treatment Period 2|Adverse Event|0|||
25011843|NCT02871778|50104691|FG003|Part A: Treatment Period 2|Adverse Event|0|||
25011844|NCT02871778|50104692|FG004|Part A: Treatment Period 2|Adverse Event|0|||
25011845|NCT02871778|50104693|FG005|Part A: Treatment Period 2|Adverse Event|0|||
25011846|NCT02871778|50104694|FG006|Part A: Treatment Period 2|Adverse Event|0|||
25011847|NCT02871778|50104695|FG007|Part A: Treatment Period 2|Adverse Event|0|||
25011848|NCT02871778|50104688|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
25011849|NCT02871778|50104689|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
25011850|NCT02871778|50104690|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
25011851|NCT02871778|50104691|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
25011852|NCT02871778|50104692|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
25011853|NCT02871778|50104693|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
25011854|NCT02871778|50104694|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
25011855|NCT02871778|50104695|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
25011856|NCT02871778|50104688|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
25011857|NCT02871778|50104689|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
25011858|NCT02871778|50104690|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
25140785|NCT02025907|50254136|FG001|Overall Study|Physician Decision|0|||
25140786|NCT02025907|50254135|FG000|Overall Study|Lost to Follow-up|2|||
25140787|NCT02025907|50254136|FG001|Overall Study|Lost to Follow-up|2|||
25140788|NCT02025907|50254135|FG000|Overall Study|Adverse Event|3|||
25140789|NCT02025907|50254136|FG001|Overall Study|Adverse Event|1|||
25140790|NCT02025907|50254135|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
25140791|NCT02025907|50254136|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
25140792|NCT01813071|50254151|FG000|Overall Study|Protocol Violation|0|||
25140793|NCT01813071|50254152|FG001|Overall Study|Protocol Violation|0|||
25140794|NCT01813071|50254153|FG002|Overall Study|Protocol Violation|0|||
25140795|NCT01813071|50254154|FG003|Overall Study|Protocol Violation|0|||
25140796|NCT01813071|50254155|FG004|Overall Study|Protocol Violation|1|||
25140797|NCT01813071|50254156|FG005|Overall Study|Protocol Violation|4|||
25140798|NCT01813071|50254157|FG006|Overall Study|Protocol Violation|2|||
25140799|NCT01813071|50254158|FG007|Overall Study|Protocol Violation|4|||
25140800|NCT01813071|50254159|FG008|Overall Study|Protocol Violation|2|||
25140801|NCT01813071|50254151|FG000|Overall Study|Withdrawal by Subject|0|||
25140802|NCT01813071|50254152|FG001|Overall Study|Withdrawal by Subject|0|||
25140803|NCT01813071|50254153|FG002|Overall Study|Withdrawal by Subject|0|||
25140804|NCT01813071|50254154|FG003|Overall Study|Withdrawal by Subject|0|||
25140805|NCT01813071|50254155|FG004|Overall Study|Withdrawal by Subject|0|||
25140806|NCT01813071|50254156|FG005|Overall Study|Withdrawal by Subject|1|||
25140807|NCT01813071|50254157|FG006|Overall Study|Withdrawal by Subject|0|||
25140808|NCT01813071|50254158|FG007|Overall Study|Withdrawal by Subject|0|||
25140809|NCT01813071|50254159|FG008|Overall Study|Withdrawal by Subject|0|||
25140810|NCT01813071|50254151|FG000|Overall Study|Adverse Event|0|||
25140811|NCT01813071|50254152|FG001|Overall Study|Adverse Event|0|||
25140812|NCT01813071|50254153|FG002|Overall Study|Adverse Event|0|||
25140813|NCT01813071|50254154|FG003|Overall Study|Adverse Event|0|||
25140814|NCT01813071|50254155|FG004|Overall Study|Adverse Event|0|||
25140815|NCT01813071|50254156|FG005|Overall Study|Adverse Event|1|||
25140816|NCT01813071|50254157|FG006|Overall Study|Adverse Event|0|||
25140817|NCT01813071|50254158|FG007|Overall Study|Adverse Event|0|||
25140818|NCT01813071|50254159|FG008|Overall Study|Adverse Event|0|||
25140819|NCT01813071|50254151|FG000|Overall Study|Physician Decision|0|||
25140820|NCT01813071|50254152|FG001|Overall Study|Physician Decision|0|||
25140821|NCT01813071|50254153|FG002|Overall Study|Physician Decision|0|||
25140822|NCT01813071|50254154|FG003|Overall Study|Physician Decision|0|||
25140823|NCT01813071|50254155|FG004|Overall Study|Physician Decision|0|||
25140824|NCT01813071|50254156|FG005|Overall Study|Physician Decision|0|||
25140825|NCT01813071|50254157|FG006|Overall Study|Physician Decision|1|||
25140826|NCT01813071|50254158|FG007|Overall Study|Physician Decision|0|||
25011859|NCT02871778|50104691|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
25011860|NCT02871778|50104692|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
25140827|NCT01813071|50254159|FG008|Overall Study|Physician Decision|0|||
25140828|NCT01813071|50254151|FG000|Overall Study|Met inc/exc criteria|0|||
25011861|NCT02871778|50104693|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
25140829|NCT01813071|50254152|FG001|Overall Study|Met inc/exc criteria|0|||
25140830|NCT01813071|50254153|FG002|Overall Study|Met inc/exc criteria|0|||
25140831|NCT01813071|50254154|FG003|Overall Study|Met inc/exc criteria|0|||
25140832|NCT01813071|50254155|FG004|Overall Study|Met inc/exc criteria|0|||
25140833|NCT01813071|50254156|FG005|Overall Study|Met inc/exc criteria|1|||
25140834|NCT01813071|50254157|FG006|Overall Study|Met inc/exc criteria|0|||
25011862|NCT02871778|50104694|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
25011863|NCT02871778|50104695|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
25011864|NCT02871778|50104688|FG000|Part B: Treatment Period 3|Adverse Event|0|||
25011865|NCT02871778|50104689|FG001|Part B: Treatment Period 3|Adverse Event|0|||
25011866|NCT02871778|50104690|FG002|Part B: Treatment Period 3|Adverse Event|0|||
25011867|NCT02871778|50104691|FG003|Part B: Treatment Period 3|Adverse Event|0|||
25011868|NCT02871778|50104692|FG004|Part B: Treatment Period 3|Adverse Event|1|||
25011869|NCT02871778|50104693|FG005|Part B: Treatment Period 3|Adverse Event|1|||
25011870|NCT02871778|50104694|FG006|Part B: Treatment Period 3|Adverse Event|1|||
25140835|NCT01813071|50254158|FG007|Overall Study|Met inc/exc criteria|1|||
25140836|NCT01813071|50254159|FG008|Overall Study|Met inc/exc criteria|1|||
25140837|NCT02025751|50254195|FG000|Overall Study|Lost to Follow-up|1|||
25140838|NCT02025751|50254196|FG001|Overall Study|Lost to Follow-up|0|||
25140839|NCT02025751|50254195|FG000|Overall Study|Adverse Event|0|||
25140840|NCT02025751|50254196|FG001|Overall Study|Adverse Event|1|||
25140841|NCT02025751|50254195|FG000|Overall Study|Physician Decision|0|||
25140842|NCT02025751|50254196|FG001|Overall Study|Physician Decision|1|||
25140843|NCT02025751|50254195|FG000|Overall Study|Withdrawal by Subject|0|||
25140844|NCT02025751|50254196|FG001|Overall Study|Withdrawal by Subject|1|||
25140845|NCT02025205|50254204|FG000|Overall Study|Withdrawal by Subject|1|||
25140846|NCT02025205|50254205|FG001|Overall Study|Withdrawal by Subject|1|||
25140847|NCT02025205|50254204|FG000|Overall Study|Protocol Violation|2|||
25140848|NCT02025205|50254205|FG001|Overall Study|Protocol Violation|1|||
25140849|NCT02025205|50254204|FG000|Overall Study|Death|0|||
25140850|NCT02025205|50254205|FG001|Overall Study|Death|1|||
25140851|NCT01812837|50254214|FG000|Overall Study|Lost to Follow-up|1|||
25140852|NCT01812837|50254215|FG001|Overall Study|Lost to Follow-up|1|||
25179176|NCT01693562|50324393|FG007|Expansion Phase|Other|3|||
25140853|NCT01812837|50254216|FG002|Overall Study|Lost to Follow-up|0|||
25140854|NCT01812837|50254214|FG000|Overall Study|Protocol Violation|1|||
25140855|NCT01812837|50254215|FG001|Overall Study|Protocol Violation|0|||
25140856|NCT01812837|50254216|FG002|Overall Study|Protocol Violation|0|||
25140857|NCT02024971|50254224|FG000|Overall Study|Data Not Available|30|||
25140858|NCT02024971|50254224|FG000|Overall Study|Lost to Follow-up|6|||
25140859|NCT01843023|50254230|FG000|Overall Study|Death|1|||
25140860|NCT01843023|50254231|FG001|Overall Study|Death|0|||
25140861|NCT01843023|50254230|FG000|Overall Study|Lost to Follow-up|24|||
25011871|NCT02871778|50104695|FG007|Part B: Treatment Period 3|Adverse Event|0|||
25011872|NCT01471444|50104728|FG000|Overall Study|Physician Decision|3|||
25140862|NCT01843023|50254231|FG001|Overall Study|Lost to Follow-up|29|||
25140863|NCT01843023|50254230|FG000|Overall Study|Withdrawal by Subject|8|||
25140864|NCT01843023|50254231|FG001|Overall Study|Withdrawal by Subject|6|||
25140865|NCT01812759|50254240|FG000|Overall Study|Physician Decision|0|||
25140866|NCT01812759|50254241|FG001|Overall Study|Physician Decision|0|||
25140867|NCT01812759|50254242|FG002|Overall Study|Physician Decision|1|||
25140868|NCT01812057|50254252|FG000|Overall Study|Protocol Violation|1|||
25140869|NCT01812057|50254253|FG001|Overall Study|Protocol Violation|0|||
25140870|NCT01812057|50254252|FG000|Overall Study|Physician Decision|1|||
25011873|NCT01471444|50104729|FG001|Overall Study|Physician Decision|2|||
25011874|NCT01471444|50104728|FG000|Overall Study|Withdrawal by Subject|0|||
25011875|NCT01471444|50104729|FG001|Overall Study|Withdrawal by Subject|1|||
25011876|NCT03443427|50104747|FG000|Overall Study|Adverse Event|2|||
25011877|NCT03443427|50104748|FG001|Overall Study|Adverse Event|3|||
25011878|NCT03443427|50104747|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
25011879|NCT03443427|50104748|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
25011880|NCT03443427|50104747|FG000|Overall Study|Other|4|||
25011881|NCT03443427|50104748|FG001|Overall Study|Other|6|||
25011882|NCT03417219|50104756|FG000|Overall Study|Lost to Follow-up|0|||
25011883|NCT03417219|50104757|FG001|Overall Study|Lost to Follow-up|3|||
25011884|NCT02953821|50104765|FG000|Overall Study|Adverse Event|0|||
25140871|NCT01812057|50254253|FG001|Overall Study|Physician Decision|0|||
25140872|NCT01842633|50254266|FG000|Overall Study|Screen Failure|1|||
25140873|NCT01842633|50254267|FG001|Overall Study|Screen Failure|0|||
25140874|NCT01842633|50254268|FG002|Overall Study|Screen Failure|0|||
25140875|NCT01842633|50254266|FG000|Overall Study|Adverse Event|1|||
25140876|NCT01842633|50254267|FG001|Overall Study|Adverse Event|1|||
25140877|NCT01842633|50254268|FG002|Overall Study|Adverse Event|0|||
25140878|NCT01842633|50254266|FG000|Overall Study|Withdrawal by Subject|0|||
25140879|NCT01842633|50254267|FG001|Overall Study|Withdrawal by Subject|1|||
25140880|NCT01842633|50254268|FG002|Overall Study|Withdrawal by Subject|0|||
25140881|NCT01842633|50254266|FG000|Overall Study|Technical issues|1|||
25140882|NCT01842633|50254267|FG001|Overall Study|Technical issues|0|||
25140883|NCT01842633|50254268|FG002|Overall Study|Technical issues|0|||
25140884|NCT01810263|50254280|FG000|Overall Study|Lost to Follow-up|8|||
25140885|NCT01810263|50254281|FG001|Overall Study|Lost to Follow-up|7|||
25140886|NCT01841697|50254289|FG000|Overall Study|Death|0|||
25140887|NCT01841697|50254290|FG001|Overall Study|Death|1|||
25140888|NCT01841697|50254289|FG000|Overall Study|Lost to Follow-up|4|||
25140889|NCT01841697|50254290|FG001|Overall Study|Lost to Follow-up|1|||
25140890|NCT01841697|50254289|FG000|Overall Study|Withdrawal by Subject|16|||
25140891|NCT01841697|50254290|FG001|Overall Study|Withdrawal by Subject|16|||
25140892|NCT01841073|50254298|FG000|Overall Study|Adverse Event|1|||
25140893|NCT01841073|50254299|FG001|Overall Study|Adverse Event|1|||
25140894|NCT01841073|50254298|FG000|Overall Study|Physician Decision|1|||
25140895|NCT01841073|50254299|FG001|Overall Study|Physician Decision|0|||
25140896|NCT01841073|50254298|FG000|Overall Study|Lost to Follow-up|0|||
25140897|NCT01841073|50254299|FG001|Overall Study|Lost to Follow-up|2|||
25140898|NCT01809327|50254312|FG000|Overall Study|Lost to Follow-up|5|||
25011885|NCT02953821|50104766|FG001|Overall Study|Adverse Event|4|||
25011886|NCT02953821|50104765|FG000|Overall Study|Death|1|||
25011887|NCT02953821|50104766|FG001|Overall Study|Death|0|||
25011888|NCT02953821|50104765|FG000|Overall Study|Progressive Disease|5|||
25011889|NCT02953821|50104766|FG001|Overall Study|Progressive Disease|1|||
25011890|NCT02953821|50104765|FG000|Overall Study|Lost to Follow-up|2|||
25011891|NCT02953821|50104766|FG001|Overall Study|Lost to Follow-up|0|||
25011892|NCT02953821|50104765|FG000|Overall Study|Physician Decision|1|||
25011893|NCT02953821|50104766|FG001|Overall Study|Physician Decision|1|||
25011894|NCT02953821|50104765|FG000|Overall Study|Withdrawal by Subject|3|||
25011895|NCT02953821|50104766|FG001|Overall Study|Withdrawal by Subject|3|||
25011896|NCT02953821|50104765|FG000|Overall Study|Change of address|0|||
25140899|NCT01809327|50254313|FG001|Overall Study|Lost to Follow-up|2|||
25140900|NCT01809327|50254314|FG002|Overall Study|Lost to Follow-up|4|||
25011897|NCT02953821|50104766|FG001|Overall Study|Change of address|1|||
25011898|NCT02953821|50104765|FG000|Overall Study|Lack of Efficacy|1|||
25011899|NCT02953821|50104766|FG001|Overall Study|Lack of Efficacy|0|||
25011900|NCT02953821|50104765|FG000|Overall Study|Out of state for indeterminate time|0|||
25011901|NCT02953821|50104766|FG001|Overall Study|Out of state for indeterminate time|1|||
25140901|NCT01809327|50254315|FG003|Overall Study|Lost to Follow-up|2|||
25140902|NCT01809327|50254316|FG004|Overall Study|Lost to Follow-up|3|||
25140903|NCT01809327|50254312|FG000|Overall Study|Withdrawal by Subject|6|||
25140904|NCT01809327|50254313|FG001|Overall Study|Withdrawal by Subject|4|||
25140905|NCT01809327|50254314|FG002|Overall Study|Withdrawal by Subject|4|||
25140906|NCT01809327|50254315|FG003|Overall Study|Withdrawal by Subject|2|||
25140907|NCT01809327|50254316|FG004|Overall Study|Withdrawal by Subject|5|||
25140908|NCT01809327|50254312|FG000|Overall Study|Adverse Event|4|||
25140909|NCT01809327|50254313|FG001|Overall Study|Adverse Event|3|||
25140910|NCT01809327|50254314|FG002|Overall Study|Adverse Event|7|||
25011902|NCT02953821|50104765|FG000|Overall Study|No improvement|0|||
25140911|NCT01809327|50254315|FG003|Overall Study|Adverse Event|4|||
25140912|NCT01809327|50254316|FG004|Overall Study|Adverse Event|8|||
25140913|NCT01809327|50254312|FG000|Overall Study|Death|1|||
25140914|NCT01809327|50254313|FG001|Overall Study|Death|0|||
25140915|NCT01809327|50254314|FG002|Overall Study|Death|0|||
25140916|NCT01809327|50254315|FG003|Overall Study|Death|0|||
25140917|NCT01809327|50254316|FG004|Overall Study|Death|0|||
25140918|NCT01809327|50254312|FG000|Overall Study|Protocol Violation|0|||
25140919|NCT01809327|50254313|FG001|Overall Study|Protocol Violation|1|||
25011903|NCT02953821|50104766|FG001|Overall Study|No improvement|1|||
25011904|NCT02953821|50104765|FG000|Overall Study|Refused follow-up visit|2|||
25140920|NCT01809327|50254314|FG002|Overall Study|Protocol Violation|0|||
25140921|NCT01809327|50254315|FG003|Overall Study|Protocol Violation|0|||
25140922|NCT01809327|50254316|FG004|Overall Study|Protocol Violation|0|||
25140923|NCT01809327|50254312|FG000|Overall Study|Physician Decision|1|||
25140924|NCT01809327|50254313|FG001|Overall Study|Physician Decision|1|||
25140925|NCT01809327|50254314|FG002|Overall Study|Physician Decision|0|||
25140926|NCT01809327|50254315|FG003|Overall Study|Physician Decision|0|||
25140927|NCT01809327|50254316|FG004|Overall Study|Physician Decision|0|||
25140928|NCT01809327|50254312|FG000|Overall Study|Pregnancy|1|||
25140929|NCT01809327|50254313|FG001|Overall Study|Pregnancy|0|||
25011905|NCT02953821|50104766|FG001|Overall Study|Refused follow-up visit|1|||
25140930|NCT01809327|50254314|FG002|Overall Study|Pregnancy|0|||
25140931|NCT01809327|50254315|FG003|Overall Study|Pregnancy|0|||
25140932|NCT01809327|50254316|FG004|Overall Study|Pregnancy|0|||
25011906|NCT03783923|50104776|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
25140933|NCT01809327|50254312|FG000|Overall Study|Other|14|||
25140934|NCT01809327|50254313|FG001|Overall Study|Other|15|||
25011907|NCT03783923|50104777|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
25140935|NCT01809327|50254314|FG002|Overall Study|Other|7|||
25140936|NCT01809327|50254315|FG003|Overall Study|Other|4|||
25140937|NCT01809327|50254316|FG004|Overall Study|Other|9|||
25140938|NCT01808313|50254337|FG000|Overall Study|Adverse Event|5|||
25140939|NCT01808313|50254337|FG000|Overall Study|Protocol Violation|2|||
25140940|NCT01808313|50254337|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
25140941|NCT01808313|50254337|FG000|Overall Study|Lost to Follow-up|1|||
25140942|NCT01808313|50254337|FG000|Overall Study|Physician Decision|1|||
25140943|NCT01840605|50254343|FG000|Overall Study|Adverse Event|0|||
25140944|NCT01840605|50254344|FG001|Overall Study|Adverse Event|1|||
25140945|NCT01840605|50254343|FG000|Overall Study|Physician Decision|2|||
25140946|NCT01840605|50254344|FG001|Overall Study|Physician Decision|1|||
25011908|NCT03783923|50104776|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
25140947|NCT02023879|50254353|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
25140948|NCT02023879|50254354|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
25140949|NCT02023879|50254355|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
25140950|NCT02023879|50254353|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
25140951|NCT02023879|50254354|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
25140952|NCT02023879|50254355|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
25140953|NCT02023879|50254353|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
25140954|NCT02023879|50254354|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
25140955|NCT02023879|50254355|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
25140956|NCT02023879|50254353|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
25140957|NCT02023879|50254354|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
25140958|NCT02023879|50254355|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
25140959|NCT02023879|50254353|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
25140960|NCT02023879|50254354|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
25011909|NCT03783923|50104777|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
25140961|NCT02023879|50254355|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
25140962|NCT02023879|50254353|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
25011910|NCT03783923|50104776|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
25011911|NCT03783923|50104777|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
25011912|NCT03783923|50104776|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
25011913|NCT03783923|50104777|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
25011914|NCT03783923|50104776|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
25011915|NCT03783923|50104777|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
25011916|NCT03417141|50104781|FG000|Overall Study|Withdrawal by Subject|1|||
25011917|NCT03417141|50104781|FG000|Overall Study|Protocol Violation|3|||
25011918|NCT03724981|50104789|FG000|First Device|Protocol Violation|1|||
25011919|NCT03724981|50104790|FG001|First Device|Protocol Violation|1|||
25011920|NCT03442569|50104798|FG000|Overall Study|Subject was ineligible after enrollment|1|||
25011921|NCT01347879|50104804|FG000|Overall Study|Adverse Event|0|||
25140963|NCT02023879|50254354|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
25011922|NCT01347879|50104805|FG001|Overall Study|Adverse Event|12|||
25011923|NCT01347879|50104804|FG000|Overall Study|Lost to Follow-up|2|||
25011924|NCT01347879|50104805|FG001|Overall Study|Lost to Follow-up|0|||
25011925|NCT01347879|50104804|FG000|Overall Study|Withdrawal by Subject|3|||
25011926|NCT01347879|50104805|FG001|Overall Study|Withdrawal by Subject|2|||
25011927|NCT01347879|50104804|FG000|Overall Study|Other|2|||
25011928|NCT01347879|50104805|FG001|Overall Study|Other|3|||
25011929|NCT03441789|50104822|FG000|Overall Study|Withdrawal by Subject|1|||
25011930|NCT03441789|50104823|FG001|Overall Study|Withdrawal by Subject|1|||
25011931|NCT03441789|50104822|FG000|Overall Study|Adverse Event|0|||
25011932|NCT03441789|50104823|FG001|Overall Study|Adverse Event|1|||
25011933|NCT03441789|50104822|FG000|Overall Study|Protocol Violation|0|||
25011934|NCT03441789|50104823|FG001|Overall Study|Protocol Violation|1|||
25011935|NCT03441789|50104822|FG000|Overall Study|Lost to Follow-up|0|||
25011936|NCT03441789|50104823|FG001|Overall Study|Lost to Follow-up|1|||
25011937|NCT03387735|50104835|FG000|Overall Study|Lost to Follow-up|4|||
25011938|NCT03387735|50104836|FG001|Overall Study|Lost to Follow-up|8|||
25011939|NCT03387735|50104835|FG000|Overall Study|Death|4|||
25011940|NCT03387735|50104836|FG001|Overall Study|Death|8|||
25011941|NCT03439137|50104844|FG000|Overall Study|Adverse Event|16|||
25011942|NCT03439137|50104845|FG001|Overall Study|Adverse Event|12|||
25011943|NCT03439137|50104844|FG000|Overall Study|Physician Decision|0|||
25011944|NCT03439137|50104845|FG001|Overall Study|Physician Decision|5|||
25011945|NCT03439137|50104844|FG000|Overall Study|Withdrawal by Subject|14|||
25011946|NCT03439137|50104845|FG001|Overall Study|Withdrawal by Subject|4|||
25011947|NCT03439137|50104844|FG000|Overall Study|Conducting rescue therapy|2|||
25011948|NCT03439137|50104845|FG001|Overall Study|Conducting rescue therapy|1|||
25011949|NCT03439137|50104844|FG000|Overall Study|Difficult to control Hb|10|||
25011950|NCT03439137|50104845|FG001|Overall Study|Difficult to control Hb|2|||
25011951|NCT03439137|50104844|FG000|Overall Study|Initiation of a renal transplant|0|||
25011952|NCT03439137|50104845|FG001|Overall Study|Initiation of a renal transplant|2|||
25011953|NCT04055090|50104853|FG000|Overall Study|screen failure|1|||
25011954|NCT04055090|50104854|FG001|Overall Study|screen failure|0|||
25011955|NCT04055090|50104853|FG000|Overall Study|Withdrawal by Subject|1|||
25011956|NCT04055090|50104854|FG001|Overall Study|Withdrawal by Subject|0|||
25011957|NCT03403413|50104877|FG000|Overall Study|Lack of Efficacy|2|||
25011958|NCT03354663|50104892|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
25011959|NCT03354663|50104892|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
25011960|NCT03354663|50104892|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
25011961|NCT03354663|50104892|FG000|Completed 30-day Visit|Missed Visit|1|||
25011962|NCT03721705|50104902|FG000|Overall Study|Adverse Event|2|||
25011963|NCT03721705|50104903|FG001|Overall Study|Adverse Event|0|||
25011964|NCT03721705|50104902|FG000|Overall Study|Withdrawal by Subject|4|||
25011965|NCT03721705|50104903|FG001|Overall Study|Withdrawal by Subject|10|||
25011966|NCT03721705|50104902|FG000|Overall Study|No Suitable Study Partner|1|||
25011967|NCT03721705|50104903|FG001|Overall Study|No Suitable Study Partner|0|||
25140964|NCT02023879|50254355|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
25140965|NCT02023879|50254353|FG000|Extension Open Label Treatment|Adverse Event|1|||
25140966|NCT02023879|50254354|FG001|Extension Open Label Treatment|Adverse Event|7|||
25140967|NCT02023879|50254355|FG002|Extension Open Label Treatment|Adverse Event|3|||
25140968|NCT02023879|50254353|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
25140969|NCT02023879|50254354|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
25140970|NCT02023879|50254355|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
25140971|NCT02023879|50254353|FG000|Extension Open Label Treatment|Participant moved|1|||
25140972|NCT02023879|50254354|FG001|Extension Open Label Treatment|Participant moved|2|||
25140973|NCT02023879|50254355|FG002|Extension Open Label Treatment|Participant moved|0|||
25140974|NCT02023879|50254353|FG000|Extension Open Label Treatment|Other than specified above|2|||
25140975|NCT02023879|50254354|FG001|Extension Open Label Treatment|Other than specified above|7|||
25140976|NCT02023879|50254355|FG002|Extension Open Label Treatment|Other than specified above|2|||
25140977|NCT02014441|50254370|FG000|Overall Study|Withdrawal by Subject|12|||
25140978|NCT02013817|50254376|FG000|Overall Study|Adverse Event|12|||
25140979|NCT02013817|50254376|FG000|Overall Study|Withdrawal by Subject|4|||
25140980|NCT02013817|50254376|FG000|Overall Study|Death|2|||
25140981|NCT02013817|50254376|FG000|Overall Study|Other|9|||
25140982|NCT01994863|50254380|FG000|Period 1|Adverse Event|4|||
25140983|NCT01994863|50254381|FG001|Period 1|Adverse Event|0|||
25140984|NCT01994863|50254380|FG000|Period 1|Withdrawal by Subject|1|||
25140985|NCT01994863|50254381|FG001|Period 1|Withdrawal by Subject|0|||
25140986|NCT01994863|50254380|FG000|Period 1|Trial stopped by sponsor|1|||
25140987|NCT01994863|50254381|FG001|Period 1|Trial stopped by sponsor|3|||
25140988|NCT01994863|50254380|FG000|Period 1|Lack of Efficacy|1|||
25140989|NCT01994863|50254381|FG001|Period 1|Lack of Efficacy|0|||
25140990|NCT01994863|50254380|FG000|Period 2|Adverse Event|0|||
25140991|NCT01994863|50254381|FG001|Period 2|Adverse Event|1|||
25140992|NCT01994863|50254380|FG000|Period 2|Lack of Efficacy|0|||
25140993|NCT01994863|50254381|FG001|Period 2|Lack of Efficacy|2|||
25140994|NCT01994863|50254380|FG000|Period 2|Withdrawal by Subject|1|||
25140995|NCT01994863|50254381|FG001|Period 2|Withdrawal by Subject|1|||
25140996|NCT02023099|50254390|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
25140997|NCT02023099|50254391|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
25140998|NCT02023099|50254392|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
25140999|NCT02023099|50254390|FG000|Overall Study|Withdrawn Consent|3|||
25141000|NCT02023099|50254391|FG001|Overall Study|Withdrawn Consent|0|||
25141001|NCT02023099|50254392|FG002|Overall Study|Withdrawn Consent|1|||
25141002|NCT02023099|50254390|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
25141003|NCT02023099|50254391|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
25141004|NCT02023099|50254392|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
25141005|NCT02013037|50254400|FG000|Overall Study|Death|6|||
25141006|NCT02013037|50254400|FG000|Overall Study|Withdrawal by Subject|1|||
25141007|NCT02013037|50254400|FG000|Overall Study|Awaiting Transplantation|7|||
25141008|NCT02013037|50254400|FG000|Overall Study|Transplanted without DSA|2|||
25141009|NCT01967719|50254407|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
25141010|NCT01967719|50254408|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
25141011|NCT01967719|50254409|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
25141012|NCT01967719|50254410|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
25141013|NCT01967719|50254407|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
25141014|NCT01967719|50254408|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
25141015|NCT01967719|50254409|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
25141016|NCT01967719|50254410|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
25141017|NCT01967173|50254428|FG000|Overall Study|Lost to Follow-up|5|||
25141018|NCT01967173|50254429|FG001|Overall Study|Lost to Follow-up|3|||
25141019|NCT01967173|50254430|FG002|Overall Study|Lost to Follow-up|2|||
25141020|NCT01967173|50254431|FG003|Overall Study|Lost to Follow-up|4|||
25141021|NCT01967173|50254432|FG004|Overall Study|Lost to Follow-up|8|||
25141022|NCT01967173|50254433|FG005|Overall Study|Lost to Follow-up|12|||
25141023|NCT01967173|50254434|FG006|Overall Study|Lost to Follow-up|6|||
25141024|NCT01967173|50254435|FG007|Overall Study|Lost to Follow-up|8|||
25141025|NCT01967173|50254428|FG000|Overall Study|Physician Decision|2|||
25141026|NCT01967173|50254429|FG001|Overall Study|Physician Decision|0|||
25141027|NCT01967173|50254430|FG002|Overall Study|Physician Decision|2|||
25141028|NCT01967173|50254431|FG003|Overall Study|Physician Decision|1|||
25141029|NCT01967173|50254432|FG004|Overall Study|Physician Decision|1|||
25141030|NCT01967173|50254433|FG005|Overall Study|Physician Decision|1|||
25141031|NCT01967173|50254434|FG006|Overall Study|Physician Decision|1|||
25141032|NCT01967173|50254435|FG007|Overall Study|Physician Decision|0|||
25141033|NCT01967173|50254428|FG000|Overall Study|Lack of Efficacy|2|||
25141034|NCT01967173|50254429|FG001|Overall Study|Lack of Efficacy|0|||
25141035|NCT01967173|50254430|FG002|Overall Study|Lack of Efficacy|2|||
25141036|NCT01967173|50254431|FG003|Overall Study|Lack of Efficacy|2|||
25141037|NCT01967173|50254432|FG004|Overall Study|Lack of Efficacy|0|||
25141038|NCT01967173|50254433|FG005|Overall Study|Lack of Efficacy|1|||
25011968|NCT03721705|50104902|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
25011969|NCT03721705|50104903|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
25011970|NCT03721705|50104902|FG000|Overall Study|Death|0|||
25011971|NCT03721705|50104903|FG001|Overall Study|Death|1|||
25011972|NCT03720847|50104909|FG000|Washout|Physician Decision|1|||
25011973|NCT03720847|50104910|FG001|Washout|Physician Decision|2|||
25011974|NCT02631070|50104919|FG000|Overall Study|Withdrawal by Subject|35|||
25011975|NCT02631070|50104920|FG001|Overall Study|Withdrawal by Subject|13|||
25011976|NCT02631070|50104919|FG000|Overall Study|Death|45|||
25011977|NCT02631070|50104920|FG001|Overall Study|Death|24|||
25011978|NCT02631070|50104919|FG000|Overall Study|Lost to Follow-up|5|||
25011979|NCT02631070|50104920|FG001|Overall Study|Lost to Follow-up|1|||
25011980|NCT02631070|50104919|FG000|Overall Study|Transition to rollover protocol|52|||
25011981|NCT02631070|50104920|FG001|Overall Study|Transition to rollover protocol|21|||
25011982|NCT02631070|50104919|FG000|Overall Study|Other reasons|12|||
25141039|NCT01967173|50254434|FG006|Overall Study|Lack of Efficacy|0|||
25141040|NCT01967173|50254435|FG007|Overall Study|Lack of Efficacy|2|||
25141041|NCT01967173|50254428|FG000|Overall Study|Pregnancy|0|||
25011983|NCT02631070|50104920|FG001|Overall Study|Other reasons|5|||
25011984|NCT00741988|50104928|FG000|Overall Study|Adverse Event|2|||
25141042|NCT01967173|50254429|FG001|Overall Study|Pregnancy|0|||
25141043|NCT01967173|50254430|FG002|Overall Study|Pregnancy|0|||
25011985|NCT00741988|50104929|FG001|Overall Study|Adverse Event|4|||
25011986|NCT00741988|50104928|FG000|Overall Study|Lack of Efficacy|2|||
25011987|NCT00741988|50104929|FG001|Overall Study|Lack of Efficacy|0|||
25011988|NCT03354429|50104937|FG000|Overall Study|Withdrawal by Subject|8|||
25011989|NCT03354429|50104938|FG001|Overall Study|Withdrawal by Subject|7|||
25011990|NCT03354429|50104937|FG000|Overall Study|Lost to Follow-up|1|||
25011991|NCT03354429|50104938|FG001|Overall Study|Lost to Follow-up|0|||
25011992|NCT03352713|50104944|FG000|Overall Study|Lost to Follow-up|8|||
25011993|NCT03352713|50104944|FG000|Overall Study|Withdrawn by investigator|5|||
25011994|NCT03352713|50104944|FG000|Overall Study|Completed 0 EMAs|8|||
25011995|NCT03352713|50104944|FG000|Overall Study|Device incompatible/stolen|5|||
25011996|NCT03901144|50104948|FG000|Overall Study|Lost to Follow-up|1|||
25011997|NCT03901144|50104949|FG001|Overall Study|Lost to Follow-up|1|||
25011998|NCT03901144|50104950|FG002|Overall Study|Lost to Follow-up|1|||
25011999|NCT03901144|50104951|FG003|Overall Study|Lost to Follow-up|1|||
25012000|NCT02952261|50104963|FG000|Overall Study|Withdrawal by Subject|4|||
25012001|NCT02952261|50104964|FG001|Overall Study|Withdrawal by Subject|5|||
25012002|NCT02952261|50104963|FG000|Overall Study|Protocol Violation|1|||
25012003|NCT02952261|50104964|FG001|Overall Study|Protocol Violation|0|||
25012004|NCT03384693|50104970|FG000|Overall Study|Adverse Event|3|||
25012005|NCT03718429|50104982|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
25012006|NCT03718429|50104983|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
25141044|NCT01967173|50254431|FG003|Overall Study|Pregnancy|0|||
25141045|NCT01967173|50254432|FG004|Overall Study|Pregnancy|0|||
25141046|NCT01967173|50254433|FG005|Overall Study|Pregnancy|0|||
25141047|NCT01967173|50254434|FG006|Overall Study|Pregnancy|1|||
25141048|NCT01967173|50254435|FG007|Overall Study|Pregnancy|1|||
25141049|NCT01967173|50254428|FG000|Overall Study|Adverse Event|0|||
25141050|NCT01967173|50254429|FG001|Overall Study|Adverse Event|0|||
25141051|NCT01967173|50254430|FG002|Overall Study|Adverse Event|0|||
25141052|NCT01967173|50254431|FG003|Overall Study|Adverse Event|0|||
25141053|NCT01967173|50254432|FG004|Overall Study|Adverse Event|0|||
25141054|NCT01967173|50254433|FG005|Overall Study|Adverse Event|0|||
25141055|NCT01967173|50254434|FG006|Overall Study|Adverse Event|0|||
25141056|NCT01967173|50254435|FG007|Overall Study|Adverse Event|1|||
25141057|NCT01967173|50254428|FG000|Overall Study|Withdrawal by Subject|15|||
25141058|NCT01967173|50254429|FG001|Overall Study|Withdrawal by Subject|14|||
25141059|NCT01967173|50254430|FG002|Overall Study|Withdrawal by Subject|10|||
25141060|NCT01967173|50254431|FG003|Overall Study|Withdrawal by Subject|7|||
25141061|NCT01967173|50254432|FG004|Overall Study|Withdrawal by Subject|8|||
25141062|NCT01967173|50254433|FG005|Overall Study|Withdrawal by Subject|9|||
25012007|NCT03718429|50104984|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
25012008|NCT03718429|50104985|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
25141063|NCT01967173|50254434|FG006|Overall Study|Withdrawal by Subject|10|||
25141064|NCT01967173|50254435|FG007|Overall Study|Withdrawal by Subject|12|||
25179177|NCT01693562|50324394|FG008|Expansion Phase|Other|1|||
25012009|NCT01285102|50105005|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
25012010|NCT03382899|50105039|FG000|Overall Study|Ineligibility Determined|0|||
25012011|NCT03382899|50105040|FG001|Overall Study|Ineligibility Determined|1|||
25012012|NCT03382899|50105039|FG000|Overall Study|Lost to Follow-up|0|||
25012013|NCT03382899|50105040|FG001|Overall Study|Lost to Follow-up|1|||
25012014|NCT03382899|50105039|FG000|Overall Study|Sponsor's decision|31|||
25012015|NCT03382899|50105040|FG001|Overall Study|Sponsor's decision|28|||
25141065|NCT01994629|50254449|FG000|Overall Study|Withdrawal by Subject|1|||
25141066|NCT01994629|50254450|FG001|Overall Study|Withdrawal by Subject|0|||
25141067|NCT01994629|50254449|FG000|Overall Study|Lost to Follow-up|0|||
25012016|NCT03382899|50105039|FG000|Overall Study|Withdrawal by Subject|0|||
25012017|NCT03382899|50105040|FG001|Overall Study|Withdrawal by Subject|5|||
25012018|NCT00709852|50105046|FG000|Period 1|Adverse Event|2|||
25012019|NCT00709852|50105047|FG001|Period 1|Adverse Event|0|||
25012020|NCT00709852|50105046|FG000|Period 1|Withdrawal by Subject|4|||
25012021|NCT00709852|50105047|FG001|Period 1|Withdrawal by Subject|2|||
25012022|NCT00709852|50105046|FG000|Period 1|Protocol Violation|1|||
25012023|NCT00709852|50105047|FG001|Period 1|Protocol Violation|0|||
25012024|NCT00709852|50105046|FG000|Period 1|Defective scanner|0|||
25012025|NCT00709852|50105047|FG001|Period 1|Defective scanner|1|||
25012026|NCT00709852|50105046|FG000|Period 1|Lost to Follow-up|1|||
25012027|NCT00709852|50105047|FG001|Period 1|Lost to Follow-up|0|||
25012028|NCT00709852|50105046|FG000|Period 2|Protocol Violation|4|||
25012029|NCT00709852|50105047|FG001|Period 2|Protocol Violation|1|||
25012030|NCT00709852|50105046|FG000|Period 2|Adverse Event|1|||
25012031|NCT00709852|50105047|FG001|Period 2|Adverse Event|1|||
25012032|NCT00709852|50105046|FG000|Period 2|Lost to Follow-up|1|||
25012033|NCT00709852|50105047|FG001|Period 2|Lost to Follow-up|0|||
25012034|NCT00709852|50105046|FG000|Period 2|No 72-hour follow-up|3|||
25012035|NCT00709852|50105047|FG001|Period 2|No 72-hour follow-up|0|||
25012036|NCT03382041|50105064|FG000|Overall Study|Consent Form Lost|2|||
25012037|NCT03382041|50105065|FG001|Overall Study|Consent Form Lost|1|||
25012038|NCT03382041|50105064|FG000|Overall Study|Withdrawal by Subject|1|||
25012039|NCT03382041|50105065|FG001|Overall Study|Withdrawal by Subject|4|||
25012040|NCT03382041|50105064|FG000|Overall Study|Lost to Follow-up|1|||
25012041|NCT03382041|50105065|FG001|Overall Study|Lost to Follow-up|4|||
25012042|NCT03351231|50105071|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
25012043|NCT03351231|50105071|FG000|Combination Therapy Period|Disease progression|2|||
25012044|NCT03351231|50105071|FG000|Combination Therapy Period|Study drug toxicity|1|||
25012045|NCT03351231|50105071|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
25012046|NCT03351231|50105071|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
25012047|NCT03351231|50105071|FG000|Safety Follow-Up Period|Other reason|2|||
25012048|NCT03381339|50105077|FG000|Overall Study|Protocol Violation|4|||
25012049|NCT03381339|50105078|FG001|Overall Study|Protocol Violation|3|||
25012050|NCT03381339|50105077|FG000|Overall Study|Lost to Follow-up|0|||
25012051|NCT03381339|50105078|FG001|Overall Study|Lost to Follow-up|1|||
25012052|NCT03401229|50105086|FG000|Overall Study|Lost to Follow-up|2|||
25012053|NCT03401229|50105087|FG001|Overall Study|Lost to Follow-up|1|||
25012054|NCT03401229|50105086|FG000|Overall Study|Other|1|||
25012055|NCT03401229|50105087|FG001|Overall Study|Other|3|||
25012056|NCT03401229|50105086|FG000|Overall Study|Adverse Event|8|||
25012057|NCT03401229|50105087|FG001|Overall Study|Adverse Event|6|||
25012058|NCT03401229|50105086|FG000|Overall Study|Withdrawal by Subject|29|||
25012059|NCT03401229|50105087|FG001|Overall Study|Withdrawal by Subject|26|||
25012060|NCT03401229|50105086|FG000|Overall Study|COVID-19|0|||
25012061|NCT03401229|50105087|FG001|Overall Study|COVID-19|1|||
25012062|NCT03349515|50105095|FG000|Overall Study|Lack of Efficacy|2|||
25012063|NCT03349515|50105096|FG001|Overall Study|Lack of Efficacy|0|||
25012064|NCT03349515|50105095|FG000|Overall Study|Physician Decision|3|||
25012065|NCT03349515|50105096|FG001|Overall Study|Physician Decision|1|||
25012066|NCT03349437|50105102|FG000|Screening|Screen Fail|4|||
25012067|NCT03349437|50105103|FG001|Screening|Screen Fail|0|||
25012068|NCT03349437|50105104|FG002|Screening|Screen Fail|0|||
25012069|NCT03349437|50105102|FG000|Screening|Withdrawn|1|||
25012070|NCT03349437|50105103|FG001|Screening|Withdrawn|0|||
25012071|NCT03349437|50105104|FG002|Screening|Withdrawn|0|||
25012072|NCT03380091|50105113|FG000|Overall Study|Withdrawal by Subject|2|||
25012073|NCT03380091|50105114|FG001|Overall Study|Withdrawal by Subject|1|||
25012074|NCT03379233|50105124|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
25012075|NCT03379233|50105125|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
25012076|NCT01377922|50105133|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
25012077|NCT01377922|50105134|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
25012078|NCT03372603|50105140|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
25012079|NCT03372603|50105141|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
25012080|NCT03372603|50105140|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
25012081|NCT03372603|50105141|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
25012082|NCT01377844|50105149|FG000|Overall Study|Withdrawal by Subject|25|||
25012083|NCT01377844|50105150|FG001|Overall Study|Withdrawal by Subject|28|||
25012084|NCT01377844|50105149|FG000|Overall Study|Protocol Violation|2|||
25012085|NCT01377844|50105150|FG001|Overall Study|Protocol Violation|3|||
25012086|NCT01377844|50105149|FG000|Overall Study|Adverse Event|3|||
25012087|NCT01377844|50105150|FG001|Overall Study|Adverse Event|0|||
25012088|NCT01377844|50105149|FG000|Overall Study|Physician Decision|6|||
25012089|NCT01377844|50105150|FG001|Overall Study|Physician Decision|3|||
25012090|NCT01377844|50105149|FG000|Overall Study|Study terminated by Sponsor|0|||
25274360|NCT01078623|50588461|FG006|Treatment Period 2|Adverse Event|1|||
25274361|NCT01078623|50588462|FG007|Treatment Period 2|Adverse Event|0|||
25274362|NCT01078623|50588463|FG008|Treatment Period 2|Adverse Event|0|||
25274363|NCT01078623|50588464|FG009|Treatment Period 2|Adverse Event|0|||
25274364|NCT01078623|50588465|FG010|Treatment Period 2|Adverse Event|0|||
25012091|NCT01377844|50105150|FG001|Overall Study|Study terminated by Sponsor|1|||
25012092|NCT03372369|50105159|FG000|Qualification Period|Withdrawal by Subject|16|||
25012093|NCT03372369|50105160|FG001|Qualification Period|Withdrawal by Subject|13|||
25141068|NCT01994629|50254450|FG001|Overall Study|Lost to Follow-up|3|||
25012094|NCT03372369|50105159|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
25012095|NCT03372369|50105160|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
25012096|NCT03372369|50105159|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
25012097|NCT03372369|50105160|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
25012098|NCT03371355|50105170|FG000|Overall Study|Investigator judgment|0|||
25012099|NCT03371355|50105171|FG001|Overall Study|Investigator judgment|0|||
25012100|NCT03371355|50105172|FG002|Overall Study|Investigator judgment|1|||
25012101|NCT03371355|50105173|FG003|Overall Study|Investigator judgment|1|||
25012102|NCT03371355|50105170|FG000|Overall Study|Voluntary withdrawal|1|||
25012103|NCT03371355|50105171|FG001|Overall Study|Voluntary withdrawal|0|||
25012104|NCT03371355|50105172|FG002|Overall Study|Voluntary withdrawal|1|||
25012105|NCT03371355|50105173|FG003|Overall Study|Voluntary withdrawal|2|||
25012106|NCT03371355|50105170|FG000|Overall Study|Adverse Event|0|||
25012107|NCT03371355|50105171|FG001|Overall Study|Adverse Event|1|||
25012108|NCT03371355|50105172|FG002|Overall Study|Adverse Event|2|||
25012109|NCT03371355|50105173|FG003|Overall Study|Adverse Event|3|||
25012110|NCT03371355|50105170|FG000|Overall Study|Reason not Specified|0|||
25012111|NCT03371355|50105171|FG001|Overall Study|Reason not Specified|1|||
25012112|NCT03371355|50105172|FG002|Overall Study|Reason not Specified|0|||
25012113|NCT03371355|50105173|FG003|Overall Study|Reason not Specified|1|||
25012114|NCT03370419|50105187|FG000|Overall Study|Lost to Follow-up|16|||
25012115|NCT03369951|50105195|FG000|Overall Study|Withdrawal by Subject|3|||
25012116|NCT03369951|50105195|FG000|Overall Study|Death|1|||
25012117|NCT03369951|50105195|FG000|Overall Study|Lost to Follow-up|1|||
25012118|NCT03369951|50105195|FG000|Overall Study|Protocol Violation|1|||
25012119|NCT04040192|50105199|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
25012120|NCT04040192|50105200|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
25012121|NCT04040192|50105201|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
25012122|NCT04040192|50105199|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
25012123|NCT04040192|50105200|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
25012124|NCT04040192|50105201|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
25012125|NCT04040192|50105199|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
25012126|NCT04040192|50105200|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
25012127|NCT04040192|50105201|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
25012128|NCT04040192|50105199|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
25012129|NCT04040192|50105200|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
25012130|NCT04040192|50105201|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
25012131|NCT04040192|50105199|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
25012132|NCT04040192|50105200|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
25012133|NCT04040192|50105201|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
25012134|NCT04040192|50105199|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
25012135|NCT04040192|50105200|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
25012136|NCT04040192|50105201|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
25012137|NCT04040192|50105199|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
25012138|NCT04040192|50105200|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
25012139|NCT04040192|50105201|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
25012140|NCT04040192|50105199|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
25012141|NCT04040192|50105200|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
25012142|NCT04040192|50105201|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
25012143|NCT04040192|50105199|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
25012144|NCT04040192|50105200|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
25012145|NCT04040192|50105201|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
25012146|NCT04040192|50105199|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
25012147|NCT04040192|50105200|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
25012148|NCT04040192|50105201|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
25012149|NCT04040192|50105199|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
25012150|NCT04040192|50105200|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
25012151|NCT04040192|50105201|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
25012152|NCT04040192|50105199|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
25012153|NCT04040192|50105200|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
25012154|NCT04040192|50105201|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
25012155|NCT04040192|50105199|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
25179178|NCT01693562|50324395|FG009|Expansion Phase|Other|28|||
25012156|NCT04040192|50105200|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
25012157|NCT04040192|50105201|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
25012158|NCT04040192|50105199|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
25012159|NCT04040192|50105200|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
25012160|NCT04040192|50105201|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
25012161|NCT04040192|50105199|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
25012162|NCT04040192|50105200|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
25012163|NCT04040192|50105201|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
25012164|NCT04040192|50105199|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
25012165|NCT04040192|50105200|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
25012166|NCT04040192|50105201|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
25012167|NCT04040192|50105199|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
25012168|NCT04040192|50105200|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
25012169|NCT04040192|50105201|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
25012170|NCT03368859|50105225|FG000|Overall Study|Withdrew Consent|5|||
25141069|NCT01994395|50254458|FG000|Overall Study|Withdrawal by Subject|1|||
25141070|NCT01994395|50254459|FG001|Overall Study|Withdrawal by Subject|2|||
25141071|NCT01992536|50254475|FG000|Overall Study|Administrative Reason|0|||
25274365|NCT01078623|50588466|FG011|Treatment Period 2|Adverse Event|0|||
25274366|NCT01078623|50588467|FG012|Treatment Period 2|Adverse Event|0|||
25274367|NCT01078623|50588468|FG013|Treatment Period 2|Adverse Event|0|||
25274368|NCT01078623|50588469|FG014|Treatment Period 2|Adverse Event|0|||
25274369|NCT01078623|50588470|FG015|Treatment Period 2|Adverse Event|0|||
25274370|NCT01078623|50588471|FG016|Treatment Period 2|Adverse Event|0|||
25274371|NCT01078623|50588472|FG017|Treatment Period 2|Adverse Event|0|||
25274372|NCT01078623|50588473|FG018|Treatment Period 2|Adverse Event|1|||
25274373|NCT01078623|50588474|FG019|Treatment Period 2|Adverse Event|0|||
25274374|NCT01078623|50588455|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25274375|NCT01078623|50588456|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25274376|NCT01078623|50588457|FG002|Treatment Period 2|Withdrawal by Subject|0|||
25274377|NCT01078623|50588458|FG003|Treatment Period 2|Withdrawal by Subject|0|||
25274378|NCT01078623|50588459|FG004|Treatment Period 2|Withdrawal by Subject|0|||
25141072|NCT01992536|50254476|FG001|Overall Study|Administrative Reason|0|||
25141073|NCT01992536|50254477|FG002|Overall Study|Administrative Reason|0|||
25141074|NCT01992536|50254478|FG003|Overall Study|Administrative Reason|0|||
25141075|NCT01992536|50254479|FG004|Overall Study|Administrative Reason|0|||
25141076|NCT01992536|50254480|FG005|Overall Study|Administrative Reason|0|||
25141077|NCT01992536|50254481|FG006|Overall Study|Administrative Reason|7|||
25141078|NCT01992536|50254482|FG007|Overall Study|Administrative Reason|0|||
25141079|NCT01992536|50254483|FG008|Overall Study|Administrative Reason|0|||
25141080|NCT01992536|50254484|FG009|Overall Study|Administrative Reason|0|||
25141081|NCT01992536|50254475|FG000|Overall Study|Lost to Follow-up|4|||
25141082|NCT01992536|50254476|FG001|Overall Study|Lost to Follow-up|2|||
25141083|NCT01992536|50254477|FG002|Overall Study|Lost to Follow-up|1|||
25141084|NCT01992536|50254478|FG003|Overall Study|Lost to Follow-up|0|||
25274379|NCT01078623|50588460|FG005|Treatment Period 2|Withdrawal by Subject|1|||
25141085|NCT01992536|50254479|FG004|Overall Study|Lost to Follow-up|0|||
25141086|NCT01992536|50254480|FG005|Overall Study|Lost to Follow-up|1|||
25274380|NCT01078623|50588461|FG006|Treatment Period 2|Withdrawal by Subject|0|||
25274381|NCT01078623|50588462|FG007|Treatment Period 2|Withdrawal by Subject|0|||
25141087|NCT01992536|50254481|FG006|Overall Study|Lost to Follow-up|0|||
25141088|NCT01992536|50254482|FG007|Overall Study|Lost to Follow-up|0|||
25141089|NCT01992536|50254483|FG008|Overall Study|Lost to Follow-up|1|||
25012171|NCT03368859|50105226|FG001|Overall Study|Withdrew Consent|4|||
25012172|NCT03368859|50105225|FG000|Overall Study|Death|12|||
25012173|NCT03368859|50105226|FG001|Overall Study|Death|6|||
25012174|NCT03368859|50105225|FG000|Overall Study|Study terminated by Sponsor|18|||
25012175|NCT03368859|50105226|FG001|Overall Study|Study terminated by Sponsor|23|||
25012176|NCT03368859|50105225|FG000|Overall Study|Other|1|||
25012177|NCT03368859|50105226|FG001|Overall Study|Other|1|||
25012178|NCT03096314|50105240|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
25012179|NCT03096314|50105241|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
25012180|NCT03335163|50105247|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
25012181|NCT03335163|50105247|FG000|Overall Study|Withdrawal by Subject|18|||
25012182|NCT03364335|50105273|FG000|Overall Study|Adverse Event|3|||
25012183|NCT03364335|50105274|FG001|Overall Study|Adverse Event|4|||
25012184|NCT03364335|50105275|FG002|Overall Study|Adverse Event|1|||
25012185|NCT03364335|50105276|FG003|Overall Study|Adverse Event|2|||
25012186|NCT03364335|50105277|FG004|Overall Study|Adverse Event|0|||
25012187|NCT03364335|50105273|FG000|Overall Study|Lost to Follow-up|7|||
25012188|NCT03364335|50105274|FG001|Overall Study|Lost to Follow-up|7|||
25012189|NCT03364335|50105275|FG002|Overall Study|Lost to Follow-up|10|||
25012190|NCT03364335|50105276|FG003|Overall Study|Lost to Follow-up|11|||
25012191|NCT03364335|50105277|FG004|Overall Study|Lost to Follow-up|11|||
25012192|NCT03334695|50105300|FG000|Overall Study|Lost to Follow-up|3|||
25012193|NCT03334695|50105301|FG001|Overall Study|Lost to Follow-up|3|||
25012194|NCT03334695|50105300|FG000|Overall Study|Physician Decision|1|||
25012195|NCT03334695|50105301|FG001|Overall Study|Physician Decision|2|||
25012196|NCT03334695|50105300|FG000|Overall Study|Protocol Violation|0|||
25012197|NCT03334695|50105301|FG001|Overall Study|Protocol Violation|1|||
25012198|NCT03364023|50105309|FG000|Overall Study|Lost to Follow-up|3|||
25012199|NCT03364023|50105309|FG000|Overall Study|Death|14|||
25012200|NCT03764813|50105333|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
25012201|NCT03764813|50105334|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
25012202|NCT03764813|50105335|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
25012203|NCT03764813|50105336|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
25012204|NCT03363321|50105357|FG000|Overall Study|Withdrawal by Subject|0|||
25012205|NCT03363321|50105358|FG001|Overall Study|Withdrawal by Subject|1|||
25012206|NCT03363321|50105359|FG002|Overall Study|Withdrawal by Subject|0|||
25012207|NCT03363321|50105360|FG003|Overall Study|Withdrawal by Subject|1|||
25012208|NCT03363321|50105361|FG004|Overall Study|Withdrawal by Subject|0|||
25012209|NCT03361605|50105374|FG000|Overall Study|Analyzable data not available|3|||
25012210|NCT03829046|50105380|FG000|Overall Study|Withdrawal by Subject|1|||
25012211|NCT03829046|50105381|FG001|Overall Study|Withdrawal by Subject|0|||
25012212|NCT03361293|50105389|FG000|Overall Study|Lost to Follow-up|0|||
25012213|NCT03361293|50105390|FG001|Overall Study|Lost to Follow-up|2|||
25012214|NCT03361293|50105389|FG000|Overall Study|Withdrawal by Subject|1|||
25012215|NCT03361293|50105390|FG001|Overall Study|Withdrawal by Subject|3|||
25012216|NCT03361137|50105401|FG000|Overall Study|Reason not specified|1|||
25012217|NCT03361137|50105402|FG001|Overall Study|Reason not specified|0|||
25012218|NCT03361137|50105403|FG002|Overall Study|Reason not specified|0|||
25012219|NCT03361137|50105404|FG003|Overall Study|Reason not specified|0|||
25012220|NCT03361137|50105405|FG004|Overall Study|Reason not specified|0|||
25012221|NCT03360747|50105419|FG000|Overall Study|Voluntary Withdrawal|1|||
25141090|NCT01992536|50254484|FG009|Overall Study|Lost to Follow-up|1|||
25141091|NCT01992536|50254475|FG000|Overall Study|Withdrawal by Subject|0|||
25141092|NCT01992536|50254476|FG001|Overall Study|Withdrawal by Subject|1|||
25141093|NCT01992536|50254477|FG002|Overall Study|Withdrawal by Subject|0|||
25141094|NCT01992536|50254478|FG003|Overall Study|Withdrawal by Subject|2|||
25141095|NCT01992536|50254479|FG004|Overall Study|Withdrawal by Subject|0|||
25012222|NCT03359811|50105425|FG000|Overall Study|Protocol Violation|2|||
25012223|NCT03359811|50105426|FG001|Overall Study|Protocol Violation|0|||
25012224|NCT03728426|50105433|FG000|Overall Study|Death|3|||
25012225|NCT02095678|50105439|FG000|Overall Study|Withdrawal by Subject|0|||
25012226|NCT02095678|50105440|FG001|Overall Study|Withdrawal by Subject|1|||
25141096|NCT01992536|50254480|FG005|Overall Study|Withdrawal by Subject|0|||
25141097|NCT01992536|50254481|FG006|Overall Study|Withdrawal by Subject|0|||
25141098|NCT01992536|50254482|FG007|Overall Study|Withdrawal by Subject|0|||
25141099|NCT01992536|50254483|FG008|Overall Study|Withdrawal by Subject|0|||
25141100|NCT01992536|50254484|FG009|Overall Study|Withdrawal by Subject|0|||
25012227|NCT02095678|50105439|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
25012228|NCT02095678|50105440|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
25012229|NCT02095678|50105439|FG000|Overall Study|lesion impacted by previous treatment|1|||
25012230|NCT02095678|50105440|FG001|Overall Study|lesion impacted by previous treatment|1|||
25012231|NCT02095678|50105439|FG000|Overall Study|No Confirmed Diagnosis|0|||
25012232|NCT02095678|50105440|FG001|Overall Study|No Confirmed Diagnosis|3|||
25012233|NCT02095678|50105439|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
25012234|NCT02095678|50105440|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
25012235|NCT02095678|50105439|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
25012236|NCT02095678|50105440|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
25012237|NCT03763877|50105453|FG000|Overall Study|Withdrawal by Subject|3|||
25012238|NCT03763877|50105454|FG001|Overall Study|Withdrawal by Subject|1|||
25012239|NCT03763877|50105455|FG002|Overall Study|Withdrawal by Subject|3|||
25012240|NCT03763877|50105456|FG003|Overall Study|Withdrawal by Subject|4|||
25012241|NCT03763877|50105453|FG000|Overall Study|Adverse Event|1|||
25012242|NCT03763877|50105454|FG001|Overall Study|Adverse Event|1|||
25012243|NCT03763877|50105455|FG002|Overall Study|Adverse Event|3|||
25012244|NCT03763877|50105456|FG003|Overall Study|Adverse Event|1|||
25012245|NCT03763877|50105453|FG000|Overall Study|Protocol Violation|1|||
25012246|NCT03763877|50105454|FG001|Overall Study|Protocol Violation|1|||
25012247|NCT03763877|50105455|FG002|Overall Study|Protocol Violation|0|||
25012248|NCT03763877|50105456|FG003|Overall Study|Protocol Violation|0|||
25012249|NCT03763877|50105453|FG000|Overall Study|Lost to Follow-up|0|||
25012250|NCT03763877|50105454|FG001|Overall Study|Lost to Follow-up|1|||
25012251|NCT03763877|50105455|FG002|Overall Study|Lost to Follow-up|1|||
25012252|NCT03763877|50105456|FG003|Overall Study|Lost to Follow-up|0|||
25012253|NCT03358407|50105489|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
25012254|NCT03358407|50105490|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
25012255|NCT03358407|50105491|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
25012256|NCT03358407|50105492|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
25012257|NCT03358407|50105493|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
25012258|NCT03358407|50105494|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
25012259|NCT03358407|50105495|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
25012260|NCT03358407|50105496|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
25012261|NCT03358407|50105497|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
25012262|NCT03358407|50105498|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
25012263|NCT03358407|50105489|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
25012264|NCT03358407|50105490|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
25012265|NCT03358407|50105491|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
25012266|NCT03358407|50105492|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
25012267|NCT03358407|50105493|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
25012268|NCT03358407|50105494|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
25012269|NCT03358407|50105495|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
25012270|NCT03358407|50105496|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
25012271|NCT03358407|50105497|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
25012272|NCT03358407|50105498|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
25012273|NCT03358407|50105489|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
25012274|NCT03358407|50105490|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
25012275|NCT03358407|50105491|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
25012276|NCT03358407|50105492|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
25012277|NCT03358407|50105493|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
25012278|NCT03358407|50105494|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
25012279|NCT03358407|50105495|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
25012280|NCT03358407|50105496|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
25012281|NCT03358407|50105497|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
25012282|NCT03358407|50105498|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
25012283|NCT03358407|50105489|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
25012284|NCT03358407|50105490|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
25012285|NCT03358407|50105491|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
25012286|NCT03358407|50105492|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
25012287|NCT03358407|50105493|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
25012288|NCT03358407|50105494|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
25012289|NCT03358407|50105495|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
25012290|NCT03358407|50105496|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
25012291|NCT03358407|50105497|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
25012292|NCT03358407|50105498|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
25012293|NCT03358407|50105489|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
25012294|NCT03358407|50105490|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
25012295|NCT03358407|50105491|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
25012296|NCT03358407|50105492|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
25012297|NCT03358407|50105493|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
25012298|NCT03358407|50105494|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
25012299|NCT03358407|50105495|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
25012300|NCT03358407|50105496|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
25012301|NCT03358407|50105497|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
25141101|NCT01993927|50254526|FG000|Overall Study|Case Report Forms Uncollected|18|||
25012302|NCT03358407|50105498|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
25012303|NCT03358407|50105489|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
25012304|NCT03358407|50105490|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
25012305|NCT03358407|50105491|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
25012306|NCT03358407|50105492|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
25012307|NCT03358407|50105493|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
25012308|NCT03358407|50105494|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
25012309|NCT03358407|50105495|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
25012310|NCT03358407|50105496|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
25012311|NCT03358407|50105497|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
25012312|NCT03358407|50105498|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
25012313|NCT02950545|50105540|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
25012314|NCT02950545|50105541|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
25012315|NCT02950545|50105542|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
25012316|NCT02950545|50105543|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
25012317|NCT02950545|50105544|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
25012318|NCT02950545|50105545|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
25012319|NCT02950545|50105540|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
25012320|NCT02950545|50105541|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
25012321|NCT02950545|50105542|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
25012322|NCT02950545|50105543|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
25012323|NCT02950545|50105544|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
25012324|NCT02950545|50105545|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
25012325|NCT02950545|50105540|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
25012326|NCT02950545|50105541|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
25012327|NCT02950545|50105542|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
25012328|NCT02950545|50105543|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
25012329|NCT02950545|50105544|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
25012330|NCT02950545|50105545|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
25012331|NCT02950545|50105540|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
25012332|NCT02950545|50105541|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
25012333|NCT02950545|50105542|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
25012334|NCT02950545|50105543|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
25012335|NCT02950545|50105544|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
25012336|NCT02950545|50105545|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
25012337|NCT02950545|50105540|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
25012338|NCT02950545|50105541|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
25012339|NCT02950545|50105542|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
25012340|NCT02950545|50105543|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
25012341|NCT02950545|50105544|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
25012342|NCT02950545|50105545|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
25012343|NCT03358329|50105551|FG000|Overall Study|Lost to Follow-up|2|||
25141102|NCT01993927|50254526|FG000|Overall Study|Protocol Violation|11|||
25141103|NCT02015390|50254532|FG000|Overall Study|Lost to Follow-up|1|||
25141104|NCT02015390|50254533|FG001|Overall Study|Lost to Follow-up|0|||
25141105|NCT02015390|50254532|FG000|Overall Study|Adverse Event|0|||
25141106|NCT02015390|50254533|FG001|Overall Study|Adverse Event|3|||
25141107|NCT02015390|50254532|FG000|Overall Study|Physician Decision|0|||
25012344|NCT03358329|50105551|FG000|Overall Study|Withdrawal by Subject|2|||
25012345|NCT03357471|50105567|FG000|Overall Study|Adverse Event|1|||
25012346|NCT03357471|50105568|FG001|Overall Study|Adverse Event|0|||
25012347|NCT03357471|50105567|FG000|Overall Study|Lost to Follow-up|1|||
25012348|NCT03357471|50105568|FG001|Overall Study|Lost to Follow-up|0|||
25012349|NCT03356145|50105576|FG000|Overall Study|Withdrawal by Subject|2|||
25012350|NCT03356145|50105577|FG001|Overall Study|Withdrawal by Subject|1|||
25012351|NCT03356145|50105576|FG000|Overall Study|Did not meet inclusion criteria|1|||
25012352|NCT03356145|50105577|FG001|Overall Study|Did not meet inclusion criteria|0|||
25012353|NCT03342963|50105587|FG000|Overall Study|Adverse Event|1|||
25012354|NCT03342963|50105588|FG001|Overall Study|Adverse Event|2|||
25141108|NCT02015390|50254533|FG001|Overall Study|Physician Decision|1|||
25141109|NCT02012959|50254540|FG000|Treatment Phase A|Adverse Event|2|||
25141110|NCT02012959|50254541|FG001|Treatment Phase A|Adverse Event|0|||
25141111|NCT02012959|50254542|FG002|Treatment Phase A|Adverse Event|0|||
25141112|NCT02012959|50254543|FG003|Treatment Phase A|Adverse Event|0|||
25141113|NCT02012959|50254544|FG004|Treatment Phase A|Adverse Event|0|||
25141114|NCT01990742|50254556|FG000|Overall Study|Withdrawal by facility|407|||
25141115|NCT01990742|50254557|FG001|Overall Study|Withdrawal by facility|1083|||
25012355|NCT03342963|50105589|FG002|Overall Study|Adverse Event|0|||
25012356|NCT03342963|50105590|FG003|Overall Study|Adverse Event|0|||
25012357|NCT03342963|50105587|FG000|Overall Study|Withdrawal by Subject|1|||
25012358|NCT03342963|50105588|FG001|Overall Study|Withdrawal by Subject|0|||
25012359|NCT03342963|50105589|FG002|Overall Study|Withdrawal by Subject|0|||
25012360|NCT03342963|50105590|FG003|Overall Study|Withdrawal by Subject|0|||
25012361|NCT03361956|50105605|FG000|Overall Study|Adverse Event|1|||
25012362|NCT03361956|50105606|FG001|Overall Study|Adverse Event|0|||
25012363|NCT03361956|50105607|FG002|Overall Study|Adverse Event|1|||
25012364|NCT03361956|50105608|FG003|Overall Study|Adverse Event|1|||
25012365|NCT03361956|50105609|FG004|Overall Study|Adverse Event|0|||
25012366|NCT03361956|50105605|FG000|Overall Study|Other|0|||
25012367|NCT03361956|50105606|FG001|Overall Study|Other|0|||
25012368|NCT03361956|50105607|FG002|Overall Study|Other|0|||
25012369|NCT03361956|50105608|FG003|Overall Study|Other|1|||
25012370|NCT03361956|50105609|FG004|Overall Study|Other|0|||
25012371|NCT03361956|50105605|FG000|Overall Study|Withdrawal by Subject|2|||
25012372|NCT03361956|50105606|FG001|Overall Study|Withdrawal by Subject|2|||
25012373|NCT03361956|50105607|FG002|Overall Study|Withdrawal by Subject|2|||
25012374|NCT03361956|50105608|FG003|Overall Study|Withdrawal by Subject|0|||
25012375|NCT03361956|50105609|FG004|Overall Study|Withdrawal by Subject|3|||
25012376|NCT03361956|50105605|FG000|Overall Study|Disease Relapse|0|||
25012377|NCT03361956|50105606|FG001|Overall Study|Disease Relapse|0|||
25012378|NCT03361956|50105607|FG002|Overall Study|Disease Relapse|1|||
25012379|NCT03361956|50105608|FG003|Overall Study|Disease Relapse|0|||
25012380|NCT03361956|50105609|FG004|Overall Study|Disease Relapse|0|||
25012381|NCT03361956|50105605|FG000|Overall Study|Physician Decision|0|||
25012382|NCT03361956|50105606|FG001|Overall Study|Physician Decision|2|||
25012383|NCT03361956|50105607|FG002|Overall Study|Physician Decision|0|||
25012384|NCT03361956|50105608|FG003|Overall Study|Physician Decision|1|||
25012385|NCT03361956|50105609|FG004|Overall Study|Physician Decision|0|||
25012386|NCT03361956|50105605|FG000|Overall Study|Lost to Follow-up|0|||
25012387|NCT03361956|50105606|FG001|Overall Study|Lost to Follow-up|0|||
25012388|NCT03361956|50105607|FG002|Overall Study|Lost to Follow-up|1|||
25012389|NCT03361956|50105608|FG003|Overall Study|Lost to Follow-up|1|||
25012390|NCT03361956|50105609|FG004|Overall Study|Lost to Follow-up|2|||
25012391|NCT03361176|50105680|FG000|Overall Study|Lost to Follow-up|1|||
25012392|NCT03361176|50105681|FG001|Overall Study|Lost to Follow-up|2|||
25012393|NCT03361176|50105680|FG000|Overall Study|Adverse Event|0|||
25012394|NCT03361176|50105681|FG001|Overall Study|Adverse Event|2|||
25012395|NCT03361176|50105680|FG000|Overall Study|Withdrawal by Subject|0|||
25012396|NCT03361176|50105681|FG001|Overall Study|Withdrawal by Subject|1|||
25012397|NCT05283499|50105689|FG000|Overall Study|Did not receive intervention|1|||
25012398|NCT05283499|50105690|FG001|Overall Study|Did not receive intervention|2|||
25012399|NCT05271175|50105699|FG000|One Week Follow up|Lost to Follow-up|10|||
25012400|NCT05271175|50105700|FG001|One Week Follow up|Lost to Follow-up|7|||
25012401|NCT05271175|50105701|FG002|One Week Follow up|Lost to Follow-up|5|||
25012402|NCT05271175|50105699|FG000|One Month Follow up|Lost to Follow-up|12|||
25012403|NCT05271175|50105700|FG001|One Month Follow up|Lost to Follow-up|7|||
25012404|NCT05271175|50105701|FG002|One Month Follow up|Lost to Follow-up|9|||
25012405|NCT05271175|50105699|FG000|Six Months Follow up|Lost to Follow-up|8|||
25012406|NCT05271175|50105700|FG001|Six Months Follow up|Lost to Follow-up|2|||
25012407|NCT05271175|50105701|FG002|Six Months Follow up|Lost to Follow-up|2|||
25012408|NCT03098030|50105713|FG000|Overall Study|Death|10|||
25012409|NCT03098030|50105714|FG001|Overall Study|Death|156|||
25012410|NCT03098030|50105715|FG002|Overall Study|Death|156|||
25012411|NCT03098030|50105716|FG003|Overall Study|Death|82|||
25012412|NCT03098030|50105713|FG000|Overall Study|Withdrawal by Subject|0|||
25012413|NCT03098030|50105714|FG001|Overall Study|Withdrawal by Subject|7|||
25012414|NCT03098030|50105715|FG002|Overall Study|Withdrawal by Subject|8|||
25012415|NCT03098030|50105716|FG003|Overall Study|Withdrawal by Subject|2|||
25012416|NCT03098030|50105713|FG000|Overall Study|Lost to Follow-up|0|||
25012417|NCT03098030|50105714|FG001|Overall Study|Lost to Follow-up|0|||
25012418|NCT03098030|50105715|FG002|Overall Study|Lost to Follow-up|2|||
25012419|NCT03098030|50105716|FG003|Overall Study|Lost to Follow-up|1|||
25012420|NCT03341637|50105727|FG000|Overall Study|Lost to Follow-up|1|||
25012421|NCT03341637|50105728|FG001|Overall Study|Lost to Follow-up|0|||
25012422|NCT03341637|50105727|FG000|Overall Study|Withdrawal by Subject|3|||
25012423|NCT03341637|50105728|FG001|Overall Study|Withdrawal by Subject|3|||
25012424|NCT03341637|50105727|FG000|Overall Study|Reason not Specified|1|||
25012425|NCT03341637|50105728|FG001|Overall Study|Reason not Specified|1|||
25012426|NCT01378858|50105736|FG000|Overall Study|Withdrawal by Subject|4|||
25012427|NCT01378858|50105737|FG001|Overall Study|Withdrawal by Subject|4|||
25012428|NCT02891850|50105745|FG000|Overall Study|Adverse Event|3|||
25012429|NCT02891850|50105746|FG001|Overall Study|Adverse Event|0|||
25012430|NCT02891850|50105745|FG000|Overall Study|Death|0|||
25012431|NCT02891850|50105746|FG001|Overall Study|Death|4|||
25012432|NCT02891850|50105745|FG000|Overall Study|Physician Decision|1|||
25012433|NCT02891850|50105746|FG001|Overall Study|Physician Decision|0|||
25012434|NCT02891850|50105745|FG000|Overall Study|Pregnancy|1|||
25012435|NCT02891850|50105746|FG001|Overall Study|Pregnancy|0|||
25012436|NCT02891850|50105745|FG000|Overall Study|Withdrawal by Subject|2|||
25012437|NCT02891850|50105746|FG001|Overall Study|Withdrawal by Subject|3|||
25012438|NCT05594173|50105752|FG000|Overall Study|Adverse Event|1|||
25012439|NCT05594173|50105752|FG000|Overall Study|COVID-19 Pandemic|2|||
25012440|NCT03339999|50105765|FG000|Overall Study|Adverse Event|1|||
25012441|NCT03339999|50105766|FG001|Overall Study|Adverse Event|2|||
25012442|NCT03339999|50105767|FG002|Overall Study|Adverse Event|2|||
25012443|NCT03339999|50105768|FG003|Overall Study|Adverse Event|1|||
25012444|NCT03339999|50105765|FG000|Overall Study|Lack of Efficacy|0|||
25012445|NCT03339999|50105766|FG001|Overall Study|Lack of Efficacy|1|||
25012446|NCT03339999|50105767|FG002|Overall Study|Lack of Efficacy|0|||
25012447|NCT03339999|50105768|FG003|Overall Study|Lack of Efficacy|0|||
25012448|NCT03339999|50105765|FG000|Overall Study|Lost to Follow-up|0|||
25012449|NCT03339999|50105766|FG001|Overall Study|Lost to Follow-up|0|||
25012450|NCT03339999|50105767|FG002|Overall Study|Lost to Follow-up|0|||
25012451|NCT03339999|50105768|FG003|Overall Study|Lost to Follow-up|1|||
25012452|NCT03339999|50105765|FG000|Overall Study|Study Terminated by Sponsor|6|||
25012453|NCT03339999|50105766|FG001|Overall Study|Study Terminated by Sponsor|3|||
25012454|NCT03339999|50105767|FG002|Overall Study|Study Terminated by Sponsor|4|||
25012455|NCT03339999|50105768|FG003|Overall Study|Study Terminated by Sponsor|3|||
25012456|NCT03339453|50105781|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
25012457|NCT03339453|50105782|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
25012458|NCT03761056|50105807|FG000|Overall Study|Still on Study|34|||
25012459|NCT03761056|50105807|FG000|Overall Study|Death|6|||
25012460|NCT03761056|50105807|FG000|Overall Study|Investigator Decision|1|||
25012461|NCT03761056|50105807|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|1|||
25012462|NCT03359850|50105832|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
25012463|NCT03359850|50105833|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
25012464|NCT03359850|50105832|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
25012465|NCT03359850|50105833|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
25012466|NCT03359850|50105832|FG000|Extension Phase (Up to 28 Months)|Death|2|||
25012467|NCT03359850|50105833|FG001|Extension Phase (Up to 28 Months)|Death|4|||
25012468|NCT03359850|50105832|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
25012469|NCT03359850|50105833|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
25012470|NCT03359850|50105832|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
25012471|NCT03359850|50105833|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
25012472|NCT00114140|50105852|FG000|Overall Study|Protocol Violation|7|||
25012473|NCT03342690|50105863|FG000|Overall Study|Missing Information|9|||
25012474|NCT03342690|50105863|FG000|Overall Study|Protocol Violation|16|||
25012475|NCT03712345|50105870|FG000|Overall Study|Failure to meet randomization criteria|0|||
25012476|NCT03712345|50105871|FG001|Overall Study|Failure to meet randomization criteria|0|||
25012477|NCT03712345|50105872|FG002|Overall Study|Failure to meet randomization criteria|1|||
25012478|NCT03358290|50105885|FG000|Overall Study|Study discontinued by Sponsor|0|||
25012479|NCT03358290|50105886|FG001|Overall Study|Study discontinued by Sponsor|1|||
25012480|NCT03358290|50105887|FG002|Overall Study|Study discontinued by Sponsor|1|||
25012481|NCT03358290|50105888|FG003|Overall Study|Study discontinued by Sponsor|0|||
25012482|NCT03358290|50105889|FG004|Overall Study|Study discontinued by Sponsor|0|||
25012483|NCT03358290|50105885|FG000|Overall Study|Adverse Event|0|||
25012484|NCT03358290|50105886|FG001|Overall Study|Adverse Event|0|||
25012485|NCT03358290|50105887|FG002|Overall Study|Adverse Event|1|||
25012486|NCT03358290|50105888|FG003|Overall Study|Adverse Event|2|||
25012487|NCT03358290|50105889|FG004|Overall Study|Adverse Event|0|||
25012488|NCT03358290|50105885|FG000|Overall Study|Withdrawal by Subject|0|||
25012489|NCT03358290|50105886|FG001|Overall Study|Withdrawal by Subject|0|||
25012490|NCT03358290|50105887|FG002|Overall Study|Withdrawal by Subject|0|||
25012491|NCT03358290|50105888|FG003|Overall Study|Withdrawal by Subject|0|||
25012492|NCT03358290|50105889|FG004|Overall Study|Withdrawal by Subject|1|||
25012493|NCT03089216|50105905|FG000|Overall Study|Adverse Event|0|||
25012494|NCT03089216|50105906|FG001|Overall Study|Adverse Event|0|||
25012495|NCT03089216|50105907|FG002|Overall Study|Adverse Event|0|||
25012496|NCT03089216|50105908|FG003|Overall Study|Adverse Event|1|||
25012497|NCT03339726|50105925|FG000|Overall Study|Withdrawal by Subject|1|||
25012498|NCT03339726|50105926|FG001|Overall Study|Withdrawal by Subject|0|||
25012499|NCT03339726|50105927|FG002|Overall Study|Withdrawal by Subject|0|||
25012500|NCT03339726|50105925|FG000|Overall Study|Lost to Follow-up|0|||
25012501|NCT03339726|50105926|FG001|Overall Study|Lost to Follow-up|1|||
25012502|NCT03339726|50105927|FG002|Overall Study|Lost to Follow-up|0|||
25012503|NCT03339297|50105937|FG000|Overall Study|Relapse of Hematologic Disease|1|||
25012504|NCT03339297|50105938|FG001|Overall Study|Relapse of Hematologic Disease|0|||
25012505|NCT03339297|50105937|FG000|Overall Study|Death|10|||
25012506|NCT03339297|50105938|FG001|Overall Study|Death|7|||
25012507|NCT03339297|50105937|FG000|Overall Study|Hepatic Candidosis|1|||
25012508|NCT03339297|50105938|FG001|Overall Study|Hepatic Candidosis|0|||
25012509|NCT03339297|50105937|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
25012510|NCT03339297|50105938|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
25012511|NCT03339297|50105937|FG000|Overall Study|Consent Withdrawn by Participant|3|||
25012512|NCT03339297|50105938|FG001|Overall Study|Consent Withdrawn by Participant|3|||
25012513|NCT03339297|50105937|FG000|Overall Study|Disease Relapse|2|||
25012514|NCT03339297|50105938|FG001|Overall Study|Disease Relapse|0|||
25012515|NCT03339297|50105937|FG000|Overall Study|Physician Decision|1|||
25012516|NCT03339297|50105938|FG001|Overall Study|Physician Decision|1|||
25012517|NCT03339297|50105937|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
25012518|NCT03339297|50105938|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
25012519|NCT03339297|50105937|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
25012520|NCT03339297|50105938|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
25012521|NCT03339297|50105937|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
25012522|NCT03339297|50105938|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
25012523|NCT03339297|50105937|FG000|Overall Study|Adverse Event, Non-fatal|1|||
25012524|NCT03339297|50105938|FG001|Overall Study|Adverse Event, Non-fatal|0|||
25012525|NCT03339297|50105937|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
25012526|NCT03339297|50105938|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
25012527|NCT03339297|50105937|FG000|Overall Study|Patient Was Not Eligible|1|||
25012528|NCT03339297|50105938|FG001|Overall Study|Patient Was Not Eligible|0|||
25012529|NCT03713281|50105964|FG000|Overall Study|Lens handling difficuluties|2|||
25012530|NCT03713281|50105964|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
25012531|NCT03339219|50105968|FG000|Overall Study|Death|12|||
25012532|NCT03339219|50105968|FG000|Overall Study|Site Terminated by Sponsor|22|||
25012533|NCT03339219|50105968|FG000|Overall Study|Withdrawal by Subject|1|||
25012534|NCT03338673|50105974|FG000|Overall Study|Lost to Follow-up|1|||
25012535|NCT03338673|50105975|FG001|Overall Study|Lost to Follow-up|1|||
25012536|NCT02949024|50105983|FG000|Overall Study|Withdrawal by Subject|0|||
25012537|NCT02949024|50105984|FG001|Overall Study|Withdrawal by Subject|1|||
25012538|NCT03093428|50105994|FG000|Overall Study|Not eligible for treatment|2|||
25012539|NCT03093428|50105995|FG001|Overall Study|Not eligible for treatment|1|||
25012540|NCT03093428|50105994|FG000|Overall Study|Progression|14|||
25012541|NCT03093428|50105995|FG001|Overall Study|Progression|4|||
25012542|NCT03093428|50105994|FG000|Overall Study|Death|1|||
25012543|NCT03093428|50105995|FG001|Overall Study|Death|0|||
25012544|NCT03093428|50105994|FG000|Overall Study|Adverse Event|1|||
25012545|NCT03093428|50105995|FG001|Overall Study|Adverse Event|0|||
25012546|NCT03093428|50105994|FG000|Overall Study|Withdrawal by Subject|1|||
25012547|NCT03093428|50105995|FG001|Overall Study|Withdrawal by Subject|1|||
25012548|NCT02735980|50106004|FG000|Overall Study|Adverse Event|0|||
25012549|NCT02735980|50106005|FG001|Overall Study|Adverse Event|4|||
25012550|NCT02735980|50106006|FG002|Overall Study|Adverse Event|1|||
25012551|NCT02735980|50106004|FG000|Overall Study|Death|5|||
25012552|NCT02735980|50106005|FG001|Overall Study|Death|4|||
25012553|NCT02735980|50106006|FG002|Overall Study|Death|0|||
25012554|NCT02735980|50106004|FG000|Overall Study|Physician Decision|3|||
25012555|NCT02735980|50106005|FG001|Overall Study|Physician Decision|1|||
25012556|NCT02735980|50106006|FG002|Overall Study|Physician Decision|0|||
25012557|NCT02735980|50106004|FG000|Overall Study|Screen failure|1|||
25012558|NCT02735980|50106005|FG001|Overall Study|Screen failure|0|||
25012559|NCT02735980|50106006|FG002|Overall Study|Screen failure|0|||
25012560|NCT02735980|50106004|FG000|Overall Study|Withdrawal by Subject|1|||
25012561|NCT02735980|50106005|FG001|Overall Study|Withdrawal by Subject|2|||
25012562|NCT02735980|50106006|FG002|Overall Study|Withdrawal by Subject|0|||
25012563|NCT03338400|50106021|FG000|Overall Study|Lost to Follow-up|1|||
25012564|NCT03338400|50106022|FG001|Overall Study|Lost to Follow-up|2|||
25012565|NCT03337113|50106040|FG000|Overall Study|Adverse Event|1|||
25012566|NCT03337113|50106041|FG001|Overall Study|Adverse Event|1|||
25141116|NCT01990742|50254556|FG000|Overall Study|Facility closed|0|||
25012567|NCT03337113|50106042|FG002|Overall Study|Adverse Event|0|||
25012568|NCT03337113|50106043|FG003|Overall Study|Adverse Event|1|||
25012569|NCT03337113|50106040|FG000|Overall Study|Physician Decision|0|||
25012570|NCT03337113|50106041|FG001|Overall Study|Physician Decision|2|||
25012571|NCT03337113|50106042|FG002|Overall Study|Physician Decision|0|||
25012572|NCT03337113|50106043|FG003|Overall Study|Physician Decision|1|||
25012573|NCT03337113|50106040|FG000|Overall Study|Withdrawal by Subject|0|||
25012574|NCT03337113|50106041|FG001|Overall Study|Withdrawal by Subject|0|||
25012575|NCT03337113|50106042|FG002|Overall Study|Withdrawal by Subject|1|||
25012576|NCT03337113|50106043|FG003|Overall Study|Withdrawal by Subject|0|||
25012577|NCT03092726|50106055|FG000|Overall Study|Adverse Event|3|||
25012578|NCT03092726|50106056|FG001|Overall Study|Adverse Event|10|||
25012579|NCT03092726|50106055|FG000|Overall Study|Lack of Efficacy|0|||
25012580|NCT03092726|50106056|FG001|Overall Study|Lack of Efficacy|1|||
25012581|NCT03092726|50106055|FG000|Overall Study|Lost to Follow-up|1|||
25012582|NCT03092726|50106056|FG001|Overall Study|Lost to Follow-up|0|||
25012583|NCT03092726|50106055|FG000|Overall Study|Withdrawal by Subject|5|||
25012584|NCT03092726|50106056|FG001|Overall Study|Withdrawal by Subject|3|||
25141117|NCT01990742|50254557|FG001|Overall Study|Facility closed|270|||
25141118|NCT02012491|50254565|FG000|Overall Study|Lost to Follow-up|1|||
25012585|NCT03338010|50106064|FG000|Overall Study|Withdrawal by Subject|14|||
25012586|NCT03338010|50106065|FG001|Overall Study|Withdrawal by Subject|8|||
25012587|NCT03338010|50106064|FG000|Overall Study|Lost to Follow-up|4|||
25012588|NCT03338010|50106065|FG001|Overall Study|Lost to Follow-up|2|||
25012589|NCT03338010|50106064|FG000|Overall Study|Adverse Event|3|||
25012590|NCT03338010|50106065|FG001|Overall Study|Adverse Event|2|||
25012591|NCT03338010|50106064|FG000|Overall Study|Physician Decision|2|||
25012592|NCT03338010|50106065|FG001|Overall Study|Physician Decision|2|||
25012593|NCT03338010|50106064|FG000|Overall Study|Non-Compliance with Study Drug|0|||
25012594|NCT03338010|50106065|FG001|Overall Study|Non-Compliance with Study Drug|3|||
25012595|NCT03338010|50106064|FG000|Overall Study|Protocol Violation|0|||
25012596|NCT03338010|50106065|FG001|Overall Study|Protocol Violation|1|||
25012597|NCT03337542|50106071|FG000|Overall Study|Withdrew Consent|17|||
25012598|NCT03337542|50106071|FG000|Overall Study|Allergic Adverse Event|1|||
25012599|NCT03337542|50106071|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
25012600|NCT03337542|50106071|FG000|Overall Study|Lost to Follow-up|1|||
25012601|NCT03337542|50106071|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
25012602|NCT01328548|50106078|FG000|Overall Study|Death|3|||
25012603|NCT01328548|50106079|FG001|Overall Study|Death|0|||
25012604|NCT01328548|50106078|FG000|Overall Study|Protocol Violation|1|||
25012605|NCT01328548|50106079|FG001|Overall Study|Protocol Violation|0|||
25012606|NCT03337308|50106117|FG000|Overall Study|Adverse Event|2|||
25012607|NCT03337308|50106118|FG001|Overall Study|Adverse Event|3|||
25012608|NCT03337308|50106119|FG002|Overall Study|Adverse Event|3|||
25012609|NCT03337308|50106120|FG003|Overall Study|Adverse Event|1|||
25012610|NCT03337308|50106117|FG000|Overall Study|Lost to Follow-up|1|||
25012611|NCT03337308|50106118|FG001|Overall Study|Lost to Follow-up|2|||
25012612|NCT03337308|50106119|FG002|Overall Study|Lost to Follow-up|0|||
25012613|NCT03337308|50106120|FG003|Overall Study|Lost to Follow-up|0|||
25012614|NCT03337308|50106117|FG000|Overall Study|Withdrawal by Subject|2|||
25012615|NCT03337308|50106118|FG001|Overall Study|Withdrawal by Subject|1|||
25012616|NCT03337308|50106119|FG002|Overall Study|Withdrawal by Subject|2|||
25012617|NCT03337308|50106120|FG003|Overall Study|Withdrawal by Subject|1|||
25012618|NCT03337308|50106117|FG000|Overall Study|Protocol Violation|0|||
25012619|NCT03337308|50106118|FG001|Overall Study|Protocol Violation|1|||
25012620|NCT03337308|50106119|FG002|Overall Study|Protocol Violation|0|||
25012621|NCT03337308|50106120|FG003|Overall Study|Protocol Violation|0|||
25012622|NCT03337152|50106132|FG000|Overall Study|Physician Decision|1|||
25012623|NCT03337152|50106133|FG001|Overall Study|Physician Decision|0|||
25012624|NCT03337152|50106132|FG000|Overall Study|Lost to Follow-up|1|||
25012625|NCT03337152|50106133|FG001|Overall Study|Lost to Follow-up|3|||
25012626|NCT03337152|50106132|FG000|Overall Study|Adverse Event|3|||
25012627|NCT03337152|50106133|FG001|Overall Study|Adverse Event|1|||
25012628|NCT03337152|50106132|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
25012629|NCT03337152|50106133|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
25012630|NCT03710161|50106147|FG000|Overall Study|Study halted due to COVID pandemic|3|||
25012631|NCT03710161|50106148|FG001|Overall Study|Study halted due to COVID pandemic|2|||
25012632|NCT03091400|50106156|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
25012633|NCT03091400|50106157|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
25141119|NCT02012491|50254566|FG001|Overall Study|Lost to Follow-up|0|||
25141120|NCT02012491|50254565|FG000|Overall Study|Protocol Violation|0|||
25141121|NCT02012491|50254566|FG001|Overall Study|Protocol Violation|1|||
25141122|NCT02012491|50254565|FG000|Overall Study|Withdrawal by Subject|1|||
25141123|NCT02012491|50254566|FG001|Overall Study|Withdrawal by Subject|0|||
25141124|NCT01990664|50254574|FG000|Overall Study|Lost to Follow-up|2|||
25141125|NCT01990664|50254575|FG001|Overall Study|Lost to Follow-up|6|||
25141126|NCT01990664|50254574|FG000|Overall Study|Withdrawal by Subject|2|||
25141127|NCT01990664|50254575|FG001|Overall Study|Withdrawal by Subject|3|||
25141128|NCT01990664|50254574|FG000|Overall Study|Protocol Violation|1|||
25141129|NCT01990664|50254575|FG001|Overall Study|Protocol Violation|0|||
25141130|NCT01990664|50254574|FG000|Overall Study|Lens Discomfort|1|||
25141131|NCT01990664|50254575|FG001|Overall Study|Lens Discomfort|1|||
25141132|NCT01990664|50254574|FG000|Overall Study|Lens Handling Difficulties|1|||
25141133|NCT01990664|50254575|FG001|Overall Study|Lens Handling Difficulties|0|||
25012634|NCT01318993|50106163|FG000|Overall Study|Adverse Event|53|||
25012635|NCT01318993|50106163|FG000|Overall Study|Lack of Efficacy|121|||
25012636|NCT01318993|50106163|FG000|Overall Study|Protocol Violation|3|||
25141134|NCT01990664|50254574|FG000|Overall Study|Unsatisfactory Visual Response|0|||
25141135|NCT01990664|50254575|FG001|Overall Study|Unsatisfactory Visual Response|1|||
25141136|NCT02038010|50254581|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
25141137|NCT02038010|50254582|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
25141138|NCT02038010|50254583|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
25141139|NCT02038010|50254584|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
25141140|NCT02038010|50254581|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
25012637|NCT01318993|50106163|FG000|Overall Study|Protocol based stopping criteria|6|||
25012638|NCT01318993|50106163|FG000|Overall Study|Study closed or terminated|174|||
25141141|NCT02038010|50254582|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
25012639|NCT01318993|50106163|FG000|Overall Study|Lost to Follow-up|4|||
25012640|NCT01318993|50106163|FG000|Overall Study|Physician Decision|13|||
25012641|NCT01318993|50106163|FG000|Overall Study|Withdrawal by Subject|24|||
25012642|NCT03090152|50106170|FG000|Overall Study|Withdrawal by Subject|0|||
25012643|NCT03090152|50106171|FG001|Overall Study|Withdrawal by Subject|2|||
25012644|NCT03090152|50106172|FG002|Overall Study|Withdrawal by Subject|1|||
25012645|NCT03090152|50106170|FG000|Overall Study|Surgery Canceled|1|||
25012646|NCT03090152|50106171|FG001|Overall Study|Surgery Canceled|0|||
25012647|NCT03090152|50106172|FG002|Overall Study|Surgery Canceled|0|||
25012648|NCT03090152|50106170|FG000|Overall Study|Epidural catheter could not be placed|0|||
25012649|NCT03090152|50106171|FG001|Overall Study|Epidural catheter could not be placed|2|||
25012650|NCT03090152|50106172|FG002|Overall Study|Epidural catheter could not be placed|0|||
25012651|NCT04252287|50106182|FG000|Overall Study|Death|5|||
25012652|NCT04252287|50106183|FG001|Overall Study|Death|3|||
25012653|NCT04252287|50106182|FG000|Overall Study|Lost to Follow-up|4|||
25012654|NCT04252287|50106183|FG001|Overall Study|Lost to Follow-up|6|||
25012655|NCT04252287|50106182|FG000|Overall Study|Withdrawal by Subject|19|||
25012656|NCT04252287|50106183|FG001|Overall Study|Withdrawal by Subject|16|||
25012657|NCT04252287|50106182|FG000|Overall Study|Protocol Violation|3|||
25012658|NCT04252287|50106183|FG001|Overall Study|Protocol Violation|4|||
25012659|NCT02735200|50106195|FG000|Overall Study|Lost to Follow-up|0|||
25012660|NCT02735200|50106196|FG001|Overall Study|Lost to Follow-up|5|||
25012661|NCT02735200|50106195|FG000|Overall Study|Withdrawal by Subject|8|||
25012662|NCT02735200|50106196|FG001|Overall Study|Withdrawal by Subject|0|||
25012663|NCT02946918|50106204|FG000|Overall Study|Patient unblinded himself|1|||
25012664|NCT02946918|50106205|FG001|Overall Study|Patient unblinded himself|0|||
25012665|NCT02946918|50106204|FG000|Overall Study|Physician Decision|0|||
25012666|NCT02946918|50106205|FG001|Overall Study|Physician Decision|2|||
25012667|NCT02946918|50106204|FG000|Overall Study|Ran out of study medication|0|||
25012668|NCT02946918|50106205|FG001|Overall Study|Ran out of study medication|1|||
25012669|NCT02734810|50106226|FG000|Overall Study|Adverse Event|1|||
25012670|NCT02734810|50106227|FG001|Overall Study|Adverse Event|0|||
25012671|NCT02734810|50106226|FG000|Overall Study|Lack of Efficacy|1|||
25012672|NCT02734810|50106227|FG001|Overall Study|Lack of Efficacy|0|||
25012673|NCT03656068|50106252|FG000|Overall Study|Withdrawal by Subject|4|||
25012674|NCT03656068|50106252|FG000|Overall Study|Adverse Event|1|||
25012675|NCT02944383|50106259|FG000|Overall Study|Lost to Follow-up|0|||
25012676|NCT02944383|50106260|FG001|Overall Study|Lost to Follow-up|0|||
25012677|NCT02944383|50106261|FG002|Overall Study|Lost to Follow-up|1|||
25012678|NCT02944383|50106259|FG000|Overall Study|Withdrawal by Subject|1|||
25012679|NCT02944383|50106260|FG001|Overall Study|Withdrawal by Subject|0|||
25012680|NCT02944383|50106261|FG002|Overall Study|Withdrawal by Subject|0|||
25012681|NCT02096588|50106273|FG000|Overall Study|Lack of Efficacy|2|||
25012682|NCT02096588|50106274|FG001|Overall Study|Lack of Efficacy|0|||
25012683|NCT02096588|50106273|FG000|Overall Study|Withdrawal by Subject|0|||
25012684|NCT02096588|50106274|FG001|Overall Study|Withdrawal by Subject|1|||
25012685|NCT03768089|50106298|FG000|Part A|Lost to Follow-up|0|||
25012686|NCT03768089|50106299|FG001|Part A|Lost to Follow-up|0|||
25141142|NCT02038010|50254583|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
25141143|NCT02038010|50254584|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
25141144|NCT02038010|50254581|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
25141145|NCT02038010|50254582|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
25141146|NCT02038010|50254583|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
25141147|NCT02038010|50254584|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
25141148|NCT02038010|50254581|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
25141149|NCT02038010|50254582|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
25141150|NCT02038010|50254583|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
25141151|NCT02038010|50254584|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
25141152|NCT02038010|50254581|FG000|Follow Up|Death|4|||
25141153|NCT02038010|50254582|FG001|Follow Up|Death|3|||
25012687|NCT03768089|50106300|FG002|Part A|Lost to Follow-up|0|||
25012688|NCT03768089|50106301|FG003|Part A|Lost to Follow-up|0|||
25012689|NCT03768089|50106302|FG004|Part A|Lost to Follow-up|1|||
25012690|NCT03768089|50106303|FG005|Part A|Lost to Follow-up|0|||
25012691|NCT03768089|50106304|FG006|Part A|Lost to Follow-up|0|||
25012692|NCT03768089|50106305|FG007|Part A|Lost to Follow-up|0|||
25012693|NCT03768089|50106306|FG008|Part A|Lost to Follow-up|0|||
25012694|NCT03768089|50106307|FG009|Part A|Lost to Follow-up|0|||
25012695|NCT03768089|50106308|FG010|Part A|Lost to Follow-up|0|||
25012696|NCT03768089|50106309|FG011|Part A|Lost to Follow-up|0|||
25012697|NCT03768089|50106310|FG012|Part A|Lost to Follow-up|0|||
25012698|NCT03768089|50106311|FG013|Part A|Lost to Follow-up|0|||
25012699|NCT03768089|50106312|FG014|Part A|Lost to Follow-up|0|||
25012700|NCT03768089|50106313|FG015|Part A|Lost to Follow-up|0|||
25012701|NCT03768089|50106314|FG016|Part A|Lost to Follow-up|0|||
25012702|NCT03768089|50106315|FG017|Part A|Lost to Follow-up|0|||
25012703|NCT03768089|50106298|FG000|Part C|Randomized, Never Dosed|0|||
25012704|NCT03768089|50106299|FG001|Part C|Randomized, Never Dosed|0|||
25012705|NCT03768089|50106300|FG002|Part C|Randomized, Never Dosed|0|||
25012706|NCT03768089|50106301|FG003|Part C|Randomized, Never Dosed|0|||
25012707|NCT03768089|50106302|FG004|Part C|Randomized, Never Dosed|0|||
25012708|NCT03768089|50106303|FG005|Part C|Randomized, Never Dosed|0|||
25012709|NCT03768089|50106304|FG006|Part C|Randomized, Never Dosed|0|||
25012710|NCT03768089|50106305|FG007|Part C|Randomized, Never Dosed|0|||
25012711|NCT03768089|50106306|FG008|Part C|Randomized, Never Dosed|0|||
25012712|NCT03768089|50106307|FG009|Part C|Randomized, Never Dosed|0|||
25012713|NCT03768089|50106308|FG010|Part C|Randomized, Never Dosed|0|||
25012714|NCT03768089|50106309|FG011|Part C|Randomized, Never Dosed|0|||
25012715|NCT03768089|50106310|FG012|Part C|Randomized, Never Dosed|0|||
25012716|NCT03768089|50106311|FG013|Part C|Randomized, Never Dosed|0|||
25012717|NCT03768089|50106312|FG014|Part C|Randomized, Never Dosed|1|||
25012718|NCT03768089|50106313|FG015|Part C|Randomized, Never Dosed|0|||
25012719|NCT03768089|50106314|FG016|Part C|Randomized, Never Dosed|0|||
25012720|NCT03768089|50106315|FG017|Part C|Randomized, Never Dosed|0|||
25012721|NCT03086330|50106376|FG000|Overall Study|Withdrawal by Subject|3|||
25012722|NCT03086330|50106377|FG001|Overall Study|Withdrawal by Subject|2|||
25012723|NCT03086330|50106376|FG000|Overall Study|Lost to Follow-up|1|||
25012724|NCT03086330|50106377|FG001|Overall Study|Lost to Follow-up|2|||
25012725|NCT02943993|50106409|FG000|Overall Study|Withdrawal by Subject|52|||
25012726|NCT02943993|50106409|FG000|Overall Study|Transfer to another institution|6|||
25012727|NCT02943993|50106409|FG000|Overall Study|Lost to Follow-up|135|||
25012728|NCT02943993|50106409|FG000|Overall Study|Death|98|||
25012729|NCT02943993|50106409|FG000|Overall Study|Other reason for premature termination|32|||
25012730|NCT02943993|50106409|FG000|Overall Study|Missing reason for termination|7|||
25012731|NCT02943447|50106433|FG000|Blinded Study Phase|Withdrew Consent|1|||
25012732|NCT02943447|50106434|FG001|Blinded Study Phase|Withdrew Consent|2|||
25012733|NCT02943447|50106435|FG002|Blinded Study Phase|Withdrew Consent|1|||
25012734|NCT02943447|50106433|FG000|Blinded Study Phase|Adverse Event|3|||
25012735|NCT02943447|50106434|FG001|Blinded Study Phase|Adverse Event|0|||
25012736|NCT02943447|50106435|FG002|Blinded Study Phase|Adverse Event|0|||
25012737|NCT02943447|50106433|FG000|Blinded Study Phase|Investigator's discretion|1|||
25012738|NCT02943447|50106434|FG001|Blinded Study Phase|Investigator's discretion|0|||
25012739|NCT02943447|50106435|FG002|Blinded Study Phase|Investigator's discretion|0|||
25012740|NCT02943447|50106433|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
25012741|NCT02943447|50106434|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
25012742|NCT02943447|50106435|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
25012743|NCT02943447|50106433|FG000|Open-Label Extension Phase|Adverse Event|4|||
25012744|NCT02943447|50106434|FG001|Open-Label Extension Phase|Adverse Event|7|||
25012745|NCT02943447|50106435|FG002|Open-Label Extension Phase|Adverse Event|3|||
25012746|NCT02943447|50106433|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
25012747|NCT02943447|50106434|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
25012748|NCT02943447|50106435|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
25012749|NCT02943447|50106433|FG000|Open-Label Extension Phase|Withdrew consent|1|||
25012750|NCT02943447|50106434|FG001|Open-Label Extension Phase|Withdrew consent|1|||
25012751|NCT02943447|50106435|FG002|Open-Label Extension Phase|Withdrew consent|1|||
25012752|NCT02943447|50106433|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
25012753|NCT02943447|50106434|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
25012754|NCT02943447|50106435|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
25012755|NCT02844777|50106464|FG000|Overall Study|Withdrawal by Subject|2|||
25012756|NCT02844777|50106465|FG001|Overall Study|Withdrawal by Subject|0|||
25012757|NCT02844777|50106466|FG002|Overall Study|Withdrawal by Subject|0|||
25012758|NCT04003142|50106477|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
25012759|NCT04003142|50106478|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
25012760|NCT04003142|50106479|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
25012761|NCT04003142|50106480|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
25012762|NCT04003142|50106481|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
25012763|NCT04003142|50106477|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
25012764|NCT04003142|50106478|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
25012765|NCT04003142|50106479|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
25012766|NCT04003142|50106480|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
25012767|NCT04003142|50106481|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
25012768|NCT04003142|50106477|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
25012769|NCT04003142|50106478|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
25012770|NCT04003142|50106479|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
25012771|NCT04003142|50106480|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
25012772|NCT04003142|50106481|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
25012773|NCT04003142|50106477|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
25012774|NCT04003142|50106478|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
25012775|NCT04003142|50106479|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
25012776|NCT04003142|50106480|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
25012777|NCT04003142|50106481|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
25012778|NCT04003142|50106477|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
25012779|NCT04003142|50106478|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
25012780|NCT04003142|50106479|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
25012781|NCT04003142|50106480|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
25012782|NCT04003142|50106481|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
25012783|NCT04003142|50106477|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
25012784|NCT04003142|50106478|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
25012785|NCT04003142|50106479|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
25012786|NCT04003142|50106480|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
25012787|NCT04003142|50106481|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
25012788|NCT04003142|50106477|FG000|Extension Period (40 Weeks)|Death|0|||
25012789|NCT04003142|50106478|FG001|Extension Period (40 Weeks)|Death|0|||
25012790|NCT04003142|50106479|FG002|Extension Period (40 Weeks)|Death|0|||
25012791|NCT04003142|50106480|FG003|Extension Period (40 Weeks)|Death|0|||
25012792|NCT04003142|50106481|FG004|Extension Period (40 Weeks)|Death|1|||
25012793|NCT04003142|50106477|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
25012794|NCT04003142|50106478|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
25012795|NCT04003142|50106479|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
25012796|NCT04003142|50106480|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
25012797|NCT04003142|50106481|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
25012798|NCT04003142|50106477|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
25012799|NCT04003142|50106478|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
25012800|NCT04003142|50106479|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
25012801|NCT04003142|50106480|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
25012802|NCT04003142|50106481|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
25012803|NCT04003142|50106477|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
25012804|NCT04003142|50106478|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
25012805|NCT04003142|50106479|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
25012806|NCT04003142|50106480|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
25012807|NCT04003142|50106481|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
25012808|NCT04003142|50106477|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
25012809|NCT04003142|50106478|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
25012810|NCT04003142|50106479|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
25012811|NCT04003142|50106480|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
25012812|NCT04003142|50106481|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
25012813|NCT02612337|50106501|FG000|Overall Study|Lack of Efficacy|1|||
25012814|NCT02612337|50106502|FG001|Overall Study|Lack of Efficacy|0|||
25012815|NCT02612337|50106501|FG000|Overall Study|Withdrawal by Subject|2|||
25012816|NCT02612337|50106502|FG001|Overall Study|Withdrawal by Subject|2|||
25012817|NCT02612337|50106501|FG000|Overall Study|Did not receive study drug|0|||
25012818|NCT02612337|50106502|FG001|Overall Study|Did not receive study drug|1|||
25012819|NCT03532451|50106516|FG000|Overall Study|Withdrawal by Subject|0|||
25012820|NCT03532451|50106517|FG001|Overall Study|Withdrawal by Subject|1|||
25012821|NCT03532451|50106516|FG000|Overall Study|Progression prior to the surgery|1|||
25012822|NCT03532451|50106517|FG001|Overall Study|Progression prior to the surgery|0|||
25012823|NCT03562767|50106526|FG000|Overall Study|Physician Decision|2|||
25012824|NCT03562767|50106527|FG001|Overall Study|Physician Decision|0|||
25012825|NCT03562767|50106528|FG002|Overall Study|Physician Decision|0|||
25012826|NCT03562767|50106526|FG000|Overall Study|Logistic Reason|1|||
25012827|NCT03562767|50106527|FG001|Overall Study|Logistic Reason|3|||
25012828|NCT03562767|50106528|FG002|Overall Study|Logistic Reason|0|||
25012829|NCT03085238|50106540|FG000|Overall Study|Adverse Event|2|||
25012830|NCT03085238|50106540|FG000|Overall Study|Death|2|||
25012831|NCT03383666|50106553|FG000|Overall Study|Withdrawal by Subject|2|||
25012832|NCT03383666|50106553|FG000|Overall Study|Lost to Follow-up|2|||
25012833|NCT03086018|50106557|FG000|Final Testing for End of Trial|Adverse Event|1|||
25012834|NCT03086018|50106557|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
25012835|NCT03319953|50106567|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
25012836|NCT03319953|50106568|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
25012837|NCT03319953|50106569|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
25012838|NCT03319953|50106570|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
25012839|NCT03319953|50106567|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
25012840|NCT03319953|50106568|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
25141154|NCT02038010|50254583|FG002|Follow Up|Death|0|||
25141155|NCT02038010|50254584|FG003|Follow Up|Death|0|||
25141156|NCT02038010|50254581|FG000|Follow Up|Other|3|||
25012841|NCT03319953|50106569|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
25012842|NCT03319953|50106570|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
25012843|NCT02927834|50106581|FG000|Overall Study|Lost to Follow-up|1|||
25012844|NCT02927834|50106582|FG001|Overall Study|Lost to Follow-up|2|||
25141157|NCT02038010|50254582|FG001|Follow Up|Other|0|||
25141158|NCT02038010|50254583|FG002|Follow Up|Other|0|||
25141159|NCT02038010|50254584|FG003|Follow Up|Other|0|||
25141160|NCT01989572|50254598|FG000|Overall Study|Lack of Efficacy|35|||
25141161|NCT01989572|50254599|FG001|Overall Study|Lack of Efficacy|48|||
25141162|NCT01989572|50254600|FG002|Overall Study|Lack of Efficacy|48|||
25141163|NCT01989572|50254601|FG003|Overall Study|Lack of Efficacy|43|||
25141164|NCT01989572|50254602|FG004|Overall Study|Lack of Efficacy|71|||
25141165|NCT01989572|50254603|FG005|Overall Study|Lack of Efficacy|79|||
25012845|NCT02927834|50106583|FG002|Overall Study|Lost to Follow-up|2|||
25012846|NCT01964547|50106597|FG000|Overall Study|Adverse Event|8|||
25012847|NCT01964547|50106598|FG001|Overall Study|Adverse Event|2|||
25012848|NCT01964547|50106597|FG000|Overall Study|Withdrawal by Subject|4|||
25012849|NCT01964547|50106598|FG001|Overall Study|Withdrawal by Subject|7|||
25012850|NCT01964547|50106597|FG000|Overall Study|Lost to Follow-up|0|||
25012851|NCT01964547|50106598|FG001|Overall Study|Lost to Follow-up|1|||
25012852|NCT01964547|50106597|FG000|Overall Study|Withdrawal by Investigator|0|||
25012853|NCT01964547|50106598|FG001|Overall Study|Withdrawal by Investigator|1|||
25012854|NCT03319719|50106604|FG000|Overall Study|Lost to Follow-up|1|||
25012855|NCT03318783|50106612|FG000|Overall Study|Withdrawal by Subject|0|||
25012856|NCT03318783|50106613|FG001|Overall Study|Withdrawal by Subject|1|||
25012857|NCT03318783|50106612|FG000|Overall Study|Death|0|||
25012858|NCT03318783|50106613|FG001|Overall Study|Death|1|||
25012859|NCT01313689|50106624|FG000|24-Week Randomization 1|Adverse Event|10|||
25012860|NCT01313689|50106625|FG001|24-Week Randomization 1|Adverse Event|5|||
25012861|NCT01313689|50106626|FG002|24-Week Randomization 1|Adverse Event|0|||
25012862|NCT01313689|50106627|FG003|24-Week Randomization 1|Adverse Event|0|||
25012863|NCT01313689|50106628|FG004|24-Week Randomization 1|Adverse Event|0|||
25012864|NCT01313689|50106624|FG000|24-Week Randomization 1|Physician Decision|4|||
25012865|NCT01313689|50106625|FG001|24-Week Randomization 1|Physician Decision|5|||
25012866|NCT01313689|50106626|FG002|24-Week Randomization 1|Physician Decision|0|||
25012867|NCT01313689|50106627|FG003|24-Week Randomization 1|Physician Decision|0|||
25012868|NCT01313689|50106628|FG004|24-Week Randomization 1|Physician Decision|0|||
25141166|NCT01989572|50254598|FG000|Overall Study|Adverse Event|2|||
25012869|NCT01313689|50106624|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
25012870|NCT01313689|50106625|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
25012871|NCT01313689|50106626|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
25141167|NCT01989572|50254599|FG001|Overall Study|Adverse Event|1|||
25012872|NCT01313689|50106627|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
25141168|NCT01989572|50254600|FG002|Overall Study|Adverse Event|3|||
25012873|NCT01313689|50106628|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
25012874|NCT01313689|50106624|FG000|24-Week Randomization 2|Adverse Event|0|||
25012875|NCT01313689|50106625|FG001|24-Week Randomization 2|Adverse Event|0|||
25012876|NCT01313689|50106626|FG002|24-Week Randomization 2|Adverse Event|2|||
25012877|NCT01313689|50106627|FG003|24-Week Randomization 2|Adverse Event|0|||
25012878|NCT01313689|50106628|FG004|24-Week Randomization 2|Adverse Event|8|||
25012879|NCT01313689|50106624|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
25012880|NCT01313689|50106625|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
25012881|NCT01313689|50106626|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
25012882|NCT01313689|50106627|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
25012883|NCT01313689|50106628|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
25012884|NCT01313689|50106624|FG000|24-Week Randomization 2|Physician Decision|0|||
25012885|NCT01313689|50106625|FG001|24-Week Randomization 2|Physician Decision|0|||
25012886|NCT01313689|50106626|FG002|24-Week Randomization 2|Physician Decision|0|||
25012887|NCT01313689|50106627|FG003|24-Week Randomization 2|Physician Decision|0|||
25012888|NCT01313689|50106628|FG004|24-Week Randomization 2|Physician Decision|4|||
25012889|NCT03318315|50106650|FG000|Overall Study|Lost to Follow-up|3|||
25012890|NCT03318315|50106651|FG001|Overall Study|Lost to Follow-up|2|||
25012891|NCT03318315|50106652|FG002|Overall Study|Lost to Follow-up|1|||
25012892|NCT03318315|50106650|FG000|Overall Study|Protocol Violation|1|||
25012893|NCT03318315|50106651|FG001|Overall Study|Protocol Violation|1|||
25012894|NCT03318315|50106652|FG002|Overall Study|Protocol Violation|1|||
25012895|NCT03318315|50106650|FG000|Overall Study|Withdrawal by Subject|0|||
25012896|NCT03318315|50106651|FG001|Overall Study|Withdrawal by Subject|0|||
25012897|NCT03318315|50106652|FG002|Overall Study|Withdrawal by Subject|2|||
25012898|NCT04460183|50106663|FG000|Overall Study|Lost to Follow-up|3|||
25012899|NCT04460183|50106664|FG001|Overall Study|Lost to Follow-up|1|||
25012900|NCT04460183|50106663|FG000|Overall Study|Withdrawal by Subject|1|||
25012901|NCT04460183|50106664|FG001|Overall Study|Withdrawal by Subject|0|||
25012902|NCT03710083|50106670|FG000|Overall Study|Withdrawal by Subject|2|||
25012903|NCT03710083|50106670|FG000|Overall Study|Unsuccessful Procedure|1|||
25012904|NCT03318003|50106676|FG000|Overall Study|Withdrawal by Subject|1|||
25012905|NCT03318003|50106677|FG001|Overall Study|Withdrawal by Subject|1|||
25012906|NCT03318003|50106676|FG000|Overall Study|fetal loss|0|||
25012907|NCT03318003|50106677|FG001|Overall Study|fetal loss|1|||
25012908|NCT03317379|50106686|FG000|Overall Study|Lost to Follow-up|0|||
25012909|NCT03317379|50106687|FG001|Overall Study|Lost to Follow-up|3|||
25012910|NCT03317379|50106688|FG002|Overall Study|Lost to Follow-up|2|||
25012911|NCT03316911|50106698|FG000|Overall Study|Lost to Follow-up|33|||
25012912|NCT03316911|50106699|FG001|Overall Study|Lost to Follow-up|29|||
25012913|NCT01106391|50106705|FG000|Overall Study|Death|12|||
25012914|NCT01106391|50106705|FG000|Overall Study|Withdrawal by Subject|7|||
25012915|NCT03316131|50106709|FG000|Treatment Period 2|Protocol deviation|1|||
25012916|NCT03316131|50106710|FG001|Treatment Period 2|Protocol deviation|0|||
25012917|NCT03301415|50106716|FG000|Overall Study|Lost to Follow-up|2|||
25012918|NCT03301415|50106716|FG000|Overall Study|Unable to comply with visit schedule|2|||
25012919|NCT02732938|50106722|FG000|Overall Study|Death|0|||
25141169|NCT01989572|50254601|FG003|Overall Study|Adverse Event|0|||
25141170|NCT01989572|50254602|FG004|Overall Study|Adverse Event|3|||
25141171|NCT01989572|50254603|FG005|Overall Study|Adverse Event|0|||
25141172|NCT01989572|50254598|FG000|Overall Study|Death|0|||
25141173|NCT01989572|50254599|FG001|Overall Study|Death|0|||
25141174|NCT01989572|50254600|FG002|Overall Study|Death|0|||
25141175|NCT01989572|50254601|FG003|Overall Study|Death|0|||
25141176|NCT01989572|50254602|FG004|Overall Study|Death|1|||
25141177|NCT01989572|50254603|FG005|Overall Study|Death|0|||
25141178|NCT01989572|50254598|FG000|Overall Study|Withdrawal by Subject|4|||
25141179|NCT01989572|50254599|FG001|Overall Study|Withdrawal by Subject|1|||
25141180|NCT01989572|50254600|FG002|Overall Study|Withdrawal by Subject|5|||
25141181|NCT01989572|50254601|FG003|Overall Study|Withdrawal by Subject|1|||
25141182|NCT01989572|50254602|FG004|Overall Study|Withdrawal by Subject|12|||
25141183|NCT01989572|50254603|FG005|Overall Study|Withdrawal by Subject|4|||
25141184|NCT01989572|50254598|FG000|Overall Study|complicating disease|1|||
25012920|NCT02732938|50106723|FG001|Overall Study|Death|11|||
25012921|NCT02732938|50106724|FG002|Overall Study|Death|0|||
25012922|NCT02732938|50106722|FG000|Overall Study|Randomized but did not receive treatment|0|||
25012923|NCT02732938|50106723|FG001|Overall Study|Randomized but did not receive treatment|1|||
25141185|NCT01989572|50254599|FG001|Overall Study|complicating disease|1|||
25141186|NCT01989572|50254600|FG002|Overall Study|complicating disease|2|||
25012924|NCT02732938|50106724|FG002|Overall Study|Randomized but did not receive treatment|0|||
25141187|NCT01989572|50254601|FG003|Overall Study|complicating disease|0|||
25141188|NCT01989572|50254602|FG004|Overall Study|complicating disease|1|||
25141189|NCT01989572|50254603|FG005|Overall Study|complicating disease|0|||
25141190|NCT01989572|50254598|FG000|Overall Study|error|2|||
25141191|NCT01989572|50254599|FG001|Overall Study|error|1|||
25141192|NCT01989572|50254600|FG002|Overall Study|error|1|||
25141193|NCT01989572|50254601|FG003|Overall Study|error|1|||
25141194|NCT01989572|50254602|FG004|Overall Study|error|1|||
25141195|NCT01989572|50254603|FG005|Overall Study|error|1|||
25141196|NCT01989572|50254598|FG000|Overall Study|maximum dose reached|0|||
25141197|NCT01989572|50254599|FG001|Overall Study|maximum dose reached|1|||
25141198|NCT01989572|50254600|FG002|Overall Study|maximum dose reached|0|||
25141199|NCT01989572|50254601|FG003|Overall Study|maximum dose reached|0|||
25141200|NCT01989572|50254602|FG004|Overall Study|maximum dose reached|1|||
25141201|NCT01989572|50254603|FG005|Overall Study|maximum dose reached|0|||
25141202|NCT01989572|50254598|FG000|Overall Study|unknown/not specify|3|||
25141203|NCT01989572|50254599|FG001|Overall Study|unknown/not specify|4|||
25141204|NCT01989572|50254600|FG002|Overall Study|unknown/not specify|1|||
25141205|NCT01989572|50254601|FG003|Overall Study|unknown/not specify|3|||
25141206|NCT01989572|50254602|FG004|Overall Study|unknown/not specify|3|||
25141207|NCT01989572|50254603|FG005|Overall Study|unknown/not specify|5|||
25141208|NCT01989572|50254598|FG000|Overall Study|not start protocol therapy|5|||
25141209|NCT01989572|50254599|FG001|Overall Study|not start protocol therapy|1|||
25141210|NCT01989572|50254600|FG002|Overall Study|not start protocol therapy|2|||
25141211|NCT01989572|50254601|FG003|Overall Study|not start protocol therapy|3|||
25141212|NCT01989572|50254602|FG004|Overall Study|not start protocol therapy|4|||
25141213|NCT01989572|50254603|FG005|Overall Study|not start protocol therapy|18|||
25141214|NCT01989572|50254598|FG000|Overall Study|alternative therapy|3|||
25141215|NCT01989572|50254599|FG001|Overall Study|alternative therapy|0|||
25141216|NCT01989572|50254600|FG002|Overall Study|alternative therapy|0|||
25141217|NCT01989572|50254601|FG003|Overall Study|alternative therapy|0|||
25274382|NCT01078623|50588463|FG008|Treatment Period 2|Withdrawal by Subject|0|||
25274383|NCT01078623|50588464|FG009|Treatment Period 2|Withdrawal by Subject|0|||
25274384|NCT01078623|50588465|FG010|Treatment Period 2|Withdrawal by Subject|0|||
25274385|NCT01078623|50588466|FG011|Treatment Period 2|Withdrawal by Subject|0|||
25274386|NCT01078623|50588467|FG012|Treatment Period 2|Withdrawal by Subject|0|||
25274387|NCT01078623|50588468|FG013|Treatment Period 2|Withdrawal by Subject|0|||
25274388|NCT01078623|50588469|FG014|Treatment Period 2|Withdrawal by Subject|0|||
25274389|NCT01078623|50588470|FG015|Treatment Period 2|Withdrawal by Subject|0|||
25274390|NCT01078623|50588471|FG016|Treatment Period 2|Withdrawal by Subject|0|||
25274391|NCT01078623|50588472|FG017|Treatment Period 2|Withdrawal by Subject|0|||
25141218|NCT01989572|50254602|FG004|Overall Study|alternative therapy|1|||
25141219|NCT01989572|50254603|FG005|Overall Study|alternative therapy|3|||
25141220|NCT02036294|50254623|FG000|Overall Study|Death|7|||
25141221|NCT02036294|50254624|FG001|Overall Study|Death|8|||
25012925|NCT02732938|50106722|FG000|Overall Study|Refused further follow-up|1|||
25012926|NCT02732938|50106723|FG001|Overall Study|Refused further follow-up|0|||
25012927|NCT02732938|50106724|FG002|Overall Study|Refused further follow-up|0|||
25141222|NCT02036294|50254623|FG000|Overall Study|Withdrawal by Subject|2|||
25141223|NCT02036294|50254624|FG001|Overall Study|Withdrawal by Subject|3|||
25141224|NCT02035748|50254630|FG000|Overall Study|Adverse Event|5|||
25012928|NCT02732938|50106722|FG000|Overall Study|Study terminated by sponsor|3|||
25012929|NCT02732938|50106723|FG001|Overall Study|Study terminated by sponsor|6|||
25012930|NCT02732938|50106724|FG002|Overall Study|Study terminated by sponsor|0|||
25012931|NCT04647721|50106732|FG000|Overall Study|Withdrawal by Subject|0|||
25012932|NCT04647721|50106733|FG001|Overall Study|Withdrawal by Subject|2|||
25012933|NCT04647721|50106732|FG000|Overall Study|Lost to Follow-up|2|||
25012934|NCT04647721|50106733|FG001|Overall Study|Lost to Follow-up|0|||
25012935|NCT03718000|50106754|FG000|Overall Study|Relocation|2|||
25012936|NCT03718000|50106755|FG001|Overall Study|Relocation|4|||
25012937|NCT03718000|50106754|FG000|Overall Study|Pregnancy|0|||
25012938|NCT03718000|50106755|FG001|Overall Study|Pregnancy|1|||
25012939|NCT03063203|50106762|FG000|Overall Study|Chose alternative therapy|3|||
25012940|NCT03063203|50106762|FG000|Overall Study|Death|2|||
25012941|NCT03063203|50106762|FG000|Overall Study|Disease progression|4|||
25012942|NCT03063203|50106762|FG000|Overall Study|Physician Decision|5|||
25012943|NCT02891226|50106781|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
25012944|NCT02891226|50106782|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
25012945|NCT02891226|50106783|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
25012946|NCT02891226|50106784|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
25012947|NCT02891226|50106785|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
25012948|NCT02891226|50106786|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
25012949|NCT02891226|50106787|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
25012950|NCT02891226|50106788|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
25012951|NCT02891226|50106789|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
25012952|NCT02891226|50106790|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
25012953|NCT02891226|50106791|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
25012954|NCT02891226|50106792|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
25012955|NCT02891226|50106793|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
25012956|NCT02891226|50106794|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
25012957|NCT02891226|50106795|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
25012958|NCT02891226|50106796|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
25012959|NCT02891226|50106781|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
25012960|NCT02891226|50106782|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
25012961|NCT02891226|50106783|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25012962|NCT02891226|50106784|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25012963|NCT02891226|50106785|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25012964|NCT02891226|50106786|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25012965|NCT02891226|50106787|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25012966|NCT02891226|50106788|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25012967|NCT02891226|50106789|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25012968|NCT02891226|50106790|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25012969|NCT02891226|50106791|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25012970|NCT02891226|50106792|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25012971|NCT02891226|50106793|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25012972|NCT02891226|50106794|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25012973|NCT02891226|50106795|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25012974|NCT02891226|50106796|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25012975|NCT02891226|50106781|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
25012976|NCT02891226|50106782|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
25012977|NCT02891226|50106783|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
25012978|NCT02891226|50106784|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
25012979|NCT02891226|50106785|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
25012980|NCT02891226|50106786|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
25012981|NCT02891226|50106787|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
25012982|NCT02891226|50106788|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
25012983|NCT02891226|50106789|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
25012984|NCT02891226|50106790|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
25012985|NCT02891226|50106791|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
25012986|NCT02891226|50106792|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
25012987|NCT02891226|50106793|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
25012988|NCT02891226|50106794|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
25141225|NCT02035748|50254630|FG000|Overall Study|Death|3|||
25012989|NCT02891226|50106795|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
25012990|NCT02891226|50106796|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
25012991|NCT02891226|50106781|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
25012992|NCT02891226|50106782|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
25012993|NCT02891226|50106783|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
25012994|NCT02891226|50106784|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
25012995|NCT02891226|50106785|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
25012996|NCT02891226|50106786|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
25012997|NCT02891226|50106787|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
25012998|NCT02891226|50106788|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
25012999|NCT02891226|50106789|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
25013000|NCT02891226|50106790|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
25013001|NCT02891226|50106791|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
25013002|NCT02891226|50106792|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
25013003|NCT02891226|50106793|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
25013004|NCT02891226|50106794|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
25013005|NCT02891226|50106795|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
25013006|NCT02891226|50106796|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
25013007|NCT02891226|50106781|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
25013008|NCT02891226|50106782|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
25013009|NCT02891226|50106783|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
25013010|NCT02891226|50106784|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
25013011|NCT02891226|50106785|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
25013012|NCT02891226|50106786|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
25013013|NCT02891226|50106787|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
25013014|NCT02891226|50106788|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
25013015|NCT02891226|50106789|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
25013016|NCT02891226|50106790|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
25013017|NCT02891226|50106791|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
25013018|NCT02891226|50106792|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
25013019|NCT02891226|50106793|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
25013020|NCT02891226|50106794|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
25013021|NCT02891226|50106795|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
25013022|NCT02891226|50106796|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
25013023|NCT02891226|50106781|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
25013024|NCT02891226|50106782|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
25013025|NCT02891226|50106783|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
25013026|NCT02891226|50106784|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
25013027|NCT02891226|50106785|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
25013028|NCT02891226|50106786|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
25013029|NCT02891226|50106787|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
25013030|NCT02891226|50106788|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
25013031|NCT02891226|50106789|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
25013032|NCT02891226|50106790|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
25013033|NCT02891226|50106791|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
25013034|NCT02891226|50106792|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
25013035|NCT02891226|50106793|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
25013036|NCT02891226|50106794|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
25013037|NCT02891226|50106795|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
25013038|NCT02891226|50106796|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
25013039|NCT02891226|50106781|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
25013040|NCT02891226|50106782|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
25013041|NCT02891226|50106783|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
25013042|NCT02891226|50106784|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
25013043|NCT02891226|50106785|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
25013044|NCT02891226|50106786|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
25013045|NCT02891226|50106787|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
25013046|NCT02891226|50106788|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
25013047|NCT02891226|50106789|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
25013048|NCT02891226|50106790|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
25013049|NCT02891226|50106791|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
25013050|NCT02891226|50106792|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
25013051|NCT02891226|50106793|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
25013052|NCT02891226|50106794|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
25013053|NCT02891226|50106795|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
25013054|NCT02891226|50106796|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
25013055|NCT02891226|50106781|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
25013056|NCT02891226|50106782|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
25013057|NCT02891226|50106783|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
25013058|NCT02891226|50106784|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
25013059|NCT02891226|50106785|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
25013060|NCT02891226|50106786|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
25013061|NCT02891226|50106787|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
25013062|NCT02891226|50106788|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
25013063|NCT02891226|50106789|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
25013064|NCT02891226|50106790|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
25013065|NCT02891226|50106791|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
25013066|NCT02891226|50106792|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
25013067|NCT02891226|50106793|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
25013068|NCT02891226|50106794|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
25013069|NCT02891226|50106795|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
25013070|NCT02891226|50106796|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
25013071|NCT02891226|50106781|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
25013072|NCT02891226|50106782|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
25013073|NCT02891226|50106783|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
25013074|NCT02891226|50106784|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
25013075|NCT02891226|50106785|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
25013076|NCT02891226|50106786|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
25013077|NCT02891226|50106787|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
25013078|NCT02891226|50106788|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
25013079|NCT02891226|50106789|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
25013080|NCT02891226|50106790|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
25013081|NCT02891226|50106791|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
25013082|NCT02891226|50106792|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
25013083|NCT02891226|50106793|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
25013084|NCT02891226|50106794|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
25013085|NCT02891226|50106795|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
25013086|NCT02891226|50106796|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
25013087|NCT02891226|50106781|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
25013088|NCT02891226|50106782|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
25013089|NCT02891226|50106783|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
25013090|NCT02891226|50106784|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
25013091|NCT02891226|50106785|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
25013092|NCT02891226|50106786|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
25013093|NCT02891226|50106787|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
25013094|NCT02891226|50106788|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
25013095|NCT02891226|50106789|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
25013096|NCT02891226|50106790|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
25141226|NCT02035748|50254630|FG000|Overall Study|Lost to Follow-up|2|||
25141227|NCT02035748|50254630|FG000|Overall Study|Physician Decision|3|||
25141228|NCT02035748|50254630|FG000|Overall Study|Withdrawal by Subject|6|||
25141229|NCT02035748|50254630|FG000|Overall Study|Progressive Disease|1|||
25141230|NCT02014376|50254638|FG000|Overall Study|Adverse Event|1|||
25141231|NCT02014376|50254639|FG001|Overall Study|Adverse Event|1|||
25141232|NCT02014376|50254640|FG002|Overall Study|Adverse Event|0|||
25141233|NCT02014376|50254638|FG000|Overall Study|Lost to Follow-up|2|||
25141234|NCT02014376|50254639|FG001|Overall Study|Lost to Follow-up|0|||
25141235|NCT02014376|50254640|FG002|Overall Study|Lost to Follow-up|0|||
25141236|NCT02035202|50254651|FG000|Overall Study|Lost to Follow-up|8|||
25141237|NCT02035202|50254652|FG001|Overall Study|Lost to Follow-up|16|||
25141238|NCT02035202|50254653|FG002|Overall Study|Lost to Follow-up|2|||
25141239|NCT01988402|50254663|FG000|Overall Study|Adverse Event|1|||
25013097|NCT02891226|50106791|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
25013098|NCT02891226|50106792|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
25013099|NCT02891226|50106793|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
25013100|NCT02891226|50106794|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
25013101|NCT02891226|50106795|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
25013102|NCT02891226|50106796|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
25013103|NCT02891226|50106781|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
25013104|NCT02891226|50106782|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
25013105|NCT02891226|50106783|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
25013106|NCT02891226|50106784|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
25013107|NCT02891226|50106785|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
25141240|NCT01988402|50254664|FG001|Overall Study|Adverse Event|2|||
25141241|NCT01988402|50254663|FG000|Overall Study|Withdrawal by Subject|1|||
25141242|NCT01988402|50254664|FG001|Overall Study|Withdrawal by Subject|0|||
25141243|NCT01988090|50254672|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
25141244|NCT01988090|50254673|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
25141245|NCT01988090|50254672|FG000|Start Treament After Randomization|Protocol Violation|0|||
25141246|NCT01988090|50254673|FG001|Start Treament After Randomization|Protocol Violation|1|||
25141247|NCT01988090|50254672|FG000|Complete Study After Start|Withdrawal by Subject|2|||
25141248|NCT01988090|50254673|FG001|Complete Study After Start|Withdrawal by Subject|0|||
25141249|NCT01988090|50254672|FG000|Complete Study After Start|Protocol Violation|1|||
25013108|NCT02891226|50106786|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
25013109|NCT02891226|50106787|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
25013110|NCT02891226|50106788|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
25013111|NCT02891226|50106789|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
25013112|NCT02891226|50106790|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
25013113|NCT02891226|50106791|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
25013114|NCT02891226|50106792|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
25013115|NCT02891226|50106793|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
25013116|NCT02891226|50106794|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
25013117|NCT02891226|50106795|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
25013118|NCT02891226|50106796|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
25013119|NCT02891226|50106781|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
25013120|NCT02891226|50106782|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
25013121|NCT02891226|50106783|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
25013122|NCT02891226|50106784|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
25013123|NCT02891226|50106785|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
25013124|NCT02891226|50106786|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
25013125|NCT02891226|50106787|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
25013126|NCT02891226|50106788|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
25013127|NCT02891226|50106789|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
25013128|NCT02891226|50106790|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
25013129|NCT02891226|50106791|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
25013130|NCT02891226|50106792|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
25013131|NCT02891226|50106793|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
25013132|NCT02891226|50106794|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
25013133|NCT02891226|50106795|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
25013134|NCT02891226|50106796|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
25141250|NCT01988090|50254673|FG001|Complete Study After Start|Protocol Violation|1|||
25141251|NCT01988012|50254679|FG000|Overall Study|Adverse Event|5|||
25141252|NCT01988012|50254679|FG000|Overall Study|Insufficient Therapeutic Response|3|||
25141253|NCT01988012|50254679|FG000|Overall Study|Patient Withdrawal of Consent|4|||
25141254|NCT01988012|50254679|FG000|Overall Study|Lost to Follow-up|1|||
25141255|NCT01988012|50254679|FG000|Overall Study|Physician Decision|1|||
25141256|NCT01988012|50254679|FG000|Overall Study|Protocol Violation|1|||
25141257|NCT02011945|50254686|FG000|Overall Study|Participant requested to Discontinue|0|||
25141258|NCT02011945|50254687|FG001|Overall Study|Participant requested to Discontinue|1|||
25141259|NCT02011945|50254688|FG002|Overall Study|Participant requested to Discontinue|1|||
25141260|NCT02011945|50254686|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
25141261|NCT02011945|50254687|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
25141262|NCT02011945|50254688|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
25141263|NCT02011945|50254686|FG000|Overall Study|Study Drug Toxicity|0|||
25141264|NCT02011945|50254687|FG001|Overall Study|Study Drug Toxicity|0|||
25141265|NCT02011945|50254688|FG002|Overall Study|Study Drug Toxicity|1|||
25141266|NCT02011945|50254686|FG000|Overall Study|Treatment Failure|0|||
25141267|NCT02011945|50254687|FG001|Overall Study|Treatment Failure|7|||
25141268|NCT02011945|50254688|FG002|Overall Study|Treatment Failure|6|||
25141269|NCT02011945|50254686|FG000|Overall Study|No Longer Meets Study Criteria|1|||
25141270|NCT02011945|50254687|FG001|Overall Study|No Longer Meets Study Criteria|0|||
25141271|NCT02011945|50254688|FG002|Overall Study|No Longer Meets Study Criteria|0|||
25141272|NCT02011945|50254686|FG000|Overall Study|Proceeded to stem cell transplant|0|||
25141273|NCT02011945|50254687|FG001|Overall Study|Proceeded to stem cell transplant|0|||
25141274|NCT02011945|50254688|FG002|Overall Study|Proceeded to stem cell transplant|1|||
25013135|NCT02891226|50106781|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
25013136|NCT02891226|50106782|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
25013137|NCT02891226|50106783|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
25013138|NCT02891226|50106784|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
25013139|NCT02891226|50106785|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
25013140|NCT02891226|50106786|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
25013141|NCT02891226|50106787|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
25013142|NCT02891226|50106788|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
25013143|NCT02891226|50106789|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
25013144|NCT02891226|50106790|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
25013145|NCT02891226|50106791|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
25013146|NCT02891226|50106792|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
25141275|NCT02011945|50254686|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
25141276|NCT02011945|50254687|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
25141277|NCT02011945|50254688|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
25013147|NCT02891226|50106793|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
25013148|NCT02891226|50106794|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
25013149|NCT02891226|50106795|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
25013150|NCT02891226|50106796|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
25013151|NCT02891226|50106781|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
25013152|NCT02891226|50106782|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
25013153|NCT02891226|50106783|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
25013154|NCT02891226|50106784|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
25013155|NCT02891226|50106785|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
25013156|NCT02891226|50106786|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
25013157|NCT02891226|50106787|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
25013158|NCT02891226|50106788|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
25013159|NCT02891226|50106789|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
25013160|NCT02891226|50106790|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
25013161|NCT02891226|50106791|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
25013162|NCT02891226|50106792|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
25013163|NCT02891226|50106793|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
25013164|NCT02891226|50106794|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
25141278|NCT02013830|50254696|FG000|Overall Study|Adverse Event|3|||
25013165|NCT02891226|50106795|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
25013166|NCT02891226|50106796|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
25013167|NCT02891226|50106781|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
25013168|NCT02891226|50106782|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
25013169|NCT02891226|50106783|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
25013170|NCT02891226|50106784|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
25013171|NCT02891226|50106785|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
25013172|NCT02891226|50106786|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
25013173|NCT02891226|50106787|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
25013174|NCT02891226|50106788|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
25013175|NCT02891226|50106789|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
25013176|NCT02891226|50106790|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
25013177|NCT02891226|50106791|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
25013178|NCT02891226|50106792|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
25013179|NCT02891226|50106793|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
25013180|NCT02891226|50106794|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
25013181|NCT02891226|50106795|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
25013182|NCT02891226|50106796|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
25013183|NCT02891226|50106781|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
25013184|NCT02891226|50106782|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
25013185|NCT02891226|50106783|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
25013186|NCT02891226|50106784|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
25013187|NCT02891226|50106785|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
25013188|NCT02891226|50106786|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
25013189|NCT02891226|50106787|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
25013190|NCT02891226|50106788|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
25013191|NCT02891226|50106789|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
25013192|NCT02891226|50106790|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
25013193|NCT02891226|50106791|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
25013194|NCT02891226|50106792|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
25013195|NCT02891226|50106793|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
25013196|NCT02891226|50106794|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
25013197|NCT02891226|50106795|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
25013198|NCT02891226|50106796|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
25013199|NCT02891226|50106781|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
25013200|NCT02891226|50106782|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
25141279|NCT02013830|50254696|FG000|Overall Study|Death|1|||
25141280|NCT02013830|50254696|FG000|Overall Study|Insufficient therapeutic response|25|||
25141281|NCT02013830|50254696|FG000|Overall Study|Refused treatment|1|||
25141282|NCT02010775|50254705|FG000|Overall Study|Adverse Event|0|||
25013201|NCT02891226|50106783|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
25013202|NCT02891226|50106784|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
25141283|NCT02010775|50254706|FG001|Overall Study|Adverse Event|0|||
25141284|NCT02010775|50254707|FG002|Overall Study|Adverse Event|0|||
25141285|NCT02010775|50254708|FG003|Overall Study|Adverse Event|0|||
25013203|NCT02891226|50106785|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
25013204|NCT02891226|50106786|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
25013205|NCT02891226|50106787|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
25013206|NCT02891226|50106788|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
25013207|NCT02891226|50106789|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
25013208|NCT02891226|50106790|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
25013209|NCT02891226|50106791|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
25013210|NCT02891226|50106792|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
25013211|NCT02891226|50106793|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
25013212|NCT02891226|50106794|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
25013213|NCT02891226|50106795|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
25013214|NCT02891226|50106796|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
25013215|NCT02891226|50106781|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
25013216|NCT02891226|50106782|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
25013217|NCT02891226|50106783|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
25013218|NCT02891226|50106784|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
25013219|NCT02891226|50106785|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
25013220|NCT02891226|50106786|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
25013221|NCT02891226|50106787|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
25013222|NCT02891226|50106788|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
25141286|NCT02010775|50254709|FG004|Overall Study|Adverse Event|1|||
25141287|NCT02010775|50254705|FG000|Overall Study|Pregnancy|0|||
25141288|NCT02010775|50254706|FG001|Overall Study|Pregnancy|0|||
25141289|NCT02010775|50254707|FG002|Overall Study|Pregnancy|2|||
25013223|NCT02891226|50106789|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
25013224|NCT02891226|50106790|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
25013225|NCT02891226|50106791|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
25013226|NCT02891226|50106792|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
25013227|NCT02891226|50106793|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
25013228|NCT02891226|50106794|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
25013229|NCT02891226|50106795|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
25013230|NCT02891226|50106796|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
25013231|NCT02891226|50106781|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
25013232|NCT02891226|50106782|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
25013233|NCT02891226|50106783|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
25013234|NCT02891226|50106784|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
25013235|NCT02891226|50106785|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
25013236|NCT02891226|50106786|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
25013237|NCT02891226|50106787|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
25013238|NCT02891226|50106788|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
25013239|NCT02891226|50106789|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
25013240|NCT02891226|50106790|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
25013241|NCT02891226|50106791|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
25013242|NCT02891226|50106792|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
25013243|NCT02891226|50106793|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
25013244|NCT02891226|50106794|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
25013245|NCT02891226|50106795|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
25013246|NCT02891226|50106796|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
25013247|NCT02891226|50106781|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
25141290|NCT02010775|50254708|FG003|Overall Study|Pregnancy|0|||
25141291|NCT02010775|50254709|FG004|Overall Study|Pregnancy|0|||
25141292|NCT02010775|50254705|FG000|Overall Study|Lost to Follow-up|2|||
25141293|NCT02010775|50254706|FG001|Overall Study|Lost to Follow-up|0|||
25141294|NCT02010775|50254707|FG002|Overall Study|Lost to Follow-up|0|||
25141295|NCT02010775|50254708|FG003|Overall Study|Lost to Follow-up|1|||
25141296|NCT02010775|50254709|FG004|Overall Study|Lost to Follow-up|1|||
25141297|NCT02010775|50254705|FG000|Overall Study|Personal Reasons|3|||
25141298|NCT02010775|50254706|FG001|Overall Study|Personal Reasons|3|||
25141299|NCT02010775|50254707|FG002|Overall Study|Personal Reasons|1|||
25141300|NCT02010775|50254708|FG003|Overall Study|Personal Reasons|2|||
25141301|NCT02010775|50254709|FG004|Overall Study|Personal Reasons|4|||
25141302|NCT01993615|50254723|FG000|Overall Study|Death|1|||
25141303|NCT01993615|50254724|FG001|Overall Study|Death|0|||
25141304|NCT01619059|50254732|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
25141305|NCT01619059|50254733|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
25141306|NCT01619059|50254732|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
25141307|NCT01619059|50254733|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
25141308|NCT01619059|50254732|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
25141309|NCT01619059|50254733|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
25141310|NCT01619059|50254732|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
25141311|NCT01619059|50254733|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
25141312|NCT01619059|50254732|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
25141313|NCT01619059|50254733|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
25141314|NCT01619059|50254732|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
25141315|NCT01619059|50254733|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
25141316|NCT01619059|50254732|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
25013248|NCT02891226|50106782|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
25141317|NCT01619059|50254733|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
25141318|NCT01619059|50254732|FG000|Long-Term (LT) Treatment Period|Death|1|||
25141319|NCT01619059|50254733|FG001|Long-Term (LT) Treatment Period|Death|0|||
25141320|NCT01619059|50254732|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
25013249|NCT02891226|50106783|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
25013250|NCT02891226|50106784|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
25013251|NCT02891226|50106785|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
25013252|NCT02891226|50106786|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
25013253|NCT02891226|50106787|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
25013254|NCT02891226|50106788|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
25013255|NCT02891226|50106789|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
25013256|NCT02891226|50106790|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
25013257|NCT02891226|50106791|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
25013258|NCT02891226|50106792|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
25013259|NCT02891226|50106793|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
25013260|NCT02891226|50106794|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
25141321|NCT01619059|50254733|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
25141322|NCT01619059|50254732|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
25179179|NCT01693562|50324396|FG010|Expansion Phase|Other|4|||
25013261|NCT02891226|50106795|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
25013262|NCT02891226|50106796|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
25013263|NCT02891226|50106781|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
25013264|NCT02891226|50106782|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
25013265|NCT02891226|50106783|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
25013266|NCT02891226|50106784|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
25013267|NCT02891226|50106785|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
25013268|NCT02891226|50106786|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
25013269|NCT02891226|50106787|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
25013270|NCT02891226|50106788|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
25013271|NCT02891226|50106789|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
25013272|NCT02891226|50106790|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
25013273|NCT02891226|50106791|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
25013274|NCT02891226|50106792|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
25013275|NCT02891226|50106793|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
25013276|NCT02891226|50106794|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
25013277|NCT02891226|50106795|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
25013278|NCT02891226|50106796|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
25013279|NCT02891226|50106781|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
25013280|NCT02891226|50106782|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
25013281|NCT02891226|50106783|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
25013282|NCT02891226|50106784|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
25013283|NCT02891226|50106785|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
25013284|NCT02891226|50106786|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
25013285|NCT02891226|50106787|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
25013286|NCT02891226|50106788|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
25013287|NCT02891226|50106789|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
25013288|NCT02891226|50106790|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
25013289|NCT02891226|50106791|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
25013290|NCT02891226|50106792|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
25013291|NCT02891226|50106793|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
25013292|NCT02891226|50106794|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
25013293|NCT02891226|50106795|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
25013294|NCT02891226|50106796|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
25013295|NCT02891226|50106781|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
25013296|NCT02891226|50106782|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
25013297|NCT02891226|50106783|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
25013298|NCT02891226|50106784|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
25013299|NCT02891226|50106785|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
25013300|NCT02891226|50106786|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
25013301|NCT02891226|50106787|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
25013302|NCT02891226|50106788|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
25013303|NCT02891226|50106789|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
25013304|NCT02891226|50106790|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
25013305|NCT02891226|50106791|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
25013306|NCT02891226|50106792|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
25013307|NCT02891226|50106793|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
25013308|NCT02891226|50106794|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
25013309|NCT02891226|50106795|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
25013310|NCT02891226|50106796|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
25013311|NCT02891226|50106781|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
25013312|NCT02891226|50106782|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
25013313|NCT02891226|50106783|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
25013314|NCT02891226|50106784|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
25013315|NCT02891226|50106785|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
25013316|NCT02891226|50106786|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
25013317|NCT02891226|50106787|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
25013318|NCT02891226|50106788|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
25013319|NCT02891226|50106789|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
25013320|NCT02891226|50106790|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
25013321|NCT02891226|50106791|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
25013322|NCT02891226|50106792|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
25013323|NCT02891226|50106793|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
25013324|NCT02891226|50106794|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
25013325|NCT02891226|50106795|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
25013326|NCT02891226|50106796|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
25013327|NCT02891226|50106781|FG000|Follow-up Period|Withdrawal by Subject|0|||
25013328|NCT02891226|50106782|FG001|Follow-up Period|Withdrawal by Subject|0|||
25013329|NCT02891226|50106783|FG002|Follow-up Period|Withdrawal by Subject|0|||
25013330|NCT02891226|50106784|FG003|Follow-up Period|Withdrawal by Subject|0|||
25013331|NCT02891226|50106785|FG004|Follow-up Period|Withdrawal by Subject|0|||
25013332|NCT02891226|50106786|FG005|Follow-up Period|Withdrawal by Subject|0|||
25013333|NCT02891226|50106787|FG006|Follow-up Period|Withdrawal by Subject|0|||
25013334|NCT02891226|50106788|FG007|Follow-up Period|Withdrawal by Subject|0|||
25013335|NCT02891226|50106789|FG008|Follow-up Period|Withdrawal by Subject|0|||
25013336|NCT02891226|50106790|FG009|Follow-up Period|Withdrawal by Subject|0|||
25013337|NCT02891226|50106791|FG010|Follow-up Period|Withdrawal by Subject|0|||
25013338|NCT02891226|50106792|FG011|Follow-up Period|Withdrawal by Subject|1|||
25013339|NCT02891226|50106793|FG012|Follow-up Period|Withdrawal by Subject|0|||
25013340|NCT02891226|50106794|FG013|Follow-up Period|Withdrawal by Subject|0|||
25013341|NCT02891226|50106795|FG014|Follow-up Period|Withdrawal by Subject|1|||
25013342|NCT02891226|50106796|FG015|Follow-up Period|Withdrawal by Subject|1|||
25013343|NCT03612856|50106823|FG000|Pre-dose Period|Physician Decision|0|||
25013344|NCT03612856|50106824|FG001|Pre-dose Period|Physician Decision|1|||
25013345|NCT03612856|50106825|FG002|Pre-dose Period|Physician Decision|1|||
25013346|NCT03612856|50106823|FG000|Pre-dose Period|Withdrawal by Subject|0|||
25141323|NCT01619059|50254733|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
25013347|NCT03612856|50106824|FG001|Pre-dose Period|Withdrawal by Subject|1|||
25013348|NCT03612856|50106825|FG002|Pre-dose Period|Withdrawal by Subject|0|||
25013349|NCT03333837|50106838|FG000|Overall Study|Adverse Event|2|||
25013350|NCT03333837|50106839|FG001|Overall Study|Adverse Event|1|||
25013351|NCT03333837|50106840|FG002|Overall Study|Adverse Event|1|||
25013352|NCT03333837|50106841|FG003|Overall Study|Adverse Event|1|||
25013353|NCT03333837|50106842|FG004|Overall Study|Adverse Event|0|||
25013354|NCT03333837|50106838|FG000|Overall Study|Caregiver withdrew|0|||
25013355|NCT03333837|50106839|FG001|Overall Study|Caregiver withdrew|2|||
25013356|NCT03333837|50106840|FG002|Overall Study|Caregiver withdrew|1|||
25013357|NCT03333837|50106841|FG003|Overall Study|Caregiver withdrew|0|||
25013358|NCT03333837|50106842|FG004|Overall Study|Caregiver withdrew|0|||
25013359|NCT03333837|50106838|FG000|Overall Study|Withdrawal by Subject|0|||
25013360|NCT03333837|50106839|FG001|Overall Study|Withdrawal by Subject|0|||
25013361|NCT03333837|50106840|FG002|Overall Study|Withdrawal by Subject|1|||
25013362|NCT03333837|50106841|FG003|Overall Study|Withdrawal by Subject|1|||
25013363|NCT03333837|50106842|FG004|Overall Study|Withdrawal by Subject|3|||
25013364|NCT03333837|50106838|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
25013365|NCT03333837|50106839|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
25013366|NCT03333837|50106840|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
25013367|NCT03333837|50106841|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
25013368|NCT03333837|50106842|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
25013369|NCT03708211|50106860|FG000|Overall Study|Progressive Disease|10|||
25013370|NCT03708211|50106861|FG001|Overall Study|Progressive Disease|7|||
25013371|NCT03708211|50106860|FG000|Overall Study|Withdrawal by Subject|0|||
25013372|NCT03708211|50106861|FG001|Overall Study|Withdrawal by Subject|1|||
25013373|NCT03708211|50106860|FG000|Overall Study|Other|2|||
25013374|NCT03708211|50106861|FG001|Overall Study|Other|0|||
25013375|NCT02948634|50106871|FG000|Overall Study|Lack of efficacy and study suspended|10|||
25013376|NCT02948634|50106872|FG001|Overall Study|Lack of efficacy and study suspended|2|||
25013377|NCT02945046|50106881|FG000|Overall Study|Adverse Event|1|||
25013378|NCT02945046|50106882|FG001|Overall Study|Adverse Event|0|||
25013379|NCT02945046|50106883|FG002|Overall Study|Adverse Event|2|||
25013380|NCT02945046|50106881|FG000|Overall Study|Withdrawal by Subject|3|||
25013381|NCT02945046|50106882|FG001|Overall Study|Withdrawal by Subject|3|||
25013382|NCT02945046|50106883|FG002|Overall Study|Withdrawal by Subject|3|||
25013383|NCT02945046|50106881|FG000|Overall Study|Protocol Violation|2|||
25013384|NCT02945046|50106882|FG001|Overall Study|Protocol Violation|3|||
25013385|NCT02945046|50106883|FG002|Overall Study|Protocol Violation|2|||
25013386|NCT02945046|50106881|FG000|Overall Study|Lost to Follow-up|1|||
25013387|NCT02945046|50106882|FG001|Overall Study|Lost to Follow-up|1|||
25013388|NCT02945046|50106883|FG002|Overall Study|Lost to Follow-up|0|||
25013389|NCT02945046|50106881|FG000|Overall Study|Lack of Efficacy|1|||
25013390|NCT02945046|50106882|FG001|Overall Study|Lack of Efficacy|2|||
25013391|NCT02945046|50106883|FG002|Overall Study|Lack of Efficacy|1|||
25013392|NCT02945046|50106881|FG000|Overall Study|Other than specified|5|||
25013393|NCT02945046|50106882|FG001|Overall Study|Other than specified|4|||
25013394|NCT02945046|50106883|FG002|Overall Study|Other than specified|7|||
25141324|NCT02013206|50254741|FG000|Overall Study|Progressive disease (PD)|14|||
25141325|NCT02013206|50254742|FG001|Overall Study|Progressive disease (PD)|17|||
25141326|NCT02013206|50254741|FG000|Overall Study|Symptomatic deterioration|3|||
25141327|NCT02013206|50254742|FG001|Overall Study|Symptomatic deterioration|1|||
25141328|NCT02013206|50254741|FG000|Overall Study|Adverse Event|1|||
25141329|NCT02013206|50254742|FG001|Overall Study|Adverse Event|0|||
25141330|NCT02013206|50254741|FG000|Overall Study|Patient refusal|2|||
25141331|NCT02013206|50254742|FG001|Overall Study|Patient refusal|0|||
25141332|NCT02013206|50254741|FG000|Overall Study|Patient non-compliance|1|||
25141333|NCT02013206|50254742|FG001|Overall Study|Patient non-compliance|0|||
25141334|NCT02013206|50254741|FG000|Overall Study|Death|1|||
25141335|NCT02013206|50254742|FG001|Overall Study|Death|2|||
25141336|NCT02013206|50254741|FG000|Overall Study|Other reasons off treatment|5|||
25141337|NCT02013206|50254742|FG001|Overall Study|Other reasons off treatment|2|||
25141338|NCT01807923|50254751|FG000|Overall Study|Adverse Event|2|||
25141339|NCT01807923|50254752|FG001|Overall Study|Adverse Event|1|||
25013395|NCT03705793|50106893|FG000|Overall Study|Lost to Follow-up|3|||
25013396|NCT03705793|50106894|FG001|Overall Study|Lost to Follow-up|4|||
25013397|NCT03705793|50106893|FG000|Overall Study|Withdrawal by Subject|2|||
25013398|NCT03705793|50106894|FG001|Overall Study|Withdrawal by Subject|1|||
25013399|NCT02944968|50106913|FG000|Overall Study|Subject excluded before study procedure|1|||
25013400|NCT02944968|50106913|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
25013401|NCT03761797|50106917|FG000|Overall Study|Changing hospital|11|||
25013402|NCT03761797|50106917|FG000|Overall Study|Improvement/remission|6|||
25141340|NCT01807923|50254753|FG002|Overall Study|Adverse Event|2|||
25141341|NCT01807923|50254751|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
25141342|NCT01807923|50254752|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
25013403|NCT03761797|50106917|FG000|Overall Study|Withdrawal by Subject|19|||
25013404|NCT03761797|50106917|FG000|Overall Study|Lost to Follow-up|33|||
25013405|NCT03761797|50106917|FG000|Overall Study|Adverse Event|37|||
25013406|NCT03761797|50106917|FG000|Overall Study|Case report form (CRF) not collected|5|||
25013407|NCT03761797|50106917|FG000|Overall Study|No patient visit after entry|13|||
25013408|NCT03761797|50106917|FG000|Overall Study|Switch to other diabetes medication|10|||
25013409|NCT03761797|50106917|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
25013410|NCT03761797|50106917|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
25013411|NCT03761797|50106917|FG000|Overall Study|Insufficient effectives|2|||
25013412|NCT03761797|50106917|FG000|Overall Study|Excessive alcohol intake|1|||
25013413|NCT02944656|50106923|FG000|Overall Study|No longer eligible|3|||
25013414|NCT02944656|50106924|FG001|Overall Study|No longer eligible|0|||
25013415|NCT02944656|50106923|FG000|Overall Study|Lost to Follow-up|7|||
25013416|NCT02944656|50106924|FG001|Overall Study|Lost to Follow-up|10|||
25013417|NCT02713529|50106937|FG000|Overall Study|Withdrawal by Subject|3|||
25013418|NCT02713529|50106938|FG001|Overall Study|Withdrawal by Subject|1|||
25013419|NCT02713529|50106939|FG002|Overall Study|Withdrawal by Subject|4|||
25013420|NCT02713529|50106940|FG003|Overall Study|Withdrawal by Subject|2|||
25013421|NCT02713529|50106941|FG004|Overall Study|Withdrawal by Subject|0|||
25013422|NCT02713529|50106942|FG005|Overall Study|Withdrawal by Subject|1|||
25013423|NCT02713529|50106943|FG006|Overall Study|Withdrawal by Subject|1|||
25013424|NCT02713529|50106937|FG000|Overall Study|Lost to Follow-up|1|||
25013425|NCT02713529|50106938|FG001|Overall Study|Lost to Follow-up|0|||
25013426|NCT02713529|50106939|FG002|Overall Study|Lost to Follow-up|1|||
25013427|NCT02713529|50106940|FG003|Overall Study|Lost to Follow-up|0|||
25013428|NCT02713529|50106941|FG004|Overall Study|Lost to Follow-up|0|||
25013429|NCT02713529|50106942|FG005|Overall Study|Lost to Follow-up|0|||
25013430|NCT02713529|50106943|FG006|Overall Study|Lost to Follow-up|0|||
25013431|NCT02713529|50106937|FG000|Overall Study|Death|3|||
25013432|NCT02713529|50106938|FG001|Overall Study|Death|3|||
25013433|NCT02713529|50106939|FG002|Overall Study|Death|26|||
25013434|NCT02713529|50106940|FG003|Overall Study|Death|27|||
25013435|NCT02713529|50106941|FG004|Overall Study|Death|3|||
25013436|NCT02713529|50106942|FG005|Overall Study|Death|13|||
25013437|NCT02713529|50106943|FG006|Overall Study|Death|3|||
25013438|NCT03707821|50106969|FG000|Overall Study|Protocol Violation|0|||
25013439|NCT03707821|50106970|FG001|Overall Study|Protocol Violation|1|||
25013440|NCT03707821|50106969|FG000|Overall Study|Unsatisfactory Visual Response|1|||
25013441|NCT03707821|50106970|FG001|Overall Study|Unsatisfactory Visual Response|0|||
25013442|NCT03707821|50106969|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
25013443|NCT03707821|50106970|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
25013444|NCT04546581|50106978|FG000|Overall Study|Adverse Event|9|||
25013445|NCT04546581|50106979|FG001|Overall Study|Adverse Event|3|||
25013446|NCT04546581|50106978|FG000|Overall Study|Physician Decision|0|||
25013447|NCT04546581|50106979|FG001|Overall Study|Physician Decision|1|||
25013448|NCT04546581|50106978|FG000|Overall Study|Protocol Violation|1|||
25013449|NCT04546581|50106979|FG001|Overall Study|Protocol Violation|2|||
25013450|NCT04546581|50106978|FG000|Overall Study|Withdrawal by Subject|3|||
25013451|NCT04546581|50106979|FG001|Overall Study|Withdrawal by Subject|7|||
25013452|NCT03707587|50106987|FG000|Overall Study|Death|0|||
25141343|NCT01807923|50254753|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
25141344|NCT01807923|50254751|FG000|Overall Study|Physician Decision|0|||
25141345|NCT01807923|50254752|FG001|Overall Study|Physician Decision|0|||
25141346|NCT01807923|50254753|FG002|Overall Study|Physician Decision|1|||
25141347|NCT01807923|50254751|FG000|Overall Study|Not Eligible (Genotype)|0|||
25141348|NCT01807923|50254752|FG001|Overall Study|Not Eligible (Genotype)|0|||
25141349|NCT01807923|50254753|FG002|Overall Study|Not Eligible (Genotype)|1|||
25141350|NCT01807923|50254751|FG000|Overall Study|Randomized But Not Treated|3|||
25141351|NCT01807923|50254752|FG001|Overall Study|Randomized But Not Treated|2|||
25141352|NCT01807923|50254753|FG002|Overall Study|Randomized But Not Treated|5|||
25141353|NCT01966003|50254765|FG000|Overall Study|Death|43|||
25013453|NCT03707587|50106988|FG001|Overall Study|Death|1|||
25141354|NCT01966003|50254766|FG001|Overall Study|Death|36|||
25141355|NCT01966003|50254765|FG000|Overall Study|Protocol Violation|6|||
25141356|NCT01966003|50254766|FG001|Overall Study|Protocol Violation|4|||
25141357|NCT01966003|50254765|FG000|Overall Study|Lost to Follow-up|4|||
25141358|NCT01966003|50254766|FG001|Overall Study|Lost to Follow-up|3|||
25013454|NCT03312933|50106994|FG000|Overall Study|Protocol Violation|15|||
25013455|NCT03312933|50106994|FG000|Overall Study|Lost to Follow-up|36|||
25013456|NCT03312933|50106994|FG000|Overall Study|Withdrawal by Subject|3|||
25013457|NCT02561273|50107000|FG000|Overall Study|Protocol Violation|1|||
25013458|NCT02561273|50107001|FG001|Overall Study|Protocol Violation|0|||
25013459|NCT03312543|50107011|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
25013460|NCT03312543|50107012|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
25013461|NCT03312543|50107011|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
25141359|NCT01966003|50254765|FG000|Overall Study|Physician Decision|12|||
25141360|NCT01966003|50254766|FG001|Overall Study|Physician Decision|13|||
25141361|NCT01966003|50254765|FG000|Overall Study|Withdrawal by Subject|29|||
25013462|NCT03312543|50107012|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
25013463|NCT03312543|50107011|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
25013464|NCT03312543|50107012|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
25013465|NCT03312543|50107011|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
25013466|NCT03312543|50107012|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
25013467|NCT03312543|50107011|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
25013468|NCT03312543|50107012|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
25013469|NCT03312543|50107011|FG000|Regression (Week 12 to Week 24)|Death|0|||
25013470|NCT03312543|50107012|FG001|Regression (Week 12 to Week 24)|Death|1|||
25013471|NCT02392559|50107020|FG000|Overall Study|Withdrawal by Subject|0|||
25013472|NCT02392559|50107021|FG001|Overall Study|Withdrawal by Subject|1|||
25013473|NCT03332589|50107035|FG000|Overall Study|Lack of Efficacy|2|||
25013474|NCT03332589|50107036|FG001|Overall Study|Lack of Efficacy|0|||
25013475|NCT03332589|50107037|FG002|Overall Study|Lack of Efficacy|0|||
25013476|NCT03332589|50107035|FG000|Overall Study|Adverse Event|1|||
25013477|NCT03332589|50107036|FG001|Overall Study|Adverse Event|0|||
25013478|NCT03332589|50107037|FG002|Overall Study|Adverse Event|0|||
25013479|NCT03332589|50107035|FG000|Overall Study|Death|1|||
25013480|NCT03332589|50107036|FG001|Overall Study|Death|0|||
25013481|NCT03332589|50107037|FG002|Overall Study|Death|0|||
25013482|NCT00458003|50107047|FG000|Overall Study|Non protocol spinal anesthesia|1|||
25013483|NCT00458003|50107048|FG001|Overall Study|Non protocol spinal anesthesia|1|||
25013484|NCT02061293|50107058|FG000|Overall Study|Elevated Blood Pressure|1|||
25013485|NCT02061293|50107059|FG001|Overall Study|Elevated Blood Pressure|1|||
25013486|NCT02913612|50107069|FG000|Overall Study|Lost to Follow-up|6|||
25013487|NCT02913612|50107070|FG001|Overall Study|Lost to Follow-up|5|||
25013488|NCT02913612|50107071|FG002|Overall Study|Lost to Follow-up|2|||
25013489|NCT02913612|50107072|FG003|Overall Study|Lost to Follow-up|0|||
25013490|NCT02913612|50107069|FG000|Overall Study|Physician Decision|1|||
25013491|NCT02913612|50107070|FG001|Overall Study|Physician Decision|4|||
25013492|NCT02913612|50107071|FG002|Overall Study|Physician Decision|1|||
25013493|NCT02913612|50107072|FG003|Overall Study|Physician Decision|0|||
25013494|NCT02913612|50107069|FG000|Overall Study|Withdrawal by Subject|2|||
25013495|NCT02913612|50107070|FG001|Overall Study|Withdrawal by Subject|4|||
25013496|NCT02913612|50107071|FG002|Overall Study|Withdrawal by Subject|0|||
25013497|NCT02913612|50107072|FG003|Overall Study|Withdrawal by Subject|0|||
25013498|NCT02913612|50107069|FG000|Overall Study|Hemangioma resolved|1|||
25013499|NCT02913612|50107070|FG001|Overall Study|Hemangioma resolved|0|||
25013500|NCT02913612|50107071|FG002|Overall Study|Hemangioma resolved|0|||
25013501|NCT02913612|50107072|FG003|Overall Study|Hemangioma resolved|0|||
25013502|NCT02913612|50107069|FG000|Overall Study|Local IRB decision|1|||
25013503|NCT02913612|50107070|FG001|Overall Study|Local IRB decision|0|||
25013504|NCT02913612|50107071|FG002|Overall Study|Local IRB decision|0|||
25013505|NCT02913612|50107072|FG003|Overall Study|Local IRB decision|0|||
25013506|NCT02913612|50107069|FG000|Overall Study|Study drug non-compliance|1|||
25013507|NCT02913612|50107070|FG001|Overall Study|Study drug non-compliance|1|||
25013508|NCT02913612|50107071|FG002|Overall Study|Study drug non-compliance|0|||
25013509|NCT02913612|50107072|FG003|Overall Study|Study drug non-compliance|0|||
25013510|NCT02913612|50107069|FG000|Overall Study|Insurance issues|0|||
25013511|NCT02913612|50107070|FG001|Overall Study|Insurance issues|1|||
25013512|NCT02913612|50107071|FG002|Overall Study|Insurance issues|0|||
25013513|NCT02913612|50107072|FG003|Overall Study|Insurance issues|0|||
25013514|NCT02913612|50107069|FG000|Overall Study|Needed to treat second hemangioma|0|||
25013515|NCT02913612|50107070|FG001|Overall Study|Needed to treat second hemangioma|1|||
25013516|NCT02913612|50107071|FG002|Overall Study|Needed to treat second hemangioma|0|||
25013517|NCT02913612|50107072|FG003|Overall Study|Needed to treat second hemangioma|0|||
25013518|NCT02913612|50107069|FG000|Overall Study|Study completion criteria not met|0|||
25013519|NCT02913612|50107070|FG001|Overall Study|Study completion criteria not met|1|||
25013520|NCT02913612|50107071|FG002|Overall Study|Study completion criteria not met|0|||
25013521|NCT02913612|50107072|FG003|Overall Study|Study completion criteria not met|0|||
25013522|NCT02913612|50107069|FG000|Overall Study|Ineligible|0|||
25013523|NCT02913612|50107070|FG001|Overall Study|Ineligible|1|||
25013524|NCT02913612|50107071|FG002|Overall Study|Ineligible|0|||
25013525|NCT02913612|50107072|FG003|Overall Study|Ineligible|0|||
25013526|NCT03312231|50107086|FG000|Overall Study|Lost to Follow-up|2|||
25013527|NCT03312231|50107087|FG001|Overall Study|Lost to Follow-up|6|||
25013528|NCT03312231|50107088|FG002|Overall Study|Lost to Follow-up|1|||
25013529|NCT03312231|50107089|FG003|Overall Study|Lost to Follow-up|3|||
25013530|NCT03312231|50107090|FG004|Overall Study|Lost to Follow-up|1|||
25013531|NCT03312231|50107086|FG000|Overall Study|Withdrawal by Subject|0|||
25013532|NCT03312231|50107087|FG001|Overall Study|Withdrawal by Subject|3|||
25013533|NCT03312231|50107088|FG002|Overall Study|Withdrawal by Subject|1|||
25013534|NCT03312231|50107089|FG003|Overall Study|Withdrawal by Subject|0|||
25013535|NCT03312231|50107090|FG004|Overall Study|Withdrawal by Subject|0|||
25013536|NCT03312231|50107086|FG000|Overall Study|Death|0|||
25013537|NCT03312231|50107087|FG001|Overall Study|Death|1|||
25013538|NCT03312231|50107088|FG002|Overall Study|Death|1|||
25013539|NCT03312231|50107089|FG003|Overall Study|Death|0|||
25013540|NCT03312231|50107090|FG004|Overall Study|Death|0|||
25013541|NCT03312231|50107086|FG000|Overall Study|Study Vaccination not Received|1|||
25013542|NCT03312231|50107087|FG001|Overall Study|Study Vaccination not Received|1|||
25013543|NCT03312231|50107088|FG002|Overall Study|Study Vaccination not Received|1|||
25013544|NCT03312231|50107089|FG003|Overall Study|Study Vaccination not Received|0|||
25274392|NCT01078623|50588473|FG018|Treatment Period 2|Withdrawal by Subject|0|||
25274393|NCT01078623|50588474|FG019|Treatment Period 2|Withdrawal by Subject|0|||
25274394|NCT01078623|50588455|FG000|Treatment Period 3|Adverse Event|0|||
25274395|NCT01078623|50588456|FG001|Treatment Period 3|Adverse Event|0|||
25274396|NCT01078623|50588457|FG002|Treatment Period 3|Adverse Event|0|||
25274397|NCT01078623|50588458|FG003|Treatment Period 3|Adverse Event|0|||
25274398|NCT01078623|50588459|FG004|Treatment Period 3|Adverse Event|1|||
25274399|NCT01078623|50588460|FG005|Treatment Period 3|Adverse Event|0|||
25274400|NCT01078623|50588461|FG006|Treatment Period 3|Adverse Event|0|||
25274401|NCT01078623|50588462|FG007|Treatment Period 3|Adverse Event|0|||
25274402|NCT01078623|50588463|FG008|Treatment Period 3|Adverse Event|0|||
25274403|NCT01078623|50588464|FG009|Treatment Period 3|Adverse Event|0|||
25274404|NCT01078623|50588465|FG010|Treatment Period 3|Adverse Event|0|||
25274405|NCT01078623|50588466|FG011|Treatment Period 3|Adverse Event|0|||
25274406|NCT01078623|50588467|FG012|Treatment Period 3|Adverse Event|0|||
25274407|NCT01078623|50588468|FG013|Treatment Period 3|Adverse Event|1|||
25013545|NCT03312231|50107090|FG004|Overall Study|Study Vaccination not Received|0|||
25013546|NCT03323736|50107105|FG000|Overall Study|Screen Failure|14|||
25013547|NCT03323736|50107106|FG001|Overall Study|Screen Failure|9|||
25013548|NCT03323736|50107107|FG002|Overall Study|Screen Failure|1|||
25013549|NCT03323736|50107105|FG000|Overall Study|Withdrawal Before Treatment|3|||
25013550|NCT03323736|50107106|FG001|Overall Study|Withdrawal Before Treatment|1|||
25013551|NCT03323736|50107107|FG002|Overall Study|Withdrawal Before Treatment|1|||
25013552|NCT03323736|50107105|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
25013553|NCT03323736|50107106|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
25013554|NCT03323736|50107107|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
25013555|NCT03311841|50107122|FG000|14-day Wash-out|Adverse Event|0|||
25013556|NCT03311841|50107123|FG001|14-day Wash-out|Adverse Event|1|||
25013557|NCT03311841|50107124|FG002|14-day Wash-out|Adverse Event|0|||
25013558|NCT03311841|50107125|FG003|14-day Wash-out|Adverse Event|0|||
25013559|NCT03311841|50107126|FG004|14-day Wash-out|Adverse Event|0|||
25013560|NCT03311841|50107122|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
25013561|NCT03311841|50107123|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
25013562|NCT03311841|50107124|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
25013563|NCT03311841|50107125|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
25013564|NCT03311841|50107126|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
25013565|NCT03311373|50107159|FG000|Overall Study|Adverse Event|1|||
25013566|NCT03311373|50107159|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
25013567|NCT03311373|50107159|FG000|Overall Study|Lost to Follow-up|1|||
25013568|NCT03311373|50107159|FG000|Overall Study|Physician Decision|1|||
25013569|NCT03311373|50107159|FG000|Overall Study|Withdrawal by Subject|3|||
25013570|NCT01155375|50107171|FG000|Overall Study|Adverse Event|1|||
25013571|NCT01155375|50107172|FG001|Overall Study|Adverse Event|0|||
25013572|NCT00628095|50107181|FG000|Overall Study|Adverse Event|5|||
25013573|NCT00628095|50107182|FG001|Overall Study|Adverse Event|3|||
25013574|NCT00628095|50107181|FG000|Overall Study|Lack of Efficacy|0|||
25013575|NCT00628095|50107182|FG001|Overall Study|Lack of Efficacy|3|||
25013576|NCT00628095|50107181|FG000|Overall Study|Withdrawal by Subject|2|||
25013577|NCT00628095|50107182|FG001|Overall Study|Withdrawal by Subject|0|||
25013578|NCT00628095|50107181|FG000|Overall Study|Other|0|||
25013579|NCT00628095|50107182|FG001|Overall Study|Other|1|||
25013580|NCT02889861|50107190|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
25013581|NCT03325881|50107201|FG000|Overall Study|Protocol Violation|0|||
25013582|NCT03325881|50107202|FG001|Overall Study|Protocol Violation|1|||
25013583|NCT03325881|50107201|FG000|Overall Study|Withdrawal by Subject|0|||
25013584|NCT03325881|50107202|FG001|Overall Study|Withdrawal by Subject|2|||
25013585|NCT03325881|50107201|FG000|Overall Study|Lack of Efficacy|2|||
25013586|NCT03325881|50107202|FG001|Overall Study|Lack of Efficacy|0|||
25013587|NCT03325881|50107201|FG000|Overall Study|Not treated|1|||
25013588|NCT03325881|50107202|FG001|Overall Study|Not treated|0|||
25013589|NCT02887989|50107212|FG000|Overall Study|Withdrawal by Subject|8|||
25013590|NCT02887989|50107213|FG001|Overall Study|Withdrawal by Subject|11|||
25013591|NCT02887989|50107212|FG000|Overall Study|Death|1|||
25013592|NCT02887989|50107213|FG001|Overall Study|Death|0|||
25013593|NCT02887521|50107221|FG000|Overall Study|Withdrawal by Subject|0|||
25013594|NCT02887521|50107222|FG001|Overall Study|Withdrawal by Subject|3|||
25013595|NCT03305055|50107230|FG000|Overall Study|Withdrawal by Subject|0|||
25013596|NCT03305055|50107231|FG001|Overall Study|Withdrawal by Subject|1|||
25013597|NCT03305055|50107230|FG000|Overall Study|Adverse Event|1|||
25013598|NCT03305055|50107231|FG001|Overall Study|Adverse Event|1|||
25013599|NCT02763189|50107239|FG000|Overall Study|Device failure|0|||
25013600|NCT02763189|50107240|FG001|Overall Study|Device failure|2|||
25013601|NCT03273387|50107248|FG000|Overall Study|Death|2|||
25013602|NCT03273387|50107249|FG001|Overall Study|Death|2|||
25141362|NCT01966003|50254766|FG001|Overall Study|Withdrawal by Subject|19|||
25013603|NCT03273387|50107248|FG000|Overall Study|Withdrawal by Subject|1|||
25013604|NCT03273387|50107249|FG001|Overall Study|Withdrawal by Subject|1|||
25013605|NCT01328080|50107255|FG000|Overall Study|Lost to Follow-up|5|||
25013606|NCT02649946|50107274|FG000|Overall Study|Withdrawal by Subject|1|||
25013607|NCT02649946|50107275|FG001|Overall Study|Withdrawal by Subject|1|||
25013608|NCT02649946|50107274|FG000|Overall Study|Death|7|||
25013609|NCT02649946|50107275|FG001|Overall Study|Death|9|||
25013610|NCT02649946|50107274|FG000|Overall Study|Physician Decision|1|||
25013611|NCT02649946|50107275|FG001|Overall Study|Physician Decision|0|||
25013612|NCT02649946|50107274|FG000|Overall Study|Lost to Follow-up|2|||
25013613|NCT02649946|50107275|FG001|Overall Study|Lost to Follow-up|1|||
25013614|NCT02649946|50107274|FG000|Overall Study|Erroneously enrolled|1|||
25013615|NCT02649946|50107275|FG001|Overall Study|Erroneously enrolled|0|||
25013616|NCT02649946|50107274|FG000|Overall Study|Missed 6-month follow-up visit|0|||
25013617|NCT02649946|50107275|FG001|Overall Study|Missed 6-month follow-up visit|4|||
25013618|NCT03273153|50107283|FG000|Overall Study|Adverse Event|1|||
25013619|NCT03273153|50107284|FG001|Overall Study|Adverse Event|2|||
25013620|NCT03273153|50107283|FG000|Overall Study|Missing|0|||
25013621|NCT03273153|50107284|FG001|Overall Study|Missing|2|||
25013622|NCT03273153|50107283|FG000|Overall Study|Other|3|||
25013623|NCT03273153|50107284|FG001|Overall Study|Other|2|||
25013624|NCT03273153|50107283|FG000|Overall Study|Symptomatic Deterioration|0|||
25013625|NCT03273153|50107284|FG001|Overall Study|Symptomatic Deterioration|1|||
25013626|NCT03273153|50107283|FG000|Overall Study|Progressive Disease|6|||
25013627|NCT03273153|50107284|FG001|Overall Study|Progressive Disease|5|||
25013628|NCT03273153|50107283|FG000|Overall Study|Physician Decision|1|||
25013629|NCT03273153|50107284|FG001|Overall Study|Physician Decision|3|||
25013630|NCT03273153|50107283|FG000|Overall Study|Study Terminated by Sponsor|112|||
25013631|NCT03273153|50107284|FG001|Overall Study|Study Terminated by Sponsor|102|||
25013632|NCT03273153|50107283|FG000|Overall Study|Withdrawal by Subject|26|||
25013633|NCT03273153|50107284|FG001|Overall Study|Withdrawal by Subject|25|||
25013634|NCT03273153|50107283|FG000|Overall Study|Protocol Deviation|3|||
25013635|NCT03273153|50107284|FG001|Overall Study|Protocol Deviation|0|||
25013636|NCT03273153|50107283|FG000|Overall Study|Lost to Follow-up|6|||
25013637|NCT03273153|50107284|FG001|Overall Study|Lost to Follow-up|11|||
25013638|NCT03273153|50107283|FG000|Overall Study|Death|66|||
25013639|NCT03273153|50107284|FG001|Overall Study|Death|69|||
25013640|NCT03323034|50107296|FG000|Overall Study|Lack of Efficacy|5|||
25013641|NCT03323034|50107297|FG001|Overall Study|Lack of Efficacy|5|||
25013642|NCT03323034|50107298|FG002|Overall Study|Lack of Efficacy|6|||
25013643|NCT03323034|50107299|FG003|Overall Study|Lack of Efficacy|5|||
25013644|NCT03323034|50107300|FG004|Overall Study|Lack of Efficacy|5|||
25013645|NCT03323034|50107296|FG000|Overall Study|Physician Decision|0|||
25013646|NCT03323034|50107297|FG001|Overall Study|Physician Decision|0|||
25013647|NCT03323034|50107298|FG002|Overall Study|Physician Decision|0|||
25013648|NCT03323034|50107299|FG003|Overall Study|Physician Decision|0|||
25013649|NCT03323034|50107300|FG004|Overall Study|Physician Decision|1|||
25013650|NCT03323034|50107296|FG000|Overall Study|Withdrawal by Subject|1|||
25013651|NCT03323034|50107297|FG001|Overall Study|Withdrawal by Subject|1|||
25013652|NCT03323034|50107298|FG002|Overall Study|Withdrawal by Subject|0|||
25013653|NCT03323034|50107299|FG003|Overall Study|Withdrawal by Subject|1|||
25013654|NCT03323034|50107300|FG004|Overall Study|Withdrawal by Subject|0|||
25013655|NCT03270657|50107331|FG000|Overall Study|Withdrawal by Subject|1|||
25013656|NCT03303417|50107335|FG000|Overall Study|Withdrawal by Subject|1|||
25013657|NCT03303417|50107336|FG001|Overall Study|Withdrawal by Subject|1|||
25013658|NCT02943564|50107345|FG000|Overall Study|Miscellaneous Reasons|0|||
25013659|NCT02943564|50107346|FG001|Overall Study|Miscellaneous Reasons|0|||
25013660|NCT02943564|50107347|FG002|Overall Study|Miscellaneous Reasons|3|||
25013661|NCT02943564|50107345|FG000|Overall Study|Site terminated by sponsor|0|||
25013662|NCT02943564|50107346|FG001|Overall Study|Site terminated by sponsor|1|||
25141363|NCT01966003|50254765|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
25141364|NCT01966003|50254766|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
25141365|NCT01966003|50254765|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
25141366|NCT01966003|50254766|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
25013663|NCT02943564|50107347|FG002|Overall Study|Site terminated by sponsor|0|||
25013664|NCT02943564|50107345|FG000|Overall Study|Non-compliance with study drug|0|||
25013665|NCT02943564|50107346|FG001|Overall Study|Non-compliance with study drug|1|||
25013666|NCT02943564|50107347|FG002|Overall Study|Non-compliance with study drug|0|||
25141367|NCT01966003|50254765|FG000|Overall Study|Other|1|||
25141368|NCT01966003|50254766|FG001|Overall Study|Other|1|||
25013667|NCT02943564|50107345|FG000|Overall Study|Pregnancy|0|||
25013668|NCT02943564|50107346|FG001|Overall Study|Pregnancy|1|||
25013669|NCT02943564|50107347|FG002|Overall Study|Pregnancy|1|||
25013670|NCT02943564|50107345|FG000|Overall Study|Protocol Violation|2|||
25013671|NCT02943564|50107346|FG001|Overall Study|Protocol Violation|2|||
25013672|NCT02943564|50107347|FG002|Overall Study|Protocol Violation|2|||
25013673|NCT02943564|50107345|FG000|Overall Study|Lost to Follow-up|1|||
25141369|NCT01839279|50254775|FG000|Overall Study|Adverse Event|4|||
25141370|NCT01839279|50254776|FG001|Overall Study|Adverse Event|1|||
25141371|NCT01839279|50254777|FG002|Overall Study|Adverse Event|1|||
25013674|NCT02943564|50107346|FG001|Overall Study|Lost to Follow-up|0|||
25013675|NCT02943564|50107347|FG002|Overall Study|Lost to Follow-up|0|||
25013676|NCT02943564|50107345|FG000|Overall Study|Withdrawal by Subject|6|||
25013677|NCT02943564|50107346|FG001|Overall Study|Withdrawal by Subject|5|||
25013678|NCT02943564|50107347|FG002|Overall Study|Withdrawal by Subject|2|||
25141372|NCT01839279|50254775|FG000|Overall Study|Withdrawal by Subject|4|||
25013679|NCT02943564|50107345|FG000|Overall Study|Adverse Event|1|||
25013680|NCT02943564|50107346|FG001|Overall Study|Adverse Event|2|||
25013681|NCT02943564|50107347|FG002|Overall Study|Adverse Event|1|||
25013682|NCT02943564|50107345|FG000|Overall Study|Lack of Efficacy|0|||
25013683|NCT02943564|50107346|FG001|Overall Study|Lack of Efficacy|1|||
25013684|NCT02943564|50107347|FG002|Overall Study|Lack of Efficacy|0|||
25013685|NCT03268941|50107359|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
25013686|NCT03268941|50107360|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
25013687|NCT03268941|50107361|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
25141373|NCT01839279|50254776|FG001|Overall Study|Withdrawal by Subject|1|||
25013688|NCT03268941|50107362|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
25013689|NCT03268941|50107363|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
25013690|NCT03268941|50107364|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
25013691|NCT03268941|50107365|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
25013692|NCT03268941|50107359|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
25013693|NCT03268941|50107360|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
25013694|NCT03268941|50107361|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
25013695|NCT03268941|50107362|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
25013696|NCT03268941|50107363|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
25013697|NCT03268941|50107364|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
25013698|NCT03268941|50107365|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
25013699|NCT03268941|50107359|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
25013700|NCT03268941|50107360|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
25013701|NCT03268941|50107361|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
25013702|NCT03268941|50107362|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
25013703|NCT03268941|50107363|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
25013704|NCT03268941|50107364|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
25013705|NCT03268941|50107365|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
25013706|NCT03268941|50107359|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
25013707|NCT03268941|50107360|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
25013708|NCT03268941|50107361|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
25013709|NCT03268941|50107362|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
25013710|NCT03268941|50107363|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
25013711|NCT03268941|50107364|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
25013712|NCT03268941|50107365|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
25013713|NCT03268941|50107359|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
25013714|NCT03268941|50107360|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
25013715|NCT03268941|50107361|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
25013716|NCT03268941|50107362|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
25013717|NCT03268941|50107363|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
25013718|NCT03268941|50107364|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
25013719|NCT03268941|50107365|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
25013720|NCT03245619|50107442|FG000|Part A (Up to Day 22)|Physician Decision|4|||
25013721|NCT03245619|50107443|FG001|Part A (Up to Day 22)|Physician Decision|6|||
25013722|NCT03245619|50107444|FG002|Part A (Up to Day 22)|Physician Decision|6|||
25013723|NCT03245619|50107445|FG003|Part A (Up to Day 22)|Physician Decision|0|||
25013724|NCT03245619|50107446|FG004|Part A (Up to Day 22)|Physician Decision|0|||
25013725|NCT03245619|50107447|FG005|Part A (Up to Day 22)|Physician Decision|0|||
25013726|NCT03245619|50107448|FG006|Part A (Up to Day 22)|Physician Decision|0|||
25013727|NCT03245619|50107449|FG007|Part A (Up to Day 22)|Physician Decision|0|||
25013728|NCT03245619|50107450|FG008|Part A (Up to Day 22)|Physician Decision|0|||
25013729|NCT03245619|50107451|FG009|Part A (Up to Day 22)|Physician Decision|0|||
25013730|NCT03245619|50107452|FG010|Part A (Up to Day 22)|Physician Decision|0|||
25013731|NCT03245619|50107453|FG011|Part A (Up to Day 22)|Physician Decision|0|||
25013732|NCT03245619|50107454|FG012|Part A (Up to Day 22)|Physician Decision|0|||
25013733|NCT03245619|50107455|FG013|Part A (Up to Day 22)|Physician Decision|0|||
25013734|NCT03245619|50107456|FG014|Part A (Up to Day 22)|Physician Decision|0|||
25013735|NCT03245619|50107457|FG015|Part A (Up to Day 22)|Physician Decision|0|||
25013736|NCT03245619|50107458|FG016|Part A (Up to Day 22)|Physician Decision|0|||
25013737|NCT04472650|50107519|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
25013738|NCT04472650|50107520|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
25013739|NCT02606461|50107532|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
25013740|NCT02606461|50107533|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
25013741|NCT02606461|50107534|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
25013742|NCT02606461|50107535|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
25013743|NCT02606461|50107536|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
25013744|NCT02606461|50107537|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
25013745|NCT03321396|50107552|FG000|Overall Study|Physician Decision|1|||
25013746|NCT03244917|50107558|FG000|Overall Study|Lost to Follow-up|2|||
25013747|NCT03244917|50107559|FG001|Overall Study|Lost to Follow-up|2|||
25013748|NCT03321006|50107567|FG000|Overall Study|Death|1|||
25013749|NCT03321006|50107568|FG001|Overall Study|Death|0|||
25013750|NCT03321006|50107567|FG000|Overall Study|Lack of Efficacy|1|||
25013751|NCT03321006|50107568|FG001|Overall Study|Lack of Efficacy|0|||
25013752|NCT02593123|50107585|FG000|Overall Study|Physician Decision|2|||
25013753|NCT02593123|50107586|FG001|Overall Study|Physician Decision|1|||
25013754|NCT02593123|50107585|FG000|Overall Study|Relapse|1|||
25013755|NCT02593123|50107586|FG001|Overall Study|Relapse|1|||
25013756|NCT03302559|50107594|FG000|Overall Study|Adverse Event|2|||
25013757|NCT03302559|50107594|FG000|Overall Study|Lost to Follow-up|1|||
25013758|NCT03302559|50107594|FG000|Overall Study|Withdrew Consent|3|||
25013759|NCT03302247|50107598|FG000|Overall Study|the study has closed prematurely|2|||
25013760|NCT03302247|50107598|FG000|Overall Study|Death|1|||
25013761|NCT04993339|50107604|FG000|Overall Study|Lost to Follow-up|0|||
25013762|NCT04993339|50107605|FG001|Overall Study|Lost to Follow-up|1|||
25013763|NCT04993339|50107604|FG000|Overall Study|no MRI scan|3|||
25013764|NCT04993339|50107605|FG001|Overall Study|no MRI scan|1|||
25013765|NCT04974697|50107613|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
25013766|NCT04974697|50107613|FG000|Overall Study|Lens discomfort|1|||
25013767|NCT03265119|50107621|FG000|Overall Study|Adverse Event|2|||
25013768|NCT03265119|50107622|FG001|Overall Study|Adverse Event|1|||
25013769|NCT03265119|50107621|FG000|Overall Study|Lack of Efficacy|3|||
25013770|NCT03265119|50107622|FG001|Overall Study|Lack of Efficacy|0|||
25013771|NCT03265119|50107621|FG000|Overall Study|Protocol Violation|1|||
25013772|NCT03265119|50107622|FG001|Overall Study|Protocol Violation|2|||
25013773|NCT03265119|50107621|FG000|Overall Study|Withdrawal by Subject|2|||
25013774|NCT03265119|50107622|FG001|Overall Study|Withdrawal by Subject|4|||
25013775|NCT03265119|50107621|FG000|Overall Study|Lost to Follow-up|1|||
25013776|NCT03265119|50107622|FG001|Overall Study|Lost to Follow-up|0|||
25013777|NCT03265119|50107621|FG000|Overall Study|Lack of Compliance|1|||
25013778|NCT03265119|50107622|FG001|Overall Study|Lack of Compliance|0|||
25013779|NCT04952701|50107628|FG000|Control Lens|Physician Decision|4|||
25013780|NCT04952701|50107628|FG000|Test Lens|Physician Decision|1|||
25013781|NCT04723173|50107634|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
25013782|NCT04919317|50107648|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
25013783|NCT04919317|50107649|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
25013784|NCT04919317|50107648|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
25013785|NCT04919317|50107649|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
25013786|NCT04919161|50107657|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
25013787|NCT04919161|50107658|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
25013788|NCT04919161|50107657|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
25013789|NCT04919161|50107658|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
25013790|NCT04919161|50107657|FG000|Overall Study|Acute ankle sprain after session 1|0|||
25013791|NCT04919161|50107658|FG001|Overall Study|Acute ankle sprain after session 1|1|||
25013792|NCT03262389|50107686|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
25013793|NCT03262389|50107686|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
25013794|NCT03262389|50107686|FG000|Overall Study|opted out of PET/MR|1|||
25013795|NCT03262233|50107694|FG000|Overall Study|Withdrawal by Subject|12|||
25013796|NCT03262233|50107695|FG001|Overall Study|Withdrawal by Subject|8|||
25013797|NCT03262233|50107696|FG002|Overall Study|Withdrawal by Subject|21|||
25013798|NCT03262233|50107697|FG003|Overall Study|Withdrawal by Subject|13|||
25013799|NCT03262233|50107694|FG000|Overall Study|Declined due to shock|1|||
25013800|NCT03262233|50107695|FG001|Overall Study|Declined due to shock|2|||
25013801|NCT03262233|50107696|FG002|Overall Study|Declined due to shock|2|||
25013802|NCT03262233|50107697|FG003|Overall Study|Declined due to shock|3|||
25013803|NCT03262233|50107694|FG000|Overall Study|Protocol Violation|5|||
25013804|NCT03262233|50107695|FG001|Overall Study|Protocol Violation|10|||
25013805|NCT03262233|50107696|FG002|Overall Study|Protocol Violation|2|||
25013806|NCT03262233|50107697|FG003|Overall Study|Protocol Violation|13|||
25013807|NCT03262233|50107694|FG000|Overall Study|data collection artifact|0|||
25013808|NCT03262233|50107695|FG001|Overall Study|data collection artifact|1|||
25013809|NCT03262233|50107696|FG002|Overall Study|data collection artifact|0|||
25013810|NCT03262233|50107697|FG003|Overall Study|data collection artifact|0|||
25013811|NCT03261531|50107708|FG000|Overall Study|Withdrawal by Subject|4|||
25013812|NCT04151290|50107712|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
25013813|NCT03260205|50107731|FG000|Overall Study|Adverse Event|2|||
25013814|NCT03260205|50107732|FG001|Overall Study|Adverse Event|0|||
25013815|NCT03260205|50107733|FG002|Overall Study|Adverse Event|2|||
25013816|NCT03260205|50107734|FG003|Overall Study|Adverse Event|2|||
25013817|NCT03260205|50107735|FG004|Overall Study|Adverse Event|4|||
25013818|NCT03260205|50107731|FG000|Overall Study|Lost to Follow-up|2|||
25013819|NCT03260205|50107732|FG001|Overall Study|Lost to Follow-up|2|||
25013820|NCT03260205|50107733|FG002|Overall Study|Lost to Follow-up|1|||
25013821|NCT03260205|50107734|FG003|Overall Study|Lost to Follow-up|1|||
25013822|NCT03260205|50107735|FG004|Overall Study|Lost to Follow-up|5|||
25013823|NCT03260205|50107731|FG000|Overall Study|Protocol Violation|0|||
25013824|NCT03260205|50107732|FG001|Overall Study|Protocol Violation|0|||
25013825|NCT03260205|50107733|FG002|Overall Study|Protocol Violation|2|||
25013826|NCT03260205|50107734|FG003|Overall Study|Protocol Violation|0|||
25013827|NCT03260205|50107735|FG004|Overall Study|Protocol Violation|1|||
25013828|NCT03260205|50107731|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
25013829|NCT03260205|50107732|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
25013830|NCT03260205|50107733|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
25013831|NCT03260205|50107734|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
25013832|NCT03260205|50107735|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
25013833|NCT03260205|50107731|FG000|Overall Study|Other: Unspecified|0|||
25013834|NCT03260205|50107732|FG001|Overall Study|Other: Unspecified|0|||
25013835|NCT03260205|50107733|FG002|Overall Study|Other: Unspecified|3|||
25013836|NCT03260205|50107734|FG003|Overall Study|Other: Unspecified|1|||
25013837|NCT03260205|50107735|FG004|Overall Study|Other: Unspecified|1|||
25013838|NCT03260205|50107731|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
25013839|NCT03260205|50107732|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
25013840|NCT03260205|50107733|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
25013841|NCT03260205|50107734|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
25013842|NCT03260205|50107735|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
25013843|NCT04666441|50107760|FG000|Overall Study|Lost to Follow-up|1|||
25013844|NCT04666441|50107761|FG001|Overall Study|Lost to Follow-up|4|||
25013845|NCT04666441|50107762|FG002|Overall Study|Lost to Follow-up|1|||
25013846|NCT04666441|50107763|FG003|Overall Study|Lost to Follow-up|3|||
25013847|NCT04666441|50107764|FG004|Overall Study|Lost to Follow-up|0|||
25013848|NCT04666441|50107765|FG005|Overall Study|Lost to Follow-up|2|||
25013849|NCT04666441|50107766|FG006|Overall Study|Lost to Follow-up|2|||
25013850|NCT04666441|50107767|FG007|Overall Study|Lost to Follow-up|2|||
25013851|NCT04666441|50107760|FG000|Overall Study|Subject Decision|1|||
25013852|NCT04666441|50107761|FG001|Overall Study|Subject Decision|1|||
25013853|NCT04666441|50107762|FG002|Overall Study|Subject Decision|3|||
25013854|NCT04666441|50107763|FG003|Overall Study|Subject Decision|1|||
25013855|NCT04666441|50107764|FG004|Overall Study|Subject Decision|0|||
25013856|NCT04666441|50107765|FG005|Overall Study|Subject Decision|1|||
25013857|NCT04666441|50107766|FG006|Overall Study|Subject Decision|3|||
25013858|NCT04666441|50107767|FG007|Overall Study|Subject Decision|2|||
25013859|NCT03320850|50107804|FG000|Overall Study|Lost to Follow-up|0|||
25013860|NCT03320850|50107805|FG001|Overall Study|Lost to Follow-up|0|||
25013861|NCT03320850|50107806|FG002|Overall Study|Lost to Follow-up|0|||
25013862|NCT03320850|50107807|FG003|Overall Study|Lost to Follow-up|0|||
25013863|NCT03320850|50107808|FG004|Overall Study|Lost to Follow-up|1|||
25013864|NCT03320850|50107809|FG005|Overall Study|Lost to Follow-up|2|||
25013865|NCT03320850|50107810|FG006|Overall Study|Lost to Follow-up|2|||
25013866|NCT03320850|50107811|FG007|Overall Study|Lost to Follow-up|0|||
25013867|NCT03320850|50107812|FG008|Overall Study|Lost to Follow-up|6|||
25013868|NCT03320850|50107813|FG009|Overall Study|Lost to Follow-up|4|||
25013869|NCT03320850|50107804|FG000|Overall Study|Withdrawal by Subject|0|||
25013870|NCT03320850|50107805|FG001|Overall Study|Withdrawal by Subject|0|||
25013871|NCT03320850|50107806|FG002|Overall Study|Withdrawal by Subject|0|||
25013872|NCT03320850|50107807|FG003|Overall Study|Withdrawal by Subject|0|||
25013873|NCT03320850|50107808|FG004|Overall Study|Withdrawal by Subject|1|||
25013874|NCT03320850|50107809|FG005|Overall Study|Withdrawal by Subject|2|||
25013875|NCT03320850|50107810|FG006|Overall Study|Withdrawal by Subject|4|||
25013876|NCT03320850|50107811|FG007|Overall Study|Withdrawal by Subject|5|||
25013877|NCT03320850|50107812|FG008|Overall Study|Withdrawal by Subject|2|||
25013878|NCT03320850|50107813|FG009|Overall Study|Withdrawal by Subject|1|||
25013879|NCT03320850|50107804|FG000|Overall Study|Lack of Efficacy|0|||
25013880|NCT03320850|50107805|FG001|Overall Study|Lack of Efficacy|0|||
25013881|NCT03320850|50107806|FG002|Overall Study|Lack of Efficacy|0|||
25013882|NCT03320850|50107807|FG003|Overall Study|Lack of Efficacy|1|||
25013883|NCT03320850|50107808|FG004|Overall Study|Lack of Efficacy|0|||
25013884|NCT03320850|50107809|FG005|Overall Study|Lack of Efficacy|1|||
25013885|NCT03320850|50107810|FG006|Overall Study|Lack of Efficacy|0|||
25013886|NCT03320850|50107811|FG007|Overall Study|Lack of Efficacy|2|||
25013887|NCT03320850|50107812|FG008|Overall Study|Lack of Efficacy|0|||
25141374|NCT01839279|50254777|FG002|Overall Study|Withdrawal by Subject|1|||
25141375|NCT01839279|50254775|FG000|Overall Study|Classified as 'Other'|5|||
25141376|NCT01839279|50254776|FG001|Overall Study|Classified as 'Other'|0|||
25141377|NCT01839279|50254777|FG002|Overall Study|Classified as 'Other'|0|||
25141378|NCT01807299|50254796|FG000|Overall Study|Protocol Violation|3|||
25141379|NCT01807299|50254797|FG001|Overall Study|Protocol Violation|1|||
25141380|NCT01807299|50254798|FG002|Overall Study|Protocol Violation|0|||
25141381|NCT01807299|50254799|FG003|Overall Study|Protocol Violation|2|||
25141382|NCT01965535|50254811|FG000|Overall Study|Lack of Efficacy|2|||
25141383|NCT01965535|50254812|FG001|Overall Study|Lack of Efficacy|1|||
25141384|NCT01964755|50254818|FG000|Overall Study|Death|2|||
25141385|NCT01964521|50254822|FG000|Overall Study|Lost to Follow-up|4|||
25141386|NCT01992757|50254827|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
25141387|NCT01991743|50254836|FG000|Overall Study|external cephalic version not performed|0|||
25013888|NCT03320850|50107813|FG009|Overall Study|Lack of Efficacy|3|||
25013889|NCT03320850|50107804|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
25013890|NCT03320850|50107805|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
25013891|NCT03320850|50107806|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
25013892|NCT03320850|50107807|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
25013893|NCT03320850|50107808|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
25013894|NCT03320850|50107809|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
25013895|NCT03320850|50107810|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
25013896|NCT03320850|50107811|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
25013897|NCT03320850|50107812|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
25013898|NCT03320850|50107813|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
25013899|NCT03320850|50107804|FG000|Overall Study|Adverse Event|0|||
25013900|NCT03320850|50107805|FG001|Overall Study|Adverse Event|0|||
25013901|NCT03320850|50107806|FG002|Overall Study|Adverse Event|0|||
25013902|NCT03320850|50107807|FG003|Overall Study|Adverse Event|0|||
25013903|NCT03320850|50107808|FG004|Overall Study|Adverse Event|0|||
25013904|NCT03320850|50107809|FG005|Overall Study|Adverse Event|2|||
25013905|NCT03320850|50107810|FG006|Overall Study|Adverse Event|1|||
25013906|NCT03320850|50107811|FG007|Overall Study|Adverse Event|0|||
25013907|NCT03320850|50107812|FG008|Overall Study|Adverse Event|2|||
25013908|NCT03320850|50107813|FG009|Overall Study|Adverse Event|0|||
25013909|NCT03320850|50107804|FG000|Overall Study|Reason Not Specified|0|||
25013910|NCT03320850|50107805|FG001|Overall Study|Reason Not Specified|0|||
25013911|NCT03320850|50107806|FG002|Overall Study|Reason Not Specified|0|||
25013912|NCT03320850|50107807|FG003|Overall Study|Reason Not Specified|0|||
25013913|NCT03320850|50107808|FG004|Overall Study|Reason Not Specified|0|||
25013914|NCT03320850|50107809|FG005|Overall Study|Reason Not Specified|1|||
25013915|NCT03320850|50107810|FG006|Overall Study|Reason Not Specified|0|||
25013916|NCT03320850|50107811|FG007|Overall Study|Reason Not Specified|0|||
25013917|NCT03320850|50107812|FG008|Overall Study|Reason Not Specified|0|||
25013918|NCT03320850|50107813|FG009|Overall Study|Reason Not Specified|1|||
25013919|NCT03301623|50107842|FG000|Overall Study|Death|3|||
25013920|NCT03301623|50107843|FG001|Overall Study|Death|1|||
25013921|NCT03301623|50107842|FG000|Overall Study|Withdrawal by Subject|11|||
25013922|NCT03301623|50107843|FG001|Overall Study|Withdrawal by Subject|13|||
25013923|NCT03301623|50107842|FG000|Overall Study|Lost to Follow-up|3|||
25013924|NCT03301623|50107843|FG001|Overall Study|Lost to Follow-up|1|||
25013925|NCT03319212|50107851|FG000|Overall Study|Discontinued as moving out of local area|0|||
25013926|NCT03319212|50107852|FG001|Overall Study|Discontinued as moving out of local area|1|||
25013927|NCT03319212|50107851|FG000|Overall Study|Adverse Event|2|||
25013928|NCT03319212|50107852|FG001|Overall Study|Adverse Event|2|||
25013929|NCT03319212|50107851|FG000|Overall Study|Withdrawal by Subject|0|||
25013930|NCT03319212|50107852|FG001|Overall Study|Withdrawal by Subject|1|||
25013931|NCT03319212|50107851|FG000|Overall Study|Lost to Follow-up|0|||
25013932|NCT03319212|50107852|FG001|Overall Study|Lost to Follow-up|1|||
25013933|NCT03319212|50107851|FG000|Overall Study|Physician Decision|1|||
25013934|NCT03319212|50107852|FG001|Overall Study|Physician Decision|0|||
25013935|NCT04656691|50107857|FG000|Overall Study|Adverse Event|1|||
25013936|NCT03301155|50107863|FG000|Overall Study|Сompliance with exclusion criteria|8|||
25141388|NCT01991743|50254837|FG001|Overall Study|external cephalic version not performed|0|||
25141389|NCT01991743|50254838|FG002|Overall Study|external cephalic version not performed|1|||
25013937|NCT03301155|50107864|FG001|Overall Study|Сompliance with exclusion criteria|7|||
25013938|NCT01952730|50107870|FG000|Overall Study|FDA shut down core lab used by study|1|||
25013939|NCT03316170|50107876|FG000|Overall Study|Death|1|||
25013940|NCT03316170|50107877|FG001|Overall Study|Death|0|||
25013941|NCT03316170|50107876|FG000|Overall Study|Lost to Follow-up|6|||
25013942|NCT03316170|50107877|FG001|Overall Study|Lost to Follow-up|7|||
25141390|NCT01991743|50254839|FG003|Overall Study|external cephalic version not performed|0|||
25141391|NCT01991197|50254851|FG000|Overall Study|Lost to Follow-up|1|||
25141392|NCT01991197|50254852|FG001|Overall Study|Lost to Follow-up|1|||
25013943|NCT03257865|50107886|FG000|Overall Study|Adverse Event|4|||
25013944|NCT03257865|50107887|FG001|Overall Study|Adverse Event|8|||
25013945|NCT03257865|50107886|FG000|Overall Study|Lack of Efficacy|1|||
25013946|NCT03257865|50107887|FG001|Overall Study|Lack of Efficacy|2|||
25013947|NCT03257865|50107886|FG000|Overall Study|Non-compliance with Study Drug|0|||
25013948|NCT03257865|50107887|FG001|Overall Study|Non-compliance with Study Drug|2|||
25013949|NCT03257865|50107886|FG000|Overall Study|Withdrawal by Subject|23|||
25013950|NCT03257865|50107887|FG001|Overall Study|Withdrawal by Subject|17|||
25013951|NCT03257865|50107886|FG000|Overall Study|Physician Decision|3|||
25013952|NCT03257865|50107887|FG001|Overall Study|Physician Decision|1|||
25013953|NCT03257865|50107886|FG000|Overall Study|Other|0|||
25013954|NCT03257865|50107887|FG001|Overall Study|Other|1|||
25013955|NCT03257865|50107886|FG000|Overall Study|Lost to Follow-up|4|||
25013956|NCT03257865|50107887|FG001|Overall Study|Lost to Follow-up|4|||
25013957|NCT04617847|50107895|FG000|Overall Study|Withdrawal by Subject|1|||
25013958|NCT04617847|50107896|FG001|Overall Study|Withdrawal by Subject|0|||
25013959|NCT04617847|50107895|FG000|Overall Study|Adverse Event|0|||
25013960|NCT04617847|50107896|FG001|Overall Study|Adverse Event|2|||
25013961|NCT04617847|50107895|FG000|Overall Study|Death|0|||
25013962|NCT04617847|50107896|FG001|Overall Study|Death|1|||
25013963|NCT04617847|50107895|FG000|Overall Study|Termination of Study by Sponsor|2|||
25013964|NCT04617847|50107896|FG001|Overall Study|Termination of Study by Sponsor|21|||
25013965|NCT04615507|50107906|FG000|Period 1|Covid-19 exposure|2|||
25013966|NCT04615507|50107907|FG001|Period 1|Covid-19 exposure|1|||
25013967|NCT04615507|50107906|FG000|Period 2|Covid-19 exposure|0|||
25013968|NCT04615507|50107907|FG001|Period 2|Covid-19 exposure|1|||
25141393|NCT01991197|50254851|FG000|Overall Study|Physician Decision|0|||
25141394|NCT01991197|50254852|FG001|Overall Study|Physician Decision|2|||
25013969|NCT04615507|50107906|FG000|Period 2|Protocol Violation|1|||
25013970|NCT04615507|50107907|FG001|Period 2|Protocol Violation|0|||
25013971|NCT04615507|50107906|FG000|Period 2|Withdrawal by Subject|1|||
25013972|NCT04615507|50107907|FG001|Period 2|Withdrawal by Subject|0|||
25013973|NCT04615507|50107906|FG000|Period 2|Adverse Event|0|||
25013974|NCT04615507|50107907|FG001|Period 2|Adverse Event|1|||
25013975|NCT04615507|50107906|FG000|Period 3|Covid-19 exposure|0|||
25013976|NCT04615507|50107907|FG001|Period 3|Covid-19 exposure|1|||
25013977|NCT04120233|50107919|FG000|Overall Study|Adverse Event|0|||
25013978|NCT04120233|50107920|FG001|Overall Study|Adverse Event|0|||
25013979|NCT04120233|50107921|FG002|Overall Study|Adverse Event|0|||
25013980|NCT04120233|50107922|FG003|Overall Study|Adverse Event|0|||
25013981|NCT04120233|50107923|FG004|Overall Study|Adverse Event|1|||
25013982|NCT04120233|50107924|FG005|Overall Study|Adverse Event|0|||
25013983|NCT01610700|50107940|FG000|Overall Study|Adverse Event|3|||
25013984|NCT01610700|50107941|FG001|Overall Study|Adverse Event|1|||
25013985|NCT01610700|50107940|FG000|Overall Study|Withdrawal by Subject|0|||
25013986|NCT01610700|50107941|FG001|Overall Study|Withdrawal by Subject|1|||
25013987|NCT01610700|50107940|FG000|Overall Study|subject took one dose of street cannabis|0|||
25013988|NCT01610700|50107941|FG001|Overall Study|subject took one dose of street cannabis|1|||
25013989|NCT03256851|50107950|FG000|Overall Study|Withdrawal by Subject|1|||
25013990|NCT03256851|50107951|FG001|Overall Study|Withdrawal by Subject|0|||
25013991|NCT04837807|50107957|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
25013992|NCT04837807|50107958|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
25141395|NCT01991197|50254851|FG000|Overall Study|Withdrawal by Subject|2|||
25141396|NCT01991197|50254852|FG001|Overall Study|Withdrawal by Subject|0|||
25141397|NCT01990573|50254866|FG000|Overall Study|Physician Decision|0|||
25141398|NCT01990573|50254867|FG001|Overall Study|Physician Decision|0|||
25141399|NCT01990573|50254868|FG002|Overall Study|Physician Decision|1|||
25141400|NCT01990495|50254878|FG000|Overall Study|Physician Decision|5|||
25141401|NCT01990495|50254879|FG001|Overall Study|Physician Decision|4|||
25141402|NCT01990339|50254887|FG000|Overall Study|Data Not Available|49|||
25141403|NCT01990339|50254887|FG000|Overall Study|Voluntary Withdrawal|1402|||
25141404|NCT01990339|50254887|FG000|Overall Study|Lost to Follow-up|861|||
25013993|NCT03256695|50107964|FG000|Overall Study|Adverse Event|8|||
25013994|NCT03256695|50107964|FG000|Overall Study|Death|2|||
25013995|NCT03256695|50107964|FG000|Overall Study|Withdrawal by Subject|14|||
25013996|NCT03256695|50107964|FG000|Overall Study|Non-compliance with study drug|1|||
25013997|NCT03256695|50107964|FG000|Overall Study|Lost to Follow-up|3|||
25013998|NCT03256695|50107964|FG000|Overall Study|Lack of Efficacy|3|||
25013999|NCT03256695|50107964|FG000|Overall Study|Protocol Violation|5|||
25014000|NCT03256695|50107964|FG000|Overall Study|Other than specified|3|||
25141405|NCT02007577|50254893|FG000|Overall Study|Adverse Event|1|||
25141406|NCT02007577|50254894|FG001|Overall Study|Adverse Event|0|||
25014001|NCT03305016|50107968|FG000|Overall Study|Withdrawal by Subject|2|||
25014002|NCT03297021|50107975|FG000|Overall Study|Incomplete/illegible data sheet|4|||
25014003|NCT03297021|50107976|FG001|Overall Study|Incomplete/illegible data sheet|2|||
25141407|NCT02007577|50254893|FG000|Overall Study|Withdrawal by Subject|0|||
25141408|NCT02007577|50254894|FG001|Overall Study|Withdrawal by Subject|1|||
25141409|NCT01990261|50254900|FG000|Overall Study|Death Before Treatment Start|2|||
25014004|NCT03297021|50107977|FG002|Overall Study|Incomplete/illegible data sheet|3|||
25014005|NCT03297021|50107975|FG000|Overall Study|Missing Post-Op Data|1|||
25014006|NCT03297021|50107976|FG001|Overall Study|Missing Post-Op Data|2|||
25014007|NCT03297021|50107977|FG002|Overall Study|Missing Post-Op Data|1|||
25014008|NCT04820491|50107987|FG000|Overall Study|Withdrawal by Subject|1|||
25014009|NCT04820491|50107988|FG001|Overall Study|Withdrawal by Subject|0|||
25014010|NCT01988571|50107996|FG000|Overall Study|Death|3|||
25014011|NCT01988571|50107997|FG001|Overall Study|Death|1|||
25014012|NCT01988571|50107996|FG000|Overall Study|Physician Decision|2|||
25014013|NCT01988571|50107997|FG001|Overall Study|Physician Decision|1|||
25014014|NCT01988571|50107996|FG000|Overall Study|Lost to Follow-up|3|||
25014015|NCT01988571|50107997|FG001|Overall Study|Lost to Follow-up|0|||
25014016|NCT01988571|50107996|FG000|Overall Study|Withdrawal by Subject|31|||
25014017|NCT01988571|50107997|FG001|Overall Study|Withdrawal by Subject|33|||
25014018|NCT04794751|50108003|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
25014019|NCT04794751|50108004|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
25014020|NCT04794751|50108003|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
25014021|NCT04794751|50108004|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
25014022|NCT04794751|50108003|FG000|Period 1|Protocol Violation|0|||
25014023|NCT04794751|50108004|FG001|Period 1|Protocol Violation|2|||
25014024|NCT04794751|50108003|FG000|Period 1|Withdrawal by Subject|0|||
25014025|NCT04794751|50108004|FG001|Period 1|Withdrawal by Subject|1|||
25014026|NCT04794751|50108003|FG000|Period 2|Withdrawal by Subject|0|||
25014027|NCT04794751|50108004|FG001|Period 2|Withdrawal by Subject|1|||
25014028|NCT04794751|50108003|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
25014029|NCT04794751|50108004|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
25014030|NCT04794751|50108003|FG000|Period 2|Protocol Violation|1|||
25014031|NCT04794751|50108004|FG001|Period 2|Protocol Violation|0|||
25014032|NCT04578457|50108019|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
25014033|NCT04578457|50108019|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
25014034|NCT04578457|50108019|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
25014035|NCT04578457|50108019|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
25014036|NCT03334188|50108029|FG000|Overall Study|Withdrawal by Subject|0|||
25014037|NCT03334188|50108030|FG001|Overall Study|Withdrawal by Subject|1|||
25014038|NCT03334188|50108029|FG000|Overall Study|Death|1|||
25014039|NCT03334188|50108030|FG001|Overall Study|Death|0|||
25014040|NCT03334188|50108029|FG000|Overall Study|Never had qualifying clinic visit|7|||
25014041|NCT03334188|50108030|FG001|Overall Study|Never had qualifying clinic visit|7|||
25014042|NCT03333876|50108039|FG000|Screening Period|Screen Failure|4|||
25014043|NCT03333876|50108039|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
25014044|NCT03333876|50108039|FG000|Mandibular Advancement|Adverse Event|2|||
25014045|NCT03333876|50108039|FG000|Mandibular Advancement|Product Damage|2|||
25014046|NCT03294681|50108052|FG000|Overall Study|Withdrawal by Subject|1|||
25014047|NCT01140867|50108056|FG000|Overall Study|Adverse Event|22|||
25014048|NCT01140867|50108056|FG000|Overall Study|Lack of Efficacy|3|||
25014049|NCT01140867|50108056|FG000|Overall Study|Lost to Follow-up|2|||
25014050|NCT01140867|50108056|FG000|Overall Study|Withdrawal by Subject|1|||
25014051|NCT01140867|50108056|FG000|Overall Study|Protocol Violation|1|||
25014052|NCT01140867|50108056|FG000|Overall Study|Uncooperative patient|2|||
25014053|NCT01140867|50108056|FG000|Overall Study|Medication Noncompliance|2|||
25014054|NCT04572997|50108060|FG000|Overall Study|Adverse Event|1|||
25014055|NCT02943096|50108070|FG000|Overall Study|Lack of Efficacy|0|||
25014056|NCT02943096|50108071|FG001|Overall Study|Lack of Efficacy|1|||
25014057|NCT04571515|50108082|FG000|Overall Study|Physician Decision|0|||
25014058|NCT04571515|50108083|FG001|Overall Study|Physician Decision|0|||
25014059|NCT04571515|50108084|FG002|Overall Study|Physician Decision|0|||
25014060|NCT04571515|50108085|FG003|Overall Study|Physician Decision|0|||
25014061|NCT04571515|50108086|FG004|Overall Study|Physician Decision|1|||
25014062|NCT04571515|50108082|FG000|Overall Study|Withdrawal by Subject|0|||
25014063|NCT04571515|50108083|FG001|Overall Study|Withdrawal by Subject|0|||
25014064|NCT04571515|50108084|FG002|Overall Study|Withdrawal by Subject|0|||
25014065|NCT04571515|50108085|FG003|Overall Study|Withdrawal by Subject|0|||
25014066|NCT04571515|50108086|FG004|Overall Study|Withdrawal by Subject|1|||
25014067|NCT04571515|50108082|FG000|Overall Study|insufficient pain|1|||
25141410|NCT01990261|50254900|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
25014068|NCT04571515|50108083|FG001|Overall Study|insufficient pain|0|||
25014069|NCT04571515|50108084|FG002|Overall Study|insufficient pain|0|||
25014070|NCT04571515|50108085|FG003|Overall Study|insufficient pain|0|||
25014071|NCT04571515|50108086|FG004|Overall Study|insufficient pain|1|||
25014072|NCT03292653|50108101|FG000|Overall Study|Adverse Event|0|||
25014073|NCT03292653|50108102|FG001|Overall Study|Adverse Event|0|||
25014074|NCT03292653|50108103|FG002|Overall Study|Adverse Event|1|||
25014075|NCT03292653|50108101|FG000|Overall Study|Did not Receive Treatment|1|||
25014076|NCT03292653|50108102|FG001|Overall Study|Did not Receive Treatment|0|||
25014077|NCT03292653|50108103|FG002|Overall Study|Did not Receive Treatment|0|||
25014078|NCT03858634|50108114|FG000|Overall Study|Withdrawal by Subject|1|||
25014079|NCT03858634|50108115|FG001|Overall Study|Withdrawal by Subject|0|||
25014080|NCT03858634|50108114|FG000|Overall Study|Adverse Event|1|||
25014081|NCT03858634|50108115|FG001|Overall Study|Adverse Event|0|||
25014082|NCT03858634|50108114|FG000|Overall Study|Lost to Follow-up|0|||
25014083|NCT03858634|50108115|FG001|Overall Study|Lost to Follow-up|1|||
25014084|NCT03858634|50108114|FG000|Overall Study|Other, Not Specified|1|||
25014085|NCT03858634|50108115|FG001|Overall Study|Other, Not Specified|1|||
25014086|NCT02891070|50108131|FG000|Overall Study|Adverse Event|1|||
25014087|NCT02891070|50108132|FG001|Overall Study|Adverse Event|0|||
25014088|NCT02891070|50108131|FG000|Overall Study|Physician Decision|0|||
25014089|NCT02891070|50108132|FG001|Overall Study|Physician Decision|1|||
25014090|NCT02891070|50108131|FG000|Overall Study|Lost to Follow-up|4|||
25014091|NCT02891070|50108132|FG001|Overall Study|Lost to Follow-up|4|||
25014092|NCT02891070|50108131|FG000|Overall Study|Other|1|||
25014093|NCT02891070|50108132|FG001|Overall Study|Other|0|||
25014094|NCT02891070|50108131|FG000|Overall Study|Protocol Violation|0|||
25014095|NCT02891070|50108132|FG001|Overall Study|Protocol Violation|1|||
25014096|NCT02891070|50108131|FG000|Overall Study|Withdrawal by Subject|1|||
25014097|NCT02891070|50108132|FG001|Overall Study|Withdrawal by Subject|2|||
25014098|NCT02891070|50108131|FG000|Overall Study|Death|3|||
25014099|NCT02891070|50108132|FG001|Overall Study|Death|0|||
25014100|NCT03255291|50108144|FG000|Overall Study|Determined to be ineligible|10|||
25014101|NCT03255291|50108145|FG001|Overall Study|Determined to be ineligible|12|||
25014102|NCT03255291|50108146|FG002|Overall Study|Determined to be ineligible|6|||
25014103|NCT03255291|50108147|FG003|Overall Study|Determined to be ineligible|6|||
25014104|NCT03255291|50108148|FG004|Overall Study|Determined to be ineligible|5|||
25014105|NCT03255291|50108149|FG005|Overall Study|Determined to be ineligible|10|||
25014106|NCT03255291|50108144|FG000|Overall Study|Baseline data collection issues|3|||
25014107|NCT03255291|50108145|FG001|Overall Study|Baseline data collection issues|0|||
25014108|NCT03255291|50108146|FG002|Overall Study|Baseline data collection issues|0|||
25014109|NCT03255291|50108147|FG003|Overall Study|Baseline data collection issues|0|||
25014110|NCT03255291|50108148|FG004|Overall Study|Baseline data collection issues|2|||
25014111|NCT03255291|50108149|FG005|Overall Study|Baseline data collection issues|0|||
25014112|NCT00381381|50108167|FG000|Overall Study|Adverse Event|3|||
25014113|NCT00381381|50108167|FG000|Overall Study|Lost to Follow-up|52|||
25014114|NCT00381381|50108167|FG000|Overall Study|Withdrawal by Subject|9|||
25014115|NCT02939937|50108173|FG000|Overall Study|Adverse Event|5|||
25014116|NCT02939937|50108174|FG001|Overall Study|Adverse Event|0|||
25014117|NCT02939937|50108173|FG000|Overall Study|Lost to Follow-up|1|||
25014118|NCT02939937|50108174|FG001|Overall Study|Lost to Follow-up|3|||
25014119|NCT02939079|50108182|FG000|Overall Study|Adverse Event|2|||
25014120|NCT02939079|50108183|FG001|Overall Study|Adverse Event|1|||
25014121|NCT02939079|50108182|FG000|Overall Study|Lost to Follow-up|0|||
25014122|NCT02939079|50108183|FG001|Overall Study|Lost to Follow-up|2|||
25014123|NCT02939079|50108182|FG000|Overall Study|Protocol Violation|1|||
25141411|NCT01990261|50254900|FG000|Overall Study|Death From other Causes|1|||
25141412|NCT01990261|50254900|FG000|Overall Study|Disease Progression (PD)|8|||
25141413|NCT01990261|50254900|FG000|Overall Study|PD Before Treatment Start|1|||
25141414|NCT01990261|50254900|FG000|Overall Study|Dossier not Approved|1|||
25141415|NCT01990261|50254900|FG000|Overall Study|Lost to Follow-up|2|||
25141416|NCT01963117|50254904|FG000|Overall Study|Death|1|||
25274408|NCT01078623|50588469|FG014|Treatment Period 3|Adverse Event|0|||
25014124|NCT02939079|50108183|FG001|Overall Study|Protocol Violation|0|||
25014125|NCT02939079|50108182|FG000|Overall Study|Withdrawal by Subject|0|||
25014126|NCT02939079|50108183|FG001|Overall Study|Withdrawal by Subject|1|||
25014127|NCT02939079|50108182|FG000|Overall Study|relapse during the study|1|||
25014128|NCT02939079|50108183|FG001|Overall Study|relapse during the study|1|||
25014129|NCT04562155|50108193|FG000|Overall Study|COVID-19 pandemic|0|||
25014130|NCT04562155|50108194|FG001|Overall Study|COVID-19 pandemic|0|||
25274409|NCT01078623|50588470|FG015|Treatment Period 3|Adverse Event|0|||
25274410|NCT01078623|50588471|FG016|Treatment Period 3|Adverse Event|0|||
25014131|NCT04562155|50108195|FG002|Overall Study|COVID-19 pandemic|0|||
25014132|NCT04562155|50108196|FG003|Overall Study|COVID-19 pandemic|1|||
25014133|NCT04562155|50108193|FG000|Overall Study|Adverse Event|7|||
25141417|NCT02007109|50254908|FG000|Overall Study|Diary not returned or excluded|102|||
25014134|NCT04562155|50108194|FG001|Overall Study|Adverse Event|3|||
25014135|NCT04562155|50108195|FG002|Overall Study|Adverse Event|8|||
25014136|NCT04562155|50108196|FG003|Overall Study|Adverse Event|1|||
25014137|NCT04562155|50108193|FG000|Overall Study|Withdrawal by Subject|3|||
25014138|NCT04562155|50108194|FG001|Overall Study|Withdrawal by Subject|6|||
25014139|NCT04562155|50108195|FG002|Overall Study|Withdrawal by Subject|3|||
25014140|NCT04562155|50108196|FG003|Overall Study|Withdrawal by Subject|3|||
25014141|NCT04562155|50108193|FG000|Overall Study|Participant personal reason|1|||
25014142|NCT04562155|50108194|FG001|Overall Study|Participant personal reason|0|||
25014143|NCT04562155|50108195|FG002|Overall Study|Participant personal reason|2|||
25014144|NCT04562155|50108196|FG003|Overall Study|Participant personal reason|1|||
25014145|NCT02896257|50108210|FG000|Providers|Without eligible patients|21|||
25014146|NCT02896257|50108211|FG001|Providers|Without eligible patients|28|||
25014147|NCT02896257|50108210|FG000|Patients|PFT entry criteria not met|43|||
25014148|NCT02896257|50108211|FG001|Patients|PFT entry criteria not met|50|||
25014149|NCT02896257|50108210|FG000|Patients|No capacity to review|8|||
25014150|NCT02896257|50108211|FG001|Patients|No capacity to review|11|||
25014151|NCT02896257|50108210|FG000|Patients|Appointment rescheduled/cancelled|5|||
25014152|NCT02896257|50108211|FG001|Patients|Appointment rescheduled/cancelled|7|||
25014153|NCT02896257|50108210|FG000|Patients|PCP not assigned a clinic|4|||
25014154|NCT02896257|50108211|FG001|Patients|PCP not assigned a clinic|0|||
25014155|NCT02896257|50108210|FG000|Patients|No history of COPD|0|||
25014156|NCT02896257|50108211|FG001|Patients|No history of COPD|1|||
25014157|NCT02896257|50108210|FG000|Patients|Deceased between review and index date|0|||
25014158|NCT02896257|50108211|FG001|Patients|Deceased between review and index date|1|||
25014159|NCT02896257|50108210|FG000|Patients|No ICS Rx upon review|1|||
25014160|NCT02896257|50108211|FG001|Patients|No ICS Rx upon review|1|||
25014161|NCT02896257|50108210|FG000|Patients|Protocol Violation|2|||
25014162|NCT02896257|50108211|FG001|Patients|Protocol Violation|1|||
25014163|NCT02896257|50108210|FG000|Patients|Hospice care|0|||
25014164|NCT02896257|50108211|FG001|Patients|Hospice care|1|||
25014165|NCT03313050|50108222|FG000|Stage 2: 12 Months|Adverse Event|0|||
25014166|NCT03313050|50108223|FG001|Stage 2: 12 Months|Adverse Event|0|||
25014167|NCT03313050|50108224|FG002|Stage 2: 12 Months|Adverse Event|0|||
25014168|NCT03313050|50108225|FG003|Stage 2: 12 Months|Adverse Event|1|||
25014169|NCT03313050|50108222|FG000|Stage 2: 12 Months|Death|0|||
25014170|NCT03313050|50108223|FG001|Stage 2: 12 Months|Death|0|||
25014171|NCT03313050|50108224|FG002|Stage 2: 12 Months|Death|3|||
25014172|NCT03313050|50108225|FG003|Stage 2: 12 Months|Death|0|||
25014173|NCT03313050|50108222|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
25014174|NCT03313050|50108223|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
25014175|NCT03313050|50108224|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
25014176|NCT03313050|50108225|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
25014177|NCT03313050|50108222|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
25014178|NCT03313050|50108223|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
25014179|NCT03313050|50108224|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
25014180|NCT03313050|50108225|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
25014181|NCT03313050|50108222|FG000|Stage 2: 12 Months|Protocol deviation|0|||
25014182|NCT03313050|50108223|FG001|Stage 2: 12 Months|Protocol deviation|0|||
25014183|NCT03313050|50108224|FG002|Stage 2: 12 Months|Protocol deviation|7|||
25014184|NCT03313050|50108225|FG003|Stage 2: 12 Months|Protocol deviation|7|||
25014185|NCT03313050|50108222|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
25014186|NCT03313050|50108223|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
25014187|NCT03313050|50108224|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
25014188|NCT03313050|50108225|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
25014189|NCT03313050|50108222|FG000|Stage 2: 12 Months|Other|0|||
25014190|NCT03313050|50108223|FG001|Stage 2: 12 Months|Other|0|||
25014191|NCT03313050|50108224|FG002|Stage 2: 12 Months|Other|0|||
25014192|NCT03313050|50108225|FG003|Stage 2: 12 Months|Other|1|||
25014193|NCT04755595|50108244|FG000|Overall Study|Lost to Follow-up|1|||
25014194|NCT04749745|50108249|FG000|Overall Study|Withdrawal by Subject|1|||
25014195|NCT04749745|50108250|FG001|Overall Study|Withdrawal by Subject|0|||
25014196|NCT03257436|50108256|FG000|Overall Study|Withdrawal by Subject|76|||
25014197|NCT03257436|50108256|FG000|Overall Study|Death|19|||
25014198|NCT04748341|50108262|FG000|Overall Study|Lost to Follow-up|1|||
25014199|NCT04748341|50108263|FG001|Overall Study|Lost to Follow-up|1|||
25014200|NCT01328002|50108269|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
25014201|NCT01328002|50108270|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
25014202|NCT01328002|50108269|FG000|Open-Label Period|Adverse Event|8|||
25014203|NCT01328002|50108270|FG001|Open-Label Period|Adverse Event|0|||
25014204|NCT01328002|50108269|FG000|Open-Label Period|Lack of Efficacy|3|||
25014205|NCT01328002|50108270|FG001|Open-Label Period|Lack of Efficacy|0|||
25014206|NCT01328002|50108269|FG000|Open-Label Period|Protocol Violation|2|||
25014207|NCT01328002|50108270|FG001|Open-Label Period|Protocol Violation|0|||
25014208|NCT01328002|50108269|FG000|Open-Label Period|Withdrawal by Subject|9|||
25014209|NCT01328002|50108270|FG001|Open-Label Period|Withdrawal by Subject|0|||
25014210|NCT01328002|50108269|FG000|Open-Label Period|Lost to Follow-up|6|||
25014211|NCT01328002|50108270|FG001|Open-Label Period|Lost to Follow-up|0|||
25014212|NCT01328002|50108269|FG000|Open-Label Period|Other Reason|2|||
25014213|NCT01328002|50108270|FG001|Open-Label Period|Other Reason|0|||
25014214|NCT01328002|50108269|FG000|Double-Blind Period|Adverse Event|1|||
25014215|NCT01328002|50108270|FG001|Double-Blind Period|Adverse Event|0|||
25014216|NCT01328002|50108269|FG000|Double-Blind Period|Lack of Efficacy|1|||
25014217|NCT01328002|50108270|FG001|Double-Blind Period|Lack of Efficacy|0|||
25014218|NCT02579265|50108279|FG000|Overall Study|Weaned off earlier than 28 days|44|||
25014219|NCT02579265|50108280|FG001|Overall Study|Weaned off earlier than 28 days|43|||
25014220|NCT02579265|50108279|FG000|Overall Study|Adverse Event|2|||
25014221|NCT02579265|50108280|FG001|Overall Study|Adverse Event|0|||
25014222|NCT02579265|50108279|FG000|Overall Study|Any other reason not specified|0|||
25014223|NCT02579265|50108280|FG001|Overall Study|Any other reason not specified|2|||
25014224|NCT02579265|50108279|FG000|Overall Study|Withdrawal by Subject|2|||
25014225|NCT02579265|50108280|FG001|Overall Study|Withdrawal by Subject|0|||
25014226|NCT02579265|50108279|FG000|Overall Study|Physician Decision|1|||
25014227|NCT02579265|50108280|FG001|Overall Study|Physician Decision|0|||
25141418|NCT02007109|50254908|FG000|Overall Study|Excluded - Age<7yo|9|||
25141419|NCT02006719|50254917|FG000|Overall Study|Withdrawal by Subject|10|||
25141420|NCT02006719|50254918|FG001|Overall Study|Withdrawal by Subject|2|||
25141421|NCT02006719|50254917|FG000|Overall Study|Lost to Follow-up|5|||
25141422|NCT02006719|50254918|FG001|Overall Study|Lost to Follow-up|1|||
25141423|NCT02006719|50254917|FG000|Overall Study|Protocol Violation|2|||
25141424|NCT02006719|50254918|FG001|Overall Study|Protocol Violation|0|||
25141425|NCT02006719|50254917|FG000|Overall Study|Adverse Event|1|||
25141426|NCT02006719|50254918|FG001|Overall Study|Adverse Event|1|||
25141427|NCT02006719|50254917|FG000|Overall Study|Other/Unknown|0|||
25141428|NCT02006719|50254918|FG001|Overall Study|Other/Unknown|1|||
25141429|NCT01962493|50254926|FG000|Overall Study|Adverse Event|1|||
25141430|NCT01962493|50254927|FG001|Overall Study|Adverse Event|2|||
25014228|NCT02579265|50108279|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
25014229|NCT02579265|50108280|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
25067372|NCT03188666|50172999|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
25067373|NCT03188666|50173000|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
25067374|NCT03188666|50173001|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
25141431|NCT01962493|50254926|FG000|Overall Study|Protocol Violation|0|||
25141432|NCT01962493|50254927|FG001|Overall Study|Protocol Violation|1|||
25141433|NCT01962493|50254926|FG000|Overall Study|Withdrawal by Subject|4|||
25141434|NCT01962493|50254927|FG001|Overall Study|Withdrawal by Subject|2|||
25014230|NCT03289533|50108286|FG000|Overall Study|Death|12|||
25014231|NCT03289533|50108286|FG000|Overall Study|Terminated from study by sponsor|10|||
25014232|NCT04727749|50108292|FG000|Overall Study|Lost to Follow-up|10|||
25014233|NCT04727749|50108293|FG001|Overall Study|Lost to Follow-up|3|||
25014234|NCT04547023|50108303|FG000|Overall Study|Did Not Receive Intervention|3|||
25014235|NCT04547023|50108304|FG001|Overall Study|Did Not Receive Intervention|2|||
25014236|NCT04547023|50108303|FG000|Overall Study|Lost to Follow-up|1|||
25014237|NCT04547023|50108304|FG001|Overall Study|Lost to Follow-up|1|||
25014238|NCT03697993|50108314|FG000|Overall Study|Became Ineligible after Enrollment|1|||
25014239|NCT03697993|50108315|FG001|Overall Study|Became Ineligible after Enrollment|3|||
25014240|NCT03697993|50108314|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
25014241|NCT03697993|50108315|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
25014242|NCT03697993|50108314|FG000|Overall Study|Lost to Follow-up|3|||
25014243|NCT03697993|50108315|FG001|Overall Study|Lost to Follow-up|0|||
25014244|NCT03697993|50108314|FG000|Overall Study|Physician Decision|4|||
25014245|NCT03697993|50108315|FG001|Overall Study|Physician Decision|0|||
25014246|NCT03697993|50108314|FG000|Overall Study|Initial Urine Culture Negative|0|||
25014247|NCT03697993|50108315|FG001|Overall Study|Initial Urine Culture Negative|1|||
25014248|NCT03289455|50108325|FG000|Overall Study|Death|1|||
25014249|NCT03289455|50108326|FG001|Overall Study|Death|0|||
25014250|NCT03289455|50108327|FG002|Overall Study|Death|0|||
25014251|NCT03289455|50108325|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
25014252|NCT03289455|50108326|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
25014253|NCT03289455|50108327|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
25014254|NCT03289455|50108325|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
25014255|NCT03289455|50108326|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
25014256|NCT03289455|50108327|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
25014257|NCT03289455|50108325|FG000|Overall Study|Progressive disease|3|||
25014258|NCT03289455|50108326|FG001|Overall Study|Progressive disease|4|||
25014259|NCT03289455|50108327|FG002|Overall Study|Progressive disease|5|||
25014260|NCT04484857|50108336|FG000|Overall Study|Adverse Event|2|||
25014261|NCT04484857|50108336|FG000|Overall Study|Death|10|||
25014262|NCT04484857|50108336|FG000|Overall Study|Withdrawal by Subject|3|||
25014263|NCT04484857|50108336|FG000|Overall Study|Transferred/Relocation|5|||
25014264|NCT04484857|50108336|FG000|Overall Study|Kidney Transplant|7|||
25014265|NCT04484857|50108336|FG000|Overall Study|Other than specified|4|||
25014266|NCT04484857|50108336|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
25014267|NCT04095793|50108340|FG000|Overall Study|Adverse Event|3|||
25014268|NCT04095793|50108340|FG000|Overall Study|Study Terminated by Sponsor|103|||
25014269|NCT04095793|50108340|FG000|Overall Study|Withdrawal by Subject|4|||
25014270|NCT04482439|50108344|FG000|Overall Study|Lost to Follow-up|1|||
25014271|NCT04482439|50108344|FG000|Overall Study|Unrelated illness|1|||
25014272|NCT04535947|50108351|FG000|Overall Study|Adverse Event|1|||
25014273|NCT04535947|50108352|FG001|Overall Study|Adverse Event|4|||
25014274|NCT04535947|50108351|FG000|Overall Study|Other reasons not specified|2|||
25014275|NCT04535947|50108352|FG001|Overall Study|Other reasons not specified|0|||
25014276|NCT04535947|50108351|FG000|Overall Study|Withdrawal by Subject|1|||
25141435|NCT01989169|50254935|FG000|Period 2|Adverse Event|0|||
25141436|NCT01989169|50254936|FG001|Period 2|Adverse Event|1|||
25014277|NCT04535947|50108352|FG001|Overall Study|Withdrawal by Subject|1|||
25014278|NCT04474405|50108364|FG000|Overall Study|Withdrawal by Subject|0|||
25014279|NCT04474405|50108365|FG001|Overall Study|Withdrawal by Subject|0|||
25014280|NCT04474405|50108366|FG002|Overall Study|Withdrawal by Subject|1|||
25014281|NCT04474405|50108367|FG003|Overall Study|Withdrawal by Subject|0|||
25014282|NCT04474405|50108368|FG004|Overall Study|Withdrawal by Subject|1|||
25014283|NCT04474405|50108369|FG005|Overall Study|Withdrawal by Subject|0|||
25014284|NCT04474405|50108364|FG000|Overall Study|Other|0|||
25014285|NCT04474405|50108365|FG001|Overall Study|Other|0|||
25014286|NCT04474405|50108366|FG002|Overall Study|Other|0|||
25014287|NCT04474405|50108367|FG003|Overall Study|Other|0|||
25014288|NCT04474405|50108368|FG004|Overall Study|Other|3|||
25014289|NCT04474405|50108369|FG005|Overall Study|Other|0|||
25141437|NCT01988779|50254944|FG000|Overall Study|Withdrawal by Subject|2|||
25141438|NCT01988779|50254945|FG001|Overall Study|Withdrawal by Subject|2|||
25141439|NCT01988779|50254944|FG000|Overall Study|Protocol Violation|1|||
25141440|NCT01988779|50254945|FG001|Overall Study|Protocol Violation|0|||
25141441|NCT01988233|50254953|FG000|Overall Study|Lost to Follow-up|64|||
25141442|NCT01988233|50254954|FG001|Overall Study|Lost to Follow-up|51|||
25141443|NCT01987765|50254960|FG000|Overall Study|Protocol Violation|65|||
25141444|NCT01987765|50254960|FG000|Overall Study|Lost to Follow-up|37|||
25141445|NCT01987609|50254964|FG000|Overall Study|Adverse Event|1|||
25141446|NCT02013674|50254980|FG000|Overall Study|Death|0|||
25141447|NCT02013674|50254981|FG001|Overall Study|Death|1|||
25141448|NCT02013674|50254980|FG000|Overall Study|Lost to Follow-up|1|||
25141449|NCT02013674|50254981|FG001|Overall Study|Lost to Follow-up|0|||
25141450|NCT01987232|50254992|FG000|Overall Study|Ongoing in Study|0|||
25141451|NCT01987232|50254993|FG001|Overall Study|Ongoing in Study|0|||
25141452|NCT01987232|50254994|FG002|Overall Study|Ongoing in Study|0|||
25141453|NCT01987232|50254995|FG003|Overall Study|Ongoing in Study|1|||
25141454|NCT01987232|50254996|FG004|Overall Study|Ongoing in Study|0|||
25141455|NCT01986920|50255010|FG000|A- 101 25%|Withdrawal by Subject|1|||
25141456|NCT01986920|50255011|FG001|A- 101 25%|Withdrawal by Subject|0|||
25141457|NCT01986920|50255012|FG002|A- 101 25%|Withdrawal by Subject|0|||
25141458|NCT01986920|50255013|FG003|A- 101 25%|Withdrawal by Subject|0|||
25141459|NCT01986920|50255010|FG000|A-101 32.5%|Withdrawal by Subject|0|||
25014290|NCT04531813|50108383|FG000|Overall Study|Protocol Violation|1|||
25014291|NCT04531813|50108383|FG000|Overall Study|Withdrawal by Subject|1|||
25014292|NCT03538444|50108389|FG000|Overall Study|opioid withdrawal|1|||
25014293|NCT03538444|50108390|FG001|Overall Study|opioid withdrawal|0|||
25014294|NCT01199302|50108400|FG000|Overall Study|Adverse Event|1|||
25014295|NCT01199302|50108401|FG001|Overall Study|Adverse Event|1|||
25014296|NCT01199302|50108402|FG002|Overall Study|Adverse Event|2|||
25014297|NCT01199302|50108403|FG003|Overall Study|Adverse Event|0|||
25014298|NCT01199302|50108400|FG000|Overall Study|Withdrawal by Subject|2|||
25014299|NCT01199302|50108401|FG001|Overall Study|Withdrawal by Subject|2|||
25014300|NCT01199302|50108402|FG002|Overall Study|Withdrawal by Subject|3|||
25014301|NCT01199302|50108403|FG003|Overall Study|Withdrawal by Subject|0|||
25014302|NCT01199302|50108400|FG000|Overall Study|Disease Progression|3|||
25014303|NCT01199302|50108401|FG001|Overall Study|Disease Progression|4|||
25014304|NCT01199302|50108402|FG002|Overall Study|Disease Progression|4|||
25014305|NCT01199302|50108403|FG003|Overall Study|Disease Progression|2|||
25014306|NCT01199302|50108400|FG000|Overall Study|Study Termination|13|||
25014307|NCT01199302|50108401|FG001|Overall Study|Study Termination|8|||
25014308|NCT01199302|50108402|FG002|Overall Study|Study Termination|11|||
25014309|NCT01199302|50108403|FG003|Overall Study|Study Termination|9|||
25014310|NCT01199302|50108400|FG000|Overall Study|Lost to Follow-up|0|||
25014311|NCT01199302|50108401|FG001|Overall Study|Lost to Follow-up|1|||
25014312|NCT01199302|50108402|FG002|Overall Study|Lost to Follow-up|0|||
25014313|NCT01199302|50108403|FG003|Overall Study|Lost to Follow-up|0|||
25014314|NCT01199302|50108400|FG000|Overall Study|Other|1|||
25014315|NCT01199302|50108401|FG001|Overall Study|Other|0|||
25014316|NCT01199302|50108402|FG002|Overall Study|Other|0|||
25014317|NCT01199302|50108403|FG003|Overall Study|Other|0|||
25014318|NCT03332784|50108430|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25014319|NCT03332784|50108431|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
25014320|NCT03332784|50108432|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25141460|NCT01986920|50255011|FG001|A-101 32.5%|Withdrawal by Subject|1|||
25141461|NCT01986920|50255012|FG002|A-101 32.5%|Withdrawal by Subject|0|||
25141462|NCT01986920|50255013|FG003|A-101 32.5%|Withdrawal by Subject|0|||
25141463|NCT01986920|50255010|FG000|A-101 40%|Withdrawal by Subject|0|||
25141464|NCT01986920|50255011|FG001|A-101 40%|Withdrawal by Subject|0|||
25141465|NCT01986920|50255012|FG002|A-101 40%|Withdrawal by Subject|1|||
25141466|NCT01986920|50255013|FG003|A-101 40%|Withdrawal by Subject|0|||
25141467|NCT01986920|50255010|FG000|Placebo|Withdrawal by Subject|0|||
25141468|NCT01986920|50255011|FG001|Placebo|Withdrawal by Subject|0|||
25014321|NCT03332784|50108433|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25014322|NCT03332784|50108434|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25014323|NCT03332784|50108435|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25014324|NCT03332784|50108436|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25014325|NCT03332784|50108437|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25014326|NCT03332784|50108438|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25141469|NCT01986920|50255012|FG002|Placebo|Withdrawal by Subject|0|||
25014327|NCT03332784|50108439|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25014328|NCT03332784|50108440|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25014329|NCT03332784|50108441|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25141470|NCT01986920|50255013|FG003|Placebo|Withdrawal by Subject|1|||
25141471|NCT02010632|50255023|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
25141472|NCT02010632|50255024|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
25141473|NCT01986140|50255032|FG000|Overall Study|Withdrawal by Subject|31|||
25141474|NCT01986140|50255033|FG001|Overall Study|Withdrawal by Subject|25|||
25014330|NCT03332784|50108442|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25014331|NCT03332784|50108443|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25014332|NCT03332784|50108444|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
25014333|NCT03332784|50108445|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25014334|NCT03332784|50108446|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25014335|NCT03332784|50108447|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25014336|NCT03332784|50108448|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25014337|NCT03332784|50108449|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
25141475|NCT01986140|50255032|FG000|Overall Study|alternative treatment|1|||
25141476|NCT01986140|50255033|FG001|Overall Study|alternative treatment|1|||
25141477|NCT01986140|50255032|FG000|Overall Study|found not eligible|3|||
25141478|NCT01986140|50255033|FG001|Overall Study|found not eligible|0|||
25141479|NCT01986140|50255032|FG000|Overall Study|Adverse Event|0|||
25014338|NCT04465357|50108513|FG000|Overall Study|Adverse Event|2|||
25014339|NCT04465357|50108513|FG000|Overall Study|Lack of Efficacy|1|||
25014340|NCT04465357|50108513|FG000|Overall Study|Lost to Follow-up|2|||
25014341|NCT04465357|50108513|FG000|Overall Study|Withdrawal by Subject|6|||
25014342|NCT04465357|50108513|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
25014343|NCT03332628|50108517|FG000|Overall Study|Physician Decision|2|||
25014344|NCT04516759|50108524|FG000|Overall Study|Withdrawal by Subject|1|||
25014345|NCT04516759|50108525|FG001|Overall Study|Withdrawal by Subject|1|||
25014346|NCT04516759|50108524|FG000|Overall Study|Other|0|||
25014347|NCT04516759|50108525|FG001|Overall Study|Other|1|||
25014348|NCT03332160|50108533|FG000|Overall Study|Withdrawal by Subject|1|||
25014349|NCT03332160|50108534|FG001|Overall Study|Withdrawal by Subject|1|||
25014350|NCT03332160|50108533|FG000|Overall Study|Adverse Event|0|||
25014351|NCT03332160|50108534|FG001|Overall Study|Adverse Event|1|||
25014352|NCT03332160|50108533|FG000|Overall Study|Developed Exclusion Criteria|0|||
25014353|NCT03332160|50108534|FG001|Overall Study|Developed Exclusion Criteria|1|||
25014354|NCT03332160|50108533|FG000|Overall Study|Non-adherence to treatment|0|||
25014355|NCT03332160|50108534|FG001|Overall Study|Non-adherence to treatment|2|||
25014356|NCT03312114|50108541|FG000|Overall Study|All the five enrolled dropped out of the|5|||
25014357|NCT03694327|50108548|FG000|Overall Study|Lost to Follow-up|13|||
25014358|NCT03694327|50108549|FG001|Overall Study|Lost to Follow-up|23|||
25014359|NCT03330288|50108557|FG000|Overall Study|Other reason|1|||
25014360|NCT03330288|50108558|FG001|Overall Study|Other reason|1|||
25014361|NCT03330288|50108557|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
25141480|NCT01986140|50255033|FG001|Overall Study|Adverse Event|1|||
25141481|NCT01986140|50255032|FG000|Overall Study|progression disease|0|||
25141482|NCT01986140|50255033|FG001|Overall Study|progression disease|1|||
25141483|NCT01986062|50255041|FG000|Overall Study|Lost to Follow-up|1|||
25141484|NCT01986062|50255042|FG001|Overall Study|Lost to Follow-up|0|||
25141485|NCT01986062|50255041|FG000|Overall Study|Withdrawal by Subject|0|||
25141486|NCT01986062|50255042|FG001|Overall Study|Withdrawal by Subject|1|||
25141487|NCT01985360|50255050|FG000|Overall Study|Withdrawal by Subject|4|||
25141488|NCT01985360|50255051|FG001|Overall Study|Withdrawal by Subject|0|||
25141489|NCT01985360|50255050|FG000|Overall Study|Lost to Follow-up|5|||
25141490|NCT01985360|50255051|FG001|Overall Study|Lost to Follow-up|3|||
25141491|NCT02032706|50255057|FG000|Overall Study|Did not qualify|5|||
25141492|NCT02032706|50255057|FG000|Overall Study|Protocol Violation|1|||
25141493|NCT02032238|50255063|FG000|Overall Study|Lost to Follow-up|2|||
25141494|NCT02032238|50255064|FG001|Overall Study|Lost to Follow-up|0|||
25274411|NCT01078623|50588472|FG017|Treatment Period 3|Adverse Event|0|||
25274412|NCT01078623|50588473|FG018|Treatment Period 3|Adverse Event|0|||
25141497|NCT02009930|50255079|FG000|Overall Study|withdrawn|5|||
25141498|NCT01985126|50255092|FG000|Overall Study|Death|15|||
25141499|NCT01985126|50255093|FG001|Overall Study|Death|69|||
25141500|NCT01985126|50255092|FG000|Overall Study|Lost to Follow-up|0|||
25141501|NCT01985126|50255093|FG001|Overall Study|Lost to Follow-up|8|||
25141502|NCT01985126|50255092|FG000|Overall Study|Study Terminated By Sponsor|1|||
25141503|NCT01985126|50255093|FG001|Overall Study|Study Terminated By Sponsor|22|||
25141504|NCT01985126|50255092|FG000|Overall Study|Withdrawal by Subject|2|||
25141505|NCT01985126|50255093|FG001|Overall Study|Withdrawal by Subject|7|||
25141506|NCT01984892|50255099|FG000|Overall Study|Progressive disease|7|||
25141507|NCT01807221|50255109|FG000|Overall Study|Progressive disease|1|||
25141508|NCT01807221|50255110|FG001|Overall Study|Progressive disease|0|||
25141509|NCT01807221|50255111|FG002|Overall Study|Progressive disease|1|||
25141510|NCT01807221|50255112|FG003|Overall Study|Progressive disease|0|||
25141511|NCT01807221|50255113|FG004|Overall Study|Progressive disease|0|||
25141512|NCT01807221|50255114|FG005|Overall Study|Progressive disease|0|||
25141513|NCT01807221|50255109|FG000|Overall Study|Death|7|||
25141514|NCT01807221|50255110|FG001|Overall Study|Death|9|||
25141515|NCT01807221|50255111|FG002|Overall Study|Death|4|||
25141516|NCT01807221|50255112|FG003|Overall Study|Death|2|||
25141517|NCT01807221|50255113|FG004|Overall Study|Death|1|||
25141518|NCT01807221|50255114|FG005|Overall Study|Death|6|||
25141519|NCT01807221|50255109|FG000|Overall Study|Physician Decision|2|||
25141520|NCT01807221|50255110|FG001|Overall Study|Physician Decision|1|||
25141521|NCT01807221|50255111|FG002|Overall Study|Physician Decision|0|||
25014362|NCT03330288|50108558|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
25141522|NCT01807221|50255112|FG003|Overall Study|Physician Decision|0|||
25141523|NCT01807221|50255113|FG004|Overall Study|Physician Decision|0|||
25014363|NCT03330288|50108557|FG000|Overall Study|Adverse Event|1|||
25014364|NCT03330288|50108558|FG001|Overall Study|Adverse Event|0|||
25014365|NCT03330288|50108557|FG000|Overall Study|Withdrawal by Subject|1|||
25014366|NCT03330288|50108558|FG001|Overall Study|Withdrawal by Subject|0|||
25014367|NCT03330288|50108557|FG000|Overall Study|Lost to Follow-up|26|||
25014368|NCT03330288|50108558|FG001|Overall Study|Lost to Follow-up|7|||
25141524|NCT01807221|50255114|FG005|Overall Study|Physician Decision|0|||
25141525|NCT01807221|50255109|FG000|Overall Study|Adverse Event|33|||
25141526|NCT01807221|50255110|FG001|Overall Study|Adverse Event|22|||
25141527|NCT01807221|50255111|FG002|Overall Study|Adverse Event|26|||
25014369|NCT03084536|50108567|FG000|Overall Study|Determined to be ineligible|0|||
25014370|NCT03084536|50108568|FG001|Overall Study|Determined to be ineligible|0|||
25014371|NCT03084536|50108569|FG002|Overall Study|Determined to be ineligible|16|||
25014372|NCT03084536|50108567|FG000|Overall Study|Withdrawal by Subject|0|||
25014373|NCT03084536|50108568|FG001|Overall Study|Withdrawal by Subject|0|||
25014374|NCT03084536|50108569|FG002|Overall Study|Withdrawal by Subject|4|||
25014375|NCT03084536|50108567|FG000|Overall Study|Physician Decision|0|||
25014376|NCT03084536|50108568|FG001|Overall Study|Physician Decision|0|||
25014377|NCT03084536|50108569|FG002|Overall Study|Physician Decision|3|||
25014378|NCT03084536|50108567|FG000|Overall Study|Death|0|||
25014379|NCT03084536|50108568|FG001|Overall Study|Death|0|||
25014380|NCT03084536|50108569|FG002|Overall Study|Death|1|||
25014381|NCT03084536|50108567|FG000|Overall Study|Lost to Follow-up|0|||
25014382|NCT03084536|50108568|FG001|Overall Study|Lost to Follow-up|0|||
25014383|NCT03084536|50108569|FG002|Overall Study|Lost to Follow-up|1|||
25014384|NCT03084536|50108567|FG000|Overall Study|Protocol Violation|0|||
25014385|NCT03084536|50108568|FG001|Overall Study|Protocol Violation|0|||
25014386|NCT03084536|50108569|FG002|Overall Study|Protocol Violation|1|||
25014387|NCT03084536|50108567|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
25014388|NCT03084536|50108568|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
25014389|NCT03084536|50108569|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
25014390|NCT05291936|50108576|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
25014391|NCT05291936|50108577|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
25014392|NCT05291936|50108576|FG000|Period 1|Withdrew Consent during study|1|||
25014393|NCT05291936|50108577|FG001|Period 1|Withdrew Consent during study|0|||
25014394|NCT05291936|50108576|FG000|Period 2|Adverse Event|0|||
25014395|NCT05291936|50108577|FG001|Period 2|Adverse Event|1|||
25014396|NCT05291936|50108576|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
25014397|NCT05291936|50108577|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
25014398|NCT03289143|50108587|FG000|Overall Study|Caregiver Unavailability|1|||
25014399|NCT03289143|50108588|FG001|Overall Study|Caregiver Unavailability|1|||
25014400|NCT03289143|50108589|FG002|Overall Study|Caregiver Unavailability|0|||
25014401|NCT03289143|50108590|FG003|Overall Study|Caregiver Unavailability|0|||
25014402|NCT03289143|50108587|FG000|Overall Study|Research Department Closure|0|||
25014403|NCT03289143|50108588|FG001|Overall Study|Research Department Closure|0|||
25014404|NCT03289143|50108589|FG002|Overall Study|Research Department Closure|1|||
25014405|NCT03289143|50108590|FG003|Overall Study|Research Department Closure|0|||
25014406|NCT03289143|50108587|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
25014407|NCT03289143|50108588|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
25014408|NCT03289143|50108589|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
25014409|NCT03289143|50108590|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
25014410|NCT03289143|50108587|FG000|Overall Study|Medical Monitor Decision|1|||
25014411|NCT03289143|50108588|FG001|Overall Study|Medical Monitor Decision|0|||
25014412|NCT03289143|50108589|FG002|Overall Study|Medical Monitor Decision|0|||
25014413|NCT03289143|50108590|FG003|Overall Study|Medical Monitor Decision|0|||
25014414|NCT03289143|50108587|FG000|Overall Study|Participant Non-Compliance|0|||
25014415|NCT03289143|50108588|FG001|Overall Study|Participant Non-Compliance|0|||
25014416|NCT03289143|50108589|FG002|Overall Study|Participant Non-Compliance|1|||
25014417|NCT03289143|50108590|FG003|Overall Study|Participant Non-Compliance|0|||
25014418|NCT03289143|50108587|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
25014419|NCT03289143|50108588|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
25014420|NCT03289143|50108589|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
25014421|NCT03289143|50108590|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
25014422|NCT03289143|50108587|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
25014423|NCT03289143|50108588|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
25014424|NCT03289143|50108589|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
25014425|NCT03289143|50108590|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
25014426|NCT03289143|50108587|FG000|Overall Study|Caregiver Passed Away|1|||
25014427|NCT03289143|50108588|FG001|Overall Study|Caregiver Passed Away|0|||
25014428|NCT03289143|50108589|FG002|Overall Study|Caregiver Passed Away|0|||
25014429|NCT03289143|50108590|FG003|Overall Study|Caregiver Passed Away|0|||
25014430|NCT03289143|50108587|FG000|Overall Study|Physician Decision|0|||
25014431|NCT03289143|50108588|FG001|Overall Study|Physician Decision|2|||
25014432|NCT03289143|50108589|FG002|Overall Study|Physician Decision|2|||
25014433|NCT03289143|50108590|FG003|Overall Study|Physician Decision|2|||
25014434|NCT03289143|50108587|FG000|Overall Study|Protocol Deviation|2|||
25014435|NCT03289143|50108588|FG001|Overall Study|Protocol Deviation|1|||
25014436|NCT03289143|50108589|FG002|Overall Study|Protocol Deviation|3|||
25014437|NCT03289143|50108590|FG003|Overall Study|Protocol Deviation|1|||
25014438|NCT03289143|50108587|FG000|Overall Study|Study Terminated By Sponsor|101|||
25014439|NCT03289143|50108588|FG001|Overall Study|Study Terminated By Sponsor|75|||
25014440|NCT03289143|50108589|FG002|Overall Study|Study Terminated By Sponsor|100|||
25014441|NCT03289143|50108590|FG003|Overall Study|Study Terminated By Sponsor|69|||
25014442|NCT03289143|50108587|FG000|Overall Study|Withdrawal by Subject|14|||
25014443|NCT03289143|50108588|FG001|Overall Study|Withdrawal by Subject|6|||
25014444|NCT03289143|50108589|FG002|Overall Study|Withdrawal by Subject|14|||
25014445|NCT03289143|50108590|FG003|Overall Study|Withdrawal by Subject|12|||
25141528|NCT01807221|50255112|FG003|Overall Study|Adverse Event|25|||
25014446|NCT03289143|50108587|FG000|Overall Study|Adverse Event|10|||
25014447|NCT03289143|50108588|FG001|Overall Study|Adverse Event|7|||
25014448|NCT03289143|50108589|FG002|Overall Study|Adverse Event|6|||
25014449|NCT03289143|50108590|FG003|Overall Study|Adverse Event|5|||
25014450|NCT03289143|50108587|FG000|Overall Study|Death|2|||
25014451|NCT03289143|50108588|FG001|Overall Study|Death|0|||
25014452|NCT03289143|50108589|FG002|Overall Study|Death|2|||
25014453|NCT03289143|50108590|FG003|Overall Study|Death|1|||
25014454|NCT03289143|50108587|FG000|Overall Study|Lost to Follow-up|2|||
25014455|NCT03289143|50108588|FG001|Overall Study|Lost to Follow-up|1|||
25014456|NCT03289143|50108589|FG002|Overall Study|Lost to Follow-up|1|||
25014457|NCT03289143|50108590|FG003|Overall Study|Lost to Follow-up|0|||
25014458|NCT03289143|50108587|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
25014459|NCT03289143|50108588|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
25014460|NCT03289143|50108589|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
25014461|NCT03289143|50108590|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
25014462|NCT03289143|50108587|FG000|Overall Study|Withdrawal by Caregiver|0|||
25014463|NCT03289143|50108588|FG001|Overall Study|Withdrawal by Caregiver|1|||
25014464|NCT03289143|50108589|FG002|Overall Study|Withdrawal by Caregiver|0|||
25014465|NCT03289143|50108590|FG003|Overall Study|Withdrawal by Caregiver|0|||
25014466|NCT03289143|50108587|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
25014467|NCT03289143|50108588|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
25014468|NCT03289143|50108589|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
25014469|NCT03289143|50108590|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
25014470|NCT03289143|50108587|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
25014471|NCT03289143|50108588|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
25014472|NCT03289143|50108589|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
25014473|NCT03289143|50108590|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
25014474|NCT03311724|50108609|FG000|Overall Study|Physician Decision|0|||
25014475|NCT03311724|50108610|FG001|Overall Study|Physician Decision|0|||
25014476|NCT03311724|50108611|FG002|Overall Study|Physician Decision|0|||
25014477|NCT03311724|50108612|FG003|Overall Study|Physician Decision|1|||
25014478|NCT03311724|50108609|FG000|Overall Study|Protocol Violation|1|||
25014479|NCT03311724|50108610|FG001|Overall Study|Protocol Violation|0|||
25014480|NCT03311724|50108611|FG002|Overall Study|Protocol Violation|1|||
25014481|NCT03311724|50108612|FG003|Overall Study|Protocol Violation|0|||
25014482|NCT03311724|50108609|FG000|Overall Study|Withdrawal by Subject|1|||
25014483|NCT03311724|50108610|FG001|Overall Study|Withdrawal by Subject|1|||
25014484|NCT03311724|50108611|FG002|Overall Study|Withdrawal by Subject|0|||
25014485|NCT03311724|50108612|FG003|Overall Study|Withdrawal by Subject|0|||
25014486|NCT03311724|50108609|FG000|Overall Study|Lost to Follow-up|1|||
25014487|NCT03311724|50108610|FG001|Overall Study|Lost to Follow-up|0|||
25014488|NCT03311724|50108611|FG002|Overall Study|Lost to Follow-up|0|||
25014489|NCT03311724|50108612|FG003|Overall Study|Lost to Follow-up|0|||
25014490|NCT03311724|50108609|FG000|Overall Study|Sponsor Decision|0|||
25014491|NCT03311724|50108610|FG001|Overall Study|Sponsor Decision|0|||
25014492|NCT03311724|50108611|FG002|Overall Study|Sponsor Decision|1|||
25014493|NCT03311724|50108612|FG003|Overall Study|Sponsor Decision|0|||
25014494|NCT03311646|50108634|FG000|Overall Study|Physician Decision|1|||
25014495|NCT03311646|50108634|FG000|Overall Study|Withdrawal by Subject|5|||
25014496|NCT03311646|50108634|FG000|Overall Study|Lost to Follow-up|5|||
25014497|NCT03311646|50108634|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
25014498|NCT01672892|50108641|FG000|Overall Study|Protocol Violation|7|||
25014499|NCT01672892|50108642|FG001|Overall Study|Protocol Violation|3|||
25014500|NCT03288987|50108653|FG000|Overall Study|Protocol Violation|10|||
25014501|NCT03288987|50108654|FG001|Overall Study|Protocol Violation|4|||
25014502|NCT02939781|50108660|FG000|Overall Study|Protocol Violation|8|||
25014503|NCT02939781|50108660|FG000|Overall Study|Withdrawal by Subject|1|||
25014504|NCT03083990|50108676|FG000|Overall Study|Adverse Event|1|||
25014505|NCT03083990|50108677|FG001|Overall Study|Adverse Event|0|||
25014506|NCT03252015|50108695|FG000|Overall Study|Withdrawal by Subject|0|||
25014507|NCT03252015|50108696|FG001|Overall Study|Withdrawal by Subject|1|||
25014508|NCT03252015|50108697|FG002|Overall Study|Withdrawal by Subject|1|||
25014509|NCT03252015|50108698|FG003|Overall Study|Withdrawal by Subject|0|||
25014510|NCT03252015|50108695|FG000|Overall Study|Adverse Event|1|||
25014511|NCT03252015|50108696|FG001|Overall Study|Adverse Event|0|||
25014512|NCT03252015|50108697|FG002|Overall Study|Adverse Event|0|||
25014513|NCT03252015|50108698|FG003|Overall Study|Adverse Event|1|||
25014514|NCT03083132|50108724|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
25014515|NCT03083132|50108725|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
25014516|NCT03083132|50108724|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
25014517|NCT03083132|50108725|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
25014518|NCT03083132|50108724|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
25014519|NCT03083132|50108725|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
25014520|NCT03683823|50108733|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
25014521|NCT03683823|50108734|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
25014522|NCT03683823|50108733|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
25014523|NCT03683823|50108734|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
25014524|NCT03683823|50108733|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
25014525|NCT03683823|50108734|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
25014526|NCT03285711|50108742|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
25014527|NCT03285711|50108743|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
25014528|NCT03285711|50108744|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
25014529|NCT03285711|50108745|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
25014530|NCT03285711|50108742|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
25014531|NCT03285711|50108743|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
25014532|NCT03285711|50108744|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
25014533|NCT03285711|50108745|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
25014534|NCT03285711|50108742|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
25014535|NCT03285711|50108743|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
25014536|NCT03285711|50108744|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
25014537|NCT03285711|50108745|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
25014538|NCT03285711|50108742|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
25014539|NCT03285711|50108743|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
25014540|NCT03285711|50108744|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
25014541|NCT03285711|50108745|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
25014542|NCT02927366|50108757|FG000|Overall Study|Adverse Event|1|||
25014543|NCT02927366|50108758|FG001|Overall Study|Adverse Event|0|||
25014544|NCT02927366|50108757|FG000|Overall Study|Patient schedule|1|||
25014545|NCT02927366|50108758|FG001|Overall Study|Patient schedule|0|||
25014546|NCT03249909|50108767|FG000|Overall Study|Withdrawal by Subject|3|||
25014547|NCT03249909|50108768|FG001|Overall Study|Withdrawal by Subject|0|||
25014548|NCT03249909|50108769|FG002|Overall Study|Withdrawal by Subject|0|||
25014549|NCT03249909|50108767|FG000|Overall Study|Adverse Event|3|||
25014550|NCT03249909|50108768|FG001|Overall Study|Adverse Event|0|||
25014551|NCT03249909|50108769|FG002|Overall Study|Adverse Event|0|||
25014552|NCT03249909|50108767|FG000|Overall Study|Lost to Follow-up|0|||
25014553|NCT03249909|50108768|FG001|Overall Study|Lost to Follow-up|1|||
25014554|NCT03249909|50108769|FG002|Overall Study|Lost to Follow-up|0|||
25014555|NCT03081884|50108780|FG000|Overall Study|deferred prostate cancer treatment|1|||
25014556|NCT03081884|50108780|FG000|Overall Study|metastasis managed with systemic therapy|3|||
25014557|NCT03077438|50108787|FG000|Overall Study|Protocol Violation|3|||
25014558|NCT03077438|50108788|FG001|Overall Study|Protocol Violation|5|||
25014559|NCT03077438|50108787|FG000|Overall Study|Withdrawal by Subject|3|||
25014560|NCT03077438|50108788|FG001|Overall Study|Withdrawal by Subject|6|||
25014561|NCT03077438|50108787|FG000|Overall Study|Lost to Follow-up|6|||
25014562|NCT03077438|50108788|FG001|Overall Study|Lost to Follow-up|3|||
25014563|NCT03076970|50108798|FG000|Washout Period 2|Adverse Event|0|||
25014564|NCT03076970|50108799|FG001|Washout Period 2|Adverse Event|0|||
25014565|NCT03076970|50108800|FG002|Washout Period 2|Adverse Event|0|||
25014566|NCT03076970|50108801|FG003|Washout Period 2|Adverse Event|0|||
25014567|NCT03076970|50108802|FG004|Washout Period 2|Adverse Event|1|||
25014568|NCT03076970|50108803|FG005|Washout Period 2|Adverse Event|0|||
25014569|NCT03076970|50108798|FG000|Period 3|Withdrawal by Subject|0|||
25014570|NCT03076970|50108799|FG001|Period 3|Withdrawal by Subject|0|||
25014571|NCT03076970|50108800|FG002|Period 3|Withdrawal by Subject|0|||
25014572|NCT03076970|50108801|FG003|Period 3|Withdrawal by Subject|0|||
25014573|NCT03076970|50108802|FG004|Period 3|Withdrawal by Subject|0|||
25014574|NCT03076970|50108803|FG005|Period 3|Withdrawal by Subject|1|||
25014575|NCT03076970|50108798|FG000|Period 3|Failure to meet I/E criteria|0|||
25014576|NCT03076970|50108799|FG001|Period 3|Failure to meet I/E criteria|0|||
25014577|NCT03076970|50108800|FG002|Period 3|Failure to meet I/E criteria|0|||
25014578|NCT03076970|50108801|FG003|Period 3|Failure to meet I/E criteria|0|||
25014579|NCT03076970|50108802|FG004|Period 3|Failure to meet I/E criteria|1|||
25014580|NCT03076970|50108803|FG005|Period 3|Failure to meet I/E criteria|0|||
25014581|NCT00726596|50108816|FG000|Overall Study|Adverse Event|2|||
25014582|NCT00726596|50108817|FG001|Overall Study|Adverse Event|1|||
25014583|NCT00726596|50108816|FG000|Overall Study|Withdrawal by Subject|3|||
25014584|NCT00726596|50108817|FG001|Overall Study|Withdrawal by Subject|3|||
25014585|NCT02890992|50108840|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
25014586|NCT02890992|50108841|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
25014587|NCT02890992|50108842|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
25014588|NCT02890992|50108843|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
25014589|NCT02890992|50108844|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
25014590|NCT02890992|50108845|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
25014591|NCT02890992|50108846|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
25014592|NCT02890992|50108847|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
25014593|NCT02890992|50108840|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
25014594|NCT02890992|50108841|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
25014595|NCT02890992|50108842|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
25014596|NCT02890992|50108843|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
25014597|NCT02890992|50108844|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
25014598|NCT02890992|50108845|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
25014599|NCT02890992|50108846|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
25014600|NCT02890992|50108847|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
25014601|NCT02890992|50108840|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
25014602|NCT02890992|50108841|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
25014603|NCT02890992|50108842|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
25014604|NCT02890992|50108843|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
25014605|NCT02890992|50108844|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
25014606|NCT02890992|50108845|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
25014607|NCT02890992|50108846|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
25014608|NCT02890992|50108847|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
25014609|NCT03076190|50108892|FG000|Overall Study|Lost to Follow-up|9|||
25014610|NCT03076190|50108893|FG001|Overall Study|Lost to Follow-up|34|||
25014611|NCT03076190|50108892|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
25014612|NCT03076190|50108893|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
25014613|NCT03329196|50108904|FG000|Overall Study|Adverse Event|10|||
25014614|NCT03329196|50108905|FG001|Overall Study|Adverse Event|5|||
25014615|NCT03329196|50108904|FG000|Overall Study|Physician Decision|2|||
25014616|NCT03329196|50108905|FG001|Overall Study|Physician Decision|2|||
25014617|NCT03329196|50108904|FG000|Overall Study|Withdrawal by Subject|11|||
25014618|NCT03329196|50108905|FG001|Overall Study|Withdrawal by Subject|3|||
25014619|NCT03329196|50108904|FG000|Overall Study|Hepatic function abnormalities|0|||
25014620|NCT03329196|50108905|FG001|Overall Study|Hepatic function abnormalities|1|||
25014621|NCT03329196|50108904|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
25014622|NCT03329196|50108905|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
25014623|NCT03329196|50108904|FG000|Overall Study|Difficult to control Hb|2|||
25014624|NCT03329196|50108905|FG001|Overall Study|Difficult to control Hb|3|||
25014625|NCT03329196|50108904|FG000|Overall Study|Dialysis or renal transplant|13|||
25014626|NCT03329196|50108905|FG001|Overall Study|Dialysis or renal transplant|15|||
25014627|NCT03328182|50108911|FG000|Overall Study|Withdrawal by Subject|1|||
25014628|NCT03328182|50108911|FG000|Overall Study|Protocol Violation|2|||
25014629|NCT03328182|50108911|FG000|Overall Study|No Product Evaluated|1|||
25014630|NCT03327402|50108915|FG000|Overall Study|Withdrawal by Subject|1|||
25014631|NCT03327402|50108915|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
25014632|NCT03075878|50108919|FG000|Overall Study|Physician Decision|1|||
25014633|NCT03326856|50108928|FG000|Overall Study|Lost to Follow-up|1|||
25014634|NCT03326856|50108929|FG001|Overall Study|Lost to Follow-up|1|||
25014635|NCT03326856|50108930|FG002|Overall Study|Lost to Follow-up|0|||
25014636|NCT03326856|50108931|FG003|Overall Study|Lost to Follow-up|0|||
25014637|NCT03326856|50108932|FG004|Overall Study|Lost to Follow-up|0|||
25014638|NCT03309696|50108946|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
25014639|NCT03309696|50108947|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
25014640|NCT03309696|50108948|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
25141529|NCT01807221|50255113|FG004|Overall Study|Adverse Event|18|||
25141530|NCT01807221|50255114|FG005|Overall Study|Adverse Event|21|||
25014641|NCT03309696|50108949|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
25014642|NCT03075644|50108963|FG000|Overall Study|Withdrawal by Subject|1|||
25014643|NCT03075644|50108964|FG001|Overall Study|Withdrawal by Subject|1|||
25014644|NCT03075410|50108980|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
25014645|NCT03075410|50108981|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
25014646|NCT03075410|50108982|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
25014647|NCT03075410|50108983|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
25014648|NCT03075410|50108984|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
25014649|NCT03075410|50108985|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
25014650|NCT03075410|50108986|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
25014651|NCT03075410|50108987|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
25014652|NCT03075410|50108988|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
25014653|NCT03075410|50108980|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
25014654|NCT03075410|50108981|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
25014655|NCT03075410|50108982|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
25014656|NCT03075410|50108983|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
25014657|NCT03075410|50108984|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
25014658|NCT03075410|50108985|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
25014659|NCT03075410|50108986|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
25014660|NCT03075410|50108987|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
25014661|NCT03075410|50108988|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
25014662|NCT03071276|50109030|FG000|Overall Study|Adverse Event|1|||
25014663|NCT03071276|50109030|FG000|Overall Study|Lack of Efficacy|14|||
25014664|NCT03074162|50109040|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
25014665|NCT03074162|50109041|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
25014666|NCT03074162|50109042|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
25014667|NCT03074162|50109043|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
25014668|NCT03074162|50109044|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
25014669|NCT03074162|50109045|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
25014670|NCT03074162|50109040|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
25014671|NCT03074162|50109041|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
25014672|NCT03074162|50109042|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
25014673|NCT03074162|50109043|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
25014674|NCT03074162|50109044|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
25014675|NCT03074162|50109045|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
25014676|NCT03074162|50109040|FG000|Period 3|Withdrawal by Subject|1|||
25014677|NCT03074162|50109041|FG001|Period 3|Withdrawal by Subject|0|||
25014678|NCT03074162|50109042|FG002|Period 3|Withdrawal by Subject|0|||
25014679|NCT03074162|50109043|FG003|Period 3|Withdrawal by Subject|0|||
25014680|NCT03074162|50109044|FG004|Period 3|Withdrawal by Subject|1|||
25014681|NCT03074162|50109045|FG005|Period 3|Withdrawal by Subject|0|||
25014682|NCT03070964|50109053|FG000|Overall Study|Progressive disease|8|||
25014683|NCT03070964|50109053|FG000|Overall Study|Treatment-unrelated adverse event|2|||
25014684|NCT03070964|50109053|FG000|Overall Study|Never treated|1|||
25014685|NCT03070964|50109053|FG000|Overall Study|Physician Decision|1|||
25014686|NCT03070964|50109053|FG000|Overall Study|Withdrawal by Subject|1|||
25141531|NCT01807221|50255109|FG000|Overall Study|Protocol Violation|0|||
25141532|NCT01807221|50255110|FG001|Overall Study|Protocol Violation|2|||
25014687|NCT03070964|50109053|FG000|Overall Study|Adverse Event|1|||
25014688|NCT04065074|50109057|FG000|Overall Study|Adverse Event|1|||
25014689|NCT04065074|50109057|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
25014690|NCT02888106|50109067|FG000|Overall Study|Withdrawal by Subject|1|||
25014691|NCT02888106|50109068|FG001|Overall Study|Withdrawal by Subject|2|||
25014692|NCT02888106|50109069|FG002|Overall Study|Withdrawal by Subject|0|||
25014693|NCT02888106|50109070|FG003|Overall Study|Withdrawal by Subject|1|||
25014694|NCT02888106|50109071|FG004|Overall Study|Withdrawal by Subject|0|||
25014695|NCT02888106|50109072|FG005|Overall Study|Withdrawal by Subject|0|||
25014696|NCT02888106|50109067|FG000|Overall Study|Lost to Follow-up|1|||
25014697|NCT02888106|50109068|FG001|Overall Study|Lost to Follow-up|0|||
25014698|NCT02888106|50109069|FG002|Overall Study|Lost to Follow-up|0|||
25014699|NCT02888106|50109070|FG003|Overall Study|Lost to Follow-up|1|||
25014700|NCT02888106|50109071|FG004|Overall Study|Lost to Follow-up|0|||
25014701|NCT02888106|50109072|FG005|Overall Study|Lost to Follow-up|1|||
25014702|NCT02888106|50109067|FG000|Overall Study|Adverse Event|2|||
25014703|NCT02888106|50109068|FG001|Overall Study|Adverse Event|0|||
25014704|NCT02888106|50109069|FG002|Overall Study|Adverse Event|0|||
25014705|NCT02888106|50109070|FG003|Overall Study|Adverse Event|0|||
25014706|NCT02888106|50109071|FG004|Overall Study|Adverse Event|0|||
25014707|NCT02888106|50109072|FG005|Overall Study|Adverse Event|0|||
25014708|NCT02888106|50109067|FG000|Overall Study|Withdrawal of consent|0|||
25014709|NCT02888106|50109068|FG001|Overall Study|Withdrawal of consent|0|||
25014710|NCT02888106|50109069|FG002|Overall Study|Withdrawal of consent|0|||
25014711|NCT02888106|50109070|FG003|Overall Study|Withdrawal of consent|0|||
25014712|NCT02888106|50109071|FG004|Overall Study|Withdrawal of consent|1|||
25014713|NCT02888106|50109072|FG005|Overall Study|Withdrawal of consent|0|||
25014714|NCT02888106|50109067|FG000|Overall Study|Pregnancy|1|||
25014715|NCT02888106|50109068|FG001|Overall Study|Pregnancy|0|||
25014716|NCT02888106|50109069|FG002|Overall Study|Pregnancy|0|||
25014717|NCT02888106|50109070|FG003|Overall Study|Pregnancy|0|||
25014718|NCT02888106|50109071|FG004|Overall Study|Pregnancy|0|||
25014719|NCT02888106|50109072|FG005|Overall Study|Pregnancy|0|||
25014720|NCT03793010|50109094|FG000|Overall Study|Withdrawal by Subject|5|||
25014721|NCT03793010|50109095|FG001|Overall Study|Withdrawal by Subject|7|||
25014722|NCT03793010|50109094|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
25014723|NCT03793010|50109095|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
25014724|NCT03793010|50109094|FG000|Overall Study|Lost to Follow-up|1|||
25014725|NCT03793010|50109095|FG001|Overall Study|Lost to Follow-up|2|||
25014726|NCT03793010|50109094|FG000|Overall Study|Patient couldn't sit still for injection|1|||
25014727|NCT03793010|50109095|FG001|Overall Study|Patient couldn't sit still for injection|0|||
25014728|NCT03793010|50109094|FG000|Overall Study|Withdrew to pursue other treatment|1|||
25014729|NCT03793010|50109095|FG001|Overall Study|Withdrew to pursue other treatment|0|||
25014730|NCT03793010|50109094|FG000|Overall Study|Did not meet eligibility criteria|1|||
25014731|NCT03793010|50109095|FG001|Overall Study|Did not meet eligibility criteria|0|||
25014732|NCT03304626|50109103|FG000|Overall Study|Adverse Event|1|||
25014733|NCT03304626|50109104|FG001|Overall Study|Adverse Event|0|||
25014734|NCT03304626|50109103|FG000|Overall Study|Lack of Efficacy|1|||
25014735|NCT03304626|50109104|FG001|Overall Study|Lack of Efficacy|1|||
25014736|NCT03274986|50109113|FG000|Overall Study|Withdrawal by Subject|0|||
25014737|NCT03274986|50109114|FG001|Overall Study|Withdrawal by Subject|1|||
25014738|NCT03274986|50109113|FG000|Overall Study|Lost to Follow-up|0|||
25014739|NCT03274986|50109114|FG001|Overall Study|Lost to Follow-up|1|||
25014740|NCT02919306|50109129|FG000|Overall Study|Withdrawal by Subject|1|||
25014741|NCT02919306|50109130|FG001|Overall Study|Withdrawal by Subject|0|||
25014742|NCT02919306|50109129|FG000|Overall Study|Protocol Violation|1|||
25014743|NCT02919306|50109130|FG001|Overall Study|Protocol Violation|0|||
25014744|NCT03274440|50109136|FG000|Overall Study|Time commitment too great|1|||
25014745|NCT03274440|50109137|FG001|Overall Study|Time commitment too great|0|||
25014746|NCT03274440|50109138|FG002|Overall Study|Time commitment too great|0|||
25014747|NCT03274440|50109139|FG003|Overall Study|Time commitment too great|1|||
25014748|NCT03274440|50109140|FG004|Overall Study|Time commitment too great|0|||
25014749|NCT03274440|50109141|FG005|Overall Study|Time commitment too great|0|||
25014750|NCT03268746|50109149|FG000|Overall Study|Withdrawal by Subject|1|||
25014751|NCT03268590|50109160|FG000|Overall Study|Previously unknown exclusion criteria|1|||
25141533|NCT01807221|50255111|FG002|Overall Study|Protocol Violation|1|||
25141534|NCT01807221|50255112|FG003|Overall Study|Protocol Violation|2|||
25141535|NCT01807221|50255113|FG004|Overall Study|Protocol Violation|0|||
25141536|NCT01807221|50255114|FG005|Overall Study|Protocol Violation|1|||
25141537|NCT01807221|50255109|FG000|Overall Study|Non-compliance|1|||
25141538|NCT01807221|50255110|FG001|Overall Study|Non-compliance|2|||
25141539|NCT01807221|50255111|FG002|Overall Study|Non-compliance|0|||
25141540|NCT01807221|50255112|FG003|Overall Study|Non-compliance|1|||
25141541|NCT01807221|50255113|FG004|Overall Study|Non-compliance|0|||
25141542|NCT01807221|50255114|FG005|Overall Study|Non-compliance|0|||
25141543|NCT01807221|50255109|FG000|Overall Study|Logistical difficulties|0|||
25141544|NCT01807221|50255110|FG001|Overall Study|Logistical difficulties|1|||
25141545|NCT01807221|50255111|FG002|Overall Study|Logistical difficulties|0|||
25014752|NCT03267576|50109169|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
25014753|NCT03267576|50109170|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
25141546|NCT01807221|50255112|FG003|Overall Study|Logistical difficulties|0|||
25141547|NCT01807221|50255113|FG004|Overall Study|Logistical difficulties|1|||
25141548|NCT01807221|50255114|FG005|Overall Study|Logistical difficulties|0|||
25141549|NCT01807221|50255109|FG000|Overall Study|Withdrawal by Subject|33|||
25014754|NCT03267576|50109169|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
25014755|NCT03267576|50109170|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
25014756|NCT03267264|50109180|FG000|Overall Study|Withdrawal by Subject|1|||
25014757|NCT03267264|50109181|FG001|Overall Study|Withdrawal by Subject|0|||
25014758|NCT03267264|50109182|FG002|Overall Study|Withdrawal by Subject|2|||
25014759|NCT03267264|50109183|FG003|Overall Study|Withdrawal by Subject|4|||
25014760|NCT03244800|50109200|FG000|Overall Study|Adverse Event|0|||
25014761|NCT03244800|50109201|FG001|Overall Study|Adverse Event|1|||
25014762|NCT03244800|50109202|FG002|Overall Study|Adverse Event|0|||
25014763|NCT03244800|50109203|FG003|Overall Study|Adverse Event|1|||
25141550|NCT01807221|50255110|FG001|Overall Study|Withdrawal by Subject|15|||
25141551|NCT01807221|50255111|FG002|Overall Study|Withdrawal by Subject|8|||
25141552|NCT01807221|50255112|FG003|Overall Study|Withdrawal by Subject|14|||
25141553|NCT01807221|50255113|FG004|Overall Study|Withdrawal by Subject|16|||
25141554|NCT01807221|50255114|FG005|Overall Study|Withdrawal by Subject|13|||
25141555|NCT01807221|50255109|FG000|Overall Study|Sponsor decision|2|||
25141556|NCT01807221|50255110|FG001|Overall Study|Sponsor decision|0|||
25141557|NCT01807221|50255111|FG002|Overall Study|Sponsor decision|1|||
25141558|NCT01807221|50255112|FG003|Overall Study|Sponsor decision|1|||
25141559|NCT01807221|50255113|FG004|Overall Study|Sponsor decision|0|||
25141560|NCT01807221|50255114|FG005|Overall Study|Sponsor decision|0|||
25141561|NCT01807221|50255109|FG000|Overall Study|Lost to Follow-up|1|||
25141562|NCT01807221|50255110|FG001|Overall Study|Lost to Follow-up|0|||
25141563|NCT01807221|50255111|FG002|Overall Study|Lost to Follow-up|2|||
25141564|NCT01807221|50255112|FG003|Overall Study|Lost to Follow-up|1|||
25141565|NCT01807221|50255113|FG004|Overall Study|Lost to Follow-up|0|||
25141566|NCT01807221|50255114|FG005|Overall Study|Lost to Follow-up|0|||
25141567|NCT01838499|50255130|FG000|Overall Study|Protocol Violation|0|||
25141568|NCT01838499|50255131|FG001|Overall Study|Protocol Violation|1|||
25141569|NCT01838499|50255130|FG000|Overall Study|Lost to Follow-up|2|||
25141570|NCT01838499|50255131|FG001|Overall Study|Lost to Follow-up|4|||
25141571|NCT01838499|50255130|FG000|Overall Study|Lack of Efficacy|1|||
25141572|NCT01838499|50255131|FG001|Overall Study|Lack of Efficacy|2|||
25141573|NCT01838499|50255130|FG000|Overall Study|Adverse Event|2|||
25141574|NCT01838499|50255131|FG001|Overall Study|Adverse Event|1|||
25141575|NCT01838499|50255130|FG000|Overall Study|Withdrawal by Subject|19|||
25141576|NCT01838499|50255131|FG001|Overall Study|Withdrawal by Subject|9|||
25014764|NCT03244800|50109200|FG000|Overall Study|Withdrew treatment|0|||
25014765|NCT03244800|50109201|FG001|Overall Study|Withdrew treatment|0|||
25014766|NCT03244800|50109202|FG002|Overall Study|Withdrew treatment|0|||
25014767|NCT03244800|50109203|FG003|Overall Study|Withdrew treatment|1|||
25014768|NCT04516291|50109224|FG000|Treatment Period (24 Weeks)|Other|1|||
25014769|NCT04516291|50109225|FG001|Treatment Period (24 Weeks)|Other|0|||
25014770|NCT04516291|50109226|FG002|Treatment Period (24 Weeks)|Other|0|||
25014771|NCT04516291|50109227|FG003|Treatment Period (24 Weeks)|Other|2|||
25014772|NCT04516291|50109228|FG004|Treatment Period (24 Weeks)|Other|2|||
25014773|NCT04516291|50109229|FG005|Treatment Period (24 Weeks)|Other|4|||
25014774|NCT04516291|50109230|FG006|Treatment Period (24 Weeks)|Other|2|||
25014775|NCT04516291|50109231|FG007|Treatment Period (24 Weeks)|Other|0|||
25014776|NCT04516291|50109224|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
25014777|NCT04516291|50109225|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
25014778|NCT04516291|50109226|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
25014779|NCT04516291|50109227|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
25014780|NCT04516291|50109228|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
25014781|NCT04516291|50109229|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
25014782|NCT04516291|50109230|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
25141577|NCT01807065|50255139|FG000|Overall Study|Receive no sip-T due to IV access|1|||
25141578|NCT01807065|50255140|FG001|Overall Study|Receive no sip-T due to IV access|1|||
25141579|NCT02031458|50255153|FG000|May 8, 2015 to January 11, 2019|Death|89|||
25141580|NCT02031458|50255154|FG001|May 8, 2015 to January 11, 2019|Death|193|||
25141581|NCT02031458|50255155|FG002|May 8, 2015 to January 11, 2019|Death|198|||
25141582|NCT02031458|50255153|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
25141583|NCT02031458|50255154|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
25141584|NCT02031458|50255155|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
25141585|NCT02031458|50255153|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
25141586|NCT02031458|50255154|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
25141587|NCT02031458|50255155|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
25141588|NCT02031458|50255153|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
25141589|NCT02031458|50255154|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
25141590|NCT02031458|50255155|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
25141591|NCT02031458|50255153|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
25014783|NCT04516291|50109231|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
25014784|NCT04516291|50109224|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
25014785|NCT04516291|50109225|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
25014786|NCT04516291|50109226|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
25014787|NCT04516291|50109227|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
25014788|NCT04516291|50109228|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
25014789|NCT04516291|50109229|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
25014790|NCT04516291|50109230|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
25141592|NCT02031458|50255154|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
25014791|NCT04516291|50109231|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
25014792|NCT04516291|50109224|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
25014793|NCT04516291|50109225|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
25014794|NCT04516291|50109226|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
25014795|NCT04516291|50109227|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
25014796|NCT04516291|50109228|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
25014797|NCT04516291|50109229|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
25014798|NCT04516291|50109230|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
25014799|NCT04516291|50109231|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
25014800|NCT04516291|50109224|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
25014801|NCT04516291|50109225|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
25014802|NCT04516291|50109226|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
25014803|NCT04516291|50109227|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
25014804|NCT04516291|50109228|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
25014805|NCT04516291|50109229|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
25014806|NCT04516291|50109230|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
25014807|NCT04516291|50109231|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
25014808|NCT04516291|50109224|FG000|Follow-up Period (12 Weeks)|Other|0|||
25014809|NCT04516291|50109225|FG001|Follow-up Period (12 Weeks)|Other|1|||
25014810|NCT04516291|50109226|FG002|Follow-up Period (12 Weeks)|Other|0|||
25014811|NCT04516291|50109227|FG003|Follow-up Period (12 Weeks)|Other|2|||
25014812|NCT04516291|50109228|FG004|Follow-up Period (12 Weeks)|Other|0|||
25014813|NCT04516291|50109229|FG005|Follow-up Period (12 Weeks)|Other|0|||
25014814|NCT04516291|50109230|FG006|Follow-up Period (12 Weeks)|Other|0|||
25014815|NCT04516291|50109231|FG007|Follow-up Period (12 Weeks)|Other|0|||
25014816|NCT04516291|50109224|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
25014817|NCT04516291|50109225|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
25014818|NCT04516291|50109226|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
25014819|NCT04516291|50109227|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
25014820|NCT04516291|50109228|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
25014821|NCT04516291|50109229|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
25014822|NCT04516291|50109230|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
25014823|NCT04516291|50109231|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
25014824|NCT04516291|50109224|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
25014825|NCT04516291|50109225|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
25141593|NCT02031458|50255155|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
25141594|NCT02031458|50255153|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
25141595|NCT02031458|50255154|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
25141596|NCT02031458|50255155|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
25141597|NCT02031458|50255153|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
25141598|NCT02031458|50255154|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
25141599|NCT02031458|50255155|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
25141600|NCT02031458|50255153|FG000|Baseline to May 8, 2015|Death|36|||
25141601|NCT02031458|50255154|FG001|Baseline to May 8, 2015|Death|87|||
25141602|NCT02031458|50255155|FG002|Baseline to May 8, 2015|Death|100|||
25141603|NCT02031458|50255153|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
25141604|NCT02031458|50255154|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
25141605|NCT02031458|50255155|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
25141606|NCT02031458|50255153|FG000|Baseline to May 8, 2015|Physician Decision|0|||
25141607|NCT02031458|50255154|FG001|Baseline to May 8, 2015|Physician Decision|1|||
25141608|NCT02031458|50255155|FG002|Baseline to May 8, 2015|Physician Decision|0|||
25141609|NCT02031458|50255153|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
25141610|NCT02031458|50255154|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
25141611|NCT02031458|50255155|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
25141612|NCT02031458|50255153|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
25141613|NCT02031458|50255154|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
25141614|NCT02031458|50255155|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
25141615|NCT02031458|50255153|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
25141616|NCT02031458|50255154|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
25274413|NCT01078623|50588474|FG019|Treatment Period 3|Adverse Event|0|||
25274414|NCT01078623|50588455|FG000|Treatment Period 4|Adverse Event|0|||
25014826|NCT04516291|50109226|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
25014827|NCT04516291|50109227|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
25014828|NCT04516291|50109228|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
25014829|NCT04516291|50109229|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
25014830|NCT04516291|50109230|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
25014831|NCT04516291|50109231|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
25014832|NCT03243630|50109249|FG000|Overall Study|Protocol Violation|1|||
25014833|NCT03243630|50109249|FG000|Overall Study|Physician Decision|1|||
25014834|NCT04450381|50109257|FG000|Overall Study|Protocol Violation|4|||
25014835|NCT04450381|50109257|FG000|Overall Study|Wrong device setting|2|||
25014836|NCT03068468|50109263|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
25014837|NCT03068468|50109264|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
25014838|NCT03068468|50109265|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
25014839|NCT03068468|50109266|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
25014840|NCT03068468|50109263|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
25014841|NCT03068468|50109264|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
25014842|NCT03068468|50109265|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
25014843|NCT03068468|50109266|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
25014844|NCT03068468|50109263|FG000|Placebo-Controlled Period|Adverse Event|16|||
25014845|NCT03068468|50109264|FG001|Placebo-Controlled Period|Adverse Event|21|||
25014846|NCT03068468|50109265|FG002|Placebo-Controlled Period|Adverse Event|0|||
25014847|NCT03068468|50109266|FG003|Placebo-Controlled Period|Adverse Event|0|||
25014848|NCT03068468|50109263|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
25014849|NCT03068468|50109264|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
25014850|NCT03068468|50109265|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
25014851|NCT03068468|50109266|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
25014852|NCT03068468|50109263|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
25014853|NCT03068468|50109264|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
25014854|NCT03068468|50109265|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
25014855|NCT03068468|50109266|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
25014856|NCT03068468|50109263|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
25014857|NCT03068468|50109264|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
25014858|NCT03068468|50109265|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
25014859|NCT03068468|50109266|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
25014860|NCT03068468|50109263|FG000|Placebo-Controlled Period|Death|0|||
25014861|NCT03068468|50109264|FG001|Placebo-Controlled Period|Death|1|||
25014862|NCT03068468|50109265|FG002|Placebo-Controlled Period|Death|0|||
25014863|NCT03068468|50109266|FG003|Placebo-Controlled Period|Death|0|||
25014864|NCT03068468|50109263|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
25014865|NCT03068468|50109264|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
25014866|NCT03068468|50109265|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
25014867|NCT03068468|50109266|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
25014868|NCT03068468|50109263|FG000|Open-Label Extension Period|Adverse Event|0|||
25014869|NCT03068468|50109264|FG001|Open-Label Extension Period|Adverse Event|0|||
25014870|NCT03068468|50109265|FG002|Open-Label Extension Period|Adverse Event|13|||
25014871|NCT03068468|50109266|FG003|Open-Label Extension Period|Adverse Event|17|||
25014872|NCT03068468|50109263|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
25014873|NCT03068468|50109264|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
25014874|NCT03068468|50109265|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
25014875|NCT03068468|50109266|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
25014876|NCT03068468|50109263|FG000|Open-Label Extension Period|Death|0|||
25014877|NCT03068468|50109264|FG001|Open-Label Extension Period|Death|0|||
25014878|NCT03068468|50109265|FG002|Open-Label Extension Period|Death|0|||
25014879|NCT03068468|50109266|FG003|Open-Label Extension Period|Death|1|||
25014880|NCT03068468|50109263|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
25014881|NCT03068468|50109264|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
25014882|NCT03068468|50109265|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
25014883|NCT03068468|50109266|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
25014884|NCT03068468|50109263|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
25014885|NCT03068468|50109264|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
25014886|NCT03068468|50109265|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
25014887|NCT03068468|50109266|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
25014888|NCT03068468|50109263|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
25014889|NCT03068468|50109264|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
25014890|NCT03068468|50109265|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
25014891|NCT03068468|50109266|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
25014892|NCT03068468|50109263|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
25014893|NCT03068468|50109264|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
25014894|NCT03068468|50109265|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
25014895|NCT03068468|50109266|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
25014896|NCT03068468|50109263|FG000|Open-Label Extension Period|Reason not Specified|0|||
25014897|NCT03068468|50109264|FG001|Open-Label Extension Period|Reason not Specified|0|||
25014898|NCT03068468|50109265|FG002|Open-Label Extension Period|Reason not Specified|1|||
25014899|NCT03068468|50109266|FG003|Open-Label Extension Period|Reason not Specified|4|||
25014900|NCT04512001|50109276|FG000|Week 0 to Week 24|Adverse Event|14|||
25014901|NCT04512001|50109277|FG001|Week 0 to Week 24|Adverse Event|10|||
25014902|NCT04512001|50109278|FG002|Week 0 to Week 24|Adverse Event|0|||
25014903|NCT04512001|50109279|FG003|Week 0 to Week 24|Adverse Event|0|||
25014904|NCT04512001|50109280|FG004|Week 0 to Week 24|Adverse Event|0|||
25014905|NCT04512001|50109276|FG000|Week 0 to Week 24|Death|0|||
25014906|NCT04512001|50109277|FG001|Week 0 to Week 24|Death|2|||
25014907|NCT04512001|50109278|FG002|Week 0 to Week 24|Death|0|||
25014908|NCT04512001|50109279|FG003|Week 0 to Week 24|Death|0|||
25014909|NCT04512001|50109280|FG004|Week 0 to Week 24|Death|0|||
25014910|NCT04512001|50109276|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
25014911|NCT04512001|50109277|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
25014912|NCT04512001|50109278|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
25014913|NCT04512001|50109279|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
25014914|NCT04512001|50109280|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
25014915|NCT04512001|50109276|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
25014916|NCT04512001|50109277|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
25014917|NCT04512001|50109278|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
25014918|NCT04512001|50109279|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
25014919|NCT04512001|50109280|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
25014920|NCT04512001|50109276|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
25014921|NCT04512001|50109277|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
25014922|NCT04512001|50109278|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
25014923|NCT04512001|50109279|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
25014924|NCT04512001|50109280|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
25014925|NCT04512001|50109276|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
25014926|NCT04512001|50109277|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
25014927|NCT04512001|50109278|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
25014928|NCT04512001|50109279|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
25014929|NCT04512001|50109280|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
25014930|NCT04512001|50109276|FG000|Week 24 to Week 63|Adverse Event|0|||
25014931|NCT04512001|50109277|FG001|Week 24 to Week 63|Adverse Event|0|||
25014932|NCT04512001|50109278|FG002|Week 24 to Week 63|Adverse Event|13|||
25014933|NCT04512001|50109279|FG003|Week 24 to Week 63|Adverse Event|8|||
25014934|NCT04512001|50109280|FG004|Week 24 to Week 63|Adverse Event|6|||
25014935|NCT04512001|50109276|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
25014936|NCT04512001|50109277|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
25014937|NCT04512001|50109278|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
25014938|NCT04512001|50109279|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
25014939|NCT04512001|50109280|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
25014940|NCT04512001|50109276|FG000|Week 24 to Week 63|Death|0|||
25014941|NCT04512001|50109277|FG001|Week 24 to Week 63|Death|0|||
25179180|NCT01693562|50324397|FG011|Expansion Phase|Other|7|||
25014942|NCT04512001|50109278|FG002|Week 24 to Week 63|Death|0|||
25014943|NCT04512001|50109279|FG003|Week 24 to Week 63|Death|1|||
25014944|NCT04512001|50109280|FG004|Week 24 to Week 63|Death|1|||
25141617|NCT02031458|50255155|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
25141618|NCT02031458|50255153|FG000|Baseline to May 8, 2015|On Treatment|43|||
25014945|NCT04512001|50109276|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
25014946|NCT04512001|50109277|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
25014947|NCT04512001|50109278|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
25014948|NCT04512001|50109279|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
25014949|NCT04512001|50109280|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
25014950|NCT04512001|50109276|FG000|Week 24 to Week 63|Miscellaneous|0|||
25014951|NCT04512001|50109277|FG001|Week 24 to Week 63|Miscellaneous|0|||
25014952|NCT04512001|50109278|FG002|Week 24 to Week 63|Miscellaneous|3|||
25179181|NCT01693562|50324398|FG012|Expansion Phase|Other|0|||
25141619|NCT02031458|50255154|FG001|Baseline to May 8, 2015|On Treatment|81|||
25141620|NCT02031458|50255155|FG002|Baseline to May 8, 2015|On Treatment|73|||
25141621|NCT02031458|50255153|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
25141622|NCT02031458|50255154|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
25141623|NCT02031458|50255155|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
25141624|NCT02009696|50255165|FG000|Overall Study|Withdrawal by Subject|2|||
25141625|NCT01806597|50255172|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
25141626|NCT01806597|50255173|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
25014953|NCT04512001|50109279|FG003|Week 24 to Week 63|Miscellaneous|2|||
25014954|NCT04512001|50109280|FG004|Week 24 to Week 63|Miscellaneous|1|||
25014955|NCT04447417|50109295|FG000|Overall Study|Withdrawal by Subject|1|||
25014956|NCT04447417|50109296|FG001|Overall Study|Withdrawal by Subject|0|||
25014957|NCT04447417|50109295|FG000|Overall Study|Failure to meet inclusion criteria|1|||
25014958|NCT04447417|50109296|FG001|Overall Study|Failure to meet inclusion criteria|0|||
25014959|NCT04447417|50109295|FG000|Overall Study|Lost to Follow-up|1|||
25014960|NCT04447417|50109296|FG001|Overall Study|Lost to Follow-up|0|||
25179182|NCT01693562|50324399|FG013|Expansion Phase|Other|1|||
25179183|NCT01693562|50324400|FG014|Expansion Phase|Other|1|||
25014961|NCT02787044|50109304|FG000|Overall Study|Lost to Follow-up|15|||
25014962|NCT02787044|50109305|FG001|Overall Study|Lost to Follow-up|19|||
25014963|NCT01345019|50109317|FG000|Blinded Treatment Phase|Death|147|||
25014964|NCT01345019|50109318|FG001|Blinded Treatment Phase|Death|137|||
25014965|NCT01345019|50109317|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
25014966|NCT01345019|50109318|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
25014967|NCT01345019|50109317|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
25014968|NCT01345019|50109318|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
25014969|NCT01345019|50109317|FG000|Blinded Treatment Phase|Disease Progression|12|||
25014970|NCT01345019|50109318|FG001|Blinded Treatment Phase|Disease Progression|10|||
25014971|NCT01345019|50109317|FG000|Blinded Treatment Phase|Adverse Event|6|||
25014972|NCT01345019|50109318|FG001|Blinded Treatment Phase|Adverse Event|13|||
25014973|NCT01345019|50109317|FG000|Blinded Treatment Phase|Administrative Decision|10|||
25014974|NCT01345019|50109318|FG001|Blinded Treatment Phase|Administrative Decision|8|||
25014975|NCT01345019|50109317|FG000|Blinded Treatment Phase|Noncompliance|5|||
25014976|NCT01345019|50109318|FG001|Blinded Treatment Phase|Noncompliance|3|||
25014977|NCT01345019|50109317|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
25014978|NCT01345019|50109318|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
25014979|NCT01345019|50109317|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
25014980|NCT01345019|50109318|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
25014981|NCT01345019|50109317|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
25014982|NCT01345019|50109318|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
25014983|NCT01345019|50109317|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
25014984|NCT01345019|50109318|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
25141627|NCT01806597|50255174|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
25141628|NCT01806597|50255175|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
25141629|NCT01806597|50255176|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
25141630|NCT01806597|50255177|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
25141631|NCT01806597|50255172|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
25141632|NCT01806597|50255173|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
25141633|NCT01806597|50255174|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
25141634|NCT01806597|50255175|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
25141635|NCT01806597|50255176|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
25141636|NCT01806597|50255177|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
25141637|NCT01806597|50255172|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
25141638|NCT01806597|50255173|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
25141639|NCT01806597|50255174|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
25014985|NCT01345019|50109317|FG000|Open Label Treatment Phase|Death|49|||
25014986|NCT01345019|50109318|FG001|Open Label Treatment Phase|Death|48|||
25014987|NCT01345019|50109317|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
25014988|NCT01345019|50109318|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
25014989|NCT01345019|50109317|FG000|Open Label Treatment Phase|Adverse Event|30|||
25014990|NCT01345019|50109318|FG001|Open Label Treatment Phase|Adverse Event|51|||
25014991|NCT01345019|50109317|FG000|Open Label Treatment Phase|Administrative Decision|30|||
25014992|NCT01345019|50109318|FG001|Open Label Treatment Phase|Administrative Decision|15|||
25014993|NCT01345019|50109317|FG000|Open Label Treatment Phase|Disease Progression|17|||
25014994|NCT01345019|50109318|FG001|Open Label Treatment Phase|Disease Progression|18|||
25014995|NCT01345019|50109317|FG000|Open Label Treatment Phase|Noncompliance|5|||
25014996|NCT01345019|50109318|FG001|Open Label Treatment Phase|Noncompliance|4|||
25014997|NCT01345019|50109317|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
25014998|NCT01345019|50109318|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
25014999|NCT01345019|50109317|FG000|Open Label Treatment Phase|Pregnancy|1|||
25015000|NCT01345019|50109318|FG001|Open Label Treatment Phase|Pregnancy|0|||
25015001|NCT01345019|50109317|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
25015002|NCT01345019|50109318|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
25015003|NCT01345019|50109317|FG000|Open Label Treatment Phase|Protocol Violation|0|||
25015004|NCT01345019|50109318|FG001|Open Label Treatment Phase|Protocol Violation|1|||
25015005|NCT04507867|50109328|FG000|Overall Study|Death|7|||
25015006|NCT04507867|50109329|FG001|Overall Study|Death|1|||
25015007|NCT03069716|50109353|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
25015008|NCT03069716|50109354|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
25015009|NCT03069716|50109355|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
25015010|NCT03069716|50109353|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
25015011|NCT03069716|50109354|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
25015012|NCT03069716|50109355|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
25015013|NCT03069716|50109353|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
25015014|NCT03069716|50109354|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
25015015|NCT03069716|50109355|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
25015016|NCT03069716|50109353|FG000|Randomized Treatment|Withdrawal by Subject|0|||
25015017|NCT03069716|50109354|FG001|Randomized Treatment|Withdrawal by Subject|2|||
25179184|NCT01693562|50324401|FG015|Expansion Phase|Other|0|||
25179185|NCT01693562|50324402|FG016|Expansion Phase|Other|28|||
25015018|NCT03069716|50109355|FG002|Randomized Treatment|Withdrawal by Subject|0|||
25015019|NCT03693625|50109368|FG000|Overall Study|Adverse Event|2|||
25015020|NCT03693625|50109369|FG001|Overall Study|Adverse Event|0|||
25015021|NCT03693625|50109368|FG000|Overall Study|Study Terminated By Sponsor|20|||
25015022|NCT03693625|50109369|FG001|Overall Study|Study Terminated By Sponsor|7|||
25015023|NCT03693625|50109368|FG000|Overall Study|Withdrawal by Subject|1|||
25015024|NCT03693625|50109369|FG001|Overall Study|Withdrawal by Subject|1|||
25015025|NCT01265537|50109377|FG000|Overall Study|Adverse Event|2|||
25015026|NCT01265537|50109378|FG001|Overall Study|Adverse Event|1|||
25015027|NCT01265537|50109377|FG000|Overall Study|Physician Decision|0|||
25015028|NCT01265537|50109378|FG001|Overall Study|Physician Decision|1|||
25015029|NCT04396639|50109384|FG000|Overall Study|Withdrawal by Subject|1|||
25015030|NCT04396639|50109384|FG000|Overall Study|Other|1|||
25015031|NCT04432298|50109390|FG000|Overall Study|Other than specified|1|||
25015032|NCT04432298|50109391|FG001|Overall Study|Other than specified|0|||
25015033|NCT04432298|50109390|FG000|Overall Study|Lost to Follow-up|0|||
25015034|NCT04432298|50109391|FG001|Overall Study|Lost to Follow-up|1|||
25015035|NCT04432298|50109390|FG000|Overall Study|Death|3|||
25015036|NCT04432298|50109391|FG001|Overall Study|Death|2|||
25015037|NCT04432298|50109390|FG000|Overall Study|Withdrawal by Subject|2|||
25015038|NCT04432298|50109391|FG001|Overall Study|Withdrawal by Subject|0|||
25015039|NCT04167085|50109399|FG000|Baseline|Withdrawal by Subject|2|||
25015040|NCT04167085|50109400|FG001|Baseline|Withdrawal by Subject|1|||
25015041|NCT04167085|50109399|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
25015042|NCT04167085|50109400|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
25015043|NCT04162795|50109406|FG000|Overall Study|Other|16|||
25015044|NCT04162795|50109406|FG000|Overall Study|Screen failures|10|||
25015045|NCT03069482|50109412|FG000|Overall Study|Lost to Follow-up|0|||
25015046|NCT03069482|50109413|FG001|Overall Study|Lost to Follow-up|1|||
25015047|NCT03069482|50109412|FG000|Overall Study|Physician Decision|1|||
25015048|NCT03069482|50109413|FG001|Overall Study|Physician Decision|0|||
25015049|NCT03266172|50109425|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
25015050|NCT03266172|50109426|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
25015051|NCT03266172|50109427|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
25015052|NCT03266172|50109425|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
25015053|NCT03266172|50109426|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
25015054|NCT03266172|50109427|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
25015055|NCT03266172|50109425|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
25015056|NCT03266172|50109426|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
25015057|NCT03266172|50109427|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
25015058|NCT03266172|50109425|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
25015059|NCT03266172|50109426|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
25141640|NCT01806597|50255175|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
25141641|NCT01806597|50255176|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
25141642|NCT01806597|50255177|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
25141643|NCT01806597|50255172|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
25141644|NCT01806597|50255173|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
25141645|NCT01806597|50255174|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
25141646|NCT01806597|50255175|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
25141647|NCT01806597|50255176|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
25141648|NCT01806597|50255177|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
25141649|NCT01806597|50255172|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
25141650|NCT01806597|50255173|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
25141651|NCT01806597|50255174|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
25141652|NCT01806597|50255175|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
25141653|NCT01806597|50255176|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
25141654|NCT01806597|50255177|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
25141655|NCT01806597|50255172|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
25141656|NCT01806597|50255173|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
25141657|NCT01806597|50255174|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
25141658|NCT01806597|50255175|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
25141659|NCT01806597|50255176|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
25141660|NCT01806597|50255177|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
25141661|NCT01806597|50255172|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
25141662|NCT01806597|50255173|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
25141663|NCT01806597|50255174|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
25141664|NCT01806597|50255175|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
25141665|NCT01806597|50255176|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
25141666|NCT01806597|50255177|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
25141667|NCT01806597|50255172|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
25141668|NCT01806597|50255173|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
25015060|NCT03266172|50109427|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
25015061|NCT03266172|50109425|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
25015062|NCT03266172|50109426|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
25015063|NCT03266172|50109427|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
25015064|NCT03266172|50109425|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
25015065|NCT03266172|50109426|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
25015066|NCT03266172|50109427|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
25015067|NCT04356937|50109479|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
25015068|NCT04356937|50109480|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
25015069|NCT03301740|50109492|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
25015070|NCT03301740|50109493|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
25015071|NCT03301740|50109492|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
25015072|NCT03301740|50109493|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
25015073|NCT04355767|50109501|FG000|Overall Study|Withdrawal by Subject|2|||
25015074|NCT04355767|50109502|FG001|Overall Study|Withdrawal by Subject|2|||
25015075|NCT04355767|50109501|FG000|Overall Study|Death|5|||
25015076|NCT04355767|50109502|FG001|Overall Study|Death|1|||
25141669|NCT01806597|50255174|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
25141670|NCT01806597|50255175|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
25141671|NCT01806597|50255176|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
25141672|NCT01806597|50255177|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
25141673|NCT01806597|50255172|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
25141674|NCT01806597|50255173|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
25141675|NCT01806597|50255174|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
25141676|NCT01806597|50255175|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
25141677|NCT01806597|50255176|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
25141678|NCT01806597|50255177|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
25141679|NCT01806597|50255172|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
25141680|NCT01806597|50255173|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
25015077|NCT00882050|50109511|FG000|Overall Study|Physician Decision|1|||
25015078|NCT00882050|50109512|FG001|Overall Study|Physician Decision|0|||
25015079|NCT00882050|50109513|FG002|Overall Study|Physician Decision|0|||
25015080|NCT03266094|50109521|FG000|Overall Study|Lost to Follow-up|1|||
25015081|NCT03266094|50109521|FG000|Overall Study|Withdrawal by Subject|1|||
25015082|NCT04161079|50109527|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
25015083|NCT03243084|50109537|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
25015084|NCT03243084|50109538|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
25015085|NCT04353817|50109547|FG000|Overall Study|Adverse Event|0|||
25015086|NCT04353817|50109548|FG001|Overall Study|Adverse Event|1|||
25015087|NCT00159588|50109557|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
25015088|NCT00159588|50109558|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
25015089|NCT00159588|50109559|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
25015090|NCT03265938|50109570|FG000|Overall Study|Withdrawal by Subject|1|||
25015091|NCT03265938|50109570|FG000|Overall Study|Physician Decision|1|||
25141681|NCT01806597|50255174|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
25141682|NCT01806597|50255175|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
25179186|NCT01693562|50324403|FG017|Expansion Phase|Other|0|||
25015092|NCT03265938|50109570|FG000|Overall Study|friable mass|6|||
25015093|NCT04353037|50109579|FG000|Overall Study|Lost to Follow-up|0|||
25015094|NCT04353037|50109580|FG001|Overall Study|Lost to Follow-up|1|||
25015095|NCT04353037|50109581|FG002|Overall Study|Lost to Follow-up|2|||
25015096|NCT04353037|50109582|FG003|Overall Study|Lost to Follow-up|3|||
25015097|NCT04353037|50109579|FG000|Overall Study|Withdrawal by Subject|0|||
25015098|NCT04353037|50109580|FG001|Overall Study|Withdrawal by Subject|2|||
25015099|NCT04353037|50109581|FG002|Overall Study|Withdrawal by Subject|3|||
25015100|NCT04353037|50109582|FG003|Overall Study|Withdrawal by Subject|5|||
25015101|NCT04353037|50109579|FG000|Overall Study|Adverse Event|0|||
25015102|NCT04353037|50109580|FG001|Overall Study|Adverse Event|0|||
25015103|NCT04353037|50109581|FG002|Overall Study|Adverse Event|2|||
25015104|NCT04353037|50109582|FG003|Overall Study|Adverse Event|0|||
25015105|NCT04353037|50109579|FG000|Overall Study|Exposure Change|0|||
25015106|NCT04353037|50109580|FG001|Overall Study|Exposure Change|0|||
25015107|NCT04353037|50109581|FG002|Overall Study|Exposure Change|0|||
25015108|NCT04353037|50109582|FG003|Overall Study|Exposure Change|2|||
25015109|NCT04349917|50109596|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
25015110|NCT04349917|50109597|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
25015111|NCT04349917|50109596|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
25015112|NCT04349917|50109597|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
25015113|NCT04156399|50109604|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
25015114|NCT04156399|50109604|FG000|Overall Study|study suspension due to COVID pandemic|3|||
25179187|NCT01693562|50324404|FG018|Expansion Phase|Other|1|||
25015115|NCT03300570|50109610|FG000|Overall Study|Adverse Event|0|||
25015116|NCT03300570|50109611|FG001|Overall Study|Adverse Event|1|||
25015117|NCT03300570|50109610|FG000|Overall Study|Withdrawal by Subject|1|||
25015118|NCT03300570|50109611|FG001|Overall Study|Withdrawal by Subject|0|||
25015119|NCT03300570|50109610|FG000|Overall Study|Inadequate bowel prep|1|||
25015120|NCT03300570|50109611|FG001|Overall Study|Inadequate bowel prep|0|||
25015121|NCT04154605|50109620|FG000|Overall Study|Procedure Canceled|1|||
25015122|NCT04154605|50109621|FG001|Overall Study|Procedure Canceled|1|||
25015123|NCT04154605|50109620|FG000|Overall Study|Missed follow up|1|||
25015124|NCT04154605|50109621|FG001|Overall Study|Missed follow up|1|||
25015125|NCT04154605|50109620|FG000|Overall Study|Withdrawal by Subject|1|||
25015126|NCT04154605|50109621|FG001|Overall Study|Withdrawal by Subject|0|||
25015127|NCT03264456|50109627|FG000|Overall Study|Withdrawal by Subject|3|||
25015128|NCT03264456|50109627|FG000|Overall Study|Lost to Follow-up|1|||
25015129|NCT03853694|50109634|FG000|Overall Study|Protocol Violation|3|||
25015130|NCT03853694|50109635|FG001|Overall Study|Protocol Violation|5|||
25015131|NCT03853694|50109636|FG002|Overall Study|Protocol Violation|3|||
25015132|NCT03853694|50109634|FG000|Overall Study|Delivered early|0|||
25015133|NCT03853694|50109635|FG001|Overall Study|Delivered early|1|||
25015134|NCT03853694|50109636|FG002|Overall Study|Delivered early|0|||
25015135|NCT03853694|50109634|FG000|Overall Study|not suitable to proceed|0|||
25015136|NCT03853694|50109635|FG001|Overall Study|not suitable to proceed|1|||
25015137|NCT03853694|50109636|FG002|Overall Study|not suitable to proceed|0|||
25015138|NCT03853694|50109634|FG000|Overall Study|difficult surgery|0|||
25015139|NCT03853694|50109635|FG001|Overall Study|difficult surgery|0|||
25141683|NCT01806597|50255176|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
25141684|NCT01806597|50255177|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
25141685|NCT01806597|50255172|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
25141686|NCT01806597|50255173|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
25141687|NCT01806597|50255174|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
25141688|NCT01806597|50255175|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
25141689|NCT01806597|50255176|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
25179188|NCT01693562|50324405|FG019|Expansion Phase|Other|0|||
25179189|NCT01693562|50324406|FG020|Expansion Phase|Other|1|||
25179190|NCT01693562|50324407|FG021|Expansion Phase|Other|17|||
25179191|NCT01693562|50324408|FG022|Expansion Phase|Other|1|||
25015140|NCT03853694|50109636|FG002|Overall Study|difficult surgery|1|||
25015141|NCT03853694|50109634|FG000|Overall Study|Lost to Follow-up|0|||
25015142|NCT03853694|50109635|FG001|Overall Study|Lost to Follow-up|1|||
25015143|NCT03853694|50109636|FG002|Overall Study|Lost to Follow-up|0|||
25015144|NCT03853694|50109634|FG000|Overall Study|Withdrawal by Subject|0|||
25015145|NCT03853694|50109635|FG001|Overall Study|Withdrawal by Subject|1|||
25015146|NCT03853694|50109636|FG002|Overall Study|Withdrawal by Subject|0|||
25015147|NCT04154293|50109647|FG000|Overall Study|Withdrawal by Subject|2|||
25015148|NCT04154293|50109648|FG001|Overall Study|Withdrawal by Subject|3|||
25015149|NCT04154293|50109649|FG002|Overall Study|Withdrawal by Subject|1|||
25015150|NCT04154293|50109647|FG000|Overall Study|Physician Decision|0|||
25015151|NCT04154293|50109648|FG001|Overall Study|Physician Decision|0|||
25015152|NCT04154293|50109649|FG002|Overall Study|Physician Decision|1|||
25015153|NCT04342897|50109659|FG000|Overall Study|Death|7|||
25015154|NCT04342897|50109660|FG001|Overall Study|Death|4|||
25015155|NCT04342897|50109659|FG000|Overall Study|Lost to Follow-up|6|||
25015156|NCT04342897|50109660|FG001|Overall Study|Lost to Follow-up|6|||
25015157|NCT04342897|50109659|FG000|Overall Study|Withdrawal by Subject|1|||
25015158|NCT04342897|50109660|FG001|Overall Study|Withdrawal by Subject|2|||
25015159|NCT04340557|50109668|FG000|Overall Study|Transferred to ICU and/or death|1|||
25015160|NCT04340557|50109669|FG001|Overall Study|Transferred to ICU and/or death|2|||
25015161|NCT04382053|50109677|FG000|Overall Study|Death|6|||
25015162|NCT04382053|50109678|FG001|Overall Study|Death|8|||
25015163|NCT04382053|50109677|FG000|Overall Study|Lost to Follow-up|0|||
25015164|NCT04382053|50109678|FG001|Overall Study|Lost to Follow-up|2|||
25015165|NCT04382053|50109677|FG000|Overall Study|Protocol Deviation|1|||
25015166|NCT04382053|50109678|FG001|Overall Study|Protocol Deviation|2|||
25015167|NCT04382053|50109677|FG000|Overall Study|Withdrawal by Subject|2|||
25015168|NCT04382053|50109678|FG001|Overall Study|Withdrawal by Subject|1|||
25015169|NCT03066830|50109687|FG000|Overall Study|At the Participant's own Request|16|||
25015170|NCT03066830|50109688|FG001|Overall Study|At the Participant's own Request|17|||
25015171|NCT03066830|50109687|FG000|Overall Study|Other|3|||
25015172|NCT03066830|50109688|FG001|Overall Study|Other|0|||
25015173|NCT03066830|50109687|FG000|Overall Study|Poor Compliance to Protocol|1|||
25015174|NCT03066830|50109688|FG001|Overall Study|Poor Compliance to Protocol|0|||
25015175|NCT03066830|50109687|FG000|Overall Study|Adverse Event|2|||
25015176|NCT03066830|50109688|FG001|Overall Study|Adverse Event|2|||
25015177|NCT03066830|50109687|FG000|Overall Study|Lost to Follow-up|11|||
25015178|NCT03066830|50109688|FG001|Overall Study|Lost to Follow-up|3|||
25015179|NCT04380961|50109697|FG000|Overall Study|Lost to Follow-up|17|||
25015180|NCT04380961|50109698|FG001|Overall Study|Lost to Follow-up|11|||
25015181|NCT04380961|50109697|FG000|Overall Study|Withdrawal by Subject|3|||
25015182|NCT04380961|50109698|FG001|Overall Study|Withdrawal by Subject|0|||
25015183|NCT04380961|50109697|FG000|Overall Study|Death|22|||
25015184|NCT04380961|50109698|FG001|Overall Study|Death|16|||
25015185|NCT04380961|50109697|FG000|Overall Study|Other|1|||
25015186|NCT04380961|50109698|FG001|Overall Study|Other|0|||
25015187|NCT04380961|50109697|FG000|Overall Study|Randomized but Not Treated|1|||
25015188|NCT04380961|50109698|FG001|Overall Study|Randomized but Not Treated|2|||
25015189|NCT04331899|50109708|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
25015190|NCT04331899|50109709|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
25015191|NCT03063632|50109717|FG000|Overall Study|Death|3|||
25015192|NCT03063632|50109718|FG001|Overall Study|Death|6|||
25015193|NCT03063632|50109717|FG000|Overall Study|Lost to Follow-up|0|||
25015194|NCT03063632|50109718|FG001|Overall Study|Lost to Follow-up|1|||
25015195|NCT03063632|50109717|FG000|Overall Study|Withdrawal by Subject|0|||
25015196|NCT03063632|50109718|FG001|Overall Study|Withdrawal by Subject|2|||
25015197|NCT03063632|50109717|FG000|Overall Study|Physician Decision|2|||
25015198|NCT03063632|50109718|FG001|Overall Study|Physician Decision|0|||
25015199|NCT03063632|50109717|FG000|Overall Study|Other: Disease progression; starting another treatment|2|||
25015200|NCT03063632|50109718|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
25015201|NCT04328467|50109727|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
25015202|NCT04328467|50109728|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
25015203|NCT04328467|50109729|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
25015204|NCT04328077|50109741|FG000|Overall Study|Lost to Follow-up|0|||
25015205|NCT04328077|50109742|FG001|Overall Study|Lost to Follow-up|1|||
25015206|NCT04328077|50109743|FG002|Overall Study|Lost to Follow-up|0|||
25015207|NCT04328077|50109744|FG003|Overall Study|Lost to Follow-up|0|||
25015208|NCT04328077|50109741|FG000|Overall Study|Withdrawal by Subject|0|||
25015209|NCT04328077|50109742|FG001|Overall Study|Withdrawal by Subject|1|||
25015210|NCT04328077|50109743|FG002|Overall Study|Withdrawal by Subject|1|||
25015211|NCT04328077|50109744|FG003|Overall Study|Withdrawal by Subject|3|||
25015212|NCT03691831|50109762|FG000|Overall Study|Lost to Follow-up|16|||
25015213|NCT03691831|50109763|FG001|Overall Study|Lost to Follow-up|12|||
25015214|NCT03691831|50109762|FG000|Overall Study|Withdrawal by Subject|9|||
25015215|NCT03691831|50109763|FG001|Overall Study|Withdrawal by Subject|17|||
25015216|NCT03691831|50109762|FG000|Overall Study|Investigator Decision|2|||
25015217|NCT03691831|50109763|FG001|Overall Study|Investigator Decision|2|||
25015218|NCT04320745|50109780|FG000|Overall Study|Adverse Event|26|||
25015219|NCT04320745|50109780|FG000|Overall Study|Withdrawal by Subject|4|||
25015220|NCT04320745|50109780|FG000|Overall Study|Lost to Follow-up|12|||
25015221|NCT04320745|50109780|FG000|Overall Study|Protocol Deviation|2|||
25015222|NCT04320745|50109780|FG000|Overall Study|Non-compliance With Study Drug|2|||
25015223|NCT04320745|50109780|FG000|Overall Study|Reason Not Specified|1|||
25015224|NCT03063086|50109784|FG000|Overall Study|technical problems|1|||
25015225|NCT03063086|50109785|FG001|Overall Study|technical problems|0|||
25015226|NCT03063086|50109786|FG002|Overall Study|technical problems|0|||
25015227|NCT03063086|50109787|FG003|Overall Study|technical problems|0|||
25015228|NCT03063086|50109788|FG004|Overall Study|technical problems|0|||
25015229|NCT03063086|50109789|FG005|Overall Study|technical problems|0|||
25015230|NCT03063086|50109784|FG000|Overall Study|Adverse Event|1|||
25015231|NCT03063086|50109785|FG001|Overall Study|Adverse Event|1|||
25015232|NCT03063086|50109786|FG002|Overall Study|Adverse Event|1|||
25015233|NCT03063086|50109787|FG003|Overall Study|Adverse Event|1|||
25015234|NCT03063086|50109788|FG004|Overall Study|Adverse Event|0|||
25015235|NCT03063086|50109789|FG005|Overall Study|Adverse Event|0|||
25015236|NCT03063086|50109784|FG000|Overall Study|subject/guardian decision|1|||
25015237|NCT03063086|50109785|FG001|Overall Study|subject/guardian decision|0|||
25015238|NCT03063086|50109786|FG002|Overall Study|subject/guardian decision|0|||
25015239|NCT03063086|50109787|FG003|Overall Study|subject/guardian decision|0|||
25015240|NCT03063086|50109788|FG004|Overall Study|subject/guardian decision|0|||
25015241|NCT03063086|50109789|FG005|Overall Study|subject/guardian decision|0|||
25015242|NCT03063086|50109784|FG000|Overall Study|Non-compliance with study treatment|0|||
25015243|NCT03063086|50109785|FG001|Overall Study|Non-compliance with study treatment|0|||
25015244|NCT03063086|50109786|FG002|Overall Study|Non-compliance with study treatment|0|||
25015245|NCT03063086|50109787|FG003|Overall Study|Non-compliance with study treatment|1|||
25015246|NCT03063086|50109788|FG004|Overall Study|Non-compliance with study treatment|0|||
25015247|NCT03063086|50109789|FG005|Overall Study|Non-compliance with study treatment|1|||
25015248|NCT03063086|50109784|FG000|Overall Study|Physician Decision|0|||
25015249|NCT03063086|50109785|FG001|Overall Study|Physician Decision|0|||
25015250|NCT03063086|50109786|FG002|Overall Study|Physician Decision|0|||
25015251|NCT03063086|50109787|FG003|Overall Study|Physician Decision|1|||
25015252|NCT03063086|50109788|FG004|Overall Study|Physician Decision|0|||
25015253|NCT03063086|50109789|FG005|Overall Study|Physician Decision|0|||
25015254|NCT04128007|50109800|FG000|Overall Study|Withdrawal by Subject|9|||
25015255|NCT04128007|50109801|FG001|Overall Study|Withdrawal by Subject|6|||
25015256|NCT04128007|50109800|FG000|Overall Study|Protocol Violation|1|||
25015257|NCT04128007|50109801|FG001|Overall Study|Protocol Violation|0|||
25015258|NCT04128007|50109800|FG000|Overall Study|Lost to Follow-up|8|||
25015259|NCT04128007|50109801|FG001|Overall Study|Lost to Follow-up|7|||
25015260|NCT04128007|50109800|FG000|Overall Study|Adverse Event|5|||
25015261|NCT04128007|50109801|FG001|Overall Study|Adverse Event|2|||
25015262|NCT04128007|50109800|FG000|Overall Study|Not reported|0|||
25015263|NCT04128007|50109801|FG001|Overall Study|Not reported|2|||
25015264|NCT04318093|50109809|FG000|Overall Study|Adverse Event|2|||
25015265|NCT04318093|50109810|FG001|Overall Study|Adverse Event|2|||
25015266|NCT04318093|50109809|FG000|Overall Study|Participant withdrew consent|1|||
25015267|NCT04318093|50109810|FG001|Overall Study|Participant withdrew consent|0|||
25015268|NCT04318093|50109809|FG000|Overall Study|Other reasons|0|||
25015269|NCT04318093|50109810|FG001|Overall Study|Other reasons|1|||
25015270|NCT04123405|50109821|FG000|Overall Study|Adverse Event|1|||
25015271|NCT04123405|50109822|FG001|Overall Study|Adverse Event|2|||
25015272|NCT04123405|50109823|FG002|Overall Study|Adverse Event|3|||
25015273|NCT04123405|50109824|FG003|Overall Study|Adverse Event|3|||
25015274|NCT04123405|50109821|FG000|Overall Study|Exclusion criteria met|1|||
25015275|NCT04123405|50109822|FG001|Overall Study|Exclusion criteria met|2|||
25015276|NCT04123405|50109823|FG002|Overall Study|Exclusion criteria met|0|||
25015277|NCT04123405|50109824|FG003|Overall Study|Exclusion criteria met|2|||
25015278|NCT04123405|50109821|FG000|Overall Study|Withdrawal by Subject|1|||
25015279|NCT04123405|50109822|FG001|Overall Study|Withdrawal by Subject|3|||
25015280|NCT04123405|50109823|FG002|Overall Study|Withdrawal by Subject|0|||
25015281|NCT04123405|50109824|FG003|Overall Study|Withdrawal by Subject|2|||
25015282|NCT04123405|50109821|FG000|Overall Study|Contact to subject lost|0|||
25141690|NCT01806597|50255177|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
25141691|NCT01806597|50255172|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
25141692|NCT01806597|50255173|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
25141693|NCT01806597|50255174|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
25141694|NCT01806597|50255175|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
25141695|NCT01806597|50255176|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
25141696|NCT01806597|50255177|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
25141697|NCT01806597|50255172|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
25015283|NCT04123405|50109822|FG001|Overall Study|Contact to subject lost|0|||
25015284|NCT04123405|50109823|FG002|Overall Study|Contact to subject lost|0|||
25015285|NCT04123405|50109824|FG003|Overall Study|Contact to subject lost|1|||
25015286|NCT04123405|50109821|FG000|Overall Study|screening failure|1|||
25015287|NCT04123405|50109822|FG001|Overall Study|screening failure|0|||
25015288|NCT04123405|50109823|FG002|Overall Study|screening failure|0|||
25015289|NCT04123405|50109824|FG003|Overall Study|screening failure|0|||
25015290|NCT04314037|50109853|FG000|Treatment Period 2|Adverse Event|1|||
25015291|NCT04314037|50109854|FG001|Treatment Period 2|Adverse Event|0|||
25015292|NCT04314037|50109853|FG000|Treatment Period 3|Protocol Violation|1|||
25015293|NCT04314037|50109854|FG001|Treatment Period 3|Protocol Violation|0|||
25015294|NCT04314037|50109853|FG000|Treatment Period 3|Adverse Event|0|||
25015295|NCT04314037|50109854|FG001|Treatment Period 3|Adverse Event|1|||
25015296|NCT03056300|50109870|FG000|Overall Study|Surgical reason per study protocol|3|||
25015297|NCT03061214|50109877|FG000|Overall Study|Withdrawal by Subject|21|||
25015298|NCT03061214|50109878|FG001|Overall Study|Withdrawal by Subject|26|||
25015299|NCT03061214|50109879|FG002|Overall Study|Withdrawal by Subject|9|||
25015300|NCT03061214|50109877|FG000|Overall Study|Lost to Follow-up|3|||
25015301|NCT03061214|50109878|FG001|Overall Study|Lost to Follow-up|1|||
25015302|NCT03061214|50109879|FG002|Overall Study|Lost to Follow-up|1|||
25015303|NCT03061214|50109877|FG000|Overall Study|Death|1|||
25015304|NCT03061214|50109878|FG001|Overall Study|Death|1|||
25015305|NCT03061214|50109879|FG002|Overall Study|Death|0|||
25015306|NCT04115839|50109890|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
25015307|NCT04115839|50109891|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
25015308|NCT04115839|50109892|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
25015309|NCT04115839|50109893|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
25015310|NCT04115839|50109894|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
25015311|NCT04115839|50109895|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
25015312|NCT04115839|50109896|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
25015313|NCT04115839|50109890|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
25015314|NCT04115839|50109891|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
25015315|NCT04115839|50109892|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
25015316|NCT04115839|50109893|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
25015317|NCT04115839|50109894|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
25015318|NCT04115839|50109895|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
25015319|NCT04115839|50109896|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
25015320|NCT04115839|50109890|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
25141698|NCT01806597|50255173|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
25141699|NCT01806597|50255174|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
25141700|NCT01806597|50255175|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
25015321|NCT04115839|50109891|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
25015322|NCT04115839|50109892|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
25015323|NCT04115839|50109893|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
25015324|NCT04115839|50109894|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
25015325|NCT04115839|50109895|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
25015326|NCT04115839|50109896|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
25015327|NCT04115839|50109890|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
25015328|NCT04115839|50109891|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
25015329|NCT04115839|50109892|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
25015330|NCT04115839|50109893|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
25015331|NCT04115839|50109894|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
25015332|NCT04115839|50109895|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
25015333|NCT04115839|50109896|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
25015334|NCT04115839|50109890|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
25015335|NCT04115839|50109891|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
25015336|NCT04115839|50109892|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
25015337|NCT04115839|50109893|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
25015338|NCT04115839|50109894|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
25015339|NCT04115839|50109895|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
25015340|NCT04115839|50109896|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
25015341|NCT04115839|50109890|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
25015342|NCT04115839|50109891|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
25015343|NCT04115839|50109892|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
25015344|NCT04115839|50109893|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
25015345|NCT04115839|50109894|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
25015346|NCT04115839|50109895|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
25015347|NCT04115839|50109896|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
25015348|NCT01561430|50109925|FG000|Overall Study|Adverse Event|0|||
25015349|NCT01561430|50109926|FG001|Overall Study|Adverse Event|0|||
25015350|NCT01561430|50109927|FG002|Overall Study|Adverse Event|3|||
25015351|NCT01561430|50109928|FG003|Overall Study|Adverse Event|1|||
25015352|NCT01561430|50109925|FG000|Overall Study|Withdrawal by Subject|0|||
25015353|NCT01561430|50109926|FG001|Overall Study|Withdrawal by Subject|0|||
25015354|NCT01561430|50109927|FG002|Overall Study|Withdrawal by Subject|1|||
25015355|NCT01561430|50109928|FG003|Overall Study|Withdrawal by Subject|0|||
25015356|NCT01561430|50109925|FG000|Overall Study|Physician Decision|0|||
25015357|NCT01561430|50109926|FG001|Overall Study|Physician Decision|1|||
25015358|NCT01561430|50109927|FG002|Overall Study|Physician Decision|0|||
25015359|NCT01561430|50109928|FG003|Overall Study|Physician Decision|0|||
25015360|NCT01561430|50109925|FG000|Overall Study|Sponsor Decision|1|||
25015361|NCT01561430|50109926|FG001|Overall Study|Sponsor Decision|14|||
25015362|NCT01561430|50109927|FG002|Overall Study|Sponsor Decision|13|||
25015363|NCT01561430|50109928|FG003|Overall Study|Sponsor Decision|12|||
25015364|NCT03000530|50109964|FG000|Overall Study|Adverse Event|0|||
25015365|NCT03000530|50109965|FG001|Overall Study|Adverse Event|0|||
25015366|NCT03000530|50109966|FG002|Overall Study|Adverse Event|2|||
25015367|NCT03000530|50109964|FG000|Overall Study|Lost to Follow-up|0|||
25015368|NCT03000530|50109965|FG001|Overall Study|Lost to Follow-up|3|||
25015369|NCT03000530|50109966|FG002|Overall Study|Lost to Follow-up|1|||
25015370|NCT03000530|50109964|FG000|Overall Study|Withdrawal by Subject|0|||
25015371|NCT03000530|50109965|FG001|Overall Study|Withdrawal by Subject|2|||
25015372|NCT03000530|50109966|FG002|Overall Study|Withdrawal by Subject|1|||
25015373|NCT03060512|50109979|FG000|Overall Study|Adverse Event|4|||
25015374|NCT03060512|50109980|FG001|Overall Study|Adverse Event|6|||
25141701|NCT01806597|50255176|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
25141702|NCT01806597|50255177|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
25141703|NCT01806597|50255172|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
25141704|NCT01806597|50255173|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
25141705|NCT01806597|50255174|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
25141706|NCT01806597|50255175|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
25141707|NCT01806597|50255176|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
25141708|NCT01806597|50255177|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
25141709|NCT01806597|50255172|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
25141710|NCT01806597|50255173|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
25141711|NCT01806597|50255174|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
25141712|NCT01806597|50255175|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
25141713|NCT01806597|50255176|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
25141714|NCT01806597|50255177|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
25179192|NCT01467713|50324505|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
25179193|NCT01467713|50324506|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
25015375|NCT03060512|50109979|FG000|Overall Study|Lost to Follow-up|1|||
25015376|NCT03060512|50109980|FG001|Overall Study|Lost to Follow-up|1|||
25274415|NCT01078623|50588456|FG001|Treatment Period 4|Adverse Event|0|||
25141715|NCT01806597|50255172|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
25141716|NCT01806597|50255173|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
25141717|NCT01806597|50255174|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
25141718|NCT01806597|50255175|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
25141719|NCT01806597|50255176|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
25141720|NCT01806597|50255177|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
25141721|NCT01806597|50255172|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
25141722|NCT01806597|50255173|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
25141723|NCT01806597|50255174|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
25141724|NCT01806597|50255175|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
25141725|NCT01806597|50255176|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
25141726|NCT01806597|50255177|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
25141727|NCT01806597|50255172|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
25141728|NCT01806597|50255173|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
25141729|NCT01806597|50255174|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
25141730|NCT01806597|50255175|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
25141731|NCT01806597|50255176|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
25141732|NCT01806597|50255177|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
25141733|NCT01806597|50255172|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
25141734|NCT01806597|50255173|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
25141735|NCT01806597|50255174|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
25141736|NCT01806597|50255175|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
25141737|NCT01806597|50255176|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
25141738|NCT01806597|50255177|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
25141739|NCT02031302|50255193|FG000|Overall Study|Death|115|||
25141740|NCT02031302|50255194|FG001|Overall Study|Death|0|||
25141741|NCT02031302|50255193|FG000|Overall Study|Not treated with study valve system|18|||
25141742|NCT02031302|50255194|FG001|Overall Study|Not treated with study valve system|0|||
25141743|NCT02031302|50255193|FG000|Overall Study|Missed Follow Up|27|||
25141744|NCT02031302|50255194|FG001|Overall Study|Missed Follow Up|0|||
25015377|NCT03060512|50109979|FG000|Overall Study|Withdrawal by Subject|1|||
25015378|NCT03060512|50109980|FG001|Overall Study|Withdrawal by Subject|0|||
25015379|NCT03060512|50109979|FG000|Overall Study|Non-compliance with study medication|1|||
25015380|NCT03060512|50109980|FG001|Overall Study|Non-compliance with study medication|2|||
25015381|NCT02539160|50110068|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
25015382|NCT02539160|50110069|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
25015383|NCT02539160|50110070|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
25015384|NCT02539160|50110071|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
25015385|NCT02539160|50110068|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
25015386|NCT02539160|50110069|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
25015387|NCT02539160|50110070|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
25015388|NCT02539160|50110071|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
25015389|NCT02539160|50110068|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
25015390|NCT02539160|50110069|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
25015391|NCT02539160|50110070|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
25015392|NCT02539160|50110071|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
25015393|NCT04292899|50110085|FG000|Overall Study|Death|21|||
25015394|NCT04292899|50110086|FG001|Overall Study|Death|28|||
25015395|NCT04292899|50110087|FG002|Overall Study|Death|188|||
25015396|NCT04292899|50110088|FG003|Overall Study|Death|371|||
25015397|NCT04292899|50110085|FG000|Overall Study|Lost to Follow-up|8|||
25015398|NCT04292899|50110086|FG001|Overall Study|Lost to Follow-up|4|||
25015399|NCT04292899|50110087|FG002|Overall Study|Lost to Follow-up|22|||
25015400|NCT04292899|50110088|FG003|Overall Study|Lost to Follow-up|235|||
25015401|NCT04292899|50110085|FG000|Overall Study|Withdrew consent|1|||
25015402|NCT04292899|50110086|FG001|Overall Study|Withdrew consent|0|||
25015403|NCT04292899|50110087|FG002|Overall Study|Withdrew consent|11|||
25015404|NCT04292899|50110088|FG003|Overall Study|Withdrew consent|32|||
25015405|NCT04292899|50110085|FG000|Overall Study|Adverse Event|2|||
25015406|NCT04292899|50110086|FG001|Overall Study|Adverse Event|1|||
25015407|NCT04292899|50110087|FG002|Overall Study|Adverse Event|2|||
25015408|NCT04292899|50110088|FG003|Overall Study|Adverse Event|2|||
25015409|NCT04292899|50110085|FG000|Overall Study|Investigator's Discretion|0|||
25015410|NCT04292899|50110086|FG001|Overall Study|Investigator's Discretion|0|||
25015411|NCT04292899|50110087|FG002|Overall Study|Investigator's Discretion|0|||
25015412|NCT04292899|50110088|FG003|Overall Study|Investigator's Discretion|3|||
25015413|NCT04292899|50110085|FG000|Overall Study|Non-compliance With Study Drug|0|||
25015414|NCT04292899|50110086|FG001|Overall Study|Non-compliance With Study Drug|0|||
25015415|NCT04292899|50110087|FG002|Overall Study|Non-compliance With Study Drug|0|||
25015416|NCT04292899|50110088|FG003|Overall Study|Non-compliance With Study Drug|1|||
25015417|NCT04292899|50110085|FG000|Overall Study|Protocol Violation|0|||
25015418|NCT04292899|50110086|FG001|Overall Study|Protocol Violation|0|||
25015419|NCT04292899|50110087|FG002|Overall Study|Protocol Violation|0|||
25015420|NCT04292899|50110088|FG003|Overall Study|Protocol Violation|1|||
25015421|NCT03241173|50110107|FG000|Overall Study|Death|3|||
25015422|NCT03241173|50110108|FG001|Overall Study|Death|2|||
25015423|NCT03241173|50110109|FG002|Overall Study|Death|4|||
25015424|NCT03241173|50110110|FG003|Overall Study|Death|4|||
25015425|NCT03241173|50110111|FG004|Overall Study|Death|2|||
25015426|NCT03241173|50110112|FG005|Overall Study|Death|2|||
25015427|NCT03241173|50110113|FG006|Overall Study|Death|3|||
25015428|NCT03241173|50110114|FG007|Overall Study|Death|1|||
25015429|NCT03241173|50110115|FG008|Overall Study|Death|0|||
25015430|NCT03241173|50110116|FG009|Overall Study|Death|5|||
25015431|NCT03241173|50110117|FG010|Overall Study|Death|4|||
25015432|NCT03241173|50110118|FG011|Overall Study|Death|3|||
25015433|NCT03241173|50110119|FG012|Overall Study|Death|0|||
25015434|NCT03241173|50110120|FG013|Overall Study|Death|0|||
25015435|NCT03241173|50110121|FG014|Overall Study|Death|0|||
25015436|NCT03241173|50110107|FG000|Overall Study|Withdrawal by Subject|0|||
25015437|NCT03241173|50110108|FG001|Overall Study|Withdrawal by Subject|0|||
25015438|NCT03241173|50110109|FG002|Overall Study|Withdrawal by Subject|1|||
25015439|NCT03241173|50110110|FG003|Overall Study|Withdrawal by Subject|0|||
25015440|NCT03241173|50110111|FG004|Overall Study|Withdrawal by Subject|0|||
25015441|NCT03241173|50110112|FG005|Overall Study|Withdrawal by Subject|1|||
25015442|NCT03241173|50110113|FG006|Overall Study|Withdrawal by Subject|0|||
25015443|NCT03241173|50110114|FG007|Overall Study|Withdrawal by Subject|0|||
25015444|NCT03241173|50110115|FG008|Overall Study|Withdrawal by Subject|0|||
25015445|NCT03241173|50110116|FG009|Overall Study|Withdrawal by Subject|0|||
25015446|NCT03241173|50110117|FG010|Overall Study|Withdrawal by Subject|0|||
25015447|NCT03241173|50110118|FG011|Overall Study|Withdrawal by Subject|0|||
25015448|NCT03241173|50110119|FG012|Overall Study|Withdrawal by Subject|0|||
25015449|NCT03241173|50110120|FG013|Overall Study|Withdrawal by Subject|0|||
25015450|NCT03241173|50110121|FG014|Overall Study|Withdrawal by Subject|0|||
25015451|NCT03241173|50110107|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
25015452|NCT03241173|50110108|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
25015453|NCT03241173|50110109|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
25015454|NCT03241173|50110110|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
25015455|NCT03241173|50110111|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
25015456|NCT03241173|50110112|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
25015457|NCT03241173|50110113|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
25015458|NCT03241173|50110114|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
25015459|NCT03241173|50110115|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
25015460|NCT03241173|50110116|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
25015461|NCT03241173|50110117|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
25015462|NCT03241173|50110118|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
25015463|NCT03241173|50110119|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
25015464|NCT03241173|50110120|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
25015465|NCT03241173|50110121|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
25015466|NCT03241173|50110107|FG000|Overall Study|Lost to Follow-up|0|||
25015467|NCT03241173|50110108|FG001|Overall Study|Lost to Follow-up|0|||
25015468|NCT03241173|50110109|FG002|Overall Study|Lost to Follow-up|0|||
25015469|NCT03241173|50110110|FG003|Overall Study|Lost to Follow-up|0|||
25015470|NCT03241173|50110111|FG004|Overall Study|Lost to Follow-up|1|||
25015471|NCT03241173|50110112|FG005|Overall Study|Lost to Follow-up|0|||
25015472|NCT03241173|50110113|FG006|Overall Study|Lost to Follow-up|0|||
25015473|NCT03241173|50110114|FG007|Overall Study|Lost to Follow-up|0|||
25015474|NCT03241173|50110115|FG008|Overall Study|Lost to Follow-up|0|||
25015475|NCT03241173|50110116|FG009|Overall Study|Lost to Follow-up|1|||
25015476|NCT03241173|50110117|FG010|Overall Study|Lost to Follow-up|0|||
25015477|NCT03241173|50110118|FG011|Overall Study|Lost to Follow-up|0|||
25015478|NCT03241173|50110119|FG012|Overall Study|Lost to Follow-up|0|||
25015479|NCT03241173|50110120|FG013|Overall Study|Lost to Follow-up|0|||
25015480|NCT03241173|50110121|FG014|Overall Study|Lost to Follow-up|0|||
25015481|NCT03264066|50110155|FG000|Overall Study|Adverse Event|1|||
25015482|NCT03264066|50110156|FG001|Overall Study|Adverse Event|1|||
25015483|NCT03264066|50110157|FG002|Overall Study|Adverse Event|0|||
25141745|NCT02031302|50255193|FG000|Overall Study|Lost to Follow-up|4|||
25015484|NCT03264066|50110158|FG003|Overall Study|Adverse Event|0|||
25015485|NCT03264066|50110159|FG004|Overall Study|Adverse Event|0|||
25015486|NCT03264066|50110160|FG005|Overall Study|Adverse Event|0|||
25015487|NCT03264066|50110155|FG000|Overall Study|Death|12|||
25015488|NCT03264066|50110156|FG001|Overall Study|Death|12|||
25015489|NCT03264066|50110157|FG002|Overall Study|Death|8|||
25015490|NCT03264066|50110158|FG003|Overall Study|Death|10|||
25015491|NCT03264066|50110159|FG004|Overall Study|Death|6|||
25015492|NCT03264066|50110160|FG005|Overall Study|Death|1|||
25015493|NCT03264066|50110155|FG000|Overall Study|Lost to Follow-up|1|||
25015494|NCT03264066|50110156|FG001|Overall Study|Lost to Follow-up|0|||
25015495|NCT03264066|50110157|FG002|Overall Study|Lost to Follow-up|0|||
25015496|NCT03264066|50110158|FG003|Overall Study|Lost to Follow-up|0|||
25015497|NCT03264066|50110159|FG004|Overall Study|Lost to Follow-up|0|||
25015498|NCT03264066|50110160|FG005|Overall Study|Lost to Follow-up|0|||
25015499|NCT03264066|50110155|FG000|Overall Study|Progressive Disease|0|||
25015500|NCT03264066|50110156|FG001|Overall Study|Progressive Disease|2|||
25015501|NCT03264066|50110157|FG002|Overall Study|Progressive Disease|1|||
25015502|NCT03264066|50110158|FG003|Overall Study|Progressive Disease|0|||
25015503|NCT03264066|50110159|FG004|Overall Study|Progressive Disease|0|||
25015504|NCT03264066|50110160|FG005|Overall Study|Progressive Disease|0|||
25015505|NCT03264066|50110155|FG000|Overall Study|Study Terminated by Sponsor|5|||
25015506|NCT03264066|50110156|FG001|Overall Study|Study Terminated by Sponsor|5|||
25015507|NCT03264066|50110157|FG002|Overall Study|Study Terminated by Sponsor|8|||
25015508|NCT03264066|50110158|FG003|Overall Study|Study Terminated by Sponsor|5|||
25015509|NCT03264066|50110159|FG004|Overall Study|Study Terminated by Sponsor|1|||
25015510|NCT03264066|50110160|FG005|Overall Study|Study Terminated by Sponsor|2|||
25015511|NCT03264066|50110155|FG000|Overall Study|Withdrawal by Subject|1|||
25015512|NCT03264066|50110156|FG001|Overall Study|Withdrawal by Subject|0|||
25015513|NCT03264066|50110157|FG002|Overall Study|Withdrawal by Subject|0|||
25015514|NCT03264066|50110158|FG003|Overall Study|Withdrawal by Subject|5|||
25015515|NCT03264066|50110159|FG004|Overall Study|Withdrawal by Subject|0|||
25015516|NCT03264066|50110160|FG005|Overall Study|Withdrawal by Subject|0|||
25015517|NCT03759041|50110178|FG000|Overall Study|Withdrawal by Subject|4|||
25015518|NCT03759041|50110179|FG001|Overall Study|Withdrawal by Subject|10|||
25015519|NCT03759041|50110180|FG002|Overall Study|Withdrawal by Subject|10|||
25015520|NCT03759041|50110178|FG000|Overall Study|Adverse Event|1|||
25015521|NCT03759041|50110179|FG001|Overall Study|Adverse Event|3|||
25015522|NCT03759041|50110180|FG002|Overall Study|Adverse Event|4|||
25015523|NCT03759041|50110178|FG000|Overall Study|Lack of Efficacy|0|||
25015524|NCT03759041|50110179|FG001|Overall Study|Lack of Efficacy|0|||
25015525|NCT03759041|50110180|FG002|Overall Study|Lack of Efficacy|1|||
25015526|NCT03759041|50110178|FG000|Overall Study|Study Terminated by Sponsor|15|||
25015527|NCT03759041|50110179|FG001|Overall Study|Study Terminated by Sponsor|16|||
25015528|NCT03759041|50110180|FG002|Overall Study|Study Terminated by Sponsor|10|||
25015529|NCT03759041|50110178|FG000|Overall Study|Other reason for discontinuation|0|||
25015530|NCT03759041|50110179|FG001|Overall Study|Other reason for discontinuation|2|||
25015531|NCT03759041|50110180|FG002|Overall Study|Other reason for discontinuation|1|||
25015532|NCT03759041|50110178|FG000|Overall Study|Lost to Follow-up|7|||
25015533|NCT03759041|50110179|FG001|Overall Study|Lost to Follow-up|2|||
25015534|NCT03759041|50110180|FG002|Overall Study|Lost to Follow-up|2|||
25015535|NCT03759041|50110178|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
25015536|NCT03759041|50110179|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
25015537|NCT03759041|50110180|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
25015538|NCT04110145|50110193|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
25015539|NCT04110145|50110194|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
25015540|NCT04110145|50110195|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
25015541|NCT04110145|50110196|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
25015542|NCT04110145|50110197|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
25015543|NCT02477618|50110211|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
25015544|NCT02477618|50110212|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
25015545|NCT02477618|50110211|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
25015546|NCT02477618|50110212|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
25141746|NCT02031302|50255194|FG001|Overall Study|Lost to Follow-up|0|||
25141747|NCT01610037|50255204|FG000|All Patients|Adverse Event|27|||
25141748|NCT01610037|50255205|FG001|All Patients|Adverse Event|22|||
25141749|NCT01610037|50255206|FG002|All Patients|Adverse Event|26|||
25141750|NCT01610037|50255204|FG000|All Patients|Withdrawal by Subject|12|||
25141751|NCT01610037|50255205|FG001|All Patients|Withdrawal by Subject|10|||
25141752|NCT01610037|50255206|FG002|All Patients|Withdrawal by Subject|20|||
25141753|NCT01610037|50255204|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
25141754|NCT01610037|50255205|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
25141755|NCT01610037|50255206|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
25141756|NCT01610037|50255204|FG000|All Patients|Death|4|||
25141757|NCT01610037|50255205|FG001|All Patients|Death|2|||
25141758|NCT01610037|50255206|FG002|All Patients|Death|1|||
25015547|NCT02477618|50110211|FG000|Overall Study|Adverse Event|1|||
25015548|NCT02477618|50110212|FG001|Overall Study|Adverse Event|1|||
25015549|NCT02477618|50110211|FG000|Overall Study|Transferred Away from Study Site|1|||
25015550|NCT02477618|50110212|FG001|Overall Study|Transferred Away from Study Site|0|||
25141759|NCT01610037|50255204|FG000|All Patients|Protocol deviation|4|||
25015551|NCT02477618|50110211|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
25015552|NCT02477618|50110212|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
25015553|NCT04102501|50110220|FG000|Overall Study|Withdrawal by Subject|7|||
25015554|NCT04102501|50110221|FG001|Overall Study|Withdrawal by Subject|9|||
25015555|NCT04102501|50110220|FG000|Overall Study|Adverse Event|1|||
25015556|NCT04102501|50110221|FG001|Overall Study|Adverse Event|3|||
25015557|NCT03285477|50110231|FG000|Treatment and Response Assessment Period|Death|1|||
25015558|NCT03285477|50110232|FG001|Treatment and Response Assessment Period|Death|0|||
25015559|NCT03285477|50110231|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
25015560|NCT03285477|50110232|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
25015561|NCT03285477|50110231|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
25015562|NCT03285477|50110232|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
25015563|NCT03285477|50110231|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
25015564|NCT03285477|50110232|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
25015565|NCT03285477|50110231|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
25015566|NCT03285477|50110232|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
25015567|NCT04289623|50110249|FG000|Wave 1 Emails|Email was not delivered|268|||
25015568|NCT04289623|50110250|FG001|Wave 1 Emails|Email was not delivered|257|||
25015569|NCT04289623|50110251|FG002|Wave 1 Emails|Email was not delivered|0|||
25015570|NCT04289623|50110252|FG003|Wave 1 Emails|Email was not delivered|0|||
25015571|NCT04289623|50110253|FG004|Wave 1 Emails|Email was not delivered|0|||
25015572|NCT04289623|50110254|FG005|Wave 1 Emails|Email was not delivered|0|||
25015573|NCT03248037|50110270|FG000|Overall Study|Withdrawal by Subject|6|||
25015574|NCT03248037|50110271|FG001|Overall Study|Withdrawal by Subject|9|||
25015575|NCT03248037|50110270|FG000|Overall Study|Adverse Event|15|||
25015576|NCT03248037|50110271|FG001|Overall Study|Adverse Event|0|||
25015577|NCT04287517|50110286|FG000|Overall Study|Withdrawal by Subject|1|||
25015578|NCT04287517|50110287|FG001|Overall Study|Withdrawal by Subject|1|||
25015579|NCT03284229|50110293|FG000|Overall Study|Lost to Follow-up|3|||
25015580|NCT03242928|50110300|FG000|Overall Study|Adverse Event|2|||
25015581|NCT03242928|50110301|FG001|Overall Study|Adverse Event|1|||
25015582|NCT03242928|50110300|FG000|Overall Study|Lost to Follow-up|2|||
25015583|NCT03242928|50110301|FG001|Overall Study|Lost to Follow-up|0|||
25015584|NCT03242928|50110300|FG000|Overall Study|Physician Decision|0|||
25015585|NCT03242928|50110301|FG001|Overall Study|Physician Decision|1|||
25015586|NCT03242928|50110300|FG000|Overall Study|Withdrawal by Subject|5|||
25015587|NCT03242928|50110301|FG001|Overall Study|Withdrawal by Subject|3|||
25015588|NCT03300024|50110309|FG000|Overall Study|Physician Decision|4|||
25015589|NCT03300024|50110310|FG001|Overall Study|Physician Decision|6|||
25015590|NCT04276207|50110318|FG000|Period 1|Withdrawal by Subject|0|||
25015591|NCT04276207|50110319|FG001|Period 1|Withdrawal by Subject|1|||
25015592|NCT03282357|50110325|FG000|Overall Study|Lost to Follow-up|3|||
25015593|NCT03282357|50110325|FG000|Overall Study|Withdrawal by Subject|4|||
25015594|NCT03282357|50110325|FG000|Overall Study|Adverse Event|1|||
25015595|NCT03282357|50110325|FG000|Overall Study|Other|9|||
25015596|NCT04272775|50110332|FG000|Overall Study|Study Terminated by Sponsor|1|||
25015597|NCT04272775|50110333|FG001|Overall Study|Study Terminated by Sponsor|0|||
25015598|NCT04272775|50110332|FG000|Overall Study|Protocol Violation|0|||
25015599|NCT04272775|50110333|FG001|Overall Study|Protocol Violation|1|||
25015600|NCT04272775|50110332|FG000|Overall Study|Symptomatic Deterioration|1|||
25015601|NCT04272775|50110333|FG001|Overall Study|Symptomatic Deterioration|1|||
25015602|NCT04272775|50110332|FG000|Overall Study|Withdrawal by Subject|1|||
25015603|NCT04272775|50110333|FG001|Overall Study|Withdrawal by Subject|2|||
25015604|NCT04272775|50110332|FG000|Overall Study|Adverse Event|1|||
25015605|NCT04272775|50110333|FG001|Overall Study|Adverse Event|2|||
25015606|NCT04272775|50110332|FG000|Overall Study|Progressive Disease|3|||
25015607|NCT04272775|50110333|FG001|Overall Study|Progressive Disease|1|||
25015608|NCT03232983|50110339|FG000|Period 1|Physician Decision|0|||
25015609|NCT03232983|50110340|FG001|Period 1|Physician Decision|0|||
25015610|NCT03232983|50110341|FG002|Period 1|Physician Decision|1|||
25015611|NCT03232983|50110342|FG003|Period 1|Physician Decision|0|||
25015612|NCT03232983|50110339|FG000|Washout Period 2|Physician Decision|0|||
25015613|NCT03232983|50110340|FG001|Washout Period 2|Physician Decision|0|||
25015614|NCT03232983|50110341|FG002|Washout Period 2|Physician Decision|1|||
25015615|NCT03232983|50110342|FG003|Washout Period 2|Physician Decision|0|||
25015616|NCT03232983|50110339|FG000|Washout Period 2|Withdrawal by Subject|0|||
25015617|NCT03232983|50110340|FG001|Washout Period 2|Withdrawal by Subject|0|||
25015618|NCT03232983|50110341|FG002|Washout Period 2|Withdrawal by Subject|0|||
25015619|NCT03232983|50110342|FG003|Washout Period 2|Withdrawal by Subject|1|||
25015620|NCT03232983|50110339|FG000|Period 4|Withdrawal by Subject|1|||
25015621|NCT03232983|50110340|FG001|Period 4|Withdrawal by Subject|0|||
25015622|NCT03232983|50110341|FG002|Period 4|Withdrawal by Subject|0|||
25015623|NCT03232983|50110342|FG003|Period 4|Withdrawal by Subject|0|||
25015624|NCT04102345|50110356|FG000|Overall Study|Withdrawal by Subject|1|||
25015625|NCT04102345|50110357|FG001|Overall Study|Withdrawal by Subject|0|||
25067375|NCT03188666|50173002|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
25015626|NCT04271605|50110363|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
25015627|NCT03299244|50110369|FG000|Overall Study|Withdrawal by Subject|34|||
25015628|NCT03299244|50110370|FG001|Overall Study|Withdrawal by Subject|29|||
25015629|NCT03299244|50110369|FG000|Overall Study|Decision by Sponsor|4|||
25015630|NCT03299244|50110370|FG001|Overall Study|Decision by Sponsor|5|||
25015631|NCT03299244|50110369|FG000|Overall Study|Death|9|||
25015632|NCT03299244|50110370|FG001|Overall Study|Death|4|||
25015633|NCT03757715|50110379|FG000|Overall Study|Lost to Follow-up|4|||
25015634|NCT03757715|50110380|FG001|Overall Study|Lost to Follow-up|9|||
25015635|NCT03757715|50110379|FG000|Overall Study|Withdrawal by Subject|1|||
25015636|NCT03757715|50110380|FG001|Overall Study|Withdrawal by Subject|1|||
25015637|NCT03281577|50110390|FG000|Overall Study|Adverse Event|0|||
25015638|NCT03281577|50110391|FG001|Overall Study|Adverse Event|0|||
25015639|NCT03281577|50110392|FG002|Overall Study|Adverse Event|0|||
25015640|NCT03281577|50110393|FG003|Overall Study|Adverse Event|1|||
25015641|NCT03281577|50110390|FG000|Overall Study|Withdrawal by Subject|1|||
25015642|NCT03281577|50110391|FG001|Overall Study|Withdrawal by Subject|0|||
25015643|NCT03281577|50110392|FG002|Overall Study|Withdrawal by Subject|0|||
25015644|NCT03281577|50110393|FG003|Overall Study|Withdrawal by Subject|0|||
25015645|NCT04098367|50110409|FG000|Overall Study|Adverse Event|0|||
25015646|NCT04098367|50110410|FG001|Overall Study|Adverse Event|0|||
25015647|NCT04098367|50110411|FG002|Overall Study|Adverse Event|1|||
25015648|NCT04098367|50110409|FG000|Overall Study|Lost to Follow-up|1|||
25015649|NCT04098367|50110410|FG001|Overall Study|Lost to Follow-up|5|||
25015650|NCT04098367|50110411|FG002|Overall Study|Lost to Follow-up|2|||
25015651|NCT04098367|50110409|FG000|Overall Study|Withdrawal by Subject|0|||
25141760|NCT01610037|50255205|FG001|All Patients|Protocol deviation|3|||
25141761|NCT01610037|50255206|FG002|All Patients|Protocol deviation|3|||
25141762|NCT01610037|50255204|FG000|All Patients|Abnormal laboratory value|1|||
25141763|NCT01610037|50255205|FG001|All Patients|Abnormal laboratory value|1|||
25141764|NCT01610037|50255206|FG002|All Patients|Abnormal laboratory value|0|||
25141765|NCT01610037|50255204|FG000|All Patients|Administrative problems|1|||
25141766|NCT01610037|50255205|FG001|All Patients|Administrative problems|4|||
25141767|NCT01610037|50255206|FG002|All Patients|Administrative problems|4|||
25141768|NCT01610037|50255204|FG000|All Patients|Lost to Follow-up|1|||
25141769|NCT01610037|50255205|FG001|All Patients|Lost to Follow-up|0|||
25141770|NCT01610037|50255206|FG002|All Patients|Lost to Follow-up|0|||
25141771|NCT01610037|50255204|FG000|All Patients|Abnormal test procedure result(s)|0|||
25141772|NCT01610037|50255205|FG001|All Patients|Abnormal test procedure result(s)|1|||
25141773|NCT01610037|50255206|FG002|All Patients|Abnormal test procedure result(s)|3|||
25141774|NCT01610037|50255204|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
25141775|NCT01610037|50255205|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
25141776|NCT01610037|50255206|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
25141777|NCT01610037|50255204|FG000|Treatment and Follow up Period|Death|10|||
25141778|NCT01610037|50255205|FG001|Treatment and Follow up Period|Death|5|||
25141779|NCT01610037|50255206|FG002|Treatment and Follow up Period|Death|4|||
25141780|NCT01610037|50255204|FG000|Treatment and Follow up Period|Administrative problems|1|||
25141781|NCT01610037|50255205|FG001|Treatment and Follow up Period|Administrative problems|3|||
25141782|NCT01610037|50255206|FG002|Treatment and Follow up Period|Administrative problems|2|||
25141783|NCT01610037|50255204|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
25141784|NCT01610037|50255205|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
25141785|NCT01610037|50255206|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
25141786|NCT01806051|50255214|FG000|Overall Study|Withdrawal by Subject|6|||
25141787|NCT01837797|50255223|FG000|Period 1|Adverse Event|9|||
25141788|NCT01837797|50255224|FG001|Period 1|Adverse Event|0|||
25141789|NCT01837797|50255225|FG002|Period 1|Adverse Event|0|||
25141790|NCT01837797|50255226|FG003|Period 1|Adverse Event|0|||
25141791|NCT01837797|50255227|FG004|Period 1|Adverse Event|0|||
25141792|NCT01837797|50255223|FG000|Period 1|Withdrawal by Subject|6|||
25141793|NCT01837797|50255224|FG001|Period 1|Withdrawal by Subject|0|||
25141794|NCT01837797|50255225|FG002|Period 1|Withdrawal by Subject|0|||
25141795|NCT01837797|50255226|FG003|Period 1|Withdrawal by Subject|0|||
25141796|NCT01837797|50255227|FG004|Period 1|Withdrawal by Subject|0|||
25141797|NCT01837797|50255223|FG000|Period 1|Administrative reasons|76|||
25141798|NCT01837797|50255224|FG001|Period 1|Administrative reasons|0|||
25141799|NCT01837797|50255225|FG002|Period 1|Administrative reasons|0|||
25141800|NCT01837797|50255226|FG003|Period 1|Administrative reasons|0|||
25141801|NCT01837797|50255227|FG004|Period 1|Administrative reasons|0|||
25141802|NCT01837797|50255223|FG000|Period 1|Withdrawal of consent before treatment|1|||
25141803|NCT01837797|50255224|FG001|Period 1|Withdrawal of consent before treatment|0|||
25141804|NCT01837797|50255225|FG002|Period 1|Withdrawal of consent before treatment|0|||
25141805|NCT01837797|50255226|FG003|Period 1|Withdrawal of consent before treatment|0|||
25141806|NCT01837797|50255227|FG004|Period 1|Withdrawal of consent before treatment|0|||
25141807|NCT01837797|50255223|FG000|Period 1|Other|10|||
25141808|NCT01837797|50255224|FG001|Period 1|Other|0|||
25141809|NCT01837797|50255225|FG002|Period 1|Other|0|||
25141810|NCT01837797|50255226|FG003|Period 1|Other|0|||
25141811|NCT01837797|50255227|FG004|Period 1|Other|0|||
25141812|NCT01837797|50255223|FG000|Period 2|Administrative or other reasons|0|||
25141813|NCT01837797|50255224|FG001|Period 2|Administrative or other reasons|5|||
25141814|NCT01837797|50255225|FG002|Period 2|Administrative or other reasons|2|||
25141815|NCT01837797|50255226|FG003|Period 2|Administrative or other reasons|4|||
25141816|NCT01837797|50255227|FG004|Period 2|Administrative or other reasons|0|||
25141817|NCT01837797|50255223|FG000|Period 2|Adverse Event|0|||
25141818|NCT01837797|50255224|FG001|Period 2|Adverse Event|0|||
25274416|NCT01078623|50588457|FG002|Treatment Period 4|Adverse Event|1|||
25274417|NCT01078623|50588458|FG003|Treatment Period 4|Adverse Event|0|||
25274418|NCT01078623|50588459|FG004|Treatment Period 4|Adverse Event|0|||
25274419|NCT01078623|50588460|FG005|Treatment Period 4|Adverse Event|0|||
25274420|NCT01078623|50588461|FG006|Treatment Period 4|Adverse Event|0|||
25274421|NCT01078623|50588462|FG007|Treatment Period 4|Adverse Event|0|||
25274422|NCT01078623|50588463|FG008|Treatment Period 4|Adverse Event|0|||
25274423|NCT01078623|50588464|FG009|Treatment Period 4|Adverse Event|0|||
25274424|NCT01078623|50588465|FG010|Treatment Period 4|Adverse Event|0|||
25141819|NCT01837797|50255225|FG002|Period 2|Adverse Event|0|||
25141820|NCT01837797|50255226|FG003|Period 2|Adverse Event|1|||
25141821|NCT01837797|50255227|FG004|Period 2|Adverse Event|0|||
25141822|NCT01837797|50255223|FG000|Period 3|Adverse Event|0|||
25141823|NCT01837797|50255224|FG001|Period 3|Adverse Event|0|||
25141824|NCT01837797|50255225|FG002|Period 3|Adverse Event|0|||
25141825|NCT01837797|50255226|FG003|Period 3|Adverse Event|0|||
25141826|NCT01837797|50255227|FG004|Period 3|Adverse Event|1|||
25141827|NCT01837797|50255223|FG000|Period 3|Administrative reasons|0|||
25141828|NCT01837797|50255224|FG001|Period 3|Administrative reasons|0|||
25141829|NCT01837797|50255225|FG002|Period 3|Administrative reasons|0|||
25141830|NCT01837797|50255226|FG003|Period 3|Administrative reasons|0|||
25141831|NCT01837797|50255227|FG004|Period 3|Administrative reasons|20|||
25141832|NCT01837797|50255223|FG000|Period 3|Other|0|||
25141833|NCT01837797|50255224|FG001|Period 3|Other|0|||
25141834|NCT01837797|50255225|FG002|Period 3|Other|0|||
25141835|NCT01837797|50255226|FG003|Period 3|Other|0|||
25141836|NCT01837797|50255227|FG004|Period 3|Other|2|||
25141837|NCT01984424|50255237|FG000|Overall Study|Withdrawal by Subject|3|||
25141838|NCT01984424|50255238|FG001|Overall Study|Withdrawal by Subject|5|||
25141839|NCT01984424|50255237|FG000|Overall Study|Sponsor Decision|0|||
25141840|NCT01984424|50255238|FG001|Overall Study|Sponsor Decision|1|||
25141841|NCT01984424|50255237|FG000|Overall Study|Lost to Follow-up|0|||
25141842|NCT01984424|50255238|FG001|Overall Study|Lost to Follow-up|1|||
25141843|NCT01837719|50255244|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
25141844|NCT01837719|50255244|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
25141845|NCT01984268|50255259|FG000|Overall Study|Study Terminated|15|||
25274425|NCT01078623|50588466|FG011|Treatment Period 4|Adverse Event|0|||
25141846|NCT02031146|50255265|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
25141847|NCT02031146|50255266|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
25141848|NCT02031146|50255267|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
25274426|NCT01078623|50588467|FG012|Treatment Period 4|Adverse Event|0|||
25274427|NCT01078623|50588468|FG013|Treatment Period 4|Adverse Event|0|||
25274428|NCT01078623|50588469|FG014|Treatment Period 4|Adverse Event|0|||
25274429|NCT01078623|50588470|FG015|Treatment Period 4|Adverse Event|0|||
25274430|NCT01078623|50588471|FG016|Treatment Period 4|Adverse Event|0|||
25274431|NCT01078623|50588472|FG017|Treatment Period 4|Adverse Event|0|||
25274432|NCT01078623|50588473|FG018|Treatment Period 4|Adverse Event|0|||
25274433|NCT01078623|50588474|FG019|Treatment Period 4|Adverse Event|0|||
25274434|NCT01078623|50588455|FG000|Treatment Period 4|Withdrawal by Subject|0|||
25274435|NCT01078623|50588456|FG001|Treatment Period 4|Withdrawal by Subject|0|||
25015652|NCT04098367|50110410|FG001|Overall Study|Withdrawal by Subject|0|||
25015653|NCT04098367|50110411|FG002|Overall Study|Withdrawal by Subject|1|||
25141849|NCT02031146|50255268|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
25141850|NCT02031146|50255269|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
25141851|NCT02031146|50255270|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
25141852|NCT02031146|50255271|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
25141853|NCT02009384|50255281|FG000|Overall Study|Death|2|||
25141854|NCT01805037|50255285|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
25141855|NCT01805037|50255286|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
25141856|NCT01805037|50255285|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
25141857|NCT01805037|50255286|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
25141858|NCT01805037|50255285|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
25141859|NCT01805037|50255286|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
25141860|NCT01805037|50255285|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
25141861|NCT01805037|50255286|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
25141862|NCT01805037|50255285|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
25141863|NCT01805037|50255286|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
25141864|NCT01805037|50255285|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
25141865|NCT01805037|50255286|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
25141866|NCT01805037|50255285|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
25141867|NCT01805037|50255286|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
25141868|NCT01805037|50255285|FG000|Follow Up (up to 3 Years)|Death|0|||
25141869|NCT01805037|50255286|FG001|Follow Up (up to 3 Years)|Death|2|||
25141870|NCT01805037|50255285|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
25141871|NCT01805037|50255286|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
25141872|NCT01805037|50255285|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
25141873|NCT01805037|50255286|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
25141874|NCT01803711|50255292|FG000|Overall Study|Adverse Event|1|||
25141875|NCT01803711|50255293|FG001|Overall Study|Adverse Event|1|||
25141876|NCT01836549|50255307|FG000|Overall Study|Did not receive study drug|0|||
25141877|NCT01836549|50255308|FG001|Overall Study|Did not receive study drug|0|||
25141878|NCT01836549|50255309|FG002|Overall Study|Did not receive study drug|1|||
25141879|NCT01836549|50255310|FG003|Overall Study|Did not receive study drug|0|||
25141880|NCT01836549|50255311|FG004|Overall Study|Did not receive study drug|0|||
25141881|NCT01836549|50255312|FG005|Overall Study|Did not receive study drug|0|||
25141882|NCT01836549|50255313|FG006|Overall Study|Did not receive study drug|0|||
25141883|NCT01836549|50255307|FG000|Overall Study|Patient declared ineligible|0|||
25141884|NCT01836549|50255308|FG001|Overall Study|Patient declared ineligible|0|||
25141885|NCT01836549|50255309|FG002|Overall Study|Patient declared ineligible|0|||
25141886|NCT01836549|50255310|FG003|Overall Study|Patient declared ineligible|1|||
25141887|NCT01836549|50255311|FG004|Overall Study|Patient declared ineligible|0|||
25141888|NCT01836549|50255312|FG005|Overall Study|Patient declared ineligible|0|||
25141889|NCT01836549|50255313|FG006|Overall Study|Patient declared ineligible|0|||
25141890|NCT01836549|50255307|FG000|Overall Study|Patient inevaluable to start therapy|0|||
25141891|NCT01836549|50255308|FG001|Overall Study|Patient inevaluable to start therapy|0|||
25141892|NCT01836549|50255309|FG002|Overall Study|Patient inevaluable to start therapy|0|||
25141893|NCT01836549|50255310|FG003|Overall Study|Patient inevaluable to start therapy|0|||
25141894|NCT01836549|50255311|FG004|Overall Study|Patient inevaluable to start therapy|0|||
25141895|NCT01836549|50255312|FG005|Overall Study|Patient inevaluable to start therapy|0|||
25141896|NCT01836549|50255313|FG006|Overall Study|Patient inevaluable to start therapy|1|||
25141897|NCT01836471|50255334|FG000|Overall Study|Pregnancy|1|||
25141898|NCT01836471|50255335|FG001|Overall Study|Pregnancy|0|||
25141899|NCT01836471|50255336|FG002|Overall Study|Pregnancy|0|||
25141900|NCT01836471|50255337|FG003|Overall Study|Pregnancy|0|||
25141901|NCT01836471|50255338|FG004|Overall Study|Pregnancy|0|||
25141902|NCT01836471|50255334|FG000|Overall Study|Withdrawal by Subject|3|||
25141903|NCT01836471|50255335|FG001|Overall Study|Withdrawal by Subject|4|||
25141904|NCT01836471|50255336|FG002|Overall Study|Withdrawal by Subject|1|||
25141905|NCT01836471|50255337|FG003|Overall Study|Withdrawal by Subject|0|||
25141906|NCT01836471|50255338|FG004|Overall Study|Withdrawal by Subject|2|||
25141907|NCT01836471|50255334|FG000|Overall Study|Physician Decision|0|||
25141908|NCT01836471|50255335|FG001|Overall Study|Physician Decision|1|||
25141909|NCT01836471|50255336|FG002|Overall Study|Physician Decision|0|||
25141910|NCT01836471|50255337|FG003|Overall Study|Physician Decision|0|||
25141911|NCT01836471|50255338|FG004|Overall Study|Physician Decision|0|||
25141912|NCT01836471|50255334|FG000|Overall Study|Lost to Follow-up|0|||
25141913|NCT01836471|50255335|FG001|Overall Study|Lost to Follow-up|0|||
25141914|NCT01836471|50255336|FG002|Overall Study|Lost to Follow-up|0|||
25141915|NCT01836471|50255337|FG003|Overall Study|Lost to Follow-up|1|||
25141916|NCT01836471|50255338|FG004|Overall Study|Lost to Follow-up|1|||
25141917|NCT01836471|50255334|FG000|Overall Study|Adverse Event|6|||
25141918|NCT01836471|50255335|FG001|Overall Study|Adverse Event|3|||
25141919|NCT01836471|50255336|FG002|Overall Study|Adverse Event|1|||
25141920|NCT01836471|50255337|FG003|Overall Study|Adverse Event|1|||
25141921|NCT01836471|50255338|FG004|Overall Study|Adverse Event|2|||
25141922|NCT01836471|50255334|FG000|Overall Study|Non compliance with tx|1|||
25141923|NCT01836471|50255335|FG001|Overall Study|Non compliance with tx|1|||
25141924|NCT01836471|50255336|FG002|Overall Study|Non compliance with tx|0|||
25141925|NCT01836471|50255337|FG003|Overall Study|Non compliance with tx|0|||
25141926|NCT01836471|50255338|FG004|Overall Study|Non compliance with tx|0|||
25141927|NCT02030600|50255353|FG000|Treatment Period 1|Adverse Event|5|||
25141928|NCT02030600|50255354|FG001|Treatment Period 1|Adverse Event|7|||
25141929|NCT02030600|50255353|FG000|Treatment Period 1|Lack of Efficacy|0|||
25141930|NCT02030600|50255354|FG001|Treatment Period 1|Lack of Efficacy|1|||
25141931|NCT02030600|50255353|FG000|Treatment Period 1|Lost to Follow-up|11|||
25141932|NCT02030600|50255354|FG001|Treatment Period 1|Lost to Follow-up|3|||
25141933|NCT02030600|50255353|FG000|Treatment Period 1|Protocol Violation|22|||
25179194|NCT01467713|50324507|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
25179195|NCT01467713|50324508|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
25141934|NCT02030600|50255354|FG001|Treatment Period 1|Protocol Violation|17|||
25141935|NCT02030600|50255353|FG000|Treatment Period 1|Withdrawal by Subject|13|||
25141936|NCT02030600|50255354|FG001|Treatment Period 1|Withdrawal by Subject|17|||
25141937|NCT02030600|50255353|FG000|Treatment Period 1|Casebook Unsigned|1|||
25141938|NCT02030600|50255354|FG001|Treatment Period 1|Casebook Unsigned|0|||
25141939|NCT02030600|50255353|FG000|Treatment Period 1|Unclassified|1|||
25141940|NCT02030600|50255354|FG001|Treatment Period 1|Unclassified|0|||
25141941|NCT02030600|50255353|FG000|Treatment Period 2|Adverse Event|4|||
25141942|NCT02030600|50255354|FG001|Treatment Period 2|Adverse Event|4|||
25141943|NCT02030600|50255353|FG000|Treatment Period 2|Lack of Efficacy|2|||
25141944|NCT02030600|50255354|FG001|Treatment Period 2|Lack of Efficacy|1|||
25141945|NCT02030600|50255353|FG000|Treatment Period 2|Lost to Follow-up|4|||
25141946|NCT02030600|50255354|FG001|Treatment Period 2|Lost to Follow-up|2|||
25141947|NCT02030600|50255353|FG000|Treatment Period 2|Protocol Violation|1|||
25141948|NCT02030600|50255354|FG001|Treatment Period 2|Protocol Violation|2|||
25141949|NCT02030600|50255353|FG000|Treatment Period 2|Withdrawal by Subject|13|||
25141950|NCT02030600|50255354|FG001|Treatment Period 2|Withdrawal by Subject|9|||
25141951|NCT02030600|50255353|FG000|Treatment Period 2|Unclassified|1|||
25141952|NCT02030600|50255354|FG001|Treatment Period 2|Unclassified|0|||
25141953|NCT01802775|50255364|FG000|Overall Study|Death|0|||
25141954|NCT01802775|50255365|FG001|Overall Study|Death|3|||
25141955|NCT01802775|50255364|FG000|Overall Study|Reason not provided|0|||
25141956|NCT01802775|50255365|FG001|Overall Study|Reason not provided|1|||
25141957|NCT01802775|50255364|FG000|Overall Study|Physician Decision|1|||
25141958|NCT01802775|50255365|FG001|Overall Study|Physician Decision|0|||
25141959|NCT01802775|50255364|FG000|Overall Study|Adverse Event|1|||
25141960|NCT01802775|50255365|FG001|Overall Study|Adverse Event|1|||
25141961|NCT01802775|50255364|FG000|Overall Study|Withdrawal by Subject|3|||
25141962|NCT01802775|50255365|FG001|Overall Study|Withdrawal by Subject|5|||
25141963|NCT01802775|50255364|FG000|Overall Study|Lost to Follow-up|1|||
25141964|NCT01802775|50255365|FG001|Overall Study|Lost to Follow-up|2|||
25141965|NCT01802385|50255373|FG000|Overall Study|Death|106|||
25141966|NCT01802385|50255374|FG001|Overall Study|Death|120|||
25141967|NCT01773993|50255380|FG000|Overall Study|No Visit After Treatment|35|||
25141968|NCT01802073|50255386|FG000|Overall Study|Lost to Follow-up|0|||
25141969|NCT01802073|50255387|FG001|Overall Study|Lost to Follow-up|1|||
25141970|NCT01802073|50255386|FG000|Overall Study|Non-compliant|4|||
25141971|NCT01802073|50255387|FG001|Overall Study|Non-compliant|2|||
25141972|NCT01802073|50255386|FG000|Overall Study|Withdrawal by Subject|1|||
25141973|NCT01802073|50255387|FG001|Overall Study|Withdrawal by Subject|1|||
25141974|NCT01802073|50255386|FG000|Overall Study|Physician Decision|0|||
25141975|NCT01802073|50255387|FG001|Overall Study|Physician Decision|7|||
25141976|NCT01607073|50255393|FG000|Overall Study|Adverse Event|1|||
25141977|NCT01773291|50255403|FG000|Overall Study|Protocol Violation|1|||
25141978|NCT01773291|50255404|FG001|Overall Study|Protocol Violation|0|||
25141979|NCT01773291|50255405|FG002|Overall Study|Protocol Violation|0|||
25141980|NCT01773291|50255403|FG000|Overall Study|Withdrawal by Subject|0|||
25141981|NCT01773291|50255404|FG001|Overall Study|Withdrawal by Subject|0|||
25141982|NCT01773291|50255405|FG002|Overall Study|Withdrawal by Subject|1|||
25141983|NCT01801917|50255418|FG000|Period 1 - Randomized|Adverse Event|1|||
25141984|NCT01801917|50255419|FG001|Period 1 - Randomized|Adverse Event|0|||
25141985|NCT01801917|50255420|FG002|Period 1 - Randomized|Adverse Event|1|||
25141986|NCT01801917|50255421|FG003|Period 1 - Randomized|Adverse Event|0|||
25141987|NCT02008916|50255435|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
25141988|NCT02008916|50255436|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
25141989|NCT02008916|50255437|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
25141990|NCT02008916|50255435|FG000|Week 16 - 156|Adverse Event|4|||
25141991|NCT02008916|50255436|FG001|Week 16 - 156|Adverse Event|2|||
25141992|NCT02008916|50255437|FG002|Week 16 - 156|Adverse Event|3|||
25141993|NCT02008916|50255435|FG000|Week 16 - 156|Withdrawal by Subject|7|||
25141994|NCT02008916|50255436|FG001|Week 16 - 156|Withdrawal by Subject|3|||
25141995|NCT02008916|50255437|FG002|Week 16 - 156|Withdrawal by Subject|5|||
25141996|NCT02008916|50255435|FG000|Week 16 - 156|No longer requires treatment|0|||
25141997|NCT02008916|50255436|FG001|Week 16 - 156|No longer requires treatment|1|||
25141998|NCT02008916|50255437|FG002|Week 16 - 156|No longer requires treatment|0|||
25141999|NCT02008916|50255435|FG000|Week 16 - 156|Lost to Follow-up|5|||
25142000|NCT02008916|50255436|FG001|Week 16 - 156|Lost to Follow-up|0|||
25142001|NCT02008916|50255437|FG002|Week 16 - 156|Lost to Follow-up|0|||
25142002|NCT02008916|50255435|FG000|Week 16 - 156|Lack of Efficacy|3|||
25142003|NCT02008916|50255436|FG001|Week 16 - 156|Lack of Efficacy|5|||
25142004|NCT02008916|50255437|FG002|Week 16 - 156|Lack of Efficacy|2|||
25142005|NCT02008916|50255435|FG000|Week 16 - 156|Pregnancy|0|||
25142006|NCT02008916|50255436|FG001|Week 16 - 156|Pregnancy|1|||
25142007|NCT02008916|50255437|FG002|Week 16 - 156|Pregnancy|0|||
25142008|NCT02008916|50255435|FG000|Week 16 - 156|Physician Decision|0|||
25142009|NCT02008916|50255436|FG001|Week 16 - 156|Physician Decision|1|||
25142010|NCT02008916|50255437|FG002|Week 16 - 156|Physician Decision|0|||
25142011|NCT01772823|50255448|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
25142012|NCT01772823|50255449|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
25142013|NCT01772823|50255448|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
25142014|NCT01772823|50255449|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
25142015|NCT01772823|50255448|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
25142016|NCT01772823|50255449|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
25142017|NCT01772823|50255448|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
25142018|NCT01772823|50255449|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
25142019|NCT01772823|50255448|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
25142020|NCT01772823|50255449|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
25142021|NCT01772823|50255448|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
25142022|NCT01772823|50255449|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
25142023|NCT01772823|50255448|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
25142024|NCT01772823|50255449|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
25142025|NCT01772823|50255448|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
25142026|NCT01772823|50255449|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
25142027|NCT01772823|50255448|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
25142028|NCT01772823|50255449|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
25142029|NCT01772823|50255448|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
25142030|NCT01772823|50255449|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
25142031|NCT01772823|50255448|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
25142032|NCT01772823|50255449|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
25142033|NCT01772823|50255448|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
25142034|NCT01772823|50255449|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
25142035|NCT01772823|50255448|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
25142036|NCT01772823|50255449|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
25142037|NCT01772823|50255448|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
25142038|NCT01772823|50255449|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
25142039|NCT01772823|50255448|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
25142040|NCT01772823|50255449|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
25142041|NCT01772823|50255448|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
25142042|NCT01772823|50255449|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
25142043|NCT02029976|50255462|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
25142044|NCT02029976|50255463|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
25142045|NCT02029976|50255462|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
25142046|NCT02029976|50255463|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
25142047|NCT02029976|50255462|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
25142048|NCT02029976|50255463|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
25142049|NCT02029976|50255462|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
25142050|NCT02029976|50255463|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
25142051|NCT01983254|50255471|FG000|Overall Study|Death|6|||
25142052|NCT01983254|50255472|FG001|Overall Study|Death|6|||
25142053|NCT01983254|50255471|FG000|Overall Study|Lost to Follow-up|17|||
25142054|NCT01983254|50255472|FG001|Overall Study|Lost to Follow-up|16|||
25142055|NCT01983254|50255471|FG000|Overall Study|too ill|11|||
25142056|NCT01983254|50255472|FG001|Overall Study|too ill|8|||
25142057|NCT01771809|50255480|FG000|Overall Study|Adverse Event|4|||
25142058|NCT01771809|50255481|FG001|Overall Study|Adverse Event|12|||
25142059|NCT01771809|50255480|FG000|Overall Study|Protocol Violation|0|||
25142060|NCT01771809|50255481|FG001|Overall Study|Protocol Violation|1|||
25142061|NCT01771809|50255480|FG000|Overall Study|Withdrawal by Subject|34|||
25142062|NCT01771809|50255481|FG001|Overall Study|Withdrawal by Subject|42|||
25142063|NCT01771809|50255480|FG000|Overall Study|Lost to Follow-up|1|||
25142064|NCT01771809|50255481|FG001|Overall Study|Lost to Follow-up|3|||
25142065|NCT01771809|50255480|FG000|Overall Study|Other (Insufficient clinical response)|22|||
25142066|NCT01771809|50255481|FG001|Overall Study|Other (Insufficient clinical response)|20|||
25142067|NCT01771809|50255480|FG000|Overall Study|Death|1|||
25142068|NCT01771809|50255481|FG001|Overall Study|Death|0|||
25142069|NCT01771809|50255480|FG000|Overall Study|Other (other)|9|||
25142070|NCT01771809|50255481|FG001|Overall Study|Other (other)|5|||
25142071|NCT01771731|50255489|FG000|Overall Study|Physician Decision|1|||
25142072|NCT01771731|50255490|FG001|Overall Study|Physician Decision|0|||
25142073|NCT01771731|50255489|FG000|Overall Study|Protocol Violation|0|||
25142074|NCT01771731|50255490|FG001|Overall Study|Protocol Violation|1|||
25142075|NCT01771731|50255489|FG000|Overall Study|Adverse event: Pain Crisis|1|||
25142076|NCT01771731|50255490|FG001|Overall Study|Adverse event: Pain Crisis|1|||
25142077|NCT01982942|50255498|FG000|Overall Study|Adverse Event|10|||
25142078|NCT01982942|50255499|FG001|Overall Study|Adverse Event|5|||
25142079|NCT01982942|50255498|FG000|Overall Study|Lost to Follow-up|4|||
25142080|NCT01982942|50255499|FG001|Overall Study|Lost to Follow-up|3|||
25142081|NCT01982942|50255498|FG000|Overall Study|Multiple sclerosis progression|3|||
25142082|NCT01982942|50255499|FG001|Overall Study|Multiple sclerosis progression|2|||
25142083|NCT01982942|50255498|FG000|Overall Study|Wanted to try therapy not permitted|1|||
25142084|NCT01982942|50255499|FG001|Overall Study|Wanted to try therapy not permitted|0|||
25142085|NCT01982942|50255498|FG000|Overall Study|Subject declined future visits|0|||
25142086|NCT01982942|50255499|FG001|Overall Study|Subject declined future visits|1|||
25142087|NCT01982942|50255498|FG000|Overall Study|Left geographical area|2|||
25142088|NCT01982942|50255499|FG001|Overall Study|Left geographical area|0|||
25142089|NCT01982942|50255498|FG000|Overall Study|Too many pills|1|||
25142090|NCT01982942|50255499|FG001|Overall Study|Too many pills|0|||
25142091|NCT01982942|50255498|FG000|Overall Study|MS Relapse|0|||
25142092|NCT01982942|50255499|FG001|Overall Study|MS Relapse|1|||
25142093|NCT01982942|50255498|FG000|Overall Study|Chose to join a stem cell trial|0|||
25142094|NCT01982942|50255499|FG001|Overall Study|Chose to join a stem cell trial|1|||
25142095|NCT01982942|50255498|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
25142096|NCT01982942|50255499|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
25142097|NCT01769469|50255505|FG000|Overall Study|Consent Withdrawn|5|||
25142098|NCT01769469|50255505|FG000|Overall Study|Moved Out Of Area|3|||
25142099|NCT01769469|50255505|FG000|Overall Study|Lost to Follow-up|17|||
25142100|NCT01769469|50255505|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
25142101|NCT01769469|50255505|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
25142102|NCT02008526|50255514|FG000|Overall Study|Death|0|||
25142103|NCT02008526|50255515|FG001|Overall Study|Death|2|||
25142104|NCT02008526|50255516|FG002|Overall Study|Death|1|||
25142105|NCT02008526|50255514|FG000|Overall Study|Withdrawal by Subject|3|||
25142106|NCT02008526|50255515|FG001|Overall Study|Withdrawal by Subject|3|||
25142107|NCT02008526|50255516|FG002|Overall Study|Withdrawal by Subject|2|||
25142108|NCT02008526|50255514|FG000|Overall Study|Lost to Follow-up|5|||
25142109|NCT02008526|50255515|FG001|Overall Study|Lost to Follow-up|9|||
25142110|NCT02008526|50255516|FG002|Overall Study|Lost to Follow-up|6|||
25142111|NCT01769391|50255526|FG000|Overall Study|Death|10|||
25142112|NCT01769391|50255527|FG001|Overall Study|Death|1|||
25142113|NCT01769391|50255526|FG000|Overall Study|Adverse Event|0|||
25142114|NCT01769391|50255527|FG001|Overall Study|Adverse Event|3|||
25142115|NCT01769391|50255526|FG000|Overall Study|Progressive Disease|1|||
25142116|NCT01769391|50255527|FG001|Overall Study|Progressive Disease|2|||
25142117|NCT01769391|50255526|FG000|Overall Study|Withdrawal by Subject|4|||
25142118|NCT01769391|50255527|FG001|Overall Study|Withdrawal by Subject|3|||
25142119|NCT01769391|50255526|FG000|Overall Study|Investigator Decision|2|||
25142120|NCT01769391|50255527|FG001|Overall Study|Investigator Decision|0|||
25142121|NCT01800903|50255539|FG000|Second Test Period|unable to catheterise|1|||
25142122|NCT01800903|50255540|FG001|Second Test Period|unable to catheterise|0|||
25142123|NCT01800903|50255541|FG002|Second Test Period|unable to catheterise|0|||
25142124|NCT01800903|50255542|FG003|Second Test Period|unable to catheterise|0|||
25142125|NCT01800903|50255543|FG004|Second Test Period|unable to catheterise|0|||
25142126|NCT01800903|50255544|FG005|Second Test Period|unable to catheterise|0|||
25142127|NCT01767987|50255552|FG000|Overall Study|Physician Decision|4|||
25142128|NCT01767987|50255553|FG001|Overall Study|Physician Decision|1|||
25142129|NCT01800201|50255561|FG000|Overall Study|Withdrawal by Subject|2|||
25142130|NCT01800201|50255562|FG001|Overall Study|Withdrawal by Subject|0|||
25142131|NCT01800201|50255561|FG000|Overall Study|patient privacy concerns|1|||
25142132|NCT01800201|50255562|FG001|Overall Study|patient privacy concerns|1|||
25142133|NCT01800201|50255561|FG000|Overall Study|did not want to use device|0|||
25142134|NCT01800201|50255562|FG001|Overall Study|did not want to use device|1|||
25142135|NCT01800201|50255561|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
25142136|NCT01800201|50255562|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
25142137|NCT01767909|50255571|FG000|Overall Study|Withdrawal by Subject|4|||
25142138|NCT01767909|50255572|FG001|Overall Study|Withdrawal by Subject|7|||
25142139|NCT01767909|50255571|FG000|Overall Study|Adverse Event|3|||
25142140|NCT01767909|50255572|FG001|Overall Study|Adverse Event|1|||
25142141|NCT01767909|50255571|FG000|Overall Study|Withdrawal by Study Partner|3|||
25142142|NCT01767909|50255572|FG001|Overall Study|Withdrawal by Study Partner|1|||
25142143|NCT01767909|50255571|FG000|Overall Study|Non-Compliance|2|||
25142144|NCT01767909|50255572|FG001|Overall Study|Non-Compliance|0|||
25142145|NCT01767909|50255571|FG000|Overall Study|Perceived Lack of Efficacy|1|||
25142146|NCT01767909|50255572|FG001|Overall Study|Perceived Lack of Efficacy|0|||
25142147|NCT01767909|50255571|FG000|Overall Study|Investigator Recommendation|0|||
25142148|NCT01767909|50255572|FG001|Overall Study|Investigator Recommendation|1|||
25142149|NCT01767909|50255571|FG000|Overall Study|Lost to Follow-up|0|||
25142150|NCT01767909|50255572|FG001|Overall Study|Lost to Follow-up|1|||
25142151|NCT01767909|50255571|FG000|Overall Study|LP uncessessful|0|||
25142152|NCT01767909|50255572|FG001|Overall Study|LP uncessessful|1|||
25142153|NCT02029274|50255584|FG000|Overall Study|Adverse Event|1|||
25142154|NCT02029274|50255585|FG001|Overall Study|Adverse Event|0|||
25142155|NCT02029274|50255586|FG002|Overall Study|Adverse Event|2|||
25142156|NCT02029274|50255587|FG003|Overall Study|Adverse Event|2|||
25142157|NCT02008370|50255601|FG000|Overall Study|Lost to Follow-up|7|||
25142158|NCT01981616|50255607|FG000|Overall Study|Adverse Event|0|||
25142159|NCT01981616|50255608|FG001|Overall Study|Adverse Event|1|||
25142160|NCT01981616|50255607|FG000|Overall Study|Protocol Violation|1|||
25142161|NCT01981616|50255608|FG001|Overall Study|Protocol Violation|0|||
25142162|NCT02104817|50255616|FG000|Overall Study|Death|363|||
25142163|NCT02104817|50255617|FG001|Overall Study|Death|330|||
25142164|NCT02104817|50255616|FG000|Overall Study|Lost to Follow-up|3|||
25142165|NCT02104817|50255617|FG001|Overall Study|Lost to Follow-up|2|||
25142166|NCT02104817|50255616|FG000|Overall Study|Protocol Violation|0|||
25142167|NCT02104817|50255617|FG001|Overall Study|Protocol Violation|1|||
25142168|NCT02104817|50255616|FG000|Overall Study|Study terminated by sponsor|5854|||
25142169|NCT02104817|50255617|FG001|Overall Study|Study terminated by sponsor|5901|||
25142170|NCT02104817|50255616|FG000|Overall Study|Withdrawal by Subject|111|||
25142171|NCT02104817|50255617|FG001|Overall Study|Withdrawal by Subject|78|||
25142172|NCT02104817|50255616|FG000|Overall Study|Other reasons|128|||
25142173|NCT02104817|50255617|FG001|Overall Study|Other reasons|135|||
25142174|NCT01962103|50255632|FG000|Phase 1|Adverse Event|4|||
25142175|NCT01962103|50255633|FG001|Phase 1|Adverse Event|0|||
25142176|NCT01962103|50255634|FG002|Phase 1|Adverse Event|2|||
25142177|NCT01962103|50255635|FG003|Phase 1|Adverse Event|1|||
25142178|NCT01962103|50255636|FG004|Phase 1|Adverse Event|2|||
25142179|NCT01962103|50255637|FG005|Phase 1|Adverse Event|2|||
25142180|NCT01962103|50255638|FG006|Phase 1|Adverse Event|0|||
25142181|NCT01962103|50255639|FG007|Phase 1|Adverse Event|0|||
25142182|NCT01962103|50255640|FG008|Phase 1|Adverse Event|0|||
25142183|NCT01962103|50255632|FG000|Phase 1|Progressive Disease|8|||
25142184|NCT01962103|50255633|FG001|Phase 1|Progressive Disease|6|||
25142185|NCT01962103|50255634|FG002|Phase 1|Progressive Disease|8|||
25142186|NCT01962103|50255635|FG003|Phase 1|Progressive Disease|4|||
25142187|NCT01962103|50255636|FG004|Phase 1|Progressive Disease|5|||
25142188|NCT01962103|50255637|FG005|Phase 1|Progressive Disease|4|||
25142189|NCT01962103|50255638|FG006|Phase 1|Progressive Disease|0|||
25142190|NCT01962103|50255639|FG007|Phase 1|Progressive Disease|0|||
25142191|NCT01962103|50255640|FG008|Phase 1|Progressive Disease|0|||
25142192|NCT01962103|50255632|FG000|Phase 1|Withdrawal by Subject|0|||
25142193|NCT01962103|50255633|FG001|Phase 1|Withdrawal by Subject|0|||
25142194|NCT01962103|50255634|FG002|Phase 1|Withdrawal by Subject|0|||
25142195|NCT01962103|50255635|FG003|Phase 1|Withdrawal by Subject|2|||
25142196|NCT01962103|50255636|FG004|Phase 1|Withdrawal by Subject|0|||
25142197|NCT01962103|50255637|FG005|Phase 1|Withdrawal by Subject|0|||
25142198|NCT01962103|50255638|FG006|Phase 1|Withdrawal by Subject|0|||
25142199|NCT01962103|50255639|FG007|Phase 1|Withdrawal by Subject|0|||
25142200|NCT01962103|50255640|FG008|Phase 1|Withdrawal by Subject|0|||
25142201|NCT01962103|50255632|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
25142202|NCT01962103|50255633|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
25142203|NCT01962103|50255634|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
25142204|NCT01962103|50255635|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
25142205|NCT01962103|50255636|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
25142206|NCT01962103|50255637|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
25142207|NCT01962103|50255638|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
25142208|NCT01962103|50255639|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
25142209|NCT01962103|50255640|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
25142210|NCT01962103|50255632|FG000|Phase 1|Physician Decision|0|||
25142211|NCT01962103|50255633|FG001|Phase 1|Physician Decision|0|||
25142212|NCT01962103|50255634|FG002|Phase 1|Physician Decision|0|||
25142213|NCT01962103|50255635|FG003|Phase 1|Physician Decision|1|||
25142214|NCT01962103|50255636|FG004|Phase 1|Physician Decision|0|||
25142215|NCT01962103|50255637|FG005|Phase 1|Physician Decision|0|||
25142216|NCT01962103|50255638|FG006|Phase 1|Physician Decision|0|||
25142217|NCT01962103|50255639|FG007|Phase 1|Physician Decision|0|||
25142218|NCT01962103|50255640|FG008|Phase 1|Physician Decision|0|||
25142219|NCT01962103|50255632|FG000|Phase 1|Symptomatic Deterioration|3|||
25142220|NCT01962103|50255633|FG001|Phase 1|Symptomatic Deterioration|2|||
25142221|NCT01962103|50255634|FG002|Phase 1|Symptomatic Deterioration|2|||
25142222|NCT01962103|50255635|FG003|Phase 1|Symptomatic Deterioration|2|||
25142223|NCT01962103|50255636|FG004|Phase 1|Symptomatic Deterioration|1|||
25142224|NCT01962103|50255637|FG005|Phase 1|Symptomatic Deterioration|1|||
25142225|NCT01962103|50255638|FG006|Phase 1|Symptomatic Deterioration|0|||
25142226|NCT01962103|50255639|FG007|Phase 1|Symptomatic Deterioration|0|||
25142227|NCT01962103|50255640|FG008|Phase 1|Symptomatic Deterioration|0|||
25142228|NCT01962103|50255632|FG000|Phase 1|Miscellaneous|1|||
25142229|NCT01962103|50255633|FG001|Phase 1|Miscellaneous|0|||
25142230|NCT01962103|50255634|FG002|Phase 1|Miscellaneous|0|||
25142231|NCT01962103|50255635|FG003|Phase 1|Miscellaneous|0|||
25142232|NCT01962103|50255636|FG004|Phase 1|Miscellaneous|0|||
25142233|NCT01962103|50255637|FG005|Phase 1|Miscellaneous|0|||
25142234|NCT01962103|50255638|FG006|Phase 1|Miscellaneous|0|||
25142235|NCT01962103|50255639|FG007|Phase 1|Miscellaneous|0|||
25142236|NCT01962103|50255640|FG008|Phase 1|Miscellaneous|0|||
25142237|NCT01962103|50255632|FG000|Phase 2|Adverse Event|0|||
25142238|NCT01962103|50255633|FG001|Phase 2|Adverse Event|0|||
25142239|NCT01962103|50255634|FG002|Phase 2|Adverse Event|0|||
25142240|NCT01962103|50255635|FG003|Phase 2|Adverse Event|0|||
25179196|NCT01467713|50324505|FG000|Overall Study|Major Protocol Deviation|2|||
25142241|NCT01962103|50255636|FG004|Phase 2|Adverse Event|0|||
25142242|NCT01962103|50255637|FG005|Phase 2|Adverse Event|0|||
25179197|NCT01467713|50324506|FG001|Overall Study|Major Protocol Deviation|4|||
25142243|NCT01962103|50255638|FG006|Phase 2|Adverse Event|1|||
25142244|NCT01962103|50255639|FG007|Phase 2|Adverse Event|0|||
25142245|NCT01962103|50255640|FG008|Phase 2|Adverse Event|3|||
25142246|NCT01962103|50255632|FG000|Phase 2|Progressive Disease|0|||
25015654|NCT04098367|50110409|FG000|Overall Study|Sick . Could not attend visit|1|||
25015655|NCT04098367|50110410|FG001|Overall Study|Sick . Could not attend visit|0|||
25015656|NCT04098367|50110411|FG002|Overall Study|Sick . Could not attend visit|0|||
25015657|NCT03759587|50110426|FG000|Overall Study|Ongoing|19|||
25142247|NCT01962103|50255633|FG001|Phase 2|Progressive Disease|0|||
25142248|NCT01962103|50255634|FG002|Phase 2|Progressive Disease|0|||
25142249|NCT01962103|50255635|FG003|Phase 2|Progressive Disease|0|||
25142250|NCT01962103|50255636|FG004|Phase 2|Progressive Disease|0|||
25142251|NCT01962103|50255637|FG005|Phase 2|Progressive Disease|0|||
25142252|NCT01962103|50255638|FG006|Phase 2|Progressive Disease|11|||
25142253|NCT01962103|50255639|FG007|Phase 2|Progressive Disease|12|||
25142254|NCT01962103|50255640|FG008|Phase 2|Progressive Disease|11|||
25142255|NCT01962103|50255632|FG000|Phase 2|Symptomatic Deterioration|0|||
25142256|NCT01962103|50255633|FG001|Phase 2|Symptomatic Deterioration|0|||
25142257|NCT01962103|50255634|FG002|Phase 2|Symptomatic Deterioration|0|||
25142258|NCT01962103|50255635|FG003|Phase 2|Symptomatic Deterioration|0|||
25142259|NCT01962103|50255636|FG004|Phase 2|Symptomatic Deterioration|0|||
25142260|NCT01962103|50255637|FG005|Phase 2|Symptomatic Deterioration|0|||
25142261|NCT01962103|50255638|FG006|Phase 2|Symptomatic Deterioration|2|||
25142262|NCT01962103|50255639|FG007|Phase 2|Symptomatic Deterioration|2|||
25142263|NCT01962103|50255640|FG008|Phase 2|Symptomatic Deterioration|0|||
25142264|NCT01961323|50255660|FG000|Overall Study|Withdrawal by Subject|7|||
25142265|NCT01961323|50255660|FG000|Overall Study|Lost to Follow-up|8|||
25142266|NCT01961323|50255660|FG000|Overall Study|screen failure|34|||
25142267|NCT01960855|50255669|FG000|Overall Study|Subject noncompliant|1|||
25142268|NCT01960855|50255670|FG001|Overall Study|Subject noncompliant|0|||
25142269|NCT01960855|50255671|FG002|Overall Study|Subject noncompliant|0|||
25142270|NCT01960855|50255672|FG003|Overall Study|Subject noncompliant|0|||
25142271|NCT01960855|50255673|FG004|Overall Study|Subject noncompliant|0|||
25142272|NCT01960855|50255669|FG000|Overall Study|Adverse Event|2|||
25142273|NCT01960855|50255670|FG001|Overall Study|Adverse Event|0|||
25142274|NCT01960855|50255671|FG002|Overall Study|Adverse Event|6|||
25142275|NCT01960855|50255672|FG003|Overall Study|Adverse Event|2|||
25142276|NCT01960855|50255673|FG004|Overall Study|Adverse Event|2|||
25142277|NCT01960855|50255669|FG000|Overall Study|Lack of Efficacy|1|||
25142278|NCT01960855|50255670|FG001|Overall Study|Lack of Efficacy|1|||
25142279|NCT01960855|50255671|FG002|Overall Study|Lack of Efficacy|0|||
25142280|NCT01960855|50255672|FG003|Overall Study|Lack of Efficacy|0|||
25142281|NCT01960855|50255673|FG004|Overall Study|Lack of Efficacy|0|||
25142282|NCT01960855|50255669|FG000|Overall Study|Other|2|||
25142283|NCT01960855|50255670|FG001|Overall Study|Other|1|||
25142284|NCT01960855|50255671|FG002|Overall Study|Other|1|||
25142285|NCT01960855|50255672|FG003|Overall Study|Other|1|||
25142286|NCT01960855|50255673|FG004|Overall Study|Other|0|||
25142287|NCT01960855|50255669|FG000|Overall Study|Consent withdrawn by subject|3|||
25142288|NCT01960855|50255670|FG001|Overall Study|Consent withdrawn by subject|1|||
25142289|NCT01960855|50255671|FG002|Overall Study|Consent withdrawn by subject|2|||
25142290|NCT01960855|50255672|FG003|Overall Study|Consent withdrawn by subject|1|||
25142291|NCT01960855|50255673|FG004|Overall Study|Consent withdrawn by subject|1|||
25142292|NCT01960855|50255669|FG000|Overall Study|Lost to Follow-up|2|||
25142293|NCT01960855|50255670|FG001|Overall Study|Lost to Follow-up|1|||
25142294|NCT01960855|50255671|FG002|Overall Study|Lost to Follow-up|0|||
25142295|NCT01960855|50255672|FG003|Overall Study|Lost to Follow-up|0|||
25142296|NCT01960855|50255673|FG004|Overall Study|Lost to Follow-up|2|||
25142297|NCT02007434|50255693|FG000|Overall Study|Lost to Follow-up|0|||
25142298|NCT02007434|50255694|FG001|Overall Study|Lost to Follow-up|1|||
25142299|NCT02007434|50255695|FG002|Overall Study|Lost to Follow-up|0|||
25142300|NCT02007434|50255696|FG003|Overall Study|Lost to Follow-up|0|||
25142301|NCT02007434|50255697|FG004|Overall Study|Lost to Follow-up|0|||
25142302|NCT02007434|50255698|FG005|Overall Study|Lost to Follow-up|0|||
25015658|NCT04091659|50110432|FG000|Overall Study|Protocol Violation|3|||
25142303|NCT02007434|50255699|FG006|Overall Study|Lost to Follow-up|0|||
25142304|NCT02007434|50255700|FG007|Overall Study|Lost to Follow-up|0|||
25142305|NCT02007434|50255693|FG000|Overall Study|Non-compliance|1|||
25142306|NCT02007434|50255694|FG001|Overall Study|Non-compliance|0|||
25142307|NCT02007434|50255695|FG002|Overall Study|Non-compliance|1|||
25142308|NCT02007434|50255696|FG003|Overall Study|Non-compliance|0|||
25142309|NCT02007434|50255697|FG004|Overall Study|Non-compliance|0|||
25142310|NCT02007434|50255698|FG005|Overall Study|Non-compliance|0|||
25142311|NCT02007434|50255699|FG006|Overall Study|Non-compliance|0|||
25142312|NCT02007434|50255700|FG007|Overall Study|Non-compliance|0|||
25142313|NCT01987453|50255722|FG000|Overall Study|Death|0|||
25142314|NCT01987453|50255723|FG001|Overall Study|Death|0|||
25142315|NCT01987453|50255724|FG002|Overall Study|Death|1|||
25142316|NCT01987453|50255722|FG000|Overall Study|Lack of Efficacy|1|||
25142317|NCT01987453|50255723|FG001|Overall Study|Lack of Efficacy|12|||
25142318|NCT01987453|50255724|FG002|Overall Study|Lack of Efficacy|0|||
25142319|NCT02006641|50255739|FG000|Overall Study|Withdrawal before treatment|2|||
25142320|NCT02006641|50255740|FG001|Overall Study|Withdrawal before treatment|5|||
25142321|NCT02006641|50255741|FG002|Overall Study|Withdrawal before treatment|3|||
25142322|NCT02006641|50255739|FG000|Overall Study|Adverse Event|15|||
25142323|NCT02006641|50255740|FG001|Overall Study|Adverse Event|11|||
25142324|NCT02006641|50255741|FG002|Overall Study|Adverse Event|15|||
25142325|NCT02006641|50255739|FG000|Overall Study|Protocol Violation|0|||
25142326|NCT02006641|50255740|FG001|Overall Study|Protocol Violation|2|||
25142327|NCT02006641|50255741|FG002|Overall Study|Protocol Violation|2|||
25142328|NCT02006641|50255739|FG000|Overall Study|Lost to Follow-up|0|||
25142329|NCT02006641|50255740|FG001|Overall Study|Lost to Follow-up|1|||
25142330|NCT02006641|50255741|FG002|Overall Study|Lost to Follow-up|0|||
25142331|NCT02006641|50255739|FG000|Overall Study|Withdrawal by Subject|7|||
25142332|NCT02006641|50255740|FG001|Overall Study|Withdrawal by Subject|12|||
25142333|NCT02006641|50255741|FG002|Overall Study|Withdrawal by Subject|11|||
25142334|NCT02006641|50255739|FG000|Overall Study|Other reason: patient didn't show up|1|||
25142335|NCT02006641|50255740|FG001|Overall Study|Other reason: patient didn't show up|0|||
25142336|NCT02006641|50255741|FG002|Overall Study|Other reason: patient didn't show up|0|||
25142337|NCT02006641|50255739|FG000|Overall Study|Other reason:patient didn't want to come|0|||
25142338|NCT02006641|50255740|FG001|Overall Study|Other reason:patient didn't want to come|0|||
25142339|NCT02006641|50255741|FG002|Overall Study|Other reason:patient didn't want to come|1|||
25142340|NCT02006641|50255739|FG000|Overall Study|Other reason: patient has moved|1|||
25142341|NCT02006641|50255740|FG001|Overall Study|Other reason: patient has moved|0|||
25142342|NCT02006641|50255741|FG002|Overall Study|Other reason: patient has moved|1|||
25142343|NCT02006641|50255739|FG000|Overall Study|Other reason: caregiver in hospital|0|||
25142344|NCT02006641|50255740|FG001|Overall Study|Other reason: caregiver in hospital|1|||
25142345|NCT02006641|50255741|FG002|Overall Study|Other reason: caregiver in hospital|0|||
25142346|NCT02006641|50255739|FG000|Overall Study|Other reason: patient's wife has died|0|||
25142347|NCT02006641|50255740|FG001|Overall Study|Other reason: patient's wife has died|0|||
25142348|NCT02006641|50255741|FG002|Overall Study|Other reason: patient's wife has died|1|||
25142349|NCT02006641|50255739|FG000|Overall Study|Other reason: hospitalisation|0|||
25142350|NCT02006641|50255740|FG001|Overall Study|Other reason: hospitalisation|1|||
25142351|NCT02006641|50255741|FG002|Overall Study|Other reason: hospitalisation|0|||
25142352|NCT02006641|50255739|FG000|Overall Study|Other reason: caregiver impossibility|0|||
25142353|NCT02006641|50255740|FG001|Overall Study|Other reason: caregiver impossibility|0|||
25142354|NCT02006641|50255741|FG002|Overall Study|Other reason: caregiver impossibility|1|||
25142355|NCT02006641|50255739|FG000|Overall Study|Other reason: protocol non-compliance|0|||
25142356|NCT02006641|50255740|FG001|Overall Study|Other reason: protocol non-compliance|0|||
25142357|NCT02006641|50255741|FG002|Overall Study|Other reason: protocol non-compliance|1|||
25142358|NCT01959919|50255749|FG000|Overall Study|Did not meet the eligibility criteria|2|||
25142359|NCT01986985|50255757|FG000|Overall Study|Withdrawal by Subject|4|||
25142360|NCT01986985|50255757|FG000|Overall Study|Scan not completed due to malfunction|3|||
25142361|NCT01986907|50255761|FG000|Overall Study|Adverse Event|11|||
25142362|NCT01986907|50255761|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
25142363|NCT01986907|50255761|FG000|Overall Study|Protocol Violation|4|||
25142364|NCT01986907|50255761|FG000|Overall Study|Withdrawal by Subject|76|||
25142365|NCT01986907|50255761|FG000|Overall Study|Lost to Follow-up|38|||
25142366|NCT01986907|50255761|FG000|Overall Study|Death|9|||
25142367|NCT01959841|50255771|FG000|Overall Study|Adverse Event|1|||
25142368|NCT01959841|50255772|FG001|Overall Study|Adverse Event|3|||
25142369|NCT01959841|50255773|FG002|Overall Study|Adverse Event|2|||
25142370|NCT01959841|50255771|FG000|Overall Study|Lack of Efficacy|5|||
25142371|NCT01959841|50255772|FG001|Overall Study|Lack of Efficacy|0|||
25142372|NCT01959841|50255773|FG002|Overall Study|Lack of Efficacy|0|||
25142373|NCT01959841|50255771|FG000|Overall Study|Lost to Follow-up|1|||
25142374|NCT01959841|50255772|FG001|Overall Study|Lost to Follow-up|1|||
25142375|NCT01959841|50255773|FG002|Overall Study|Lost to Follow-up|0|||
25142376|NCT01959841|50255771|FG000|Overall Study|Physician Decision|0|||
25142377|NCT01959841|50255772|FG001|Overall Study|Physician Decision|2|||
25142378|NCT01959841|50255773|FG002|Overall Study|Physician Decision|3|||
25142379|NCT01959841|50255771|FG000|Overall Study|Protocol Violation|16|||
25142380|NCT01959841|50255772|FG001|Overall Study|Protocol Violation|23|||
25142381|NCT01959841|50255773|FG002|Overall Study|Protocol Violation|16|||
25142382|NCT01959841|50255771|FG000|Overall Study|Withdrawal by Subject|7|||
25142383|NCT01959841|50255772|FG001|Overall Study|Withdrawal by Subject|7|||
25142384|NCT01959841|50255773|FG002|Overall Study|Withdrawal by Subject|5|||
25179198|NCT01467713|50324507|FG002|Overall Study|Major Protocol Deviation|4|||
25015659|NCT04091659|50110433|FG001|Overall Study|Protocol Violation|0|||
25142385|NCT01959841|50255771|FG000|Overall Study|Clinical laboratory value|2|||
25142386|NCT01959841|50255772|FG001|Overall Study|Clinical laboratory value|6|||
25142387|NCT01959841|50255773|FG002|Overall Study|Clinical laboratory value|6|||
25142388|NCT01959841|50255771|FG000|Overall Study|Platelet count below on day1 or 4|11|||
25142389|NCT01959841|50255772|FG001|Overall Study|Platelet count below on day1 or 4|15|||
25142390|NCT01959841|50255773|FG002|Overall Study|Platelet count below on day1 or 4|11|||
25142391|NCT02005627|50255783|FG000|Overall Study|Lost to Follow-up|1|||
25142392|NCT02005627|50255784|FG001|Overall Study|Lost to Follow-up|2|||
25142393|NCT02005627|50255783|FG000|Overall Study|Withdrawal by Subject|1|||
25142394|NCT02005627|50255784|FG001|Overall Study|Withdrawal by Subject|2|||
25142395|NCT02104583|50255796|FG000|Overall Study|New ICD or CRT-D implanted|2|||
25142396|NCT02104583|50255797|FG001|Overall Study|New ICD or CRT-D implanted|0|||
25142397|NCT02104583|50255798|FG002|Overall Study|New ICD or CRT-D implanted|1|||
25142398|NCT02104583|50255799|FG003|Overall Study|New ICD or CRT-D implanted|0|||
25142399|NCT02104583|50255800|FG004|Overall Study|New ICD or CRT-D implanted|0|||
25142400|NCT02104583|50255796|FG000|Overall Study|Death|2|||
25142401|NCT02104583|50255797|FG001|Overall Study|Death|1|||
25142402|NCT02104583|50255798|FG002|Overall Study|Death|3|||
25142403|NCT02104583|50255799|FG003|Overall Study|Death|3|||
25142404|NCT02104583|50255800|FG004|Overall Study|Death|5|||
25142405|NCT02104583|50255796|FG000|Overall Study|Subject required cardiac ablation|6|||
25142406|NCT02104583|50255797|FG001|Overall Study|Subject required cardiac ablation|4|||
25142407|NCT02104583|50255798|FG002|Overall Study|Subject required cardiac ablation|4|||
25142408|NCT02104583|50255799|FG003|Overall Study|Subject required cardiac ablation|5|||
25142409|NCT02104583|50255800|FG004|Overall Study|Subject required cardiac ablation|4|||
25142410|NCT02104583|50255796|FG000|Overall Study|Subject required prohibited medication|0|||
25142411|NCT02104583|50255797|FG001|Overall Study|Subject required prohibited medication|1|||
25142412|NCT02104583|50255798|FG002|Overall Study|Subject required prohibited medication|1|||
25142413|NCT02104583|50255799|FG003|Overall Study|Subject required prohibited medication|0|||
25142414|NCT02104583|50255800|FG004|Overall Study|Subject required prohibited medication|1|||
25142415|NCT02104583|50255796|FG000|Overall Study|Withdrew Consent|3|||
25142416|NCT02104583|50255797|FG001|Overall Study|Withdrew Consent|2|||
25142417|NCT02104583|50255798|FG002|Overall Study|Withdrew Consent|0|||
25142418|NCT02104583|50255799|FG003|Overall Study|Withdrew Consent|2|||
25142419|NCT02104583|50255800|FG004|Overall Study|Withdrew Consent|1|||
25142420|NCT02104583|50255796|FG000|Overall Study|Investigator's Discretion|1|||
25142421|NCT02104583|50255797|FG001|Overall Study|Investigator's Discretion|0|||
25142422|NCT02104583|50255798|FG002|Overall Study|Investigator's Discretion|0|||
25142423|NCT02104583|50255799|FG003|Overall Study|Investigator's Discretion|0|||
25142424|NCT02104583|50255800|FG004|Overall Study|Investigator's Discretion|0|||
25142425|NCT02104583|50255796|FG000|Overall Study|Protocol Violation|0|||
25142426|NCT02104583|50255797|FG001|Overall Study|Protocol Violation|0|||
25142427|NCT02104583|50255798|FG002|Overall Study|Protocol Violation|1|||
25142428|NCT02104583|50255799|FG003|Overall Study|Protocol Violation|0|||
25142429|NCT02104583|50255800|FG004|Overall Study|Protocol Violation|0|||
25142430|NCT02104583|50255796|FG000|Overall Study|Adverse Event|3|||
25142431|NCT02104583|50255797|FG001|Overall Study|Adverse Event|3|||
25142432|NCT02104583|50255798|FG002|Overall Study|Adverse Event|6|||
25142433|NCT02104583|50255799|FG003|Overall Study|Adverse Event|6|||
25142434|NCT02104583|50255800|FG004|Overall Study|Adverse Event|1|||
25142435|NCT02104583|50255796|FG000|Overall Study|Lost to Follow-up|1|||
25142436|NCT02104583|50255797|FG001|Overall Study|Lost to Follow-up|0|||
25142437|NCT02104583|50255798|FG002|Overall Study|Lost to Follow-up|0|||
25142438|NCT02104583|50255799|FG003|Overall Study|Lost to Follow-up|0|||
25142439|NCT02104583|50255800|FG004|Overall Study|Lost to Follow-up|0|||
25142440|NCT02104583|50255796|FG000|Overall Study|Randomized but Never Treated|0|||
25142441|NCT02104583|50255797|FG001|Overall Study|Randomized but Never Treated|0|||
25142442|NCT02104583|50255798|FG002|Overall Study|Randomized but Never Treated|0|||
25142443|NCT02104583|50255799|FG003|Overall Study|Randomized but Never Treated|1|||
25142444|NCT02104583|50255800|FG004|Overall Study|Randomized but Never Treated|0|||
25142445|NCT02074553|50255823|FG000|Intervention Period 1|Family Emergency|0|||
25142446|NCT02074553|50255824|FG001|Intervention Period 1|Family Emergency|0|||
25142447|NCT02074553|50255825|FG002|Intervention Period 1|Family Emergency|0|||
25142448|NCT02074553|50255826|FG003|Intervention Period 1|Family Emergency|1|||
25142449|NCT02074553|50255827|FG004|Intervention Period 1|Family Emergency|0|||
25142450|NCT02074553|50255828|FG005|Intervention Period 1|Family Emergency|0|||
25142451|NCT02074553|50255829|FG006|Intervention Period 1|Family Emergency|0|||
25142452|NCT02074553|50255830|FG007|Intervention Period 1|Family Emergency|0|||
25142453|NCT02074553|50255823|FG000|Washout Period 1|Adverse Event|1|||
25142454|NCT02074553|50255824|FG001|Washout Period 1|Adverse Event|0|||
25142455|NCT02074553|50255825|FG002|Washout Period 1|Adverse Event|0|||
25142456|NCT02074553|50255826|FG003|Washout Period 1|Adverse Event|0|||
25142457|NCT02074553|50255827|FG004|Washout Period 1|Adverse Event|0|||
25142458|NCT02074553|50255828|FG005|Washout Period 1|Adverse Event|0|||
25142459|NCT02074553|50255829|FG006|Washout Period 1|Adverse Event|0|||
25142460|NCT02074553|50255830|FG007|Washout Period 1|Adverse Event|0|||
25142461|NCT02074553|50255823|FG000|Washout Period 1|Physician Decision|0|||
25142462|NCT02074553|50255824|FG001|Washout Period 1|Physician Decision|0|||
25142463|NCT02074553|50255825|FG002|Washout Period 1|Physician Decision|0|||
25142464|NCT02074553|50255826|FG003|Washout Period 1|Physician Decision|1|||
25142465|NCT02074553|50255827|FG004|Washout Period 1|Physician Decision|0|||
25142466|NCT02074553|50255828|FG005|Washout Period 1|Physician Decision|0|||
25142467|NCT02074553|50255829|FG006|Washout Period 1|Physician Decision|0|||
25142468|NCT02074553|50255830|FG007|Washout Period 1|Physician Decision|0|||
25142469|NCT02074553|50255823|FG000|Washout Period 1|Other|0|||
25142470|NCT02074553|50255824|FG001|Washout Period 1|Other|0|||
25142471|NCT02074553|50255825|FG002|Washout Period 1|Other|0|||
25142472|NCT02074553|50255826|FG003|Washout Period 1|Other|0|||
25142473|NCT02074553|50255827|FG004|Washout Period 1|Other|0|||
25142474|NCT02074553|50255828|FG005|Washout Period 1|Other|1|||
25142475|NCT02074553|50255829|FG006|Washout Period 1|Other|0|||
25142476|NCT02074553|50255830|FG007|Washout Period 1|Other|0|||
25142477|NCT02074553|50255823|FG000|Washout Period 2|Adverse Event|0|||
25142478|NCT02074553|50255824|FG001|Washout Period 2|Adverse Event|0|||
25142479|NCT02074553|50255825|FG002|Washout Period 2|Adverse Event|0|||
25142480|NCT02074553|50255826|FG003|Washout Period 2|Adverse Event|0|||
25142481|NCT02074553|50255827|FG004|Washout Period 2|Adverse Event|0|||
25142482|NCT02074553|50255828|FG005|Washout Period 2|Adverse Event|0|||
25142483|NCT02074553|50255829|FG006|Washout Period 2|Adverse Event|1|||
25142484|NCT02074553|50255830|FG007|Washout Period 2|Adverse Event|0|||
25142485|NCT02074553|50255823|FG000|Washout Period 2|Physician Decision|0|||
25142486|NCT02074553|50255824|FG001|Washout Period 2|Physician Decision|0|||
25142487|NCT02074553|50255825|FG002|Washout Period 2|Physician Decision|0|||
25142488|NCT02074553|50255826|FG003|Washout Period 2|Physician Decision|0|||
25142489|NCT02074553|50255827|FG004|Washout Period 2|Physician Decision|0|||
25142490|NCT02074553|50255828|FG005|Washout Period 2|Physician Decision|1|||
25142491|NCT02074553|50255829|FG006|Washout Period 2|Physician Decision|0|||
25142492|NCT02074553|50255830|FG007|Washout Period 2|Physician Decision|0|||
25142493|NCT02074553|50255823|FG000|Washout Period 2|Lost to Follow-up|0|||
25142494|NCT02074553|50255824|FG001|Washout Period 2|Lost to Follow-up|0|||
25142495|NCT02074553|50255825|FG002|Washout Period 2|Lost to Follow-up|1|||
25142496|NCT02074553|50255826|FG003|Washout Period 2|Lost to Follow-up|0|||
25179199|NCT01467713|50324508|FG003|Overall Study|Major Protocol Deviation|1|||
25142497|NCT02074553|50255827|FG004|Washout Period 2|Lost to Follow-up|0|||
25142498|NCT02074553|50255828|FG005|Washout Period 2|Lost to Follow-up|0|||
25142499|NCT02074553|50255829|FG006|Washout Period 2|Lost to Follow-up|0|||
25142500|NCT02074553|50255830|FG007|Washout Period 2|Lost to Follow-up|0|||
25142501|NCT02074553|50255823|FG000|Washout Period 3|Physician Decision|0|||
25142502|NCT02074553|50255824|FG001|Washout Period 3|Physician Decision|0|||
25142503|NCT02074553|50255825|FG002|Washout Period 3|Physician Decision|0|||
25142504|NCT02074553|50255826|FG003|Washout Period 3|Physician Decision|0|||
25142505|NCT02074553|50255827|FG004|Washout Period 3|Physician Decision|0|||
25142506|NCT02074553|50255828|FG005|Washout Period 3|Physician Decision|0|||
25142507|NCT02074553|50255829|FG006|Washout Period 3|Physician Decision|0|||
25142508|NCT02074553|50255830|FG007|Washout Period 3|Physician Decision|1|||
25142509|NCT02073929|50255850|FG000|Overall Study|Lost to Follow-up|2|||
25142510|NCT02073929|50255851|FG001|Overall Study|Lost to Follow-up|1|||
25142511|NCT02073929|50255850|FG000|Overall Study|Adverse Event|2|||
25142512|NCT02073929|50255851|FG001|Overall Study|Adverse Event|1|||
25142513|NCT02073929|50255850|FG000|Overall Study|Withdrawal by Subject|0|||
25142514|NCT02073929|50255851|FG001|Overall Study|Withdrawal by Subject|1|||
25142515|NCT02113007|50255857|FG000|Overall Study|Progressive disease|2|||
25142516|NCT02005471|50255863|FG000|Overall Study|Ongoing in Study|144|||
25142517|NCT02005471|50255864|FG001|Overall Study|Ongoing in Study|171|||
25142518|NCT02005471|50255863|FG000|Overall Study|Adverse Event|1|||
25142519|NCT02005471|50255864|FG001|Overall Study|Adverse Event|0|||
25142520|NCT02005471|50255863|FG000|Overall Study|Death|26|||
25142521|NCT02005471|50255864|FG001|Overall Study|Death|15|||
25142522|NCT02005471|50255863|FG000|Overall Study|Lost to Follow-up|1|||
25142523|NCT02005471|50255864|FG001|Overall Study|Lost to Follow-up|0|||
25142524|NCT02005471|50255863|FG000|Overall Study|Physician Decision|2|||
25142525|NCT02005471|50255864|FG001|Overall Study|Physician Decision|1|||
25142526|NCT02005471|50255863|FG000|Overall Study|Progressive Disease|3|||
25142527|NCT02005471|50255864|FG001|Overall Study|Progressive Disease|0|||
25142528|NCT02005471|50255863|FG000|Overall Study|Withdrawal by Subject|18|||
25142529|NCT02005471|50255864|FG001|Overall Study|Withdrawal by Subject|7|||
25142530|NCT02104505|50255875|FG000|First Intervention (14 Days)|Adverse Event|2|||
25142531|NCT02104505|50255876|FG001|First Intervention (14 Days)|Adverse Event|0|||
25142532|NCT02104505|50255875|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
25142533|NCT02104505|50255876|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
25142534|NCT02104505|50255875|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
25142535|NCT02104505|50255876|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
25142536|NCT02104505|50255875|FG000|First Intervention (14 Days)|exclusionary condition|0|||
25142537|NCT02104505|50255876|FG001|First Intervention (14 Days)|exclusionary condition|1|||
25142538|NCT02104505|50255875|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
25142539|NCT02104505|50255876|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
25142540|NCT02104505|50255875|FG000|Second Intervention (14 Days)|Adverse Event|2|||
25142541|NCT02104505|50255876|FG001|Second Intervention (14 Days)|Adverse Event|0|||
25142542|NCT02111993|50255885|FG000|Overall Study|Physician Decision|5|||
25142543|NCT02111993|50255886|FG001|Overall Study|Physician Decision|4|||
25142544|NCT01959607|50255896|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
25142545|NCT01959607|50255897|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
25142546|NCT01959607|50255898|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
25142547|NCT01959607|50255899|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
25142548|NCT02111603|50255908|FG000|Overall Study|Withdrawal by Subject|1|||
25142549|NCT02102399|50255914|FG000|Overall Study|Withdrawal by Subject|6|||
25142550|NCT02102399|50255915|FG001|Overall Study|Withdrawal by Subject|4|||
25142551|NCT02111369|50255926|FG000|Overall Study|Lost to Follow-up|2|||
25142552|NCT02111369|50255926|FG000|Overall Study|Withdrawal by Subject|1|||
25142553|NCT02111213|50255932|FG000|Overall Study|Withdrawal by Subject|3|||
25142554|NCT02111213|50255933|FG001|Overall Study|Withdrawal by Subject|2|||
25142555|NCT02111213|50255932|FG000|Overall Study|Lost to Follow-up|3|||
25142556|NCT02111213|50255933|FG001|Overall Study|Lost to Follow-up|4|||
25142557|NCT02110901|50255941|FG000|Overall Study|Death|6|||
25142558|NCT02110901|50255942|FG001|Overall Study|Death|3|||
25142559|NCT02110901|50255941|FG000|Overall Study|Lost to Follow-up|12|||
25142560|NCT02110901|50255942|FG001|Overall Study|Lost to Follow-up|8|||
25142561|NCT02110901|50255941|FG000|Overall Study|Withdrawal by Subject|7|||
25142562|NCT02110901|50255942|FG001|Overall Study|Withdrawal by Subject|3|||
25142563|NCT02110901|50255941|FG000|Overall Study|received a kidney transplant|5|||
25142564|NCT02110901|50255942|FG001|Overall Study|received a kidney transplant|0|||
25142565|NCT02070965|50255952|FG000|Overall Study|Lost to Follow-up|0|||
25142566|NCT02070965|50255953|FG001|Overall Study|Lost to Follow-up|1|||
25142567|NCT02070965|50255954|FG002|Overall Study|Lost to Follow-up|0|||
25142568|NCT02070965|50255952|FG000|Overall Study|Withdrawal by Subject|1|||
25142569|NCT02070965|50255953|FG001|Overall Study|Withdrawal by Subject|1|||
25142570|NCT02070965|50255954|FG002|Overall Study|Withdrawal by Subject|1|||
25142571|NCT02070965|50255952|FG000|Overall Study|Subject moved|1|||
25142572|NCT02070965|50255953|FG001|Overall Study|Subject moved|0|||
25142573|NCT02070965|50255954|FG002|Overall Study|Subject moved|0|||
25142574|NCT02109107|50255962|FG000|Overall Study|Lost to Follow-up|2|||
25142575|NCT02100839|50255968|FG000|Multiple Ascending Dose|Adverse Event|2|||
25142576|NCT02100839|50255969|FG001|Multiple Ascending Dose|Adverse Event|0|||
25142577|NCT02100839|50255968|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
25142578|NCT02100839|50255969|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
25142579|NCT02069093|50255975|FG000|Overall Study|Disease progression|14|||
25142580|NCT02069093|50255975|FG000|Overall Study|New cancer therapy|1|||
25142581|NCT02069093|50255975|FG000|Overall Study|Death|1|||
25142582|NCT02069093|50255975|FG000|Overall Study|Administrative problems|1|||
25142583|NCT02069093|50255975|FG000|Overall Study|Withdrawal by Subject|2|||
25142584|NCT02069093|50255975|FG000|Overall Study|Abnormal laboratory values|1|||
25142585|NCT02069093|50255975|FG000|Overall Study|Adverse Event|10|||
25142586|NCT02109029|50255982|FG000|Part B|Adverse Event|0|||
25142587|NCT02109029|50255983|FG001|Part B|Adverse Event|0|||
25142588|NCT02109029|50255984|FG002|Part B|Adverse Event|0|||
25142589|NCT02109029|50255985|FG003|Part B|Adverse Event|0|||
25142590|NCT02109029|50255986|FG004|Part B|Adverse Event|1|||
25142591|NCT02109029|50255987|FG005|Part B|Adverse Event|1|||
25142592|NCT02069015|50256000|FG000|Overall Study|Lost to Follow-up|39|||
25142593|NCT02069015|50256001|FG001|Overall Study|Lost to Follow-up|32|||
25142594|NCT02069015|50256000|FG000|Overall Study|Withdrawal by Subject|1|||
25142595|NCT02069015|50256001|FG001|Overall Study|Withdrawal by Subject|1|||
25142596|NCT01598129|50256008|FG000|Overall Study|Disease progression|6|||
25142597|NCT01598129|50256008|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
25142598|NCT01598129|50256008|FG000|Overall Study|Withdrawal by Subject|1|||
25142599|NCT02068547|50256015|FG000|Overall Study|Lost to Follow-up|3|||
25142600|NCT02068547|50256016|FG001|Overall Study|Lost to Follow-up|3|||
25142601|NCT02068547|50256015|FG000|Overall Study|Physician Decision|1|||
25142602|NCT02068547|50256016|FG001|Overall Study|Physician Decision|0|||
25142603|NCT02108951|50256022|FG000|Overall Study|Lost to Follow-up|1|||
25142604|NCT02108951|50256022|FG000|Overall Study|Patient's/guardian's decision|1|||
25142605|NCT02108951|50256022|FG000|Overall Study|Study Terminated by Sponsor|14|||
25142606|NCT02107859|50256026|FG000|Overall Study|Withdrawal by Subject|14|||
25142607|NCT02107859|50256026|FG000|Overall Study|Adverse Event|3|||
25142608|NCT02107859|50256026|FG000|Overall Study|Study closure|41|||
25142609|NCT02107859|50256026|FG000|Overall Study|Other than specified|3|||
25142610|NCT02007278|50256032|FG000|Overall Study|Failure to comply with an eligibility|0|||
25142611|NCT02007278|50256033|FG001|Overall Study|Failure to comply with an eligibility|1|||
25142612|NCT02007278|50256032|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
25142613|NCT02007278|50256033|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
25142614|NCT02007278|50256032|FG000|Overall Study|Incorrect medication administration|1|||
25142615|NCT02007278|50256033|FG001|Overall Study|Incorrect medication administration|0|||
25142616|NCT02007278|50256032|FG000|Overall Study|Mis-randomization|1|||
25142617|NCT02007278|50256033|FG001|Overall Study|Mis-randomization|1|||
25142618|NCT02107313|50256039|FG000|Overall Study|One participant did not do the FED cohor|0|||
25142619|NCT02107313|50256040|FG001|Overall Study|One participant did not do the FED cohor|1|||
25142620|NCT02028338|50256048|FG000|Overall Study|Withdrawal by Subject|3|||
25142621|NCT02028338|50256049|FG001|Overall Study|Withdrawal by Subject|1|||
25142622|NCT02028338|50256048|FG000|Overall Study|Unable to contact participant|1|||
25142623|NCT02028338|50256049|FG001|Overall Study|Unable to contact participant|0|||
25142624|NCT01625897|50256057|FG000|Overall Study|Adverse Event|27|||
25142625|NCT01625897|50256058|FG001|Overall Study|Adverse Event|10|||
25142626|NCT01625897|50256057|FG000|Overall Study|Physician Decision|0|||
25142627|NCT01625897|50256058|FG001|Overall Study|Physician Decision|1|||
25142628|NCT01625897|50256057|FG000|Overall Study|Withdrawal by Subject|25|||
25142629|NCT01625897|50256058|FG001|Overall Study|Withdrawal by Subject|3|||
25142630|NCT02106923|50256067|FG000|Overall Study|Protocol Violation|0|||
25142631|NCT02106923|50256068|FG001|Overall Study|Protocol Violation|0|||
25142632|NCT02106923|50256069|FG002|Overall Study|Protocol Violation|0|||
25142633|NCT02106923|50256070|FG003|Overall Study|Protocol Violation|0|||
25142634|NCT02106923|50256071|FG004|Overall Study|Protocol Violation|0|||
25142635|NCT02106923|50256072|FG005|Overall Study|Protocol Violation|1|||
25142636|NCT02006732|50256090|FG000|Overall Study|Adverse Event|10|||
25142637|NCT02006732|50256091|FG001|Overall Study|Adverse Event|7|||
25142638|NCT02006732|50256092|FG002|Overall Study|Adverse Event|4|||
25142639|NCT02006732|50256093|FG003|Overall Study|Adverse Event|2|||
25142640|NCT02006732|50256090|FG000|Overall Study|Lack of Efficacy|6|||
25142641|NCT02006732|50256091|FG001|Overall Study|Lack of Efficacy|3|||
25142642|NCT02006732|50256092|FG002|Overall Study|Lack of Efficacy|1|||
25142643|NCT02006732|50256093|FG003|Overall Study|Lack of Efficacy|1|||
25142644|NCT02006732|50256090|FG000|Overall Study|Protocol Violation|1|||
25142645|NCT02006732|50256091|FG001|Overall Study|Protocol Violation|1|||
25142646|NCT02006732|50256092|FG002|Overall Study|Protocol Violation|0|||
25142647|NCT02006732|50256093|FG003|Overall Study|Protocol Violation|0|||
25142648|NCT02006732|50256090|FG000|Overall Study|Lost to Follow-up|0|||
25142649|NCT02006732|50256091|FG001|Overall Study|Lost to Follow-up|1|||
25142650|NCT02006732|50256092|FG002|Overall Study|Lost to Follow-up|0|||
25142651|NCT02006732|50256093|FG003|Overall Study|Lost to Follow-up|0|||
25142652|NCT02006732|50256090|FG000|Overall Study|Withdrawal by Subject|3|||
25142653|NCT02006732|50256091|FG001|Overall Study|Withdrawal by Subject|0|||
25142654|NCT02006732|50256092|FG002|Overall Study|Withdrawal by Subject|4|||
25142655|NCT02006732|50256093|FG003|Overall Study|Withdrawal by Subject|1|||
25142656|NCT02098733|50256103|FG000|Overall Study|Data Not Available|5|||
25142657|NCT02098733|50256103|FG000|Overall Study|Lost to Follow-up|5|||
25142658|NCT02028182|50256107|FG000|Overall Study|Protocol Violation|2|||
25142659|NCT02098109|50256114|FG000|Overall Study|Protocol Violation|3|||
25142660|NCT02098109|50256115|FG001|Overall Study|Protocol Violation|0|||
25142661|NCT02097719|50256123|FG000|Overall Study|Subject Withdrew Consent|1|||
25142662|NCT02097719|50256124|FG001|Overall Study|Subject Withdrew Consent|0|||
25142663|NCT02097719|50256123|FG000|Overall Study|Lost to Follow-up|0|||
25142664|NCT02097719|50256124|FG001|Overall Study|Lost to Follow-up|1|||
25142665|NCT02097719|50256123|FG000|Overall Study|Adverse Event|2|||
25142666|NCT02097719|50256124|FG001|Overall Study|Adverse Event|0|||
25142667|NCT01449370|50256155|FG000|Overall Study|Disease Progression|5|||
25142668|NCT01449370|50256156|FG001|Overall Study|Disease Progression|4|||
25142669|NCT01449370|50256157|FG002|Overall Study|Disease Progression|8|||
25142670|NCT01449370|50256158|FG003|Overall Study|Disease Progression|3|||
25142671|NCT01449370|50256159|FG004|Overall Study|Disease Progression|3|||
25142672|NCT01449370|50256160|FG005|Overall Study|Disease Progression|3|||
25142673|NCT01449370|50256161|FG006|Overall Study|Disease Progression|3|||
25142674|NCT01449370|50256162|FG007|Overall Study|Disease Progression|2|||
25142675|NCT01449370|50256163|FG008|Overall Study|Disease Progression|9|||
25142676|NCT01449370|50256164|FG009|Overall Study|Disease Progression|1|||
25142677|NCT01449370|50256165|FG010|Overall Study|Disease Progression|3|||
25142678|NCT01449370|50256166|FG011|Overall Study|Disease Progression|3|||
25142679|NCT01449370|50256167|FG012|Overall Study|Disease Progression|2|||
25142680|NCT01449370|50256168|FG013|Overall Study|Disease Progression|8|||
25142681|NCT01449370|50256169|FG014|Overall Study|Disease Progression|3|||
25142682|NCT01449370|50256170|FG015|Overall Study|Disease Progression|1|||
25142683|NCT01449370|50256171|FG016|Overall Study|Disease Progression|4|||
25142684|NCT01449370|50256172|FG017|Overall Study|Disease Progression|3|||
25142685|NCT01449370|50256173|FG018|Overall Study|Disease Progression|1|||
25142686|NCT01449370|50256174|FG019|Overall Study|Disease Progression|2|||
25142687|NCT01449370|50256175|FG020|Overall Study|Disease Progression|5|||
25142688|NCT01449370|50256176|FG021|Overall Study|Disease Progression|2|||
25142689|NCT01449370|50256177|FG022|Overall Study|Disease Progression|3|||
25142690|NCT01449370|50256178|FG023|Overall Study|Disease Progression|7|||
25142691|NCT01449370|50256179|FG024|Overall Study|Disease Progression|3|||
25142692|NCT01449370|50256155|FG000|Overall Study|Adverse Event|1|||
25142693|NCT01449370|50256156|FG001|Overall Study|Adverse Event|2|||
25142694|NCT01449370|50256157|FG002|Overall Study|Adverse Event|0|||
25142695|NCT01449370|50256158|FG003|Overall Study|Adverse Event|1|||
25142696|NCT01449370|50256159|FG004|Overall Study|Adverse Event|0|||
25142697|NCT01449370|50256160|FG005|Overall Study|Adverse Event|0|||
25142698|NCT01449370|50256161|FG006|Overall Study|Adverse Event|0|||
25142699|NCT01449370|50256162|FG007|Overall Study|Adverse Event|0|||
25142700|NCT01449370|50256163|FG008|Overall Study|Adverse Event|1|||
25142701|NCT01449370|50256164|FG009|Overall Study|Adverse Event|1|||
25142702|NCT01449370|50256165|FG010|Overall Study|Adverse Event|0|||
25142703|NCT01449370|50256166|FG011|Overall Study|Adverse Event|0|||
25142704|NCT01449370|50256167|FG012|Overall Study|Adverse Event|0|||
25142705|NCT01449370|50256168|FG013|Overall Study|Adverse Event|2|||
25142706|NCT01449370|50256169|FG014|Overall Study|Adverse Event|0|||
25142707|NCT01449370|50256170|FG015|Overall Study|Adverse Event|1|||
25142708|NCT01449370|50256171|FG016|Overall Study|Adverse Event|0|||
25142709|NCT01449370|50256172|FG017|Overall Study|Adverse Event|0|||
25142710|NCT01449370|50256173|FG018|Overall Study|Adverse Event|1|||
25142711|NCT01449370|50256174|FG019|Overall Study|Adverse Event|1|||
25142712|NCT01449370|50256175|FG020|Overall Study|Adverse Event|0|||
25142713|NCT01449370|50256176|FG021|Overall Study|Adverse Event|1|||
25142714|NCT01449370|50256177|FG022|Overall Study|Adverse Event|0|||
25142715|NCT01449370|50256178|FG023|Overall Study|Adverse Event|1|||
25142716|NCT01449370|50256179|FG024|Overall Study|Adverse Event|3|||
25142717|NCT01449370|50256155|FG000|Overall Study|Participant Decision|0|||
25142718|NCT01449370|50256156|FG001|Overall Study|Participant Decision|0|||
25142719|NCT01449370|50256157|FG002|Overall Study|Participant Decision|0|||
25142720|NCT01449370|50256158|FG003|Overall Study|Participant Decision|0|||
25142721|NCT01449370|50256159|FG004|Overall Study|Participant Decision|0|||
25142722|NCT01449370|50256160|FG005|Overall Study|Participant Decision|0|||
25142723|NCT01449370|50256161|FG006|Overall Study|Participant Decision|0|||
25142724|NCT01449370|50256162|FG007|Overall Study|Participant Decision|1|||
25142725|NCT01449370|50256163|FG008|Overall Study|Participant Decision|1|||
25142726|NCT01449370|50256164|FG009|Overall Study|Participant Decision|0|||
25142727|NCT01449370|50256165|FG010|Overall Study|Participant Decision|0|||
25142728|NCT01449370|50256166|FG011|Overall Study|Participant Decision|0|||
25142729|NCT01449370|50256167|FG012|Overall Study|Participant Decision|1|||
25142730|NCT01449370|50256168|FG013|Overall Study|Participant Decision|1|||
25142731|NCT01449370|50256169|FG014|Overall Study|Participant Decision|0|||
25142732|NCT01449370|50256170|FG015|Overall Study|Participant Decision|1|||
25142733|NCT01449370|50256171|FG016|Overall Study|Participant Decision|3|||
25142734|NCT01449370|50256172|FG017|Overall Study|Participant Decision|0|||
25142735|NCT01449370|50256173|FG018|Overall Study|Participant Decision|1|||
25142736|NCT01449370|50256174|FG019|Overall Study|Participant Decision|0|||
25142737|NCT01449370|50256175|FG020|Overall Study|Participant Decision|0|||
25142738|NCT01449370|50256176|FG021|Overall Study|Participant Decision|1|||
25142739|NCT01449370|50256177|FG022|Overall Study|Participant Decision|0|||
25142740|NCT01449370|50256178|FG023|Overall Study|Participant Decision|0|||
25142741|NCT01449370|50256179|FG024|Overall Study|Participant Decision|1|||
25142742|NCT01449370|50256155|FG000|Overall Study|Lost to Follow-up|0|||
25142743|NCT01449370|50256156|FG001|Overall Study|Lost to Follow-up|0|||
25142744|NCT01449370|50256157|FG002|Overall Study|Lost to Follow-up|0|||
25142745|NCT01449370|50256158|FG003|Overall Study|Lost to Follow-up|0|||
25142746|NCT01449370|50256159|FG004|Overall Study|Lost to Follow-up|0|||
25142747|NCT01449370|50256160|FG005|Overall Study|Lost to Follow-up|0|||
25142748|NCT01449370|50256161|FG006|Overall Study|Lost to Follow-up|0|||
25142749|NCT01449370|50256162|FG007|Overall Study|Lost to Follow-up|0|||
25142750|NCT01449370|50256163|FG008|Overall Study|Lost to Follow-up|0|||
25142751|NCT01449370|50256164|FG009|Overall Study|Lost to Follow-up|0|||
25142752|NCT01449370|50256165|FG010|Overall Study|Lost to Follow-up|0|||
25142753|NCT01449370|50256166|FG011|Overall Study|Lost to Follow-up|0|||
25142754|NCT01449370|50256167|FG012|Overall Study|Lost to Follow-up|0|||
25142755|NCT01449370|50256168|FG013|Overall Study|Lost to Follow-up|0|||
25142756|NCT01449370|50256169|FG014|Overall Study|Lost to Follow-up|0|||
25142757|NCT01449370|50256170|FG015|Overall Study|Lost to Follow-up|0|||
25142758|NCT01449370|50256171|FG016|Overall Study|Lost to Follow-up|0|||
25142759|NCT01449370|50256172|FG017|Overall Study|Lost to Follow-up|0|||
25142760|NCT01449370|50256173|FG018|Overall Study|Lost to Follow-up|0|||
25142761|NCT01449370|50256174|FG019|Overall Study|Lost to Follow-up|0|||
25142762|NCT01449370|50256175|FG020|Overall Study|Lost to Follow-up|1|||
25142763|NCT01449370|50256176|FG021|Overall Study|Lost to Follow-up|0|||
25142764|NCT01449370|50256177|FG022|Overall Study|Lost to Follow-up|0|||
25142765|NCT01449370|50256178|FG023|Overall Study|Lost to Follow-up|0|||
25142766|NCT01449370|50256179|FG024|Overall Study|Lost to Follow-up|0|||
25142767|NCT01449370|50256155|FG000|Overall Study|Other|0|||
25142768|NCT01449370|50256156|FG001|Overall Study|Other|0|||
25142769|NCT01449370|50256157|FG002|Overall Study|Other|0|||
25142770|NCT01449370|50256158|FG003|Overall Study|Other|0|||
25142771|NCT01449370|50256159|FG004|Overall Study|Other|0|||
25142772|NCT01449370|50256160|FG005|Overall Study|Other|0|||
25142773|NCT01449370|50256161|FG006|Overall Study|Other|0|||
25142774|NCT01449370|50256162|FG007|Overall Study|Other|0|||
25142775|NCT01449370|50256163|FG008|Overall Study|Other|1|||
25142776|NCT01449370|50256164|FG009|Overall Study|Other|1|||
25142777|NCT01449370|50256165|FG010|Overall Study|Other|0|||
25142778|NCT01449370|50256166|FG011|Overall Study|Other|0|||
25142779|NCT01449370|50256167|FG012|Overall Study|Other|0|||
25142780|NCT01449370|50256168|FG013|Overall Study|Other|0|||
25142781|NCT01449370|50256169|FG014|Overall Study|Other|0|||
25142782|NCT01449370|50256170|FG015|Overall Study|Other|0|||
25142783|NCT01449370|50256171|FG016|Overall Study|Other|0|||
25142784|NCT01449370|50256172|FG017|Overall Study|Other|0|||
25142785|NCT01449370|50256173|FG018|Overall Study|Other|0|||
25142786|NCT01449370|50256174|FG019|Overall Study|Other|0|||
25142787|NCT01449370|50256175|FG020|Overall Study|Other|0|||
25142788|NCT01449370|50256176|FG021|Overall Study|Other|0|||
25142789|NCT01449370|50256177|FG022|Overall Study|Other|1|||
25142790|NCT01449370|50256178|FG023|Overall Study|Other|1|||
25142791|NCT01449370|50256179|FG024|Overall Study|Other|0|||
25142792|NCT01449370|50256155|FG000|Overall Study|Medication Prohibited by Protocol|0|||
25142793|NCT01449370|50256156|FG001|Overall Study|Medication Prohibited by Protocol|0|||
25142794|NCT01449370|50256157|FG002|Overall Study|Medication Prohibited by Protocol|0|||
25142795|NCT01449370|50256158|FG003|Overall Study|Medication Prohibited by Protocol|0|||
25142796|NCT01449370|50256159|FG004|Overall Study|Medication Prohibited by Protocol|0|||
25142797|NCT01449370|50256160|FG005|Overall Study|Medication Prohibited by Protocol|0|||
25142798|NCT01449370|50256161|FG006|Overall Study|Medication Prohibited by Protocol|0|||
25142799|NCT01449370|50256162|FG007|Overall Study|Medication Prohibited by Protocol|0|||
25142800|NCT01449370|50256163|FG008|Overall Study|Medication Prohibited by Protocol|0|||
25142801|NCT01449370|50256164|FG009|Overall Study|Medication Prohibited by Protocol|0|||
25142802|NCT01449370|50256165|FG010|Overall Study|Medication Prohibited by Protocol|0|||
25142803|NCT01449370|50256166|FG011|Overall Study|Medication Prohibited by Protocol|0|||
25142804|NCT01449370|50256167|FG012|Overall Study|Medication Prohibited by Protocol|0|||
25179200|NCT01467713|50324505|FG000|Overall Study|Lost to Follow-up|9|||
25142805|NCT01449370|50256168|FG013|Overall Study|Medication Prohibited by Protocol|0|||
25142806|NCT01449370|50256169|FG014|Overall Study|Medication Prohibited by Protocol|0|||
25142807|NCT01449370|50256170|FG015|Overall Study|Medication Prohibited by Protocol|0|||
25142808|NCT01449370|50256171|FG016|Overall Study|Medication Prohibited by Protocol|0|||
25142809|NCT01449370|50256172|FG017|Overall Study|Medication Prohibited by Protocol|0|||
25142810|NCT01449370|50256173|FG018|Overall Study|Medication Prohibited by Protocol|0|||
25142811|NCT01449370|50256174|FG019|Overall Study|Medication Prohibited by Protocol|0|||
25142812|NCT01449370|50256175|FG020|Overall Study|Medication Prohibited by Protocol|0|||
25142813|NCT01449370|50256176|FG021|Overall Study|Medication Prohibited by Protocol|0|||
25142814|NCT01449370|50256177|FG022|Overall Study|Medication Prohibited by Protocol|0|||
25142815|NCT01449370|50256178|FG023|Overall Study|Medication Prohibited by Protocol|1|||
25142816|NCT01449370|50256179|FG024|Overall Study|Medication Prohibited by Protocol|0|||
25142817|NCT01449370|50256155|FG000|Overall Study|Death|0|||
25142818|NCT01449370|50256156|FG001|Overall Study|Death|0|||
25142819|NCT01449370|50256157|FG002|Overall Study|Death|0|||
25142820|NCT01449370|50256158|FG003|Overall Study|Death|0|||
25142821|NCT01449370|50256159|FG004|Overall Study|Death|0|||
25142822|NCT01449370|50256160|FG005|Overall Study|Death|0|||
25142823|NCT01449370|50256161|FG006|Overall Study|Death|0|||
25142824|NCT01449370|50256162|FG007|Overall Study|Death|0|||
25142825|NCT01449370|50256163|FG008|Overall Study|Death|0|||
25142826|NCT01449370|50256164|FG009|Overall Study|Death|0|||
25142827|NCT01449370|50256165|FG010|Overall Study|Death|0|||
25142828|NCT01449370|50256166|FG011|Overall Study|Death|0|||
25142829|NCT01449370|50256167|FG012|Overall Study|Death|0|||
25142830|NCT01449370|50256168|FG013|Overall Study|Death|0|||
25142831|NCT01449370|50256169|FG014|Overall Study|Death|0|||
25142832|NCT01449370|50256170|FG015|Overall Study|Death|0|||
25142833|NCT01449370|50256171|FG016|Overall Study|Death|0|||
25142834|NCT01449370|50256172|FG017|Overall Study|Death|0|||
25142835|NCT01449370|50256173|FG018|Overall Study|Death|0|||
25142836|NCT01449370|50256174|FG019|Overall Study|Death|0|||
25142837|NCT01449370|50256175|FG020|Overall Study|Death|0|||
25142838|NCT01449370|50256176|FG021|Overall Study|Death|0|||
25142839|NCT01449370|50256177|FG022|Overall Study|Death|0|||
25142840|NCT01449370|50256178|FG023|Overall Study|Death|0|||
25142841|NCT01449370|50256179|FG024|Overall Study|Death|1|||
25142842|NCT02067533|50256254|FG000|Overall Study|Lost to Follow-up|4|||
25142843|NCT02067533|50256255|FG001|Overall Study|Lost to Follow-up|2|||
25142844|NCT02066129|50256263|FG000|Overall Study|Lost to Follow-up|13|||
25142845|NCT02066129|50256264|FG001|Overall Study|Lost to Follow-up|12|||
25142846|NCT02066129|50256263|FG000|Overall Study|Withdrawal by Subject|7|||
25015660|NCT04091659|50110432|FG000|Overall Study|Lost to Follow-up|0|||
25015661|NCT04091659|50110433|FG001|Overall Study|Lost to Follow-up|1|||
25015662|NCT04256785|50110470|FG000|Overall Study|Adverse Event|8|||
25142847|NCT02066129|50256264|FG001|Overall Study|Withdrawal by Subject|10|||
25142848|NCT02066129|50256263|FG000|Overall Study|Lack of Efficacy|8|||
25142849|NCT02066129|50256264|FG001|Overall Study|Lack of Efficacy|10|||
25142850|NCT02066129|50256263|FG000|Overall Study|Physician Decision|1|||
25142851|NCT02066129|50256264|FG001|Overall Study|Physician Decision|1|||
25142852|NCT02066051|50256270|FG000|Overall Study|Subject developed active GVHD|1|||
25142853|NCT01980992|50256276|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
25142854|NCT01980992|50256277|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
25142855|NCT01980992|50256276|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
25142856|NCT01980992|50256277|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
25142857|NCT01980992|50256276|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
25142858|NCT01980992|50256277|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
25142859|NCT01980992|50256276|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
25142860|NCT01980992|50256277|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
25142861|NCT01980992|50256276|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
25142862|NCT01980992|50256277|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
25142863|NCT01980992|50256276|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
25142864|NCT01980992|50256277|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
25142865|NCT02065895|50256290|FG000|Overall Study|Protocol Violation|1|||
25142866|NCT02065895|50256291|FG001|Overall Study|Protocol Violation|0|||
25142867|NCT02065895|50256292|FG002|Overall Study|Protocol Violation|0|||
25142868|NCT02065895|50256293|FG003|Overall Study|Protocol Violation|1|||
25142869|NCT02065895|50256294|FG004|Overall Study|Protocol Violation|0|||
25142870|NCT02065895|50256295|FG005|Overall Study|Protocol Violation|0|||
25142871|NCT02065895|50256290|FG000|Overall Study|Scheduling conflicts|0|||
25142872|NCT02065895|50256291|FG001|Overall Study|Scheduling conflicts|1|||
25142873|NCT02065895|50256292|FG002|Overall Study|Scheduling conflicts|0|||
25142874|NCT02065895|50256293|FG003|Overall Study|Scheduling conflicts|0|||
25142875|NCT02065895|50256294|FG004|Overall Study|Scheduling conflicts|0|||
25142876|NCT02065895|50256295|FG005|Overall Study|Scheduling conflicts|0|||
25142877|NCT02106455|50256312|FG000|Overall Study|Case Report Form Uncollected|6|||
25142878|NCT02106455|50256312|FG000|Overall Study|Protocol Deviation|2|||
25142879|NCT02006654|50256318|FG000|Overall Study|Withdrawal before treatment|4|||
25142880|NCT02006654|50256319|FG001|Overall Study|Withdrawal before treatment|2|||
25142881|NCT02006654|50256318|FG000|Overall Study|Adverse Event|16|||
25142882|NCT02006654|50256319|FG001|Overall Study|Adverse Event|17|||
25142883|NCT02006654|50256318|FG000|Overall Study|Death|1|||
25142884|NCT02006654|50256319|FG001|Overall Study|Death|0|||
25142885|NCT02006654|50256318|FG000|Overall Study|Withdrawal by Subject|14|||
25142886|NCT02006654|50256319|FG001|Overall Study|Withdrawal by Subject|12|||
25142887|NCT02006654|50256318|FG000|Overall Study|Protocol Violation|5|||
25142888|NCT02006654|50256319|FG001|Overall Study|Protocol Violation|8|||
25142889|NCT02006654|50256318|FG000|Overall Study|Lost to Follow-up|1|||
25142890|NCT02006654|50256319|FG001|Overall Study|Lost to Follow-up|0|||
25142891|NCT02006654|50256318|FG000|Overall Study|patient's will|2|||
25142892|NCT02006654|50256319|FG001|Overall Study|patient's will|1|||
25142893|NCT02006654|50256318|FG000|Overall Study|insufficient compliance|1|||
25142894|NCT02006654|50256319|FG001|Overall Study|insufficient compliance|0|||
25142895|NCT02006654|50256318|FG000|Overall Study|worsening cognitive condition|0|||
25142896|NCT02006654|50256319|FG001|Overall Study|worsening cognitive condition|1|||
25142897|NCT02006654|50256318|FG000|Overall Study|faecal incontinence|0|||
25142898|NCT02006654|50256319|FG001|Overall Study|faecal incontinence|1|||
25142899|NCT02006654|50256318|FG000|Overall Study|mood disorder|0|||
25142900|NCT02006654|50256319|FG001|Overall Study|mood disorder|1|||
25142901|NCT02006654|50256318|FG000|Overall Study|disallowed medication|1|||
25142902|NCT02006654|50256319|FG001|Overall Study|disallowed medication|0|||
25142903|NCT02006654|50256318|FG000|Overall Study|moving out of state|0|||
25142904|NCT02006654|50256319|FG001|Overall Study|moving out of state|1|||
25142905|NCT01980056|50256329|FG000|Overall Study|Death|1|||
25015663|NCT04256785|50110471|FG001|Overall Study|Adverse Event|6|||
25142906|NCT01980056|50256330|FG001|Overall Study|Death|1|||
25142907|NCT01980056|50256331|FG002|Overall Study|Death|0|||
25142908|NCT02027558|50256345|FG000|Overall Study|Death|0|||
25142909|NCT02027558|50256346|FG001|Overall Study|Death|1|||
25142910|NCT02027558|50256345|FG000|Overall Study|Withdrawal by Subject|2|||
25142911|NCT02027558|50256346|FG001|Overall Study|Withdrawal by Subject|0|||
25142912|NCT02027558|50256345|FG000|Overall Study|Lost to Follow-up|4|||
25015664|NCT04256785|50110470|FG000|Overall Study|Lack of Efficacy|3|||
25142913|NCT02027558|50256346|FG001|Overall Study|Lost to Follow-up|1|||
25142914|NCT02027558|50256345|FG000|Overall Study|Refused assessment|3|||
25142915|NCT02027558|50256346|FG001|Overall Study|Refused assessment|0|||
25142916|NCT02006576|50256357|FG000|Overall Study|Withdrawal by Subject|4|||
25142917|NCT02006576|50256358|FG001|Overall Study|Withdrawal by Subject|6|||
25142918|NCT02006576|50256359|FG002|Overall Study|Withdrawal by Subject|2|||
25142919|NCT02006576|50256357|FG000|Overall Study|Death|0|||
25142920|NCT02006576|50256358|FG001|Overall Study|Death|0|||
25142921|NCT02006576|50256359|FG002|Overall Study|Death|1|||
25142922|NCT02006576|50256357|FG000|Overall Study|Lost to Follow-up|1|||
25142923|NCT02006576|50256358|FG001|Overall Study|Lost to Follow-up|0|||
25142924|NCT02006576|50256359|FG002|Overall Study|Lost to Follow-up|1|||
25142925|NCT02006576|50256357|FG000|Overall Study|Screen Failure, too sick, other|13|||
25142926|NCT02006576|50256358|FG001|Overall Study|Screen Failure, too sick, other|1|||
25142927|NCT02006576|50256359|FG002|Overall Study|Screen Failure, too sick, other|13|||
25142928|NCT02027402|50256369|FG000|Overall Study|Withdrawal by Subject|4|||
25142929|NCT02027402|50256370|FG001|Overall Study|Withdrawal by Subject|1|||
25142930|NCT01448824|50256386|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
25142931|NCT01448824|50256387|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
25142932|NCT01448824|50256388|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
25142933|NCT01448824|50256389|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
25142934|NCT01448824|50256390|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
25142935|NCT01448824|50256391|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
25142936|NCT01448824|50256392|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
25142937|NCT01448824|50256393|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
25142938|NCT01448824|50256386|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
25142939|NCT01448824|50256387|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
25142940|NCT01448824|50256388|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
25142941|NCT01448824|50256389|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
25142942|NCT01448824|50256390|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
25142943|NCT01448824|50256391|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
25142944|NCT01448824|50256392|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
25142945|NCT01448824|50256393|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
25142946|NCT01448824|50256386|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
25142947|NCT01448824|50256387|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
25142948|NCT01448824|50256388|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
25142949|NCT01448824|50256389|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
25142950|NCT01448824|50256390|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
25142951|NCT01448824|50256391|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
25142952|NCT01448824|50256392|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
25142953|NCT01448824|50256393|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
25142954|NCT01448824|50256386|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
25142955|NCT01448824|50256387|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
25142956|NCT01448824|50256388|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
25142957|NCT01448824|50256389|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
25142958|NCT01448824|50256390|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
25142959|NCT01448824|50256391|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
25142960|NCT01448824|50256392|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
25142961|NCT01448824|50256393|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
25142962|NCT01448824|50256386|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
25142963|NCT01448824|50256387|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
25142964|NCT01448824|50256388|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
25142965|NCT01448824|50256389|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
25142966|NCT01448824|50256390|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
25142967|NCT01448824|50256391|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
25142968|NCT01448824|50256392|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
25142969|NCT01448824|50256393|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
25142970|NCT01448824|50256386|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
25142971|NCT01448824|50256387|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
25142972|NCT01448824|50256388|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
25142973|NCT01448824|50256389|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
25142974|NCT01448824|50256390|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
25142975|NCT01448824|50256391|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
25142976|NCT01448824|50256392|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
25142977|NCT01448824|50256393|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
25142978|NCT01448824|50256386|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
25142979|NCT01448824|50256387|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
25142980|NCT01448824|50256388|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
25142981|NCT01448824|50256389|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
25142982|NCT01448824|50256390|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
25142983|NCT01448824|50256391|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
25142984|NCT01448824|50256392|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
25142985|NCT01448824|50256393|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
25142986|NCT01448824|50256386|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
25142987|NCT01448824|50256387|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
25142988|NCT01448824|50256388|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
25142989|NCT01448824|50256389|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
25142990|NCT01448824|50256390|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
25142991|NCT01448824|50256391|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
25142992|NCT01448824|50256392|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
25142993|NCT01448824|50256393|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
25142994|NCT02005562|50256423|FG000|Overall Study|Death|2|||
25142995|NCT02005562|50256424|FG001|Overall Study|Death|2|||
25142996|NCT02005562|50256423|FG000|Overall Study|Graft loss|7|||
25142997|NCT02005562|50256424|FG001|Overall Study|Graft loss|6|||
25142998|NCT02005562|50256423|FG000|Overall Study|Withdrawal by Subject|2|||
25142999|NCT02005562|50256424|FG001|Overall Study|Withdrawal by Subject|2|||
25143000|NCT02005562|50256423|FG000|Overall Study|No transplant|1|||
25143001|NCT02005562|50256424|FG001|Overall Study|No transplant|4|||
25143002|NCT02005562|50256423|FG000|Overall Study|Physician Decision|0|||
25143003|NCT02005562|50256424|FG001|Overall Study|Physician Decision|1|||
25143004|NCT01448044|50256432|FG000|Treatment Period|Adverse Event|4|||
25143005|NCT01448044|50256433|FG001|Treatment Period|Adverse Event|3|||
25143006|NCT01448044|50256432|FG000|Treatment Period|Lack of Efficacy|5|||
25143007|NCT01448044|50256433|FG001|Treatment Period|Lack of Efficacy|12|||
25143008|NCT01448044|50256432|FG000|Treatment Period|Subject requested discontinue study drug|1|||
25143009|NCT01448044|50256433|FG001|Treatment Period|Subject requested discontinue study drug|0|||
25143010|NCT01448044|50256432|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
25143011|NCT01448044|50256433|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
25143012|NCT01448044|50256432|FG000|Treatment Period|Participant does not meet study criteria|1|||
25143013|NCT01448044|50256433|FG001|Treatment Period|Participant does not meet study criteria|0|||
25143014|NCT01448044|50256432|FG000|Treatment Period|Lost to Follow-up|2|||
25143015|NCT01448044|50256433|FG001|Treatment Period|Lost to Follow-up|1|||
25143016|NCT01448044|50256432|FG000|Treatment Period|Other reason|2|||
25143017|NCT01448044|50256433|FG001|Treatment Period|Other reason|0|||
25143018|NCT01448044|50256432|FG000|Follow Up Period|Withdrawal by Subject|1|||
25143019|NCT01448044|50256433|FG001|Follow Up Period|Withdrawal by Subject|1|||
25143020|NCT01448044|50256432|FG000|Follow Up Period|Lost to Follow-up|6|||
25143021|NCT01448044|50256433|FG001|Follow Up Period|Lost to Follow-up|2|||
25143022|NCT01448044|50256432|FG000|Follow Up Period|Other|5|||
25143023|NCT01448044|50256433|FG001|Follow Up Period|Other|11|||
25143024|NCT02025530|50256441|FG000|Overall Study|No longer met elligibility criteria|5|||
25143025|NCT02025530|50256442|FG001|Overall Study|No longer met elligibility criteria|1|||
25143026|NCT01472380|50256448|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
25143027|NCT01472380|50256448|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
25143028|NCT01978262|50256455|FG000|Overall Study|Withdrawal by Subject|9|||
25143029|NCT01978262|50256455|FG000|Overall Study|Lost to Follow-up|2|||
25143030|NCT01447576|50256460|FG000|Overall Study|Lost to Follow-up|52|||
25143031|NCT01447576|50256460|FG000|Overall Study|Adverse Event|127|||
25143032|NCT01447576|50256460|FG000|Overall Study|Participant met withdrawal criteria|40|||
25143033|NCT01447576|50256460|FG000|Overall Study|Withdrawal by Subject|100|||
25143034|NCT01447576|50256460|FG000|Overall Study|Protocol deviation|83|||
25143035|NCT01447576|50256460|FG000|Overall Study|Lack of Efficacy|68|||
25143036|NCT01447576|50256460|FG000|Overall Study|Physician Decision|6|||
25143037|NCT01447420|50256467|FG000|Overall Study|Adverse Event|2|||
25143038|NCT01447420|50256468|FG001|Overall Study|Adverse Event|4|||
25143039|NCT01447420|50256469|FG002|Overall Study|Adverse Event|2|||
25143040|NCT01447420|50256467|FG000|Overall Study|Protocol Violation|3|||
25143041|NCT01447420|50256468|FG001|Overall Study|Protocol Violation|3|||
25143042|NCT01447420|50256469|FG002|Overall Study|Protocol Violation|0|||
25143043|NCT01447420|50256467|FG000|Overall Study|Withdrawal by Subject|4|||
25143044|NCT01447420|50256468|FG001|Overall Study|Withdrawal by Subject|1|||
25143045|NCT01447420|50256469|FG002|Overall Study|Withdrawal by Subject|0|||
25143046|NCT01447420|50256467|FG000|Overall Study|Lack of Efficacy|1|||
25143047|NCT01447420|50256468|FG001|Overall Study|Lack of Efficacy|19|||
25143048|NCT01447420|50256469|FG002|Overall Study|Lack of Efficacy|8|||
25143049|NCT01446874|50256479|FG000|Overall Study|Not eligible|1|||
25143050|NCT01446874|50256480|FG001|Overall Study|Not eligible|0|||
25143051|NCT01446874|50256481|FG002|Overall Study|Not eligible|0|||
25143052|NCT01446874|50256479|FG000|Overall Study|No surgery/No qualifying surgery|1|||
25143053|NCT01446874|50256480|FG001|Overall Study|No surgery/No qualifying surgery|0|||
25143054|NCT01446874|50256481|FG002|Overall Study|No surgery/No qualifying surgery|12|||
25143055|NCT01446874|50256479|FG000|Overall Study|Non-compliance|0|||
25143056|NCT01446874|50256480|FG001|Overall Study|Non-compliance|4|||
25143057|NCT01446874|50256481|FG002|Overall Study|Non-compliance|0|||
25143058|NCT01446874|50256479|FG000|Overall Study|Antibiotics for pre-op infection|0|||
25143059|NCT01446874|50256480|FG001|Overall Study|Antibiotics for pre-op infection|0|||
25143060|NCT01446874|50256481|FG002|Overall Study|Antibiotics for pre-op infection|2|||
25143061|NCT01446874|50256479|FG000|Overall Study|Withdrawal by Subject|0|||
25143062|NCT01446874|50256480|FG001|Overall Study|Withdrawal by Subject|0|||
25143063|NCT01446874|50256481|FG002|Overall Study|Withdrawal by Subject|4|||
25143064|NCT01446796|50256489|FG000|Overall Study|Withdrawal by Subject|1|||
25143065|NCT01446796|50256490|FG001|Overall Study|Withdrawal by Subject|0|||
25143066|NCT01439074|50256500|FG000|Overall Study|Lost to Follow-up|3|||
25143067|NCT01439074|50256501|FG001|Overall Study|Lost to Follow-up|4|||
25143068|NCT01439074|50256500|FG000|Overall Study|Subject shedding|1|||
25143069|NCT01439074|50256501|FG001|Overall Study|Subject shedding|0|||
25143070|NCT01439074|50256500|FG000|Overall Study|Withdrawal by Subject|1|||
25143071|NCT01439074|50256501|FG001|Overall Study|Withdrawal by Subject|5|||
25143072|NCT01439074|50256500|FG000|Overall Study|Other|4|||
25143073|NCT01439074|50256501|FG001|Overall Study|Other|4|||
25143074|NCT01438996|50256510|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
25143075|NCT01438996|50256511|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
25143076|NCT01438996|50256512|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
25143077|NCT01438840|50256522|FG000|Core Study|Adverse Event|0|||
25143078|NCT01438840|50256523|FG001|Core Study|Adverse Event|3|||
25143079|NCT01438840|50256524|FG002|Core Study|Adverse Event|0|||
25143080|NCT01438840|50256522|FG000|Core Study|Lack of Efficacy|15|||
25143081|NCT01438840|50256523|FG001|Core Study|Lack of Efficacy|7|||
25143082|NCT01438840|50256524|FG002|Core Study|Lack of Efficacy|0|||
25143083|NCT01438840|50256522|FG000|Core Study|Withdrawal of consent|1|||
25143084|NCT01438840|50256523|FG001|Core Study|Withdrawal of consent|0|||
25143085|NCT01438840|50256524|FG002|Core Study|Withdrawal of consent|0|||
25143086|NCT01438840|50256522|FG000|Extension Phase|Adverse Event|0|||
25143087|NCT01438840|50256523|FG001|Extension Phase|Adverse Event|0|||
25143088|NCT01438840|50256524|FG002|Extension Phase|Adverse Event|3|||
25143089|NCT01438840|50256522|FG000|Extension Phase|Lost to Follow-up|0|||
25143090|NCT01438840|50256523|FG001|Extension Phase|Lost to Follow-up|0|||
25143091|NCT01438840|50256524|FG002|Extension Phase|Lost to Follow-up|1|||
25143092|NCT01438840|50256522|FG000|Extension Phase|Withdrawal by Subject|0|||
25143093|NCT01438840|50256523|FG001|Extension Phase|Withdrawal by Subject|0|||
25143094|NCT01438840|50256524|FG002|Extension Phase|Withdrawal by Subject|3|||
25143095|NCT01438840|50256522|FG000|Extension Phase|Lack of Efficacy|0|||
25143096|NCT01438840|50256523|FG001|Extension Phase|Lack of Efficacy|0|||
25143097|NCT01438840|50256524|FG002|Extension Phase|Lack of Efficacy|2|||
25143098|NCT01438840|50256522|FG000|Extension Phase|Other|0|||
25143099|NCT01438840|50256523|FG001|Extension Phase|Other|0|||
25143100|NCT01438840|50256524|FG002|Extension Phase|Other|1|||
25143101|NCT01471054|50256533|FG000|Overall Study|Study terminated prematurely|4|||
25143102|NCT01471054|50256534|FG001|Overall Study|Study terminated prematurely|0|||
25143103|NCT01978184|50256552|FG000|Overall Study|Progressive disease|5|||
25143104|NCT01978184|50256553|FG001|Overall Study|Progressive disease|5|||
25143105|NCT01978184|50256552|FG000|Overall Study|Other than PDA|2|||
25143106|NCT01978184|50256553|FG001|Overall Study|Other than PDA|2|||
25143107|NCT01978184|50256552|FG000|Overall Study|Physician Decision|0|||
25143108|NCT01978184|50256553|FG001|Overall Study|Physician Decision|3|||
25143109|NCT01978184|50256552|FG000|Overall Study|Noncompliance|1|||
25143110|NCT01978184|50256553|FG001|Overall Study|Noncompliance|2|||
25143111|NCT01978184|50256552|FG000|Overall Study|Death|1|||
25143112|NCT01978184|50256553|FG001|Overall Study|Death|0|||
25143113|NCT01978184|50256552|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
25143114|NCT01978184|50256553|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
25143115|NCT01445548|50256559|FG000|Overall Study|Adverse Event|1|||
25143116|NCT01977794|50256565|FG000|Overall Study|Adverse Event|2|||
25143117|NCT01977794|50256566|FG001|Overall Study|Adverse Event|2|||
25143118|NCT01977794|50256565|FG000|Overall Study|Lost to Follow-up|2|||
25143119|NCT01977794|50256566|FG001|Overall Study|Lost to Follow-up|1|||
25143120|NCT01977794|50256565|FG000|Overall Study|Protocol Violation|1|||
25143121|NCT01977794|50256566|FG001|Overall Study|Protocol Violation|0|||
25143122|NCT01977794|50256565|FG000|Overall Study|Death|1|||
25143123|NCT01977794|50256566|FG001|Overall Study|Death|1|||
25143124|NCT01977794|50256565|FG000|Overall Study|Withdrew consent|2|||
25143125|NCT01977794|50256566|FG001|Overall Study|Withdrew consent|1|||
25143126|NCT01977794|50256565|FG000|Overall Study|Other|0|||
25143127|NCT01977794|50256566|FG001|Overall Study|Other|1|||
25143128|NCT02005484|50256572|FG000|Overall Study|Death|1|||
25143129|NCT02005484|50256572|FG000|Overall Study|Disease progression|1|||
25143130|NCT02005484|50256572|FG000|Overall Study|Changed to a Different Study|1|||
25143131|NCT02005484|50256572|FG000|Overall Study|Sponsor decision|1|||
25143132|NCT02005250|50256578|FG000|Overall Study|Lost to Follow-up|15|||
25274436|NCT01078623|50588457|FG002|Treatment Period 4|Withdrawal by Subject|0|||
25143133|NCT02005250|50256579|FG001|Overall Study|Lost to Follow-up|5|||
25143134|NCT02024750|50256587|FG000|Overall Study|Withdrawal by Subject|2|||
25015665|NCT04256785|50110471|FG001|Overall Study|Lack of Efficacy|4|||
25015666|NCT04256785|50110470|FG000|Overall Study|Lost to Follow-up|7|||
25143135|NCT02024750|50256588|FG001|Overall Study|Withdrawal by Subject|1|||
25143136|NCT01597973|50256596|FG000|Overall Study|Found ineligible before study medication started|4|||
25143137|NCT01597973|50256597|FG001|Overall Study|Found ineligible before study medication started|2|||
25143138|NCT01597973|50256596|FG000|Overall Study|Eligible pathogen not confirmed|14|||
25143139|NCT01597973|50256597|FG001|Overall Study|Eligible pathogen not confirmed|15|||
25143140|NCT01597973|50256596|FG000|Overall Study|LAR not authorized to consent|0|||
25143141|NCT01597973|50256597|FG001|Overall Study|LAR not authorized to consent|1|||
25143142|NCT01597973|50256596|FG000|Overall Study|Ineligible due to early seizures|1|||
25143143|NCT01597973|50256597|FG001|Overall Study|Ineligible due to early seizures|0|||
25143144|NCT01597973|50256596|FG000|Overall Study|Ineligible due to non-target infection|1|||
25143145|NCT01597973|50256597|FG001|Overall Study|Ineligible due to non-target infection|1|||
25143146|NCT02023268|50256607|FG000|Overall Study|Lack of Efficacy|0|||
25143147|NCT02023268|50256608|FG001|Overall Study|Lack of Efficacy|1|||
25143148|NCT02023268|50256607|FG000|Overall Study|Adverse Event|0|||
25179201|NCT01467713|50324506|FG001|Overall Study|Lost to Follow-up|12|||
25179202|NCT01467713|50324507|FG002|Overall Study|Lost to Follow-up|6|||
25179203|NCT01467713|50324508|FG003|Overall Study|Lost to Follow-up|9|||
25179204|NCT01467713|50324505|FG000|Overall Study|Voluntary Withdrawal|18|||
25179205|NCT01467713|50324506|FG001|Overall Study|Voluntary Withdrawal|14|||
25179206|NCT01467713|50324507|FG002|Overall Study|Voluntary Withdrawal|21|||
25143149|NCT02023268|50256608|FG001|Overall Study|Adverse Event|2|||
25143150|NCT02023268|50256607|FG000|Overall Study|Withdrawal by Subject|0|||
25143151|NCT02023268|50256608|FG001|Overall Study|Withdrawal by Subject|1|||
25143152|NCT02047253|50256614|FG000|Overall Study|Lost to Follow-up|8|||
25143153|NCT02096705|50256620|FG000|Treatment|Adverse Event|6|||
25143154|NCT02096705|50256621|FG001|Treatment|Adverse Event|3|||
25143155|NCT02096705|50256620|FG000|Treatment|Subject request to discontinue treatment|1|||
25179207|NCT01467713|50324508|FG003|Overall Study|Voluntary Withdrawal|20|||
25179208|NCT01467713|50324505|FG000|Overall Study|Study Termination|23|||
25179209|NCT01467713|50324506|FG001|Overall Study|Study Termination|33|||
25179210|NCT01467713|50324507|FG002|Overall Study|Study Termination|28|||
25179211|NCT01467713|50324508|FG003|Overall Study|Study Termination|29|||
25179212|NCT01467713|50324505|FG000|Overall Study|Pregnancy|0|||
25179213|NCT01467713|50324506|FG001|Overall Study|Pregnancy|1|||
25179214|NCT01467713|50324507|FG002|Overall Study|Pregnancy|1|||
25179215|NCT01467713|50324508|FG003|Overall Study|Pregnancy|3|||
25179216|NCT01467713|50324505|FG000|Overall Study|Relapse|35|||
25179217|NCT01467713|50324506|FG001|Overall Study|Relapse|25|||
25179218|NCT01467713|50324507|FG002|Overall Study|Relapse|28|||
25179219|NCT01467713|50324508|FG003|Overall Study|Relapse|35|||
25179220|NCT01467713|50324505|FG000|Overall Study|Reason not Specified|6|||
25179221|NCT01467713|50324506|FG001|Overall Study|Reason not Specified|11|||
25179222|NCT01467713|50324507|FG002|Overall Study|Reason not Specified|8|||
25179223|NCT01467713|50324508|FG003|Overall Study|Reason not Specified|7|||
25179224|NCT01693250|50324538|FG000|Overall Study|Lost to Follow-up|2|||
25179225|NCT01693250|50324539|FG001|Overall Study|Lost to Follow-up|2|||
25179226|NCT01590758|50324562|FG000|Overall Study|Withdrawal by Subject|0|||
25179227|NCT01590758|50324563|FG001|Overall Study|Withdrawal by Subject|3|||
25179228|NCT01590758|50324562|FG000|Overall Study|Physician Decision|1|||
25179229|NCT01590758|50324563|FG001|Overall Study|Physician Decision|2|||
25179230|NCT01590758|50324562|FG000|Overall Study|Lost to Follow-up|4|||
25179231|NCT01590758|50324563|FG001|Overall Study|Lost to Follow-up|2|||
25179232|NCT01590212|50324572|FG000|Overall Study|Withdrawal by Subject|2|||
25179233|NCT01590212|50324573|FG001|Overall Study|Withdrawal by Subject|2|||
25179234|NCT01590212|50324574|FG002|Overall Study|Withdrawal by Subject|2|||
25179235|NCT01590212|50324572|FG000|Overall Study|Lost to Follow-up|1|||
25179236|NCT01590212|50324573|FG001|Overall Study|Lost to Follow-up|2|||
25179237|NCT01590212|50324574|FG002|Overall Study|Lost to Follow-up|3|||
25179238|NCT01692938|50324585|FG000|Overall Study|Protocol Deviation|1|||
25179239|NCT01692938|50324586|FG001|Overall Study|Protocol Deviation|1|||
25179240|NCT01692938|50324585|FG000|Overall Study|Study completed prior to site completion|3|||
25179241|NCT01692938|50324586|FG001|Overall Study|Study completed prior to site completion|3|||
25179242|NCT01692782|50324599|FG000|Overall Study|Adverse Event|12|||
25143156|NCT02096705|50256621|FG001|Treatment|Subject request to discontinue treatment|1|||
25143157|NCT02096705|50256620|FG000|Treatment|Withdrawal by Subject|1|||
25143158|NCT02096705|50256621|FG001|Treatment|Withdrawal by Subject|0|||
25179243|NCT01692782|50324600|FG001|Overall Study|Adverse Event|32|||
25179244|NCT01692782|50324601|FG002|Overall Study|Adverse Event|2|||
25179245|NCT01692782|50324599|FG000|Overall Study|Lack of Efficacy|1|||
25179246|NCT01692782|50324600|FG001|Overall Study|Lack of Efficacy|2|||
25179247|NCT01692782|50324601|FG002|Overall Study|Lack of Efficacy|0|||
25179248|NCT01692782|50324599|FG000|Overall Study|Lost to Follow-up|2|||
25179249|NCT01692782|50324600|FG001|Overall Study|Lost to Follow-up|7|||
25143159|NCT02096705|50256620|FG000|Treatment|Other|1|||
25143160|NCT02096705|50256621|FG001|Treatment|Other|1|||
25179250|NCT01692782|50324601|FG002|Overall Study|Lost to Follow-up|1|||
25179251|NCT01692782|50324599|FG000|Overall Study|Pregnancy|1|||
25179252|NCT01692782|50324600|FG001|Overall Study|Pregnancy|0|||
25179253|NCT01692782|50324601|FG002|Overall Study|Pregnancy|0|||
25179254|NCT01692782|50324599|FG000|Overall Study|Protocol Violation|1|||
25179255|NCT01692782|50324600|FG001|Overall Study|Protocol Violation|0|||
25179256|NCT01692782|50324601|FG002|Overall Study|Protocol Violation|2|||
25179257|NCT01692782|50324599|FG000|Overall Study|Non-complance with study drug|0|||
25143161|NCT02096705|50256620|FG000|Follow-up|Withdrawal by Subject|1|||
25143162|NCT02096705|50256621|FG001|Follow-up|Withdrawal by Subject|0|||
25143163|NCT02096705|50256620|FG000|Follow-up|Adverse Event|2|||
25143164|NCT02096705|50256621|FG001|Follow-up|Adverse Event|2|||
25143165|NCT02096705|50256620|FG000|Follow-up|Subjects not reporting status|1|||
25143166|NCT02096705|50256621|FG001|Follow-up|Subjects not reporting status|2|||
25143167|NCT02096471|50256627|FG000|Overall Study|Adverse Event|1|||
25143168|NCT02096471|50256627|FG000|Overall Study|Lack of Efficacy|7|||
25143169|NCT02096471|50256627|FG000|Overall Study|Withdrawal by Subject|3|||
25143170|NCT02096471|50256627|FG000|Overall Study|Non-Compliant|2|||
25143171|NCT02096003|50256633|FG000|Overall Study|Protocol Violation|0|||
25143172|NCT02096003|50256634|FG001|Overall Study|Protocol Violation|2|||
25179258|NCT01692782|50324600|FG001|Overall Study|Non-complance with study drug|4|||
25143173|NCT02096003|50256633|FG000|Overall Study|additional surgery|2|||
25143174|NCT02096003|50256634|FG001|Overall Study|additional surgery|1|||
25143175|NCT02062385|50256644|FG000|Overall Study|Adverse Event|19|||
25143176|NCT02062385|50256645|FG001|Overall Study|Adverse Event|13|||
25143177|NCT02062385|50256646|FG002|Overall Study|Adverse Event|1|||
25143178|NCT02062385|50256647|FG003|Overall Study|Adverse Event|0|||
25143179|NCT02062385|50256644|FG000|Overall Study|Protocol Violation|1|||
25143180|NCT02062385|50256645|FG001|Overall Study|Protocol Violation|0|||
25143181|NCT02062385|50256646|FG002|Overall Study|Protocol Violation|0|||
25143182|NCT02062385|50256647|FG003|Overall Study|Protocol Violation|0|||
25143183|NCT02062385|50256644|FG000|Overall Study|Incomplete EPI by database lock|2|||
25143184|NCT02062385|50256645|FG001|Overall Study|Incomplete EPI by database lock|0|||
25143185|NCT02062385|50256646|FG002|Overall Study|Incomplete EPI by database lock|0|||
25143186|NCT02062385|50256647|FG003|Overall Study|Incomplete EPI by database lock|0|||
25143187|NCT02062385|50256644|FG000|Overall Study|Moved|10|||
25143188|NCT02062385|50256645|FG001|Overall Study|Moved|11|||
25143189|NCT02062385|50256646|FG002|Overall Study|Moved|1|||
25143190|NCT02062385|50256647|FG003|Overall Study|Moved|0|||
25179259|NCT01692782|50324601|FG002|Overall Study|Non-complance with study drug|1|||
25179260|NCT01692782|50324599|FG000|Overall Study|Non-compliant with study visits|0|||
25179261|NCT01692782|50324600|FG001|Overall Study|Non-compliant with study visits|0|||
25179262|NCT01692782|50324601|FG002|Overall Study|Non-compliant with study visits|1|||
25179263|NCT01692782|50324599|FG000|Overall Study|SAE not related to study drug|0|||
25179264|NCT01692782|50324600|FG001|Overall Study|SAE not related to study drug|1|||
25179265|NCT01692782|50324601|FG002|Overall Study|SAE not related to study drug|0|||
25179266|NCT01692782|50324599|FG000|Overall Study|Withdrawal by Subject|3|||
25179267|NCT01692782|50324600|FG001|Overall Study|Withdrawal by Subject|10|||
25179268|NCT01692782|50324601|FG002|Overall Study|Withdrawal by Subject|3|||
25179269|NCT01692626|50324609|FG000|Overall Study|Death|0|||
25179270|NCT01692626|50324610|FG001|Overall Study|Death|1|||
25179271|NCT01692626|50324609|FG000|Overall Study|Adverse Event|2|||
25179272|NCT01692626|50324610|FG001|Overall Study|Adverse Event|3|||
25179273|NCT01692626|50324609|FG000|Overall Study|Protocol Violation|1|||
25179274|NCT01692626|50324610|FG001|Overall Study|Protocol Violation|2|||
25179275|NCT01692626|50324609|FG000|Overall Study|Withdrawal by Subject|1|||
25179276|NCT01692626|50324610|FG001|Overall Study|Withdrawal by Subject|0|||
25179277|NCT01475461|50324636|FG000|Run-in Period|Not meet eligibility criteria|16|||
25015667|NCT04256785|50110471|FG001|Overall Study|Lost to Follow-up|7|||
25015668|NCT04256785|50110470|FG000|Overall Study|Protocol Violation|1|||
25015669|NCT04256785|50110471|FG001|Overall Study|Protocol Violation|0|||
25015670|NCT04256785|50110470|FG000|Overall Study|Withdrawal by Subject|4|||
25015671|NCT04256785|50110471|FG001|Overall Study|Withdrawal by Subject|1|||
25015672|NCT04256785|50110470|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
25015673|NCT04256785|50110471|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
25015674|NCT02959918|50110493|FG000|Overall Study|Adverse Event|1|||
25143191|NCT02062385|50256644|FG000|Overall Study|Withdrawn by parent/guardian|46|||
25143192|NCT02062385|50256645|FG001|Overall Study|Withdrawn by parent/guardian|41|||
25179278|NCT01475461|50324637|FG001|Run-in Period|Not meet eligibility criteria|0|||
25179279|NCT01475461|50324638|FG002|Run-in Period|Not meet eligibility criteria|0|||
25179280|NCT01475461|50324639|FG003|Run-in Period|Not meet eligibility criteria|0|||
25015675|NCT02959918|50110494|FG001|Overall Study|Adverse Event|1|||
25143193|NCT02062385|50256646|FG002|Overall Study|Withdrawn by parent/guardian|9|||
25143194|NCT02062385|50256647|FG003|Overall Study|Withdrawn by parent/guardian|8|||
25143195|NCT02062385|50256644|FG000|Overall Study|Death|0|||
25143196|NCT02062385|50256645|FG001|Overall Study|Death|0|||
25143197|NCT02062385|50256646|FG002|Overall Study|Death|0|||
25143198|NCT02062385|50256647|FG003|Overall Study|Death|1|||
25015676|NCT02959918|50110495|FG002|Overall Study|Adverse Event|2|||
25143199|NCT02062385|50256644|FG000|Overall Study|Lost to Follow-up|0|||
25143200|NCT02062385|50256645|FG001|Overall Study|Lost to Follow-up|0|||
25143201|NCT02062385|50256646|FG002|Overall Study|Lost to Follow-up|1|||
25143202|NCT02062385|50256647|FG003|Overall Study|Lost to Follow-up|0|||
25143203|NCT02062151|50256655|FG000|Overall Study|screen failure|1|||
25143204|NCT02060903|50256661|FG000|Overall Study|Lost to Follow-up|4|||
25143205|NCT02060903|50256662|FG001|Overall Study|Lost to Follow-up|0|||
25143206|NCT02060903|50256661|FG000|Overall Study|Withdrawal by Subject|0|||
25143207|NCT02060903|50256662|FG001|Overall Study|Withdrawal by Subject|7|||
25143208|NCT02095691|50256668|FG000|Overall Study|Physician Decision|1|||
25143209|NCT02095535|50256684|FG000|Recruitment|Protocol Violation|2|||
25143210|NCT02095223|50256690|FG000|Overall Study|Withdrawal by Subject|1|||
25143211|NCT02095223|50256691|FG001|Overall Study|Withdrawal by Subject|0|||
25143212|NCT02095145|50256699|FG000|Overall Study|Withdrawal by Subject|1|||
25143213|NCT02095145|50256700|FG001|Overall Study|Withdrawal by Subject|0|||
25143214|NCT02059187|50256710|FG000|Overall Study|Adverse Event|0|||
25143215|NCT02059187|50256711|FG001|Overall Study|Adverse Event|3|||
25143216|NCT02059187|50256710|FG000|Overall Study|Death|1|||
25143217|NCT02059187|50256711|FG001|Overall Study|Death|1|||
25179281|NCT01475461|50324640|FG004|Run-in Period|Not meet eligibility criteria|0|||
25179282|NCT01475461|50324641|FG005|Run-in Period|Not meet eligibility criteria|0|||
25179283|NCT01475461|50324642|FG006|Run-in Period|Not meet eligibility criteria|0|||
25179284|NCT01475461|50324636|FG000|Run-in Period|Lost to Follow-up|7|||
25179285|NCT01475461|50324637|FG001|Run-in Period|Lost to Follow-up|0|||
25179286|NCT01475461|50324638|FG002|Run-in Period|Lost to Follow-up|0|||
25179287|NCT01475461|50324639|FG003|Run-in Period|Lost to Follow-up|0|||
25179288|NCT01475461|50324640|FG004|Run-in Period|Lost to Follow-up|0|||
25179289|NCT01475461|50324641|FG005|Run-in Period|Lost to Follow-up|0|||
25179290|NCT01475461|50324642|FG006|Run-in Period|Lost to Follow-up|0|||
25179291|NCT01475461|50324636|FG000|Run-in Period|Withdrawal by Subject|11|||
25179292|NCT01475461|50324637|FG001|Run-in Period|Withdrawal by Subject|0|||
25179293|NCT01475461|50324638|FG002|Run-in Period|Withdrawal by Subject|0|||
25179294|NCT01475461|50324639|FG003|Run-in Period|Withdrawal by Subject|0|||
25179295|NCT01475461|50324640|FG004|Run-in Period|Withdrawal by Subject|0|||
25179296|NCT01475461|50324641|FG005|Run-in Period|Withdrawal by Subject|0|||
25179297|NCT01475461|50324642|FG006|Run-in Period|Withdrawal by Subject|0|||
25179298|NCT01475461|50324636|FG000|Run-in Period|Other|3|||
25179299|NCT01475461|50324637|FG001|Run-in Period|Other|0|||
25179300|NCT01475461|50324638|FG002|Run-in Period|Other|0|||
25179301|NCT01475461|50324639|FG003|Run-in Period|Other|0|||
25179302|NCT01475461|50324640|FG004|Run-in Period|Other|0|||
25179303|NCT01475461|50324641|FG005|Run-in Period|Other|0|||
25179304|NCT01475461|50324642|FG006|Run-in Period|Other|0|||
25179305|NCT01475461|50324636|FG000|Run-in Period|Protocol Violation|4|||
25179306|NCT01475461|50324637|FG001|Run-in Period|Protocol Violation|0|||
25179307|NCT01475461|50324638|FG002|Run-in Period|Protocol Violation|0|||
25179308|NCT01475461|50324639|FG003|Run-in Period|Protocol Violation|0|||
25179309|NCT01475461|50324640|FG004|Run-in Period|Protocol Violation|0|||
25179310|NCT01475461|50324641|FG005|Run-in Period|Protocol Violation|0|||
25179311|NCT01475461|50324642|FG006|Run-in Period|Protocol Violation|0|||
25179312|NCT01475461|50324636|FG000|Treatment Period|Death|0|||
25179313|NCT01475461|50324637|FG001|Treatment Period|Death|0|||
25179314|NCT01475461|50324638|FG002|Treatment Period|Death|0|||
25179315|NCT01475461|50324639|FG003|Treatment Period|Death|1|||
25179316|NCT01475461|50324640|FG004|Treatment Period|Death|0|||
25179317|NCT01475461|50324641|FG005|Treatment Period|Death|0|||
25143218|NCT02059187|50256710|FG000|Overall Study|Lost to Follow-up|9|||
25143219|NCT02059187|50256711|FG001|Overall Study|Lost to Follow-up|8|||
25143220|NCT02059187|50256710|FG000|Overall Study|Non-compliance with study drug|1|||
25143221|NCT02059187|50256711|FG001|Overall Study|Non-compliance with study drug|0|||
25143222|NCT02059187|50256710|FG000|Overall Study|Physician Decision|1|||
25143223|NCT02059187|50256711|FG001|Overall Study|Physician Decision|2|||
25143224|NCT02059187|50256710|FG000|Overall Study|Protocol Violation|1|||
25143225|NCT02059187|50256711|FG001|Overall Study|Protocol Violation|0|||
25143226|NCT02059187|50256710|FG000|Overall Study|Withdrawal by Subject|12|||
25143227|NCT02059187|50256711|FG001|Overall Study|Withdrawal by Subject|8|||
25143228|NCT02043899|50256717|FG000|Overall Study|Adverse Event|3|||
25179318|NCT01475461|50324642|FG006|Treatment Period|Death|0|||
25179319|NCT01475461|50324636|FG000|Treatment Period|Lost to Follow-up|0|||
25179320|NCT01475461|50324637|FG001|Treatment Period|Lost to Follow-up|3|||
25179321|NCT01475461|50324638|FG002|Treatment Period|Lost to Follow-up|2|||
25179322|NCT01475461|50324639|FG003|Treatment Period|Lost to Follow-up|3|||
25179323|NCT01475461|50324640|FG004|Treatment Period|Lost to Follow-up|1|||
25179324|NCT01475461|50324641|FG005|Treatment Period|Lost to Follow-up|2|||
25179325|NCT01475461|50324642|FG006|Treatment Period|Lost to Follow-up|1|||
25143229|NCT02043899|50256717|FG000|Overall Study|Physician Decision|1|||
25143230|NCT02043899|50256717|FG000|Overall Study|Withdrawal by Subject|2|||
25143231|NCT02043899|50256717|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
25179326|NCT01475461|50324636|FG000|Treatment Period|Withdrawal by Subject|0|||
25179327|NCT01475461|50324637|FG001|Treatment Period|Withdrawal by Subject|2|||
25179328|NCT01475461|50324638|FG002|Treatment Period|Withdrawal by Subject|2|||
25179329|NCT01475461|50324639|FG003|Treatment Period|Withdrawal by Subject|0|||
25179330|NCT01475461|50324640|FG004|Treatment Period|Withdrawal by Subject|2|||
25179331|NCT01475461|50324641|FG005|Treatment Period|Withdrawal by Subject|2|||
25179332|NCT01475461|50324642|FG006|Treatment Period|Withdrawal by Subject|0|||
25179333|NCT01475461|50324636|FG000|Treatment Period|Other|0|||
25179334|NCT01475461|50324637|FG001|Treatment Period|Other|1|||
25179335|NCT01475461|50324638|FG002|Treatment Period|Other|0|||
25179336|NCT01475461|50324639|FG003|Treatment Period|Other|0|||
25179337|NCT01475461|50324640|FG004|Treatment Period|Other|0|||
25179338|NCT01475461|50324641|FG005|Treatment Period|Other|0|||
25179339|NCT01475461|50324642|FG006|Treatment Period|Other|0|||
25179340|NCT01475461|50324636|FG000|Treatment Period|Protocol Violation|0|||
25179341|NCT01475461|50324637|FG001|Treatment Period|Protocol Violation|1|||
25179342|NCT01475461|50324638|FG002|Treatment Period|Protocol Violation|0|||
25179343|NCT01475461|50324639|FG003|Treatment Period|Protocol Violation|0|||
25015677|NCT02959918|50110496|FG003|Overall Study|Adverse Event|0|||
25015678|NCT02959918|50110497|FG004|Overall Study|Adverse Event|0|||
25015679|NCT02959918|50110498|FG005|Overall Study|Adverse Event|2|||
25015680|NCT02959918|50110499|FG006|Overall Study|Adverse Event|2|||
25015681|NCT02959918|50110500|FG007|Overall Study|Adverse Event|1|||
25015682|NCT02959918|50110501|FG008|Overall Study|Adverse Event|2|||
25015683|NCT02959918|50110502|FG009|Overall Study|Adverse Event|1|||
25015684|NCT02959918|50110503|FG010|Overall Study|Adverse Event|1|||
25015685|NCT02959918|50110504|FG011|Overall Study|Adverse Event|3|||
25015686|NCT02959918|50110505|FG012|Overall Study|Adverse Event|2|||
25015687|NCT02959918|50110506|FG013|Overall Study|Adverse Event|4|||
25015688|NCT02959918|50110493|FG000|Overall Study|Lost to Follow-up|0|||
25015689|NCT02959918|50110494|FG001|Overall Study|Lost to Follow-up|0|||
25015690|NCT02959918|50110495|FG002|Overall Study|Lost to Follow-up|0|||
25015691|NCT02959918|50110496|FG003|Overall Study|Lost to Follow-up|0|||
25015692|NCT02959918|50110497|FG004|Overall Study|Lost to Follow-up|0|||
25015693|NCT02959918|50110498|FG005|Overall Study|Lost to Follow-up|0|||
25015694|NCT02959918|50110499|FG006|Overall Study|Lost to Follow-up|0|||
25015695|NCT02959918|50110500|FG007|Overall Study|Lost to Follow-up|0|||
25015696|NCT02959918|50110501|FG008|Overall Study|Lost to Follow-up|0|||
25015697|NCT02959918|50110502|FG009|Overall Study|Lost to Follow-up|1|||
25015698|NCT02959918|50110503|FG010|Overall Study|Lost to Follow-up|0|||
25015699|NCT02959918|50110504|FG011|Overall Study|Lost to Follow-up|0|||
25015700|NCT02959918|50110505|FG012|Overall Study|Lost to Follow-up|1|||
25015701|NCT02959918|50110506|FG013|Overall Study|Lost to Follow-up|0|||
25015702|NCT02959918|50110493|FG000|Overall Study|Withdrawal by Subject|0|||
25015703|NCT02959918|50110494|FG001|Overall Study|Withdrawal by Subject|0|||
25015704|NCT02959918|50110495|FG002|Overall Study|Withdrawal by Subject|1|||
25143232|NCT02043899|50256717|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
25143233|NCT02043899|50256717|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
25143234|NCT02043899|50256717|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
25143235|NCT02043899|50256717|FG000|Overall Study|Treatment delayed|1|||
25143236|NCT02043509|50256723|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
25143237|NCT02043509|50256724|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
25143238|NCT02043509|50256723|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
25143239|NCT02043509|50256724|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
25143240|NCT02043509|50256723|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
25143241|NCT02043509|50256724|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
25143242|NCT02043509|50256723|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
25179344|NCT01475461|50324640|FG004|Treatment Period|Protocol Violation|0|||
25179345|NCT01475461|50324641|FG005|Treatment Period|Protocol Violation|0|||
25179346|NCT01475461|50324642|FG006|Treatment Period|Protocol Violation|1|||
25179347|NCT01475461|50324636|FG000|Treatment Period|Lack of Efficacy|0|||
25015705|NCT02959918|50110496|FG003|Overall Study|Withdrawal by Subject|2|||
25015706|NCT02959918|50110497|FG004|Overall Study|Withdrawal by Subject|0|||
25015707|NCT02959918|50110498|FG005|Overall Study|Withdrawal by Subject|0|||
25015708|NCT02959918|50110499|FG006|Overall Study|Withdrawal by Subject|1|||
25015709|NCT02959918|50110500|FG007|Overall Study|Withdrawal by Subject|0|||
25179348|NCT01475461|50324637|FG001|Treatment Period|Lack of Efficacy|2|||
25274437|NCT01078623|50588458|FG003|Treatment Period 4|Withdrawal by Subject|0|||
25015710|NCT02959918|50110501|FG008|Overall Study|Withdrawal by Subject|1|||
25015711|NCT02959918|50110502|FG009|Overall Study|Withdrawal by Subject|1|||
25015712|NCT02959918|50110503|FG010|Overall Study|Withdrawal by Subject|2|||
25179349|NCT01475461|50324638|FG002|Treatment Period|Lack of Efficacy|0|||
25015713|NCT02959918|50110504|FG011|Overall Study|Withdrawal by Subject|3|||
25015714|NCT02959918|50110505|FG012|Overall Study|Withdrawal by Subject|1|||
25015715|NCT02959918|50110506|FG013|Overall Study|Withdrawal by Subject|1|||
25015716|NCT02959918|50110493|FG000|Overall Study|Protocol Violation|0|||
25015717|NCT02959918|50110494|FG001|Overall Study|Protocol Violation|0|||
25015718|NCT02959918|50110495|FG002|Overall Study|Protocol Violation|1|||
25015719|NCT02959918|50110496|FG003|Overall Study|Protocol Violation|0|||
25015720|NCT02959918|50110497|FG004|Overall Study|Protocol Violation|0|||
25015721|NCT02959918|50110498|FG005|Overall Study|Protocol Violation|1|||
25179350|NCT01475461|50324639|FG003|Treatment Period|Lack of Efficacy|2|||
25179351|NCT01475461|50324640|FG004|Treatment Period|Lack of Efficacy|1|||
25179352|NCT01475461|50324641|FG005|Treatment Period|Lack of Efficacy|1|||
25179353|NCT01475461|50324642|FG006|Treatment Period|Lack of Efficacy|0|||
25179354|NCT01475461|50324636|FG000|Treatment Period|Medication Error|0|||
25179355|NCT01475461|50324637|FG001|Treatment Period|Medication Error|0|||
25179356|NCT01475461|50324638|FG002|Treatment Period|Medication Error|0|||
25179357|NCT01475461|50324639|FG003|Treatment Period|Medication Error|1|||
25179358|NCT01475461|50324640|FG004|Treatment Period|Medication Error|0|||
25179359|NCT01475461|50324641|FG005|Treatment Period|Medication Error|0|||
25179360|NCT01475461|50324642|FG006|Treatment Period|Medication Error|0|||
25179361|NCT01475461|50324636|FG000|Treatment Period|Adverse Event|0|||
25179362|NCT01475461|50324637|FG001|Treatment Period|Adverse Event|0|||
25179363|NCT01475461|50324638|FG002|Treatment Period|Adverse Event|0|||
25179364|NCT01475461|50324639|FG003|Treatment Period|Adverse Event|1|||
25179365|NCT01475461|50324640|FG004|Treatment Period|Adverse Event|0|||
25179366|NCT01475461|50324641|FG005|Treatment Period|Adverse Event|0|||
25179367|NCT01475461|50324642|FG006|Treatment Period|Adverse Event|0|||
25179368|NCT01589822|50324678|FG000|Overall Study|Withdrawal by Subject|1|||
25179369|NCT01589822|50324679|FG001|Overall Study|Withdrawal by Subject|2|||
25179370|NCT01589822|50324680|FG002|Overall Study|Withdrawal by Subject|0|||
25179371|NCT01589822|50324678|FG000|Overall Study|Death|1|||
25179372|NCT01589822|50324679|FG001|Overall Study|Death|0|||
25179373|NCT01589822|50324680|FG002|Overall Study|Death|0|||
25179374|NCT01589822|50324678|FG000|Overall Study|Missed 90 day visit|2|||
25179375|NCT01589822|50324679|FG001|Overall Study|Missed 90 day visit|1|||
25179376|NCT01589822|50324680|FG002|Overall Study|Missed 90 day visit|1|||
25179377|NCT01565642|50324692|FG000|Overall Study|Withdrawal by Subject|2|||
25179378|NCT01565642|50324693|FG001|Overall Study|Withdrawal by Subject|1|||
25179379|NCT01475071|50324699|FG000|Overall Study|Physician Decision|1|||
25179380|NCT01475071|50324699|FG000|Overall Study|Withdrawal by Subject|6|||
25179381|NCT01475071|50324699|FG000|Overall Study|Lost to Follow-up|1|||
25179382|NCT01474993|50324707|FG000|Overall Study|Lost to Follow-up|1|||
25179383|NCT01474993|50324708|FG001|Overall Study|Lost to Follow-up|2|||
25179384|NCT01474993|50324707|FG000|Overall Study|Adverse Event|0|||
25179385|NCT01474993|50324708|FG001|Overall Study|Adverse Event|1|||
25179386|NCT01691768|50324718|FG000|Overall Study|Death|0|||
25179387|NCT01691768|50324719|FG001|Overall Study|Death|2|||
25179388|NCT01691768|50324718|FG000|Overall Study|Lost to Follow-up|4|||
25179389|NCT01691768|50324719|FG001|Overall Study|Lost to Follow-up|3|||
25179390|NCT01691768|50324718|FG000|Overall Study|Withdrawal by Subject|10|||
25179391|NCT01691768|50324719|FG001|Overall Study|Withdrawal by Subject|9|||
25179392|NCT01691768|50324718|FG000|Overall Study|Relocated|0|||
25179393|NCT01691768|50324719|FG001|Overall Study|Relocated|1|||
25179394|NCT01691768|50324718|FG000|Overall Study|Investigator decision|1|||
25179395|NCT01691768|50324719|FG001|Overall Study|Investigator decision|1|||
25179396|NCT01503229|50324726|FG000|Overall Study|Withdrew consent|1|||
25179397|NCT01691612|50324730|FG000|Overall Study|deemed ineligible after 1st visit|6|||
25179398|NCT01691612|50324730|FG000|Overall Study|Adverse Event|1|||
25179399|NCT01565564|50324736|FG000|Overall Study|Lost to Follow-up|5|||
25179400|NCT01565564|50324737|FG001|Overall Study|Lost to Follow-up|1|||
25179401|NCT01460407|50324743|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
25179402|NCT01460407|50324744|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
25179403|NCT01502371|50324756|FG000|Overall Study|Withdrawal by Subject|1|||
25179404|NCT01502371|50324757|FG001|Overall Study|Withdrawal by Subject|2|||
25179405|NCT01502371|50324758|FG002|Overall Study|Withdrawal by Subject|1|||
25015722|NCT02959918|50110499|FG006|Overall Study|Protocol Violation|0|||
25015723|NCT02959918|50110500|FG007|Overall Study|Protocol Violation|0|||
25015724|NCT02959918|50110501|FG008|Overall Study|Protocol Violation|2|||
25015725|NCT02959918|50110502|FG009|Overall Study|Protocol Violation|1|||
25179406|NCT01502371|50324759|FG003|Overall Study|Withdrawal by Subject|1|||
25179407|NCT01502371|50324760|FG004|Overall Study|Withdrawal by Subject|1|||
25179408|NCT01502371|50324756|FG000|Overall Study|Adverse Event|2|||
25179409|NCT01502371|50324757|FG001|Overall Study|Adverse Event|1|||
25179410|NCT01502371|50324758|FG002|Overall Study|Adverse Event|0|||
25179411|NCT01502371|50324759|FG003|Overall Study|Adverse Event|4|||
25179412|NCT01502371|50324760|FG004|Overall Study|Adverse Event|3|||
25179413|NCT01502371|50324756|FG000|Overall Study|Treatment Failure|22|||
25179414|NCT01502371|50324757|FG001|Overall Study|Treatment Failure|20|||
25015726|NCT02959918|50110503|FG010|Overall Study|Protocol Violation|0|||
25015727|NCT02959918|50110504|FG011|Overall Study|Protocol Violation|1|||
25179415|NCT01502371|50324758|FG002|Overall Study|Treatment Failure|12|||
25179416|NCT01502371|50324759|FG003|Overall Study|Treatment Failure|19|||
25179417|NCT01502371|50324760|FG004|Overall Study|Treatment Failure|30|||
25179418|NCT01502371|50324756|FG000|Overall Study|Lack of Efficacy|3|||
25179419|NCT01502371|50324757|FG001|Overall Study|Lack of Efficacy|3|||
25179420|NCT01502371|50324758|FG002|Overall Study|Lack of Efficacy|2|||
25179421|NCT01502371|50324759|FG003|Overall Study|Lack of Efficacy|2|||
25179422|NCT01502371|50324760|FG004|Overall Study|Lack of Efficacy|4|||
25179423|NCT01502371|50324756|FG000|Overall Study|Physician Decision|3|||
25179424|NCT01502371|50324757|FG001|Overall Study|Physician Decision|0|||
25179425|NCT01502371|50324758|FG002|Overall Study|Physician Decision|0|||
25179426|NCT01502371|50324759|FG003|Overall Study|Physician Decision|0|||
25179427|NCT01502371|50324760|FG004|Overall Study|Physician Decision|1|||
25179428|NCT01502371|50324756|FG000|Overall Study|Noncompliance with Study Drug|0|||
25179429|NCT01502371|50324757|FG001|Overall Study|Noncompliance with Study Drug|0|||
25179430|NCT01502371|50324758|FG002|Overall Study|Noncompliance with Study Drug|1|||
25179431|NCT01502371|50324759|FG003|Overall Study|Noncompliance with Study Drug|2|||
25179432|NCT01502371|50324760|FG004|Overall Study|Noncompliance with Study Drug|1|||
25179433|NCT01502371|50324756|FG000|Overall Study|Technical Problems|1|||
25179434|NCT01502371|50324757|FG001|Overall Study|Technical Problems|0|||
25179435|NCT01502371|50324758|FG002|Overall Study|Technical Problems|2|||
25179436|NCT01502371|50324759|FG003|Overall Study|Technical Problems|4|||
25179437|NCT01502371|50324760|FG004|Overall Study|Technical Problems|1|||
25179438|NCT01502371|50324756|FG000|Overall Study|Protocol Violation|9|||
25179439|NCT01502371|50324757|FG001|Overall Study|Protocol Violation|5|||
25179440|NCT01502371|50324758|FG002|Overall Study|Protocol Violation|6|||
25179441|NCT01502371|50324759|FG003|Overall Study|Protocol Violation|5|||
25179442|NCT01502371|50324760|FG004|Overall Study|Protocol Violation|10|||
25179443|NCT01502371|50324756|FG000|Overall Study|Excluded Medication|0|||
25179444|NCT01502371|50324757|FG001|Overall Study|Excluded Medication|1|||
25179445|NCT01502371|50324758|FG002|Overall Study|Excluded Medication|1|||
25179446|NCT01502371|50324759|FG003|Overall Study|Excluded Medication|0|||
25179447|NCT01502371|50324760|FG004|Overall Study|Excluded Medication|1|||
25179448|NCT01588496|50324776|FG000|Overall Study|Withdrawal by Subject|0|||
25179449|NCT01588496|50324777|FG001|Overall Study|Withdrawal by Subject|1|||
25179450|NCT01588496|50324778|FG002|Overall Study|Withdrawal by Subject|0|||
25179451|NCT01502293|50324789|FG000|Overall Study|Progressive Disease|20|||
25179452|NCT01502293|50324790|FG001|Overall Study|Progressive Disease|12|||
25179453|NCT01502293|50324791|FG002|Overall Study|Progressive Disease|2|||
25179454|NCT01502293|50324789|FG000|Overall Study|Withdrawal by Subject|3|||
25179455|NCT01502293|50324790|FG001|Overall Study|Withdrawal by Subject|3|||
25179456|NCT01502293|50324791|FG002|Overall Study|Withdrawal by Subject|1|||
25179457|NCT01502293|50324789|FG000|Overall Study|Adverse Event|0|||
25179458|NCT01502293|50324790|FG001|Overall Study|Adverse Event|2|||
25179459|NCT01502293|50324791|FG002|Overall Study|Adverse Event|0|||
25179460|NCT01502293|50324789|FG000|Overall Study|Reason Not Specified|2|||
25179461|NCT01502293|50324790|FG001|Overall Study|Reason Not Specified|0|||
25179462|NCT01502293|50324791|FG002|Overall Study|Reason Not Specified|0|||
25179463|NCT01502293|50324789|FG000|Overall Study|Physician Decision|0|||
25179464|NCT01502293|50324790|FG001|Overall Study|Physician Decision|0|||
25179465|NCT01502293|50324791|FG002|Overall Study|Physician Decision|1|||
25179466|NCT01474681|50324804|FG000|Overall Study|Death|0|||
25179467|NCT01474681|50324805|FG001|Overall Study|Death|3|||
25179468|NCT01474681|50324806|FG002|Overall Study|Death|2|||
25179469|NCT01474681|50324807|FG003|Overall Study|Death|6|||
25179470|NCT01459783|50324823|FG000|Baseline to 6 Months|Death|1|||
25179471|NCT01459783|50324824|FG001|Baseline to 6 Months|Death|0|||
25179472|NCT01459783|50324823|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
25179473|NCT01459783|50324824|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
25179474|NCT01459783|50324823|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
25179475|NCT01459783|50324824|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
25179476|NCT01459783|50324823|FG000|6 Months to 12 Months|Death|0|||
25179477|NCT01459783|50324824|FG001|6 Months to 12 Months|Death|1|||
25179478|NCT01459783|50324823|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
25179479|NCT01459783|50324824|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
25179480|NCT01459783|50324823|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
25179481|NCT01459783|50324824|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
25179482|NCT01459783|50324823|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
25179483|NCT01459783|50324824|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
25179484|NCT01588184|50324836|FG000|Overall Study|Death|1|||
25179485|NCT01588184|50324837|FG001|Overall Study|Death|0|||
25179486|NCT01588184|50324838|FG002|Overall Study|Death|0|||
25179487|NCT01588184|50324839|FG003|Overall Study|Death|1|||
25179488|NCT01588184|50324840|FG004|Overall Study|Death|1|||
25179489|NCT01588184|50324841|FG005|Overall Study|Death|1|||
25274438|NCT01078623|50588459|FG004|Treatment Period 4|Withdrawal by Subject|0|||
25179490|NCT01588184|50324836|FG000|Overall Study|Withdrawal by Subject|2|||
25179491|NCT01588184|50324837|FG001|Overall Study|Withdrawal by Subject|4|||
25179492|NCT01588184|50324838|FG002|Overall Study|Withdrawal by Subject|0|||
25179493|NCT01588184|50324839|FG003|Overall Study|Withdrawal by Subject|1|||
25179494|NCT01588184|50324840|FG004|Overall Study|Withdrawal by Subject|0|||
25179495|NCT01588184|50324841|FG005|Overall Study|Withdrawal by Subject|0|||
25179496|NCT01588184|50324836|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
25179497|NCT01588184|50324837|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
25179498|NCT01588184|50324838|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
25179499|NCT01588184|50324839|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
25179500|NCT01588184|50324840|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
25179501|NCT01588184|50324841|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
25179502|NCT01588184|50324836|FG000|Overall Study|multiple reasons|0|||
25179503|NCT01588184|50324837|FG001|Overall Study|multiple reasons|3|||
25179504|NCT01588184|50324838|FG002|Overall Study|multiple reasons|0|||
25179505|NCT01588184|50324839|FG003|Overall Study|multiple reasons|1|||
25179506|NCT01588184|50324840|FG004|Overall Study|multiple reasons|0|||
25179507|NCT01588184|50324841|FG005|Overall Study|multiple reasons|0|||
25179508|NCT01588106|50324857|FG000|Overall Study|Withdrawal by Subject|5|||
25179509|NCT01588106|50324858|FG001|Overall Study|Withdrawal by Subject|4|||
25179510|NCT01564862|50324867|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
25179511|NCT01564862|50324868|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
25179512|NCT01564862|50324869|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
25179513|NCT01564862|50324867|FG000|Overall Study|Major Protocol Deviation|3|||
25179514|NCT01564862|50324868|FG001|Overall Study|Major Protocol Deviation|3|||
25179515|NCT01564862|50324869|FG002|Overall Study|Major Protocol Deviation|4|||
25143243|NCT02043509|50256724|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
25143244|NCT02058563|50256732|FG000|Overall Study|Lost to Follow-up|26|||
25143245|NCT02058563|50256733|FG001|Overall Study|Lost to Follow-up|22|||
25179516|NCT01564862|50324867|FG000|Overall Study|Lost to Follow-up|10|||
25179517|NCT01564862|50324868|FG001|Overall Study|Lost to Follow-up|8|||
25179518|NCT01564862|50324869|FG002|Overall Study|Lost to Follow-up|6|||
25179519|NCT01564862|50324867|FG000|Overall Study|Voluntary Withdrawal|9|||
25179520|NCT01564862|50324868|FG001|Overall Study|Voluntary Withdrawal|6|||
25179521|NCT01564862|50324869|FG002|Overall Study|Voluntary Withdrawal|8|||
25179522|NCT01564862|50324867|FG000|Overall Study|Lack of Efficacy|1|||
25179523|NCT01564862|50324868|FG001|Overall Study|Lack of Efficacy|5|||
25179524|NCT01564862|50324869|FG002|Overall Study|Lack of Efficacy|6|||
25179525|NCT01564862|50324867|FG000|Overall Study|Other reason(s)|1|||
25179526|NCT01564862|50324868|FG001|Overall Study|Other reason(s)|0|||
25179527|NCT01564862|50324869|FG002|Overall Study|Other reason(s)|0|||
25179528|NCT01691378|50324879|FG000|Overall Study|Withdrawal by Subject|2|||
25179529|NCT01691378|50324880|FG001|Overall Study|Withdrawal by Subject|0|||
25179530|NCT01691378|50324879|FG000|Overall Study|Lost to Follow-up|5|||
25179531|NCT01691378|50324880|FG001|Overall Study|Lost to Follow-up|2|||
25179532|NCT01467479|50324889|FG000|Overall Study|No Study Medication|1|||
25179533|NCT01467479|50324890|FG001|Overall Study|No Study Medication|0|||
25179534|NCT01467479|50324891|FG002|Overall Study|No Study Medication|2|||
25179535|NCT01467479|50324889|FG000|Overall Study|Adverse Event|1|||
25179536|NCT01467479|50324890|FG001|Overall Study|Adverse Event|2|||
25179537|NCT01467479|50324891|FG002|Overall Study|Adverse Event|0|||
25179538|NCT01467479|50324889|FG000|Overall Study|Death|0|||
25179539|NCT01467479|50324890|FG001|Overall Study|Death|0|||
25179540|NCT01467479|50324891|FG002|Overall Study|Death|1|||
25179541|NCT01467479|50324889|FG000|Overall Study|Lost to Follow-up|2|||
25179542|NCT01467479|50324890|FG001|Overall Study|Lost to Follow-up|5|||
25179543|NCT01467479|50324891|FG002|Overall Study|Lost to Follow-up|3|||
25179544|NCT01467479|50324889|FG000|Overall Study|Withdrawal of Consent|3|||
25179545|NCT01467479|50324890|FG001|Overall Study|Withdrawal of Consent|7|||
25143246|NCT02058563|50256732|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
25143247|NCT02058563|50256733|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
25143248|NCT02058563|50256732|FG000|Overall Study|Consent Withdrawal|1|||
25143249|NCT02058563|50256733|FG001|Overall Study|Consent Withdrawal|1|||
25143250|NCT02058563|50256732|FG000|Overall Study|Other (patient incarcerated)|0|||
25143251|NCT02058563|50256733|FG001|Overall Study|Other (patient incarcerated)|1|||
25143252|NCT01622231|50256739|FG000|Overall Study|Physician Decision|1|||
25143253|NCT01622231|50256739|FG000|Overall Study|Withdrawal by Subject|1|||
25143254|NCT02042183|50256745|FG000|Overall Study|Physician Decision|7|||
25143255|NCT02042183|50256746|FG001|Overall Study|Physician Decision|2|||
25143256|NCT02042183|50256745|FG000|Overall Study|Lack of Efficacy|4|||
25179546|NCT01467479|50324891|FG002|Overall Study|Withdrawal of Consent|7|||
25179547|NCT01467479|50324889|FG000|Overall Study|Study Terminated by Sponsor|1|||
25143257|NCT02042183|50256746|FG001|Overall Study|Lack of Efficacy|3|||
25179548|NCT01467479|50324890|FG001|Overall Study|Study Terminated by Sponsor|3|||
25179549|NCT01467479|50324891|FG002|Overall Study|Study Terminated by Sponsor|3|||
25179550|NCT01467479|50324889|FG000|Overall Study|Other|1|||
25179551|NCT01467479|50324890|FG001|Overall Study|Other|0|||
25143258|NCT02042183|50256745|FG000|Overall Study|Non-compliance with Study Drug|2|||
25143259|NCT02042183|50256746|FG001|Overall Study|Non-compliance with Study Drug|3|||
25143260|NCT02042183|50256745|FG000|Overall Study|Adverse Event|17|||
25179552|NCT01467479|50324891|FG002|Overall Study|Other|0|||
25179553|NCT01466387|50324906|FG000|Overall Study|Adverse Event|0|||
25179554|NCT01466387|50324907|FG001|Overall Study|Adverse Event|0|||
25179555|NCT01466387|50324908|FG002|Overall Study|Adverse Event|1|||
25179556|NCT01466387|50324909|FG003|Overall Study|Adverse Event|1|||
25179557|NCT01466387|50324910|FG004|Overall Study|Adverse Event|0|||
25179558|NCT01466387|50324911|FG005|Overall Study|Adverse Event|0|||
25179559|NCT01466387|50324906|FG000|Overall Study|Lost to Follow-up|0|||
25179560|NCT01466387|50324907|FG001|Overall Study|Lost to Follow-up|0|||
25179561|NCT01466387|50324908|FG002|Overall Study|Lost to Follow-up|0|||
25179562|NCT01466387|50324909|FG003|Overall Study|Lost to Follow-up|0|||
25179563|NCT01466387|50324910|FG004|Overall Study|Lost to Follow-up|0|||
25179564|NCT01466387|50324911|FG005|Overall Study|Lost to Follow-up|1|||
25179565|NCT01466387|50324906|FG000|Overall Study|Protocol Violation|1|||
25179566|NCT01466387|50324907|FG001|Overall Study|Protocol Violation|0|||
25179567|NCT01466387|50324908|FG002|Overall Study|Protocol Violation|0|||
25179568|NCT01466387|50324909|FG003|Overall Study|Protocol Violation|1|||
25179569|NCT01466387|50324910|FG004|Overall Study|Protocol Violation|0|||
25179570|NCT01466387|50324911|FG005|Overall Study|Protocol Violation|0|||
25179571|NCT01564784|50325042|FG000|Overall Study|Other|1|||
25179572|NCT01564784|50325043|FG001|Overall Study|Other|0|||
25179573|NCT01564784|50325042|FG000|Overall Study|Subject refused further follow-up|1|||
25179574|NCT01564784|50325043|FG001|Overall Study|Subject refused further follow-up|6|||
25179575|NCT01564784|50325042|FG000|Overall Study|Lost to Follow-up|1|||
25179576|NCT01564784|50325043|FG001|Overall Study|Lost to Follow-up|1|||
25179577|NCT01564784|50325042|FG000|Overall Study|Death|131|||
25179578|NCT01564784|50325043|FG001|Overall Study|Death|126|||
25179579|NCT01564394|50325094|FG000|Overall Study|Withdrawal by Subject|6|||
25179580|NCT01564394|50325095|FG001|Overall Study|Withdrawal by Subject|10|||
25179581|NCT01690988|50325109|FG000|Overall Study|Withdrawal by Subject|2|||
25179582|NCT01690988|50325110|FG001|Overall Study|Withdrawal by Subject|2|||
25179583|NCT01690988|50325111|FG002|Overall Study|Withdrawal by Subject|3|||
25179584|NCT01690988|50325109|FG000|Overall Study|Physician Decision|0|||
25179585|NCT01690988|50325110|FG001|Overall Study|Physician Decision|0|||
25179586|NCT01690988|50325111|FG002|Overall Study|Physician Decision|1|||
25179587|NCT01690988|50325109|FG000|Overall Study|Operation Cancelled|1|||
25179588|NCT01690988|50325110|FG001|Overall Study|Operation Cancelled|1|||
25179589|NCT01690988|50325111|FG002|Overall Study|Operation Cancelled|0|||
25179590|NCT01690988|50325109|FG000|Overall Study|Determined ineligible|1|||
25179591|NCT01690988|50325110|FG001|Overall Study|Determined ineligible|0|||
25179592|NCT01690988|50325111|FG002|Overall Study|Determined ineligible|0|||
25179593|NCT01690988|50325109|FG000|Overall Study|Death|1|||
25179594|NCT01690988|50325110|FG001|Overall Study|Death|1|||
25179595|NCT01690988|50325111|FG002|Overall Study|Death|1|||
25179596|NCT01690988|50325109|FG000|Overall Study|Sedated|1|||
25179597|NCT01690988|50325110|FG001|Overall Study|Sedated|1|||
25179598|NCT01690988|50325111|FG002|Overall Study|Sedated|2|||
25179599|NCT01466153|50325142|FG000|Overall Study|Disease Progression|2|||
25179600|NCT01466153|50325143|FG001|Overall Study|Disease Progression|2|||
25179601|NCT01466153|50325144|FG002|Overall Study|Disease Progression|0|||
25179602|NCT01466153|50325142|FG000|Overall Study|Adverse Event|14|||
25179603|NCT01466153|50325143|FG001|Overall Study|Adverse Event|13|||
25179604|NCT01466153|50325144|FG002|Overall Study|Adverse Event|17|||
25179605|NCT01466153|50325142|FG000|Overall Study|Withdrawal of Consent|2|||
25179606|NCT01466153|50325143|FG001|Overall Study|Withdrawal of Consent|0|||
25179607|NCT01466153|50325144|FG002|Overall Study|Withdrawal of Consent|0|||
25179608|NCT01466153|50325142|FG000|Overall Study|Investigator Discretion|3|||
25179609|NCT01466153|50325143|FG001|Overall Study|Investigator Discretion|2|||
25179610|NCT01466153|50325144|FG002|Overall Study|Investigator Discretion|2|||
25179611|NCT01466153|50325142|FG000|Overall Study|Randomized-Not Treated|2|||
25179612|NCT01466153|50325143|FG001|Overall Study|Randomized-Not Treated|3|||
25179613|NCT01466153|50325144|FG002|Overall Study|Randomized-Not Treated|4|||
25179614|NCT01466153|50325142|FG000|Overall Study|Other-Unspecified|6|||
25179615|NCT01466153|50325143|FG001|Overall Study|Other-Unspecified|4|||
25179616|NCT01466153|50325144|FG002|Overall Study|Other-Unspecified|2|||
25179617|NCT01474291|50325165|FG000|Overall Study|Not Evaluable for Efficacy|26|||
25179618|NCT01474291|50325165|FG000|Overall Study|Lack of Treatment Efficacy|88|||
25179619|NCT01474291|50325165|FG000|Overall Study|Adverse Event|53|||
25179620|NCT01474291|50325165|FG000|Overall Study|Lost to Follow-up|29|||
25179621|NCT01474291|50325165|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
25179622|NCT01474291|50325165|FG000|Overall Study|No Reason Reported|10|||
25179623|NCT01474291|50325165|FG000|Overall Study|Death|2|||
25179624|NCT01465997|50325174|FG000|Overall Study|Adverse Event|12|||
25179625|NCT01465997|50325175|FG001|Overall Study|Adverse Event|22|||
25179626|NCT01465997|50325174|FG000|Overall Study|Lack of Efficacy|13|||
25179627|NCT01465997|50325175|FG001|Overall Study|Lack of Efficacy|1|||
25179628|NCT01465997|50325174|FG000|Overall Study|Protocol Violation|1|||
25179629|NCT01465997|50325175|FG001|Overall Study|Protocol Violation|4|||
25179630|NCT01465997|50325174|FG000|Overall Study|Lost to Follow-up|6|||
25179631|NCT01465997|50325175|FG001|Overall Study|Lost to Follow-up|9|||
25179632|NCT01465997|50325174|FG000|Overall Study|Withdrawal by Subject|32|||
25179633|NCT01465997|50325175|FG001|Overall Study|Withdrawal by Subject|35|||
25179634|NCT01465997|50325174|FG000|Overall Study|investigator's decision|1|||
25179635|NCT01465997|50325175|FG001|Overall Study|investigator's decision|1|||
25179636|NCT01465997|50325174|FG000|Overall Study|Death|0|||
25179637|NCT01465997|50325175|FG001|Overall Study|Death|1|||
25179638|NCT01465997|50325174|FG000|Overall Study|sponsor's decision|1|||
25179639|NCT01465997|50325175|FG001|Overall Study|sponsor's decision|1|||
25179640|NCT01465997|50325174|FG000|Overall Study|subject withdrew consent|1|||
25179641|NCT01465997|50325175|FG001|Overall Study|subject withdrew consent|0|||
25179642|NCT01465997|50325174|FG000|Overall Study|local lab unblinded site|1|||
25179643|NCT01465997|50325175|FG001|Overall Study|local lab unblinded site|0|||
25179644|NCT01465997|50325174|FG000|Overall Study|withdrew before follow-up|0|||
25179645|NCT01465997|50325175|FG001|Overall Study|withdrew before follow-up|13|||
25179646|NCT01465997|50325174|FG000|Overall Study|decision by site staff|0|||
25179647|NCT01465997|50325175|FG001|Overall Study|decision by site staff|1|||
25179648|NCT01465997|50325174|FG000|Overall Study|subject left participation SP0993|0|||
25179649|NCT01465997|50325175|FG001|Overall Study|subject left participation SP0993|1|||
25179650|NCT01465763|50325196|FG000|Overall Study|Withdrawal by Subject|4|||
25179651|NCT01465763|50325197|FG001|Overall Study|Withdrawal by Subject|0|||
25179652|NCT01465763|50325198|FG002|Overall Study|Withdrawal by Subject|1|||
25179653|NCT01465763|50325196|FG000|Overall Study|Insufficient Clinical Response|11|||
25179654|NCT01465763|50325197|FG001|Overall Study|Insufficient Clinical Response|0|||
25179655|NCT01465763|50325198|FG002|Overall Study|Insufficient Clinical Response|1|||
25179656|NCT01465763|50325196|FG000|Overall Study|Adverse Event|9|||
25179657|NCT01465763|50325197|FG001|Overall Study|Adverse Event|0|||
25179658|NCT01465763|50325198|FG002|Overall Study|Adverse Event|1|||
25179659|NCT01465763|50325196|FG000|Overall Study|Other|2|||
25179660|NCT01465763|50325197|FG001|Overall Study|Other|0|||
25179661|NCT01465763|50325198|FG002|Overall Study|Other|0|||
25179662|NCT01465763|50325196|FG000|Overall Study|Protocol Violation|4|||
25179663|NCT01465763|50325197|FG001|Overall Study|Protocol Violation|1|||
25179664|NCT01465763|50325198|FG002|Overall Study|Protocol Violation|1|||
25179665|NCT01465763|50325196|FG000|Overall Study|Death|1|||
25179666|NCT01465763|50325197|FG001|Overall Study|Death|0|||
25179667|NCT01465763|50325198|FG002|Overall Study|Death|0|||
25179668|NCT01690520|50325231|FG000|Overall Study|Death|25|||
25179669|NCT01690520|50325232|FG001|Overall Study|Death|21|||
25179670|NCT01690520|50325231|FG000|Overall Study|Lost to Follow-up|2|||
25179671|NCT01690520|50325232|FG001|Overall Study|Lost to Follow-up|3|||
25179672|NCT01690520|50325231|FG000|Overall Study|Withdrawal by Subject|2|||
25179673|NCT01690520|50325232|FG001|Overall Study|Withdrawal by Subject|0|||
25179674|NCT01690520|50325231|FG000|Overall Study|Relapse|0|||
25179675|NCT01690520|50325232|FG001|Overall Study|Relapse|1|||
25179676|NCT01690520|50325231|FG000|Overall Study|Other|0|||
25179677|NCT01690520|50325232|FG001|Overall Study|Other|1|||
25179678|NCT01690520|50325231|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
25179679|NCT01690520|50325232|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
25179680|NCT01563536|50325253|FG000|Overall Study|Withdrawal by Subject|0|||
25179681|NCT01563536|50325254|FG001|Overall Study|Withdrawal by Subject|2|||
25179682|NCT01563536|50325253|FG000|Overall Study|Lost to Follow-up|1|||
25179683|NCT01563536|50325254|FG001|Overall Study|Lost to Follow-up|0|||
25179684|NCT01690130|50325262|FG000|Overall Study|Subject have cancelled visit.|1|||
25179685|NCT01690130|50325263|FG001|Overall Study|Subject have cancelled visit.|0|||
25179686|NCT01690052|50325269|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
25179687|NCT01690052|50325270|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
25179688|NCT01689974|50325297|FG000|Overall Study|Termination of Study|5|||
25143261|NCT02042183|50256746|FG001|Overall Study|Adverse Event|6|||
25143262|NCT02042183|50256745|FG000|Overall Study|Other|3|||
25143263|NCT02042183|50256746|FG001|Overall Study|Other|3|||
25143264|NCT02042183|50256745|FG000|Overall Study|Withdrawal by Subject|21|||
25143265|NCT02042183|50256746|FG001|Overall Study|Withdrawal by Subject|16|||
25143266|NCT02042183|50256745|FG000|Overall Study|Site Terminated by Sponsor|2|||
25143267|NCT02042183|50256746|FG001|Overall Study|Site Terminated by Sponsor|1|||
25143268|NCT02042183|50256745|FG000|Overall Study|Lost to Follow-up|9|||
25143269|NCT02042183|50256746|FG001|Overall Study|Lost to Follow-up|2|||
25143270|NCT01977482|50256760|FG000|Overall Study|Adverse Event|0|||
25143271|NCT01977482|50256761|FG001|Overall Study|Adverse Event|1|||
25179689|NCT01689974|50325298|FG001|Overall Study|Termination of Study|5|||
25179690|NCT01587014|50325304|FG000|Overall Study|Death|2|||
25179691|NCT01458535|50325416|FG000|Overall Study|Other|0|||
25179692|NCT01458535|50325417|FG001|Overall Study|Other|0|||
25179693|NCT01458535|50325418|FG002|Overall Study|Other|0|||
25179694|NCT01458535|50325419|FG003|Overall Study|Other|0|||
25179695|NCT01458535|50325420|FG004|Overall Study|Other|1|||
25179696|NCT01458535|50325421|FG005|Overall Study|Other|1|||
25179697|NCT01458535|50325416|FG000|Overall Study|Withdrawal by Subject|0|||
25179698|NCT01458535|50325417|FG001|Overall Study|Withdrawal by Subject|0|||
25179699|NCT01458535|50325418|FG002|Overall Study|Withdrawal by Subject|2|||
25179700|NCT01458535|50325419|FG003|Overall Study|Withdrawal by Subject|0|||
25179701|NCT01458535|50325420|FG004|Overall Study|Withdrawal by Subject|1|||
25179702|NCT01458535|50325421|FG005|Overall Study|Withdrawal by Subject|1|||
25179703|NCT01458535|50325416|FG000|Overall Study|Lost to Follow-up|0|||
25179704|NCT01458535|50325417|FG001|Overall Study|Lost to Follow-up|2|||
25179705|NCT01458535|50325418|FG002|Overall Study|Lost to Follow-up|0|||
25179706|NCT01458535|50325419|FG003|Overall Study|Lost to Follow-up|3|||
25179707|NCT01458535|50325420|FG004|Overall Study|Lost to Follow-up|2|||
25179708|NCT01458535|50325421|FG005|Overall Study|Lost to Follow-up|2|||
25179709|NCT01458535|50325416|FG000|Overall Study|Adverse Event|0|||
25179710|NCT01458535|50325417|FG001|Overall Study|Adverse Event|0|||
25179711|NCT01458535|50325418|FG002|Overall Study|Adverse Event|0|||
25179712|NCT01458535|50325419|FG003|Overall Study|Adverse Event|1|||
25179713|NCT01458535|50325420|FG004|Overall Study|Adverse Event|0|||
25179714|NCT01458535|50325421|FG005|Overall Study|Adverse Event|0|||
25179715|NCT01464827|50325449|FG000|Overall Study|Adverse Event|0|||
25179716|NCT01464827|50325450|FG001|Overall Study|Adverse Event|0|||
25179717|NCT01464827|50325451|FG002|Overall Study|Adverse Event|0|||
25179718|NCT01464827|50325452|FG003|Overall Study|Adverse Event|0|||
25179719|NCT01464827|50325453|FG004|Overall Study|Adverse Event|0|||
25179720|NCT01464827|50325454|FG005|Overall Study|Adverse Event|0|||
25179721|NCT01464827|50325455|FG006|Overall Study|Adverse Event|0|||
25179722|NCT01464827|50325456|FG007|Overall Study|Adverse Event|0|||
25179723|NCT01464827|50325457|FG008|Overall Study|Adverse Event|0|||
25179724|NCT01464827|50325458|FG009|Overall Study|Adverse Event|0|||
25179725|NCT01464827|50325459|FG010|Overall Study|Adverse Event|0|||
25179726|NCT01464827|50325460|FG011|Overall Study|Adverse Event|0|||
25179727|NCT01464827|50325461|FG012|Overall Study|Adverse Event|1|||
25179728|NCT01464827|50325462|FG013|Overall Study|Adverse Event|0|||
25179729|NCT01464827|50325449|FG000|Overall Study|Withdrawal by Subject|1|||
25179730|NCT01464827|50325450|FG001|Overall Study|Withdrawal by Subject|0|||
25179731|NCT01464827|50325451|FG002|Overall Study|Withdrawal by Subject|0|||
25179732|NCT01464827|50325452|FG003|Overall Study|Withdrawal by Subject|0|||
25179733|NCT01464827|50325453|FG004|Overall Study|Withdrawal by Subject|1|||
25179734|NCT01464827|50325454|FG005|Overall Study|Withdrawal by Subject|0|||
25179735|NCT01464827|50325455|FG006|Overall Study|Withdrawal by Subject|0|||
25179736|NCT01464827|50325456|FG007|Overall Study|Withdrawal by Subject|1|||
25179737|NCT01464827|50325457|FG008|Overall Study|Withdrawal by Subject|0|||
25179738|NCT01464827|50325458|FG009|Overall Study|Withdrawal by Subject|0|||
25143272|NCT01977482|50256762|FG002|Overall Study|Adverse Event|1|||
25143273|NCT01977482|50256763|FG003|Overall Study|Adverse Event|0|||
25143274|NCT01977482|50256764|FG004|Overall Study|Adverse Event|2|||
25143275|NCT01977482|50256765|FG005|Overall Study|Adverse Event|0|||
25143276|NCT01977482|50256760|FG000|Overall Study|Lost to Follow-up|1|||
25143277|NCT01977482|50256761|FG001|Overall Study|Lost to Follow-up|0|||
25143278|NCT01977482|50256762|FG002|Overall Study|Lost to Follow-up|0|||
25143279|NCT01977482|50256763|FG003|Overall Study|Lost to Follow-up|0|||
25143280|NCT01977482|50256764|FG004|Overall Study|Lost to Follow-up|0|||
25143281|NCT01977482|50256765|FG005|Overall Study|Lost to Follow-up|0|||
25143282|NCT01977482|50256760|FG000|Overall Study|Physician Decision|0|||
25143283|NCT01977482|50256761|FG001|Overall Study|Physician Decision|1|||
25143284|NCT01977482|50256762|FG002|Overall Study|Physician Decision|0|||
25143285|NCT01977482|50256763|FG003|Overall Study|Physician Decision|0|||
25143286|NCT01977482|50256764|FG004|Overall Study|Physician Decision|0|||
25143287|NCT01977482|50256765|FG005|Overall Study|Physician Decision|0|||
25143288|NCT01977482|50256760|FG000|Overall Study|Protocol Violation|0|||
25143289|NCT01977482|50256761|FG001|Overall Study|Protocol Violation|0|||
25143290|NCT01977482|50256762|FG002|Overall Study|Protocol Violation|1|||
25143291|NCT01977482|50256763|FG003|Overall Study|Protocol Violation|0|||
25143292|NCT01977482|50256764|FG004|Overall Study|Protocol Violation|0|||
25143293|NCT01977482|50256765|FG005|Overall Study|Protocol Violation|0|||
25143294|NCT01977482|50256760|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
25143295|NCT01977482|50256761|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
25143296|NCT01977482|50256762|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
25179739|NCT01464827|50325459|FG010|Overall Study|Withdrawal by Subject|0|||
25143297|NCT01977482|50256763|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
25143298|NCT01977482|50256764|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
25143299|NCT01977482|50256765|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
25143300|NCT01977482|50256760|FG000|Overall Study|Withdrawal by Subject|2|||
25143301|NCT01977482|50256761|FG001|Overall Study|Withdrawal by Subject|4|||
25143302|NCT01977482|50256762|FG002|Overall Study|Withdrawal by Subject|1|||
25179740|NCT01464827|50325460|FG011|Overall Study|Withdrawal by Subject|0|||
25179741|NCT01464827|50325461|FG012|Overall Study|Withdrawal by Subject|0|||
25179742|NCT01464827|50325462|FG013|Overall Study|Withdrawal by Subject|0|||
25179743|NCT01464827|50325449|FG000|Overall Study|Lost to Follow-up|0|||
25143303|NCT01977482|50256763|FG003|Overall Study|Withdrawal by Subject|3|||
25143304|NCT01977482|50256764|FG004|Overall Study|Withdrawal by Subject|1|||
25143305|NCT01977482|50256765|FG005|Overall Study|Withdrawal by Subject|5|||
25143306|NCT02058095|50256786|FG000|Overall Study|Adverse Event|1|||
25143307|NCT02058095|50256787|FG001|Overall Study|Adverse Event|0|||
25143308|NCT02023112|50256795|FG000|Overall Study|Withdrawal by Subject|2|||
25143309|NCT02023112|50256796|FG001|Overall Study|Withdrawal by Subject|1|||
25143310|NCT01977092|50256806|FG000|Overall Study|Death|3|||
25143311|NCT01977092|50256807|FG001|Overall Study|Death|4|||
25143312|NCT01977092|50256806|FG000|Overall Study|Lost to Follow-up|23|||
25143313|NCT01977092|50256807|FG001|Overall Study|Lost to Follow-up|14|||
25143314|NCT01977092|50256806|FG000|Overall Study|Withdrawal by Subject|2|||
25143315|NCT01977092|50256807|FG001|Overall Study|Withdrawal by Subject|1|||
25143316|NCT01977092|50256806|FG000|Overall Study|In prison|3|||
25143317|NCT01977092|50256807|FG001|Overall Study|In prison|11|||
25143318|NCT01976624|50256813|FG000|Overall Study|Participants contraindicated|2|||
25143319|NCT01976624|50256813|FG000|Overall Study|Participants age less than 19 years|12|||
25143320|NCT02041091|50256819|FG000|Treatment|Adverse Event|3|||
25143321|NCT02041091|50256820|FG001|Treatment|Adverse Event|3|||
25143322|NCT02041091|50256819|FG000|Treatment|Withdrawal by Subject|2|||
25143323|NCT02041091|50256820|FG001|Treatment|Withdrawal by Subject|4|||
25143324|NCT02041091|50256819|FG000|Treatment|Physician Decision|1|||
25143325|NCT02041091|50256820|FG001|Treatment|Physician Decision|0|||
25143326|NCT02041091|50256819|FG000|Treatment|Sponsor Decision|15|||
25143327|NCT02041091|50256820|FG001|Treatment|Sponsor Decision|16|||
25143328|NCT02041091|50256819|FG000|Treatment|Lost to Follow-up|1|||
25143329|NCT02041091|50256820|FG001|Treatment|Lost to Follow-up|0|||
25143330|NCT02041091|50256819|FG000|Optional Safety Extension Period|Adverse Event|4|||
25143331|NCT02041091|50256820|FG001|Optional Safety Extension Period|Adverse Event|2|||
25143332|NCT02041091|50256819|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
25143333|NCT02041091|50256820|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
25143334|NCT02041091|50256819|FG000|Optional Safety Extension Period|Protocol Violation|2|||
25143335|NCT02041091|50256820|FG001|Optional Safety Extension Period|Protocol Violation|0|||
25143336|NCT02041091|50256819|FG000|Optional Safety Extension Period|Physician Decision|2|||
25143337|NCT02041091|50256820|FG001|Optional Safety Extension Period|Physician Decision|1|||
25143338|NCT02041091|50256819|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
25143339|NCT02041091|50256820|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
25143340|NCT02041091|50256819|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
25143341|NCT02041091|50256820|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
25143342|NCT02057549|50256834|FG000|Overall Study|Lost to Follow-up|1|||
25143343|NCT02057549|50256835|FG001|Overall Study|Lost to Follow-up|0|||
25143344|NCT02057549|50256834|FG000|Overall Study|Physician Decision|1|||
25143345|NCT02057549|50256835|FG001|Overall Study|Physician Decision|0|||
25143346|NCT02057549|50256834|FG000|Overall Study|Withdrawal by Subject|1|||
25143347|NCT02057549|50256835|FG001|Overall Study|Withdrawal by Subject|0|||
25143348|NCT02057393|50256841|FG000|Overall Study|Withdrawal by Subject|1|||
25143349|NCT02057393|50256841|FG000|Overall Study|Patient did not meet criteria|1|||
25143350|NCT02040779|50256848|FG000|Overall Study|Adverse Event|1|||
25143351|NCT02040779|50256849|FG001|Overall Study|Adverse Event|0|||
25143352|NCT02040779|50256850|FG002|Overall Study|Adverse Event|0|||
25143353|NCT02040779|50256848|FG000|Overall Study|Withdrawal by Subject|4|||
25143354|NCT02040779|50256849|FG001|Overall Study|Withdrawal by Subject|1|||
25143355|NCT02040779|50256850|FG002|Overall Study|Withdrawal by Subject|3|||
25143356|NCT02040779|50256848|FG000|Overall Study|Non-compliance|0|||
25143357|NCT02040779|50256849|FG001|Overall Study|Non-compliance|1|||
25143358|NCT02040779|50256850|FG002|Overall Study|Non-compliance|0|||
25143359|NCT02040779|50256848|FG000|Overall Study|Protocol Violation|2|||
25143360|NCT02040779|50256849|FG001|Overall Study|Protocol Violation|1|||
25143361|NCT02040779|50256850|FG002|Overall Study|Protocol Violation|0|||
25143362|NCT02040779|50256848|FG000|Overall Study|Lost to Follow-up|1|||
25143363|NCT02040779|50256849|FG001|Overall Study|Lost to Follow-up|2|||
25143364|NCT02040779|50256850|FG002|Overall Study|Lost to Follow-up|1|||
25143365|NCT02040779|50256848|FG000|Overall Study|Lack of Efficacy|4|||
25143366|NCT02040779|50256849|FG001|Overall Study|Lack of Efficacy|2|||
25143367|NCT02040779|50256850|FG002|Overall Study|Lack of Efficacy|0|||
25143368|NCT02056301|50256860|FG000|Overall Study|Protocol Violation|1|||
25143369|NCT02056301|50256861|FG001|Overall Study|Protocol Violation|2|||
25143370|NCT02056301|50256860|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
25143371|NCT02056301|50256861|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
25143372|NCT02056301|50256860|FG000|Overall Study|Withdrawal by Subject|0|||
25143373|NCT02056301|50256861|FG001|Overall Study|Withdrawal by Subject|1|||
25143374|NCT02056301|50256860|FG000|Overall Study|Issues with epidural|0|||
25143375|NCT02056301|50256861|FG001|Overall Study|Issues with epidural|3|||
25143376|NCT01967888|50256869|FG000|Overall Study|Lost to Follow-up|6|||
25143377|NCT01967888|50256870|FG001|Overall Study|Lost to Follow-up|4|||
25143378|NCT01967888|50256869|FG000|Overall Study|Withdrawal by Subject|1|||
25143379|NCT01967888|50256870|FG001|Overall Study|Withdrawal by Subject|1|||
25143380|NCT01967888|50256869|FG000|Overall Study|Did Not Have Transplant|1|||
25143381|NCT01967888|50256870|FG001|Overall Study|Did Not Have Transplant|0|||
25143382|NCT01967888|50256869|FG000|Overall Study|Research visit not done, data recorded|1|||
25143383|NCT01967888|50256870|FG001|Overall Study|Research visit not done, data recorded|0|||
25143384|NCT01967888|50256869|FG000|Overall Study|Subject excluded after randomization|1|||
25143385|NCT01967888|50256870|FG001|Overall Study|Subject excluded after randomization|0|||
25143386|NCT01967888|50256869|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
25179744|NCT01464827|50325450|FG001|Overall Study|Lost to Follow-up|2|||
25179745|NCT01464827|50325451|FG002|Overall Study|Lost to Follow-up|0|||
25179746|NCT01464827|50325452|FG003|Overall Study|Lost to Follow-up|2|||
25179747|NCT01464827|50325453|FG004|Overall Study|Lost to Follow-up|3|||
25179748|NCT01464827|50325454|FG005|Overall Study|Lost to Follow-up|1|||
25179749|NCT01464827|50325455|FG006|Overall Study|Lost to Follow-up|2|||
25179750|NCT01464827|50325456|FG007|Overall Study|Lost to Follow-up|2|||
25179751|NCT01464827|50325457|FG008|Overall Study|Lost to Follow-up|0|||
25179752|NCT01464827|50325458|FG009|Overall Study|Lost to Follow-up|0|||
25179753|NCT01464827|50325459|FG010|Overall Study|Lost to Follow-up|0|||
25179754|NCT01464827|50325460|FG011|Overall Study|Lost to Follow-up|1|||
25179755|NCT01464827|50325461|FG012|Overall Study|Lost to Follow-up|0|||
25179756|NCT01464827|50325462|FG013|Overall Study|Lost to Follow-up|1|||
25179757|NCT01464827|50325449|FG000|Overall Study|Other|2|||
25179758|NCT01464827|50325450|FG001|Overall Study|Other|3|||
25179759|NCT01464827|50325451|FG002|Overall Study|Other|0|||
25179760|NCT01464827|50325452|FG003|Overall Study|Other|2|||
25179761|NCT01464827|50325453|FG004|Overall Study|Other|3|||
25179762|NCT01464827|50325454|FG005|Overall Study|Other|0|||
25179763|NCT01464827|50325455|FG006|Overall Study|Other|1|||
25143387|NCT01967888|50256870|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
25143388|NCT01967888|50256869|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
25143389|NCT01967888|50256870|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
25143390|NCT01967732|50256878|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
25143391|NCT01967732|50256879|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
25143392|NCT01967732|50256880|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
25143393|NCT01967732|50256881|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
25143394|NCT01967732|50256878|FG000|First Intervention (Day 1)|Poor venous access|0|||
25143395|NCT01967732|50256879|FG001|First Intervention (Day 1)|Poor venous access|1|||
25143396|NCT01967732|50256880|FG002|First Intervention (Day 1)|Poor venous access|0|||
25143397|NCT01967732|50256881|FG003|First Intervention (Day 1)|Poor venous access|0|||
25143398|NCT01967576|50256889|FG000|Overall Study|Withdrawal by Subject|3|||
25143399|NCT01967576|50256889|FG000|Overall Study|Progressed/Removed from treatment|1|||
25143400|NCT01967576|50256889|FG000|Overall Study|Study closing at site|1|||
25143401|NCT01967576|50256889|FG000|Overall Study|Adverse Event|1|||
25143402|NCT01967576|50256889|FG000|Overall Study|Refused further treatment|1|||
25143403|NCT02039687|50256897|FG000|Overall Study|Adverse Event|0|||
25143404|NCT02039687|50256898|FG001|Overall Study|Adverse Event|0|||
25143405|NCT02039687|50256899|FG002|Overall Study|Adverse Event|1|||
25143406|NCT02039687|50256900|FG003|Overall Study|Adverse Event|0|||
25143407|NCT02039687|50256897|FG000|Overall Study|Withdrawal by Subject|0|||
25143408|NCT02039687|50256898|FG001|Overall Study|Withdrawal by Subject|1|||
25143409|NCT02039687|50256899|FG002|Overall Study|Withdrawal by Subject|0|||
25143410|NCT02039687|50256900|FG003|Overall Study|Withdrawal by Subject|0|||
25143411|NCT02039687|50256897|FG000|Overall Study|treatment assignment could not be confir|0|||
25143412|NCT02039687|50256898|FG001|Overall Study|treatment assignment could not be confir|0|||
25143413|NCT02039687|50256899|FG002|Overall Study|treatment assignment could not be confir|2|||
25143414|NCT02039687|50256900|FG003|Overall Study|treatment assignment could not be confir|0|||
25143415|NCT02003534|50256910|FG000|Overall Study|Lost to Follow-up|47|||
25143416|NCT02055365|50256914|FG000|Overall Study|Prematurely Withdrawn|1|||
25143417|NCT02039375|50256925|FG000|Overall Study|Lost to Follow-up|2|||
25143418|NCT02054897|50256932|FG000|Overall Study|Withdrawal by Subject|2|||
25143419|NCT02054897|50256933|FG001|Overall Study|Withdrawal by Subject|0|||
25143420|NCT02054897|50256934|FG002|Overall Study|Withdrawal by Subject|2|||
25143421|NCT02054897|50256932|FG000|Overall Study|Missing follow-up information|3|||
25143422|NCT02054897|50256933|FG001|Overall Study|Missing follow-up information|5|||
25143423|NCT02054897|50256934|FG002|Overall Study|Missing follow-up information|3|||
25143424|NCT02054897|50256932|FG000|Overall Study|Lost to Follow-up|4|||
25143425|NCT02054897|50256933|FG001|Overall Study|Lost to Follow-up|2|||
25143426|NCT02054897|50256934|FG002|Overall Study|Lost to Follow-up|7|||
25143427|NCT02054897|50256932|FG000|Overall Study|Randomized but not exposed|1|||
25179764|NCT01464827|50325456|FG007|Overall Study|Other|0|||
25179765|NCT01464827|50325457|FG008|Overall Study|Other|3|||
25179766|NCT01464827|50325458|FG009|Overall Study|Other|1|||
25179767|NCT01464827|50325459|FG010|Overall Study|Other|2|||
25179768|NCT01464827|50325460|FG011|Overall Study|Other|0|||
25179769|NCT01464827|50325461|FG012|Overall Study|Other|1|||
25179770|NCT01464827|50325462|FG013|Overall Study|Other|0|||
25179771|NCT01464827|50325449|FG000|Overall Study|Not Treated|0|||
25179772|NCT01464827|50325450|FG001|Overall Study|Not Treated|2|||
25179773|NCT01464827|50325451|FG002|Overall Study|Not Treated|0|||
25179774|NCT01464827|50325452|FG003|Overall Study|Not Treated|0|||
25179775|NCT01464827|50325453|FG004|Overall Study|Not Treated|1|||
25179776|NCT01464827|50325454|FG005|Overall Study|Not Treated|0|||
25179777|NCT01464827|50325455|FG006|Overall Study|Not Treated|1|||
25179778|NCT01464827|50325456|FG007|Overall Study|Not Treated|0|||
25179779|NCT01464827|50325457|FG008|Overall Study|Not Treated|0|||
25179780|NCT01464827|50325458|FG009|Overall Study|Not Treated|2|||
25179781|NCT01464827|50325459|FG010|Overall Study|Not Treated|0|||
25179782|NCT01464827|50325460|FG011|Overall Study|Not Treated|1|||
25179783|NCT01464827|50325461|FG012|Overall Study|Not Treated|0|||
25179784|NCT01464827|50325462|FG013|Overall Study|Not Treated|2|||
25179785|NCT01463111|50325503|FG000|Overall Study|Withdrawal by Subject|2|||
25179786|NCT01463111|50325503|FG000|Overall Study|Lost to Follow-up|5|||
25179787|NCT01463111|50325503|FG000|Overall Study|Physician Decision|2|||
25179788|NCT01463033|50325509|FG000|Overall Study|Lost to Follow-up|4|||
25179789|NCT01463033|50325510|FG001|Overall Study|Lost to Follow-up|4|||
25179790|NCT01463033|50325509|FG000|Overall Study|Death|3|||
25143428|NCT02054897|50256933|FG001|Overall Study|Randomized but not exposed|0|||
25143429|NCT02054897|50256934|FG002|Overall Study|Randomized but not exposed|0|||
25143430|NCT01976312|50256944|FG000|Overall Study|Pregnancy|0|||
25143431|NCT01976312|50256945|FG001|Overall Study|Pregnancy|1|||
25143432|NCT01976312|50256944|FG000|Overall Study|Lost to Follow-up|2|||
25143433|NCT01976312|50256945|FG001|Overall Study|Lost to Follow-up|0|||
25143434|NCT01976312|50256944|FG000|Overall Study|Withdrawal by Subject|7|||
25143435|NCT01976312|50256945|FG001|Overall Study|Withdrawal by Subject|2|||
25143436|NCT01976312|50256944|FG000|Overall Study|Adverse Event|6|||
25143437|NCT01976312|50256945|FG001|Overall Study|Adverse Event|6|||
25143438|NCT01976312|50256944|FG000|Overall Study|Protocol Violation|2|||
25143439|NCT01976312|50256945|FG001|Overall Study|Protocol Violation|0|||
25143440|NCT02039219|50256954|FG000|Treatment|Withdrawal by Subject|1|||
25143441|NCT02039219|50256955|FG001|Treatment|Withdrawal by Subject|0|||
25143442|NCT02039219|50256954|FG000|Treatment|Adverse Event|0|||
25143443|NCT02039219|50256955|FG001|Treatment|Adverse Event|1|||
25179791|NCT01463033|50325510|FG001|Overall Study|Death|2|||
25143444|NCT02039219|50256954|FG000|Treatment|Physician Decision|1|||
25143445|NCT02039219|50256955|FG001|Treatment|Physician Decision|0|||
25143446|NCT02039219|50256954|FG000|Treatment|Lost to Follow-up|0|||
25143447|NCT02039219|50256955|FG001|Treatment|Lost to Follow-up|1|||
25143448|NCT02039219|50256954|FG000|Treatment|Protocol Violation|1|||
25143449|NCT02039219|50256955|FG001|Treatment|Protocol Violation|0|||
25143450|NCT02039219|50256954|FG000|Treatment|Death|1|||
25143451|NCT02039219|50256955|FG001|Treatment|Death|0|||
25143452|NCT02039219|50256954|FG000|Follow up|Adverse Event|0|||
25143453|NCT02039219|50256955|FG001|Follow up|Adverse Event|1|||
25179792|NCT01461707|50325519|FG000|Overall Study|Withdrawal by Subject|1|||
25179793|NCT01461707|50325520|FG001|Overall Study|Withdrawal by Subject|0|||
25179794|NCT01461551|50325529|FG000|Overall Study|Physician Decision|2|||
25143454|NCT02053493|50256963|FG000|Overall Study|Withdrawal by Subject|1|||
25143455|NCT02053493|50256964|FG001|Overall Study|Withdrawal by Subject|1|||
25143456|NCT02003144|50256972|FG000|Open Label Maintenance Phase|Other than specified|2|||
25143457|NCT02003144|50256973|FG001|Open Label Maintenance Phase|Other than specified|4|||
25143458|NCT02003144|50256972|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
25143459|NCT02003144|50256973|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
25143460|NCT02003144|50256972|FG000|Open Label Maintenance Phase|Pregnancy|0|||
25143461|NCT02003144|50256973|FG001|Open Label Maintenance Phase|Pregnancy|2|||
25143462|NCT02003144|50256972|FG000|Open Label Maintenance Phase|Physician Decision|1|||
25143463|NCT02003144|50256973|FG001|Open Label Maintenance Phase|Physician Decision|1|||
25143464|NCT02003144|50256972|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
25143465|NCT02003144|50256973|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
25143466|NCT02003144|50256972|FG000|Open Label Maintenance Phase|Adverse Event|2|||
25143467|NCT02003144|50256973|FG001|Open Label Maintenance Phase|Adverse Event|1|||
25143468|NCT02001194|50256984|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
25179795|NCT01461551|50325530|FG001|Overall Study|Physician Decision|1|||
25179796|NCT01461551|50325531|FG002|Overall Study|Physician Decision|2|||
25179797|NCT01461005|50325539|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
25143469|NCT02001194|50256985|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
25179798|NCT01460381|50325546|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
25179799|NCT01460381|50325547|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
25179800|NCT01473589|50325631|FG000|Overall Study|Adverse Event|1|||
25179801|NCT01473589|50325632|FG001|Overall Study|Adverse Event|1|||
25143470|NCT02001194|50256986|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
25143471|NCT02001194|50256987|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
25179802|NCT01473589|50325631|FG000|Overall Study|Death|2|||
25143472|NCT02001194|50256984|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
25179803|NCT01473589|50325632|FG001|Overall Study|Death|0|||
25179804|NCT01473589|50325631|FG000|Overall Study|Lost to Follow-up|2|||
25179805|NCT01473589|50325632|FG001|Overall Study|Lost to Follow-up|2|||
25179806|NCT01473589|50325631|FG000|Overall Study|Protocol Violation|1|||
25179807|NCT01473589|50325632|FG001|Overall Study|Protocol Violation|0|||
25179808|NCT01473589|50325631|FG000|Overall Study|Withdrawal by Subject|5|||
25179809|NCT01473589|50325632|FG001|Overall Study|Withdrawal by Subject|11|||
25179810|NCT01473589|50325631|FG000|Overall Study|Physician Decision|0|||
25179811|NCT01473589|50325632|FG001|Overall Study|Physician Decision|1|||
25179812|NCT01473589|50325631|FG000|Overall Study|Entry criteria not met|0|||
25179813|NCT01473589|50325632|FG001|Overall Study|Entry criteria not met|1|||
25179814|NCT01500187|50325651|FG000|Overall Study|Lost to Follow-up|6|||
25143473|NCT02001194|50256985|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
25143474|NCT02001194|50256986|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
25179815|NCT01500187|50325652|FG001|Overall Study|Lost to Follow-up|0|||
25179816|NCT01500031|50325670|FG000|Overall Study|Death|1|||
25143475|NCT02001194|50256987|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
25143476|NCT02038907|50257011|FG000|Overall Study|Protocol Violation|0|||
25143477|NCT02038907|50257012|FG001|Overall Study|Protocol Violation|0|||
25143478|NCT02038907|50257013|FG002|Overall Study|Protocol Violation|0|||
25179817|NCT01500031|50325670|FG000|Overall Study|Withdrawal by Subject|4|||
25179818|NCT01473355|50325683|FG000|Overall Study|Protocol Violation|2|||
25179819|NCT01473355|50325683|FG000|Overall Study|Adverse Event|2|||
25179820|NCT01473355|50325683|FG000|Overall Study|Lost to Follow-up|2|||
25179821|NCT01472965|50325693|FG000|Overall Study|Withdrawal by Subject|1|||
25179822|NCT01472965|50325694|FG001|Overall Study|Withdrawal by Subject|0|||
25179823|NCT01457053|50325704|FG000|Overall Study|Unable to undergo selected treatment|1|||
25179824|NCT01457053|50325705|FG001|Overall Study|Unable to undergo selected treatment|1|||
25143479|NCT02038907|50257014|FG003|Overall Study|Protocol Violation|0|||
25179825|NCT01472341|50325720|FG000|Overall Study|Started insulin therapy|55|||
25274439|NCT01078623|50588460|FG005|Treatment Period 4|Withdrawal by Subject|0|||
25274440|NCT01078623|50588461|FG006|Treatment Period 4|Withdrawal by Subject|0|||
25274441|NCT01078623|50588462|FG007|Treatment Period 4|Withdrawal by Subject|0|||
25274442|NCT01078623|50588463|FG008|Treatment Period 4|Withdrawal by Subject|0|||
25274443|NCT01078623|50588464|FG009|Treatment Period 4|Withdrawal by Subject|0|||
25274444|NCT01078623|50588465|FG010|Treatment Period 4|Withdrawal by Subject|0|||
25274445|NCT01078623|50588466|FG011|Treatment Period 4|Withdrawal by Subject|0|||
25274446|NCT01078623|50588467|FG012|Treatment Period 4|Withdrawal by Subject|0|||
25274447|NCT01078623|50588468|FG013|Treatment Period 4|Withdrawal by Subject|0|||
25274448|NCT01078623|50588469|FG014|Treatment Period 4|Withdrawal by Subject|0|||
25274449|NCT01078623|50588470|FG015|Treatment Period 4|Withdrawal by Subject|1|||
25143480|NCT02038907|50257015|FG004|Overall Study|Protocol Violation|0|||
25274450|NCT01078623|50588471|FG016|Treatment Period 4|Withdrawal by Subject|0|||
25274451|NCT01078623|50588472|FG017|Treatment Period 4|Withdrawal by Subject|0|||
25274452|NCT01078623|50588473|FG018|Treatment Period 4|Withdrawal by Subject|0|||
25274453|NCT01078623|50588474|FG019|Treatment Period 4|Withdrawal by Subject|0|||
25274454|NCT01092507|50588488|FG000|Overall Study|Withdrawal by Subject|2|||
25274455|NCT01092507|50588489|FG001|Overall Study|Withdrawal by Subject|0|||
25274456|NCT01078545|50588495|FG000|Overall Study|Lost to Follow-up|13|||
25274457|NCT01078545|50588495|FG000|Overall Study|Physician Decision|6|||
25274458|NCT01078545|50588495|FG000|Overall Study|Withdrawal by Subject|3|||
25274459|NCT01078545|50588495|FG000|Overall Study|Death|3|||
25274460|NCT01078545|50588495|FG000|Overall Study|Participant moved to another physician|1|||
25274461|NCT01202760|50588502|FG000|Overall Study|Entry Criteria Not Met|0|||
25274462|NCT01202760|50588503|FG001|Overall Study|Entry Criteria Not Met|3|||
25274463|NCT01202760|50588504|FG002|Overall Study|Entry Criteria Not Met|1|||
25274464|NCT01202760|50588502|FG000|Overall Study|Adverse Event|11|||
25274465|NCT01202760|50588503|FG001|Overall Study|Adverse Event|9|||
25143481|NCT02038907|50257016|FG005|Overall Study|Protocol Violation|0|||
25274466|NCT01202760|50588504|FG002|Overall Study|Adverse Event|10|||
25274467|NCT01202760|50588502|FG000|Overall Study|Death|2|||
25274468|NCT01202760|50588503|FG001|Overall Study|Death|1|||
25274469|NCT01202760|50588504|FG002|Overall Study|Death|0|||
25143482|NCT02038907|50257017|FG006|Overall Study|Protocol Violation|0|||
25274470|NCT01202760|50588502|FG000|Overall Study|Lack of Efficacy|6|||
25274471|NCT01202760|50588503|FG001|Overall Study|Lack of Efficacy|8|||
25274472|NCT01202760|50588504|FG002|Overall Study|Lack of Efficacy|7|||
25143483|NCT02038907|50257018|FG007|Overall Study|Protocol Violation|0|||
25143484|NCT02038907|50257019|FG008|Overall Study|Protocol Violation|0|||
25274473|NCT01202760|50588502|FG000|Overall Study|Lost to Follow-up|0|||
25143485|NCT02038907|50257020|FG009|Overall Study|Protocol Violation|0|||
25179826|NCT01472341|50325720|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
25274474|NCT01202760|50588503|FG001|Overall Study|Lost to Follow-up|2|||
25179827|NCT01472341|50325720|FG000|Overall Study|Withdrawal by Subject|39|||
25179828|NCT01472341|50325720|FG000|Overall Study|Lost to Follow-up|52|||
25179829|NCT01472341|50325720|FG000|Overall Study|Laboratory parameters unavailable|25|||
25179830|NCT01472341|50325720|FG000|Overall Study|Death|9|||
25179831|NCT01472185|50325726|FG000|Overall Study|Randomized but Not Treated|0|||
25179832|NCT01472185|50325727|FG001|Overall Study|Randomized but Not Treated|1|||
25179833|NCT01472185|50325726|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
25179834|NCT01472185|50325727|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
25179835|NCT01472185|50325726|FG000|Overall Study|Hyperglycemia|5|||
25179836|NCT01472185|50325727|FG001|Overall Study|Hyperglycemia|2|||
25179837|NCT01472185|50325726|FG000|Overall Study|Investigator's Discretion|3|||
25179838|NCT01472185|50325727|FG001|Overall Study|Investigator's Discretion|1|||
25179839|NCT01472185|50325726|FG000|Overall Study|Lost to Follow-up|4|||
25179840|NCT01472185|50325727|FG001|Overall Study|Lost to Follow-up|1|||
25179841|NCT01472185|50325726|FG000|Overall Study|Protocol Violation|5|||
25179842|NCT01472185|50325727|FG001|Overall Study|Protocol Violation|1|||
25179843|NCT01472185|50325726|FG000|Overall Study|Subject Noncompliance|8|||
25179844|NCT01472185|50325727|FG001|Overall Study|Subject Noncompliance|15|||
25179845|NCT01472185|50325726|FG000|Overall Study|Subject Withdrew Consent|6|||
25179846|NCT01472185|50325727|FG001|Overall Study|Subject Withdrew Consent|3|||
25179847|NCT01456897|50325748|FG000|Overall Study|Adverse Event|19|||
25179848|NCT01456897|50325749|FG001|Overall Study|Adverse Event|22|||
25179849|NCT01456897|50325748|FG000|Overall Study|Protocol Violation|3|||
25179850|NCT01456897|50325749|FG001|Overall Study|Protocol Violation|4|||
25179851|NCT01456897|50325748|FG000|Overall Study|Physician Decision|5|||
25179852|NCT01456897|50325749|FG001|Overall Study|Physician Decision|3|||
25179853|NCT01456897|50325748|FG000|Overall Study|Withdrawal by Subject|44|||
25179854|NCT01456897|50325749|FG001|Overall Study|Withdrawal by Subject|17|||
25179855|NCT01456897|50325748|FG000|Overall Study|Lack of Efficacy|4|||
25179856|NCT01456897|50325749|FG001|Overall Study|Lack of Efficacy|11|||
25179857|NCT01456195|50325762|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
25179858|NCT01456195|50325763|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
25179859|NCT01456195|50325764|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
25179860|NCT01456195|50325762|FG000|Overall Study|Lost to Follow-up|3|||
25179861|NCT01456195|50325763|FG001|Overall Study|Lost to Follow-up|1|||
25179862|NCT01456195|50325764|FG002|Overall Study|Lost to Follow-up|3|||
25179863|NCT01456195|50325762|FG000|Overall Study|Voluntary Withdrawal|5|||
25179864|NCT01456195|50325763|FG001|Overall Study|Voluntary Withdrawal|3|||
25179865|NCT01456195|50325764|FG002|Overall Study|Voluntary Withdrawal|7|||
25179866|NCT01456195|50325762|FG000|Overall Study|Lack of Efficacy|0|||
25179867|NCT01456195|50325763|FG001|Overall Study|Lack of Efficacy|1|||
25179868|NCT01456195|50325764|FG002|Overall Study|Lack of Efficacy|0|||
25179869|NCT01456195|50325762|FG000|Overall Study|Other Reasons|2|||
25179870|NCT01456195|50325763|FG001|Overall Study|Other Reasons|1|||
25179871|NCT01456195|50325764|FG002|Overall Study|Other Reasons|3|||
25179872|NCT01456039|50325832|FG000|Phase 1 (First Step)|Disease Progression|1|||
25179873|NCT01456039|50325833|FG001|Phase 1 (First Step)|Disease Progression|1|||
25179874|NCT01456039|50325834|FG002|Phase 1 (First Step)|Disease Progression|0|||
25179875|NCT01456039|50325832|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
25179876|NCT01456039|50325833|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
25179877|NCT01456039|50325834|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
25179878|NCT01456039|50325832|FG000|Phase 1 (First Step)|Adverse Event|0|||
25179879|NCT01456039|50325833|FG001|Phase 1 (First Step)|Adverse Event|3|||
25179880|NCT01456039|50325834|FG002|Phase 1 (First Step)|Adverse Event|0|||
25179881|NCT01456039|50325832|FG000|Phase 1 (First Step)|Other|0|||
25179882|NCT01456039|50325833|FG001|Phase 1 (First Step)|Other|1|||
25179883|NCT01456039|50325834|FG002|Phase 1 (First Step)|Other|0|||
25179884|NCT01456039|50325832|FG000|Phase 2 (Second Step)|Disease Progression|0|||
25179885|NCT01456039|50325833|FG001|Phase 2 (Second Step)|Disease Progression|0|||
25179886|NCT01456039|50325834|FG002|Phase 2 (Second Step)|Disease Progression|17|||
25179887|NCT01456039|50325832|FG000|Phase 2 (Second Step)|Adverse Event|0|||
25179888|NCT01456039|50325833|FG001|Phase 2 (Second Step)|Adverse Event|0|||
25179889|NCT01456039|50325834|FG002|Phase 2 (Second Step)|Adverse Event|10|||
25179890|NCT01456039|50325832|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
25179891|NCT01456039|50325833|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
25179892|NCT01456039|50325834|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
25179893|NCT01456039|50325832|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
25179894|NCT01456039|50325833|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
25179895|NCT01456039|50325834|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
25179896|NCT01456039|50325832|FG000|Phase 2 (Second Step)|Other|0|||
25179897|NCT01456039|50325833|FG001|Phase 2 (Second Step)|Other|0|||
25179898|NCT01456039|50325834|FG002|Phase 2 (Second Step)|Other|1|||
25179899|NCT01455415|50325852|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
25179900|NCT01455415|50325853|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
25179901|NCT01455415|50325852|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
25179902|NCT01455415|50325853|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
25179903|NCT01455415|50325852|FG000|Period 1|Drug Error not Associated to AE|0|||
25179904|NCT01455415|50325853|FG001|Period 1|Drug Error not Associated to AE|1|||
25179905|NCT01455415|50325852|FG000|Period 1|AE Not Related to Study Drug|2|||
25179906|NCT01455415|50325853|FG001|Period 1|AE Not Related to Study Drug|6|||
25179907|NCT01455415|50325852|FG000|Period 1|Withdrawal by Subject|4|||
25179908|NCT01455415|50325853|FG001|Period 1|Withdrawal by Subject|5|||
25179909|NCT01455415|50325852|FG000|Period 1|Unspecified Reason|1|||
25179910|NCT01455415|50325853|FG001|Period 1|Unspecified Reason|1|||
25179911|NCT01455415|50325852|FG000|Period 1|Protocol Violation|0|||
25179912|NCT01455415|50325853|FG001|Period 1|Protocol Violation|2|||
25179913|NCT01455415|50325852|FG000|Washout|AE Related to Study Drug|2|||
25143486|NCT02038907|50257021|FG010|Overall Study|Protocol Violation|1|||
25143487|NCT02038907|50257022|FG011|Overall Study|Protocol Violation|0|||
25143488|NCT02038907|50257023|FG012|Overall Study|Protocol Violation|0|||
25143489|NCT02038907|50257024|FG013|Overall Study|Protocol Violation|0|||
25143490|NCT02038907|50257011|FG000|Overall Study|Withdrawal by Subject|0|||
25143491|NCT02038907|50257012|FG001|Overall Study|Withdrawal by Subject|0|||
25143492|NCT02038907|50257013|FG002|Overall Study|Withdrawal by Subject|0|||
25143493|NCT02038907|50257014|FG003|Overall Study|Withdrawal by Subject|0|||
25143494|NCT02038907|50257015|FG004|Overall Study|Withdrawal by Subject|0|||
25143495|NCT02038907|50257016|FG005|Overall Study|Withdrawal by Subject|0|||
25143496|NCT02038907|50257017|FG006|Overall Study|Withdrawal by Subject|0|||
25143497|NCT02038907|50257018|FG007|Overall Study|Withdrawal by Subject|0|||
25143498|NCT02038907|50257019|FG008|Overall Study|Withdrawal by Subject|0|||
25179914|NCT01455415|50325853|FG001|Washout|AE Related to Study Drug|0|||
25179915|NCT01455415|50325852|FG000|Washout|Lost to Follow-up|1|||
25179916|NCT01455415|50325853|FG001|Washout|Lost to Follow-up|0|||
25179917|NCT01455415|50325852|FG000|Washout|Drug Error not Associated to AE|2|||
25179918|NCT01455415|50325853|FG001|Washout|Drug Error not Associated to AE|1|||
25179919|NCT01455415|50325852|FG000|Washout|AE Not Related to Study Drug|2|||
25179920|NCT01455415|50325853|FG001|Washout|AE Not Related to Study Drug|3|||
25179921|NCT01455415|50325852|FG000|Washout|Unspecified Reason|1|||
25179922|NCT01455415|50325853|FG001|Washout|Unspecified Reason|2|||
25179923|NCT01455415|50325852|FG000|Washout|Protocol Violation|0|||
25179924|NCT01455415|50325853|FG001|Washout|Protocol Violation|1|||
25179925|NCT01455415|50325852|FG000|Period 2|AE Related to Study Drug|1|||
25179926|NCT01455415|50325853|FG001|Period 2|AE Related to Study Drug|2|||
25179927|NCT01455415|50325852|FG000|Period 2|Lost to Follow-up|2|||
25179928|NCT01455415|50325853|FG001|Period 2|Lost to Follow-up|1|||
25179929|NCT01455415|50325852|FG000|Period 2|AE Not Related to Study Drug|2|||
25143499|NCT02038907|50257020|FG009|Overall Study|Withdrawal by Subject|0|||
25179930|NCT01455415|50325853|FG001|Period 2|AE Not Related to Study Drug|1|||
25179931|NCT01455415|50325852|FG000|Period 2|Lack of Efficacy|2|||
25143500|NCT02038907|50257021|FG010|Overall Study|Withdrawal by Subject|1|||
25179932|NCT01455415|50325853|FG001|Period 2|Lack of Efficacy|0|||
25179933|NCT01455415|50325852|FG000|Period 2|Withdrawal by Subject|2|||
25179934|NCT01455415|50325853|FG001|Period 2|Withdrawal by Subject|3|||
25179935|NCT01455415|50325852|FG000|Period 2|Unspecified Reason|2|||
25179936|NCT01455415|50325853|FG001|Period 2|Unspecified Reason|3|||
25179937|NCT01455415|50325852|FG000|Period 2|Protocol Violation|2|||
25179938|NCT01455415|50325853|FG001|Period 2|Protocol Violation|0|||
25179939|NCT01455415|50325852|FG000|Follow-up|AE Related to Study Drug|0|||
25179940|NCT01455415|50325853|FG001|Follow-up|AE Related to Study Drug|1|||
25179941|NCT01455415|50325852|FG000|Follow-up|Lack of Efficacy|0|||
25143501|NCT02038907|50257022|FG011|Overall Study|Withdrawal by Subject|0|||
25143502|NCT02038907|50257023|FG012|Overall Study|Withdrawal by Subject|0|||
25143503|NCT02038907|50257024|FG013|Overall Study|Withdrawal by Subject|0|||
25143504|NCT02038829|50257056|FG000|Washout Period 1|Death|0|||
25143505|NCT02038829|50257057|FG001|Washout Period 1|Death|0|||
25143506|NCT02038829|50257058|FG002|Washout Period 1|Death|0|||
25143507|NCT02038829|50257059|FG003|Washout Period 1|Death|0|||
25143508|NCT02038829|50257060|FG004|Washout Period 1|Death|1|||
25143509|NCT02038829|50257061|FG005|Washout Period 1|Death|0|||
25143510|NCT02038829|50257062|FG006|Washout Period 1|Death|0|||
25143511|NCT02038829|50257063|FG007|Washout Period 1|Death|0|||
25143512|NCT02038829|50257064|FG008|Washout Period 1|Death|0|||
25143513|NCT02038829|50257065|FG009|Washout Period 1|Death|0|||
25143514|NCT02038829|50257066|FG010|Washout Period 1|Death|0|||
25143515|NCT02038829|50257067|FG011|Washout Period 1|Death|0|||
25143516|NCT02038829|50257056|FG000|Treatment Period 2|Adverse Event|0|||
25143517|NCT02038829|50257057|FG001|Treatment Period 2|Adverse Event|0|||
25143518|NCT02038829|50257058|FG002|Treatment Period 2|Adverse Event|0|||
25143519|NCT02038829|50257059|FG003|Treatment Period 2|Adverse Event|0|||
25143520|NCT02038829|50257060|FG004|Treatment Period 2|Adverse Event|0|||
25143521|NCT02038829|50257061|FG005|Treatment Period 2|Adverse Event|0|||
25143522|NCT02038829|50257062|FG006|Treatment Period 2|Adverse Event|0|||
25143523|NCT02038829|50257063|FG007|Treatment Period 2|Adverse Event|0|||
25143524|NCT02038829|50257064|FG008|Treatment Period 2|Adverse Event|0|||
25143525|NCT02038829|50257065|FG009|Treatment Period 2|Adverse Event|0|||
25143526|NCT02038829|50257066|FG010|Treatment Period 2|Adverse Event|1|||
25143527|NCT02038829|50257067|FG011|Treatment Period 2|Adverse Event|0|||
25143528|NCT02038829|50257056|FG000|Treatment Period 2|Withdrawal by Subject|1|||
25143529|NCT02038829|50257057|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25143530|NCT02038829|50257058|FG002|Treatment Period 2|Withdrawal by Subject|0|||
25143531|NCT02038829|50257059|FG003|Treatment Period 2|Withdrawal by Subject|0|||
25143532|NCT02038829|50257060|FG004|Treatment Period 2|Withdrawal by Subject|0|||
25143533|NCT02038829|50257061|FG005|Treatment Period 2|Withdrawal by Subject|0|||
25143534|NCT02038829|50257062|FG006|Treatment Period 2|Withdrawal by Subject|0|||
25143535|NCT02038829|50257063|FG007|Treatment Period 2|Withdrawal by Subject|0|||
25143536|NCT02038829|50257064|FG008|Treatment Period 2|Withdrawal by Subject|0|||
25143537|NCT02038829|50257065|FG009|Treatment Period 2|Withdrawal by Subject|0|||
25143538|NCT02038829|50257066|FG010|Treatment Period 2|Withdrawal by Subject|0|||
25143539|NCT02038829|50257067|FG011|Treatment Period 2|Withdrawal by Subject|0|||
25143540|NCT02038829|50257056|FG000|Washout Period 2|Adverse Event|0|||
25143541|NCT02038829|50257057|FG001|Washout Period 2|Adverse Event|0|||
25143542|NCT02038829|50257058|FG002|Washout Period 2|Adverse Event|0|||
25143543|NCT02038829|50257059|FG003|Washout Period 2|Adverse Event|0|||
25143544|NCT02038829|50257060|FG004|Washout Period 2|Adverse Event|0|||
25143545|NCT02038829|50257061|FG005|Washout Period 2|Adverse Event|0|||
25143546|NCT02038829|50257062|FG006|Washout Period 2|Adverse Event|0|||
25143547|NCT02038829|50257063|FG007|Washout Period 2|Adverse Event|0|||
25143548|NCT02038829|50257064|FG008|Washout Period 2|Adverse Event|1|||
25143549|NCT02038829|50257065|FG009|Washout Period 2|Adverse Event|0|||
25143550|NCT02038829|50257066|FG010|Washout Period 2|Adverse Event|0|||
25143551|NCT02038829|50257067|FG011|Washout Period 2|Adverse Event|0|||
25143552|NCT02038829|50257056|FG000|Washout Period 2|Withdrawal by Subject|0|||
25179942|NCT01455415|50325853|FG001|Follow-up|Lack of Efficacy|1|||
25179943|NCT01455415|50325852|FG000|Follow-up|Withdrawal by Subject|2|||
25179944|NCT01455415|50325853|FG001|Follow-up|Withdrawal by Subject|0|||
25179945|NCT01455415|50325852|FG000|Follow-up|Unspecified Reason|1|||
25179946|NCT01455415|50325853|FG001|Follow-up|Unspecified Reason|0|||
25179947|NCT01471171|50325859|FG000|Treatment Period 1|Adverse Event|4|||
25143553|NCT02038829|50257057|FG001|Washout Period 2|Withdrawal by Subject|0|||
25143554|NCT02038829|50257058|FG002|Washout Period 2|Withdrawal by Subject|0|||
25143555|NCT02038829|50257059|FG003|Washout Period 2|Withdrawal by Subject|0|||
25143556|NCT02038829|50257060|FG004|Washout Period 2|Withdrawal by Subject|0|||
25143557|NCT02038829|50257061|FG005|Washout Period 2|Withdrawal by Subject|1|||
25143558|NCT02038829|50257062|FG006|Washout Period 2|Withdrawal by Subject|0|||
25143559|NCT02038829|50257063|FG007|Washout Period 2|Withdrawal by Subject|0|||
25143560|NCT02038829|50257064|FG008|Washout Period 2|Withdrawal by Subject|0|||
25143561|NCT02038829|50257065|FG009|Washout Period 2|Withdrawal by Subject|0|||
25143562|NCT02038829|50257066|FG010|Washout Period 2|Withdrawal by Subject|0|||
25143563|NCT02038829|50257067|FG011|Washout Period 2|Withdrawal by Subject|0|||
25143564|NCT02038829|50257056|FG000|Treatment Period 4|Adverse Event|0|||
25143565|NCT02038829|50257057|FG001|Treatment Period 4|Adverse Event|1|||
25143566|NCT02038829|50257058|FG002|Treatment Period 4|Adverse Event|0|||
25143567|NCT02038829|50257059|FG003|Treatment Period 4|Adverse Event|0|||
25143568|NCT02038829|50257060|FG004|Treatment Period 4|Adverse Event|0|||
25143569|NCT02038829|50257061|FG005|Treatment Period 4|Adverse Event|0|||
25143570|NCT02038829|50257062|FG006|Treatment Period 4|Adverse Event|0|||
25143571|NCT02038829|50257063|FG007|Treatment Period 4|Adverse Event|0|||
25143572|NCT02038829|50257064|FG008|Treatment Period 4|Adverse Event|0|||
25143573|NCT02038829|50257065|FG009|Treatment Period 4|Adverse Event|0|||
25143574|NCT02038829|50257066|FG010|Treatment Period 4|Adverse Event|0|||
25143575|NCT02038829|50257067|FG011|Treatment Period 4|Adverse Event|0|||
25143576|NCT02038829|50257056|FG000|Washout Period 4|Adverse Event|0|||
25143577|NCT02038829|50257057|FG001|Washout Period 4|Adverse Event|0|||
25143578|NCT02038829|50257058|FG002|Washout Period 4|Adverse Event|0|||
25143579|NCT02038829|50257059|FG003|Washout Period 4|Adverse Event|0|||
25143580|NCT02038829|50257060|FG004|Washout Period 4|Adverse Event|0|||
25143581|NCT02038829|50257061|FG005|Washout Period 4|Adverse Event|0|||
25143582|NCT02038829|50257062|FG006|Washout Period 4|Adverse Event|1|||
25179948|NCT01471171|50325860|FG001|Treatment Period 1|Adverse Event|1|||
25179949|NCT01471171|50325859|FG000|Treatment Period 2|Adverse Event|1|||
25179950|NCT01471171|50325860|FG001|Treatment Period 2|Adverse Event|0|||
25179951|NCT01471093|50325868|FG000|Overall Study|Adverse Event|1|||
25179952|NCT01471093|50325869|FG001|Overall Study|Adverse Event|0|||
25179953|NCT01471093|50325870|FG002|Overall Study|Adverse Event|0|||
25179954|NCT01471093|50325871|FG003|Overall Study|Adverse Event|0|||
25179955|NCT01471015|50325880|FG000|Overall Study|Death|0|||
25179956|NCT01471015|50325881|FG001|Overall Study|Death|1|||
25179957|NCT01471015|50325882|FG002|Overall Study|Death|1|||
25179958|NCT01497067|50325890|FG000|Overall Study|Lost to Follow-up|56|||
25179959|NCT01497067|50325890|FG000|Overall Study|Adverse Event|3|||
25179960|NCT01497067|50325890|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
25179961|NCT01497067|50325890|FG000|Overall Study|Other|13|||
25179962|NCT01470469|50325920|FG000|Overall Study|Withdrawal by Subject|4|||
25179963|NCT01470469|50325921|FG001|Overall Study|Withdrawal by Subject|6|||
25179964|NCT01470469|50325920|FG000|Overall Study|Lack of Efficacy|1|||
25179965|NCT01470469|50325921|FG001|Overall Study|Lack of Efficacy|7|||
25179966|NCT01470469|50325920|FG000|Overall Study|Adverse Event|0|||
25179967|NCT01470469|50325921|FG001|Overall Study|Adverse Event|7|||
25179968|NCT01470469|50325920|FG000|Overall Study|Lost to Follow-up|2|||
25179969|NCT01470469|50325921|FG001|Overall Study|Lost to Follow-up|2|||
25143583|NCT02038829|50257063|FG007|Washout Period 4|Adverse Event|0|||
25143584|NCT02038829|50257064|FG008|Washout Period 4|Adverse Event|0|||
25143585|NCT02038829|50257065|FG009|Washout Period 4|Adverse Event|0|||
25143586|NCT02038829|50257066|FG010|Washout Period 4|Adverse Event|0|||
25143587|NCT02038829|50257067|FG011|Washout Period 4|Adverse Event|0|||
25143588|NCT02038829|50257056|FG000|Treatment Period 6|Adverse Event|0|||
25143589|NCT02038829|50257057|FG001|Treatment Period 6|Adverse Event|0|||
25143590|NCT02038829|50257058|FG002|Treatment Period 6|Adverse Event|1|||
25143591|NCT02038829|50257059|FG003|Treatment Period 6|Adverse Event|0|||
25143592|NCT02038829|50257060|FG004|Treatment Period 6|Adverse Event|0|||
25143593|NCT02038829|50257061|FG005|Treatment Period 6|Adverse Event|0|||
25143594|NCT02038829|50257062|FG006|Treatment Period 6|Adverse Event|0|||
25143595|NCT02038829|50257063|FG007|Treatment Period 6|Adverse Event|0|||
25143596|NCT02038829|50257064|FG008|Treatment Period 6|Adverse Event|0|||
25143597|NCT02038829|50257065|FG009|Treatment Period 6|Adverse Event|0|||
25143598|NCT02038829|50257066|FG010|Treatment Period 6|Adverse Event|0|||
25143599|NCT02038829|50257067|FG011|Treatment Period 6|Adverse Event|0|||
25143600|NCT02038049|50257084|FG000|Overall Study|Lost to Follow-up|1|||
25143601|NCT02038049|50257085|FG001|Overall Study|Lost to Follow-up|0|||
25143602|NCT02052011|50257097|FG000|Overall Study|Lost to Follow-up|3|||
25143603|NCT02052011|50257098|FG001|Overall Study|Lost to Follow-up|0|||
25143604|NCT02052011|50257097|FG000|Overall Study|Withdrawal by Subject|1|||
25143605|NCT02052011|50257098|FG001|Overall Study|Withdrawal by Subject|2|||
25143606|NCT02036645|50257116|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
25143607|NCT02036645|50257117|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
25143608|NCT02036645|50257118|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
25143609|NCT02036645|50257119|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
25179970|NCT01470469|50325920|FG000|Overall Study|Protocol Violation|1|||
25179971|NCT01470469|50325921|FG001|Overall Study|Protocol Violation|1|||
25179972|NCT01470469|50325920|FG000|Overall Study|Other|2|||
25179973|NCT01470469|50325921|FG001|Overall Study|Other|1|||
25179974|NCT01470001|50325929|FG000|Overall Study|Lost to Follow-up|1|||
25179975|NCT01470001|50325930|FG001|Overall Study|Lost to Follow-up|1|||
25179976|NCT01470001|50325929|FG000|Overall Study|Physician Decision|2|||
25143610|NCT02036645|50257120|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
25143611|NCT02036645|50257121|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
25143612|NCT02036645|50257122|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
25143613|NCT02036645|50257123|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
25179977|NCT01470001|50325930|FG001|Overall Study|Physician Decision|0|||
25179978|NCT01470001|50325929|FG000|Overall Study|Withdrawal by Subject|2|||
25143614|NCT02036645|50257124|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
25143615|NCT02036645|50257125|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
25143616|NCT02036645|50257126|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
25143617|NCT02036645|50257127|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
25143618|NCT02036645|50257116|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
25143619|NCT02036645|50257117|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
25143620|NCT02036645|50257118|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
25143621|NCT02036645|50257119|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
25143622|NCT02036645|50257120|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
25143623|NCT02036645|50257121|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
25143624|NCT02036645|50257122|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
25143625|NCT02036645|50257123|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
25143626|NCT02036645|50257124|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
25143627|NCT02036645|50257125|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
25143628|NCT02036645|50257126|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
25143629|NCT02036645|50257127|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
25143630|NCT02051933|50257167|FG000|Overall Study|Physician Decision|0|||
25143631|NCT02051933|50257168|FG001|Overall Study|Physician Decision|1|||
25143632|NCT02050373|50257181|FG000|Overall Study|Adverse Event|4|||
25143633|NCT02050373|50257182|FG001|Overall Study|Adverse Event|7|||
25143634|NCT02050373|50257181|FG000|Overall Study|Death|3|||
25143635|NCT02050373|50257182|FG001|Overall Study|Death|3|||
25143636|NCT02049437|50257191|FG000|Period 1|Adverse Event|1|||
25143637|NCT02049437|50257192|FG001|Period 1|Adverse Event|1|||
25143638|NCT02049437|50257191|FG000|Period 1|Adverse Event|1|||
25143639|NCT02049437|50257192|FG001|Period 1|Adverse Event|0|||
25143640|NCT02035553|50257200|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
25143641|NCT02035553|50257201|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
25143642|NCT02035553|50257200|FG000|Overall Study|Adverse Event|10|||
25143643|NCT02035553|50257201|FG001|Overall Study|Adverse Event|6|||
25143644|NCT02035553|50257200|FG000|Overall Study|Physician Decision|3|||
25143645|NCT02035553|50257201|FG001|Overall Study|Physician Decision|2|||
25143646|NCT02035553|50257200|FG000|Overall Study|Lack of Efficacy|1|||
25143647|NCT02035553|50257201|FG001|Overall Study|Lack of Efficacy|1|||
25143648|NCT02035553|50257200|FG000|Overall Study|Withdrawal by Subject|4|||
25143649|NCT02035553|50257201|FG001|Overall Study|Withdrawal by Subject|7|||
25143650|NCT02035553|50257200|FG000|Overall Study|Non-compliance with Study Drug|0|||
25143651|NCT02035553|50257201|FG001|Overall Study|Non-compliance with Study Drug|1|||
25143652|NCT02035553|50257200|FG000|Overall Study|Lost to Follow-up|0|||
25143653|NCT02035553|50257201|FG001|Overall Study|Lost to Follow-up|1|||
25143654|NCT02035553|50257200|FG000|Overall Study|Other Reason|0|||
25143655|NCT02035553|50257201|FG001|Overall Study|Other Reason|4|||
25143656|NCT01445080|50257216|FG000|Overall Study|Adverse Event|5|||
25143657|NCT01445080|50257217|FG001|Overall Study|Adverse Event|3|||
25143658|NCT01445080|50257218|FG002|Overall Study|Adverse Event|11|||
25143659|NCT01445080|50257219|FG003|Overall Study|Adverse Event|6|||
25143660|NCT01445080|50257220|FG004|Overall Study|Adverse Event|2|||
25143661|NCT01445080|50257221|FG005|Overall Study|Adverse Event|3|||
25143662|NCT01445080|50257222|FG006|Overall Study|Adverse Event|0|||
25143663|NCT01445080|50257223|FG007|Overall Study|Adverse Event|3|||
25143664|NCT01445080|50257224|FG008|Overall Study|Adverse Event|10|||
25143665|NCT01445080|50257216|FG000|Overall Study|Physician Decision|0|||
25143666|NCT01445080|50257217|FG001|Overall Study|Physician Decision|0|||
25143667|NCT01445080|50257218|FG002|Overall Study|Physician Decision|1|||
25143668|NCT01445080|50257219|FG003|Overall Study|Physician Decision|0|||
25143669|NCT01445080|50257220|FG004|Overall Study|Physician Decision|0|||
25143670|NCT01445080|50257221|FG005|Overall Study|Physician Decision|3|||
25143671|NCT01445080|50257222|FG006|Overall Study|Physician Decision|2|||
25143672|NCT01445080|50257223|FG007|Overall Study|Physician Decision|2|||
25143673|NCT01445080|50257224|FG008|Overall Study|Physician Decision|0|||
25143674|NCT01445080|50257216|FG000|Overall Study|Withdrawal by Subject|1|||
25143675|NCT01445080|50257217|FG001|Overall Study|Withdrawal by Subject|0|||
25143676|NCT01445080|50257218|FG002|Overall Study|Withdrawal by Subject|0|||
25143677|NCT01445080|50257219|FG003|Overall Study|Withdrawal by Subject|1|||
25143678|NCT01445080|50257220|FG004|Overall Study|Withdrawal by Subject|0|||
25143679|NCT01445080|50257221|FG005|Overall Study|Withdrawal by Subject|0|||
25143680|NCT01445080|50257222|FG006|Overall Study|Withdrawal by Subject|0|||
25143681|NCT01445080|50257223|FG007|Overall Study|Withdrawal by Subject|0|||
25143682|NCT01445080|50257224|FG008|Overall Study|Withdrawal by Subject|2|||
25143683|NCT01445080|50257216|FG000|Overall Study|Ineligible/Inevaluable|1|||
25143684|NCT01445080|50257217|FG001|Overall Study|Ineligible/Inevaluable|2|||
25143685|NCT01445080|50257218|FG002|Overall Study|Ineligible/Inevaluable|0|||
25143686|NCT01445080|50257219|FG003|Overall Study|Ineligible/Inevaluable|1|||
25143687|NCT01445080|50257220|FG004|Overall Study|Ineligible/Inevaluable|2|||
25143688|NCT01445080|50257221|FG005|Overall Study|Ineligible/Inevaluable|3|||
25143689|NCT01445080|50257222|FG006|Overall Study|Ineligible/Inevaluable|0|||
25179979|NCT01470001|50325930|FG001|Overall Study|Withdrawal by Subject|1|||
25179980|NCT01469377|50325939|FG000|Overall Study|Protocol Deviation|7|||
25179981|NCT01469377|50325940|FG001|Overall Study|Protocol Deviation|10|||
25179982|NCT01469377|50325941|FG002|Overall Study|Protocol Deviation|10|||
25179983|NCT01469377|50325939|FG000|Overall Study|Lost to Follow-up|3|||
25179984|NCT01469377|50325940|FG001|Overall Study|Lost to Follow-up|2|||
25179985|NCT01469377|50325941|FG002|Overall Study|Lost to Follow-up|5|||
25179986|NCT01469377|50325939|FG000|Overall Study|Withdrawal of Consent|12|||
25143690|NCT01445080|50257223|FG007|Overall Study|Ineligible/Inevaluable|0|||
25143691|NCT01445080|50257224|FG008|Overall Study|Ineligible/Inevaluable|6|||
25179987|NCT01469377|50325940|FG001|Overall Study|Withdrawal of Consent|14|||
25179988|NCT01469377|50325941|FG002|Overall Study|Withdrawal of Consent|15|||
25179989|NCT01469377|50325939|FG000|Overall Study|Adverse Event|8|||
25179990|NCT01469377|50325940|FG001|Overall Study|Adverse Event|18|||
25179991|NCT01469377|50325941|FG002|Overall Study|Adverse Event|36|||
25179992|NCT01469377|50325939|FG000|Overall Study|Insufficient Therapeutic Response|3|||
25179993|NCT01469377|50325940|FG001|Overall Study|Insufficient Therapeutic Response|4|||
25143692|NCT02035475|50257259|FG000|Overall Study|Withdrawal by Subject|4|||
25143693|NCT02035475|50257259|FG000|Overall Study|Physician Decision|1|||
25143694|NCT02035475|50257259|FG000|Overall Study|Equipment Error|1|||
25143695|NCT01444456|50257265|FG000|Overall Study|Withdrawal by Subject|21|||
25143696|NCT01444456|50257265|FG000|Overall Study|Physician Decision|9|||
25179994|NCT01469377|50325941|FG002|Overall Study|Insufficient Therapeutic Response|0|||
25179995|NCT01469377|50325939|FG000|Overall Study|Other Miscellaneous Reasons|2|||
25179996|NCT01469377|50325940|FG001|Overall Study|Other Miscellaneous Reasons|0|||
25179997|NCT01469377|50325941|FG002|Overall Study|Other Miscellaneous Reasons|0|||
25179998|NCT01469221|50325951|FG000|Double Blind Phase|Protocol Violation|1|||
25179999|NCT01469221|50325952|FG001|Double Blind Phase|Protocol Violation|0|||
25180000|NCT01469221|50325953|FG002|Double Blind Phase|Protocol Violation|0|||
25180001|NCT01469221|50325951|FG000|Double Blind Phase|Physician Decision|1|||
25180002|NCT01469221|50325952|FG001|Double Blind Phase|Physician Decision|1|||
25180003|NCT01469221|50325953|FG002|Double Blind Phase|Physician Decision|0|||
25180004|NCT01469221|50325951|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
25180005|NCT01469221|50325952|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
25180006|NCT01469221|50325953|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
25180007|NCT01453855|50325962|FG000|Overall Study|Adverse Event|3|||
25180008|NCT01453855|50325963|FG001|Overall Study|Adverse Event|4|||
25180009|NCT01453855|50325962|FG000|Overall Study|Lost to Follow-up|2|||
25180010|NCT01453855|50325963|FG001|Overall Study|Lost to Follow-up|1|||
25180011|NCT01453855|50325962|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
25180012|NCT01453855|50325963|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
25180013|NCT01453855|50325962|FG000|Overall Study|Noncompliance|1|||
25180014|NCT01453855|50325963|FG001|Overall Study|Noncompliance|0|||
25180015|NCT01453855|50325962|FG000|Overall Study|Inadequate Control of IOP|1|||
25180016|NCT01453855|50325963|FG001|Overall Study|Inadequate Control of IOP|5|||
25180017|NCT01453855|50325962|FG000|Overall Study|Other|0|||
25180018|NCT01453855|50325963|FG001|Overall Study|Other|1|||
25180019|NCT01469065|50325974|FG000|Overall Study|Lack of Efficacy|0|||
25180020|NCT01469065|50325975|FG001|Overall Study|Lack of Efficacy|0|||
25180021|NCT01469065|50325976|FG002|Overall Study|Lack of Efficacy|0|||
25180022|NCT01469065|50325977|FG003|Overall Study|Lack of Efficacy|0|||
25180023|NCT01469065|50325978|FG004|Overall Study|Lack of Efficacy|1|||
25180024|NCT01469065|50325974|FG000|Overall Study|Other|0|||
25180025|NCT01469065|50325975|FG001|Overall Study|Other|1|||
25180026|NCT01469065|50325976|FG002|Overall Study|Other|0|||
25180027|NCT01469065|50325977|FG003|Overall Study|Other|0|||
25180028|NCT01469065|50325978|FG004|Overall Study|Other|0|||
25180029|NCT01586624|50326002|FG000|Overall Study|Adverse Event|3|||
25180030|NCT01586624|50326003|FG001|Overall Study|Adverse Event|0|||
25180031|NCT01586624|50326004|FG002|Overall Study|Adverse Event|2|||
25180032|NCT01586624|50326005|FG003|Overall Study|Adverse Event|1|||
25180033|NCT01586624|50326006|FG004|Overall Study|Adverse Event|3|||
25180034|NCT01586624|50326007|FG005|Overall Study|Adverse Event|3|||
25180035|NCT01586624|50326008|FG006|Overall Study|Adverse Event|2|||
25180036|NCT01586624|50326009|FG007|Overall Study|Adverse Event|3|||
25180037|NCT01586624|50326002|FG000|Overall Study|Physician Decision|0|||
25180038|NCT01586624|50326003|FG001|Overall Study|Physician Decision|1|||
25180039|NCT01586624|50326004|FG002|Overall Study|Physician Decision|1|||
25180040|NCT01586624|50326005|FG003|Overall Study|Physician Decision|0|||
25143697|NCT01444456|50257265|FG000|Overall Study|Lost to Follow-up|37|||
25143698|NCT01444456|50257265|FG000|Overall Study|Death|73|||
25180041|NCT01586624|50326006|FG004|Overall Study|Physician Decision|2|||
25180042|NCT01586624|50326007|FG005|Overall Study|Physician Decision|0|||
25180043|NCT01586624|50326008|FG006|Overall Study|Physician Decision|1|||
25180044|NCT01586624|50326009|FG007|Overall Study|Physician Decision|1|||
25180045|NCT01586624|50326002|FG000|Overall Study|Withdrawal by Subject|0|||
25180046|NCT01586624|50326003|FG001|Overall Study|Withdrawal by Subject|0|||
25180047|NCT01586624|50326004|FG002|Overall Study|Withdrawal by Subject|0|||
25180048|NCT01586624|50326005|FG003|Overall Study|Withdrawal by Subject|1|||
25180049|NCT01586624|50326006|FG004|Overall Study|Withdrawal by Subject|0|||
25180050|NCT01586624|50326007|FG005|Overall Study|Withdrawal by Subject|0|||
25180051|NCT01586624|50326008|FG006|Overall Study|Withdrawal by Subject|0|||
25180052|NCT01586624|50326009|FG007|Overall Study|Withdrawal by Subject|0|||
25180053|NCT01586624|50326002|FG000|Overall Study|Evidence of disease progression|1|||
25180054|NCT01586624|50326003|FG001|Overall Study|Evidence of disease progression|3|||
25180055|NCT01586624|50326004|FG002|Overall Study|Evidence of disease progression|2|||
25143699|NCT01444456|50257265|FG000|Overall Study|Ineligibility determined|23|||
25143700|NCT01444456|50257265|FG000|Overall Study|Other|18|||
25180056|NCT01586624|50326005|FG003|Overall Study|Evidence of disease progression|5|||
25180057|NCT01586624|50326006|FG004|Overall Study|Evidence of disease progression|3|||
25180058|NCT01586624|50326007|FG005|Overall Study|Evidence of disease progression|5|||
25180059|NCT01586624|50326008|FG006|Overall Study|Evidence of disease progression|4|||
25180060|NCT01586624|50326009|FG007|Overall Study|Evidence of disease progression|6|||
25180061|NCT01586624|50326002|FG000|Overall Study|Screen failure (no treatment received)|0|||
25180062|NCT01586624|50326003|FG001|Overall Study|Screen failure (no treatment received)|0|||
25180063|NCT01586624|50326004|FG002|Overall Study|Screen failure (no treatment received)|0|||
25180064|NCT01586624|50326005|FG003|Overall Study|Screen failure (no treatment received)|0|||
25180065|NCT01586624|50326006|FG004|Overall Study|Screen failure (no treatment received)|0|||
25180066|NCT01586624|50326007|FG005|Overall Study|Screen failure (no treatment received)|0|||
25180067|NCT01586624|50326008|FG006|Overall Study|Screen failure (no treatment received)|1|||
25180068|NCT01586624|50326009|FG007|Overall Study|Screen failure (no treatment received)|0|||
25180069|NCT01586156|50326031|FG000|Overall Study|Pregnancy|0|||
25143701|NCT01444456|50257265|FG000|Overall Study|Not treated|104|||
25143702|NCT01438294|50257271|FG000|Overall Study|Lost to Follow-up|3|||
25143703|NCT01438294|50257272|FG001|Overall Study|Lost to Follow-up|7|||
25143704|NCT02033759|50257280|FG000|Overall Study|Withdrawal by Subject|2|||
25143705|NCT02033759|50257281|FG001|Overall Study|Withdrawal by Subject|1|||
25143706|NCT02033759|50257280|FG000|Overall Study|Protocol Violation|1|||
25143707|NCT02033759|50257281|FG001|Overall Study|Protocol Violation|1|||
25143708|NCT01959529|50257289|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
25143709|NCT01959529|50257290|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
25143710|NCT01959529|50257289|FG000|Overall Study|Lost to Follow-up|4|||
25143711|NCT01959529|50257290|FG001|Overall Study|Lost to Follow-up|1|||
25143712|NCT01959529|50257289|FG000|Overall Study|Other|70|||
25143713|NCT01959529|50257290|FG001|Overall Study|Other|68|||
25143714|NCT01959529|50257289|FG000|Overall Study|Hypoglycaemia|1|||
25143715|NCT01959529|50257290|FG001|Overall Study|Hypoglycaemia|1|||
25143716|NCT01959529|50257289|FG000|Overall Study|Lack of glycaemic control|1|||
25143717|NCT01959529|50257290|FG001|Overall Study|Lack of glycaemic control|1|||
25143718|NCT02033369|50257298|FG000|Overall Study|Physician Decision|1|||
25143719|NCT02033369|50257299|FG001|Overall Study|Physician Decision|2|||
25143720|NCT02033369|50257298|FG000|Overall Study|Not a good demographic match|0|||
25180070|NCT01586156|50326032|FG001|Overall Study|Pregnancy|1|||
25180071|NCT01586156|50326033|FG002|Overall Study|Pregnancy|0|||
25180072|NCT01459913|50326045|FG000|Overall Study|Adverse Event|0|||
25180073|NCT01459913|50326046|FG001|Overall Study|Adverse Event|0|||
25180074|NCT01459913|50326047|FG002|Overall Study|Adverse Event|0|||
25180075|NCT01459913|50326048|FG003|Overall Study|Adverse Event|3|||
25274475|NCT01202760|50588504|FG002|Overall Study|Lost to Follow-up|1|||
25274476|NCT01202760|50588502|FG000|Overall Study|Parent / Caregiver Decision|0|||
25143721|NCT02033369|50257299|FG001|Overall Study|Not a good demographic match|2|||
25143722|NCT02033369|50257298|FG000|Overall Study|Withdrawal by Subject|1|||
25143723|NCT02033369|50257299|FG001|Overall Study|Withdrawal by Subject|1|||
25143724|NCT02033369|50257298|FG000|Overall Study|Lost to Follow-up|1|||
25143725|NCT02033369|50257299|FG001|Overall Study|Lost to Follow-up|0|||
25143726|NCT02033369|50257298|FG000|Overall Study|Protocol Violation|2|||
25143727|NCT02033369|50257299|FG001|Overall Study|Protocol Violation|0|||
25143728|NCT02032901|50257305|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
25143729|NCT02032901|50257306|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
25180076|NCT01459913|50326045|FG000|Overall Study|Withdrawal by Subject|4|||
25180077|NCT01459913|50326046|FG001|Overall Study|Withdrawal by Subject|0|||
25180078|NCT01459913|50326047|FG002|Overall Study|Withdrawal by Subject|0|||
25180079|NCT01459913|50326048|FG003|Overall Study|Withdrawal by Subject|5|||
25180080|NCT01459913|50326045|FG000|Overall Study|Lost to Follow-up|7|||
25143730|NCT02032901|50257305|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
25143731|NCT02032901|50257306|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
25180081|NCT01459913|50326046|FG001|Overall Study|Lost to Follow-up|4|||
25180082|NCT01459913|50326047|FG002|Overall Study|Lost to Follow-up|1|||
25180083|NCT01459913|50326048|FG003|Overall Study|Lost to Follow-up|8|||
25180084|NCT01459913|50326045|FG000|Overall Study|Death|0|||
25143732|NCT02020967|50257316|FG000|Overall Study|Withdrawal by Subject|51|||
25143733|NCT01986829|50257322|FG000|Overall Study|Death|1|||
25143734|NCT01986751|50257331|FG000|Overall Study|improperly consented|10|||
25143735|NCT01986751|50257332|FG001|Overall Study|improperly consented|2|||
25143736|NCT02004847|50257344|FG000|Overall Study|Protocol Violation|1|||
25143737|NCT02004847|50257345|FG001|Overall Study|Protocol Violation|1|||
25143738|NCT01438060|50257362|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
25143739|NCT01438060|50257363|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
25143740|NCT01438060|50257362|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
25143741|NCT01438060|50257363|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
25143742|NCT01438060|50257362|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
25143743|NCT01438060|50257363|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
25143744|NCT01438060|50257362|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
25180085|NCT01459913|50326046|FG001|Overall Study|Death|0|||
25180086|NCT01459913|50326047|FG002|Overall Study|Death|0|||
25180087|NCT01459913|50326048|FG003|Overall Study|Death|1|||
25180088|NCT01459913|50326045|FG000|Overall Study|Non- Compliance|0|||
25180089|NCT01459913|50326046|FG001|Overall Study|Non- Compliance|0|||
25180090|NCT01459913|50326047|FG002|Overall Study|Non- Compliance|0|||
25180091|NCT01459913|50326048|FG003|Overall Study|Non- Compliance|3|||
25180092|NCT01459913|50326045|FG000|Overall Study|Physician Decision|0|||
25180093|NCT01459913|50326046|FG001|Overall Study|Physician Decision|1|||
25180094|NCT01459913|50326047|FG002|Overall Study|Physician Decision|0|||
25180095|NCT01459913|50326048|FG003|Overall Study|Physician Decision|0|||
25143745|NCT01438060|50257363|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
25143746|NCT01438060|50257362|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
25143747|NCT01438060|50257363|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
25143748|NCT01438060|50257362|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
25143749|NCT01438060|50257363|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
25180096|NCT01459913|50326045|FG000|Overall Study|Study Terminated by Sponsor|30|||
25180097|NCT01459913|50326046|FG001|Overall Study|Study Terminated by Sponsor|15|||
25143750|NCT01438060|50257362|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
25180098|NCT01459913|50326047|FG002|Overall Study|Study Terminated by Sponsor|9|||
25180099|NCT01459913|50326048|FG003|Overall Study|Study Terminated by Sponsor|11|||
25143751|NCT01438060|50257363|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
25143752|NCT01438060|50257362|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
25143753|NCT01438060|50257363|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
25143754|NCT01438060|50257362|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
25143755|NCT01438060|50257363|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
25143756|NCT01438060|50257362|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
25143757|NCT01438060|50257363|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
25143758|NCT01438060|50257362|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
25143759|NCT01438060|50257363|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
25180100|NCT01459913|50326045|FG000|Overall Study|Other|0|||
25180101|NCT01459913|50326046|FG001|Overall Study|Other|0|||
25180102|NCT01459913|50326047|FG002|Overall Study|Other|3|||
25143760|NCT01438060|50257362|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
25143761|NCT01438060|50257363|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
25143762|NCT01438060|50257362|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
25143763|NCT01438060|50257363|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
25143764|NCT01438060|50257362|FG000|On Study Beyond Week 140|Adverse Event|0|||
25143765|NCT01438060|50257363|FG001|On Study Beyond Week 140|Adverse Event|2|||
25143766|NCT01438060|50257362|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
25143767|NCT01438060|50257363|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
25143768|NCT01438060|50257362|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
25143769|NCT01438060|50257363|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
25143770|NCT01438060|50257362|FG000|On Study Beyond Week 140|Death|0|||
25143771|NCT01438060|50257363|FG001|On Study Beyond Week 140|Death|1|||
25143772|NCT01438060|50257362|FG000|On Study Beyond Week 140|Other Reason|0|||
25143773|NCT01438060|50257363|FG001|On Study Beyond Week 140|Other Reason|3|||
25143774|NCT01469182|50257376|FG000|Overall Study|Adverse Event|21|||
25143775|NCT01469182|50257377|FG001|Overall Study|Adverse Event|3|||
25143776|NCT01469182|50257376|FG000|Overall Study|Lost to Follow-up|3|||
25143777|NCT01469182|50257377|FG001|Overall Study|Lost to Follow-up|0|||
25143778|NCT01469182|50257376|FG000|Overall Study|Withdrawal by Subject|4|||
25143779|NCT01469182|50257377|FG001|Overall Study|Withdrawal by Subject|1|||
25015728|NCT02959918|50110505|FG012|Overall Study|Protocol Violation|1|||
25015729|NCT02959918|50110506|FG013|Overall Study|Protocol Violation|0|||
25015730|NCT02959918|50110493|FG000|Overall Study|Stopping Rule Met|1|||
25015731|NCT02959918|50110494|FG001|Overall Study|Stopping Rule Met|0|||
25180103|NCT01459913|50326048|FG003|Overall Study|Other|1|||
25180104|NCT01459913|50326045|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
25180105|NCT01459913|50326046|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
25180106|NCT01459913|50326047|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
25015732|NCT02959918|50110495|FG002|Overall Study|Stopping Rule Met|3|||
25015733|NCT02959918|50110496|FG003|Overall Study|Stopping Rule Met|4|||
25015734|NCT02959918|50110497|FG004|Overall Study|Stopping Rule Met|5|||
25015735|NCT02959918|50110498|FG005|Overall Study|Stopping Rule Met|3|||
25015736|NCT02959918|50110499|FG006|Overall Study|Stopping Rule Met|2|||
25180107|NCT01459913|50326048|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
25180108|NCT01458587|50326062|FG000|Overall Study|Withdrawal by Subject|1|||
25180109|NCT01458587|50326063|FG001|Overall Study|Withdrawal by Subject|0|||
25180110|NCT01458275|50326074|FG000|Overall Study|Adverse Event|3|||
25180111|NCT01458275|50326075|FG001|Overall Study|Adverse Event|4|||
25180112|NCT01458275|50326076|FG002|Overall Study|Adverse Event|1|||
25180113|NCT01458275|50326074|FG000|Overall Study|Lost to Follow-up|3|||
25015737|NCT02959918|50110500|FG007|Overall Study|Stopping Rule Met|4|||
25015738|NCT02959918|50110501|FG008|Overall Study|Stopping Rule Met|1|||
25015739|NCT02959918|50110502|FG009|Overall Study|Stopping Rule Met|1|||
25015740|NCT02959918|50110503|FG010|Overall Study|Stopping Rule Met|3|||
25015741|NCT02959918|50110504|FG011|Overall Study|Stopping Rule Met|5|||
25015742|NCT02959918|50110505|FG012|Overall Study|Stopping Rule Met|2|||
25143780|NCT01469182|50257376|FG000|Overall Study|Protocol Violation|4|||
25143781|NCT01469182|50257377|FG001|Overall Study|Protocol Violation|2|||
25143782|NCT01469182|50257376|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
25143783|NCT01469182|50257377|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
25180114|NCT01458275|50326075|FG001|Overall Study|Lost to Follow-up|2|||
25180115|NCT01458275|50326076|FG002|Overall Study|Lost to Follow-up|5|||
25180116|NCT01458275|50326074|FG000|Overall Study|Protocol Violation|5|||
25180117|NCT01458275|50326075|FG001|Overall Study|Protocol Violation|5|||
25143784|NCT01444378|50257383|FG000|Overall Study|Lost to Follow-up|1|||
25143785|NCT01444378|50257383|FG000|Overall Study|Withdrawal by Subject|1|||
25143786|NCT01444378|50257383|FG000|Overall Study|Death|3|||
25143787|NCT01444378|50257383|FG000|Overall Study|Administrative Closure Of The Study|2|||
25143788|NCT01444378|50257383|FG000|Overall Study|Missed Visits|10|||
25143789|NCT02020889|50257392|FG000|Overall Study|Adverse Event|0|||
25180118|NCT01458275|50326076|FG002|Overall Study|Protocol Violation|2|||
25180119|NCT01458275|50326074|FG000|Overall Study|Withdrawal by Subject|3|||
25180120|NCT01458275|50326075|FG001|Overall Study|Withdrawal by Subject|2|||
25180121|NCT01458275|50326076|FG002|Overall Study|Withdrawal by Subject|1|||
25143790|NCT02020889|50257393|FG001|Overall Study|Adverse Event|1|||
25143791|NCT02020889|50257392|FG000|Overall Study|Lack of Efficacy|1|||
25180122|NCT01458119|50326086|FG000|Overall Study|Physician Decision|4|||
25180123|NCT01458119|50326086|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
25180124|NCT01458119|50326086|FG000|Overall Study|Pregnancy|1|||
25180125|NCT01458119|50326086|FG000|Overall Study|Death|2|||
25180126|NCT01458119|50326086|FG000|Overall Study|Adverse Event|1|||
25180127|NCT01458119|50326086|FG000|Overall Study|Consent Withdrawn by Participant|8|||
25180128|NCT01458119|50326086|FG000|Overall Study|Non-compliance With Study Drug|3|||
25180129|NCT01688882|50326101|FG000|Overall Study|Adverse Event|1|||
25180130|NCT01688882|50326102|FG001|Overall Study|Adverse Event|0|||
25180131|NCT01688882|50326101|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25180132|NCT01688882|50326102|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
25180133|NCT01688882|50326101|FG000|Overall Study|Administrative problems|1|||
25180134|NCT01688882|50326102|FG001|Overall Study|Administrative problems|0|||
25180135|NCT01688726|50326114|FG000|Overall Study|Adverse Event|1|||
25180136|NCT01688726|50326115|FG001|Overall Study|Adverse Event|0|||
25180137|NCT01688726|50326114|FG000|Overall Study|Relocated abroad|0|||
25180138|NCT01688726|50326115|FG001|Overall Study|Relocated abroad|1|||
25180139|NCT01585766|50326131|FG000|Overall Study|Withdrawal by Subject|0|||
25180140|NCT01585766|50326132|FG001|Overall Study|Withdrawal by Subject|1|||
25180141|NCT01585766|50326133|FG002|Overall Study|Withdrawal by Subject|1|||
25180142|NCT01585766|50326134|FG003|Overall Study|Withdrawal by Subject|0|||
25143792|NCT02020889|50257393|FG001|Overall Study|Lack of Efficacy|0|||
25143793|NCT02020889|50257392|FG000|Overall Study|Lost to Follow-up|1|||
25143794|NCT02020889|50257393|FG001|Overall Study|Lost to Follow-up|0|||
25143795|NCT02020889|50257392|FG000|Overall Study|Physician Decision|2|||
25143796|NCT02020889|50257393|FG001|Overall Study|Physician Decision|0|||
25143797|NCT02020889|50257392|FG000|Overall Study|Withdrawal by Subject|3|||
25143798|NCT02020889|50257393|FG001|Overall Study|Withdrawal by Subject|2|||
25143799|NCT01444300|50257401|FG000|Overall Study|Adverse Event|4|||
25143800|NCT01444300|50257402|FG001|Overall Study|Adverse Event|0|||
25143801|NCT01443364|50257409|FG000|Overall Study|Lack of Efficacy|14|||
25143802|NCT01443364|50257409|FG000|Overall Study|Lost to Follow-up|3|||
25143803|NCT01443364|50257409|FG000|Overall Study|Withdrawal by Subject|5|||
25015743|NCT02959918|50110506|FG013|Overall Study|Stopping Rule Met|1|||
25180143|NCT01585766|50326135|FG004|Overall Study|Withdrawal by Subject|0|||
25180144|NCT01585766|50326136|FG005|Overall Study|Withdrawal by Subject|0|||
25180145|NCT01585766|50326131|FG000|Overall Study|Death|0|||
25180146|NCT01585766|50326132|FG001|Overall Study|Death|1|||
25180147|NCT01585766|50326133|FG002|Overall Study|Death|0|||
25180148|NCT01585766|50326134|FG003|Overall Study|Death|0|||
25180149|NCT01585766|50326135|FG004|Overall Study|Death|0|||
25180150|NCT01585766|50326136|FG005|Overall Study|Death|0|||
25180151|NCT01585766|50326131|FG000|Overall Study|Physician Decision|0|||
25143804|NCT01443364|50257409|FG000|Overall Study|Other Reason|4|||
25143805|NCT01443364|50257409|FG000|Overall Study|SAE, non-fatal|6|||
25180152|NCT01585766|50326132|FG001|Overall Study|Physician Decision|0|||
25180153|NCT01585766|50326133|FG002|Overall Study|Physician Decision|1|||
25180154|NCT01585766|50326134|FG003|Overall Study|Physician Decision|0|||
25180155|NCT01585766|50326135|FG004|Overall Study|Physician Decision|0|||
25180156|NCT01585766|50326136|FG005|Overall Study|Physician Decision|0|||
25180157|NCT01562444|50326160|FG000|Overall Study|Did not meet entry criteria|2|||
25180158|NCT01562444|50326161|FG001|Overall Study|Did not meet entry criteria|0|||
25180159|NCT01562444|50326162|FG002|Overall Study|Did not meet entry criteria|3|||
25180160|NCT01562444|50326160|FG000|Overall Study|Did not comply with blood draw schedule|1|||
25180161|NCT01562444|50326161|FG001|Overall Study|Did not comply with blood draw schedule|0|||
25180162|NCT01562444|50326162|FG002|Overall Study|Did not comply with blood draw schedule|1|||
25180163|NCT01562444|50326160|FG000|Overall Study|Unavailable serological results|0|||
25180164|NCT01562444|50326161|FG001|Overall Study|Unavailable serological results|2|||
25180165|NCT01562444|50326162|FG002|Overall Study|Unavailable serological results|2|||
25180166|NCT01562444|50326160|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
25180167|NCT01562444|50326161|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
25180168|NCT01562444|50326162|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
25180169|NCT01562444|50326160|FG000|Overall Study|Protocol forbidden medication|1|||
25180170|NCT01562444|50326161|FG001|Overall Study|Protocol forbidden medication|0|||
25180171|NCT01562444|50326162|FG002|Overall Study|Protocol forbidden medication|0|||
25180172|NCT01457339|50326172|FG000|Period 3 (100 mg)|Adverse Event|0|||
25180173|NCT01457339|50326173|FG001|Period 3 (100 mg)|Adverse Event|1|||
25180174|NCT01457339|50326172|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
25180175|NCT01457339|50326173|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
25180176|NCT01457339|50326172|FG000|Period 6 (250 mg)|Family Emergency|1|||
25180177|NCT01457339|50326173|FG001|Period 6 (250 mg)|Family Emergency|0|||
25180178|NCT01457339|50326172|FG000|Period 6 (250 mg)|Personal appointment|0|||
25180179|NCT01457339|50326173|FG001|Period 6 (250 mg)|Personal appointment|1|||
25180180|NCT01456949|50326196|FG000|Enrollment|PI death- incomplete data|6|||
25180181|NCT01456949|50326196|FG000|Enrollment|Death|1|||
25180182|NCT01456949|50326196|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
25180183|NCT01456949|50326196|FG000|Enrollment|Physician Decision|10|||
25180184|NCT01456949|50326196|FG000|Enrollment|Withdrawal by Subject|7|||
25180185|NCT01456949|50326196|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
25180186|NCT01456949|50326196|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
25180187|NCT01456949|50326196|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
25180188|NCT01456949|50326196|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
25180189|NCT01456949|50326196|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
25180190|NCT01456949|50326196|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
25180191|NCT01456949|50326196|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
25180192|NCT01456949|50326196|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
25180193|NCT01456169|50326203|FG000|Overall Study|Adverse Event|1|||
25180194|NCT01456169|50326204|FG001|Overall Study|Adverse Event|2|||
25180195|NCT01456169|50326205|FG002|Overall Study|Adverse Event|7|||
25180196|NCT01456169|50326203|FG000|Overall Study|Major Protocol Deviation|3|||
25180197|NCT01456169|50326204|FG001|Overall Study|Major Protocol Deviation|2|||
25180198|NCT01456169|50326205|FG002|Overall Study|Major Protocol Deviation|3|||
25180199|NCT01456169|50326203|FG000|Overall Study|Voluntary Withdrawal|3|||
25180200|NCT01456169|50326204|FG001|Overall Study|Voluntary Withdrawal|0|||
25143806|NCT01443364|50257409|FG000|Overall Study|AE, non-serious non-fatal|8|||
25143807|NCT01443364|50257409|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
25143808|NCT02020577|50257415|FG000|Overall Study|Progressive disease|3|||
25143809|NCT02020577|50257416|FG001|Overall Study|Progressive disease|38|||
25143810|NCT02020577|50257415|FG000|Overall Study|Other AE or clinical progression|0|||
25143811|NCT02020577|50257416|FG001|Overall Study|Other AE or clinical progression|15|||
25143812|NCT02020577|50257415|FG000|Overall Study|Withdrawal by Subject|0|||
25143813|NCT02020577|50257416|FG001|Overall Study|Withdrawal by Subject|1|||
25143814|NCT02020577|50257415|FG000|Overall Study|Other than stated above|0|||
25143815|NCT02020577|50257416|FG001|Overall Study|Other than stated above|1|||
25143816|NCT02020031|50257426|FG000|Overall Study|Physician Decision|1|||
25143817|NCT02020031|50257427|FG001|Overall Study|Physician Decision|1|||
25143818|NCT04179305|50257437|FG000|Overall Study|Death|1|||
25143819|NCT04179305|50257438|FG001|Overall Study|Death|1|||
25180201|NCT01456169|50326205|FG002|Overall Study|Voluntary Withdrawal|2|||
25180202|NCT01456169|50326203|FG000|Overall Study|Lack of Efficacy|2|||
25180203|NCT01456169|50326204|FG001|Overall Study|Lack of Efficacy|0|||
25180204|NCT01456169|50326205|FG002|Overall Study|Lack of Efficacy|0|||
25180205|NCT01456169|50326203|FG000|Overall Study|Other|1|||
25143820|NCT04179305|50257439|FG002|Overall Study|Death|0|||
25180206|NCT01456169|50326204|FG001|Overall Study|Other|1|||
25180207|NCT01456169|50326205|FG002|Overall Study|Other|0|||
25180208|NCT01454531|50326214|FG000|Overall Study|Adverse Event|14|||
25180209|NCT01454531|50326214|FG000|Overall Study|Withdrawal by Subject|5|||
25180210|NCT01454531|50326214|FG000|Overall Study|Lost to Follow-up|1|||
25143821|NCT04179305|50257440|FG003|Overall Study|Death|0|||
25143822|NCT04179305|50257437|FG000|Overall Study|Lost to Follow-up|1|||
25143823|NCT04179305|50257438|FG001|Overall Study|Lost to Follow-up|1|||
25143824|NCT04179305|50257439|FG002|Overall Study|Lost to Follow-up|0|||
25143825|NCT04179305|50257440|FG003|Overall Study|Lost to Follow-up|0|||
25143826|NCT04179305|50257437|FG000|Overall Study|Withdrawal by Subject|0|||
25143827|NCT04179305|50257438|FG001|Overall Study|Withdrawal by Subject|1|||
25143828|NCT04179305|50257439|FG002|Overall Study|Withdrawal by Subject|0|||
25143829|NCT04179305|50257440|FG003|Overall Study|Withdrawal by Subject|0|||
25143830|NCT04179305|50257437|FG000|Overall Study|Did not have scan|1|||
25143831|NCT04179305|50257438|FG001|Overall Study|Did not have scan|0|||
25143832|NCT04179305|50257439|FG002|Overall Study|Did not have scan|0|||
25143833|NCT04179305|50257440|FG003|Overall Study|Did not have scan|0|||
25143834|NCT04179305|50257437|FG000|Overall Study|In hospice care|3|||
25143835|NCT04179305|50257438|FG001|Overall Study|In hospice care|0|||
25143836|NCT04179305|50257439|FG002|Overall Study|In hospice care|0|||
25143837|NCT04179305|50257440|FG003|Overall Study|In hospice care|0|||
25143838|NCT02019719|50257456|FG000|Overall Study|Adverse Event|1|||
25143839|NCT02019719|50257457|FG001|Overall Study|Adverse Event|0|||
25143840|NCT02019719|50257458|FG002|Overall Study|Adverse Event|0|||
25143841|NCT02019719|50257459|FG003|Overall Study|Adverse Event|1|||
25143842|NCT02019719|50257460|FG004|Overall Study|Adverse Event|1|||
25143843|NCT02019719|50257456|FG000|Overall Study|Protocol Violation|1|||
25143844|NCT02019719|50257457|FG001|Overall Study|Protocol Violation|1|||
25143845|NCT02019719|50257458|FG002|Overall Study|Protocol Violation|0|||
25143846|NCT02019719|50257459|FG003|Overall Study|Protocol Violation|0|||
25143847|NCT02019719|50257460|FG004|Overall Study|Protocol Violation|0|||
25143848|NCT02019719|50257456|FG000|Overall Study|Protocol defined stopping criteria|2|||
25143849|NCT02019719|50257457|FG001|Overall Study|Protocol defined stopping criteria|0|||
25143850|NCT02019719|50257458|FG002|Overall Study|Protocol defined stopping criteria|0|||
25143851|NCT02019719|50257459|FG003|Overall Study|Protocol defined stopping criteria|1|||
25143852|NCT02019719|50257460|FG004|Overall Study|Protocol defined stopping criteria|1|||
25143853|NCT02019719|50257456|FG000|Overall Study|Physician Decision|2|||
25143854|NCT02019719|50257457|FG001|Overall Study|Physician Decision|0|||
25143855|NCT02019719|50257458|FG002|Overall Study|Physician Decision|0|||
25143856|NCT02019719|50257459|FG003|Overall Study|Physician Decision|0|||
25143857|NCT02019719|50257460|FG004|Overall Study|Physician Decision|0|||
25143858|NCT02030405|50257479|FG000|Overall Study|Withdrawal by Subject|1|||
25143859|NCT02030405|50257479|FG000|Overall Study|Lost to Follow-up|1|||
25143860|NCT01975376|50257486|FG000|Overall Study|Adverse Event|5|||
25143861|NCT01975376|50257487|FG001|Overall Study|Adverse Event|5|||
25143862|NCT01975376|50257486|FG000|Overall Study|Death|65|||
25143863|NCT01975376|50257487|FG001|Overall Study|Death|72|||
25143864|NCT01975376|50257486|FG000|Overall Study|Lost to Follow-up|70|||
25143865|NCT01975376|50257487|FG001|Overall Study|Lost to Follow-up|66|||
25143866|NCT01975376|50257486|FG000|Overall Study|Withdrew consent|68|||
25143867|NCT01975376|50257487|FG001|Overall Study|Withdrew consent|62|||
25143868|NCT01975376|50257486|FG000|Overall Study|Other|2|||
25143869|NCT01975376|50257487|FG001|Overall Study|Other|4|||
25143870|NCT01975376|50257486|FG000|Overall Study|Randomized, Not Treated|16|||
25143871|NCT01975376|50257487|FG001|Overall Study|Randomized, Not Treated|8|||
25143872|NCT01443130|50257499|FG000|Overall Study|Lost to Follow-up|44|||
25143873|NCT01443130|50257500|FG001|Overall Study|Lost to Follow-up|42|||
25143874|NCT01443130|50257501|FG002|Overall Study|Lost to Follow-up|50|||
25143875|NCT01443130|50257502|FG003|Overall Study|Lost to Follow-up|23|||
25143876|NCT01443130|50257503|FG004|Overall Study|Lost to Follow-up|25|||
25143877|NCT01443130|50257504|FG005|Overall Study|Lost to Follow-up|21|||
25143878|NCT01443130|50257499|FG000|Overall Study|Death|0|||
25143879|NCT01443130|50257500|FG001|Overall Study|Death|1|||
25143880|NCT01443130|50257501|FG002|Overall Study|Death|0|||
25143881|NCT01443130|50257502|FG003|Overall Study|Death|7|||
25143882|NCT01443130|50257503|FG004|Overall Study|Death|10|||
25143883|NCT01443130|50257504|FG005|Overall Study|Death|8|||
25143884|NCT01443130|50257499|FG000|Overall Study|Adverse Event|2|||
25143885|NCT01443130|50257500|FG001|Overall Study|Adverse Event|1|||
25143886|NCT01443130|50257501|FG002|Overall Study|Adverse Event|1|||
25143887|NCT01443130|50257502|FG003|Overall Study|Adverse Event|0|||
25143888|NCT01443130|50257503|FG004|Overall Study|Adverse Event|0|||
25143889|NCT01443130|50257504|FG005|Overall Study|Adverse Event|0|||
25143890|NCT01443130|50257499|FG000|Overall Study|Protocol Violation|2|||
25143891|NCT01443130|50257500|FG001|Overall Study|Protocol Violation|1|||
25143892|NCT01443130|50257501|FG002|Overall Study|Protocol Violation|3|||
25143893|NCT01443130|50257502|FG003|Overall Study|Protocol Violation|2|||
25143894|NCT01443130|50257503|FG004|Overall Study|Protocol Violation|2|||
25143895|NCT01443130|50257504|FG005|Overall Study|Protocol Violation|3|||
25143896|NCT01443130|50257499|FG000|Overall Study|Withdrawal by Subject|15|||
25143897|NCT01443130|50257500|FG001|Overall Study|Withdrawal by Subject|14|||
25143898|NCT01443130|50257501|FG002|Overall Study|Withdrawal by Subject|12|||
25143899|NCT01443130|50257502|FG003|Overall Study|Withdrawal by Subject|7|||
25143900|NCT01443130|50257503|FG004|Overall Study|Withdrawal by Subject|7|||
25143901|NCT01443130|50257504|FG005|Overall Study|Withdrawal by Subject|2|||
25143902|NCT01443130|50257499|FG000|Overall Study|Death of Subject's Infant|5|||
25143903|NCT01443130|50257500|FG001|Overall Study|Death of Subject's Infant|10|||
25143904|NCT01443130|50257501|FG002|Overall Study|Death of Subject's Infant|11|||
25143905|NCT01443130|50257502|FG003|Overall Study|Death of Subject's Infant|0|||
25143906|NCT01443130|50257503|FG004|Overall Study|Death of Subject's Infant|0|||
25143907|NCT01443130|50257504|FG005|Overall Study|Death of Subject's Infant|0|||
25143908|NCT01436500|50257520|FG000|Overall Study|Death|1|||
25143909|NCT01436500|50257521|FG001|Overall Study|Death|0|||
25143910|NCT01436500|50257522|FG002|Overall Study|Death|0|||
25143911|NCT01436500|50257523|FG003|Overall Study|Death|0|||
25143912|NCT01436500|50257524|FG004|Overall Study|Death|0|||
25143913|NCT01436500|50257520|FG000|Overall Study|Adverse Event|0|||
25143914|NCT01436500|50257521|FG001|Overall Study|Adverse Event|2|||
25143915|NCT01436500|50257522|FG002|Overall Study|Adverse Event|2|||
25143916|NCT01436500|50257523|FG003|Overall Study|Adverse Event|0|||
25143917|NCT01436500|50257524|FG004|Overall Study|Adverse Event|1|||
25143918|NCT01436500|50257520|FG000|Overall Study|Withdrawal by Subject|0|||
25143919|NCT01436500|50257521|FG001|Overall Study|Withdrawal by Subject|0|||
25143920|NCT01436500|50257522|FG002|Overall Study|Withdrawal by Subject|2|||
25143921|NCT01436500|50257523|FG003|Overall Study|Withdrawal by Subject|0|||
25143922|NCT01436500|50257524|FG004|Overall Study|Withdrawal by Subject|2|||
25143923|NCT01436500|50257520|FG000|Overall Study|Physician Decision|0|||
25143924|NCT01436500|50257521|FG001|Overall Study|Physician Decision|0|||
25143925|NCT01436500|50257522|FG002|Overall Study|Physician Decision|1|||
25143926|NCT01436500|50257523|FG003|Overall Study|Physician Decision|0|||
25143927|NCT01436500|50257524|FG004|Overall Study|Physician Decision|0|||
25143928|NCT01436500|50257520|FG000|Overall Study|liver transplant|1|||
25143929|NCT01436500|50257521|FG001|Overall Study|liver transplant|0|||
25143930|NCT01436500|50257522|FG002|Overall Study|liver transplant|0|||
25143931|NCT01436500|50257523|FG003|Overall Study|liver transplant|0|||
25143932|NCT01436500|50257524|FG004|Overall Study|liver transplant|0|||
25143933|NCT01436500|50257520|FG000|Overall Study|initiation of dialysis|0|||
25143934|NCT01436500|50257521|FG001|Overall Study|initiation of dialysis|0|||
25143935|NCT01436500|50257522|FG002|Overall Study|initiation of dialysis|0|||
25143936|NCT01436500|50257523|FG003|Overall Study|initiation of dialysis|0|||
25143937|NCT01436500|50257524|FG004|Overall Study|initiation of dialysis|1|||
25143938|NCT01436500|50257520|FG000|Overall Study|discontinued study drug|1|||
25143939|NCT01436500|50257521|FG001|Overall Study|discontinued study drug|0|||
25143940|NCT01436500|50257522|FG002|Overall Study|discontinued study drug|0|||
25143941|NCT01436500|50257523|FG003|Overall Study|discontinued study drug|0|||
25143942|NCT01436500|50257524|FG004|Overall Study|discontinued study drug|0|||
25143943|NCT01436500|50257520|FG000|Overall Study|Other|0|||
25143944|NCT01436500|50257521|FG001|Overall Study|Other|1|||
25143945|NCT01436500|50257522|FG002|Overall Study|Other|0|||
25143946|NCT01436500|50257523|FG003|Overall Study|Other|1|||
25143947|NCT01436500|50257524|FG004|Overall Study|Other|0|||
25143948|NCT01958827|50257537|FG000|Overall Study|Adverse Event|3|||
25143949|NCT01958827|50257537|FG000|Overall Study|Lack of Efficacy|6|||
25143950|NCT01958827|50257537|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
25143951|NCT01620086|50257543|FG000|Overall Study|Withdrawal by Subject|3|||
25143952|NCT01620086|50257544|FG001|Overall Study|Withdrawal by Subject|3|||
25143953|NCT01620086|50257545|FG002|Overall Study|Withdrawal by Subject|0|||
25143954|NCT01620086|50257543|FG000|Overall Study|failed study criteria|1|||
25143955|NCT01620086|50257544|FG001|Overall Study|failed study criteria|4|||
25143956|NCT01620086|50257545|FG002|Overall Study|failed study criteria|0|||
25143957|NCT01620086|50257543|FG000|Overall Study|Physician Decision|1|||
25143958|NCT01620086|50257544|FG001|Overall Study|Physician Decision|0|||
25143959|NCT01620086|50257545|FG002|Overall Study|Physician Decision|0|||
25143960|NCT01436110|50257557|FG000|Overall Study|Lack of Efficacy|23|||
25143961|NCT01436110|50257558|FG001|Overall Study|Lack of Efficacy|14|||
25143962|NCT01436110|50257559|FG002|Overall Study|Lack of Efficacy|9|||
25143963|NCT01436110|50257557|FG000|Overall Study|Withdrawal by Subject|6|||
25143964|NCT01436110|50257558|FG001|Overall Study|Withdrawal by Subject|8|||
25143965|NCT01436110|50257559|FG002|Overall Study|Withdrawal by Subject|4|||
25143966|NCT01436110|50257557|FG000|Overall Study|Adverse Event|2|||
25143967|NCT01436110|50257558|FG001|Overall Study|Adverse Event|1|||
25143968|NCT01436110|50257559|FG002|Overall Study|Adverse Event|2|||
25143969|NCT01436110|50257557|FG000|Overall Study|Physician Decision|3|||
25143970|NCT01436110|50257558|FG001|Overall Study|Physician Decision|1|||
25143971|NCT01436110|50257559|FG002|Overall Study|Physician Decision|1|||
25143972|NCT01436110|50257557|FG000|Overall Study|Lost to Follow-up|1|||
25143973|NCT01436110|50257558|FG001|Overall Study|Lost to Follow-up|1|||
25143974|NCT01436110|50257559|FG002|Overall Study|Lost to Follow-up|3|||
25143975|NCT01436110|50257557|FG000|Overall Study|Protocol Violation|3|||
25143976|NCT01436110|50257558|FG001|Overall Study|Protocol Violation|1|||
25143977|NCT01436110|50257559|FG002|Overall Study|Protocol Violation|1|||
25143978|NCT01436110|50257557|FG000|Overall Study|Did Not Receive Trial Medication|1|||
25143979|NCT01436110|50257558|FG001|Overall Study|Did Not Receive Trial Medication|0|||
25143980|NCT01436110|50257559|FG002|Overall Study|Did Not Receive Trial Medication|3|||
25143981|NCT01619852|50257569|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
25143982|NCT01619852|50257570|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
25143983|NCT01619852|50257569|FG000|3 Month Follow up|Lost to Follow-up|31|||
25143984|NCT01619852|50257570|FG001|3 Month Follow up|Lost to Follow-up|34|||
25143985|NCT02000882|50257577|FG000|Overall Study|Adverse Event|3|||
25143986|NCT02000882|50257577|FG000|Overall Study|Physician Decision|2|||
25143987|NCT02000882|50257577|FG000|Overall Study|Withdrawal by Subject|1|||
25143988|NCT01965938|50257583|FG000|Overall Study|Withdrawal by Subject|1|||
25143989|NCT01965938|50257584|FG001|Overall Study|Withdrawal by Subject|0|||
25143990|NCT01965860|50257595|FG000|Overall Study|Pregnancy|1|||
25143991|NCT01965860|50257596|FG001|Overall Study|Pregnancy|0|||
25143992|NCT01965860|50257597|FG002|Overall Study|Pregnancy|1|||
25143993|NCT01965860|50257595|FG000|Overall Study|Logistics|1|||
25143994|NCT01965860|50257596|FG001|Overall Study|Logistics|0|||
25143995|NCT01965860|50257597|FG002|Overall Study|Logistics|0|||
25143996|NCT01965704|50257618|FG000|Overall Study|Withdrawal by Subject|2|||
25143997|NCT01965704|50257619|FG001|Overall Study|Withdrawal by Subject|2|||
25143998|NCT01965704|50257620|FG002|Overall Study|Withdrawal by Subject|1|||
25143999|NCT01965704|50257621|FG003|Overall Study|Withdrawal by Subject|1|||
25144000|NCT01965704|50257618|FG000|Overall Study|Delivered at home|1|||
25144001|NCT01965704|50257619|FG001|Overall Study|Delivered at home|1|||
25144002|NCT01965704|50257620|FG002|Overall Study|Delivered at home|0|||
25144003|NCT01965704|50257621|FG003|Overall Study|Delivered at home|0|||
25144004|NCT01965704|50257618|FG000|Overall Study|Experienced complications|0|||
25144005|NCT01965704|50257619|FG001|Overall Study|Experienced complications|0|||
25144006|NCT01965704|50257620|FG002|Overall Study|Experienced complications|2|||
25144007|NCT01965704|50257621|FG003|Overall Study|Experienced complications|2|||
25144008|NCT01965704|50257618|FG000|Overall Study|Adverse Event|0|||
25144009|NCT01965704|50257619|FG001|Overall Study|Adverse Event|0|||
25144010|NCT01965704|50257620|FG002|Overall Study|Adverse Event|1|||
25144011|NCT01965704|50257621|FG003|Overall Study|Adverse Event|1|||
25144012|NCT01965704|50257618|FG000|Overall Study|Did not meet inclusion criteria|0|||
25144013|NCT01965704|50257619|FG001|Overall Study|Did not meet inclusion criteria|0|||
25144014|NCT01965704|50257620|FG002|Overall Study|Did not meet inclusion criteria|1|||
25144015|NCT01965704|50257621|FG003|Overall Study|Did not meet inclusion criteria|1|||
25144016|NCT02003365|50257632|FG000|Overall Study|Lost to Follow-up|0|||
25144017|NCT02003365|50257633|FG001|Overall Study|Lost to Follow-up|0|||
25144018|NCT02003365|50257634|FG002|Overall Study|Lost to Follow-up|1|||
25144019|NCT01975220|50257645|FG000|Test Period 1|Not treated|0|||
25144020|NCT01975220|50257646|FG001|Test Period 1|Not treated|1|||
25144021|NCT01975220|50257647|FG002|Test Period 1|Not treated|0|||
25144022|NCT01975220|50257648|FG003|Test Period 1|Not treated|0|||
25144023|NCT01975220|50257649|FG004|Test Period 1|Not treated|0|||
25144024|NCT01975220|50257650|FG005|Test Period 1|Not treated|0|||
25144025|NCT01958437|50257667|FG000|Overall Study|Incidental MRI findings|0|||
25144026|NCT01958437|50257668|FG001|Overall Study|Incidental MRI findings|0|||
25144027|NCT01958437|50257669|FG002|Overall Study|Incidental MRI findings|1|||
25144028|NCT01958437|50257670|FG003|Overall Study|Incidental MRI findings|1|||
25144029|NCT01974752|50257689|FG000|Overall Study|Death|33|||
25144030|NCT01974752|50257690|FG001|Overall Study|Death|11|||
25144031|NCT01974752|50257689|FG000|Overall Study|Lost to Follow-up|2|||
25144032|NCT01974752|50257690|FG001|Overall Study|Lost to Follow-up|0|||
25144033|NCT01974752|50257689|FG000|Overall Study|Withdrawal by Subject|2|||
25144034|NCT01974752|50257690|FG001|Overall Study|Withdrawal by Subject|3|||
25144035|NCT01974752|50257689|FG000|Overall Study|Other Eligibility Criteria|0|||
25144036|NCT01974752|50257690|FG001|Overall Study|Other Eligibility Criteria|1|||
25144037|NCT01999946|50257699|FG000|Overall Study|Participant not released from jail|2|||
25144038|NCT01999946|50257700|FG001|Overall Study|Participant not released from jail|2|||
25144039|NCT01999946|50257701|FG002|Overall Study|Participant not released from jail|0|||
25144040|NCT01999946|50257699|FG000|Overall Study|Not included in primary outcome analysis|0|||
25144041|NCT01999946|50257700|FG001|Overall Study|Not included in primary outcome analysis|0|||
25144042|NCT01999946|50257701|FG002|Overall Study|Not included in primary outcome analysis|79|||
25144043|NCT01958281|50257711|FG000|Overall Study|Lack of Efficacy|5|||
25144044|NCT01958281|50257712|FG001|Overall Study|Lack of Efficacy|2|||
25144045|NCT01958281|50257713|FG002|Overall Study|Lack of Efficacy|0|||
25144046|NCT01958281|50257711|FG000|Overall Study|Adverse Event|0|||
25144047|NCT01958281|50257712|FG001|Overall Study|Adverse Event|2|||
25144048|NCT01958281|50257713|FG002|Overall Study|Adverse Event|0|||
25144049|NCT01958281|50257711|FG000|Overall Study|Withdrew Consent|1|||
25144050|NCT01958281|50257712|FG001|Overall Study|Withdrew Consent|0|||
25144051|NCT01958281|50257713|FG002|Overall Study|Withdrew Consent|0|||
25144052|NCT01958125|50257724|FG000|Overall Study|Missing diary data|2|||
25144053|NCT01958125|50257725|FG001|Overall Study|Missing diary data|6|||
25144054|NCT01958125|50257724|FG000|Overall Study|No headache attacks|0|||
25144055|NCT01958125|50257725|FG001|Overall Study|No headache attacks|2|||
25144056|NCT02002975|50257731|FG000|Overall Study|Case Report Forms Uncollected|135|||
25144057|NCT02002975|50257731|FG000|Overall Study|Protocol Deviation|437|||
25144058|NCT02001181|50257737|FG000|Overall Study|Adverse Event|0|||
25144059|NCT02001181|50257738|FG001|Overall Study|Adverse Event|2|||
25144060|NCT02001181|50257737|FG000|Overall Study|Lost to Follow-up|1|||
25144061|NCT02001181|50257738|FG001|Overall Study|Lost to Follow-up|0|||
25144062|NCT02001181|50257737|FG000|Overall Study|Withdrawal by Subject|0|||
25144063|NCT02001181|50257738|FG001|Overall Study|Withdrawal by Subject|1|||
25144064|NCT01999465|50257746|FG000|Overall Study|Lost to Follow-up|0|||
25144065|NCT01999465|50257747|FG001|Overall Study|Lost to Follow-up|2|||
25144066|NCT01999465|50257746|FG000|Overall Study|Protocol Violation|0|||
25144067|NCT01999465|50257747|FG001|Overall Study|Protocol Violation|1|||
25144068|NCT01982773|50257755|FG000|Overall Study|Withdrawal by Subject|1|||
25144069|NCT01982773|50257756|FG001|Overall Study|Withdrawal by Subject|3|||
25144070|NCT01982773|50257755|FG000|Overall Study|Lost to Follow-up|7|||
25144071|NCT01982773|50257756|FG001|Overall Study|Lost to Follow-up|1|||
25144072|NCT01974206|50257764|FG000|Overall Study|Did Not Take Study Drug|0|||
25144073|NCT01974206|50257765|FG001|Overall Study|Did Not Take Study Drug|1|||
25144074|NCT01974206|50257764|FG000|Overall Study|Physician Decision|1|||
25144075|NCT01974206|50257765|FG001|Overall Study|Physician Decision|0|||
25144076|NCT01974206|50257764|FG000|Overall Study|Withdrawal by Subject|3|||
25144077|NCT01974206|50257765|FG001|Overall Study|Withdrawal by Subject|0|||
25144078|NCT01974206|50257764|FG000|Overall Study|Lost to Follow-up|1|||
25144079|NCT01974206|50257765|FG001|Overall Study|Lost to Follow-up|0|||
25144080|NCT01974206|50257764|FG000|Overall Study|Death|1|||
25144081|NCT01974206|50257765|FG001|Overall Study|Death|0|||
25144082|NCT01999868|50257774|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
25144083|NCT01999868|50257775|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
25144084|NCT01999868|50257776|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
25144085|NCT01999868|50257774|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
25144086|NCT01999868|50257775|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
25144087|NCT01999868|50257776|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
25144088|NCT01999868|50257774|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
25144089|NCT01999868|50257775|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
25144090|NCT01999868|50257776|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
25144091|NCT01999868|50257774|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
25144092|NCT01999868|50257775|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
25144093|NCT01999868|50257776|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
25144094|NCT01999868|50257774|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
25144095|NCT01999868|50257775|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
25144096|NCT01999868|50257776|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
25144097|NCT01999868|50257774|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
25144098|NCT01999868|50257775|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
25144099|NCT01999868|50257776|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
25144100|NCT01999868|50257774|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
25144101|NCT01999868|50257775|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
25144102|NCT01999868|50257776|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
25144103|NCT01999868|50257774|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
25144104|NCT01999868|50257775|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
25144105|NCT01999868|50257776|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
25144106|NCT01999868|50257774|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
25144107|NCT01999868|50257775|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
25144108|NCT01999868|50257776|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
25144109|NCT01999868|50257774|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
25144110|NCT01999868|50257775|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
25144111|NCT01999868|50257776|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
25144112|NCT01999868|50257774|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
25144113|NCT01999868|50257775|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
25144114|NCT01999868|50257776|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
25144115|NCT01999868|50257774|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
25144116|NCT01999868|50257775|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
25144117|NCT01999868|50257776|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
25144118|NCT01999868|50257774|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
25144119|NCT01999868|50257775|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
25144120|NCT01999868|50257776|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
25144121|NCT01999868|50257774|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
25144122|NCT01999868|50257775|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
25144123|NCT01999868|50257776|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
25144124|NCT01999868|50257774|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
25144125|NCT01999868|50257775|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
25144126|NCT01999868|50257776|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
25144127|NCT01957579|50257788|FG000|Overall Study|Withdrawal of concent|0|||
25144128|NCT01957579|50257789|FG001|Overall Study|Withdrawal of concent|1|||
25144129|NCT01957579|50257790|FG002|Overall Study|Withdrawal of concent|0|||
25144130|NCT01957579|50257791|FG003|Overall Study|Withdrawal of concent|0|||
25144131|NCT01957579|50257788|FG000|Overall Study|Death|0|||
25144132|NCT01957579|50257789|FG001|Overall Study|Death|0|||
25144133|NCT01957579|50257790|FG002|Overall Study|Death|2|||
25144134|NCT01957579|50257791|FG003|Overall Study|Death|0|||
25144135|NCT01999322|50257820|FG000|Overall Study|Adverse Event|1|||
25144136|NCT01999322|50257821|FG001|Overall Study|Adverse Event|0|||
25144137|NCT01996982|50257827|FG000|Overall Study|PI/team left institution|7|||
25144138|NCT01965158|50257833|FG000|Overall Study|Adverse Event|14|||
25144139|NCT01965158|50257834|FG001|Overall Study|Adverse Event|5|||
25144140|NCT01965158|50257833|FG000|Overall Study|Withdrawal by Subject|16|||
25144141|NCT01965158|50257834|FG001|Overall Study|Withdrawal by Subject|24|||
25144142|NCT01965158|50257833|FG000|Overall Study|Lost to Follow-up|7|||
25144143|NCT01965158|50257834|FG001|Overall Study|Lost to Follow-up|5|||
25144144|NCT01965158|50257833|FG000|Overall Study|Protocol Violation|1|||
25144145|NCT01965158|50257834|FG001|Overall Study|Protocol Violation|1|||
25144146|NCT01965158|50257833|FG000|Overall Study|Other - Miscellaneous|3|||
25144147|NCT01965158|50257834|FG001|Overall Study|Other - Miscellaneous|0|||
25144148|NCT01964924|50257840|FG000|Trametinib Monotherapy|Progression|19|||
25144149|NCT01964924|50257841|FG001|Trametinib Monotherapy|Progression|0|||
25144150|NCT01964378|50257852|FG000|Overall Study|Disc. due to death before first dosing|0|||
25144151|NCT01964378|50257853|FG001|Overall Study|Disc. due to death before first dosing|1|||
25144152|NCT01964378|50257852|FG000|Overall Study|Disc. due to AE before first dosing|1|||
25144153|NCT01964378|50257853|FG001|Overall Study|Disc. due to AE before first dosing|0|||
25144154|NCT01964378|50257852|FG000|Overall Study|Death|3|||
25144155|NCT01964378|50257853|FG001|Overall Study|Death|2|||
25144156|NCT01964378|50257852|FG000|Overall Study|Adverse Event|12|||
25144157|NCT01964378|50257853|FG001|Overall Study|Adverse Event|5|||
25144158|NCT01964378|50257852|FG000|Overall Study|Lack of Efficacy|0|||
25144159|NCT01964378|50257853|FG001|Overall Study|Lack of Efficacy|1|||
25144160|NCT01964378|50257852|FG000|Overall Study|Protocol Violation|0|||
25144161|NCT01964378|50257853|FG001|Overall Study|Protocol Violation|1|||
25144162|NCT01964378|50257852|FG000|Overall Study|Lost to Follow-up|0|||
25144163|NCT01964378|50257853|FG001|Overall Study|Lost to Follow-up|1|||
25144164|NCT01964378|50257852|FG000|Overall Study|Withdrawal by Subject|7|||
25144165|NCT01964378|50257853|FG001|Overall Study|Withdrawal by Subject|5|||
25144166|NCT01964378|50257852|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
25144167|NCT01964378|50257853|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
25144168|NCT01964378|50257852|FG000|Overall Study|Other|1|||
25144169|NCT01964378|50257853|FG001|Overall Study|Other|2|||
25144170|NCT01442038|50257861|FG000|Overall Study|Death|35|||
25144171|NCT01442038|50257862|FG001|Overall Study|Death|29|||
25144172|NCT01442038|50257861|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
25144173|NCT01442038|50257862|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
25144174|NCT01442038|50257861|FG000|Overall Study|Participant Withdrew Consent|137|||
25144175|NCT01442038|50257862|FG001|Overall Study|Participant Withdrew Consent|102|||
25144176|NCT01442038|50257861|FG000|Overall Study|Lost to Follow-up|37|||
25144177|NCT01442038|50257862|FG001|Overall Study|Lost to Follow-up|51|||
25144178|NCT01442038|50257861|FG000|Overall Study|Adverse Event|26|||
25144179|NCT01442038|50257862|FG001|Overall Study|Adverse Event|15|||
25144180|NCT01442038|50257861|FG000|Overall Study|Protocol Deviation|9|||
25144181|NCT01442038|50257862|FG001|Overall Study|Protocol Deviation|20|||
25144182|NCT01442038|50257861|FG000|Overall Study|Investigator's Discretion|13|||
25144183|NCT01442038|50257862|FG001|Overall Study|Investigator's Discretion|16|||
25144184|NCT01442038|50257861|FG000|Overall Study|Study Terminated By Sponsor|2|||
25144185|NCT01442038|50257862|FG001|Overall Study|Study Terminated By Sponsor|3|||
25144186|NCT01998919|50257870|FG000|Overall Study|Death|2|||
25144187|NCT01998919|50257871|FG001|Overall Study|Death|2|||
25144188|NCT01998919|50257870|FG000|Overall Study|Adverse Event|0|||
25144189|NCT01998919|50257871|FG001|Overall Study|Adverse Event|5|||
25144190|NCT01998919|50257870|FG000|Overall Study|Disease progression|31|||
25144191|NCT01998919|50257871|FG001|Overall Study|Disease progression|22|||
25144192|NCT01998919|50257870|FG000|Overall Study|Withdrawal by Subject|2|||
25144193|NCT01998919|50257871|FG001|Overall Study|Withdrawal by Subject|4|||
25144194|NCT01998919|50257870|FG000|Overall Study|Lost to Follow-up|2|||
25144195|NCT01998919|50257871|FG001|Overall Study|Lost to Follow-up|0|||
25144196|NCT01998919|50257870|FG000|Overall Study|Other|5|||
25144197|NCT01998919|50257871|FG001|Overall Study|Other|2|||
25144198|NCT01957111|50257879|FG000|Overall Study|Withdrawal by Subject|1|||
25144199|NCT01957111|50257880|FG001|Overall Study|Withdrawal by Subject|1|||
25144200|NCT01964300|50257888|FG000|Overall Study|Ineligible after enrollment|0|||
25144201|NCT01964300|50257889|FG001|Overall Study|Ineligible after enrollment|1|||
25144202|NCT01964300|50257888|FG000|Overall Study|Adverse Event|1|||
25144203|NCT01964300|50257889|FG001|Overall Study|Adverse Event|1|||
25144204|NCT01964300|50257888|FG000|Overall Study|Lack of Efficacy|3|||
25144205|NCT01964300|50257889|FG001|Overall Study|Lack of Efficacy|5|||
25144206|NCT01964300|50257888|FG000|Overall Study|Withdrawal by Subject|0|||
25144207|NCT01964300|50257889|FG001|Overall Study|Withdrawal by Subject|1|||
25144208|NCT01964300|50257888|FG000|Overall Study|To receive alternative therapy|1|||
25144209|NCT01964300|50257889|FG001|Overall Study|To receive alternative therapy|2|||
25144210|NCT01964300|50257888|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
25144211|NCT01964300|50257889|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
25144212|NCT01964300|50257888|FG000|Overall Study|Weight criteria not met|0|||
25144213|NCT01964300|50257889|FG001|Overall Study|Weight criteria not met|1|||
25144214|NCT01964222|50257897|FG000|Overall Study|Lost to Follow-up|7|||
25144215|NCT01964222|50257898|FG001|Overall Study|Lost to Follow-up|5|||
25144216|NCT01964222|50257897|FG000|Overall Study|Withdrawal by Subject|6|||
25144217|NCT01964222|50257898|FG001|Overall Study|Withdrawal by Subject|6|||
25144218|NCT01964222|50257897|FG000|Overall Study|Screening Failure|2|||
25144219|NCT01964222|50257898|FG001|Overall Study|Screening Failure|0|||
25144220|NCT01467700|50257908|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
25144221|NCT01467700|50257909|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
25144222|NCT01467700|50257910|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
25144223|NCT01467700|50257911|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
25144224|NCT01467700|50257908|FG000|Overall Study|Major Protocol Deviation|3|||
25144225|NCT01467700|50257909|FG001|Overall Study|Major Protocol Deviation|3|||
25144226|NCT01467700|50257910|FG002|Overall Study|Major Protocol Deviation|2|||
25144227|NCT01467700|50257911|FG003|Overall Study|Major Protocol Deviation|3|||
25144228|NCT01467700|50257908|FG000|Overall Study|Lost to Follow-up|6|||
25144229|NCT01467700|50257909|FG001|Overall Study|Lost to Follow-up|5|||
25144230|NCT01467700|50257910|FG002|Overall Study|Lost to Follow-up|2|||
25144231|NCT01467700|50257911|FG003|Overall Study|Lost to Follow-up|3|||
25144232|NCT01467700|50257908|FG000|Overall Study|Voluntary Withdrawal|5|||
25144233|NCT01467700|50257909|FG001|Overall Study|Voluntary Withdrawal|7|||
25144234|NCT01467700|50257910|FG002|Overall Study|Voluntary Withdrawal|6|||
25144235|NCT01467700|50257911|FG003|Overall Study|Voluntary Withdrawal|2|||
25144236|NCT01467700|50257908|FG000|Overall Study|Study Termination|6|||
25144237|NCT01467700|50257909|FG001|Overall Study|Study Termination|5|||
25144238|NCT01467700|50257910|FG002|Overall Study|Study Termination|10|||
25144239|NCT01467700|50257911|FG003|Overall Study|Study Termination|7|||
25144240|NCT01467700|50257908|FG000|Overall Study|Pregnancy|0|||
25144241|NCT01467700|50257909|FG001|Overall Study|Pregnancy|1|||
25144242|NCT01467700|50257910|FG002|Overall Study|Pregnancy|1|||
25144243|NCT01467700|50257911|FG003|Overall Study|Pregnancy|0|||
25144244|NCT01467700|50257908|FG000|Overall Study|Lack of Efficacy|2|||
25144245|NCT01467700|50257909|FG001|Overall Study|Lack of Efficacy|0|||
25144246|NCT01467700|50257910|FG002|Overall Study|Lack of Efficacy|2|||
25144247|NCT01467700|50257911|FG003|Overall Study|Lack of Efficacy|1|||
25144248|NCT01467700|50257908|FG000|Overall Study|Reason not Specified|1|||
25144249|NCT01467700|50257909|FG001|Overall Study|Reason not Specified|3|||
25144250|NCT01467700|50257910|FG002|Overall Study|Reason not Specified|2|||
25144251|NCT01467700|50257911|FG003|Overall Study|Reason not Specified|8|||
25144252|NCT01972724|50257924|FG000|Double-Blind|Rescue Criteria Met|1|||
25144253|NCT01972724|50257925|FG001|Double-Blind|Rescue Criteria Met|0|||
25144254|NCT01972724|50257926|FG002|Double-Blind|Rescue Criteria Met|0|||
25144255|NCT01972724|50257924|FG000|Double-Blind|Adverse Event|1|||
25144256|NCT01972724|50257925|FG001|Double-Blind|Adverse Event|0|||
25144257|NCT01972724|50257926|FG002|Double-Blind|Adverse Event|0|||
25144258|NCT01972724|50257924|FG000|Double-Blind|Withdrawal of Consent|2|||
25144259|NCT01972724|50257925|FG001|Double-Blind|Withdrawal of Consent|1|||
25144260|NCT01972724|50257926|FG002|Double-Blind|Withdrawal of Consent|0|||
25144261|NCT01972724|50257924|FG000|Double-Blind|Significant Protocol Deviation|5|||
25144262|NCT01972724|50257925|FG001|Double-Blind|Significant Protocol Deviation|8|||
25144263|NCT01972724|50257926|FG002|Double-Blind|Significant Protocol Deviation|0|||
25144264|NCT01972724|50257924|FG000|Open-Label|Withdrew Consent|0|||
25144265|NCT01972724|50257925|FG001|Open-Label|Withdrew Consent|0|||
25144266|NCT01972724|50257926|FG002|Open-Label|Withdrew Consent|3|||
25144267|NCT01972724|50257924|FG000|Open-Label|Significant Protocol Deviation|0|||
25144268|NCT01972724|50257925|FG001|Open-Label|Significant Protocol Deviation|0|||
25144269|NCT01972724|50257926|FG002|Open-Label|Significant Protocol Deviation|2|||
25144270|NCT01441960|50257934|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
25144271|NCT01441960|50257935|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
25144272|NCT01441960|50257934|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
25144273|NCT01441960|50257935|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
25144274|NCT01441960|50257934|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
25144275|NCT01441960|50257935|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
25144276|NCT01955707|50257951|FG000|Overall Study|Adverse Event|1|||
25144277|NCT01955707|50257952|FG001|Overall Study|Adverse Event|2|||
25144278|NCT01955707|50257951|FG000|Overall Study|Lost to Follow-up|2|||
25180211|NCT01454531|50326214|FG000|Overall Study|Physician Decision|1|||
25180212|NCT01454531|50326214|FG000|Overall Study|Delay in IMP administration|1|||
25180213|NCT01454531|50326214|FG000|Overall Study|Other|1|||
25180214|NCT01454063|50326220|FG000|Randomized|Adverse Event|1|||
25180215|NCT01454063|50326221|FG001|Randomized|Adverse Event|1|||
25015744|NCT02959918|50110493|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
25144279|NCT01955707|50257952|FG001|Overall Study|Lost to Follow-up|1|||
25144280|NCT01955707|50257951|FG000|Overall Study|Withdrawal by Subject|0|||
25144281|NCT01955707|50257952|FG001|Overall Study|Withdrawal by Subject|3|||
25144282|NCT01955707|50257951|FG000|Overall Study|Death|13|||
25144283|NCT01955707|50257952|FG001|Overall Study|Death|14|||
25144284|NCT01955707|50257951|FG000|Overall Study|Other|4|||
25144285|NCT01955707|50257952|FG001|Overall Study|Other|2|||
25144286|NCT01435798|50257958|FG000|Overall Study|Withdrawal by Subject|1|||
25144287|NCT01972568|50257971|FG000|Overall Study|Other events|3|||
25180216|NCT01454063|50326220|FG000|Randomized|Protocol Violation|0|||
25144288|NCT01972568|50257972|FG001|Overall Study|Other events|0|||
25144289|NCT01972568|50257973|FG002|Overall Study|Other events|0|||
25144290|NCT01972568|50257971|FG000|Overall Study|Lack of Efficacy|0|||
25144291|NCT01972568|50257972|FG001|Overall Study|Lack of Efficacy|1|||
25144292|NCT01972568|50257973|FG002|Overall Study|Lack of Efficacy|2|||
25144293|NCT01972568|50257971|FG000|Overall Study|Protocol Violation|1|||
25144294|NCT01972568|50257972|FG001|Overall Study|Protocol Violation|2|||
25144295|NCT01972568|50257973|FG002|Overall Study|Protocol Violation|2|||
25144296|NCT01972568|50257971|FG000|Overall Study|Withdrawal by Subject|6|||
25144297|NCT01972568|50257972|FG001|Overall Study|Withdrawal by Subject|3|||
25144298|NCT01972568|50257973|FG002|Overall Study|Withdrawal by Subject|7|||
25144299|NCT01972568|50257971|FG000|Overall Study|Lost to Follow-up|1|||
25144300|NCT01972568|50257972|FG001|Overall Study|Lost to Follow-up|0|||
25144301|NCT01972568|50257973|FG002|Overall Study|Lost to Follow-up|0|||
25144302|NCT01972568|50257971|FG000|Overall Study|Adverse Event|5|||
25144303|NCT01972568|50257972|FG001|Overall Study|Adverse Event|6|||
25144304|NCT01972568|50257973|FG002|Overall Study|Adverse Event|5|||
25144305|NCT01955161|50257984|FG000|Overall Study|Withdrawal before treatment|2|||
25144306|NCT01955161|50257985|FG001|Overall Study|Withdrawal before treatment|0|||
25144307|NCT01955161|50257986|FG002|Overall Study|Withdrawal before treatment|1|||
25144308|NCT01955161|50257984|FG000|Overall Study|Adverse Event|10|||
25144309|NCT01955161|50257985|FG001|Overall Study|Adverse Event|14|||
25144310|NCT01955161|50257986|FG002|Overall Study|Adverse Event|15|||
25144311|NCT01955161|50257984|FG000|Overall Study|Death|1|||
25144312|NCT01955161|50257985|FG001|Overall Study|Death|1|||
25144313|NCT01955161|50257986|FG002|Overall Study|Death|3|||
25144314|NCT01955161|50257984|FG000|Overall Study|Withdrawal by Subject|9|||
25144315|NCT01955161|50257985|FG001|Overall Study|Withdrawal by Subject|8|||
25144316|NCT01955161|50257986|FG002|Overall Study|Withdrawal by Subject|12|||
25144317|NCT01955161|50257984|FG000|Overall Study|Protocol Violation|2|||
25144318|NCT01955161|50257985|FG001|Overall Study|Protocol Violation|0|||
25144319|NCT01955161|50257986|FG002|Overall Study|Protocol Violation|0|||
25144320|NCT01955161|50257984|FG000|Overall Study|Other reason: physician decision|0|||
25144321|NCT01955161|50257985|FG001|Overall Study|Other reason: physician decision|1|||
25144322|NCT01955161|50257986|FG002|Overall Study|Other reason: physician decision|1|||
25144323|NCT01955161|50257984|FG000|Overall Study|Other reason: disallowed medication|1|||
25144324|NCT01955161|50257985|FG001|Overall Study|Other reason: disallowed medication|0|||
25144325|NCT01955161|50257986|FG002|Overall Study|Other reason: disallowed medication|1|||
25144326|NCT01955161|50257984|FG000|Overall Study|Other reason: caregiver unavailable|1|||
25144327|NCT01955161|50257985|FG001|Overall Study|Other reason: caregiver unavailable|0|||
25144328|NCT01955161|50257986|FG002|Overall Study|Other reason: caregiver unavailable|0|||
25144329|NCT01955161|50257984|FG000|Overall Study|Other reason: moved to nursing home|0|||
25144330|NCT01955161|50257985|FG001|Overall Study|Other reason: moved to nursing home|1|||
25144331|NCT01955161|50257986|FG002|Overall Study|Other reason: moved to nursing home|0|||
25144332|NCT01955161|50257984|FG000|Overall Study|Other reason: insufficient compliance|0|||
25144333|NCT01955161|50257985|FG001|Overall Study|Other reason: insufficient compliance|0|||
25144334|NCT01955161|50257986|FG002|Overall Study|Other reason: insufficient compliance|1|||
25144335|NCT01955161|50257984|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
25144336|NCT01955161|50257985|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
25144337|NCT01955161|50257986|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
25144338|NCT01955161|50257984|FG000|Overall Study|Other reason: patient's will|0|||
25144339|NCT01955161|50257985|FG001|Overall Study|Other reason: patient's will|0|||
25144340|NCT01955161|50257986|FG002|Overall Study|Other reason: patient's will|1|||
25144341|NCT01441414|50257994|FG000|Overall Study|Participant died|9|||
25144342|NCT01441414|50257994|FG000|Overall Study|Other reasons|3|||
25144343|NCT01441414|50257994|FG000|Overall Study|Study terminated by sponsor|2|||
25144344|NCT01441414|50257994|FG000|Overall Study|Subject refused further follow-up|1|||
25144345|NCT01971554|50258014|FG000|Overall Study|Lost to Follow-up|1|||
25144346|NCT01971554|50258015|FG001|Overall Study|Lost to Follow-up|0|||
25144347|NCT01971554|50258016|FG002|Overall Study|Lost to Follow-up|0|||
25144348|NCT01971554|50258017|FG003|Overall Study|Lost to Follow-up|0|||
25144349|NCT01955083|50258029|FG000|Overall Study|Lost to Follow-up|1|||
25144350|NCT01955083|50258030|FG001|Overall Study|Lost to Follow-up|1|||
25144351|NCT01955005|50258062|FG000|Overall Study|Withdrawal by Subject|3|||
25144352|NCT01955005|50258063|FG001|Overall Study|Withdrawal by Subject|5|||
25144353|NCT01954927|50258071|FG000|Overall Study|Withdrawal by Subject|3|||
25144354|NCT01954927|50258072|FG001|Overall Study|Withdrawal by Subject|1|||
25144355|NCT01954771|50258081|FG000|Overall Study|Missing HbA1c of end-point|1|||
25144356|NCT01954771|50258082|FG001|Overall Study|Missing HbA1c of end-point|1|||
25144357|NCT01954771|50258083|FG002|Overall Study|Missing HbA1c of end-point|0|||
25144358|NCT01954771|50258081|FG000|Overall Study|Missing CGMS of end-point|1|||
25144359|NCT01954771|50258082|FG001|Overall Study|Missing CGMS of end-point|1|||
25144360|NCT01954771|50258083|FG002|Overall Study|Missing CGMS of end-point|0|||
25144361|NCT01954771|50258081|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
25144362|NCT01954771|50258082|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
25180217|NCT01454063|50326221|FG001|Randomized|Protocol Violation|1|||
25144363|NCT01954771|50258083|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
25144364|NCT01997281|50258096|FG000|Overall Study|Withdrawal by Subject|1|||
25144365|NCT01997281|50258097|FG001|Overall Study|Withdrawal by Subject|0|||
25144366|NCT01996033|50258103|FG000|Overall Study|Death|1|||
25144367|NCT01996033|50258103|FG000|Overall Study|Physician Decision|1|||
25144368|NCT01996033|50258103|FG000|Overall Study|Withdrawal by Subject|4|||
25144369|NCT01996033|50258103|FG000|Overall Study|Lost to Follow-up|3|||
25144370|NCT01953913|50258107|FG000|Overall Study|Disease Progression|349|||
25144371|NCT01953913|50258107|FG000|Overall Study|Worsening of underlying cancer|22|||
25144372|NCT01953913|50258107|FG000|Overall Study|Adverse Event|20|||
25144373|NCT01953913|50258107|FG000|Overall Study|Protocol Violation|6|||
25144374|NCT01953913|50258107|FG000|Overall Study|Lost to Follow-up|4|||
25144375|NCT01953913|50258107|FG000|Overall Study|Withdrawal by Subject|32|||
25144376|NCT01953913|50258107|FG000|Overall Study|Other than listed|108|||
25144377|NCT01953913|50258107|FG000|Overall Study|Not Treated|1|||
25144378|NCT01971476|50258114|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
25144379|NCT01971476|50258115|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
25144380|NCT01971476|50258116|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
25144381|NCT01971476|50258114|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
25144382|NCT01971476|50258115|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
25144383|NCT01971476|50258116|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
25144384|NCT01971476|50258114|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
25144385|NCT01971476|50258115|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
25144386|NCT01971476|50258116|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
25144387|NCT01996904|50258135|FG000|Overall Study|Lost to Follow-up|38|||
25144388|NCT01996904|50258136|FG001|Overall Study|Lost to Follow-up|27|||
25144389|NCT01970540|50258145|FG000|Overall Study|Non-treatment-related AE|0|||
25144390|NCT01970540|50258146|FG001|Overall Study|Non-treatment-related AE|0|||
25144391|NCT01970540|50258147|FG002|Overall Study|Non-treatment-related AE|1|||
25144392|NCT01970540|50258145|FG000|Overall Study|Progressive disease|55|||
25144393|NCT01970540|50258146|FG001|Overall Study|Progressive disease|23|||
25144394|NCT01970540|50258147|FG002|Overall Study|Progressive disease|10|||
25180218|NCT01453595|50326230|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
25180219|NCT01453595|50326231|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
25180220|NCT01453595|50326232|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
25180221|NCT01453439|50326240|FG000|Treatment Phase|Withdrawal by Subject|13|||
25180222|NCT01453439|50326241|FG001|Treatment Phase|Withdrawal by Subject|10|||
25180223|NCT01453439|50326240|FG000|Treatment Phase|Suicidal Ideation|2|||
25180224|NCT01453439|50326241|FG001|Treatment Phase|Suicidal Ideation|0|||
25180225|NCT01453439|50326240|FG000|Treatment Phase|Need for higher level of care|1|||
25015745|NCT02959918|50110494|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
25144395|NCT01970540|50258145|FG000|Overall Study|Treatment delay over protocol|0|||
25144396|NCT01970540|50258146|FG001|Overall Study|Treatment delay over protocol|0|||
25144397|NCT01970540|50258147|FG002|Overall Study|Treatment delay over protocol|1|||
25144398|NCT01970540|50258145|FG000|Overall Study|Physician Decision|7|||
25144399|NCT01970540|50258146|FG001|Overall Study|Physician Decision|2|||
25144400|NCT01970540|50258147|FG002|Overall Study|Physician Decision|0|||
25180226|NCT01453439|50326241|FG001|Treatment Phase|Need for higher level of care|1|||
25180227|NCT01453439|50326240|FG000|Treatment Phase|Therapist conflict of interest|1|||
25015746|NCT02959918|50110495|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
25144401|NCT01970540|50258145|FG000|Overall Study|Clinical progression|0|||
25144402|NCT01970540|50258146|FG001|Overall Study|Clinical progression|1|||
25180228|NCT01453439|50326241|FG001|Treatment Phase|Therapist conflict of interest|0|||
25180229|NCT01453439|50326240|FG000|Follow-up|Withdrawal by Subject|0|||
25180230|NCT01453439|50326241|FG001|Follow-up|Withdrawal by Subject|1|||
25180231|NCT01453439|50326240|FG000|Follow-up|Lost to Follow-up|5|||
25180232|NCT01453439|50326241|FG001|Follow-up|Lost to Follow-up|10|||
25180233|NCT01453361|50326247|FG000|Overall Study|Disease Progression|6|||
25180234|NCT01453361|50326247|FG000|Overall Study|Screen-Failures|10|||
25180235|NCT01585298|50326251|FG000|Overall Study|Study completion was not documented.|1|||
25180236|NCT01585298|50326251|FG000|Overall Study|Protocol deviation|1|||
25180237|NCT01585298|50326251|FG000|Overall Study|Administrative problems|4|||
25180238|NCT01585298|50326251|FG000|Overall Study|Lost to Follow-up|2|||
25180239|NCT01585298|50326251|FG000|Overall Study|Withdrawal by Subject|4|||
25180240|NCT01585298|50326251|FG000|Overall Study|Abnormal test procedure results|1|||
25015747|NCT02959918|50110496|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
25015748|NCT02959918|50110497|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
25144403|NCT01970540|50258147|FG002|Overall Study|Clinical progression|1|||
25144404|NCT01970540|50258145|FG000|Overall Study|End of study|2|||
25144405|NCT01970540|50258146|FG001|Overall Study|End of study|0|||
25144406|NCT01970540|50258147|FG002|Overall Study|End of study|2|||
25144407|NCT01970540|50258145|FG000|Overall Study|Adverse Event|0|||
25144408|NCT01970540|50258146|FG001|Overall Study|Adverse Event|2|||
25144409|NCT01970540|50258147|FG002|Overall Study|Adverse Event|1|||
25144410|NCT01970540|50258145|FG000|Overall Study|Treatment-related AE|4|||
25180241|NCT01585298|50326251|FG000|Overall Study|Adverse Event|24|||
25180242|NCT01453205|50326258|FG000|Overall Study|Lost to Follow-up|3|||
25180243|NCT01453205|50326259|FG001|Overall Study|Lost to Follow-up|0|||
25180244|NCT01453205|50326260|FG002|Overall Study|Lost to Follow-up|1|||
25180245|NCT01453205|50326258|FG000|Overall Study|Withdrawal by Subject|8|||
25180246|NCT01453205|50326259|FG001|Overall Study|Withdrawal by Subject|3|||
25180247|NCT01453205|50326260|FG002|Overall Study|Withdrawal by Subject|0|||
25180248|NCT01453205|50326258|FG000|Overall Study|Death|24|||
25180249|NCT01453205|50326259|FG001|Overall Study|Death|22|||
25180250|NCT01453205|50326260|FG002|Overall Study|Death|18|||
25180251|NCT01453205|50326258|FG000|Overall Study|Other|45|||
25180252|NCT01453205|50326259|FG001|Overall Study|Other|27|||
25180253|NCT01453205|50326260|FG002|Overall Study|Other|35|||
25180254|NCT01453049|50326273|FG000|Overall Study|Protocol Violation|2|||
25180255|NCT01453049|50326274|FG001|Overall Study|Protocol Violation|5|||
25180256|NCT01453049|50326273|FG000|Overall Study|Lost to Follow-up|2|||
25180257|NCT01453049|50326274|FG001|Overall Study|Lost to Follow-up|1|||
25180258|NCT01453049|50326273|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
25180259|NCT01453049|50326274|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
25180260|NCT01453049|50326273|FG000|Overall Study|Withdrawal by Subject|1|||
25180261|NCT01453049|50326274|FG001|Overall Study|Withdrawal by Subject|0|||
25180262|NCT01453049|50326273|FG000|Overall Study|Randomized in Error|1|||
25180263|NCT01453049|50326274|FG001|Overall Study|Randomized in Error|0|||
25180264|NCT01452347|50326282|FG000|Overall Study|Adverse Event|2|||
25180265|NCT01452347|50326283|FG001|Overall Study|Adverse Event|1|||
25180266|NCT01452347|50326282|FG000|Overall Study|Non compliance protocol|2|||
25180267|NCT01452347|50326283|FG001|Overall Study|Non compliance protocol|0|||
25180268|NCT01452347|50326282|FG000|Overall Study|Lost to Follow-up|2|||
25180269|NCT01452347|50326283|FG001|Overall Study|Lost to Follow-up|0|||
25180270|NCT01452347|50326282|FG000|Overall Study|Withdrawal by Subject|3|||
25180271|NCT01452347|50326283|FG001|Overall Study|Withdrawal by Subject|3|||
25180272|NCT01452347|50326282|FG000|Overall Study|Not treated|6|||
25180273|NCT01452347|50326283|FG001|Overall Study|Not treated|3|||
25180274|NCT01452347|50326282|FG000|Overall Study|Other reason not defined above|2|||
25180275|NCT01452347|50326283|FG001|Overall Study|Other reason not defined above|0|||
25180276|NCT01451723|50326293|FG000|Overall Study|study halted|6|||
25180277|NCT01451723|50326294|FG001|Overall Study|study halted|5|||
25180278|NCT01451645|50326302|FG000|Overall Study|Protocol Violation|1|||
25180279|NCT01451645|50326303|FG001|Overall Study|Protocol Violation|0|||
25015749|NCT02959918|50110498|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
25015750|NCT02959918|50110499|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
25015751|NCT02959918|50110500|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
25015752|NCT02959918|50110501|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
25015753|NCT02959918|50110502|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
25015754|NCT02959918|50110503|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
25015755|NCT02959918|50110504|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
25144411|NCT01970540|50258146|FG001|Overall Study|Treatment-related AE|0|||
25180280|NCT01451645|50326302|FG000|Overall Study|Adverse Event|0|||
25180281|NCT01451645|50326303|FG001|Overall Study|Adverse Event|3|||
25180282|NCT01451645|50326302|FG000|Overall Study|Withdrawal by Subject|4|||
25180283|NCT01451645|50326303|FG001|Overall Study|Withdrawal by Subject|2|||
25180284|NCT01451645|50326302|FG000|Overall Study|Lost to Follow-up|4|||
25144412|NCT01970540|50258147|FG002|Overall Study|Treatment-related AE|2|||
25144413|NCT01970540|50258145|FG000|Overall Study|Withdrawal by Subject|4|||
25144414|NCT01970540|50258146|FG001|Overall Study|Withdrawal by Subject|0|||
25144415|NCT01970540|50258147|FG002|Overall Study|Withdrawal by Subject|1|||
25144416|NCT01970540|50258145|FG000|Overall Study|Clinical deterioration|1|||
25144417|NCT01970540|50258146|FG001|Overall Study|Clinical deterioration|0|||
25144418|NCT01970540|50258147|FG002|Overall Study|Clinical deterioration|0|||
25144419|NCT01963676|50258168|FG000|Overall Study|Withdrawal by Subject|1|||
25144420|NCT01963676|50258169|FG001|Overall Study|Withdrawal by Subject|0|||
25144421|NCT01996826|50258177|FG000|Overall Study|Lost to Follow-up|6|||
25144422|NCT01996826|50258178|FG001|Overall Study|Lost to Follow-up|2|||
25144423|NCT01996826|50258177|FG000|Overall Study|Physician Decision|1|||
25144424|NCT01996826|50258178|FG001|Overall Study|Physician Decision|1|||
25144425|NCT01996748|50258186|FG000|Overall Study|Personal reason|1|||
25144426|NCT01996748|50258187|FG001|Overall Study|Personal reason|0|||
25144427|NCT01996748|50258186|FG000|Overall Study|Physician Decision|2|||
25144428|NCT01996748|50258187|FG001|Overall Study|Physician Decision|0|||
25144429|NCT01996748|50258186|FG000|Overall Study|Adverse Event|1|||
25180285|NCT01451645|50326303|FG001|Overall Study|Lost to Follow-up|3|||
25144430|NCT01996748|50258187|FG001|Overall Study|Adverse Event|4|||
25144431|NCT01996748|50258186|FG000|Overall Study|Withdrawal by Subject|0|||
25180286|NCT01450943|50326312|FG000|Overall Study|Screen failure, loss to follow-up|2|||
25180287|NCT01450943|50326313|FG001|Overall Study|Screen failure, loss to follow-up|7|||
25180288|NCT01450943|50326314|FG002|Overall Study|Screen failure, loss to follow-up|6|||
25180289|NCT01450631|50326328|FG000|Overall Study|Lost to Follow-up|2|||
25180290|NCT01450631|50326329|FG001|Overall Study|Lost to Follow-up|4|||
25180291|NCT01450631|50326328|FG000|Overall Study|Withdrawal by Subject|1|||
25180292|NCT01450631|50326329|FG001|Overall Study|Withdrawal by Subject|0|||
25180293|NCT01450007|50326338|FG000|Overall Study|Late exclusion before treatment|2|||
25144432|NCT01996748|50258187|FG001|Overall Study|Withdrawal by Subject|1|||
25144433|NCT01996748|50258186|FG000|Overall Study|Lost to Follow-up|4|||
25144434|NCT01996748|50258187|FG001|Overall Study|Lost to Follow-up|1|||
25144435|NCT01621178|50258198|FG000|Overall Study|Adverse Event|5|||
25180294|NCT01450007|50326339|FG001|Overall Study|Late exclusion before treatment|3|||
25180295|NCT01450007|50326340|FG002|Overall Study|Late exclusion before treatment|2|||
25180296|NCT01450007|50326338|FG000|Overall Study|Protocol Violation|0|||
25180297|NCT01450007|50326339|FG001|Overall Study|Protocol Violation|1|||
25180298|NCT01450007|50326340|FG002|Overall Study|Protocol Violation|1|||
25180299|NCT01450007|50326338|FG000|Overall Study|Adverse Event|0|||
25180300|NCT01450007|50326339|FG001|Overall Study|Adverse Event|1|||
25180301|NCT01450007|50326340|FG002|Overall Study|Adverse Event|0|||
25180302|NCT01496365|50326355|FG000|Overall Study|Adverse Event|2|||
25180303|NCT01496365|50326356|FG001|Overall Study|Adverse Event|3|||
25180304|NCT01496365|50326357|FG002|Overall Study|Adverse Event|3|||
25180305|NCT01496365|50326358|FG003|Overall Study|Adverse Event|2|||
25180306|NCT01496365|50326359|FG004|Overall Study|Adverse Event|5|||
25180307|NCT01496365|50326360|FG005|Overall Study|Adverse Event|6|||
25180308|NCT01496365|50326361|FG006|Overall Study|Adverse Event|4|||
25180309|NCT01496365|50326355|FG000|Overall Study|Withdrawal by Subject|6|||
25180310|NCT01496365|50326356|FG001|Overall Study|Withdrawal by Subject|6|||
25180311|NCT01496365|50326357|FG002|Overall Study|Withdrawal by Subject|0|||
25180312|NCT01496365|50326358|FG003|Overall Study|Withdrawal by Subject|1|||
25180313|NCT01496365|50326359|FG004|Overall Study|Withdrawal by Subject|3|||
25180314|NCT01496365|50326360|FG005|Overall Study|Withdrawal by Subject|2|||
25180315|NCT01496365|50326361|FG006|Overall Study|Withdrawal by Subject|1|||
25180316|NCT01496365|50326355|FG000|Overall Study|Protocol Violation|2|||
25180317|NCT01496365|50326356|FG001|Overall Study|Protocol Violation|1|||
25180318|NCT01496365|50326357|FG002|Overall Study|Protocol Violation|1|||
25180319|NCT01496365|50326358|FG003|Overall Study|Protocol Violation|0|||
25180320|NCT01496365|50326359|FG004|Overall Study|Protocol Violation|0|||
25180321|NCT01496365|50326360|FG005|Overall Study|Protocol Violation|1|||
25180322|NCT01496365|50326361|FG006|Overall Study|Protocol Violation|0|||
25180323|NCT01496365|50326355|FG000|Overall Study|Lack of Efficacy|1|||
25180324|NCT01496365|50326356|FG001|Overall Study|Lack of Efficacy|0|||
25180325|NCT01496365|50326357|FG002|Overall Study|Lack of Efficacy|0|||
25180326|NCT01496365|50326358|FG003|Overall Study|Lack of Efficacy|0|||
25180327|NCT01496365|50326359|FG004|Overall Study|Lack of Efficacy|0|||
25180328|NCT01496365|50326360|FG005|Overall Study|Lack of Efficacy|1|||
25180329|NCT01496365|50326361|FG006|Overall Study|Lack of Efficacy|0|||
25180330|NCT01496365|50326355|FG000|Overall Study|Lost to Follow-up|0|||
25180331|NCT01496365|50326356|FG001|Overall Study|Lost to Follow-up|1|||
25180332|NCT01496365|50326357|FG002|Overall Study|Lost to Follow-up|0|||
25180333|NCT01496365|50326358|FG003|Overall Study|Lost to Follow-up|0|||
25180334|NCT01496365|50326359|FG004|Overall Study|Lost to Follow-up|2|||
25180335|NCT01496365|50326360|FG005|Overall Study|Lost to Follow-up|0|||
25180336|NCT01496365|50326361|FG006|Overall Study|Lost to Follow-up|0|||
25180337|NCT01496365|50326355|FG000|Overall Study|Other|4|||
25180338|NCT01496365|50326356|FG001|Overall Study|Other|4|||
25180339|NCT01496365|50326357|FG002|Overall Study|Other|2|||
25180340|NCT01496365|50326358|FG003|Overall Study|Other|1|||
25144436|NCT01621178|50258199|FG001|Overall Study|Adverse Event|2|||
25144437|NCT01621178|50258200|FG002|Overall Study|Adverse Event|8|||
25144438|NCT01621178|50258198|FG000|Overall Study|Death|6|||
25180341|NCT01496365|50326359|FG004|Overall Study|Other|3|||
25180342|NCT01496365|50326360|FG005|Overall Study|Other|0|||
25180343|NCT01496365|50326361|FG006|Overall Study|Other|1|||
25180344|NCT01496287|50326377|FG000|Overall Study|Lost to Follow-up|1|||
25180345|NCT01496287|50326377|FG000|Overall Study|Incomplete anesthesia|5|||
25144439|NCT01621178|50258199|FG001|Overall Study|Death|7|||
25144440|NCT01621178|50258200|FG002|Overall Study|Death|2|||
25180346|NCT01495975|50326384|FG000|Overall Study|Lost to Follow-up|1|||
25180347|NCT01495975|50326385|FG001|Overall Study|Lost to Follow-up|0|||
25180348|NCT01468987|50326393|FG000|Overall Study|Adverse Event|12|||
25180349|NCT01468987|50326394|FG001|Overall Study|Adverse Event|9|||
25180350|NCT01468987|50326393|FG000|Overall Study|Death|4|||
25180351|NCT01468987|50326394|FG001|Overall Study|Death|1|||
25180352|NCT01468987|50326393|FG000|Overall Study|Lost to Follow-up|10|||
25180353|NCT01468987|50326394|FG001|Overall Study|Lost to Follow-up|5|||
25180354|NCT01468987|50326393|FG000|Overall Study|Protocol Violation|8|||
25180355|NCT01468987|50326394|FG001|Overall Study|Protocol Violation|2|||
25180356|NCT01468987|50326393|FG000|Overall Study|Withdrawal by Subject|28|||
25180357|NCT01468987|50326394|FG001|Overall Study|Withdrawal by Subject|28|||
25180358|NCT01468987|50326393|FG000|Overall Study|Physician Decision|8|||
25180359|NCT01468987|50326394|FG001|Overall Study|Physician Decision|15|||
25180360|NCT01468987|50326393|FG000|Overall Study|Sponsor Decision|1|||
25180361|NCT01468987|50326394|FG001|Overall Study|Sponsor Decision|0|||
25180362|NCT01687712|50326404|FG000|Cycle 1|Not Biochemically Pregnant|386|||
25180363|NCT01687712|50326405|FG001|Cycle 1|Not Biochemically Pregnant|348|||
25180364|NCT01687712|50326404|FG000|Cycle 1|Early Pregnancy Loss|43|||
25180365|NCT01687712|50326405|FG001|Cycle 1|Early Pregnancy Loss|60|||
25180366|NCT01687712|50326404|FG000|Cycle 1|Ectopic Pregnancy|5|||
25180367|NCT01687712|50326405|FG001|Cycle 1|Ectopic Pregnancy|5|||
25180368|NCT01687712|50326404|FG000|Cycle 1|Heterotropic Pregnancy|1|||
25180369|NCT01687712|50326405|FG001|Cycle 1|Heterotropic Pregnancy|0|||
25180370|NCT01687712|50326404|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
25180371|NCT01687712|50326405|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
25180372|NCT01687712|50326404|FG000|Cycle 1|Abortion|3|||
25180373|NCT01687712|50326405|FG001|Cycle 1|Abortion|0|||
25180374|NCT01687712|50326404|FG000|Cycle 1|Intrauterine Fetal Death|0|||
25180375|NCT01687712|50326405|FG001|Cycle 1|Intrauterine Fetal Death|1|||
25144441|NCT01621178|50258198|FG000|Overall Study|Lost to Follow-up|1|||
25144442|NCT01621178|50258199|FG001|Overall Study|Lost to Follow-up|2|||
25180376|NCT01687712|50326404|FG000|Cycle 1|Lost to Follow-up|1|||
25180377|NCT01687712|50326405|FG001|Cycle 1|Lost to Follow-up|1|||
25180378|NCT01687712|50326404|FG000|Cycle 2|Not Biochemically Pregnant|74|||
25180379|NCT01687712|50326405|FG001|Cycle 2|Not Biochemically Pregnant|77|||
25180380|NCT01687712|50326404|FG000|Cycle 2|Early Pregnancy Loss|18|||
25180381|NCT01687712|50326405|FG001|Cycle 2|Early Pregnancy Loss|16|||
25180382|NCT01687712|50326404|FG000|Cycle 2|Ectopic Pregnancy|0|||
25180383|NCT01687712|50326405|FG001|Cycle 2|Ectopic Pregnancy|1|||
25180384|NCT01687712|50326404|FG000|Cycle 2|Still Birth|1|||
25180385|NCT01687712|50326405|FG001|Cycle 2|Still Birth|0|||
25180386|NCT01687712|50326404|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
25180387|NCT01687712|50326405|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
25180388|NCT01687712|50326404|FG000|Cycle 3|Not Biochemically Pregnant|21|||
25180389|NCT01687712|50326405|FG001|Cycle 3|Not Biochemically Pregnant|22|||
25180390|NCT01687712|50326404|FG000|Cycle 3|Early Pregnancy Loss|1|||
25180391|NCT01687712|50326405|FG001|Cycle 3|Early Pregnancy Loss|2|||
25180392|NCT01687712|50326404|FG000|Cycle 3|Ectopic Pregnancy|1|||
25015756|NCT02959918|50110505|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
25015757|NCT02959918|50110506|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
25015758|NCT02959918|50110493|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
25144443|NCT01621178|50258200|FG002|Overall Study|Lost to Follow-up|1|||
25144444|NCT01621178|50258198|FG000|Overall Study|Withdrawal by Subject|14|||
25144445|NCT01621178|50258199|FG001|Overall Study|Withdrawal by Subject|17|||
25144446|NCT01621178|50258200|FG002|Overall Study|Withdrawal by Subject|18|||
25144447|NCT01621178|50258198|FG000|Overall Study|Physician Decision|5|||
25144448|NCT01621178|50258199|FG001|Overall Study|Physician Decision|2|||
25144449|NCT01621178|50258200|FG002|Overall Study|Physician Decision|7|||
25144450|NCT01962974|50258212|FG000|Overall Study|Study termination|7|||
25180393|NCT01687712|50326405|FG001|Cycle 3|Ectopic Pregnancy|0|||
25180394|NCT01687712|50326404|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
25180395|NCT01687712|50326405|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
25015759|NCT02959918|50110494|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
25015760|NCT02959918|50110495|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
25015761|NCT02959918|50110496|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
25015762|NCT02959918|50110497|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
25015763|NCT02959918|50110498|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
25015764|NCT02959918|50110499|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
25015765|NCT02959918|50110500|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
25015766|NCT02959918|50110501|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
25015767|NCT02959918|50110502|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
25015768|NCT02959918|50110503|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
25015769|NCT02959918|50110504|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
25015770|NCT02959918|50110505|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
25144451|NCT01996592|50258216|FG000|Overall Study|no response to text/no diary entry|32|||
25144452|NCT01996592|50258216|FG000|Overall Study|change in surgical date|4|||
25144453|NCT01996592|50258216|FG000|Overall Study|Withdrawal by Subject|5|||
25180396|NCT01603628|50326418|FG000|Overall Study|Personal Reasons|1|||
25180397|NCT01603628|50326419|FG001|Overall Study|Personal Reasons|1|||
25180398|NCT01603628|50326420|FG002|Overall Study|Personal Reasons|2|||
25180399|NCT01603628|50326418|FG000|Overall Study|Protocol Violation|1|||
25180400|NCT01603628|50326419|FG001|Overall Study|Protocol Violation|1|||
25180401|NCT01603628|50326420|FG002|Overall Study|Protocol Violation|0|||
25180402|NCT01603628|50326418|FG000|Overall Study|Lost to Follow-up|0|||
25180403|NCT01603628|50326419|FG001|Overall Study|Lost to Follow-up|1|||
25180404|NCT01603628|50326420|FG002|Overall Study|Lost to Follow-up|0|||
25180405|NCT01603628|50326418|FG000|Overall Study|Other Miscellaneous Reason|1|||
25180406|NCT01603628|50326419|FG001|Overall Study|Other Miscellaneous Reason|0|||
25180407|NCT01603628|50326420|FG002|Overall Study|Other Miscellaneous Reason|0|||
25180408|NCT01453153|50326431|FG000|Overall Study|Physician Decision|0|||
25180409|NCT01453153|50326432|FG001|Overall Study|Physician Decision|0|||
25180410|NCT01453153|50326433|FG002|Overall Study|Physician Decision|1|||
25180411|NCT01453153|50326431|FG000|Overall Study|Progressive Disease|3|||
25180412|NCT01453153|50326432|FG001|Overall Study|Progressive Disease|2|||
25180413|NCT01453153|50326433|FG002|Overall Study|Progressive Disease|16|||
25180414|NCT01453153|50326431|FG000|Overall Study|Withdrawal by Subject|0|||
25180415|NCT01453153|50326432|FG001|Overall Study|Withdrawal by Subject|1|||
25180416|NCT01453153|50326433|FG002|Overall Study|Withdrawal by Subject|2|||
25180417|NCT01453153|50326431|FG000|Overall Study|Adverse Event|1|||
25180418|NCT01453153|50326432|FG001|Overall Study|Adverse Event|1|||
25180419|NCT01453153|50326433|FG002|Overall Study|Adverse Event|1|||
25180420|NCT01584440|50326447|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
25180421|NCT01584440|50326448|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
25180422|NCT01584440|50326449|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
25180423|NCT01584440|50326450|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
25180424|NCT01584440|50326451|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
25180425|NCT01584440|50326447|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
25180426|NCT01584440|50326448|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
25180427|NCT01584440|50326449|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
25180428|NCT01584440|50326450|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
25180429|NCT01584440|50326451|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
25180430|NCT01584440|50326447|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
25180431|NCT01584440|50326448|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
25180432|NCT01584440|50326449|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
25180433|NCT01584440|50326450|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
25180434|NCT01584440|50326451|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
25015771|NCT02959918|50110506|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
25015772|NCT02959918|50110493|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
25015773|NCT02959918|50110494|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
25144454|NCT01996592|50258216|FG000|Overall Study|change in mode of delivery|4|||
25015774|NCT02959918|50110495|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
25144455|NCT01962896|50258225|FG000|Overall Study|Lack of Efficacy|4|||
25144456|NCT01970462|50258232|FG000|Overall Study|Lost to Follow-up|0|||
25144457|NCT01970462|50258233|FG001|Overall Study|Lost to Follow-up|2|||
25144458|NCT01958671|50258242|FG000|Overall Study|Adverse Event|1|||
25144459|NCT01958671|50258243|FG001|Overall Study|Adverse Event|1|||
25144460|NCT01958671|50258244|FG002|Overall Study|Adverse Event|5|||
25144461|NCT01958671|50258242|FG000|Overall Study|Death|1|||
25144462|NCT01958671|50258243|FG001|Overall Study|Death|0|||
25144463|NCT01958671|50258244|FG002|Overall Study|Death|0|||
25144464|NCT01958671|50258242|FG000|Overall Study|Excluded medication|0|||
25144465|NCT01958671|50258243|FG001|Overall Study|Excluded medication|0|||
25144466|NCT01958671|50258244|FG002|Overall Study|Excluded medication|1|||
25144467|NCT01958671|50258242|FG000|Overall Study|Hyperglycemia|0|||
25144468|NCT01958671|50258243|FG001|Overall Study|Hyperglycemia|0|||
25144469|NCT01958671|50258244|FG002|Overall Study|Hyperglycemia|2|||
25144470|NCT01958671|50258242|FG000|Overall Study|Lost to Follow-up|7|||
25144471|NCT01958671|50258243|FG001|Overall Study|Lost to Follow-up|11|||
25144472|NCT01958671|50258244|FG002|Overall Study|Lost to Follow-up|7|||
25144473|NCT01958671|50258242|FG000|Overall Study|Non-compliance with study drug|1|||
25144474|NCT01958671|50258243|FG001|Overall Study|Non-compliance with study drug|1|||
25015775|NCT02959918|50110496|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
25015776|NCT02959918|50110497|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
25015777|NCT02959918|50110498|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
25015778|NCT02959918|50110499|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
25015779|NCT02959918|50110500|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
25015780|NCT02959918|50110501|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
25015781|NCT02959918|50110502|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
25015782|NCT02959918|50110503|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
25015783|NCT02959918|50110504|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
25015784|NCT02959918|50110505|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
25144475|NCT01958671|50258244|FG002|Overall Study|Non-compliance with study drug|1|||
25144476|NCT01958671|50258242|FG000|Overall Study|Pregnancy|0|||
25144477|NCT01958671|50258243|FG001|Overall Study|Pregnancy|0|||
25144478|NCT01958671|50258244|FG002|Overall Study|Pregnancy|1|||
25144479|NCT01958671|50258242|FG000|Overall Study|Protocol Violation|0|||
25144480|NCT01958671|50258243|FG001|Overall Study|Protocol Violation|1|||
25144481|NCT01958671|50258244|FG002|Overall Study|Protocol Violation|0|||
25180435|NCT01584440|50326447|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
25144482|NCT01958671|50258242|FG000|Overall Study|Study site terminated by sponsor|1|||
25144483|NCT01958671|50258243|FG001|Overall Study|Study site terminated by sponsor|0|||
25144484|NCT01958671|50258244|FG002|Overall Study|Study site terminated by sponsor|1|||
25144485|NCT01958671|50258242|FG000|Overall Study|Participant moved|0|||
25144486|NCT01958671|50258243|FG001|Overall Study|Participant moved|0|||
25144487|NCT01958671|50258244|FG002|Overall Study|Participant moved|1|||
25144488|NCT01958671|50258242|FG000|Overall Study|Withdrawal by Subject|8|||
25144489|NCT01958671|50258243|FG001|Overall Study|Withdrawal by Subject|10|||
25144490|NCT01958671|50258244|FG002|Overall Study|Withdrawal by Subject|13|||
25144491|NCT01995266|50258256|FG000|Overall Study|Death|1|||
25144492|NCT01995266|50258256|FG000|Overall Study|Lack of Efficacy|6|||
25144493|NCT01995266|50258256|FG000|Overall Study|Adverse Event|2|||
25144494|NCT01969058|50258262|FG000|Overall Study|Withdrawal by Subject|2|||
25144495|NCT01969058|50258263|FG001|Overall Study|Withdrawal by Subject|0|||
25144496|NCT01969058|50258262|FG000|Overall Study|Adverse Event|1|||
25144497|NCT01969058|50258263|FG001|Overall Study|Adverse Event|0|||
25144498|NCT01968980|50258271|FG000|Overall Study|Death|0|||
25144499|NCT01968980|50258272|FG001|Overall Study|Death|1|||
25144500|NCT01968980|50258271|FG000|Overall Study|Adverse Event|1|||
25144501|NCT01968980|50258272|FG001|Overall Study|Adverse Event|3|||
25144502|NCT01968980|50258271|FG000|Overall Study|Does not meet entry criteria|1|||
25144503|NCT01968980|50258272|FG001|Overall Study|Does not meet entry criteria|3|||
25144504|NCT01968980|50258271|FG000|Overall Study|Withdrawal by Subject|13|||
25144505|NCT01968980|50258272|FG001|Overall Study|Withdrawal by Subject|5|||
25144506|NCT01968980|50258271|FG000|Overall Study|Other unspecified|1|||
25144507|NCT01968980|50258272|FG001|Overall Study|Other unspecified|2|||
25144508|NCT01961882|50258281|FG000|Overall Study|Adverse Event|3|||
25144509|NCT01961882|50258282|FG001|Overall Study|Adverse Event|2|||
25144510|NCT01961882|50258281|FG000|Overall Study|Physician Decision|1|||
25144511|NCT01961882|50258282|FG001|Overall Study|Physician Decision|0|||
25144512|NCT01961882|50258281|FG000|Overall Study|Withdrawal by Subject|4|||
25144513|NCT01961882|50258282|FG001|Overall Study|Withdrawal by Subject|1|||
25144514|NCT01961882|50258281|FG000|Overall Study|Relapse of AML|39|||
25144515|NCT01961882|50258282|FG001|Overall Study|Relapse of AML|37|||
25144516|NCT01961882|50258281|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
25144517|NCT01961882|50258282|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
25144518|NCT01961882|50258281|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
25144519|NCT01961882|50258282|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
25144520|NCT01968434|50258290|FG000|Overall Study|Lost to Follow-up|3|||
25144521|NCT01968434|50258291|FG001|Overall Study|Lost to Follow-up|6|||
25144522|NCT01946438|50258301|FG000|Overall Study|Adverse Event|0|||
25144523|NCT01946438|50258302|FG001|Overall Study|Adverse Event|0|||
25144524|NCT01946438|50258303|FG002|Overall Study|Adverse Event|0|||
25144525|NCT01946438|50258304|FG003|Overall Study|Adverse Event|1|||
25144526|NCT01946438|50258301|FG000|Overall Study|Serious Adverse event|1|||
25144527|NCT01946438|50258302|FG001|Overall Study|Serious Adverse event|0|||
25144528|NCT01946438|50258303|FG002|Overall Study|Serious Adverse event|0|||
25144529|NCT01946438|50258304|FG003|Overall Study|Serious Adverse event|0|||
25144530|NCT01946438|50258301|FG000|Overall Study|Protocol Violation|0|||
25144531|NCT01946438|50258302|FG001|Overall Study|Protocol Violation|0|||
25144532|NCT01946438|50258303|FG002|Overall Study|Protocol Violation|1|||
25144533|NCT01946438|50258304|FG003|Overall Study|Protocol Violation|0|||
25144534|NCT01946438|50258301|FG000|Overall Study|Withdrawal by Subject|1|||
25144535|NCT01946438|50258302|FG001|Overall Study|Withdrawal by Subject|0|||
25144536|NCT01946438|50258303|FG002|Overall Study|Withdrawal by Subject|0|||
25144537|NCT01946438|50258304|FG003|Overall Study|Withdrawal by Subject|0|||
25144538|NCT01946282|50258323|FG000|Year 1|Did not return FIT kit|4186|||
25144539|NCT01946282|50258324|FG001|Year 1|Did not return FIT kit|608|||
25144540|NCT01946282|50258325|FG002|Year 1|Did not return FIT kit|654|||
25144541|NCT01946282|50258323|FG000|Year 2|Did not return FIT kit|803|||
25144542|NCT01946282|50258324|FG001|Year 2|Did not return FIT kit|131|||
25144543|NCT01946282|50258325|FG002|Year 2|Did not return FIT kit|115|||
25144544|NCT01946282|50258323|FG000|Year 3|Did not return FIT kit|288|||
25144545|NCT01946282|50258324|FG001|Year 3|Did not return FIT kit|43|||
25144546|NCT01946282|50258325|FG002|Year 3|Did not return FIT kit|30|||
25144547|NCT01945580|50258337|FG000|Overall Study|Withdrawal by Subject|13|||
25144548|NCT01945580|50258338|FG001|Overall Study|Withdrawal by Subject|35|||
25144549|NCT01945580|50258337|FG000|Overall Study|Physician Decision|3|||
25144550|NCT01945580|50258338|FG001|Overall Study|Physician Decision|2|||
25144551|NCT01945580|50258337|FG000|Overall Study|Lost to Follow-up|26|||
25015785|NCT02959918|50110506|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
25144552|NCT01945580|50258338|FG001|Overall Study|Lost to Follow-up|39|||
25144553|NCT01945580|50258337|FG000|Overall Study|Death|7|||
25144554|NCT01945580|50258338|FG001|Overall Study|Death|2|||
25144555|NCT01945580|50258337|FG000|Overall Study|Patient moved out of state|0|||
25144556|NCT01945580|50258338|FG001|Overall Study|Patient moved out of state|1|||
25144557|NCT01945580|50258337|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
25144558|NCT01945580|50258338|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
25144559|NCT01945580|50258337|FG000|Overall Study|Family illness - unable to return|0|||
25144560|NCT01945580|50258338|FG001|Overall Study|Family illness - unable to return|1|||
25144561|NCT01945580|50258337|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
25144562|NCT01945580|50258338|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
25144563|NCT01945580|50258337|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
25144564|NCT01945580|50258338|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
25144565|NCT01945580|50258337|FG000|Overall Study|Noncompliance with 36 month visit|1|||
25144566|NCT01945580|50258338|FG001|Overall Study|Noncompliance with 36 month visit|0|||
25144567|NCT01945580|50258337|FG000|Overall Study|The patient moved.|1|||
25144568|NCT01945580|50258338|FG001|Overall Study|The patient moved.|0|||
25144569|NCT01945580|50258337|FG000|Overall Study|No data available|0|||
25144570|NCT01945580|50258338|FG001|Overall Study|No data available|2|||
25144571|NCT01945034|50258351|FG000|Overall Study|Medication Error|0|||
25144572|NCT01945034|50258352|FG001|Overall Study|Medication Error|1|||
25144573|NCT01945034|50258353|FG002|Overall Study|Medication Error|0|||
25144574|NCT01945034|50258351|FG000|Overall Study|Withdrawal by Subject|0|||
25144575|NCT01945034|50258352|FG001|Overall Study|Withdrawal by Subject|3|||
25144576|NCT01945034|50258353|FG002|Overall Study|Withdrawal by Subject|1|||
25144577|NCT01945034|50258351|FG000|Overall Study|Other|0|||
25144578|NCT01945034|50258352|FG001|Overall Study|Other|1|||
25144579|NCT01945034|50258353|FG002|Overall Study|Other|3|||
25144580|NCT01945034|50258351|FG000|Overall Study|Lost to Follow-up|0|||
25144581|NCT01945034|50258352|FG001|Overall Study|Lost to Follow-up|0|||
25144582|NCT01945034|50258353|FG002|Overall Study|Lost to Follow-up|2|||
25144583|NCT01945034|50258351|FG000|Overall Study|Protocol Violation|1|||
25144584|NCT01945034|50258352|FG001|Overall Study|Protocol Violation|0|||
25144585|NCT01945034|50258353|FG002|Overall Study|Protocol Violation|1|||
25144586|NCT01960790|50258361|FG000|Overall Study|Survey forms could not be recovered|3|||
25144587|NCT01960790|50258361|FG000|Overall Study|Treat with Humira outside survey period|3|||
25144588|NCT01960790|50258361|FG000|Overall Study|Transferred to another hospital|4|||
25144589|NCT01960790|50258361|FG000|Overall Study|Unevaluable for safety|1|||
25144590|NCT01618214|50258367|FG000|Overall Study|Adverse Event|3|||
25144591|NCT01618214|50258368|FG001|Overall Study|Adverse Event|1|||
25144592|NCT01618214|50258367|FG000|Overall Study|Lack of Efficacy|1|||
25144593|NCT01618214|50258368|FG001|Overall Study|Lack of Efficacy|1|||
25144594|NCT01618214|50258367|FG000|Overall Study|Protocol Violation|1|||
25144595|NCT01618214|50258368|FG001|Overall Study|Protocol Violation|4|||
25144596|NCT01618214|50258367|FG000|Overall Study|Withdrawal Criteria|1|||
25144597|NCT01618214|50258368|FG001|Overall Study|Withdrawal Criteria|2|||
25144598|NCT01618214|50258367|FG000|Overall Study|Unclassified|4|||
25144599|NCT01618214|50258368|FG001|Overall Study|Unclassified|5|||
25144600|NCT01917968|50258376|FG000|Overall Study|Death|3|||
25144601|NCT01917968|50258377|FG001|Overall Study|Death|2|||
25144602|NCT01917968|50258376|FG000|Overall Study|Lost to Follow-up|21|||
25180436|NCT01584440|50326448|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
25180437|NCT01584440|50326449|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
25180438|NCT01584440|50326450|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
25180439|NCT01584440|50326451|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
25180440|NCT01584440|50326447|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
25180441|NCT01584440|50326448|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
25180442|NCT01584440|50326449|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
25180443|NCT01584440|50326450|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
25180444|NCT01584440|50326451|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
25180445|NCT01584440|50326447|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
25180446|NCT01584440|50326448|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
25180447|NCT01584440|50326449|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
25180448|NCT01584440|50326450|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
25180449|NCT01584440|50326451|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
25180450|NCT01584440|50326447|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
25180451|NCT01584440|50326448|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
25180452|NCT01584440|50326449|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
25180453|NCT01584440|50326450|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
25180454|NCT01584440|50326451|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
25180455|NCT01584440|50326447|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
25180456|NCT01584440|50326448|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
25180457|NCT01584440|50326449|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
25180458|NCT01584440|50326450|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
25180459|NCT01584440|50326451|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
25180460|NCT01584440|50326447|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
25144603|NCT01917968|50258377|FG001|Overall Study|Lost to Follow-up|39|||
25144604|NCT01917968|50258376|FG000|Overall Study|Physician Decision|1|||
25144605|NCT01917968|50258377|FG001|Overall Study|Physician Decision|2|||
25144606|NCT01917968|50258376|FG000|Overall Study|Withdrawal by Subject|20|||
25180461|NCT01584440|50326448|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
25180462|NCT01584440|50326449|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
25180463|NCT01584440|50326450|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
25180464|NCT01584440|50326451|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
25180465|NCT01687478|50326466|FG000|Overall Study|Adverse Event|3|||
25180466|NCT01687478|50326467|FG001|Overall Study|Adverse Event|10|||
25180467|NCT01687478|50326466|FG000|Overall Study|Lost to Follow-up|1|||
25180468|NCT01687478|50326467|FG001|Overall Study|Lost to Follow-up|3|||
25180469|NCT01687478|50326466|FG000|Overall Study|Protocol Violation|0|||
25144607|NCT01917968|50258377|FG001|Overall Study|Withdrawal by Subject|35|||
25144608|NCT01917968|50258376|FG000|Overall Study|Subject Relocation|5|||
25144609|NCT01917968|50258377|FG001|Overall Study|Subject Relocation|1|||
25144610|NCT01917968|50258376|FG000|Overall Study|36M Missed Visit|3|||
25144611|NCT01917968|50258377|FG001|Overall Study|36M Missed Visit|2|||
25144612|NCT01917968|50258376|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
25180470|NCT01687478|50326467|FG001|Overall Study|Protocol Violation|2|||
25180471|NCT01687478|50326466|FG000|Overall Study|Withdrawal by Subject|21|||
25180472|NCT01687478|50326467|FG001|Overall Study|Withdrawal by Subject|19|||
25180473|NCT01687478|50326466|FG000|Overall Study|Physician Decision|1|||
25180474|NCT01687478|50326467|FG001|Overall Study|Physician Decision|3|||
25180475|NCT01687478|50326466|FG000|Overall Study|Entry Criteria Not Met|6|||
25180476|NCT01687478|50326467|FG001|Overall Study|Entry Criteria Not Met|2|||
25180477|NCT01468909|50326475|FG000|Overall Study|Never Treated|2|||
25180478|NCT01468909|50326476|FG001|Overall Study|Never Treated|2|||
25180479|NCT01468597|50326482|FG000|Overall Study|Found ineligible|17|||
25180480|NCT01468597|50326482|FG000|Overall Study|concomitant valves|12|||
25180481|NCT01468597|50326482|FG000|Overall Study|off-pump CABG|1|||
25180482|NCT01468597|50326482|FG000|Overall Study|no platelet function data|5|||
25180483|NCT01687166|50326490|FG000|Overall Study|Attempt subject|2|||
25180484|NCT01687166|50326491|FG001|Overall Study|Attempt subject|3|||
25180485|NCT01687166|50326492|FG002|Overall Study|Attempt subject|2|||
25180486|NCT01687166|50326493|FG003|Overall Study|Attempt subject|0|||
25180487|NCT01687166|50326490|FG000|Overall Study|Did not meet eligibility criteria|4|||
25180488|NCT01687166|50326491|FG001|Overall Study|Did not meet eligibility criteria|6|||
25015786|NCT02959918|50110493|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
25015787|NCT02959918|50110494|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
25015788|NCT02959918|50110495|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
25015789|NCT02959918|50110496|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
25015790|NCT02959918|50110497|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
25015791|NCT02959918|50110498|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
25015792|NCT02959918|50110499|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
25015793|NCT02959918|50110500|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
25015794|NCT02959918|50110501|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
25180489|NCT01687166|50326492|FG002|Overall Study|Did not meet eligibility criteria|1|||
25180490|NCT01687166|50326493|FG003|Overall Study|Did not meet eligibility criteria|1|||
25180491|NCT01687166|50326490|FG000|Overall Study|Adverse Event|2|||
25180492|NCT01687166|50326491|FG001|Overall Study|Adverse Event|1|||
25180493|NCT01687166|50326492|FG002|Overall Study|Adverse Event|0|||
25180494|NCT01687166|50326493|FG003|Overall Study|Adverse Event|0|||
25180495|NCT01687166|50326490|FG000|Overall Study|Physician Decision|3|||
25180496|NCT01687166|50326491|FG001|Overall Study|Physician Decision|2|||
25180497|NCT01687166|50326492|FG002|Overall Study|Physician Decision|1|||
25180498|NCT01687166|50326493|FG003|Overall Study|Physician Decision|0|||
25180499|NCT01687166|50326490|FG000|Overall Study|Withdrawal by Subject|11|||
25180500|NCT01687166|50326491|FG001|Overall Study|Withdrawal by Subject|4|||
25180501|NCT01687166|50326492|FG002|Overall Study|Withdrawal by Subject|3|||
25180502|NCT01687166|50326493|FG003|Overall Study|Withdrawal by Subject|0|||
25180503|NCT01687166|50326490|FG000|Overall Study|Lost to Follow-up|2|||
25180504|NCT01687166|50326491|FG001|Overall Study|Lost to Follow-up|5|||
25180505|NCT01687166|50326492|FG002|Overall Study|Lost to Follow-up|1|||
25180506|NCT01687166|50326493|FG003|Overall Study|Lost to Follow-up|0|||
25180507|NCT01687166|50326490|FG000|Overall Study|Equipment/Device Availability|0|||
25180508|NCT01687166|50326491|FG001|Overall Study|Equipment/Device Availability|1|||
25180509|NCT01687166|50326492|FG002|Overall Study|Equipment/Device Availability|0|||
25180510|NCT01687166|50326493|FG003|Overall Study|Equipment/Device Availability|0|||
25144613|NCT01917968|50258377|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
25180511|NCT01687166|50326490|FG000|Overall Study|Death|1|||
25180512|NCT01687166|50326491|FG001|Overall Study|Death|1|||
25180513|NCT01687166|50326492|FG002|Overall Study|Death|0|||
25180514|NCT01687166|50326493|FG003|Overall Study|Death|0|||
25180515|NCT01687166|50326490|FG000|Overall Study|Protocol Violation|1|||
25180516|NCT01687166|50326491|FG001|Overall Study|Protocol Violation|1|||
25180517|NCT01687166|50326492|FG002|Overall Study|Protocol Violation|1|||
25180518|NCT01687166|50326493|FG003|Overall Study|Protocol Violation|0|||
25180519|NCT01687166|50326490|FG000|Overall Study|Subject moved out of state|0|||
25180520|NCT01687166|50326491|FG001|Overall Study|Subject moved out of state|1|||
25180521|NCT01687166|50326492|FG002|Overall Study|Subject moved out of state|0|||
25180522|NCT01687166|50326493|FG003|Overall Study|Subject moved out of state|0|||
25180523|NCT01687166|50326490|FG000|Overall Study|Patient unable to be compliant|1|||
25144614|NCT01917968|50258376|FG000|Overall Study|Change in Family Circumstances|0|||
25144615|NCT01917968|50258377|FG001|Overall Study|Change in Family Circumstances|1|||
25144616|NCT01917968|50258376|FG000|Overall Study|No Data Available|0|||
25144617|NCT01917968|50258377|FG001|Overall Study|No Data Available|2|||
25180524|NCT01687166|50326491|FG001|Overall Study|Patient unable to be compliant|0|||
25180525|NCT01687166|50326492|FG002|Overall Study|Patient unable to be compliant|0|||
25180526|NCT01687166|50326493|FG003|Overall Study|Patient unable to be compliant|0|||
25180527|NCT01687166|50326490|FG000|Overall Study|Physician choice to use different device|1|||
25180528|NCT01687166|50326491|FG001|Overall Study|Physician choice to use different device|2|||
25180529|NCT01687166|50326492|FG002|Overall Study|Physician choice to use different device|4|||
25180530|NCT01687166|50326493|FG003|Overall Study|Physician choice to use different device|0|||
25180531|NCT01687166|50326490|FG000|Overall Study|Insurance|0|||
25180532|NCT01687166|50326491|FG001|Overall Study|Insurance|0|||
25180533|NCT01687166|50326492|FG002|Overall Study|Insurance|1|||
25180534|NCT01687166|50326493|FG003|Overall Study|Insurance|1|||
25180535|NCT01561976|50326507|FG000|Period 1|Adverse Event|0|||
25144618|NCT01917656|50258392|FG000|Overall Study|Adverse Event|11|||
25144619|NCT01917656|50258393|FG001|Overall Study|Adverse Event|0|||
25144620|NCT01917656|50258392|FG000|Overall Study|Withdrawal criteria|8|||
25144621|NCT01917656|50258393|FG001|Overall Study|Withdrawal criteria|14|||
25144622|NCT01917656|50258392|FG000|Overall Study|Unclassified|0|||
25144623|NCT01917656|50258393|FG001|Overall Study|Unclassified|3|||
25144624|NCT01917656|50258392|FG000|Overall Study|Withdrawal by Subject|4|||
25144625|NCT01917656|50258393|FG001|Overall Study|Withdrawal by Subject|3|||
25144626|NCT01917656|50258392|FG000|Overall Study|Lost to Follow-up|3|||
25144627|NCT01917656|50258393|FG001|Overall Study|Lost to Follow-up|4|||
25144628|NCT02018861|50258409|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
25144629|NCT02018861|50258410|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
25144630|NCT02018861|50258411|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
25144631|NCT02018861|50258412|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
25180536|NCT01561976|50326508|FG001|Period 1|Adverse Event|0|||
25180537|NCT01561976|50326509|FG002|Period 1|Adverse Event|1|||
25144632|NCT02018861|50258413|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
25180538|NCT01561976|50326510|FG003|Period 1|Adverse Event|0|||
25144633|NCT02018861|50258414|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
25180539|NCT01561976|50326511|FG004|Period 1|Adverse Event|0|||
25180540|NCT01561976|50326512|FG005|Period 1|Adverse Event|0|||
25180541|NCT01561976|50326507|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
25180542|NCT01561976|50326508|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
25180543|NCT01561976|50326509|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
25180544|NCT01561976|50326510|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
25180545|NCT01561976|50326511|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
25180546|NCT01561976|50326512|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
25180547|NCT01561976|50326507|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
25180548|NCT01561976|50326508|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
25180549|NCT01561976|50326509|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
25180550|NCT01561976|50326510|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
25180551|NCT01561976|50326511|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
25180552|NCT01561976|50326512|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
25180553|NCT01561976|50326507|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
25180554|NCT01561976|50326508|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
25180555|NCT01561976|50326509|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
25180556|NCT01561976|50326510|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
25180557|NCT01561976|50326511|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
25180558|NCT01561976|50326512|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
25180559|NCT01686932|50326522|FG000|Period 1|Adverse Event|1|||
25180560|NCT01686932|50326523|FG001|Period 1|Adverse Event|1|||
25180561|NCT01468207|50326531|FG000|Treatment Period 1|Adverse Event|1|||
25180562|NCT01468207|50326532|FG001|Treatment Period 1|Adverse Event|0|||
25180563|NCT01468207|50326533|FG002|Treatment Period 1|Adverse Event|0|||
25180564|NCT01468207|50326534|FG003|Treatment Period 1|Adverse Event|0|||
25180565|NCT01468207|50326535|FG004|Treatment Period 1|Adverse Event|0|||
25180566|NCT01468207|50326536|FG005|Treatment Period 1|Adverse Event|0|||
25180567|NCT01468207|50326531|FG000|Treatment Period 1|Protocol Violation|1|||
25180568|NCT01468207|50326532|FG001|Treatment Period 1|Protocol Violation|1|||
25180569|NCT01468207|50326533|FG002|Treatment Period 1|Protocol Violation|0|||
25180570|NCT01468207|50326534|FG003|Treatment Period 1|Protocol Violation|0|||
25180571|NCT01468207|50326535|FG004|Treatment Period 1|Protocol Violation|0|||
25180572|NCT01468207|50326536|FG005|Treatment Period 1|Protocol Violation|0|||
25180573|NCT01468207|50326531|FG000|Treatment Period 1|Withdrawal by Subject|5|||
25180574|NCT01468207|50326532|FG001|Treatment Period 1|Withdrawal by Subject|4|||
25180575|NCT01468207|50326533|FG002|Treatment Period 1|Withdrawal by Subject|0|||
25180576|NCT01468207|50326534|FG003|Treatment Period 1|Withdrawal by Subject|0|||
25180577|NCT01468207|50326535|FG004|Treatment Period 1|Withdrawal by Subject|0|||
25180578|NCT01468207|50326536|FG005|Treatment Period 1|Withdrawal by Subject|0|||
25180579|NCT01468207|50326531|FG000|Treatment Period 1|Lost to Follow-up|2|||
25180580|NCT01468207|50326532|FG001|Treatment Period 1|Lost to Follow-up|1|||
25180581|NCT01468207|50326533|FG002|Treatment Period 1|Lost to Follow-up|0|||
25180582|NCT01468207|50326534|FG003|Treatment Period 1|Lost to Follow-up|0|||
25180583|NCT01468207|50326535|FG004|Treatment Period 1|Lost to Follow-up|0|||
25180584|NCT01468207|50326536|FG005|Treatment Period 1|Lost to Follow-up|0|||
25180585|NCT01468207|50326531|FG000|Treatment Period 1|Other|0|||
25180586|NCT01468207|50326532|FG001|Treatment Period 1|Other|2|||
25180587|NCT01468207|50326533|FG002|Treatment Period 1|Other|0|||
25180588|NCT01468207|50326534|FG003|Treatment Period 1|Other|0|||
25180589|NCT01468207|50326535|FG004|Treatment Period 1|Other|0|||
25180590|NCT01468207|50326536|FG005|Treatment Period 1|Other|0|||
25180591|NCT01468207|50326531|FG000|Treatment Period 2|Adverse Event|0|||
25180592|NCT01468207|50326532|FG001|Treatment Period 2|Adverse Event|0|||
25180593|NCT01468207|50326533|FG002|Treatment Period 2|Adverse Event|6|||
25180594|NCT01468207|50326534|FG003|Treatment Period 2|Adverse Event|1|||
25180595|NCT01468207|50326535|FG004|Treatment Period 2|Adverse Event|2|||
25180596|NCT01468207|50326536|FG005|Treatment Period 2|Adverse Event|1|||
25180597|NCT01468207|50326531|FG000|Treatment Period 2|Lack of Efficacy|0|||
25180598|NCT01468207|50326532|FG001|Treatment Period 2|Lack of Efficacy|0|||
25180599|NCT01468207|50326533|FG002|Treatment Period 2|Lack of Efficacy|1|||
25180600|NCT01468207|50326534|FG003|Treatment Period 2|Lack of Efficacy|1|||
25180601|NCT01468207|50326535|FG004|Treatment Period 2|Lack of Efficacy|0|||
25180602|NCT01468207|50326536|FG005|Treatment Period 2|Lack of Efficacy|2|||
25180603|NCT01468207|50326531|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25180604|NCT01468207|50326532|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25180605|NCT01468207|50326533|FG002|Treatment Period 2|Withdrawal by Subject|5|||
25180606|NCT01468207|50326534|FG003|Treatment Period 2|Withdrawal by Subject|0|||
25180607|NCT01468207|50326535|FG004|Treatment Period 2|Withdrawal by Subject|0|||
25180608|NCT01468207|50326536|FG005|Treatment Period 2|Withdrawal by Subject|2|||
25180609|NCT01468207|50326531|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
25180610|NCT01468207|50326532|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
25180611|NCT01468207|50326533|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
25180612|NCT01468207|50326534|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
25180613|NCT01468207|50326535|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
25180614|NCT01468207|50326536|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
25180615|NCT01468207|50326531|FG000|Treatment Period 2|Lost to Follow-up|0|||
25180616|NCT01468207|50326532|FG001|Treatment Period 2|Lost to Follow-up|0|||
25180617|NCT01468207|50326533|FG002|Treatment Period 2|Lost to Follow-up|5|||
25180618|NCT01468207|50326534|FG003|Treatment Period 2|Lost to Follow-up|1|||
25180619|NCT01468207|50326535|FG004|Treatment Period 2|Lost to Follow-up|0|||
25180620|NCT01468207|50326536|FG005|Treatment Period 2|Lost to Follow-up|0|||
25180621|NCT01468207|50326531|FG000|Treatment Period 2|Other|0|||
25180622|NCT01468207|50326532|FG001|Treatment Period 2|Other|0|||
25180623|NCT01468207|50326533|FG002|Treatment Period 2|Other|5|||
25180624|NCT01468207|50326534|FG003|Treatment Period 2|Other|1|||
25180625|NCT01468207|50326535|FG004|Treatment Period 2|Other|1|||
25180626|NCT01468207|50326536|FG005|Treatment Period 2|Other|2|||
25180627|NCT01494649|50326556|FG000|Overall Study|Lost to Follow-up|0|||
25180628|NCT01494649|50326557|FG001|Overall Study|Lost to Follow-up|1|||
25180629|NCT01686152|50326568|FG000|Overall Study|Withdrawal by Subject|11|||
25180630|NCT01686152|50326569|FG001|Overall Study|Withdrawal by Subject|11|||
25180631|NCT01686152|50326570|FG002|Overall Study|Withdrawal by Subject|3|||
25180632|NCT01686152|50326568|FG000|Overall Study|Drug Code Unblinded|0|||
25180633|NCT01686152|50326569|FG001|Overall Study|Drug Code Unblinded|1|||
25180634|NCT01686152|50326570|FG002|Overall Study|Drug Code Unblinded|0|||
25180635|NCT01686152|50326568|FG000|Overall Study|Protocol Violation|6|||
25180636|NCT01686152|50326569|FG001|Overall Study|Protocol Violation|1|||
25180637|NCT01686152|50326570|FG002|Overall Study|Protocol Violation|0|||
25180638|NCT01686152|50326568|FG000|Overall Study|Adverse Event|12|||
25180639|NCT01686152|50326569|FG001|Overall Study|Adverse Event|11|||
25180640|NCT01686152|50326570|FG002|Overall Study|Adverse Event|0|||
25180641|NCT01686152|50326568|FG000|Overall Study|Lack of Efficacy|0|||
25180642|NCT01686152|50326569|FG001|Overall Study|Lack of Efficacy|0|||
25180643|NCT01686152|50326570|FG002|Overall Study|Lack of Efficacy|1|||
25180644|NCT01686152|50326568|FG000|Overall Study|IP Non-compliance|5|||
25180645|NCT01686152|50326569|FG001|Overall Study|IP Non-compliance|5|||
25180646|NCT01686152|50326570|FG002|Overall Study|IP Non-compliance|0|||
25180647|NCT01686152|50326568|FG000|Overall Study|Lost to Follow-up|7|||
25180648|NCT01686152|50326569|FG001|Overall Study|Lost to Follow-up|6|||
25180649|NCT01686152|50326570|FG002|Overall Study|Lost to Follow-up|5|||
25180650|NCT01452919|50326578|FG000|Open-Label Treatment|Adverse Event|5|||
25180651|NCT01452919|50326579|FG001|Open-Label Treatment|Adverse Event|0|||
25180652|NCT01452919|50326580|FG002|Open-Label Treatment|Adverse Event|0|||
25180653|NCT01452919|50326578|FG000|Open-Label Treatment|Lost to Follow-up|4|||
25180654|NCT01452919|50326579|FG001|Open-Label Treatment|Lost to Follow-up|0|||
25180655|NCT01452919|50326580|FG002|Open-Label Treatment|Lost to Follow-up|0|||
25144634|NCT02018861|50258415|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
25144635|NCT02018861|50258416|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
25144636|NCT02018861|50258417|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
25144637|NCT02018861|50258418|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
25144638|NCT02018861|50258409|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
25144639|NCT02018861|50258410|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
25144640|NCT02018861|50258411|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
25144641|NCT02018861|50258412|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
25144642|NCT02018861|50258413|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
25180656|NCT01452919|50326578|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
25180657|NCT01452919|50326579|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
25180658|NCT01452919|50326580|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
25180659|NCT01452919|50326578|FG000|Open-Label Treatment|Protocol Violation|4|||
25180660|NCT01452919|50326579|FG001|Open-Label Treatment|Protocol Violation|0|||
25180661|NCT01452919|50326580|FG002|Open-Label Treatment|Protocol Violation|0|||
25180662|NCT01452919|50326578|FG000|Open-Label Treatment|Sponsor Decision|1|||
25180663|NCT01452919|50326579|FG001|Open-Label Treatment|Sponsor Decision|0|||
25180664|NCT01452919|50326580|FG002|Open-Label Treatment|Sponsor Decision|0|||
25180665|NCT01452919|50326578|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
25180666|NCT01452919|50326579|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
25180667|NCT01452919|50326580|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
25180668|NCT01452919|50326578|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
25180669|NCT01452919|50326579|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
25180670|NCT01452919|50326580|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
25180671|NCT01452919|50326578|FG000|Randomization Treatment|Adverse Event|0|||
25180672|NCT01452919|50326579|FG001|Randomization Treatment|Adverse Event|0|||
25180673|NCT01452919|50326580|FG002|Randomization Treatment|Adverse Event|2|||
25180674|NCT01452919|50326578|FG000|Randomization Treatment|Sponsor Decision|0|||
25180675|NCT01452919|50326579|FG001|Randomization Treatment|Sponsor Decision|1|||
25180676|NCT01452919|50326580|FG002|Randomization Treatment|Sponsor Decision|0|||
25180677|NCT01452919|50326578|FG000|Randomization Treatment|Withdrawal by Subject|0|||
25180678|NCT01452919|50326579|FG001|Randomization Treatment|Withdrawal by Subject|1|||
25180679|NCT01452919|50326580|FG002|Randomization Treatment|Withdrawal by Subject|0|||
25180680|NCT01452919|50326578|FG000|Randomization Treatment|Subject is moving or has moved|0|||
25180681|NCT01452919|50326579|FG001|Randomization Treatment|Subject is moving or has moved|1|||
25180682|NCT01452919|50326580|FG002|Randomization Treatment|Subject is moving or has moved|0|||
25180683|NCT01582178|50326592|FG000|Overall Study|Physician Decision|6|||
25180684|NCT01582178|50326593|FG001|Overall Study|Physician Decision|5|||
25180685|NCT01561898|50326603|FG000|Overall Study|Withdrawal by Subject|0|||
25180686|NCT01561898|50326604|FG001|Overall Study|Withdrawal by Subject|8|||
25180687|NCT01561898|50326605|FG002|Overall Study|Withdrawal by Subject|12|||
25180688|NCT01561898|50326606|FG003|Overall Study|Withdrawal by Subject|5|||
25180689|NCT01561898|50326603|FG000|Overall Study|Lack of Efficacy|0|||
25180690|NCT01561898|50326604|FG001|Overall Study|Lack of Efficacy|8|||
25180691|NCT01561898|50326605|FG002|Overall Study|Lack of Efficacy|10|||
25180692|NCT01561898|50326606|FG003|Overall Study|Lack of Efficacy|5|||
25180693|NCT01561898|50326603|FG000|Overall Study|Worsening of complications|0|||
25180694|NCT01561898|50326604|FG001|Overall Study|Worsening of complications|1|||
25180695|NCT01561898|50326605|FG002|Overall Study|Worsening of complications|0|||
25144643|NCT02018861|50258414|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
25144644|NCT02018861|50258415|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
25144645|NCT02018861|50258416|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
25180696|NCT01561898|50326606|FG003|Overall Study|Worsening of complications|0|||
25180697|NCT01561898|50326603|FG000|Overall Study|Lost to Follow-up|0|||
25180698|NCT01561898|50326604|FG001|Overall Study|Lost to Follow-up|0|||
25180699|NCT01561898|50326605|FG002|Overall Study|Lost to Follow-up|1|||
25180700|NCT01561898|50326606|FG003|Overall Study|Lost to Follow-up|0|||
25180701|NCT01561898|50326603|FG000|Overall Study|Adverse Event|1|||
25180702|NCT01561898|50326604|FG001|Overall Study|Adverse Event|19|||
25180703|NCT01561898|50326605|FG002|Overall Study|Adverse Event|14|||
25144646|NCT02018861|50258417|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
25144647|NCT02018861|50258418|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
25144648|NCT02018861|50258409|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
25144649|NCT02018861|50258410|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
25144650|NCT02018861|50258411|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
25144651|NCT02018861|50258412|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
25180704|NCT01561898|50326606|FG003|Overall Study|Adverse Event|9|||
25180705|NCT01561898|50326603|FG000|Overall Study|Physician Decision|1|||
25015795|NCT02959918|50110502|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
25015796|NCT02959918|50110503|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
25015797|NCT02959918|50110504|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
25180706|NCT01561898|50326604|FG001|Overall Study|Physician Decision|5|||
25180707|NCT01561898|50326605|FG002|Overall Study|Physician Decision|7|||
25144652|NCT02018861|50258413|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
25144653|NCT02018861|50258414|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
25144654|NCT02018861|50258415|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
25144655|NCT02018861|50258416|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
25144656|NCT02018861|50258417|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
25144657|NCT02018861|50258418|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
25144658|NCT02018861|50258409|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
25144659|NCT02018861|50258410|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
25144660|NCT02018861|50258411|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
25180708|NCT01561898|50326606|FG003|Overall Study|Physician Decision|1|||
25180709|NCT01685840|50326616|FG000|Overall Study|Death|77|||
25180710|NCT01685840|50326617|FG001|Overall Study|Death|66|||
25180711|NCT01685840|50326616|FG000|Overall Study|Lost to Follow-up|27|||
25180712|NCT01685840|50326617|FG001|Overall Study|Lost to Follow-up|25|||
25180713|NCT01685840|50326616|FG000|Overall Study|Physician Decision|3|||
25180714|NCT01685840|50326617|FG001|Overall Study|Physician Decision|7|||
25180715|NCT01685840|50326616|FG000|Overall Study|Withdrawal by Subject|14|||
25180716|NCT01685840|50326617|FG001|Overall Study|Withdrawal by Subject|17|||
25180717|NCT01685840|50326616|FG000|Overall Study|Futility|197|||
25180718|NCT01685840|50326617|FG001|Overall Study|Futility|200|||
25180719|NCT01685840|50326616|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
25180720|NCT01685840|50326617|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
25180721|NCT01452529|50326627|FG000|Run-in Period|Adverse Event|96|||
25180722|NCT01452529|50326628|FG001|Run-in Period|Adverse Event|0|||
25180723|NCT01452529|50326629|FG002|Run-in Period|Adverse Event|0|||
25180724|NCT01452529|50326627|FG000|Run-in Period|Withdrawal by Subject|49|||
25180725|NCT01452529|50326628|FG001|Run-in Period|Withdrawal by Subject|0|||
25180726|NCT01452529|50326629|FG002|Run-in Period|Withdrawal by Subject|0|||
25180727|NCT01452529|50326627|FG000|Run-in Period|Lost to Follow-up|19|||
25180728|NCT01452529|50326628|FG001|Run-in Period|Lost to Follow-up|0|||
25180729|NCT01452529|50326629|FG002|Run-in Period|Lost to Follow-up|0|||
25180730|NCT01452529|50326627|FG000|Run-in Period|Lack of Efficacy|46|||
25180731|NCT01452529|50326628|FG001|Run-in Period|Lack of Efficacy|0|||
25180732|NCT01452529|50326629|FG002|Run-in Period|Lack of Efficacy|0|||
25274477|NCT01202760|50588503|FG001|Overall Study|Parent / Caregiver Decision|1|||
25144661|NCT02018861|50258412|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
25144662|NCT02018861|50258413|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
25144663|NCT02018861|50258414|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
25144664|NCT02018861|50258415|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
25144665|NCT02018861|50258416|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
25144666|NCT02018861|50258417|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
25144667|NCT02018861|50258418|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
25180733|NCT01452529|50326627|FG000|Run-in Period|Confirmed or suspected diversion|23|||
25180734|NCT01452529|50326628|FG001|Run-in Period|Confirmed or suspected diversion|0|||
25180735|NCT01452529|50326629|FG002|Run-in Period|Confirmed or suspected diversion|0|||
25180736|NCT01452529|50326627|FG000|Run-in Period|Administrative|21|||
25180737|NCT01452529|50326628|FG001|Run-in Period|Administrative|0|||
25274478|NCT01202760|50588504|FG002|Overall Study|Parent / Caregiver Decision|0|||
25180738|NCT01452529|50326629|FG002|Run-in Period|Administrative|0|||
25180739|NCT01452529|50326627|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
25144668|NCT02018861|50258409|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
25144669|NCT02018861|50258410|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
25015798|NCT02959918|50110505|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
25144670|NCT02018861|50258411|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
25144671|NCT02018861|50258412|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
25144672|NCT02018861|50258413|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
25144673|NCT02018861|50258414|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
25144674|NCT02018861|50258415|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
25144675|NCT02018861|50258416|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
25144676|NCT02018861|50258417|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
25144677|NCT02018861|50258418|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
25144678|NCT02018861|50258409|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
25144679|NCT02018861|50258410|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
25144680|NCT02018861|50258411|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
25144681|NCT02018861|50258412|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
25144682|NCT02018861|50258413|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
25144683|NCT02018861|50258414|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
25144684|NCT02018861|50258415|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
25015799|NCT02959918|50110506|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
25144685|NCT02018861|50258416|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
25144686|NCT02018861|50258417|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
25144687|NCT02018861|50258418|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
25144688|NCT02018861|50258409|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
25144689|NCT02018861|50258410|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
25144690|NCT02018861|50258411|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
25144691|NCT02018861|50258412|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
25144692|NCT02018861|50258413|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
25144693|NCT02018861|50258414|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
25144694|NCT02018861|50258415|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
25144695|NCT02018861|50258416|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
25144696|NCT02018861|50258417|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
25144697|NCT02018861|50258418|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
25144698|NCT02018861|50258409|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
25144699|NCT02018861|50258410|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
25144700|NCT02018861|50258411|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
25144701|NCT02018861|50258412|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
25144702|NCT02018861|50258413|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
25144703|NCT02018861|50258414|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
25144704|NCT02018861|50258415|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
25144705|NCT02018861|50258416|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
25144706|NCT02018861|50258417|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
25144707|NCT02018861|50258418|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
25144708|NCT02018861|50258409|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
25144709|NCT02018861|50258410|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
25144710|NCT02018861|50258411|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
25144711|NCT02018861|50258412|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
25144712|NCT02018861|50258413|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
25015800|NCT03263442|50110541|FG000|Inpatient Phase|Death|1|||
25015801|NCT03263442|50110542|FG001|Inpatient Phase|Death|0|||
25015802|NCT03263442|50110541|FG000|Inpatient Phase|Withdrawal by Subject|1|||
25015803|NCT03263442|50110542|FG001|Inpatient Phase|Withdrawal by Subject|0|||
25015804|NCT03263442|50110541|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
25015805|NCT03263442|50110542|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
25015806|NCT03263442|50110541|FG000|1-month Follow-Up|Lost to Follow-up|1|||
25015807|NCT03263442|50110542|FG001|1-month Follow-Up|Lost to Follow-up|0|||
25015808|NCT03263442|50110541|FG000|3-month Follow-Up|Lost to Follow-up|1|||
25015809|NCT03263442|50110542|FG001|3-month Follow-Up|Lost to Follow-up|3|||
25015810|NCT03263442|50110541|FG000|6-month Follow-Up|Lost to Follow-up|2|||
25144713|NCT02018861|50258414|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
25144714|NCT02018861|50258415|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
25144715|NCT02018861|50258416|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
25144716|NCT02018861|50258417|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
25144717|NCT02018861|50258418|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
25144718|NCT02018861|50258409|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
25144719|NCT02018861|50258410|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
25015811|NCT03263442|50110542|FG001|6-month Follow-Up|Lost to Follow-up|2|||
25144720|NCT02018861|50258411|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
25180740|NCT01452529|50326628|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
25180741|NCT01452529|50326629|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
25180742|NCT01452529|50326627|FG000|Double-blind (DB) Period|Adverse Event|0|||
25180743|NCT01452529|50326628|FG001|Double-blind (DB) Period|Adverse Event|18|||
25180744|NCT01452529|50326629|FG002|Double-blind (DB) Period|Adverse Event|11|||
25180745|NCT01452529|50326627|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
25180746|NCT01452529|50326628|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
25180747|NCT01452529|50326629|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
25180748|NCT01452529|50326627|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
25180749|NCT01452529|50326628|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
25180750|NCT01452529|50326629|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
25180751|NCT01452529|50326627|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
25015812|NCT04245709|50110550|FG000|Overall Study|Adverse Event|13|||
25144721|NCT02018861|50258412|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
25144722|NCT02018861|50258413|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
25144723|NCT02018861|50258414|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
25144724|NCT02018861|50258415|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
25144725|NCT02018861|50258416|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
25144726|NCT02018861|50258417|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
25144727|NCT02018861|50258418|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
25144728|NCT02018861|50258409|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
25144729|NCT02018861|50258410|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
25144730|NCT02018861|50258411|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
25144731|NCT02018861|50258412|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
25144732|NCT02018861|50258413|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
25144733|NCT02018861|50258414|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
25144734|NCT02018861|50258415|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
25144735|NCT02018861|50258416|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
25144736|NCT02018861|50258417|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
25144737|NCT02018861|50258418|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
25144738|NCT02018861|50258409|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
25144739|NCT02018861|50258410|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
25144740|NCT02018861|50258411|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
25144741|NCT02018861|50258412|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
25144742|NCT02018861|50258413|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
25144743|NCT02018861|50258414|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
25180752|NCT01452529|50326628|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
25180753|NCT01452529|50326629|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
25180754|NCT01452529|50326627|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
25144744|NCT02018861|50258415|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
25144745|NCT02018861|50258416|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
25144746|NCT02018861|50258417|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
25144747|NCT02018861|50258418|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
25144748|NCT02018861|50258409|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
25144749|NCT02018861|50258410|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
25144750|NCT02018861|50258411|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
25144751|NCT02018861|50258412|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
25144752|NCT02018861|50258413|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
25144753|NCT02018861|50258414|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
25180755|NCT01452529|50326628|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
25180756|NCT01452529|50326629|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
25180757|NCT01452529|50326627|FG000|Double-blind (DB) Period|Administrative|0|||
25144754|NCT02018861|50258415|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
25144755|NCT02018861|50258416|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
25144756|NCT02018861|50258417|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
25144757|NCT02018861|50258418|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
25144758|NCT01944722|50258449|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
25144759|NCT01944722|50258449|FG000|Overall Study|Specimen Shipping Issues|34|||
25144760|NCT01944722|50258449|FG000|Overall Study|Improper Storage/Transport|5|||
25144761|NCT01944722|50258449|FG000|Overall Study|Insufficient Volume for Test|1|||
25144762|NCT01944722|50258449|FG000|Overall Study|Missing Specimens|3|||
25144763|NCT01944722|50258449|FG000|Overall Study|Specimens Mislabeled|2|||
25144764|NCT01944722|50258449|FG000|Overall Study|Withdrawal by Subject|8|||
25144765|NCT01944722|50258449|FG000|Overall Study|NILM Subjects <30 years old|8106|||
25144766|NCT01944722|50258449|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
25144767|NCT01944722|50258449|FG000|Overall Study|>ASCUS Cytology|1122|||
25144768|NCT01917344|50258458|FG000|Overall Study|Withdrawal by Subject|1|||
25144769|NCT02017535|50258466|FG000|Overall Study|Withdrawal by Subject|1|||
25144770|NCT02017535|50258467|FG001|Overall Study|Withdrawal by Subject|0|||
25144771|NCT02017535|50258468|FG002|Overall Study|Withdrawal by Subject|0|||
25144772|NCT02017535|50258469|FG003|Overall Study|Withdrawal by Subject|0|||
25144773|NCT01944098|50258481|FG000|Overall Study|Physician Decision|1|||
25144774|NCT01944098|50258482|FG001|Overall Study|Physician Decision|0|||
25144775|NCT02017223|50258488|FG000|Overall Study|Algorithm problems|2|||
25144776|NCT01944020|50258494|FG000|Overall Study|Withdrawal by Subject|5|||
25144777|NCT01944020|50258495|FG001|Overall Study|Withdrawal by Subject|0|||
25144778|NCT01943552|50258503|FG000|Overall Study|Adverse Event|3|||
25144779|NCT01943552|50258504|FG001|Overall Study|Adverse Event|2|||
25144780|NCT01943552|50258503|FG000|Overall Study|Withdrawal by Subject|6|||
25144781|NCT01943552|50258504|FG001|Overall Study|Withdrawal by Subject|6|||
25144782|NCT01943552|50258503|FG000|Overall Study|Other Reasons|16|||
25144783|NCT01943552|50258504|FG001|Overall Study|Other Reasons|17|||
25144784|NCT01915940|50258512|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
25144785|NCT01915940|50258513|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
25144786|NCT01915940|50258514|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
25144787|NCT01915940|50258512|FG000|Treatment Period|Decision of Participant|0|||
25144788|NCT01915940|50258513|FG001|Treatment Period|Decision of Participant|1|||
25180758|NCT01452529|50326628|FG001|Double-blind (DB) Period|Administrative|11|||
25180759|NCT01452529|50326629|FG002|Double-blind (DB) Period|Administrative|7|||
25180760|NCT01560416|50326638|FG000|Randomized Phase|Crossover Participants|7|||
25180761|NCT01560416|50326639|FG001|Randomized Phase|Crossover Participants|0|||
25180762|NCT01685606|50326647|FG000|Overall Study|Withdrawal by Subject|1|||
25180763|NCT01685372|50326653|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
25180764|NCT01685372|50326654|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
25180765|NCT01685216|50326660|FG000|Overall Study|Did not receive study drug|1|||
25180766|NCT01685138|50326664|FG000|Overall Study|Lost to Follow-up|1|||
25180767|NCT01685138|50326664|FG000|Overall Study|Protocol Violation|1|||
25180768|NCT01685138|50326664|FG000|Overall Study|No longer requires treatment|1|||
25180769|NCT01685138|50326664|FG000|Overall Study|Subject/guardian decision|2|||
25180770|NCT01685138|50326664|FG000|Overall Study|Physician Decision|6|||
25180771|NCT01685138|50326664|FG000|Overall Study|Death|10|||
25180772|NCT01685138|50326664|FG000|Overall Study|Adverse Event|18|||
25180773|NCT01685138|50326664|FG000|Overall Study|Progressive disease|53|||
25015813|NCT04245709|50110550|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
25180774|NCT01685060|50326668|FG000|Overall Study|Rollover patients|16|||
25180775|NCT01685060|50326668|FG000|Overall Study|Adverse Event|12|||
25144789|NCT01915940|50258514|FG002|Treatment Period|Decision of Participant|3|||
25144790|NCT01915940|50258512|FG000|Treatment Period|Adverse Event|0|||
25144791|NCT01915940|50258513|FG001|Treatment Period|Adverse Event|9|||
25144792|NCT01915940|50258514|FG002|Treatment Period|Adverse Event|1|||
25144793|NCT01915940|50258512|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
25144794|NCT01915940|50258513|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
25144795|NCT01915940|50258514|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
25144796|NCT01914926|50258522|FG000|Overall Study|Adverse Event|1|||
25144797|NCT01914926|50258523|FG001|Overall Study|Adverse Event|0|||
25144798|NCT01914926|50258522|FG000|Overall Study|uncooperative, agitated and removed|0|||
25144799|NCT01914926|50258523|FG001|Overall Study|uncooperative, agitated and removed|1|||
25144800|NCT02016755|50258529|FG000|Overall Study|Major amputation of index limb|2|||
25144801|NCT02016755|50258529|FG000|Overall Study|Adverse Event|2|||
25144802|NCT02016755|50258529|FG000|Overall Study|Physician Decision|1|||
25144803|NCT02016755|50258529|FG000|Overall Study|Death|2|||
25144804|NCT01942148|50258533|FG000|Overall Study|Adverse Event|4|||
25144805|NCT01942148|50258533|FG000|Overall Study|Lack of Efficacy|2|||
25144806|NCT01942148|50258533|FG000|Overall Study|Physician Decision|11|||
25144807|NCT01942148|50258533|FG000|Overall Study|Protocol Violation|1|||
25144808|NCT01942148|50258533|FG000|Overall Study|Withdrawal by Subject|8|||
25144809|NCT01942148|50258533|FG000|Overall Study|Use of the prohibition medicine|1|||
25144810|NCT02030015|50258537|FG000|Overall Study|Withdrawal by Subject|3|||
25144811|NCT02030015|50258537|FG000|Overall Study|Death|13|||
25144812|NCT02029235|50258543|FG000|Overall Study|Non-compliance with study meds or diary|4|||
25144813|NCT02029235|50258544|FG001|Overall Study|Non-compliance with study meds or diary|1|||
25144814|NCT01617434|50258552|FG000|Overall Study|Adverse Event|12|||
25144815|NCT01617434|50258553|FG001|Overall Study|Adverse Event|3|||
25144816|NCT01617434|50258552|FG000|Overall Study|Protocol Violation|8|||
25144817|NCT01617434|50258553|FG001|Overall Study|Protocol Violation|7|||
25144818|NCT01617434|50258552|FG000|Overall Study|Withdrawal Criteria|12|||
25144819|NCT01617434|50258553|FG001|Overall Study|Withdrawal Criteria|37|||
25144820|NCT01617434|50258552|FG000|Overall Study|Unclassified|3|||
25144821|NCT01617434|50258553|FG001|Overall Study|Unclassified|4|||
25144822|NCT01940900|50258561|FG000|Overall Study|Physician Decision|4|||
25144823|NCT01940900|50258562|FG001|Overall Study|Physician Decision|0|||
25144824|NCT01940900|50258561|FG000|Overall Study|Adverse Event|10|||
25144825|NCT01940900|50258562|FG001|Overall Study|Adverse Event|15|||
25144826|NCT01940900|50258561|FG000|Overall Study|Withdrawal by Subject|11|||
25144827|NCT01940900|50258562|FG001|Overall Study|Withdrawal by Subject|15|||
25144828|NCT01940900|50258561|FG000|Overall Study|Lost to Follow-up|1|||
25144829|NCT01940900|50258562|FG001|Overall Study|Lost to Follow-up|0|||
25144830|NCT01940900|50258561|FG000|Overall Study|Sponsor Decision|1|||
25144831|NCT01940900|50258562|FG001|Overall Study|Sponsor Decision|0|||
25144832|NCT01940900|50258561|FG000|Overall Study|subject non-compliance|1|||
25144833|NCT01940900|50258562|FG001|Overall Study|subject non-compliance|1|||
25144834|NCT01940900|50258561|FG000|Overall Study|other|1|||
25144835|NCT01940900|50258562|FG001|Overall Study|other|0|||
25144836|NCT01940354|50258570|FG000|Overall Study|Withdrawal by Subject|4|||
25144837|NCT01940354|50258571|FG001|Overall Study|Withdrawal by Subject|2|||
25144838|NCT01940120|50258577|FG000|Overall Study|Death|40|||
25144839|NCT01940120|50258577|FG000|Overall Study|Withdrawal by Subject|8|||
25144840|NCT01911260|50258586|FG000|Supplementation Period|transference or evasion of school|7|||
25144841|NCT01911260|50258587|FG001|Supplementation Period|transference or evasion of school|9|||
25144842|NCT01911260|50258588|FG002|Supplementation Period|transference or evasion of school|7|||
25144843|NCT01911260|50258589|FG003|Supplementation Period|transference or evasion of school|6|||
25144844|NCT01911260|50258586|FG000|Supplementation Period|Adverse Event|2|||
25144845|NCT01911260|50258587|FG001|Supplementation Period|Adverse Event|0|||
25144846|NCT01911260|50258588|FG002|Supplementation Period|Adverse Event|1|||
25144847|NCT01911260|50258589|FG003|Supplementation Period|Adverse Event|0|||
25144848|NCT01911260|50258586|FG000|Supplementation Period|refused to receive supplement|1|||
25144849|NCT01911260|50258587|FG001|Supplementation Period|refused to receive supplement|0|||
25144850|NCT01911260|50258588|FG002|Supplementation Period|refused to receive supplement|1|||
25144851|NCT01911260|50258589|FG003|Supplementation Period|refused to receive supplement|0|||
25144852|NCT01911260|50258586|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
25144853|NCT01911260|50258587|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
25144854|NCT01911260|50258588|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
25015814|NCT04091581|50110556|FG000|Overall Study|Lost to Follow-up|0|||
25144855|NCT01911260|50258589|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
25144856|NCT01911260|50258586|FG000|Follow-up Period|transference or evasion of school|13|||
25144857|NCT01911260|50258587|FG001|Follow-up Period|transference or evasion of school|20|||
25144858|NCT01911260|50258588|FG002|Follow-up Period|transference or evasion of school|15|||
25144859|NCT01911260|50258589|FG003|Follow-up Period|transference or evasion of school|12|||
25144860|NCT02015819|50258603|FG000|Overall Study|Rickham catheter was misaligned|0|||
25144861|NCT02015819|50258604|FG001|Overall Study|Rickham catheter was misaligned|0|||
25144862|NCT02015819|50258605|FG002|Overall Study|Rickham catheter was misaligned|0|||
25144863|NCT02015819|50258606|FG003|Overall Study|Rickham catheter was misaligned|1|||
25180776|NCT01685060|50326668|FG000|Overall Study|Progressive disease|69|||
25180777|NCT01685060|50326668|FG000|Overall Study|Physician Decision|14|||
25180778|NCT01685060|50326668|FG000|Overall Study|Subject/guardian decision|20|||
25180779|NCT01685060|50326668|FG000|Overall Study|Lost to Follow-up|1|||
25180780|NCT01685060|50326668|FG000|Overall Study|Death|8|||
25180781|NCT01582100|50326672|FG000|Overall Study|Adverse Event|1|||
25180782|NCT01582100|50326672|FG000|Overall Study|Withdrawal by Subject|1|||
25180783|NCT01579916|50326678|FG000|Overall Study|Lost to Follow-up|6|||
25180784|NCT01579916|50326679|FG001|Overall Study|Lost to Follow-up|1|||
25180785|NCT01579916|50326678|FG000|Overall Study|Withdrawal by Subject|1|||
25180786|NCT01579916|50326679|FG001|Overall Study|Withdrawal by Subject|1|||
25180787|NCT01579916|50326678|FG000|Overall Study|Death|1|||
25180788|NCT01579916|50326679|FG001|Overall Study|Death|0|||
25180789|NCT01684202|50326689|FG000|Dose-escalation Period|Adverse Event|0|||
25144864|NCT01939496|50258623|FG000|Overall Study|Adverse Event|2|||
25144865|NCT01939496|50258624|FG001|Overall Study|Adverse Event|0|||
25144866|NCT01939496|50258625|FG002|Overall Study|Adverse Event|0|||
25144867|NCT01939496|50258623|FG000|Overall Study|Lost to Follow-up|1|||
25144868|NCT01939496|50258624|FG001|Overall Study|Lost to Follow-up|1|||
25144869|NCT01939496|50258625|FG002|Overall Study|Lost to Follow-up|0|||
25144870|NCT01939496|50258623|FG000|Overall Study|Physician Decision|1|||
25144871|NCT01939496|50258624|FG001|Overall Study|Physician Decision|0|||
25144872|NCT01939496|50258625|FG002|Overall Study|Physician Decision|0|||
25144873|NCT01939496|50258623|FG000|Overall Study|Protocol Violation|3|||
25144874|NCT01939496|50258624|FG001|Overall Study|Protocol Violation|0|||
25144875|NCT01939496|50258625|FG002|Overall Study|Protocol Violation|0|||
25144876|NCT01939496|50258623|FG000|Overall Study|Withdrawal by Subject|0|||
25144877|NCT01939496|50258624|FG001|Overall Study|Withdrawal by Subject|1|||
25144878|NCT01939496|50258625|FG002|Overall Study|Withdrawal by Subject|1|||
25180790|NCT01684202|50326690|FG001|Dose-escalation Period|Adverse Event|1|||
25180791|NCT01684202|50326691|FG002|Dose-escalation Period|Adverse Event|0|||
25180792|NCT01684202|50326692|FG003|Dose-escalation Period|Adverse Event|0|||
25180793|NCT01684202|50326689|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
25180794|NCT01684202|50326690|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
25180795|NCT01684202|50326691|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
25180796|NCT01684202|50326692|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
25180797|NCT01684202|50326689|FG000|Maintenance Period|Adverse Event|1|||
25180798|NCT01684202|50326690|FG001|Maintenance Period|Adverse Event|1|||
25180799|NCT01684202|50326691|FG002|Maintenance Period|Adverse Event|1|||
25180800|NCT01684202|50326692|FG003|Maintenance Period|Adverse Event|1|||
25180801|NCT01684202|50326689|FG000|Maintenance Period|Physician Decision|0|||
25180802|NCT01684202|50326690|FG001|Maintenance Period|Physician Decision|1|||
25180803|NCT01684202|50326691|FG002|Maintenance Period|Physician Decision|0|||
25180804|NCT01684202|50326692|FG003|Maintenance Period|Physician Decision|0|||
25180805|NCT01684202|50326689|FG000|Maintenance Period|Withdrawal by Subject|0|||
25180806|NCT01684202|50326690|FG001|Maintenance Period|Withdrawal by Subject|1|||
25180807|NCT01684202|50326691|FG002|Maintenance Period|Withdrawal by Subject|0|||
25180808|NCT01684202|50326692|FG003|Maintenance Period|Withdrawal by Subject|0|||
25180809|NCT01684046|50326702|FG000|Period 1, First 30 Days|Adverse Event|0|||
25180810|NCT01684046|50326703|FG001|Period 1, First 30 Days|Adverse Event|2|||
25180811|NCT01559090|50326712|FG000|Stage I|Withdrawal by Subject|2|||
25144879|NCT01939496|50258623|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
25144880|NCT01939496|50258624|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
25144881|NCT01939496|50258625|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
25144882|NCT01939496|50258623|FG000|Overall Study|Other|2|||
25144883|NCT01939496|50258624|FG001|Overall Study|Other|0|||
25144884|NCT01939496|50258625|FG002|Overall Study|Other|1|||
25144885|NCT01939028|50258633|FG000|Overall Study|Withdrawal by Subject|5|||
25144886|NCT01939028|50258633|FG000|Overall Study|Physician Decision|7|||
25180812|NCT01559090|50326713|FG001|Stage I|Withdrawal by Subject|2|||
25180813|NCT01559090|50326714|FG002|Stage I|Withdrawal by Subject|3|||
25180814|NCT01559090|50326712|FG000|Stage II|Withdrawal by Subject|1|||
25180815|NCT01559090|50326713|FG001|Stage II|Withdrawal by Subject|0|||
25180816|NCT01559090|50326714|FG002|Stage II|Withdrawal by Subject|0|||
25180817|NCT01683266|50326724|FG000|Overall Study|Adverse Event|5|||
25180818|NCT01683266|50326725|FG001|Overall Study|Adverse Event|4|||
25015815|NCT04091581|50110557|FG001|Overall Study|Lost to Follow-up|1|||
25144887|NCT01938716|50258637|FG000|Overall Study|Physician Decision|2|||
25180819|NCT01683266|50326724|FG000|Overall Study|Lack of Efficacy|5|||
25180820|NCT01683266|50326725|FG001|Overall Study|Lack of Efficacy|2|||
25180821|NCT01683266|50326724|FG000|Overall Study|Protocol Violation|13|||
25180822|NCT01683266|50326725|FG001|Overall Study|Protocol Violation|6|||
25180823|NCT01683266|50326724|FG000|Overall Study|Personal Reason|17|||
25180824|NCT01683266|50326725|FG001|Overall Study|Personal Reason|25|||
25180825|NCT01683266|50326724|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
25180826|NCT01683266|50326725|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
25180827|NCT01683266|50326724|FG000|Overall Study|Lost to Follow-up|5|||
25180828|NCT01683266|50326725|FG001|Overall Study|Lost to Follow-up|0|||
25180829|NCT01683266|50326724|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
25180830|NCT01683266|50326725|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
25180831|NCT01683266|50326724|FG000|Overall Study|Nonserious Hypoglycemia|0|||
25180832|NCT01683266|50326725|FG001|Overall Study|Nonserious Hypoglycemia|3|||
25180833|NCT01683266|50326724|FG000|Overall Study|Perceived Lack of Efficacy|1|||
25180834|NCT01683266|50326725|FG001|Overall Study|Perceived Lack of Efficacy|1|||
25180835|NCT01683266|50326724|FG000|Overall Study|Possibly Hypoglycemia|1|||
25180836|NCT01683266|50326725|FG001|Overall Study|Possibly Hypoglycemia|0|||
25180837|NCT01683266|50326724|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
25180838|NCT01683266|50326725|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
25180839|NCT01467661|50326731|FG000|Overall Study|Adverse Event|16|||
25180840|NCT01467661|50326731|FG000|Overall Study|Withdrawal by Subject|1|||
25180841|NCT01467661|50326731|FG000|Overall Study|Lack of Efficacy|3|||
25180842|NCT01467661|50326731|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
25180843|NCT01577186|50326737|FG000|Overall Study|Adverse Event|23|||
25180844|NCT01577186|50326737|FG000|Overall Study|Death|1|||
25180845|NCT01577186|50326737|FG000|Overall Study|Lost to Follow-up|28|||
25180846|NCT01577186|50326737|FG000|Overall Study|Withdrawal by Subject|35|||
25180847|NCT01577186|50326737|FG000|Overall Study|Insufficient Response|18|||
25180848|NCT01577186|50326737|FG000|Overall Study|Ineligible to Continue|15|||
25144888|NCT01938716|50258637|FG000|Overall Study|Withdrawal by Subject|2|||
25144889|NCT01937390|50258641|FG000|Overall Study|Death|2|||
25144890|NCT01937390|50258641|FG000|Overall Study|Lost to Follow-up|7|||
25015816|NCT02940522|50110565|FG000|Overall Study|Lost to Follow-up|1|||
25015817|NCT02940522|50110566|FG001|Overall Study|Lost to Follow-up|2|||
25144891|NCT01937390|50258641|FG000|Overall Study|Withdrawal by Subject|5|||
25015818|NCT02940522|50110565|FG000|Overall Study|Withdrawal by Subject|1|||
25015819|NCT02940522|50110566|FG001|Overall Study|Withdrawal by Subject|0|||
25144892|NCT01937390|50258641|FG000|Overall Study|Fail to return|21|||
25180849|NCT01577186|50326737|FG000|Overall Study|Non-Compliant|8|||
25180850|NCT01577186|50326737|FG000|Overall Study|Other|2|||
25180851|NCT01559012|50326743|FG000|Overall Study|Withdrawal by Subject|0|||
25180852|NCT01559012|50326744|FG001|Overall Study|Withdrawal by Subject|1|||
25180853|NCT01451827|50326769|FG000|Overall Study|Adverse Event|2|||
25180854|NCT01451827|50326770|FG001|Overall Study|Adverse Event|0|||
25180855|NCT01451827|50326771|FG002|Overall Study|Adverse Event|1|||
25180856|NCT01451827|50326772|FG003|Overall Study|Adverse Event|1|||
25274479|NCT01202760|50588502|FG000|Overall Study|Withdrawal by Subject|17|||
25274480|NCT01202760|50588503|FG001|Overall Study|Withdrawal by Subject|18|||
25274481|NCT01202760|50588504|FG002|Overall Study|Withdrawal by Subject|14|||
25274482|NCT01202760|50588502|FG000|Overall Study|Physician Decision|0|||
25274483|NCT01202760|50588503|FG001|Overall Study|Physician Decision|1|||
25274484|NCT01202760|50588504|FG002|Overall Study|Physician Decision|0|||
25274485|NCT01202760|50588502|FG000|Overall Study|Protocol Violation|7|||
25274486|NCT01202760|50588503|FG001|Overall Study|Protocol Violation|5|||
25274487|NCT01202760|50588504|FG002|Overall Study|Protocol Violation|2|||
25274488|NCT01202760|50588502|FG000|Overall Study|Sponsor Decision|4|||
25180857|NCT01451827|50326769|FG000|Overall Study|Protocol deviation|1|||
25180858|NCT01451827|50326770|FG001|Overall Study|Protocol deviation|0|||
25274489|NCT01202760|50588503|FG001|Overall Study|Sponsor Decision|4|||
25274490|NCT01202760|50588504|FG002|Overall Study|Sponsor Decision|0|||
25015820|NCT03262038|50110574|FG000|Overall Study|Withdrawal by Subject|0|||
25015821|NCT03262038|50110575|FG001|Overall Study|Withdrawal by Subject|1|||
25015822|NCT02472964|50110583|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
25015823|NCT02472964|50110584|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
25015824|NCT02472964|50110583|FG000|Part 1 (up to Week 24)|disease progression|58|||
25144893|NCT02028767|50258645|FG000|Treatment Period 2|Non compliant with protocol|1|||
25144894|NCT02028767|50258646|FG001|Treatment Period 2|Non compliant with protocol|0|||
25144895|NCT02028767|50258645|FG000|Treatment Period 2|Reason other than those specified above|1|||
25144896|NCT02028767|50258646|FG001|Treatment Period 2|Reason other than those specified above|0|||
25144897|NCT01959932|50258655|FG000|Overall Study|Withdrawal by Subject|1|||
25144898|NCT01959932|50258656|FG001|Overall Study|Withdrawal by Subject|0|||
25144899|NCT01959932|50258657|FG002|Overall Study|Withdrawal by Subject|0|||
25144900|NCT02028065|50258669|FG000|Randomization Through Start Treatment|Not treated|1|||
25144901|NCT02028065|50258670|FG001|Randomization Through Start Treatment|Not treated|3|||
25180859|NCT01451827|50326771|FG002|Overall Study|Protocol deviation|0|||
25180860|NCT01451827|50326772|FG003|Overall Study|Protocol deviation|0|||
25180861|NCT01451827|50326769|FG000|Overall Study|Lost to Follow-up|0|||
25180862|NCT01451827|50326770|FG001|Overall Study|Lost to Follow-up|3|||
25180863|NCT01451827|50326771|FG002|Overall Study|Lost to Follow-up|0|||
25180864|NCT01451827|50326772|FG003|Overall Study|Lost to Follow-up|2|||
25180865|NCT01451827|50326769|FG000|Overall Study|Participant met withdrawal criteria|0|||
25180866|NCT01451827|50326770|FG001|Overall Study|Participant met withdrawal criteria|2|||
25015825|NCT02472964|50110584|FG001|Part 1 (up to Week 24)|disease progression|47|||
25015826|NCT02472964|50110583|FG000|Part 1 (up to Week 24)|Death|3|||
25015827|NCT02472964|50110584|FG001|Part 1 (up to Week 24)|Death|6|||
25015828|NCT02472964|50110583|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
25015829|NCT02472964|50110584|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
25180867|NCT01451827|50326771|FG002|Overall Study|Participant met withdrawal criteria|0|||
25015830|NCT02472964|50110583|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
25015831|NCT02472964|50110584|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
25015832|NCT02472964|50110583|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
25015833|NCT02472964|50110584|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
25015834|NCT02472964|50110583|FG000|Part 1 (up to Week 24)|Other|2|||
25015835|NCT02472964|50110584|FG001|Part 1 (up to Week 24)|Other|1|||
25015836|NCT02472964|50110583|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
25015837|NCT02472964|50110584|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
25015838|NCT02472964|50110583|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
25015839|NCT02472964|50110584|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
25015840|NCT02472964|50110583|FG000|Part 2 (Week 24-week 48)|Death|0|||
25015841|NCT02472964|50110584|FG001|Part 2 (Week 24-week 48)|Death|1|||
25015842|NCT02472964|50110583|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
25015843|NCT02472964|50110584|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
25015844|NCT02472964|50110583|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
25015845|NCT02472964|50110584|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
25015846|NCT02472964|50110583|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
25015847|NCT02472964|50110584|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
25015848|NCT02472964|50110583|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
25015849|NCT02472964|50110584|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
25015850|NCT04079803|50110597|FG000|Overall Study|Withdrawal by Subject|0|||
25015851|NCT04079803|50110598|FG001|Overall Study|Withdrawal by Subject|0|||
25015852|NCT04079803|50110599|FG002|Overall Study|Withdrawal by Subject|1|||
25015853|NCT03278613|50110627|FG000|Overall Study|Lost to Follow-up|3|||
25015854|NCT03278613|50110628|FG001|Overall Study|Lost to Follow-up|1|||
25015855|NCT03761147|50110636|FG000|Overall Study|Withdrawal by Subject|6|||
25015856|NCT03761147|50110637|FG001|Overall Study|Withdrawal by Subject|1|||
25180868|NCT01451827|50326772|FG003|Overall Study|Participant met withdrawal criteria|0|||
25180869|NCT01451827|50326769|FG000|Overall Study|Withdrawal by Subject|0|||
25180870|NCT01451827|50326770|FG001|Overall Study|Withdrawal by Subject|0|||
25180871|NCT01451827|50326771|FG002|Overall Study|Withdrawal by Subject|1|||
25180872|NCT01451827|50326772|FG003|Overall Study|Withdrawal by Subject|1|||
25180873|NCT01557920|50326782|FG000|Overall Study|Withdrawal by Subject|2|||
25180874|NCT01557920|50326783|FG001|Overall Study|Withdrawal by Subject|3|||
25180875|NCT01557920|50326782|FG000|Overall Study|Lack of Efficacy|1|||
25180876|NCT01557920|50326783|FG001|Overall Study|Lack of Efficacy|0|||
25180877|NCT01467583|50326819|FG000|Overall Study|Death|1|||
25180878|NCT01467583|50326820|FG001|Overall Study|Death|1|||
25180879|NCT01467583|50326821|FG002|Overall Study|Death|0|||
25180880|NCT01467583|50326819|FG000|Overall Study|Withdrawal by Subject|1|||
25180881|NCT01467583|50326820|FG001|Overall Study|Withdrawal by Subject|0|||
25180882|NCT01467583|50326821|FG002|Overall Study|Withdrawal by Subject|0|||
25180883|NCT01467583|50326819|FG000|Overall Study|Protocol Violation|0|||
25180884|NCT01467583|50326820|FG001|Overall Study|Protocol Violation|0|||
25180885|NCT01467583|50326821|FG002|Overall Study|Protocol Violation|2|||
25180886|NCT01576718|50326838|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
25180887|NCT01576718|50326839|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
25015857|NCT03761147|50110636|FG000|Overall Study|Adverse Event|1|||
25015858|NCT03761147|50110637|FG001|Overall Study|Adverse Event|3|||
25015859|NCT04076917|50110643|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
25015860|NCT04076917|50110643|FG000|Overall Study|Study closure|13|||
25015861|NCT04076917|50110643|FG000|Overall Study|Physician Decision|3|||
25015862|NCT04076917|50110643|FG000|Overall Study|Death|1|||
25015863|NCT04076917|50110643|FG000|Overall Study|Lost to Follow-up|1|||
25015864|NCT04076917|50110643|FG000|Overall Study|Withdrawal by Subject|1|||
25144902|NCT02028065|50258671|FG002|Randomization Through Start Treatment|Not treated|3|||
25144903|NCT02028065|50258669|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
25144904|NCT02028065|50258670|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
25144905|NCT02028065|50258671|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
25144906|NCT02028065|50258669|FG000|Treatment Through Study Completion|Physician Decision|1|||
25144907|NCT02028065|50258670|FG001|Treatment Through Study Completion|Physician Decision|0|||
25180888|NCT01576718|50326840|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
25180889|NCT01576718|50326841|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
25180890|NCT01576718|50326842|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
25144908|NCT02028065|50258671|FG002|Treatment Through Study Completion|Physician Decision|0|||
25144909|NCT02028065|50258669|FG000|Treatment Through Study Completion|Protocol Violation|1|||
25144910|NCT02028065|50258670|FG001|Treatment Through Study Completion|Protocol Violation|4|||
25144911|NCT02028065|50258671|FG002|Treatment Through Study Completion|Protocol Violation|0|||
25144912|NCT02028065|50258669|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
25144913|NCT02028065|50258670|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
25144914|NCT02028065|50258671|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
25144915|NCT02028065|50258669|FG000|Treatment Through Study Completion|Adverse Event|3|||
25144916|NCT02028065|50258670|FG001|Treatment Through Study Completion|Adverse Event|3|||
25144917|NCT02028065|50258671|FG002|Treatment Through Study Completion|Adverse Event|5|||
25144918|NCT02015195|50258686|FG000|Overall Study|Adverse Event|0|||
25144919|NCT02015195|50258687|FG001|Overall Study|Adverse Event|0|||
25144920|NCT02015195|50258688|FG002|Overall Study|Adverse Event|0|||
25144921|NCT02015195|50258689|FG003|Overall Study|Adverse Event|1|||
25144922|NCT02015195|50258690|FG004|Overall Study|Adverse Event|0|||
25144923|NCT02015195|50258691|FG005|Overall Study|Adverse Event|0|||
25144924|NCT02015195|50258692|FG006|Overall Study|Adverse Event|0|||
25144925|NCT02015039|50258709|FG000|Overall Study|Not eligible|0|||
25144926|NCT02015039|50258710|FG001|Overall Study|Not eligible|1|||
25144927|NCT02025725|50258718|FG000|Overall Study|Adverse Event|5|||
25144928|NCT02025725|50258719|FG001|Overall Study|Adverse Event|0|||
25144929|NCT02025725|50258718|FG000|Overall Study|Lost to Follow-up|2|||
25144930|NCT02025725|50258719|FG001|Overall Study|Lost to Follow-up|0|||
25144931|NCT02025725|50258718|FG000|Overall Study|Protocol Violation|1|||
25144932|NCT02025725|50258719|FG001|Overall Study|Protocol Violation|1|||
25144933|NCT02025725|50258718|FG000|Overall Study|Withdrawal by Subject|3|||
25144934|NCT02025725|50258719|FG001|Overall Study|Withdrawal by Subject|2|||
25274491|NCT01091259|50588524|FG000|Overall Study|Adverse Event|3|||
25015865|NCT04076917|50110643|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
25144935|NCT02025725|50258718|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
25274492|NCT01091259|50588524|FG000|Overall Study|Lack of Efficacy|2|||
25274493|NCT01091103|50588528|FG000|Overall Study|Adverse Event|1|||
25015866|NCT04222699|50110647|FG000|Overall Study|Lost to Follow-up|2|||
25144936|NCT02025725|50258719|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
25274494|NCT01091103|50588528|FG000|Overall Study|Progressive Disease|3|||
25180891|NCT01576718|50326843|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
25180892|NCT01576718|50326844|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
25180893|NCT01576718|50326838|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
25180894|NCT01576718|50326839|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
25180895|NCT01576718|50326840|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
25180896|NCT01576718|50326841|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
25180897|NCT01576718|50326842|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
25180898|NCT01576718|50326843|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
25180899|NCT01576718|50326844|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
25180900|NCT01576718|50326838|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
25180901|NCT01576718|50326839|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
25180902|NCT01576718|50326840|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
25180903|NCT01576718|50326841|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
25180904|NCT01576718|50326842|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
25180905|NCT01576718|50326843|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
25180906|NCT01576718|50326844|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
25180907|NCT01576718|50326838|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
25180908|NCT01576718|50326839|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
25180909|NCT01576718|50326840|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
25180910|NCT01576718|50326841|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
25180911|NCT01576718|50326842|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
25180912|NCT01576718|50326843|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
25180913|NCT01576718|50326844|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
25180914|NCT01576718|50326838|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
25180915|NCT01576718|50326839|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
25180916|NCT01576718|50326840|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
25180917|NCT01576718|50326841|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
25180918|NCT01576718|50326842|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
25274495|NCT01078389|50588536|FG000|Overall Study|Adverse Event|10|||
25180919|NCT01576718|50326843|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
25180920|NCT01576718|50326844|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
25180921|NCT01576718|50326838|FG000|Treatment Period|Adverse Event|0|||
25180922|NCT01576718|50326839|FG001|Treatment Period|Adverse Event|1|||
25180923|NCT01576718|50326840|FG002|Treatment Period|Adverse Event|1|||
25180924|NCT01576718|50326841|FG003|Treatment Period|Adverse Event|1|||
25180925|NCT01576718|50326842|FG004|Treatment Period|Adverse Event|1|||
25180926|NCT01576718|50326843|FG005|Treatment Period|Adverse Event|1|||
25180927|NCT01576718|50326844|FG006|Treatment Period|Adverse Event|0|||
25180928|NCT01576718|50326838|FG000|Treatment Period|Withdrawal by Subject|0|||
25180929|NCT01576718|50326839|FG001|Treatment Period|Withdrawal by Subject|1|||
25180930|NCT01576718|50326840|FG002|Treatment Period|Withdrawal by Subject|1|||
25180931|NCT01576718|50326841|FG003|Treatment Period|Withdrawal by Subject|0|||
25144937|NCT02025179|50258730|FG000|Overall Study|Lost to Follow-up|0|||
25144938|NCT02025179|50258731|FG001|Overall Study|Lost to Follow-up|0|||
25144939|NCT02025179|50258732|FG002|Overall Study|Lost to Follow-up|1|||
25144940|NCT02013791|50258749|FG000|Period 1|Lost to Follow-up|0|||
25144941|NCT02013791|50258750|FG001|Period 1|Lost to Follow-up|0|||
25144942|NCT02013791|50258751|FG002|Period 1|Lost to Follow-up|0|||
25144943|NCT02013791|50258752|FG003|Period 1|Lost to Follow-up|1|||
25144944|NCT02013791|50258753|FG004|Period 1|Lost to Follow-up|0|||
25144945|NCT02013791|50258754|FG005|Period 1|Lost to Follow-up|0|||
25144946|NCT02013791|50258755|FG006|Period 1|Lost to Follow-up|1|||
25144947|NCT02013791|50258756|FG007|Period 1|Lost to Follow-up|1|||
25144948|NCT02013791|50258757|FG008|Period 1|Lost to Follow-up|0|||
25144949|NCT02013791|50258749|FG000|Period 1|Other Miscellaneous Reasons|0|||
25144950|NCT02013791|50258750|FG001|Period 1|Other Miscellaneous Reasons|2|||
25144951|NCT02013791|50258751|FG002|Period 1|Other Miscellaneous Reasons|0|||
25144952|NCT02013791|50258752|FG003|Period 1|Other Miscellaneous Reasons|0|||
25144953|NCT02013791|50258753|FG004|Period 1|Other Miscellaneous Reasons|0|||
25015867|NCT02731690|50110660|FG000|Overall Study|Adverse Event|1|||
25015868|NCT02731690|50110660|FG000|Overall Study|Withdrawal by Subject|3|||
25144954|NCT02013791|50258754|FG005|Period 1|Other Miscellaneous Reasons|0|||
25144955|NCT02013791|50258755|FG006|Period 1|Other Miscellaneous Reasons|0|||
25144956|NCT02013791|50258756|FG007|Period 1|Other Miscellaneous Reasons|0|||
25144957|NCT02013791|50258757|FG008|Period 1|Other Miscellaneous Reasons|0|||
25144958|NCT02024867|50258780|FG000|Overall Study|Protocol Violation|3|||
25144959|NCT02024867|50258781|FG001|Overall Study|Protocol Violation|3|||
25144960|NCT02024867|50258780|FG000|Overall Study|Lost to Follow-up|6|||
25144961|NCT02024867|50258781|FG001|Overall Study|Lost to Follow-up|4|||
25144962|NCT01953601|50258790|FG000|Part 1 (Base Study)|Adverse Event|24|||
25144963|NCT01953601|50258791|FG001|Part 1 (Base Study)|Adverse Event|37|||
25015869|NCT02731690|50110660|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
25144964|NCT01953601|50258792|FG002|Part 1 (Base Study)|Adverse Event|15|||
25144965|NCT01953601|50258790|FG000|Part 1 (Base Study)|Death|2|||
25144966|NCT01953601|50258791|FG001|Part 1 (Base Study)|Death|0|||
25144967|NCT01953601|50258792|FG002|Part 1 (Base Study)|Death|3|||
25144968|NCT01953601|50258790|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
25144969|NCT01953601|50258791|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
25144970|NCT01953601|50258792|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
25144971|NCT01953601|50258790|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
25144972|NCT01953601|50258791|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
25144973|NCT01953601|50258792|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
25144974|NCT01953601|50258790|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
25144975|NCT01953601|50258791|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
25144976|NCT01953601|50258792|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
25144977|NCT01953601|50258790|FG000|Part 1 (Base Study)|Physician Decision|3|||
25144978|NCT01953601|50258791|FG001|Part 1 (Base Study)|Physician Decision|7|||
25144979|NCT01953601|50258792|FG002|Part 1 (Base Study)|Physician Decision|4|||
25144980|NCT01953601|50258790|FG000|Part 1 (Base Study)|Screen failure|1|||
25144981|NCT01953601|50258791|FG001|Part 1 (Base Study)|Screen failure|0|||
25144982|NCT01953601|50258792|FG002|Part 1 (Base Study)|Screen failure|1|||
25144983|NCT01953601|50258790|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
25144984|NCT01953601|50258791|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
25144985|NCT01953601|50258792|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
25180932|NCT01576718|50326842|FG004|Treatment Period|Withdrawal by Subject|2|||
25144986|NCT01953601|50258790|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
25144987|NCT01953601|50258791|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
25144988|NCT01953601|50258792|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
25144989|NCT01953601|50258790|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
25144990|NCT01953601|50258791|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
25144991|NCT01953601|50258792|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
25144992|NCT01953601|50258790|FG000|Part 1 (Base Study)|Subject moved|2|||
25274496|NCT01078389|50588537|FG001|Overall Study|Adverse Event|6|||
25180933|NCT01576718|50326843|FG005|Treatment Period|Withdrawal by Subject|4|||
25180934|NCT01576718|50326844|FG006|Treatment Period|Withdrawal by Subject|2|||
25180935|NCT01576718|50326838|FG000|Treatment Period|Physician Decision|0|||
25180936|NCT01576718|50326839|FG001|Treatment Period|Physician Decision|1|||
25274497|NCT01078389|50588536|FG000|Overall Study|Major Protocol Deviation|2|||
25274498|NCT01078389|50588537|FG001|Overall Study|Major Protocol Deviation|0|||
25274499|NCT01078389|50588536|FG000|Overall Study|Lost to Follow-up|23|||
25274500|NCT01078389|50588537|FG001|Overall Study|Lost to Follow-up|23|||
25274501|NCT01078389|50588536|FG000|Overall Study|Voluntary Withdrawal|20|||
25274502|NCT01078389|50588537|FG001|Overall Study|Voluntary Withdrawal|36|||
25274503|NCT01078389|50588536|FG000|Overall Study|Other|9|||
25274504|NCT01078389|50588537|FG001|Overall Study|Other|2|||
25015870|NCT04075513|50110666|FG000|Overall Study|Withdrawal by Subject|2|||
25015871|NCT04075513|50110667|FG001|Overall Study|Withdrawal by Subject|2|||
25274505|NCT01090323|50588545|FG000|Overall Study|Adverse Event|12|||
25180937|NCT01576718|50326840|FG002|Treatment Period|Physician Decision|1|||
25180938|NCT01576718|50326841|FG003|Treatment Period|Physician Decision|1|||
25180939|NCT01576718|50326842|FG004|Treatment Period|Physician Decision|1|||
25180940|NCT01576718|50326843|FG005|Treatment Period|Physician Decision|0|||
25180941|NCT01576718|50326844|FG006|Treatment Period|Physician Decision|0|||
25180942|NCT01576718|50326838|FG000|Treatment Period|Protocol Violation|0|||
25180943|NCT01576718|50326839|FG001|Treatment Period|Protocol Violation|5|||
25180944|NCT01576718|50326840|FG002|Treatment Period|Protocol Violation|4|||
25180945|NCT01576718|50326841|FG003|Treatment Period|Protocol Violation|10|||
25180946|NCT01576718|50326842|FG004|Treatment Period|Protocol Violation|6|||
25274506|NCT01090323|50588546|FG001|Overall Study|Adverse Event|2|||
25274507|NCT01090323|50588545|FG000|Overall Study|Abnormal Lab Values|3|||
25274508|NCT01090323|50588546|FG001|Overall Study|Abnormal Lab Values|1|||
25274509|NCT01090323|50588545|FG000|Overall Study|Abnormal Test Procedure Results|2|||
25274510|NCT01090323|50588546|FG001|Overall Study|Abnormal Test Procedure Results|0|||
25274511|NCT01090323|50588545|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
25274512|NCT01090323|50588546|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
25274513|NCT01090323|50588545|FG000|Overall Study|Condition no longer requires drug|5|||
25274514|NCT01090323|50588546|FG001|Overall Study|Condition no longer requires drug|4|||
25274515|NCT01090323|50588545|FG000|Overall Study|Protocol Violation|2|||
25274516|NCT01090323|50588546|FG001|Overall Study|Protocol Violation|1|||
25274517|NCT01090323|50588545|FG000|Overall Study|Withdrew consent|33|||
25274518|NCT01090323|50588546|FG001|Overall Study|Withdrew consent|11|||
25180947|NCT01576718|50326843|FG005|Treatment Period|Protocol Violation|8|||
25180948|NCT01576718|50326844|FG006|Treatment Period|Protocol Violation|12|||
25180949|NCT01576718|50326838|FG000|Treatment Period|Sponsor request|0|||
25274519|NCT01090323|50588545|FG000|Overall Study|Lost to Follow-up|11|||
25274520|NCT01090323|50588546|FG001|Overall Study|Lost to Follow-up|6|||
25274521|NCT01090323|50588545|FG000|Overall Study|Administrative problems|6|||
25274522|NCT01090323|50588546|FG001|Overall Study|Administrative problems|4|||
25015872|NCT04075513|50110666|FG000|Overall Study|Lack of Efficacy|1|||
25274523|NCT01090323|50588545|FG000|Overall Study|Death|1|||
25274524|NCT01090323|50588546|FG001|Overall Study|Death|2|||
25274525|NCT01090323|50588545|FG000|Overall Study|Stopped end of core|7|||
25144993|NCT01953601|50258791|FG001|Part 1 (Base Study)|Subject moved|2|||
25274526|NCT01090323|50588546|FG001|Overall Study|Stopped end of core|0|||
25274527|NCT01090323|50588545|FG000|Overall Study|Stopped end of extension 1#|3|||
25274528|NCT01090323|50588546|FG001|Overall Study|Stopped end of extension 1#|1|||
25274529|NCT01078155|50588552|FG000|Overall Study|Adverse Event|7|||
25274530|NCT01078155|50588552|FG000|Overall Study|Lack of Efficacy|16|||
25274531|NCT01078155|50588552|FG000|Overall Study|Participant's Decision|6|||
25144994|NCT01953601|50258792|FG002|Part 1 (Base Study)|Subject moved|1|||
25144995|NCT01953601|50258790|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
25144996|NCT01953601|50258791|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
25144997|NCT01953601|50258792|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
25144998|NCT01953601|50258790|FG000|Part 2 (Extension Study)|Adverse Event|1|||
25144999|NCT01953601|50258791|FG001|Part 2 (Extension Study)|Adverse Event|1|||
25145000|NCT01953601|50258792|FG002|Part 2 (Extension Study)|Adverse Event|10|||
25145001|NCT01953601|50258790|FG000|Part 2 (Extension Study)|Death|0|||
25145002|NCT01953601|50258791|FG001|Part 2 (Extension Study)|Death|3|||
25145003|NCT01953601|50258792|FG002|Part 2 (Extension Study)|Death|0|||
25145004|NCT01953601|50258790|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
25145005|NCT01953601|50258791|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
25145006|NCT01953601|50258792|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
25145007|NCT01953601|50258790|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
25145008|NCT01953601|50258791|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
25145009|NCT01953601|50258792|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
25145010|NCT01953601|50258790|FG000|Part 2 (Extension Study)|Physician Decision|2|||
25180950|NCT01576718|50326839|FG001|Treatment Period|Sponsor request|1|||
25145011|NCT01953601|50258791|FG001|Part 2 (Extension Study)|Physician Decision|0|||
25015873|NCT04075513|50110667|FG001|Overall Study|Lack of Efficacy|0|||
25015874|NCT04075513|50110666|FG000|Overall Study|Lost to Follow-up|4|||
25015875|NCT04075513|50110667|FG001|Overall Study|Lost to Follow-up|2|||
25015876|NCT04075513|50110666|FG000|Overall Study|Switch to insulin pump|1|||
25180951|NCT01576718|50326840|FG002|Treatment Period|Sponsor request|0|||
25180952|NCT01576718|50326841|FG003|Treatment Period|Sponsor request|0|||
25180953|NCT01576718|50326842|FG004|Treatment Period|Sponsor request|0|||
25180954|NCT01576718|50326843|FG005|Treatment Period|Sponsor request|1|||
25180955|NCT01576718|50326844|FG006|Treatment Period|Sponsor request|0|||
25274532|NCT01078155|50588552|FG000|Overall Study|Lost to Follow-up|15|||
25015877|NCT04075513|50110667|FG001|Overall Study|Switch to insulin pump|0|||
25015878|NCT04073407|50110675|FG000|Part 1|Withdrawal by Subject|1|||
25274533|NCT01201356|50588556|FG000|Overall Study|Adverse Event|170|||
25180956|NCT01576718|50326838|FG000|Treatment Period|Met stopping criteria|0|||
25145012|NCT01953601|50258792|FG002|Part 2 (Extension Study)|Physician Decision|2|||
25145013|NCT01953601|50258790|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
25145014|NCT01953601|50258791|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
25145015|NCT01953601|50258792|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
25145016|NCT01953601|50258790|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
25145017|NCT01953601|50258791|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
25145018|NCT01953601|50258792|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
25180957|NCT01576718|50326839|FG001|Treatment Period|Met stopping criteria|16|||
25180958|NCT01576718|50326840|FG002|Treatment Period|Met stopping criteria|13|||
25180959|NCT01576718|50326841|FG003|Treatment Period|Met stopping criteria|19|||
25180960|NCT01576718|50326842|FG004|Treatment Period|Met stopping criteria|16|||
25180961|NCT01576718|50326843|FG005|Treatment Period|Met stopping criteria|33|||
25180962|NCT01576718|50326844|FG006|Treatment Period|Met stopping criteria|15|||
25180963|NCT01576718|50326838|FG000|Treatment Period|Lost to Follow-up|0|||
25180964|NCT01576718|50326839|FG001|Treatment Period|Lost to Follow-up|0|||
25145019|NCT01953601|50258790|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
25145020|NCT01953601|50258791|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
25145021|NCT01953601|50258792|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
25145022|NCT01953601|50258790|FG000|Part 2 (Extension Study)|Subject moved|0|||
25145023|NCT01953601|50258791|FG001|Part 2 (Extension Study)|Subject moved|0|||
25180965|NCT01576718|50326840|FG002|Treatment Period|Lost to Follow-up|0|||
25180966|NCT01576718|50326841|FG003|Treatment Period|Lost to Follow-up|0|||
25180967|NCT01576718|50326842|FG004|Treatment Period|Lost to Follow-up|1|||
25145024|NCT01953601|50258792|FG002|Part 2 (Extension Study)|Subject moved|1|||
25145025|NCT01953601|50258790|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
25145026|NCT01953601|50258791|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
25145027|NCT01953601|50258792|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
25145028|NCT01952665|50258805|FG000|Overall Study|Physician Decision|3|||
25145029|NCT01952665|50258806|FG001|Overall Study|Physician Decision|2|||
25145030|NCT01952665|50258805|FG000|Overall Study|Lost to Follow-up|1|||
25145031|NCT01952665|50258806|FG001|Overall Study|Lost to Follow-up|2|||
25145032|NCT01952665|50258805|FG000|Overall Study|Adverse Event|2|||
25145033|NCT01952665|50258806|FG001|Overall Study|Adverse Event|1|||
25145034|NCT01952665|50258805|FG000|Overall Study|Protocol Violation|0|||
25180968|NCT01576718|50326843|FG005|Treatment Period|Lost to Follow-up|0|||
25180969|NCT01576718|50326844|FG006|Treatment Period|Lost to Follow-up|0|||
25180970|NCT01576718|50326838|FG000|Treatment Period|Noncompliance to study medication|0|||
25180971|NCT01576718|50326839|FG001|Treatment Period|Noncompliance to study medication|0|||
25180972|NCT01576718|50326840|FG002|Treatment Period|Noncompliance to study medication|0|||
25180973|NCT01576718|50326841|FG003|Treatment Period|Noncompliance to study medication|0|||
25180974|NCT01576718|50326842|FG004|Treatment Period|Noncompliance to study medication|0|||
25180975|NCT01576718|50326843|FG005|Treatment Period|Noncompliance to study medication|1|||
25180976|NCT01576718|50326844|FG006|Treatment Period|Noncompliance to study medication|1|||
25180977|NCT01493557|50326861|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
25180978|NCT01493557|50326862|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
25180979|NCT01493557|50326863|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
25145035|NCT01952665|50258806|FG001|Overall Study|Protocol Violation|1|||
25180980|NCT01493557|50326861|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
25145036|NCT01952041|50258817|FG000|Overall Study|Lost to Follow-up|9|||
25145037|NCT01952041|50258818|FG001|Overall Study|Lost to Follow-up|16|||
25145038|NCT01952041|50258817|FG000|Overall Study|Withdrawal by Subject|7|||
25145039|NCT01952041|50258818|FG001|Overall Study|Withdrawal by Subject|5|||
25145040|NCT01952041|50258817|FG000|Overall Study|Death|1|||
25145041|NCT01952041|50258818|FG001|Overall Study|Death|0|||
25145042|NCT01951573|50258824|FG000|Washout Period|Adverse Event|0|||
25180981|NCT01493557|50326862|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
25180982|NCT01493557|50326863|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
25145043|NCT01951573|50258825|FG001|Washout Period|Adverse Event|1|||
25145044|NCT02023697|50258834|FG000|Treatment Period|Radiological progression|13|||
25145045|NCT02023697|50258835|FG001|Treatment Period|Radiological progression|17|||
25180983|NCT01493557|50326861|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
25180984|NCT01493557|50326862|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
25180985|NCT01493557|50326863|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
25180986|NCT01493557|50326861|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
25180987|NCT01493557|50326862|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
25180988|NCT01493557|50326863|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
25180989|NCT01493557|50326861|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
25180990|NCT01493557|50326862|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
25180991|NCT01493557|50326863|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
25180992|NCT01493557|50326861|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
25180993|NCT01493557|50326862|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
25180994|NCT01493557|50326863|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
25145046|NCT02023697|50258836|FG002|Treatment Period|Radiological progression|26|||
25145047|NCT02023697|50258834|FG000|Treatment Period|Never Treated|5|||
25145048|NCT02023697|50258835|FG001|Treatment Period|Never Treated|6|||
25145049|NCT02023697|50258836|FG002|Treatment Period|Never Treated|10|||
25145050|NCT02023697|50258834|FG000|Treatment Period|Adverse Event|13|||
25145051|NCT02023697|50258835|FG001|Treatment Period|Adverse Event|25|||
25145052|NCT02023697|50258836|FG002|Treatment Period|Adverse Event|23|||
25145053|NCT02023697|50258834|FG000|Treatment Period|Logistical difficulties|1|||
25145054|NCT02023697|50258835|FG001|Treatment Period|Logistical difficulties|1|||
25145055|NCT02023697|50258836|FG002|Treatment Period|Logistical difficulties|1|||
25180995|NCT01493557|50326861|FG000|Not Randomized to Management Strategies|Early termination|0|||
25180996|NCT01493557|50326862|FG001|Not Randomized to Management Strategies|Early termination|0|||
25180997|NCT01493557|50326863|FG002|Not Randomized to Management Strategies|Early termination|34|||
25274534|NCT01201356|50588556|FG000|Overall Study|Abnormal laboratory value(s)|51|||
25145056|NCT02023697|50258834|FG000|Treatment Period|Clinical progression|10|||
25145057|NCT02023697|50258835|FG001|Treatment Period|Clinical progression|8|||
25145058|NCT02023697|50258836|FG002|Treatment Period|Clinical progression|28|||
25145059|NCT02023697|50258834|FG000|Treatment Period|Withdrawal by Subject|4|||
25015879|NCT04073407|50110676|FG001|Part 1|Withdrawal by Subject|0|||
25180998|NCT01493557|50326861|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
25180999|NCT01493557|50326862|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
25181000|NCT01493557|50326863|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
25181001|NCT01493557|50326861|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
25181002|NCT01493557|50326862|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
25181003|NCT01493557|50326863|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
25274535|NCT01201356|50588556|FG000|Overall Study|Abnormal test procedure result(s)|3|||
25274536|NCT01201356|50588556|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
25145060|NCT02023697|50258835|FG001|Treatment Period|Withdrawal by Subject|5|||
25145061|NCT02023697|50258836|FG002|Treatment Period|Withdrawal by Subject|13|||
25145062|NCT02023697|50258834|FG000|Treatment Period|Safety outcome reached|0|||
25145063|NCT02023697|50258835|FG001|Treatment Period|Safety outcome reached|1|||
25145064|NCT02023697|50258836|FG002|Treatment Period|Safety outcome reached|0|||
25145065|NCT02023697|50258834|FG000|Treatment Period|Physician Decision|0|||
25145066|NCT02023697|50258835|FG001|Treatment Period|Physician Decision|0|||
25145067|NCT02023697|50258836|FG002|Treatment Period|Physician Decision|1|||
25145068|NCT02023697|50258834|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
25145069|NCT02023697|50258835|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
25145070|NCT02023697|50258836|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
25145071|NCT02023697|50258834|FG000|Active Follow-up Period|Lost to Follow-up|1|||
25145072|NCT02023697|50258835|FG001|Active Follow-up Period|Lost to Follow-up|1|||
25145073|NCT02023697|50258836|FG002|Active Follow-up Period|Lost to Follow-up|1|||
25145074|NCT02023697|50258834|FG000|Active Follow-up Period|Deterioration of general condition|1|||
25145075|NCT02023697|50258835|FG001|Active Follow-up Period|Deterioration of general condition|1|||
25145076|NCT02023697|50258836|FG002|Active Follow-up Period|Deterioration of general condition|1|||
25145077|NCT02023697|50258834|FG000|Active Follow-up Period|Other unspecified|2|||
25145078|NCT02023697|50258835|FG001|Active Follow-up Period|Other unspecified|0|||
25145079|NCT02023697|50258836|FG002|Active Follow-up Period|Other unspecified|1|||
25181004|NCT01493557|50326861|FG000|Randomized to Management Strategies|Other adverse event|8|||
25181005|NCT01493557|50326862|FG001|Randomized to Management Strategies|Other adverse event|5|||
25181006|NCT01493557|50326863|FG002|Randomized to Management Strategies|Other adverse event|0|||
25181007|NCT01493557|50326861|FG000|Randomized to Management Strategies|Protocol Violation|3|||
25181008|NCT01493557|50326862|FG001|Randomized to Management Strategies|Protocol Violation|0|||
25181009|NCT01493557|50326863|FG002|Randomized to Management Strategies|Protocol Violation|0|||
25181010|NCT01493557|50326861|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
25181011|NCT01493557|50326862|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
25181012|NCT01493557|50326863|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
25181013|NCT01493557|50326861|FG000|Randomized to Management Strategies|Other than stated above|1|||
25181014|NCT01493557|50326862|FG001|Randomized to Management Strategies|Other than stated above|3|||
25181015|NCT01493557|50326863|FG002|Randomized to Management Strategies|Other than stated above|0|||
25181016|NCT01493557|50326861|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
25181017|NCT01493557|50326862|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
25145080|NCT02023697|50258834|FG000|Active Follow-up Period|Clinical progression|0|||
25145081|NCT02023697|50258835|FG001|Active Follow-up Period|Clinical progression|2|||
25145082|NCT02023697|50258836|FG002|Active Follow-up Period|Clinical progression|1|||
25145083|NCT02023697|50258834|FG000|Active Follow-up Period|Radiological progression|0|||
25145084|NCT02023697|50258835|FG001|Active Follow-up Period|Radiological progression|0|||
25145085|NCT02023697|50258836|FG002|Active Follow-up Period|Radiological progression|1|||
25181018|NCT01493557|50326863|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
25145086|NCT02023697|50258834|FG000|Active Follow-up Period|Death|83|||
25145087|NCT02023697|50258835|FG001|Active Follow-up Period|Death|82|||
25145088|NCT02023697|50258836|FG002|Active Follow-up Period|Death|87|||
25145089|NCT02023697|50258834|FG000|Long-term Follow-up Period|Death|9|||
25145090|NCT02023697|50258835|FG001|Long-term Follow-up Period|Death|6|||
25145091|NCT02023697|50258836|FG002|Long-term Follow-up Period|Death|4|||
25145092|NCT02023697|50258834|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
25145093|NCT02023697|50258835|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
25181019|NCT01493557|50326861|FG000|Adding the Second Strategy|Other adverse event|1|||
25181020|NCT01493557|50326862|FG001|Adding the Second Strategy|Other adverse event|2|||
25181021|NCT01493557|50326863|FG002|Adding the Second Strategy|Other adverse event|0|||
25181022|NCT01493557|50326861|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
25181023|NCT01493557|50326862|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
25181024|NCT01493557|50326863|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
25181025|NCT01451749|50326872|FG000|Overall Study|Protocol Violation|14|||
25181026|NCT01451749|50326873|FG001|Overall Study|Protocol Violation|7|||
25181027|NCT01451749|50326872|FG000|Overall Study|Lost to Follow-up|15|||
25181028|NCT01451749|50326873|FG001|Overall Study|Lost to Follow-up|5|||
25181029|NCT01451749|50326872|FG000|Overall Study|Meet the exclusion criteria,and|1|||
25181030|NCT01451749|50326873|FG001|Overall Study|Meet the exclusion criteria,and|1|||
25181031|NCT01451749|50326872|FG000|Overall Study|Adverse Event|2|||
25181032|NCT01451749|50326873|FG001|Overall Study|Adverse Event|0|||
25181033|NCT01451749|50326872|FG000|Overall Study|Withdrawal by Subject|0|||
25181034|NCT01451749|50326873|FG001|Overall Study|Withdrawal by Subject|1|||
25181035|NCT01576484|50326883|FG000|Overall Study|Adverse Event|1|||
25181036|NCT01576484|50326884|FG001|Overall Study|Adverse Event|1|||
25181037|NCT01576484|50326883|FG000|Overall Study|Protocol Violation|0|||
25181038|NCT01576484|50326884|FG001|Overall Study|Protocol Violation|2|||
25181039|NCT01576484|50326883|FG000|Overall Study|Sponsor Decision|2|||
25181040|NCT01576484|50326884|FG001|Overall Study|Sponsor Decision|8|||
25181041|NCT01576484|50326883|FG000|Overall Study|Withdrawal by Subject|0|||
25181042|NCT01576484|50326884|FG001|Overall Study|Withdrawal by Subject|3|||
25181043|NCT01576484|50326883|FG000|Overall Study|Other|2|||
25181044|NCT01576484|50326884|FG001|Overall Study|Other|5|||
25181045|NCT01467505|50326894|FG000|Overall Study|Adverse Event|1|||
25181046|NCT01467505|50326895|FG001|Overall Study|Adverse Event|0|||
25181047|NCT01467505|50326894|FG000|Overall Study|Withdrawal by Subject|4|||
25181048|NCT01467505|50326895|FG001|Overall Study|Withdrawal by Subject|0|||
25181049|NCT01467505|50326894|FG000|Overall Study|Study Terminated by Sponsor|28|||
25181050|NCT01467505|50326895|FG001|Overall Study|Study Terminated by Sponsor|3|||
25181051|NCT01467271|50326901|FG000|Overall Study|Death|84|||
25181052|NCT01467271|50326901|FG000|Overall Study|Lost to Follow-up|83|||
25181053|NCT01467271|50326901|FG000|Overall Study|Retraction of patient's consent|21|||
25181054|NCT01467271|50326901|FG000|Overall Study|Other reason|14|||
25181055|NCT01449929|50326907|FG000|Randomization Phase 96 Week|Adverse Event|5|||
25181056|NCT01449929|50326908|FG001|Randomization Phase 96 Week|Adverse Event|13|||
25181057|NCT01449929|50326909|FG002|Randomization Phase 96 Week|Adverse Event|0|||
25181058|NCT01449929|50326907|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
25145094|NCT02023697|50258836|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
25145095|NCT02023697|50258834|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
25145096|NCT02023697|50258835|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
25145097|NCT02023697|50258836|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
25145098|NCT02023697|50258834|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
25274537|NCT01201356|50588556|FG000|Overall Study|Condition no longer requires study drug|12|||
25145099|NCT02023697|50258835|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
25145100|NCT02023697|50258836|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
25145101|NCT02023697|50258834|FG000|Long-term Follow-up Period|Technical problems|0|||
25145102|NCT02023697|50258835|FG001|Long-term Follow-up Period|Technical problems|0|||
25145103|NCT02023697|50258836|FG002|Long-term Follow-up Period|Technical problems|1|||
25145104|NCT02023697|50258834|FG000|Long-term Follow-up Period|Other unspecified|6|||
25145105|NCT02023697|50258835|FG001|Long-term Follow-up Period|Other unspecified|3|||
25145106|NCT02023697|50258836|FG002|Long-term Follow-up Period|Other unspecified|5|||
25145107|NCT01951417|50258851|FG000|Overall Study|Withdrawal by Subject|1|||
25145108|NCT01951417|50258851|FG000|Overall Study|Protocol Violation|2|||
25145109|NCT01951417|50258851|FG000|Overall Study|Lost to Follow-up|6|||
25145110|NCT01951261|50258861|FG000|Overall Study|Death|1|||
25015880|NCT04073407|50110675|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
25145111|NCT01951261|50258862|FG001|Overall Study|Death|0|||
25181059|NCT01449929|50326908|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
25181060|NCT01449929|50326909|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
25181061|NCT01449929|50326907|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
25181062|NCT01449929|50326908|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
25181063|NCT01449929|50326909|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
25181064|NCT01449929|50326907|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
25181065|NCT01449929|50326908|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
25181066|NCT01449929|50326909|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
25181067|NCT01449929|50326907|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
25181068|NCT01449929|50326908|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
25181069|NCT01449929|50326909|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
25181070|NCT01449929|50326907|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
25181071|NCT01449929|50326908|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
25181072|NCT01449929|50326909|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
25181073|NCT01449929|50326907|FG000|Randomization Phase 96 Week|Physician Decision|2|||
25181074|NCT01449929|50326908|FG001|Randomization Phase 96 Week|Physician Decision|3|||
25181075|NCT01449929|50326909|FG002|Randomization Phase 96 Week|Physician Decision|0|||
25181076|NCT01449929|50326907|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
25181077|NCT01449929|50326908|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
25181078|NCT01449929|50326909|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
25181079|NCT01449929|50326907|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
25181080|NCT01449929|50326908|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
25181081|NCT01449929|50326909|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
25181082|NCT01449929|50326907|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
25181083|NCT01449929|50326908|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
25181084|NCT01449929|50326909|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
25181085|NCT01449929|50326907|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
25181086|NCT01449929|50326908|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
25181087|NCT01449929|50326909|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
25181088|NCT01449539|50326919|FG000|Overall Study|Withdrawal by Subject|3|||
25181089|NCT01449539|50326919|FG000|Overall Study|Toxicity not study related|1|||
25181090|NCT01451515|50326926|FG000|Overall Study|Death|0|||
25181091|NCT01451515|50326927|FG001|Overall Study|Death|1|||
25181092|NCT01451515|50326928|FG002|Overall Study|Death|0|||
25181093|NCT01451515|50326926|FG000|Overall Study|Withdrawal by Subject|0|||
25181094|NCT01451515|50326927|FG001|Overall Study|Withdrawal by Subject|1|||
25181095|NCT01451515|50326928|FG002|Overall Study|Withdrawal by Subject|0|||
25181096|NCT01451515|50326926|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
25181097|NCT01451515|50326927|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
25145112|NCT01951261|50258861|FG000|Overall Study|Lost to Follow-up|4|||
25145113|NCT01951261|50258862|FG001|Overall Study|Lost to Follow-up|3|||
25145114|NCT01951261|50258861|FG000|Overall Study|Protocol Violation|4|||
25145115|NCT01951261|50258862|FG001|Overall Study|Protocol Violation|3|||
25145116|NCT02023151|50258868|FG000|Overall Study|Lost to Follow-up|4|||
25145117|NCT01979185|50258874|FG000|Period 2|Other|0|||
25145118|NCT01979185|50258875|FG001|Period 2|Other|1|||
25145119|NCT01946425|50258883|FG000|Overall Study|Protocol Violation|1|||
25145120|NCT01946425|50258884|FG001|Overall Study|Protocol Violation|0|||
25145121|NCT01946425|50258883|FG000|Overall Study|Withdrawal by Subject|1|||
25145122|NCT01946425|50258884|FG001|Overall Study|Withdrawal by Subject|0|||
25145123|NCT01946191|50258893|FG000|Allocation|Did not complete orientation|1|||
25145124|NCT01946191|50258894|FG001|Allocation|Did not complete orientation|1|||
25145125|NCT01946191|50258893|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
25145126|NCT01946191|50258894|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
25145127|NCT01946191|50258893|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
25145128|NCT01946191|50258894|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
25181098|NCT01451515|50326928|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
25181099|NCT01451515|50326926|FG000|Overall Study|Relapse (except CNS)|1|||
25181100|NCT01451515|50326927|FG001|Overall Study|Relapse (except CNS)|1|||
25181101|NCT01451515|50326928|FG002|Overall Study|Relapse (except CNS)|0|||
25181102|NCT01466881|50326939|FG000|Overall Study|Ineligible|5|||
25181103|NCT01466881|50326939|FG000|Overall Study|Adverse Event|6|||
25181104|NCT01466881|50326939|FG000|Overall Study|Progression/relapse|20|||
25181105|NCT01466881|50326939|FG000|Overall Study|Death|4|||
25181106|NCT01466881|50326939|FG000|Overall Study|Other reason not protocol specified|5|||
25015881|NCT04073407|50110676|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
25015882|NCT04073407|50110675|FG000|Part 2|Withdrawal by Subject|0|||
25015883|NCT04073407|50110676|FG001|Part 2|Withdrawal by Subject|1|||
25145129|NCT01946191|50258893|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
25145130|NCT01946191|50258894|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
25145131|NCT01959698|50258908|FG000|Overall Study|Adverse Event|0|||
25145132|NCT01959698|50258909|FG001|Overall Study|Adverse Event|0|||
25145133|NCT01959698|50258910|FG002|Overall Study|Adverse Event|0|||
25145134|NCT01959698|50258911|FG003|Overall Study|Adverse Event|0|||
25145135|NCT01959698|50258912|FG004|Overall Study|Adverse Event|0|||
25145136|NCT01959698|50258913|FG005|Overall Study|Adverse Event|0|||
25181107|NCT01576406|50326951|FG000|Overall Study|Lost to Follow-up|1|||
25181108|NCT01576406|50326952|FG001|Overall Study|Lost to Follow-up|2|||
25145137|NCT01959698|50258914|FG006|Overall Study|Adverse Event|1|||
25145138|NCT01959698|50258908|FG000|Overall Study|Physician Decision|1|||
25145139|NCT01959698|50258909|FG001|Overall Study|Physician Decision|0|||
25145140|NCT01959698|50258910|FG002|Overall Study|Physician Decision|1|||
25145141|NCT01959698|50258911|FG003|Overall Study|Physician Decision|2|||
25145142|NCT01959698|50258912|FG004|Overall Study|Physician Decision|0|||
25145143|NCT01959698|50258913|FG005|Overall Study|Physician Decision|3|||
25145144|NCT01959698|50258914|FG006|Overall Study|Physician Decision|3|||
25015884|NCT02778204|50110686|FG000|Overall Study|Adverse Event|1|||
25145145|NCT01910402|50258933|FG000|Randomized Phase|Adverse Event|10|||
25145146|NCT01910402|50258934|FG001|Randomized Phase|Adverse Event|18|||
25145147|NCT01910402|50258933|FG000|Randomized Phase|Physician Decision|1|||
25145148|NCT01910402|50258934|FG001|Randomized Phase|Physician Decision|0|||
25145149|NCT01910402|50258933|FG000|Randomized Phase|Lack of Efficacy|5|||
25181109|NCT01576406|50326953|FG002|Overall Study|Lost to Follow-up|0|||
25181110|NCT01576406|50326954|FG003|Overall Study|Lost to Follow-up|0|||
25181111|NCT01576406|50326955|FG004|Overall Study|Lost to Follow-up|0|||
25181112|NCT01576406|50326956|FG005|Overall Study|Lost to Follow-up|0|||
25181113|NCT01576406|50326951|FG000|Overall Study|Death|3|||
25015885|NCT02778204|50110687|FG001|Overall Study|Adverse Event|0|||
25015886|NCT02778204|50110688|FG002|Overall Study|Adverse Event|0|||
25015887|NCT02778204|50110689|FG003|Overall Study|Adverse Event|0|||
25145150|NCT01910402|50258934|FG001|Randomized Phase|Lack of Efficacy|4|||
25145151|NCT01910402|50258933|FG000|Randomized Phase|Lost to Follow-up|11|||
25145152|NCT01910402|50258934|FG001|Randomized Phase|Lost to Follow-up|13|||
25181114|NCT01576406|50326952|FG001|Overall Study|Death|4|||
25181115|NCT01576406|50326953|FG002|Overall Study|Death|8|||
25181116|NCT01576406|50326954|FG003|Overall Study|Death|5|||
25015888|NCT02778204|50110686|FG000|Overall Study|Withdrawal by Subject|0|||
25181117|NCT01576406|50326955|FG004|Overall Study|Death|7|||
25015889|NCT02778204|50110687|FG001|Overall Study|Withdrawal by Subject|0|||
25015890|NCT02778204|50110688|FG002|Overall Study|Withdrawal by Subject|1|||
25015891|NCT02778204|50110689|FG003|Overall Study|Withdrawal by Subject|2|||
25015892|NCT02778204|50110686|FG000|Overall Study|Lost to Follow-up|1|||
25015893|NCT02778204|50110687|FG001|Overall Study|Lost to Follow-up|0|||
25015894|NCT02778204|50110688|FG002|Overall Study|Lost to Follow-up|2|||
25015895|NCT02778204|50110689|FG003|Overall Study|Lost to Follow-up|1|||
25015896|NCT02778204|50110686|FG000|Overall Study|Protocol Violation|0|||
25015897|NCT02778204|50110687|FG001|Overall Study|Protocol Violation|0|||
25181118|NCT01576406|50326956|FG005|Overall Study|Death|9|||
25181119|NCT01576406|50326951|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
25181120|NCT01576406|50326952|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
25181121|NCT01576406|50326953|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
25181122|NCT01576406|50326954|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
25181123|NCT01576406|50326955|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
25181124|NCT01576406|50326956|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
25181125|NCT01576406|50326951|FG000|Overall Study|Withdrawal the consent|2|||
25181126|NCT01576406|50326952|FG001|Overall Study|Withdrawal the consent|2|||
25181127|NCT01576406|50326953|FG002|Overall Study|Withdrawal the consent|5|||
25181128|NCT01576406|50326954|FG003|Overall Study|Withdrawal the consent|1|||
25181129|NCT01576406|50326955|FG004|Overall Study|Withdrawal the consent|1|||
25181130|NCT01576406|50326956|FG005|Overall Study|Withdrawal the consent|3|||
25181131|NCT01576406|50326951|FG000|Overall Study|Other|0|||
25181132|NCT01576406|50326952|FG001|Overall Study|Other|0|||
25181133|NCT01576406|50326953|FG002|Overall Study|Other|2|||
25181134|NCT01576406|50326954|FG003|Overall Study|Other|2|||
25181135|NCT01576406|50326955|FG004|Overall Study|Other|0|||
25181136|NCT01576406|50326956|FG005|Overall Study|Other|0|||
25181137|NCT01576172|50326972|FG000|Overall Study|Ineligible|2|||
25181138|NCT01576172|50326973|FG001|Overall Study|Ineligible|1|||
25181139|NCT01576172|50326972|FG000|Overall Study|Withdrawal by Subject|2|||
25181140|NCT01576172|50326973|FG001|Overall Study|Withdrawal by Subject|0|||
25181141|NCT01576172|50326972|FG000|Overall Study|Insurance issue|1|||
25181142|NCT01576172|50326973|FG001|Overall Study|Insurance issue|0|||
25181143|NCT01542788|50326983|FG000|Overall Study|Randomized but Not Treated|2|||
25181144|NCT01542788|50326984|FG001|Overall Study|Randomized but Not Treated|0|||
25181145|NCT01542788|50326983|FG000|Overall Study|Lack of Efficacy|41|||
25181146|NCT01542788|50326984|FG001|Overall Study|Lack of Efficacy|71|||
25181147|NCT01542788|50326983|FG000|Overall Study|Lost to Follow-up|5|||
25181148|NCT01542788|50326984|FG001|Overall Study|Lost to Follow-up|0|||
25181149|NCT01542788|50326983|FG000|Overall Study|Death|3|||
25181150|NCT01542788|50326984|FG001|Overall Study|Death|0|||
25181151|NCT01542788|50326983|FG000|Overall Study|Protocol Violation|2|||
25181152|NCT01542788|50326984|FG001|Overall Study|Protocol Violation|0|||
25181153|NCT01542788|50326983|FG000|Overall Study|Physician Decision|1|||
25181154|NCT01542788|50326984|FG001|Overall Study|Physician Decision|0|||
25181155|NCT01542788|50326983|FG000|Overall Study|Withdrawal by Subject|1|||
25181156|NCT01542788|50326984|FG001|Overall Study|Withdrawal by Subject|0|||
25181157|NCT01542632|50326996|FG000|Overall Study|Withdrawal of Consent|0|||
25181158|NCT01542632|50326997|FG001|Overall Study|Withdrawal of Consent|0|||
25181159|NCT01542632|50326998|FG002|Overall Study|Withdrawal of Consent|0|||
25181160|NCT01542632|50326999|FG003|Overall Study|Withdrawal of Consent|2|||
25181161|NCT01542632|50327000|FG004|Overall Study|Withdrawal of Consent|3|||
25181162|NCT01542632|50327001|FG005|Overall Study|Withdrawal of Consent|0|||
25181163|NCT01542632|50326996|FG000|Overall Study|Adverse Event|0|||
25181164|NCT01542632|50326997|FG001|Overall Study|Adverse Event|0|||
25015898|NCT02778204|50110688|FG002|Overall Study|Protocol Violation|1|||
25015899|NCT02778204|50110689|FG003|Overall Study|Protocol Violation|0|||
25015900|NCT02778204|50110686|FG000|Overall Study|Eligibility Violation|0|||
25015901|NCT02778204|50110687|FG001|Overall Study|Eligibility Violation|0|||
25015902|NCT02778204|50110688|FG002|Overall Study|Eligibility Violation|0|||
25181165|NCT01542632|50326998|FG002|Overall Study|Adverse Event|1|||
25181166|NCT01542632|50326999|FG003|Overall Study|Adverse Event|0|||
25181167|NCT01542632|50327000|FG004|Overall Study|Adverse Event|0|||
25181168|NCT01542632|50327001|FG005|Overall Study|Adverse Event|0|||
25181169|NCT01542632|50326996|FG000|Overall Study|Lost to Follow-up|0|||
25181170|NCT01542632|50326997|FG001|Overall Study|Lost to Follow-up|1|||
25181171|NCT01542632|50326998|FG002|Overall Study|Lost to Follow-up|0|||
25181172|NCT01542632|50326999|FG003|Overall Study|Lost to Follow-up|0|||
25181173|NCT01542632|50327000|FG004|Overall Study|Lost to Follow-up|0|||
25181174|NCT01542632|50327001|FG005|Overall Study|Lost to Follow-up|0|||
25181175|NCT01542632|50326996|FG000|Overall Study|Sponsor/Investigator Decision|0|||
25181176|NCT01542632|50326997|FG001|Overall Study|Sponsor/Investigator Decision|0|||
25181177|NCT01542632|50326998|FG002|Overall Study|Sponsor/Investigator Decision|0|||
25181178|NCT01542632|50326999|FG003|Overall Study|Sponsor/Investigator Decision|0|||
25181179|NCT01542632|50327000|FG004|Overall Study|Sponsor/Investigator Decision|1|||
25181180|NCT01542632|50327001|FG005|Overall Study|Sponsor/Investigator Decision|0|||
25181181|NCT01557842|50327022|FG000|Overall Study|Lost to Follow-up|0|||
25015903|NCT02778204|50110689|FG003|Overall Study|Eligibility Violation|1|||
25015904|NCT04072159|50110703|FG000|Overall Study|Lost to Follow-up|6|||
25015905|NCT04072159|50110704|FG001|Overall Study|Lost to Follow-up|6|||
25181182|NCT01557842|50327023|FG001|Overall Study|Lost to Follow-up|1|||
25181183|NCT01557842|50327022|FG000|Overall Study|Death|1|||
25015906|NCT04072159|50110703|FG000|Overall Study|Withdrawal by Subject|2|||
25181184|NCT01557842|50327023|FG001|Overall Study|Death|0|||
25015907|NCT04072159|50110704|FG001|Overall Study|Withdrawal by Subject|0|||
25015908|NCT03232281|50110714|FG000|Overall Study|Adverse Event|1|||
25015909|NCT03232281|50110715|FG001|Overall Study|Adverse Event|1|||
25015910|NCT03232281|50110714|FG000|Overall Study|Withdrawal by Subject|5|||
25015911|NCT03232281|50110715|FG001|Overall Study|Withdrawal by Subject|4|||
25015912|NCT03232281|50110714|FG000|Overall Study|Protocol Deviation|1|||
25015913|NCT03232281|50110715|FG001|Overall Study|Protocol Deviation|1|||
25015914|NCT04071301|50110721|FG000|Overall Study|Withdrawal by Subject|6|||
25015915|NCT04071301|50110721|FG000|Overall Study|Death|1|||
25015916|NCT03261336|50110725|FG000|Overall Study|Adverse Event|1|||
25015917|NCT00462748|50110732|FG000|Overall Study|Adverse Event|7|||
25015918|NCT00462748|50110733|FG001|Overall Study|Adverse Event|5|||
25015919|NCT00462748|50110734|FG002|Overall Study|Adverse Event|9|||
25015920|NCT00462748|50110732|FG000|Overall Study|Protocol Violation|0|||
25181185|NCT01557842|50327022|FG000|Overall Study|Lack of Efficacy|0|||
25181186|NCT01557842|50327023|FG001|Overall Study|Lack of Efficacy|1|||
25181187|NCT01557842|50327022|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
25181188|NCT01557842|50327023|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
25015921|NCT00462748|50110733|FG001|Overall Study|Protocol Violation|2|||
25015922|NCT00462748|50110734|FG002|Overall Study|Protocol Violation|1|||
25015923|NCT00462748|50110732|FG000|Overall Study|Withdrew consent|3|||
25015924|NCT00462748|50110733|FG001|Overall Study|Withdrew consent|3|||
25015925|NCT00462748|50110734|FG002|Overall Study|Withdrew consent|0|||
25015926|NCT00462748|50110732|FG000|Overall Study|Lost to Follow-up|1|||
25015927|NCT00462748|50110733|FG001|Overall Study|Lost to Follow-up|1|||
25015928|NCT00462748|50110734|FG002|Overall Study|Lost to Follow-up|1|||
25015929|NCT00462748|50110732|FG000|Overall Study|Discontinued after 41 days Rx|1|||
25015930|NCT00462748|50110733|FG001|Overall Study|Discontinued after 41 days Rx|0|||
25015931|NCT00462748|50110734|FG002|Overall Study|Discontinued after 41 days Rx|0|||
25015932|NCT04206085|50110745|FG000|Overall Study|Lost to Follow-up|0|||
25015933|NCT04206085|50110746|FG001|Overall Study|Lost to Follow-up|1|||
25015934|NCT04206085|50110747|FG002|Overall Study|Lost to Follow-up|0|||
25015935|NCT04206085|50110745|FG000|Overall Study|Lost to Follow-up|0|||
25015936|NCT04206085|50110746|FG001|Overall Study|Lost to Follow-up|0|||
25015937|NCT04206085|50110747|FG002|Overall Study|Lost to Follow-up|1|||
25015938|NCT04202497|50110755|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
25015939|NCT04202497|50110756|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
25015940|NCT04202497|50110757|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
25015941|NCT04202497|50110758|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
25181189|NCT01557842|50327022|FG000|Overall Study|Study Terminated by Sponsor|3|||
25181190|NCT01557842|50327023|FG001|Overall Study|Study Terminated by Sponsor|4|||
25181191|NCT01557842|50327022|FG000|Overall Study|Not Ablated|2|||
25181192|NCT01557842|50327023|FG001|Overall Study|Not Ablated|0|||
25181193|NCT01541930|50327029|FG000|Overall Study|Withdrawal by Subject|1|||
25274538|NCT01201356|50588556|FG000|Overall Study|Withdrawal by Subject|144|||
25015942|NCT03297294|50110774|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
25015943|NCT03297294|50110775|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
25181194|NCT01576016|50327046|FG000|Lead Safety|Death|132|||
25015944|NCT03297294|50110776|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
25181195|NCT01576016|50327047|FG001|Lead Safety|Death|0|||
25274539|NCT01201356|50588556|FG000|Overall Study|Lost to Follow-up|50|||
25181196|NCT01576016|50327046|FG000|Lead Safety|Withdrawal by Subject|81|||
25181197|NCT01576016|50327047|FG001|Lead Safety|Withdrawal by Subject|0|||
25181198|NCT01576016|50327046|FG000|Lead Safety|System Explanted without Replacement|24|||
25181199|NCT01576016|50327047|FG001|Lead Safety|System Explanted without Replacement|0|||
25181200|NCT01576016|50327046|FG000|Lead Safety|Physician Decision|14|||
25181201|NCT01576016|50327047|FG001|Lead Safety|Physician Decision|0|||
25181202|NCT01576016|50327046|FG000|Lead Safety|Lost to Follow-up|13|||
25181203|NCT01576016|50327047|FG001|Lead Safety|Lost to Follow-up|0|||
25181204|NCT01576016|50327046|FG000|Lead Safety|Unsuccessful implant|2|||
25181205|NCT01576016|50327047|FG001|Lead Safety|Unsuccessful implant|0|||
25015945|NCT03297294|50110777|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
25015946|NCT03297294|50110778|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
25015947|NCT03297294|50110774|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
25015948|NCT03297294|50110775|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
25015949|NCT03297294|50110776|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
25145153|NCT01910402|50258933|FG000|Randomized Phase|Protocol Violation|10|||
25145154|NCT01910402|50258934|FG001|Randomized Phase|Protocol Violation|13|||
25145155|NCT01910402|50258933|FG000|Randomized Phase|Withdrawal by Subject|5|||
25145156|NCT01910402|50258934|FG001|Randomized Phase|Withdrawal by Subject|7|||
25145157|NCT01910402|50258933|FG000|Continuation Phase|Ongoing|84|||
25145158|NCT01910402|50258934|FG001|Continuation Phase|Ongoing|0|||
25145159|NCT01910402|50258933|FG000|Continuation Phase|Adverse Event|1|||
25145160|NCT01910402|50258934|FG001|Continuation Phase|Adverse Event|0|||
25145161|NCT01910402|50258933|FG000|Continuation Phase|Protocol Violation|3|||
25145162|NCT01910402|50258934|FG001|Continuation Phase|Protocol Violation|0|||
25145163|NCT01910402|50258933|FG000|Continuation Phase|Withdrawal by Subject|2|||
25145164|NCT01910402|50258934|FG001|Continuation Phase|Withdrawal by Subject|0|||
25145165|NCT01937312|50258944|FG000|Overall Study|Adverse Event|10|||
25145166|NCT01937312|50258945|FG001|Overall Study|Adverse Event|1|||
25145167|NCT01937312|50258944|FG000|Overall Study|Lack of Efficacy|0|||
25145168|NCT01937312|50258945|FG001|Overall Study|Lack of Efficacy|1|||
25145169|NCT01937312|50258944|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
25145170|NCT01937312|50258945|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
25145171|NCT01909934|50258952|FG000|Overall Study|Ongoing|23|||
25145172|NCT01909934|50258952|FG000|Overall Study|Withdrawal by Subject|3|||
25145173|NCT01909934|50258952|FG000|Overall Study|Lost to Follow-up|1|||
25145174|NCT01909934|50258952|FG000|Overall Study|Withdrawal of Informed Consent|1|||
25145175|NCT01909934|50258952|FG000|Overall Study|Death|22|||
25145176|NCT01935128|50258956|FG000|Overall Study|Death|1|||
25145177|NCT01935128|50258956|FG000|Overall Study|Adverse Event|6|||
25274540|NCT01201356|50588556|FG000|Overall Study|administrative problems|74|||
25145178|NCT01934972|50258962|FG000|Overall Study|Withdrawal by Subject|9|||
25015950|NCT03297294|50110777|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
25015951|NCT03297294|50110778|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
25015952|NCT03297294|50110774|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
25015953|NCT03297294|50110775|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
25181206|NCT01576016|50327046|FG000|Lead Safety|Sponsor request|1|||
25274541|NCT01201356|50588556|FG000|Overall Study|Death|16|||
25181207|NCT01576016|50327047|FG001|Lead Safety|Sponsor request|0|||
25181208|NCT01576016|50327046|FG000|Lead Safety|Device replaced with CRT-D|1|||
25181209|NCT01576016|50327047|FG001|Lead Safety|Device replaced with CRT-D|0|||
25181210|NCT01576016|50327046|FG000|Lead Safety|Patient on Palliative Care|1|||
25181211|NCT01576016|50327047|FG001|Lead Safety|Patient on Palliative Care|0|||
25181212|NCT01576016|50327046|FG000|Lead Safety|Patient noncompliance|1|||
25181213|NCT01576016|50327047|FG001|Lead Safety|Patient noncompliance|0|||
25181214|NCT01576016|50327046|FG000|Lead Safety|Too far from study site|1|||
25181215|NCT01576016|50327047|FG001|Lead Safety|Too far from study site|0|||
25181216|NCT01576016|50327046|FG000|Lead Safety|System deactivated|1|||
25181217|NCT01576016|50327047|FG001|Lead Safety|System deactivated|0|||
25181218|NCT01576016|50327046|FG000|Lead Safety|Patient no longer followed by study PI|1|||
25181219|NCT01576016|50327047|FG001|Lead Safety|Patient no longer followed by study PI|0|||
25181220|NCT01576016|50327046|FG000|MRI Safety|Withdrawal by Subject|0|||
25181221|NCT01576016|50327047|FG001|MRI Safety|Withdrawal by Subject|10|||
25274542|NCT01201356|50588556|FG000|Overall Study|Protocol Violation|12|||
25181222|NCT01576016|50327046|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
25181223|NCT01576016|50327047|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
25015954|NCT03297294|50110776|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
25015955|NCT03297294|50110777|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
25015956|NCT03297294|50110778|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
25145179|NCT01934972|50258963|FG001|Overall Study|Withdrawal by Subject|6|||
25015957|NCT03297294|50110774|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
25015958|NCT03297294|50110775|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
25015959|NCT03297294|50110776|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
25015960|NCT03297294|50110777|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
25015961|NCT03297294|50110778|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
25015962|NCT03297294|50110774|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
25015963|NCT03297294|50110775|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
25015964|NCT03297294|50110776|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
25015965|NCT03297294|50110777|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
25015966|NCT03297294|50110778|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
25015967|NCT03238911|50110792|FG000|Overall Study|Withdrawal by Subject|1|||
25015968|NCT03238911|50110793|FG001|Overall Study|Withdrawal by Subject|2|||
25015969|NCT03238911|50110792|FG000|Overall Study|Lost to Follow-up|2|||
25015970|NCT03238911|50110793|FG001|Overall Study|Lost to Follow-up|1|||
25015971|NCT00418834|50110802|FG000|Overall Study|Adverse Event|16|||
25015972|NCT00418834|50110803|FG001|Overall Study|Adverse Event|9|||
25015973|NCT00418834|50110802|FG000|Overall Study|Lost to Follow-up|0|||
25015974|NCT00418834|50110803|FG001|Overall Study|Lost to Follow-up|1|||
25015975|NCT00418834|50110802|FG000|Overall Study|Protocol Violation|4|||
25015976|NCT00418834|50110803|FG001|Overall Study|Protocol Violation|3|||
25015977|NCT00418834|50110802|FG000|Overall Study|Withdrawal by Subject|3|||
25015978|NCT00418834|50110803|FG001|Overall Study|Withdrawal by Subject|7|||
25015979|NCT03276975|50110811|FG000|Overall Study|Withdrawal by Subject|1|||
25015980|NCT03276975|50110812|FG001|Overall Study|Withdrawal by Subject|0|||
25145180|NCT01959230|50258971|FG000|Overall Study|Failure to follow study procedures|0|||
25145181|NCT01959230|50258972|FG001|Overall Study|Failure to follow study procedures|1|||
25145182|NCT01959230|50258971|FG000|Overall Study|Administrative reasons|2|||
25145183|NCT01959230|50258972|FG001|Overall Study|Administrative reasons|0|||
25145184|NCT01959230|50258971|FG000|Overall Study|Withdrawal by Subject|2|||
25145185|NCT01959230|50258972|FG001|Overall Study|Withdrawal by Subject|0|||
25145186|NCT01909778|50258978|FG000|Overall Study|failed screening|1|||
25145187|NCT01977937|50258986|FG000|Overall Study|Withdrawal by Subject|2|||
25145188|NCT01977937|50258987|FG001|Overall Study|Withdrawal by Subject|1|||
25145189|NCT01977937|50258986|FG000|Overall Study|Adverse Event|1|||
25145190|NCT01977937|50258987|FG001|Overall Study|Adverse Event|0|||
25145191|NCT01977937|50258986|FG000|Overall Study|Physician Decision|0|||
25145192|NCT01977937|50258987|FG001|Overall Study|Physician Decision|1|||
25145193|NCT02015663|50258995|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
25145194|NCT02015663|50258996|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
25145195|NCT02015663|50258995|FG000|Overall Study|Withdrawal by Subject|1|||
25145196|NCT02015663|50258996|FG001|Overall Study|Withdrawal by Subject|0|||
25145197|NCT02015663|50258995|FG000|Overall Study|Protocol Violation|0|||
25145198|NCT02015663|50258996|FG001|Overall Study|Protocol Violation|1|||
25145199|NCT02015663|50258995|FG000|Overall Study|Adverse Event|3|||
25145200|NCT02015663|50258996|FG001|Overall Study|Adverse Event|0|||
25145201|NCT02015663|50258995|FG000|Overall Study|Administrative problems|10|||
25145202|NCT02015663|50258996|FG001|Overall Study|Administrative problems|11|||
25145203|NCT01978093|50259005|FG000|Overall Study|Death|1|||
25145204|NCT01978093|50259006|FG001|Overall Study|Death|0|||
25145205|NCT01978093|50259005|FG000|Overall Study|Adverse Event|0|||
25145206|NCT01978093|50259006|FG001|Overall Study|Adverse Event|5|||
25145207|NCT01978093|50259005|FG000|Overall Study|Protocol Violation|8|||
25274543|NCT01200810|50588562|FG000|Overall Study|Physician Decision|1|||
25015981|NCT03297216|50110820|FG000|Overall Study|Death|0|||
25145208|NCT01978093|50259006|FG001|Overall Study|Protocol Violation|2|||
25145209|NCT01978093|50259005|FG000|Overall Study|Withdrawal by Subject|29|||
25145210|NCT01978093|50259006|FG001|Overall Study|Withdrawal by Subject|25|||
25145211|NCT01978093|50259005|FG000|Overall Study|Lost to Follow-up|11|||
25145212|NCT01978093|50259006|FG001|Overall Study|Lost to Follow-up|15|||
25145213|NCT01978093|50259005|FG000|Overall Study|Migrated/moved from study area|11|||
25145214|NCT01978093|50259006|FG001|Overall Study|Migrated/moved from study area|13|||
25145215|NCT01978093|50259005|FG000|Overall Study|Loss of kaiser coverage|4|||
25145216|NCT01978093|50259006|FG001|Overall Study|Loss of kaiser coverage|10|||
25181224|NCT01576016|50327046|FG000|MRI Safety|Has not yet completed MRI scan|0|||
25181225|NCT01576016|50327047|FG001|MRI Safety|Has not yet completed MRI scan|56|||
25181226|NCT01576016|50327046|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
25181227|NCT01576016|50327047|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
25181228|NCT01540838|50327057|FG000|Overall Study|Open nasogastric tube|9|||
25181229|NCT01540838|50327058|FG001|Overall Study|Open nasogastric tube|7|||
25181230|NCT01540838|50327057|FG000|Overall Study|Treatment doses missing|8|||
25181231|NCT01540838|50327058|FG001|Overall Study|Treatment doses missing|12|||
25181232|NCT01540838|50327057|FG000|Overall Study|Additional antibiotic treatment|1|||
25181233|NCT01540838|50327058|FG001|Overall Study|Additional antibiotic treatment|2|||
25181234|NCT01540838|50327057|FG000|Overall Study|Died before treatment initiation|1|||
25181235|NCT01540838|50327058|FG001|Overall Study|Died before treatment initiation|1|||
25181236|NCT01540838|50327057|FG000|Overall Study|Not BM. Other treatment|3|||
25181237|NCT01540838|50327058|FG001|Overall Study|Not BM. Other treatment|1|||
25181238|NCT01451437|50327073|FG000|Overall Study|Adverse Event|0|||
25181239|NCT01451437|50327074|FG001|Overall Study|Adverse Event|0|||
25181240|NCT01451437|50327075|FG002|Overall Study|Adverse Event|0|||
25181241|NCT01451437|50327076|FG003|Overall Study|Adverse Event|0|||
25015982|NCT03297216|50110821|FG001|Overall Study|Death|1|||
25015983|NCT03297216|50110820|FG000|Overall Study|Miscarriage|0|||
25015984|NCT03297216|50110821|FG001|Overall Study|Miscarriage|2|||
25015985|NCT03297216|50110820|FG000|Overall Study|Lost to Follow-up|3|||
25145217|NCT01978093|50259005|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
25145218|NCT01978093|50259006|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
25145219|NCT01978093|50259005|FG000|Overall Study|Mother lost custody of child|0|||
25145220|NCT01978093|50259006|FG001|Overall Study|Mother lost custody of child|1|||
25145221|NCT01978093|50259005|FG000|Overall Study|Child was in care of grandmother|0|||
25145222|NCT01978093|50259006|FG001|Overall Study|Child was in care of grandmother|1|||
25145223|NCT01978093|50259005|FG000|Overall Study|N/A for vaccine administration|0|||
25145224|NCT01978093|50259006|FG001|Overall Study|N/A for vaccine administration|1|||
25181242|NCT01451437|50327077|FG004|Overall Study|Adverse Event|0|||
25181243|NCT01451437|50327078|FG005|Overall Study|Adverse Event|1|||
25015986|NCT03297216|50110821|FG001|Overall Study|Lost to Follow-up|2|||
25145225|NCT01951105|50259018|FG000|Overall Study|Adverse Event|0|||
25145226|NCT01951105|50259019|FG001|Overall Study|Adverse Event|5|||
25145227|NCT01951105|50259020|FG002|Overall Study|Adverse Event|0|||
25145228|NCT01951105|50259018|FG000|Overall Study|Lost to Follow-up|0|||
25145229|NCT01951105|50259019|FG001|Overall Study|Lost to Follow-up|1|||
25145230|NCT01951105|50259020|FG002|Overall Study|Lost to Follow-up|0|||
25145231|NCT01951105|50259018|FG000|Overall Study|Protocol Violation|1|||
25145232|NCT01951105|50259019|FG001|Overall Study|Protocol Violation|1|||
25145233|NCT01951105|50259020|FG002|Overall Study|Protocol Violation|1|||
25145234|NCT01951105|50259018|FG000|Overall Study|Withdrawal by Subject|0|||
25015987|NCT03260868|50110836|FG000|Overall Study|Poor Compliance to Protocol|0|||
25015988|NCT03260868|50110837|FG001|Overall Study|Poor Compliance to Protocol|2|||
25015989|NCT03260868|50110836|FG000|Overall Study|Study Terminated By Sponsor|2|||
25015990|NCT03260868|50110837|FG001|Overall Study|Study Terminated By Sponsor|1|||
25015991|NCT03260868|50110836|FG000|Overall Study|Other than specified above|1|||
25015992|NCT03260868|50110837|FG001|Overall Study|Other than specified above|0|||
25015993|NCT03293394|50110845|FG000|Follow-up (6 Months)|Adverse Event|4|||
25015994|NCT03293394|50110846|FG001|Follow-up (6 Months)|Adverse Event|2|||
25015995|NCT03259308|50110855|FG000|Overall Study|Adverse Event|5|||
25015996|NCT03259308|50110856|FG001|Overall Study|Adverse Event|4|||
25145235|NCT01951105|50259019|FG001|Overall Study|Withdrawal by Subject|3|||
25145236|NCT01951105|50259020|FG002|Overall Study|Withdrawal by Subject|1|||
25145237|NCT01958918|50259036|FG000|Overall Study|Death|1|||
25015997|NCT03259308|50110857|FG002|Overall Study|Adverse Event|1|||
25015998|NCT03259308|50110855|FG000|Overall Study|Withdrawal by Subject|2|||
25015999|NCT03259308|50110856|FG001|Overall Study|Withdrawal by Subject|1|||
25016000|NCT03259308|50110857|FG002|Overall Study|Withdrawal by Subject|3|||
25016001|NCT03259308|50110855|FG000|Overall Study|Lost to Follow-up|0|||
25016002|NCT03259308|50110856|FG001|Overall Study|Lost to Follow-up|0|||
25016003|NCT03259308|50110857|FG002|Overall Study|Lost to Follow-up|1|||
25016004|NCT03259308|50110855|FG000|Overall Study|Pregnancy|0|||
25016005|NCT03259308|50110856|FG001|Overall Study|Pregnancy|0|||
25016006|NCT03259308|50110857|FG002|Overall Study|Pregnancy|1|||
25016007|NCT03259308|50110855|FG000|Overall Study|Protocol Deviation|0|||
25016008|NCT03259308|50110856|FG001|Overall Study|Protocol Deviation|3|||
25181244|NCT01451437|50327079|FG006|Overall Study|Adverse Event|1|||
25181245|NCT01451437|50327080|FG007|Overall Study|Adverse Event|2|||
25181246|NCT01451437|50327081|FG008|Overall Study|Adverse Event|1|||
25181247|NCT01451437|50327073|FG000|Overall Study|Physician Decision|1|||
25181248|NCT01451437|50327074|FG001|Overall Study|Physician Decision|1|||
25181249|NCT01451437|50327075|FG002|Overall Study|Physician Decision|2|||
25181250|NCT01451437|50327076|FG003|Overall Study|Physician Decision|0|||
25016009|NCT03259308|50110857|FG002|Overall Study|Protocol Deviation|0|||
25145238|NCT01958918|50259037|FG001|Overall Study|Death|3|||
25145239|NCT01958918|50259036|FG000|Overall Study|Lost to Follow-up|4|||
25145240|NCT01958918|50259037|FG001|Overall Study|Lost to Follow-up|7|||
25145241|NCT01958918|50259036|FG000|Overall Study|Withdrawal by Subject|13|||
25145242|NCT01958918|50259037|FG001|Overall Study|Withdrawal by Subject|8|||
25145243|NCT01958918|50259036|FG000|Overall Study|Lack of Efficacy|13|||
25145244|NCT01958918|50259037|FG001|Overall Study|Lack of Efficacy|10|||
25145245|NCT01958918|50259036|FG000|Overall Study|Adverse Event|12|||
25145246|NCT01958918|50259037|FG001|Overall Study|Adverse Event|12|||
25145247|NCT01958918|50259036|FG000|Overall Study|administrative problems|0|||
25145248|NCT01958918|50259037|FG001|Overall Study|administrative problems|2|||
25145249|NCT01945489|50259045|FG000|Cycle 1|Adverse Event|2|||
25145250|NCT01945489|50259046|FG001|Cycle 1|Adverse Event|0|||
25145251|NCT01945489|50259045|FG000|Cycle 1|Lost to Follow-up|4|||
25145252|NCT01945489|50259046|FG001|Cycle 1|Lost to Follow-up|0|||
25145253|NCT01945489|50259045|FG000|Cycle 1|Personal Reasons|4|||
25145254|NCT01945489|50259046|FG001|Cycle 1|Personal Reasons|2|||
25145255|NCT01945489|50259045|FG000|Cycle 1|Protocol Violation|0|||
25181251|NCT01451437|50327077|FG004|Overall Study|Physician Decision|0|||
25181252|NCT01451437|50327078|FG005|Overall Study|Physician Decision|0|||
25181253|NCT01451437|50327079|FG006|Overall Study|Physician Decision|0|||
25181254|NCT01451437|50327080|FG007|Overall Study|Physician Decision|0|||
25181255|NCT01451437|50327081|FG008|Overall Study|Physician Decision|0|||
25181256|NCT01451437|50327073|FG000|Overall Study|Disease Progression|0|||
25181257|NCT01451437|50327074|FG001|Overall Study|Disease Progression|0|||
25181258|NCT01451437|50327075|FG002|Overall Study|Disease Progression|1|||
25181259|NCT01451437|50327076|FG003|Overall Study|Disease Progression|1|||
25145256|NCT01945489|50259046|FG001|Cycle 1|Protocol Violation|1|||
25145257|NCT01945489|50259045|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
25145258|NCT01945489|50259046|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
25181260|NCT01451437|50327077|FG004|Overall Study|Disease Progression|3|||
25181261|NCT01451437|50327078|FG005|Overall Study|Disease Progression|2|||
25181262|NCT01451437|50327079|FG006|Overall Study|Disease Progression|3|||
25181263|NCT01451437|50327080|FG007|Overall Study|Disease Progression|1|||
25181264|NCT01451437|50327081|FG008|Overall Study|Disease Progression|3|||
25181265|NCT01451437|50327073|FG000|Overall Study|Protocol Violation|0|||
25181266|NCT01451437|50327074|FG001|Overall Study|Protocol Violation|0|||
25181267|NCT01451437|50327075|FG002|Overall Study|Protocol Violation|0|||
25181268|NCT01451437|50327076|FG003|Overall Study|Protocol Violation|0|||
25181269|NCT01451437|50327077|FG004|Overall Study|Protocol Violation|0|||
25181270|NCT01451437|50327078|FG005|Overall Study|Protocol Violation|0|||
25181271|NCT01451437|50327079|FG006|Overall Study|Protocol Violation|1|||
25181272|NCT01451437|50327080|FG007|Overall Study|Protocol Violation|0|||
25145259|NCT01945489|50259045|FG000|Cycle 2|Adverse Event|1|||
25145260|NCT01945489|50259046|FG001|Cycle 2|Adverse Event|0|||
25145261|NCT01945489|50259045|FG000|Cycle 2|Lost to Follow-up|0|||
25145262|NCT01945489|50259046|FG001|Cycle 2|Lost to Follow-up|1|||
25145263|NCT01934894|50259055|FG000|Overall Study|Adverse Event|1|||
25145264|NCT01934894|50259056|FG001|Overall Study|Adverse Event|2|||
25145265|NCT01934894|50259055|FG000|Overall Study|Death|2|||
25145266|NCT01934894|50259056|FG001|Overall Study|Death|0|||
25145267|NCT01934894|50259055|FG000|Overall Study|Withdrawal by Subject|0|||
25181273|NCT01451437|50327081|FG008|Overall Study|Protocol Violation|0|||
25181274|NCT01451437|50327073|FG000|Overall Study|Withdrawal by Subject|0|||
25181275|NCT01451437|50327074|FG001|Overall Study|Withdrawal by Subject|0|||
25145268|NCT01934894|50259056|FG001|Overall Study|Withdrawal by Subject|1|||
25145269|NCT01934894|50259055|FG000|Overall Study|Progressive Disease|3|||
25145270|NCT01934894|50259056|FG001|Overall Study|Progressive Disease|2|||
25181276|NCT01451437|50327075|FG002|Overall Study|Withdrawal by Subject|0|||
25181277|NCT01451437|50327076|FG003|Overall Study|Withdrawal by Subject|0|||
25145271|NCT01950169|50259068|FG000|Overall Study|Withdrawal by Subject|2|||
25145272|NCT01950169|50259069|FG001|Overall Study|Withdrawal by Subject|8|||
25145273|NCT01950169|50259070|FG002|Overall Study|Withdrawal by Subject|1|||
25145274|NCT01950169|50259068|FG000|Overall Study|Death|1|||
25145275|NCT01950169|50259069|FG001|Overall Study|Death|0|||
25145276|NCT01950169|50259070|FG002|Overall Study|Death|0|||
25274544|NCT01200810|50588563|FG001|Overall Study|Physician Decision|0|||
25274545|NCT01200810|50588562|FG000|Overall Study|Withdrawal by Subject|1|||
25274546|NCT01200810|50588563|FG001|Overall Study|Withdrawal by Subject|2|||
25274547|NCT01200810|50588562|FG000|Overall Study|Sponsor stopped making study drug|3|||
25145277|NCT01934504|50259083|FG000|Overall Study|Protocol Deviation|0|||
25145278|NCT01934504|50259084|FG001|Overall Study|Protocol Deviation|0|||
25145279|NCT01934504|50259085|FG002|Overall Study|Protocol Deviation|0|||
25145280|NCT01934504|50259086|FG003|Overall Study|Protocol Deviation|2|||
25145281|NCT01934504|50259083|FG000|Overall Study|Study Terminated by Sponsor|1|||
25145282|NCT01934504|50259084|FG001|Overall Study|Study Terminated by Sponsor|0|||
25016010|NCT03259308|50110855|FG000|Overall Study|Lack of Efficacy|0|||
25181278|NCT01451437|50327077|FG004|Overall Study|Withdrawal by Subject|1|||
25181279|NCT01451437|50327078|FG005|Overall Study|Withdrawal by Subject|0|||
25181280|NCT01451437|50327079|FG006|Overall Study|Withdrawal by Subject|1|||
25181281|NCT01451437|50327080|FG007|Overall Study|Withdrawal by Subject|0|||
25181282|NCT01451437|50327081|FG008|Overall Study|Withdrawal by Subject|0|||
25181283|NCT01451203|50327112|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
25181284|NCT01451203|50327113|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
25181285|NCT01451203|50327112|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
25181286|NCT01451203|50327113|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
25181287|NCT01451203|50327112|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
25181288|NCT01451203|50327113|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
25181289|NCT01451203|50327112|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
25181290|NCT01451203|50327113|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
25181291|NCT01451203|50327112|FG000|Double-blind Treatment Period|Adverse Event|6|||
25181292|NCT01451203|50327113|FG001|Double-blind Treatment Period|Adverse Event|9|||
25181293|NCT01451203|50327112|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
25181294|NCT01451203|50327113|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
25181295|NCT01451203|50327112|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
25181296|NCT01451203|50327113|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
25145283|NCT01934504|50259085|FG002|Overall Study|Study Terminated by Sponsor|5|||
25145284|NCT01934504|50259086|FG003|Overall Study|Study Terminated by Sponsor|5|||
25145285|NCT01950013|50259099|FG000|Overall Study|Withdrawal by Subject|0|||
25145286|NCT01950013|50259100|FG001|Overall Study|Withdrawal by Subject|2|||
25145287|NCT01950013|50259101|FG002|Overall Study|Withdrawal by Subject|0|||
25181297|NCT01451203|50327112|FG000|Double-blind Treatment Period|Investigator decision|2|||
25181298|NCT01451203|50327113|FG001|Double-blind Treatment Period|Investigator decision|0|||
25181299|NCT01451203|50327112|FG000|Post-treatment Period|Consent withdrawn|2|||
25181300|NCT01451203|50327113|FG001|Post-treatment Period|Consent withdrawn|4|||
25181301|NCT01451203|50327112|FG000|Post-treatment Period|Lack of Efficacy|12|||
25145288|NCT01949155|50259111|FG000|Overall Study|Lost to Follow-up|1|||
25145289|NCT01949155|50259112|FG001|Overall Study|Lost to Follow-up|0|||
25145290|NCT01949155|50259111|FG000|Overall Study|Protocol Violation|1|||
25145291|NCT01949155|50259112|FG001|Overall Study|Protocol Violation|0|||
25145292|NCT01909466|50259119|FG000|Overall Study|Lost to Follow-up|5|||
25145293|NCT01909466|50259120|FG001|Overall Study|Lost to Follow-up|7|||
25145294|NCT01909466|50259119|FG000|Overall Study|Adverse Event|3|||
25145295|NCT01909466|50259120|FG001|Overall Study|Adverse Event|4|||
25145296|NCT01909466|50259119|FG000|Overall Study|Met Withdrawal Criteria|0|||
25145297|NCT01909466|50259120|FG001|Overall Study|Met Withdrawal Criteria|3|||
25145298|NCT01909466|50259119|FG000|Overall Study|Physician Decision|2|||
25145299|NCT01909466|50259120|FG001|Overall Study|Physician Decision|0|||
25145300|NCT01909466|50259119|FG000|Overall Study|Withdrawal by Subject|11|||
25145301|NCT01909466|50259120|FG001|Overall Study|Withdrawal by Subject|9|||
25145302|NCT01909466|50259119|FG000|Overall Study|Lack of Efficacy|1|||
25145303|NCT01909466|50259120|FG001|Overall Study|Lack of Efficacy|0|||
25145304|NCT01977625|50259124|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
25145305|NCT01977625|50259125|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
25145306|NCT01977625|50259124|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
25145307|NCT01977625|50259125|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
25145308|NCT01944631|50259135|FG000|Overall Study|Adverse Event|1|||
25145309|NCT01944631|50259136|FG001|Overall Study|Adverse Event|0|||
25145310|NCT01944631|50259135|FG000|Overall Study|Lost to Follow-up|3|||
25145311|NCT01944631|50259136|FG001|Overall Study|Lost to Follow-up|1|||
25145312|NCT01944631|50259135|FG000|Overall Study|Withdrawal by Subject|0|||
25145313|NCT01944631|50259136|FG001|Overall Study|Withdrawal by Subject|1|||
25145314|NCT01948063|50259144|FG000|Overall Study|Boston MCI halted research protocol|0|||
25145315|NCT01948063|50259145|FG001|Overall Study|Boston MCI halted research protocol|1|||
25145316|NCT01948063|50259144|FG000|Overall Study|Discovered an enrollment in other study|0|||
25145317|NCT01948063|50259145|FG001|Overall Study|Discovered an enrollment in other study|1|||
25145318|NCT01948063|50259144|FG000|Overall Study|Blood samples were accidentally thawed|1|||
25145319|NCT01948063|50259145|FG001|Overall Study|Blood samples were accidentally thawed|0|||
25145320|NCT01995071|50259163|FG000|Overall Study|Adverse Event|0|||
25181302|NCT01451203|50327113|FG001|Post-treatment Period|Lack of Efficacy|28|||
25181303|NCT01451203|50327112|FG000|Post-treatment Period|Adverse Event|0|||
25181304|NCT01451203|50327113|FG001|Post-treatment Period|Adverse Event|1|||
25181305|NCT01451203|50327112|FG000|Post-treatment Period|Investigator decision|0|||
25181306|NCT01451203|50327113|FG001|Post-treatment Period|Investigator decision|1|||
25181307|NCT01556438|50327121|FG000|Overall Study|Adverse Event|4|||
25181308|NCT01556438|50327122|FG001|Overall Study|Adverse Event|2|||
25181309|NCT01556438|50327121|FG000|Overall Study|Sponsor Decision|0|||
25181310|NCT01556438|50327122|FG001|Overall Study|Sponsor Decision|2|||
25181311|NCT01556438|50327121|FG000|Overall Study|Progressive Disease|0|||
25181312|NCT01556438|50327122|FG001|Overall Study|Progressive Disease|6|||
25181313|NCT01556438|50327121|FG000|Overall Study|Death|0|||
25181314|NCT01556438|50327122|FG001|Overall Study|Death|1|||
25181315|NCT01554176|50327148|FG000|Treatment Phase|Protocol Violation|1|||
25181316|NCT01554176|50327149|FG001|Treatment Phase|Protocol Violation|2|||
25181317|NCT01554176|50327150|FG002|Treatment Phase|Protocol Violation|0|||
25181318|NCT01554176|50327151|FG003|Treatment Phase|Protocol Violation|0|||
25181319|NCT01554176|50327152|FG004|Treatment Phase|Protocol Violation|0|||
25181320|NCT01554176|50327148|FG000|Treatment Phase|Physician Decision|1|||
25181321|NCT01554176|50327149|FG001|Treatment Phase|Physician Decision|1|||
25181322|NCT01554176|50327150|FG002|Treatment Phase|Physician Decision|0|||
25181323|NCT01554176|50327151|FG003|Treatment Phase|Physician Decision|0|||
25181324|NCT01554176|50327152|FG004|Treatment Phase|Physician Decision|0|||
25181325|NCT01554176|50327148|FG000|Treatment Phase|Lack of Efficacy|0|||
25181326|NCT01554176|50327149|FG001|Treatment Phase|Lack of Efficacy|1|||
25181327|NCT01554176|50327150|FG002|Treatment Phase|Lack of Efficacy|0|||
25181328|NCT01554176|50327151|FG003|Treatment Phase|Lack of Efficacy|0|||
25181329|NCT01554176|50327152|FG004|Treatment Phase|Lack of Efficacy|0|||
25181330|NCT01554176|50327148|FG000|Treatment Phase|Adverse event, non-fatal|1|||
25181331|NCT01554176|50327149|FG001|Treatment Phase|Adverse event, non-fatal|1|||
25145321|NCT01995071|50259164|FG001|Overall Study|Adverse Event|0|||
25145322|NCT01995071|50259165|FG002|Overall Study|Adverse Event|0|||
25145323|NCT01995071|50259166|FG003|Overall Study|Adverse Event|0|||
25145324|NCT01995071|50259167|FG004|Overall Study|Adverse Event|0|||
25145325|NCT01995071|50259168|FG005|Overall Study|Adverse Event|0|||
25145326|NCT01995071|50259169|FG006|Overall Study|Adverse Event|1|||
25145327|NCT01995071|50259170|FG007|Overall Study|Adverse Event|0|||
25145328|NCT01995071|50259171|FG008|Overall Study|Adverse Event|0|||
25145329|NCT01995071|50259172|FG009|Overall Study|Adverse Event|0|||
25145330|NCT01995071|50259173|FG010|Overall Study|Adverse Event|0|||
25145331|NCT01995071|50259174|FG011|Overall Study|Adverse Event|0|||
25145332|NCT01995071|50259163|FG000|Overall Study|Moved|0|||
25145333|NCT01995071|50259164|FG001|Overall Study|Moved|0|||
25145334|NCT01995071|50259165|FG002|Overall Study|Moved|1|||
25145335|NCT01995071|50259166|FG003|Overall Study|Moved|0|||
25181332|NCT01554176|50327150|FG002|Treatment Phase|Adverse event, non-fatal|0|||
25181333|NCT01554176|50327151|FG003|Treatment Phase|Adverse event, non-fatal|0|||
25181334|NCT01554176|50327152|FG004|Treatment Phase|Adverse event, non-fatal|0|||
25181335|NCT01554176|50327148|FG000|Treatment Phase|Non-compliance with study drug|1|||
25181336|NCT01554176|50327149|FG001|Treatment Phase|Non-compliance with study drug|0|||
25181337|NCT01554176|50327150|FG002|Treatment Phase|Non-compliance with study drug|0|||
25181338|NCT01554176|50327151|FG003|Treatment Phase|Non-compliance with study drug|0|||
25181339|NCT01554176|50327152|FG004|Treatment Phase|Non-compliance with study drug|0|||
25181340|NCT01554176|50327148|FG000|Treatment Phase|Withdrawal by Subject|1|||
25181341|NCT01554176|50327149|FG001|Treatment Phase|Withdrawal by Subject|0|||
25145336|NCT01995071|50259167|FG004|Overall Study|Moved|1|||
25145337|NCT01995071|50259168|FG005|Overall Study|Moved|0|||
25145338|NCT01995071|50259169|FG006|Overall Study|Moved|0|||
25145339|NCT01995071|50259170|FG007|Overall Study|Moved|0|||
25145340|NCT01995071|50259171|FG008|Overall Study|Moved|0|||
25145341|NCT01995071|50259172|FG009|Overall Study|Moved|0|||
25145342|NCT01995071|50259173|FG010|Overall Study|Moved|1|||
25145343|NCT01995071|50259174|FG011|Overall Study|Moved|0|||
25145344|NCT01995071|50259163|FG000|Overall Study|Lost to Follow-up|1|||
25145345|NCT01995071|50259164|FG001|Overall Study|Lost to Follow-up|0|||
25145346|NCT01995071|50259165|FG002|Overall Study|Lost to Follow-up|0|||
25145347|NCT01995071|50259166|FG003|Overall Study|Lost to Follow-up|0|||
25145348|NCT01995071|50259167|FG004|Overall Study|Lost to Follow-up|0|||
25145349|NCT01995071|50259168|FG005|Overall Study|Lost to Follow-up|0|||
25145350|NCT01995071|50259169|FG006|Overall Study|Lost to Follow-up|0|||
25145351|NCT01995071|50259170|FG007|Overall Study|Lost to Follow-up|1|||
25145352|NCT01995071|50259171|FG008|Overall Study|Lost to Follow-up|1|||
25145353|NCT01995071|50259172|FG009|Overall Study|Lost to Follow-up|0|||
25145354|NCT01995071|50259173|FG010|Overall Study|Lost to Follow-up|0|||
25145355|NCT01995071|50259174|FG011|Overall Study|Lost to Follow-up|0|||
25145356|NCT01995071|50259163|FG000|Overall Study|Incarcerated|0|||
25145357|NCT01995071|50259164|FG001|Overall Study|Incarcerated|0|||
25145358|NCT01995071|50259165|FG002|Overall Study|Incarcerated|0|||
25145359|NCT01995071|50259166|FG003|Overall Study|Incarcerated|0|||
25145360|NCT01995071|50259167|FG004|Overall Study|Incarcerated|0|||
25145361|NCT01995071|50259168|FG005|Overall Study|Incarcerated|0|||
25145362|NCT01995071|50259169|FG006|Overall Study|Incarcerated|0|||
25145363|NCT01995071|50259170|FG007|Overall Study|Incarcerated|1|||
25145364|NCT01995071|50259171|FG008|Overall Study|Incarcerated|0|||
25145365|NCT01995071|50259172|FG009|Overall Study|Incarcerated|0|||
25145366|NCT01995071|50259173|FG010|Overall Study|Incarcerated|0|||
25145367|NCT01995071|50259174|FG011|Overall Study|Incarcerated|0|||
25145368|NCT01994837|50259206|FG000|Overall Study|Progressive disease per protocol|23|||
25145369|NCT01994837|50259206|FG000|Overall Study|Adv event related to progressive disease|3|||
25145370|NCT01994837|50259206|FG000|Overall Study|Fatal progressive disease|2|||
25145371|NCT01994837|50259206|FG000|Overall Study|Adverse event not related to progression|1|||
25145372|NCT01994837|50259206|FG000|Overall Study|Chose palliative care|1|||
25145373|NCT01994837|50259206|FG000|Overall Study|Proceeded to transplant|1|||
25145374|NCT01994837|50259206|FG000|Overall Study|Removed from study due to no response|1|||
25145375|NCT02010593|50259212|FG000|Overall Study|Lost to Follow-up|1|||
25145376|NCT02010593|50259213|FG001|Overall Study|Lost to Follow-up|0|||
25145377|NCT02010593|50259212|FG000|Overall Study|Physician Decision|1|||
25145378|NCT02010593|50259213|FG001|Overall Study|Physician Decision|0|||
25145379|NCT02010593|50259212|FG000|Overall Study|Unable to adhere to visit schedule|0|||
25145380|NCT02010593|50259213|FG001|Overall Study|Unable to adhere to visit schedule|2|||
25145381|NCT01994291|50259222|FG000|Overall Study|Adverse Event|4|||
25145382|NCT01994291|50259223|FG001|Overall Study|Adverse Event|1|||
25145383|NCT01994291|50259224|FG002|Overall Study|Adverse Event|3|||
25145384|NCT01994291|50259222|FG000|Overall Study|Lost to Follow-up|1|||
25145385|NCT01994291|50259223|FG001|Overall Study|Lost to Follow-up|1|||
25145386|NCT01994291|50259224|FG002|Overall Study|Lost to Follow-up|0|||
25145387|NCT01994291|50259222|FG000|Overall Study|Does not meet entrance criteria|1|||
25181342|NCT01554176|50327150|FG002|Treatment Phase|Withdrawal by Subject|0|||
25181343|NCT01554176|50327151|FG003|Treatment Phase|Withdrawal by Subject|0|||
25181344|NCT01554176|50327152|FG004|Treatment Phase|Withdrawal by Subject|0|||
25181345|NCT01554176|50327148|FG000|Treatment Phase|Lost to Follow-up|3|||
25181346|NCT01554176|50327149|FG001|Treatment Phase|Lost to Follow-up|0|||
25181347|NCT01554176|50327150|FG002|Treatment Phase|Lost to Follow-up|0|||
25181348|NCT01554176|50327151|FG003|Treatment Phase|Lost to Follow-up|0|||
25181349|NCT01554176|50327152|FG004|Treatment Phase|Lost to Follow-up|0|||
25181350|NCT01554176|50327148|FG000|Run-out Phase|Protocol Violation|0|||
25181351|NCT01554176|50327149|FG001|Run-out Phase|Protocol Violation|0|||
25181352|NCT01554176|50327150|FG002|Run-out Phase|Protocol Violation|0|||
25181353|NCT01554176|50327151|FG003|Run-out Phase|Protocol Violation|1|||
25181354|NCT01554176|50327152|FG004|Run-out Phase|Protocol Violation|0|||
25181355|NCT01466491|50327168|FG000|Overall Study|Protocol Violation|0|||
25181356|NCT01466491|50327169|FG001|Overall Study|Protocol Violation|3|||
25181357|NCT01466491|50327170|FG002|Overall Study|Protocol Violation|2|||
25181358|NCT01466491|50327171|FG003|Overall Study|Protocol Violation|0|||
25181359|NCT01466491|50327168|FG000|Overall Study|Missing Data|0|||
25181360|NCT01466491|50327169|FG001|Overall Study|Missing Data|0|||
25181361|NCT01466491|50327170|FG002|Overall Study|Missing Data|1|||
25181362|NCT01466491|50327171|FG003|Overall Study|Missing Data|0|||
25181363|NCT01466179|50327181|FG000|Overall Study|Ongoing in core study|2|||
25181364|NCT01466179|50327181|FG000|Overall Study|Physician Decision|46|||
25181365|NCT01466179|50327181|FG000|Overall Study|Progressive disease|43|||
25181366|NCT01466179|50327181|FG000|Overall Study|Adverse Event|32|||
25181367|NCT01466179|50327181|FG000|Overall Study|Disease relapse|23|||
25181368|NCT01466179|50327181|FG000|Overall Study|Lack of Efficacy|14|||
25181369|NCT01466179|50327181|FG000|Overall Study|Death|7|||
25181370|NCT01466179|50327181|FG000|Overall Study|Withdrawal by Subject|7|||
25181371|NCT01466179|50327181|FG000|Overall Study|Protocol Violation|2|||
25181372|NCT01466179|50327181|FG000|Overall Study|Other|3|||
25181373|NCT01493089|50327190|FG000|Overall Study|Protocol Violation|2|||
25181374|NCT01493089|50327191|FG001|Overall Study|Protocol Violation|2|||
25181375|NCT01493089|50327190|FG000|Overall Study|Withdrawal by Subject|1|||
25181376|NCT01493089|50327191|FG001|Overall Study|Withdrawal by Subject|0|||
25145388|NCT01994291|50259223|FG001|Overall Study|Does not meet entrance criteria|0|||
25145389|NCT01994291|50259224|FG002|Overall Study|Does not meet entrance criteria|0|||
25145390|NCT01994291|50259222|FG000|Overall Study|Medication error without associated AE|1|||
25145391|NCT01994291|50259223|FG001|Overall Study|Medication error without associated AE|0|||
25145392|NCT01994291|50259224|FG002|Overall Study|Medication error without associated AE|1|||
25145393|NCT01994291|50259222|FG000|Overall Study|Protocol Violation|1|||
25145394|NCT01994291|50259223|FG001|Overall Study|Protocol Violation|0|||
25145395|NCT01994291|50259224|FG002|Overall Study|Protocol Violation|0|||
25145396|NCT01994291|50259222|FG000|Overall Study|Withdrawal by Subject|6|||
25145397|NCT01994291|50259223|FG001|Overall Study|Withdrawal by Subject|3|||
25145398|NCT01994291|50259224|FG002|Overall Study|Withdrawal by Subject|5|||
25181377|NCT01493089|50327190|FG000|Overall Study|Physician Decision|0|||
25181378|NCT01493089|50327191|FG001|Overall Study|Physician Decision|1|||
25181379|NCT01450813|50327203|FG000|Overall Study|Physician Decision|1|||
25181380|NCT01450813|50327204|FG001|Overall Study|Physician Decision|1|||
25145399|NCT01994291|50259222|FG000|Overall Study|Other|1|||
25145400|NCT01994291|50259223|FG001|Overall Study|Other|2|||
25145401|NCT01994291|50259224|FG002|Overall Study|Other|0|||
25145402|NCT02094677|50259235|FG000|Overall Study|Screening|3|||
25145403|NCT02094677|50259236|FG001|Overall Study|Screening|1|||
25145404|NCT01993823|50259251|FG000|Overall Study|Requested by the patient|6|||
25145405|NCT01993823|50259252|FG001|Overall Study|Requested by the patient|11|||
25145406|NCT01993823|50259251|FG000|Overall Study|Protocol Violation|0|||
25145407|NCT01993823|50259252|FG001|Overall Study|Protocol Violation|1|||
25145408|NCT01993823|50259251|FG000|Overall Study|Lost to Follow-up|1|||
25145409|NCT01993823|50259252|FG001|Overall Study|Lost to Follow-up|4|||
25145410|NCT01993667|50259260|FG000|Overall Study|Insufficient data to analyze|16|||
25145411|NCT01993667|50259261|FG001|Overall Study|Insufficient data to analyze|16|||
25145412|NCT01993667|50259260|FG000|Overall Study|Insufficient altitude reached|3|||
25145413|NCT01993667|50259261|FG001|Overall Study|Insufficient altitude reached|1|||
25145414|NCT01993667|50259260|FG000|Overall Study|Lost to Follow-up|2|||
25145415|NCT01993667|50259261|FG001|Overall Study|Lost to Follow-up|2|||
25145416|NCT01992107|50259270|FG000|Overall Study|Administrative reasons|2|||
25145417|NCT01992107|50259271|FG001|Overall Study|Administrative reasons|0|||
25145418|NCT01992107|50259272|FG002|Overall Study|Administrative reasons|0|||
25145419|NCT01992107|50259270|FG000|Overall Study|Adverse Event|0|||
25145420|NCT01992107|50259271|FG001|Overall Study|Adverse Event|1|||
25145421|NCT01992107|50259272|FG002|Overall Study|Adverse Event|0|||
25145422|NCT01992107|50259270|FG000|Overall Study|Lost to Follow-up|46|||
25145423|NCT01992107|50259271|FG001|Overall Study|Lost to Follow-up|22|||
25145424|NCT01992107|50259272|FG002|Overall Study|Lost to Follow-up|26|||
25145425|NCT01992107|50259270|FG000|Overall Study|noncompliance and were unavailable|7|||
25145426|NCT01992107|50259271|FG001|Overall Study|noncompliance and were unavailable|3|||
25145427|NCT01992107|50259272|FG002|Overall Study|noncompliance and were unavailable|2|||
25145428|NCT01992107|50259270|FG000|Overall Study|Withdrawal by Subject|13|||
25145429|NCT01992107|50259271|FG001|Overall Study|Withdrawal by Subject|7|||
25181381|NCT01450813|50327205|FG002|Overall Study|Physician Decision|0|||
25181382|NCT01450813|50327206|FG003|Overall Study|Physician Decision|3|||
25181383|NCT01539512|50327220|FG000|Overall Study|Adverse Event|9|||
25181384|NCT01539512|50327221|FG001|Overall Study|Adverse Event|7|||
25181385|NCT01539512|50327220|FG000|Overall Study|Physician Decision|1|||
25181386|NCT01539512|50327221|FG001|Overall Study|Physician Decision|1|||
25181387|NCT01539512|50327220|FG000|Overall Study|Withdrawal by Subject|12|||
25181388|NCT01539512|50327221|FG001|Overall Study|Withdrawal by Subject|5|||
25181389|NCT01539512|50327220|FG000|Overall Study|Richter's Transformation|1|||
25181390|NCT01539512|50327221|FG001|Overall Study|Richter's Transformation|0|||
25181391|NCT01449955|50327229|FG000|Overall Study|Withdrawal by Subject|1|||
25181392|NCT01449955|50327230|FG001|Overall Study|Withdrawal by Subject|2|||
25181393|NCT01574612|50327243|FG000|Overall Study|Adverse Event|3|||
25181394|NCT01574612|50327243|FG000|Overall Study|non compliant with drug|2|||
25181395|NCT01574612|50327243|FG000|Overall Study|Withdrawal by Subject|1|||
25181396|NCT01574612|50327243|FG000|Overall Study|Lost to Follow-up|2|||
25181397|NCT01573910|50327249|FG000|Overall Study|Adverse Event|4|||
25181398|NCT01573910|50327250|FG001|Overall Study|Adverse Event|4|||
25181399|NCT01573910|50327249|FG000|Overall Study|Lost to Follow-up|2|||
25181400|NCT01573910|50327250|FG001|Overall Study|Lost to Follow-up|1|||
25181401|NCT01573910|50327249|FG000|Overall Study|Withdrawal by Subject|0|||
25181402|NCT01573910|50327250|FG001|Overall Study|Withdrawal by Subject|1|||
25181403|NCT01573910|50327249|FG000|Overall Study|Protocol Violation|3|||
25181404|NCT01573910|50327250|FG001|Overall Study|Protocol Violation|0|||
25181405|NCT01573910|50327249|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
25181406|NCT01573910|50327250|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
25181407|NCT01491919|50327259|FG000|Overall Study|Insufficient PK sampling|1|||
25181408|NCT01491919|50327260|FG001|Overall Study|Insufficient PK sampling|2|||
25181409|NCT01491919|50327261|FG002|Overall Study|Insufficient PK sampling|1|||
25181410|NCT01573442|50327273|FG000|Overall Study|Cancels|9|||
25181411|NCT01573442|50327274|FG001|Overall Study|Cancels|10|||
25181412|NCT01491841|50327343|FG000|Overall Study|Screen Failure|10|||
25181413|NCT01491841|50327343|FG000|Overall Study|Withdrawal by Subject|1|||
25181414|NCT01553318|50327362|FG000|Overall Study|Protocol Violation|3|||
25181415|NCT01553318|50327363|FG001|Overall Study|Protocol Violation|2|||
25181416|NCT01572740|50327382|FG000|Overall Study|Adverse Event|1|||
25181417|NCT01572740|50327383|FG001|Overall Study|Adverse Event|1|||
25274548|NCT01200810|50588563|FG001|Overall Study|Sponsor stopped making study drug|3|||
25274549|NCT01200342|50588569|FG000|Overall Study|Disease Progression|1|||
25145430|NCT01992107|50259272|FG002|Overall Study|Withdrawal by Subject|8|||
25145431|NCT01934192|50259301|FG000|Overall Study|Protocol Violation|0|||
25145432|NCT01934192|50259302|FG001|Overall Study|Protocol Violation|0|||
25145433|NCT01934192|50259303|FG002|Overall Study|Protocol Violation|0|||
25145434|NCT01934192|50259304|FG003|Overall Study|Protocol Violation|1|||
25145435|NCT01934192|50259301|FG000|Overall Study|Other: reached stopping criteria|6|||
25181418|NCT01572740|50327382|FG000|Overall Study|Withdrawal by Subject|1|||
25181419|NCT01572740|50327383|FG001|Overall Study|Withdrawal by Subject|1|||
25181420|NCT01572740|50327382|FG000|Overall Study|unclassified|4|||
25181421|NCT01572740|50327383|FG001|Overall Study|unclassified|3|||
25181422|NCT01491607|50327393|FG000|Overall Study|Lost to Follow-up|7|||
25145436|NCT01934192|50259302|FG001|Overall Study|Other: reached stopping criteria|5|||
25145437|NCT01934192|50259303|FG002|Overall Study|Other: reached stopping criteria|1|||
25145438|NCT01934192|50259304|FG003|Overall Study|Other: reached stopping criteria|0|||
25145439|NCT01934192|50259301|FG000|Overall Study|Physician Decision|3|||
25145440|NCT01934192|50259302|FG001|Overall Study|Physician Decision|2|||
25181423|NCT01491607|50327393|FG000|Overall Study|Withdrawal by Subject|3|||
25181424|NCT01449721|50327476|FG000|Overall Study|Physician Decision|0|||
25181425|NCT01449721|50327477|FG001|Overall Study|Physician Decision|1|||
25181426|NCT01449721|50327476|FG000|Overall Study|Physician Decision|0|||
25181427|NCT01449721|50327477|FG001|Overall Study|Physician Decision|1|||
25181428|NCT01553084|50327486|FG000|Overall Study|Withdrawal by Subject|15|||
25181429|NCT01553084|50327487|FG001|Overall Study|Withdrawal by Subject|13|||
25181430|NCT01553084|50327488|FG002|Overall Study|Withdrawal by Subject|35|||
25181431|NCT01536860|50327498|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
25181432|NCT01536860|50327499|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
25181433|NCT01536860|50327500|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
25181434|NCT01552928|50327512|FG000|Period 3|Adverse Event|0|||
25181435|NCT01552928|50327513|FG001|Period 3|Adverse Event|0|||
25181436|NCT01552928|50327514|FG002|Period 3|Adverse Event|1|||
25181437|NCT01552928|50327515|FG003|Period 3|Adverse Event|0|||
25181438|NCT01448707|50327534|FG000|Overall Study|Adverse Event|3|||
25181439|NCT01448707|50327535|FG001|Overall Study|Adverse Event|1|||
25181440|NCT01448707|50327534|FG000|Overall Study|Lost to Follow-up|2|||
25181441|NCT01448707|50327535|FG001|Overall Study|Lost to Follow-up|6|||
25181442|NCT01448707|50327534|FG000|Overall Study|Withdrawal by Subject|6|||
25181443|NCT01448707|50327535|FG001|Overall Study|Withdrawal by Subject|7|||
25181444|NCT01448707|50327534|FG000|Overall Study|Other|7|||
25181445|NCT01448707|50327535|FG001|Overall Study|Other|4|||
25181446|NCT01536704|50327541|FG000|Washout Period 1|Withdrawal by Subject|1|||
25181447|NCT01536704|50327542|FG001|Washout Period 1|Withdrawal by Subject|2|||
25181448|NCT01536704|50327543|FG002|Washout Period 1|Withdrawal by Subject|0|||
25181449|NCT01536704|50327544|FG003|Washout Period 1|Withdrawal by Subject|0|||
25181450|NCT01536704|50327541|FG000|Washout Period 2|Adverse Event|1|||
25181451|NCT01536704|50327542|FG001|Washout Period 2|Adverse Event|0|||
25181452|NCT01536704|50327543|FG002|Washout Period 2|Adverse Event|0|||
25181453|NCT01536704|50327544|FG003|Washout Period 2|Adverse Event|0|||
25181454|NCT01536704|50327541|FG000|Washout Period 2|Withdrawal by Subject|0|||
25181455|NCT01536704|50327542|FG001|Washout Period 2|Withdrawal by Subject|0|||
25181456|NCT01536704|50327543|FG002|Washout Period 2|Withdrawal by Subject|0|||
25181457|NCT01536704|50327544|FG003|Washout Period 2|Withdrawal by Subject|1|||
25181458|NCT01536704|50327541|FG000|Period 3|Adverse Event|0|||
25181459|NCT01536704|50327542|FG001|Period 3|Adverse Event|0|||
25181460|NCT01536704|50327543|FG002|Period 3|Adverse Event|0|||
25181461|NCT01536704|50327544|FG003|Period 3|Adverse Event|1|||
25181462|NCT01536704|50327541|FG000|Washout Period 3|Adverse Event|0|||
25181463|NCT01536704|50327542|FG001|Washout Period 3|Adverse Event|0|||
25181464|NCT01536704|50327543|FG002|Washout Period 3|Adverse Event|1|||
25181465|NCT01536704|50327544|FG003|Washout Period 3|Adverse Event|0|||
25181466|NCT01552772|50327558|FG000|Overall Study|Lost to Follow-up|2|||
25181467|NCT01552772|50327558|FG000|Overall Study|Adverse Event|1|||
25181468|NCT01552772|50327558|FG000|Overall Study|Protocol Deviation|1|||
25181469|NCT01552694|50327565|FG000|Overall Study|Lost to Follow-up|0|||
25181470|NCT01552694|50327566|FG001|Overall Study|Lost to Follow-up|1|||
25145441|NCT01934192|50259303|FG002|Overall Study|Physician Decision|0|||
25145442|NCT01934192|50259304|FG003|Overall Study|Physician Decision|0|||
25145443|NCT01933880|50259327|FG000|Overall Study|Withdrawal by Subject|5|||
25145444|NCT01933880|50259328|FG001|Overall Study|Withdrawal by Subject|0|||
25145445|NCT01933880|50259327|FG000|Overall Study|Lack of Efficacy|1|||
25145446|NCT01933880|50259328|FG001|Overall Study|Lack of Efficacy|0|||
25145447|NCT01933880|50259327|FG000|Overall Study|Concomitant medication Interference|0|||
25145448|NCT01933880|50259328|FG001|Overall Study|Concomitant medication Interference|1|||
25145449|NCT01933880|50259327|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
25145450|NCT01933880|50259328|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
25145451|NCT01933880|50259327|FG000|Overall Study|Other|4|||
25181471|NCT01552694|50327565|FG000|Overall Study|Protocol Violation|0|||
25181472|NCT01552694|50327566|FG001|Overall Study|Protocol Violation|1|||
25181473|NCT01464931|50327574|FG000|Overall Study|Withdrawal by Subject|1|||
25274550|NCT01199016|50588573|FG000|Overall Study|No longer meets eligibility criteria|4|||
25181474|NCT01464931|50327575|FG001|Overall Study|Withdrawal by Subject|0|||
25016011|NCT03259308|50110856|FG001|Overall Study|Lack of Efficacy|0|||
25181475|NCT01536392|50327600|FG000|Overall Study|Adverse Event|2|||
25181476|NCT01536392|50327601|FG001|Overall Study|Adverse Event|2|||
25181477|NCT01536392|50327600|FG000|Overall Study|Physician Decision|2|||
25181478|NCT01536392|50327601|FG001|Overall Study|Physician Decision|3|||
25181479|NCT01536392|50327600|FG000|Overall Study|Withdrawal by Subject|3|||
25181480|NCT01536392|50327601|FG001|Overall Study|Withdrawal by Subject|6|||
25181481|NCT01536392|50327600|FG000|Overall Study|Non Compliance|3|||
25145452|NCT01933880|50259328|FG001|Overall Study|Other|0|||
25145453|NCT01933880|50259327|FG000|Overall Study|Protocol Violation|1|||
25145454|NCT01933880|50259328|FG001|Overall Study|Protocol Violation|0|||
25181482|NCT01536392|50327601|FG001|Overall Study|Non Compliance|4|||
25181483|NCT01536392|50327600|FG000|Overall Study|Completed therapy early|3|||
25181484|NCT01536392|50327601|FG001|Overall Study|Completed therapy early|0|||
25181485|NCT01464619|50327609|FG000|Overall Study|Lost to Follow-up|3|||
25181486|NCT01464619|50327610|FG001|Overall Study|Lost to Follow-up|4|||
25181487|NCT01490125|50327676|FG000|Period I|Adverse Event|4|||
25181488|NCT01490125|50327677|FG001|Period I|Adverse Event|1|||
25181489|NCT01490125|50327678|FG002|Period I|Adverse Event|1|||
25181490|NCT01490125|50327679|FG003|Period I|Adverse Event|3|||
25181491|NCT01490125|50327680|FG004|Period I|Adverse Event|2|||
25181492|NCT01490125|50327681|FG005|Period I|Adverse Event|4|||
25181493|NCT01490125|50327676|FG000|Period I|Protocol Violation|1|||
25181494|NCT01490125|50327677|FG001|Period I|Protocol Violation|1|||
25181495|NCT01490125|50327678|FG002|Period I|Protocol Violation|1|||
25181496|NCT01490125|50327679|FG003|Period I|Protocol Violation|1|||
25181497|NCT01490125|50327680|FG004|Period I|Protocol Violation|0|||
25181498|NCT01490125|50327681|FG005|Period I|Protocol Violation|0|||
25181499|NCT01490125|50327676|FG000|Period I|Withdrawal by Subject|1|||
25181500|NCT01490125|50327677|FG001|Period I|Withdrawal by Subject|3|||
25181501|NCT01490125|50327678|FG002|Period I|Withdrawal by Subject|2|||
25181502|NCT01490125|50327679|FG003|Period I|Withdrawal by Subject|1|||
25181503|NCT01490125|50327680|FG004|Period I|Withdrawal by Subject|2|||
25181504|NCT01490125|50327681|FG005|Period I|Withdrawal by Subject|1|||
25181505|NCT01490125|50327676|FG000|Period II|Adverse Event|2|||
25181506|NCT01490125|50327677|FG001|Period II|Adverse Event|3|||
25181507|NCT01490125|50327678|FG002|Period II|Adverse Event|2|||
25181508|NCT01490125|50327679|FG003|Period II|Adverse Event|2|||
25181509|NCT01490125|50327680|FG004|Period II|Adverse Event|4|||
25181510|NCT01490125|50327681|FG005|Period II|Adverse Event|2|||
25181511|NCT01490125|50327676|FG000|Period II|Protocol Violation|0|||
25145455|NCT02008877|50259339|FG000|Overall Study|Inevaluable|0|||
25145456|NCT02008877|50259340|FG001|Overall Study|Inevaluable|1|||
25145457|NCT02008877|50259341|FG002|Overall Study|Inevaluable|0|||
25145458|NCT01933334|50259352|FG000|Overall Study|Adverse Event|5|||
25145459|NCT01933334|50259353|FG001|Overall Study|Adverse Event|1|||
25145460|NCT01933334|50259352|FG000|Overall Study|Withdrawal by Subject|0|||
25145461|NCT01933334|50259353|FG001|Overall Study|Withdrawal by Subject|1|||
25145462|NCT01908140|50259361|FG000|Overall Study|Other or Progressive Disease|5|||
25016012|NCT03259308|50110857|FG002|Overall Study|Lack of Efficacy|1|||
25016013|NCT03258762|50110867|FG000|Overall Study|Lost to Follow-up|0|||
25145463|NCT01908140|50259362|FG001|Overall Study|Other or Progressive Disease|12|||
25145464|NCT01908140|50259361|FG000|Overall Study|Lack of Efficacy|7|||
25145465|NCT01908140|50259362|FG001|Overall Study|Lack of Efficacy|5|||
25181512|NCT01490125|50327677|FG001|Period II|Protocol Violation|0|||
25181513|NCT01490125|50327678|FG002|Period II|Protocol Violation|1|||
25181514|NCT01490125|50327679|FG003|Period II|Protocol Violation|1|||
25181515|NCT01490125|50327680|FG004|Period II|Protocol Violation|0|||
25181516|NCT01490125|50327681|FG005|Period II|Protocol Violation|0|||
25181517|NCT01490125|50327676|FG000|Period II|Lost to Follow-up|0|||
25181518|NCT01490125|50327677|FG001|Period II|Lost to Follow-up|1|||
25145466|NCT01908140|50259361|FG000|Overall Study|Withdrawal by Subject|23|||
25145467|NCT01908140|50259362|FG001|Overall Study|Withdrawal by Subject|24|||
25145468|NCT01908140|50259361|FG000|Overall Study|Lost to Follow-up|1|||
25145469|NCT01908140|50259362|FG001|Overall Study|Lost to Follow-up|6|||
25145470|NCT01908140|50259361|FG000|Overall Study|Protocol Violation|8|||
25181519|NCT01490125|50327678|FG002|Period II|Lost to Follow-up|0|||
25181520|NCT01490125|50327679|FG003|Period II|Lost to Follow-up|0|||
25181521|NCT01490125|50327680|FG004|Period II|Lost to Follow-up|0|||
25145471|NCT01908140|50259362|FG001|Overall Study|Protocol Violation|9|||
25181522|NCT01490125|50327681|FG005|Period II|Lost to Follow-up|0|||
25181523|NCT01490125|50327676|FG000|Period II|Withdrawal by Subject|1|||
25181524|NCT01490125|50327677|FG001|Period II|Withdrawal by Subject|0|||
25181525|NCT01490125|50327678|FG002|Period II|Withdrawal by Subject|0|||
25181526|NCT01490125|50327679|FG003|Period II|Withdrawal by Subject|0|||
25181527|NCT01490125|50327680|FG004|Period II|Withdrawal by Subject|0|||
25181528|NCT01490125|50327681|FG005|Period II|Withdrawal by Subject|0|||
25181529|NCT01490125|50327676|FG000|Period III|Adverse Event|3|||
25181530|NCT01490125|50327677|FG001|Period III|Adverse Event|1|||
25181531|NCT01490125|50327678|FG002|Period III|Adverse Event|0|||
25181532|NCT01490125|50327679|FG003|Period III|Adverse Event|1|||
25181533|NCT01490125|50327680|FG004|Period III|Adverse Event|0|||
25181534|NCT01490125|50327681|FG005|Period III|Adverse Event|0|||
25181535|NCT01490125|50327676|FG000|Period III|Death|0|||
25181536|NCT01490125|50327677|FG001|Period III|Death|0|||
25181537|NCT01490125|50327678|FG002|Period III|Death|0|||
25181538|NCT01490125|50327679|FG003|Period III|Death|1|||
25181539|NCT01490125|50327680|FG004|Period III|Death|0|||
25181540|NCT01490125|50327681|FG005|Period III|Death|0|||
25181541|NCT01490125|50327676|FG000|Period III|Lack of Efficacy|0|||
25181542|NCT01490125|50327677|FG001|Period III|Lack of Efficacy|0|||
25181543|NCT01490125|50327678|FG002|Period III|Lack of Efficacy|0|||
25181544|NCT01490125|50327679|FG003|Period III|Lack of Efficacy|0|||
25181545|NCT01490125|50327680|FG004|Period III|Lack of Efficacy|1|||
25181546|NCT01490125|50327681|FG005|Period III|Lack of Efficacy|0|||
25181547|NCT01446913|50327692|FG000|Overall Study|Significant illness|1|||
25181548|NCT01446913|50327693|FG001|Overall Study|Significant illness|1|||
25181549|NCT01446913|50327694|FG002|Overall Study|Significant illness|1|||
25181550|NCT01446913|50327692|FG000|Overall Study|Withdrawal by Subject|5|||
25181551|NCT01446913|50327693|FG001|Overall Study|Withdrawal by Subject|3|||
25181552|NCT01446913|50327694|FG002|Overall Study|Withdrawal by Subject|5|||
25181553|NCT01446913|50327692|FG000|Overall Study|Physician Decision|0|||
25181554|NCT01446913|50327693|FG001|Overall Study|Physician Decision|0|||
25181555|NCT01446913|50327694|FG002|Overall Study|Physician Decision|2|||
25181556|NCT01446913|50327692|FG000|Overall Study|Lost to Follow-up|3|||
25181557|NCT01446913|50327693|FG001|Overall Study|Lost to Follow-up|5|||
25181558|NCT01446913|50327694|FG002|Overall Study|Lost to Follow-up|3|||
25181559|NCT01420549|50327725|FG000|Overall Study|Adverse Event|1|||
25181560|NCT01420549|50327726|FG001|Overall Study|Adverse Event|1|||
25181561|NCT01420549|50327725|FG000|Overall Study|Lost to Follow-up|2|||
25181562|NCT01420549|50327726|FG001|Overall Study|Lost to Follow-up|2|||
25181563|NCT01420549|50327725|FG000|Overall Study|Protocol Violation|0|||
25181564|NCT01420549|50327726|FG001|Overall Study|Protocol Violation|1|||
25181565|NCT01420549|50327725|FG000|Overall Study|Non-adherence to medication|4|||
25181566|NCT01420549|50327726|FG001|Overall Study|Non-adherence to medication|1|||
25181567|NCT01440595|50327747|FG000|Overall Study|Lost to Follow-up|0|||
25181568|NCT01440595|50327748|FG001|Overall Study|Lost to Follow-up|1|||
25181569|NCT01440595|50327749|FG002|Overall Study|Lost to Follow-up|0|||
25181570|NCT01440595|50327747|FG000|Overall Study|Study terminated by sponsor.|1|||
25181571|NCT01440595|50327748|FG001|Overall Study|Study terminated by sponsor.|2|||
25181572|NCT01440595|50327749|FG002|Overall Study|Study terminated by sponsor.|1|||
25181573|NCT01440517|50327755|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
25145472|NCT01908140|50259361|FG000|Overall Study|Adverse Event|22|||
25145473|NCT01908140|50259362|FG001|Overall Study|Adverse Event|23|||
25145474|NCT02008565|50259372|FG000|Overall Study|Protocol Violation|1|||
25145475|NCT02008565|50259373|FG001|Overall Study|Protocol Violation|1|||
25181574|NCT01440283|50327759|FG000|Overall Study|Death|3|||
25181575|NCT01440283|50327759|FG000|Overall Study|Withdrawal by Subject|4|||
25181576|NCT01440283|50327759|FG000|Overall Study|Physician Decision|3|||
25181577|NCT01440049|50327769|FG000|Overall Study|Adverse Event|5|||
25181578|NCT01439971|50327830|FG000|Overall Study|Required number in cohort dosed|0|||
25181579|NCT01439971|50327831|FG001|Overall Study|Required number in cohort dosed|1|||
25181580|NCT01439971|50327832|FG002|Overall Study|Required number in cohort dosed|2|||
25181581|NCT01439971|50327833|FG003|Overall Study|Required number in cohort dosed|0|||
25181582|NCT01439971|50327834|FG004|Overall Study|Required number in cohort dosed|1|||
25016014|NCT03258762|50110868|FG001|Overall Study|Lost to Follow-up|1|||
25145476|NCT02008565|50259374|FG002|Overall Study|Protocol Violation|2|||
25145477|NCT02008565|50259375|FG003|Overall Study|Protocol Violation|0|||
25145478|NCT01907906|50259389|FG000|Overall Study|Withdrawal by Subject|1|||
25145479|NCT01907906|50259390|FG001|Overall Study|Withdrawal by Subject|0|||
25145480|NCT01907906|50259389|FG000|Overall Study|Physician Decision|3|||
25145481|NCT01907906|50259390|FG001|Overall Study|Physician Decision|1|||
25145482|NCT01907828|50259400|FG000|Overall Study|Exclusion criteria not met|0|||
25181583|NCT01447927|50327897|FG000|Overall Study|Adverse Event|4|||
25181584|NCT01447927|50327898|FG001|Overall Study|Adverse Event|3|||
25181585|NCT01447927|50327897|FG000|Overall Study|Withdrawal by Subject|1|||
25181586|NCT01447927|50327898|FG001|Overall Study|Withdrawal by Subject|0|||
25181587|NCT01551758|50327920|FG000|Overall Study|Adverse Event|29|||
25181588|NCT01551758|50327921|FG001|Overall Study|Adverse Event|43|||
25181589|NCT01551758|50327920|FG000|Overall Study|Lack of Efficacy|0|||
25181590|NCT01551758|50327921|FG001|Overall Study|Lack of Efficacy|1|||
25274551|NCT01199016|50588573|FG000|Overall Study|Entrance criteria|5|||
25145483|NCT01907828|50259401|FG001|Overall Study|Exclusion criteria not met|1|||
25145484|NCT01907828|50259400|FG000|Overall Study|Withdrawal by Subject|3|||
25181591|NCT01551758|50327920|FG000|Overall Study|Protocol Violation|5|||
25181592|NCT01551758|50327921|FG001|Overall Study|Protocol Violation|6|||
25181593|NCT01551758|50327920|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
25181594|NCT01551758|50327921|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
25181595|NCT01551758|50327920|FG000|Overall Study|Lost to Follow-up|29|||
25181596|NCT01551758|50327921|FG001|Overall Study|Lost to Follow-up|25|||
25181597|NCT01551758|50327920|FG000|Overall Study|Physician Decision|9|||
25181598|NCT01551758|50327921|FG001|Overall Study|Physician Decision|3|||
25181599|NCT01551758|50327920|FG000|Overall Study|Withdrawal by Subject|14|||
25181600|NCT01551758|50327921|FG001|Overall Study|Withdrawal by Subject|17|||
25181601|NCT01449461|50328124|FG000|Overall Study|Adverse Event|0|||
25181602|NCT01449461|50328125|FG001|Overall Study|Adverse Event|3|||
25181603|NCT01449461|50328126|FG002|Overall Study|Adverse Event|2|||
25181604|NCT01449461|50328127|FG003|Overall Study|Adverse Event|3|||
25181605|NCT01449461|50328128|FG004|Overall Study|Adverse Event|4|||
25181606|NCT01449461|50328129|FG005|Overall Study|Adverse Event|4|||
25181607|NCT01449461|50328124|FG000|Overall Study|Death|0|||
25181608|NCT01449461|50328125|FG001|Overall Study|Death|2|||
25181609|NCT01449461|50328126|FG002|Overall Study|Death|0|||
25181610|NCT01449461|50328127|FG003|Overall Study|Death|0|||
25181611|NCT01449461|50328128|FG004|Overall Study|Death|7|||
25181612|NCT01449461|50328129|FG005|Overall Study|Death|1|||
25181613|NCT01449461|50328124|FG000|Overall Study|Physician Decision|0|||
25181614|NCT01449461|50328125|FG001|Overall Study|Physician Decision|1|||
25181615|NCT01449461|50328126|FG002|Overall Study|Physician Decision|0|||
25181616|NCT01449461|50328127|FG003|Overall Study|Physician Decision|4|||
25181617|NCT01449461|50328128|FG004|Overall Study|Physician Decision|1|||
25181618|NCT01449461|50328129|FG005|Overall Study|Physician Decision|0|||
25181619|NCT01449461|50328124|FG000|Overall Study|Documented Progressive Disease|4|||
25181620|NCT01449461|50328125|FG001|Overall Study|Documented Progressive Disease|7|||
25181621|NCT01449461|50328126|FG002|Overall Study|Documented Progressive Disease|14|||
25181622|NCT01449461|50328127|FG003|Overall Study|Documented Progressive Disease|15|||
25181623|NCT01449461|50328128|FG004|Overall Study|Documented Progressive Disease|24|||
25181624|NCT01449461|50328129|FG005|Overall Study|Documented Progressive Disease|5|||
25181625|NCT01449461|50328124|FG000|Overall Study|Clinical Progressive Disease|2|||
25181626|NCT01449461|50328125|FG001|Overall Study|Clinical Progressive Disease|2|||
25181627|NCT01449461|50328126|FG002|Overall Study|Clinical Progressive Disease|0|||
25181628|NCT01449461|50328127|FG003|Overall Study|Clinical Progressive Disease|3|||
25181629|NCT01449461|50328128|FG004|Overall Study|Clinical Progressive Disease|4|||
25181630|NCT01449461|50328129|FG005|Overall Study|Clinical Progressive Disease|2|||
25181631|NCT01449461|50328124|FG000|Overall Study|Protocol Violation|0|||
25181632|NCT01449461|50328125|FG001|Overall Study|Protocol Violation|0|||
25181633|NCT01449461|50328126|FG002|Overall Study|Protocol Violation|0|||
25181634|NCT01449461|50328127|FG003|Overall Study|Protocol Violation|1|||
25181635|NCT01449461|50328128|FG004|Overall Study|Protocol Violation|0|||
25181636|NCT01449461|50328129|FG005|Overall Study|Protocol Violation|0|||
25181637|NCT01449461|50328124|FG000|Overall Study|Site Terminated by Sponsor|0|||
25145485|NCT01907828|50259401|FG001|Overall Study|Withdrawal by Subject|4|||
25145486|NCT01907828|50259400|FG000|Overall Study|Lost to Follow-up|3|||
25145487|NCT01907828|50259401|FG001|Overall Study|Lost to Follow-up|0|||
25145488|NCT01907828|50259400|FG000|Overall Study|Participant refused 24-month follow-up|1|||
25145489|NCT01907828|50259401|FG001|Overall Study|Participant refused 24-month follow-up|0|||
25145490|NCT01907828|50259400|FG000|Overall Study|Participant met exclusion criteria|0|||
25145491|NCT01907828|50259401|FG001|Overall Study|Participant met exclusion criteria|1|||
25145492|NCT01907516|50259409|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
25145493|NCT01907516|50259410|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
25145494|NCT01907516|50259409|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
25145495|NCT01907516|50259410|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
25145496|NCT01907516|50259409|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
25145497|NCT01907516|50259410|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
25145498|NCT01907516|50259409|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
25181638|NCT01449461|50328125|FG001|Overall Study|Site Terminated by Sponsor|1|||
25181639|NCT01449461|50328126|FG002|Overall Study|Site Terminated by Sponsor|2|||
25181640|NCT01449461|50328127|FG003|Overall Study|Site Terminated by Sponsor|3|||
25181641|NCT01449461|50328128|FG004|Overall Study|Site Terminated by Sponsor|4|||
25181642|NCT01449461|50328129|FG005|Overall Study|Site Terminated by Sponsor|1|||
25181643|NCT01449461|50328124|FG000|Overall Study|Withdrawal by Subject|0|||
25181644|NCT01449461|50328125|FG001|Overall Study|Withdrawal by Subject|1|||
25181645|NCT01449461|50328126|FG002|Overall Study|Withdrawal by Subject|0|||
25181646|NCT01449461|50328127|FG003|Overall Study|Withdrawal by Subject|0|||
25181647|NCT01449461|50328128|FG004|Overall Study|Withdrawal by Subject|2|||
25181648|NCT01449461|50328129|FG005|Overall Study|Withdrawal by Subject|1|||
25181649|NCT01449461|50328124|FG000|Overall Study|Reason not Specified|0|||
25181650|NCT01449461|50328125|FG001|Overall Study|Reason not Specified|1|||
25181651|NCT01449461|50328126|FG002|Overall Study|Reason not Specified|0|||
25181652|NCT01449461|50328127|FG003|Overall Study|Reason not Specified|3|||
25181653|NCT01449461|50328128|FG004|Overall Study|Reason not Specified|2|||
25181654|NCT01449461|50328129|FG005|Overall Study|Reason not Specified|1|||
25181655|NCT01572038|50328165|FG000|Overall Study|Death|648|||
25181656|NCT01572038|50328165|FG000|Overall Study|Withdrawal by Subject|204|||
25181657|NCT01572038|50328165|FG000|Overall Study|Lost to Follow-up|81|||
25181658|NCT01572038|50328165|FG000|Overall Study|Physician Decision|20|||
25181659|NCT01572038|50328165|FG000|Overall Study|Patient Decision|14|||
25181660|NCT01572038|50328165|FG000|Overall Study|Progressive Disease|8|||
25181661|NCT01572038|50328165|FG000|Overall Study|Site Closed Before Completing Form|6|||
25181662|NCT01572038|50328165|FG000|Overall Study|Enrolled into Another Trial|3|||
25181663|NCT01572038|50328165|FG000|Overall Study|Participated in Another Trial|3|||
25181664|NCT01572038|50328165|FG000|Overall Study|Termination by Sponsor|2|||
25181665|NCT01572038|50328165|FG000|Overall Study|Patient Deterioration|1|||
25181666|NCT01572038|50328165|FG000|Overall Study|Sponsor Decision|1|||
25181667|NCT01448213|50328193|FG000|Overall Study|Lost to Follow-up|12|||
25181668|NCT01448213|50328194|FG001|Overall Study|Lost to Follow-up|10|||
25181669|NCT01448213|50328193|FG000|Overall Study|Adverse Event|4|||
25181670|NCT01448213|50328194|FG001|Overall Study|Adverse Event|10|||
25181671|NCT01448213|50328193|FG000|Overall Study|Protocol Violation|1|||
25181672|NCT01448213|50328194|FG001|Overall Study|Protocol Violation|2|||
25181673|NCT01448057|50328211|FG000|Overall Study|Protocol Violation|3|||
25181674|NCT01448057|50328212|FG001|Overall Study|Protocol Violation|2|||
25181675|NCT01448057|50328211|FG000|Overall Study|Lost to Follow-up|3|||
25181676|NCT01448057|50328212|FG001|Overall Study|Lost to Follow-up|0|||
25181677|NCT01448057|50328211|FG000|Overall Study|Adverse Event|0|||
25181678|NCT01448057|50328212|FG001|Overall Study|Adverse Event|2|||
25181679|NCT01448057|50328211|FG000|Overall Study|Withdrawal by Subject|2|||
25181680|NCT01448057|50328212|FG001|Overall Study|Withdrawal by Subject|0|||
25181681|NCT01447433|50328220|FG000|Overall Study|Lost to Follow-up|0|||
25181682|NCT01447433|50328221|FG001|Overall Study|Lost to Follow-up|2|||
25181683|NCT01447433|50328220|FG000|Overall Study|Withdrawal by Subject|3|||
25181684|NCT01447433|50328221|FG001|Overall Study|Withdrawal by Subject|3|||
25181685|NCT01447433|50328220|FG000|Overall Study|Protocol Violation|1|||
25181686|NCT01447433|50328221|FG001|Overall Study|Protocol Violation|1|||
25181687|NCT01446965|50328229|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
25181688|NCT01446965|50328230|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
25016015|NCT04502589|50110877|FG000|Overall Study|Physician Decision|1|||
25145499|NCT01907516|50259410|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
25145500|NCT01931462|50259417|FG000|Overall Study|Withdrawal by Subject|1|||
25145501|NCT01931150|50259423|FG000|Overall Study|Withdrawal by Subject|1|||
25145502|NCT01931150|50259424|FG001|Overall Study|Withdrawal by Subject|2|||
25145503|NCT01930214|50259433|FG000|Overall Study|Death|4|||
25145504|NCT01930214|50259434|FG001|Overall Study|Death|4|||
25145505|NCT01930214|50259435|FG002|Overall Study|Death|11|||
25145506|NCT01930214|50259433|FG000|Overall Study|Lost to Follow-up|12|||
25145507|NCT01930214|50259434|FG001|Overall Study|Lost to Follow-up|13|||
25145508|NCT01930214|50259435|FG002|Overall Study|Lost to Follow-up|12|||
25145509|NCT01930214|50259433|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
25145510|NCT01930214|50259434|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
25145511|NCT01930214|50259435|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
25145512|NCT01930214|50259433|FG000|Overall Study|Physician Decision|2|||
25145513|NCT01930214|50259434|FG001|Overall Study|Physician Decision|0|||
25145514|NCT01930214|50259435|FG002|Overall Study|Physician Decision|0|||
25145515|NCT01958294|50259443|FG000|Overall Study|Clinical Circumstances|2|||
25145516|NCT01906346|50259447|FG000|Overall Study|AEs|1|||
25181689|NCT01446965|50328229|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
25181690|NCT01446965|50328230|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
25181691|NCT01446809|50328238|FG000|Overall Study|Adverse Event|0|||
25181692|NCT01446809|50328239|FG001|Overall Study|Adverse Event|0|||
25181693|NCT01446809|50328240|FG002|Overall Study|Adverse Event|1|||
25181694|NCT01446809|50328238|FG000|Overall Study|Failure to complete study procedures|0|||
25181695|NCT01446809|50328239|FG001|Overall Study|Failure to complete study procedures|0|||
25181696|NCT01446809|50328240|FG002|Overall Study|Failure to complete study procedures|1|||
25181697|NCT01446419|50328251|FG000|Overall Study|Death|1|||
25181698|NCT01446419|50328252|FG001|Overall Study|Death|0|||
25181699|NCT01446419|50328251|FG000|Overall Study|Withdrawal by Subject|1|||
25181700|NCT01446419|50328252|FG001|Overall Study|Withdrawal by Subject|1|||
25181701|NCT01446419|50328251|FG000|Overall Study|Terminated per protocol|3|||
25181702|NCT01446419|50328252|FG001|Overall Study|Terminated per protocol|0|||
25181703|NCT01445951|50328261|FG000|Overall Study|Adverse Event|16|||
25181704|NCT01445951|50328262|FG001|Overall Study|Adverse Event|9|||
25181705|NCT01445951|50328263|FG002|Overall Study|Adverse Event|0|||
25181706|NCT01445951|50328261|FG000|Overall Study|Protocol Violation|2|||
25181707|NCT01445951|50328262|FG001|Overall Study|Protocol Violation|2|||
25181708|NCT01445951|50328263|FG002|Overall Study|Protocol Violation|2|||
25181709|NCT01445951|50328261|FG000|Overall Study|Withdrawal by Subject|21|||
25181710|NCT01445951|50328262|FG001|Overall Study|Withdrawal by Subject|16|||
25181711|NCT01445951|50328263|FG002|Overall Study|Withdrawal by Subject|8|||
25181712|NCT01445951|50328261|FG000|Overall Study|Physician Decision|3|||
25181713|NCT01445951|50328262|FG001|Overall Study|Physician Decision|1|||
25145517|NCT01958060|50259459|FG000|Overall Study|Not treated|2|||
25145518|NCT01958060|50259460|FG001|Overall Study|Not treated|0|||
25145519|NCT01958060|50259461|FG002|Overall Study|Not treated|0|||
25145520|NCT01958060|50259462|FG003|Overall Study|Not treated|0|||
25145521|NCT01958060|50259463|FG004|Overall Study|Not treated|1|||
25145522|NCT01958060|50259464|FG005|Overall Study|Not treated|0|||
25145523|NCT01929980|50259483|FG000|Overall Study|Physician Decision|1|||
25145524|NCT01363076|50259489|FG000|Overall Study|Withdrawal by Subject|0|||
25145525|NCT01363076|50259490|FG001|Overall Study|Withdrawal by Subject|1|||
25145526|NCT01929044|50259498|FG000|Overall Study|Adverse Event|1|||
25145527|NCT01929044|50259499|FG001|Overall Study|Adverse Event|0|||
25145528|NCT01929044|50259498|FG000|Overall Study|Protocol Violation|9|||
25145529|NCT01929044|50259499|FG001|Overall Study|Protocol Violation|14|||
25145530|NCT01929044|50259498|FG000|Overall Study|Not Treated|1|||
25145531|NCT01929044|50259499|FG001|Overall Study|Not Treated|3|||
25145532|NCT01903460|50259509|FG000|Overall Study|Adverse Event|0|||
25145533|NCT01903460|50259510|FG001|Overall Study|Adverse Event|0|||
25145534|NCT01903460|50259511|FG002|Overall Study|Adverse Event|0|||
25145535|NCT01903460|50259512|FG003|Overall Study|Adverse Event|1|||
25181714|NCT01445951|50328263|FG002|Overall Study|Physician Decision|0|||
25181715|NCT01445951|50328261|FG000|Overall Study|Lost to Follow-up|1|||
25181716|NCT01445951|50328262|FG001|Overall Study|Lost to Follow-up|2|||
25181717|NCT01445951|50328263|FG002|Overall Study|Lost to Follow-up|4|||
25181718|NCT01445951|50328261|FG000|Overall Study|Pregnancy|0|||
25181719|NCT01445951|50328262|FG001|Overall Study|Pregnancy|1|||
25181720|NCT01445951|50328263|FG002|Overall Study|Pregnancy|4|||
25181721|NCT01445951|50328261|FG000|Overall Study|Death|0|||
25181722|NCT01445951|50328262|FG001|Overall Study|Death|0|||
25145536|NCT01957202|50259521|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
25145537|NCT01957202|50259522|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
25181723|NCT01445951|50328263|FG002|Overall Study|Death|1|||
25181724|NCT01445951|50328261|FG000|Overall Study|Non-compliance with study drug|1|||
25145538|NCT01957202|50259523|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
25145539|NCT01957202|50259524|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
25181725|NCT01445951|50328262|FG001|Overall Study|Non-compliance with study drug|2|||
25274552|NCT01199016|50588573|FG000|Overall Study|Protocol Violation|9|||
25181726|NCT01445951|50328263|FG002|Overall Study|Non-compliance with study drug|0|||
25181727|NCT01445951|50328261|FG000|Overall Study|Non-compliance with protocol|0|||
25181728|NCT01445951|50328262|FG001|Overall Study|Non-compliance with protocol|1|||
25181729|NCT01445951|50328263|FG002|Overall Study|Non-compliance with protocol|0|||
25181730|NCT01445951|50328261|FG000|Overall Study|Sponsor decision - subject travel|0|||
25181731|NCT01445951|50328262|FG001|Overall Study|Sponsor decision - subject travel|1|||
25181732|NCT01445951|50328263|FG002|Overall Study|Sponsor decision - subject travel|0|||
25181733|NCT01445951|50328261|FG000|Overall Study|Cough|0|||
25181734|NCT01445951|50328262|FG001|Overall Study|Cough|1|||
25181735|NCT01445951|50328263|FG002|Overall Study|Cough|0|||
25181736|NCT01445171|50328275|FG000|Overall Study|Lost to Follow-up|11|||
25181737|NCT01445171|50328275|FG000|Overall Study|Withdrawal by Subject|16|||
25181738|NCT01445171|50328275|FG000|Overall Study|Death|51|||
25181739|NCT01445171|50328275|FG000|Overall Study|Subjects declined to return for followup|9|||
25181740|NCT01445171|50328275|FG000|Overall Study|Consented but did not receive device|8|||
25181741|NCT01444781|50328284|FG000|Overall Study|Lost to Follow-up|0|||
25181742|NCT01444781|50328285|FG001|Overall Study|Lost to Follow-up|3|||
25181743|NCT01444781|50328286|FG002|Overall Study|Lost to Follow-up|1|||
25181744|NCT01444781|50328284|FG000|Overall Study|Withdrawal by Subject|3|||
25181745|NCT01444781|50328285|FG001|Overall Study|Withdrawal by Subject|1|||
25181746|NCT01444781|50328286|FG002|Overall Study|Withdrawal by Subject|2|||
25181747|NCT01444391|50328301|FG000|Overall Study|Death|1|||
25145540|NCT01957202|50259525|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
25145541|NCT01957202|50259526|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
25145542|NCT01957202|50259527|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
25145543|NCT01957202|50259528|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
25145544|NCT01957202|50259529|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
25145545|NCT01957202|50259530|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
25145546|NCT01957202|50259531|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
25145547|NCT01957202|50259532|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
25145548|NCT01957202|50259533|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
25145549|NCT01957202|50259534|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
25145550|NCT01957202|50259535|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
25145551|NCT01957202|50259536|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
25145552|NCT01957202|50259537|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
25145553|NCT01957202|50259538|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
25145554|NCT01957202|50259521|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
25145555|NCT01957202|50259522|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
25145556|NCT01957202|50259523|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
25145557|NCT01957202|50259524|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
25145558|NCT01957202|50259525|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
25145559|NCT01957202|50259526|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
25145560|NCT01957202|50259527|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
25145561|NCT01957202|50259528|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
25145562|NCT01957202|50259529|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
25145563|NCT01957202|50259530|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
25145564|NCT01957202|50259531|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
25181748|NCT01443923|50328307|FG000|Overall Study|Adverse Event|1|||
25181749|NCT01443923|50328308|FG001|Overall Study|Adverse Event|0|||
25181750|NCT01551212|50328320|FG000|Overall Study|Graft loss/Retransplantation|0|||
25274553|NCT01199016|50588573|FG000|Overall Study|Other|13|||
25181751|NCT01551212|50328321|FG001|Overall Study|Graft loss/Retransplantation|1|||
25181752|NCT01551212|50328320|FG000|Overall Study|Administrative problems|1|||
25181753|NCT01551212|50328321|FG001|Overall Study|Administrative problems|2|||
25145565|NCT01957202|50259532|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
25145566|NCT01957202|50259533|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
25145567|NCT01957202|50259534|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
25145568|NCT01957202|50259535|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
25145569|NCT01957202|50259536|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
25145570|NCT01957202|50259537|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
25145571|NCT01957202|50259538|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
25145572|NCT01616654|50259553|FG000|Overall Study|Lack of Efficacy|1|||
25145573|NCT01616654|50259554|FG001|Overall Study|Lack of Efficacy|0|||
25145574|NCT01616654|50259555|FG002|Overall Study|Lack of Efficacy|0|||
25145575|NCT01616654|50259556|FG003|Overall Study|Lack of Efficacy|0|||
25145576|NCT01616654|50259557|FG004|Overall Study|Lack of Efficacy|1|||
25145577|NCT01616654|50259553|FG000|Overall Study|Adverse Event|0|||
25145578|NCT01616654|50259554|FG001|Overall Study|Adverse Event|1|||
25145579|NCT01616654|50259555|FG002|Overall Study|Adverse Event|2|||
25145580|NCT01616654|50259556|FG003|Overall Study|Adverse Event|1|||
25145581|NCT01616654|50259557|FG004|Overall Study|Adverse Event|0|||
25145582|NCT01616654|50259553|FG000|Overall Study|Withdrawal by Subject|2|||
25145583|NCT01616654|50259554|FG001|Overall Study|Withdrawal by Subject|2|||
25145584|NCT01616654|50259555|FG002|Overall Study|Withdrawal by Subject|3|||
25145585|NCT01616654|50259556|FG003|Overall Study|Withdrawal by Subject|1|||
25145586|NCT01616654|50259557|FG004|Overall Study|Withdrawal by Subject|5|||
25181754|NCT01551212|50328320|FG000|Overall Study|Lost to Follow-up|0|||
25145587|NCT01616654|50259553|FG000|Overall Study|Protocol Violation|0|||
25145588|NCT01616654|50259554|FG001|Overall Study|Protocol Violation|5|||
25016016|NCT04502589|50110878|FG001|Overall Study|Physician Decision|0|||
25181755|NCT01551212|50328321|FG001|Overall Study|Lost to Follow-up|1|||
25145589|NCT01616654|50259555|FG002|Overall Study|Protocol Violation|2|||
25181756|NCT01551212|50328320|FG000|Overall Study|Protocol Violation|0|||
25181757|NCT01551212|50328321|FG001|Overall Study|Protocol Violation|1|||
25181758|NCT01551212|50328320|FG000|Overall Study|Withdrawal by Subject|0|||
25145590|NCT01616654|50259556|FG003|Overall Study|Protocol Violation|4|||
25181759|NCT01551212|50328321|FG001|Overall Study|Withdrawal by Subject|7|||
25181760|NCT01551212|50328320|FG000|Overall Study|Death|2|||
25181761|NCT01551212|50328321|FG001|Overall Study|Death|4|||
25181762|NCT01551212|50328320|FG000|Overall Study|Never Received Study Treatment|2|||
25181763|NCT01551212|50328321|FG001|Overall Study|Never Received Study Treatment|4|||
25181764|NCT01550744|50328381|FG000|Open-Label|Lost to Follow-up|7|||
25181765|NCT01550744|50328382|FG001|Open-Label|Lost to Follow-up|0|||
25181766|NCT01550744|50328383|FG002|Open-Label|Lost to Follow-up|0|||
25181767|NCT01550744|50328381|FG000|Open-Label|Withdrawal by Subject|13|||
25181768|NCT01550744|50328382|FG001|Open-Label|Withdrawal by Subject|0|||
25145591|NCT01616654|50259557|FG004|Overall Study|Protocol Violation|4|||
25145592|NCT01616654|50259553|FG000|Overall Study|Lost to Follow-up|1|||
25145593|NCT01616654|50259554|FG001|Overall Study|Lost to Follow-up|0|||
25145594|NCT01616654|50259555|FG002|Overall Study|Lost to Follow-up|3|||
25145595|NCT01616654|50259556|FG003|Overall Study|Lost to Follow-up|2|||
25145596|NCT01616654|50259557|FG004|Overall Study|Lost to Follow-up|1|||
25145597|NCT01616654|50259553|FG000|Overall Study|Pregnancy|1|||
25145598|NCT01616654|50259554|FG001|Overall Study|Pregnancy|0|||
25145599|NCT01616654|50259555|FG002|Overall Study|Pregnancy|0|||
25145600|NCT01616654|50259556|FG003|Overall Study|Pregnancy|0|||
25145601|NCT01616654|50259557|FG004|Overall Study|Pregnancy|1|||
25145602|NCT01902290|50259572|FG000|Overall Study|Withdrawal by Subject|19|||
25145603|NCT01902290|50259573|FG001|Overall Study|Withdrawal by Subject|27|||
25145604|NCT01902290|50259572|FG000|Overall Study|Lost to Follow-up|2|||
25145605|NCT01902290|50259573|FG001|Overall Study|Lost to Follow-up|2|||
25145606|NCT01902290|50259572|FG000|Overall Study|Death|1|||
25145607|NCT01902290|50259573|FG001|Overall Study|Death|0|||
25145608|NCT01902290|50259572|FG000|Overall Study|Sponsor Decision|26|||
25145609|NCT01902290|50259573|FG001|Overall Study|Sponsor Decision|24|||
25145610|NCT01927562|50259580|FG000|Overall Study|Lost to Follow-up|30|||
25145611|NCT01927562|50259580|FG000|Overall Study|Withdrawal by Subject|3|||
25145612|NCT01927562|50259580|FG000|Overall Study|Physician Decision|5|||
25145613|NCT01467466|50259588|FG000|Overall Study|Withdrawal by Subject|15|||
25145614|NCT01467466|50259589|FG001|Overall Study|Withdrawal by Subject|18|||
25145615|NCT01467466|50259590|FG002|Overall Study|Withdrawal by Subject|13|||
25145616|NCT01467466|50259591|FG003|Overall Study|Withdrawal by Subject|11|||
25181769|NCT01550744|50328383|FG002|Open-Label|Withdrawal by Subject|0|||
25181770|NCT01550744|50328381|FG000|Open-Label|Adverse Event|11|||
25181771|NCT01550744|50328382|FG001|Open-Label|Adverse Event|0|||
25181772|NCT01550744|50328383|FG002|Open-Label|Adverse Event|0|||
25181773|NCT01550744|50328381|FG000|Open-Label|Lack of Efficacy|4|||
25181774|NCT01550744|50328382|FG001|Open-Label|Lack of Efficacy|0|||
25181775|NCT01550744|50328383|FG002|Open-Label|Lack of Efficacy|0|||
25181776|NCT01550744|50328381|FG000|Open-Label|Protocol Violation|4|||
25181777|NCT01550744|50328382|FG001|Open-Label|Protocol Violation|0|||
25181778|NCT01550744|50328383|FG002|Open-Label|Protocol Violation|0|||
25181779|NCT01550744|50328381|FG000|Open-Label|Not all 3 study drug injections received|2|||
25181780|NCT01550744|50328382|FG001|Open-Label|Not all 3 study drug injections received|0|||
25181781|NCT01550744|50328383|FG002|Open-Label|Not all 3 study drug injections received|0|||
25181782|NCT01550744|50328381|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
25181783|NCT01550744|50328382|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
25181784|NCT01550744|50328383|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
25181785|NCT01550744|50328381|FG000|Open-Label|Other|1|||
25145617|NCT01467466|50259588|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
25145618|NCT01467466|50259589|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
25145619|NCT01467466|50259590|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
25145620|NCT01467466|50259591|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
25145621|NCT01467466|50259588|FG000|Overall Study|Procedure Cancelled|46|||
25181786|NCT01550744|50328382|FG001|Open-Label|Other|0|||
25181787|NCT01550744|50328383|FG002|Open-Label|Other|0|||
25181788|NCT01550744|50328381|FG000|Double-Blind|Lost to Follow-up|0|||
25145622|NCT01467466|50259589|FG001|Overall Study|Procedure Cancelled|45|||
25145623|NCT01467466|50259590|FG002|Overall Study|Procedure Cancelled|25|||
25145624|NCT01467466|50259591|FG003|Overall Study|Procedure Cancelled|29|||
25145625|NCT01467466|50259588|FG000|Overall Study|No Endpoint Blood Draw|38|||
25145626|NCT01467466|50259589|FG001|Overall Study|No Endpoint Blood Draw|32|||
25145627|NCT01467466|50259590|FG002|Overall Study|No Endpoint Blood Draw|51|||
25145628|NCT01467466|50259591|FG003|Overall Study|No Endpoint Blood Draw|43|||
25145629|NCT01441180|50259604|FG000|Overall Study|Lost to Follow-up|1|||
25181789|NCT01550744|50328382|FG001|Double-Blind|Lost to Follow-up|6|||
25181790|NCT01550744|50328383|FG002|Double-Blind|Lost to Follow-up|12|||
25181791|NCT01550744|50328381|FG000|Double-Blind|Withdrawal by Subject|0|||
25181792|NCT01550744|50328382|FG001|Double-Blind|Withdrawal by Subject|2|||
25181793|NCT01550744|50328383|FG002|Double-Blind|Withdrawal by Subject|15|||
25181794|NCT01550744|50328381|FG000|Double-Blind|Adverse Event|0|||
25145630|NCT01441180|50259605|FG001|Overall Study|Lost to Follow-up|1|||
25145631|NCT01441180|50259606|FG002|Overall Study|Lost to Follow-up|1|||
25145632|NCT01441180|50259604|FG000|Overall Study|Discontinued|0|||
25145633|NCT01441180|50259605|FG001|Overall Study|Discontinued|0|||
25145634|NCT01441180|50259606|FG002|Overall Study|Discontinued|2|||
25145635|NCT01441102|50259617|FG000|Overall Study|Adverse Event|1|||
25145636|NCT01441102|50259617|FG000|Overall Study|Withdrawal by Subject|2|||
25145637|NCT01467076|50259624|FG000|Overall Study|Lost to Follow-up|1|||
25145638|NCT01467076|50259625|FG001|Overall Study|Lost to Follow-up|0|||
25145639|NCT01467076|50259626|FG002|Overall Study|Lost to Follow-up|0|||
25145640|NCT01466062|50259634|FG000|Overall Study|Adverse Event|1|||
25145641|NCT01466062|50259634|FG000|Overall Study|Withdrawal by Subject|1|||
25145642|NCT01435018|50259641|FG000|Overall Study|Death|37|||
25145643|NCT01435018|50259642|FG001|Overall Study|Death|18|||
25145644|NCT01435018|50259643|FG002|Overall Study|Death|25|||
25145645|NCT01435018|50259641|FG000|Overall Study|Site is closing|4|||
25145646|NCT01435018|50259642|FG001|Overall Study|Site is closing|9|||
25145647|NCT01435018|50259643|FG002|Overall Study|Site is closing|7|||
25145648|NCT01435018|50259641|FG000|Overall Study|Withdrew consent|0|||
25145649|NCT01435018|50259642|FG001|Overall Study|Withdrew consent|3|||
25145650|NCT01435018|50259643|FG002|Overall Study|Withdrew consent|1|||
25145651|NCT01435018|50259641|FG000|Overall Study|Not willing to adhere to requirements|0|||
25145652|NCT01435018|50259642|FG001|Overall Study|Not willing to adhere to requirements|2|||
25145653|NCT01435018|50259643|FG002|Overall Study|Not willing to adhere to requirements|3|||
25181795|NCT01550744|50328382|FG001|Double-Blind|Adverse Event|4|||
25181796|NCT01550744|50328383|FG002|Double-Blind|Adverse Event|15|||
25181797|NCT01550744|50328381|FG000|Double-Blind|Death|0|||
25181798|NCT01550744|50328382|FG001|Double-Blind|Death|1|||
25181799|NCT01550744|50328383|FG002|Double-Blind|Death|0|||
25181800|NCT01550744|50328381|FG000|Double-Blind|Lack of Efficacy|0|||
25145654|NCT01435018|50259641|FG000|Overall Study|Not able to get to clinic|2|||
25181801|NCT01550744|50328382|FG001|Double-Blind|Lack of Efficacy|2|||
25181802|NCT01550744|50328383|FG002|Double-Blind|Lack of Efficacy|8|||
25181803|NCT01550744|50328381|FG000|Double-Blind|Protocol Violation|0|||
25145655|NCT01435018|50259642|FG001|Overall Study|Not able to get to clinic|0|||
25145656|NCT01435018|50259643|FG002|Overall Study|Not able to get to clinic|2|||
25181804|NCT01550744|50328382|FG001|Double-Blind|Protocol Violation|0|||
25181805|NCT01550744|50328383|FG002|Double-Blind|Protocol Violation|4|||
25181806|NCT01550744|50328381|FG000|Double-Blind|Pregnancy|0|||
25181807|NCT01550744|50328382|FG001|Double-Blind|Pregnancy|0|||
25181808|NCT01550744|50328383|FG002|Double-Blind|Pregnancy|3|||
25181809|NCT01550744|50328381|FG000|Double-Blind|Other|0|||
25181810|NCT01550744|50328382|FG001|Double-Blind|Other|2|||
25181811|NCT01550744|50328383|FG002|Double-Blind|Other|10|||
25181812|NCT01549964|50328444|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
25181813|NCT01549964|50328445|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
25181814|NCT01549964|50328446|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
25181815|NCT01549964|50328447|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
25181816|NCT01549964|50328444|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
25181817|NCT01549964|50328445|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
25181818|NCT01549964|50328446|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
25181819|NCT01549964|50328447|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
25181820|NCT01549964|50328444|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
25181821|NCT01549964|50328445|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
25181822|NCT01549964|50328446|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
25181823|NCT01549964|50328447|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
25181824|NCT01549964|50328444|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
25181825|NCT01549964|50328445|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
25181826|NCT01549964|50328446|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
25181827|NCT01549964|50328447|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
25181828|NCT01549964|50328444|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
25181829|NCT01549964|50328445|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
25145657|NCT01435018|50259641|FG000|Overall Study|Severe debilitation, unable to continue|0|||
25145658|NCT01435018|50259642|FG001|Overall Study|Severe debilitation, unable to continue|0|||
25145659|NCT01435018|50259643|FG002|Overall Study|Severe debilitation, unable to continue|1|||
25145660|NCT01435018|50259641|FG000|Overall Study|Unable to contact participant/parent|1|||
25145661|NCT01435018|50259642|FG001|Overall Study|Unable to contact participant/parent|1|||
25145662|NCT01435018|50259643|FG002|Overall Study|Unable to contact participant/parent|1|||
25145663|NCT01435018|50259641|FG000|Overall Study|Enrollment Violation|0|||
25181830|NCT01549964|50328446|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
25181831|NCT01549964|50328447|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
25181832|NCT01549964|50328444|FG000|24-Week Treatment Period|Other|1|||
25181833|NCT01549964|50328445|FG001|24-Week Treatment Period|Other|0|||
25181834|NCT01549964|50328446|FG002|24-Week Treatment Period|Other|1|||
25181835|NCT01549964|50328447|FG003|24-Week Treatment Period|Other|0|||
25181836|NCT01549964|50328444|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
25181837|NCT01549964|50328445|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
25181838|NCT01549964|50328446|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
25181839|NCT01549964|50328447|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
25181840|NCT01549964|50328444|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
25181841|NCT01549964|50328445|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
25181842|NCT01549964|50328446|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
25181843|NCT01549964|50328447|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
25181844|NCT01549964|50328444|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
25181845|NCT01549964|50328445|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
25181846|NCT01549964|50328446|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
25181847|NCT01549964|50328447|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
25181848|NCT01549964|50328444|FG000|80-Week Extension Period|Pregnancy|0|||
25181849|NCT01549964|50328445|FG001|80-Week Extension Period|Pregnancy|0|||
25181850|NCT01549964|50328446|FG002|80-Week Extension Period|Pregnancy|1|||
25181851|NCT01549964|50328447|FG003|80-Week Extension Period|Pregnancy|0|||
25181852|NCT01549964|50328444|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
25181853|NCT01549964|50328445|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
25181854|NCT01549964|50328446|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
25181855|NCT01549964|50328447|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
25181856|NCT01549964|50328444|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
25181857|NCT01549964|50328445|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
25181858|NCT01549964|50328446|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
25181859|NCT01549964|50328447|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
25181860|NCT01549964|50328444|FG000|80-Week Extension Period|Lost to Follow-up|1|||
25181861|NCT01549964|50328445|FG001|80-Week Extension Period|Lost to Follow-up|0|||
25181862|NCT01549964|50328446|FG002|80-Week Extension Period|Lost to Follow-up|2|||
25181863|NCT01549964|50328447|FG003|80-Week Extension Period|Lost to Follow-up|1|||
25181864|NCT01549964|50328444|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
25181865|NCT01549964|50328445|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
25181866|NCT01549964|50328446|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
25181867|NCT01549964|50328447|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
25181868|NCT01570244|50328529|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
25181869|NCT01535222|50328564|FG000|Overall Study|Inclusion/exclusion|0|||
25181870|NCT01535222|50328565|FG001|Overall Study|Inclusion/exclusion|0|||
25181871|NCT01535222|50328566|FG002|Overall Study|Inclusion/exclusion|1|||
25181872|NCT01535222|50328567|FG003|Overall Study|Inclusion/exclusion|0|||
25181873|NCT01535222|50328568|FG004|Overall Study|Inclusion/exclusion|0|||
25181874|NCT01535222|50328569|FG005|Overall Study|Inclusion/exclusion|0|||
25181875|NCT01549886|50328585|FG000|Overall Study|Sponsor's decision|2|||
25181876|NCT01549886|50328586|FG001|Overall Study|Sponsor's decision|3|||
25181877|NCT01443845|50328615|FG000|Overall Study|Protocol Violation|43|||
25181878|NCT01443845|50328616|FG001|Overall Study|Protocol Violation|45|||
25181879|NCT01443845|50328615|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
25181880|NCT01443845|50328616|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
25181881|NCT01443845|50328615|FG000|Overall Study|Deterioration in pulmonary function|1|||
25181882|NCT01443845|50328616|FG001|Overall Study|Deterioration in pulmonary function|4|||
25181883|NCT01443845|50328615|FG000|Overall Study|Lack of Efficacy|10|||
25181884|NCT01443845|50328616|FG001|Overall Study|Lack of Efficacy|5|||
25181885|NCT01443845|50328615|FG000|Overall Study|Adverse Event|64|||
25181886|NCT01443845|50328616|FG001|Overall Study|Adverse Event|138|||
25181887|NCT01443845|50328615|FG000|Overall Study|Withdrawal by Subject|63|||
25181888|NCT01443845|50328616|FG001|Overall Study|Withdrawal by Subject|67|||
25181889|NCT01443845|50328615|FG000|Overall Study|Military Conflict - Site Terminated|20|||
25181890|NCT01443845|50328616|FG001|Overall Study|Military Conflict - Site Terminated|21|||
25181891|NCT01443845|50328615|FG000|Overall Study|Lost to Follow-up|9|||
25181892|NCT01443845|50328616|FG001|Overall Study|Lost to Follow-up|13|||
25145664|NCT01435018|50259642|FG001|Overall Study|Enrollment Violation|1|||
25145665|NCT01435018|50259643|FG002|Overall Study|Enrollment Violation|0|||
25145666|NCT01435018|50259641|FG000|Overall Study|Never started chemotherapy|3|||
25145667|NCT01435018|50259642|FG001|Overall Study|Never started chemotherapy|0|||
25145668|NCT01435018|50259643|FG002|Overall Study|Never started chemotherapy|1|||
25145669|NCT01419184|50259655|FG000|Overall Study|Site data not available|3|||
25145670|NCT01419184|50259656|FG001|Overall Study|Site data not available|2|||
25145671|NCT01419184|50259655|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
25145672|NCT01419184|50259656|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
25181893|NCT01549652|50328625|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
25181894|NCT01549652|50328626|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
25145673|NCT01419184|50259655|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
25145674|NCT01419184|50259656|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
25181895|NCT01549652|50328627|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
25181896|NCT01549652|50328628|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
25181897|NCT01549652|50328625|FG000|Overall Study|Study Drug Titration Failure|5|||
25181898|NCT01549652|50328626|FG001|Overall Study|Study Drug Titration Failure|6|||
25181899|NCT01549652|50328627|FG002|Overall Study|Study Drug Titration Failure|0|||
25181900|NCT01549652|50328628|FG003|Overall Study|Study Drug Titration Failure|0|||
25181901|NCT01549652|50328625|FG000|Overall Study|Withdrawal Effect|0|||
25181902|NCT01549652|50328626|FG001|Overall Study|Withdrawal Effect|2|||
25181903|NCT01549652|50328627|FG002|Overall Study|Withdrawal Effect|0|||
25181904|NCT01549652|50328628|FG003|Overall Study|Withdrawal Effect|0|||
25181905|NCT01549652|50328625|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
25181906|NCT01549652|50328626|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
25181907|NCT01549652|50328627|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
25181908|NCT01549652|50328628|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
25181909|NCT01549652|50328625|FG000|Overall Study|Problem with Infusion|1|||
25181910|NCT01549652|50328626|FG001|Overall Study|Problem with Infusion|0|||
25181911|NCT01549652|50328627|FG002|Overall Study|Problem with Infusion|0|||
25181912|NCT01549652|50328628|FG003|Overall Study|Problem with Infusion|0|||
25181913|NCT01549652|50328625|FG000|Overall Study|Titration Non-Compliance|1|||
25181914|NCT01549652|50328626|FG001|Overall Study|Titration Non-Compliance|3|||
25181915|NCT01549652|50328627|FG002|Overall Study|Titration Non-Compliance|4|||
25181916|NCT01549652|50328628|FG003|Overall Study|Titration Non-Compliance|5|||
25181917|NCT01549652|50328625|FG000|Overall Study|Titration Side Effects|0|||
25181918|NCT01549652|50328626|FG001|Overall Study|Titration Side Effects|0|||
25181919|NCT01549652|50328627|FG002|Overall Study|Titration Side Effects|6|||
25181920|NCT01549652|50328628|FG003|Overall Study|Titration Side Effects|3|||
25181921|NCT01549652|50328625|FG000|Overall Study|Withdrawal by Subject|0|||
25181922|NCT01549652|50328626|FG001|Overall Study|Withdrawal by Subject|0|||
25181923|NCT01549652|50328627|FG002|Overall Study|Withdrawal by Subject|5|||
25181924|NCT01549652|50328628|FG003|Overall Study|Withdrawal by Subject|3|||
25181925|NCT01569464|50328636|FG000|Overall Study|Adverse Event|4|||
25181926|NCT01569464|50328637|FG001|Overall Study|Adverse Event|0|||
25181927|NCT01569464|50328636|FG000|Overall Study|Lack of Efficacy|1|||
25181928|NCT01569464|50328637|FG001|Overall Study|Lack of Efficacy|0|||
25181929|NCT01569464|50328636|FG000|Overall Study|Protocol Violation|1|||
25181930|NCT01569464|50328637|FG001|Overall Study|Protocol Violation|0|||
25181931|NCT01569464|50328636|FG000|Overall Study|Lost to Follow-up|2|||
25145675|NCT01419184|50259655|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
25145676|NCT01419184|50259656|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
25145677|NCT01419184|50259655|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
25145678|NCT01419184|50259656|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
25145679|NCT01419184|50259655|FG000|Overall Study|Participant randomized, not treated|1|||
25145680|NCT01419184|50259656|FG001|Overall Study|Participant randomized, not treated|0|||
25145681|NCT01417234|50259662|FG000|Overall Study|Subject non-compliant|3|||
25145682|NCT01417156|50259666|FG000|Overall Study|Adverse Event|12|||
25145683|NCT01417156|50259666|FG000|Overall Study|Protocol Violation|2|||
25145684|NCT01417078|50259670|FG000|Overall Study|Withdrawal by Subject|1|||
25145685|NCT01954394|50259678|FG000|Overall Study|Enrolled but not treated|1|||
25145686|NCT01954394|50259679|FG001|Overall Study|Enrolled but not treated|0|||
25145687|NCT01954394|50259678|FG000|Overall Study|Adverse Event|10|||
25145688|NCT01954394|50259679|FG001|Overall Study|Adverse Event|23|||
25145689|NCT01954394|50259678|FG000|Overall Study|Poor compliance to protocol|7|||
25145690|NCT01954394|50259679|FG001|Overall Study|Poor compliance to protocol|7|||
25145691|NCT01954394|50259678|FG000|Overall Study|Participant Moved|0|||
25145692|NCT01954394|50259679|FG001|Overall Study|Participant Moved|4|||
25145693|NCT01954394|50259678|FG000|Overall Study|Related to Study Drug administration|2|||
25145694|NCT01954394|50259679|FG001|Overall Study|Related to Study Drug administration|2|||
25145695|NCT01954394|50259678|FG000|Overall Study|Other than specified above|10|||
25145696|NCT01954394|50259679|FG001|Overall Study|Other than specified above|21|||
25145697|NCT01464424|50259687|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
25181932|NCT01569464|50328637|FG001|Overall Study|Lost to Follow-up|3|||
25181933|NCT01569464|50328636|FG000|Overall Study|Withdrawal by Subject|1|||
25145698|NCT01464424|50259688|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
25181934|NCT01569464|50328637|FG001|Overall Study|Withdrawal by Subject|1|||
25181935|NCT01569464|50328636|FG000|Overall Study|Other|1|||
25145699|NCT01902134|50259700|FG000|Overall Study|Adverse Event|3|||
25145700|NCT01902134|50259701|FG001|Overall Study|Adverse Event|1|||
25145701|NCT01902134|50259702|FG002|Overall Study|Adverse Event|2|||
25145702|NCT01902134|50259703|FG003|Overall Study|Adverse Event|1|||
25145703|NCT01902134|50259704|FG004|Overall Study|Adverse Event|1|||
25145704|NCT01902134|50259705|FG005|Overall Study|Adverse Event|3|||
25181936|NCT01569464|50328637|FG001|Overall Study|Other|1|||
25181937|NCT01534676|50328647|FG000|Overall Study|Study closed due to poor enrollment|2|||
25181938|NCT01534676|50328648|FG001|Overall Study|Study closed due to poor enrollment|1|||
25181939|NCT01442675|50328654|FG000|Overall Study|Protocol Violation|6|||
25181940|NCT01442675|50328654|FG000|Overall Study|Lost to Follow-up|2|||
25181941|NCT01442675|50328654|FG000|Overall Study|Withdrawal by Subject|4|||
25181942|NCT01534520|50328661|FG000|Overall Study|Adverse Event|0|||
25181943|NCT01534520|50328662|FG001|Overall Study|Adverse Event|1|||
25181944|NCT01534208|50328692|FG000|Overall Study|Lost to Follow-up|19|||
25181945|NCT01534208|50328693|FG001|Overall Study|Lost to Follow-up|14|||
25181946|NCT01534208|50328692|FG000|Overall Study|Withdrawal by Subject|6|||
25181947|NCT01534208|50328693|FG001|Overall Study|Withdrawal by Subject|20|||
25181948|NCT01534208|50328692|FG000|Overall Study|Adverse Event|15|||
25181949|NCT01534208|50328693|FG001|Overall Study|Adverse Event|8|||
25181950|NCT01534208|50328692|FG000|Overall Study|Physician Decision|2|||
25181951|NCT01534208|50328693|FG001|Overall Study|Physician Decision|0|||
25181952|NCT01534208|50328692|FG000|Overall Study|Lack of Efficacy|0|||
25181953|NCT01534208|50328693|FG001|Overall Study|Lack of Efficacy|3|||
25181954|NCT01534208|50328692|FG000|Overall Study|Protocol Violation|2|||
25181955|NCT01534208|50328693|FG001|Overall Study|Protocol Violation|2|||
25181956|NCT01534208|50328692|FG000|Overall Study|Sponsor decision|4|||
25181957|NCT01534208|50328693|FG001|Overall Study|Sponsor decision|1|||
25181958|NCT01534208|50328692|FG000|Overall Study|Subject relocation|2|||
25181959|NCT01534208|50328693|FG001|Overall Study|Subject relocation|0|||
25181960|NCT01534208|50328692|FG000|Overall Study|Lab assessment|2|||
25181961|NCT01534208|50328693|FG001|Overall Study|Lab assessment|1|||
25181962|NCT01534208|50328692|FG000|Overall Study|Eligibility error|3|||
25181963|NCT01534208|50328693|FG001|Overall Study|Eligibility error|0|||
25181964|NCT01534208|50328692|FG000|Overall Study|PCP decision|1|||
25181965|NCT01534208|50328693|FG001|Overall Study|PCP decision|0|||
25181966|NCT01534208|50328692|FG000|Overall Study|Needed prohibited meds|1|||
25181967|NCT01534208|50328693|FG001|Overall Study|Needed prohibited meds|0|||
25181968|NCT01548638|50328699|FG000|Overall Study|Protocol Violation|3|||
25181969|NCT01548638|50328699|FG000|Overall Study|Withdrawal by Subject|1|||
25181970|NCT01533428|50328723|FG000|Overall Study|Adverse Event|0|||
25181971|NCT01533428|50328724|FG001|Overall Study|Adverse Event|1|||
25181972|NCT01533428|50328723|FG000|Overall Study|Lost to Follow-up|2|||
25181973|NCT01533428|50328724|FG001|Overall Study|Lost to Follow-up|1|||
25181974|NCT01533428|50328723|FG000|Overall Study|Withdrawal by Subject|7|||
25181975|NCT01533428|50328724|FG001|Overall Study|Withdrawal by Subject|6|||
25145705|NCT01902134|50259700|FG000|Overall Study|Lack of Efficacy|0|||
25145706|NCT01902134|50259701|FG001|Overall Study|Lack of Efficacy|0|||
25145707|NCT01902134|50259702|FG002|Overall Study|Lack of Efficacy|2|||
25145708|NCT01902134|50259703|FG003|Overall Study|Lack of Efficacy|0|||
25145709|NCT01902134|50259704|FG004|Overall Study|Lack of Efficacy|0|||
25145710|NCT01902134|50259705|FG005|Overall Study|Lack of Efficacy|1|||
25145711|NCT01902134|50259700|FG000|Overall Study|Physician Decision|0|||
25145712|NCT01902134|50259701|FG001|Overall Study|Physician Decision|1|||
25145713|NCT01902134|50259702|FG002|Overall Study|Physician Decision|0|||
25145714|NCT01902134|50259703|FG003|Overall Study|Physician Decision|0|||
25145715|NCT01902134|50259704|FG004|Overall Study|Physician Decision|0|||
25145716|NCT01902134|50259705|FG005|Overall Study|Physician Decision|0|||
25145717|NCT01902134|50259700|FG000|Overall Study|Protocol Violation|0|||
25145718|NCT01902134|50259701|FG001|Overall Study|Protocol Violation|0|||
25145719|NCT01902134|50259702|FG002|Overall Study|Protocol Violation|0|||
25145720|NCT01902134|50259703|FG003|Overall Study|Protocol Violation|0|||
25145721|NCT01902134|50259704|FG004|Overall Study|Protocol Violation|0|||
25145722|NCT01902134|50259705|FG005|Overall Study|Protocol Violation|1|||
25145723|NCT01902134|50259700|FG000|Overall Study|Withdrawal by Subject|4|||
25145724|NCT01902134|50259701|FG001|Overall Study|Withdrawal by Subject|8|||
25145725|NCT01902134|50259702|FG002|Overall Study|Withdrawal by Subject|9|||
25145726|NCT01902134|50259703|FG003|Overall Study|Withdrawal by Subject|1|||
25181976|NCT01517984|50328733|FG000|Overall Study|Lost to Follow-up|0|||
25181977|NCT01517984|50328734|FG001|Overall Study|Lost to Follow-up|1|||
25181978|NCT01517984|50328735|FG002|Overall Study|Lost to Follow-up|0|||
25181979|NCT01517984|50328736|FG003|Overall Study|Lost to Follow-up|0|||
25145727|NCT01902134|50259704|FG004|Overall Study|Withdrawal by Subject|5|||
25145728|NCT01902134|50259705|FG005|Overall Study|Withdrawal by Subject|4|||
25145729|NCT01902134|50259700|FG000|Overall Study|no compliance|1|||
25145730|NCT01902134|50259701|FG001|Overall Study|no compliance|0|||
25145731|NCT01902134|50259702|FG002|Overall Study|no compliance|0|||
25181980|NCT01517984|50328733|FG000|Overall Study|Withdrawal by Subject|1|||
25181981|NCT01517984|50328734|FG001|Overall Study|Withdrawal by Subject|8|||
25181982|NCT01517984|50328735|FG002|Overall Study|Withdrawal by Subject|4|||
25181983|NCT01517984|50328736|FG003|Overall Study|Withdrawal by Subject|1|||
25145732|NCT01902134|50259703|FG003|Overall Study|no compliance|0|||
25145733|NCT01902134|50259704|FG004|Overall Study|no compliance|0|||
25145734|NCT01902134|50259705|FG005|Overall Study|no compliance|0|||
25145735|NCT01902134|50259700|FG000|Overall Study|Other|0|||
25145736|NCT01902134|50259701|FG001|Overall Study|Other|1|||
25145737|NCT01902134|50259702|FG002|Overall Study|Other|2|||
25181984|NCT01517984|50328733|FG000|Overall Study|Screen Failure|4|||
25181985|NCT01517984|50328734|FG001|Overall Study|Screen Failure|0|||
25181986|NCT01517984|50328735|FG002|Overall Study|Screen Failure|0|||
25145738|NCT01902134|50259703|FG003|Overall Study|Other|0|||
25145739|NCT01902134|50259704|FG004|Overall Study|Other|1|||
25145740|NCT01902134|50259705|FG005|Overall Study|Other|0|||
25181987|NCT01517984|50328736|FG003|Overall Study|Screen Failure|0|||
25181988|NCT01517984|50328733|FG000|Overall Study|Ineligible for randomization|0|||
25181989|NCT01517984|50328734|FG001|Overall Study|Ineligible for randomization|14|||
25181990|NCT01517984|50328735|FG002|Overall Study|Ineligible for randomization|0|||
25181991|NCT01517984|50328736|FG003|Overall Study|Ineligible for randomization|0|||
25181992|NCT01517750|50328764|FG000|Overall Study|Lost to Follow-up|1|||
25181993|NCT01517750|50328765|FG001|Overall Study|Lost to Follow-up|2|||
25181994|NCT01517750|50328766|FG002|Overall Study|Lost to Follow-up|4|||
25145741|NCT01954082|50259723|FG000|Overall Study|Study Suspension|42|||
25145742|NCT01954082|50259724|FG001|Overall Study|Study Suspension|36|||
25145743|NCT01954082|50259723|FG000|Overall Study|Adverse Event|10|||
25145744|NCT01954082|50259724|FG001|Overall Study|Adverse Event|4|||
25145745|NCT01954082|50259723|FG000|Overall Study|Intolerance|0|||
25181995|NCT01517750|50328767|FG003|Overall Study|Lost to Follow-up|1|||
25181996|NCT01548404|50328792|FG000|Overall Study|Adverse Event|3|||
25181997|NCT01548404|50328793|FG001|Overall Study|Adverse Event|1|||
25181998|NCT01548404|50328792|FG000|Overall Study|Physician Decision|2|||
25181999|NCT01548404|50328793|FG001|Overall Study|Physician Decision|1|||
25182000|NCT01548404|50328792|FG000|Overall Study|Inadequate response to study treatment|23|||
25182001|NCT01548404|50328793|FG001|Overall Study|Inadequate response to study treatment|7|||
25182002|NCT01548404|50328792|FG000|Overall Study|Lost to Follow-up|2|||
25182003|NCT01548404|50328793|FG001|Overall Study|Lost to Follow-up|0|||
25182004|NCT01548404|50328792|FG000|Overall Study|Withdrawal by Subject|0|||
25182005|NCT01548404|50328793|FG001|Overall Study|Withdrawal by Subject|3|||
25182006|NCT01548404|50328792|FG000|Overall Study|Other than specified above|0|||
25182007|NCT01548404|50328793|FG001|Overall Study|Other than specified above|2|||
25182008|NCT01547780|50328807|FG000|Baseline PET Scan|Physician Decision|1|||
25182009|NCT01547780|50328808|FG001|Baseline PET Scan|Physician Decision|0|||
25182010|NCT01547780|50328809|FG002|Baseline PET Scan|Physician Decision|1|||
25182011|NCT01547780|50328810|FG003|Baseline PET Scan|Physician Decision|0|||
25182012|NCT01547780|50328807|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
25182013|NCT01547780|50328808|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
25182014|NCT01547780|50328809|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
25182015|NCT01547780|50328810|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
25182016|NCT01547390|50328832|FG000|Overall Study|Withdrawal by Subject|10|||
25182017|NCT01547390|50328833|FG001|Overall Study|Withdrawal by Subject|7|||
25182018|NCT01547390|50328832|FG000|Overall Study|termination of pregnancy|0|||
25182019|NCT01547390|50328833|FG001|Overall Study|termination of pregnancy|1|||
25182020|NCT01547390|50328832|FG000|Overall Study|Lost to Follow-up|0|||
25182021|NCT01547390|50328833|FG001|Overall Study|Lost to Follow-up|2|||
25182022|NCT01547390|50328832|FG000|Overall Study|Adverse Event|3|||
25182023|NCT01547390|50328833|FG001|Overall Study|Adverse Event|0|||
25182024|NCT01546922|50328839|FG000|First Period of 10 Weeks|Protocol Violation|3|||
25182025|NCT01546922|50328840|FG001|First Period of 10 Weeks|Protocol Violation|1|||
25182026|NCT01546922|50328839|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
25182027|NCT01546922|50328840|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
25182028|NCT01546922|50328839|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
25182029|NCT01546922|50328840|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
25182030|NCT01546922|50328839|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
25182031|NCT01546922|50328840|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
25182032|NCT01546922|50328839|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
25182033|NCT01546922|50328840|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
25182034|NCT01532648|50328857|FG000|Overall Study|Lost to Follow-up|3|||
25182035|NCT01532648|50328858|FG001|Overall Study|Lost to Follow-up|4|||
25182036|NCT01532648|50328857|FG000|Overall Study|Lack of Efficacy|4|||
25182037|NCT01532648|50328858|FG001|Overall Study|Lack of Efficacy|1|||
25182038|NCT01532648|50328857|FG000|Overall Study|Protocol Violation|1|||
25182039|NCT01532648|50328858|FG001|Overall Study|Protocol Violation|1|||
25182040|NCT01532648|50328857|FG000|Overall Study|Adverse Event|12|||
25182041|NCT01532648|50328858|FG001|Overall Study|Adverse Event|9|||
25182042|NCT01532648|50328857|FG000|Overall Study|Withdrawal by Subject|16|||
25182043|NCT01532648|50328858|FG001|Overall Study|Withdrawal by Subject|2|||
25182044|NCT01532570|50328888|FG000|Overall Study|Lack of Efficacy|1|||
25182045|NCT01532570|50328889|FG001|Overall Study|Lack of Efficacy|0|||
25182046|NCT01532570|50328890|FG002|Overall Study|Lack of Efficacy|0|||
25182047|NCT01532570|50328891|FG003|Overall Study|Lack of Efficacy|0|||
25145746|NCT01954082|50259724|FG001|Overall Study|Intolerance|1|||
25145747|NCT01954082|50259723|FG000|Overall Study|Non-compliance|6|||
25145748|NCT01954082|50259724|FG001|Overall Study|Non-compliance|4|||
25182048|NCT01532570|50328888|FG000|Overall Study|Withdrawal by Subject|0|||
25182049|NCT01532570|50328889|FG001|Overall Study|Withdrawal by Subject|1|||
25274554|NCT01199016|50588573|FG000|Overall Study|Withdrawal by Subject|21|||
25145749|NCT01954082|50259723|FG000|Overall Study|Physician Decision|2|||
25182050|NCT01532570|50328890|FG002|Overall Study|Withdrawal by Subject|0|||
25182051|NCT01532570|50328891|FG003|Overall Study|Withdrawal by Subject|0|||
25182052|NCT01532414|50328937|FG000|Overall Study|Lost to Follow-up|3|||
25182053|NCT01532414|50328938|FG001|Overall Study|Lost to Follow-up|0|||
25182054|NCT01532414|50328939|FG002|Overall Study|Lost to Follow-up|1|||
25182055|NCT01532414|50328937|FG000|Overall Study|Withdrawal by Subject|3|||
25182056|NCT01532414|50328938|FG001|Overall Study|Withdrawal by Subject|0|||
25182057|NCT01532414|50328939|FG002|Overall Study|Withdrawal by Subject|0|||
25182058|NCT01532414|50328937|FG000|Overall Study|No V6 semen sample|0|||
25182059|NCT01532414|50328938|FG001|Overall Study|No V6 semen sample|1|||
25182060|NCT01532414|50328939|FG002|Overall Study|No V6 semen sample|0|||
25182061|NCT01532414|50328937|FG000|Overall Study|Adverse Event|0|||
25182062|NCT01532414|50328938|FG001|Overall Study|Adverse Event|1|||
25182063|NCT01532414|50328939|FG002|Overall Study|Adverse Event|1|||
25182064|NCT01532414|50328937|FG000|Overall Study|Unable to complete 24 hour PK|0|||
25182065|NCT01532414|50328938|FG001|Overall Study|Unable to complete 24 hour PK|0|||
25182066|NCT01532414|50328939|FG002|Overall Study|Unable to complete 24 hour PK|1|||
25182067|NCT01532414|50328937|FG000|Overall Study|Withdrawn by sponsor|1|||
25182068|NCT01532414|50328938|FG001|Overall Study|Withdrawn by sponsor|0|||
25182069|NCT01532414|50328939|FG002|Overall Study|Withdrawn by sponsor|0|||
25182070|NCT01441973|50328949|FG000|Overall Study|Disease progression|8|||
25182071|NCT01441973|50328950|FG001|Overall Study|Disease progression|6|||
25182072|NCT01441973|50328949|FG000|Overall Study|Adverse event unrelated to study drug|3|||
25182073|NCT01441973|50328950|FG001|Overall Study|Adverse event unrelated to study drug|2|||
25182074|NCT01441973|50328949|FG000|Overall Study|Participant request to discontinue|1|||
25182075|NCT01441973|50328950|FG001|Overall Study|Participant request to discontinue|1|||
25182076|NCT01441973|50328949|FG000|Overall Study|Poor compliance/noncompliance|0|||
25182077|NCT01441973|50328950|FG001|Overall Study|Poor compliance/noncompliance|1|||
25182078|NCT01441973|50328949|FG000|Overall Study|Administrative reason by sponsor|3|||
25182079|NCT01441973|50328950|FG001|Overall Study|Administrative reason by sponsor|5|||
25182080|NCT01441973|50328949|FG000|Overall Study|Participant withdrew consent|0|||
25182081|NCT01441973|50328950|FG001|Overall Study|Participant withdrew consent|1|||
25182082|NCT01575899|50328969|FG000|Overall Study|Lost to Follow-up|3|||
25182083|NCT01575899|50328970|FG001|Overall Study|Lost to Follow-up|4|||
25182084|NCT01575899|50328971|FG002|Overall Study|Lost to Follow-up|2|||
25182085|NCT01575899|50328969|FG000|Overall Study|Protocol Violation|2|||
25182086|NCT01575899|50328970|FG001|Overall Study|Protocol Violation|1|||
25182087|NCT01575899|50328971|FG002|Overall Study|Protocol Violation|0|||
25182088|NCT01440881|50328983|FG000|Overall Study|Death|0|||
25182089|NCT01440881|50328984|FG001|Overall Study|Death|1|||
25182090|NCT01575197|50328999|FG000|Overall Study|Migration out of study area|1|||
25182091|NCT01575197|50329000|FG001|Overall Study|Migration out of study area|5|||
25182092|NCT01575197|50329001|FG002|Overall Study|Migration out of study area|4|||
25182093|NCT01575197|50328999|FG000|Overall Study|SAE|0|||
25182094|NCT01575197|50329000|FG001|Overall Study|SAE|1|||
25182095|NCT01575197|50329001|FG002|Overall Study|SAE|0|||
25182096|NCT01575197|50328999|FG000|Overall Study|Lost to Follow-up|0|||
25182097|NCT01575197|50329000|FG001|Overall Study|Lost to Follow-up|1|||
25182098|NCT01575197|50329001|FG002|Overall Study|Lost to Follow-up|0|||
25182099|NCT01575197|50328999|FG000|Overall Study|Withdrawal by Subject|0|||
25182100|NCT01575197|50329000|FG001|Overall Study|Withdrawal by Subject|1|||
25182101|NCT01575197|50329001|FG002|Overall Study|Withdrawal by Subject|1|||
25182102|NCT01575197|50328999|FG000|Overall Study|Protocol Violation|2|||
25182103|NCT01575197|50329000|FG001|Overall Study|Protocol Violation|1|||
25182104|NCT01575197|50329001|FG002|Overall Study|Protocol Violation|1|||
25182105|NCT01574651|50329032|FG000|Overall Study|Lost to Follow-up|2|||
25182106|NCT01574651|50329033|FG001|Overall Study|Lost to Follow-up|4|||
25182107|NCT01574651|50329032|FG000|Overall Study|Administrative problems|0|||
25182108|NCT01574651|50329033|FG001|Overall Study|Administrative problems|1|||
25182109|NCT01574651|50329032|FG000|Overall Study|Death|3|||
25182110|NCT01574651|50329033|FG001|Overall Study|Death|3|||
25182111|NCT01574651|50329032|FG000|Overall Study|Patient's inability to use the device|0|||
25182112|NCT01574651|50329033|FG001|Overall Study|Patient's inability to use the device|1|||
25182113|NCT01574651|50329032|FG000|Overall Study|Adverse Event|36|||
25182114|NCT01574651|50329033|FG001|Overall Study|Adverse Event|27|||
25182115|NCT01574651|50329032|FG000|Overall Study|Abnormal laboratory value(s)|1|||
25182116|NCT01574651|50329033|FG001|Overall Study|Abnormal laboratory value(s)|0|||
25182117|NCT01574651|50329032|FG000|Overall Study|Abnormal test procedure result(s)|1|||
25182118|NCT01574651|50329033|FG001|Overall Study|Abnormal test procedure result(s)|1|||
25182119|NCT01574651|50329032|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
25182120|NCT01574651|50329033|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
25182121|NCT01574651|50329032|FG000|Overall Study|Protocol Violation|3|||
25182122|NCT01574651|50329033|FG001|Overall Study|Protocol Violation|5|||
25274555|NCT01199016|50588573|FG000|Overall Study|Lost to Follow-up|25|||
25182123|NCT01574651|50329032|FG000|Overall Study|Withdrawal by Subject|9|||
25182124|NCT01574651|50329033|FG001|Overall Study|Withdrawal by Subject|10|||
25182125|NCT01440803|50329045|FG000|Overall Study|Met study stopping rule|2|||
25182126|NCT01440803|50329046|FG001|Overall Study|Met study stopping rule|1|||
25182127|NCT01440803|50329045|FG000|Overall Study|Lost to Follow-up|0|||
25182128|NCT01440803|50329046|FG001|Overall Study|Lost to Follow-up|2|||
25182129|NCT01440803|50329045|FG000|Overall Study|Withdrawal by Subject|0|||
25182130|NCT01440803|50329046|FG001|Overall Study|Withdrawal by Subject|1|||
25182131|NCT01517282|50329057|FG000|Overall Study|Consent withdrawn|0|||
25182132|NCT01517282|50329058|FG001|Overall Study|Consent withdrawn|1|||
25182133|NCT01517282|50329059|FG002|Overall Study|Consent withdrawn|1|||
25182134|NCT01517282|50329060|FG003|Overall Study|Consent withdrawn|1|||
25182135|NCT01517282|50329057|FG000|Overall Study|Physician Decision|1|||
25182136|NCT01517282|50329058|FG001|Overall Study|Physician Decision|0|||
25182137|NCT01517282|50329059|FG002|Overall Study|Physician Decision|0|||
25182138|NCT01517282|50329060|FG003|Overall Study|Physician Decision|0|||
25182139|NCT01440647|50329081|FG000|Overall Study|Death|2|||
25182140|NCT01440647|50329082|FG001|Overall Study|Death|3|||
25182141|NCT01516970|50329090|FG000|Overall Study|Lost to Follow-up|7|||
25182142|NCT01516970|50329091|FG001|Overall Study|Lost to Follow-up|8|||
25182143|NCT01516970|50329090|FG000|Overall Study|Adverse Event|1|||
25182144|NCT01516970|50329091|FG001|Overall Study|Adverse Event|5|||
25182145|NCT01516970|50329090|FG000|Overall Study|Withdrawal by Subject|1|||
25182146|NCT01516970|50329091|FG001|Overall Study|Withdrawal by Subject|1|||
25182147|NCT01516970|50329090|FG000|Overall Study|Other|9|||
25182148|NCT01516970|50329091|FG001|Overall Study|Other|7|||
25182149|NCT01516892|50329112|FG000|Overall Study|Adverse Event|25|||
25182150|NCT01516892|50329112|FG000|Overall Study|Lack of Efficacy|35|||
25182151|NCT01516892|50329112|FG000|Overall Study|Pregnancy|5|||
25182152|NCT01516892|50329112|FG000|Overall Study|Lost to Follow-up|82|||
25182153|NCT01516892|50329112|FG000|Overall Study|Subject Withdrew Consent|92|||
25182154|NCT01516892|50329112|FG000|Overall Study|Protocol Violation|60|||
25182155|NCT01516892|50329112|FG000|Overall Study|Other Miscellaneous Reasons|43|||
25182156|NCT01516892|50329112|FG000|Overall Study|Missing|1|||
25182157|NCT01516736|50329137|FG000|Overall Study|Withdrawal by Subject|10|||
25182158|NCT01516736|50329138|FG001|Overall Study|Withdrawal by Subject|4|||
25182159|NCT01516736|50329137|FG000|Overall Study|Adverse Event|4|||
25182160|NCT01516736|50329138|FG001|Overall Study|Adverse Event|5|||
25182161|NCT01516736|50329137|FG000|Overall Study|Death|3|||
25182162|NCT01516736|50329138|FG001|Overall Study|Death|1|||
25182163|NCT01516736|50329137|FG000|Overall Study|Physician Decision|2|||
25182164|NCT01516736|50329138|FG001|Overall Study|Physician Decision|1|||
25182165|NCT01516736|50329137|FG000|Overall Study|Lack of Efficacy|1|||
25182166|NCT01516736|50329138|FG001|Overall Study|Lack of Efficacy|0|||
25182167|NCT01516736|50329137|FG000|Overall Study|Protocol Violation|0|||
25182168|NCT01516736|50329138|FG001|Overall Study|Protocol Violation|1|||
25182169|NCT01516736|50329137|FG000|Overall Study|Other (not specified)|0|||
25182170|NCT01516736|50329138|FG001|Overall Study|Other (not specified)|1|||
25182171|NCT01546688|50329150|FG000|Overall Study|Adverse Event|0|||
25182172|NCT01546688|50329151|FG001|Overall Study|Adverse Event|4|||
25182173|NCT01546688|50329150|FG000|Overall Study|Withdrawal by Subject|2|||
25182174|NCT01546688|50329151|FG001|Overall Study|Withdrawal by Subject|1|||
25182175|NCT01546688|50329150|FG000|Overall Study|Lack of Efficacy|1|||
25182176|NCT01546688|50329151|FG001|Overall Study|Lack of Efficacy|0|||
25182177|NCT01516034|50329157|FG000|Overall Study|Physician Decision|1|||
25182178|NCT01516034|50329157|FG000|Overall Study|Lack of Efficacy|7|||
25182179|NCT01440569|50329168|FG000|Main Study|Enrolled but not treated|1|||
25274556|NCT01198548|50588577|FG000|Overall Study|Disease Progression|9|||
25145750|NCT01954082|50259724|FG001|Overall Study|Physician Decision|0|||
25145751|NCT01954082|50259723|FG000|Overall Study|Parent Decision|1|||
25145752|NCT01954082|50259724|FG001|Overall Study|Parent Decision|0|||
25145753|NCT01954082|50259723|FG000|Overall Study|Withdrawal by Subject|0|||
25145754|NCT01954082|50259724|FG001|Overall Study|Withdrawal by Subject|1|||
25145755|NCT01954082|50259723|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
25145756|NCT01954082|50259724|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
25274557|NCT01198548|50588577|FG000|Overall Study|Administrative Decision|1|||
25145757|NCT01954082|50259723|FG000|Overall Study|Redirection of Care|0|||
25145758|NCT01954082|50259724|FG001|Overall Study|Redirection of Care|2|||
25145759|NCT01954082|50259723|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
25145760|NCT01954082|50259724|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
25145761|NCT01954082|50259723|FG000|Overall Study|Comfort Care|0|||
25145762|NCT01954082|50259724|FG001|Overall Study|Comfort Care|1|||
25182180|NCT01440569|50329169|FG001|Main Study|Enrolled but not treated|0|||
25274558|NCT01198470|50588581|FG000|Overall Study|Adverse Event|2|||
25145763|NCT01954082|50259723|FG000|Overall Study|Infant Moved|0|||
25182181|NCT01440569|50329168|FG000|Main Study|Adverse Event|9|||
25182182|NCT01440569|50329169|FG001|Main Study|Adverse Event|0|||
25182183|NCT01440569|50329168|FG000|Main Study|Pregnancy|1|||
25182184|NCT01440569|50329169|FG001|Main Study|Pregnancy|0|||
25182185|NCT01440569|50329168|FG000|Main Study|Investigator's Discretion|1|||
25182186|NCT01440569|50329169|FG001|Main Study|Investigator's Discretion|1|||
25145764|NCT01954082|50259724|FG001|Overall Study|Infant Moved|1|||
25145765|NCT01954082|50259723|FG000|Overall Study|Randomized not Treated|4|||
25145766|NCT01954082|50259724|FG001|Overall Study|Randomized not Treated|2|||
25145767|NCT01417000|50259732|FG000|Overall Study|Death|59|||
25145768|NCT01417000|50259733|FG001|Overall Study|Death|28|||
25145769|NCT01417000|50259732|FG000|Overall Study|Lost to Follow-up|1|||
25145770|NCT01417000|50259733|FG001|Overall Study|Lost to Follow-up|0|||
25145771|NCT01417000|50259732|FG000|Overall Study|Study Terminated by Sponsor|1|||
25145772|NCT01417000|50259733|FG001|Overall Study|Study Terminated by Sponsor|1|||
25145773|NCT01416610|50259739|FG000|Overall Study|Adverse Event|4|||
25145774|NCT01416610|50259739|FG000|Overall Study|Adverse Event -Patient decision|3|||
25145775|NCT01416610|50259739|FG000|Overall Study|Lack of Efficacy|4|||
25145776|NCT01416610|50259739|FG000|Overall Study|No reason given|5|||
25145777|NCT01416610|50259739|FG000|Overall Study|Withdrawal by Subject|13|||
25145778|NCT01416610|50259739|FG000|Overall Study|Lost to Follow-up|7|||
25145779|NCT01416610|50259739|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
25145780|NCT01416142|50259747|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
25145781|NCT01416142|50259748|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
25145782|NCT01416142|50259749|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
25145783|NCT01415986|50259757|FG000|Overall Study|Lost to Follow-up|1|||
25145784|NCT01415908|50259764|FG000|Overall Study|Withdrawal by Subject|1|||
25145785|NCT01415908|50259765|FG001|Overall Study|Withdrawal by Subject|0|||
25145786|NCT01415518|50259773|FG000|Overall Study|Withdrawal by Subject|2|||
25145787|NCT01415518|50259774|FG001|Overall Study|Withdrawal by Subject|12|||
25145788|NCT01415518|50259773|FG000|Overall Study|Protocol Violation|6|||
25145789|NCT01415518|50259774|FG001|Overall Study|Protocol Violation|8|||
25145790|NCT01415518|50259773|FG000|Overall Study|Lost to Follow-up|3|||
25182187|NCT01440569|50329168|FG000|Main Study|Withdrew Consent|7|||
25182188|NCT01440569|50329169|FG001|Main Study|Withdrew Consent|1|||
25182189|NCT01440569|50329168|FG000|Main Study|Lost to Follow-up|13|||
25182190|NCT01440569|50329169|FG001|Main Study|Lost to Follow-up|2|||
25182191|NCT01440569|50329168|FG000|Main Study|Subject Non-Compliance|3|||
25182192|NCT01440569|50329169|FG001|Main Study|Subject Non-Compliance|0|||
25145791|NCT01415518|50259774|FG001|Overall Study|Lost to Follow-up|5|||
25145792|NCT01415518|50259773|FG000|Overall Study|Adverse Event|3|||
25145793|NCT01415518|50259774|FG001|Overall Study|Adverse Event|4|||
25145794|NCT01415518|50259773|FG000|Overall Study|Death|1|||
25145795|NCT01415518|50259774|FG001|Overall Study|Death|1|||
25145796|NCT01415518|50259773|FG000|Overall Study|Condition under Investigation Worsened|1|||
25145797|NCT01415518|50259774|FG001|Overall Study|Condition under Investigation Worsened|1|||
25145798|NCT01393600|50259780|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
25145799|NCT01393600|50259781|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
25145800|NCT01393600|50259782|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
25145801|NCT01393600|50259783|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
25145802|NCT01393600|50259780|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
25145803|NCT01393600|50259781|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
25145804|NCT01393600|50259782|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
25145805|NCT01393600|50259783|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
25145806|NCT01393600|50259780|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
25145807|NCT01393600|50259781|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
25145808|NCT01393600|50259782|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
25145809|NCT01393600|50259783|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
25145810|NCT01393600|50259780|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
25145811|NCT01393600|50259781|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
25145812|NCT01393600|50259782|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
25145813|NCT01393600|50259783|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
25145814|NCT01393600|50259780|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
25145815|NCT01393600|50259781|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
25145816|NCT01393600|50259782|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
25145817|NCT01393600|50259783|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
25145818|NCT01393600|50259780|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
25145819|NCT01393600|50259781|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
25145820|NCT01393600|50259782|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
25145821|NCT01393600|50259783|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
25145822|NCT01393600|50259780|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
25145823|NCT01393600|50259781|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
25145824|NCT01393600|50259782|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
25145825|NCT01393600|50259783|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
25145826|NCT01432756|50259799|FG000|Overall Study|Lost to Follow-up|1|||
25145827|NCT01432756|50259800|FG001|Overall Study|Lost to Follow-up|0|||
25182193|NCT01440569|50329168|FG000|Main Study|Protocol Violation|1|||
25182194|NCT01440569|50329169|FG001|Main Study|Protocol Violation|0|||
25182195|NCT01440569|50329168|FG000|Open-Label Rollover Phase|Adverse Event|3|||
25145828|NCT01432756|50259801|FG002|Overall Study|Lost to Follow-up|2|||
25145829|NCT01432756|50259802|FG003|Overall Study|Lost to Follow-up|1|||
25145830|NCT01432600|50259813|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
25145831|NCT01432600|50259814|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
25145832|NCT01432600|50259815|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
25145833|NCT01432444|50259825|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
25145834|NCT01432444|50259826|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
25145835|NCT01432444|50259827|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
25145836|NCT01432444|50259825|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
25145837|NCT01432444|50259826|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
25145838|NCT01432444|50259827|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
25145839|NCT01432444|50259825|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
25145840|NCT01432444|50259826|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
25145841|NCT01432444|50259827|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
25182196|NCT01440569|50329169|FG001|Open-Label Rollover Phase|Adverse Event|0|||
25182197|NCT01440569|50329168|FG000|Open-Label Rollover Phase|Pregnancy|1|||
25182198|NCT01440569|50329169|FG001|Open-Label Rollover Phase|Pregnancy|0|||
25182199|NCT01440569|50329168|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
25182200|NCT01440569|50329169|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
25182201|NCT01440569|50329168|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
25182202|NCT01440569|50329169|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
25182203|NCT01440569|50329168|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
25182204|NCT01440569|50329169|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
25182205|NCT01440569|50329168|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
25182206|NCT01440569|50329169|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
25182207|NCT01440569|50329168|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
25182208|NCT01440569|50329169|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
25182209|NCT01546142|50329192|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
25182210|NCT01546142|50329193|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
25182211|NCT01546142|50329192|FG000|Overall Study|Subject Noncompliance|1|||
25182212|NCT01546142|50329193|FG001|Overall Study|Subject Noncompliance|1|||
25182213|NCT01546142|50329192|FG000|Overall Study|Adverse Event|6|||
25182214|NCT01546142|50329193|FG001|Overall Study|Adverse Event|3|||
25145842|NCT01432444|50259825|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
25145843|NCT01432444|50259826|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
25145844|NCT01432444|50259827|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
25145845|NCT01432444|50259825|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
25145846|NCT01432444|50259826|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
25182215|NCT01546142|50329192|FG000|Overall Study|Lost to Follow-up|20|||
25182216|NCT01546142|50329193|FG001|Overall Study|Lost to Follow-up|15|||
25182217|NCT01546142|50329192|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
25182218|NCT01546142|50329193|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
25182219|NCT01546142|50329192|FG000|Overall Study|Subject Randomized but Not Treated|1|||
25182220|NCT01546142|50329193|FG001|Overall Study|Subject Randomized but Not Treated|0|||
25182221|NCT01440101|50329227|FG000|Overall Study|Adverse Event|2|||
25182222|NCT01440101|50329228|FG001|Overall Study|Adverse Event|0|||
25182223|NCT01440101|50329229|FG002|Overall Study|Adverse Event|0|||
25182224|NCT01440101|50329227|FG000|Overall Study|Withdrawal by Subject|0|||
25182225|NCT01440101|50329228|FG001|Overall Study|Withdrawal by Subject|3|||
25182226|NCT01440101|50329229|FG002|Overall Study|Withdrawal by Subject|1|||
25182227|NCT01440101|50329227|FG000|Overall Study|Other|0|||
25182228|NCT01440101|50329228|FG001|Overall Study|Other|1|||
25182229|NCT01440101|50329229|FG002|Overall Study|Other|0|||
25182230|NCT01530464|50329240|FG000|Washout (24h)|Withdrawal by Subject|1|||
25182231|NCT01530464|50329241|FG001|Washout (24h)|Withdrawal by Subject|0|||
25182232|NCT01530464|50329240|FG000|Washout (24h)|Withdrawal by Subject|0|||
25182233|NCT01530464|50329241|FG001|Washout (24h)|Withdrawal by Subject|1|||
25182234|NCT01439945|50329308|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
25182235|NCT01439945|50329309|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
25182236|NCT01439945|50329310|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
25182237|NCT01439945|50329311|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
25182238|NCT01439945|50329308|FG000|Double-Blind Treatment Phase|Ineligible|1|||
25182239|NCT01439945|50329309|FG001|Double-Blind Treatment Phase|Ineligible|2|||
25182240|NCT01439945|50329310|FG002|Double-Blind Treatment Phase|Ineligible|0|||
25182241|NCT01439945|50329311|FG003|Double-Blind Treatment Phase|Ineligible|1|||
25182242|NCT01420081|50329416|FG000|Overall Study|Death|1|||
25182243|NCT01420081|50329417|FG001|Overall Study|Death|0|||
25182244|NCT01420081|50329418|FG002|Overall Study|Death|8|||
25182245|NCT01420081|50329419|FG003|Overall Study|Death|0|||
25145847|NCT01432444|50259827|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
25145848|NCT01432444|50259825|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
25182246|NCT01420081|50329420|FG004|Overall Study|Death|7|||
25182247|NCT01420081|50329421|FG005|Overall Study|Death|12|||
25182248|NCT01420081|50329422|FG006|Overall Study|Death|0|||
25182249|NCT01420081|50329423|FG007|Overall Study|Death|1|||
25182250|NCT01420081|50329424|FG008|Overall Study|Death|1|||
25182251|NCT01420081|50329416|FG000|Overall Study|Lost to Follow-up|0|||
25182252|NCT01420081|50329417|FG001|Overall Study|Lost to Follow-up|0|||
25182253|NCT01420081|50329418|FG002|Overall Study|Lost to Follow-up|0|||
25182254|NCT01420081|50329419|FG003|Overall Study|Lost to Follow-up|0|||
25182255|NCT01420081|50329420|FG004|Overall Study|Lost to Follow-up|1|||
25182256|NCT01420081|50329421|FG005|Overall Study|Lost to Follow-up|1|||
25182257|NCT01420081|50329422|FG006|Overall Study|Lost to Follow-up|0|||
25182258|NCT01420081|50329423|FG007|Overall Study|Lost to Follow-up|0|||
25182259|NCT01420081|50329424|FG008|Overall Study|Lost to Follow-up|0|||
25182260|NCT01420081|50329416|FG000|Overall Study|Study Terminated by Sponsor|2|||
25182261|NCT01420081|50329417|FG001|Overall Study|Study Terminated by Sponsor|1|||
25182262|NCT01420081|50329418|FG002|Overall Study|Study Terminated by Sponsor|1|||
25182263|NCT01420081|50329419|FG003|Overall Study|Study Terminated by Sponsor|3|||
25182264|NCT01420081|50329420|FG004|Overall Study|Study Terminated by Sponsor|11|||
25182265|NCT01420081|50329421|FG005|Overall Study|Study Terminated by Sponsor|7|||
25182266|NCT01420081|50329422|FG006|Overall Study|Study Terminated by Sponsor|3|||
25182267|NCT01420081|50329423|FG007|Overall Study|Study Terminated by Sponsor|2|||
25182268|NCT01420081|50329424|FG008|Overall Study|Study Terminated by Sponsor|2|||
25182269|NCT01420081|50329416|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
25182270|NCT01420081|50329417|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
25182271|NCT01420081|50329418|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
25182272|NCT01420081|50329419|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
25182273|NCT01420081|50329420|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
25182274|NCT01420081|50329421|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
25182275|NCT01420081|50329422|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
25182276|NCT01420081|50329423|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
25182277|NCT01420081|50329424|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
25182278|NCT01420081|50329416|FG000|Overall Study|Other Reasons|0|||
25182279|NCT01420081|50329417|FG001|Overall Study|Other Reasons|0|||
25182280|NCT01420081|50329418|FG002|Overall Study|Other Reasons|1|||
25182281|NCT01420081|50329419|FG003|Overall Study|Other Reasons|0|||
25182282|NCT01420081|50329420|FG004|Overall Study|Other Reasons|0|||
25182283|NCT01420081|50329421|FG005|Overall Study|Other Reasons|0|||
25182284|NCT01420081|50329422|FG006|Overall Study|Other Reasons|0|||
25182285|NCT01420081|50329423|FG007|Overall Study|Other Reasons|0|||
25182286|NCT01420081|50329424|FG008|Overall Study|Other Reasons|0|||
25182287|NCT01439867|50329442|FG000|Overall Study|Non-compliance|0|||
25182288|NCT01439867|50329443|FG001|Overall Study|Non-compliance|1|||
25182289|NCT01439867|50329442|FG000|Overall Study|Withdrawal by Subject|1|||
25182290|NCT01439867|50329443|FG001|Overall Study|Withdrawal by Subject|2|||
25182291|NCT01439867|50329442|FG000|Overall Study|Administrative Decision|4|||
25182292|NCT01439867|50329443|FG001|Overall Study|Administrative Decision|5|||
25182293|NCT01439867|50329442|FG000|Overall Study|Protocol-specified Criteria|1|||
25182294|NCT01439867|50329443|FG001|Overall Study|Protocol-specified Criteria|0|||
25182295|NCT01439711|50329460|FG000|Overall Study|Ineligible|13|||
25182296|NCT01439711|50329460|FG000|Overall Study|Cancel|3|||
25182297|NCT01439711|50329460|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
25182298|NCT01439711|50329460|FG000|Overall Study|Adverse Event|5|||
25182299|NCT01439711|50329460|FG000|Overall Study|Withdrawal by Subject|3|||
25182300|NCT01439711|50329460|FG000|Overall Study|Progression During Active Tx|3|||
25182301|NCT01439711|50329460|FG000|Overall Study|Noncompliance|3|||
25182302|NCT01439711|50329460|FG000|Overall Study|No MRI|9|||
25182303|NCT01439555|50329464|FG000|Overall Study|Protocol Violation|1|||
25182304|NCT01544582|50329484|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
25182305|NCT01544582|50329485|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
25182306|NCT01544582|50329486|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
25182307|NCT01544582|50329487|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
25182308|NCT01544582|50329484|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
25182309|NCT01544582|50329485|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
25182310|NCT01544582|50329486|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
25182311|NCT01544582|50329487|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
25182312|NCT01544582|50329484|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
25182313|NCT01544582|50329485|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
25182314|NCT01544582|50329486|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
25182315|NCT01544582|50329487|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
25182316|NCT01544582|50329484|FG000|Analysis Population|Physician Decision|0|||
25182317|NCT01544582|50329485|FG001|Analysis Population|Physician Decision|13|||
25182318|NCT01544582|50329486|FG002|Analysis Population|Physician Decision|10|||
25182319|NCT01544582|50329487|FG003|Analysis Population|Physician Decision|9|||
25182320|NCT01544582|50329484|FG000|Analysis Population|Safety Reason|0|||
25182321|NCT01544582|50329485|FG001|Analysis Population|Safety Reason|33|||
25182322|NCT01544582|50329486|FG002|Analysis Population|Safety Reason|31|||
25182323|NCT01544582|50329487|FG003|Analysis Population|Safety Reason|8|||
25182324|NCT01544582|50329484|FG000|Analysis Population|Effectiveness Reason|0|||
25182325|NCT01544582|50329485|FG001|Analysis Population|Effectiveness Reason|48|||
25182326|NCT01544582|50329486|FG002|Analysis Population|Effectiveness Reason|29|||
25182327|NCT01544582|50329487|FG003|Analysis Population|Effectiveness Reason|12|||
25182328|NCT01544582|50329484|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
25182329|NCT01544582|50329485|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
25182330|NCT01544582|50329486|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
25182331|NCT01544582|50329487|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
25182332|NCT01544582|50329484|FG000|Analysis Population|Lost to Follow-up|0|||
25182333|NCT01544582|50329485|FG001|Analysis Population|Lost to Follow-up|6|||
25182334|NCT01544582|50329486|FG002|Analysis Population|Lost to Follow-up|6|||
25182335|NCT01544582|50329487|FG003|Analysis Population|Lost to Follow-up|5|||
25182336|NCT01544582|50329484|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
25182337|NCT01544582|50329485|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
25182338|NCT01544582|50329486|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
25182339|NCT01544582|50329487|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
25182340|NCT01544582|50329484|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
25182341|NCT01544582|50329485|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
25182342|NCT01544582|50329486|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
25182343|NCT01544582|50329487|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
25182344|NCT01544582|50329484|FG000|Analysis Population|Intolerance|0|||
25182345|NCT01544582|50329485|FG001|Analysis Population|Intolerance|1|||
25182346|NCT01544582|50329486|FG002|Analysis Population|Intolerance|0|||
25182347|NCT01544582|50329487|FG003|Analysis Population|Intolerance|0|||
25145849|NCT01432444|50259826|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
25145850|NCT01432444|50259827|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
25145851|NCT01432444|50259825|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
25145852|NCT01432444|50259826|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
25145853|NCT01432444|50259827|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
25145854|NCT01432444|50259825|FG000|Treatment Phase|Lost to Follow-up|0|||
25145855|NCT01432444|50259826|FG001|Treatment Phase|Lost to Follow-up|33|||
25145856|NCT01432444|50259827|FG002|Treatment Phase|Lost to Follow-up|0|||
25182348|NCT01544582|50329484|FG000|Analysis Population|Liver Transplantation|0|||
25182349|NCT01544582|50329485|FG001|Analysis Population|Liver Transplantation|0|||
25182350|NCT01544582|50329486|FG002|Analysis Population|Liver Transplantation|1|||
25182351|NCT01544582|50329487|FG003|Analysis Population|Liver Transplantation|0|||
25182352|NCT01544582|50329484|FG000|Analysis Population|No Social Insurance|0|||
25182353|NCT01544582|50329485|FG001|Analysis Population|No Social Insurance|0|||
25182354|NCT01544582|50329486|FG002|Analysis Population|No Social Insurance|1|||
25182355|NCT01544582|50329487|FG003|Analysis Population|No Social Insurance|0|||
25182356|NCT01544582|50329484|FG000|Analysis Population|Poor Adherence|0|||
25182357|NCT01544582|50329485|FG001|Analysis Population|Poor Adherence|0|||
25182358|NCT01544582|50329486|FG002|Analysis Population|Poor Adherence|1|||
25182359|NCT01544582|50329487|FG003|Analysis Population|Poor Adherence|0|||
25182360|NCT01544582|50329484|FG000|Analysis Population|Poor Participant Compliance|0|||
25182361|NCT01544582|50329485|FG001|Analysis Population|Poor Participant Compliance|1|||
25182362|NCT01544582|50329486|FG002|Analysis Population|Poor Participant Compliance|0|||
25274559|NCT00977938|50588589|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
25274560|NCT00977938|50588590|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
25145857|NCT01432444|50259825|FG000|Treatment Phase|Adverse Event|0|||
25145858|NCT01432444|50259826|FG001|Treatment Phase|Adverse Event|37|||
25145859|NCT01432444|50259827|FG002|Treatment Phase|Adverse Event|0|||
25145860|NCT01432444|50259825|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
25145861|NCT01432444|50259826|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
25145862|NCT01432444|50259827|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
25145863|NCT01432444|50259825|FG000|Treatment Phase|Physician Decision|0|||
25145864|NCT01432444|50259826|FG001|Treatment Phase|Physician Decision|5|||
25145865|NCT01432444|50259827|FG002|Treatment Phase|Physician Decision|0|||
25145866|NCT01432444|50259825|FG000|Treatment Phase|Withdrawal by Subject|0|||
25145867|NCT01432444|50259826|FG001|Treatment Phase|Withdrawal by Subject|41|||
25145868|NCT01432444|50259827|FG002|Treatment Phase|Withdrawal by Subject|0|||
25145869|NCT01432444|50259825|FG000|Treatment Phase|Protocol Deviation|0|||
25145870|NCT01432444|50259826|FG001|Treatment Phase|Protocol Deviation|3|||
25145871|NCT01432444|50259827|FG002|Treatment Phase|Protocol Deviation|0|||
25145872|NCT01432444|50259825|FG000|Treatment Phase|Lack of Efficacy|0|||
25145873|NCT01432444|50259826|FG001|Treatment Phase|Lack of Efficacy|10|||
25145874|NCT01432444|50259827|FG002|Treatment Phase|Lack of Efficacy|0|||
25145875|NCT01432444|50259825|FG000|Extension Phase|Lost to Follow-up|0|||
25145876|NCT01432444|50259826|FG001|Extension Phase|Lost to Follow-up|0|||
25145877|NCT01432444|50259827|FG002|Extension Phase|Lost to Follow-up|17|||
25145878|NCT01432444|50259825|FG000|Extension Phase|Adverse Event|0|||
25182363|NCT01544582|50329487|FG003|Analysis Population|Poor Participant Compliance|0|||
25182364|NCT01544582|50329484|FG000|Analysis Population|Programmed Surgery|0|||
25182365|NCT01544582|50329485|FG001|Analysis Population|Programmed Surgery|1|||
25182366|NCT01544582|50329486|FG002|Analysis Population|Programmed Surgery|0|||
25182367|NCT01544582|50329487|FG003|Analysis Population|Programmed Surgery|0|||
25182368|NCT01544582|50329484|FG000|Analysis Population|Participant in Jail|0|||
25182369|NCT01544582|50329485|FG001|Analysis Population|Participant in Jail|0|||
25182370|NCT01544582|50329486|FG002|Analysis Population|Participant in Jail|1|||
25145879|NCT01432444|50259826|FG001|Extension Phase|Adverse Event|0|||
25145880|NCT01432444|50259827|FG002|Extension Phase|Adverse Event|10|||
25182371|NCT01544582|50329487|FG003|Analysis Population|Participant in Jail|0|||
25182372|NCT01439165|50329515|FG000|Overall Study|Protocol Violation|3|||
25182373|NCT01439165|50329516|FG001|Overall Study|Protocol Violation|0|||
25182374|NCT01439165|50329515|FG000|Overall Study|Lost to Follow-up|11|||
25182375|NCT01439165|50329516|FG001|Overall Study|Lost to Follow-up|1|||
25182376|NCT01439165|50329515|FG000|Overall Study|Withdrawal by Subject|7|||
25182377|NCT01439165|50329516|FG001|Overall Study|Withdrawal by Subject|1|||
25182378|NCT01529606|50329530|FG000|Overall Study|Lost to Follow-up|21|||
25182379|NCT01529606|50329531|FG001|Overall Study|Lost to Follow-up|18|||
25182380|NCT01439009|50329548|FG000|Overall Study|Physician Decision|5|||
25182381|NCT01439009|50329549|FG001|Overall Study|Physician Decision|3|||
25182382|NCT01439009|50329548|FG000|Overall Study|Protocol Violation|2|||
25182383|NCT01439009|50329549|FG001|Overall Study|Protocol Violation|0|||
25182384|NCT01439009|50329548|FG000|Overall Study|Deviation of exclusion criteria|1|||
25182385|NCT01439009|50329549|FG001|Overall Study|Deviation of exclusion criteria|0|||
25182386|NCT01572389|50329568|FG000|Overall Study|Death|1|||
25182387|NCT01572389|50329569|FG001|Overall Study|Death|3|||
25182388|NCT01572389|50329568|FG000|Overall Study|Withdrawal by Subject|14|||
25182389|NCT01572389|50329569|FG001|Overall Study|Withdrawal by Subject|2|||
25182390|NCT01572389|50329568|FG000|Overall Study|Lost to Follow-up|25|||
25182391|NCT01572389|50329569|FG001|Overall Study|Lost to Follow-up|14|||
25182392|NCT01572389|50329568|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
25182393|NCT01572389|50329569|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
25182394|NCT01571453|50329581|FG000|Overall Study|Adverse Event|14|||
25182395|NCT01571453|50329582|FG001|Overall Study|Adverse Event|32|||
25182396|NCT01571453|50329581|FG000|Overall Study|Lack of Efficacy|8|||
25182397|NCT01571453|50329582|FG001|Overall Study|Lack of Efficacy|3|||
25182398|NCT01571453|50329581|FG000|Overall Study|Non-compliance|2|||
25182399|NCT01571453|50329582|FG001|Overall Study|Non-compliance|4|||
25182400|NCT01571453|50329581|FG000|Overall Study|Protocol Violation|1|||
25182401|NCT01571453|50329582|FG001|Overall Study|Protocol Violation|5|||
25182402|NCT01571453|50329581|FG000|Overall Study|Withdrawal of consent|5|||
25182403|NCT01571453|50329582|FG001|Overall Study|Withdrawal of consent|13|||
25182404|NCT01571453|50329581|FG000|Overall Study|Lost to Follow-up|4|||
25182405|NCT01571453|50329582|FG001|Overall Study|Lost to Follow-up|2|||
25182406|NCT01571453|50329581|FG000|Overall Study|Administrative or other reason(s)|4|||
25182407|NCT01571453|50329582|FG001|Overall Study|Administrative or other reason(s)|3|||
25182408|NCT01446289|50329592|FG000|Overall Study|Withdrawal by Subject|1|||
25182409|NCT01446289|50329593|FG001|Overall Study|Withdrawal by Subject|0|||
25182410|NCT01446289|50329594|FG002|Overall Study|Withdrawal by Subject|1|||
25182411|NCT01446289|50329595|FG003|Overall Study|Withdrawal by Subject|0|||
25182412|NCT01438541|50329607|FG000|Overall Study|Physician Decision|1|||
25182413|NCT01438541|50329607|FG000|Overall Study|Withdrawal by Subject|1|||
25182414|NCT01438541|50329607|FG000|Overall Study|discharge from the hospital|5|||
25145881|NCT01432444|50259825|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
25145882|NCT01432444|50259826|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
25145883|NCT01432444|50259827|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
25145884|NCT01432444|50259825|FG000|Extension Phase|Met Withdrawal Criteria|0|||
25145885|NCT01432444|50259826|FG001|Extension Phase|Met Withdrawal Criteria|0|||
25145886|NCT01432444|50259827|FG002|Extension Phase|Met Withdrawal Criteria|144|||
25145887|NCT01432444|50259825|FG000|Extension Phase|Physician Decision|0|||
25145888|NCT01432444|50259826|FG001|Extension Phase|Physician Decision|0|||
25145889|NCT01432444|50259827|FG002|Extension Phase|Physician Decision|1|||
25145890|NCT01432444|50259825|FG000|Extension Phase|Withdrawal by Subject|0|||
25145891|NCT01432444|50259826|FG001|Extension Phase|Withdrawal by Subject|0|||
25145892|NCT01432444|50259827|FG002|Extension Phase|Withdrawal by Subject|13|||
25145893|NCT01432366|50259832|FG000|Overall Study|Non-Responder|7|||
25145894|NCT01432366|50259832|FG000|Overall Study|Adverse Event|8|||
25182415|NCT01419769|50329611|FG000|Overall Study|Did not receive the AXIOS stent|3|||
25182416|NCT01419769|50329611|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
25182417|NCT01438307|50329617|FG000|Overall Study|Death|1|||
25182418|NCT01438307|50329618|FG001|Overall Study|Death|1|||
25182419|NCT01444651|50329626|FG000|Overall Study|Adverse Event|3|||
25182420|NCT01444651|50329627|FG001|Overall Study|Adverse Event|2|||
25182421|NCT01444651|50329626|FG000|Overall Study|Lost to Follow-up|5|||
25182422|NCT01444651|50329627|FG001|Overall Study|Lost to Follow-up|5|||
25182423|NCT01444651|50329626|FG000|Overall Study|Non-fasting|2|||
25145895|NCT01432366|50259832|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
25182424|NCT01444651|50329627|FG001|Overall Study|Non-fasting|1|||
25182425|NCT01444651|50329626|FG000|Overall Study|Missing data|1|||
25182426|NCT01444651|50329627|FG001|Overall Study|Missing data|1|||
25182427|NCT01570751|50329635|FG000|Period A (16 Weeks)|Protocol Violation|1|||
25182428|NCT01570751|50329636|FG001|Period A (16 Weeks)|Protocol Violation|1|||
25182429|NCT01570751|50329635|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
25182430|NCT01570751|50329636|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
25182431|NCT01570751|50329635|FG000|Period A (16 Weeks)|Unclassified|2|||
25182432|NCT01570751|50329636|FG001|Period A (16 Weeks)|Unclassified|3|||
25182433|NCT01570751|50329635|FG000|Period B (16 Weeks)|Adverse Event|1|||
25182434|NCT01570751|50329636|FG001|Period B (16 Weeks)|Adverse Event|0|||
25182435|NCT01570751|50329635|FG000|Period B (16 Weeks)|Protocol Violation|0|||
25182436|NCT01570751|50329636|FG001|Period B (16 Weeks)|Protocol Violation|1|||
25182437|NCT01419535|50329646|FG000|Overall Study|could not maintain iv line|1|||
25182438|NCT01419535|50329647|FG001|Overall Study|could not maintain iv line|1|||
25182439|NCT01419535|50329646|FG000|Overall Study|Withdrawal by Subject|0|||
25182440|NCT01419535|50329647|FG001|Overall Study|Withdrawal by Subject|1|||
25182441|NCT01438151|50329653|FG000|Overall Study|study terminated|8|||
25182442|NCT01418365|50329679|FG000|First Intervention|Withdrawal by Subject|0|||
25182443|NCT01418365|50329680|FG001|First Intervention|Withdrawal by Subject|1|||
25182444|NCT01418365|50329679|FG000|First Intervention|Non-compliance|1|||
25182445|NCT01418365|50329680|FG001|First Intervention|Non-compliance|0|||
25182446|NCT01418365|50329679|FG000|Second Intervention|Withdrawal by Subject|0|||
25182447|NCT01418365|50329680|FG001|Second Intervention|Withdrawal by Subject|1|||
25182448|NCT01437995|50329715|FG000|Overall Study|Lost to Follow-up|11|||
25182449|NCT01437995|50329716|FG001|Overall Study|Lost to Follow-up|18|||
25182450|NCT01437995|50329717|FG002|Overall Study|Lost to Follow-up|20|||
25182451|NCT01439347|50329766|FG000|Overall Study|Death|10|||
25182452|NCT01439347|50329767|FG001|Overall Study|Death|9|||
25182453|NCT01439347|50329766|FG000|Overall Study|Withdrawal by Subject|0|||
25182454|NCT01439347|50329767|FG001|Overall Study|Withdrawal by Subject|1|||
25182455|NCT01439347|50329766|FG000|Overall Study|Physician Decision|1|||
25182456|NCT01439347|50329767|FG001|Overall Study|Physician Decision|0|||
25182457|NCT01439347|50329766|FG000|Overall Study|Sponsor Terminated Study|2|||
25182458|NCT01439347|50329767|FG001|Overall Study|Sponsor Terminated Study|3|||
25182459|NCT01438957|50329814|FG000|Overall Study|Physician Decision|1|||
25182460|NCT01438957|50329815|FG001|Overall Study|Physician Decision|1|||
25182461|NCT01438957|50329816|FG002|Overall Study|Physician Decision|0|||
25182462|NCT01438957|50329817|FG003|Overall Study|Physician Decision|1|||
25182463|NCT01438957|50329818|FG004|Overall Study|Physician Decision|0|||
25182464|NCT01444417|50329867|FG000|Overall Study|Ineligibility Determined|0|||
25182465|NCT01444417|50329868|FG001|Overall Study|Ineligibility Determined|1|||
25182466|NCT01444417|50329867|FG000|Overall Study|Withdrawal by Subject|2|||
25182467|NCT01444417|50329868|FG001|Overall Study|Withdrawal by Subject|0|||
25182468|NCT01444027|50329895|FG000|Overall Study|Withdrawal by Subject|4|||
25182469|NCT01444027|50329896|FG001|Overall Study|Withdrawal by Subject|10|||
25182470|NCT01444027|50329897|FG002|Overall Study|Withdrawal by Subject|24|||
25182471|NCT01444027|50329895|FG000|Overall Study|Lost to Follow-up|26|||
25182472|NCT01444027|50329896|FG001|Overall Study|Lost to Follow-up|20|||
25182473|NCT01444027|50329897|FG002|Overall Study|Lost to Follow-up|14|||
25182474|NCT01438489|50329939|FG000|Overall Study|Lost to Follow-up|4|||
25182475|NCT01438489|50329940|FG001|Overall Study|Lost to Follow-up|2|||
25182476|NCT01438489|50329941|FG002|Overall Study|Lost to Follow-up|2|||
25182477|NCT01438489|50329939|FG000|Overall Study|Withdrawal by Subject|11|||
25182478|NCT01438489|50329940|FG001|Overall Study|Withdrawal by Subject|3|||
25145896|NCT01432366|50259832|FG000|Overall Study|Pregnancy|1|||
25145897|NCT01432366|50259832|FG000|Overall Study|Lost to Follow-up|13|||
25145898|NCT01432366|50259832|FG000|Overall Study|Lack of Efficacy|1|||
25145899|NCT01432366|50259832|FG000|Overall Study|Site Closed|20|||
25145900|NCT01432366|50259832|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
25145901|NCT01432366|50259832|FG000|Overall Study|Other|14|||
25145902|NCT01415440|50259839|FG000|Overall Study|Lost to Follow-up|0|||
25182479|NCT01438489|50329941|FG002|Overall Study|Withdrawal by Subject|8|||
25145903|NCT01415440|50259840|FG001|Overall Study|Lost to Follow-up|1|||
25182480|NCT01438489|50329939|FG000|Overall Study|Death|0|||
25182481|NCT01438489|50329940|FG001|Overall Study|Death|0|||
25182482|NCT01438489|50329941|FG002|Overall Study|Death|1|||
25182483|NCT01438489|50329939|FG000|Overall Study|Sponsor decision|4|||
25182484|NCT01438489|50329940|FG001|Overall Study|Sponsor decision|1|||
25182485|NCT01438489|50329941|FG002|Overall Study|Sponsor decision|4|||
25182486|NCT01438489|50329939|FG000|Overall Study|Subject choice/Subject moved|2|||
25182487|NCT01438489|50329940|FG001|Overall Study|Subject choice/Subject moved|1|||
25182488|NCT01438489|50329941|FG002|Overall Study|Subject choice/Subject moved|1|||
25182489|NCT01438489|50329939|FG000|Overall Study|Investigator decision|0|||
25182490|NCT01438489|50329940|FG001|Overall Study|Investigator decision|1|||
25182491|NCT01438489|50329941|FG002|Overall Study|Investigator decision|0|||
25182492|NCT01438489|50329939|FG000|Overall Study|AE/SAEs|2|||
25145904|NCT01415440|50259841|FG002|Overall Study|Lost to Follow-up|2|||
25145905|NCT01415440|50259839|FG000|Overall Study|Physician Decision|3|||
25182493|NCT01438489|50329940|FG001|Overall Study|AE/SAEs|1|||
25182494|NCT01438489|50329941|FG002|Overall Study|AE/SAEs|1|||
25182495|NCT01438489|50329939|FG000|Overall Study|Received prohibited medication|1|||
25182496|NCT01438489|50329940|FG001|Overall Study|Received prohibited medication|0|||
25182497|NCT01438489|50329941|FG002|Overall Study|Received prohibited medication|0|||
25182498|NCT01438489|50329939|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
25182499|NCT01438489|50329940|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
25182500|NCT01438489|50329941|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
25182501|NCT01438489|50329939|FG000|Overall Study|Inadequate venous access|0|||
25182502|NCT01438489|50329940|FG001|Overall Study|Inadequate venous access|2|||
25182503|NCT01438489|50329941|FG002|Overall Study|Inadequate venous access|0|||
25182504|NCT01418209|50329967|FG000|Overall Study|Withdrawal by Subject|1|||
25182505|NCT01418209|50329968|FG001|Overall Study|Withdrawal by Subject|0|||
25182506|NCT01418209|50329969|FG002|Overall Study|Withdrawal by Subject|1|||
25182507|NCT01418209|50329967|FG000|Overall Study|Did not provide hot flash diary data|1|||
25182508|NCT01418209|50329968|FG001|Overall Study|Did not provide hot flash diary data|3|||
25182509|NCT01418209|50329969|FG002|Overall Study|Did not provide hot flash diary data|3|||
25182510|NCT01570361|50329988|FG000|Overall Study|Subject discontinued|1|||
25182511|NCT01570361|50329989|FG001|Overall Study|Subject discontinued|2|||
25182512|NCT01570361|50329988|FG000|Overall Study|Sponsor closing the study|51|||
25182513|NCT01570361|50329989|FG001|Overall Study|Sponsor closing the study|50|||
25182514|NCT01570361|50329988|FG000|Overall Study|Subject excluded|5|||
25182515|NCT01570361|50329989|FG001|Overall Study|Subject excluded|3|||
25182516|NCT01570361|50329988|FG000|Overall Study|Subject withdrew consent|14|||
25182517|NCT01570361|50329989|FG001|Overall Study|Subject withdrew consent|9|||
25182518|NCT01570361|50329988|FG000|Overall Study|Adverse Event|2|||
25182519|NCT01570361|50329989|FG001|Overall Study|Adverse Event|1|||
25182520|NCT01570361|50329988|FG000|Overall Study|Lost to Follow-up|4|||
25182521|NCT01570361|50329989|FG001|Overall Study|Lost to Follow-up|4|||
25182522|NCT01570361|50329988|FG000|Overall Study|Death|5|||
25182523|NCT01570361|50329989|FG001|Overall Study|Death|4|||
25182524|NCT01570361|50329988|FG000|Overall Study|Other|0|||
25182525|NCT01570361|50329989|FG001|Overall Study|Other|2|||
25182526|NCT01417195|50330000|FG000|Overall Study|Stimulation failure|1|||
25182527|NCT01417195|50330001|FG001|Overall Study|Stimulation failure|0|||
25182528|NCT01417195|50330000|FG000|Overall Study|No embryos for transfer|0|||
25182529|NCT01417195|50330001|FG001|Overall Study|No embryos for transfer|1|||
25182530|NCT01417195|50330000|FG000|Overall Study|No transfer due to risk of OHSS|1|||
25182531|NCT01417195|50330001|FG001|Overall Study|No transfer due to risk of OHSS|0|||
25182532|NCT01417195|50330000|FG000|Overall Study|No transfer due to elevated progesterone|1|||
25182533|NCT01417195|50330001|FG001|Overall Study|No transfer due to elevated progesterone|0|||
25182534|NCT01438411|50330026|FG000|Overall Study|Adverse Event|8|||
25182535|NCT01438411|50330026|FG000|Overall Study|Lost to Follow-up|1|||
25182536|NCT01438411|50330026|FG000|Overall Study|Lack of Efficacy|1|||
25182537|NCT01438411|50330026|FG000|Overall Study|Withdrawal by Subject|3|||
25182538|NCT01443403|50330038|FG000|Overall Study|Adverse Event|1|||
25182539|NCT01443403|50330039|FG001|Overall Study|Adverse Event|1|||
25182540|NCT01443403|50330040|FG002|Overall Study|Adverse Event|4|||
25182541|NCT01443403|50330041|FG003|Overall Study|Adverse Event|5|||
25182542|NCT01443403|50330038|FG000|Overall Study|Withdrawal by Subject|0|||
25182543|NCT01443403|50330039|FG001|Overall Study|Withdrawal by Subject|1|||
25182544|NCT01443403|50330040|FG002|Overall Study|Withdrawal by Subject|2|||
25182545|NCT01443403|50330041|FG003|Overall Study|Withdrawal by Subject|1|||
25182546|NCT01443403|50330038|FG000|Overall Study|Lost to Follow-up|0|||
25182547|NCT01443403|50330039|FG001|Overall Study|Lost to Follow-up|0|||
25182548|NCT01443403|50330040|FG002|Overall Study|Lost to Follow-up|0|||
25182549|NCT01443403|50330041|FG003|Overall Study|Lost to Follow-up|1|||
25182550|NCT01443403|50330038|FG000|Overall Study|Protocol Violation|2|||
25182551|NCT01443403|50330039|FG001|Overall Study|Protocol Violation|1|||
25182552|NCT01443403|50330040|FG002|Overall Study|Protocol Violation|1|||
25182553|NCT01443403|50330041|FG003|Overall Study|Protocol Violation|1|||
25182554|NCT01443403|50330038|FG000|Overall Study|Use of Prohibited Treatment|2|||
25182555|NCT01443403|50330039|FG001|Overall Study|Use of Prohibited Treatment|3|||
25182556|NCT01443403|50330040|FG002|Overall Study|Use of Prohibited Treatment|0|||
25182557|NCT01443403|50330041|FG003|Overall Study|Use of Prohibited Treatment|0|||
25182558|NCT01443403|50330038|FG000|Overall Study|Other - Miscellaneous|1|||
25182559|NCT01443403|50330039|FG001|Overall Study|Other - Miscellaneous|0|||
25182560|NCT01443403|50330040|FG002|Overall Study|Other - Miscellaneous|0|||
25182561|NCT01443403|50330041|FG003|Overall Study|Other - Miscellaneous|1|||
25182562|NCT01438177|50330054|FG000|Overall Study|Withdrawal by Subject|1|||
25182563|NCT01438177|50330054|FG000|Overall Study|Initiation of new therapy|1|||
25182564|NCT01442779|50330058|FG000|Overall Study|Withdrawal by Subject|3|||
25182565|NCT01442779|50330058|FG000|Overall Study|Death|3|||
25182566|NCT01442779|50330058|FG000|Overall Study|Non-compliance|1|||
25182567|NCT01416805|50330064|FG000|Overall Study|Lost to Follow-up|4|||
25182568|NCT01416805|50330065|FG001|Overall Study|Lost to Follow-up|4|||
25182569|NCT01437943|50330073|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
25182570|NCT01437943|50330074|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
25182571|NCT01437943|50330073|FG000|Overall Study|Subject expressed pregnancy plans|1|||
25182572|NCT01437943|50330074|FG001|Overall Study|Subject expressed pregnancy plans|0|||
25182573|NCT01437943|50330073|FG000|Overall Study|Adverse Event|2|||
25182574|NCT01437943|50330074|FG001|Overall Study|Adverse Event|0|||
25182575|NCT01570283|50330083|FG000|Cohort 1: Dose Level 1|Death|0|||
25182576|NCT01570283|50330084|FG001|Cohort 1: Dose Level 1|Death|1|||
25182577|NCT01570283|50330085|FG002|Cohort 1: Dose Level 1|Death|0|||
25182578|NCT01570283|50330086|FG003|Cohort 1: Dose Level 1|Death|0|||
25182579|NCT01570283|50330087|FG004|Cohort 1: Dose Level 1|Death|0|||
25182580|NCT01570283|50330088|FG005|Cohort 1: Dose Level 1|Death|0|||
25182581|NCT01570283|50330083|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
25182582|NCT01570283|50330084|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
25182583|NCT01570283|50330085|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
25182584|NCT01570283|50330086|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
25182585|NCT01570283|50330087|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
25182586|NCT01570283|50330088|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
25182587|NCT01570283|50330083|FG000|Cohort 2: Dose Level 2|Death|0|||
25182588|NCT01570283|50330084|FG001|Cohort 2: Dose Level 2|Death|0|||
25182589|NCT01570283|50330085|FG002|Cohort 2: Dose Level 2|Death|1|||
25182590|NCT01570283|50330086|FG003|Cohort 2: Dose Level 2|Death|0|||
25182591|NCT01570283|50330087|FG004|Cohort 2: Dose Level 2|Death|0|||
25182592|NCT01570283|50330088|FG005|Cohort 2: Dose Level 2|Death|0|||
25182593|NCT01570283|50330083|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
25182594|NCT01570283|50330084|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
25182595|NCT01570283|50330085|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
25182596|NCT01570283|50330086|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
25182597|NCT01570283|50330087|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
25182598|NCT01570283|50330088|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
25182599|NCT01570283|50330083|FG000|Cohort 3: Dose Level 3|Death|0|||
25182600|NCT01570283|50330084|FG001|Cohort 3: Dose Level 3|Death|0|||
25182601|NCT01570283|50330085|FG002|Cohort 3: Dose Level 3|Death|0|||
25182602|NCT01570283|50330086|FG003|Cohort 3: Dose Level 3|Death|0|||
25182603|NCT01570283|50330087|FG004|Cohort 3: Dose Level 3|Death|0|||
25182604|NCT01570283|50330088|FG005|Cohort 3: Dose Level 3|Death|1|||
25182605|NCT01570283|50330083|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
25182606|NCT01570283|50330084|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
25182607|NCT01570283|50330085|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
25182608|NCT01570283|50330086|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
25182609|NCT01570283|50330087|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
25182610|NCT01570283|50330088|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
25182611|NCT01436357|50330104|FG000|Overall Study|Death|5|||
25182612|NCT01436357|50330105|FG001|Overall Study|Death|1|||
25182613|NCT01436357|50330104|FG000|Overall Study|Enrolled but not vaccinated|1|||
25182614|NCT01436357|50330105|FG001|Overall Study|Enrolled but not vaccinated|1|||
25182615|NCT01436357|50330104|FG000|Overall Study|Incarceration|18|||
25182616|NCT01436357|50330105|FG001|Overall Study|Incarceration|20|||
25182617|NCT01436357|50330104|FG000|Overall Study|Lost to Follow-up|67|||
25182618|NCT01436357|50330105|FG001|Overall Study|Lost to Follow-up|61|||
25145906|NCT01415440|50259840|FG001|Overall Study|Physician Decision|0|||
25145907|NCT01415440|50259841|FG002|Overall Study|Physician Decision|0|||
25145908|NCT01415440|50259839|FG000|Overall Study|Withdrawal by Subject|1|||
25145909|NCT01415440|50259840|FG001|Overall Study|Withdrawal by Subject|0|||
25145910|NCT01415440|50259841|FG002|Overall Study|Withdrawal by Subject|0|||
25145911|NCT01932788|50259859|FG000|Overall Study|Protocol Violation|18|||
25145912|NCT01932788|50259860|FG001|Overall Study|Protocol Violation|0|||
25145913|NCT01932788|50259859|FG000|Overall Study|Lost to Follow-up|18|||
25145914|NCT01932788|50259860|FG001|Overall Study|Lost to Follow-up|46|||
25145915|NCT01932788|50259859|FG000|Overall Study|Lack of Efficacy|2|||
25145916|NCT01932788|50259860|FG001|Overall Study|Lack of Efficacy|0|||
25145917|NCT01932788|50259859|FG000|Overall Study|Withdrawal by Subject|0|||
25145918|NCT01932788|50259860|FG001|Overall Study|Withdrawal by Subject|5|||
25145919|NCT01414738|50259866|FG000|Overall Study|Death|26|||
25145920|NCT01414738|50259866|FG000|Overall Study|Refused testing|5|||
25145921|NCT01414738|50259866|FG000|Overall Study|Lost to Follow-up|2|||
25145922|NCT01414738|50259866|FG000|Overall Study|Refused, disease progression|8|||
25182619|NCT01436357|50330104|FG000|Overall Study|Protocol Violation|1|||
25182620|NCT01436357|50330105|FG001|Overall Study|Protocol Violation|0|||
25182621|NCT01436357|50330104|FG000|Overall Study|Withdrawal by Subject|26|||
25145923|NCT01414738|50259866|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
25182622|NCT01436357|50330105|FG001|Overall Study|Withdrawal by Subject|38|||
25182623|NCT01436357|50330104|FG000|Overall Study|Physician Decision|3|||
25182624|NCT01436357|50330105|FG001|Overall Study|Physician Decision|4|||
25145924|NCT01414114|50259870|FG000|Overall Study|Adverse Event|2|||
25182625|NCT01436357|50330104|FG000|Overall Study|Moved out of area|1|||
25182626|NCT01436357|50330105|FG001|Overall Study|Moved out of area|2|||
25182627|NCT01436357|50330104|FG000|Overall Study|Subject in rehab|0|||
25182628|NCT01436357|50330105|FG001|Overall Study|Subject in rehab|1|||
25182629|NCT01436201|50330111|FG000|Overall Study|Adverse Event|2|||
25182630|NCT01436201|50330111|FG000|Overall Study|Withdrawal by Subject|1|||
25182631|NCT01436201|50330111|FG000|Overall Study|Protocol Violation|1|||
25182632|NCT01437397|50330122|FG000|Overall Study|Lost to Follow-up|9|||
25182633|NCT01437397|50330123|FG001|Overall Study|Lost to Follow-up|4|||
25182634|NCT01437397|50330124|FG002|Overall Study|Lost to Follow-up|2|||
25182635|NCT01437397|50330125|FG003|Overall Study|Lost to Follow-up|4|||
25182636|NCT01437397|50330126|FG004|Overall Study|Lost to Follow-up|5|||
25182637|NCT01437397|50330122|FG000|Overall Study|Withdrawal by Subject|11|||
25182638|NCT01437397|50330123|FG001|Overall Study|Withdrawal by Subject|12|||
25182639|NCT01437397|50330124|FG002|Overall Study|Withdrawal by Subject|24|||
25182640|NCT01437397|50330125|FG003|Overall Study|Withdrawal by Subject|11|||
25182641|NCT01437397|50330126|FG004|Overall Study|Withdrawal by Subject|22|||
25182642|NCT01437397|50330122|FG000|Overall Study|Protocol Violation|10|||
25182643|NCT01437397|50330123|FG001|Overall Study|Protocol Violation|12|||
25182644|NCT01437397|50330124|FG002|Overall Study|Protocol Violation|13|||
25182645|NCT01437397|50330125|FG003|Overall Study|Protocol Violation|21|||
25182646|NCT01437397|50330126|FG004|Overall Study|Protocol Violation|19|||
25182647|NCT01437397|50330122|FG000|Overall Study|Lack of Efficacy|5|||
25182648|NCT01437397|50330123|FG001|Overall Study|Lack of Efficacy|4|||
25182649|NCT01437397|50330124|FG002|Overall Study|Lack of Efficacy|8|||
25182650|NCT01437397|50330125|FG003|Overall Study|Lack of Efficacy|10|||
25182651|NCT01437397|50330126|FG004|Overall Study|Lack of Efficacy|20|||
25182652|NCT01437397|50330122|FG000|Overall Study|Adverse Event|21|||
25182653|NCT01437397|50330123|FG001|Overall Study|Adverse Event|22|||
25182654|NCT01437397|50330124|FG002|Overall Study|Adverse Event|16|||
25182655|NCT01437397|50330125|FG003|Overall Study|Adverse Event|14|||
25182656|NCT01437397|50330126|FG004|Overall Study|Adverse Event|21|||
25182657|NCT01437397|50330122|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
25182658|NCT01437397|50330123|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
25182659|NCT01437397|50330124|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
25182660|NCT01437397|50330125|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
25182661|NCT01437397|50330126|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
25182662|NCT01437319|50330138|FG000|Phase I|Lost to Follow-up|2|||
25182663|NCT01437319|50330139|FG001|Phase I|Lost to Follow-up|0|||
25182664|NCT01437319|50330140|FG002|Phase I|Lost to Follow-up|0|||
25182665|NCT01437319|50330138|FG000|Phase I|Protocol Violation|1|||
25182666|NCT01437319|50330139|FG001|Phase I|Protocol Violation|0|||
25182667|NCT01437319|50330140|FG002|Phase I|Protocol Violation|0|||
25182668|NCT01437319|50330138|FG000|Phase I|Study related symptoms/complaints|27|||
25182669|NCT01437319|50330139|FG001|Phase I|Study related symptoms/complaints|0|||
25182670|NCT01437319|50330140|FG002|Phase I|Study related symptoms/complaints|0|||
25182671|NCT01437319|50330138|FG000|Phase I|Withdrawal by Subject|25|||
25182672|NCT01437319|50330139|FG001|Phase I|Withdrawal by Subject|0|||
25182673|NCT01437319|50330140|FG002|Phase I|Withdrawal by Subject|0|||
25182674|NCT01437319|50330138|FG000|Phase II|Withdrawal by Subject|0|||
25182675|NCT01437319|50330139|FG001|Phase II|Withdrawal by Subject|8|||
25182676|NCT01437319|50330140|FG002|Phase II|Withdrawal by Subject|16|||
25182677|NCT01437319|50330138|FG000|Phase II|Lost to Follow-up|0|||
25182678|NCT01437319|50330139|FG001|Phase II|Lost to Follow-up|7|||
25182679|NCT01437319|50330140|FG002|Phase II|Lost to Follow-up|2|||
25145925|NCT01414114|50259870|FG000|Overall Study|Withdrawal by Subject|1|||
25145926|NCT01414114|50259870|FG000|Overall Study|Other|2|||
25145927|NCT01393444|50259876|FG000|Overall Study|Withdrawal by Subject|1|||
25145928|NCT01393444|50259876|FG000|Overall Study|Determined ineligible during screening.|2|||
25145929|NCT01431976|50259880|FG000|Overall Study|Adverse Event|6|||
25145930|NCT01431976|50259880|FG000|Overall Study|Lack of Efficacy|2|||
25145931|NCT01431976|50259880|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
25182680|NCT01437319|50330138|FG000|Phase II|Study related symptoms/complaints|0|||
25182681|NCT01437319|50330139|FG001|Phase II|Study related symptoms/complaints|28|||
25182682|NCT01437319|50330140|FG002|Phase II|Study related symptoms/complaints|19|||
25182683|NCT01437319|50330138|FG000|Phase II|Protocol Violation|0|||
25182684|NCT01437319|50330139|FG001|Phase II|Protocol Violation|1|||
25145932|NCT01431976|50259880|FG000|Overall Study|Physician Decision|1|||
25145933|NCT01431976|50259880|FG000|Overall Study|Withdrawal by Subject|1|||
25145934|NCT01392742|50259884|FG000|Overall Study|Premature study termination|42|||
25145935|NCT01392742|50259884|FG000|Overall Study|Failure to return|35|||
25145936|NCT01392742|50259884|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
25182685|NCT01437319|50330140|FG002|Phase II|Protocol Violation|0|||
25182686|NCT01416571|50330149|FG000|Overall Study|Lost to Follow-up|2|||
25182687|NCT01442155|50330170|FG000|Overall Study|Complete remission|35|||
25182688|NCT01442155|50330170|FG000|Overall Study|Recurrence|26|||
25182689|NCT01442155|50330170|FG000|Overall Study|Adverse Event|2|||
25182690|NCT01442155|50330170|FG000|Overall Study|Lost to Follow-up|2|||
25182691|NCT01416181|50330176|FG000|Part 1|Other|10|||
25182692|NCT01416181|50330177|FG001|Part 1|Other|24|||
25182693|NCT01416181|50330176|FG000|Part 1|Death|0|||
25182694|NCT01416181|50330177|FG001|Part 1|Death|1|||
25182695|NCT01416181|50330176|FG000|Part 1|Investigator Decision|7|||
25182696|NCT01416181|50330177|FG001|Part 1|Investigator Decision|6|||
25182697|NCT01416181|50330176|FG000|Part 1|Withdrawal by Subject|74|||
25182698|NCT01416181|50330177|FG001|Part 1|Withdrawal by Subject|48|||
25182699|NCT01416181|50330176|FG000|Part 1|Lack of Efficacy|16|||
25182700|NCT01416181|50330177|FG001|Part 1|Lack of Efficacy|8|||
25182701|NCT01416181|50330176|FG000|Part 1|Lost to Follow-up|1|||
25182702|NCT01416181|50330177|FG001|Part 1|Lost to Follow-up|1|||
25182703|NCT01416181|50330176|FG000|Part 1|Adverse Event|15|||
25182704|NCT01416181|50330177|FG001|Part 1|Adverse Event|18|||
25182705|NCT01416181|50330176|FG000|Part 1|Ongoing in Follow-Up|14|||
25182706|NCT01416181|50330177|FG001|Part 1|Ongoing in Follow-Up|8|||
25182707|NCT01416181|50330176|FG000|Part 2|Adverse Event|11|||
25182708|NCT01416181|50330177|FG001|Part 2|Adverse Event|4|||
25182709|NCT01416181|50330176|FG000|Part 2|Other|234|||
25182710|NCT01416181|50330177|FG001|Part 2|Other|267|||
25182711|NCT01416181|50330176|FG000|Part 2|Investigator Decision|6|||
25182712|NCT01416181|50330177|FG001|Part 2|Investigator Decision|7|||
25182713|NCT01416181|50330176|FG000|Part 2|Withdrawal by Subject|14|||
25182714|NCT01416181|50330177|FG001|Part 2|Withdrawal by Subject|5|||
25182715|NCT01416181|50330176|FG000|Part 2|Lack of Efficacy|4|||
25182716|NCT01416181|50330177|FG001|Part 2|Lack of Efficacy|1|||
25182717|NCT01416181|50330176|FG000|Part 2|Lost to Follow-up|2|||
25182718|NCT01416181|50330177|FG001|Part 2|Lost to Follow-up|2|||
25182719|NCT01441765|50330185|FG000|Overall Study|Death|1|||
25182720|NCT01441765|50330186|FG001|Overall Study|Death|0|||
25182721|NCT01419665|50330194|FG000|Combination Treatment|Adverse Event|7|||
25182722|NCT01419665|50330195|FG001|Combination Treatment|Adverse Event|10|||
25182723|NCT01419665|50330194|FG000|Combination Treatment|Physician Decision|5|||
25182724|NCT01419665|50330195|FG001|Combination Treatment|Physician Decision|8|||
25182725|NCT01419665|50330194|FG000|Combination Treatment|Protocol Violation|6|||
25182726|NCT01419665|50330195|FG001|Combination Treatment|Protocol Violation|2|||
25182727|NCT01419665|50330194|FG000|Combination Treatment|disease progression|10|||
25182728|NCT01419665|50330195|FG001|Combination Treatment|disease progression|9|||
25182729|NCT01419665|50330194|FG000|Combination Treatment|Death|5|||
25182730|NCT01419665|50330195|FG001|Combination Treatment|Death|7|||
25182731|NCT01419665|50330194|FG000|Combination Treatment|administrative problems|0|||
25182732|NCT01419665|50330195|FG001|Combination Treatment|administrative problems|1|||
25182733|NCT01419665|50330194|FG000|Combination Treatment|Withdrawal by Subject|5|||
25182734|NCT01419665|50330195|FG001|Combination Treatment|Withdrawal by Subject|4|||
25145937|NCT01392742|50259884|FG000|Overall Study|Lost to Follow-up|34|||
25145938|NCT01392742|50259884|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
25145939|NCT01392742|50259884|FG000|Overall Study|ITR and Protocol deviation|1|||
25145940|NCT01392742|50259884|FG000|Overall Study|Adverse event/intercurrent illness|17|||
25145941|NCT01392742|50259884|FG000|Overall Study|Protocol Violation|14|||
25145942|NCT01392742|50259884|FG000|Overall Study|Other|3|||
25145943|NCT01392742|50259884|FG000|Overall Study|Missing information|13|||
25145944|NCT01413958|50259890|FG000|Overall Study|Lost to Follow-up|0|||
25145945|NCT01413958|50259891|FG001|Overall Study|Lost to Follow-up|1|||
25145946|NCT01413178|50259900|FG000|Overall Study|Toxicity|1|||
25145947|NCT01413178|50259901|FG001|Overall Study|Toxicity|0|||
25145948|NCT01413178|50259900|FG000|Overall Study|Ineligible|0|||
25145949|NCT01413178|50259901|FG001|Overall Study|Ineligible|2|||
25145950|NCT01799889|50259919|FG000|Overall Study|Adverse Event|4|||
25145951|NCT01799889|50259920|FG001|Overall Study|Adverse Event|4|||
25182735|NCT01419665|50330194|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
25145952|NCT01799889|50259921|FG002|Overall Study|Adverse Event|5|||
25182736|NCT01419665|50330195|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
25182737|NCT01419665|50330194|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
25182738|NCT01419665|50330195|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
25145953|NCT01799889|50259922|FG003|Overall Study|Adverse Event|1|||
25145954|NCT01799889|50259923|FG004|Overall Study|Adverse Event|11|||
25145955|NCT01799889|50259924|FG005|Overall Study|Adverse Event|1|||
25182739|NCT01419665|50330194|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
25182740|NCT01419665|50330195|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
25182741|NCT01419665|50330194|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
25182742|NCT01419665|50330195|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
25182743|NCT01419665|50330194|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
25182744|NCT01419665|50330195|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
25182745|NCT01419665|50330194|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
25182746|NCT01419665|50330195|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
25182747|NCT01419665|50330194|FG000|Maintenance Treatment and/or Follow up|Death|1|||
25182748|NCT01419665|50330195|FG001|Maintenance Treatment and/or Follow up|Death|2|||
25182749|NCT01419665|50330194|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
25182750|NCT01419665|50330195|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
25182751|NCT01419665|50330194|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
25182752|NCT01419665|50330195|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
25182753|NCT01419665|50330194|FG000|Open Label Phase|Death|1|||
25182754|NCT01419665|50330195|FG001|Open Label Phase|Death|0|||
25182755|NCT01419665|50330194|FG000|Open Label Phase|disease progression|0|||
25182756|NCT01419665|50330195|FG001|Open Label Phase|disease progression|1|||
25182757|NCT01436305|50330206|FG000|Overall Study|Death|1|||
25182758|NCT01436305|50330207|FG001|Overall Study|Death|0|||
25182759|NCT01436305|50330208|FG002|Overall Study|Death|0|||
25145956|NCT01799889|50259925|FG006|Overall Study|Adverse Event|5|||
25145957|NCT01799889|50259926|FG007|Overall Study|Adverse Event|2|||
25145958|NCT01799889|50259927|FG008|Overall Study|Adverse Event|3|||
25145959|NCT01799889|50259928|FG009|Overall Study|Adverse Event|1|||
25145960|NCT01799889|50259929|FG010|Overall Study|Adverse Event|1|||
25145961|NCT01799889|50259930|FG011|Overall Study|Adverse Event|0|||
25182760|NCT01436305|50330206|FG000|Overall Study|Lost to Follow-up|0|||
25182761|NCT01436305|50330207|FG001|Overall Study|Lost to Follow-up|1|||
25182762|NCT01436305|50330208|FG002|Overall Study|Lost to Follow-up|0|||
25182763|NCT01436305|50330206|FG000|Overall Study|Withdrawal by Subject|1|||
25182764|NCT01436305|50330207|FG001|Overall Study|Withdrawal by Subject|3|||
25182765|NCT01436305|50330208|FG002|Overall Study|Withdrawal by Subject|0|||
25182766|NCT01436149|50330218|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
25182767|NCT01436149|50330219|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
25182768|NCT01436149|50330220|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
25182769|NCT01436149|50330218|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
25182770|NCT01436149|50330219|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
25182771|NCT01436149|50330220|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
25182772|NCT01436149|50330218|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
25182773|NCT01436149|50330219|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
25145962|NCT01799889|50259919|FG000|Overall Study|Death|1|||
25145963|NCT01799889|50259920|FG001|Overall Study|Death|0|||
25145964|NCT01799889|50259921|FG002|Overall Study|Death|5|||
25145965|NCT01799889|50259922|FG003|Overall Study|Death|3|||
25182774|NCT01436149|50330220|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
25182775|NCT01436149|50330218|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
25182776|NCT01436149|50330219|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
25182777|NCT01436149|50330220|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
25182778|NCT01436149|50330218|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
25182779|NCT01436149|50330219|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
25182780|NCT01436149|50330220|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
25182781|NCT01436149|50330218|FG000|Antidepressant Lead-in Phase|Other|119|||
25182782|NCT01436149|50330219|FG001|Antidepressant Lead-in Phase|Other|0|||
25145966|NCT01799889|50259923|FG004|Overall Study|Death|1|||
25145967|NCT01799889|50259924|FG005|Overall Study|Death|0|||
25145968|NCT01799889|50259925|FG006|Overall Study|Death|0|||
25145969|NCT01799889|50259926|FG007|Overall Study|Death|0|||
25145970|NCT01799889|50259927|FG008|Overall Study|Death|1|||
25145971|NCT01799889|50259928|FG009|Overall Study|Death|0|||
25145972|NCT01799889|50259929|FG010|Overall Study|Death|1|||
25145973|NCT01799889|50259930|FG011|Overall Study|Death|0|||
25145974|NCT01799889|50259919|FG000|Overall Study|Lack of Efficacy|1|||
25145975|NCT01799889|50259920|FG001|Overall Study|Lack of Efficacy|1|||
25145976|NCT01799889|50259921|FG002|Overall Study|Lack of Efficacy|0|||
25145977|NCT01799889|50259922|FG003|Overall Study|Lack of Efficacy|1|||
25145978|NCT01799889|50259923|FG004|Overall Study|Lack of Efficacy|2|||
25145979|NCT01799889|50259924|FG005|Overall Study|Lack of Efficacy|2|||
25145980|NCT01799889|50259925|FG006|Overall Study|Lack of Efficacy|0|||
25145981|NCT01799889|50259926|FG007|Overall Study|Lack of Efficacy|0|||
25145982|NCT01799889|50259927|FG008|Overall Study|Lack of Efficacy|2|||
25182783|NCT01436149|50330220|FG002|Antidepressant Lead-in Phase|Other|0|||
25182784|NCT01436149|50330218|FG000|Randomized Phase|Adverse Event|9|||
25182785|NCT01436149|50330219|FG001|Randomized Phase|Adverse Event|10|||
25145983|NCT01799889|50259928|FG009|Overall Study|Lack of Efficacy|0|||
25182786|NCT01436149|50330220|FG002|Randomized Phase|Adverse Event|11|||
25182787|NCT01436149|50330218|FG000|Randomized Phase|Protocol Violation|4|||
25145984|NCT01799889|50259929|FG010|Overall Study|Lack of Efficacy|1|||
25145985|NCT01799889|50259930|FG011|Overall Study|Lack of Efficacy|0|||
25145986|NCT01799889|50259919|FG000|Overall Study|Lost to Follow-up|0|||
25145987|NCT01799889|50259920|FG001|Overall Study|Lost to Follow-up|1|||
25182788|NCT01436149|50330219|FG001|Randomized Phase|Protocol Violation|5|||
25145988|NCT01799889|50259921|FG002|Overall Study|Lost to Follow-up|0|||
25145989|NCT01799889|50259922|FG003|Overall Study|Lost to Follow-up|0|||
25145990|NCT01799889|50259923|FG004|Overall Study|Lost to Follow-up|0|||
25145991|NCT01799889|50259924|FG005|Overall Study|Lost to Follow-up|0|||
25145992|NCT01799889|50259925|FG006|Overall Study|Lost to Follow-up|0|||
25145993|NCT01799889|50259926|FG007|Overall Study|Lost to Follow-up|0|||
25145994|NCT01799889|50259927|FG008|Overall Study|Lost to Follow-up|0|||
25145995|NCT01799889|50259928|FG009|Overall Study|Lost to Follow-up|0|||
25145996|NCT01799889|50259929|FG010|Overall Study|Lost to Follow-up|0|||
25145997|NCT01799889|50259930|FG011|Overall Study|Lost to Follow-up|0|||
25145998|NCT01799889|50259919|FG000|Overall Study|Physician Decision|3|||
25145999|NCT01799889|50259920|FG001|Overall Study|Physician Decision|2|||
25182789|NCT01436149|50330220|FG002|Randomized Phase|Protocol Violation|0|||
25146000|NCT01799889|50259921|FG002|Overall Study|Physician Decision|4|||
25182790|NCT01436149|50330218|FG000|Randomized Phase|Withdrawal by Subject|16|||
25146001|NCT01799889|50259922|FG003|Overall Study|Physician Decision|4|||
25146002|NCT01799889|50259923|FG004|Overall Study|Physician Decision|5|||
25146003|NCT01799889|50259924|FG005|Overall Study|Physician Decision|5|||
25146004|NCT01799889|50259925|FG006|Overall Study|Physician Decision|5|||
25182791|NCT01436149|50330219|FG001|Randomized Phase|Withdrawal by Subject|10|||
25182792|NCT01436149|50330220|FG002|Randomized Phase|Withdrawal by Subject|10|||
25182793|NCT01436149|50330218|FG000|Randomized Phase|Lost to Follow-up|34|||
25182794|NCT01436149|50330219|FG001|Randomized Phase|Lost to Follow-up|5|||
25182795|NCT01436149|50330220|FG002|Randomized Phase|Lost to Follow-up|6|||
25182796|NCT01436149|50330218|FG000|Randomized Phase|Lack of Efficacy|0|||
25182797|NCT01436149|50330219|FG001|Randomized Phase|Lack of Efficacy|0|||
25182798|NCT01436149|50330220|FG002|Randomized Phase|Lack of Efficacy|1|||
25182799|NCT01436149|50330218|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
25182800|NCT01436149|50330219|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
25182801|NCT01436149|50330220|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
25182802|NCT01436149|50330218|FG000|Randomized Phase|Other|12|||
25182803|NCT01436149|50330219|FG001|Randomized Phase|Other|5|||
25182804|NCT01436149|50330220|FG002|Randomized Phase|Other|11|||
25182805|NCT01415401|50330226|FG000|Overall Study|Adverse Event|5|||
25182806|NCT01415401|50330226|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
25182807|NCT01415401|50330226|FG000|Overall Study|Terminated by Sponsor|1|||
25182808|NCT01414855|50330230|FG000|Overall Study|Death|17|||
25182809|NCT01414855|50330230|FG000|Overall Study|Lost to Follow-up|5|||
25182810|NCT01414855|50330230|FG000|Overall Study|Withdrawal by Subject|7|||
25182811|NCT01527500|50330238|FG000|Part A|Administrative|11|||
25182812|NCT01527500|50330239|FG001|Part A|Administrative|7|||
25182813|NCT01527500|50330238|FG000|Part A|Adverse Event|4|||
25182814|NCT01527500|50330239|FG001|Part A|Adverse Event|2|||
25182815|NCT01527500|50330238|FG000|Part A|Death|4|||
25182816|NCT01527500|50330239|FG001|Part A|Death|1|||
25182817|NCT01527500|50330238|FG000|Part A|Lost to Follow-up|0|||
25182818|NCT01527500|50330239|FG001|Part A|Lost to Follow-up|1|||
25182819|NCT01527500|50330238|FG000|Part A|Protocol Deviation|9|||
25182820|NCT01527500|50330239|FG001|Part A|Protocol Deviation|2|||
25182821|NCT01527500|50330238|FG000|Part A|Withdrawal by Subject|2|||
25182822|NCT01527500|50330239|FG001|Part A|Withdrawal by Subject|0|||
25182823|NCT01527500|50330238|FG000|Part B|Adverse Event|1|||
25182824|NCT01527500|50330239|FG001|Part B|Adverse Event|0|||
25182825|NCT01527110|50330264|FG000|Overall Study|Adverse Event|1|||
25182826|NCT01441063|50330268|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
25182827|NCT01441063|50330268|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
25182828|NCT01436071|50330277|FG000|Overall Study|Adverse Event|1|||
25182829|NCT01436071|50330278|FG001|Overall Study|Adverse Event|0|||
25182830|NCT01436071|50330277|FG000|Overall Study|Lack of Efficacy|16|||
25182831|NCT01436071|50330278|FG001|Overall Study|Lack of Efficacy|7|||
25182832|NCT01436071|50330277|FG000|Overall Study|Protocol Violation|0|||
25182833|NCT01436071|50330278|FG001|Overall Study|Protocol Violation|1|||
25182834|NCT01436071|50330277|FG000|Overall Study|Lost to Follow-up|3|||
25182835|NCT01436071|50330278|FG001|Overall Study|Lost to Follow-up|1|||
25182836|NCT01436071|50330277|FG000|Overall Study|Physician Decision|1|||
25182837|NCT01436071|50330278|FG001|Overall Study|Physician Decision|0|||
25182838|NCT01436071|50330277|FG000|Overall Study|Withdrawal by Subject|2|||
25182839|NCT01436071|50330278|FG001|Overall Study|Withdrawal by Subject|2|||
25182840|NCT01436071|50330277|FG000|Overall Study|Did Not Receive Trial Medication|3|||
25182841|NCT01436071|50330278|FG001|Overall Study|Did Not Receive Trial Medication|3|||
25182842|NCT01514864|50330286|FG000|Overall Study|Disease progression|7|||
25182843|NCT01514864|50330287|FG001|Overall Study|Disease progression|5|||
25182844|NCT01514864|50330286|FG000|Overall Study|Study drug toxicity|2|||
25182845|NCT01514864|50330287|FG001|Overall Study|Study drug toxicity|0|||
25182846|NCT01514240|50330296|FG000|Overall Study|Adverse Event|4|||
25182847|NCT01514240|50330297|FG001|Overall Study|Adverse Event|4|||
25182848|NCT01514240|50330296|FG000|Overall Study|Subject Decision|2|||
25182849|NCT01514240|50330297|FG001|Overall Study|Subject Decision|7|||
25182850|NCT01435759|50330308|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
25182851|NCT01435759|50330309|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
25182852|NCT01435759|50330310|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
25182853|NCT01435759|50330311|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
25182854|NCT01435759|50330312|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
25182855|NCT01435759|50330313|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
25182856|NCT01435759|50330308|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
25182857|NCT01435759|50330309|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
25182858|NCT01435759|50330310|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
25182859|NCT01435759|50330311|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
25182860|NCT01435759|50330312|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
25182861|NCT01435759|50330313|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
25182862|NCT01435759|50330308|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
25182863|NCT01435759|50330309|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
25182864|NCT01435759|50330310|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
25182865|NCT01435759|50330311|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
25182866|NCT01435759|50330312|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
25182867|NCT01435759|50330313|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
25182868|NCT01435759|50330308|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
25182869|NCT01435759|50330309|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
25182870|NCT01435759|50330310|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
25182871|NCT01435759|50330311|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
25182872|NCT01435759|50330312|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
25182873|NCT01435759|50330313|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
25182874|NCT01435759|50330308|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
25182875|NCT01435759|50330309|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
25182876|NCT01435759|50330310|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
25182877|NCT01435759|50330311|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
25182878|NCT01435759|50330312|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
25182879|NCT01435759|50330313|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
25182880|NCT01435759|50330308|FG000|Antidepressant Lead-in Phase|Other|119|||
25182881|NCT01435759|50330309|FG001|Antidepressant Lead-in Phase|Other|0|||
25182882|NCT01435759|50330310|FG002|Antidepressant Lead-in Phase|Other|0|||
25182883|NCT01435759|50330311|FG003|Antidepressant Lead-in Phase|Other|0|||
25182884|NCT01435759|50330312|FG004|Antidepressant Lead-in Phase|Other|0|||
25182885|NCT01435759|50330313|FG005|Antidepressant Lead-in Phase|Other|0|||
25182886|NCT01435759|50330308|FG000|Double-blind Phase|Adverse Event|7|||
25182887|NCT01435759|50330309|FG001|Double-blind Phase|Adverse Event|0|||
25182888|NCT01435759|50330310|FG002|Double-blind Phase|Adverse Event|1|||
25182889|NCT01435759|50330311|FG003|Double-blind Phase|Adverse Event|1|||
25182890|NCT01435759|50330312|FG004|Double-blind Phase|Adverse Event|1|||
25182891|NCT01435759|50330313|FG005|Double-blind Phase|Adverse Event|3|||
25146005|NCT01799889|50259926|FG007|Overall Study|Physician Decision|2|||
25146006|NCT01799889|50259927|FG008|Overall Study|Physician Decision|6|||
25146007|NCT01799889|50259928|FG009|Overall Study|Physician Decision|0|||
25146008|NCT01799889|50259929|FG010|Overall Study|Physician Decision|0|||
25146009|NCT01799889|50259930|FG011|Overall Study|Physician Decision|1|||
25146010|NCT01799889|50259919|FG000|Overall Study|Progressive Disease|30|||
25146011|NCT01799889|50259920|FG001|Overall Study|Progressive Disease|26|||
25146012|NCT01799889|50259921|FG002|Overall Study|Progressive Disease|25|||
25146013|NCT01799889|50259922|FG003|Overall Study|Progressive Disease|30|||
25146014|NCT01799889|50259923|FG004|Overall Study|Progressive Disease|23|||
25146015|NCT01799889|50259924|FG005|Overall Study|Progressive Disease|9|||
25146016|NCT01799889|50259925|FG006|Overall Study|Progressive Disease|8|||
25146017|NCT01799889|50259926|FG007|Overall Study|Progressive Disease|13|||
25146018|NCT01799889|50259927|FG008|Overall Study|Progressive Disease|18|||
25146019|NCT01799889|50259928|FG009|Overall Study|Progressive Disease|5|||
25146020|NCT01799889|50259929|FG010|Overall Study|Progressive Disease|3|||
25146021|NCT01799889|50259930|FG011|Overall Study|Progressive Disease|1|||
25146022|NCT01799889|50259919|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
25146023|NCT01799889|50259920|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
25146024|NCT01799889|50259921|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
25146025|NCT01799889|50259922|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
25146026|NCT01799889|50259923|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
25146027|NCT01799889|50259924|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
25182892|NCT01435759|50330308|FG000|Double-blind Phase|Protocol Violation|2|||
25182893|NCT01435759|50330309|FG001|Double-blind Phase|Protocol Violation|0|||
25182894|NCT01435759|50330310|FG002|Double-blind Phase|Protocol Violation|1|||
25016017|NCT03291288|50110884|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
25016018|NCT03291288|50110885|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
25016019|NCT03291288|50110884|FG000|Drug-drug Interaction Phase|Disease progression|1|||
25016020|NCT03291288|50110885|FG001|Drug-drug Interaction Phase|Disease progression|0|||
25016021|NCT03291288|50110884|FG000|Drug-drug Interaction Phase|Other|3|||
25016022|NCT03291288|50110885|FG001|Drug-drug Interaction Phase|Other|0|||
25016023|NCT03291288|50110884|FG000|Pexidartinib Only|Ongoing|0|||
25016024|NCT03291288|50110885|FG001|Pexidartinib Only|Ongoing|2|||
25016025|NCT03257358|50110910|FG000|Overall Study|Adverse Event|25|||
25016026|NCT03257358|50110911|FG001|Overall Study|Adverse Event|12|||
25016027|NCT03257358|50110910|FG000|Overall Study|Lack of Efficacy|1|||
25016028|NCT03257358|50110911|FG001|Overall Study|Lack of Efficacy|1|||
25016029|NCT03257358|50110910|FG000|Overall Study|Lost to Follow-up|12|||
25016030|NCT03257358|50110911|FG001|Overall Study|Lost to Follow-up|4|||
25016031|NCT03257358|50110910|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
25016032|NCT03257358|50110911|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
25016033|NCT03257358|50110910|FG000|Overall Study|Physician Decision|2|||
25146028|NCT01799889|50259925|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
25182895|NCT01435759|50330311|FG003|Double-blind Phase|Protocol Violation|2|||
25016034|NCT03257358|50110911|FG001|Overall Study|Physician Decision|2|||
25016035|NCT03257358|50110910|FG000|Overall Study|Protocol Violation|5|||
25016036|NCT03257358|50110911|FG001|Overall Study|Protocol Violation|3|||
25016037|NCT03257358|50110910|FG000|Overall Study|Technical problems|4|||
25016038|NCT03257358|50110911|FG001|Overall Study|Technical problems|1|||
25016039|NCT03257358|50110910|FG000|Overall Study|Withdrawal by Subject|8|||
25016040|NCT03257358|50110911|FG001|Overall Study|Withdrawal by Subject|3|||
25182896|NCT01435759|50330312|FG004|Double-blind Phase|Protocol Violation|0|||
25182897|NCT01435759|50330313|FG005|Double-blind Phase|Protocol Violation|1|||
25182898|NCT01435759|50330308|FG000|Double-blind Phase|Withdrawal by Subject|17|||
25182899|NCT01435759|50330309|FG001|Double-blind Phase|Withdrawal by Subject|4|||
25182900|NCT01435759|50330310|FG002|Double-blind Phase|Withdrawal by Subject|3|||
25182901|NCT01435759|50330311|FG003|Double-blind Phase|Withdrawal by Subject|4|||
25182902|NCT01435759|50330312|FG004|Double-blind Phase|Withdrawal by Subject|2|||
25182903|NCT01435759|50330313|FG005|Double-blind Phase|Withdrawal by Subject|2|||
25182904|NCT01435759|50330308|FG000|Double-blind Phase|Lost to Follow-up|31|||
25182905|NCT01435759|50330309|FG001|Double-blind Phase|Lost to Follow-up|1|||
25182906|NCT01435759|50330310|FG002|Double-blind Phase|Lost to Follow-up|2|||
25016041|NCT03257358|50110910|FG000|Overall Study|Withdrawal of informed consent|9|||
25016042|NCT03257358|50110911|FG001|Overall Study|Withdrawal of informed consent|5|||
25016043|NCT03257358|50110910|FG000|Overall Study|New therapy for study indication|1|||
25016044|NCT03257358|50110911|FG001|Overall Study|New therapy for study indication|0|||
25016045|NCT03257358|50110910|FG000|Overall Study|No longer requires treatment|0|||
25016046|NCT03257358|50110911|FG001|Overall Study|No longer requires treatment|1|||
25016047|NCT02936037|50110919|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
25182907|NCT01435759|50330311|FG003|Double-blind Phase|Lost to Follow-up|0|||
25182908|NCT01435759|50330312|FG004|Double-blind Phase|Lost to Follow-up|3|||
25182909|NCT01435759|50330313|FG005|Double-blind Phase|Lost to Follow-up|3|||
25182910|NCT01435759|50330308|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
25182911|NCT01435759|50330309|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
25182912|NCT01435759|50330310|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
25182913|NCT01435759|50330311|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
25182914|NCT01435759|50330312|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
25182915|NCT01435759|50330313|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
25182916|NCT01435759|50330308|FG000|Double-blind Phase|Other|8|||
25182917|NCT01435759|50330309|FG001|Double-blind Phase|Other|2|||
25182918|NCT01435759|50330310|FG002|Double-blind Phase|Other|0|||
25182919|NCT01435759|50330311|FG003|Double-blind Phase|Other|2|||
25182920|NCT01435759|50330312|FG004|Double-blind Phase|Other|0|||
25182921|NCT01435759|50330313|FG005|Double-blind Phase|Other|0|||
25182922|NCT01393405|50330325|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
25182923|NCT01393405|50330326|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
25182924|NCT01393405|50330327|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
25182925|NCT01393405|50330325|FG000|Induction Period (week1-16)|Adverse Event|16|||
25182926|NCT01393405|50330326|FG001|Induction Period (week1-16)|Adverse Event|0|||
25182927|NCT01393405|50330327|FG002|Induction Period (week1-16)|Adverse Event|0|||
25182928|NCT01393405|50330325|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
25182929|NCT01393405|50330326|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
25182930|NCT01393405|50330327|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
25182931|NCT01393405|50330325|FG000|Maintenance Period Week|Lack of Efficacy|0|||
25182932|NCT01393405|50330326|FG001|Maintenance Period Week|Lack of Efficacy|22|||
25182933|NCT01393405|50330327|FG002|Maintenance Period Week|Lack of Efficacy|22|||
25182934|NCT01393405|50330325|FG000|Maintenance Period Week|Adverse Event|0|||
25182935|NCT01393405|50330326|FG001|Maintenance Period Week|Adverse Event|5|||
25182936|NCT01393405|50330327|FG002|Maintenance Period Week|Adverse Event|2|||
25182937|NCT01393405|50330325|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
25182938|NCT01393405|50330326|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
25182939|NCT01393405|50330327|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
25182940|NCT01393405|50330325|FG000|Maintenance Period Week|Lost to Follow-up|0|||
25182941|NCT01393405|50330326|FG001|Maintenance Period Week|Lost to Follow-up|1|||
25182942|NCT01393405|50330327|FG002|Maintenance Period Week|Lost to Follow-up|0|||
25182943|NCT01419197|50330339|FG000|Overall Study|Death|247|||
25182944|NCT01419197|50330340|FG001|Overall Study|Death|122|||
25182945|NCT01419197|50330339|FG000|Overall Study|Physician Decision|4|||
25182946|NCT01419197|50330340|FG001|Overall Study|Physician Decision|4|||
25016048|NCT02936037|50110920|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
25016049|NCT02936037|50110919|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
25182947|NCT01419197|50330339|FG000|Overall Study|Non-compliance|3|||
25182948|NCT01419197|50330340|FG001|Overall Study|Non-compliance|1|||
25182949|NCT01419197|50330339|FG000|Overall Study|Withdrawal by Subject|33|||
25182950|NCT01419197|50330340|FG001|Overall Study|Withdrawal by Subject|32|||
25182951|NCT01419197|50330339|FG000|Overall Study|Study Completed by Sponsor|103|||
25182952|NCT01419197|50330340|FG001|Overall Study|Study Completed by Sponsor|34|||
25182953|NCT01419197|50330339|FG000|Overall Study|Reason Not Specified|0|||
25182954|NCT01419197|50330340|FG001|Overall Study|Reason Not Specified|1|||
25182955|NCT01419197|50330339|FG000|Overall Study|Lost to Follow-up|14|||
25182956|NCT01419197|50330340|FG001|Overall Study|Lost to Follow-up|4|||
25182957|NCT01414075|50330351|FG000|Overall Study|Adverse Event|1|||
25182958|NCT01414075|50330352|FG001|Overall Study|Adverse Event|0|||
25182959|NCT01414075|50330353|FG002|Overall Study|Adverse Event|1|||
25182960|NCT01414075|50330354|FG003|Overall Study|Adverse Event|0|||
25182961|NCT01414075|50330351|FG000|Overall Study|Death|1|||
25182962|NCT01414075|50330352|FG001|Overall Study|Death|0|||
25182963|NCT01414075|50330353|FG002|Overall Study|Death|0|||
25182964|NCT01414075|50330354|FG003|Overall Study|Death|1|||
25016050|NCT02936037|50110920|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
25016051|NCT02936037|50110919|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
25016052|NCT02936037|50110920|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
25016053|NCT02936037|50110919|FG000|Double-Blind Treatment Period|Death|0|||
25016054|NCT02936037|50110920|FG001|Double-Blind Treatment Period|Death|1|||
25016055|NCT02936037|50110919|FG000|Double-Blind Treatment Period|Adverse Event|11|||
25182965|NCT01414075|50330351|FG000|Overall Study|Withdrawal by Subject|0|||
25182966|NCT01414075|50330352|FG001|Overall Study|Withdrawal by Subject|0|||
25182967|NCT01414075|50330353|FG002|Overall Study|Withdrawal by Subject|0|||
25182968|NCT01414075|50330354|FG003|Overall Study|Withdrawal by Subject|1|||
25182969|NCT01414075|50330351|FG000|Overall Study|Other than specified|1|||
25182970|NCT01414075|50330352|FG001|Overall Study|Other than specified|0|||
25182971|NCT01414075|50330353|FG002|Overall Study|Other than specified|1|||
25182972|NCT01414075|50330354|FG003|Overall Study|Other than specified|0|||
25182973|NCT01434823|50330366|FG000|Overall Study|Incomplete data in medical record|4|||
25182974|NCT01434823|50330367|FG001|Overall Study|Incomplete data in medical record|7|||
25182975|NCT01513460|50330377|FG000|Overall Study|Death|0|||
25182976|NCT01513460|50330378|FG001|Overall Study|Death|0|||
25182977|NCT01513460|50330379|FG002|Overall Study|Death|1|||
25182978|NCT01513460|50330377|FG000|Overall Study|Lost to Follow-up|0|||
25182979|NCT01513460|50330378|FG001|Overall Study|Lost to Follow-up|0|||
25182980|NCT01513460|50330379|FG002|Overall Study|Lost to Follow-up|2|||
25182981|NCT01513460|50330377|FG000|Overall Study|Abnormal laboratory value|1|||
25182982|NCT01513460|50330378|FG001|Overall Study|Abnormal laboratory value|0|||
25182983|NCT01513460|50330379|FG002|Overall Study|Abnormal laboratory value|1|||
25182984|NCT01513460|50330377|FG000|Overall Study|Lack of Efficacy|1|||
25182985|NCT01513460|50330378|FG001|Overall Study|Lack of Efficacy|2|||
25182986|NCT01513460|50330379|FG002|Overall Study|Lack of Efficacy|5|||
25182987|NCT01513460|50330377|FG000|Overall Study|Protocol deviations|3|||
25182988|NCT01513460|50330378|FG001|Overall Study|Protocol deviations|4|||
25182989|NCT01513460|50330379|FG002|Overall Study|Protocol deviations|3|||
25182990|NCT01513460|50330377|FG000|Overall Study|Withdrawal by Subject|7|||
25182991|NCT01513460|50330378|FG001|Overall Study|Withdrawal by Subject|8|||
25182992|NCT01513460|50330379|FG002|Overall Study|Withdrawal by Subject|21|||
25182993|NCT01513460|50330377|FG000|Overall Study|Adverse Event|16|||
25016056|NCT02936037|50110920|FG001|Double-Blind Treatment Period|Adverse Event|11|||
25016057|NCT02936037|50110919|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
25016058|NCT02936037|50110920|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
25016059|NCT02936037|50110919|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
25016060|NCT02936037|50110920|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
25016061|NCT02936037|50110919|FG000|Open Label Extension|Adverse Event|0|||
25016062|NCT02936037|50110920|FG001|Open Label Extension|Adverse Event|3|||
25016063|NCT02936037|50110919|FG000|Open Label Extension|Other|0|||
25016064|NCT02936037|50110920|FG001|Open Label Extension|Other|3|||
25016065|NCT02936037|50110919|FG000|Open Label Extension|Withdrawal by Subject|0|||
25016066|NCT02936037|50110920|FG001|Open Label Extension|Withdrawal by Subject|4|||
25016067|NCT03288714|50110928|FG000|Overall Study|Lost to Follow-up|2|||
25016068|NCT03288714|50110929|FG001|Overall Study|Lost to Follow-up|1|||
25016069|NCT03288714|50110928|FG000|Overall Study|Non-compliance with study schedule|2|||
25146029|NCT01799889|50259926|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
25146030|NCT01799889|50259927|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
25146031|NCT01799889|50259928|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
25146032|NCT01799889|50259929|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
25146033|NCT01799889|50259930|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
25146034|NCT01799889|50259919|FG000|Overall Study|Study Terminated By Sponsor|1|||
25016070|NCT03288714|50110929|FG001|Overall Study|Non-compliance with study schedule|0|||
25016071|NCT03288714|50110928|FG000|Overall Study|Withdrawal by Subject|3|||
25016072|NCT03288714|50110929|FG001|Overall Study|Withdrawal by Subject|1|||
25016073|NCT03288714|50110928|FG000|Overall Study|Clinical Worsening|2|||
25146035|NCT01799889|50259920|FG001|Overall Study|Study Terminated By Sponsor|0|||
25146036|NCT01799889|50259921|FG002|Overall Study|Study Terminated By Sponsor|0|||
25146037|NCT01799889|50259922|FG003|Overall Study|Study Terminated By Sponsor|0|||
25146038|NCT01799889|50259923|FG004|Overall Study|Study Terminated By Sponsor|2|||
25146039|NCT01799889|50259924|FG005|Overall Study|Study Terminated By Sponsor|1|||
25146040|NCT01799889|50259925|FG006|Overall Study|Study Terminated By Sponsor|0|||
25146041|NCT01799889|50259926|FG007|Overall Study|Study Terminated By Sponsor|2|||
25146042|NCT01799889|50259927|FG008|Overall Study|Study Terminated By Sponsor|1|||
25182994|NCT01513460|50330378|FG001|Overall Study|Adverse Event|18|||
25182995|NCT01513460|50330379|FG002|Overall Study|Adverse Event|23|||
25182996|NCT01513460|50330377|FG000|Overall Study|Abnormal test procedure|1|||
25182997|NCT01513460|50330378|FG001|Overall Study|Abnormal test procedure|0|||
25146043|NCT01799889|50259928|FG009|Overall Study|Study Terminated By Sponsor|1|||
25146044|NCT01799889|50259929|FG010|Overall Study|Study Terminated By Sponsor|0|||
25146045|NCT01799889|50259930|FG011|Overall Study|Study Terminated By Sponsor|0|||
25146046|NCT01799889|50259919|FG000|Overall Study|Withdrawal by Subject|1|||
25146047|NCT01799889|50259920|FG001|Overall Study|Withdrawal by Subject|6|||
25182998|NCT01513460|50330379|FG002|Overall Study|Abnormal test procedure|0|||
25182999|NCT01392547|50330389|FG000|Overall Study|Adverse Event|2|||
25183000|NCT01392547|50330389|FG000|Overall Study|Non-compliance|2|||
25183001|NCT01392547|50330389|FG000|Overall Study|Withdrawal criteria|3|||
25183002|NCT01392547|50330389|FG000|Overall Study|Unclassified|1|||
25183003|NCT01435655|50330395|FG000|Overall Study|Death|2|||
25183004|NCT01435655|50330395|FG000|Overall Study|Other|1|||
25146048|NCT01799889|50259921|FG002|Overall Study|Withdrawal by Subject|4|||
25146049|NCT01799889|50259922|FG003|Overall Study|Withdrawal by Subject|0|||
25146050|NCT01799889|50259923|FG004|Overall Study|Withdrawal by Subject|5|||
25146051|NCT01799889|50259924|FG005|Overall Study|Withdrawal by Subject|1|||
25146052|NCT01799889|50259925|FG006|Overall Study|Withdrawal by Subject|3|||
25146053|NCT01799889|50259926|FG007|Overall Study|Withdrawal by Subject|1|||
25146054|NCT01799889|50259927|FG008|Overall Study|Withdrawal by Subject|2|||
25146055|NCT01799889|50259928|FG009|Overall Study|Withdrawal by Subject|1|||
25183005|NCT01434667|50330401|FG000|Overall Study|Lost to Follow-up|5|||
25183006|NCT01434667|50330402|FG001|Overall Study|Lost to Follow-up|10|||
25183007|NCT01513148|50330410|FG000|Overall Study|Protocol Violation|2|||
25183008|NCT01513148|50330411|FG001|Overall Study|Protocol Violation|2|||
25183009|NCT01418339|50330459|FG000|Overall Study|Adverse Event|5|||
25183010|NCT01418339|50330460|FG001|Overall Study|Adverse Event|2|||
25183011|NCT01418339|50330459|FG000|Overall Study|Subject Withdrew Consent|1|||
25183012|NCT01418339|50330460|FG001|Overall Study|Subject Withdrew Consent|2|||
25183013|NCT01418339|50330459|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
25183014|NCT01418339|50330460|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
25183015|NCT01512368|50330466|FG000|Overall Study|Protocol Violation|3|||
25183016|NCT01412983|50330470|FG000|1st Period|Ineligible|0|||
25183017|NCT01412983|50330471|FG001|1st Period|Ineligible|1|||
25183018|NCT01412983|50330470|FG000|1st Period|Positive slit lamp finding|0|||
25146056|NCT01799889|50259929|FG010|Overall Study|Withdrawal by Subject|1|||
25146057|NCT01799889|50259930|FG011|Overall Study|Withdrawal by Subject|1|||
25183019|NCT01412983|50330471|FG001|1st Period|Positive slit lamp finding|1|||
25183020|NCT01412983|50330470|FG000|1st Period|Unacceptable lens movement|0|||
25183021|NCT01412983|50330471|FG001|1st Period|Unacceptable lens movement|1|||
25183022|NCT01412983|50330470|FG000|1st Period|Inability to maintain wear|0|||
25183023|NCT01412983|50330471|FG001|1st Period|Inability to maintain wear|1|||
25183024|NCT01417481|50330480|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
25183025|NCT01417481|50330481|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
25183026|NCT01392469|50330487|FG000|Overall Study|Adverse Event|2|||
25183027|NCT01392469|50330487|FG000|Overall Study|Withdrawal by Subject|1|||
25183028|NCT01392469|50330487|FG000|Overall Study|Protocol Violation|1|||
25183029|NCT01435577|50330504|FG000|Overall Study|Adverse Event|10|||
25183030|NCT01435577|50330505|FG001|Overall Study|Adverse Event|0|||
25183031|NCT01435577|50330504|FG000|Overall Study|Lack of Efficacy|7|||
25183032|NCT01435577|50330505|FG001|Overall Study|Lack of Efficacy|51|||
25183033|NCT01435577|50330504|FG000|Overall Study|Alternative treatment started|0|||
25183034|NCT01435577|50330505|FG001|Overall Study|Alternative treatment started|1|||
25183035|NCT01411891|50330517|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
25183036|NCT01411891|50330518|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
25183037|NCT01416389|50330526|FG000|Overall Study|Lost to Follow-up|1|||
25183038|NCT01416389|50330527|FG001|Overall Study|Lost to Follow-up|0|||
25183039|NCT01416389|50330526|FG000|Overall Study|Started New Therapy|2|||
25183040|NCT01416389|50330527|FG001|Overall Study|Started New Therapy|0|||
25183041|NCT01544348|50330543|FG000|Overall Study|Lost to Follow-up|1|||
25183042|NCT01544348|50330544|FG001|Overall Study|Lost to Follow-up|0|||
25183043|NCT01544348|50330545|FG002|Overall Study|Lost to Follow-up|0|||
25183044|NCT01544348|50330546|FG003|Overall Study|Lost to Follow-up|0|||
25183045|NCT01544348|50330547|FG004|Overall Study|Lost to Follow-up|0|||
25183046|NCT01544348|50330548|FG005|Overall Study|Lost to Follow-up|0|||
25183047|NCT01544348|50330549|FG006|Overall Study|Lost to Follow-up|1|||
25183048|NCT01544348|50330550|FG007|Overall Study|Lost to Follow-up|0|||
25183049|NCT01544348|50330543|FG000|Overall Study|Withdrawal by Subject|1|||
25146058|NCT01799889|50259919|FG000|Overall Study|Non-Compliance With Study Drug|0|||
25146059|NCT01799889|50259920|FG001|Overall Study|Non-Compliance With Study Drug|0|||
25146060|NCT01799889|50259921|FG002|Overall Study|Non-Compliance With Study Drug|0|||
25183050|NCT01544348|50330544|FG001|Overall Study|Withdrawal by Subject|0|||
25183051|NCT01544348|50330545|FG002|Overall Study|Withdrawal by Subject|0|||
25183052|NCT01544348|50330546|FG003|Overall Study|Withdrawal by Subject|0|||
25183053|NCT01544348|50330547|FG004|Overall Study|Withdrawal by Subject|1|||
25183054|NCT01544348|50330548|FG005|Overall Study|Withdrawal by Subject|2|||
25183055|NCT01544348|50330549|FG006|Overall Study|Withdrawal by Subject|1|||
25183056|NCT01544348|50330550|FG007|Overall Study|Withdrawal by Subject|0|||
25183057|NCT01544348|50330543|FG000|Overall Study|Physician Decision|0|||
25146061|NCT01799889|50259922|FG003|Overall Study|Non-Compliance With Study Drug|0|||
25146062|NCT01799889|50259923|FG004|Overall Study|Non-Compliance With Study Drug|0|||
25146063|NCT01799889|50259924|FG005|Overall Study|Non-Compliance With Study Drug|1|||
25146064|NCT01799889|50259925|FG006|Overall Study|Non-Compliance With Study Drug|0|||
25146065|NCT01799889|50259926|FG007|Overall Study|Non-Compliance With Study Drug|0|||
25146066|NCT01799889|50259927|FG008|Overall Study|Non-Compliance With Study Drug|0|||
25146067|NCT01799889|50259928|FG009|Overall Study|Non-Compliance With Study Drug|0|||
25146068|NCT01799889|50259929|FG010|Overall Study|Non-Compliance With Study Drug|0|||
25183058|NCT01544348|50330544|FG001|Overall Study|Physician Decision|0|||
25183059|NCT01544348|50330545|FG002|Overall Study|Physician Decision|0|||
25183060|NCT01544348|50330546|FG003|Overall Study|Physician Decision|0|||
25183061|NCT01544348|50330547|FG004|Overall Study|Physician Decision|0|||
25183062|NCT01544348|50330548|FG005|Overall Study|Physician Decision|1|||
25183063|NCT01544348|50330549|FG006|Overall Study|Physician Decision|0|||
25183064|NCT01544348|50330550|FG007|Overall Study|Physician Decision|0|||
25183065|NCT01416155|50330575|FG000|Overall Study|Adverse Event|8|||
25183066|NCT01416155|50330575|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
25183067|NCT01416155|50330575|FG000|Overall Study|Withdrawal by Subject|33|||
25183068|NCT01416155|50330575|FG000|Overall Study|Investigator decision|8|||
25183069|NCT01416155|50330575|FG000|Overall Study|Other|7|||
25183070|NCT01415921|50330581|FG000|Overall Study|Adverse Event|0|||
25183071|NCT01415921|50330582|FG001|Overall Study|Adverse Event|1|||
25183072|NCT01415921|50330581|FG000|Overall Study|Physician Decision|1|||
25183073|NCT01415921|50330582|FG001|Overall Study|Physician Decision|1|||
25183074|NCT01415921|50330581|FG000|Overall Study|Withdrawal by Subject|0|||
25183075|NCT01415921|50330582|FG001|Overall Study|Withdrawal by Subject|1|||
25183076|NCT01415921|50330581|FG000|Overall Study|Other|2|||
25183077|NCT01415921|50330582|FG001|Overall Study|Other|0|||
25183078|NCT01415531|50330590|FG000|Overall Study|Adverse Event|7|||
25183079|NCT01415531|50330591|FG001|Overall Study|Adverse Event|10|||
25183080|NCT01415531|50330590|FG000|Overall Study|Lack of Efficacy|3|||
25183081|NCT01415531|50330591|FG001|Overall Study|Lack of Efficacy|2|||
25183082|NCT01415531|50330590|FG000|Overall Study|Protocol Violation|0|||
25183083|NCT01415531|50330591|FG001|Overall Study|Protocol Violation|1|||
25183084|NCT01415531|50330590|FG000|Overall Study|Withdrawal by Subject|5|||
25183085|NCT01415531|50330591|FG001|Overall Study|Withdrawal by Subject|4|||
25183086|NCT01415531|50330590|FG000|Overall Study|Lost to Follow-up|6|||
25146069|NCT01799889|50259930|FG011|Overall Study|Non-Compliance With Study Drug|0|||
25183087|NCT01415531|50330591|FG001|Overall Study|Lost to Follow-up|14|||
25183088|NCT01415531|50330590|FG000|Overall Study|Lack of Compliance|1|||
25183089|NCT01415531|50330591|FG001|Overall Study|Lack of Compliance|4|||
25183090|NCT01415531|50330590|FG000|Overall Study|Other Reasons|3|||
25146070|NCT01412944|50259969|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
25183091|NCT01415531|50330591|FG001|Overall Study|Other Reasons|2|||
25183092|NCT01544114|50330600|FG000|Overall Study|Withdrawal by Subject|0|||
25183093|NCT01544114|50330601|FG001|Overall Study|Withdrawal by Subject|0|||
25183094|NCT01544114|50330602|FG002|Overall Study|Withdrawal by Subject|3|||
25183095|NCT01544114|50330600|FG000|Overall Study|Lost to Follow-up|0|||
25183096|NCT01544114|50330601|FG001|Overall Study|Lost to Follow-up|2|||
25183097|NCT01544114|50330602|FG002|Overall Study|Lost to Follow-up|0|||
25146071|NCT01412944|50259970|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
25146072|NCT01412944|50259971|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
25146073|NCT01412944|50259972|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
25146074|NCT01412944|50259973|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
25146075|NCT01412944|50259974|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
25146076|NCT01412944|50259969|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
25146077|NCT01412944|50259970|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
25146078|NCT01412944|50259971|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
25146079|NCT01412944|50259972|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
25183098|NCT01544114|50330600|FG000|Overall Study|Adverse Event|1|||
25183099|NCT01544114|50330601|FG001|Overall Study|Adverse Event|1|||
25183100|NCT01544114|50330602|FG002|Overall Study|Adverse Event|2|||
25183101|NCT01544114|50330600|FG000|Overall Study|Protocol Violation|0|||
25183102|NCT01544114|50330601|FG001|Overall Study|Protocol Violation|1|||
25183103|NCT01544114|50330602|FG002|Overall Study|Protocol Violation|0|||
25183104|NCT01435265|50330614|FG000|Overall Study|Lost to Follow-up|0|||
25183105|NCT01435265|50330615|FG001|Overall Study|Lost to Follow-up|1|||
25183106|NCT01433263|50330623|FG000|Overall Study|Adverse Event|3|||
25183107|NCT01433263|50330624|FG001|Overall Study|Adverse Event|1|||
25183108|NCT01433263|50330623|FG000|Overall Study|Death|5|||
25183109|NCT01433263|50330624|FG001|Overall Study|Death|3|||
25183110|NCT01433263|50330623|FG000|Overall Study|Lost to Follow-up|0|||
25183111|NCT01433263|50330624|FG001|Overall Study|Lost to Follow-up|1|||
25183112|NCT01433263|50330623|FG000|Overall Study|Protocol Deviation|1|||
25183113|NCT01433263|50330624|FG001|Overall Study|Protocol Deviation|0|||
25183114|NCT01433263|50330623|FG000|Overall Study|Withdrawal by Subject|10|||
25183115|NCT01433263|50330624|FG001|Overall Study|Withdrawal by Subject|7|||
25183116|NCT01432951|50330633|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
25183117|NCT01432327|50330642|FG000|Posttest 3 Months|depression|3|||
25183118|NCT01432327|50330643|FG001|Posttest 3 Months|depression|0|||
25183119|NCT01432327|50330644|FG002|Posttest 3 Months|depression|0|||
25183120|NCT01432327|50330645|FG003|Posttest 3 Months|depression|0|||
25146080|NCT01412944|50259973|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
25183121|NCT01432327|50330642|FG000|Posttest 3 Months|Lost to Follow-up|1|||
25183122|NCT01432327|50330643|FG001|Posttest 3 Months|Lost to Follow-up|0|||
25183123|NCT01432327|50330644|FG002|Posttest 3 Months|Lost to Follow-up|2|||
25183124|NCT01432327|50330645|FG003|Posttest 3 Months|Lost to Follow-up|1|||
25183125|NCT01432327|50330642|FG000|Posttest 3 Months|Allergic reaction|0|||
25183126|NCT01432327|50330643|FG001|Posttest 3 Months|Allergic reaction|2|||
25183127|NCT01432327|50330644|FG002|Posttest 3 Months|Allergic reaction|0|||
25183128|NCT01432327|50330645|FG003|Posttest 3 Months|Allergic reaction|0|||
25146081|NCT01412944|50259974|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
25146082|NCT01412944|50259969|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
25146083|NCT01412944|50259970|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
25183129|NCT01432327|50330642|FG000|Posttest 6 Months|Lost to Follow-up|0|||
25183130|NCT01432327|50330643|FG001|Posttest 6 Months|Lost to Follow-up|0|||
25183131|NCT01432327|50330644|FG002|Posttest 6 Months|Lost to Follow-up|3|||
25183132|NCT01432327|50330645|FG003|Posttest 6 Months|Lost to Follow-up|2|||
25183133|NCT01432327|50330642|FG000|Posttest 6 Months|Allergic reaction|0|||
25183134|NCT01432327|50330643|FG001|Posttest 6 Months|Allergic reaction|0|||
25183135|NCT01432327|50330644|FG002|Posttest 6 Months|Allergic reaction|1|||
25183136|NCT01432327|50330645|FG003|Posttest 6 Months|Allergic reaction|0|||
25183137|NCT01432327|50330642|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
25183138|NCT01432327|50330643|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
25183139|NCT01432327|50330644|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
25183140|NCT01432327|50330645|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
25183141|NCT01432327|50330642|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
25183142|NCT01432327|50330643|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
25183143|NCT01432327|50330644|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
25183144|NCT01432327|50330645|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
25183145|NCT01432327|50330642|FG000|Posttest 1 Year|Lost to Follow-up|0|||
25183146|NCT01432327|50330643|FG001|Posttest 1 Year|Lost to Follow-up|0|||
25183147|NCT01432327|50330644|FG002|Posttest 1 Year|Lost to Follow-up|4|||
25183148|NCT01432327|50330645|FG003|Posttest 1 Year|Lost to Follow-up|2|||
25183149|NCT01432327|50330642|FG000|Posttest 1 Year|Allergic reaction|0|||
25183150|NCT01432327|50330643|FG001|Posttest 1 Year|Allergic reaction|0|||
25183151|NCT01432327|50330644|FG002|Posttest 1 Year|Allergic reaction|1|||
25183152|NCT01432327|50330645|FG003|Posttest 1 Year|Allergic reaction|1|||
25183153|NCT01410799|50330655|FG000|Overall Study|PI decision|13|||
25146084|NCT01412944|50259971|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
25146085|NCT01412944|50259972|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
25146086|NCT01412944|50259973|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
25146087|NCT01412944|50259974|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
25146088|NCT01412944|50259969|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
25146089|NCT01412944|50259970|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
25146090|NCT01412944|50259971|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
25146091|NCT01412944|50259972|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
25146092|NCT01412944|50259973|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
25146093|NCT01412944|50259974|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
25146094|NCT01412944|50259969|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
25146095|NCT01412944|50259970|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
25146096|NCT01412944|50259971|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
25146097|NCT01412944|50259972|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
25146098|NCT01412944|50259973|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
25146099|NCT01412944|50259974|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
25183154|NCT01432171|50330661|FG000|Overall Study|Death|1|||
25183155|NCT01432171|50330662|FG001|Overall Study|Death|2|||
25016074|NCT03288714|50110929|FG001|Overall Study|Clinical Worsening|1|||
25146100|NCT01412944|50259969|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
25146101|NCT01412944|50259970|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
25183156|NCT01432171|50330661|FG000|Overall Study|Lost to Follow-up|6|||
25183157|NCT01432171|50330662|FG001|Overall Study|Lost to Follow-up|5|||
25183158|NCT01432171|50330661|FG000|Overall Study|Withdrawal by Subject|3|||
25146102|NCT01412944|50259971|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
25146103|NCT01412944|50259972|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
25146104|NCT01412944|50259973|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
25183159|NCT01432171|50330662|FG001|Overall Study|Withdrawal by Subject|1|||
25183160|NCT01432171|50330661|FG000|Overall Study|Noncompliance|2|||
25183161|NCT01432171|50330662|FG001|Overall Study|Noncompliance|3|||
25183162|NCT01432171|50330661|FG000|Overall Study|Insurance denial trial coverage|1|||
25146105|NCT01412944|50259974|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
25146106|NCT01412944|50259969|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
25183163|NCT01432171|50330662|FG001|Overall Study|Insurance denial trial coverage|0|||
25183164|NCT01432171|50330661|FG000|Overall Study|Patient moved to palliative care|1|||
25183165|NCT01432171|50330662|FG001|Overall Study|Patient moved to palliative care|0|||
25183166|NCT01435031|50330672|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
25183167|NCT01435031|50330672|FG000|ITT at 1 Month|Death|1|||
25183168|NCT01435031|50330672|FG000|ITT at 1 Month|Lost to Follow-up|4|||
25183169|NCT01435031|50330672|FG000|ITT at 6 Months|Death|2|||
25183170|NCT01435031|50330672|FG000|ITT at 6 Months|Lost to Follow-up|3|||
25183171|NCT01435031|50330672|FG000|ITT at 1 Year|Death|1|||
25183172|NCT01435031|50330672|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
25183173|NCT01435031|50330672|FG000|ITT at 1 Year|Lost to Follow-up|6|||
25183174|NCT01435031|50330672|FG000|ITT at 2 Years|Death|7|||
25183175|NCT01435031|50330672|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
25183176|NCT01435031|50330672|FG000|ITT at 2 Years|Lost to Follow-up|4|||
25183177|NCT01435031|50330672|FG000|ITT at 3 Years|Death|5|||
25183178|NCT01435031|50330672|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
25183179|NCT01435031|50330672|FG000|ITT at 3 Years|Lost to Follow-up|4|||
25183180|NCT01435031|50330672|FG000|ITT at 4 Years|Death|4|||
25183181|NCT01435031|50330672|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
25183182|NCT01435031|50330672|FG000|ITT at 4 Years|Lost to Follow-up|1|||
25183183|NCT01433549|50330676|FG000|Phase 2: Second Study Product|Adverse Event|0|||
25183184|NCT01433549|50330677|FG001|Phase 2: Second Study Product|Adverse Event|1|||
25183185|NCT01414205|50330685|FG000|Overall Study|Death|5|||
25183186|NCT01414205|50330686|FG001|Overall Study|Death|1|||
25183187|NCT01414205|50330685|FG000|Overall Study|Lost to Follow-up|1|||
25183188|NCT01414205|50330686|FG001|Overall Study|Lost to Follow-up|4|||
25183189|NCT01414205|50330685|FG000|Overall Study|Physician Decision|0|||
25183190|NCT01414205|50330686|FG001|Overall Study|Physician Decision|1|||
25183191|NCT01414205|50330685|FG000|Overall Study|Randomized but not Treated|1|||
25183192|NCT01414205|50330686|FG001|Overall Study|Randomized but not Treated|1|||
25183193|NCT01433471|50330694|FG000|Overall Study|Withdrawal by Subject|0|||
25183194|NCT01433471|50330695|FG001|Overall Study|Withdrawal by Subject|1|||
25183195|NCT01433159|50330705|FG000|Overall Study|Adverse Event|1|||
25183196|NCT01433159|50330706|FG001|Overall Study|Adverse Event|0|||
25183197|NCT01433159|50330705|FG000|Overall Study|Physician Decision|1|||
25183198|NCT01433159|50330706|FG001|Overall Study|Physician Decision|0|||
25183199|NCT01433159|50330705|FG000|Overall Study|Protocol Violation|0|||
25183200|NCT01433159|50330706|FG001|Overall Study|Protocol Violation|1|||
25183201|NCT01413503|50330721|FG000|Overall Study|Lost to Follow-up|1|||
25183202|NCT01413191|50330725|FG000|Overall Study|Lost to Follow-up|5|||
25183203|NCT01413191|50330725|FG000|Overall Study|Disease Progression|5|||
25183204|NCT01413191|50330725|FG000|Overall Study|Death|1|||
25183205|NCT02036970|50330739|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
25183206|NCT02036970|50330740|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
25183207|NCT02036970|50330741|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
25183208|NCT02036970|50330742|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
25183209|NCT02036970|50330743|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
25183210|NCT02036970|50330744|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
25016075|NCT03288714|50110928|FG000|Overall Study|Adverse Event|1|||
25146107|NCT01412944|50259970|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
25146108|NCT01412944|50259971|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
25146109|NCT01412944|50259972|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
25146110|NCT01412944|50259973|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
25146111|NCT01412944|50259974|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
25146112|NCT01412944|50259969|FG000|Entire: IV + Maintenance|Adverse Event|0|||
25183211|NCT02036970|50330745|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
25183212|NCT02036970|50330746|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
25183213|NCT02036970|50330747|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
25183214|NCT02036970|50330748|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
25183215|NCT02036970|50330739|FG000|Part 1: Day 1 Through Week 16|Death|0|||
25183216|NCT02036970|50330740|FG001|Part 1: Day 1 Through Week 16|Death|0|||
25183217|NCT02036970|50330741|FG002|Part 1: Day 1 Through Week 16|Death|0|||
25183218|NCT02036970|50330742|FG003|Part 1: Day 1 Through Week 16|Death|0|||
25146113|NCT01412944|50259970|FG001|Entire: IV + Maintenance|Adverse Event|0|||
25146114|NCT01412944|50259971|FG002|Entire: IV + Maintenance|Adverse Event|0|||
25183219|NCT02036970|50330743|FG004|Part 1: Day 1 Through Week 16|Death|0|||
25183220|NCT02036970|50330744|FG005|Part 1: Day 1 Through Week 16|Death|0|||
25183221|NCT02036970|50330745|FG006|Part 1: Day 1 Through Week 16|Death|0|||
25183222|NCT02036970|50330746|FG007|Part 1: Day 1 Through Week 16|Death|0|||
25183223|NCT02036970|50330747|FG008|Part 1: Day 1 Through Week 16|Death|1|||
25183224|NCT02036970|50330748|FG009|Part 1: Day 1 Through Week 16|Death|0|||
25183225|NCT02036970|50330739|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
25183226|NCT02036970|50330740|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
25183227|NCT02036970|50330741|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
25183228|NCT02036970|50330742|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
25183229|NCT02036970|50330743|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
25183230|NCT02036970|50330744|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
25183231|NCT02036970|50330745|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
25183232|NCT02036970|50330746|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
25183233|NCT02036970|50330747|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
25183234|NCT02036970|50330748|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
25183235|NCT02036970|50330739|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
25183236|NCT02036970|50330740|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
25183237|NCT02036970|50330741|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
25183238|NCT02036970|50330742|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
25183239|NCT02036970|50330743|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
25183240|NCT02036970|50330744|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
25183241|NCT02036970|50330745|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
25183242|NCT02036970|50330746|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
25183243|NCT02036970|50330747|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
25183244|NCT02036970|50330748|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
25183245|NCT02036970|50330739|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
25183246|NCT02036970|50330740|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
25183247|NCT02036970|50330741|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
25183248|NCT02036970|50330742|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
25183249|NCT02036970|50330743|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
25183250|NCT02036970|50330744|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
25183251|NCT02036970|50330745|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
25183252|NCT02036970|50330746|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
25183253|NCT02036970|50330747|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
25183254|NCT02036970|50330748|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
25183255|NCT02036970|50330739|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
25183256|NCT02036970|50330740|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
25183257|NCT02036970|50330741|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
25183258|NCT02036970|50330742|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
25183259|NCT02036970|50330743|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
25183260|NCT02036970|50330744|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
25183261|NCT02036970|50330745|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
25183262|NCT02036970|50330746|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
25183263|NCT02036970|50330747|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
25183264|NCT02036970|50330748|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
25183265|NCT02036970|50330739|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
25183266|NCT02036970|50330740|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
25183267|NCT02036970|50330741|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
25183268|NCT02036970|50330742|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
25183269|NCT02036970|50330743|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
25183270|NCT02036970|50330744|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
25183271|NCT02036970|50330745|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
25183272|NCT02036970|50330746|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
25183273|NCT02036970|50330747|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
25183274|NCT02036970|50330748|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
25183275|NCT02036970|50330739|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
25183276|NCT02036970|50330740|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
25183277|NCT02036970|50330741|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
25183278|NCT02036970|50330742|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
25183279|NCT02036970|50330743|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
25183280|NCT02036970|50330744|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
25183281|NCT02036970|50330745|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
25183282|NCT02036970|50330746|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
25183283|NCT02036970|50330747|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
25183284|NCT02036970|50330748|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
25183285|NCT02036970|50330739|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
25183286|NCT02036970|50330740|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
25183287|NCT02036970|50330741|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
25183288|NCT02036970|50330742|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
25183289|NCT02036970|50330743|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
25183290|NCT02036970|50330744|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
25183291|NCT02036970|50330745|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
25183292|NCT02036970|50330746|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
25183293|NCT02036970|50330747|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
25183294|NCT02036970|50330748|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
25183295|NCT01412957|50330782|FG000|Overall Study|Withdrawal by Subject|6|||
25183296|NCT01412957|50330783|FG001|Overall Study|Withdrawal by Subject|22|||
25183297|NCT01412957|50330782|FG000|Overall Study|Lost to Follow-up|7|||
25183298|NCT01412957|50330783|FG001|Overall Study|Lost to Follow-up|2|||
25183299|NCT01412957|50330782|FG000|Overall Study|Death|136|||
25183300|NCT01412957|50330783|FG001|Overall Study|Death|133|||
25183301|NCT01432457|50330792|FG000|Overall Study|Adverse Event|7|||
25183302|NCT01432457|50330793|FG001|Overall Study|Adverse Event|10|||
25183303|NCT01432457|50330794|FG002|Overall Study|Adverse Event|16|||
25183304|NCT01432457|50330792|FG000|Overall Study|Lack of Efficacy|2|||
25183305|NCT01432457|50330793|FG001|Overall Study|Lack of Efficacy|1|||
25183306|NCT01432457|50330794|FG002|Overall Study|Lack of Efficacy|1|||
25183307|NCT01432457|50330792|FG000|Overall Study|Lost to Follow-up|11|||
25183308|NCT01432457|50330793|FG001|Overall Study|Lost to Follow-up|15|||
25183309|NCT01432457|50330794|FG002|Overall Study|Lost to Follow-up|20|||
25183310|NCT01432457|50330792|FG000|Overall Study|Protocol Violation|3|||
25183311|NCT01432457|50330793|FG001|Overall Study|Protocol Violation|2|||
25183312|NCT01432457|50330794|FG002|Overall Study|Protocol Violation|6|||
25183313|NCT01432457|50330792|FG000|Overall Study|Withdrawal by Subject|6|||
25183314|NCT01432457|50330793|FG001|Overall Study|Withdrawal by Subject|11|||
25183315|NCT01432457|50330794|FG002|Overall Study|Withdrawal by Subject|9|||
25183316|NCT01432457|50330792|FG000|Overall Study|Reasons not defined|2|||
25183317|NCT01432457|50330793|FG001|Overall Study|Reasons not defined|3|||
25183318|NCT01432457|50330794|FG002|Overall Study|Reasons not defined|4|||
25183319|NCT01432457|50330792|FG000|Overall Study|Did not take study drug|6|||
25183320|NCT01432457|50330793|FG001|Overall Study|Did not take study drug|6|||
25183321|NCT01432457|50330794|FG002|Overall Study|Did not take study drug|3|||
25183322|NCT01390441|50330816|FG000|Treatment Period|Protocol Violation|0|||
25183323|NCT01390441|50330817|FG001|Treatment Period|Protocol Violation|1|||
25183324|NCT01390441|50330818|FG002|Treatment Period|Protocol Violation|0|||
25183325|NCT01390441|50330819|FG003|Treatment Period|Protocol Violation|0|||
25183326|NCT01390441|50330820|FG004|Treatment Period|Protocol Violation|0|||
25183327|NCT01390441|50330816|FG000|Treatment Period|Physician Decision|0|||
25183328|NCT01390441|50330817|FG001|Treatment Period|Physician Decision|0|||
25183329|NCT01390441|50330818|FG002|Treatment Period|Physician Decision|0|||
25183330|NCT01390441|50330819|FG003|Treatment Period|Physician Decision|1|||
25183331|NCT01390441|50330820|FG004|Treatment Period|Physician Decision|0|||
25183332|NCT01390441|50330816|FG000|Treatment Period|Lack of Efficacy|0|||
25183333|NCT01390441|50330817|FG001|Treatment Period|Lack of Efficacy|0|||
25183334|NCT01390441|50330818|FG002|Treatment Period|Lack of Efficacy|0|||
25183335|NCT01390441|50330819|FG003|Treatment Period|Lack of Efficacy|0|||
25183336|NCT01390441|50330820|FG004|Treatment Period|Lack of Efficacy|1|||
25183337|NCT01390441|50330816|FG000|Treatment Period|Unknown due to early stopping of study|0|||
25183338|NCT01390441|50330817|FG001|Treatment Period|Unknown due to early stopping of study|0|||
25183339|NCT01390441|50330818|FG002|Treatment Period|Unknown due to early stopping of study|8|||
25183340|NCT01390441|50330819|FG003|Treatment Period|Unknown due to early stopping of study|11|||
25183341|NCT01390441|50330820|FG004|Treatment Period|Unknown due to early stopping of study|7|||
25183342|NCT01390441|50330816|FG000|Treatment Period|Adverse Event|0|||
25183343|NCT01390441|50330817|FG001|Treatment Period|Adverse Event|0|||
25183344|NCT01390441|50330818|FG002|Treatment Period|Adverse Event|1|||
25146115|NCT01412944|50259972|FG003|Entire: IV + Maintenance|Adverse Event|0|||
25146116|NCT01412944|50259973|FG004|Entire: IV + Maintenance|Adverse Event|1|||
25146117|NCT01412944|50259974|FG005|Entire: IV + Maintenance|Adverse Event|0|||
25146118|NCT01412944|50259969|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
25146119|NCT01412944|50259970|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
25146120|NCT01412944|50259971|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
25146121|NCT01412944|50259972|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
25146122|NCT01412944|50259973|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
25146123|NCT01412944|50259974|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
25146124|NCT01412944|50259969|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
25146125|NCT01412944|50259970|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
25146126|NCT01412944|50259971|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
25146127|NCT01412944|50259972|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
25146128|NCT01412944|50259973|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
25146129|NCT01412944|50259974|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
25146130|NCT01412944|50259969|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
25183345|NCT01390441|50330819|FG003|Treatment Period|Adverse Event|1|||
25183346|NCT01390441|50330820|FG004|Treatment Period|Adverse Event|2|||
25146131|NCT01412944|50259970|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
25146132|NCT01412944|50259971|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
25146133|NCT01412944|50259972|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
25183347|NCT01390441|50330816|FG000|Treatment Period|Withdrawal by Subject|0|||
25183348|NCT01390441|50330817|FG001|Treatment Period|Withdrawal by Subject|0|||
25183349|NCT01390441|50330818|FG002|Treatment Period|Withdrawal by Subject|1|||
25183350|NCT01390441|50330819|FG003|Treatment Period|Withdrawal by Subject|0|||
25183351|NCT01390441|50330820|FG004|Treatment Period|Withdrawal by Subject|1|||
25183352|NCT01390441|50330816|FG000|Treatment Period|Lost to Follow-up|1|||
25183353|NCT01390441|50330817|FG001|Treatment Period|Lost to Follow-up|0|||
25183354|NCT01390441|50330818|FG002|Treatment Period|Lost to Follow-up|0|||
25183355|NCT01390441|50330819|FG003|Treatment Period|Lost to Follow-up|0|||
25183356|NCT01390441|50330820|FG004|Treatment Period|Lost to Follow-up|0|||
25183357|NCT01390441|50330816|FG000|Extension Period|Protocol Violation|3|||
25183358|NCT01390441|50330817|FG001|Extension Period|Protocol Violation|1|||
25183359|NCT01390441|50330818|FG002|Extension Period|Protocol Violation|0|||
25183360|NCT01390441|50330819|FG003|Extension Period|Protocol Violation|1|||
25183361|NCT01390441|50330820|FG004|Extension Period|Protocol Violation|0|||
25183362|NCT01412879|50330869|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
25183363|NCT01412879|50330870|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
25183364|NCT01412879|50330871|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
25183365|NCT01412879|50330869|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
25183366|NCT01412879|50330870|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
25183367|NCT01412879|50330871|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
25183368|NCT01412879|50330869|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
25183369|NCT01412879|50330870|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
25183370|NCT01412879|50330871|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
25183371|NCT01412879|50330869|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
25183372|NCT01412879|50330870|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
25183373|NCT01412879|50330871|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
25183374|NCT01412879|50330869|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
25183375|NCT01412879|50330870|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
25183376|NCT01412879|50330871|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
25183377|NCT01431079|50330883|FG000|Overall Study|Lost to Follow-up|35|||
25183378|NCT01431079|50330884|FG001|Overall Study|Lost to Follow-up|39|||
25183379|NCT01430611|50330916|FG000|Overall Study|Adverse Event|0|||
25183380|NCT01430611|50330917|FG001|Overall Study|Adverse Event|1|||
25183381|NCT01430611|50330916|FG000|Overall Study|Protocol Violation|1|||
25183382|NCT01430611|50330917|FG001|Overall Study|Protocol Violation|0|||
25183383|NCT01430611|50330916|FG000|Overall Study|Lost to Follow-up|1|||
25183384|NCT01430611|50330917|FG001|Overall Study|Lost to Follow-up|0|||
25183385|NCT01430611|50330916|FG000|Overall Study|Withdrawal by Subject|15|||
25183386|NCT01430611|50330917|FG001|Overall Study|Withdrawal by Subject|14|||
25183387|NCT01409707|50330926|FG000|Overall Study|Withdrawal by Subject|5|||
25183388|NCT01409707|50330927|FG001|Overall Study|Withdrawal by Subject|17|||
25183389|NCT01409707|50330928|FG002|Overall Study|Withdrawal by Subject|16|||
25183390|NCT01389973|50330935|FG000|Overall Study|Lost to Follow-up|1|||
25183391|NCT01389973|50330935|FG000|Overall Study|Trial Stopped by Sponsor|9|||
25146134|NCT01412944|50259973|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
25146135|NCT01412944|50259974|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
25146136|NCT01412944|50259969|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
25146137|NCT01412944|50259970|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
25146138|NCT01412944|50259971|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
25146139|NCT01412944|50259972|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
25146140|NCT01412944|50259973|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
25146141|NCT01412944|50259974|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
25146142|NCT01412944|50259969|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
25183392|NCT01389973|50330935|FG000|Overall Study|Other|10|||
25183393|NCT01389817|50330955|FG000|Overall Study|Physician Decision|1|||
25183394|NCT01389817|50330956|FG001|Overall Study|Physician Decision|0|||
25183395|NCT01389817|50330955|FG000|Overall Study|Lost to Follow-up|1|||
25183396|NCT01389817|50330956|FG001|Overall Study|Lost to Follow-up|0|||
25183397|NCT01389817|50330955|FG000|Overall Study|Withdrawal by Subject|2|||
25183398|NCT01389817|50330956|FG001|Overall Study|Withdrawal by Subject|0|||
25183399|NCT01430455|50330971|FG000|Overall Study|Withdrawal by Subject|1|||
25183400|NCT01430455|50330971|FG000|Overall Study|Switched to follow-up phase|1|||
25183401|NCT01429441|50330999|FG000|Overall Study|Adverse Event|5|||
25183402|NCT01429441|50331000|FG001|Overall Study|Adverse Event|1|||
25146143|NCT01412944|50259970|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
25183403|NCT01429441|50330999|FG000|Overall Study|Death|0|||
25016076|NCT03288714|50110929|FG001|Overall Study|Adverse Event|0|||
25183404|NCT01429441|50331000|FG001|Overall Study|Death|2|||
25183405|NCT01429441|50330999|FG000|Overall Study|Lost to Follow-up|5|||
25183406|NCT01429441|50331000|FG001|Overall Study|Lost to Follow-up|2|||
25183407|NCT01429441|50330999|FG000|Overall Study|Physician Decision|1|||
25183408|NCT01429441|50331000|FG001|Overall Study|Physician Decision|0|||
25183409|NCT01429441|50330999|FG000|Overall Study|Withdrawal by Subject|27|||
25183410|NCT01429441|50331000|FG001|Overall Study|Withdrawal by Subject|18|||
25183411|NCT01429285|50331035|FG000|Overall Study|Protocol Violation|9|||
25183412|NCT01429285|50331036|FG001|Overall Study|Protocol Violation|4|||
25183413|NCT01429285|50331035|FG000|Overall Study|Missing Data|5|||
25183414|NCT01429285|50331036|FG001|Overall Study|Missing Data|3|||
25183415|NCT01429285|50331035|FG000|Overall Study|Erroneously Enrolled Twice|8|||
25183416|NCT01429285|50331036|FG001|Overall Study|Erroneously Enrolled Twice|2|||
25183417|NCT01429051|50331113|FG000|Titration Phase|Death|1|||
25183418|NCT01429051|50331113|FG000|Titration Phase|Withdrawal by Subject|7|||
25183419|NCT01429051|50331113|FG000|Titration Phase|Physician Decision|1|||
25183420|NCT01429051|50331113|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
25274561|NCT00977938|50588591|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
25183421|NCT01429051|50331113|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
25183422|NCT01429051|50331113|FG000|Efficacy Phase|Adverse Event|1|||
25183423|NCT01429051|50331113|FG000|Efficacy Phase|Death|1|||
25183424|NCT01429051|50331113|FG000|Tolerability Phase|Death|5|||
25183425|NCT01429051|50331113|FG000|Tolerability Phase|Adverse Event|2|||
25183426|NCT01429051|50331113|FG000|Tolerability Phase|Withdrawal by Subject|5|||
25183427|NCT01429051|50331113|FG000|Tolerability Phase|Physician Decision|1|||
25183428|NCT01429051|50331113|FG000|Tolerability Phase|Other|2|||
25183429|NCT01428661|50331146|FG000|Double-Masked Phase|Protocol Violation|9|||
25183430|NCT01428661|50331147|FG001|Double-Masked Phase|Protocol Violation|4|||
25183431|NCT01428661|50331148|FG002|Double-Masked Phase|Protocol Violation|0|||
25183432|NCT01428661|50331146|FG000|Double-Masked Phase|Adverse Event|13|||
25183433|NCT01428661|50331147|FG001|Double-Masked Phase|Adverse Event|4|||
25183434|NCT01428661|50331148|FG002|Double-Masked Phase|Adverse Event|0|||
25146144|NCT01412944|50259971|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
25146145|NCT01412944|50259972|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
25146146|NCT01412944|50259973|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
25146147|NCT01412944|50259974|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
25146148|NCT01412944|50259969|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
25146149|NCT01412944|50259970|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
25146150|NCT01412944|50259971|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
25146151|NCT01412944|50259972|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
25146152|NCT01412944|50259973|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
25146153|NCT01412944|50259974|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
25146154|NCT01412944|50259969|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
25146155|NCT01412944|50259970|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
25146156|NCT01412944|50259971|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
25146157|NCT01412944|50259972|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
25146158|NCT01412944|50259973|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
25146159|NCT01412944|50259974|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
25146160|NCT01412944|50259969|FG000|Entire: IV + Maintenance|Adverse Event|0|||
25146161|NCT01412944|50259970|FG001|Entire: IV + Maintenance|Adverse Event|1|||
25146162|NCT01412944|50259971|FG002|Entire: IV + Maintenance|Adverse Event|0|||
25146163|NCT01412944|50259972|FG003|Entire: IV + Maintenance|Adverse Event|0|||
25146164|NCT01412944|50259973|FG004|Entire: IV + Maintenance|Adverse Event|0|||
25146165|NCT01412944|50259974|FG005|Entire: IV + Maintenance|Adverse Event|0|||
25146166|NCT01798485|50259992|FG000|Overall Study|Adverse Event|32|||
25146167|NCT01798485|50259993|FG001|Overall Study|Adverse Event|40|||
25146168|NCT01798485|50259992|FG000|Overall Study|Withdrawal by Subject|27|||
25146169|NCT01798485|50259993|FG001|Overall Study|Withdrawal by Subject|31|||
25146170|NCT01798485|50259992|FG000|Overall Study|Lost to Follow-up|0|||
25146171|NCT01798485|50259993|FG001|Overall Study|Lost to Follow-up|3|||
25146172|NCT01798485|50259992|FG000|Overall Study|Physician Decision|14|||
25146173|NCT01798485|50259993|FG001|Overall Study|Physician Decision|10|||
25146174|NCT01798485|50259992|FG000|Overall Study|Objective Disease Progression|152|||
25146175|NCT01798485|50259993|FG001|Overall Study|Objective Disease Progression|106|||
25146176|NCT01798485|50259992|FG000|Overall Study|Death|25|||
25146177|NCT01798485|50259993|FG001|Overall Study|Death|22|||
25146178|NCT01798485|50259992|FG000|Overall Study|Sponsor Decision|61|||
25146179|NCT01798485|50259993|FG001|Overall Study|Sponsor Decision|54|||
25146180|NCT01798485|50259992|FG000|Overall Study|Clinical Progression|35|||
25146181|NCT01798485|50259993|FG001|Overall Study|Clinical Progression|24|||
25146182|NCT01767597|50260001|FG000|Overall Study|Incomplete intervention|3|||
25146183|NCT01767597|50260002|FG001|Overall Study|Incomplete intervention|1|||
25146184|NCT01767597|50260001|FG000|Overall Study|Withdrawal by Subject|1|||
25146185|NCT01767597|50260002|FG001|Overall Study|Withdrawal by Subject|0|||
25146186|NCT01767519|50260011|FG000|Overall Study|Other Reasons|4|||
25146187|NCT01767519|50260012|FG001|Overall Study|Other Reasons|4|||
25146188|NCT01767519|50260013|FG002|Overall Study|Other Reasons|2|||
25146189|NCT01767519|50260011|FG000|Overall Study|Protocol Violation|0|||
25146190|NCT01767519|50260012|FG001|Overall Study|Protocol Violation|3|||
25146191|NCT01767519|50260013|FG002|Overall Study|Protocol Violation|0|||
25146192|NCT01767519|50260011|FG000|Overall Study|Personal Reasons|1|||
25146193|NCT01767519|50260012|FG001|Overall Study|Personal Reasons|0|||
25183435|NCT01428661|50331146|FG000|Double-Masked Phase|Lost to Follow-up|14|||
25183436|NCT01428661|50331147|FG001|Double-Masked Phase|Lost to Follow-up|14|||
25183437|NCT01428661|50331148|FG002|Double-Masked Phase|Lost to Follow-up|0|||
25146194|NCT01767519|50260013|FG002|Overall Study|Personal Reasons|0|||
25146195|NCT01767519|50260011|FG000|Overall Study|Lost to Follow-up|3|||
25146196|NCT01767519|50260012|FG001|Overall Study|Lost to Follow-up|1|||
25146197|NCT01767519|50260013|FG002|Overall Study|Lost to Follow-up|2|||
25146198|NCT01767519|50260011|FG000|Overall Study|Lack of Efficacy|1|||
25146199|NCT01767519|50260012|FG001|Overall Study|Lack of Efficacy|0|||
25146200|NCT01767519|50260013|FG002|Overall Study|Lack of Efficacy|0|||
25183438|NCT01428661|50331146|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
25183439|NCT01428661|50331147|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
25183440|NCT01428661|50331148|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
25146201|NCT01767519|50260011|FG000|Overall Study|Adverse Event|5|||
25146202|NCT01767519|50260012|FG001|Overall Study|Adverse Event|5|||
25146203|NCT01767519|50260013|FG002|Overall Study|Adverse Event|1|||
25183441|NCT01428661|50331146|FG000|Double-Masked Phase|Lack of Efficacy|2|||
25183442|NCT01428661|50331147|FG001|Double-Masked Phase|Lack of Efficacy|1|||
25183443|NCT01428661|50331148|FG002|Double-Masked Phase|Lack of Efficacy|0|||
25183444|NCT01428661|50331146|FG000|Double-Masked Phase|*Various|1|||
25183445|NCT01428661|50331147|FG001|Double-Masked Phase|*Various|6|||
25183446|NCT01428661|50331148|FG002|Double-Masked Phase|*Various|0|||
25183447|NCT01428661|50331146|FG000|Open Label Extension|Protocol Violation|0|||
25183448|NCT01428661|50331147|FG001|Open Label Extension|Protocol Violation|0|||
25183449|NCT01428661|50331148|FG002|Open Label Extension|Protocol Violation|9|||
25146204|NCT01797783|50260023|FG000|Overall Study|Adverse Event|1|||
25146205|NCT01797783|50260024|FG001|Overall Study|Adverse Event|1|||
25146206|NCT01797783|50260023|FG000|Overall Study|Withdrawal by Subject|1|||
25146207|NCT01797783|50260024|FG001|Overall Study|Withdrawal by Subject|0|||
25146208|NCT01766817|50260041|FG000|Overall Study|Drug-related adverse event|1|||
25146209|NCT01766817|50260042|FG001|Overall Study|Drug-related adverse event|2|||
25146210|NCT01766817|50260043|FG002|Overall Study|Drug-related adverse event|1|||
25146211|NCT01766817|50260041|FG000|Overall Study|Drug-unrelated adverse event|3|||
25146212|NCT01766817|50260042|FG001|Overall Study|Drug-unrelated adverse event|3|||
25146213|NCT01766817|50260043|FG002|Overall Study|Drug-unrelated adverse event|3|||
25183450|NCT01428661|50331146|FG000|Open Label Extension|Adverse Event|0|||
25183451|NCT01428661|50331147|FG001|Open Label Extension|Adverse Event|0|||
25183452|NCT01428661|50331148|FG002|Open Label Extension|Adverse Event|15|||
25146214|NCT01766817|50260041|FG000|Overall Study|Death|1|||
25146215|NCT01766817|50260042|FG001|Overall Study|Death|1|||
25183453|NCT01428661|50331146|FG000|Open Label Extension|Lost to Follow-up|0|||
25183454|NCT01428661|50331147|FG001|Open Label Extension|Lost to Follow-up|0|||
25183455|NCT01428661|50331148|FG002|Open Label Extension|Lost to Follow-up|38|||
25146216|NCT01766817|50260043|FG002|Overall Study|Death|0|||
25146217|NCT01766817|50260041|FG000|Overall Study|Unable to take study drug|0|||
25146218|NCT01766817|50260042|FG001|Overall Study|Unable to take study drug|1|||
25146219|NCT01766817|50260043|FG002|Overall Study|Unable to take study drug|0|||
25146220|NCT01766817|50260041|FG000|Overall Study|Withdrawal by Subject|2|||
25146221|NCT01766817|50260042|FG001|Overall Study|Withdrawal by Subject|0|||
25146222|NCT01766817|50260043|FG002|Overall Study|Withdrawal by Subject|3|||
25146223|NCT01766817|50260041|FG000|Overall Study|Subject non-compliance|0|||
25146224|NCT01766817|50260042|FG001|Overall Study|Subject non-compliance|1|||
25146225|NCT01766817|50260043|FG002|Overall Study|Subject non-compliance|2|||
25146226|NCT01766817|50260041|FG000|Overall Study|Physician Decision|3|||
25146227|NCT01766817|50260042|FG001|Overall Study|Physician Decision|3|||
25146228|NCT01766817|50260043|FG002|Overall Study|Physician Decision|4|||
25146229|NCT01766817|50260041|FG000|Overall Study|Other|1|||
25146230|NCT01766817|50260042|FG001|Overall Study|Other|0|||
25146231|NCT01766817|50260043|FG002|Overall Study|Other|0|||
25146232|NCT01797705|50260051|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
25146233|NCT01797705|50260051|FG000|Overall Study|Withdrawal by Subject|1|||
25146234|NCT01797081|50260059|FG000|Overall Study|Adverse Event|1|||
25146235|NCT01797081|50260060|FG001|Overall Study|Adverse Event|0|||
25146236|NCT01797081|50260061|FG002|Overall Study|Adverse Event|1|||
25146237|NCT01797081|50260062|FG003|Overall Study|Adverse Event|0|||
25146238|NCT01797081|50260059|FG000|Overall Study|Pregnancy|1|||
25146239|NCT01797081|50260060|FG001|Overall Study|Pregnancy|0|||
25146240|NCT01797081|50260061|FG002|Overall Study|Pregnancy|0|||
25146241|NCT01797081|50260062|FG003|Overall Study|Pregnancy|0|||
25146242|NCT01797081|50260059|FG000|Overall Study|Personal Reasons|12|||
25146243|NCT01797081|50260060|FG001|Overall Study|Personal Reasons|4|||
25146244|NCT01797081|50260061|FG002|Overall Study|Personal Reasons|4|||
25146245|NCT01797081|50260062|FG003|Overall Study|Personal Reasons|8|||
25146246|NCT01797081|50260059|FG000|Overall Study|Protocol Violation|0|||
25146247|NCT01797081|50260060|FG001|Overall Study|Protocol Violation|0|||
25146248|NCT01797081|50260061|FG002|Overall Study|Protocol Violation|0|||
25146249|NCT01797081|50260062|FG003|Overall Study|Protocol Violation|1|||
25146250|NCT01794117|50260074|FG000|Overall Study|Adverse Event|1|||
25146251|NCT01794117|50260075|FG001|Overall Study|Adverse Event|0|||
25146252|NCT01794117|50260076|FG002|Overall Study|Adverse Event|0|||
25146253|NCT01794117|50260077|FG003|Overall Study|Adverse Event|0|||
25146254|NCT01794117|50260074|FG000|Overall Study|Participant noncompliance|0|||
25146255|NCT01794117|50260075|FG001|Overall Study|Participant noncompliance|1|||
25146256|NCT01794117|50260076|FG002|Overall Study|Participant noncompliance|0|||
25146257|NCT01794117|50260077|FG003|Overall Study|Participant noncompliance|0|||
25146258|NCT01794117|50260074|FG000|Overall Study|Refused further treatment|0|||
25146259|NCT01794117|50260075|FG001|Overall Study|Refused further treatment|2|||
25146260|NCT01794117|50260076|FG002|Overall Study|Refused further treatment|0|||
25146261|NCT01794117|50260077|FG003|Overall Study|Refused further treatment|0|||
25146262|NCT01766037|50260090|FG000|Overall Study|Adverse Event|1|||
25146263|NCT01766037|50260091|FG001|Overall Study|Adverse Event|0|||
25146264|NCT01766037|50260090|FG000|Overall Study|Lack of Efficacy|1|||
25146265|NCT01766037|50260091|FG001|Overall Study|Lack of Efficacy|0|||
25146266|NCT01766037|50260090|FG000|Overall Study|Lost to Follow-up|0|||
25146267|NCT01766037|50260091|FG001|Overall Study|Lost to Follow-up|10|||
25146268|NCT01766037|50260090|FG000|Overall Study|Physician Decision|0|||
25146269|NCT01766037|50260091|FG001|Overall Study|Physician Decision|1|||
25146270|NCT01766037|50260090|FG000|Overall Study|Withdrawal by Subject|18|||
25146271|NCT01766037|50260091|FG001|Overall Study|Withdrawal by Subject|16|||
25146272|NCT01766037|50260090|FG000|Overall Study|Moved from area|5|||
25146273|NCT01766037|50260091|FG001|Overall Study|Moved from area|0|||
25146274|NCT01766037|50260090|FG000|Overall Study|medical - unrelated|1|||
25146275|NCT01766037|50260091|FG001|Overall Study|medical - unrelated|2|||
25146276|NCT01766037|50260090|FG000|Overall Study|nausea / discomfort|3|||
25146277|NCT01766037|50260091|FG001|Overall Study|nausea / discomfort|0|||
25146278|NCT01765569|50260097|FG000|Period B|Withdrawal by Subject|1|||
25146279|NCT01765569|50260097|FG000|Period C|Death|1|||
25146280|NCT01609257|50260106|FG000|Overall Study|Lost to Follow-up|2|||
25146281|NCT01609257|50260107|FG001|Overall Study|Lost to Follow-up|1|||
25146282|NCT01609257|50260106|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
25146283|NCT01609257|50260107|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
25146284|NCT01609257|50260106|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
25146285|NCT01609257|50260107|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
25146286|NCT01609023|50260116|FG000|Overall Study|Lack of Efficacy|3|||
25146287|NCT01609023|50260116|FG000|Overall Study|Withdrawal by Subject|4|||
25146288|NCT01609023|50260116|FG000|Overall Study|Lost to Follow-up|8|||
25146289|NCT01609023|50260116|FG000|Overall Study|Toxicity|3|||
25016077|NCT04068181|50110941|FG000|Overall Study|Withdrawal by Subject|2|||
25146290|NCT01609023|50260116|FG000|Overall Study|Disease progression|10|||
25183456|NCT01428661|50331146|FG000|Open Label Extension|Withdrawal by Subject|0|||
25146291|NCT01609023|50260116|FG000|Overall Study|Physician Decision|2|||
25146292|NCT01609023|50260116|FG000|Overall Study|Death|2|||
25146293|NCT01609023|50260116|FG000|Overall Study|Personal reasons|1|||
25146294|NCT01765179|50260120|FG000|Overall Study|Adverse Event|3|||
25183457|NCT01428661|50331147|FG001|Open Label Extension|Withdrawal by Subject|0|||
25016078|NCT04068181|50110942|FG001|Overall Study|Withdrawal by Subject|0|||
25146295|NCT01765179|50260120|FG000|Overall Study|Lost to Follow-up|5|||
25146296|NCT01765179|50260120|FG000|Overall Study|Non-compliance with study drug|2|||
25146297|NCT01765179|50260120|FG000|Overall Study|Protocol Violation|1|||
25146298|NCT01765179|50260120|FG000|Overall Study|Withdrawal by Subject|8|||
25183458|NCT01428661|50331148|FG002|Open Label Extension|Withdrawal by Subject|49|||
25146299|NCT01765179|50260120|FG000|Overall Study|Hematocrit >54%|3|||
25146300|NCT01765179|50260120|FG000|Overall Study|prohibited med|1|||
25146301|NCT01765179|50260120|FG000|Overall Study|Out of country unable to finish study|1|||
25146302|NCT01765179|50260120|FG000|Overall Study|lack of venous access|1|||
25146303|NCT01765179|50260120|FG000|Overall Study|work conflict|1|||
25146304|NCT01765179|50260120|FG000|Overall Study|Ca elevated 10.6|1|||
25146305|NCT01764945|50260132|FG000|Overall Study|Adverse Event|0|||
25146306|NCT01764945|50260133|FG001|Overall Study|Adverse Event|1|||
25146307|NCT01764945|50260134|FG002|Overall Study|Adverse Event|0|||
25146308|NCT01764945|50260135|FG003|Overall Study|Adverse Event|0|||
25146309|NCT01764945|50260136|FG004|Overall Study|Adverse Event|0|||
25146310|NCT01764945|50260137|FG005|Overall Study|Adverse Event|0|||
25146311|NCT01764945|50260138|FG006|Overall Study|Adverse Event|1|||
25146312|NCT01764945|50260139|FG007|Overall Study|Adverse Event|0|||
25146313|NCT01793883|50260160|FG000|Overall Study|Withdrawal by Subject|3|||
25146314|NCT01793883|50260161|FG001|Overall Study|Withdrawal by Subject|7|||
25146315|NCT01793883|50260162|FG002|Overall Study|Withdrawal by Subject|3|||
25146316|NCT01793883|50260160|FG000|Overall Study|Subject noncompliance|0|||
25146317|NCT01793883|50260161|FG001|Overall Study|Subject noncompliance|1|||
25146318|NCT01793883|50260162|FG002|Overall Study|Subject noncompliance|1|||
25146319|NCT01793883|50260160|FG000|Overall Study|Lost to Follow-up|5|||
25146320|NCT01793883|50260161|FG001|Overall Study|Lost to Follow-up|1|||
25146321|NCT01793883|50260162|FG002|Overall Study|Lost to Follow-up|3|||
25146322|NCT01793883|50260160|FG000|Overall Study|Randomized in error|1|||
25146323|NCT01793883|50260161|FG001|Overall Study|Randomized in error|0|||
25146324|NCT01793883|50260162|FG002|Overall Study|Randomized in error|0|||
25146325|NCT01793883|50260160|FG000|Overall Study|Unable to complete spriometry|1|||
25146326|NCT01793883|50260161|FG001|Overall Study|Unable to complete spriometry|0|||
25146327|NCT01793883|50260162|FG002|Overall Study|Unable to complete spriometry|0|||
25146328|NCT01793883|50260160|FG000|Overall Study|Unable to complete measurements|1|||
25146329|NCT01793883|50260161|FG001|Overall Study|Unable to complete measurements|0|||
25146330|NCT01793883|50260162|FG002|Overall Study|Unable to complete measurements|0|||
25146331|NCT01793883|50260160|FG000|Overall Study|Met exclusion criteria|1|||
25146332|NCT01793883|50260161|FG001|Overall Study|Met exclusion criteria|0|||
25146333|NCT01793883|50260162|FG002|Overall Study|Met exclusion criteria|0|||
25146334|NCT01793883|50260160|FG000|Overall Study|Dosing error|0|||
25146335|NCT01793883|50260161|FG001|Overall Study|Dosing error|1|||
25146336|NCT01793883|50260162|FG002|Overall Study|Dosing error|0|||
25146337|NCT01793883|50260160|FG000|Overall Study|Respiratory distress during spirometry|0|||
25146338|NCT01793883|50260161|FG001|Overall Study|Respiratory distress during spirometry|0|||
25146339|NCT01793883|50260162|FG002|Overall Study|Respiratory distress during spirometry|1|||
25146340|NCT01792635|50260173|FG000|Part B|Adverse Event|0|||
25146341|NCT01792635|50260174|FG001|Part B|Adverse Event|0|||
25146342|NCT01792635|50260175|FG002|Part B|Adverse Event|1|||
25146343|NCT01792635|50260173|FG000|Part B|Study terminated|0|||
25146344|NCT01792635|50260174|FG001|Part B|Study terminated|4|||
25146345|NCT01792635|50260175|FG002|Part B|Study terminated|3|||
25146346|NCT01953692|50260193|FG000|Overall Study|Adverse Event|5|||
25146347|NCT01953692|50260194|FG001|Overall Study|Adverse Event|2|||
25146348|NCT01953692|50260195|FG002|Overall Study|Adverse Event|4|||
25146349|NCT01953692|50260196|FG003|Overall Study|Adverse Event|2|||
25146350|NCT01953692|50260197|FG004|Overall Study|Adverse Event|1|||
25146351|NCT01953692|50260198|FG005|Overall Study|Adverse Event|2|||
25146352|NCT01953692|50260199|FG006|Overall Study|Adverse Event|0|||
25146353|NCT01953692|50260200|FG007|Overall Study|Adverse Event|0|||
25146354|NCT01953692|50260201|FG008|Overall Study|Adverse Event|0|||
25146355|NCT01953692|50260193|FG000|Overall Study|Clinical Progression|0|||
25146356|NCT01953692|50260194|FG001|Overall Study|Clinical Progression|15|||
25146357|NCT01953692|50260195|FG002|Overall Study|Clinical Progression|7|||
25146358|NCT01953692|50260196|FG003|Overall Study|Clinical Progression|5|||
25146359|NCT01953692|50260197|FG004|Overall Study|Clinical Progression|0|||
25146360|NCT01953692|50260198|FG005|Overall Study|Clinical Progression|7|||
25146361|NCT01953692|50260199|FG006|Overall Study|Clinical Progression|20|||
25016079|NCT04068181|50110943|FG002|Overall Study|Withdrawal by Subject|0|||
25146362|NCT01953692|50260200|FG007|Overall Study|Clinical Progression|3|||
25146363|NCT01953692|50260201|FG008|Overall Study|Clinical Progression|3|||
25146364|NCT01953692|50260193|FG000|Overall Study|Death|5|||
25183459|NCT01428661|50331146|FG000|Open Label Extension|Lack of Efficacy|0|||
25183460|NCT01428661|50331147|FG001|Open Label Extension|Lack of Efficacy|0|||
25183461|NCT01428661|50331148|FG002|Open Label Extension|Lack of Efficacy|24|||
25183462|NCT01428661|50331146|FG000|Open Label Extension|**Various|0|||
25146365|NCT01953692|50260194|FG001|Overall Study|Death|0|||
25146366|NCT01953692|50260195|FG002|Overall Study|Death|2|||
25146367|NCT01953692|50260196|FG003|Overall Study|Death|2|||
25146368|NCT01953692|50260197|FG004|Overall Study|Death|1|||
25146369|NCT01953692|50260198|FG005|Overall Study|Death|3|||
25146370|NCT01953692|50260199|FG006|Overall Study|Death|6|||
25146371|NCT01953692|50260200|FG007|Overall Study|Death|2|||
25146372|NCT01953692|50260201|FG008|Overall Study|Death|1|||
25183463|NCT01428661|50331147|FG001|Open Label Extension|**Various|0|||
25183464|NCT01428661|50331148|FG002|Open Label Extension|**Various|185|||
25183465|NCT01428583|50331156|FG000|Overall Study|Adverse Event|75|||
25183466|NCT01428583|50331156|FG000|Overall Study|Withdrawal by Subject|51|||
25183467|NCT01428583|50331156|FG000|Overall Study|Lack of Efficacy|37|||
25183468|NCT01428583|50331156|FG000|Overall Study|Lost to Follow-up|17|||
25183469|NCT01428583|50331156|FG000|Overall Study|Death|1|||
25183470|NCT01428583|50331156|FG000|Overall Study|Pregnancy|1|||
25183471|NCT01428583|50331156|FG000|Overall Study|Protocol Violation|1|||
25183472|NCT01428583|50331156|FG000|Overall Study|Physician Decision|12|||
25183473|NCT01428583|50331156|FG000|Overall Study|Non-compliant|25|||
25183474|NCT01428583|50331156|FG000|Overall Study|Confirmed positive urine drug test|8|||
25183475|NCT01428583|50331156|FG000|Overall Study|Sponsor's request|3|||
25183476|NCT01428583|50331156|FG000|Overall Study|Other|6|||
25146373|NCT01953692|50260193|FG000|Overall Study|Excluded Medication|1|||
25146374|NCT01953692|50260194|FG001|Overall Study|Excluded Medication|0|||
25183477|NCT01428193|50331173|FG000|Overall Study|Physician Decision|1|||
25183478|NCT01428193|50331173|FG000|Overall Study|Elevated screening liver enzymes|1|||
25183479|NCT01428115|50331177|FG000|Overall Study|Lack of Efficacy|3|||
25183480|NCT01428115|50331177|FG000|Overall Study|Lost to Follow-up|10|||
25146375|NCT01953692|50260195|FG002|Overall Study|Excluded Medication|0|||
25146376|NCT01953692|50260196|FG003|Overall Study|Excluded Medication|0|||
25183481|NCT01428115|50331177|FG000|Overall Study|Pregnancy|1|||
25183482|NCT01428115|50331177|FG000|Overall Study|Protocol Violation|3|||
25183483|NCT01428115|50331177|FG000|Overall Study|Withdrawal by Subject|4|||
25183484|NCT01427803|50331184|FG000|Overall Study|Lost to Follow-up|32|||
25183485|NCT01427803|50331185|FG001|Overall Study|Lost to Follow-up|26|||
25146377|NCT01953692|50260197|FG004|Overall Study|Excluded Medication|0|||
25146378|NCT01953692|50260198|FG005|Overall Study|Excluded Medication|0|||
25146379|NCT01953692|50260199|FG006|Overall Study|Excluded Medication|0|||
25146380|NCT01953692|50260200|FG007|Overall Study|Excluded Medication|0|||
25016080|NCT04068181|50110944|FG003|Overall Study|Withdrawal by Subject|0|||
25016081|NCT04068181|50110941|FG000|Overall Study|Lost to Follow-up|1|||
25016082|NCT04068181|50110942|FG001|Overall Study|Lost to Follow-up|0|||
25016083|NCT04068181|50110943|FG002|Overall Study|Lost to Follow-up|0|||
25016084|NCT04068181|50110944|FG003|Overall Study|Lost to Follow-up|0|||
25016085|NCT04068181|50110941|FG000|Overall Study|Death|8|||
25146381|NCT01953692|50260201|FG008|Overall Study|Excluded Medication|0|||
25146382|NCT01953692|50260193|FG000|Overall Study|Lost to Follow-up|1|||
25146383|NCT01953692|50260194|FG001|Overall Study|Lost to Follow-up|0|||
25146384|NCT01953692|50260195|FG002|Overall Study|Lost to Follow-up|3|||
25146385|NCT01953692|50260196|FG003|Overall Study|Lost to Follow-up|1|||
25146386|NCT01953692|50260197|FG004|Overall Study|Lost to Follow-up|0|||
25146387|NCT01953692|50260198|FG005|Overall Study|Lost to Follow-up|1|||
25146388|NCT01953692|50260199|FG006|Overall Study|Lost to Follow-up|0|||
25146389|NCT01953692|50260200|FG007|Overall Study|Lost to Follow-up|0|||
25146390|NCT01953692|50260201|FG008|Overall Study|Lost to Follow-up|0|||
25146391|NCT01953692|50260193|FG000|Overall Study|Physician Decision|11|||
25146392|NCT01953692|50260194|FG001|Overall Study|Physician Decision|4|||
25146393|NCT01953692|50260195|FG002|Overall Study|Physician Decision|2|||
25146394|NCT01953692|50260196|FG003|Overall Study|Physician Decision|2|||
25146395|NCT01953692|50260197|FG004|Overall Study|Physician Decision|1|||
25146396|NCT01953692|50260198|FG005|Overall Study|Physician Decision|2|||
25146397|NCT01953692|50260199|FG006|Overall Study|Physician Decision|4|||
25146398|NCT01953692|50260200|FG007|Overall Study|Physician Decision|1|||
25146399|NCT01953692|50260201|FG008|Overall Study|Physician Decision|0|||
25146400|NCT01953692|50260193|FG000|Overall Study|Protocol Violation|0|||
25146401|NCT01953692|50260194|FG001|Overall Study|Protocol Violation|2|||
25146402|NCT01953692|50260195|FG002|Overall Study|Protocol Violation|1|||
25146403|NCT01953692|50260196|FG003|Overall Study|Protocol Violation|0|||
25146404|NCT01953692|50260197|FG004|Overall Study|Protocol Violation|0|||
25146405|NCT01953692|50260198|FG005|Overall Study|Protocol Violation|0|||
25146406|NCT01953692|50260199|FG006|Overall Study|Protocol Violation|0|||
25146407|NCT01953692|50260200|FG007|Overall Study|Protocol Violation|1|||
25146408|NCT01953692|50260201|FG008|Overall Study|Protocol Violation|0|||
25146409|NCT01953692|50260193|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
25146410|NCT01953692|50260194|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
25146411|NCT01953692|50260195|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
25146412|NCT01953692|50260196|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
25146413|NCT01953692|50260197|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
25146414|NCT01953692|50260198|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
25146415|NCT01953692|50260199|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
25146416|NCT01953692|50260200|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
25146417|NCT01953692|50260201|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
25146418|NCT01953692|50260193|FG000|Overall Study|Withdrawal by Subject|4|||
25146419|NCT01953692|50260194|FG001|Overall Study|Withdrawal by Subject|2|||
25146420|NCT01953692|50260195|FG002|Overall Study|Withdrawal by Subject|1|||
25146421|NCT01953692|50260196|FG003|Overall Study|Withdrawal by Subject|2|||
25146422|NCT01953692|50260197|FG004|Overall Study|Withdrawal by Subject|0|||
25146423|NCT01953692|50260198|FG005|Overall Study|Withdrawal by Subject|3|||
25146424|NCT01953692|50260199|FG006|Overall Study|Withdrawal by Subject|2|||
25146425|NCT01953692|50260200|FG007|Overall Study|Withdrawal by Subject|1|||
25146426|NCT01953692|50260201|FG008|Overall Study|Withdrawal by Subject|1|||
25183486|NCT01427803|50331184|FG000|Overall Study|Withdrawal by Subject|20|||
25146427|NCT01791153|50260235|FG000|Part 1: Blinded Period|Adverse Event|7|||
25146428|NCT01791153|50260236|FG001|Part 1: Blinded Period|Adverse Event|3|||
25146429|NCT01791153|50260237|FG002|Part 1: Blinded Period|Adverse Event|2|||
25146430|NCT01791153|50260238|FG003|Part 1: Blinded Period|Adverse Event|0|||
25146431|NCT01791153|50260239|FG004|Part 1: Blinded Period|Adverse Event|0|||
25146432|NCT01791153|50260240|FG005|Part 1: Blinded Period|Adverse Event|0|||
25146433|NCT01791153|50260241|FG006|Part 1: Blinded Period|Adverse Event|0|||
25146434|NCT01791153|50260242|FG007|Part 1: Blinded Period|Adverse Event|0|||
25146435|NCT01791153|50260235|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
25146436|NCT01791153|50260236|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
25146437|NCT01791153|50260237|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
25183487|NCT01427803|50331185|FG001|Overall Study|Withdrawal by Subject|0|||
25016086|NCT04068181|50110942|FG001|Overall Study|Death|8|||
25146438|NCT01791153|50260238|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
25146439|NCT01791153|50260239|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
25146440|NCT01791153|50260240|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
25146441|NCT01791153|50260241|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
25183488|NCT01427803|50331184|FG000|Overall Study|Unable to complete full treatment period|6|||
25183489|NCT01427803|50331185|FG001|Overall Study|Unable to complete full treatment period|0|||
25183490|NCT01427803|50331184|FG000|Overall Study|Protocol Violation|1|||
25183491|NCT01427803|50331185|FG001|Overall Study|Protocol Violation|0|||
25183492|NCT01427803|50331184|FG000|Overall Study|Physician Decision|3|||
25183493|NCT01427803|50331185|FG001|Overall Study|Physician Decision|0|||
25183494|NCT01427803|50331184|FG000|Overall Study|did not take product|1|||
25183495|NCT01427803|50331185|FG001|Overall Study|did not take product|0|||
25183496|NCT01408537|50331189|FG000|Overall Study|Withdrawal by Subject|2|||
25183497|NCT01408537|50331189|FG000|Overall Study|Protocol Violation|3|||
25183498|NCT01408537|50331189|FG000|Overall Study|Lost to Follow-up|3|||
25183499|NCT01408459|50331222|FG000|Overall Study|Withdrawal by Subject|1|||
25183500|NCT01408459|50331223|FG001|Overall Study|Withdrawal by Subject|1|||
25183501|NCT01408303|50331242|FG000|Overall Study|Adverse Event|3|||
25183502|NCT01408303|50331243|FG001|Overall Study|Adverse Event|7|||
25183503|NCT01408303|50331244|FG002|Overall Study|Adverse Event|2|||
25183504|NCT01408303|50331242|FG000|Overall Study|Lost to Follow-up|0|||
25183505|NCT01408303|50331243|FG001|Overall Study|Lost to Follow-up|1|||
25183506|NCT01408303|50331244|FG002|Overall Study|Lost to Follow-up|2|||
25183507|NCT01408303|50331242|FG000|Overall Study|Withdrawal by Subject|2|||
25183508|NCT01408303|50331243|FG001|Overall Study|Withdrawal by Subject|3|||
25183509|NCT01408303|50331244|FG002|Overall Study|Withdrawal by Subject|1|||
25183510|NCT01408303|50331242|FG000|Overall Study|Protocol Violation|0|||
25183511|NCT01408303|50331243|FG001|Overall Study|Protocol Violation|1|||
25183512|NCT01408303|50331244|FG002|Overall Study|Protocol Violation|0|||
25183513|NCT01408303|50331242|FG000|Overall Study|Noncompliance|1|||
25183514|NCT01408303|50331243|FG001|Overall Study|Noncompliance|0|||
25183515|NCT01408303|50331244|FG002|Overall Study|Noncompliance|1|||
25183516|NCT01408147|50331265|FG000|Overall Study|Withdrawal by Subject|0|||
25183517|NCT01408147|50331266|FG001|Overall Study|Withdrawal by Subject|1|||
25183518|NCT01407367|50331274|FG000|Overall Study|Death|24|||
25183519|NCT01407367|50331275|FG001|Overall Study|Death|32|||
25183520|NCT01407367|50331274|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
25183521|NCT01407367|50331275|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
25183522|NCT01407367|50331274|FG000|Overall Study|Withdrawal by Subject|4|||
25183523|NCT01407367|50331275|FG001|Overall Study|Withdrawal by Subject|15|||
25183524|NCT01407367|50331274|FG000|Overall Study|Lost to Follow-up|0|||
25183525|NCT01407367|50331275|FG001|Overall Study|Lost to Follow-up|2|||
25183526|NCT01405027|50331311|FG000|Overall Study|Withdrawn consent|3|||
25183527|NCT01405027|50331312|FG001|Overall Study|Withdrawn consent|0|||
25183528|NCT01405027|50331311|FG000|Overall Study|Lost to Follow-up|16|||
25183529|NCT01405027|50331312|FG001|Overall Study|Lost to Follow-up|24|||
25183530|NCT01405027|50331311|FG000|Overall Study|Investigator judgement|0|||
25183531|NCT01405027|50331312|FG001|Overall Study|Investigator judgement|2|||
25183532|NCT01405027|50331311|FG000|Overall Study|Death|1|||
25183533|NCT01405027|50331312|FG001|Overall Study|Death|0|||
25183534|NCT01405027|50331311|FG000|Overall Study|Other or Unknown|12|||
25183535|NCT01405027|50331312|FG001|Overall Study|Other or Unknown|25|||
25183536|NCT01412801|50331333|FG000|Overall Study|Death|0|||
25183537|NCT01412801|50331334|FG001|Overall Study|Death|1|||
25183538|NCT01412801|50331335|FG002|Overall Study|Death|0|||
25183539|NCT01412801|50331336|FG003|Overall Study|Death|4|||
25183540|NCT01412801|50331337|FG004|Overall Study|Death|2|||
25183541|NCT01412801|50331338|FG005|Overall Study|Death|2|||
25183542|NCT01412801|50331333|FG000|Overall Study|Lost to Follow-up|1|||
25183543|NCT01412801|50331334|FG001|Overall Study|Lost to Follow-up|2|||
25183544|NCT01412801|50331335|FG002|Overall Study|Lost to Follow-up|4|||
25183545|NCT01412801|50331336|FG003|Overall Study|Lost to Follow-up|0|||
25183546|NCT01412801|50331337|FG004|Overall Study|Lost to Follow-up|1|||
25183547|NCT01412801|50331338|FG005|Overall Study|Lost to Follow-up|1|||
25183548|NCT01412801|50331333|FG000|Overall Study|Withdrawal by Subject|3|||
25183549|NCT01412801|50331334|FG001|Overall Study|Withdrawal by Subject|2|||
25183550|NCT01412801|50331335|FG002|Overall Study|Withdrawal by Subject|1|||
25183551|NCT01412801|50331336|FG003|Overall Study|Withdrawal by Subject|0|||
25183552|NCT01412801|50331337|FG004|Overall Study|Withdrawal by Subject|0|||
25183553|NCT01412801|50331338|FG005|Overall Study|Withdrawal by Subject|0|||
25183554|NCT01412801|50331333|FG000|Overall Study|Relocated to another area|0|||
25183555|NCT01412801|50331334|FG001|Overall Study|Relocated to another area|0|||
25183556|NCT01412801|50331335|FG002|Overall Study|Relocated to another area|2|||
25183557|NCT01412801|50331336|FG003|Overall Study|Relocated to another area|0|||
25183558|NCT01412801|50331337|FG004|Overall Study|Relocated to another area|0|||
25183559|NCT01412801|50331338|FG005|Overall Study|Relocated to another area|0|||
25183560|NCT01525628|50331386|FG000|Overall Study|Adverse Event|1|||
25183561|NCT01525628|50331387|FG001|Overall Study|Adverse Event|1|||
25183562|NCT01525628|50331388|FG002|Overall Study|Adverse Event|2|||
25183563|NCT01525628|50331389|FG003|Overall Study|Adverse Event|0|||
25183564|NCT01525628|50331390|FG004|Overall Study|Adverse Event|1|||
25183565|NCT01525628|50331386|FG000|Overall Study|Lack of Efficacy|0|||
25183566|NCT01525628|50331387|FG001|Overall Study|Lack of Efficacy|2|||
25183567|NCT01525628|50331388|FG002|Overall Study|Lack of Efficacy|2|||
25183568|NCT01525628|50331389|FG003|Overall Study|Lack of Efficacy|1|||
25183569|NCT01525628|50331390|FG004|Overall Study|Lack of Efficacy|2|||
25183570|NCT01525628|50331386|FG000|Overall Study|Protocol Violation|0|||
25183571|NCT01525628|50331387|FG001|Overall Study|Protocol Violation|0|||
25183572|NCT01525628|50331388|FG002|Overall Study|Protocol Violation|1|||
25183573|NCT01525628|50331389|FG003|Overall Study|Protocol Violation|0|||
25183574|NCT01525628|50331390|FG004|Overall Study|Protocol Violation|0|||
25016087|NCT04068181|50110943|FG002|Overall Study|Death|4|||
25183575|NCT01525628|50331386|FG000|Overall Study|Lost to Follow-up|1|||
25183576|NCT01525628|50331387|FG001|Overall Study|Lost to Follow-up|1|||
25183577|NCT01525628|50331388|FG002|Overall Study|Lost to Follow-up|0|||
25183578|NCT01525628|50331389|FG003|Overall Study|Lost to Follow-up|0|||
25183579|NCT01525628|50331390|FG004|Overall Study|Lost to Follow-up|0|||
25183580|NCT01525628|50331386|FG000|Overall Study|Withdrawal by Subject|0|||
25183581|NCT01525628|50331387|FG001|Overall Study|Withdrawal by Subject|1|||
25183582|NCT01525628|50331388|FG002|Overall Study|Withdrawal by Subject|0|||
25183583|NCT01525628|50331389|FG003|Overall Study|Withdrawal by Subject|0|||
25183584|NCT01525628|50331390|FG004|Overall Study|Withdrawal by Subject|0|||
25183585|NCT01525628|50331386|FG000|Overall Study|Other reason not defined above|0|||
25183586|NCT01525628|50331387|FG001|Overall Study|Other reason not defined above|0|||
25183587|NCT01525628|50331388|FG002|Overall Study|Other reason not defined above|0|||
25183588|NCT01525628|50331389|FG003|Overall Study|Other reason not defined above|3|||
25183589|NCT01525628|50331390|FG004|Overall Study|Other reason not defined above|0|||
25183590|NCT01412021|50331408|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
25146442|NCT01791153|50260242|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
25146443|NCT01791153|50260235|FG000|Part 1: Blinded Period|Non-Compliance|1|||
25146444|NCT01791153|50260236|FG001|Part 1: Blinded Period|Non-Compliance|0|||
25146445|NCT01791153|50260237|FG002|Part 1: Blinded Period|Non-Compliance|0|||
25146446|NCT01791153|50260238|FG003|Part 1: Blinded Period|Non-Compliance|0|||
25146447|NCT01791153|50260239|FG004|Part 1: Blinded Period|Non-Compliance|0|||
25146448|NCT01791153|50260240|FG005|Part 1: Blinded Period|Non-Compliance|0|||
25146449|NCT01791153|50260241|FG006|Part 1: Blinded Period|Non-Compliance|0|||
25146450|NCT01791153|50260242|FG007|Part 1: Blinded Period|Non-Compliance|0|||
25146451|NCT01791153|50260235|FG000|Part 1: Blinded Period|Physician Decision|0|||
25146452|NCT01791153|50260236|FG001|Part 1: Blinded Period|Physician Decision|0|||
25146453|NCT01791153|50260237|FG002|Part 1: Blinded Period|Physician Decision|0|||
25146454|NCT01791153|50260238|FG003|Part 1: Blinded Period|Physician Decision|1|||
25146455|NCT01791153|50260239|FG004|Part 1: Blinded Period|Physician Decision|0|||
25183591|NCT01412021|50331408|FG000|Overall Study|Treatment Prior to Approval|3|||
25183592|NCT01412021|50331408|FG000|Overall Study|Transferred to Other Hospital|9|||
25183593|NCT01426789|50331414|FG000|Part 1|Protocol deviation|0|||
25183594|NCT01426789|50331415|FG001|Part 1|Protocol deviation|1|||
25183595|NCT01426789|50331416|FG002|Part 1|Protocol deviation|0|||
25146456|NCT01791153|50260240|FG005|Part 1: Blinded Period|Physician Decision|0|||
25183596|NCT01426789|50331417|FG003|Part 1|Protocol deviation|0|||
25183597|NCT01426789|50331418|FG004|Part 1|Protocol deviation|0|||
25183598|NCT01426789|50331419|FG005|Part 1|Protocol deviation|0|||
25183599|NCT01426789|50331414|FG000|Part 1|Lost to Follow-up|1|||
25183600|NCT01426789|50331415|FG001|Part 1|Lost to Follow-up|2|||
25183601|NCT01426789|50331416|FG002|Part 1|Lost to Follow-up|0|||
25183602|NCT01426789|50331417|FG003|Part 1|Lost to Follow-up|0|||
25183603|NCT01426789|50331418|FG004|Part 1|Lost to Follow-up|0|||
25146457|NCT01791153|50260241|FG006|Part 1: Blinded Period|Physician Decision|0|||
25146458|NCT01791153|50260242|FG007|Part 1: Blinded Period|Physician Decision|0|||
25146459|NCT01791153|50260235|FG000|Part 1: Blinded Period|Protocol Violation|0|||
25183604|NCT01426789|50331419|FG005|Part 1|Lost to Follow-up|0|||
25183605|NCT01426789|50331414|FG000|Part 1|Lack of Efficacy|2|||
25183606|NCT01426789|50331415|FG001|Part 1|Lack of Efficacy|1|||
25183607|NCT01426789|50331416|FG002|Part 1|Lack of Efficacy|0|||
25183608|NCT01426789|50331417|FG003|Part 1|Lack of Efficacy|0|||
25183609|NCT01426789|50331418|FG004|Part 1|Lack of Efficacy|0|||
25183610|NCT01426789|50331419|FG005|Part 1|Lack of Efficacy|0|||
25183611|NCT01426789|50331414|FG000|Part 1|Adverse Event|3|||
25183612|NCT01426789|50331415|FG001|Part 1|Adverse Event|0|||
25183613|NCT01426789|50331416|FG002|Part 1|Adverse Event|0|||
25183614|NCT01426789|50331417|FG003|Part 1|Adverse Event|0|||
25183615|NCT01426789|50331418|FG004|Part 1|Adverse Event|0|||
25183616|NCT01426789|50331419|FG005|Part 1|Adverse Event|0|||
25183617|NCT01426789|50331414|FG000|Part 2|Protocol deviation|0|||
25183618|NCT01426789|50331415|FG001|Part 2|Protocol deviation|0|||
25274562|NCT00977938|50588592|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
25183619|NCT01426789|50331416|FG002|Part 2|Protocol deviation|1|||
25183620|NCT01426789|50331417|FG003|Part 2|Protocol deviation|0|||
25183621|NCT01426789|50331418|FG004|Part 2|Protocol deviation|0|||
25183622|NCT01426789|50331419|FG005|Part 2|Protocol deviation|0|||
25183623|NCT01426789|50331414|FG000|Part 2|Death|0|||
25274563|NCT00977938|50588589|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
25274564|NCT00977938|50588590|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
25183624|NCT01426789|50331415|FG001|Part 2|Death|0|||
25183625|NCT01426789|50331416|FG002|Part 2|Death|1|||
25274565|NCT00977938|50588591|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
25274566|NCT00977938|50588592|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
25183626|NCT01426789|50331417|FG003|Part 2|Death|0|||
25183627|NCT01426789|50331418|FG004|Part 2|Death|1|||
25183628|NCT01426789|50331419|FG005|Part 2|Death|0|||
25183629|NCT01426789|50331414|FG000|Part 2|Administrative problems|0|||
25274567|NCT00977938|50588589|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
25274568|NCT00977938|50588590|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
25146460|NCT01791153|50260236|FG001|Part 1: Blinded Period|Protocol Violation|0|||
25146461|NCT01791153|50260237|FG002|Part 1: Blinded Period|Protocol Violation|0|||
25146462|NCT01791153|50260238|FG003|Part 1: Blinded Period|Protocol Violation|1|||
25146463|NCT01791153|50260239|FG004|Part 1: Blinded Period|Protocol Violation|0|||
25146464|NCT01791153|50260240|FG005|Part 1: Blinded Period|Protocol Violation|0|||
25183630|NCT01426789|50331415|FG001|Part 2|Administrative problems|0|||
25183631|NCT01426789|50331416|FG002|Part 2|Administrative problems|2|||
25146465|NCT01791153|50260241|FG006|Part 1: Blinded Period|Protocol Violation|0|||
25146466|NCT01791153|50260242|FG007|Part 1: Blinded Period|Protocol Violation|0|||
25146467|NCT01791153|50260235|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
25146468|NCT01791153|50260236|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
25146469|NCT01791153|50260237|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
25146470|NCT01791153|50260238|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
25146471|NCT01791153|50260239|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
25146472|NCT01791153|50260240|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
25146473|NCT01791153|50260241|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
25183632|NCT01426789|50331417|FG003|Part 2|Administrative problems|0|||
25183633|NCT01426789|50331418|FG004|Part 2|Administrative problems|1|||
25183634|NCT01426789|50331419|FG005|Part 2|Administrative problems|0|||
25183635|NCT01426789|50331414|FG000|Part 2|Lost to Follow-up|0|||
25183636|NCT01426789|50331415|FG001|Part 2|Lost to Follow-up|0|||
25146474|NCT01791153|50260242|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
25183637|NCT01426789|50331416|FG002|Part 2|Lost to Follow-up|4|||
25183638|NCT01426789|50331417|FG003|Part 2|Lost to Follow-up|0|||
25183639|NCT01426789|50331418|FG004|Part 2|Lost to Follow-up|1|||
25183640|NCT01426789|50331419|FG005|Part 2|Lost to Follow-up|0|||
25183641|NCT01426789|50331414|FG000|Part 2|Withdrawal by Subject|0|||
25183642|NCT01426789|50331415|FG001|Part 2|Withdrawal by Subject|0|||
25183643|NCT01426789|50331416|FG002|Part 2|Withdrawal by Subject|0|||
25146475|NCT01791153|50260235|FG000|Part 2: Open-label Period|Adverse Event|0|||
25146476|NCT01791153|50260236|FG001|Part 2: Open-label Period|Adverse Event|0|||
25146477|NCT01791153|50260237|FG002|Part 2: Open-label Period|Adverse Event|0|||
25146478|NCT01791153|50260238|FG003|Part 2: Open-label Period|Adverse Event|0|||
25146479|NCT01791153|50260239|FG004|Part 2: Open-label Period|Adverse Event|0|||
25146480|NCT01791153|50260240|FG005|Part 2: Open-label Period|Adverse Event|1|||
25146481|NCT01791153|50260241|FG006|Part 2: Open-label Period|Adverse Event|1|||
25146482|NCT01791153|50260242|FG007|Part 2: Open-label Period|Adverse Event|2|||
25183644|NCT01426789|50331417|FG003|Part 2|Withdrawal by Subject|1|||
25183645|NCT01426789|50331418|FG004|Part 2|Withdrawal by Subject|2|||
25183646|NCT01426789|50331419|FG005|Part 2|Withdrawal by Subject|0|||
25183647|NCT01426789|50331414|FG000|Part 2|Lack of Efficacy|0|||
25183648|NCT01426789|50331415|FG001|Part 2|Lack of Efficacy|0|||
25183649|NCT01426789|50331416|FG002|Part 2|Lack of Efficacy|5|||
25183650|NCT01426789|50331417|FG003|Part 2|Lack of Efficacy|0|||
25183651|NCT01426789|50331418|FG004|Part 2|Lack of Efficacy|2|||
25183652|NCT01426789|50331419|FG005|Part 2|Lack of Efficacy|0|||
25183653|NCT01426789|50331414|FG000|Part 2|Adverse Event|0|||
25183654|NCT01426789|50331415|FG001|Part 2|Adverse Event|0|||
25183655|NCT01426789|50331416|FG002|Part 2|Adverse Event|2|||
25183656|NCT01426789|50331417|FG003|Part 2|Adverse Event|0|||
25183657|NCT01426789|50331418|FG004|Part 2|Adverse Event|1|||
25183658|NCT01426789|50331419|FG005|Part 2|Adverse Event|0|||
25183659|NCT01426009|50331440|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
25183660|NCT01426009|50331440|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
25183661|NCT01426009|50331440|FG000|Washout 1|Withdrawal by Subject|1|||
25183662|NCT01426009|50331440|FG000|Washout 1|Personal Reasons|1|||
25183663|NCT01426009|50331440|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
25183664|NCT01426009|50331440|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
25183665|NCT01426009|50331440|FG000|Washout 2|electrive surgery|1|||
25183666|NCT01426009|50331440|FG000|Washout 3|personal reasons|1|||
25183667|NCT01426009|50331440|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
25183668|NCT01426009|50331440|FG000|Washout 4|Lost to Follow-up|1|||
25183669|NCT01411319|50331469|FG000|Overall Study|Lost to Follow-up|1|||
25183670|NCT01543958|50331473|FG000|Overall Study|Loss to follow-up|3|||
25146483|NCT01791153|50260235|FG000|Part 2: Open-label Period|Death|0|||
25183671|NCT01543958|50331473|FG000|Overall Study|ART initiation|1|||
25183672|NCT01411085|50331477|FG000|Overall Study|Physician Decision|1|||
25183673|NCT01411085|50331477|FG000|Overall Study|Protocol Violation|1|||
25183674|NCT01411085|50331477|FG000|Overall Study|Adverse Event|1|||
25183675|NCT01543490|50331483|FG000|Overall Study|Adverse Event|4|||
25183676|NCT01543490|50331484|FG001|Overall Study|Adverse Event|0|||
25183677|NCT01543490|50331483|FG000|Overall Study|Physician Decision|1|||
25183678|NCT01543490|50331484|FG001|Overall Study|Physician Decision|0|||
25146484|NCT01791153|50260236|FG001|Part 2: Open-label Period|Death|0|||
25146485|NCT01791153|50260237|FG002|Part 2: Open-label Period|Death|0|||
25183679|NCT01543490|50331483|FG000|Overall Study|Lack of Efficacy|3|||
25183680|NCT01543490|50331484|FG001|Overall Study|Lack of Efficacy|3|||
25183681|NCT01543490|50331483|FG000|Overall Study|Lost to Follow-up|5|||
25146486|NCT01791153|50260238|FG003|Part 2: Open-label Period|Death|0|||
25146487|NCT01791153|50260239|FG004|Part 2: Open-label Period|Death|0|||
25146488|NCT01791153|50260240|FG005|Part 2: Open-label Period|Death|1|||
25146489|NCT01791153|50260241|FG006|Part 2: Open-label Period|Death|1|||
25146490|NCT01791153|50260242|FG007|Part 2: Open-label Period|Death|1|||
25146491|NCT01791153|50260235|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
25146492|NCT01791153|50260236|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
25146493|NCT01791153|50260237|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
25146494|NCT01791153|50260238|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
25146495|NCT01791153|50260239|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
25146496|NCT01791153|50260240|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
25146497|NCT01791153|50260241|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
25146498|NCT01791153|50260242|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
25146499|NCT01791153|50260235|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
25146500|NCT01791153|50260236|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
25146501|NCT01791153|50260237|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
25146502|NCT01791153|50260238|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
25146503|NCT01791153|50260239|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
25183682|NCT01543490|50331484|FG001|Overall Study|Lost to Follow-up|0|||
25016088|NCT04068181|50110944|FG003|Overall Study|Death|2|||
25146504|NCT01791153|50260240|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
25016089|NCT04068181|50110941|FG000|Overall Study|Continuing Study|16|||
25146505|NCT01791153|50260241|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
25146506|NCT01791153|50260242|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
25183683|NCT01543490|50331483|FG000|Overall Study|Withdrawal by Subject|2|||
25183684|NCT01543490|50331484|FG001|Overall Study|Withdrawal by Subject|0|||
25146507|NCT01791153|50260235|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
25146508|NCT01791153|50260236|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
25146509|NCT01791153|50260237|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
25146510|NCT01791153|50260238|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
25146511|NCT01791153|50260239|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
25146512|NCT01791153|50260240|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
25146513|NCT01791153|50260241|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
25146514|NCT01791153|50260242|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
25146515|NCT01791153|50260235|FG000|Part 2: Open-label Period|Physician Decision|0|||
25146516|NCT01791153|50260236|FG001|Part 2: Open-label Period|Physician Decision|0|||
25146517|NCT01791153|50260237|FG002|Part 2: Open-label Period|Physician Decision|0|||
25146518|NCT01791153|50260238|FG003|Part 2: Open-label Period|Physician Decision|0|||
25146519|NCT01791153|50260239|FG004|Part 2: Open-label Period|Physician Decision|1|||
25146520|NCT01791153|50260240|FG005|Part 2: Open-label Period|Physician Decision|1|||
25146521|NCT01791153|50260241|FG006|Part 2: Open-label Period|Physician Decision|0|||
25146522|NCT01791153|50260242|FG007|Part 2: Open-label Period|Physician Decision|0|||
25146523|NCT01926782|50260263|FG000|Overall Study|Participant moved|2|||
25146524|NCT01926782|50260264|FG001|Overall Study|Participant moved|0|||
25146525|NCT01926782|50260265|FG002|Overall Study|Participant moved|1|||
25146526|NCT01926782|50260266|FG003|Overall Study|Participant moved|1|||
25146527|NCT01926782|50260267|FG004|Overall Study|Participant moved|0|||
25146528|NCT01926782|50260268|FG005|Overall Study|Participant moved|3|||
25146529|NCT01926782|50260263|FG000|Overall Study|Physician Decision|0|||
25146530|NCT01926782|50260264|FG001|Overall Study|Physician Decision|2|||
25146531|NCT01926782|50260265|FG002|Overall Study|Physician Decision|1|||
25146532|NCT01926782|50260266|FG003|Overall Study|Physician Decision|1|||
25146533|NCT01926782|50260267|FG004|Overall Study|Physician Decision|0|||
25183685|NCT01543490|50331483|FG000|Overall Study|Other-Various Administrative Reasons|1|||
25016090|NCT04068181|50110942|FG001|Overall Study|Continuing Study|7|||
25146534|NCT01926782|50260268|FG005|Overall Study|Physician Decision|0|||
25146535|NCT01926782|50260263|FG000|Overall Study|Other than specified|2|||
25016091|NCT04068181|50110943|FG002|Overall Study|Continuing Study|11|||
25016092|NCT04068181|50110944|FG003|Overall Study|Continuing Study|13|||
25016093|NCT03256578|50110956|FG000|Overall Study|Excluded Post Randomization|66|||
25016094|NCT03256578|50110957|FG001|Overall Study|Excluded Post Randomization|56|||
25016095|NCT03227445|50110963|FG000|Period 1 (28 Days)|Adverse Event|1|||
25016096|NCT03227445|50110964|FG001|Period 1 (28 Days)|Adverse Event|2|||
25016097|NCT03227445|50110965|FG002|Period 1 (28 Days)|Adverse Event|0|||
25016098|NCT03227445|50110966|FG003|Period 1 (28 Days)|Adverse Event|1|||
25016099|NCT03227445|50110963|FG000|Period 1 (28 Days)|Protocol Violation|1|||
25016100|NCT03227445|50110964|FG001|Period 1 (28 Days)|Protocol Violation|0|||
25016101|NCT03227445|50110965|FG002|Period 1 (28 Days)|Protocol Violation|0|||
25016102|NCT03227445|50110966|FG003|Period 1 (28 Days)|Protocol Violation|0|||
25016103|NCT03227445|50110963|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
25016104|NCT03227445|50110964|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
25016105|NCT03227445|50110965|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
25016106|NCT03227445|50110966|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
25146536|NCT01926782|50260264|FG001|Overall Study|Other than specified|3|||
25146537|NCT01926782|50260265|FG002|Overall Study|Other than specified|5|||
25146538|NCT01926782|50260266|FG003|Overall Study|Other than specified|12|||
25146539|NCT01926782|50260267|FG004|Overall Study|Other than specified|4|||
25183686|NCT01543490|50331484|FG001|Overall Study|Other-Various Administrative Reasons|2|||
25183687|NCT01404949|50331490|FG000|Overall Study|Not Treated|1|||
25183688|NCT01431521|50331498|FG000|Overall Study|Withdrawal by Subject|0|||
25183689|NCT01431521|50331499|FG001|Overall Study|Withdrawal by Subject|0|||
25183690|NCT01431521|50331500|FG002|Overall Study|Withdrawal by Subject|1|||
25183691|NCT01431521|50331501|FG003|Overall Study|Withdrawal by Subject|0|||
25183692|NCT01404325|50331586|FG000|Overall Study|Lost to Follow-up|1|||
25183693|NCT01404325|50331587|FG001|Overall Study|Lost to Follow-up|0|||
25183694|NCT01404325|50331586|FG000|Overall Study|Death|2|||
25183695|NCT01404325|50331587|FG001|Overall Study|Death|0|||
25183696|NCT01404325|50331586|FG000|Overall Study|Graft loss/Retransplantation|1|||
25183697|NCT01404325|50331587|FG001|Overall Study|Graft loss/Retransplantation|0|||
25183698|NCT01404325|50331586|FG000|Overall Study|non-specified reason|0|||
25183699|NCT01404325|50331587|FG001|Overall Study|non-specified reason|2|||
25183700|NCT01425463|50331608|FG000|Overall Study|Adverse Event|5|||
25183701|NCT01425463|50331609|FG001|Overall Study|Adverse Event|7|||
25146540|NCT01926782|50260268|FG005|Overall Study|Other than specified|11|||
25146541|NCT01926782|50260263|FG000|Overall Study|Adverse Event|13|||
25183702|NCT01425463|50331608|FG000|Overall Study|Lack of Efficacy|1|||
25183703|NCT01425463|50331609|FG001|Overall Study|Lack of Efficacy|1|||
25183704|NCT01425463|50331608|FG000|Overall Study|Protocol Violation|2|||
25183705|NCT01425463|50331609|FG001|Overall Study|Protocol Violation|2|||
25146542|NCT01926782|50260264|FG001|Overall Study|Adverse Event|4|||
25146543|NCT01926782|50260265|FG002|Overall Study|Adverse Event|17|||
25146544|NCT01926782|50260266|FG003|Overall Study|Adverse Event|4|||
25146545|NCT01926782|50260267|FG004|Overall Study|Adverse Event|3|||
25183706|NCT01425463|50331608|FG000|Overall Study|Lost to Follow-up|5|||
25183707|NCT01425463|50331609|FG001|Overall Study|Lost to Follow-up|2|||
25183708|NCT01425463|50331608|FG000|Overall Study|Withdrawal by Subject|7|||
25183709|NCT01425463|50331609|FG001|Overall Study|Withdrawal by Subject|5|||
25183710|NCT01425463|50331608|FG000|Overall Study|Unknown Reason|4|||
25183711|NCT01425463|50331609|FG001|Overall Study|Unknown Reason|7|||
25183712|NCT04655586|50331631|FG000|Overall Study|Physician Decision|1|||
25183713|NCT04655586|50331632|FG001|Overall Study|Physician Decision|3|||
25016107|NCT03227445|50110963|FG000|Period 2 (28 Days)|Adverse Event|1|||
25183714|NCT04655586|50331633|FG002|Overall Study|Physician Decision|4|||
25146546|NCT01926782|50260268|FG005|Overall Study|Adverse Event|14|||
25183715|NCT04655586|50331631|FG000|Overall Study|Withdrawal by Subject|1|||
25183716|NCT04655586|50331632|FG001|Overall Study|Withdrawal by Subject|3|||
25183717|NCT04655586|50331633|FG002|Overall Study|Withdrawal by Subject|1|||
25183718|NCT01388647|50331656|FG000|Overall Study|Adverse Event|1|||
25183719|NCT01388647|50331657|FG001|Overall Study|Adverse Event|2|||
25183720|NCT01402063|50331732|FG000|Overall Study|Withdrawal by Subject|3|||
25183721|NCT01402063|50331733|FG001|Overall Study|Withdrawal by Subject|3|||
25183722|NCT01796301|50331741|FG000|Overall Study|Withdrawal by Subject|15|||
25183723|NCT01796301|50331742|FG001|Overall Study|Withdrawal by Subject|15|||
25183724|NCT01796301|50331741|FG000|Overall Study|Lost to Follow-up|3|||
25183725|NCT01796301|50331742|FG001|Overall Study|Lost to Follow-up|3|||
25146547|NCT01926782|50260263|FG000|Overall Study|Poor compliance to protocol|5|||
25146548|NCT01926782|50260264|FG001|Overall Study|Poor compliance to protocol|3|||
25016108|NCT03227445|50110964|FG001|Period 2 (28 Days)|Adverse Event|0|||
25016109|NCT03227445|50110965|FG002|Period 2 (28 Days)|Adverse Event|2|||
25016110|NCT03227445|50110966|FG003|Period 2 (28 Days)|Adverse Event|1|||
25016111|NCT03227445|50110963|FG000|Period 2 (28 Days)|Protocol Violation|0|||
25016112|NCT03227445|50110964|FG001|Period 2 (28 Days)|Protocol Violation|0|||
25016113|NCT03227445|50110965|FG002|Period 2 (28 Days)|Protocol Violation|0|||
25016114|NCT03227445|50110966|FG003|Period 2 (28 Days)|Protocol Violation|1|||
25016115|NCT03227445|50110963|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
25016116|NCT03227445|50110964|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
25016117|NCT03227445|50110965|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
25016118|NCT03227445|50110966|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
25016119|NCT04067401|50110977|FG000|Overall Study|Withdrawal by Subject|7|||
25146549|NCT01926782|50260265|FG002|Overall Study|Poor compliance to protocol|8|||
25146550|NCT01926782|50260266|FG003|Overall Study|Poor compliance to protocol|0|||
25146551|NCT01926782|50260267|FG004|Overall Study|Poor compliance to protocol|1|||
25146552|NCT01926782|50260268|FG005|Overall Study|Poor compliance to protocol|6|||
25146553|NCT01926782|50260263|FG000|Overall Study|Randomized and not treated|0|||
25146554|NCT01926782|50260264|FG001|Overall Study|Randomized and not treated|0|||
25146555|NCT01926782|50260265|FG002|Overall Study|Randomized and not treated|0|||
25146556|NCT01926782|50260266|FG003|Overall Study|Randomized and not treated|1|||
25146557|NCT01926782|50260267|FG004|Overall Study|Randomized and not treated|0|||
25146558|NCT01926782|50260268|FG005|Overall Study|Randomized and not treated|0|||
25146559|NCT01926782|50260263|FG000|Overall Study|Withdrawal by Subject|6|||
25183726|NCT01796301|50331741|FG000|Overall Study|Death|0|||
25183727|NCT01796301|50331742|FG001|Overall Study|Death|1|||
25183728|NCT01796301|50331741|FG000|Overall Study|Decision by Sponsor|0|||
25183729|NCT01796301|50331742|FG001|Overall Study|Decision by Sponsor|1|||
25183730|NCT01388335|50331761|FG000|Period 1|Progressive Disease|1|||
25183731|NCT01388335|50331761|FG000|Period 2|Progressive Disease|2|||
25183732|NCT01388335|50331761|FG000|Period 2|Sponsor Decision|1|||
25183733|NCT01388335|50331761|FG000|Safety Extension|Progressive Disease|7|||
25183734|NCT01401361|50331808|FG000|Overall Study|Withdrawal by Subject|16|||
25183735|NCT01401361|50331808|FG000|Overall Study|Lack of Efficacy|6|||
25183736|NCT01401361|50331808|FG000|Overall Study|Physician Decision|1|||
25274569|NCT00977938|50588591|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
25183737|NCT01401361|50331808|FG000|Overall Study|Lost to Follow-up|3|||
25183738|NCT01401361|50331808|FG000|Overall Study|Subject/family decision post procedure|2|||
25183739|NCT01401283|50331814|FG000|Overall Study|surgery cancelled|5|||
25183740|NCT01401283|50331815|FG001|Overall Study|surgery cancelled|8|||
25183741|NCT01401283|50331814|FG000|Overall Study|preoperative arrhythmia|5|||
25146560|NCT01926782|50260264|FG001|Overall Study|Withdrawal by Subject|1|||
25146561|NCT01926782|50260265|FG002|Overall Study|Withdrawal by Subject|8|||
25146562|NCT01926782|50260266|FG003|Overall Study|Withdrawal by Subject|1|||
25146563|NCT01926782|50260267|FG004|Overall Study|Withdrawal by Subject|0|||
25146564|NCT01926782|50260268|FG005|Overall Study|Withdrawal by Subject|5|||
25146565|NCT01926782|50260263|FG000|Overall Study|Related to study drug administration|0|||
25146566|NCT01926782|50260264|FG001|Overall Study|Related to study drug administration|0|||
25146567|NCT01926782|50260265|FG002|Overall Study|Related to study drug administration|0|||
25146568|NCT01926782|50260266|FG003|Overall Study|Related to study drug administration|0|||
25146569|NCT01926782|50260267|FG004|Overall Study|Related to study drug administration|0|||
25146570|NCT01926782|50260268|FG005|Overall Study|Related to study drug administration|2|||
25146571|NCT01926626|50260283|FG000|Overall Study|Withdrawal by Subject|15|||
25146572|NCT01926626|50260283|FG000|Overall Study|Lost to Follow-up|7|||
25146573|NCT01953224|50260289|FG000|Overall Study|Lost to Follow-up|1|||
25146574|NCT01953224|50260290|FG001|Overall Study|Lost to Follow-up|1|||
25146575|NCT01953224|50260289|FG000|Overall Study|Withdrawal by Subject|1|||
25146576|NCT01953224|50260290|FG001|Overall Study|Withdrawal by Subject|2|||
25146577|NCT01900730|50260298|FG000|Overall Study|Withdrawal by Subject|1|||
25146578|NCT01900730|50260299|FG001|Overall Study|Withdrawal by Subject|0|||
25146579|NCT01900730|50260298|FG000|Overall Study|Screen Failure|1|||
25183742|NCT01401283|50331815|FG001|Overall Study|preoperative arrhythmia|0|||
25146580|NCT01900730|50260299|FG001|Overall Study|Screen Failure|0|||
25146581|NCT01952834|50260305|FG000|Overall Study|Adverse Event|1|||
25183743|NCT01401283|50331814|FG000|Overall Study|no central venous access|0|||
25183744|NCT01401283|50331815|FG001|Overall Study|no central venous access|1|||
25183745|NCT01401283|50331814|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
25183746|NCT01401283|50331815|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
25183747|NCT01422889|50331838|FG000|Overall Study|No Data Entered for Study Stent|9|||
25183748|NCT01400971|50331842|FG000|Overall Study|Death|82|||
25183749|NCT01400971|50331842|FG000|Overall Study|Lost to Follow-up|196|||
25183750|NCT01400971|50331842|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
25183751|NCT01400971|50331842|FG000|Overall Study|Physician Decision|57|||
25183752|NCT01400971|50331842|FG000|Overall Study|Withdrawal by Subject|158|||
25183753|NCT01400971|50331842|FG000|Overall Study|Other|422|||
25183754|NCT01387789|50331846|FG000|Overall Study|Adverse Event|5|||
25183755|NCT01387789|50331846|FG000|Overall Study|Lack of Efficacy|2|||
25183756|NCT01387789|50331846|FG000|Overall Study|Lost to Follow-up|1|||
25183757|NCT01400893|50331857|FG000|Overall Study|Death|27|||
25183758|NCT01400893|50331858|FG001|Overall Study|Death|21|||
25183759|NCT01400893|50331857|FG000|Overall Study|Lost to Follow-up|0|||
25183760|NCT01400893|50331858|FG001|Overall Study|Lost to Follow-up|6|||
25183761|NCT01400815|50331898|FG000|Overall Study|Adverse Event|3|||
25183762|NCT01400815|50331899|FG001|Overall Study|Adverse Event|0|||
25183763|NCT01400815|50331898|FG000|Overall Study|Death|0|||
25183764|NCT01400815|50331899|FG001|Overall Study|Death|1|||
25183765|NCT01400815|50331898|FG000|Overall Study|Lost to Follow-up|18|||
25183766|NCT01400815|50331899|FG001|Overall Study|Lost to Follow-up|11|||
25183767|NCT01400815|50331898|FG000|Overall Study|Protocol Violation|0|||
25183768|NCT01400815|50331899|FG001|Overall Study|Protocol Violation|1|||
25183769|NCT01400815|50331898|FG000|Overall Study|Physician Decision|1|||
25183770|NCT01400815|50331899|FG001|Overall Study|Physician Decision|0|||
25183771|NCT01400815|50331898|FG000|Overall Study|Withdrawal by Subject|15|||
25183772|NCT01400815|50331899|FG001|Overall Study|Withdrawal by Subject|8|||
25183773|NCT01400815|50331898|FG000|Overall Study|Subject in jail|1|||
25183774|NCT01400815|50331899|FG001|Overall Study|Subject in jail|0|||
25183775|NCT01400503|50331953|FG000|Overall Study|Withdrawal by Subject|1|||
25183776|NCT01400503|50331953|FG000|Overall Study|Study Terminated by Sponsor|58|||
25183777|NCT01400503|50331953|FG000|Overall Study|Other|1|||
25183778|NCT01400425|50331969|FG000|Overall Study|Withdrawal by Subject|10|||
25183779|NCT01421719|50331975|FG000|Overall Study|Withdrawal by Subject|4|||
25183780|NCT01421641|50331982|FG000|Overall Study|Protocol Violation|2|||
25183781|NCT01421641|50331983|FG001|Overall Study|Protocol Violation|2|||
25183782|NCT01385995|50331991|FG000|Period 1, 2 Months|Physician Decision|1|||
25183783|NCT01385995|50331992|FG001|Period 1, 2 Months|Physician Decision|0|||
25183784|NCT01421017|50332003|FG000|Overall Study|Withdrawal by Subject|2|||
25183785|NCT01421017|50332004|FG001|Overall Study|Withdrawal by Subject|0|||
25183786|NCT01421017|50332005|FG002|Overall Study|Withdrawal by Subject|0|||
25183787|NCT01421017|50332003|FG000|Overall Study|POD|0|||
25183788|NCT01421017|50332004|FG001|Overall Study|POD|6|||
25183789|NCT01421017|50332005|FG002|Overall Study|POD|3|||
25183790|NCT01420627|50332052|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
25183791|NCT01400113|50332062|FG000|Overall Study|Withdrawal by Subject|1|||
25183792|NCT01400113|50332063|FG001|Overall Study|Withdrawal by Subject|1|||
25183793|NCT01399723|50332071|FG000|Overall Study|Lost to Follow-up|0|||
25183794|NCT01399723|50332072|FG001|Overall Study|Lost to Follow-up|1|||
25183795|NCT01385371|50332081|FG000|Overall Study|Adverse Event|54|||
25183796|NCT01385371|50332082|FG001|Overall Study|Adverse Event|19|||
25183797|NCT01385371|50332081|FG000|Overall Study|Lost to Follow-up|16|||
25183798|NCT01385371|50332082|FG001|Overall Study|Lost to Follow-up|16|||
25183799|NCT01385371|50332081|FG000|Overall Study|Withdrawal by Subject|52|||
25183800|NCT01385371|50332082|FG001|Overall Study|Withdrawal by Subject|39|||
25183801|NCT01385371|50332081|FG000|Overall Study|Protocol Violation|25|||
25183802|NCT01385371|50332082|FG001|Overall Study|Protocol Violation|21|||
25183803|NCT01385371|50332081|FG000|Overall Study|Administrative|2|||
25183804|NCT01385371|50332082|FG001|Overall Study|Administrative|2|||
25183805|NCT01399099|50332088|FG000|Overall Study|Lost to Follow-up|11|||
25146582|NCT01952366|50260310|FG000|Overall Study|Death|22|||
25146583|NCT01952366|50260310|FG000|Overall Study|Withdrawal by Subject|9|||
25146584|NCT01952054|50260317|FG000|Overall Study|Physician Decision|1|||
25146585|NCT01925768|50260323|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
25146586|NCT01925768|50260324|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25146587|NCT01925768|50260323|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
25146588|NCT01925768|50260324|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
25146589|NCT01925768|50260323|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
25146590|NCT01925768|50260324|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
25146591|NCT01925768|50260323|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
25146592|NCT01925768|50260324|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
25146593|NCT01925768|50260323|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
25146594|NCT01925768|50260324|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
25146595|NCT01925768|50260323|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
25146596|NCT01925768|50260324|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
25146597|NCT01925768|50260323|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
25146598|NCT01925768|50260324|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
25146599|NCT01925768|50260323|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
25146600|NCT01925768|50260324|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
25274570|NCT00977938|50588592|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
25146601|NCT01925768|50260323|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
25146602|NCT01925768|50260324|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
25146603|NCT01925768|50260323|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
25146604|NCT01925768|50260324|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
25146605|NCT01925768|50260323|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
25146606|NCT01925768|50260324|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
25146607|NCT01431274|50260339|FG000|Overall Study|Adverse Event|51|||
25146608|NCT01431274|50260340|FG001|Overall Study|Adverse Event|37|||
25146609|NCT01431274|50260341|FG002|Overall Study|Adverse Event|43|||
25146610|NCT01431274|50260342|FG003|Overall Study|Adverse Event|30|||
25146611|NCT01431274|50260343|FG004|Overall Study|Adverse Event|37|||
25146612|NCT01431274|50260339|FG000|Overall Study|Consent withdrawn not due to AE|29|||
25146613|NCT01431274|50260340|FG001|Overall Study|Consent withdrawn not due to AE|20|||
25146614|NCT01431274|50260341|FG002|Overall Study|Consent withdrawn not due to AE|17|||
25146615|NCT01431274|50260342|FG003|Overall Study|Consent withdrawn not due to AE|20|||
25146616|NCT01431274|50260343|FG004|Overall Study|Consent withdrawn not due to AE|11|||
25183806|NCT01399099|50332088|FG000|Overall Study|Physician Decision|1|||
25183807|NCT01399099|50332088|FG000|Overall Study|Protocol Violation|1|||
25183808|NCT01399099|50332088|FG000|Overall Study|Skin Irritation|13|||
25183809|NCT01399099|50332088|FG000|Overall Study|Infection|1|||
25183810|NCT01399099|50332088|FG000|Overall Study|Miscellaneous|4|||
25183811|NCT01398787|50332093|FG000|Overall Study|Adverse Event|1|||
25183812|NCT01383499|50332099|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
25183813|NCT01383499|50332100|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
25183814|NCT01383499|50332101|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
25183815|NCT01383499|50332102|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
25183816|NCT01397461|50332118|FG000|Overall Study|Withdrawal by Subject|2|||
25183817|NCT01397461|50332119|FG001|Overall Study|Withdrawal by Subject|1|||
25183818|NCT01397461|50332120|FG002|Overall Study|Withdrawal by Subject|0|||
25183819|NCT01397461|50332118|FG000|Overall Study|Lost to Follow-up|0|||
25146617|NCT01431274|50260339|FG000|Overall Study|Non compliant with protocol|5|||
25146618|NCT01431274|50260340|FG001|Overall Study|Non compliant with protocol|8|||
25183820|NCT01397461|50332119|FG001|Overall Study|Lost to Follow-up|2|||
25183821|NCT01397461|50332120|FG002|Overall Study|Lost to Follow-up|1|||
25146619|NCT01431274|50260341|FG002|Overall Study|Non compliant with protocol|4|||
25146620|NCT01431274|50260342|FG003|Overall Study|Non compliant with protocol|4|||
25146621|NCT01431274|50260343|FG004|Overall Study|Non compliant with protocol|4|||
25146622|NCT01431274|50260339|FG000|Overall Study|Lost to Follow-up|6|||
25146623|NCT01431274|50260340|FG001|Overall Study|Lost to Follow-up|7|||
25146624|NCT01431274|50260341|FG002|Overall Study|Lost to Follow-up|1|||
25146625|NCT01431274|50260342|FG003|Overall Study|Lost to Follow-up|4|||
25146626|NCT01431274|50260343|FG004|Overall Study|Lost to Follow-up|0|||
25146627|NCT01431274|50260339|FG000|Overall Study|Other reason not stated above|6|||
25183822|NCT01397461|50332118|FG000|Overall Study|Lack of Efficacy|0|||
25146628|NCT01431274|50260340|FG001|Overall Study|Other reason not stated above|5|||
25146629|NCT01431274|50260341|FG002|Overall Study|Other reason not stated above|7|||
25146630|NCT01431274|50260342|FG003|Overall Study|Other reason not stated above|2|||
25146631|NCT01431274|50260343|FG004|Overall Study|Other reason not stated above|4|||
25146632|NCT01991795|50260357|FG000|Overall Study|Lost to Follow-up|6|||
25146633|NCT01991795|50260358|FG001|Overall Study|Lost to Follow-up|4|||
25146634|NCT01991795|50260357|FG000|Overall Study|Withdrawal by Subject|117|||
25146635|NCT01991795|50260358|FG001|Overall Study|Withdrawal by Subject|94|||
25146636|NCT01991795|50260357|FG000|Overall Study|Site prematurely closed by sponsor|26|||
25146637|NCT01991795|50260358|FG001|Overall Study|Site prematurely closed by sponsor|25|||
25146638|NCT01411852|50260399|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
25146639|NCT01411852|50260400|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
25274571|NCT00977938|50588589|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
25146640|NCT01411852|50260399|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
25183823|NCT01397461|50332119|FG001|Overall Study|Lack of Efficacy|3|||
25183824|NCT01397461|50332120|FG002|Overall Study|Lack of Efficacy|0|||
25183825|NCT01397461|50332118|FG000|Overall Study|Not treated|0|||
25183826|NCT01397461|50332119|FG001|Overall Study|Not treated|0|||
25183827|NCT01397461|50332120|FG002|Overall Study|Not treated|1|||
25183828|NCT01382251|50332130|FG000|Overall Study|Surgeries cancelled or delayed|16|||
25183829|NCT01382251|50332131|FG001|Overall Study|Surgeries cancelled or delayed|16|||
25183830|NCT01382251|50332130|FG000|Overall Study|Lost to Follow-up|4|||
25183831|NCT01382251|50332131|FG001|Overall Study|Lost to Follow-up|4|||
25183832|NCT01382251|50332130|FG000|Overall Study|Contacted after study closed|1|||
25183833|NCT01382251|50332131|FG001|Overall Study|Contacted after study closed|1|||
25183834|NCT01396525|50332136|FG000|Overall Study|Withdrawal by Subject|8|||
25183835|NCT01396525|50332136|FG000|Overall Study|Death|14|||
25146641|NCT01411852|50260400|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
25146642|NCT01411852|50260399|FG000|Prehospital Intervention Phase|Found to be under age|0|||
25183836|NCT01396525|50332136|FG000|Overall Study|Lost to Follow-up|4|||
25183837|NCT02849652|50332148|FG000|Overall Study|Lost to Follow-up|104|||
25183838|NCT02849652|50332149|FG001|Overall Study|Lost to Follow-up|35|||
25146643|NCT01411852|50260400|FG001|Prehospital Intervention Phase|Found to be under age|1|||
25146644|NCT01411852|50260399|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
25146645|NCT01411852|50260400|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
25146646|NCT01411852|50260399|FG000|Hospital Intervention Phase|Severe head injury|5|||
25146647|NCT01411852|50260400|FG001|Hospital Intervention Phase|Severe head injury|4|||
25146648|NCT01411852|50260399|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
25183839|NCT02849652|50332150|FG002|Overall Study|Lost to Follow-up|116|||
25183840|NCT02849652|50332151|FG003|Overall Study|Lost to Follow-up|22|||
25183841|NCT02849652|50332148|FG000|Overall Study|Withdrawal by Subject|10|||
25183842|NCT02849652|50332149|FG001|Overall Study|Withdrawal by Subject|2|||
25183843|NCT02849652|50332150|FG002|Overall Study|Withdrawal by Subject|8|||
25183844|NCT02849652|50332151|FG003|Overall Study|Withdrawal by Subject|4|||
25183845|NCT01396447|50332163|FG000|Overall Study|Did Not Receive Treatment|3|||
25183846|NCT01396447|50332164|FG001|Overall Study|Did Not Receive Treatment|2|||
25183847|NCT01396447|50332165|FG002|Overall Study|Did Not Receive Treatment|1|||
25183848|NCT01396447|50332166|FG003|Overall Study|Did Not Receive Treatment|0|||
25183849|NCT01396447|50332163|FG000|Overall Study|Adverse Event|15|||
25183850|NCT01396447|50332164|FG001|Overall Study|Adverse Event|12|||
25274572|NCT00977938|50588590|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
25146649|NCT01411852|50260400|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
25146650|NCT01411852|50260399|FG000|Hospital Intervention Phase|Miscommunication error|1|||
25183851|NCT01396447|50332165|FG002|Overall Study|Adverse Event|12|||
25183852|NCT01396447|50332166|FG003|Overall Study|Adverse Event|17|||
25183853|NCT01396447|50332163|FG000|Overall Study|Insufficient Therapeutic Response|5|||
25183854|NCT01396447|50332164|FG001|Overall Study|Insufficient Therapeutic Response|5|||
25183855|NCT01396447|50332165|FG002|Overall Study|Insufficient Therapeutic Response|2|||
25183856|NCT01396447|50332166|FG003|Overall Study|Insufficient Therapeutic Response|4|||
25183857|NCT01396447|50332163|FG000|Overall Study|Protocol Violation|5|||
25183858|NCT01396447|50332164|FG001|Overall Study|Protocol Violation|2|||
25183859|NCT01396447|50332165|FG002|Overall Study|Protocol Violation|3|||
25183860|NCT01396447|50332166|FG003|Overall Study|Protocol Violation|7|||
25183861|NCT01396447|50332163|FG000|Overall Study|Withdrawal of Consent|11|||
25183862|NCT01396447|50332164|FG001|Overall Study|Withdrawal of Consent|9|||
25183863|NCT01396447|50332165|FG002|Overall Study|Withdrawal of Consent|4|||
25183864|NCT01396447|50332166|FG003|Overall Study|Withdrawal of Consent|15|||
25183865|NCT01396447|50332163|FG000|Overall Study|Lost to Follow-up|4|||
25183866|NCT01396447|50332164|FG001|Overall Study|Lost to Follow-up|8|||
25183867|NCT01396447|50332165|FG002|Overall Study|Lost to Follow-up|7|||
25183868|NCT01396447|50332166|FG003|Overall Study|Lost to Follow-up|9|||
25183869|NCT01396447|50332163|FG000|Overall Study|Other Miscellaneous Reasons|0|||
25183870|NCT01396447|50332164|FG001|Overall Study|Other Miscellaneous Reasons|2|||
25183871|NCT01396447|50332165|FG002|Overall Study|Other Miscellaneous Reasons|1|||
25183872|NCT01396447|50332166|FG003|Overall Study|Other Miscellaneous Reasons|0|||
25183873|NCT01678560|50332250|FG000|Overall Study|Physician Decision|4|||
25183874|NCT01678560|50332251|FG001|Overall Study|Physician Decision|4|||
25183875|NCT01678560|50332250|FG000|Overall Study|Death|0|||
25183876|NCT01678560|50332251|FG001|Overall Study|Death|1|||
25183877|NCT01678560|50332250|FG000|Overall Study|Withdrawal by Subject|0|||
25183878|NCT01678560|50332251|FG001|Overall Study|Withdrawal by Subject|1|||
25183879|NCT01381549|50332290|FG000|Overall Study|Ineligible: No organisms isolated|0|||
25183880|NCT01381549|50332291|FG001|Overall Study|Ineligible: No organisms isolated|0|||
25183881|NCT01381549|50332292|FG002|Overall Study|Ineligible: No organisms isolated|1|||
25183882|NCT00159432|50332301|FG000|Overall Study|Adverse Event|1|||
25183883|NCT00159432|50332301|FG000|Overall Study|Death|1|||
25183884|NCT00159432|50332301|FG000|Overall Study|Lack of Efficacy|8|||
25183885|NCT01396057|50332307|FG000|Overall Study|Adverse Event|2|||
25183886|NCT01396057|50332308|FG001|Overall Study|Adverse Event|6|||
25183887|NCT01396057|50332307|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
25146651|NCT01411852|50260400|FG001|Hospital Intervention Phase|Miscommunication error|2|||
25146652|NCT01411852|50260399|FG000|Hospital Intervention Phase|CPR administered|3|||
25146653|NCT01411852|50260400|FG001|Hospital Intervention Phase|CPR administered|1|||
25146654|NCT01411852|50260399|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
25146655|NCT01411852|50260400|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
25146656|NCT01411852|50260399|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
25183888|NCT01396057|50332308|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
25183889|NCT01396057|50332307|FG000|Overall Study|Protocol deviation|4|||
25183890|NCT01396057|50332308|FG001|Overall Study|Protocol deviation|4|||
25183891|NCT01396057|50332307|FG000|Overall Study|Consent withdrawn|3|||
25183892|NCT01396057|50332308|FG001|Overall Study|Consent withdrawn|2|||
25183893|NCT01380769|50332325|FG000|Overall Study|Withdrawal by Subject|7|||
25183894|NCT01380769|50332326|FG001|Overall Study|Withdrawal by Subject|11|||
25183895|NCT01380769|50332325|FG000|Overall Study|Physician Decision|1|||
25183896|NCT01380769|50332326|FG001|Overall Study|Physician Decision|1|||
25183897|NCT01380769|50332325|FG000|Overall Study|Adverse Event|1|||
25183898|NCT01380769|50332326|FG001|Overall Study|Adverse Event|1|||
25183899|NCT01380769|50332325|FG000|Overall Study|Protocol Violation|0|||
25183900|NCT01380769|50332326|FG001|Overall Study|Protocol Violation|1|||
25183901|NCT01395901|50332334|FG000|Overall Study|Lost to Follow-up|4|||
25183902|NCT01395901|50332335|FG001|Overall Study|Lost to Follow-up|0|||
25146657|NCT01411852|50260400|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
25146658|NCT01411852|50260399|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
25146659|NCT01411852|50260400|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
25146660|NCT01411852|50260399|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
25146661|NCT01411852|50260400|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
25146662|NCT01411852|50260399|FG000|Hospital Intervention Phase|Other ineligible|2|||
25146663|NCT01411852|50260400|FG001|Hospital Intervention Phase|Other ineligible|2|||
25146664|NCT01411852|50260399|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
25183903|NCT01395901|50332334|FG000|Overall Study|Randomized but not received study drug|5|||
25183904|NCT01395901|50332335|FG001|Overall Study|Randomized but not received study drug|4|||
25183905|NCT01395901|50332334|FG000|Overall Study|Adverse Event|0|||
25183906|NCT01395901|50332335|FG001|Overall Study|Adverse Event|1|||
25183907|NCT01395901|50332334|FG000|Overall Study|Withdrawal of consent|1|||
25183908|NCT01395901|50332335|FG001|Overall Study|Withdrawal of consent|0|||
25183909|NCT01395823|50332343|FG000|Overall Study|Death|4|||
25183910|NCT01395823|50332344|FG001|Overall Study|Death|4|||
25183911|NCT01395823|50332343|FG000|Overall Study|Physician Decision|3|||
25183912|NCT01395823|50332344|FG001|Overall Study|Physician Decision|1|||
25183913|NCT01395823|50332343|FG000|Overall Study|Lost to Follow-up|1|||
25146665|NCT01411852|50260400|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
25146666|NCT01411852|50260399|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
25146667|NCT01411852|50260400|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
25146668|NCT01411852|50260399|FG000|Hospital Intervention Phase|Vascular access failed|1|||
25146669|NCT01411852|50260400|FG001|Hospital Intervention Phase|Vascular access failed|0|||
25146670|NCT01411774|50260410|FG000|Overall Study|Withdrawal by Subject|0|||
25146671|NCT01411774|50260411|FG001|Overall Study|Withdrawal by Subject|3|||
25146672|NCT01411228|50260420|FG000|Overall Study|Lost to Follow-up|0|||
25146673|NCT01411228|50260421|FG001|Overall Study|Lost to Follow-up|0|||
25146674|NCT01411228|50260422|FG002|Overall Study|Lost to Follow-up|1|||
25146675|NCT01411228|50260420|FG000|Overall Study|Withdrawal by Subject|1|||
25146676|NCT01411228|50260421|FG001|Overall Study|Withdrawal by Subject|0|||
25146677|NCT01411228|50260422|FG002|Overall Study|Withdrawal by Subject|0|||
25146678|NCT01410604|50260432|FG000|Overall Study|Adverse Event|2|||
25146679|NCT01410604|50260433|FG001|Overall Study|Adverse Event|1|||
25146680|NCT01410604|50260432|FG000|Overall Study|Lost to Follow-up|1|||
25146681|NCT01410604|50260433|FG001|Overall Study|Lost to Follow-up|0|||
25146682|NCT01410604|50260432|FG000|Overall Study|Physician Decision|0|||
25146683|NCT01410604|50260433|FG001|Overall Study|Physician Decision|1|||
25146684|NCT01991483|50260443|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
25146685|NCT01991483|50260444|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
25146686|NCT01991483|50260445|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
25146687|NCT01991483|50260446|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
25146688|NCT01991483|50260443|FG000|Dose Level 600 mg|Physician Decision|0|||
25146689|NCT01991483|50260444|FG001|Dose Level 600 mg|Physician Decision|0|||
25146690|NCT01991483|50260445|FG002|Dose Level 600 mg|Physician Decision|1|||
25146691|NCT01991483|50260446|FG003|Dose Level 600 mg|Physician Decision|0|||
25146692|NCT01991483|50260443|FG000|Dose Level 1000 mg|Protocol Violation|0|||
25146693|NCT01991483|50260444|FG001|Dose Level 1000 mg|Protocol Violation|0|||
25146694|NCT01991483|50260445|FG002|Dose Level 1000 mg|Protocol Violation|0|||
25146695|NCT01991483|50260446|FG003|Dose Level 1000 mg|Protocol Violation|1|||
25146696|NCT01410448|50260461|FG000|Overall Study|No conversion to everolimus|0|||
25146697|NCT01410448|50260462|FG001|Overall Study|No conversion to everolimus|24|||
25146698|NCT01410448|50260461|FG000|Overall Study|Graft loss|4|||
25146699|NCT01410448|50260462|FG001|Overall Study|Graft loss|1|||
25146700|NCT01410448|50260461|FG000|Overall Study|Administrative issues|2|||
25146701|NCT01410448|50260462|FG001|Overall Study|Administrative issues|1|||
25146702|NCT01410448|50260461|FG000|Overall Study|Lost to Follow-up|1|||
25146703|NCT01410448|50260462|FG001|Overall Study|Lost to Follow-up|0|||
25146704|NCT01410448|50260461|FG000|Overall Study|Withdrawal by Subject|3|||
25146705|NCT01410448|50260462|FG001|Overall Study|Withdrawal by Subject|2|||
25183914|NCT01395823|50332344|FG001|Overall Study|Lost to Follow-up|0|||
25146706|NCT01410448|50260461|FG000|Overall Study|Protocol Violation|0|||
25146707|NCT01410448|50260462|FG001|Overall Study|Protocol Violation|4|||
25146708|NCT01410448|50260461|FG000|Overall Study|Death|2|||
25146709|NCT01410448|50260462|FG001|Overall Study|Death|3|||
25146710|NCT01943851|50260486|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
25146711|NCT01943851|50260487|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
25146712|NCT01943851|50260488|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
25146713|NCT01943851|50260489|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
25183915|NCT01395823|50332343|FG000|Overall Study|Transplant|1|||
25183916|NCT01395823|50332344|FG001|Overall Study|Transplant|0|||
25183917|NCT01395823|50332343|FG000|Overall Study|GI symptoms|1|||
25183918|NCT01395823|50332344|FG001|Overall Study|GI symptoms|0|||
25183919|NCT01395823|50332343|FG000|Overall Study|Withdrawal by Subject|5|||
25183920|NCT01395823|50332344|FG001|Overall Study|Withdrawal by Subject|4|||
25183921|NCT00158184|50332352|FG000|Overall Study|personal issues|3|||
25183922|NCT00158184|50332353|FG001|Overall Study|personal issues|1|||
25183923|NCT00158184|50332352|FG000|Overall Study|failed for follow unit/study rules|2|||
25183924|NCT00158184|50332353|FG001|Overall Study|failed for follow unit/study rules|0|||
25183925|NCT00158184|50332352|FG000|Overall Study|Adverse Event|1|||
25183926|NCT00158184|50332353|FG001|Overall Study|Adverse Event|1|||
25183927|NCT01380691|50332361|FG000|Washout (7 Days)|Protocol Violation|0|||
25183928|NCT01380691|50332362|FG001|Washout (7 Days)|Protocol Violation|0|||
25183929|NCT01380691|50332363|FG002|Washout (7 Days)|Protocol Violation|0|||
25183930|NCT01380691|50332364|FG003|Washout (7 Days)|Protocol Violation|1|||
25183931|NCT01380691|50332361|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
25183932|NCT01380691|50332362|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
25183933|NCT01380691|50332363|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
25183934|NCT01380691|50332364|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
25183935|NCT01380535|50332390|FG000|Overall Study|Adverse Event|3|||
25183936|NCT01380535|50332391|FG001|Overall Study|Adverse Event|3|||
25183937|NCT01380535|50332390|FG000|Overall Study|Death|3|||
25183938|NCT01380535|50332391|FG001|Overall Study|Death|0|||
25146714|NCT01943851|50260490|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
25146715|NCT01943851|50260491|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
25183939|NCT01380535|50332390|FG000|Overall Study|Study site closed|0|||
25183940|NCT01380535|50332391|FG001|Overall Study|Study site closed|5|||
25183941|NCT01380535|50332390|FG000|Overall Study|Withdrawal by Subject|1|||
25183942|NCT01380535|50332391|FG001|Overall Study|Withdrawal by Subject|2|||
25183943|NCT01380535|50332390|FG000|Overall Study|Protocol Violation|0|||
25183944|NCT01380535|50332391|FG001|Overall Study|Protocol Violation|2|||
25183945|NCT01380535|50332390|FG000|Overall Study|Lack of Efficacy|0|||
25183946|NCT01380535|50332391|FG001|Overall Study|Lack of Efficacy|3|||
25183947|NCT01380379|50332401|FG000|Overall Study|Pregnancy|1|||
25183948|NCT01380145|50332405|FG000|Overall Study|Progressive disease|4|||
25146716|NCT01943851|50260492|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
25146717|NCT01943851|50260493|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
25146718|NCT01943851|50260494|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
25183949|NCT03420222|50332431|FG000|Overall Study|Withdrawal by Subject|5|||
25183950|NCT03420222|50332432|FG001|Overall Study|Withdrawal by Subject|0|||
25183951|NCT03420222|50332431|FG000|Overall Study|Physician Decision|0|||
25183952|NCT03420222|50332432|FG001|Overall Study|Physician Decision|1|||
25183953|NCT01394185|50332438|FG000|Overall Study|Withdrawal by Subject|2|||
25274573|NCT00977938|50588591|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
25146719|NCT01943851|50260495|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
25146720|NCT01943851|50260496|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
25146721|NCT01943851|50260497|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
25183954|NCT01394185|50332439|FG001|Overall Study|Withdrawal by Subject|0|||
25183955|NCT01394185|50332440|FG002|Overall Study|Withdrawal by Subject|0|||
25183956|NCT01394185|50332441|FG003|Overall Study|Withdrawal by Subject|0|||
25183957|NCT01394185|50332442|FG004|Overall Study|Withdrawal by Subject|1|||
25183958|NCT01394185|50332443|FG005|Overall Study|Withdrawal by Subject|0|||
25146722|NCT01943851|50260498|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
25146723|NCT01943851|50260499|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
25146724|NCT01943851|50260500|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
25146725|NCT01943851|50260501|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
25146726|NCT01943851|50260502|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
25146727|NCT01943851|50260503|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
25146728|NCT01943851|50260486|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
25146729|NCT01943851|50260487|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
25146730|NCT01943851|50260488|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
25183959|NCT01394185|50332438|FG000|Overall Study|Change in protocol|3|||
25183960|NCT01394185|50332439|FG001|Overall Study|Change in protocol|0|||
25183961|NCT01394185|50332440|FG002|Overall Study|Change in protocol|0|||
25183962|NCT01394185|50332441|FG003|Overall Study|Change in protocol|0|||
25183963|NCT01394185|50332442|FG004|Overall Study|Change in protocol|3|||
25183964|NCT01394185|50332443|FG005|Overall Study|Change in protocol|0|||
25146731|NCT01943851|50260489|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
25146732|NCT01943851|50260490|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
25146733|NCT01943851|50260491|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
25146734|NCT01943851|50260492|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
25146735|NCT01943851|50260493|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
25146736|NCT01943851|50260494|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
25146737|NCT01943851|50260495|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
25146738|NCT01943851|50260496|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
25146739|NCT01943851|50260497|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
25146740|NCT01943851|50260498|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
25146741|NCT01943851|50260499|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
25146742|NCT01943851|50260500|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
25183965|NCT01394185|50332438|FG000|Overall Study|Protocol Violation|1|||
25183966|NCT01394185|50332439|FG001|Overall Study|Protocol Violation|0|||
25146743|NCT01943851|50260501|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
25146744|NCT01943851|50260502|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
25183967|NCT01394185|50332440|FG002|Overall Study|Protocol Violation|0|||
25183968|NCT01394185|50332441|FG003|Overall Study|Protocol Violation|1|||
25183969|NCT01394185|50332442|FG004|Overall Study|Protocol Violation|0|||
25183970|NCT01394185|50332443|FG005|Overall Study|Protocol Violation|1|||
25183971|NCT01677936|50332476|FG000|Overall Study|Lost to Follow-up|4|||
25183972|NCT01677936|50332477|FG001|Overall Study|Lost to Follow-up|1|||
25183973|NCT01677936|50332476|FG000|Overall Study|Protocol Violation|3|||
25183974|NCT01677936|50332477|FG001|Overall Study|Protocol Violation|0|||
25183975|NCT01677936|50332476|FG000|Overall Study|Adverse Event|1|||
25183976|NCT01677936|50332477|FG001|Overall Study|Adverse Event|0|||
25183977|NCT01677936|50332476|FG000|Overall Study|Lost to Follow-up|1|||
25183978|NCT01677936|50332477|FG001|Overall Study|Lost to Follow-up|0|||
25183979|NCT01677936|50332476|FG000|Overall Study|Protocol Violation|0|||
25274574|NCT00977938|50588592|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
25274575|NCT00977938|50588589|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
25274576|NCT00977938|50588590|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
25183980|NCT01677936|50332477|FG001|Overall Study|Protocol Violation|4|||
25183981|NCT01525550|50332508|FG000|Overall Study|Lost to Follow-up|8|||
25183982|NCT01525550|50332509|FG001|Overall Study|Lost to Follow-up|2|||
25183983|NCT01525550|50332508|FG000|Overall Study|Death|19|||
25183984|NCT01525550|50332509|FG001|Overall Study|Death|28|||
25183985|NCT01525550|50332508|FG000|Overall Study|Other|0|||
25183986|NCT01525550|50332509|FG001|Overall Study|Other|4|||
25183987|NCT01525550|50332508|FG000|Overall Study|Sponsor's Decision|30|||
25183988|NCT01525550|50332509|FG001|Overall Study|Sponsor's Decision|11|||
25183989|NCT01525550|50332508|FG000|Overall Study|Withdrawal by Subject|4|||
25183990|NCT01525550|50332509|FG001|Overall Study|Withdrawal by Subject|0|||
25183991|NCT00211237|50332530|FG000|Baseline|Withdrew|1|||
25183992|NCT00211237|50332531|FG001|Baseline|Withdrew|3|||
25183993|NCT00211237|50332532|FG002|Baseline|Withdrew|0|||
25183994|NCT00211237|50332530|FG000|Baseline|Refused random assignment|1|||
25183995|NCT00211237|50332531|FG001|Baseline|Refused random assignment|0|||
25183996|NCT00211237|50332532|FG002|Baseline|Refused random assignment|0|||
25183997|NCT00211237|50332530|FG000|1 Month|Death|2|||
25183998|NCT00211237|50332531|FG001|1 Month|Death|1|||
25183999|NCT00211237|50332532|FG002|1 Month|Death|0|||
25184000|NCT00211237|50332530|FG000|1 Month|Lost to Follow-up|0|||
25184001|NCT00211237|50332531|FG001|1 Month|Lost to Follow-up|2|||
25184002|NCT00211237|50332532|FG002|1 Month|Lost to Follow-up|0|||
25184003|NCT00211237|50332530|FG000|1 Month|Withdrew|0|||
25184004|NCT00211237|50332531|FG001|1 Month|Withdrew|4|||
25184005|NCT00211237|50332532|FG002|1 Month|Withdrew|0|||
25184006|NCT00211237|50332530|FG000|1 Month|Additional surgery needed|1|||
25184007|NCT00211237|50332531|FG001|1 Month|Additional surgery needed|0|||
25184008|NCT00211237|50332532|FG002|1 Month|Additional surgery needed|0|||
25184009|NCT00211237|50332530|FG000|1 Month|Non-medical problem|0|||
25184010|NCT00211237|50332531|FG001|1 Month|Non-medical problem|2|||
25184011|NCT00211237|50332532|FG002|1 Month|Non-medical problem|0|||
25184012|NCT00211237|50332530|FG000|3 Months|Death|7|||
25184013|NCT00211237|50332531|FG001|3 Months|Death|3|||
25184014|NCT00211237|50332532|FG002|3 Months|Death|0|||
25184015|NCT00211237|50332530|FG000|3 Months|Could not comply with protocol|1|||
25184016|NCT00211237|50332531|FG001|3 Months|Could not comply with protocol|0|||
25184017|NCT00211237|50332532|FG002|3 Months|Could not comply with protocol|0|||
25184018|NCT00211237|50332530|FG000|3 Months|Withdrew|0|||
25146745|NCT01943851|50260503|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
25146746|NCT01943851|50260486|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
25146747|NCT01943851|50260487|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
25146748|NCT01943851|50260488|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
25146749|NCT01943851|50260489|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
25146750|NCT01943851|50260490|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
25146751|NCT01943851|50260491|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
25146752|NCT01943851|50260492|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
25146753|NCT01943851|50260493|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
25146754|NCT01943851|50260494|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
25146755|NCT01943851|50260495|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
25146756|NCT01943851|50260496|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
25146757|NCT01943851|50260497|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
25146758|NCT01943851|50260498|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
25146759|NCT01943851|50260499|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
25146760|NCT01943851|50260500|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
25146761|NCT01943851|50260501|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
25146762|NCT01943851|50260502|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
25146763|NCT01943851|50260503|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
25146764|NCT01943851|50260486|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
25184019|NCT00211237|50332531|FG001|3 Months|Withdrew|1|||
25184020|NCT00211237|50332532|FG002|3 Months|Withdrew|0|||
25146765|NCT01943851|50260487|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
25146766|NCT01943851|50260488|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
25146767|NCT01943851|50260489|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
25184021|NCT00211237|50332530|FG000|3 Months|Non-medical problem|0|||
25184022|NCT00211237|50332531|FG001|3 Months|Non-medical problem|0|||
25184023|NCT00211237|50332532|FG002|3 Months|Non-medical problem|1|||
25184024|NCT00211237|50332530|FG000|6 Months|Death|6|||
25184025|NCT00211237|50332531|FG001|6 Months|Death|0|||
25274577|NCT00977938|50588591|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
25184026|NCT00211237|50332532|FG002|6 Months|Death|3|||
25184027|NCT00211237|50332530|FG000|6 Months|Lost to Follow-up|2|||
25184028|NCT00211237|50332531|FG001|6 Months|Lost to Follow-up|0|||
25184029|NCT00211237|50332532|FG002|6 Months|Lost to Follow-up|0|||
25184030|NCT00211237|50332530|FG000|6 Months|Could not comply with protocol|0|||
25146768|NCT01943851|50260490|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
25146769|NCT01943851|50260491|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
25146770|NCT01943851|50260492|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
25146771|NCT01943851|50260493|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
25146772|NCT01943851|50260494|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
25146773|NCT01943851|50260495|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
25146774|NCT01943851|50260496|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
25146775|NCT01943851|50260497|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
25146776|NCT01943851|50260498|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
25146777|NCT01943851|50260499|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
25146778|NCT01943851|50260500|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
25184031|NCT00211237|50332531|FG001|6 Months|Could not comply with protocol|2|||
25146779|NCT01943851|50260501|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
25146780|NCT01943851|50260502|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
25184032|NCT00211237|50332532|FG002|6 Months|Could not comply with protocol|0|||
25184033|NCT00211237|50332530|FG000|12 Months|Death|8|||
25146781|NCT01943851|50260503|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
25146782|NCT01943851|50260486|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
25146783|NCT01943851|50260487|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
25146784|NCT01943851|50260488|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
25184034|NCT00211237|50332531|FG001|12 Months|Death|2|||
25184035|NCT00211237|50332532|FG002|12 Months|Death|3|||
25184036|NCT00211237|50332530|FG000|12 Months|Lost to Follow-up|1|||
25184037|NCT00211237|50332531|FG001|12 Months|Lost to Follow-up|0|||
25184038|NCT00211237|50332532|FG002|12 Months|Lost to Follow-up|1|||
25184039|NCT00211237|50332530|FG000|12 Months|Withdrew|0|||
25184040|NCT00211237|50332531|FG001|12 Months|Withdrew|0|||
25184041|NCT00211237|50332532|FG002|12 Months|Withdrew|1|||
25184042|NCT00211237|50332530|FG000|12 Months|unrelated medical problem|0|||
25184043|NCT00211237|50332531|FG001|12 Months|unrelated medical problem|0|||
25184044|NCT00211237|50332532|FG002|12 Months|unrelated medical problem|1|||
25184045|NCT01489358|50332552|FG000|Overall Study|Lost to Follow-up|0|||
25184046|NCT01489358|50332553|FG001|Overall Study|Lost to Follow-up|0|||
25184047|NCT01489358|50332554|FG002|Overall Study|Lost to Follow-up|2|||
25184048|NCT01525238|50332565|FG000|Overall Study|Withdrawal by Subject|1|||
25184049|NCT01525238|50332566|FG001|Overall Study|Withdrawal by Subject|0|||
25184050|NCT01525238|50332567|FG002|Overall Study|Withdrawal by Subject|0|||
25184051|NCT01525082|50332588|FG000|Overall Study|Death|1|||
25274578|NCT00977938|50588592|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
25274579|NCT00977938|50588589|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
25274580|NCT00977938|50588590|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
25274581|NCT00977938|50588591|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
25274582|NCT00977938|50588592|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
25274583|NCT02716675|50588607|FG000|Overall Study|Death|2|||
25274584|NCT02716675|50588608|FG001|Overall Study|Death|3|||
25274585|NCT02716675|50588609|FG002|Overall Study|Death|0|||
25274586|NCT02716675|50588607|FG000|Overall Study|Physician Decision|2|||
25274587|NCT02716675|50588608|FG001|Overall Study|Physician Decision|1|||
25146785|NCT01943851|50260489|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
25146786|NCT01943851|50260490|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
25146787|NCT01943851|50260491|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
25146788|NCT01943851|50260492|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
25146789|NCT01943851|50260493|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
25146790|NCT01943851|50260494|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
25146791|NCT01943851|50260495|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
25146792|NCT01943851|50260496|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
25146793|NCT01943851|50260497|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
25146794|NCT01943851|50260498|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
25274588|NCT02716675|50588609|FG002|Overall Study|Physician Decision|1|||
25146795|NCT01943851|50260499|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
25184052|NCT01488578|50332595|FG000|Overall Study|Protocol Violation|1836|||
25184053|NCT01524770|50332636|FG000|First Intervention|Withdrawal by Subject|1|||
25184054|NCT01524770|50332637|FG001|First Intervention|Withdrawal by Subject|0|||
25274589|NCT02716675|50588607|FG000|Overall Study|Lost to Follow-up|100|||
25146796|NCT01943851|50260500|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
25146797|NCT01943851|50260501|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
25146798|NCT01943851|50260502|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
25146799|NCT01943851|50260503|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
25146800|NCT01430104|50260544|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
25146801|NCT01990859|50260551|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
25146802|NCT01990859|50260551|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
25146803|NCT02093897|50260556|FG000|Overall Study|Physician Decision|1|||
25184055|NCT01524770|50332636|FG000|First Intervention|Adverse Event|1|||
25184056|NCT01524770|50332637|FG001|First Intervention|Adverse Event|1|||
25184057|NCT01524770|50332636|FG000|First Intervention|Protocol Violation|1|||
25184058|NCT01524770|50332637|FG001|First Intervention|Protocol Violation|0|||
25184059|NCT01524692|50332643|FG000|Overall Study|Withdrawal by Subject|3|||
25184060|NCT01431287|50332662|FG000|Overall Study|not treated|0|||
25184061|NCT01431287|50332663|FG001|Overall Study|not treated|0|||
25184062|NCT01431287|50332664|FG002|Overall Study|not treated|1|||
25184063|NCT01431287|50332665|FG003|Overall Study|not treated|0|||
25184064|NCT01431287|50332666|FG004|Overall Study|not treated|0|||
25146804|NCT02093897|50260556|FG000|Overall Study|Planned age group closure - no's reached|17|||
25146805|NCT02093897|50260556|FG000|Overall Study|Adverse event, non-fatal|1|||
25146806|NCT01990313|50260567|FG000|Overall Study|Lost to Follow-up|1|||
25146807|NCT01947517|50260573|FG000|Overall Study|Withdrawal by Subject|1|||
25146808|NCT01947517|50260574|FG001|Overall Study|Withdrawal by Subject|1|||
25146809|NCT02006927|50260580|FG000|Overall Study|Adverse Event|2|||
25146810|NCT02006927|50260580|FG000|Overall Study|Withdrawal by Subject|1|||
25146811|NCT01947283|50260591|FG000|Overall Study|Death|1|||
25146812|NCT01947283|50260592|FG001|Overall Study|Death|1|||
25146813|NCT01947283|50260593|FG002|Overall Study|Death|1|||
25146814|NCT01947283|50260594|FG003|Overall Study|Death|0|||
25146815|NCT01947283|50260595|FG004|Overall Study|Death|0|||
25146816|NCT01947283|50260596|FG005|Overall Study|Death|0|||
25146817|NCT01947283|50260597|FG006|Overall Study|Death|0|||
25146818|NCT01947283|50260591|FG000|Overall Study|Lost to Follow-up|4|||
25146819|NCT01947283|50260592|FG001|Overall Study|Lost to Follow-up|6|||
25146820|NCT01947283|50260593|FG002|Overall Study|Lost to Follow-up|5|||
25146821|NCT01947283|50260594|FG003|Overall Study|Lost to Follow-up|5|||
25146822|NCT01947283|50260595|FG004|Overall Study|Lost to Follow-up|0|||
25146823|NCT01947283|50260596|FG005|Overall Study|Lost to Follow-up|2|||
25146824|NCT01947283|50260597|FG006|Overall Study|Lost to Follow-up|5|||
25146825|NCT01947283|50260591|FG000|Overall Study|Withdrawal by Subject|10|||
25146826|NCT01947283|50260592|FG001|Overall Study|Withdrawal by Subject|8|||
25146827|NCT01947283|50260593|FG002|Overall Study|Withdrawal by Subject|4|||
25146828|NCT01947283|50260594|FG003|Overall Study|Withdrawal by Subject|1|||
25146829|NCT01947283|50260595|FG004|Overall Study|Withdrawal by Subject|0|||
25146830|NCT01947283|50260596|FG005|Overall Study|Withdrawal by Subject|0|||
25146831|NCT01947283|50260597|FG006|Overall Study|Withdrawal by Subject|2|||
25146832|NCT01947283|50260591|FG000|Overall Study|No Clinical Recording|12|||
25146833|NCT01947283|50260592|FG001|Overall Study|No Clinical Recording|6|||
25146834|NCT01947283|50260593|FG002|Overall Study|No Clinical Recording|8|||
25146835|NCT01947283|50260594|FG003|Overall Study|No Clinical Recording|10|||
25146836|NCT01947283|50260595|FG004|Overall Study|No Clinical Recording|0|||
25146837|NCT01947283|50260596|FG005|Overall Study|No Clinical Recording|0|||
25184065|NCT01431287|50332662|FG000|Overall Study|Adverse Event|59|||
25146838|NCT01947283|50260597|FG006|Overall Study|No Clinical Recording|0|||
25146839|NCT01947283|50260591|FG000|Overall Study|Non-coding Clinical Recording language|0|||
25184066|NCT01431287|50332663|FG001|Overall Study|Adverse Event|57|||
25184067|NCT01431287|50332664|FG002|Overall Study|Adverse Event|53|||
25184068|NCT01431287|50332665|FG003|Overall Study|Adverse Event|33|||
25146840|NCT01947283|50260592|FG001|Overall Study|Non-coding Clinical Recording language|0|||
25146841|NCT01947283|50260593|FG002|Overall Study|Non-coding Clinical Recording language|0|||
25146842|NCT01947283|50260594|FG003|Overall Study|Non-coding Clinical Recording language|1|||
25184069|NCT01431287|50332666|FG004|Overall Study|Adverse Event|41|||
25184070|NCT01431287|50332662|FG000|Overall Study|Non compliant with protocol|6|||
25184071|NCT01431287|50332663|FG001|Overall Study|Non compliant with protocol|6|||
25184072|NCT01431287|50332664|FG002|Overall Study|Non compliant with protocol|5|||
25184073|NCT01431287|50332665|FG003|Overall Study|Non compliant with protocol|6|||
25184074|NCT01431287|50332666|FG004|Overall Study|Non compliant with protocol|5|||
25184075|NCT01431287|50332662|FG000|Overall Study|Lost to Follow-up|0|||
25184076|NCT01431287|50332663|FG001|Overall Study|Lost to Follow-up|3|||
25184077|NCT01431287|50332664|FG002|Overall Study|Lost to Follow-up|2|||
25184078|NCT01431287|50332665|FG003|Overall Study|Lost to Follow-up|3|||
25184079|NCT01431287|50332666|FG004|Overall Study|Lost to Follow-up|1|||
25146843|NCT01947283|50260595|FG004|Overall Study|Non-coding Clinical Recording language|0|||
25274590|NCT02716675|50588608|FG001|Overall Study|Lost to Follow-up|87|||
25146844|NCT01947283|50260596|FG005|Overall Study|Non-coding Clinical Recording language|0|||
25146845|NCT01947283|50260597|FG006|Overall Study|Non-coding Clinical Recording language|0|||
25146846|NCT01947283|50260591|FG000|Overall Study|Missing Follow-up Assessment|2|||
25184080|NCT01431287|50332662|FG000|Overall Study|Consent withdrawn not due to AE|29|||
25184081|NCT01431287|50332663|FG001|Overall Study|Consent withdrawn not due to AE|30|||
25184082|NCT01431287|50332664|FG002|Overall Study|Consent withdrawn not due to AE|34|||
25184083|NCT01431287|50332665|FG003|Overall Study|Consent withdrawn not due to AE|19|||
25184084|NCT01431287|50332666|FG004|Overall Study|Consent withdrawn not due to AE|29|||
25184085|NCT01431287|50332662|FG000|Overall Study|not stated above|4|||
25184086|NCT01431287|50332663|FG001|Overall Study|not stated above|2|||
25184087|NCT01431287|50332664|FG002|Overall Study|not stated above|2|||
25184088|NCT01431287|50332665|FG003|Overall Study|not stated above|2|||
25184089|NCT01431287|50332666|FG004|Overall Study|not stated above|1|||
25146847|NCT01947283|50260592|FG001|Overall Study|Missing Follow-up Assessment|2|||
25146848|NCT01947283|50260593|FG002|Overall Study|Missing Follow-up Assessment|3|||
25146849|NCT01947283|50260594|FG003|Overall Study|Missing Follow-up Assessment|0|||
25146850|NCT01947283|50260595|FG004|Overall Study|Missing Follow-up Assessment|0|||
25146851|NCT01947283|50260596|FG005|Overall Study|Missing Follow-up Assessment|2|||
25146852|NCT01947283|50260597|FG006|Overall Study|Missing Follow-up Assessment|0|||
25146853|NCT01947283|50260591|FG000|Overall Study|No patients were enrolled in study|0|||
25146854|NCT01947283|50260592|FG001|Overall Study|No patients were enrolled in study|0|||
25146855|NCT01947283|50260593|FG002|Overall Study|No patients were enrolled in study|0|||
25146856|NCT01947283|50260594|FG003|Overall Study|No patients were enrolled in study|0|||
25146857|NCT01947283|50260595|FG004|Overall Study|No patients were enrolled in study|0|||
25146858|NCT01947283|50260596|FG005|Overall Study|No patients were enrolled in study|3|||
25146859|NCT01947283|50260597|FG006|Overall Study|No patients were enrolled in study|1|||
25146860|NCT02006693|50260616|FG000|Overall Study|No Reason Specified|6|||
25184090|NCT01274715|50332712|FG000|Overall Study|Lost to Follow-up|1|||
25184091|NCT01274715|50332712|FG000|Overall Study|After consent, met exclusion criteria.|1|||
25146861|NCT02006693|50260617|FG001|Overall Study|No Reason Specified|8|||
25146862|NCT02006693|50260616|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
25146863|NCT02006693|50260617|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
25184092|NCT01274715|50332712|FG000|Overall Study|After consent, met exclusion criteria.|1|||
25184093|NCT01274715|50332712|FG000|Overall Study|After consent, met exclusion criteria.|1|||
25184094|NCT01410227|50332716|FG000|Overall Study|Adverse Event|1|||
25184095|NCT01410227|50332717|FG001|Overall Study|Adverse Event|0|||
25184096|NCT01410227|50332718|FG002|Overall Study|Adverse Event|0|||
25184097|NCT01410227|50332719|FG003|Overall Study|Adverse Event|0|||
25184098|NCT01410227|50332716|FG000|Overall Study|Withdrawal by Subject|3|||
25184099|NCT01410227|50332717|FG001|Overall Study|Withdrawal by Subject|0|||
25184100|NCT01410227|50332718|FG002|Overall Study|Withdrawal by Subject|1|||
25184101|NCT01410227|50332719|FG003|Overall Study|Withdrawal by Subject|0|||
25184102|NCT01410227|50332716|FG000|Overall Study|Pregnancy|0|||
25184103|NCT01410227|50332717|FG001|Overall Study|Pregnancy|0|||
25184104|NCT01410227|50332718|FG002|Overall Study|Pregnancy|0|||
25184105|NCT01410227|50332719|FG003|Overall Study|Pregnancy|1|||
25184106|NCT01410227|50332716|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
25184107|NCT01410227|50332717|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
25184108|NCT01410227|50332718|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
25184109|NCT01410227|50332719|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
25184110|NCT01274559|50332731|FG000|Overall Study|Adverse Event|57|||
25184111|NCT01274559|50332732|FG001|Overall Study|Adverse Event|13|||
25184112|NCT01274559|50332731|FG000|Overall Study|Death|1|||
25184113|NCT01274559|50332732|FG001|Overall Study|Death|1|||
25184114|NCT01274559|50332731|FG000|Overall Study|Lost to Follow-up|3|||
25184115|NCT01274559|50332732|FG001|Overall Study|Lost to Follow-up|3|||
25184116|NCT01274559|50332731|FG000|Overall Study|Non-compliance with Study Drug|2|||
25184117|NCT01274559|50332732|FG001|Overall Study|Non-compliance with Study Drug|4|||
25184118|NCT01274559|50332731|FG000|Overall Study|Physician Decision|2|||
25184119|NCT01274559|50332732|FG001|Overall Study|Physician Decision|1|||
25184120|NCT01274559|50332731|FG000|Overall Study|Protocol Violation|28|||
25184121|NCT01274559|50332732|FG001|Overall Study|Protocol Violation|23|||
25184122|NCT01274559|50332731|FG000|Overall Study|Study Terminated by Sponsor|79|||
25184123|NCT01274559|50332732|FG001|Overall Study|Study Terminated by Sponsor|87|||
25184124|NCT01274559|50332731|FG000|Overall Study|Withdrawal by Subject|25|||
25184125|NCT01274559|50332732|FG001|Overall Study|Withdrawal by Subject|13|||
25184126|NCT01409993|50332740|FG000|Overall Study|Adverse Event|4|||
25184127|NCT01409993|50332741|FG001|Overall Study|Adverse Event|4|||
25184128|NCT01409993|50332742|FG002|Overall Study|Adverse Event|3|||
25184129|NCT01409993|50332743|FG003|Overall Study|Adverse Event|1|||
25184130|NCT01409993|50332740|FG000|Overall Study|Withdrawal by Subject|0|||
25184131|NCT01409993|50332741|FG001|Overall Study|Withdrawal by Subject|0|||
25184132|NCT01409993|50332742|FG002|Overall Study|Withdrawal by Subject|0|||
25184133|NCT01409993|50332743|FG003|Overall Study|Withdrawal by Subject|4|||
25184134|NCT01409993|50332740|FG000|Overall Study|Lost to Follow-up|0|||
25184135|NCT01409993|50332741|FG001|Overall Study|Lost to Follow-up|1|||
25184136|NCT01409993|50332742|FG002|Overall Study|Lost to Follow-up|0|||
25184137|NCT01409993|50332743|FG003|Overall Study|Lost to Follow-up|0|||
25184138|NCT01273623|50332757|FG000|Overall Study|did not meet IVUS criteria|29|||
25184139|NCT01409915|50332765|FG000|Overall Study|Adverse Event|0|||
25184140|NCT01409915|50332766|FG001|Overall Study|Adverse Event|2|||
25184141|NCT01409915|50332765|FG000|Overall Study|Withdrawal by Subject|0|||
25184142|NCT01409915|50332766|FG001|Overall Study|Withdrawal by Subject|1|||
25184143|NCT01409915|50332765|FG000|Overall Study|Protocol Violation|1|||
25184144|NCT01409915|50332766|FG001|Overall Study|Protocol Violation|0|||
25184145|NCT01272921|50332774|FG000|Overall Study|Protocol Violation|2|||
25184146|NCT01272921|50332775|FG001|Overall Study|Protocol Violation|1|||
25184147|NCT01409837|50332785|FG000|Overall Study|Withdrawal by Subject|2|||
25184148|NCT01409837|50332786|FG001|Overall Study|Withdrawal by Subject|1|||
25184149|NCT01409837|50332785|FG000|Overall Study|Lost to Follow-up|1|||
25184150|NCT01409837|50332786|FG001|Overall Study|Lost to Follow-up|0|||
25184151|NCT01409837|50332785|FG000|Overall Study|Physician Decision|0|||
25184152|NCT01409837|50332786|FG001|Overall Study|Physician Decision|1|||
25184153|NCT01430585|50332805|FG000|Overall Study|Death|1|||
25184154|NCT01430585|50332805|FG000|Overall Study|Objective Progression or Relapse|3|||
25184155|NCT01430585|50332805|FG000|Overall Study|Study Terminated by Sponsor|3|||
25184156|NCT01430585|50332805|FG000|Overall Study|Other|7|||
25184157|NCT01408901|50332828|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
25184158|NCT01408901|50332829|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
25184159|NCT01408901|50332830|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
25184160|NCT01408901|50332831|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
25184161|NCT01408901|50332828|FG000|6-Week Follow-Up|Death|1|||
25184162|NCT01408901|50332829|FG001|6-Week Follow-Up|Death|0|||
25184163|NCT01408901|50332830|FG002|6-Week Follow-Up|Death|0|||
25184164|NCT01408901|50332831|FG003|6-Week Follow-Up|Death|0|||
25184165|NCT01408901|50332828|FG000|6-Week Follow-Up|Cancelled visit|0|||
25184166|NCT01408901|50332829|FG001|6-Week Follow-Up|Cancelled visit|1|||
25184167|NCT01408901|50332830|FG002|6-Week Follow-Up|Cancelled visit|0|||
25184168|NCT01408901|50332831|FG003|6-Week Follow-Up|Cancelled visit|2|||
25184169|NCT01408901|50332828|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
25184170|NCT01408901|50332829|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
25184171|NCT01408901|50332830|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
25146864|NCT02006693|50260616|FG000|Overall Study|XEN Implant Explantation|0|||
25146865|NCT02006693|50260617|FG001|Overall Study|XEN Implant Explantation|1|||
25146866|NCT02006693|50260616|FG000|Overall Study|Death|2|||
25146867|NCT02006693|50260617|FG001|Overall Study|Death|2|||
25146868|NCT02006693|50260616|FG000|Overall Study|Lost to Follow-up|4|||
25146869|NCT02006693|50260617|FG001|Overall Study|Lost to Follow-up|1|||
25146870|NCT02006693|50260616|FG000|Overall Study|Patient Decision|4|||
25146871|NCT02006693|50260617|FG001|Overall Study|Patient Decision|0|||
25184172|NCT01408901|50332831|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
25184173|NCT01408901|50332828|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
25184174|NCT01408901|50332829|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
25184175|NCT01408901|50332830|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
25184176|NCT01408901|50332831|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
25184177|NCT01408901|50332828|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
25184178|NCT01408901|50332829|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
25184179|NCT01408901|50332830|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
25184180|NCT01408901|50332831|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
25184181|NCT01408901|50332828|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
25184182|NCT01408901|50332829|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
25184183|NCT01408901|50332830|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
25184184|NCT01408901|50332831|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
25184185|NCT01408901|50332828|FG000|26-Week Follow-Up|Death|0|||
25184186|NCT01408901|50332829|FG001|26-Week Follow-Up|Death|1|||
25184187|NCT01408901|50332830|FG002|26-Week Follow-Up|Death|0|||
25184188|NCT01408901|50332831|FG003|26-Week Follow-Up|Death|0|||
25184189|NCT01428713|50332847|FG000|Overall Study|Non-compliance|2|||
25184190|NCT01428713|50332848|FG001|Overall Study|Non-compliance|2|||
25184191|NCT01428713|50332847|FG000|Overall Study|Withdrawal by Subject|1|||
25184192|NCT01428713|50332848|FG001|Overall Study|Withdrawal by Subject|1|||
25184193|NCT01428713|50332847|FG000|Overall Study|Adverse Event|0|||
25184194|NCT01428713|50332848|FG001|Overall Study|Adverse Event|2|||
25184195|NCT01408277|50332856|FG000|Overall Study|Adverse Event|3|||
25184196|NCT01408277|50332857|FG001|Overall Study|Adverse Event|4|||
25184197|NCT01408277|50332856|FG000|Overall Study|Lost to Follow-up|1|||
25184198|NCT01408277|50332857|FG001|Overall Study|Lost to Follow-up|0|||
25184199|NCT01408277|50332856|FG000|Overall Study|Withdrawal by Subject|2|||
25184200|NCT01408277|50332857|FG001|Overall Study|Withdrawal by Subject|0|||
25184201|NCT01408277|50332856|FG000|Overall Study|Protocol Violation|2|||
25184202|NCT01408277|50332857|FG001|Overall Study|Protocol Violation|0|||
25184203|NCT01408043|50332863|FG000|Overall Study|unable to collect cells|1|||
25184204|NCT01524224|50332875|FG000|Overall Study|Progressive Disease|1|||
25184205|NCT01524224|50332876|FG001|Overall Study|Progressive Disease|0|||
25184206|NCT01524224|50332877|FG002|Overall Study|Progressive Disease|2|||
25184207|NCT01524224|50332878|FG003|Overall Study|Progressive Disease|1|||
25146872|NCT01947127|50260625|FG000|Overall Study|Protocol Violation|18|||
25146873|NCT01947127|50260626|FG001|Overall Study|Protocol Violation|38|||
25146874|NCT01947127|50260625|FG000|Overall Study|Withdrawal by Subject|1|||
25146875|NCT01947127|50260626|FG001|Overall Study|Withdrawal by Subject|1|||
25146876|NCT01947127|50260625|FG000|Overall Study|Data loss|4|||
25146877|NCT01947127|50260626|FG001|Overall Study|Data loss|4|||
25146878|NCT01976845|50260635|FG000|Overall Study|Physician Decision|8|||
25146879|NCT01976845|50260636|FG001|Overall Study|Physician Decision|8|||
25146880|NCT01976845|50260637|FG002|Overall Study|Physician Decision|3|||
25146881|NCT01989689|50260647|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
25146882|NCT01989689|50260648|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
25146883|NCT01989689|50260647|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
25146884|NCT01989689|50260648|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
25146885|NCT01943539|50260656|FG000|Overall Study|Non-compliance with at-home intervention|4|||
25146886|NCT01943539|50260657|FG001|Overall Study|Non-compliance with at-home intervention|0|||
25146887|NCT01942993|50260664|FG000|Overall Study|Lost to Follow-up|1|||
25146888|NCT01942993|50260664|FG000|Overall Study|Physician Decision|1|||
25146889|NCT01989455|50260673|FG000|Overall Study|Adverse Event|0|||
25146890|NCT01989455|50260674|FG001|Overall Study|Adverse Event|1|||
25146891|NCT01989455|50260675|FG002|Overall Study|Adverse Event|0|||
25146892|NCT01989455|50260676|FG003|Overall Study|Adverse Event|0|||
25184208|NCT01524224|50332879|FG004|Overall Study|Progressive Disease|2|||
25184209|NCT01524224|50332880|FG005|Overall Study|Progressive Disease|1|||
25184210|NCT01524224|50332881|FG006|Overall Study|Progressive Disease|1|||
25184211|NCT01524224|50332882|FG007|Overall Study|Progressive Disease|5|||
25184212|NCT01524224|50332875|FG000|Overall Study|Withdrawal by Subject|2|||
25184213|NCT01524224|50332876|FG001|Overall Study|Withdrawal by Subject|0|||
25184214|NCT01524224|50332877|FG002|Overall Study|Withdrawal by Subject|0|||
25184215|NCT01524224|50332878|FG003|Overall Study|Withdrawal by Subject|0|||
25184216|NCT01524224|50332879|FG004|Overall Study|Withdrawal by Subject|0|||
25184217|NCT01524224|50332880|FG005|Overall Study|Withdrawal by Subject|0|||
25184218|NCT01524224|50332881|FG006|Overall Study|Withdrawal by Subject|2|||
25146893|NCT01989455|50260677|FG004|Overall Study|Adverse Event|0|||
25184219|NCT01524224|50332882|FG007|Overall Study|Withdrawal by Subject|0|||
25184220|NCT01524224|50332875|FG000|Overall Study|Adverse Event|0|||
25184221|NCT01524224|50332876|FG001|Overall Study|Adverse Event|1|||
25184222|NCT01524224|50332877|FG002|Overall Study|Adverse Event|0|||
25184223|NCT01524224|50332878|FG003|Overall Study|Adverse Event|0|||
25184224|NCT01524224|50332879|FG004|Overall Study|Adverse Event|0|||
25184225|NCT01524224|50332880|FG005|Overall Study|Adverse Event|1|||
25184226|NCT01524224|50332881|FG006|Overall Study|Adverse Event|0|||
25184227|NCT01524224|50332882|FG007|Overall Study|Adverse Event|0|||
25184228|NCT01524224|50332875|FG000|Overall Study|Physician Decision|0|||
25184229|NCT01524224|50332876|FG001|Overall Study|Physician Decision|0|||
25184230|NCT01524224|50332877|FG002|Overall Study|Physician Decision|0|||
25184231|NCT01524224|50332878|FG003|Overall Study|Physician Decision|1|||
25184232|NCT01524224|50332879|FG004|Overall Study|Physician Decision|1|||
25146894|NCT01989455|50260673|FG000|Overall Study|Withdrawal by Subject|0|||
25146895|NCT01989455|50260674|FG001|Overall Study|Withdrawal by Subject|1|||
25146896|NCT01989455|50260675|FG002|Overall Study|Withdrawal by Subject|0|||
25146897|NCT01989455|50260676|FG003|Overall Study|Withdrawal by Subject|0|||
25146898|NCT01989455|50260677|FG004|Overall Study|Withdrawal by Subject|0|||
25146899|NCT01989455|50260673|FG000|Overall Study|Technical problems with infusion|0|||
25146900|NCT01989455|50260674|FG001|Overall Study|Technical problems with infusion|0|||
25146901|NCT01989455|50260675|FG002|Overall Study|Technical problems with infusion|1|||
25146902|NCT01989455|50260676|FG003|Overall Study|Technical problems with infusion|0|||
25146903|NCT01989455|50260677|FG004|Overall Study|Technical problems with infusion|1|||
25146904|NCT01942837|50260693|FG000|Overall Study|Death|1|||
25146905|NCT01942837|50260693|FG000|Overall Study|Symptomatic or radiographic progression|49|||
25146906|NCT01942837|50260693|FG000|Overall Study|Adverse Event|6|||
25146907|NCT01942837|50260693|FG000|Overall Study|Physician Decision|3|||
25146908|NCT01942837|50260693|FG000|Overall Study|Withdrawal by Subject|2|||
25146909|NCT01942837|50260693|FG000|Overall Study|Intercurrent Illness|1|||
25146910|NCT01942837|50260693|FG000|Overall Study|On treatment|3|||
25146911|NCT01942837|50260693|FG000|Overall Study|Never initiate the treatment|2|||
25146912|NCT01987895|50260700|FG000|Overall Study|Withdrawal by Subject|12|||
25146913|NCT01987895|50260701|FG001|Overall Study|Withdrawal by Subject|7|||
25146914|NCT01987895|50260700|FG000|Overall Study|Physician Decision|8|||
25146915|NCT01987895|50260701|FG001|Overall Study|Physician Decision|10|||
25146916|NCT01987895|50260700|FG000|Overall Study|Death|7|||
25146917|NCT01987895|50260701|FG001|Overall Study|Death|7|||
25146918|NCT01987895|50260700|FG000|Overall Study|Lost to Follow-up|3|||
25184233|NCT01524224|50332880|FG005|Overall Study|Physician Decision|0|||
25184234|NCT01524224|50332881|FG006|Overall Study|Physician Decision|0|||
25184235|NCT01524224|50332882|FG007|Overall Study|Physician Decision|1|||
25016120|NCT04067401|50110978|FG001|Overall Study|Withdrawal by Subject|0|||
25016121|NCT04067401|50110977|FG000|Overall Study|no data provided|1|||
25016122|NCT04067401|50110978|FG001|Overall Study|no data provided|0|||
25016123|NCT04194151|50110990|FG000|Overall Study|Physician Decision|1|||
25016124|NCT04194151|50110991|FG001|Overall Study|Physician Decision|1|||
25016125|NCT04194151|50110992|FG002|Overall Study|Physician Decision|1|||
25016126|NCT04194151|50110993|FG003|Overall Study|Physician Decision|1|||
25016127|NCT04194151|50110994|FG004|Overall Study|Physician Decision|0|||
25016128|NCT04194151|50110995|FG005|Overall Study|Physician Decision|1|||
25016129|NCT04194151|50110990|FG000|Overall Study|Monitorization problem|0|||
25016130|NCT04194151|50110991|FG001|Overall Study|Monitorization problem|1|||
25016131|NCT04194151|50110992|FG002|Overall Study|Monitorization problem|0|||
25016132|NCT04194151|50110993|FG003|Overall Study|Monitorization problem|0|||
25016133|NCT04194151|50110994|FG004|Overall Study|Monitorization problem|0|||
25016134|NCT04194151|50110995|FG005|Overall Study|Monitorization problem|0|||
25016135|NCT03820323|50111011|FG000|Overall Study|Lost to Follow-up|2|||
25016136|NCT03820323|50111012|FG001|Overall Study|Lost to Follow-up|1|||
25016137|NCT03820323|50111011|FG000|Overall Study|Missed 12-month visit|22|||
25016138|NCT03820323|50111012|FG001|Overall Study|Missed 12-month visit|14|||
25016139|NCT03820323|50111011|FG000|Overall Study|Death|2|||
25016140|NCT03820323|50111012|FG001|Overall Study|Death|1|||
25016141|NCT03820323|50111011|FG000|Overall Study|Transferred out|13|||
25016142|NCT03820323|50111012|FG001|Overall Study|Transferred out|11|||
25016143|NCT03820323|50111011|FG000|Overall Study|Terminated|0|||
25016144|NCT03820323|50111012|FG001|Overall Study|Terminated|3|||
25016145|NCT03820323|50111011|FG000|Overall Study|Withdrawal by Subject|1|||
25146919|NCT01987895|50260701|FG001|Overall Study|Lost to Follow-up|5|||
25146920|NCT01987895|50260700|FG000|Overall Study|randomized before giving IC|0|||
25146921|NCT01987895|50260701|FG001|Overall Study|randomized before giving IC|1|||
25146922|NCT02005445|50260709|FG000|Overall Study|Dual study enrollment|0|||
25146923|NCT02005445|50260710|FG001|Overall Study|Dual study enrollment|1|||
25146924|NCT01618669|50260718|FG000|Overall Study|Lost to Follow-up|1|||
25146925|NCT01618669|50260719|FG001|Overall Study|Lost to Follow-up|1|||
25146926|NCT01618669|50260718|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
25146927|NCT01618669|50260719|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
25146928|NCT01618669|50260718|FG000|Overall Study|Adverse Event|16|||
25146929|NCT01618669|50260719|FG001|Overall Study|Adverse Event|7|||
25146930|NCT01618669|50260718|FG000|Overall Study|Protocol Violation|5|||
25146931|NCT01618669|50260719|FG001|Overall Study|Protocol Violation|3|||
25146932|NCT01618669|50260718|FG000|Overall Study|Withdrawal by Subject|9|||
25146933|NCT01618669|50260719|FG001|Overall Study|Withdrawal by Subject|9|||
25146934|NCT01618669|50260718|FG000|Overall Study|Miscellaneous Reason|0|||
25146935|NCT01618669|50260719|FG001|Overall Study|Miscellaneous Reason|1|||
25146936|NCT01390948|50260740|FG000|Overall Study|End of Study|1|||
25146937|NCT01390948|50260741|FG001|Overall Study|End of Study|0|||
25146938|NCT01390948|50260742|FG002|Overall Study|End of Study|0|||
25146939|NCT01390948|50260740|FG000|Overall Study|Withdrew consent|2|||
25146940|NCT01390948|50260741|FG001|Overall Study|Withdrew consent|2|||
25146941|NCT01390948|50260742|FG002|Overall Study|Withdrew consent|0|||
25146942|NCT01390948|50260740|FG000|Overall Study|Progressive Disease|2|||
25146943|NCT01390948|50260741|FG001|Overall Study|Progressive Disease|5|||
25146944|NCT01390948|50260742|FG002|Overall Study|Progressive Disease|0|||
25146945|NCT01390948|50260740|FG000|Overall Study|Death during follow-up|10|||
25146946|NCT01390948|50260741|FG001|Overall Study|Death during follow-up|11|||
25146947|NCT01390948|50260742|FG002|Overall Study|Death during follow-up|1|||
25146948|NCT02005211|50260756|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
25146949|NCT02005211|50260757|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
25146950|NCT02005211|50260758|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
25146951|NCT02005211|50260759|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
25146952|NCT02005211|50260760|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
25146953|NCT02005211|50260761|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
25146954|NCT02005211|50260762|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
25146955|NCT01429792|50260785|FG000|Overall Study|Other Reasons|67|||
25146956|NCT01429792|50260785|FG000|Overall Study|Unknown Disposition|94|||
25146957|NCT01429792|50260785|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
25146958|NCT01429792|50260785|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
25146959|NCT01429792|50260785|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
25146960|NCT01429792|50260785|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
25146961|NCT01429792|50260785|FG000|Overall Study|Withdrawal by Subject|70|||
25146962|NCT01429792|50260785|FG000|Overall Study|Lost to Follow-up|88|||
25146963|NCT01409434|50260789|FG000|Overall Study|Protocol Violation|4|||
25146964|NCT01940887|50260795|FG000|Year 1|Protocol Violation|0|||
25146965|NCT01940887|50260796|FG001|Year 1|Protocol Violation|1|||
25146966|NCT01940887|50260795|FG000|Year 1|Physician Decision|7|||
25146967|NCT01940887|50260796|FG001|Year 1|Physician Decision|3|||
25146968|NCT01940887|50260795|FG000|Year 1|Death|5|||
25146969|NCT01940887|50260796|FG001|Year 1|Death|3|||
25146970|NCT01940887|50260795|FG000|Year 1|Adverse Event|7|||
25146971|NCT01940887|50260796|FG001|Year 1|Adverse Event|6|||
25146972|NCT01940887|50260795|FG000|Year 1|Withdrawal by Subject|18|||
25146973|NCT01940887|50260796|FG001|Year 1|Withdrawal by Subject|9|||
25146974|NCT01940887|50260795|FG000|Year 1|Lost to Follow-up|2|||
25146975|NCT01940887|50260796|FG001|Year 1|Lost to Follow-up|1|||
25146976|NCT01940887|50260795|FG000|Year 2|Physician Decision|8|||
25146977|NCT01940887|50260796|FG001|Year 2|Physician Decision|1|||
25146978|NCT01940887|50260795|FG000|Year 2|Death|0|||
25146979|NCT01940887|50260796|FG001|Year 2|Death|2|||
25146980|NCT01940887|50260795|FG000|Year 2|Sponsor Decision, early termination|192|||
25146981|NCT01940887|50260796|FG001|Year 2|Sponsor Decision, early termination|203|||
25146982|NCT01940887|50260795|FG000|Year 2|Adverse Event|8|||
25146983|NCT01940887|50260796|FG001|Year 2|Adverse Event|2|||
25146984|NCT01940887|50260795|FG000|Year 2|Withdrawal by Subject|8|||
25146985|NCT01940887|50260796|FG001|Year 2|Withdrawal by Subject|8|||
25146986|NCT01940887|50260795|FG000|Year 2|Lost to Follow-up|1|||
25146987|NCT01940887|50260796|FG001|Year 2|Lost to Follow-up|6|||
25146988|NCT01925612|50260807|FG000|Overall Study|Progressive Disease|1|||
25146989|NCT01925612|50260808|FG001|Overall Study|Progressive Disease|1|||
25146990|NCT01925612|50260809|FG002|Overall Study|Progressive Disease|1|||
25146991|NCT01925612|50260810|FG003|Overall Study|Progressive Disease|0|||
25146992|NCT01925612|50260811|FG004|Overall Study|Progressive Disease|0|||
25146993|NCT01925612|50260807|FG000|Overall Study|Adverse Event|3|||
25146994|NCT01925612|50260808|FG001|Overall Study|Adverse Event|3|||
25146995|NCT01925612|50260809|FG002|Overall Study|Adverse Event|0|||
25146996|NCT01925612|50260810|FG003|Overall Study|Adverse Event|1|||
25146997|NCT01925612|50260811|FG004|Overall Study|Adverse Event|2|||
25146998|NCT02093663|50260823|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
25146999|NCT02093663|50260824|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
25147000|NCT02093663|50260825|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
25147001|NCT02093663|50260826|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
25147002|NCT02093663|50260827|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
25147003|NCT02093663|50260823|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
25147004|NCT02093663|50260824|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
25184236|NCT01524224|50332875|FG000|Overall Study|Sponsor Decision|0|||
25184237|NCT01524224|50332876|FG001|Overall Study|Sponsor Decision|0|||
25184238|NCT01524224|50332877|FG002|Overall Study|Sponsor Decision|0|||
25184239|NCT01524224|50332878|FG003|Overall Study|Sponsor Decision|0|||
25184240|NCT01524224|50332879|FG004|Overall Study|Sponsor Decision|1|||
25184241|NCT01524224|50332880|FG005|Overall Study|Sponsor Decision|0|||
25184242|NCT01524224|50332881|FG006|Overall Study|Sponsor Decision|0|||
25184243|NCT01524224|50332882|FG007|Overall Study|Sponsor Decision|0|||
25184244|NCT00219349|50332900|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
25184245|NCT00219349|50332900|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
25184246|NCT00219349|50332900|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
25184247|NCT00219349|50332900|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
25184248|NCT01523756|50332904|FG000|Baseline Period|Adverse Event|0|||
25184249|NCT01523756|50332905|FG001|Baseline Period|Adverse Event|1|||
25184250|NCT01523756|50332904|FG000|Test Period 1|Adverse Event|1|||
25184251|NCT01523756|50332905|FG001|Test Period 1|Adverse Event|0|||
25184252|NCT01523756|50332904|FG000|Test Period 2|Withdrawal by Subject|0|||
25184253|NCT01523756|50332905|FG001|Test Period 2|Withdrawal by Subject|1|||
25184254|NCT00218257|50332913|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
25184255|NCT00218257|50332914|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
25184256|NCT01523366|50332925|FG000|Treatment Period 1|Withdrawal by Subject|1|||
25184257|NCT01523366|50332926|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25184258|NCT01523366|50332925|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
25184259|NCT01523366|50332926|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
25184260|NCT01427933|50332936|FG000|Overall Study|Withdrawal by Subject|5|||
25184261|NCT01427933|50332937|FG001|Overall Study|Withdrawal by Subject|8|||
25184262|NCT01427933|50332936|FG000|Overall Study|Lost to Follow-up|1|||
25184263|NCT01427933|50332937|FG001|Overall Study|Lost to Follow-up|5|||
25184264|NCT01427933|50332936|FG000|Overall Study|Other|1|||
25184265|NCT01427933|50332937|FG001|Overall Study|Other|0|||
25184266|NCT01427933|50332936|FG000|Overall Study|Investigator's Decision|1|||
25184267|NCT01427933|50332937|FG001|Overall Study|Investigator's Decision|0|||
25184268|NCT00217087|50332946|FG000|Overall Study|decided to have esophagectomy|1|||
25184269|NCT00217087|50332947|FG001|Overall Study|decided to have esophagectomy|2|||
25184270|NCT00217087|50332946|FG000|Overall Study|completed less than 12 months return|10|||
25184271|NCT00217087|50332947|FG001|Overall Study|completed less than 12 months return|18|||
25147005|NCT02093663|50260825|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
25147006|NCT02093663|50260826|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
25147007|NCT02093663|50260827|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
25147008|NCT02093663|50260823|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
25184272|NCT01406873|50332961|FG000|Overall Study|Withdrawal by Subject|1|||
25184273|NCT01406873|50332962|FG001|Overall Study|Withdrawal by Subject|1|||
25184274|NCT01406795|50332978|FG000|Overall Study|Withdrawal by Subject|1|||
25147009|NCT02093663|50260824|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
25147010|NCT02093663|50260825|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
25147011|NCT02093663|50260826|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
25147012|NCT02093663|50260827|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
25147013|NCT02093663|50260823|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
25147014|NCT02093663|50260824|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
25147015|NCT02093663|50260825|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
25184275|NCT01406717|50332984|FG000|Overall Study|Subject non-compliance|4|||
25184276|NCT01406717|50332985|FG001|Overall Study|Subject non-compliance|3|||
25184277|NCT01406717|50332984|FG000|Overall Study|Protocol Violation|5|||
25184278|NCT01406717|50332985|FG001|Overall Study|Protocol Violation|1|||
25184279|NCT01406717|50332984|FG000|Overall Study|Lost to Follow-up|14|||
25184280|NCT01406717|50332985|FG001|Overall Study|Lost to Follow-up|8|||
25184281|NCT01406717|50332984|FG000|Overall Study|Withdrawal by Subject|19|||
25184282|NCT01406717|50332985|FG001|Overall Study|Withdrawal by Subject|15|||
25184283|NCT01406717|50332984|FG000|Overall Study|Adverse Event|1|||
25184284|NCT01406717|50332985|FG001|Overall Study|Adverse Event|2|||
25184285|NCT01406717|50332984|FG000|Overall Study|Lack of Efficacy|0|||
25184286|NCT01406717|50332985|FG001|Overall Study|Lack of Efficacy|1|||
25184287|NCT01406717|50332984|FG000|Overall Study|Non-completion of visit activity|0|||
25184288|NCT01406717|50332985|FG001|Overall Study|Non-completion of visit activity|1|||
25184289|NCT01406015|50333003|FG000|Overall Study|Withdrawal by Subject|3|||
25184290|NCT01406015|50333004|FG001|Overall Study|Withdrawal by Subject|3|||
25184291|NCT00215683|50333013|FG000|Overall Study|Adverse Event|15|||
25184292|NCT00215683|50333014|FG001|Overall Study|Adverse Event|16|||
25184293|NCT00215683|50333015|FG002|Overall Study|Adverse Event|15|||
25184294|NCT00215683|50333013|FG000|Overall Study|Lack of Efficacy|5|||
25184295|NCT00215683|50333014|FG001|Overall Study|Lack of Efficacy|1|||
25184296|NCT00215683|50333015|FG002|Overall Study|Lack of Efficacy|2|||
25184297|NCT00215683|50333013|FG000|Overall Study|Lost to Follow-up|0|||
25184298|NCT00215683|50333014|FG001|Overall Study|Lost to Follow-up|2|||
25184299|NCT00215683|50333015|FG002|Overall Study|Lost to Follow-up|1|||
25184300|NCT00215683|50333013|FG000|Overall Study|Withdrawal by Subject|9|||
25184301|NCT00215683|50333014|FG001|Overall Study|Withdrawal by Subject|4|||
25184302|NCT00215683|50333015|FG002|Overall Study|Withdrawal by Subject|13|||
25184303|NCT00215683|50333013|FG000|Overall Study|Physician Decision|0|||
25184304|NCT00215683|50333014|FG001|Overall Study|Physician Decision|0|||
25184305|NCT00215683|50333015|FG002|Overall Study|Physician Decision|1|||
25184306|NCT00215683|50333013|FG000|Overall Study|Difficult to attend visits|0|||
25184307|NCT00215683|50333014|FG001|Overall Study|Difficult to attend visits|1|||
25184308|NCT00215683|50333015|FG002|Overall Study|Difficult to attend visits|0|||
25184309|NCT00215683|50333013|FG000|Overall Study|No study drug available|0|||
25184310|NCT00215683|50333014|FG001|Overall Study|No study drug available|1|||
25184311|NCT00215683|50333015|FG002|Overall Study|No study drug available|0|||
25184312|NCT00215683|50333013|FG000|Overall Study|Intermittent therapy required|0|||
25184313|NCT00215683|50333014|FG001|Overall Study|Intermittent therapy required|1|||
25184314|NCT00215683|50333015|FG002|Overall Study|Intermittent therapy required|0|||
25184315|NCT00215137|50333023|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
25184316|NCT00215137|50333024|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
25184317|NCT00215137|50333025|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
25184318|NCT00215137|50333023|FG000|Randomization Period|Lost to Follow-up|0|||
25184319|NCT00215137|50333024|FG001|Randomization Period|Lost to Follow-up|1|||
25184320|NCT00215137|50333025|FG002|Randomization Period|Lost to Follow-up|0|||
25184321|NCT00215137|50333023|FG000|Randomization Period|Withdrawal by Subject|0|||
25184322|NCT00215137|50333024|FG001|Randomization Period|Withdrawal by Subject|1|||
25184323|NCT00215137|50333025|FG002|Randomization Period|Withdrawal by Subject|0|||
25147016|NCT02093663|50260826|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
25147017|NCT02093663|50260827|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
25147018|NCT02093663|50260823|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
25147019|NCT02093663|50260824|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
25147020|NCT02093663|50260825|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
25147021|NCT02093663|50260826|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
25147022|NCT02093663|50260827|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
25184324|NCT00214201|50333035|FG000|Overall Study|Withdrawal by Subject|2|||
25184325|NCT00214201|50333036|FG001|Overall Study|Withdrawal by Subject|0|||
25184326|NCT00214201|50333035|FG000|Overall Study|Death|0|||
25184327|NCT00214201|50333036|FG001|Overall Study|Death|2|||
25184328|NCT01486784|50333049|FG000|Overall Study|Withdrawal by Subject|0|||
25184329|NCT01486784|50333050|FG001|Overall Study|Withdrawal by Subject|0|||
25184330|NCT01486784|50333051|FG002|Overall Study|Withdrawal by Subject|1|||
25184331|NCT01486784|50333052|FG003|Overall Study|Withdrawal by Subject|0|||
25184332|NCT01486784|50333053|FG004|Overall Study|Withdrawal by Subject|1|||
25147023|NCT02093663|50260823|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
25184333|NCT01486784|50333054|FG005|Overall Study|Withdrawal by Subject|2|||
25184334|NCT01486784|50333049|FG000|Overall Study|Subject did not meet entry criteria|0|||
25184335|NCT01486784|50333050|FG001|Overall Study|Subject did not meet entry criteria|0|||
25184336|NCT01486784|50333051|FG002|Overall Study|Subject did not meet entry criteria|0|||
25184337|NCT01486784|50333052|FG003|Overall Study|Subject did not meet entry criteria|0|||
25184338|NCT01486784|50333053|FG004|Overall Study|Subject did not meet entry criteria|1|||
25184339|NCT01486784|50333054|FG005|Overall Study|Subject did not meet entry criteria|0|||
25184340|NCT01486784|50333049|FG000|Overall Study|Death|0|||
25184341|NCT01486784|50333050|FG001|Overall Study|Death|0|||
25184342|NCT01486784|50333051|FG002|Overall Study|Death|0|||
25184343|NCT01486784|50333052|FG003|Overall Study|Death|0|||
25184344|NCT01486784|50333053|FG004|Overall Study|Death|0|||
25184345|NCT01486784|50333054|FG005|Overall Study|Death|1|||
25184346|NCT01521884|50333068|FG000|Overall Study|Non Responders|10|||
25184347|NCT01521884|50333068|FG000|Overall Study|Adverse Event|5|||
25184348|NCT01521884|50333068|FG000|Overall Study|Pregnancy|1|||
25184349|NCT01521884|50333068|FG000|Overall Study|Withdrawal by Subject|1|||
25184350|NCT01521884|50333068|FG000|Overall Study|Physician Decision|2|||
25184351|NCT01521884|50333068|FG000|Overall Study|Protocol Violation|3|||
25184352|NCT01521884|50333068|FG000|Overall Study|Participant non-eligible|1|||
25184353|NCT01521884|50333068|FG000|Overall Study|Lost to Follow-up|4|||
25184354|NCT01677858|50333077|FG000|Overall Study|Adverse Event|0|||
25184355|NCT01677858|50333078|FG001|Overall Study|Adverse Event|0|||
25184356|NCT01677858|50333079|FG002|Overall Study|Adverse Event|2|||
25184357|NCT01677858|50333080|FG003|Overall Study|Adverse Event|3|||
25184358|NCT01677858|50333081|FG004|Overall Study|Adverse Event|13|||
25184359|NCT01677858|50333077|FG000|Overall Study|Death|0|||
25184360|NCT01677858|50333078|FG001|Overall Study|Death|0|||
25184361|NCT01677858|50333079|FG002|Overall Study|Death|0|||
25184362|NCT01677858|50333080|FG003|Overall Study|Death|0|||
25184363|NCT01677858|50333081|FG004|Overall Study|Death|1|||
25184364|NCT01677858|50333077|FG000|Overall Study|Physician Decision|1|||
25184365|NCT01677858|50333078|FG001|Overall Study|Physician Decision|0|||
25184366|NCT01677858|50333079|FG002|Overall Study|Physician Decision|2|||
25184367|NCT01677858|50333080|FG003|Overall Study|Physician Decision|0|||
25184368|NCT01677858|50333081|FG004|Overall Study|Physician Decision|12|||
25184369|NCT01677858|50333077|FG000|Overall Study|Progressive Disease|2|||
25184370|NCT01677858|50333078|FG001|Overall Study|Progressive Disease|1|||
25184371|NCT01677858|50333079|FG002|Overall Study|Progressive Disease|9|||
25184372|NCT01677858|50333080|FG003|Overall Study|Progressive Disease|3|||
25184373|NCT01677858|50333081|FG004|Overall Study|Progressive Disease|43|||
25184374|NCT01677858|50333077|FG000|Overall Study|Withdrawal by Subject|0|||
25184375|NCT01677858|50333078|FG001|Overall Study|Withdrawal by Subject|1|||
25184376|NCT01677858|50333079|FG002|Overall Study|Withdrawal by Subject|1|||
25184377|NCT01677858|50333080|FG003|Overall Study|Withdrawal by Subject|0|||
25184378|NCT01677858|50333081|FG004|Overall Study|Withdrawal by Subject|15|||
25184379|NCT01677858|50333077|FG000|Overall Study|Lost to Follow-up|0|||
25184380|NCT01677858|50333078|FG001|Overall Study|Lost to Follow-up|0|||
25184381|NCT01677858|50333079|FG002|Overall Study|Lost to Follow-up|0|||
25184382|NCT01677858|50333080|FG003|Overall Study|Lost to Follow-up|0|||
25184383|NCT01677858|50333081|FG004|Overall Study|Lost to Follow-up|1|||
25184384|NCT01486316|50333101|FG000|Overall Study|Device explanted with/without re-implant|3|||
25184385|NCT01486316|50333102|FG001|Overall Study|Device explanted with/without re-implant|2|||
25184386|NCT01486316|50333103|FG002|Overall Study|Device explanted with/without re-implant|0|||
25184387|NCT01486316|50333104|FG003|Overall Study|Device explanted with/without re-implant|2|||
25184388|NCT01486316|50333101|FG000|Overall Study|Not meeting eligibility criteria|0|||
25184389|NCT01486316|50333102|FG001|Overall Study|Not meeting eligibility criteria|0|||
25184390|NCT01486316|50333103|FG002|Overall Study|Not meeting eligibility criteria|1|||
25184391|NCT01486316|50333104|FG003|Overall Study|Not meeting eligibility criteria|0|||
25184392|NCT01486316|50333101|FG000|Overall Study|Withdrawal by Subject|1|||
25184393|NCT01486316|50333102|FG001|Overall Study|Withdrawal by Subject|0|||
25184394|NCT01486316|50333103|FG002|Overall Study|Withdrawal by Subject|3|||
25184395|NCT01486316|50333104|FG003|Overall Study|Withdrawal by Subject|0|||
25184396|NCT01486316|50333101|FG000|Overall Study|Physician Decision|0|||
25184397|NCT01486316|50333102|FG001|Overall Study|Physician Decision|0|||
25184398|NCT01486316|50333103|FG002|Overall Study|Physician Decision|1|||
25184399|NCT01486316|50333104|FG003|Overall Study|Physician Decision|0|||
25184400|NCT01486316|50333101|FG000|Overall Study|Death|0|||
25184401|NCT01486316|50333102|FG001|Overall Study|Death|1|||
25184402|NCT01486316|50333103|FG002|Overall Study|Death|0|||
25184403|NCT01486316|50333104|FG003|Overall Study|Death|0|||
25184404|NCT01486238|50333115|FG000|Overall Study|Death|0|||
25184405|NCT01486238|50333116|FG001|Overall Study|Death|2|||
25184406|NCT01486238|50333115|FG000|Overall Study|Withdrawal by Subject|2|||
25184407|NCT01486238|50333116|FG001|Overall Study|Withdrawal by Subject|1|||
25184408|NCT01486238|50333115|FG000|Overall Study|Lost to Follow-up|0|||
25184409|NCT01486238|50333116|FG001|Overall Study|Lost to Follow-up|3|||
25184410|NCT01602744|50333124|FG000|Overall Study|Death|17|||
25184411|NCT01602744|50333125|FG001|Overall Study|Death|15|||
25184412|NCT01602744|50333124|FG000|Overall Study|Lost to Follow-up|13|||
25184413|NCT01602744|50333125|FG001|Overall Study|Lost to Follow-up|8|||
25184414|NCT03598777|50333136|FG000|Overall Study|Study Terminated by Sponsor|3|||
25184415|NCT03598777|50333137|FG001|Overall Study|Study Terminated by Sponsor|0|||
25184416|NCT03598777|50333138|FG002|Overall Study|Study Terminated by Sponsor|0|||
25184417|NCT03598777|50333139|FG003|Overall Study|Study Terminated by Sponsor|0|||
25184418|NCT03598777|50333140|FG004|Overall Study|Study Terminated by Sponsor|15|||
25184419|NCT03598777|50333136|FG000|Overall Study|Withdrawal by Subject|1|||
25184420|NCT03598777|50333137|FG001|Overall Study|Withdrawal by Subject|1|||
25184421|NCT03598777|50333138|FG002|Overall Study|Withdrawal by Subject|0|||
25184422|NCT03598777|50333139|FG003|Overall Study|Withdrawal by Subject|0|||
25184423|NCT03598777|50333140|FG004|Overall Study|Withdrawal by Subject|0|||
25184424|NCT03598777|50333136|FG000|Overall Study|Adverse Event|1|||
25184425|NCT03598777|50333137|FG001|Overall Study|Adverse Event|0|||
25184426|NCT03598777|50333138|FG002|Overall Study|Adverse Event|0|||
25184427|NCT03598777|50333139|FG003|Overall Study|Adverse Event|0|||
25184428|NCT03598777|50333140|FG004|Overall Study|Adverse Event|0|||
25184429|NCT03598777|50333136|FG000|Overall Study|Lost to Follow-up|1|||
25184430|NCT03598777|50333137|FG001|Overall Study|Lost to Follow-up|0|||
25184431|NCT03598777|50333138|FG002|Overall Study|Lost to Follow-up|0|||
25184432|NCT03598777|50333139|FG003|Overall Study|Lost to Follow-up|0|||
25184433|NCT03598777|50333140|FG004|Overall Study|Lost to Follow-up|0|||
25184434|NCT03594955|50333155|FG000|Overall Study|Adverse Event|1|||
25184435|NCT03594955|50333155|FG000|Overall Study|Progressive disease|5|||
25184436|NCT03594955|50333155|FG000|Overall Study|Sponsor's decision|1|||
25184437|NCT01677624|50333183|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
25184438|NCT01272219|50333204|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
25184439|NCT01272219|50333205|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
25184440|NCT01272219|50333206|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
25184441|NCT01272219|50333207|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
25184442|NCT01272219|50333208|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
25184443|NCT01272219|50333209|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
25184444|NCT01272219|50333204|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
25184445|NCT01272219|50333205|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
25184446|NCT01272219|50333206|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
25184447|NCT01272219|50333207|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
25184448|NCT01272219|50333208|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
25184449|NCT01272219|50333209|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
25184450|NCT01272219|50333204|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
25184451|NCT01272219|50333205|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
25184452|NCT01272219|50333206|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
25184453|NCT01272219|50333207|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
25184454|NCT01272219|50333208|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
25184455|NCT01272219|50333209|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
25184456|NCT01272219|50333204|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
25184457|NCT01272219|50333205|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
25184458|NCT01272219|50333206|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
25184459|NCT01272219|50333207|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
25184460|NCT01272219|50333208|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
25184461|NCT01272219|50333209|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
25184462|NCT01272219|50333204|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
25184463|NCT01272219|50333205|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
25184464|NCT01272219|50333206|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
25184465|NCT01272219|50333207|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
25184466|NCT01272219|50333208|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
25184467|NCT01272219|50333209|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
25184468|NCT01272219|50333204|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
25184469|NCT01272219|50333205|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
25184470|NCT01272219|50333206|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
25184471|NCT01272219|50333207|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
25184472|NCT01272219|50333208|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
25184473|NCT01272219|50333209|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
25184474|NCT01272219|50333204|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
25184475|NCT01272219|50333205|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
25184476|NCT01272219|50333206|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
25184477|NCT01272219|50333207|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
25274591|NCT02716675|50588609|FG002|Overall Study|Lost to Follow-up|99|||
25274592|NCT02716675|50588607|FG000|Overall Study|Withdrawal by Subject|22|||
25147024|NCT02093663|50260824|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
25147025|NCT02093663|50260825|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
25147026|NCT02093663|50260826|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
25147027|NCT02093663|50260827|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
25147028|NCT02093663|50260823|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
25147029|NCT02093663|50260824|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
25147030|NCT02093663|50260825|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
25274593|NCT02716675|50588608|FG001|Overall Study|Withdrawal by Subject|25|||
25184478|NCT01272219|50333208|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
25147031|NCT02093663|50260826|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
25147032|NCT02093663|50260827|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
25147033|NCT02093663|50260823|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
25147034|NCT02093663|50260824|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
25147035|NCT02093663|50260825|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
25147036|NCT02093663|50260826|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
25147037|NCT02093663|50260827|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
25147038|NCT02093663|50260823|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
25147039|NCT02093663|50260824|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
25147040|NCT02093663|50260825|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
25147041|NCT02093663|50260826|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
25147042|NCT02093663|50260827|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
25147043|NCT01408888|50260844|FG000|First Intervention|Adverse Event|0|||
25147044|NCT01408888|50260845|FG001|First Intervention|Adverse Event|1|||
25147045|NCT01408888|50260844|FG000|First Intervention|Withdrawal by Subject|0|||
25147046|NCT01408888|50260845|FG001|First Intervention|Withdrawal by Subject|2|||
25147047|NCT01408888|50260844|FG000|Second Intervention|Withdrawal by Subject|1|||
25147048|NCT01408888|50260845|FG001|Second Intervention|Withdrawal by Subject|0|||
25147049|NCT01408888|50260844|FG000|Second Intervention|Adverse Event|1|||
25147050|NCT01408888|50260845|FG001|Second Intervention|Adverse Event|0|||
25147051|NCT01918033|50260864|FG000|Overall Study|Adverse Event|1|||
25147052|NCT01918033|50260865|FG001|Overall Study|Adverse Event|0|||
25147053|NCT01918033|50260866|FG002|Overall Study|Adverse Event|2|||
25147054|NCT01918033|50260864|FG000|Overall Study|Lost to Follow-up|0|||
25147055|NCT01918033|50260865|FG001|Overall Study|Lost to Follow-up|1|||
25147056|NCT01918033|50260866|FG002|Overall Study|Lost to Follow-up|0|||
25147057|NCT01918033|50260864|FG000|Overall Study|Protocol Violation|2|||
25147058|NCT01918033|50260865|FG001|Overall Study|Protocol Violation|0|||
25147059|NCT01918033|50260866|FG002|Overall Study|Protocol Violation|1|||
25147060|NCT01918033|50260864|FG000|Overall Study|Withdrawal by Subject|2|||
25147061|NCT01918033|50260865|FG001|Overall Study|Withdrawal by Subject|1|||
25147062|NCT01918033|50260866|FG002|Overall Study|Withdrawal by Subject|0|||
25147063|NCT01408732|50260874|FG000|Overall Study|Withdrawal by Subject|2|||
25147064|NCT01408732|50260875|FG001|Overall Study|Withdrawal by Subject|2|||
25274594|NCT02716675|50588609|FG002|Overall Study|Withdrawal by Subject|20|||
25147065|NCT01390402|50260881|FG000|Overall Study|Death|1|||
25147066|NCT01390402|50260881|FG000|Overall Study|Disease Progression|4|||
25147067|NCT01976299|50260887|FG000|Overall Study|Withdrawal by Subject|3|||
25147068|NCT01976299|50260888|FG001|Overall Study|Withdrawal by Subject|1|||
25147069|NCT01976299|50260887|FG000|Overall Study|Death|4|||
25147070|NCT01976299|50260888|FG001|Overall Study|Death|2|||
25147071|NCT01976299|50260887|FG000|Overall Study|Lost to Follow-up|7|||
25147072|NCT01976299|50260888|FG001|Overall Study|Lost to Follow-up|1|||
25147073|NCT01976299|50260887|FG000|Overall Study|See clarification above in comments|9|||
25147074|NCT01976299|50260888|FG001|Overall Study|See clarification above in comments|2|||
25147075|NCT01428076|50260896|FG000|Overall Study|Adverse Event|0|||
25147076|NCT01428076|50260897|FG001|Overall Study|Adverse Event|1|||
25147077|NCT01900652|50260907|FG000|Overall Study|Progressive Disease|1|||
25147078|NCT01900652|50260908|FG001|Overall Study|Progressive Disease|0|||
25147079|NCT01900652|50260907|FG000|Overall Study|Consent withdrawn by subject|1|||
25147080|NCT01900652|50260908|FG001|Overall Study|Consent withdrawn by subject|1|||
25147081|NCT01900652|50260907|FG000|Overall Study|Death|3|||
25147082|NCT01900652|50260908|FG001|Overall Study|Death|0|||
25147083|NCT01900652|50260907|FG000|Overall Study|Adverse Event|2|||
25147084|NCT01900652|50260908|FG001|Overall Study|Adverse Event|1|||
25147085|NCT01900652|50260907|FG000|Overall Study|Physician Decision|1|||
25147086|NCT01900652|50260908|FG001|Overall Study|Physician Decision|1|||
25147087|NCT02093351|50260922|FG000|Part A|Adverse Event|0|||
25147088|NCT02093351|50260923|FG001|Part A|Adverse Event|1|||
25147089|NCT02093351|50260924|FG002|Part A|Adverse Event|1|||
25147090|NCT02093351|50260925|FG003|Part A|Adverse Event|0|||
25147091|NCT02093351|50260922|FG000|Part A|Condition under investigation worsened|2|||
25147092|NCT02093351|50260923|FG001|Part A|Condition under investigation worsened|0|||
25147093|NCT02093351|50260924|FG002|Part A|Condition under investigation worsened|2|||
25147094|NCT02093351|50260925|FG003|Part A|Condition under investigation worsened|0|||
25147095|NCT02093351|50260922|FG000|Part A|Death|0|||
25147096|NCT02093351|50260923|FG001|Part A|Death|1|||
25147097|NCT02093351|50260924|FG002|Part A|Death|0|||
25147098|NCT02093351|50260925|FG003|Part A|Death|0|||
25147099|NCT02093351|50260922|FG000|Part B|Patient decision|0|||
25147100|NCT02093351|50260923|FG001|Part B|Patient decision|0|||
25147101|NCT02093351|50260924|FG002|Part B|Patient decision|0|||
25147102|NCT02093351|50260925|FG003|Part B|Patient decision|3|||
25147103|NCT02093351|50260922|FG000|Part B|Disease progression|0|||
25147104|NCT02093351|50260923|FG001|Part B|Disease progression|0|||
25147105|NCT02093351|50260924|FG002|Part B|Disease progression|0|||
25147106|NCT02093351|50260925|FG003|Part B|Disease progression|4|||
25147107|NCT02093351|50260922|FG000|Part B|Complete response|0|||
25147108|NCT02093351|50260923|FG001|Part B|Complete response|0|||
25147109|NCT02093351|50260924|FG002|Part B|Complete response|0|||
25147110|NCT02093351|50260925|FG003|Part B|Complete response|1|||
25184479|NCT01272219|50333209|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
25184480|NCT01272219|50333204|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
25184481|NCT01272219|50333205|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
25184482|NCT01272219|50333206|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
25184483|NCT01272219|50333207|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
25184484|NCT01272219|50333208|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
25147111|NCT02093351|50260922|FG000|Part B|Adverse event + disease progression|0|||
25147112|NCT02093351|50260923|FG001|Part B|Adverse event + disease progression|0|||
25147113|NCT02093351|50260924|FG002|Part B|Adverse event + disease progression|0|||
25147114|NCT02093351|50260925|FG003|Part B|Adverse event + disease progression|1|||
25147115|NCT02093351|50260922|FG000|Part B|Lack of therapeutic response|0|||
25184485|NCT01272219|50333209|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
25184486|NCT01272219|50333204|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
25274595|NCT02716675|50588607|FG000|Overall Study|Protocol Violation|0|||
25147116|NCT02093351|50260923|FG001|Part B|Lack of therapeutic response|0|||
25147117|NCT02093351|50260924|FG002|Part B|Lack of therapeutic response|0|||
25147118|NCT02093351|50260925|FG003|Part B|Lack of therapeutic response|12|||
25147119|NCT02093351|50260922|FG000|Part B|Condition under investigation worsened|0|||
25147120|NCT02093351|50260923|FG001|Part B|Condition under investigation worsened|0|||
25147121|NCT02093351|50260924|FG002|Part B|Condition under investigation worsened|0|||
25147122|NCT02093351|50260925|FG003|Part B|Condition under investigation worsened|39|||
25147123|NCT02093351|50260922|FG000|Part B|Adverse Event|0|||
25147124|NCT02093351|50260923|FG001|Part B|Adverse Event|0|||
25147125|NCT02093351|50260924|FG002|Part B|Adverse Event|0|||
25147126|NCT02093351|50260925|FG003|Part B|Adverse Event|2|||
25147127|NCT02093351|50260922|FG000|Part B|Death|0|||
25184487|NCT01272219|50333205|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
25147128|NCT02093351|50260923|FG001|Part B|Death|0|||
25147129|NCT02093351|50260924|FG002|Part B|Death|0|||
25147130|NCT02093351|50260925|FG003|Part B|Death|1|||
25147131|NCT02092961|50260964|FG000|Overall Study|Not reported|1|||
25147132|NCT02092961|50260965|FG001|Overall Study|Not reported|0|||
25147133|NCT02092961|50260966|FG002|Overall Study|Not reported|1|||
25147134|NCT02092961|50260964|FG000|Overall Study|Study stopped|13|||
25147135|NCT02092961|50260965|FG001|Overall Study|Study stopped|9|||
25147136|NCT02092961|50260966|FG002|Overall Study|Study stopped|12|||
25147137|NCT02092961|50260964|FG000|Overall Study|Lack of therapeutic response|2|||
25147138|NCT02092961|50260965|FG001|Overall Study|Lack of therapeutic response|1|||
25184488|NCT01272219|50333206|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
25147139|NCT02092961|50260966|FG002|Overall Study|Lack of therapeutic response|3|||
25147140|NCT02092961|50260964|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
25147141|NCT02092961|50260965|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
25016146|NCT03820323|50111012|FG001|Overall Study|Withdrawal by Subject|6|||
25016147|NCT03287622|50111027|FG000|Overall Study|Withdrawal by Subject|1|||
25016148|NCT03287622|50111028|FG001|Overall Study|Withdrawal by Subject|0|||
25016149|NCT03287622|50111027|FG000|Overall Study|Lost to Follow-up|27|||
25016150|NCT03287622|50111028|FG001|Overall Study|Lost to Follow-up|15|||
25016151|NCT03287622|50111027|FG000|Overall Study|No prescripion after surgery|28|||
25016152|NCT03287622|50111028|FG001|Overall Study|No prescripion after surgery|31|||
25016153|NCT03287622|50111027|FG000|Overall Study|prolonged Length of stay|2|||
25016154|NCT03287622|50111028|FG001|Overall Study|prolonged Length of stay|0|||
25016155|NCT03287622|50111027|FG000|Overall Study|surgery related|0|||
25016156|NCT03287622|50111028|FG001|Overall Study|surgery related|2|||
25016157|NCT04063657|50111043|FG000|Overall Study|Lost to Follow-up|1|||
25016158|NCT04063657|50111044|FG001|Overall Study|Lost to Follow-up|0|||
25016159|NCT04058353|50111061|FG000|Overall Study|Adverse Event|2|||
25147142|NCT02092961|50260966|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
25147143|NCT02092961|50260964|FG000|Overall Study|Adverse Event|2|||
25147144|NCT02092961|50260965|FG001|Overall Study|Adverse Event|4|||
25147145|NCT02092961|50260966|FG002|Overall Study|Adverse Event|0|||
25147146|NCT01898078|50260977|FG000|Overall Study|Progressive Disease|1|||
25147147|NCT01898078|50260978|FG001|Overall Study|Progressive Disease|5|||
25147148|NCT01898078|50260977|FG000|Overall Study|Adverse Event|2|||
25147149|NCT01898078|50260978|FG001|Overall Study|Adverse Event|1|||
25147150|NCT01898078|50260977|FG000|Overall Study|Withdrawal by Subject|1|||
25147151|NCT01898078|50260978|FG001|Overall Study|Withdrawal by Subject|1|||
25147152|NCT01898078|50260977|FG000|Overall Study|Symptomatic Deterioration|2|||
25147153|NCT01898078|50260978|FG001|Overall Study|Symptomatic Deterioration|0|||
25147154|NCT01898078|50260977|FG000|Overall Study|Reason not Specified|0|||
25147155|NCT01898078|50260978|FG001|Overall Study|Reason not Specified|1|||
25147156|NCT01987817|50260988|FG000|Overall Study|Adverse Event|4|||
25016160|NCT04058353|50111062|FG001|Overall Study|Adverse Event|1|||
25016161|NCT04058353|50111061|FG000|Overall Study|Physician Decision|1|||
25016162|NCT04058353|50111062|FG001|Overall Study|Physician Decision|0|||
25016163|NCT04058353|50111061|FG000|Overall Study|Other|1|||
25016164|NCT04058353|50111062|FG001|Overall Study|Other|0|||
25016165|NCT03226353|50111069|FG000|Overall Study|Withdrawal by Subject|1|||
25016166|NCT03226353|50111069|FG000|Overall Study|Screen Failure|5|||
25016167|NCT02730598|50111078|FG000|Overall Study|Withdrawal by Subject|3|||
25016168|NCT02730598|50111079|FG001|Overall Study|Withdrawal by Subject|3|||
25016169|NCT02730598|50111078|FG000|Overall Study|Protocol Violation|0|||
25016170|NCT02730598|50111079|FG001|Overall Study|Protocol Violation|1|||
25016171|NCT02730598|50111078|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
25147157|NCT01987817|50260989|FG001|Overall Study|Adverse Event|0|||
25147158|NCT01987817|50260988|FG000|Overall Study|Withdrawal by Subject|1|||
25147159|NCT01987817|50260989|FG001|Overall Study|Withdrawal by Subject|1|||
25147160|NCT01987817|50260988|FG000|Overall Study|Physician Decision|1|||
25147161|NCT01987817|50260989|FG001|Overall Study|Physician Decision|0|||
25147162|NCT01940497|50260998|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
25184489|NCT01272219|50333207|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
25184490|NCT01272219|50333208|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
25016172|NCT02730598|50111079|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
25016173|NCT03226275|50111089|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
25016174|NCT03226275|50111090|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
25016175|NCT03226275|50111091|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
25016176|NCT03226275|50111092|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
25147163|NCT01940497|50260999|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
25147164|NCT01940497|50260998|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
25147165|NCT01940497|50260999|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
25147166|NCT01940497|50260998|FG000|Overall Study|Violation of Entry Criteria|1|||
25147167|NCT01940497|50260999|FG001|Overall Study|Violation of Entry Criteria|1|||
25147168|NCT01940497|50260998|FG000|Overall Study|Refused Treatment|1|||
25147169|NCT01940497|50260999|FG001|Overall Study|Refused Treatment|3|||
25147170|NCT01940497|50260998|FG000|Overall Study|Withdrew Consent|6|||
25147171|NCT01940497|50260999|FG001|Overall Study|Withdrew Consent|2|||
25147172|NCT01940497|50260998|FG000|Overall Study|Administrative/Other|1|||
25147173|NCT01940497|50260999|FG001|Overall Study|Administrative/Other|1|||
25147174|NCT01924754|50261019|FG000|Overall Study|Lost to Follow-up|1|||
25147175|NCT01924754|50261020|FG001|Overall Study|Lost to Follow-up|2|||
25147176|NCT01924754|50261021|FG002|Overall Study|Lost to Follow-up|1|||
25147177|NCT01924754|50261019|FG000|Overall Study|Pregnancy|0|||
25147178|NCT01924754|50261020|FG001|Overall Study|Pregnancy|1|||
25147179|NCT01924754|50261021|FG002|Overall Study|Pregnancy|2|||
25147180|NCT01924364|50261032|FG000|Overall Study|Physician Decision|3|||
25147181|NCT01987505|50261049|FG000|Overall Study|Other|9|||
25147182|NCT01987505|50261049|FG000|Overall Study|Withdrawal by Subject|2|||
25147183|NCT01987505|50261049|FG000|Overall Study|Other Reason|2|||
25147184|NCT01987505|50261049|FG000|Overall Study|Lost to Follow-up|15|||
25147185|NCT01987505|50261049|FG000|Overall Study|Investigator Decision|2|||
25147186|NCT01987505|50261049|FG000|Overall Study|Death|4|||
25147187|NCT01923896|50261057|FG000|Overall Study|Adverse Event|1|||
25147188|NCT01923896|50261058|FG001|Overall Study|Adverse Event|0|||
25147189|NCT02004353|50261064|FG000|Overall Study|Voluntary participation|1334|||
25147190|NCT01938625|50261070|FG000|Overall Study|Withdrawal by Subject|0|||
25147191|NCT01938625|50261071|FG001|Overall Study|Withdrawal by Subject|1|||
25147192|NCT01938625|50261070|FG000|Overall Study|Adverse Event|0|||
25147193|NCT01938625|50261071|FG001|Overall Study|Adverse Event|1|||
25147194|NCT01975675|50261081|FG000|Overall Study|Death|0|||
25147195|NCT01975675|50261082|FG001|Overall Study|Death|1|||
25147196|NCT01975675|50261083|FG002|Overall Study|Death|0|||
25147197|NCT01975675|50261084|FG003|Overall Study|Death|0|||
25147198|NCT01975285|50261096|FG000|Overall Study|Failed Block and follow up|2|||
25147199|NCT01975285|50261097|FG001|Overall Study|Failed Block and follow up|2|||
25147200|NCT01974895|50261105|FG000|Overall Study|Protocol Violation|1|||
25147201|NCT01974895|50261106|FG001|Overall Study|Protocol Violation|0|||
25147202|NCT01974895|50261105|FG000|Overall Study|Lost to Follow-up|4|||
25147203|NCT01974895|50261106|FG001|Overall Study|Lost to Follow-up|6|||
25147204|NCT01974895|50261105|FG000|Overall Study|Withdrawal by Subject|0|||
25147205|NCT01974895|50261106|FG001|Overall Study|Withdrawal by Subject|1|||
25147206|NCT01974895|50261105|FG000|Overall Study|Other (Missed Visit)|1|||
25147207|NCT01974895|50261106|FG001|Overall Study|Other (Missed Visit)|0|||
25147208|NCT01974895|50261105|FG000|Overall Study|Other (Reason unknown)|9|||
25147209|NCT01974895|50261106|FG001|Overall Study|Other (Reason unknown)|8|||
25147210|NCT01974817|50261112|FG000|Overall Study|Death|4|||
25147211|NCT01974817|50261112|FG000|Overall Study|Lost to Follow-up|2|||
25147212|NCT01974817|50261112|FG000|Overall Study|Protocol Violation|2|||
25168626|NCT00633243|50298231|FG000|Overall Study|Couldn't tolerate side-effects|1|||
25168627|NCT00633243|50298232|FG001|Overall Study|Couldn't tolerate side-effects|1|||
25168628|NCT01872689|50298242|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
25168629|NCT01872689|50298243|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
25168630|NCT01872689|50298244|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
25168631|NCT01872689|50298245|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
25168632|NCT01872689|50298242|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
25147213|NCT01915849|50261120|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
25147214|NCT01915849|50261121|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
25147215|NCT01915849|50261122|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
25147216|NCT01915849|50261123|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
25147217|NCT01915849|50261120|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
25147218|NCT01915849|50261121|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
25147219|NCT01915849|50261122|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
25147220|NCT01915849|50261123|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
25147221|NCT01915771|50261133|FG000|Day 1|Withdrawal by Subject|1|||
25147222|NCT01915771|50261133|FG000|Day 15|Withdrawal by Subject|1|||
25147223|NCT01938391|50261141|FG000|6 Month Follow up|Withdrawal by Subject|1|||
25147224|NCT01938391|50261141|FG000|12 Month Follow up|Physician Decision|1|||
25147225|NCT01938391|50261141|FG000|12 Month Follow up|Withdrawal by Subject|1|||
25147226|NCT01915303|50261145|FG000|Core Phase|Adverse Event|7|||
25147227|NCT01915303|50261145|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
25147228|NCT01915303|50261145|FG000|Core Phase|Death|2|||
25147229|NCT01915303|50261145|FG000|Core Phase|Protocol Violation|2|||
25147230|NCT01915303|50261145|FG000|Core Phase|Abnormal lab value|1|||
25147231|NCT01915303|50261145|FG000|Core Phase|Withdrawal by Subject|1|||
25147232|NCT01915303|50261145|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
25147233|NCT01915303|50261145|FG000|Extension Phase|Withdrawal by Subject|4|||
25147234|NCT01915303|50261145|FG000|Extension Phase|Adverse Event|3|||
25147235|NCT01915303|50261145|FG000|Extension Phase|Death|1|||
25147236|NCT01915303|50261145|FG000|Extension Phase|Protocol Violation|1|||
25147237|NCT01987427|50261152|FG000|Overall Study|Adverse Event|4|||
25147238|NCT01987427|50261153|FG001|Overall Study|Adverse Event|2|||
25147239|NCT01987427|50261154|FG002|Overall Study|Adverse Event|8|||
25147240|NCT01987427|50261152|FG000|Overall Study|Lost to Follow-up|6|||
25147241|NCT01987427|50261153|FG001|Overall Study|Lost to Follow-up|6|||
25147242|NCT01987427|50261154|FG002|Overall Study|Lost to Follow-up|9|||
25147243|NCT01987427|50261152|FG000|Overall Study|Withdrawal by Subject|2|||
25147244|NCT01987427|50261153|FG001|Overall Study|Withdrawal by Subject|1|||
25147245|NCT01987427|50261154|FG002|Overall Study|Withdrawal by Subject|3|||
25147246|NCT01987427|50261152|FG000|Overall Study|Lack of Efficacy|1|||
25147247|NCT01987427|50261153|FG001|Overall Study|Lack of Efficacy|0|||
25147248|NCT01987427|50261154|FG002|Overall Study|Lack of Efficacy|0|||
25147249|NCT01987427|50261152|FG000|Overall Study|Other|1|||
25184491|NCT01272219|50333209|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
25147250|NCT01987427|50261153|FG001|Overall Study|Other|1|||
25147251|NCT01987427|50261154|FG002|Overall Study|Other|0|||
25147252|NCT01937299|50261164|FG000|Overall Study|Adverse Event|13|||
25147253|NCT01937299|50261165|FG001|Overall Study|Adverse Event|0|||
25147254|NCT01937299|50261164|FG000|Overall Study|Lack of Efficacy|0|||
25147255|NCT01937299|50261165|FG001|Overall Study|Lack of Efficacy|4|||
25147256|NCT01937299|50261164|FG000|Overall Study|Withdrawal by Subject|1|||
25147257|NCT01937299|50261165|FG001|Overall Study|Withdrawal by Subject|0|||
25147258|NCT02003963|50261174|FG000|Overall Study|Lost to Follow-up|2|||
25147259|NCT02003963|50261175|FG001|Overall Study|Lost to Follow-up|1|||
25147260|NCT01606761|50261186|FG000|Prior to Week 24|Lost to Follow-up|0|||
25147261|NCT01606761|50261187|FG001|Prior to Week 24|Lost to Follow-up|3|||
25147262|NCT01606761|50261188|FG002|Prior to Week 24|Lost to Follow-up|2|||
25147263|NCT01606761|50261189|FG003|Prior to Week 24|Lost to Follow-up|0|||
25147264|NCT01606761|50261190|FG004|Prior to Week 24|Lost to Follow-up|0|||
25147265|NCT01606761|50261186|FG000|Prior to Week 24|Withdrawal by Subject|12|||
25147266|NCT01606761|50261187|FG001|Prior to Week 24|Withdrawal by Subject|10|||
25147267|NCT01606761|50261188|FG002|Prior to Week 24|Withdrawal by Subject|9|||
25147268|NCT01606761|50261189|FG003|Prior to Week 24|Withdrawal by Subject|0|||
25147269|NCT01606761|50261190|FG004|Prior to Week 24|Withdrawal by Subject|0|||
25274596|NCT02716675|50588608|FG001|Overall Study|Protocol Violation|3|||
25147270|NCT01606761|50261186|FG000|Prior to Week 24|Adverse Event|11|||
25147271|NCT01606761|50261187|FG001|Prior to Week 24|Adverse Event|18|||
25147272|NCT01606761|50261188|FG002|Prior to Week 24|Adverse Event|22|||
25147273|NCT01606761|50261189|FG003|Prior to Week 24|Adverse Event|0|||
25184492|NCT01272219|50333204|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
25147274|NCT01606761|50261190|FG004|Prior to Week 24|Adverse Event|0|||
25147275|NCT01606761|50261186|FG000|Prior to Week 24|Lack of Efficacy|15|||
25147276|NCT01606761|50261187|FG001|Prior to Week 24|Lack of Efficacy|14|||
25147277|NCT01606761|50261188|FG002|Prior to Week 24|Lack of Efficacy|8|||
25147278|NCT01606761|50261189|FG003|Prior to Week 24|Lack of Efficacy|0|||
25147279|NCT01606761|50261190|FG004|Prior to Week 24|Lack of Efficacy|0|||
25147280|NCT01606761|50261186|FG000|Prior to Week 24|Physician Decision|0|||
25147281|NCT01606761|50261187|FG001|Prior to Week 24|Physician Decision|3|||
25147282|NCT01606761|50261188|FG002|Prior to Week 24|Physician Decision|1|||
25147283|NCT01606761|50261189|FG003|Prior to Week 24|Physician Decision|0|||
25147284|NCT01606761|50261190|FG004|Prior to Week 24|Physician Decision|0|||
25147285|NCT01606761|50261186|FG000|Prior to Week 24|Other|4|||
25147286|NCT01606761|50261187|FG001|Prior to Week 24|Other|7|||
25147287|NCT01606761|50261188|FG002|Prior to Week 24|Other|5|||
25147288|NCT01606761|50261189|FG003|Prior to Week 24|Other|0|||
25147289|NCT01606761|50261190|FG004|Prior to Week 24|Other|0|||
25147290|NCT01606761|50261186|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
25147291|NCT01606761|50261187|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
25147292|NCT01606761|50261188|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
25147293|NCT01606761|50261189|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
25147294|NCT01606761|50261190|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
25147295|NCT01606761|50261186|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
25147296|NCT01606761|50261187|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
25147297|NCT01606761|50261188|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
25147298|NCT01606761|50261189|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
25147299|NCT01606761|50261190|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
25147300|NCT01606761|50261186|FG000|Week 24 to Week 52|Adverse Event|0|||
25147301|NCT01606761|50261187|FG001|Week 24 to Week 52|Adverse Event|11|||
25147302|NCT01606761|50261188|FG002|Week 24 to Week 52|Adverse Event|14|||
25147303|NCT01606761|50261189|FG003|Week 24 to Week 52|Adverse Event|3|||
25147304|NCT01606761|50261190|FG004|Week 24 to Week 52|Adverse Event|15|||
25147305|NCT01606761|50261186|FG000|Week 24 to Week 52|Death|0|||
25147306|NCT01606761|50261187|FG001|Week 24 to Week 52|Death|0|||
25147307|NCT01606761|50261188|FG002|Week 24 to Week 52|Death|2|||
25147308|NCT01606761|50261189|FG003|Week 24 to Week 52|Death|1|||
25147309|NCT01606761|50261190|FG004|Week 24 to Week 52|Death|0|||
25147310|NCT01606761|50261186|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
25147311|NCT01606761|50261187|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
25147312|NCT01606761|50261188|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
25147313|NCT01606761|50261189|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
25147314|NCT01606761|50261190|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
25147315|NCT01606761|50261186|FG000|Week 24 to Week 52|Physician Decision|0|||
25147316|NCT01606761|50261187|FG001|Week 24 to Week 52|Physician Decision|1|||
25147317|NCT01606761|50261188|FG002|Week 24 to Week 52|Physician Decision|1|||
25147318|NCT01606761|50261189|FG003|Week 24 to Week 52|Physician Decision|0|||
25147319|NCT01606761|50261190|FG004|Week 24 to Week 52|Physician Decision|0|||
25147320|NCT01606761|50261186|FG000|Week 24 to Week 52|Other|0|||
25147321|NCT01606761|50261187|FG001|Week 24 to Week 52|Other|1|||
25147322|NCT01606761|50261188|FG002|Week 24 to Week 52|Other|5|||
25147323|NCT01606761|50261189|FG003|Week 24 to Week 52|Other|2|||
25147324|NCT01606761|50261190|FG004|Week 24 to Week 52|Other|2|||
25147325|NCT01606761|50261186|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
25147326|NCT01606761|50261187|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
25147327|NCT01606761|50261188|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
25147328|NCT01606761|50261189|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
25147329|NCT01606761|50261190|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
25147330|NCT01606761|50261186|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
25147331|NCT01606761|50261187|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
25147332|NCT01606761|50261188|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
25147333|NCT01606761|50261189|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
25147334|NCT01606761|50261190|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
25147335|NCT01606761|50261186|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
25147336|NCT01606761|50261187|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
25147337|NCT01606761|50261188|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
25147338|NCT01606761|50261189|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
25147339|NCT01606761|50261190|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
25147340|NCT01606761|50261186|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
25147341|NCT01606761|50261187|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
25147342|NCT01606761|50261188|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
25147343|NCT01606761|50261189|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
25147344|NCT01606761|50261190|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
25147345|NCT01790295|50261205|FG000|Overall Study|Adverse Event|1|||
25147346|NCT01790295|50261205|FG000|Overall Study|Death|4|||
25147347|NCT01790295|50261205|FG000|Overall Study|Lack of Efficacy|2|||
25147348|NCT01790295|50261205|FG000|Overall Study|Study closure|4|||
25147349|NCT01597557|50261212|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
25147350|NCT01597557|50261213|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
25147351|NCT01760733|50261219|FG000|Waiting List|Death|18|||
25147352|NCT01760733|50261219|FG000|Waiting List|Removed from waiting list|41|||
25147353|NCT01760733|50261219|FG000|Waiting List|Not received a transplant yet|13|||
25147354|NCT01760733|50261219|FG000|Transplanted|Not reached 10 years post transplant|184|||
25147355|NCT01760733|50261219|FG000|Transplanted|Death|26|||
25147356|NCT01760733|50261219|FG000|Transplanted|Graft loss|7|||
25147357|NCT01914757|50261227|FG000|Overall Study|Severe non-compliance to protocol|3|||
25147358|NCT01914757|50261228|FG001|Overall Study|Severe non-compliance to protocol|1|||
25147359|NCT01914757|50261229|FG002|Overall Study|Severe non-compliance to protocol|2|||
25147360|NCT01914757|50261227|FG000|Overall Study|Lost to Follow-up|5|||
25147361|NCT01914757|50261228|FG001|Overall Study|Lost to Follow-up|8|||
25147362|NCT01914757|50261229|FG002|Overall Study|Lost to Follow-up|6|||
25147363|NCT01914757|50261227|FG000|Overall Study|Withdrawal by Subject|15|||
25147364|NCT01914757|50261228|FG001|Overall Study|Withdrawal by Subject|27|||
25147365|NCT01914757|50261229|FG002|Overall Study|Withdrawal by Subject|19|||
25147366|NCT01914757|50261227|FG000|Overall Study|Death|2|||
25147367|NCT01914757|50261228|FG001|Overall Study|Death|2|||
25147368|NCT01914757|50261229|FG002|Overall Study|Death|1|||
25147369|NCT01914757|50261227|FG000|Overall Study|Adverse Event|4|||
25147370|NCT01914757|50261228|FG001|Overall Study|Adverse Event|3|||
25147371|NCT01914757|50261229|FG002|Overall Study|Adverse Event|4|||
25147372|NCT01914757|50261227|FG000|Overall Study|Study specific withdrawal criteria|0|||
25147373|NCT01914757|50261228|FG001|Overall Study|Study specific withdrawal criteria|1|||
25147374|NCT01914757|50261229|FG002|Overall Study|Study specific withdrawal criteria|0|||
25147375|NCT01914757|50261227|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
25147376|NCT01914757|50261228|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
25147377|NCT01914757|50261229|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
25147378|NCT01914757|50261227|FG000|Overall Study|Other reasons|5|||
25147379|NCT01914757|50261228|FG001|Overall Study|Other reasons|9|||
25147380|NCT01914757|50261229|FG002|Overall Study|Other reasons|4|||
25147381|NCT02003573|50261240|FG000|Overall Study|Progressive disease|2|||
25147382|NCT02003573|50261241|FG001|Overall Study|Progressive disease|0|||
25147383|NCT02003573|50261242|FG002|Overall Study|Progressive disease|1|||
25147384|NCT02003573|50261240|FG000|Overall Study|Other Adverse event|0|||
25147385|NCT02003573|50261241|FG001|Overall Study|Other Adverse event|1|||
25147386|NCT02003573|50261242|FG002|Overall Study|Other Adverse event|1|||
25147387|NCT02003573|50261240|FG000|Overall Study|Refuse to take trial medication|0|||
25147388|NCT02003573|50261241|FG001|Overall Study|Refuse to take trial medication|1|||
25147389|NCT02003573|50261242|FG002|Overall Study|Refuse to take trial medication|1|||
25147390|NCT02003573|50261240|FG000|Overall Study|Other than specified|1|||
25147391|NCT02003573|50261241|FG001|Overall Study|Other than specified|2|||
25147392|NCT02003573|50261242|FG002|Overall Study|Other than specified|3|||
25147393|NCT01914679|50261252|FG000|Overall Study|Lack of Efficacy|1|||
25147394|NCT01914679|50261252|FG000|Overall Study|Sponsor terminated study|4|||
25147395|NCT01789281|50261258|FG000|Overall Study|Disease progression|15|||
25147396|NCT01789281|50261259|FG001|Overall Study|Disease progression|4|||
25147397|NCT01789281|50261258|FG000|Overall Study|Adverse Event|5|||
25147398|NCT01789281|50261259|FG001|Overall Study|Adverse Event|5|||
25147399|NCT01789281|50261258|FG000|Overall Study|Withdrawal by Subject|1|||
25147400|NCT01789281|50261259|FG001|Overall Study|Withdrawal by Subject|0|||
25147401|NCT01789281|50261258|FG000|Overall Study|Lost to Follow-up|1|||
25147402|NCT01789281|50261259|FG001|Overall Study|Lost to Follow-up|0|||
25147403|NCT01789281|50261258|FG000|Overall Study|Administrative problems|0|||
25147404|NCT01789281|50261259|FG001|Overall Study|Administrative problems|1|||
25147405|NCT01923740|50261268|FG000|Overall Study|Lost to Follow-up|4|||
25147406|NCT01923740|50261269|FG001|Overall Study|Lost to Follow-up|9|||
25147407|NCT01923740|50261268|FG000|Overall Study|Withdrawal by Subject|2|||
25147408|NCT01923740|50261269|FG001|Overall Study|Withdrawal by Subject|0|||
25147409|NCT01789203|50261277|FG000|Overall Study|Adverse Event|2|||
25147410|NCT01789203|50261278|FG001|Overall Study|Adverse Event|2|||
25147411|NCT01789203|50261277|FG000|Overall Study|Withdrawal by Subject|1|||
25147412|NCT01789203|50261278|FG001|Overall Study|Withdrawal by Subject|0|||
25147413|NCT01789203|50261277|FG000|Overall Study|Death|1|||
25147414|NCT01789203|50261278|FG001|Overall Study|Death|0|||
25147415|NCT01789203|50261277|FG000|Overall Study|Protocol Violation|2|||
25147416|NCT01789203|50261278|FG001|Overall Study|Protocol Violation|1|||
25147417|NCT01789203|50261277|FG000|Overall Study|Other|1|||
25147418|NCT01789203|50261278|FG001|Overall Study|Other|1|||
25147419|NCT01789203|50261277|FG000|Overall Study|patient non-adherent|2|||
25016177|NCT03226275|50111089|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
25147420|NCT01789203|50261278|FG001|Overall Study|patient non-adherent|0|||
25147421|NCT01789047|50261288|FG000|Overall Study|Adverse Event|3|||
25147422|NCT01789047|50261289|FG001|Overall Study|Adverse Event|2|||
25147423|NCT01789047|50261288|FG000|Overall Study|Withdrawal by Subject|1|||
25147424|NCT01789047|50261289|FG001|Overall Study|Withdrawal by Subject|2|||
25147425|NCT01788423|50261298|FG000|Overall Study|See Comments in Completed (above)|0|||
25147426|NCT01788423|50261299|FG001|Overall Study|See Comments in Completed (above)|4|||
25147427|NCT01788423|50261300|FG002|Overall Study|See Comments in Completed (above)|5|||
25147428|NCT01617187|50261312|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
25147429|NCT01617187|50261313|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
25147430|NCT01617187|50261314|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
25147431|NCT01617187|50261315|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
25147432|NCT01617187|50261312|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
25147433|NCT01617187|50261313|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
25147434|NCT01617187|50261314|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
25147435|NCT01617187|50261315|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
25147436|NCT01617187|50261312|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
25147437|NCT01617187|50261313|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
25147438|NCT01617187|50261314|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
25147439|NCT01617187|50261315|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
25147440|NCT01617187|50261312|FG000|Treatment Through Study Completion|Adverse Event|1|||
25147441|NCT01617187|50261313|FG001|Treatment Through Study Completion|Adverse Event|1|||
25147442|NCT01617187|50261314|FG002|Treatment Through Study Completion|Adverse Event|0|||
25147443|NCT01617187|50261315|FG003|Treatment Through Study Completion|Adverse Event|1|||
25147444|NCT01617187|50261312|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
25147445|NCT01617187|50261313|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
25147446|NCT01617187|50261314|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
25147447|NCT01617187|50261315|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
25147448|NCT01617187|50261312|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
25147449|NCT01617187|50261313|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
25147450|NCT01617187|50261314|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
25147451|NCT01617187|50261315|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
25184493|NCT01272219|50333205|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
25184494|NCT01272219|50333206|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
25184495|NCT01272219|50333207|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
25184496|NCT01272219|50333208|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
25184497|NCT01272219|50333209|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
25147452|NCT01617187|50261312|FG000|Treatment Through Study Completion|Protocol Violation|1|||
25147453|NCT01617187|50261313|FG001|Treatment Through Study Completion|Protocol Violation|0|||
25147454|NCT01617187|50261314|FG002|Treatment Through Study Completion|Protocol Violation|0|||
25147455|NCT01617187|50261315|FG003|Treatment Through Study Completion|Protocol Violation|1|||
25147456|NCT01759407|50261327|FG000|Overall Study|Protocol Violation|0|||
25147457|NCT01759407|50261328|FG001|Overall Study|Protocol Violation|2|||
25147458|NCT01787331|50261334|FG000|Overall Study|Physician Decision|1|||
25147459|NCT01787331|50261334|FG000|Overall Study|Withdrawal by Subject|1|||
25147460|NCT01757847|50261340|FG000|Overall Study|Withdrawal by Subject|3|||
25147461|NCT01757847|50261341|FG001|Overall Study|Withdrawal by Subject|4|||
25147462|NCT01787097|50261347|FG000|Overall Study|Withdrawal by Subject|1|||
25147463|NCT01787097|50261348|FG001|Overall Study|Withdrawal by Subject|0|||
25147464|NCT01787097|50261349|FG002|Overall Study|Withdrawal by Subject|0|||
25147465|NCT01787097|50261350|FG003|Overall Study|Withdrawal by Subject|0|||
25147466|NCT01757691|50261370|FG000|Overall Study|Administrative problems|2|||
25147467|NCT01757691|50261371|FG001|Overall Study|Administrative problems|0|||
25147468|NCT01786707|50261379|FG000|Overall Study|Lost to Follow-up|1|||
25147469|NCT01786707|50261380|FG001|Overall Study|Lost to Follow-up|1|||
25147470|NCT01786629|50261388|FG000|Overall Study|Lack of Efficacy|0|||
25147471|NCT01786629|50261389|FG001|Overall Study|Lack of Efficacy|4|||
25147472|NCT01786629|50261388|FG000|Overall Study|Adverse Event|0|||
25147473|NCT01786629|50261389|FG001|Overall Study|Adverse Event|1|||
25147474|NCT01786551|50261395|FG000|Overall Study|Participant withdrew consent|2|||
25147475|NCT01973569|50261402|FG000|Overall Study|Adverse Event|9|||
25147476|NCT01973569|50261403|FG001|Overall Study|Adverse Event|2|||
25147477|NCT01973569|50261404|FG002|Overall Study|Adverse Event|4|||
25274597|NCT02716675|50588609|FG002|Overall Study|Protocol Violation|1|||
25274598|NCT02716675|50588607|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
25274599|NCT02716675|50588608|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
25147478|NCT01973569|50261402|FG000|Overall Study|Protocol Violation|2|||
25147479|NCT01973569|50261403|FG001|Overall Study|Protocol Violation|1|||
25147480|NCT01973569|50261404|FG002|Overall Study|Protocol Violation|3|||
25147481|NCT01973569|50261402|FG000|Overall Study|Withdrawal by Subject|7|||
25147482|NCT01973569|50261403|FG001|Overall Study|Withdrawal by Subject|5|||
25147483|NCT01973569|50261404|FG002|Overall Study|Withdrawal by Subject|2|||
25147484|NCT01973569|50261402|FG000|Overall Study|Invasive dental treatment|3|||
25147485|NCT01973569|50261403|FG001|Overall Study|Invasive dental treatment|5|||
25147486|NCT01973569|50261404|FG002|Overall Study|Invasive dental treatment|6|||
25147487|NCT01973569|50261402|FG000|Overall Study|Prohibited concomitant d|1|||
25147488|NCT01973569|50261403|FG001|Overall Study|Prohibited concomitant d|5|||
25147489|NCT01973569|50261404|FG002|Overall Study|Prohibited concomitant d|0|||
25147490|NCT01973569|50261402|FG000|Overall Study|Disease progression|0|||
25147491|NCT01973569|50261403|FG001|Overall Study|Disease progression|3|||
25147492|NCT01973569|50261404|FG002|Overall Study|Disease progression|0|||
25147493|NCT01973569|50261402|FG000|Overall Study|Other|1|||
25147494|NCT01973569|50261403|FG001|Overall Study|Other|1|||
25147495|NCT01973569|50261404|FG002|Overall Study|Other|0|||
25274600|NCT02716675|50588609|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
25274601|NCT02716675|50588607|FG000|Overall Study|Other|38|||
25147496|NCT01973569|50261402|FG000|Overall Study|Did not receive study drug|6|||
25147497|NCT01973569|50261403|FG001|Overall Study|Did not receive study drug|3|||
25147498|NCT01973569|50261404|FG002|Overall Study|Did not receive study drug|3|||
25147499|NCT01973491|50261412|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
25147500|NCT01973491|50261412|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
25147501|NCT01973491|50261412|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
25147502|NCT01951586|50261418|FG000|Overall Study|Death|61|||
25147503|NCT01951586|50261419|FG001|Overall Study|Death|120|||
25147504|NCT01951586|50261418|FG000|Overall Study|Withdrawal by Subject|8|||
25147505|NCT01951586|50261419|FG001|Overall Study|Withdrawal by Subject|17|||
25147506|NCT01951586|50261418|FG000|Overall Study|Lost to Follow-up|0|||
25147507|NCT01951586|50261419|FG001|Overall Study|Lost to Follow-up|1|||
25147508|NCT01951586|50261418|FG000|Overall Study|Sponsor Decision|9|||
25147509|NCT01951586|50261419|FG001|Overall Study|Sponsor Decision|10|||
25147510|NCT01785849|50261428|FG000|Overall Study|Death|7|||
25147511|NCT01785849|50261429|FG001|Overall Study|Death|9|||
25147512|NCT01785849|50261428|FG000|Overall Study|Protocol Specified Criteria|29|||
25147513|NCT01785849|50261429|FG001|Overall Study|Protocol Specified Criteria|1|||
25147514|NCT01785849|50261428|FG000|Overall Study|Withdrawal by Subject|15|||
25147515|NCT01785849|50261429|FG001|Overall Study|Withdrawal by Subject|12|||
25147516|NCT01785849|50261428|FG000|Overall Study|Sponsor Decision|0|||
25147517|NCT01785849|50261429|FG001|Overall Study|Sponsor Decision|1|||
25147518|NCT01785849|50261428|FG000|Overall Study|Lost to Follow-up|10|||
25147519|NCT01785849|50261429|FG001|Overall Study|Lost to Follow-up|11|||
25147520|NCT01756833|50261437|FG000|Overall Study|Withdrawal by Subject|4|||
25147521|NCT01756833|50261438|FG001|Overall Study|Withdrawal by Subject|3|||
25147522|NCT01617967|50261450|FG000|Overall Study|Protocol Violation|0|||
25147523|NCT01617967|50261451|FG001|Overall Study|Protocol Violation|0|||
25147524|NCT01617967|50261452|FG002|Overall Study|Protocol Violation|0|||
25147525|NCT01617967|50261453|FG003|Overall Study|Protocol Violation|1|||
25147526|NCT01617967|50261454|FG004|Overall Study|Protocol Violation|0|||
25147527|NCT01617967|50261455|FG005|Overall Study|Protocol Violation|0|||
25147528|NCT01617967|50261450|FG000|Overall Study|Withdrawal by Subject|0|||
25147529|NCT01617967|50261451|FG001|Overall Study|Withdrawal by Subject|0|||
25147530|NCT01617967|50261452|FG002|Overall Study|Withdrawal by Subject|0|||
25147531|NCT01617967|50261453|FG003|Overall Study|Withdrawal by Subject|0|||
25147532|NCT01617967|50261454|FG004|Overall Study|Withdrawal by Subject|0|||
25147533|NCT01617967|50261455|FG005|Overall Study|Withdrawal by Subject|1|||
25147534|NCT01617967|50261450|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
25147535|NCT01617967|50261451|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
25147536|NCT01617967|50261452|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
25147537|NCT01617967|50261453|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
25147538|NCT01617967|50261454|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
25147539|NCT01617967|50261455|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
25147540|NCT01785615|50261473|FG000|Dietary Phase|Lost to Follow-up|0|||
25147541|NCT01785615|50261474|FG001|Dietary Phase|Lost to Follow-up|0|||
25147542|NCT01785615|50261475|FG002|Dietary Phase|Lost to Follow-up|0|||
25147543|NCT01785615|50261476|FG003|Dietary Phase|Lost to Follow-up|24|||
25147544|NCT01913041|50261488|FG000|Overall Study|Protocol Violation|35|||
25274602|NCT02716675|50588608|FG001|Overall Study|Other|47|||
25147545|NCT01913041|50261488|FG000|Overall Study|Withdrawal by Subject|3|||
25147546|NCT01913041|50261488|FG000|Overall Study|Physician Decision|1|||
25147547|NCT01756053|50261492|FG000|Period 1 (10 Days)|Protocol Violation|1|||
25147548|NCT01756053|50261493|FG001|Period 1 (10 Days)|Protocol Violation|1|||
25147549|NCT01756053|50261492|FG000|Period 2 (10 Days)|Protocol Violation|0|||
25147550|NCT01756053|50261493|FG001|Period 2 (10 Days)|Protocol Violation|2|||
25147551|NCT01785069|50261503|FG000|Overall Study|Implanted with nonstudy device|1|||
25147552|NCT01785069|50261504|FG001|Overall Study|Implanted with nonstudy device|2|||
25147553|NCT01785069|50261505|FG002|Overall Study|Implanted with nonstudy device|1|||
25147554|NCT01785069|50261506|FG003|Overall Study|Implanted with nonstudy device|0|||
25147555|NCT01785069|50261503|FG000|Overall Study|Death|0|||
25147556|NCT01785069|50261504|FG001|Overall Study|Death|0|||
25147557|NCT01785069|50261505|FG002|Overall Study|Death|2|||
25147558|NCT01785069|50261506|FG003|Overall Study|Death|0|||
25147559|NCT01785069|50261503|FG000|Overall Study|Subject choice|2|||
25147560|NCT01785069|50261504|FG001|Overall Study|Subject choice|2|||
25147561|NCT01785069|50261505|FG002|Overall Study|Subject choice|0|||
25147562|NCT01785069|50261506|FG003|Overall Study|Subject choice|1|||
25147563|NCT01785069|50261503|FG000|Overall Study|Lost to Follow-up|1|||
25147564|NCT01785069|50261504|FG001|Overall Study|Lost to Follow-up|2|||
25147565|NCT01785069|50261505|FG002|Overall Study|Lost to Follow-up|4|||
25147566|NCT01785069|50261506|FG003|Overall Study|Lost to Follow-up|1|||
25147567|NCT01785069|50261503|FG000|Overall Study|Reason not Specified|1|||
25147568|NCT01785069|50261504|FG001|Overall Study|Reason not Specified|2|||
25147569|NCT01785069|50261505|FG002|Overall Study|Reason not Specified|1|||
25147570|NCT01785069|50261506|FG003|Overall Study|Reason not Specified|4|||
25147571|NCT01785069|50261503|FG000|Overall Study|Not evaluable|7|||
25147572|NCT01785069|50261504|FG001|Overall Study|Not evaluable|4|||
25147573|NCT01785069|50261505|FG002|Overall Study|Not evaluable|5|||
25147574|NCT01785069|50261506|FG003|Overall Study|Not evaluable|8|||
25147575|NCT01784523|50261518|FG000|Overall Study|Study closed early|7|||
25147576|NCT01784523|50261519|FG001|Overall Study|Study closed early|4|||
25147577|NCT01784211|50261527|FG000|Part A (Days 1-15)|Adverse Event|1|||
25147578|NCT01784211|50261528|FG001|Part A (Days 1-15)|Adverse Event|1|||
25147579|NCT01784211|50261529|FG002|Part A (Days 1-15)|Adverse Event|0|||
25147580|NCT01784211|50261530|FG003|Part A (Days 1-15)|Adverse Event|0|||
25147581|NCT01784211|50261531|FG004|Part A (Days 1-15)|Adverse Event|0|||
25147582|NCT01784211|50261532|FG005|Part A (Days 1-15)|Adverse Event|0|||
25147583|NCT01784211|50261527|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
25147584|NCT01784211|50261528|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
25147585|NCT01784211|50261529|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
25147586|NCT01784211|50261530|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
25147587|NCT01784211|50261531|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
25147588|NCT01784211|50261532|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
25147589|NCT01783821|50261546|FG000|Overall Study|Screen Failure|1|||
25147590|NCT01783821|50261547|FG001|Overall Study|Screen Failure|1|||
25147591|NCT01783743|50261555|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
25147592|NCT01783743|50261556|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
25147593|NCT01783743|50261555|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
25184498|NCT01272219|50333204|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
25147594|NCT01783743|50261556|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
25147595|NCT01783743|50261555|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
25147596|NCT01783743|50261556|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
25147597|NCT01608321|50261564|FG000|Overall Study|Withdrawal by Subject|1|||
25147598|NCT01608321|50261565|FG001|Overall Study|Withdrawal by Subject|0|||
25147599|NCT01608087|50261574|FG000|Overall Study|Lost to Follow-up|0|||
25147600|NCT01608087|50261575|FG001|Overall Study|Lost to Follow-up|1|||
25147601|NCT01608087|50261576|FG002|Overall Study|Lost to Follow-up|0|||
25147602|NCT01608087|50261574|FG000|Overall Study|Other Reason|0|||
25147603|NCT01608087|50261575|FG001|Overall Study|Other Reason|1|||
25147604|NCT01608087|50261576|FG002|Overall Study|Other Reason|0|||
25147605|NCT01912963|50261587|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
25147606|NCT01912963|50261588|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
25147607|NCT01912963|50261589|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
25147608|NCT01912963|50261587|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
25147609|NCT01912963|50261588|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
25147610|NCT01912963|50261589|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
25147611|NCT01912963|50261587|FG000|Overall Study|Adverse Event|0|||
25147612|NCT01912963|50261588|FG001|Overall Study|Adverse Event|1|||
25147613|NCT01912963|50261589|FG002|Overall Study|Adverse Event|1|||
25147614|NCT01912963|50261587|FG000|Overall Study|Withdrawal by Subject|0|||
25147615|NCT01912963|50261588|FG001|Overall Study|Withdrawal by Subject|1|||
25147616|NCT01912963|50261589|FG002|Overall Study|Withdrawal by Subject|0|||
25147617|NCT01912963|50261587|FG000|Overall Study|Sought treatment locally|0|||
25147618|NCT01912963|50261588|FG001|Overall Study|Sought treatment locally|1|||
25147619|NCT01912963|50261589|FG002|Overall Study|Sought treatment locally|0|||
25147620|NCT01754727|50261597|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
25274603|NCT02716675|50588609|FG002|Overall Study|Other|48|||
25147621|NCT01912807|50261603|FG000|Overall Study|Did not meet elegibility criteria|6|||
25147622|NCT01912807|50261604|FG001|Overall Study|Did not meet elegibility criteria|4|||
25147623|NCT01912807|50261603|FG000|Overall Study|Lost to Follow-up|36|||
25147624|NCT01912807|50261604|FG001|Overall Study|Lost to Follow-up|37|||
25147625|NCT01782885|50261612|FG000|Overall Study|Lost to Follow-up|4|||
25147626|NCT01782885|50261613|FG001|Overall Study|Lost to Follow-up|6|||
25147627|NCT01912729|50261621|FG000|Overall Study|Withdrawal by Subject|0|||
25147628|NCT01912729|50261622|FG001|Overall Study|Withdrawal by Subject|1|||
25147629|NCT01754493|50261628|FG000|Overall Study|Adverse Event|1|||
25147630|NCT01754493|50261628|FG000|Overall Study|Lost to Follow-up|3|||
25147631|NCT01754493|50261628|FG000|Overall Study|Withdrawal by Subject|1|||
25147632|NCT01754493|50261628|FG000|Overall Study|Moved out of town|1|||
25184499|NCT01272219|50333205|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
25184500|NCT01272219|50333206|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
25184501|NCT01272219|50333207|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
25184502|NCT01272219|50333208|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
25184503|NCT01272219|50333209|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
25184504|NCT01272219|50333204|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
25147633|NCT01754493|50261628|FG000|Overall Study|Scheduling conflict|1|||
25147634|NCT01972789|50261634|FG000|Overall Study|Adverse Event|11|||
25147635|NCT01972789|50261635|FG001|Overall Study|Adverse Event|4|||
25147636|NCT01972789|50261634|FG000|Overall Study|Subject withdrew consent|14|||
25147637|NCT01972789|50261635|FG001|Overall Study|Subject withdrew consent|12|||
25147638|NCT01972789|50261634|FG000|Overall Study|Lost to Follow-up|4|||
25147639|NCT01972789|50261635|FG001|Overall Study|Lost to Follow-up|7|||
25147640|NCT01972789|50261634|FG000|Overall Study|Death|7|||
25147641|NCT01972789|50261635|FG001|Overall Study|Death|5|||
25147642|NCT01972789|50261634|FG000|Overall Study|Protocol deviation|1|||
25147643|NCT01972789|50261635|FG001|Overall Study|Protocol deviation|0|||
25184505|NCT01272219|50333205|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
25147644|NCT01972789|50261634|FG000|Overall Study|Physician Decision|3|||
25147645|NCT01972789|50261635|FG001|Overall Study|Physician Decision|2|||
25147646|NCT01934335|50261643|FG000|Overall Study|Withdrawal by Subject|1|||
25147647|NCT01934335|50261644|FG001|Overall Study|Withdrawal by Subject|1|||
25147648|NCT01912339|50261652|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
25147649|NCT01912339|50261653|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
25147650|NCT01912339|50261654|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
25147651|NCT01912339|50261652|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
25147652|NCT01912339|50261653|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
25147653|NCT01912339|50261654|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
25147654|NCT01912339|50261652|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
25147655|NCT01912339|50261653|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
25147656|NCT01912339|50261654|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
25147657|NCT01912339|50261652|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
25147658|NCT01912339|50261653|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
25147659|NCT01912339|50261654|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
25147660|NCT01912339|50261652|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
25147661|NCT01912339|50261653|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
25147662|NCT01912339|50261654|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
25147663|NCT01912339|50261652|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
25147664|NCT01912339|50261653|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
25147665|NCT01912339|50261654|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
25147666|NCT01912339|50261652|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
25184506|NCT01272219|50333206|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
25184507|NCT01272219|50333207|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
25184508|NCT01272219|50333208|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
25184509|NCT01272219|50333209|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
25184510|NCT01272219|50333204|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
25274604|NCT00977548|50588622|FG000|Overall Study|Ineligible|4|||
25274605|NCT00977548|50588622|FG000|Overall Study|Adverse Event|8|||
25184511|NCT01272219|50333205|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
25147667|NCT01912339|50261653|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
25274606|NCT00977548|50588622|FG000|Overall Study|Withdrawal by Subject|1|||
25147668|NCT01912339|50261654|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
25147669|NCT01912339|50261652|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
25147670|NCT01912339|50261653|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
25147671|NCT01912339|50261654|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
25147672|NCT01912339|50261652|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
25147673|NCT01912339|50261653|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
25147674|NCT01912339|50261654|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
25147675|NCT01912339|50261652|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
25147676|NCT01912339|50261653|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
25147677|NCT01912339|50261654|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
25147678|NCT01912339|50261652|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
25147679|NCT01912339|50261653|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
25147680|NCT01912339|50261654|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
25147681|NCT01912339|50261652|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
25147682|NCT01912339|50261653|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
25147683|NCT01912339|50261654|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
25147684|NCT01912339|50261652|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
25147685|NCT01912339|50261653|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
25147686|NCT01912339|50261654|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
25147687|NCT01911793|50261662|FG000|Overall Study|Physician Decision|1|||
25147688|NCT01911793|50261663|FG001|Overall Study|Physician Decision|5|||
25147689|NCT01933789|50261678|FG000|Overall Study|Death|0|||
25147690|NCT01933789|50261679|FG001|Overall Study|Death|0|||
25147691|NCT01933789|50261680|FG002|Overall Study|Death|0|||
25147692|NCT01933789|50261681|FG003|Overall Study|Death|0|||
25147693|NCT01933789|50261682|FG004|Overall Study|Death|21|||
25147694|NCT01933789|50261683|FG005|Overall Study|Death|32|||
25147695|NCT01933789|50261684|FG006|Overall Study|Death|0|||
25147696|NCT01933789|50261685|FG007|Overall Study|Death|0|||
25147697|NCT01933789|50261686|FG008|Overall Study|Death|0|||
25147698|NCT01933789|50261678|FG000|Overall Study|Lost to Follow-up|0|||
25147699|NCT01933789|50261679|FG001|Overall Study|Lost to Follow-up|0|||
25147700|NCT01933789|50261680|FG002|Overall Study|Lost to Follow-up|0|||
25147701|NCT01933789|50261681|FG003|Overall Study|Lost to Follow-up|1|||
25147702|NCT01933789|50261682|FG004|Overall Study|Lost to Follow-up|8|||
25147703|NCT01933789|50261683|FG005|Overall Study|Lost to Follow-up|9|||
25147704|NCT01933789|50261684|FG006|Overall Study|Lost to Follow-up|1|||
25147705|NCT01933789|50261685|FG007|Overall Study|Lost to Follow-up|4|||
25147706|NCT01933789|50261686|FG008|Overall Study|Lost to Follow-up|0|||
25147707|NCT01933789|50261678|FG000|Overall Study|Withdrawal by Subject|2|||
25147708|NCT01933789|50261679|FG001|Overall Study|Withdrawal by Subject|1|||
25147709|NCT01933789|50261680|FG002|Overall Study|Withdrawal by Subject|0|||
25147710|NCT01933789|50261681|FG003|Overall Study|Withdrawal by Subject|0|||
25147711|NCT01933789|50261682|FG004|Overall Study|Withdrawal by Subject|17|||
25147712|NCT01933789|50261683|FG005|Overall Study|Withdrawal by Subject|16|||
25147713|NCT01933789|50261684|FG006|Overall Study|Withdrawal by Subject|1|||
25147714|NCT01933789|50261685|FG007|Overall Study|Withdrawal by Subject|4|||
25147715|NCT01933789|50261686|FG008|Overall Study|Withdrawal by Subject|0|||
25147716|NCT01933789|50261678|FG000|Overall Study|Became Ineligible|4|||
25147717|NCT01933789|50261679|FG001|Overall Study|Became Ineligible|0|||
25147718|NCT01933789|50261680|FG002|Overall Study|Became Ineligible|0|||
25147719|NCT01933789|50261681|FG003|Overall Study|Became Ineligible|0|||
25147720|NCT01933789|50261682|FG004|Overall Study|Became Ineligible|13|||
25147721|NCT01933789|50261683|FG005|Overall Study|Became Ineligible|10|||
25147722|NCT01933789|50261684|FG006|Overall Study|Became Ineligible|13|||
25147723|NCT01933789|50261685|FG007|Overall Study|Became Ineligible|6|||
25147724|NCT01933789|50261686|FG008|Overall Study|Became Ineligible|0|||
25147725|NCT01910389|50261708|FG000|Overall Study|Withdrawal by Subject|2|||
25184512|NCT01272219|50333206|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
25184513|NCT01272219|50333207|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
25184514|NCT01272219|50333208|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
25184515|NCT01272219|50333209|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
25184516|NCT01272219|50333204|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
25184517|NCT01272219|50333205|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
25184518|NCT01272219|50333206|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
25184519|NCT01272219|50333207|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
25274607|NCT01090011|50588626|FG000|Overall Study|Progressive disease|128|||
25147726|NCT01910389|50261709|FG001|Overall Study|Withdrawal by Subject|0|||
25147727|NCT01910389|50261708|FG000|Overall Study|Study Closed|13|||
25147728|NCT01910389|50261709|FG001|Overall Study|Study Closed|8|||
25147729|NCT01970995|50261718|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
25147730|NCT01970995|50261719|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
25147731|NCT01970995|50261720|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
25147732|NCT01970995|50261718|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
25147733|NCT01970995|50261719|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
25147734|NCT01970995|50261720|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
25147735|NCT01932697|50261730|FG000|Overall Study|Received a different amount of tx|1|||
25147736|NCT01932697|50261731|FG001|Overall Study|Received a different amount of tx|0|||
25147737|NCT01932697|50261730|FG000|Overall Study|Ineligible|1|||
25147738|NCT01932697|50261731|FG001|Overall Study|Ineligible|0|||
25147739|NCT01970527|50261741|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
25147740|NCT01970527|50261742|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
25147741|NCT01970527|50261741|FG000|Treatment|Disease progression|0|||
25147742|NCT01970527|50261742|FG001|Treatment|Disease progression|1|||
25147743|NCT01970527|50261741|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
25147744|NCT01970527|50261742|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
25274608|NCT01090011|50588626|FG000|Overall Study|Adverse Event|32|||
25147745|NCT01970527|50261741|FG000|Treatment|Death|0|||
25147746|NCT01970527|50261742|FG001|Treatment|Death|1|||
25147747|NCT01970527|50261741|FG000|Follow-up Clinic Visit|Disease progression|1|||
25147748|NCT01970527|50261742|FG001|Follow-up Clinic Visit|Disease progression|1|||
25147749|NCT01970527|50261741|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
25147750|NCT01970527|50261742|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
25147751|NCT01970527|50261741|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
25147752|NCT01970527|50261742|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
25147753|NCT01931995|50261753|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
25147754|NCT01931995|50261754|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
25147755|NCT01931995|50261753|FG000|First Intervention (1 Day)|Physician Decision|1|||
25147756|NCT01931995|50261754|FG001|First Intervention (1 Day)|Physician Decision|1|||
25147757|NCT01931995|50261753|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
25147758|NCT01931995|50261754|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
25147759|NCT01408576|50261763|FG000|Overall Study|Lack of Efficacy|17|||
25147760|NCT01408576|50261764|FG001|Overall Study|Lack of Efficacy|30|||
25147761|NCT01408576|50261765|FG002|Overall Study|Lack of Efficacy|48|||
25147762|NCT01408576|50261763|FG000|Overall Study|Protocol Violation|1|||
25147763|NCT01408576|50261764|FG001|Overall Study|Protocol Violation|2|||
25147764|NCT01408576|50261765|FG002|Overall Study|Protocol Violation|2|||
25147765|NCT01408576|50261763|FG000|Overall Study|Lost to Follow-up|10|||
25147766|NCT01408576|50261764|FG001|Overall Study|Lost to Follow-up|9|||
25147767|NCT01408576|50261765|FG002|Overall Study|Lost to Follow-up|17|||
25147768|NCT01408576|50261763|FG000|Overall Study|Withdrawal by Subject|34|||
25147769|NCT01408576|50261764|FG001|Overall Study|Withdrawal by Subject|60|||
25147770|NCT01408576|50261765|FG002|Overall Study|Withdrawal by Subject|66|||
25147771|NCT01408576|50261763|FG000|Overall Study|Sponsor terminated study|89|||
25147772|NCT01408576|50261764|FG001|Overall Study|Sponsor terminated study|333|||
25147773|NCT01408576|50261765|FG002|Overall Study|Sponsor terminated study|330|||
25147774|NCT01408576|50261763|FG000|Overall Study|AE, serious fatal|4|||
25147775|NCT01408576|50261764|FG001|Overall Study|AE, serious fatal|4|||
25147776|NCT01408576|50261765|FG002|Overall Study|AE, serious fatal|1|||
25147777|NCT01408576|50261763|FG000|Overall Study|SAE, non-fatal|11|||
25147778|NCT01408576|50261764|FG001|Overall Study|SAE, non-fatal|23|||
25147779|NCT01408576|50261765|FG002|Overall Study|SAE, non-fatal|14|||
25147780|NCT01408576|50261763|FG000|Overall Study|AE, non-serious non-fatal|12|||
25147781|NCT01408576|50261764|FG001|Overall Study|AE, non-serious non-fatal|19|||
25147782|NCT01408576|50261765|FG002|Overall Study|AE, non-serious non-fatal|11|||
25147783|NCT01408576|50261763|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
25147784|NCT01408576|50261764|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
25147785|NCT01408576|50261765|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
25147786|NCT01408576|50261763|FG000|Overall Study|AE, unknown type|0|||
25147787|NCT01408576|50261764|FG001|Overall Study|AE, unknown type|1|||
25147788|NCT01408576|50261765|FG002|Overall Study|AE, unknown type|0|||
25147789|NCT01408576|50261763|FG000|Overall Study|Other|10|||
25147790|NCT01408576|50261764|FG001|Overall Study|Other|16|||
25147791|NCT01408576|50261765|FG002|Overall Study|Other|18|||
25147792|NCT01427920|50261787|FG000|Overall Study|Adverse Event|1|||
25147793|NCT01427920|50261788|FG001|Overall Study|Adverse Event|2|||
25147794|NCT01427920|50261787|FG000|Overall Study|Lack of Efficacy|1|||
25147795|NCT01427920|50261788|FG001|Overall Study|Lack of Efficacy|0|||
25147796|NCT01427920|50261787|FG000|Overall Study|Protocol Violation|1|||
25147797|NCT01427920|50261788|FG001|Overall Study|Protocol Violation|3|||
25147798|NCT01427920|50261787|FG000|Overall Study|Withdrawal Criteria|4|||
25147799|NCT01427920|50261788|FG001|Overall Study|Withdrawal Criteria|4|||
25147800|NCT01427920|50261787|FG000|Overall Study|Unclassified|2|||
25147801|NCT01427920|50261788|FG001|Overall Study|Unclassified|8|||
25147802|NCT01427608|50261796|FG000|Overall Study|Death|1|||
25147803|NCT01427608|50261797|FG001|Overall Study|Death|0|||
25147804|NCT01427608|50261796|FG000|Overall Study|Withdrawal by Subject|7|||
25147805|NCT01427608|50261797|FG001|Overall Study|Withdrawal by Subject|3|||
25147806|NCT01427608|50261796|FG000|Overall Study|Relapsed-all cause|13|||
25147807|NCT01427608|50261797|FG001|Overall Study|Relapsed-all cause|34|||
25147808|NCT01427608|50261796|FG000|Overall Study|Events not attributed to study meds|0|||
25147809|NCT01427608|50261797|FG001|Overall Study|Events not attributed to study meds|1|||
25147810|NCT01408030|50261809|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
25147811|NCT01408030|50261810|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
25147812|NCT01408030|50261811|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
25147813|NCT01408030|50261812|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
25147814|NCT01408030|50261809|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
25147815|NCT01408030|50261810|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
25147816|NCT01408030|50261811|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
25147817|NCT01408030|50261812|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
25147818|NCT01408030|50261809|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
25147819|NCT01408030|50261810|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
25147820|NCT01408030|50261811|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
25147821|NCT01408030|50261812|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
25147822|NCT01408030|50261809|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
25147823|NCT01408030|50261810|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
25147824|NCT01408030|50261811|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
25147825|NCT01408030|50261812|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
25147826|NCT01408030|50261809|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
25147827|NCT01408030|50261810|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
25147828|NCT01408030|50261811|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
25147829|NCT01408030|50261812|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
25147830|NCT01408030|50261809|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
25147831|NCT01408030|50261810|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
25147832|NCT01408030|50261811|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
25147833|NCT01408030|50261812|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
25147834|NCT01408030|50261809|FG000|Observation Phase (Off Drug)|Other|1|||
25147835|NCT01408030|50261810|FG001|Observation Phase (Off Drug)|Other|1|||
25147836|NCT01408030|50261811|FG002|Observation Phase (Off Drug)|Other|1|||
25147837|NCT01408030|50261812|FG003|Observation Phase (Off Drug)|Other|1|||
25147838|NCT01897532|50261824|FG000|Discontinuation From Treatment|Not Treated|7|||
25147839|NCT01897532|50261825|FG001|Discontinuation From Treatment|Not Treated|5|||
25147840|NCT01897532|50261824|FG000|Discontinuation From Treatment|Other reason than specified|196|||
25147841|NCT01897532|50261825|FG001|Discontinuation From Treatment|Other reason than specified|176|||
25147842|NCT01897532|50261824|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
25147843|NCT01897532|50261825|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
25147844|NCT01897532|50261824|FG000|Discontinuation From Treatment|Non compliance|24|||
25147845|NCT01897532|50261825|FG001|Discontinuation From Treatment|Non compliance|15|||
25147846|NCT01897532|50261824|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
25147847|NCT01897532|50261825|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
25147848|NCT01897532|50261824|FG000|Discontinuation From Trial|Not Treated|7|||
25147849|NCT01897532|50261825|FG001|Discontinuation From Trial|Not Treated|5|||
25147850|NCT01897532|50261824|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
25147851|NCT01897532|50261825|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
25147852|NCT01923428|50261835|FG000|Overall Study|Adverse Event|8|||
25147853|NCT01923428|50261836|FG001|Overall Study|Adverse Event|6|||
25147854|NCT01923428|50261837|FG002|Overall Study|Adverse Event|3|||
25147855|NCT01923428|50261838|FG003|Overall Study|Adverse Event|3|||
25147856|NCT01923428|50261835|FG000|Overall Study|Withdrawal by Subject|5|||
25147857|NCT01923428|50261836|FG001|Overall Study|Withdrawal by Subject|3|||
25147858|NCT01923428|50261837|FG002|Overall Study|Withdrawal by Subject|0|||
25147859|NCT01923428|50261838|FG003|Overall Study|Withdrawal by Subject|4|||
25147860|NCT01923428|50261835|FG000|Overall Study|Lost to Follow-up|2|||
25147861|NCT01923428|50261836|FG001|Overall Study|Lost to Follow-up|1|||
25147862|NCT01923428|50261837|FG002|Overall Study|Lost to Follow-up|5|||
25147863|NCT01923428|50261838|FG003|Overall Study|Lost to Follow-up|0|||
25147864|NCT01923428|50261835|FG000|Overall Study|Protocol Violation|3|||
25147865|NCT01923428|50261836|FG001|Overall Study|Protocol Violation|0|||
25147866|NCT01923428|50261837|FG002|Overall Study|Protocol Violation|2|||
25147867|NCT01923428|50261838|FG003|Overall Study|Protocol Violation|1|||
25274609|NCT01090011|50588626|FG000|Overall Study|Protocol Violation|1|||
25147868|NCT01923428|50261835|FG000|Overall Study|Non Compliance to treatment|1|||
25147869|NCT01923428|50261836|FG001|Overall Study|Non Compliance to treatment|2|||
25147870|NCT01923428|50261837|FG002|Overall Study|Non Compliance to treatment|0|||
25147871|NCT01923428|50261838|FG003|Overall Study|Non Compliance to treatment|1|||
25147872|NCT01923428|50261835|FG000|Overall Study|Lack of Efficacy|0|||
25147873|NCT01923428|50261836|FG001|Overall Study|Lack of Efficacy|0|||
25147874|NCT01923428|50261837|FG002|Overall Study|Lack of Efficacy|1|||
25147875|NCT01923428|50261838|FG003|Overall Study|Lack of Efficacy|1|||
25147876|NCT01896986|50261850|FG000|Overall Study|samples lost|14|||
25147877|NCT01896986|50261851|FG001|Overall Study|samples lost|23|||
25147878|NCT01896128|50261859|FG000|Overall Study|Withdrawal by Subject|3|||
25147879|NCT01896128|50261860|FG001|Overall Study|Withdrawal by Subject|3|||
25147880|NCT01949870|50261866|FG000|Overall Study|Lack of Efficacy|2|||
25147881|NCT01949870|50261866|FG000|Overall Study|Adverse Event|1|||
25147882|NCT01949870|50261866|FG000|Overall Study|Study termination|1|||
25274610|NCT01090011|50588626|FG000|Overall Study|Refusal to start/continue medication|5|||
25147883|NCT01949870|50261866|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
25147884|NCT01949480|50261872|FG000|Overall Study|Physician Decision|5|||
25147885|NCT01949480|50261873|FG001|Overall Study|Physician Decision|8|||
25147886|NCT01949090|50261884|FG000|Overall Study|Serious Adverse Event|0|||
25147887|NCT01949090|50261885|FG001|Overall Study|Serious Adverse Event|1|||
25147888|NCT01949090|50261886|FG002|Overall Study|Serious Adverse Event|2|||
25147889|NCT01949090|50261887|FG003|Overall Study|Serious Adverse Event|0|||
25147890|NCT01949090|50261888|FG004|Overall Study|Serious Adverse Event|1|||
25147891|NCT01949090|50261884|FG000|Overall Study|Withdrawal by Subject|2|||
25147892|NCT01949090|50261885|FG001|Overall Study|Withdrawal by Subject|0|||
25147893|NCT01949090|50261886|FG002|Overall Study|Withdrawal by Subject|0|||
25147894|NCT01949090|50261887|FG003|Overall Study|Withdrawal by Subject|0|||
25147895|NCT01949090|50261888|FG004|Overall Study|Withdrawal by Subject|1|||
25147896|NCT01949090|50261884|FG000|Overall Study|Protocol non-compliance|0|||
25147897|NCT01949090|50261885|FG001|Overall Study|Protocol non-compliance|0|||
25147898|NCT01949090|50261886|FG002|Overall Study|Protocol non-compliance|0|||
25147899|NCT01949090|50261887|FG003|Overall Study|Protocol non-compliance|0|||
25147900|NCT01949090|50261888|FG004|Overall Study|Protocol non-compliance|1|||
25147901|NCT01949090|50261884|FG000|Overall Study|Lost to Follow-up|2|||
25147902|NCT01949090|50261885|FG001|Overall Study|Lost to Follow-up|1|||
25147903|NCT01949090|50261886|FG002|Overall Study|Lost to Follow-up|0|||
25147904|NCT01949090|50261887|FG003|Overall Study|Lost to Follow-up|1|||
25147905|NCT01949090|50261888|FG004|Overall Study|Lost to Follow-up|1|||
25147906|NCT01948076|50261903|FG000|Overall Study|Withdrawal by Subject|0|||
25147907|NCT01948076|50261904|FG001|Overall Study|Withdrawal by Subject|1|||
25147908|NCT01922258|50261914|FG000|Overall Study|Lost to Follow-up|1|||
25147909|NCT01922258|50261915|FG001|Overall Study|Lost to Follow-up|1|||
25147910|NCT01922258|50261914|FG000|Overall Study|Adverse Event|9|||
25147911|NCT01922258|50261915|FG001|Overall Study|Adverse Event|2|||
25147912|NCT01922258|50261914|FG000|Overall Study|Met Withdrawal Criteria|0|||
25147913|NCT01922258|50261915|FG001|Overall Study|Met Withdrawal Criteria|4|||
25147914|NCT01922258|50261914|FG000|Overall Study|Withdrawn by the Investigator|1|||
25147915|NCT01922258|50261915|FG001|Overall Study|Withdrawn by the Investigator|4|||
25147916|NCT01922258|50261914|FG000|Overall Study|Withdrawal by participant|5|||
25147917|NCT01922258|50261915|FG001|Overall Study|Withdrawal by participant|5|||
25147918|NCT01406938|50261923|FG000|Induction Period|Subject/guardian decision|6|||
25147919|NCT01406938|50261924|FG001|Induction Period|Subject/guardian decision|8|||
25147920|NCT01406938|50261925|FG002|Induction Period|Subject/guardian decision|0|||
25147921|NCT01406938|50261926|FG003|Induction Period|Subject/guardian decision|0|||
25147922|NCT01406938|50261927|FG004|Induction Period|Subject/guardian decision|0|||
25147923|NCT01406938|50261928|FG005|Induction Period|Subject/guardian decision|0|||
25147924|NCT01406938|50261923|FG000|Induction Period|Protocol deviation|1|||
25147925|NCT01406938|50261924|FG001|Induction Period|Protocol deviation|0|||
25147926|NCT01406938|50261925|FG002|Induction Period|Protocol deviation|0|||
25147927|NCT01406938|50261926|FG003|Induction Period|Protocol deviation|0|||
25147928|NCT01406938|50261927|FG004|Induction Period|Protocol deviation|0|||
25147929|NCT01406938|50261928|FG005|Induction Period|Protocol deviation|0|||
25147930|NCT01406938|50261923|FG000|Induction Period|Adverse Event|8|||
25147931|NCT01406938|50261924|FG001|Induction Period|Adverse Event|9|||
25147932|NCT01406938|50261925|FG002|Induction Period|Adverse Event|0|||
25147933|NCT01406938|50261926|FG003|Induction Period|Adverse Event|0|||
25147934|NCT01406938|50261927|FG004|Induction Period|Adverse Event|0|||
25147935|NCT01406938|50261928|FG005|Induction Period|Adverse Event|0|||
25147936|NCT01406938|50261923|FG000|Induction Period|Lack of Efficacy|1|||
25147937|NCT01406938|50261924|FG001|Induction Period|Lack of Efficacy|0|||
25147938|NCT01406938|50261925|FG002|Induction Period|Lack of Efficacy|0|||
25147939|NCT01406938|50261926|FG003|Induction Period|Lack of Efficacy|0|||
25147940|NCT01406938|50261927|FG004|Induction Period|Lack of Efficacy|0|||
25147941|NCT01406938|50261928|FG005|Induction Period|Lack of Efficacy|0|||
25147942|NCT01406938|50261923|FG000|Induction Period|Lost to Follow-up|2|||
25147943|NCT01406938|50261924|FG001|Induction Period|Lost to Follow-up|3|||
25147944|NCT01406938|50261925|FG002|Induction Period|Lost to Follow-up|0|||
25147945|NCT01406938|50261926|FG003|Induction Period|Lost to Follow-up|0|||
25147946|NCT01406938|50261927|FG004|Induction Period|Lost to Follow-up|0|||
25147947|NCT01406938|50261928|FG005|Induction Period|Lost to Follow-up|0|||
25147948|NCT01406938|50261923|FG000|Maintenance Period|Adverse Event|0|||
25147949|NCT01406938|50261924|FG001|Maintenance Period|Adverse Event|0|||
25147950|NCT01406938|50261925|FG002|Maintenance Period|Adverse Event|2|||
25147951|NCT01406938|50261926|FG003|Maintenance Period|Adverse Event|8|||
25147952|NCT01406938|50261927|FG004|Maintenance Period|Adverse Event|4|||
25147953|NCT01406938|50261928|FG005|Maintenance Period|Adverse Event|2|||
25147954|NCT01406938|50261923|FG000|Maintenance Period|Death|0|||
25147955|NCT01406938|50261924|FG001|Maintenance Period|Death|0|||
25147956|NCT01406938|50261925|FG002|Maintenance Period|Death|0|||
25147957|NCT01406938|50261926|FG003|Maintenance Period|Death|0|||
25147958|NCT01406938|50261927|FG004|Maintenance Period|Death|1|||
25147959|NCT01406938|50261928|FG005|Maintenance Period|Death|0|||
25147960|NCT01406938|50261923|FG000|Maintenance Period|Subject/guardian decision|0|||
25147961|NCT01406938|50261924|FG001|Maintenance Period|Subject/guardian decision|0|||
25147962|NCT01406938|50261925|FG002|Maintenance Period|Subject/guardian decision|11|||
25147963|NCT01406938|50261926|FG003|Maintenance Period|Subject/guardian decision|7|||
25147964|NCT01406938|50261927|FG004|Maintenance Period|Subject/guardian decision|10|||
25147965|NCT01406938|50261928|FG005|Maintenance Period|Subject/guardian decision|7|||
25147966|NCT01406938|50261923|FG000|Maintenance Period|Protocol Violation|0|||
25147967|NCT01406938|50261924|FG001|Maintenance Period|Protocol Violation|0|||
25147968|NCT01406938|50261925|FG002|Maintenance Period|Protocol Violation|2|||
25147969|NCT01406938|50261926|FG003|Maintenance Period|Protocol Violation|2|||
25147970|NCT01406938|50261927|FG004|Maintenance Period|Protocol Violation|2|||
25147971|NCT01406938|50261928|FG005|Maintenance Period|Protocol Violation|2|||
25147972|NCT01406938|50261923|FG000|Maintenance Period|Pregnancy|0|||
25147973|NCT01406938|50261924|FG001|Maintenance Period|Pregnancy|0|||
25147974|NCT01406938|50261925|FG002|Maintenance Period|Pregnancy|0|||
25147975|NCT01406938|50261926|FG003|Maintenance Period|Pregnancy|0|||
25147976|NCT01406938|50261927|FG004|Maintenance Period|Pregnancy|1|||
25147977|NCT01406938|50261928|FG005|Maintenance Period|Pregnancy|0|||
25147978|NCT01406938|50261923|FG000|Maintenance Period|Lost to Follow-up|0|||
25147979|NCT01406938|50261924|FG001|Maintenance Period|Lost to Follow-up|0|||
25147980|NCT01406938|50261925|FG002|Maintenance Period|Lost to Follow-up|0|||
25147981|NCT01406938|50261926|FG003|Maintenance Period|Lost to Follow-up|0|||
25147982|NCT01406938|50261927|FG004|Maintenance Period|Lost to Follow-up|4|||
25147983|NCT01406938|50261928|FG005|Maintenance Period|Lost to Follow-up|0|||
25147984|NCT01406938|50261923|FG000|Maintenance Period|Lack of Efficacy|0|||
25147985|NCT01406938|50261924|FG001|Maintenance Period|Lack of Efficacy|0|||
25147986|NCT01406938|50261925|FG002|Maintenance Period|Lack of Efficacy|2|||
25147987|NCT01406938|50261926|FG003|Maintenance Period|Lack of Efficacy|1|||
25147988|NCT01406938|50261927|FG004|Maintenance Period|Lack of Efficacy|3|||
25147989|NCT01406938|50261928|FG005|Maintenance Period|Lack of Efficacy|5|||
25147990|NCT01406938|50261923|FG000|Follow up|Lack of Efficacy|3|||
25147991|NCT01406938|50261924|FG001|Follow up|Lack of Efficacy|2|||
25147992|NCT01406938|50261925|FG002|Follow up|Lack of Efficacy|1|||
25016178|NCT03226275|50111090|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
25016179|NCT03226275|50111091|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
25016180|NCT03226275|50111092|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
25147993|NCT01406938|50261926|FG003|Follow up|Lack of Efficacy|0|||
25147994|NCT01406938|50261927|FG004|Follow up|Lack of Efficacy|0|||
25147995|NCT01406938|50261928|FG005|Follow up|Lack of Efficacy|0|||
25147996|NCT01406938|50261923|FG000|Follow up|Patient/guardian decision|4|||
25147997|NCT01406938|50261924|FG001|Follow up|Patient/guardian decision|2|||
25147998|NCT01406938|50261925|FG002|Follow up|Patient/guardian decision|4|||
25147999|NCT01406938|50261926|FG003|Follow up|Patient/guardian decision|2|||
25148000|NCT01406938|50261927|FG004|Follow up|Patient/guardian decision|4|||
25148001|NCT01406938|50261928|FG005|Follow up|Patient/guardian decision|1|||
25148002|NCT01406938|50261923|FG000|Follow up|Protocol Violation|0|||
25148003|NCT01406938|50261924|FG001|Follow up|Protocol Violation|0|||
25148004|NCT01406938|50261925|FG002|Follow up|Protocol Violation|1|||
25148005|NCT01406938|50261926|FG003|Follow up|Protocol Violation|0|||
25148006|NCT01406938|50261927|FG004|Follow up|Protocol Violation|0|||
25148007|NCT01406938|50261928|FG005|Follow up|Protocol Violation|0|||
25148008|NCT01406938|50261923|FG000|Follow up|Physician Decision|0|||
25148009|NCT01406938|50261924|FG001|Follow up|Physician Decision|0|||
25148010|NCT01406938|50261925|FG002|Follow up|Physician Decision|2|||
25148011|NCT01406938|50261926|FG003|Follow up|Physician Decision|0|||
25148012|NCT01406938|50261927|FG004|Follow up|Physician Decision|3|||
25148013|NCT01406938|50261928|FG005|Follow up|Physician Decision|1|||
25148014|NCT01406938|50261923|FG000|Follow up|Lost to Follow-up|1|||
25148015|NCT01406938|50261924|FG001|Follow up|Lost to Follow-up|1|||
25148016|NCT01406938|50261925|FG002|Follow up|Lost to Follow-up|0|||
25148017|NCT01406938|50261926|FG003|Follow up|Lost to Follow-up|1|||
25148018|NCT01406938|50261927|FG004|Follow up|Lost to Follow-up|2|||
25148019|NCT01406938|50261928|FG005|Follow up|Lost to Follow-up|1|||
25184520|NCT01272219|50333208|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
25148020|NCT01405924|50261948|FG000|Overall Study|Protocol Violation|8|||
25016181|NCT04189081|50111105|FG000|Overall Study|Lost to Follow-up|1|||
25016182|NCT04189081|50111106|FG001|Overall Study|Lost to Follow-up|0|||
25016183|NCT04189081|50111107|FG002|Overall Study|Lost to Follow-up|0|||
25016184|NCT04189081|50111105|FG000|Overall Study|Withdrawal by Subject|0|||
25016185|NCT04189081|50111106|FG001|Overall Study|Withdrawal by Subject|0|||
25016186|NCT04189081|50111107|FG002|Overall Study|Withdrawal by Subject|1|||
25016187|NCT04187989|50111117|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
25016188|NCT04187989|50111118|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
25016189|NCT04187989|50111117|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
25016190|NCT04187989|50111118|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
25016191|NCT01150890|50111128|FG000|Overall Study|Other|0|||
25016192|NCT01150890|50111129|FG001|Overall Study|Other|1|||
25016193|NCT01150890|50111130|FG002|Overall Study|Other|0|||
25016194|NCT01150890|50111131|FG003|Overall Study|Other|2|||
25016195|NCT01150890|50111128|FG000|Overall Study|Pregnancy|0|||
25016196|NCT01150890|50111129|FG001|Overall Study|Pregnancy|0|||
25016197|NCT01150890|50111130|FG002|Overall Study|Pregnancy|0|||
25016198|NCT01150890|50111131|FG003|Overall Study|Pregnancy|1|||
25016199|NCT01150890|50111128|FG000|Overall Study|Administrative Decision|4|||
25016200|NCT01150890|50111129|FG001|Overall Study|Administrative Decision|4|||
25016201|NCT01150890|50111130|FG002|Overall Study|Administrative Decision|5|||
25016202|NCT01150890|50111131|FG003|Overall Study|Administrative Decision|6|||
25016203|NCT01150890|50111128|FG000|Overall Study|Ineligibility determined|0|||
25016204|NCT01150890|50111129|FG001|Overall Study|Ineligibility determined|1|||
25016205|NCT01150890|50111130|FG002|Overall Study|Ineligibility determined|0|||
25016206|NCT01150890|50111131|FG003|Overall Study|Ineligibility determined|0|||
25148021|NCT01405924|50261948|FG000|Overall Study|Missing/Incomplete Data|2|||
25016207|NCT01150890|50111128|FG000|Overall Study|Adverse Event|0|||
25148022|NCT01426438|50261956|FG000|Overall Study|Lost to Follow-up|1|||
25148023|NCT01426438|50261957|FG001|Overall Study|Lost to Follow-up|3|||
25148024|NCT01426438|50261956|FG000|Overall Study|Off study Treatment|9|||
25148025|NCT01426438|50261957|FG001|Overall Study|Off study Treatment|3|||
25148026|NCT01426438|50261956|FG000|Overall Study|Poor scan quality|3|||
25148027|NCT01426438|50261957|FG001|Overall Study|Poor scan quality|2|||
25148028|NCT01426438|50261956|FG000|Overall Study|Missed Scan|2|||
25148029|NCT01426438|50261957|FG001|Overall Study|Missed Scan|2|||
25148030|NCT01425814|50261963|FG000|Period 1|Stability criteria not fulfilled|0|||
25148031|NCT01425814|50261964|FG001|Period 1|Stability criteria not fulfilled|1|||
25148032|NCT01425814|50261965|FG002|Period 1|Stability criteria not fulfilled|0|||
25274611|NCT01090011|50588626|FG000|Overall Study|Other reason not defined above|5|||
25148033|NCT01425814|50261966|FG003|Period 1|Stability criteria not fulfilled|0|||
25148034|NCT01425814|50261967|FG004|Period 1|Stability criteria not fulfilled|0|||
25148035|NCT01425814|50261968|FG005|Period 1|Stability criteria not fulfilled|0|||
25148036|NCT01425814|50261963|FG000|Period 2|Stability criteria not fulfilled|0|||
25148037|NCT01425814|50261964|FG001|Period 2|Stability criteria not fulfilled|1|||
25148038|NCT01425814|50261965|FG002|Period 2|Stability criteria not fulfilled|0|||
25148039|NCT01425814|50261966|FG003|Period 2|Stability criteria not fulfilled|0|||
25148040|NCT01425814|50261967|FG004|Period 2|Stability criteria not fulfilled|0|||
25148041|NCT01425814|50261968|FG005|Period 2|Stability criteria not fulfilled|0|||
25148042|NCT01425814|50261963|FG000|Period 3|Adverse Event|0|||
25148043|NCT01425814|50261964|FG001|Period 3|Adverse Event|0|||
25148044|NCT01425814|50261965|FG002|Period 3|Adverse Event|0|||
25148045|NCT01425814|50261966|FG003|Period 3|Adverse Event|0|||
25274612|NCT01251653|50588647|FG000|Overall Study|Progressive Disease|1|||
25274613|NCT01251653|50588648|FG001|Overall Study|Progressive Disease|7|||
25148046|NCT01425814|50261967|FG004|Period 3|Adverse Event|0|||
25148047|NCT01425814|50261968|FG005|Period 3|Adverse Event|1|||
25148048|NCT01425814|50261963|FG000|Period 4|Adverse Event|1|||
25148049|NCT01425814|50261964|FG001|Period 4|Adverse Event|0|||
25148050|NCT01425814|50261965|FG002|Period 4|Adverse Event|1|||
25148051|NCT01425814|50261966|FG003|Period 4|Adverse Event|0|||
25148052|NCT01425814|50261967|FG004|Period 4|Adverse Event|0|||
25148053|NCT01425814|50261968|FG005|Period 4|Adverse Event|0|||
25148054|NCT01425814|50261963|FG000|Period 5|Stability criteria not fulfilled|0|||
25148055|NCT01425814|50261964|FG001|Period 5|Stability criteria not fulfilled|0|||
25148056|NCT01425814|50261965|FG002|Period 5|Stability criteria not fulfilled|1|||
25148057|NCT01425814|50261966|FG003|Period 5|Stability criteria not fulfilled|0|||
25148058|NCT01425814|50261967|FG004|Period 5|Stability criteria not fulfilled|0|||
25148059|NCT01425814|50261968|FG005|Period 5|Stability criteria not fulfilled|1|||
25148060|NCT01782495|50261993|FG000|Overall Study|Adverse Event|0|||
25148061|NCT01782495|50261994|FG001|Overall Study|Adverse Event|0|||
25148062|NCT01782495|50261995|FG002|Overall Study|Adverse Event|0|||
25148063|NCT01782495|50261996|FG003|Overall Study|Adverse Event|0|||
25148064|NCT01782495|50261997|FG004|Overall Study|Adverse Event|0|||
25148065|NCT01782495|50261998|FG005|Overall Study|Adverse Event|0|||
25148066|NCT01782495|50261999|FG006|Overall Study|Adverse Event|0|||
25148067|NCT01782495|50262000|FG007|Overall Study|Adverse Event|2|||
25148068|NCT01782495|50262001|FG008|Overall Study|Adverse Event|0|||
25148069|NCT01782495|50262002|FG009|Overall Study|Adverse Event|0|||
25148070|NCT01782495|50262003|FG010|Overall Study|Adverse Event|0|||
25148071|NCT01782495|50261993|FG000|Overall Study|Withdrew Consent|0|||
25148072|NCT01782495|50261994|FG001|Overall Study|Withdrew Consent|1|||
25148073|NCT01782495|50261995|FG002|Overall Study|Withdrew Consent|0|||
25148074|NCT01782495|50261996|FG003|Overall Study|Withdrew Consent|0|||
25016208|NCT01150890|50111129|FG001|Overall Study|Adverse Event|0|||
25148075|NCT01782495|50261997|FG004|Overall Study|Withdrew Consent|0|||
25148076|NCT01782495|50261998|FG005|Overall Study|Withdrew Consent|0|||
25148077|NCT01782495|50261999|FG006|Overall Study|Withdrew Consent|0|||
25148078|NCT01782495|50262000|FG007|Overall Study|Withdrew Consent|1|||
25148079|NCT01782495|50262001|FG008|Overall Study|Withdrew Consent|0|||
25148080|NCT01782495|50262002|FG009|Overall Study|Withdrew Consent|0|||
25148081|NCT01782495|50262003|FG010|Overall Study|Withdrew Consent|0|||
25148082|NCT01922102|50262030|FG000|Overall Study|Withdrawal by Subject|7|||
25148083|NCT01922102|50262031|FG001|Overall Study|Withdrawal by Subject|3|||
25148084|NCT01922102|50262032|FG002|Overall Study|Withdrawal by Subject|7|||
25148085|NCT01922102|50262030|FG000|Overall Study|Physician Decision|0|||
25148086|NCT01922102|50262031|FG001|Overall Study|Physician Decision|2|||
25148087|NCT01922102|50262032|FG002|Overall Study|Physician Decision|1|||
25148088|NCT01922102|50262030|FG000|Overall Study|Adverse Event|1|||
25148089|NCT01922102|50262031|FG001|Overall Study|Adverse Event|2|||
25148090|NCT01922102|50262032|FG002|Overall Study|Adverse Event|0|||
25148091|NCT01922102|50262030|FG000|Overall Study|Lost to Follow-up|1|||
25148092|NCT01922102|50262031|FG001|Overall Study|Lost to Follow-up|0|||
25148093|NCT01922102|50262032|FG002|Overall Study|Lost to Follow-up|0|||
25148094|NCT01922102|50262030|FG000|Overall Study|Administrative problems|0|||
25148095|NCT01922102|50262031|FG001|Overall Study|Administrative problems|2|||
25148096|NCT01922102|50262032|FG002|Overall Study|Administrative problems|0|||
25148097|NCT01405768|50262046|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
25148098|NCT01405768|50262047|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
25148099|NCT01913353|50262055|FG000|Overall Study|Adverse Event|2|||
25148100|NCT01913353|50262056|FG001|Overall Study|Adverse Event|0|||
25148101|NCT01913353|50262055|FG000|Overall Study|Physician Decision|0|||
25148102|NCT01913353|50262056|FG001|Overall Study|Physician Decision|2|||
25148103|NCT01913353|50262055|FG000|Overall Study|Withdrawal by Subject|20|||
25148104|NCT01913353|50262056|FG001|Overall Study|Withdrawal by Subject|6|||
25148105|NCT01913353|50262055|FG000|Overall Study|multiple reasons|10|||
25148106|NCT01913353|50262056|FG001|Overall Study|multiple reasons|7|||
25148107|NCT01754259|50262071|FG000|Overall Study|Withdrawal by Subject|2|||
25148108|NCT01754259|50262072|FG001|Overall Study|Withdrawal by Subject|4|||
25148109|NCT01754259|50262071|FG000|Overall Study|Adverse Event|3|||
25148110|NCT01754259|50262072|FG001|Overall Study|Adverse Event|1|||
25148111|NCT01754259|50262071|FG000|Overall Study|Lost to Follow-up|0|||
25148112|NCT01754259|50262072|FG001|Overall Study|Lost to Follow-up|1|||
25148113|NCT01405456|50262080|FG000|Overall Study|Lost to Follow-up|2|||
25148114|NCT01405456|50262081|FG001|Overall Study|Lost to Follow-up|1|||
25148115|NCT01405456|50262080|FG000|Overall Study|Physician Decision|1|||
25148116|NCT01405456|50262081|FG001|Overall Study|Physician Decision|0|||
25148117|NCT01404988|50262090|FG000|Overall Study|Death|2|||
25148118|NCT01404988|50262091|FG001|Overall Study|Death|0|||
25148119|NCT01404988|50262092|FG002|Overall Study|Death|2|||
25148120|NCT01404988|50262090|FG000|Overall Study|Adverse Event|1|||
25148121|NCT01404988|50262091|FG001|Overall Study|Adverse Event|0|||
25148122|NCT01404988|50262092|FG002|Overall Study|Adverse Event|0|||
25148123|NCT01404988|50262090|FG000|Overall Study|Withdrawal by Subject|2|||
25148124|NCT01404988|50262091|FG001|Overall Study|Withdrawal by Subject|2|||
25148125|NCT01404988|50262092|FG002|Overall Study|Withdrawal by Subject|0|||
25148126|NCT01404988|50262090|FG000|Overall Study|Lost to Follow-up|1|||
25148127|NCT01404988|50262091|FG001|Overall Study|Lost to Follow-up|2|||
25148128|NCT01404988|50262092|FG002|Overall Study|Lost to Follow-up|1|||
25148129|NCT01389232|50262103|FG000|Overall Study|Had scaffold removed|15|||
25148130|NCT01389232|50262103|FG000|Overall Study|Personal reasons|2|||
25148131|NCT01389232|50262103|FG000|Overall Study|Adverse Event|1|||
25148132|NCT01389232|50262103|FG000|Overall Study|Death|1|||
25148133|NCT01404208|50262119|FG000|Overall Study|Discontinued|3|||
25148134|NCT01404208|50262120|FG001|Overall Study|Discontinued|0|||
25148135|NCT01617668|50262128|FG000|Overall Study|Adverse Event|7|||
25148136|NCT01617668|50262129|FG001|Overall Study|Adverse Event|0|||
25148137|NCT01617668|50262130|FG002|Overall Study|Adverse Event|12|||
25148138|NCT01617668|50262131|FG003|Overall Study|Adverse Event|5|||
25148139|NCT01617668|50262128|FG000|Overall Study|Physician Decision|1|||
25148140|NCT01617668|50262129|FG001|Overall Study|Physician Decision|2|||
25148141|NCT01617668|50262130|FG002|Overall Study|Physician Decision|3|||
25148142|NCT01617668|50262131|FG003|Overall Study|Physician Decision|0|||
25148143|NCT01617668|50262128|FG000|Overall Study|Progressive Disease|4|||
25148144|NCT01617668|50262129|FG001|Overall Study|Progressive Disease|4|||
25148145|NCT01617668|50262130|FG002|Overall Study|Progressive Disease|6|||
25148146|NCT01617668|50262131|FG003|Overall Study|Progressive Disease|9|||
25148147|NCT01617668|50262128|FG000|Overall Study|Subject/guardian decision|1|||
25148148|NCT01617668|50262129|FG001|Overall Study|Subject/guardian decision|3|||
25148149|NCT01617668|50262130|FG002|Overall Study|Subject/guardian decision|2|||
25148150|NCT01617668|50262131|FG003|Overall Study|Subject/guardian decision|1|||
25148151|NCT01425268|50262147|FG000|Overall Study|Withdrawal by Subject|2|||
25148152|NCT01425268|50262148|FG001|Overall Study|Withdrawal by Subject|0|||
25148153|NCT01425268|50262147|FG000|Overall Study|Sponsor Decision|5|||
25148154|NCT01425268|50262148|FG001|Overall Study|Sponsor Decision|0|||
25148155|NCT01425268|50262147|FG000|Overall Study|Physician Decision|1|||
25148156|NCT01425268|50262148|FG001|Overall Study|Physician Decision|0|||
25148157|NCT01425190|50262157|FG000|Overall Study|Full dose not consumed.|1|||
25148158|NCT01425190|50262158|FG001|Overall Study|Full dose not consumed.|0|||
25148159|NCT01425190|50262159|FG002|Overall Study|Full dose not consumed.|0|||
25148160|NCT01388530|50262167|FG000|Overall Study|Lost to Follow-up|5|||
25148161|NCT01895270|50262173|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
25148162|NCT01895270|50262174|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
25148163|NCT01895270|50262173|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
25148164|NCT01895270|50262174|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
25148165|NCT01895270|50262173|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
25148166|NCT01895270|50262174|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
25148167|NCT01895270|50262173|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
25148168|NCT01895270|50262174|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
25148169|NCT01895270|50262173|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
25148170|NCT01895270|50262174|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
25148171|NCT01895270|50262173|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
25148172|NCT01895270|50262174|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
25148173|NCT01895270|50262173|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
25148174|NCT01895270|50262174|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
25148175|NCT01424722|50262180|FG000|Overall Study|Sponsor terminated investigation|2258|||
25148176|NCT01424644|50262186|FG000|Overall Study|Adverse Event|2|||
25148177|NCT01424644|50262187|FG001|Overall Study|Adverse Event|0|||
25148178|NCT01424644|50262186|FG000|Overall Study|Withdrawal by Subject|9|||
25148179|NCT01424644|50262187|FG001|Overall Study|Withdrawal by Subject|12|||
25148180|NCT01424644|50262186|FG000|Overall Study|Lost to Follow-up|16|||
25148181|NCT01424644|50262187|FG001|Overall Study|Lost to Follow-up|12|||
25148182|NCT01424644|50262186|FG000|Overall Study|Protocol Violation|4|||
25148183|NCT01424644|50262187|FG001|Overall Study|Protocol Violation|3|||
25148184|NCT01424644|50262186|FG000|Overall Study|Administrative Reason|1|||
25148185|NCT01424644|50262187|FG001|Overall Study|Administrative Reason|0|||
25148186|NCT01424644|50262186|FG000|Overall Study|Unable to Classify|1|||
25148187|NCT01424644|50262187|FG001|Overall Study|Unable to Classify|0|||
25148188|NCT01920854|50262200|FG000|Overall Study|Withdrawal by Subject|1|||
25148189|NCT01920854|50262201|FG001|Overall Study|Withdrawal by Subject|0|||
25148190|NCT01920854|50262202|FG002|Overall Study|Withdrawal by Subject|0|||
25148191|NCT01920854|50262203|FG003|Overall Study|Withdrawal by Subject|0|||
25274614|NCT01251653|50588649|FG002|Overall Study|Progressive Disease|16|||
25148192|NCT01920854|50262204|FG004|Overall Study|Withdrawal by Subject|1|||
25148193|NCT01920854|50262205|FG005|Overall Study|Withdrawal by Subject|0|||
25148194|NCT01920854|50262206|FG006|Overall Study|Withdrawal by Subject|1|||
25148195|NCT01403194|50262241|FG000|Overall Study|Screen Failure|2|||
25148196|NCT01403194|50262241|FG000|Overall Study|Lost to Follow-up|8|||
25148197|NCT01403116|50262247|FG000|Overall Study|Adverse Event|7|||
25148198|NCT01403116|50262248|FG001|Overall Study|Adverse Event|4|||
25148199|NCT01403116|50262247|FG000|Overall Study|Lost to Follow-up|7|||
25148200|NCT01403116|50262248|FG001|Overall Study|Lost to Follow-up|5|||
25148201|NCT01403116|50262247|FG000|Overall Study|Withdrawal by Subject|12|||
25148202|NCT01403116|50262248|FG001|Overall Study|Withdrawal by Subject|15|||
25016209|NCT01150890|50111130|FG002|Overall Study|Adverse Event|2|||
25148203|NCT01403116|50262247|FG000|Overall Study|Non-compliance of study drug|3|||
25148204|NCT01403116|50262248|FG001|Overall Study|Non-compliance of study drug|0|||
25148205|NCT01403116|50262247|FG000|Overall Study|Protocol Violation|0|||
25148206|NCT01403116|50262248|FG001|Overall Study|Protocol Violation|1|||
25148207|NCT01403116|50262247|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
25148208|NCT01403116|50262248|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
25148209|NCT01403116|50262247|FG000|Overall Study|Hct >54%|2|||
25148210|NCT01403116|50262248|FG001|Overall Study|Hct >54%|0|||
25148211|NCT01403116|50262247|FG000|Overall Study|unable to keep appointments|0|||
25148212|NCT01403116|50262248|FG001|Overall Study|unable to keep appointments|2|||
25148213|NCT01402570|50262254|FG000|Overall Study|Adverse Event|1|||
25148214|NCT01753401|50262261|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
25148215|NCT01753401|50262262|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
25148216|NCT01753401|50262263|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
25148217|NCT01753401|50262264|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
25148218|NCT01753401|50262261|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
25148219|NCT01753401|50262262|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
25148220|NCT01753401|50262263|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
25148221|NCT01753401|50262264|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
25148222|NCT01753401|50262261|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
25148223|NCT01753401|50262262|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
25148224|NCT01753401|50262263|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
25148225|NCT01753401|50262264|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
25148226|NCT01753401|50262261|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
25274615|NCT01251653|50588650|FG003|Overall Study|Progressive Disease|4|||
25274616|NCT01251653|50588651|FG004|Overall Study|Progressive Disease|0|||
25016210|NCT01150890|50111131|FG003|Overall Study|Adverse Event|0|||
25148227|NCT01753401|50262262|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
25148228|NCT01753401|50262263|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
25148229|NCT01753401|50262264|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
25148230|NCT01753401|50262261|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
25148231|NCT01753401|50262262|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
25148232|NCT01753401|50262263|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
25148233|NCT01753401|50262264|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
25148234|NCT01753401|50262261|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
25148235|NCT01753401|50262262|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
25148236|NCT01753401|50262263|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
25148237|NCT01753401|50262264|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
25016211|NCT01150890|50111128|FG000|Overall Study|Withdrawal by Subject|0|||
25148238|NCT01753401|50262261|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
25148239|NCT01753401|50262262|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
25148240|NCT01753401|50262263|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
25148241|NCT01753401|50262264|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
25148242|NCT01618916|50262280|FG000|Overall Study|Adverse Event|1|||
25148243|NCT01618916|50262281|FG001|Overall Study|Adverse Event|0|||
25148244|NCT01618916|50262282|FG002|Overall Study|Adverse Event|0|||
25148245|NCT01618916|50262283|FG003|Overall Study|Adverse Event|0|||
25148246|NCT01618916|50262284|FG004|Overall Study|Adverse Event|0|||
25148247|NCT01618916|50262285|FG005|Overall Study|Adverse Event|0|||
25148248|NCT01618916|50262280|FG000|Overall Study|Withdrawal by Subject|0|||
25148249|NCT01618916|50262281|FG001|Overall Study|Withdrawal by Subject|1|||
25148250|NCT01618916|50262282|FG002|Overall Study|Withdrawal by Subject|1|||
25148251|NCT01618916|50262283|FG003|Overall Study|Withdrawal by Subject|0|||
25148252|NCT01618916|50262284|FG004|Overall Study|Withdrawal by Subject|1|||
25148253|NCT01618916|50262285|FG005|Overall Study|Withdrawal by Subject|0|||
25148254|NCT01618916|50262280|FG000|Overall Study|Lost to Follow-up|1|||
25148255|NCT01618916|50262281|FG001|Overall Study|Lost to Follow-up|0|||
25148256|NCT01618916|50262282|FG002|Overall Study|Lost to Follow-up|0|||
25148257|NCT01618916|50262283|FG003|Overall Study|Lost to Follow-up|2|||
25148258|NCT01618916|50262284|FG004|Overall Study|Lost to Follow-up|0|||
25148259|NCT01618916|50262285|FG005|Overall Study|Lost to Follow-up|0|||
25148260|NCT01753323|50262301|FG000|Overall Study|Lack of Efficacy|0|||
25148261|NCT01753323|50262302|FG001|Overall Study|Lack of Efficacy|0|||
25148262|NCT01753323|50262303|FG002|Overall Study|Lack of Efficacy|8|||
25148263|NCT01753323|50262301|FG000|Overall Study|Protocol deviation|1|||
25148264|NCT01753323|50262302|FG001|Overall Study|Protocol deviation|0|||
25148265|NCT01753323|50262303|FG002|Overall Study|Protocol deviation|0|||
25148266|NCT01753323|50262301|FG000|Overall Study|Adverse Event|0|||
25148267|NCT01753323|50262302|FG001|Overall Study|Adverse Event|0|||
25148268|NCT01753323|50262303|FG002|Overall Study|Adverse Event|1|||
25148269|NCT01894568|50262314|FG000|Overall Study|Adverse Event|2|||
25148270|NCT01894568|50262315|FG001|Overall Study|Adverse Event|3|||
25148271|NCT01894568|50262314|FG000|Overall Study|Protocol required discontinuation|2|||
25148272|NCT01894568|50262315|FG001|Overall Study|Protocol required discontinuation|1|||
25148273|NCT01894568|50262314|FG000|Overall Study|Withdrawal by Subject|5|||
25148274|NCT01894568|50262315|FG001|Overall Study|Withdrawal by Subject|5|||
25148275|NCT01894568|50262314|FG000|Overall Study|Physician Decision|1|||
25148276|NCT01894568|50262315|FG001|Overall Study|Physician Decision|0|||
25148277|NCT01894568|50262314|FG000|Overall Study|Lost to Follow-up|0|||
25148278|NCT01894568|50262315|FG001|Overall Study|Lost to Follow-up|1|||
25148279|NCT01618838|50262322|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
25148280|NCT01920152|50262329|FG000|Overall Study|Withdrawal by Subject|1|||
25148281|NCT01920152|50262330|FG001|Overall Study|Withdrawal by Subject|2|||
25148282|NCT01752933|50262338|FG000|Treatment|Disease Progression|3|||
25148283|NCT01752933|50262339|FG001|Treatment|Disease Progression|29|||
25148284|NCT01752933|50262338|FG000|Treatment|Withdrawal by Subject|0|||
25148285|NCT01752933|50262339|FG001|Treatment|Withdrawal by Subject|5|||
25148286|NCT01752933|50262338|FG000|Treatment|Adverse Event|1|||
25148287|NCT01752933|50262339|FG001|Treatment|Adverse Event|4|||
25148288|NCT01752933|50262338|FG000|Treatment|Physician Decision|0|||
25148289|NCT01752933|50262339|FG001|Treatment|Physician Decision|3|||
25148290|NCT01752933|50262338|FG000|Treatment|Death|0|||
25148291|NCT01752933|50262339|FG001|Treatment|Death|2|||
25148292|NCT01752933|50262338|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
25148293|NCT01752933|50262339|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
25148294|NCT01752933|50262338|FG000|Treatment|Patient noncompliant|0|||
25148295|NCT01752933|50262339|FG001|Treatment|Patient noncompliant|1|||
25148296|NCT01752933|50262338|FG000|Treatment|Patient unable to travel to appointments|0|||
25016212|NCT01150890|50111129|FG001|Overall Study|Withdrawal by Subject|0|||
25016213|NCT01150890|50111130|FG002|Overall Study|Withdrawal by Subject|2|||
25016214|NCT01150890|50111131|FG003|Overall Study|Withdrawal by Subject|1|||
25016215|NCT01150890|50111128|FG000|Overall Study|Disease progression|0|||
25016216|NCT01150890|50111129|FG001|Overall Study|Disease progression|7|||
25148297|NCT01752933|50262339|FG001|Treatment|Patient unable to travel to appointments|1|||
25148298|NCT01752933|50262338|FG000|Overall Study and Follow-up|Death|4|||
25148299|NCT01752933|50262339|FG001|Overall Study and Follow-up|Death|34|||
25016217|NCT01150890|50111130|FG002|Overall Study|Disease progression|3|||
25148300|NCT01752933|50262338|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
25148301|NCT01752933|50262339|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
25016218|NCT01150890|50111131|FG003|Overall Study|Disease progression|7|||
25148302|NCT01752933|50262338|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
25148303|NCT01752933|50262339|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
25148304|NCT01752933|50262338|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
25148305|NCT01752933|50262339|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
25148306|NCT01752855|50262348|FG000|Overall Study|Adverse Event|1|||
25148307|NCT01752855|50262349|FG001|Overall Study|Adverse Event|0|||
25148308|NCT01752855|50262348|FG000|Overall Study|Withdrew Consent|0|||
25148309|NCT01752855|50262349|FG001|Overall Study|Withdrew Consent|2|||
25148310|NCT01752855|50262348|FG000|Overall Study|Lack of Efficacy|0|||
25148311|NCT01752855|50262349|FG001|Overall Study|Lack of Efficacy|2|||
25148312|NCT01402492|50262358|FG000|Overall Study|Withdrawal by Subject|17|||
25148313|NCT01402492|50262359|FG001|Overall Study|Withdrawal by Subject|11|||
25148314|NCT01402492|50262360|FG002|Overall Study|Withdrawal by Subject|11|||
25148315|NCT01402492|50262358|FG000|Overall Study|Adverse Event|2|||
25148316|NCT01402492|50262359|FG001|Overall Study|Adverse Event|3|||
25148317|NCT01402492|50262360|FG002|Overall Study|Adverse Event|4|||
25148318|NCT01402492|50262358|FG000|Overall Study|Physician Decision|0|||
25148319|NCT01402492|50262359|FG001|Overall Study|Physician Decision|3|||
25148320|NCT01402492|50262360|FG002|Overall Study|Physician Decision|0|||
25148321|NCT01402492|50262358|FG000|Overall Study|Incarcerated (N=3)|2|||
25148322|NCT01402492|50262359|FG001|Overall Study|Incarcerated (N=3)|0|||
25148323|NCT01402492|50262360|FG002|Overall Study|Incarcerated (N=3)|1|||
25148324|NCT01402102|50262370|FG000|Overall Study|Protocol Violation|1|||
25148325|NCT01402102|50262371|FG001|Overall Study|Protocol Violation|0|||
25148326|NCT01402102|50262370|FG000|Overall Study|Insufficiency of compliance|1|||
25148327|NCT01402102|50262371|FG001|Overall Study|Insufficiency of compliance|1|||
25148328|NCT01402102|50262370|FG000|Overall Study|Withdrawal by Subject|0|||
25148329|NCT01402102|50262371|FG001|Overall Study|Withdrawal by Subject|2|||
25148330|NCT01423084|50262381|FG000|Overall Study|Adverse Event|0|||
25148331|NCT01423084|50262382|FG001|Overall Study|Adverse Event|1|||
25148332|NCT01423084|50262381|FG000|Overall Study|Withdrawal by Subject|2|||
25148333|NCT01423084|50262382|FG001|Overall Study|Withdrawal by Subject|3|||
25148334|NCT01894256|50262392|FG000|Part A|Adverse Event|0|||
25148335|NCT01894256|50262393|FG001|Part A|Adverse Event|1|||
25148336|NCT01894256|50262394|FG002|Part A|Adverse Event|0|||
25148337|NCT01894256|50262392|FG000|Part B|Death|0|||
25148338|NCT01894256|50262393|FG001|Part B|Death|1|||
25148339|NCT01894256|50262394|FG002|Part B|Death|1|||
25148340|NCT01894256|50262392|FG000|Part B|Withdrawal by Subject|0|||
25148341|NCT01894256|50262393|FG001|Part B|Withdrawal by Subject|1|||
25148342|NCT01894256|50262394|FG002|Part B|Withdrawal by Subject|0|||
25148343|NCT01894256|50262392|FG000|Part B|Lack of Efficacy|15|||
25148344|NCT01894256|50262393|FG001|Part B|Lack of Efficacy|12|||
25148345|NCT01894256|50262394|FG002|Part B|Lack of Efficacy|13|||
25148346|NCT01780935|50262407|FG000|Overall Study|Admin problems due to early termination|321|||
25148347|NCT01780935|50262408|FG001|Overall Study|Admin problems due to early termination|309|||
25148348|NCT01780935|50262407|FG000|Overall Study|Adverse Event|2|||
25148349|NCT01780935|50262408|FG001|Overall Study|Adverse Event|4|||
25148350|NCT01780935|50262407|FG000|Overall Study|Death|1|||
25148351|NCT01780935|50262408|FG001|Overall Study|Death|6|||
25148352|NCT01780935|50262407|FG000|Overall Study|Lost to Follow-up|2|||
25148353|NCT01780935|50262408|FG001|Overall Study|Lost to Follow-up|6|||
25148354|NCT01780935|50262407|FG000|Overall Study|Physician Decision|1|||
25148355|NCT01780935|50262408|FG001|Overall Study|Physician Decision|1|||
25148356|NCT01780935|50262407|FG000|Overall Study|Protocol deviation|0|||
25148357|NCT01780935|50262408|FG001|Overall Study|Protocol deviation|1|||
25148358|NCT01780935|50262407|FG000|Overall Study|Patient withdrew consent|8|||
25148359|NCT01780935|50262408|FG001|Overall Study|Patient withdrew consent|9|||
25148360|NCT01894100|50262416|FG000|Overall Study|Lost to Follow-up|0|||
25148361|NCT01894100|50262417|FG001|Overall Study|Lost to Follow-up|1|||
25148362|NCT01894100|50262416|FG000|Overall Study|Withdrawal by Subject|3|||
25148363|NCT01894100|50262417|FG001|Overall Study|Withdrawal by Subject|0|||
25148364|NCT01401478|50262463|FG000|Overall Study|Study drug not available|6|||
25148365|NCT01401478|50262463|FG000|Overall Study|Adverse Event|5|||
25148366|NCT01401478|50262463|FG000|Overall Study|Hyperphosphatemia|5|||
25148367|NCT01401478|50262463|FG000|Overall Study|Lost to Follow-up|5|||
25148368|NCT01401478|50262463|FG000|Overall Study|Kidney transplantation|3|||
25148369|NCT01401478|50262463|FG000|Overall Study|Withdrawal by Subject|3|||
25148370|NCT01401478|50262463|FG000|Overall Study|Blood samples not available|1|||
25148371|NCT01401478|50262463|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
25148372|NCT01401478|50262463|FG000|Overall Study|Low intact parathyroid hormone|1|||
25148373|NCT01401478|50262463|FG000|Overall Study|Serious adverse event|1|||
25148374|NCT01422850|50262467|FG000|Overall Study|Physician Decision|3|||
25148375|NCT01422538|50262476|FG000|Overall Study|Lost to Follow-up|0|||
25148376|NCT01422538|50262477|FG001|Overall Study|Lost to Follow-up|1|||
25148377|NCT01422538|50262478|FG002|Overall Study|Lost to Follow-up|1|||
25148378|NCT01422538|50262476|FG000|Overall Study|Missed visit|0|||
25184521|NCT01272219|50333209|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
25148379|NCT01422538|50262477|FG001|Overall Study|Missed visit|1|||
25148380|NCT01422538|50262478|FG002|Overall Study|Missed visit|1|||
25148381|NCT01422382|50262487|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
25148382|NCT01401322|50262491|FG000|Overall Study|Withdrawal by Subject|1|||
25148383|NCT01401322|50262491|FG000|Overall Study|Physician Decision|1|||
25148384|NCT01387594|50262497|FG000|Overall Study|Withdrawal by Subject|0|||
25148385|NCT01387594|50262498|FG001|Overall Study|Withdrawal by Subject|2|||
25148386|NCT01387594|50262497|FG000|Overall Study|Lost to Follow-up|0|||
25148387|NCT01387594|50262498|FG001|Overall Study|Lost to Follow-up|1|||
25148388|NCT01401010|50262509|FG000|Overall Study|Could not interpret assay results|1|||
25148389|NCT01401010|50262510|FG001|Overall Study|Could not interpret assay results|0|||
25148390|NCT01400932|50262523|FG000|Overall Study|Adverse Event|10|||
25148391|NCT01400932|50262524|FG001|Overall Study|Adverse Event|5|||
25148392|NCT01400932|50262523|FG000|Overall Study|Lack of Efficacy|0|||
25184522|NCT01272219|50333204|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
25184523|NCT01272219|50333205|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
25148393|NCT01400932|50262524|FG001|Overall Study|Lack of Efficacy|3|||
25148394|NCT01400932|50262523|FG000|Overall Study|Withdrawal by Subject|2|||
25148395|NCT01400932|50262524|FG001|Overall Study|Withdrawal by Subject|6|||
25148396|NCT01400932|50262523|FG000|Overall Study|Lost to Follow-up|1|||
25148397|NCT01400932|50262524|FG001|Overall Study|Lost to Follow-up|0|||
25148398|NCT01400932|50262523|FG000|Overall Study|Protocol Deviation|0|||
25148399|NCT01400932|50262524|FG001|Overall Study|Protocol Deviation|1|||
25148400|NCT01400932|50262523|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
25148401|NCT01400932|50262524|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
25148402|NCT01400698|50262534|FG000|Overall Study|Lost to Follow-up|2|||
25148403|NCT01400698|50262535|FG001|Overall Study|Lost to Follow-up|5|||
25148404|NCT01400698|50262536|FG002|Overall Study|Lost to Follow-up|2|||
25148405|NCT01400698|50262537|FG003|Overall Study|Lost to Follow-up|1|||
25148406|NCT01400698|50262538|FG004|Overall Study|Lost to Follow-up|4|||
25148407|NCT01400698|50262539|FG005|Overall Study|Lost to Follow-up|3|||
25148408|NCT01400698|50262534|FG000|Overall Study|Withdrawal by Subject|8|||
25148409|NCT01400698|50262535|FG001|Overall Study|Withdrawal by Subject|2|||
25148410|NCT01400698|50262536|FG002|Overall Study|Withdrawal by Subject|0|||
25148411|NCT01400698|50262537|FG003|Overall Study|Withdrawal by Subject|4|||
25148412|NCT01400698|50262538|FG004|Overall Study|Withdrawal by Subject|1|||
25148413|NCT01400698|50262539|FG005|Overall Study|Withdrawal by Subject|3|||
25148414|NCT01400698|50262534|FG000|Overall Study|Protocol Violation|0|||
25148415|NCT01400698|50262535|FG001|Overall Study|Protocol Violation|1|||
25148416|NCT01400698|50262536|FG002|Overall Study|Protocol Violation|0|||
25148417|NCT01400698|50262537|FG003|Overall Study|Protocol Violation|0|||
25148418|NCT01400698|50262538|FG004|Overall Study|Protocol Violation|1|||
25148419|NCT01400698|50262539|FG005|Overall Study|Protocol Violation|0|||
25148420|NCT01400698|50262534|FG000|Overall Study|Non-compliance|0|||
25148421|NCT01400698|50262535|FG001|Overall Study|Non-compliance|1|||
25148422|NCT01400698|50262536|FG002|Overall Study|Non-compliance|0|||
25148423|NCT01400698|50262537|FG003|Overall Study|Non-compliance|1|||
25148424|NCT01400698|50262538|FG004|Overall Study|Non-compliance|0|||
25148425|NCT01400698|50262539|FG005|Overall Study|Non-compliance|0|||
25148426|NCT01400698|50262534|FG000|Overall Study|Adverse Event|1|||
25148427|NCT01400698|50262535|FG001|Overall Study|Adverse Event|0|||
25184524|NCT01272219|50333206|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
25148428|NCT01400698|50262536|FG002|Overall Study|Adverse Event|0|||
25184525|NCT01272219|50333207|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
25184526|NCT01272219|50333208|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
25148429|NCT01400698|50262537|FG003|Overall Study|Adverse Event|0|||
25148430|NCT01400698|50262538|FG004|Overall Study|Adverse Event|0|||
25148431|NCT01400698|50262539|FG005|Overall Study|Adverse Event|0|||
25148432|NCT01400698|50262534|FG000|Overall Study|Other|4|||
25148433|NCT01400698|50262535|FG001|Overall Study|Other|2|||
25148434|NCT01400698|50262536|FG002|Overall Study|Other|0|||
25148435|NCT01400698|50262537|FG003|Overall Study|Other|2|||
25148436|NCT01400698|50262538|FG004|Overall Study|Other|1|||
25148437|NCT01400698|50262539|FG005|Overall Study|Other|0|||
25148438|NCT01890746|50262551|FG000|Overall Study|Death|39|||
25148439|NCT01890746|50262552|FG001|Overall Study|Death|30|||
25148440|NCT01890746|50262551|FG000|Overall Study|Adverse Event|1|||
25148441|NCT01890746|50262552|FG001|Overall Study|Adverse Event|0|||
25148442|NCT01890746|50262551|FG000|Overall Study|Lost to Follow-up|4|||
25148443|NCT01890746|50262552|FG001|Overall Study|Lost to Follow-up|1|||
25148444|NCT01890746|50262551|FG000|Overall Study|Physician Decision|3|||
25148445|NCT01890746|50262552|FG001|Overall Study|Physician Decision|2|||
25148446|NCT01890746|50262551|FG000|Overall Study|Withdrawal by Subject|5|||
25148447|NCT01890746|50262552|FG001|Overall Study|Withdrawal by Subject|8|||
25148448|NCT01422304|50262560|FG000|Overall Study|Adverse Event|0|||
25148449|NCT01422304|50262561|FG001|Overall Study|Adverse Event|1|||
25148450|NCT01422304|50262560|FG000|Overall Study|Lost to Follow-up|14|||
25148451|NCT01422304|50262561|FG001|Overall Study|Lost to Follow-up|20|||
25148452|NCT01422304|50262560|FG000|Overall Study|Never Entered Follow-up|2|||
25148453|NCT01422304|50262561|FG001|Overall Study|Never Entered Follow-up|1|||
25148454|NCT01422304|50262560|FG000|Overall Study|Protocol Violation|1|||
25148455|NCT01422304|50262561|FG001|Overall Study|Protocol Violation|0|||
25148456|NCT01422304|50262560|FG000|Overall Study|Withdrawal by Subject|4|||
25148457|NCT01422304|50262561|FG001|Overall Study|Withdrawal by Subject|2|||
25148458|NCT01422304|50262560|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
25148459|NCT01422304|50262561|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
25016219|NCT04057573|50111146|FG000|24-Week Double-Blind Period|Adverse Event|2|||
25016220|NCT04057573|50111147|FG001|24-Week Double-Blind Period|Adverse Event|0|||
25016221|NCT04057573|50111148|FG002|24-Week Double-Blind Period|Adverse Event|0|||
25016222|NCT04057573|50111149|FG003|24-Week Double-Blind Period|Adverse Event|0|||
25016223|NCT04057573|50111146|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
25016224|NCT04057573|50111147|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
25016225|NCT04057573|50111148|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
25016226|NCT04057573|50111149|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
25148460|NCT01422304|50262560|FG000|Overall Study|Not Treated|3|||
25148461|NCT01422304|50262561|FG001|Overall Study|Not Treated|11|||
25148462|NCT01387516|50262571|FG000|Overall Study|Lost to Follow-up|4|||
25148463|NCT01387516|50262572|FG001|Overall Study|Lost to Follow-up|4|||
25148464|NCT01387516|50262573|FG002|Overall Study|Lost to Follow-up|2|||
25148465|NCT01387516|50262574|FG003|Overall Study|Lost to Follow-up|3|||
25148466|NCT01387516|50262571|FG000|Overall Study|Withdrawal by Subject|1|||
25148467|NCT01387516|50262572|FG001|Overall Study|Withdrawal by Subject|1|||
25148468|NCT01387516|50262573|FG002|Overall Study|Withdrawal by Subject|2|||
25148469|NCT01387516|50262574|FG003|Overall Study|Withdrawal by Subject|0|||
25148470|NCT01387516|50262571|FG000|Overall Study|Death|0|||
25148471|NCT01387516|50262572|FG001|Overall Study|Death|0|||
25148472|NCT01387516|50262573|FG002|Overall Study|Death|0|||
25148473|NCT01387516|50262574|FG003|Overall Study|Death|1|||
25148474|NCT01421134|50262595|FG000|Overall Study|Adverse Event|3|||
25148475|NCT01421134|50262596|FG001|Overall Study|Adverse Event|5|||
25148476|NCT01421134|50262595|FG000|Overall Study|Lack of Efficacy|2|||
25148477|NCT01421134|50262596|FG001|Overall Study|Lack of Efficacy|4|||
25148478|NCT01421134|50262595|FG000|Overall Study|Protocol Violation|0|||
25148479|NCT01421134|50262596|FG001|Overall Study|Protocol Violation|3|||
25148480|NCT01421134|50262595|FG000|Overall Study|Withdrawal by Subject|1|||
25184527|NCT01272219|50333209|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
25148481|NCT01421134|50262596|FG001|Overall Study|Withdrawal by Subject|1|||
25148482|NCT01421134|50262595|FG000|Overall Study|Administrative|0|||
25148483|NCT01421134|50262596|FG001|Overall Study|Administrative|1|||
25148484|NCT01421134|50262595|FG000|Overall Study|Lost to Follow-up|1|||
25148485|NCT01421134|50262596|FG001|Overall Study|Lost to Follow-up|1|||
25148486|NCT01894022|50262604|FG000|Overall Study|Death|1|||
25148487|NCT01894022|50262605|FG001|Overall Study|Death|0|||
25148488|NCT01894022|50262604|FG000|Overall Study|Adverse Event, non-fatal|1|||
25148489|NCT01894022|50262605|FG001|Overall Study|Adverse Event, non-fatal|0|||
25148490|NCT01894022|50262604|FG000|Overall Study|Study Closed/terminated|7|||
25148491|NCT01894022|50262605|FG001|Overall Study|Study Closed/terminated|10|||
25148492|NCT01615328|50262614|FG000|Overall Study|Lost to Follow-up|3|||
25148493|NCT01615328|50262615|FG001|Overall Study|Lost to Follow-up|5|||
25148494|NCT01890512|50262625|FG000|Overall Study|Physician Decision|1|||
25148495|NCT01890512|50262625|FG000|Overall Study|Withdrawal by Subject|1|||
25148496|NCT01890512|50262625|FG000|Overall Study|Protocol Violation|1|||
25148497|NCT01387282|50262631|FG000|Overall Study|Death|47|||
25148498|NCT01387282|50262632|FG001|Overall Study|Death|16|||
25148499|NCT01387282|50262631|FG000|Overall Study|Other|5|||
25148500|NCT01387282|50262632|FG001|Overall Study|Other|1|||
25148501|NCT01387282|50262631|FG000|Overall Study|Unrelated AE|6|||
25148502|NCT01387282|50262632|FG001|Overall Study|Unrelated AE|4|||
25148503|NCT01387282|50262631|FG000|Overall Study|Withdrawal by patient|33|||
25148504|NCT01387282|50262632|FG001|Overall Study|Withdrawal by patient|23|||
25148505|NCT01387282|50262631|FG000|Overall Study|Study drug-related AE|2|||
25148506|NCT01387282|50262632|FG001|Overall Study|Study drug-related AE|2|||
25148507|NCT01387282|50262631|FG000|Overall Study|Lost to Follow-up|4|||
25148508|NCT01387282|50262632|FG001|Overall Study|Lost to Follow-up|1|||
25148509|NCT01386970|50262640|FG000|Overall Study|Withdrawal by Subject|0|||
25148510|NCT01386970|50262641|FG001|Overall Study|Withdrawal by Subject|1|||
25148511|NCT01386970|50262640|FG000|Overall Study|Adverse Event|4|||
25148512|NCT01386970|50262641|FG001|Overall Study|Adverse Event|1|||
25148513|NCT01890434|50262649|FG000|Overall Study|Adverse Event|8|||
25148514|NCT01890434|50262649|FG000|Overall Study|PCI at external hospital|1|||
25148515|NCT01890434|50262649|FG000|Overall Study|Assessment discrepancy|1|||
25148516|NCT01890434|50262649|FG000|Overall Study|CRC didn't contact participant for FU|1|||
25148517|NCT01890434|50262649|FG000|Overall Study|Could not get whole set of images|1|||
25148518|NCT01890434|50262649|FG000|Overall Study|Decline to return for GSPECT|1|||
25148519|NCT01890434|50262649|FG000|Overall Study|GSPECT at rest was not done|1|||
25148520|NCT01890434|50262649|FG000|Overall Study|Participant didn't complete MRI|1|||
25148521|NCT01890434|50262649|FG000|Overall Study|Uncontactable by phone|1|||
25148522|NCT01890434|50262649|FG000|Overall Study|Moved out of position|1|||
25148523|NCT01890434|50262649|FG000|Overall Study|Unable to contact|1|||
25148524|NCT01890434|50262649|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
25148525|NCT01385566|50262659|FG000|Overall Study|Lost to Follow-up|1|||
25148526|NCT01385566|50262660|FG001|Overall Study|Lost to Follow-up|0|||
25148527|NCT01385566|50262661|FG002|Overall Study|Lost to Follow-up|0|||
25148528|NCT01385566|50262662|FG003|Overall Study|Lost to Follow-up|0|||
25148529|NCT01385566|50262663|FG004|Overall Study|Lost to Follow-up|0|||
25148530|NCT01385566|50262664|FG005|Overall Study|Lost to Follow-up|0|||
25148531|NCT01385566|50262659|FG000|Overall Study|Withdrawal by Subject|0|||
25148532|NCT01385566|50262660|FG001|Overall Study|Withdrawal by Subject|0|||
25148533|NCT01385566|50262661|FG002|Overall Study|Withdrawal by Subject|0|||
25148534|NCT01385566|50262662|FG003|Overall Study|Withdrawal by Subject|1|||
25148535|NCT01385566|50262663|FG004|Overall Study|Withdrawal by Subject|0|||
25148536|NCT01385566|50262664|FG005|Overall Study|Withdrawal by Subject|0|||
25148537|NCT01780545|50262682|FG000|Overall Study|Withdrawal by Subject|3|||
25148538|NCT01780545|50262683|FG001|Overall Study|Withdrawal by Subject|1|||
25148539|NCT01780545|50262682|FG000|Overall Study|Lost to Follow-up|1|||
25148540|NCT01780545|50262683|FG001|Overall Study|Lost to Follow-up|1|||
25148541|NCT01780389|50262692|FG000|Overall Study|Adverse Event|1|||
25148542|NCT01778985|50262699|FG000|Overall Study|Lost to Follow-up|1|||
25148543|NCT01778985|50262700|FG001|Overall Study|Lost to Follow-up|0|||
25148544|NCT01778985|50262699|FG000|Overall Study|Physician Decision|2|||
25148545|NCT01778985|50262700|FG001|Overall Study|Physician Decision|2|||
25148546|NCT01778985|50262699|FG000|Overall Study|Protocol Violation|4|||
25148547|NCT01778985|50262700|FG001|Overall Study|Protocol Violation|1|||
25148548|NCT01778751|50262708|FG000|Overall Study|Lost to Follow-up|1|||
25148549|NCT01778751|50262709|FG001|Overall Study|Lost to Follow-up|0|||
25274617|NCT01251653|50588652|FG005|Overall Study|Progressive Disease|17|||
25148550|NCT01778751|50262708|FG000|Overall Study|Withdrawal by Subject|0|||
25148551|NCT01778751|50262709|FG001|Overall Study|Withdrawal by Subject|2|||
25148552|NCT01778751|50262708|FG000|Overall Study|Transfered care|1|||
25148553|NCT01778751|50262709|FG001|Overall Study|Transfered care|0|||
25148554|NCT01865084|50262718|FG000|Double Blind Period (DB)|Adverse Event|2|||
25148555|NCT01865084|50262719|FG001|Double Blind Period (DB)|Adverse Event|2|||
25148556|NCT01865084|50262720|FG002|Double Blind Period (DB)|Adverse Event|1|||
25148557|NCT01865084|50262718|FG000|Double Blind Period (DB)|Protocol Violation|0|||
25148558|NCT01865084|50262719|FG001|Double Blind Period (DB)|Protocol Violation|0|||
25148559|NCT01865084|50262720|FG002|Double Blind Period (DB)|Protocol Violation|1|||
25148560|NCT01865084|50262718|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
25148561|NCT01865084|50262719|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
25148562|NCT01865084|50262720|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
25148563|NCT01865084|50262718|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
25148564|NCT01865084|50262719|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
25148565|NCT01865084|50262720|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
25148566|NCT01865084|50262718|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
25148567|NCT01865084|50262719|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
25148568|NCT01865084|50262720|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
25148569|NCT01865084|50262718|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
25148570|NCT01865084|50262719|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
25148571|NCT01865084|50262720|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
25148572|NCT01865084|50262718|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
25148573|NCT01865084|50262719|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
25148574|NCT01865084|50262720|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
25148575|NCT01865084|50262718|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
25148576|NCT01865084|50262719|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
25148577|NCT01865084|50262720|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
25148578|NCT01865084|50262718|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
25148579|NCT01865084|50262719|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
25148580|NCT01865084|50262720|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
25148581|NCT01778127|50262735|FG000|Overall Study|Lost to Follow-up|5|||
25148582|NCT01778127|50262736|FG001|Overall Study|Lost to Follow-up|1|||
25148583|NCT01778127|50262737|FG002|Overall Study|Lost to Follow-up|2|||
25148584|NCT01778127|50262735|FG000|Overall Study|Withdrawal by Subject|3|||
25148585|NCT01778127|50262736|FG001|Overall Study|Withdrawal by Subject|1|||
25148586|NCT01778127|50262737|FG002|Overall Study|Withdrawal by Subject|4|||
25148587|NCT01892540|50262748|FG000|Overall Study|Did not complete PET/MRI|0|||
25148588|NCT01892540|50262749|FG001|Overall Study|Did not complete PET/MRI|0|||
25148589|NCT01892540|50262750|FG002|Overall Study|Did not complete PET/MRI|2|||
25148590|NCT01892540|50262748|FG000|Overall Study|Did not fit in scanner|0|||
25148591|NCT01892540|50262749|FG001|Overall Study|Did not fit in scanner|0|||
25148592|NCT01892540|50262750|FG002|Overall Study|Did not fit in scanner|1|||
25148593|NCT01399372|50262760|FG000|Overall Study|Protocol Violation|3|||
25148594|NCT01399372|50262761|FG001|Overall Study|Protocol Violation|1|||
25148595|NCT01385098|50262767|FG000|Overall Study|Adverse Event|10|||
25148596|NCT01385098|50262767|FG000|Overall Study|Lost to Follow-up|4|||
25148597|NCT01398514|50262775|FG000|Overall Study|Adverse Event|1|||
25148598|NCT01398514|50262776|FG001|Overall Study|Adverse Event|0|||
25184528|NCT01272219|50333204|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
25184529|NCT01272219|50333205|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
25148599|NCT01398514|50262775|FG000|Overall Study|Non-compliance with study procedures|2|||
25148600|NCT01398514|50262776|FG001|Overall Study|Non-compliance with study procedures|0|||
25148601|NCT01398514|50262775|FG000|Overall Study|Physiologic non-responsiveness|1|||
25274618|NCT01251653|50588653|FG006|Overall Study|Progressive Disease|14|||
25274619|NCT01251653|50588654|FG007|Overall Study|Progressive Disease|7|||
25016227|NCT04057573|50111146|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
25016228|NCT04057573|50111147|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
25016229|NCT04057573|50111148|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
25016230|NCT04057573|50111149|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
25016231|NCT04057573|50111146|FG000|24-Week Double-Blind Period|Physician Decision|1|||
25016232|NCT04057573|50111147|FG001|24-Week Double-Blind Period|Physician Decision|0|||
25016233|NCT04057573|50111148|FG002|24-Week Double-Blind Period|Physician Decision|0|||
25148602|NCT01398514|50262776|FG001|Overall Study|Physiologic non-responsiveness|3|||
25148603|NCT01398514|50262775|FG000|Overall Study|Failure to show a conditioned response|4|||
25016234|NCT04057573|50111149|FG003|24-Week Double-Blind Period|Physician Decision|0|||
25148604|NCT01398514|50262776|FG001|Overall Study|Failure to show a conditioned response|3|||
25148605|NCT01398358|50262787|FG000|Overall Study|Lost to Follow-up|11|||
25148606|NCT01398358|50262788|FG001|Overall Study|Lost to Follow-up|21|||
25148607|NCT01398358|50262789|FG002|Overall Study|Lost to Follow-up|18|||
25148608|NCT01398358|50262787|FG000|Overall Study|Withdrawal by Subject|3|||
25148609|NCT01398358|50262788|FG001|Overall Study|Withdrawal by Subject|2|||
25148610|NCT01398358|50262789|FG002|Overall Study|Withdrawal by Subject|2|||
25148611|NCT01398358|50262787|FG000|Overall Study|no longer eligible|1|||
25148612|NCT01398358|50262788|FG001|Overall Study|no longer eligible|0|||
25148613|NCT01398358|50262789|FG002|Overall Study|no longer eligible|1|||
25148614|NCT01778049|50262799|FG000|Open Label Treatment Period|Adverse Event|5|||
25148615|NCT01778049|50262800|FG001|Open Label Treatment Period|Adverse Event|15|||
25148616|NCT01778049|50262801|FG002|Open Label Treatment Period|Adverse Event|0|||
25148617|NCT01778049|50262802|FG003|Open Label Treatment Period|Adverse Event|0|||
25148618|NCT01778049|50262803|FG004|Open Label Treatment Period|Adverse Event|0|||
25148619|NCT01778049|50262804|FG005|Open Label Treatment Period|Adverse Event|0|||
25148620|NCT01778049|50262799|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
25148621|NCT01778049|50262800|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
25148622|NCT01778049|50262801|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
25148623|NCT01778049|50262802|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
25148624|NCT01778049|50262803|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
25148625|NCT01778049|50262804|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
25148626|NCT01778049|50262799|FG000|Open Label Treatment Period|Protocol Violation|5|||
25148627|NCT01778049|50262800|FG001|Open Label Treatment Period|Protocol Violation|5|||
25148628|NCT01778049|50262801|FG002|Open Label Treatment Period|Protocol Violation|0|||
25148629|NCT01778049|50262802|FG003|Open Label Treatment Period|Protocol Violation|0|||
25148630|NCT01778049|50262803|FG004|Open Label Treatment Period|Protocol Violation|0|||
25148631|NCT01778049|50262804|FG005|Open Label Treatment Period|Protocol Violation|0|||
25148632|NCT01778049|50262799|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
25148633|NCT01778049|50262800|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
25148634|NCT01778049|50262801|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
25148635|NCT01778049|50262802|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
25148636|NCT01778049|50262803|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
25274620|NCT01251653|50588655|FG008|Overall Study|Progressive Disease|5|||
25016235|NCT04057573|50111146|FG000|24-Week Double-Blind Period|Pregnancy|1|||
25016236|NCT04057573|50111147|FG001|24-Week Double-Blind Period|Pregnancy|0|||
25016237|NCT04057573|50111148|FG002|24-Week Double-Blind Period|Pregnancy|0|||
25016238|NCT04057573|50111149|FG003|24-Week Double-Blind Period|Pregnancy|0|||
25148637|NCT01778049|50262804|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
25148638|NCT01778049|50262799|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
25148639|NCT01778049|50262800|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
25148640|NCT01778049|50262801|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
25148641|NCT01778049|50262802|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
25148642|NCT01778049|50262803|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
25148643|NCT01778049|50262804|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
25148644|NCT01778049|50262799|FG000|Open Label Treatment Period|Not treated|2|||
25148645|NCT01778049|50262800|FG001|Open Label Treatment Period|Not treated|1|||
25148646|NCT01778049|50262801|FG002|Open Label Treatment Period|Not treated|0|||
25148647|NCT01778049|50262802|FG003|Open Label Treatment Period|Not treated|0|||
25148648|NCT01778049|50262803|FG004|Open Label Treatment Period|Not treated|0|||
25148649|NCT01778049|50262804|FG005|Open Label Treatment Period|Not treated|0|||
25148650|NCT01778049|50262799|FG000|Open Label Treatment Period|Other reason not defined above|77|||
25148651|NCT01778049|50262800|FG001|Open Label Treatment Period|Other reason not defined above|94|||
25148652|NCT01778049|50262801|FG002|Open Label Treatment Period|Other reason not defined above|0|||
25148653|NCT01778049|50262802|FG003|Open Label Treatment Period|Other reason not defined above|0|||
25148654|NCT01778049|50262803|FG004|Open Label Treatment Period|Other reason not defined above|0|||
25148655|NCT01778049|50262804|FG005|Open Label Treatment Period|Other reason not defined above|0|||
25148656|NCT01778049|50262799|FG000|Double Blind Treatment Period|Adverse Event|0|||
25148657|NCT01778049|50262800|FG001|Double Blind Treatment Period|Adverse Event|0|||
25148658|NCT01778049|50262801|FG002|Double Blind Treatment Period|Adverse Event|4|||
25148659|NCT01778049|50262802|FG003|Double Blind Treatment Period|Adverse Event|5|||
25148660|NCT01778049|50262803|FG004|Double Blind Treatment Period|Adverse Event|3|||
25148661|NCT01778049|50262804|FG005|Double Blind Treatment Period|Adverse Event|2|||
25148662|NCT01778049|50262799|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
25016239|NCT04057573|50111146|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
25016240|NCT04057573|50111147|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
25148663|NCT01778049|50262800|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
25148664|NCT01778049|50262801|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
25148665|NCT01778049|50262802|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
25148666|NCT01778049|50262803|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
25148667|NCT01778049|50262804|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
25148668|NCT01778049|50262799|FG000|Double Blind Treatment Period|Protocol Violation|0|||
25148669|NCT01778049|50262800|FG001|Double Blind Treatment Period|Protocol Violation|0|||
25148670|NCT01778049|50262801|FG002|Double Blind Treatment Period|Protocol Violation|2|||
25148671|NCT01778049|50262802|FG003|Double Blind Treatment Period|Protocol Violation|0|||
25148672|NCT01778049|50262803|FG004|Double Blind Treatment Period|Protocol Violation|0|||
25148673|NCT01778049|50262804|FG005|Double Blind Treatment Period|Protocol Violation|0|||
25148674|NCT01778049|50262799|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
25148675|NCT01778049|50262800|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
25148676|NCT01778049|50262801|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
25148677|NCT01778049|50262802|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
25148678|NCT01778049|50262803|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
25148679|NCT01778049|50262804|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
25148680|NCT01778049|50262799|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
25148681|NCT01778049|50262800|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
25148682|NCT01778049|50262801|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
25148683|NCT01778049|50262802|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
25148684|NCT01778049|50262803|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
25148685|NCT01778049|50262804|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
25148686|NCT01778049|50262799|FG000|Double Blind Treatment Period|Not treated|0|||
25148687|NCT01778049|50262800|FG001|Double Blind Treatment Period|Not treated|0|||
25148688|NCT01778049|50262801|FG002|Double Blind Treatment Period|Not treated|0|||
25148689|NCT01778049|50262802|FG003|Double Blind Treatment Period|Not treated|2|||
25148690|NCT01778049|50262803|FG004|Double Blind Treatment Period|Not treated|2|||
25148691|NCT01778049|50262804|FG005|Double Blind Treatment Period|Not treated|0|||
25148692|NCT01778049|50262799|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
25148693|NCT01778049|50262800|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
25148694|NCT01778049|50262801|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
25148695|NCT01778049|50262802|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
25148696|NCT01778049|50262803|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
25148697|NCT01778049|50262804|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
25148698|NCT01777581|50262818|FG000|Overall Study|Lost to Follow-up|1|||
25148699|NCT01777581|50262819|FG001|Overall Study|Lost to Follow-up|1|||
25148700|NCT01777581|50262818|FG000|Overall Study|Adverse Event|2|||
25148701|NCT01777581|50262819|FG001|Overall Study|Adverse Event|0|||
25148702|NCT01777581|50262818|FG000|Overall Study|Lack of Efficacy|0|||
25148703|NCT01777581|50262819|FG001|Overall Study|Lack of Efficacy|1|||
25148704|NCT01864148|50262830|FG000|Overall Study|Other|2|||
25148705|NCT01864148|50262831|FG001|Overall Study|Other|1|||
25148706|NCT01864148|50262832|FG002|Overall Study|Other|1|||
25148707|NCT01864148|50262833|FG003|Overall Study|Other|3|||
25148708|NCT01864148|50262834|FG004|Overall Study|Other|1|||
25148709|NCT01864148|50262830|FG000|Overall Study|Death|0|||
25148710|NCT01864148|50262831|FG001|Overall Study|Death|0|||
25148711|NCT01864148|50262832|FG002|Overall Study|Death|0|||
25148712|NCT01864148|50262833|FG003|Overall Study|Death|1|||
25148713|NCT01864148|50262834|FG004|Overall Study|Death|0|||
25148714|NCT01864148|50262830|FG000|Overall Study|Investigator Decision|5|||
25148715|NCT01864148|50262831|FG001|Overall Study|Investigator Decision|0|||
25148716|NCT01864148|50262832|FG002|Overall Study|Investigator Decision|0|||
25148717|NCT01864148|50262833|FG003|Overall Study|Investigator Decision|4|||
25148718|NCT01864148|50262834|FG004|Overall Study|Investigator Decision|6|||
25148719|NCT01864148|50262830|FG000|Overall Study|Withdrawal by Subject|9|||
25148720|NCT01864148|50262831|FG001|Overall Study|Withdrawal by Subject|2|||
25148721|NCT01864148|50262832|FG002|Overall Study|Withdrawal by Subject|6|||
25148722|NCT01864148|50262833|FG003|Overall Study|Withdrawal by Subject|8|||
25274621|NCT01251653|50588647|FG000|Overall Study|Dose-limiting toxicity|0|||
25148723|NCT01864148|50262834|FG004|Overall Study|Withdrawal by Subject|8|||
25148724|NCT01864148|50262830|FG000|Overall Study|Lost to Follow-up|0|||
25148725|NCT01864148|50262831|FG001|Overall Study|Lost to Follow-up|0|||
25148726|NCT01864148|50262832|FG002|Overall Study|Lost to Follow-up|0|||
25148727|NCT01864148|50262833|FG003|Overall Study|Lost to Follow-up|2|||
25148728|NCT01864148|50262834|FG004|Overall Study|Lost to Follow-up|1|||
25148729|NCT01864148|50262830|FG000|Overall Study|Adverse Event|4|||
25148730|NCT01864148|50262831|FG001|Overall Study|Adverse Event|2|||
25148731|NCT01864148|50262832|FG002|Overall Study|Adverse Event|4|||
25148732|NCT01864148|50262833|FG003|Overall Study|Adverse Event|7|||
25148733|NCT01864148|50262834|FG004|Overall Study|Adverse Event|7|||
25148734|NCT01864148|50262830|FG000|Overall Study|Not Dosed|0|||
25148735|NCT01864148|50262831|FG001|Overall Study|Not Dosed|0|||
25148736|NCT01864148|50262832|FG002|Overall Study|Not Dosed|0|||
25148737|NCT01864148|50262833|FG003|Overall Study|Not Dosed|1|||
25148738|NCT01864148|50262834|FG004|Overall Study|Not Dosed|0|||
25148739|NCT01751139|50262851|FG000|Overall Study|Other|135|||
25148740|NCT01751139|50262851|FG000|Overall Study|Sponsor study termination|1609|||
25148741|NCT01751139|50262851|FG000|Overall Study|Lost to Follow-up|240|||
25148742|NCT01751139|50262851|FG000|Overall Study|Withdrawal by Subject|251|||
25148743|NCT01751139|50262851|FG000|Overall Study|Adverse Event|1|||
25148744|NCT01751139|50262851|FG000|Overall Study|Death|31|||
25148745|NCT01890122|50262859|FG000|Overall Study|Adverse Event|1|||
25148746|NCT01890122|50262860|FG001|Overall Study|Adverse Event|1|||
25148747|NCT01890122|50262861|FG002|Overall Study|Adverse Event|1|||
25148748|NCT01890122|50262862|FG003|Overall Study|Adverse Event|2|||
25184530|NCT01272219|50333206|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
25184531|NCT01272219|50333207|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
25184532|NCT01272219|50333208|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
25184533|NCT01272219|50333209|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
25184534|NCT01510028|50333226|FG000|Overall Study|Lack of Efficacy|1|||
25184535|NCT01510028|50333227|FG001|Overall Study|Lack of Efficacy|0|||
25184536|NCT01510028|50333228|FG002|Overall Study|Lack of Efficacy|0|||
25148749|NCT01890122|50262859|FG000|Overall Study|Major Protocol Deviation|3|||
25148750|NCT01890122|50262860|FG001|Overall Study|Major Protocol Deviation|1|||
25148751|NCT01890122|50262861|FG002|Overall Study|Major Protocol Deviation|0|||
25148752|NCT01890122|50262862|FG003|Overall Study|Major Protocol Deviation|1|||
25148753|NCT01890122|50262859|FG000|Overall Study|Lost to Follow-up|0|||
25148754|NCT01890122|50262860|FG001|Overall Study|Lost to Follow-up|1|||
25148755|NCT01890122|50262861|FG002|Overall Study|Lost to Follow-up|2|||
25148756|NCT01890122|50262862|FG003|Overall Study|Lost to Follow-up|2|||
25148757|NCT01890122|50262859|FG000|Overall Study|Voluntary Withdrawal|8|||
25184537|NCT01510028|50333229|FG003|Overall Study|Lack of Efficacy|0|||
25148758|NCT01890122|50262860|FG001|Overall Study|Voluntary Withdrawal|8|||
25148759|NCT01890122|50262861|FG002|Overall Study|Voluntary Withdrawal|2|||
25148760|NCT01890122|50262862|FG003|Overall Study|Voluntary Withdrawal|11|||
25184538|NCT01521494|50333250|FG000|Overall Study|Adverse Event|1|||
25184539|NCT01521494|50333251|FG001|Overall Study|Adverse Event|2|||
25148761|NCT01890122|50262859|FG000|Overall Study|Lack of Efficacy|14|||
25148762|NCT01890122|50262860|FG001|Overall Study|Lack of Efficacy|24|||
25148763|NCT01890122|50262861|FG002|Overall Study|Lack of Efficacy|7|||
25148764|NCT01890122|50262862|FG003|Overall Study|Lack of Efficacy|41|||
25148765|NCT01890122|50262859|FG000|Overall Study|Reason not Specified|0|||
25148766|NCT01890122|50262860|FG001|Overall Study|Reason not Specified|1|||
25148767|NCT01890122|50262861|FG002|Overall Study|Reason not Specified|1|||
25148768|NCT01890122|50262862|FG003|Overall Study|Reason not Specified|2|||
25148769|NCT01890122|50262859|FG000|Overall Study|Randomized but not Treated|1|||
25148770|NCT01890122|50262860|FG001|Overall Study|Randomized but not Treated|1|||
25148771|NCT01890122|50262861|FG002|Overall Study|Randomized but not Treated|0|||
25148772|NCT01890122|50262862|FG003|Overall Study|Randomized but not Treated|0|||
25148773|NCT01397890|50262874|FG000|Overall Study|Withdrawal by Subject|7|||
25148774|NCT01397890|50262875|FG001|Overall Study|Withdrawal by Subject|11|||
25148775|NCT01397890|50262874|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
25148776|NCT01397890|50262875|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
25148777|NCT01397890|50262874|FG000|Overall Study|Death|2|||
25148778|NCT01397890|50262875|FG001|Overall Study|Death|3|||
25148779|NCT01397890|50262874|FG000|Overall Study|Lost to Follow-up|1|||
25148780|NCT01397890|50262875|FG001|Overall Study|Lost to Follow-up|4|||
25148781|NCT01397890|50262874|FG000|Overall Study|Condition under Investigation Worsened|1|||
25148782|NCT01397890|50262875|FG001|Overall Study|Condition under Investigation Worsened|3|||
25184540|NCT01521494|50333252|FG002|Overall Study|Adverse Event|9|||
25184541|NCT01521494|50333253|FG003|Overall Study|Adverse Event|6|||
25184542|NCT01521494|50333254|FG004|Overall Study|Adverse Event|2|||
25016241|NCT04057573|50111148|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
25148783|NCT01397890|50262874|FG000|Overall Study|Adverse Event|1|||
25148784|NCT01397890|50262875|FG001|Overall Study|Adverse Event|2|||
25148785|NCT01397890|50262874|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
25148786|NCT01397890|50262875|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
25148787|NCT01397890|50262874|FG000|Overall Study|Others|2|||
25148788|NCT01397890|50262875|FG001|Overall Study|Others|1|||
25148789|NCT01777269|50262883|FG000|Overall Study|Adverse Event|24|||
25184543|NCT01521494|50333250|FG000|Overall Study|Lack of Efficacy|0|||
25148790|NCT01777269|50262884|FG001|Overall Study|Adverse Event|33|||
25148791|NCT01777269|50262883|FG000|Overall Study|Lack of Efficacy|8|||
25148792|NCT01777269|50262884|FG001|Overall Study|Lack of Efficacy|10|||
25148793|NCT01777269|50262883|FG000|Overall Study|Protocol Violation|4|||
25148794|NCT01777269|50262884|FG001|Overall Study|Protocol Violation|4|||
25148795|NCT01777269|50262883|FG000|Overall Study|Participants reached stopping criteria|1|||
25148796|NCT01777269|50262884|FG001|Overall Study|Participants reached stopping criteria|1|||
25148797|NCT01777269|50262883|FG000|Overall Study|Lost to Follow-up|4|||
25148798|NCT01777269|50262884|FG001|Overall Study|Lost to Follow-up|0|||
25148799|NCT01777269|50262883|FG000|Overall Study|Physician Decision|5|||
25148800|NCT01777269|50262884|FG001|Overall Study|Physician Decision|2|||
25148801|NCT01777269|50262883|FG000|Overall Study|Withdrawal by Subject|9|||
25148802|NCT01777269|50262884|FG001|Overall Study|Withdrawal by Subject|9|||
25148803|NCT04016272|50262892|FG000|Overall Study|Withdrawal by Subject|1|||
25148804|NCT04016272|50262893|FG001|Overall Study|Withdrawal by Subject|2|||
25148805|NCT01751061|50262901|FG000|Overall Study|Death|1|||
25148806|NCT01751061|50262902|FG001|Overall Study|Death|0|||
25148807|NCT01751061|50262901|FG000|Overall Study|patient death|5|||
25148808|NCT01751061|50262902|FG001|Overall Study|patient death|0|||
25148809|NCT01751061|50262901|FG000|Overall Study|Lost to Follow-up|40|||
25148810|NCT01751061|50262902|FG001|Overall Study|Lost to Follow-up|25|||
25148811|NCT01751061|50262901|FG000|Overall Study|patient regained decisional capacity|4|||
25148812|NCT01751061|50262902|FG001|Overall Study|patient regained decisional capacity|8|||
25148813|NCT01751061|50262901|FG000|Overall Study|Withdrawal by Subject|4|||
25148814|NCT01751061|50262902|FG001|Overall Study|Withdrawal by Subject|1|||
25148815|NCT01751061|50262901|FG000|Overall Study|Physician Decision|2|||
25148816|NCT01751061|50262902|FG001|Overall Study|Physician Decision|0|||
25148817|NCT01777191|50262910|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
25184544|NCT01521494|50333251|FG001|Overall Study|Lack of Efficacy|0|||
25184545|NCT01521494|50333252|FG002|Overall Study|Lack of Efficacy|0|||
25184546|NCT01521494|50333253|FG003|Overall Study|Lack of Efficacy|0|||
25148818|NCT01777191|50262911|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
25148819|NCT01777191|50262910|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
25148820|NCT01777191|50262911|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
25148821|NCT01777191|50262910|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
25148822|NCT01777191|50262911|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
25148823|NCT01777191|50262910|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
25148824|NCT01777191|50262911|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
25184547|NCT01521494|50333254|FG004|Overall Study|Lack of Efficacy|2|||
25016242|NCT04057573|50111149|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
25148825|NCT01777191|50262910|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
25148826|NCT01777191|50262911|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
25148827|NCT01777191|50262910|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
25148828|NCT01777191|50262911|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
25148829|NCT01777191|50262910|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
25148830|NCT01777191|50262911|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
25148831|NCT01777191|50262910|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
25148832|NCT01777191|50262911|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
25148833|NCT01777191|50262910|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
25148834|NCT01777191|50262911|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
25148835|NCT01777191|50262910|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
25148836|NCT01777191|50262911|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
25148837|NCT01777191|50262910|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
25148838|NCT01777191|50262911|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
25148839|NCT01896050|50262922|FG000|Overall Study|Adverse Event|37|||
25148840|NCT01896050|50262923|FG001|Overall Study|Adverse Event|2|||
25148841|NCT01896050|50262922|FG000|Overall Study|Death|1|||
25148842|NCT01896050|50262923|FG001|Overall Study|Death|0|||
25148843|NCT01775787|50262931|FG000|First 7-10 Days|Adverse Event|0|||
25148844|NCT01775787|50262932|FG001|First 7-10 Days|Adverse Event|1|||
25148845|NCT01775787|50262931|FG000|First 7-10 Days|family emergency|0|||
25148846|NCT01775787|50262932|FG001|First 7-10 Days|family emergency|1|||
25148847|NCT01775787|50262931|FG000|First 7-10 Days|time commitment|0|||
25148848|NCT01775787|50262932|FG001|First 7-10 Days|time commitment|2|||
25148849|NCT01775787|50262931|FG000|First 7-10 Days|concerns with using IV|1|||
25148850|NCT01775787|50262932|FG001|First 7-10 Days|concerns with using IV|2|||
25148851|NCT01775787|50262931|FG000|Second 7-10 Days|time commitment|0|||
25148852|NCT01775787|50262932|FG001|Second 7-10 Days|time commitment|1|||
25148853|NCT01775787|50262931|FG000|Second 7-10 Days|concerns with using IV|0|||
25148854|NCT01775787|50262932|FG001|Second 7-10 Days|concerns with using IV|1|||
25148855|NCT01775553|50262940|FG000|Overall Study|Adverse Event|1|||
25148856|NCT01775553|50262940|FG000|Overall Study|Disease Progression|12|||
25148857|NCT01775475|50262946|FG000|Overall Study|Death|3|||
25148858|NCT01775475|50262947|FG001|Overall Study|Death|3|||
25148859|NCT01774929|50262953|FG000|Overall Study|Adverse Event|3|||
25148860|NCT01888874|50262964|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
25148861|NCT01888874|50262965|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
25148862|NCT01888874|50262966|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
25148863|NCT01888874|50262967|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
25148864|NCT01888874|50262968|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
25148865|NCT01888874|50262969|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
25148866|NCT01888874|50262970|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
25148867|NCT01888874|50262964|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
25148868|NCT01888874|50262965|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
25148869|NCT01888874|50262966|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
25148870|NCT01888874|50262967|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
25148871|NCT01888874|50262968|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
25148872|NCT01888874|50262969|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
25148873|NCT01888874|50262970|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
25148874|NCT01888874|50262964|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
25148875|NCT01888874|50262965|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
25148876|NCT01888874|50262966|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
25148877|NCT01888874|50262967|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
25148878|NCT01888874|50262968|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
25148879|NCT01888874|50262969|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
25148880|NCT01888874|50262970|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
25148881|NCT01888874|50262964|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
25148882|NCT01888874|50262965|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
25148883|NCT01888874|50262966|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
25148884|NCT01888874|50262967|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
25148885|NCT01888874|50262968|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
25016243|NCT04057573|50111146|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
25274622|NCT01251653|50588648|FG001|Overall Study|Dose-limiting toxicity|1|||
25067376|NCT03188666|50172999|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
25148886|NCT01888874|50262969|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
25148887|NCT01888874|50262970|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
25148888|NCT01888874|50262964|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
25148889|NCT01888874|50262965|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
25148890|NCT01888874|50262966|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
25148891|NCT01888874|50262967|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
25148892|NCT01888874|50262968|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
25148893|NCT01888874|50262969|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
25148894|NCT01888874|50262970|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
25148895|NCT01888874|50262964|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
25184548|NCT01521494|50333250|FG000|Overall Study|Withdrawal by Subject|1|||
25184549|NCT01521494|50333251|FG001|Overall Study|Withdrawal by Subject|1|||
25016244|NCT04057573|50111147|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
25148896|NCT01888874|50262965|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
25148897|NCT01888874|50262966|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
25148898|NCT01888874|50262967|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
25148899|NCT01888874|50262968|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
25148900|NCT01888874|50262969|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
25148901|NCT01888874|50262970|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
25148902|NCT01888874|50262964|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
25148903|NCT01888874|50262965|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
25148904|NCT01888874|50262966|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
25148905|NCT01888874|50262967|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
25148906|NCT01888874|50262968|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
25148907|NCT01888874|50262969|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
25148908|NCT01888874|50262970|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
25148909|NCT01888874|50262964|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
25148910|NCT01888874|50262965|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
25148911|NCT01888874|50262966|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
25148912|NCT01888874|50262967|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
25148913|NCT01888874|50262968|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
25148914|NCT01888874|50262969|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
25148915|NCT01888874|50262970|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
25148916|NCT01888874|50262964|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
25148917|NCT01888874|50262965|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
25148918|NCT01888874|50262966|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
25148919|NCT01888874|50262967|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
25148920|NCT01888874|50262968|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
25148921|NCT01888874|50262969|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
25184550|NCT01521494|50333252|FG002|Overall Study|Withdrawal by Subject|0|||
25184551|NCT01521494|50333253|FG003|Overall Study|Withdrawal by Subject|2|||
25016245|NCT04057573|50111148|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
25016246|NCT04057573|50111149|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
25016247|NCT04057573|50111146|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
25016248|NCT04057573|50111147|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
25184552|NCT01521494|50333254|FG004|Overall Study|Withdrawal by Subject|0|||
25184553|NCT01521494|50333250|FG000|Overall Study|Decrease in serum phosphate|0|||
25184554|NCT01521494|50333251|FG001|Overall Study|Decrease in serum phosphate|2|||
25184555|NCT01521494|50333252|FG002|Overall Study|Decrease in serum phosphate|3|||
25184556|NCT01521494|50333253|FG003|Overall Study|Decrease in serum phosphate|12|||
25184557|NCT01521494|50333254|FG004|Overall Study|Decrease in serum phosphate|0|||
25184558|NCT01521494|50333250|FG000|Overall Study|Decrease in serum calcium|0|||
25184559|NCT01521494|50333251|FG001|Overall Study|Decrease in serum calcium|0|||
25184560|NCT01521494|50333252|FG002|Overall Study|Decrease in serum calcium|0|||
25184561|NCT01521494|50333253|FG003|Overall Study|Decrease in serum calcium|1|||
25184562|NCT01521494|50333254|FG004|Overall Study|Decrease in serum calcium|1|||
25184563|NCT01521494|50333250|FG000|Overall Study|Physician Decision|0|||
25184564|NCT01521494|50333251|FG001|Overall Study|Physician Decision|0|||
25184565|NCT01521494|50333252|FG002|Overall Study|Physician Decision|0|||
25184566|NCT01521494|50333253|FG003|Overall Study|Physician Decision|0|||
25184567|NCT01521494|50333254|FG004|Overall Study|Physician Decision|2|||
25184568|NCT01270971|50333268|FG000|Overall Study|Withdrawal by Subject|24|||
25184569|NCT01270971|50333269|FG001|Overall Study|Withdrawal by Subject|11|||
25184570|NCT01270971|50333268|FG000|Overall Study|Lost to Follow-up|18|||
25184571|NCT01270971|50333269|FG001|Overall Study|Lost to Follow-up|5|||
25184572|NCT01270971|50333268|FG000|Overall Study|Adverse Event|1|||
25184573|NCT01270971|50333269|FG001|Overall Study|Adverse Event|2|||
25184574|NCT01270971|50333268|FG000|Overall Study|Non compliance|2|||
25184575|NCT01270971|50333269|FG001|Overall Study|Non compliance|2|||
25184576|NCT01270971|50333268|FG000|Overall Study|Non-specific|7|||
25184577|NCT01270971|50333269|FG001|Overall Study|Non-specific|3|||
25184578|NCT01270503|50333296|FG000|Overall Study|Lost to Follow-up|1|||
25184579|NCT01277211|50333313|FG000|Overall Study|Adverse Event|60|||
25184580|NCT01277211|50333314|FG001|Overall Study|Adverse Event|22|||
25184581|NCT01277211|50333313|FG000|Overall Study|Pregnancy|9|||
25184582|NCT01277211|50333314|FG001|Overall Study|Pregnancy|4|||
25184583|NCT01277211|50333313|FG000|Overall Study|Lost to Follow-up|14|||
25184584|NCT01277211|50333314|FG001|Overall Study|Lost to Follow-up|9|||
25184585|NCT01277211|50333313|FG000|Overall Study|Did not wish to continue|17|||
25184586|NCT01277211|50333314|FG001|Overall Study|Did not wish to continue|0|||
25184587|NCT01277211|50333313|FG000|Overall Study|Withdrew Consent|9|||
25184588|NCT01277211|50333314|FG001|Overall Study|Withdrew Consent|9|||
25184589|NCT01277211|50333313|FG000|Overall Study|Non-compliance with protocol|13|||
25184590|NCT01277211|50333314|FG001|Overall Study|Non-compliance with protocol|4|||
25184591|NCT01277211|50333313|FG000|Overall Study|Did not meet protocol eligibility|1|||
25184592|NCT01277211|50333314|FG001|Overall Study|Did not meet protocol eligibility|0|||
25184593|NCT01277211|50333313|FG000|Overall Study|Administrative|3|||
25184594|NCT01277211|50333314|FG001|Overall Study|Administrative|0|||
25184595|NCT01277211|50333313|FG000|Overall Study|Pregnancy wish|0|||
25184596|NCT01277211|50333314|FG001|Overall Study|Pregnancy wish|2|||
25184597|NCT01277211|50333313|FG000|Overall Study|Discontinued prior to treatment|24|||
25184598|NCT01277211|50333314|FG001|Overall Study|Discontinued prior to treatment|13|||
25184599|NCT01676220|50333322|FG000|Overall Study|Randomized But Not Treated|4|||
25184600|NCT01676220|50333323|FG001|Overall Study|Randomized But Not Treated|1|||
25184601|NCT01676220|50333322|FG000|Overall Study|Adverse Event|10|||
25184602|NCT01676220|50333323|FG001|Overall Study|Adverse Event|8|||
25184603|NCT01676220|50333322|FG000|Overall Study|Lack of Efficacy|2|||
25184604|NCT01676220|50333323|FG001|Overall Study|Lack of Efficacy|5|||
25184605|NCT01676220|50333322|FG000|Overall Study|Protocol Violation|11|||
25184606|NCT01676220|50333323|FG001|Overall Study|Protocol Violation|12|||
25184607|NCT01676220|50333322|FG000|Overall Study|Received Rescue Therapy|14|||
25184608|NCT01676220|50333323|FG001|Overall Study|Received Rescue Therapy|22|||
25184609|NCT01676220|50333322|FG000|Overall Study|Personal Reason|34|||
25184610|NCT01676220|50333323|FG001|Overall Study|Personal Reason|45|||
25184611|NCT01676220|50333322|FG000|Overall Study|Lost to Follow-up|11|||
25184612|NCT01676220|50333323|FG001|Overall Study|Lost to Follow-up|18|||
25184613|NCT01676220|50333322|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
25184614|NCT01676220|50333323|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
25184615|NCT01676220|50333322|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
25184616|NCT01676220|50333323|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
25184617|NCT01676220|50333322|FG000|Overall Study|Perceived Lack of Efficacy|3|||
25184618|NCT01676220|50333323|FG001|Overall Study|Perceived Lack of Efficacy|1|||
25184619|NCT01676220|50333322|FG000|Overall Study|Non Serious Hypoglycemia|2|||
25184620|NCT01676220|50333323|FG001|Overall Study|Non Serious Hypoglycemia|0|||
25184621|NCT01676220|50333322|FG000|Overall Study|No More Need of Insulin|1|||
25184622|NCT01676220|50333323|FG001|Overall Study|No More Need of Insulin|0|||
25184623|NCT01485614|50333353|FG000|Randomization|Not Treated|1|||
25184624|NCT01485614|50333354|FG001|Randomization|Not Treated|0|||
25184625|NCT01485614|50333355|FG002|Randomization|Not Treated|0|||
25184626|NCT01485614|50333356|FG003|Randomization|Not Treated|0|||
25184627|NCT01485614|50333353|FG000|Weeks 0-20|Lost to Follow-up|2|||
25184628|NCT01485614|50333354|FG001|Weeks 0-20|Lost to Follow-up|0|||
25184629|NCT01485614|50333355|FG002|Weeks 0-20|Lost to Follow-up|0|||
25184630|NCT01485614|50333356|FG003|Weeks 0-20|Lost to Follow-up|0|||
25184631|NCT01485614|50333353|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
25184632|NCT01485614|50333354|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
25184633|NCT01485614|50333355|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
25184634|NCT01485614|50333356|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
25184635|NCT01485614|50333353|FG000|Weeks 0-20|Withdrawal by Subject|3|||
25184636|NCT01485614|50333354|FG001|Weeks 0-20|Withdrawal by Subject|2|||
25184637|NCT01485614|50333355|FG002|Weeks 0-20|Withdrawal by Subject|1|||
25184638|NCT01485614|50333356|FG003|Weeks 0-20|Withdrawal by Subject|0|||
25148922|NCT01888874|50262970|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
25148923|NCT01888874|50262964|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
25148924|NCT01888874|50262965|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
25148925|NCT01888874|50262966|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
25148926|NCT01888874|50262967|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
25148927|NCT01888874|50262968|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
25148928|NCT01888874|50262969|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
25148929|NCT01888874|50262970|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
25148930|NCT01888874|50262964|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
25148931|NCT01888874|50262965|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
25148932|NCT01888874|50262966|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
25148933|NCT01888874|50262967|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
25148934|NCT01888874|50262968|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
25148935|NCT01888874|50262969|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
25148936|NCT01888874|50262970|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
25148937|NCT01888874|50262964|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
25148938|NCT01888874|50262965|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
25148939|NCT01888874|50262966|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
25148940|NCT01888874|50262967|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
25148941|NCT01888874|50262968|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
25148942|NCT01888874|50262969|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
25148943|NCT01888874|50262970|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
25148944|NCT01888874|50262964|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
25148945|NCT01888874|50262965|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
25148946|NCT01888874|50262966|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
25148947|NCT01888874|50262967|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
25148948|NCT01888874|50262968|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
25148949|NCT01888874|50262969|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
25148950|NCT01888874|50262970|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
25148951|NCT01749735|50262989|FG000|Overall Study|Withdrawal by Subject|1|||
25148952|NCT01749735|50262990|FG001|Overall Study|Withdrawal by Subject|0|||
25148953|NCT01749033|50262999|FG000|Overall Study|Did not receive allocated intervention|3|||
25148954|NCT01749033|50263000|FG001|Overall Study|Did not receive allocated intervention|3|||
25148955|NCT01749033|50263001|FG002|Overall Study|Did not receive allocated intervention|0|||
25148956|NCT01749033|50262999|FG000|Overall Study|Lost to Follow-up|0|||
25148957|NCT01749033|50263000|FG001|Overall Study|Lost to Follow-up|2|||
25148958|NCT01749033|50263001|FG002|Overall Study|Lost to Follow-up|1|||
25148959|NCT01774305|50263012|FG000|Overall Study|Physician Decision|1|||
25148960|NCT01774305|50263013|FG001|Overall Study|Physician Decision|0|||
25148961|NCT01737021|50263021|FG000|Overall Study|Lost to Follow-up|5|||
25148962|NCT01737021|50263022|FG001|Overall Study|Lost to Follow-up|3|||
25148963|NCT01397422|50263032|FG000|Overall Study|Adverse Event|0|||
25148964|NCT01397422|50263033|FG001|Overall Study|Adverse Event|3|||
25148965|NCT01397422|50263034|FG002|Overall Study|Adverse Event|3|||
25148966|NCT01397422|50263035|FG003|Overall Study|Adverse Event|8|||
25016249|NCT04057573|50111148|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
25016250|NCT04057573|50111149|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
25016251|NCT04057573|50111146|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
25016252|NCT04057573|50111147|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
25016253|NCT04057573|50111148|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
25016254|NCT04057573|50111149|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
25016255|NCT04057573|50111146|FG000|24-Week Double-Blind Period|Not Treated|1|||
25016256|NCT04057573|50111147|FG001|24-Week Double-Blind Period|Not Treated|0|||
25016257|NCT04057573|50111148|FG002|24-Week Double-Blind Period|Not Treated|0|||
25016258|NCT04057573|50111149|FG003|24-Week Double-Blind Period|Not Treated|0|||
25016259|NCT04057573|50111146|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
25016260|NCT04057573|50111147|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
25148967|NCT01397422|50263032|FG000|Overall Study|Withdrawal by Subject|1|||
25148968|NCT01397422|50263033|FG001|Overall Study|Withdrawal by Subject|0|||
25148969|NCT01397422|50263034|FG002|Overall Study|Withdrawal by Subject|0|||
25148970|NCT01397422|50263035|FG003|Overall Study|Withdrawal by Subject|0|||
25148971|NCT01397422|50263032|FG000|Overall Study|Increased bradykinesia related to PD|1|||
25184639|NCT01485614|50333353|FG000|Weeks 20-54|Lost to Follow-up|4|||
25184640|NCT01485614|50333354|FG001|Weeks 20-54|Lost to Follow-up|3|||
25148972|NCT01397422|50263033|FG001|Overall Study|Increased bradykinesia related to PD|0|||
25148973|NCT01397422|50263034|FG002|Overall Study|Increased bradykinesia related to PD|0|||
25148974|NCT01397422|50263035|FG003|Overall Study|Increased bradykinesia related to PD|0|||
25148975|NCT01736553|50263049|FG000|Overall Study|Death|12|||
25148976|NCT01736553|50263050|FG001|Overall Study|Death|0|||
25148977|NCT01736553|50263049|FG000|Overall Study|Withdrawal by Subject|5|||
25148978|NCT01736553|50263050|FG001|Overall Study|Withdrawal by Subject|2|||
25148979|NCT01736553|50263049|FG000|Overall Study|Lost to Follow-up|2|||
25148980|NCT01736553|50263050|FG001|Overall Study|Lost to Follow-up|2|||
25274623|NCT01251653|50588649|FG002|Overall Study|Dose-limiting toxicity|1|||
25016261|NCT04057573|50111148|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
25148981|NCT01888640|50263077|FG000|Overall Study|Lost to Follow-up|1|||
25148982|NCT01888640|50263078|FG001|Overall Study|Lost to Follow-up|2|||
25148983|NCT01888640|50263079|FG002|Overall Study|Lost to Follow-up|0|||
25148984|NCT01888640|50263077|FG000|Overall Study|Withdrawal by Subject|15|||
25148985|NCT01888640|50263078|FG001|Overall Study|Withdrawal by Subject|11|||
25148986|NCT01888640|50263079|FG002|Overall Study|Withdrawal by Subject|4|||
25148987|NCT01888640|50263077|FG000|Overall Study|Minimum dose not met|10|||
25148988|NCT01888640|50263078|FG001|Overall Study|Minimum dose not met|16|||
25148989|NCT01888640|50263079|FG002|Overall Study|Minimum dose not met|0|||
25148990|NCT01888640|50263077|FG000|Overall Study|Given wrong unit (placebo)|1|||
25148991|NCT01888640|50263078|FG001|Overall Study|Given wrong unit (placebo)|0|||
25148992|NCT01888640|50263079|FG002|Overall Study|Given wrong unit (placebo)|0|||
25148993|NCT01888640|50263077|FG000|Overall Study|Excluded for prior TENS|0|||
25148994|NCT01888640|50263078|FG001|Overall Study|Excluded for prior TENS|1|||
25148995|NCT01888640|50263079|FG002|Overall Study|Excluded for prior TENS|0|||
25148996|NCT01888640|50263077|FG000|Overall Study|Researcher Termination of Participant|0|||
25274624|NCT01251653|50588650|FG003|Overall Study|Dose-limiting toxicity|1|||
25148997|NCT01888640|50263078|FG001|Overall Study|Researcher Termination of Participant|1|||
25148998|NCT01888640|50263079|FG002|Overall Study|Researcher Termination of Participant|1|||
25148999|NCT01736475|50263092|FG000|Overall Study|Adverse Event|4|||
25149000|NCT01736475|50263093|FG001|Overall Study|Adverse Event|0|||
25184641|NCT01485614|50333355|FG002|Weeks 20-54|Lost to Follow-up|1|||
25184642|NCT01485614|50333356|FG003|Weeks 20-54|Lost to Follow-up|0|||
25184643|NCT01485614|50333353|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
25184644|NCT01485614|50333354|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
25184645|NCT01485614|50333355|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
25184646|NCT01485614|50333356|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
25149001|NCT01736475|50263092|FG000|Overall Study|Withdrawal by Subject|2|||
25149002|NCT01736475|50263093|FG001|Overall Study|Withdrawal by Subject|0|||
25149003|NCT01736475|50263092|FG000|Overall Study|Protocol Violation|4|||
25149004|NCT01736475|50263093|FG001|Overall Study|Protocol Violation|0|||
25149005|NCT01736475|50263092|FG000|Overall Study|Other - Screen failure|1|||
25149006|NCT01736475|50263093|FG001|Overall Study|Other - Screen failure|0|||
25184647|NCT01485614|50333353|FG000|Weeks 20-54|Withdrawal by Subject|5|||
25184648|NCT01485614|50333354|FG001|Weeks 20-54|Withdrawal by Subject|3|||
25184649|NCT01485614|50333355|FG002|Weeks 20-54|Withdrawal by Subject|0|||
25184650|NCT01485614|50333356|FG003|Weeks 20-54|Withdrawal by Subject|0|||
25184651|NCT01485536|50333406|FG000|Overall Study|Withdrawal by Subject|3|||
25184652|NCT01485536|50333406|FG000|Overall Study|Adverse Event|1|||
25184653|NCT02658630|50333410|FG000|Overall Study|Withdrawal by Subject|4|||
25149007|NCT01736475|50263092|FG000|Overall Study|Other - Surgical procedure|1|||
25149008|NCT01736475|50263093|FG001|Overall Study|Other - Surgical procedure|0|||
25168633|NCT01872689|50298243|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
25184654|NCT01484912|50333416|FG000|Overall Study|Withdrawal by Subject|1|||
25149009|NCT01863758|50263110|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
25149010|NCT01863758|50263110|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
25149011|NCT01863680|50263114|FG000|Overall Study|Adverse Event|17|||
25149012|NCT01863680|50263114|FG000|Overall Study|Risk of OHSS|17|||
25149013|NCT01863680|50263114|FG000|Overall Study|Spontaneous pregnancy|2|||
25149014|NCT01863680|50263114|FG000|Overall Study|Withdrawal by Subject|1|||
25149015|NCT01863680|50263114|FG000|Overall Study|Did not undergo IVF/ET|14|||
25149016|NCT01863680|50263114|FG000|Overall Study|Other|6|||
25149017|NCT01747629|50263120|FG000|Overall Study|Adverse Event|1|||
25149018|NCT01747629|50263121|FG001|Overall Study|Adverse Event|2|||
25149019|NCT01747629|50263120|FG000|Overall Study|Withdrawal by Subject|2|||
25149020|NCT01747629|50263121|FG001|Overall Study|Withdrawal by Subject|2|||
25149021|NCT01747629|50263120|FG000|Overall Study|Noncompliance|1|||
25149022|NCT01747629|50263121|FG001|Overall Study|Noncompliance|1|||
25149023|NCT01747629|50263120|FG000|Overall Study|Inclusion criteria not met|1|||
25149024|NCT01747629|50263121|FG001|Overall Study|Inclusion criteria not met|0|||
25149025|NCT01747629|50263120|FG000|Overall Study|Not treated|1|||
25149026|NCT01747629|50263121|FG001|Overall Study|Not treated|0|||
25149027|NCT01747629|50263120|FG000|Overall Study|Other|2|||
25149028|NCT01747629|50263121|FG001|Overall Study|Other|1|||
25149029|NCT01863368|50263129|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
25149030|NCT01863368|50263130|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
25149031|NCT01863368|50263129|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
25149032|NCT01863368|50263130|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
25149033|NCT01863368|50263129|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
25149034|NCT01863368|50263130|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
25149035|NCT01863368|50263129|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
25149036|NCT01863368|50263130|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
25149037|NCT01863368|50263129|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
25149038|NCT01863368|50263130|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
25149039|NCT01863368|50263129|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
25149040|NCT01863368|50263130|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
25149041|NCT01886690|50263139|FG000|Overall Study|Protocol Violation|0|||
25149042|NCT01886690|50263140|FG001|Overall Study|Protocol Violation|1|||
25149043|NCT01886690|50263139|FG000|Overall Study|Personal Reasons|0|||
25149044|NCT01886690|50263140|FG001|Overall Study|Personal Reasons|1|||
25149045|NCT01886378|50263146|FG000|Overall Study|Adverse Event|1|||
25149046|NCT01886378|50263146|FG000|Overall Study|Withdrawal by Subject|4|||
25149047|NCT01886300|50263150|FG000|Overall Study|Trial terminated by sponsor|16|||
25149048|NCT01885208|50263156|FG000|Overall Study|Unclassified|32|||
25149049|NCT01885208|50263157|FG001|Overall Study|Unclassified|38|||
25149050|NCT01859702|50263163|FG000|Overall Study|Protocol deviation|3|||
25149051|NCT01859702|50263163|FG000|Overall Study|Adverse Event|2|||
25149052|NCT01835132|50263167|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
25149053|NCT01747551|50263173|FG000|Overall Study|Progressive Disease|24|||
25149054|NCT01747551|50263174|FG001|Overall Study|Progressive Disease|17|||
25149055|NCT01747551|50263173|FG000|Overall Study|Death|3|||
25149056|NCT01747551|50263174|FG001|Overall Study|Death|1|||
25149057|NCT01747551|50263173|FG000|Overall Study|Adverse Event|7|||
25149058|NCT01747551|50263174|FG001|Overall Study|Adverse Event|1|||
25149059|NCT01747551|50263173|FG000|Overall Study|Prolonged Treatment Delay|2|||
25149060|NCT01747551|50263174|FG001|Overall Study|Prolonged Treatment Delay|0|||
25149061|NCT01747551|50263173|FG000|Overall Study|Withdrawal by Subject|3|||
25016262|NCT04057573|50111149|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
25149062|NCT01747551|50263174|FG001|Overall Study|Withdrawal by Subject|1|||
25149063|NCT01747551|50263173|FG000|Overall Study|Physician Decision|2|||
25149064|NCT01747551|50263174|FG001|Overall Study|Physician Decision|1|||
25149065|NCT01747551|50263173|FG000|Overall Study|Other|2|||
25149066|NCT01747551|50263174|FG001|Overall Study|Other|0|||
25149067|NCT01736397|50263182|FG000|Overall Study|Lack of Efficacy|1|||
25149068|NCT01736397|50263183|FG001|Overall Study|Lack of Efficacy|11|||
25149069|NCT01736397|50263182|FG000|Overall Study|Withdrawal by Subject|6|||
25149070|NCT01736397|50263183|FG001|Overall Study|Withdrawal by Subject|5|||
25149071|NCT01736397|50263182|FG000|Overall Study|Lost to Follow-up|0|||
25149072|NCT01736397|50263183|FG001|Overall Study|Lost to Follow-up|1|||
25149073|NCT01736397|50263182|FG000|Overall Study|Adverse Event|6|||
25149074|NCT01736397|50263183|FG001|Overall Study|Adverse Event|3|||
25016263|NCT04057573|50111146|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
25016264|NCT04057573|50111147|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
25149075|NCT01736397|50263182|FG000|Overall Study|Not stated|1|||
25149076|NCT01736397|50263183|FG001|Overall Study|Not stated|4|||
25149077|NCT01859390|50263191|FG000|Overall Study|Insufficient Sputum Collected|1|||
25149078|NCT01859390|50263192|FG001|Overall Study|Insufficient Sputum Collected|3|||
25149079|NCT01859390|50263191|FG000|Overall Study|Sample Missing Collection Date|0|||
25149080|NCT01859390|50263192|FG001|Overall Study|Sample Missing Collection Date|1|||
25149081|NCT01859390|50263191|FG000|Overall Study|Tube Cracked|0|||
25149082|NCT01859390|50263192|FG001|Overall Study|Tube Cracked|2|||
25149083|NCT01859390|50263191|FG000|Overall Study|Shipment Error|0|||
25184655|NCT01484912|50333417|FG001|Overall Study|Withdrawal by Subject|0|||
25184656|NCT01484912|50333416|FG000|Overall Study|Physician Decision|0|||
25184657|NCT01484912|50333417|FG001|Overall Study|Physician Decision|1|||
25184658|NCT01520870|50333423|FG000|Overall Study|Withdrawal by Subject|2|||
25184659|NCT01520714|50333429|FG000|Overall Study|Protocol Violation|0|||
25184660|NCT01520714|50333430|FG001|Overall Study|Protocol Violation|3|||
25184661|NCT01520714|50333429|FG000|Overall Study|Adverse Event|0|||
25184662|NCT01520714|50333430|FG001|Overall Study|Adverse Event|2|||
25184663|NCT01520714|50333429|FG000|Overall Study|Lack of Efficacy|0|||
25184664|NCT01520714|50333430|FG001|Overall Study|Lack of Efficacy|1|||
25184665|NCT02659098|50333449|FG000|Overall Study|Withdrawal by Subject|7|||
25184666|NCT01508936|50333460|FG000|Overall Study|Adverse Event|11|||
25184667|NCT01508936|50333461|FG001|Overall Study|Adverse Event|32|||
25184668|NCT01508936|50333460|FG000|Overall Study|Lack of Efficacy|0|||
25184669|NCT01508936|50333461|FG001|Overall Study|Lack of Efficacy|1|||
25184670|NCT01508936|50333460|FG000|Overall Study|Withdrawal by Subject|4|||
25184671|NCT01508936|50333461|FG001|Overall Study|Withdrawal by Subject|18|||
25184672|NCT01508936|50333460|FG000|Overall Study|Protocol Violation|2|||
25184673|NCT01508936|50333461|FG001|Overall Study|Protocol Violation|3|||
25184674|NCT01508936|50333460|FG000|Overall Study|Lost to Follow-up|2|||
25184675|NCT01508936|50333461|FG001|Overall Study|Lost to Follow-up|9|||
25184676|NCT01508936|50333460|FG000|Overall Study|Other|0|||
25184677|NCT01508936|50333461|FG001|Overall Study|Other|5|||
25016265|NCT04057573|50111148|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
25149084|NCT01859390|50263192|FG001|Overall Study|Shipment Error|1|||
25149085|NCT01858766|50263217|FG000|Overall Study|Randomized but Never Treated|0|||
25149086|NCT01858766|50263218|FG001|Overall Study|Randomized but Never Treated|0|||
25016266|NCT04057573|50111149|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
25016267|NCT04057573|50111146|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
25016268|NCT04057573|50111147|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
25016269|NCT04057573|50111148|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
25016270|NCT04057573|50111149|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
25016271|NCT04057573|50111146|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
25016272|NCT04057573|50111147|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
25149087|NCT01858766|50263219|FG002|Overall Study|Randomized but Never Treated|0|||
25149088|NCT01858766|50263220|FG003|Overall Study|Randomized but Never Treated|0|||
25149089|NCT01858766|50263221|FG004|Overall Study|Randomized but Never Treated|0|||
25149090|NCT01858766|50263222|FG005|Overall Study|Randomized but Never Treated|1|||
25149091|NCT01858766|50263223|FG006|Overall Study|Randomized but Never Treated|0|||
25149092|NCT01858766|50263224|FG007|Overall Study|Randomized but Never Treated|0|||
25149093|NCT01858766|50263225|FG008|Overall Study|Randomized but Never Treated|0|||
25149094|NCT01858766|50263226|FG009|Overall Study|Randomized but Never Treated|0|||
25149095|NCT01858766|50263227|FG010|Overall Study|Randomized but Never Treated|0|||
25149096|NCT01858766|50263228|FG011|Overall Study|Randomized but Never Treated|0|||
25149097|NCT01858766|50263229|FG012|Overall Study|Randomized but Never Treated|0|||
25149098|NCT01858766|50263230|FG013|Overall Study|Randomized but Never Treated|0|||
25149099|NCT01858766|50263231|FG014|Overall Study|Randomized but Never Treated|0|||
25016273|NCT04057573|50111148|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
25016274|NCT04057573|50111149|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
25149100|NCT01858766|50263232|FG015|Overall Study|Randomized but Never Treated|0|||
25149101|NCT01858766|50263233|FG016|Overall Study|Randomized but Never Treated|0|||
25149102|NCT01858766|50263234|FG017|Overall Study|Randomized but Never Treated|1|||
25149103|NCT01858766|50263235|FG018|Overall Study|Randomized but Never Treated|0|||
25149104|NCT01858766|50263217|FG000|Overall Study|Death|0|||
25149105|NCT01858766|50263218|FG001|Overall Study|Death|0|||
25016275|NCT04057573|50111146|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
25149106|NCT01858766|50263219|FG002|Overall Study|Death|1|||
25149107|NCT01858766|50263220|FG003|Overall Study|Death|0|||
25149108|NCT01858766|50263221|FG004|Overall Study|Death|0|||
25149109|NCT01858766|50263222|FG005|Overall Study|Death|0|||
25149110|NCT01858766|50263223|FG006|Overall Study|Death|0|||
25149111|NCT01858766|50263224|FG007|Overall Study|Death|0|||
25149112|NCT01858766|50263225|FG008|Overall Study|Death|0|||
25149113|NCT01858766|50263226|FG009|Overall Study|Death|0|||
25149114|NCT01858766|50263227|FG010|Overall Study|Death|0|||
25149115|NCT01858766|50263228|FG011|Overall Study|Death|0|||
25149116|NCT01858766|50263229|FG012|Overall Study|Death|0|||
25149117|NCT01858766|50263230|FG013|Overall Study|Death|0|||
25149118|NCT01858766|50263231|FG014|Overall Study|Death|0|||
25149119|NCT01858766|50263232|FG015|Overall Study|Death|0|||
25149120|NCT01858766|50263233|FG016|Overall Study|Death|0|||
25149121|NCT01858766|50263234|FG017|Overall Study|Death|0|||
25149122|NCT01858766|50263235|FG018|Overall Study|Death|0|||
25149123|NCT01858766|50263217|FG000|Overall Study|Lack of Efficacy|1|||
25149124|NCT01858766|50263218|FG001|Overall Study|Lack of Efficacy|0|||
25149125|NCT01858766|50263219|FG002|Overall Study|Lack of Efficacy|0|||
25149126|NCT01858766|50263220|FG003|Overall Study|Lack of Efficacy|0|||
25149127|NCT01858766|50263221|FG004|Overall Study|Lack of Efficacy|1|||
25149128|NCT01858766|50263222|FG005|Overall Study|Lack of Efficacy|2|||
25149129|NCT01858766|50263223|FG006|Overall Study|Lack of Efficacy|0|||
25149130|NCT01858766|50263224|FG007|Overall Study|Lack of Efficacy|0|||
25149131|NCT01858766|50263225|FG008|Overall Study|Lack of Efficacy|0|||
25149132|NCT01858766|50263226|FG009|Overall Study|Lack of Efficacy|0|||
25149133|NCT01858766|50263227|FG010|Overall Study|Lack of Efficacy|0|||
25149134|NCT01858766|50263228|FG011|Overall Study|Lack of Efficacy|3|||
25149135|NCT01858766|50263229|FG012|Overall Study|Lack of Efficacy|5|||
25149136|NCT01858766|50263230|FG013|Overall Study|Lack of Efficacy|3|||
25149137|NCT01858766|50263231|FG014|Overall Study|Lack of Efficacy|5|||
25149138|NCT01858766|50263232|FG015|Overall Study|Lack of Efficacy|5|||
25184678|NCT01508936|50333460|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
25184679|NCT01508936|50333461|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
25184680|NCT01508702|50333482|FG000|Overall Study|Adverse Event|7|||
25184681|NCT01508702|50333483|FG001|Overall Study|Adverse Event|3|||
25184682|NCT01508702|50333482|FG000|Overall Study|Gout flare|2|||
25184683|NCT01508702|50333483|FG001|Overall Study|Gout flare|0|||
25184684|NCT01508702|50333482|FG000|Overall Study|Protocol Violation|2|||
25184685|NCT01508702|50333483|FG001|Overall Study|Protocol Violation|1|||
25184686|NCT01508702|50333482|FG000|Overall Study|Lost to Follow-up|1|||
25184687|NCT01508702|50333483|FG001|Overall Study|Lost to Follow-up|2|||
25184688|NCT01508702|50333482|FG000|Overall Study|Withdrawal by Subject|11|||
25149139|NCT01858766|50263233|FG016|Overall Study|Lack of Efficacy|2|||
25149140|NCT01858766|50263234|FG017|Overall Study|Lack of Efficacy|3|||
25149141|NCT01858766|50263235|FG018|Overall Study|Lack of Efficacy|3|||
25149142|NCT01858766|50263217|FG000|Overall Study|Lost to Follow-up|0|||
25149143|NCT01858766|50263218|FG001|Overall Study|Lost to Follow-up|0|||
25149144|NCT01858766|50263219|FG002|Overall Study|Lost to Follow-up|0|||
25184689|NCT01508702|50333483|FG001|Overall Study|Withdrawal by Subject|7|||
25149145|NCT01858766|50263220|FG003|Overall Study|Lost to Follow-up|0|||
25149146|NCT01858766|50263221|FG004|Overall Study|Lost to Follow-up|0|||
25149147|NCT01858766|50263222|FG005|Overall Study|Lost to Follow-up|1|||
25149148|NCT01858766|50263223|FG006|Overall Study|Lost to Follow-up|0|||
25149149|NCT01858766|50263224|FG007|Overall Study|Lost to Follow-up|2|||
25149150|NCT01858766|50263225|FG008|Overall Study|Lost to Follow-up|0|||
25149151|NCT01858766|50263226|FG009|Overall Study|Lost to Follow-up|0|||
25149152|NCT01858766|50263227|FG010|Overall Study|Lost to Follow-up|0|||
25149153|NCT01858766|50263228|FG011|Overall Study|Lost to Follow-up|1|||
25149154|NCT01858766|50263229|FG012|Overall Study|Lost to Follow-up|0|||
25149155|NCT01858766|50263230|FG013|Overall Study|Lost to Follow-up|0|||
25149156|NCT01858766|50263231|FG014|Overall Study|Lost to Follow-up|3|||
25149157|NCT01858766|50263232|FG015|Overall Study|Lost to Follow-up|1|||
25149158|NCT01858766|50263233|FG016|Overall Study|Lost to Follow-up|1|||
25149159|NCT01858766|50263234|FG017|Overall Study|Lost to Follow-up|0|||
25149160|NCT01858766|50263235|FG018|Overall Study|Lost to Follow-up|1|||
25149161|NCT01858766|50263217|FG000|Overall Study|Withdrew Consent|0|||
25149162|NCT01858766|50263218|FG001|Overall Study|Withdrew Consent|0|||
25184690|NCT01484834|50333497|FG000|Overall Study|Lost to Follow-up|5|||
25184691|NCT01484834|50333498|FG001|Overall Study|Lost to Follow-up|8|||
25149163|NCT01858766|50263219|FG002|Overall Study|Withdrew Consent|0|||
25149164|NCT01858766|50263220|FG003|Overall Study|Withdrew Consent|0|||
25149165|NCT01858766|50263221|FG004|Overall Study|Withdrew Consent|0|||
25149166|NCT01858766|50263222|FG005|Overall Study|Withdrew Consent|0|||
25016276|NCT04057573|50111147|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
25016277|NCT04057573|50111148|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
25149167|NCT01858766|50263223|FG006|Overall Study|Withdrew Consent|0|||
25149168|NCT01858766|50263224|FG007|Overall Study|Withdrew Consent|0|||
25149169|NCT01858766|50263225|FG008|Overall Study|Withdrew Consent|0|||
25149170|NCT01858766|50263226|FG009|Overall Study|Withdrew Consent|0|||
25149171|NCT01858766|50263227|FG010|Overall Study|Withdrew Consent|0|||
25149172|NCT01858766|50263228|FG011|Overall Study|Withdrew Consent|1|||
25149173|NCT01858766|50263229|FG012|Overall Study|Withdrew Consent|0|||
25149174|NCT01858766|50263230|FG013|Overall Study|Withdrew Consent|0|||
25149175|NCT01858766|50263231|FG014|Overall Study|Withdrew Consent|0|||
25149176|NCT01858766|50263232|FG015|Overall Study|Withdrew Consent|0|||
25149177|NCT01858766|50263233|FG016|Overall Study|Withdrew Consent|0|||
25149178|NCT01858766|50263234|FG017|Overall Study|Withdrew Consent|0|||
25067377|NCT03188666|50173000|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
25149179|NCT01858766|50263235|FG018|Overall Study|Withdrew Consent|0|||
25149180|NCT01734993|50263268|FG000|Overall Study|Adverse Event|1|||
25149181|NCT01734993|50263268|FG000|Overall Study|Lack of Efficacy|1|||
25149182|NCT01745367|50263275|FG000|Overall Study|Death|1|||
25149183|NCT01745367|50263276|FG001|Overall Study|Death|0|||
25149184|NCT01745367|50263275|FG000|Overall Study|Withdrawal by Subject|1|||
25184692|NCT01484834|50333499|FG002|Overall Study|Lost to Follow-up|1|||
25184693|NCT01484834|50333500|FG003|Overall Study|Lost to Follow-up|4|||
25184694|NCT01484132|50333510|FG000|Overall Study|Lost to Follow-up|8|||
25149185|NCT01745367|50263276|FG001|Overall Study|Withdrawal by Subject|2|||
25067378|NCT03188666|50173001|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
25184695|NCT01484132|50333510|FG000|Overall Study|Difficulty with time commitment|2|||
25274625|NCT01251653|50588651|FG004|Overall Study|Dose-limiting toxicity|0|||
25274626|NCT01251653|50588652|FG005|Overall Study|Dose-limiting toxicity|0|||
25274627|NCT01251653|50588653|FG006|Overall Study|Dose-limiting toxicity|2|||
25274628|NCT01251653|50588654|FG007|Overall Study|Dose-limiting toxicity|0|||
25274629|NCT01251653|50588655|FG008|Overall Study|Dose-limiting toxicity|0|||
25274630|NCT01251653|50588647|FG000|Overall Study|Adverse Event|1|||
25149186|NCT01745367|50263275|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
25149187|NCT01745367|50263276|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
25149188|NCT01745367|50263275|FG000|Overall Study|Other Reasons Unspecified|0|||
25149189|NCT01745367|50263276|FG001|Overall Study|Other Reasons Unspecified|2|||
25149190|NCT01733121|50263284|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
25149191|NCT01733121|50263285|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
25149192|NCT01733121|50263284|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
25149193|NCT01733121|50263285|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
25149194|NCT01733121|50263284|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
25149195|NCT01733121|50263285|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
25149196|NCT01733121|50263284|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
25149197|NCT01733121|50263285|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
25149198|NCT01744977|50263295|FG000|Overall Study|Withdrawal by Subject|1|||
25184696|NCT01484132|50333510|FG000|Overall Study|Ineligible|1|||
25184697|NCT01484132|50333510|FG000|Overall Study|No pre-treatment urine sample collected|1|||
25149199|NCT01744977|50263296|FG001|Overall Study|Withdrawal by Subject|2|||
25149200|NCT01744977|50263295|FG000|Overall Study|Death|2|||
25149201|NCT01744977|50263296|FG001|Overall Study|Death|3|||
25149202|NCT01744977|50263295|FG000|Overall Study|Lost to Follow-up|2|||
25149203|NCT01744977|50263296|FG001|Overall Study|Lost to Follow-up|0|||
25149204|NCT01744977|50263295|FG000|Overall Study|No longer meets inclusion|6|||
25149205|NCT01744977|50263296|FG001|Overall Study|No longer meets inclusion|0|||
25149206|NCT01383928|50263305|FG000|Overall Study|Initiation of ASCT|2|||
25149207|NCT01383928|50263306|FG001|Overall Study|Initiation of ASCT|1|||
25149208|NCT01383928|50263307|FG002|Overall Study|Initiation of ASCT|18|||
25149209|NCT01383928|50263305|FG000|Overall Study|Adverse Event|1|||
25149210|NCT01383928|50263306|FG001|Overall Study|Adverse Event|2|||
25149211|NCT01383928|50263307|FG002|Overall Study|Adverse Event|8|||
25149212|NCT01383928|50263305|FG000|Overall Study|Other|1|||
25149213|NCT01383928|50263306|FG001|Overall Study|Other|3|||
25149214|NCT01383928|50263307|FG002|Overall Study|Other|4|||
25149215|NCT01383928|50263305|FG000|Overall Study|Progressive Disease|1|||
25149216|NCT01383928|50263306|FG001|Overall Study|Progressive Disease|1|||
25149217|NCT01383928|50263307|FG002|Overall Study|Progressive Disease|5|||
25149218|NCT01383928|50263305|FG000|Overall Study|Withdrawal by Subject|0|||
25149219|NCT01383928|50263306|FG001|Overall Study|Withdrawal by Subject|0|||
25149220|NCT01383928|50263307|FG002|Overall Study|Withdrawal by Subject|4|||
25149221|NCT01383928|50263305|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
25149222|NCT01383928|50263306|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
25149223|NCT01383928|50263307|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
25149224|NCT01382602|50263319|FG000|Overall Study|Protocol Violation|0|||
25149225|NCT01382602|50263320|FG001|Overall Study|Protocol Violation|3|||
25149226|NCT01382602|50263319|FG000|Overall Study|Withdrawal by Subject|0|||
25149227|NCT01382602|50263320|FG001|Overall Study|Withdrawal by Subject|1|||
25149228|NCT04801420|50263329|FG000|Overall Study|Other|1|||
25149229|NCT04801420|50263330|FG001|Overall Study|Other|2|||
25149230|NCT04801420|50263331|FG002|Overall Study|Other|1|||
25149231|NCT04801420|50263329|FG000|Overall Study|Lost to Follow-up|7|||
25149232|NCT04801420|50263330|FG001|Overall Study|Lost to Follow-up|9|||
25149233|NCT04801420|50263331|FG002|Overall Study|Lost to Follow-up|10|||
25149234|NCT04801420|50263329|FG000|Overall Study|Moved from study area|0|||
25149235|NCT04801420|50263330|FG001|Overall Study|Moved from study area|1|||
25149236|NCT04801420|50263331|FG002|Overall Study|Moved from study area|1|||
25149237|NCT04801420|50263329|FG000|Overall Study|Withdrawal by Subject|5|||
25149238|NCT04801420|50263330|FG001|Overall Study|Withdrawal by Subject|1|||
25149239|NCT04801420|50263331|FG002|Overall Study|Withdrawal by Subject|4|||
25149240|NCT04801420|50263329|FG000|Overall Study|Individual stopping criteria reached|0|||
25149241|NCT04801420|50263330|FG001|Overall Study|Individual stopping criteria reached|1|||
25149242|NCT04801420|50263331|FG002|Overall Study|Individual stopping criteria reached|0|||
25149243|NCT04801420|50263329|FG000|Overall Study|Ongoing in the study|195|||
25149244|NCT04801420|50263330|FG001|Overall Study|Ongoing in the study|195|||
25149245|NCT04801420|50263331|FG002|Overall Study|Ongoing in the study|192|||
25149246|NCT04294472|50263346|FG000|Overall Study|Adverse Event|0|||
25149247|NCT04294472|50263347|FG001|Overall Study|Adverse Event|1|||
25149248|NCT04294472|50263348|FG002|Overall Study|Adverse Event|1|||
25149249|NCT04294472|50263346|FG000|Overall Study|Randomized but not treated|0|||
25274631|NCT01251653|50588648|FG001|Overall Study|Adverse Event|0|||
25274632|NCT01251653|50588649|FG002|Overall Study|Adverse Event|2|||
25149250|NCT04294472|50263347|FG001|Overall Study|Randomized but not treated|1|||
25149251|NCT04294472|50263348|FG002|Overall Study|Randomized but not treated|1|||
25149252|NCT04233918|50263358|FG000|Part C (Extension Period)|Ongoing in study|0|||
25149253|NCT04233918|50263359|FG001|Part C (Extension Period)|Ongoing in study|0|||
25149254|NCT04233918|50263360|FG002|Part C (Extension Period)|Ongoing in study|15|||
25149255|NCT04060251|50263372|FG000|Overall Study|Study terminated due to low enrollment.|7|||
25149256|NCT04060251|50263373|FG001|Overall Study|Study terminated due to low enrollment.|5|||
25149257|NCT04060251|50263374|FG002|Overall Study|Study terminated due to low enrollment.|7|||
25149258|NCT04060251|50263372|FG000|Overall Study|Adverse Event|1|||
25149259|NCT04060251|50263373|FG001|Overall Study|Adverse Event|1|||
25149260|NCT04060251|50263374|FG002|Overall Study|Adverse Event|0|||
25149261|NCT04048876|50263386|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
25149262|NCT04048876|50263387|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
25149263|NCT04048876|50263388|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
25149264|NCT04048876|50263389|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
25149265|NCT04048876|50263386|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
25149266|NCT04048876|50263387|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
25149267|NCT04048876|50263388|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
25149268|NCT04048876|50263389|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
25149269|NCT04048876|50263386|FG000|Placebo Controlled Phase|Adverse Event|0|||
25149270|NCT04048876|50263387|FG001|Placebo Controlled Phase|Adverse Event|1|||
25149271|NCT04048876|50263388|FG002|Placebo Controlled Phase|Adverse Event|0|||
25149272|NCT04048876|50263389|FG003|Placebo Controlled Phase|Adverse Event|0|||
25149273|NCT04048876|50263386|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
25149274|NCT04048876|50263387|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
25149275|NCT04048876|50263388|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
25149276|NCT04048876|50263389|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
25149277|NCT03921424|50263416|FG000|Overall Study|Lost to Follow-up|0|||
25149278|NCT03921424|50263417|FG001|Overall Study|Lost to Follow-up|1|||
25149279|NCT03921424|50263416|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
25274633|NCT01251653|50588650|FG003|Overall Study|Adverse Event|1|||
25149280|NCT03921424|50263417|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
25149281|NCT03852628|50263440|FG000|Overall Study|Lost to Follow-up|7|||
25149282|NCT03852628|50263441|FG001|Overall Study|Lost to Follow-up|6|||
25149283|NCT03852628|50263440|FG000|Overall Study|Lack of Efficacy|6|||
25149284|NCT03852628|50263441|FG001|Overall Study|Lack of Efficacy|6|||
25149285|NCT03602976|50263447|FG000|Overall Study|Withdrawal by Subject|1|||
25149286|NCT03474107|50263456|FG000|Overall Study|Adverse Event|42|||
25149287|NCT03474107|50263457|FG001|Overall Study|Adverse Event|46|||
25184698|NCT01484132|50333510|FG000|Overall Study|No post-treatment urine sample collected|10|||
25149288|NCT03474107|50263456|FG000|Overall Study|Death|2|||
25149289|NCT03474107|50263457|FG001|Overall Study|Death|2|||
25149290|NCT03474107|50263456|FG000|Overall Study|Lost to Follow-up|0|||
25149291|NCT03474107|50263457|FG001|Overall Study|Lost to Follow-up|1|||
25149292|NCT03474107|50263456|FG000|Overall Study|Progressive Disease|177|||
25149293|NCT03474107|50263457|FG001|Overall Study|Progressive Disease|180|||
25149294|NCT03474107|50263456|FG000|Overall Study|Protocol Violation|1|||
25149295|NCT03474107|50263457|FG001|Overall Study|Protocol Violation|1|||
25149296|NCT03474107|50263456|FG000|Overall Study|Withdrawal by Subject|15|||
25184699|NCT01276041|50333514|FG000|Overall Study|Adverse Event|2|||
25149297|NCT03474107|50263457|FG001|Overall Study|Withdrawal by Subject|27|||
25149298|NCT03474107|50263456|FG000|Overall Study|Physician Decision|7|||
25149299|NCT03474107|50263457|FG001|Overall Study|Physician Decision|22|||
25149300|NCT03474107|50263456|FG000|Overall Study|Miscellaneous|1|||
25149301|NCT03474107|50263457|FG001|Overall Study|Miscellaneous|6|||
25149302|NCT03278106|50263472|FG000|Overall Study|No protocol treatment|1|||
25149303|NCT03214198|50263476|FG000|Overall Study|Case Report Forms Uncollected|18|||
25149304|NCT03214198|50263476|FG000|Overall Study|Protocol Deviation|18|||
25149305|NCT03182907|50263482|FG000|Overall Study|Death|3|||
25149306|NCT03182907|50263483|FG001|Overall Study|Death|0|||
25149307|NCT03182907|50263482|FG000|Overall Study|Protocol Violation|4|||
25149308|NCT03182907|50263483|FG001|Overall Study|Protocol Violation|0|||
25149309|NCT03182907|50263482|FG000|Overall Study|Lost to Follow-up|1|||
25149310|NCT03182907|50263483|FG001|Overall Study|Lost to Follow-up|0|||
25149311|NCT03182907|50263482|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
25149312|NCT03182907|50263483|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
25149313|NCT03052608|50263501|FG000|Treatment Phase|Adverse Event|10|||
25149314|NCT03052608|50263502|FG001|Treatment Phase|Adverse Event|12|||
25149315|NCT03052608|50263501|FG000|Treatment Phase|Death|6|||
25149316|NCT03052608|50263502|FG001|Treatment Phase|Death|4|||
25149317|NCT03052608|50263501|FG000|Treatment Phase|Withdrawal by Subject|4|||
25149318|NCT03052608|50263502|FG001|Treatment Phase|Withdrawal by Subject|12|||
25149319|NCT03052608|50263501|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
25149320|NCT03052608|50263502|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
25149321|NCT03052608|50263501|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
25149322|NCT03052608|50263502|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
25149323|NCT03052608|50263501|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
25149324|NCT03052608|50263502|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
25149325|NCT03052608|50263501|FG000|Treatment Phase|Ongoing|103|||
25149326|NCT03052608|50263502|FG001|Treatment Phase|Ongoing|31|||
25149327|NCT03052608|50263501|FG000|Long-Term Follow-up Phase|Death|23|||
25149328|NCT03052608|50263502|FG001|Long-Term Follow-up Phase|Death|28|||
25149329|NCT03052608|50263501|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
25149330|NCT03052608|50263502|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
25149331|NCT03052608|50263501|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
25149332|NCT03052608|50263502|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
25149333|NCT03052608|50263501|FG000|Long-Term Follow-up Phase|Ongoing|122|||
25149334|NCT03052608|50263502|FG001|Long-Term Follow-up Phase|Ongoing|99|||
25149335|NCT03004443|50263510|FG000|Overall Study|Pregnancy|0|||
25149336|NCT03004443|50263511|FG001|Overall Study|Pregnancy|1|||
25149337|NCT02914639|50263519|FG000|Overall Study|Withdrawal by Subject|0|||
25149338|NCT02914639|50263520|FG001|Overall Study|Withdrawal by Subject|2|||
25149339|NCT02865018|50263527|FG000|Overall Study|Withdrawal by Subject|1|||
25149340|NCT02704208|50263542|FG000|Overall Study|Lost to Follow-up|42|||
25149341|NCT02704208|50263543|FG001|Overall Study|Lost to Follow-up|37|||
25149342|NCT02618408|50263552|FG000|Overall Study|Withdrawal by Subject|1|||
25149343|NCT02618408|50263553|FG001|Overall Study|Withdrawal by Subject|0|||
25149344|NCT02618408|50263554|FG002|Overall Study|Withdrawal by Subject|4|||
25149345|NCT02618408|50263552|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
25149346|NCT02618408|50263553|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
25149347|NCT02618408|50263554|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
25149348|NCT02618408|50263552|FG000|Overall Study|Lost to Follow-up|4|||
25149349|NCT02618408|50263553|FG001|Overall Study|Lost to Follow-up|2|||
25149350|NCT02618408|50263554|FG002|Overall Study|Lost to Follow-up|6|||
25149351|NCT02618408|50263552|FG000|Overall Study|Adverse Event|4|||
25149352|NCT02618408|50263553|FG001|Overall Study|Adverse Event|0|||
25149353|NCT02618408|50263554|FG002|Overall Study|Adverse Event|10|||
25149354|NCT02618408|50263552|FG000|Overall Study|Physician Decision|1|||
25149355|NCT02618408|50263553|FG001|Overall Study|Physician Decision|1|||
25149356|NCT02618408|50263554|FG002|Overall Study|Physician Decision|2|||
25149357|NCT02618408|50263552|FG000|Overall Study|Protocol Violation|1|||
25149358|NCT02618408|50263553|FG001|Overall Study|Protocol Violation|1|||
25149359|NCT02618408|50263554|FG002|Overall Study|Protocol Violation|2|||
25149360|NCT02618408|50263552|FG000|Overall Study|Other, Multiple Categories|0|||
25149361|NCT02618408|50263553|FG001|Overall Study|Other, Multiple Categories|0|||
25149362|NCT02618408|50263554|FG002|Overall Study|Other, Multiple Categories|4|||
25149363|NCT02553460|50263565|FG000|Overall Study|Death|3|||
25149364|NCT02553460|50263565|FG000|Overall Study|Withdrawal by Subject|1|||
25149365|NCT02553460|50263565|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
25149366|NCT02553460|50263565|FG000|Overall Study|Relapse or Transplant|14|||
25149367|NCT02553460|50263565|FG000|Overall Study|No response to treatment|2|||
25149368|NCT02553460|50263565|FG000|Overall Study|Still on therapy|7|||
25149369|NCT02553460|50263565|FG000|Overall Study|CAR T cells|1|||
25149370|NCT02288247|50263578|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52|||
25149371|NCT02288247|50263579|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0|||
25149372|NCT02288247|50263578|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35|||
25184700|NCT01276041|50333514|FG000|Overall Study|Protocol Violation|1|||
25067379|NCT03188666|50173002|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
25067380|NCT03188666|50172999|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
25067381|NCT03188666|50173000|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
25067382|NCT03188666|50173001|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
25067383|NCT03188666|50173002|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
25067384|NCT03188666|50172999|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
25067385|NCT03188666|50173000|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
25067386|NCT03188666|50173001|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
25067387|NCT03188666|50173002|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
25149373|NCT02288247|50263579|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0|||
25149374|NCT02288247|50263578|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1|||
25149375|NCT02288247|50263579|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0|||
25149376|NCT02288247|50263578|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392|||
25149377|NCT02288247|50263579|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0|||
25149378|NCT02288247|50263578|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9|||
25149379|NCT02288247|50263579|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0|||
25149380|NCT02288247|50263578|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52|||
25149381|NCT02288247|50263579|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0|||
25149382|NCT02288247|50263578|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106|||
25149383|NCT02288247|50263579|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0|||
25149384|NCT02288247|50263578|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
25149385|NCT02288247|50263579|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
25149386|NCT02288247|50263578|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
25149387|NCT02288247|50263579|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
25149388|NCT02288247|50263578|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
25149389|NCT02288247|50263579|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
25149390|NCT02288247|50263578|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
25149391|NCT02288247|50263579|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
25149392|NCT02288247|50263578|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
25149393|NCT02288247|50263579|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
25149394|NCT02288247|50263578|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
25149395|NCT02288247|50263579|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
25149396|NCT02288247|50263578|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20|||
25149397|NCT02288247|50263579|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
25149398|NCT02288247|50263578|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
25149399|NCT02288247|50263579|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
25149400|NCT02157883|50263587|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
25149401|NCT02157883|50263587|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
25274634|NCT01251653|50588651|FG004|Overall Study|Adverse Event|1|||
25149402|NCT02157883|50263587|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
25149403|NCT02157883|50263587|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
25149404|NCT02157883|50263587|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
25149405|NCT02071290|50263596|FG000|Overall Study|Death|1|||
25149406|NCT02071290|50263597|FG001|Overall Study|Death|0|||
25149407|NCT02071290|50263596|FG000|Overall Study|Withdrawal by Subject|0|||
25149408|NCT02071290|50263597|FG001|Overall Study|Withdrawal by Subject|1|||
25149409|NCT02071290|50263596|FG000|Overall Study|Protocol Violation|3|||
25149410|NCT02071290|50263597|FG001|Overall Study|Protocol Violation|5|||
25149411|NCT02071290|50263596|FG000|Overall Study|Physician Decision|0|||
25149412|NCT02071290|50263597|FG001|Overall Study|Physician Decision|1|||
25149413|NCT02066181|50263605|FG000|Overall Study|Withdrawal by Subject|1|||
25149414|NCT02066181|50263606|FG001|Overall Study|Withdrawal by Subject|1|||
25149415|NCT01972217|50263619|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
25149416|NCT01972217|50263620|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
25149417|NCT01972217|50263621|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
25149418|NCT01972217|50263622|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
25149419|NCT01972217|50263619|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
25149420|NCT01972217|50263620|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
25149421|NCT01972217|50263621|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
25149422|NCT01972217|50263622|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
25149423|NCT01972217|50263619|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
25149424|NCT01972217|50263620|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
25149425|NCT01972217|50263621|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
25149426|NCT01972217|50263622|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
25149427|NCT01972217|50263619|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
25149428|NCT01972217|50263620|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
25149429|NCT01972217|50263621|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
25149430|NCT01972217|50263622|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
25149431|NCT01972217|50263619|FG000|Part B Double-blind, Randomised Period|Death|0|||
25149432|NCT01972217|50263620|FG001|Part B Double-blind, Randomised Period|Death|0|||
25149433|NCT01972217|50263621|FG002|Part B Double-blind, Randomised Period|Death|43|||
25149434|NCT01972217|50263622|FG003|Part B Double-blind, Randomised Period|Death|44|||
25149435|NCT01972217|50263619|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
25149436|NCT01972217|50263620|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
25149437|NCT01972217|50263621|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
25149438|NCT01972217|50263622|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
25149439|NCT01972217|50263619|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
25149440|NCT01972217|50263620|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
25149441|NCT01972217|50263621|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
25149442|NCT01972217|50263622|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
25149443|NCT01972217|50263619|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
25149444|NCT01972217|50263620|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
25149445|NCT01972217|50263621|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
25149446|NCT01972217|50263622|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
25149447|NCT01972217|50263619|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
25149448|NCT01972217|50263620|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
25149449|NCT01972217|50263621|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
25149450|NCT01972217|50263622|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
25149451|NCT01970865|50263651|FG000|Overall Study|Death|3|||
25149452|NCT01970865|50263652|FG001|Overall Study|Death|1|||
25149453|NCT01970865|50263653|FG002|Overall Study|Death|3|||
25149454|NCT01970865|50263654|FG003|Overall Study|Death|4|||
25149455|NCT01970865|50263655|FG004|Overall Study|Death|6|||
25149456|NCT01970865|50263656|FG005|Overall Study|Death|3|||
25149457|NCT01970865|50263657|FG006|Overall Study|Death|1|||
25149458|NCT01970865|50263658|FG007|Overall Study|Death|3|||
25149459|NCT01970865|50263659|FG008|Overall Study|Death|2|||
25149460|NCT01970865|50263660|FG009|Overall Study|Death|1|||
25149461|NCT01970865|50263661|FG010|Overall Study|Death|1|||
25149462|NCT01970865|50263662|FG011|Overall Study|Death|4|||
25016278|NCT04057573|50111149|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
25149463|NCT01970865|50263663|FG012|Overall Study|Death|14|||
25149464|NCT01970865|50263664|FG013|Overall Study|Death|19|||
25149465|NCT01970865|50263665|FG014|Overall Study|Death|15|||
25149466|NCT01970865|50263666|FG015|Overall Study|Death|10|||
25149467|NCT01970865|50263667|FG016|Overall Study|Death|1|||
25149468|NCT01970865|50263651|FG000|Overall Study|Lost to Follow-up|0|||
25149469|NCT01970865|50263652|FG001|Overall Study|Lost to Follow-up|0|||
25149470|NCT01970865|50263653|FG002|Overall Study|Lost to Follow-up|0|||
25149471|NCT01970865|50263654|FG003|Overall Study|Lost to Follow-up|1|||
25149472|NCT01970865|50263655|FG004|Overall Study|Lost to Follow-up|1|||
25149473|NCT01970865|50263656|FG005|Overall Study|Lost to Follow-up|0|||
25149474|NCT01970865|50263657|FG006|Overall Study|Lost to Follow-up|0|||
25149475|NCT01970865|50263658|FG007|Overall Study|Lost to Follow-up|0|||
25149476|NCT01970865|50263659|FG008|Overall Study|Lost to Follow-up|0|||
25149477|NCT01970865|50263660|FG009|Overall Study|Lost to Follow-up|0|||
25149478|NCT01970865|50263661|FG010|Overall Study|Lost to Follow-up|0|||
25149479|NCT01970865|50263662|FG011|Overall Study|Lost to Follow-up|0|||
25149480|NCT01970865|50263663|FG012|Overall Study|Lost to Follow-up|1|||
25149481|NCT01970865|50263664|FG013|Overall Study|Lost to Follow-up|0|||
25149482|NCT01970865|50263665|FG014|Overall Study|Lost to Follow-up|0|||
25149483|NCT01970865|50263666|FG015|Overall Study|Lost to Follow-up|0|||
25149484|NCT01970865|50263667|FG016|Overall Study|Lost to Follow-up|0|||
25149485|NCT01970865|50263651|FG000|Overall Study|Withdrawal by Subject|0|||
25149486|NCT01970865|50263652|FG001|Overall Study|Withdrawal by Subject|0|||
25149487|NCT01970865|50263653|FG002|Overall Study|Withdrawal by Subject|0|||
25149488|NCT01970865|50263654|FG003|Overall Study|Withdrawal by Subject|1|||
25149489|NCT01970865|50263655|FG004|Overall Study|Withdrawal by Subject|2|||
25149490|NCT01970865|50263656|FG005|Overall Study|Withdrawal by Subject|0|||
25149491|NCT01970865|50263657|FG006|Overall Study|Withdrawal by Subject|0|||
25149492|NCT01970865|50263658|FG007|Overall Study|Withdrawal by Subject|0|||
25149493|NCT01970865|50263659|FG008|Overall Study|Withdrawal by Subject|0|||
25149494|NCT01970865|50263660|FG009|Overall Study|Withdrawal by Subject|0|||
25149495|NCT01970865|50263661|FG010|Overall Study|Withdrawal by Subject|0|||
25149496|NCT01970865|50263662|FG011|Overall Study|Withdrawal by Subject|1|||
25149497|NCT01970865|50263663|FG012|Overall Study|Withdrawal by Subject|2|||
25149498|NCT01970865|50263664|FG013|Overall Study|Withdrawal by Subject|5|||
25149499|NCT01970865|50263665|FG014|Overall Study|Withdrawal by Subject|2|||
25149500|NCT01970865|50263666|FG015|Overall Study|Withdrawal by Subject|7|||
25149501|NCT01970865|50263667|FG016|Overall Study|Withdrawal by Subject|0|||
25149502|NCT01970865|50263651|FG000|Overall Study|Other|0|||
25149503|NCT01970865|50263652|FG001|Overall Study|Other|0|||
25149504|NCT01970865|50263653|FG002|Overall Study|Other|0|||
25149505|NCT01970865|50263654|FG003|Overall Study|Other|1|||
25149506|NCT01970865|50263655|FG004|Overall Study|Other|0|||
25149507|NCT01970865|50263656|FG005|Overall Study|Other|0|||
25149508|NCT01970865|50263657|FG006|Overall Study|Other|0|||
25149509|NCT01970865|50263658|FG007|Overall Study|Other|0|||
25149510|NCT01970865|50263659|FG008|Overall Study|Other|0|||
25149511|NCT01970865|50263660|FG009|Overall Study|Other|0|||
25149512|NCT01970865|50263661|FG010|Overall Study|Other|0|||
25149513|NCT01970865|50263662|FG011|Overall Study|Other|0|||
25149514|NCT01970865|50263663|FG012|Overall Study|Other|0|||
25149515|NCT01970865|50263664|FG013|Overall Study|Other|1|||
25149516|NCT01970865|50263665|FG014|Overall Study|Other|0|||
25149517|NCT01970865|50263666|FG015|Overall Study|Other|1|||
25149518|NCT01970865|50263667|FG016|Overall Study|Other|0|||
25149519|NCT01970865|50263651|FG000|Overall Study|Study ongoing|0|||
25149520|NCT01970865|50263652|FG001|Overall Study|Study ongoing|2|||
25149521|NCT01970865|50263653|FG002|Overall Study|Study ongoing|0|||
25149522|NCT01970865|50263654|FG003|Overall Study|Study ongoing|6|||
25149523|NCT01970865|50263655|FG004|Overall Study|Study ongoing|8|||
25149524|NCT01970865|50263656|FG005|Overall Study|Study ongoing|0|||
25149525|NCT01970865|50263657|FG006|Overall Study|Study ongoing|2|||
25149526|NCT01970865|50263658|FG007|Overall Study|Study ongoing|0|||
25149527|NCT01970865|50263659|FG008|Overall Study|Study ongoing|1|||
25149528|NCT01970865|50263660|FG009|Overall Study|Study ongoing|3|||
25149529|NCT01970865|50263661|FG010|Overall Study|Study ongoing|29|||
25149530|NCT01970865|50263662|FG011|Overall Study|Study ongoing|22|||
25149531|NCT01970865|50263663|FG012|Overall Study|Study ongoing|43|||
25149532|NCT01970865|50263664|FG013|Overall Study|Study ongoing|41|||
25149533|NCT01970865|50263665|FG014|Overall Study|Study ongoing|29|||
25149534|NCT01970865|50263666|FG015|Overall Study|Study ongoing|29|||
25149535|NCT01970865|50263667|FG016|Overall Study|Study ongoing|2|||
25149536|NCT01711541|50263742|FG000|Overall Study|Cancel prior to treatment|0|||
25149537|NCT01711541|50263743|FG001|Overall Study|Cancel prior to treatment|0|||
25149538|NCT01711541|50263744|FG002|Overall Study|Cancel prior to treatment|0|||
25149539|NCT01711541|50263745|FG003|Overall Study|Cancel prior to treatment|1|||
25149540|NCT01711541|50263746|FG004|Overall Study|Cancel prior to treatment|0|||
25149541|NCT01711541|50263742|FG000|Overall Study|Ineligible|0|||
25149542|NCT01711541|50263743|FG001|Overall Study|Ineligible|1|||
25149543|NCT01711541|50263744|FG002|Overall Study|Ineligible|0|||
25149544|NCT01711541|50263745|FG003|Overall Study|Ineligible|0|||
25016279|NCT04054765|50111162|FG000|Baseline|Withdrawal by Subject|5|||
25016280|NCT04054765|50111163|FG001|Baseline|Withdrawal by Subject|3|||
25067388|NCT02836769|50173016|FG000|Overall Study|Lost to Follow-up|10|||
25149545|NCT01711541|50263746|FG004|Overall Study|Ineligible|0|||
25149546|NCT01382446|50263793|FG000|Overall Study|Withdrawal by Subject|0|||
25149547|NCT01382446|50263794|FG001|Overall Study|Withdrawal by Subject|1|||
25149548|NCT01382446|50263793|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
25149549|NCT01382446|50263794|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
25149550|NCT01382212|50263800|FG000|Overall Study|Kidney transplant|1|||
25149551|NCT01382212|50263800|FG000|Overall Study|Withdrew consent|1|||
25149552|NCT01381900|50263807|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
25149553|NCT01381900|50263808|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
25149554|NCT01381900|50263809|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
25149555|NCT01381900|50263807|FG000|Overall Study|Adverse Event|4|||
25149556|NCT01381900|50263808|FG001|Overall Study|Adverse Event|6|||
25149557|NCT01381900|50263809|FG002|Overall Study|Adverse Event|7|||
25149558|NCT01381900|50263807|FG000|Overall Study|Noncompliance with study drug|0|||
25184701|NCT01275339|50333522|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
25274635|NCT01251653|50588652|FG005|Overall Study|Adverse Event|0|||
25016281|NCT04054765|50111162|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
25016282|NCT04054765|50111163|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
25184702|NCT01275339|50333523|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
25184703|NCT01275339|50333524|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
25184704|NCT01275339|50333525|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
25184705|NCT01275339|50333522|FG000|Overall Study|Withdrawal by Subject|0|||
25184706|NCT01275339|50333523|FG001|Overall Study|Withdrawal by Subject|0|||
25184707|NCT01275339|50333524|FG002|Overall Study|Withdrawal by Subject|1|||
25184708|NCT01275339|50333525|FG003|Overall Study|Withdrawal by Subject|0|||
25184709|NCT01520402|50333535|FG000|Overall Study|Withdrawal by Subject|2|||
25274636|NCT01251653|50588653|FG006|Overall Study|Adverse Event|2|||
25184710|NCT01520402|50333535|FG000|Overall Study|Physician Decision|3|||
25149559|NCT01381900|50263808|FG001|Overall Study|Noncompliance with study drug|0|||
25149560|NCT01381900|50263809|FG002|Overall Study|Noncompliance with study drug|1|||
25149561|NCT01381900|50263807|FG000|Overall Study|Physician Decision|0|||
25149562|NCT01381900|50263808|FG001|Overall Study|Physician Decision|1|||
25149563|NCT01381900|50263809|FG002|Overall Study|Physician Decision|1|||
25149564|NCT01381900|50263807|FG000|Overall Study|Protocol Violation|0|||
25149565|NCT01381900|50263808|FG001|Overall Study|Protocol Violation|1|||
25149566|NCT01381900|50263809|FG002|Overall Study|Protocol Violation|1|||
25149567|NCT01381900|50263807|FG000|Overall Study|Withdrawal by Subject|0|||
25149568|NCT01381900|50263808|FG001|Overall Study|Withdrawal by Subject|0|||
25149569|NCT01381900|50263809|FG002|Overall Study|Withdrawal by Subject|1|||
25274637|NCT01251653|50588654|FG007|Overall Study|Adverse Event|2|||
25149570|NCT01381900|50263807|FG000|Overall Study|Early withdraw|3|||
25016283|NCT04054765|50111162|FG000|3-month Follow up|Withdrawal by Subject|0|||
25016284|NCT04054765|50111163|FG001|3-month Follow up|Withdrawal by Subject|3|||
25149571|NCT01381900|50263808|FG001|Overall Study|Early withdraw|1|||
25149572|NCT01381900|50263809|FG002|Overall Study|Early withdraw|1|||
25149573|NCT01744665|50263817|FG000|Monitoring Phase|Adverse Event|4|||
25149574|NCT01744665|50263817|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
25149575|NCT01744665|50263817|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
25149576|NCT01744665|50263817|FG000|Monitoring Phase|Withdrawal by Subject|5|||
25149577|NCT01744665|50263817|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
25149578|NCT01744665|50263817|FG000|Consolidation Phase|Adverse Event|2|||
25149579|NCT01744665|50263817|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
25149580|NCT01744665|50263817|FG000|Consolidation Phase|Withdrawal by Subject|4|||
25149581|NCT01744665|50263817|FG000|Consolidation Phase|Administrative problems|9|||
25149582|NCT01744665|50263817|FG000|Re-initiation Phase|Administrative problems|10|||
25149583|NCT01744665|50263817|FG000|Re-initiation Phase|Adverse Event|1|||
25149584|NCT01744665|50263817|FG000|Re-initiation Phase|No longer required treatment|1|||
25149585|NCT01744665|50263817|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
25149586|NCT01744197|50263826|FG000|Overall Study|Received 1 patch|2|||
25149587|NCT01744197|50263827|FG001|Overall Study|Received 1 patch|1|||
25149588|NCT01744197|50263826|FG000|Overall Study|No patch received|2|||
25149589|NCT01744197|50263827|FG001|Overall Study|No patch received|2|||
25149590|NCT01732107|50263833|FG000|Overall Study|Adverse Event|2|||
25149591|NCT01732107|50263833|FG000|Overall Study|Disease Progression|8|||
25149592|NCT01732107|50263833|FG000|Overall Study|Physician Decision|1|||
25149593|NCT01732107|50263833|FG000|Overall Study|Withdrawal by Subject|2|||
25149594|NCT01743027|50263841|FG000|Overall Study|Adverse Event|2|||
25149595|NCT01743027|50263842|FG001|Overall Study|Adverse Event|0|||
25149596|NCT01743027|50263843|FG002|Overall Study|Adverse Event|0|||
25149597|NCT01743027|50263844|FG003|Overall Study|Adverse Event|0|||
25149598|NCT01743027|50263841|FG000|Overall Study|Lost to Follow-up|0|||
25149599|NCT01743027|50263842|FG001|Overall Study|Lost to Follow-up|0|||
25149600|NCT01743027|50263843|FG002|Overall Study|Lost to Follow-up|2|||
25149601|NCT01743027|50263844|FG003|Overall Study|Lost to Follow-up|0|||
25149602|NCT01743027|50263841|FG000|Overall Study|Progressive Disease|1|||
25149603|NCT01743027|50263842|FG001|Overall Study|Progressive Disease|4|||
25149604|NCT01743027|50263843|FG002|Overall Study|Progressive Disease|3|||
25149605|NCT01743027|50263844|FG003|Overall Study|Progressive Disease|0|||
25149606|NCT01743027|50263841|FG000|Overall Study|Protocol Violation|1|||
25149607|NCT01743027|50263842|FG001|Overall Study|Protocol Violation|1|||
25274638|NCT01251653|50588655|FG008|Overall Study|Adverse Event|1|||
25149608|NCT01743027|50263843|FG002|Overall Study|Protocol Violation|1|||
25149609|NCT01743027|50263844|FG003|Overall Study|Protocol Violation|0|||
25149610|NCT01743027|50263841|FG000|Overall Study|Withdrawal by Subject|1|||
25149611|NCT01743027|50263842|FG001|Overall Study|Withdrawal by Subject|0|||
25149612|NCT01743027|50263843|FG002|Overall Study|Withdrawal by Subject|3|||
25149613|NCT01743027|50263844|FG003|Overall Study|Withdrawal by Subject|1|||
25149614|NCT01380730|50263862|FG000|Overall Study|Death|0|||
25149615|NCT01380730|50263863|FG001|Overall Study|Death|0|||
25149616|NCT01380730|50263864|FG002|Overall Study|Death|0|||
25149617|NCT01380730|50263865|FG003|Overall Study|Death|0|||
25149618|NCT01380730|50263866|FG004|Overall Study|Death|1|||
25149619|NCT01380730|50263867|FG005|Overall Study|Death|0|||
25149620|NCT01380730|50263868|FG006|Overall Study|Death|0|||
25149621|NCT01380730|50263869|FG007|Overall Study|Death|0|||
25149622|NCT01395784|50263887|FG000|Overall Study|Lost to Follow-up|7|||
25149623|NCT01395784|50263887|FG000|Overall Study|Withdrawal by Subject|3|||
25149624|NCT01395784|50263887|FG000|Overall Study|Physician Decision|5|||
25149625|NCT01380184|50263891|FG000|Part 1 (19 Days)|Adverse Event|1|||
25149626|NCT01380184|50263891|FG000|Part 2|Adverse Event|5|||
25149627|NCT01380184|50263891|FG000|Part 2|Disease Progression|8|||
25149628|NCT01380184|50263891|FG000|Part 2|Lost to Follow-up|1|||
25149629|NCT01395394|50263898|FG000|Baseline Study Visit|Protocol Violation|1|||
25149630|NCT01395394|50263899|FG001|Baseline Study Visit|Protocol Violation|0|||
25149631|NCT01395394|50263900|FG002|Baseline Study Visit|Protocol Violation|0|||
25149632|NCT01395316|50263908|FG000|Overall Study|Lost to Follow-up|2|||
25274639|NCT01251653|50588647|FG000|Overall Study|Withdrawal by Subject|1|||
25274640|NCT01251653|50588648|FG001|Overall Study|Withdrawal by Subject|0|||
25149633|NCT01395316|50263908|FG000|Overall Study|poor MRI quality|1|||
25149634|NCT01742091|50263918|FG000|Overall Study|Adverse Event|0|||
25149635|NCT01742091|50263919|FG001|Overall Study|Adverse Event|0|||
25149636|NCT01742091|50263920|FG002|Overall Study|Adverse Event|0|||
25149637|NCT01742091|50263921|FG003|Overall Study|Adverse Event|0|||
25149638|NCT01742091|50263922|FG004|Overall Study|Adverse Event|1|||
25149639|NCT01742091|50263923|FG005|Overall Study|Adverse Event|0|||
25149640|NCT01742091|50263918|FG000|Overall Study|Physician Decision|0|||
25149641|NCT01742091|50263919|FG001|Overall Study|Physician Decision|0|||
25149642|NCT01742091|50263920|FG002|Overall Study|Physician Decision|0|||
25149643|NCT01742091|50263921|FG003|Overall Study|Physician Decision|0|||
25149644|NCT01742091|50263922|FG004|Overall Study|Physician Decision|0|||
25149645|NCT01742091|50263923|FG005|Overall Study|Physician Decision|1|||
25149646|NCT01742091|50263918|FG000|Overall Study|Withdrawal by Subject|0|||
25149647|NCT01742091|50263919|FG001|Overall Study|Withdrawal by Subject|0|||
25149648|NCT01742091|50263920|FG002|Overall Study|Withdrawal by Subject|0|||
25149649|NCT01742091|50263921|FG003|Overall Study|Withdrawal by Subject|1|||
25149650|NCT01742091|50263922|FG004|Overall Study|Withdrawal by Subject|0|||
25149651|NCT01742091|50263923|FG005|Overall Study|Withdrawal by Subject|0|||
25149652|NCT01742091|50263918|FG000|Overall Study|Lost to Follow-up|0|||
25149653|NCT01742091|50263919|FG001|Overall Study|Lost to Follow-up|0|||
25149654|NCT01742091|50263920|FG002|Overall Study|Lost to Follow-up|0|||
25149655|NCT01742091|50263921|FG003|Overall Study|Lost to Follow-up|0|||
25149656|NCT01742091|50263922|FG004|Overall Study|Lost to Follow-up|0|||
25149657|NCT01742091|50263923|FG005|Overall Study|Lost to Follow-up|1|||
25149658|NCT01731951|50263943|FG000|Overall Study|Documented Disease Progression|1|||
25149659|NCT01731951|50263944|FG001|Overall Study|Documented Disease Progression|0|||
25149660|NCT01731951|50263945|FG002|Overall Study|Documented Disease Progression|0|||
25149661|NCT01731951|50263946|FG003|Overall Study|Documented Disease Progression|0|||
25149662|NCT01731951|50263947|FG004|Overall Study|Documented Disease Progression|0|||
25149663|NCT01731951|50263948|FG005|Overall Study|Documented Disease Progression|0|||
25149664|NCT01731951|50263943|FG000|Overall Study|Lost to Follow-up|2|||
25149665|NCT01731951|50263944|FG001|Overall Study|Lost to Follow-up|0|||
25149666|NCT01731951|50263945|FG002|Overall Study|Lost to Follow-up|0|||
25149667|NCT01731951|50263946|FG003|Overall Study|Lost to Follow-up|1|||
25149668|NCT01731951|50263947|FG004|Overall Study|Lost to Follow-up|3|||
25149669|NCT01731951|50263948|FG005|Overall Study|Lost to Follow-up|1|||
25149670|NCT01731951|50263943|FG000|Overall Study|Withdrawal of Consent|1|||
25149671|NCT01731951|50263944|FG001|Overall Study|Withdrawal of Consent|0|||
25149672|NCT01731951|50263945|FG002|Overall Study|Withdrawal of Consent|0|||
25149673|NCT01731951|50263946|FG003|Overall Study|Withdrawal of Consent|0|||
25149674|NCT01731951|50263947|FG004|Overall Study|Withdrawal of Consent|0|||
25149675|NCT01731951|50263948|FG005|Overall Study|Withdrawal of Consent|2|||
25149676|NCT01731951|50263943|FG000|Overall Study|Death|13|||
25149677|NCT01731951|50263944|FG001|Overall Study|Death|15|||
25149678|NCT01731951|50263945|FG002|Overall Study|Death|9|||
25149679|NCT01731951|50263946|FG003|Overall Study|Death|8|||
25274641|NCT01251653|50588649|FG002|Overall Study|Withdrawal by Subject|1|||
25274642|NCT01251653|50588650|FG003|Overall Study|Withdrawal by Subject|0|||
25274643|NCT01251653|50588651|FG004|Overall Study|Withdrawal by Subject|1|||
25274644|NCT01251653|50588652|FG005|Overall Study|Withdrawal by Subject|1|||
25274645|NCT01251653|50588653|FG006|Overall Study|Withdrawal by Subject|0|||
25274646|NCT01251653|50588654|FG007|Overall Study|Withdrawal by Subject|1|||
25274647|NCT01251653|50588655|FG008|Overall Study|Withdrawal by Subject|0|||
25274648|NCT01251653|50588647|FG000|Overall Study|Other reason not mentioned above|0|||
25274649|NCT01251653|50588648|FG001|Overall Study|Other reason not mentioned above|0|||
25274650|NCT01251653|50588649|FG002|Overall Study|Other reason not mentioned above|0|||
25274651|NCT01251653|50588650|FG003|Overall Study|Other reason not mentioned above|0|||
25274652|NCT01251653|50588651|FG004|Overall Study|Other reason not mentioned above|0|||
25274653|NCT01251653|50588652|FG005|Overall Study|Other reason not mentioned above|0|||
25274654|NCT01251653|50588653|FG006|Overall Study|Other reason not mentioned above|0|||
25149680|NCT01731951|50263947|FG004|Overall Study|Death|9|||
25149681|NCT01731951|50263948|FG005|Overall Study|Death|6|||
25016285|NCT04054765|50111162|FG000|6-month Follow up|Lost to Follow-up|32|||
25016286|NCT04054765|50111163|FG001|6-month Follow up|Lost to Follow-up|32|||
25016287|NCT04179721|50111171|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
25184711|NCT01520324|50333550|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
25184712|NCT01519934|50333554|FG000|Overall Study|Lost to Follow-up|3|||
25184713|NCT01484054|50333558|FG000|Period 1|Withdrawal by Subject|0|||
25184714|NCT01484054|50333559|FG001|Period 1|Withdrawal by Subject|1|||
25184715|NCT01483820|50333566|FG000|Overall Study|Lack of Efficacy|6|||
25184716|NCT01483820|50333566|FG000|Overall Study|Adverse Event|1|||
25184717|NCT01483820|50333566|FG000|Overall Study|Death|1|||
25184718|NCT01507298|50333581|FG000|Overall Study|Protocol Violation|0|||
25184719|NCT01507298|50333582|FG001|Overall Study|Protocol Violation|6|||
25184720|NCT01483118|50333591|FG000|Overall Study|Lost to Follow-up|12|||
25149682|NCT01731171|50263968|FG000|Overall Study|Withdrawal by Subject|4|||
25149683|NCT01731171|50263969|FG001|Overall Study|Withdrawal by Subject|1|||
25149684|NCT01731171|50263968|FG000|Overall Study|Lost to Follow-up|3|||
25149685|NCT01731171|50263969|FG001|Overall Study|Lost to Follow-up|2|||
25184721|NCT01483118|50333592|FG001|Overall Study|Lost to Follow-up|16|||
25184722|NCT01506908|50333602|FG000|Overall Study|Adverse Event|1|||
25184723|NCT01506908|50333603|FG001|Overall Study|Adverse Event|0|||
25184724|NCT01519778|50333611|FG000|Overall Study|Withdrawal by Subject|3|||
25184725|NCT01519778|50333611|FG000|Overall Study|Lost to Follow-up|10|||
25184726|NCT01519778|50333611|FG000|Overall Study|Physician Decision|1|||
25149686|NCT01731171|50263968|FG000|Overall Study|Moved out of Area|0|||
25149687|NCT01731171|50263969|FG001|Overall Study|Moved out of Area|2|||
25149688|NCT01731171|50263968|FG000|Overall Study|Terminated for Lack of Adherence|0|||
25149689|NCT01731171|50263969|FG001|Overall Study|Terminated for Lack of Adherence|1|||
25149690|NCT01731171|50263968|FG000|Overall Study|Terminated for Safety Reasons|0|||
25149691|NCT01731171|50263969|FG001|Overall Study|Terminated for Safety Reasons|1|||
25149692|NCT01741701|50263977|FG000|Overall Study|Adverse Event|5|||
25149693|NCT01741701|50263978|FG001|Overall Study|Adverse Event|1|||
25149694|NCT01741701|50263977|FG000|Overall Study|Withdrawal by Subject|0|||
25149695|NCT01741701|50263978|FG001|Overall Study|Withdrawal by Subject|1|||
25149696|NCT01741545|50263986|FG000|Treatment Period|Lack of Efficacy|0|||
25184727|NCT01519700|50333619|FG000|Overall Study|Death|1|||
25184728|NCT01519700|50333620|FG001|Overall Study|Death|0|||
25149697|NCT01741545|50263987|FG001|Treatment Period|Lack of Efficacy|1|||
25149698|NCT01741545|50263986|FG000|Treatment Period|Adverse event, non-fatal|1|||
25149699|NCT01741545|50263987|FG001|Treatment Period|Adverse event, non-fatal|3|||
25149700|NCT01741545|50263986|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
25149701|NCT01741545|50263987|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
25149702|NCT01741545|50263986|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
25149703|NCT01741545|50263987|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
25149704|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
25149705|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
25149706|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
25149707|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
25149708|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
25149709|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
25149710|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
25149711|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
25149712|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
25149713|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
25184729|NCT01519700|50333621|FG002|Overall Study|Death|0|||
25016288|NCT04179721|50111172|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
25016289|NCT04179721|50111171|FG000|Overall Study|Lost to Follow-up|0|||
25016290|NCT04179721|50111172|FG001|Overall Study|Lost to Follow-up|1|||
25016291|NCT03286218|50111178|FG000|Qualification Phase Period 1|Adverse Event|1|||
25016292|NCT03286218|50111179|FG001|Qualification Phase Period 1|Adverse Event|0|||
25016293|NCT03286218|50111180|FG002|Qualification Phase Period 1|Adverse Event|0|||
25016294|NCT03286218|50111181|FG003|Qualification Phase Period 1|Adverse Event|0|||
25016295|NCT03286218|50111182|FG004|Qualification Phase Period 1|Adverse Event|0|||
25016296|NCT03286218|50111183|FG005|Qualification Phase Period 1|Adverse Event|0|||
25149714|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
25149715|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
25184730|NCT01519700|50333622|FG003|Overall Study|Death|0|||
25149716|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
25149717|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
25149718|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
25274655|NCT01251653|50588654|FG007|Overall Study|Other reason not mentioned above|2|||
25149719|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
25184731|NCT01519700|50333619|FG000|Overall Study|Lost to Follow-up|0|||
25184732|NCT01519700|50333620|FG001|Overall Study|Lost to Follow-up|0|||
25149720|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
25149721|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
25149722|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
25149723|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
25149724|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
25149725|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
25149726|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
25149727|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
25149728|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
25184733|NCT01519700|50333621|FG002|Overall Study|Lost to Follow-up|1|||
25184734|NCT01519700|50333622|FG003|Overall Study|Lost to Follow-up|1|||
25149729|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
25149730|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
25149731|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
25149732|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
25149733|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
25149734|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
25149735|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
25184735|NCT01519700|50333619|FG000|Overall Study|Physician Decision|1|||
25184736|NCT01519700|50333620|FG001|Overall Study|Physician Decision|1|||
25184737|NCT01519700|50333621|FG002|Overall Study|Physician Decision|3|||
25184738|NCT01519700|50333622|FG003|Overall Study|Physician Decision|0|||
25184739|NCT01519700|50333619|FG000|Overall Study|Withdrawal by Subject|5|||
25184740|NCT01519700|50333620|FG001|Overall Study|Withdrawal by Subject|3|||
25184741|NCT01519700|50333621|FG002|Overall Study|Withdrawal by Subject|3|||
25184742|NCT01519700|50333622|FG003|Overall Study|Withdrawal by Subject|2|||
25184743|NCT01519700|50333619|FG000|Overall Study|Other Reason|2|||
25184744|NCT01519700|50333620|FG001|Overall Study|Other Reason|2|||
25016297|NCT03286218|50111184|FG006|Qualification Phase Period 1|Adverse Event|0|||
25016298|NCT03286218|50111185|FG007|Qualification Phase Period 1|Adverse Event|0|||
25016299|NCT03286218|50111186|FG008|Qualification Phase Period 1|Adverse Event|0|||
25016300|NCT03286218|50111187|FG009|Qualification Phase Period 1|Adverse Event|0|||
25149736|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
25149737|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
25149738|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
25149739|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
25149740|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
25149741|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
25149742|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
25149743|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
25149744|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
25149745|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
25149746|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
25149747|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
25149748|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
25149749|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
25149750|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
25149751|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
25149752|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
25149753|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
25149754|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
25149755|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
25149756|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
25149757|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
25149758|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
25149759|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
25149760|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
25149761|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
25149762|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
25149763|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
25184745|NCT01519700|50333621|FG002|Overall Study|Other Reason|0|||
25184746|NCT01519700|50333622|FG003|Overall Study|Other Reason|4|||
25184747|NCT02656680|50333640|FG000|Overall Study|Lost to Follow-up|0|||
25184748|NCT02656680|50333641|FG001|Overall Study|Lost to Follow-up|1|||
25067389|NCT02836769|50173016|FG000|Overall Study|Medical withdrawal|2|||
25149764|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
25149765|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
25149766|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
25149767|NCT01884350|50263995|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
25149768|NCT01884350|50263996|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
25149769|NCT01884350|50263997|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
25149770|NCT01614795|50264011|FG000|Overall Study|Adverse Event|0|||
25149771|NCT01614795|50264012|FG001|Overall Study|Adverse Event|0|||
25149772|NCT01614795|50264013|FG002|Overall Study|Adverse Event|1|||
25149773|NCT01614795|50264014|FG003|Overall Study|Adverse Event|1|||
25149774|NCT01614795|50264011|FG000|Overall Study|Lack of Efficacy|10|||
25149775|NCT01614795|50264012|FG001|Overall Study|Lack of Efficacy|10|||
25149776|NCT01614795|50264013|FG002|Overall Study|Lack of Efficacy|9|||
25016301|NCT03286218|50111188|FG010|Qualification Phase Period 1|Adverse Event|0|||
25149777|NCT01614795|50264014|FG003|Overall Study|Lack of Efficacy|8|||
25149778|NCT01614795|50264011|FG000|Overall Study|Physician Decision|1|||
25149779|NCT01614795|50264012|FG001|Overall Study|Physician Decision|0|||
25149780|NCT01614795|50264013|FG002|Overall Study|Physician Decision|1|||
25149781|NCT01614795|50264014|FG003|Overall Study|Physician Decision|1|||
25149782|NCT01614795|50264011|FG000|Overall Study|Withdrawal by Subject|0|||
25149783|NCT01614795|50264012|FG001|Overall Study|Withdrawal by Subject|1|||
25149784|NCT01614795|50264013|FG002|Overall Study|Withdrawal by Subject|0|||
25149785|NCT01614795|50264014|FG003|Overall Study|Withdrawal by Subject|2|||
25149786|NCT01614795|50264011|FG000|Overall Study|Ineligible|0|||
25149787|NCT01614795|50264012|FG001|Overall Study|Ineligible|1|||
25149788|NCT01614795|50264013|FG002|Overall Study|Ineligible|0|||
25149789|NCT01614795|50264014|FG003|Overall Study|Ineligible|0|||
25149790|NCT01834586|50264025|FG000|Overall Study|Adverse Event|1|||
25149791|NCT01614249|50264031|FG000|Overall Study|Lost to Follow-up|11|||
25149792|NCT01614249|50264032|FG001|Overall Study|Lost to Follow-up|23|||
25149793|NCT01597778|50264040|FG000|Overall Study|Death|7|||
25149794|NCT01597778|50264041|FG001|Overall Study|Death|10|||
25149795|NCT01597778|50264040|FG000|Overall Study|Withdrawal by Subject|3|||
25149796|NCT01597778|50264041|FG001|Overall Study|Withdrawal by Subject|4|||
25149797|NCT01597778|50264040|FG000|Overall Study|Adverse Event|1|||
25149798|NCT01597778|50264041|FG001|Overall Study|Adverse Event|1|||
25149799|NCT01597778|50264040|FG000|Overall Study|Protocol Violation|1|||
25149800|NCT01597778|50264041|FG001|Overall Study|Protocol Violation|11|||
25149801|NCT01597778|50264040|FG000|Overall Study|Transplanted off protocol|2|||
25149802|NCT01597778|50264041|FG001|Overall Study|Transplanted off protocol|3|||
25149803|NCT01614093|50264047|FG000|Overall Study|Withdrawal by Subject|1|||
25149804|NCT01834274|50264054|FG000|Overall Study|Study Termination|41|||
25149805|NCT01834274|50264055|FG001|Overall Study|Study Termination|38|||
25149806|NCT01834274|50264054|FG000|Overall Study|Withdrawal by Subject|1|||
25149807|NCT01834274|50264055|FG001|Overall Study|Withdrawal by Subject|1|||
25149808|NCT01834274|50264054|FG000|Overall Study|Lost to Follow-up|3|||
25149809|NCT01834274|50264055|FG001|Overall Study|Lost to Follow-up|1|||
25149810|NCT01834274|50264054|FG000|Overall Study|Other|2|||
25149811|NCT01834274|50264055|FG001|Overall Study|Other|1|||
25149812|NCT01739595|50264064|FG000|Overall Study|Adverse Event|3|||
25149813|NCT01739595|50264065|FG001|Overall Study|Adverse Event|0|||
25149814|NCT01739595|50264066|FG002|Overall Study|Adverse Event|0|||
25149815|NCT01739595|50264064|FG000|Overall Study|Lost to Follow-up|2|||
25149816|NCT01739595|50264065|FG001|Overall Study|Lost to Follow-up|0|||
25149817|NCT01739595|50264066|FG002|Overall Study|Lost to Follow-up|0|||
25149818|NCT01739595|50264064|FG000|Overall Study|Withdrawal by Subject|2|||
25149819|NCT01739595|50264065|FG001|Overall Study|Withdrawal by Subject|1|||
25149820|NCT01739595|50264066|FG002|Overall Study|Withdrawal by Subject|2|||
25149821|NCT01739595|50264064|FG000|Overall Study|Eligibility issue|3|||
25149822|NCT01739595|50264065|FG001|Overall Study|Eligibility issue|0|||
25149823|NCT01739595|50264066|FG002|Overall Study|Eligibility issue|0|||
25184749|NCT02658084|50333677|FG000|Overall Study|Withdrawal by Subject|1|||
25149824|NCT01739595|50264064|FG000|Overall Study|Protocol Violation|1|||
25149825|NCT01739595|50264065|FG001|Overall Study|Protocol Violation|0|||
25149826|NCT01739595|50264066|FG002|Overall Study|Protocol Violation|0|||
25149827|NCT01739595|50264064|FG000|Overall Study|Lab assessment|1|||
25149828|NCT01739595|50264065|FG001|Overall Study|Lab assessment|0|||
25149829|NCT01739595|50264066|FG002|Overall Study|Lab assessment|0|||
25149830|NCT01739595|50264064|FG000|Overall Study|Drug discrepancy|1|||
25149831|NCT01739595|50264065|FG001|Overall Study|Drug discrepancy|0|||
25149832|NCT01739595|50264066|FG002|Overall Study|Drug discrepancy|0|||
25149833|NCT01833494|50264073|FG000|Overall Study|Adverse Event|24|||
25149834|NCT01833494|50264073|FG000|Overall Study|Physician Decision|6|||
25149835|NCT01833494|50264073|FG000|Overall Study|Withdrawal by Subject|6|||
25149836|NCT01833494|50264073|FG000|Overall Study|Decrease in serum phosphorus|4|||
25149837|NCT01833494|50264073|FG000|Overall Study|Decrease in serum calcium|4|||
25149838|NCT01833494|50264073|FG000|Overall Study|Increase in serum ferritin|1|||
25149839|NCT01738971|50264080|FG000|Overall Study|Lost to Follow-up|19|||
25149840|NCT01738971|50264081|FG001|Overall Study|Lost to Follow-up|30|||
25149841|NCT01738971|50264082|FG002|Overall Study|Lost to Follow-up|17|||
25149842|NCT01738581|50264092|FG000|Overall Study|Lost to Follow-up|1|||
25149843|NCT01738581|50264093|FG001|Overall Study|Lost to Follow-up|0|||
25149844|NCT01738503|50264105|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
25149845|NCT01738503|50264106|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
25149846|NCT01738503|50264107|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
25149847|NCT01738503|50264108|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
25149848|NCT01738503|50264109|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
25016302|NCT03286218|50111189|FG011|Qualification Phase Period 1|Adverse Event|0|||
25184750|NCT02658084|50333678|FG001|Overall Study|Withdrawal by Subject|0|||
25184751|NCT02658084|50333677|FG000|Overall Study|Study Termination|1|||
25274656|NCT01251653|50588655|FG008|Overall Study|Other reason not mentioned above|0|||
25016303|NCT03286218|50111178|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
25149849|NCT01738503|50264110|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
25149850|NCT01738503|50264111|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
25149851|NCT01738503|50264105|FG000|Treatment Period|Adverse Event|0|||
25149852|NCT01738503|50264106|FG001|Treatment Period|Adverse Event|1|||
25149853|NCT01738503|50264107|FG002|Treatment Period|Adverse Event|0|||
25149854|NCT01738503|50264108|FG003|Treatment Period|Adverse Event|1|||
25149855|NCT01738503|50264109|FG004|Treatment Period|Adverse Event|2|||
25149856|NCT01738503|50264110|FG005|Treatment Period|Adverse Event|2|||
25149857|NCT01738503|50264111|FG006|Treatment Period|Adverse Event|2|||
25149858|NCT01738503|50264105|FG000|Treatment Period|Lost to Follow-up|0|||
25149859|NCT01738503|50264106|FG001|Treatment Period|Lost to Follow-up|0|||
25149860|NCT01738503|50264107|FG002|Treatment Period|Lost to Follow-up|3|||
25149861|NCT01738503|50264108|FG003|Treatment Period|Lost to Follow-up|4|||
25149862|NCT01738503|50264109|FG004|Treatment Period|Lost to Follow-up|1|||
25149863|NCT01738503|50264110|FG005|Treatment Period|Lost to Follow-up|1|||
25149864|NCT01738503|50264111|FG006|Treatment Period|Lost to Follow-up|5|||
25149865|NCT01738503|50264105|FG000|Treatment Period|Withdrawal by Subject|0|||
25149866|NCT01738503|50264106|FG001|Treatment Period|Withdrawal by Subject|1|||
25184752|NCT02658084|50333678|FG001|Overall Study|Study Termination|0|||
25149867|NCT01738503|50264107|FG002|Treatment Period|Withdrawal by Subject|0|||
25149868|NCT01738503|50264108|FG003|Treatment Period|Withdrawal by Subject|1|||
25149869|NCT01738503|50264109|FG004|Treatment Period|Withdrawal by Subject|1|||
25149870|NCT01738503|50264110|FG005|Treatment Period|Withdrawal by Subject|1|||
25149871|NCT01738503|50264111|FG006|Treatment Period|Withdrawal by Subject|1|||
25149872|NCT01738503|50264105|FG000|Treatment Period|Protocol Violation|0|||
25149873|NCT01738503|50264106|FG001|Treatment Period|Protocol Violation|3|||
25149874|NCT01738503|50264107|FG002|Treatment Period|Protocol Violation|1|||
25149875|NCT01738503|50264108|FG003|Treatment Period|Protocol Violation|0|||
25149876|NCT01738503|50264109|FG004|Treatment Period|Protocol Violation|4|||
25149877|NCT01738503|50264110|FG005|Treatment Period|Protocol Violation|2|||
25149878|NCT01738503|50264111|FG006|Treatment Period|Protocol Violation|0|||
25149879|NCT01738503|50264105|FG000|Treatment Period|Other|0|||
25149880|NCT01738503|50264106|FG001|Treatment Period|Other|0|||
25149881|NCT01738503|50264107|FG002|Treatment Period|Other|1|||
25149882|NCT01738503|50264108|FG003|Treatment Period|Other|0|||
25149883|NCT01738503|50264109|FG004|Treatment Period|Other|0|||
25149884|NCT01738503|50264110|FG005|Treatment Period|Other|0|||
25149885|NCT01738503|50264111|FG006|Treatment Period|Other|0|||
25149886|NCT01738503|50264105|FG000|PET Imaging Sub-study|Adverse Event|0|||
25149887|NCT01738503|50264106|FG001|PET Imaging Sub-study|Adverse Event|0|||
25149888|NCT01738503|50264107|FG002|PET Imaging Sub-study|Adverse Event|0|||
25149889|NCT01738503|50264108|FG003|PET Imaging Sub-study|Adverse Event|0|||
25149890|NCT01738503|50264109|FG004|PET Imaging Sub-study|Adverse Event|0|||
25149891|NCT01738503|50264110|FG005|PET Imaging Sub-study|Adverse Event|1|||
25149892|NCT01738503|50264111|FG006|PET Imaging Sub-study|Adverse Event|0|||
25149893|NCT01738503|50264105|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
25149894|NCT01738503|50264106|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
25149895|NCT01738503|50264107|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
25149896|NCT01738503|50264108|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
25149897|NCT01738503|50264109|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
25149898|NCT01738503|50264110|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
25149899|NCT01738503|50264111|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
25149900|NCT01738191|50264135|FG000|Overall Study|Withdrawal by Subject|4|||
25149901|NCT01738191|50264136|FG001|Overall Study|Withdrawal by Subject|1|||
25149902|NCT01737879|50264142|FG000|Overall Study|Death|1|||
25149903|NCT01737879|50264142|FG000|Overall Study|Sponsor decision|40|||
25149904|NCT01879683|50264146|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
25149905|NCT01605825|50264152|FG000|Overall Study|Adverse Event|4|||
25149906|NCT01605825|50264153|FG001|Overall Study|Adverse Event|2|||
25149907|NCT01605825|50264152|FG000|Overall Study|Withdrawal by Subject|0|||
25149908|NCT01605825|50264153|FG001|Overall Study|Withdrawal by Subject|1|||
25149909|NCT01605825|50264152|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
25149910|NCT01605825|50264153|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
25149911|NCT01605825|50264152|FG000|Overall Study|Non-Compliance with Protocol|3|||
25149912|NCT01605825|50264153|FG001|Overall Study|Non-Compliance with Protocol|0|||
25149913|NCT01727505|50264159|FG000|First 24 Hours|Adverse Event|0|||
25149914|NCT01727505|50264160|FG001|First 24 Hours|Adverse Event|1|||
25149915|NCT01727505|50264159|FG000|Second 24 Hours|Missing data|0|||
25149916|NCT01727505|50264160|FG001|Second 24 Hours|Missing data|1|||
25149917|NCT01726803|50264168|FG000|Overall Study|Lost to Follow-up|6|||
25149918|NCT01726803|50264169|FG001|Overall Study|Lost to Follow-up|1|||
25149919|NCT01726803|50264168|FG000|Overall Study|Withdrawal by Subject|1|||
25149920|NCT01726803|50264169|FG001|Overall Study|Withdrawal by Subject|0|||
25149921|NCT01726335|50264175|FG000|Overall Study|Lost to Follow-up|2|||
25184753|NCT01482962|50333694|FG000|Overall Study|Progressive Disease|65|||
25149922|NCT01726335|50264175|FG000|Overall Study|Withdrawal by Subject|15|||
25149923|NCT01726335|50264175|FG000|Overall Study|Adverse Event|4|||
25149924|NCT01726335|50264175|FG000|Overall Study|Lost to Follow-up|2|||
25149925|NCT01726335|50264175|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
25149926|NCT01877421|50264211|FG000|Phase 2|Lost to Follow-up|0|||
25149927|NCT01877421|50264212|FG001|Phase 2|Lost to Follow-up|0|||
25149928|NCT01877421|50264213|FG002|Phase 2|Lost to Follow-up|0|||
25149929|NCT01877421|50264214|FG003|Phase 2|Lost to Follow-up|0|||
25149930|NCT01877421|50264215|FG004|Phase 2|Lost to Follow-up|0|||
25149931|NCT01877421|50264216|FG005|Phase 2|Lost to Follow-up|0|||
25149932|NCT01877421|50264217|FG006|Phase 2|Lost to Follow-up|1|||
25149933|NCT01877421|50264218|FG007|Phase 2|Lost to Follow-up|0|||
25149934|NCT01877421|50264219|FG008|Phase 2|Lost to Follow-up|0|||
25149935|NCT01877421|50264220|FG009|Phase 2|Lost to Follow-up|0|||
25149936|NCT01877421|50264221|FG010|Phase 2|Lost to Follow-up|0|||
25149937|NCT01877421|50264222|FG011|Phase 2|Lost to Follow-up|0|||
25149938|NCT01877421|50264223|FG012|Phase 2|Lost to Follow-up|0|||
25149939|NCT01877421|50264224|FG013|Phase 2|Lost to Follow-up|0|||
25149940|NCT01877421|50264225|FG014|Phase 2|Lost to Follow-up|0|||
25149941|NCT01877421|50264226|FG015|Phase 2|Lost to Follow-up|0|||
25149942|NCT01877421|50264227|FG016|Phase 2|Lost to Follow-up|0|||
25184754|NCT01482962|50333695|FG001|Overall Study|Progressive Disease|53|||
25184755|NCT01482962|50333694|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
25184756|NCT01482962|50333695|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
25149943|NCT01877421|50264228|FG017|Phase 2|Lost to Follow-up|0|||
25149944|NCT01877421|50264211|FG000|Phase 2|Withdrawal by Subject|0|||
25149945|NCT01877421|50264212|FG001|Phase 2|Withdrawal by Subject|0|||
25149946|NCT01877421|50264213|FG002|Phase 2|Withdrawal by Subject|0|||
25149947|NCT01877421|50264214|FG003|Phase 2|Withdrawal by Subject|0|||
25149948|NCT01877421|50264215|FG004|Phase 2|Withdrawal by Subject|0|||
25149949|NCT01877421|50264216|FG005|Phase 2|Withdrawal by Subject|0|||
25149950|NCT01877421|50264217|FG006|Phase 2|Withdrawal by Subject|0|||
25149951|NCT01877421|50264218|FG007|Phase 2|Withdrawal by Subject|0|||
25149952|NCT01877421|50264219|FG008|Phase 2|Withdrawal by Subject|1|||
25149953|NCT01877421|50264220|FG009|Phase 2|Withdrawal by Subject|0|||
25149954|NCT01877421|50264221|FG010|Phase 2|Withdrawal by Subject|1|||
25149955|NCT01877421|50264222|FG011|Phase 2|Withdrawal by Subject|0|||
25149956|NCT01877421|50264223|FG012|Phase 2|Withdrawal by Subject|1|||
25149957|NCT01877421|50264224|FG013|Phase 2|Withdrawal by Subject|0|||
25016304|NCT03286218|50111179|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
25016305|NCT03286218|50111180|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
25149958|NCT01877421|50264225|FG014|Phase 2|Withdrawal by Subject|0|||
25184757|NCT01482962|50333694|FG000|Overall Study|Adverse Event|18|||
25149959|NCT01877421|50264226|FG015|Phase 2|Withdrawal by Subject|1|||
25149960|NCT01877421|50264227|FG016|Phase 2|Withdrawal by Subject|0|||
25149961|NCT01877421|50264228|FG017|Phase 2|Withdrawal by Subject|0|||
25149962|NCT01877421|50264211|FG000|Phase 2|Protocol Violation|0|||
25149963|NCT01877421|50264212|FG001|Phase 2|Protocol Violation|0|||
25149964|NCT01877421|50264213|FG002|Phase 2|Protocol Violation|0|||
25149965|NCT01877421|50264214|FG003|Phase 2|Protocol Violation|0|||
25149966|NCT01877421|50264215|FG004|Phase 2|Protocol Violation|0|||
25149967|NCT01877421|50264216|FG005|Phase 2|Protocol Violation|0|||
25149968|NCT01877421|50264217|FG006|Phase 2|Protocol Violation|0|||
25149969|NCT01877421|50264218|FG007|Phase 2|Protocol Violation|0|||
25149970|NCT01877421|50264219|FG008|Phase 2|Protocol Violation|0|||
25149971|NCT01877421|50264220|FG009|Phase 2|Protocol Violation|0|||
25149972|NCT01877421|50264221|FG010|Phase 2|Protocol Violation|1|||
25149973|NCT01877421|50264222|FG011|Phase 2|Protocol Violation|0|||
25149974|NCT01877421|50264223|FG012|Phase 2|Protocol Violation|0|||
25149975|NCT01877421|50264224|FG013|Phase 2|Protocol Violation|0|||
25149976|NCT01877421|50264225|FG014|Phase 2|Protocol Violation|0|||
25149977|NCT01877421|50264226|FG015|Phase 2|Protocol Violation|0|||
25184758|NCT01482962|50333695|FG001|Overall Study|Adverse Event|22|||
25149978|NCT01877421|50264227|FG016|Phase 2|Protocol Violation|0|||
25149979|NCT01877421|50264228|FG017|Phase 2|Protocol Violation|0|||
25149980|NCT01726023|50264310|FG000|Overall Study|Death|1|||
25149981|NCT01726023|50264311|FG001|Overall Study|Death|1|||
25149982|NCT01726023|50264310|FG000|Overall Study|Lost to Follow-up|5|||
25149983|NCT01726023|50264311|FG001|Overall Study|Lost to Follow-up|10|||
25149984|NCT01726023|50264310|FG000|Overall Study|Other Eligibility criteria|7|||
25149985|NCT01726023|50264311|FG001|Overall Study|Other Eligibility criteria|7|||
25149986|NCT01726023|50264310|FG000|Overall Study|Withdrawal by Subject|16|||
25149987|NCT01726023|50264311|FG001|Overall Study|Withdrawal by Subject|8|||
25149988|NCT01877265|50264324|FG000|Treatment Period 1|Sponsor Decision|0|||
25149989|NCT01877265|50264325|FG001|Treatment Period 1|Sponsor Decision|0|||
25149990|NCT01877265|50264326|FG002|Treatment Period 1|Sponsor Decision|1|||
25149991|NCT01877265|50264327|FG003|Treatment Period 1|Sponsor Decision|0|||
25149992|NCT01877265|50264328|FG004|Treatment Period 1|Sponsor Decision|0|||
25149993|NCT01877265|50264329|FG005|Treatment Period 1|Sponsor Decision|0|||
25149994|NCT01877265|50264324|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
25149995|NCT01877265|50264325|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
25149996|NCT01877265|50264326|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
25149997|NCT01877265|50264327|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
25149998|NCT01877265|50264328|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
25149999|NCT01877265|50264329|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
25150000|NCT01877265|50264324|FG000|Treatment Period 3|Lost to Follow-up|1|||
25150001|NCT01877265|50264325|FG001|Treatment Period 3|Lost to Follow-up|0|||
25150002|NCT01877265|50264326|FG002|Treatment Period 3|Lost to Follow-up|0|||
25150003|NCT01877265|50264327|FG003|Treatment Period 3|Lost to Follow-up|0|||
25150004|NCT01877265|50264328|FG004|Treatment Period 3|Lost to Follow-up|0|||
25150005|NCT01877265|50264329|FG005|Treatment Period 3|Lost to Follow-up|0|||
25150006|NCT01877187|50264340|FG000|Overall Study|Death|2|||
25150007|NCT01877187|50264340|FG000|Overall Study|Withdrawal by Subject|4|||
25150008|NCT01877187|50264340|FG000|Overall Study|Lost to Follow-up|3|||
25150009|NCT01877187|50264340|FG000|Overall Study|Declining clinical status|11|||
25150010|NCT01877187|50264340|FG000|Overall Study|Liver transplant|2|||
25150011|NCT01858532|50264351|FG000|Overall Study|Adverse Event|58|||
25150012|NCT01858532|50264352|FG001|Overall Study|Adverse Event|50|||
25150013|NCT01858532|50264353|FG002|Overall Study|Adverse Event|23|||
25150014|NCT01858532|50264354|FG003|Overall Study|Adverse Event|28|||
25150015|NCT01858532|50264351|FG000|Overall Study|Withdrew consent|71|||
25150016|NCT01858532|50264352|FG001|Overall Study|Withdrew consent|93|||
25150017|NCT01858532|50264353|FG002|Overall Study|Withdrew consent|46|||
25150018|NCT01858532|50264354|FG003|Overall Study|Withdrew consent|27|||
25150019|NCT01858532|50264351|FG000|Overall Study|Lost to Follow-up|17|||
25150020|NCT01858532|50264352|FG001|Overall Study|Lost to Follow-up|26|||
25150021|NCT01858532|50264353|FG002|Overall Study|Lost to Follow-up|11|||
25150022|NCT01858532|50264354|FG003|Overall Study|Lost to Follow-up|14|||
25150023|NCT01858532|50264351|FG000|Overall Study|Deterioration of medical status|3|||
25150024|NCT01858532|50264352|FG001|Overall Study|Deterioration of medical status|4|||
25150025|NCT01858532|50264353|FG002|Overall Study|Deterioration of medical status|3|||
25150026|NCT01858532|50264354|FG003|Overall Study|Deterioration of medical status|7|||
25150027|NCT01858532|50264351|FG000|Overall Study|Investigator request|3|||
25150028|NCT01858532|50264352|FG001|Overall Study|Investigator request|4|||
25150029|NCT01858532|50264353|FG002|Overall Study|Investigator request|2|||
25150030|NCT01858532|50264354|FG003|Overall Study|Investigator request|6|||
25150031|NCT01858532|50264351|FG000|Overall Study|Other, not specified|29|||
25150032|NCT01858532|50264352|FG001|Overall Study|Other, not specified|15|||
25150033|NCT01858532|50264353|FG002|Overall Study|Other, not specified|13|||
25150034|NCT01858532|50264354|FG003|Overall Study|Other, not specified|11|||
25150035|NCT01883492|50264366|FG000|Overall Study|Lost to Follow-up|3|||
25150036|NCT01883492|50264367|FG001|Overall Study|Lost to Follow-up|4|||
25150037|NCT01883492|50264366|FG000|Overall Study|Surgery on contra-lateral hip|0|||
25150038|NCT01883492|50264367|FG001|Overall Study|Surgery on contra-lateral hip|1|||
25150039|NCT01883492|50264366|FG000|Overall Study|Poor X-ray quality|7|||
25150040|NCT01883492|50264367|FG001|Overall Study|Poor X-ray quality|4|||
25150041|NCT01883492|50264366|FG000|Overall Study|Withdrawal by Subject|1|||
25150042|NCT01883492|50264367|FG001|Overall Study|Withdrawal by Subject|0|||
25150043|NCT01883492|50264366|FG000|Overall Study|inappropriate implant used|1|||
25150044|NCT01883492|50264367|FG001|Overall Study|inappropriate implant used|1|||
25150045|NCT01883492|50264366|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
25150046|NCT01883492|50264367|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
25150047|NCT01832480|50264375|FG000|Overall Study|Lost to Follow-up|33|||
25150048|NCT01832480|50264376|FG001|Overall Study|Lost to Follow-up|30|||
25150049|NCT01832480|50264375|FG000|Overall Study|Withdrawal by Subject|0|||
25150050|NCT01832480|50264376|FG001|Overall Study|Withdrawal by Subject|2|||
25184759|NCT01482962|50333694|FG000|Overall Study|Withdrawal by Participant|8|||
25184760|NCT01482962|50333695|FG001|Overall Study|Withdrawal by Participant|13|||
25150051|NCT01832480|50264375|FG000|Overall Study|post randomization ineligible|8|||
25150052|NCT01832480|50264376|FG001|Overall Study|post randomization ineligible|10|||
25150053|NCT01858376|50264382|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
25274657|NCT00910663|50588693|FG000|Period 1|Withdrawal by Subject|0|||
25150054|NCT01831856|50264388|FG000|Overall Study|Adverse Event|5|||
25150055|NCT01831856|50264389|FG001|Overall Study|Adverse Event|8|||
25150056|NCT01831856|50264388|FG000|Overall Study|Lack of Efficacy|13|||
25150057|NCT01831856|50264389|FG001|Overall Study|Lack of Efficacy|11|||
25150058|NCT01831856|50264388|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
25150059|NCT01831856|50264389|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
25150060|NCT01831544|50264395|FG000|Overall Study|Death|1|||
25150061|NCT01831544|50264395|FG000|Overall Study|Still on original MVAD device|2|||
25184761|NCT01482962|50333694|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
25184762|NCT01482962|50333695|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
25184763|NCT01482962|50333694|FG000|Overall Study|Other Reason|1|||
25184764|NCT01482962|50333695|FG001|Overall Study|Other Reason|5|||
25184765|NCT01482962|50333694|FG000|Overall Study|Study Terminated by Sponsor|5|||
25184766|NCT01482962|50333695|FG001|Overall Study|Study Terminated by Sponsor|2|||
25184767|NCT01482962|50333694|FG000|Overall Study|Did not Receive Study Drug|1|||
25184768|NCT01482962|50333695|FG001|Overall Study|Did not Receive Study Drug|6|||
25184769|NCT02655666|50333703|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
25184770|NCT01506596|50333707|FG000|Overall Study|ineligible pathology|1|||
25184771|NCT01482884|50333726|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
25184772|NCT01482884|50333727|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
25184773|NCT01482884|50333726|FG000|Overall Study|Protocol Violation|1|||
25274658|NCT00910663|50588694|FG001|Period 1|Withdrawal by Subject|1|||
25274659|NCT01077375|50588702|FG000|Overall Study|Adverse Event|2|||
25274660|NCT01077375|50588703|FG001|Overall Study|Adverse Event|15|||
25016306|NCT03286218|50111181|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
25016307|NCT03286218|50111182|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
25150062|NCT01857206|50264401|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
25150063|NCT01857206|50264402|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
25274661|NCT01077375|50588702|FG000|Overall Study|Lack of Efficacy|6|||
25150064|NCT01857206|50264401|FG000|Overall Study|Lost to Follow-up|9|||
25150065|NCT01857206|50264402|FG001|Overall Study|Lost to Follow-up|6|||
25150066|NCT01857206|50264401|FG000|Overall Study|Unclassified|3|||
25150067|NCT01857206|50264402|FG001|Overall Study|Unclassified|3|||
25150068|NCT01857206|50264401|FG000|Overall Study|Withdrawal by Subject|1|||
25150069|NCT01857206|50264402|FG001|Overall Study|Withdrawal by Subject|0|||
25150070|NCT01882088|50264412|FG000|Overall Study|Intolerance of esophageal manometry|1|||
25150071|NCT01882088|50264412|FG000|Overall Study|no possibility to place the catheter|1|||
25150072|NCT01882088|50264412|FG000|Overall Study|Protocol Violation|1|||
25150073|NCT01882088|50264412|FG000|Overall Study|inadequate pH-impedance tracings|2|||
25150074|NCT01881776|50264419|FG000|Overall Study|Lost to Follow-up|1|||
25150075|NCT01881776|50264420|FG001|Overall Study|Lost to Follow-up|2|||
25150076|NCT01881776|50264421|FG002|Overall Study|Lost to Follow-up|1|||
25150077|NCT01881776|50264419|FG000|Overall Study|Protocol Violation|0|||
25150078|NCT01881776|50264420|FG001|Overall Study|Protocol Violation|2|||
25150079|NCT01881776|50264421|FG002|Overall Study|Protocol Violation|1|||
25150080|NCT01708161|50264435|FG000|Overall Study|Adverse Event|1|||
25150081|NCT01708161|50264436|FG001|Overall Study|Adverse Event|3|||
25150082|NCT01708161|50264437|FG002|Overall Study|Adverse Event|4|||
25150083|NCT01708161|50264438|FG003|Overall Study|Adverse Event|2|||
25150084|NCT01708161|50264439|FG004|Overall Study|Adverse Event|3|||
25150085|NCT01708161|50264440|FG005|Overall Study|Adverse Event|0|||
25150086|NCT01708161|50264435|FG000|Overall Study|Death|0|||
25150087|NCT01708161|50264436|FG001|Overall Study|Death|0|||
25150088|NCT01708161|50264437|FG002|Overall Study|Death|0|||
25150089|NCT01708161|50264438|FG003|Overall Study|Death|1|||
25150090|NCT01708161|50264439|FG004|Overall Study|Death|0|||
25150091|NCT01708161|50264440|FG005|Overall Study|Death|1|||
25150092|NCT01708161|50264435|FG000|Overall Study|Withdrawal by Subject|0|||
25150093|NCT01708161|50264436|FG001|Overall Study|Withdrawal by Subject|1|||
25150094|NCT01708161|50264437|FG002|Overall Study|Withdrawal by Subject|1|||
25150095|NCT01708161|50264438|FG003|Overall Study|Withdrawal by Subject|0|||
25150096|NCT01708161|50264439|FG004|Overall Study|Withdrawal by Subject|0|||
25150097|NCT01708161|50264440|FG005|Overall Study|Withdrawal by Subject|0|||
25150098|NCT01708161|50264435|FG000|Overall Study|Administrative problems|0|||
25184774|NCT01482884|50333727|FG001|Overall Study|Protocol Violation|0|||
25184775|NCT01482884|50333726|FG000|Overall Study|Lost to Follow-up|2|||
25184776|NCT01482884|50333727|FG001|Overall Study|Lost to Follow-up|2|||
25274662|NCT01077375|50588703|FG001|Overall Study|Lack of Efficacy|8|||
25150099|NCT01708161|50264436|FG001|Overall Study|Administrative problems|1|||
25150100|NCT01708161|50264437|FG002|Overall Study|Administrative problems|0|||
25150101|NCT01708161|50264438|FG003|Overall Study|Administrative problems|0|||
25150102|NCT01708161|50264439|FG004|Overall Study|Administrative problems|0|||
25150103|NCT01708161|50264440|FG005|Overall Study|Administrative problems|0|||
25150104|NCT01708161|50264435|FG000|Overall Study|Disease progression|3|||
25150105|NCT01708161|50264436|FG001|Overall Study|Disease progression|5|||
25150106|NCT01708161|50264437|FG002|Overall Study|Disease progression|5|||
25150107|NCT01708161|50264438|FG003|Overall Study|Disease progression|13|||
25150108|NCT01708161|50264439|FG004|Overall Study|Disease progression|3|||
25150109|NCT01708161|50264440|FG005|Overall Study|Disease progression|0|||
25150110|NCT01707693|50264456|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
25150111|NCT01707693|50264457|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
25150112|NCT01707693|50264456|FG000|Overall Study Allocation|Protocol Violation|4|||
25150113|NCT01707693|50264457|FG001|Overall Study Allocation|Protocol Violation|3|||
25150114|NCT01707693|50264456|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
25150115|NCT01707693|50264457|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
25150116|NCT01707693|50264456|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
25150117|NCT01707693|50264457|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
25150118|NCT01722669|50264470|FG000|Overall Study|Withdrawal by Subject|0|||
25150119|NCT01722669|50264471|FG001|Overall Study|Withdrawal by Subject|0|||
25150120|NCT01722669|50264472|FG002|Overall Study|Withdrawal by Subject|0|||
25150121|NCT01722669|50264473|FG003|Overall Study|Withdrawal by Subject|0|||
25150122|NCT01722669|50264474|FG004|Overall Study|Withdrawal by Subject|0|||
25150123|NCT01722669|50264475|FG005|Overall Study|Withdrawal by Subject|2|||
25150124|NCT01707147|50264495|FG000|Overall Study|Administered Trajenta prior to contract|5|||
25150125|NCT01707147|50264495|FG000|Overall Study|Patients who have not taken Trajenta|1|||
25150126|NCT01707147|50264495|FG000|Overall Study|Follow-up failure|17|||
25150127|NCT01707147|50264495|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
25150128|NCT01876251|50264502|FG000|Overall Study|Clinical progression|1|||
25150129|NCT01876251|50264503|FG001|Overall Study|Clinical progression|0|||
25150130|NCT01876251|50264504|FG002|Overall Study|Clinical progression|0|||
25150131|NCT01876251|50264502|FG000|Overall Study|Death|2|||
25150132|NCT01876251|50264503|FG001|Overall Study|Death|0|||
25150133|NCT01876251|50264504|FG002|Overall Study|Death|1|||
25150134|NCT01876251|50264502|FG000|Overall Study|Participant started new treatment|1|||
25150135|NCT01876251|50264503|FG001|Overall Study|Participant started new treatment|0|||
25150136|NCT01876251|50264504|FG002|Overall Study|Participant started new treatment|1|||
25150137|NCT01876251|50264502|FG000|Overall Study|Participant refused further follow-up|0|||
25150138|NCT01876251|50264503|FG001|Overall Study|Participant refused further follow-up|0|||
25150139|NCT01876251|50264504|FG002|Overall Study|Participant refused further follow-up|1|||
25150140|NCT01876251|50264502|FG000|Overall Study|Study terminated|1|||
25150141|NCT01876251|50264503|FG001|Overall Study|Study terminated|0|||
25150142|NCT01876251|50264504|FG002|Overall Study|Study terminated|0|||
25150143|NCT01876251|50264502|FG000|Overall Study|Objective progression or relapse|10|||
25150144|NCT01876251|50264503|FG001|Overall Study|Objective progression or relapse|3|||
25150145|NCT01876251|50264504|FG002|Overall Study|Objective progression or relapse|8|||
25150146|NCT01875471|50264515|FG000|Overall Study|Adverse Event|0|||
25150147|NCT01875471|50264516|FG001|Overall Study|Adverse Event|1|||
25150148|NCT01875471|50264515|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
25150149|NCT01875471|50264516|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
25150150|NCT01875237|50264524|FG000|Overall Study|GVDH before DLI|1|||
25150151|NCT01875237|50264525|FG001|Overall Study|GVDH before DLI|0|||
25150152|NCT01875237|50264524|FG000|Overall Study|DLI cells could not be produced|1|||
25150153|NCT01875237|50264525|FG001|Overall Study|DLI cells could not be produced|0|||
25150154|NCT01874535|50264535|FG000|Overall Study|Lost to Follow-up|10|||
25150155|NCT01874535|50264536|FG001|Overall Study|Lost to Follow-up|9|||
25150156|NCT01874535|50264535|FG000|Overall Study|incomplete symptom resolution|45|||
25150157|NCT01874535|50264536|FG001|Overall Study|incomplete symptom resolution|35|||
25150158|NCT01722045|50264542|FG000|Overall Study|Adverse Event|8|||
25150159|NCT01722045|50264542|FG000|Overall Study|Death|3|||
25150160|NCT01722045|50264542|FG000|Overall Study|Withdrawal by Subject|8|||
25150161|NCT01722045|50264542|FG000|Overall Study|Lost to Follow-up|4|||
25150162|NCT01722045|50264542|FG000|Overall Study|Protocol Deviation|1|||
25150163|NCT01722045|50264542|FG000|Overall Study|Physician Decision|3|||
25150164|NCT01722045|50264542|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
25150165|NCT01721109|50264546|FG000|Overall Study|Lack of Efficacy|1|||
25150166|NCT01721109|50264546|FG000|Overall Study|Non- Compliance with Study Drug|3|||
25150167|NCT01721109|50264546|FG000|Overall Study|Withdrew Consent|1|||
25150168|NCT01721109|50264546|FG000|Overall Study|Lost to Follow-up|2|||
25150169|NCT01874145|50264552|FG000|Core Period|Non-compliance|1|||
25150170|NCT01874145|50264553|FG001|Core Period|Non-compliance|0|||
25150171|NCT01874145|50264552|FG000|Core Period|Protocol Violation|1|||
25150172|NCT01874145|50264553|FG001|Core Period|Protocol Violation|1|||
25150173|NCT01874145|50264552|FG000|Core Period|Physician Decision|1|||
25150174|NCT01874145|50264553|FG001|Core Period|Physician Decision|1|||
25150175|NCT01874145|50264552|FG000|Core Period|Adverse Event|0|||
25150176|NCT01874145|50264553|FG001|Core Period|Adverse Event|1|||
25150177|NCT01874145|50264552|FG000|Core Period|Withdrawal by Subject|0|||
25150178|NCT01874145|50264553|FG001|Core Period|Withdrawal by Subject|4|||
25150179|NCT01874145|50264552|FG000|Extension Period|Adverse Event|3|||
25150180|NCT01874145|50264553|FG001|Extension Period|Adverse Event|2|||
25150181|NCT01874145|50264552|FG000|Extension Period|Withdrawal by Subject|2|||
25150182|NCT01874145|50264553|FG001|Extension Period|Withdrawal by Subject|1|||
25150183|NCT01874145|50264552|FG000|Extension Period|Lost to Follow-up|1|||
25150184|NCT01874145|50264553|FG001|Extension Period|Lost to Follow-up|1|||
25150185|NCT01720797|50264565|FG000|Overall Study|Withdrawal by Subject|3|||
25150186|NCT01720797|50264566|FG001|Overall Study|Withdrawal by Subject|0|||
25150187|NCT01831466|50264584|FG000|Overall Study|Protocol Violation|1|||
25150188|NCT01831466|50264585|FG001|Overall Study|Protocol Violation|1|||
25150189|NCT01831466|50264586|FG002|Overall Study|Protocol Violation|2|||
25150190|NCT01831466|50264587|FG003|Overall Study|Protocol Violation|0|||
25150191|NCT01831466|50264588|FG004|Overall Study|Protocol Violation|0|||
25150192|NCT01831466|50264589|FG005|Overall Study|Protocol Violation|1|||
25150193|NCT01831466|50264590|FG006|Overall Study|Protocol Violation|0|||
25150194|NCT01831466|50264591|FG007|Overall Study|Protocol Violation|0|||
25150195|NCT01831466|50264592|FG008|Overall Study|Protocol Violation|0|||
25150196|NCT01831466|50264593|FG009|Overall Study|Protocol Violation|0|||
25150197|NCT01831466|50264594|FG010|Overall Study|Protocol Violation|0|||
25150198|NCT01831466|50264595|FG011|Overall Study|Protocol Violation|0|||
25150199|NCT01831466|50264584|FG000|Overall Study|Other|2|||
25150200|NCT01831466|50264585|FG001|Overall Study|Other|3|||
25150201|NCT01831466|50264586|FG002|Overall Study|Other|2|||
25150202|NCT01831466|50264587|FG003|Overall Study|Other|2|||
25150203|NCT01831466|50264588|FG004|Overall Study|Other|2|||
25150204|NCT01831466|50264589|FG005|Overall Study|Other|1|||
25150205|NCT01831466|50264590|FG006|Overall Study|Other|0|||
25150206|NCT01831466|50264591|FG007|Overall Study|Other|0|||
25150207|NCT01831466|50264592|FG008|Overall Study|Other|0|||
25150208|NCT01831466|50264593|FG009|Overall Study|Other|0|||
25150209|NCT01831466|50264594|FG010|Overall Study|Other|0|||
25150210|NCT01831466|50264595|FG011|Overall Study|Other|0|||
25150211|NCT01831466|50264584|FG000|Overall Study|Non-compliance with study treatment|2|||
25150212|NCT01831466|50264585|FG001|Overall Study|Non-compliance with study treatment|1|||
25150213|NCT01831466|50264586|FG002|Overall Study|Non-compliance with study treatment|1|||
25150214|NCT01831466|50264587|FG003|Overall Study|Non-compliance with study treatment|0|||
25150215|NCT01831466|50264588|FG004|Overall Study|Non-compliance with study treatment|0|||
25150216|NCT01831466|50264589|FG005|Overall Study|Non-compliance with study treatment|1|||
25150217|NCT01831466|50264590|FG006|Overall Study|Non-compliance with study treatment|0|||
25150218|NCT01831466|50264591|FG007|Overall Study|Non-compliance with study treatment|0|||
25150219|NCT01831466|50264592|FG008|Overall Study|Non-compliance with study treatment|0|||
25150220|NCT01831466|50264593|FG009|Overall Study|Non-compliance with study treatment|0|||
25150221|NCT01831466|50264594|FG010|Overall Study|Non-compliance with study treatment|0|||
25150222|NCT01831466|50264595|FG011|Overall Study|Non-compliance with study treatment|0|||
25150223|NCT01831466|50264584|FG000|Overall Study|Death|0|||
25150224|NCT01831466|50264585|FG001|Overall Study|Death|1|||
25150225|NCT01831466|50264586|FG002|Overall Study|Death|0|||
25150226|NCT01831466|50264587|FG003|Overall Study|Death|0|||
25150227|NCT01831466|50264588|FG004|Overall Study|Death|0|||
25150228|NCT01831466|50264589|FG005|Overall Study|Death|0|||
25150229|NCT01831466|50264590|FG006|Overall Study|Death|0|||
25150230|NCT01831466|50264591|FG007|Overall Study|Death|0|||
25150231|NCT01831466|50264592|FG008|Overall Study|Death|0|||
25150232|NCT01831466|50264593|FG009|Overall Study|Death|0|||
25150233|NCT01831466|50264594|FG010|Overall Study|Death|0|||
25150234|NCT01831466|50264595|FG011|Overall Study|Death|0|||
25150235|NCT01831466|50264584|FG000|Overall Study|Withdrawal by Subject|6|||
25150236|NCT01831466|50264585|FG001|Overall Study|Withdrawal by Subject|3|||
25150237|NCT01831466|50264586|FG002|Overall Study|Withdrawal by Subject|3|||
25150238|NCT01831466|50264587|FG003|Overall Study|Withdrawal by Subject|3|||
25150239|NCT01831466|50264588|FG004|Overall Study|Withdrawal by Subject|3|||
25150240|NCT01831466|50264589|FG005|Overall Study|Withdrawal by Subject|5|||
25150241|NCT01831466|50264590|FG006|Overall Study|Withdrawal by Subject|0|||
25150242|NCT01831466|50264591|FG007|Overall Study|Withdrawal by Subject|0|||
25150243|NCT01831466|50264592|FG008|Overall Study|Withdrawal by Subject|0|||
25150244|NCT01831466|50264593|FG009|Overall Study|Withdrawal by Subject|1|||
25150245|NCT01831466|50264594|FG010|Overall Study|Withdrawal by Subject|0|||
25150246|NCT01831466|50264595|FG011|Overall Study|Withdrawal by Subject|1|||
25150247|NCT01831466|50264584|FG000|Overall Study|Lost to Follow-up|0|||
25150248|NCT01831466|50264585|FG001|Overall Study|Lost to Follow-up|1|||
25150249|NCT01831466|50264586|FG002|Overall Study|Lost to Follow-up|4|||
25150250|NCT01831466|50264587|FG003|Overall Study|Lost to Follow-up|2|||
25150251|NCT01831466|50264588|FG004|Overall Study|Lost to Follow-up|0|||
25150252|NCT01831466|50264589|FG005|Overall Study|Lost to Follow-up|3|||
25150253|NCT01831466|50264590|FG006|Overall Study|Lost to Follow-up|0|||
25150254|NCT01831466|50264591|FG007|Overall Study|Lost to Follow-up|0|||
25150255|NCT01831466|50264592|FG008|Overall Study|Lost to Follow-up|0|||
25150256|NCT01831466|50264593|FG009|Overall Study|Lost to Follow-up|1|||
25150257|NCT01831466|50264594|FG010|Overall Study|Lost to Follow-up|0|||
25150258|NCT01831466|50264595|FG011|Overall Study|Lost to Follow-up|1|||
25150259|NCT01831466|50264584|FG000|Overall Study|Lack of Efficacy|5|||
25150260|NCT01831466|50264585|FG001|Overall Study|Lack of Efficacy|8|||
25150261|NCT01831466|50264586|FG002|Overall Study|Lack of Efficacy|7|||
25150262|NCT01831466|50264587|FG003|Overall Study|Lack of Efficacy|6|||
25150263|NCT01831466|50264588|FG004|Overall Study|Lack of Efficacy|9|||
25150264|NCT01831466|50264589|FG005|Overall Study|Lack of Efficacy|8|||
25150265|NCT01831466|50264590|FG006|Overall Study|Lack of Efficacy|1|||
25150266|NCT01831466|50264591|FG007|Overall Study|Lack of Efficacy|1|||
25150267|NCT01831466|50264592|FG008|Overall Study|Lack of Efficacy|2|||
25150268|NCT01831466|50264593|FG009|Overall Study|Lack of Efficacy|2|||
25150269|NCT01831466|50264594|FG010|Overall Study|Lack of Efficacy|2|||
25150270|NCT01831466|50264595|FG011|Overall Study|Lack of Efficacy|0|||
25150271|NCT01831466|50264584|FG000|Overall Study|Adverse Event|0|||
25150272|NCT01831466|50264585|FG001|Overall Study|Adverse Event|0|||
25150273|NCT01831466|50264586|FG002|Overall Study|Adverse Event|4|||
25150274|NCT01831466|50264587|FG003|Overall Study|Adverse Event|6|||
25150275|NCT01831466|50264588|FG004|Overall Study|Adverse Event|3|||
25150276|NCT01831466|50264589|FG005|Overall Study|Adverse Event|7|||
25150277|NCT01831466|50264590|FG006|Overall Study|Adverse Event|0|||
25150278|NCT01831466|50264591|FG007|Overall Study|Adverse Event|1|||
25150279|NCT01831466|50264592|FG008|Overall Study|Adverse Event|1|||
25150280|NCT01831466|50264593|FG009|Overall Study|Adverse Event|1|||
25150281|NCT01831466|50264594|FG010|Overall Study|Adverse Event|0|||
25150282|NCT01831466|50264595|FG011|Overall Study|Adverse Event|2|||
25150283|NCT01881620|50264615|FG000|Overall Study|Protocol Violation|4|||
25150284|NCT01830920|50264624|FG000|Overall Study|Adverse Event|1|||
25150285|NCT01830920|50264625|FG001|Overall Study|Adverse Event|0|||
25150286|NCT01830920|50264626|FG002|Overall Study|Adverse Event|1|||
25150287|NCT01830920|50264627|FG003|Overall Study|Adverse Event|0|||
25150288|NCT01830920|50264628|FG004|Overall Study|Adverse Event|0|||
25150289|NCT01830920|50264624|FG000|Overall Study|Withdrawal by Subject|2|||
25150290|NCT01830920|50264625|FG001|Overall Study|Withdrawal by Subject|2|||
25150291|NCT01830920|50264626|FG002|Overall Study|Withdrawal by Subject|1|||
25150292|NCT01830920|50264627|FG003|Overall Study|Withdrawal by Subject|7|||
25150293|NCT01830920|50264628|FG004|Overall Study|Withdrawal by Subject|1|||
25150294|NCT01830920|50264624|FG000|Overall Study|Death|3|||
25150295|NCT01830920|50264625|FG001|Overall Study|Death|3|||
25150296|NCT01830920|50264626|FG002|Overall Study|Death|5|||
25150297|NCT01830920|50264627|FG003|Overall Study|Death|4|||
25150298|NCT01830920|50264628|FG004|Overall Study|Death|4|||
25150299|NCT01830920|50264624|FG000|Overall Study|Other|15|||
25150300|NCT01830920|50264625|FG001|Overall Study|Other|1|||
25150301|NCT01830920|50264626|FG002|Overall Study|Other|1|||
25150302|NCT01830920|50264627|FG003|Overall Study|Other|5|||
25150303|NCT01830920|50264628|FG004|Overall Study|Other|3|||
25150304|NCT01881230|50264643|FG000|Overall Study|Death|2|||
25274663|NCT01077375|50588702|FG000|Overall Study|Withdrawal by Subject|0|||
25150305|NCT01881230|50264644|FG001|Overall Study|Death|0|||
25150306|NCT01881230|50264645|FG002|Overall Study|Death|1|||
25150307|NCT01881230|50264643|FG000|Overall Study|Adverse Event|9|||
25150308|NCT01881230|50264644|FG001|Overall Study|Adverse Event|13|||
25150309|NCT01881230|50264645|FG002|Overall Study|Adverse Event|12|||
25150310|NCT01881230|50264643|FG000|Overall Study|Progressive Disease|31|||
25150311|NCT01881230|50264644|FG001|Overall Study|Progressive Disease|35|||
25150312|NCT01881230|50264645|FG002|Overall Study|Progressive Disease|36|||
25150313|NCT01881230|50264643|FG000|Overall Study|Symptomatic Deterioration|3|||
25150314|NCT01881230|50264644|FG001|Overall Study|Symptomatic Deterioration|3|||
25150315|NCT01881230|50264645|FG002|Overall Study|Symptomatic Deterioration|1|||
25150316|NCT01881230|50264643|FG000|Overall Study|Withdrawal by Subject|6|||
25150317|NCT01881230|50264644|FG001|Overall Study|Withdrawal by Subject|4|||
25150318|NCT01881230|50264645|FG002|Overall Study|Withdrawal by Subject|6|||
25150319|NCT01881230|50264643|FG000|Overall Study|Physician Decision|4|||
25150320|NCT01881230|50264644|FG001|Overall Study|Physician Decision|3|||
25150321|NCT01881230|50264645|FG002|Overall Study|Physician Decision|6|||
25184777|NCT01482884|50333726|FG000|Overall Study|Lack of Efficacy|0|||
25150322|NCT01881230|50264643|FG000|Overall Study|Non-Compliance with Study Drug|1|||
25150323|NCT01881230|50264644|FG001|Overall Study|Non-Compliance with Study Drug|2|||
25150324|NCT01881230|50264645|FG002|Overall Study|Non-Compliance with Study Drug|0|||
25150325|NCT01881230|50264643|FG000|Overall Study|Given Commercially Available Drug|0|||
25150326|NCT01881230|50264644|FG001|Overall Study|Given Commercially Available Drug|0|||
25150327|NCT01881230|50264645|FG002|Overall Study|Given Commercially Available Drug|2|||
25150328|NCT01881230|50264643|FG000|Overall Study|Protocol Violation|1|||
25274664|NCT01077375|50588703|FG001|Overall Study|Withdrawal by Subject|6|||
25274665|NCT01077375|50588702|FG000|Overall Study|Lost to Follow-up|2|||
25150329|NCT01881230|50264644|FG001|Overall Study|Protocol Violation|1|||
25150330|NCT01881230|50264645|FG002|Overall Study|Protocol Violation|0|||
25150331|NCT01881230|50264643|FG000|Overall Study|Miscellaneous|3|||
25150332|NCT01881230|50264644|FG001|Overall Study|Miscellaneous|3|||
25150333|NCT01881230|50264645|FG002|Overall Study|Miscellaneous|0|||
25150334|NCT01881230|50264643|FG000|Overall Study|Untreated: Other|0|||
25150335|NCT01881230|50264644|FG001|Overall Study|Untreated: Other|0|||
25150336|NCT01881230|50264645|FG002|Overall Study|Untreated: Other|1|||
25150337|NCT01881230|50264643|FG000|Overall Study|Untreated: Death|0|||
25150338|NCT01881230|50264644|FG001|Overall Study|Untreated: Death|0|||
25150339|NCT01881230|50264645|FG002|Overall Study|Untreated: Death|1|||
25150340|NCT01881230|50264643|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
25150341|NCT01881230|50264644|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
25150342|NCT01881230|50264645|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
25150343|NCT01856582|50264653|FG000|Overall Study|Died prior to Boost infusion|1|||
25150344|NCT01829360|50264661|FG000|Overall Study|Protocol Violation|0|||
25150345|NCT01829360|50264662|FG001|Overall Study|Protocol Violation|0|||
25150346|NCT01829360|50264663|FG002|Overall Study|Protocol Violation|1|||
25150347|NCT01829360|50264664|FG003|Overall Study|Protocol Violation|0|||
25150348|NCT01856114|50264680|FG000|Overall Study|Withdrawal by Subject|1|||
25150349|NCT01856114|50264681|FG001|Overall Study|Withdrawal by Subject|0|||
25150350|NCT01856114|50264680|FG000|Overall Study|Adverse Event|1|||
25150351|NCT01856114|50264681|FG001|Overall Study|Adverse Event|0|||
25150352|NCT01855958|50264689|FG000|Overall Study|Withdrawal by Subject|1|||
25150353|NCT01855958|50264690|FG001|Overall Study|Withdrawal by Subject|0|||
25150354|NCT01855412|50264701|FG000|Overall Study|Death|77|||
25150355|NCT01855412|50264702|FG001|Overall Study|Death|123|||
25150356|NCT01855412|50264703|FG002|Overall Study|Death|30|||
25150357|NCT01855412|50264701|FG000|Overall Study|Lost to Follow-up|28|||
25150358|NCT01855412|50264702|FG001|Overall Study|Lost to Follow-up|46|||
25150359|NCT01855412|50264703|FG002|Overall Study|Lost to Follow-up|15|||
25150360|NCT01855412|50264701|FG000|Overall Study|Withdrawal by Subject|77|||
25150361|NCT01855412|50264702|FG001|Overall Study|Withdrawal by Subject|123|||
25150362|NCT01855412|50264703|FG002|Overall Study|Withdrawal by Subject|24|||
25150363|NCT01855412|50264701|FG000|Overall Study|Physician Decision|25|||
25274666|NCT01077375|50588703|FG001|Overall Study|Lost to Follow-up|5|||
25274667|NCT01077375|50588702|FG000|Overall Study|Other Reason|0|||
25150364|NCT01855412|50264702|FG001|Overall Study|Physician Decision|31|||
25150365|NCT01855412|50264703|FG002|Overall Study|Physician Decision|3|||
25150366|NCT01855412|50264701|FG000|Overall Study|Site Closure|4|||
25150367|NCT01855412|50264702|FG001|Overall Study|Site Closure|18|||
25150368|NCT01855412|50264703|FG002|Overall Study|Site Closure|1|||
25150369|NCT01855412|50264701|FG000|Overall Study|Reason not Specified|1|||
25150370|NCT01855412|50264702|FG001|Overall Study|Reason not Specified|2|||
25150371|NCT01855412|50264703|FG002|Overall Study|Reason not Specified|3|||
25150372|NCT01614470|50264719|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
25150373|NCT01614470|50264720|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
25150374|NCT01614470|50264721|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
25150375|NCT01614470|50264719|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
25150376|NCT01614470|50264720|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
25150377|NCT01614470|50264721|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
25150378|NCT01880528|50264732|FG000|Overall Study|Other|1|||
25150379|NCT01880528|50264733|FG001|Overall Study|Other|1|||
25150380|NCT01854944|50264742|FG000|Overall Study|Withdrawal by Subject|0|||
25150381|NCT01854944|50264743|FG001|Overall Study|Withdrawal by Subject|0|||
25150382|NCT01854944|50264744|FG002|Overall Study|Withdrawal by Subject|1|||
25150383|NCT01829048|50264771|FG000|Overall Study|Withdrawal by Subject|0|||
25150384|NCT01829048|50264772|FG001|Overall Study|Withdrawal by Subject|0|||
25184778|NCT01482884|50333727|FG001|Overall Study|Lack of Efficacy|1|||
25274668|NCT01077375|50588703|FG001|Overall Study|Other Reason|1|||
25150385|NCT01829048|50264773|FG002|Overall Study|Withdrawal by Subject|0|||
25150386|NCT01829048|50264774|FG003|Overall Study|Withdrawal by Subject|2|||
25150387|NCT01829048|50264775|FG004|Overall Study|Withdrawal by Subject|0|||
25150388|NCT01854710|50264788|FG000|Overall Study|Withdrawal by Subject|2|||
25150389|NCT01854710|50264789|FG001|Overall Study|Withdrawal by Subject|1|||
25150390|NCT01854710|50264790|FG002|Overall Study|Withdrawal by Subject|0|||
25150391|NCT01854710|50264791|FG003|Overall Study|Withdrawal by Subject|0|||
25150392|NCT01854710|50264792|FG004|Overall Study|Withdrawal by Subject|0|||
25150393|NCT01854710|50264793|FG005|Overall Study|Withdrawal by Subject|0|||
25150394|NCT01854710|50264788|FG000|Overall Study|CRI procedural error|2|||
25150395|NCT01854710|50264789|FG001|Overall Study|CRI procedural error|2|||
25150396|NCT01854710|50264790|FG002|Overall Study|CRI procedural error|2|||
25150397|NCT01854710|50264791|FG003|Overall Study|CRI procedural error|2|||
25150398|NCT01854710|50264792|FG004|Overall Study|CRI procedural error|2|||
25150399|NCT01854710|50264793|FG005|Overall Study|CRI procedural error|2|||
25150400|NCT01828034|50264807|FG000|Overall Study|Withdrawal by Subject|0|||
25150401|NCT01828034|50264808|FG001|Overall Study|Withdrawal by Subject|0|||
25150402|NCT01828034|50264809|FG002|Overall Study|Withdrawal by Subject|0|||
25150403|NCT01828034|50264810|FG003|Overall Study|Withdrawal by Subject|1|||
25150404|NCT01853696|50264819|FG000|Overall Study|Withdrawal by Subject|1|||
25150405|NCT01853696|50264820|FG001|Overall Study|Withdrawal by Subject|1|||
25150406|NCT01853696|50264819|FG000|Overall Study|Lost to Follow-up|5|||
25150407|NCT01853696|50264820|FG001|Overall Study|Lost to Follow-up|4|||
25150408|NCT01871805|50264832|FG000|Phase I|Death|7|||
25150409|NCT01871805|50264833|FG001|Phase I|Death|4|||
25150410|NCT01871805|50264834|FG002|Phase I|Death|6|||
25150411|NCT01871805|50264835|FG003|Phase I|Death|2|||
25150412|NCT01871805|50264836|FG004|Phase I|Death|9|||
25150413|NCT01871805|50264837|FG005|Phase I|Death|0|||
25150414|NCT01871805|50264832|FG000|Phase I|Alive in Survival Follow-up|0|||
25150415|NCT01871805|50264833|FG001|Phase I|Alive in Survival Follow-up|2|||
25150416|NCT01871805|50264834|FG002|Phase I|Alive in Survival Follow-up|4|||
25150417|NCT01871805|50264835|FG003|Phase I|Alive in Survival Follow-up|5|||
25150418|NCT01871805|50264836|FG004|Phase I|Alive in Survival Follow-up|4|||
25150419|NCT01871805|50264837|FG005|Phase I|Alive in Survival Follow-up|0|||
25150420|NCT01871805|50264832|FG000|Phase I|Lost to Follow-up|0|||
25150421|NCT01871805|50264833|FG001|Phase I|Lost to Follow-up|1|||
25150422|NCT01871805|50264834|FG002|Phase I|Lost to Follow-up|3|||
25150423|NCT01871805|50264835|FG003|Phase I|Lost to Follow-up|0|||
25150424|NCT01871805|50264836|FG004|Phase I|Lost to Follow-up|0|||
25150425|NCT01871805|50264837|FG005|Phase I|Lost to Follow-up|0|||
25150426|NCT01871805|50264832|FG000|Phase II|Death|0|||
25150427|NCT01871805|50264833|FG001|Phase II|Death|0|||
25150428|NCT01871805|50264834|FG002|Phase II|Death|0|||
25150429|NCT01871805|50264835|FG003|Phase II|Death|0|||
25150430|NCT01871805|50264836|FG004|Phase II|Death|0|||
25150431|NCT01871805|50264837|FG005|Phase II|Death|45|||
25150432|NCT01871805|50264832|FG000|Phase II|Alive in Survival Follow-up|0|||
25150433|NCT01871805|50264833|FG001|Phase II|Alive in Survival Follow-up|0|||
25150434|NCT01871805|50264834|FG002|Phase II|Alive in Survival Follow-up|0|||
25150435|NCT01871805|50264835|FG003|Phase II|Alive in Survival Follow-up|0|||
25150436|NCT01871805|50264836|FG004|Phase II|Alive in Survival Follow-up|0|||
25150437|NCT01871805|50264837|FG005|Phase II|Alive in Survival Follow-up|29|||
25184779|NCT01482884|50333726|FG000|Overall Study|Adverse Event|2|||
25184780|NCT01482884|50333727|FG001|Overall Study|Adverse Event|1|||
25150438|NCT01871805|50264832|FG000|Phase II|Lost to Follow-up|0|||
25150439|NCT01871805|50264833|FG001|Phase II|Lost to Follow-up|0|||
25150440|NCT01871805|50264834|FG002|Phase II|Lost to Follow-up|0|||
25150441|NCT01871805|50264835|FG003|Phase II|Lost to Follow-up|0|||
25150442|NCT01871805|50264836|FG004|Phase II|Lost to Follow-up|0|||
25150443|NCT01871805|50264837|FG005|Phase II|Lost to Follow-up|13|||
25150444|NCT01719861|50264868|FG000|Cycle 1|Death|4|||
25150445|NCT01719861|50264868|FG000|Cycle 2|Death|1|||
25150446|NCT01853618|50264878|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
25150447|NCT01853618|50264879|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
25150448|NCT01853618|50264880|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
25150449|NCT01853618|50264881|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
25150450|NCT01853618|50264882|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
25150451|NCT01853618|50264878|FG000|Overall Study|Progressive disease|1|||
25150452|NCT01853618|50264879|FG001|Overall Study|Progressive disease|1|||
25150453|NCT01853618|50264880|FG002|Overall Study|Progressive disease|1|||
25150454|NCT01853618|50264881|FG003|Overall Study|Progressive disease|1|||
25150455|NCT01853618|50264882|FG004|Overall Study|Progressive disease|2|||
25150456|NCT01853618|50264878|FG000|Overall Study|Physician Decision|0|||
25150457|NCT01853618|50264879|FG001|Overall Study|Physician Decision|1|||
25150458|NCT01853618|50264880|FG002|Overall Study|Physician Decision|1|||
25150459|NCT01853618|50264881|FG003|Overall Study|Physician Decision|0|||
25150460|NCT01853618|50264882|FG004|Overall Study|Physician Decision|0|||
25150461|NCT01853618|50264878|FG000|Overall Study|Refused further treatment|0|||
25150462|NCT01853618|50264879|FG001|Overall Study|Refused further treatment|0|||
25150463|NCT01853618|50264880|FG002|Overall Study|Refused further treatment|0|||
25150464|NCT01853618|50264881|FG003|Overall Study|Refused further treatment|0|||
25150465|NCT01853618|50264882|FG004|Overall Study|Refused further treatment|1|||
25150466|NCT01853462|50264897|FG000|Overall Study|Withdrawal by Subject|1|||
25150467|NCT01853462|50264898|FG001|Overall Study|Withdrawal by Subject|1|||
25150468|NCT01719783|50264908|FG000|Dose 2|Physician Decision|1|||
25150469|NCT01719783|50264909|FG001|Dose 2|Physician Decision|0|||
25150470|NCT01853384|50264937|FG000|Randomized|Adverse Event|5|||
25150471|NCT01853384|50264938|FG001|Randomized|Adverse Event|3|||
25150472|NCT01853384|50264937|FG000|Randomized|Death|1|||
25150473|NCT01853384|50264938|FG001|Randomized|Death|2|||
25150474|NCT01853384|50264937|FG000|Randomized|Lost to Follow-up|1|||
25150475|NCT01853384|50264938|FG001|Randomized|Lost to Follow-up|1|||
25150476|NCT01853384|50264937|FG000|Randomized|Withdrawal by Subject|5|||
25150477|NCT01853384|50264938|FG001|Randomized|Withdrawal by Subject|3|||
25150478|NCT01853384|50264937|FG000|Randomized|Sponsor Decision|47|||
25150479|NCT01853384|50264938|FG001|Randomized|Sponsor Decision|34|||
25150480|NCT01853384|50264937|FG000|Randomized|Other|3|||
25150481|NCT01853384|50264938|FG001|Randomized|Other|3|||
25150482|NCT01853384|50264937|FG000|Completed Follow up Visit 1|Early Termination|13|||
25150483|NCT01853384|50264938|FG001|Completed Follow up Visit 1|Early Termination|9|||
25150484|NCT01853384|50264937|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
25150485|NCT01853384|50264938|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
25150486|NCT01853384|50264937|FG000|Completed Follow up Visit 2|Adverse Event|1|||
25150487|NCT01853384|50264938|FG001|Completed Follow up Visit 2|Adverse Event|0|||
25150488|NCT01853384|50264937|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
25150489|NCT01853384|50264938|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
25150490|NCT01853384|50264937|FG000|Completed Follow up Visit 2|Death|1|||
25150491|NCT01853384|50264938|FG001|Completed Follow up Visit 2|Death|0|||
25150492|NCT01853384|50264937|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
25150493|NCT01853384|50264938|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
25150494|NCT01878890|50264948|FG000|Overall Study|Protocol Violation|0|||
25150495|NCT01878890|50264949|FG001|Overall Study|Protocol Violation|1|||
25150496|NCT01878890|50264950|FG002|Overall Study|Protocol Violation|0|||
25150497|NCT01878890|50264951|FG003|Overall Study|Protocol Violation|0|||
25150498|NCT01827332|50264964|FG000|Overall Study|Lost to Follow-up|2|||
25150499|NCT01827332|50264965|FG001|Overall Study|Lost to Follow-up|1|||
25150500|NCT01719003|50264979|FG000|Overall Study|Non compliant with protocol|1|||
25150501|NCT01719003|50264980|FG001|Overall Study|Non compliant with protocol|1|||
25150502|NCT01719003|50264981|FG002|Overall Study|Non compliant with protocol|0|||
25150503|NCT01719003|50264982|FG003|Overall Study|Non compliant with protocol|1|||
25150504|NCT01719003|50264983|FG004|Overall Study|Non compliant with protocol|2|||
25150505|NCT01719003|50264984|FG005|Overall Study|Non compliant with protocol|1|||
25150506|NCT01719003|50264985|FG006|Overall Study|Non compliant with protocol|2|||
25150507|NCT01719003|50264986|FG007|Overall Study|Non compliant with protocol|3|||
25150508|NCT01719003|50264987|FG008|Overall Study|Non compliant with protocol|0|||
25150509|NCT01719003|50264979|FG000|Overall Study|Adverse Event|6|||
25150510|NCT01719003|50264980|FG001|Overall Study|Adverse Event|5|||
25184781|NCT01482884|50333726|FG000|Overall Study|Withdrawal by Subject|8|||
25150511|NCT01719003|50264981|FG002|Overall Study|Adverse Event|4|||
25150512|NCT01719003|50264982|FG003|Overall Study|Adverse Event|3|||
25150513|NCT01719003|50264983|FG004|Overall Study|Adverse Event|4|||
25184782|NCT01482884|50333727|FG001|Overall Study|Withdrawal by Subject|13|||
25150514|NCT01719003|50264984|FG005|Overall Study|Adverse Event|3|||
25184783|NCT01518374|50333733|FG000|Overall Study|Withdrawal by Subject|2|||
25150515|NCT01719003|50264985|FG006|Overall Study|Adverse Event|6|||
25150516|NCT01719003|50264986|FG007|Overall Study|Adverse Event|5|||
25150517|NCT01719003|50264987|FG008|Overall Study|Adverse Event|0|||
25150518|NCT01719003|50264979|FG000|Overall Study|Lost to Follow-up|0|||
25150519|NCT01719003|50264980|FG001|Overall Study|Lost to Follow-up|6|||
25150520|NCT01719003|50264981|FG002|Overall Study|Lost to Follow-up|7|||
25150521|NCT01719003|50264982|FG003|Overall Study|Lost to Follow-up|2|||
25150522|NCT01719003|50264983|FG004|Overall Study|Lost to Follow-up|3|||
25150523|NCT01719003|50264984|FG005|Overall Study|Lost to Follow-up|4|||
25150524|NCT01719003|50264985|FG006|Overall Study|Lost to Follow-up|3|||
25150525|NCT01719003|50264986|FG007|Overall Study|Lost to Follow-up|2|||
25150526|NCT01719003|50264987|FG008|Overall Study|Lost to Follow-up|2|||
25150527|NCT01719003|50264979|FG000|Overall Study|Refusal to continue, not due to AE|2|||
25150528|NCT01719003|50264980|FG001|Overall Study|Refusal to continue, not due to AE|5|||
25150529|NCT01719003|50264981|FG002|Overall Study|Refusal to continue, not due to AE|4|||
25150530|NCT01719003|50264982|FG003|Overall Study|Refusal to continue, not due to AE|4|||
25150531|NCT01719003|50264983|FG004|Overall Study|Refusal to continue, not due to AE|4|||
25150532|NCT01719003|50264984|FG005|Overall Study|Refusal to continue, not due to AE|3|||
25150533|NCT01719003|50264985|FG006|Overall Study|Refusal to continue, not due to AE|8|||
25150534|NCT01719003|50264986|FG007|Overall Study|Refusal to continue, not due to AE|7|||
25150535|NCT01719003|50264987|FG008|Overall Study|Refusal to continue, not due to AE|1|||
25150536|NCT01719003|50264979|FG000|Overall Study|Reason other than those specified|0|||
25150537|NCT01719003|50264980|FG001|Overall Study|Reason other than those specified|0|||
25150538|NCT01719003|50264981|FG002|Overall Study|Reason other than those specified|2|||
25150539|NCT01719003|50264982|FG003|Overall Study|Reason other than those specified|3|||
25150540|NCT01719003|50264983|FG004|Overall Study|Reason other than those specified|4|||
25150541|NCT01719003|50264984|FG005|Overall Study|Reason other than those specified|1|||
25150542|NCT01719003|50264985|FG006|Overall Study|Reason other than those specified|0|||
25150543|NCT01719003|50264986|FG007|Overall Study|Reason other than those specified|3|||
25150544|NCT01719003|50264987|FG008|Overall Study|Reason other than those specified|1|||
25150545|NCT01719003|50264979|FG000|Overall Study|Lack of Efficacy|0|||
25150546|NCT01719003|50264980|FG001|Overall Study|Lack of Efficacy|0|||
25150547|NCT01719003|50264981|FG002|Overall Study|Lack of Efficacy|0|||
25150548|NCT01719003|50264982|FG003|Overall Study|Lack of Efficacy|0|||
25150549|NCT01719003|50264983|FG004|Overall Study|Lack of Efficacy|0|||
25150550|NCT01719003|50264984|FG005|Overall Study|Lack of Efficacy|0|||
25150551|NCT01719003|50264985|FG006|Overall Study|Lack of Efficacy|1|||
25150552|NCT01719003|50264986|FG007|Overall Study|Lack of Efficacy|0|||
25150553|NCT01719003|50264987|FG008|Overall Study|Lack of Efficacy|0|||
25016308|NCT03286218|50111183|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
25150554|NCT01853228|50265006|FG000|Phase 1|Lack of Efficacy|8|||
25150555|NCT01853228|50265007|FG001|Phase 1|Lack of Efficacy|0|||
25150556|NCT01853228|50265006|FG000|Phase 1|Other|1|||
25150557|NCT01853228|50265007|FG001|Phase 1|Other|0|||
25150558|NCT01853228|50265006|FG000|Phase 2|Physician Decision|0|||
25150559|NCT01853228|50265007|FG001|Phase 2|Physician Decision|1|||
25150560|NCT01853228|50265006|FG000|Phase 2|Proceed To Transplant|0|||
25150561|NCT01853228|50265007|FG001|Phase 2|Proceed To Transplant|3|||
25150562|NCT01853228|50265006|FG000|Phase 2|Lack of Efficacy|0|||
25150563|NCT01853228|50265007|FG001|Phase 2|Lack of Efficacy|4|||
25150564|NCT01705587|50265014|FG000|Overall Study|Withdrawal by Subject|0|||
25150565|NCT01705587|50265015|FG001|Overall Study|Withdrawal by Subject|1|||
25150566|NCT01718535|50265031|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
25150567|NCT01718535|50265032|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
25150568|NCT01718535|50265033|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
25150569|NCT01718535|50265034|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
25150570|NCT01718535|50265035|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
25150571|NCT01718535|50265036|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
25150572|NCT01718535|50265037|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
25150573|NCT01718535|50265038|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
25150574|NCT01718535|50265039|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
25150575|NCT01718535|50265040|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
25150576|NCT01717989|50265062|FG000|Overall Study|Ineligibility determined|6|||
25150577|NCT01717989|50265062|FG000|Overall Study|Protocol deviation|6|||
25150578|NCT01717989|50265062|FG000|Overall Study|Withdrawal by Subject|11|||
25150579|NCT01717989|50265062|FG000|Overall Study|Physician Decision|2|||
25150580|NCT01717989|50265062|FG000|Overall Study|Lost to Follow-up|11|||
25150581|NCT01717989|50265062|FG000|Overall Study|Death|439|||
25150582|NCT01717989|50265062|FG000|Overall Study|Protocol-specified criteria|551|||
25150583|NCT01717989|50265062|FG000|Overall Study|Other|40|||
25150584|NCT01705509|50265081|FG000|Inclusion CPET|Screen Failure|5|||
25150585|NCT01705509|50265081|FG000|Inclusion CPET|Withdrawal by Subject|2|||
25150586|NCT01705509|50265081|FG000|CPET w/ Ranexa|Screen Failure|2|||
25150587|NCT01853072|50265087|FG000|Overall Study|Adverse event prior to treatment|0|||
25150588|NCT01853072|50265088|FG001|Overall Study|Adverse event prior to treatment|1|||
25150589|NCT01853072|50265087|FG000|Overall Study|Adverse Event|0|||
25150590|NCT01853072|50265088|FG001|Overall Study|Adverse Event|3|||
25184784|NCT01518374|50333733|FG000|Overall Study|Protocol Violation|3|||
25150591|NCT01853072|50265087|FG000|Overall Study|Death|1|||
25150592|NCT01853072|50265088|FG001|Overall Study|Death|4|||
25150593|NCT01853072|50265087|FG000|Overall Study|Lost to Follow-up|0|||
25150594|NCT01853072|50265088|FG001|Overall Study|Lost to Follow-up|3|||
25016309|NCT03286218|50111184|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
25016310|NCT03286218|50111185|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
25150595|NCT01853072|50265087|FG000|Overall Study|Non-compliance with study drug|0|||
25016311|NCT03286218|50111186|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
25016312|NCT03286218|50111187|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
25016313|NCT03286218|50111188|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
25016314|NCT03286218|50111189|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
25016315|NCT03286218|50111178|FG000|Qualification Phase Period 2|Adverse Event|0|||
25016316|NCT03286218|50111179|FG001|Qualification Phase Period 2|Adverse Event|1|||
25016317|NCT03286218|50111180|FG002|Qualification Phase Period 2|Adverse Event|0|||
25184785|NCT01518374|50333733|FG000|Overall Study|Lost to Follow-up|2|||
25016318|NCT03286218|50111181|FG003|Qualification Phase Period 2|Adverse Event|0|||
25016319|NCT03286218|50111182|FG004|Qualification Phase Period 2|Adverse Event|0|||
25016320|NCT03286218|50111183|FG005|Qualification Phase Period 2|Adverse Event|0|||
25184786|NCT01481324|50333740|FG000|Overall Study|Missing Data|0|||
25016321|NCT03286218|50111184|FG006|Qualification Phase Period 2|Adverse Event|0|||
25016322|NCT03286218|50111185|FG007|Qualification Phase Period 2|Adverse Event|0|||
25016323|NCT03286218|50111186|FG008|Qualification Phase Period 2|Adverse Event|0|||
25016324|NCT03286218|50111187|FG009|Qualification Phase Period 2|Adverse Event|0|||
25016325|NCT03286218|50111188|FG010|Qualification Phase Period 2|Adverse Event|0|||
25016326|NCT03286218|50111189|FG011|Qualification Phase Period 2|Adverse Event|0|||
25016327|NCT03286218|50111178|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
25016328|NCT03286218|50111179|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
25016329|NCT03286218|50111180|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
25016330|NCT03286218|50111181|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
25016331|NCT03286218|50111182|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
25016332|NCT03286218|50111183|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
25016333|NCT03286218|50111184|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
25016334|NCT03286218|50111185|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
25016335|NCT03286218|50111186|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
25016336|NCT03286218|50111187|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
25016337|NCT03286218|50111188|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
25016338|NCT03286218|50111189|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
25016339|NCT03286218|50111178|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
25016340|NCT03286218|50111179|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
25016341|NCT03286218|50111180|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
25016342|NCT03286218|50111181|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
25016343|NCT03286218|50111182|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
25016344|NCT03286218|50111183|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
25016345|NCT03286218|50111184|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
25016346|NCT03286218|50111185|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
25016347|NCT03286218|50111186|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
25150596|NCT01853072|50265088|FG001|Overall Study|Non-compliance with study drug|1|||
25150597|NCT01853072|50265087|FG000|Overall Study|Physician Decision|1|||
25150598|NCT01853072|50265088|FG001|Overall Study|Physician Decision|1|||
25016348|NCT03286218|50111187|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
25016349|NCT03286218|50111188|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
25150599|NCT01853072|50265087|FG000|Overall Study|Withdrawal by Subject|1|||
25016350|NCT03286218|50111189|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
25150600|NCT01853072|50265088|FG001|Overall Study|Withdrawal by Subject|2|||
25150601|NCT01853072|50265087|FG000|Overall Study|Reason not specified|9|||
25016351|NCT03286218|50111178|FG000|Qualification Phase Period 2|Protocol Violation|2|||
25016352|NCT03286218|50111179|FG001|Qualification Phase Period 2|Protocol Violation|0|||
25016353|NCT03286218|50111180|FG002|Qualification Phase Period 2|Protocol Violation|0|||
25016354|NCT03286218|50111181|FG003|Qualification Phase Period 2|Protocol Violation|0|||
25016355|NCT03286218|50111182|FG004|Qualification Phase Period 2|Protocol Violation|0|||
25016356|NCT03286218|50111183|FG005|Qualification Phase Period 2|Protocol Violation|0|||
25016357|NCT03286218|50111184|FG006|Qualification Phase Period 2|Protocol Violation|0|||
25016358|NCT03286218|50111185|FG007|Qualification Phase Period 2|Protocol Violation|0|||
25016359|NCT03286218|50111186|FG008|Qualification Phase Period 2|Protocol Violation|0|||
25016360|NCT03286218|50111187|FG009|Qualification Phase Period 2|Protocol Violation|0|||
25016361|NCT03286218|50111188|FG010|Qualification Phase Period 2|Protocol Violation|0|||
25016362|NCT03286218|50111189|FG011|Qualification Phase Period 2|Protocol Violation|0|||
25016363|NCT03286218|50111178|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
25016364|NCT03286218|50111179|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
25016365|NCT03286218|50111180|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
25016366|NCT03286218|50111181|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
25184787|NCT01481324|50333741|FG001|Overall Study|Missing Data|2|||
25016367|NCT03286218|50111182|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
25016368|NCT03286218|50111183|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
25016369|NCT03286218|50111184|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
25016370|NCT03286218|50111185|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
25016371|NCT03286218|50111186|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
25016372|NCT03286218|50111187|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
25016373|NCT03286218|50111188|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
25016374|NCT03286218|50111189|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
25016375|NCT03286218|50111178|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
25016376|NCT03286218|50111179|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
25016377|NCT03286218|50111180|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
25016378|NCT03286218|50111181|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
25016379|NCT03286218|50111182|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
25016380|NCT03286218|50111183|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
25016381|NCT03286218|50111184|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
25016382|NCT03286218|50111185|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
25016383|NCT03286218|50111186|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
25016384|NCT03286218|50111187|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
25016385|NCT03286218|50111188|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
25016386|NCT03286218|50111189|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
25016387|NCT03286218|50111178|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
25016388|NCT03286218|50111179|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
25016389|NCT03286218|50111180|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
25016390|NCT03286218|50111181|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
25016391|NCT03286218|50111182|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
25016392|NCT03286218|50111183|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
25016393|NCT03286218|50111184|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
25016394|NCT03286218|50111185|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
25016395|NCT03286218|50111186|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
25016396|NCT03286218|50111187|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
25016397|NCT03286218|50111188|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
25016398|NCT03286218|50111189|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
25016399|NCT03224325|50111223|FG000|Overall Study|Adverse Event|1|||
25016400|NCT03224325|50111224|FG001|Overall Study|Adverse Event|0|||
25016401|NCT03224325|50111225|FG002|Overall Study|Adverse Event|0|||
25016402|NCT03224325|50111226|FG003|Overall Study|Adverse Event|0|||
25016403|NCT03224325|50111227|FG004|Overall Study|Adverse Event|0|||
25016404|NCT03224325|50111228|FG005|Overall Study|Adverse Event|0|||
25016405|NCT03224325|50111229|FG006|Overall Study|Adverse Event|1|||
25016406|NCT03224325|50111223|FG000|Overall Study|Withdrawal by Subject|0|||
25016407|NCT03224325|50111224|FG001|Overall Study|Withdrawal by Subject|0|||
25016408|NCT03224325|50111225|FG002|Overall Study|Withdrawal by Subject|0|||
25016409|NCT03224325|50111226|FG003|Overall Study|Withdrawal by Subject|1|||
25016410|NCT03224325|50111227|FG004|Overall Study|Withdrawal by Subject|0|||
25016411|NCT03224325|50111228|FG005|Overall Study|Withdrawal by Subject|0|||
25016412|NCT03224325|50111229|FG006|Overall Study|Withdrawal by Subject|0|||
25016413|NCT04016779|50111253|FG000|Overall Study|Adverse Event|9|||
25016414|NCT04016779|50111254|FG001|Overall Study|Adverse Event|17|||
25150602|NCT01853072|50265088|FG001|Overall Study|Reason not specified|6|||
25150603|NCT01877720|50265096|FG000|Overall Study|Adverse Event|1|||
25150604|NCT01877720|50265097|FG001|Overall Study|Adverse Event|0|||
25150605|NCT01870869|50265107|FG000|Overall Study|Implanted with nonstudy device|1|||
25150606|NCT01870869|50265108|FG001|Overall Study|Implanted with nonstudy device|3|||
25150607|NCT01870869|50265109|FG002|Overall Study|Implanted with nonstudy device|14|||
25150608|NCT01870869|50265110|FG003|Overall Study|Implanted with nonstudy device|4|||
25150609|NCT01870869|50265107|FG000|Overall Study|Death|0|||
25150610|NCT01870869|50265108|FG001|Overall Study|Death|0|||
25150611|NCT01870869|50265109|FG002|Overall Study|Death|7|||
25150612|NCT01870869|50265110|FG003|Overall Study|Death|1|||
25150613|NCT01870869|50265107|FG000|Overall Study|Subject choice|6|||
25150614|NCT01870869|50265108|FG001|Overall Study|Subject choice|2|||
25150615|NCT01870869|50265109|FG002|Overall Study|Subject choice|22|||
25150616|NCT01870869|50265110|FG003|Overall Study|Subject choice|8|||
25150617|NCT01870869|50265107|FG000|Overall Study|Lost to Follow-up|10|||
25150618|NCT01870869|50265108|FG001|Overall Study|Lost to Follow-up|2|||
25150619|NCT01870869|50265109|FG002|Overall Study|Lost to Follow-up|25|||
25150620|NCT01870869|50265110|FG003|Overall Study|Lost to Follow-up|3|||
25150621|NCT01870869|50265107|FG000|Overall Study|Reason not Specified|1|||
25150622|NCT01870869|50265108|FG001|Overall Study|Reason not Specified|2|||
25150623|NCT01870869|50265109|FG002|Overall Study|Reason not Specified|20|||
25150624|NCT01870869|50265110|FG003|Overall Study|Reason not Specified|4|||
25150625|NCT01870869|50265107|FG000|Overall Study|Not evaluable|10|||
25150626|NCT01870869|50265108|FG001|Overall Study|Not evaluable|5|||
25150627|NCT01870869|50265109|FG002|Overall Study|Not evaluable|42|||
25150628|NCT01870869|50265110|FG003|Overall Study|Not evaluable|10|||
25150629|NCT01877408|50265122|FG000|Overall Study|Lost to Follow-up|0|||
25150630|NCT01877408|50265123|FG001|Overall Study|Lost to Follow-up|2|||
25150631|NCT01717287|50265132|FG000|Overall Study|Lost to Follow-up|0|||
25150632|NCT01717287|50265133|FG001|Overall Study|Lost to Follow-up|2|||
25150633|NCT01717287|50265132|FG000|Overall Study|Protocol Violation|0|||
25016415|NCT04016779|50111253|FG000|Overall Study|Lack of Efficacy|4|||
25016416|NCT04016779|50111254|FG001|Overall Study|Lack of Efficacy|1|||
25016417|NCT04016779|50111253|FG000|Overall Study|Lost to Follow-up|5|||
25016418|NCT04016779|50111254|FG001|Overall Study|Lost to Follow-up|14|||
25016419|NCT04016779|50111253|FG000|Overall Study|Physician Decision|1|||
25016420|NCT04016779|50111254|FG001|Overall Study|Physician Decision|3|||
25016421|NCT04016779|50111253|FG000|Overall Study|Withdrawal by Subject|6|||
25016422|NCT04016779|50111254|FG001|Overall Study|Withdrawal by Subject|8|||
25016423|NCT04016779|50111253|FG000|Overall Study|Non-compliance with Study Drug|2|||
25016424|NCT04016779|50111254|FG001|Overall Study|Non-compliance with Study Drug|3|||
25016425|NCT04016779|50111253|FG000|Overall Study|Other, Multiple categories|17|||
25016426|NCT04016779|50111254|FG001|Overall Study|Other, Multiple categories|17|||
25016427|NCT02857426|50111264|FG000|Overall Study|Disease progression|34|||
25016428|NCT02857426|50111265|FG001|Overall Study|Disease progression|13|||
25016429|NCT02857426|50111264|FG000|Overall Study|Study drug toxicity|4|||
25016430|NCT02857426|50111265|FG001|Overall Study|Study drug toxicity|1|||
25016431|NCT02857426|50111264|FG000|Overall Study|Death|1|||
25016432|NCT02857426|50111265|FG001|Overall Study|Death|0|||
25016433|NCT02857426|50111264|FG000|Overall Study|Adverse event unrelated to study drug|6|||
25150634|NCT01717287|50265133|FG001|Overall Study|Protocol Violation|1|||
25016434|NCT02857426|50111265|FG001|Overall Study|Adverse event unrelated to study drug|2|||
25016435|NCT02857426|50111264|FG000|Overall Study|Participant withdrew consent|1|||
25016436|NCT02857426|50111265|FG001|Overall Study|Participant withdrew consent|1|||
25016437|NCT02857426|50111264|FG000|Overall Study|Maximum clinical benefit|1|||
25016438|NCT02857426|50111265|FG001|Overall Study|Maximum clinical benefit|0|||
25016439|NCT02857426|50111264|FG000|Overall Study|Completed treatment|0|||
25016440|NCT02857426|50111265|FG001|Overall Study|Completed treatment|2|||
25016441|NCT01127256|50111273|FG000|Overall Study|Adverse Event|13|||
25016442|NCT01127256|50111274|FG001|Overall Study|Adverse Event|13|||
25016443|NCT01127256|50111273|FG000|Overall Study|Lack of Efficacy|4|||
25016444|NCT01127256|50111274|FG001|Overall Study|Lack of Efficacy|0|||
25016445|NCT01127256|50111273|FG000|Overall Study|Lost to Follow-up|16|||
25016446|NCT01127256|50111274|FG001|Overall Study|Lost to Follow-up|17|||
25016447|NCT01127256|50111273|FG000|Overall Study|Withdrawal by Subject|5|||
25016448|NCT01127256|50111274|FG001|Overall Study|Withdrawal by Subject|9|||
25016449|NCT01127256|50111273|FG000|Overall Study|Protocol Violation|1|||
25016450|NCT01127256|50111274|FG001|Overall Study|Protocol Violation|0|||
25016451|NCT03668613|50111282|FG000|Overall Study|Adverse Event|0|||
25150635|NCT01827254|50265139|FG000|Overall Study|Death|10|||
25016452|NCT03668613|50111283|FG001|Overall Study|Adverse Event|2|||
25016453|NCT03668613|50111282|FG000|Overall Study|Lack of Efficacy|0|||
25150636|NCT01827254|50265139|FG000|Overall Study|Case report form not completed|4|||
25150637|NCT01827254|50265139|FG000|Overall Study|Invalidated centre|3|||
25150638|NCT01827254|50265139|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
25150639|NCT01827254|50265139|FG000|Overall Study|Did not complete re-challenge|1|||
25150640|NCT01827254|50265139|FG000|Overall Study|Disease progression|36|||
25150641|NCT01827254|50265139|FG000|Overall Study|Intolerance to treatment|4|||
25150642|NCT01824602|50265151|FG000|Overall Study|Withdrawal by Subject|0|||
25150643|NCT01824602|50265152|FG001|Overall Study|Withdrawal by Subject|0|||
25150644|NCT01824602|50265153|FG002|Overall Study|Withdrawal by Subject|1|||
25150645|NCT01824602|50265154|FG003|Overall Study|Withdrawal by Subject|2|||
25150646|NCT01824602|50265151|FG000|Overall Study|Patient non-compliance|0|||
25150647|NCT01824602|50265152|FG001|Overall Study|Patient non-compliance|0|||
25150648|NCT01824602|50265153|FG002|Overall Study|Patient non-compliance|1|||
25150649|NCT01824602|50265154|FG003|Overall Study|Patient non-compliance|0|||
25150650|NCT01824602|50265151|FG000|Overall Study|Adverse Event|1|||
25150651|NCT01824602|50265152|FG001|Overall Study|Adverse Event|0|||
25150652|NCT01824602|50265153|FG002|Overall Study|Adverse Event|2|||
25150653|NCT01824602|50265154|FG003|Overall Study|Adverse Event|2|||
25150654|NCT01824602|50265151|FG000|Overall Study|Treatment failure|0|||
25150655|NCT01824602|50265152|FG001|Overall Study|Treatment failure|0|||
25150656|NCT01824602|50265153|FG002|Overall Study|Treatment failure|0|||
25150657|NCT01824602|50265154|FG003|Overall Study|Treatment failure|1|||
25150658|NCT01704651|50265166|FG000|Overall Study|Pre-op withdrawal by subject|1|||
25150659|NCT01704651|50265167|FG001|Overall Study|Pre-op withdrawal by subject|1|||
25150660|NCT01704651|50265166|FG000|Overall Study|Pre-op change in treatment plan|1|||
25150661|NCT01704651|50265167|FG001|Overall Study|Pre-op change in treatment plan|4|||
25150662|NCT01704651|50265166|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
25150663|NCT01704651|50265167|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
25150664|NCT01704651|50265166|FG000|Overall Study|Post-op did not have laparotomy|2|||
25150665|NCT01704651|50265167|FG001|Overall Study|Post-op did not have laparotomy|1|||
25150666|NCT01876706|50265173|FG000|Overall Study|BPH Intervention|9|||
25150667|NCT01876706|50265173|FG000|Overall Study|Lost to Follow-up|7|||
25150668|NCT01876706|50265173|FG000|Overall Study|Withdrawals|6|||
25150669|NCT01876706|50265173|FG000|Overall Study|Death|3|||
25150670|NCT01876082|50265179|FG000|Overall Study|Withdrawal by Subject|0|||
25150671|NCT01876082|50265180|FG001|Overall Study|Withdrawal by Subject|2|||
25150672|NCT01876082|50265179|FG000|Overall Study|Protocol Violation|1|||
25150673|NCT01876082|50265180|FG001|Overall Study|Protocol Violation|0|||
25150674|NCT01876082|50265179|FG000|Overall Study|Adverse Event|1|||
25150675|NCT01876082|50265180|FG001|Overall Study|Adverse Event|1|||
25150676|NCT01876082|50265179|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
25016454|NCT03668613|50111283|FG001|Overall Study|Lack of Efficacy|1|||
25150677|NCT01876082|50265180|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
25150678|NCT01704495|50265190|FG000|Subjects Randomized|Other Reason|3|||
25150679|NCT01704495|50265191|FG001|Subjects Randomized|Other Reason|2|||
25150680|NCT01704495|50265192|FG002|Subjects Randomized|Other Reason|3|||
25150681|NCT01704495|50265193|FG003|Subjects Randomized|Other Reason|2|||
25150682|NCT01704495|50265190|FG000|Subjects Randomized|Discontinuation criteria met|4|||
25150683|NCT01704495|50265191|FG001|Subjects Randomized|Discontinuation criteria met|2|||
25150684|NCT01704495|50265192|FG002|Subjects Randomized|Discontinuation criteria met|2|||
25150685|NCT01704495|50265193|FG003|Subjects Randomized|Discontinuation criteria met|0|||
25150686|NCT01704495|50265190|FG000|Subjects Randomized|Adverse Event|8|||
25150687|NCT01704495|50265191|FG001|Subjects Randomized|Adverse Event|2|||
25150688|NCT01704495|50265192|FG002|Subjects Randomized|Adverse Event|0|||
25150689|NCT01704495|50265193|FG003|Subjects Randomized|Adverse Event|7|||
25150690|NCT01704495|50265190|FG000|Subjects Randomized|Withdrawal by Subject|5|||
25150691|NCT01704495|50265191|FG001|Subjects Randomized|Withdrawal by Subject|5|||
25150692|NCT01704495|50265192|FG002|Subjects Randomized|Withdrawal by Subject|5|||
25150693|NCT01704495|50265193|FG003|Subjects Randomized|Withdrawal by Subject|5|||
25150694|NCT01704495|50265190|FG000|Subjects Randomized|Protocol Violation|1|||
25150695|NCT01704495|50265191|FG001|Subjects Randomized|Protocol Violation|1|||
25150696|NCT01704495|50265192|FG002|Subjects Randomized|Protocol Violation|2|||
25150697|NCT01704495|50265193|FG003|Subjects Randomized|Protocol Violation|0|||
25150698|NCT01704495|50265190|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
25150699|NCT01704495|50265191|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
25150700|NCT01704495|50265192|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
25150701|NCT01704495|50265193|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
25150702|NCT01704495|50265190|FG000|Optional Safety Extension|Adverse Event|0|||
25150703|NCT01704495|50265191|FG001|Optional Safety Extension|Adverse Event|4|||
25150704|NCT01704495|50265192|FG002|Optional Safety Extension|Adverse Event|0|||
25150705|NCT01704495|50265193|FG003|Optional Safety Extension|Adverse Event|1|||
25150706|NCT01704495|50265190|FG000|Optional Safety Extension|Other reason|27|||
25150707|NCT01704495|50265191|FG001|Optional Safety Extension|Other reason|29|||
25150708|NCT01704495|50265192|FG002|Optional Safety Extension|Other reason|30|||
25150709|NCT01704495|50265193|FG003|Optional Safety Extension|Other reason|28|||
25016455|NCT04016311|50111292|FG000|Overall Study|Withdrawal by Subject|1|||
25016456|NCT04016311|50111293|FG001|Overall Study|Withdrawal by Subject|0|||
25016457|NCT04052425|50111303|FG000|24-Week Double-blind Period|Adverse Event|0|||
25016458|NCT04052425|50111304|FG001|24-Week Double-blind Period|Adverse Event|1|||
25016459|NCT04052425|50111305|FG002|24-Week Double-blind Period|Adverse Event|0|||
25016460|NCT04052425|50111306|FG003|24-Week Double-blind Period|Adverse Event|0|||
25016461|NCT04052425|50111303|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
25016462|NCT04052425|50111304|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
25184788|NCT01481324|50333742|FG002|Overall Study|Missing Data|2|||
25150710|NCT01704495|50265190|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
25150711|NCT01704495|50265191|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
25150712|NCT01704495|50265192|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
25150713|NCT01704495|50265193|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
25150714|NCT01716663|50265203|FG000|Overall Study|Withdrawn prior to procedure|4|||
25150715|NCT01716663|50265203|FG000|Overall Study|Treated with non-study catheter|2|||
25150716|NCT01716585|50265209|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
25150717|NCT01716585|50265210|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
25184789|NCT04591626|50333752|FG000|Overall Study|Adverse Event|4|||
25016463|NCT04052425|50111305|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
25016464|NCT04052425|50111306|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
25016465|NCT04052425|50111303|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
25016466|NCT04052425|50111304|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
25016467|NCT04052425|50111305|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
25016468|NCT04052425|50111306|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
25016469|NCT04052425|50111303|FG000|24-Week Double-blind Period|Physician Decision|1|||
25150718|NCT01716585|50265209|FG000|Double-blind Treatment|Adverse Event|2|||
25150719|NCT01716585|50265210|FG001|Double-blind Treatment|Adverse Event|1|||
25150720|NCT01716585|50265209|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
25150721|NCT01716585|50265210|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
25150722|NCT01716585|50265209|FG000|Double-blind Treatment|Lost to Follow-up|2|||
25150723|NCT01716585|50265210|FG001|Double-blind Treatment|Lost to Follow-up|0|||
25150724|NCT01716585|50265209|FG000|Double-blind Treatment|Subject Noncompliant|1|||
25150725|NCT01716585|50265210|FG001|Double-blind Treatment|Subject Noncompliant|0|||
25150726|NCT01716585|50265209|FG000|Double-blind Treatment|Other|1|||
25150727|NCT01716585|50265210|FG001|Double-blind Treatment|Other|0|||
25150728|NCT01716585|50265209|FG000|Open-label Treatment|Adverse Event|0|||
25150729|NCT01716585|50265210|FG001|Open-label Treatment|Adverse Event|2|||
25150730|NCT01716585|50265209|FG000|Open-label Treatment|Virologic Failure|0|||
25150731|NCT01716585|50265210|FG001|Open-label Treatment|Virologic Failure|2|||
25150732|NCT01716585|50265209|FG000|Open-label Treatment|Withdrawal by Subject|0|||
25150733|NCT01716585|50265210|FG001|Open-label Treatment|Withdrawal by Subject|3|||
25150734|NCT01852292|50265219|FG000|Overall Study|Untreated - did not receive study drug|3|||
25150735|NCT01852292|50265220|FG001|Overall Study|Untreated - did not receive study drug|1|||
25150736|NCT01852292|50265219|FG000|Overall Study|Death|9|||
25150737|NCT01852292|50265220|FG001|Overall Study|Death|8|||
25150738|NCT01852292|50265219|FG000|Overall Study|Patient/guardian decision|8|||
25150739|NCT01852292|50265220|FG001|Overall Study|Patient/guardian decision|4|||
25150740|NCT01852292|50265219|FG000|Overall Study|Adverse Event|8|||
25150741|NCT01852292|50265220|FG001|Overall Study|Adverse Event|11|||
25150742|NCT01852292|50265219|FG000|Overall Study|Physician Decision|6|||
25150743|NCT01852292|50265220|FG001|Overall Study|Physician Decision|2|||
25150744|NCT01852292|50265219|FG000|Overall Study|Protocol Violation|2|||
25150745|NCT01852292|50265220|FG001|Overall Study|Protocol Violation|0|||
25150746|NCT01852292|50265219|FG000|Overall Study|Non-compliance with study treatment|1|||
25184790|NCT04591626|50333753|FG001|Overall Study|Adverse Event|0|||
25016470|NCT04052425|50111304|FG001|24-Week Double-blind Period|Physician Decision|0|||
25016471|NCT04052425|50111305|FG002|24-Week Double-blind Period|Physician Decision|0|||
25016472|NCT04052425|50111306|FG003|24-Week Double-blind Period|Physician Decision|0|||
25016473|NCT04052425|50111303|FG000|24-Week Double-blind Period|Protocol Violation|1|||
25016474|NCT04052425|50111304|FG001|24-Week Double-blind Period|Protocol Violation|0|||
25016475|NCT04052425|50111305|FG002|24-Week Double-blind Period|Protocol Violation|0|||
25016476|NCT04052425|50111306|FG003|24-Week Double-blind Period|Protocol Violation|0|||
25016477|NCT04052425|50111303|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
25016478|NCT04052425|50111304|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
25016479|NCT04052425|50111305|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
25016480|NCT04052425|50111306|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
25016481|NCT04052425|50111303|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
25016482|NCT04052425|50111304|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
25016483|NCT04052425|50111305|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
25016484|NCT04052425|50111306|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
25016485|NCT04052425|50111303|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
25150747|NCT01852292|50265220|FG001|Overall Study|Non-compliance with study treatment|0|||
25150748|NCT01852292|50265219|FG000|Overall Study|Study terminated by Sponsor|0|||
25150749|NCT01852292|50265220|FG001|Overall Study|Study terminated by Sponsor|1|||
25150750|NCT01852292|50265219|FG000|Overall Study|Progressive disease|42|||
25016486|NCT04052425|50111304|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
25016487|NCT04052425|50111305|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
25016488|NCT04052425|50111306|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
25016489|NCT04052425|50111303|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
25150751|NCT01852292|50265220|FG001|Overall Study|Progressive disease|52|||
25150752|NCT01715805|50265226|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
25150753|NCT01715805|50265227|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
25150754|NCT01715805|50265228|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
25150755|NCT01715805|50265229|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
25150756|NCT01715805|50265226|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
25150757|NCT01715805|50265227|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
25150758|NCT01715805|50265228|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
25150759|NCT01715805|50265229|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
25150760|NCT01715805|50265226|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
25150761|NCT01715805|50265227|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
25016490|NCT04052425|50111304|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
25016491|NCT04052425|50111305|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
25016492|NCT04052425|50111306|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
25016493|NCT04052425|50111303|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
25016494|NCT04052425|50111304|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
25016495|NCT04052425|50111305|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
25016496|NCT04052425|50111306|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
25016497|NCT04052425|50111303|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
25016498|NCT04052425|50111304|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
25016499|NCT04052425|50111305|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
25016500|NCT04052425|50111306|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
25016501|NCT04052425|50111303|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
25016502|NCT04052425|50111304|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
25016503|NCT04052425|50111305|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
25016504|NCT04052425|50111306|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
25016505|NCT04052425|50111303|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
25016506|NCT04052425|50111304|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
25016507|NCT04052425|50111305|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
25016508|NCT04052425|50111306|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
25016509|NCT04052425|50111303|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
25016510|NCT04052425|50111304|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
25016511|NCT04052425|50111305|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
25016512|NCT04052425|50111306|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
25016513|NCT03235089|50111316|FG000|Overall Study|Lost to Follow-up|1|||
25016514|NCT03235089|50111317|FG001|Overall Study|Lost to Follow-up|1|||
25016515|NCT03235089|50111316|FG000|Overall Study|Physician Decision|2|||
25016516|NCT03235089|50111317|FG001|Overall Study|Physician Decision|2|||
25016517|NCT04013191|50111326|FG000|Overall Study|Adverse Event|1|||
25016518|NCT04013191|50111327|FG001|Overall Study|Adverse Event|0|||
25016519|NCT03285594|50111340|FG000|Overall Study|At the Participant's Own Request|10|||
25016520|NCT03285594|50111341|FG001|Overall Study|At the Participant's Own Request|5|||
25016521|NCT03285594|50111342|FG002|Overall Study|At the Participant's Own Request|21|||
25016522|NCT03285594|50111340|FG000|Overall Study|Adverse Event|2|||
25016523|NCT03285594|50111341|FG001|Overall Study|Adverse Event|2|||
25016524|NCT03285594|50111342|FG002|Overall Study|Adverse Event|6|||
25016525|NCT03285594|50111340|FG000|Overall Study|Poor Compliance to Protocol|0|||
25016526|NCT03285594|50111341|FG001|Overall Study|Poor Compliance to Protocol|0|||
25016527|NCT03285594|50111342|FG002|Overall Study|Poor Compliance to Protocol|1|||
25150762|NCT01715805|50265228|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
25150763|NCT01715805|50265229|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
25150764|NCT01715805|50265226|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
25150765|NCT01715805|50265227|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
25016528|NCT03285594|50111340|FG000|Overall Study|Lost to Follow-up|0|||
25016529|NCT03285594|50111341|FG001|Overall Study|Lost to Follow-up|0|||
25016530|NCT03285594|50111342|FG002|Overall Study|Lost to Follow-up|1|||
25016531|NCT03285594|50111340|FG000|Overall Study|Reason Not Specified|3|||
25016532|NCT03285594|50111341|FG001|Overall Study|Reason Not Specified|4|||
25016533|NCT03285594|50111342|FG002|Overall Study|Reason Not Specified|8|||
25016534|NCT03234465|50111353|FG000|Overall Study|Adverse Event|4|||
25016535|NCT03234465|50111354|FG001|Overall Study|Adverse Event|2|||
25016536|NCT03234465|50111353|FG000|Overall Study|Death|0|||
25016537|NCT03234465|50111354|FG001|Overall Study|Death|1|||
25016538|NCT03234465|50111353|FG000|Overall Study|Lost to Follow-up|1|||
25016539|NCT03234465|50111354|FG001|Overall Study|Lost to Follow-up|1|||
25016540|NCT03234465|50111353|FG000|Overall Study|Withdrawal by Subject|12|||
25016541|NCT03234465|50111354|FG001|Overall Study|Withdrawal by Subject|27|||
25016542|NCT03234465|50111353|FG000|Overall Study|Symptomatic deterioration|0|||
25016543|NCT03234465|50111354|FG001|Overall Study|Symptomatic deterioration|1|||
25016544|NCT03234465|50111353|FG000|Overall Study|Non-compliance|2|||
25016545|NCT03234465|50111354|FG001|Overall Study|Non-compliance|0|||
25016546|NCT03234465|50111353|FG000|Overall Study|Other|14|||
25016547|NCT03234465|50111354|FG001|Overall Study|Other|8|||
25016548|NCT03290131|50111363|FG000|Overall Study|Adverse Event|22|||
25016549|NCT03290131|50111364|FG001|Overall Study|Adverse Event|57|||
25016550|NCT03290131|50111365|FG002|Overall Study|Adverse Event|11|||
25016551|NCT03290131|50111363|FG000|Overall Study|Withdrawal by Subject|18|||
25016552|NCT03290131|50111364|FG001|Overall Study|Withdrawal by Subject|13|||
25016553|NCT03290131|50111365|FG002|Overall Study|Withdrawal by Subject|8|||
25016554|NCT03290131|50111363|FG000|Overall Study|MS Relapse|2|||
25016555|NCT03290131|50111364|FG001|Overall Study|MS Relapse|1|||
25016556|NCT03290131|50111365|FG002|Overall Study|MS Relapse|0|||
25016557|NCT03290131|50111363|FG000|Overall Study|Unknown reason|0|||
25016558|NCT03290131|50111364|FG001|Overall Study|Unknown reason|1|||
25016559|NCT03290131|50111365|FG002|Overall Study|Unknown reason|0|||
25016560|NCT04050865|50111376|FG000|Overall Study|Adverse Event|1|||
25016561|NCT04050865|50111377|FG001|Overall Study|Adverse Event|0|||
25016562|NCT04050865|50111376|FG000|Overall Study|no insert|1|||
25016563|NCT04050865|50111377|FG001|Overall Study|no insert|0|||
25016564|NCT04050865|50111376|FG000|Overall Study|Only 1 insert|2|||
25016565|NCT04050865|50111377|FG001|Overall Study|Only 1 insert|3|||
25016566|NCT04050865|50111376|FG000|Overall Study|Physician Decision|0|||
25016567|NCT04050865|50111377|FG001|Overall Study|Physician Decision|1|||
25016568|NCT04050865|50111376|FG000|Overall Study|Withdrawal by Subject|0|||
25016569|NCT04050865|50111377|FG001|Overall Study|Withdrawal by Subject|1|||
25016570|NCT03283566|50111385|FG000|Overall Study|Lost to Follow-up|1|||
25016571|NCT03283566|50111386|FG001|Overall Study|Lost to Follow-up|2|||
25016572|NCT03210519|50111394|FG000|Overall Study|Adverse Event|2|||
25016573|NCT03210519|50111395|FG001|Overall Study|Adverse Event|0|||
25016574|NCT04048681|50111401|FG000|Overall Study|family emergency|0|||
25016575|NCT04048681|50111402|FG001|Overall Study|family emergency|0|||
25016576|NCT04048681|50111403|FG002|Overall Study|family emergency|0|||
25016577|NCT04048681|50111404|FG003|Overall Study|family emergency|1|||
25016578|NCT04048681|50111405|FG004|Overall Study|family emergency|0|||
25016579|NCT04007107|50111413|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
25016580|NCT04007107|50111414|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
25016581|NCT04007107|50111415|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
25016582|NCT04007107|50111416|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
25016583|NCT04046341|50111421|FG000|Overall Study|Lost to Follow-up|2|||
25016584|NCT04046341|50111421|FG000|Overall Study|Withdrawal by Subject|1|||
25016585|NCT03233529|50111425|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
25016586|NCT03233529|50111425|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
25016587|NCT04006171|50111435|FG000|Overall Study|Withdrawal by Subject|8|||
25016588|NCT04006171|50111436|FG001|Overall Study|Withdrawal by Subject|7|||
25016589|NCT04006171|50111435|FG000|Overall Study|missing serum samples|2|||
25016590|NCT04006171|50111436|FG001|Overall Study|missing serum samples|2|||
25016591|NCT04006171|50111435|FG000|Overall Study|insufficient sample volume|2|||
25016592|NCT04006171|50111436|FG001|Overall Study|insufficient sample volume|3|||
25016593|NCT04043143|50111449|FG000|Overall Study|Lost to Follow-up|5|||
25016594|NCT04043143|50111450|FG001|Overall Study|Lost to Follow-up|5|||
25016595|NCT04043143|50111449|FG000|Overall Study|screen failure|1|||
25016596|NCT04043143|50111450|FG001|Overall Study|screen failure|0|||
25016597|NCT03283098|50111458|FG000|Overall Study|Withdrawal by Subject|0|||
25016598|NCT03283098|50111459|FG001|Overall Study|Withdrawal by Subject|1|||
25016599|NCT03655951|50111467|FG000|Overall Study|Lost to Follow-up|39|||
25016600|NCT03655951|50111468|FG001|Overall Study|Lost to Follow-up|20|||
25016601|NCT03655951|50111467|FG000|Overall Study|Withdrawal by Subject|0|||
25016602|NCT03655951|50111468|FG001|Overall Study|Withdrawal by Subject|1|||
25016603|NCT02527798|50111480|FG000|Overall Study|Physician Decision|1|||
25016604|NCT02527798|50111481|FG001|Overall Study|Physician Decision|0|||
25150766|NCT01715805|50265228|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
25016605|NCT02527798|50111482|FG002|Overall Study|Physician Decision|1|||
25016606|NCT02527798|50111483|FG003|Overall Study|Physician Decision|1|||
25150767|NCT01715805|50265229|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
25150768|NCT01715805|50265226|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
25150769|NCT01715805|50265227|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
25016607|NCT02527798|50111484|FG004|Overall Study|Physician Decision|0|||
25016608|NCT02527798|50111485|FG005|Overall Study|Physician Decision|0|||
25016609|NCT02527798|50111480|FG000|Overall Study|Death|0|||
25016610|NCT02527798|50111481|FG001|Overall Study|Death|0|||
25016611|NCT02527798|50111482|FG002|Overall Study|Death|1|||
25016612|NCT02527798|50111483|FG003|Overall Study|Death|0|||
25016613|NCT02527798|50111484|FG004|Overall Study|Death|0|||
25016614|NCT02527798|50111485|FG005|Overall Study|Death|0|||
25016615|NCT02527798|50111480|FG000|Overall Study|Withdrawal by Subject|0|||
25016616|NCT02527798|50111481|FG001|Overall Study|Withdrawal by Subject|1|||
25016617|NCT02527798|50111482|FG002|Overall Study|Withdrawal by Subject|2|||
25016618|NCT02527798|50111483|FG003|Overall Study|Withdrawal by Subject|0|||
25016619|NCT02527798|50111484|FG004|Overall Study|Withdrawal by Subject|0|||
25016620|NCT02527798|50111485|FG005|Overall Study|Withdrawal by Subject|0|||
25016621|NCT02527798|50111480|FG000|Overall Study|Reason undisclosed|1|||
25016622|NCT02527798|50111481|FG001|Overall Study|Reason undisclosed|0|||
25016623|NCT02527798|50111482|FG002|Overall Study|Reason undisclosed|1|||
25016624|NCT02527798|50111483|FG003|Overall Study|Reason undisclosed|0|||
25016625|NCT02527798|50111484|FG004|Overall Study|Reason undisclosed|0|||
25016626|NCT02527798|50111485|FG005|Overall Study|Reason undisclosed|0|||
25016627|NCT02527798|50111480|FG000|Overall Study|Did not receive intervention|1|||
25016628|NCT02527798|50111481|FG001|Overall Study|Did not receive intervention|1|||
25016629|NCT02527798|50111482|FG002|Overall Study|Did not receive intervention|0|||
25016630|NCT02527798|50111483|FG003|Overall Study|Did not receive intervention|0|||
25016631|NCT02527798|50111484|FG004|Overall Study|Did not receive intervention|0|||
25016632|NCT02527798|50111485|FG005|Overall Study|Did not receive intervention|0|||
25016633|NCT03188991|50111516|FG000|Overall Study|Withdrawal by Subject|0|||
25016634|NCT03188991|50111517|FG001|Overall Study|Withdrawal by Subject|0|||
25016635|NCT03188991|50111518|FG002|Overall Study|Withdrawal by Subject|0|||
25016636|NCT03188991|50111519|FG003|Overall Study|Withdrawal by Subject|1|||
25016637|NCT03857542|50111531|FG000|Overall Study|Adverse Event|1|||
25016638|NCT03857542|50111532|FG001|Overall Study|Adverse Event|3|||
25016639|NCT03857542|50111531|FG000|Overall Study|Withdrawal by Subject|2|||
25016640|NCT03857542|50111532|FG001|Overall Study|Withdrawal by Subject|1|||
25016641|NCT03857542|50111531|FG000|Overall Study|Lost to Follow-up|2|||
25016642|NCT03857542|50111532|FG001|Overall Study|Lost to Follow-up|1|||
25016643|NCT03857542|50111531|FG000|Overall Study|Reason not Specified|1|||
25016644|NCT03857542|50111532|FG001|Overall Study|Reason not Specified|0|||
25016645|NCT03209973|50111539|FG000|Overall Study|Withdrawal by Subject|7|||
25016646|NCT03209973|50111539|FG000|Overall Study|Lost to Follow-up|2|||
25016647|NCT03209973|50111539|FG000|Overall Study|Death|8|||
25016648|NCT03209973|50111539|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
25016649|NCT03209973|50111539|FG000|Overall Study|Sponsor Decision|18|||
25016650|NCT03209973|50111539|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
25016651|NCT03209973|50111539|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
25016652|NCT03751631|50111545|FG000|Overall Study|Withdrawal by Subject|0|||
25016653|NCT03751631|50111546|FG001|Overall Study|Withdrawal by Subject|0|||
25016654|NCT03751631|50111547|FG002|Overall Study|Withdrawal by Subject|1|||
25016655|NCT03751631|50111548|FG003|Overall Study|Withdrawal by Subject|1|||
25016656|NCT03751631|50111549|FG004|Overall Study|Withdrawal by Subject|0|||
25016657|NCT03751631|50111550|FG005|Overall Study|Withdrawal by Subject|0|||
25016658|NCT03688711|50111563|FG000|Overall Study|Withdrawal by Subject|0|||
25016659|NCT03688711|50111564|FG001|Overall Study|Withdrawal by Subject|1|||
25016660|NCT03188055|50111572|FG000|Overall Study|Unavailable for training|0|||
25016661|NCT03188055|50111573|FG001|Overall Study|Unavailable for training|0|||
25016662|NCT03188055|50111574|FG002|Overall Study|Unavailable for training|19|||
25016663|NCT03188055|50111575|FG003|Overall Study|Unavailable for training|0|||
25016664|NCT03188055|50111576|FG004|Overall Study|Unavailable for training|0|||
25016665|NCT03188055|50111577|FG005|Overall Study|Unavailable for training||||
25016666|NCT03188055|50111572|FG000|Overall Study|Lost to Follow-up|0|||
25016667|NCT03188055|50111573|FG001|Overall Study|Lost to Follow-up|18|||
25016668|NCT03188055|50111574|FG002|Overall Study|Lost to Follow-up|0|||
25016669|NCT03188055|50111575|FG003|Overall Study|Lost to Follow-up|11|||
25016670|NCT03188055|50111576|FG004|Overall Study|Lost to Follow-up|0|||
25016671|NCT03188055|50111577|FG005|Overall Study|Lost to Follow-up||||
25016672|NCT03188055|50111572|FG000|Overall Study|Withdrawal by Subject|0|||
25016673|NCT03188055|50111573|FG001|Overall Study|Withdrawal by Subject|1|||
25016674|NCT03188055|50111574|FG002|Overall Study|Withdrawal by Subject|0|||
25016675|NCT03188055|50111575|FG003|Overall Study|Withdrawal by Subject|1|||
25016676|NCT03188055|50111576|FG004|Overall Study|Withdrawal by Subject|0|||
25016677|NCT03188055|50111577|FG005|Overall Study|Withdrawal by Subject||||
25016678|NCT04035577|50111588|FG000|Overall Study|Lost to Follow-up|1|||
25016679|NCT04035577|50111588|FG000|Overall Study|Withdrawal by Subject|1|||
25016680|NCT03655717|50111616|FG000|Overall Study|Withdrawal by Subject|4|||
25016681|NCT03655717|50111617|FG001|Overall Study|Withdrawal by Subject|8|||
25016682|NCT03655717|50111618|FG002|Overall Study|Withdrawal by Subject|1|||
25016683|NCT03655717|50111619|FG003|Overall Study|Withdrawal by Subject|0|||
25016684|NCT03655717|50111620|FG004|Overall Study|Withdrawal by Subject|0|||
25016685|NCT03655717|50111621|FG005|Overall Study|Withdrawal by Subject|1|||
25016686|NCT03655717|50111622|FG006|Overall Study|Withdrawal by Subject|3|||
25016687|NCT03655717|50111623|FG007|Overall Study|Withdrawal by Subject|1|||
25016688|NCT03655717|50111624|FG008|Overall Study|Withdrawal by Subject|2|||
25016689|NCT03655717|50111625|FG009|Overall Study|Withdrawal by Subject|0|||
25016690|NCT03655717|50111626|FG010|Overall Study|Withdrawal by Subject|0|||
25016691|NCT03655717|50111627|FG011|Overall Study|Withdrawal by Subject|1|||
25016692|NCT03655717|50111628|FG012|Overall Study|Withdrawal by Subject|0|||
25016693|NCT03655717|50111629|FG013|Overall Study|Withdrawal by Subject|3|||
25016694|NCT03655717|50111630|FG014|Overall Study|Withdrawal by Subject|0|||
25016695|NCT03655717|50111631|FG015|Overall Study|Withdrawal by Subject|1|||
25016696|NCT03655717|50111632|FG016|Overall Study|Withdrawal by Subject|0|||
25150770|NCT01715805|50265228|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
25150771|NCT01715805|50265229|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
25150772|NCT01715805|50265226|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
25150773|NCT01715805|50265227|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
25150774|NCT01715805|50265228|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
25150775|NCT01715805|50265229|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
25150776|NCT01715805|50265226|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
25150777|NCT01715805|50265227|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
25150778|NCT01715805|50265228|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
25150779|NCT01715805|50265229|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
25150780|NCT01715805|50265226|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
25150781|NCT01715805|50265227|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
25150782|NCT01715805|50265228|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
25016697|NCT03655717|50111633|FG017|Overall Study|Withdrawal by Subject|0|||
25016698|NCT03655717|50111634|FG018|Overall Study|Withdrawal by Subject|1|||
25016699|NCT03655717|50111635|FG019|Overall Study|Withdrawal by Subject|0|||
25016700|NCT03655717|50111636|FG020|Overall Study|Withdrawal by Subject|0|||
25016701|NCT03655717|50111637|FG021|Overall Study|Withdrawal by Subject|1|||
25016702|NCT03655717|50111638|FG022|Overall Study|Withdrawal by Subject|2|||
25016703|NCT03655717|50111639|FG023|Overall Study|Withdrawal by Subject|1|||
25016704|NCT03655717|50111640|FG024|Overall Study|Withdrawal by Subject|1|||
25016705|NCT03655717|50111641|FG025|Overall Study|Withdrawal by Subject|0|||
25016706|NCT03655717|50111616|FG000|Overall Study|Physician Decision|3|||
25016707|NCT03655717|50111617|FG001|Overall Study|Physician Decision|3|||
25016708|NCT03655717|50111618|FG002|Overall Study|Physician Decision|0|||
25016709|NCT03655717|50111619|FG003|Overall Study|Physician Decision|0|||
25016710|NCT03655717|50111620|FG004|Overall Study|Physician Decision|0|||
25016711|NCT03655717|50111621|FG005|Overall Study|Physician Decision|0|||
25016712|NCT03655717|50111622|FG006|Overall Study|Physician Decision|0|||
25016713|NCT03655717|50111623|FG007|Overall Study|Physician Decision|0|||
25016714|NCT03655717|50111624|FG008|Overall Study|Physician Decision|0|||
25016715|NCT03655717|50111625|FG009|Overall Study|Physician Decision|1|||
25016716|NCT03655717|50111626|FG010|Overall Study|Physician Decision|0|||
25016717|NCT03655717|50111627|FG011|Overall Study|Physician Decision|0|||
25016718|NCT03655717|50111628|FG012|Overall Study|Physician Decision|0|||
25016719|NCT03655717|50111629|FG013|Overall Study|Physician Decision|0|||
25016720|NCT03655717|50111630|FG014|Overall Study|Physician Decision|0|||
25016721|NCT03655717|50111631|FG015|Overall Study|Physician Decision|0|||
25184791|NCT04591626|50333752|FG000|Overall Study|Withdrawal by Subject|5|||
25016722|NCT03655717|50111632|FG016|Overall Study|Physician Decision|0|||
25016723|NCT03655717|50111633|FG017|Overall Study|Physician Decision|0|||
25016724|NCT03655717|50111634|FG018|Overall Study|Physician Decision|0|||
25016725|NCT03655717|50111635|FG019|Overall Study|Physician Decision|1|||
25016726|NCT03655717|50111636|FG020|Overall Study|Physician Decision|0|||
25016727|NCT03655717|50111637|FG021|Overall Study|Physician Decision|0|||
25016728|NCT03655717|50111638|FG022|Overall Study|Physician Decision|0|||
25016729|NCT03655717|50111639|FG023|Overall Study|Physician Decision|1|||
25016730|NCT03655717|50111640|FG024|Overall Study|Physician Decision|0|||
25016731|NCT03655717|50111641|FG025|Overall Study|Physician Decision|0|||
25016732|NCT03655717|50111616|FG000|Overall Study|Lost to Follow-up|3|||
25016733|NCT03655717|50111617|FG001|Overall Study|Lost to Follow-up|1|||
25016734|NCT03655717|50111618|FG002|Overall Study|Lost to Follow-up|0|||
25016735|NCT03655717|50111619|FG003|Overall Study|Lost to Follow-up|1|||
25016736|NCT03655717|50111620|FG004|Overall Study|Lost to Follow-up|0|||
25016737|NCT03655717|50111621|FG005|Overall Study|Lost to Follow-up|1|||
25016738|NCT03655717|50111622|FG006|Overall Study|Lost to Follow-up|0|||
25016739|NCT03655717|50111623|FG007|Overall Study|Lost to Follow-up|0|||
25016740|NCT03655717|50111624|FG008|Overall Study|Lost to Follow-up|0|||
25016741|NCT03655717|50111625|FG009|Overall Study|Lost to Follow-up|0|||
25016742|NCT03655717|50111626|FG010|Overall Study|Lost to Follow-up|0|||
25016743|NCT03655717|50111627|FG011|Overall Study|Lost to Follow-up|1|||
25016744|NCT03655717|50111628|FG012|Overall Study|Lost to Follow-up|0|||
25016745|NCT03655717|50111629|FG013|Overall Study|Lost to Follow-up|0|||
25150783|NCT01715805|50265229|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
25016746|NCT03655717|50111630|FG014|Overall Study|Lost to Follow-up|0|||
25016747|NCT03655717|50111631|FG015|Overall Study|Lost to Follow-up|0|||
25016748|NCT03655717|50111632|FG016|Overall Study|Lost to Follow-up|0|||
25016749|NCT03655717|50111633|FG017|Overall Study|Lost to Follow-up|0|||
25016750|NCT03655717|50111634|FG018|Overall Study|Lost to Follow-up|0|||
25016751|NCT03655717|50111635|FG019|Overall Study|Lost to Follow-up|0|||
25016752|NCT03655717|50111636|FG020|Overall Study|Lost to Follow-up|0|||
25016753|NCT03655717|50111637|FG021|Overall Study|Lost to Follow-up|0|||
25016754|NCT03655717|50111638|FG022|Overall Study|Lost to Follow-up|0|||
25016755|NCT03655717|50111639|FG023|Overall Study|Lost to Follow-up|0|||
25016756|NCT03655717|50111640|FG024|Overall Study|Lost to Follow-up|0|||
25016757|NCT03655717|50111641|FG025|Overall Study|Lost to Follow-up|0|||
25016758|NCT04032613|50111657|FG000|Overall Study|Did not complete post-program assessment|5|||
25016759|NCT04032613|50111658|FG001|Overall Study|Did not complete post-program assessment|2|||
25016760|NCT04000165|50111664|FG000|Overall Study|Physician Decision|1|||
25016761|NCT04000165|50111664|FG000|Overall Study|Withdrawal by Subject|1|||
25016762|NCT03187197|50111671|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
25016763|NCT03187197|50111672|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
25016764|NCT03187197|50111673|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
25016765|NCT03187197|50111671|FG000|Overall Study|Withdrawal by Subject|8|||
25150784|NCT01715805|50265226|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
25150785|NCT01715805|50265227|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
25150786|NCT01715805|50265228|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
25150787|NCT01715805|50265229|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
25150788|NCT01715805|50265226|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
25150789|NCT01715805|50265227|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
25150790|NCT01715805|50265228|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
25150791|NCT01715805|50265229|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
25150792|NCT01715805|50265226|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
25150793|NCT01715805|50265227|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
25150794|NCT01715805|50265228|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
25150795|NCT01715805|50265229|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
25150796|NCT01715805|50265226|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
25150797|NCT01715805|50265227|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
25150798|NCT01715805|50265228|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
25150799|NCT01715805|50265229|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
25150800|NCT01715805|50265226|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
25150801|NCT01715805|50265227|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
25150802|NCT01715805|50265228|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
25184792|NCT04591626|50333753|FG001|Overall Study|Withdrawal by Subject|3|||
25184793|NCT04591626|50333752|FG000|Overall Study|Physician Decision|0|||
25150803|NCT01715805|50265229|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
25184794|NCT04591626|50333753|FG001|Overall Study|Physician Decision|1|||
25274669|NCT01250873|50588711|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
25016766|NCT03187197|50111672|FG001|Overall Study|Withdrawal by Subject|63|||
25016767|NCT03187197|50111673|FG002|Overall Study|Withdrawal by Subject|4|||
25016768|NCT03187197|50111671|FG000|Overall Study|Lost to Follow-up|1|||
25016769|NCT03187197|50111672|FG001|Overall Study|Lost to Follow-up|60|||
25016770|NCT03187197|50111673|FG002|Overall Study|Lost to Follow-up|7|||
25016771|NCT03187197|50111671|FG000|Overall Study|Adverse Event|6|||
25016772|NCT03187197|50111672|FG001|Overall Study|Adverse Event|29|||
25016773|NCT03187197|50111673|FG002|Overall Study|Adverse Event|0|||
25016774|NCT03187197|50111671|FG000|Overall Study|Death|0|||
25016775|NCT03187197|50111672|FG001|Overall Study|Death|11|||
25016776|NCT03187197|50111673|FG002|Overall Study|Death|0|||
25016777|NCT03187197|50111671|FG000|Overall Study|Administrative problem|1|||
25016778|NCT03187197|50111672|FG001|Overall Study|Administrative problem|1|||
25016779|NCT03187197|50111673|FG002|Overall Study|Administrative problem|0|||
25016780|NCT03187197|50111671|FG000|Overall Study|Reason not listed|2|||
25016781|NCT03187197|50111672|FG001|Overall Study|Reason not listed|54|||
25016782|NCT03187197|50111673|FG002|Overall Study|Reason not listed|1|||
25016783|NCT03187197|50111671|FG000|Overall Study|Missing|1|||
25016784|NCT03187197|50111672|FG001|Overall Study|Missing|32|||
25016785|NCT03187197|50111673|FG002|Overall Study|Missing|3|||
25016786|NCT03187197|50111671|FG000|Overall Study|Status missing|2|||
25016787|NCT03187197|50111672|FG001|Overall Study|Status missing|33|||
25016788|NCT03187197|50111673|FG002|Overall Study|Status missing|3|||
25016789|NCT03187197|50111671|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
25016790|NCT03187197|50111672|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
25016791|NCT03187197|50111673|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
25016792|NCT04000009|50111681|FG000|Overall Study|Adverse Event|13|||
25016793|NCT04000009|50111681|FG000|Overall Study|Lack of Efficacy|7|||
25016794|NCT04000009|50111681|FG000|Overall Study|Lost to Follow-up|8|||
25016795|NCT04000009|50111681|FG000|Overall Study|Noncompliance with study drug|4|||
25016796|NCT04000009|50111681|FG000|Overall Study|Physician Decision|1|||
25016797|NCT04000009|50111681|FG000|Overall Study|Use of prohibited medication|3|||
25016798|NCT04000009|50111681|FG000|Overall Study|Pregnancy|1|||
25016799|NCT04000009|50111681|FG000|Overall Study|Withdrawal by Subject|22|||
25016800|NCT04000009|50111681|FG000|Overall Study|Study terminated by sponsor|98|||
25016801|NCT04000009|50111681|FG000|Overall Study|Not further specified|8|||
25016802|NCT03282240|50111688|FG000|Overall Study|Adverse Event|2|||
25016803|NCT03282240|50111689|FG001|Overall Study|Adverse Event|2|||
25150804|NCT01715805|50265226|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
25150805|NCT01715805|50265227|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
25150806|NCT01715805|50265228|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
25150807|NCT01715805|50265229|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
25150808|NCT01852214|50265237|FG000|Period 1|Adverse Event|1|||
25150809|NCT01852214|50265238|FG001|Period 1|Adverse Event|2|||
25150810|NCT01852214|50265237|FG000|Period 1|Withdrawal by Subject|0|||
25150811|NCT01852214|50265238|FG001|Period 1|Withdrawal by Subject|1|||
25184795|NCT04591626|50333752|FG000|Overall Study|Death|0|||
25184796|NCT04591626|50333753|FG001|Overall Study|Death|1|||
25016804|NCT03282240|50111690|FG002|Overall Study|Adverse Event|0|||
25016805|NCT03282240|50111688|FG000|Overall Study|Lost to Follow-up|3|||
25016806|NCT03282240|50111689|FG001|Overall Study|Lost to Follow-up|0|||
25016807|NCT03282240|50111690|FG002|Overall Study|Lost to Follow-up|0|||
25016808|NCT03282240|50111688|FG000|Overall Study|Protocol Deviation|4|||
25016809|NCT03282240|50111689|FG001|Overall Study|Protocol Deviation|1|||
25016810|NCT03282240|50111690|FG002|Overall Study|Protocol Deviation|2|||
25016811|NCT03282240|50111688|FG000|Overall Study|Withdrawal by Subject|1|||
25150812|NCT01852214|50265237|FG000|Washout Period|Withdrawal by Subject|0|||
25150813|NCT01852214|50265238|FG001|Washout Period|Withdrawal by Subject|1|||
25150814|NCT01393990|50265263|FG000|Overall Study|Adverse Event|0|||
25150815|NCT01393990|50265264|FG001|Overall Study|Adverse Event|0|||
25150816|NCT01393990|50265265|FG002|Overall Study|Adverse Event|0|||
25150817|NCT01393990|50265266|FG003|Overall Study|Adverse Event|0|||
25150818|NCT01393990|50265267|FG004|Overall Study|Adverse Event|0|||
25150819|NCT01393990|50265268|FG005|Overall Study|Adverse Event|0|||
25150820|NCT01393990|50265269|FG006|Overall Study|Adverse Event|0|||
25150821|NCT01393990|50265270|FG007|Overall Study|Adverse Event|0|||
25150822|NCT01393990|50265271|FG008|Overall Study|Adverse Event|0|||
25150823|NCT01393990|50265272|FG009|Overall Study|Adverse Event|0|||
25150824|NCT01393990|50265273|FG010|Overall Study|Adverse Event|0|||
25150825|NCT01393990|50265274|FG011|Overall Study|Adverse Event|0|||
25016812|NCT03282240|50111689|FG001|Overall Study|Withdrawal by Subject|0|||
25016813|NCT03282240|50111690|FG002|Overall Study|Withdrawal by Subject|1|||
25016814|NCT03185949|50111703|FG000|ITT Analysis|Withdrawal by Subject|4|||
25016815|NCT03185949|50111704|FG001|ITT Analysis|Withdrawal by Subject|3|||
25016816|NCT03185949|50111703|FG000|PP Analysis|Protocol Violation|2|||
25016817|NCT03185949|50111704|FG001|PP Analysis|Protocol Violation|2|||
25016818|NCT03185949|50111703|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
25016819|NCT03185949|50111704|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
25016820|NCT03655405|50111714|FG000|Overall Study|Death after initial data collection|4|||
25016821|NCT03655405|50111715|FG001|Overall Study|Death after initial data collection|2|||
25016822|NCT03655405|50111714|FG000|Overall Study|Died before initial data collection|1|||
25016823|NCT03655405|50111715|FG001|Overall Study|Died before initial data collection|2|||
25016824|NCT03655405|50111714|FG000|Overall Study|Protocol Violation|0|||
25016825|NCT03655405|50111715|FG001|Overall Study|Protocol Violation|1|||
25016826|NCT03510598|50111721|FG000|Overall Study|Withdrawal by Subject|1|||
25150826|NCT01393990|50265275|FG012|Overall Study|Adverse Event|0|||
25150827|NCT01393990|50265276|FG013|Overall Study|Adverse Event|0|||
25150828|NCT01393990|50265277|FG014|Overall Study|Adverse Event|1|||
25150829|NCT01393990|50265278|FG015|Overall Study|Adverse Event|1|||
25150830|NCT01393990|50265279|FG016|Overall Study|Adverse Event|0|||
25016827|NCT03222141|50111725|FG000|Overall Study|Death|15|||
25016828|NCT03222141|50111725|FG000|Overall Study|Lost to Follow-up|3|||
25016829|NCT04029961|50111732|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
25016830|NCT04029961|50111733|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
25016831|NCT04029961|50111732|FG000|Overall Study|Change in Treatment Course|0|||
25016832|NCT04029961|50111733|FG001|Overall Study|Change in Treatment Course|1|||
25016833|NCT03997825|50111739|FG000|Overall Study|Death|3|||
25150831|NCT01393990|50265280|FG017|Overall Study|Adverse Event|0|||
25150832|NCT01393990|50265263|FG000|Overall Study|Progressive Disease|1|||
25016834|NCT03997825|50111739|FG000|Overall Study|Lost to Follow-up|10|||
25016835|NCT03997825|50111739|FG000|Overall Study|Withdrawal by Subject|3|||
25016836|NCT03997825|50111739|FG000|Overall Study|Refused participation|1|||
25016837|NCT04024891|50111745|FG000|Overall Study|Pregnancy|0|||
25016838|NCT04024891|50111746|FG001|Overall Study|Pregnancy|1|||
25016839|NCT03250182|50111752|FG000|Overall Study|Withdrawal by Subject|1|||
25150833|NCT01393990|50265264|FG001|Overall Study|Progressive Disease|0|||
25016840|NCT03993379|50111760|FG000|Overall Study|The study was terminated early due to business decision.|0|||
25016841|NCT03993379|50111761|FG001|Overall Study|The study was terminated early due to business decision.|2|||
25016842|NCT03993379|50111762|FG002|Overall Study|The study was terminated early due to business decision.|0|||
25016843|NCT03993379|50111763|FG003|Overall Study|The study was terminated early due to business decision.|0|||
25016844|NCT03993379|50111760|FG000|Overall Study|Withdrawal by Subject|0|||
25016845|NCT03993379|50111761|FG001|Overall Study|Withdrawal by Subject|1|||
25016846|NCT03993379|50111762|FG002|Overall Study|Withdrawal by Subject|0|||
25016847|NCT03993379|50111763|FG003|Overall Study|Withdrawal by Subject|0|||
25016848|NCT03370120|50111773|FG000|Overall Study|Adverse event, non-fatal|24|||
25016849|NCT03370120|50111773|FG000|Overall Study|Withdrawal by Subject|6|||
25016850|NCT03370120|50111773|FG000|Overall Study|Lost to Follow-up|1|||
25016851|NCT03370120|50111773|FG000|Overall Study|Lack of Efficacy|37|||
25016852|NCT03370120|50111773|FG000|Overall Study|Per sponsor's instructions|1|||
25016853|NCT03370120|50111773|FG000|Overall Study|Study was terminated by parent company UCB|2|||
25016854|NCT03370120|50111773|FG000|Overall Study|The study was ended by the promoter|3|||
25016855|NCT03370120|50111773|FG000|Overall Study|Discontinuation of drug development|3|||
25016856|NCT03370120|50111773|FG000|Overall Study|End of project|2|||
25016857|NCT03370120|50111773|FG000|Overall Study|Premature study closure|2|||
25016858|NCT03370120|50111773|FG000|Overall Study|Premature program termination|1|||
25016859|NCT03370120|50111773|FG000|Overall Study|Premature study termination|7|||
25016860|NCT03370120|50111773|FG000|Overall Study|Trial terminated by sponsor|2|||
25016861|NCT03370120|50111773|FG000|Overall Study|Trial discontinued by sponsor|2|||
25016862|NCT03370120|50111773|FG000|Overall Study|Study ended|15|||
25016863|NCT03370120|50111773|FG000|Overall Study|Clinical trial has been cancelled|1|||
25016864|NCT03370120|50111773|FG000|Overall Study|End of study per sponsor decision|2|||
25016865|NCT03370120|50111773|FG000|Overall Study|Promoter's decision|2|||
25016866|NCT03370120|50111773|FG000|Overall Study|The trial has been suspended|3|||
25016867|NCT03370120|50111773|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
25016868|NCT03370120|50111773|FG000|Overall Study|Early termination by order of sponsor|2|||
25016869|NCT03370120|50111773|FG000|Overall Study|Discontinuation of the study|5|||
25016870|NCT03370120|50111773|FG000|Overall Study|End of clinical trial discontinuation|1|||
25016871|NCT03370120|50111773|FG000|Overall Study|Because the clinical trial ended halfway|4|||
25016872|NCT03370120|50111773|FG000|Overall Study|Development discontinued|5|||
25016873|NCT03370120|50111773|FG000|Overall Study|Padsenovil program closed|3|||
25016874|NCT03370120|50111773|FG000|Overall Study|End of project|2|||
25016875|NCT03370120|50111773|FG000|Overall Study|Termination of project|1|||
25016876|NCT03370120|50111773|FG000|Overall Study|The study was interrupted by sponsor|4|||
25016877|NCT03370120|50111773|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
25016878|NCT03370120|50111773|FG000|Overall Study|End of sponsor decision|1|||
25016879|NCT03370120|50111773|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
25016880|NCT03370120|50111773|FG000|Overall Study|Early termination of studies|5|||
25016881|NCT03370120|50111773|FG000|Overall Study|This study is ended early|1|||
25016882|NCT03370120|50111773|FG000|Overall Study|End of padsevonil program|2|||
25016883|NCT03370120|50111773|FG000|Overall Study|Decision of sponsor|6|||
25016884|NCT03370120|50111773|FG000|Overall Study|Asked by the sponsor|3|||
25016885|NCT03370120|50111773|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
25016886|NCT03370120|50111773|FG000|Overall Study|PI decision poor compliance from participant|1|||
25016887|NCT03370120|50111773|FG000|Overall Study|Promoter ended the study|3|||
25016888|NCT03370120|50111773|FG000|Overall Study|Premature study close by sponsor's decision|4|||
25016889|NCT03370120|50111773|FG000|Overall Study|Study terminated by sponsor|33|||
25016890|NCT03370120|50111773|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
25016891|NCT03370120|50111773|FG000|Overall Study|Sponsor decision to terminate study|63|||
25016892|NCT03370120|50111773|FG000|Overall Study|Program closure|3|||
25016893|NCT03370120|50111773|FG000|Overall Study|Study ended prematurely|1|||
25016894|NCT03370120|50111773|FG000|Overall Study|Study stopped by sponsor|2|||
25016895|NCT03370120|50111773|FG000|Overall Study|Program termination|55|||
25016896|NCT03370120|50111773|FG000|Overall Study|Sponsor decision|62|||
25016897|NCT03370120|50111773|FG000|Overall Study|Sponsor study closure|10|||
25016898|NCT03247686|50111781|FG000|Overall Study|Withdrawal by Subject|1|||
25016899|NCT03247686|50111782|FG001|Overall Study|Withdrawal by Subject|2|||
25016900|NCT03990649|50111793|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
25016901|NCT03990649|50111794|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
25016902|NCT03990649|50111795|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
25016903|NCT03990649|50111793|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
25016904|NCT03990649|50111794|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
25016905|NCT03990649|50111795|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
25016906|NCT03990649|50111793|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
25016907|NCT03990649|50111794|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
25150834|NCT01393990|50265265|FG002|Overall Study|Progressive Disease|0|||
25016908|NCT03990649|50111795|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
25016909|NCT03990649|50111793|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
25016910|NCT03990649|50111794|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
25016911|NCT03990649|50111795|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
25016912|NCT03990649|50111793|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
25016913|NCT03990649|50111794|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
25016914|NCT03990649|50111795|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
25150835|NCT01393990|50265266|FG003|Overall Study|Progressive Disease|1|||
25150836|NCT01393990|50265267|FG004|Overall Study|Progressive Disease|1|||
25016915|NCT03990649|50111793|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
25016916|NCT03990649|50111794|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
25016917|NCT03990649|50111795|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
25150837|NCT01393990|50265268|FG005|Overall Study|Progressive Disease|1|||
25016918|NCT03990649|50111793|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
25016919|NCT03990649|50111794|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
25016920|NCT03990649|50111795|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
25150838|NCT01393990|50265269|FG006|Overall Study|Progressive Disease|1|||
25274670|NCT01250873|50588711|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
25150839|NCT01393990|50265270|FG007|Overall Study|Progressive Disease|1|||
25150840|NCT01393990|50265271|FG008|Overall Study|Progressive Disease|3|||
25184797|NCT04591626|50333752|FG000|Overall Study|Non-Compliance with Study Drug|1|||
25184798|NCT04591626|50333753|FG001|Overall Study|Non-Compliance with Study Drug|0|||
25187778|NCT03593213|50338761|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
25150841|NCT01393990|50265272|FG009|Overall Study|Progressive Disease|1|||
25150842|NCT01393990|50265273|FG010|Overall Study|Progressive Disease|0|||
25150843|NCT01393990|50265274|FG011|Overall Study|Progressive Disease|0|||
25150844|NCT01393990|50265275|FG012|Overall Study|Progressive Disease|0|||
25150845|NCT01393990|50265276|FG013|Overall Study|Progressive Disease|1|||
25150846|NCT01393990|50265277|FG014|Overall Study|Progressive Disease|6|||
25150847|NCT01393990|50265278|FG015|Overall Study|Progressive Disease|1|||
25150848|NCT01393990|50265279|FG016|Overall Study|Progressive Disease|0|||
25150849|NCT01393990|50265280|FG017|Overall Study|Progressive Disease|0|||
25150850|NCT01393990|50265263|FG000|Overall Study|Death|0|||
25150851|NCT01393990|50265264|FG001|Overall Study|Death|0|||
25150852|NCT01393990|50265265|FG002|Overall Study|Death|0|||
25150853|NCT01393990|50265266|FG003|Overall Study|Death|0|||
25150854|NCT01393990|50265267|FG004|Overall Study|Death|1|||
25150855|NCT01393990|50265268|FG005|Overall Study|Death|0|||
25150856|NCT01393990|50265269|FG006|Overall Study|Death|0|||
25150857|NCT01393990|50265270|FG007|Overall Study|Death|0|||
25150858|NCT01393990|50265271|FG008|Overall Study|Death|0|||
25150859|NCT01393990|50265272|FG009|Overall Study|Death|0|||
25150860|NCT01393990|50265273|FG010|Overall Study|Death|0|||
25150861|NCT01393990|50265274|FG011|Overall Study|Death|0|||
25150862|NCT01393990|50265275|FG012|Overall Study|Death|0|||
25150863|NCT01393990|50265276|FG013|Overall Study|Death|1|||
25150864|NCT01393990|50265277|FG014|Overall Study|Death|1|||
25150865|NCT01393990|50265278|FG015|Overall Study|Death|0|||
25150866|NCT01393990|50265279|FG016|Overall Study|Death|0|||
25150867|NCT01393990|50265280|FG017|Overall Study|Death|0|||
25150868|NCT01393990|50265263|FG000|Overall Study|Withdrawal by Subject|0|||
25150869|NCT01393990|50265264|FG001|Overall Study|Withdrawal by Subject|0|||
25150870|NCT01393990|50265265|FG002|Overall Study|Withdrawal by Subject|0|||
25150871|NCT01393990|50265266|FG003|Overall Study|Withdrawal by Subject|0|||
25150872|NCT01393990|50265267|FG004|Overall Study|Withdrawal by Subject|0|||
25150873|NCT01393990|50265268|FG005|Overall Study|Withdrawal by Subject|0|||
25150874|NCT01393990|50265269|FG006|Overall Study|Withdrawal by Subject|0|||
25150875|NCT01393990|50265270|FG007|Overall Study|Withdrawal by Subject|0|||
25150876|NCT01393990|50265271|FG008|Overall Study|Withdrawal by Subject|0|||
25150877|NCT01393990|50265272|FG009|Overall Study|Withdrawal by Subject|0|||
25150878|NCT01393990|50265273|FG010|Overall Study|Withdrawal by Subject|0|||
25150879|NCT01393990|50265274|FG011|Overall Study|Withdrawal by Subject|0|||
25150880|NCT01393990|50265275|FG012|Overall Study|Withdrawal by Subject|0|||
25150881|NCT01393990|50265276|FG013|Overall Study|Withdrawal by Subject|0|||
25150882|NCT01393990|50265277|FG014|Overall Study|Withdrawal by Subject|1|||
25150883|NCT01393990|50265278|FG015|Overall Study|Withdrawal by Subject|1|||
25150884|NCT01393990|50265279|FG016|Overall Study|Withdrawal by Subject|0|||
25150885|NCT01393990|50265280|FG017|Overall Study|Withdrawal by Subject|0|||
25150886|NCT00210184|50265329|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
25150887|NCT00210106|50265333|FG000|Overall Study|Death|1|||
25150888|NCT00210106|50265333|FG000|Overall Study|Protocol Violation|13|||
25150889|NCT01852058|50265341|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
25150890|NCT01852058|50265342|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
25150891|NCT01852058|50265343|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
25150892|NCT01852058|50265344|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
25150893|NCT01852058|50265345|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
25150894|NCT01852058|50265346|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
25150895|NCT01852058|50265347|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
25150896|NCT01852058|50265348|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
25150897|NCT01852058|50265349|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
25150898|NCT01852058|50265350|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
25150899|NCT01852058|50265351|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
25150900|NCT01852058|50265352|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
25150901|NCT01852058|50265341|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
25150902|NCT01852058|50265342|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
25150903|NCT01852058|50265343|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
25274671|NCT01250171|50588720|FG000|Overall Study|Administrative reasons|1|||
25274672|NCT01250171|50588721|FG001|Overall Study|Administrative reasons|0|||
25274673|NCT01250171|50588722|FG002|Overall Study|Administrative reasons|0|||
25274674|NCT01077063|50588732|FG000|Overall Study|Adverse Event|3|||
25274675|NCT01077063|50588733|FG001|Overall Study|Adverse Event|0|||
25274676|NCT01077063|50588732|FG000|Overall Study|Death|1|||
25274677|NCT01077063|50588733|FG001|Overall Study|Death|1|||
25274678|NCT01077063|50588732|FG000|Overall Study|Withdrawal by Subject|0|||
25274679|NCT01077063|50588733|FG001|Overall Study|Withdrawal by Subject|2|||
25274680|NCT01248065|50588741|FG000|Overall Study|Lost to Follow-up|3|||
25274681|NCT01248065|50588742|FG001|Overall Study|Lost to Follow-up|5|||
25274682|NCT01248065|50588741|FG000|Overall Study|Withdrawal by Subject|14|||
25274683|NCT01248065|50588742|FG001|Overall Study|Withdrawal by Subject|11|||
25274684|NCT01248065|50588741|FG000|Overall Study|Adverse Event|3|||
25274685|NCT01248065|50588742|FG001|Overall Study|Adverse Event|0|||
25274686|NCT01248065|50588741|FG000|Overall Study|Third treatment failure event|3|||
25274687|NCT01248065|50588742|FG001|Overall Study|Third treatment failure event|1|||
25274688|NCT01248065|50588741|FG000|Overall Study|Other|3|||
25274689|NCT01248065|50588742|FG001|Overall Study|Other|5|||
25274690|NCT01250756|50588750|FG000|Infant Series|Withdrawal by Subject|4|||
25274691|NCT01250756|50588751|FG001|Infant Series|Withdrawal by Subject|5|||
25150904|NCT01852058|50265344|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
25150905|NCT01852058|50265345|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
25150906|NCT01852058|50265346|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
25274692|NCT01250756|50588750|FG000|Infant Series|Randomized, Not Vaccinated|2|||
25150907|NCT01852058|50265347|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
25274693|NCT01250756|50588751|FG001|Infant Series|Randomized, Not Vaccinated|2|||
25274694|NCT01250756|50588750|FG000|Infant Series|Other|22|||
25274695|NCT01250756|50588751|FG001|Infant Series|Other|0|||
25274696|NCT01250756|50588750|FG000|After Infant Series|Adverse Event|5|||
25274697|NCT01250756|50588751|FG001|After Infant Series|Adverse Event|2|||
25274698|NCT01250756|50588750|FG000|After Infant Series|Withdrawal by Subject|4|||
25274699|NCT01250756|50588751|FG001|After Infant Series|Withdrawal by Subject|1|||
25274700|NCT01250756|50588750|FG000|After Infant Series|Other|2|||
25274701|NCT01250756|50588751|FG001|After Infant Series|Other|1|||
25274702|NCT01250756|50588750|FG000|Toddler Dose|Adverse Event|0|||
25274703|NCT01250756|50588751|FG001|Toddler Dose|Adverse Event|1|||
25274704|NCT01250756|50588750|FG000|After Toddler Dose|Adverse Event|0|||
25274705|NCT01250756|50588751|FG001|After Toddler Dose|Adverse Event|1|||
25274706|NCT01250054|50588763|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
25274707|NCT01250054|50588764|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
25274708|NCT00977470|50588772|FG000|Overall Study|Lack of Efficacy|32|||
25274709|NCT00977470|50588773|FG001|Overall Study|Lack of Efficacy|30|||
25274710|NCT00977470|50588772|FG000|Overall Study|Physician Decision|2|||
25274711|NCT00977470|50588773|FG001|Overall Study|Physician Decision|0|||
25274712|NCT00977470|50588772|FG000|Overall Study|Adverse Event|1|||
25274713|NCT00977470|50588773|FG001|Overall Study|Adverse Event|2|||
25274714|NCT00977470|50588772|FG000|Overall Study|Protocol Violation|1|||
25274715|NCT00977470|50588773|FG001|Overall Study|Protocol Violation|0|||
25274716|NCT00977470|50588772|FG000|Overall Study|Withdrawal by Subject|0|||
25274717|NCT00977470|50588773|FG001|Overall Study|Withdrawal by Subject|2|||
25274718|NCT00977470|50588772|FG000|Overall Study|Death|0|||
25274719|NCT00977470|50588773|FG001|Overall Study|Death|2|||
25274720|NCT00977470|50588772|FG000|Overall Study|clinical decline|0|||
25274721|NCT00977470|50588773|FG001|Overall Study|clinical decline|1|||
25274722|NCT00977470|50588772|FG000|Overall Study|prolonged recovery post-surgery|0|||
25274723|NCT00977470|50588773|FG001|Overall Study|prolonged recovery post-surgery|1|||
25274724|NCT00977470|50588772|FG000|Overall Study|Still on-study|2|||
25274725|NCT00977470|50588773|FG001|Overall Study|Still on-study|0|||
25274726|NCT01245374|50588779|FG000|Overall Study|Protocol Violation|1|||
25274727|NCT01245374|50588779|FG000|Overall Study|Withdrawal by Subject|3|||
25274728|NCT00977314|50588786|FG000|Overall Study|Withdrawal by Subject|1|||
25274729|NCT00977314|50588787|FG001|Overall Study|Withdrawal by Subject|0|||
25016977|NCT03185481|50111837|FG000|Overall Study|Adverse Event|1|||
25016978|NCT03185481|50111837|FG000|Overall Study|Study Terminated by Sponsor|4|||
25016979|NCT03652675|50111843|FG000|Overall Study|Lost to Follow-up|4|||
25150908|NCT01852058|50265348|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
25016980|NCT03652675|50111844|FG001|Overall Study|Lost to Follow-up|4|||
25016981|NCT03241368|50111850|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
25150909|NCT01852058|50265349|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
25016982|NCT03241368|50111850|FG000|Overall Study|Lost to Follow-up|1|||
25274730|NCT00977314|50588786|FG000|Overall Study|Physician Decision|1|||
25274731|NCT00977314|50588787|FG001|Overall Study|Physician Decision|0|||
25274732|NCT01087203|50588795|FG000|Overall Study|Lost to Follow-up|2|||
25274733|NCT01087203|50588796|FG001|Overall Study|Lost to Follow-up|0|||
25274734|NCT01087203|50588795|FG000|Overall Study|Withdrawal by Subject|2|||
25274735|NCT01087203|50588796|FG001|Overall Study|Withdrawal by Subject|6|||
25274736|NCT01087203|50588795|FG000|Overall Study|Lack of Efficacy|1|||
25274737|NCT01087203|50588796|FG001|Overall Study|Lack of Efficacy|2|||
25016983|NCT03241368|50111850|FG000|Overall Study|Physician Decision|6|||
25016984|NCT03241368|50111850|FG000|Overall Study|Withdrawal by Subject|6|||
25016985|NCT03241368|50111850|FG000|Overall Study|Protocol Violation|1|||
25016986|NCT03220581|50111857|FG000|Overall Study|Withdrawal by Subject|0|||
25016987|NCT03220581|50111858|FG001|Overall Study|Withdrawal by Subject|1|||
25016988|NCT03220581|50111857|FG000|Overall Study|Lost to Follow-up|3|||
25016989|NCT03220581|50111858|FG001|Overall Study|Lost to Follow-up|6|||
25016990|NCT02954575|50111866|FG000|Overall Study|Withdrawal by Subject|2|||
25016991|NCT02954575|50111866|FG000|Overall Study|Adverse Event|1|||
25016992|NCT03184701|50111874|FG000|Overall Study|Death|3|||
25016993|NCT03184701|50111874|FG000|Overall Study|Physician Decision|3|||
25016994|NCT03184701|50111874|FG000|Overall Study|Withdrawal by Subject|6|||
25016995|NCT03184701|50111874|FG000|Overall Study|Lost to Follow-up|5|||
25016996|NCT03247530|50111881|FG000|Overall Study|Withdrawal by caregiver|19|||
25016997|NCT03247530|50111882|FG001|Overall Study|Withdrawal by caregiver|8|||
25016998|NCT03247530|50111883|FG002|Overall Study|Withdrawal by caregiver|10|||
25016999|NCT03247530|50111881|FG000|Overall Study|Lost to Follow-up|3|||
25017000|NCT03247530|50111882|FG001|Overall Study|Lost to Follow-up|9|||
25017001|NCT03247530|50111883|FG002|Overall Study|Lost to Follow-up|6|||
25017002|NCT03247530|50111881|FG000|Overall Study|Adverse Event|2|||
25017003|NCT03247530|50111882|FG001|Overall Study|Adverse Event|5|||
25017004|NCT03247530|50111883|FG002|Overall Study|Adverse Event|2|||
25017005|NCT03247530|50111881|FG000|Overall Study|Failure to follow procedure|1|||
25017006|NCT03247530|50111882|FG001|Overall Study|Failure to follow procedure|1|||
25017007|NCT03247530|50111883|FG002|Overall Study|Failure to follow procedure|1|||
25017008|NCT03247530|50111881|FG000|Overall Study|Withdrawal by Subject|1|||
25017009|NCT03247530|50111882|FG001|Overall Study|Withdrawal by Subject|1|||
25017010|NCT03247530|50111883|FG002|Overall Study|Withdrawal by Subject|0|||
25017011|NCT03247530|50111881|FG000|Overall Study|Study medication misuse|0|||
25017012|NCT03247530|50111882|FG001|Overall Study|Study medication misuse|1|||
25017013|NCT03247530|50111883|FG002|Overall Study|Study medication misuse|0|||
25017014|NCT03247530|50111881|FG000|Overall Study|Other, multiple categories|1|||
25017015|NCT03247530|50111882|FG001|Overall Study|Other, multiple categories|3|||
25017016|NCT03247530|50111883|FG002|Overall Study|Other, multiple categories|1|||
25017017|NCT03246672|50111894|FG000|Overall Study|Lost to Follow-up|2|||
25017018|NCT03983317|50111898|FG000|Overall Study|Physician Decision|5|||
25017019|NCT03207243|50111904|FG000|Overall Study|Adverse Event|2|||
25017020|NCT03207243|50111905|FG001|Overall Study|Adverse Event|2|||
25017021|NCT03207243|50111904|FG000|Overall Study|Loss of Asthma Control|47|||
25017022|NCT03207243|50111905|FG001|Overall Study|Loss of Asthma Control|31|||
25017023|NCT03207243|50111904|FG000|Overall Study|Withdrawal by Subject|2|||
25017024|NCT03207243|50111905|FG001|Overall Study|Withdrawal by Subject|4|||
25017025|NCT03207243|50111904|FG000|Overall Study|Physician Decision|1|||
25017026|NCT03207243|50111905|FG001|Overall Study|Physician Decision|1|||
25017027|NCT03207243|50111904|FG000|Overall Study|Lost to Follow-up|0|||
25017028|NCT03207243|50111905|FG001|Overall Study|Lost to Follow-up|1|||
25017029|NCT03207243|50111904|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
25017030|NCT03207243|50111905|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
25017031|NCT03207243|50111904|FG000|Overall Study|Protocol Violation|0|||
25017032|NCT03207243|50111905|FG001|Overall Study|Protocol Violation|3|||
25017033|NCT03982069|50111916|FG000|Overall Study|Lost to Follow-up|5|||
25150910|NCT01852058|50265350|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
25150911|NCT01852058|50265351|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
25150912|NCT01852058|50265352|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
25017034|NCT03982069|50111917|FG001|Overall Study|Lost to Follow-up|5|||
25017035|NCT03982069|50111918|FG002|Overall Study|Lost to Follow-up|3|||
25017036|NCT03982069|50111919|FG003|Overall Study|Lost to Follow-up|5|||
25017037|NCT03982069|50111916|FG000|Overall Study|Physician Decision|0|||
25017038|NCT03982069|50111917|FG001|Overall Study|Physician Decision|1|||
25017039|NCT03982069|50111918|FG002|Overall Study|Physician Decision|0|||
25017040|NCT03982069|50111919|FG003|Overall Study|Physician Decision|0|||
25017041|NCT03982069|50111916|FG000|Overall Study|Withdrawal by Subject|2|||
25017042|NCT03982069|50111917|FG001|Overall Study|Withdrawal by Subject|1|||
25017043|NCT03982069|50111918|FG002|Overall Study|Withdrawal by Subject|5|||
25017044|NCT03982069|50111919|FG003|Overall Study|Withdrawal by Subject|2|||
25017045|NCT03982069|50111916|FG000|Overall Study|Specimen loss|3|||
25017046|NCT03982069|50111917|FG001|Overall Study|Specimen loss|3|||
25017047|NCT03982069|50111918|FG002|Overall Study|Specimen loss|1|||
25017048|NCT03982069|50111919|FG003|Overall Study|Specimen loss|1|||
25017049|NCT02937870|50111927|FG000|Overall Study|Adverse Event|1|||
25017050|NCT02937870|50111927|FG000|Overall Study|Protocol Deviation|2|||
25017051|NCT03629041|50111941|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
25017052|NCT03629041|50111942|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
25017053|NCT03629041|50111943|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
25017054|NCT03629041|50111944|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
25017055|NCT03219723|50111962|FG000|Overall Study|Case Report Forms Uncollected|6|||
25017056|NCT03219723|50111962|FG000|Overall Study|Protocol Deviation|4|||
25017057|NCT03628417|50111966|FG000|Overall Study|Death|1|||
25017058|NCT03628417|50111967|FG001|Overall Study|Death|1|||
25017059|NCT03184077|50111979|FG000|Overall Study|Lost to Follow-up|21|||
25017060|NCT03184077|50111980|FG001|Overall Study|Lost to Follow-up|21|||
25017061|NCT03245736|50111986|FG000|Overall Study|Adverse Event|1|||
25017062|NCT03245736|50111986|FG000|Overall Study|Progressive Disease|4|||
25017063|NCT02954887|50111990|FG000|Overall Study|Withdrawal by Subject|3|||
25017064|NCT02954887|50111990|FG000|Overall Study|Lack of Efficacy|3|||
25017065|NCT02954887|50111990|FG000|Overall Study|Other|1|||
25017066|NCT03183063|50111997|FG000|Overall Study|Withdrawal by Subject|2|||
25017067|NCT03183063|50111998|FG001|Overall Study|Withdrawal by Subject|0|||
25017068|NCT03183063|50111999|FG002|Overall Study|Withdrawal by Subject|0|||
25017069|NCT03183063|50111997|FG000|Overall Study|Physician Decision|3|||
25017070|NCT03183063|50111998|FG001|Overall Study|Physician Decision|4|||
25017071|NCT03183063|50111999|FG002|Overall Study|Physician Decision|4|||
25017072|NCT03182829|50112015|FG000|Overall Study|Protocol Violation|12|||
25017073|NCT03182829|50112016|FG001|Overall Study|Protocol Violation|12|||
25150913|NCT01852058|50265341|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
25150914|NCT01852058|50265342|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
25017074|NCT03182829|50112015|FG000|Overall Study|Other|4|||
25017075|NCT03182829|50112016|FG001|Overall Study|Other|3|||
25017076|NCT03278028|50112024|FG000|Overall Study|Lost to Follow-up|1|||
25017077|NCT03278028|50112025|FG001|Overall Study|Lost to Follow-up|0|||
25017078|NCT03278028|50112024|FG000|Overall Study|Withdrawal by Subject|3|||
25017079|NCT03278028|50112025|FG001|Overall Study|Withdrawal by Subject|1|||
25017080|NCT03278028|50112024|FG000|Overall Study|Pregnancy|0|||
25017081|NCT03278028|50112025|FG001|Overall Study|Pregnancy|1|||
25017082|NCT03181503|50112033|FG000|Overall Study|Adverse Event|2|||
25017083|NCT03181503|50112034|FG001|Overall Study|Adverse Event|2|||
25017084|NCT03181503|50112033|FG000|Overall Study|Protocol Violation|1|||
25017085|NCT03181503|50112034|FG001|Overall Study|Protocol Violation|0|||
25017086|NCT03181503|50112033|FG000|Overall Study|Withdrawal by Subject|3|||
25017087|NCT03181503|50112034|FG001|Overall Study|Withdrawal by Subject|0|||
25017088|NCT03181503|50112033|FG000|Overall Study|Lost to Follow-up|1|||
25017089|NCT03181503|50112034|FG001|Overall Study|Lost to Follow-up|1|||
25017090|NCT03277794|50112045|FG000|Overall Study|Lost to Follow-up|2|||
25017091|NCT03277794|50112046|FG001|Overall Study|Lost to Follow-up|4|||
25017092|NCT03277794|50112045|FG000|Overall Study|Withdrew due to high acuity|1|||
25017093|NCT03277794|50112046|FG001|Overall Study|Withdrew due to high acuity|0|||
25017094|NCT03276078|50112053|FG000|Overall Study|Adverse Event|1|||
25017095|NCT03180801|50112060|FG000|Overall Study|Physician Decision|3|||
25017096|NCT03180801|50112061|FG001|Overall Study|Physician Decision|3|||
25017097|NCT03180801|50112062|FG002|Overall Study|Physician Decision|1|||
25017098|NCT03180801|50112060|FG000|Overall Study|Non-compliance|1|||
25017099|NCT03180801|50112061|FG001|Overall Study|Non-compliance|4|||
25017100|NCT03180801|50112062|FG002|Overall Study|Non-compliance|0|||
25017101|NCT03180801|50112060|FG000|Overall Study|Inoculation Target Reached|1|||
25017102|NCT03180801|50112061|FG001|Overall Study|Inoculation Target Reached|1|||
25017103|NCT03180801|50112062|FG002|Overall Study|Inoculation Target Reached|3|||
25017104|NCT03180801|50112060|FG000|Overall Study|Adverse Event|1|||
25017105|NCT03180801|50112061|FG001|Overall Study|Adverse Event|0|||
25017106|NCT03180801|50112062|FG002|Overall Study|Adverse Event|2|||
25017107|NCT03180801|50112060|FG000|Overall Study|Withdrawal by Subject|2|||
25017108|NCT03180801|50112061|FG001|Overall Study|Withdrawal by Subject|2|||
25017109|NCT03180801|50112062|FG002|Overall Study|Withdrawal by Subject|1|||
25017110|NCT03180801|50112060|FG000|Overall Study|Lost to Follow-up|0|||
25017111|NCT03180801|50112061|FG001|Overall Study|Lost to Follow-up|2|||
25017112|NCT03180801|50112062|FG002|Overall Study|Lost to Follow-up|3|||
25017113|NCT03742271|50112073|FG000|Overall Study|Unsatisfactory Visual Response|1|||
25017114|NCT03742271|50112073|FG000|Overall Study|Withdrawal by Subject|3|||
25017115|NCT03742271|50112073|FG000|Overall Study|Lost to Follow-up|4|||
25017116|NCT03742271|50112073|FG000|Overall Study|Failed Insertion & removal|3|||
25017117|NCT03742271|50112073|FG000|Overall Study|Protocol Violation|1|||
25017118|NCT03214224|50112077|FG000|Overall Study|Protocol Violation|1|||
25017119|NCT03214224|50112077|FG000|Overall Study|Withdrawal by Subject|2|||
25017120|NCT03214224|50112077|FG000|Overall Study|Practice controls or therapists|6|||
25017121|NCT03180645|50112084|FG000|Overall Study|Adverse Event|0|||
25017122|NCT03180645|50112085|FG001|Overall Study|Adverse Event|1|||
25017123|NCT03180645|50112086|FG002|Overall Study|Adverse Event|2|||
25017124|NCT03750695|50112098|FG000|Overall Study|Lost to Follow-up|0|||
25017125|NCT03750695|50112099|FG001|Overall Study|Lost to Follow-up|1|||
25017126|NCT03748823|50112112|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
25017127|NCT03748823|50112113|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
25017128|NCT03748823|50112112|FG000|Extension Period|Withdrawal by Subject|1|||
25017129|NCT03748823|50112113|FG001|Extension Period|Withdrawal by Subject|2|||
25017130|NCT03748823|50112112|FG000|Extension Period|Death|0|||
25017131|NCT03748823|50112113|FG001|Extension Period|Death|1|||
25017132|NCT03748823|50112112|FG000|Extension Period|Protocol Violation|1|||
25017133|NCT03748823|50112113|FG001|Extension Period|Protocol Violation|0|||
25017134|NCT03748823|50112112|FG000|Extension Period|Ongoing in the Extension Period|41|||
25017135|NCT03748823|50112113|FG001|Extension Period|Ongoing in the Extension Period|84|||
25017136|NCT03231228|50112122|FG000|Overall Study|Lost to Follow-up|2|||
25017137|NCT03231228|50112123|FG001|Overall Study|Lost to Follow-up|0|||
25017138|NCT03231228|50112122|FG000|Overall Study|Physician Decision|1|||
25017139|NCT03231228|50112123|FG001|Overall Study|Physician Decision|0|||
25017140|NCT03213366|50112131|FG000|Overall Study|Lost to Follow-up|9|||
25017141|NCT03213366|50112132|FG001|Overall Study|Lost to Follow-up|4|||
25150915|NCT01852058|50265343|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
25150916|NCT01852058|50265344|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
25150917|NCT01852058|50265345|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
25150918|NCT01852058|50265346|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
25150919|NCT01852058|50265347|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
25150920|NCT01852058|50265348|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
25150921|NCT01852058|50265349|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
25150922|NCT01852058|50265350|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
25150923|NCT01852058|50265351|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
25150924|NCT01852058|50265352|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
25150925|NCT01852058|50265341|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
25150926|NCT01852058|50265342|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
25150927|NCT01852058|50265343|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
25150928|NCT01852058|50265344|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
25150929|NCT01852058|50265345|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
25150930|NCT01852058|50265346|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
25150931|NCT01852058|50265347|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
25150932|NCT01852058|50265348|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
25150933|NCT01852058|50265349|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
25150934|NCT01852058|50265350|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
25150935|NCT01852058|50265351|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
25150936|NCT01852058|50265352|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
25150937|NCT01852058|50265341|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
25187779|NCT03593213|50338762|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
25017142|NCT03213210|50112138|FG000|Overall Study|Lost to Follow-up|2|||
25017143|NCT03213210|50112138|FG000|Overall Study|Study termination|3|||
25017144|NCT02932878|50112144|FG000|Overall Study|Due to Lab Results|2|||
25017145|NCT02932878|50112145|FG001|Overall Study|Due to Lab Results|1|||
25017146|NCT03230292|50112151|FG000|Overall Study|Adverse Event|1|||
25017147|NCT03230292|50112151|FG000|Overall Study|Protocol Violation|1|||
25017148|NCT03230292|50112151|FG000|Overall Study|Lost to Follow-up|1|||
25017149|NCT03230292|50112151|FG000|Overall Study|Withdrawal by Subject|3|||
25017150|NCT03228420|50112163|FG000|Overall Study|Lost to Follow-up|5|||
25017151|NCT03228420|50112164|FG001|Overall Study|Lost to Follow-up|3|||
25017152|NCT03228420|50112163|FG000|Overall Study|Withdrawal by Subject|10|||
25017153|NCT03228420|50112164|FG001|Overall Study|Withdrawal by Subject|0|||
25017154|NCT03228420|50112163|FG000|Overall Study|Adverse Event|5|||
25017155|NCT03228420|50112164|FG001|Overall Study|Adverse Event|2|||
25017156|NCT03117049|50112172|FG000|Overall Study|Continued the follow-up period|109|||
25017157|NCT03117049|50112173|FG001|Overall Study|Continued the follow-up period|129|||
25150938|NCT01852058|50265342|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
25150939|NCT01852058|50265343|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
25150940|NCT01852058|50265344|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
25150941|NCT01852058|50265345|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
25150942|NCT01852058|50265346|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
25150943|NCT01852058|50265347|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
25150944|NCT01852058|50265348|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
25150945|NCT01852058|50265349|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
25150946|NCT01852058|50265350|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
25150947|NCT01852058|50265351|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
25150948|NCT01852058|50265352|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
25150949|NCT01852058|50265341|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
25150950|NCT01852058|50265342|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
25150951|NCT01852058|50265343|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
25150952|NCT01852058|50265344|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
25150953|NCT01852058|50265345|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
25150954|NCT01852058|50265346|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
25150955|NCT01852058|50265347|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
25150956|NCT01852058|50265348|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
25150957|NCT01852058|50265349|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
25150958|NCT01852058|50265350|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
25150959|NCT01852058|50265351|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
25150960|NCT01852058|50265352|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
25150961|NCT01852058|50265341|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
25150962|NCT01852058|50265342|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
25150963|NCT01852058|50265343|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
25150964|NCT01852058|50265344|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
25150965|NCT01852058|50265345|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
25150966|NCT01852058|50265346|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
25150967|NCT01852058|50265347|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
25150968|NCT01852058|50265348|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
25150969|NCT01852058|50265349|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
25150970|NCT01852058|50265350|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
25150971|NCT01852058|50265351|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
25150972|NCT01852058|50265352|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
25150973|NCT01852058|50265341|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
25150974|NCT01852058|50265342|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
25150975|NCT01852058|50265343|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
25150976|NCT01852058|50265344|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
25150977|NCT01852058|50265345|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
25150978|NCT01852058|50265346|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
25150979|NCT01852058|50265347|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
25150980|NCT01852058|50265348|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
25150981|NCT01852058|50265349|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
25150982|NCT01852058|50265350|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
25150983|NCT01852058|50265351|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
25150984|NCT01852058|50265352|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
25150985|NCT01852058|50265341|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
25150986|NCT01852058|50265342|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
25150987|NCT01852058|50265343|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
25150988|NCT01852058|50265344|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
25150989|NCT01852058|50265345|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
25150990|NCT01852058|50265346|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
25150991|NCT01852058|50265347|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
25150992|NCT01852058|50265348|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
25150993|NCT01852058|50265349|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
25150994|NCT01852058|50265350|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
25150995|NCT01852058|50265351|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
25150996|NCT01852058|50265352|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
25150997|NCT01851590|50265390|FG000|Overall Study|Withdrawal by Subject|0|||
25150998|NCT01851590|50265391|FG001|Overall Study|Withdrawal by Subject|0|||
25150999|NCT01851590|50265392|FG002|Overall Study|Withdrawal by Subject|1|||
25151000|NCT01851590|50265390|FG000|Overall Study|Adverse Event|0|||
25151001|NCT01851590|50265391|FG001|Overall Study|Adverse Event|0|||
25151002|NCT01851590|50265392|FG002|Overall Study|Adverse Event|2|||
25151003|NCT01851590|50265390|FG000|Overall Study|Lack of Efficacy|0|||
25151004|NCT01851590|50265391|FG001|Overall Study|Lack of Efficacy|1|||
25151005|NCT01851590|50265392|FG002|Overall Study|Lack of Efficacy|0|||
25151006|NCT00218296|50265406|FG000|Overall Study|Lost to Follow-up|9|||
25151007|NCT00218296|50265407|FG001|Overall Study|Lost to Follow-up|7|||
25151008|NCT00218296|50265406|FG000|Overall Study|Withdrawal by Subject|36|||
25151009|NCT00218296|50265407|FG001|Overall Study|Withdrawal by Subject|47|||
25151010|NCT00218296|50265406|FG000|Overall Study|Randomized but did not enter treatment|66|||
25151011|NCT00218296|50265407|FG001|Overall Study|Randomized but did not enter treatment|67|||
25151012|NCT00217672|50265415|FG000|Allocation|Ineligible|2|||
25151013|NCT00217672|50265416|FG001|Allocation|Ineligible|0|||
25151014|NCT00217672|50265415|FG000|Treatment|disease progression|33|||
25151015|NCT00217672|50265416|FG001|Treatment|disease progression|4|||
25151016|NCT00217672|50265415|FG000|Treatment|Adverse Event|18|||
25151017|NCT00217672|50265416|FG001|Treatment|Adverse Event|2|||
25151018|NCT00217672|50265415|FG000|Treatment|reqd treatment not permitted by protocol|6|||
25151019|NCT00217672|50265416|FG001|Treatment|reqd treatment not permitted by protocol|0|||
25151020|NCT00217672|50265415|FG000|Treatment|Physician Decision|6|||
25151021|NCT00217672|50265416|FG001|Treatment|Physician Decision|0|||
25151022|NCT00217672|50265415|FG000|Treatment|insurance issues|1|||
25151023|NCT00217672|50265416|FG001|Treatment|insurance issues|1|||
25151024|NCT00217672|50265415|FG000|Treatment|Death|2|||
25151025|NCT00217672|50265416|FG001|Treatment|Death|0|||
25151026|NCT00217672|50265415|FG000|Treatment|secondary malignancy|1|||
25151027|NCT00217672|50265416|FG001|Treatment|secondary malignancy|0|||
25151028|NCT00217672|50265415|FG000|Follow-up|Withdrawal by Subject|4|||
25151029|NCT00217672|50265416|FG001|Follow-up|Withdrawal by Subject|0|||
25151030|NCT00217672|50265415|FG000|Follow-up|Lost to Follow-up|1|||
25151031|NCT00217672|50265416|FG001|Follow-up|Lost to Follow-up|0|||
25151032|NCT00216736|50265422|FG000|Overall Study|Lost to Follow-up|1|||
25151033|NCT00216736|50265423|FG001|Overall Study|Lost to Follow-up|1|||
25151034|NCT01850030|50265431|FG000|Overall Study|Adverse Event|64|||
25151035|NCT01850030|50265432|FG001|Overall Study|Adverse Event|82|||
25151036|NCT01850030|50265431|FG000|Overall Study|Lack of Efficacy|3|||
25151037|NCT01850030|50265432|FG001|Overall Study|Lack of Efficacy|1|||
25151038|NCT01850030|50265431|FG000|Overall Study|Lost to Follow-up|5|||
25151039|NCT01850030|50265432|FG001|Overall Study|Lost to Follow-up|5|||
25151040|NCT01850030|50265431|FG000|Overall Study|Withdrawal by Subject|3|||
25151041|NCT01850030|50265432|FG001|Overall Study|Withdrawal by Subject|4|||
25151042|NCT01850030|50265431|FG000|Overall Study|Protocol Violation|24|||
25151043|NCT01850030|50265432|FG001|Overall Study|Protocol Violation|28|||
25151044|NCT01850030|50265431|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
25151045|NCT01850030|50265432|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
25151046|NCT00215644|50265440|FG000|Overall Study|Disease Progression|28|||
25151047|NCT00215644|50265441|FG001|Overall Study|Disease Progression|10|||
25151048|NCT00215644|50265440|FG000|Overall Study|Adverse Event|2|||
25151049|NCT00215644|50265441|FG001|Overall Study|Adverse Event|9|||
25151050|NCT00215644|50265440|FG000|Overall Study|Death|1|||
25151051|NCT00215644|50265441|FG001|Overall Study|Death|2|||
25151052|NCT00215644|50265440|FG000|Overall Study|Withdrawal by Subject|1|||
25151053|NCT00215644|50265441|FG001|Overall Study|Withdrawal by Subject|0|||
25151054|NCT00215644|50265440|FG000|Overall Study|Other|3|||
25151055|NCT00215644|50265441|FG001|Overall Study|Other|15|||
25151056|NCT00215644|50265440|FG000|Overall Study|Randomized but Not Treated|1|||
25151057|NCT00215644|50265441|FG001|Overall Study|Randomized but Not Treated|0|||
25151058|NCT01870401|50265449|FG000|Overall Study|Death|48|||
25151059|NCT01870401|50265450|FG001|Overall Study|Death|24|||
25017158|NCT03117049|50112172|FG000|Overall Study|Died|82|||
25151060|NCT01870401|50265449|FG000|Overall Study|Withdrawal by Subject|39|||
25151061|NCT01870401|50265450|FG001|Overall Study|Withdrawal by Subject|26|||
25151062|NCT01870401|50265449|FG000|Overall Study|Lost to Follow-up|19|||
25151063|NCT01870401|50265450|FG001|Overall Study|Lost to Follow-up|14|||
25151064|NCT01870401|50265449|FG000|Overall Study|Other|9|||
25151065|NCT01870401|50265450|FG001|Overall Study|Other|7|||
25151066|NCT01870401|50265449|FG000|Overall Study|On-going in the Study|35|||
25151067|NCT01870401|50265450|FG001|Overall Study|On-going in the Study|25|||
25151068|NCT00213148|50265462|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
25151069|NCT00213148|50265463|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
25151070|NCT00213148|50265464|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
25151071|NCT00213148|50265465|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
25151072|NCT00213148|50265466|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
25151073|NCT00213148|50265462|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
25151074|NCT00213148|50265463|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
25151075|NCT00213148|50265464|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
25151076|NCT00213148|50265465|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
25151077|NCT00213148|50265466|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
25151078|NCT00213148|50265462|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
25017159|NCT03117049|50112173|FG001|Overall Study|Died|93|||
25017160|NCT03117049|50112172|FG000|Overall Study|Consent withdrawal|7|||
25017161|NCT03117049|50112173|FG001|Overall Study|Consent withdrawal|6|||
25017162|NCT03117049|50112172|FG000|Overall Study|Missing contact|3|||
25017163|NCT03117049|50112173|FG001|Overall Study|Missing contact|3|||
25017164|NCT03746483|50112181|FG000|Overall Study|Adverse Event|0|||
25151079|NCT00213148|50265463|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
25151080|NCT00213148|50265464|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
25151081|NCT00213148|50265465|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
25151082|NCT00213148|50265466|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
25151083|NCT00213148|50265462|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
25151084|NCT00213148|50265463|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
25151085|NCT00213148|50265464|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
25151086|NCT00213148|50265465|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
25151087|NCT00213148|50265466|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
25151088|NCT00213148|50265462|FG000|Cycle 1 (1 Month)|Other|3|||
25151089|NCT00213148|50265463|FG001|Cycle 1 (1 Month)|Other|0|||
25151090|NCT00213148|50265464|FG002|Cycle 1 (1 Month)|Other|2|||
25151091|NCT00213148|50265465|FG003|Cycle 1 (1 Month)|Other|2|||
25151092|NCT00213148|50265466|FG004|Cycle 1 (1 Month)|Other|7|||
25017165|NCT03746483|50112182|FG001|Overall Study|Adverse Event|1|||
25017166|NCT03746483|50112181|FG000|Overall Study|Lack of Efficacy|3|||
25017167|NCT03746483|50112182|FG001|Overall Study|Lack of Efficacy|2|||
25017168|NCT03746483|50112181|FG000|Overall Study|Lost to Follow-up|1|||
25151093|NCT00213148|50265462|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
25151094|NCT00213148|50265463|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
25151095|NCT00213148|50265464|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
25151096|NCT00213148|50265465|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
25151097|NCT00213148|50265466|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
25017169|NCT03746483|50112182|FG001|Overall Study|Lost to Follow-up|0|||
25151098|NCT00213148|50265462|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
25151099|NCT00213148|50265463|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
25151100|NCT00213148|50265464|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
25151101|NCT00213148|50265465|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
25151102|NCT00213148|50265466|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
25151103|NCT00213148|50265462|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
25151104|NCT00213148|50265463|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
25151105|NCT00213148|50265464|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
25151106|NCT00213148|50265465|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
25151107|NCT00213148|50265466|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
25151108|NCT00213148|50265462|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
25151109|NCT00213148|50265463|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
25151110|NCT00213148|50265464|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
25151111|NCT00213148|50265465|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
25151112|NCT00213148|50265466|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
25151113|NCT00213148|50265462|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
25151114|NCT00213148|50265463|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
25151115|NCT00213148|50265464|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
25151116|NCT00213148|50265465|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
25151117|NCT00213148|50265466|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
25151118|NCT00213148|50265462|FG000|Cycle 2 (1 Month)|Other|2|||
25151119|NCT00213148|50265463|FG001|Cycle 2 (1 Month)|Other|1|||
25151120|NCT00213148|50265464|FG002|Cycle 2 (1 Month)|Other|2|||
25151121|NCT00213148|50265465|FG003|Cycle 2 (1 Month)|Other|8|||
25151122|NCT00213148|50265466|FG004|Cycle 2 (1 Month)|Other|7|||
25151123|NCT00213148|50265462|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
25151124|NCT00213148|50265463|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
25151125|NCT00213148|50265464|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
25151126|NCT00213148|50265465|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
25151127|NCT00213148|50265466|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
25151128|NCT00213148|50265462|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
25151129|NCT00213148|50265463|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
25151130|NCT00213148|50265464|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
25151131|NCT00213148|50265465|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
25151132|NCT00213148|50265466|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
25151133|NCT00213148|50265462|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
25151134|NCT00213148|50265463|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
25151135|NCT00213148|50265464|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
25151136|NCT00213148|50265465|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
25151137|NCT00213148|50265466|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
25151138|NCT00213148|50265462|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
25151139|NCT00213148|50265463|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
25151140|NCT00213148|50265464|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
25151141|NCT00213148|50265465|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
25151142|NCT00213148|50265466|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
25151143|NCT00213148|50265462|FG000|Cycle 3 (1 Month)|Other|0|||
25151144|NCT00213148|50265463|FG001|Cycle 3 (1 Month)|Other|0|||
25151145|NCT00213148|50265464|FG002|Cycle 3 (1 Month)|Other|1|||
25151146|NCT00213148|50265465|FG003|Cycle 3 (1 Month)|Other|1|||
25151147|NCT00213148|50265466|FG004|Cycle 3 (1 Month)|Other|0|||
25151148|NCT01704261|50265488|FG000|Overall Study|Withdrawal by Subject|12|||
25151149|NCT01704261|50265489|FG001|Overall Study|Withdrawal by Subject|15|||
25151150|NCT01704261|50265488|FG000|Overall Study|Lost to Follow-up|1|||
25151151|NCT01704261|50265489|FG001|Overall Study|Lost to Follow-up|0|||
25151152|NCT01715571|50265495|FG000|Overall Study|Lost to Follow-up|8|||
25151153|NCT00212758|50265499|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
25151154|NCT00212758|50265500|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
25151155|NCT00212758|50265499|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
25151156|NCT00212758|50265500|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
25151157|NCT01824290|50265508|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
25151158|NCT01824290|50265509|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
25151159|NCT01824290|50265510|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
25151160|NCT01824290|50265511|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
25151161|NCT01824290|50265508|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
25151162|NCT01824290|50265509|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
25151163|NCT01824290|50265510|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
25151164|NCT01824290|50265511|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
25151165|NCT01824290|50265508|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
25151166|NCT01824290|50265509|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
25151167|NCT01824290|50265510|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
25151168|NCT01824290|50265511|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
25151169|NCT01824290|50265508|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
25151170|NCT01824290|50265509|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
25151171|NCT01824290|50265510|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
25151172|NCT01824290|50265511|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
25151173|NCT01824290|50265508|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
25151174|NCT01824290|50265509|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
25151175|NCT01824290|50265510|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
25151176|NCT01824290|50265511|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
25151177|NCT01824290|50265508|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
25151178|NCT01824290|50265509|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
25151179|NCT01824290|50265510|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
25151180|NCT01824290|50265511|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
25151181|NCT01715415|50265525|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
25151182|NCT01715415|50265526|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
25151183|NCT01715415|50265525|FG000|Double-blind Treatment|Adverse Event|3|||
25151184|NCT01715415|50265526|FG001|Double-blind Treatment|Adverse Event|0|||
25151185|NCT01715415|50265525|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
25151186|NCT01715415|50265526|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
25151187|NCT01715415|50265525|FG000|Double-blind Treatment|Other|1|||
25151188|NCT01715415|50265526|FG001|Double-blind Treatment|Other|0|||
25151189|NCT01715415|50265525|FG000|Open-label Treatment|Adverse Event|0|||
25151190|NCT01715415|50265526|FG001|Open-label Treatment|Adverse Event|1|||
25151191|NCT01715415|50265525|FG000|Open-label Treatment|Subject Noncompliant|0|||
25151192|NCT01715415|50265526|FG001|Open-label Treatment|Subject Noncompliant|1|||
25151193|NCT00211510|50265535|FG000|Overall Study|Physician Decision|3|||
25151194|NCT00211510|50265536|FG001|Overall Study|Physician Decision|1|||
25151195|NCT00211510|50265535|FG000|Overall Study|Withdrawal by Subject|3|||
25151196|NCT00211510|50265536|FG001|Overall Study|Withdrawal by Subject|1|||
25151197|NCT01869777|50265545|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
25151198|NCT01714947|50265549|FG000|Part B|Progressive Disease|3|||
25151199|NCT01869699|50265555|FG000|Overall Study|Withdrawal by Subject|1|||
25151200|NCT01869699|50265556|FG001|Overall Study|Withdrawal by Subject|0|||
25151201|NCT01714635|50265565|FG000|Overall Study|Discontinued|1|||
25151202|NCT01714635|50265566|FG001|Overall Study|Discontinued|0|||
25151203|NCT01714635|50265567|FG002|Overall Study|Discontinued|2|||
25151204|NCT01714635|50265565|FG000|Overall Study|Missed 6-month exam|1|||
25151205|NCT01714635|50265566|FG001|Overall Study|Missed 6-month exam|0|||
25151206|NCT01714635|50265567|FG002|Overall Study|Missed 6-month exam|0|||
25151207|NCT01849874|50265577|FG000|Overall Study|Death|34|||
25151208|NCT01849874|50265578|FG001|Overall Study|Death|16|||
25151209|NCT01849874|50265577|FG000|Overall Study|Withdrawal by Subject|4|||
25151210|NCT01849874|50265578|FG001|Overall Study|Withdrawal by Subject|8|||
25151211|NCT01849874|50265577|FG000|Overall Study|Lost to Follow-up|0|||
25151212|NCT01849874|50265578|FG001|Overall Study|Lost to Follow-up|1|||
25151213|NCT01849874|50265577|FG000|Overall Study|Randomized but Never Treated|1|||
25151214|NCT01849874|50265578|FG001|Overall Study|Randomized but Never Treated|8|||
25151215|NCT01849874|50265577|FG000|Overall Study|Ongoing|162|||
25151216|NCT01849874|50265578|FG001|Overall Study|Ongoing|69|||
25151217|NCT01713933|50265584|FG000|Overall Study|Lost to Follow-up|2|||
25151218|NCT01713933|50265584|FG000|Overall Study|Withdrawal by Subject|3|||
25151219|NCT01713933|50265584|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
25151220|NCT01868997|50265590|FG000|Overall Study|Adverse Event|2|||
25151221|NCT01868997|50265591|FG001|Overall Study|Adverse Event|5|||
25151222|NCT01868997|50265590|FG000|Overall Study|Lack of Efficacy|2|||
25151223|NCT01868997|50265591|FG001|Overall Study|Lack of Efficacy|0|||
25151224|NCT01868997|50265590|FG000|Overall Study|Other|3|||
25151225|NCT01868997|50265591|FG001|Overall Study|Other|1|||
25151226|NCT01875848|50265599|FG000|Overall Study|Withdrawal by Subject|2|||
25151227|NCT01875848|50265600|FG001|Overall Study|Withdrawal by Subject|0|||
25151228|NCT04191382|50265609|FG000|Overall Study|Withdrawal by Subject|1|||
25151229|NCT04191382|50265610|FG001|Overall Study|Withdrawal by Subject|0|||
25151230|NCT04191382|50265611|FG002|Overall Study|Withdrawal by Subject|0|||
25151231|NCT01703091|50265621|FG000|Overall Study|Adverse Event|5|||
25151232|NCT01703091|50265622|FG001|Overall Study|Adverse Event|3|||
25151233|NCT01703091|50265621|FG000|Overall Study|Physician Decision|2|||
25151234|NCT01703091|50265622|FG001|Overall Study|Physician Decision|1|||
25151235|NCT01703091|50265621|FG000|Overall Study|Withdrawal by Subject|1|||
25151236|NCT01703091|50265622|FG001|Overall Study|Withdrawal by Subject|0|||
25151237|NCT01703091|50265621|FG000|Overall Study|Sponsor Decision|1|||
25151238|NCT01703091|50265622|FG001|Overall Study|Sponsor Decision|0|||
25151239|NCT01712685|50265628|FG000|Overall Study|pt declined to participate before trmt|1|||
25151240|NCT01867671|50265634|FG000|Overall Study|Adverse Event|5|||
25151241|NCT01867671|50265635|FG001|Overall Study|Adverse Event|3|||
25151242|NCT01867671|50265634|FG000|Overall Study|Anaphylaxis|0|||
25151243|NCT01867671|50265635|FG001|Overall Study|Anaphylaxis|1|||
25184799|NCT03583333|50333761|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
25017170|NCT03746483|50112181|FG000|Overall Study|Protocol Violation|2|||
25017171|NCT03746483|50112182|FG001|Overall Study|Protocol Violation|0|||
25184800|NCT03583333|50333762|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
25184801|NCT03583333|50333761|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
25184802|NCT03583333|50333762|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
25184803|NCT03583333|50333761|FG000|Overall Study|Withdrawal by Subject|9|||
25184804|NCT03583333|50333762|FG001|Overall Study|Withdrawal by Subject|5|||
25184805|NCT03583333|50333761|FG000|Overall Study|Physician Decision|3|||
25184806|NCT03583333|50333762|FG001|Overall Study|Physician Decision|2|||
25184807|NCT03583333|50333761|FG000|Overall Study|Death|12|||
25184808|NCT03583333|50333762|FG001|Overall Study|Death|7|||
25184809|NCT01602510|50333768|FG000|Open Label Phase|Adverse Event|46|||
25184810|NCT01602510|50333769|FG001|Open Label Phase|Adverse Event|0|||
25184811|NCT01602510|50333770|FG002|Open Label Phase|Adverse Event|0|||
25017172|NCT03746405|50112192|FG000|Overall Study|Withdrawal by Subject|3|||
25184812|NCT01602510|50333768|FG000|Open Label Phase|Lack of Efficacy|22|||
25184813|NCT01602510|50333769|FG001|Open Label Phase|Lack of Efficacy|0|||
25184814|NCT01602510|50333770|FG002|Open Label Phase|Lack of Efficacy|0|||
25184815|NCT01602510|50333768|FG000|Open Label Phase|Protocol Violation|15|||
25184816|NCT01602510|50333769|FG001|Open Label Phase|Protocol Violation|0|||
25017173|NCT03746405|50112193|FG001|Overall Study|Withdrawal by Subject|0|||
25017174|NCT03746405|50112192|FG000|Overall Study|technical difficulties|0|||
25017175|NCT03746405|50112193|FG001|Overall Study|technical difficulties|2|||
25017176|NCT03226392|50112201|FG000|Overall Study|Protocol Deviation|1|||
25151244|NCT01867671|50265634|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
25151245|NCT01867671|50265635|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
25151246|NCT01867671|50265634|FG000|Overall Study|Lost to Follow-up|0|||
25184817|NCT01602510|50333770|FG002|Open Label Phase|Protocol Violation|0|||
25184818|NCT01602510|50333768|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
25184819|NCT01602510|50333769|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
25184820|NCT01602510|50333770|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
25184821|NCT01602510|50333768|FG000|Open Label Phase|Lost to Follow-up|22|||
25184822|NCT01602510|50333769|FG001|Open Label Phase|Lost to Follow-up|0|||
25184823|NCT01602510|50333770|FG002|Open Label Phase|Lost to Follow-up|0|||
25184824|NCT01602510|50333768|FG000|Open Label Phase|Physician Decision|19|||
25184825|NCT01602510|50333769|FG001|Open Label Phase|Physician Decision|0|||
25184826|NCT01602510|50333770|FG002|Open Label Phase|Physician Decision|0|||
25184827|NCT01602510|50333768|FG000|Open Label Phase|Withdrawal by Subject|57|||
25184828|NCT01602510|50333769|FG001|Open Label Phase|Withdrawal by Subject|0|||
25184829|NCT01602510|50333770|FG002|Open Label Phase|Withdrawal by Subject|0|||
25184830|NCT01602510|50333768|FG000|Randomized Phase|Adverse Event|0|||
25184831|NCT01602510|50333769|FG001|Randomized Phase|Adverse Event|2|||
25184832|NCT01602510|50333770|FG002|Randomized Phase|Adverse Event|6|||
25184833|NCT01602510|50333768|FG000|Randomized Phase|Lack of Efficacy|0|||
25184834|NCT01602510|50333769|FG001|Randomized Phase|Lack of Efficacy|4|||
25184835|NCT01602510|50333770|FG002|Randomized Phase|Lack of Efficacy|4|||
25184836|NCT01602510|50333768|FG000|Randomized Phase|Protocol Violation|0|||
25184837|NCT01602510|50333769|FG001|Randomized Phase|Protocol Violation|3|||
25184838|NCT01602510|50333770|FG002|Randomized Phase|Protocol Violation|3|||
25184839|NCT01602510|50333768|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
25184840|NCT01602510|50333769|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
25184841|NCT01602510|50333770|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
25184842|NCT01602510|50333768|FG000|Randomized Phase|Lost to Follow-up|0|||
25184843|NCT01602510|50333769|FG001|Randomized Phase|Lost to Follow-up|1|||
25184844|NCT01602510|50333770|FG002|Randomized Phase|Lost to Follow-up|3|||
25184845|NCT01602510|50333768|FG000|Randomized Phase|Physician Decision|0|||
25151247|NCT01867671|50265635|FG001|Overall Study|Lost to Follow-up|1|||
25151248|NCT01867671|50265634|FG000|Overall Study|Non-compliance with Study Drug|1|||
25151249|NCT01867671|50265635|FG001|Overall Study|Non-compliance with Study Drug|2|||
25151250|NCT01867671|50265634|FG000|Overall Study|Withdrawal by Subject|21|||
25151251|NCT01867671|50265635|FG001|Overall Study|Withdrawal by Subject|21|||
25151252|NCT01702311|50265643|FG000|Overall Study|Withdrawal by Subject|3|||
25151253|NCT01702311|50265644|FG001|Overall Study|Withdrawal by Subject|2|||
25151254|NCT01702311|50265643|FG000|Overall Study|Discharge less than 24 hours|10|||
25151255|NCT01702311|50265644|FG001|Overall Study|Discharge less than 24 hours|7|||
25151256|NCT01702311|50265643|FG000|Overall Study|Physician Decision|3|||
25151257|NCT01702311|50265644|FG001|Overall Study|Physician Decision|4|||
25151258|NCT01712061|50265660|FG000|Overall Study|Adverse Event|4|||
25151259|NCT01712061|50265661|FG001|Overall Study|Adverse Event|9|||
25151260|NCT01712061|50265662|FG002|Overall Study|Adverse Event|5|||
25151261|NCT01712061|50265660|FG000|Overall Study|Death|0|||
25151262|NCT01712061|50265661|FG001|Overall Study|Death|0|||
25151263|NCT01712061|50265662|FG002|Overall Study|Death|1|||
25151264|NCT01712061|50265660|FG000|Overall Study|Lost to Follow-up|1|||
25151265|NCT01712061|50265661|FG001|Overall Study|Lost to Follow-up|0|||
25151266|NCT01712061|50265662|FG002|Overall Study|Lost to Follow-up|1|||
25151267|NCT01712061|50265660|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
25151268|NCT01712061|50265661|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
25151269|NCT01712061|50265662|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
25151270|NCT01712061|50265660|FG000|Overall Study|Medication Error Without Associated AE|0|||
25151271|NCT01712061|50265661|FG001|Overall Study|Medication Error Without Associated AE|1|||
25151272|NCT01712061|50265662|FG002|Overall Study|Medication Error Without Associated AE|0|||
25151273|NCT01712061|50265660|FG000|Overall Study|Withdrawal by Subject|1|||
25151274|NCT01712061|50265661|FG001|Overall Study|Withdrawal by Subject|7|||
25151275|NCT01712061|50265662|FG002|Overall Study|Withdrawal by Subject|1|||
25151276|NCT01712061|50265660|FG000|Overall Study|Other|0|||
25151277|NCT01712061|50265661|FG001|Overall Study|Other|3|||
25151278|NCT01712061|50265662|FG002|Overall Study|Other|0|||
25151279|NCT03592186|50265673|FG000|Overall Study|Withdrawal by Subject|1|||
25151280|NCT03592186|50265674|FG001|Overall Study|Withdrawal by Subject|0|||
25151281|NCT03592186|50265673|FG000|Overall Study|Lost to Follow-up|16|||
25151282|NCT03592186|50265674|FG001|Overall Study|Lost to Follow-up|11|||
25184846|NCT01602510|50333769|FG001|Randomized Phase|Physician Decision|0|||
25151283|NCT03598114|50265682|FG000|Overall Study|Staff turnover/left the program|3|||
25151284|NCT03598114|50265683|FG001|Overall Study|Staff turnover/left the program|39|||
25151285|NCT01711983|50265710|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
25151286|NCT01711983|50265710|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
25151287|NCT01711983|50265710|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
25151288|NCT01711983|50265710|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
25151289|NCT01874288|50265724|FG000|Overall Study|Withdrawal by Subject|1|||
25151290|NCT01874288|50265725|FG001|Overall Study|Withdrawal by Subject|0|||
25151291|NCT01874288|50265726|FG002|Overall Study|Withdrawal by Subject|2|||
25151292|NCT01874288|50265727|FG003|Overall Study|Withdrawal by Subject|1|||
25151293|NCT01874288|50265728|FG004|Overall Study|Withdrawal by Subject|1|||
25151294|NCT01874288|50265724|FG000|Overall Study|Physician Decision|0|||
25151295|NCT01874288|50265725|FG001|Overall Study|Physician Decision|0|||
25151296|NCT01874288|50265726|FG002|Overall Study|Physician Decision|0|||
25151297|NCT01874288|50265727|FG003|Overall Study|Physician Decision|1|||
25151298|NCT01874288|50265728|FG004|Overall Study|Physician Decision|0|||
25151299|NCT01874288|50265724|FG000|Overall Study|Progressive disease|2|||
25151300|NCT01874288|50265725|FG001|Overall Study|Progressive disease|0|||
25151301|NCT01874288|50265726|FG002|Overall Study|Progressive disease|3|||
25151302|NCT01874288|50265727|FG003|Overall Study|Progressive disease|5|||
25151303|NCT01874288|50265728|FG004|Overall Study|Progressive disease|1|||
25151304|NCT01874054|50265757|FG000|Overall Study|Withdrawal by Subject|3|||
25151305|NCT01874054|50265757|FG000|Overall Study|Study Termination by Sponsor|42|||
25151306|NCT01874054|50265757|FG000|Overall Study|Lost to Follow-up|5|||
25151307|NCT01874054|50265757|FG000|Overall Study|Death|5|||
25151308|NCT01873742|50265763|FG000|Overall Study|Lost to Follow-up|68|||
25151309|NCT01873742|50265764|FG001|Overall Study|Lost to Follow-up|76|||
25151310|NCT01873586|50265770|FG000|Overall Study|Lost to Follow-up|3|||
25151311|NCT01849562|50265780|FG000|Overall Study|Lost to Follow-up|1|||
25151312|NCT01849562|50265781|FG001|Overall Study|Lost to Follow-up|0|||
25151313|NCT01849562|50265782|FG002|Overall Study|Lost to Follow-up|0|||
25151314|NCT01849562|50265780|FG000|Overall Study|Non-compliance with Study Drug|1|||
25151315|NCT01849562|50265781|FG001|Overall Study|Non-compliance with Study Drug|0|||
25151316|NCT01849562|50265782|FG002|Overall Study|Non-compliance with Study Drug|0|||
25151317|NCT04027348|50265818|FG000|Overall Study|Adverse Event|2|||
25151318|NCT04196686|50265831|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
25151319|NCT04196686|50265832|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
25151320|NCT01611974|50265841|FG000|Overall Study|Death|10|||
25151321|NCT01611974|50265842|FG001|Overall Study|Death|12|||
25151322|NCT01611974|50265843|FG002|Overall Study|Death|10|||
25151323|NCT01611974|50265841|FG000|Overall Study|Lost to Follow-up|0|||
25151324|NCT01611974|50265842|FG001|Overall Study|Lost to Follow-up|1|||
25151325|NCT01611974|50265843|FG002|Overall Study|Lost to Follow-up|0|||
25151326|NCT01611974|50265841|FG000|Overall Study|Physician Decision|5|||
25151327|NCT01611974|50265842|FG001|Overall Study|Physician Decision|1|||
25151328|NCT01611974|50265843|FG002|Overall Study|Physician Decision|2|||
25151329|NCT01611974|50265841|FG000|Overall Study|Withdrawal by Subject|0|||
25151330|NCT01611974|50265842|FG001|Overall Study|Withdrawal by Subject|1|||
25151331|NCT01611974|50265843|FG002|Overall Study|Withdrawal by Subject|4|||
25151332|NCT01848938|50265853|FG000|Overall Study|Lost to Follow-up|1|||
25151333|NCT01848938|50265854|FG001|Overall Study|Lost to Follow-up|1|||
25151334|NCT01871870|50265860|FG000|Overall Study|Hardware issues|7|||
25151335|NCT01871870|50265860|FG000|Overall Study|hyperglycemia|2|||
25151336|NCT01871558|50265873|FG000|Overall Study|Other reason|0|||
25151337|NCT01871558|50265874|FG001|Overall Study|Other reason|1|||
25151338|NCT01871558|50265873|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
25151339|NCT01871558|50265874|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
25151340|NCT01871558|50265873|FG000|Overall Study|Withdrawal by Subject|2|||
25151341|NCT01871558|50265874|FG001|Overall Study|Withdrawal by Subject|0|||
25151342|NCT01711359|50265883|FG000|Treatment Period|Withdrawal by Subject|18|||
25151343|NCT01711359|50265884|FG001|Treatment Period|Withdrawal by Subject|7|||
25151344|NCT01711359|50265885|FG002|Treatment Period|Withdrawal by Subject|13|||
25151345|NCT01711359|50265883|FG000|Treatment Period|Lack of Efficacy|13|||
25151346|NCT01711359|50265884|FG001|Treatment Period|Lack of Efficacy|2|||
25151347|NCT01711359|50265885|FG002|Treatment Period|Lack of Efficacy|2|||
25151348|NCT01711359|50265883|FG000|Treatment Period|Adverse Event|8|||
25151349|NCT01711359|50265884|FG001|Treatment Period|Adverse Event|10|||
25151350|NCT01711359|50265885|FG002|Treatment Period|Adverse Event|24|||
25151351|NCT01711359|50265883|FG000|Treatment Period|Physician Decision|4|||
25151352|NCT01711359|50265884|FG001|Treatment Period|Physician Decision|3|||
25151353|NCT01711359|50265885|FG002|Treatment Period|Physician Decision|2|||
25151354|NCT01711359|50265883|FG000|Treatment Period|Death|3|||
25151355|NCT01711359|50265884|FG001|Treatment Period|Death|0|||
25151356|NCT01711359|50265885|FG002|Treatment Period|Death|0|||
25151357|NCT01711359|50265883|FG000|Treatment Period|Entry Criteria Not Met|1|||
25151358|NCT01711359|50265884|FG001|Treatment Period|Entry Criteria Not Met|0|||
25151359|NCT01711359|50265885|FG002|Treatment Period|Entry Criteria Not Met|0|||
25151360|NCT01711359|50265883|FG000|Treatment Period|Sponsor Decision|1|||
25151361|NCT01711359|50265884|FG001|Treatment Period|Sponsor Decision|0|||
25151362|NCT01711359|50265885|FG002|Treatment Period|Sponsor Decision|0|||
25151363|NCT01711359|50265883|FG000|Treatment Period|Lost to Follow-up|1|||
25151364|NCT01711359|50265884|FG001|Treatment Period|Lost to Follow-up|1|||
25017177|NCT03226392|50112202|FG001|Overall Study|Protocol Deviation|0|||
25017178|NCT03226392|50112201|FG000|Overall Study|Physician Decision|1|||
25017179|NCT03226392|50112202|FG001|Overall Study|Physician Decision|0|||
25017180|NCT03226392|50112201|FG000|Overall Study|Lost to Follow-up|1|||
25017181|NCT03226392|50112202|FG001|Overall Study|Lost to Follow-up|0|||
25017182|NCT03226392|50112201|FG000|Overall Study|Adverse Event|1|||
25017183|NCT03226392|50112202|FG001|Overall Study|Adverse Event|0|||
25017184|NCT03226392|50112201|FG000|Overall Study|Technical Problems|0|||
25017185|NCT03226392|50112202|FG001|Overall Study|Technical Problems|2|||
25017186|NCT03226392|50112201|FG000|Overall Study|Subject/Guardian Decision|7|||
25017187|NCT03226392|50112202|FG001|Overall Study|Subject/Guardian Decision|6|||
25017188|NCT03205371|50112220|FG000|Overall Study|Withdrawal by Subject|4|||
25017189|NCT03205371|50112221|FG001|Overall Study|Withdrawal by Subject|1|||
25017190|NCT03205371|50112222|FG002|Overall Study|Withdrawal by Subject|0|||
25017191|NCT03205371|50112223|FG003|Overall Study|Withdrawal by Subject|0|||
25017192|NCT03205371|50112224|FG004|Overall Study|Withdrawal by Subject|0|||
25017193|NCT03205371|50112225|FG005|Overall Study|Withdrawal by Subject|0|||
25151365|NCT01711359|50265885|FG002|Treatment Period|Lost to Follow-up|1|||
25151366|NCT01711359|50265883|FG000|Treatment Period|Randomized, Not Treated|3|||
25017194|NCT03205371|50112226|FG006|Overall Study|Withdrawal by Subject|4|||
25017195|NCT03205371|50112227|FG007|Overall Study|Withdrawal by Subject|0|||
25151367|NCT01711359|50265884|FG001|Treatment Period|Randomized, Not Treated|1|||
25151368|NCT01711359|50265885|FG002|Treatment Period|Randomized, Not Treated|0|||
25151369|NCT01710657|50265912|FG000|Overall Study|Lost to Follow-up|2|||
25151370|NCT01710657|50265913|FG001|Overall Study|Lost to Follow-up|0|||
25151371|NCT01710657|50265914|FG002|Overall Study|Lost to Follow-up|1|||
25151372|NCT01710657|50265912|FG000|Overall Study|Protocol Violation|2|||
25151373|NCT01710657|50265913|FG001|Overall Study|Protocol Violation|2|||
25151374|NCT01710657|50265914|FG002|Overall Study|Protocol Violation|0|||
25151375|NCT01710657|50265912|FG000|Overall Study|Adverse Event|14|||
25151376|NCT01710657|50265913|FG001|Overall Study|Adverse Event|8|||
25151377|NCT01710657|50265914|FG002|Overall Study|Adverse Event|28|||
25151378|NCT01710657|50265912|FG000|Overall Study|Withdrawal by Subject|0|||
25151379|NCT01710657|50265913|FG001|Overall Study|Withdrawal by Subject|1|||
25151380|NCT01710657|50265914|FG002|Overall Study|Withdrawal by Subject|2|||
25151381|NCT01710657|50265912|FG000|Overall Study|Lack of Efficacy|0|||
25017196|NCT03205371|50112228|FG008|Overall Study|Withdrawal by Subject|2|||
25017197|NCT03205371|50112229|FG009|Overall Study|Withdrawal by Subject|0|||
25017198|NCT03205371|50112230|FG010|Overall Study|Withdrawal by Subject|0|||
25017199|NCT03205371|50112231|FG011|Overall Study|Withdrawal by Subject|1|||
25017200|NCT03205371|50112220|FG000|Overall Study|Lost to Follow-up|0|||
25017201|NCT03205371|50112221|FG001|Overall Study|Lost to Follow-up|0|||
25017202|NCT03205371|50112222|FG002|Overall Study|Lost to Follow-up|0|||
25017203|NCT03205371|50112223|FG003|Overall Study|Lost to Follow-up|0|||
25017204|NCT03205371|50112224|FG004|Overall Study|Lost to Follow-up|0|||
25017205|NCT03205371|50112225|FG005|Overall Study|Lost to Follow-up|0|||
25017206|NCT03205371|50112226|FG006|Overall Study|Lost to Follow-up|5|||
25017207|NCT03205371|50112227|FG007|Overall Study|Lost to Follow-up|2|||
25017208|NCT03205371|50112228|FG008|Overall Study|Lost to Follow-up|3|||
25017209|NCT03205371|50112229|FG009|Overall Study|Lost to Follow-up|0|||
25017210|NCT03205371|50112230|FG010|Overall Study|Lost to Follow-up|0|||
25017211|NCT03205371|50112231|FG011|Overall Study|Lost to Follow-up|0|||
25017212|NCT03205371|50112220|FG000|Overall Study|Protocol Violation|0|||
25017213|NCT03205371|50112221|FG001|Overall Study|Protocol Violation|0|||
25017214|NCT03205371|50112222|FG002|Overall Study|Protocol Violation|0|||
25017215|NCT03205371|50112223|FG003|Overall Study|Protocol Violation|0|||
25017216|NCT03205371|50112224|FG004|Overall Study|Protocol Violation|0|||
25017217|NCT03205371|50112225|FG005|Overall Study|Protocol Violation|0|||
25151382|NCT01710657|50265913|FG001|Overall Study|Lack of Efficacy|1|||
25151383|NCT01710657|50265914|FG002|Overall Study|Lack of Efficacy|1|||
25151384|NCT01701063|50265925|FG000|Overall Study|Lost to Follow-up|0|||
25151385|NCT01701063|50265926|FG001|Overall Study|Lost to Follow-up|1|||
25151386|NCT01701063|50265927|FG002|Overall Study|Lost to Follow-up|0|||
25017218|NCT03205371|50112226|FG006|Overall Study|Protocol Violation|1|||
25151387|NCT01701063|50265925|FG000|Overall Study|Withdrawal by Subject|0|||
25151388|NCT01701063|50265926|FG001|Overall Study|Withdrawal by Subject|0|||
25151389|NCT01701063|50265927|FG002|Overall Study|Withdrawal by Subject|1|||
25151390|NCT01701063|50265925|FG000|Overall Study|Other|0|||
25151391|NCT01701063|50265926|FG001|Overall Study|Other|0|||
25151392|NCT01701063|50265927|FG002|Overall Study|Other|1|||
25151393|NCT01700985|50265938|FG000|Overall Study|Incarcerated|0|||
25151394|NCT01700985|50265939|FG001|Overall Study|Incarcerated|1|||
25151395|NCT01710501|50265948|FG000|Overall Study|Lost to Follow-up|2|||
25151396|NCT01710501|50265949|FG001|Overall Study|Lost to Follow-up|0|||
25151397|NCT01710501|50265950|FG002|Overall Study|Lost to Follow-up|0|||
25151398|NCT01700829|50265960|FG000|Overall Study|Withdrawal by Subject|1|||
25151399|NCT01700829|50265961|FG001|Overall Study|Withdrawal by Subject|1|||
25151400|NCT01710345|50265970|FG000|Overall Study|Adverse Event|0|||
25151401|NCT01710345|50265971|FG001|Overall Study|Adverse Event|2|||
25151402|NCT01710345|50265972|FG002|Overall Study|Adverse Event|0|||
25151403|NCT01710345|50265970|FG000|Overall Study|Lack of Efficacy|2|||
25151404|NCT01710345|50265971|FG001|Overall Study|Lack of Efficacy|3|||
25151405|NCT01710345|50265972|FG002|Overall Study|Lack of Efficacy|1|||
25151406|NCT01710345|50265970|FG000|Overall Study|Drug Dosing Error|1|||
25151407|NCT01710345|50265971|FG001|Overall Study|Drug Dosing Error|0|||
25151408|NCT01710345|50265972|FG002|Overall Study|Drug Dosing Error|0|||
25151409|NCT01710033|50265988|FG000|Stage 2|Adverse Event|0|||
25151410|NCT01710033|50265989|FG001|Stage 2|Adverse Event|0|||
25151411|NCT01710033|50265990|FG002|Stage 2|Adverse Event|0|||
25151412|NCT01710033|50265991|FG003|Stage 2|Adverse Event|0|||
25151413|NCT01710033|50265992|FG004|Stage 2|Adverse Event|1|||
25151414|NCT01822496|50266009|FG000|Overall Study|Protocol Violation|2|||
25151415|NCT01822496|50266010|FG001|Overall Study|Protocol Violation|2|||
25151416|NCT01822496|50266011|FG002|Overall Study|Protocol Violation|0|||
25151417|NCT01822496|50266012|FG003|Overall Study|Protocol Violation|1|||
25151418|NCT01822496|50266009|FG000|Overall Study|Withdrawal by Subject|0|||
25151419|NCT01822496|50266010|FG001|Overall Study|Withdrawal by Subject|0|||
25151420|NCT01822496|50266011|FG002|Overall Study|Withdrawal by Subject|0|||
25151421|NCT01822496|50266012|FG003|Overall Study|Withdrawal by Subject|3|||
25151422|NCT01867047|50266024|FG000|Overall Study|Lost to Follow-up|3|||
25151423|NCT01867047|50266025|FG001|Overall Study|Lost to Follow-up|3|||
25151424|NCT01867047|50266024|FG000|Overall Study|Withdrawal by Subject|2|||
25151425|NCT01867047|50266025|FG001|Overall Study|Withdrawal by Subject|0|||
25151426|NCT01867047|50266024|FG000|Overall Study|Physician Decision|2|||
25151427|NCT01867047|50266025|FG001|Overall Study|Physician Decision|0|||
25151428|NCT01867047|50266024|FG000|Overall Study|surgery not indicated in protocol|1|||
25151429|NCT01867047|50266025|FG001|Overall Study|surgery not indicated in protocol|2|||
25151430|NCT01821560|50266037|FG000|Overall Study|Lost to Follow-up|5|||
25151431|NCT01821560|50266038|FG001|Overall Study|Lost to Follow-up|5|||
25151432|NCT01821560|50266037|FG000|Overall Study|Withdrawal by Subject|1|||
25151433|NCT01821560|50266038|FG001|Overall Study|Withdrawal by Subject|1|||
25151434|NCT01821560|50266037|FG000|Overall Study|Protocol Violation|0|||
25151435|NCT01821560|50266038|FG001|Overall Study|Protocol Violation|1|||
25151436|NCT01871402|50266046|FG000|Overall Study|Lost to Follow-up|1|||
25151437|NCT01871402|50266047|FG001|Overall Study|Lost to Follow-up|0|||
25151438|NCT01871402|50266046|FG000|Overall Study|Withdrawal by Subject|0|||
25151439|NCT01871402|50266047|FG001|Overall Study|Withdrawal by Subject|2|||
25151440|NCT01871402|50266046|FG000|Overall Study|Non-compliance|0|||
25151441|NCT01871402|50266047|FG001|Overall Study|Non-compliance|1|||
25151442|NCT01846442|50266066|FG000|Overall Study|Adverse Event|2|||
25151443|NCT01846442|50266067|FG001|Overall Study|Adverse Event|4|||
25151444|NCT01846442|50266068|FG002|Overall Study|Adverse Event|2|||
25151445|NCT01846442|50266069|FG003|Overall Study|Adverse Event|1|||
25151446|NCT01846442|50266066|FG000|Overall Study|Lost to Follow-up|0|||
25151447|NCT01846442|50266067|FG001|Overall Study|Lost to Follow-up|0|||
25151448|NCT01846442|50266068|FG002|Overall Study|Lost to Follow-up|1|||
25151449|NCT01846442|50266069|FG003|Overall Study|Lost to Follow-up|0|||
25151450|NCT01846442|50266066|FG000|Overall Study|Withdrawal by Subject|3|||
25151451|NCT01846442|50266067|FG001|Overall Study|Withdrawal by Subject|2|||
25151452|NCT01846442|50266068|FG002|Overall Study|Withdrawal by Subject|0|||
25151453|NCT01846442|50266069|FG003|Overall Study|Withdrawal by Subject|1|||
25151454|NCT01846442|50266066|FG000|Overall Study|Left the city/Lost medication|1|||
25151455|NCT01846442|50266067|FG001|Overall Study|Left the city/Lost medication|0|||
25151456|NCT01846442|50266068|FG002|Overall Study|Left the city/Lost medication|1|||
25151457|NCT01846442|50266069|FG003|Overall Study|Left the city/Lost medication|1|||
25151458|NCT01709721|50266082|FG000|Open Label Phase|Withdrawal by Subject|0|||
25151459|NCT01709721|50266083|FG001|Open Label Phase|Withdrawal by Subject|0|||
25151460|NCT01709721|50266084|FG002|Open Label Phase|Withdrawal by Subject|5|||
25151461|NCT01709721|50266082|FG000|Open Label Phase|Adverse Event|0|||
25151462|NCT01709721|50266083|FG001|Open Label Phase|Adverse Event|0|||
25151463|NCT01709721|50266084|FG002|Open Label Phase|Adverse Event|8|||
25151464|NCT01709721|50266082|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
25151465|NCT01709721|50266083|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
25184847|NCT01602510|50333770|FG002|Randomized Phase|Physician Decision|2|||
25184848|NCT01602510|50333768|FG000|Randomized Phase|Withdrawal by Subject|0|||
25184849|NCT01602510|50333769|FG001|Randomized Phase|Withdrawal by Subject|6|||
25151466|NCT01709721|50266084|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
25151467|NCT01709721|50266082|FG000|Open Label Phase|Investigator Decision|0|||
25151468|NCT01709721|50266083|FG001|Open Label Phase|Investigator Decision|0|||
25151469|NCT01709721|50266084|FG002|Open Label Phase|Investigator Decision|1|||
25151470|NCT01709721|50266082|FG000|Open Label Phase|Sponsor Decision|0|||
25151471|NCT01709721|50266083|FG001|Open Label Phase|Sponsor Decision|0|||
25151472|NCT01709721|50266084|FG002|Open Label Phase|Sponsor Decision|2|||
25151473|NCT01709721|50266082|FG000|Open Label Phase|Protocol Violation|0|||
25151474|NCT01709721|50266083|FG001|Open Label Phase|Protocol Violation|0|||
25151475|NCT01709721|50266084|FG002|Open Label Phase|Protocol Violation|1|||
25151476|NCT01709721|50266082|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
25151477|NCT01709721|50266083|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
25151478|NCT01709721|50266084|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
25151479|NCT01709721|50266082|FG000|Open Label Phase|Inadequate Pain Control|0|||
25151480|NCT01709721|50266083|FG001|Open Label Phase|Inadequate Pain Control|0|||
25151481|NCT01709721|50266084|FG002|Open Label Phase|Inadequate Pain Control|37|||
25151482|NCT01709721|50266082|FG000|Open Label Phase|Other, Specify in text field in database|0|||
25151483|NCT01709721|50266083|FG001|Open Label Phase|Other, Specify in text field in database|0|||
25151484|NCT01709721|50266084|FG002|Open Label Phase|Other, Specify in text field in database|14|||
25151485|NCT01709721|50266082|FG000|Randomized Phase|Adverse Event|0|||
25151486|NCT01709721|50266083|FG001|Randomized Phase|Adverse Event|1|||
25017219|NCT03205371|50112227|FG007|Overall Study|Protocol Violation|0|||
25017220|NCT03205371|50112228|FG008|Overall Study|Protocol Violation|0|||
25017221|NCT03205371|50112229|FG009|Overall Study|Protocol Violation|0|||
25017222|NCT03205371|50112230|FG010|Overall Study|Protocol Violation|0|||
25017223|NCT03205371|50112231|FG011|Overall Study|Protocol Violation|0|||
25017224|NCT03205371|50112220|FG000|Overall Study|Adverse Event|0|||
25017225|NCT03205371|50112221|FG001|Overall Study|Adverse Event|0|||
25017226|NCT03205371|50112222|FG002|Overall Study|Adverse Event|0|||
25017227|NCT03205371|50112223|FG003|Overall Study|Adverse Event|0|||
25017228|NCT03205371|50112224|FG004|Overall Study|Adverse Event|0|||
25017229|NCT03205371|50112225|FG005|Overall Study|Adverse Event|0|||
25017230|NCT03205371|50112226|FG006|Overall Study|Adverse Event|0|||
25017231|NCT03205371|50112227|FG007|Overall Study|Adverse Event|1|||
25017232|NCT03205371|50112228|FG008|Overall Study|Adverse Event|0|||
25017233|NCT03205371|50112229|FG009|Overall Study|Adverse Event|0|||
25017234|NCT03205371|50112230|FG010|Overall Study|Adverse Event|0|||
25151487|NCT01709721|50266084|FG002|Randomized Phase|Adverse Event|0|||
25151488|NCT01709721|50266082|FG000|Randomized Phase|Lost to Follow-up|1|||
25151489|NCT01709721|50266083|FG001|Randomized Phase|Lost to Follow-up|0|||
25151490|NCT01709721|50266084|FG002|Randomized Phase|Lost to Follow-up|0|||
25151491|NCT01709721|50266082|FG000|Randomized Phase|Inadequate Pain Control|1|||
25151492|NCT01709721|50266083|FG001|Randomized Phase|Inadequate Pain Control|2|||
25151493|NCT01709721|50266084|FG002|Randomized Phase|Inadequate Pain Control|0|||
25151494|NCT01709721|50266082|FG000|Randomized Phase|Other, Specify text field in database|1|||
25151495|NCT01709721|50266083|FG001|Randomized Phase|Other, Specify text field in database|3|||
25151496|NCT01709721|50266084|FG002|Randomized Phase|Other, Specify text field in database|0|||
25151497|NCT01866657|50266094|FG000|Overall Study|Surgery canceled|2|||
25151498|NCT01866657|50266095|FG001|Overall Study|Surgery canceled|0|||
25151499|NCT01700205|50266103|FG000|Overall Study|Withdrawal by Subject|13|||
25151500|NCT01700205|50266104|FG001|Overall Study|Withdrawal by Subject|13|||
25151501|NCT01700205|50266103|FG000|Overall Study|Protocol Violation|2|||
25151502|NCT01700205|50266104|FG001|Overall Study|Protocol Violation|2|||
25151503|NCT01700049|50266110|FG000|Overall Study|Withdrawal by Subject|1|||
25151504|NCT01699815|50266117|FG000|Overall Study|Protocol Violation|4|||
25151505|NCT01699815|50266118|FG001|Overall Study|Protocol Violation|7|||
25151506|NCT01699815|50266117|FG000|Overall Study|record could not be located|1|||
25151507|NCT01699815|50266118|FG001|Overall Study|record could not be located|0|||
25151508|NCT01699815|50266117|FG000|Overall Study|Adverse Event|0|||
25151509|NCT01699815|50266118|FG001|Overall Study|Adverse Event|1|||
25151510|NCT01866423|50266124|FG000|Overall Study|Lack of Efficacy|3|||
25151511|NCT01866423|50266124|FG000|Overall Study|Sponsor Decision|1|||
25151512|NCT01846208|50266131|FG000|Overall Study|Withdrew prior to treatment|1|||
25151513|NCT01846208|50266132|FG001|Overall Study|Withdrew prior to treatment|1|||
25151514|NCT01846208|50266133|FG002|Overall Study|Withdrew prior to treatment|1|||
25151515|NCT01846208|50266131|FG000|Overall Study|Dosing Symptoms|1|||
25151516|NCT01846208|50266132|FG001|Overall Study|Dosing Symptoms|2|||
25151517|NCT01846208|50266133|FG002|Overall Study|Dosing Symptoms|6|||
25151518|NCT01846208|50266131|FG000|Overall Study|Withdrawal by Subject|5|||
25184850|NCT01602510|50333770|FG002|Randomized Phase|Withdrawal by Subject|7|||
25151519|NCT01846208|50266132|FG001|Overall Study|Withdrawal by Subject|0|||
25151520|NCT01846208|50266133|FG002|Overall Study|Withdrawal by Subject|0|||
25184851|NCT01675596|50333785|FG000|Overall Study|Death|6|||
25151521|NCT01846208|50266131|FG000|Overall Study|Non-compliance|1|||
25151522|NCT01846208|50266132|FG001|Overall Study|Non-compliance|1|||
25151523|NCT01846208|50266133|FG002|Overall Study|Non-compliance|0|||
25151524|NCT01846208|50266131|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
25151525|NCT01846208|50266132|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
25151526|NCT01846208|50266133|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
25151527|NCT01846208|50266131|FG000|Overall Study|Refused SU OFC|0|||
25151528|NCT01846208|50266132|FG001|Overall Study|Refused SU OFC|0|||
25151529|NCT01846208|50266133|FG002|Overall Study|Refused SU OFC|1|||
25151530|NCT01845974|50266143|FG000|Overall Study|screen failure|1|||
25151531|NCT01845974|50266144|FG001|Overall Study|screen failure|0|||
25151532|NCT01865487|50266156|FG000|Overall Study|Lost to Follow-up|0|||
25151533|NCT01865487|50266157|FG001|Overall Study|Lost to Follow-up|0|||
25151534|NCT01865487|50266158|FG002|Overall Study|Lost to Follow-up|0|||
25151535|NCT01865487|50266159|FG003|Overall Study|Lost to Follow-up|1|||
25151536|NCT01865487|50266160|FG004|Overall Study|Lost to Follow-up|0|||
25151537|NCT01865487|50266161|FG005|Overall Study|Lost to Follow-up|0|||
25151538|NCT01865487|50266162|FG006|Overall Study|Lost to Follow-up|1|||
25151539|NCT01865487|50266163|FG007|Overall Study|Lost to Follow-up|0|||
25151540|NCT01865487|50266164|FG008|Overall Study|Lost to Follow-up|0|||
25151541|NCT01865487|50266165|FG009|Overall Study|Lost to Follow-up|0|||
25151542|NCT01865487|50266156|FG000|Overall Study|Withdrawal by Subject|0|||
25151543|NCT01865487|50266157|FG001|Overall Study|Withdrawal by Subject|0|||
25151544|NCT01865487|50266158|FG002|Overall Study|Withdrawal by Subject|0|||
25151545|NCT01865487|50266159|FG003|Overall Study|Withdrawal by Subject|0|||
25151546|NCT01865487|50266160|FG004|Overall Study|Withdrawal by Subject|1|||
25151547|NCT01865487|50266161|FG005|Overall Study|Withdrawal by Subject|0|||
25151548|NCT01865487|50266162|FG006|Overall Study|Withdrawal by Subject|0|||
25151549|NCT01865487|50266163|FG007|Overall Study|Withdrawal by Subject|0|||
25151550|NCT01865487|50266164|FG008|Overall Study|Withdrawal by Subject|0|||
25151551|NCT01865487|50266165|FG009|Overall Study|Withdrawal by Subject|0|||
25151552|NCT01699503|50266195|FG000|Overall Study|Death|31|||
25151553|NCT01699503|50266196|FG001|Overall Study|Death|40|||
25151554|NCT01699503|50266195|FG000|Overall Study|Withdrawal by Subject|65|||
25151555|NCT01699503|50266196|FG001|Overall Study|Withdrawal by Subject|57|||
25151556|NCT01699503|50266195|FG000|Overall Study|Lost to Follow-up|121|||
25151557|NCT01699503|50266196|FG001|Overall Study|Lost to Follow-up|117|||
25151558|NCT01699503|50266195|FG000|Overall Study|Excluded due to quality|783|||
25151559|NCT01699503|50266196|FG001|Overall Study|Excluded due to quality|791|||
25151560|NCT01709409|50266204|FG000|Overall Study|Protocol Violation|1|||
25151561|NCT01709409|50266205|FG001|Overall Study|Protocol Violation|0|||
25151562|NCT01698879|50266214|FG000|Overall Study|Withdrawal by Subject|1|||
25151563|NCT01698879|50266215|FG001|Overall Study|Withdrawal by Subject|0|||
25151564|NCT01698879|50266216|FG002|Overall Study|Withdrawal by Subject|0|||
25151565|NCT01698801|50266255|FG000|Treatment Phase|Adverse Event|4|||
25151566|NCT01698801|50266255|FG000|Treatment Phase|Protocol Violation|1|||
25151567|NCT01698801|50266255|FG000|Treatment Phase|Other|4|||
25151568|NCT01698801|50266255|FG000|Treatment Phase|Withdrawal by Subject|1|||
25151569|NCT01698801|50266255|FG000|Treatment Phase|Disease progression|1|||
25151570|NCT01698801|50266255|FG000|Follow Up Phase|Withdrawal by Subject|1|||
25151571|NCT01698801|50266255|FG000|Follow Up Phase|Death|4|||
25151572|NCT01682811|50266267|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
25151573|NCT01682811|50266268|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
25151574|NCT01682811|50266269|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
25151575|NCT01682811|50266270|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
25151576|NCT01682811|50266271|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
25151577|NCT01682811|50266272|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
25151578|NCT01682811|50266273|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
25151579|NCT01682811|50266267|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
25151580|NCT01682811|50266268|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
25151581|NCT01682811|50266269|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
25151582|NCT01682811|50266270|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
25184852|NCT01675596|50333785|FG000|Overall Study|Exit with other reason|1|||
25184853|NCT01675596|50333785|FG000|Overall Study|Missed Visit|1|||
25151583|NCT01682811|50266271|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
25151584|NCT01682811|50266272|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
25184854|NCT02653326|50333795|FG000|Overall Study|Lost to Follow-up|10|||
25151585|NCT01682811|50266273|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
25151586|NCT01682811|50266267|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
25151587|NCT01682811|50266268|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
25151588|NCT01682811|50266269|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
25151589|NCT01682811|50266270|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
25151590|NCT01682811|50266271|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
25151591|NCT01682811|50266272|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
25151592|NCT01682811|50266273|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
25151593|NCT01682811|50266267|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
25151594|NCT01682811|50266268|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
25151595|NCT01682811|50266269|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
25151596|NCT01682811|50266270|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
25151597|NCT01682811|50266271|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
25151598|NCT01682811|50266272|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
25151599|NCT01682811|50266273|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
25151600|NCT01682031|50266294|FG000|Overall Study|Withdrawal by Subject|0|||
25151601|NCT01682031|50266295|FG001|Overall Study|Withdrawal by Subject|1|||
25151602|NCT01682031|50266294|FG000|Overall Study|Adverse Event|0|||
25151603|NCT01682031|50266295|FG001|Overall Study|Adverse Event|2|||
25151604|NCT01682031|50266294|FG000|Overall Study|MRI results indicate increased nodul|0|||
25151605|NCT01682031|50266295|FG001|Overall Study|MRI results indicate increased nodul|1|||
25151606|NCT01682031|50266294|FG000|Overall Study|Patient could not swallow tablets|1|||
25151607|NCT01682031|50266295|FG001|Overall Study|Patient could not swallow tablets|0|||
25151608|NCT01682031|50266294|FG000|Overall Study|Patient stopped selenium on his own|0|||
25151609|NCT01682031|50266295|FG001|Overall Study|Patient stopped selenium on his own|1|||
25151610|NCT01567527|50266316|FG000|Conversion Phase.|Protocol deviation|3|||
25151611|NCT01567527|50266317|FG001|Conversion Phase.|Protocol deviation|0|||
25151612|NCT01567527|50266318|FG002|Conversion Phase.|Protocol deviation|0|||
25151613|NCT01567527|50266319|FG003|Conversion Phase.|Protocol deviation|0|||
25184855|NCT02653326|50333796|FG001|Overall Study|Lost to Follow-up|7|||
25151614|NCT01567527|50266320|FG004|Conversion Phase.|Protocol deviation|0|||
25151615|NCT01567527|50266316|FG000|Conversion Phase.|Met withdrawal criteria|10|||
25151616|NCT01567527|50266317|FG001|Conversion Phase.|Met withdrawal criteria|0|||
25151617|NCT01567527|50266318|FG002|Conversion Phase.|Met withdrawal criteria|0|||
25151618|NCT01567527|50266319|FG003|Conversion Phase.|Met withdrawal criteria|0|||
25151619|NCT01567527|50266320|FG004|Conversion Phase.|Met withdrawal criteria|0|||
25151620|NCT01567527|50266316|FG000|Conversion Phase.|Withdrawal by Subject|32|||
25151621|NCT01567527|50266317|FG001|Conversion Phase.|Withdrawal by Subject|0|||
25151622|NCT01567527|50266318|FG002|Conversion Phase.|Withdrawal by Subject|0|||
25151623|NCT01567527|50266319|FG003|Conversion Phase.|Withdrawal by Subject|0|||
25151624|NCT01567527|50266320|FG004|Conversion Phase.|Withdrawal by Subject|0|||
25151625|NCT01567527|50266316|FG000|Conversion Phase.|Lost to Follow-up|16|||
25151626|NCT01567527|50266317|FG001|Conversion Phase.|Lost to Follow-up|0|||
25151627|NCT01567527|50266318|FG002|Conversion Phase.|Lost to Follow-up|0|||
25151628|NCT01567527|50266319|FG003|Conversion Phase.|Lost to Follow-up|0|||
25151629|NCT01567527|50266320|FG004|Conversion Phase.|Lost to Follow-up|0|||
25151630|NCT01567527|50266316|FG000|Conversion Phase.|Lack of Efficacy|2|||
25151631|NCT01567527|50266317|FG001|Conversion Phase.|Lack of Efficacy|0|||
25151632|NCT01567527|50266318|FG002|Conversion Phase.|Lack of Efficacy|0|||
25151633|NCT01567527|50266319|FG003|Conversion Phase.|Lack of Efficacy|0|||
25151634|NCT01567527|50266320|FG004|Conversion Phase.|Lack of Efficacy|0|||
25151635|NCT01567527|50266316|FG000|Conversion Phase.|Adverse Event|33|||
25151636|NCT01567527|50266317|FG001|Conversion Phase.|Adverse Event|0|||
25151637|NCT01567527|50266318|FG002|Conversion Phase.|Adverse Event|0|||
25151638|NCT01567527|50266319|FG003|Conversion Phase.|Adverse Event|0|||
25151639|NCT01567527|50266320|FG004|Conversion Phase.|Adverse Event|0|||
25151640|NCT01567527|50266316|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
25151641|NCT01567527|50266317|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
25017235|NCT03205371|50112231|FG011|Overall Study|Adverse Event|0|||
25017236|NCT03682705|50112283|FG000|Overall Study|Adverse Event|1|||
25017237|NCT03682705|50112284|FG001|Overall Study|Adverse Event|1|||
25017238|NCT03682705|50112285|FG002|Overall Study|Adverse Event|1|||
25017239|NCT03682705|50112286|FG003|Overall Study|Adverse Event|0|||
25017240|NCT03682705|50112287|FG004|Overall Study|Adverse Event|1|||
25017241|NCT03682705|50112288|FG005|Overall Study|Adverse Event|1|||
25151642|NCT01567527|50266318|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
25017242|NCT03682705|50112283|FG000|Overall Study|Withdrawal by Subject|1|||
25017243|NCT03682705|50112284|FG001|Overall Study|Withdrawal by Subject|3|||
25151643|NCT01567527|50266319|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
25184856|NCT02653170|50333805|FG000|Overall Study|Withdrawal by Subject|3|||
25151644|NCT01567527|50266320|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
25184857|NCT02653170|50333806|FG001|Overall Study|Withdrawal by Subject|8|||
25184858|NCT02653170|50333807|FG002|Overall Study|Withdrawal by Subject|3|||
25151645|NCT01567527|50266316|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
25151646|NCT01567527|50266317|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
25151647|NCT01567527|50266318|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
25151648|NCT01567527|50266319|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
25151649|NCT01567527|50266320|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
25151650|NCT01567527|50266316|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
25151651|NCT01567527|50266317|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
25151652|NCT01567527|50266318|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
25151653|NCT01567527|50266319|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
25151654|NCT01567527|50266320|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
25151655|NCT01567527|50266316|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
25151656|NCT01567527|50266317|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
25151657|NCT01567527|50266318|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
25151658|NCT01567527|50266319|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
25151659|NCT01567527|50266320|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
25151660|NCT01567527|50266316|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
25151661|NCT01567527|50266317|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
25151662|NCT01567527|50266318|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
25151663|NCT01567527|50266319|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
25151664|NCT01567527|50266320|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
25151665|NCT01567527|50266316|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
25151666|NCT01567527|50266317|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
25151667|NCT01567527|50266318|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
25151668|NCT01567527|50266319|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
25151669|NCT01567527|50266320|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
25151670|NCT01567527|50266316|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
25151671|NCT01567527|50266317|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
25151672|NCT01567527|50266318|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
25151673|NCT01567527|50266319|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
25151674|NCT01567527|50266320|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
25151675|NCT01567527|50266316|FG000|IM Depot Stabilization.|Protocol deviation|0|||
25151676|NCT01567527|50266317|FG001|IM Depot Stabilization.|Protocol deviation|0|||
25151677|NCT01567527|50266318|FG002|IM Depot Stabilization.|Protocol deviation|5|||
25151678|NCT01567527|50266319|FG003|IM Depot Stabilization.|Protocol deviation|0|||
25151679|NCT01567527|50266320|FG004|IM Depot Stabilization.|Protocol deviation|0|||
25151680|NCT01567527|50266316|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
25151681|NCT01567527|50266317|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
25151682|NCT01567527|50266318|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
25151683|NCT01567527|50266319|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
25151684|NCT01567527|50266320|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
25151685|NCT01567527|50266316|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
25017244|NCT03682705|50112285|FG002|Overall Study|Withdrawal by Subject|2|||
25017245|NCT03682705|50112286|FG003|Overall Study|Withdrawal by Subject|4|||
25017246|NCT03682705|50112287|FG004|Overall Study|Withdrawal by Subject|0|||
25017247|NCT03682705|50112288|FG005|Overall Study|Withdrawal by Subject|1|||
25017248|NCT03682705|50112283|FG000|Overall Study|Other, not specified|0|||
25017249|NCT03682705|50112284|FG001|Overall Study|Other, not specified|0|||
25017250|NCT03682705|50112285|FG002|Overall Study|Other, not specified|0|||
25017251|NCT03682705|50112286|FG003|Overall Study|Other, not specified|1|||
25017252|NCT03682705|50112287|FG004|Overall Study|Other, not specified|2|||
25017253|NCT03682705|50112288|FG005|Overall Study|Other, not specified|0|||
25017254|NCT03682705|50112283|FG000|Overall Study|Lost to Follow-up|0|||
25017255|NCT03682705|50112284|FG001|Overall Study|Lost to Follow-up|0|||
25017256|NCT03682705|50112285|FG002|Overall Study|Lost to Follow-up|0|||
25017257|NCT03682705|50112286|FG003|Overall Study|Lost to Follow-up|0|||
25184859|NCT02653170|50333805|FG000|Overall Study|withdrawn by study team|2|||
25151686|NCT01567527|50266317|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
25151687|NCT01567527|50266318|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
25151688|NCT01567527|50266319|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
25151689|NCT01567527|50266320|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
25151690|NCT01567527|50266316|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
25151691|NCT01567527|50266317|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
25151692|NCT01567527|50266318|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
25151693|NCT01567527|50266319|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
25151694|NCT01567527|50266320|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
25151695|NCT01567527|50266316|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
25184860|NCT02653170|50333806|FG001|Overall Study|withdrawn by study team|4|||
25184861|NCT02653170|50333807|FG002|Overall Study|withdrawn by study team|5|||
25184862|NCT02653170|50333805|FG000|Overall Study|Lost to Follow-up|12|||
25151696|NCT01567527|50266317|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
25151697|NCT01567527|50266318|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
25151698|NCT01567527|50266319|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
25151699|NCT01567527|50266320|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
25151700|NCT01567527|50266316|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
25151701|NCT01567527|50266317|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
25151702|NCT01567527|50266318|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
25151703|NCT01567527|50266319|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
25151704|NCT01567527|50266320|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
25151705|NCT01567527|50266316|FG000|IM Depot Stabilization.|Adverse Event|0|||
25151706|NCT01567527|50266317|FG001|IM Depot Stabilization.|Adverse Event|0|||
25151707|NCT01567527|50266318|FG002|IM Depot Stabilization.|Adverse Event|37|||
25151708|NCT01567527|50266319|FG003|IM Depot Stabilization.|Adverse Event|0|||
25151709|NCT01567527|50266320|FG004|IM Depot Stabilization.|Adverse Event|0|||
25151710|NCT01567527|50266316|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
25151711|NCT01567527|50266317|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
25151712|NCT01567527|50266318|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
25151713|NCT01567527|50266319|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
25151714|NCT01567527|50266320|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
25151715|NCT01567527|50266316|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
25151716|NCT01567527|50266317|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
25151717|NCT01567527|50266318|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
25151718|NCT01567527|50266319|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
25151719|NCT01567527|50266320|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
25151720|NCT01567527|50266316|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
25151721|NCT01567527|50266317|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
25168634|NCT01872689|50298244|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
25184863|NCT02653170|50333806|FG001|Overall Study|Lost to Follow-up|4|||
25151722|NCT01567527|50266318|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
25151723|NCT01567527|50266319|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
25151724|NCT01567527|50266320|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
25151725|NCT01567527|50266316|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
25151726|NCT01567527|50266317|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
25151727|NCT01567527|50266318|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
25151728|NCT01567527|50266319|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
25151729|NCT01567527|50266320|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
25151730|NCT01567527|50266316|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
25151731|NCT01567527|50266317|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
25151732|NCT01567527|50266318|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
25151733|NCT01567527|50266319|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
25151734|NCT01567527|50266320|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
25151735|NCT01567527|50266316|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
25151736|NCT01567527|50266317|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
25151737|NCT01567527|50266318|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
25151738|NCT01567527|50266319|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
25151739|NCT01567527|50266320|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
25151740|NCT01567527|50266316|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
25151741|NCT01567527|50266317|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
25151742|NCT01567527|50266318|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
25151743|NCT01567527|50266319|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
25151744|NCT01567527|50266320|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
25151745|NCT01567527|50266316|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
25151746|NCT01567527|50266317|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
25151747|NCT01567527|50266318|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
25151748|NCT01567527|50266319|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
25151749|NCT01567527|50266320|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
25151750|NCT01567527|50266316|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
25151751|NCT01567527|50266317|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
25151752|NCT01567527|50266318|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
25151753|NCT01567527|50266319|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
25151754|NCT01567527|50266320|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
25151755|NCT01818752|50266331|FG000|Overall Study|Adverse Event|64|||
25151756|NCT01818752|50266332|FG001|Overall Study|Adverse Event|74|||
25151757|NCT01818752|50266331|FG000|Overall Study|Death|14|||
25151758|NCT01818752|50266332|FG001|Overall Study|Death|18|||
25151759|NCT01818752|50266331|FG000|Overall Study|Non-compliance|16|||
25151760|NCT01818752|50266332|FG001|Overall Study|Non-compliance|20|||
25151761|NCT01818752|50266331|FG000|Overall Study|Withdrawal by Subject|15|||
25151762|NCT01818752|50266332|FG001|Overall Study|Withdrawal by Subject|14|||
25151763|NCT01818752|50266331|FG000|Overall Study|Physician Decision|9|||
25151764|NCT01818752|50266332|FG001|Overall Study|Physician Decision|8|||
25151765|NCT01818752|50266331|FG000|Overall Study|Disease Progression|54|||
25151766|NCT01818752|50266332|FG001|Overall Study|Disease Progression|48|||
25151767|NCT01818752|50266331|FG000|Overall Study|Other|7|||
25151768|NCT01818752|50266332|FG001|Overall Study|Other|8|||
25151769|NCT01818752|50266331|FG000|Overall Study|Continuing Treatment|1|||
25151770|NCT01818752|50266332|FG001|Overall Study|Continuing Treatment|4|||
25151771|NCT01818752|50266331|FG000|Overall Study|Randomized but not Dosed|7|||
25151772|NCT01818752|50266332|FG001|Overall Study|Randomized but not Dosed|4|||
25151773|NCT01845818|50266340|FG000|Overall Study|Withdrawal by Subject|0|||
25151774|NCT01845818|50266341|FG001|Overall Study|Withdrawal by Subject|1|||
25151775|NCT01845818|50266340|FG000|Overall Study|Lost to Follow-up|7|||
25151776|NCT01845818|50266341|FG001|Overall Study|Lost to Follow-up|5|||
25151777|NCT01845818|50266340|FG000|Overall Study|Administrative Reasons|3|||
25151778|NCT01845818|50266341|FG001|Overall Study|Administrative Reasons|1|||
25151779|NCT01845818|50266340|FG000|Overall Study|Serious Adverse Event|1|||
25151780|NCT01845818|50266341|FG001|Overall Study|Serious Adverse Event|1|||
25151781|NCT01845818|50266340|FG000|Overall Study|Other|25|||
25151782|NCT01845818|50266341|FG001|Overall Study|Other|8|||
25151783|NCT01845818|50266340|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
25151784|NCT01845818|50266341|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
25151785|NCT01845818|50266340|FG000|Overall Study|No Follow-Up Data Available|4|||
25151786|NCT01845818|50266341|FG001|Overall Study|No Follow-Up Data Available|1|||
25151787|NCT01362608|50266351|FG000|Overall Study|Protocol Violation|0|||
25151788|NCT01362608|50266352|FG001|Overall Study|Protocol Violation|1|||
25151789|NCT01362608|50266351|FG000|Overall Study|Lost to Follow-up|3|||
25151790|NCT01362608|50266352|FG001|Overall Study|Lost to Follow-up|1|||
25151791|NCT01362608|50266351|FG000|Overall Study|Withdrawal by Subject|1|||
25151792|NCT01362608|50266352|FG001|Overall Study|Withdrawal by Subject|2|||
25151793|NCT01362608|50266351|FG000|Overall Study|Lack of Efficacy|0|||
25151794|NCT01362608|50266352|FG001|Overall Study|Lack of Efficacy|2|||
25151795|NCT01362608|50266351|FG000|Overall Study|Adverse Event|0|||
25151796|NCT01362608|50266352|FG001|Overall Study|Adverse Event|2|||
25151797|NCT01871090|50266360|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
25151798|NCT01871090|50266361|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
25151799|NCT01871090|50266360|FG000|Overall Study|Interrogation not completed correctly|1|||
25151800|NCT01871090|50266361|FG001|Overall Study|Interrogation not completed correctly|0|||
25151801|NCT01871090|50266360|FG000|Overall Study|Subject Non-Compliance|0|||
25151802|NCT01871090|50266361|FG001|Overall Study|Subject Non-Compliance|1|||
25151803|NCT01818596|50266369|FG000|Overall Study|Enrolled but Not Treated|4|||
25151804|NCT01818596|50266370|FG001|Overall Study|Enrolled but Not Treated|0|||
25151805|NCT01818596|50266369|FG000|Overall Study|Adverse Event|7|||
25151806|NCT01818596|50266370|FG001|Overall Study|Adverse Event|0|||
25151807|NCT01818596|50266369|FG000|Overall Study|Death|3|||
25151808|NCT01818596|50266370|FG001|Overall Study|Death|0|||
25151809|NCT01818596|50266369|FG000|Overall Study|Investigator's Discretion|4|||
25151810|NCT01818596|50266370|FG001|Overall Study|Investigator's Discretion|0|||
25151811|NCT01818596|50266369|FG000|Overall Study|Protocol Violation|1|||
25151812|NCT01818596|50266370|FG001|Overall Study|Protocol Violation|0|||
25151813|NCT01818596|50266369|FG000|Overall Study|Withdrew Consent|5|||
25151814|NCT01818596|50266370|FG001|Overall Study|Withdrew Consent|0|||
25151815|NCT01818596|50266369|FG000|Overall Study|Lost to Follow-up|7|||
25151816|NCT01818596|50266370|FG001|Overall Study|Lost to Follow-up|0|||
25151817|NCT04577794|50266383|FG000|Overall Study|Adverse Event|1|||
25151818|NCT04577794|50266384|FG001|Overall Study|Adverse Event|1|||
25151819|NCT01594281|50266401|FG000|Interventional Core Phase|Protocol Deviation|1|||
25151820|NCT01594281|50266402|FG001|Interventional Core Phase|Protocol Deviation|0|||
25151821|NCT01594281|50266403|FG002|Interventional Core Phase|Protocol Deviation|0|||
25151822|NCT01594281|50266401|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
25151823|NCT01594281|50266402|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
25151824|NCT01594281|50266403|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
25151825|NCT01594281|50266401|FG000|Interventional Core Phase|Death|1|||
25151826|NCT01594281|50266402|FG001|Interventional Core Phase|Death|1|||
25151827|NCT01594281|50266403|FG002|Interventional Core Phase|Death|2|||
25151828|NCT01594281|50266401|FG000|Interventional Core Phase|Lost to Follow-up|1|||
25151829|NCT01594281|50266402|FG001|Interventional Core Phase|Lost to Follow-up|4|||
25151830|NCT01594281|50266403|FG002|Interventional Core Phase|Lost to Follow-up|1|||
25151831|NCT01594281|50266401|FG000|Interventional Core Phase|Adverse Event|4|||
25151832|NCT01594281|50266402|FG001|Interventional Core Phase|Adverse Event|4|||
25151833|NCT01594281|50266403|FG002|Interventional Core Phase|Adverse Event|4|||
25151834|NCT01594281|50266401|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
25151835|NCT01594281|50266402|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
25151836|NCT01594281|50266403|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
25151837|NCT01594281|50266401|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
25151838|NCT01594281|50266402|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
25184864|NCT02653170|50333807|FG002|Overall Study|Lost to Follow-up|10|||
25151839|NCT01594281|50266403|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
25151840|NCT01594281|50266401|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
25151841|NCT01594281|50266402|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
25151842|NCT01594281|50266403|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
25151843|NCT01566981|50266416|FG000|Overall Study|Lost to Follow-up|5|||
25151844|NCT01566981|50266417|FG001|Overall Study|Lost to Follow-up|8|||
25151845|NCT01870778|50266427|FG000|Overall Study|Withdrawal by Subject|8|||
25151846|NCT01870778|50266428|FG001|Overall Study|Withdrawal by Subject|7|||
25151847|NCT01870778|50266427|FG000|Overall Study|Lost to Follow-up|0|||
25151848|NCT01870778|50266428|FG001|Overall Study|Lost to Follow-up|2|||
25151849|NCT01818284|50266441|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
25151850|NCT01818284|50266442|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
25151851|NCT01818284|50266441|FG000|Overall Study|Death|0|||
25151852|NCT01818284|50266442|FG001|Overall Study|Death|2|||
25151853|NCT01610492|50266478|FG000|Overall Study|Adverse Event|1|||
25151854|NCT01610492|50266478|FG000|Overall Study|Lack of Efficacy|3|||
25151855|NCT01610492|50266478|FG000|Overall Study|Other: Reached stopping criteria|1|||
25151856|NCT01610492|50266478|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
25151857|NCT01817582|50266485|FG000|Overall Study|Withdrawal by Subject|0|||
25151858|NCT01817582|50266486|FG001|Overall Study|Withdrawal by Subject|1|||
25151859|NCT01817582|50266487|FG002|Overall Study|Withdrawal by Subject|0|||
25151860|NCT01817582|50266485|FG000|Overall Study|Participant revealed masked treatment|1|||
25151861|NCT01817582|50266486|FG001|Overall Study|Participant revealed masked treatment|0|||
25274738|NCT01087203|50588795|FG000|Overall Study|Study terminated by sponsor|27|||
25274739|NCT01087203|50588796|FG001|Overall Study|Study terminated by sponsor|27|||
25017258|NCT03682705|50112287|FG004|Overall Study|Lost to Follow-up|3|||
25017259|NCT03682705|50112288|FG005|Overall Study|Lost to Follow-up|0|||
25017260|NCT03179787|50112302|FG000|Overall Study|Lost to Follow-up|15|||
25184865|NCT01463696|50333827|FG000|Overall Study|Adverse Event|0|||
25151862|NCT01817582|50266487|FG002|Overall Study|Participant revealed masked treatment|0|||
25151863|NCT01817582|50266485|FG000|Overall Study|Randomized but exclusion criteria met|1|||
25151864|NCT01817582|50266486|FG001|Overall Study|Randomized but exclusion criteria met|0|||
25151865|NCT01817582|50266487|FG002|Overall Study|Randomized but exclusion criteria met|0|||
25151866|NCT01594125|50266500|FG000|Overall Study|Withdrawal by Subject|1|||
25151867|NCT01594125|50266501|FG001|Overall Study|Withdrawal by Subject|0|||
25151868|NCT01594125|50266502|FG002|Overall Study|Withdrawal by Subject|0|||
25151869|NCT01594125|50266503|FG003|Overall Study|Withdrawal by Subject|1|||
25151870|NCT01594125|50266504|FG004|Overall Study|Withdrawal by Subject|0|||
25151871|NCT01594125|50266500|FG000|Overall Study|Progressive Disease|3|||
25151872|NCT01594125|50266501|FG001|Overall Study|Progressive Disease|12|||
25151873|NCT01594125|50266502|FG002|Overall Study|Progressive Disease|3|||
25151874|NCT01594125|50266503|FG003|Overall Study|Progressive Disease|3|||
25151875|NCT01594125|50266504|FG004|Overall Study|Progressive Disease|7|||
25151876|NCT01870076|50266520|FG000|Overall Study|Withdrawal by Subject|1|||
25151877|NCT01870076|50266521|FG001|Overall Study|Withdrawal by Subject|0|||
25151878|NCT01870076|50266522|FG002|Overall Study|Withdrawal by Subject|1|||
25151879|NCT01870076|50266523|FG003|Overall Study|Withdrawal by Subject|0|||
25151880|NCT01592721|50266533|FG000|Long-term Follow-up|Death|1|||
25151881|NCT01613378|50266537|FG000|Overall Study|Lack of Efficacy|13|||
25151882|NCT01613378|50266537|FG000|Overall Study|Adverse Event|11|||
25151883|NCT01613378|50266537|FG000|Overall Study|Withdrawal by Subject|8|||
25151884|NCT01613378|50266537|FG000|Overall Study|Death|2|||
25151885|NCT01613378|50266537|FG000|Overall Study|Lost to Follow-up|1|||
25151886|NCT01613378|50266537|FG000|Overall Study|Other Reason|4|||
25151887|NCT01592409|50266543|FG000|Overall Study|Withdrawal by Subject|0|||
25151888|NCT01592409|50266544|FG001|Overall Study|Withdrawal by Subject|1|||
25151889|NCT01697319|50266563|FG000|Primary Phase|Withdrawal by Subject|1|||
25151890|NCT01697319|50266563|FG000|Extension Phase|Terminated by Sponsor|15|||
25151891|NCT01566435|50266578|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
25151892|NCT01696929|50266586|FG000|Overall Study|Physician Decision|1|||
25151893|NCT01696773|50266596|FG000|Days 15-27, Washout|Adverse Event|1|||
25151894|NCT01696773|50266597|FG001|Days 15-27, Washout|Adverse Event|0|||
25151895|NCT01696695|50266603|FG000|Overall Study|Disease progression|373|||
25151896|NCT01696695|50266603|FG000|Overall Study|Death|29|||
25151897|NCT01696695|50266603|FG000|Overall Study|Adverse Event|74|||
25151898|NCT01696695|50266603|FG000|Overall Study|Withdrawal by Subject|92|||
25151899|NCT01696695|50266603|FG000|Overall Study|Lost to Follow-up|48|||
25151900|NCT01696695|50266603|FG000|Overall Study|Other|74|||
25151901|NCT01696695|50266603|FG000|Overall Study|Major Protocol Violation|192|||
25151902|NCT01565889|50266622|FG000|Part A|Withdrawal by Subject|1|||
25151903|NCT01565889|50266623|FG001|Part A|Withdrawal by Subject|0|||
25151904|NCT01565889|50266624|FG002|Part A|Withdrawal by Subject|0|||
25151905|NCT01565889|50266625|FG003|Part A|Withdrawal by Subject|0|||
25151906|NCT01565889|50266626|FG004|Part A|Withdrawal by Subject|0|||
25151907|NCT01565889|50266627|FG005|Part A|Withdrawal by Subject|0|||
25151908|NCT01565889|50266622|FG000|Part B|Withdrawal by Subject|0|||
25151909|NCT01565889|50266623|FG001|Part B|Withdrawal by Subject|0|||
25151910|NCT01565889|50266624|FG002|Part B|Withdrawal by Subject|0|||
25151911|NCT01565889|50266625|FG003|Part B|Withdrawal by Subject|0|||
25151912|NCT01565889|50266626|FG004|Part B|Withdrawal by Subject|0|||
25151913|NCT01565889|50266627|FG005|Part B|Withdrawal by Subject|1|||
25151914|NCT01565889|50266622|FG000|Part B|Lack of Efficacy|0|||
25151915|NCT01565889|50266623|FG001|Part B|Lack of Efficacy|0|||
25151916|NCT01565889|50266624|FG002|Part B|Lack of Efficacy|0|||
25151917|NCT01565889|50266625|FG003|Part B|Lack of Efficacy|0|||
25151918|NCT01565889|50266626|FG004|Part B|Lack of Efficacy|0|||
25151919|NCT01565889|50266627|FG005|Part B|Lack of Efficacy|2|||
25151920|NCT01565889|50266622|FG000|Part B|Lost to Follow-up|0|||
25151921|NCT01565889|50266623|FG001|Part B|Lost to Follow-up|0|||
25151922|NCT01565889|50266624|FG002|Part B|Lost to Follow-up|0|||
25151923|NCT01565889|50266625|FG003|Part B|Lost to Follow-up|0|||
25151924|NCT01565889|50266626|FG004|Part B|Lost to Follow-up|0|||
25151925|NCT01565889|50266627|FG005|Part B|Lost to Follow-up|1|||
25151926|NCT01696071|50266642|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
25151927|NCT01696071|50266643|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
25151928|NCT01591863|50266654|FG000|Overall Study|Adverse Event|3|||
25151929|NCT01591863|50266654|FG000|Overall Study|Withdrawal by Subject|1|||
25151930|NCT01591863|50266654|FG000|Overall Study|recurrence|9|||
25151931|NCT01591863|50266654|FG000|Overall Study|Lack of Efficacy|1|||
25151932|NCT01591785|50266660|FG000|Overall Study|worsening condition|1|||
25151933|NCT01591785|50266661|FG001|Overall Study|worsening condition|2|||
25151934|NCT01591785|50266660|FG000|Overall Study|Protocol Violation|2|||
25151935|NCT01591785|50266661|FG001|Overall Study|Protocol Violation|0|||
25151936|NCT01591785|50266660|FG000|Overall Study|Lost to Follow-up|1|||
25151937|NCT01591785|50266661|FG001|Overall Study|Lost to Follow-up|0|||
25151938|NCT01695993|50266670|FG000|Overall Study|Lost to Follow-up|2|||
25151939|NCT01695993|50266671|FG001|Overall Study|Lost to Follow-up|1|||
25151940|NCT01695993|50266672|FG002|Overall Study|Lost to Follow-up|3|||
25151941|NCT01695993|50266670|FG000|Overall Study|Withdrawal by Subject|2|||
25151942|NCT01695993|50266671|FG001|Overall Study|Withdrawal by Subject|2|||
25151943|NCT01695993|50266672|FG002|Overall Study|Withdrawal by Subject|2|||
25184866|NCT01463696|50333828|FG001|Overall Study|Adverse Event|1|||
25274740|NCT01246583|50588807|FG000|Overall Study|Lost to Follow-up|0|||
25274741|NCT01246583|50588808|FG001|Overall Study|Lost to Follow-up|0|||
25151944|NCT01695993|50266670|FG000|Overall Study|To ill to continue|1|||
25151945|NCT01695993|50266671|FG001|Overall Study|To ill to continue|2|||
25151946|NCT01695993|50266672|FG002|Overall Study|To ill to continue|0|||
25151947|NCT01695993|50266670|FG000|Overall Study|Changed Medical Facility|0|||
25151948|NCT01695993|50266671|FG001|Overall Study|Changed Medical Facility|0|||
25151949|NCT01695993|50266672|FG002|Overall Study|Changed Medical Facility|1|||
25151950|NCT01565343|50266683|FG000|Overall Study|Administrative decision/technical issues|1|||
25151951|NCT01565343|50266684|FG001|Overall Study|Administrative decision/technical issues|0|||
25151952|NCT01565343|50266685|FG002|Overall Study|Administrative decision/technical issues|0|||
25151953|NCT01695135|50266710|FG000|Double-blind Treatment Phase|Progressive disease|50|||
25151954|NCT01695135|50266711|FG001|Double-blind Treatment Phase|Progressive disease|110|||
25151955|NCT01695135|50266712|FG002|Double-blind Treatment Phase|Progressive disease|0|||
25151956|NCT01695135|50266713|FG003|Double-blind Treatment Phase|Progressive disease|0|||
25151957|NCT01695135|50266710|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
25151958|NCT01695135|50266711|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
25017261|NCT03179787|50112302|FG000|Overall Study|Case report failures|2|||
25151959|NCT01695135|50266712|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
25017262|NCT03179787|50112302|FG000|Overall Study|Treatment not administered|1|||
25017263|NCT03745937|50112310|FG000|Overall Study|Withdrawal by Subject|0|||
25017264|NCT03745937|50112311|FG001|Overall Study|Withdrawal by Subject|0|||
25017265|NCT03745937|50112312|FG002|Overall Study|Withdrawal by Subject|0|||
25017266|NCT03745937|50112313|FG003|Overall Study|Withdrawal by Subject|1|||
25017267|NCT03745937|50112310|FG000|Overall Study|Not-specifed|0|||
25017268|NCT03745937|50112311|FG001|Overall Study|Not-specifed|1|||
25017269|NCT03745937|50112312|FG002|Overall Study|Not-specifed|0|||
25017270|NCT03745937|50112313|FG003|Overall Study|Not-specifed|1|||
25017271|NCT02956057|50112330|FG000|Overall Study|Discontinued intervention|14|||
25017272|NCT02956057|50112331|FG001|Overall Study|Discontinued intervention|10|||
25017273|NCT02956057|50112332|FG002|Overall Study|Discontinued intervention|7|||
25017274|NCT02956057|50112333|FG003|Overall Study|Discontinued intervention|14|||
25017275|NCT02956057|50112334|FG004|Overall Study|Discontinued intervention|4|||
25017276|NCT02956057|50112335|FG005|Overall Study|Discontinued intervention|17|||
25017277|NCT02956057|50112330|FG000|Overall Study|Lost to Follow-up|0|||
25017278|NCT02956057|50112331|FG001|Overall Study|Lost to Follow-up|2|||
25017279|NCT02956057|50112332|FG002|Overall Study|Lost to Follow-up|1|||
25017280|NCT02956057|50112333|FG003|Overall Study|Lost to Follow-up|1|||
25017281|NCT02956057|50112334|FG004|Overall Study|Lost to Follow-up|1|||
25017282|NCT02956057|50112335|FG005|Overall Study|Lost to Follow-up|0|||
25017283|NCT03179319|50112351|FG000|Overall Study|Lost to Follow-up|6|||
25017284|NCT03179319|50112352|FG001|Overall Study|Lost to Follow-up|0|||
25017285|NCT03627091|50112361|FG000|Overall Study|Adverse Event|0|||
25017286|NCT03627091|50112362|FG001|Overall Study|Adverse Event|0|||
25017287|NCT03627091|50112363|FG002|Overall Study|Adverse Event|2|||
25017288|NCT03627091|50112361|FG000|Overall Study|Withdrawal by Subject|2|||
25151960|NCT01695135|50266713|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
25017289|NCT03627091|50112362|FG001|Overall Study|Withdrawal by Subject|0|||
25017290|NCT03627091|50112363|FG002|Overall Study|Withdrawal by Subject|2|||
25017291|NCT03627091|50112361|FG000|Overall Study|Physician Decision|2|||
25017292|NCT03627091|50112362|FG001|Overall Study|Physician Decision|0|||
25017293|NCT03627091|50112363|FG002|Overall Study|Physician Decision|0|||
25017294|NCT03627091|50112361|FG000|Overall Study|Site terminated by sponsor|0|||
25017295|NCT03627091|50112362|FG001|Overall Study|Site terminated by sponsor|1|||
25017296|NCT03627091|50112363|FG002|Overall Study|Site terminated by sponsor|0|||
25017297|NCT03627091|50112361|FG000|Overall Study|Disease relapse|7|||
25017298|NCT03627091|50112362|FG001|Overall Study|Disease relapse|5|||
25017299|NCT03627091|50112363|FG002|Overall Study|Disease relapse|1|||
25151961|NCT01695135|50266710|FG000|Double-blind Treatment Phase|Adverse Event|7|||
25151962|NCT01695135|50266711|FG001|Double-blind Treatment Phase|Adverse Event|7|||
25017300|NCT03627091|50112361|FG000|Overall Study|Other|1|||
25017301|NCT03627091|50112362|FG001|Overall Study|Other|0|||
25017302|NCT03627091|50112363|FG002|Overall Study|Other|0|||
25017303|NCT04237584|50112376|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
25017304|NCT04237584|50112377|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
25017305|NCT04237584|50112378|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
25017306|NCT04237584|50112379|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
25017307|NCT04237584|50112376|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
25017308|NCT04237584|50112377|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
25017309|NCT04237584|50112378|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
25017310|NCT04237584|50112379|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
25151963|NCT01695135|50266712|FG002|Double-blind Treatment Phase|Adverse Event|0|||
25151964|NCT01695135|50266713|FG003|Double-blind Treatment Phase|Adverse Event|0|||
25151965|NCT01695135|50266710|FG000|Double-blind Treatment Phase|Other|1|||
25151966|NCT01695135|50266711|FG001|Double-blind Treatment Phase|Other|3|||
25151967|NCT01695135|50266712|FG002|Double-blind Treatment Phase|Other|0|||
25151968|NCT01695135|50266713|FG003|Double-blind Treatment Phase|Other|0|||
25151969|NCT01695135|50266710|FG000|Double-blind Treatment Phase|Physician Decision|6|||
25151970|NCT01695135|50266711|FG001|Double-blind Treatment Phase|Physician Decision|3|||
25151971|NCT01695135|50266712|FG002|Double-blind Treatment Phase|Physician Decision|0|||
25151972|NCT01695135|50266713|FG003|Double-blind Treatment Phase|Physician Decision|0|||
25151973|NCT01695135|50266710|FG000|Double-blind Treatment Phase|Death|1|||
25151974|NCT01695135|50266711|FG001|Double-blind Treatment Phase|Death|1|||
25151975|NCT01695135|50266712|FG002|Double-blind Treatment Phase|Death|0|||
25151976|NCT01695135|50266713|FG003|Double-blind Treatment Phase|Death|0|||
25151977|NCT01695135|50266710|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
25151978|NCT01695135|50266711|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
25151979|NCT01695135|50266712|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
25151980|NCT01695135|50266713|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
25151981|NCT01695135|50266710|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
25151982|NCT01695135|50266711|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
25151983|NCT01695135|50266712|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
25151984|NCT01695135|50266713|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
25151985|NCT01695135|50266710|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
25151986|NCT01695135|50266711|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
25151987|NCT01695135|50266712|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
25151988|NCT01695135|50266713|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
25151989|NCT01695135|50266710|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
25151990|NCT01695135|50266711|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
25151991|NCT01695135|50266712|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
25151992|NCT01695135|50266713|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
25151993|NCT01695135|50266710|FG000|Open Label Extension Treatment Phase|Other|0|||
25151994|NCT01695135|50266711|FG001|Open Label Extension Treatment Phase|Other|0|||
25151995|NCT01695135|50266712|FG002|Open Label Extension Treatment Phase|Other|4|||
25151996|NCT01695135|50266713|FG003|Open Label Extension Treatment Phase|Other|7|||
25151997|NCT01695135|50266710|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
25151998|NCT01695135|50266711|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
25151999|NCT01695135|50266712|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
25152000|NCT01695135|50266713|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
25152001|NCT01695135|50266710|FG000|Open Label Extension Treatment Phase|Death|0|||
25152002|NCT01695135|50266711|FG001|Open Label Extension Treatment Phase|Death|0|||
25152003|NCT01695135|50266712|FG002|Open Label Extension Treatment Phase|Death|2|||
25152004|NCT01695135|50266713|FG003|Open Label Extension Treatment Phase|Death|7|||
25152005|NCT01695135|50266710|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
25152006|NCT01695135|50266711|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
25152007|NCT01695135|50266712|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
25152008|NCT01695135|50266713|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
25152009|NCT01610414|50266723|FG000|Study Start - Month 13|Serious Adverse Event|65|||
25152010|NCT01610414|50266724|FG001|Study Start - Month 13|Serious Adverse Event|67|||
25152011|NCT01610414|50266723|FG000|Study Start - Month 13|Adverse Event|14|||
25152012|NCT01610414|50266724|FG001|Study Start - Month 13|Adverse Event|14|||
25152013|NCT01610414|50266723|FG000|Study Start - Month 13|Protocol Violation|3|||
25152014|NCT01610414|50266724|FG001|Study Start - Month 13|Protocol Violation|1|||
25152015|NCT01610414|50266723|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
25152016|NCT01610414|50266724|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
25152017|NCT01610414|50266723|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
25152018|NCT01610414|50266724|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
25152019|NCT01610414|50266723|FG000|Study Start - Month 13|Lost to Follow-up|4|||
25152020|NCT01610414|50266724|FG001|Study Start - Month 13|Lost to Follow-up|6|||
25152021|NCT01610414|50266723|FG000|Study Start - Month 13|Suspected HZ episode|1|||
25152022|NCT01610414|50266724|FG001|Study Start - Month 13|Suspected HZ episode|3|||
25152023|NCT01610414|50266723|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
25152024|NCT01610414|50266724|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
25152025|NCT01610414|50266723|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
25152026|NCT01610414|50266724|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
25152027|NCT01610414|50266723|FG000|Month 13 - Month 25|Adverse Event|8|||
25152028|NCT01610414|50266724|FG001|Month 13 - Month 25|Adverse Event|4|||
25152029|NCT01610414|50266723|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
25152030|NCT01610414|50266724|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
25152031|NCT01610414|50266723|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
25152032|NCT01610414|50266724|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
25152033|NCT01610414|50266723|FG000|Month 13 - Month 25|Protocol Violation|0|||
25152034|NCT01610414|50266724|FG001|Month 13 - Month 25|Protocol Violation|2|||
25152035|NCT01610414|50266723|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
25152036|NCT01610414|50266724|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
25152037|NCT01610414|50266723|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
25152038|NCT01610414|50266724|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
25152039|NCT01610414|50266723|FG000|After Month 25|Study end not reached|48|||
25152040|NCT01610414|50266724|FG001|After Month 25|Study end not reached|53|||
25152041|NCT01564407|50266752|FG000|Overall Study|Lost to Follow-up|0|||
25152042|NCT01564407|50266753|FG001|Overall Study|Lost to Follow-up|1|||
25152043|NCT01564407|50266754|FG002|Overall Study|Lost to Follow-up|0|||
25152044|NCT01564407|50266755|FG003|Overall Study|Lost to Follow-up|0|||
25152045|NCT01564407|50266756|FG004|Overall Study|Lost to Follow-up|0|||
25152046|NCT01564407|50266752|FG000|Overall Study|Withdrawal by Subject|0|||
25152047|NCT01564407|50266753|FG001|Overall Study|Withdrawal by Subject|1|||
25152048|NCT01564407|50266754|FG002|Overall Study|Withdrawal by Subject|0|||
25152049|NCT01564407|50266755|FG003|Overall Study|Withdrawal by Subject|0|||
25152050|NCT01564407|50266756|FG004|Overall Study|Withdrawal by Subject|0|||
25152051|NCT01564407|50266752|FG000|Overall Study|funding lost, study ended|0|||
25152052|NCT01564407|50266753|FG001|Overall Study|funding lost, study ended|0|||
25152053|NCT01564407|50266754|FG002|Overall Study|funding lost, study ended|0|||
25067390|NCT02836769|50173016|FG000|Overall Study|Withdrawal by Subject|3|||
25152054|NCT01564407|50266755|FG003|Overall Study|funding lost, study ended|1|||
25152055|NCT01564407|50266756|FG004|Overall Study|funding lost, study ended|0|||
25152056|NCT01590771|50266779|FG000|Overall Study|Other Protocol Specified Criteria|5|||
25067391|NCT02836613|50173022|FG000|Overall Study|Accidental drowning|1|||
25067392|NCT02836613|50173023|FG001|Overall Study|Accidental drowning|0|||
25067393|NCT02836613|50173022|FG000|Overall Study|Lost to Follow-up|0|||
25067394|NCT02836613|50173023|FG001|Overall Study|Lost to Follow-up|1|||
25067395|NCT02836613|50173022|FG000|Overall Study|Withdrawal by Subject|0|||
25067396|NCT02836613|50173023|FG001|Overall Study|Withdrawal by Subject|2|||
25067397|NCT02397460|50173037|FG000|Treatment Period 2|Adverse Event|0|||
25152057|NCT01590771|50266780|FG001|Overall Study|Other Protocol Specified Criteria|14|||
25152058|NCT01590771|50266779|FG000|Overall Study|Withdrawal by Subject|8|||
25152059|NCT01590771|50266780|FG001|Overall Study|Withdrawal by Subject|15|||
25152060|NCT01590771|50266779|FG000|Overall Study|Protocol Violation|1|||
25152061|NCT01590771|50266780|FG001|Overall Study|Protocol Violation|2|||
25152062|NCT01590771|50266779|FG000|Overall Study|Lost to Follow-up|1|||
25152063|NCT01590771|50266780|FG001|Overall Study|Lost to Follow-up|1|||
25152064|NCT01590771|50266779|FG000|Overall Study|Lack of Efficacy|1|||
25152065|NCT01590771|50266780|FG001|Overall Study|Lack of Efficacy|0|||
25152066|NCT01590771|50266779|FG000|Overall Study|Adverse Event|3|||
25152067|NCT01590771|50266780|FG001|Overall Study|Adverse Event|7|||
25152068|NCT01563237|50266786|FG000|Overall Study|Lost to Follow-up|6|||
25152069|NCT01563237|50266787|FG001|Overall Study|Lost to Follow-up|0|||
25152070|NCT01563237|50266786|FG000|Overall Study|Withdrawal by Subject|1|||
25152071|NCT01563237|50266787|FG001|Overall Study|Withdrawal by Subject|0|||
25152072|NCT01563237|50266786|FG000|Overall Study|Adverse Event|1|||
25152073|NCT01563237|50266787|FG001|Overall Study|Adverse Event|0|||
25152074|NCT01563237|50266786|FG000|Overall Study|Medical Reasons|1|||
25152075|NCT01563237|50266787|FG001|Overall Study|Medical Reasons|0|||
25184867|NCT01463696|50333829|FG002|Overall Study|Adverse Event|0|||
25152076|NCT01563237|50266786|FG000|Overall Study|Death|1|||
25152077|NCT01563237|50266787|FG001|Overall Study|Death|0|||
25152078|NCT01694433|50266803|FG000|Overall Study|Adverse Event|7|||
25152079|NCT01694433|50266804|FG001|Overall Study|Adverse Event|0|||
25152080|NCT01694433|50266803|FG000|Overall Study|Physician Decision|1|||
25152081|NCT01694433|50266804|FG001|Overall Study|Physician Decision|0|||
25152082|NCT01694433|50266803|FG000|Overall Study|Withdrawal by Subject|3|||
25152083|NCT01694433|50266804|FG001|Overall Study|Withdrawal by Subject|4|||
25152084|NCT01694121|50266812|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
25152085|NCT01694121|50266813|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
25152086|NCT01562613|50266819|FG000|Overall Study|Lost to Follow-up|2|||
25017311|NCT04237584|50112376|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
25017312|NCT04237584|50112377|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
25017313|NCT04237584|50112378|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
25017314|NCT04237584|50112379|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
25017315|NCT04237584|50112376|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
25017316|NCT04237584|50112377|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
25017317|NCT04237584|50112378|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
25017318|NCT04237584|50112379|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
25017319|NCT04237584|50112376|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
25017320|NCT04237584|50112377|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
25017321|NCT04237584|50112378|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
25017322|NCT04237584|50112379|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
25017323|NCT03224598|50112396|FG000|Overall Study|Lost to Follow-up|0|||
25017324|NCT03224598|50112397|FG001|Overall Study|Lost to Follow-up|2|||
25152087|NCT01562613|50266819|FG000|Overall Study|Withdrawal by Subject|2|||
25017325|NCT03224598|50112398|FG002|Overall Study|Lost to Follow-up|0|||
25017326|NCT03224598|50112396|FG000|Overall Study|Other|0|||
25017327|NCT03224598|50112397|FG001|Overall Study|Other|1|||
25017328|NCT03224598|50112398|FG002|Overall Study|Other|0|||
25017329|NCT03681691|50112408|FG000|Overall Study|COVID|1|||
25017330|NCT03681691|50112409|FG001|Overall Study|COVID|0|||
25017331|NCT03681691|50112408|FG000|Overall Study|prolonged bleeding|1|||
25017332|NCT03681691|50112409|FG001|Overall Study|prolonged bleeding|0|||
25017333|NCT03681691|50112408|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
25152088|NCT01693185|50266825|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
25152089|NCT01693185|50266826|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
25152090|NCT01693029|50266841|FG000|Overall Study|Withdrawal by Subject|15|||
25067398|NCT02397460|50173038|FG001|Treatment Period 2|Adverse Event|0|||
25152091|NCT01693029|50266842|FG001|Overall Study|Withdrawal by Subject|22|||
25152092|NCT01693029|50266841|FG000|Overall Study|Kidney transplantation|7|||
25152093|NCT01693029|50266842|FG001|Overall Study|Kidney transplantation|7|||
25152094|NCT01693029|50266841|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
25152095|NCT01693029|50266842|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
25152096|NCT01693029|50266841|FG000|Overall Study|Protocol Violation|6|||
25152097|NCT01693029|50266842|FG001|Overall Study|Protocol Violation|7|||
25152098|NCT01693029|50266841|FG000|Overall Study|Change in dialysis modality|2|||
25152099|NCT01693029|50266842|FG001|Overall Study|Change in dialysis modality|1|||
25152100|NCT01693029|50266841|FG000|Overall Study|Physician Decision|0|||
25152101|NCT01693029|50266842|FG001|Overall Study|Physician Decision|2|||
25152102|NCT01693029|50266841|FG000|Overall Study|Lost to Follow-up|0|||
25152103|NCT01693029|50266842|FG001|Overall Study|Lost to Follow-up|1|||
25152104|NCT01693029|50266841|FG000|Overall Study|Adverse Event|1|||
25152105|NCT01693029|50266842|FG001|Overall Study|Adverse Event|6|||
25152106|NCT01693029|50266841|FG000|Overall Study|Death|5|||
25152107|NCT01693029|50266842|FG001|Overall Study|Death|8|||
25152108|NCT01693029|50266841|FG000|Overall Study|Non-compliance|2|||
25152109|NCT01693029|50266842|FG001|Overall Study|Non-compliance|1|||
25152110|NCT01589445|50266848|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
25152111|NCT01589445|50266848|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
25274742|NCT01246583|50588809|FG002|Overall Study|Lost to Follow-up|0|||
25274743|NCT01246583|50588810|FG003|Overall Study|Lost to Follow-up|1|||
25274744|NCT01246583|50588807|FG000|Overall Study|Protocol Violation|0|||
25274745|NCT01246583|50588808|FG001|Overall Study|Protocol Violation|0|||
25274746|NCT01246583|50588809|FG002|Overall Study|Protocol Violation|1|||
25274747|NCT01246583|50588810|FG003|Overall Study|Protocol Violation|0|||
25274748|NCT01246583|50588807|FG000|Overall Study|Withdrawal by Subject|1|||
25274749|NCT01246583|50588808|FG001|Overall Study|Withdrawal by Subject|0|||
25274750|NCT01246583|50588809|FG002|Overall Study|Withdrawal by Subject|0|||
25274751|NCT01246583|50588810|FG003|Overall Study|Withdrawal by Subject|0|||
25274752|NCT01084239|50588823|FG000|28-Day Follow-up|Lost to Follow-up|4|||
25274753|NCT01084239|50588824|FG001|28-Day Follow-up|Lost to Follow-up|9|||
25274754|NCT01244906|50588832|FG000|Overall Study|Death|2|||
25274755|NCT01244906|50588832|FG000|Overall Study|Progression of disease post treatment|6|||
25274756|NCT01080807|50588838|FG000|Overall Study|Adverse Event|9|||
25274757|NCT01080807|50588839|FG001|Overall Study|Adverse Event|1|||
25274758|NCT01080807|50588838|FG000|Overall Study|Lack of Efficacy|0|||
25274759|NCT01080807|50588839|FG001|Overall Study|Lack of Efficacy|1|||
25274760|NCT01080807|50588838|FG000|Overall Study|Withdrawal by Subject|7|||
25274761|NCT01080807|50588839|FG001|Overall Study|Withdrawal by Subject|2|||
25274762|NCT01080807|50588838|FG000|Overall Study|Protocol Violation|7|||
25274763|NCT01080807|50588839|FG001|Overall Study|Protocol Violation|6|||
25274764|NCT01080807|50588838|FG000|Overall Study|Lost to Follow-up|6|||
25274765|NCT01080807|50588839|FG001|Overall Study|Lost to Follow-up|4|||
25274766|NCT01080807|50588838|FG000|Overall Study|Noncompliance with drug administration|1|||
25274767|NCT01080807|50588839|FG001|Overall Study|Noncompliance with drug administration|1|||
25274768|NCT01080807|50588838|FG000|Overall Study|Noncompliance to study procedures|1|||
25274769|NCT01080807|50588839|FG001|Overall Study|Noncompliance to study procedures|1|||
25274770|NCT01080807|50588838|FG000|Overall Study|Began working day shift|0|||
25274771|NCT01080807|50588839|FG001|Overall Study|Began working day shift|2|||
25152112|NCT01589445|50266848|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
25152113|NCT01589445|50266848|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
25274772|NCT01080807|50588838|FG000|Overall Study|Laid off or terminated from job|1|||
25274773|NCT01080807|50588839|FG001|Overall Study|Laid off or terminated from job|2|||
25152114|NCT01589445|50266848|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
25152115|NCT01589445|50266848|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
25152116|NCT01589445|50266848|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
25274774|NCT01080807|50588838|FG000|Overall Study|Stopped working consistent night shifts|0|||
25017334|NCT03681691|50112409|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
25017335|NCT02935842|50112421|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
25017336|NCT02935842|50112422|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
25017337|NCT02935842|50112423|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
25017338|NCT02935842|50112424|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
25017339|NCT02935842|50112421|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
25017340|NCT02935842|50112422|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
25017341|NCT02935842|50112423|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
25017342|NCT02935842|50112424|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
25017343|NCT02935842|50112421|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
25017344|NCT02935842|50112422|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
25152117|NCT01589445|50266848|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
25152118|NCT01589445|50266848|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
25017345|NCT02935842|50112423|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
25017346|NCT02935842|50112424|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
25017347|NCT02935842|50112421|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
25017348|NCT02935842|50112422|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
25017349|NCT02935842|50112423|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
25017350|NCT02935842|50112424|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
25017351|NCT02935842|50112421|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
25017352|NCT02935842|50112422|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
25017353|NCT02935842|50112423|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
25017354|NCT02935842|50112424|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
25017355|NCT01064479|50112443|FG000|Overall Study|Death|10|||
25017356|NCT01064479|50112444|FG001|Overall Study|Death|11|||
25017357|NCT01064479|50112443|FG000|Overall Study|Withdrawal by Subject|2|||
25274775|NCT01080807|50588839|FG001|Overall Study|Stopped working consistent night shifts|1|||
25274776|NCT01080807|50588838|FG000|Overall Study|Work schedule changing|1|||
25274777|NCT01080807|50588839|FG001|Overall Study|Work schedule changing|1|||
25274778|NCT01080807|50588838|FG000|Overall Study|Work schedule and travel|0|||
25274779|NCT01080807|50588839|FG001|Overall Study|Work schedule and travel|1|||
25274780|NCT01080807|50588838|FG000|Overall Study|Switched to first shift|1|||
25274781|NCT01080807|50588839|FG001|Overall Study|Switched to first shift|0|||
25274782|NCT01080807|50588838|FG000|Overall Study|Moved away without notifying center|1|||
25274783|NCT01080807|50588839|FG001|Overall Study|Moved away without notifying center|0|||
25274784|NCT01076361|50588845|FG000|Overall Study|22 leads were excluded from analysis|21|||
25017358|NCT01064479|50112444|FG001|Overall Study|Withdrawal by Subject|2|||
25274785|NCT01079949|50588851|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
25184868|NCT01463696|50333830|FG003|Overall Study|Adverse Event|2|||
25017359|NCT01064479|50112443|FG000|Overall Study|Disease progression|1|||
25017360|NCT01064479|50112444|FG001|Overall Study|Disease progression|1|||
25017361|NCT01064479|50112443|FG000|Overall Study|Toxicity|1|||
25017362|NCT01064479|50112444|FG001|Overall Study|Toxicity|1|||
25017363|NCT01064479|50112443|FG000|Overall Study|Other|1|||
25017364|NCT01064479|50112444|FG001|Overall Study|Other|2|||
25017365|NCT03680911|50112452|FG000|At Home Treatment|Study Termination|3|||
25017366|NCT03680911|50112453|FG001|At Home Treatment|Study Termination|0|||
25017367|NCT03680911|50112452|FG000|At Home Treatment|Lost to Follow-up|0|||
25152119|NCT01589445|50266848|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
25152120|NCT01588509|50266865|FG000|Overall Study|Lost to Follow-up|1|||
25152121|NCT01588509|50266866|FG001|Overall Study|Lost to Follow-up|0|||
25152122|NCT01588353|50266875|FG000|Step2|Withdrawal by Subject|0|||
25184869|NCT01463696|50333831|FG004|Overall Study|Adverse Event|0|||
25017368|NCT03680911|50112453|FG001|At Home Treatment|Lost to Follow-up|1|||
25152123|NCT01588353|50266876|FG001|Step2|Withdrawal by Subject|1|||
25017369|NCT03680911|50112452|FG000|At Home Treatment|Withdrawal by Subject|0|||
25017370|NCT03680911|50112453|FG001|At Home Treatment|Withdrawal by Subject|2|||
25017371|NCT03680911|50112452|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
25017372|NCT03680911|50112453|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
25152124|NCT01588353|50266877|FG002|Step2|Withdrawal by Subject|0|||
25152125|NCT01588353|50266875|FG000|Step3|Adverse Event|0|||
25017373|NCT03224130|50112461|FG000|Overall Study|consent issue|0|||
25017374|NCT03224130|50112462|FG001|Overall Study|consent issue|1|||
25017375|NCT03680521|50112470|FG000|Overall Study|Ongoing in long-term follow up|7|||
25017376|NCT03680521|50112471|FG001|Overall Study|Ongoing in long-term follow up|11|||
25017377|NCT03679741|50112480|FG000|Period 1|No longer meet eligibility criteria|1|||
25017378|NCT03679741|50112481|FG001|Period 1|No longer meet eligibility criteria|0|||
25017379|NCT03679741|50112480|FG000|Period 1|Lost to Follow-up|0|||
25017380|NCT03679741|50112481|FG001|Period 1|Lost to Follow-up|1|||
25017381|NCT03679741|50112480|FG000|Period 1|Adverse Event|1|||
25017382|NCT03679741|50112481|FG001|Period 1|Adverse Event|1|||
25017383|NCT03679741|50112480|FG000|Period 1|Withdrawal by Subject|0|||
25017384|NCT03679741|50112481|FG001|Period 1|Withdrawal by Subject|1|||
25017385|NCT03679741|50112480|FG000|Period 2|Adverse Event|2|||
25017386|NCT03679741|50112481|FG001|Period 2|Adverse Event|1|||
25017387|NCT03679741|50112480|FG000|Period 2|Withdrawal by Subject|1|||
25017388|NCT03679741|50112481|FG001|Period 2|Withdrawal by Subject|1|||
25017389|NCT03678103|50112487|FG000|Overall Study|Withdrawn prior to completion|4|||
25017390|NCT03649477|50112494|FG000|Overall Study|Adverse Event|2|||
25017391|NCT03649477|50112495|FG001|Overall Study|Adverse Event|0|||
25017392|NCT03649477|50112496|FG002|Overall Study|Adverse Event|0|||
25017393|NCT03677869|50112504|FG000|Overall Study|Withdrawal by Subject|1|||
25017394|NCT03677401|50112510|FG000|Overall Study|Adverse Event|4|||
25017395|NCT03677401|50112511|FG001|Overall Study|Adverse Event|14|||
25017396|NCT03677401|50112510|FG000|Overall Study|Lack of Efficacy|3|||
25017397|NCT03677401|50112511|FG001|Overall Study|Lack of Efficacy|1|||
25017398|NCT03677401|50112510|FG000|Overall Study|Withdrawal by Subject|2|||
25017399|NCT03677401|50112511|FG001|Overall Study|Withdrawal by Subject|2|||
25017400|NCT03677401|50112510|FG000|Overall Study|Sponsor decision|0|||
25017401|NCT03677401|50112511|FG001|Overall Study|Sponsor decision|1|||
25017402|NCT03677401|50112510|FG000|Overall Study|Reason Unspecified|1|||
25017403|NCT03677401|50112511|FG001|Overall Study|Reason Unspecified|0|||
25017404|NCT03218787|50112517|FG000|Overall Study|Lost to Follow-up|12|||
25017405|NCT03218787|50112517|FG000|Overall Study|Withdrawal by Subject|72|||
25017406|NCT03218787|50112517|FG000|Overall Study|Physician Decision|11|||
25017407|NCT03218787|50112517|FG000|Overall Study|Death|111|||
25017408|NCT01348087|50112521|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
25017409|NCT01348087|50112521|FG000|Overall Study|Administrative problems|79|||
25017410|NCT01348087|50112521|FG000|Overall Study|protocol deviation|1|||
25017411|NCT01348087|50112521|FG000|Overall Study|Lost to Follow-up|1|||
25017412|NCT01348087|50112521|FG000|Overall Study|Subject withdrew consent|7|||
25017413|NCT01348087|50112521|FG000|Overall Study|Adverse Event|25|||
25017414|NCT01347931|50112535|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
25017415|NCT03645421|50112545|FG000|Overall Study|Adverse Event|0|||
25017416|NCT03645421|50112546|FG001|Overall Study|Adverse Event|0|||
25017417|NCT03645421|50112547|FG002|Overall Study|Adverse Event|4|||
25017418|NCT03645421|50112548|FG003|Overall Study|Adverse Event|1|||
25152126|NCT01588353|50266876|FG001|Step3|Adverse Event|0|||
25152127|NCT01588353|50266877|FG002|Step3|Adverse Event|2|||
25152128|NCT01588197|50266886|FG000|Overall Study|Lack of Efficacy|0|||
25017419|NCT03645421|50112545|FG000|Overall Study|Withdrawal by patient|0|||
25017420|NCT03645421|50112546|FG001|Overall Study|Withdrawal by patient|0|||
25152129|NCT01588197|50266887|FG001|Overall Study|Lack of Efficacy|1|||
25152130|NCT01588197|50266886|FG000|Overall Study|No MRI|1|||
25152131|NCT01588197|50266887|FG001|Overall Study|No MRI|0|||
25152132|NCT01561989|50266895|FG000|Overall Study|accural target not met.|5|||
25152133|NCT01561989|50266896|FG001|Overall Study|accural target not met.|6|||
25152134|NCT01587885|50266911|FG000|Treatment Period 1|Failure to Return|0|||
25152135|NCT01587885|50266912|FG001|Treatment Period 1|Failure to Return|1|||
25152136|NCT01587885|50266911|FG000|Treatment Period 1|Protocol Violation|0|||
25152137|NCT01587885|50266912|FG001|Treatment Period 1|Protocol Violation|2|||
25152138|NCT01587651|50266922|FG000|Overall Study|Adverse Event|0|||
25152139|NCT01587651|50266923|FG001|Overall Study|Adverse Event|1|||
25152140|NCT01587651|50266924|FG002|Overall Study|Adverse Event|0|||
25017421|NCT03645421|50112547|FG002|Overall Study|Withdrawal by patient|0|||
25017422|NCT03645421|50112548|FG003|Overall Study|Withdrawal by patient|3|||
25017423|NCT03645421|50112545|FG000|Overall Study|Study specific withdrawal criteria|0|||
25017424|NCT03645421|50112546|FG001|Overall Study|Study specific withdrawal criteria|0|||
25017425|NCT03645421|50112547|FG002|Overall Study|Study specific withdrawal criteria|1|||
25017426|NCT03645421|50112548|FG003|Overall Study|Study specific withdrawal criteria|0|||
25017427|NCT03207750|50112563|FG000|Overall Study|Adverse Event|3|||
25017428|NCT03207750|50112564|FG001|Overall Study|Adverse Event|2|||
25017429|NCT03207750|50112563|FG000|Overall Study|Lost to Follow-up|21|||
25152141|NCT01587651|50266922|FG000|Overall Study|Protocol Violation|0|||
25152142|NCT01587651|50266923|FG001|Overall Study|Protocol Violation|1|||
25152143|NCT01587651|50266924|FG002|Overall Study|Protocol Violation|1|||
25017430|NCT03207750|50112564|FG001|Overall Study|Lost to Follow-up|29|||
25017431|NCT03207750|50112563|FG000|Overall Study|Protocol Violation|0|||
25017432|NCT03207750|50112564|FG001|Overall Study|Protocol Violation|1|||
25152144|NCT01587651|50266922|FG000|Overall Study|Withdrawal by Subject|0|||
25152145|NCT01587651|50266923|FG001|Overall Study|Withdrawal by Subject|1|||
25067399|NCT02397460|50173039|FG002|Treatment Period 2|Adverse Event|0|||
25067400|NCT02397460|50173040|FG003|Treatment Period 2|Adverse Event|0|||
25067401|NCT02397460|50173041|FG004|Treatment Period 2|Adverse Event|0|||
25067402|NCT02397460|50173042|FG005|Treatment Period 2|Adverse Event|0|||
25067403|NCT02397460|50173043|FG006|Treatment Period 2|Adverse Event|0|||
25067404|NCT02397460|50173044|FG007|Treatment Period 2|Adverse Event|1|||
25067405|NCT02397460|50173037|FG000|Treatment Period 4|Adverse Event|0|||
25067406|NCT02397460|50173038|FG001|Treatment Period 4|Adverse Event|1|||
25067407|NCT02397460|50173039|FG002|Treatment Period 4|Adverse Event|0|||
25067408|NCT02397460|50173040|FG003|Treatment Period 4|Adverse Event|0|||
25067409|NCT02397460|50173041|FG004|Treatment Period 4|Adverse Event|0|||
25067410|NCT02397460|50173042|FG005|Treatment Period 4|Adverse Event|0|||
25067411|NCT02397460|50173043|FG006|Treatment Period 4|Adverse Event|0|||
25067412|NCT02397460|50173044|FG007|Treatment Period 4|Adverse Event|0|||
25067413|NCT02397460|50173037|FG000|Treatment Period 4|Physician Decision|0|||
25017433|NCT03207750|50112563|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
25017434|NCT03207750|50112564|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
25017435|NCT03207750|50112563|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
25017436|NCT03207750|50112564|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
25017437|NCT03207750|50112563|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
25017438|NCT03207750|50112564|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
25017439|NCT03207750|50112563|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
25017440|NCT03207750|50112564|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
25017441|NCT03207750|50112563|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
25017442|NCT03207750|50112564|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
25017443|NCT03674281|50112573|FG000|Overall Study|screen failure|2|||
25017444|NCT03674281|50112574|FG001|Overall Study|screen failure|0|||
25152146|NCT01587651|50266924|FG002|Overall Study|Withdrawal by Subject|0|||
25152147|NCT01691859|50266946|FG000|Overall Study|Adverse Event|19|||
25152148|NCT01691859|50266946|FG000|Overall Study|Lack of Efficacy|11|||
25152149|NCT01691859|50266946|FG000|Overall Study|Protocol Violation|4|||
25152150|NCT01691859|50266946|FG000|Overall Study|Product commercially available|221|||
25152151|NCT01691859|50266946|FG000|Overall Study|Study closed/terminated|50|||
25152152|NCT01691859|50266946|FG000|Overall Study|Lost to Follow-up|5|||
25152153|NCT01691859|50266946|FG000|Overall Study|Physician Decision|6|||
25152154|NCT01691859|50266946|FG000|Overall Study|Withdrawal by Subject|31|||
25152155|NCT01691781|50266990|FG000|Overall Study|Withdrawal by Subject|4|||
25152156|NCT01691781|50266991|FG001|Overall Study|Withdrawal by Subject|3|||
25152157|NCT01691781|50266990|FG000|Overall Study|Physician Decision|1|||
25152158|NCT01691781|50266991|FG001|Overall Study|Physician Decision|1|||
25152159|NCT01691781|50266990|FG000|Overall Study|Protocol Violation|2|||
25152160|NCT01691781|50266991|FG001|Overall Study|Protocol Violation|2|||
25152161|NCT01691781|50266990|FG000|Overall Study|Adverse Event|0|||
25152162|NCT01691781|50266991|FG001|Overall Study|Adverse Event|1|||
25184870|NCT01463696|50333832|FG005|Overall Study|Adverse Event|1|||
25152163|NCT01561755|50266999|FG000|Overall Study|Lost to Follow-up|0|||
25152164|NCT01561755|50267000|FG001|Overall Study|Lost to Follow-up|1|||
25152165|NCT01585155|50267020|FG000|Overall Study|Adverse Event|1|||
25152166|NCT01585155|50267020|FG000|Overall Study|Lack of Efficacy|2|||
25152167|NCT01585155|50267020|FG000|Overall Study|Worsening ulcerative colitis|2|||
25152168|NCT01560507|50267027|FG000|Overall Study|Lost to Follow-up|3|||
25184871|NCT01463696|50333833|FG006|Overall Study|Adverse Event|3|||
25184872|NCT01463696|50333834|FG007|Overall Study|Adverse Event|2|||
25184873|NCT01463696|50333827|FG000|Overall Study|Lost to Follow-up|0|||
25184874|NCT01463696|50333828|FG001|Overall Study|Lost to Follow-up|0|||
25184875|NCT01463696|50333829|FG002|Overall Study|Lost to Follow-up|1|||
25184876|NCT01463696|50333830|FG003|Overall Study|Lost to Follow-up|0|||
25184877|NCT01463696|50333831|FG004|Overall Study|Lost to Follow-up|0|||
25184878|NCT01463696|50333832|FG005|Overall Study|Lost to Follow-up|0|||
25184879|NCT01463696|50333833|FG006|Overall Study|Lost to Follow-up|0|||
25184880|NCT01463696|50333834|FG007|Overall Study|Lost to Follow-up|0|||
25184881|NCT01463696|50333827|FG000|Overall Study|Progressive Disease|0|||
25184882|NCT01463696|50333828|FG001|Overall Study|Progressive Disease|1|||
25184883|NCT01463696|50333829|FG002|Overall Study|Progressive Disease|0|||
25152169|NCT01560507|50267028|FG001|Overall Study|Lost to Follow-up|1|||
25152170|NCT01560507|50267029|FG002|Overall Study|Lost to Follow-up|2|||
25152171|NCT01560507|50267027|FG000|Overall Study|Withdrawal by Subject|1|||
25152172|NCT01560507|50267028|FG001|Overall Study|Withdrawal by Subject|1|||
25152173|NCT01560507|50267029|FG002|Overall Study|Withdrawal by Subject|0|||
25152174|NCT01584843|50267044|FG000|First Treatment Period|Adverse Event|0|||
25152175|NCT01584843|50267045|FG001|First Treatment Period|Adverse Event|0|||
25152176|NCT01584843|50267046|FG002|First Treatment Period|Adverse Event|1|||
25152177|NCT01584843|50267047|FG003|First Treatment Period|Adverse Event|0|||
25152178|NCT01584843|50267048|FG004|First Treatment Period|Adverse Event|0|||
25017445|NCT03674281|50112575|FG002|Overall Study|screen failure|0|||
25017446|NCT03674281|50112573|FG000|Overall Study|Withdrawal by Subject|1|||
25017447|NCT03674281|50112574|FG001|Overall Study|Withdrawal by Subject|3|||
25017448|NCT03674281|50112575|FG002|Overall Study|Withdrawal by Subject|3|||
25017449|NCT03673345|50112599|FG000|Overall Study|Lost to Follow-up|1|||
25017450|NCT03673345|50112600|FG001|Overall Study|Lost to Follow-up|0|||
25017451|NCT03673345|50112601|FG002|Overall Study|Lost to Follow-up|3|||
25017452|NCT03673345|50112602|FG003|Overall Study|Lost to Follow-up|3|||
25017453|NCT03673345|50112603|FG004|Overall Study|Lost to Follow-up|2|||
25017454|NCT03673345|50112604|FG005|Overall Study|Lost to Follow-up|1|||
25017455|NCT03673345|50112605|FG006|Overall Study|Lost to Follow-up|0|||
25017456|NCT03673345|50112606|FG007|Overall Study|Lost to Follow-up|0|||
25017457|NCT03673345|50112599|FG000|Overall Study|Withdrawal by Subject|1|||
25017458|NCT03673345|50112600|FG001|Overall Study|Withdrawal by Subject|0|||
25017459|NCT03673345|50112601|FG002|Overall Study|Withdrawal by Subject|4|||
25017460|NCT03673345|50112602|FG003|Overall Study|Withdrawal by Subject|2|||
25017461|NCT03673345|50112603|FG004|Overall Study|Withdrawal by Subject|0|||
25017462|NCT03673345|50112604|FG005|Overall Study|Withdrawal by Subject|0|||
25017463|NCT03673345|50112605|FG006|Overall Study|Withdrawal by Subject|0|||
25017464|NCT03673345|50112606|FG007|Overall Study|Withdrawal by Subject|0|||
25017465|NCT03673345|50112599|FG000|Overall Study|Physician Decision|0|||
25017466|NCT03673345|50112600|FG001|Overall Study|Physician Decision|0|||
25017467|NCT03673345|50112601|FG002|Overall Study|Physician Decision|2|||
25017468|NCT03673345|50112602|FG003|Overall Study|Physician Decision|0|||
25017469|NCT03673345|50112603|FG004|Overall Study|Physician Decision|0|||
25017470|NCT03673345|50112604|FG005|Overall Study|Physician Decision|0|||
25152179|NCT01584843|50267049|FG005|First Treatment Period|Adverse Event|0|||
25184884|NCT01463696|50333830|FG003|Overall Study|Progressive Disease|1|||
25017471|NCT03673345|50112605|FG006|Overall Study|Physician Decision|0|||
25017472|NCT03673345|50112606|FG007|Overall Study|Physician Decision|0|||
25017473|NCT03223662|50112624|FG000|Overall Study|Physician Decision|1|||
25017474|NCT03223662|50112624|FG000|Overall Study|Study closure|1|||
25017475|NCT03672097|50112628|FG000|Period 1|Withdrawal by Subject|2|||
25152180|NCT01584843|50267044|FG000|First Treatment Period|Protocol Violation|0|||
25152181|NCT01584843|50267045|FG001|First Treatment Period|Protocol Violation|0|||
25152182|NCT01584843|50267046|FG002|First Treatment Period|Protocol Violation|0|||
25152183|NCT01584843|50267047|FG003|First Treatment Period|Protocol Violation|0|||
25184885|NCT01463696|50333831|FG004|Overall Study|Progressive Disease|0|||
25274786|NCT01079949|50588852|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
25017476|NCT03672097|50112628|FG000|Period 1|Adverse Event|1|||
25017477|NCT03672097|50112628|FG000|Period 1|Did not receive treatment|1|||
25017478|NCT03672097|50112628|FG000|Period 2|Withdrawal by Subject|3|||
25017479|NCT03672097|50112628|FG000|Period 2|Other|1|||
25017480|NCT03847896|50112637|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
25017481|NCT03847896|50112638|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
25017482|NCT03847896|50112639|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
25017483|NCT03847896|50112640|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
25017484|NCT03847896|50112641|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
25017485|NCT03847896|50112637|FG000|Overall Study|Withdrawal by Subject|2|||
25017486|NCT03847896|50112638|FG001|Overall Study|Withdrawal by Subject|10|||
25017487|NCT03847896|50112639|FG002|Overall Study|Withdrawal by Subject|5|||
25017488|NCT03847896|50112640|FG003|Overall Study|Withdrawal by Subject|9|||
25017489|NCT03847896|50112641|FG004|Overall Study|Withdrawal by Subject|8|||
25017490|NCT03847896|50112637|FG000|Overall Study|Withdrawal by parent/guardian|0|||
25017491|NCT03847896|50112638|FG001|Overall Study|Withdrawal by parent/guardian|0|||
25017492|NCT03847896|50112639|FG002|Overall Study|Withdrawal by parent/guardian|1|||
25017493|NCT03847896|50112640|FG003|Overall Study|Withdrawal by parent/guardian|0|||
25017494|NCT03847896|50112641|FG004|Overall Study|Withdrawal by parent/guardian|0|||
25017495|NCT03847896|50112637|FG000|Overall Study|Adverse Event|2|||
25017496|NCT03847896|50112638|FG001|Overall Study|Adverse Event|1|||
25017497|NCT03847896|50112639|FG002|Overall Study|Adverse Event|3|||
25017498|NCT03847896|50112640|FG003|Overall Study|Adverse Event|2|||
25017499|NCT03847896|50112641|FG004|Overall Study|Adverse Event|4|||
25017500|NCT03847896|50112637|FG000|Overall Study|A severe exacerbation event|0|||
25017501|NCT03847896|50112638|FG001|Overall Study|A severe exacerbation event|0|||
25017502|NCT03847896|50112639|FG002|Overall Study|A severe exacerbation event|0|||
25017503|NCT03847896|50112640|FG003|Overall Study|A severe exacerbation event|0|||
25152184|NCT01584843|50267048|FG004|First Treatment Period|Protocol Violation|0|||
25017504|NCT03847896|50112641|FG004|Overall Study|A severe exacerbation event|3|||
25017505|NCT03847896|50112637|FG000|Overall Study|Protocol Violation|0|||
25017506|NCT03847896|50112638|FG001|Overall Study|Protocol Violation|2|||
25017507|NCT03847896|50112639|FG002|Overall Study|Protocol Violation|1|||
25017508|NCT03847896|50112640|FG003|Overall Study|Protocol Violation|0|||
25152185|NCT01584843|50267049|FG005|First Treatment Period|Protocol Violation|1|||
25152186|NCT01584843|50267044|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
25152187|NCT01584843|50267045|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
25152188|NCT01584843|50267046|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
25152189|NCT01584843|50267047|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
25152190|NCT01584843|50267048|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
25152191|NCT01584843|50267049|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
25017509|NCT03847896|50112641|FG004|Overall Study|Protocol Violation|2|||
25017510|NCT03847896|50112637|FG000|Overall Study|Lost to Follow-up|0|||
25017511|NCT03847896|50112638|FG001|Overall Study|Lost to Follow-up|0|||
25017512|NCT03847896|50112639|FG002|Overall Study|Lost to Follow-up|0|||
25017513|NCT03847896|50112640|FG003|Overall Study|Lost to Follow-up|1|||
25017514|NCT03847896|50112641|FG004|Overall Study|Lost to Follow-up|0|||
25017515|NCT03847896|50112637|FG000|Overall Study|Condition under investigation worsened|0|||
25017516|NCT03847896|50112638|FG001|Overall Study|Condition under investigation worsened|0|||
25017517|NCT03847896|50112639|FG002|Overall Study|Condition under investigation worsened|0|||
25017518|NCT03847896|50112640|FG003|Overall Study|Condition under investigation worsened|1|||
25017519|NCT03847896|50112641|FG004|Overall Study|Condition under investigation worsened|1|||
25017520|NCT03847896|50112637|FG000|Overall Study|Lack of Efficacy|0|||
25017521|NCT03847896|50112638|FG001|Overall Study|Lack of Efficacy|0|||
25017522|NCT03847896|50112639|FG002|Overall Study|Lack of Efficacy|0|||
25017523|NCT03847896|50112640|FG003|Overall Study|Lack of Efficacy|2|||
25017524|NCT03847896|50112641|FG004|Overall Study|Lack of Efficacy|2|||
25017525|NCT03847896|50112637|FG000|Overall Study|Other reasons|3|||
25017526|NCT03847896|50112638|FG001|Overall Study|Other reasons|3|||
25017527|NCT03847896|50112639|FG002|Overall Study|Other reasons|1|||
25017528|NCT03847896|50112640|FG003|Overall Study|Other reasons|2|||
25017529|NCT03847896|50112641|FG004|Overall Study|Other reasons|1|||
25017530|NCT03670537|50112653|FG000|Overall Study|Protocol Violation|1|||
25017531|NCT03619837|50112657|FG000|Screening|received organs from HCV-negative donors|47|||
25017532|NCT03619837|50112657|FG000|Screening|died on the wait-list|2|||
25017533|NCT03619837|50112657|FG000|Screening|remained on the wait list|40|||
25017534|NCT03619837|50112657|FG000|Screening|didn't meet eligibility criteria|3|||
25017535|NCT03619837|50112657|FG000|Screening|withdrew consent|2|||
25152192|NCT01584843|50267044|FG000|Second Treatment Period|Withdrawal by Subject|0|||
25017536|NCT03619837|50112657|FG000|Screening|never listed for HCV-viremic donor|1|||
25017537|NCT03619837|50112657|FG000|Screening|developed exclusion criteria|2|||
25152193|NCT01584843|50267045|FG001|Second Treatment Period|Withdrawal by Subject|0|||
25017538|NCT03619837|50112657|FG000|Screening|excluded by the investigator due to non-compliance|1|||
25017539|NCT03206970|50112661|FG000|Overall Study|Death|21|||
25017540|NCT03206970|50112661|FG000|Overall Study|Withdrawal by Subject|13|||
25152194|NCT01584843|50267046|FG002|Second Treatment Period|Withdrawal by Subject|0|||
25274787|NCT01079949|50588851|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
25152195|NCT01584843|50267047|FG003|Second Treatment Period|Withdrawal by Subject|0|||
25152196|NCT01584843|50267048|FG004|Second Treatment Period|Withdrawal by Subject|0|||
25152197|NCT01584843|50267049|FG005|Second Treatment Period|Withdrawal by Subject|1|||
25152198|NCT01560429|50267067|FG000|Overall Study|Protocol Violation|3|||
25152199|NCT01560429|50267068|FG001|Overall Study|Protocol Violation|6|||
25152200|NCT01582971|50267078|FG000|Overall Study|Death|2|||
25152201|NCT01582971|50267079|FG001|Overall Study|Death|1|||
25152202|NCT01582971|50267078|FG000|Overall Study|Lost to Follow-up|18|||
25152203|NCT01582971|50267079|FG001|Overall Study|Lost to Follow-up|21|||
25152204|NCT01582971|50267078|FG000|Overall Study|Withdrawal by Subject|4|||
25152205|NCT01582971|50267079|FG001|Overall Study|Withdrawal by Subject|2|||
25152206|NCT01582971|50267078|FG000|Overall Study|Other|15|||
25152207|NCT01582971|50267079|FG001|Overall Study|Other|13|||
25152208|NCT01690299|50267094|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
25152209|NCT01690299|50267095|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
25274788|NCT01079949|50588852|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
25017541|NCT03206970|50112661|FG000|Overall Study|Lost to Follow-up|3|||
25017542|NCT03206970|50112661|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
25017543|NCT03644173|50112665|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
25017544|NCT03644173|50112665|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
25152210|NCT01690299|50267096|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
25152211|NCT01690299|50267097|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
25152212|NCT01690299|50267098|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
25152213|NCT01690299|50267099|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
25152214|NCT01690299|50267094|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
25152215|NCT01690299|50267095|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
25152216|NCT01690299|50267096|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
25152217|NCT01690299|50267097|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
25152218|NCT01690299|50267098|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
25152219|NCT01690299|50267099|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
25152220|NCT01690299|50267094|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
25152221|NCT01690299|50267095|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
25152222|NCT01690299|50267096|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
25152223|NCT01690299|50267097|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
25152224|NCT01690299|50267098|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
25152225|NCT01690299|50267099|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
25152226|NCT01690299|50267094|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
25152227|NCT01690299|50267095|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
25152228|NCT01690299|50267096|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
25152229|NCT01690299|50267097|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
25152230|NCT01690299|50267098|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
25152231|NCT01690299|50267099|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
25152232|NCT01690299|50267094|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
25152233|NCT01690299|50267095|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
25152234|NCT01690299|50267096|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
25152235|NCT01690299|50267097|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
25152236|NCT01690299|50267098|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
25152237|NCT01690299|50267099|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
25152238|NCT01690299|50267094|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
25152239|NCT01690299|50267095|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
25152240|NCT01690299|50267096|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
25152241|NCT01690299|50267097|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
25152242|NCT01690299|50267098|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
25152243|NCT01690299|50267099|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
25152244|NCT01690299|50267094|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
25152245|NCT01690299|50267095|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
25152246|NCT01690299|50267096|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
25152247|NCT01690299|50267097|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
25152248|NCT01690299|50267098|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
25152249|NCT01690299|50267099|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
25152250|NCT01690299|50267094|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
25152251|NCT01690299|50267095|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
25152252|NCT01690299|50267096|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
25152253|NCT01690299|50267097|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
25152254|NCT01690299|50267098|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
25152255|NCT01690299|50267099|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
25152256|NCT01690299|50267094|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
25152257|NCT01690299|50267095|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
25152258|NCT01690299|50267096|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
25152259|NCT01690299|50267097|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
25152260|NCT01690299|50267098|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
25152261|NCT01690299|50267099|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
25152262|NCT01690299|50267094|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
25152263|NCT01690299|50267095|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
25152264|NCT01690299|50267096|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
25152265|NCT01690299|50267097|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
25152266|NCT01690299|50267098|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
25152267|NCT01690299|50267099|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
25152268|NCT01690143|50267128|FG000|Overall Study|Withdrawal by Subject|1|||
25152269|NCT01559259|50267151|FG000|Overall Study|Withdrawal by Subject|0|||
25152270|NCT01559259|50267152|FG001|Overall Study|Withdrawal by Subject|0|||
25152271|NCT01559259|50267153|FG002|Overall Study|Withdrawal by Subject|0|||
25152272|NCT01559259|50267154|FG003|Overall Study|Withdrawal by Subject|1|||
25184886|NCT01463696|50333832|FG005|Overall Study|Progressive Disease|1|||
25017545|NCT03644173|50112665|FG000|Participants at the 1-month Follow up|Death|2|||
25017546|NCT03644173|50112665|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
25017547|NCT03178851|50112673|FG000|Overall Study|Death|48|||
25017548|NCT03178851|50112674|FG001|Overall Study|Death|2|||
25017549|NCT03178851|50112675|FG002|Overall Study|Death|25|||
25184887|NCT01463696|50333833|FG006|Overall Study|Progressive Disease|4|||
25017550|NCT03178851|50112673|FG000|Overall Study|Withdrawal by Subject|8|||
25017551|NCT03178851|50112674|FG001|Overall Study|Withdrawal by Subject|0|||
25017552|NCT03178851|50112675|FG002|Overall Study|Withdrawal by Subject|0|||
25017553|NCT03178851|50112673|FG000|Overall Study|Lost to Follow-up|5|||
25017554|NCT03178851|50112674|FG001|Overall Study|Lost to Follow-up|2|||
25017555|NCT03178851|50112675|FG002|Overall Study|Lost to Follow-up|0|||
25017556|NCT03178851|50112673|FG000|Overall Study|Adverse Event|0|||
25017557|NCT03178851|50112674|FG001|Overall Study|Adverse Event|0|||
25017558|NCT03178851|50112675|FG002|Overall Study|Adverse Event|1|||
25017559|NCT03178851|50112673|FG000|Overall Study|Study Termination by Sponsor|31|||
25017560|NCT03178851|50112674|FG001|Overall Study|Study Termination by Sponsor|7|||
25017561|NCT03178851|50112675|FG002|Overall Study|Study Termination by Sponsor|26|||
25017562|NCT03643159|50112686|FG000|Overall Study|Adverse Event|1|||
25017563|NCT03643159|50112686|FG000|Overall Study|Withdrawal by Subject|1|||
25017564|NCT03205566|50112693|FG000|Phase 1|Protocol Violation|1|||
25017565|NCT03205566|50112694|FG001|Phase 1|Protocol Violation|1|||
25017566|NCT02935452|50112706|FG000|Overall Study|work and life commintment|3|||
25017567|NCT02935452|50112707|FG001|Overall Study|work and life commintment|1|||
25017568|NCT03178773|50112715|FG000|Overall Study|Death|0|||
25017569|NCT03178773|50112716|FG001|Overall Study|Death|1|||
25017570|NCT03178773|50112715|FG000|Overall Study|Lost to Follow-up|29|||
25017571|NCT03178773|50112716|FG001|Overall Study|Lost to Follow-up|25|||
25017572|NCT03178773|50112715|FG000|Overall Study|Withdrawal by Subject|10|||
25152273|NCT01559259|50267155|FG004|Overall Study|Withdrawal by Subject|0|||
25152274|NCT01559259|50267151|FG000|Overall Study|Adverse Event|0|||
25152275|NCT01559259|50267152|FG001|Overall Study|Adverse Event|1|||
25017573|NCT03178773|50112716|FG001|Overall Study|Withdrawal by Subject|14|||
25017574|NCT03713034|50112725|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
25152276|NCT01559259|50267153|FG002|Overall Study|Adverse Event|1|||
25017575|NCT03713034|50112726|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
25017576|NCT03218397|50112736|FG000|Overall Study|Prior positive blood culture|8|||
25017577|NCT03218397|50112737|FG001|Overall Study|Prior positive blood culture|13|||
25017578|NCT03218397|50112736|FG000|Overall Study|Comfort care|8|||
25017579|NCT03218397|50112737|FG001|Overall Study|Comfort care|5|||
25017580|NCT03218397|50112736|FG000|Overall Study|Comfort care and positive blood culture|1|||
25017581|NCT03218397|50112737|FG001|Overall Study|Comfort care and positive blood culture|0|||
25017582|NCT03218397|50112736|FG000|Overall Study|Comfort care and mixed culture|0|||
25017583|NCT03218397|50112737|FG001|Overall Study|Comfort care and mixed culture|1|||
25017584|NCT03218397|50112736|FG000|Overall Study|Mixed culture|2|||
25017585|NCT03218397|50112737|FG001|Overall Study|Mixed culture|2|||
25017586|NCT03218397|50112736|FG000|Overall Study|Inaccessible hospital records|2|||
25017587|NCT03218397|50112737|FG001|Overall Study|Inaccessible hospital records|5|||
25017588|NCT03218397|50112736|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
25017589|NCT03218397|50112737|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
25017590|NCT03218397|50112736|FG000|Overall Study|Randomized during laboratory off hours|2|||
25017591|NCT03218397|50112737|FG001|Overall Study|Randomized during laboratory off hours|1|||
25017592|NCT03618823|50112745|FG000|Overall Study|Lost to Follow-up|63|||
25017593|NCT03618823|50112746|FG001|Overall Study|Lost to Follow-up|61|||
25017594|NCT03640507|50112758|FG000|Overall Study|Withdrawal by Subject|0|||
25017595|NCT03640507|50112759|FG001|Overall Study|Withdrawal by Subject|0|||
25017596|NCT03640507|50112760|FG002|Overall Study|Withdrawal by Subject|1|||
25017597|NCT02937636|50112770|FG000|Overall Study|Other (Not specified)|3|||
25017598|NCT02937636|50112771|FG001|Overall Study|Other (Not specified)|2|||
25017599|NCT03638635|50112780|FG000|Initial Hospitalization|Study terminated prematurely|0|||
25017600|NCT03638635|50112781|FG001|Initial Hospitalization|Study terminated prematurely|1|||
25017601|NCT03638635|50112780|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
25017602|NCT03638635|50112781|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
25017603|NCT03638635|50112780|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
25017604|NCT03638635|50112781|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
25017605|NCT03204981|50112787|FG000|Overall Study|Physician Decision|2|||
25017606|NCT03204981|50112787|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
25017607|NCT03205488|50112796|FG000|Overall Study|Adverse Event|1|||
25017608|NCT03205488|50112797|FG001|Overall Study|Adverse Event|2|||
25017609|NCT03205488|50112798|FG002|Overall Study|Adverse Event|4|||
25017610|NCT03205488|50112796|FG000|Overall Study|Protocol Violation|0|||
25017611|NCT03205488|50112797|FG001|Overall Study|Protocol Violation|0|||
25184888|NCT01463696|50333834|FG007|Overall Study|Progressive Disease|2|||
25017612|NCT03205488|50112798|FG002|Overall Study|Protocol Violation|1|||
25017613|NCT03204279|50112812|FG000|Overall Study|Withdrawal by Subject|0|||
25017614|NCT03204279|50112813|FG001|Overall Study|Withdrawal by Subject|1|||
25017615|NCT03173547|50112822|FG000|Overall Study|Adverse Event|2|||
25017616|NCT03173547|50112823|FG001|Overall Study|Adverse Event|0|||
25017617|NCT03173547|50112822|FG000|Overall Study|Withdrawal by Subject|2|||
25017618|NCT03173547|50112823|FG001|Overall Study|Withdrawal by Subject|2|||
25017619|NCT02954653|50112831|FG000|Overall Study|Death|3|||
25152277|NCT01559259|50267154|FG003|Overall Study|Adverse Event|0|||
25017620|NCT02954653|50112832|FG001|Overall Study|Death|1|||
25017621|NCT02954653|50112833|FG002|Overall Study|Death|0|||
25017622|NCT02954653|50112834|FG003|Overall Study|Death|0|||
25017623|NCT02954653|50112835|FG004|Overall Study|Death|0|||
25017624|NCT02954653|50112836|FG005|Overall Study|Death|0|||
25017625|NCT02954653|50112837|FG006|Overall Study|Death|0|||
25017626|NCT02954653|50112838|FG007|Overall Study|Death|0|||
25017627|NCT02954653|50112839|FG008|Overall Study|Death|0|||
25017628|NCT02954653|50112831|FG000|Overall Study|Randomized but did not receive treatment|1|||
25017629|NCT02954653|50112832|FG001|Overall Study|Randomized but did not receive treatment|0|||
25017630|NCT02954653|50112833|FG002|Overall Study|Randomized but did not receive treatment|0|||
25017631|NCT02954653|50112834|FG003|Overall Study|Randomized but did not receive treatment|0|||
25017632|NCT02954653|50112835|FG004|Overall Study|Randomized but did not receive treatment|0|||
25152278|NCT01559259|50267155|FG004|Overall Study|Adverse Event|0|||
25152279|NCT01670500|50267179|FG000|Overall Study|Withdrawal by Subject|1|||
25152280|NCT01670500|50267180|FG001|Overall Study|Withdrawal by Subject|0|||
25152281|NCT02400736|50267188|FG000|Overall Study|Lost to Follow-up|6|||
25152282|NCT02400736|50267189|FG001|Overall Study|Lost to Follow-up|6|||
25017633|NCT02954653|50112836|FG005|Overall Study|Randomized but did not receive treatment|0|||
25017634|NCT02954653|50112837|FG006|Overall Study|Randomized but did not receive treatment|0|||
25017635|NCT02954653|50112838|FG007|Overall Study|Randomized but did not receive treatment|0|||
25152283|NCT02400736|50267188|FG000|Overall Study|Withdrawal by Subject|2|||
25152284|NCT02400736|50267189|FG001|Overall Study|Withdrawal by Subject|1|||
25152285|NCT02400736|50267188|FG000|Overall Study|Moved from the area|3|||
25152286|NCT02400736|50267189|FG001|Overall Study|Moved from the area|1|||
25152287|NCT01689519|50267201|FG000|Intent to Treat|Death|157|||
25152288|NCT01689519|50267202|FG001|Intent to Treat|Death|167|||
25152289|NCT01689519|50267201|FG000|Intent to Treat|Lost to Follow-up|4|||
25152290|NCT01689519|50267202|FG001|Intent to Treat|Lost to Follow-up|8|||
25152291|NCT01689519|50267201|FG000|Intent to Treat|Other|2|||
25152292|NCT01689519|50267202|FG001|Intent to Treat|Other|4|||
25017636|NCT02954653|50112839|FG008|Overall Study|Randomized but did not receive treatment|0|||
25017637|NCT02954653|50112831|FG000|Overall Study|Started another anti-cancer therapy|0|||
25152293|NCT01689519|50267201|FG000|Intent to Treat|Physician Decision|4|||
25152294|NCT01689519|50267202|FG001|Intent to Treat|Physician Decision|1|||
25152295|NCT01689519|50267201|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
25152296|NCT01689519|50267202|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
25017638|NCT02954653|50112832|FG001|Overall Study|Started another anti-cancer therapy|1|||
25017639|NCT02954653|50112833|FG002|Overall Study|Started another anti-cancer therapy|0|||
25017640|NCT02954653|50112834|FG003|Overall Study|Started another anti-cancer therapy|0|||
25017641|NCT02954653|50112835|FG004|Overall Study|Started another anti-cancer therapy|0|||
25017642|NCT02954653|50112836|FG005|Overall Study|Started another anti-cancer therapy|0|||
25017643|NCT02954653|50112837|FG006|Overall Study|Started another anti-cancer therapy|0|||
25017644|NCT02954653|50112838|FG007|Overall Study|Started another anti-cancer therapy|0|||
25017645|NCT02954653|50112839|FG008|Overall Study|Started another anti-cancer therapy|0|||
25017646|NCT02954653|50112831|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
25017647|NCT02954653|50112832|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
25017648|NCT02954653|50112833|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
25017649|NCT02954653|50112834|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
25017650|NCT02954653|50112835|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
25152297|NCT01689519|50267201|FG000|Intent to Treat|Withdrawal by Subject|21|||
25152298|NCT01689519|50267202|FG001|Intent to Treat|Withdrawal by Subject|20|||
25152299|NCT01689519|50267201|FG000|Safety Population|Death|158|||
25152300|NCT01689519|50267202|FG001|Safety Population|Death|165|||
25152301|NCT01689519|50267201|FG000|Safety Population|Lost to Follow-up|4|||
25152302|NCT01689519|50267202|FG001|Safety Population|Lost to Follow-up|8|||
25152303|NCT01689519|50267201|FG000|Safety Population|Other|2|||
25152304|NCT01689519|50267202|FG001|Safety Population|Other|4|||
25152305|NCT01689519|50267201|FG000|Safety Population|Physician Decision|4|||
25152306|NCT01689519|50267202|FG001|Safety Population|Physician Decision|1|||
25152307|NCT01689519|50267201|FG000|Safety Population|Study Terminated By Sponsor|60|||
25152308|NCT01689519|50267202|FG001|Safety Population|Study Terminated By Sponsor|47|||
25152309|NCT01689519|50267201|FG000|Safety Population|Withdrawal by Subject|20|||
25152310|NCT01689519|50267202|FG001|Safety Population|Withdrawal by Subject|20|||
25152311|NCT01689363|50267208|FG000|Overall Study|Protocol Violation|0|||
25152312|NCT01689363|50267209|FG001|Overall Study|Protocol Violation|1|||
25152313|NCT01689363|50267210|FG002|Overall Study|Protocol Violation|0|||
25152314|NCT01689363|50267211|FG003|Overall Study|Protocol Violation|0|||
25152315|NCT01689363|50267212|FG004|Overall Study|Protocol Violation|0|||
25017651|NCT02954653|50112836|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
25017652|NCT02954653|50112837|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
25017653|NCT02954653|50112838|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
25152316|NCT01689363|50267213|FG005|Overall Study|Protocol Violation|0|||
25152317|NCT01689363|50267214|FG006|Overall Study|Protocol Violation|0|||
25152318|NCT01689363|50267215|FG007|Overall Study|Protocol Violation|0|||
25152319|NCT01558635|50267231|FG000|Overall Study|Death|1|||
25152320|NCT01558635|50267231|FG000|Overall Study|Withdrawal by Subject|2|||
25017654|NCT02954653|50112839|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
25017655|NCT03173313|50112853|FG000|Overall Study|Lost to Follow-up|2|||
25017656|NCT03173313|50112854|FG001|Overall Study|Lost to Follow-up|3|||
25017657|NCT03173313|50112853|FG000|Overall Study|Withdrawal by Subject|0|||
25017658|NCT03173313|50112854|FG001|Overall Study|Withdrawal by Subject|1|||
25017659|NCT03173313|50112853|FG000|Overall Study|Death|5|||
25017660|NCT03173313|50112854|FG001|Overall Study|Death|0|||
25017661|NCT03173313|50112853|FG000|Overall Study|Physician Decision|1|||
25017662|NCT03173313|50112854|FG001|Overall Study|Physician Decision|0|||
25017663|NCT03173313|50112853|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
25017664|NCT03173313|50112854|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
25017665|NCT03173313|50112853|FG000|Overall Study|Bone Fracture|1|||
25152321|NCT01558635|50267231|FG000|Overall Study|Physician Decision|1|||
25274789|NCT01079949|50588851|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
25017666|NCT03173313|50112854|FG001|Overall Study|Bone Fracture|0|||
25017667|NCT03215667|50112860|FG000|Overall Study|Physician Decision|4|||
25017668|NCT03634579|50112864|FG000|Overall Study|study termination|9|||
25017669|NCT02730208|50112870|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
25152322|NCT01558635|50267231|FG000|Overall Study|Subject received other treatment|1|||
25152323|NCT01558635|50267231|FG000|Overall Study|Reveal XT was explanted|1|||
25152324|NCT00089986|50267245|FG000|Overall Study|Adverse Event|6|||
25152325|NCT00089986|50267246|FG001|Overall Study|Adverse Event|9|||
25152326|NCT00089986|50267247|FG002|Overall Study|Adverse Event|6|||
25152327|NCT00089986|50267245|FG000|Overall Study|Lost to Follow-up|3|||
25017670|NCT02730208|50112871|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
25017671|NCT03170349|50112877|FG000|At 30 Days Follow-up|Death|1|||
25017672|NCT03170349|50112877|FG000|At 6 Months Follow-up|Death|3|||
25017673|NCT03170349|50112877|FG000|At 6 Months Follow-up|Withdrawal by Subject|1|||
25017674|NCT03170349|50112877|FG000|At 6 Months Follow-up|Exited for Other Reasons|5|||
25017675|NCT03170349|50112877|FG000|At 1 Year Follow-up|Death|6|||
25017676|NCT03170349|50112877|FG000|At 1 Year Follow-up|Exited for Other Reasons|2|||
25017677|NCT03201900|50112881|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
25017678|NCT03201900|50112881|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
25017679|NCT03201900|50112881|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
25017680|NCT03201900|50112881|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
25017681|NCT03201900|50112881|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
25017682|NCT03201900|50112881|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
25017683|NCT03201900|50112881|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
25017684|NCT03201900|50112881|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
25017685|NCT03201900|50112881|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
25017686|NCT03201900|50112881|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
25017687|NCT03201900|50112881|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
25017688|NCT03201900|50112881|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
25017689|NCT03201900|50112881|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
25017690|NCT03170271|50112896|FG000|Overall Study|Adverse Event|7|||
25017691|NCT03170271|50112897|FG001|Overall Study|Adverse Event|2|||
25017692|NCT03170271|50112896|FG000|Overall Study|Lost to Follow-up|0|||
25017693|NCT03170271|50112897|FG001|Overall Study|Lost to Follow-up|1|||
25017694|NCT03170271|50112896|FG000|Overall Study|Physician Decision|1|||
25017695|NCT03170271|50112897|FG001|Overall Study|Physician Decision|0|||
25017696|NCT03170271|50112896|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
25017697|NCT03170271|50112897|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
25017698|NCT03170271|50112896|FG000|Overall Study|Withdrawal by Subject|17|||
25017699|NCT03170271|50112897|FG001|Overall Study|Withdrawal by Subject|5|||
25017700|NCT03170271|50112896|FG000|Overall Study|Other|2|||
25017701|NCT03170271|50112897|FG001|Overall Study|Other|2|||
25017702|NCT03170271|50112896|FG000|Overall Study|Randomized in error|4|||
25152328|NCT00089986|50267246|FG001|Overall Study|Lost to Follow-up|1|||
25152329|NCT00089986|50267247|FG002|Overall Study|Lost to Follow-up|1|||
25017703|NCT03170271|50112897|FG001|Overall Study|Randomized in error|0|||
25017704|NCT03613129|50112907|FG000|Pre-treatment Assessment|Protocol Violation|2|||
25017705|NCT03613129|50112908|FG001|Pre-treatment Assessment|Protocol Violation|0|||
25017706|NCT03613129|50112909|FG002|Pre-treatment Assessment|Protocol Violation|0|||
25017707|NCT03613129|50112910|FG003|Pre-treatment Assessment|Protocol Violation|0|||
25017708|NCT03613129|50112911|FG004|Pre-treatment Assessment|Protocol Violation|0|||
25017709|NCT03613129|50112907|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
25017710|NCT03613129|50112908|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
25017711|NCT03613129|50112909|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
25017712|NCT03613129|50112910|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
25017713|NCT03613129|50112911|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
25017714|NCT03235284|50112926|FG000|Overall Study|Adverse Event|1|||
25017715|NCT03235284|50112927|FG001|Overall Study|Adverse Event|2|||
25017716|NCT03235284|50112928|FG002|Overall Study|Adverse Event|1|||
25017717|NCT03170193|50112943|FG000|Overall Study|Withdrawal by Subject|0|||
25017718|NCT03170193|50112944|FG001|Overall Study|Withdrawal by Subject|0|||
25017719|NCT03170193|50112945|FG002|Overall Study|Withdrawal by Subject|0|||
25017720|NCT03170193|50112946|FG003|Overall Study|Withdrawal by Subject|1|||
25017721|NCT03170193|50112947|FG004|Overall Study|Withdrawal by Subject|0|||
25017722|NCT03170193|50112948|FG005|Overall Study|Withdrawal by Subject|0|||
25017723|NCT03170193|50112949|FG006|Overall Study|Withdrawal by Subject|0|||
25017724|NCT03170193|50112943|FG000|Overall Study|Lost to Follow-up|1|||
25017725|NCT03170193|50112944|FG001|Overall Study|Lost to Follow-up|1|||
25017726|NCT03170193|50112945|FG002|Overall Study|Lost to Follow-up|0|||
25017727|NCT03170193|50112946|FG003|Overall Study|Lost to Follow-up|0|||
25017728|NCT03170193|50112947|FG004|Overall Study|Lost to Follow-up|0|||
25017729|NCT03170193|50112948|FG005|Overall Study|Lost to Follow-up|0|||
25017730|NCT03170193|50112949|FG006|Overall Study|Lost to Follow-up|0|||
25017731|NCT03633331|50112971|FG000|Overall Study|Withdrawal by Subject|1|||
25017732|NCT03201003|50112977|FG000|Overall Study|Adverse Event|14|||
25017733|NCT03201003|50112978|FG001|Overall Study|Adverse Event|1|||
25017734|NCT03201003|50112977|FG000|Overall Study|Other reasons|5|||
25017735|NCT03201003|50112978|FG001|Overall Study|Other reasons|1|||
25017736|NCT03201003|50112977|FG000|Overall Study|Withdrawal by Subject|4|||
25017737|NCT03201003|50112978|FG001|Overall Study|Withdrawal by Subject|1|||
25017738|NCT03201003|50112977|FG000|Overall Study|Lost to Follow-up|2|||
25017739|NCT03201003|50112978|FG001|Overall Study|Lost to Follow-up|0|||
25017740|NCT03201003|50112977|FG000|Overall Study|Protocol Violation|1|||
25017741|NCT03201003|50112978|FG001|Overall Study|Protocol Violation|0|||
25017742|NCT03166215|50112986|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
25017743|NCT03166215|50112987|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
25017744|NCT03166215|50112988|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
25017745|NCT03166215|50112986|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
25017746|NCT03166215|50112987|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
25017747|NCT03166215|50112988|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
25017748|NCT03168711|50113010|FG000|Overall Study|Adverse Event|2|||
25017749|NCT03168711|50113011|FG001|Overall Study|Adverse Event|0|||
25017750|NCT03168711|50113010|FG000|Overall Study|Withdrawal by Subject|0|||
25017751|NCT03168711|50113011|FG001|Overall Study|Withdrawal by Subject|1|||
25017752|NCT03168711|50113010|FG000|Overall Study|Death|0|||
25017753|NCT03168711|50113011|FG001|Overall Study|Death|1|||
25017754|NCT03738215|50113020|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
25017755|NCT03738215|50113021|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
25017756|NCT03738215|50113022|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
25017757|NCT03738215|50113020|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
25017758|NCT03738215|50113021|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
25017759|NCT03738215|50113022|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
25017760|NCT03738215|50113020|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
25017761|NCT03738215|50113021|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
25017762|NCT03738215|50113022|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
25017763|NCT03738215|50113020|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
25017764|NCT03738215|50113021|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
25017765|NCT03738215|50113022|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
25017766|NCT03738215|50113020|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
25017767|NCT03738215|50113021|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
25017768|NCT03738215|50113022|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
25017769|NCT03738215|50113020|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
25017770|NCT03738215|50113021|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
25017771|NCT03738215|50113022|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
25017772|NCT03738215|50113020|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
25017773|NCT03738215|50113021|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
25017774|NCT03738215|50113022|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
25017775|NCT03738215|50113020|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
25017776|NCT03738215|50113021|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
25017777|NCT03738215|50113022|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
25017778|NCT03738215|50113020|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
25017779|NCT03738215|50113021|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
25017780|NCT03738215|50113022|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
25017781|NCT03738215|50113020|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
25017782|NCT03738215|50113021|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
25017783|NCT03738215|50113022|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
25017784|NCT03199911|50113032|FG000|Overall Study|Lost to Follow-up|5|||
25152330|NCT00089986|50267245|FG000|Overall Study|Protocol Violation|0|||
25152331|NCT00089986|50267246|FG001|Overall Study|Protocol Violation|1|||
25152332|NCT00089986|50267247|FG002|Overall Study|Protocol Violation|0|||
25017785|NCT03199911|50113033|FG001|Overall Study|Lost to Follow-up|5|||
25152333|NCT00089986|50267245|FG000|Overall Study|Patient transferred to another hospital|2|||
25152334|NCT00089986|50267246|FG001|Overall Study|Patient transferred to another hospital|1|||
25152335|NCT00089986|50267247|FG002|Overall Study|Patient transferred to another hospital|0|||
25152336|NCT00089986|50267245|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
25152337|NCT00089986|50267246|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
25152338|NCT00089986|50267247|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
25152339|NCT00089986|50267245|FG000|Overall Study|Hemohlobin stopping rule|0|||
25152340|NCT00089986|50267246|FG001|Overall Study|Hemohlobin stopping rule|1|||
25152341|NCT00089986|50267247|FG002|Overall Study|Hemohlobin stopping rule|0|||
25152342|NCT00089986|50267245|FG000|Overall Study|Investigator decision to withdrew|0|||
25152343|NCT00089986|50267246|FG001|Overall Study|Investigator decision to withdrew|1|||
25152344|NCT00089986|50267247|FG002|Overall Study|Investigator decision to withdrew|0|||
25152345|NCT00089986|50267245|FG000|Overall Study|Enrollment in another study|0|||
25152346|NCT00089986|50267246|FG001|Overall Study|Enrollment in another study|1|||
25152347|NCT00089986|50267247|FG002|Overall Study|Enrollment in another study|0|||
25152348|NCT00089986|50267245|FG000|Overall Study|Family decision|0|||
25152349|NCT00089986|50267246|FG001|Overall Study|Family decision|1|||
25152350|NCT00089986|50267247|FG002|Overall Study|Family decision|0|||
25152351|NCT00089986|50267245|FG000|Overall Study|Do not resuscitate (DNR)|0|||
25152352|NCT00089986|50267246|FG001|Overall Study|Do not resuscitate (DNR)|0|||
25152353|NCT00089986|50267247|FG002|Overall Study|Do not resuscitate (DNR)|1|||
25152354|NCT00089986|50267245|FG000|Overall Study|Withdrawal by Subject|3|||
25152355|NCT00089986|50267246|FG001|Overall Study|Withdrawal by Subject|6|||
25152356|NCT00089986|50267247|FG002|Overall Study|Withdrawal by Subject|2|||
25152357|NCT01689207|50267270|FG000|Overall Study|Adverse Event|0|||
25152358|NCT01689207|50267271|FG001|Overall Study|Adverse Event|1|||
25152359|NCT01689207|50267272|FG002|Overall Study|Adverse Event|0|||
25152360|NCT01689207|50267273|FG003|Overall Study|Adverse Event|0|||
25152361|NCT01689207|50267274|FG004|Overall Study|Adverse Event|2|||
25184889|NCT01463696|50333827|FG000|Overall Study|Withdrawal by Subject|0|||
25184890|NCT01463696|50333828|FG001|Overall Study|Withdrawal by Subject|0|||
25152362|NCT01689207|50267275|FG005|Overall Study|Adverse Event|1|||
25152363|NCT01689207|50267276|FG006|Overall Study|Adverse Event|0|||
25152364|NCT01689207|50267277|FG007|Overall Study|Adverse Event|0|||
25152365|NCT01689207|50267278|FG008|Overall Study|Adverse Event|1|||
25152366|NCT01689207|50267279|FG009|Overall Study|Adverse Event|0|||
25152367|NCT01689207|50267280|FG010|Overall Study|Adverse Event|0|||
25152368|NCT00089284|50267315|FG000|Overall Study|Adverse event before starting treatment|0|||
25152369|NCT00089284|50267316|FG001|Overall Study|Adverse event before starting treatment|0|||
25152370|NCT00089284|50267317|FG002|Overall Study|Adverse event before starting treatment|0|||
25152371|NCT00089284|50267318|FG003|Overall Study|Adverse event before starting treatment|0|||
25152372|NCT00089284|50267319|FG004|Overall Study|Adverse event before starting treatment|0|||
25152373|NCT00089284|50267320|FG005|Overall Study|Adverse event before starting treatment|0|||
25152374|NCT00089284|50267321|FG006|Overall Study|Adverse event before starting treatment|1|||
25152375|NCT01688973|50267345|FG000|Overall Study|Ineligible|2|||
25152376|NCT01688973|50267346|FG001|Overall Study|Ineligible|3|||
25152377|NCT00087646|50267357|FG000|Overall Study|Adverse Event|37|||
25152378|NCT00087646|50267358|FG001|Overall Study|Adverse Event|6|||
25152379|NCT00087646|50267359|FG002|Overall Study|Adverse Event|18|||
25152380|NCT00087646|50267360|FG003|Overall Study|Adverse Event|20|||
25152381|NCT00087646|50267357|FG000|Overall Study|Death|0|||
25152382|NCT00087646|50267358|FG001|Overall Study|Death|1|||
25152383|NCT00087646|50267359|FG002|Overall Study|Death|0|||
25152384|NCT00087646|50267360|FG003|Overall Study|Death|0|||
25152385|NCT00087646|50267357|FG000|Overall Study|Withdrawal by Subject|6|||
25152386|NCT00087646|50267358|FG001|Overall Study|Withdrawal by Subject|1|||
25152387|NCT00087646|50267359|FG002|Overall Study|Withdrawal by Subject|2|||
25274790|NCT01079949|50588852|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
25152388|NCT00087646|50267360|FG003|Overall Study|Withdrawal by Subject|2|||
25152389|NCT00087646|50267357|FG000|Overall Study|Insufficient therapeutic response|64|||
25152390|NCT00087646|50267358|FG001|Overall Study|Insufficient therapeutic response|24|||
25152391|NCT00087646|50267359|FG002|Overall Study|Insufficient therapeutic response|38|||
25152392|NCT00087646|50267360|FG003|Overall Study|Insufficient therapeutic response|51|||
25152393|NCT00087646|50267357|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
25152394|NCT00087646|50267358|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
25152395|NCT00087646|50267359|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
25152396|NCT00087646|50267360|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
25152397|NCT00087646|50267357|FG000|Overall Study|Failure to Return|5|||
25152398|NCT00087646|50267358|FG001|Overall Study|Failure to Return|2|||
25152399|NCT00087646|50267359|FG002|Overall Study|Failure to Return|2|||
25152400|NCT00087646|50267360|FG003|Overall Study|Failure to Return|3|||
25152401|NCT00087646|50267357|FG000|Overall Study|Administrative/Other|6|||
25152402|NCT00087646|50267358|FG001|Overall Study|Administrative/Other|1|||
25152403|NCT00087646|50267359|FG002|Overall Study|Administrative/Other|1|||
25152404|NCT00087646|50267360|FG003|Overall Study|Administrative/Other|2|||
25152405|NCT00087646|50267357|FG000|Overall Study|Other Protocol Violation|3|||
25152406|NCT00087646|50267358|FG001|Overall Study|Other Protocol Violation|1|||
25152407|NCT00087646|50267359|FG002|Overall Study|Other Protocol Violation|0|||
25152408|NCT00087646|50267360|FG003|Overall Study|Other Protocol Violation|0|||
25152409|NCT00087646|50267357|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
25152410|NCT00087646|50267358|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
25152411|NCT00087646|50267359|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
25152412|NCT00087646|50267360|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
25152413|NCT00087568|50267377|FG000|Overall Study|Adverse Event|4|||
25152414|NCT00087568|50267378|FG001|Overall Study|Adverse Event|0|||
25152415|NCT00087568|50267377|FG000|Overall Study|Withdrawal by Subject|1|||
25152416|NCT00087568|50267378|FG001|Overall Study|Withdrawal by Subject|1|||
25152417|NCT00087568|50267377|FG000|Overall Study|Lost to Follow-up|1|||
25152418|NCT00087568|50267378|FG001|Overall Study|Lost to Follow-up|0|||
25152419|NCT00087568|50267377|FG000|Overall Study|Lack of Efficacy|24|||
25152420|NCT00087568|50267378|FG001|Overall Study|Lack of Efficacy|1|||
25152421|NCT00085540|50267390|FG000|Overall Study|Withdrawal by Subject|0|||
25152422|NCT00085540|50267391|FG001|Overall Study|Withdrawal by Subject|1|||
25152423|NCT00085540|50267390|FG000|Overall Study|Protocol Violation|0|||
25152424|NCT00085540|50267391|FG001|Overall Study|Protocol Violation|1|||
25152425|NCT01688739|50267407|FG000|Overall Study|Administrative Decision|1|||
25152426|NCT01688739|50267408|FG001|Overall Study|Administrative Decision|0|||
25017786|NCT03199911|50113032|FG000|Overall Study|Did not proceed with surgery|2|||
25152427|NCT01688739|50267409|FG002|Overall Study|Administrative Decision|0|||
25152428|NCT01688739|50267410|FG003|Overall Study|Administrative Decision|0|||
25152429|NCT01688739|50267411|FG004|Overall Study|Administrative Decision|0|||
25152430|NCT01688739|50267412|FG005|Overall Study|Administrative Decision|0|||
25152431|NCT01688739|50267413|FG006|Overall Study|Administrative Decision|0|||
25152432|NCT01688739|50267414|FG007|Overall Study|Administrative Decision|0|||
25152433|NCT01688739|50267415|FG008|Overall Study|Administrative Decision|0|||
25152434|NCT01688739|50267416|FG009|Overall Study|Administrative Decision|0|||
25152435|NCT00084838|50267446|FG000|Overall Study|Death|1|||
25152436|NCT00084838|50267446|FG000|Overall Study|Adverse Event|2|||
25152437|NCT00084838|50267446|FG000|Overall Study|Withdrawal by Subject|1|||
25152438|NCT00084838|50267446|FG000|Overall Study|Progressive Disease|4|||
25017787|NCT03199911|50113033|FG001|Overall Study|Did not proceed with surgery|1|||
25017788|NCT03736967|50113043|FG000|Overall Study|Withdrawal by Subject|26|||
25017789|NCT03736967|50113044|FG001|Overall Study|Withdrawal by Subject|25|||
25017790|NCT03736967|50113045|FG002|Overall Study|Withdrawal by Subject|23|||
25017791|NCT03736967|50113046|FG003|Overall Study|Withdrawal by Subject|26|||
25017792|NCT03736967|50113043|FG000|Overall Study|Lost to Follow-up|3|||
25017793|NCT03736967|50113044|FG001|Overall Study|Lost to Follow-up|2|||
25017794|NCT03736967|50113045|FG002|Overall Study|Lost to Follow-up|1|||
25017795|NCT03736967|50113046|FG003|Overall Study|Lost to Follow-up|1|||
25017796|NCT03736967|50113043|FG000|Overall Study|Physician Decision|1|||
25017797|NCT03736967|50113044|FG001|Overall Study|Physician Decision|0|||
25017798|NCT03736967|50113045|FG002|Overall Study|Physician Decision|0|||
25017799|NCT03736967|50113046|FG003|Overall Study|Physician Decision|1|||
25017800|NCT03736967|50113043|FG000|Overall Study|Adverse Event|0|||
25017801|NCT03736967|50113044|FG001|Overall Study|Adverse Event|1|||
25017802|NCT03736967|50113045|FG002|Overall Study|Adverse Event|0|||
25152439|NCT00084838|50267446|FG000|Overall Study|Pt Non-Compliance|1|||
25152440|NCT00084838|50267446|FG000|Overall Study|Ineligible|4|||
25152441|NCT01558089|50267452|FG000|Overall Study|Adverse Event|1|||
25152442|NCT01558089|50267452|FG000|Overall Study|Lack of Efficacy|1|||
25152443|NCT01558089|50267452|FG000|Overall Study|Lost to Follow-up|5|||
25152444|NCT01558089|50267452|FG000|Overall Study|Withdrawal by Subject|6|||
25152445|NCT01581021|50267458|FG000|Overall Study|Lost to Follow-up|4|||
25152446|NCT01581021|50267459|FG001|Overall Study|Lost to Follow-up|6|||
25152447|NCT01581021|50267458|FG000|Overall Study|More than 2 hooks in thoracic|3|||
25017803|NCT03736967|50113046|FG003|Overall Study|Adverse Event|1|||
25017804|NCT03736967|50113043|FG000|Overall Study|Death|0|||
25017805|NCT03736967|50113044|FG001|Overall Study|Death|0|||
25017806|NCT03736967|50113045|FG002|Overall Study|Death|0|||
25017807|NCT03736967|50113046|FG003|Overall Study|Death|1|||
25152448|NCT01581021|50267459|FG001|Overall Study|More than 2 hooks in thoracic|0|||
25152449|NCT01581021|50267458|FG000|Overall Study|Neuromuscular|2|||
25017808|NCT03736967|50113043|FG000|Overall Study|Randomized but never treated|1|||
25017809|NCT03736967|50113044|FG001|Overall Study|Randomized but never treated|0|||
25152450|NCT01581021|50267459|FG001|Overall Study|Neuromuscular|1|||
25152451|NCT01581021|50267458|FG000|Overall Study|Not Randomized|1|||
25152452|NCT01581021|50267459|FG001|Overall Study|Not Randomized|2|||
25017810|NCT03736967|50113045|FG002|Overall Study|Randomized but never treated|0|||
25017811|NCT03736967|50113046|FG003|Overall Study|Randomized but never treated|0|||
25017812|NCT03168555|50113059|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
25017813|NCT03168555|50113059|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
25017814|NCT03168555|50113059|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
25017815|NCT03168555|50113059|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
25017816|NCT03235050|50113071|FG000|Overall Study|Adverse Event|0|||
25017817|NCT03235050|50113072|FG001|Overall Study|Adverse Event|0|||
25017818|NCT03235050|50113073|FG002|Overall Study|Adverse Event|1|||
25017819|NCT03235050|50113074|FG003|Overall Study|Adverse Event|4|||
25017820|NCT03235050|50113075|FG004|Overall Study|Adverse Event|1|||
25017821|NCT03235050|50113071|FG000|Overall Study|Death|0|||
25184891|NCT01463696|50333829|FG002|Overall Study|Withdrawal by Subject|0|||
25184892|NCT01463696|50333830|FG003|Overall Study|Withdrawal by Subject|1|||
25017822|NCT03235050|50113072|FG001|Overall Study|Death|0|||
25017823|NCT03235050|50113073|FG002|Overall Study|Death|0|||
25152453|NCT01581021|50267458|FG000|Overall Study|Lenke 6 Classification|0|||
25152454|NCT01581021|50267459|FG001|Overall Study|Lenke 6 Classification|1|||
25152455|NCT01581021|50267458|FG000|Overall Study|Lack of Efficacy|0|||
25152456|NCT01581021|50267459|FG001|Overall Study|Lack of Efficacy|1|||
25152457|NCT00084682|50267465|FG000|Overall Study|Withdrawal by Subject|1|||
25152458|NCT01556997|50267473|FG000|Overall Study|Adverse Event|10|||
25152459|NCT01556997|50267474|FG001|Overall Study|Adverse Event|12|||
25152460|NCT01556997|50267475|FG002|Overall Study|Adverse Event|12|||
25152461|NCT01556997|50267473|FG000|Overall Study|Lost to Follow-up|6|||
25152462|NCT01556997|50267474|FG001|Overall Study|Lost to Follow-up|6|||
25152463|NCT01556997|50267475|FG002|Overall Study|Lost to Follow-up|4|||
25152464|NCT01556997|50267473|FG000|Overall Study|Physician Decision|1|||
25152465|NCT01556997|50267474|FG001|Overall Study|Physician Decision|1|||
25152466|NCT01556997|50267475|FG002|Overall Study|Physician Decision|1|||
25152467|NCT01556997|50267473|FG000|Overall Study|Withdrawal by Subject|7|||
25152468|NCT01556997|50267474|FG001|Overall Study|Withdrawal by Subject|6|||
25152469|NCT01556997|50267475|FG002|Overall Study|Withdrawal by Subject|8|||
25152470|NCT01556997|50267473|FG000|Overall Study|Other|2|||
25152471|NCT01556997|50267474|FG001|Overall Study|Other|3|||
25152472|NCT01556997|50267475|FG002|Overall Study|Other|7|||
25152473|NCT00082888|50267486|FG000|Overall Study|Ineligible|1|||
25152474|NCT00082888|50267487|FG001|Overall Study|Ineligible|0|||
25152475|NCT00082888|50267488|FG002|Overall Study|Ineligible|0|||
25152476|NCT00082810|50267497|FG000|Overall Study|Adverse Event|3|||
25152477|NCT00082810|50267497|FG000|Overall Study|Progressive disease|24|||
25152478|NCT00082810|50267497|FG000|Overall Study|Withdrawal by Subject|4|||
25152479|NCT01577745|50267508|FG000|Overall Study|Withdrawal by Subject|0|||
25152480|NCT01577745|50267509|FG001|Overall Study|Withdrawal by Subject|1|||
25152481|NCT01577745|50267510|FG002|Overall Study|Withdrawal by Subject|0|||
25152482|NCT01577745|50267511|FG003|Overall Study|Withdrawal by Subject|3|||
25152483|NCT01577745|50267512|FG004|Overall Study|Withdrawal by Subject|2|||
25152484|NCT01577745|50267513|FG005|Overall Study|Withdrawal by Subject|0|||
25152485|NCT01577745|50267508|FG000|Overall Study|Death|3|||
25152486|NCT01577745|50267509|FG001|Overall Study|Death|2|||
25152487|NCT01577745|50267510|FG002|Overall Study|Death|2|||
25152488|NCT01577745|50267511|FG003|Overall Study|Death|1|||
25152489|NCT01577745|50267512|FG004|Overall Study|Death|1|||
25152490|NCT01577745|50267513|FG005|Overall Study|Death|3|||
25017824|NCT03235050|50113074|FG003|Overall Study|Death|2|||
25017825|NCT03235050|50113075|FG004|Overall Study|Death|1|||
25017826|NCT03235050|50113071|FG000|Overall Study|Lost to Follow-up|1|||
25017827|NCT03235050|50113072|FG001|Overall Study|Lost to Follow-up|2|||
25017828|NCT03235050|50113073|FG002|Overall Study|Lost to Follow-up|1|||
25017829|NCT03235050|50113074|FG003|Overall Study|Lost to Follow-up|2|||
25017830|NCT03235050|50113075|FG004|Overall Study|Lost to Follow-up|0|||
25017831|NCT03235050|50113071|FG000|Overall Study|Withdrawal by Subject|3|||
25017832|NCT03235050|50113072|FG001|Overall Study|Withdrawal by Subject|2|||
25017833|NCT03235050|50113073|FG002|Overall Study|Withdrawal by Subject|2|||
25017834|NCT03235050|50113074|FG003|Overall Study|Withdrawal by Subject|5|||
25017835|NCT03235050|50113075|FG004|Overall Study|Withdrawal by Subject|7|||
25017836|NCT03235050|50113071|FG000|Overall Study|Other reasons|0|||
25017837|NCT03235050|50113072|FG001|Overall Study|Other reasons|1|||
25017838|NCT03235050|50113073|FG002|Overall Study|Other reasons|0|||
25017839|NCT03235050|50113074|FG003|Overall Study|Other reasons|1|||
25017840|NCT03235050|50113075|FG004|Overall Study|Other reasons|2|||
25017841|NCT04502212|50113104|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
25017842|NCT04502212|50113104|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
25152491|NCT01577745|50267508|FG000|Overall Study|Physician Decision|0|||
25152492|NCT01577745|50267509|FG001|Overall Study|Physician Decision|0|||
25152493|NCT01577745|50267510|FG002|Overall Study|Physician Decision|0|||
25152494|NCT01577745|50267511|FG003|Overall Study|Physician Decision|1|||
25152495|NCT01577745|50267512|FG004|Overall Study|Physician Decision|1|||
25152496|NCT01577745|50267513|FG005|Overall Study|Physician Decision|0|||
25152497|NCT01577745|50267508|FG000|Overall Study|Lost to Follow-up|0|||
25017843|NCT03167619|50113111|FG000|Overall Study|Death|11|||
25017844|NCT03167619|50113112|FG001|Overall Study|Death|8|||
25017845|NCT03167619|50113111|FG000|Overall Study|Withdrawal by Subject|1|||
25017846|NCT03167619|50113112|FG001|Overall Study|Withdrawal by Subject|2|||
25152498|NCT01577745|50267509|FG001|Overall Study|Lost to Follow-up|0|||
25152499|NCT01577745|50267510|FG002|Overall Study|Lost to Follow-up|0|||
25017847|NCT03167619|50113111|FG000|Overall Study|Physician Decision|0|||
25017848|NCT03167619|50113112|FG001|Overall Study|Physician Decision|1|||
25017849|NCT03578809|50113122|FG000|Overall Study|Death|0|||
25017850|NCT03578809|50113123|FG001|Overall Study|Death|2|||
25017851|NCT03578809|50113124|FG002|Overall Study|Death|0|||
25017852|NCT03578809|50113125|FG003|Overall Study|Death|1|||
25017853|NCT03578809|50113122|FG000|Overall Study|Lost to Follow-up|0|||
25017854|NCT03578809|50113123|FG001|Overall Study|Lost to Follow-up|1|||
25017855|NCT03578809|50113124|FG002|Overall Study|Lost to Follow-up|0|||
25017856|NCT03578809|50113125|FG003|Overall Study|Lost to Follow-up|0|||
25017857|NCT03578809|50113122|FG000|Overall Study|Withdrawal by Subject|3|||
25017858|NCT03578809|50113123|FG001|Overall Study|Withdrawal by Subject|5|||
25017859|NCT03578809|50113124|FG002|Overall Study|Withdrawal by Subject|2|||
25017860|NCT03578809|50113125|FG003|Overall Study|Withdrawal by Subject|0|||
25017861|NCT03578809|50113122|FG000|Overall Study|Other|3|||
25017862|NCT03578809|50113123|FG001|Overall Study|Other|6|||
25017863|NCT03578809|50113124|FG002|Overall Study|Other|2|||
25017864|NCT03578809|50113125|FG003|Overall Study|Other|8|||
25017865|NCT03198507|50113140|FG000|Overall Study|Withdrawal by Subject|1|||
25017866|NCT03198507|50113141|FG001|Overall Study|Withdrawal by Subject|0|||
25017867|NCT03610165|50113149|FG000|Overall Study|Device didn't work|0|||
25017868|NCT03610165|50113150|FG001|Overall Study|Device didn't work|1|||
25017869|NCT03609619|50113158|FG000|Overall Study|Adverse Event|1|||
25017870|NCT03609619|50113159|FG001|Overall Study|Adverse Event|0|||
25017871|NCT03609619|50113158|FG000|Overall Study|Lack of Efficacy|1|||
25017872|NCT03609619|50113159|FG001|Overall Study|Lack of Efficacy|2|||
25017873|NCT03609619|50113158|FG000|Overall Study|Protocol Violation|5|||
25017874|NCT03609619|50113159|FG001|Overall Study|Protocol Violation|0|||
25017875|NCT03609619|50113158|FG000|Overall Study|Withdrawal by Subject|2|||
25017876|NCT03609619|50113159|FG001|Overall Study|Withdrawal by Subject|3|||
25017877|NCT03609619|50113158|FG000|Overall Study|Lost to Follow-up|1|||
25274791|NCT01079949|50588851|FG000|Overall Study|Randomized but not treated|1|||
25017878|NCT03609619|50113159|FG001|Overall Study|Lost to Follow-up|1|||
25017879|NCT03167151|50113168|FG000|Overall Study|Withdrawal by Subject|1|||
25017880|NCT03167151|50113169|FG001|Overall Study|Withdrawal by Subject|0|||
25017881|NCT03167151|50113170|FG002|Overall Study|Withdrawal by Subject|0|||
25017882|NCT03167151|50113168|FG000|Overall Study|No evidence of tumour at surgery|0|||
25017883|NCT03167151|50113169|FG001|Overall Study|No evidence of tumour at surgery|1|||
25017884|NCT03167151|50113170|FG002|Overall Study|No evidence of tumour at surgery|1|||
25017885|NCT03660943|50113180|FG000|Overall Study|Adverse Event|5|||
25017886|NCT03660943|50113181|FG001|Overall Study|Adverse Event|3|||
25017887|NCT03660943|50113180|FG000|Overall Study|Death|0|||
25017888|NCT03660943|50113181|FG001|Overall Study|Death|2|||
25017889|NCT03660943|50113180|FG000|Overall Study|Lost to Follow-up|7|||
25017890|NCT03660943|50113181|FG001|Overall Study|Lost to Follow-up|3|||
25152500|NCT01577745|50267511|FG003|Overall Study|Lost to Follow-up|0|||
25152501|NCT01577745|50267512|FG004|Overall Study|Lost to Follow-up|0|||
25152502|NCT01577745|50267513|FG005|Overall Study|Lost to Follow-up|1|||
25152503|NCT01577745|50267508|FG000|Overall Study|Alternative Therapy|0|||
25017891|NCT03660943|50113180|FG000|Overall Study|Protocol Violation|3|||
25017892|NCT03660943|50113181|FG001|Overall Study|Protocol Violation|5|||
25017893|NCT03660943|50113180|FG000|Overall Study|Withdrawal by Subject|8|||
25017894|NCT03660943|50113181|FG001|Overall Study|Withdrawal by Subject|15|||
25017895|NCT03660943|50113180|FG000|Overall Study|Lack of Efficacy|9|||
25017896|NCT03660943|50113181|FG001|Overall Study|Lack of Efficacy|12|||
25017897|NCT03660943|50113180|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
25017898|NCT03660943|50113181|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
25017899|NCT03167073|50113189|FG000|Overall Study|Stillbirth|1|||
25017900|NCT03167073|50113190|FG001|Overall Study|Stillbirth|0|||
25017901|NCT03657277|50113196|FG000|Overall Study|Physician Decision|2|||
25017902|NCT03657277|50113196|FG000|Overall Study|Lost to Follow-up|1|||
25017903|NCT03657277|50113196|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
25017904|NCT03197883|50113202|FG000|Overall Study|Adverse Event|1|||
25017905|NCT03197883|50113203|FG001|Overall Study|Adverse Event|1|||
25017906|NCT03197883|50113202|FG000|Overall Study|Lost to Follow-up|1|||
25017907|NCT03197883|50113203|FG001|Overall Study|Lost to Follow-up|0|||
25017908|NCT03197883|50113202|FG000|Overall Study|Protocol Violation|1|||
25017909|NCT03197883|50113203|FG001|Overall Study|Protocol Violation|0|||
25017910|NCT03197883|50113202|FG000|Overall Study|Other (Not Specified)|0|||
25152504|NCT01577745|50267509|FG001|Overall Study|Alternative Therapy|0|||
25152505|NCT01577745|50267510|FG002|Overall Study|Alternative Therapy|0|||
25152506|NCT01577745|50267511|FG003|Overall Study|Alternative Therapy|1|||
25017911|NCT03197883|50113203|FG001|Overall Study|Other (Not Specified)|5|||
25152507|NCT01577745|50267512|FG004|Overall Study|Alternative Therapy|1|||
25017912|NCT03234036|50113212|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
25017913|NCT03234036|50113213|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
25017914|NCT03234036|50113214|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
25017915|NCT03234036|50113215|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
25017916|NCT03606109|50113233|FG000|Overall Study|Lost to Follow-up|2|||
25017917|NCT03606109|50113234|FG001|Overall Study|Lost to Follow-up|1|||
25274792|NCT01079949|50588852|FG001|Overall Study|Randomized but not treated|0|||
25274793|NCT00910429|50588860|FG000|Overall Study|Death|18|||
25274794|NCT00910429|50588861|FG001|Overall Study|Death|12|||
25274795|NCT00910429|50588860|FG000|Overall Study|Withdrawal by Subject|3|||
25274796|NCT00910429|50588861|FG001|Overall Study|Withdrawal by Subject|2|||
25017918|NCT03768336|50113240|FG000|Overall Study|Lost to Follow-up|3|||
25017919|NCT03768336|50113241|FG001|Overall Study|Lost to Follow-up|2|||
25017920|NCT03768336|50113240|FG000|Overall Study|Became Ineligible|2|||
25017921|NCT03768336|50113241|FG001|Overall Study|Became Ineligible|0|||
25017922|NCT03768336|50113240|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
25017923|NCT03768336|50113241|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
25017924|NCT03768336|50113240|FG000|Overall Study|Missed final survey (post-treatment|0|||
25017925|NCT03768336|50113241|FG001|Overall Study|Missed final survey (post-treatment|1|||
25017926|NCT02729896|50113251|FG000|Overall Study|Death|0|||
25017927|NCT02729896|50113252|FG001|Overall Study|Death|2|||
25017928|NCT02729896|50113253|FG002|Overall Study|Death|13|||
25017929|NCT02729896|50113251|FG000|Overall Study|Lost to Follow-up|0|||
25017930|NCT02729896|50113252|FG001|Overall Study|Lost to Follow-up|2|||
25017931|NCT02729896|50113253|FG002|Overall Study|Lost to Follow-up|3|||
25017932|NCT02729896|50113251|FG000|Overall Study|Other|0|||
25017933|NCT02729896|50113252|FG001|Overall Study|Other|2|||
25017934|NCT02729896|50113253|FG002|Overall Study|Other|0|||
25017935|NCT02729896|50113251|FG000|Overall Study|Physician Decision|1|||
25017936|NCT02729896|50113252|FG001|Overall Study|Physician Decision|2|||
25017937|NCT02729896|50113253|FG002|Overall Study|Physician Decision|3|||
25017938|NCT02729896|50113251|FG000|Overall Study|Progressive Disease|0|||
25017939|NCT02729896|50113252|FG001|Overall Study|Progressive Disease|1|||
25017940|NCT02729896|50113253|FG002|Overall Study|Progressive Disease|0|||
25017941|NCT02729896|50113251|FG000|Overall Study|Withdrawal by Subject|1|||
25017942|NCT02729896|50113252|FG001|Overall Study|Withdrawal by Subject|0|||
25152508|NCT01577745|50267513|FG005|Overall Study|Alternative Therapy|0|||
25274797|NCT00910429|50588860|FG000|Overall Study|Protocol Violation|1|||
25274798|NCT00910429|50588861|FG001|Overall Study|Protocol Violation|0|||
25017943|NCT02729896|50113253|FG002|Overall Study|Withdrawal by Subject|3|||
25017944|NCT03575065|50113264|FG000|Overall Study|Death|31|||
25017945|NCT03575065|50113265|FG001|Overall Study|Death|12|||
25017946|NCT03575065|50113264|FG000|Overall Study|Sponsor's Decision|28|||
25017947|NCT03575065|50113265|FG001|Overall Study|Sponsor's Decision|13|||
25017948|NCT03575065|50113264|FG000|Overall Study|Withdrawal by Subject|2|||
25017949|NCT03575065|50113265|FG001|Overall Study|Withdrawal by Subject|1|||
25017950|NCT03575065|50113264|FG000|Overall Study|Lost to Follow-up|1|||
25017951|NCT03575065|50113265|FG001|Overall Study|Lost to Follow-up|0|||
25017952|NCT03514134|50113274|FG000|Overall Study|Lost to Follow-up|0|||
25017953|NCT03514134|50113275|FG001|Overall Study|Lost to Follow-up|1|||
25017954|NCT03188718|50113281|FG000|Overall Study|Participant noncompliance|4|||
25017955|NCT03188718|50113281|FG000|Overall Study|Withdrawal by Subject|1|||
25017956|NCT03188718|50113281|FG000|Overall Study|Device failure|3|||
25017957|NCT03574753|50113285|FG000|Overall Study|Adverse Event|3|||
25017958|NCT03574753|50113285|FG000|Overall Study|Progression/relapse|19|||
25184893|NCT01463696|50333831|FG004|Overall Study|Withdrawal by Subject|1|||
25017959|NCT03574753|50113285|FG000|Overall Study|Death|1|||
25184894|NCT01463696|50333832|FG005|Overall Study|Withdrawal by Subject|1|||
25017960|NCT03573505|50113292|FG000|Overall Study|Adverse Event|1|||
25017961|NCT03573505|50113293|FG001|Overall Study|Adverse Event|1|||
25017962|NCT03573505|50113292|FG000|Overall Study|Consent withdrawn|0|||
25017963|NCT03573505|50113293|FG001|Overall Study|Consent withdrawn|1|||
25017964|NCT03573505|50113292|FG000|Overall Study|Disease progression|0|||
25017965|NCT03573505|50113293|FG001|Overall Study|Disease progression|1|||
25017966|NCT03573505|50113292|FG000|Overall Study|Site Terminated by Sponsor|1|||
25017967|NCT03573505|50113293|FG001|Overall Study|Site Terminated by Sponsor|1|||
25017968|NCT03573505|50113292|FG000|Overall Study|Study terminated by sponsor|50|||
25017969|NCT03573505|50113293|FG001|Overall Study|Study terminated by sponsor|45|||
25017970|NCT03573505|50113292|FG000|Overall Study|Reason not specified|0|||
25017971|NCT03573505|50113293|FG001|Overall Study|Reason not specified|1|||
25017972|NCT03573505|50113292|FG000|Overall Study|Death|0|||
25017973|NCT03573505|50113293|FG001|Overall Study|Death|4|||
25017974|NCT01376908|50113302|FG000|Overall Study|Protocol Violation|1|||
25017975|NCT01376908|50113303|FG001|Overall Study|Protocol Violation|1|||
25017976|NCT01376908|50113302|FG000|Overall Study|Withdrawal by Subject|1|||
25017977|NCT01376908|50113303|FG001|Overall Study|Withdrawal by Subject|2|||
25017978|NCT02668653|50113318|FG000|Overall Study|Refractory disease|41|||
25017979|NCT02668653|50113319|FG001|Overall Study|Refractory disease|70|||
25017980|NCT02668653|50113318|FG000|Overall Study|Relapse|44|||
25017981|NCT02668653|50113319|FG001|Overall Study|Relapse|65|||
25017982|NCT02668653|50113318|FG000|Overall Study|Adverse Event|58|||
25017983|NCT02668653|50113319|FG001|Overall Study|Adverse Event|23|||
25017984|NCT02668653|50113318|FG000|Overall Study|Subject decision to stop study drug|25|||
25017985|NCT02668653|50113319|FG001|Overall Study|Subject decision to stop study drug|23|||
25017986|NCT02668653|50113318|FG000|Overall Study|Other reasons not specified|16|||
25017987|NCT02668653|50113319|FG001|Overall Study|Other reasons not specified|11|||
25017988|NCT02668653|50113318|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
25017989|NCT02668653|50113319|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
25017990|NCT02668653|50113318|FG000|Overall Study|Investigator decision|10|||
25017991|NCT02668653|50113319|FG001|Overall Study|Investigator decision|7|||
25017992|NCT02668653|50113318|FG000|Overall Study|Failure to meet continuation criteria|5|||
25017993|NCT02668653|50113319|FG001|Overall Study|Failure to meet continuation criteria|12|||
25017994|NCT02668653|50113318|FG000|Overall Study|Lost to Follow-up|1|||
25017995|NCT02668653|50113319|FG001|Overall Study|Lost to Follow-up|0|||
25017996|NCT02668653|50113318|FG000|Overall Study|Pregnancy|0|||
25017997|NCT02668653|50113319|FG001|Overall Study|Pregnancy|1|||
25017998|NCT02668653|50113318|FG000|Overall Study|Death|0|||
25017999|NCT02668653|50113319|FG001|Overall Study|Death|1|||
25018000|NCT03736031|50113327|FG000|Overall Study|Death|2|||
25018001|NCT03736031|50113328|FG001|Overall Study|Death|4|||
25018002|NCT03736031|50113327|FG000|Overall Study|Lost to Follow-up|21|||
25018003|NCT03736031|50113328|FG001|Overall Study|Lost to Follow-up|2|||
25274799|NCT00910429|50588860|FG000|Overall Study|Lost to Follow-up|2|||
25274800|NCT00910429|50588861|FG001|Overall Study|Lost to Follow-up|1|||
25274801|NCT00910429|50588860|FG000|Overall Study|Adverse Event|10|||
25274802|NCT00910429|50588861|FG001|Overall Study|Adverse Event|5|||
25274803|NCT00910429|50588860|FG000|Overall Study|Drug non-compliance|1|||
25152516|NCT01688037|50267539|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
25152517|NCT01688037|50267540|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
25152518|NCT01688037|50267541|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
25152519|NCT01688037|50267539|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
25152520|NCT01688037|50267540|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
25018004|NCT03736031|50113327|FG000|Overall Study|Withdrawal by Subject|9|||
25152521|NCT01688037|50267541|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
25018005|NCT03736031|50113328|FG001|Overall Study|Withdrawal by Subject|0|||
25018006|NCT03555565|50113334|FG000|Overall Study|Case Report Forms Uncollected|2|||
25018007|NCT03555565|50113334|FG000|Overall Study|Protocol Deviation|13|||
25018008|NCT03602053|50113341|FG000|Overall Study|Withdrawal by Subject|7|||
25018009|NCT03602053|50113342|FG001|Overall Study|Withdrawal by Subject|9|||
25018010|NCT03602053|50113343|FG002|Overall Study|Withdrawal by Subject|7|||
25018011|NCT03602053|50113341|FG000|Overall Study|Lost to Follow-up|5|||
25152522|NCT01688037|50267539|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
25018012|NCT03602053|50113342|FG001|Overall Study|Lost to Follow-up|6|||
25018013|NCT03602053|50113343|FG002|Overall Study|Lost to Follow-up|0|||
25018014|NCT03602053|50113341|FG000|Overall Study|Protocol Violation|3|||
25018015|NCT03602053|50113342|FG001|Overall Study|Protocol Violation|0|||
25018016|NCT03602053|50113343|FG002|Overall Study|Protocol Violation|4|||
25018017|NCT03602053|50113341|FG000|Overall Study|Physician Decision|1|||
25018018|NCT03602053|50113342|FG001|Overall Study|Physician Decision|0|||
25018019|NCT03602053|50113343|FG002|Overall Study|Physician Decision|0|||
25018020|NCT03602053|50113341|FG000|Overall Study|migration|2|||
25018021|NCT03602053|50113342|FG001|Overall Study|migration|3|||
25018022|NCT03602053|50113343|FG002|Overall Study|migration|0|||
25018023|NCT03602053|50113341|FG000|Overall Study|Other|1|||
25018024|NCT03602053|50113342|FG001|Overall Study|Other|0|||
25018025|NCT03602053|50113343|FG002|Overall Study|Other|0|||
25018026|NCT04831515|50113355|FG000|First Intervention|Adverse Event|0|||
25018027|NCT04831515|50113356|FG001|First Intervention|Adverse Event|1|||
25018028|NCT03554629|50113362|FG000|Overall Study|Inadequate data|6|||
25018029|NCT03196791|50113392|FG000|Overall Study|Protocol Violation|7|||
25018030|NCT03196791|50113393|FG001|Overall Study|Protocol Violation|3|||
25018031|NCT03196791|50113392|FG000|Overall Study|Withdrawal by Subject|3|||
25152523|NCT01688037|50267540|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
25152524|NCT01688037|50267541|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
25152525|NCT01688037|50267539|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
25152526|NCT01688037|50267540|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
25152527|NCT01688037|50267541|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
25152528|NCT01688037|50267539|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
25152529|NCT01688037|50267540|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
25152530|NCT01688037|50267541|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
25152531|NCT01688037|50267539|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
25152532|NCT01688037|50267540|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
25152533|NCT01688037|50267541|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
25152534|NCT01688037|50267539|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
25152535|NCT01688037|50267540|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
25152536|NCT01688037|50267541|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
25152537|NCT01688037|50267539|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
25152538|NCT01688037|50267540|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
25152539|NCT01688037|50267541|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
25152540|NCT01688037|50267539|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
25152541|NCT01688037|50267540|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
25152542|NCT01688037|50267541|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
25152543|NCT01688037|50267539|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
25152544|NCT01688037|50267540|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
25152545|NCT01688037|50267541|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
25152546|NCT01610336|50267574|FG000|Overall Study|Progressive Disease|4|||
25152547|NCT01610336|50267575|FG001|Overall Study|Progressive Disease|6|||
25152548|NCT01610336|50267576|FG002|Overall Study|Progressive Disease|6|||
25152549|NCT01610336|50267577|FG003|Overall Study|Progressive Disease|5|||
25152550|NCT01610336|50267578|FG004|Overall Study|Progressive Disease|3|||
25152551|NCT01610336|50267579|FG005|Overall Study|Progressive Disease|10|||
25018032|NCT03196791|50113393|FG001|Overall Study|Withdrawal by Subject|2|||
25018033|NCT03196635|50113399|FG000|Overall Study|Withdrawal by Subject|1|||
25018034|NCT03194217|50113421|FG000|Overall Study|Adverse Event|0|||
25018035|NCT03194217|50113422|FG001|Overall Study|Adverse Event|2|||
25018036|NCT03194217|50113423|FG002|Overall Study|Adverse Event|3|||
25018037|NCT03194217|50113424|FG003|Overall Study|Adverse Event|3|||
25018038|NCT03194217|50113421|FG000|Overall Study|Failure to meet randomisation criteria|0|||
25018039|NCT03194217|50113422|FG001|Overall Study|Failure to meet randomisation criteria|0|||
25018040|NCT03194217|50113423|FG002|Overall Study|Failure to meet randomisation criteria|0|||
25018041|NCT03194217|50113424|FG003|Overall Study|Failure to meet randomisation criteria|1|||
25018042|NCT03194217|50113421|FG000|Overall Study|Other|0|||
25152552|NCT01610336|50267580|FG006|Overall Study|Progressive Disease|1|||
25152553|NCT01610336|50267581|FG007|Overall Study|Progressive Disease|6|||
25152554|NCT01610336|50267582|FG008|Overall Study|Progressive Disease|6|||
25152555|NCT01610336|50267583|FG009|Overall Study|Progressive Disease|40|||
25152556|NCT01610336|50267584|FG010|Overall Study|Progressive Disease|36|||
25152557|NCT01610336|50267574|FG000|Overall Study|Adverse Event|0|||
25152558|NCT01610336|50267575|FG001|Overall Study|Adverse Event|0|||
25152559|NCT01610336|50267576|FG002|Overall Study|Adverse Event|0|||
25152560|NCT01610336|50267577|FG003|Overall Study|Adverse Event|1|||
25152561|NCT01610336|50267578|FG004|Overall Study|Adverse Event|1|||
25152562|NCT01610336|50267579|FG005|Overall Study|Adverse Event|1|||
25152563|NCT01610336|50267580|FG006|Overall Study|Adverse Event|0|||
25152564|NCT01610336|50267581|FG007|Overall Study|Adverse Event|0|||
25152565|NCT01610336|50267582|FG008|Overall Study|Adverse Event|2|||
25152566|NCT01610336|50267583|FG009|Overall Study|Adverse Event|8|||
25152567|NCT01610336|50267584|FG010|Overall Study|Adverse Event|6|||
25152568|NCT01610336|50267574|FG000|Overall Study|Subject/Guardian decision|1|||
25152569|NCT01610336|50267575|FG001|Overall Study|Subject/Guardian decision|1|||
25152570|NCT01610336|50267576|FG002|Overall Study|Subject/Guardian decision|0|||
25152571|NCT01610336|50267577|FG003|Overall Study|Subject/Guardian decision|1|||
25152572|NCT01610336|50267578|FG004|Overall Study|Subject/Guardian decision|0|||
25152573|NCT01610336|50267579|FG005|Overall Study|Subject/Guardian decision|0|||
25152574|NCT01610336|50267580|FG006|Overall Study|Subject/Guardian decision|0|||
25152575|NCT01610336|50267581|FG007|Overall Study|Subject/Guardian decision|1|||
25152576|NCT01610336|50267582|FG008|Overall Study|Subject/Guardian decision|0|||
25152577|NCT01610336|50267583|FG009|Overall Study|Subject/Guardian decision|2|||
25018043|NCT03194217|50113422|FG001|Overall Study|Other|1|||
25018044|NCT03194217|50113423|FG002|Overall Study|Other|1|||
25018045|NCT03194217|50113424|FG003|Overall Study|Other|0|||
25018046|NCT00709618|50113434|FG000|Overall Study|Withdrawal by Subject|4|||
25018047|NCT00709618|50113434|FG000|Overall Study|Lost to Follow-up|1|||
25018048|NCT00709618|50113434|FG000|Overall Study|Study Closed/Terminated|25|||
25018049|NCT03193047|50113440|FG000|Overall Study|Physician Decision|1|||
25152578|NCT01610336|50267584|FG010|Overall Study|Subject/Guardian decision|2|||
25152579|NCT01610336|50267574|FG000|Overall Study|Death|0|||
25152580|NCT01610336|50267575|FG001|Overall Study|Death|0|||
25152581|NCT01610336|50267576|FG002|Overall Study|Death|0|||
25152582|NCT01610336|50267577|FG003|Overall Study|Death|0|||
25152583|NCT01610336|50267578|FG004|Overall Study|Death|0|||
25152584|NCT01610336|50267579|FG005|Overall Study|Death|1|||
25152585|NCT01610336|50267580|FG006|Overall Study|Death|3|||
25152586|NCT01610336|50267581|FG007|Overall Study|Death|0|||
25152587|NCT01610336|50267582|FG008|Overall Study|Death|0|||
25152588|NCT01610336|50267583|FG009|Overall Study|Death|1|||
25152589|NCT01610336|50267584|FG010|Overall Study|Death|2|||
25152590|NCT01610336|50267574|FG000|Overall Study|Non-Compliance with study treatment|0|||
25184895|NCT01463696|50333833|FG006|Overall Study|Withdrawal by Subject|2|||
25152591|NCT01610336|50267575|FG001|Overall Study|Non-Compliance with study treatment|0|||
25184896|NCT01463696|50333834|FG007|Overall Study|Withdrawal by Subject|0|||
25018050|NCT03193047|50113441|FG001|Overall Study|Physician Decision|0|||
25152592|NCT01610336|50267576|FG002|Overall Study|Non-Compliance with study treatment|0|||
25152593|NCT01610336|50267577|FG003|Overall Study|Non-Compliance with study treatment|0|||
25152594|NCT01610336|50267578|FG004|Overall Study|Non-Compliance with study treatment|0|||
25018051|NCT03193047|50113440|FG000|Overall Study|Participant Left State|1|||
25018052|NCT03193047|50113441|FG001|Overall Study|Participant Left State|0|||
25018053|NCT02918019|50113453|FG000|Overall Study|Death|0|||
25018054|NCT02918019|50113454|FG001|Overall Study|Death|0|||
25018055|NCT02918019|50113455|FG002|Overall Study|Death|1|||
25018056|NCT02918019|50113456|FG003|Overall Study|Death|0|||
25018057|NCT02918019|50113453|FG000|Overall Study|Lost to Follow-up|1|||
25018058|NCT02918019|50113454|FG001|Overall Study|Lost to Follow-up|1|||
25018059|NCT02918019|50113455|FG002|Overall Study|Lost to Follow-up|0|||
25018060|NCT02918019|50113456|FG003|Overall Study|Lost to Follow-up|1|||
25018061|NCT02918019|50113453|FG000|Overall Study|Principal investigator request|0|||
25018062|NCT02918019|50113454|FG001|Overall Study|Principal investigator request|0|||
25018063|NCT02918019|50113455|FG002|Overall Study|Principal investigator request|0|||
25018064|NCT02918019|50113456|FG003|Overall Study|Principal investigator request|1|||
25018065|NCT02918019|50113453|FG000|Overall Study|Physician Decision|1|||
25018066|NCT02918019|50113454|FG001|Overall Study|Physician Decision|3|||
25018067|NCT02918019|50113455|FG002|Overall Study|Physician Decision|2|||
25018068|NCT02918019|50113456|FG003|Overall Study|Physician Decision|0|||
25018069|NCT02918019|50113453|FG000|Overall Study|Protocol deviation|1|||
25018070|NCT02918019|50113454|FG001|Overall Study|Protocol deviation|1|||
25018071|NCT02918019|50113455|FG002|Overall Study|Protocol deviation|0|||
25018072|NCT02918019|50113456|FG003|Overall Study|Protocol deviation|2|||
25018073|NCT02918019|50113453|FG000|Overall Study|Withdrawal by Subject|3|||
25018074|NCT02918019|50113454|FG001|Overall Study|Withdrawal by Subject|4|||
25018075|NCT02918019|50113455|FG002|Overall Study|Withdrawal by Subject|6|||
25018076|NCT02918019|50113456|FG003|Overall Study|Withdrawal by Subject|4|||
25018077|NCT02918019|50113453|FG000|Overall Study|Adverse Event|0|||
25018078|NCT02918019|50113454|FG001|Overall Study|Adverse Event|1|||
25018079|NCT02918019|50113455|FG002|Overall Study|Adverse Event|0|||
25018080|NCT02918019|50113456|FG003|Overall Study|Adverse Event|1|||
25018081|NCT03055988|50113474|FG000|Period 1|Adverse Event|0|||
25018082|NCT03055988|50113475|FG001|Period 1|Adverse Event|1|||
25018083|NCT03055988|50113474|FG000|Period 1|Lost to Follow-up|1|||
25018084|NCT03055988|50113475|FG001|Period 1|Lost to Follow-up|0|||
25018085|NCT03055988|50113474|FG000|Period 1|Withdrawal by Subject|0|||
25018086|NCT03055988|50113475|FG001|Period 1|Withdrawal by Subject|4|||
25018087|NCT03055988|50113474|FG000|Period 2|Adverse Event|0|||
25018088|NCT03055988|50113475|FG001|Period 2|Adverse Event|1|||
25018089|NCT03055988|50113474|FG000|Period 2|Other than listed|1|||
25018090|NCT03055988|50113475|FG001|Period 2|Other than listed|1|||
25018091|NCT01250912|50113481|FG000|Overall Study|Lost to Follow-up|1|||
25018092|NCT03733301|50113491|FG000|Overall Study|Screen Fail|1|||
25018093|NCT03733301|50113492|FG001|Overall Study|Screen Fail|0|||
25018094|NCT03733301|50113493|FG002|Overall Study|Screen Fail|0|||
25018095|NCT03733301|50113491|FG000|Overall Study|Non-compliance|1|||
25018096|NCT03733301|50113492|FG001|Overall Study|Non-compliance|0|||
25018097|NCT03733301|50113493|FG002|Overall Study|Non-compliance|0|||
25018098|NCT03733301|50113491|FG000|Overall Study|Lack of Efficacy|2|||
25018099|NCT03733301|50113492|FG001|Overall Study|Lack of Efficacy|3|||
25018100|NCT03733301|50113493|FG002|Overall Study|Lack of Efficacy|0|||
25018101|NCT03733301|50113491|FG000|Overall Study|Adverse Event|0|||
25018102|NCT03733301|50113492|FG001|Overall Study|Adverse Event|1|||
25018103|NCT03733301|50113493|FG002|Overall Study|Adverse Event|3|||
25018104|NCT03733301|50113491|FG000|Overall Study|Withdrawal by Subject|3|||
25018105|NCT03733301|50113492|FG001|Overall Study|Withdrawal by Subject|5|||
25018106|NCT03733301|50113493|FG002|Overall Study|Withdrawal by Subject|1|||
25018107|NCT02871297|50113502|FG000|Overall Study|Adverse Event|34|||
25018108|NCT02871297|50113502|FG000|Overall Study|Lack of Efficacy|10|||
25018109|NCT02871297|50113502|FG000|Overall Study|Non-compliance with study drug|15|||
25018110|NCT02871297|50113502|FG000|Overall Study|Protocol Violation|3|||
25018111|NCT02871297|50113502|FG000|Overall Study|Withdrawal by Subject|20|||
25018112|NCT02871297|50113502|FG000|Overall Study|Lost to Follow-up|13|||
25018113|NCT02871297|50113502|FG000|Overall Study|Rolled over to 13546A|2|||
25018114|NCT02871297|50113502|FG000|Overall Study|Other than specified|39|||
25018115|NCT03554005|50113512|FG000|Overall Study|Not in participant's best interest|0|||
25018116|NCT03554005|50113513|FG001|Overall Study|Not in participant's best interest|0|||
25018117|NCT03554005|50113514|FG002|Overall Study|Not in participant's best interest|0|||
25152595|NCT01610336|50267579|FG005|Overall Study|Non-Compliance with study treatment|0|||
25152596|NCT01610336|50267580|FG006|Overall Study|Non-Compliance with study treatment|0|||
25018118|NCT03554005|50113515|FG003|Overall Study|Not in participant's best interest|0|||
25018119|NCT03554005|50113516|FG004|Overall Study|Not in participant's best interest|0|||
25018120|NCT03554005|50113517|FG005|Overall Study|Not in participant's best interest|1|||
25018121|NCT03554005|50113512|FG000|Overall Study|Disease Progression|1|||
25018122|NCT03554005|50113513|FG001|Overall Study|Disease Progression|1|||
25018123|NCT03554005|50113514|FG002|Overall Study|Disease Progression|1|||
25018124|NCT03554005|50113515|FG003|Overall Study|Disease Progression|1|||
25018125|NCT03554005|50113516|FG004|Overall Study|Disease Progression|5|||
25018126|NCT03554005|50113517|FG005|Overall Study|Disease Progression|6|||
25018127|NCT03554005|50113512|FG000|Overall Study|Adverse Event|0|||
25018128|NCT03554005|50113513|FG001|Overall Study|Adverse Event|0|||
25018129|NCT03554005|50113514|FG002|Overall Study|Adverse Event|0|||
25018130|NCT03554005|50113515|FG003|Overall Study|Adverse Event|0|||
25018131|NCT03554005|50113516|FG004|Overall Study|Adverse Event|0|||
25018132|NCT03554005|50113517|FG005|Overall Study|Adverse Event|3|||
25018133|NCT03554005|50113512|FG000|Overall Study|Physician Decision|0|||
25018134|NCT03554005|50113513|FG001|Overall Study|Physician Decision|0|||
25018135|NCT03554005|50113514|FG002|Overall Study|Physician Decision|0|||
25018136|NCT03554005|50113515|FG003|Overall Study|Physician Decision|0|||
25018137|NCT03554005|50113516|FG004|Overall Study|Physician Decision|1|||
25018138|NCT03554005|50113517|FG005|Overall Study|Physician Decision|0|||
25018139|NCT03554005|50113512|FG000|Overall Study|Other|0|||
25018140|NCT03554005|50113513|FG001|Overall Study|Other|0|||
25018141|NCT03554005|50113514|FG002|Overall Study|Other|0|||
25018142|NCT03554005|50113515|FG003|Overall Study|Other|0|||
25018143|NCT03554005|50113516|FG004|Overall Study|Other|0|||
25018144|NCT03554005|50113517|FG005|Overall Study|Other|1|||
25018145|NCT00709228|50113531|FG000|Overall Study|Not treated|14|||
25018146|NCT00709228|50113531|FG000|Overall Study|Eligibility criteria not met|281|||
25018147|NCT00709228|50113531|FG000|Overall Study|Adverse events|2|||
25018148|NCT00709228|50113531|FG000|Overall Study|Discontinued treatment|14|||
25018149|NCT00709228|50113531|FG000|Overall Study|Did not enter follow-up|4|||
25018150|NCT00709228|50113531|FG000|Overall Study|Discontinued follow-up|5|||
25018151|NCT00709228|50113531|FG000|Overall Study|Disease progression|1|||
25018152|NCT00709228|50113531|FG000|Overall Study|Lost to Follow-up|6|||
25018153|NCT00709228|50113531|FG000|Overall Study|Non-compliance|5|||
25018154|NCT03219372|50113554|FG000|Overall Study|Withdrawal by Subject|1|||
25018155|NCT03219372|50113555|FG001|Overall Study|Withdrawal by Subject|0|||
25018156|NCT03056690|50113570|FG000|Overall Study|Adverse Event|3|||
25018157|NCT03056690|50113571|FG001|Overall Study|Adverse Event|2|||
25018158|NCT03056690|50113570|FG000|Overall Study|Lack of Efficacy|1|||
25018159|NCT03056690|50113571|FG001|Overall Study|Lack of Efficacy|2|||
25018160|NCT03056690|50113570|FG000|Overall Study|Lost to Follow-up|3|||
25018161|NCT03056690|50113571|FG001|Overall Study|Lost to Follow-up|2|||
25018162|NCT03056690|50113570|FG000|Overall Study|Protocol Violation|2|||
25018163|NCT03056690|50113571|FG001|Overall Study|Protocol Violation|2|||
25018164|NCT03056690|50113570|FG000|Overall Study|Withdrawal by Subject|3|||
25018165|NCT03056690|50113571|FG001|Overall Study|Withdrawal by Subject|6|||
25018166|NCT03056690|50113570|FG000|Overall Study|Non-compliance with Study Drug|1|||
25018167|NCT03056690|50113571|FG001|Overall Study|Non-compliance with Study Drug|0|||
25018168|NCT03056690|50113570|FG000|Overall Study|Miscellaneous|1|||
25018169|NCT03056690|50113571|FG001|Overall Study|Miscellaneous|2|||
25018170|NCT03191799|50113577|FG000|Overall Study|Withdrawal by Subject|4|||
25018171|NCT03191799|50113577|FG000|Overall Study|Physician Decision|2|||
25018172|NCT03191799|50113577|FG000|Overall Study|Lost to Follow-up|1|||
25018173|NCT03191799|50113577|FG000|Overall Study|Death|2|||
25018174|NCT00708916|50113581|FG000|Overall Study|Subject Noncompliance|2|||
25018175|NCT00708916|50113581|FG000|Overall Study|Adverse Event|2|||
25018176|NCT02352753|50113586|FG000|6-Month Dosing Period|Decision by sponsor|2|||
25018177|NCT02352753|50113586|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
25018178|NCT02352753|50113586|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
25018179|NCT02352753|50113586|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
25018180|NCT02352753|50113586|FG000|3-Month Dosing Period|Decision by sponsor|14|||
25018181|NCT02352753|50113586|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
25018182|NCT04532294|50113597|FG000|Overall Study|Withdrawal by Subject|0|||
25018183|NCT04532294|50113598|FG001|Overall Study|Withdrawal by Subject|0|||
25018184|NCT04532294|50113599|FG002|Overall Study|Withdrawal by Subject|1|||
25018185|NCT04532294|50113597|FG000|Overall Study|Participants Not Dosed|0|||
25018186|NCT04532294|50113598|FG001|Overall Study|Participants Not Dosed|0|||
25018187|NCT04532294|50113599|FG002|Overall Study|Participants Not Dosed|2|||
25018188|NCT03197766|50113611|FG000|Overall Study|Withdrawal by Subject|2|||
25018189|NCT03197766|50113612|FG001|Overall Study|Withdrawal by Subject|0|||
25018190|NCT03738332|50113618|FG000|Overall Study|Withdrawal by Subject|1|||
25018191|NCT03173456|50113628|FG000|Baseline|Medication dispensing system malfunction'|0|||
25274804|NCT00910429|50588861|FG001|Overall Study|Drug non-compliance|0|||
25274805|NCT00910429|50588860|FG000|Overall Study|Lack of Efficacy|4|||
25018192|NCT03173456|50113629|FG001|Baseline|Medication dispensing system malfunction'|1|||
25018193|NCT03173456|50113630|FG002|Baseline|Medication dispensing system malfunction'|0|||
25018194|NCT03173456|50113631|FG003|Baseline|Medication dispensing system malfunction'|0|||
25018195|NCT03173456|50113632|FG004|Baseline|Medication dispensing system malfunction'|2|||
25018196|NCT03173456|50113628|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
25018197|NCT03173456|50113629|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
25018198|NCT03173456|50113630|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
25018199|NCT03173456|50113631|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
25018200|NCT03173456|50113632|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
25018201|NCT03197376|50113655|FG000|Primary and Booster Phase|Adverse Event|0|||
25018202|NCT03197376|50113656|FG001|Primary and Booster Phase|Adverse Event|0|||
25018203|NCT03197376|50113657|FG002|Primary and Booster Phase|Adverse Event|0|||
25018204|NCT03197376|50113658|FG003|Primary and Booster Phase|Adverse Event|1|||
25018205|NCT03197376|50113655|FG000|Primary and Booster Phase|Death|1|||
25018206|NCT03197376|50113656|FG001|Primary and Booster Phase|Death|0|||
25018207|NCT03197376|50113657|FG002|Primary and Booster Phase|Death|0|||
25018208|NCT03197376|50113658|FG003|Primary and Booster Phase|Death|2|||
25018209|NCT03197376|50113655|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
25018210|NCT03197376|50113656|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
25018211|NCT03197376|50113657|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
25018212|NCT03197376|50113658|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
25018213|NCT03197376|50113655|FG000|Primary and Booster Phase|Physician Decision|1|||
25018214|NCT03197376|50113656|FG001|Primary and Booster Phase|Physician Decision|0|||
25018215|NCT03197376|50113657|FG002|Primary and Booster Phase|Physician Decision|1|||
25018216|NCT03197376|50113658|FG003|Primary and Booster Phase|Physician Decision|3|||
25018217|NCT03197376|50113655|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
25018218|NCT03197376|50113656|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
25018219|NCT03197376|50113657|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
25018220|NCT03197376|50113658|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
25018221|NCT03197376|50113655|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
25018222|NCT03197376|50113656|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
25018223|NCT03197376|50113657|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
25018224|NCT03197376|50113658|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
25018225|NCT03197376|50113655|FG000|Primary and Booster Phase|Not vaccine related|1|||
25018226|NCT03197376|50113656|FG001|Primary and Booster Phase|Not vaccine related|2|||
25018227|NCT03197376|50113657|FG002|Primary and Booster Phase|Not vaccine related|0|||
25018228|NCT03197376|50113658|FG003|Primary and Booster Phase|Not vaccine related|6|||
25018229|NCT03197376|50113655|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
25018230|NCT03197376|50113656|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
25018231|NCT03197376|50113657|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
25018232|NCT03197376|50113658|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
25018233|NCT03197376|50113655|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
25018234|NCT03197376|50113656|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
25152597|NCT01610336|50267581|FG007|Overall Study|Non-Compliance with study treatment|0|||
25152598|NCT01610336|50267582|FG008|Overall Study|Non-Compliance with study treatment|0|||
25152599|NCT01610336|50267583|FG009|Overall Study|Non-Compliance with study treatment|1|||
25152600|NCT01610336|50267584|FG010|Overall Study|Non-Compliance with study treatment|0|||
25274806|NCT00910429|50588861|FG001|Overall Study|Lack of Efficacy|1|||
25152601|NCT01610336|50267574|FG000|Overall Study|Physician Decision|0|||
25018235|NCT03197376|50113657|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
25018236|NCT03197376|50113658|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
25018237|NCT03197376|50113655|FG000|Immune Persistence Phase|Not vaccine related|1|||
25018238|NCT03197376|50113656|FG001|Immune Persistence Phase|Not vaccine related|0|||
25018239|NCT03197376|50113657|FG002|Immune Persistence Phase|Not vaccine related|1|||
25018240|NCT03197376|50113658|FG003|Immune Persistence Phase|Not vaccine related|1|||
25018241|NCT03600805|50113695|FG000|Overall Study|Adverse Event|2|||
25018242|NCT03600805|50113696|FG001|Overall Study|Adverse Event|1|||
25018243|NCT03600805|50113697|FG002|Overall Study|Adverse Event|1|||
25018244|NCT03600805|50113698|FG003|Overall Study|Adverse Event|7|||
25018245|NCT03600805|50113695|FG000|Overall Study|Lack of Efficacy|2|||
25018246|NCT03600805|50113696|FG001|Overall Study|Lack of Efficacy|1|||
25018247|NCT03600805|50113697|FG002|Overall Study|Lack of Efficacy|0|||
25018248|NCT03600805|50113698|FG003|Overall Study|Lack of Efficacy|0|||
25018249|NCT03600805|50113695|FG000|Overall Study|Withdrawal by Subject|1|||
25018250|NCT03600805|50113696|FG001|Overall Study|Withdrawal by Subject|0|||
25018251|NCT03600805|50113697|FG002|Overall Study|Withdrawal by Subject|0|||
25018252|NCT03600805|50113698|FG003|Overall Study|Withdrawal by Subject|1|||
25018253|NCT03600805|50113695|FG000|Overall Study|Other unspecified|14|||
25018254|NCT03600805|50113696|FG001|Overall Study|Other unspecified|6|||
25018255|NCT03600805|50113697|FG002|Overall Study|Other unspecified|7|||
25018256|NCT03600805|50113698|FG003|Overall Study|Other unspecified|11|||
25018257|NCT02729740|50113710|FG000|Overall Study|Early Termination|130|||
25018258|NCT02729740|50113710|FG000|Overall Study|Other|1|||
25018259|NCT03196284|50113720|FG000|Main Part|Withdrawal by Subject|0|||
25152602|NCT01610336|50267575|FG001|Overall Study|Physician Decision|0|||
25152603|NCT01610336|50267576|FG002|Overall Study|Physician Decision|0|||
25152604|NCT01610336|50267577|FG003|Overall Study|Physician Decision|0|||
25152605|NCT01610336|50267578|FG004|Overall Study|Physician Decision|0|||
25152606|NCT01610336|50267579|FG005|Overall Study|Physician Decision|0|||
25152607|NCT01610336|50267580|FG006|Overall Study|Physician Decision|1|||
25018260|NCT03196284|50113721|FG001|Main Part|Withdrawal by Subject|1|||
25018261|NCT03196284|50113722|FG002|Main Part|Withdrawal by Subject|0|||
25018262|NCT03196284|50113720|FG000|Extension Part|Lack of Efficacy|0|||
25018263|NCT03196284|50113721|FG001|Extension Part|Lack of Efficacy|0|||
25018264|NCT03196284|50113722|FG002|Extension Part|Lack of Efficacy|1|||
25018265|NCT03196284|50113720|FG000|Extension Part|Withdrawal by Subject|0|||
25018266|NCT03196284|50113721|FG001|Extension Part|Withdrawal by Subject|0|||
25018267|NCT03196284|50113722|FG002|Extension Part|Withdrawal by Subject|1|||
25018268|NCT03196284|50113720|FG000|Extension Part|Physician Decision|0|||
25018269|NCT03196284|50113721|FG001|Extension Part|Physician Decision|0|||
25018270|NCT03196284|50113722|FG002|Extension Part|Physician Decision|1|||
25018271|NCT03730961|50113744|FG000|Overall Study|Adverse Event|0|||
25018272|NCT03730961|50113745|FG001|Overall Study|Adverse Event|1|||
25018273|NCT01078454|50113753|FG000|Overall Study|Adverse Event|1|||
25018274|NCT01078454|50113754|FG001|Overall Study|Adverse Event|1|||
25018275|NCT01078454|50113753|FG000|Overall Study|Death|0|||
25018276|NCT01078454|50113754|FG001|Overall Study|Death|1|||
25018277|NCT03345004|50113771|FG000|Overall Study|Physician Decision|1|||
25018278|NCT03345004|50113772|FG001|Overall Study|Physician Decision|0|||
25018279|NCT03345004|50113771|FG000|Overall Study|Withdrawal by Subject|0|||
25018280|NCT03345004|50113772|FG001|Overall Study|Withdrawal by Subject|1|||
25018281|NCT03552757|50113783|FG000|Overall Study|Withdrawal by Subject|10|||
25018282|NCT03552757|50113784|FG001|Overall Study|Withdrawal by Subject|5|||
25018283|NCT03552757|50113785|FG002|Overall Study|Withdrawal by Subject|12|||
25018284|NCT03552757|50113783|FG000|Overall Study|Lost to Follow-up|2|||
25018285|NCT03552757|50113784|FG001|Overall Study|Lost to Follow-up|7|||
25018286|NCT03552757|50113785|FG002|Overall Study|Lost to Follow-up|7|||
25018287|NCT03552757|50113783|FG000|Overall Study|Death|1|||
25018288|NCT03552757|50113784|FG001|Overall Study|Death|1|||
25018289|NCT03552757|50113785|FG002|Overall Study|Death|1|||
25018290|NCT03730103|50113798|FG000|Overall Study|Did not meet inclusion criteria|0|||
25018291|NCT03730103|50113799|FG001|Overall Study|Did not meet inclusion criteria|5|||
25018292|NCT03727841|50113807|FG000|Overall Study|Physician Decision|3|||
25018293|NCT03727841|50113808|FG001|Overall Study|Physician Decision|1|||
25018294|NCT03552523|50113814|FG000|Overall Study|Withdrawal by Subject|1|||
25018295|NCT03552523|50113815|FG001|Overall Study|Withdrawal by Subject|1|||
25018296|NCT03345550|50113823|FG000|Overall Study|Withdrawal by Subject|1|||
25018297|NCT03345550|50113824|FG001|Overall Study|Withdrawal by Subject|0|||
25018298|NCT03345550|50113823|FG000|Overall Study|Lost to Follow-up|4|||
25018299|NCT03345550|50113824|FG001|Overall Study|Lost to Follow-up|5|||
25018300|NCT03186378|50113832|FG000|Overall Study|Lost to Follow-up|1|||
25018301|NCT03186378|50113833|FG001|Overall Study|Lost to Follow-up|0|||
25018302|NCT00687596|50113841|FG000|Overall Study|Adverse Event (AE)|10|||
25274807|NCT00909727|50588869|FG000|Overall Study|Adverse Event|1|||
25018303|NCT00687596|50113842|FG001|Overall Study|Adverse Event (AE)|3|||
25152608|NCT01610336|50267581|FG007|Overall Study|Physician Decision|0|||
25152609|NCT01610336|50267582|FG008|Overall Study|Physician Decision|0|||
25152610|NCT01610336|50267583|FG009|Overall Study|Physician Decision|0|||
25152611|NCT01610336|50267584|FG010|Overall Study|Physician Decision|0|||
25152612|NCT01610336|50267574|FG000|Overall Study|Protocol Deviation|0|||
25152613|NCT01610336|50267575|FG001|Overall Study|Protocol Deviation|0|||
25018304|NCT00687596|50113841|FG000|Overall Study|Radiological Disease Progression|6|||
25152614|NCT01610336|50267576|FG002|Overall Study|Protocol Deviation|0|||
25152615|NCT01610336|50267577|FG003|Overall Study|Protocol Deviation|0|||
25152616|NCT01610336|50267578|FG004|Overall Study|Protocol Deviation|0|||
25152617|NCT01610336|50267579|FG005|Overall Study|Protocol Deviation|0|||
25152618|NCT01610336|50267580|FG006|Overall Study|Protocol Deviation|0|||
25152619|NCT01610336|50267581|FG007|Overall Study|Protocol Deviation|0|||
25184897|NCT01463696|50333827|FG000|Overall Study|Not Treated|0|||
25018305|NCT00687596|50113842|FG001|Overall Study|Radiological Disease Progression|2|||
25018306|NCT00687596|50113841|FG000|Overall Study|Clinical Disease Progression|1|||
25152620|NCT01610336|50267582|FG008|Overall Study|Protocol Deviation|0|||
25184898|NCT01463696|50333828|FG001|Overall Study|Not Treated|0|||
25018307|NCT00687596|50113842|FG001|Overall Study|Clinical Disease Progression|3|||
25018308|NCT00687596|50113841|FG000|Overall Study|Investigator Discretion|3|||
25018309|NCT00687596|50113842|FG001|Overall Study|Investigator Discretion|1|||
25018310|NCT00687596|50113841|FG000|Overall Study|Sponsor Terminated Study|6|||
25018311|NCT00687596|50113842|FG001|Overall Study|Sponsor Terminated Study|17|||
25018312|NCT02892409|50113850|FG000|Overall Study|Adverse Event|1|||
25018313|NCT02892409|50113851|FG001|Overall Study|Adverse Event|0|||
25018314|NCT02892409|50113850|FG000|Overall Study|Withdrawal by Subject|2|||
25018315|NCT02892409|50113851|FG001|Overall Study|Withdrawal by Subject|1|||
25018316|NCT03219216|50113859|FG000|Overall Study|Lost to Follow-up|0|||
25018317|NCT03219216|50113860|FG001|Overall Study|Lost to Follow-up|1|||
25018318|NCT03195660|50113874|FG000|Overall Study|The study was terminated|2|||
25018319|NCT03194490|50113880|FG000|Overall Study|Lost to Follow-up|1|||
25018320|NCT03194490|50113881|FG001|Overall Study|Lost to Follow-up|3|||
25018321|NCT03194490|50113880|FG000|Overall Study|participant developed specific neck pain|1|||
25018322|NCT03194490|50113881|FG001|Overall Study|participant developed specific neck pain|0|||
25018323|NCT03217968|50113888|FG000|Overall Study|Withdrawal by Subject|4|||
25018324|NCT03217968|50113888|FG000|Overall Study|Lost to Follow-up|1|||
25018325|NCT03217968|50113888|FG000|Overall Study|Protocol Violation|6|||
25018326|NCT03192306|50113894|FG000|Overall Study|Did not treat cold sore during study|149|||
25018327|NCT03192306|50113895|FG001|Overall Study|Did not treat cold sore during study|143|||
25018328|NCT03192306|50113894|FG000|Overall Study|Withdrawal by Subject|1|||
25018329|NCT03192306|50113895|FG001|Overall Study|Withdrawal by Subject|1|||
25018330|NCT03192306|50113894|FG000|Overall Study|Lost to Follow-up|1|||
25018331|NCT03192306|50113895|FG001|Overall Study|Lost to Follow-up|0|||
25018332|NCT03192306|50113894|FG000|Overall Study|Protocol Violation|1|||
25018333|NCT03192306|50113895|FG001|Overall Study|Protocol Violation|1|||
25018334|NCT03216954|50113918|FG000|Overall Study|Adverse Event|0|||
25018335|NCT03216954|50113919|FG001|Overall Study|Adverse Event|0|||
25018336|NCT03216954|50113920|FG002|Overall Study|Adverse Event|1|||
25018337|NCT03216954|50113921|FG003|Overall Study|Adverse Event|0|||
25018338|NCT03216954|50113922|FG004|Overall Study|Adverse Event|1|||
25018339|NCT03216954|50113918|FG000|Overall Study|Withdrawal by Subject|2|||
25018340|NCT03216954|50113919|FG001|Overall Study|Withdrawal by Subject|0|||
25018341|NCT03216954|50113920|FG002|Overall Study|Withdrawal by Subject|0|||
25018342|NCT03216954|50113921|FG003|Overall Study|Withdrawal by Subject|0|||
25274808|NCT00909727|50588870|FG001|Overall Study|Adverse Event|0|||
25018343|NCT03216954|50113922|FG004|Overall Study|Withdrawal by Subject|0|||
25018344|NCT03216954|50113918|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
25152621|NCT01610336|50267583|FG009|Overall Study|Protocol Deviation|1|||
25152622|NCT01610336|50267584|FG010|Overall Study|Protocol Deviation|0|||
25152623|NCT01610336|50267574|FG000|Overall Study|Transfer to another trial|0|||
25152624|NCT01610336|50267575|FG001|Overall Study|Transfer to another trial|0|||
25152625|NCT01610336|50267576|FG002|Overall Study|Transfer to another trial|0|||
25018345|NCT03216954|50113919|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
25152626|NCT01610336|50267577|FG003|Overall Study|Transfer to another trial|0|||
25152627|NCT01610336|50267578|FG004|Overall Study|Transfer to another trial|0|||
25152628|NCT01610336|50267579|FG005|Overall Study|Transfer to another trial|0|||
25152629|NCT01610336|50267580|FG006|Overall Study|Transfer to another trial|0|||
25152630|NCT01610336|50267581|FG007|Overall Study|Transfer to another trial|0|||
25152631|NCT01610336|50267582|FG008|Overall Study|Transfer to another trial|0|||
25152632|NCT01610336|50267583|FG009|Overall Study|Transfer to another trial|0|||
25152633|NCT01610336|50267584|FG010|Overall Study|Transfer to another trial|1|||
25152634|NCT01613222|50267612|FG000|Overall Study|Physician Decision|1|||
25152635|NCT01613222|50267612|FG000|Overall Study|Unable to place arterial line|1|||
25152636|NCT01613222|50267612|FG000|Overall Study|Reused disposable sensors|10|||
25152637|NCT01612676|50267659|FG000|Overall Study|Adverse Event|2|||
25152638|NCT01612676|50267660|FG001|Overall Study|Adverse Event|3|||
25152639|NCT01612676|50267661|FG002|Overall Study|Adverse Event|1|||
25152640|NCT01612676|50267662|FG003|Overall Study|Adverse Event|3|||
25152641|NCT01612676|50267659|FG000|Overall Study|Protocol Violation|0|||
25152642|NCT01612676|50267660|FG001|Overall Study|Protocol Violation|1|||
25152643|NCT01612676|50267661|FG002|Overall Study|Protocol Violation|0|||
25152644|NCT01612676|50267662|FG003|Overall Study|Protocol Violation|0|||
25152645|NCT01869764|50267676|FG000|Overall Study|Withdrawal by Subject|0|||
25152646|NCT01869764|50267677|FG001|Overall Study|Withdrawal by Subject|2|||
25152647|NCT01842620|50267683|FG000|Period 1|Withdrawal by Subject|1|||
25018346|NCT03216954|50113920|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
25018347|NCT03216954|50113921|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
25018348|NCT03216954|50113922|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
25018349|NCT03599089|50113934|FG000|Overall Study|Lost to Follow-up|1|||
25018350|NCT03599089|50113935|FG001|Overall Study|Lost to Follow-up|0|||
25018351|NCT03599089|50113936|FG002|Overall Study|Lost to Follow-up|0|||
25018352|NCT03599089|50113937|FG003|Overall Study|Lost to Follow-up|0|||
25152648|NCT01842620|50267684|FG001|Period 1|Withdrawal by Subject|0|||
25152649|NCT01931839|50267710|FG000|Overall Study|Death|0|||
25152650|NCT01931839|50267711|FG001|Overall Study|Death|1|||
25152651|NCT01931839|50267712|FG002|Overall Study|Death|2|||
25152652|NCT01931839|50267713|FG003|Overall Study|Death|0|||
25152653|NCT01931839|50267714|FG004|Overall Study|Death|0|||
25152654|NCT01931839|50267715|FG005|Overall Study|Death|0|||
25018353|NCT03599089|50113934|FG000|Overall Study|Withdrawal by Subject|2|||
25018354|NCT03599089|50113935|FG001|Overall Study|Withdrawal by Subject|1|||
25018355|NCT03599089|50113936|FG002|Overall Study|Withdrawal by Subject|0|||
25018356|NCT03599089|50113937|FG003|Overall Study|Withdrawal by Subject|0|||
25018357|NCT03599089|50113934|FG000|Overall Study|Lack of Efficacy|0|||
25018358|NCT03599089|50113935|FG001|Overall Study|Lack of Efficacy|0|||
25018359|NCT03599089|50113936|FG002|Overall Study|Lack of Efficacy|1|||
25018360|NCT03599089|50113937|FG003|Overall Study|Lack of Efficacy|2|||
25018361|NCT03192150|50113949|FG000|Overall Study|Adverse Event|14|||
25018362|NCT03192150|50113950|FG001|Overall Study|Adverse Event|12|||
25018363|NCT03192150|50113949|FG000|Overall Study|Lack of Efficacy|23|||
25018364|NCT03192150|50113950|FG001|Overall Study|Lack of Efficacy|30|||
25018365|NCT03192150|50113949|FG000|Overall Study|Lost to Follow-up|1|||
25018366|NCT03192150|50113950|FG001|Overall Study|Lost to Follow-up|1|||
25018367|NCT03192150|50113949|FG000|Overall Study|Withdrawal by Subject|4|||
25018368|NCT03192150|50113950|FG001|Overall Study|Withdrawal by Subject|2|||
25018369|NCT03192150|50113949|FG000|Overall Study|Protocol Violation|5|||
25018370|NCT03192150|50113950|FG001|Overall Study|Protocol Violation|2|||
25018371|NCT03192150|50113949|FG000|Overall Study|Surgery Canceled|6|||
25018372|NCT03192150|50113950|FG001|Overall Study|Surgery Canceled|2|||
25018373|NCT03192150|50113949|FG000|Overall Study|Other-Various Administrative Reasons|2|||
25018374|NCT03192150|50113950|FG001|Overall Study|Other-Various Administrative Reasons|5|||
25018375|NCT03597529|50113958|FG000|Overall Study|Lost to Follow-up|10|||
25018376|NCT03597529|50113959|FG001|Overall Study|Lost to Follow-up|12|||
25018377|NCT03597529|50113958|FG000|Overall Study|Physician Decision|3|||
25018378|NCT03597529|50113959|FG001|Overall Study|Physician Decision|1|||
25018379|NCT03597529|50113958|FG000|Overall Study|Withdrawal by Subject|6|||
25018380|NCT03597529|50113959|FG001|Overall Study|Withdrawal by Subject|3|||
25018381|NCT03597529|50113958|FG000|Overall Study|Non-compliant with study activities|1|||
25018382|NCT03597529|50113959|FG001|Overall Study|Non-compliant with study activities|2|||
25018383|NCT03180528|50113965|FG000|Overall Study|Adverse Event|1|||
25018384|NCT03180528|50113965|FG000|Overall Study|Withdrawal by Subject|1|||
25018385|NCT03180528|50113965|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
25018386|NCT03597295|50113969|FG000|Overall Study|Death|70|||
25018387|NCT03597295|50113969|FG000|Overall Study|Lost to Follow-up|7|||
25018388|NCT03180138|50113976|FG000|Overall Study|Mobile-phone could not be verified|2|||
25018389|NCT03180138|50113977|FG001|Overall Study|Mobile-phone could not be verified|13|||
25018390|NCT03180138|50113978|FG002|Overall Study|Mobile-phone could not be verified|15|||
25018391|NCT03180138|50113976|FG000|Overall Study|No prior immunization records|17|||
25018392|NCT03180138|50113977|FG001|Overall Study|No prior immunization records|0|||
25018393|NCT03180138|50113978|FG002|Overall Study|No prior immunization records|6|||
25018394|NCT03180138|50113976|FG000|Overall Study|Found to be >24 mon after randomization|3|||
25018395|NCT03180138|50113977|FG001|Overall Study|Found to be >24 mon after randomization|0|||
25018396|NCT03180138|50113978|FG002|Overall Study|Found to be >24 mon after randomization|3|||
25018397|NCT03597139|50113988|FG000|Overall Study|Adverse Event|3|||
25018398|NCT03597139|50113989|FG001|Overall Study|Adverse Event|0|||
25018399|NCT03597139|50113988|FG000|Overall Study|Protocol Non-compliance|1|||
25018400|NCT03597139|50113989|FG001|Overall Study|Protocol Non-compliance|0|||
25018401|NCT03179202|50113995|FG000|Overall Study|Screen Failure|67|||
25018402|NCT03179202|50113995|FG000|Overall Study|Subject Lost to Follow Up|12|||
25018403|NCT03179202|50113995|FG000|Overall Study|Withdrawal by Subject|7|||
25018404|NCT03179202|50113995|FG000|Overall Study|Adverse Event|3|||
25018405|NCT03179202|50113995|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
25018406|NCT03179202|50113995|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
25018407|NCT00708214|50114004|FG000|Overall Study|Other Adverse Event|3|||
25018408|NCT00708214|50114005|FG001|Overall Study|Other Adverse Event|6|||
25018409|NCT00708214|50114006|FG002|Overall Study|Other Adverse Event|2|||
25018410|NCT00708214|50114004|FG000|Overall Study|Other|0|||
25018411|NCT00708214|50114005|FG001|Overall Study|Other|1|||
25018412|NCT00708214|50114006|FG002|Overall Study|Other|1|||
25018413|NCT00708214|50114004|FG000|Overall Study|Progressive Disease|4|||
25018414|NCT00708214|50114005|FG001|Overall Study|Progressive Disease|6|||
25018415|NCT00708214|50114006|FG002|Overall Study|Progressive Disease|5|||
25018416|NCT03570697|50114021|FG000|Overall Study|Lost to Follow-up|0|||
25018417|NCT03570697|50114022|FG001|Overall Study|Lost to Follow-up|1|||
25018418|NCT03570697|50114021|FG000|Overall Study|Death|2|||
25018419|NCT03570697|50114022|FG001|Overall Study|Death|0|||
25018420|NCT03570697|50114021|FG000|Overall Study|Withdrawal by Subject|4|||
25018421|NCT03570697|50114022|FG001|Overall Study|Withdrawal by Subject|2|||
25018422|NCT03569371|50114039|FG000|Overall Study|Lack of Efficacy|1|||
25018423|NCT03569371|50114039|FG000|Overall Study|Lost to Follow-up|1|||
25152655|NCT01931839|50267716|FG006|Overall Study|Death|0|||
25018424|NCT03569371|50114039|FG000|Overall Study|Adverse Event|1|||
25018425|NCT01318070|50114046|FG000|Overall Study|Adverse Event|1|||
25018426|NCT01318070|50114047|FG001|Overall Study|Adverse Event|1|||
25018427|NCT01318070|50114048|FG002|Overall Study|Adverse Event|5|||
25018428|NCT01318070|50114046|FG000|Overall Study|Withdrawal by Subject|0|||
25018429|NCT01318070|50114047|FG001|Overall Study|Withdrawal by Subject|1|||
25018430|NCT01318070|50114048|FG002|Overall Study|Withdrawal by Subject|1|||
25018431|NCT01318070|50114046|FG000|Overall Study|Lack of Efficacy|0|||
25018432|NCT01318070|50114047|FG001|Overall Study|Lack of Efficacy|0|||
25018433|NCT01318070|50114048|FG002|Overall Study|Lack of Efficacy|1|||
25018434|NCT01318070|50114046|FG000|Overall Study|Principal Investigator Discretion|1|||
25018435|NCT01318070|50114047|FG001|Overall Study|Principal Investigator Discretion|0|||
25018436|NCT01318070|50114048|FG002|Overall Study|Principal Investigator Discretion|0|||
25018437|NCT02895295|50114059|FG000|Overall Study|Survey Non-response|71|||
25018438|NCT02895295|50114060|FG001|Overall Study|Survey Non-response|94|||
25018439|NCT02895295|50114061|FG002|Overall Study|Survey Non-response|92|||
24907546|NCT00623805|50001588|FG000|Overall Study|Reason not Specified|3|||
24907547|NCT00623805|50001589|FG001|Overall Study|Reason not Specified|6|||
24907548|NCT00621309|50001595|FG000|Overall Study|Withdrawal by Subject|2|||
24907549|NCT00621309|50001596|FG001|Overall Study|Withdrawal by Subject|0|||
24907550|NCT00621309|50001597|FG002|Overall Study|Withdrawal by Subject|1|||
24907551|NCT00621309|50001598|FG003|Overall Study|Withdrawal by Subject|1|||
24907552|NCT00621309|50001599|FG004|Overall Study|Withdrawal by Subject|1|||
24907553|NCT00621309|50001600|FG005|Overall Study|Withdrawal by Subject|1|||
24907554|NCT00567190|50001608|FG000|Overall Study|Death|235|||
24907555|NCT00567190|50001609|FG001|Overall Study|Death|280|||
24907556|NCT00567190|50001608|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
24907557|NCT00567190|50001609|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
24907558|NCT00691938|50001627|FG000|Overall Study|QTc prolongation|1|||
25018440|NCT00245960|50114071|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
25018441|NCT00245960|50114072|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
25018442|NCT00245960|50114071|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
25152656|NCT01931839|50267710|FG000|Overall Study|Physician Decision|1|||
24907559|NCT00691938|50001628|FG001|Overall Study|QTc prolongation|0|||
24907560|NCT00691938|50001629|FG002|Overall Study|QTc prolongation|0|||
24907561|NCT00691938|50001630|FG003|Overall Study|QTc prolongation|0|||
24907562|NCT00691938|50001631|FG004|Overall Study|QTc prolongation|0|||
24907563|NCT00691938|50001632|FG005|Overall Study|QTc prolongation|0|||
24907564|NCT00691938|50001633|FG006|Overall Study|QTc prolongation|0|||
24907565|NCT00365365|50001647|FG000|Overall Study|Randomized but not treated|0|||
24907566|NCT00365365|50001648|FG001|Overall Study|Randomized but not treated|2|||
24907567|NCT00365365|50001649|FG002|Overall Study|Randomized but not treated|0|||
24907568|NCT00365365|50001647|FG000|Overall Study|Poor compliance to protocol|0|||
24907569|NCT00365365|50001648|FG001|Overall Study|Poor compliance to protocol|1|||
24907570|NCT00365365|50001649|FG002|Overall Study|Poor compliance to protocol|0|||
24907571|NCT00365365|50001647|FG000|Overall Study|Lost to Follow-up|3|||
24907572|NCT00365365|50001648|FG001|Overall Study|Lost to Follow-up|3|||
24907573|NCT00365365|50001649|FG002|Overall Study|Lost to Follow-up|3|||
24907574|NCT00365365|50001647|FG000|Overall Study|Death|1|||
24907575|NCT00365365|50001648|FG001|Overall Study|Death|3|||
24907576|NCT00365365|50001649|FG002|Overall Study|Death|0|||
24907577|NCT00365365|50001647|FG000|Overall Study|Subject's request|11|||
24907578|NCT00365365|50001648|FG001|Overall Study|Subject's request|13|||
24907579|NCT00365365|50001649|FG002|Overall Study|Subject's request|1|||
24907580|NCT00365365|50001647|FG000|Overall Study|Disease progression/relapse|9|||
24907581|NCT00365365|50001648|FG001|Overall Study|Disease progression/relapse|6|||
24907582|NCT00365365|50001649|FG002|Overall Study|Disease progression/relapse|7|||
24907583|NCT00365365|50001647|FG000|Overall Study|Adverse Event|6|||
24907584|NCT00365365|50001648|FG001|Overall Study|Adverse Event|6|||
24907585|NCT00365365|50001649|FG002|Overall Study|Adverse Event|3|||
24907586|NCT00365365|50001647|FG000|Overall Study|Moved|2|||
24907587|NCT00365365|50001648|FG001|Overall Study|Moved|0|||
24907588|NCT00365365|50001649|FG002|Overall Study|Moved|0|||
24907589|NCT00365365|50001647|FG000|Overall Study|New cancer|1|||
24907590|NCT00365365|50001648|FG001|Overall Study|New cancer|0|||
24907591|NCT00365365|50001649|FG002|Overall Study|New cancer|0|||
24907592|NCT00365365|50001647|FG000|Overall Study|Withdrew consent|1|||
24907593|NCT00365365|50001648|FG001|Overall Study|Withdrew consent|1|||
24907594|NCT00365365|50001649|FG002|Overall Study|Withdrew consent|0|||
24907595|NCT00365365|50001647|FG000|Overall Study|Second malignancy|0|||
24907596|NCT00365365|50001648|FG001|Overall Study|Second malignancy|1|||
24907597|NCT00365365|50001649|FG002|Overall Study|Second malignancy|0|||
24907598|NCT00365365|50001647|FG000|Overall Study|Patient/physician decision|0|||
24907599|NCT00365365|50001648|FG001|Overall Study|Patient/physician decision|0|||
24907600|NCT00365365|50001649|FG002|Overall Study|Patient/physician decision|1|||
24907601|NCT00623727|50001659|FG000|Double Blind (DB)|Adverse Event|1|||
24907602|NCT00623727|50001660|FG001|Double Blind (DB)|Adverse Event|3|||
24907603|NCT00623727|50001659|FG000|Double Blind (DB)|Physician Decision|0|||
24907604|NCT00623727|50001660|FG001|Double Blind (DB)|Physician Decision|1|||
24907605|NCT00623727|50001659|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
25152657|NCT01931839|50267711|FG001|Overall Study|Physician Decision|0|||
25152658|NCT01931839|50267712|FG002|Overall Study|Physician Decision|1|||
24907606|NCT00623727|50001660|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
24907607|NCT00623727|50001659|FG000|Double Blind (DB)|Lack of Efficacy|2|||
24907608|NCT00623727|50001660|FG001|Double Blind (DB)|Lack of Efficacy|2|||
24907609|NCT00623727|50001659|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
24907610|NCT00623727|50001660|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
24907611|NCT00623727|50001659|FG000|Double Blind (DB)|Lost to Follow-up|1|||
24907612|NCT00623727|50001660|FG001|Double Blind (DB)|Lost to Follow-up|1|||
24907613|NCT00623727|50001659|FG000|Double Blind (DB)|Protocol Violation|2|||
24907614|NCT00623727|50001660|FG001|Double Blind (DB)|Protocol Violation|2|||
24907615|NCT00623727|50001659|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
24907616|NCT00623727|50001660|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
24907617|NCT00623727|50001659|FG000|Open Label Follow-up|Study termination|0|||
24907618|NCT00623727|50001660|FG001|Open Label Follow-up|Study termination|6|||
24907619|NCT00623727|50001659|FG000|Open Label Follow-up|Participant convenience|0|||
24907620|NCT00623727|50001660|FG001|Open Label Follow-up|Participant convenience|1|||
24907621|NCT00372775|50001668|FG000|Overall Study|Adverse Event|8|||
24907622|NCT00372775|50001668|FG000|Overall Study|Death|15|||
24907623|NCT00372775|50001668|FG000|Overall Study|Objective progression or relapse|30|||
24907624|NCT00372775|50001668|FG000|Overall Study|Global deterioration of health status|6|||
24907625|NCT00372775|50001668|FG000|Overall Study|Withdrawal by Subject|1|||
24907626|NCT00372775|50001668|FG000|Overall Study|Other|1|||
24907627|NCT00372775|50001668|FG000|Overall Study|Not Treated|2|||
24907628|NCT00372697|50001674|FG000|Overall Study|Protocol Violation|1|||
24907629|NCT00372697|50001675|FG001|Overall Study|Protocol Violation|1|||
24907630|NCT00690378|50001687|FG000|Overall Study|Adverse Event|1|||
24907631|NCT00690378|50001688|FG001|Overall Study|Adverse Event|0|||
24907632|NCT00690378|50001687|FG000|Overall Study|Withdrawal by Subject|2|||
24907633|NCT00690378|50001688|FG001|Overall Study|Withdrawal by Subject|0|||
24907634|NCT00690378|50001687|FG000|Overall Study|Protocol Violation|1|||
24907635|NCT00690378|50001688|FG001|Overall Study|Protocol Violation|0|||
24907636|NCT00690378|50001687|FG000|Overall Study|Lost to Follow-up|2|||
24907637|NCT00690378|50001688|FG001|Overall Study|Lost to Follow-up|3|||
24907638|NCT00690378|50001687|FG000|Overall Study|Did not meet inc/exc criteria|13|||
24907639|NCT00690378|50001688|FG001|Overall Study|Did not meet inc/exc criteria|11|||
24907640|NCT00690378|50001687|FG000|Overall Study|Social problem|1|||
24907641|NCT00690378|50001688|FG001|Overall Study|Social problem|0|||
24907642|NCT00574275|50001696|FG000|Overall Study|Randomized but not treated|2|||
24907643|NCT00574275|50001697|FG001|Overall Study|Randomized but not treated|3|||
24907644|NCT00574275|50001696|FG000|Overall Study|Adverse Event|32|||
24907645|NCT00574275|50001697|FG001|Overall Study|Adverse Event|76|||
24907646|NCT00574275|50001696|FG000|Overall Study|Disease progression|160|||
24907647|NCT00574275|50001697|FG001|Overall Study|Disease progression|146|||
24907648|NCT00574275|50001696|FG000|Overall Study|Lost to Follow-up|2|||
24907649|NCT00574275|50001697|FG001|Overall Study|Lost to Follow-up|1|||
24907650|NCT00574275|50001696|FG000|Overall Study|Study stopped based on DMC decision|62|||
24907651|NCT00574275|50001697|FG001|Overall Study|Study stopped based on DMC decision|23|||
25018443|NCT00245960|50114072|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
25018444|NCT00245960|50114071|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
25152659|NCT01931839|50267713|FG003|Overall Study|Physician Decision|0|||
25152660|NCT01931839|50267714|FG004|Overall Study|Physician Decision|0|||
25152661|NCT01931839|50267715|FG005|Overall Study|Physician Decision|0|||
25152662|NCT01931839|50267716|FG006|Overall Study|Physician Decision|1|||
25152663|NCT01931839|50267710|FG000|Overall Study|Withdrawal of consent|0|||
25152664|NCT01931839|50267711|FG001|Overall Study|Withdrawal of consent|0|||
25152665|NCT01931839|50267712|FG002|Overall Study|Withdrawal of consent|0|||
25152666|NCT01931839|50267713|FG003|Overall Study|Withdrawal of consent|0|||
25152667|NCT01931839|50267714|FG004|Overall Study|Withdrawal of consent|1|||
25152668|NCT01931839|50267715|FG005|Overall Study|Withdrawal of consent|0|||
25152669|NCT01931839|50267716|FG006|Overall Study|Withdrawal of consent|0|||
25152670|NCT01931839|50267710|FG000|Overall Study|Adverse Event|9|||
25152671|NCT01931839|50267711|FG001|Overall Study|Adverse Event|4|||
25152672|NCT01931839|50267712|FG002|Overall Study|Adverse Event|1|||
25152673|NCT01931839|50267713|FG003|Overall Study|Adverse Event|3|||
25152674|NCT01931839|50267714|FG004|Overall Study|Adverse Event|0|||
25152675|NCT01931839|50267715|FG005|Overall Study|Adverse Event|0|||
25152676|NCT01931839|50267716|FG006|Overall Study|Adverse Event|1|||
25152677|NCT01931839|50267710|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
25152678|NCT01931839|50267711|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
25152679|NCT01931839|50267712|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
25152680|NCT01931839|50267713|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
25152681|NCT01931839|50267714|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
25152682|NCT01931839|50267715|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
25152683|NCT01931839|50267716|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
25152684|NCT01931839|50267710|FG000|Overall Study|Other non-compliance|15|||
24907652|NCT00574275|50001696|FG000|Overall Study|Withdrawal by Subject|15|||
24907653|NCT00574275|50001697|FG001|Overall Study|Withdrawal by Subject|17|||
24907654|NCT00574275|50001696|FG000|Overall Study|Error calculating tumor measurement|1|||
24907655|NCT00574275|50001697|FG001|Overall Study|Error calculating tumor measurement|0|||
25018445|NCT00245960|50114072|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
25152685|NCT01931839|50267711|FG001|Overall Study|Other non-compliance|9|||
25152686|NCT01931839|50267712|FG002|Overall Study|Other non-compliance|12|||
25152687|NCT01931839|50267713|FG003|Overall Study|Other non-compliance|3|||
25152688|NCT01931839|50267714|FG004|Overall Study|Other non-compliance|0|||
25274809|NCT00909727|50588869|FG000|Overall Study|Wrong Genotype|1|||
25152689|NCT01931839|50267715|FG005|Overall Study|Other non-compliance|3|||
25152690|NCT01931839|50267716|FG006|Overall Study|Other non-compliance|0|||
25152691|NCT01931839|50267710|FG000|Overall Study|Lost to Follow-up|1|||
25152692|NCT01931839|50267711|FG001|Overall Study|Lost to Follow-up|2|||
25152693|NCT01931839|50267712|FG002|Overall Study|Lost to Follow-up|4|||
24907656|NCT00574275|50001696|FG000|Overall Study|Physician Decision|1|||
24907657|NCT00574275|50001697|FG001|Overall Study|Physician Decision|1|||
24907658|NCT00574275|50001696|FG000|Overall Study|Protocol Violation|0|||
24907659|NCT00574275|50001697|FG001|Overall Study|Protocol Violation|1|||
24907660|NCT00574275|50001696|FG000|Overall Study|Patient and Investigator decision|0|||
24907661|NCT00574275|50001697|FG001|Overall Study|Patient and Investigator decision|1|||
24907662|NCT00574275|50001696|FG000|Overall Study|Insurance change|0|||
24907663|NCT00574275|50001697|FG001|Overall Study|Insurance change|1|||
24907664|NCT00574275|50001696|FG000|Overall Study|Operation for curative intent|0|||
24907665|NCT00574275|50001697|FG001|Overall Study|Operation for curative intent|1|||
24907666|NCT00567112|50001703|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
24907667|NCT00567112|50001704|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
24907668|NCT00567112|50001705|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
24907669|NCT00567112|50001703|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
24907670|NCT00567112|50001704|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
24907671|NCT00567112|50001705|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
24907672|NCT00567112|50001703|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
24907673|NCT00567112|50001704|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
24907674|NCT00567112|50001705|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
24907675|NCT01618656|50001725|FG000|Overall Study|Withdrawal by Subject|7|||
24907676|NCT01618656|50001726|FG001|Overall Study|Withdrawal by Subject|3|||
24907677|NCT01618656|50001725|FG000|Overall Study|Physician Decision|1|||
24907678|NCT01618656|50001726|FG001|Overall Study|Physician Decision|1|||
24907679|NCT03978832|50001732|FG000|Overall Study|Adverse Event|1|||
24907680|NCT03978832|50001732|FG000|Overall Study|Lost to Follow-up|1|||
24907681|NCT03978832|50001732|FG000|Overall Study|Withdrawal by Subject|6|||
24907682|NCT03978832|50001732|FG000|Overall Study|Physician Decision|2|||
24907683|NCT03978832|50001732|FG000|Overall Study|did not pass screening criteria|44|||
24907684|NCT00566722|50001739|FG000|Overall Study|Adverse Event|0|||
24907685|NCT00566722|50001740|FG001|Overall Study|Adverse Event|1|||
24907686|NCT00566722|50001741|FG002|Overall Study|Adverse Event|0|||
24907687|NCT00566722|50001739|FG000|Overall Study|Withdrawal by Subject|0|||
24907688|NCT00566722|50001740|FG001|Overall Study|Withdrawal by Subject|0|||
24907689|NCT00566722|50001741|FG002|Overall Study|Withdrawal by Subject|1|||
24907690|NCT00566722|50001739|FG000|Overall Study|Lost to Follow-up|1|||
24907691|NCT00566722|50001740|FG001|Overall Study|Lost to Follow-up|1|||
24907692|NCT00566722|50001741|FG002|Overall Study|Lost to Follow-up|1|||
24907693|NCT00566722|50001739|FG000|Overall Study|Lack of Efficacy|1|||
24907694|NCT00566722|50001740|FG001|Overall Study|Lack of Efficacy|2|||
24907695|NCT00566722|50001741|FG002|Overall Study|Lack of Efficacy|4|||
24907696|NCT00566722|50001739|FG000|Overall Study|Did not meet exclusion criteria|0|||
24907697|NCT00566722|50001740|FG001|Overall Study|Did not meet exclusion criteria|0|||
24907698|NCT00566722|50001741|FG002|Overall Study|Did not meet exclusion criteria|2|||
24907699|NCT00566722|50001739|FG000|Overall Study|Serious adverse event|0|||
24907700|NCT00566722|50001740|FG001|Overall Study|Serious adverse event|1|||
24907701|NCT00566722|50001741|FG002|Overall Study|Serious adverse event|0|||
24907702|NCT00566722|50001739|FG000|Overall Study|Noncompliant with drug administration|0|||
24907703|NCT00566722|50001740|FG001|Overall Study|Noncompliant with drug administration|0|||
24907704|NCT00566722|50001741|FG002|Overall Study|Noncompliant with drug administration|1|||
24907705|NCT00691704|50001752|FG000|Induction Therapy|Disease Progression|1|||
24907706|NCT00691704|50001752|FG000|Induction Therapy|Active Hepatitis|1|||
24907707|NCT00691704|50001752|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
24907708|NCT00691704|50001752|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
24907709|NCT00691704|50001752|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
24907710|NCT00566020|50001756|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
24907711|NCT00566020|50001757|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
24907712|NCT00566020|50001756|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
24907713|NCT00566020|50001757|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
24907714|NCT00566020|50001756|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
24907715|NCT00566020|50001757|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
24907716|NCT00566020|50001756|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
24907717|NCT00566020|50001757|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
24907718|NCT00566020|50001756|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
24907719|NCT00566020|50001757|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
24907720|NCT00566020|50001756|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
24907721|NCT00566020|50001757|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
24907722|NCT00564070|50001764|FG000|Overall Study|Lost to Follow-up|9|||
25152694|NCT01931839|50267713|FG003|Overall Study|Lost to Follow-up|5|||
24907723|NCT00564070|50001765|FG001|Overall Study|Lost to Follow-up|7|||
24907724|NCT00564070|50001764|FG000|Overall Study|Worsening depression, referred to care|3|||
24907725|NCT00564070|50001765|FG001|Overall Study|Worsening depression, referred to care|0|||
24907726|NCT00690612|50001771|FG000|Overall Study|Adverse Event|1|||
24907727|NCT00690612|50001771|FG000|Overall Study|Withdrawal by Subject|2|||
24907728|NCT00621153|50001777|FG000|Overall Study|Safety Reason|8|||
24907729|NCT00621153|50001778|FG001|Overall Study|Safety Reason|7|||
24907730|NCT00621153|50001777|FG000|Overall Study|Adverse Event|3|||
24907731|NCT00621153|50001778|FG001|Overall Study|Adverse Event|2|||
24907732|NCT00621153|50001777|FG000|Overall Study|Lost to Follow-up|5|||
24907733|NCT00621153|50001778|FG001|Overall Study|Lost to Follow-up|1|||
24907734|NCT00621153|50001777|FG000|Overall Study|Withdrawal by Subject|4|||
24907735|NCT00621153|50001778|FG001|Overall Study|Withdrawal by Subject|5|||
24907736|NCT00574119|50001784|FG000|Overall Study|Adverse Event|1|||
24907737|NCT00574119|50001784|FG000|Overall Study|Protocol Violation|1|||
24907738|NCT00574119|50001784|FG000|Overall Study|Withdrawal by Subject|1|||
24907739|NCT00574119|50001784|FG000|Overall Study|Physician Decision|1|||
24907740|NCT00705614|50001790|FG000|Initial Intervention|Adverse Event|40|||
24907741|NCT00705614|50001791|FG001|Initial Intervention|Adverse Event|21|||
24907742|NCT00705614|50001790|FG000|Initial Intervention|Lost to Follow-up|310|||
24907743|NCT00705614|50001791|FG001|Initial Intervention|Lost to Follow-up|191|||
24907744|NCT00705614|50001790|FG000|Initial Intervention|Withdrawal by Subject|114|||
24907745|NCT00705614|50001791|FG001|Initial Intervention|Withdrawal by Subject|71|||
24907746|NCT00705614|50001790|FG000|Initial Intervention|Administrative Reason|51|||
24907747|NCT00705614|50001791|FG001|Initial Intervention|Administrative Reason|38|||
24907748|NCT00705614|50001790|FG000|Initial Intervention|Status completion unknown|3|||
24907749|NCT00705614|50001791|FG001|Initial Intervention|Status completion unknown|0|||
24907750|NCT00705614|50001790|FG000|Switch to Remicade|Adverse Event|0|||
24907751|NCT00705614|50001791|FG001|Switch to Remicade|Adverse Event|5|||
24907752|NCT00705614|50001790|FG000|Switch to Remicade|Lost to Follow-up|0|||
24907753|NCT00705614|50001791|FG001|Switch to Remicade|Lost to Follow-up|23|||
24907754|NCT00705614|50001790|FG000|Switch to Remicade|Withdrawal by Subject|0|||
24907755|NCT00705614|50001791|FG001|Switch to Remicade|Withdrawal by Subject|12|||
24907756|NCT00705614|50001790|FG000|Switch to Remicade|Administrative Reason|0|||
24907757|NCT00705614|50001791|FG001|Switch to Remicade|Administrative Reason|9|||
24907758|NCT00620763|50001799|FG000|Period: First Intervention|Withdrawal by Subject|0|||
24907759|NCT00620763|50001800|FG001|Period: First Intervention|Withdrawal by Subject|2|||
24907760|NCT00620763|50001799|FG000|Period: First Intervention|Protocol Violation|0|||
24907761|NCT00620763|50001800|FG001|Period: First Intervention|Protocol Violation|3|||
24907762|NCT00620763|50001799|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
24907763|NCT00620763|50001800|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
24907764|NCT00562978|50001808|FG000|Overall Study|Patient had imaging dose only|1|||
24907765|NCT00562978|50001809|FG001|Overall Study|Patient had imaging dose only|11|||
24907766|NCT00620373|50001815|FG000|Overall Study|Unverified cancer status|33|||
24907767|NCT00372619|50001829|FG000|Overall Study|Ineligible|0|||
24907768|NCT00372619|50001830|FG001|Overall Study|Ineligible|0|||
24907769|NCT00372619|50001831|FG002|Overall Study|Ineligible|0|||
24907770|NCT00372619|50001832|FG003|Overall Study|Ineligible|0|||
24907771|NCT00372619|50001833|FG004|Overall Study|Ineligible|0|||
24907772|NCT00372619|50001834|FG005|Overall Study|Ineligible|2|||
24907773|NCT00372619|50001835|FG006|Overall Study|Ineligible|0|||
24907774|NCT00372619|50001829|FG000|Overall Study|Inevaluable|0|||
24907775|NCT00372619|50001830|FG001|Overall Study|Inevaluable|0|||
25152695|NCT01931839|50267714|FG004|Overall Study|Lost to Follow-up|0|||
25152696|NCT01931839|50267715|FG005|Overall Study|Lost to Follow-up|0|||
25152697|NCT01931839|50267716|FG006|Overall Study|Lost to Follow-up|0|||
25152698|NCT01931839|50267710|FG000|Overall Study|Other|4|||
25152699|NCT01931839|50267711|FG001|Overall Study|Other|2|||
25152700|NCT01931839|50267712|FG002|Overall Study|Other|6|||
25152701|NCT01931839|50267713|FG003|Overall Study|Other|0|||
25152702|NCT01931839|50267714|FG004|Overall Study|Other|0|||
25152703|NCT01931839|50267715|FG005|Overall Study|Other|0|||
25152704|NCT01931839|50267716|FG006|Overall Study|Other|0|||
24907776|NCT00372619|50001831|FG002|Overall Study|Inevaluable|0|||
24907777|NCT00372619|50001832|FG003|Overall Study|Inevaluable|0|||
24907778|NCT00372619|50001833|FG004|Overall Study|Inevaluable|0|||
24907779|NCT00372619|50001834|FG005|Overall Study|Inevaluable|1|||
24907780|NCT00372619|50001835|FG006|Overall Study|Inevaluable|0|||
24907781|NCT00562588|50001853|FG000|Overall Study|Adverse Event|40|||
24907782|NCT00562588|50001854|FG001|Overall Study|Adverse Event|58|||
24907783|NCT00562588|50001853|FG000|Overall Study|Protocol Violation|30|||
24907784|NCT00562588|50001854|FG001|Overall Study|Protocol Violation|26|||
24907785|NCT00562588|50001853|FG000|Overall Study|Lost to Follow-up|12|||
24907786|NCT00562588|50001854|FG001|Overall Study|Lost to Follow-up|4|||
24907787|NCT00562588|50001853|FG000|Overall Study|Withdrawal by Subject|10|||
24907788|NCT00562588|50001854|FG001|Overall Study|Withdrawal by Subject|9|||
24907789|NCT00562588|50001853|FG000|Overall Study|Other|0|||
24907790|NCT00562588|50001854|FG001|Overall Study|Other|2|||
24907791|NCT00622167|50001860|FG000|Overall Study|Did not meet angiographic criteria|20|||
24907792|NCT00562354|50001866|FG000|Overall Study|Physician Decision|0|||
24907793|NCT00562354|50001867|FG001|Overall Study|Physician Decision|1|||
24907794|NCT00562354|50001866|FG000|Overall Study|Lost to Follow-up|0|||
24907795|NCT00562354|50001867|FG001|Overall Study|Lost to Follow-up|1|||
24907796|NCT00372385|50001879|FG000|Overall Study|Adverse Event|6|||
24907797|NCT00372385|50001880|FG001|Overall Study|Adverse Event|11|||
24907798|NCT00372385|50001881|FG002|Overall Study|Adverse Event|9|||
24907799|NCT00372385|50001882|FG003|Overall Study|Adverse Event|7|||
24907800|NCT00372385|50001879|FG000|Overall Study|Noncompliance|0|||
24907801|NCT00372385|50001880|FG001|Overall Study|Noncompliance|1|||
24907802|NCT00372385|50001881|FG002|Overall Study|Noncompliance|1|||
24907803|NCT00372385|50001882|FG003|Overall Study|Noncompliance|1|||
24907804|NCT00372385|50001879|FG000|Overall Study|Physician Decision|1|||
24907805|NCT00372385|50001880|FG001|Overall Study|Physician Decision|0|||
24907806|NCT00372385|50001881|FG002|Overall Study|Physician Decision|0|||
24907807|NCT00372385|50001882|FG003|Overall Study|Physician Decision|0|||
24907808|NCT00372385|50001879|FG000|Overall Study|Lost to Follow-up|2|||
24907809|NCT00372385|50001880|FG001|Overall Study|Lost to Follow-up|0|||
24907810|NCT00372385|50001881|FG002|Overall Study|Lost to Follow-up|0|||
24907811|NCT00372385|50001882|FG003|Overall Study|Lost to Follow-up|0|||
24907812|NCT00372385|50001879|FG000|Overall Study|Withdrawal by Subject|2|||
24907813|NCT00372385|50001880|FG001|Overall Study|Withdrawal by Subject|1|||
24907814|NCT00372385|50001881|FG002|Overall Study|Withdrawal by Subject|0|||
24907815|NCT00372385|50001882|FG003|Overall Study|Withdrawal by Subject|0|||
24907816|NCT00372385|50001879|FG000|Overall Study|Refusal of Treatment|3|||
24907817|NCT00372385|50001880|FG001|Overall Study|Refusal of Treatment|6|||
24907818|NCT00372385|50001881|FG002|Overall Study|Refusal of Treatment|0|||
24907819|NCT00372385|50001882|FG003|Overall Study|Refusal of Treatment|0|||
24907820|NCT00372385|50001879|FG000|Overall Study|No Response|1|||
24907821|NCT00372385|50001880|FG001|Overall Study|No Response|1|||
24907822|NCT00372385|50001881|FG002|Overall Study|No Response|0|||
24907823|NCT00372385|50001882|FG003|Overall Study|No Response|0|||
24907824|NCT00372385|50001879|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
24907825|NCT00372385|50001880|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
24907826|NCT00372385|50001881|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
24907827|NCT00372385|50001882|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
24907828|NCT00372385|50001879|FG000|Overall Study|Virologic Stopping Rule|17|||
24907829|NCT00372385|50001880|FG001|Overall Study|Virologic Stopping Rule|0|||
24907830|NCT00372385|50001881|FG002|Overall Study|Virologic Stopping Rule|0|||
24907831|NCT00372385|50001882|FG003|Overall Study|Virologic Stopping Rule|0|||
24907832|NCT03830281|50001895|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
24907833|NCT03830281|50001896|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
24907834|NCT03830281|50001895|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
24907835|NCT03830281|50001896|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
24907836|NCT03830281|50001895|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
24907837|NCT03830281|50001896|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
25152705|NCT01842308|50267741|FG000|Overall Study|Withdrawal by Subject|0|||
25152706|NCT01842308|50267742|FG001|Overall Study|Withdrawal by Subject|0|||
24907838|NCT03830281|50001895|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
24907839|NCT03830281|50001896|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
24907840|NCT03830281|50001895|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
24907841|NCT03830281|50001896|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
24907842|NCT03830281|50001895|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
24907843|NCT03830281|50001896|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
24907844|NCT03830281|50001895|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
24907845|NCT03830281|50001896|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
24907846|NCT03830281|50001895|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
24907847|NCT03830281|50001896|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
24907848|NCT03830281|50001895|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
24907849|NCT03830281|50001896|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
24907850|NCT00563368|50001910|FG000|Overall Study|Lost to Follow-up|14|||
24907851|NCT00563368|50001911|FG001|Overall Study|Lost to Follow-up|14|||
24907852|NCT00563368|50001912|FG002|Overall Study|Lost to Follow-up|12|||
24907853|NCT00563368|50001913|FG003|Overall Study|Lost to Follow-up|6|||
24907854|NCT00563368|50001914|FG004|Overall Study|Lost to Follow-up|9|||
25018446|NCT00245960|50114071|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
25018447|NCT00245960|50114072|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
25018448|NCT00245960|50114071|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
25018449|NCT00245960|50114072|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
25018450|NCT00245960|50114071|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
25018451|NCT00245960|50114072|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
25018452|NCT00245960|50114071|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
25018453|NCT00245960|50114072|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
25018454|NCT00245960|50114071|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
25018455|NCT00245960|50114072|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
25018456|NCT00245960|50114071|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
25018457|NCT00245960|50114072|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
25018458|NCT00245960|50114071|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
25018459|NCT00245960|50114072|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
25018460|NCT00245960|50114071|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
25018461|NCT00245960|50114072|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
25018462|NCT00245960|50114071|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
25018463|NCT00245960|50114072|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
25018464|NCT02729194|50114078|FG000|Overall Study|Withdrawal by Subject|3|||
25018465|NCT03215706|50114084|FG000|Randomization|Adverse Event unrelated to study drug|1|||
25018466|NCT03215706|50114085|FG001|Randomization|Adverse Event unrelated to study drug|0|||
25018467|NCT03215706|50114084|FG000|Randomization|participant withdrew consent|1|||
25018468|NCT03215706|50114085|FG001|Randomization|participant withdrew consent|3|||
25018469|NCT03215706|50114084|FG000|Randomization|no longer meets study criteria|1|||
25018470|NCT03215706|50114085|FG001|Randomization|no longer meets study criteria|4|||
24907855|NCT00563368|50001915|FG005|Overall Study|Lost to Follow-up|8|||
24907856|NCT00563368|50001916|FG006|Overall Study|Lost to Follow-up|9|||
24907857|NCT00563368|50001910|FG000|Overall Study|Adverse Event|3|||
24907858|NCT00563368|50001911|FG001|Overall Study|Adverse Event|4|||
25018471|NCT03215706|50114084|FG000|Randomization|other reasons|0|||
25018472|NCT03215706|50114085|FG001|Randomization|other reasons|2|||
24907859|NCT00563368|50001912|FG002|Overall Study|Adverse Event|5|||
24907860|NCT00563368|50001913|FG003|Overall Study|Adverse Event|9|||
24907861|NCT00563368|50001914|FG004|Overall Study|Adverse Event|6|||
24907862|NCT00563368|50001915|FG005|Overall Study|Adverse Event|10|||
24907863|NCT00563368|50001916|FG006|Overall Study|Adverse Event|17|||
25018473|NCT03215706|50114084|FG000|Treatment Period|Disease Progression|150|||
25184899|NCT01463696|50333829|FG002|Overall Study|Not Treated|0|||
24907864|NCT00563368|50001910|FG000|Overall Study|Withdrawal by Subject|11|||
24907865|NCT00563368|50001911|FG001|Overall Study|Withdrawal by Subject|6|||
24907866|NCT00563368|50001912|FG002|Overall Study|Withdrawal by Subject|5|||
24907867|NCT00563368|50001913|FG003|Overall Study|Withdrawal by Subject|7|||
24907868|NCT00563368|50001914|FG004|Overall Study|Withdrawal by Subject|8|||
24907869|NCT00563368|50001915|FG005|Overall Study|Withdrawal by Subject|5|||
24907870|NCT00563368|50001916|FG006|Overall Study|Withdrawal by Subject|4|||
24907871|NCT00563368|50001910|FG000|Overall Study|protocol non-compliance|1|||
24907872|NCT00563368|50001911|FG001|Overall Study|protocol non-compliance|1|||
24907873|NCT00563368|50001912|FG002|Overall Study|protocol non-compliance|2|||
24907874|NCT00563368|50001913|FG003|Overall Study|protocol non-compliance|1|||
24907875|NCT00563368|50001914|FG004|Overall Study|protocol non-compliance|0|||
24907876|NCT00563368|50001915|FG005|Overall Study|protocol non-compliance|1|||
24907877|NCT00563368|50001916|FG006|Overall Study|protocol non-compliance|3|||
24907878|NCT00563368|50001910|FG000|Overall Study|Pregnancy|1|||
24907879|NCT00563368|50001911|FG001|Overall Study|Pregnancy|0|||
24907880|NCT00563368|50001912|FG002|Overall Study|Pregnancy|1|||
24907881|NCT00563368|50001913|FG003|Overall Study|Pregnancy|2|||
24907882|NCT00563368|50001914|FG004|Overall Study|Pregnancy|1|||
24907883|NCT00563368|50001915|FG005|Overall Study|Pregnancy|2|||
25152707|NCT01842308|50267743|FG002|Overall Study|Withdrawal by Subject|0|||
24907884|NCT00563368|50001916|FG006|Overall Study|Pregnancy|0|||
24907885|NCT00563368|50001910|FG000|Overall Study|requirement for restricted medication|0|||
24907886|NCT00563368|50001911|FG001|Overall Study|requirement for restricted medication|0|||
24907887|NCT00563368|50001912|FG002|Overall Study|requirement for restricted medication|2|||
24907888|NCT00563368|50001913|FG003|Overall Study|requirement for restricted medication|0|||
24907889|NCT00563368|50001914|FG004|Overall Study|requirement for restricted medication|0|||
24907890|NCT00563368|50001915|FG005|Overall Study|requirement for restricted medication|0|||
24907891|NCT00563368|50001916|FG006|Overall Study|requirement for restricted medication|0|||
24907892|NCT00563368|50001910|FG000|Overall Study|Other|5|||
24907893|NCT00563368|50001911|FG001|Overall Study|Other|5|||
24907894|NCT00563368|50001912|FG002|Overall Study|Other|3|||
24907895|NCT00563368|50001913|FG003|Overall Study|Other|4|||
24907896|NCT00563368|50001914|FG004|Overall Study|Other|4|||
24907897|NCT00563368|50001915|FG005|Overall Study|Other|4|||
24907898|NCT00563368|50001916|FG006|Overall Study|Other|0|||
24907899|NCT00390013|50001935|FG000|Phase 1|tired|0|||
24907900|NCT00390013|50001936|FG001|Phase 1|tired|0|||
24907901|NCT00390013|50001937|FG002|Phase 1|tired|0|||
24907902|NCT00390013|50001938|FG003|Phase 1|tired|1|||
24907903|NCT00390013|50001935|FG000|Phase 2 First Treatment|tired|1|||
24907904|NCT00390013|50001936|FG001|Phase 2 First Treatment|tired|0|||
24907905|NCT00390013|50001937|FG002|Phase 2 First Treatment|tired|0|||
24907906|NCT00390013|50001938|FG003|Phase 2 First Treatment|tired|0|||
24907907|NCT00390013|50001935|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
24907908|NCT00390013|50001936|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
25018474|NCT03215706|50114085|FG001|Treatment Period|Disease Progression|142|||
25018475|NCT03215706|50114084|FG000|Treatment Period|Study Drug Toxicity|53|||
25018476|NCT03215706|50114085|FG001|Treatment Period|Study Drug Toxicity|21|||
25018477|NCT03215706|50114084|FG000|Treatment Period|Death|2|||
25018478|NCT03215706|50114085|FG001|Treatment Period|Death|1|||
25018479|NCT03215706|50114084|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
25018480|NCT03215706|50114085|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
25018481|NCT03215706|50114084|FG000|Treatment Period|Request to D/C treatment|1|||
25018482|NCT03215706|50114085|FG001|Treatment Period|Request to D/C treatment|6|||
25018483|NCT03215706|50114084|FG000|Treatment Period|Participant withdrew consent|3|||
25018484|NCT03215706|50114085|FG001|Treatment Period|Participant withdrew consent|4|||
25018485|NCT03215706|50114084|FG000|Treatment Period|Lost to Follow-up|0|||
25018486|NCT03215706|50114085|FG001|Treatment Period|Lost to Follow-up|1|||
25018487|NCT03215706|50114084|FG000|Treatment Period|Other Reasons|4|||
25018488|NCT03215706|50114085|FG001|Treatment Period|Other Reasons|5|||
25018489|NCT03215706|50114084|FG000|Treatment Period|Ongoing in the treatment period|105|||
25018490|NCT03215706|50114085|FG001|Treatment Period|Ongoing in the treatment period|43|||
25018491|NCT03178266|50114093|FG000|Overall Study|Death|0|||
25152708|NCT01842308|50267744|FG003|Overall Study|Withdrawal by Subject|0|||
25152709|NCT01842308|50267745|FG004|Overall Study|Withdrawal by Subject|1|||
24907909|NCT00390013|50001937|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
24907910|NCT00390013|50001938|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
25018492|NCT03178266|50114094|FG001|Overall Study|Death|1|||
25018493|NCT03178266|50114093|FG000|Overall Study|Disont. Early|0|||
25152710|NCT01931059|50267760|FG000|Day 1|Pregnancy|0|||
25152711|NCT01931059|50267761|FG001|Day 1|Pregnancy|1|||
25184900|NCT01463696|50333830|FG003|Overall Study|Not Treated|0|||
24907911|NCT00561652|50001946|FG000|Overall Study|Withdrawal by Subject|0|||
25018494|NCT03178266|50114094|FG001|Overall Study|Disont. Early|1|||
25018495|NCT03178266|50114093|FG000|Overall Study|Withdrawal by Subject|0|||
24907912|NCT00561652|50001947|FG001|Overall Study|Withdrawal by Subject|1|||
24907913|NCT00697346|50001956|FG000|Overall Study|Adverse Event|4|||
25152712|NCT01931059|50267760|FG000|Day3|Lost to Follow-up|1|||
25018496|NCT03178266|50114094|FG001|Overall Study|Withdrawal by Subject|2|||
25018497|NCT03548935|50114102|FG000|Overall Study|Withdrawal by Subject|26|||
25018498|NCT03548935|50114103|FG001|Overall Study|Withdrawal by Subject|17|||
25018499|NCT03548935|50114102|FG000|Overall Study|Lost to Follow-up|39|||
25018500|NCT03548935|50114103|FG001|Overall Study|Lost to Follow-up|28|||
25018501|NCT03548935|50114102|FG000|Overall Study|Death|1|||
25018502|NCT03548935|50114103|FG001|Overall Study|Death|1|||
24907914|NCT00697346|50001957|FG001|Overall Study|Adverse Event|5|||
24907915|NCT00697346|50001958|FG002|Overall Study|Adverse Event|0|||
24907916|NCT00697346|50001956|FG000|Overall Study|Progressive Disease|19|||
24907917|NCT00697346|50001957|FG001|Overall Study|Progressive Disease|18|||
24907918|NCT00697346|50001958|FG002|Overall Study|Progressive Disease|0|||
24907919|NCT00697346|50001956|FG000|Overall Study|Symptomatic Deterioration|0|||
24907920|NCT00697346|50001957|FG001|Overall Study|Symptomatic Deterioration|1|||
24907921|NCT00697346|50001958|FG002|Overall Study|Symptomatic Deterioration|0|||
24907922|NCT00697346|50001956|FG000|Overall Study|Withdrawal by Subject|2|||
24907923|NCT00697346|50001957|FG001|Overall Study|Withdrawal by Subject|2|||
24907924|NCT00697346|50001958|FG002|Overall Study|Withdrawal by Subject|0|||
24907925|NCT00697346|50001956|FG000|Overall Study|Reason not Specified|3|||
24907926|NCT00697346|50001957|FG001|Overall Study|Reason not Specified|0|||
24907927|NCT00697346|50001958|FG002|Overall Study|Reason not Specified|1|||
24907928|NCT00562120|50001985|FG000|First Intervention Period|Adverse Event|1|||
25018503|NCT03547687|50114109|FG000|Overall Study|Withdrawal by Subject|1|||
25152713|NCT01931059|50267761|FG001|Day3|Lost to Follow-up|0|||
25152714|NCT01841762|50267773|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
25018504|NCT03547687|50114109|FG000|Overall Study|Death|1|||
24907929|NCT00562120|50001986|FG001|First Intervention Period|Adverse Event|0|||
24907930|NCT00562120|50001987|FG002|First Intervention Period|Adverse Event|0|||
24907931|NCT00562120|50001988|FG003|First Intervention Period|Adverse Event|0|||
25152715|NCT01841762|50267773|FG000|Treatment Period|Adverse Event|16|||
24907932|NCT00562120|50001985|FG000|First Intervention Period|Randomized but not Treated|1|||
24907933|NCT00562120|50001986|FG001|First Intervention Period|Randomized but not Treated|0|||
24907934|NCT00562120|50001987|FG002|First Intervention Period|Randomized but not Treated|0|||
24907935|NCT00562120|50001988|FG003|First Intervention Period|Randomized but not Treated|0|||
24907936|NCT00561730|50001998|FG000|Overall Study|Adverse Event|2|||
24907937|NCT00561730|50001998|FG000|Overall Study|Handling of the drug|1|||
24907938|NCT00561730|50001998|FG000|Overall Study|Lost to Follow-up|5|||
24907939|NCT00561730|50001998|FG000|Overall Study|Not specified reasons|1|||
24907940|NCT00697112|50002004|FG000|Overall Study|Adverse Event|8|||
24907941|NCT00697112|50002004|FG000|Overall Study|Lost to Follow-up|1|||
25152716|NCT01841762|50267773|FG000|Treatment Period|Death|1|||
25152717|NCT01841762|50267773|FG000|Treatment Period|Withdrawal by Subject|7|||
25152718|NCT01841762|50267773|FG000|Treatment Period|Lost to Follow-up|1|||
25152719|NCT01841762|50267773|FG000|Treatment Period|Physician Decision|2|||
24907942|NCT00697112|50002004|FG000|Overall Study|Did not meet inclusion criteria|1|||
24907943|NCT00621855|50002013|FG000|Overall Study|Adverse Event|32|||
24907944|NCT00621855|50002014|FG001|Overall Study|Adverse Event|31|||
24907945|NCT00621855|50002015|FG002|Overall Study|Adverse Event|48|||
24907946|NCT00621855|50002016|FG003|Overall Study|Adverse Event|34|||
24907947|NCT00621855|50002017|FG004|Overall Study|Adverse Event|31|||
24907948|NCT00621855|50002013|FG000|Overall Study|Lost to Follow-up|0|||
24907949|NCT00621855|50002014|FG001|Overall Study|Lost to Follow-up|1|||
24907950|NCT00621855|50002015|FG002|Overall Study|Lost to Follow-up|3|||
24907951|NCT00621855|50002016|FG003|Overall Study|Lost to Follow-up|4|||
24907952|NCT00621855|50002017|FG004|Overall Study|Lost to Follow-up|1|||
24907953|NCT00621855|50002013|FG000|Overall Study|Protocol Violation|16|||
24907954|NCT00621855|50002014|FG001|Overall Study|Protocol Violation|8|||
24907955|NCT00621855|50002015|FG002|Overall Study|Protocol Violation|6|||
24907956|NCT00621855|50002016|FG003|Overall Study|Protocol Violation|7|||
24907957|NCT00621855|50002017|FG004|Overall Study|Protocol Violation|8|||
24907958|NCT00621855|50002013|FG000|Overall Study|Withdrawal by Subject|16|||
25018505|NCT03547531|50114115|FG000|Overall Study|not coming in data collection : sick|2|||
25018506|NCT03547531|50114116|FG001|Overall Study|not coming in data collection : sick|2|||
25018507|NCT03547531|50114115|FG000|Overall Study|having family occasion|0|||
25018508|NCT03547531|50114116|FG001|Overall Study|having family occasion|2|||
24907959|NCT00621855|50002014|FG001|Overall Study|Withdrawal by Subject|11|||
24907960|NCT00621855|50002015|FG002|Overall Study|Withdrawal by Subject|13|||
24907961|NCT00621855|50002016|FG003|Overall Study|Withdrawal by Subject|13|||
24907962|NCT00621855|50002017|FG004|Overall Study|Withdrawal by Subject|9|||
24907963|NCT00621855|50002013|FG000|Overall Study|Other|9|||
24907964|NCT00621855|50002014|FG001|Overall Study|Other|7|||
24907965|NCT00621855|50002015|FG002|Overall Study|Other|6|||
24907966|NCT00621855|50002016|FG003|Overall Study|Other|5|||
24907967|NCT00621855|50002017|FG004|Overall Study|Other|4|||
24907968|NCT00621855|50002013|FG000|Overall Study|Patients did not receive study drug|3|||
24907969|NCT00621855|50002014|FG001|Overall Study|Patients did not receive study drug|3|||
24907970|NCT00621855|50002015|FG002|Overall Study|Patients did not receive study drug|5|||
24907971|NCT00621855|50002016|FG003|Overall Study|Patients did not receive study drug|4|||
24907972|NCT00621855|50002017|FG004|Overall Study|Patients did not receive study drug|2|||
24907973|NCT04222088|50002031|FG000|Overall Study|Lost to Follow-up|5|||
24907974|NCT04222088|50002032|FG001|Overall Study|Lost to Follow-up|1|||
25018509|NCT03566485|50114124|FG000|Overall Study|Disease progression|5|||
25018510|NCT03566485|50114125|FG001|Overall Study|Disease progression|4|||
25018511|NCT03566485|50114124|FG000|Overall Study|Clinical progression|0|||
25152720|NCT01841762|50267773|FG000|Treatment Period|Other, including non-compliance|5|||
24907975|NCT04222088|50002031|FG000|Overall Study|Withdrawal by Subject|4|||
24907976|NCT04222088|50002032|FG001|Overall Study|Withdrawal by Subject|0|||
24907977|NCT00561574|50002040|FG000|Overall Study|Adverse Event|21|||
24907978|NCT00561574|50002041|FG001|Overall Study|Adverse Event|24|||
24907979|NCT00561574|50002040|FG000|Overall Study|Lack of Efficacy|11|||
24907980|NCT00561574|50002041|FG001|Overall Study|Lack of Efficacy|21|||
24907981|NCT00561574|50002040|FG000|Overall Study|Withdrawal by Subject|4|||
24907982|NCT00561574|50002041|FG001|Overall Study|Withdrawal by Subject|4|||
24907983|NCT00561574|50002040|FG000|Overall Study|Reason Unrelated to Trial|6|||
24907984|NCT00561574|50002041|FG001|Overall Study|Reason Unrelated to Trial|2|||
24907985|NCT00561574|50002040|FG000|Overall Study|Lost to Follow-up|1|||
24907986|NCT00561574|50002041|FG001|Overall Study|Lost to Follow-up|0|||
24907987|NCT00561574|50002040|FG000|Overall Study|Other|5|||
24907988|NCT00561574|50002041|FG001|Overall Study|Other|7|||
24907989|NCT00619827|50002049|FG000|Overall Study|Adverse Event|1|||
24907990|NCT00619827|50002050|FG001|Overall Study|Adverse Event|2|||
24907991|NCT00619827|50002049|FG000|Overall Study|Withdrawal by Subject|2|||
24907992|NCT00619827|50002050|FG001|Overall Study|Withdrawal by Subject|2|||
24907993|NCT00687804|50002059|FG000|Core Study|Adverse Event|5|||
24907994|NCT00687804|50002060|FG001|Core Study|Adverse Event|3|||
24907995|NCT00687804|50002061|FG002|Core Study|Adverse Event|3|||
24907996|NCT00687804|50002059|FG000|Core Study|Abnormal laboratory value(s)|1|||
24907997|NCT00687804|50002060|FG001|Core Study|Abnormal laboratory value(s)|0|||
24907998|NCT00687804|50002061|FG002|Core Study|Abnormal laboratory value(s)|0|||
24907999|NCT00687804|50002059|FG000|Core Study|Lack of Efficacy|1|||
24908000|NCT00687804|50002060|FG001|Core Study|Lack of Efficacy|1|||
24908001|NCT00687804|50002061|FG002|Core Study|Lack of Efficacy|1|||
24908002|NCT00687804|50002059|FG000|Core Study|Withdrawal by Subject|4|||
24908003|NCT00687804|50002060|FG001|Core Study|Withdrawal by Subject|7|||
24908004|NCT00687804|50002061|FG002|Core Study|Withdrawal by Subject|7|||
24908005|NCT00687804|50002059|FG000|Core Study|Lost to Follow-up|0|||
24908006|NCT00687804|50002060|FG001|Core Study|Lost to Follow-up|1|||
24908007|NCT00687804|50002061|FG002|Core Study|Lost to Follow-up|0|||
24908008|NCT00687804|50002059|FG000|Core Study|Death|2|||
24908009|NCT00687804|50002060|FG001|Core Study|Death|2|||
24908010|NCT00687804|50002061|FG002|Core Study|Death|2|||
24908011|NCT00687804|50002059|FG000|Core Study|Protocol Violation|1|||
24908012|NCT00687804|50002060|FG001|Core Study|Protocol Violation|1|||
24908013|NCT00687804|50002061|FG002|Core Study|Protocol Violation|0|||
24908014|NCT00687804|50002059|FG000|Open-Label Extension Study|Adverse Event|2|||
24908015|NCT00687804|50002060|FG001|Open-Label Extension Study|Adverse Event|2|||
24908016|NCT00687804|50002061|FG002|Open-Label Extension Study|Adverse Event|2|||
24908017|NCT00687804|50002059|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
24908018|NCT00687804|50002060|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
24908019|NCT00687804|50002061|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
24908020|NCT00687804|50002059|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
24908021|NCT00687804|50002060|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
24908022|NCT00687804|50002061|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
24908023|NCT00687804|50002059|FG000|Open-Label Extension Study|Administrative problems|1|||
24908024|NCT00687804|50002060|FG001|Open-Label Extension Study|Administrative problems|1|||
25152721|NCT01841762|50267773|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
24908025|NCT00687804|50002061|FG002|Open-Label Extension Study|Administrative problems|0|||
25152722|NCT01841762|50267773|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
24908026|NCT00687804|50002059|FG000|Open-Label Extension Study|Death|2|||
24908027|NCT00687804|50002060|FG001|Open-Label Extension Study|Death|3|||
24908028|NCT00687804|50002061|FG002|Open-Label Extension Study|Death|3|||
25152723|NCT01841762|50267773|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
25152724|NCT01841762|50267773|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
25152725|NCT01841060|50267790|FG000|Overall Study|Protocol Violation|10|||
24908029|NCT00689052|50002088|FG000|Overall Study|Adverse Event|4|||
24908030|NCT00689052|50002089|FG001|Overall Study|Adverse Event|6|||
24908031|NCT00689052|50002088|FG000|Overall Study|Protocol Violation|1|||
24908032|NCT00689052|50002089|FG001|Overall Study|Protocol Violation|0|||
25152726|NCT01814696|50267796|FG000|Overall Study|Withdrawal by Subject|1|||
25152727|NCT01814696|50267797|FG001|Overall Study|Withdrawal by Subject|0|||
24908033|NCT00689052|50002088|FG000|Overall Study|Lost to Follow-up|2|||
25018512|NCT03566485|50114125|FG001|Overall Study|Clinical progression|1|||
24908034|NCT00689052|50002089|FG001|Overall Study|Lost to Follow-up|0|||
24908035|NCT00689052|50002088|FG000|Overall Study|Withdrawal by Subject|2|||
24908036|NCT00689052|50002089|FG001|Overall Study|Withdrawal by Subject|0|||
24908037|NCT00689052|50002088|FG000|Overall Study|Early termination of the trial|22|||
24908038|NCT00689052|50002089|FG001|Overall Study|Early termination of the trial|24|||
24908039|NCT00560950|50002099|FG000|Overall Study|Lost to Follow-up|1|||
24908040|NCT00560950|50002100|FG001|Overall Study|Lost to Follow-up|0|||
24908041|NCT00576758|50002110|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
24908042|NCT00576758|50002111|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
24908043|NCT00576758|50002110|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
24908044|NCT00576758|50002111|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
24908045|NCT00576758|50002110|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
24908046|NCT00576758|50002111|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
24908047|NCT00576758|50002110|FG000|Induction Treatment Period|Death|1|||
24908048|NCT00576758|50002111|FG001|Induction Treatment Period|Death|0|||
24908049|NCT00576758|50002110|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
24908050|NCT00576758|50002111|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
24908051|NCT00576758|50002110|FG000|Induction Treatment Period|Withdrew consent|1|||
24908052|NCT00576758|50002111|FG001|Induction Treatment Period|Withdrew consent|0|||
25018513|NCT03566485|50114124|FG000|Overall Study|Toxicity|0|||
25018514|NCT03566485|50114125|FG001|Overall Study|Toxicity|2|||
25018515|NCT03176238|50114133|FG000|Overall Study|Unacceptable AEs|15|||
25018516|NCT03176238|50114134|FG001|Overall Study|Unacceptable AEs|8|||
25018517|NCT03176238|50114133|FG000|Overall Study|Abnormal lab value(s)|2|||
25018518|NCT03176238|50114134|FG001|Overall Study|Abnormal lab value(s)|0|||
25018519|NCT03176238|50114133|FG000|Overall Study|Inter-current illness|0|||
25018520|NCT03176238|50114134|FG001|Overall Study|Inter-current illness|1|||
25018521|NCT03176238|50114133|FG000|Overall Study|Consent withdrawal|14|||
25018522|NCT03176238|50114134|FG001|Overall Study|Consent withdrawal|2|||
25018523|NCT03176238|50114133|FG000|Overall Study|Lost to Follow-up|3|||
25018524|NCT03176238|50114134|FG001|Overall Study|Lost to Follow-up|0|||
25018525|NCT03176238|50114133|FG000|Overall Study|Administrative problems|1|||
25018526|NCT03176238|50114134|FG001|Overall Study|Administrative problems|0|||
25018527|NCT03176238|50114133|FG000|Overall Study|Death|3|||
25152728|NCT01814696|50267796|FG000|Overall Study|Randomized to wrong group|1|||
25018528|NCT03176238|50114134|FG001|Overall Study|Death|0|||
25018529|NCT03176238|50114133|FG000|Overall Study|Disease Progression|133|||
25018530|NCT03176238|50114134|FG001|Overall Study|Disease Progression|22|||
25018531|NCT03176238|50114133|FG000|Overall Study|Tx duration completed per EAP|0|||
25018532|NCT03176238|50114134|FG001|Overall Study|Tx duration completed per EAP|1|||
25018533|NCT03176238|50114133|FG000|Overall Study|Patient is switched to commercial drug|16|||
25018534|NCT03176238|50114134|FG001|Overall Study|Patient is switched to commercial drug|1|||
25018535|NCT03176238|50114133|FG000|Overall Study|Protocol Violation|1|||
25018536|NCT03176238|50114134|FG001|Overall Study|Protocol Violation|0|||
25018537|NCT03176238|50114133|FG000|Overall Study|Changes in the patient's condition|2|||
25152729|NCT01814696|50267797|FG001|Overall Study|Randomized to wrong group|0|||
25184901|NCT01463696|50333831|FG004|Overall Study|Not Treated|0|||
24908053|NCT00576758|50002110|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
24908054|NCT00576758|50002111|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
24908055|NCT00576758|50002110|FG000|Extension Treatment Period|Death|1|||
24908056|NCT00576758|50002111|FG001|Extension Treatment Period|Death|1|||
24908057|NCT00576758|50002110|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
24908058|NCT00576758|50002111|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
24908059|NCT00576758|50002110|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
24908060|NCT00576758|50002111|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
24908061|NCT00576758|50002110|FG000|Extension Treatment Period|Administrative/Other|3|||
24908062|NCT00576758|50002111|FG001|Extension Treatment Period|Administrative/Other|1|||
24908063|NCT00576758|50002110|FG000|Follow-up Period|Administrative/Other|6|||
24908064|NCT00576758|50002111|FG001|Follow-up Period|Administrative/Other|8|||
24908065|NCT00576758|50002110|FG000|Follow-up Period|Death|3|||
24908066|NCT00576758|50002111|FG001|Follow-up Period|Death|3|||
24908067|NCT00576758|50002110|FG000|Follow-up Period|Insufficient therapeutic response|16|||
24908068|NCT00576758|50002111|FG001|Follow-up Period|Insufficient therapeutic response|5|||
24908069|NCT00576758|50002110|FG000|Follow-up Period|Withdrew consent|2|||
24908070|NCT00576758|50002111|FG001|Follow-up Period|Withdrew consent|1|||
24908071|NCT00560794|50002118|FG000|Overall Study|Adverse Event|2|||
24908072|NCT00560794|50002118|FG000|Overall Study|Patient was not Compliant|1|||
24908073|NCT00560794|50002118|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
24908074|NCT00560794|50002118|FG000|Overall Study|Hematological Relapse|1|||
24908075|NCT00560794|50002118|FG000|Overall Study|Received Bone Marrow Transplant|6|||
24908076|NCT00619359|50002126|FG000|Overall Study|Adverse Event|32|||
24908077|NCT00619359|50002127|FG001|Overall Study|Adverse Event|36|||
24908078|NCT00619359|50002126|FG000|Overall Study|Lost to Follow-up|12|||
24908079|NCT00619359|50002127|FG001|Overall Study|Lost to Follow-up|16|||
24908080|NCT00619359|50002126|FG000|Overall Study|Physician Decision|0|||
24908081|NCT00619359|50002127|FG001|Overall Study|Physician Decision|7|||
24908082|NCT00619359|50002126|FG000|Overall Study|Protocol Violation|1|||
25018538|NCT03176238|50114134|FG001|Overall Study|Changes in the patient's condition|1|||
25152730|NCT01970371|50267806|FG000|Overall Study|Death|8|||
24908083|NCT00619359|50002127|FG001|Overall Study|Protocol Violation|1|||
24908084|NCT00619359|50002126|FG000|Overall Study|Withdrawal by Subject|19|||
24908085|NCT00619359|50002127|FG001|Overall Study|Withdrawal by Subject|20|||
24908086|NCT00619359|50002126|FG000|Overall Study|Progressive Disease|3|||
24908087|NCT00619359|50002127|FG001|Overall Study|Progressive Disease|1|||
24908088|NCT00372229|50002135|FG000|Study Phase|Graft loss|0|||
24908089|NCT00372229|50002136|FG001|Study Phase|Graft loss|3|||
24908090|NCT00372229|50002135|FG000|Study Phase|Protocol Violation|3|||
24908091|NCT00372229|50002136|FG001|Study Phase|Protocol Violation|4|||
24908092|NCT00372229|50002135|FG000|Study Phase|Consent withdrawn|16|||
24908093|NCT00372229|50002136|FG001|Study Phase|Consent withdrawn|14|||
24908094|NCT00372229|50002135|FG000|Study Phase|Refused treatment/did not cooperate|3|||
24908095|NCT00372229|50002136|FG001|Study Phase|Refused treatment/did not cooperate|1|||
24908096|NCT00372229|50002135|FG000|Study Phase|Death|3|||
24908097|NCT00372229|50002136|FG001|Study Phase|Death|2|||
24908098|NCT00372229|50002135|FG000|Study Phase|Reason not specified|3|||
24908099|NCT00372229|50002136|FG001|Study Phase|Reason not specified|2|||
24908100|NCT00372229|50002135|FG000|Study Phase|Lost to Follow-up|3|||
24908101|NCT00372229|50002136|FG001|Study Phase|Lost to Follow-up|3|||
24908102|NCT00372229|50002135|FG000|Follow-Up Phase|Graft loss|8|||
24908103|NCT00372229|50002136|FG001|Follow-Up Phase|Graft loss|7|||
24908104|NCT00372229|50002135|FG000|Follow-Up Phase|Consent withdrawn|13|||
24908105|NCT00372229|50002136|FG001|Follow-Up Phase|Consent withdrawn|19|||
24908106|NCT00372229|50002135|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
24908107|NCT00372229|50002136|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
24908108|NCT00372229|50002135|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
24908109|NCT00372229|50002136|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
24908110|NCT00372229|50002135|FG000|Follow-Up Phase|Death|9|||
24908111|NCT00372229|50002136|FG001|Follow-Up Phase|Death|12|||
24908112|NCT00372229|50002135|FG000|Follow-Up Phase|Administrative|1|||
24908113|NCT00372229|50002136|FG001|Follow-Up Phase|Administrative|0|||
24908114|NCT00372229|50002135|FG000|Follow-Up Phase|Reason not specified|2|||
24908115|NCT00372229|50002136|FG001|Follow-Up Phase|Reason not specified|3|||
24908116|NCT00372229|50002135|FG000|Follow-Up Phase|Lost to Follow-up|12|||
24908117|NCT00372229|50002136|FG001|Follow-Up Phase|Lost to Follow-up|10|||
24908118|NCT00698828|50002149|FG000|Overall Study|Adverse Event|3|||
24908119|NCT00698828|50002150|FG001|Overall Study|Adverse Event|4|||
24908120|NCT00698828|50002151|FG002|Overall Study|Adverse Event|4|||
24908121|NCT00698828|50002149|FG000|Overall Study|Death|0|||
24908122|NCT00698828|50002150|FG001|Overall Study|Death|0|||
25184902|NCT01463696|50333832|FG005|Overall Study|Not Treated|0|||
24908123|NCT00698828|50002151|FG002|Overall Study|Death|1|||
24908124|NCT00698828|50002149|FG000|Overall Study|Exacerbation of COPD|1|||
24908125|NCT00698828|50002150|FG001|Overall Study|Exacerbation of COPD|3|||
24908126|NCT00698828|50002151|FG002|Overall Study|Exacerbation of COPD|0|||
24908127|NCT00698828|50002149|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
24908128|NCT00698828|50002150|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
24908129|NCT00698828|50002151|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
25184903|NCT01463696|50333833|FG006|Overall Study|Not Treated|1|||
25184904|NCT01463696|50333834|FG007|Overall Study|Not Treated|0|||
24908130|NCT00698828|50002149|FG000|Overall Study|Investigator/Sponsor decision|1|||
24908131|NCT00698828|50002150|FG001|Overall Study|Investigator/Sponsor decision|0|||
24908132|NCT00698828|50002151|FG002|Overall Study|Investigator/Sponsor decision|2|||
24908133|NCT00698828|50002149|FG000|Overall Study|Lost to Follow-up|1|||
24908134|NCT00698828|50002150|FG001|Overall Study|Lost to Follow-up|1|||
24908135|NCT00698828|50002151|FG002|Overall Study|Lost to Follow-up|0|||
24908136|NCT00698828|50002149|FG000|Overall Study|Withdrew consent|0|||
24908137|NCT00698828|50002150|FG001|Overall Study|Withdrew consent|7|||
25184905|NCT02653482|50333854|FG000|Overall Study|Death|1|||
24908138|NCT00698828|50002151|FG002|Overall Study|Withdrew consent|4|||
24908139|NCT00698828|50002149|FG000|Overall Study|Withdrew consent (not treated)|2|||
24908140|NCT00698828|50002150|FG001|Overall Study|Withdrew consent (not treated)|0|||
24908141|NCT00698828|50002151|FG002|Overall Study|Withdrew consent (not treated)|0|||
24908142|NCT00619515|50002159|FG000|Overall Study|Study Termination by IRB|73|||
24908143|NCT03167606|50002165|FG000|Overall Study|Lost to Follow-up|73|||
24908144|NCT03167606|50002166|FG001|Overall Study|Lost to Follow-up|64|||
24908145|NCT03167606|50002165|FG000|Overall Study|Withdrawal by Subject|6|||
24908146|NCT03167606|50002166|FG001|Overall Study|Withdrawal by Subject|5|||
24908147|NCT03167606|50002165|FG000|Overall Study|Withdrawal by Investigator|0|||
24908148|NCT03167606|50002166|FG001|Overall Study|Withdrawal by Investigator|2|||
24908149|NCT00688740|50002174|FG000|Overall Study|Adverse Event|45|||
24908150|NCT00688740|50002175|FG001|Overall Study|Adverse Event|8|||
24908151|NCT00688740|50002174|FG000|Overall Study|Death|2|||
24908152|NCT00688740|50002175|FG001|Overall Study|Death|2|||
24908153|NCT00688740|50002174|FG000|Overall Study|Lost to Follow-up|0|||
24908154|NCT00688740|50002175|FG001|Overall Study|Lost to Follow-up|1|||
24908155|NCT00688740|50002174|FG000|Overall Study|Consent Withdrawn|17|||
24908156|NCT00688740|50002175|FG001|Overall Study|Consent Withdrawn|17|||
24908157|NCT00688740|50002174|FG000|Overall Study|Breast Cancer Relapse|1|||
24908158|NCT00688740|50002175|FG001|Overall Study|Breast Cancer Relapse|4|||
24908159|NCT00688740|50002174|FG000|Overall Study|Violation of Inclusion Criteria|1|||
24908160|NCT00688740|50002175|FG001|Overall Study|Violation of Inclusion Criteria|3|||
24908161|NCT00552760|50002183|FG000|Overall Study|Adverse Event|3|||
24908162|NCT00552760|50002184|FG001|Overall Study|Adverse Event|5|||
24908163|NCT00552760|50002183|FG000|Overall Study|Relapsed- Depressed Event|10|||
24908164|NCT00552760|50002184|FG001|Overall Study|Relapsed- Depressed Event|16|||
24908165|NCT00552760|50002183|FG000|Overall Study|Relapse- Manic Event|3|||
24908166|NCT00552760|50002184|FG001|Overall Study|Relapse- Manic Event|3|||
24908167|NCT00552760|50002183|FG000|Overall Study|Relapsed- Mixed Event|3|||
24908168|NCT00552760|50002184|FG001|Overall Study|Relapsed- Mixed Event|5|||
24908169|NCT00552760|50002183|FG000|Overall Study|Protocol Violation|0|||
24908170|NCT00552760|50002184|FG001|Overall Study|Protocol Violation|1|||
24908171|NCT00552760|50002183|FG000|Overall Study|Lost to Follow-up|1|||
24908172|NCT00552760|50002184|FG001|Overall Study|Lost to Follow-up|1|||
24908173|NCT00552760|50002183|FG000|Overall Study|Non-compliance|1|||
24908174|NCT00552760|50002184|FG001|Overall Study|Non-compliance|1|||
24908175|NCT00552760|50002183|FG000|Overall Study|Medical Condition|1|||
24908176|NCT00552760|50002184|FG001|Overall Study|Medical Condition|1|||
24908177|NCT00552760|50002183|FG000|Overall Study|Withdrawal by Subject|3|||
24908178|NCT00552760|50002184|FG001|Overall Study|Withdrawal by Subject|0|||
24908179|NCT00552760|50002183|FG000|Overall Study|Medication Change|1|||
24908180|NCT00552760|50002184|FG001|Overall Study|Medication Change|0|||
24908181|NCT00686790|50002190|FG000|Overall Study|Adverse Event|2|||
24908182|NCT00686790|50002190|FG000|Overall Study|Withdrawal by Subject|1|||
24908183|NCT00686790|50002190|FG000|Overall Study|Death|1|||
24908184|NCT00686790|50002190|FG000|Overall Study|Lost to Follow-up|12|||
25152731|NCT01970371|50267807|FG001|Overall Study|Death|13|||
25152732|NCT01970371|50267808|FG002|Overall Study|Death|12|||
24908185|NCT00686712|50002197|FG000|Overall Study|Protocol Violation|8|||
24908186|NCT00686712|50002198|FG001|Overall Study|Protocol Violation|8|||
24908187|NCT00686712|50002199|FG002|Overall Study|Protocol Violation|10|||
24908188|NCT00686712|50002197|FG000|Overall Study|Lost to Follow-up|1|||
24908189|NCT00686712|50002198|FG001|Overall Study|Lost to Follow-up|2|||
24908190|NCT00686712|50002199|FG002|Overall Study|Lost to Follow-up|3|||
24908191|NCT00686712|50002197|FG000|Overall Study|Adverse Event|1|||
24908192|NCT00686712|50002198|FG001|Overall Study|Adverse Event|1|||
24908193|NCT00686712|50002199|FG002|Overall Study|Adverse Event|0|||
24908194|NCT00686634|50002210|FG000|Overall Study|Protocol Violation|6|||
24908195|NCT00560404|50002217|FG000|Overall Study|Adverse Event|2|||
24908196|NCT00560404|50002218|FG001|Overall Study|Adverse Event|3|||
24908197|NCT00560404|50002217|FG000|Overall Study|Death|3|||
24908198|NCT00560404|50002218|FG001|Overall Study|Death|3|||
24908199|NCT00560404|50002217|FG000|Overall Study|Protocol Violation|12|||
24908200|NCT00560404|50002218|FG001|Overall Study|Protocol Violation|7|||
24908201|NCT00560404|50002217|FG000|Overall Study|Administrative Reasons|1|||
24908202|NCT00560404|50002218|FG001|Overall Study|Administrative Reasons|1|||
24908203|NCT00560404|50002217|FG000|Overall Study|Withdrew Consent|4|||
24908204|NCT00560404|50002218|FG001|Overall Study|Withdrew Consent|0|||
24908205|NCT00560404|50002217|FG000|Overall Study|Failure to return|1|||
24908206|NCT00560404|50002218|FG001|Overall Study|Failure to return|2|||
24908207|NCT00560404|50002217|FG000|Overall Study|Other withdrawal reason|13|||
24908208|NCT00560404|50002218|FG001|Overall Study|Other withdrawal reason|5|||
24908209|NCT03967444|50002226|FG000|Overall Study|Lost to Follow-up|1|||
24908210|NCT03967444|50002227|FG001|Overall Study|Lost to Follow-up|2|||
24908211|NCT00619983|50002237|FG000|Test Drug Alone|Withdrawal by Subject|1|||
24908212|NCT00619983|50002238|FG001|Test Drug Alone|Withdrawal by Subject|0|||
24908213|NCT00619983|50002239|FG002|Test Drug Alone|Withdrawal by Subject|0|||
24908214|NCT00619983|50002240|FG003|Test Drug Alone|Withdrawal by Subject|1|||
24908215|NCT00619983|50002237|FG000|Test Drug Alone|Failure of daily diary device|1|||
24908216|NCT00619983|50002238|FG001|Test Drug Alone|Failure of daily diary device|1|||
24908217|NCT00619983|50002239|FG002|Test Drug Alone|Failure of daily diary device|2|||
24908218|NCT00619983|50002240|FG003|Test Drug Alone|Failure of daily diary device|2|||
24908219|NCT00576420|50002253|FG000|Overall Study|Death|0|||
24908220|NCT00576420|50002254|FG001|Overall Study|Death|0|||
24908221|NCT00576420|50002255|FG002|Overall Study|Death|1|||
24908222|NCT03961204|50002304|FG000|Overall Study|Withdrawal by Subject|2|||
24908223|NCT03961204|50002304|FG000|Overall Study|Lost to Follow-up|3|||
24908224|NCT03961204|50002304|FG000|Overall Study|Other|1|||
24908225|NCT03961204|50002304|FG000|Overall Study|Missing|1|||
24908226|NCT00364351|50002310|FG000|Overall Study|Adverse Event|90|||
24908227|NCT00364351|50002311|FG001|Overall Study|Adverse Event|44|||
24908228|NCT00364351|50002310|FG000|Overall Study|Condition under investigation worsened|469|||
25018539|NCT03176238|50114133|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
25018540|NCT03176238|50114134|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
25018541|NCT03565315|50114148|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
25018542|NCT03565315|50114149|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
25018543|NCT03565315|50114150|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
25018544|NCT03565315|50114151|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
25018545|NCT03565237|50114174|FG000|Overall Study|Non-compliance of Investigational Product|1|||
25018546|NCT03565237|50114174|FG000|Overall Study|Physician Decision|1|||
25018547|NCT01345682|50114180|FG000|Overall Study|Progressive disease per RECIST|226|||
25018548|NCT01345682|50114181|FG001|Overall Study|Progressive disease per RECIST|93|||
25018549|NCT01345682|50114180|FG000|Overall Study|Worsening of underlying cancer disease|23|||
25018550|NCT01345682|50114181|FG001|Overall Study|Worsening of underlying cancer disease|12|||
25018551|NCT01345682|50114180|FG000|Overall Study|Adverse Event|51|||
25152733|NCT01970371|50267806|FG000|Overall Study|Lost to Follow-up|0|||
25152734|NCT01970371|50267807|FG001|Overall Study|Lost to Follow-up|0|||
25152735|NCT01970371|50267808|FG002|Overall Study|Lost to Follow-up|1|||
24908229|NCT00364351|50002311|FG001|Overall Study|Condition under investigation worsened|497|||
24908230|NCT00364351|50002310|FG000|Overall Study|Prohibited concomitant medication|0|||
24908231|NCT00364351|50002311|FG001|Overall Study|Prohibited concomitant medication|2|||
24908232|NCT00364351|50002310|FG000|Overall Study|Lost to Follow-up|1|||
24908233|NCT00364351|50002311|FG001|Overall Study|Lost to Follow-up|1|||
24908234|NCT00364351|50002310|FG000|Overall Study|Withdrawal by Subject|30|||
24908235|NCT00364351|50002311|FG001|Overall Study|Withdrawal by Subject|29|||
24908236|NCT00364351|50002310|FG000|Overall Study|Incorrect enrollment|1|||
24908237|NCT00364351|50002311|FG001|Overall Study|Incorrect enrollment|1|||
24908238|NCT00364351|50002310|FG000|Overall Study|Sponsor decision|1|||
24908239|NCT00364351|50002311|FG001|Overall Study|Sponsor decision|0|||
24908240|NCT00364351|50002310|FG000|Overall Study|Poor treatment compliance|0|||
24908241|NCT00364351|50002311|FG001|Overall Study|Poor treatment compliance|3|||
24908242|NCT00364351|50002310|FG000|Overall Study|Investigator error|0|||
24908243|NCT00364351|50002311|FG001|Overall Study|Investigator error|2|||
24908244|NCT00364351|50002310|FG000|Overall Study|Patient could not travel to site|0|||
24908245|NCT00364351|50002311|FG001|Overall Study|Patient could not travel to site|1|||
24908246|NCT00364351|50002310|FG000|Overall Study|Randomised treatment not started|0|||
24908247|NCT00364351|50002311|FG001|Overall Study|Randomised treatment not started|3|||
24908248|NCT00388297|50002321|FG000|Overall Study|Lost to Follow-up|16|||
24908249|NCT00388297|50002322|FG001|Overall Study|Lost to Follow-up|12|||
24908250|NCT00388297|50002323|FG002|Overall Study|Lost to Follow-up|11|||
24908251|NCT00388297|50002324|FG003|Overall Study|Lost to Follow-up|8|||
24908252|NCT00686166|50002334|FG000|Overall Study|Adverse Event|7|||
24908253|NCT00686166|50002334|FG000|Overall Study|Withdrawal by Subject|1|||
24908254|NCT00686166|50002334|FG000|Overall Study|Progression/Relapse|1|||
24908255|NCT00686166|50002334|FG000|Overall Study|Death|1|||
24908256|NCT00686166|50002334|FG000|Overall Study|Not Protocol Specified|1|||
24908257|NCT00686166|50002334|FG000|Overall Study|Ineligible|5|||
24908258|NCT00686166|50002334|FG000|Overall Study|Did not begin protocol therapy|4|||
24908259|NCT00363649|50002345|FG000|Overall Study|Withdrawal by Subject|1|||
24908260|NCT00363649|50002346|FG001|Overall Study|Withdrawal by Subject|1|||
24908261|NCT00363649|50002345|FG000|Overall Study|Adverse Event|6|||
24908262|NCT00363649|50002346|FG001|Overall Study|Adverse Event|0|||
24908263|NCT00684060|50002354|FG000|Overall Study|Lost to Follow-up|1|||
24908264|NCT00684060|50002355|FG001|Overall Study|Lost to Follow-up|0|||
24908265|NCT00684060|50002354|FG000|Overall Study|New stenosis identified|1|||
24908266|NCT00684060|50002355|FG001|Overall Study|New stenosis identified|0|||
24908267|NCT00684060|50002354|FG000|Overall Study|Unable to collect MRI|1|||
24908268|NCT00684060|50002355|FG001|Overall Study|Unable to collect MRI|2|||
24908269|NCT00684060|50002354|FG000|Overall Study|Death|0|||
24908270|NCT00684060|50002355|FG001|Overall Study|Death|1|||
24908271|NCT03131648|50002363|FG000|Initial Treatment Period|Not dosed|2|||
24908272|NCT03131648|50002364|FG001|Initial Treatment Period|Not dosed|2|||
24908273|NCT03131648|50002365|FG002|Initial Treatment Period|Not dosed|0|||
24908274|NCT03131648|50002366|FG003|Initial Treatment Period|Not dosed|0|||
24908275|NCT03131648|50002367|FG004|Initial Treatment Period|Not dosed|0|||
25018552|NCT01345682|50114181|FG001|Overall Study|Adverse Event|41|||
25018553|NCT01345682|50114180|FG000|Overall Study|Non-compliance with protocol|0|||
24908276|NCT03131648|50002368|FG005|Initial Treatment Period|Not dosed|0|||
24908277|NCT03131648|50002369|FG006|Initial Treatment Period|Not dosed|0|||
24908278|NCT03131648|50002370|FG007|Initial Treatment Period|Not dosed|0|||
24908279|NCT03131648|50002363|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
24908280|NCT03131648|50002364|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
24908281|NCT03131648|50002365|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
24908282|NCT03131648|50002366|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
24908283|NCT03131648|50002367|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
24908284|NCT03131648|50002368|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
25018554|NCT01345682|50114181|FG001|Overall Study|Non-compliance with protocol|1|||
24908285|NCT03131648|50002369|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
24908286|NCT03131648|50002370|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
24908287|NCT03131648|50002363|FG000|Open-label Treatment|Discontinued IMP|0|||
25018555|NCT01345682|50114180|FG000|Overall Study|Lost to Follow-up|0|||
25018556|NCT01345682|50114181|FG001|Overall Study|Lost to Follow-up|1|||
24908288|NCT03131648|50002364|FG001|Open-label Treatment|Discontinued IMP|0|||
24908289|NCT03131648|50002365|FG002|Open-label Treatment|Discontinued IMP|0|||
24908290|NCT03131648|50002366|FG003|Open-label Treatment|Discontinued IMP|0|||
24908291|NCT03131648|50002367|FG004|Open-label Treatment|Discontinued IMP|0|||
24908292|NCT03131648|50002368|FG005|Open-label Treatment|Discontinued IMP|0|||
24908293|NCT03131648|50002369|FG006|Open-label Treatment|Discontinued IMP|112|||
24908294|NCT03131648|50002370|FG007|Open-label Treatment|Discontinued IMP|0|||
24908295|NCT03131648|50002363|FG000|Open-label Treatment|Completed Week 50|0|||
24908296|NCT03131648|50002364|FG001|Open-label Treatment|Completed Week 50|0|||
24908297|NCT03131648|50002365|FG002|Open-label Treatment|Completed Week 50|0|||
24908298|NCT03131648|50002366|FG003|Open-label Treatment|Completed Week 50|0|||
24908299|NCT03131648|50002367|FG004|Open-label Treatment|Completed Week 50|0|||
24908300|NCT03131648|50002368|FG005|Open-label Treatment|Completed Week 50|0|||
24908301|NCT03131648|50002369|FG006|Open-label Treatment|Completed Week 50|6|||
24908302|NCT03131648|50002370|FG007|Open-label Treatment|Completed Week 50|0|||
24908303|NCT03131648|50002363|FG000|Maintenance Treatment Period|Not dosed|0|||
24908304|NCT03131648|50002364|FG001|Maintenance Treatment Period|Not dosed|0|||
25152736|NCT01868594|50267829|FG000|Overall Study|Do not meet inclusion criteria|4|||
25152737|NCT01868594|50267830|FG001|Overall Study|Do not meet inclusion criteria|3|||
25184906|NCT02653482|50333855|FG001|Overall Study|Death|1|||
25274810|NCT00909727|50588870|FG001|Overall Study|Wrong Genotype|0|||
24908305|NCT03131648|50002365|FG002|Maintenance Treatment Period|Not dosed|3|||
24908306|NCT03131648|50002366|FG003|Maintenance Treatment Period|Not dosed|2|||
24908307|NCT03131648|50002367|FG004|Maintenance Treatment Period|Not dosed|1|||
24908308|NCT03131648|50002368|FG005|Maintenance Treatment Period|Not dosed|0|||
24908309|NCT03131648|50002369|FG006|Maintenance Treatment Period|Not dosed|0|||
24908310|NCT03131648|50002370|FG007|Maintenance Treatment Period|Not dosed|0|||
24908311|NCT03131648|50002363|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
24908312|NCT03131648|50002364|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
24908313|NCT03131648|50002365|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
24908314|NCT03131648|50002366|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
24908315|NCT03131648|50002367|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
24908316|NCT03131648|50002368|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
24908317|NCT03131648|50002369|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
24908318|NCT03131648|50002370|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
24908319|NCT03131648|50002363|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
24908320|NCT03131648|50002364|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
24908321|NCT03131648|50002365|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
24908322|NCT03131648|50002366|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
24908323|NCT03131648|50002367|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
24908324|NCT03131648|50002368|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
24908325|NCT03131648|50002369|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
24908326|NCT03131648|50002370|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
24908327|NCT03131648|50002363|FG000|Maintenance Treatment Period|Completed Week 50|0|||
24908328|NCT03131648|50002364|FG001|Maintenance Treatment Period|Completed Week 50|0|||
24908329|NCT03131648|50002365|FG002|Maintenance Treatment Period|Completed Week 50|0|||
24908330|NCT03131648|50002366|FG003|Maintenance Treatment Period|Completed Week 50|0|||
24908331|NCT03131648|50002367|FG004|Maintenance Treatment Period|Completed Week 50|1|||
24908332|NCT03131648|50002368|FG005|Maintenance Treatment Period|Completed Week 50|0|||
24908333|NCT03131648|50002369|FG006|Maintenance Treatment Period|Completed Week 50|0|||
24908334|NCT03131648|50002370|FG007|Maintenance Treatment Period|Completed Week 50|0|||
24908335|NCT03131648|50002363|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
24908336|NCT03131648|50002364|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
24908337|NCT03131648|50002365|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
24908338|NCT03131648|50002366|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
24908339|NCT03131648|50002367|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
24908340|NCT03131648|50002368|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
24908341|NCT03131648|50002369|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
24908342|NCT03131648|50002370|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
24908343|NCT00618813|50002387|FG000|Overall Study|Lack of Efficacy|1|||
24908344|NCT00618813|50002387|FG000|Overall Study|Physician Decision|2|||
24908345|NCT00618813|50002387|FG000|Overall Study|Withdrawal by Subject|1|||
24908346|NCT00554788|50002394|FG000|Overall Study|Adverse Event|0|||
24908347|NCT00554788|50002395|FG001|Overall Study|Adverse Event|1|||
24908348|NCT00554788|50002396|FG002|Overall Study|Adverse Event|2|||
24908349|NCT00554788|50002394|FG000|Overall Study|Lost to Follow-up|4|||
24908350|NCT00554788|50002395|FG001|Overall Study|Lost to Follow-up|3|||
24908351|NCT00554788|50002396|FG002|Overall Study|Lost to Follow-up|3|||
24908352|NCT00554788|50002394|FG000|Overall Study|Physician Decision|1|||
24908353|NCT00554788|50002395|FG001|Overall Study|Physician Decision|1|||
24908354|NCT00554788|50002396|FG002|Overall Study|Physician Decision|3|||
24908355|NCT00554788|50002394|FG000|Overall Study|Withdrawal by Subject|0|||
24908356|NCT00554788|50002395|FG001|Overall Study|Withdrawal by Subject|0|||
24908357|NCT00554788|50002396|FG002|Overall Study|Withdrawal by Subject|1|||
24908358|NCT00554788|50002394|FG000|Overall Study|Refusal of further protocol therapy|0|||
24908359|NCT00554788|50002395|FG001|Overall Study|Refusal of further protocol therapy|1|||
24908360|NCT00554788|50002396|FG002|Overall Study|Refusal of further protocol therapy|1|||
24908361|NCT00554788|50002394|FG000|Overall Study|Progressive disease|0|||
24908362|NCT00554788|50002395|FG001|Overall Study|Progressive disease|0|||
24908363|NCT00554788|50002396|FG002|Overall Study|Progressive disease|3|||
24908364|NCT00554788|50002394|FG000|Overall Study|Ineligible|2|||
24908365|NCT00554788|50002395|FG001|Overall Study|Ineligible|0|||
24908366|NCT00554788|50002396|FG002|Overall Study|Ineligible|1|||
24908367|NCT00685698|50002405|FG000|Overall Study|Withdrawal by Subject|1|||
24908368|NCT00685698|50002405|FG000|Overall Study|Protocol Violation|6|||
24908369|NCT00685698|50002405|FG000|Overall Study|Adverse Event|3|||
24908370|NCT00685698|50002405|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
24908371|NCT00685698|50002405|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
24908372|NCT00685698|50002405|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
25152738|NCT01616953|50267840|FG000|Overall Study|Lost to Follow-up|1|||
24908373|NCT00549328|50002421|FG000|Overall Study|Adverse Event|2|||
24908374|NCT00549328|50002421|FG000|Overall Study|Disease Progression|10|||
24908375|NCT00549328|50002421|FG000|Overall Study|Death|1|||
24908376|NCT00549328|50002421|FG000|Overall Study|Use of Prohibited Medication|1|||
24908377|NCT00696410|50002427|FG000|Overall Study|Lost to Follow-up|2|||
24908378|NCT00696410|50002428|FG001|Overall Study|Lost to Follow-up|0|||
24908379|NCT00696410|50002427|FG000|Overall Study|Withdrawal by Subject|8|||
24908380|NCT00696410|50002428|FG001|Overall Study|Withdrawal by Subject|0|||
24908381|NCT00696410|50002427|FG000|Overall Study|Physician Decision|3|||
24908382|NCT00696410|50002428|FG001|Overall Study|Physician Decision|0|||
24908383|NCT00683904|50002441|FG000|Dose Level 1|Disease progression|2|||
24908384|NCT00683904|50002442|FG001|Dose Level 1|Disease progression|0|||
24908385|NCT00683904|50002441|FG000|Dose Level 1|Adverse Event|1|||
24908386|NCT00683904|50002442|FG001|Dose Level 1|Adverse Event|0|||
24908387|NCT00683904|50002441|FG000|Dose Level 2|Adverse Event|0|||
24908388|NCT00683904|50002442|FG001|Dose Level 2|Adverse Event|2|||
24908389|NCT00363415|50002456|FG000|Overall Study|Progressive Disease|196|||
24908390|NCT00363415|50002457|FG001|Overall Study|Progressive Disease|107|||
24908391|NCT00363415|50002456|FG000|Overall Study|Sponsor Decision|67|||
24908392|NCT00363415|50002457|FG001|Overall Study|Sponsor Decision|31|||
24908393|NCT00363415|50002456|FG000|Overall Study|Death|32|||
24908394|NCT00363415|50002457|FG001|Overall Study|Death|29|||
24908395|NCT00363415|50002456|FG000|Overall Study|Adverse Event|24|||
24908396|NCT00363415|50002457|FG001|Overall Study|Adverse Event|15|||
24908397|NCT00363415|50002456|FG000|Overall Study|Physician Decision|18|||
24908398|NCT00363415|50002457|FG001|Overall Study|Physician Decision|35|||
24908399|NCT00363415|50002456|FG000|Overall Study|Entry Criteria Not Met|11|||
24908400|NCT00363415|50002457|FG001|Overall Study|Entry Criteria Not Met|10|||
24908401|NCT00363415|50002456|FG000|Overall Study|Withdrawal by Subject|9|||
24908402|NCT00363415|50002457|FG001|Overall Study|Withdrawal by Subject|15|||
24908403|NCT00363415|50002456|FG000|Overall Study|Lost to Follow-up|3|||
24908404|NCT00363415|50002457|FG001|Overall Study|Lost to Follow-up|3|||
24908405|NCT00363415|50002456|FG000|Overall Study|Protocol Violation|1|||
24908406|NCT00363415|50002457|FG001|Overall Study|Protocol Violation|4|||
24908407|NCT00696020|50002467|FG000|Overall Study|Adverse Event|3|||
24908408|NCT00696020|50002468|FG001|Overall Study|Adverse Event|1|||
24908409|NCT00696020|50002469|FG002|Overall Study|Adverse Event|2|||
24908410|NCT00696020|50002470|FG003|Overall Study|Adverse Event|1|||
24908411|NCT00696020|50002467|FG000|Overall Study|Lack of Efficacy|1|||
24908412|NCT00696020|50002468|FG001|Overall Study|Lack of Efficacy|0|||
24908413|NCT00696020|50002469|FG002|Overall Study|Lack of Efficacy|0|||
24908414|NCT00696020|50002470|FG003|Overall Study|Lack of Efficacy|0|||
25018557|NCT01345682|50114180|FG000|Overall Study|Refused to continue trial medication|16|||
25018558|NCT01345682|50114181|FG001|Overall Study|Refused to continue trial medication|9|||
25018559|NCT01345682|50114180|FG000|Overall Study|Not treated|2|||
25018560|NCT01345682|50114181|FG001|Overall Study|Not treated|1|||
24908415|NCT00696020|50002467|FG000|Overall Study|Protocol Violation|0|||
24908416|NCT00696020|50002468|FG001|Overall Study|Protocol Violation|0|||
24908417|NCT00696020|50002469|FG002|Overall Study|Protocol Violation|0|||
24908418|NCT00696020|50002470|FG003|Overall Study|Protocol Violation|1|||
24908419|NCT00696020|50002467|FG000|Overall Study|Withdrawal by Subject|0|||
24908420|NCT00696020|50002468|FG001|Overall Study|Withdrawal by Subject|1|||
24908421|NCT00696020|50002469|FG002|Overall Study|Withdrawal by Subject|0|||
24908422|NCT00696020|50002470|FG003|Overall Study|Withdrawal by Subject|1|||
24908423|NCT00696020|50002467|FG000|Overall Study|Other not stated above|0|||
24908424|NCT00696020|50002468|FG001|Overall Study|Other not stated above|0|||
24908425|NCT00696020|50002469|FG002|Overall Study|Other not stated above|1|||
24908426|NCT00696020|50002470|FG003|Overall Study|Other not stated above|1|||
24908427|NCT00576576|50002482|FG000|Overall Study|Lost to Follow-up|6|||
24908428|NCT00576576|50002482|FG000|Overall Study|Protocol Violation|1|||
24908429|NCT00695864|50002501|FG000|Placebo|Withdrawal by Subject|1|||
24908430|NCT00695864|50002501|FG000|Placebo|Physician Decision|4|||
24908431|NCT00684996|50002507|FG000|Overall Study|Adverse Event|1|||
24908432|NCT00684996|50002507|FG000|Overall Study|Refusal unrelated to adverse event|1|||
24908433|NCT00684996|50002507|FG000|Overall Study|Progression/relapse|2|||
24908434|NCT00684996|50002507|FG000|Overall Study|Other reasons not protocol specified|1|||
25018561|NCT01345682|50114180|FG000|Overall Study|Reason other than those specified above|4|||
25018562|NCT01345682|50114181|FG001|Overall Study|Reason other than those specified above|3|||
24908435|NCT00684762|50002514|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
24908436|NCT00684762|50002515|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
24908437|NCT00695786|50002525|FG000|Overall Study|Adverse Event|0|||
24908438|NCT00695786|50002526|FG001|Overall Study|Adverse Event|3|||
24908439|NCT00695786|50002527|FG002|Overall Study|Adverse Event|4|||
24908440|NCT00695786|50002528|FG003|Overall Study|Adverse Event|2|||
24908441|NCT00695786|50002525|FG000|Overall Study|Lost to Follow-up|0|||
25018563|NCT03562117|50114190|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
25018564|NCT03562117|50114191|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
25018565|NCT03562117|50114192|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
25018566|NCT03561883|50114202|FG000|Overall Study|Adverse Event|10|||
25018567|NCT03561883|50114203|FG001|Overall Study|Adverse Event|13|||
25018568|NCT03561883|50114202|FG000|Overall Study|Non-Compliance With Study Drug|1|||
25018569|NCT03561883|50114203|FG001|Overall Study|Non-Compliance With Study Drug|2|||
25018570|NCT03561883|50114202|FG000|Overall Study|Protocol Violation|2|||
25018571|NCT03561883|50114203|FG001|Overall Study|Protocol Violation|3|||
25018572|NCT03561883|50114202|FG000|Overall Study|Withdrawal by Subject|14|||
25018573|NCT03561883|50114203|FG001|Overall Study|Withdrawal by Subject|6|||
25018574|NCT03561883|50114202|FG000|Overall Study|Lost to Follow-up|2|||
25018575|NCT03561883|50114203|FG001|Overall Study|Lost to Follow-up|6|||
25018576|NCT03561883|50114202|FG000|Overall Study|Study Terminated by Sponsor|12|||
25018577|NCT03561883|50114203|FG001|Overall Study|Study Terminated by Sponsor|11|||
25018578|NCT03561883|50114202|FG000|Overall Study|Physician Decision|1|||
25018579|NCT03561883|50114203|FG001|Overall Study|Physician Decision|0|||
25018580|NCT03561883|50114202|FG000|Overall Study|Randomized by Mistake|1|||
25018581|NCT03561883|50114203|FG001|Overall Study|Randomized by Mistake|0|||
25018582|NCT03561883|50114202|FG000|Overall Study|Other, Not Specified|3|||
25018583|NCT03561883|50114203|FG001|Overall Study|Other, Not Specified|2|||
25018584|NCT03546907|50114211|FG000|Overall Study|Lack of Efficacy|1|||
25018585|NCT03546907|50114212|FG001|Overall Study|Lack of Efficacy|1|||
25018586|NCT03546907|50114211|FG000|Overall Study|Withdrawal by Subject|8|||
25018587|NCT03546907|50114212|FG001|Overall Study|Withdrawal by Subject|9|||
25018588|NCT03546907|50114211|FG000|Overall Study|Adverse events (AEs)|7|||
25018589|NCT03546907|50114212|FG001|Overall Study|Adverse events (AEs)|10|||
25018590|NCT03546907|50114211|FG000|Overall Study|Other-unspecified|1|||
25018591|NCT03546907|50114212|FG001|Overall Study|Other-unspecified|1|||
25018592|NCT01318382|50114218|FG000|Overall Study|Physician Decision|2|||
25018593|NCT01318382|50114218|FG000|Overall Study|Device Malfunction|10|||
25018594|NCT01318382|50114218|FG000|Overall Study|Protocol Violation|1|||
25018595|NCT03053180|50114236|FG000|Overall Study|Failure to Return|1|||
25018596|NCT03560869|50114240|FG000|Overall Study|Withdrawal by Subject|3|||
25018597|NCT03560869|50114241|FG001|Overall Study|Withdrawal by Subject|4|||
25018598|NCT03560869|50114240|FG000|Overall Study|Screening failure|4|||
25018599|NCT03560869|50114241|FG001|Overall Study|Screening failure|4|||
25018600|NCT03560869|50114240|FG000|Overall Study|Withdrawal by PI|0|||
25018601|NCT03560869|50114241|FG001|Overall Study|Withdrawal by PI|1|||
25018602|NCT03590743|50114249|FG000|Overall Study|Withdrawal by Subject|0|||
25018603|NCT03590743|50114250|FG001|Overall Study|Withdrawal by Subject|1|||
25018604|NCT03053102|50114256|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
25018605|NCT03053102|50114256|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
25018606|NCT03589885|50114264|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
25018607|NCT03589885|50114265|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
25018608|NCT03589885|50114266|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
25018609|NCT03589885|50114267|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
25018610|NCT03589885|50114268|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
25018611|NCT03589885|50114264|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
25018612|NCT03589885|50114265|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
25018613|NCT03589885|50114266|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
25018614|NCT03589885|50114267|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
25018615|NCT03589885|50114268|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
25018616|NCT03589885|50114264|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
25018617|NCT03589885|50114265|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
25018618|NCT03589885|50114266|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
25018619|NCT03589885|50114267|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
25018620|NCT03589885|50114268|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
25018621|NCT03589885|50114264|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
25018622|NCT03589885|50114265|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
24908442|NCT00695786|50002526|FG001|Overall Study|Lost to Follow-up|5|||
25018623|NCT03589885|50114266|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
25018624|NCT03589885|50114267|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
25018625|NCT03589885|50114268|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
25018626|NCT03589885|50114264|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
25018627|NCT03589885|50114265|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
25018628|NCT03589885|50114266|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
25018629|NCT03589885|50114267|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
24908443|NCT00695786|50002527|FG002|Overall Study|Lost to Follow-up|1|||
24908444|NCT00695786|50002528|FG003|Overall Study|Lost to Follow-up|1|||
24908445|NCT00695786|50002525|FG000|Overall Study|Withdrawal by Subject|0|||
24908446|NCT00695786|50002526|FG001|Overall Study|Withdrawal by Subject|4|||
24908447|NCT00695786|50002527|FG002|Overall Study|Withdrawal by Subject|3|||
24908448|NCT00695786|50002528|FG003|Overall Study|Withdrawal by Subject|1|||
24908449|NCT00695786|50002525|FG000|Overall Study|Deemed Ineligible|1|||
24908450|NCT00695786|50002526|FG001|Overall Study|Deemed Ineligible|0|||
24908451|NCT00695786|50002527|FG002|Overall Study|Deemed Ineligible|0|||
24908452|NCT00695786|50002528|FG003|Overall Study|Deemed Ineligible|0|||
24908453|NCT00695786|50002525|FG000|Overall Study|Lack of Efficacy|0|||
24908454|NCT00695786|50002526|FG001|Overall Study|Lack of Efficacy|0|||
24908455|NCT00695786|50002527|FG002|Overall Study|Lack of Efficacy|0|||
24908456|NCT00695786|50002528|FG003|Overall Study|Lack of Efficacy|4|||
24908457|NCT00387127|50002540|FG000|Overall Study|Lost to Follow-up|0|||
25018630|NCT03589885|50114268|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
25018631|NCT03589885|50114264|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
25018632|NCT03589885|50114265|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
25018633|NCT03589885|50114266|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
25018634|NCT03589885|50114267|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
25018635|NCT03589885|50114268|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
25018636|NCT03589885|50114264|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
25018637|NCT03589885|50114265|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
25018638|NCT03589885|50114266|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
25018639|NCT03589885|50114267|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
25018640|NCT03589885|50114268|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
25018641|NCT03589885|50114264|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
25018642|NCT03589885|50114265|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
25018643|NCT03589885|50114266|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
25018644|NCT03589885|50114267|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
25018645|NCT03589885|50114268|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
25018646|NCT03545503|50114288|FG000|Overall Study|Protocol Violation|14|||
25018647|NCT03545503|50114289|FG001|Overall Study|Protocol Violation|16|||
25018648|NCT03545113|50114297|FG000|Overall Study|Surgery Cancelled|1|||
25018649|NCT03545113|50114298|FG001|Overall Study|Surgery Cancelled|0|||
25018650|NCT03545113|50114297|FG000|Overall Study|Death|1|||
25018651|NCT03545113|50114298|FG001|Overall Study|Death|0|||
25018652|NCT03545113|50114297|FG000|Overall Study|Adverse Event|2|||
25018653|NCT03545113|50114298|FG001|Overall Study|Adverse Event|0|||
25018654|NCT03545113|50114297|FG000|Overall Study|Received different surgery|1|||
25018655|NCT03545113|50114298|FG001|Overall Study|Received different surgery|0|||
25018656|NCT03214380|50114310|FG000|Lead-in|Adverse Event|3|||
25018657|NCT03214380|50114311|FG001|Lead-in|Adverse Event|0|||
25018658|NCT03214380|50114312|FG002|Lead-in|Adverse Event|0|||
25018659|NCT03214380|50114313|FG003|Lead-in|Adverse Event|1|||
25018660|NCT03214380|50114314|FG004|Lead-in|Adverse Event|0|||
25018661|NCT03214380|50114315|FG005|Lead-in|Adverse Event|0|||
25018662|NCT03214380|50114310|FG000|Lead-in|Lost to Follow-up|4|||
25018663|NCT03214380|50114311|FG001|Lead-in|Lost to Follow-up|0|||
25018664|NCT03214380|50114312|FG002|Lead-in|Lost to Follow-up|0|||
25018665|NCT03214380|50114313|FG003|Lead-in|Lost to Follow-up|1|||
25018666|NCT03214380|50114314|FG004|Lead-in|Lost to Follow-up|0|||
25018667|NCT03214380|50114315|FG005|Lead-in|Lost to Follow-up|0|||
24908458|NCT00387127|50002541|FG001|Overall Study|Lost to Follow-up|4|||
24908459|NCT00387127|50002540|FG000|Overall Study|Death|16|||
24908460|NCT00387127|50002541|FG001|Overall Study|Death|16|||
24908461|NCT00387127|50002540|FG000|Overall Study|Physician Decision|0|||
25018668|NCT03214380|50114310|FG000|Lead-in|Eligibility Criteria|3|||
24908462|NCT00387127|50002541|FG001|Overall Study|Physician Decision|1|||
25018669|NCT03214380|50114311|FG001|Lead-in|Eligibility Criteria|0|||
24908463|NCT00387127|50002540|FG000|Overall Study|Withdrawal by Subject|3|||
24908464|NCT00387127|50002541|FG001|Overall Study|Withdrawal by Subject|2|||
24908465|NCT00387127|50002540|FG000|Overall Study|Required by Protocol Amendment #4|12|||
24908466|NCT00387127|50002541|FG001|Overall Study|Required by Protocol Amendment #4|10|||
24908467|NCT00387127|50002540|FG000|Overall Study|Serious Adverse Event|1|||
24908468|NCT00387127|50002541|FG001|Overall Study|Serious Adverse Event|1|||
24908469|NCT00387127|50002540|FG000|Overall Study|Sponsor Unblinded|1|||
24908470|NCT00387127|50002541|FG001|Overall Study|Sponsor Unblinded|0|||
24908471|NCT00683592|50002551|FG000|Overall Study|Adverse Event|12|||
24908472|NCT00683592|50002552|FG001|Overall Study|Adverse Event|4|||
24908473|NCT00683592|50002551|FG000|Overall Study|Withdrawal by Subject|11|||
25018670|NCT03214380|50114312|FG002|Lead-in|Eligibility Criteria|0|||
25018671|NCT03214380|50114313|FG003|Lead-in|Eligibility Criteria|0|||
25018672|NCT03214380|50114314|FG004|Lead-in|Eligibility Criteria|0|||
25018673|NCT03214380|50114315|FG005|Lead-in|Eligibility Criteria|0|||
25018674|NCT03214380|50114310|FG000|Lead-in|Physician Decision|6|||
25018675|NCT03214380|50114311|FG001|Lead-in|Physician Decision|0|||
25018676|NCT03214380|50114312|FG002|Lead-in|Physician Decision|0|||
25018677|NCT03214380|50114313|FG003|Lead-in|Physician Decision|0|||
24908474|NCT00683592|50002552|FG001|Overall Study|Withdrawal by Subject|11|||
24908475|NCT00683592|50002551|FG000|Overall Study|Lost to Follow-up|17|||
24908476|NCT00683592|50002552|FG001|Overall Study|Lost to Follow-up|17|||
24908477|NCT00683592|50002551|FG000|Overall Study|Lack of Efficacy|3|||
24908478|NCT00683592|50002552|FG001|Overall Study|Lack of Efficacy|7|||
24908479|NCT00683592|50002551|FG000|Overall Study|Physician Decision|0|||
24908480|NCT00683592|50002552|FG001|Overall Study|Physician Decision|1|||
24908481|NCT00683592|50002551|FG000|Overall Study|Non-compliance|3|||
24908482|NCT00683592|50002552|FG001|Overall Study|Non-compliance|5|||
24908483|NCT00683592|50002551|FG000|Overall Study|Other|1|||
24908484|NCT00683592|50002552|FG001|Overall Study|Other|1|||
24908485|NCT00695396|50002561|FG000|Overall Study|Study Closed Prematurely|5|||
24908486|NCT00695396|50002562|FG001|Overall Study|Study Closed Prematurely|6|||
24908487|NCT00695396|50002563|FG002|Overall Study|Study Closed Prematurely|8|||
25018678|NCT03214380|50114314|FG004|Lead-in|Physician Decision|0|||
25018679|NCT03214380|50114315|FG005|Lead-in|Physician Decision|0|||
25018680|NCT03214380|50114310|FG000|Lead-in|Protocol Deviation|7|||
25018681|NCT03214380|50114311|FG001|Lead-in|Protocol Deviation|0|||
25018682|NCT03214380|50114312|FG002|Lead-in|Protocol Deviation|0|||
25018683|NCT03214380|50114313|FG003|Lead-in|Protocol Deviation|3|||
25018684|NCT03214380|50114314|FG004|Lead-in|Protocol Deviation|0|||
25018685|NCT03214380|50114315|FG005|Lead-in|Protocol Deviation|0|||
25018686|NCT03214380|50114310|FG000|Lead-in|Withdrawal by Subject|41|||
24908488|NCT00695396|50002561|FG000|Overall Study|Withdrawal by Subject|2|||
24908489|NCT00695396|50002562|FG001|Overall Study|Withdrawal by Subject|2|||
24908490|NCT00695396|50002563|FG002|Overall Study|Withdrawal by Subject|0|||
24908491|NCT02656706|50002571|FG000|Overall Study|Insurance Denial|1|||
24908492|NCT00575328|50002577|FG000|Overall Study|Adverse Event|1|||
24908493|NCT00575328|50002578|FG001|Overall Study|Adverse Event|1|||
24908494|NCT00575328|50002577|FG000|Overall Study|Lost to Follow-up|2|||
24908495|NCT00575328|50002578|FG001|Overall Study|Lost to Follow-up|1|||
24908496|NCT00575094|50002584|FG000|Overall Study|Adverse Event|2|||
24908497|NCT00575094|50002584|FG000|Overall Study|Withdrawal by Subject|1|||
24908498|NCT00553696|50002592|FG000|Overall Study|Adverse Event|2|||
24908499|NCT00553696|50002593|FG001|Overall Study|Adverse Event|4|||
24908500|NCT00553696|50002594|FG002|Overall Study|Adverse Event|0|||
24908501|NCT00553696|50002595|FG003|Overall Study|Adverse Event|1|||
24908502|NCT00553696|50002592|FG000|Overall Study|Global deterioration of health status|0|||
24908503|NCT00553696|50002593|FG001|Overall Study|Global deterioration of health status|2|||
24908504|NCT00553696|50002594|FG002|Overall Study|Global deterioration of health status|0|||
24908505|NCT00553696|50002595|FG003|Overall Study|Global deterioration of health status|0|||
24908506|NCT00553696|50002592|FG000|Overall Study|Objective progression or relapse|2|||
24908507|NCT00553696|50002593|FG001|Overall Study|Objective progression or relapse|9|||
24908508|NCT00553696|50002594|FG002|Overall Study|Objective progression or relapse|6|||
24908509|NCT00553696|50002595|FG003|Overall Study|Objective progression or relapse|0|||
24908510|NCT00553696|50002592|FG000|Overall Study|Withdrawal by Subject|0|||
25018687|NCT03214380|50114311|FG001|Lead-in|Withdrawal by Subject|0|||
25018688|NCT03214380|50114312|FG002|Lead-in|Withdrawal by Subject|0|||
25018689|NCT03214380|50114313|FG003|Lead-in|Withdrawal by Subject|14|||
24908511|NCT00553696|50002593|FG001|Overall Study|Withdrawal by Subject|1|||
24908512|NCT00553696|50002594|FG002|Overall Study|Withdrawal by Subject|0|||
24908513|NCT00553696|50002595|FG003|Overall Study|Withdrawal by Subject|0|||
24908514|NCT00553540|50002610|FG000|Overall Study|discharged after first visit|2|||
24908515|NCT00553540|50002611|FG001|Overall Study|discharged after first visit|5|||
24908516|NCT00617409|50002620|FG000|Overall Study|Withdrawal by Subject|4|||
24908517|NCT00617409|50002621|FG001|Overall Study|Withdrawal by Subject|1|||
24908518|NCT00617409|50002622|FG002|Overall Study|Withdrawal by Subject|2|||
24908519|NCT00617409|50002620|FG000|Overall Study|Adverse Event|0|||
24908520|NCT00617409|50002621|FG001|Overall Study|Adverse Event|2|||
24908521|NCT00617409|50002622|FG002|Overall Study|Adverse Event|3|||
24908522|NCT00617409|50002620|FG000|Overall Study|Disease Progression|8|||
24908523|NCT00617409|50002621|FG001|Overall Study|Disease Progression|8|||
24908524|NCT00617409|50002622|FG002|Overall Study|Disease Progression|18|||
24908525|NCT00617409|50002620|FG000|Overall Study|Death|3|||
24908526|NCT00617409|50002621|FG001|Overall Study|Death|5|||
24908527|NCT00617409|50002622|FG002|Overall Study|Death|4|||
24908528|NCT00617409|50002620|FG000|Overall Study|Alternative Therapy|1|||
24908529|NCT00617409|50002621|FG001|Overall Study|Alternative Therapy|2|||
24908530|NCT00617409|50002622|FG002|Overall Study|Alternative Therapy|0|||
24908531|NCT00695318|50002633|FG000|Overall Study|Lost to Follow-up|1|||
24908532|NCT00695318|50002634|FG001|Overall Study|Lost to Follow-up|0|||
24908533|NCT00695318|50002633|FG000|Overall Study|Withdrawal by Subject|2|||
24908534|NCT00695318|50002634|FG001|Overall Study|Withdrawal by Subject|0|||
24908535|NCT00695318|50002633|FG000|Overall Study|Death|1|||
24908536|NCT00695318|50002634|FG001|Overall Study|Death|1|||
24908537|NCT00695318|50002633|FG000|Overall Study|Study Terminated|1|||
24908538|NCT00695318|50002634|FG001|Overall Study|Study Terminated|0|||
24908539|NCT00386425|50002648|FG000|Overall Study|Physician Decision|3|||
24908540|NCT00386425|50002649|FG001|Overall Study|Physician Decision|0|||
24908541|NCT00386425|50002650|FG002|Overall Study|Physician Decision|0|||
24908542|NCT00386425|50002648|FG000|Overall Study|Withdrawal by Subject|0|||
25018690|NCT03214380|50114314|FG004|Lead-in|Withdrawal by Subject|0|||
25018691|NCT03214380|50114315|FG005|Lead-in|Withdrawal by Subject|0|||
24908543|NCT00386425|50002649|FG001|Overall Study|Withdrawal by Subject|1|||
24908544|NCT00386425|50002650|FG002|Overall Study|Withdrawal by Subject|0|||
24908545|NCT00694304|50002662|FG000|Overall Study|Adverse Event|42|||
24908546|NCT00694304|50002662|FG000|Overall Study|Lack of Efficacy|35|||
24908547|NCT00694304|50002662|FG000|Overall Study|Non-compliance With Study Product|16|||
24908548|NCT00694304|50002662|FG000|Overall Study|Protocol Violation|6|||
24908549|NCT00694304|50002662|FG000|Overall Study|Withdrawal of Consent|61|||
24908550|NCT00694304|50002662|FG000|Overall Study|Lost to Follow-up|15|||
24908551|NCT00694304|50002662|FG000|Overall Study|Administrative or Other Reasons|32|||
24908552|NCT00371839|50002669|FG000|Overall Study|Death|4|||
24908553|NCT00371839|50002670|FG001|Overall Study|Death|0|||
24908554|NCT00371839|50002671|FG002|Overall Study|Death|0|||
24908555|NCT00371839|50002669|FG000|Overall Study|Withdrawal by Subject|7|||
24908556|NCT00371839|50002670|FG001|Overall Study|Withdrawal by Subject|4|||
24908557|NCT00371839|50002671|FG002|Overall Study|Withdrawal by Subject|0|||
24908558|NCT00371839|50002669|FG000|Overall Study|Lost to Follow-up|6|||
24908559|NCT00371839|50002670|FG001|Overall Study|Lost to Follow-up|3|||
24908560|NCT00371839|50002671|FG002|Overall Study|Lost to Follow-up|2|||
24908561|NCT00682890|50002679|FG000|Overall Study|Lost to Follow-up|1|||
24908562|NCT00682890|50002680|FG001|Overall Study|Lost to Follow-up|1|||
24908563|NCT00682890|50002679|FG000|Overall Study|subject moved away|0|||
24908564|NCT00682890|50002680|FG001|Overall Study|subject moved away|1|||
24908565|NCT00682890|50002679|FG000|Overall Study|heavy menstrual bleeding|1|||
24908566|NCT00682890|50002680|FG001|Overall Study|heavy menstrual bleeding|0|||
24908567|NCT00385723|50002689|FG000|Overall Study|Lost to Follow-up|1|||
24908568|NCT00385723|50002690|FG001|Overall Study|Lost to Follow-up|1|||
24908569|NCT00385723|50002691|FG002|Overall Study|Lost to Follow-up|0|||
24908570|NCT00385723|50002689|FG000|Overall Study|Withdrawal by Subject|1|||
24908571|NCT00385723|50002690|FG001|Overall Study|Withdrawal by Subject|0|||
24908572|NCT00385723|50002691|FG002|Overall Study|Withdrawal by Subject|2|||
24908573|NCT00698516|50002699|FG000|Overall Study|Study Termination|2|||
24908574|NCT00698516|50002699|FG000|Overall Study|Withdrawal by Subject|3|||
24908575|NCT00679302|50002709|FG000|Overall Study|Lost to Follow-up|8|||
24908576|NCT00679302|50002710|FG001|Overall Study|Lost to Follow-up|4|||
24908577|NCT00690482|50002739|FG000|Overall Study|Adverse Event|2|||
24908578|NCT00690482|50002740|FG001|Overall Study|Adverse Event|1|||
24908579|NCT00690482|50002739|FG000|Overall Study|Incorrect enrolment|0|||
24908580|NCT00690482|50002740|FG001|Overall Study|Incorrect enrolment|1|||
24908581|NCT00690482|50002739|FG000|Overall Study|Study-specific discontinuation criteria|1|||
24908582|NCT00690482|50002740|FG001|Overall Study|Study-specific discontinuation criteria|0|||
24908583|NCT00690482|50002739|FG000|Overall Study|Intake of prohibited medicine|1|||
24908584|NCT00690482|50002740|FG001|Overall Study|Intake of prohibited medicine|0|||
24908585|NCT00690482|50002739|FG000|Overall Study|withdrew consent at rand.day|0|||
24908586|NCT00690482|50002740|FG001|Overall Study|withdrew consent at rand.day|1|||
24908587|NCT00385255|50002748|FG000|Overall Study|Serious Adverse Event|1|||
24908588|NCT00385255|50002749|FG001|Overall Study|Serious Adverse Event|2|||
24908589|NCT00385255|50002748|FG000|Overall Study|Protocol Violation|0|||
24908590|NCT00385255|50002749|FG001|Overall Study|Protocol Violation|4|||
24908591|NCT00385255|50002748|FG000|Overall Study|Withdrawal by Subject|0|||
24908592|NCT00385255|50002749|FG001|Overall Study|Withdrawal by Subject|8|||
24908593|NCT00385255|50002748|FG000|Overall Study|Migrated/moved from study area|0|||
24908594|NCT00385255|50002749|FG001|Overall Study|Migrated/moved from study area|1|||
24908595|NCT00385255|50002748|FG000|Overall Study|Lost to Follow-up|20|||
24908596|NCT00385255|50002749|FG001|Overall Study|Lost to Follow-up|58|||
24908597|NCT00571662|50002759|FG000|Overall Study|Withdrawal by Subject|2|||
24908598|NCT00571662|50002759|FG000|Overall Study|psychiatric instability|1|||
24908599|NCT00571662|50002759|FG000|Overall Study|Adverse Event|5|||
24908600|NCT00698204|50002767|FG000|Overall Study|Withdrawal by Subject|1|||
24908601|NCT00698204|50002768|FG001|Overall Study|Withdrawal by Subject|0|||
24908602|NCT00549718|50002780|FG000|Overall Study|Insufficient clinical response|20|||
24908603|NCT00549718|50002781|FG001|Overall Study|Insufficient clinical response|7|||
25018692|NCT03214380|50114310|FG000|Lead-in|Family Emergency|1|||
24908604|NCT00549718|50002782|FG002|Overall Study|Insufficient clinical response|18|||
24908605|NCT00549718|50002783|FG003|Overall Study|Insufficient clinical response|32|||
24908606|NCT00549718|50002780|FG000|Overall Study|Adverse Event|6|||
24908607|NCT00549718|50002781|FG001|Overall Study|Adverse Event|8|||
24908608|NCT00549718|50002782|FG002|Overall Study|Adverse Event|7|||
24908609|NCT00549718|50002783|FG003|Overall Study|Adverse Event|3|||
24908610|NCT00549718|50002780|FG000|Overall Study|Lost to Follow-up|4|||
24908611|NCT00549718|50002781|FG001|Overall Study|Lost to Follow-up|2|||
24908612|NCT00549718|50002782|FG002|Overall Study|Lost to Follow-up|0|||
24908613|NCT00549718|50002783|FG003|Overall Study|Lost to Follow-up|6|||
24908614|NCT00549718|50002780|FG000|Overall Study|Withdrawal by Subject|9|||
24908615|NCT00549718|50002781|FG001|Overall Study|Withdrawal by Subject|18|||
24908616|NCT00549718|50002782|FG002|Overall Study|Withdrawal by Subject|12|||
24908617|NCT00549718|50002783|FG003|Overall Study|Withdrawal by Subject|13|||
25152739|NCT01616953|50267841|FG001|Overall Study|Lost to Follow-up|0|||
25152740|NCT01616953|50267840|FG000|Overall Study|lack of bone and soft tissue|1|||
25152741|NCT01616953|50267841|FG001|Overall Study|lack of bone and soft tissue|0|||
25152742|NCT01867658|50267847|FG000|Overall Study|Withdrawal by Subject|6|||
25152743|NCT01867658|50267847|FG000|Overall Study|Death|2|||
25152744|NCT01867658|50267847|FG000|Overall Study|Subject could not be contacted|1|||
25152745|NCT01867580|50267853|FG000|Overall Study|Withdrawal by Subject|2|||
24908618|NCT00549718|50002780|FG000|Overall Study|Administrative|2|||
24908619|NCT00549718|50002781|FG001|Overall Study|Administrative|2|||
24908620|NCT00549718|50002782|FG002|Overall Study|Administrative|2|||
25018693|NCT03214380|50114311|FG001|Lead-in|Family Emergency|0|||
25018694|NCT03214380|50114312|FG002|Lead-in|Family Emergency|0|||
25018695|NCT03214380|50114313|FG003|Lead-in|Family Emergency|0|||
25018696|NCT03214380|50114314|FG004|Lead-in|Family Emergency|0|||
25018697|NCT03214380|50114315|FG005|Lead-in|Family Emergency|0|||
25018698|NCT03214380|50114310|FG000|Lead-in|Natural Disaster|9|||
25018699|NCT03214380|50114311|FG001|Lead-in|Natural Disaster|0|||
25018700|NCT03214380|50114312|FG002|Lead-in|Natural Disaster|0|||
25018701|NCT03214380|50114313|FG003|Lead-in|Natural Disaster|0|||
25018702|NCT03214380|50114314|FG004|Lead-in|Natural Disaster|0|||
25018703|NCT03214380|50114315|FG005|Lead-in|Natural Disaster|0|||
25018704|NCT03214380|50114310|FG000|Lead-in|Non Compliance|1|||
25018705|NCT03214380|50114311|FG001|Lead-in|Non Compliance|0|||
25018706|NCT03214380|50114312|FG002|Lead-in|Non Compliance|0|||
25018707|NCT03214380|50114313|FG003|Lead-in|Non Compliance|0|||
25018708|NCT03214380|50114314|FG004|Lead-in|Non Compliance|0|||
25018709|NCT03214380|50114315|FG005|Lead-in|Non Compliance|0|||
25018710|NCT03214380|50114310|FG000|Lead-in|Participant Schedule|2|||
25018711|NCT03214380|50114311|FG001|Lead-in|Participant Schedule|0|||
25018712|NCT03214380|50114312|FG002|Lead-in|Participant Schedule|0|||
25018713|NCT03214380|50114313|FG003|Lead-in|Participant Schedule|0|||
25018714|NCT03214380|50114314|FG004|Lead-in|Participant Schedule|0|||
25018715|NCT03214380|50114315|FG005|Lead-in|Participant Schedule|0|||
25018716|NCT03214380|50114310|FG000|Treatment Period|Adverse Event|0|||
24908621|NCT00549718|50002783|FG003|Overall Study|Administrative|1|||
25018717|NCT03214380|50114311|FG001|Treatment Period|Adverse Event|1|||
25018718|NCT03214380|50114312|FG002|Treatment Period|Adverse Event|1|||
25018719|NCT03214380|50114313|FG003|Treatment Period|Adverse Event|0|||
25018720|NCT03214380|50114314|FG004|Treatment Period|Adverse Event|1|||
25018721|NCT03214380|50114315|FG005|Treatment Period|Adverse Event|0|||
25018722|NCT03214380|50114310|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
25018723|NCT03214380|50114311|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
25018724|NCT03214380|50114312|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
25018725|NCT03214380|50114313|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
25018726|NCT03214380|50114314|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
25018727|NCT03214380|50114315|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
25018728|NCT03214380|50114310|FG000|Treatment Period|Withdrawal by Subject|0|||
25152746|NCT01867580|50267854|FG001|Overall Study|Withdrawal by Subject|3|||
25152747|NCT01867580|50267853|FG000|Overall Study|Physician Decision|17|||
25152748|NCT01867580|50267854|FG001|Overall Study|Physician Decision|12|||
24908622|NCT00371761|50002795|FG000|Overall Study|Adverse Event|1|||
25018729|NCT03214380|50114311|FG001|Treatment Period|Withdrawal by Subject|10|||
25018730|NCT03214380|50114312|FG002|Treatment Period|Withdrawal by Subject|8|||
25018731|NCT03214380|50114313|FG003|Treatment Period|Withdrawal by Subject|0|||
25018732|NCT03214380|50114314|FG004|Treatment Period|Withdrawal by Subject|7|||
25018733|NCT03214380|50114315|FG005|Treatment Period|Withdrawal by Subject|11|||
24908623|NCT00371761|50002796|FG001|Overall Study|Adverse Event|1|||
24908624|NCT00371761|50002795|FG000|Overall Study|Withdrawal by Subject|1|||
24908625|NCT00371761|50002796|FG001|Overall Study|Withdrawal by Subject|3|||
24908626|NCT00371761|50002795|FG000|Overall Study|Investigator Judgment|2|||
24908627|NCT00371761|50002796|FG001|Overall Study|Investigator Judgment|3|||
24908628|NCT00371761|50002795|FG000|Overall Study|Study termination|4|||
24908629|NCT00371761|50002796|FG001|Overall Study|Study termination|3|||
24908630|NCT00549640|50002804|FG000|Overall Study|Withdrawal by Subject|6|||
24908631|NCT00549640|50002805|FG001|Overall Study|Withdrawal by Subject|12|||
24908632|NCT00549640|50002804|FG000|Overall Study|Adverse Event|5|||
24908633|NCT00549640|50002805|FG001|Overall Study|Adverse Event|0|||
24908634|NCT00549640|50002804|FG000|Overall Study|Lost to Follow-up|7|||
24908635|NCT00549640|50002805|FG001|Overall Study|Lost to Follow-up|4|||
24908636|NCT00549562|50002827|FG000|Overall Study|Adverse Event|1|||
24908637|NCT00549562|50002827|FG000|Overall Study|Lack of Efficacy|1|||
24908638|NCT00681564|50002833|FG000|Overall Study|Lost to Follow-up|6|||
24908639|NCT00681564|50002834|FG001|Overall Study|Lost to Follow-up|6|||
24908640|NCT00681564|50002833|FG000|Overall Study|Withdrawal by Subject|0|||
24908641|NCT00681564|50002834|FG001|Overall Study|Withdrawal by Subject|1|||
25018734|NCT03214380|50114310|FG000|Treatment Period|Death|0|||
25018735|NCT03214380|50114311|FG001|Treatment Period|Death|1|||
25274811|NCT00909727|50588869|FG000|Overall Study|Withdrawal of Consent|1|||
24908642|NCT00681564|50002833|FG000|Overall Study|Death|0|||
24908643|NCT00681564|50002834|FG001|Overall Study|Death|1|||
24908644|NCT00677352|50002842|FG000|Treatment Phase|Adverse Event|14|||
24908645|NCT00677352|50002843|FG001|Treatment Phase|Adverse Event|22|||
24908646|NCT00677352|50002842|FG000|Treatment Phase|Lack of Efficacy|2|||
24908647|NCT00677352|50002843|FG001|Treatment Phase|Lack of Efficacy|3|||
24908648|NCT00677352|50002842|FG000|Treatment Phase|Lost to Follow-up|0|||
24908649|NCT00677352|50002843|FG001|Treatment Phase|Lost to Follow-up|1|||
24908650|NCT00677352|50002842|FG000|Treatment Phase|Withdrawal by Subject|7|||
24908651|NCT00677352|50002843|FG001|Treatment Phase|Withdrawal by Subject|7|||
24908652|NCT00677352|50002842|FG000|Treatment Phase|Physician Decision|1|||
24908653|NCT00677352|50002843|FG001|Treatment Phase|Physician Decision|0|||
24908654|NCT00677352|50002842|FG000|Treatment Phase|Pregnancy|0|||
24908655|NCT00677352|50002843|FG001|Treatment Phase|Pregnancy|1|||
24908656|NCT00677352|50002842|FG000|Treatment Phase|Protocol Violation|1|||
24908657|NCT00677352|50002843|FG001|Treatment Phase|Protocol Violation|1|||
24908658|NCT00677352|50002842|FG000|Treatment Phase|Transference or work related matter|0|||
24908659|NCT00677352|50002843|FG001|Treatment Phase|Transference or work related matter|5|||
24908660|NCT00677352|50002842|FG000|Treatment Phase|Not treated|0|||
24908661|NCT00677352|50002843|FG001|Treatment Phase|Not treated|2|||
24908662|NCT00677352|50002842|FG000|Tapering Phase|Adverse Event|1|||
24908663|NCT00677352|50002843|FG001|Tapering Phase|Adverse Event|5|||
24908664|NCT00677352|50002842|FG000|Tapering Phase|Withdrawal by Subject|5|||
24908665|NCT00677352|50002843|FG001|Tapering Phase|Withdrawal by Subject|3|||
24908666|NCT00677352|50002842|FG000|Tapering Phase|Pregnancy|0|||
24908667|NCT00677352|50002843|FG001|Tapering Phase|Pregnancy|1|||
25018736|NCT03214380|50114312|FG002|Treatment Period|Death|2|||
24908668|NCT00677352|50002842|FG000|Tapering Phase|Job transfer|0|||
24908669|NCT00677352|50002843|FG001|Tapering Phase|Job transfer|1|||
24908670|NCT00371683|50002856|FG000|DB Treatment Period-Randomized Patients|Death|1|||
24908671|NCT00371683|50002857|FG001|DB Treatment Period-Randomized Patients|Death|1|||
24908672|NCT00371683|50002856|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
24908673|NCT00371683|50002857|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
24908674|NCT00371683|50002856|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
24908675|NCT00371683|50002857|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
24908676|NCT00371683|50002856|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
24908677|NCT00371683|50002857|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
24908678|NCT00371683|50002856|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
24908679|NCT00371683|50002857|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
25018737|NCT03214380|50114313|FG003|Treatment Period|Death|0|||
24908680|NCT00371683|50002856|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
24908681|NCT00371683|50002857|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
24908682|NCT00371683|50002856|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
24908683|NCT00371683|50002857|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
24908684|NCT00371683|50002856|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
24908685|NCT00371683|50002857|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
24908686|NCT00371683|50002856|FG000|Follow-Up Period - Randomized Patients|Death|0|||
24908687|NCT00371683|50002857|FG001|Follow-Up Period - Randomized Patients|Death|2|||
24908688|NCT00371683|50002856|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
24908689|NCT00371683|50002857|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
24908690|NCT00371683|50002856|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
24908691|NCT00371683|50002857|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
24908692|NCT03951766|50002873|FG000|Treatment Phase|Lost to Follow-up|1|||
24908693|NCT03951766|50002873|FG000|Follow-up Phase|Lost to Follow-up|10|||
24908694|NCT00371137|50002882|FG000|Overall Study|Adverse Event|20|||
24908695|NCT00371137|50002883|FG001|Overall Study|Adverse Event|35|||
24908696|NCT00371137|50002884|FG002|Overall Study|Adverse Event|42|||
24908697|NCT00371137|50002882|FG000|Overall Study|Withdrawal by Subject|11|||
24908698|NCT00371137|50002883|FG001|Overall Study|Withdrawal by Subject|10|||
24908699|NCT00371137|50002884|FG002|Overall Study|Withdrawal by Subject|15|||
24908700|NCT00371137|50002882|FG000|Overall Study|Lost to Follow-up|6|||
24908701|NCT00371137|50002883|FG001|Overall Study|Lost to Follow-up|3|||
24908702|NCT00371137|50002884|FG002|Overall Study|Lost to Follow-up|5|||
24908703|NCT00371137|50002882|FG000|Overall Study|Lack of Efficacy|30|||
24908704|NCT00371137|50002883|FG001|Overall Study|Lack of Efficacy|12|||
24908705|NCT00371137|50002884|FG002|Overall Study|Lack of Efficacy|13|||
24908706|NCT00371137|50002882|FG000|Overall Study|Sponsor Decision|2|||
24908707|NCT00371137|50002883|FG001|Overall Study|Sponsor Decision|1|||
24908708|NCT00371137|50002884|FG002|Overall Study|Sponsor Decision|2|||
24908709|NCT00371137|50002882|FG000|Overall Study|Physician Decision|1|||
24908710|NCT00371137|50002883|FG001|Overall Study|Physician Decision|1|||
24908711|NCT00371137|50002884|FG002|Overall Study|Physician Decision|1|||
24908712|NCT00371137|50002882|FG000|Overall Study|Protocol Violation|2|||
24908713|NCT00371137|50002883|FG001|Overall Study|Protocol Violation|1|||
24908714|NCT00371137|50002884|FG002|Overall Study|Protocol Violation|1|||
24908715|NCT00616239|50002892|FG000|Overall Study|Withdrawal by Subject|2|||
24908716|NCT00547534|50002896|FG000|Overall Study|Adverse Event|7|||
24908717|NCT00547534|50002896|FG000|Overall Study|Disease Progression|4|||
25018738|NCT03214380|50114314|FG004|Treatment Period|Death|0|||
25018739|NCT03214380|50114315|FG005|Treatment Period|Death|0|||
25018740|NCT03214380|50114310|FG000|Treatment Period|Lost to Follow-up|0|||
25018741|NCT03214380|50114311|FG001|Treatment Period|Lost to Follow-up|6|||
25018742|NCT03214380|50114312|FG002|Treatment Period|Lost to Follow-up|3|||
25018743|NCT03214380|50114313|FG003|Treatment Period|Lost to Follow-up|0|||
25018744|NCT03214380|50114314|FG004|Treatment Period|Lost to Follow-up|0|||
25018745|NCT03214380|50114315|FG005|Treatment Period|Lost to Follow-up|0|||
25018746|NCT03214380|50114310|FG000|Treatment Period|Participant schedule|0|||
25018747|NCT03214380|50114311|FG001|Treatment Period|Participant schedule|0|||
25018748|NCT03214380|50114312|FG002|Treatment Period|Participant schedule|1|||
25018749|NCT03214380|50114313|FG003|Treatment Period|Participant schedule|0|||
25152749|NCT01867580|50267853|FG000|Overall Study|Lost to Follow-up|3|||
25152750|NCT01867580|50267854|FG001|Overall Study|Lost to Follow-up|5|||
24908718|NCT00384397|50002904|FG000|Overall Study|Adverse Event|0|||
24908719|NCT00384397|50002905|FG001|Overall Study|Adverse Event|1|||
25152751|NCT01867580|50267853|FG000|Overall Study|Sponsor terminated study|1|||
24908720|NCT00384397|50002906|FG002|Overall Study|Adverse Event|2|||
24908721|NCT00384397|50002904|FG000|Overall Study|Protocol Violation|7|||
24908722|NCT00384397|50002905|FG001|Overall Study|Protocol Violation|15|||
24908723|NCT00384397|50002906|FG002|Overall Study|Protocol Violation|13|||
24908724|NCT00384397|50002904|FG000|Overall Study|Lost to Follow-up|11|||
24908725|NCT00384397|50002905|FG001|Overall Study|Lost to Follow-up|13|||
25018750|NCT03214380|50114314|FG004|Treatment Period|Participant schedule|0|||
25018751|NCT03214380|50114315|FG005|Treatment Period|Participant schedule|0|||
25018752|NCT03214380|50114310|FG000|Treatment Period|Treatment Interruption|0|||
25018753|NCT03214380|50114311|FG001|Treatment Period|Treatment Interruption|0|||
24908726|NCT00384397|50002906|FG002|Overall Study|Lost to Follow-up|3|||
24908727|NCT00384397|50002904|FG000|Overall Study|Withdrawal by Subject|14|||
24908728|NCT00384397|50002905|FG001|Overall Study|Withdrawal by Subject|17|||
24908729|NCT00384397|50002906|FG002|Overall Study|Withdrawal by Subject|15|||
24908730|NCT00384085|50002917|FG000|Overall Study|Adverse Event|5|||
24908731|NCT00384085|50002918|FG001|Overall Study|Adverse Event|5|||
24908732|NCT00384085|50002919|FG002|Overall Study|Adverse Event|4|||
24908733|NCT00384085|50002917|FG000|Overall Study|Lack of Efficacy|0|||
24908734|NCT00384085|50002918|FG001|Overall Study|Lack of Efficacy|3|||
24908735|NCT00384085|50002919|FG002|Overall Study|Lack of Efficacy|2|||
24908736|NCT00384085|50002917|FG000|Overall Study|No longer Requires Study Treatment|1|||
24908737|NCT00384085|50002918|FG001|Overall Study|No longer Requires Study Treatment|0|||
24908738|NCT00384085|50002919|FG002|Overall Study|No longer Requires Study Treatment|1|||
24908739|NCT00384085|50002917|FG000|Overall Study|Protocol Violation|2|||
24908740|NCT00384085|50002918|FG001|Overall Study|Protocol Violation|2|||
24908741|NCT00384085|50002919|FG002|Overall Study|Protocol Violation|2|||
24908742|NCT00384085|50002917|FG000|Overall Study|Lost to Follow-up|9|||
24908743|NCT00384085|50002918|FG001|Overall Study|Lost to Follow-up|9|||
24908744|NCT00384085|50002919|FG002|Overall Study|Lost to Follow-up|10|||
24908745|NCT00384085|50002917|FG000|Overall Study|Progressive Disease|0|||
24908746|NCT00384085|50002918|FG001|Overall Study|Progressive Disease|1|||
24908747|NCT00384085|50002919|FG002|Overall Study|Progressive Disease|0|||
24908748|NCT00384085|50002917|FG000|Overall Study|Withdrawal by Subject|14|||
24908749|NCT00384085|50002918|FG001|Overall Study|Withdrawal by Subject|19|||
24908750|NCT00384085|50002919|FG002|Overall Study|Withdrawal by Subject|29|||
24908751|NCT00384085|50002917|FG000|Overall Study|Patient non-compliant|4|||
24908752|NCT00384085|50002918|FG001|Overall Study|Patient non-compliant|4|||
24908753|NCT00384085|50002919|FG002|Overall Study|Patient non-compliant|5|||
24908754|NCT00384085|50002917|FG000|Overall Study|Physician Decision|1|||
24908755|NCT00384085|50002918|FG001|Overall Study|Physician Decision|0|||
24908756|NCT00384085|50002919|FG002|Overall Study|Physician Decision|0|||
24908757|NCT00384085|50002917|FG000|Overall Study|Loss of site personnel|1|||
24908758|NCT00384085|50002918|FG001|Overall Study|Loss of site personnel|0|||
24908759|NCT00384085|50002919|FG002|Overall Study|Loss of site personnel|1|||
24908760|NCT00384085|50002917|FG000|Overall Study|Sponsor decision|1|||
24908761|NCT00384085|50002918|FG001|Overall Study|Sponsor decision|2|||
24908762|NCT00384085|50002919|FG002|Overall Study|Sponsor decision|1|||
24908763|NCT00384085|50002917|FG000|Overall Study|Patient moved|1|||
24908764|NCT00384085|50002918|FG001|Overall Study|Patient moved|0|||
24908765|NCT00384085|50002919|FG002|Overall Study|Patient moved|1|||
24908766|NCT00384085|50002917|FG000|Overall Study|Patient required surgery|0|||
24908767|NCT00384085|50002918|FG001|Overall Study|Patient required surgery|1|||
24908768|NCT00384085|50002919|FG002|Overall Study|Patient required surgery|0|||
24908769|NCT00361231|50002929|FG000|Overall Study|Physician Decision|3|||
24908770|NCT00361231|50002929|FG000|Overall Study|Symptomatic deterioration|5|||
24908771|NCT00361231|50002929|FG000|Overall Study|Radiographic disease progression|16|||
24908772|NCT00361231|50002929|FG000|Overall Study|Withdrawal by Subject|4|||
24908773|NCT00361231|50002929|FG000|Overall Study|Adverse Event|6|||
24908774|NCT00676650|50002935|FG000|Overall Study|Death|45|||
24908775|NCT00676650|50002936|FG001|Overall Study|Death|14|||
25152752|NCT01867580|50267854|FG001|Overall Study|Sponsor terminated study|0|||
25152753|NCT01867580|50267853|FG000|Overall Study|Missed follow-up assessment|2|||
25152754|NCT01867580|50267854|FG001|Overall Study|Missed follow-up assessment|1|||
25152755|NCT01867580|50267853|FG000|Overall Study|Interruption to therapy|3|||
25152756|NCT01867580|50267854|FG001|Overall Study|Interruption to therapy|0|||
25152757|NCT01867580|50267853|FG000|Overall Study|Osteomyelitis|0|||
25152758|NCT01867580|50267854|FG001|Overall Study|Osteomyelitis|1|||
25152759|NCT01867580|50267853|FG000|Overall Study|Continuation of therapy|0|||
25152760|NCT01867580|50267854|FG001|Overall Study|Continuation of therapy|1|||
25152761|NCT01867580|50267853|FG000|Overall Study|Wound recurrence|0|||
25152762|NCT01867580|50267854|FG001|Overall Study|Wound recurrence|1|||
25152763|NCT01839656|50267868|FG000|Overall Study|Withdrawal by Subject|1|||
25152764|NCT01839656|50267869|FG001|Overall Study|Withdrawal by Subject|1|||
25152765|NCT01839656|50267868|FG000|Overall Study|Adverse event, serious fatal|1|||
25152766|NCT01839656|50267869|FG001|Overall Study|Adverse event, serious fatal|4|||
25152767|NCT01839656|50267868|FG000|Overall Study|Early study closure|0|||
25152768|NCT01839656|50267869|FG001|Overall Study|Early study closure|11|||
25152769|NCT01839656|50267868|FG000|Overall Study|Adverse Event|1|||
24908776|NCT00676650|50002935|FG000|Overall Study|Adverse Event|159|||
24908777|NCT00676650|50002936|FG001|Overall Study|Adverse Event|21|||
24908778|NCT00676650|50002935|FG000|Overall Study|Global deterioration of health status|66|||
24908779|NCT00676650|50002936|FG001|Overall Study|Global deterioration of health status|31|||
24908780|NCT00676650|50002935|FG000|Overall Study|Lost to Follow-up|0|||
25152770|NCT01839656|50267869|FG001|Overall Study|Adverse Event|0|||
24908781|NCT00676650|50002936|FG001|Overall Study|Lost to Follow-up|1|||
25018754|NCT03214380|50114312|FG002|Treatment Period|Treatment Interruption|1|||
25184907|NCT01362348|50333861|FG000|Overall Study|Protocol-defined stopping criteria|9|||
25184908|NCT01362348|50333861|FG000|Overall Study|Study closed/terminated|5|||
25184909|NCT01675128|50333931|FG000|Overall Study|Disease progression on study|1|||
25184910|NCT01675128|50333932|FG001|Overall Study|Disease progression on study|1|||
25184911|NCT01675128|50333933|FG002|Overall Study|Disease progression on study|1|||
25184912|NCT01675128|50333931|FG000|Overall Study|Refused further treatment|1|||
24908782|NCT00676650|50002935|FG000|Overall Study|Objective progression or relapse|189|||
24908783|NCT00676650|50002936|FG001|Overall Study|Objective progression or relapse|140|||
24908784|NCT00676650|50002935|FG000|Overall Study|Other|14|||
24908785|NCT00676650|50002936|FG001|Overall Study|Other|10|||
24908786|NCT00676650|50002935|FG000|Overall Study|Protocol Violation|3|||
24908787|NCT00676650|50002936|FG001|Overall Study|Protocol Violation|1|||
24908788|NCT00676650|50002935|FG000|Overall Study|Study terminated by sponsor|57|||
24908789|NCT00676650|50002936|FG001|Overall Study|Study terminated by sponsor|43|||
24908790|NCT00676650|50002935|FG000|Overall Study|Withdrawal by Subject|48|||
24908791|NCT00676650|50002936|FG001|Overall Study|Withdrawal by Subject|24|||
24908792|NCT00676650|50002935|FG000|Overall Study|Randomized but not treated|3|||
24908793|NCT00676650|50002936|FG001|Overall Study|Randomized but not treated|4|||
24908794|NCT00573183|50002944|FG000|Overall Study|Lost to Follow-up|52|||
24908795|NCT00573183|50002945|FG001|Overall Study|Lost to Follow-up|50|||
24908796|NCT00573183|50002944|FG000|Overall Study|Withdrawal by Subject|8|||
24908797|NCT00573183|50002945|FG001|Overall Study|Withdrawal by Subject|2|||
24908798|NCT00573183|50002944|FG000|Overall Study|Death|0|||
24908799|NCT00573183|50002945|FG001|Overall Study|Death|1|||
24908800|NCT00573183|50002944|FG000|Overall Study|Adverse Event|2|||
24908801|NCT00573183|50002945|FG001|Overall Study|Adverse Event|0|||
24908802|NCT00573183|50002944|FG000|Overall Study|Incarceration|5|||
24908803|NCT00573183|50002945|FG001|Overall Study|Incarceration|8|||
24908804|NCT00573183|50002944|FG000|Overall Study|Other|5|||
24908805|NCT00573183|50002945|FG001|Overall Study|Other|2|||
24908806|NCT00615459|50002953|FG000|Period I|Adverse Event|2|||
24908807|NCT00615459|50002954|FG001|Period I|Adverse Event|0|||
24908808|NCT00615459|50002955|FG002|Period I|Adverse Event|1|||
24908809|NCT00615459|50002956|FG003|Period I|Adverse Event|0|||
24908810|NCT00615459|50002953|FG000|Period I|Subject withdrew consent|1|||
24908811|NCT00615459|50002954|FG001|Period I|Subject withdrew consent|0|||
24908812|NCT00615459|50002955|FG002|Period I|Subject withdrew consent|0|||
24908813|NCT00615459|50002956|FG003|Period I|Subject withdrew consent|1|||
24908814|NCT00615459|50002953|FG000|Period I|Abnormal test procedure results|1|||
25152771|NCT01839188|50267875|FG000|Overall Study|Withdrawal by Subject|1|||
25152772|NCT01838876|50267884|FG000|Overall Study|Adverse Event|49|||
25152773|NCT01838876|50267884|FG000|Overall Study|Insufficient Therapeutic Response|10|||
25152774|NCT01838876|50267884|FG000|Overall Study|Protocol Violation|34|||
25152775|NCT01838876|50267884|FG000|Overall Study|Withdrawal of Consent|33|||
25152776|NCT01838876|50267884|FG000|Overall Study|Lost to Follow-up|21|||
25152777|NCT01838876|50267884|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
25152778|NCT01838876|50267884|FG000|Overall Study|Reason not Specified|7|||
25152779|NCT01838876|50267884|FG000|Overall Study|Did not meet eligibility criteria|78|||
25152780|NCT01838642|50267899|FG000|Overall Study|Died on study|1|||
25152781|NCT01611194|50267906|FG000|Overall Study|Lost to Follow-up|0|||
25152782|NCT01611194|50267907|FG001|Overall Study|Lost to Follow-up|1|||
25152783|NCT01611194|50267906|FG000|Overall Study|Withdrawal by Subject|0|||
25152784|NCT01611194|50267907|FG001|Overall Study|Withdrawal by Subject|1|||
25152785|NCT01611194|50267906|FG000|Overall Study|drug use|0|||
25152786|NCT01611194|50267907|FG001|Overall Study|drug use|1|||
25152787|NCT01813058|50267915|FG000|Overall Study|Withdrawal by Subject|5|||
25184913|NCT01675128|50333932|FG001|Overall Study|Refused further treatment|0|||
25184914|NCT01675128|50333933|FG002|Overall Study|Refused further treatment|0|||
24908815|NCT00615459|50002954|FG001|Period I|Abnormal test procedure results|1|||
24908816|NCT00615459|50002955|FG002|Period I|Abnormal test procedure results|1|||
24908817|NCT00615459|50002956|FG003|Period I|Abnormal test procedure results|0|||
24908818|NCT00615459|50002953|FG000|Period II|Adverse Event|1|||
24908819|NCT00615459|50002954|FG001|Period II|Adverse Event|0|||
24908820|NCT00615459|50002955|FG002|Period II|Adverse Event|0|||
25152788|NCT01813058|50267916|FG001|Overall Study|Withdrawal by Subject|4|||
24908821|NCT00615459|50002956|FG003|Period II|Adverse Event|0|||
24908822|NCT00615459|50002953|FG000|Period II|Lost to Follow-up|0|||
24908823|NCT00615459|50002954|FG001|Period II|Lost to Follow-up|0|||
25018755|NCT03214380|50114313|FG003|Treatment Period|Treatment Interruption|0|||
25018756|NCT03214380|50114314|FG004|Treatment Period|Treatment Interruption|0|||
25018757|NCT03214380|50114315|FG005|Treatment Period|Treatment Interruption|0|||
25018758|NCT02674464|50114329|FG000|Overall Study|Death|10|||
25018759|NCT02674464|50114330|FG001|Overall Study|Death|21|||
25018760|NCT02674464|50114329|FG000|Overall Study|Withdrawal by Subject|24|||
25018761|NCT02674464|50114330|FG001|Overall Study|Withdrawal by Subject|44|||
25018762|NCT02674464|50114329|FG000|Overall Study|Lost to Follow-up|97|||
25018763|NCT02674464|50114330|FG001|Overall Study|Lost to Follow-up|92|||
25018764|NCT02674464|50114329|FG000|Overall Study|Outside survey window|6|||
25018765|NCT02674464|50114330|FG001|Overall Study|Outside survey window|3|||
25018766|NCT03172026|50114338|FG000|Overall Study|Withdrawal by Subject|1|||
25018767|NCT03172026|50114339|FG001|Overall Study|Withdrawal by Subject|0|||
25018768|NCT03172026|50114338|FG000|Overall Study|COVID restrictions|1|||
25018769|NCT03172026|50114339|FG001|Overall Study|COVID restrictions|0|||
25018770|NCT01343888|50114349|FG000|Overall Study|Adverse Event|12|||
25018771|NCT01343888|50114350|FG001|Overall Study|Adverse Event|22|||
25018772|NCT01343888|50114351|FG002|Overall Study|Adverse Event|5|||
25018773|NCT01343888|50114349|FG000|Overall Study|Lack of Efficacy|9|||
25018774|NCT01343888|50114350|FG001|Overall Study|Lack of Efficacy|9|||
25018775|NCT01343888|50114351|FG002|Overall Study|Lack of Efficacy|13|||
25018776|NCT01343888|50114349|FG000|Overall Study|Lost to Follow-up|0|||
25018777|NCT01343888|50114350|FG001|Overall Study|Lost to Follow-up|2|||
25018778|NCT01343888|50114351|FG002|Overall Study|Lost to Follow-up|1|||
25018779|NCT01343888|50114349|FG000|Overall Study|Protocol Violation|0|||
25018780|NCT01343888|50114350|FG001|Overall Study|Protocol Violation|2|||
25018781|NCT01343888|50114351|FG002|Overall Study|Protocol Violation|0|||
25018782|NCT01343888|50114349|FG000|Overall Study|Withdrawal by Subject|4|||
25018783|NCT01343888|50114350|FG001|Overall Study|Withdrawal by Subject|4|||
25018784|NCT01343888|50114351|FG002|Overall Study|Withdrawal by Subject|2|||
25018785|NCT01343888|50114349|FG000|Overall Study|other than stated above|0|||
25018786|NCT01343888|50114350|FG001|Overall Study|other than stated above|0|||
24908824|NCT00615459|50002955|FG002|Period II|Lost to Follow-up|0|||
24908825|NCT00615459|50002956|FG003|Period II|Lost to Follow-up|1|||
24908826|NCT00615459|50002953|FG000|Period III|Adverse Event|0|||
24908827|NCT00615459|50002954|FG001|Period III|Adverse Event|1|||
25018787|NCT01343888|50114351|FG002|Overall Study|other than stated above|1|||
25018788|NCT03589807|50114365|FG000|Overall Study|Lost to Follow-up|0|||
25018789|NCT03589807|50114366|FG001|Overall Study|Lost to Follow-up|2|||
25018790|NCT03589807|50114367|FG002|Overall Study|Lost to Follow-up|2|||
25018791|NCT03589807|50114368|FG003|Overall Study|Lost to Follow-up|3|||
24908828|NCT00615459|50002955|FG002|Period III|Adverse Event|0|||
24908829|NCT00615459|50002956|FG003|Period III|Adverse Event|0|||
24908830|NCT00615459|50002953|FG000|Period III|Administrative problems|0|||
24908831|NCT00615459|50002954|FG001|Period III|Administrative problems|1|||
24908832|NCT00615459|50002955|FG002|Period III|Administrative problems|1|||
24908833|NCT00615459|50002956|FG003|Period III|Administrative problems|0|||
24908834|NCT00615459|50002953|FG000|Period III|Unsatisfactory therapeutic effect|0|||
24908835|NCT00615459|50002954|FG001|Period III|Unsatisfactory therapeutic effect|1|||
24908836|NCT00615459|50002955|FG002|Period III|Unsatisfactory therapeutic effect|0|||
24908837|NCT00615459|50002956|FG003|Period III|Unsatisfactory therapeutic effect|0|||
24908838|NCT00383149|50002970|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
24908839|NCT00383149|50002970|FG000|Overall Study|Death|2|||
24908840|NCT00383149|50002970|FG000|Overall Study|Disease Progression|38|||
24908841|NCT00383149|50002970|FG000|Overall Study|Lost to Follow-up|1|||
24908842|NCT00383149|50002970|FG000|Overall Study|Other|1|||
24908843|NCT00383149|50002970|FG000|Overall Study|Study Drug Toxicity|4|||
24908844|NCT00383149|50002970|FG000|Overall Study|Request to Discontinue Treatment|4|||
24908845|NCT00383149|50002970|FG000|Overall Study|Participant Withdrew Consent|1|||
25018792|NCT03589807|50114369|FG004|Overall Study|Lost to Follow-up|1|||
25018793|NCT03589807|50114370|FG005|Overall Study|Lost to Follow-up|1|||
25018794|NCT03589807|50114365|FG000|Overall Study|Withdrawal by Subject|0|||
25018795|NCT03589807|50114366|FG001|Overall Study|Withdrawal by Subject|5|||
25018796|NCT03589807|50114367|FG002|Overall Study|Withdrawal by Subject|0|||
25018797|NCT03589807|50114368|FG003|Overall Study|Withdrawal by Subject|0|||
25018798|NCT03589807|50114369|FG004|Overall Study|Withdrawal by Subject|0|||
25018799|NCT03589807|50114370|FG005|Overall Study|Withdrawal by Subject|0|||
24908846|NCT00382993|50002976|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
24908847|NCT00382993|50002977|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
24908848|NCT00382993|50002976|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
24908849|NCT00382993|50002977|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
24908850|NCT00382993|50002976|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
24908851|NCT00382993|50002977|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
24908852|NCT00382993|50002976|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
24908853|NCT00382993|50002977|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
24908854|NCT00382993|50002976|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
24908855|NCT00382993|50002977|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
24908856|NCT00382993|50002976|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
24908857|NCT00382993|50002977|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
24908858|NCT00382993|50002976|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
24908859|NCT00382993|50002977|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
24908860|NCT00382993|50002976|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
24908861|NCT00382993|50002977|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
24908862|NCT00382993|50002976|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
24908863|NCT00382993|50002977|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
24908864|NCT00382993|50002976|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
24908865|NCT00382993|50002977|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
24908866|NCT00369967|50002985|FG000|Overall Study|Lost to Follow-up|23|||
24908867|NCT00369967|50002986|FG001|Overall Study|Lost to Follow-up|12|||
24908868|NCT00616629|50003001|FG000|Overall Study|Protocol Violation|1|||
24908869|NCT00616629|50003002|FG001|Overall Study|Protocol Violation|2|||
24908870|NCT00616629|50003003|FG002|Overall Study|Protocol Violation|1|||
24908871|NCT00616629|50003004|FG003|Overall Study|Protocol Violation|0|||
24908872|NCT00616629|50003005|FG004|Overall Study|Protocol Violation|0|||
24908873|NCT00616629|50003001|FG000|Overall Study|AV-block|1|||
24908874|NCT00616629|50003002|FG001|Overall Study|AV-block|0|||
24908875|NCT00616629|50003003|FG002|Overall Study|AV-block|0|||
24908876|NCT00616629|50003004|FG003|Overall Study|AV-block|0|||
24908877|NCT00616629|50003005|FG004|Overall Study|AV-block|0|||
24908878|NCT00369655|50003017|FG000|Overall Study|Refusal of further treatment|2|||
24908879|NCT00615069|50003021|FG000|Overall Study|Death|10|||
24908880|NCT00615069|50003021|FG000|Overall Study|Physician Decision|2|||
24908881|NCT00615069|50003021|FG000|Overall Study|Withdrawal by Subject|4|||
24908882|NCT00676338|50003029|FG000|Overall Study|Adverse Event|6|||
25018800|NCT03589807|50114365|FG000|Overall Study|Protocol Violation|0|||
25018801|NCT03589807|50114366|FG001|Overall Study|Protocol Violation|0|||
25184915|NCT01675128|50333931|FG000|Overall Study|Pulmonary complication; off study|0|||
24908883|NCT00676338|50003030|FG001|Overall Study|Adverse Event|6|||
24908884|NCT00676338|50003031|FG002|Overall Study|Adverse Event|5|||
24908885|NCT00676338|50003032|FG003|Overall Study|Adverse Event|1|||
24908886|NCT00676338|50003029|FG000|Overall Study|Lost to Follow-up|4|||
24908887|NCT00676338|50003030|FG001|Overall Study|Lost to Follow-up|1|||
24908888|NCT00676338|50003031|FG002|Overall Study|Lost to Follow-up|3|||
24908889|NCT00676338|50003032|FG003|Overall Study|Lost to Follow-up|4|||
25018802|NCT03589807|50114367|FG002|Overall Study|Protocol Violation|0|||
24908890|NCT00676338|50003029|FG000|Overall Study|Physician Decision|3|||
24908891|NCT00676338|50003030|FG001|Overall Study|Physician Decision|3|||
24908892|NCT00676338|50003031|FG002|Overall Study|Physician Decision|2|||
24908893|NCT00676338|50003032|FG003|Overall Study|Physician Decision|3|||
24908894|NCT00676338|50003029|FG000|Overall Study|Protocol Violation|5|||
24908895|NCT00676338|50003030|FG001|Overall Study|Protocol Violation|9|||
24908896|NCT00676338|50003031|FG002|Overall Study|Protocol Violation|2|||
24908897|NCT00676338|50003032|FG003|Overall Study|Protocol Violation|5|||
24908898|NCT00676338|50003029|FG000|Overall Study|Withdrawal by Subject|17|||
24908899|NCT00676338|50003030|FG001|Overall Study|Withdrawal by Subject|9|||
24908900|NCT00676338|50003031|FG002|Overall Study|Withdrawal by Subject|12|||
24908901|NCT00676338|50003032|FG003|Overall Study|Withdrawal by Subject|6|||
24908902|NCT00676338|50003029|FG000|Overall Study|Entry Criteria Not Met|0|||
25152789|NCT01867424|50267924|FG000|Overall Study|Patient noncompliance|2|||
25152790|NCT01867424|50267925|FG001|Overall Study|Patient noncompliance|1|||
25152791|NCT01811732|50267933|FG000|Overall Study|Lost to Follow-up|24|||
25152792|NCT01811732|50267934|FG001|Overall Study|Lost to Follow-up|30|||
25152793|NCT01811732|50267933|FG000|Overall Study|Withdrawal by Subject|16|||
25152794|NCT01811732|50267934|FG001|Overall Study|Withdrawal by Subject|10|||
24908903|NCT00676338|50003030|FG001|Overall Study|Entry Criteria Not Met|2|||
24908904|NCT00676338|50003031|FG002|Overall Study|Entry Criteria Not Met|1|||
24908905|NCT00676338|50003032|FG003|Overall Study|Entry Criteria Not Met|1|||
24908906|NCT00676338|50003029|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
24908907|NCT00676338|50003030|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
24908908|NCT00676338|50003031|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
24908909|NCT00676338|50003032|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
24908910|NCT00382291|50003045|FG000|Overall Study|Adverse Event|1|||
24908911|NCT00382291|50003046|FG001|Overall Study|Adverse Event|2|||
24908912|NCT00382291|50003047|FG002|Overall Study|Adverse Event|2|||
24908913|NCT00382291|50003045|FG000|Overall Study|Protocol Violation|1|||
24908914|NCT00382291|50003046|FG001|Overall Study|Protocol Violation|0|||
24908915|NCT00382291|50003047|FG002|Overall Study|Protocol Violation|0|||
24908916|NCT00382291|50003045|FG000|Overall Study|Temporary study suspension|2|||
24908917|NCT00382291|50003046|FG001|Overall Study|Temporary study suspension|2|||
24908918|NCT00382291|50003047|FG002|Overall Study|Temporary study suspension|5|||
24908919|NCT00382291|50003045|FG000|Overall Study|Withdrawal by Subject|0|||
24908920|NCT00382291|50003046|FG001|Overall Study|Withdrawal by Subject|2|||
24908921|NCT00382291|50003047|FG002|Overall Study|Withdrawal by Subject|0|||
24908922|NCT00382291|50003045|FG000|Overall Study|Physician Decision|0|||
24908923|NCT00382291|50003046|FG001|Overall Study|Physician Decision|1|||
24908924|NCT00382291|50003047|FG002|Overall Study|Physician Decision|0|||
24908925|NCT00382291|50003045|FG000|Overall Study|Lack of Efficacy|0|||
24908926|NCT00382291|50003046|FG001|Overall Study|Lack of Efficacy|0|||
25018803|NCT03589807|50114368|FG003|Overall Study|Protocol Violation|1|||
25018804|NCT03589807|50114369|FG004|Overall Study|Protocol Violation|0|||
25018805|NCT03589807|50114370|FG005|Overall Study|Protocol Violation|0|||
25018806|NCT03589807|50114365|FG000|Overall Study|Enrolled but treatment not administered|0|||
25018807|NCT03589807|50114366|FG001|Overall Study|Enrolled but treatment not administered|0|||
25018808|NCT03589807|50114367|FG002|Overall Study|Enrolled but treatment not administered|0|||
24908927|NCT00382291|50003047|FG002|Overall Study|Lack of Efficacy|1|||
24908928|NCT00547378|50003069|FG000|Randomized Cohort|Withdrawal by Subject|7|||
24908929|NCT00547378|50003070|FG001|Randomized Cohort|Withdrawal by Subject|5|||
24908930|NCT00547378|50003071|FG002|Randomized Cohort|Withdrawal by Subject|0|||
24908931|NCT00547378|50003069|FG000|Randomized Cohort|Death|0|||
24908932|NCT00547378|50003070|FG001|Randomized Cohort|Death|1|||
24908933|NCT00547378|50003071|FG002|Randomized Cohort|Death|0|||
24908934|NCT00547378|50003069|FG000|Randomized Cohort|Lost to Follow-up|1|||
24908935|NCT00547378|50003070|FG001|Randomized Cohort|Lost to Follow-up|0|||
24908936|NCT00547378|50003071|FG002|Randomized Cohort|Lost to Follow-up|0|||
24908937|NCT00547378|50003069|FG000|Randomized Cohort|Adverse Event|1|||
24908938|NCT00547378|50003070|FG001|Randomized Cohort|Adverse Event|0|||
24908939|NCT00547378|50003071|FG002|Randomized Cohort|Adverse Event|0|||
24908940|NCT00547378|50003069|FG000|Randomized Cohort|Other reasons|2|||
24908941|NCT00547378|50003070|FG001|Randomized Cohort|Other reasons|0|||
24908942|NCT00547378|50003071|FG002|Randomized Cohort|Other reasons|0|||
24908943|NCT00547378|50003069|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
24908944|NCT00547378|50003070|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
24908945|NCT00547378|50003071|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
24908946|NCT00547378|50003069|FG000|All Implanted Cohort|Adverse Event|4|||
24908947|NCT00547378|50003070|FG001|All Implanted Cohort|Adverse Event|10|||
24908948|NCT00547378|50003071|FG002|All Implanted Cohort|Adverse Event|17|||
24908949|NCT00547378|50003069|FG000|All Implanted Cohort|Lost to Follow-up|0|||
24908950|NCT00547378|50003070|FG001|All Implanted Cohort|Lost to Follow-up|1|||
24908951|NCT00547378|50003071|FG002|All Implanted Cohort|Lost to Follow-up|14|||
24908952|NCT00547378|50003069|FG000|All Implanted Cohort|Death|3|||
25018809|NCT03589807|50114368|FG003|Overall Study|Enrolled but treatment not administered|0|||
24908953|NCT00547378|50003070|FG001|All Implanted Cohort|Death|1|||
24908954|NCT00547378|50003071|FG002|All Implanted Cohort|Death|4|||
24908955|NCT00547378|50003069|FG000|All Implanted Cohort|Physician Decision|0|||
25018810|NCT03589807|50114369|FG004|Overall Study|Enrolled but treatment not administered|1|||
24908956|NCT00547378|50003070|FG001|All Implanted Cohort|Physician Decision|2|||
25018811|NCT03589807|50114370|FG005|Overall Study|Enrolled but treatment not administered|0|||
25018812|NCT03544333|50114389|FG000|Overall Study|Withdrawal by Subject|1|||
25018813|NCT03544333|50114390|FG001|Overall Study|Withdrawal by Subject|0|||
25018814|NCT03560245|50114398|FG000|Overall Study|Withdrawal by Subject|3|||
25018815|NCT03560245|50114399|FG001|Overall Study|Withdrawal by Subject|2|||
25018816|NCT03560245|50114398|FG000|Overall Study|Adverse Event|1|||
25018817|NCT03560245|50114399|FG001|Overall Study|Adverse Event|1|||
25018818|NCT03560245|50114398|FG000|Overall Study|Protocol Violation|1|||
25018819|NCT03560245|50114399|FG001|Overall Study|Protocol Violation|0|||
25018820|NCT03560245|50114398|FG000|Overall Study|Death|0|||
25018821|NCT03560245|50114399|FG001|Overall Study|Death|1|||
25018822|NCT03560245|50114398|FG000|Overall Study|Lost to Follow-up|0|||
25018823|NCT03560245|50114399|FG001|Overall Study|Lost to Follow-up|1|||
25018824|NCT03560245|50114398|FG000|Overall Study|Physician Decision|0|||
25018825|NCT03560245|50114399|FG001|Overall Study|Physician Decision|1|||
25018826|NCT03560245|50114398|FG000|Overall Study|Other|0|||
25018827|NCT03560245|50114399|FG001|Overall Study|Other|1|||
25018828|NCT00707434|50114407|FG000|Overall Study|Adverse Event|1|||
25018829|NCT03054428|50114414|FG000|Overall Study|Physician Decision|0|||
25018830|NCT03054428|50114415|FG001|Overall Study|Physician Decision|1|||
25018831|NCT03054428|50114416|FG002|Overall Study|Physician Decision|1|||
25018832|NCT03054428|50114414|FG000|Overall Study|Lack of Efficacy|3|||
25018833|NCT03054428|50114415|FG001|Overall Study|Lack of Efficacy|1|||
25018834|NCT03054428|50114416|FG002|Overall Study|Lack of Efficacy|0|||
25018835|NCT03054428|50114414|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
25018836|NCT03054428|50114415|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
25274812|NCT00909727|50588870|FG001|Overall Study|Withdrawal of Consent|0|||
25274813|NCT00909727|50588869|FG000|Overall Study|Prohibited Medication|1|||
25274814|NCT00909727|50588870|FG001|Overall Study|Prohibited Medication|0|||
25274815|NCT00977080|50588880|FG000|Overall Study|Adverse Event|2|||
25274816|NCT00977080|50588881|FG001|Overall Study|Adverse Event|7|||
25274817|NCT00977080|50588882|FG002|Overall Study|Adverse Event|7|||
25274818|NCT00977080|50588883|FG003|Overall Study|Adverse Event|7|||
25274819|NCT00977080|50588880|FG000|Overall Study|Withdrawal by Subject|1|||
25274820|NCT00977080|50588881|FG001|Overall Study|Withdrawal by Subject|5|||
25274821|NCT00977080|50588882|FG002|Overall Study|Withdrawal by Subject|1|||
25274822|NCT00977080|50588883|FG003|Overall Study|Withdrawal by Subject|5|||
24908957|NCT00547378|50003071|FG002|All Implanted Cohort|Physician Decision|6|||
24908958|NCT00547378|50003069|FG000|All Implanted Cohort|Site closure|2|||
24908959|NCT00547378|50003070|FG001|All Implanted Cohort|Site closure|0|||
24908960|NCT00547378|50003071|FG002|All Implanted Cohort|Site closure|1|||
24908961|NCT00547378|50003069|FG000|All Implanted Cohort|Other reasons|1|||
24908962|NCT00547378|50003070|FG001|All Implanted Cohort|Other reasons|0|||
24908963|NCT00547378|50003071|FG002|All Implanted Cohort|Other reasons|1|||
24908964|NCT00381043|50003081|FG000|Overall Study|Lost to Follow-up|8|||
24908965|NCT00381043|50003082|FG001|Overall Study|Lost to Follow-up|6|||
24908966|NCT00381043|50003081|FG000|Overall Study|Withdrawal by Subject|3|||
24908967|NCT00381043|50003082|FG001|Overall Study|Withdrawal by Subject|1|||
24908968|NCT00381043|50003081|FG000|Overall Study|wanted more care|0|||
24908969|NCT00381043|50003082|FG001|Overall Study|wanted more care|1|||
24908970|NCT00381043|50003081|FG000|Overall Study|incarcerated|1|||
25274823|NCT00977080|50588880|FG000|Overall Study|Protocol Violation|7|||
25274824|NCT00977080|50588881|FG001|Overall Study|Protocol Violation|3|||
24908971|NCT00381043|50003082|FG001|Overall Study|incarcerated|0|||
25274825|NCT00977080|50588882|FG002|Overall Study|Protocol Violation|4|||
25274826|NCT00977080|50588883|FG003|Overall Study|Protocol Violation|3|||
25274827|NCT00977080|50588880|FG000|Overall Study|Noncompliance|0|||
25018837|NCT03054428|50114416|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
25018838|NCT03054428|50114414|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
25018839|NCT03054428|50114415|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
25274828|NCT00977080|50588881|FG001|Overall Study|Noncompliance|2|||
25274829|NCT00977080|50588882|FG002|Overall Study|Noncompliance|1|||
25274830|NCT00977080|50588883|FG003|Overall Study|Noncompliance|0|||
24908972|NCT00614991|50003094|FG000|Overall Study|Adverse Event|3|||
24908973|NCT00614991|50003095|FG001|Overall Study|Adverse Event|3|||
25018840|NCT03054428|50114416|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
24908974|NCT00614991|50003096|FG002|Overall Study|Adverse Event|0|||
24908975|NCT00614991|50003097|FG003|Overall Study|Adverse Event|0|||
24908976|NCT00614991|50003098|FG004|Overall Study|Adverse Event|1|||
25018841|NCT03054428|50114414|FG000|Overall Study|Transitioned to OLE study|76|||
25018842|NCT03054428|50114415|FG001|Overall Study|Transitioned to OLE study|76|||
25018843|NCT03054428|50114416|FG002|Overall Study|Transitioned to OLE study|73|||
25018844|NCT03054428|50114414|FG000|Overall Study|Withdrawal by Subject|3|||
25018845|NCT03054428|50114415|FG001|Overall Study|Withdrawal by Subject|2|||
25018846|NCT03054428|50114416|FG002|Overall Study|Withdrawal by Subject|3|||
25018847|NCT03054428|50114414|FG000|Overall Study|Lost to Follow-up|0|||
25018848|NCT03054428|50114415|FG001|Overall Study|Lost to Follow-up|0|||
25018849|NCT03054428|50114416|FG002|Overall Study|Lost to Follow-up|1|||
25018850|NCT03558997|50114428|FG000|Overall Study|Adverse Event|0|||
24908977|NCT00614991|50003099|FG005|Overall Study|Adverse Event|0|||
24908978|NCT00360529|50003121|FG000|Overall Study|Adverse Event|10|||
24908979|NCT00360529|50003122|FG001|Overall Study|Adverse Event|23|||
24908980|NCT00360529|50003123|FG002|Overall Study|Adverse Event|33|||
24908981|NCT00360529|50003121|FG000|Overall Study|Protocol Violation|3|||
24908982|NCT00360529|50003122|FG001|Overall Study|Protocol Violation|3|||
24908983|NCT00360529|50003123|FG002|Overall Study|Protocol Violation|11|||
24908984|NCT00360529|50003121|FG000|Overall Study|Lost to Follow-up|14|||
24908985|NCT00360529|50003122|FG001|Overall Study|Lost to Follow-up|10|||
24908986|NCT00360529|50003123|FG002|Overall Study|Lost to Follow-up|13|||
24908987|NCT00360529|50003121|FG000|Overall Study|Withdrawal by Subject|22|||
24908988|NCT00360529|50003122|FG001|Overall Study|Withdrawal by Subject|14|||
24908989|NCT00360529|50003123|FG002|Overall Study|Withdrawal by Subject|18|||
24908990|NCT00360529|50003121|FG000|Overall Study|Lack of Efficacy|8|||
25018851|NCT03558997|50114429|FG001|Overall Study|Adverse Event|2|||
25018852|NCT03558997|50114430|FG002|Overall Study|Adverse Event|5|||
25018853|NCT03558997|50114431|FG003|Overall Study|Adverse Event|1|||
25018854|NCT03558997|50114428|FG000|Overall Study|Physician Decision|0|||
25018855|NCT03558997|50114429|FG001|Overall Study|Physician Decision|0|||
25018856|NCT03558997|50114430|FG002|Overall Study|Physician Decision|1|||
25018857|NCT03558997|50114431|FG003|Overall Study|Physician Decision|0|||
25018858|NCT03558997|50114428|FG000|Overall Study|Withdrawal by Subject|1|||
25018859|NCT03558997|50114429|FG001|Overall Study|Withdrawal by Subject|0|||
25018860|NCT03558997|50114430|FG002|Overall Study|Withdrawal by Subject|1|||
25018861|NCT03558997|50114431|FG003|Overall Study|Withdrawal by Subject|1|||
25018862|NCT03558997|50114428|FG000|Overall Study|Lost to Follow-up|0|||
25018863|NCT03558997|50114429|FG001|Overall Study|Lost to Follow-up|0|||
25018864|NCT03558997|50114430|FG002|Overall Study|Lost to Follow-up|1|||
25018865|NCT03558997|50114431|FG003|Overall Study|Lost to Follow-up|0|||
25018866|NCT03052400|50114446|FG000|Overall Study|Lost to Follow-up|1|||
25018867|NCT03052400|50114447|FG001|Overall Study|Lost to Follow-up|0|||
25018868|NCT03052400|50114446|FG000|Overall Study|Withdrawal by Subject|0|||
25018869|NCT03052400|50114447|FG001|Overall Study|Withdrawal by Subject|1|||
25018870|NCT03538951|50114455|FG000|Overall Study|Withdrawal by Subject|1|||
25018871|NCT03538951|50114456|FG001|Overall Study|Withdrawal by Subject|2|||
25018872|NCT03052322|50114464|FG000|Overall Study|Other un-specified|1|||
25018873|NCT03052322|50114465|FG001|Overall Study|Other un-specified|2|||
25018874|NCT03052322|50114464|FG000|Overall Study|Withdrawal by Subject|10|||
25018875|NCT03052322|50114465|FG001|Overall Study|Withdrawal by Subject|9|||
25018876|NCT03052322|50114464|FG000|Overall Study|Death|0|||
25018877|NCT03052322|50114465|FG001|Overall Study|Death|2|||
24908991|NCT00360529|50003122|FG001|Overall Study|Lack of Efficacy|6|||
24908992|NCT00360529|50003123|FG002|Overall Study|Lack of Efficacy|5|||
25018878|NCT03052322|50114464|FG000|Overall Study|Lack of Efficacy|1|||
25018879|NCT03052322|50114465|FG001|Overall Study|Lack of Efficacy|2|||
25018880|NCT03052322|50114464|FG000|Overall Study|Protocol Violation|1|||
25018881|NCT03052322|50114465|FG001|Overall Study|Protocol Violation|0|||
25018882|NCT03052322|50114464|FG000|Overall Study|Lost to Follow-up|2|||
24908993|NCT00360529|50003121|FG000|Overall Study|Reason discontinued not explained above|4|||
24908994|NCT00360529|50003122|FG001|Overall Study|Reason discontinued not explained above|9|||
24908995|NCT00360529|50003123|FG002|Overall Study|Reason discontinued not explained above|11|||
24908996|NCT00369577|50003138|FG000|Overall Study|Withdrawal by Subject|0|||
24908997|NCT00369577|50003139|FG001|Overall Study|Withdrawal by Subject|0|||
24908998|NCT00369577|50003140|FG002|Overall Study|Withdrawal by Subject|1|||
24908999|NCT00678288|50003150|FG000|Overall Study|Adverse Event|0|||
24909000|NCT00678288|50003151|FG001|Overall Study|Adverse Event|2|||
24909001|NCT00678288|50003150|FG000|Overall Study|Withdrawal by Subject|1|||
24909002|NCT00678288|50003151|FG001|Overall Study|Withdrawal by Subject|1|||
24909003|NCT00678288|50003150|FG000|Overall Study|Study terminated by the sponsor|2|||
24909004|NCT00678288|50003151|FG001|Overall Study|Study terminated by the sponsor|0|||
24909005|NCT00678288|50003150|FG000|Overall Study|Not compliant with study medication|0|||
24909006|NCT00678288|50003151|FG001|Overall Study|Not compliant with study medication|1|||
25018883|NCT03052322|50114465|FG001|Overall Study|Lost to Follow-up|4|||
25018884|NCT03052322|50114464|FG000|Overall Study|Adverse Event|6|||
25018885|NCT03052322|50114465|FG001|Overall Study|Adverse Event|13|||
25018886|NCT03521791|50114473|FG000|Overall Study|Protocol Violation|7|||
25018887|NCT03521791|50114474|FG001|Overall Study|Protocol Violation|17|||
25018888|NCT03521635|50114482|FG000|Overall Study|Adverse Event|1|||
25018889|NCT03521635|50114483|FG001|Overall Study|Adverse Event|1|||
25018890|NCT03521635|50114482|FG000|Overall Study|Refused to complete study visit|1|||
25018891|NCT03521635|50114483|FG001|Overall Study|Refused to complete study visit|0|||
25018892|NCT03521635|50114482|FG000|Overall Study|Refused to continue trial medication|2|||
25018893|NCT03521635|50114483|FG001|Overall Study|Refused to continue trial medication|2|||
25018894|NCT03521635|50114482|FG000|Overall Study|Lost to Follow-up|0|||
25018895|NCT03521635|50114483|FG001|Overall Study|Lost to Follow-up|1|||
25018896|NCT03521635|50114482|FG000|Overall Study|Meet exclusion criteria|0|||
25018897|NCT03521635|50114483|FG001|Overall Study|Meet exclusion criteria|1|||
25018898|NCT03521635|50114482|FG000|Overall Study|Patient not taken study medicine|0|||
25018899|NCT03521635|50114483|FG001|Overall Study|Patient not taken study medicine|1|||
25018900|NCT03170544|50114501|FG000|Part 1|Lost to Follow-up|1|||
25018901|NCT03170544|50114502|FG001|Part 1|Lost to Follow-up|0|||
25018902|NCT03170544|50114503|FG002|Part 1|Lost to Follow-up|0|||
25018903|NCT03170544|50114504|FG003|Part 1|Lost to Follow-up|0|||
25018904|NCT03170544|50114505|FG004|Part 1|Lost to Follow-up|0|||
25018905|NCT03170544|50114506|FG005|Part 1|Lost to Follow-up|0|||
25018906|NCT03170544|50114507|FG006|Part 1|Lost to Follow-up|0|||
25018907|NCT03170544|50114508|FG007|Part 1|Lost to Follow-up|0|||
25018908|NCT03170544|50114509|FG008|Part 1|Lost to Follow-up|0|||
25018909|NCT03170544|50114510|FG009|Part 1|Lost to Follow-up|0|||
25018910|NCT03170544|50114511|FG010|Part 1|Lost to Follow-up|0|||
25018911|NCT03170544|50114512|FG011|Part 1|Lost to Follow-up|0|||
25018912|NCT03170544|50114501|FG000|Part 1|Not treated|0|||
25018913|NCT03170544|50114502|FG001|Part 1|Not treated|0|||
25018914|NCT03170544|50114503|FG002|Part 1|Not treated|0|||
25018915|NCT03170544|50114504|FG003|Part 1|Not treated|1|||
25018916|NCT03170544|50114505|FG004|Part 1|Not treated|0|||
25152795|NCT01811732|50267933|FG000|Overall Study|Adverse Event|3|||
24909007|NCT00678288|50003150|FG000|Overall Study|Switch to commercial drug|0|||
24909008|NCT00678288|50003151|FG001|Overall Study|Switch to commercial drug|1|||
24909009|NCT00678288|50003150|FG000|Overall Study|Reason not reported|1|||
24909010|NCT00678288|50003151|FG001|Overall Study|Reason not reported|0|||
24909011|NCT00678288|50003150|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
24909012|NCT00678288|50003151|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
24909013|NCT00369343|50003159|FG000|Double-blind Phase|Adverse Event|19|||
24909014|NCT00369343|50003160|FG001|Double-blind Phase|Adverse Event|4|||
24909015|NCT00369343|50003159|FG000|Double-blind Phase|Failed to return|2|||
24909016|NCT00369343|50003160|FG001|Double-blind Phase|Failed to return|0|||
24909017|NCT00369343|50003159|FG000|Double-blind Phase|Lost to Follow-up|9|||
24909018|NCT00369343|50003160|FG001|Double-blind Phase|Lost to Follow-up|2|||
24909019|NCT00369343|50003159|FG000|Double-blind Phase|Protocol Violation|2|||
25018917|NCT03170544|50114506|FG005|Part 1|Not treated|0|||
25018918|NCT03170544|50114507|FG006|Part 1|Not treated|0|||
25018919|NCT03170544|50114508|FG007|Part 1|Not treated|0|||
25018920|NCT03170544|50114509|FG008|Part 1|Not treated|0|||
25152796|NCT01811732|50267934|FG001|Overall Study|Adverse Event|9|||
25152797|NCT01811732|50267933|FG000|Overall Study|Lack of Efficacy|3|||
25152798|NCT01811732|50267934|FG001|Overall Study|Lack of Efficacy|1|||
25152799|NCT01811732|50267933|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
24909020|NCT00369343|50003160|FG001|Double-blind Phase|Protocol Violation|0|||
24909021|NCT00369343|50003159|FG000|Double-blind Phase|Withdrawal by Subject|8|||
24909022|NCT00369343|50003160|FG001|Double-blind Phase|Withdrawal by Subject|6|||
25018921|NCT03170544|50114510|FG009|Part 1|Not treated|0|||
25018922|NCT03170544|50114511|FG010|Part 1|Not treated|0|||
25018923|NCT03170544|50114512|FG011|Part 1|Not treated|0|||
25018924|NCT03582943|50114597|FG000|Allocated to Groups|Withdrawal by Subject|1|||
25018925|NCT03582943|50114598|FG001|Allocated to Groups|Withdrawal by Subject|1|||
24909023|NCT00369343|50003159|FG000|Double-blind Phase|Lack of Efficacy|0|||
24909024|NCT00369343|50003160|FG001|Double-blind Phase|Lack of Efficacy|4|||
24909025|NCT00369343|50003159|FG000|Double-blind Phase|Protocol deviation|4|||
24909026|NCT00369343|50003160|FG001|Double-blind Phase|Protocol deviation|0|||
24909027|NCT00369343|50003159|FG000|Open-label Phase|Adverse Event|19|||
24909028|NCT00369343|50003160|FG001|Open-label Phase|Adverse Event|7|||
24909029|NCT00369343|50003159|FG000|Open-label Phase|Failed to return|4|||
24909030|NCT00369343|50003160|FG001|Open-label Phase|Failed to return|0|||
24909031|NCT00369343|50003159|FG000|Open-label Phase|Physician Decision|2|||
24909032|NCT00369343|50003160|FG001|Open-label Phase|Physician Decision|0|||
24909033|NCT00369343|50003159|FG000|Open-label Phase|Lost to Follow-up|5|||
24909034|NCT00369343|50003160|FG001|Open-label Phase|Lost to Follow-up|3|||
24909035|NCT00369343|50003159|FG000|Open-label Phase|inadvertently reported study completers|3|||
24909036|NCT00369343|50003160|FG001|Open-label Phase|inadvertently reported study completers|2|||
24909037|NCT00369343|50003159|FG000|Open-label Phase|Protocol Violation|1|||
24909038|NCT00369343|50003160|FG001|Open-label Phase|Protocol Violation|3|||
24909039|NCT00369343|50003159|FG000|Open-label Phase|Withdrawal by Subject|15|||
24909040|NCT00369343|50003160|FG001|Open-label Phase|Withdrawal by Subject|6|||
24909041|NCT00369343|50003159|FG000|Open-label Phase|Lack of Efficacy|4|||
24909042|NCT00369343|50003160|FG001|Open-label Phase|Lack of Efficacy|3|||
24909043|NCT00369343|50003159|FG000|Open-label Phase|Lack of continuance tolerability|3|||
24909044|NCT00369343|50003160|FG001|Open-label Phase|Lack of continuance tolerability|4|||
24909045|NCT00369343|50003159|FG000|Open-label Phase|did not take study drug|1|||
24909046|NCT00369343|50003160|FG001|Open-label Phase|did not take study drug|2|||
24909047|NCT00369265|50003175|FG000|Overall Study|Study terminated|4|||
24909048|NCT00369265|50003176|FG001|Overall Study|Study terminated|7|||
24909049|NCT00368875|50003182|FG000|Overall Study|Adverse Event|0|||
24909050|NCT00368875|50003183|FG001|Overall Study|Adverse Event|12|||
24909051|NCT00368875|50003182|FG000|Overall Study|Progressive disease|3|||
24909052|NCT00368875|50003183|FG001|Overall Study|Progressive disease|27|||
24909053|NCT00368875|50003182|FG000|Overall Study|Withdrawal by Subject|2|||
24909054|NCT00368875|50003183|FG001|Overall Study|Withdrawal by Subject|6|||
24909055|NCT00368875|50003182|FG000|Overall Study|Other Reason|0|||
24909056|NCT00368875|50003183|FG001|Overall Study|Other Reason|2|||
24909057|NCT00368875|50003182|FG000|Overall Study|Alternative Therapy|1|||
24909058|NCT00368875|50003183|FG001|Overall Study|Alternative Therapy|1|||
24909059|NCT00614055|50003192|FG000|Overall Study|Adverse Event|1|||
24909060|NCT00614055|50003193|FG001|Overall Study|Adverse Event|0|||
24909061|NCT00614055|50003194|FG002|Overall Study|Adverse Event|0|||
24909062|NCT00614055|50003192|FG000|Overall Study|Protocol Violation|2|||
24909063|NCT00614055|50003193|FG001|Overall Study|Protocol Violation|2|||
24909064|NCT00614055|50003194|FG002|Overall Study|Protocol Violation|1|||
24909065|NCT00614055|50003192|FG000|Overall Study|Lack of Efficacy|0|||
24909066|NCT00614055|50003193|FG001|Overall Study|Lack of Efficacy|0|||
24909067|NCT00614055|50003194|FG002|Overall Study|Lack of Efficacy|2|||
24909068|NCT00614055|50003192|FG000|Overall Study|Unclassified|1|||
24909069|NCT00614055|50003193|FG001|Overall Study|Unclassified|4|||
24909070|NCT00614055|50003194|FG002|Overall Study|Unclassified|2|||
24909071|NCT00613821|50003207|FG000|Overall Study|Withdrawal by Subject|1|||
24909072|NCT00613821|50003208|FG001|Overall Study|Withdrawal by Subject|0|||
24909073|NCT00613821|50003207|FG000|Overall Study|Physician Decision|1|||
24909074|NCT00613821|50003208|FG001|Overall Study|Physician Decision|1|||
24909075|NCT00548548|50003216|FG000|Overall Study|Death|345|||
24909076|NCT00548548|50003217|FG001|Overall Study|Death|348|||
24909077|NCT00548548|50003216|FG000|Overall Study|Lost to Follow-up|17|||
24909078|NCT00548548|50003217|FG001|Overall Study|Lost to Follow-up|18|||
24909079|NCT00613509|50003225|FG000|Cycle 1|Adverse Event|2|||
24909080|NCT00613509|50003226|FG001|Cycle 1|Adverse Event|1|||
24909081|NCT00613509|50003225|FG000|Cycle 1|Disease Progression|2|||
24909082|NCT00613509|50003226|FG001|Cycle 1|Disease Progression|6|||
24909083|NCT00613509|50003225|FG000|Cycle 1|Unacceptable Toxicity|1|||
24909084|NCT00613509|50003226|FG001|Cycle 1|Unacceptable Toxicity|0|||
24909085|NCT00613509|50003225|FG000|Cycle 1|Other administrative reason|0|||
24909086|NCT00613509|50003226|FG001|Cycle 1|Other administrative reason|1|||
24909087|NCT00547300|50003251|FG000|Overall Study|Study was Administratively Terminated|25|||
24909088|NCT00547300|50003252|FG001|Overall Study|Study was Administratively Terminated|24|||
24909089|NCT00547300|50003251|FG000|Overall Study|Did not Meet Entry Criteria|0|||
24909090|NCT00547300|50003252|FG001|Overall Study|Did not Meet Entry Criteria|2|||
24909091|NCT00612807|50003260|FG000|Overall Study|Withdrawal by Subject|2|||
24909092|NCT00612807|50003261|FG001|Overall Study|Withdrawal by Subject|0|||
24909093|NCT00678210|50003271|FG000|Overall Study|Adverse Event|1|||
24909094|NCT00678210|50003272|FG001|Overall Study|Adverse Event|2|||
24909095|NCT00678210|50003273|FG002|Overall Study|Adverse Event|3|||
24909096|NCT00678210|50003274|FG003|Overall Study|Adverse Event|3|||
24909097|NCT00678210|50003271|FG000|Overall Study|Lack of Efficacy|2|||
24909098|NCT00678210|50003272|FG001|Overall Study|Lack of Efficacy|3|||
24909099|NCT00678210|50003273|FG002|Overall Study|Lack of Efficacy|1|||
24909100|NCT00678210|50003274|FG003|Overall Study|Lack of Efficacy|9|||
24909101|NCT00678210|50003271|FG000|Overall Study|Lost to Follow-up|4|||
24909102|NCT00678210|50003272|FG001|Overall Study|Lost to Follow-up|2|||
24909103|NCT00678210|50003273|FG002|Overall Study|Lost to Follow-up|0|||
24909104|NCT00678210|50003274|FG003|Overall Study|Lost to Follow-up|1|||
24909105|NCT00678210|50003271|FG000|Overall Study|Withdrawal by Subject|3|||
24909106|NCT00678210|50003272|FG001|Overall Study|Withdrawal by Subject|4|||
24909107|NCT00678210|50003273|FG002|Overall Study|Withdrawal by Subject|1|||
24909108|NCT00678210|50003274|FG003|Overall Study|Withdrawal by Subject|7|||
24909109|NCT00678210|50003271|FG000|Overall Study|Other|1|||
24909110|NCT00678210|50003272|FG001|Overall Study|Other|0|||
24909111|NCT00678210|50003273|FG002|Overall Study|Other|1|||
24909112|NCT00678210|50003274|FG003|Overall Study|Other|0|||
24909113|NCT00611715|50003286|FG000|Overall Study|Disease Progression|24|||
24909114|NCT00611715|50003287|FG001|Overall Study|Disease Progression|4|||
24909115|NCT00611715|50003286|FG000|Overall Study|Withdrawal by Subject|5|||
24909116|NCT00611715|50003287|FG001|Overall Study|Withdrawal by Subject|1|||
24909117|NCT00611715|50003286|FG000|Overall Study|Adverse Event|9|||
24909118|NCT00611715|50003287|FG001|Overall Study|Adverse Event|1|||
24909119|NCT00611715|50003286|FG000|Overall Study|Death|1|||
24909120|NCT00611715|50003287|FG001|Overall Study|Death|0|||
25152800|NCT01811732|50267934|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
24909121|NCT00611715|50003286|FG000|Overall Study|two patients are still on treatment|2|||
24909122|NCT00611715|50003287|FG001|Overall Study|two patients are still on treatment|0|||
24909123|NCT00677820|50003301|FG000|Overall Study|Lost to Follow-up|1|||
24909124|NCT00677820|50003302|FG001|Overall Study|Lost to Follow-up|0|||
24909125|NCT00611559|50003311|FG000|Overall Study|Lost to Follow-up|0|||
24909126|NCT00611559|50003312|FG001|Overall Study|Lost to Follow-up|1|||
24909127|NCT00611559|50003313|FG002|Overall Study|Lost to Follow-up|0|||
24909128|NCT00611559|50003311|FG000|Overall Study|Protocol Violation|1|||
24909129|NCT00611559|50003312|FG001|Overall Study|Protocol Violation|0|||
24909130|NCT00611559|50003313|FG002|Overall Study|Protocol Violation|1|||
24909131|NCT00611247|50003323|FG000|Overall Study|Death|1|||
24909132|NCT00611247|50003324|FG001|Overall Study|Death|5|||
24909133|NCT00611247|50003323|FG000|Overall Study|Lack of Efficacy|1|||
24909134|NCT00611247|50003324|FG001|Overall Study|Lack of Efficacy|16|||
24909135|NCT00675948|50003333|FG000|Overall Study|Adverse Event|23|||
24909136|NCT00675948|50003334|FG001|Overall Study|Adverse Event|1|||
24909137|NCT00675948|50003333|FG000|Overall Study|Lack of Efficacy|3|||
24909138|NCT00675948|50003334|FG001|Overall Study|Lack of Efficacy|0|||
24909139|NCT00675948|50003333|FG000|Overall Study|Withdrawal by Subject|7|||
24909140|NCT00675948|50003334|FG001|Overall Study|Withdrawal by Subject|0|||
24909141|NCT00675948|50003333|FG000|Overall Study|Lost to Follow-up|2|||
24909142|NCT00675948|50003334|FG001|Overall Study|Lost to Follow-up|0|||
24909143|NCT00675948|50003333|FG000|Overall Study|Protocol Violation|1|||
24909144|NCT00675948|50003334|FG001|Overall Study|Protocol Violation|0|||
24909145|NCT00675948|50003333|FG000|Overall Study|Pain under control|1|||
25018926|NCT03582943|50114597|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
25018927|NCT03582943|50114598|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
25018928|NCT03582943|50114597|FG000|Analyzed|Protocol Violation|4|||
25018929|NCT03582943|50114598|FG001|Analyzed|Protocol Violation|1|||
25018930|NCT03532009|50114606|FG000|Overall Study|Other|1|||
25018931|NCT03532009|50114607|FG001|Overall Study|Other|1|||
25018932|NCT03532009|50114606|FG000|Overall Study|Death|1|||
25018933|NCT03532009|50114607|FG001|Overall Study|Death|1|||
25018934|NCT03532009|50114606|FG000|Overall Study|Withdrawal by Patient|0|||
25018935|NCT03532009|50114607|FG001|Overall Study|Withdrawal by Patient|2|||
25018936|NCT03520387|50114618|FG000|Pre-Randomization|Withdrawal by Subject|1|||
25018937|NCT03520387|50114619|FG001|Pre-Randomization|Withdrawal by Subject|0|||
25018938|NCT03520387|50114620|FG002|Pre-Randomization|Withdrawal by Subject|0|||
25018939|NCT03520387|50114621|FG003|Pre-Randomization|Withdrawal by Subject|0|||
25018940|NCT03520387|50114622|FG004|Pre-Randomization|Withdrawal by Subject|0|||
25018941|NCT03520387|50114618|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
25018942|NCT03520387|50114619|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
25018943|NCT03520387|50114620|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
25018944|NCT03520387|50114621|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
25018945|NCT03520387|50114622|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
25018946|NCT03170232|50114635|FG000|Overall Study|Adverse Event|0|||
25018947|NCT03170232|50114636|FG001|Overall Study|Adverse Event|1|||
25018948|NCT03170232|50114635|FG000|Overall Study|Protocol Violation|0|||
25018949|NCT03170232|50114636|FG001|Overall Study|Protocol Violation|1|||
25018950|NCT03170232|50114635|FG000|Overall Study|Lack of Efficacy|0|||
25018951|NCT03170232|50114636|FG001|Overall Study|Lack of Efficacy|1|||
25018952|NCT03170232|50114635|FG000|Overall Study|Study closed/terminated|26|||
25018953|NCT03170232|50114636|FG001|Overall Study|Study closed/terminated|23|||
25018954|NCT03170232|50114635|FG000|Overall Study|Lost to Follow-up|1|||
25018955|NCT03170232|50114636|FG001|Overall Study|Lost to Follow-up|0|||
24909146|NCT00675948|50003334|FG001|Overall Study|Pain under control|0|||
24909147|NCT00675948|50003333|FG000|Overall Study|Sponsor decision|0|||
24909148|NCT00675948|50003334|FG001|Overall Study|Sponsor decision|1|||
24909149|NCT00675948|50003333|FG000|Overall Study|Patient died|1|||
24909150|NCT00675948|50003334|FG001|Overall Study|Patient died|0|||
24909151|NCT00675948|50003333|FG000|Overall Study|Patient unable to comply with diaries|1|||
25018956|NCT03170232|50114635|FG000|Overall Study|Withdrawal by Subject|0|||
25018957|NCT03170232|50114636|FG001|Overall Study|Withdrawal by Subject|1|||
24909152|NCT00675948|50003334|FG001|Overall Study|Patient unable to comply with diaries|0|||
24909153|NCT00675948|50003333|FG000|Overall Study|Patient feels unable to take medication|0|||
25018958|NCT03519919|50114642|FG000|Overall Study|Withdrawal by Subject|1|||
25018959|NCT03519919|50114642|FG000|Overall Study|Lack of Efficacy|1|||
25018960|NCT03519919|50114642|FG000|Overall Study|Screen Failure|1|||
25018961|NCT03478969|50114675|FG000|Overall Study|Withdrawal by Subject|4|||
25018962|NCT03478969|50114676|FG001|Overall Study|Withdrawal by Subject|7|||
25018963|NCT03478969|50114677|FG002|Overall Study|Withdrawal by Subject|6|||
25018964|NCT03478969|50114675|FG000|Overall Study|Adverse Event|2|||
25018965|NCT03478969|50114676|FG001|Overall Study|Adverse Event|0|||
25018966|NCT03478969|50114677|FG002|Overall Study|Adverse Event|1|||
25018967|NCT03478969|50114675|FG000|Overall Study|Pregnancy|1|||
25018968|NCT03478969|50114676|FG001|Overall Study|Pregnancy|0|||
25018969|NCT03478969|50114677|FG002|Overall Study|Pregnancy|0|||
25018970|NCT03478969|50114675|FG000|Overall Study|Personal Reasons|1|||
25018971|NCT03478969|50114676|FG001|Overall Study|Personal Reasons|0|||
25018972|NCT03478969|50114677|FG002|Overall Study|Personal Reasons|1|||
25018973|NCT03478969|50114675|FG000|Overall Study|Covid-19|1|||
25018974|NCT03478969|50114676|FG001|Overall Study|Covid-19|4|||
25018975|NCT03478969|50114677|FG002|Overall Study|Covid-19|3|||
25018976|NCT03478969|50114675|FG000|Overall Study|Multiple Reasons|0|||
25018977|NCT03478969|50114676|FG001|Overall Study|Multiple Reasons|1|||
25018978|NCT03478969|50114677|FG002|Overall Study|Multiple Reasons|1|||
25018979|NCT03478969|50114675|FG000|Overall Study|Eligibility Criteria|0|||
25018980|NCT03478969|50114676|FG001|Overall Study|Eligibility Criteria|0|||
25018981|NCT03478969|50114677|FG002|Overall Study|Eligibility Criteria|5|||
25018982|NCT03478969|50114675|FG000|Overall Study|Lost to Follow-up|0|||
25018983|NCT03478969|50114676|FG001|Overall Study|Lost to Follow-up|0|||
25018984|NCT03478969|50114677|FG002|Overall Study|Lost to Follow-up|1|||
25018985|NCT04823949|50114708|FG000|Overall Study|Withdrawal by Subject|0|||
25018986|NCT04823949|50114709|FG001|Overall Study|Withdrawal by Subject|4|||
25152801|NCT01811732|50267933|FG000|Overall Study|Physician Decision|2|||
25152802|NCT01811732|50267934|FG001|Overall Study|Physician Decision|0|||
25152803|NCT01811732|50267933|FG000|Overall Study|Death|1|||
25152804|NCT01811732|50267934|FG001|Overall Study|Death|1|||
25152805|NCT01811732|50267933|FG000|Overall Study|Insufficient venous access|0|||
25152806|NCT01811732|50267934|FG001|Overall Study|Insufficient venous access|1|||
25152807|NCT01811732|50267933|FG000|Overall Study|Protocol Violation|0|||
25184916|NCT01675128|50333932|FG001|Overall Study|Pulmonary complication; off study|1|||
25184917|NCT01675128|50333933|FG002|Overall Study|Pulmonary complication; off study|0|||
25018987|NCT04823949|50114708|FG000|Overall Study|Physician Decision|0|||
25018988|NCT04823949|50114709|FG001|Overall Study|Physician Decision|1|||
25018989|NCT04499482|50114724|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
25018990|NCT04408794|50114743|FG000|Overall Study|Adverse Event|43|||
25018991|NCT04408794|50114743|FG000|Overall Study|Infrequent study drug usage|43|||
25018992|NCT04408794|50114743|FG000|Overall Study|Lack of Efficacy|61|||
25018993|NCT04408794|50114743|FG000|Overall Study|Lost to Follow-up|33|||
25018994|NCT04408794|50114743|FG000|Overall Study|Non-compliance|6|||
25018995|NCT04408794|50114743|FG000|Overall Study|Physician Decision|1|||
25018996|NCT04408794|50114743|FG000|Overall Study|Pregnancy|6|||
25018997|NCT04408794|50114743|FG000|Overall Study|Protocol Deviation|9|||
25018998|NCT04408794|50114743|FG000|Overall Study|Sheehan-STS Result|1|||
25018999|NCT04408794|50114743|FG000|Overall Study|Withdrawal by Subject|57|||
25019000|NCT04408794|50114743|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
25019001|NCT04408794|50114743|FG000|Overall Study|Never Treated Migraine|5|||
25152808|NCT01811732|50267934|FG001|Overall Study|Protocol Violation|1|||
25152809|NCT01811732|50267933|FG000|Overall Study|Subject incarcerated|1|||
25184918|NCT01427309|50333979|FG000|Overall Study|Lost to Follow-up|130|||
25184919|NCT01427309|50333980|FG001|Overall Study|Lost to Follow-up|145|||
25184920|NCT01427309|50333981|FG002|Overall Study|Lost to Follow-up|122|||
25184921|NCT01427309|50333982|FG003|Overall Study|Lost to Follow-up|135|||
25184922|NCT01427309|50333979|FG000|Overall Study|Protocol Violation|42|||
25184923|NCT01427309|50333980|FG001|Overall Study|Protocol Violation|69|||
25184924|NCT01427309|50333981|FG002|Overall Study|Protocol Violation|125|||
25184925|NCT01427309|50333982|FG003|Overall Study|Protocol Violation|124|||
25184926|NCT01427309|50333979|FG000|Overall Study|Adverse Event|0|||
25019002|NCT04305405|50114787|FG000|Overall Study|Withdrawal by parent/guardian|0|||
25019003|NCT04305405|50114788|FG001|Overall Study|Withdrawal by parent/guardian|1|||
25019004|NCT04152200|50114805|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
25019005|NCT04152200|50114806|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
25019006|NCT03905694|50114814|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18|||
25152810|NCT01811732|50267934|FG001|Overall Study|Subject incarcerated|2|||
25152811|NCT01811732|50267933|FG000|Overall Study|Admitted to another facility|1|||
25184927|NCT01427309|50333980|FG001|Overall Study|Adverse Event|0|||
25184928|NCT01427309|50333981|FG002|Overall Study|Adverse Event|3|||
25019007|NCT03681184|50114820|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
25019008|NCT03681184|50114821|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
25019009|NCT03681184|50114820|FG000|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12|||
25019010|NCT03681184|50114821|FG001|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23|||
25019011|NCT03681184|50114820|FG000|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
25019012|NCT03681184|50114821|FG001|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
25019013|NCT03668119|50114829|FG000|Pre-treatment|Disease Progression|1|||
25019014|NCT03668119|50114830|FG001|Pre-treatment|Disease Progression|0|||
25019015|NCT03668119|50114829|FG000|Treatment|Disease Progression|75|||
25019016|NCT03668119|50114830|FG001|Treatment|Disease Progression|55|||
25019017|NCT03668119|50114829|FG000|Treatment|Study drug toxicity|19|||
25019018|NCT03668119|50114830|FG001|Treatment|Study drug toxicity|1|||
25019019|NCT03668119|50114829|FG000|Treatment|Death|3|||
25019020|NCT03668119|50114830|FG001|Treatment|Death|0|||
25019021|NCT03668119|50114829|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
25019022|NCT03668119|50114830|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
25019023|NCT03668119|50114829|FG000|Treatment|Withdrawal by Subject|2|||
25019024|NCT03668119|50114830|FG001|Treatment|Withdrawal by Subject|1|||
25019025|NCT03668119|50114829|FG000|Treatment|Participant request to discontinue study treatment|3|||
25019026|NCT03668119|50114830|FG001|Treatment|Participant request to discontinue study treatment|1|||
25019027|NCT03668119|50114829|FG000|Treatment|Maximum Clinical Benefit|0|||
25019028|NCT03668119|50114830|FG001|Treatment|Maximum Clinical Benefit|1|||
25019029|NCT03668119|50114829|FG000|Treatment|Participants completed treatment|20|||
25019030|NCT03668119|50114830|FG001|Treatment|Participants completed treatment|8|||
25019031|NCT03668119|50114829|FG000|Treatment|Other reasons|1|||
25019032|NCT03668119|50114830|FG001|Treatment|Other reasons|2|||
25019033|NCT03543410|50114845|FG000|Overall Study|Adverse Event|10|||
25019034|NCT03543410|50114846|FG001|Overall Study|Adverse Event|8|||
25019035|NCT03543410|50114847|FG002|Overall Study|Adverse Event|2|||
25019036|NCT03543410|50114845|FG000|Overall Study|Lack of Efficacy|0|||
25019037|NCT03543410|50114846|FG001|Overall Study|Lack of Efficacy|1|||
25019038|NCT03543410|50114847|FG002|Overall Study|Lack of Efficacy|0|||
25019039|NCT03543410|50114845|FG000|Overall Study|Lost to Follow-up|0|||
25019040|NCT03543410|50114846|FG001|Overall Study|Lost to Follow-up|1|||
25019041|NCT03543410|50114847|FG002|Overall Study|Lost to Follow-up|0|||
25019042|NCT03543410|50114845|FG000|Overall Study|Withdrawal by Subject|5|||
25019043|NCT03543410|50114846|FG001|Overall Study|Withdrawal by Subject|2|||
25019044|NCT03543410|50114847|FG002|Overall Study|Withdrawal by Subject|8|||
25019045|NCT03543410|50114845|FG000|Overall Study|Protocol Violation|0|||
25019046|NCT03543410|50114846|FG001|Overall Study|Protocol Violation|1|||
25019047|NCT03543410|50114847|FG002|Overall Study|Protocol Violation|0|||
25019048|NCT03543410|50114845|FG000|Overall Study|Due to COVID-19|4|||
25019049|NCT03543410|50114846|FG001|Overall Study|Due to COVID-19|0|||
25019050|NCT03543410|50114847|FG002|Overall Study|Due to COVID-19|2|||
25019051|NCT03543410|50114845|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
25019052|NCT03543410|50114846|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
25019053|NCT03543410|50114847|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
25019054|NCT03543410|50114845|FG000|Overall Study|Not Due to COVID-19|2|||
25019055|NCT03543410|50114846|FG001|Overall Study|Not Due to COVID-19|0|||
25019056|NCT03543410|50114847|FG002|Overall Study|Not Due to COVID-19|1|||
25019057|NCT03294590|50114857|FG000|Overall Study|Lost to Follow-up|105|||
25019058|NCT03294590|50114858|FG001|Overall Study|Lost to Follow-up|107|||
25019059|NCT02908074|50114872|FG000|Overall Study|sponsor/ICON decision|0|||
25019060|NCT02908074|50114873|FG001|Overall Study|sponsor/ICON decision|0|||
25019061|NCT02908074|50114874|FG002|Overall Study|sponsor/ICON decision|1|||
25019062|NCT02908074|50114875|FG003|Overall Study|sponsor/ICON decision|0|||
25019063|NCT02908074|50114876|FG004|Overall Study|sponsor/ICON decision|0|||
25019064|NCT02908074|50114877|FG005|Overall Study|sponsor/ICON decision|0|||
25019065|NCT02908074|50114872|FG000|Overall Study|Protocol Violation|0|||
25019066|NCT02908074|50114873|FG001|Overall Study|Protocol Violation|1|||
25152812|NCT01811732|50267934|FG001|Overall Study|Admitted to another facility|0|||
25152813|NCT01811732|50267933|FG000|Overall Study|Correct study drug not available on site|1|||
25152814|NCT01811732|50267934|FG001|Overall Study|Correct study drug not available on site|0|||
25152815|NCT01836458|50267945|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
25152816|NCT01836458|50267946|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
25152817|NCT01836458|50267947|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
25152818|NCT01836458|50267948|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
25152819|NCT01811186|50267960|FG000|Overall Study|Adverse Event|54|||
25152820|NCT01811186|50267961|FG001|Overall Study|Adverse Event|38|||
25019067|NCT02908074|50114874|FG002|Overall Study|Protocol Violation|0|||
25019068|NCT02908074|50114875|FG003|Overall Study|Protocol Violation|0|||
25019069|NCT02908074|50114876|FG004|Overall Study|Protocol Violation|0|||
25019070|NCT02908074|50114877|FG005|Overall Study|Protocol Violation|0|||
25019071|NCT02908074|50114872|FG000|Overall Study|Adverse Event|5|||
25019072|NCT02908074|50114873|FG001|Overall Study|Adverse Event|2|||
25019073|NCT02908074|50114874|FG002|Overall Study|Adverse Event|0|||
25019074|NCT02908074|50114875|FG003|Overall Study|Adverse Event|0|||
25019075|NCT02908074|50114876|FG004|Overall Study|Adverse Event|1|||
25019076|NCT02908074|50114877|FG005|Overall Study|Adverse Event|0|||
25019077|NCT02908074|50114872|FG000|Overall Study|AESI|1|||
25019078|NCT02908074|50114873|FG001|Overall Study|AESI|0|||
25019079|NCT02908074|50114874|FG002|Overall Study|AESI|1|||
25019080|NCT02908074|50114875|FG003|Overall Study|AESI|0|||
25019081|NCT02908074|50114876|FG004|Overall Study|AESI|1|||
25019082|NCT02908074|50114877|FG005|Overall Study|AESI|0|||
25019083|NCT02908074|50114872|FG000|Overall Study|Discontinuation criteria per protocol|0|||
25019084|NCT02908074|50114873|FG001|Overall Study|Discontinuation criteria per protocol|0|||
25019085|NCT02908074|50114874|FG002|Overall Study|Discontinuation criteria per protocol|1|||
25019086|NCT02908074|50114875|FG003|Overall Study|Discontinuation criteria per protocol|0|||
25019087|NCT02908074|50114876|FG004|Overall Study|Discontinuation criteria per protocol|0|||
25019088|NCT02908074|50114877|FG005|Overall Study|Discontinuation criteria per protocol|1|||
25019089|NCT02908074|50114872|FG000|Overall Study|Withdrawal by Subject|3|||
25019090|NCT02908074|50114873|FG001|Overall Study|Withdrawal by Subject|2|||
25019091|NCT02908074|50114874|FG002|Overall Study|Withdrawal by Subject|2|||
25019092|NCT02908074|50114875|FG003|Overall Study|Withdrawal by Subject|2|||
25019093|NCT02908074|50114876|FG004|Overall Study|Withdrawal by Subject|2|||
25019094|NCT02908074|50114877|FG005|Overall Study|Withdrawal by Subject|2|||
25019095|NCT02908074|50114872|FG000|Overall Study|Lost to Follow-up|0|||
25019096|NCT02908074|50114873|FG001|Overall Study|Lost to Follow-up|1|||
25019097|NCT02908074|50114874|FG002|Overall Study|Lost to Follow-up|1|||
25019098|NCT02908074|50114875|FG003|Overall Study|Lost to Follow-up|1|||
25019099|NCT02908074|50114876|FG004|Overall Study|Lost to Follow-up|0|||
25019100|NCT02908074|50114877|FG005|Overall Study|Lost to Follow-up|1|||
25019101|NCT02907359|50114896|FG000|Overall Study|Death|234|||
25019102|NCT02907359|50114897|FG001|Overall Study|Death|117|||
25019103|NCT02907359|50114896|FG000|Overall Study|Withdrawal by Subject|6|||
25019104|NCT02907359|50114897|FG001|Overall Study|Withdrawal by Subject|11|||
25019105|NCT02907359|50114896|FG000|Overall Study|Lost to Follow-up|1|||
25019106|NCT02907359|50114897|FG001|Overall Study|Lost to Follow-up|0|||
25019107|NCT02714205|50114905|FG000|Overall Study|Cannot tolerate medication|1|||
25019108|NCT02714205|50114906|FG001|Overall Study|Cannot tolerate medication|0|||
25019109|NCT02714205|50114905|FG000|Overall Study|Adverse Event|2|||
25019110|NCT02714205|50114906|FG001|Overall Study|Adverse Event|0|||
25019111|NCT02714205|50114905|FG000|Overall Study|Too busy|1|||
25019112|NCT02714205|50114906|FG001|Overall Study|Too busy|0|||
25019113|NCT02714205|50114905|FG000|Overall Study|Incomplete outcome data|0|||
25019114|NCT02714205|50114906|FG001|Overall Study|Incomplete outcome data|1|||
25274831|NCT00977080|50588880|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
25274832|NCT00977080|50588881|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
25274833|NCT00977080|50588882|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
25274834|NCT00977080|50588883|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
25274835|NCT00977080|50588880|FG000|Overall Study|Required kidney transplantation|1|||
25274836|NCT00977080|50588881|FG001|Overall Study|Required kidney transplantation|3|||
25274837|NCT00977080|50588882|FG002|Overall Study|Required kidney transplantation|3|||
25274838|NCT00977080|50588883|FG003|Overall Study|Required kidney transplantation|1|||
25274839|NCT00977080|50588880|FG000|Overall Study|Travel for family reasons|1|||
25274840|NCT00977080|50588881|FG001|Overall Study|Travel for family reasons|0|||
25274841|NCT00977080|50588882|FG002|Overall Study|Travel for family reasons|0|||
25274842|NCT00977080|50588883|FG003|Overall Study|Travel for family reasons|0|||
25274843|NCT00975676|50588895|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
25274844|NCT00975676|50588896|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
25274845|NCT00975286|50588909|FG000|Overall Study|Adverse Event|9|||
25274846|NCT00975286|50588910|FG001|Overall Study|Adverse Event|19|||
25274847|NCT00975286|50588909|FG000|Overall Study|Protocol Violation|1|||
25274848|NCT00975286|50588910|FG001|Overall Study|Protocol Violation|2|||
25274849|NCT00975286|50588909|FG000|Overall Study|Withdrawal by Subject|0|||
25274850|NCT00975286|50588910|FG001|Overall Study|Withdrawal by Subject|2|||
25274851|NCT00975286|50588909|FG000|Overall Study|Familial and Personal Reasons|2|||
25274852|NCT00975286|50588910|FG001|Overall Study|Familial and Personal Reasons|2|||
25274853|NCT00975286|50588909|FG000|Overall Study|Poor Compliance to Protocol|0|||
25274854|NCT00975286|50588910|FG001|Overall Study|Poor Compliance to Protocol|2|||
25274855|NCT00975286|50588909|FG000|Overall Study|Sponsor Decision|0|||
25274856|NCT00975286|50588910|FG001|Overall Study|Sponsor Decision|2|||
25274857|NCT00907777|50588918|FG000|Overall Study|Withdrawal by Subject|0|||
25274858|NCT00907777|50588919|FG001|Overall Study|Withdrawal by Subject|1|||
25274859|NCT00908011|50588927|FG000|Overall Study|Withdrawal by Subject|2|||
25274860|NCT00908011|50588928|FG001|Overall Study|Withdrawal by Subject|2|||
25274861|NCT00976456|50588936|FG000|Overall Study|Adverse Event|17|||
25184929|NCT01427309|50333982|FG003|Overall Study|Adverse Event|1|||
25019147|NCT02369458|50114939|FG000|Overall Study|Determined to be not eligible|1|||
25019148|NCT02369458|50114940|FG001|Overall Study|Determined to be not eligible|0|||
25019149|NCT02152995|50114948|FG000|Overall Study|Withdrawal by Subject|1|||
25019150|NCT02152995|50114949|FG001|Overall Study|Withdrawal by Subject|0|||
25019151|NCT00920387|50114958|FG000|Stage 1|Adverse Event|1|||
24909154|NCT00675948|50003334|FG001|Overall Study|Patient feels unable to take medication|1|||
24909155|NCT00610935|50003343|FG000|Overall Study|Lost to Follow-up|0|||
25184930|NCT01427309|50333979|FG000|Overall Study|Serious adverse event|52|||
25184931|NCT01427309|50333980|FG001|Overall Study|Serious adverse event|45|||
25184932|NCT01427309|50333981|FG002|Overall Study|Serious adverse event|50|||
25184933|NCT01427309|50333982|FG003|Overall Study|Serious adverse event|61|||
25184934|NCT01427309|50333979|FG000|Overall Study|Withdrawal by Subject|148|||
25184935|NCT01427309|50333980|FG001|Overall Study|Withdrawal by Subject|148|||
25184936|NCT01427309|50333981|FG002|Overall Study|Withdrawal by Subject|61|||
25184937|NCT01427309|50333982|FG003|Overall Study|Withdrawal by Subject|55|||
25184938|NCT01426373|50333992|FG000|Overall Study|Adverse Event|6|||
25184939|NCT01426373|50333992|FG000|Overall Study|Lost to Follow-up|14|||
25019152|NCT00920387|50114959|FG001|Stage 1|Adverse Event|0|||
24909156|NCT00610935|50003344|FG001|Overall Study|Lost to Follow-up|1|||
24909157|NCT00610935|50003343|FG000|Overall Study|Withdrawal by Subject|0|||
24909158|NCT00610935|50003344|FG001|Overall Study|Withdrawal by Subject|2|||
24909159|NCT00610935|50003343|FG000|Overall Study|Sponsor Discontinuation|1|||
24909160|NCT00610935|50003344|FG001|Overall Study|Sponsor Discontinuation|0|||
24909161|NCT00610857|50003359|FG000|Overall Study|Not evaluable for response|2|||
24909162|NCT00672984|50003366|FG000|First Intervention|Adverse Event|5|||
24909163|NCT00672984|50003367|FG001|First Intervention|Adverse Event|0|||
24909164|NCT00672984|50003368|FG002|First Intervention|Adverse Event|0|||
24909165|NCT00672984|50003366|FG000|First Intervention|Withdrawal by Subject|1|||
24909166|NCT00672984|50003367|FG001|First Intervention|Withdrawal by Subject|2|||
24909167|NCT00672984|50003368|FG002|First Intervention|Withdrawal by Subject|2|||
24909168|NCT00672984|50003366|FG000|First Intervention|Sponsor decision|3|||
24909169|NCT00672984|50003367|FG001|First Intervention|Sponsor decision|0|||
24909170|NCT00672984|50003368|FG002|First Intervention|Sponsor decision|0|||
24909171|NCT00672984|50003366|FG000|Second Intervention|Non-compliance with facility policies|0|||
24909172|NCT00672984|50003367|FG001|Second Intervention|Non-compliance with facility policies|2|||
24909173|NCT00672984|50003368|FG002|Second Intervention|Non-compliance with facility policies|0|||
24909174|NCT00672984|50003366|FG000|Second Intervention|Withdrawal by Subject|0|||
24909175|NCT00672984|50003367|FG001|Second Intervention|Withdrawal by Subject|3|||
24909176|NCT00672984|50003368|FG002|Second Intervention|Withdrawal by Subject|0|||
24909177|NCT00672984|50003366|FG000|Second Intervention|Protocol Violation|0|||
24909178|NCT00672984|50003367|FG001|Second Intervention|Protocol Violation|1|||
24909179|NCT00672984|50003368|FG002|Second Intervention|Protocol Violation|1|||
24909180|NCT00672984|50003366|FG000|Third Intervention|Adverse Event|1|||
24909181|NCT00672984|50003367|FG001|Third Intervention|Adverse Event|0|||
24909182|NCT00672984|50003368|FG002|Third Intervention|Adverse Event|1|||
24909183|NCT00546364|50003381|FG000|Overall Study|Disease progression|5|||
24909184|NCT00546364|50003382|FG001|Overall Study|Disease progression|11|||
24909185|NCT00546364|50003383|FG002|Overall Study|Disease progression|8|||
24909186|NCT00546364|50003381|FG000|Overall Study|Completed and off treatment|1|||
24909187|NCT00546364|50003382|FG001|Overall Study|Completed and off treatment|0|||
24909188|NCT00546364|50003383|FG002|Overall Study|Completed and off treatment|2|||
24909189|NCT00546364|50003381|FG000|Overall Study|Administrative reason by sponsor|1|||
24909190|NCT00546364|50003382|FG001|Overall Study|Administrative reason by sponsor|0|||
24909191|NCT00546364|50003383|FG002|Overall Study|Administrative reason by sponsor|0|||
24909192|NCT00546364|50003381|FG000|Overall Study|Poor compliance/noncompliance|0|||
25019153|NCT00920387|50114960|FG002|Stage 1|Adverse Event|0|||
25019154|NCT00583752|50114969|FG000|Overall Study|Lost to Follow-up|5|||
25019155|NCT00583752|50114970|FG001|Overall Study|Lost to Follow-up|5|||
25019156|NCT02318784|50114977|FG000|Overall Study|Adverse Event|13|||
24909193|NCT00546364|50003382|FG001|Overall Study|Poor compliance/noncompliance|0|||
25019157|NCT02318784|50114977|FG000|Overall Study|Death|2|||
25019158|NCT02318784|50114977|FG000|Overall Study|Progressive Disease|37|||
24909194|NCT00546364|50003383|FG002|Overall Study|Poor compliance/noncompliance|1|||
24909195|NCT00546364|50003381|FG000|Overall Study|No longer meets study criteria|1|||
25019159|NCT02318784|50114977|FG000|Overall Study|Withdrawal by Subject|10|||
25184940|NCT01426373|50333992|FG000|Overall Study|Participant Convenience|10|||
25184941|NCT01426373|50333992|FG000|Overall Study|Miscellaneous Reasons|4|||
25019160|NCT03170154|50114992|FG000|Overall Study|Lost to Follow-up|4|||
25019161|NCT03170154|50114992|FG000|Overall Study|Death|2|||
25019162|NCT03170154|50114992|FG000|Overall Study|Withdrawal by Subject|2|||
25019163|NCT03518125|50115007|FG000|Overall Study|Lost to Follow-up|0|||
25019164|NCT03518125|50115008|FG001|Overall Study|Lost to Follow-up|2|||
25019165|NCT03518125|50115009|FG002|Overall Study|Lost to Follow-up|0|||
25019166|NCT03518125|50115010|FG003|Overall Study|Lost to Follow-up|0|||
25019167|NCT03518125|50115011|FG004|Overall Study|Lost to Follow-up|3|||
25019168|NCT03518125|50115012|FG005|Overall Study|Lost to Follow-up|5|||
25019169|NCT03518125|50115007|FG000|Overall Study|Physician Decision|0|||
25019170|NCT03518125|50115008|FG001|Overall Study|Physician Decision|1|||
25019171|NCT03518125|50115009|FG002|Overall Study|Physician Decision|0|||
25019172|NCT03518125|50115010|FG003|Overall Study|Physician Decision|0|||
25019173|NCT03518125|50115011|FG004|Overall Study|Physician Decision|0|||
25019174|NCT03518125|50115012|FG005|Overall Study|Physician Decision|0|||
25019175|NCT03518125|50115007|FG000|Overall Study|Withdrawal by Subject|1|||
25019176|NCT03518125|50115008|FG001|Overall Study|Withdrawal by Subject|1|||
25019177|NCT03518125|50115009|FG002|Overall Study|Withdrawal by Subject|0|||
25019178|NCT03518125|50115010|FG003|Overall Study|Withdrawal by Subject|1|||
25019179|NCT03518125|50115011|FG004|Overall Study|Withdrawal by Subject|1|||
25019180|NCT03518125|50115012|FG005|Overall Study|Withdrawal by Subject|3|||
25019181|NCT03518125|50115007|FG000|Overall Study|Missed Day 394 Visit|1|||
25019182|NCT03518125|50115008|FG001|Overall Study|Missed Day 394 Visit|0|||
25019183|NCT03518125|50115009|FG002|Overall Study|Missed Day 394 Visit|0|||
25019184|NCT03518125|50115010|FG003|Overall Study|Missed Day 394 Visit|0|||
25019185|NCT03518125|50115011|FG004|Overall Study|Missed Day 394 Visit|0|||
25019186|NCT03518125|50115012|FG005|Overall Study|Missed Day 394 Visit|0|||
25019187|NCT03169530|50115029|FG000|Overall Study|Study ended by NIH|15|||
25019188|NCT03169530|50115030|FG001|Overall Study|Study ended by NIH|17|||
25019189|NCT03478891|50115048|FG000|Overall Study|Enrolled, but product never administered|0|||
25019190|NCT03478891|50115049|FG001|Overall Study|Enrolled, but product never administered|0|||
25019191|NCT03478891|50115050|FG002|Overall Study|Enrolled, but product never administered|1|||
25019192|NCT03478891|50115048|FG000|Overall Study|Moved from area|0|||
25019193|NCT03478891|50115049|FG001|Overall Study|Moved from area|0|||
25019194|NCT03478891|50115050|FG002|Overall Study|Moved from area|1|||
25019195|NCT03478891|50115048|FG000|Overall Study|Lost to Follow-up|1|||
25019196|NCT03478891|50115049|FG001|Overall Study|Lost to Follow-up|0|||
25019197|NCT03478891|50115050|FG002|Overall Study|Lost to Follow-up|1|||
25019198|NCT01585103|50115062|FG000|Overall Study|Unable to swallow Cytosponge|6|||
25019199|NCT03168906|50115068|FG000|Overall Study|Lack of Efficacy|6|||
25019200|NCT03168906|50115069|FG001|Overall Study|Lack of Efficacy|6|||
25019201|NCT00706966|50115076|FG000|Overall Study|Adverse Event|1|||
25019202|NCT03478657|50115110|FG000|Overall Study|Withdrawal by Subject|0|||
25019203|NCT03478657|50115111|FG001|Overall Study|Withdrawal by Subject|1|||
25019204|NCT03515941|50115119|FG000|Overall Study|Adverse Event|1|||
25019205|NCT03515941|50115120|FG001|Overall Study|Adverse Event|0|||
25019206|NCT03011034|50115128|FG000|Overall Study|Adverse Event|1|||
25019207|NCT03011034|50115129|FG001|Overall Study|Adverse Event|0|||
25019208|NCT03515629|50115137|FG000|Overall Study|Death|0|||
25019209|NCT03515629|50115138|FG001|Overall Study|Death|1|||
25019210|NCT03515629|50115139|FG002|Overall Study|Death|1|||
25019211|NCT03515629|50115137|FG000|Overall Study|Progressive disease|0|||
25019212|NCT03515629|50115138|FG001|Overall Study|Progressive disease|1|||
25019213|NCT03515629|50115139|FG002|Overall Study|Progressive disease|0|||
25019214|NCT03512353|50115148|FG000|Overall Study|Sponsor Decision|3|||
25019215|NCT03512353|50115148|FG000|Overall Study|Death|1|||
25019216|NCT03512275|50115156|FG000|Overall Study|Withdrawal by Subject|1|||
25019217|NCT03512275|50115157|FG001|Overall Study|Withdrawal by Subject|3|||
25019218|NCT03512275|50115156|FG000|Overall Study|Physician Decision|0|||
25019219|NCT03512275|50115157|FG001|Overall Study|Physician Decision|1|||
25152821|NCT01811186|50267960|FG000|Overall Study|Protocol Violation|5|||
25152822|NCT01811186|50267961|FG001|Overall Study|Protocol Violation|6|||
25152823|NCT01811186|50267960|FG000|Overall Study|Withdrawal by Subject|5|||
25019220|NCT03512275|50115156|FG000|Overall Study|Lost to Follow-up|0|||
25019221|NCT03512275|50115157|FG001|Overall Study|Lost to Follow-up|3|||
25019222|NCT03512275|50115156|FG000|Overall Study|Other|1|||
25019223|NCT03512275|50115157|FG001|Overall Study|Other|0|||
25019224|NCT03473197|50115163|FG000|Overall Study|Adverse Event|4|||
25019225|NCT03473197|50115163|FG000|Overall Study|Lost to Follow-up|1|||
25019226|NCT03473197|50115163|FG000|Overall Study|Withdrawal by Subject|5|||
25019227|NCT03511105|50115169|FG000|Overall Study|Adverse Event|1|||
25019228|NCT03511105|50115170|FG001|Overall Study|Adverse Event|0|||
25019229|NCT03511105|50115169|FG000|Overall Study|Withdrew consent|1|||
25019230|NCT03511105|50115170|FG001|Overall Study|Withdrew consent|0|||
25019231|NCT03510715|50115190|FG000|Overall Study|Adverse Event|1|||
25019232|NCT03510715|50115191|FG001|Overall Study|Adverse Event|0|||
25019233|NCT03508843|50115198|FG000|Overall Study|Withdrawal by Subject|1|||
25019234|NCT03508843|50115198|FG000|Overall Study|technical difficulties|2|||
25019235|NCT03508609|50115202|FG000|Overall Study|Withdrawal by Subject|1|||
25019236|NCT03054350|50115212|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
25019237|NCT03054350|50115213|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
25184942|NCT01426217|50334000|FG000|Overall Study|lost sample|8|||
25019238|NCT03054350|50115214|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
25184943|NCT01426217|50334001|FG001|Overall Study|lost sample|14|||
24909196|NCT00546364|50003382|FG001|Overall Study|No longer meets study criteria|1|||
24909197|NCT00546364|50003383|FG002|Overall Study|No longer meets study criteria|0|||
24909198|NCT00546364|50003381|FG000|Overall Study|Withdrawal by Subject|5|||
24909199|NCT00546364|50003382|FG001|Overall Study|Withdrawal by Subject|6|||
24909200|NCT00546364|50003383|FG002|Overall Study|Withdrawal by Subject|3|||
24909201|NCT00546364|50003381|FG000|Overall Study|Prior taxotere|1|||
24909202|NCT00546364|50003382|FG001|Overall Study|Prior taxotere|0|||
24909203|NCT00546364|50003383|FG002|Overall Study|Prior taxotere|0|||
24909204|NCT00546364|50003381|FG000|Overall Study|Mixed response|1|||
24909205|NCT00546364|50003382|FG001|Overall Study|Mixed response|0|||
24909206|NCT00546364|50003383|FG002|Overall Study|Mixed response|0|||
24909207|NCT00546364|50003381|FG000|Overall Study|Palliative treatment|1|||
24909208|NCT00546364|50003382|FG001|Overall Study|Palliative treatment|0|||
24909209|NCT00546364|50003383|FG002|Overall Study|Palliative treatment|1|||
24909210|NCT00546364|50003381|FG000|Overall Study|Target lesions resected|1|||
24909211|NCT00546364|50003382|FG001|Overall Study|Target lesions resected|0|||
24909212|NCT00546364|50003383|FG002|Overall Study|Target lesions resected|0|||
24909213|NCT00546364|50003381|FG000|Overall Study|Physician Decision|0|||
24909214|NCT00546364|50003382|FG001|Overall Study|Physician Decision|0|||
24909215|NCT00546364|50003383|FG002|Overall Study|Physician Decision|1|||
24909216|NCT00546364|50003381|FG000|Overall Study|Sponsor decision|0|||
24909217|NCT00546364|50003382|FG001|Overall Study|Sponsor decision|0|||
24909218|NCT00546364|50003383|FG002|Overall Study|Sponsor decision|1|||
24909219|NCT00612105|50003393|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
24909220|NCT00612105|50003394|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
24909221|NCT00612105|50003393|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
24909222|NCT00612105|50003394|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
24909223|NCT00612105|50003393|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
24909224|NCT00612105|50003394|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
24909225|NCT00612105|50003393|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
24909226|NCT00612105|50003394|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
24909227|NCT00612105|50003393|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
24909228|NCT00612105|50003394|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
24909229|NCT00612105|50003393|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
24909230|NCT00612105|50003394|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
24909231|NCT00612105|50003393|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
24909232|NCT00612105|50003394|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
24909233|NCT00612105|50003393|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
24909234|NCT00612105|50003394|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
24909235|NCT00612105|50003393|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
24909236|NCT00612105|50003394|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
24909237|NCT00612105|50003393|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
24909238|NCT00612105|50003394|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
24909239|NCT00612105|50003393|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
24909240|NCT00612105|50003394|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
24909241|NCT00612105|50003393|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
24909242|NCT00612105|50003394|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
25019239|NCT03054350|50115215|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
25019240|NCT03054350|50115216|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
25019241|NCT03054350|50115217|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
25019242|NCT03054350|50115212|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
25019243|NCT03054350|50115213|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
25019244|NCT03054350|50115214|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
25019245|NCT03054350|50115215|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
25019246|NCT03054350|50115216|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
25019247|NCT03054350|50115217|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
25274862|NCT00976456|50588937|FG001|Overall Study|Adverse Event|22|||
25019248|NCT03054350|50115212|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
25019249|NCT03054350|50115213|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
25019250|NCT03054350|50115214|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
25019251|NCT03054350|50115215|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
25019252|NCT03054350|50115216|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
25019253|NCT03054350|50115217|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
25019254|NCT03054350|50115212|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
25019255|NCT03054350|50115213|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
25019256|NCT03054350|50115214|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
25019257|NCT03054350|50115215|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
25019258|NCT03054350|50115216|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
25019259|NCT03054350|50115217|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
25019260|NCT03528577|50115248|FG000|Sequence 1|Failed Spirometry|1|||
25019261|NCT03528577|50115248|FG000|Sequence 1|Restricted medication|1|||
25019262|NCT03528577|50115248|FG000|Sequence 2|Adverse Event|1|||
25019263|NCT03528577|50115248|FG000|Sequence 2|Withdrawal by Subject|1|||
25019264|NCT03528577|50115248|FG000|Sequence 2|Failed Spirometry|1|||
25019265|NCT03528577|50115248|FG000|Sequence 3|Failed Spirometry|1|||
25019266|NCT03528577|50115248|FG000|Sequence 4|Failed Spirometry|2|||
25019267|NCT03528577|50115248|FG000|Sequence 4|Adverse Event|1|||
25019268|NCT00706654|50115258|FG000|Conversion Phase|Lost to Follow-up|4|||
25019269|NCT00706654|50115259|FG001|Conversion Phase|Lost to Follow-up|0|||
25019270|NCT00706654|50115260|FG002|Conversion Phase|Lost to Follow-up|0|||
25019271|NCT00706654|50115261|FG003|Conversion Phase|Lost to Follow-up|0|||
25019272|NCT00706654|50115258|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
25019273|NCT00706654|50115259|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
24909243|NCT00546052|50003400|FG000|Overall Study|Adverse Event|47|||
24909244|NCT00546052|50003400|FG000|Overall Study|Lost to Follow-up|144|||
24909245|NCT00546052|50003400|FG000|Overall Study|Protocol Violation|9|||
24909246|NCT00546052|50003400|FG000|Overall Study|Withdrawal by Subject|20|||
24909247|NCT00546052|50003400|FG000|Overall Study|Non Compliance|7|||
24909248|NCT00673920|50003415|FG000|Baseline up to Week 48|Withdrew consent|1|||
24909249|NCT00673920|50003416|FG001|Baseline up to Week 48|Withdrew consent|0|||
24909250|NCT00673920|50003417|FG002|Baseline up to Week 48|Withdrew consent|2|||
24909251|NCT00673920|50003418|FG003|Baseline up to Week 48|Withdrew consent|0|||
24909252|NCT00673920|50003419|FG004|Baseline up to Week 48|Withdrew consent|0|||
24909253|NCT00673920|50003420|FG005|Baseline up to Week 48|Withdrew consent|0|||
24909254|NCT00673920|50003421|FG006|Baseline up to Week 48|Withdrew consent|0|||
24909255|NCT00673920|50003422|FG007|Baseline up to Week 48|Withdrew consent|0|||
24909256|NCT00673920|50003415|FG000|Baseline up to Week 48|Refused treatment|1|||
24909257|NCT00673920|50003416|FG001|Baseline up to Week 48|Refused treatment|0|||
24909258|NCT00673920|50003417|FG002|Baseline up to Week 48|Refused treatment|0|||
24909259|NCT00673920|50003418|FG003|Baseline up to Week 48|Refused treatment|0|||
24909260|NCT00673920|50003419|FG004|Baseline up to Week 48|Refused treatment|0|||
24909261|NCT00673920|50003420|FG005|Baseline up to Week 48|Refused treatment|0|||
24909262|NCT00673920|50003421|FG006|Baseline up to Week 48|Refused treatment|0|||
24909263|NCT00673920|50003422|FG007|Baseline up to Week 48|Refused treatment|0|||
24909264|NCT00673920|50003415|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
24909265|NCT00673920|50003416|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
24909266|NCT00673920|50003417|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
24909267|NCT00673920|50003418|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
24909268|NCT00673920|50003419|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
24909269|NCT00673920|50003420|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
24909270|NCT00673920|50003421|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
24909271|NCT00673920|50003422|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
24909272|NCT00673920|50003415|FG000|Baseline up to Week 48|Protocol Violation|0|||
24909273|NCT00673920|50003416|FG001|Baseline up to Week 48|Protocol Violation|0|||
24909274|NCT00673920|50003417|FG002|Baseline up to Week 48|Protocol Violation|1|||
24909275|NCT00673920|50003418|FG003|Baseline up to Week 48|Protocol Violation|0|||
24909276|NCT00673920|50003419|FG004|Baseline up to Week 48|Protocol Violation|0|||
24909277|NCT00673920|50003420|FG005|Baseline up to Week 48|Protocol Violation|0|||
24909278|NCT00673920|50003421|FG006|Baseline up to Week 48|Protocol Violation|0|||
24909279|NCT00673920|50003422|FG007|Baseline up to Week 48|Protocol Violation|0|||
24909280|NCT00673920|50003415|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
24909281|NCT00673920|50003416|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
24909282|NCT00673920|50003417|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
25019274|NCT00706654|50115260|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
25019275|NCT00706654|50115261|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
25019276|NCT00706654|50115258|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
25019277|NCT00706654|50115259|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
24909283|NCT00673920|50003418|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
24909284|NCT00673920|50003419|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
24909285|NCT00673920|50003420|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
24909286|NCT00673920|50003421|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
24909287|NCT00673920|50003422|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
24909288|NCT00673920|50003415|FG000|Baseline up to Week 48|Administrative/Other|0|||
24909289|NCT00673920|50003416|FG001|Baseline up to Week 48|Administrative/Other|1|||
24909290|NCT00673920|50003417|FG002|Baseline up to Week 48|Administrative/Other|2|||
24909291|NCT00673920|50003418|FG003|Baseline up to Week 48|Administrative/Other|0|||
24909292|NCT00673920|50003419|FG004|Baseline up to Week 48|Administrative/Other|0|||
24909293|NCT00673920|50003420|FG005|Baseline up to Week 48|Administrative/Other|0|||
24909294|NCT00673920|50003421|FG006|Baseline up to Week 48|Administrative/Other|0|||
24909295|NCT00673920|50003422|FG007|Baseline up to Week 48|Administrative/Other|0|||
24909296|NCT00673920|50003415|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
24909297|NCT00673920|50003416|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
24909298|NCT00673920|50003417|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
24909299|NCT00673920|50003418|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
24909300|NCT00673920|50003419|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
24909301|NCT00673920|50003420|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
24909302|NCT00673920|50003421|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
24909303|NCT00673920|50003422|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
24909304|NCT00673920|50003415|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
24909305|NCT00673920|50003416|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
24909306|NCT00673920|50003417|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
24909307|NCT00673920|50003418|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
24909308|NCT00673920|50003419|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
24909309|NCT00673920|50003420|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
24909310|NCT00673920|50003421|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
24909311|NCT00673920|50003422|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
24909312|NCT00673920|50003415|FG000|Week 24 to Week 48|Failure to return|0|||
24909313|NCT00673920|50003416|FG001|Week 24 to Week 48|Failure to return|0|||
24909314|NCT00673920|50003417|FG002|Week 24 to Week 48|Failure to return|0|||
24909315|NCT00673920|50003418|FG003|Week 24 to Week 48|Failure to return|0|||
24909316|NCT00673920|50003419|FG004|Week 24 to Week 48|Failure to return|0|||
24909317|NCT00673920|50003420|FG005|Week 24 to Week 48|Failure to return|1|||
24909318|NCT00673920|50003421|FG006|Week 24 to Week 48|Failure to return|0|||
24909319|NCT00673920|50003422|FG007|Week 24 to Week 48|Failure to return|0|||
24909320|NCT00673920|50003415|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
24909321|NCT00673920|50003416|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
24909322|NCT00673920|50003417|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
24909323|NCT00673920|50003418|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
24909324|NCT00673920|50003419|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
24909325|NCT00673920|50003420|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
24909326|NCT00673920|50003421|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
24909327|NCT00673920|50003422|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
24909328|NCT00673920|50003415|FG000|Week 24 to Week 48|Death|0|||
24909329|NCT00673920|50003416|FG001|Week 24 to Week 48|Death|0|||
24909330|NCT00673920|50003417|FG002|Week 24 to Week 48|Death|0|||
24909331|NCT00673920|50003418|FG003|Week 24 to Week 48|Death|0|||
24909332|NCT00673920|50003419|FG004|Week 24 to Week 48|Death|0|||
24909333|NCT00673920|50003420|FG005|Week 24 to Week 48|Death|1|||
24909334|NCT00673920|50003421|FG006|Week 24 to Week 48|Death|0|||
24909335|NCT00673920|50003422|FG007|Week 24 to Week 48|Death|0|||
24909336|NCT00673920|50003415|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
24909337|NCT00673920|50003416|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
24909338|NCT00673920|50003417|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
24909339|NCT00673920|50003418|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
24909340|NCT00673920|50003419|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
24909341|NCT00673920|50003420|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
24909342|NCT00673920|50003421|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
24909343|NCT00673920|50003422|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
24909344|NCT00379795|50003449|FG000|Overall Study|Death|31|||
24909345|NCT00379795|50003450|FG001|Overall Study|Death|8|||
24909346|NCT00379795|50003451|FG002|Overall Study|Death|6|||
25274863|NCT00976456|50588936|FG000|Overall Study|Death|7|||
24909347|NCT00379795|50003452|FG003|Overall Study|Death|4|||
24909348|NCT00379795|50003453|FG004|Overall Study|Death|7|||
24909349|NCT00379795|50003449|FG000|Overall Study|Adverse Event|17|||
24909350|NCT00379795|50003450|FG001|Overall Study|Adverse Event|3|||
24909351|NCT00379795|50003451|FG002|Overall Study|Adverse Event|3|||
24909352|NCT00379795|50003452|FG003|Overall Study|Adverse Event|1|||
24909353|NCT00379795|50003453|FG004|Overall Study|Adverse Event|4|||
24909354|NCT00379795|50003449|FG000|Overall Study|Lost to Follow-up|8|||
24909355|NCT00379795|50003450|FG001|Overall Study|Lost to Follow-up|1|||
24909356|NCT00379795|50003451|FG002|Overall Study|Lost to Follow-up|2|||
24909357|NCT00379795|50003452|FG003|Overall Study|Lost to Follow-up|1|||
24909358|NCT00379795|50003453|FG004|Overall Study|Lost to Follow-up|4|||
24909359|NCT00379795|50003449|FG000|Overall Study|Physician Decision|25|||
24909360|NCT00379795|50003450|FG001|Overall Study|Physician Decision|0|||
24909361|NCT00379795|50003451|FG002|Overall Study|Physician Decision|2|||
24909362|NCT00379795|50003452|FG003|Overall Study|Physician Decision|2|||
24909363|NCT00379795|50003453|FG004|Overall Study|Physician Decision|2|||
24909364|NCT00379795|50003449|FG000|Overall Study|Withdrawal by Subject|94|||
24909365|NCT00379795|50003450|FG001|Overall Study|Withdrawal by Subject|11|||
24909366|NCT00379795|50003451|FG002|Overall Study|Withdrawal by Subject|19|||
24909367|NCT00379795|50003452|FG003|Overall Study|Withdrawal by Subject|7|||
24909368|NCT00379795|50003453|FG004|Overall Study|Withdrawal by Subject|14|||
24909369|NCT00379795|50003449|FG000|Overall Study|Subject non-compliance|7|||
24909370|NCT00379795|50003450|FG001|Overall Study|Subject non-compliance|2|||
24909371|NCT00379795|50003451|FG002|Overall Study|Subject non-compliance|0|||
24909372|NCT00379795|50003452|FG003|Overall Study|Subject non-compliance|0|||
24909373|NCT00379795|50003453|FG004|Overall Study|Subject non-compliance|1|||
24909374|NCT00379795|50003449|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
24909375|NCT00379795|50003450|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
24909376|NCT00379795|50003451|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
24909377|NCT00379795|50003452|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
24909378|NCT00379795|50003453|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
24909379|NCT00379795|50003449|FG000|Overall Study|Subjects condition mandated intervention|34|||
24909380|NCT00379795|50003450|FG001|Overall Study|Subjects condition mandated intervention|9|||
24909381|NCT00379795|50003451|FG002|Overall Study|Subjects condition mandated intervention|7|||
24909382|NCT00379795|50003452|FG003|Overall Study|Subjects condition mandated intervention|5|||
24909383|NCT00379795|50003453|FG004|Overall Study|Subjects condition mandated intervention|7|||
24909384|NCT00379795|50003449|FG000|Overall Study|Sponsor's decision|257|||
24909385|NCT00379795|50003450|FG001|Overall Study|Sponsor's decision|17|||
24909386|NCT00379795|50003451|FG002|Overall Study|Sponsor's decision|54|||
24909387|NCT00379795|50003452|FG003|Overall Study|Sponsor's decision|47|||
24909388|NCT00379795|50003453|FG004|Overall Study|Sponsor's decision|10|||
24909389|NCT00610155|50003468|FG000|Period 1|Withdrawal by Subject|0|||
24909390|NCT00610155|50003469|FG001|Period 1|Withdrawal by Subject|0|||
24909391|NCT00610155|50003470|FG002|Period 1|Withdrawal by Subject|1|||
24909392|NCT00610155|50003471|FG003|Period 1|Withdrawal by Subject|0|||
24909393|NCT00610155|50003472|FG004|Period 1|Withdrawal by Subject|0|||
24909394|NCT00610155|50003473|FG005|Period 1|Withdrawal by Subject|0|||
24909395|NCT00610155|50003468|FG000|Period 3|Adverse Event|1|||
24909396|NCT00610155|50003469|FG001|Period 3|Adverse Event|0|||
24909397|NCT00610155|50003470|FG002|Period 3|Adverse Event|0|||
24909398|NCT00610155|50003471|FG003|Period 3|Adverse Event|0|||
24909399|NCT00610155|50003472|FG004|Period 3|Adverse Event|0|||
24909400|NCT00610155|50003473|FG005|Period 3|Adverse Event|0|||
24909401|NCT00674700|50003484|FG000|Year 1|Adverse Event|17|||
24909402|NCT00674700|50003485|FG001|Year 1|Adverse Event|20|||
24909403|NCT00674700|50003486|FG002|Year 1|Adverse Event|5|||
24909404|NCT00674700|50003484|FG000|Year 1|Withdrawal by Subject|7|||
24909405|NCT00674700|50003485|FG001|Year 1|Withdrawal by Subject|7|||
24909406|NCT00674700|50003486|FG002|Year 1|Withdrawal by Subject|6|||
24909407|NCT00674700|50003484|FG000|Year 1|Any other reason not above-mentioned|7|||
24909408|NCT00674700|50003485|FG001|Year 1|Any other reason not above-mentioned|7|||
24909409|NCT00674700|50003486|FG002|Year 1|Any other reason not above-mentioned|6|||
24909410|NCT00674700|50003484|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
24909411|NCT00674700|50003485|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
24909412|NCT00674700|50003486|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
24909413|NCT00674700|50003484|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
24909414|NCT00674700|50003485|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
24909415|NCT00674700|50003486|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
24909416|NCT00674700|50003484|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
24909417|NCT00674700|50003485|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
24909418|NCT00674700|50003486|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
24909419|NCT00546910|50003496|FG000|Overall Study|Adverse Event|2|||
25184944|NCT01425749|50334009|FG000|Overall Study|progression of melanoma|0|||
24909420|NCT00546910|50003497|FG001|Overall Study|Adverse Event|3|||
24909421|NCT00546910|50003496|FG000|Overall Study|Lack of Efficacy|5|||
24909422|NCT00546910|50003497|FG001|Overall Study|Lack of Efficacy|7|||
24909423|NCT00546910|50003496|FG000|Overall Study|Physician Decision|0|||
24909424|NCT00546910|50003497|FG001|Overall Study|Physician Decision|1|||
24909425|NCT00546910|50003496|FG000|Overall Study|Withdrawal by Subject|2|||
24909426|NCT00546910|50003497|FG001|Overall Study|Withdrawal by Subject|0|||
24909427|NCT00379639|50003508|FG000|Overall Study|Disease Progression|3|||
24909428|NCT00379639|50003509|FG001|Overall Study|Disease Progression|3|||
24909429|NCT00379639|50003510|FG002|Overall Study|Disease Progression|3|||
25184945|NCT01425749|50334010|FG001|Overall Study|progression of melanoma|1|||
24909430|NCT00379639|50003511|FG003|Overall Study|Disease Progression|4|||
24909431|NCT00379639|50003512|FG004|Overall Study|Disease Progression|4|||
24909432|NCT00379639|50003508|FG000|Overall Study|Physician Decision|0|||
24909433|NCT00379639|50003509|FG001|Overall Study|Physician Decision|2|||
24909434|NCT00379639|50003510|FG002|Overall Study|Physician Decision|1|||
24909435|NCT00379639|50003511|FG003|Overall Study|Physician Decision|1|||
24909436|NCT00379639|50003512|FG004|Overall Study|Physician Decision|0|||
24909437|NCT00379639|50003508|FG000|Overall Study|Symptomatic Deterioration|0|||
24909438|NCT00379639|50003509|FG001|Overall Study|Symptomatic Deterioration|0|||
24909439|NCT00379639|50003510|FG002|Overall Study|Symptomatic Deterioration|1|||
24909440|NCT00379639|50003511|FG003|Overall Study|Symptomatic Deterioration|0|||
24909441|NCT00379639|50003512|FG004|Overall Study|Symptomatic Deterioration|1|||
24909442|NCT00379639|50003508|FG000|Overall Study|Adverse Event|0|||
24909443|NCT00379639|50003509|FG001|Overall Study|Adverse Event|0|||
24909444|NCT00379639|50003510|FG002|Overall Study|Adverse Event|1|||
24909445|NCT00379639|50003511|FG003|Overall Study|Adverse Event|0|||
24909446|NCT00379639|50003512|FG004|Overall Study|Adverse Event|1|||
24909447|NCT00379639|50003508|FG000|Overall Study|Lost to Follow-up|0|||
24909448|NCT00379639|50003509|FG001|Overall Study|Lost to Follow-up|0|||
24909449|NCT00379639|50003510|FG002|Overall Study|Lost to Follow-up|0|||
24909450|NCT00379639|50003511|FG003|Overall Study|Lost to Follow-up|1|||
24909451|NCT00379639|50003512|FG004|Overall Study|Lost to Follow-up|0|||
24909452|NCT00379639|50003508|FG000|Overall Study|Other|0|||
24909453|NCT00379639|50003509|FG001|Overall Study|Other|0|||
24909454|NCT00379639|50003510|FG002|Overall Study|Other|3|||
24909455|NCT00379639|50003511|FG003|Overall Study|Other|0|||
24909456|NCT00379639|50003512|FG004|Overall Study|Other|0|||
24909457|NCT03948334|50003526|FG000|Overall Study|Adverse Event|1|||
24909458|NCT03948334|50003527|FG001|Overall Study|Adverse Event|4|||
24909459|NCT03948334|50003526|FG000|Overall Study|Lack of Efficacy|2|||
24909460|NCT03948334|50003527|FG001|Overall Study|Lack of Efficacy|0|||
24909461|NCT03948334|50003526|FG000|Overall Study|Lost to Follow-up|1|||
24909462|NCT03948334|50003527|FG001|Overall Study|Lost to Follow-up|0|||
24909463|NCT03948334|50003526|FG000|Overall Study|Physician Decision|1|||
24909464|NCT03948334|50003527|FG001|Overall Study|Physician Decision|0|||
24909465|NCT03948334|50003526|FG000|Overall Study|Pregnancy|0|||
24909466|NCT03948334|50003527|FG001|Overall Study|Pregnancy|1|||
24909467|NCT03948334|50003526|FG000|Overall Study|Protocol Deviation|1|||
25152824|NCT01811186|50267961|FG001|Overall Study|Withdrawal by Subject|10|||
24909468|NCT03948334|50003527|FG001|Overall Study|Protocol Deviation|0|||
24909469|NCT03948334|50003526|FG000|Overall Study|Study terminated by Sponsor|50|||
24909470|NCT03948334|50003527|FG001|Overall Study|Study terminated by Sponsor|51|||
24909471|NCT03948334|50003526|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
24909472|NCT03948334|50003527|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
24909473|NCT00609765|50003541|FG000|Overall Study|Study ended prior to 12 months|1|||
24909474|NCT00608829|50003545|FG000|Overall Study|Death|6|||
24909475|NCT00608829|50003545|FG000|Overall Study|Withdrawal by Subject|4|||
25152825|NCT01811186|50267960|FG000|Overall Study|Lack of Efficacy|3|||
24909476|NCT00608829|50003545|FG000|Overall Study|Subject refuses to follow up or return.|5|||
24909477|NCT00545818|50003551|FG000|Overall Study|Protocol Violation|1|||
24909478|NCT00545818|50003552|FG001|Overall Study|Protocol Violation|0|||
24909479|NCT00545818|50003551|FG000|Overall Study|Adverse Event|1|||
24909480|NCT00545818|50003552|FG001|Overall Study|Adverse Event|1|||
24909481|NCT00545818|50003551|FG000|Overall Study|Lost to Follow-up|1|||
24909482|NCT00545818|50003552|FG001|Overall Study|Lost to Follow-up|6|||
24909483|NCT00674154|50003560|FG000|Overall Study|Withdrawal by Subject|3|||
24909484|NCT00674154|50003561|FG001|Overall Study|Withdrawal by Subject|1|||
24909485|NCT00674154|50003560|FG000|Overall Study|Did not want parathyroidectomy|0|||
24909486|NCT00674154|50003561|FG001|Overall Study|Did not want parathyroidectomy|2|||
24909487|NCT00608517|50003570|FG000|Overall Study|Death|1|||
24909488|NCT00608517|50003571|FG001|Overall Study|Death|0|||
24909489|NCT00608517|50003572|FG002|Overall Study|Death|0|||
24909490|NCT00608205|50003583|FG000|Overall Study|Adverse Event|3|||
24909491|NCT00608205|50003584|FG001|Overall Study|Adverse Event|2|||
24909492|NCT00608205|50003583|FG000|Overall Study|Patient non-compliant|0|||
24909493|NCT00608205|50003584|FG001|Overall Study|Patient non-compliant|1|||
24909494|NCT00670800|50003594|FG000|Overall Study|2 controls were insulin resistant|0|||
24909495|NCT00670800|50003595|FG001|Overall Study|2 controls were insulin resistant|2|||
24909496|NCT00607893|50003605|FG000|Overall Study|Lost to Follow-up|4|||
24909497|NCT00607893|50003606|FG001|Overall Study|Lost to Follow-up|0|||
24909498|NCT00607893|50003605|FG000|Overall Study|withdrew due to loss of interest|0|||
24909499|NCT00607893|50003606|FG001|Overall Study|withdrew due to loss of interest|1|||
24909500|NCT00607893|50003605|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
24909501|NCT00607893|50003606|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
24909502|NCT00607893|50003605|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
24909503|NCT00607893|50003606|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
24909504|NCT00607893|50003605|FG000|Overall Study|Declined to be treated|1|||
24909505|NCT00607893|50003606|FG001|Overall Study|Declined to be treated|0|||
24909506|NCT00607893|50003605|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
24909507|NCT00607893|50003606|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
24909508|NCT00571038|50003616|FG000|Overall Study|Lost to Follow-up|1|||
24909509|NCT00571038|50003617|FG001|Overall Study|Lost to Follow-up|4|||
24909510|NCT00571038|50003616|FG000|Overall Study|Death|7|||
24909511|NCT00571038|50003617|FG001|Overall Study|Death|5|||
24909512|NCT00571038|50003616|FG000|Overall Study|Withdrawal by Subject|1|||
24909513|NCT00571038|50003617|FG001|Overall Study|Withdrawal by Subject|3|||
24909514|NCT00571038|50003616|FG000|Overall Study|Moved out of state|2|||
24909515|NCT00571038|50003617|FG001|Overall Study|Moved out of state|2|||
24909516|NCT00545740|50003627|FG000|Overall Study|Lack of Efficacy|34|||
24909517|NCT00545740|50003628|FG001|Overall Study|Lack of Efficacy|35|||
24909518|NCT00545740|50003629|FG002|Overall Study|Lack of Efficacy|47|||
24909519|NCT00545740|50003630|FG003|Overall Study|Lack of Efficacy|36|||
24909520|NCT00545740|50003627|FG000|Overall Study|Withdrawal by Subject|17|||
24909521|NCT00545740|50003628|FG001|Overall Study|Withdrawal by Subject|15|||
24909522|NCT00545740|50003629|FG002|Overall Study|Withdrawal by Subject|16|||
24909523|NCT00545740|50003630|FG003|Overall Study|Withdrawal by Subject|18|||
24909524|NCT00545740|50003627|FG000|Overall Study|Adverse Event|10|||
24909525|NCT00545740|50003628|FG001|Overall Study|Adverse Event|18|||
24909526|NCT00545740|50003629|FG002|Overall Study|Adverse Event|19|||
24909527|NCT00545740|50003630|FG003|Overall Study|Adverse Event|9|||
24909528|NCT00545740|50003627|FG000|Overall Study|Lost to Follow-up|7|||
24909529|NCT00545740|50003628|FG001|Overall Study|Lost to Follow-up|5|||
24909530|NCT00545740|50003629|FG002|Overall Study|Lost to Follow-up|5|||
24909531|NCT00545740|50003630|FG003|Overall Study|Lost to Follow-up|6|||
24909532|NCT00545740|50003627|FG000|Overall Study|Protocol Violation|1|||
24909533|NCT00545740|50003628|FG001|Overall Study|Protocol Violation|3|||
24909534|NCT00545740|50003629|FG002|Overall Study|Protocol Violation|1|||
24909535|NCT00545740|50003630|FG003|Overall Study|Protocol Violation|0|||
24909536|NCT00545740|50003627|FG000|Overall Study|Non-compliance|0|||
24909537|NCT00545740|50003628|FG001|Overall Study|Non-compliance|2|||
24909538|NCT00545740|50003629|FG002|Overall Study|Non-compliance|1|||
24909539|NCT00545740|50003630|FG003|Overall Study|Non-compliance|0|||
24909540|NCT00545740|50003627|FG000|Overall Study|Moved|2|||
24909541|NCT00545740|50003628|FG001|Overall Study|Moved|0|||
24909542|NCT00545740|50003629|FG002|Overall Study|Moved|1|||
24909543|NCT00545740|50003630|FG003|Overall Study|Moved|0|||
24909544|NCT00545740|50003627|FG000|Overall Study|Diverticulitis attack|0|||
24909545|NCT00545740|50003628|FG001|Overall Study|Diverticulitis attack|0|||
24909546|NCT00545740|50003629|FG002|Overall Study|Diverticulitis attack|1|||
24909547|NCT00545740|50003630|FG003|Overall Study|Diverticulitis attack|1|||
24909548|NCT00545740|50003627|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
24909549|NCT00545740|50003628|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
24909550|NCT00545740|50003629|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
24909551|NCT00545740|50003630|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
24909552|NCT00545740|50003627|FG000|Overall Study|Site closure|1|||
24909553|NCT00545740|50003628|FG001|Overall Study|Site closure|0|||
24909554|NCT00545740|50003629|FG002|Overall Study|Site closure|0|||
24909555|NCT00545740|50003630|FG003|Overall Study|Site closure|0|||
24909556|NCT00545740|50003627|FG000|Overall Study|Missed visit|1|||
24909557|NCT00545740|50003628|FG001|Overall Study|Missed visit|0|||
24909558|NCT00545740|50003629|FG002|Overall Study|Missed visit|0|||
24909559|NCT00545740|50003630|FG003|Overall Study|Missed visit|0|||
24909560|NCT00545740|50003627|FG000|Overall Study|Physician Decision|0|||
24909561|NCT00545740|50003628|FG001|Overall Study|Physician Decision|0|||
24909562|NCT00545740|50003629|FG002|Overall Study|Physician Decision|3|||
24909563|NCT00545740|50003630|FG003|Overall Study|Physician Decision|0|||
24909564|NCT00545740|50003627|FG000|Overall Study|Accepted only monthly telephone calls|1|||
24909565|NCT00545740|50003628|FG001|Overall Study|Accepted only monthly telephone calls|0|||
24909566|NCT00545740|50003629|FG002|Overall Study|Accepted only monthly telephone calls|0|||
24909567|NCT00545740|50003630|FG003|Overall Study|Accepted only monthly telephone calls|0|||
25019278|NCT00706654|50115260|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
24909568|NCT00545740|50003627|FG000|Overall Study|Sponsor decision|0|||
24909569|NCT00545740|50003628|FG001|Overall Study|Sponsor decision|1|||
24909570|NCT00545740|50003629|FG002|Overall Study|Sponsor decision|0|||
24909571|NCT00545740|50003630|FG003|Overall Study|Sponsor decision|0|||
24909572|NCT00545740|50003627|FG000|Overall Study|Lack of time|0|||
24909573|NCT00545740|50003628|FG001|Overall Study|Lack of time|1|||
24909574|NCT00545740|50003629|FG002|Overall Study|Lack of time|0|||
24909575|NCT00545740|50003630|FG003|Overall Study|Lack of time|0|||
24909576|NCT00545740|50003627|FG000|Overall Study|Non-adherence to visits|0|||
24909577|NCT00545740|50003628|FG001|Overall Study|Non-adherence to visits|1|||
24909578|NCT00545740|50003629|FG002|Overall Study|Non-adherence to visits|0|||
24909579|NCT00545740|50003630|FG003|Overall Study|Non-adherence to visits|0|||
24909580|NCT00545740|50003627|FG000|Overall Study|Patient difficulties|0|||
24909581|NCT00545740|50003628|FG001|Overall Study|Patient difficulties|1|||
24909582|NCT00545740|50003629|FG002|Overall Study|Patient difficulties|0|||
24909583|NCT00545740|50003630|FG003|Overall Study|Patient difficulties|0|||
24909584|NCT00545740|50003627|FG000|Overall Study|Husband against study|0|||
24909585|NCT00545740|50003628|FG001|Overall Study|Husband against study|0|||
24909586|NCT00545740|50003629|FG002|Overall Study|Husband against study|1|||
24909587|NCT00545740|50003630|FG003|Overall Study|Husband against study|0|||
24909588|NCT00609609|50003642|FG000|Overall Study|Withdrawal by Subject|2|||
24909589|NCT00609609|50003643|FG001|Overall Study|Withdrawal by Subject|0|||
24909590|NCT00609609|50003642|FG000|Overall Study|Progression|4|||
24909591|NCT00609609|50003643|FG001|Overall Study|Progression|2|||
24909592|NCT00673452|50003651|FG000|Acute Double-Blind Phase|Adverse Event|41|||
24909593|NCT00673452|50003652|FG001|Acute Double-Blind Phase|Adverse Event|24|||
24909594|NCT00673452|50003651|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
24909595|NCT00673452|50003652|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
24909596|NCT00673452|50003651|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
24909597|NCT00673452|50003652|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
24909598|NCT00673452|50003651|FG000|Acute Double-Blind Phase|Physician Decision|0|||
24909599|NCT00673452|50003652|FG001|Acute Double-Blind Phase|Physician Decision|6|||
24909600|NCT00673452|50003651|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
24909601|NCT00673452|50003652|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
24909602|NCT00673452|50003651|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
24909603|NCT00673452|50003652|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
24909604|NCT00673452|50003651|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
24909605|NCT00673452|50003652|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
24909606|NCT00673452|50003651|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
24909607|NCT00673452|50003652|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
24909608|NCT00673452|50003651|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
24909609|NCT00673452|50003652|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
24909610|NCT00673452|50003651|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
24909611|NCT00673452|50003652|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
24909612|NCT00673452|50003651|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
25019279|NCT00706654|50115261|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
25019280|NCT00706654|50115258|FG000|Conversion Phase|Withdrawn by Investigator|14|||
25019281|NCT00706654|50115259|FG001|Conversion Phase|Withdrawn by Investigator|0|||
25019282|NCT00706654|50115260|FG002|Conversion Phase|Withdrawn by Investigator|0|||
25019283|NCT00706654|50115261|FG003|Conversion Phase|Withdrawn by Investigator|0|||
25274864|NCT00976456|50588937|FG001|Overall Study|Death|9|||
25274865|NCT00976456|50588936|FG000|Overall Study|Lack of Efficacy|5|||
25274866|NCT00976456|50588937|FG001|Overall Study|Lack of Efficacy|2|||
25274867|NCT00976456|50588936|FG000|Overall Study|Withdrawal by Subject|3|||
25274868|NCT00976456|50588937|FG001|Overall Study|Withdrawal by Subject|1|||
25274869|NCT00976456|50588936|FG000|Overall Study|screening failure, unknown|11|||
25274870|NCT00976456|50588937|FG001|Overall Study|screening failure, unknown|4|||
25274871|NCT01243151|50588948|FG000|Overall Study|Adverse Event|0|||
25274872|NCT01243151|50588949|FG001|Overall Study|Adverse Event|1|||
25274873|NCT01243151|50588950|FG002|Overall Study|Adverse Event|0|||
25274874|NCT01243151|50588951|FG003|Overall Study|Adverse Event|0|||
25274875|NCT01243151|50588952|FG004|Overall Study|Adverse Event|0|||
25274876|NCT01243151|50588948|FG000|Overall Study|Protocol Violation|0|||
24909613|NCT00673452|50003652|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
25274877|NCT01243151|50588949|FG001|Overall Study|Protocol Violation|0|||
24909614|NCT00673452|50003651|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
24909615|NCT00673452|50003652|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
25274878|NCT01243151|50588950|FG002|Overall Study|Protocol Violation|1|||
25274879|NCT01243151|50588951|FG003|Overall Study|Protocol Violation|0|||
25274880|NCT01243151|50588952|FG004|Overall Study|Protocol Violation|0|||
25274881|NCT01243151|50588948|FG000|Overall Study|Other|0|||
25274882|NCT01243151|50588949|FG001|Overall Study|Other|0|||
25274883|NCT01243151|50588950|FG002|Overall Study|Other|0|||
25274884|NCT01243151|50588951|FG003|Overall Study|Other|1|||
25274885|NCT01243151|50588952|FG004|Overall Study|Other|0|||
25274886|NCT01243151|50588948|FG000|Overall Study|Randomized but not treated|0|||
25274887|NCT01243151|50588949|FG001|Overall Study|Randomized but not treated|0|||
25274888|NCT01243151|50588950|FG002|Overall Study|Randomized but not treated|0|||
25274889|NCT01243151|50588951|FG003|Overall Study|Randomized but not treated|1|||
25274890|NCT01243151|50588952|FG004|Overall Study|Randomized but not treated|0|||
25274891|NCT00993148|50588968|FG000|Overall Study|Lost to Follow-up|2|||
25274892|NCT00993148|50588968|FG000|Overall Study|never initiated treatment|1|||
25274893|NCT00907621|50588974|FG000|Overall Study|Lost to Follow-up|6|||
24909616|NCT00673452|50003651|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
24909617|NCT00673452|50003652|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
24909618|NCT00673452|50003651|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
24909619|NCT00673452|50003652|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
24909620|NCT00673452|50003651|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
24909621|NCT00673452|50003652|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
24909622|NCT00545584|50003661|FG000|Overall Study|Only one reason for discontinuation|62|||
24909623|NCT00545584|50003662|FG001|Overall Study|Only one reason for discontinuation|61|||
24909624|NCT00545584|50003663|FG002|Overall Study|Only one reason for discontinuation|48|||
24909625|NCT00545584|50003661|FG000|Overall Study|Two or more reasons for discontinuation|17|||
24909626|NCT00545584|50003662|FG001|Overall Study|Two or more reasons for discontinuation|19|||
24909627|NCT00545584|50003663|FG002|Overall Study|Two or more reasons for discontinuation|8|||
24909628|NCT00378703|50003675|FG000|Overall Study|Disease progression|59|||
24909629|NCT00378703|50003676|FG001|Overall Study|Disease progression|43|||
24909630|NCT00378703|50003677|FG002|Overall Study|Disease progression|48|||
24909631|NCT00378703|50003678|FG003|Overall Study|Disease progression|49|||
24909632|NCT00378703|50003675|FG000|Overall Study|Adverse Event|11|||
24909633|NCT00378703|50003676|FG001|Overall Study|Adverse Event|17|||
24909634|NCT00378703|50003677|FG002|Overall Study|Adverse Event|20|||
24909635|NCT00378703|50003678|FG003|Overall Study|Adverse Event|18|||
24909636|NCT00378703|50003675|FG000|Overall Study|Death|2|||
24909637|NCT00378703|50003676|FG001|Overall Study|Death|2|||
24909638|NCT00378703|50003677|FG002|Overall Study|Death|4|||
24909639|NCT00378703|50003678|FG003|Overall Study|Death|3|||
24909640|NCT00378703|50003675|FG000|Overall Study|Withdrawal by Subject|4|||
24909641|NCT00378703|50003676|FG001|Overall Study|Withdrawal by Subject|8|||
24909642|NCT00378703|50003677|FG002|Overall Study|Withdrawal by Subject|5|||
24909643|NCT00378703|50003678|FG003|Overall Study|Withdrawal by Subject|7|||
24909644|NCT00378703|50003675|FG000|Overall Study|Physician Decision|1|||
24909645|NCT00378703|50003676|FG001|Overall Study|Physician Decision|4|||
24909646|NCT00378703|50003677|FG002|Overall Study|Physician Decision|1|||
24909647|NCT00378703|50003678|FG003|Overall Study|Physician Decision|0|||
24909648|NCT00378703|50003675|FG000|Overall Study|Alternative therapy|4|||
24909649|NCT00378703|50003676|FG001|Overall Study|Alternative therapy|2|||
24909650|NCT00378703|50003677|FG002|Overall Study|Alternative therapy|0|||
25152826|NCT01811186|50267961|FG001|Overall Study|Lack of Efficacy|6|||
25152827|NCT01811186|50267960|FG000|Overall Study|Lost to Follow-up|4|||
25152828|NCT01811186|50267961|FG001|Overall Study|Lost to Follow-up|2|||
25152829|NCT01866098|50267974|FG000|Overall Study|Lost to Follow-up|11|||
25152830|NCT01866098|50267975|FG001|Overall Study|Lost to Follow-up|18|||
25152831|NCT01866098|50267976|FG002|Overall Study|Lost to Follow-up|13|||
25152832|NCT01866098|50267974|FG000|Overall Study|Physician Decision|0|||
24909651|NCT00378703|50003678|FG003|Overall Study|Alternative therapy|0|||
24909652|NCT00378703|50003675|FG000|Overall Study|Other complicated disease|0|||
24909653|NCT00378703|50003676|FG001|Overall Study|Other complicated disease|2|||
24909654|NCT00378703|50003677|FG002|Overall Study|Other complicated disease|2|||
25152833|NCT01866098|50267975|FG001|Overall Study|Physician Decision|1|||
25152834|NCT01866098|50267976|FG002|Overall Study|Physician Decision|2|||
25274894|NCT00907621|50588975|FG001|Overall Study|Lost to Follow-up|3|||
24909655|NCT00378703|50003678|FG003|Overall Study|Other complicated disease|0|||
24909656|NCT00378703|50003675|FG000|Overall Study|Symptomatic deterioration|0|||
25152835|NCT01866098|50267974|FG000|Overall Study|Adverse Event|1|||
24909657|NCT00378703|50003676|FG001|Overall Study|Symptomatic deterioration|1|||
24909658|NCT00378703|50003677|FG002|Overall Study|Symptomatic deterioration|0|||
24909659|NCT00378703|50003678|FG003|Overall Study|Symptomatic deterioration|2|||
24909660|NCT00378703|50003675|FG000|Overall Study|Surgery|1|||
24909661|NCT00378703|50003676|FG001|Overall Study|Surgery|0|||
24909662|NCT00378703|50003677|FG002|Overall Study|Surgery|0|||
24909663|NCT00378703|50003678|FG003|Overall Study|Surgery|1|||
25019284|NCT00706654|50115258|FG000|Conversion Phase|Withdrew Consent|38|||
25152836|NCT01866098|50267975|FG001|Overall Study|Adverse Event|5|||
25274895|NCT00907621|50588974|FG000|Overall Study|intercurrent febrile illness|1|||
24909664|NCT00378703|50003675|FG000|Overall Study|Joint decision of physician and patient|1|||
24909665|NCT00378703|50003676|FG001|Overall Study|Joint decision of physician and patient|0|||
24909666|NCT00378703|50003677|FG002|Overall Study|Joint decision of physician and patient|0|||
24909667|NCT00378703|50003678|FG003|Overall Study|Joint decision of physician and patient|0|||
24909668|NCT00378703|50003675|FG000|Overall Study|Adverse events and progressive disease|0|||
25152837|NCT01866098|50267976|FG002|Overall Study|Adverse Event|4|||
25152838|NCT01866098|50267974|FG000|Overall Study|Protocol Violation|1|||
25152839|NCT01866098|50267975|FG001|Overall Study|Protocol Violation|0|||
25152840|NCT01866098|50267976|FG002|Overall Study|Protocol Violation|0|||
24909669|NCT00378703|50003676|FG001|Overall Study|Adverse events and progressive disease|0|||
24909670|NCT00378703|50003677|FG002|Overall Study|Adverse events and progressive disease|0|||
24909671|NCT00378703|50003678|FG003|Overall Study|Adverse events and progressive disease|1|||
24909672|NCT00378703|50003675|FG000|Overall Study|Relocation|0|||
24909673|NCT00378703|50003676|FG001|Overall Study|Relocation|0|||
24909674|NCT00378703|50003677|FG002|Overall Study|Relocation|1|||
24909675|NCT00378703|50003678|FG003|Overall Study|Relocation|0|||
24909676|NCT00378703|50003675|FG000|Overall Study|Ineligible|4|||
24909677|NCT00378703|50003676|FG001|Overall Study|Ineligible|7|||
24909678|NCT00378703|50003677|FG002|Overall Study|Ineligible|7|||
24909679|NCT00378703|50003678|FG003|Overall Study|Ineligible|7|||
24909680|NCT00378703|50003675|FG000|Overall Study|Never started treatment|1|||
24909681|NCT00378703|50003676|FG001|Overall Study|Never started treatment|4|||
24909682|NCT00378703|50003677|FG002|Overall Study|Never started treatment|0|||
24909683|NCT00378703|50003678|FG003|Overall Study|Never started treatment|0|||
24909684|NCT00378703|50003675|FG000|Overall Study|Other|1|||
24909685|NCT00378703|50003676|FG001|Overall Study|Other|1|||
24909686|NCT00378703|50003677|FG002|Overall Study|Other|2|||
24909687|NCT00378703|50003678|FG003|Overall Study|Other|3|||
24909688|NCT00368641|50003694|FG000|Overall Study|Adverse Event|2|||
24909689|NCT00368641|50003695|FG001|Overall Study|Adverse Event|1|||
24909690|NCT00368641|50003694|FG000|Overall Study|Death|1|||
24909691|NCT00368641|50003695|FG001|Overall Study|Death|0|||
24909692|NCT00368641|50003694|FG000|Overall Study|Withdrawal by Subject|1|||
24909693|NCT00368641|50003695|FG001|Overall Study|Withdrawal by Subject|0|||
24909694|NCT00368641|50003694|FG000|Overall Study|Sponsor decision to terminate study|2|||
24909695|NCT00368641|50003695|FG001|Overall Study|Sponsor decision to terminate study|5|||
24909696|NCT00608985|50003705|FG000|Overall Study|Adverse Event|2|||
24909697|NCT00608985|50003706|FG001|Overall Study|Adverse Event|7|||
24909698|NCT00608985|50003707|FG002|Overall Study|Adverse Event|4|||
24909699|NCT00608985|50003708|FG003|Overall Study|Adverse Event|6|||
24909700|NCT00608985|50003705|FG000|Overall Study|Administrative/Other|7|||
24909701|NCT00608985|50003706|FG001|Overall Study|Administrative/Other|4|||
24909702|NCT00608985|50003707|FG002|Overall Study|Administrative/Other|1|||
24909703|NCT00608985|50003708|FG003|Overall Study|Administrative/Other|2|||
24909704|NCT00608985|50003705|FG000|Overall Study|Withdrawal of Consent|5|||
24909705|NCT00608985|50003706|FG001|Overall Study|Withdrawal of Consent|1|||
24909706|NCT00608985|50003707|FG002|Overall Study|Withdrawal of Consent|1|||
24909707|NCT00608985|50003708|FG003|Overall Study|Withdrawal of Consent|1|||
24909708|NCT00608985|50003705|FG000|Overall Study|Lost to Follow-up|2|||
24909709|NCT00608985|50003706|FG001|Overall Study|Lost to Follow-up|1|||
24909710|NCT00608985|50003707|FG002|Overall Study|Lost to Follow-up|0|||
24909711|NCT00608985|50003708|FG003|Overall Study|Lost to Follow-up|0|||
24909712|NCT00368251|50003721|FG000|Overall Study|SAE, non-fatal|1|||
24909713|NCT00368251|50003722|FG001|Overall Study|SAE, non-fatal|0|||
24909714|NCT00368251|50003723|FG002|Overall Study|SAE, non-fatal|0|||
24909715|NCT00368251|50003721|FG000|Overall Study|AE, non-serious non-fatal|0|||
24909716|NCT00368251|50003722|FG001|Overall Study|AE, non-serious non-fatal|0|||
24909717|NCT00368251|50003723|FG002|Overall Study|AE, non-serious non-fatal|1|||
24909718|NCT00378079|50003734|FG000|Overall Study|Lost to Follow-up|6|||
24909719|NCT00378079|50003735|FG001|Overall Study|Lost to Follow-up|1|||
24909720|NCT00378079|50003736|FG002|Overall Study|Lost to Follow-up|0|||
24909721|NCT03936244|50003746|FG000|Overall Study|Lost to Follow-up|5|||
24909722|NCT03936244|50003747|FG001|Overall Study|Lost to Follow-up|1|||
24909723|NCT03936244|50003746|FG000|Overall Study|Physician Decision|7|||
24909724|NCT03936244|50003747|FG001|Overall Study|Physician Decision|3|||
24909725|NCT03923530|50003754|FG000|Overall Study|Withdrawal by Subject|1|||
24909726|NCT03923530|50003754|FG000|Overall Study|screen failure|3|||
24909727|NCT00608907|50003761|FG000|Overall Study|Adverse Event|6|||
24909728|NCT00608907|50003762|FG001|Overall Study|Adverse Event|0|||
24909729|NCT00608907|50003763|FG002|Overall Study|Adverse Event|1|||
24909730|NCT00608907|50003761|FG000|Overall Study|Death|1|||
24909731|NCT00608907|50003762|FG001|Overall Study|Death|0|||
24909732|NCT00608907|50003763|FG002|Overall Study|Death|0|||
24909733|NCT00608907|50003761|FG000|Overall Study|Withdrawal by Subject|4|||
24909734|NCT00608907|50003762|FG001|Overall Study|Withdrawal by Subject|0|||
24909735|NCT00608907|50003763|FG002|Overall Study|Withdrawal by Subject|0|||
25152841|NCT01866098|50267974|FG000|Overall Study|Withdrawal by Subject|1|||
24909736|NCT00608907|50003761|FG000|Overall Study|Progressive Disease|1|||
24909737|NCT00608907|50003762|FG001|Overall Study|Progressive Disease|0|||
25152842|NCT01866098|50267975|FG001|Overall Study|Withdrawal by Subject|2|||
25152843|NCT01866098|50267976|FG002|Overall Study|Withdrawal by Subject|0|||
25152844|NCT01866098|50267974|FG000|Overall Study|Unrelated Hospitalization|2|||
24909738|NCT00608907|50003763|FG002|Overall Study|Progressive Disease|0|||
24909739|NCT00377611|50003773|FG000|Overall Study|Adverse Event|2|||
24909740|NCT00377611|50003774|FG001|Overall Study|Adverse Event|9|||
25152845|NCT01866098|50267975|FG001|Overall Study|Unrelated Hospitalization|0|||
25152846|NCT01866098|50267976|FG002|Overall Study|Unrelated Hospitalization|1|||
25152847|NCT01866098|50267974|FG000|Overall Study|Non-compliance|1|||
25152848|NCT01866098|50267975|FG001|Overall Study|Non-compliance|0|||
25152849|NCT01866098|50267976|FG002|Overall Study|Non-compliance|1|||
25152850|NCT01866098|50267974|FG000|Overall Study|Pregnancy|2|||
25152851|NCT01866098|50267975|FG001|Overall Study|Pregnancy|0|||
25152852|NCT01866098|50267976|FG002|Overall Study|Pregnancy|0|||
25152853|NCT01866098|50267974|FG000|Overall Study|Death|0|||
25152854|NCT01866098|50267975|FG001|Overall Study|Death|1|||
25152855|NCT01866098|50267976|FG002|Overall Study|Death|0|||
25152856|NCT01865552|50267990|FG000|Period 1|Adverse Event|1|||
25152857|NCT01865552|50267991|FG001|Period 1|Adverse Event|0|||
25152858|NCT01865552|50267992|FG002|Period 1|Adverse Event|0|||
25152859|NCT01865552|50267993|FG003|Period 1|Adverse Event|1|||
25152860|NCT01865552|50267994|FG004|Period 1|Adverse Event|1|||
25152861|NCT01865552|50267995|FG005|Period 1|Adverse Event|1|||
25152862|NCT01865552|50267990|FG000|Period 1|Pathological lab|0|||
25152863|NCT01865552|50267991|FG001|Period 1|Pathological lab|0|||
25152864|NCT01865552|50267992|FG002|Period 1|Pathological lab|0|||
25152865|NCT01865552|50267993|FG003|Period 1|Pathological lab|0|||
25152866|NCT01865552|50267994|FG004|Period 1|Pathological lab|1|||
25152867|NCT01865552|50267995|FG005|Period 1|Pathological lab|0|||
25152868|NCT01865552|50267990|FG000|Period 1|Other|0|||
25152869|NCT01865552|50267991|FG001|Period 1|Other|0|||
25152870|NCT01865552|50267992|FG002|Period 1|Other|0|||
25152871|NCT01865552|50267993|FG003|Period 1|Other|0|||
25152872|NCT01865552|50267994|FG004|Period 1|Other|1|||
25152873|NCT01865552|50267995|FG005|Period 1|Other|0|||
25152874|NCT01809314|50268009|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
25152875|NCT01809314|50268009|FG000|Overall Study|Adverse Event|6|||
25152876|NCT01809314|50268009|FG000|Overall Study|Insufficient Therapeutic Response|14|||
25152877|NCT01809314|50268009|FG000|Overall Study|Lost to Follow-up|724|||
25152878|NCT01803464|50268017|FG000|Overall Study|Incomplete data|0|||
25152879|NCT01803464|50268018|FG001|Overall Study|Incomplete data|0|||
25152880|NCT01803464|50268019|FG002|Overall Study|Incomplete data|4|||
25152881|NCT01803464|50268020|FG003|Overall Study|Incomplete data|0|||
25152882|NCT01803464|50268017|FG000|Overall Study|Withdrawal by Subject|1|||
25152883|NCT01803464|50268018|FG001|Overall Study|Withdrawal by Subject|0|||
25152884|NCT01803464|50268019|FG002|Overall Study|Withdrawal by Subject|0|||
25152885|NCT01803464|50268020|FG003|Overall Study|Withdrawal by Subject|0|||
25152886|NCT01808690|50268036|FG000|Overall Study|Withdrawal by Subject|1|||
25152887|NCT01808690|50268037|FG001|Overall Study|Withdrawal by Subject|2|||
25152888|NCT01363297|50268048|FG000|Overall Study|Other|0|||
25152889|NCT01363297|50268049|FG001|Overall Study|Other|0|||
25152890|NCT01363297|50268050|FG002|Overall Study|Other|0|||
25152891|NCT01363297|50268051|FG003|Overall Study|Other|0|||
25152892|NCT01363297|50268052|FG004|Overall Study|Other|1|||
25152893|NCT01363297|50268048|FG000|Overall Study|Death|3|||
25152894|NCT01363297|50268049|FG001|Overall Study|Death|6|||
25152895|NCT01363297|50268050|FG002|Overall Study|Death|6|||
25152896|NCT01363297|50268051|FG003|Overall Study|Death|10|||
25152897|NCT01363297|50268052|FG004|Overall Study|Death|30|||
25152898|NCT01908907|50268071|FG000|Overall Study|Physician Decision|1|||
25152899|NCT01908907|50268072|FG001|Overall Study|Physician Decision|0|||
25152900|NCT01908907|50268071|FG000|Overall Study|Protocol Violation|1|||
24909741|NCT00377611|50003773|FG000|Overall Study|Protocol Violation|2|||
24909742|NCT00377611|50003774|FG001|Overall Study|Protocol Violation|0|||
25152901|NCT01908907|50268072|FG001|Overall Study|Protocol Violation|0|||
25152902|NCT01808612|50268085|FG000|Treatment Period|Adverse Event|8|||
25152903|NCT01808612|50268086|FG001|Treatment Period|Adverse Event|4|||
25152904|NCT01808612|50268087|FG002|Treatment Period|Adverse Event|3|||
25152905|NCT01808612|50268085|FG000|Treatment Period|Lost to Follow-up|2|||
25152906|NCT01808612|50268086|FG001|Treatment Period|Lost to Follow-up|2|||
25152907|NCT01808612|50268087|FG002|Treatment Period|Lost to Follow-up|1|||
25152908|NCT01808612|50268085|FG000|Treatment Period|Protocol Violation|1|||
25019285|NCT00706654|50115259|FG001|Conversion Phase|Withdrew Consent|0|||
25019286|NCT00706654|50115260|FG002|Conversion Phase|Withdrew Consent|0|||
25019287|NCT00706654|50115261|FG003|Conversion Phase|Withdrew Consent|0|||
25019288|NCT00706654|50115258|FG000|Conversion Phase|Adverse Event|18|||
25019289|NCT00706654|50115259|FG001|Conversion Phase|Adverse Event|0|||
25019290|NCT00706654|50115260|FG002|Conversion Phase|Adverse Event|0|||
25019291|NCT00706654|50115261|FG003|Conversion Phase|Adverse Event|0|||
25019292|NCT00706654|50115258|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
25019293|NCT00706654|50115259|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
25019294|NCT00706654|50115260|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
24909743|NCT00377611|50003773|FG000|Overall Study|Withdrawal by Subject|0|||
24909744|NCT00377611|50003774|FG001|Overall Study|Withdrawal by Subject|5|||
24909745|NCT00377611|50003773|FG000|Overall Study|Lost to Follow-up|18|||
24909746|NCT00377611|50003774|FG001|Overall Study|Lost to Follow-up|16|||
24909747|NCT00377611|50003773|FG000|Overall Study|Other|0|||
24909748|NCT00377611|50003774|FG001|Overall Study|Other|3|||
24909749|NCT00545272|50003787|FG000|Overall Study|Protocol deviation|0|||
24909750|NCT00545272|50003788|FG001|Overall Study|Protocol deviation|1|||
24909751|NCT00545272|50003789|FG002|Overall Study|Protocol deviation|0|||
24909752|NCT00545272|50003790|FG003|Overall Study|Protocol deviation|1|||
24909753|NCT00545272|50003791|FG004|Overall Study|Protocol deviation|0|||
24909754|NCT00545272|50003792|FG005|Overall Study|Protocol deviation|1|||
24909755|NCT00545272|50003787|FG000|Overall Study|Adverse Event|0|||
24909756|NCT00545272|50003788|FG001|Overall Study|Adverse Event|0|||
24909757|NCT00545272|50003789|FG002|Overall Study|Adverse Event|1|||
24909758|NCT00545272|50003790|FG003|Overall Study|Adverse Event|0|||
24909759|NCT00545272|50003791|FG004|Overall Study|Adverse Event|0|||
24909760|NCT00545272|50003792|FG005|Overall Study|Adverse Event|1|||
24909761|NCT00545272|50003787|FG000|Overall Study|Abnormal laboratory value(s)|0|||
24909762|NCT00545272|50003788|FG001|Overall Study|Abnormal laboratory value(s)|0|||
24909763|NCT00545272|50003789|FG002|Overall Study|Abnormal laboratory value(s)|0|||
24909764|NCT00545272|50003790|FG003|Overall Study|Abnormal laboratory value(s)|0|||
24909765|NCT00545272|50003791|FG004|Overall Study|Abnormal laboratory value(s)|0|||
24909766|NCT00545272|50003792|FG005|Overall Study|Abnormal laboratory value(s)|1|||
24909767|NCT00545272|50003787|FG000|Overall Study|Abnormal test procedure result(s)|0|||
24909768|NCT00545272|50003788|FG001|Overall Study|Abnormal test procedure result(s)|0|||
24909769|NCT00545272|50003789|FG002|Overall Study|Abnormal test procedure result(s)|0|||
24909770|NCT00545272|50003790|FG003|Overall Study|Abnormal test procedure result(s)|0|||
24909771|NCT00545272|50003791|FG004|Overall Study|Abnormal test procedure result(s)|1|||
24909772|NCT00545272|50003792|FG005|Overall Study|Abnormal test procedure result(s)|0|||
24909773|NCT00545272|50003787|FG000|Overall Study|Lost to Follow-up|0|||
24909774|NCT00545272|50003788|FG001|Overall Study|Lost to Follow-up|0|||
24909775|NCT00545272|50003789|FG002|Overall Study|Lost to Follow-up|0|||
24909776|NCT00545272|50003790|FG003|Overall Study|Lost to Follow-up|0|||
24909777|NCT00545272|50003791|FG004|Overall Study|Lost to Follow-up|1|||
24909778|NCT00545272|50003792|FG005|Overall Study|Lost to Follow-up|0|||
24909779|NCT00377455|50003806|FG000|Overall Study|Withdrawal by Subject|1|||
24909780|NCT00377299|50003812|FG000|Overall Study|Lost to Follow-up|14|||
24909781|NCT00377299|50003813|FG001|Overall Study|Lost to Follow-up|19|||
25019295|NCT00706654|50115261|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
25019296|NCT00706654|50115258|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
25019297|NCT00706654|50115259|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
25152909|NCT01808612|50268086|FG001|Treatment Period|Protocol Violation|0|||
25274896|NCT00907621|50588975|FG001|Overall Study|intercurrent febrile illness|1|||
24909782|NCT00377299|50003812|FG000|Overall Study|Adverse Event|0|||
24909783|NCT00377299|50003813|FG001|Overall Study|Adverse Event|1|||
25019298|NCT00706654|50115260|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
25019299|NCT00706654|50115261|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
24909784|NCT00377299|50003812|FG000|Overall Study|Withdrawal by Subject|5|||
24909785|NCT00377299|50003813|FG001|Overall Study|Withdrawal by Subject|4|||
24909786|NCT00376675|50003822|FG000|Overall Study|Withdrawal by Subject|9|||
24909787|NCT00376675|50003823|FG001|Overall Study|Withdrawal by Subject|2|||
24909788|NCT00376675|50003822|FG000|Overall Study|Adverse Event|10|||
24909789|NCT00376675|50003823|FG001|Overall Study|Adverse Event|5|||
25019300|NCT00706654|50115258|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
24909790|NCT00376675|50003822|FG000|Overall Study|Other Reason|1|||
24909791|NCT00376675|50003823|FG001|Overall Study|Other Reason|7|||
24909792|NCT03931330|50003829|FG000|Overall Study|Physician Decision|1|||
24909793|NCT00367237|50003836|FG000|Overall Study|Adverse Event|7|||
24909794|NCT00367237|50003837|FG001|Overall Study|Adverse Event|2|||
24909795|NCT00367237|50003836|FG000|Overall Study|Lost to Follow-up|1|||
24909796|NCT00367237|50003837|FG001|Overall Study|Lost to Follow-up|0|||
24909797|NCT00367237|50003836|FG000|Overall Study|Withdrawal by Subject|0|||
24909798|NCT00367237|50003837|FG001|Overall Study|Withdrawal by Subject|4|||
24909799|NCT00367237|50003836|FG000|Overall Study|Protocol Violation|2|||
24909800|NCT00367237|50003837|FG001|Overall Study|Protocol Violation|5|||
24909801|NCT00544882|50003845|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
24909802|NCT00544882|50003846|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
24909803|NCT00544882|50003847|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
25019301|NCT00706654|50115259|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
25019302|NCT00706654|50115260|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
25019303|NCT00706654|50115261|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
25019304|NCT00706654|50115258|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
25019305|NCT00706654|50115259|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
25019306|NCT00706654|50115260|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
24909804|NCT00544882|50003845|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
24909805|NCT00544882|50003846|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
24909806|NCT00544882|50003847|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
24909807|NCT00544882|50003845|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
24909808|NCT00544882|50003846|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
24909809|NCT00544882|50003847|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
24909810|NCT00544882|50003845|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
24909811|NCT00544882|50003846|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
24909812|NCT00544882|50003847|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
24909813|NCT00544882|50003845|FG000|Cycle 3: Follow-up|Noncompliance|0|||
24909814|NCT00544882|50003846|FG001|Cycle 3: Follow-up|Noncompliance|1|||
24909815|NCT00544882|50003847|FG002|Cycle 3: Follow-up|Noncompliance|0|||
24909816|NCT00544882|50003845|FG000|Cycle 3: Follow-up|Pregnancy|0|||
24909817|NCT00544882|50003846|FG001|Cycle 3: Follow-up|Pregnancy|1|||
24909818|NCT00544882|50003847|FG002|Cycle 3: Follow-up|Pregnancy|0|||
24909819|NCT00606801|50003855|FG000|Intervention|Protocol Violation|3|||
24909820|NCT00606801|50003856|FG001|Intervention|Protocol Violation|3|||
24909821|NCT00606177|50003868|FG000|Overall Study|Adverse Event|9|||
24909822|NCT00606177|50003869|FG001|Overall Study|Adverse Event|5|||
24909823|NCT00606177|50003868|FG000|Overall Study|Lack of Efficacy|3|||
24909824|NCT00606177|50003869|FG001|Overall Study|Lack of Efficacy|7|||
24909825|NCT00606177|50003868|FG000|Overall Study|Physician Decision|1|||
24909826|NCT00606177|50003869|FG001|Overall Study|Physician Decision|0|||
24909827|NCT00606177|50003868|FG000|Overall Study|Protocol Violation|1|||
24909828|NCT00606177|50003869|FG001|Overall Study|Protocol Violation|4|||
24909829|NCT00606177|50003868|FG000|Overall Study|Withdrawal by Subject|5|||
24909830|NCT00606177|50003869|FG001|Overall Study|Withdrawal by Subject|6|||
24909831|NCT00606177|50003868|FG000|Overall Study|Progression to depressive phase|6|||
24909832|NCT00606177|50003869|FG001|Overall Study|Progression to depressive phase|1|||
24909833|NCT00606177|50003868|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
24909834|NCT00606177|50003869|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
24909835|NCT00606177|50003868|FG000|Overall Study|Change of residence or other commitments|1|||
24909836|NCT00606177|50003869|FG001|Overall Study|Change of residence or other commitments|1|||
24909837|NCT00359281|50003884|FG000|Overall Study|Adverse Event|1|||
25019307|NCT00706654|50115261|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
25184946|NCT01403987|50334026|FG000|Overall Study|Residents forgot their secret PIN|18|||
24909838|NCT00359281|50003885|FG001|Overall Study|Adverse Event|0|||
24909839|NCT00359281|50003886|FG002|Overall Study|Adverse Event|0|||
24909840|NCT00359281|50003887|FG003|Overall Study|Adverse Event|0|||
24909841|NCT00359281|50003888|FG004|Overall Study|Adverse Event|0|||
24909842|NCT00359281|50003889|FG005|Overall Study|Adverse Event|0|||
24909843|NCT00359281|50003890|FG006|Overall Study|Adverse Event|1|||
24909844|NCT00359281|50003891|FG007|Overall Study|Adverse Event|0|||
24909845|NCT00359281|50003892|FG008|Overall Study|Adverse Event|0|||
24909846|NCT00359281|50003884|FG000|Overall Study|Withdrawal by Subject|0|||
24909847|NCT00359281|50003885|FG001|Overall Study|Withdrawal by Subject|0|||
24909848|NCT00359281|50003886|FG002|Overall Study|Withdrawal by Subject|0|||
24909849|NCT00359281|50003887|FG003|Overall Study|Withdrawal by Subject|0|||
24909850|NCT00359281|50003888|FG004|Overall Study|Withdrawal by Subject|0|||
24909851|NCT00359281|50003889|FG005|Overall Study|Withdrawal by Subject|0|||
24909852|NCT00359281|50003890|FG006|Overall Study|Withdrawal by Subject|1|||
24909853|NCT00359281|50003891|FG007|Overall Study|Withdrawal by Subject|0|||
24909854|NCT00359281|50003892|FG008|Overall Study|Withdrawal by Subject|0|||
24909855|NCT00366535|50003921|FG000|First Phase: 12 Weeks|Adverse Event|1|||
24909856|NCT00366535|50003922|FG001|First Phase: 12 Weeks|Adverse Event|3|||
24909857|NCT00366535|50003921|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
24909858|NCT00366535|50003922|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
24909859|NCT00366535|50003921|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
24909860|NCT00366535|50003922|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
24909861|NCT00366535|50003921|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
24909862|NCT00366535|50003922|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
24909863|NCT00350545|50003936|FG000|Overall Study|Withdrawal by Subject|2|||
24909864|NCT00349921|50003944|FG000|First Spinal Injection|Physician Decision|1|||
24909865|NCT00349921|50003945|FG001|First Spinal Injection|Physician Decision|0|||
24909866|NCT00349921|50003946|FG002|First Spinal Injection|Physician Decision|0|||
24909867|NCT00349921|50003947|FG003|First Spinal Injection|Physician Decision|0|||
24909868|NCT00349921|50003944|FG000|First Spinal Injection|Adverse Event|0|||
24909869|NCT00349921|50003945|FG001|First Spinal Injection|Adverse Event|0|||
24909870|NCT00349921|50003946|FG002|First Spinal Injection|Adverse Event|1|||
24909871|NCT00349921|50003947|FG003|First Spinal Injection|Adverse Event|0|||
24909872|NCT00606021|50003958|FG000|Induction Phase|Death|73|||
24909873|NCT00606021|50003959|FG001|Induction Phase|Death|0|||
24909874|NCT00606021|50003960|FG002|Induction Phase|Death|0|||
24909875|NCT00606021|50003958|FG000|Induction Phase|Physician Decision|2|||
24909876|NCT00606021|50003959|FG001|Induction Phase|Physician Decision|0|||
24909877|NCT00606021|50003960|FG002|Induction Phase|Physician Decision|0|||
24909878|NCT00606021|50003958|FG000|Induction Phase|Withdrawal by Subject|2|||
24909879|NCT00606021|50003959|FG001|Induction Phase|Withdrawal by Subject|0|||
24909880|NCT00606021|50003960|FG002|Induction Phase|Withdrawal by Subject|0|||
24909881|NCT00606021|50003958|FG000|Induction Phase|Lost to Follow-up|10|||
24909882|NCT00606021|50003959|FG001|Induction Phase|Lost to Follow-up|0|||
24909883|NCT00606021|50003960|FG002|Induction Phase|Lost to Follow-up|0|||
24909884|NCT00606021|50003958|FG000|Maintenance Phase|Death|0|||
24909885|NCT00606021|50003959|FG001|Maintenance Phase|Death|17|||
25019308|NCT00706654|50115258|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
24909886|NCT00606021|50003960|FG002|Maintenance Phase|Death|15|||
25019309|NCT00706654|50115259|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
24909887|NCT00606021|50003958|FG000|Maintenance Phase|Physician Decision|0|||
24909888|NCT00606021|50003959|FG001|Maintenance Phase|Physician Decision|1|||
24909889|NCT00606021|50003960|FG002|Maintenance Phase|Physician Decision|0|||
24909890|NCT00606021|50003958|FG000|Maintenance Phase|Lost to Follow-up|0|||
24909891|NCT00606021|50003959|FG001|Maintenance Phase|Lost to Follow-up|5|||
25274897|NCT00907153|50588994|FG000|Overall Study|Lost to Follow-up|1|||
24909892|NCT00606021|50003960|FG002|Maintenance Phase|Lost to Follow-up|2|||
24909893|NCT00337675|50003971|FG000|Overall Study|Adverse Event|10|||
24909894|NCT00337675|50003972|FG001|Overall Study|Adverse Event|9|||
24909895|NCT00337675|50003973|FG002|Overall Study|Adverse Event|19|||
24909896|NCT00337675|50003971|FG000|Overall Study|Lack of Efficacy|10|||
24909897|NCT00337675|50003972|FG001|Overall Study|Lack of Efficacy|7|||
24909898|NCT00337675|50003973|FG002|Overall Study|Lack of Efficacy|9|||
24909899|NCT00337675|50003971|FG000|Overall Study|Lost to Follow-up|22|||
24909900|NCT00337675|50003972|FG001|Overall Study|Lost to Follow-up|19|||
24909901|NCT00337675|50003973|FG002|Overall Study|Lost to Follow-up|17|||
24909902|NCT00337675|50003971|FG000|Overall Study|Physician Decision|9|||
25019310|NCT00706654|50115260|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
25019311|NCT00706654|50115261|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
25274898|NCT00907153|50588995|FG001|Overall Study|Lost to Follow-up|1|||
25274899|NCT00907153|50588994|FG000|Overall Study|Withdrawal by Subject|1|||
24909903|NCT00337675|50003972|FG001|Overall Study|Physician Decision|17|||
24909904|NCT00337675|50003973|FG002|Overall Study|Physician Decision|14|||
24909905|NCT00337675|50003971|FG000|Overall Study|Protocol Violation|21|||
24909906|NCT00337675|50003972|FG001|Overall Study|Protocol Violation|24|||
24909907|NCT00337675|50003973|FG002|Overall Study|Protocol Violation|19|||
24909908|NCT00337675|50003971|FG000|Overall Study|Withdrawal by Subject|25|||
24909909|NCT00337675|50003972|FG001|Overall Study|Withdrawal by Subject|25|||
24909910|NCT00337675|50003973|FG002|Overall Study|Withdrawal by Subject|19|||
24909911|NCT00337675|50003971|FG000|Overall Study|Progressive Disease|0|||
24909912|NCT00337675|50003972|FG001|Overall Study|Progressive Disease|2|||
24909913|NCT00337675|50003973|FG002|Overall Study|Progressive Disease|0|||
24909914|NCT00337675|50003971|FG000|Overall Study|Trial Terminated|0|||
24909915|NCT00337675|50003972|FG001|Overall Study|Trial Terminated|0|||
24909916|NCT00337675|50003973|FG002|Overall Study|Trial Terminated|2|||
24909917|NCT00337285|50003981|FG000|Overall Study|Withdrawal by Subject|42|||
24909918|NCT00337285|50003981|FG000|Overall Study|Lost to Follow-up|41|||
24909919|NCT00337285|50003981|FG000|Overall Study|Adverse Event|28|||
24909920|NCT00337285|50003981|FG000|Overall Study|Protocol Violation|27|||
24909921|NCT00337285|50003981|FG000|Overall Study|Lack of Efficacy|11|||
24909922|NCT00337285|50003981|FG000|Overall Study|Death|1|||
24909923|NCT00337285|50003981|FG000|Overall Study|Physician Decision|1|||
24909924|NCT00337285|50003981|FG000|Overall Study|Lack of protocol compliance|7|||
24909925|NCT00605865|50003985|FG000|Overall Study|Protocol Violation|115|||
24909926|NCT00348673|50004025|FG000|Stage 1|Randomized but not Treated|0|||
24909927|NCT00348673|50004026|FG001|Stage 1|Randomized but not Treated|0|||
24909928|NCT00348673|50004027|FG002|Stage 1|Randomized but not Treated|1|||
24909929|NCT00348673|50004028|FG003|Stage 1|Randomized but not Treated|0|||
24909930|NCT00348673|50004029|FG004|Stage 1|Randomized but not Treated|0|||
24909931|NCT00348673|50004030|FG005|Stage 1|Randomized but not Treated|0|||
24909932|NCT00348673|50004031|FG006|Stage 1|Randomized but not Treated|0|||
24909933|NCT00348673|50004032|FG007|Stage 1|Randomized but not Treated|0|||
24909934|NCT00348673|50004033|FG008|Stage 1|Randomized but not Treated|0|||
24909935|NCT00337207|50004051|FG000|Overall Study|Withdrawal by Subject|3|||
24909936|NCT00604695|50004058|FG000|Overall Study|Did not receive first bolus.|0|||
24909937|NCT00604695|50004059|FG001|Overall Study|Did not receive first bolus.|4|||
24909938|NCT00348595|50004067|FG000|Overall Study|Adverse Event|5|||
24909939|NCT00348595|50004068|FG001|Overall Study|Adverse Event|8|||
24909940|NCT00337129|50004074|FG000|Overall Study|Adverse Event|4|||
24909941|NCT00337129|50004074|FG000|Overall Study|Withdrawal by Subject|1|||
24909942|NCT00337129|50004074|FG000|Overall Study|Lack of Efficacy|32|||
24909943|NCT00337129|50004074|FG000|Overall Study|Death|2|||
24909944|NCT00337129|50004074|FG000|Overall Study|not protocol specified|1|||
24909945|NCT00605085|50004080|FG000|Overall Study|Withdrawal by Subject|8|||
24909946|NCT00605085|50004081|FG001|Overall Study|Withdrawal by Subject|5|||
24909947|NCT00605085|50004080|FG000|Overall Study|Adverse Event|9|||
24909948|NCT00605085|50004081|FG001|Overall Study|Adverse Event|5|||
24909949|NCT00605085|50004080|FG000|Overall Study|Pregnancy|2|||
24909950|NCT00605085|50004081|FG001|Overall Study|Pregnancy|0|||
24909951|NCT00605085|50004080|FG000|Overall Study|Protocol Violation|3|||
24909952|NCT00605085|50004081|FG001|Overall Study|Protocol Violation|2|||
24909953|NCT00605085|50004080|FG000|Overall Study|Lost to Follow-up|10|||
24909954|NCT00605085|50004081|FG001|Overall Study|Lost to Follow-up|5|||
24909955|NCT00605085|50004080|FG000|Overall Study|administrative reasons|18|||
24909956|NCT00605085|50004081|FG001|Overall Study|administrative reasons|8|||
24909957|NCT00348283|50004089|FG000|Induction|Adverse Event|0|||
24909958|NCT00348283|50004090|FG001|Induction|Adverse Event|2|||
25152910|NCT01808612|50268087|FG002|Treatment Period|Protocol Violation|0|||
24909959|NCT00348283|50004089|FG000|Induction|Protocol Violation|0|||
24909960|NCT00348283|50004090|FG001|Induction|Protocol Violation|4|||
24909961|NCT00348283|50004089|FG000|Double Blind|Adverse Event|2|||
24909962|NCT00348283|50004090|FG001|Double Blind|Adverse Event|5|||
24909963|NCT00348283|50004089|FG000|Double Blind|Withdrawal by Subject|1|||
24909964|NCT00348283|50004090|FG001|Double Blind|Withdrawal by Subject|1|||
24909965|NCT00348283|50004089|FG000|Double Blind|Protocol Violation|0|||
24909966|NCT00348283|50004090|FG001|Double Blind|Protocol Violation|1|||
24909967|NCT00348283|50004089|FG000|Double Blind|Lack of Efficacy|2|||
24909968|NCT00348283|50004090|FG001|Double Blind|Lack of Efficacy|2|||
24909969|NCT00348283|50004089|FG000|Double Blind|Pregnancy|0|||
24909970|NCT00348283|50004090|FG001|Double Blind|Pregnancy|1|||
24909971|NCT00348283|50004089|FG000|Open Label|Adverse Event|0|||
24909972|NCT00348283|50004090|FG001|Open Label|Adverse Event|8|||
24909973|NCT00348283|50004089|FG000|Open Label|Withdrawal by Subject|0|||
24909974|NCT00348283|50004090|FG001|Open Label|Withdrawal by Subject|4|||
24909975|NCT00348283|50004089|FG000|Open Label|Lost to Follow-up|0|||
24909976|NCT00348283|50004090|FG001|Open Label|Lost to Follow-up|1|||
24909977|NCT00348283|50004089|FG000|Open Label|Lack of Efficacy|0|||
24909978|NCT00348283|50004090|FG001|Open Label|Lack of Efficacy|13|||
24909979|NCT00348283|50004089|FG000|Open Label|Administrative reasons|0|||
24909980|NCT00348283|50004090|FG001|Open Label|Administrative reasons|5|||
24909981|NCT00348283|50004089|FG000|Open Label|Subject moved to the United States|0|||
24909982|NCT00348283|50004090|FG001|Open Label|Subject moved to the United States|1|||
24909983|NCT00348283|50004089|FG000|Open Label|Pregnancy|0|||
24909984|NCT00348283|50004090|FG001|Open Label|Pregnancy|1|||
24909985|NCT00348283|50004089|FG000|Open Label|Sponsor decision|0|||
24909986|NCT00348283|50004090|FG001|Open Label|Sponsor decision|1|||
24909987|NCT00336895|50004096|FG000|Overall Study|diarrhea|1|||
24909988|NCT00336895|50004096|FG000|Overall Study|nausea and upset stomach|1|||
24909989|NCT00336895|50004096|FG000|Overall Study|Physician Decision|1|||
24909990|NCT00336895|50004096|FG000|Overall Study|screen failed|1|||
24909991|NCT00336583|50004100|FG000|Overall Study|Lost to Follow-up|1|||
24909992|NCT00336583|50004100|FG000|Overall Study|Death|1|||
24909993|NCT00336505|50004106|FG000|Overall Study|Adverse Event|10|||
24909994|NCT00336505|50004107|FG001|Overall Study|Adverse Event|9|||
24909995|NCT00336505|50004106|FG000|Overall Study|Lack of Efficacy|8|||
24909996|NCT00336505|50004107|FG001|Overall Study|Lack of Efficacy|4|||
24909997|NCT00336505|50004106|FG000|Overall Study|Lost to Follow-up|7|||
24909998|NCT00336505|50004107|FG001|Overall Study|Lost to Follow-up|4|||
24909999|NCT00336505|50004106|FG000|Overall Study|Withdrawal by Subject|5|||
24910000|NCT00336505|50004107|FG001|Overall Study|Withdrawal by Subject|3|||
24910001|NCT00336505|50004106|FG000|Overall Study|Other|7|||
24910002|NCT00336505|50004107|FG001|Overall Study|Other|7|||
24910003|NCT00357877|50004115|FG000|Overall Study|Death|2|||
24910004|NCT00357877|50004116|FG001|Overall Study|Death|1|||
24910005|NCT00357877|50004115|FG000|Overall Study|Lost to Follow-up|20|||
24910006|NCT00357877|50004116|FG001|Overall Study|Lost to Follow-up|23|||
24910007|NCT00357877|50004115|FG000|Overall Study|Withdrawal by Subject|3|||
24910008|NCT00357877|50004116|FG001|Overall Study|Withdrawal by Subject|3|||
24910009|NCT00357877|50004115|FG000|Overall Study|Administrative withdrawal|1|||
24910010|NCT00357877|50004116|FG001|Overall Study|Administrative withdrawal|1|||
24910011|NCT00357877|50004115|FG000|Overall Study|Other|0|||
24910012|NCT00357877|50004116|FG001|Overall Study|Other|2|||
24910013|NCT00335959|50004124|FG000|Overall Study|Adverse Event|2|||
24910014|NCT00335959|50004124|FG000|Overall Study|Ineligible|1|||
24910015|NCT00670488|50004139|FG000|Overall Study|Adverse Event|0|||
24910016|NCT00670488|50004140|FG001|Overall Study|Adverse Event|7|||
24910017|NCT00670488|50004141|FG002|Overall Study|Adverse Event|0|||
24910018|NCT00670488|50004142|FG003|Overall Study|Adverse Event|3|||
24910019|NCT00670488|50004143|FG004|Overall Study|Adverse Event|1|||
24910020|NCT00670488|50004144|FG005|Overall Study|Adverse Event|1|||
24910021|NCT00670488|50004145|FG006|Overall Study|Adverse Event|5|||
24910022|NCT00670488|50004146|FG007|Overall Study|Adverse Event|1|||
24910023|NCT00670488|50004147|FG008|Overall Study|Adverse Event|0|||
24910024|NCT00670488|50004148|FG009|Overall Study|Adverse Event|1|||
24910025|NCT00670488|50004139|FG000|Overall Study|Physician Decision|1|||
24910026|NCT00670488|50004140|FG001|Overall Study|Physician Decision|9|||
24910027|NCT00670488|50004141|FG002|Overall Study|Physician Decision|0|||
24910028|NCT00670488|50004142|FG003|Overall Study|Physician Decision|1|||
24910029|NCT00670488|50004143|FG004|Overall Study|Physician Decision|0|||
24910030|NCT00670488|50004144|FG005|Overall Study|Physician Decision|0|||
24910031|NCT00670488|50004145|FG006|Overall Study|Physician Decision|0|||
24910032|NCT00670488|50004146|FG007|Overall Study|Physician Decision|0|||
24910033|NCT00670488|50004147|FG008|Overall Study|Physician Decision|0|||
24910034|NCT00670488|50004148|FG009|Overall Study|Physician Decision|0|||
24910035|NCT00670488|50004139|FG000|Overall Study|Progressive Disease|2|||
24910036|NCT00670488|50004140|FG001|Overall Study|Progressive Disease|41|||
24910037|NCT00670488|50004141|FG002|Overall Study|Progressive Disease|3|||
24910038|NCT00670488|50004142|FG003|Overall Study|Progressive Disease|2|||
24910039|NCT00670488|50004143|FG004|Overall Study|Progressive Disease|2|||
24910040|NCT00670488|50004144|FG005|Overall Study|Progressive Disease|4|||
24910041|NCT00670488|50004145|FG006|Overall Study|Progressive Disease|11|||
24910042|NCT00670488|50004146|FG007|Overall Study|Progressive Disease|2|||
24910043|NCT00670488|50004147|FG008|Overall Study|Progressive Disease|2|||
24910044|NCT00670488|50004148|FG009|Overall Study|Progressive Disease|1|||
24910045|NCT00670488|50004139|FG000|Overall Study|Withdrawal by Subject|0|||
24910046|NCT00670488|50004140|FG001|Overall Study|Withdrawal by Subject|1|||
24910047|NCT00670488|50004141|FG002|Overall Study|Withdrawal by Subject|0|||
24910048|NCT00670488|50004142|FG003|Overall Study|Withdrawal by Subject|1|||
24910049|NCT00670488|50004143|FG004|Overall Study|Withdrawal by Subject|0|||
24910050|NCT00670488|50004144|FG005|Overall Study|Withdrawal by Subject|0|||
24910051|NCT00670488|50004145|FG006|Overall Study|Withdrawal by Subject|1|||
24910052|NCT00670488|50004146|FG007|Overall Study|Withdrawal by Subject|0|||
24910053|NCT00670488|50004147|FG008|Overall Study|Withdrawal by Subject|1|||
24910054|NCT00670488|50004148|FG009|Overall Study|Withdrawal by Subject|0|||
25019312|NCT00706654|50115258|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
25019313|NCT00706654|50115259|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
25019314|NCT00706654|50115260|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
24910055|NCT00671658|50004170|FG000|Overall Study|Physician Decision|5|||
24910056|NCT00542386|50004180|FG000|Overall Study|Adverse Event|1|||
24910057|NCT00542386|50004181|FG001|Overall Study|Adverse Event|7|||
24910058|NCT00542386|50004182|FG002|Overall Study|Adverse Event|7|||
24910059|NCT00542386|50004183|FG003|Overall Study|Adverse Event|8|||
24910060|NCT00542386|50004184|FG004|Overall Study|Adverse Event|13|||
24910061|NCT00542386|50004185|FG005|Overall Study|Adverse Event|4|||
24910062|NCT00542386|50004180|FG000|Overall Study|Death|0|||
24910063|NCT00542386|50004181|FG001|Overall Study|Death|0|||
24910064|NCT00542386|50004182|FG002|Overall Study|Death|1|||
24910065|NCT00542386|50004183|FG003|Overall Study|Death|2|||
24910066|NCT00542386|50004184|FG004|Overall Study|Death|1|||
24910067|NCT00542386|50004185|FG005|Overall Study|Death|2|||
24910068|NCT00542386|50004180|FG000|Overall Study|Lack of Efficacy|32|||
24910069|NCT00542386|50004181|FG001|Overall Study|Lack of Efficacy|12|||
24910070|NCT00542386|50004182|FG002|Overall Study|Lack of Efficacy|10|||
24910071|NCT00542386|50004183|FG003|Overall Study|Lack of Efficacy|13|||
24910072|NCT00542386|50004184|FG004|Overall Study|Lack of Efficacy|7|||
24910073|NCT00542386|50004185|FG005|Overall Study|Lack of Efficacy|31|||
24910074|NCT00542386|50004180|FG000|Overall Study|Physician Decision|1|||
24910075|NCT00542386|50004181|FG001|Overall Study|Physician Decision|0|||
24910076|NCT00542386|50004182|FG002|Overall Study|Physician Decision|0|||
24910077|NCT00542386|50004183|FG003|Overall Study|Physician Decision|1|||
24910078|NCT00542386|50004184|FG004|Overall Study|Physician Decision|0|||
24910079|NCT00542386|50004185|FG005|Overall Study|Physician Decision|0|||
24910080|NCT00542386|50004180|FG000|Overall Study|Protocol Violation|0|||
24910081|NCT00542386|50004181|FG001|Overall Study|Protocol Violation|0|||
24910082|NCT00542386|50004182|FG002|Overall Study|Protocol Violation|1|||
24910083|NCT00542386|50004183|FG003|Overall Study|Protocol Violation|0|||
24910084|NCT00542386|50004184|FG004|Overall Study|Protocol Violation|0|||
24910085|NCT00542386|50004185|FG005|Overall Study|Protocol Violation|4|||
24910086|NCT00542386|50004180|FG000|Overall Study|Withdrawal by Subject|5|||
24910087|NCT00542386|50004181|FG001|Overall Study|Withdrawal by Subject|8|||
24910088|NCT00542386|50004182|FG002|Overall Study|Withdrawal by Subject|10|||
24910089|NCT00542386|50004183|FG003|Overall Study|Withdrawal by Subject|11|||
24910090|NCT00542386|50004184|FG004|Overall Study|Withdrawal by Subject|15|||
24910091|NCT00542386|50004185|FG005|Overall Study|Withdrawal by Subject|7|||
24910092|NCT00542386|50004180|FG000|Overall Study|Other Reasons|4|||
24910093|NCT00542386|50004181|FG001|Overall Study|Other Reasons|1|||
25019315|NCT00706654|50115261|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
25019316|NCT00706654|50115258|FG000|Oral Stabilization Phase|Withdrew consent|55|||
25019317|NCT00706654|50115259|FG001|Oral Stabilization Phase|Withdrew consent|0|||
25019318|NCT00706654|50115260|FG002|Oral Stabilization Phase|Withdrew consent|0|||
25019319|NCT00706654|50115261|FG003|Oral Stabilization Phase|Withdrew consent|0|||
25019320|NCT00706654|50115258|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
25019321|NCT00706654|50115259|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
25019322|NCT00706654|50115260|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
25019323|NCT00706654|50115261|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
25019324|NCT00706654|50115258|FG000|Oral Stabilization Phase|Adverse Event|21|||
25019325|NCT00706654|50115259|FG001|Oral Stabilization Phase|Adverse Event|0|||
25019326|NCT00706654|50115260|FG002|Oral Stabilization Phase|Adverse Event|0|||
25019327|NCT00706654|50115261|FG003|Oral Stabilization Phase|Adverse Event|0|||
25019328|NCT00706654|50115258|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
25019329|NCT00706654|50115259|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
25019330|NCT00706654|50115260|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
25274900|NCT00907153|50588995|FG001|Overall Study|Withdrawal by Subject|3|||
25019331|NCT00706654|50115261|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
25019332|NCT00706654|50115258|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
25019333|NCT00706654|50115259|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
25274901|NCT00904033|50589005|FG000|Overall Study|Withdrawal by Subject|1|||
24910094|NCT00542386|50004182|FG002|Overall Study|Other Reasons|4|||
24910095|NCT00542386|50004183|FG003|Overall Study|Other Reasons|3|||
24910096|NCT00542386|50004184|FG004|Overall Study|Other Reasons|4|||
24910097|NCT00542386|50004185|FG005|Overall Study|Other Reasons|2|||
24910098|NCT00604383|50004201|FG000|Overall Study|Withdrawal by Subject|33|||
24910099|NCT00604383|50004202|FG001|Overall Study|Withdrawal by Subject|31|||
24910100|NCT00604383|50004201|FG000|Overall Study|Lost to Follow-up|24|||
24910101|NCT00604383|50004202|FG001|Overall Study|Lost to Follow-up|19|||
24910102|NCT00604383|50004201|FG000|Overall Study|Death|14|||
24910103|NCT00604383|50004202|FG001|Overall Study|Death|22|||
24910104|NCT00604383|50004201|FG000|Overall Study|Adverse Event|16|||
24910105|NCT00604383|50004202|FG001|Overall Study|Adverse Event|9|||
24910106|NCT00604383|50004201|FG000|Overall Study|Physician Decision|0|||
24910107|NCT00604383|50004202|FG001|Overall Study|Physician Decision|3|||
24910108|NCT00333775|50004211|FG000|Overall Study|Death|144|||
24910109|NCT00333775|50004212|FG001|Overall Study|Death|149|||
24910110|NCT00333775|50004213|FG002|Overall Study|Death|143|||
24910111|NCT00333775|50004211|FG000|Overall Study|In Follow-up When Study Stopped|87|||
24910112|NCT00333775|50004212|FG001|Overall Study|In Follow-up When Study Stopped|92|||
24910113|NCT00333775|50004213|FG002|Overall Study|In Follow-up When Study Stopped|96|||
24910114|NCT00333775|50004211|FG000|Overall Study|Lost to Follow-up|10|||
24910115|NCT00333775|50004212|FG001|Overall Study|Lost to Follow-up|7|||
24910116|NCT00333775|50004213|FG002|Overall Study|Lost to Follow-up|8|||
24910117|NCT00605475|50004231|FG000|Overall Study|Abnormal Laboratory Values|0|||
24910118|NCT00605475|50004232|FG001|Overall Study|Abnormal Laboratory Values|0|||
24910119|NCT00605475|50004233|FG002|Overall Study|Abnormal Laboratory Values|0|||
24910120|NCT00605475|50004234|FG003|Overall Study|Abnormal Laboratory Values|0|||
24910121|NCT00605475|50004235|FG004|Overall Study|Abnormal Laboratory Values|0|||
24910122|NCT00605475|50004236|FG005|Overall Study|Abnormal Laboratory Values|0|||
24910123|NCT00605475|50004237|FG006|Overall Study|Abnormal Laboratory Values|0|||
24910124|NCT00605475|50004238|FG007|Overall Study|Abnormal Laboratory Values|0|||
24910125|NCT00605475|50004239|FG008|Overall Study|Abnormal Laboratory Values|1|||
24910126|NCT00605475|50004240|FG009|Overall Study|Abnormal Laboratory Values|0|||
24910127|NCT00605475|50004231|FG000|Overall Study|Administrative problems|0|||
24910128|NCT00605475|50004232|FG001|Overall Study|Administrative problems|0|||
24910129|NCT00605475|50004233|FG002|Overall Study|Administrative problems|0|||
24910130|NCT00605475|50004234|FG003|Overall Study|Administrative problems|0|||
24910131|NCT00605475|50004235|FG004|Overall Study|Administrative problems|0|||
24910132|NCT00605475|50004236|FG005|Overall Study|Administrative problems|0|||
24910133|NCT00605475|50004237|FG006|Overall Study|Administrative problems|1|||
24910134|NCT00605475|50004238|FG007|Overall Study|Administrative problems|0|||
24910135|NCT00605475|50004239|FG008|Overall Study|Administrative problems|0|||
24910136|NCT00605475|50004240|FG009|Overall Study|Administrative problems|0|||
24910137|NCT00605475|50004231|FG000|Overall Study|Lost to Follow-up|0|||
24910138|NCT00605475|50004232|FG001|Overall Study|Lost to Follow-up|0|||
24910139|NCT00605475|50004233|FG002|Overall Study|Lost to Follow-up|0|||
24910140|NCT00605475|50004234|FG003|Overall Study|Lost to Follow-up|0|||
24910141|NCT00605475|50004235|FG004|Overall Study|Lost to Follow-up|0|||
24910142|NCT00605475|50004236|FG005|Overall Study|Lost to Follow-up|0|||
24910143|NCT00605475|50004237|FG006|Overall Study|Lost to Follow-up|0|||
24910144|NCT00605475|50004238|FG007|Overall Study|Lost to Follow-up|0|||
24910145|NCT00605475|50004239|FG008|Overall Study|Lost to Follow-up|1|||
25019334|NCT00706654|50115260|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
24910146|NCT00605475|50004240|FG009|Overall Study|Lost to Follow-up|1|||
24910147|NCT00605475|50004231|FG000|Overall Study|Protocol Violation|0|||
24910148|NCT00605475|50004232|FG001|Overall Study|Protocol Violation|0|||
24910149|NCT00605475|50004233|FG002|Overall Study|Protocol Violation|0|||
24910150|NCT00605475|50004234|FG003|Overall Study|Protocol Violation|0|||
24910151|NCT00605475|50004235|FG004|Overall Study|Protocol Violation|1|||
25019335|NCT00706654|50115261|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
25019336|NCT00706654|50115258|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
25019337|NCT00706654|50115259|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
25019338|NCT00706654|50115260|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
25019339|NCT00706654|50115261|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
25019340|NCT00706654|50115258|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
25019341|NCT00706654|50115259|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
25019342|NCT00706654|50115260|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
25019343|NCT00706654|50115261|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
25019344|NCT00706654|50115258|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
25019345|NCT00706654|50115259|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
25019346|NCT00706654|50115260|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
25019347|NCT00706654|50115261|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
25019348|NCT00706654|50115258|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
25019349|NCT00706654|50115259|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
25019350|NCT00706654|50115260|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
25019351|NCT00706654|50115261|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
25184947|NCT01403987|50334027|FG001|Overall Study|Residents forgot their secret PIN|17|||
25184948|NCT01403987|50334028|FG002|Overall Study|Residents forgot their secret PIN|18|||
24910152|NCT00605475|50004236|FG005|Overall Study|Protocol Violation|0|||
24910153|NCT00605475|50004237|FG006|Overall Study|Protocol Violation|0|||
24910154|NCT00605475|50004238|FG007|Overall Study|Protocol Violation|0|||
24910155|NCT00605475|50004239|FG008|Overall Study|Protocol Violation|0|||
24910156|NCT00605475|50004240|FG009|Overall Study|Protocol Violation|0|||
24910157|NCT00605475|50004231|FG000|Overall Study|Withdrawal by Subject|0|||
24910158|NCT00605475|50004232|FG001|Overall Study|Withdrawal by Subject|0|||
24910159|NCT00605475|50004233|FG002|Overall Study|Withdrawal by Subject|0|||
24910160|NCT00605475|50004234|FG003|Overall Study|Withdrawal by Subject|0|||
24910161|NCT00605475|50004235|FG004|Overall Study|Withdrawal by Subject|0|||
24910162|NCT00605475|50004236|FG005|Overall Study|Withdrawal by Subject|2|||
24910163|NCT00605475|50004237|FG006|Overall Study|Withdrawal by Subject|0|||
24910164|NCT00605475|50004238|FG007|Overall Study|Withdrawal by Subject|0|||
25019352|NCT00706654|50115258|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
25019353|NCT00706654|50115259|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
25019354|NCT00706654|50115260|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
25019355|NCT00706654|50115261|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
25019356|NCT00706654|50115258|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
25019357|NCT00706654|50115259|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
25019358|NCT00706654|50115260|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
25019359|NCT00706654|50115261|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
25019360|NCT00706654|50115258|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
25019361|NCT00706654|50115259|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
25019362|NCT00706654|50115260|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
25019363|NCT00706654|50115261|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
25019364|NCT00706654|50115258|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
25019365|NCT00706654|50115259|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
24910165|NCT00605475|50004239|FG008|Overall Study|Withdrawal by Subject|0|||
24910166|NCT00605475|50004240|FG009|Overall Study|Withdrawal by Subject|1|||
24910167|NCT00333619|50004285|FG000|Overall Study|Death|12|||
24910168|NCT00333619|50004286|FG001|Overall Study|Death|6|||
24910169|NCT00333619|50004285|FG000|Overall Study|Withdrawal by Subject|6|||
24910170|NCT00333619|50004286|FG001|Overall Study|Withdrawal by Subject|1|||
24910171|NCT00333619|50004285|FG000|Overall Study|Lost to Follow-up|3|||
24910172|NCT00333619|50004286|FG001|Overall Study|Lost to Follow-up|3|||
24910173|NCT00605319|50004294|FG000|Overall Study|Adverse Event|6|||
24910174|NCT00333229|50004306|FG000|Overall Study|Lack of Efficacy|0|||
24910175|NCT00333229|50004307|FG001|Overall Study|Lack of Efficacy|1|||
24910176|NCT00332839|50004315|FG000|Core (Months 0 - 12)|Administrative problems|1|||
25019366|NCT00706654|50115260|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
25019367|NCT00706654|50115261|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
25152911|NCT01808612|50268085|FG000|Treatment Period|Withdrawal by Subject|1|||
25152912|NCT01808612|50268086|FG001|Treatment Period|Withdrawal by Subject|0|||
24910177|NCT00332839|50004316|FG001|Core (Months 0 - 12)|Administrative problems|1|||
24910178|NCT00332839|50004315|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
24910179|NCT00332839|50004316|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
24910180|NCT00332839|50004315|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
24910181|NCT00332839|50004316|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
24910182|NCT00332839|50004315|FG000|Core (Months 0 - 12)|Adverse Event|5|||
24910183|NCT00332839|50004316|FG001|Core (Months 0 - 12)|Adverse Event|15|||
24910184|NCT00332839|50004315|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
25019368|NCT03471871|50115273|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
24910185|NCT00332839|50004316|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
24910186|NCT00332839|50004315|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
25067414|NCT02397460|50173038|FG001|Treatment Period 4|Physician Decision|0|||
25152913|NCT01808612|50268087|FG002|Treatment Period|Withdrawal by Subject|4|||
24910187|NCT00332839|50004316|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
24910188|NCT00332839|50004315|FG000|Follow-up (Months 12 - 60)|Death|1|||
24910189|NCT00332839|50004316|FG001|Follow-up (Months 12 - 60)|Death|1|||
24910190|NCT00357097|50004324|FG000|Overall Study|Did not meet inclusion criteria|5|||
24910191|NCT00357097|50004325|FG001|Overall Study|Did not meet inclusion criteria|3|||
24910192|NCT00357097|50004324|FG000|Overall Study|Adverse Event|34|||
24910193|NCT00357097|50004325|FG001|Overall Study|Adverse Event|6|||
24910194|NCT00357097|50004324|FG000|Overall Study|Withdrawal by Subject|8|||
24910195|NCT00357097|50004325|FG001|Overall Study|Withdrawal by Subject|7|||
24910196|NCT00357097|50004324|FG000|Overall Study|Non-compliance|1|||
24910197|NCT00357097|50004325|FG001|Overall Study|Non-compliance|2|||
24910198|NCT00357097|50004324|FG000|Overall Study|Lack of Efficacy|2|||
24910199|NCT00357097|50004325|FG001|Overall Study|Lack of Efficacy|8|||
24910200|NCT00357097|50004324|FG000|Overall Study|Met Exclusion Criteria|3|||
24910201|NCT00357097|50004325|FG001|Overall Study|Met Exclusion Criteria|1|||
24910202|NCT00357097|50004324|FG000|Overall Study|Other|1|||
24910203|NCT00357097|50004325|FG001|Overall Study|Other|1|||
24910204|NCT00357097|50004324|FG000|Overall Study|Increase of RLS Symptoms|0|||
24910205|NCT00357097|50004325|FG001|Overall Study|Increase of RLS Symptoms|1|||
24910206|NCT00356863|50004333|FG000|Overall Study|Death|16|||
24910207|NCT00356863|50004334|FG001|Overall Study|Death|32|||
24910208|NCT00356863|50004333|FG000|Overall Study|Lost to Follow-up|76|||
24910209|NCT00356863|50004334|FG001|Overall Study|Lost to Follow-up|43|||
24910210|NCT00355615|50004357|FG000|Randomized Double Blind Period|Adverse Event|1|||
24910211|NCT00355615|50004358|FG001|Randomized Double Blind Period|Adverse Event|0|||
24910212|NCT00355615|50004359|FG002|Randomized Double Blind Period|Adverse Event|0|||
24910213|NCT00355615|50004360|FG003|Randomized Double Blind Period|Adverse Event|0|||
24910214|NCT00355615|50004361|FG004|Randomized Double Blind Period|Adverse Event|0|||
24910215|NCT00355615|50004357|FG000|Randomized Double Blind Period|Protocol Violation|0|||
24910216|NCT00355615|50004358|FG001|Randomized Double Blind Period|Protocol Violation|0|||
24910217|NCT00355615|50004359|FG002|Randomized Double Blind Period|Protocol Violation|1|||
25152914|NCT01808612|50268085|FG000|Treatment Period|Physician Decision|1|||
25152915|NCT01808612|50268086|FG001|Treatment Period|Physician Decision|0|||
25152916|NCT01808612|50268087|FG002|Treatment Period|Physician Decision|4|||
25152917|NCT01808612|50268085|FG000|Treatment Period|Sponsor Decision|1|||
25152918|NCT01808612|50268086|FG001|Treatment Period|Sponsor Decision|0|||
25152919|NCT01808612|50268087|FG002|Treatment Period|Sponsor Decision|0|||
25152920|NCT01808612|50268085|FG000|Treatment Period|Lack of Efficacy|1|||
25152921|NCT01808612|50268086|FG001|Treatment Period|Lack of Efficacy|1|||
24910218|NCT00355615|50004360|FG003|Randomized Double Blind Period|Protocol Violation|1|||
24910219|NCT00355615|50004361|FG004|Randomized Double Blind Period|Protocol Violation|0|||
24910220|NCT00355615|50004357|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
24910221|NCT00355615|50004358|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
24910222|NCT00355615|50004359|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
24910223|NCT00355615|50004360|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
24910224|NCT00355615|50004361|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
24910225|NCT00355615|50004357|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
24910226|NCT00355615|50004358|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
24910227|NCT00355615|50004359|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
24910228|NCT00355615|50004360|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
24910229|NCT00355615|50004361|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
25152922|NCT01808612|50268087|FG002|Treatment Period|Lack of Efficacy|2|||
25152923|NCT01808612|50268085|FG000|Discontinuation Period|Adverse Event|1|||
24910230|NCT00355615|50004357|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
24910231|NCT00355615|50004358|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
25152924|NCT01808612|50268086|FG001|Discontinuation Period|Adverse Event|0|||
24910232|NCT00355615|50004359|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
24910233|NCT00355615|50004360|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
24910234|NCT00355615|50004361|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
24910235|NCT00355615|50004357|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
24910236|NCT00355615|50004358|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
24910237|NCT00355615|50004359|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
24910238|NCT00355615|50004360|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
24910239|NCT00355615|50004361|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
24910240|NCT00347269|50004374|FG000|Overall Study|Lost to Follow-up|74|||
24910241|NCT00347269|50004375|FG001|Overall Study|Lost to Follow-up|65|||
24910242|NCT00347269|50004374|FG000|Overall Study|Withdrawal by Subject|18|||
24910243|NCT00347269|50004375|FG001|Overall Study|Withdrawal by Subject|38|||
24910244|NCT00347269|50004374|FG000|Overall Study|Death|2|||
24910245|NCT00347269|50004375|FG001|Overall Study|Death|3|||
24910246|NCT00544648|50004383|FG000|Overall Study|Withdrawal by Subject|1|||
24910247|NCT00544648|50004384|FG001|Overall Study|Withdrawal by Subject|0|||
24910248|NCT00544648|50004383|FG000|Overall Study|Adverse Event|1|||
24910249|NCT00544648|50004384|FG001|Overall Study|Adverse Event|1|||
24910250|NCT00544648|50004383|FG000|Overall Study|progression of disease|1|||
24910251|NCT00544648|50004384|FG001|Overall Study|progression of disease|0|||
24910252|NCT00346333|50004394|FG000|Overall Study|Death|1|||
24910253|NCT00346333|50004395|FG001|Overall Study|Death|0|||
24910254|NCT00346333|50004394|FG000|Overall Study|unwilling or unable to continue|4|||
24910255|NCT00346333|50004395|FG001|Overall Study|unwilling or unable to continue|8|||
24910256|NCT00330967|50004405|FG000|Overall Study|Withdrawal by Subject|0|||
24910257|NCT00330967|50004406|FG001|Overall Study|Withdrawal by Subject|5|||
24910258|NCT00330967|50004405|FG000|Overall Study|Physician Decision|0|||
24910259|NCT00330967|50004406|FG001|Overall Study|Physician Decision|9|||
24910260|NCT00330343|50004412|FG000|Overall Study|Lost to Follow-up|5|||
24910261|NCT00330187|50004420|FG000|Overall Study|Lost to Follow-up|12|||
24910262|NCT00330187|50004421|FG001|Overall Study|Lost to Follow-up|13|||
24910263|NCT00330187|50004422|FG002|Overall Study|Lost to Follow-up|14|||
24910264|NCT00330187|50004423|FG003|Overall Study|Lost to Follow-up|10|||
24910265|NCT00330187|50004420|FG000|Overall Study|Withdrawal by Subject|8|||
24910266|NCT00330187|50004421|FG001|Overall Study|Withdrawal by Subject|5|||
24910267|NCT00330187|50004422|FG002|Overall Study|Withdrawal by Subject|4|||
24910268|NCT00330187|50004423|FG003|Overall Study|Withdrawal by Subject|4|||
24910269|NCT03914950|50004433|FG000|Overall Study|Physician Decision|54|||
24910270|NCT00329797|50004445|FG000|Overall Study|Protocol Violation|1|||
25019369|NCT03471871|50115274|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
25019370|NCT03471871|50115275|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
25019371|NCT03471871|50115276|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
25019372|NCT03471871|50115277|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
25019373|NCT03471871|50115273|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
25019374|NCT03471871|50115274|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
24910271|NCT00329797|50004446|FG001|Overall Study|Protocol Violation|0|||
25019375|NCT03471871|50115275|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
25019376|NCT03471871|50115276|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
25019377|NCT03471871|50115277|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
25019378|NCT03471871|50115273|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
25019379|NCT03471871|50115274|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
25019380|NCT03471871|50115275|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
25019381|NCT03471871|50115276|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
25019382|NCT03471871|50115277|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
25019383|NCT03471871|50115273|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
25019384|NCT03471871|50115274|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
25019385|NCT03471871|50115275|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
25019386|NCT03471871|50115276|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
25019387|NCT03471871|50115277|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
25019388|NCT03471871|50115273|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
25019389|NCT03471871|50115274|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
25019390|NCT03471871|50115275|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
25019391|NCT03471871|50115276|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
25019392|NCT03471871|50115277|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
25019393|NCT01957176|50115295|FG000|Overall Study|Adverse Event|2|||
25019394|NCT01957176|50115296|FG001|Overall Study|Adverse Event|0|||
25019395|NCT01957176|50115295|FG000|Overall Study|Physician Decision|2|||
25019396|NCT01957176|50115296|FG001|Overall Study|Physician Decision|1|||
25019397|NCT01957176|50115295|FG000|Overall Study|Withdrawal by Subject|1|||
25019398|NCT01957176|50115296|FG001|Overall Study|Withdrawal by Subject|0|||
25019399|NCT03527173|50115305|FG000|Overall Study|Lost to Follow-up|4|||
25019400|NCT03527173|50115306|FG001|Overall Study|Lost to Follow-up|2|||
25019401|NCT03527173|50115305|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
25019402|NCT03527173|50115306|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
25019403|NCT03527173|50115305|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
25019404|NCT03527173|50115306|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
25019405|NCT03527173|50115305|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
25019406|NCT03527173|50115306|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
25019407|NCT00707980|50115312|FG000|Overall Study|Adverse Event|49|||
25019408|NCT00707980|50115312|FG000|Overall Study|Lack of Efficacy|35|||
25019409|NCT00707980|50115312|FG000|Overall Study|Non-Compliance with Study Drug|28|||
25019410|NCT00707980|50115312|FG000|Overall Study|Protocol Deviations|19|||
25019411|NCT00707980|50115312|FG000|Overall Study|Withdrawal of Consent|81|||
25019412|NCT00707980|50115312|FG000|Overall Study|Lost to Follow-up|59|||
25019413|NCT00707980|50115312|FG000|Overall Study|Other|39|||
25019414|NCT03506425|50115319|FG000|Overall Study|Adverse Event|1|||
25019415|NCT03506425|50115320|FG001|Overall Study|Adverse Event|3|||
25019416|NCT03506425|50115321|FG002|Overall Study|Adverse Event|0|||
25019417|NCT03506425|50115319|FG000|Overall Study|Death|1|||
25019418|NCT03506425|50115320|FG001|Overall Study|Death|0|||
25019419|NCT03506425|50115321|FG002|Overall Study|Death|0|||
25019420|NCT03506425|50115319|FG000|Overall Study|Withdrawal by Subject|0|||
25019421|NCT03506425|50115320|FG001|Overall Study|Withdrawal by Subject|0|||
25019422|NCT03506425|50115321|FG002|Overall Study|Withdrawal by Subject|1|||
25019423|NCT03051620|50115330|FG000|Overall Study|Lost to Follow-up|6|||
25019424|NCT03051620|50115330|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
25019425|NCT03053492|50115336|FG000|Overall Study|Adverse Event|1|||
25019426|NCT03053492|50115337|FG001|Overall Study|Adverse Event|1|||
25019427|NCT03053492|50115336|FG000|Overall Study|Withdrawal by Subject|7|||
25019428|NCT03053492|50115337|FG001|Overall Study|Withdrawal by Subject|5|||
25019429|NCT04239872|50115343|FG000|Overall Study|Lost to Follow-up|0|||
25019430|NCT04239872|50115344|FG001|Overall Study|Lost to Follow-up|1|||
25019431|NCT03164772|50115352|FG000|Overall Study|Death|4|||
25019432|NCT03164772|50115353|FG001|Overall Study|Death|2|||
25019433|NCT03164772|50115352|FG000|Overall Study|Adverse Event|1|||
25019434|NCT03164772|50115353|FG001|Overall Study|Adverse Event|4|||
25019435|NCT03164772|50115352|FG000|Overall Study|Progressive Disease|11|||
25019436|NCT03164772|50115353|FG001|Overall Study|Progressive Disease|21|||
25152925|NCT01808612|50268087|FG002|Discontinuation Period|Adverse Event|0|||
25152926|NCT01808612|50268085|FG000|Discontinuation Period|Physician Decision|1|||
25152927|NCT01808612|50268086|FG001|Discontinuation Period|Physician Decision|0|||
25019437|NCT03164772|50115352|FG000|Overall Study|Physician Decision|2|||
25019438|NCT03164772|50115353|FG001|Overall Study|Physician Decision|0|||
25019439|NCT03164772|50115352|FG000|Overall Study|Withdrawal by Subject|0|||
25019440|NCT03164772|50115353|FG001|Overall Study|Withdrawal by Subject|4|||
25019441|NCT03050450|50115376|FG000|Overall Study|Physician Decision|1|||
25019442|NCT03050450|50115377|FG001|Overall Study|Physician Decision|0|||
25019443|NCT03050450|50115378|FG002|Overall Study|Physician Decision|0|||
25019444|NCT03050450|50115379|FG003|Overall Study|Physician Decision|0|||
25152928|NCT01808612|50268087|FG002|Discontinuation Period|Physician Decision|0|||
25152929|NCT01808612|50268085|FG000|Discontinuation Period|Lost to Follow-up|0|||
25152930|NCT01808612|50268086|FG001|Discontinuation Period|Lost to Follow-up|1|||
25152931|NCT01808612|50268087|FG002|Discontinuation Period|Lost to Follow-up|0|||
25152932|NCT01908829|50268101|FG000|Overall Study|Adverse Event|13|||
25152933|NCT01908829|50268102|FG001|Overall Study|Adverse Event|11|||
25152934|NCT01908829|50268103|FG002|Overall Study|Adverse Event|13|||
25152935|NCT01908829|50268101|FG000|Overall Study|Lost to Follow-up|4|||
25019445|NCT03050450|50115380|FG004|Overall Study|Physician Decision|0|||
25152936|NCT01908829|50268102|FG001|Overall Study|Lost to Follow-up|2|||
25152937|NCT01908829|50268103|FG002|Overall Study|Lost to Follow-up|1|||
25019446|NCT03505021|50115394|FG000|Overall Study|Protocol Violation|1|||
25019447|NCT03505021|50115395|FG001|Overall Study|Protocol Violation|0|||
25019448|NCT03505021|50115394|FG000|Overall Study|Death|9|||
25019449|NCT03505021|50115395|FG001|Overall Study|Death|8|||
25019450|NCT03505021|50115394|FG000|Overall Study|Consent withdrawn by subject|6|||
25019451|NCT03505021|50115395|FG001|Overall Study|Consent withdrawn by subject|1|||
25019452|NCT03505021|50115394|FG000|Overall Study|Lost to Follow-up|5|||
25019453|NCT03505021|50115395|FG001|Overall Study|Lost to Follow-up|3|||
25019454|NCT03505021|50115394|FG000|Overall Study|Adverse Event|26|||
25019455|NCT03505021|50115395|FG001|Overall Study|Adverse Event|9|||
25019456|NCT03505021|50115394|FG000|Overall Study|Disease progression|33|||
25019457|NCT03505021|50115395|FG001|Overall Study|Disease progression|17|||
25019458|NCT03505021|50115394|FG000|Overall Study|Other|11|||
25019459|NCT03505021|50115395|FG001|Overall Study|Other|5|||
25019460|NCT03505021|50115394|FG000|Overall Study|Personal reason|21|||
25019461|NCT03505021|50115395|FG001|Overall Study|Personal reason|12|||
25019462|NCT03050372|50115401|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
25019463|NCT03050372|50115402|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
25019464|NCT03050372|50115401|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
25019465|NCT03050372|50115402|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
25019466|NCT03470545|50115409|FG000|Overall Study|Death|0|||
25019467|NCT03470545|50115410|FG001|Overall Study|Death|1|||
25019468|NCT03470545|50115409|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
25019469|NCT03470545|50115410|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
25019470|NCT03470545|50115409|FG000|Overall Study|Adverse Event|2|||
25019471|NCT03470545|50115410|FG001|Overall Study|Adverse Event|0|||
25019472|NCT03470545|50115409|FG000|Overall Study|Withdrawal by Subject|1|||
25019473|NCT03470545|50115410|FG001|Overall Study|Withdrawal by Subject|1|||
25019474|NCT03470545|50115409|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
25019475|NCT03470545|50115410|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
25019476|NCT03163446|50115419|FG000|Overall Study|Unable to return for Day 180 visit|2|||
25019477|NCT03163446|50115420|FG001|Overall Study|Unable to return for Day 180 visit|0|||
25019478|NCT03163446|50115419|FG000|Overall Study|Withdrawal by Subject|2|||
25019479|NCT03163446|50115420|FG001|Overall Study|Withdrawal by Subject|6|||
25019480|NCT03163446|50115419|FG000|Overall Study|Death|16|||
24910272|NCT00329797|50004445|FG000|Overall Study|Withdrawal by Subject|6|||
24910273|NCT00329797|50004446|FG001|Overall Study|Withdrawal by Subject|6|||
25019481|NCT03163446|50115420|FG001|Overall Study|Death|5|||
25019482|NCT03163446|50115419|FG000|Overall Study|Lost to Follow-up|6|||
25019483|NCT03163446|50115420|FG001|Overall Study|Lost to Follow-up|5|||
25019484|NCT03163446|50115419|FG000|Overall Study|Physician Decision|1|||
25019485|NCT03163446|50115420|FG001|Overall Study|Physician Decision|1|||
25019486|NCT03163446|50115419|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
25019487|NCT03163446|50115420|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
25019488|NCT03722485|50115434|FG000|Overall Study|Withdrawal by Subject|1|||
25019489|NCT03722485|50115435|FG001|Overall Study|Withdrawal by Subject|0|||
25019490|NCT03722485|50115434|FG000|Overall Study|Adverse Event|0|||
25019491|NCT03722485|50115435|FG001|Overall Study|Adverse Event|2|||
25019492|NCT03722485|50115434|FG000|Overall Study|subject discharged prior to study completion|1|||
25019493|NCT03722485|50115435|FG001|Overall Study|subject discharged prior to study completion|5|||
25019494|NCT03722485|50115434|FG000|Overall Study|eligibility criteria not met|2|||
24910274|NCT00541450|50004454|FG000|Phase A|Adverse Event|3|||
24910275|NCT00541450|50004455|FG001|Phase A|Adverse Event|0|||
24910276|NCT00541450|50004454|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
24910277|NCT00541450|50004455|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
24910278|NCT00541450|50004454|FG000|Phase A|Hyperglycemia|0|||
24910279|NCT00541450|50004455|FG001|Phase A|Hyperglycemia|1|||
24910280|NCT00541450|50004454|FG000|Phase A|Lost to Follow-up|6|||
25019495|NCT03722485|50115435|FG001|Overall Study|eligibility criteria not met|0|||
25274902|NCT00904033|50589006|FG001|Overall Study|Withdrawal by Subject|1|||
25274903|NCT00904033|50589007|FG002|Overall Study|Withdrawal by Subject|0|||
25019498|NCT03047720|50115469|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
25152938|NCT01908829|50268101|FG000|Overall Study|Randomized no double-blind drug received|1|||
25019499|NCT03047720|50115470|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
25019500|NCT03626168|50115495|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
25019501|NCT03626168|50115496|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
25019502|NCT03626168|50115495|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
25019503|NCT03626168|50115496|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
25019504|NCT03626168|50115495|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
25019505|NCT03626168|50115496|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
25019506|NCT02966873|50115504|FG000|Overall Study|Lost to Follow-up|16|||
24910281|NCT00541450|50004455|FG001|Phase A|Lost to Follow-up|4|||
24910282|NCT00541450|50004454|FG000|Phase A|Physician Decision|2|||
25019507|NCT02966873|50115505|FG001|Overall Study|Lost to Follow-up|15|||
25019508|NCT01389024|50115513|FG000|Overall Study|Withdrawal by Subject|0|||
25019509|NCT01389024|50115514|FG001|Overall Study|Withdrawal by Subject|1|||
25019510|NCT01389024|50115513|FG000|Overall Study|Lost to Follow-up|1|||
25019511|NCT01389024|50115514|FG001|Overall Study|Lost to Follow-up|0|||
25019512|NCT03050060|50115524|FG000|Overall Study|Adverse Event|7|||
25019513|NCT03050060|50115524|FG000|Overall Study|Withdrawal by Subject|1|||
25019514|NCT03050060|50115524|FG000|Overall Study|Progression|7|||
25019515|NCT00706342|50115537|FG000|Overall Study|Adverse Event|3|||
25152939|NCT01908829|50268102|FG001|Overall Study|Randomized no double-blind drug received|0|||
25019516|NCT00706342|50115537|FG000|Overall Study|Not responding to treatment|2|||
25019517|NCT00706342|50115537|FG000|Overall Study|Withdrawn due to failure to respond|1|||
25019518|NCT00706342|50115537|FG000|Overall Study|Death|1|||
25019519|NCT00706342|50115537|FG000|Overall Study|Withdrew from the study on his own.|1|||
25019520|NCT00706342|50115537|FG000|Overall Study|Investigator discretion|2|||
25019521|NCT00706342|50115537|FG000|Overall Study|Non-responder Week 12|1|||
25019522|NCT00706342|50115537|FG000|Overall Study|Ongoing|6|||
25019523|NCT00706342|50115537|FG000|Overall Study|WIthdrawal of consent|1|||
25019524|NCT03049748|50115543|FG000|Overall Study|Lost to Follow-up|1|||
25019525|NCT03049748|50115544|FG001|Overall Study|Lost to Follow-up|0|||
25152940|NCT01908829|50268103|FG002|Overall Study|Randomized no double-blind drug received|1|||
25152941|NCT01908829|50268101|FG000|Overall Study|Discontinued (no EoT page)|2|||
25152942|NCT01908829|50268102|FG001|Overall Study|Discontinued (no EoT page)|0|||
24910283|NCT00541450|50004455|FG001|Phase A|Physician Decision|0|||
24910284|NCT00541450|50004454|FG000|Phase A|Protocol Violation|2|||
24910285|NCT00541450|50004455|FG001|Phase A|Protocol Violation|3|||
25019526|NCT03049748|50115543|FG000|Overall Study|Death|3|||
25019527|NCT03049748|50115544|FG001|Overall Study|Death|0|||
25019528|NCT03049748|50115543|FG000|Overall Study|Withdrawal by Subject|0|||
25019529|NCT03049748|50115544|FG001|Overall Study|Withdrawal by Subject|3|||
25019530|NCT03049748|50115543|FG000|Overall Study|Protocol Violation|0|||
25019531|NCT03049748|50115544|FG001|Overall Study|Protocol Violation|2|||
25019532|NCT03049748|50115543|FG000|Overall Study|Moved out of state (relocation)|0|||
25019533|NCT03049748|50115544|FG001|Overall Study|Moved out of state (relocation)|1|||
25019534|NCT03501277|50115558|FG000|Intervention Period 1 (4 Days)|Other|0|||
25019535|NCT03501277|50115559|FG001|Intervention Period 1 (4 Days)|Other|0|||
25019536|NCT03501277|50115560|FG002|Intervention Period 1 (4 Days)|Other|1|||
25019537|NCT03501277|50115561|FG003|Intervention Period 1 (4 Days)|Other|0|||
25019538|NCT03501277|50115558|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
25019539|NCT03501277|50115559|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
25019540|NCT03501277|50115560|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
25019541|NCT03501277|50115561|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
25019542|NCT03501277|50115558|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
25019543|NCT03501277|50115559|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
25019544|NCT03501277|50115560|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
25019545|NCT03501277|50115561|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
25019546|NCT03501277|50115558|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
25019547|NCT03501277|50115559|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
24910286|NCT00541450|50004454|FG000|Phase A|Withdrawal by Subject|7|||
24910287|NCT00541450|50004455|FG001|Phase A|Withdrawal by Subject|7|||
24910288|NCT00541450|50004454|FG000|Phase B|Adverse Event|6|||
24910289|NCT00541450|50004455|FG001|Phase B|Adverse Event|6|||
24910290|NCT00541450|50004454|FG000|Phase B|Hyperglycemia|10|||
24910291|NCT00541450|50004455|FG001|Phase B|Hyperglycemia|9|||
25019548|NCT03501277|50115560|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
25019549|NCT03501277|50115561|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
25019550|NCT03500419|50115573|FG000|Overall Study|Withdrawal by Subject|2|||
25019551|NCT03500419|50115574|FG001|Overall Study|Withdrawal by Subject|25|||
25019552|NCT03500341|50115580|FG000|Overall Study|Withdrawn prior to Completion|2|||
25019553|NCT01316900|50115601|FG000|Overall Study|Adverse Event|10|||
25019554|NCT01316900|50115602|FG001|Overall Study|Adverse Event|10|||
25019555|NCT01316900|50115603|FG002|Overall Study|Adverse Event|15|||
25019556|NCT01316900|50115604|FG003|Overall Study|Adverse Event|9|||
25019557|NCT01316900|50115601|FG000|Overall Study|Lack of Efficacy|17|||
25019558|NCT01316900|50115602|FG001|Overall Study|Lack of Efficacy|9|||
25019559|NCT01316900|50115603|FG002|Overall Study|Lack of Efficacy|5|||
25019560|NCT01316900|50115604|FG003|Overall Study|Lack of Efficacy|7|||
25019561|NCT01316900|50115601|FG000|Overall Study|Protocol Violation|7|||
25019562|NCT01316900|50115602|FG001|Overall Study|Protocol Violation|1|||
25152943|NCT01908829|50268103|FG002|Overall Study|Discontinued (no EoT page)|0|||
25152944|NCT01908829|50268101|FG000|Overall Study|Miscellaneous|0|||
25019563|NCT01316900|50115603|FG002|Overall Study|Protocol Violation|4|||
25019564|NCT01316900|50115604|FG003|Overall Study|Protocol Violation|0|||
25019565|NCT01316900|50115601|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
25019566|NCT01316900|50115602|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
24910292|NCT00541450|50004454|FG000|Phase B|Lost to Follow-up|6|||
24910293|NCT00541450|50004455|FG001|Phase B|Lost to Follow-up|4|||
25019567|NCT01316900|50115603|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
25019568|NCT01316900|50115604|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
25019569|NCT01316900|50115601|FG000|Overall Study|Lost to Follow-up|1|||
25019570|NCT01316900|50115602|FG001|Overall Study|Lost to Follow-up|0|||
25019571|NCT01316900|50115603|FG002|Overall Study|Lost to Follow-up|1|||
25019572|NCT01316900|50115604|FG003|Overall Study|Lost to Follow-up|1|||
25019573|NCT01316900|50115601|FG000|Overall Study|Withdrawal by Subject|7|||
25019574|NCT01316900|50115602|FG001|Overall Study|Withdrawal by Subject|8|||
25019575|NCT01316900|50115603|FG002|Overall Study|Withdrawal by Subject|6|||
25019576|NCT01316900|50115604|FG003|Overall Study|Withdrawal by Subject|9|||
25019577|NCT03714815|50115614|FG000|Overall Study|Physician Decision|2|||
25019578|NCT03714815|50115614|FG000|Overall Study|Withdrawal by Subject|2|||
25019579|NCT03714815|50115614|FG000|Overall Study|Death|11|||
25019580|NCT00936390|50115620|FG000|Overall Study|Protocol Violation|21|||
25019581|NCT00936390|50115621|FG001|Overall Study|Protocol Violation|25|||
25019582|NCT03499873|50115632|FG000|Overall Study|Withdrawal by Subject|4|||
25019583|NCT03499873|50115633|FG001|Overall Study|Withdrawal by Subject|6|||
25019584|NCT03499873|50115634|FG002|Overall Study|Withdrawal by Subject|1|||
25019585|NCT03499873|50115632|FG000|Overall Study|Subjects condition worsened|0|||
25019586|NCT03499873|50115633|FG001|Overall Study|Subjects condition worsened|3|||
25019587|NCT03499873|50115634|FG002|Overall Study|Subjects condition worsened|11|||
25019588|NCT03499873|50115632|FG000|Overall Study|Adverse Event|8|||
25019589|NCT03499873|50115633|FG001|Overall Study|Adverse Event|3|||
25019590|NCT03499873|50115634|FG002|Overall Study|Adverse Event|6|||
25019591|NCT03499873|50115632|FG000|Overall Study|Physician Decision|1|||
25019592|NCT03499873|50115633|FG001|Overall Study|Physician Decision|0|||
25019593|NCT03499873|50115634|FG002|Overall Study|Physician Decision|0|||
25019594|NCT03499873|50115632|FG000|Overall Study|Administrative reasons|0|||
25019595|NCT03499873|50115633|FG001|Overall Study|Administrative reasons|1|||
25019596|NCT03499873|50115634|FG002|Overall Study|Administrative reasons|0|||
25019597|NCT03499873|50115632|FG000|Overall Study|Concomitant therapy|5|||
25019598|NCT03499873|50115633|FG001|Overall Study|Concomitant therapy|4|||
25019599|NCT03499873|50115634|FG002|Overall Study|Concomitant therapy|7|||
25019600|NCT03499873|50115632|FG000|Overall Study|Miscellaneous|1|||
25019601|NCT03499873|50115633|FG001|Overall Study|Miscellaneous|2|||
25019602|NCT03499873|50115634|FG002|Overall Study|Miscellaneous|2|||
25019603|NCT03499873|50115632|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
24910294|NCT00541450|50004454|FG000|Phase B|Physician Decision|4|||
24910295|NCT00541450|50004455|FG001|Phase B|Physician Decision|2|||
24910296|NCT00541450|50004454|FG000|Phase B|Pregnancy|0|||
25019604|NCT03499873|50115633|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
25019605|NCT03499873|50115634|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
25019606|NCT03467971|50115644|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25019607|NCT03467971|50115645|FG001|Treatment Period 2|Withdrawal by Subject|1|||
25019608|NCT03049280|50115661|FG000|Overall Study|Physician Decision|1|||
25019609|NCT03048500|50115667|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
24910297|NCT00541450|50004455|FG001|Phase B|Pregnancy|1|||
24910298|NCT00541450|50004454|FG000|Phase B|Protocol Violation|3|||
24910299|NCT00541450|50004455|FG001|Phase B|Protocol Violation|3|||
24910300|NCT00541450|50004454|FG000|Phase B|Withdrawal by Subject|8|||
24910301|NCT00541450|50004455|FG001|Phase B|Withdrawal by Subject|6|||
25019610|NCT03048500|50115667|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
25019611|NCT03048500|50115667|FG000|Reached 1st Response/Continued Treatment|Death|1|||
25019612|NCT03048500|50115667|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
25019613|NCT03048500|50115667|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
25019614|NCT03048500|50115667|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
24910302|NCT00355147|50004467|FG000|Overall Study|Lost to Follow-up|10|||
24910303|NCT00355147|50004468|FG001|Overall Study|Lost to Follow-up|8|||
24910304|NCT00355147|50004467|FG000|Overall Study|Withdrawal by Subject|8|||
24910305|NCT00355147|50004468|FG001|Overall Study|Withdrawal by Subject|12|||
25274904|NCT00904033|50589008|FG003|Overall Study|Withdrawal by Subject|0|||
25274905|NCT00904033|50589005|FG000|Overall Study|Physician Decision|0|||
25019615|NCT03048500|50115667|FG000|Follow up for 3 Years|Death|12|||
25019616|NCT00908076|50115673|FG000|Overall Study|Lack of Efficacy|1|||
25274906|NCT00904033|50589006|FG001|Overall Study|Physician Decision|0|||
25274907|NCT00904033|50589007|FG002|Overall Study|Physician Decision|1|||
25274908|NCT00904033|50589008|FG003|Overall Study|Physician Decision|0|||
24910311|NCT00540124|50004488|FG000|Overall Study|Adverse Event|0|||
24910312|NCT00540124|50004489|FG001|Overall Study|Adverse Event|2|||
24910313|NCT00540124|50004490|FG002|Overall Study|Adverse Event|1|||
24910314|NCT00540124|50004488|FG000|Overall Study|Entry Criteria Not Met|2|||
24910315|NCT00540124|50004489|FG001|Overall Study|Entry Criteria Not Met|0|||
24910316|NCT00540124|50004490|FG002|Overall Study|Entry Criteria Not Met|0|||
24910317|NCT00540124|50004488|FG000|Overall Study|Lack of Efficacy|1|||
24910318|NCT00540124|50004489|FG001|Overall Study|Lack of Efficacy|0|||
24910319|NCT00540124|50004490|FG002|Overall Study|Lack of Efficacy|0|||
24910320|NCT00540124|50004488|FG000|Overall Study|Withdrawal by Subject|1|||
24910321|NCT00540124|50004489|FG001|Overall Study|Withdrawal by Subject|1|||
24910322|NCT00540124|50004490|FG002|Overall Study|Withdrawal by Subject|0|||
24910323|NCT00540046|50004500|FG000|Overall Study|Lost to Follow-up|33|||
24910324|NCT00540046|50004501|FG001|Overall Study|Lost to Follow-up|23|||
24910325|NCT00689936|50004512|FG000|Active Treatment Phase|Adverse Event|68|||
24910326|NCT00689936|50004513|FG001|Active Treatment Phase|Adverse Event|71|||
24910327|NCT00689936|50004514|FG002|Active Treatment Phase|Adverse Event|76|||
24910328|NCT00689936|50004512|FG000|Active Treatment Phase|Disease Progression|273|||
24910329|NCT00689936|50004513|FG001|Active Treatment Phase|Disease Progression|362|||
24910330|NCT00689936|50004514|FG002|Active Treatment Phase|Disease Progression|339|||
24910331|NCT00689936|50004512|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
24910332|NCT00689936|50004513|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
24910333|NCT00689936|50004514|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
24910334|NCT00689936|50004512|FG000|Active Treatment Phase|Death|60|||
24910335|NCT00689936|50004513|FG001|Active Treatment Phase|Death|28|||
24910336|NCT00689936|50004514|FG002|Active Treatment Phase|Death|37|||
24910337|NCT00689936|50004512|FG000|Active Treatment Phase|Lost to Follow-up|0|||
24910338|NCT00689936|50004513|FG001|Active Treatment Phase|Lost to Follow-up|2|||
24910339|NCT00689936|50004514|FG002|Active Treatment Phase|Lost to Follow-up|2|||
24910340|NCT00689936|50004512|FG000|Active Treatment Phase|Protocol Violation|2|||
24910341|NCT00689936|50004513|FG001|Active Treatment Phase|Protocol Violation|2|||
24910342|NCT00689936|50004514|FG002|Active Treatment Phase|Protocol Violation|4|||
24910343|NCT00689936|50004512|FG000|Active Treatment Phase|Study Close Out|64|||
24910344|NCT00689936|50004513|FG001|Active Treatment Phase|Study Close Out|26|||
24910345|NCT00689936|50004514|FG002|Active Treatment Phase|Study Close Out|21|||
24910346|NCT00689936|50004512|FG000|Active Treatment Phase|Miscellaneous|52|||
25184949|NCT01425359|50334038|FG000|Overall Study|Randomized but Not Treated|2|||
24910347|NCT00689936|50004513|FG001|Active Treatment Phase|Miscellaneous|34|||
24910348|NCT00689936|50004514|FG002|Active Treatment Phase|Miscellaneous|47|||
24910349|NCT00689936|50004512|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
24910350|NCT00689936|50004513|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
24910351|NCT00689936|50004514|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
24910352|NCT00671034|50004525|FG000|Overall Study|Adverse Event|5|||
24910353|NCT00671034|50004526|FG001|Overall Study|Adverse Event|7|||
24910354|NCT00671034|50004527|FG002|Overall Study|Adverse Event|1|||
24910355|NCT00671034|50004525|FG000|Overall Study|Death|3|||
24910356|NCT00671034|50004526|FG001|Overall Study|Death|2|||
24910357|NCT00671034|50004527|FG002|Overall Study|Death|1|||
24910358|NCT00671034|50004525|FG000|Overall Study|Physician Decision|12|||
24910359|NCT00671034|50004526|FG001|Overall Study|Physician Decision|4|||
24910360|NCT00671034|50004527|FG002|Overall Study|Physician Decision|5|||
24910361|NCT00671034|50004525|FG000|Overall Study|VHR ALL feature|8|||
24910362|NCT00671034|50004526|FG001|Overall Study|VHR ALL feature|3|||
24910363|NCT00671034|50004527|FG002|Overall Study|VHR ALL feature|5|||
24910364|NCT00671034|50004525|FG000|Overall Study|Refusal|5|||
24910365|NCT00671034|50004526|FG001|Overall Study|Refusal|3|||
24910366|NCT00671034|50004527|FG002|Overall Study|Refusal|5|||
24910367|NCT00671034|50004525|FG000|Overall Study|includes Alternative therapy, etc.|6|||
24910368|NCT00671034|50004526|FG001|Overall Study|includes Alternative therapy, etc.|1|||
24910369|NCT00671034|50004527|FG002|Overall Study|includes Alternative therapy, etc.|7|||
24910370|NCT04404478|50004538|FG000|Overall Study|Withdrawal by Subject|1|||
24910371|NCT04404478|50004539|FG001|Overall Study|Withdrawal by Subject|3|||
24910372|NCT00539734|50004547|FG000|Overall Study|Protocol Violation|1|||
24910373|NCT03907072|50004554|FG000|Overall Study|Study Terminated by Sponsor|2|||
24910374|NCT03907072|50004555|FG001|Overall Study|Study Terminated by Sponsor|2|||
24910375|NCT03907072|50004556|FG002|Overall Study|Study Terminated by Sponsor|2|||
24910376|NCT00329719|50004581|FG000|Overall Study|Lost to Follow-up|0|||
24910377|NCT00329719|50004582|FG001|Overall Study|Lost to Follow-up|0|||
24910378|NCT00329719|50004583|FG002|Overall Study|Lost to Follow-up|0|||
24910379|NCT00329719|50004584|FG003|Overall Study|Lost to Follow-up|1|||
24910380|NCT00329641|50004594|FG000|Overall Study|Did not start treatment|1|||
24910381|NCT00329641|50004594|FG000|Overall Study|Not eligible|1|||
24910382|NCT00329641|50004594|FG000|Overall Study|Adverse Event|3|||
24910383|NCT00329641|50004594|FG000|Overall Study|Other reason, not protocol specified|1|||
24910384|NCT00329407|50004608|FG000|Overall Study|Withdrawal by Subject|1|||
24910385|NCT00328783|50004612|FG000|Overall Study|Could not tolerate ABC|21|||
24910386|NCT00328783|50004612|FG000|Overall Study|No heart in RT field|4|||
24910387|NCT00328783|50004612|FG000|Overall Study|Withdrawal by Subject|1|||
24910388|NCT00567489|50004620|FG000|Overall Study|Adverse Event|6|||
25019617|NCT00908076|50115674|FG001|Overall Study|Lack of Efficacy|1|||
24910389|NCT00567489|50004621|FG001|Overall Study|Adverse Event|14|||
24910390|NCT00567489|50004620|FG000|Overall Study|Physician Decision|0|||
25019618|NCT03467425|50115682|FG000|Overall Study|Adverse Event|9|||
24910391|NCT00567489|50004621|FG001|Overall Study|Physician Decision|4|||
24910392|NCT00567489|50004620|FG000|Overall Study|Withdrawal by Subject|0|||
24910393|NCT00567489|50004621|FG001|Overall Study|Withdrawal by Subject|2|||
24910394|NCT00567489|50004620|FG000|Overall Study|Renal Transplantation|0|||
24910395|NCT00567489|50004621|FG001|Overall Study|Renal Transplantation|3|||
25019619|NCT03467425|50115683|FG001|Overall Study|Adverse Event|9|||
25019620|NCT03467425|50115682|FG000|Overall Study|Lack of Efficacy|3|||
24910396|NCT00567489|50004620|FG000|Overall Study|Other|1|||
24910397|NCT00567489|50004621|FG001|Overall Study|Other|0|||
24910398|NCT00669942|50004639|FG000|Parts 2 and 3|Adverse Event|0|||
24910399|NCT00669942|50004640|FG001|Parts 2 and 3|Adverse Event|0|||
24910400|NCT00669942|50004641|FG002|Parts 2 and 3|Adverse Event|0|||
24910401|NCT00669942|50004642|FG003|Parts 2 and 3|Adverse Event|0|||
25152945|NCT01908829|50268102|FG001|Overall Study|Miscellaneous|2|||
25152946|NCT01908829|50268103|FG002|Overall Study|Miscellaneous|0|||
25152947|NCT01908829|50268101|FG000|Overall Study|Protocol Violation|2|||
25152948|NCT01908829|50268102|FG001|Overall Study|Protocol Violation|2|||
25152949|NCT01908829|50268103|FG002|Overall Study|Protocol Violation|0|||
25152950|NCT01908829|50268101|FG000|Overall Study|Lack of Efficacy|1|||
25152951|NCT01908829|50268102|FG001|Overall Study|Lack of Efficacy|3|||
25152952|NCT01908829|50268103|FG002|Overall Study|Lack of Efficacy|2|||
25152953|NCT01908829|50268101|FG000|Overall Study|Withdrawal by Subject|26|||
25152954|NCT01908829|50268102|FG001|Overall Study|Withdrawal by Subject|29|||
25152955|NCT01908829|50268103|FG002|Overall Study|Withdrawal by Subject|22|||
25152956|NCT01773122|50268115|FG000|Overall Study|Due to amended age eligibility criteria|3|||
25152957|NCT01773122|50268116|FG001|Overall Study|Due to amended age eligibility criteria|1|||
25152958|NCT01773122|50268117|FG002|Overall Study|Due to amended age eligibility criteria|0|||
25152959|NCT01773122|50268118|FG003|Overall Study|Due to amended age eligibility criteria|1|||
25152960|NCT01808534|50268128|FG000|Overall Study|Disease progression|3|||
25152961|NCT01808534|50268128|FG000|Overall Study|Physician Decision|1|||
25152962|NCT01808222|50268132|FG000|Overall Study|mpMR scan was not performed|1|||
25152963|NCT01772576|50268136|FG000|Overall Study|Death|15|||
25152964|NCT01772576|50268136|FG000|Overall Study|Protocol Violation|1|||
25152965|NCT01772576|50268136|FG000|Overall Study|Lost to Follow-up|3|||
25152966|NCT01772576|50268136|FG000|Overall Study|Study device not used|3|||
24910402|NCT00669942|50004643|FG004|Parts 2 and 3|Adverse Event|0|||
24910403|NCT00669942|50004644|FG005|Parts 2 and 3|Adverse Event|0|||
24910404|NCT00669942|50004645|FG006|Parts 2 and 3|Adverse Event|0|||
25019621|NCT03467425|50115683|FG001|Overall Study|Lack of Efficacy|1|||
25019622|NCT03467425|50115682|FG000|Overall Study|Protocol Violation|0|||
25019623|NCT03467425|50115683|FG001|Overall Study|Protocol Violation|1|||
25019624|NCT03467425|50115682|FG000|Overall Study|Lost to Follow-up|18|||
24910405|NCT00669942|50004646|FG007|Parts 2 and 3|Adverse Event|2|||
24910406|NCT00669942|50004647|FG008|Parts 2 and 3|Adverse Event|1|||
24910407|NCT00669942|50004648|FG009|Parts 2 and 3|Adverse Event|0|||
24910408|NCT00669942|50004649|FG010|Parts 2 and 3|Adverse Event|0|||
25019625|NCT03467425|50115683|FG001|Overall Study|Lost to Follow-up|25|||
25019626|NCT03467425|50115682|FG000|Overall Study|Physician Decision|2|||
25019627|NCT03467425|50115683|FG001|Overall Study|Physician Decision|1|||
25019628|NCT03467425|50115682|FG000|Overall Study|Withdrawal by Subject|15|||
25019629|NCT03467425|50115683|FG001|Overall Study|Withdrawal by Subject|17|||
25019630|NCT02886702|50115692|FG000|Overall Study|Other|4|||
24910409|NCT00669942|50004650|FG011|Parts 2 and 3|Adverse Event|0|||
25019631|NCT02886702|50115693|FG001|Overall Study|Other|3|||
25019632|NCT02886702|50115694|FG002|Overall Study|Other|9|||
25019633|NCT02886702|50115692|FG000|Overall Study|Withdrawal by Subject|24|||
25019634|NCT02886702|50115693|FG001|Overall Study|Withdrawal by Subject|18|||
25019635|NCT02886702|50115694|FG002|Overall Study|Withdrawal by Subject|22|||
25019636|NCT02886702|50115692|FG000|Overall Study|Significant Worsening of Condition|0|||
25019637|NCT02886702|50115693|FG001|Overall Study|Significant Worsening of Condition|1|||
25019638|NCT02886702|50115694|FG002|Overall Study|Significant Worsening of Condition|0|||
25019639|NCT02886702|50115692|FG000|Overall Study|Protocol Violation|2|||
25019640|NCT02886702|50115693|FG001|Overall Study|Protocol Violation|2|||
25019641|NCT02886702|50115694|FG002|Overall Study|Protocol Violation|1|||
25019642|NCT02886702|50115692|FG000|Overall Study|Non-Compliance With Study Drug|0|||
25152967|NCT01772576|50268136|FG000|Overall Study|Adverse Event|6|||
25152968|NCT01772576|50268136|FG000|Overall Study|Withdrawal by Subject|6|||
25152969|NCT01802216|50268163|FG000|4 Month Visit|Participant did not show to visit|3|||
24910410|NCT00669942|50004639|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
24910411|NCT00669942|50004640|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
24910412|NCT00669942|50004641|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
24910413|NCT00669942|50004642|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
25019643|NCT02886702|50115693|FG001|Overall Study|Non-Compliance With Study Drug|1|||
25019644|NCT02886702|50115694|FG002|Overall Study|Non-Compliance With Study Drug|4|||
25019645|NCT02886702|50115692|FG000|Overall Study|Lost to Follow-up|11|||
25152970|NCT01802216|50268164|FG001|4 Month Visit|Participant did not show to visit|4|||
25152971|NCT01802216|50268163|FG000|8 Month Visit|Participant did not show to visit|3|||
25152972|NCT01802216|50268164|FG001|8 Month Visit|Participant did not show to visit|5|||
24910414|NCT00669942|50004643|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
24910415|NCT00669942|50004644|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
25019646|NCT02886702|50115693|FG001|Overall Study|Lost to Follow-up|13|||
25019647|NCT02886702|50115694|FG002|Overall Study|Lost to Follow-up|8|||
25019648|NCT02886702|50115692|FG000|Overall Study|Lack of Efficacy|3|||
25019649|NCT02886702|50115693|FG001|Overall Study|Lack of Efficacy|4|||
25019650|NCT02886702|50115694|FG002|Overall Study|Lack of Efficacy|5|||
25019651|NCT02886702|50115692|FG000|Overall Study|Adverse Event|4|||
25019652|NCT02886702|50115693|FG001|Overall Study|Adverse Event|9|||
25019653|NCT02886702|50115694|FG002|Overall Study|Adverse Event|3|||
25019654|NCT02886702|50115692|FG000|Overall Study|Administrative Reasons|0|||
25019655|NCT02886702|50115693|FG001|Overall Study|Administrative Reasons|0|||
25019656|NCT02886702|50115694|FG002|Overall Study|Administrative Reasons|1|||
25019657|NCT03498313|50115708|FG000|Experimental Period 1|Adverse Event|1|||
24910416|NCT00669942|50004645|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
24910417|NCT00669942|50004646|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
24910418|NCT00669942|50004647|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
24910419|NCT00669942|50004648|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
24910420|NCT00669942|50004649|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
24910421|NCT00669942|50004650|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
24910422|NCT00669942|50004639|FG000|Parts 2 and 3|Protocol Violation|0|||
24910423|NCT00669942|50004640|FG001|Parts 2 and 3|Protocol Violation|0|||
24910424|NCT00669942|50004641|FG002|Parts 2 and 3|Protocol Violation|0|||
24910425|NCT00669942|50004642|FG003|Parts 2 and 3|Protocol Violation|0|||
24910426|NCT00669942|50004643|FG004|Parts 2 and 3|Protocol Violation|0|||
24910427|NCT00669942|50004644|FG005|Parts 2 and 3|Protocol Violation|1|||
24910428|NCT00669942|50004645|FG006|Parts 2 and 3|Protocol Violation|0|||
24910429|NCT00669942|50004646|FG007|Parts 2 and 3|Protocol Violation|0|||
24910430|NCT00669942|50004647|FG008|Parts 2 and 3|Protocol Violation|0|||
24910431|NCT00669942|50004648|FG009|Parts 2 and 3|Protocol Violation|0|||
24910432|NCT00669942|50004649|FG010|Parts 2 and 3|Protocol Violation|0|||
24910433|NCT00669942|50004650|FG011|Parts 2 and 3|Protocol Violation|0|||
24910434|NCT00669864|50004673|FG000|Overall Study|Lost to Follow-up|2|||
24910435|NCT00669864|50004673|FG000|Overall Study|Protocol Violation|2|||
24910436|NCT00669864|50004673|FG000|Overall Study|Withdrawal by Subject|3|||
24910437|NCT00669864|50004673|FG000|Overall Study|Other|2|||
24910438|NCT00668148|50004677|FG000|Overall Study|Adverse Event|5|||
24910439|NCT00668148|50004677|FG000|Overall Study|Subject Non-compliance|1|||
24910440|NCT00668148|50004677|FG000|Overall Study|Progressive Disease Before Treatment|2|||
24910441|NCT00668148|50004677|FG000|Overall Study|Withdrawal of Consent|2|||
24910442|NCT00667992|50004694|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
24910443|NCT00667992|50004695|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
24910444|NCT00667992|50004694|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
24910445|NCT00667992|50004695|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
24910446|NCT00667992|50004694|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
24910447|NCT00667992|50004695|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
24910448|NCT00667992|50004694|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
24910449|NCT00667992|50004695|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
24910450|NCT00667992|50004694|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
24910451|NCT00667992|50004695|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
24910452|NCT00667992|50004694|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
24910453|NCT00667992|50004695|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
24910454|NCT00667992|50004694|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
24910455|NCT00667992|50004695|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
24910456|NCT00667992|50004694|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
24910457|NCT00667992|50004695|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
24910458|NCT00667992|50004694|FG000|Wash-out|Not within one doubling dilution|4|||
24910459|NCT00667992|50004695|FG001|Wash-out|Not within one doubling dilution|3|||
24910460|NCT00667992|50004694|FG000|Wash-out|Failure to wash-out|2|||
24910461|NCT00667992|50004695|FG001|Wash-out|Failure to wash-out|2|||
24910462|NCT00667992|50004694|FG000|Wash-out|Withdrawal by Subject|1|||
24910463|NCT00667992|50004695|FG001|Wash-out|Withdrawal by Subject|0|||
24910464|NCT00667992|50004694|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
24910465|NCT00667992|50004695|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
25019658|NCT03498313|50115709|FG001|Experimental Period 1|Adverse Event|0|||
25019659|NCT03498313|50115710|FG002|Experimental Period 1|Adverse Event|0|||
25019660|NCT03498313|50115711|FG003|Experimental Period 1|Adverse Event|1|||
24910466|NCT00667992|50004694|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
24910467|NCT00667992|50004695|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
24910468|NCT00669396|50004713|FG000|Overall Study|Lost to Follow-up|10|||
24910469|NCT00669396|50004714|FG001|Overall Study|Lost to Follow-up|12|||
25019661|NCT03498313|50115712|FG004|Experimental Period 1|Adverse Event|0|||
24910470|NCT00669318|50004720|FG000|Overall Study|Withdrawal by Subject|2|||
24910471|NCT00669240|50004724|FG000|Overall Study|Lack of Efficacy|33|||
24910472|NCT00669240|50004724|FG000|Overall Study|Withdrawal by Subject|42|||
24910473|NCT00669240|50004724|FG000|Overall Study|Lost to Follow-up|34|||
24910474|NCT00669240|50004724|FG000|Overall Study|Adverse Event|21|||
24910475|NCT00669240|50004724|FG000|Overall Study|Other|19|||
24910476|NCT00669240|50004724|FG000|Overall Study|Enrolled but not treated|15|||
24910477|NCT00669240|50004724|FG000|Overall Study|Enrolled but no dosing record|1|||
24910478|NCT00669162|50004728|FG000|Overall Study|Withdrawal by Subject|1|||
24910479|NCT00400946|50004737|FG000|Overall Study|Ineligible|0|||
24910480|NCT00400946|50004738|FG001|Overall Study|Ineligible|0|||
24910481|NCT00400946|50004739|FG002|Overall Study|Ineligible|0|||
24910482|NCT00400946|50004740|FG003|Overall Study|Ineligible|5|||
24910483|NCT00400946|50004741|FG004|Overall Study|Ineligible|1|||
24910484|NCT00400946|50004737|FG000|Overall Study|Induction Failure|0|||
24910485|NCT00400946|50004738|FG001|Overall Study|Induction Failure|0|||
24910486|NCT00400946|50004739|FG002|Overall Study|Induction Failure|0|||
24910487|NCT00400946|50004740|FG003|Overall Study|Induction Failure|11|||
24910488|NCT00400946|50004741|FG004|Overall Study|Induction Failure|8|||
24910489|NCT00400946|50004737|FG000|Overall Study|Induction Death|0|||
24910490|NCT00400946|50004738|FG001|Overall Study|Induction Death|0|||
24910491|NCT00400946|50004739|FG002|Overall Study|Induction Death|0|||
24910492|NCT00400946|50004740|FG003|Overall Study|Induction Death|13|||
24910493|NCT00400946|50004741|FG004|Overall Study|Induction Death|3|||
24910494|NCT00400946|50004737|FG000|Overall Study|Lost to Follow-up|1|||
24910495|NCT00400946|50004738|FG001|Overall Study|Lost to Follow-up|1|||
24910496|NCT00400946|50004739|FG002|Overall Study|Lost to Follow-up|0|||
24910497|NCT00400946|50004740|FG003|Overall Study|Lost to Follow-up|0|||
24910498|NCT00400946|50004741|FG004|Overall Study|Lost to Follow-up|1|||
24910499|NCT00400946|50004737|FG000|Overall Study|Remission Death|1|||
24910500|NCT00400946|50004738|FG001|Overall Study|Remission Death|1|||
24910501|NCT00400946|50004739|FG002|Overall Study|Remission Death|0|||
24910502|NCT00400946|50004740|FG003|Overall Study|Remission Death|0|||
24910503|NCT00400946|50004741|FG004|Overall Study|Remission Death|1|||
24910504|NCT00400946|50004737|FG000|Overall Study|Relapse|9|||
24910505|NCT00400946|50004738|FG001|Overall Study|Relapse|2|||
24910506|NCT00400946|50004739|FG002|Overall Study|Relapse|1|||
24910507|NCT00400946|50004740|FG003|Overall Study|Relapse|1|||
24910508|NCT00400946|50004741|FG004|Overall Study|Relapse|5|||
24910509|NCT00400946|50004737|FG000|Overall Study|Transplant in CR1|0|||
24910510|NCT00400946|50004738|FG001|Overall Study|Transplant in CR1|0|||
24910511|NCT00400946|50004739|FG002|Overall Study|Transplant in CR1|0|||
24910512|NCT00400946|50004740|FG003|Overall Study|Transplant in CR1|10|||
24910513|NCT00400946|50004741|FG004|Overall Study|Transplant in CR1|1|||
24910514|NCT00400946|50004737|FG000|Overall Study|Withdrawal by Subject|2|||
24910515|NCT00400946|50004738|FG001|Overall Study|Withdrawal by Subject|5|||
24910516|NCT00400946|50004739|FG002|Overall Study|Withdrawal by Subject|1|||
24910517|NCT00400946|50004740|FG003|Overall Study|Withdrawal by Subject|5|||
24910518|NCT00400946|50004741|FG004|Overall Study|Withdrawal by Subject|8|||
24910519|NCT00400946|50004737|FG000|Overall Study|Clinical|1|||
24910520|NCT00400946|50004738|FG001|Overall Study|Clinical|2|||
24910521|NCT00400946|50004739|FG002|Overall Study|Clinical|0|||
24910522|NCT00400946|50004740|FG003|Overall Study|Clinical|2|||
24910523|NCT00400946|50004741|FG004|Overall Study|Clinical|9|||
24910524|NCT00400946|50004737|FG000|Overall Study|Other|0|||
24910525|NCT00400946|50004738|FG001|Overall Study|Other|0|||
24910526|NCT00400946|50004739|FG002|Overall Study|Other|0|||
24910527|NCT00400946|50004740|FG003|Overall Study|Other|0|||
24910528|NCT00400946|50004741|FG004|Overall Study|Other|1|||
24910529|NCT00666588|50004772|FG000|Overall Study|ineligible|2|||
24910530|NCT00666588|50004773|FG001|Overall Study|ineligible|0|||
24910531|NCT00666588|50004774|FG002|Overall Study|ineligible|0|||
24910532|NCT00666588|50004775|FG003|Overall Study|ineligible|2|||
25019662|NCT03498313|50115713|FG005|Experimental Period 1|Adverse Event|0|||
25019663|NCT03498313|50115708|FG000|Experimental Period 1|Withdrawal by Subject|0|||
25152973|NCT01802216|50268163|FG000|12 Month Visit|Participant did not show to visit|3|||
24910533|NCT00666588|50004772|FG000|Overall Study|inevaluable|2|||
24910534|NCT00666588|50004773|FG001|Overall Study|inevaluable|0|||
24910535|NCT00666588|50004774|FG002|Overall Study|inevaluable|0|||
24910536|NCT00666588|50004775|FG003|Overall Study|inevaluable|0|||
24910537|NCT00689390|50004787|FG000|Overall Study|Adverse Event|19|||
24910538|NCT00689390|50004788|FG001|Overall Study|Adverse Event|0|||
24910539|NCT00689390|50004787|FG000|Overall Study|Lost to Follow-up|179|||
24910540|NCT00689390|50004788|FG001|Overall Study|Lost to Follow-up|7|||
24910541|NCT00689390|50004787|FG000|Overall Study|Withdrawal by Subject|117|||
24910542|NCT00689390|50004788|FG001|Overall Study|Withdrawal by Subject|3|||
24910543|NCT00689390|50004787|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
25019664|NCT03498313|50115709|FG001|Experimental Period 1|Withdrawal by Subject|1|||
24910544|NCT00689390|50004788|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
24910545|NCT00689390|50004787|FG000|Overall Study|Non-Compliance With Protocol|21|||
24910546|NCT00689390|50004788|FG001|Overall Study|Non-Compliance With Protocol|0|||
24910547|NCT00689390|50004787|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
24910548|NCT00689390|50004788|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
24910549|NCT00689390|50004787|FG000|Overall Study|Administrative|37|||
24910550|NCT00689390|50004788|FG001|Overall Study|Administrative|0|||
24910551|NCT00567879|50004805|FG000|Overall Study|Adverse Event|2|||
24910552|NCT00567879|50004806|FG001|Overall Study|Adverse Event|0|||
24910553|NCT00567879|50004807|FG002|Overall Study|Adverse Event|1|||
24910554|NCT00567879|50004808|FG003|Overall Study|Adverse Event|0|||
24910555|NCT00567879|50004809|FG004|Overall Study|Adverse Event|1|||
24910556|NCT00567879|50004810|FG005|Overall Study|Adverse Event|0|||
24910557|NCT00567879|50004805|FG000|Overall Study|Abnormal test procedure(s)|0|||
24910558|NCT00567879|50004806|FG001|Overall Study|Abnormal test procedure(s)|0|||
24910559|NCT00567879|50004807|FG002|Overall Study|Abnormal test procedure(s)|1|||
24910560|NCT00567879|50004808|FG003|Overall Study|Abnormal test procedure(s)|0|||
24910561|NCT00567879|50004809|FG004|Overall Study|Abnormal test procedure(s)|0|||
24910562|NCT00567879|50004810|FG005|Overall Study|Abnormal test procedure(s)|0|||
24910563|NCT00567879|50004805|FG000|Overall Study|Withdrawal by Subject|0|||
24910564|NCT00567879|50004806|FG001|Overall Study|Withdrawal by Subject|0|||
24910565|NCT00567879|50004807|FG002|Overall Study|Withdrawal by Subject|3|||
24910566|NCT00567879|50004808|FG003|Overall Study|Withdrawal by Subject|1|||
24910567|NCT00567879|50004809|FG004|Overall Study|Withdrawal by Subject|0|||
24910568|NCT00567879|50004810|FG005|Overall Study|Withdrawal by Subject|0|||
24910569|NCT00567879|50004805|FG000|Overall Study|New cancer therapy|0|||
24910570|NCT00567879|50004806|FG001|Overall Study|New cancer therapy|0|||
25019665|NCT03498313|50115710|FG002|Experimental Period 1|Withdrawal by Subject|0|||
25019666|NCT03498313|50115711|FG003|Experimental Period 1|Withdrawal by Subject|0|||
25019667|NCT03498313|50115712|FG004|Experimental Period 1|Withdrawal by Subject|0|||
25019668|NCT03498313|50115713|FG005|Experimental Period 1|Withdrawal by Subject|0|||
25019669|NCT03498313|50115708|FG000|Washout Period 1|Anovulation|1|||
25019670|NCT03498313|50115709|FG001|Washout Period 1|Anovulation|0|||
25019671|NCT03498313|50115710|FG002|Washout Period 1|Anovulation|0|||
25019672|NCT03498313|50115711|FG003|Washout Period 1|Anovulation|0|||
25019673|NCT03498313|50115712|FG004|Washout Period 1|Anovulation|0|||
25019674|NCT03498313|50115713|FG005|Washout Period 1|Anovulation|0|||
24910571|NCT00567879|50004807|FG002|Overall Study|New cancer therapy|1|||
24910572|NCT00567879|50004808|FG003|Overall Study|New cancer therapy|0|||
24910573|NCT00567879|50004809|FG004|Overall Study|New cancer therapy|0|||
24910574|NCT00567879|50004810|FG005|Overall Study|New cancer therapy|0|||
24910575|NCT00567879|50004805|FG000|Overall Study|Disease progression|5|||
24910576|NCT00567879|50004806|FG001|Overall Study|Disease progression|7|||
24910577|NCT00567879|50004807|FG002|Overall Study|Disease progression|15|||
24910578|NCT00567879|50004808|FG003|Overall Study|Disease progression|5|||
24910579|NCT00567879|50004809|FG004|Overall Study|Disease progression|11|||
24910580|NCT00567879|50004810|FG005|Overall Study|Disease progression|3|||
24910581|NCT00603915|50004828|FG000|Overall Study|Physician Decision|1|||
24910582|NCT00603837|50004834|FG000|Overall Study|Physician Decision|3|||
24910583|NCT00603837|50004835|FG001|Overall Study|Physician Decision|0|||
24910584|NCT00667602|50004844|FG000|Overall Study|Withdrawal by Subject|4|||
24910585|NCT00667602|50004845|FG001|Overall Study|Withdrawal by Subject|9|||
24910586|NCT00667602|50004846|FG002|Overall Study|Withdrawal by Subject|10|||
24910587|NCT00667602|50004844|FG000|Overall Study|Lost to Follow-up|4|||
24910588|NCT00667602|50004845|FG001|Overall Study|Lost to Follow-up|5|||
24910589|NCT00667602|50004846|FG002|Overall Study|Lost to Follow-up|6|||
24910590|NCT00667602|50004844|FG000|Overall Study|Administrative reason|0|||
24910591|NCT00667602|50004845|FG001|Overall Study|Administrative reason|0|||
24910592|NCT00667602|50004846|FG002|Overall Study|Administrative reason|2|||
24910593|NCT00667602|50004844|FG000|Overall Study|Protocol Violation|0|||
24910594|NCT00667602|50004845|FG001|Overall Study|Protocol Violation|1|||
24910595|NCT00667602|50004846|FG002|Overall Study|Protocol Violation|0|||
24910596|NCT00691028|50004862|FG000|Open-label Period|Adverse Event|0|||
24910597|NCT00691028|50004863|FG001|Open-label Period|Adverse Event|0|||
24910598|NCT00691028|50004864|FG002|Open-label Period|Adverse Event|0|||
25152974|NCT01802216|50268164|FG001|12 Month Visit|Participant did not show to visit|4|||
24910599|NCT00691028|50004865|FG003|Open-label Period|Adverse Event|16|||
24910600|NCT00691028|50004862|FG000|Open-label Period|Withdrawal by Subject|0|||
24910601|NCT00691028|50004863|FG001|Open-label Period|Withdrawal by Subject|0|||
24910602|NCT00691028|50004864|FG002|Open-label Period|Withdrawal by Subject|0|||
24910603|NCT00691028|50004865|FG003|Open-label Period|Withdrawal by Subject|3|||
24910604|NCT00691028|50004862|FG000|Open-label Period|not come to a hospital|0|||
24910605|NCT00691028|50004863|FG001|Open-label Period|not come to a hospital|0|||
24910606|NCT00691028|50004864|FG002|Open-label Period|not come to a hospital|0|||
24910607|NCT00691028|50004865|FG003|Open-label Period|not come to a hospital|1|||
24910608|NCT00691028|50004862|FG000|Double-blind Period|Adverse Event|8|||
24910609|NCT00691028|50004863|FG001|Double-blind Period|Adverse Event|9|||
24910610|NCT00691028|50004864|FG002|Double-blind Period|Adverse Event|6|||
24910611|NCT00691028|50004865|FG003|Double-blind Period|Adverse Event|0|||
24910612|NCT00691028|50004862|FG000|Double-blind Period|Lack of Efficacy|4|||
24910613|NCT00691028|50004863|FG001|Double-blind Period|Lack of Efficacy|3|||
25019675|NCT03498313|50115708|FG000|Washout Period 1|Withdrawal by Subject|0|||
24910614|NCT00691028|50004864|FG002|Double-blind Period|Lack of Efficacy|2|||
24910615|NCT00691028|50004865|FG003|Double-blind Period|Lack of Efficacy|0|||
24910616|NCT00691028|50004862|FG000|Double-blind Period|Withdrawal by Subject|1|||
24910617|NCT00691028|50004863|FG001|Double-blind Period|Withdrawal by Subject|0|||
24910618|NCT00691028|50004864|FG002|Double-blind Period|Withdrawal by Subject|1|||
24910619|NCT00691028|50004865|FG003|Double-blind Period|Withdrawal by Subject|0|||
24910620|NCT00691028|50004862|FG000|Double-blind Period|not come to a hospital.|0|||
24910621|NCT00691028|50004863|FG001|Double-blind Period|not come to a hospital.|1|||
24910622|NCT00691028|50004864|FG002|Double-blind Period|not come to a hospital.|0|||
24910623|NCT00691028|50004865|FG003|Double-blind Period|not come to a hospital.|0|||
24910624|NCT00690794|50004879|FG000|Overall Study|Adverse Event|12|||
24910625|NCT00690794|50004880|FG001|Overall Study|Adverse Event|10|||
24910626|NCT00690794|50004879|FG000|Overall Study|Lost to Follow-up|1|||
24910627|NCT00690794|50004880|FG001|Overall Study|Lost to Follow-up|4|||
24910628|NCT00690794|50004879|FG000|Overall Study|Withdrawal by Subject|0|||
24910629|NCT00690794|50004880|FG001|Overall Study|Withdrawal by Subject|9|||
24910630|NCT00690794|50004879|FG000|Overall Study|Protocol Violation|6|||
24910631|NCT00690794|50004880|FG001|Overall Study|Protocol Violation|7|||
24910632|NCT00690794|50004879|FG000|Overall Study|Noncompliance|1|||
24910633|NCT00690794|50004880|FG001|Overall Study|Noncompliance|2|||
24910634|NCT00690794|50004879|FG000|Overall Study|Other not specified|1|||
24910635|NCT00690794|50004880|FG001|Overall Study|Other not specified|3|||
24910636|NCT00666276|50004886|FG000|Overall Study|Protocol Violation|34|||
24910637|NCT00567255|50004911|FG000|Overall Study|Adverse Event|241|||
24910638|NCT00567255|50004912|FG001|Overall Study|Adverse Event|68|||
24910639|NCT00567255|50004911|FG000|Overall Study|Lost to Follow-up|77|||
24910640|NCT00567255|50004912|FG001|Overall Study|Lost to Follow-up|48|||
24910641|NCT00567255|50004911|FG000|Overall Study|Withdrawal by Subject|75|||
24910642|NCT00567255|50004912|FG001|Overall Study|Withdrawal by Subject|56|||
24910643|NCT00567255|50004911|FG000|Overall Study|Lack of Efficacy|19|||
24910644|NCT00567255|50004912|FG001|Overall Study|Lack of Efficacy|33|||
24910645|NCT00567255|50004911|FG000|Overall Study|Protocol Violation|20|||
24910646|NCT00567255|50004912|FG001|Overall Study|Protocol Violation|8|||
24910647|NCT00567255|50004911|FG000|Overall Study|Pregnancy|6|||
24910648|NCT00567255|50004912|FG001|Overall Study|Pregnancy|0|||
24910649|NCT00567255|50004911|FG000|Overall Study|Drug noncompliance,moved,other|25|||
24910650|NCT00567255|50004912|FG001|Overall Study|Drug noncompliance,moved,other|15|||
24910651|NCT00667446|50004920|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
24910652|NCT00667446|50004921|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
24910653|NCT00667446|50004920|FG000|Treatment Period (36 Months)|Other|2|||
24910654|NCT00667446|50004921|FG001|Treatment Period (36 Months)|Other|2|||
24910655|NCT00667446|50004920|FG000|Treatment Period (36 Months)|Personal reasons|2|||
24910656|NCT00667446|50004921|FG001|Treatment Period (36 Months)|Personal reasons|2|||
24910657|NCT00667446|50004920|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
24910658|NCT00667446|50004921|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
24910659|NCT00667446|50004920|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
24910660|NCT00667446|50004921|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
24910661|NCT00667446|50004920|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
24910662|NCT00667446|50004921|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
24910663|NCT00667446|50004920|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
24910664|NCT00667446|50004921|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
24910665|NCT00667446|50004920|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
24910666|NCT00667446|50004921|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
24910667|NCT00667446|50004920|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
24910668|NCT00667446|50004921|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
24910669|NCT00688844|50004927|FG000|Overall Study|Lost to Follow-up|10|||
24910670|NCT00667368|50004933|FG000|Overall Study|Lost to Follow-up|176|||
24910671|NCT00667368|50004934|FG001|Overall Study|Lost to Follow-up|155|||
24910672|NCT00667368|50004933|FG000|Overall Study|Discontinued early|24|||
24910673|NCT00667368|50004934|FG001|Overall Study|Discontinued early|17|||
24910674|NCT00567567|50004943|FG000|Overall Study|Adverse Event|0|||
24910675|NCT00567567|50004944|FG001|Overall Study|Adverse Event|2|||
24910676|NCT00567567|50004945|FG002|Overall Study|Adverse Event|5|||
24910677|NCT00567567|50004943|FG000|Overall Study|Death|8|||
24910678|NCT00567567|50004944|FG001|Overall Study|Death|1|||
24910679|NCT00567567|50004945|FG002|Overall Study|Death|5|||
24910680|NCT00567567|50004943|FG000|Overall Study|Lack of Efficacy|16|||
24910681|NCT00567567|50004944|FG001|Overall Study|Lack of Efficacy|17|||
24910682|NCT00567567|50004945|FG002|Overall Study|Lack of Efficacy|48|||
24910683|NCT00567567|50004943|FG000|Overall Study|Lost to Follow-up|0|||
24910684|NCT00567567|50004944|FG001|Overall Study|Lost to Follow-up|0|||
24910685|NCT00567567|50004945|FG002|Overall Study|Lost to Follow-up|1|||
24910686|NCT00567567|50004943|FG000|Overall Study|Physician Decision|16|||
24910687|NCT00567567|50004944|FG001|Overall Study|Physician Decision|18|||
24910688|NCT00567567|50004945|FG002|Overall Study|Physician Decision|84|||
24910689|NCT00567567|50004943|FG000|Overall Study|Withdrawal by Subject|0|||
24910690|NCT00567567|50004944|FG001|Overall Study|Withdrawal by Subject|0|||
24910691|NCT00567567|50004945|FG002|Overall Study|Withdrawal by Subject|2|||
24910692|NCT00567567|50004943|FG000|Overall Study|Ineligible|4|||
24910693|NCT00567567|50004944|FG001|Overall Study|Ineligible|0|||
24910694|NCT00567567|50004945|FG002|Overall Study|Ineligible|9|||
24910695|NCT00567567|50004943|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
24910696|NCT00567567|50004944|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
24910697|NCT00567567|50004945|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
24910698|NCT00567567|50004943|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
24910699|NCT00567567|50004944|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
24910700|NCT00567567|50004945|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
24910701|NCT00567567|50004943|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
24910702|NCT00567567|50004944|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
24910703|NCT00567567|50004945|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
24910704|NCT00666198|50004955|FG000|Overall Study|Protocol Violation|10|||
24910705|NCT00666198|50004955|FG000|Overall Study|No Visit After First Day of Treatment|13|||
24910706|NCT00666198|50004955|FG000|Overall Study|Safety Not Assessable|6|||
24910707|NCT00666198|50004955|FG000|Overall Study|No Drug Administration|4|||
24910708|NCT00664560|50004962|FG000|Overall Study|Adverse Event|19|||
24910709|NCT00664560|50004963|FG001|Overall Study|Adverse Event|16|||
24910710|NCT00664560|50004964|FG002|Overall Study|Adverse Event|7|||
24910711|NCT00664560|50004962|FG000|Overall Study|Withdrawal by Subject|9|||
24910712|NCT00664560|50004963|FG001|Overall Study|Withdrawal by Subject|13|||
24910713|NCT00664560|50004964|FG002|Overall Study|Withdrawal by Subject|7|||
24910714|NCT00664560|50004962|FG000|Overall Study|Lost to Follow-up|0|||
24910715|NCT00664560|50004963|FG001|Overall Study|Lost to Follow-up|2|||
24910716|NCT00664560|50004964|FG002|Overall Study|Lost to Follow-up|0|||
24910717|NCT00664560|50004962|FG000|Overall Study|Other|11|||
24910718|NCT00664560|50004963|FG001|Overall Study|Other|4|||
24910719|NCT00664560|50004964|FG002|Overall Study|Other|5|||
24910720|NCT00566709|50004974|FG000|Overall Study|Protocol Violation|5|||
24910721|NCT00566709|50004975|FG001|Overall Study|Protocol Violation|0|||
24910722|NCT00688688|50004984|FG000|Overall Study|Eligibility criterion not met|7|||
24910723|NCT00688688|50004985|FG001|Overall Study|Eligibility criterion not met|7|||
24910724|NCT00688688|50004986|FG002|Overall Study|Eligibility criterion not met|10|||
24910725|NCT00688688|50004984|FG000|Overall Study|Adverse Event|52|||
24910726|NCT00688688|50004985|FG001|Overall Study|Adverse Event|51|||
24910727|NCT00688688|50004986|FG002|Overall Study|Adverse Event|50|||
24910728|NCT00688688|50004984|FG000|Overall Study|Lack of Efficacy|34|||
24910729|NCT00688688|50004985|FG001|Overall Study|Lack of Efficacy|25|||
24910730|NCT00688688|50004986|FG002|Overall Study|Lack of Efficacy|45|||
24910731|NCT00688688|50004984|FG000|Overall Study|Withdrawal by Subject|66|||
24910732|NCT00688688|50004985|FG001|Overall Study|Withdrawal by Subject|75|||
24910733|NCT00688688|50004986|FG002|Overall Study|Withdrawal by Subject|65|||
24910734|NCT00688688|50004984|FG000|Overall Study|Lost to Follow-up|14|||
24910735|NCT00688688|50004985|FG001|Overall Study|Lost to Follow-up|7|||
24910736|NCT00688688|50004986|FG002|Overall Study|Lost to Follow-up|7|||
24910737|NCT00688688|50004984|FG000|Overall Study|Protocol Violation|6|||
24910738|NCT00688688|50004985|FG001|Overall Study|Protocol Violation|9|||
24910739|NCT00688688|50004986|FG002|Overall Study|Protocol Violation|11|||
24910740|NCT00688688|50004984|FG000|Overall Study|Randomized but never received study drug|1|||
24910741|NCT00688688|50004985|FG001|Overall Study|Randomized but never received study drug|0|||
24910742|NCT00688688|50004986|FG002|Overall Study|Randomized but never received study drug|0|||
24910743|NCT00688688|50004984|FG000|Overall Study|Non-compliance with study procedures|5|||
24910744|NCT00688688|50004985|FG001|Overall Study|Non-compliance with study procedures|3|||
24910745|NCT00688688|50004986|FG002|Overall Study|Non-compliance with study procedures|4|||
24910746|NCT00688688|50004984|FG000|Overall Study|Taking exclusionary medications|1|||
24910747|NCT00688688|50004985|FG001|Overall Study|Taking exclusionary medications|0|||
24910748|NCT00688688|50004986|FG002|Overall Study|Taking exclusionary medications|0|||
24910749|NCT00688688|50004984|FG000|Overall Study|Site closure|0|||
24910750|NCT00688688|50004985|FG001|Overall Study|Site closure|1|||
24910751|NCT00688688|50004986|FG002|Overall Study|Site closure|0|||
24910752|NCT00688688|50004984|FG000|Overall Study|Violation of exclusion criterion|0|||
24910753|NCT00688688|50004985|FG001|Overall Study|Violation of exclusion criterion|1|||
24910754|NCT00688688|50004986|FG002|Overall Study|Violation of exclusion criterion|0|||
24910755|NCT00664326|50004994|FG000|Overall Study|Adverse Event|14|||
24910756|NCT00664326|50004994|FG000|Overall Study|Noncompliance with study medication|3|||
24910757|NCT00664326|50004994|FG000|Overall Study|Withdrawal by Subject|1|||
24910758|NCT00664326|50004994|FG000|Overall Study|Physician Decision|1|||
24910759|NCT00664326|50004994|FG000|Overall Study|Other Reasons|3|||
24910760|NCT00664326|50004994|FG000|Overall Study|Death|2|||
24910761|NCT00664326|50004994|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
24910762|NCT00686972|50004998|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
24910763|NCT00665652|50005002|FG000|Overall Study|Adverse Event|4|||
24910764|NCT00665652|50005002|FG000|Overall Study|Death|1|||
24910765|NCT00665652|50005002|FG000|Overall Study|No longer met inclusion criteria.|1|||
24910766|NCT00566631|50005006|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
24910767|NCT00566631|50005006|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
24910768|NCT00566631|50005006|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
24910769|NCT00566631|50005006|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
24910770|NCT00566631|50005006|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
24910771|NCT00566631|50005006|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
24910772|NCT00566631|50005006|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
24910773|NCT00566631|50005006|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
24910774|NCT00566631|50005006|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
24910775|NCT00566631|50005006|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
24910776|NCT00566631|50005006|FG000|Part 2: Extension Phase|Adverse Event|11|||
24910777|NCT00566631|50005006|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
24910778|NCT00566631|50005006|FG000|Part 2: Extension Phase|Death|1|||
24910779|NCT00566631|50005006|FG000|Part 2: Extension Phase|Other|5|||
24910780|NCT00661830|50005012|FG000|Overall Study|Death|37|||
24910781|NCT00661830|50005013|FG001|Overall Study|Death|33|||
24910782|NCT00661830|50005012|FG000|Overall Study|Lost to Follow-up|1|||
24910783|NCT00661830|50005013|FG001|Overall Study|Lost to Follow-up|3|||
24910784|NCT00661830|50005012|FG000|Overall Study|Withdrawal by Subject|1|||
24910785|NCT00661830|50005013|FG001|Overall Study|Withdrawal by Subject|1|||
24910786|NCT00661830|50005012|FG000|Overall Study|Other reason|1|||
24910787|NCT00661830|50005013|FG001|Overall Study|Other reason|5|||
24910788|NCT00540592|50005029|FG000|Overall Study|Adverse Event|0|||
24910789|NCT00540592|50005030|FG001|Overall Study|Adverse Event|1|||
24910790|NCT00540592|50005031|FG002|Overall Study|Adverse Event|0|||
24910791|NCT00540592|50005032|FG003|Overall Study|Adverse Event|0|||
24910792|NCT00540592|50005033|FG004|Overall Study|Adverse Event|1|||
24910793|NCT00540592|50005034|FG005|Overall Study|Adverse Event|0|||
25152975|NCT01808144|50268172|FG000|Overall Study|Death|1|||
25152976|NCT01808144|50268173|FG001|Overall Study|Death|0|||
25152977|NCT01808144|50268172|FG000|Overall Study|Withdrawal by Subject|16|||
25152978|NCT01808144|50268173|FG001|Overall Study|Withdrawal by Subject|23|||
25152979|NCT01808144|50268172|FG000|Overall Study|Lost to Follow-up|6|||
25152980|NCT01808144|50268173|FG001|Overall Study|Lost to Follow-up|3|||
25152981|NCT01808144|50268172|FG000|Overall Study|Protocol Violation|6|||
25152982|NCT01808144|50268173|FG001|Overall Study|Protocol Violation|6|||
25152983|NCT01808144|50268172|FG000|Overall Study|Gout flare|0|||
25152984|NCT01808144|50268173|FG001|Overall Study|Gout flare|1|||
25152985|NCT01808144|50268172|FG000|Overall Study|Adverse Event|11|||
25152986|NCT01808144|50268173|FG001|Overall Study|Adverse Event|15|||
25152987|NCT01801982|50268179|FG000|Overall Study|Lost to Follow-up|1|||
25152988|NCT01808066|50268192|FG000|Overall Study|Withdrawal by Subject|15|||
25152989|NCT01604343|50268200|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
25152990|NCT01604343|50268201|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
25152991|NCT01604343|50268202|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
25152992|NCT01604343|50268203|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
25152993|NCT01604343|50268204|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
25152994|NCT01604343|50268200|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
25152995|NCT01604343|50268201|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
25152996|NCT01604343|50268202|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
25152997|NCT01604343|50268203|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
25152998|NCT01604343|50268204|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
25152999|NCT01604343|50268200|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
25153000|NCT01604343|50268201|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
25153001|NCT01604343|50268202|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
25153002|NCT01604343|50268203|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
25153003|NCT01604343|50268204|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
25153004|NCT01604343|50268200|FG000|Prior to W52 Administration(Through W52)|Death|5|||
25153005|NCT01604343|50268201|FG001|Prior to W52 Administration(Through W52)|Death|0|||
25153006|NCT01604343|50268202|FG002|Prior to W52 Administration(Through W52)|Death|2|||
25153007|NCT01604343|50268203|FG003|Prior to W52 Administration(Through W52)|Death|0|||
25153008|NCT01604343|50268204|FG004|Prior to W52 Administration(Through W52)|Death|4|||
24910794|NCT00540592|50005035|FG006|Overall Study|Adverse Event|0|||
25153009|NCT01604343|50268200|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
25153010|NCT01604343|50268201|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
25153011|NCT01604343|50268202|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
24910795|NCT00540592|50005036|FG007|Overall Study|Adverse Event|1|||
24910796|NCT00540592|50005037|FG008|Overall Study|Adverse Event|1|||
24910797|NCT00540592|50005038|FG009|Overall Study|Adverse Event|2|||
24910798|NCT00540592|50005029|FG000|Overall Study|Lost to Follow-up|2|||
24910799|NCT00540592|50005030|FG001|Overall Study|Lost to Follow-up|0|||
24910800|NCT00540592|50005031|FG002|Overall Study|Lost to Follow-up|0|||
24910801|NCT00540592|50005032|FG003|Overall Study|Lost to Follow-up|0|||
24910802|NCT00540592|50005033|FG004|Overall Study|Lost to Follow-up|0|||
24910803|NCT00540592|50005034|FG005|Overall Study|Lost to Follow-up|0|||
24910804|NCT00540592|50005035|FG006|Overall Study|Lost to Follow-up|0|||
24910805|NCT00540592|50005036|FG007|Overall Study|Lost to Follow-up|0|||
24910806|NCT00540592|50005037|FG008|Overall Study|Lost to Follow-up|0|||
24910807|NCT00540592|50005038|FG009|Overall Study|Lost to Follow-up|0|||
24910808|NCT00540592|50005029|FG000|Overall Study|Withdrawal by Subject|0|||
24910809|NCT00540592|50005030|FG001|Overall Study|Withdrawal by Subject|0|||
24910810|NCT00540592|50005031|FG002|Overall Study|Withdrawal by Subject|1|||
24910811|NCT00540592|50005032|FG003|Overall Study|Withdrawal by Subject|1|||
24910812|NCT00540592|50005033|FG004|Overall Study|Withdrawal by Subject|0|||
24910813|NCT00540592|50005034|FG005|Overall Study|Withdrawal by Subject|0|||
24910814|NCT00540592|50005035|FG006|Overall Study|Withdrawal by Subject|0|||
24910815|NCT00540592|50005036|FG007|Overall Study|Withdrawal by Subject|0|||
24910816|NCT00540592|50005037|FG008|Overall Study|Withdrawal by Subject|0|||
24910817|NCT00540592|50005038|FG009|Overall Study|Withdrawal by Subject|0|||
24910818|NCT03970395|50005062|FG000|Overall Study|Withdrawal by Subject|3|||
24910819|NCT03970395|50005063|FG001|Overall Study|Withdrawal by Subject|4|||
25019676|NCT03498313|50115709|FG001|Washout Period 1|Withdrawal by Subject|3|||
24910820|NCT03970395|50005062|FG000|Overall Study|Lost to Follow-up|4|||
24910821|NCT03970395|50005063|FG001|Overall Study|Lost to Follow-up|8|||
24910822|NCT00565773|50005073|FG000|Overall Study|Withdrawal by Subject|1|||
24910823|NCT00565773|50005073|FG000|Overall Study|Physician Decision|1|||
24910824|NCT00570492|50005079|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
24910825|NCT00570492|50005080|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
24910826|NCT00570492|50005081|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
24910827|NCT00570492|50005079|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
25153012|NCT01604343|50268203|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
24910828|NCT00570492|50005080|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
24910829|NCT00570492|50005081|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
24910830|NCT00570492|50005079|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
24910831|NCT00570492|50005080|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
24910832|NCT00570492|50005081|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
24910833|NCT00570492|50005079|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
24910834|NCT00570492|50005080|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
24910835|NCT00570492|50005081|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
24910836|NCT00570492|50005079|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
24910837|NCT00570492|50005080|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
24910838|NCT00570492|50005081|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
24910839|NCT00570492|50005079|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
24910840|NCT00570492|50005080|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
24910841|NCT00570492|50005081|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
24910842|NCT00570492|50005079|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
24910843|NCT00570492|50005080|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
24910844|NCT00570492|50005081|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
24910845|NCT00570492|50005079|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
24910846|NCT00570492|50005080|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
24910847|NCT00570492|50005081|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
24910848|NCT00570492|50005079|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
24910849|NCT00570492|50005080|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
24910850|NCT00570492|50005081|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
24910851|NCT00570492|50005079|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
24910852|NCT00570492|50005080|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
24910853|NCT00570492|50005081|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
24910854|NCT00570492|50005079|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
24910855|NCT00570492|50005080|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
24910856|NCT00570492|50005081|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
25019677|NCT03498313|50115710|FG002|Washout Period 1|Withdrawal by Subject|0|||
25019678|NCT03498313|50115711|FG003|Washout Period 1|Withdrawal by Subject|1|||
25019679|NCT03498313|50115712|FG004|Washout Period 1|Withdrawal by Subject|0|||
25019680|NCT03498313|50115713|FG005|Washout Period 1|Withdrawal by Subject|1|||
25019681|NCT03498313|50115708|FG000|Experimental Period 2|Adverse Event|0|||
25019682|NCT03498313|50115709|FG001|Experimental Period 2|Adverse Event|0|||
25019683|NCT03498313|50115710|FG002|Experimental Period 2|Adverse Event|0|||
25153013|NCT01604343|50268204|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
25019684|NCT03498313|50115711|FG003|Experimental Period 2|Adverse Event|0|||
24910857|NCT00570492|50005079|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
24910858|NCT00570492|50005080|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
24910859|NCT00570492|50005081|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
24910860|NCT00570492|50005079|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
24910861|NCT00570492|50005080|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
24910862|NCT00570492|50005081|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
24910863|NCT00570492|50005079|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
24910864|NCT00570492|50005080|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
24910865|NCT00570492|50005081|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
24910866|NCT00571922|50005089|FG000|Overall Study|Completion unknown|36|||
24910867|NCT00571922|50005090|FG001|Overall Study|Completion unknown|36|||
24910868|NCT00686894|50005096|FG000|Overall Study|Relapse|2|||
24910869|NCT00686894|50005096|FG000|Overall Study|Protocol Violation|4|||
24910870|NCT00328627|50005112|FG000|Overall Study|Hyperglycemic Rescue|41|||
24910871|NCT00328627|50005113|FG001|Overall Study|Hyperglycemic Rescue|18|||
24910872|NCT00328627|50005114|FG002|Overall Study|Hyperglycemic Rescue|16|||
24910873|NCT00328627|50005115|FG003|Overall Study|Hyperglycemic Rescue|13|||
25019685|NCT03498313|50115712|FG004|Experimental Period 2|Adverse Event|1|||
25019686|NCT03498313|50115713|FG005|Experimental Period 2|Adverse Event|2|||
25019687|NCT03498313|50115708|FG000|Washout Period 2|Physician Decision|1|||
25019688|NCT03498313|50115709|FG001|Washout Period 2|Physician Decision|0|||
25019689|NCT03498313|50115710|FG002|Washout Period 2|Physician Decision|0|||
25019690|NCT03498313|50115711|FG003|Washout Period 2|Physician Decision|1|||
25019691|NCT03498313|50115712|FG004|Washout Period 2|Physician Decision|0|||
25019692|NCT03498313|50115713|FG005|Washout Period 2|Physician Decision|1|||
25019693|NCT03498313|50115708|FG000|Washout Period 2|Withdrawal by Subject|3|||
25019694|NCT03498313|50115709|FG001|Washout Period 2|Withdrawal by Subject|2|||
25019695|NCT03498313|50115710|FG002|Washout Period 2|Withdrawal by Subject|0|||
25019696|NCT03498313|50115711|FG003|Washout Period 2|Withdrawal by Subject|0|||
25019697|NCT03498313|50115712|FG004|Washout Period 2|Withdrawal by Subject|2|||
25019698|NCT03498313|50115713|FG005|Washout Period 2|Withdrawal by Subject|0|||
25019699|NCT03498313|50115708|FG000|Washout Period 2|Anovulation|0|||
25019700|NCT03498313|50115709|FG001|Washout Period 2|Anovulation|0|||
25019701|NCT03498313|50115710|FG002|Washout Period 2|Anovulation|0|||
25019702|NCT03498313|50115711|FG003|Washout Period 2|Anovulation|0|||
25019703|NCT03498313|50115712|FG004|Washout Period 2|Anovulation|0|||
25019704|NCT03498313|50115713|FG005|Washout Period 2|Anovulation|1|||
25019705|NCT02601014|50115723|FG000|Overall Study|Adverse Event|3|||
25019706|NCT02601014|50115724|FG001|Overall Study|Adverse Event|3|||
25019707|NCT02601014|50115723|FG000|Overall Study|Death|3|||
25019708|NCT02601014|50115724|FG001|Overall Study|Death|1|||
25019709|NCT02601014|50115723|FG000|Overall Study|Disease progression|4|||
25019710|NCT02601014|50115724|FG001|Overall Study|Disease progression|8|||
25019711|NCT01307046|50115732|FG000|Overall Study|Adverse Event|3|||
25019712|NCT01307046|50115733|FG001|Overall Study|Adverse Event|3|||
25019713|NCT01307046|50115732|FG000|Overall Study|Lack of Efficacy|0|||
25019714|NCT01307046|50115733|FG001|Overall Study|Lack of Efficacy|2|||
25019715|NCT01307046|50115732|FG000|Overall Study|Physician Decision|2|||
25019716|NCT01307046|50115733|FG001|Overall Study|Physician Decision|0|||
25019717|NCT01307046|50115732|FG000|Overall Study|Withdrawal by Subject|1|||
25019718|NCT01307046|50115733|FG001|Overall Study|Withdrawal by Subject|1|||
25019719|NCT01307046|50115732|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
25019720|NCT01307046|50115733|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
25019721|NCT01307046|50115732|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
25019722|NCT01307046|50115733|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
25019723|NCT03495817|50115739|FG000|26 Week Open Label|Adverse Event|3|||
25019724|NCT03495817|50115739|FG000|26 Week Open Label|Withdrawal by Subject|4|||
25019725|NCT03495817|50115739|FG000|26 Week Open Label|Lost to Follow-up|1|||
25019726|NCT03495817|50115739|FG000|26 Week Extension|Lost to Follow-up|2|||
25019727|NCT02886624|50115743|FG000|12-week Post Treatment Follow-up|Death|1|||
25019728|NCT02886624|50115743|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
25019729|NCT02963766|50115750|FG000|Double-Blind Period|Adverse Event|1|||
25019730|NCT02963766|50115751|FG001|Double-Blind Period|Adverse Event|0|||
25019731|NCT02963766|50115752|FG002|Double-Blind Period|Adverse Event|1|||
25153014|NCT01604343|50268200|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
25153015|NCT01604343|50268201|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
25153016|NCT01604343|50268202|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
24910874|NCT00328627|50005116|FG004|Overall Study|Hyperglycemic Rescue|6|||
25019732|NCT02963766|50115750|FG000|Double-Blind Period|Physician Decision|1|||
25019733|NCT02963766|50115751|FG001|Double-Blind Period|Physician Decision|0|||
25019734|NCT02963766|50115752|FG002|Double-Blind Period|Physician Decision|0|||
25019735|NCT02963766|50115750|FG000|Double-Blind Period|Withdrawal by Subject|1|||
25019736|NCT02963766|50115751|FG001|Double-Blind Period|Withdrawal by Subject|1|||
25019737|NCT02963766|50115752|FG002|Double-Blind Period|Withdrawal by Subject|0|||
25019738|NCT02963766|50115750|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
25019739|NCT02963766|50115751|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
25019740|NCT02963766|50115752|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
25019741|NCT02963766|50115750|FG000|Double-Blind Period|Protocol Violation|1|||
25019742|NCT02963766|50115751|FG001|Double-Blind Period|Protocol Violation|0|||
25019743|NCT02963766|50115752|FG002|Double-Blind Period|Protocol Violation|0|||
25019744|NCT02963766|50115750|FG000|Double-Blind Period|Lost to Follow-up|0|||
25019745|NCT02963766|50115751|FG001|Double-Blind Period|Lost to Follow-up|1|||
25019746|NCT02963766|50115752|FG002|Double-Blind Period|Lost to Follow-up|0|||
25019747|NCT02963766|50115750|FG000|Open Label Extension (OLE)|Physician Decision|1|||
25019748|NCT02963766|50115751|FG001|Open Label Extension (OLE)|Physician Decision|2|||
25019749|NCT02963766|50115752|FG002|Open Label Extension (OLE)|Physician Decision|2|||
25019750|NCT02963766|50115750|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
25019751|NCT02963766|50115751|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
25019752|NCT02963766|50115752|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
25019753|NCT04839965|50115772|FG000|Overall Study|Death|6|||
25019754|NCT04839965|50115773|FG001|Overall Study|Death|6|||
25019755|NCT04839965|50115772|FG000|Overall Study|Lost to Follow-up|1|||
25019756|NCT04839965|50115773|FG001|Overall Study|Lost to Follow-up|0|||
25019757|NCT03466099|50115782|FG000|Overall Study|Adverse Event|1|||
25019758|NCT03466099|50115783|FG001|Overall Study|Adverse Event|1|||
25019759|NCT03466099|50115784|FG002|Overall Study|Adverse Event|1|||
25019760|NCT03466099|50115782|FG000|Overall Study|Withdrawal by Subject|2|||
25019761|NCT03466099|50115783|FG001|Overall Study|Withdrawal by Subject|3|||
25019762|NCT03466099|50115784|FG002|Overall Study|Withdrawal by Subject|1|||
25019763|NCT03466099|50115782|FG000|Overall Study|Use of rescue medication|8|||
24910875|NCT00328627|50005117|FG005|Overall Study|Hyperglycemic Rescue|5|||
24910876|NCT00328627|50005118|FG006|Overall Study|Hyperglycemic Rescue|19|||
24910877|NCT00328627|50005119|FG007|Overall Study|Hyperglycemic Rescue|6|||
24910878|NCT00328627|50005120|FG008|Overall Study|Hyperglycemic Rescue|6|||
24910879|NCT00328627|50005121|FG009|Overall Study|Hyperglycemic Rescue|11|||
24910880|NCT00328627|50005122|FG010|Overall Study|Hyperglycemic Rescue|3|||
24910881|NCT00328627|50005123|FG011|Overall Study|Hyperglycemic Rescue|2|||
24910882|NCT00328627|50005112|FG000|Overall Study|Adverse Event|3|||
24910883|NCT00328627|50005113|FG001|Overall Study|Adverse Event|1|||
24910884|NCT00328627|50005114|FG002|Overall Study|Adverse Event|2|||
24910885|NCT00328627|50005115|FG003|Overall Study|Adverse Event|3|||
24910886|NCT00328627|50005116|FG004|Overall Study|Adverse Event|1|||
24910887|NCT00328627|50005117|FG005|Overall Study|Adverse Event|2|||
24910888|NCT00328627|50005118|FG006|Overall Study|Adverse Event|1|||
24910889|NCT00328627|50005119|FG007|Overall Study|Adverse Event|2|||
24910890|NCT00328627|50005120|FG008|Overall Study|Adverse Event|0|||
24910891|NCT00328627|50005121|FG009|Overall Study|Adverse Event|7|||
24910892|NCT00328627|50005122|FG010|Overall Study|Adverse Event|5|||
24910893|NCT00328627|50005123|FG011|Overall Study|Adverse Event|4|||
24910894|NCT00328627|50005112|FG000|Overall Study|Protocol Violation|2|||
24910895|NCT00328627|50005113|FG001|Overall Study|Protocol Violation|2|||
24910896|NCT00328627|50005114|FG002|Overall Study|Protocol Violation|2|||
24910897|NCT00328627|50005115|FG003|Overall Study|Protocol Violation|8|||
24910898|NCT00328627|50005116|FG004|Overall Study|Protocol Violation|5|||
24910899|NCT00328627|50005117|FG005|Overall Study|Protocol Violation|5|||
24910900|NCT00328627|50005118|FG006|Overall Study|Protocol Violation|6|||
24910901|NCT00328627|50005119|FG007|Overall Study|Protocol Violation|2|||
24910902|NCT00328627|50005120|FG008|Overall Study|Protocol Violation|1|||
24910903|NCT00328627|50005121|FG009|Overall Study|Protocol Violation|4|||
24910904|NCT00328627|50005122|FG010|Overall Study|Protocol Violation|6|||
24910905|NCT00328627|50005123|FG011|Overall Study|Protocol Violation|2|||
24910906|NCT00328627|50005112|FG000|Overall Study|Lost to Follow-up|4|||
24910907|NCT00328627|50005113|FG001|Overall Study|Lost to Follow-up|2|||
24910908|NCT00328627|50005114|FG002|Overall Study|Lost to Follow-up|2|||
24910909|NCT00328627|50005115|FG003|Overall Study|Lost to Follow-up|4|||
24910910|NCT00328627|50005116|FG004|Overall Study|Lost to Follow-up|0|||
24910911|NCT00328627|50005117|FG005|Overall Study|Lost to Follow-up|2|||
24910912|NCT00328627|50005118|FG006|Overall Study|Lost to Follow-up|3|||
24910913|NCT00328627|50005119|FG007|Overall Study|Lost to Follow-up|0|||
24910914|NCT00328627|50005120|FG008|Overall Study|Lost to Follow-up|3|||
24910915|NCT00328627|50005121|FG009|Overall Study|Lost to Follow-up|2|||
24910916|NCT00328627|50005122|FG010|Overall Study|Lost to Follow-up|0|||
24910917|NCT00328627|50005123|FG011|Overall Study|Lost to Follow-up|1|||
24910918|NCT00328627|50005112|FG000|Overall Study|Withdrawal by Subject|5|||
24910919|NCT00328627|50005113|FG001|Overall Study|Withdrawal by Subject|4|||
25019764|NCT03466099|50115783|FG001|Overall Study|Use of rescue medication|9|||
25019765|NCT03466099|50115784|FG002|Overall Study|Use of rescue medication|13|||
25019766|NCT03466099|50115782|FG000|Overall Study|Rescued without meeting criteria|4|||
25019767|NCT03466099|50115783|FG001|Overall Study|Rescued without meeting criteria|1|||
25019768|NCT03466099|50115784|FG002|Overall Study|Rescued without meeting criteria|1|||
25019769|NCT03466099|50115782|FG000|Overall Study|Subject compliance|2|||
25019770|NCT03466099|50115783|FG001|Overall Study|Subject compliance|0|||
25019771|NCT03466099|50115784|FG002|Overall Study|Subject compliance|0|||
25019772|NCT03466099|50115782|FG000|Overall Study|Worsening disease|0|||
25019773|NCT03466099|50115783|FG001|Overall Study|Worsening disease|0|||
25019774|NCT03466099|50115784|FG002|Overall Study|Worsening disease|1|||
25019775|NCT00739674|50115794|FG000|Overall Study|Screening failures|19|||
25019776|NCT00739674|50115795|FG001|Overall Study|Screening failures|17|||
25019777|NCT00739674|50115794|FG000|Overall Study|Site 212 removal|19|||
25019778|NCT00739674|50115795|FG001|Overall Study|Site 212 removal|13|||
25019779|NCT00739674|50115794|FG000|Overall Study|No follow-up data|33|||
25019780|NCT00739674|50115795|FG001|Overall Study|No follow-up data|18|||
25019781|NCT00739674|50115794|FG000|Overall Study|Dietician consultation >30 days|1|||
25019782|NCT00739674|50115795|FG001|Overall Study|Dietician consultation >30 days|9|||
25019783|NCT00739674|50115794|FG000|Overall Study|Adverse Event|22|||
25019784|NCT00739674|50115795|FG001|Overall Study|Adverse Event|13|||
25019785|NCT00739674|50115794|FG000|Overall Study|Death|1|||
25019786|NCT00739674|50115795|FG001|Overall Study|Death|0|||
25019787|NCT00739674|50115794|FG000|Overall Study|Lack of Efficacy|1|||
25019788|NCT00739674|50115795|FG001|Overall Study|Lack of Efficacy|0|||
25019789|NCT00739674|50115794|FG000|Overall Study|Lost to Follow-up|52|||
25019790|NCT00739674|50115795|FG001|Overall Study|Lost to Follow-up|30|||
25153017|NCT01604343|50268203|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
25153018|NCT01604343|50268204|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
25153019|NCT01604343|50268200|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
24910920|NCT00328627|50005114|FG002|Overall Study|Withdrawal by Subject|5|||
24910921|NCT00328627|50005115|FG003|Overall Study|Withdrawal by Subject|6|||
24910922|NCT00328627|50005116|FG004|Overall Study|Withdrawal by Subject|2|||
24910923|NCT00328627|50005117|FG005|Overall Study|Withdrawal by Subject|5|||
24910924|NCT00328627|50005118|FG006|Overall Study|Withdrawal by Subject|4|||
24910925|NCT00328627|50005119|FG007|Overall Study|Withdrawal by Subject|4|||
24910926|NCT00328627|50005120|FG008|Overall Study|Withdrawal by Subject|4|||
24910927|NCT00328627|50005121|FG009|Overall Study|Withdrawal by Subject|5|||
24910928|NCT00328627|50005122|FG010|Overall Study|Withdrawal by Subject|2|||
24910929|NCT00328627|50005123|FG011|Overall Study|Withdrawal by Subject|7|||
24910930|NCT00328627|50005112|FG000|Overall Study|Pregnancy|0|||
24910931|NCT00328627|50005113|FG001|Overall Study|Pregnancy|1|||
24910932|NCT00328627|50005114|FG002|Overall Study|Pregnancy|0|||
24910933|NCT00328627|50005115|FG003|Overall Study|Pregnancy|0|||
24910934|NCT00328627|50005116|FG004|Overall Study|Pregnancy|0|||
25153020|NCT01604343|50268201|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
25153021|NCT01604343|50268202|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
25274909|NCT00904033|50589005|FG000|Overall Study|Unable to obtain final blood draw|0|||
25274910|NCT00904033|50589006|FG001|Overall Study|Unable to obtain final blood draw|0|||
24910935|NCT00328627|50005117|FG005|Overall Study|Pregnancy|0|||
24910936|NCT00328627|50005118|FG006|Overall Study|Pregnancy|0|||
24910937|NCT00328627|50005119|FG007|Overall Study|Pregnancy|0|||
24910938|NCT00328627|50005120|FG008|Overall Study|Pregnancy|0|||
24910939|NCT00328627|50005121|FG009|Overall Study|Pregnancy|0|||
24910940|NCT00328627|50005122|FG010|Overall Study|Pregnancy|0|||
24910941|NCT00328627|50005123|FG011|Overall Study|Pregnancy|0|||
24910942|NCT00328627|50005112|FG000|Overall Study|Physician Decision|4|||
24910943|NCT00328627|50005113|FG001|Overall Study|Physician Decision|3|||
24910944|NCT00328627|50005114|FG002|Overall Study|Physician Decision|1|||
24910945|NCT00328627|50005115|FG003|Overall Study|Physician Decision|2|||
24910946|NCT00328627|50005116|FG004|Overall Study|Physician Decision|1|||
24910947|NCT00328627|50005117|FG005|Overall Study|Physician Decision|1|||
24910948|NCT00328627|50005118|FG006|Overall Study|Physician Decision|1|||
24910949|NCT00328627|50005119|FG007|Overall Study|Physician Decision|0|||
24910950|NCT00328627|50005120|FG008|Overall Study|Physician Decision|3|||
24910951|NCT00328627|50005121|FG009|Overall Study|Physician Decision|2|||
24910952|NCT00328627|50005122|FG010|Overall Study|Physician Decision|1|||
24910953|NCT00328627|50005123|FG011|Overall Study|Physician Decision|0|||
24910954|NCT00328627|50005112|FG000|Overall Study|Other|0|||
24910955|NCT00328627|50005113|FG001|Overall Study|Other|0|||
24910956|NCT00328627|50005114|FG002|Overall Study|Other|0|||
24910957|NCT00328627|50005115|FG003|Overall Study|Other|1|||
24910958|NCT00328627|50005116|FG004|Overall Study|Other|0|||
25274911|NCT00904033|50589007|FG002|Overall Study|Unable to obtain final blood draw|0|||
24910959|NCT00328627|50005117|FG005|Overall Study|Other|0|||
24910960|NCT00328627|50005118|FG006|Overall Study|Other|1|||
24910961|NCT00328627|50005119|FG007|Overall Study|Other|0|||
24910962|NCT00328627|50005120|FG008|Overall Study|Other|0|||
24910963|NCT00328627|50005121|FG009|Overall Study|Other|1|||
24910964|NCT00328627|50005122|FG010|Overall Study|Other|1|||
24910965|NCT00328627|50005123|FG011|Overall Study|Other|0|||
24910966|NCT03977727|50005159|FG000|Second Treatment|Lost to Follow-up|0|||
24910967|NCT03977727|50005160|FG001|Second Treatment|Lost to Follow-up|3|||
24910968|NCT00663858|50005169|FG000|Overall Study|Adverse Event|9|||
25019791|NCT00739674|50115794|FG000|Overall Study|Protocol Violation|5|||
25019792|NCT00739674|50115795|FG001|Overall Study|Protocol Violation|5|||
25019793|NCT00739674|50115794|FG000|Overall Study|Withdrawal by Subject|9|||
24910969|NCT00663858|50005170|FG001|Overall Study|Adverse Event|1|||
24910970|NCT00663858|50005171|FG002|Overall Study|Adverse Event|6|||
24910971|NCT00663858|50005169|FG000|Overall Study|Lack of Efficacy|5|||
25153022|NCT01604343|50268203|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
24910972|NCT00663858|50005170|FG001|Overall Study|Lack of Efficacy|1|||
24910973|NCT00663858|50005171|FG002|Overall Study|Lack of Efficacy|3|||
24910974|NCT00663858|50005169|FG000|Overall Study|Withdrawal by Subject|7|||
24910975|NCT00663858|50005170|FG001|Overall Study|Withdrawal by Subject|3|||
24910976|NCT00663858|50005171|FG002|Overall Study|Withdrawal by Subject|3|||
24910977|NCT00663858|50005169|FG000|Overall Study|Protocol Violation|5|||
24910978|NCT00663858|50005170|FG001|Overall Study|Protocol Violation|3|||
24910979|NCT00663858|50005171|FG002|Overall Study|Protocol Violation|4|||
24910980|NCT00663858|50005169|FG000|Overall Study|Other|8|||
24910981|NCT00663858|50005170|FG001|Overall Study|Other|2|||
25153023|NCT01604343|50268204|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
24910982|NCT00663858|50005171|FG002|Overall Study|Other|4|||
24910983|NCT00659880|50005179|FG000|Overall Study|Lost to Follow-up|5|||
24910984|NCT00683774|50005186|FG000|Overall Study|Withdrawal by Subject|0|||
25019794|NCT00739674|50115795|FG001|Overall Study|Withdrawal by Subject|9|||
24910985|NCT00683774|50005187|FG001|Overall Study|Withdrawal by Subject|1|||
24910986|NCT00683774|50005186|FG000|Overall Study|Physician Decision|3|||
24910987|NCT00683774|50005187|FG001|Overall Study|Physician Decision|0|||
24910988|NCT00354679|50005193|FG000|Overall Study|Patient Not Treated|1|||
24910989|NCT00683696|50005199|FG000|Overall Study|Withdrawn due to study closure|337|||
24910990|NCT00683696|50005200|FG001|Overall Study|Withdrawn due to study closure|338|||
24910991|NCT00683696|50005199|FG000|Overall Study|Withdrawn prior to study closure|13|||
24910992|NCT00683696|50005200|FG001|Overall Study|Withdrawn prior to study closure|28|||
24910993|NCT00683696|50005199|FG000|Overall Study|Lost to Follow-up|5|||
24910994|NCT00683696|50005200|FG001|Overall Study|Lost to Follow-up|6|||
24910995|NCT00683696|50005199|FG000|Overall Study|Vital status follow-up only|3|||
24910996|NCT00683696|50005200|FG001|Overall Study|Vital status follow-up only|3|||
24910997|NCT00683696|50005199|FG000|Overall Study|Death|46|||
24910998|NCT00683696|50005200|FG001|Overall Study|Death|30|||
24910999|NCT00345631|50005210|FG000|Overall Study|Withdrawal by Subject|1|||
24911000|NCT00345631|50005211|FG001|Overall Study|Withdrawal by Subject|0|||
24911001|NCT00345631|50005212|FG002|Overall Study|Withdrawal by Subject|1|||
24911002|NCT00345631|50005210|FG000|Overall Study|Adverse Event|0|||
24911003|NCT00345631|50005211|FG001|Overall Study|Adverse Event|1|||
24911004|NCT00345631|50005212|FG002|Overall Study|Adverse Event|0|||
24911005|NCT00345631|50005210|FG000|Overall Study|Lost to Follow-up|3|||
24911006|NCT00345631|50005211|FG001|Overall Study|Lost to Follow-up|7|||
24911007|NCT00345631|50005212|FG002|Overall Study|Lost to Follow-up|4|||
24911008|NCT00345631|50005210|FG000|Overall Study|Other reasons|0|||
24911009|NCT00345631|50005211|FG001|Overall Study|Other reasons|0|||
24911010|NCT00345631|50005212|FG002|Overall Study|Other reasons|1|||
24911011|NCT00540514|50005224|FG000|Overall Study|Still on treatment|3|||
24911012|NCT00540514|50005225|FG001|Overall Study|Still on treatment|0|||
24911013|NCT00540514|50005224|FG000|Overall Study|Unacceptable Toxicity|61|||
24911014|NCT00540514|50005225|FG001|Overall Study|Unacceptable Toxicity|62|||
24911015|NCT00540514|50005224|FG000|Overall Study|Adverse Event|20|||
24911016|NCT00540514|50005225|FG001|Overall Study|Adverse Event|24|||
24911017|NCT00540514|50005224|FG000|Overall Study|Physician Decision|86|||
24911018|NCT00540514|50005225|FG001|Overall Study|Physician Decision|99|||
25019795|NCT00739674|50115794|FG000|Overall Study|Reason missing|2|||
25019796|NCT00739674|50115795|FG001|Overall Study|Reason missing|0|||
25019797|NCT00739674|50115794|FG000|Overall Study|Clinic closed|6|||
25019798|NCT00739674|50115795|FG001|Overall Study|Clinic closed|4|||
25019799|NCT00739674|50115794|FG000|Overall Study|Patient moved|3|||
25019800|NCT00739674|50115795|FG001|Overall Study|Patient moved|2|||
24911019|NCT00540514|50005224|FG000|Overall Study|Protocol Deviation|3|||
24911020|NCT00540514|50005225|FG001|Overall Study|Protocol Deviation|4|||
24911021|NCT00540514|50005224|FG000|Overall Study|Lost to Follow-up|1|||
25019801|NCT00739674|50115794|FG000|Overall Study|Non compliant|4|||
25019802|NCT00739674|50115795|FG001|Overall Study|Non compliant|0|||
25153024|NCT01604343|50268200|FG000|Prior to W52 Administration(Through W52)|Other|15|||
24911022|NCT00540514|50005225|FG001|Overall Study|Lost to Follow-up|1|||
24911023|NCT00540514|50005224|FG000|Overall Study|Withdrawal by Subject|65|||
24911024|NCT00540514|50005225|FG001|Overall Study|Withdrawal by Subject|67|||
24911025|NCT00540514|50005224|FG000|Overall Study|Excluded prior to treatment|7|||
24911026|NCT00540514|50005225|FG001|Overall Study|Excluded prior to treatment|7|||
24911027|NCT00540514|50005224|FG000|Overall Study|Paclitaxel not available|0|||
24911028|NCT00540514|50005225|FG001|Overall Study|Paclitaxel not available|2|||
24911029|NCT00663702|50005234|FG000|Overall Study|Adverse Event|8|||
24911030|NCT00663702|50005235|FG001|Overall Study|Adverse Event|4|||
24911031|NCT00663702|50005234|FG000|Overall Study|Withdrawal by Subject|3|||
24911032|NCT00663702|50005235|FG001|Overall Study|Withdrawal by Subject|1|||
24911033|NCT00663702|50005234|FG000|Overall Study|Pregnancy|0|||
24911034|NCT00663702|50005235|FG001|Overall Study|Pregnancy|1|||
25019803|NCT00739674|50115794|FG000|Overall Study|Unable to attend visit|3|||
24911035|NCT00663702|50005234|FG000|Overall Study|Lost to Follow-up|3|||
24911036|NCT00663702|50005235|FG001|Overall Study|Lost to Follow-up|0|||
24911037|NCT00663702|50005234|FG000|Overall Study|Death|1|||
24911038|NCT00663702|50005235|FG001|Overall Study|Death|1|||
24911039|NCT00663702|50005234|FG000|Overall Study|Lack of Efficacy|3|||
24911040|NCT00663702|50005235|FG001|Overall Study|Lack of Efficacy|3|||
24911041|NCT00683618|50005244|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
24911042|NCT00683618|50005245|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
24911043|NCT00683618|50005246|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
24911044|NCT00683618|50005244|FG000|Randomised Treatment Period|Protocol Violation|0|||
24911045|NCT00683618|50005245|FG001|Randomised Treatment Period|Protocol Violation|1|||
24911046|NCT00683618|50005246|FG002|Randomised Treatment Period|Protocol Violation|0|||
24911047|NCT00683618|50005244|FG000|Randomised Treatment Period|Adverse Event|2|||
24911048|NCT00683618|50005245|FG001|Randomised Treatment Period|Adverse Event|0|||
24911049|NCT00683618|50005246|FG002|Randomised Treatment Period|Adverse Event|2|||
24911050|NCT00683618|50005244|FG000|Randomised Treatment Period|Reason not provided|0|||
24911051|NCT00683618|50005245|FG001|Randomised Treatment Period|Reason not provided|0|||
24911052|NCT00683618|50005246|FG002|Randomised Treatment Period|Reason not provided|2|||
24911053|NCT00683618|50005244|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
24911054|NCT00683618|50005245|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
24911055|NCT00683618|50005246|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
24911056|NCT00683618|50005244|FG000|Extension Treatment Period|Adverse Event|1|||
24911057|NCT00683618|50005245|FG001|Extension Treatment Period|Adverse Event|0|||
24911058|NCT00683618|50005246|FG002|Extension Treatment Period|Adverse Event|0|||
24911059|NCT00683618|50005244|FG000|Extension Treatment Period|Protocol Violation|1|||
24911060|NCT00683618|50005245|FG001|Extension Treatment Period|Protocol Violation|0|||
24911061|NCT00683618|50005246|FG002|Extension Treatment Period|Protocol Violation|0|||
24911062|NCT00688064|50005258|FG000|Overall Study|Protocol Violation|0|||
24911063|NCT00688064|50005259|FG001|Overall Study|Protocol Violation|1|||
24911064|NCT00688064|50005258|FG000|Overall Study|Adverse Event|2|||
24911065|NCT00688064|50005259|FG001|Overall Study|Adverse Event|4|||
24911066|NCT00688064|50005258|FG000|Overall Study|Withdrawal by Subject|7|||
24911067|NCT00688064|50005259|FG001|Overall Study|Withdrawal by Subject|7|||
24911068|NCT00688064|50005258|FG000|Overall Study|Lost to Follow-up|10|||
24911069|NCT00688064|50005259|FG001|Overall Study|Lost to Follow-up|10|||
24911070|NCT00688064|50005258|FG000|Overall Study|Lack of Efficacy|0|||
24911071|NCT00688064|50005259|FG001|Overall Study|Lack of Efficacy|1|||
24911072|NCT00688064|50005258|FG000|Overall Study|Pregnancy|1|||
24911073|NCT00688064|50005259|FG001|Overall Study|Pregnancy|0|||
24911074|NCT00688064|50005258|FG000|Overall Study|Any other reasons|1|||
24911075|NCT00688064|50005259|FG001|Overall Study|Any other reasons|3|||
24911076|NCT00663234|50005265|FG000|Overall Study|Not willing to adhere to requirements|1|||
24911077|NCT00683384|50005273|FG000|Overall Study|Death|1|||
24911078|NCT00683384|50005273|FG000|Overall Study|Adverse Event|1|||
24911079|NCT00326911|50005279|FG000|Overall Study|Hospitalization prior to treatment|0|||
24911080|NCT00326911|50005280|FG001|Overall Study|Hospitalization prior to treatment|1|||
24911081|NCT00326911|50005279|FG000|Overall Study|Physician decision prior to treatment|1|||
24911082|NCT00326911|50005280|FG001|Overall Study|Physician decision prior to treatment|0|||
24911083|NCT00326911|50005279|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
24911084|NCT00326911|50005280|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
24911085|NCT00540436|50005286|FG000|First 12-Week Treatment Period|Adverse Event|1|||
24911086|NCT00540436|50005286|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
24911087|NCT00540436|50005286|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
24911088|NCT00540436|50005286|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
24911089|NCT00687440|50005290|FG000|Overall Study|Adverse Event|3|||
24911090|NCT00687440|50005290|FG000|Overall Study|Lost to Follow-up|3|||
24911091|NCT00687440|50005290|FG000|Overall Study|Lack of Efficacy|2|||
24911092|NCT00687440|50005290|FG000|Overall Study|Death|2|||
24911093|NCT00687440|50005290|FG000|Overall Study|Other|1|||
24911094|NCT00687440|50005290|FG000|Overall Study|Missing|1|||
24911095|NCT00659490|50005297|FG000|Overall Study|Lost to Follow-up|2|||
24911096|NCT00659490|50005298|FG001|Overall Study|Lost to Follow-up|0|||
24911097|NCT00659490|50005299|FG002|Overall Study|Lost to Follow-up|1|||
24911098|NCT00539500|50005307|FG000|Overall Study|Disease Progression|1|||
24911099|NCT00539500|50005307|FG000|Overall Study|Lost to Follow-up|2|||
24911100|NCT00662532|50005313|FG000|Overall Study|Adverse Event|0|||
24911101|NCT00662532|50005314|FG001|Overall Study|Adverse Event|1|||
24911102|NCT00662532|50005313|FG000|Overall Study|Lost to Follow-up|0|||
24911103|NCT00662532|50005314|FG001|Overall Study|Lost to Follow-up|1|||
24911104|NCT00686036|50005322|FG000|Overall Study|Adverse Event|3|||
24911105|NCT00686036|50005323|FG001|Overall Study|Adverse Event|0|||
24911106|NCT00686036|50005322|FG000|Overall Study|Withdrawal by Subject|3|||
24911107|NCT00686036|50005323|FG001|Overall Study|Withdrawal by Subject|1|||
24911108|NCT00686036|50005322|FG000|Overall Study|Study terminated by AstraZeneca|2|||
24911109|NCT00686036|50005323|FG001|Overall Study|Study terminated by AstraZeneca|1|||
24911110|NCT00686036|50005322|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
24911111|NCT00686036|50005323|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
24911112|NCT00686036|50005322|FG000|Overall Study|Other reasons not identified|0|||
24911113|NCT00686036|50005323|FG001|Overall Study|Other reasons not identified|4|||
24911114|NCT00682448|50005331|FG000|Overall Study|Adverse Event|1|||
24911115|NCT00682448|50005332|FG001|Overall Study|Adverse Event|2|||
24911116|NCT00682448|50005331|FG000|Overall Study|Lack of Efficacy|1|||
24911117|NCT00682448|50005332|FG001|Overall Study|Lack of Efficacy|0|||
25153025|NCT01604343|50268201|FG001|Prior to W52 Administration(Through W52)|Other|0|||
25153026|NCT01604343|50268202|FG002|Prior to W52 Administration(Through W52)|Other|10|||
25153027|NCT01604343|50268203|FG003|Prior to W52 Administration(Through W52)|Other|0|||
25153028|NCT01604343|50268204|FG004|Prior to W52 Administration(Through W52)|Other|6|||
25153029|NCT01604343|50268200|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
24911118|NCT00682448|50005331|FG000|Overall Study|Lost to Follow-up|1|||
24911119|NCT00682448|50005332|FG001|Overall Study|Lost to Follow-up|3|||
24911120|NCT00682448|50005331|FG000|Overall Study|Pregnancy|0|||
24911121|NCT00682448|50005332|FG001|Overall Study|Pregnancy|1|||
24911122|NCT00682448|50005331|FG000|Overall Study|Withdrawal by Subject|2|||
25019804|NCT00739674|50115795|FG001|Overall Study|Unable to attend visit|1|||
25019805|NCT00739674|50115794|FG000|Overall Study|Home monitoring off meds|1|||
25019806|NCT00739674|50115795|FG001|Overall Study|Home monitoring off meds|0|||
25019807|NCT00739674|50115794|FG000|Overall Study|Erectile dysfunction|0|||
25019808|NCT00739674|50115795|FG001|Overall Study|Erectile dysfunction|1|||
25019809|NCT03494725|50115803|FG000|Overall Study|Withdrawal by Subject|0|||
25019810|NCT03494725|50115804|FG001|Overall Study|Withdrawal by Subject|2|||
25019811|NCT03494725|50115803|FG000|Overall Study|Antibiotic use|1|||
25019812|NCT03494725|50115804|FG001|Overall Study|Antibiotic use|0|||
25019813|NCT00705718|50115818|FG000|Overall Study|Death|6|||
24911123|NCT00682448|50005332|FG001|Overall Study|Withdrawal by Subject|0|||
24911124|NCT00681824|50005341|FG000|Overall Study|withdrawn by investigator|0|||
24911125|NCT00681824|50005342|FG001|Overall Study|withdrawn by investigator|0|||
24911126|NCT00681824|50005343|FG002|Overall Study|withdrawn by investigator|1|||
24911127|NCT00681824|50005341|FG000|Overall Study|scheduling conflict|1|||
24911128|NCT00681824|50005342|FG001|Overall Study|scheduling conflict|0|||
24911129|NCT00681824|50005343|FG002|Overall Study|scheduling conflict|0|||
24911130|NCT00681824|50005341|FG000|Overall Study|Death|0|||
24911131|NCT00681824|50005342|FG001|Overall Study|Death|1|||
24911132|NCT00681824|50005343|FG002|Overall Study|Death|0|||
24911133|NCT00681668|50005351|FG000|Overall Study|Protocol Violation|1|||
24911134|NCT00681668|50005351|FG000|Overall Study|Withdrawal by Subject|1|||
24911135|NCT00539188|50005357|FG000|Overall Study|Withdrawal by Subject|1|||
24911136|NCT00539188|50005358|FG001|Overall Study|Withdrawal by Subject|0|||
24911137|NCT00539188|50005357|FG000|Overall Study|Lost to Follow-up|2|||
24911138|NCT00539188|50005358|FG001|Overall Study|Lost to Follow-up|1|||
24911139|NCT00681590|50005366|FG000|Overall Study|Withdrawal by Subject|2|||
24911140|NCT00681590|50005367|FG001|Overall Study|Withdrawal by Subject|12|||
24911141|NCT04980456|50005375|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
24911142|NCT04980456|50005376|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
24911143|NCT04980456|50005375|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
24911144|NCT04980456|50005376|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
24911145|NCT04980456|50005375|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
24911146|NCT04980456|50005376|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
24911147|NCT04980456|50005375|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
24911148|NCT04980456|50005376|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
24911149|NCT00326599|50005389|FG000|Overall Study|Withdrawal by Subject|1|||
24911150|NCT00326599|50005390|FG001|Overall Study|Withdrawal by Subject|0|||
25019814|NCT00705718|50115819|FG001|Overall Study|Death|6|||
25019815|NCT00705718|50115818|FG000|Overall Study|Not due for Visit|0|||
25019816|NCT00705718|50115819|FG001|Overall Study|Not due for Visit|12|||
25153030|NCT01604343|50268201|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
25274912|NCT00904033|50589008|FG003|Overall Study|Unable to obtain final blood draw|2|||
25274913|NCT00903877|50589019|FG000|Overall Study|Did not meet study criteria|33|||
24911151|NCT00326599|50005391|FG002|Overall Study|Withdrawal by Subject|5|||
24911152|NCT00326599|50005392|FG003|Overall Study|Withdrawal by Subject|2|||
24911153|NCT00326599|50005389|FG000|Overall Study|Adverse Event|1|||
24911154|NCT00326599|50005390|FG001|Overall Study|Adverse Event|0|||
24911155|NCT00326599|50005391|FG002|Overall Study|Adverse Event|32|||
25019817|NCT00705718|50115818|FG000|Overall Study|Follow up not done|1|||
24911156|NCT00326599|50005392|FG003|Overall Study|Adverse Event|3|||
24911157|NCT00326599|50005389|FG000|Overall Study|Disease Progression|3|||
24911158|NCT00326599|50005390|FG001|Overall Study|Disease Progression|1|||
24911159|NCT00326599|50005391|FG002|Overall Study|Disease Progression|13|||
24911160|NCT00326599|50005392|FG003|Overall Study|Disease Progression|11|||
24911161|NCT00326599|50005389|FG000|Overall Study|Alternate Treatment|1|||
24911162|NCT00326599|50005390|FG001|Overall Study|Alternate Treatment|0|||
24911163|NCT00326599|50005391|FG002|Overall Study|Alternate Treatment|0|||
24911164|NCT00326599|50005392|FG003|Overall Study|Alternate Treatment|0|||
24911165|NCT00326599|50005389|FG000|Overall Study|Death|0|||
24911166|NCT00326599|50005390|FG001|Overall Study|Death|0|||
24911167|NCT00326599|50005391|FG002|Overall Study|Death|1|||
24911168|NCT00326599|50005392|FG003|Overall Study|Death|2|||
24911169|NCT00326599|50005389|FG000|Overall Study|Other Unspecified Reason|0|||
25019818|NCT00705718|50115819|FG001|Overall Study|Follow up not done|4|||
25019819|NCT03435211|50115834|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
25019820|NCT03465709|50115847|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
25019821|NCT03465709|50115847|FG000|Overall Study|Withdrawal by Subject|3|||
25153031|NCT01604343|50268202|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
25274914|NCT00903877|50589019|FG000|Overall Study|Withdrawal by Subject|3|||
24911170|NCT00326599|50005390|FG001|Overall Study|Other Unspecified Reason|0|||
24911171|NCT00326599|50005391|FG002|Overall Study|Other Unspecified Reason|2|||
24911172|NCT00326599|50005392|FG003|Overall Study|Other Unspecified Reason|1|||
24911173|NCT00539032|50005403|FG000|Overall Study|Withdrawal by Subject|2|||
24911174|NCT00539032|50005404|FG001|Overall Study|Withdrawal by Subject|1|||
24911175|NCT00685802|50005410|FG000|Washout Period of 7 Days|Protocol Violation|2|||
24911176|NCT00685802|50005411|FG001|Washout Period of 7 Days|Protocol Violation|0|||
24911177|NCT00685802|50005410|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
24911178|NCT00685802|50005411|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
24911179|NCT00354601|50005417|FG000|Overall Study|Protocol Violation|1|||
24911180|NCT00354601|50005417|FG000|Overall Study|progression|1|||
24911181|NCT03827473|50005423|FG000|Overall Study|Withdrawal by Subject|1|||
24911182|NCT03827473|50005424|FG001|Overall Study|Withdrawal by Subject|0|||
24911183|NCT00345397|50005430|FG000|Overall Study|Death|1|||
24911184|NCT00326209|50005435|FG000|Overall Study|Adverse Event|28|||
24911185|NCT00326209|50005435|FG000|Overall Study|Withdrawal by Subject|22|||
24911186|NCT00326209|50005435|FG000|Overall Study|Lack of Efficacy|31|||
24911187|NCT00326209|50005435|FG000|Overall Study|Lost to Follow-up|18|||
24911188|NCT00326209|50005435|FG000|Overall Study|Participant non-compliant|6|||
24911189|NCT00326209|50005435|FG000|Overall Study|Sponsor closed study|173|||
24911190|NCT00326209|50005435|FG000|Overall Study|Prohibited medication use|1|||
24911191|NCT00326209|50005435|FG000|Overall Study|Violation of entry criteria|1|||
24911192|NCT00326209|50005435|FG000|Overall Study|Withdrawn in error|1|||
24911193|NCT00326209|50005435|FG000|Overall Study|Pregnancy|1|||
24911194|NCT00537940|50005441|FG000|Overall Study|Adverse Event|20|||
24911195|NCT00537940|50005442|FG001|Overall Study|Adverse Event|19|||
24911196|NCT00537940|50005441|FG000|Overall Study|Lack of Efficacy|8|||
24911197|NCT00537940|50005442|FG001|Overall Study|Lack of Efficacy|16|||
24911198|NCT00537940|50005441|FG000|Overall Study|Lost to Follow-up|23|||
24911199|NCT00537940|50005442|FG001|Overall Study|Lost to Follow-up|29|||
24911200|NCT00537940|50005441|FG000|Overall Study|Withdrawal by Subject|113|||
24911201|NCT00537940|50005442|FG001|Overall Study|Withdrawal by Subject|95|||
24911202|NCT00537940|50005441|FG000|Overall Study|Protocol Violation|6|||
24911203|NCT00537940|50005442|FG001|Overall Study|Protocol Violation|4|||
24911204|NCT00537940|50005441|FG000|Overall Study|Pregnancy|1|||
24911205|NCT00537940|50005442|FG001|Overall Study|Pregnancy|1|||
24911206|NCT00537940|50005441|FG000|Overall Study|Study terminated by sponsor|2|||
24911207|NCT00537940|50005442|FG001|Overall Study|Study terminated by sponsor|3|||
24911208|NCT00537940|50005441|FG000|Overall Study|Other|10|||
24911209|NCT00537940|50005442|FG001|Overall Study|Other|12|||
24911210|NCT00661362|50005450|FG000|Overall Study|Adverse Event|5|||
24911211|NCT00661362|50005451|FG001|Overall Study|Adverse Event|4|||
24911212|NCT00661362|50005450|FG000|Overall Study|Incorrect enrollment|2|||
24911213|NCT00661362|50005451|FG001|Overall Study|Incorrect enrollment|0|||
24911214|NCT00661362|50005450|FG000|Overall Study|Study specific discontinuation criteria|4|||
24911215|NCT00661362|50005451|FG001|Overall Study|Study specific discontinuation criteria|11|||
24911216|NCT00661362|50005450|FG000|Overall Study|Withdrawal by Subject|13|||
24911217|NCT00661362|50005451|FG001|Overall Study|Withdrawal by Subject|23|||
24911218|NCT00661362|50005450|FG000|Overall Study|Lost to Follow-up|3|||
24911219|NCT00661362|50005451|FG001|Overall Study|Lost to Follow-up|1|||
24911220|NCT00661362|50005450|FG000|Overall Study|Severe non-compliance to protocol|0|||
24911221|NCT00661362|50005451|FG001|Overall Study|Severe non-compliance to protocol|1|||
24911222|NCT00661362|50005450|FG000|Overall Study|Safety reasons|1|||
24911223|NCT00661362|50005451|FG001|Overall Study|Safety reasons|0|||
24911224|NCT00661362|50005450|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
24911225|NCT00661362|50005451|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
24911226|NCT00325897|50005459|FG000|Overall Study|Lost to Follow-up|12|||
24911227|NCT00325897|50005460|FG001|Overall Study|Lost to Follow-up|13|||
24911228|NCT00344773|50005469|FG000|Overall Study|Adverse Event|2|||
24911229|NCT00344773|50005469|FG000|Overall Study|Objective Disease Progression|16|||
24911230|NCT00344773|50005469|FG000|Overall Study|Withdrawal by Subject|1|||
24911231|NCT00344773|50005469|FG000|Overall Study|Not Eligible for the study|2|||
24911232|NCT00325819|50005475|FG000|Overall Study|Study product lost in mail|2|||
24911233|NCT00325819|50005476|FG001|Overall Study|Study product lost in mail|1|||
24911234|NCT00325819|50005475|FG000|Overall Study|Did not take a dose of study product|4|||
24911235|NCT00325819|50005476|FG001|Overall Study|Did not take a dose of study product|9|||
24911236|NCT00325819|50005475|FG000|Overall Study|Lost to Follow-up|3|||
24911237|NCT00325819|50005476|FG001|Overall Study|Lost to Follow-up|3|||
24911238|NCT00687362|50005484|FG000|Overall Study|Protocol Violation|2|||
24911239|NCT00687362|50005484|FG000|Overall Study|Withdrawal by Subject|1|||
24911240|NCT00325195|50005491|FG000|Randomized|Not dosed|5|||
24911241|NCT00325195|50005492|FG001|Randomized|Not dosed|5|||
24911242|NCT00325195|50005493|FG002|Randomized|Not dosed|3|||
24911243|NCT00325195|50005491|FG000|Received Intervention: ITT Population|Adverse Event|15|||
24911244|NCT00325195|50005492|FG001|Received Intervention: ITT Population|Adverse Event|17|||
24911245|NCT00325195|50005493|FG002|Received Intervention: ITT Population|Adverse Event|1|||
24911246|NCT00325195|50005491|FG000|Received Intervention: ITT Population|Death|3|||
24911247|NCT00325195|50005492|FG001|Received Intervention: ITT Population|Death|1|||
24911248|NCT00325195|50005493|FG002|Received Intervention: ITT Population|Death|0|||
24911249|NCT00325195|50005491|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
24911250|NCT00325195|50005492|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
24911251|NCT00325195|50005493|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
24911252|NCT00325195|50005491|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
24911253|NCT00325195|50005492|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
24911254|NCT00325195|50005493|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
25019822|NCT03435055|50115853|FG000|Screening|Physician Decision|2|||
25153032|NCT01604343|50268203|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
25153033|NCT01604343|50268204|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
25153034|NCT01604343|50268200|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
25153035|NCT01604343|50268201|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
25153036|NCT01604343|50268202|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
25153037|NCT01604343|50268203|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
25153038|NCT01604343|50268204|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
25153039|NCT01604343|50268200|FG000|Week 52 to Week 104|Adverse Event|0|||
25153040|NCT01604343|50268201|FG001|Week 52 to Week 104|Adverse Event|12|||
25153041|NCT01604343|50268202|FG002|Week 52 to Week 104|Adverse Event|26|||
25153042|NCT01604343|50268203|FG003|Week 52 to Week 104|Adverse Event|21|||
25153043|NCT01604343|50268204|FG004|Week 52 to Week 104|Adverse Event|27|||
25153044|NCT01604343|50268200|FG000|Week 52 to Week 104|Death|0|||
25153045|NCT01604343|50268201|FG001|Week 52 to Week 104|Death|4|||
25153046|NCT01604343|50268202|FG002|Week 52 to Week 104|Death|2|||
25153047|NCT01604343|50268203|FG003|Week 52 to Week 104|Death|5|||
25153048|NCT01604343|50268204|FG004|Week 52 to Week 104|Death|0|||
25153049|NCT01604343|50268200|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
25184950|NCT01425359|50334039|FG001|Overall Study|Randomized but Not Treated|3|||
25274915|NCT00903877|50589019|FG000|Overall Study|Adverse Event|2|||
25274916|NCT00903877|50589019|FG000|Overall Study|Lost to Follow-up|1|||
24911255|NCT00325195|50005491|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
24911256|NCT00325195|50005492|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
24911257|NCT00325195|50005493|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
24911258|NCT03976401|50005507|FG000|Overall Study|Adverse Event|2|||
24911259|NCT03976401|50005508|FG001|Overall Study|Adverse Event|0|||
24911260|NCT03976401|50005509|FG002|Overall Study|Adverse Event|4|||
25153050|NCT01604343|50268201|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
25153051|NCT01604343|50268202|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
25153052|NCT01604343|50268203|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
24911261|NCT03976401|50005510|FG003|Overall Study|Adverse Event|1|||
25019823|NCT03435055|50115853|FG000|Received Intervention|Did not complete nitrous administration|3|||
25019824|NCT03434977|50115866|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
24911262|NCT03976401|50005511|FG004|Overall Study|Adverse Event|1|||
24911263|NCT03976401|50005512|FG005|Overall Study|Adverse Event|0|||
24911264|NCT03976401|50005507|FG000|Overall Study|Withdrawal by Subject|0|||
24911265|NCT03976401|50005508|FG001|Overall Study|Withdrawal by Subject|1|||
25019825|NCT03434977|50115867|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
25019826|NCT03434119|50115875|FG000|Overall Study|Randomized but not treated|1|||
25019827|NCT03434119|50115876|FG001|Overall Study|Randomized but not treated|0|||
25019828|NCT03434119|50115875|FG000|Overall Study|Adverse Event|1|||
25019829|NCT03434119|50115876|FG001|Overall Study|Adverse Event|0|||
25153053|NCT01604343|50268204|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
25153054|NCT01604343|50268200|FG000|Week 52 to Week 104|Physician Decision|0|||
25153055|NCT01604343|50268201|FG001|Week 52 to Week 104|Physician Decision|1|||
25153056|NCT01604343|50268202|FG002|Week 52 to Week 104|Physician Decision|0|||
25019830|NCT03434119|50115875|FG000|Overall Study|Poor Compliance to Protocol|0|||
25019831|NCT03434119|50115876|FG001|Overall Study|Poor Compliance to Protocol|1|||
25019832|NCT03434119|50115875|FG000|Overall Study|Study Terminated by Sponsor|91|||
25019833|NCT03434119|50115876|FG001|Overall Study|Study Terminated by Sponsor|102|||
25019834|NCT03434119|50115875|FG000|Overall Study|Withdrawal by Subject|7|||
24911266|NCT03976401|50005509|FG002|Overall Study|Withdrawal by Subject|0|||
24911267|NCT03976401|50005510|FG003|Overall Study|Withdrawal by Subject|0|||
24911268|NCT03976401|50005511|FG004|Overall Study|Withdrawal by Subject|0|||
24911269|NCT03976401|50005512|FG005|Overall Study|Withdrawal by Subject|1|||
24911270|NCT03976401|50005507|FG000|Overall Study|Physician Decision|0|||
24911271|NCT03976401|50005508|FG001|Overall Study|Physician Decision|0|||
24911272|NCT03976401|50005509|FG002|Overall Study|Physician Decision|1|||
24911273|NCT03976401|50005510|FG003|Overall Study|Physician Decision|0|||
24911274|NCT03976401|50005511|FG004|Overall Study|Physician Decision|0|||
24911275|NCT03976401|50005512|FG005|Overall Study|Physician Decision|0|||
24911276|NCT03976401|50005507|FG000|Overall Study|Lost to Follow-up|1|||
24911277|NCT03976401|50005508|FG001|Overall Study|Lost to Follow-up|2|||
24911278|NCT03976401|50005509|FG002|Overall Study|Lost to Follow-up|0|||
24911279|NCT03976401|50005510|FG003|Overall Study|Lost to Follow-up|0|||
24911280|NCT03976401|50005511|FG004|Overall Study|Lost to Follow-up|0|||
24911281|NCT03976401|50005512|FG005|Overall Study|Lost to Follow-up|0|||
24911282|NCT03976401|50005507|FG000|Overall Study|Protocol Violation|0|||
24911283|NCT03976401|50005508|FG001|Overall Study|Protocol Violation|1|||
24911284|NCT03976401|50005509|FG002|Overall Study|Protocol Violation|0|||
24911285|NCT03976401|50005510|FG003|Overall Study|Protocol Violation|0|||
24911286|NCT03976401|50005511|FG004|Overall Study|Protocol Violation|0|||
24911287|NCT03976401|50005512|FG005|Overall Study|Protocol Violation|0|||
24911288|NCT03976401|50005507|FG000|Overall Study|Withdrew Consent|0|||
24911289|NCT03976401|50005508|FG001|Overall Study|Withdrew Consent|0|||
24911290|NCT03976401|50005509|FG002|Overall Study|Withdrew Consent|0|||
24911291|NCT03976401|50005510|FG003|Overall Study|Withdrew Consent|1|||
24911292|NCT03976401|50005511|FG004|Overall Study|Withdrew Consent|0|||
24911293|NCT03976401|50005512|FG005|Overall Study|Withdrew Consent|0|||
24911294|NCT00685334|50005528|FG000|Overall Study|Withdrawal by Subject|5|||
24911295|NCT00685334|50005529|FG001|Overall Study|Withdrawal by Subject|6|||
24911296|NCT00685334|50005528|FG000|Overall Study|Lost to Follow-up|4|||
24911297|NCT00685334|50005529|FG001|Overall Study|Lost to Follow-up|0|||
24911298|NCT00685334|50005528|FG000|Overall Study|Chose to enter hospital|1|||
24911299|NCT00685334|50005529|FG001|Overall Study|Chose to enter hospital|1|||
24911300|NCT00325039|50005537|FG000|Overall Study|Lost to Follow-up|18|||
24911301|NCT00325039|50005538|FG001|Overall Study|Lost to Follow-up|14|||
24911302|NCT00344461|50005544|FG000|Overall Study|Adverse Event|6|||
24911303|NCT00344461|50005544|FG000|Overall Study|Death|1|||
24911304|NCT00344461|50005544|FG000|Overall Study|Lack of Efficacy|2|||
24911305|NCT00344461|50005544|FG000|Overall Study|Lost to Follow-up|2|||
24911306|NCT00344461|50005544|FG000|Overall Study|Physician Decision|2|||
24911307|NCT00344461|50005544|FG000|Overall Study|Protocol Violation|6|||
24911308|NCT00344461|50005544|FG000|Overall Study|Withdrawal by Subject|2|||
24911309|NCT00685178|50005553|FG000|Overall Study|Adverse Event|1|||
25019835|NCT03434119|50115876|FG001|Overall Study|Withdrawal by Subject|5|||
25019836|NCT03434119|50115875|FG000|Overall Study|Other than specified|7|||
25153057|NCT01604343|50268203|FG003|Week 52 to Week 104|Physician Decision|0|||
24911310|NCT00685178|50005554|FG001|Overall Study|Adverse Event|5|||
24911311|NCT00685178|50005555|FG002|Overall Study|Adverse Event|2|||
24911312|NCT00685178|50005556|FG003|Overall Study|Adverse Event|4|||
24911313|NCT00685178|50005553|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
24911314|NCT00685178|50005554|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
24911315|NCT00685178|50005555|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
24911316|NCT00685178|50005556|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
24911317|NCT00685178|50005553|FG000|Overall Study|voluntary study discharge|4|||
24911318|NCT00685178|50005554|FG001|Overall Study|voluntary study discharge|5|||
24911319|NCT00685178|50005555|FG002|Overall Study|voluntary study discharge|1|||
24911320|NCT00685178|50005556|FG003|Overall Study|voluntary study discharge|1|||
24911321|NCT00685178|50005553|FG000|Overall Study|incarcerated|1|||
24911322|NCT00685178|50005554|FG001|Overall Study|incarcerated|3|||
24911323|NCT00685178|50005555|FG002|Overall Study|incarcerated|7|||
24911324|NCT00685178|50005556|FG003|Overall Study|incarcerated|0|||
24911325|NCT00685178|50005553|FG000|Overall Study|administrative (disciplinary) discharge|0|||
24911326|NCT00685178|50005554|FG001|Overall Study|administrative (disciplinary) discharge|1|||
24911327|NCT00685178|50005555|FG002|Overall Study|administrative (disciplinary) discharge|0|||
24911328|NCT00685178|50005556|FG003|Overall Study|administrative (disciplinary) discharge|2|||
24911329|NCT00685178|50005553|FG000|Overall Study|Pregnancy|0|||
24911330|NCT00685178|50005554|FG001|Overall Study|Pregnancy|0|||
24911331|NCT00685178|50005555|FG002|Overall Study|Pregnancy|0|||
24911332|NCT00685178|50005556|FG003|Overall Study|Pregnancy|1|||
24911333|NCT00537394|50005569|FG000|First Year of Follow-up|Death|7|||
24911334|NCT00537394|50005570|FG001|First Year of Follow-up|Death|0|||
24911335|NCT00537394|50005571|FG002|First Year of Follow-up|Death|0|||
24911336|NCT00537394|50005569|FG000|First Year of Follow-up|Severe debilitation|1|||
24911337|NCT00537394|50005570|FG001|First Year of Follow-up|Severe debilitation|0|||
25019837|NCT03434119|50115876|FG001|Overall Study|Other than specified|5|||
24911338|NCT00537394|50005571|FG002|First Year of Follow-up|Severe debilitation|1|||
24911339|NCT00537394|50005569|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
24911340|NCT00537394|50005570|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
24911341|NCT00537394|50005571|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
24911342|NCT00537394|50005569|FG000|First Year of Follow-up|Lost to Follow-up|1|||
24911343|NCT00537394|50005570|FG001|First Year of Follow-up|Lost to Follow-up|5|||
24911344|NCT00537394|50005571|FG002|First Year of Follow-up|Lost to Follow-up|1|||
24911345|NCT00537394|50005569|FG000|2nd Year of Follow-up|Death|4|||
24911346|NCT00537394|50005570|FG001|2nd Year of Follow-up|Death|1|||
24911347|NCT00537394|50005571|FG002|2nd Year of Follow-up|Death|2|||
24911348|NCT00537394|50005569|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
24911349|NCT00537394|50005570|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
24911350|NCT00537394|50005571|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
24911351|NCT00537394|50005569|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
24911352|NCT00537394|50005570|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
24911353|NCT00537394|50005571|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
24911354|NCT00537394|50005569|FG000|2nd Year of Follow-up|Clinic site closure|1|||
24911355|NCT00537394|50005570|FG001|2nd Year of Follow-up|Clinic site closure|0|||
24911356|NCT00537394|50005571|FG002|2nd Year of Follow-up|Clinic site closure|0|||
24911357|NCT00352885|50005579|FG000|Overall Study|Withdrawal by Subject|0|||
24911358|NCT00352885|50005580|FG001|Overall Study|Withdrawal by Subject|3|||
24911359|NCT00352885|50005579|FG000|Overall Study|Development of major depression|0|||
24911360|NCT00352885|50005580|FG001|Overall Study|Development of major depression|1|||
24911361|NCT00352885|50005579|FG000|Overall Study|Progression of metastatic melanoma|5|||
24911362|NCT00352885|50005580|FG001|Overall Study|Progression of metastatic melanoma|3|||
24911363|NCT00352885|50005579|FG000|Overall Study|Side effects of IL-2 administration|1|||
24911364|NCT00352885|50005580|FG001|Overall Study|Side effects of IL-2 administration|0|||
24911365|NCT00660660|50005588|FG000|Overall Study|Adverse Event|1|||
24911366|NCT00660660|50005589|FG001|Overall Study|Adverse Event|0|||
24911367|NCT00660660|50005588|FG000|Overall Study|Lost to Follow-up|0|||
24911368|NCT00660660|50005589|FG001|Overall Study|Lost to Follow-up|6|||
24911369|NCT00660660|50005588|FG000|Overall Study|Lack of Efficacy|0|||
24911370|NCT00660660|50005589|FG001|Overall Study|Lack of Efficacy|2|||
24911371|NCT00660660|50005588|FG000|Overall Study|Withdrawal by Subject|3|||
24911372|NCT00660660|50005589|FG001|Overall Study|Withdrawal by Subject|0|||
24911373|NCT00660660|50005588|FG000|Overall Study|Incorrect enrollment and other|0|||
24911374|NCT00660660|50005589|FG001|Overall Study|Incorrect enrollment and other|1|||
24911375|NCT00660660|50005588|FG000|Overall Study|New medication after randomization|1|||
24911376|NCT00660660|50005589|FG001|Overall Study|New medication after randomization|0|||
24911377|NCT00344305|50005597|FG000|Overall Study|Lost to Follow-up|2|||
24911378|NCT00344305|50005598|FG001|Overall Study|Lost to Follow-up|0|||
24911379|NCT00344305|50005597|FG000|Overall Study|Participant was not contacted in window|0|||
24911380|NCT00344305|50005598|FG001|Overall Study|Participant was not contacted in window|1|||
24911381|NCT00660816|50005607|FG000|Overall Study|Adverse Event|1|||
24911382|NCT00660816|50005608|FG001|Overall Study|Adverse Event|2|||
24911383|NCT00660816|50005607|FG000|Overall Study|Withdrawal by Subject|1|||
24911384|NCT00660816|50005608|FG001|Overall Study|Withdrawal by Subject|0|||
24911385|NCT00660816|50005607|FG000|Overall Study|Death|0|||
24911386|NCT00660816|50005608|FG001|Overall Study|Death|2|||
24911387|NCT00660816|50005607|FG000|Overall Study|Lack of Efficacy|1|||
24911388|NCT00660816|50005608|FG001|Overall Study|Lack of Efficacy|0|||
25019838|NCT00378378|50115885|FG000|Overall Study|Withdrawal by Subject|0|||
24911389|NCT00660816|50005607|FG000|Overall Study|Physician Decision|0|||
24911390|NCT00660816|50005608|FG001|Overall Study|Physician Decision|2|||
24911391|NCT00660816|50005607|FG000|Overall Study|Protocol Violation|1|||
24911392|NCT00660816|50005608|FG001|Overall Study|Protocol Violation|0|||
24911393|NCT00660816|50005607|FG000|Overall Study|Disease Progression|16|||
24911394|NCT00660816|50005608|FG001|Overall Study|Disease Progression|12|||
24911395|NCT00660816|50005607|FG000|Overall Study|Complicating Disease|0|||
24911396|NCT00660816|50005608|FG001|Overall Study|Complicating Disease|1|||
24911397|NCT00576056|50005614|FG000|Overall Study|Adverse Event|1|||
24911398|NCT00576056|50005614|FG000|Overall Study|Death|1|||
24911399|NCT00576056|50005614|FG000|Overall Study|Lack of Efficacy|1|||
24911400|NCT00576056|50005614|FG000|Overall Study|Withdrawal by Subject|2|||
24911401|NCT00576056|50005614|FG000|Overall Study|did not meet eligibility criteria|8|||
24911402|NCT00576056|50005614|FG000|Overall Study|Physician Decision|1|||
24911403|NCT00575510|50005621|FG000|Overall Study|Lost to Follow-up|4|||
24911404|NCT00575510|50005622|FG001|Overall Study|Lost to Follow-up|6|||
24911405|NCT00575510|50005623|FG002|Overall Study|Lost to Follow-up|9|||
24911406|NCT00575510|50005621|FG000|Overall Study|Withdrawal by Subject|1|||
24911407|NCT00575510|50005622|FG001|Overall Study|Withdrawal by Subject|0|||
24911408|NCT00575510|50005623|FG002|Overall Study|Withdrawal by Subject|0|||
24911409|NCT00575510|50005621|FG000|Overall Study|Clinic Called Patient|7|||
24911410|NCT00575510|50005622|FG001|Overall Study|Clinic Called Patient|7|||
24911411|NCT00575510|50005623|FG002|Overall Study|Clinic Called Patient|7|||
24911412|NCT00575510|50005621|FG000|Overall Study|Pregnancy|0|||
24911413|NCT00575510|50005622|FG001|Overall Study|Pregnancy|0|||
24911414|NCT00575510|50005623|FG002|Overall Study|Pregnancy|1|||
24911415|NCT02636439|50005634|FG000|Overall Study|Adverse Event|2|||
24911416|NCT02636439|50005635|FG001|Overall Study|Adverse Event|2|||
24911417|NCT02636439|50005634|FG000|Overall Study|Lost to Follow-up|1|||
24911418|NCT02636439|50005635|FG001|Overall Study|Lost to Follow-up|0|||
24911419|NCT02636439|50005634|FG000|Overall Study|Non-compliance|1|||
24911420|NCT02636439|50005635|FG001|Overall Study|Non-compliance|1|||
24911421|NCT02636439|50005634|FG000|Overall Study|Personal reasons|2|||
24911422|NCT02636439|50005635|FG001|Overall Study|Personal reasons|0|||
24911423|NCT00343915|50005643|FG000|Primary Study|Withdrawal by Subject|1|||
24911424|NCT00343915|50005644|FG001|Primary Study|Withdrawal by Subject|0|||
24911425|NCT00343915|50005643|FG000|Primary Study|Lost to Follow-up|2|||
24911426|NCT00343915|50005644|FG001|Primary Study|Lost to Follow-up|3|||
24911427|NCT00343915|50005643|FG000|Primary Study|Other|1|||
24911428|NCT00343915|50005644|FG001|Primary Study|Other|0|||
24911429|NCT00575666|50005655|FG000|Overall Study|Withdrawal by Subject|3|||
24911430|NCT00575666|50005656|FG001|Overall Study|Withdrawal by Subject|2|||
24911431|NCT00575666|50005655|FG000|Overall Study|Physician Decision|1|||
24911432|NCT00575666|50005656|FG001|Overall Study|Physician Decision|1|||
24911433|NCT00658632|50005664|FG000|Overall Study|Adverse Event|13|||
24911434|NCT00658632|50005665|FG001|Overall Study|Adverse Event|11|||
24911435|NCT00658632|50005664|FG000|Overall Study|Lost to Follow-up|25|||
24911436|NCT00658632|50005665|FG001|Overall Study|Lost to Follow-up|23|||
24911437|NCT00658632|50005664|FG000|Overall Study|Withdrawal by Subject|10|||
24911438|NCT00658632|50005665|FG001|Overall Study|Withdrawal by Subject|7|||
24911439|NCT00658632|50005664|FG000|Overall Study|Lack of Efficacy|0|||
24911440|NCT00658632|50005665|FG001|Overall Study|Lack of Efficacy|1|||
24911441|NCT00658632|50005664|FG000|Overall Study|Withdrawal of consent|8|||
24911442|NCT00658632|50005665|FG001|Overall Study|Withdrawal of consent|14|||
24911443|NCT00658632|50005664|FG000|Overall Study|Pregnancy|1|||
24911444|NCT00658632|50005665|FG001|Overall Study|Pregnancy|1|||
24911445|NCT00658632|50005664|FG000|Overall Study|Other|7|||
24911446|NCT00658632|50005665|FG001|Overall Study|Other|8|||
24911447|NCT00677534|50005671|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
24911448|NCT00677534|50005671|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
24911449|NCT00677534|50005671|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
24911450|NCT00660348|50005677|FG000|Overall Study|Withdrawal by Subject|1|||
24911451|NCT00660348|50005678|FG001|Overall Study|Withdrawal by Subject|0|||
24911452|NCT00660192|50005686|FG000|Overall Study|Lost to Follow-up|2|||
24911453|NCT00660192|50005687|FG001|Overall Study|Lost to Follow-up|3|||
24911454|NCT00571688|50005695|FG000|Overall Study|Lost to Follow-up|3|||
24911455|NCT00571688|50005696|FG001|Overall Study|Lost to Follow-up|6|||
24911456|NCT00571688|50005695|FG000|Overall Study|subject did not tolerate Consta|1|||
24911457|NCT00571688|50005696|FG001|Overall Study|subject did not tolerate Consta|0|||
24911458|NCT00571688|50005695|FG000|Overall Study|subject moved out of the area|1|||
24911459|NCT00571688|50005696|FG001|Overall Study|subject moved out of the area|0|||
24911460|NCT00343291|50005704|FG000|Overall Study|Adverse Event|13|||
25019839|NCT00378378|50115886|FG001|Overall Study|Withdrawal by Subject|1|||
25019840|NCT00378378|50115887|FG002|Overall Study|Withdrawal by Subject|0|||
24911461|NCT00343291|50005705|FG001|Overall Study|Adverse Event|13|||
24911462|NCT00343291|50005704|FG000|Overall Study|Death|3|||
24911463|NCT00343291|50005705|FG001|Overall Study|Death|2|||
24911464|NCT00343291|50005704|FG000|Overall Study|Progressive disease|33|||
24911465|NCT00343291|50005705|FG001|Overall Study|Progressive disease|34|||
24911466|NCT00343291|50005704|FG000|Overall Study|Withdrawal by Subject|0|||
24911467|NCT00343291|50005705|FG001|Overall Study|Withdrawal by Subject|2|||
24911468|NCT00343291|50005704|FG000|Overall Study|Other|8|||
24911469|NCT00343291|50005705|FG001|Overall Study|Other|5|||
24911470|NCT00658788|50005711|FG000|Overall Study|Adverse Event|11|||
24911471|NCT00658788|50005711|FG000|Overall Study|Withdrawal by Subject|13|||
24911472|NCT00658788|50005711|FG000|Overall Study|Lost to Follow-up|18|||
24911473|NCT00658788|50005711|FG000|Overall Study|Treatment Discontinuation|32|||
24911474|NCT04829214|50005726|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
24911475|NCT04829214|50005727|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
24911476|NCT04829214|50005726|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
24911477|NCT04829214|50005727|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
24911478|NCT00562965|50005737|FG000|Overall Study|Withdrawal by Subject|0|||
24911479|NCT00562965|50005738|FG001|Overall Study|Withdrawal by Subject|1|||
24911480|NCT00562965|50005737|FG000|Overall Study|Death|2|||
24911481|NCT00562965|50005738|FG001|Overall Study|Death|4|||
24911482|NCT00562965|50005737|FG000|Overall Study|Lost to Follow-up|1|||
24911483|NCT00562965|50005738|FG001|Overall Study|Lost to Follow-up|0|||
24911484|NCT00562965|50005737|FG000|Overall Study|Other|0|||
24911485|NCT00562965|50005738|FG001|Overall Study|Other|1|||
24911486|NCT00537082|50005747|FG000|Overall Study|Adverse Event|6|||
24911487|NCT00537082|50005748|FG001|Overall Study|Adverse Event|6|||
24911488|NCT00537082|50005749|FG002|Overall Study|Adverse Event|3|||
24911489|NCT00537082|50005747|FG000|Overall Study|Protocol Violation|0|||
24911490|NCT00537082|50005748|FG001|Overall Study|Protocol Violation|2|||
24911491|NCT00537082|50005749|FG002|Overall Study|Protocol Violation|1|||
24911492|NCT00537082|50005747|FG000|Overall Study|Lack of Efficacy|0|||
24911493|NCT00537082|50005748|FG001|Overall Study|Lack of Efficacy|0|||
24911494|NCT00537082|50005749|FG002|Overall Study|Lack of Efficacy|2|||
24911495|NCT00537082|50005747|FG000|Overall Study|Withdrawal by Subject|0|||
24911496|NCT00537082|50005748|FG001|Overall Study|Withdrawal by Subject|1|||
24911497|NCT00537082|50005749|FG002|Overall Study|Withdrawal by Subject|0|||
24911498|NCT00537082|50005747|FG000|Overall Study|Discontinued before initiating treatment|3|||
24911499|NCT00537082|50005748|FG001|Overall Study|Discontinued before initiating treatment|0|||
24911500|NCT00537082|50005749|FG002|Overall Study|Discontinued before initiating treatment|0|||
24911501|NCT03828487|50005757|FG000|Overall Study|Physician Decision|1|||
24911502|NCT00324961|50005761|FG000|Overall Study|Adverse Event|5|||
24911503|NCT00324961|50005761|FG000|Overall Study|Consent Withdrawn|11|||
25019841|NCT00378378|50115885|FG000|Overall Study|Treatment Failure|0|||
24911504|NCT00324961|50005761|FG000|Overall Study|Lost to Follow-up|22|||
24911505|NCT00324961|50005761|FG000|Overall Study|Protocol Violation|3|||
24911506|NCT00324961|50005761|FG000|Overall Study|Other|2|||
24911507|NCT00324649|50005769|FG000|Overall Study|Adverse Event|1|||
24911508|NCT00324649|50005770|FG001|Overall Study|Adverse Event|4|||
24911509|NCT00324649|50005769|FG000|Overall Study|Withdrawal by Subject|0|||
24911510|NCT00324649|50005770|FG001|Overall Study|Withdrawal by Subject|1|||
24911511|NCT00324649|50005769|FG000|Overall Study|Noncompliance|1|||
24911512|NCT00324649|50005770|FG001|Overall Study|Noncompliance|0|||
24911513|NCT00656370|50005776|FG000|Overall Study|Screen Failures|7|||
24911514|NCT00656370|50005776|FG000|Overall Study|Alternates|3|||
24911515|NCT00680186|50005784|FG000|Overall Study|Adverse Event|47|||
24911516|NCT00680186|50005785|FG001|Overall Study|Adverse Event|44|||
24911517|NCT00680186|50005784|FG000|Overall Study|Protocol Violation|31|||
24911518|NCT00680186|50005785|FG001|Overall Study|Protocol Violation|26|||
24911519|NCT00680186|50005784|FG000|Overall Study|Lost to Follow-up|11|||
24911520|NCT00680186|50005785|FG001|Overall Study|Lost to Follow-up|6|||
24911521|NCT00680186|50005784|FG000|Overall Study|Withdrawal by Subject|32|||
24911522|NCT00680186|50005785|FG001|Overall Study|Withdrawal by Subject|39|||
24911523|NCT00680186|50005784|FG000|Overall Study|Other|4|||
24911524|NCT00680186|50005785|FG001|Overall Study|Other|1|||
24911525|NCT00656292|50005793|FG000|Overall Study|Withdrawal by Subject|2|||
24911526|NCT00656292|50005794|FG001|Overall Study|Withdrawal by Subject|3|||
24911527|NCT00656292|50005793|FG000|Overall Study|Screen failure|1|||
24911528|NCT00656292|50005794|FG001|Overall Study|Screen failure|2|||
24911529|NCT00352417|50005802|FG000|Overall Study|Adverse Event|1|||
24911530|NCT00352417|50005803|FG001|Overall Study|Adverse Event|0|||
24911531|NCT00352417|50005802|FG000|Overall Study|Protocol Violation|0|||
24911532|NCT00352417|50005803|FG001|Overall Study|Protocol Violation|2|||
24911533|NCT00352417|50005802|FG000|Overall Study|Withdrawal by Subject|1|||
24911534|NCT00352417|50005803|FG001|Overall Study|Withdrawal by Subject|2|||
24911535|NCT00352417|50005802|FG000|Overall Study|Lost to Follow-up|1|||
24911536|NCT00352417|50005803|FG001|Overall Study|Lost to Follow-up|0|||
24911537|NCT00352417|50005802|FG000|Overall Study|Schedule Change|2|||
24911538|NCT00352417|50005803|FG001|Overall Study|Schedule Change|1|||
24911539|NCT00323869|50005809|FG000|Overall Study|Death|1|||
24911540|NCT00323557|50005815|FG000|Overall Study|Physician Decision|1|||
24911541|NCT00323557|50005816|FG001|Overall Study|Physician Decision|0|||
24911542|NCT00558363|50005825|FG000|Overall Study|Physician Decision|18|||
24911543|NCT00558363|50005826|FG001|Overall Study|Physician Decision|4|||
24911544|NCT00558363|50005825|FG000|Overall Study|Withdrawal by Subject|11|||
24911545|NCT00558363|50005826|FG001|Overall Study|Withdrawal by Subject|4|||
24911546|NCT00558363|50005825|FG000|Overall Study|Adverse Event|5|||
24911547|NCT00558363|50005826|FG001|Overall Study|Adverse Event|5|||
24911548|NCT00558363|50005825|FG000|Overall Study|Lack of Efficacy|2|||
24911549|NCT00558363|50005826|FG001|Overall Study|Lack of Efficacy|2|||
24911550|NCT00558363|50005825|FG000|Overall Study|Protocol Violation|2|||
24911551|NCT00558363|50005826|FG001|Overall Study|Protocol Violation|1|||
24911552|NCT00558363|50005825|FG000|Overall Study|Lost to Follow-up|0|||
24911553|NCT00558363|50005826|FG001|Overall Study|Lost to Follow-up|1|||
24911554|NCT00558363|50005825|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
24911555|NCT00558363|50005826|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
24911556|NCT00558363|50005825|FG000|Overall Study|Randomized in Error|1|||
24911557|NCT00558363|50005826|FG001|Overall Study|Randomized in Error|2|||
24911558|NCT00558363|50005825|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
25019842|NCT00378378|50115886|FG001|Overall Study|Treatment Failure|0|||
25019843|NCT00378378|50115887|FG002|Overall Study|Treatment Failure|1|||
25019844|NCT00378378|50115885|FG000|Overall Study|Non-compliance with protocol|0|||
25019845|NCT00378378|50115886|FG001|Overall Study|Non-compliance with protocol|0|||
24911559|NCT00558363|50005826|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
24911560|NCT00323479|50005832|FG000|Overall Study|Adverse Event|2|||
24911561|NCT00323479|50005832|FG000|Overall Study|Withdrawal by Subject|2|||
24911562|NCT00323479|50005832|FG000|Overall Study|Protocol Violation|3|||
24911563|NCT00323479|50005832|FG000|Overall Study|house moving|1|||
24911564|NCT00352105|50005836|FG000|Overall Study|Death|5|||
24911565|NCT00352105|50005836|FG000|Overall Study|Withdrawal by Subject|5|||
24911566|NCT00352105|50005836|FG000|Overall Study|Lack of Efficacy|9|||
24911567|NCT00352105|50005836|FG000|Overall Study|Adverse Event|19|||
25153058|NCT01604343|50268204|FG004|Week 52 to Week 104|Physician Decision|2|||
24911568|NCT00352105|50005836|FG000|Overall Study|Protocol Violation|2|||
24911569|NCT00350779|50005842|FG000|Overall Study|Adverse Event|4|||
24911570|NCT00350779|50005843|FG001|Overall Study|Adverse Event|2|||
24911571|NCT00350779|50005842|FG000|Overall Study|Lack of Efficacy|0|||
24911572|NCT00350779|50005843|FG001|Overall Study|Lack of Efficacy|4|||
24911573|NCT00350779|50005842|FG000|Overall Study|Lost to Follow-up|2|||
24911574|NCT00350779|50005843|FG001|Overall Study|Lost to Follow-up|0|||
25274917|NCT00903877|50589019|FG000|Overall Study|Participation put on hold|4|||
24911575|NCT00350779|50005842|FG000|Overall Study|Physician Decision|2|||
24911576|NCT00350779|50005843|FG001|Overall Study|Physician Decision|4|||
24911577|NCT00350779|50005842|FG000|Overall Study|Protocol Violation|3|||
24911578|NCT00350779|50005843|FG001|Overall Study|Protocol Violation|1|||
24911579|NCT00350779|50005842|FG000|Overall Study|Withdrawal by Subject|9|||
24911580|NCT00350779|50005843|FG001|Overall Study|Withdrawal by Subject|8|||
24911581|NCT00350779|50005842|FG000|Overall Study|Patient Moved|2|||
24911582|NCT00350779|50005843|FG001|Overall Study|Patient Moved|1|||
24911583|NCT00350779|50005842|FG000|Overall Study|Non-compliance with study procedures|0|||
25019846|NCT00378378|50115887|FG002|Overall Study|Non-compliance with protocol|1|||
25019847|NCT03490981|50115897|FG000|Overall Study|Lost to Follow-up|1|||
25019848|NCT03490981|50115898|FG001|Overall Study|Lost to Follow-up|2|||
25019849|NCT03160716|50115904|FG000|Overall Study|Lost to Follow-up|1|||
25019850|NCT03713021|50115908|FG000|Overall Study|Did not have CT sim scan available|6|||
25019851|NCT03713021|50115908|FG000|Overall Study|Not eligible|4|||
25019852|NCT03713021|50115908|FG000|Overall Study|Issues with TraceIT markers|5|||
25019853|NCT03160560|50115916|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
25019854|NCT03160560|50115917|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
25019855|NCT03160560|50115918|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
25019856|NCT03160560|50115919|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
25019857|NCT03160560|50115916|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
25019858|NCT03160560|50115917|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
25019859|NCT03160560|50115918|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
25019860|NCT03160560|50115919|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
25019861|NCT03489343|50115936|FG000|Overall Study|Documented progressive disease|1|||
25019862|NCT03489343|50115937|FG001|Overall Study|Documented progressive disease|0|||
25019863|NCT03489343|50115938|FG002|Overall Study|Documented progressive disease|3|||
25019864|NCT03489343|50115939|FG003|Overall Study|Documented progressive disease|1|||
25019865|NCT03489343|50115940|FG004|Overall Study|Documented progressive disease|3|||
25019866|NCT03489343|50115941|FG005|Overall Study|Documented progressive disease|5|||
25019867|NCT03489343|50115942|FG006|Overall Study|Documented progressive disease|4|||
25019868|NCT03489343|50115936|FG000|Overall Study|Adverse Event|0|||
25019869|NCT03489343|50115937|FG001|Overall Study|Adverse Event|1|||
25019870|NCT03489343|50115938|FG002|Overall Study|Adverse Event|0|||
25019871|NCT03489343|50115939|FG003|Overall Study|Adverse Event|0|||
25019872|NCT03489343|50115940|FG004|Overall Study|Adverse Event|0|||
25019873|NCT03489343|50115941|FG005|Overall Study|Adverse Event|1|||
25019874|NCT03489343|50115942|FG006|Overall Study|Adverse Event|0|||
25019875|NCT03489343|50115936|FG000|Overall Study|Withdrawal by Subject|0|||
25019876|NCT03489343|50115937|FG001|Overall Study|Withdrawal by Subject|0|||
25019877|NCT03489343|50115938|FG002|Overall Study|Withdrawal by Subject|0|||
25019878|NCT03489343|50115939|FG003|Overall Study|Withdrawal by Subject|1|||
25019879|NCT03489343|50115940|FG004|Overall Study|Withdrawal by Subject|0|||
25019880|NCT03489343|50115941|FG005|Overall Study|Withdrawal by Subject|1|||
25019881|NCT03489343|50115942|FG006|Overall Study|Withdrawal by Subject|1|||
25019882|NCT03489343|50115936|FG000|Overall Study|Clinical progression|0|||
25019883|NCT03489343|50115937|FG001|Overall Study|Clinical progression|0|||
25019884|NCT03489343|50115938|FG002|Overall Study|Clinical progression|0|||
25019885|NCT03489343|50115939|FG003|Overall Study|Clinical progression|1|||
25019886|NCT03489343|50115940|FG004|Overall Study|Clinical progression|0|||
25019887|NCT03489343|50115941|FG005|Overall Study|Clinical progression|0|||
25019888|NCT03489343|50115942|FG006|Overall Study|Clinical progression|1|||
25019889|NCT03489109|50115960|FG000|Overall Study|Lost to Follow-up|1|||
25019890|NCT03489109|50115961|FG001|Overall Study|Lost to Follow-up|2|||
25019891|NCT03709823|50115973|FG000|Overall Study|Adverse Event|0|||
25019892|NCT03709823|50115974|FG001|Overall Study|Adverse Event|0|||
25019893|NCT03709823|50115975|FG002|Overall Study|Adverse Event|1|||
25019894|NCT03709823|50115976|FG003|Overall Study|Adverse Event|0|||
25019895|NCT03709823|50115977|FG004|Overall Study|Adverse Event|0|||
25019896|NCT03709823|50115978|FG005|Overall Study|Adverse Event|0|||
25019897|NCT03709823|50115973|FG000|Overall Study|Lost to Follow-up|2|||
24911584|NCT00350779|50005843|FG001|Overall Study|Non-compliance with study procedures|1|||
24911585|NCT00350623|50005854|FG000|Overall Study|Lost to Follow-up|8|||
24911586|NCT00350623|50005855|FG001|Overall Study|Lost to Follow-up|3|||
24911587|NCT00350623|50005856|FG002|Overall Study|Lost to Follow-up|4|||
25019898|NCT03709823|50115974|FG001|Overall Study|Lost to Follow-up|2|||
25019899|NCT03709823|50115975|FG002|Overall Study|Lost to Follow-up|2|||
25019900|NCT03709823|50115976|FG003|Overall Study|Lost to Follow-up|1|||
25019901|NCT03709823|50115977|FG004|Overall Study|Lost to Follow-up|1|||
25019902|NCT03709823|50115978|FG005|Overall Study|Lost to Follow-up|0|||
25019903|NCT03709823|50115973|FG000|Overall Study|Withdrawal by Subject|1|||
25153059|NCT01604343|50268200|FG000|Week 52 to Week 104|Pregnancy|0|||
24911588|NCT00350623|50005854|FG000|Overall Study|Withdrawal by Subject|0|||
24911589|NCT00350623|50005855|FG001|Overall Study|Withdrawal by Subject|1|||
25019904|NCT03709823|50115974|FG001|Overall Study|Withdrawal by Subject|3|||
25019905|NCT03709823|50115975|FG002|Overall Study|Withdrawal by Subject|0|||
25019906|NCT03709823|50115976|FG003|Overall Study|Withdrawal by Subject|0|||
25274918|NCT01241591|50589027|FG000|Overall Study|Lack of Efficacy|5|||
25274919|NCT01241591|50589028|FG001|Overall Study|Lack of Efficacy|2|||
24911590|NCT00350623|50005856|FG002|Overall Study|Withdrawal by Subject|1|||
24911591|NCT00350623|50005854|FG000|Overall Study|patient traveling outside the country|0|||
25019907|NCT03709823|50115977|FG004|Overall Study|Withdrawal by Subject|0|||
25019908|NCT03709823|50115978|FG005|Overall Study|Withdrawal by Subject|0|||
25019909|NCT03709823|50115973|FG000|Overall Study|Other, Not Specified|0|||
25019910|NCT03709823|50115974|FG001|Overall Study|Other, Not Specified|0|||
25019911|NCT03709823|50115975|FG002|Overall Study|Other, Not Specified|0|||
25019912|NCT03709823|50115976|FG003|Overall Study|Other, Not Specified|1|||
25019913|NCT03709823|50115977|FG004|Overall Study|Other, Not Specified|0|||
25019914|NCT03709823|50115978|FG005|Overall Study|Other, Not Specified|0|||
25019915|NCT03488563|50115998|FG000|Overall Study|Lost to Follow-up|7|||
25019916|NCT03488563|50115999|FG001|Overall Study|Lost to Follow-up|6|||
25019917|NCT03488563|50116000|FG002|Overall Study|Lost to Follow-up|7|||
25019918|NCT03488563|50115998|FG000|Overall Study|Withdrawal by Subject|8|||
25019919|NCT03488563|50115999|FG001|Overall Study|Withdrawal by Subject|7|||
25019920|NCT03488563|50116000|FG002|Overall Study|Withdrawal by Subject|7|||
25019921|NCT03488563|50115998|FG000|Overall Study|Physician Decision|0|||
24911592|NCT00350623|50005855|FG001|Overall Study|patient traveling outside the country|0|||
25153060|NCT01604343|50268201|FG001|Week 52 to Week 104|Pregnancy|0|||
24911593|NCT00350623|50005856|FG002|Overall Study|patient traveling outside the country|1|||
24911594|NCT00656136|50005866|FG000|Overall Study|Progressive disease|177|||
24911595|NCT00656136|50005867|FG001|Overall Study|Progressive disease|322|||
24911596|NCT00656136|50005866|FG000|Overall Study|Other Adverse Event|5|||
24911597|NCT00656136|50005867|FG001|Overall Study|Other Adverse Event|51|||
24911598|NCT00656136|50005866|FG000|Overall Study|Protocol Violation|2|||
24911599|NCT00656136|50005867|FG001|Overall Study|Protocol Violation|3|||
24911600|NCT00656136|50005866|FG000|Overall Study|Patient refused to take study medication|7|||
24911601|NCT00656136|50005867|FG001|Overall Study|Patient refused to take study medication|10|||
24911602|NCT00656136|50005866|FG000|Overall Study|Unknown and others|4|||
24911603|NCT00656136|50005867|FG001|Overall Study|Unknown and others|4|||
24911604|NCT00676520|50005873|FG000|Overall Study|Withdrawal by Subject|163|||
24911605|NCT00676520|50005873|FG000|Overall Study|Lost to Follow-up|162|||
24911606|NCT00676520|50005873|FG000|Overall Study|Death|159|||
24911607|NCT00676520|50005873|FG000|Overall Study|Physician Decision|20|||
24911608|NCT00676520|50005873|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
24911609|NCT00676520|50005873|FG000|Overall Study|Other Reason|18|||
24911610|NCT00652938|50005885|FG000|Overall Study|Adverse Event|1|||
24911611|NCT00652938|50005886|FG001|Overall Study|Adverse Event|0|||
24911612|NCT00652938|50005887|FG002|Overall Study|Adverse Event|2|||
24911613|NCT00652938|50005885|FG000|Overall Study|Withdrawal by Subject|0|||
24911614|NCT00652938|50005886|FG001|Overall Study|Withdrawal by Subject|6|||
24911615|NCT00652938|50005887|FG002|Overall Study|Withdrawal by Subject|1|||
25153061|NCT01604343|50268202|FG002|Week 52 to Week 104|Pregnancy|1|||
25153062|NCT01604343|50268203|FG003|Week 52 to Week 104|Pregnancy|2|||
24911616|NCT00652938|50005885|FG000|Overall Study|Lost to Follow-up|0|||
24911617|NCT00652938|50005886|FG001|Overall Study|Lost to Follow-up|0|||
24911618|NCT00652938|50005887|FG002|Overall Study|Lost to Follow-up|2|||
24911619|NCT00652938|50005885|FG000|Overall Study|fear of blood sampling|0|||
24911620|NCT00652938|50005886|FG001|Overall Study|fear of blood sampling|1|||
24911621|NCT00652938|50005887|FG002|Overall Study|fear of blood sampling|0|||
24911622|NCT00322621|50005895|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
24911623|NCT00322621|50005896|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
24911624|NCT00322621|50005897|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
24911625|NCT00322621|50005895|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
24911626|NCT00322621|50005896|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
24911627|NCT00322621|50005897|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
25019922|NCT03488563|50115999|FG001|Overall Study|Physician Decision|0|||
24911628|NCT00322621|50005895|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
24911629|NCT00322621|50005896|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
24911630|NCT00322621|50005897|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
24911631|NCT00322621|50005895|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
24911632|NCT00322621|50005896|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
24911633|NCT00322621|50005897|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
25019923|NCT03488563|50116000|FG002|Overall Study|Physician Decision|1|||
25153063|NCT01604343|50268204|FG004|Week 52 to Week 104|Pregnancy|1|||
25153064|NCT01604343|50268200|FG000|Week 52 to Week 104|Other|0|||
24911634|NCT00322621|50005895|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
24911635|NCT00322621|50005896|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
24911636|NCT00322621|50005897|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
24911637|NCT00322621|50005895|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
24911638|NCT00322621|50005896|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
24911639|NCT00322621|50005897|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
24911640|NCT00322621|50005895|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
24911641|NCT00322621|50005896|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
24911642|NCT00322621|50005897|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
24911643|NCT00322621|50005895|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
24911644|NCT00322621|50005896|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
24911645|NCT00322621|50005897|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
24911646|NCT00322621|50005895|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
24911647|NCT00322621|50005896|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
24911648|NCT00322621|50005897|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
24911649|NCT00322621|50005895|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
24911650|NCT00322621|50005896|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
24911651|NCT00322621|50005897|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
24911652|NCT00322621|50005895|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
24911653|NCT00322621|50005896|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
24911654|NCT00322621|50005897|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
24911655|NCT00575042|50005910|FG000|Overall Study|Adverse Event|2|||
24911656|NCT00575042|50005910|FG000|Overall Study|Lost to Follow-up|1|||
24911657|NCT00676208|50005917|FG000|Overall Study|Lost to Follow-up|0|||
24911658|NCT00676208|50005918|FG001|Overall Study|Lost to Follow-up|2|||
24911659|NCT00676208|50005917|FG000|Overall Study|Incomplete data|2|||
24911660|NCT00676208|50005918|FG001|Overall Study|Incomplete data|4|||
24911661|NCT00656058|50005926|FG000|Overall Study|Withdrawal by Subject|2|||
24911662|NCT00656058|50005926|FG000|Overall Study|Withdrawal by Subject|4|||
24911663|NCT00537316|50005936|FG000|Part 1|Adverse Event|7|||
24911664|NCT00537316|50005937|FG001|Part 1|Adverse Event|11|||
24911665|NCT00537316|50005938|FG002|Part 1|Adverse Event|8|||
24911666|NCT00537316|50005939|FG003|Part 1|Adverse Event|0|||
24911667|NCT00537316|50005940|FG004|Part 1|Adverse Event|0|||
24911668|NCT00537316|50005941|FG005|Part 1|Adverse Event|0|||
24911669|NCT00537316|50005942|FG006|Part 1|Adverse Event|0|||
24911670|NCT00537316|50005936|FG000|Part 1|Protocol defined clinical event|1|||
24911671|NCT00537316|50005937|FG001|Part 1|Protocol defined clinical event|0|||
24911672|NCT00537316|50005938|FG002|Part 1|Protocol defined clinical event|0|||
24911673|NCT00537316|50005939|FG003|Part 1|Protocol defined clinical event|0|||
24911674|NCT00537316|50005940|FG004|Part 1|Protocol defined clinical event|0|||
24911675|NCT00537316|50005941|FG005|Part 1|Protocol defined clinical event|0|||
24911676|NCT00537316|50005942|FG006|Part 1|Protocol defined clinical event|0|||
24911677|NCT00537316|50005936|FG000|Part 1|Lost to Follow-up|1|||
24911678|NCT00537316|50005937|FG001|Part 1|Lost to Follow-up|0|||
24911679|NCT00537316|50005938|FG002|Part 1|Lost to Follow-up|0|||
24911680|NCT00537316|50005939|FG003|Part 1|Lost to Follow-up|0|||
24911681|NCT00537316|50005940|FG004|Part 1|Lost to Follow-up|0|||
24911682|NCT00537316|50005941|FG005|Part 1|Lost to Follow-up|0|||
24911683|NCT00537316|50005942|FG006|Part 1|Lost to Follow-up|0|||
24911684|NCT00537316|50005936|FG000|Part 1|Withdrawal by Subject|3|||
24911685|NCT00537316|50005937|FG001|Part 1|Withdrawal by Subject|8|||
24911686|NCT00537316|50005938|FG002|Part 1|Withdrawal by Subject|4|||
24911687|NCT00537316|50005939|FG003|Part 1|Withdrawal by Subject|0|||
24911688|NCT00537316|50005940|FG004|Part 1|Withdrawal by Subject|0|||
24911689|NCT00537316|50005941|FG005|Part 1|Withdrawal by Subject|0|||
24911690|NCT00537316|50005942|FG006|Part 1|Withdrawal by Subject|0|||
24911691|NCT00537316|50005936|FG000|Part 1|Protocol Violation|1|||
25019924|NCT03488563|50115998|FG000|Overall Study|Protocol Violation|3|||
25019925|NCT03488563|50115999|FG001|Overall Study|Protocol Violation|2|||
25019926|NCT03488563|50116000|FG002|Overall Study|Protocol Violation|6|||
25019927|NCT03488563|50115998|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
25019928|NCT03488563|50115999|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
25019929|NCT03488563|50116000|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
25019930|NCT03488563|50115998|FG000|Overall Study|Use of prohibited medication|2|||
25019931|NCT03488563|50115999|FG001|Overall Study|Use of prohibited medication|0|||
25019932|NCT03488563|50116000|FG002|Overall Study|Use of prohibited medication|0|||
25019933|NCT03488563|50115998|FG000|Overall Study|Adverse Event|1|||
24911692|NCT00537316|50005937|FG001|Part 1|Protocol Violation|5|||
24911693|NCT00537316|50005938|FG002|Part 1|Protocol Violation|1|||
24911694|NCT00537316|50005939|FG003|Part 1|Protocol Violation|0|||
24911695|NCT00537316|50005940|FG004|Part 1|Protocol Violation|0|||
24911696|NCT00537316|50005941|FG005|Part 1|Protocol Violation|0|||
24911697|NCT00537316|50005942|FG006|Part 1|Protocol Violation|0|||
24911698|NCT00537316|50005936|FG000|Part 1|Did not meet protocol eligibility|1|||
24911699|NCT00537316|50005937|FG001|Part 1|Did not meet protocol eligibility|3|||
24911700|NCT00537316|50005938|FG002|Part 1|Did not meet protocol eligibility|2|||
24911701|NCT00537316|50005939|FG003|Part 1|Did not meet protocol eligibility|0|||
24911702|NCT00537316|50005940|FG004|Part 1|Did not meet protocol eligibility|0|||
24911703|NCT00537316|50005941|FG005|Part 1|Did not meet protocol eligibility|0|||
24911704|NCT00537316|50005942|FG006|Part 1|Did not meet protocol eligibility|0|||
24911705|NCT00537316|50005936|FG000|Part 1|Administrative|0|||
24911706|NCT00537316|50005937|FG001|Part 1|Administrative|0|||
24911707|NCT00537316|50005938|FG002|Part 1|Administrative|2|||
24911708|NCT00537316|50005939|FG003|Part 1|Administrative|0|||
24911709|NCT00537316|50005940|FG004|Part 1|Administrative|0|||
24911710|NCT00537316|50005941|FG005|Part 1|Administrative|0|||
24911711|NCT00537316|50005942|FG006|Part 1|Administrative|0|||
24911712|NCT00537316|50005936|FG000|Part 2|Never entered follow-up|0|||
24911713|NCT00537316|50005937|FG001|Part 2|Never entered follow-up|0|||
24911714|NCT00537316|50005938|FG002|Part 2|Never entered follow-up|0|||
24911715|NCT00537316|50005939|FG003|Part 2|Never entered follow-up|0|||
24911716|NCT00537316|50005940|FG004|Part 2|Never entered follow-up|0|||
24911717|NCT00537316|50005941|FG005|Part 2|Never entered follow-up|0|||
24911718|NCT00537316|50005942|FG006|Part 2|Never entered follow-up|1|||
24911719|NCT00537316|50005936|FG000|Part 2|Adverse Event|4|||
24911720|NCT00537316|50005937|FG001|Part 2|Adverse Event|0|||
24911721|NCT00537316|50005938|FG002|Part 2|Adverse Event|2|||
24911722|NCT00537316|50005939|FG003|Part 2|Adverse Event|0|||
24911723|NCT00537316|50005940|FG004|Part 2|Adverse Event|0|||
24911724|NCT00537316|50005941|FG005|Part 2|Adverse Event|0|||
24911725|NCT00537316|50005942|FG006|Part 2|Adverse Event|0|||
24911726|NCT00537316|50005936|FG000|Part 2|Lost to Follow-up|1|||
24911727|NCT00537316|50005937|FG001|Part 2|Lost to Follow-up|0|||
24911728|NCT00537316|50005938|FG002|Part 2|Lost to Follow-up|2|||
24911729|NCT00537316|50005939|FG003|Part 2|Lost to Follow-up|0|||
24911730|NCT00537316|50005940|FG004|Part 2|Lost to Follow-up|0|||
24911731|NCT00537316|50005941|FG005|Part 2|Lost to Follow-up|0|||
24911732|NCT00537316|50005942|FG006|Part 2|Lost to Follow-up|0|||
24911733|NCT00537316|50005936|FG000|Part 2|Withdrawal by Subject|5|||
24911734|NCT00537316|50005937|FG001|Part 2|Withdrawal by Subject|1|||
24911735|NCT00537316|50005938|FG002|Part 2|Withdrawal by Subject|4|||
24911736|NCT00537316|50005939|FG003|Part 2|Withdrawal by Subject|0|||
24911737|NCT00537316|50005940|FG004|Part 2|Withdrawal by Subject|0|||
24911738|NCT00537316|50005941|FG005|Part 2|Withdrawal by Subject|0|||
24911739|NCT00537316|50005942|FG006|Part 2|Withdrawal by Subject|0|||
24911740|NCT00537316|50005936|FG000|Part 2|Administrative|16|||
24911741|NCT00537316|50005937|FG001|Part 2|Administrative|8|||
24911742|NCT00537316|50005938|FG002|Part 2|Administrative|24|||
24911743|NCT00537316|50005939|FG003|Part 2|Administrative|3|||
24911744|NCT00537316|50005940|FG004|Part 2|Administrative|1|||
24911745|NCT00537316|50005941|FG005|Part 2|Administrative|4|||
24911746|NCT00537316|50005942|FG006|Part 2|Administrative|1|||
24911747|NCT03827395|50005963|FG000|Overall Study|Lost to Follow-up|1|||
24911748|NCT03827395|50005964|FG001|Overall Study|Lost to Follow-up|0|||
24911749|NCT03827395|50005963|FG000|Overall Study|Protocol Violation|1|||
24911750|NCT03827395|50005964|FG001|Overall Study|Protocol Violation|0|||
24911751|NCT03827395|50005963|FG000|Overall Study|Became ineligible after enrollment|1|||
24911752|NCT03827395|50005964|FG001|Overall Study|Became ineligible after enrollment|2|||
24911753|NCT00655980|50005973|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
25019934|NCT03488563|50115999|FG001|Overall Study|Adverse Event|0|||
25019935|NCT03488563|50116000|FG002|Overall Study|Adverse Event|1|||
24911754|NCT00655980|50005974|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
24911755|NCT00655980|50005975|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
24911756|NCT00679172|50005991|FG000|Overall Study|Non-compliance|1|||
24911757|NCT00679172|50005992|FG001|Overall Study|Non-compliance|1|||
24911758|NCT00679172|50005993|FG002|Overall Study|Non-compliance|0|||
24911759|NCT00679172|50005994|FG003|Overall Study|Non-compliance|1|||
24911760|NCT00679172|50005995|FG004|Overall Study|Non-compliance|0|||
24911761|NCT00679172|50005991|FG000|Overall Study|Other not specified|0|||
24911762|NCT00679172|50005992|FG001|Overall Study|Other not specified|0|||
24911763|NCT00679172|50005993|FG002|Overall Study|Other not specified|1|||
24911764|NCT00679172|50005994|FG003|Overall Study|Other not specified|0|||
24911765|NCT00679172|50005995|FG004|Overall Study|Other not specified|0|||
24911766|NCT00676130|50006012|FG000|Overall Study|Lost to Follow-up|0|||
24911767|NCT00676130|50006013|FG001|Overall Study|Lost to Follow-up|1|||
24911768|NCT00676130|50006012|FG000|Overall Study|Found ineligible|3|||
24911769|NCT00676130|50006013|FG001|Overall Study|Found ineligible|2|||
24911770|NCT00676130|50006012|FG000|Overall Study|Withdrawal by Subject|0|||
24911771|NCT00676130|50006013|FG001|Overall Study|Withdrawal by Subject|1|||
24911772|NCT00676052|50006025|FG000|Overall Study|Adverse Event|0|||
24911773|NCT00676052|50006026|FG001|Overall Study|Adverse Event|1|||
24911774|NCT00676052|50006027|FG002|Overall Study|Adverse Event|1|||
24911775|NCT00676052|50006028|FG003|Overall Study|Adverse Event|2|||
24911776|NCT00676052|50006029|FG004|Overall Study|Adverse Event|2|||
24911777|NCT00676052|50006030|FG005|Overall Study|Adverse Event|2|||
24911778|NCT00676052|50006025|FG000|Overall Study|Lack of Efficacy|2|||
24911779|NCT00676052|50006026|FG001|Overall Study|Lack of Efficacy|2|||
24911780|NCT00676052|50006027|FG002|Overall Study|Lack of Efficacy|1|||
24911781|NCT00676052|50006028|FG003|Overall Study|Lack of Efficacy|1|||
24911782|NCT00676052|50006029|FG004|Overall Study|Lack of Efficacy|2|||
24911783|NCT00676052|50006030|FG005|Overall Study|Lack of Efficacy|1|||
24911784|NCT00676052|50006025|FG000|Overall Study|Protocol Violation|5|||
24911785|NCT00676052|50006026|FG001|Overall Study|Protocol Violation|3|||
24911786|NCT00676052|50006027|FG002|Overall Study|Protocol Violation|2|||
24911787|NCT00676052|50006028|FG003|Overall Study|Protocol Violation|2|||
24911788|NCT00676052|50006029|FG004|Overall Study|Protocol Violation|1|||
24911789|NCT00676052|50006030|FG005|Overall Study|Protocol Violation|2|||
24911790|NCT00676052|50006025|FG000|Overall Study|Lost to Follow-up|0|||
24911791|NCT00676052|50006026|FG001|Overall Study|Lost to Follow-up|0|||
24911792|NCT00676052|50006027|FG002|Overall Study|Lost to Follow-up|0|||
24911793|NCT00676052|50006028|FG003|Overall Study|Lost to Follow-up|0|||
24911794|NCT00676052|50006029|FG004|Overall Study|Lost to Follow-up|1|||
24911795|NCT00676052|50006030|FG005|Overall Study|Lost to Follow-up|0|||
24911796|NCT00676052|50006025|FG000|Overall Study|Physician Decision|1|||
24911797|NCT00676052|50006026|FG001|Overall Study|Physician Decision|1|||
24911798|NCT00676052|50006027|FG002|Overall Study|Physician Decision|1|||
24911799|NCT00676052|50006028|FG003|Overall Study|Physician Decision|0|||
24911800|NCT00676052|50006029|FG004|Overall Study|Physician Decision|0|||
24911801|NCT00676052|50006030|FG005|Overall Study|Physician Decision|1|||
24911802|NCT00676052|50006025|FG000|Overall Study|Withdrawal by Subject|1|||
24911803|NCT00676052|50006026|FG001|Overall Study|Withdrawal by Subject|0|||
24911804|NCT00676052|50006027|FG002|Overall Study|Withdrawal by Subject|1|||
24911805|NCT00676052|50006028|FG003|Overall Study|Withdrawal by Subject|0|||
24911806|NCT00676052|50006029|FG004|Overall Study|Withdrawal by Subject|0|||
24911807|NCT00676052|50006030|FG005|Overall Study|Withdrawal by Subject|0|||
24911808|NCT00535288|50006049|FG000|Overall Study|Adverse Event|20|||
24911809|NCT00535288|50006050|FG001|Overall Study|Adverse Event|19|||
24911810|NCT00535288|50006051|FG002|Overall Study|Adverse Event|25|||
24911811|NCT00535288|50006052|FG003|Overall Study|Adverse Event|20|||
24911812|NCT00535288|50006053|FG004|Overall Study|Adverse Event|30|||
24911813|NCT00535288|50006049|FG000|Overall Study|Lost to Follow-up|0|||
24911814|NCT00535288|50006050|FG001|Overall Study|Lost to Follow-up|3|||
24911815|NCT00535288|50006051|FG002|Overall Study|Lost to Follow-up|0|||
25274920|NCT01241591|50589029|FG002|Overall Study|Lack of Efficacy|2|||
24911816|NCT00535288|50006052|FG003|Overall Study|Lost to Follow-up|0|||
24911817|NCT00535288|50006053|FG004|Overall Study|Lost to Follow-up|0|||
25153065|NCT01604343|50268201|FG001|Week 52 to Week 104|Other|11|||
25153066|NCT01604343|50268202|FG002|Week 52 to Week 104|Other|11|||
25153067|NCT01604343|50268203|FG003|Week 52 to Week 104|Other|6|||
25153068|NCT01604343|50268204|FG004|Week 52 to Week 104|Other|3|||
24911818|NCT00535288|50006049|FG000|Overall Study|Lack of Efficacy|26|||
24911819|NCT00535288|50006050|FG001|Overall Study|Lack of Efficacy|3|||
24911820|NCT00535288|50006051|FG002|Overall Study|Lack of Efficacy|4|||
24911821|NCT00535288|50006052|FG003|Overall Study|Lack of Efficacy|4|||
24911822|NCT00535288|50006053|FG004|Overall Study|Lack of Efficacy|7|||
24911823|NCT00535288|50006049|FG000|Overall Study|Unwilling to cooperate|6|||
24911824|NCT00535288|50006050|FG001|Overall Study|Unwilling to cooperate|6|||
24911825|NCT00535288|50006051|FG002|Overall Study|Unwilling to cooperate|3|||
25153069|NCT01604343|50268200|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
25153070|NCT01604343|50268201|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
25153071|NCT01604343|50268202|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
25153072|NCT01604343|50268203|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
25153073|NCT01604343|50268204|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
25153074|NCT01604343|50268200|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
25153075|NCT01604343|50268201|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
25153076|NCT01604343|50268202|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
25153077|NCT01604343|50268203|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
25153078|NCT01604343|50268204|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
25153079|NCT01604343|50268200|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
25153080|NCT01604343|50268201|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
25153081|NCT01604343|50268202|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
25153082|NCT01604343|50268203|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
25153083|NCT01604343|50268204|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
25153084|NCT01801436|50268214|FG000|Overall Study|Withdrawal by Subject|3|||
25153085|NCT01801436|50268214|FG000|Overall Study|Adverse Event|2|||
25153086|NCT01801436|50268214|FG000|Overall Study|Progressive disease|4|||
25153087|NCT01771250|50268218|FG000|Period 1|Met exclusion criteria|1|||
25153088|NCT01771250|50268219|FG001|Period 1|Met exclusion criteria|0|||
25153089|NCT01770860|50268225|FG000|Overall Study|Withdrawal by Subject|4|||
24911826|NCT00535288|50006052|FG003|Overall Study|Unwilling to cooperate|3|||
24911827|NCT00535288|50006053|FG004|Overall Study|Unwilling to cooperate|4|||
24911828|NCT00535288|50006049|FG000|Overall Study|Other|2|||
24911829|NCT00535288|50006050|FG001|Overall Study|Other|1|||
24911830|NCT00535288|50006051|FG002|Overall Study|Other|1|||
24911831|NCT00535288|50006052|FG003|Overall Study|Other|2|||
24911832|NCT00535288|50006053|FG004|Overall Study|Other|1|||
24911833|NCT03904420|50006072|FG000|Overall Study|Study terminated|2|||
24911834|NCT03904420|50006073|FG001|Overall Study|Study terminated|2|||
24911835|NCT00675506|50006081|FG000|Overall Study|Lost to Follow-up|1|||
24911836|NCT00675506|50006082|FG001|Overall Study|Lost to Follow-up|5|||
24911837|NCT00675506|50006081|FG000|Overall Study|Lost interest|3|||
24911838|NCT00675506|50006082|FG001|Overall Study|Lost interest|5|||
25019936|NCT03488563|50115998|FG000|Overall Study|Subject returned for ET visit|0|||
25019937|NCT03488563|50115999|FG001|Overall Study|Subject returned for ET visit|1|||
25153090|NCT01770860|50268225|FG000|Overall Study|Lost to Follow-up|1|||
25153091|NCT01770860|50268225|FG000|Overall Study|Administrative decision made by the PI|1|||
25153092|NCT01603875|50268236|FG000|Overall Study|Preexisting rabies antibody|3|||
25153093|NCT01603875|50268237|FG001|Overall Study|Preexisting rabies antibody|4|||
25153094|NCT01603875|50268238|FG002|Overall Study|Preexisting rabies antibody|3|||
25153095|NCT01603875|50268236|FG000|Overall Study|Lost to Follow-up|4|||
25153096|NCT01603875|50268237|FG001|Overall Study|Lost to Follow-up|3|||
25153097|NCT01603875|50268238|FG002|Overall Study|Lost to Follow-up|6|||
25153098|NCT01603875|50268236|FG000|Overall Study|Protocol Violation|0|||
25153099|NCT01603875|50268237|FG001|Overall Study|Protocol Violation|1|||
25153100|NCT01603875|50268238|FG002|Overall Study|Protocol Violation|0|||
25019938|NCT03488563|50116000|FG002|Overall Study|Subject returned for ET visit|0|||
25153101|NCT01770392|50268246|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
25153102|NCT01603641|50268256|FG000|Overall Study|Did not Receive Treatment|3|||
25153103|NCT01603641|50268256|FG000|Overall Study|Adverse Event|1|||
25184951|NCT01425359|50334038|FG000|Overall Study|Adverse Event|9|||
25184952|NCT01425359|50334039|FG001|Overall Study|Adverse Event|8|||
24911839|NCT00675506|50006081|FG000|Overall Study|Elevated fasting glucose|2|||
24911840|NCT00675506|50006082|FG001|Overall Study|Elevated fasting glucose|1|||
24911841|NCT00675506|50006081|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
24911842|NCT00675506|50006082|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
24911843|NCT00675506|50006081|FG000|Overall Study|Elevated IGF-1|2|||
24911844|NCT00675506|50006082|FG001|Overall Study|Elevated IGF-1|0|||
25153104|NCT01603641|50268256|FG000|Overall Study|Lack of Efficacy|1|||
25153105|NCT01603641|50268256|FG000|Overall Study|Lost to Follow-up|6|||
25153106|NCT01603641|50268256|FG000|Overall Study|Personal Reasons|18|||
25019939|NCT03488563|50115998|FG000|Overall Study|Sponsor's decision|0|||
25019940|NCT03488563|50115999|FG001|Overall Study|Sponsor's decision|0|||
25019941|NCT03488563|50116000|FG002|Overall Study|Sponsor's decision|1|||
25019942|NCT00706030|50116014|FG000|Overall Study|Disease Progression|4|||
25019943|NCT00706030|50116015|FG001|Overall Study|Disease Progression|6|||
25019944|NCT00706030|50116016|FG002|Overall Study|Disease Progression|46|||
24911845|NCT00675506|50006081|FG000|Overall Study|Hypersensitivity Reaction|1|||
24911846|NCT00675506|50006082|FG001|Overall Study|Hypersensitivity Reaction|0|||
24911847|NCT00675506|50006081|FG000|Overall Study|Disclosed history of cancer|1|||
24911848|NCT00675506|50006082|FG001|Overall Study|Disclosed history of cancer|0|||
24911849|NCT00675506|50006081|FG000|Overall Study|Declined participation|1|||
24911850|NCT00675506|50006082|FG001|Overall Study|Declined participation|0|||
24911851|NCT00675506|50006081|FG000|Overall Study|Schedule conflict|0|||
24911852|NCT00675506|50006082|FG001|Overall Study|Schedule conflict|1|||
24911853|NCT03895840|50006089|FG000|Overall Study|Withdrawal by Subject|21|||
24911854|NCT00310375|50006095|FG000|Primary Reporting Phase|Adverse Event|28|||
24911855|NCT00310375|50006096|FG001|Primary Reporting Phase|Adverse Event|22|||
24911856|NCT00310375|50006097|FG002|Primary Reporting Phase|Adverse Event|0|||
24911857|NCT00310375|50006095|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
24911858|NCT00310375|50006096|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
24911859|NCT00310375|50006097|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
24911860|NCT00310375|50006095|FG000|Primary Reporting Phase|Pregnancy|2|||
24911861|NCT00310375|50006096|FG001|Primary Reporting Phase|Pregnancy|2|||
24911862|NCT00310375|50006097|FG002|Primary Reporting Phase|Pregnancy|0|||
24911863|NCT00310375|50006095|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
25153107|NCT01603641|50268256|FG000|Overall Study|Other Miscellaneous Reasons|6|||
25153108|NCT01556763|50268263|FG000|Overall Study|Withdrawal by Subject|0|||
25153109|NCT01556763|50268264|FG001|Overall Study|Withdrawal by Subject|1|||
24911864|NCT00310375|50006096|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
24911865|NCT00310375|50006097|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
24911866|NCT00310375|50006095|FG000|Primary Reporting Phase|Protocol Violation|8|||
24911867|NCT00310375|50006096|FG001|Primary Reporting Phase|Protocol Violation|5|||
24911868|NCT00310375|50006097|FG002|Primary Reporting Phase|Protocol Violation|0|||
24911869|NCT00310375|50006095|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
24911870|NCT00310375|50006096|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
24911871|NCT00310375|50006097|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
24911872|NCT00310375|50006095|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
24911873|NCT00310375|50006096|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
24911874|NCT00310375|50006097|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
24911875|NCT00310375|50006095|FG000|Primary Reporting Phase|Physician Decision|5|||
24911876|NCT00310375|50006096|FG001|Primary Reporting Phase|Physician Decision|3|||
24911877|NCT00310375|50006097|FG002|Primary Reporting Phase|Physician Decision|0|||
24911878|NCT00310375|50006095|FG000|Primary Reporting Phase|Request of the sponsor|2|||
24911879|NCT00310375|50006096|FG001|Primary Reporting Phase|Request of the sponsor|2|||
24911880|NCT00310375|50006097|FG002|Primary Reporting Phase|Request of the sponsor|0|||
24911881|NCT00310375|50006095|FG000|Primary Reporting Phase|Failed to return|1|||
24911882|NCT00310375|50006096|FG001|Primary Reporting Phase|Failed to return|3|||
24911883|NCT00310375|50006097|FG002|Primary Reporting Phase|Failed to return|0|||
24911884|NCT00310375|50006095|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
24911885|NCT00310375|50006096|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
24911886|NCT00310375|50006097|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
24911887|NCT00310375|50006095|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
24911888|NCT00310375|50006096|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
24911889|NCT00310375|50006097|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
24911890|NCT00310375|50006095|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
24911891|NCT00310375|50006096|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
24911892|NCT00310375|50006097|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
24911893|NCT00310375|50006095|FG000|Primary Reporting Phase|Site closure|3|||
24911894|NCT00310375|50006096|FG001|Primary Reporting Phase|Site closure|0|||
24911895|NCT00310375|50006097|FG002|Primary Reporting Phase|Site closure|0|||
24911896|NCT00310375|50006095|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
25184953|NCT01425359|50334038|FG000|Overall Study|Revascularization|0|||
24911897|NCT00310375|50006096|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
24911898|NCT00310375|50006097|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
24911899|NCT00310375|50006095|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
24911900|NCT00310375|50006096|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
24911901|NCT00310375|50006097|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
24911902|NCT00310375|50006095|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
24911903|NCT00310375|50006096|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
24911904|NCT00310375|50006097|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
24911905|NCT00310375|50006095|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
24911906|NCT00310375|50006096|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
24911907|NCT00310375|50006097|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
24911908|NCT00309907|50006106|FG000|Overall Study|Death|4|||
24911909|NCT00309907|50006106|FG000|Overall Study|Physician Decision|1|||
24911910|NCT00309907|50006106|FG000|Overall Study|Ineligible|11|||
24911911|NCT00309907|50006106|FG000|Overall Study|Major infectious event|4|||
24911912|NCT00655824|50006111|FG000|Overall Study|Adverse Event|3|||
24911913|NCT00655824|50006111|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
24911914|NCT00655824|50006111|FG000|Overall Study|Protocol Violation|1|||
24911915|NCT00655824|50006111|FG000|Overall Study|Withdrawal by Subject|4|||
24911916|NCT00655824|50006111|FG000|Overall Study|Deterioration of Trial Disease|2|||
24911917|NCT00575588|50006117|FG000|Overall Study|Adverse Event|11|||
24911918|NCT00575588|50006118|FG001|Overall Study|Adverse Event|13|||
24911919|NCT00575588|50006117|FG000|Overall Study|Withdrawal by Subject|27|||
24911920|NCT00575588|50006118|FG001|Overall Study|Withdrawal by Subject|31|||
24911921|NCT00575588|50006117|FG000|Overall Study|Lost to Follow-up|1|||
24911922|NCT00575588|50006118|FG001|Overall Study|Lost to Follow-up|3|||
24911923|NCT00575588|50006117|FG000|Overall Study|Death|4|||
24911924|NCT00575588|50006118|FG001|Overall Study|Death|2|||
24911925|NCT00575588|50006117|FG000|Overall Study|Incorrect enrollment|8|||
24911926|NCT00575588|50006118|FG001|Overall Study|Incorrect enrollment|4|||
24911927|NCT00575588|50006117|FG000|Overall Study|Study specific discontinuation criteria|203|||
24911928|NCT00575588|50006118|FG001|Overall Study|Study specific discontinuation criteria|218|||
24911929|NCT00575588|50006117|FG000|Overall Study|Severe non-compliance to protocol|5|||
24911930|NCT00575588|50006118|FG001|Overall Study|Severe non-compliance to protocol|7|||
24911931|NCT00575588|50006117|FG000|Overall Study|Safety reasons|2|||
24911932|NCT00575588|50006118|FG001|Overall Study|Safety reasons|1|||
24911933|NCT00575588|50006117|FG000|Overall Study|Elevated triglyceride|1|||
24911934|NCT00575588|50006118|FG001|Overall Study|Elevated triglyceride|0|||
24911935|NCT00575588|50006117|FG000|Overall Study|Patient moved|1|||
24911936|NCT00575588|50006118|FG001|Overall Study|Patient moved|3|||
24911937|NCT00575588|50006117|FG000|Overall Study|Impossible to determine HbA1c|0|||
24911938|NCT00575588|50006118|FG001|Overall Study|Impossible to determine HbA1c|1|||
24911939|NCT00675428|50006126|FG000|Overall Study|Disease Progression|2|||
24911940|NCT00675428|50006127|FG001|Overall Study|Disease Progression|2|||
24911941|NCT00675428|50006126|FG000|Overall Study|No Disease Response After Cycle 6|0|||
24911942|NCT00675428|50006127|FG001|Overall Study|No Disease Response After Cycle 6|1|||
24911943|NCT00675428|50006126|FG000|Overall Study|Physician Decision|1|||
24911944|NCT00675428|50006127|FG001|Overall Study|Physician Decision|0|||
24911945|NCT00557505|50006151|FG000|Overall Study|Death|0|||
24911946|NCT00557505|50006152|FG001|Overall Study|Death|0|||
24911947|NCT00557505|50006153|FG002|Overall Study|Death|0|||
24911948|NCT00557505|50006154|FG003|Overall Study|Death|0|||
24911949|NCT00557505|50006155|FG004|Overall Study|Death|0|||
24911950|NCT00557505|50006156|FG005|Overall Study|Death|0|||
24911951|NCT00557505|50006157|FG006|Overall Study|Death|0|||
24911952|NCT00557505|50006158|FG007|Overall Study|Death|0|||
24911953|NCT00557505|50006159|FG008|Overall Study|Death|1|||
24911954|NCT00557505|50006151|FG000|Overall Study|Adverse Event|0|||
24911955|NCT00557505|50006152|FG001|Overall Study|Adverse Event|0|||
24911956|NCT00557505|50006153|FG002|Overall Study|Adverse Event|1|||
24911957|NCT00557505|50006154|FG003|Overall Study|Adverse Event|0|||
24911958|NCT00557505|50006155|FG004|Overall Study|Adverse Event|0|||
24911959|NCT00557505|50006156|FG005|Overall Study|Adverse Event|0|||
24911960|NCT00557505|50006157|FG006|Overall Study|Adverse Event|1|||
24911961|NCT00557505|50006158|FG007|Overall Study|Adverse Event|0|||
24911962|NCT00557505|50006159|FG008|Overall Study|Adverse Event|0|||
24911963|NCT00557505|50006151|FG000|Overall Study|Global deterioration of health|1|||
24911964|NCT00557505|50006152|FG001|Overall Study|Global deterioration of health|0|||
24911965|NCT00557505|50006153|FG002|Overall Study|Global deterioration of health|0|||
24911966|NCT00557505|50006154|FG003|Overall Study|Global deterioration of health|0|||
24911967|NCT00557505|50006155|FG004|Overall Study|Global deterioration of health|0|||
24911968|NCT00557505|50006156|FG005|Overall Study|Global deterioration of health|0|||
24911969|NCT00557505|50006157|FG006|Overall Study|Global deterioration of health|0|||
24911970|NCT00557505|50006158|FG007|Overall Study|Global deterioration of health|0|||
24911971|NCT00557505|50006159|FG008|Overall Study|Global deterioration of health|0|||
24911972|NCT00557505|50006151|FG000|Overall Study|Objective progression or relapse|2|||
24911973|NCT00557505|50006152|FG001|Overall Study|Objective progression or relapse|3|||
24911974|NCT00557505|50006153|FG002|Overall Study|Objective progression or relapse|3|||
24911975|NCT00557505|50006154|FG003|Overall Study|Objective progression or relapse|2|||
24911976|NCT00557505|50006155|FG004|Overall Study|Objective progression or relapse|2|||
24911977|NCT00557505|50006156|FG005|Overall Study|Objective progression or relapse|3|||
24911978|NCT00557505|50006157|FG006|Overall Study|Objective progression or relapse|2|||
24911979|NCT00557505|50006158|FG007|Overall Study|Objective progression or relapse|5|||
24911980|NCT00557505|50006159|FG008|Overall Study|Objective progression or relapse|15|||
24911981|NCT00557505|50006151|FG000|Overall Study|Withdrawal by Subject|0|||
24911982|NCT00557505|50006152|FG001|Overall Study|Withdrawal by Subject|0|||
24911983|NCT00557505|50006153|FG002|Overall Study|Withdrawal by Subject|0|||
24911984|NCT00557505|50006154|FG003|Overall Study|Withdrawal by Subject|1|||
24911985|NCT00557505|50006155|FG004|Overall Study|Withdrawal by Subject|0|||
24911986|NCT00557505|50006156|FG005|Overall Study|Withdrawal by Subject|0|||
24911987|NCT00557505|50006157|FG006|Overall Study|Withdrawal by Subject|0|||
24911988|NCT00557505|50006158|FG007|Overall Study|Withdrawal by Subject|0|||
24911989|NCT00557505|50006159|FG008|Overall Study|Withdrawal by Subject|1|||
24911990|NCT00674570|50006185|FG000|Overall Study|Withdrawal by Subject|0|||
24911991|NCT00674570|50006186|FG001|Overall Study|Withdrawal by Subject|2|||
24911992|NCT00674570|50006187|FG002|Overall Study|Withdrawal by Subject|0|||
24911993|NCT00561951|50006198|FG000|Overall Study|Adverse Event|11|||
24911994|NCT00561951|50006199|FG001|Overall Study|Adverse Event|14|||
24911995|NCT00561951|50006200|FG002|Overall Study|Adverse Event|14|||
24911996|NCT00561951|50006198|FG000|Overall Study|Lack of Efficacy|5|||
24911997|NCT00561951|50006199|FG001|Overall Study|Lack of Efficacy|3|||
24911998|NCT00561951|50006200|FG002|Overall Study|Lack of Efficacy|2|||
24911999|NCT00561951|50006198|FG000|Overall Study|Lost to Follow-up|1|||
24912000|NCT00561951|50006199|FG001|Overall Study|Lost to Follow-up|1|||
24912001|NCT00561951|50006200|FG002|Overall Study|Lost to Follow-up|0|||
24912002|NCT00561951|50006198|FG000|Overall Study|Withdrawal by Subject|10|||
24912003|NCT00561951|50006199|FG001|Overall Study|Withdrawal by Subject|9|||
24912004|NCT00561951|50006200|FG002|Overall Study|Withdrawal by Subject|10|||
24912005|NCT00561951|50006198|FG000|Overall Study|Protocol Violation|4|||
24912006|NCT00561951|50006199|FG001|Overall Study|Protocol Violation|3|||
24912007|NCT00561951|50006200|FG002|Overall Study|Protocol Violation|4|||
24912008|NCT00561951|50006198|FG000|Overall Study|Physician Decision|1|||
24912009|NCT00561951|50006199|FG001|Overall Study|Physician Decision|0|||
24912010|NCT00561951|50006200|FG002|Overall Study|Physician Decision|0|||
24912011|NCT00561951|50006198|FG000|Overall Study|Pregnancy|0|||
24912012|NCT00561951|50006199|FG001|Overall Study|Pregnancy|1|||
24912013|NCT00561951|50006200|FG002|Overall Study|Pregnancy|0|||
24912014|NCT00561951|50006198|FG000|Overall Study|Meet Withdrawal Criterion|0|||
24912015|NCT00561951|50006199|FG001|Overall Study|Meet Withdrawal Criterion|1|||
24912016|NCT00561951|50006200|FG002|Overall Study|Meet Withdrawal Criterion|1|||
24912017|NCT00561951|50006198|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
24912018|NCT00561951|50006199|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
24912019|NCT00561951|50006200|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
24912020|NCT00322387|50006210|FG000|Treatment Period|Adverse Event|0|||
24912021|NCT00322387|50006211|FG001|Treatment Period|Adverse Event|1|||
25019945|NCT00706030|50116017|FG003|Overall Study|Disease Progression|12|||
25019946|NCT00706030|50116014|FG000|Overall Study|Adverse Event|1|||
25019947|NCT00706030|50116015|FG001|Overall Study|Adverse Event|0|||
25019948|NCT00706030|50116016|FG002|Overall Study|Adverse Event|4|||
25019949|NCT00706030|50116017|FG003|Overall Study|Adverse Event|2|||
25019950|NCT00706030|50116014|FG000|Overall Study|Withdrawal by Subject|1|||
24912022|NCT00322387|50006210|FG000|Follow-up Period|Final assessment not done|1|||
24912023|NCT00322387|50006211|FG001|Follow-up Period|Final assessment not done|3|||
24912024|NCT00322387|50006210|FG000|Follow-up Period|Death|1|||
24912025|NCT00322387|50006211|FG001|Follow-up Period|Death|0|||
24912026|NCT00561015|50006234|FG000|Overall Study|Adverse Event|0|||
24912027|NCT00561015|50006235|FG001|Overall Study|Adverse Event|0|||
24912028|NCT00561015|50006236|FG002|Overall Study|Adverse Event|0|||
24912029|NCT00561015|50006237|FG003|Overall Study|Adverse Event|0|||
24912030|NCT00561015|50006238|FG004|Overall Study|Adverse Event|1|||
24912031|NCT00561015|50006239|FG005|Overall Study|Adverse Event|0|||
24912032|NCT00561015|50006234|FG000|Overall Study|Lost to Follow-up|2|||
24912033|NCT00561015|50006235|FG001|Overall Study|Lost to Follow-up|0|||
24912034|NCT00561015|50006236|FG002|Overall Study|Lost to Follow-up|0|||
24912035|NCT00561015|50006237|FG003|Overall Study|Lost to Follow-up|1|||
24912036|NCT00561015|50006238|FG004|Overall Study|Lost to Follow-up|0|||
24912037|NCT00561015|50006239|FG005|Overall Study|Lost to Follow-up|3|||
24912038|NCT00561015|50006234|FG000|Overall Study|Participant non-compliance|2|||
24912039|NCT00561015|50006235|FG001|Overall Study|Participant non-compliance|0|||
24912040|NCT00561015|50006236|FG002|Overall Study|Participant non-compliance|0|||
24912041|NCT00561015|50006237|FG003|Overall Study|Participant non-compliance|0|||
25019951|NCT00706030|50116015|FG001|Overall Study|Withdrawal by Subject|0|||
24912042|NCT00561015|50006238|FG004|Overall Study|Participant non-compliance|0|||
24912043|NCT00561015|50006239|FG005|Overall Study|Participant non-compliance|0|||
24912044|NCT00560937|50006259|FG000|Overall Study|Withdrawal by Subject|0|||
24912045|NCT00560937|50006260|FG001|Overall Study|Withdrawal by Subject|1|||
24912046|NCT00560937|50006259|FG000|Overall Study|Physician Decision|1|||
24912047|NCT00560937|50006260|FG001|Overall Study|Physician Decision|1|||
24912048|NCT00561795|50006268|FG000|Overall Study|Adverse Event|3|||
24912049|NCT00561795|50006269|FG001|Overall Study|Adverse Event|3|||
24912050|NCT00561795|50006270|FG002|Overall Study|Adverse Event|0|||
24912051|NCT00561795|50006271|FG003|Overall Study|Adverse Event|0|||
24912052|NCT00561795|50006268|FG000|Overall Study|Study Closed/Terminated|0|||
24912053|NCT00561795|50006269|FG001|Overall Study|Study Closed/Terminated|3|||
24912054|NCT00561795|50006270|FG002|Overall Study|Study Closed/Terminated|0|||
24912055|NCT00561795|50006271|FG003|Overall Study|Study Closed/Terminated|0|||
24912056|NCT00561795|50006268|FG000|Overall Study|Physician Decision|1|||
24912057|NCT00561795|50006269|FG001|Overall Study|Physician Decision|0|||
24912058|NCT00561795|50006270|FG002|Overall Study|Physician Decision|0|||
24912059|NCT00561795|50006271|FG003|Overall Study|Physician Decision|0|||
24912060|NCT00652626|50006286|FG000|Initial Treatment Phase|Adverse Event|0|||
24912061|NCT00652626|50006287|FG001|Initial Treatment Phase|Adverse Event|0|||
24912062|NCT00652626|50006288|FG002|Initial Treatment Phase|Adverse Event|0|||
24912063|NCT00652626|50006289|FG003|Initial Treatment Phase|Adverse Event|0|||
24912064|NCT00652626|50006290|FG004|Initial Treatment Phase|Adverse Event|1|||
25019952|NCT00706030|50116016|FG002|Overall Study|Withdrawal by Subject|2|||
25019953|NCT00706030|50116017|FG003|Overall Study|Withdrawal by Subject|0|||
24912065|NCT00652626|50006291|FG005|Initial Treatment Phase|Adverse Event|0|||
24912066|NCT00652626|50006292|FG006|Initial Treatment Phase|Adverse Event|0|||
24912067|NCT00652626|50006286|FG000|Initial Treatment Phase|Protocol Violation|0|||
25019954|NCT00706030|50116014|FG000|Overall Study|Physician Decision|0|||
25019955|NCT00706030|50116015|FG001|Overall Study|Physician Decision|0|||
25019956|NCT00706030|50116016|FG002|Overall Study|Physician Decision|2|||
25019957|NCT00706030|50116017|FG003|Overall Study|Physician Decision|0|||
25019958|NCT00706030|50116014|FG000|Overall Study|Not recorded|0|||
25019959|NCT00706030|50116015|FG001|Overall Study|Not recorded|0|||
25019960|NCT00706030|50116016|FG002|Overall Study|Not recorded|2|||
25019961|NCT00706030|50116017|FG003|Overall Study|Not recorded|0|||
25019962|NCT00706030|50116014|FG000|Overall Study|Protocol Violation|0|||
25019963|NCT00706030|50116015|FG001|Overall Study|Protocol Violation|0|||
25019964|NCT00706030|50116016|FG002|Overall Study|Protocol Violation|1|||
25019965|NCT00706030|50116017|FG003|Overall Study|Protocol Violation|1|||
25019966|NCT00706030|50116014|FG000|Overall Study|Failed to return|0|||
25019967|NCT00706030|50116015|FG001|Overall Study|Failed to return|0|||
25019968|NCT00706030|50116016|FG002|Overall Study|Failed to return|1|||
25019969|NCT00706030|50116017|FG003|Overall Study|Failed to return|0|||
25019970|NCT00706030|50116014|FG000|Overall Study|Symptomatic Deterioration|0|||
25019971|NCT00706030|50116015|FG001|Overall Study|Symptomatic Deterioration|0|||
25019972|NCT00706030|50116016|FG002|Overall Study|Symptomatic Deterioration|1|||
25019973|NCT00706030|50116017|FG003|Overall Study|Symptomatic Deterioration|0|||
25019974|NCT00706030|50116014|FG000|Overall Study|No treatment received|0|||
25019975|NCT00706030|50116015|FG001|Overall Study|No treatment received|0|||
25019976|NCT00706030|50116016|FG002|Overall Study|No treatment received|0|||
25019977|NCT00706030|50116017|FG003|Overall Study|No treatment received|1|||
25019978|NCT00706030|50116014|FG000|Overall Study|Death|0|||
25019979|NCT00706030|50116015|FG001|Overall Study|Death|0|||
25019980|NCT00706030|50116016|FG002|Overall Study|Death|1|||
25019981|NCT00706030|50116017|FG003|Overall Study|Death|0|||
25019982|NCT03488251|50116032|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
24912068|NCT00652626|50006287|FG001|Initial Treatment Phase|Protocol Violation|0|||
24912069|NCT00652626|50006288|FG002|Initial Treatment Phase|Protocol Violation|0|||
24912070|NCT00652626|50006289|FG003|Initial Treatment Phase|Protocol Violation|1|||
24912071|NCT00652626|50006290|FG004|Initial Treatment Phase|Protocol Violation|0|||
24912072|NCT00652626|50006291|FG005|Initial Treatment Phase|Protocol Violation|0|||
24912073|NCT00652626|50006292|FG006|Initial Treatment Phase|Protocol Violation|0|||
24912074|NCT00652626|50006286|FG000|Initial Treatment Phase|Physician Decision|0|||
25019983|NCT03488251|50116033|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
25019984|NCT03488251|50116034|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
25019985|NCT03488251|50116035|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
24912075|NCT00652626|50006287|FG001|Initial Treatment Phase|Physician Decision|0|||
24912076|NCT00652626|50006288|FG002|Initial Treatment Phase|Physician Decision|0|||
24912077|NCT00652626|50006289|FG003|Initial Treatment Phase|Physician Decision|0|||
24912078|NCT00652626|50006290|FG004|Initial Treatment Phase|Physician Decision|1|||
24912079|NCT00652626|50006291|FG005|Initial Treatment Phase|Physician Decision|0|||
24912080|NCT00652626|50006292|FG006|Initial Treatment Phase|Physician Decision|0|||
24912081|NCT00652626|50006286|FG000|Initial Treatment Phase|Sponsor Request|0|||
24912082|NCT00652626|50006287|FG001|Initial Treatment Phase|Sponsor Request|0|||
24912083|NCT00652626|50006288|FG002|Initial Treatment Phase|Sponsor Request|1|||
24912084|NCT00652626|50006289|FG003|Initial Treatment Phase|Sponsor Request|0|||
24912085|NCT00652626|50006290|FG004|Initial Treatment Phase|Sponsor Request|0|||
25153110|NCT01556763|50268265|FG002|Overall Study|Withdrawal by Subject|0|||
25019986|NCT03488251|50116032|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
25019987|NCT03488251|50116033|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
25019988|NCT03488251|50116034|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
25019989|NCT03488251|50116035|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
25019990|NCT03488251|50116032|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
25153111|NCT01576575|50268275|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
25019991|NCT03488251|50116033|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
25019992|NCT03488251|50116034|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
25019993|NCT03488251|50116035|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
25019994|NCT03488251|50116032|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
25019995|NCT03488251|50116033|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
25019996|NCT03488251|50116034|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
25019997|NCT03488251|50116035|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
25019998|NCT03488251|50116032|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
25019999|NCT03488251|50116033|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
25020000|NCT03488251|50116034|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
25020001|NCT03488251|50116035|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
25020002|NCT02727322|50116048|FG000|Overall Study|Withdrawal by Subject|1|||
25020003|NCT02727322|50116049|FG001|Overall Study|Withdrawal by Subject|1|||
25020004|NCT02727322|50116048|FG000|Overall Study|Protocol Violation|1|||
25020005|NCT02727322|50116049|FG001|Overall Study|Protocol Violation|0|||
25020006|NCT03431857|50116059|FG000|Overall Study|Death|6|||
25020007|NCT03431857|50116059|FG000|Overall Study|Lost to Follow-up|41|||
25020008|NCT03431857|50116059|FG000|Overall Study|Adverse Event|6|||
25020009|NCT03431857|50116059|FG000|Overall Study|Withdrawal by Subject|1|||
25020010|NCT03487549|50116065|FG000|Overall Study|Protocol Violation|0|||
25020011|NCT03487549|50116066|FG001|Overall Study|Protocol Violation|1|||
25020012|NCT03487549|50116065|FG000|Overall Study|Lost to Follow-up|2|||
25020013|NCT03487549|50116066|FG001|Overall Study|Lost to Follow-up|1|||
25020014|NCT03487549|50116065|FG000|Overall Study|Withdrawal by Subject|2|||
25020015|NCT03487549|50116066|FG001|Overall Study|Withdrawal by Subject|0|||
25020016|NCT03464383|50116075|FG000|Overall Study|Lost to Follow-up|1|||
25020017|NCT03464383|50116076|FG001|Overall Study|Lost to Follow-up|0|||
25020018|NCT03464383|50116077|FG002|Overall Study|Lost to Follow-up|0|||
25020019|NCT03464383|50116075|FG000|Overall Study|Withdrawal by Subject|0|||
25020020|NCT03464383|50116076|FG001|Overall Study|Withdrawal by Subject|1|||
25020021|NCT03464383|50116077|FG002|Overall Study|Withdrawal by Subject|0|||
25020022|NCT01444092|50116086|FG000|Overall Study|Adverse Event|8|||
25020023|NCT01444092|50116086|FG000|Overall Study|Protocol Violation|1|||
25020024|NCT01444092|50116086|FG000|Overall Study|Withdrawal by Subject|1|||
25020025|NCT01444092|50116086|FG000|Overall Study|Other Eligibility criteria|7|||
25020026|NCT01265784|50116093|FG000|Overall Study|Lost to Follow-up|5|||
25020027|NCT01265784|50116094|FG001|Overall Study|Lost to Follow-up|3|||
25020028|NCT01265784|50116095|FG002|Overall Study|Lost to Follow-up|2|||
25020029|NCT01265784|50116093|FG000|Overall Study|Withdrawal by Subject|0|||
25020030|NCT01265784|50116094|FG001|Overall Study|Withdrawal by Subject|5|||
25020031|NCT01265784|50116095|FG002|Overall Study|Withdrawal by Subject|0|||
25020032|NCT01265784|50116093|FG000|Overall Study|Physician Decision|1|||
25020033|NCT01265784|50116094|FG001|Overall Study|Physician Decision|0|||
25020034|NCT01265784|50116095|FG002|Overall Study|Physician Decision|1|||
25020035|NCT01265784|50116093|FG000|Overall Study|Adverse Event|1|||
25020036|NCT01265784|50116094|FG001|Overall Study|Adverse Event|0|||
24912086|NCT00652626|50006291|FG005|Initial Treatment Phase|Sponsor Request|0|||
24912087|NCT00652626|50006292|FG006|Initial Treatment Phase|Sponsor Request|0|||
24912088|NCT00652626|50006286|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
25020037|NCT01265784|50116095|FG002|Overall Study|Adverse Event|0|||
25020038|NCT01265784|50116093|FG000|Overall Study|Death|3|||
25020039|NCT01265784|50116094|FG001|Overall Study|Death|0|||
25020040|NCT01265784|50116095|FG002|Overall Study|Death|0|||
25020041|NCT01265784|50116093|FG000|Overall Study|Protocol Violation|2|||
25020042|NCT01265784|50116094|FG001|Overall Study|Protocol Violation|0|||
24912089|NCT00652626|50006287|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
24912090|NCT00652626|50006288|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
24912091|NCT00652626|50006289|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
24912092|NCT00652626|50006290|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
24912093|NCT00652626|50006291|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
24912094|NCT00652626|50006292|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
24912095|NCT00652626|50006286|FG000|Extension Phase|Withdrawal by Subject|0|||
24912096|NCT00652626|50006287|FG001|Extension Phase|Withdrawal by Subject|0|||
24912097|NCT00652626|50006288|FG002|Extension Phase|Withdrawal by Subject|0|||
25184954|NCT01425359|50334039|FG001|Overall Study|Revascularization|1|||
24912098|NCT00652626|50006289|FG003|Extension Phase|Withdrawal by Subject|0|||
24912099|NCT00652626|50006290|FG004|Extension Phase|Withdrawal by Subject|0|||
24912100|NCT00652626|50006291|FG005|Extension Phase|Withdrawal by Subject|2|||
24912101|NCT00652626|50006292|FG006|Extension Phase|Withdrawal by Subject|0|||
24912102|NCT00652626|50006286|FG000|Extension Phase|Adverse Event|0|||
24912103|NCT00652626|50006287|FG001|Extension Phase|Adverse Event|0|||
24912104|NCT00652626|50006288|FG002|Extension Phase|Adverse Event|0|||
24912105|NCT00652626|50006289|FG003|Extension Phase|Adverse Event|0|||
24912106|NCT00652626|50006290|FG004|Extension Phase|Adverse Event|0|||
24912107|NCT00652626|50006291|FG005|Extension Phase|Adverse Event|2|||
24912108|NCT00652626|50006292|FG006|Extension Phase|Adverse Event|1|||
24912109|NCT00652626|50006286|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
24912110|NCT00652626|50006287|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
24912111|NCT00652626|50006288|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
24912112|NCT00652626|50006289|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
24912113|NCT00652626|50006290|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
24912114|NCT00652626|50006291|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
25020043|NCT01265784|50116095|FG002|Overall Study|Protocol Violation|0|||
25020044|NCT01265784|50116093|FG000|Overall Study|Incorrectly Randomized|0|||
25020045|NCT01265784|50116094|FG001|Overall Study|Incorrectly Randomized|0|||
25020046|NCT01265784|50116095|FG002|Overall Study|Incorrectly Randomized|1|||
25020047|NCT03156504|50116103|FG000|Overall Study|Withdrawal by Subject|1|||
25020048|NCT03159468|50116113|FG000|Overall Study|Withdrawal by Subject|0|||
25020049|NCT03159468|50116114|FG001|Overall Study|Withdrawal by Subject|0|||
25020050|NCT03159468|50116115|FG002|Overall Study|Withdrawal by Subject|3|||
25020051|NCT03159468|50116116|FG003|Overall Study|Withdrawal by Subject|0|||
25020052|NCT03159468|50116117|FG004|Overall Study|Withdrawal by Subject|0|||
25020053|NCT03159468|50116118|FG005|Overall Study|Withdrawal by Subject|0|||
25020054|NCT03430063|50116135|FG000|Overall Study|Adverse Event|0|||
24912115|NCT00652626|50006292|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
24912116|NCT00652626|50006286|FG000|Extension Phase|Physician Decision|0|||
24912117|NCT00652626|50006287|FG001|Extension Phase|Physician Decision|0|||
24912118|NCT00652626|50006288|FG002|Extension Phase|Physician Decision|0|||
24912119|NCT00652626|50006289|FG003|Extension Phase|Physician Decision|0|||
24912120|NCT00652626|50006290|FG004|Extension Phase|Physician Decision|0|||
24912121|NCT00652626|50006291|FG005|Extension Phase|Physician Decision|1|||
24912122|NCT00652626|50006292|FG006|Extension Phase|Physician Decision|1|||
24912123|NCT00652626|50006286|FG000|Extension Phase|Death|0|||
24912124|NCT00652626|50006287|FG001|Extension Phase|Death|0|||
24912125|NCT00652626|50006288|FG002|Extension Phase|Death|0|||
24912126|NCT00652626|50006289|FG003|Extension Phase|Death|0|||
24912127|NCT00652626|50006290|FG004|Extension Phase|Death|0|||
24912128|NCT00652626|50006291|FG005|Extension Phase|Death|1|||
24912129|NCT00652626|50006292|FG006|Extension Phase|Death|1|||
24912130|NCT00560703|50006312|FG000|Overall Study|Adverse Event|0|||
24912131|NCT00560703|50006313|FG001|Overall Study|Adverse Event|2|||
24912132|NCT00560703|50006312|FG000|Overall Study|Protocol Violation|0|||
24912133|NCT00560703|50006313|FG001|Overall Study|Protocol Violation|2|||
24912134|NCT00560703|50006312|FG000|Overall Study|Withdrawal by Subject|0|||
24912135|NCT00560703|50006313|FG001|Overall Study|Withdrawal by Subject|1|||
25020055|NCT03430063|50116136|FG001|Overall Study|Adverse Event|1|||
25020056|NCT03430063|50116137|FG002|Overall Study|Adverse Event|0|||
25020057|NCT03430063|50116135|FG000|Overall Study|Death|3|||
25020058|NCT03430063|50116136|FG001|Overall Study|Death|2|||
25020059|NCT03430063|50116137|FG002|Overall Study|Death|3|||
25020060|NCT03430063|50116135|FG000|Overall Study|Lost to Follow-up|0|||
24912136|NCT00560703|50006312|FG000|Overall Study|non-compliance|0|||
24912137|NCT00560703|50006313|FG001|Overall Study|non-compliance|1|||
24912138|NCT00308737|50006322|FG000|Overall Study|Adverse Event|104|||
24912139|NCT00308737|50006323|FG001|Overall Study|Adverse Event|9|||
25020061|NCT03430063|50116136|FG001|Overall Study|Lost to Follow-up|1|||
25020062|NCT03430063|50116137|FG002|Overall Study|Lost to Follow-up|0|||
25020063|NCT03430063|50116135|FG000|Overall Study|Withdrawal by Subject|0|||
25020064|NCT03430063|50116136|FG001|Overall Study|Withdrawal by Subject|0|||
24912140|NCT00308737|50006324|FG002|Overall Study|Adverse Event|0|||
24912141|NCT00308737|50006322|FG000|Overall Study|Death|4|||
24912142|NCT00308737|50006323|FG001|Overall Study|Death|3|||
24912143|NCT00308737|50006324|FG002|Overall Study|Death|0|||
24912144|NCT00308737|50006322|FG000|Overall Study|Lost to Follow-up|56|||
24912145|NCT00308737|50006323|FG001|Overall Study|Lost to Follow-up|80|||
24912146|NCT00308737|50006324|FG002|Overall Study|Lost to Follow-up|5|||
24912147|NCT00308737|50006322|FG000|Overall Study|Physician Decision|15|||
24912148|NCT00308737|50006323|FG001|Overall Study|Physician Decision|2|||
24912149|NCT00308737|50006324|FG002|Overall Study|Physician Decision|1|||
24912150|NCT00308737|50006322|FG000|Overall Study|Protocol Violation|34|||
24912151|NCT00308737|50006323|FG001|Overall Study|Protocol Violation|9|||
24912152|NCT00308737|50006324|FG002|Overall Study|Protocol Violation|5|||
24912153|NCT00308737|50006322|FG000|Overall Study|Withdrawal by Subject|218|||
24912154|NCT00308737|50006323|FG001|Overall Study|Withdrawal by Subject|166|||
24912155|NCT00308737|50006324|FG002|Overall Study|Withdrawal by Subject|18|||
24912156|NCT00308737|50006322|FG000|Overall Study|Various|32|||
24912157|NCT00308737|50006323|FG001|Overall Study|Various|20|||
24912158|NCT00308737|50006324|FG002|Overall Study|Various|8|||
24912159|NCT00655746|50006332|FG000|Overall Study|Withdrawal by Subject|1|||
24912160|NCT00338455|50006342|FG000|Overall Study|Death|2|||
24912161|NCT00338455|50006343|FG001|Overall Study|Death|1|||
24912162|NCT00338455|50006342|FG000|Overall Study|Physician Decision|1|||
24912163|NCT00338455|50006343|FG001|Overall Study|Physician Decision|0|||
24912164|NCT00651924|50006351|FG000|Overall Study|Withdrawal by PI|0|||
24912165|NCT00651924|50006352|FG001|Overall Study|Withdrawal by PI|2|||
24912166|NCT00651924|50006351|FG000|Overall Study|Withdrawal by Subject|0|||
24912167|NCT00651924|50006352|FG001|Overall Study|Withdrawal by Subject|5|||
24912168|NCT00678392|50006360|FG000|Overall Study|Adverse Event|0|||
24912169|NCT00678392|50006361|FG001|Overall Study|Adverse Event|6|||
25020065|NCT03430063|50116137|FG002|Overall Study|Withdrawal by Subject|1|||
25020066|NCT03430063|50116135|FG000|Overall Study|Withdrawal of consent|3|||
24912170|NCT00678392|50006360|FG000|Overall Study|Death|280|||
24912171|NCT00678392|50006361|FG001|Overall Study|Death|269|||
24912172|NCT00678392|50006360|FG000|Overall Study|Lost to Follow-up|15|||
24912173|NCT00678392|50006361|FG001|Overall Study|Lost to Follow-up|13|||
24912174|NCT00678392|50006360|FG000|Overall Study|Objective Progression or Relapse|3|||
24912175|NCT00678392|50006361|FG001|Overall Study|Objective Progression or Relapse|8|||
24912176|NCT00678392|50006360|FG000|Overall Study|Sponsor's Decision|1|||
24912177|NCT00678392|50006361|FG001|Overall Study|Sponsor's Decision|2|||
24912178|NCT00678392|50006360|FG000|Overall Study|Withdrawal by Subject|4|||
24912179|NCT00678392|50006361|FG001|Overall Study|Withdrawal by Subject|4|||
24912180|NCT00678392|50006360|FG000|Overall Study|Randomized But Not Treated|2|||
24912181|NCT00678392|50006361|FG001|Overall Study|Randomized But Not Treated|7|||
24912182|NCT00678392|50006360|FG000|Overall Study|Other|56|||
24912183|NCT00678392|50006361|FG001|Overall Study|Other|53|||
25020067|NCT03430063|50116136|FG001|Overall Study|Withdrawal of consent|1|||
25020068|NCT03430063|50116137|FG002|Overall Study|Withdrawal of consent|2|||
25020069|NCT03430063|50116135|FG000|Overall Study|Progressive disease|1|||
24912184|NCT00308581|50006367|FG000|Induction Phase|Adverse Event|0|||
24912185|NCT00308581|50006368|FG001|Induction Phase|Adverse Event|0|||
24912186|NCT00308581|50006369|FG002|Induction Phase|Adverse Event|37|||
24912187|NCT00308581|50006367|FG000|Induction Phase|Lack of Efficacy|0|||
24912188|NCT00308581|50006368|FG001|Induction Phase|Lack of Efficacy|0|||
24912189|NCT00308581|50006369|FG002|Induction Phase|Lack of Efficacy|121|||
24912190|NCT00308581|50006367|FG000|Induction Phase|Withdrawal by Subject|0|||
24912191|NCT00308581|50006368|FG001|Induction Phase|Withdrawal by Subject|0|||
24912192|NCT00308581|50006369|FG002|Induction Phase|Withdrawal by Subject|5|||
24912193|NCT00308581|50006367|FG000|Induction Phase|Unknown reason|0|||
24912194|NCT00308581|50006368|FG001|Induction Phase|Unknown reason|0|||
24912195|NCT00308581|50006369|FG002|Induction Phase|Unknown reason|3|||
24912196|NCT00308581|50006367|FG000|Randomized Maintenance Phase|Adverse Event|10|||
24912197|NCT00308581|50006368|FG001|Randomized Maintenance Phase|Adverse Event|17|||
24912198|NCT00308581|50006369|FG002|Randomized Maintenance Phase|Adverse Event|0|||
24912199|NCT00308581|50006367|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
24912200|NCT00308581|50006368|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
24912201|NCT00308581|50006369|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
24912202|NCT00308581|50006367|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
24912203|NCT00308581|50006368|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
24912204|NCT00308581|50006369|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
24912205|NCT00308581|50006367|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
24912206|NCT00308581|50006368|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
24912207|NCT00308581|50006369|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
24912208|NCT00308581|50006367|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
24912209|NCT00308581|50006368|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
24912210|NCT00308581|50006369|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
24912211|NCT00308581|50006367|FG000|Randomized Maintenance Phase|Unknown reason|3|||
24912212|NCT00308581|50006368|FG001|Randomized Maintenance Phase|Unknown reason|0|||
24912213|NCT00308581|50006369|FG002|Randomized Maintenance Phase|Unknown reason|0|||
25020070|NCT03430063|50116136|FG001|Overall Study|Progressive disease|2|||
25020071|NCT03430063|50116137|FG002|Overall Study|Progressive disease|1|||
24912214|NCT00678080|50006379|FG000|Overall Study|Physician Decision|2|||
24912215|NCT00678080|50006380|FG001|Overall Study|Physician Decision|0|||
24912216|NCT00678080|50006379|FG000|Overall Study|Lost to Follow-up|1|||
24912217|NCT00678080|50006380|FG001|Overall Study|Lost to Follow-up|0|||
24912218|NCT00678080|50006379|FG000|Overall Study|Withdrawal by Subject|0|||
24912219|NCT00678080|50006380|FG001|Overall Study|Withdrawal by Subject|1|||
24912220|NCT00658320|50006388|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
24912221|NCT00658320|50006389|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
24912222|NCT00658320|50006388|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
24912223|NCT00658320|50006389|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
24912224|NCT00658320|50006388|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
24912225|NCT00658320|50006389|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
24912226|NCT00658320|50006388|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
24912227|NCT00658320|50006389|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
24912228|NCT00322153|50006399|FG000|Overall Study|Adverse Event|21|||
24912229|NCT00322153|50006400|FG001|Overall Study|Adverse Event|34|||
24912230|NCT00322153|50006399|FG000|Overall Study|Protocol Violation|6|||
24912231|NCT00322153|50006400|FG001|Overall Study|Protocol Violation|14|||
24912232|NCT00322153|50006399|FG000|Overall Study|Withdrawal by Subject|18|||
24912233|NCT00322153|50006400|FG001|Overall Study|Withdrawal by Subject|10|||
24912234|NCT00322153|50006399|FG000|Overall Study|Lack of Efficacy|8|||
24912235|NCT00322153|50006400|FG001|Overall Study|Lack of Efficacy|3|||
24912236|NCT00322153|50006399|FG000|Overall Study|Lost to Follow-up|5|||
24912237|NCT00322153|50006400|FG001|Overall Study|Lost to Follow-up|4|||
24912238|NCT00322153|50006399|FG000|Overall Study|Withdrawn for other reasons|5|||
24912239|NCT00322153|50006400|FG001|Overall Study|Withdrawn for other reasons|4|||
24912240|NCT00657618|50006406|FG000|Overall Study|Adverse Event|32|||
24912241|NCT00657618|50006406|FG000|Overall Study|Withdrawal by Subject|8|||
24912242|NCT00657618|50006406|FG000|Overall Study|negative for leishmaniasis|2|||
24912243|NCT00657618|50006406|FG000|Overall Study|didn't start due to schedule conflicts|1|||
24912244|NCT00657540|50006412|FG000|Overall Study|Lost to Follow-up|1|||
24912245|NCT00657540|50006413|FG001|Overall Study|Lost to Follow-up|4|||
24912246|NCT00672620|50006423|FG000|Overall Study|Adverse Event|7|||
24912247|NCT00672620|50006424|FG001|Overall Study|Adverse Event|7|||
24912248|NCT00672620|50006425|FG002|Overall Study|Adverse Event|12|||
24912249|NCT00672620|50006426|FG003|Overall Study|Adverse Event|17|||
24912250|NCT00672620|50006423|FG000|Overall Study|Lack of Efficacy|1|||
24912251|NCT00672620|50006424|FG001|Overall Study|Lack of Efficacy|2|||
24912252|NCT00672620|50006425|FG002|Overall Study|Lack of Efficacy|2|||
24912253|NCT00672620|50006426|FG003|Overall Study|Lack of Efficacy|0|||
24912254|NCT00672620|50006423|FG000|Overall Study|Noncompliance with Study Drug|3|||
24912255|NCT00672620|50006424|FG001|Overall Study|Noncompliance with Study Drug|4|||
24912256|NCT00672620|50006425|FG002|Overall Study|Noncompliance with Study Drug|0|||
24912257|NCT00672620|50006426|FG003|Overall Study|Noncompliance with Study Drug|2|||
24912258|NCT00672620|50006423|FG000|Overall Study|Protocol Deviations|5|||
24912259|NCT00672620|50006424|FG001|Overall Study|Protocol Deviations|7|||
24912260|NCT00672620|50006425|FG002|Overall Study|Protocol Deviations|2|||
24912261|NCT00672620|50006426|FG003|Overall Study|Protocol Deviations|5|||
24912262|NCT00672620|50006423|FG000|Overall Study|Withdrawal of Consent|6|||
24912263|NCT00672620|50006424|FG001|Overall Study|Withdrawal of Consent|12|||
24912264|NCT00672620|50006425|FG002|Overall Study|Withdrawal of Consent|5|||
24912265|NCT00672620|50006426|FG003|Overall Study|Withdrawal of Consent|6|||
24912266|NCT00672620|50006423|FG000|Overall Study|Lost to Follow-up|8|||
24912267|NCT00672620|50006424|FG001|Overall Study|Lost to Follow-up|19|||
24912268|NCT00672620|50006425|FG002|Overall Study|Lost to Follow-up|8|||
24912269|NCT00672620|50006426|FG003|Overall Study|Lost to Follow-up|11|||
25184955|NCT01425359|50334038|FG000|Overall Study|Death|0|||
24912270|NCT00672620|50006423|FG000|Overall Study|Reason not Specified|3|||
24912271|NCT00672620|50006424|FG001|Overall Study|Reason not Specified|3|||
24912272|NCT00672620|50006425|FG002|Overall Study|Reason not Specified|2|||
24912273|NCT00672620|50006426|FG003|Overall Study|Reason not Specified|1|||
24912274|NCT00673790|50006439|FG000|Overall Study|Adverse Event|23|||
24912275|NCT00673790|50006440|FG001|Overall Study|Adverse Event|14|||
24912276|NCT00673790|50006441|FG002|Overall Study|Adverse Event|2|||
24912277|NCT00673790|50006439|FG000|Overall Study|Lack of Efficacy|2|||
24912278|NCT00673790|50006440|FG001|Overall Study|Lack of Efficacy|2|||
24912279|NCT00673790|50006441|FG002|Overall Study|Lack of Efficacy|2|||
24912280|NCT00673790|50006439|FG000|Overall Study|Protocol Violation|6|||
24912281|NCT00673790|50006440|FG001|Overall Study|Protocol Violation|9|||
24912282|NCT00673790|50006441|FG002|Overall Study|Protocol Violation|1|||
24912283|NCT00673790|50006439|FG000|Overall Study|Withdrawal by Subject|7|||
24912284|NCT00673790|50006440|FG001|Overall Study|Withdrawal by Subject|4|||
24912285|NCT00673790|50006441|FG002|Overall Study|Withdrawal by Subject|1|||
24912286|NCT00673790|50006439|FG000|Overall Study|Lost to Follow-up|6|||
24912287|NCT00673790|50006440|FG001|Overall Study|Lost to Follow-up|6|||
24912288|NCT00673790|50006441|FG002|Overall Study|Lost to Follow-up|5|||
25184956|NCT01425359|50334039|FG001|Overall Study|Death|1|||
24912289|NCT00673790|50006439|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
24912290|NCT00673790|50006440|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
24912291|NCT00673790|50006441|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
24912292|NCT00673790|50006439|FG000|Overall Study|Poor compliance|1|||
24912293|NCT00673790|50006440|FG001|Overall Study|Poor compliance|0|||
24912294|NCT00673790|50006441|FG002|Overall Study|Poor compliance|0|||
24912295|NCT00673790|50006439|FG000|Overall Study|Participated in two Nebivolol studies|0|||
24912296|NCT00673790|50006440|FG001|Overall Study|Participated in two Nebivolol studies|0|||
24912297|NCT00673790|50006441|FG002|Overall Study|Participated in two Nebivolol studies|1|||
24912298|NCT00673790|50006439|FG000|Overall Study|Unconfirmed pregnancy|0|||
24912299|NCT00673790|50006440|FG001|Overall Study|Unconfirmed pregnancy|1|||
24912300|NCT00673790|50006441|FG002|Overall Study|Unconfirmed pregnancy|0|||
24912301|NCT00673790|50006439|FG000|Overall Study|Randomization criteria not met|0|||
24912302|NCT00673790|50006440|FG001|Overall Study|Randomization criteria not met|1|||
24912303|NCT00673790|50006441|FG002|Overall Study|Randomization criteria not met|0|||
24912304|NCT00657150|50006452|FG000|Overall Study|Adverse Event|19|||
24912305|NCT00657150|50006453|FG001|Overall Study|Adverse Event|10|||
24912306|NCT00657150|50006452|FG000|Overall Study|Non-compliant with protocol|5|||
24912307|NCT00657150|50006453|FG001|Overall Study|Non-compliant with protocol|9|||
24912308|NCT00657150|50006452|FG000|Overall Study|Lost to Follow-up|2|||
24912309|NCT00657150|50006453|FG001|Overall Study|Lost to Follow-up|0|||
24912310|NCT00657150|50006452|FG000|Overall Study|Withdrawal by Subject|51|||
24912311|NCT00657150|50006453|FG001|Overall Study|Withdrawal by Subject|36|||
24912312|NCT00657150|50006452|FG000|Overall Study|Other|38|||
24912313|NCT00657150|50006453|FG001|Overall Study|Other|38|||
24912314|NCT00657150|50006452|FG000|Treatment|Adverse Event|60|||
24912315|NCT00657150|50006453|FG001|Treatment|Adverse Event|53|||
24912316|NCT00657150|50006452|FG000|Treatment|Non-compliant with protocol|10|||
24912317|NCT00657150|50006453|FG001|Treatment|Non-compliant with protocol|9|||
24912318|NCT00657150|50006452|FG000|Treatment|Lost to Follow-up|1|||
24912319|NCT00657150|50006453|FG001|Treatment|Lost to Follow-up|0|||
24912320|NCT00657150|50006452|FG000|Treatment|Withdrawal by Subject|23|||
24912321|NCT00657150|50006453|FG001|Treatment|Withdrawal by Subject|20|||
24912322|NCT00657150|50006452|FG000|Treatment|Other|13|||
24912323|NCT00657150|50006453|FG001|Treatment|Other|15|||
24912324|NCT00670748|50006463|FG000|Overall Study|Death during treatment|1|||
24912325|NCT00670748|50006464|FG001|Overall Study|Death during treatment|1|||
24912326|NCT00670748|50006465|FG002|Overall Study|Death during treatment|1|||
24912327|NCT00670748|50006466|FG003|Overall Study|Death during treatment|0|||
24912328|NCT00670748|50006463|FG000|Overall Study|Not off study|2|||
24912329|NCT00670748|50006464|FG001|Overall Study|Not off study|1|||
24912330|NCT00670748|50006465|FG002|Overall Study|Not off study|1|||
24912331|NCT00670748|50006466|FG003|Overall Study|Not off study|1|||
24912332|NCT00646776|50006478|FG000|Overall Study|Adverse Event|1|||
24912333|NCT00646776|50006479|FG001|Overall Study|Adverse Event|9|||
24912334|NCT00646776|50006478|FG000|Overall Study|Investigator discretion|0|||
24912335|NCT00646776|50006479|FG001|Overall Study|Investigator discretion|4|||
24912336|NCT00655668|50006488|FG000|Overall Study|Adverse Event|6|||
24912337|NCT00655668|50006488|FG000|Overall Study|Death|5|||
24912338|NCT00655668|50006488|FG000|Overall Study|Disease Progression|27|||
24912339|NCT00655668|50006488|FG000|Overall Study|Study Terminated|9|||
24912340|NCT00655668|50006488|FG000|Overall Study|Other|1|||
24912341|NCT00655668|50006488|FG000|Overall Study|New Lymphoma Treatment Started|4|||
24912342|NCT00655668|50006488|FG000|Overall Study|Withdrawal by Subject|2|||
24912343|NCT00569166|50006495|FG000|Overall Study|Withdrawal by Subject|7|||
24912344|NCT00569166|50006496|FG001|Overall Study|Withdrawal by Subject|5|||
24912345|NCT00569166|50006497|FG002|Overall Study|Withdrawal by Subject|3|||
24912346|NCT00569166|50006495|FG000|Overall Study|Lost to Follow-up|2|||
24912347|NCT00569166|50006496|FG001|Overall Study|Lost to Follow-up|1|||
24912348|NCT00569166|50006497|FG002|Overall Study|Lost to Follow-up|1|||
24912349|NCT00655356|50006507|FG000|Overall Study|Withdrawal by Subject|3|||
24912350|NCT00655356|50006508|FG001|Overall Study|Withdrawal by Subject|4|||
24912351|NCT00655356|50006507|FG000|Overall Study|Sponsor Request|10|||
24912352|NCT00655356|50006508|FG001|Overall Study|Sponsor Request|4|||
24912353|NCT00655356|50006507|FG000|Overall Study|Adverse Event|1|||
24912354|NCT00655356|50006508|FG001|Overall Study|Adverse Event|1|||
24912355|NCT00655356|50006507|FG000|Overall Study|Protocol Violation|2|||
24912356|NCT00655356|50006508|FG001|Overall Study|Protocol Violation|1|||
24912357|NCT00655356|50006507|FG000|Overall Study|Other Reason|1|||
24912358|NCT00655356|50006508|FG001|Overall Study|Other Reason|0|||
24912359|NCT00571064|50006514|FG000|Overall Study|Adverse Event|13|||
24912360|NCT00571064|50006514|FG000|Overall Study|Protocol Violation|4|||
24912361|NCT00571064|50006514|FG000|Overall Study|Withdrawal by Subject|2|||
24912362|NCT00571064|50006514|FG000|Overall Study|Other|2|||
24912363|NCT03895372|50006527|FG000|Investigational Treatment Period|Adverse Event|1|||
24912364|NCT03895372|50006528|FG001|Investigational Treatment Period|Adverse Event|0|||
24912365|NCT03895372|50006529|FG002|Investigational Treatment Period|Adverse Event|0|||
24912366|NCT03895372|50006530|FG003|Investigational Treatment Period|Adverse Event|0|||
24912367|NCT03895372|50006531|FG004|Investigational Treatment Period|Adverse Event|0|||
24912368|NCT03895372|50006532|FG005|Investigational Treatment Period|Adverse Event|0|||
24912369|NCT03895372|50006533|FG006|Investigational Treatment Period|Adverse Event|4|||
24912370|NCT03895372|50006534|FG007|Investigational Treatment Period|Adverse Event|3|||
24912371|NCT03895372|50006527|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
24912372|NCT03895372|50006528|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
24912373|NCT03895372|50006529|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
24912374|NCT03895372|50006530|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
24912375|NCT03895372|50006531|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
24912376|NCT03895372|50006532|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
24912377|NCT03895372|50006533|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
24912378|NCT03895372|50006534|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
24912379|NCT03895372|50006527|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
24912380|NCT03895372|50006528|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
24912381|NCT03895372|50006529|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
24912382|NCT03895372|50006530|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
24912383|NCT03895372|50006531|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
24912384|NCT03895372|50006532|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
24912385|NCT03895372|50006533|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
24912386|NCT03895372|50006534|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
24912387|NCT03895372|50006527|FG000|Investigational Treatment Period|Other|0|||
24912388|NCT03895372|50006528|FG001|Investigational Treatment Period|Other|0|||
24912389|NCT03895372|50006529|FG002|Investigational Treatment Period|Other|0|||
24912390|NCT03895372|50006530|FG003|Investigational Treatment Period|Other|0|||
24912391|NCT03895372|50006531|FG004|Investigational Treatment Period|Other|0|||
24912392|NCT03895372|50006532|FG005|Investigational Treatment Period|Other|1|||
24912393|NCT03895372|50006533|FG006|Investigational Treatment Period|Other|0|||
24912394|NCT03895372|50006534|FG007|Investigational Treatment Period|Other|2|||
24912395|NCT03895372|50006527|FG000|Investigational Treatment Period|Protocol Violation|0|||
24912396|NCT03895372|50006528|FG001|Investigational Treatment Period|Protocol Violation|0|||
24912397|NCT03895372|50006529|FG002|Investigational Treatment Period|Protocol Violation|0|||
24912398|NCT03895372|50006530|FG003|Investigational Treatment Period|Protocol Violation|1|||
24912399|NCT03895372|50006531|FG004|Investigational Treatment Period|Protocol Violation|0|||
24912400|NCT03895372|50006532|FG005|Investigational Treatment Period|Protocol Violation|0|||
24912401|NCT03895372|50006533|FG006|Investigational Treatment Period|Protocol Violation|0|||
24912402|NCT03895372|50006534|FG007|Investigational Treatment Period|Protocol Violation|0|||
24912403|NCT03895372|50006527|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
24912404|NCT03895372|50006528|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
24912405|NCT03895372|50006529|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
25020072|NCT03430063|50116135|FG000|Overall Study|Other un-specified|1|||
25020073|NCT03430063|50116136|FG001|Overall Study|Other un-specified|1|||
25020074|NCT03430063|50116137|FG002|Overall Study|Other un-specified|0|||
25020075|NCT03430063|50116135|FG000|Overall Study|Randomized, but never treated|0|||
25020076|NCT03430063|50116136|FG001|Overall Study|Randomized, but never treated|0|||
25020077|NCT03430063|50116137|FG002|Overall Study|Randomized, but never treated|1|||
25020078|NCT03158220|50116148|FG000|Overall Study|Screen Failure|0|||
25020079|NCT03158220|50116149|FG001|Overall Study|Screen Failure|1|||
25020080|NCT03158220|50116148|FG000|Overall Study|Withdrawal by Subject|8|||
25020081|NCT03158220|50116149|FG001|Overall Study|Withdrawal by Subject|9|||
25020082|NCT03158220|50116148|FG000|Overall Study|Status unknown|0|||
25020083|NCT03158220|50116149|FG001|Overall Study|Status unknown|1|||
25020084|NCT03158220|50116148|FG000|Overall Study|Lost to Follow-up|8|||
25020085|NCT03158220|50116149|FG001|Overall Study|Lost to Follow-up|5|||
25020086|NCT03158220|50116148|FG000|Overall Study|Physician Decision|1|||
25020087|NCT03158220|50116149|FG001|Overall Study|Physician Decision|0|||
24912406|NCT03895372|50006530|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
24912407|NCT03895372|50006531|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
24912408|NCT03895372|50006532|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
24912409|NCT03895372|50006533|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
24912410|NCT03895372|50006534|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
25020088|NCT03156270|50116155|FG000|Overall Study|Failed pre-treatment screening|1|||
25020089|NCT03156270|50116155|FG000|Overall Study|Lost to Follow-up|1|||
25020090|NCT03429049|50116163|FG000|Overall Study|Adverse Event|2|||
25020091|NCT03429049|50116164|FG001|Overall Study|Adverse Event|3|||
25020092|NCT03429049|50116163|FG000|Overall Study|Death|0|||
25020093|NCT03429049|50116164|FG001|Overall Study|Death|1|||
25153112|NCT01576575|50268275|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
24912411|NCT03895372|50006527|FG000|Extension Treatment Period|Adverse Event|0|||
24912412|NCT03895372|50006528|FG001|Extension Treatment Period|Adverse Event|1|||
24912413|NCT03895372|50006529|FG002|Extension Treatment Period|Adverse Event|0|||
25020094|NCT03429049|50116163|FG000|Overall Study|Lack of Efficacy|4|||
25020095|NCT03429049|50116164|FG001|Overall Study|Lack of Efficacy|2|||
25020096|NCT03429049|50116163|FG000|Overall Study|Lost to Follow-up|9|||
25020097|NCT03429049|50116164|FG001|Overall Study|Lost to Follow-up|8|||
25020098|NCT03429049|50116163|FG000|Overall Study|Physician Decision|1|||
25020099|NCT03429049|50116164|FG001|Overall Study|Physician Decision|0|||
25020100|NCT03429049|50116163|FG000|Overall Study|Protocol Violation|3|||
25020101|NCT03429049|50116164|FG001|Overall Study|Protocol Violation|0|||
25020102|NCT03429049|50116163|FG000|Overall Study|Sponsor Decision|2|||
25020103|NCT03429049|50116164|FG001|Overall Study|Sponsor Decision|0|||
25020104|NCT03429049|50116163|FG000|Overall Study|Withdrawal by Subject|4|||
25020105|NCT03429049|50116164|FG001|Overall Study|Withdrawal by Subject|20|||
25020106|NCT03429049|50116163|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
25020107|NCT03429049|50116164|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
25020108|NCT03428815|50116172|FG000|Overall Study|Lost to Follow-up|2|||
25020109|NCT03428815|50116173|FG001|Overall Study|Lost to Follow-up|2|||
25020110|NCT03428815|50116172|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
25020111|NCT03428815|50116173|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
25020112|NCT03428815|50116172|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
25020113|NCT03428815|50116173|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
25020114|NCT03155724|50116179|FG000|Overall Study|Death|3|||
25020115|NCT03155724|50116179|FG000|Overall Study|Physician Decision|1|||
25020116|NCT03155724|50116179|FG000|Overall Study|Study closure|7|||
25020117|NCT03426787|50116183|FG000|Overall Study|Withdrawal by Subject|6|||
25020118|NCT03426787|50116183|FG000|Overall Study|Lost to Follow-up|7|||
25020119|NCT03426787|50116183|FG000|Overall Study|Unrelated to intervention death|1|||
25020120|NCT03426631|50116193|FG000|Overall Study|Lost to Follow-up|0|||
25020121|NCT03426631|50116194|FG001|Overall Study|Lost to Follow-up|1|||
25020122|NCT03484429|50116202|FG000|Overall Study|Withdrawal by Subject|1|||
24912414|NCT03895372|50006530|FG003|Extension Treatment Period|Adverse Event|1|||
24912415|NCT03895372|50006531|FG004|Extension Treatment Period|Adverse Event|0|||
24912416|NCT03895372|50006532|FG005|Extension Treatment Period|Adverse Event|0|||
24912417|NCT03895372|50006533|FG006|Extension Treatment Period|Adverse Event|3|||
24912418|NCT03895372|50006534|FG007|Extension Treatment Period|Adverse Event|3|||
24912419|NCT03895372|50006527|FG000|Extension Treatment Period|Other|1|||
24912420|NCT03895372|50006528|FG001|Extension Treatment Period|Other|3|||
24912421|NCT03895372|50006529|FG002|Extension Treatment Period|Other|0|||
24912422|NCT03895372|50006530|FG003|Extension Treatment Period|Other|0|||
24912423|NCT03895372|50006531|FG004|Extension Treatment Period|Other|1|||
24912424|NCT03895372|50006532|FG005|Extension Treatment Period|Other|0|||
24912425|NCT03895372|50006533|FG006|Extension Treatment Period|Other|0|||
24912426|NCT03895372|50006534|FG007|Extension Treatment Period|Other|2|||
24912427|NCT03895372|50006527|FG000|Extension Treatment Period|Pregnancy|0|||
24912428|NCT03895372|50006528|FG001|Extension Treatment Period|Pregnancy|0|||
24912429|NCT03895372|50006529|FG002|Extension Treatment Period|Pregnancy|0|||
24912430|NCT03895372|50006530|FG003|Extension Treatment Period|Pregnancy|0|||
24912431|NCT03895372|50006531|FG004|Extension Treatment Period|Pregnancy|1|||
24912432|NCT03895372|50006532|FG005|Extension Treatment Period|Pregnancy|0|||
24912433|NCT03895372|50006533|FG006|Extension Treatment Period|Pregnancy|0|||
24912434|NCT03895372|50006534|FG007|Extension Treatment Period|Pregnancy|0|||
24912435|NCT03895372|50006527|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
24912436|NCT03895372|50006528|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
24912437|NCT03895372|50006529|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
24912438|NCT03895372|50006530|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
24912439|NCT03895372|50006531|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
24912440|NCT03895372|50006532|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
24912441|NCT03895372|50006533|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
24912442|NCT03895372|50006534|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
24912443|NCT00669110|50006559|FG000|Overall Study|Adverse Event|4|||
24912444|NCT00669110|50006560|FG001|Overall Study|Adverse Event|3|||
25153113|NCT01576575|50268275|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
25153114|NCT01555983|50268285|FG000|Overall Study|Withdrawal by Subject|1|||
25184957|NCT01425359|50334038|FG000|Overall Study|Unsatisfactory Response|1|||
25184958|NCT01425359|50334039|FG001|Overall Study|Unsatisfactory Response|0|||
25153115|NCT01555983|50268286|FG001|Overall Study|Withdrawal by Subject|0|||
25153116|NCT01555983|50268287|FG002|Overall Study|Withdrawal by Subject|0|||
25153117|NCT01555983|50268288|FG003|Overall Study|Withdrawal by Subject|0|||
25153118|NCT01555983|50268289|FG004|Overall Study|Withdrawal by Subject|1|||
25153119|NCT01555983|50268290|FG005|Overall Study|Withdrawal by Subject|1|||
25153120|NCT01576341|50268298|FG000|Overall Study|Withdrawal by Subject|24|||
25153121|NCT01576341|50268298|FG000|Overall Study|Adverse Event|10|||
25153122|NCT01576341|50268298|FG000|Overall Study|Death|21|||
25153123|NCT01576341|50268298|FG000|Overall Study|Physician Decision|2|||
25153124|NCT01576341|50268298|FG000|Overall Study|Lost to Follow-up|2|||
25153125|NCT01576341|50268298|FG000|Overall Study|Kidney transplantation|10|||
25153126|NCT01576341|50268298|FG000|Overall Study|Protocol Violation|12|||
25153127|NCT01576341|50268298|FG000|Overall Study|Other|12|||
25153128|NCT04276090|50268307|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
25153129|NCT04276090|50268308|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
25153130|NCT01892722|50268316|FG000|Overall Study|Protocol deviation|0|||
25153131|NCT01892722|50268317|FG001|Overall Study|Protocol deviation|1|||
25153132|NCT01892722|50268316|FG000|Overall Study|Administrative problems|0|||
25153133|NCT01892722|50268317|FG001|Overall Study|Administrative problems|1|||
25153134|NCT01892722|50268316|FG000|Overall Study|Patient/guardian decision|0|||
25153135|NCT01892722|50268317|FG001|Overall Study|Patient/guardian decision|2|||
25153136|NCT01892722|50268316|FG000|Overall Study|Physician Decision|1|||
25153137|NCT01892722|50268317|FG001|Overall Study|Physician Decision|2|||
25153138|NCT01892722|50268316|FG000|Overall Study|Adverse Event|3|||
25153139|NCT01892722|50268317|FG001|Overall Study|Adverse Event|2|||
25153140|NCT01892722|50268316|FG000|Overall Study|Lack of Efficacy|0|||
25153141|NCT01892722|50268317|FG001|Overall Study|Lack of Efficacy|7|||
25184959|NCT01425359|50334038|FG000|Overall Study|Protocol Violation|1|||
25184960|NCT01425359|50334039|FG001|Overall Study|Protocol Violation|2|||
24912445|NCT00669110|50006559|FG000|Overall Study|Caregiver request|3|||
24912446|NCT00669110|50006560|FG001|Overall Study|Caregiver request|2|||
24912447|NCT00669110|50006559|FG000|Overall Study|Physician Decision|0|||
24912448|NCT00669110|50006560|FG001|Overall Study|Physician Decision|1|||
24912449|NCT00669110|50006559|FG000|Overall Study|Lost to Follow-up|1|||
24912450|NCT00669110|50006560|FG001|Overall Study|Lost to Follow-up|0|||
25153142|NCT01892722|50268316|FG000|Overall Study|Withdrawal by Subject|3|||
25153143|NCT01892722|50268317|FG001|Overall Study|Withdrawal by Subject|5|||
25153144|NCT01687413|50268334|FG000|Overall Study|Withdrawal by Subject|0|||
25153145|NCT01687413|50268335|FG001|Overall Study|Withdrawal by Subject|2|||
25153146|NCT01687413|50268334|FG000|Overall Study|Not eligible|0|||
25184961|NCT01425359|50334038|FG000|Overall Study|Subject Withdrew Consent|1|||
24912451|NCT00669110|50006559|FG000|Overall Study|Protocol Violation|0|||
24912452|NCT00669110|50006560|FG001|Overall Study|Protocol Violation|5|||
24912453|NCT00669110|50006559|FG000|Overall Study|Withdrawal by Subject|0|||
24912454|NCT00669110|50006560|FG001|Overall Study|Withdrawal by Subject|2|||
24912455|NCT00654732|50006568|FG000|Overall Study|Adverse Event|4|||
24912456|NCT00654732|50006569|FG001|Overall Study|Adverse Event|6|||
24912457|NCT00649428|50006577|FG000|Overall Study|Adverse Event|2|||
24912458|NCT00649428|50006578|FG001|Overall Study|Adverse Event|2|||
24912459|NCT00649428|50006577|FG000|Overall Study|Withdrawal by Subject|6|||
24912460|NCT00649428|50006578|FG001|Overall Study|Withdrawal by Subject|6|||
24912461|NCT00649428|50006577|FG000|Overall Study|Lost to Follow-up|1|||
24912462|NCT00649428|50006578|FG001|Overall Study|Lost to Follow-up|3|||
24912463|NCT00649428|50006577|FG000|Overall Study|Insufficient manufacturing yield|5|||
25020123|NCT03484429|50116203|FG001|Overall Study|Withdrawal by Subject|0|||
24912464|NCT00649428|50006578|FG001|Overall Study|Insufficient manufacturing yield|1|||
24912465|NCT00649428|50006577|FG000|Overall Study|Protocol Violation|6|||
24912466|NCT00649428|50006578|FG001|Overall Study|Protocol Violation|2|||
24912467|NCT00649428|50006577|FG000|Overall Study|Physician Decision|0|||
24912468|NCT00649428|50006578|FG001|Overall Study|Physician Decision|1|||
24912469|NCT00669032|50006587|FG000|Overall Study|Lost to Follow-up|6|||
24912470|NCT00669032|50006588|FG001|Overall Study|Lost to Follow-up|5|||
24912471|NCT00669032|50006587|FG000|Overall Study|Lack of Efficacy|8|||
24912472|NCT00669032|50006588|FG001|Overall Study|Lack of Efficacy|19|||
24912473|NCT00669032|50006587|FG000|Overall Study|Withdrawal by Subject|12|||
24912474|NCT00669032|50006588|FG001|Overall Study|Withdrawal by Subject|13|||
24912475|NCT00669032|50006587|FG000|Overall Study|Adverse Event|12|||
24912476|NCT00669032|50006588|FG001|Overall Study|Adverse Event|16|||
24912477|NCT00669032|50006587|FG000|Overall Study|Physician Decision|1|||
24912478|NCT00669032|50006588|FG001|Overall Study|Physician Decision|1|||
24912479|NCT00669032|50006587|FG000|Overall Study|No fulfilment of the selection criteria|5|||
24912480|NCT00669032|50006588|FG001|Overall Study|No fulfilment of the selection criteria|5|||
24912481|NCT00654498|50006596|FG000|Overall Study|Not Treated|1|||
24912482|NCT00654498|50006597|FG001|Overall Study|Not Treated|0|||
24912483|NCT00654498|50006596|FG000|Overall Study|Adverse Event|6|||
24912484|NCT00654498|50006597|FG001|Overall Study|Adverse Event|1|||
24912485|NCT00654498|50006596|FG000|Overall Study|Protocol Violation|1|||
24912486|NCT00654498|50006597|FG001|Overall Study|Protocol Violation|1|||
24912487|NCT00654498|50006596|FG000|Overall Study|Lost to Follow-up|1|||
24912488|NCT00654498|50006597|FG001|Overall Study|Lost to Follow-up|5|||
24912489|NCT00654498|50006596|FG000|Overall Study|Withdrawal by Subject|1|||
24912490|NCT00654498|50006597|FG001|Overall Study|Withdrawal by Subject|0|||
24912491|NCT00654498|50006596|FG000|Overall Study|Other reason not defined above|4|||
24912492|NCT00654498|50006597|FG001|Overall Study|Other reason not defined above|5|||
24912493|NCT00670046|50006605|FG000|Overall Study|Lost to Follow-up|1|||
24912494|NCT00670046|50006606|FG001|Overall Study|Lost to Follow-up|1|||
24912495|NCT00670046|50006605|FG000|Overall Study|Withdrawal by Subject|0|||
24912496|NCT00670046|50006606|FG001|Overall Study|Withdrawal by Subject|1|||
24912497|NCT00560391|50006617|FG000|Overall Study|Still on treatment|0|||
24912498|NCT00560391|50006618|FG001|Overall Study|Still on treatment|0|||
24912499|NCT00560391|50006619|FG002|Overall Study|Still on treatment|0|||
24912500|NCT00560391|50006620|FG003|Overall Study|Still on treatment|1|||
24912501|NCT00560391|50006621|FG004|Overall Study|Still on treatment|2|||
24912502|NCT00537238|50006636|FG000|Overall Study|Death|1|||
24912503|NCT00537238|50006637|FG001|Overall Study|Death|2|||
24912504|NCT00537238|50006636|FG000|Overall Study|Adverse Event|31|||
24912505|NCT00537238|50006637|FG001|Overall Study|Adverse Event|22|||
24912506|NCT00537238|50006636|FG000|Overall Study|Lack of Efficacy|20|||
24912507|NCT00537238|50006637|FG001|Overall Study|Lack of Efficacy|21|||
24912508|NCT00537238|50006636|FG000|Overall Study|Lost to Follow-up|12|||
24912509|NCT00537238|50006637|FG001|Overall Study|Lost to Follow-up|8|||
24912510|NCT00537238|50006636|FG000|Overall Study|Withdrawal by Subject|51|||
24912511|NCT00537238|50006637|FG001|Overall Study|Withdrawal by Subject|47|||
24912512|NCT00537238|50006636|FG000|Overall Study|Protocol Violation|15|||
24912513|NCT00537238|50006637|FG001|Overall Study|Protocol Violation|19|||
24912514|NCT00537238|50006636|FG000|Overall Study|Does not meet entrance criteria|0|||
24912515|NCT00537238|50006637|FG001|Overall Study|Does not meet entrance criteria|2|||
25020124|NCT03484429|50116202|FG000|Overall Study|Adverse Event|2|||
24912516|NCT00537238|50006636|FG000|Overall Study|Other|44|||
24912517|NCT00537238|50006637|FG001|Overall Study|Other|52|||
24912518|NCT03966885|50006645|FG000|Overall Study|Death|1|||
24912519|NCT03966885|50006646|FG001|Overall Study|Death|0|||
24912520|NCT03966885|50006645|FG000|Overall Study|Lost to Follow-up|1|||
24912521|NCT03966885|50006646|FG001|Overall Study|Lost to Follow-up|2|||
24912522|NCT03966885|50006645|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
24912523|NCT03966885|50006646|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
24912524|NCT03966885|50006645|FG000|Overall Study|Moved from study area.|0|||
24912525|NCT03966885|50006646|FG001|Overall Study|Moved from study area.|2|||
24912526|NCT03965403|50006653|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
24912527|NCT00552669|50006659|FG000|Overall Study|Death|3|||
24912528|NCT00552669|50006660|FG001|Overall Study|Death|7|||
24912529|NCT00552513|50006668|FG000|Overall Study|Lost to Follow-up|5|||
24912530|NCT00552513|50006669|FG001|Overall Study|Lost to Follow-up|1|||
24912531|NCT00560313|50006677|FG000|Overall Study|Adverse Events or Death|2|||
25184962|NCT01425359|50334039|FG001|Overall Study|Subject Withdrew Consent|2|||
25184963|NCT01425359|50334038|FG000|Overall Study|Investigator's Discretion|2|||
25184964|NCT01425359|50334039|FG001|Overall Study|Investigator's Discretion|0|||
25184965|NCT01425359|50334038|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
25184966|NCT01425359|50334039|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
25184967|NCT01403051|50334059|FG000|Overall Study|Protocol Violation|2|||
25184968|NCT01403051|50334060|FG001|Overall Study|Protocol Violation|0|||
25184969|NCT01403051|50334059|FG000|Overall Study|Death|1|||
25184970|NCT01403051|50334060|FG001|Overall Study|Death|0|||
25184971|NCT01403051|50334059|FG000|Overall Study|Withdrawal by Subject|2|||
25184972|NCT01403051|50334060|FG001|Overall Study|Withdrawal by Subject|1|||
25184973|NCT01403051|50334059|FG000|Overall Study|Lost to Follow-up|5|||
24912532|NCT00560313|50006677|FG000|Overall Study|Withdrawal by Subject|2|||
24912533|NCT00560313|50006677|FG000|Overall Study|Lost to Follow-up|1|||
24912534|NCT00560313|50006677|FG000|Overall Study|Protocol Violation|1|||
24912535|NCT00667862|50006696|FG000|Overall Study|Adverse Event|9|||
24912536|NCT00667862|50006696|FG000|Overall Study|Death|1|||
24912537|NCT00667862|50006696|FG000|Overall Study|Disease Progression|22|||
24912538|NCT00667862|50006696|FG000|Overall Study|Withdrawal by Subject|3|||
24912539|NCT00535132|50006702|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
24912540|NCT00535132|50006703|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
24912541|NCT00535132|50006702|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
24912542|NCT00535132|50006703|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
24912543|NCT00570908|50006711|FG000|Overall Study|Adverse Event|5|||
24912544|NCT00570908|50006711|FG000|Overall Study|Withdrawal by Subject|2|||
24912545|NCT00321919|50006717|FG000|Overall Study|Adverse Event|17|||
24912546|NCT00321919|50006718|FG001|Overall Study|Adverse Event|10|||
24912547|NCT00321919|50006717|FG000|Overall Study|Death|21|||
24912548|NCT00321919|50006718|FG001|Overall Study|Death|17|||
24912549|NCT00321919|50006717|FG000|Overall Study|Insufficient Therapeutic Response|1|||
24912550|NCT00321919|50006718|FG001|Overall Study|Insufficient Therapeutic Response|0|||
25020125|NCT03484429|50116203|FG001|Overall Study|Adverse Event|0|||
24912551|NCT00321919|50006717|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
24912552|NCT00321919|50006718|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
24912553|NCT00321919|50006717|FG000|Overall Study|Refused Treatment|23|||
24912554|NCT00321919|50006718|FG001|Overall Study|Refused Treatment|14|||
24912555|NCT00321919|50006717|FG000|Overall Study|Other Protocol Violation|2|||
24912556|NCT00321919|50006718|FG001|Overall Study|Other Protocol Violation|3|||
24912557|NCT00321919|50006717|FG000|Overall Study|Failure to Return|3|||
24912558|NCT00321919|50006718|FG001|Overall Study|Failure to Return|1|||
24912559|NCT00321919|50006717|FG000|Overall Study|Other withdrawal reason|7|||
24912560|NCT00321919|50006718|FG001|Overall Study|Other withdrawal reason|6|||
24912561|NCT00781391|50006728|FG000|Overall Study|never received study drug|24|||
24912562|NCT00781391|50006729|FG001|Overall Study|never received study drug|23|||
24912563|NCT00781391|50006730|FG002|Overall Study|never received study drug|32|||
24912564|NCT00781391|50006728|FG000|Overall Study|Protocol Violation|19|||
24912565|NCT00781391|50006729|FG001|Overall Study|Protocol Violation|17|||
24912566|NCT00781391|50006730|FG002|Overall Study|Protocol Violation|20|||
24912567|NCT00781391|50006728|FG000|Overall Study|Death|789|||
24912568|NCT00781391|50006729|FG001|Overall Study|Death|730|||
24912569|NCT00781391|50006730|FG002|Overall Study|Death|706|||
24912570|NCT00781391|50006728|FG000|Overall Study|Withdrawal by Subject|47|||
24912571|NCT00781391|50006729|FG001|Overall Study|Withdrawal by Subject|37|||
24912572|NCT00781391|50006730|FG002|Overall Study|Withdrawal by Subject|25|||
24912573|NCT00781391|50006728|FG000|Overall Study|Lost to Follow-up|0|||
24912574|NCT00781391|50006729|FG001|Overall Study|Lost to Follow-up|0|||
24912575|NCT00781391|50006730|FG002|Overall Study|Lost to Follow-up|1|||
24912576|NCT00534976|50006740|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
24912577|NCT00534976|50006741|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
24912578|NCT00534976|50006740|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
24912579|NCT00534976|50006741|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
24912580|NCT00534976|50006740|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
24912581|NCT00534976|50006741|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
24912582|NCT00321763|50006751|FG000|Overall Study|Adverse Event|1|||
25184974|NCT01403051|50334060|FG001|Overall Study|Lost to Follow-up|5|||
25184975|NCT04115748|50334075|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
25184976|NCT04115748|50334076|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
24912583|NCT00321763|50006752|FG001|Overall Study|Adverse Event|1|||
24912584|NCT00321763|50006753|FG002|Overall Study|Adverse Event|0|||
24912585|NCT00321763|50006754|FG003|Overall Study|Adverse Event|1|||
24912586|NCT00321763|50006751|FG000|Overall Study|Withdrawal by Subject|2|||
24912587|NCT00321763|50006752|FG001|Overall Study|Withdrawal by Subject|0|||
24912588|NCT00321763|50006753|FG002|Overall Study|Withdrawal by Subject|1|||
24912589|NCT00321763|50006754|FG003|Overall Study|Withdrawal by Subject|0|||
24912590|NCT00321763|50006751|FG000|Overall Study|Lost to Follow-up|3|||
24912591|NCT00321763|50006752|FG001|Overall Study|Lost to Follow-up|1|||
24912592|NCT00321763|50006753|FG002|Overall Study|Lost to Follow-up|5|||
24912593|NCT00321763|50006754|FG003|Overall Study|Lost to Follow-up|4|||
24912594|NCT00308113|50006770|FG000|Overall Study|Protocol closure|0|||
24912595|NCT00308113|50006771|FG001|Overall Study|Protocol closure|0|||
24912596|NCT00308113|50006772|FG002|Overall Study|Protocol closure|0|||
24912597|NCT00308113|50006773|FG003|Overall Study|Protocol closure|1|||
24912598|NCT00307801|50006789|FG000|Overall Study|Adverse Event|12|||
24912599|NCT00307801|50006790|FG001|Overall Study|Adverse Event|4|||
24912600|NCT00307801|50006789|FG000|Overall Study|Withdrawal by Subject|9|||
24912601|NCT00307801|50006790|FG001|Overall Study|Withdrawal by Subject|4|||
24912602|NCT00307801|50006789|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
24912603|NCT00307801|50006790|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
24912604|NCT00307801|50006789|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
24912605|NCT00307801|50006790|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
24912606|NCT00307801|50006789|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
24912607|NCT00307801|50006790|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
24912608|NCT00307801|50006789|FG000|Overall Study|Wrong Randomization|1|||
24912609|NCT00307801|50006790|FG001|Overall Study|Wrong Randomization|0|||
24912610|NCT00307801|50006789|FG000|Overall Study|Lack of Efficacy|0|||
24912611|NCT00307801|50006790|FG001|Overall Study|Lack of Efficacy|2|||
24912612|NCT00307801|50006789|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
24912613|NCT00307801|50006790|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
24912614|NCT00307801|50006789|FG000|Overall Study|Frustration with e-diary|1|||
24912615|NCT00307801|50006790|FG001|Overall Study|Frustration with e-diary|0|||
24912616|NCT00307801|50006789|FG000|Overall Study|Protocol Violation|3|||
24912617|NCT00307801|50006790|FG001|Overall Study|Protocol Violation|2|||
24912618|NCT00307801|50006789|FG000|Overall Study|No reason specified|2|||
24912619|NCT00307801|50006790|FG001|Overall Study|No reason specified|0|||
24912620|NCT00307801|50006789|FG000|Overall Study|Pregnancy|0|||
24912621|NCT00307801|50006790|FG001|Overall Study|Pregnancy|1|||
24912622|NCT00671060|50006799|FG000|Overall Study|Protocol Violation|1|||
24912623|NCT00671060|50006800|FG001|Overall Study|Protocol Violation|0|||
24912624|NCT00671060|50006799|FG000|Overall Study|Physician Decision|0|||
24912625|NCT00671060|50006800|FG001|Overall Study|Physician Decision|1|||
24912626|NCT00654420|50006810|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
24912627|NCT00654420|50006811|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
24912628|NCT00654420|50006812|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
24912629|NCT00654420|50006813|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
24912630|NCT00654420|50006810|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
24912631|NCT00654420|50006811|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
24912632|NCT00654420|50006812|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
24912633|NCT00654420|50006813|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
25020126|NCT03484273|50116209|FG000|Overall Study|Equipment Malfunction|1|||
25020127|NCT03484273|50116209|FG000|Overall Study|Data excluded from analysis|1|||
25020128|NCT02724592|50116223|FG000|Overall Study|Lost to Follow-up|4|||
25020129|NCT02724592|50116224|FG001|Overall Study|Lost to Follow-up|1|||
25153147|NCT01687413|50268335|FG001|Overall Study|Not eligible|2|||
25153148|NCT01687413|50268334|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
24912634|NCT00654420|50006810|FG000|Phase II|Adverse Event|0|||
24912635|NCT00654420|50006811|FG001|Phase II|Adverse Event|0|||
24912636|NCT00654420|50006812|FG002|Phase II|Adverse Event|3|||
24912637|NCT00654420|50006813|FG003|Phase II|Adverse Event|3|||
24912638|NCT00654420|50006810|FG000|Phase II|Lost to Follow-up|0|||
24912639|NCT00654420|50006811|FG001|Phase II|Lost to Follow-up|0|||
24912640|NCT00654420|50006812|FG002|Phase II|Lost to Follow-up|0|||
24912641|NCT00654420|50006813|FG003|Phase II|Lost to Follow-up|1|||
24912642|NCT00654420|50006810|FG000|Phase II|Physician Decision|0|||
24912643|NCT00654420|50006811|FG001|Phase II|Physician Decision|0|||
25274921|NCT01241591|50589030|FG003|Overall Study|Lack of Efficacy|3|||
24912644|NCT00654420|50006812|FG002|Phase II|Physician Decision|0|||
24912645|NCT00654420|50006813|FG003|Phase II|Physician Decision|4|||
24912646|NCT00654420|50006810|FG000|Phase II|Progressive Disease|0|||
24912647|NCT00654420|50006811|FG001|Phase II|Progressive Disease|0|||
24912648|NCT00654420|50006812|FG002|Phase II|Progressive Disease|29|||
24912649|NCT00654420|50006813|FG003|Phase II|Progressive Disease|29|||
25274922|NCT01241591|50589027|FG000|Overall Study|Protocol Violation|5|||
24912650|NCT00654420|50006810|FG000|Phase II|Withdrawal by Subject|0|||
24912651|NCT00654420|50006811|FG001|Phase II|Withdrawal by Subject|0|||
25020130|NCT03154476|50116232|FG000|Overall Study|Lost to Follow-up|4|||
25020131|NCT03154476|50116233|FG001|Overall Study|Lost to Follow-up|4|||
24912652|NCT00654420|50006812|FG002|Phase II|Withdrawal by Subject|4|||
24912653|NCT00654420|50006813|FG003|Phase II|Withdrawal by Subject|1|||
24912654|NCT00654420|50006810|FG000|Phase II|Missing Disposition Record|0|||
24912655|NCT00654420|50006811|FG001|Phase II|Missing Disposition Record|0|||
24912656|NCT00654420|50006812|FG002|Phase II|Missing Disposition Record|1|||
24912657|NCT00654420|50006813|FG003|Phase II|Missing Disposition Record|0|||
24912658|NCT00307489|50006825|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
24912659|NCT00307489|50006826|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
24912660|NCT00307489|50006825|FG000|Baseline Through Week 48|Physician Decision|1|||
24912661|NCT00307489|50006826|FG001|Baseline Through Week 48|Physician Decision|0|||
24912662|NCT00307489|50006825|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
24912663|NCT00307489|50006826|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
24912664|NCT00307489|50006825|FG000|Week 48 Through Week 168|Adverse Event|1|||
24912665|NCT00307489|50006826|FG001|Week 48 Through Week 168|Adverse Event|0|||
24912666|NCT00307489|50006825|FG000|Week 48 Through Week 168|Physician Decision|1|||
24912667|NCT00307489|50006826|FG001|Week 48 Through Week 168|Physician Decision|0|||
24912668|NCT00307489|50006825|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
24912669|NCT00307489|50006826|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
24912670|NCT00307489|50006825|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
24912671|NCT00307489|50006826|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
24912672|NCT00307489|50006825|FG000|Week 48 Through Week 168|Death|0|||
24912673|NCT00307489|50006826|FG001|Week 48 Through Week 168|Death|1|||
24912674|NCT00307489|50006825|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
24912675|NCT00307489|50006826|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
24912676|NCT00307489|50006825|FG000|Week 48 Through Week 168|Seroconversion|1|||
24912677|NCT00307489|50006826|FG001|Week 48 Through Week 168|Seroconversion|0|||
24912678|NCT00645840|50006832|FG000|Overall Study|Protocol Violation|3|||
24912679|NCT00307333|50006838|FG000|Overall Study|Lost to Follow-up|11|||
24912680|NCT00307333|50006839|FG001|Overall Study|Lost to Follow-up|3|||
24912681|NCT00762359|50006847|FG000|Overall Study|Adverse Event|20|||
24912682|NCT00762359|50006848|FG001|Overall Study|Adverse Event|23|||
24912683|NCT00762359|50006847|FG000|Overall Study|Protocol Violation|21|||
24912684|NCT00762359|50006848|FG001|Overall Study|Protocol Violation|13|||
24912685|NCT00762359|50006847|FG000|Overall Study|Withdrawal by Subject|13|||
24912686|NCT00762359|50006848|FG001|Overall Study|Withdrawal by Subject|10|||
24912687|NCT00762359|50006847|FG000|Overall Study|Lack of Efficacy|0|||
24912688|NCT00762359|50006848|FG001|Overall Study|Lack of Efficacy|4|||
24912689|NCT00762359|50006847|FG000|Overall Study|Institution closed|2|||
24912690|NCT00762359|50006848|FG001|Overall Study|Institution closed|3|||
24912691|NCT00762359|50006847|FG000|Overall Study|Physician Decision|2|||
24912692|NCT00762359|50006848|FG001|Overall Study|Physician Decision|3|||
24912693|NCT00762359|50006847|FG000|Overall Study|Removal|0|||
24912694|NCT00762359|50006848|FG001|Overall Study|Removal|1|||
24912695|NCT00762359|50006847|FG000|Overall Study|Withdrew consent|1|||
24912696|NCT00762359|50006848|FG001|Overall Study|Withdrew consent|0|||
24912697|NCT00654186|50006854|FG000|Overall Study|Withdrawal by Subject|5|||
24912698|NCT00761969|50006860|FG000|Overall Study|Death|112|||
24912699|NCT00761969|50006861|FG001|Overall Study|Death|47|||
24912700|NCT00761969|50006860|FG000|Overall Study|Lost to Follow-up|88|||
24912701|NCT00761969|50006861|FG001|Overall Study|Lost to Follow-up|93|||
24912702|NCT00761891|50006872|FG000|Overall Study|Withdrawal by Subject|10|||
24912703|NCT00321685|50006877|FG000|Overall Study|Adverse Event|18|||
24912704|NCT00321685|50006877|FG000|Overall Study|Death|2|||
24912705|NCT00321685|50006877|FG000|Overall Study|Withdrawal by Subject|8|||
24912706|NCT00321685|50006877|FG000|Overall Study|Alternative therapy|1|||
24912707|NCT00321685|50006877|FG000|Overall Study|Complicating disese|1|||
24912708|NCT00321685|50006877|FG000|Overall Study|Other|5|||
24912709|NCT00321685|50006877|FG000|Overall Study|Not start protocol therapy|2|||
24912710|NCT00321685|50006877|FG000|Overall Study|Ineligible|2|||
24912711|NCT03902392|50006883|FG000|Overall Study|Lost to Follow-up|7|||
24912712|NCT03902392|50006884|FG001|Overall Study|Lost to Follow-up|7|||
24912713|NCT00306787|50006892|FG000|Overall Study|Discontinued without taking study drug|208|||
24912714|NCT00306787|50006893|FG001|Overall Study|Discontinued without taking study drug|215|||
24912715|NCT00306787|50006892|FG000|Overall Study|Adverse Event|1|||
24912716|NCT00306787|50006893|FG001|Overall Study|Adverse Event|1|||
24912717|NCT00306787|50006892|FG000|Overall Study|Lack of Efficacy|1|||
24912718|NCT00306787|50006893|FG001|Overall Study|Lack of Efficacy|0|||
24912719|NCT00306787|50006892|FG000|Overall Study|Protocol Violation|8|||
24912720|NCT00306787|50006893|FG001|Overall Study|Protocol Violation|10|||
24912721|NCT00306787|50006892|FG000|Overall Study|Withdrawal by Subject|2|||
24912722|NCT00306787|50006893|FG001|Overall Study|Withdrawal by Subject|9|||
24912723|NCT00306787|50006892|FG000|Overall Study|Lost to Follow-up|9|||
24912724|NCT00306787|50006893|FG001|Overall Study|Lost to Follow-up|6|||
24912725|NCT00306787|50006892|FG000|Overall Study|Administrative problems|4|||
24912726|NCT00306787|50006893|FG001|Overall Study|Administrative problems|0|||
24912727|NCT00306787|50006892|FG000|Overall Study|Abnormal laboratory value(s)|1|||
24912728|NCT00306787|50006893|FG001|Overall Study|Abnormal laboratory value(s)|0|||
24912729|NCT00769067|50006901|FG000|Overall Study|Death|89|||
24912730|NCT00769067|50006902|FG001|Overall Study|Death|86|||
24912731|NCT00769067|50006901|FG000|Overall Study|Lost to Follow-up|3|||
24912732|NCT00769067|50006902|FG001|Overall Study|Lost to Follow-up|1|||
24912733|NCT00769067|50006901|FG000|Overall Study|Study terminated by sponsor|1|||
24912734|NCT00769067|50006902|FG001|Overall Study|Study terminated by sponsor|3|||
24912735|NCT00769067|50006901|FG000|Overall Study|Other|1|||
24912736|NCT00769067|50006902|FG001|Overall Study|Other|3|||
24912737|NCT00769067|50006901|FG000|Overall Study|Withdrawal by Subject|0|||
24912738|NCT00769067|50006902|FG001|Overall Study|Withdrawal by Subject|1|||
24912739|NCT00321373|50006912|FG000|Overall Study|Adverse Event|0|||
24912740|NCT00321373|50006913|FG001|Overall Study|Adverse Event|0|||
24912741|NCT00321373|50006914|FG002|Overall Study|Adverse Event|1|||
24912742|NCT00321373|50006912|FG000|Overall Study|Lost to Follow-up|1|||
24912743|NCT00321373|50006913|FG001|Overall Study|Lost to Follow-up|0|||
24912744|NCT00321373|50006914|FG002|Overall Study|Lost to Follow-up|1|||
24912745|NCT00321373|50006912|FG000|Overall Study|Withdrawal by Subject|1|||
24912746|NCT00321373|50006913|FG001|Overall Study|Withdrawal by Subject|0|||
24912747|NCT00321373|50006914|FG002|Overall Study|Withdrawal by Subject|0|||
24912748|NCT00321373|50006912|FG000|Overall Study|Other|0|||
24912749|NCT00321373|50006913|FG001|Overall Study|Other|0|||
24912750|NCT00321373|50006914|FG002|Overall Study|Other|1|||
24912751|NCT00667394|50006924|FG000|Overall Study|Adverse Event|3|||
24912752|NCT00667394|50006925|FG001|Overall Study|Adverse Event|0|||
24912753|NCT00667394|50006924|FG000|Overall Study|Progressive disease|1|||
24912754|NCT00667394|50006925|FG001|Overall Study|Progressive disease|0|||
24912755|NCT00761735|50006931|FG000|Overall Study|Lost to Follow-up|6|||
24912756|NCT00761735|50006931|FG000|Overall Study|Withdrawal by Subject|6|||
24912757|NCT00761735|50006931|FG000|Overall Study|Non-compliance with protocol|1|||
24912758|NCT00761735|50006931|FG000|Overall Study|Administrative|1|||
24912759|NCT00569946|50006939|FG000|Overall Study|Adverse Event|16|||
24912760|NCT00569946|50006939|FG000|Overall Study|Objective Progression or Relapse|42|||
24912761|NCT00569946|50006939|FG000|Overall Study|Global Deterioration of Health Status|1|||
24912762|NCT00645528|50006943|FG000|Overall Study|Did not show up for Visit 2|7|||
24912763|NCT00295633|50006950|FG000|Overall Study|Lack of Efficacy|19|||
24912764|NCT00295633|50006951|FG001|Overall Study|Lack of Efficacy|7|||
24912765|NCT00295633|50006952|FG002|Overall Study|Lack of Efficacy|16|||
24912766|NCT00295633|50006950|FG000|Overall Study|Withdrawal of consent by subject|16|||
24912767|NCT00295633|50006951|FG001|Overall Study|Withdrawal of consent by subject|16|||
24912768|NCT00295633|50006952|FG002|Overall Study|Withdrawal of consent by subject|26|||
24912769|NCT00295633|50006950|FG000|Overall Study|Adverse Event|9|||
24912770|NCT00295633|50006951|FG001|Overall Study|Adverse Event|17|||
24912771|NCT00295633|50006952|FG002|Overall Study|Adverse Event|9|||
24912772|NCT00295633|50006950|FG000|Overall Study|Lost to Follow-up|6|||
24912773|NCT00295633|50006951|FG001|Overall Study|Lost to Follow-up|11|||
24912774|NCT00295633|50006952|FG002|Overall Study|Lost to Follow-up|7|||
24912775|NCT00295633|50006950|FG000|Overall Study|Physician Decision|9|||
24912776|NCT00295633|50006951|FG001|Overall Study|Physician Decision|10|||
24912777|NCT00295633|50006952|FG002|Overall Study|Physician Decision|8|||
24912778|NCT00295633|50006950|FG000|Overall Study|Poor/Noncompliance|2|||
24912779|NCT00295633|50006951|FG001|Overall Study|Poor/Noncompliance|2|||
24912780|NCT00295633|50006952|FG002|Overall Study|Poor/Noncompliance|6|||
24912781|NCT00295633|50006950|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
24912782|NCT00295633|50006951|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
24912783|NCT00295633|50006952|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
24912784|NCT00295633|50006950|FG000|Overall Study|Death|1|||
24912785|NCT00295633|50006951|FG001|Overall Study|Death|1|||
24912786|NCT00295633|50006952|FG002|Overall Study|Death|0|||
24912787|NCT00295633|50006950|FG000|Overall Study|Administrative reason by sponsor|0|||
24912788|NCT00295633|50006951|FG001|Overall Study|Administrative reason by sponsor|0|||
24912789|NCT00295633|50006952|FG002|Overall Study|Administrative reason by sponsor|1|||
24912790|NCT00570674|50006960|FG000|Overall Study|Withdrawal by Subject|0|||
24912791|NCT00570674|50006961|FG001|Overall Study|Withdrawal by Subject|0|||
24912792|NCT00570674|50006962|FG002|Overall Study|Withdrawal by Subject|1|||
24912793|NCT00570674|50006963|FG003|Overall Study|Withdrawal by Subject|0|||
24912794|NCT00570674|50006964|FG004|Overall Study|Withdrawal by Subject|0|||
24912795|NCT00570674|50006965|FG005|Overall Study|Withdrawal by Subject|0|||
24912796|NCT00570674|50006966|FG006|Overall Study|Withdrawal by Subject|0|||
24912797|NCT00768989|50006979|FG000|Prior to Week 24|Withdrawal by Subject|1|||
24912798|NCT00768989|50006980|FG001|Prior to Week 24|Withdrawal by Subject|0|||
24912799|NCT00768989|50006979|FG000|Prior to Week 24|Adverse Event|3|||
24912800|NCT00768989|50006980|FG001|Prior to Week 24|Adverse Event|0|||
24912801|NCT00768989|50006979|FG000|Prior to Week 24|Lost to Follow-up|0|||
24912802|NCT00768989|50006980|FG001|Prior to Week 24|Lost to Follow-up|1|||
24912803|NCT00768989|50006979|FG000|Prior to Week 24|Protocol Violation|0|||
24912804|NCT00768989|50006980|FG001|Prior to Week 24|Protocol Violation|2|||
24912805|NCT00768989|50006979|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
24912806|NCT00768989|50006980|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
24912807|NCT00768989|50006979|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
24912808|NCT00768989|50006980|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
24912809|NCT00768989|50006979|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
24912810|NCT00768989|50006980|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
24912811|NCT00768989|50006979|FG000|On or After Week 36|Lack of Efficacy|1|||
24912812|NCT00768989|50006980|FG001|On or After Week 36|Lack of Efficacy|0|||
24912813|NCT00768989|50006979|FG000|On or After Week 36|Adverse Event|0|||
24912814|NCT00768989|50006980|FG001|On or After Week 36|Adverse Event|1|||
24912815|NCT00768989|50006979|FG000|On or After Week 36|Lost to Follow-up|1|||
24912816|NCT00768989|50006980|FG001|On or After Week 36|Lost to Follow-up|0|||
24912817|NCT00768989|50006979|FG000|On or After Week 36|Poor Compliance|1|||
24912818|NCT00768989|50006980|FG001|On or After Week 36|Poor Compliance|0|||
24912819|NCT00768989|50006979|FG000|On or After Week 36|Protocol Violation|1|||
24912820|NCT00768989|50006980|FG001|On or After Week 36|Protocol Violation|0|||
24912821|NCT00768989|50006979|FG000|On or After Week 36|Did not attend termination visit|2|||
24912822|NCT00768989|50006980|FG001|On or After Week 36|Did not attend termination visit|0|||
24912823|NCT00768989|50006979|FG000|On or After Week 36|Sponsor Termination|45|||
24912824|NCT00768989|50006980|FG001|On or After Week 36|Sponsor Termination|26|||
24912825|NCT00305773|50006990|FG000|Overall Study|Death|3|||
24912826|NCT00305773|50006991|FG001|Overall Study|Death|2|||
24912827|NCT00305773|50006990|FG000|Overall Study|Adverse Event|1|||
24912828|NCT00305773|50006991|FG001|Overall Study|Adverse Event|2|||
24912829|NCT00305773|50006990|FG000|Overall Study|Alternative Treatment|4|||
24912830|NCT00305773|50006991|FG001|Overall Study|Alternative Treatment|4|||
24912831|NCT00305773|50006990|FG000|Overall Study|Physician Decision|1|||
24912832|NCT00305773|50006991|FG001|Overall Study|Physician Decision|1|||
24912833|NCT00305773|50006990|FG000|Overall Study|Withdrawal by Subject|1|||
24912834|NCT00305773|50006991|FG001|Overall Study|Withdrawal by Subject|4|||
24912835|NCT00305773|50006990|FG000|Overall Study|Disease Progression|1|||
24912836|NCT00305773|50006991|FG001|Overall Study|Disease Progression|3|||
25020132|NCT02726074|50116239|FG000|Overall Study|Withdrawal by Subject|4|||
25020133|NCT02726074|50116239|FG000|Overall Study|Adverse Event|14|||
25020134|NCT02726074|50116239|FG000|Overall Study|Protocol Violation|3|||
25020135|NCT02726074|50116239|FG000|Overall Study|Lost to Follow-up|2|||
25020136|NCT02726074|50116239|FG000|Overall Study|Others|3|||
25020137|NCT03483961|50116253|FG000|Overall Study|Lost to Follow-up|7|||
25020138|NCT03483961|50116254|FG001|Overall Study|Lost to Follow-up|6|||
25020139|NCT03483961|50116255|FG002|Overall Study|Lost to Follow-up|6|||
25020140|NCT03483961|50116256|FG003|Overall Study|Lost to Follow-up|6|||
25020141|NCT03483961|50116257|FG004|Overall Study|Lost to Follow-up|6|||
25020142|NCT03483961|50116258|FG005|Overall Study|Lost to Follow-up|4|||
25020143|NCT03483961|50116259|FG006|Overall Study|Lost to Follow-up|4|||
25020144|NCT03483961|50116260|FG007|Overall Study|Lost to Follow-up|11|||
25020145|NCT03483961|50116261|FG008|Overall Study|Lost to Follow-up|1|||
25020146|NCT03483961|50116262|FG009|Overall Study|Lost to Follow-up|0|||
25020147|NCT03483961|50116253|FG000|Overall Study|Withdrawal by Subject|3|||
25020148|NCT03483961|50116254|FG001|Overall Study|Withdrawal by Subject|4|||
25020149|NCT03483961|50116255|FG002|Overall Study|Withdrawal by Subject|5|||
25020150|NCT03483961|50116256|FG003|Overall Study|Withdrawal by Subject|3|||
25020151|NCT03483961|50116257|FG004|Overall Study|Withdrawal by Subject|4|||
25020152|NCT03483961|50116258|FG005|Overall Study|Withdrawal by Subject|2|||
24912837|NCT00305773|50006990|FG000|Overall Study|All other reasons|3|||
24912838|NCT00305773|50006991|FG001|Overall Study|All other reasons|2|||
24912839|NCT00305695|50006999|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
24912840|NCT00305695|50007000|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
24912841|NCT00305695|50006999|FG000|Overall Study|Did not have baseline scan|1|||
24912842|NCT00305695|50007000|FG001|Overall Study|Did not have baseline scan|1|||
24912843|NCT00647556|50007008|FG000|Overall Study|Adverse Event|0|||
24912844|NCT00647556|50007009|FG001|Overall Study|Adverse Event|1|||
24912845|NCT00647556|50007008|FG000|Overall Study|Lost to Follow-up|1|||
24912846|NCT00647556|50007009|FG001|Overall Study|Lost to Follow-up|0|||
24912847|NCT00647556|50007008|FG000|Overall Study|Protocol Violation|0|||
24912848|NCT00647556|50007009|FG001|Overall Study|Protocol Violation|1|||
24912849|NCT00647556|50007008|FG000|Overall Study|Withdrawal by Subject|1|||
24912850|NCT00647556|50007009|FG001|Overall Study|Withdrawal by Subject|0|||
24912851|NCT00647556|50007008|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
24912852|NCT00647556|50007009|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
24912853|NCT00320593|50007017|FG000|Overall Study|Lost to Follow-up|3|||
24912854|NCT00320593|50007018|FG001|Overall Study|Lost to Follow-up|0|||
24912855|NCT00320593|50007017|FG000|Overall Study|Moved to another state|1|||
24912856|NCT00320593|50007018|FG001|Overall Study|Moved to another state|0|||
25020153|NCT03483961|50116259|FG006|Overall Study|Withdrawal by Subject|1|||
25020154|NCT03483961|50116260|FG007|Overall Study|Withdrawal by Subject|2|||
25020155|NCT03483961|50116261|FG008|Overall Study|Withdrawal by Subject|1|||
25020156|NCT03483961|50116262|FG009|Overall Study|Withdrawal by Subject|0|||
24912857|NCT00320593|50007017|FG000|Overall Study|Withdrawal by Subject|2|||
24912858|NCT00320593|50007018|FG001|Overall Study|Withdrawal by Subject|1|||
24912859|NCT00320593|50007017|FG000|Overall Study|Withdrawal by clinical center|1|||
24912860|NCT00320593|50007018|FG001|Overall Study|Withdrawal by clinical center|0|||
24912861|NCT00320515|50007024|FG000|Overall Study|Death|33|||
24912862|NCT00320515|50007024|FG000|Overall Study|Lost to Follow-up|6|||
24912863|NCT00320515|50007024|FG000|Overall Study|Physician Decision|2|||
24912864|NCT00320515|50007024|FG000|Overall Study|Withdrawal by Subject|8|||
24912865|NCT00662012|50007028|FG000|Overall Study|Lost to Follow-up|85|||
24912866|NCT00662012|50007028|FG000|Overall Study|Death|1|||
24912867|NCT00662012|50007028|FG000|Overall Study|Withdrawal by Subject|1|||
24912868|NCT00661778|50007032|FG000|Overall Study|Disease Progression|23|||
24912869|NCT00661778|50007032|FG000|Overall Study|Adverse Event|18|||
24912870|NCT00661778|50007032|FG000|Overall Study|Reason not Specified|6|||
24912871|NCT00661778|50007032|FG000|Overall Study|Protocol Violation|2|||
24912872|NCT00661778|50007032|FG000|Overall Study|Withdrawal of Consent|1|||
24912873|NCT00319735|50007036|FG000|Overall Study|Death|2|||
24912874|NCT00653328|50007041|FG000|Overall Study|Withdrawal by Subject|1|||
24912875|NCT00653328|50007041|FG000|Overall Study|Adverse Event|2|||
24912876|NCT00653328|50007041|FG000|Overall Study|Disease progression|10|||
24912877|NCT00653328|50007041|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
24912878|NCT00642642|50007054|FG000|Treatment & Follow Up|Adverse Event|2|||
24912879|NCT00642642|50007054|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
24912880|NCT00642642|50007054|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
24912881|NCT00534352|50007064|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
24912882|NCT00534352|50007064|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
24912883|NCT00534352|50007064|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
24912884|NCT00534352|50007064|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
24912885|NCT00534352|50007064|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
24912886|NCT00534352|50007064|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
24912887|NCT00642174|50007079|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
24912888|NCT00642174|50007080|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
24912889|NCT00665366|50007088|FG000|Overall Study|Lack of Efficacy|11|||
24912890|NCT00665366|50007089|FG001|Overall Study|Lack of Efficacy|10|||
24912891|NCT00665366|50007088|FG000|Overall Study|Adverse Event|25|||
24912892|NCT00665366|50007089|FG001|Overall Study|Adverse Event|23|||
24912893|NCT00665366|50007088|FG000|Overall Study|Withdrawal by Subject|11|||
24912894|NCT00665366|50007089|FG001|Overall Study|Withdrawal by Subject|14|||
24912895|NCT00665366|50007088|FG000|Overall Study|Lost to Follow-up|3|||
24912896|NCT00665366|50007089|FG001|Overall Study|Lost to Follow-up|5|||
24912897|NCT00665366|50007088|FG000|Overall Study|Poor compliance/noncompliance|3|||
24912898|NCT00665366|50007089|FG001|Overall Study|Poor compliance/noncompliance|5|||
24912899|NCT00665366|50007088|FG000|Overall Study|Pregnancy|1|||
24912900|NCT00665366|50007089|FG001|Overall Study|Pregnancy|0|||
24912901|NCT00665366|50007088|FG000|Overall Study|No longer meets study criteria|0|||
24912902|NCT00665366|50007089|FG001|Overall Study|No longer meets study criteria|1|||
24912903|NCT00665366|50007088|FG000|Overall Study|Other reasons|4|||
24912904|NCT00665366|50007089|FG001|Overall Study|Other reasons|1|||
24912905|NCT00642018|50007119|FG000|Overall Study|Adverse Event|11|||
24912906|NCT00642018|50007120|FG001|Overall Study|Adverse Event|36|||
24912907|NCT00642018|50007119|FG000|Overall Study|Withdrawal by Subject|4|||
24912908|NCT00642018|50007120|FG001|Overall Study|Withdrawal by Subject|10|||
24912909|NCT00642018|50007119|FG000|Overall Study|Progressive Disease|13|||
24912910|NCT00642018|50007120|FG001|Overall Study|Progressive Disease|18|||
24912911|NCT00642018|50007119|FG000|Overall Study|Physician Decision|0|||
24912912|NCT00642018|50007120|FG001|Overall Study|Physician Decision|10|||
24912913|NCT00642018|50007119|FG000|Overall Study|Protocol Violation|0|||
24912914|NCT00642018|50007120|FG001|Overall Study|Protocol Violation|1|||
24912915|NCT00642018|50007119|FG000|Overall Study|Death|0|||
24912916|NCT00642018|50007120|FG001|Overall Study|Death|3|||
24912917|NCT00642018|50007119|FG000|Overall Study|Entry Criteria Not Met|0|||
24912918|NCT00642018|50007120|FG001|Overall Study|Entry Criteria Not Met|1|||
24912919|NCT00532948|50007130|FG000|Overall Study|Protocol Violation|1|||
24912920|NCT00532948|50007131|FG001|Overall Study|Protocol Violation|0|||
24912921|NCT00532948|50007132|FG002|Overall Study|Protocol Violation|0|||
24912922|NCT00532948|50007130|FG000|Overall Study|Death|3|||
24912923|NCT00532948|50007131|FG001|Overall Study|Death|3|||
24912924|NCT00532948|50007132|FG002|Overall Study|Death|4|||
24912925|NCT00532948|50007130|FG000|Overall Study|Violation of selection criteria at entry|0|||
24912926|NCT00532948|50007131|FG001|Overall Study|Violation of selection criteria at entry|1|||
24912927|NCT00532948|50007132|FG002|Overall Study|Violation of selection criteria at entry|0|||
24912928|NCT00532948|50007130|FG000|Overall Study|Failure to return|0|||
24912929|NCT00532948|50007131|FG001|Overall Study|Failure to return|1|||
24912930|NCT00532948|50007132|FG002|Overall Study|Failure to return|0|||
24912931|NCT00641706|50007146|FG000|Overall Study|Adverse Event|2|||
24912932|NCT00641706|50007147|FG001|Overall Study|Adverse Event|1|||
24912933|NCT00641706|50007146|FG000|Overall Study|Withdrawal by Subject|6|||
24912934|NCT00641706|50007147|FG001|Overall Study|Withdrawal by Subject|1|||
24912935|NCT00641706|50007146|FG000|Overall Study|Clinical Decline|1|||
24912936|NCT00641706|50007147|FG001|Overall Study|Clinical Decline|0|||
24912937|NCT00641706|50007146|FG000|Overall Study|Lead Investigator Decision|0|||
24912938|NCT00641706|50007147|FG001|Overall Study|Lead Investigator Decision|1|||
24912939|NCT00644358|50007153|FG000|Overall Study|Adverse Event|124|||
24912940|NCT00644358|50007153|FG000|Overall Study|Lost to Follow-up|105|||
24912941|NCT00644358|50007153|FG000|Overall Study|Consent Withdrawal|64|||
24912942|NCT00644358|50007153|FG000|Overall Study|Lack of Effectiveness|39|||
24912943|NCT00644358|50007153|FG000|Overall Study|Protocol Violation|5|||
24912944|NCT00644358|50007153|FG000|Overall Study|Noncompliance|14|||
24912945|NCT00644358|50007153|FG000|Overall Study|Other Unspecified|11|||
24912946|NCT00640926|50007160|FG000|Overall Study|Adverse Event|2|||
24912947|NCT00640926|50007161|FG001|Overall Study|Adverse Event|3|||
24912948|NCT00640926|50007162|FG002|Overall Study|Adverse Event|2|||
24912949|NCT00640926|50007160|FG000|Overall Study|Lack of Efficacy|0|||
24912950|NCT00640926|50007161|FG001|Overall Study|Lack of Efficacy|2|||
24912951|NCT00640926|50007162|FG002|Overall Study|Lack of Efficacy|1|||
24912952|NCT00640926|50007160|FG000|Overall Study|Protocol Violation|2|||
24912953|NCT00640926|50007161|FG001|Overall Study|Protocol Violation|0|||
24912954|NCT00640926|50007162|FG002|Overall Study|Protocol Violation|2|||
24912955|NCT00640926|50007160|FG000|Overall Study|Lost to Follow-up|3|||
24912956|NCT00640926|50007161|FG001|Overall Study|Lost to Follow-up|1|||
24912957|NCT00640926|50007162|FG002|Overall Study|Lost to Follow-up|2|||
24912958|NCT00640926|50007160|FG000|Overall Study|Withdrawal by Subject|1|||
25020157|NCT03483961|50116253|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
25020158|NCT03483961|50116254|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
25020159|NCT03483961|50116255|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
25020160|NCT03483961|50116256|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
25020161|NCT03483961|50116257|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
25020162|NCT03483961|50116258|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
25020163|NCT03483961|50116259|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
25020164|NCT03483961|50116260|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
25020165|NCT03483961|50116261|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
25020166|NCT03483961|50116262|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
25020167|NCT03483961|50116253|FG000|Overall Study|Adverse Event|0|||
25020168|NCT03483961|50116254|FG001|Overall Study|Adverse Event|0|||
25020169|NCT03483961|50116255|FG002|Overall Study|Adverse Event|1|||
25020170|NCT03483961|50116256|FG003|Overall Study|Adverse Event|0|||
25020171|NCT03483961|50116257|FG004|Overall Study|Adverse Event|0|||
24912959|NCT00640926|50007161|FG001|Overall Study|Withdrawal by Subject|0|||
24912960|NCT00640926|50007162|FG002|Overall Study|Withdrawal by Subject|1|||
24912961|NCT03892564|50007170|FG000|Overall Study|Withdrawal by Subject|2|||
24912962|NCT03891862|50007177|FG000|Open-label Period|Adverse Event|2|||
24912963|NCT03891862|50007178|FG001|Open-label Period|Adverse Event|0|||
24912964|NCT03891862|50007179|FG002|Open-label Period|Adverse Event|0|||
24912965|NCT03891862|50007177|FG000|Open-label Period|Protocol Violation|5|||
24912966|NCT03891862|50007178|FG001|Open-label Period|Protocol Violation|0|||
24912967|NCT03891862|50007179|FG002|Open-label Period|Protocol Violation|0|||
24912968|NCT03891862|50007177|FG000|Open-label Period|Withdrawal by Subject|6|||
24912969|NCT03891862|50007178|FG001|Open-label Period|Withdrawal by Subject|0|||
24912970|NCT03891862|50007179|FG002|Open-label Period|Withdrawal by Subject|0|||
25020172|NCT03483961|50116258|FG005|Overall Study|Adverse Event|0|||
25020173|NCT03483961|50116259|FG006|Overall Study|Adverse Event|0|||
25020174|NCT03483961|50116260|FG007|Overall Study|Adverse Event|0|||
25020175|NCT03483961|50116261|FG008|Overall Study|Adverse Event|0|||
25020176|NCT03483961|50116262|FG009|Overall Study|Adverse Event|0|||
25020177|NCT03482635|50116287|FG000|Overall Study|Lack of Efficacy|0|||
24912971|NCT03891862|50007177|FG000|Open-label Period|Death|1|||
24912972|NCT03891862|50007178|FG001|Open-label Period|Death|0|||
24912973|NCT03891862|50007179|FG002|Open-label Period|Death|0|||
24912974|NCT03891862|50007177|FG000|Open-label Period|Lost to Follow-up|2|||
24912975|NCT03891862|50007178|FG001|Open-label Period|Lost to Follow-up|0|||
24912976|NCT03891862|50007179|FG002|Open-label Period|Lost to Follow-up|0|||
24912977|NCT03891862|50007177|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
24912978|NCT03891862|50007178|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
24912979|NCT03891862|50007179|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
24912980|NCT03891862|50007177|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
24912981|NCT03891862|50007178|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
24912982|NCT03891862|50007179|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
24912983|NCT03891862|50007177|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
24912984|NCT03891862|50007178|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
24912985|NCT03891862|50007179|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
24912986|NCT03891862|50007177|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
24912987|NCT03891862|50007178|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
24912988|NCT03891862|50007179|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
24912989|NCT00640614|50007188|FG000|Overall Study|Lost to Follow-up|1|||
24912990|NCT00640614|50007189|FG001|Overall Study|Lost to Follow-up|0|||
24912991|NCT00761657|50007227|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
24912992|NCT00761657|50007228|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
24912993|NCT00761657|50007229|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
24912994|NCT00761657|50007230|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
24912995|NCT00761657|50007231|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
24912996|NCT00761657|50007232|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
24912997|NCT00761657|50007233|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
24912998|NCT00761657|50007234|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
24912999|NCT00761657|50007235|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
24913000|NCT00761657|50007227|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
24913001|NCT00761657|50007228|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
24913002|NCT00761657|50007229|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
25020178|NCT03482635|50116288|FG001|Overall Study|Lack of Efficacy|0|||
25020179|NCT03482635|50116289|FG002|Overall Study|Lack of Efficacy|1|||
25020180|NCT03482635|50116290|FG003|Overall Study|Lack of Efficacy|3|||
25020181|NCT03482635|50116287|FG000|Overall Study|Adverse Event|2|||
25020182|NCT03482635|50116288|FG001|Overall Study|Adverse Event|2|||
25020183|NCT03482635|50116289|FG002|Overall Study|Adverse Event|0|||
24913003|NCT00761657|50007230|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
24913004|NCT00761657|50007231|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
24913005|NCT00761657|50007232|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
24913006|NCT00761657|50007233|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
24913007|NCT00761657|50007234|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
24913008|NCT00761657|50007235|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
24913009|NCT00761657|50007227|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
24913010|NCT00761657|50007228|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
24913011|NCT00761657|50007229|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
24913012|NCT00761657|50007230|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
24913013|NCT00761657|50007231|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
24913014|NCT00761657|50007232|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
24913015|NCT00761657|50007233|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
24913016|NCT00761657|50007234|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
24913017|NCT00761657|50007235|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
24913018|NCT00761657|50007227|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
24913019|NCT00761657|50007228|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
24913020|NCT00761657|50007229|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
24913021|NCT00761657|50007230|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
24913022|NCT00761657|50007231|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
24913023|NCT00761657|50007232|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
24913024|NCT00761657|50007233|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
24913025|NCT00761657|50007234|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
24913026|NCT00761657|50007235|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
24913027|NCT00319501|50007267|FG000|Double-blind Period|Withdrawal by Subject|0|||
24913028|NCT00319501|50007268|FG001|Double-blind Period|Withdrawal by Subject|3|||
24913029|NCT00319501|50007267|FG000|Double-blind Period|Sponsor Request|1|||
24913030|NCT00319501|50007268|FG001|Double-blind Period|Sponsor Request|0|||
24913031|NCT00319501|50007267|FG000|Double-blind Period|Did not receive treatment|42|||
24913032|NCT00319501|50007268|FG001|Double-blind Period|Did not receive treatment|29|||
24913033|NCT00319501|50007267|FG000|Open-label Period|Adverse Event|5|||
25020184|NCT03482635|50116290|FG003|Overall Study|Adverse Event|3|||
25020185|NCT03482635|50116287|FG000|Overall Study|Withdrawal by Subject|2|||
25020186|NCT03482635|50116288|FG001|Overall Study|Withdrawal by Subject|1|||
25020187|NCT03482635|50116289|FG002|Overall Study|Withdrawal by Subject|0|||
25020188|NCT03482635|50116290|FG003|Overall Study|Withdrawal by Subject|1|||
25020189|NCT03482635|50116287|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
25020190|NCT03482635|50116288|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
25020191|NCT03482635|50116289|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
25020192|NCT03482635|50116290|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
25153149|NCT01687413|50268335|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
25153150|NCT01555671|50268361|FG000|Overall Study|Physician Decision|20|||
24913034|NCT00319501|50007268|FG001|Open-label Period|Adverse Event|0|||
24913035|NCT00319501|50007267|FG000|Open-label Period|Protocol Violation|6|||
24913036|NCT00319501|50007268|FG001|Open-label Period|Protocol Violation|0|||
24913037|NCT00319501|50007267|FG000|Open-label Period|Withdrawal by Subject|38|||
24913038|NCT00319501|50007268|FG001|Open-label Period|Withdrawal by Subject|0|||
24913039|NCT00319501|50007267|FG000|Open-label Period|Principal Investigator decision|6|||
24913040|NCT00319501|50007268|FG001|Open-label Period|Principal Investigator decision|0|||
24913041|NCT00319501|50007267|FG000|Open-label Period|Sponsor request|12|||
25020193|NCT03482635|50116287|FG000|Overall Study|Not treated|0|||
25020194|NCT03482635|50116288|FG001|Overall Study|Not treated|0|||
25020195|NCT03482635|50116289|FG002|Overall Study|Not treated|0|||
25020196|NCT03482635|50116290|FG003|Overall Study|Not treated|1|||
24913042|NCT00319501|50007268|FG001|Open-label Period|Sponsor request|0|||
24913043|NCT00319501|50007267|FG000|Open-label Period|Lost to Follow-up|5|||
24913044|NCT00319501|50007268|FG001|Open-label Period|Lost to Follow-up|0|||
24913045|NCT00319501|50007267|FG000|Open-label Period|Did not receive treatment|33|||
24913046|NCT00319501|50007268|FG001|Open-label Period|Did not receive treatment|0|||
24913047|NCT00319501|50007267|FG000|Open-label Period|Other|11|||
24913048|NCT00319501|50007268|FG001|Open-label Period|Other|0|||
24913049|NCT00319501|50007267|FG000|Open-label Extension Period|Adverse Event|2|||
24913050|NCT00319501|50007268|FG001|Open-label Extension Period|Adverse Event|0|||
24913051|NCT00319501|50007267|FG000|Open-label Extension Period|Did not receive treatment|18|||
24913052|NCT00319501|50007268|FG001|Open-label Extension Period|Did not receive treatment|0|||
24913053|NCT00319501|50007267|FG000|Open-label Extension Period|Other|1|||
24913054|NCT00319501|50007268|FG001|Open-label Extension Period|Other|0|||
24913055|NCT00319501|50007267|FG000|Open-label Extension Period|Principal investigator decision|2|||
25184977|NCT04115748|50334077|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
25184978|NCT04115748|50334078|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
24913056|NCT00319501|50007268|FG001|Open-label Extension Period|Principal investigator decision|0|||
24913057|NCT00319501|50007267|FG000|Open-label Extension Period|Sponsor request|26|||
24913058|NCT00319501|50007268|FG001|Open-label Extension Period|Sponsor request|0|||
24913059|NCT00319501|50007267|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
24913060|NCT00319501|50007268|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
24913061|NCT00761579|50007279|FG000|Overall Study|Adverse Event|10|||
24913062|NCT00761579|50007279|FG000|Overall Study|Death|2|||
24913063|NCT00761579|50007279|FG000|Overall Study|Lack of Efficacy|21|||
24913064|NCT00761579|50007279|FG000|Overall Study|Lost to Follow-up|16|||
24913065|NCT00761579|50007279|FG000|Overall Study|Pregnancy|1|||
24913066|NCT00761579|50007279|FG000|Overall Study|Withdrawal by Subject|34|||
24913067|NCT00761579|50007279|FG000|Overall Study|Lack of compliance|2|||
24913068|NCT00761579|50007279|FG000|Overall Study|Protocol deviation|1|||
24913069|NCT00761579|50007279|FG000|Overall Study|Drug overdose|1|||
24913070|NCT00761579|50007279|FG000|Overall Study|Aggravation of depression|1|||
24913071|NCT00761579|50007279|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
24913072|NCT00761579|50007279|FG000|Overall Study|Lost survey form|1|||
24913073|NCT00761579|50007279|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
24913074|NCT00627042|50007285|FG000|Overall Study|Withdrawal by Subject|2|||
24913075|NCT00319111|50007289|FG000|Overall Study|Adverse Event|20|||
24913076|NCT00319111|50007289|FG000|Overall Study|Withdrawal of consent|11|||
24913077|NCT00319111|50007289|FG000|Overall Study|Death|9|||
24913078|NCT00319111|50007289|FG000|Overall Study|Lack of clinical improvement|4|||
24913079|NCT00319111|50007289|FG000|Overall Study|Administrative|2|||
24913080|NCT00319111|50007289|FG000|Overall Study|Treatment failure|1|||
24913081|NCT00640224|50007297|FG000|Overall Study|Lost to Follow-up|5|||
24913082|NCT00640224|50007298|FG001|Overall Study|Lost to Follow-up|2|||
24913083|NCT00640224|50007299|FG002|Overall Study|Lost to Follow-up|0|||
24913084|NCT00640224|50007300|FG003|Overall Study|Lost to Follow-up|0|||
24913085|NCT00640224|50007297|FG000|Overall Study|Withdrawal by Subject|1|||
24913086|NCT00640224|50007298|FG001|Overall Study|Withdrawal by Subject|0|||
24913087|NCT00640224|50007299|FG002|Overall Study|Withdrawal by Subject|0|||
24913088|NCT00640224|50007300|FG003|Overall Study|Withdrawal by Subject|0|||
24913089|NCT00640224|50007297|FG000|Overall Study|Headaches|0|||
24913090|NCT00640224|50007298|FG001|Overall Study|Headaches|1|||
24913091|NCT00640224|50007299|FG002|Overall Study|Headaches|0|||
24913092|NCT00640224|50007300|FG003|Overall Study|Headaches|0|||
24913093|NCT00318643|50007315|FG000|Overall Study|Adverse Event|0|||
24913094|NCT00318643|50007316|FG001|Overall Study|Adverse Event|0|||
24913095|NCT00318643|50007317|FG002|Overall Study|Adverse Event|0|||
24913096|NCT00318643|50007318|FG003|Overall Study|Adverse Event|0|||
24913097|NCT00318643|50007319|FG004|Overall Study|Adverse Event|1|||
24913098|NCT00318643|50007315|FG000|Overall Study|Participant's Decision|0|||
24913099|NCT00318643|50007316|FG001|Overall Study|Participant's Decision|0|||
24913100|NCT00318643|50007317|FG002|Overall Study|Participant's Decision|0|||
24913101|NCT00318643|50007318|FG003|Overall Study|Participant's Decision|0|||
25020197|NCT03712787|50116304|FG000|Overall Study|Adverse Event|2|||
24913102|NCT00318643|50007319|FG004|Overall Study|Participant's Decision|1|||
24913103|NCT00318643|50007315|FG000|Overall Study|Investigator's Decision|0|||
25274923|NCT01241591|50589028|FG001|Overall Study|Protocol Violation|2|||
24913104|NCT00318643|50007316|FG001|Overall Study|Investigator's Decision|0|||
24913105|NCT00318643|50007317|FG002|Overall Study|Investigator's Decision|0|||
24913106|NCT00318643|50007318|FG003|Overall Study|Investigator's Decision|0|||
24913107|NCT00318643|50007319|FG004|Overall Study|Investigator's Decision|1|||
24913108|NCT00318565|50007332|FG000|Overall Study|Excluded per protocol|24|||
24913109|NCT00304915|50007338|FG000|Overall Study|Lost to Follow-up|11|||
24913110|NCT00304915|50007339|FG001|Overall Study|Lost to Follow-up|11|||
24913111|NCT00304915|50007338|FG000|Overall Study|Death|4|||
24913112|NCT00304915|50007339|FG001|Overall Study|Death|5|||
24913113|NCT00304915|50007338|FG000|Overall Study|Withdrawal by Subject|3|||
24913114|NCT00304915|50007339|FG001|Overall Study|Withdrawal by Subject|0|||
25020198|NCT03712787|50116305|FG001|Overall Study|Adverse Event|3|||
25020199|NCT03712787|50116306|FG002|Overall Study|Adverse Event|0|||
25153151|NCT01555671|50268362|FG001|Overall Study|Physician Decision|25|||
25153152|NCT01801358|50268376|FG000|Overall Study|Adverse Event|0|||
25153153|NCT01801358|50268377|FG001|Overall Study|Adverse Event|2|||
25153154|NCT01801358|50268378|FG002|Overall Study|Adverse Event|1|||
25153155|NCT01801358|50268379|FG003|Overall Study|Adverse Event|0|||
25153156|NCT01801358|50268380|FG004|Overall Study|Adverse Event|0|||
25153157|NCT01801358|50268381|FG005|Overall Study|Adverse Event|1|||
25153158|NCT01801358|50268376|FG000|Overall Study|Physician Decision|0|||
25153159|NCT01801358|50268377|FG001|Overall Study|Physician Decision|0|||
25153160|NCT01801358|50268378|FG002|Overall Study|Physician Decision|1|||
25153161|NCT01801358|50268379|FG003|Overall Study|Physician Decision|0|||
25153162|NCT01801358|50268380|FG004|Overall Study|Physician Decision|0|||
25153163|NCT01801358|50268381|FG005|Overall Study|Physician Decision|0|||
25153164|NCT01801358|50268376|FG000|Overall Study|Progressive Disease|6|||
25153165|NCT01801358|50268377|FG001|Overall Study|Progressive Disease|4|||
25153166|NCT01801358|50268378|FG002|Overall Study|Progressive Disease|4|||
25153167|NCT01801358|50268379|FG003|Overall Study|Progressive Disease|5|||
25153168|NCT01801358|50268380|FG004|Overall Study|Progressive Disease|6|||
25153169|NCT01801358|50268381|FG005|Overall Study|Progressive Disease|5|||
25153170|NCT01801358|50268376|FG000|Overall Study|Withdrawal by Subject|0|||
25153171|NCT01801358|50268377|FG001|Overall Study|Withdrawal by Subject|0|||
25153172|NCT01801358|50268378|FG002|Overall Study|Withdrawal by Subject|0|||
25153173|NCT01801358|50268379|FG003|Overall Study|Withdrawal by Subject|1|||
25153174|NCT01801358|50268380|FG004|Overall Study|Withdrawal by Subject|0|||
25153175|NCT01801358|50268381|FG005|Overall Study|Withdrawal by Subject|2|||
25153176|NCT01807598|50268416|FG000|Overall Study|Withdrawal by Subject|4|||
25153177|NCT01807598|50268416|FG000|Overall Study|Adverse Event|1|||
25153178|NCT01807598|50268416|FG000|Overall Study|Other Physician Decision|1|||
25153179|NCT01801280|50268424|FG000|Period 1|Withdrawal by Subject|0|||
25153180|NCT01801280|50268425|FG001|Period 1|Withdrawal by Subject|1|||
25153181|NCT01801280|50268426|FG002|Period 1|Withdrawal by Subject|0|||
25153182|NCT01801280|50268427|FG003|Period 1|Withdrawal by Subject|0|||
25153183|NCT01801280|50268424|FG000|Period 2|Withdrawal by Subject|1|||
25153184|NCT01801280|50268425|FG001|Period 2|Withdrawal by Subject|0|||
25153185|NCT01801280|50268426|FG002|Period 2|Withdrawal by Subject|0|||
25153186|NCT01801280|50268427|FG003|Period 2|Withdrawal by Subject|0|||
25153187|NCT01801280|50268424|FG000|Period 4|Protocol Violation|0|||
25153188|NCT01801280|50268425|FG001|Period 4|Protocol Violation|0|||
25153189|NCT01801280|50268426|FG002|Period 4|Protocol Violation|1|||
25153190|NCT01801280|50268427|FG003|Period 4|Protocol Violation|0|||
25153191|NCT01769456|50268437|FG000|Overall Study|Lost to Follow-up|19|||
25153192|NCT01769456|50268437|FG000|Overall Study|Withdrawal by Subject|3|||
25153193|NCT01769456|50268437|FG000|Overall Study|Did not receive PCC intervention|6|||
25153194|NCT01769456|50268437|FG000|Overall Study|Moved out of the area|3|||
25153195|NCT01769456|50268437|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
25153196|NCT01769456|50268437|FG000|Overall Study|Parental request to youth to withdraw|1|||
25153197|NCT01769378|50268444|FG000|Overall Study|Adverse Event|10|||
25153198|NCT01769378|50268445|FG001|Overall Study|Adverse Event|0|||
25153199|NCT01769378|50268444|FG000|Overall Study|Entry criteria not met|1|||
25153200|NCT01769378|50268445|FG001|Overall Study|Entry criteria not met|0|||
25153201|NCT01769378|50268444|FG000|Overall Study|Protocol Violation|1|||
25153202|NCT01769378|50268445|FG001|Overall Study|Protocol Violation|1|||
25153203|NCT01769378|50268444|FG000|Overall Study|Withdrawal by Subject|10|||
25153204|NCT01769378|50268445|FG001|Overall Study|Withdrawal by Subject|3|||
25020200|NCT03712787|50116307|FG003|Overall Study|Adverse Event|4|||
25020201|NCT03712787|50116304|FG000|Overall Study|Withdrawal by Subject|4|||
25020202|NCT03712787|50116305|FG001|Overall Study|Withdrawal by Subject|14|||
25020203|NCT03712787|50116306|FG002|Overall Study|Withdrawal by Subject|12|||
25020204|NCT03712787|50116307|FG003|Overall Study|Withdrawal by Subject|8|||
25020205|NCT03712787|50116304|FG000|Overall Study|Lost to Follow-up|1|||
25020206|NCT03712787|50116305|FG001|Overall Study|Lost to Follow-up|1|||
25020207|NCT03712787|50116306|FG002|Overall Study|Lost to Follow-up|2|||
25153205|NCT01769378|50268444|FG000|Overall Study|Sponsor Decision|1|||
25153206|NCT01769378|50268445|FG001|Overall Study|Sponsor Decision|0|||
25020208|NCT03712787|50116307|FG003|Overall Study|Lost to Follow-up|1|||
25020209|NCT03712787|50116304|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
25153207|NCT01769378|50268444|FG000|Overall Study|Lost to Follow-up|2|||
25153208|NCT01769378|50268445|FG001|Overall Study|Lost to Follow-up|0|||
25153209|NCT01807520|50268454|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
25153210|NCT01807520|50268455|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
25153211|NCT01807520|50268456|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
25020210|NCT03712787|50116305|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
25153212|NCT01807520|50268457|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
25153213|NCT01807520|50268458|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
25274924|NCT01241591|50589029|FG002|Overall Study|Protocol Violation|3|||
24913115|NCT03687970|50007347|FG000|Overall Study|visit scheduling conflicts|2|||
24913116|NCT03687970|50007348|FG001|Overall Study|visit scheduling conflicts|0|||
24913117|NCT00530920|50007359|FG000|Overall Study|Randomized but not treated|0|||
24913118|NCT00530920|50007360|FG001|Overall Study|Randomized but not treated|2|||
24913119|NCT00530920|50007361|FG002|Overall Study|Randomized but not treated|0|||
24913120|NCT00530920|50007359|FG000|Overall Study|Adverse Event|0|||
24913121|NCT00530920|50007360|FG001|Overall Study|Adverse Event|0|||
24913122|NCT00530920|50007361|FG002|Overall Study|Adverse Event|3|||
24913123|NCT00530920|50007359|FG000|Overall Study|Withdrawal by Subject|0|||
24913124|NCT00530920|50007360|FG001|Overall Study|Withdrawal by Subject|0|||
24913125|NCT00530920|50007361|FG002|Overall Study|Withdrawal by Subject|1|||
24913126|NCT03878758|50007370|FG000|Overall Study|Withdrawal by Subject|1|||
24913127|NCT03878758|50007370|FG000|Overall Study|Protocol defined|2|||
24913128|NCT03878758|50007370|FG000|Overall Study|Improper consent documentation|1|||
24913129|NCT03878602|50007385|FG000|Overall Study|cord blood donation|7|||
24913130|NCT03878602|50007386|FG001|Overall Study|cord blood donation|1|||
24913131|NCT03878602|50007385|FG000|Overall Study|incomplete data collection|2|||
24913132|NCT03878602|50007386|FG001|Overall Study|incomplete data collection|0|||
24913133|NCT00768755|50007398|FG000|Phase 1|Death|6|||
24913134|NCT00768755|50007399|FG001|Phase 1|Death|0|||
24913135|NCT00768755|50007400|FG002|Phase 1|Death|0|||
24913136|NCT00768755|50007401|FG003|Phase 1|Death|0|||
24913137|NCT00768755|50007398|FG000|Phase 1|Other|4|||
24913138|NCT00768755|50007399|FG001|Phase 1|Other|0|||
24913139|NCT00768755|50007400|FG002|Phase 1|Other|0|||
24913140|NCT00768755|50007401|FG003|Phase 1|Other|0|||
24913141|NCT00768755|50007398|FG000|Phase 2|Death|0|||
24913142|NCT00768755|50007399|FG001|Phase 2|Death|37|||
24913143|NCT00768755|50007400|FG002|Phase 2|Death|48|||
24913144|NCT00768755|50007401|FG003|Phase 2|Death|31|||
24913145|NCT00768755|50007398|FG000|Phase 2|Protocol Violation|0|||
24913146|NCT00768755|50007399|FG001|Phase 2|Protocol Violation|2|||
24913147|NCT00768755|50007400|FG002|Phase 2|Protocol Violation|0|||
24913148|NCT00768755|50007401|FG003|Phase 2|Protocol Violation|1|||
24913149|NCT00768755|50007398|FG000|Phase 2|Lost to Follow-up|0|||
24913150|NCT00768755|50007399|FG001|Phase 2|Lost to Follow-up|1|||
24913151|NCT00768755|50007400|FG002|Phase 2|Lost to Follow-up|1|||
24913152|NCT00768755|50007401|FG003|Phase 2|Lost to Follow-up|4|||
24913153|NCT00768755|50007398|FG000|Phase 2|Withdrawal by Subject|0|||
24913154|NCT00768755|50007399|FG001|Phase 2|Withdrawal by Subject|1|||
24913155|NCT00768755|50007400|FG002|Phase 2|Withdrawal by Subject|0|||
24913156|NCT00768755|50007401|FG003|Phase 2|Withdrawal by Subject|1|||
24913157|NCT00768755|50007398|FG000|Phase 2|Other|0|||
24913158|NCT00768755|50007399|FG001|Phase 2|Other|1|||
24913159|NCT00768755|50007400|FG002|Phase 2|Other|2|||
24913160|NCT00768755|50007401|FG003|Phase 2|Other|4|||
24913161|NCT00768755|50007398|FG000|Phase 2|Study Terminated by Sponsor|0|||
24913162|NCT00768755|50007399|FG001|Phase 2|Study Terminated by Sponsor|13|||
24913163|NCT00768755|50007400|FG002|Phase 2|Study Terminated by Sponsor|7|||
24913164|NCT00768755|50007401|FG003|Phase 2|Study Terminated by Sponsor|14|||
24913165|NCT00768755|50007398|FG000|Phase 2|Randomized but not treated|0|||
24913166|NCT00768755|50007399|FG001|Phase 2|Randomized but not treated|0|||
24913167|NCT00768755|50007400|FG002|Phase 2|Randomized but not treated|0|||
24913168|NCT00768755|50007401|FG003|Phase 2|Randomized but not treated|2|||
25153214|NCT01807520|50268459|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
25153215|NCT01807520|50268460|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
24913169|NCT00530842|50007412|FG000|Overall Study|Adverse Event|10|||
24913170|NCT00530842|50007413|FG001|Overall Study|Adverse Event|6|||
24913171|NCT00530842|50007412|FG000|Overall Study|Lack of Efficacy|2|||
24913172|NCT00530842|50007413|FG001|Overall Study|Lack of Efficacy|1|||
24913173|NCT00530842|50007412|FG000|Overall Study|Lost to Follow-up|0|||
24913174|NCT00530842|50007413|FG001|Overall Study|Lost to Follow-up|4|||
24913175|NCT00530842|50007412|FG000|Overall Study|Protocol Violation|3|||
24913176|NCT00530842|50007413|FG001|Overall Study|Protocol Violation|2|||
24913177|NCT00530842|50007412|FG000|Overall Study|Withdrawal by Subject|4|||
24913178|NCT00530842|50007413|FG001|Overall Study|Withdrawal by Subject|5|||
24913179|NCT00530842|50007412|FG000|Overall Study|Individual different reasons|4|||
24913180|NCT00530842|50007413|FG001|Overall Study|Individual different reasons|3|||
24913181|NCT00530842|50007412|FG000|Period 1|Adverse Event|7|||
24913182|NCT00530842|50007413|FG001|Period 1|Adverse Event|3|||
24913183|NCT00530842|50007412|FG000|Period 1|Lack of Efficacy|1|||
24913184|NCT00530842|50007413|FG001|Period 1|Lack of Efficacy|1|||
24913185|NCT00530842|50007412|FG000|Period 1|Protocol Violation|2|||
25020211|NCT03712787|50116306|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
25020212|NCT03712787|50116307|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
24913186|NCT00530842|50007413|FG001|Period 1|Protocol Violation|1|||
24913187|NCT00530842|50007412|FG000|Period 1|Withdrawal by Subject|2|||
24913188|NCT00530842|50007413|FG001|Period 1|Withdrawal by Subject|3|||
24913189|NCT00530842|50007412|FG000|Period 1|Individual different reasons|2|||
24913190|NCT00530842|50007413|FG001|Period 1|Individual different reasons|3|||
24913191|NCT00530842|50007412|FG000|Period 2|Adverse Event|3|||
24913192|NCT00530842|50007413|FG001|Period 2|Adverse Event|3|||
24913193|NCT00530842|50007412|FG000|Period 2|Lack of Efficacy|1|||
24913194|NCT00530842|50007413|FG001|Period 2|Lack of Efficacy|0|||
24913195|NCT00530842|50007412|FG000|Period 2|Lost to Follow-up|0|||
24913196|NCT00530842|50007413|FG001|Period 2|Lost to Follow-up|4|||
24913197|NCT00530842|50007412|FG000|Period 2|Protocol Violation|1|||
24913198|NCT00530842|50007413|FG001|Period 2|Protocol Violation|0|||
24913199|NCT00530842|50007412|FG000|Period 2|Withdrawal by Subject|1|||
24913200|NCT00530842|50007413|FG001|Period 2|Withdrawal by Subject|2|||
24913201|NCT00530842|50007412|FG000|Period 2|Individual different reasons|2|||
24913202|NCT00530842|50007413|FG001|Period 2|Individual different reasons|0|||
24913203|NCT03882424|50007424|FG000|Overall Study|Lost to Follow-up|3|||
24913204|NCT03882424|50007425|FG001|Overall Study|Lost to Follow-up|0|||
24913205|NCT03882424|50007426|FG002|Overall Study|Lost to Follow-up|0|||
25020213|NCT03712787|50116304|FG000|Overall Study|COVID-19 Infection|0|||
25020214|NCT03712787|50116305|FG001|Overall Study|COVID-19 Infection|1|||
25020215|NCT03712787|50116306|FG002|Overall Study|COVID-19 Infection|0|||
25020216|NCT03712787|50116307|FG003|Overall Study|COVID-19 Infection|0|||
25020217|NCT03712787|50116304|FG000|Overall Study|Other, Not Specified|79|||
25020218|NCT03712787|50116305|FG001|Overall Study|Other, Not Specified|77|||
25020219|NCT03712787|50116306|FG002|Overall Study|Other, Not Specified|74|||
25020220|NCT03712787|50116307|FG003|Overall Study|Other, Not Specified|78|||
25020221|NCT03048422|50116339|FG000|Overall Study|Death|1|||
25020222|NCT03048422|50116340|FG001|Overall Study|Death|0|||
25020223|NCT03048422|50116341|FG002|Overall Study|Death|0|||
25020224|NCT03048422|50116339|FG000|Overall Study|Lost to Follow-up|5|||
24913206|NCT03882424|50007424|FG000|Overall Study|schedule conflict|1|||
24913207|NCT03882424|50007425|FG001|Overall Study|schedule conflict|0|||
24913208|NCT03882424|50007426|FG002|Overall Study|schedule conflict|0|||
24913209|NCT03879772|50007439|FG000|Overall Study|Adverse Event|2|||
24913210|NCT03879772|50007440|FG001|Overall Study|Adverse Event|2|||
24913211|NCT03879772|50007441|FG002|Overall Study|Adverse Event|3|||
24913212|NCT03879772|50007442|FG003|Overall Study|Adverse Event|4|||
24913213|NCT03879772|50007443|FG004|Overall Study|Adverse Event|3|||
24913214|NCT03879772|50007439|FG000|Overall Study|Treatment Failure|1|||
24913215|NCT03879772|50007440|FG001|Overall Study|Treatment Failure|0|||
24913216|NCT03879772|50007441|FG002|Overall Study|Treatment Failure|0|||
24913217|NCT03879772|50007442|FG003|Overall Study|Treatment Failure|2|||
24913218|NCT03879772|50007443|FG004|Overall Study|Treatment Failure|1|||
24913219|NCT03879772|50007439|FG000|Overall Study|Lost to Follow-up|0|||
25020225|NCT03048422|50116340|FG001|Overall Study|Lost to Follow-up|0|||
25020226|NCT03048422|50116341|FG002|Overall Study|Lost to Follow-up|1|||
25020227|NCT03048422|50116339|FG000|Overall Study|Withdrawal by Subject|5|||
25020228|NCT03048422|50116340|FG001|Overall Study|Withdrawal by Subject|7|||
25020229|NCT03048422|50116341|FG002|Overall Study|Withdrawal by Subject|4|||
25020230|NCT03048422|50116339|FG000|Overall Study|Moved|3|||
25020231|NCT03048422|50116340|FG001|Overall Study|Moved|2|||
25020232|NCT03048422|50116341|FG002|Overall Study|Moved|2|||
25020233|NCT03048422|50116339|FG000|Overall Study|Noncompliant with Study Requirements|2|||
25020234|NCT03048422|50116340|FG001|Overall Study|Noncompliant with Study Requirements|1|||
25020235|NCT03048422|50116341|FG002|Overall Study|Noncompliant with Study Requirements|2|||
25020236|NCT03048422|50116339|FG000|Overall Study|Not Able to Get to Clinic|1|||
25020237|NCT03048422|50116340|FG001|Overall Study|Not Able to Get to Clinic|0|||
25020238|NCT03048422|50116341|FG002|Overall Study|Not Able to Get to Clinic|0|||
25020239|NCT04664855|50116361|FG000|Overall Study|Withdrawal by Subject|0|||
25020240|NCT04664855|50116362|FG001|Overall Study|Withdrawal by Subject|2|||
25153216|NCT01807520|50268454|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
25274925|NCT01241591|50589030|FG003|Overall Study|Protocol Violation|0|||
24913220|NCT03879772|50007440|FG001|Overall Study|Lost to Follow-up|0|||
24913221|NCT03879772|50007441|FG002|Overall Study|Lost to Follow-up|0|||
24913222|NCT03879772|50007442|FG003|Overall Study|Lost to Follow-up|0|||
25020241|NCT04664153|50116372|FG000|Overall Study|Lack of Efficacy|0|||
25020242|NCT04664153|50116373|FG001|Overall Study|Lack of Efficacy|0|||
25020243|NCT04664153|50116374|FG002|Overall Study|Lack of Efficacy|1|||
25020244|NCT04664153|50116375|FG003|Overall Study|Lack of Efficacy|0|||
25020245|NCT04664153|50116372|FG000|Overall Study|Physician Decision|0|||
25020246|NCT04664153|50116373|FG001|Overall Study|Physician Decision|0|||
25153217|NCT01807520|50268455|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
25153218|NCT01807520|50268456|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
25153219|NCT01807520|50268457|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
24913223|NCT03879772|50007443|FG004|Overall Study|Lost to Follow-up|1|||
24913224|NCT03879772|50007439|FG000|Overall Study|Withdrawal by Subject|0|||
24913225|NCT03879772|50007440|FG001|Overall Study|Withdrawal by Subject|1|||
24913226|NCT03879772|50007441|FG002|Overall Study|Withdrawal by Subject|3|||
24913227|NCT03879772|50007442|FG003|Overall Study|Withdrawal by Subject|1|||
24913228|NCT03879772|50007443|FG004|Overall Study|Withdrawal by Subject|1|||
24913229|NCT03879772|50007439|FG000|Overall Study|Protocol Violation|0|||
25020247|NCT04664153|50116374|FG002|Overall Study|Physician Decision|1|||
24913230|NCT03879772|50007440|FG001|Overall Study|Protocol Violation|0|||
24913231|NCT03879772|50007441|FG002|Overall Study|Protocol Violation|3|||
24913232|NCT03879772|50007442|FG003|Overall Study|Protocol Violation|1|||
24913233|NCT03879772|50007443|FG004|Overall Study|Protocol Violation|2|||
24913234|NCT03879772|50007439|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
24913235|NCT03879772|50007440|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
24913236|NCT03879772|50007441|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
24913237|NCT03879772|50007442|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
24913238|NCT03879772|50007443|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
24913239|NCT00642954|50007460|FG000|Overall Study|Progressive Disease|3|||
24913240|NCT00642954|50007461|FG001|Overall Study|Progressive Disease|3|||
24913241|NCT00642954|50007462|FG002|Overall Study|Progressive Disease|3|||
24913242|NCT00642954|50007463|FG003|Overall Study|Progressive Disease|3|||
24913243|NCT00642954|50007464|FG004|Overall Study|Progressive Disease|9|||
24913244|NCT00642954|50007460|FG000|Overall Study|Withdrawal by Subject|0|||
24913245|NCT00642954|50007461|FG001|Overall Study|Withdrawal by Subject|0|||
24913246|NCT00642954|50007462|FG002|Overall Study|Withdrawal by Subject|0|||
24913247|NCT00642954|50007463|FG003|Overall Study|Withdrawal by Subject|0|||
24913248|NCT00642954|50007464|FG004|Overall Study|Withdrawal by Subject|1|||
24913249|NCT00642954|50007460|FG000|Overall Study|Adverse Event|1|||
24913250|NCT00642954|50007461|FG001|Overall Study|Adverse Event|1|||
24913251|NCT00642954|50007462|FG002|Overall Study|Adverse Event|0|||
24913252|NCT00642954|50007463|FG003|Overall Study|Adverse Event|0|||
24913253|NCT00642954|50007464|FG004|Overall Study|Adverse Event|6|||
24913254|NCT00640146|50007478|FG000|Overall Study|Adverse Event|2|||
24913255|NCT00640146|50007479|FG001|Overall Study|Adverse Event|0|||
24913256|NCT00640146|50007478|FG000|Overall Study|Lost to Follow-up|0|||
24913257|NCT00640146|50007479|FG001|Overall Study|Lost to Follow-up|1|||
24913258|NCT00640146|50007478|FG000|Overall Study|Lack of Efficacy|0|||
24913259|NCT00640146|50007479|FG001|Overall Study|Lack of Efficacy|1|||
24913260|NCT00640146|50007478|FG000|Overall Study|Withdrawal by Subject|1|||
24913261|NCT00640146|50007479|FG001|Overall Study|Withdrawal by Subject|1|||
24913262|NCT00640146|50007478|FG000|Overall Study|Randomized but not treated|1|||
25020248|NCT04664153|50116375|FG003|Overall Study|Physician Decision|0|||
25020249|NCT04664153|50116372|FG000|Overall Study|Withdrawal by Subject|3|||
25020250|NCT04664153|50116373|FG001|Overall Study|Withdrawal by Subject|2|||
25020251|NCT04664153|50116374|FG002|Overall Study|Withdrawal by Subject|1|||
25020252|NCT04664153|50116375|FG003|Overall Study|Withdrawal by Subject|2|||
25020253|NCT04664153|50116372|FG000|Overall Study|Other|0|||
25020254|NCT04664153|50116373|FG001|Overall Study|Other|1|||
25020255|NCT04664153|50116374|FG002|Overall Study|Other|0|||
25020256|NCT04664153|50116375|FG003|Overall Study|Other|0|||
25020257|NCT04664153|50116372|FG000|Overall Study|Adverse Event|4|||
25020258|NCT04664153|50116373|FG001|Overall Study|Adverse Event|0|||
25020259|NCT04664153|50116374|FG002|Overall Study|Adverse Event|1|||
25020260|NCT04664153|50116375|FG003|Overall Study|Adverse Event|0|||
25020261|NCT04663295|50116387|FG000|Run-in Period|Withdrawal by Subject|3|||
25020262|NCT04663295|50116387|FG000|Overall Study Period|Pregnancy|1|||
25020263|NCT04663295|50116387|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
25020264|NCT04228445|50116398|FG000|Overall Study|Lost to Follow-up|1|||
25020265|NCT04228445|50116399|FG001|Overall Study|Lost to Follow-up|1|||
25020266|NCT04228445|50116398|FG000|Overall Study|Physician Decision|1|||
25020267|NCT04228445|50116399|FG001|Overall Study|Physician Decision|2|||
25020268|NCT04228445|50116398|FG000|Overall Study|Withdrawal by Subject|0|||
25020269|NCT04228445|50116399|FG001|Overall Study|Withdrawal by Subject|1|||
25020270|NCT04228445|50116398|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
24913263|NCT00640146|50007479|FG001|Overall Study|Randomized but not treated|3|||
24913264|NCT00317473|50007491|FG000|Overall Study|Withdrawal by Subject|2|||
24913265|NCT00317473|50007492|FG001|Overall Study|Withdrawal by Subject|1|||
24913266|NCT00317473|50007493|FG002|Overall Study|Withdrawal by Subject|2|||
24913267|NCT00317473|50007494|FG003|Overall Study|Withdrawal by Subject|1|||
24913268|NCT00317473|50007495|FG004|Overall Study|Withdrawal by Subject|3|||
24913269|NCT00317473|50007496|FG005|Overall Study|Withdrawal by Subject|1|||
24913270|NCT00317473|50007491|FG000|Overall Study|Relocation|1|||
24913271|NCT00317473|50007492|FG001|Overall Study|Relocation|0|||
24913272|NCT00317473|50007493|FG002|Overall Study|Relocation|1|||
24913273|NCT00317473|50007494|FG003|Overall Study|Relocation|1|||
24913274|NCT00317473|50007495|FG004|Overall Study|Relocation|5|||
24913275|NCT00317473|50007496|FG005|Overall Study|Relocation|2|||
24913276|NCT00317473|50007491|FG000|Overall Study|Death|1|||
24913277|NCT00317473|50007492|FG001|Overall Study|Death|0|||
24913278|NCT00317473|50007493|FG002|Overall Study|Death|0|||
25020271|NCT04228445|50116399|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
25020272|NCT04641299|50116411|FG000|Overall Study|Adverse Event|0|||
25020273|NCT04641299|50116412|FG001|Overall Study|Adverse Event|0|||
25020274|NCT04641299|50116413|FG002|Overall Study|Adverse Event|2|||
25020275|NCT04641299|50116414|FG003|Overall Study|Adverse Event|0|||
24913279|NCT00317473|50007494|FG003|Overall Study|Death|0|||
25020276|NCT04641299|50116411|FG000|Overall Study|Lost to Follow-up|0|||
25020277|NCT04641299|50116412|FG001|Overall Study|Lost to Follow-up|1|||
25020278|NCT04641299|50116413|FG002|Overall Study|Lost to Follow-up|0|||
25020279|NCT04641299|50116414|FG003|Overall Study|Lost to Follow-up|0|||
25020280|NCT04641299|50116411|FG000|Overall Study|Withdrawal by Subject|1|||
25020281|NCT04641299|50116412|FG001|Overall Study|Withdrawal by Subject|0|||
24913280|NCT00317473|50007495|FG004|Overall Study|Death|0|||
24913281|NCT00317473|50007496|FG005|Overall Study|Death|0|||
24913282|NCT00317473|50007491|FG000|Overall Study|Other|0|||
24913283|NCT00317473|50007492|FG001|Overall Study|Other|2|||
24913284|NCT00317473|50007493|FG002|Overall Study|Other|0|||
24913285|NCT00317473|50007494|FG003|Overall Study|Other|0|||
24913286|NCT00317473|50007495|FG004|Overall Study|Other|0|||
24913287|NCT00317473|50007496|FG005|Overall Study|Other|0|||
24913288|NCT00530218|50007520|FG000|Overall Study|CMV Not Detected|13|||
24913289|NCT00530218|50007520|FG000|Overall Study|Death|12|||
25020282|NCT04641299|50116413|FG002|Overall Study|Withdrawal by Subject|0|||
25020283|NCT04641299|50116414|FG003|Overall Study|Withdrawal by Subject|0|||
25020284|NCT04641299|50116411|FG000|Overall Study|Reason not given|1|||
25020285|NCT04641299|50116412|FG001|Overall Study|Reason not given|0|||
25020286|NCT04641299|50116413|FG002|Overall Study|Reason not given|0|||
25020287|NCT04641299|50116414|FG003|Overall Study|Reason not given|0|||
25020288|NCT03703817|50116430|FG000|Overall Study|Not meeting eligibility criteria|7|||
25020289|NCT03703817|50116431|FG001|Overall Study|Not meeting eligibility criteria|4|||
24913290|NCT00761267|50007530|FG000|Overall Study|Death|1|||
24913291|NCT00761267|50007531|FG001|Overall Study|Death|2|||
24913292|NCT00761267|50007532|FG002|Overall Study|Death|5|||
24913293|NCT00761267|50007530|FG000|Overall Study|Lost to Follow-up|0|||
24913294|NCT00761267|50007531|FG001|Overall Study|Lost to Follow-up|0|||
24913295|NCT00761267|50007532|FG002|Overall Study|Lost to Follow-up|1|||
24913296|NCT00761267|50007530|FG000|Overall Study|Randomized but not treated|1|||
24913297|NCT00761267|50007531|FG001|Overall Study|Randomized but not treated|1|||
24913298|NCT00761267|50007532|FG002|Overall Study|Randomized but not treated|0|||
24913299|NCT00761267|50007530|FG000|Overall Study|Withdrawal by Subject|0|||
24913300|NCT00761267|50007531|FG001|Overall Study|Withdrawal by Subject|1|||
24913301|NCT00761267|50007532|FG002|Overall Study|Withdrawal by Subject|0|||
24913302|NCT00303667|50007553|FG000|Overall Study|Death|0|||
24913303|NCT00303667|50007554|FG001|Overall Study|Death|4|||
24913304|NCT00761189|50007560|FG000|Overall Study|Adverse Event|42|||
25020290|NCT03698591|50116439|FG000|Overall Study|Withdrawal by Subject|2|||
25020291|NCT03698591|50116440|FG001|Overall Study|Withdrawal by Subject|2|||
25274926|NCT01241591|50589027|FG000|Overall Study|Lost to Follow-up|1|||
24913305|NCT00761189|50007560|FG000|Overall Study|Lack of Efficacy|45|||
24913306|NCT00761189|50007560|FG000|Overall Study|Lost to Follow-up|36|||
24913307|NCT00761189|50007560|FG000|Overall Study|Withdrawal by Subject|49|||
24913308|NCT00761189|50007560|FG000|Overall Study|Other|13|||
24913309|NCT00529516|50007567|FG000|Overall Study|Adverse Event|2|||
24913310|NCT00529516|50007568|FG001|Overall Study|Adverse Event|1|||
24913311|NCT00529516|50007569|FG002|Overall Study|Adverse Event|0|||
24913312|NCT00529516|50007567|FG000|Overall Study|Withdrawal by Subject|1|||
24913313|NCT00529516|50007568|FG001|Overall Study|Withdrawal by Subject|1|||
24913314|NCT00529516|50007569|FG002|Overall Study|Withdrawal by Subject|0|||
24913315|NCT00529516|50007567|FG000|Overall Study|Lost to Follow-up|0|||
24913316|NCT00529516|50007568|FG001|Overall Study|Lost to Follow-up|0|||
24913317|NCT00529516|50007569|FG002|Overall Study|Lost to Follow-up|1|||
24913318|NCT00316693|50007579|FG000|Overall Study|Adverse Event|6|||
24913319|NCT00316693|50007580|FG001|Overall Study|Adverse Event|1|||
25020292|NCT03698591|50116439|FG000|Overall Study|Failed drug screen|1|||
25020293|NCT03698591|50116440|FG001|Overall Study|Failed drug screen|1|||
25020294|NCT03698591|50116439|FG000|Overall Study|Failed health screen|0|||
25020295|NCT03698591|50116440|FG001|Overall Study|Failed health screen|1|||
25020296|NCT03698591|50116439|FG000|Overall Study|Ineligible for financial compensation|1|||
25020297|NCT03698591|50116440|FG001|Overall Study|Ineligible for financial compensation|0|||
25020298|NCT03698591|50116439|FG000|Overall Study|Equipment Error|1|||
25020299|NCT03698591|50116440|FG001|Overall Study|Equipment Error|0|||
25020300|NCT03698591|50116439|FG000|Overall Study|Could not establish TMS dosage|0|||
25020301|NCT03698591|50116440|FG001|Overall Study|Could not establish TMS dosage|1|||
25020302|NCT04606199|50116446|FG000|Overall Study|Withdrawal by Subject|2|||
25020303|NCT05085665|50116452|FG000|Overall Study|Physician Decision|2|||
25020304|NCT05017493|50116458|FG000|Overall Study|Withdrawal by Subject|26|||
25020305|NCT05017493|50116459|FG001|Overall Study|Withdrawal by Subject|0|||
25020306|NCT05017493|50116458|FG000|Overall Study|Physician Decision|15|||
25020307|NCT05017493|50116459|FG001|Overall Study|Physician Decision|0|||
25020308|NCT05017493|50116458|FG000|Overall Study|Protocol Violation|81|||
25020309|NCT05017493|50116459|FG001|Overall Study|Protocol Violation|0|||
25020310|NCT04599803|50116465|FG000|Overall Study|Withdrawal by Subject|5|||
25020311|NCT04599803|50116465|FG000|Overall Study|Lost to Follow-up|26|||
25020312|NCT05002985|50116469|FG000|Overall Study|Withdrawal by Subject|1|||
25020313|NCT04580303|50116475|FG000|Overall Study|Adverse Event|0|||
25020314|NCT04580303|50116476|FG001|Overall Study|Adverse Event|1|||
25020315|NCT04580303|50116477|FG002|Overall Study|Adverse Event|0|||
25020316|NCT04580303|50116478|FG003|Overall Study|Adverse Event|0|||
25020317|NCT04580303|50116475|FG000|Overall Study|Withdrawal by Subject|0|||
25020318|NCT04580303|50116476|FG001|Overall Study|Withdrawal by Subject|0|||
25020319|NCT04580303|50116477|FG002|Overall Study|Withdrawal by Subject|1|||
25020320|NCT04580303|50116478|FG003|Overall Study|Withdrawal by Subject|0|||
25020321|NCT04577183|50116488|FG000|Overall Study|Death|1|||
25020322|NCT04577183|50116488|FG000|Overall Study|Withdrawal by Subject|3|||
25020323|NCT04577183|50116488|FG000|Overall Study|Early termination|2|||
25020324|NCT03704051|50116492|FG000|Overall Study|Withdrawal by Subject|4|||
25020325|NCT03704051|50116493|FG001|Overall Study|Withdrawal by Subject|0|||
25020326|NCT04574999|50116503|FG000|Overall Study|Adverse Event|1|||
25020327|NCT04574999|50116504|FG001|Overall Study|Adverse Event|0|||
25020328|NCT04574999|50116503|FG000|Overall Study|Lack of Efficacy|2|||
25020329|NCT04574999|50116504|FG001|Overall Study|Lack of Efficacy|3|||
25020330|NCT04574999|50116503|FG000|Overall Study|Protocol Violation|1|||
25020331|NCT04574999|50116504|FG001|Overall Study|Protocol Violation|0|||
25020332|NCT04574999|50116503|FG000|Overall Study|Withdrawal by Subject|2|||
25020333|NCT04574999|50116504|FG001|Overall Study|Withdrawal by Subject|2|||
25020334|NCT04574999|50116503|FG000|Overall Study|Lost to Follow-up|1|||
25020335|NCT04574999|50116504|FG001|Overall Study|Lost to Follow-up|0|||
25020336|NCT04574999|50116503|FG000|Overall Study|Personal problems|1|||
25020337|NCT04574999|50116504|FG001|Overall Study|Personal problems|0|||
25020338|NCT04574999|50116503|FG000|Overall Study|Previous planned surgery|1|||
25020339|NCT04574999|50116504|FG001|Overall Study|Previous planned surgery|0|||
25020340|NCT04565249|50116514|FG000|Overall Study|Death|0|||
25020341|NCT04565249|50116515|FG001|Overall Study|Death|0|||
25020342|NCT04565249|50116516|FG002|Overall Study|Death|0|||
24913320|NCT00316693|50007579|FG000|Overall Study|Protocol Violation|1|||
25020343|NCT04565249|50116517|FG003|Overall Study|Death|1|||
25020344|NCT04942925|50116529|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
25020345|NCT04942925|50116530|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
25020346|NCT04942925|50116529|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
25020347|NCT04942925|50116530|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
25020348|NCT04854707|50116542|FG000|Overall Study|Lack of Efficacy|78|||
25020349|NCT04854707|50116543|FG001|Overall Study|Lack of Efficacy|59|||
25020350|NCT04854707|50116544|FG002|Overall Study|Lack of Efficacy|30|||
25020351|NCT04557371|50116559|FG000|Overall Study|Covid-19-related|0|||
25020352|NCT04557371|50116560|FG001|Overall Study|Covid-19-related|1|||
25020353|NCT04557371|50116561|FG002|Overall Study|Covid-19-related|0|||
25020354|NCT04557371|50116559|FG000|Overall Study|Withdrawal by Subject|0|||
24913321|NCT00316693|50007580|FG001|Overall Study|Protocol Violation|0|||
24913322|NCT00316693|50007579|FG000|Overall Study|Withdrawal by Subject|6|||
25020355|NCT04557371|50116560|FG001|Overall Study|Withdrawal by Subject|1|||
25020356|NCT04557371|50116561|FG002|Overall Study|Withdrawal by Subject|0|||
24913323|NCT00316693|50007580|FG001|Overall Study|Withdrawal by Subject|6|||
24913324|NCT00316693|50007579|FG000|Overall Study|Lost to Follow-up|26|||
24913325|NCT00316693|50007580|FG001|Overall Study|Lost to Follow-up|34|||
24913326|NCT00316693|50007579|FG000|Overall Study|Other|38|||
24913327|NCT00316693|50007580|FG001|Overall Study|Other|44|||
24913328|NCT00316303|50007588|FG000|Overall Study|Lost to Follow-up|11|||
24913329|NCT00316303|50007589|FG001|Overall Study|Lost to Follow-up|16|||
24913330|NCT00760877|50007600|FG000|Overall Study|Protocol Violation|1|||
24913331|NCT00760877|50007601|FG001|Overall Study|Protocol Violation|0|||
24913332|NCT00760877|50007600|FG000|Overall Study|Non-compliance with protocol treatment|2|||
24913333|NCT00760877|50007601|FG001|Overall Study|Non-compliance with protocol treatment|1|||
24913334|NCT00760877|50007600|FG000|Overall Study|Pregnancy|1|||
24913335|NCT00760877|50007601|FG001|Overall Study|Pregnancy|4|||
24913336|NCT00760877|50007600|FG000|Overall Study|Death|2|||
24913337|NCT00760877|50007601|FG001|Overall Study|Death|1|||
24913338|NCT00760877|50007600|FG000|Overall Study|Withdrawal by Subject|7|||
24913339|NCT00760877|50007601|FG001|Overall Study|Withdrawal by Subject|3|||
24913340|NCT00760877|50007600|FG000|Overall Study|Adverse Event|19|||
24913341|NCT00760877|50007601|FG001|Overall Study|Adverse Event|12|||
24913342|NCT00760877|50007600|FG000|Overall Study|Participant diagnosed with AML|0|||
24913343|NCT00760877|50007601|FG001|Overall Study|Participant diagnosed with AML|1|||
24913344|NCT00760877|50007600|FG000|Overall Study|Participant not eligible to cross-over|0|||
24913345|NCT00760877|50007601|FG001|Overall Study|Participant not eligible to cross-over|1|||
24913346|NCT00760877|50007600|FG000|Overall Study|Physician Decision|1|||
24913347|NCT00760877|50007601|FG001|Overall Study|Physician Decision|2|||
24913348|NCT00760877|50007600|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
24913349|NCT00760877|50007601|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
24913350|NCT00760877|50007600|FG000|Overall Study|Treatment failure|1|||
24913351|NCT00760877|50007601|FG001|Overall Study|Treatment failure|0|||
24913352|NCT00302731|50007612|FG000|Overall Study|Lost to Follow-up|1|||
24913353|NCT00302731|50007613|FG001|Overall Study|Lost to Follow-up|2|||
24913354|NCT00302731|50007614|FG002|Overall Study|Lost to Follow-up|0|||
24913355|NCT00302731|50007615|FG003|Overall Study|Lost to Follow-up|0|||
24913356|NCT00302731|50007612|FG000|Overall Study|Adverse Event|0|||
24913357|NCT00302731|50007613|FG001|Overall Study|Adverse Event|2|||
24913358|NCT00302731|50007614|FG002|Overall Study|Adverse Event|2|||
24913359|NCT00302731|50007615|FG003|Overall Study|Adverse Event|0|||
24913360|NCT00302731|50007612|FG000|Overall Study|Withdrawal by Subject|1|||
24913361|NCT00302731|50007613|FG001|Overall Study|Withdrawal by Subject|1|||
24913362|NCT00302731|50007614|FG002|Overall Study|Withdrawal by Subject|0|||
24913363|NCT00302731|50007615|FG003|Overall Study|Withdrawal by Subject|0|||
24913364|NCT00302731|50007612|FG000|Overall Study|Protocol Violation|1|||
24913365|NCT00302731|50007613|FG001|Overall Study|Protocol Violation|0|||
24913366|NCT00302731|50007614|FG002|Overall Study|Protocol Violation|0|||
24913367|NCT00302731|50007615|FG003|Overall Study|Protocol Violation|0|||
24913368|NCT00302731|50007612|FG000|Overall Study|cancer unrelated to study discovered|1|||
24913369|NCT00302731|50007613|FG001|Overall Study|cancer unrelated to study discovered|0|||
24913370|NCT00302731|50007614|FG002|Overall Study|cancer unrelated to study discovered|1|||
24913371|NCT00302731|50007615|FG003|Overall Study|cancer unrelated to study discovered|0|||
24913372|NCT00780143|50007625|FG000|Overall Study|Progressive disease|1|||
24913373|NCT00780143|50007625|FG000|Overall Study|Toxicity|1|||
24913374|NCT00780143|50007625|FG000|Overall Study|Adverse Event|1|||
24913375|NCT00779909|50007633|FG000|Overall Study|Lost to Follow-up|1|||
24913376|NCT00779909|50007634|FG001|Overall Study|Lost to Follow-up|0|||
24913377|NCT00779909|50007635|FG002|Overall Study|Lost to Follow-up|0|||
24913378|NCT00779909|50007636|FG003|Overall Study|Lost to Follow-up|1|||
24913379|NCT00779909|50007633|FG000|Overall Study|Withdrawal by Subject|0|||
24913380|NCT00779909|50007634|FG001|Overall Study|Withdrawal by Subject|1|||
24913381|NCT00779909|50007635|FG002|Overall Study|Withdrawal by Subject|0|||
24913382|NCT00779909|50007636|FG003|Overall Study|Withdrawal by Subject|0|||
24913383|NCT00302107|50007655|FG000|Overall Study|Lost to Follow-up|6|||
24913384|NCT00302107|50007656|FG001|Overall Study|Lost to Follow-up|5|||
24913385|NCT00302107|50007655|FG000|Overall Study|Protocol Violation|1|||
24913386|NCT00302107|50007656|FG001|Overall Study|Protocol Violation|0|||
24913387|NCT00302107|50007655|FG000|Overall Study|Relocation|0|||
24913388|NCT00302107|50007656|FG001|Overall Study|Relocation|1|||
25020357|NCT04557371|50116559|FG000|Overall Study|Adverse Event|1|||
24913389|NCT00302107|50007655|FG000|Overall Study|Withdrawal by Subject|0|||
24913390|NCT00302107|50007656|FG001|Overall Study|Withdrawal by Subject|3|||
24913391|NCT00302107|50007655|FG000|Overall Study|Adverse Event|1|||
24913392|NCT00302107|50007656|FG001|Overall Study|Adverse Event|0|||
24913393|NCT00760487|50007662|FG000|Overall Study|Unilateral implantation|3|||
24913394|NCT00316225|50007666|FG000|Overall Study|Adverse Event|2|||
24913395|NCT00316225|50007666|FG000|Overall Study|Physician Decision|3|||
24913396|NCT00316225|50007666|FG000|Overall Study|Progressive Disease|15|||
24913397|NCT00316225|50007666|FG000|Overall Study|Withdrawal by Subject|3|||
24913398|NCT00316225|50007666|FG000|Overall Study|Death|2|||
24913399|NCT00586703|50007670|FG000|Overall Study|Death|12|||
24913400|NCT00586625|50007676|FG000|Overall Study|Adverse Event|6|||
24913401|NCT00586625|50007677|FG001|Overall Study|Adverse Event|6|||
24913402|NCT00586625|50007676|FG000|Overall Study|Protocol Violation|3|||
24913403|NCT00586625|50007677|FG001|Overall Study|Protocol Violation|0|||
24913404|NCT00586625|50007676|FG000|Overall Study|Withdrawal by Subject|32|||
24913405|NCT00586625|50007677|FG001|Overall Study|Withdrawal by Subject|10|||
24913406|NCT00586625|50007676|FG000|Overall Study|Subject non-compliance|0|||
24913407|NCT00586625|50007677|FG001|Overall Study|Subject non-compliance|1|||
24913408|NCT00586625|50007676|FG000|Overall Study|Subject unable to return for visit|2|||
24913409|NCT00586625|50007677|FG001|Overall Study|Subject unable to return for visit|0|||
24913410|NCT00636168|50007685|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
24913411|NCT00636168|50007686|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
24913412|NCT00636168|50007685|FG000|Randomized to Study Drug|Adverse Event|1|||
24913413|NCT00636168|50007686|FG001|Randomized to Study Drug|Adverse Event|0|||
24913414|NCT00636168|50007685|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
24913415|NCT00636168|50007686|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
24913416|NCT00636168|50007685|FG000|Treated With Study Drug|Recurrence of disease|135|||
24913417|NCT00636168|50007686|FG001|Treated With Study Drug|Recurrence of disease|282|||
24913418|NCT00636168|50007685|FG000|Treated With Study Drug|Adverse Event|250|||
24913419|NCT00636168|50007686|FG001|Treated With Study Drug|Adverse Event|22|||
24913420|NCT00636168|50007685|FG000|Treated With Study Drug|Participant withdrew consent|16|||
24913421|NCT00636168|50007686|FG001|Treated With Study Drug|Participant withdrew consent|21|||
24913422|NCT00636168|50007685|FG000|Treated With Study Drug|Poor/non-compliance|1|||
24913423|NCT00636168|50007686|FG001|Treated With Study Drug|Poor/non-compliance|3|||
24913424|NCT00636168|50007685|FG000|Treated With Study Drug|Death|3|||
24913425|NCT00636168|50007686|FG001|Treated With Study Drug|Death|0|||
24913426|NCT00636168|50007685|FG000|Treated With Study Drug|Pregnancy|1|||
24913427|NCT00636168|50007686|FG001|Treated With Study Drug|Pregnancy|0|||
24913428|NCT00636168|50007685|FG000|Treated With Study Drug|No longer meets study criteria|1|||
24913429|NCT00636168|50007686|FG001|Treated With Study Drug|No longer meets study criteria|0|||
24913430|NCT00636168|50007685|FG000|Treated With Study Drug|Other reason|1|||
24913431|NCT00636168|50007686|FG001|Treated With Study Drug|Other reason|3|||
24913432|NCT00636168|50007685|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
24913433|NCT00636168|50007686|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
24913434|NCT00636168|50007685|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
24913435|NCT00636168|50007686|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
24913436|NCT00636168|50007685|FG000|Long Term Follow-Up|Death|8|||
24913437|NCT00636168|50007686|FG001|Long Term Follow-Up|Death|9|||
24913438|NCT00759941|50007694|FG000|Overall Study|Use of medication|1|||
24913439|NCT00759941|50007695|FG001|Overall Study|Use of medication|0|||
24913440|NCT00759941|50007694|FG000|Overall Study|Adverse Event|1|||
24913441|NCT00759941|50007695|FG001|Overall Study|Adverse Event|0|||
24913442|NCT00759941|50007694|FG000|Overall Study|Exited in error by site|1|||
24913443|NCT00759941|50007695|FG001|Overall Study|Exited in error by site|1|||
24913444|NCT00528424|50007701|FG000|Overall Study|Lost to Follow-up|13|||
24913445|NCT00528424|50007701|FG000|Overall Study|Withdrew consent|2|||
24913446|NCT00528424|50007701|FG000|Overall Study|Administrative reason|2|||
25020358|NCT04557371|50116560|FG001|Overall Study|Adverse Event|0|||
25020359|NCT04557371|50116561|FG002|Overall Study|Adverse Event|0|||
25020360|NCT04821245|50116569|FG000|Overall Study|Withdrawal by Subject|3|||
25020361|NCT04821245|50116569|FG000|Overall Study|Physician Decision|1|||
25020362|NCT04821245|50116569|FG000|Overall Study|Protocol Violation|5|||
24913447|NCT00528424|50007701|FG000|Overall Study|Other|12|||
24913448|NCT00315445|50007708|FG000|Overall Study|Adverse Event|7|||
24913449|NCT00315445|50007709|FG001|Overall Study|Adverse Event|12|||
24913450|NCT00315445|50007710|FG002|Overall Study|Adverse Event|15|||
24913451|NCT00315445|50007708|FG000|Overall Study|Lack of Efficacy|16|||
24913452|NCT00315445|50007709|FG001|Overall Study|Lack of Efficacy|1|||
24913453|NCT00315445|50007710|FG002|Overall Study|Lack of Efficacy|7|||
24913454|NCT00315445|50007708|FG000|Overall Study|Lost to Follow-up|1|||
24913455|NCT00315445|50007709|FG001|Overall Study|Lost to Follow-up|0|||
24913456|NCT00315445|50007710|FG002|Overall Study|Lost to Follow-up|1|||
24913457|NCT00315445|50007708|FG000|Overall Study|Protocol Violation|2|||
24913458|NCT00315445|50007709|FG001|Overall Study|Protocol Violation|0|||
24913459|NCT00315445|50007710|FG002|Overall Study|Protocol Violation|1|||
24913460|NCT00315445|50007708|FG000|Overall Study|Other|1|||
24913461|NCT00315445|50007709|FG001|Overall Study|Other|3|||
24913462|NCT00315445|50007710|FG002|Overall Study|Other|0|||
24913463|NCT03687736|50007718|FG000|Overall Study|Lost to Follow-up|7|||
24913464|NCT03687736|50007718|FG000|Overall Study|Withdrawal by Subject|3|||
24913465|NCT00779675|50007724|FG000|Treatment Period|Adverse Event|87|||
24913466|NCT00779675|50007724|FG000|Treatment Period|Treatment Failure|80|||
24913467|NCT00779675|50007724|FG000|Treatment Period|Transferred to Another Study|38|||
24913468|NCT00779675|50007724|FG000|Treatment Period|Lost to Follow-up|23|||
25020363|NCT04539275|50116577|FG000|Overall Study|Death|2|||
24913469|NCT00779675|50007724|FG000|Treatment Period|Withdrawal by Subject|46|||
24913470|NCT00779675|50007724|FG000|Treatment Period|Protocol Violation|54|||
24913471|NCT00779675|50007724|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
24913472|NCT00779675|50007724|FG000|Treatment Period|Administrative|3|||
24913473|NCT00779675|50007724|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
24913474|NCT00779675|50007724|FG000|Extended Treatment Period|Protocol Violation|13|||
24913475|NCT00779675|50007724|FG000|Extended Treatment Period|Adverse Event|6|||
24913476|NCT00779675|50007724|FG000|Extended Treatment Period|Treatment Failure|11|||
24913477|NCT00779675|50007724|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
25153220|NCT01807520|50268458|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
25153221|NCT01807520|50268459|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
25153222|NCT01807520|50268460|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
25153223|NCT01807520|50268454|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
25153224|NCT01807520|50268455|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
25153225|NCT01807520|50268456|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
25153226|NCT01807520|50268457|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
25153227|NCT01807520|50268458|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
25153228|NCT01807520|50268459|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
25153229|NCT01807520|50268460|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
25153230|NCT01807520|50268454|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
25153231|NCT01807520|50268455|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
25153232|NCT01807520|50268456|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
25153233|NCT01807520|50268457|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
25153234|NCT01807520|50268458|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
25153235|NCT01807520|50268459|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
25153236|NCT01807520|50268460|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
25153237|NCT01807520|50268454|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
25153238|NCT01807520|50268455|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
25153239|NCT01807520|50268456|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
25153240|NCT01807520|50268457|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
25153241|NCT01807520|50268458|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
25153242|NCT01807520|50268459|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
25153243|NCT01807520|50268460|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
25153244|NCT01807520|50268454|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
25153245|NCT01807520|50268455|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
25153246|NCT01807520|50268456|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
25153247|NCT01807520|50268457|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
25153248|NCT01807520|50268458|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
25153249|NCT01807520|50268459|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
25153250|NCT01807520|50268460|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
25153251|NCT01807520|50268454|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
25153252|NCT01807520|50268455|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
25153253|NCT01807520|50268456|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
25153254|NCT01807520|50268457|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
25153255|NCT01807520|50268458|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
25153256|NCT01807520|50268459|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
25153257|NCT01807520|50268460|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
25153258|NCT01807520|50268454|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
25153259|NCT01807520|50268455|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
25153260|NCT01807520|50268456|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
25153261|NCT01807520|50268457|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
25153262|NCT01807520|50268458|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
25153263|NCT01807520|50268459|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
25153264|NCT01807520|50268460|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
25153265|NCT01807520|50268454|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
25153266|NCT01807520|50268455|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
25153267|NCT01807520|50268456|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
25153268|NCT01807520|50268457|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
25153269|NCT01807520|50268458|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
25153270|NCT01807520|50268459|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
25153271|NCT01807520|50268460|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
25153272|NCT01807520|50268454|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
25153273|NCT01807520|50268455|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
25153274|NCT01807520|50268456|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
25153275|NCT01807520|50268457|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
25153276|NCT01807520|50268458|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
24913478|NCT00779675|50007724|FG000|Extended Treatment Period|Lost to Follow-up|6|||
24913479|NCT00759863|50007734|FG000|Overall Study|Death, moved, or lost contact|20|||
24913480|NCT00759863|50007735|FG001|Overall Study|Death, moved, or lost contact|18|||
24913481|NCT00759785|50007743|FG000|Overall Study|Participant sample not evaluable|11|||
24913482|NCT00759785|50007744|FG001|Overall Study|Participant sample not evaluable|2|||
24913483|NCT00759785|50007743|FG000|Overall Study|Participant sample lost|0|||
24913484|NCT00759785|50007744|FG001|Overall Study|Participant sample lost|1|||
24913485|NCT00759785|50007743|FG000|Overall Study|Protocol Violation|1|||
24913486|NCT00759785|50007744|FG001|Overall Study|Protocol Violation|0|||
24913487|NCT00759785|50007743|FG000|Overall Study|Physician Decision|0|||
24913488|NCT00759785|50007744|FG001|Overall Study|Physician Decision|1|||
24913489|NCT00759785|50007743|FG000|Overall Study|Withdrawal by Subject|0|||
24913490|NCT00759785|50007744|FG001|Overall Study|Withdrawal by Subject|1|||
24913491|NCT00300781|50007752|FG000|Overall Study|Disease Progression|55|||
24913492|NCT00300781|50007753|FG001|Overall Study|Disease Progression|52|||
24913493|NCT00300781|50007752|FG000|Overall Study|Adverse Event|5|||
24913494|NCT00300781|50007753|FG001|Overall Study|Adverse Event|6|||
24913495|NCT00300781|50007752|FG000|Overall Study|Withdrawal by Subject|1|||
24913496|NCT00300781|50007753|FG001|Overall Study|Withdrawal by Subject|2|||
24913497|NCT00300781|50007752|FG000|Overall Study|Physician Decision|1|||
24913498|NCT00300781|50007753|FG001|Overall Study|Physician Decision|0|||
24913499|NCT00300781|50007752|FG000|Overall Study|Not Recorded|0|||
24913500|NCT00300781|50007753|FG001|Overall Study|Not Recorded|1|||
24913501|NCT00300781|50007752|FG000|Overall Study|Symptomatic Deterioration|1|||
24913502|NCT00300781|50007753|FG001|Overall Study|Symptomatic Deterioration|0|||
24913503|NCT00300781|50007752|FG000|Overall Study|Lost to Follow-up|0|||
24913504|NCT00300781|50007753|FG001|Overall Study|Lost to Follow-up|1|||
24913505|NCT00315055|50007761|FG000|Overall Study|Protocol Violation|2|||
24913506|NCT00315055|50007762|FG001|Overall Study|Protocol Violation|4|||
24913507|NCT00315055|50007761|FG000|Overall Study|Lost to Follow-up|1|||
24913508|NCT00315055|50007762|FG001|Overall Study|Lost to Follow-up|1|||
24913509|NCT00528970|50007774|FG000|Overall Study|Adverse Event|6|||
25020364|NCT04539275|50116578|FG001|Overall Study|Death|4|||
25020365|NCT04539275|50116577|FG000|Overall Study|Lost to Follow-up|1|||
25020366|NCT04539275|50116578|FG001|Overall Study|Lost to Follow-up|1|||
25020367|NCT04539275|50116577|FG000|Overall Study|Withdrawal by Subject|3|||
25020368|NCT04539275|50116578|FG001|Overall Study|Withdrawal by Subject|0|||
25020369|NCT04784897|50116587|FG000|Overall Study|Death|4|||
25020370|NCT04784897|50116588|FG001|Overall Study|Death|2|||
25020371|NCT04784897|50116589|FG002|Overall Study|Death|1|||
25020372|NCT04784897|50116587|FG000|Overall Study|Withdrawal by Subject|0|||
25020373|NCT04784897|50116588|FG001|Overall Study|Withdrawal by Subject|0|||
25020374|NCT04784897|50116589|FG002|Overall Study|Withdrawal by Subject|1|||
25020375|NCT02780804|50116603|FG000|Overall Study|Death|1|||
25020376|NCT02780804|50116604|FG001|Overall Study|Death|0|||
25020377|NCT02780804|50116605|FG002|Overall Study|Death|0|||
25020378|NCT02780804|50116603|FG000|Overall Study|Lack of Efficacy|5|||
25020379|NCT02780804|50116604|FG001|Overall Study|Lack of Efficacy|8|||
25020380|NCT02780804|50116605|FG002|Overall Study|Lack of Efficacy|4|||
25020381|NCT02780804|50116603|FG000|Overall Study|Physician Decision|0|||
24913510|NCT00528970|50007775|FG001|Overall Study|Adverse Event|8|||
24913511|NCT00528970|50007776|FG002|Overall Study|Adverse Event|5|||
24913512|NCT00528970|50007774|FG000|Overall Study|Lost to Follow-up|0|||
24913513|NCT00528970|50007775|FG001|Overall Study|Lost to Follow-up|0|||
24913514|NCT00528970|50007776|FG002|Overall Study|Lost to Follow-up|1|||
24913515|NCT00528970|50007774|FG000|Overall Study|Other than specified|2|||
24913516|NCT00528970|50007775|FG001|Overall Study|Other than specified|3|||
24913517|NCT00528970|50007776|FG002|Overall Study|Other than specified|3|||
24913518|NCT00528970|50007774|FG000|Overall Study|Protocol Violation|2|||
24913519|NCT00528970|50007775|FG001|Overall Study|Protocol Violation|1|||
24913520|NCT00528970|50007776|FG002|Overall Study|Protocol Violation|4|||
24913521|NCT00528970|50007774|FG000|Overall Study|Lack of Efficacy|0|||
24913522|NCT00528970|50007775|FG001|Overall Study|Lack of Efficacy|0|||
25020382|NCT02780804|50116604|FG001|Overall Study|Physician Decision|0|||
25020383|NCT02780804|50116605|FG002|Overall Study|Physician Decision|2|||
24913523|NCT00528970|50007776|FG002|Overall Study|Lack of Efficacy|1|||
24913524|NCT00528970|50007774|FG000|Overall Study|Withdrawal by Subject|4|||
25020384|NCT02780804|50116603|FG000|Overall Study|Withdrawal by Subject|0|||
24913525|NCT00528970|50007775|FG001|Overall Study|Withdrawal by Subject|3|||
24913526|NCT00528970|50007776|FG002|Overall Study|Withdrawal by Subject|5|||
24913527|NCT00528970|50007774|FG000|Overall Study|Randomized but not treated|0|||
24913528|NCT00528970|50007775|FG001|Overall Study|Randomized but not treated|0|||
24913529|NCT00528970|50007776|FG002|Overall Study|Randomized but not treated|1|||
25020385|NCT02780804|50116604|FG001|Overall Study|Withdrawal by Subject|1|||
24913530|NCT00759395|50007786|FG000|Overall Study|Adverse Event|1|||
24913531|NCT00759395|50007787|FG001|Overall Study|Adverse Event|0|||
24913532|NCT00759395|50007786|FG000|Overall Study|Withdrawal by Subject|1|||
24913533|NCT00759395|50007787|FG001|Overall Study|Withdrawal by Subject|0|||
25020386|NCT02780804|50116605|FG002|Overall Study|Withdrawal by Subject|0|||
25020387|NCT04537949|50116622|FG000|Overall Study|personal reasons not related to the IMP|1|||
24913534|NCT00759395|50007786|FG000|Overall Study|Lack of Efficacy|0|||
24913535|NCT00759395|50007787|FG001|Overall Study|Lack of Efficacy|2|||
24913536|NCT00293293|50007795|FG000|Overall Study|Withdrawal by Subject|1|||
24913537|NCT00293293|50007796|FG001|Overall Study|Withdrawal by Subject|1|||
24913538|NCT00293293|50007795|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
24913539|NCT00293293|50007796|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
24913540|NCT00293293|50007795|FG000|Overall Study|Patient discontinued chemotherapy|0|||
24913541|NCT00293293|50007796|FG001|Overall Study|Patient discontinued chemotherapy|1|||
24913542|NCT04864639|50007803|FG000|Overall Study|Death|1|||
24913543|NCT04864639|50007803|FG000|Overall Study|Lost to Follow-up|1|||
25274927|NCT01241591|50589028|FG001|Overall Study|Lost to Follow-up|2|||
25274928|NCT01241591|50589029|FG002|Overall Study|Lost to Follow-up|2|||
25274929|NCT01241591|50589030|FG003|Overall Study|Lost to Follow-up|2|||
25274930|NCT01241591|50589027|FG000|Overall Study|Screen Failure|3|||
25274931|NCT01241591|50589028|FG001|Overall Study|Screen Failure|2|||
25274932|NCT01241591|50589029|FG002|Overall Study|Screen Failure|1|||
25274933|NCT01241591|50589030|FG003|Overall Study|Screen Failure|0|||
25274934|NCT01241591|50589027|FG000|Overall Study|Withdrawal by Subject|6|||
25274935|NCT01241591|50589028|FG001|Overall Study|Withdrawal by Subject|4|||
25274936|NCT01241591|50589029|FG002|Overall Study|Withdrawal by Subject|2|||
25274937|NCT01241591|50589030|FG003|Overall Study|Withdrawal by Subject|2|||
25274938|NCT01241591|50589027|FG000|Overall Study|Other|0|||
25274939|NCT01241591|50589028|FG001|Overall Study|Other|1|||
25274940|NCT01241591|50589029|FG002|Overall Study|Other|0|||
24913558|NCT04245449|50007837|FG000|Overall Study|COVID shutdown|7|||
24913559|NCT03887221|50007847|FG000|Overall Study|Protocol Violation|1|||
24913560|NCT03887221|50007848|FG001|Overall Study|Protocol Violation|0|||
24913561|NCT02782741|50007868|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
24913562|NCT02782741|50007869|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
24913563|NCT02782741|50007868|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
24913564|NCT02782741|50007869|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
24913565|NCT02782741|50007868|FG000|Open-label Long-term: Week 50 to 145|Adverse Event|2|||
24913566|NCT02782741|50007869|FG001|Open-label Long-term: Week 50 to 145|Adverse Event|1|||
24913567|NCT02782741|50007868|FG000|Open-label Long-term: Week 50 to 145|Other|1|||
24913568|NCT02782741|50007869|FG001|Open-label Long-term: Week 50 to 145|Other|0|||
24913569|NCT02782741|50007868|FG000|Open-label Long-term: Week 50 to 145|Ongoing|48|||
24913570|NCT02782741|50007869|FG001|Open-label Long-term: Week 50 to 145|Ongoing|43|||
24913571|NCT02771626|50007885|FG000|Overall Study|Adverse Event|1|||
24913572|NCT02771626|50007886|FG001|Overall Study|Adverse Event|5|||
25153277|NCT01807520|50268459|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
25153278|NCT01807520|50268460|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
25153279|NCT01807520|50268454|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
25153280|NCT01807520|50268455|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
24913573|NCT02771626|50007887|FG002|Overall Study|Adverse Event|3|||
24913574|NCT02771626|50007888|FG003|Overall Study|Adverse Event|0|||
24913575|NCT02771626|50007889|FG004|Overall Study|Adverse Event|1|||
24913576|NCT02771626|50007890|FG005|Overall Study|Adverse Event|1|||
24913577|NCT02771626|50007885|FG000|Overall Study|Radiologic Disease Progression|6|||
24913578|NCT02771626|50007886|FG001|Overall Study|Radiologic Disease Progression|13|||
24913579|NCT02771626|50007887|FG002|Overall Study|Radiologic Disease Progression|10|||
24913580|NCT02771626|50007888|FG003|Overall Study|Radiologic Disease Progression|7|||
24913581|NCT02771626|50007889|FG004|Overall Study|Radiologic Disease Progression|28|||
24913582|NCT02771626|50007890|FG005|Overall Study|Radiologic Disease Progression|15|||
24913583|NCT02771626|50007885|FG000|Overall Study|Symptomatic Deterioration|0|||
24913584|NCT02771626|50007886|FG001|Overall Study|Symptomatic Deterioration|4|||
24913585|NCT02771626|50007887|FG002|Overall Study|Symptomatic Deterioration|2|||
24913586|NCT02771626|50007888|FG003|Overall Study|Symptomatic Deterioration|0|||
24913587|NCT02771626|50007889|FG004|Overall Study|Symptomatic Deterioration|5|||
24913588|NCT02771626|50007890|FG005|Overall Study|Symptomatic Deterioration|2|||
24913589|NCT02771626|50007885|FG000|Overall Study|Participant Request|0|||
24913590|NCT02771626|50007886|FG001|Overall Study|Participant Request|1|||
24913591|NCT02771626|50007887|FG002|Overall Study|Participant Request|0|||
24913592|NCT02771626|50007888|FG003|Overall Study|Participant Request|2|||
24913593|NCT02771626|50007889|FG004|Overall Study|Participant Request|0|||
25274941|NCT01241591|50589030|FG003|Overall Study|Other|1|||
24913594|NCT02771626|50007890|FG005|Overall Study|Participant Request|1|||
24913595|NCT02771626|50007885|FG000|Overall Study|Investigator Decision|0|||
24913596|NCT02771626|50007886|FG001|Overall Study|Investigator Decision|1|||
24913597|NCT02771626|50007887|FG002|Overall Study|Investigator Decision|0|||
24913598|NCT02771626|50007888|FG003|Overall Study|Investigator Decision|0|||
24913599|NCT02771626|50007889|FG004|Overall Study|Investigator Decision|1|||
24913600|NCT02771626|50007890|FG005|Overall Study|Investigator Decision|0|||
24913601|NCT02771626|50007885|FG000|Overall Study|Study Termination by Sponsor|0|||
24913602|NCT02771626|50007886|FG001|Overall Study|Study Termination by Sponsor|2|||
24913603|NCT02771626|50007887|FG002|Overall Study|Study Termination by Sponsor|1|||
24913604|NCT02771626|50007888|FG003|Overall Study|Study Termination by Sponsor|0|||
24913605|NCT02771626|50007889|FG004|Overall Study|Study Termination by Sponsor|1|||
24913606|NCT02771626|50007890|FG005|Overall Study|Study Termination by Sponsor|0|||
24913607|NCT02771626|50007885|FG000|Overall Study|Informed Consent Withdrawn|0|||
24913608|NCT02771626|50007886|FG001|Overall Study|Informed Consent Withdrawn|0|||
24913609|NCT02771626|50007887|FG002|Overall Study|Informed Consent Withdrawn|1|||
24913610|NCT02771626|50007888|FG003|Overall Study|Informed Consent Withdrawn|0|||
24913611|NCT02771626|50007889|FG004|Overall Study|Informed Consent Withdrawn|1|||
24913612|NCT02771626|50007890|FG005|Overall Study|Informed Consent Withdrawn|1|||
24913613|NCT02771626|50007885|FG000|Overall Study|Other, Not Specified|1|||
24913614|NCT02771626|50007886|FG001|Overall Study|Other, Not Specified|0|||
24913615|NCT02771626|50007887|FG002|Overall Study|Other, Not Specified|0|||
24913616|NCT02771626|50007888|FG003|Overall Study|Other, Not Specified|0|||
24913617|NCT02771626|50007889|FG004|Overall Study|Other, Not Specified|0|||
24913618|NCT02771626|50007890|FG005|Overall Study|Other, Not Specified|1|||
24913619|NCT02272790|50007910|FG000|Overall Study|Physician Decision|0|||
24913620|NCT02272790|50007911|FG001|Overall Study|Physician Decision|1|||
24913621|NCT02272790|50007912|FG002|Overall Study|Physician Decision|0|||
24913622|NCT02272790|50007913|FG003|Overall Study|Physician Decision|0|||
24913623|NCT02272790|50007914|FG004|Overall Study|Physician Decision|0|||
24913624|NCT02272790|50007915|FG005|Overall Study|Physician Decision|0|||
24913625|NCT01464164|50007942|FG000|Overall Study|Screen failure|0|||
24913626|NCT01464164|50007943|FG001|Overall Study|Screen failure|1|||
24913627|NCT01464164|50007944|FG002|Overall Study|Screen failure|2|||
24913628|NCT01464164|50007945|FG003|Overall Study|Screen failure|0|||
24913629|NCT01464164|50007946|FG004|Overall Study|Screen failure|0|||
24913630|NCT01464164|50007947|FG005|Overall Study|Screen failure|0|||
24913631|NCT01464164|50007948|FG006|Overall Study|Screen failure|0|||
24913632|NCT01464164|50007942|FG000|Overall Study|Physician Decision|0|||
24913633|NCT01464164|50007943|FG001|Overall Study|Physician Decision|1|||
24913634|NCT01464164|50007944|FG002|Overall Study|Physician Decision|0|||
24913635|NCT01464164|50007945|FG003|Overall Study|Physician Decision|0|||
24913636|NCT01464164|50007946|FG004|Overall Study|Physician Decision|0|||
25020388|NCT04537949|50116623|FG001|Overall Study|personal reasons not related to the IMP|0|||
25020389|NCT04537949|50116624|FG002|Overall Study|personal reasons not related to the IMP|0|||
24913637|NCT01464164|50007947|FG005|Overall Study|Physician Decision|0|||
24913638|NCT01464164|50007948|FG006|Overall Study|Physician Decision|2|||
24913639|NCT01377389|50007964|FG000|Overall Study|Withdrawal by Subject|1|||
24913640|NCT01377389|50007964|FG000|Overall Study|Screen failure|2|||
24913641|NCT01194271|50007968|FG000|Overall Study|Withdrawal by Subject|1|||
24913642|NCT01194271|50007968|FG000|Overall Study|Ineligible, Screen Failure|1|||
24913643|NCT01194271|50007968|FG000|Overall Study|Death|1|||
24913644|NCT01119508|50007972|FG000|Overall Study|Adverse Event|56|||
24913645|NCT01119508|50007972|FG000|Overall Study|Withdrawal by Subject|2|||
24913646|NCT01119508|50007972|FG000|Overall Study|Died before tumor response evaluation|1|||
24913647|NCT00568776|50008003|FG000|Overall Study|Adverse Event|8|||
24913648|NCT00568776|50008004|FG001|Overall Study|Adverse Event|8|||
24913649|NCT00568776|50008005|FG002|Overall Study|Adverse Event|10|||
25020390|NCT04537949|50116625|FG003|Overall Study|personal reasons not related to the IMP|0|||
24913650|NCT00568776|50008006|FG003|Overall Study|Adverse Event|8|||
24913651|NCT00568776|50008003|FG000|Overall Study|Death|0|||
25020391|NCT04537949|50116626|FG004|Overall Study|personal reasons not related to the IMP|0|||
25020392|NCT04537949|50116627|FG005|Overall Study|personal reasons not related to the IMP|0|||
25020393|NCT04537949|50116628|FG006|Overall Study|personal reasons not related to the IMP|0|||
25020394|NCT04537949|50116629|FG007|Overall Study|personal reasons not related to the IMP|0|||
25020395|NCT04532099|50116650|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
25020396|NCT04532099|50116651|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
24913652|NCT00568776|50008004|FG001|Overall Study|Death|1|||
24913653|NCT00568776|50008005|FG002|Overall Study|Death|4|||
24913654|NCT00568776|50008006|FG003|Overall Study|Death|3|||
24913655|NCT00568776|50008003|FG000|Overall Study|Physician Decision|0|||
24913656|NCT00568776|50008004|FG001|Overall Study|Physician Decision|2|||
24913657|NCT00568776|50008005|FG002|Overall Study|Physician Decision|0|||
24913658|NCT00568776|50008006|FG003|Overall Study|Physician Decision|0|||
24913659|NCT00568776|50008003|FG000|Overall Study|Lack of Efficacy|2|||
24913660|NCT00568776|50008004|FG001|Overall Study|Lack of Efficacy|2|||
25020397|NCT04532099|50116652|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
25020398|NCT03041792|50116666|FG000|Overall Study|Adverse Event|4|||
24913661|NCT00568776|50008005|FG002|Overall Study|Lack of Efficacy|2|||
24913662|NCT00568776|50008006|FG003|Overall Study|Lack of Efficacy|4|||
24913663|NCT00568776|50008003|FG000|Overall Study|Lost to Follow-up|1|||
24913664|NCT00568776|50008004|FG001|Overall Study|Lost to Follow-up|1|||
24913665|NCT00568776|50008005|FG002|Overall Study|Lost to Follow-up|1|||
24913666|NCT00568776|50008006|FG003|Overall Study|Lost to Follow-up|1|||
24913667|NCT00568776|50008003|FG000|Overall Study|Protocol Violation|1|||
24913668|NCT00568776|50008004|FG001|Overall Study|Protocol Violation|0|||
24913669|NCT00568776|50008005|FG002|Overall Study|Protocol Violation|1|||
24913670|NCT00568776|50008006|FG003|Overall Study|Protocol Violation|1|||
24913671|NCT00568776|50008003|FG000|Overall Study|Withdrawal by Subject|13|||
24913672|NCT00568776|50008004|FG001|Overall Study|Withdrawal by Subject|15|||
24913673|NCT00568776|50008005|FG002|Overall Study|Withdrawal by Subject|13|||
25020399|NCT03041792|50116667|FG001|Overall Study|Adverse Event|0|||
25020400|NCT03041792|50116666|FG000|Overall Study|Death in the family|0|||
25020401|NCT03041792|50116667|FG001|Overall Study|Death in the family|2|||
25020402|NCT03041792|50116666|FG000|Overall Study|Randomized but not treated|0|||
25020403|NCT03041792|50116667|FG001|Overall Study|Randomized but not treated|1|||
25020404|NCT04507763|50116673|FG000|Overall Study|Participants did not meet entrance criteria|201|||
25020405|NCT03045302|50116680|FG000|Overall Study|Pre-treatment adverse event|1|||
25020406|NCT00705484|50116686|FG000|Overall Study|Adverse Event|28|||
25020407|NCT00705484|50116687|FG001|Overall Study|Adverse Event|27|||
25020408|NCT00705484|50116686|FG000|Overall Study|Lost to Follow-up|169|||
25020409|NCT00705484|50116687|FG001|Overall Study|Lost to Follow-up|250|||
25020410|NCT00705484|50116686|FG000|Overall Study|Withdrawal by Subject|96|||
25020411|NCT00705484|50116687|FG001|Overall Study|Withdrawal by Subject|72|||
25020412|NCT00705484|50116686|FG000|Overall Study|Administrative|89|||
24913674|NCT00568776|50008006|FG003|Overall Study|Withdrawal by Subject|7|||
24913675|NCT00568776|50008003|FG000|Overall Study|Loss of Caregiver|0|||
24913676|NCT00568776|50008004|FG001|Overall Study|Loss of Caregiver|2|||
24913677|NCT00568776|50008005|FG002|Overall Study|Loss of Caregiver|1|||
25020413|NCT00705484|50116687|FG001|Overall Study|Administrative|59|||
25020414|NCT04523831|50116697|FG000|Overall Study|Lost to Follow-up|15|||
25020415|NCT04523831|50116698|FG001|Overall Study|Lost to Follow-up|17|||
25020416|NCT04523831|50116697|FG000|Overall Study|Death|0|||
25020417|NCT04523831|50116698|FG001|Overall Study|Death|3|||
25020418|NCT04523831|50116697|FG000|Overall Study|Adverse Event|2|||
24913678|NCT00568776|50008006|FG003|Overall Study|Loss of Caregiver|2|||
24913679|NCT00568776|50008003|FG000|Overall Study|Sponsor Decision|2|||
24913680|NCT00568776|50008004|FG001|Overall Study|Sponsor Decision|2|||
24913681|NCT00568776|50008005|FG002|Overall Study|Sponsor Decision|41|||
24913682|NCT00568776|50008006|FG003|Overall Study|Sponsor Decision|42|||
24913683|NCT00568776|50008003|FG000|Overall Study|Miscellaeneous|3|||
24913684|NCT00568776|50008004|FG001|Overall Study|Miscellaeneous|3|||
24913685|NCT00568776|50008005|FG002|Overall Study|Miscellaeneous|1|||
24913686|NCT00568776|50008006|FG003|Overall Study|Miscellaeneous|4|||
24913687|NCT00758771|50008018|FG000|Overall Study|Withdrawal by Subject|1|||
24913688|NCT00758771|50008019|FG001|Overall Study|Withdrawal by Subject|1|||
24913689|NCT00758771|50008018|FG000|Overall Study|Did not meet eligibility criteria|2|||
24913690|NCT00758771|50008019|FG001|Overall Study|Did not meet eligibility criteria|4|||
24913691|NCT00635154|50008025|FG000|Overall Study|Alternative Treatment|8|||
24913692|NCT00635154|50008025|FG000|Overall Study|Other|4|||
24913693|NCT00635154|50008025|FG000|Overall Study|Still on treatment|21|||
24913694|NCT00778895|50008034|FG000|Active Phase|Adverse Event|3|||
24913695|NCT00778895|50008035|FG001|Active Phase|Adverse Event|1|||
24913696|NCT00778895|50008036|FG002|Active Phase|Adverse Event|0|||
24913697|NCT00778895|50008034|FG000|Active Phase|Withdrawal by Subject|1|||
24913698|NCT00778895|50008035|FG001|Active Phase|Withdrawal by Subject|4|||
24913699|NCT00778895|50008036|FG002|Active Phase|Withdrawal by Subject|0|||
24913700|NCT00778895|50008034|FG000|Active Phase|Lost to Follow-up|1|||
24913701|NCT00778895|50008035|FG001|Active Phase|Lost to Follow-up|1|||
24913702|NCT00778895|50008036|FG002|Active Phase|Lost to Follow-up|0|||
24913703|NCT00778895|50008034|FG000|Active Phase|Other|2|||
24913704|NCT00778895|50008035|FG001|Active Phase|Other|0|||
24913705|NCT00778895|50008036|FG002|Active Phase|Other|0|||
24913706|NCT00778895|50008034|FG000|ESFU Phase|Adverse Event|2|||
24913707|NCT00778895|50008035|FG001|ESFU Phase|Adverse Event|1|||
24913708|NCT00778895|50008036|FG002|ESFU Phase|Adverse Event|0|||
24913709|NCT00778895|50008034|FG000|ESFU Phase|Withdrawal by Subject|1|||
24913710|NCT00778895|50008035|FG001|ESFU Phase|Withdrawal by Subject|4|||
24913711|NCT00778895|50008036|FG002|ESFU Phase|Withdrawal by Subject|0|||
24913712|NCT00778895|50008034|FG000|ESFU Phase|Lost to Follow-up|6|||
25274942|NCT01241591|50589027|FG000|Overall Study|Adverse Event|3|||
24913713|NCT00778895|50008035|FG001|ESFU Phase|Lost to Follow-up|7|||
24913714|NCT00778895|50008036|FG002|ESFU Phase|Lost to Follow-up|2|||
24913715|NCT00778895|50008034|FG000|ESFU Phase|Other|2|||
24913716|NCT00778895|50008035|FG001|ESFU Phase|Other|0|||
24913717|NCT00778895|50008036|FG002|ESFU Phase|Other|0|||
24913718|NCT00293215|50008047|FG000|Overall Study|Progressive disease|3|||
24913719|NCT00293215|50008048|FG001|Overall Study|Progressive disease|1|||
24913720|NCT00293215|50008047|FG000|Overall Study|Adverse Event|2|||
24913721|NCT00293215|50008048|FG001|Overall Study|Adverse Event|2|||
24913722|NCT00778817|50008054|FG000|Overall Study|Adverse Event|2|||
24913723|NCT00778817|50008054|FG000|Overall Study|Withdrawal by Subject|2|||
24913724|NCT00293059|50008060|FG000|Overall Study|Adverse Event|12|||
24913725|NCT00293059|50008061|FG001|Overall Study|Adverse Event|4|||
24913726|NCT00293059|50008060|FG000|Overall Study|Lack of Efficacy|2|||
25020419|NCT04523831|50116698|FG001|Overall Study|Adverse Event|0|||
25020420|NCT04707664|50116709|FG000|Overall Study|Adverse Event|2|||
25020421|NCT04707664|50116710|FG001|Overall Study|Adverse Event|0|||
25020422|NCT04707664|50116709|FG000|Overall Study|Death|1|||
25020423|NCT04707664|50116710|FG001|Overall Study|Death|2|||
25020424|NCT04707664|50116709|FG000|Overall Study|Withdrawal by Subject|13|||
25274943|NCT01241591|50589028|FG001|Overall Study|Adverse Event|11|||
25274944|NCT01241591|50589029|FG002|Overall Study|Adverse Event|12|||
24913727|NCT00293059|50008061|FG001|Overall Study|Lack of Efficacy|0|||
24913728|NCT00293059|50008060|FG000|Overall Study|Lost to Follow-up|2|||
24913729|NCT00293059|50008061|FG001|Overall Study|Lost to Follow-up|3|||
25020425|NCT04707664|50116710|FG001|Overall Study|Withdrawal by Subject|21|||
25020426|NCT04707664|50116709|FG000|Overall Study|Lost to Follow-up|11|||
25020427|NCT04707664|50116710|FG001|Overall Study|Lost to Follow-up|13|||
25020428|NCT04707664|50116709|FG000|Overall Study|Not treated|2|||
25020429|NCT04707664|50116710|FG001|Overall Study|Not treated|0|||
25020430|NCT01316276|50116716|FG000|Overall Study|Death|1|||
25020431|NCT01316276|50116716|FG000|Overall Study|Adverse Event|19|||
25020432|NCT01316276|50116716|FG000|Overall Study|Withdrawal of consent|24|||
25020433|NCT01316276|50116716|FG000|Overall Study|Lost to Follow-up|1|||
25020434|NCT01316276|50116716|FG000|Overall Study|Other|22|||
25020435|NCT04668989|50116721|FG000|First Intervention|Covid-19 related self-isolation|0|||
25020436|NCT04668989|50116722|FG001|First Intervention|Covid-19 related self-isolation|1|||
25020437|NCT04668989|50116721|FG000|Second Intervention|Adverse Event|0|||
25020438|NCT04668989|50116722|FG001|Second Intervention|Adverse Event|1|||
25020439|NCT03700385|50116728|FG000|Overall Study|Lost to Follow-up|1|||
25020440|NCT04498403|50116734|FG000|Overall Study|Adverse Event|1|||
25020441|NCT04498403|50116735|FG001|Overall Study|Adverse Event|0|||
25020442|NCT04498403|50116734|FG000|Overall Study|Study Terminated By Sponsor|29|||
25020443|NCT04498403|50116735|FG001|Overall Study|Study Terminated By Sponsor|10|||
25020444|NCT04362137|50116743|FG000|Overall Study|Death|9|||
24913730|NCT00293059|50008060|FG000|Overall Study|Pregnancy|1|||
24913731|NCT00293059|50008061|FG001|Overall Study|Pregnancy|1|||
24913732|NCT00293059|50008060|FG000|Overall Study|Protocol Violation|2|||
24913733|NCT00293059|50008061|FG001|Overall Study|Protocol Violation|0|||
25020445|NCT04362137|50116744|FG001|Overall Study|Death|3|||
25020446|NCT04362137|50116743|FG000|Overall Study|Patient decision|6|||
25020447|NCT04362137|50116744|FG001|Overall Study|Patient decision|3|||
25020448|NCT04362137|50116743|FG000|Overall Study|Adverse Event|1|||
24913734|NCT00293059|50008060|FG000|Overall Study|Withdrawal by Subject|11|||
24913735|NCT00293059|50008061|FG001|Overall Study|Withdrawal by Subject|5|||
24913736|NCT00293059|50008060|FG000|Overall Study|Participant moved out of state|1|||
24913737|NCT00293059|50008061|FG001|Overall Study|Participant moved out of state|0|||
24913738|NCT00293059|50008060|FG000|Overall Study|Participant stopped study drug|1|||
24913739|NCT00293059|50008061|FG001|Overall Study|Participant stopped study drug|0|||
24913740|NCT00293059|50008060|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
24913741|NCT00293059|50008061|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
24913742|NCT00293059|50008060|FG000|Overall Study|missing|3|||
24913743|NCT00293059|50008061|FG001|Overall Study|missing|5|||
24913744|NCT00756275|50008069|FG000|Overall Study|Lost to Follow-up|25|||
24913745|NCT00756275|50008070|FG001|Overall Study|Lost to Follow-up|21|||
24913746|NCT00756275|50008069|FG000|Overall Study|Withdrawal by Subject|4|||
24913747|NCT00756275|50008070|FG001|Overall Study|Withdrawal by Subject|7|||
24913748|NCT00758459|50008078|FG000|Overall Study|Adverse Event|3|||
24913749|NCT00758459|50008079|FG001|Overall Study|Adverse Event|2|||
24913750|NCT00758459|50008078|FG000|Overall Study|Protocol Violation|0|||
24913751|NCT00758459|50008079|FG001|Overall Study|Protocol Violation|1|||
24913752|NCT00758459|50008078|FG000|Overall Study|Withdrawal by Subject|0|||
24913753|NCT00758459|50008079|FG001|Overall Study|Withdrawal by Subject|1|||
24913754|NCT00298831|50008085|FG000|Overall Study|Adverse Event|1|||
24913755|NCT00298831|50008085|FG000|Overall Study|Lost to Follow-up|3|||
24913756|NCT00298831|50008085|FG000|Overall Study|Withdrawal by Subject|1|||
24913757|NCT00298831|50008085|FG000|Overall Study|Participants did not receive treatment|27|||
24913758|NCT00758069|50008092|FG000|Overall Study|Lack of Efficacy|0|||
24913759|NCT00758069|50008093|FG001|Overall Study|Lack of Efficacy|0|||
24913760|NCT00758069|50008094|FG002|Overall Study|Lack of Efficacy|1|||
24913761|NCT00758069|50008092|FG000|Overall Study|Incorrect Study Drug|1|||
24913762|NCT00758069|50008093|FG001|Overall Study|Incorrect Study Drug|0|||
25020449|NCT04362137|50116744|FG001|Overall Study|Adverse Event|0|||
25020450|NCT04362137|50116743|FG000|Overall Study|Lost to Follow-up|1|||
25020451|NCT04362137|50116744|FG001|Overall Study|Lost to Follow-up|0|||
25020452|NCT04362137|50116743|FG000|Overall Study|Protocol deviation|1|||
25020453|NCT04362137|50116744|FG001|Overall Study|Protocol deviation|0|||
24913763|NCT00758069|50008094|FG002|Overall Study|Incorrect Study Drug|0|||
24913764|NCT00311623|50008105|FG000|Overall Study|Physician Decision|0|||
24913765|NCT00311623|50008106|FG001|Overall Study|Physician Decision|0|||
24913766|NCT00311623|50008107|FG002|Overall Study|Physician Decision|2|||
24913767|NCT00528112|50008118|FG000|Treatment up to 3 Years|Adverse Event|313|||
24913768|NCT00528112|50008119|FG001|Treatment up to 3 Years|Adverse Event|278|||
24913769|NCT00528112|50008118|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
25020454|NCT05099380|50116752|FG000|Overall Study|Subject enrolled in error|1|||
25020455|NCT05099380|50116753|FG001|Overall Study|Subject enrolled in error|0|||
24913770|NCT00528112|50008119|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
25020456|NCT05099380|50116752|FG000|Overall Study|Study Procedure|1|||
25020457|NCT05099380|50116753|FG001|Overall Study|Study Procedure|0|||
24913771|NCT00528112|50008118|FG000|Treatment up to 3 Years|Protocol Violation|16|||
24913772|NCT00528112|50008119|FG001|Treatment up to 3 Years|Protocol Violation|16|||
24913773|NCT00528112|50008118|FG000|Treatment up to 3 Years|Death|0|||
24913774|NCT00528112|50008119|FG001|Treatment up to 3 Years|Death|1|||
24913775|NCT00528112|50008118|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
24913776|NCT00528112|50008119|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
24913777|NCT00528112|50008118|FG000|Treatment up to 3 Years|Pregnancy|9|||
24913778|NCT00528112|50008119|FG001|Treatment up to 3 Years|Pregnancy|10|||
24913779|NCT00528112|50008118|FG000|Treatment up to 3 Years|Other reasons|186|||
24913780|NCT00528112|50008119|FG001|Treatment up to 3 Years|Other reasons|186|||
24913781|NCT00528112|50008118|FG000|Extension Phase|Withdrawal by Subject|0|||
24913782|NCT00528112|50008119|FG001|Extension Phase|Withdrawal by Subject|3|||
24913783|NCT00528112|50008118|FG000|Extension Phase|Other reasons|0|||
24913784|NCT00528112|50008119|FG001|Extension Phase|Other reasons|100|||
24913785|NCT00528112|50008118|FG000|Extension Phase|Pregnancy|0|||
24913786|NCT00528112|50008119|FG001|Extension Phase|Pregnancy|3|||
24913787|NCT00528112|50008118|FG000|Extension Phase|Lost to Follow-up|0|||
24913788|NCT00528112|50008119|FG001|Extension Phase|Lost to Follow-up|12|||
24913789|NCT00528112|50008118|FG000|Extension Phase|Death|0|||
24913790|NCT00528112|50008119|FG001|Extension Phase|Death|1|||
24913791|NCT00528112|50008118|FG000|Extension Phase|Adverse Event|0|||
24913792|NCT00528112|50008119|FG001|Extension Phase|Adverse Event|36|||
25274945|NCT01241591|50589030|FG003|Overall Study|Adverse Event|4|||
25274946|NCT00906373|50589042|FG000|Overall Study|Withdrawal by Subject|0|||
25274947|NCT00906373|50589043|FG001|Overall Study|Withdrawal by Subject|5|||
25274948|NCT00906373|50589042|FG000|Overall Study|Other|0|||
25274949|NCT00906373|50589043|FG001|Overall Study|Other|1|||
25274950|NCT00906373|50589042|FG000|Overall Study|Still on treatment at cutoff date|0|||
25274951|NCT00906373|50589043|FG001|Overall Study|Still on treatment at cutoff date|2|||
24913793|NCT00528112|50008118|FG000|Extension Phase|Protocol Violation|0|||
24913794|NCT00528112|50008119|FG001|Extension Phase|Protocol Violation|2|||
24913795|NCT00633594|50008130|FG000|Overall Study|Adverse Event|0|||
24913796|NCT00633594|50008131|FG001|Overall Study|Adverse Event|4|||
24913797|NCT00633594|50008132|FG002|Overall Study|Adverse Event|7|||
24913798|NCT00633594|50008130|FG000|Overall Study|Death|0|||
24913799|NCT00633594|50008131|FG001|Overall Study|Death|1|||
25020458|NCT05099380|50116752|FG000|Overall Study|Protocol Violation|1|||
25020459|NCT05099380|50116753|FG001|Overall Study|Protocol Violation|0|||
25020460|NCT05099380|50116752|FG000|Overall Study|Adverse Event|1|||
25020461|NCT05099380|50116753|FG001|Overall Study|Adverse Event|1|||
25020462|NCT05099380|50116752|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
25020463|NCT05099380|50116753|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
25153281|NCT01807520|50268456|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
25153282|NCT01807520|50268457|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
25153283|NCT01807520|50268458|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
24913800|NCT00633594|50008132|FG002|Overall Study|Death|2|||
24913801|NCT00633594|50008130|FG000|Overall Study|Disease Progression|0|||
24913802|NCT00633594|50008131|FG001|Overall Study|Disease Progression|0|||
24913803|NCT00633594|50008132|FG002|Overall Study|Disease Progression|1|||
24913804|NCT00755807|50008145|FG000|Acute Phase|Adverse Event|16|||
24913805|NCT00755807|50008146|FG001|Acute Phase|Adverse Event|5|||
24913806|NCT00755807|50008145|FG000|Acute Phase|Protocol Violation|1|||
25274952|NCT00905437|50589052|FG000|Overall Study|Adverse Event|3|||
24913807|NCT00755807|50008146|FG001|Acute Phase|Protocol Violation|3|||
24913808|NCT00755807|50008145|FG000|Acute Phase|Withdrawal by Subject|1|||
24913809|NCT00755807|50008146|FG001|Acute Phase|Withdrawal by Subject|2|||
24913810|NCT00755807|50008145|FG000|Acute Phase|Lack of Efficacy|0|||
24913811|NCT00755807|50008146|FG001|Acute Phase|Lack of Efficacy|1|||
24913812|NCT00755807|50008145|FG000|Acute Phase|Physician Decision|0|||
24913813|NCT00755807|50008146|FG001|Acute Phase|Physician Decision|1|||
24913814|NCT00755807|50008145|FG000|Open-label Extension Phase|Adverse Event|7|||
24913815|NCT00755807|50008146|FG001|Open-label Extension Phase|Adverse Event|7|||
24913816|NCT00755807|50008145|FG000|Open-label Extension Phase|Protocol Violation|5|||
24913817|NCT00755807|50008146|FG001|Open-label Extension Phase|Protocol Violation|2|||
25153284|NCT01807520|50268459|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
25153285|NCT01807520|50268460|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
25153286|NCT01807520|50268454|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
25153287|NCT01807520|50268455|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
25153288|NCT01807520|50268456|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
25153289|NCT01807520|50268457|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
25153290|NCT01807520|50268458|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
25153291|NCT01807520|50268459|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
24913818|NCT00755807|50008145|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
24913819|NCT00755807|50008146|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
24913820|NCT00755807|50008145|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
24913821|NCT00755807|50008146|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
24913822|NCT00755807|50008145|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
24913823|NCT00755807|50008146|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
24913824|NCT00755807|50008145|FG000|Open-label Extension Phase|Sponsor Decision|0|||
24913825|NCT00755807|50008146|FG001|Open-label Extension Phase|Sponsor Decision|1|||
24913826|NCT00631410|50008158|FG000|Overall Study|Adverse Event|1|||
24913827|NCT00631410|50008159|FG001|Overall Study|Adverse Event|3|||
24913828|NCT00631410|50008158|FG000|Overall Study|Objective Progression or Relapse|4|||
24913829|NCT00631410|50008159|FG001|Overall Study|Objective Progression or Relapse|3|||
24913830|NCT00631410|50008158|FG000|Overall Study|Surgery|1|||
24913831|NCT00631410|50008159|FG001|Overall Study|Surgery|0|||
24913832|NCT03686176|50008171|FG000|Overall Study|Procedure cancelled|1|||
24913833|NCT03686176|50008172|FG001|Overall Study|Procedure cancelled|0|||
24913834|NCT03686176|50008173|FG002|Overall Study|Procedure cancelled|0|||
24913835|NCT03686176|50008171|FG000|Overall Study|VR Malfunction|1|||
24913836|NCT03686176|50008172|FG001|Overall Study|VR Malfunction|0|||
24913837|NCT03686176|50008173|FG002|Overall Study|VR Malfunction|0|||
24913838|NCT00755417|50008184|FG000|Overall Study|Adverse Event|28|||
24913839|NCT00755417|50008185|FG001|Overall Study|Adverse Event|20|||
24913840|NCT00755417|50008186|FG002|Overall Study|Adverse Event|7|||
24913841|NCT00755417|50008184|FG000|Overall Study|Lack of Efficacy|8|||
24913842|NCT00755417|50008185|FG001|Overall Study|Lack of Efficacy|4|||
24913843|NCT00755417|50008186|FG002|Overall Study|Lack of Efficacy|9|||
24913844|NCT00755417|50008184|FG000|Overall Study|Protocol Violation|2|||
24913845|NCT00755417|50008185|FG001|Overall Study|Protocol Violation|1|||
24913846|NCT00755417|50008186|FG002|Overall Study|Protocol Violation|1|||
24913847|NCT00755417|50008184|FG000|Overall Study|Lost to Follow-up|3|||
24913848|NCT00755417|50008185|FG001|Overall Study|Lost to Follow-up|0|||
24913849|NCT00755417|50008186|FG002|Overall Study|Lost to Follow-up|1|||
25153292|NCT01807520|50268460|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
24913850|NCT00755417|50008184|FG000|Overall Study|Withdrawal by Subject|12|||
25274953|NCT00905437|50589053|FG001|Overall Study|Adverse Event|2|||
24913851|NCT00755417|50008185|FG001|Overall Study|Withdrawal by Subject|12|||
24913852|NCT00755417|50008186|FG002|Overall Study|Withdrawal by Subject|12|||
24913853|NCT00755417|50008184|FG000|Overall Study|Not specified or missing data|9|||
24913854|NCT00755417|50008185|FG001|Overall Study|Not specified or missing data|18|||
24913855|NCT00755417|50008186|FG002|Overall Study|Not specified or missing data|12|||
24913856|NCT03685708|50008197|FG000|Overall Study|Withdrawal by Subject|0|||
24913857|NCT03685708|50008198|FG001|Overall Study|Withdrawal by Subject|0|||
24913858|NCT03685708|50008199|FG002|Overall Study|Withdrawal by Subject|1|||
24913859|NCT03685708|50008197|FG000|Overall Study|Screen Fail|0|||
24913860|NCT03685708|50008198|FG001|Overall Study|Screen Fail|1|||
24913861|NCT03685708|50008199|FG002|Overall Study|Screen Fail|1|||
24913862|NCT03685708|50008197|FG000|Overall Study|COVID 19 Pandemic|1|||
24913863|NCT03685708|50008198|FG001|Overall Study|COVID 19 Pandemic|1|||
24913864|NCT03685708|50008199|FG002|Overall Study|COVID 19 Pandemic|6|||
24913865|NCT03685708|50008197|FG000|Overall Study|Disease Progression|0|||
24913866|NCT03685708|50008198|FG001|Overall Study|Disease Progression|0|||
24913867|NCT03685708|50008199|FG002|Overall Study|Disease Progression|1|||
24913868|NCT03684928|50008207|FG000|First Intervention|Lost to Follow-up|0|||
24913869|NCT03684928|50008208|FG001|First Intervention|Lost to Follow-up|1|||
24913870|NCT03684928|50008207|FG000|First Intervention|Withdrawal by Subject|0|||
24913871|NCT03684928|50008208|FG001|First Intervention|Withdrawal by Subject|2|||
24913872|NCT03684928|50008207|FG000|Second Intervention|Soft Tissue Injury|1|||
24913873|NCT03684928|50008208|FG001|Second Intervention|Soft Tissue Injury|0|||
24913874|NCT00777803|50008216|FG000|Overall Study|Lost to Follow-up|12|||
24913875|NCT00777803|50008217|FG001|Overall Study|Lost to Follow-up|5|||
24913876|NCT00777803|50008216|FG000|Overall Study|Adverse Event|1|||
24913877|NCT00777803|50008217|FG001|Overall Study|Adverse Event|0|||
24913878|NCT00777803|50008216|FG000|Overall Study|Non-compliance|2|||
24913879|NCT00777803|50008217|FG001|Overall Study|Non-compliance|2|||
24913880|NCT00527488|50008227|FG000|Overall Study|Withdrawn prior to dosing|0|||
24913881|NCT00527488|50008228|FG001|Overall Study|Withdrawn prior to dosing|1|||
24913882|NCT00527488|50008229|FG002|Overall Study|Withdrawn prior to dosing|1|||
24913883|NCT00527488|50008230|FG003|Overall Study|Withdrawn prior to dosing|0|||
24913884|NCT00527332|50008242|FG000|Overall Study|Protocol Violation|4|||
24913885|NCT00527332|50008243|FG001|Overall Study|Protocol Violation|8|||
24913886|NCT00527332|50008242|FG000|Overall Study|Withdrew consent|5|||
24913887|NCT00527332|50008243|FG001|Overall Study|Withdrew consent|1|||
24913888|NCT00752609|50008251|FG000|Overall Study|Adverse Event|2|||
24913889|NCT00752609|50008252|FG001|Overall Study|Adverse Event|2|||
24913890|NCT00752609|50008251|FG000|Overall Study|Withdrawal by Subject|3|||
24913891|NCT00752609|50008252|FG001|Overall Study|Withdrawal by Subject|0|||
24913892|NCT00752609|50008251|FG000|Overall Study|Physician Decision|1|||
24913893|NCT00752609|50008252|FG001|Overall Study|Physician Decision|0|||
24913894|NCT00752609|50008251|FG000|Overall Study|Death|1|||
24913895|NCT00752609|50008252|FG001|Overall Study|Death|0|||
24913896|NCT00752609|50008251|FG000|Overall Study|Met exclusion criteria|1|||
24913897|NCT00752609|50008252|FG001|Overall Study|Met exclusion criteria|0|||
24913898|NCT00752609|50008251|FG000|Overall Study|Received Aranesp in error|1|||
24913899|NCT00752609|50008252|FG001|Overall Study|Received Aranesp in error|0|||
24913900|NCT03684304|50008263|FG000|Overall Study|Lost to Follow-up|19|||
24913901|NCT03684304|50008264|FG001|Overall Study|Lost to Follow-up|17|||
24913902|NCT00629772|50008272|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
24913903|NCT00629772|50008273|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
24913904|NCT00629772|50008272|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
24913905|NCT00629772|50008273|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
24913906|NCT00526630|50008280|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
24913907|NCT00526630|50008281|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
24913908|NCT00526630|50008280|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
24913909|NCT00526630|50008281|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
24913910|NCT00755183|50008291|FG000|Overall Study|Adverse Event|5|||
24913911|NCT00755183|50008292|FG001|Overall Study|Adverse Event|2|||
24913912|NCT00755183|50008291|FG000|Overall Study|Protocol Violation|0|||
24913913|NCT00755183|50008292|FG001|Overall Study|Protocol Violation|1|||
24913914|NCT00755183|50008291|FG000|Overall Study|Withdrawal by Subject|0|||
24913915|NCT00755183|50008292|FG001|Overall Study|Withdrawal by Subject|2|||
24913916|NCT00755183|50008291|FG000|Overall Study|Administrative|2|||
24913917|NCT00755183|50008292|FG001|Overall Study|Administrative|1|||
24913918|NCT00755105|50008303|FG000|Overall Study|Withdrawal by Subject|9|||
24913919|NCT00755105|50008304|FG001|Overall Study|Withdrawal by Subject|11|||
24913920|NCT00755105|50008305|FG002|Overall Study|Withdrawal by Subject|4|||
24913921|NCT00526162|50008313|FG000|Overall Study|Device not implanted|3|||
24913922|NCT03875482|50008323|FG000|Overall Study|Adverse Event|0|||
24913923|NCT03875482|50008324|FG001|Overall Study|Adverse Event|1|||
24913924|NCT03875482|50008323|FG000|Overall Study|Withdrew consent|5|||
24913925|NCT03875482|50008324|FG001|Overall Study|Withdrew consent|6|||
24913926|NCT03875482|50008323|FG000|Overall Study|Lost to Follow-up|8|||
24913927|NCT03875482|50008324|FG001|Overall Study|Lost to Follow-up|2|||
24913928|NCT03875482|50008323|FG000|Overall Study|Lack of Efficacy|0|||
24913929|NCT03875482|50008324|FG001|Overall Study|Lack of Efficacy|11|||
24913930|NCT00754793|50008332|FG000|Overall Study|voluntary withdrawn from study|0|||
24913931|NCT00754793|50008333|FG001|Overall Study|voluntary withdrawn from study|1|||
25153293|NCT01807520|50268454|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
25153294|NCT01807520|50268455|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
25153295|NCT01807520|50268456|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
25153296|NCT01807520|50268457|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
25153297|NCT01807520|50268458|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
25153298|NCT01807520|50268459|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
25153299|NCT01807520|50268460|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
25153300|NCT01807520|50268454|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
25020464|NCT03614728|50116763|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
25020465|NCT03614728|50116764|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
25020466|NCT03614728|50116765|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
25020467|NCT03614728|50116766|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
25020468|NCT03614728|50116763|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
25020469|NCT03614728|50116764|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
25020470|NCT03614728|50116765|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
25020471|NCT03614728|50116766|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
25020472|NCT03154086|50116789|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
25020473|NCT03154086|50116790|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
25020474|NCT03154086|50116791|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
25020475|NCT03154086|50116792|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
25153301|NCT01807520|50268455|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
25153302|NCT01807520|50268456|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
25153303|NCT01807520|50268457|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
25153304|NCT01807520|50268458|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
25153305|NCT01807520|50268459|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
25153306|NCT01807520|50268460|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
25153307|NCT01807520|50268454|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
25153308|NCT01807520|50268455|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
25153309|NCT01807520|50268456|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
25153310|NCT01807520|50268457|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
25153311|NCT01807520|50268458|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
25153312|NCT01807520|50268459|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
25153313|NCT01807520|50268460|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
25153314|NCT01807520|50268454|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
25153315|NCT01807520|50268455|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
25153316|NCT01807520|50268456|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
25153317|NCT01807520|50268457|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
25020476|NCT03154086|50116793|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
25020477|NCT03154086|50116794|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
25153318|NCT01807520|50268458|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
25153319|NCT01807520|50268459|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
25153320|NCT01807520|50268460|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
25153321|NCT01807520|50268454|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
25153322|NCT01807520|50268455|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
25274954|NCT00905437|50589052|FG000|Overall Study|Lost to Follow-up|0|||
24913932|NCT00586469|50008341|FG000|Overall Study|Adverse Event|0|||
25153323|NCT01807520|50268456|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
25020478|NCT03154086|50116795|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
25020479|NCT03154086|50116796|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
25020480|NCT03154086|50116797|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
25020481|NCT03154086|50116798|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
25153324|NCT01807520|50268457|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
25153325|NCT01807520|50268458|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
24913933|NCT00586469|50008342|FG001|Overall Study|Adverse Event|1|||
24913934|NCT00626028|50008350|FG000|Overall Study|Adverse Event|1|||
24913935|NCT00626028|50008351|FG001|Overall Study|Adverse Event|1|||
24913936|NCT00626028|50008350|FG000|Overall Study|Device Failure|0|||
24913937|NCT00626028|50008351|FG001|Overall Study|Device Failure|1|||
24913938|NCT00626028|50008350|FG000|Overall Study|Physician Decision|2|||
24913939|NCT00626028|50008351|FG001|Overall Study|Physician Decision|1|||
24913940|NCT00626028|50008350|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
24913941|NCT00626028|50008351|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
24913942|NCT00777257|50008360|FG000|Overall Study|Adverse Event|3|||
24913943|NCT00777257|50008361|FG001|Overall Study|Adverse Event|1|||
24913944|NCT00777257|50008362|FG002|Overall Study|Adverse Event|0|||
24913945|NCT00777257|50008360|FG000|Overall Study|Lost to Follow-up|3|||
24913946|NCT00777257|50008361|FG001|Overall Study|Lost to Follow-up|3|||
24913947|NCT00777257|50008362|FG002|Overall Study|Lost to Follow-up|2|||
24913948|NCT00777257|50008360|FG000|Overall Study|Protocol Violation|2|||
24913949|NCT00777257|50008361|FG001|Overall Study|Protocol Violation|2|||
24913950|NCT00777257|50008362|FG002|Overall Study|Protocol Violation|2|||
24913951|NCT00777257|50008360|FG000|Overall Study|Withdrawal by Subject|3|||
24913952|NCT00777257|50008361|FG001|Overall Study|Withdrawal by Subject|6|||
24913953|NCT00777257|50008362|FG002|Overall Study|Withdrawal by Subject|5|||
24913954|NCT00628758|50008372|FG000|Overall Study|Adverse Event|2|||
24913955|NCT00628758|50008373|FG001|Overall Study|Adverse Event|3|||
24913956|NCT00628758|50008372|FG000|Overall Study|Withdrawal by Subject|6|||
24913957|NCT00628758|50008373|FG001|Overall Study|Withdrawal by Subject|3|||
24913958|NCT00628758|50008372|FG000|Overall Study|Death|1|||
24913959|NCT00628758|50008373|FG001|Overall Study|Death|0|||
24913960|NCT00628758|50008372|FG000|Overall Study|Protocol Violation|5|||
24913961|NCT00628758|50008373|FG001|Overall Study|Protocol Violation|1|||
24913962|NCT00628758|50008372|FG000|Overall Study|Lost to Follow-up|25|||
24913963|NCT00628758|50008373|FG001|Overall Study|Lost to Follow-up|31|||
24913964|NCT00628758|50008372|FG000|Overall Study|Pregnancy|2|||
24913965|NCT00628758|50008373|FG001|Overall Study|Pregnancy|2|||
24913966|NCT00628758|50008372|FG000|Overall Study|Investigator Moved|3|||
24913967|NCT00628758|50008373|FG001|Overall Study|Investigator Moved|0|||
25020482|NCT03154086|50116799|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
25020483|NCT03154086|50116800|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
25020484|NCT03154086|50116801|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
25020485|NCT03154086|50116802|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
25020486|NCT03154086|50116803|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
24913968|NCT00628758|50008372|FG000|Overall Study|Treatment Failure|0|||
24913969|NCT00628758|50008373|FG001|Overall Study|Treatment Failure|2|||
24913970|NCT04491604|50008381|FG000|Overall Study|Withdrawal by Subject|3|||
24913971|NCT00628446|50008386|FG000|Overall Study|Lost to Follow-up|3|||
24913972|NCT00628446|50008386|FG000|Overall Study|Withdrawal by Subject|1|||
24913973|NCT00628446|50008386|FG000|Overall Study|Protocol Violation|3|||
24913974|NCT00754559|50008391|FG000|Overall Study|Adverse Event|15|||
24913975|NCT00754559|50008391|FG000|Overall Study|Protocol Violation|11|||
24913976|NCT00754559|50008391|FG000|Overall Study|Lack of Efficacy|10|||
24913977|NCT00754559|50008391|FG000|Overall Study|Lost to Follow-up|2|||
24913978|NCT00754559|50008391|FG000|Overall Study|Administrative reason|1|||
24913979|NCT00754559|50008391|FG000|Overall Study|Other|5|||
24913980|NCT00754559|50008391|FG000|Overall Study|Withdrawal by Subject|3|||
24913981|NCT00525148|50008402|FG000|Overall Study|Other Adverse Event|3|||
24913982|NCT00525148|50008403|FG001|Overall Study|Other Adverse Event|5|||
24913983|NCT00525148|50008404|FG002|Overall Study|Other Adverse Event|1|||
24913984|NCT00525148|50008405|FG003|Overall Study|Other Adverse Event|8|||
25020487|NCT03154086|50116789|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
24913985|NCT00525148|50008402|FG000|Overall Study|Progressive disease|18|||
24913986|NCT00525148|50008403|FG001|Overall Study|Progressive disease|30|||
24913987|NCT00525148|50008404|FG002|Overall Study|Progressive disease|6|||
24913988|NCT00525148|50008405|FG003|Overall Study|Progressive disease|49|||
24913989|NCT00525148|50008402|FG000|Overall Study|Refused continuation of study medication|0|||
24913990|NCT00525148|50008403|FG001|Overall Study|Refused continuation of study medication|2|||
24913991|NCT00525148|50008404|FG002|Overall Study|Refused continuation of study medication|0|||
24913992|NCT00525148|50008405|FG003|Overall Study|Refused continuation of study medication|1|||
24913993|NCT00525148|50008402|FG000|Overall Study|Other than stated|2|||
24913994|NCT00525148|50008403|FG001|Overall Study|Other than stated|1|||
24913995|NCT00525148|50008404|FG002|Overall Study|Other than stated|0|||
24913996|NCT00525148|50008405|FG003|Overall Study|Other than stated|3|||
24913997|NCT00754325|50008417|FG000|Initial Treatment|Continuing Active Treatment|4|||
24913998|NCT00754325|50008418|FG001|Initial Treatment|Continuing Active Treatment|5|||
24913999|NCT00754325|50008417|FG000|Initial Treatment|Adverse Event|7|||
24914000|NCT00754325|50008418|FG001|Initial Treatment|Adverse Event|6|||
24914001|NCT00754325|50008417|FG000|Initial Treatment|Withdrawal by Subject|2|||
24914002|NCT00754325|50008418|FG001|Initial Treatment|Withdrawal by Subject|2|||
24914003|NCT00754325|50008417|FG000|Initial Treatment|Physician Decision|2|||
24914004|NCT00754325|50008418|FG001|Initial Treatment|Physician Decision|0|||
24914005|NCT00754325|50008417|FG000|Initial Treatment|Sponsor Request|0|||
24914006|NCT00754325|50008418|FG001|Initial Treatment|Sponsor Request|1|||
24914007|NCT00754325|50008417|FG000|Initial Treatment|Disease Progression|35|||
24914008|NCT00754325|50008418|FG001|Initial Treatment|Disease Progression|35|||
24914009|NCT00524680|50008429|FG000|Overall Study|progression|0|||
24914010|NCT00524680|50008430|FG001|Overall Study|progression|0|||
24914011|NCT00524680|50008431|FG002|Overall Study|progression|0|||
24914012|NCT00524680|50008432|FG003|Overall Study|progression|1|||
24914013|NCT00524680|50008429|FG000|Overall Study|Adverse Event|2|||
24914014|NCT00524680|50008430|FG001|Overall Study|Adverse Event|0|||
24914015|NCT00524680|50008431|FG002|Overall Study|Adverse Event|0|||
24914016|NCT00524680|50008432|FG003|Overall Study|Adverse Event|1|||
24914017|NCT00524680|50008429|FG000|Overall Study|Other|0|||
24914018|NCT00524680|50008430|FG001|Overall Study|Other|1|||
24914019|NCT00524680|50008431|FG002|Overall Study|Other|2|||
24914020|NCT00524680|50008432|FG003|Overall Study|Other|3|||
24914021|NCT00524680|50008429|FG000|Overall Study|Withdrawal by Subject|1|||
24914022|NCT00524680|50008430|FG001|Overall Study|Withdrawal by Subject|0|||
24914023|NCT00524680|50008431|FG002|Overall Study|Withdrawal by Subject|1|||
24914024|NCT00524680|50008432|FG003|Overall Study|Withdrawal by Subject|1|||
24914025|NCT00628212|50008446|FG000|Overall Study|Adverse Event|2|||
24914026|NCT00628212|50008447|FG001|Overall Study|Adverse Event|0|||
24914027|NCT00628212|50008448|FG002|Overall Study|Adverse Event|1|||
24914028|NCT00628212|50008449|FG003|Overall Study|Adverse Event|2|||
24914029|NCT00628212|50008446|FG000|Overall Study|Physician Decision|1|||
24914030|NCT00628212|50008447|FG001|Overall Study|Physician Decision|1|||
24914031|NCT00628212|50008448|FG002|Overall Study|Physician Decision|2|||
24914032|NCT00628212|50008449|FG003|Overall Study|Physician Decision|3|||
24914033|NCT00298363|50008462|FG000|Overall Study|Lost to Follow-up|0|||
24914034|NCT00298363|50008463|FG001|Overall Study|Lost to Follow-up|0|||
24914035|NCT00298363|50008464|FG002|Overall Study|Lost to Follow-up|1|||
24914036|NCT00298363|50008462|FG000|Overall Study|Physician Decision|4|||
24914037|NCT00298363|50008463|FG001|Overall Study|Physician Decision|1|||
24914038|NCT00298363|50008464|FG002|Overall Study|Physician Decision|0|||
24914039|NCT00298363|50008462|FG000|Overall Study|Protocol Violation|1|||
24914040|NCT00298363|50008463|FG001|Overall Study|Protocol Violation|1|||
24914041|NCT00298363|50008464|FG002|Overall Study|Protocol Violation|0|||
24914042|NCT00298363|50008462|FG000|Overall Study|Withdrawal by Subject|5|||
24914043|NCT00298363|50008463|FG001|Overall Study|Withdrawal by Subject|1|||
24914044|NCT00298363|50008464|FG002|Overall Study|Withdrawal by Subject|3|||
24914045|NCT00298363|50008462|FG000|Overall Study|Adverse Event|5|||
24914046|NCT00298363|50008463|FG001|Overall Study|Adverse Event|2|||
24914047|NCT00298363|50008464|FG002|Overall Study|Adverse Event|2|||
24914048|NCT00298363|50008462|FG000|Overall Study|Lack of Efficacy|2|||
24914049|NCT00298363|50008463|FG001|Overall Study|Lack of Efficacy|3|||
24914050|NCT00298363|50008464|FG002|Overall Study|Lack of Efficacy|0|||
24914051|NCT00524368|50008480|FG000|Overall Study|Adverse Event|10|||
24914052|NCT00524368|50008481|FG001|Overall Study|Adverse Event|12|||
24914053|NCT00524368|50008480|FG000|Overall Study|Lost to Follow-up|9|||
24914054|NCT00524368|50008481|FG001|Overall Study|Lost to Follow-up|13|||
24914055|NCT00524368|50008480|FG000|Overall Study|Withdrawal by Subject|4|||
24914056|NCT00524368|50008481|FG001|Overall Study|Withdrawal by Subject|5|||
24914057|NCT00524368|50008480|FG000|Overall Study|Non-compliant|8|||
24914058|NCT00524368|50008481|FG001|Overall Study|Non-compliant|9|||
25020488|NCT03154086|50116790|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
24914059|NCT00524368|50008480|FG000|Overall Study|Reached a Virologic Endpoint|3|||
24914060|NCT00524368|50008481|FG001|Overall Study|Reached a Virologic Endpoint|2|||
24914061|NCT00524368|50008480|FG000|Overall Study|Sponsor's Decision|2|||
24914062|NCT00524368|50008481|FG001|Overall Study|Sponsor's Decision|0|||
24914063|NCT00524368|50008480|FG000|Overall Study|Ineligible to Continue the study|2|||
24914064|NCT00524368|50008481|FG001|Overall Study|Ineligible to Continue the study|5|||
24914065|NCT00524368|50008480|FG000|Overall Study|Other|3|||
24914066|NCT00524368|50008481|FG001|Overall Study|Other|2|||
24914067|NCT00777101|50008489|FG000|Overall Study|Death|48|||
24914068|NCT00777101|50008490|FG001|Overall Study|Death|43|||
24914069|NCT00777101|50008489|FG000|Overall Study|Withdrawal by Subject|11|||
24914070|NCT00777101|50008490|FG001|Overall Study|Withdrawal by Subject|6|||
24914071|NCT00777101|50008489|FG000|Overall Study|Lost to Follow-up|2|||
24914072|NCT00777101|50008490|FG001|Overall Study|Lost to Follow-up|1|||
24914073|NCT00777101|50008489|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
24914074|NCT00777101|50008490|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
24914075|NCT00777101|50008489|FG000|Overall Study|Failed to Return|0|||
24914076|NCT00777101|50008490|FG001|Overall Study|Failed to Return|1|||
24914077|NCT00297427|50008499|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
24914078|NCT00297427|50008500|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
24914079|NCT00297427|50008499|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
24914080|NCT00297427|50008500|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
24914081|NCT00297427|50008499|FG000|Phase 1: Initial Intervention|Death|0|||
24914082|NCT00297427|50008500|FG001|Phase 1: Initial Intervention|Death|1|||
24914083|NCT00297427|50008499|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
24914084|NCT00297427|50008500|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
24914085|NCT00297427|50008499|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
24914086|NCT00297427|50008500|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
24914087|NCT00297427|50008499|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
24914088|NCT00297427|50008500|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
24914089|NCT00297427|50008499|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
24914090|NCT00297427|50008500|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
24914091|NCT00297427|50008499|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
24914092|NCT00297427|50008500|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
24914093|NCT00524134|50008514|FG000|Overall Study|Withdrawal by Subject|1|||
24914094|NCT00524134|50008514|FG000|Overall Study|Physician Decision|1|||
24914095|NCT00777023|50008521|FG000|Overall Study|Adverse Event|15|||
24914096|NCT00777023|50008522|FG001|Overall Study|Adverse Event|21|||
24914097|NCT00777023|50008523|FG002|Overall Study|Adverse Event|8|||
24914098|NCT00777023|50008521|FG000|Overall Study|Lack of Efficacy|1|||
24914099|NCT00777023|50008522|FG001|Overall Study|Lack of Efficacy|0|||
24914100|NCT00777023|50008523|FG002|Overall Study|Lack of Efficacy|14|||
24914101|NCT00777023|50008521|FG000|Overall Study|Protocol Violation|2|||
24914102|NCT00777023|50008522|FG001|Overall Study|Protocol Violation|1|||
24914103|NCT00777023|50008523|FG002|Overall Study|Protocol Violation|1|||
24914104|NCT00777023|50008521|FG000|Overall Study|Lost to Follow-up|2|||
24914105|NCT00777023|50008522|FG001|Overall Study|Lost to Follow-up|3|||
24914106|NCT00777023|50008523|FG002|Overall Study|Lost to Follow-up|3|||
24914107|NCT00777023|50008521|FG000|Overall Study|Death|0|||
24914108|NCT00777023|50008522|FG001|Overall Study|Death|1|||
24914109|NCT00777023|50008523|FG002|Overall Study|Death|0|||
24914110|NCT00777023|50008521|FG000|Overall Study|Withdrawal by Subject|7|||
25020489|NCT03154086|50116791|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
25020490|NCT03154086|50116792|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
25020491|NCT03154086|50116793|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
25020492|NCT03154086|50116794|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
25020493|NCT03154086|50116795|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
25020494|NCT03154086|50116796|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
25020495|NCT03154086|50116797|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
25020496|NCT03154086|50116798|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
25020497|NCT03154086|50116799|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
25020498|NCT03154086|50116800|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
25020499|NCT03154086|50116801|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
25020500|NCT03154086|50116802|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
24914111|NCT00777023|50008522|FG001|Overall Study|Withdrawal by Subject|7|||
24914112|NCT00777023|50008523|FG002|Overall Study|Withdrawal by Subject|8|||
24914113|NCT00777023|50008521|FG000|Overall Study|Missing data|1|||
25020501|NCT03154086|50116803|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
25020502|NCT03154086|50116789|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
25020503|NCT03154086|50116790|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
25020504|NCT03154086|50116791|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
25020505|NCT03154086|50116792|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
25020506|NCT03154086|50116793|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
25020507|NCT03154086|50116794|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
25020508|NCT03154086|50116795|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
25020509|NCT03154086|50116796|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
25020510|NCT03154086|50116797|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
25020511|NCT03154086|50116798|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
25020512|NCT03154086|50116799|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
24914114|NCT00777023|50008522|FG001|Overall Study|Missing data|1|||
24914115|NCT00777023|50008523|FG002|Overall Study|Missing data|0|||
24914116|NCT00777023|50008521|FG000|Overall Study|Reasons not specified|4|||
24914117|NCT00777023|50008522|FG001|Overall Study|Reasons not specified|4|||
24914118|NCT00777023|50008523|FG002|Overall Study|Reasons not specified|2|||
25020513|NCT03154086|50116800|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
25274955|NCT00905437|50589053|FG001|Overall Study|Lost to Follow-up|1|||
24914119|NCT00777023|50008521|FG000|Overall Study|Last dose date unknown|3|||
24914120|NCT00777023|50008522|FG001|Overall Study|Last dose date unknown|3|||
24914121|NCT00777023|50008523|FG002|Overall Study|Last dose date unknown|1|||
24914122|NCT00297037|50008533|FG000|Overall Study|Withdrawal by Subject|2|||
24914123|NCT00297037|50008534|FG001|Overall Study|Withdrawal by Subject|0|||
24914124|NCT00292981|50008542|FG000|Overall Study|Adverse Event|1|||
24914125|NCT00292981|50008542|FG000|Overall Study|Lost to Follow-up|13|||
24914126|NCT00292981|50008542|FG000|Overall Study|Withdrawal by Subject|22|||
24914127|NCT00292981|50008542|FG000|Overall Study|Other|3|||
24914128|NCT00296725|50008546|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
24914129|NCT00296725|50008546|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
24914130|NCT00296725|50008546|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
24914131|NCT00625872|50008554|FG000|Overall Study|Withdrawal by Subject|1|||
24914132|NCT00625872|50008555|FG001|Overall Study|Withdrawal by Subject|0|||
24914133|NCT00625872|50008554|FG000|Overall Study|Does not meet inclusion criteria|1|||
24914134|NCT00625872|50008555|FG001|Overall Study|Does not meet inclusion criteria|0|||
24914135|NCT00625872|50008554|FG000|Overall Study|Terminated by sponsor|2|||
24914136|NCT00625872|50008555|FG001|Overall Study|Terminated by sponsor|5|||
24914137|NCT00625872|50008554|FG000|Overall Study|Randomized but not treated|0|||
24914138|NCT00625872|50008555|FG001|Overall Study|Randomized but not treated|1|||
24914139|NCT00523978|50008563|FG000|Overall Study|Withdrawal by Subject|3|||
24914140|NCT00523978|50008564|FG001|Overall Study|Withdrawal by Subject|7|||
24914141|NCT00523978|50008563|FG000|Overall Study|Screen Failures|5|||
24914142|NCT00523978|50008564|FG001|Overall Study|Screen Failures|1|||
24914143|NCT00523978|50008563|FG000|Overall Study|Death|1|||
24914144|NCT00523978|50008564|FG001|Overall Study|Death|0|||
24914145|NCT00296647|50008576|FG000|Overall Study|Death|4|||
24914146|NCT00296647|50008577|FG001|Overall Study|Death|1|||
24914147|NCT00296647|50008578|FG002|Overall Study|Death|2|||
24914148|NCT00296647|50008579|FG003|Overall Study|Death|1|||
24914149|NCT00296647|50008580|FG004|Overall Study|Death|1|||
24914150|NCT00296647|50008576|FG000|Overall Study|Withdrawal by Subject|28|||
24914151|NCT00296647|50008577|FG001|Overall Study|Withdrawal by Subject|27|||
24914152|NCT00296647|50008578|FG002|Overall Study|Withdrawal by Subject|32|||
25020514|NCT03154086|50116801|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
25020515|NCT03154086|50116802|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
25020516|NCT03154086|50116803|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
24914153|NCT00296647|50008579|FG003|Overall Study|Withdrawal by Subject|16|||
24914154|NCT00296647|50008580|FG004|Overall Study|Withdrawal by Subject|19|||
24914155|NCT00754013|50008594|FG000|Overall Study|Lost to Follow-up|1|||
24914156|NCT00754013|50008595|FG001|Overall Study|Lost to Follow-up|1|||
24914157|NCT00754013|50008594|FG000|Overall Study|didn't return after study termed|3|||
24914158|NCT00754013|50008595|FG001|Overall Study|didn't return after study termed|4|||
24914159|NCT00523744|50008601|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
24914160|NCT00523744|50008601|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
24914161|NCT00523744|50008601|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
24914162|NCT00523744|50008601|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
24914163|NCT00523744|50008601|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
24914164|NCT00523744|50008601|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
24914165|NCT00752219|50008619|FG000|Overall Study|Clinical failure|0|||
24914166|NCT00752219|50008620|FG001|Overall Study|Clinical failure|1|||
24914167|NCT00752219|50008619|FG000|Overall Study|Adverse Event|5|||
24914168|NCT00752219|50008620|FG001|Overall Study|Adverse Event|3|||
24914169|NCT00752219|50008619|FG000|Overall Study|Protocol deviation|1|||
24914170|NCT00752219|50008620|FG001|Overall Study|Protocol deviation|0|||
24914171|NCT00752219|50008619|FG000|Overall Study|Lost to Follow-up|1|||
24914172|NCT00752219|50008620|FG001|Overall Study|Lost to Follow-up|2|||
24914173|NCT00752219|50008619|FG000|Overall Study|Randomized but not treated|1|||
24914174|NCT00752219|50008620|FG001|Overall Study|Randomized but not treated|0|||
24914175|NCT00752219|50008619|FG000|Overall Study|Other|3|||
24914176|NCT00752219|50008620|FG001|Overall Study|Other|0|||
24914177|NCT00622908|50008628|FG000|Overall Study|Protocol Violation|1|||
24914178|NCT00622908|50008629|FG001|Overall Study|Protocol Violation|0|||
24914179|NCT00622908|50008628|FG000|Overall Study|Adverse Event|0|||
24914180|NCT00622908|50008629|FG001|Overall Study|Adverse Event|1|||
24914181|NCT00622908|50008628|FG000|Overall Study|Lack of Efficacy|1|||
24914182|NCT00622908|50008629|FG001|Overall Study|Lack of Efficacy|7|||
24914183|NCT00622908|50008628|FG000|Overall Study|Lost to Follow-up|1|||
24914184|NCT00622908|50008629|FG001|Overall Study|Lost to Follow-up|0|||
24914185|NCT00622908|50008628|FG000|Overall Study|Refusal|0|||
24914186|NCT00622908|50008629|FG001|Overall Study|Refusal|1|||
24914187|NCT00622908|50008628|FG000|Overall Study|Termination by study sponser|0|||
24914188|NCT00622908|50008629|FG001|Overall Study|Termination by study sponser|1|||
24914189|NCT00296491|50008639|FG000|Overall Study|Low Pollen Counts|18|||
24914190|NCT00296491|50008640|FG001|Overall Study|Low Pollen Counts|26|||
24914191|NCT00296491|50008641|FG002|Overall Study|Low Pollen Counts|25|||
24914192|NCT00296491|50008642|FG003|Overall Study|Low Pollen Counts|16|||
24914193|NCT00296491|50008639|FG000|Overall Study|Protocol Violation|4|||
24914194|NCT00296491|50008640|FG001|Overall Study|Protocol Violation|6|||
24914195|NCT00296491|50008641|FG002|Overall Study|Protocol Violation|2|||
24914196|NCT00296491|50008642|FG003|Overall Study|Protocol Violation|3|||
24914197|NCT00296491|50008639|FG000|Overall Study|Adverse Event|1|||
24914198|NCT00296491|50008640|FG001|Overall Study|Adverse Event|3|||
24914199|NCT00296491|50008641|FG002|Overall Study|Adverse Event|1|||
24914200|NCT00296491|50008642|FG003|Overall Study|Adverse Event|4|||
24914201|NCT00296491|50008639|FG000|Overall Study|Withdrawn due to Asthma|0|||
24914202|NCT00296491|50008640|FG001|Overall Study|Withdrawn due to Asthma|0|||
24914203|NCT00296491|50008641|FG002|Overall Study|Withdrawn due to Asthma|0|||
24914204|NCT00296491|50008642|FG003|Overall Study|Withdrawn due to Asthma|4|||
24914205|NCT00296491|50008639|FG000|Overall Study|Withdrawal by Subject|7|||
24914206|NCT00296491|50008640|FG001|Overall Study|Withdrawal by Subject|3|||
24914207|NCT00296491|50008641|FG002|Overall Study|Withdrawal by Subject|3|||
24914208|NCT00296491|50008642|FG003|Overall Study|Withdrawal by Subject|2|||
24914209|NCT00296491|50008639|FG000|Overall Study|Non-Compliance|12|||
24914210|NCT00296491|50008640|FG001|Overall Study|Non-Compliance|13|||
24914211|NCT00296491|50008641|FG002|Overall Study|Non-Compliance|10|||
24914212|NCT00296491|50008642|FG003|Overall Study|Non-Compliance|14|||
24914213|NCT00296491|50008639|FG000|Overall Study|Lost to Follow-up|0|||
24914214|NCT00296491|50008640|FG001|Overall Study|Lost to Follow-up|2|||
24914215|NCT00296491|50008641|FG002|Overall Study|Lost to Follow-up|2|||
24914216|NCT00296491|50008642|FG003|Overall Study|Lost to Follow-up|0|||
24914217|NCT00747617|50008661|FG000|Overall Study|Lost to Follow-up|3|||
24914218|NCT00747617|50008662|FG001|Overall Study|Lost to Follow-up|1|||
24914219|NCT00296335|50008670|FG000|Overall Study|Recurrence|3|||
24914220|NCT00296335|50008671|FG001|Overall Study|Recurrence|51|||
24914221|NCT00296335|50008670|FG000|Overall Study|Adverse Event|17|||
24914222|NCT00296335|50008671|FG001|Overall Study|Adverse Event|27|||
24914223|NCT00296335|50008670|FG000|Overall Study|Lost to Follow-up|7|||
24914224|NCT00296335|50008671|FG001|Overall Study|Lost to Follow-up|33|||
24914225|NCT00296335|50008670|FG000|Overall Study|Physician Decision|3|||
24914226|NCT00296335|50008671|FG001|Overall Study|Physician Decision|11|||
24914227|NCT00747461|50008679|FG000|Overall Study|study terminated by sponsor|5|||
24914228|NCT03683758|50008686|FG000|Overall Study|Non-study commitment conflict|1|||
24914229|NCT03683758|50008687|FG001|Overall Study|Non-study commitment conflict|3|||
24914230|NCT03683758|50008686|FG000|Overall Study|Illness preventing participation|1|||
24914231|NCT03683758|50008687|FG001|Overall Study|Illness preventing participation|0|||
24914232|NCT03683758|50008686|FG000|Overall Study|Adverse Event|1|||
24914233|NCT03683758|50008687|FG001|Overall Study|Adverse Event|0|||
24914234|NCT00522418|50008695|FG000|Overall Study|Local IRB Consent Violation|5|||
24914235|NCT00522418|50008696|FG001|Overall Study|Local IRB Consent Violation|5|||
25020517|NCT03154086|50116789|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
25020518|NCT03154086|50116790|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
25020519|NCT03154086|50116791|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
25020520|NCT03154086|50116792|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
25020521|NCT03154086|50116793|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
24914236|NCT00522418|50008695|FG000|Overall Study|Early Study Termination|46|||
24914237|NCT00522418|50008696|FG001|Overall Study|Early Study Termination|47|||
25153326|NCT01807520|50268459|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
25153327|NCT01807520|50268460|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
25153328|NCT01806896|50268473|FG000|Overall Study|Adverse Event|2|||
25153329|NCT01806896|50268474|FG001|Overall Study|Adverse Event|0|||
25153330|NCT01806896|50268473|FG000|Overall Study|Other|1|||
25153331|NCT01806896|50268474|FG001|Overall Study|Other|0|||
24914238|NCT00522418|50008695|FG000|Overall Study|Noncompliance|2|||
25153332|NCT01768676|50268482|FG000|Overall Study|Adverse Event|3|||
24914239|NCT00522418|50008696|FG001|Overall Study|Noncompliance|2|||
24914240|NCT00522418|50008695|FG000|Overall Study|Reason Not Specified|3|||
24914241|NCT00522418|50008696|FG001|Overall Study|Reason Not Specified|1|||
24914242|NCT00522418|50008695|FG000|Overall Study|Consent Withdraw|1|||
24914243|NCT00522418|50008696|FG001|Overall Study|Consent Withdraw|2|||
24914244|NCT00522418|50008695|FG000|Overall Study|Lack of Efficacy|0|||
24914245|NCT00522418|50008696|FG001|Overall Study|Lack of Efficacy|1|||
24914246|NCT00624780|50008710|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
24914247|NCT00624780|50008711|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
24914248|NCT00624780|50008712|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
24914249|NCT00624780|50008713|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
24914250|NCT00624780|50008714|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
24914251|NCT00624780|50008715|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
24914252|NCT00624780|50008710|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
24914253|NCT00624780|50008711|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
24914254|NCT00624780|50008712|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
24914255|NCT00624780|50008713|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
24914256|NCT00624780|50008714|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
24914257|NCT00624780|50008715|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
24914258|NCT00624780|50008710|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
24914259|NCT00624780|50008711|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
24914260|NCT00624780|50008712|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
24914261|NCT00624780|50008713|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
24914262|NCT00624780|50008714|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
24914263|NCT00624780|50008715|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
24914264|NCT00624780|50008710|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
24914265|NCT00624780|50008711|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
24914266|NCT00624780|50008712|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
24914267|NCT00624780|50008713|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
24914268|NCT00624780|50008714|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
24914269|NCT00624780|50008715|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
24914270|NCT00624780|50008710|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
24914271|NCT00624780|50008711|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
24914272|NCT00624780|50008712|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
24914273|NCT00624780|50008713|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
24914274|NCT00624780|50008714|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
24914275|NCT00624780|50008715|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
24914276|NCT00624780|50008710|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
24914277|NCT00624780|50008711|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
24914278|NCT00624780|50008712|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
24914279|NCT00624780|50008713|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
24914280|NCT00624780|50008714|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
24914281|NCT00624780|50008715|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
24914282|NCT00624780|50008710|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
24914283|NCT00624780|50008711|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
24914284|NCT00624780|50008712|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
24914285|NCT00624780|50008713|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
24914286|NCT00624780|50008714|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
24914287|NCT00624780|50008715|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
24914288|NCT00624780|50008710|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
24914289|NCT00624780|50008711|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
24914290|NCT00624780|50008712|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
24914291|NCT00624780|50008713|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
24914292|NCT00624780|50008714|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
24914293|NCT00624780|50008715|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
24914294|NCT00624780|50008710|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
24914295|NCT00624780|50008711|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
25020522|NCT03154086|50116794|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
25020523|NCT03154086|50116795|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
25020524|NCT03154086|50116796|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
25020525|NCT03154086|50116797|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
25020526|NCT03154086|50116798|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
25020527|NCT03154086|50116799|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
25020528|NCT03154086|50116800|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
25020529|NCT03154086|50116801|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
25020530|NCT03154086|50116802|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
25020531|NCT03154086|50116803|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
25020532|NCT03154086|50116789|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
24914296|NCT00624780|50008712|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
24914297|NCT00624780|50008713|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
24914298|NCT00624780|50008714|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
24914299|NCT00624780|50008715|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
24914300|NCT00624780|50008710|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
24914301|NCT00624780|50008711|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
24914302|NCT00624780|50008712|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
24914303|NCT00624780|50008713|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
24914304|NCT00624780|50008714|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
24914305|NCT00624780|50008715|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
24914306|NCT00624780|50008710|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
24914307|NCT00624780|50008711|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
24914308|NCT00624780|50008712|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
24914309|NCT00624780|50008713|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
24914310|NCT00624780|50008714|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
24914311|NCT00624780|50008715|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
24914312|NCT00624780|50008710|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
24914313|NCT00624780|50008711|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
24914314|NCT00624780|50008712|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
24914315|NCT00624780|50008713|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
24914316|NCT00624780|50008714|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
24914317|NCT00624780|50008715|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
24914318|NCT00624780|50008710|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
24914319|NCT00624780|50008711|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
24914320|NCT00624780|50008712|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
24914321|NCT00624780|50008713|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
24914322|NCT00624780|50008714|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
24914323|NCT00624780|50008715|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
24914324|NCT00624780|50008710|FG000|Follow-up (Week 26)|Death|0|||
24914325|NCT00624780|50008711|FG001|Follow-up (Week 26)|Death|0|||
24914326|NCT00624780|50008712|FG002|Follow-up (Week 26)|Death|1|||
24914327|NCT00624780|50008713|FG003|Follow-up (Week 26)|Death|0|||
24914328|NCT00624780|50008714|FG004|Follow-up (Week 26)|Death|0|||
24914329|NCT00624780|50008715|FG005|Follow-up (Week 26)|Death|0|||
24914330|NCT00624780|50008710|FG000|Follow-up (Week 26)|Adverse Event|0|||
24914331|NCT00624780|50008711|FG001|Follow-up (Week 26)|Adverse Event|0|||
24914332|NCT00624780|50008712|FG002|Follow-up (Week 26)|Adverse Event|0|||
24914333|NCT00624780|50008713|FG003|Follow-up (Week 26)|Adverse Event|0|||
24914334|NCT00624780|50008714|FG004|Follow-up (Week 26)|Adverse Event|1|||
24914335|NCT00624780|50008715|FG005|Follow-up (Week 26)|Adverse Event|0|||
24914336|NCT00624780|50008710|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
24914337|NCT00624780|50008711|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
24914338|NCT00624780|50008712|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
24914339|NCT00624780|50008713|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
25020533|NCT03154086|50116790|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
25020534|NCT03154086|50116791|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
25020535|NCT03154086|50116792|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
25020536|NCT03154086|50116793|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
25020537|NCT03154086|50116794|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
25020538|NCT03154086|50116795|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
25020539|NCT03154086|50116796|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
25020540|NCT03154086|50116797|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
25020541|NCT03154086|50116798|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
25020542|NCT03154086|50116799|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
25020543|NCT03154086|50116800|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
25020544|NCT03154086|50116801|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
25020545|NCT03154086|50116802|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
25020546|NCT03154086|50116803|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
25020547|NCT03154086|50116789|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
25020548|NCT03154086|50116790|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
25020549|NCT03154086|50116791|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
25020550|NCT03154086|50116792|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
25020551|NCT03154086|50116793|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
25020552|NCT03154086|50116794|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
25020553|NCT03154086|50116795|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
25153333|NCT01768676|50268483|FG001|Overall Study|Adverse Event|3|||
24914340|NCT00624780|50008714|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
24914341|NCT00624780|50008715|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
24914342|NCT00624780|50008710|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
24914343|NCT00624780|50008711|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
24914344|NCT00624780|50008712|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
25020554|NCT03154086|50116796|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
25020555|NCT03154086|50116797|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
25020556|NCT03154086|50116798|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
25020557|NCT03154086|50116799|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
25020558|NCT03154086|50116800|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
25020559|NCT03154086|50116801|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
25020560|NCT03154086|50116802|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
25020561|NCT03154086|50116803|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
25020562|NCT03154086|50116789|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
25020563|NCT03154086|50116790|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
25020564|NCT03154086|50116791|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
25020565|NCT03154086|50116792|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
25020566|NCT03154086|50116793|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
25020567|NCT03154086|50116794|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
24914345|NCT00624780|50008713|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
24914346|NCT00624780|50008714|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
24914347|NCT00624780|50008715|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
24914348|NCT00624780|50008710|FG000|Follow-up (Week 26)|Other|1|||
24914349|NCT00624780|50008711|FG001|Follow-up (Week 26)|Other|1|||
24914350|NCT00624780|50008712|FG002|Follow-up (Week 26)|Other|0|||
24914351|NCT00624780|50008713|FG003|Follow-up (Week 26)|Other|0|||
24914352|NCT00624780|50008714|FG004|Follow-up (Week 26)|Other|0|||
24914353|NCT00624780|50008715|FG005|Follow-up (Week 26)|Other|0|||
25020568|NCT03154086|50116795|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
25020569|NCT03154086|50116796|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
25020570|NCT03154086|50116797|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
25020571|NCT03154086|50116798|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
24914354|NCT00750893|50008732|FG000|Overall Study|Adverse Event|5|||
24914355|NCT00750893|50008732|FG000|Overall Study|Withdrawal by Subject|10|||
24914356|NCT00750893|50008732|FG000|Overall Study|Lost to Follow-up|510|||
25020572|NCT03154086|50116799|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
25020573|NCT03154086|50116800|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
25020574|NCT03154086|50116801|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
25020575|NCT03154086|50116802|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
25020576|NCT03154086|50116803|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
25020577|NCT02723344|50116866|FG000|Overall Study|Lost to Follow-up|0|||
25020578|NCT02723344|50116867|FG001|Overall Study|Lost to Follow-up|4|||
25020579|NCT02723188|50116876|FG000|Overall Study|Withdrawal by Subject|1|||
25020580|NCT02723188|50116877|FG001|Overall Study|Withdrawal by Subject|0|||
25020581|NCT02723188|50116878|FG002|Overall Study|Withdrawal by Subject|0|||
25020582|NCT00705406|50116888|FG000|Overall Study|Lost to Follow-up|3|||
25020583|NCT00705406|50116889|FG001|Overall Study|Lost to Follow-up|3|||
25020584|NCT00705406|50116888|FG000|Overall Study|Did not receive study drug|1|||
25020585|NCT00705406|50116889|FG001|Overall Study|Did not receive study drug|2|||
25020586|NCT03155178|50116900|FG000|Overall Study|Did not meet treatment day baseline|7|||
25020587|NCT03155178|50116901|FG001|Overall Study|Did not meet treatment day baseline|7|||
25020588|NCT03155178|50116902|FG002|Overall Study|Did not meet treatment day baseline|7|||
25020589|NCT03155178|50116903|FG003|Overall Study|Did not meet treatment day baseline|7|||
25020590|NCT00705250|50116927|FG000|Overall Study|Withdrawal by Subject|1|||
25153334|NCT01768676|50268482|FG000|Overall Study|Lost to Follow-up|13|||
24914357|NCT00750893|50008732|FG000|Overall Study|Other|17|||
24914358|NCT00753623|50008738|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
24914359|NCT00753623|50008739|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
25020591|NCT00705250|50116927|FG000|Overall Study|Patient died in car accident|1|||
25020592|NCT03078192|50116933|FG000|Overall Study|Withdrawal by Subject|2|||
25020593|NCT03078192|50116934|FG001|Overall Study|Withdrawal by Subject|1|||
25020594|NCT03078192|50116933|FG000|Overall Study|screen failure|0|||
25020595|NCT03078192|50116934|FG001|Overall Study|screen failure|3|||
25020596|NCT00703846|50116940|FG000|Overall Study|Adverse Event|8|||
25020597|NCT00703846|50116940|FG000|Overall Study|Lost to Follow-up|55|||
25020598|NCT00703846|50116940|FG000|Overall Study|Lack of Efficacy|15|||
25020599|NCT00703846|50116940|FG000|Overall Study|Noncompliance with Study Treatment|2|||
25020600|NCT00703846|50116940|FG000|Overall Study|Withdrawal by Subject|40|||
25020601|NCT00703846|50116940|FG000|Overall Study|Death|1|||
25020602|NCT00703846|50116940|FG000|Overall Study|Other|14|||
25020603|NCT00703846|50116940|FG000|Overall Study|Did Not Receive Study Drug|2|||
25020604|NCT01314872|50116955|FG000|Treatment Period 1|Protocol Violation|2|||
25020605|NCT01314872|50116956|FG001|Treatment Period 1|Protocol Violation|1|||
25020606|NCT01314872|50116957|FG002|Treatment Period 1|Protocol Violation|1|||
25020607|NCT01314872|50116958|FG003|Treatment Period 1|Protocol Violation|0|||
25020608|NCT01314872|50116959|FG004|Treatment Period 1|Protocol Violation|1|||
25020609|NCT01314872|50116960|FG005|Treatment Period 1|Protocol Violation|0|||
25020610|NCT01314872|50116961|FG006|Treatment Period 1|Protocol Violation|0|||
25020611|NCT01314872|50116962|FG007|Treatment Period 1|Protocol Violation|0|||
25020612|NCT01314872|50116963|FG008|Treatment Period 1|Protocol Violation|0|||
25020613|NCT01314872|50116964|FG009|Treatment Period 1|Protocol Violation|1|||
25020614|NCT01314872|50116965|FG010|Treatment Period 1|Protocol Violation|1|||
25020615|NCT01314872|50116966|FG011|Treatment Period 1|Protocol Violation|0|||
25020616|NCT01314872|50116967|FG012|Treatment Period 1|Protocol Violation|0|||
25020617|NCT01314872|50116968|FG013|Treatment Period 1|Protocol Violation|0|||
25020618|NCT01314872|50116969|FG014|Treatment Period 1|Protocol Violation|0|||
25020619|NCT01314872|50116955|FG000|Treatment Period 1|Physician Decision|0|||
25020620|NCT01314872|50116956|FG001|Treatment Period 1|Physician Decision|1|||
25020621|NCT01314872|50116957|FG002|Treatment Period 1|Physician Decision|0|||
25020622|NCT01314872|50116958|FG003|Treatment Period 1|Physician Decision|1|||
25020623|NCT01314872|50116959|FG004|Treatment Period 1|Physician Decision|0|||
25153335|NCT01768676|50268483|FG001|Overall Study|Lost to Follow-up|16|||
25153336|NCT01768676|50268482|FG000|Overall Study|Protocol Violation|1|||
24914360|NCT00753623|50008738|FG000|Phase I (14 Days)|Physician Decision|1|||
24914361|NCT00753623|50008739|FG001|Phase I (14 Days)|Physician Decision|2|||
24914362|NCT00753623|50008738|FG000|Phase I (14 Days)|Adverse Event|0|||
24914363|NCT00753623|50008739|FG001|Phase I (14 Days)|Adverse Event|1|||
24914364|NCT00753623|50008738|FG000|Washout (7 Days)|Physician Decision|1|||
24914365|NCT00753623|50008739|FG001|Washout (7 Days)|Physician Decision|0|||
24914366|NCT00753623|50008738|FG000|Phase II (14 Days)|Physician Decision|0|||
24914367|NCT00753623|50008739|FG001|Phase II (14 Days)|Physician Decision|1|||
24914368|NCT00750737|50008747|FG000|Overall Study|Withdrawal by Subject|3|||
24914369|NCT00750737|50008748|FG001|Overall Study|Withdrawal by Subject|3|||
24914370|NCT00622440|50008756|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
24914371|NCT00622440|50008757|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
24914372|NCT00622440|50008756|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
24914373|NCT00622440|50008757|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
24914374|NCT00622440|50008756|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
24914375|NCT00622440|50008757|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
24914376|NCT00622440|50008756|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
24914377|NCT00622440|50008757|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
24914378|NCT00744653|50008763|FG000|Overall Study|antineoplastic treatment|11|||
24914379|NCT00744653|50008763|FG000|Overall Study|Death|1|||
24914380|NCT00744653|50008763|FG000|Overall Study|Lost to Follow-up|1|||
24914381|NCT00744653|50008763|FG000|Overall Study|Physician Decision|3|||
24914382|NCT00311311|50008770|FG000|Overall Study|Adverse Event|3|||
24914383|NCT00311311|50008771|FG001|Overall Study|Adverse Event|2|||
24914384|NCT00311311|50008770|FG000|Overall Study|Withdrawal by Subject|1|||
24914385|NCT00311311|50008771|FG001|Overall Study|Withdrawal by Subject|1|||
24914386|NCT00311311|50008770|FG000|Overall Study|Noncompliance|0|||
24914387|NCT00311311|50008771|FG001|Overall Study|Noncompliance|1|||
24914388|NCT00311311|50008770|FG000|Overall Study|Study Termination by Sponsor|3|||
24914389|NCT00311311|50008771|FG001|Overall Study|Study Termination by Sponsor|4|||
24914390|NCT00311311|50008770|FG000|Overall Study|Death|1|||
25020624|NCT01314872|50116960|FG005|Treatment Period 1|Physician Decision|0|||
25020625|NCT01314872|50116961|FG006|Treatment Period 1|Physician Decision|0|||
25020626|NCT01314872|50116962|FG007|Treatment Period 1|Physician Decision|0|||
25153337|NCT01768676|50268483|FG001|Overall Study|Protocol Violation|1|||
25020627|NCT01314872|50116963|FG008|Treatment Period 1|Physician Decision|0|||
25020628|NCT01314872|50116964|FG009|Treatment Period 1|Physician Decision|1|||
24914391|NCT00311311|50008771|FG001|Overall Study|Death|0|||
24914392|NCT00311311|50008770|FG000|Overall Study|Lack of ancillary assistance|0|||
24914393|NCT00311311|50008771|FG001|Overall Study|Lack of ancillary assistance|1|||
24914394|NCT00521404|50008777|FG000|Overall Study|Adverse Event|13|||
24914395|NCT00521404|50008777|FG000|Overall Study|Disease Progression|33|||
24914396|NCT00521404|50008777|FG000|Overall Study|Investigator decision|5|||
24914397|NCT00521404|50008777|FG000|Overall Study|Withdrawal of consent|3|||
24914398|NCT00521404|50008777|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
24914399|NCT00521404|50008777|FG000|Overall Study|Other|7|||
24914400|NCT00311155|50008781|FG000|Overall Study|Adverse Event|21|||
24914401|NCT00311155|50008781|FG000|Overall Study|Withdrawal by Subject|17|||
24914402|NCT00311155|50008781|FG000|Overall Study|Did not meet entry criteria|55|||
24914403|NCT00292045|50008785|FG000|Core Study (Through Week 13)|Adverse Event|1|||
24914404|NCT00292045|50008785|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
24914405|NCT00274651|50008791|FG000|Overall Study|Adverse Event|6|||
24914406|NCT00274651|50008792|FG001|Overall Study|Adverse Event|3|||
24914407|NCT00274651|50008791|FG000|Overall Study|Lack of Efficacy|13|||
24914408|NCT00274651|50008792|FG001|Overall Study|Lack of Efficacy|6|||
24914409|NCT00274651|50008791|FG000|Overall Study|Death|1|||
24914410|NCT00274651|50008792|FG001|Overall Study|Death|3|||
24914411|NCT00274651|50008791|FG000|Overall Study|Withdrawal by Subject|0|||
24914412|NCT00274651|50008792|FG001|Overall Study|Withdrawal by Subject|1|||
24914413|NCT00274651|50008791|FG000|Overall Study|Physician Decision|8|||
24914414|NCT00274651|50008792|FG001|Overall Study|Physician Decision|7|||
24914415|NCT00274261|50008801|FG000|Overall Study|Adverse Event|19|||
24914416|NCT00274261|50008802|FG001|Overall Study|Adverse Event|11|||
24914417|NCT00274261|50008801|FG000|Overall Study|Pregnancy|114|||
24914418|NCT00274261|50008802|FG001|Overall Study|Pregnancy|83|||
24914419|NCT00274261|50008801|FG000|Overall Study|Withdrawal by Subject|179|||
25153338|NCT01768676|50268482|FG000|Overall Study|Physician Decision|4|||
25153339|NCT01768676|50268483|FG001|Overall Study|Physician Decision|1|||
25153340|NCT01768676|50268482|FG000|Overall Study|Withdrawal by Subject|3|||
25153341|NCT01768676|50268483|FG001|Overall Study|Withdrawal by Subject|10|||
25153342|NCT01555125|50268492|FG000|Induction Period|Lost to Follow-up|0|||
25153343|NCT01555125|50268493|FG001|Induction Period|Lost to Follow-up|2|||
25153344|NCT01555125|50268494|FG002|Induction Period|Lost to Follow-up|0|||
25153345|NCT01555125|50268495|FG003|Induction Period|Lost to Follow-up|0|||
25153346|NCT01555125|50268496|FG004|Induction Period|Lost to Follow-up|0|||
25153347|NCT01555125|50268492|FG000|Induction Period|Adverse Event|0|||
25153348|NCT01555125|50268493|FG001|Induction Period|Adverse Event|1|||
25153349|NCT01555125|50268494|FG002|Induction Period|Adverse Event|0|||
25153350|NCT01555125|50268495|FG003|Induction Period|Adverse Event|0|||
25153351|NCT01555125|50268496|FG004|Induction Period|Adverse Event|1|||
25153352|NCT01555125|50268492|FG000|Induction Period|Subject / guardian decision|0|||
25153353|NCT01555125|50268493|FG001|Induction Period|Subject / guardian decision|0|||
25020629|NCT01314872|50116965|FG010|Treatment Period 1|Physician Decision|0|||
25020630|NCT01314872|50116966|FG011|Treatment Period 1|Physician Decision|0|||
25020631|NCT01314872|50116967|FG012|Treatment Period 1|Physician Decision|0|||
24914420|NCT00274261|50008802|FG001|Overall Study|Withdrawal by Subject|126|||
24914421|NCT00274261|50008801|FG000|Overall Study|Protocol Violation|71|||
24914422|NCT00274261|50008802|FG001|Overall Study|Protocol Violation|42|||
24914423|NCT00274261|50008801|FG000|Overall Study|Lost to Follow-up|106|||
24914424|NCT00274261|50008802|FG001|Overall Study|Lost to Follow-up|75|||
24914425|NCT00624468|50008812|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
24914426|NCT00624468|50008813|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
24914427|NCT00624468|50008814|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
25020632|NCT01314872|50116968|FG013|Treatment Period 1|Physician Decision|0|||
25020633|NCT01314872|50116969|FG014|Treatment Period 1|Physician Decision|0|||
25020634|NCT01314872|50116955|FG000|Treatment Period 1|Lack of Efficacy|1|||
24914428|NCT00624468|50008815|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
24914429|NCT00624468|50008812|FG000|Double-blind Period|Withdrew Prematurely|1|||
24914430|NCT00624468|50008813|FG001|Double-blind Period|Withdrew Prematurely|1|||
24914431|NCT00624468|50008814|FG002|Double-blind Period|Withdrew Prematurely|0|||
24914432|NCT00624468|50008815|FG003|Double-blind Period|Withdrew Prematurely|0|||
24914433|NCT00624468|50008812|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
24914434|NCT00624468|50008813|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
24914435|NCT00624468|50008814|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
24914436|NCT00624468|50008815|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
24914437|NCT00624468|50008812|FG000|Safety Follow-up (SFU) Period|Other|0|||
24914438|NCT00624468|50008813|FG001|Safety Follow-up (SFU) Period|Other|0|||
24914439|NCT00624468|50008814|FG002|Safety Follow-up (SFU) Period|Other|1|||
25020635|NCT01314872|50116956|FG001|Treatment Period 1|Lack of Efficacy|0|||
25020636|NCT01314872|50116957|FG002|Treatment Period 1|Lack of Efficacy|0|||
25020637|NCT01314872|50116958|FG003|Treatment Period 1|Lack of Efficacy|0|||
25153354|NCT01555125|50268494|FG002|Induction Period|Subject / guardian decision|0|||
25153355|NCT01555125|50268495|FG003|Induction Period|Subject / guardian decision|0|||
25153356|NCT01555125|50268496|FG004|Induction Period|Subject / guardian decision|2|||
24914440|NCT00624468|50008815|FG003|Safety Follow-up (SFU) Period|Other|1|||
24914441|NCT00521014|50008823|FG000|Overall Study|Inevaluable, not treated|1|||
24914442|NCT00560235|50008830|FG000|Phase 1|Discontinued|8|||
24914443|NCT00560235|50008831|FG001|Phase 1|Discontinued|0|||
24914444|NCT00560235|50008832|FG002|Phase 1|Discontinued|0|||
24914445|NCT00560235|50008830|FG000|Phase 1B|Discontinued|0|||
24914446|NCT00560235|50008831|FG001|Phase 1B|Discontinued|19|||
24914447|NCT00560235|50008832|FG002|Phase 1B|Discontinued|0|||
24914448|NCT00560235|50008830|FG000|Phase 2|Discontinued|0|||
24914449|NCT00560235|50008831|FG001|Phase 2|Discontinued|0|||
25020638|NCT01314872|50116959|FG004|Treatment Period 1|Lack of Efficacy|0|||
24914450|NCT00560235|50008832|FG002|Phase 2|Discontinued|96|||
24914451|NCT00560235|50008830|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
24914452|NCT00560235|50008831|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
24914453|NCT00560235|50008832|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
24914454|NCT00291577|50008850|FG000|Overall Study|Adverse Event|1|||
24914455|NCT00291577|50008850|FG000|Overall Study|Other|4|||
24914456|NCT00291577|50008850|FG000|Overall Study|Withdrawal by Subject|2|||
24914457|NCT00291577|50008850|FG000|Overall Study|Lack of Efficacy|14|||
24914458|NCT00520936|50008862|FG000|Overall Study|Physician Decision|0|||
24914459|NCT00520936|50008863|FG001|Overall Study|Physician Decision|2|||
24914460|NCT00520936|50008864|FG002|Overall Study|Physician Decision|1|||
24914461|NCT00520936|50008865|FG003|Overall Study|Physician Decision|0|||
25020639|NCT01314872|50116960|FG005|Treatment Period 1|Lack of Efficacy|1|||
25020640|NCT01314872|50116961|FG006|Treatment Period 1|Lack of Efficacy|0|||
25020641|NCT01314872|50116962|FG007|Treatment Period 1|Lack of Efficacy|2|||
25020642|NCT01314872|50116963|FG008|Treatment Period 1|Lack of Efficacy|0|||
25020643|NCT01314872|50116964|FG009|Treatment Period 1|Lack of Efficacy|0|||
25020644|NCT01314872|50116965|FG010|Treatment Period 1|Lack of Efficacy|0|||
25020645|NCT01314872|50116966|FG011|Treatment Period 1|Lack of Efficacy|0|||
25020646|NCT01314872|50116967|FG012|Treatment Period 1|Lack of Efficacy|0|||
25020647|NCT01314872|50116968|FG013|Treatment Period 1|Lack of Efficacy|0|||
25020648|NCT01314872|50116969|FG014|Treatment Period 1|Lack of Efficacy|0|||
25020649|NCT01314872|50116955|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
25020650|NCT01314872|50116956|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
25020651|NCT01314872|50116957|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
25020652|NCT01314872|50116958|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
25020653|NCT01314872|50116959|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
25020654|NCT01314872|50116960|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
25020655|NCT01314872|50116961|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
24914462|NCT00520936|50008866|FG004|Overall Study|Physician Decision|0|||
24914463|NCT00520936|50008867|FG005|Overall Study|Physician Decision|0|||
24914464|NCT00520936|50008868|FG006|Overall Study|Physician Decision|0|||
24914465|NCT00520936|50008869|FG007|Overall Study|Physician Decision|0|||
24914466|NCT00520936|50008862|FG000|Overall Study|Withdrawal by Subject|0|||
24914467|NCT00520936|50008863|FG001|Overall Study|Withdrawal by Subject|0|||
24914468|NCT00520936|50008864|FG002|Overall Study|Withdrawal by Subject|0|||
24914469|NCT00520936|50008865|FG003|Overall Study|Withdrawal by Subject|0|||
24914470|NCT00520936|50008866|FG004|Overall Study|Withdrawal by Subject|0|||
24914471|NCT00520936|50008867|FG005|Overall Study|Withdrawal by Subject|0|||
24914472|NCT00520936|50008868|FG006|Overall Study|Withdrawal by Subject|0|||
24914473|NCT00520936|50008869|FG007|Overall Study|Withdrawal by Subject|1|||
24914474|NCT00520936|50008862|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
24914475|NCT00520936|50008863|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
24914476|NCT00520936|50008864|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
24914477|NCT00520936|50008865|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
24914478|NCT00520936|50008866|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
24914479|NCT00520936|50008867|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
24914480|NCT00520936|50008868|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
24914481|NCT00520936|50008869|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
24914482|NCT00520936|50008862|FG000|Overall Study|Death|0|||
24914483|NCT00520936|50008863|FG001|Overall Study|Death|0|||
24914484|NCT00520936|50008864|FG002|Overall Study|Death|0|||
24914485|NCT00520936|50008865|FG003|Overall Study|Death|0|||
24914486|NCT00520936|50008866|FG004|Overall Study|Death|0|||
24914487|NCT00520936|50008867|FG005|Overall Study|Death|0|||
24914488|NCT00520936|50008868|FG006|Overall Study|Death|1|||
25020656|NCT01314872|50116962|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
25020657|NCT01314872|50116963|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
25153357|NCT01555125|50268492|FG000|Induction Period|Death|1|||
25153358|NCT01555125|50268493|FG001|Induction Period|Death|0|||
24914489|NCT00520936|50008869|FG007|Overall Study|Death|0|||
24914490|NCT00520936|50008862|FG000|Overall Study|Protocol Violation|0|||
24914491|NCT00520936|50008863|FG001|Overall Study|Protocol Violation|1|||
24914492|NCT00520936|50008864|FG002|Overall Study|Protocol Violation|1|||
24914493|NCT00520936|50008865|FG003|Overall Study|Protocol Violation|0|||
24914494|NCT00520936|50008866|FG004|Overall Study|Protocol Violation|1|||
25020658|NCT01314872|50116964|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
25020659|NCT01314872|50116965|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
24914495|NCT00520936|50008867|FG005|Overall Study|Protocol Violation|0|||
24914496|NCT00520936|50008868|FG006|Overall Study|Protocol Violation|1|||
24914497|NCT00520936|50008869|FG007|Overall Study|Protocol Violation|0|||
24914498|NCT03867760|50008882|FG000|Overall Study|Lost to Follow-up|2|||
24914499|NCT03867760|50008883|FG001|Overall Study|Lost to Follow-up|3|||
24914500|NCT03867760|50008882|FG000|Overall Study|Withdrawal by Subject|1|||
24914501|NCT03867760|50008883|FG001|Overall Study|Withdrawal by Subject|2|||
24914502|NCT03867760|50008882|FG000|Overall Study|subject could not meet study logistics|3|||
24914503|NCT03867760|50008883|FG001|Overall Study|subject could not meet study logistics|3|||
24914504|NCT03865732|50008893|FG000|Overall Study|Adverse Event|0|||
24914505|NCT03865732|50008894|FG001|Overall Study|Adverse Event|1|||
24914506|NCT00520546|50008901|FG000|Overall Study|Withdrawal by Subject|1|||
24914507|NCT00520546|50008901|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
24914508|NCT00555009|50008912|FG000|Overall Study|Withdrawal by Subject|0|||
24914509|NCT00555009|50008913|FG001|Overall Study|Withdrawal by Subject|1|||
24914510|NCT00555009|50008912|FG000|Overall Study|Terminated by Sponsor|2|||
24914511|NCT00555009|50008913|FG001|Overall Study|Terminated by Sponsor|5|||
24914512|NCT00623766|50008921|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
24914513|NCT00623766|50008922|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
24914514|NCT00623766|50008921|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
24914515|NCT00623766|50008922|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
24914516|NCT00623766|50008921|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
24914517|NCT00623766|50008922|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
24914518|NCT00623766|50008921|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
24914519|NCT00623766|50008922|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
24914520|NCT00623766|50008921|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
24914521|NCT00623766|50008922|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
24914522|NCT00550407|50008934|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
24914523|NCT00550407|50008935|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
24914524|NCT00550407|50008936|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
24914525|NCT00550407|50008934|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
24914526|NCT00550407|50008935|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
24914527|NCT00550407|50008936|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
24914528|NCT00550407|50008934|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
24914529|NCT00550407|50008935|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
24914530|NCT00550407|50008936|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
24914531|NCT00550407|50008934|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
24914532|NCT00550407|50008935|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
24914533|NCT00550407|50008936|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
24914534|NCT00550407|50008934|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
24914535|NCT00550407|50008935|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
24914536|NCT00550407|50008936|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
24914537|NCT00550407|50008934|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
24914538|NCT00550407|50008935|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
24914539|NCT00550407|50008936|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
24914540|NCT00550407|50008934|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
24914541|NCT00550407|50008935|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
24914542|NCT00550407|50008936|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
24914543|NCT00550407|50008934|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
24914544|NCT00550407|50008935|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
24914545|NCT00550407|50008936|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
24914546|NCT00550407|50008934|FG000|26-Week Randomized Phase|Adverse Event|0|||
24914547|NCT00550407|50008935|FG001|26-Week Randomized Phase|Adverse Event|5|||
24914548|NCT00550407|50008936|FG002|26-Week Randomized Phase|Adverse Event|2|||
24914549|NCT00550407|50008934|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
24914550|NCT00550407|50008935|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
24914551|NCT00550407|50008936|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
24914552|NCT00550407|50008934|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
24914553|NCT00550407|50008935|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
24914554|NCT00550407|50008936|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
24914555|NCT00550407|50008934|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
24914556|NCT00550407|50008935|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
24914557|NCT00550407|50008936|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
24914558|NCT00531934|50008946|FG000|Overall Study|Adverse Event|4|||
24914559|NCT00531934|50008947|FG001|Overall Study|Adverse Event|8|||
25020660|NCT01314872|50116966|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
24914560|NCT00531934|50008946|FG000|Overall Study|Progression|52|||
24914561|NCT00531934|50008947|FG001|Overall Study|Progression|42|||
24914562|NCT00531934|50008946|FG000|Overall Study|Death|7|||
24914563|NCT00531934|50008947|FG001|Overall Study|Death|10|||
24914564|NCT00531934|50008946|FG000|Overall Study|Withdrawal by Subject|1|||
24914565|NCT00531934|50008947|FG001|Overall Study|Withdrawal by Subject|1|||
24914566|NCT00531934|50008946|FG000|Overall Study|Other|2|||
24914567|NCT00531934|50008947|FG001|Overall Study|Other|2|||
24914568|NCT00549939|50008956|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
25153359|NCT01555125|50268494|FG002|Induction Period|Death|0|||
25153360|NCT01555125|50268495|FG003|Induction Period|Death|0|||
25153361|NCT01555125|50268496|FG004|Induction Period|Death|0|||
25153362|NCT01555125|50268492|FG000|Maintenance Period|Adverse Event|1|||
25153363|NCT01555125|50268493|FG001|Maintenance Period|Adverse Event|1|||
25153364|NCT01555125|50268494|FG002|Maintenance Period|Adverse Event|0|||
24914569|NCT00549939|50008957|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
24914570|NCT00549939|50008958|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
24914571|NCT00549939|50008956|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
24914572|NCT00549939|50008957|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
24914573|NCT00549939|50008958|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
24914574|NCT00549939|50008956|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
24914575|NCT00549939|50008957|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
24914576|NCT00549939|50008958|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
24914577|NCT00549939|50008956|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
24914578|NCT00549939|50008957|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
24914579|NCT00549939|50008958|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
24914580|NCT00549939|50008956|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
24914581|NCT00549939|50008957|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
24914582|NCT00549939|50008958|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
24914583|NCT00549939|50008956|FG000|40-week Open Label Treatment Period|Other|0|||
24914584|NCT00549939|50008957|FG001|40-week Open Label Treatment Period|Other|1|||
24914585|NCT00549939|50008958|FG002|40-week Open Label Treatment Period|Other|4|||
24914586|NCT00272779|50008970|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
24914587|NCT00272779|50008971|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
24914588|NCT00272779|50008970|FG000|Baseline Through Week 48|Death before Week 48|4|||
24914589|NCT00272779|50008971|FG001|Baseline Through Week 48|Death before Week 48|4|||
24914590|NCT00272779|50008970|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
24914591|NCT00272779|50008971|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
24914592|NCT00272779|50008970|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
24914593|NCT00272779|50008971|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
24914594|NCT00272779|50008970|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
24914595|NCT00272779|50008971|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
24914596|NCT00272779|50008970|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
24914597|NCT00272779|50008971|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
24914598|NCT00272779|50008970|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
24914599|NCT00272779|50008971|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
24914600|NCT00272779|50008970|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
24914601|NCT00272779|50008971|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
24914602|NCT00272779|50008970|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
24914603|NCT00272779|50008971|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
24914604|NCT00272779|50008970|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
24914605|NCT00272779|50008971|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
24914606|NCT00272779|50008970|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
24914607|NCT00272779|50008971|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
24914608|NCT00272779|50008970|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
24914609|NCT00272779|50008971|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
24914610|NCT00272779|50008970|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
24914611|NCT00272779|50008971|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
24914612|NCT00272779|50008970|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
24914613|NCT00272779|50008971|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
24914614|NCT00272779|50008970|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
24914615|NCT00272779|50008971|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
24914616|NCT00272779|50008970|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
24914617|NCT00272779|50008971|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
24914618|NCT00272779|50008970|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
25153365|NCT01555125|50268495|FG003|Maintenance Period|Adverse Event|0|||
25153366|NCT01555125|50268496|FG004|Maintenance Period|Adverse Event|0|||
24914619|NCT00272779|50008971|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
24914620|NCT00272779|50008970|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
25020661|NCT01314872|50116967|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
25020662|NCT01314872|50116968|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
25020663|NCT01314872|50116969|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
25020664|NCT01314872|50116955|FG000|Treatment Period 1|Withdrawal by Subject|3|||
25020665|NCT01314872|50116956|FG001|Treatment Period 1|Withdrawal by Subject|1|||
25020666|NCT01314872|50116957|FG002|Treatment Period 1|Withdrawal by Subject|0|||
25020667|NCT01314872|50116958|FG003|Treatment Period 1|Withdrawal by Subject|2|||
25020668|NCT01314872|50116959|FG004|Treatment Period 1|Withdrawal by Subject|3|||
25020669|NCT01314872|50116960|FG005|Treatment Period 1|Withdrawal by Subject|1|||
25020670|NCT01314872|50116961|FG006|Treatment Period 1|Withdrawal by Subject|3|||
25020671|NCT01314872|50116962|FG007|Treatment Period 1|Withdrawal by Subject|2|||
25020672|NCT01314872|50116963|FG008|Treatment Period 1|Withdrawal by Subject|2|||
25020673|NCT01314872|50116964|FG009|Treatment Period 1|Withdrawal by Subject|2|||
25020674|NCT01314872|50116965|FG010|Treatment Period 1|Withdrawal by Subject|1|||
25020675|NCT01314872|50116966|FG011|Treatment Period 1|Withdrawal by Subject|0|||
25020676|NCT01314872|50116967|FG012|Treatment Period 1|Withdrawal by Subject|0|||
25020677|NCT01314872|50116968|FG013|Treatment Period 1|Withdrawal by Subject|0|||
25020678|NCT01314872|50116969|FG014|Treatment Period 1|Withdrawal by Subject|0|||
25020679|NCT01314872|50116955|FG000|Treatment Period 1|Lost to Follow-up|0|||
25020680|NCT01314872|50116956|FG001|Treatment Period 1|Lost to Follow-up|1|||
25020681|NCT01314872|50116957|FG002|Treatment Period 1|Lost to Follow-up|2|||
25020682|NCT01314872|50116958|FG003|Treatment Period 1|Lost to Follow-up|2|||
25020683|NCT01314872|50116959|FG004|Treatment Period 1|Lost to Follow-up|1|||
25020684|NCT01314872|50116960|FG005|Treatment Period 1|Lost to Follow-up|1|||
25020685|NCT01314872|50116961|FG006|Treatment Period 1|Lost to Follow-up|1|||
25020686|NCT01314872|50116962|FG007|Treatment Period 1|Lost to Follow-up|1|||
25020687|NCT01314872|50116963|FG008|Treatment Period 1|Lost to Follow-up|1|||
25020688|NCT01314872|50116964|FG009|Treatment Period 1|Lost to Follow-up|0|||
25020689|NCT01314872|50116965|FG010|Treatment Period 1|Lost to Follow-up|0|||
25020690|NCT01314872|50116966|FG011|Treatment Period 1|Lost to Follow-up|0|||
24914621|NCT00272779|50008971|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
24914622|NCT00272779|50008970|FG000|Baseline Through Week 48|Continuing treatment|385|||
24914623|NCT00272779|50008971|FG001|Baseline Through Week 48|Continuing treatment|368|||
24914624|NCT00272779|50008970|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
24914625|NCT00272779|50008971|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
24914626|NCT00272779|50008970|FG000|Baseline Through Week 48|Never treated|2|||
24914627|NCT00272779|50008971|FG001|Baseline Through Week 48|Never treated|3|||
24914628|NCT00272779|50008970|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
24914629|NCT00272779|50008971|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
24914630|NCT00272779|50008970|FG000|Baseline Through Week 96|Death before Week 96|6|||
24914631|NCT00272779|50008971|FG001|Baseline Through Week 96|Death before Week 96|5|||
24914632|NCT00272779|50008970|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
24914633|NCT00272779|50008971|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
24914634|NCT00272779|50008970|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
24914635|NCT00272779|50008971|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
24914636|NCT00272779|50008970|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
24914637|NCT00272779|50008971|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
24914638|NCT00272779|50008970|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
24914639|NCT00272779|50008971|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
24914640|NCT00272779|50008970|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
24914641|NCT00272779|50008971|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
24914642|NCT00272779|50008970|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
24914643|NCT00272779|50008971|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
24914644|NCT00272779|50008970|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
24914645|NCT00272779|50008971|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
24914646|NCT00272779|50008970|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
24914647|NCT00272779|50008971|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
24914648|NCT00272779|50008970|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
24914649|NCT00272779|50008971|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
24914650|NCT00272779|50008970|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
24914651|NCT00272779|50008971|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
24914652|NCT00272779|50008970|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
24914653|NCT00272779|50008971|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
24914654|NCT00272779|50008970|FG000|Baseline Through Week 96|Never treated|2|||
24914655|NCT00272779|50008971|FG001|Baseline Through Week 96|Never treated|3|||
25020691|NCT01314872|50116967|FG012|Treatment Period 1|Lost to Follow-up|0|||
24914656|NCT00272779|50008970|FG000|Baseline Through Week 96|Continuing on treatment|61|||
25020692|NCT01314872|50116968|FG013|Treatment Period 1|Lost to Follow-up|0|||
25020693|NCT01314872|50116969|FG014|Treatment Period 1|Lost to Follow-up|0|||
25020694|NCT01314872|50116955|FG000|Period 2|Protocol Violation|0|||
24914657|NCT00272779|50008971|FG001|Baseline Through Week 96|Continuing on treatment|38|||
24914658|NCT00511810|50008980|FG000|Overall Study|Lost to Follow-up|1|||
24914659|NCT00511810|50008981|FG001|Overall Study|Lost to Follow-up|2|||
24914660|NCT00511810|50008980|FG000|Overall Study|Lack of Efficacy|0|||
24914661|NCT00511810|50008981|FG001|Overall Study|Lack of Efficacy|2|||
24914662|NCT00511810|50008980|FG000|Overall Study|Refused second scn|0|||
24914663|NCT00511810|50008981|FG001|Overall Study|Refused second scn|1|||
24914664|NCT00291499|50008989|FG000|Overall Study|Adverse Event|3|||
24914665|NCT00291499|50008990|FG001|Overall Study|Adverse Event|8|||
24914666|NCT00291499|50008989|FG000|Overall Study|Change to other therapy|2|||
24914667|NCT00291499|50008990|FG001|Overall Study|Change to other therapy|1|||
24914668|NCT00291499|50008989|FG000|Overall Study|Intercurrent illness|1|||
24914669|NCT00291499|50008990|FG001|Overall Study|Intercurrent illness|0|||
24914670|NCT00291499|50008989|FG000|Overall Study|Protocol Violation|2|||
24914671|NCT00291499|50008990|FG001|Overall Study|Protocol Violation|2|||
24914672|NCT00291499|50008989|FG000|Overall Study|Other reasons|1|||
24914673|NCT00291499|50008990|FG001|Overall Study|Other reasons|4|||
24914674|NCT00553605|50008998|FG000|Overall Study|Did not meet entrance criteria|1|||
24914675|NCT00553605|50008999|FG001|Overall Study|Did not meet entrance criteria|3|||
24914676|NCT00553605|50008998|FG000|Overall Study|Did not receive full dose|1|||
24914677|NCT00553605|50008999|FG001|Overall Study|Did not receive full dose|0|||
24914678|NCT00553605|50008998|FG000|Overall Study|Randomized but not treated|2|||
24914679|NCT00553605|50008999|FG001|Overall Study|Randomized but not treated|0|||
24914680|NCT00621582|50009005|FG000|Overall Study|Adverse Event|7|||
24914681|NCT00621582|50009005|FG000|Overall Study|Protocol Violation|57|||
24914682|NCT00621582|50009005|FG000|Overall Study|Lost to Follow-up|24|||
25020695|NCT01314872|50116956|FG001|Period 2|Protocol Violation|0|||
25020696|NCT01314872|50116957|FG002|Period 2|Protocol Violation|0|||
25020697|NCT01314872|50116958|FG003|Period 2|Protocol Violation|0|||
25020698|NCT01314872|50116959|FG004|Period 2|Protocol Violation|0|||
24914683|NCT00621582|50009005|FG000|Overall Study|issues not identified by investigators|18|||
24914684|NCT00744497|50009011|FG000|Overall Study|Withdrawal by Subject|21|||
24914685|NCT00744497|50009012|FG001|Overall Study|Withdrawal by Subject|18|||
24914686|NCT00744497|50009011|FG000|Overall Study|Death|11|||
24914687|NCT00744497|50009012|FG001|Overall Study|Death|9|||
24914688|NCT00744497|50009011|FG000|Overall Study|Lost to Follow-up|4|||
24914689|NCT00744497|50009012|FG001|Overall Study|Lost to Follow-up|2|||
24914690|NCT00744497|50009011|FG000|Overall Study|Poor compliance/noncompliance|9|||
24914691|NCT00744497|50009012|FG001|Overall Study|Poor compliance/noncompliance|5|||
24914692|NCT00744497|50009011|FG000|Overall Study|No longer meets study criteria|7|||
24914693|NCT00744497|50009012|FG001|Overall Study|No longer meets study criteria|3|||
24914694|NCT00744497|50009011|FG000|Overall Study|Administrative Reason By Sponsor|25|||
24914695|NCT00744497|50009012|FG001|Overall Study|Administrative Reason By Sponsor|8|||
24914696|NCT00744497|50009011|FG000|Overall Study|Disease progression|312|||
24914697|NCT00744497|50009012|FG001|Overall Study|Disease progression|219|||
24914698|NCT00744497|50009011|FG000|Overall Study|Study drug toxicity|68|||
24914699|NCT00744497|50009012|FG001|Overall Study|Study drug toxicity|141|||
24914700|NCT00744497|50009011|FG000|Overall Study|Adverse event unrelated to study drug|78|||
24914701|NCT00744497|50009012|FG001|Overall Study|Adverse event unrelated to study drug|122|||
24914702|NCT00744497|50009011|FG000|Overall Study|Patient requested to stop study drug|65|||
24914703|NCT00744497|50009012|FG001|Overall Study|Patient requested to stop study drug|80|||
24914704|NCT00744497|50009011|FG000|Overall Study|Maximum clinical benefit|141|||
24914705|NCT00744497|50009012|FG001|Overall Study|Maximum clinical benefit|142|||
24914706|NCT00744497|50009011|FG000|Overall Study|Not defined|19|||
24914707|NCT00744497|50009012|FG001|Overall Study|Not defined|13|||
24914708|NCT00747227|50009020|FG000|Overall Study|Death|3|||
24914709|NCT00747227|50009021|FG001|Overall Study|Death|1|||
24914710|NCT00747227|50009020|FG000|Overall Study|Withdrawal by Subject|1|||
24914711|NCT00747227|50009021|FG001|Overall Study|Withdrawal by Subject|0|||
24914712|NCT00747227|50009020|FG000|Overall Study|Lost to Follow-up|1|||
24914713|NCT00747227|50009021|FG001|Overall Study|Lost to Follow-up|2|||
25020699|NCT01314872|50116960|FG005|Period 2|Protocol Violation|0|||
25020700|NCT01314872|50116961|FG006|Period 2|Protocol Violation|0|||
24914714|NCT00747227|50009020|FG000|Overall Study|Illness|1|||
25020701|NCT01314872|50116962|FG007|Period 2|Protocol Violation|0|||
24914715|NCT00747227|50009021|FG001|Overall Study|Illness|1|||
24914716|NCT00747149|50009029|FG000|Overall Study|Adverse Event|0|||
24914717|NCT00747149|50009030|FG001|Overall Study|Adverse Event|15|||
24914718|NCT00747149|50009029|FG000|Overall Study|Lost to Follow-up|0|||
24914719|NCT00747149|50009030|FG001|Overall Study|Lost to Follow-up|10|||
24914720|NCT00747149|50009029|FG000|Overall Study|Withdrawal by Subject|0|||
24914721|NCT00747149|50009030|FG001|Overall Study|Withdrawal by Subject|6|||
24914722|NCT00747149|50009029|FG000|Overall Study|Did not receive treatment|0|||
24914723|NCT00747149|50009030|FG001|Overall Study|Did not receive treatment|1|||
24914724|NCT00747149|50009029|FG000|Overall Study|Incorrect enrollment|0|||
24914725|NCT00747149|50009030|FG001|Overall Study|Incorrect enrollment|6|||
25020702|NCT01314872|50116963|FG008|Period 2|Protocol Violation|0|||
25020703|NCT01314872|50116964|FG009|Period 2|Protocol Violation|0|||
24914726|NCT00747149|50009029|FG000|Overall Study|Severe non-compliance to protocol|0|||
24914727|NCT00747149|50009030|FG001|Overall Study|Severe non-compliance to protocol|1|||
24914728|NCT00747149|50009029|FG000|Overall Study|Not reported|1|||
24914729|NCT00747149|50009030|FG001|Overall Study|Not reported|4|||
24914730|NCT00271609|50009044|FG000|Overall Study|Adverse Event|11|||
24914731|NCT00271609|50009045|FG001|Overall Study|Adverse Event|3|||
24914732|NCT00271609|50009044|FG000|Overall Study|Withdrawal by Subject|2|||
24914733|NCT00271609|50009045|FG001|Overall Study|Withdrawal by Subject|0|||
25020704|NCT01314872|50116965|FG010|Period 2|Protocol Violation|0|||
25020705|NCT01314872|50116966|FG011|Period 2|Protocol Violation|3|||
25020706|NCT01314872|50116967|FG012|Period 2|Protocol Violation|3|||
25020707|NCT01314872|50116968|FG013|Period 2|Protocol Violation|2|||
25020708|NCT01314872|50116969|FG014|Period 2|Protocol Violation|0|||
25020709|NCT01314872|50116955|FG000|Period 2|Non-compliance with study drug|0|||
25020710|NCT01314872|50116956|FG001|Period 2|Non-compliance with study drug|0|||
25020711|NCT01314872|50116957|FG002|Period 2|Non-compliance with study drug|0|||
25020712|NCT01314872|50116958|FG003|Period 2|Non-compliance with study drug|0|||
25020713|NCT01314872|50116959|FG004|Period 2|Non-compliance with study drug|0|||
25020714|NCT01314872|50116960|FG005|Period 2|Non-compliance with study drug|0|||
25020715|NCT01314872|50116961|FG006|Period 2|Non-compliance with study drug|0|||
25020716|NCT01314872|50116962|FG007|Period 2|Non-compliance with study drug|0|||
25020717|NCT01314872|50116963|FG008|Period 2|Non-compliance with study drug|0|||
25020718|NCT01314872|50116964|FG009|Period 2|Non-compliance with study drug|0|||
25020719|NCT01314872|50116965|FG010|Period 2|Non-compliance with study drug|0|||
25020720|NCT01314872|50116966|FG011|Period 2|Non-compliance with study drug|3|||
25020721|NCT01314872|50116967|FG012|Period 2|Non-compliance with study drug|3|||
25020722|NCT01314872|50116968|FG013|Period 2|Non-compliance with study drug|1|||
25020723|NCT01314872|50116969|FG014|Period 2|Non-compliance with study drug|2|||
25020724|NCT01314872|50116955|FG000|Period 2|Lack of Efficacy|0|||
25020725|NCT01314872|50116956|FG001|Period 2|Lack of Efficacy|0|||
25020726|NCT01314872|50116957|FG002|Period 2|Lack of Efficacy|0|||
25020727|NCT01314872|50116958|FG003|Period 2|Lack of Efficacy|0|||
25020728|NCT01314872|50116959|FG004|Period 2|Lack of Efficacy|0|||
25020729|NCT01314872|50116960|FG005|Period 2|Lack of Efficacy|0|||
25020730|NCT01314872|50116961|FG006|Period 2|Lack of Efficacy|0|||
25020731|NCT01314872|50116962|FG007|Period 2|Lack of Efficacy|0|||
25020732|NCT01314872|50116963|FG008|Period 2|Lack of Efficacy|0|||
25020733|NCT01314872|50116964|FG009|Period 2|Lack of Efficacy|0|||
25020734|NCT01314872|50116965|FG010|Period 2|Lack of Efficacy|0|||
25020735|NCT01314872|50116966|FG011|Period 2|Lack of Efficacy|7|||
25020736|NCT01314872|50116967|FG012|Period 2|Lack of Efficacy|12|||
24914734|NCT00548847|50009051|FG000|Overall Study|Disease progression|7|||
24914735|NCT00290407|50009055|FG000|Overall Study|Physician Decision|2|||
24914736|NCT00749411|50009061|FG000|Overall Study|Adverse Event|0|||
24914737|NCT00749411|50009062|FG001|Overall Study|Adverse Event|2|||
24914738|NCT00749411|50009061|FG000|Overall Study|Lack of Efficacy|0|||
24914739|NCT00749411|50009062|FG001|Overall Study|Lack of Efficacy|1|||
24914740|NCT00749411|50009061|FG000|Overall Study|Protocol Violation|1|||
24914741|NCT00749411|50009062|FG001|Overall Study|Protocol Violation|1|||
24914742|NCT00749411|50009061|FG000|Overall Study|Protocol-defined stopping criteria|0|||
24914743|NCT00749411|50009062|FG001|Overall Study|Protocol-defined stopping criteria|1|||
24914744|NCT03958149|50009070|FG000|Overall Study|Withdrawal by Subject|0|||
24914745|NCT03958149|50009071|FG001|Overall Study|Withdrawal by Subject|1|||
24914746|NCT00549549|50009085|FG000|Overall Study|Adverse Event|5|||
24914747|NCT00549549|50009086|FG001|Overall Study|Adverse Event|3|||
24914748|NCT00549549|50009087|FG002|Overall Study|Adverse Event|1|||
24914749|NCT00549549|50009088|FG003|Overall Study|Adverse Event|9|||
24914750|NCT00549549|50009085|FG000|Overall Study|Lack of Efficacy|9|||
24914751|NCT00549549|50009086|FG001|Overall Study|Lack of Efficacy|6|||
24914752|NCT00549549|50009087|FG002|Overall Study|Lack of Efficacy|4|||
24914753|NCT00549549|50009088|FG003|Overall Study|Lack of Efficacy|2|||
25020737|NCT01314872|50116968|FG013|Period 2|Lack of Efficacy|9|||
25020738|NCT01314872|50116969|FG014|Period 2|Lack of Efficacy|2|||
25020739|NCT01314872|50116955|FG000|Period 2|Pregnancy|0|||
25020740|NCT01314872|50116956|FG001|Period 2|Pregnancy|0|||
25020741|NCT01314872|50116957|FG002|Period 2|Pregnancy|0|||
25020742|NCT01314872|50116958|FG003|Period 2|Pregnancy|0|||
24914754|NCT00549549|50009085|FG000|Overall Study|Lost to Follow-up|1|||
24914755|NCT00549549|50009086|FG001|Overall Study|Lost to Follow-up|0|||
25020743|NCT01314872|50116959|FG004|Period 2|Pregnancy|0|||
24914756|NCT00549549|50009087|FG002|Overall Study|Lost to Follow-up|1|||
24914757|NCT00549549|50009088|FG003|Overall Study|Lost to Follow-up|2|||
24914758|NCT00549549|50009085|FG000|Overall Study|Withdrawal by Subject|0|||
24914759|NCT00549549|50009086|FG001|Overall Study|Withdrawal by Subject|4|||
25020744|NCT01314872|50116960|FG005|Period 2|Pregnancy|0|||
25020745|NCT01314872|50116961|FG006|Period 2|Pregnancy|0|||
24914760|NCT00549549|50009087|FG002|Overall Study|Withdrawal by Subject|1|||
24914761|NCT00549549|50009088|FG003|Overall Study|Withdrawal by Subject|0|||
25020746|NCT01314872|50116962|FG007|Period 2|Pregnancy|0|||
25020747|NCT01314872|50116963|FG008|Period 2|Pregnancy|0|||
25020748|NCT01314872|50116964|FG009|Period 2|Pregnancy|0|||
25184979|NCT04115748|50334079|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
25184980|NCT04115748|50334080|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
24914762|NCT00549549|50009085|FG000|Overall Study|Other|9|||
24914763|NCT00549549|50009086|FG001|Overall Study|Other|9|||
24914764|NCT00549549|50009087|FG002|Overall Study|Other|9|||
24914765|NCT00549549|50009088|FG003|Overall Study|Other|11|||
24914766|NCT00549549|50009085|FG000|Overall Study|Randomized but not treated|0|||
24914767|NCT00549549|50009086|FG001|Overall Study|Randomized but not treated|0|||
24914768|NCT00549549|50009087|FG002|Overall Study|Randomized but not treated|1|||
24914769|NCT00549549|50009088|FG003|Overall Study|Randomized but not treated|1|||
24914770|NCT00270205|50009102|FG000|Overall Study|Lost to Follow-up|1|||
24914771|NCT00270205|50009103|FG001|Overall Study|Lost to Follow-up|0|||
24914772|NCT00270205|50009104|FG002|Overall Study|Lost to Follow-up|0|||
24914773|NCT00270205|50009105|FG003|Overall Study|Lost to Follow-up|1|||
24914774|NCT00622284|50009117|FG000|Overall Study|Lack of Efficacy|45|||
24914775|NCT00622284|50009118|FG001|Overall Study|Lack of Efficacy|15|||
24914776|NCT00622284|50009117|FG000|Overall Study|Adverse Event|61|||
24914777|NCT00622284|50009118|FG001|Overall Study|Adverse Event|90|||
24914778|NCT00622284|50009117|FG000|Overall Study|Protocol Violation|12|||
24914779|NCT00622284|50009118|FG001|Overall Study|Protocol Violation|5|||
24914780|NCT00622284|50009117|FG000|Overall Study|Lost to Follow-up|11|||
24914781|NCT00622284|50009118|FG001|Overall Study|Lost to Follow-up|13|||
24914782|NCT00622284|50009117|FG000|Overall Study|Withdrawal by Subject|27|||
24914783|NCT00622284|50009118|FG001|Overall Study|Withdrawal by Subject|24|||
24914784|NCT00622284|50009117|FG000|Overall Study|Other reason (not specified)|33|||
24914785|NCT00622284|50009118|FG001|Overall Study|Other reason (not specified)|24|||
24914786|NCT00269113|50009126|FG000|Overall Study|Adverse Event|14|||
24914787|NCT00269113|50009127|FG001|Overall Study|Adverse Event|7|||
24914788|NCT00269113|50009126|FG000|Overall Study|Lack of Efficacy|35|||
24914789|NCT00269113|50009127|FG001|Overall Study|Lack of Efficacy|18|||
24914790|NCT00269113|50009126|FG000|Overall Study|Early Improvement|2|||
24914791|NCT00269113|50009127|FG001|Overall Study|Early Improvement|0|||
24914792|NCT00269113|50009126|FG000|Overall Study|Withdrawal by Subject|0|||
24914793|NCT00269113|50009127|FG001|Overall Study|Withdrawal by Subject|2|||
24914794|NCT00269113|50009126|FG000|Overall Study|Death|6|||
24914795|NCT00269113|50009127|FG001|Overall Study|Death|2|||
24914796|NCT00269113|50009126|FG000|Overall Study|Lost to Follow-up|2|||
24914797|NCT00269113|50009127|FG001|Overall Study|Lost to Follow-up|1|||
24914798|NCT00269113|50009126|FG000|Overall Study|Protocol Violation|15|||
24914799|NCT00269113|50009127|FG001|Overall Study|Protocol Violation|5|||
24914800|NCT00269113|50009126|FG000|Overall Study|Other|0|||
24914801|NCT00269113|50009127|FG001|Overall Study|Other|2|||
24914802|NCT00291187|50009137|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
24914803|NCT00291187|50009138|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
24914804|NCT00291187|50009139|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
24914805|NCT00291187|50009140|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
24914806|NCT00546819|50009156|FG000|Overall Study|Adverse Event|2|||
24914807|NCT00546819|50009157|FG001|Overall Study|Adverse Event|3|||
24914808|NCT00546819|50009156|FG000|Overall Study|Lost to Follow-up|2|||
24914809|NCT00546819|50009157|FG001|Overall Study|Lost to Follow-up|1|||
24914810|NCT00546819|50009156|FG000|Overall Study|Withdrawal by Subject|4|||
24914811|NCT00546819|50009157|FG001|Overall Study|Withdrawal by Subject|2|||
24914812|NCT00621504|50009165|FG000|Overall Study|Adverse Event|1|||
24914813|NCT00621504|50009166|FG001|Overall Study|Adverse Event|3|||
24914814|NCT00621504|50009165|FG000|Overall Study|At the request of sponsor/investigator|1|||
24914815|NCT00621504|50009166|FG001|Overall Study|At the request of sponsor/investigator|0|||
24914816|NCT00621504|50009165|FG000|Overall Study|Withdrew consent|9|||
24914817|NCT00621504|50009166|FG001|Overall Study|Withdrew consent|6|||
24914818|NCT00621504|50009165|FG000|Overall Study|Lost to Follow-up|8|||
24914819|NCT00621504|50009166|FG001|Overall Study|Lost to Follow-up|10|||
24914820|NCT00621504|50009165|FG000|Overall Study|Other|1|||
24914821|NCT00621504|50009166|FG001|Overall Study|Other|0|||
24914822|NCT00621504|50009165|FG000|Overall Study|Death|6|||
25184981|NCT04115748|50334081|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
24914823|NCT00621504|50009166|FG001|Overall Study|Death|6|||
24914824|NCT00548145|50009174|FG000|Overall Study|Death|0|||
24914825|NCT00548145|50009175|FG001|Overall Study|Death|1|||
24914826|NCT00548145|50009174|FG000|Overall Study|Withdrawal by Subject|0|||
24914827|NCT00548145|50009175|FG001|Overall Study|Withdrawal by Subject|2|||
24914828|NCT00548145|50009174|FG000|Overall Study|Physician Decision|1|||
24914829|NCT00548145|50009175|FG001|Overall Study|Physician Decision|1|||
24914830|NCT00547911|50009185|FG000|Overall Study|Adverse Event|0|||
24914831|NCT00547911|50009186|FG001|Overall Study|Adverse Event|0|||
24914832|NCT00547911|50009187|FG002|Overall Study|Adverse Event|0|||
24914833|NCT00547911|50009188|FG003|Overall Study|Adverse Event|1|||
24914834|NCT00547911|50009189|FG004|Overall Study|Adverse Event|0|||
24914835|NCT00547911|50009190|FG005|Overall Study|Adverse Event|0|||
24914836|NCT00289783|50009205|FG000|Primary Phase|Adverse Event|10|||
24914837|NCT00289783|50009206|FG001|Primary Phase|Adverse Event|1|||
25020749|NCT01314872|50116965|FG010|Period 2|Pregnancy|0|||
25020750|NCT01314872|50116966|FG011|Period 2|Pregnancy|0|||
25020751|NCT01314872|50116967|FG012|Period 2|Pregnancy|0|||
25020752|NCT01314872|50116968|FG013|Period 2|Pregnancy|0|||
25020753|NCT01314872|50116969|FG014|Period 2|Pregnancy|1|||
25020754|NCT01314872|50116955|FG000|Period 2|Study terminated by Sponsor|0|||
25020755|NCT01314872|50116956|FG001|Period 2|Study terminated by Sponsor|0|||
25020756|NCT01314872|50116957|FG002|Period 2|Study terminated by Sponsor|0|||
25020757|NCT01314872|50116958|FG003|Period 2|Study terminated by Sponsor|0|||
25020758|NCT01314872|50116959|FG004|Period 2|Study terminated by Sponsor|0|||
25020759|NCT01314872|50116960|FG005|Period 2|Study terminated by Sponsor|0|||
25020760|NCT01314872|50116961|FG006|Period 2|Study terminated by Sponsor|0|||
25020761|NCT01314872|50116962|FG007|Period 2|Study terminated by Sponsor|0|||
25020762|NCT01314872|50116963|FG008|Period 2|Study terminated by Sponsor|0|||
25020763|NCT01314872|50116964|FG009|Period 2|Study terminated by Sponsor|0|||
25020764|NCT01314872|50116965|FG010|Period 2|Study terminated by Sponsor|0|||
25020765|NCT01314872|50116966|FG011|Period 2|Study terminated by Sponsor|2|||
25020766|NCT01314872|50116967|FG012|Period 2|Study terminated by Sponsor|2|||
25020767|NCT01314872|50116968|FG013|Period 2|Study terminated by Sponsor|3|||
25020768|NCT01314872|50116969|FG014|Period 2|Study terminated by Sponsor|0|||
25020769|NCT01314872|50116955|FG000|Period 2|Adverse event, non-fatal|0|||
25020770|NCT01314872|50116956|FG001|Period 2|Adverse event, non-fatal|0|||
25020771|NCT01314872|50116957|FG002|Period 2|Adverse event, non-fatal|0|||
25020772|NCT01314872|50116958|FG003|Period 2|Adverse event, non-fatal|0|||
25020773|NCT01314872|50116959|FG004|Period 2|Adverse event, non-fatal|0|||
25020774|NCT01314872|50116960|FG005|Period 2|Adverse event, non-fatal|0|||
25020775|NCT01314872|50116961|FG006|Period 2|Adverse event, non-fatal|0|||
25020776|NCT01314872|50116962|FG007|Period 2|Adverse event, non-fatal|0|||
25020777|NCT01314872|50116963|FG008|Period 2|Adverse event, non-fatal|0|||
25020778|NCT01314872|50116964|FG009|Period 2|Adverse event, non-fatal|0|||
25020779|NCT01314872|50116965|FG010|Period 2|Adverse event, non-fatal|0|||
25020780|NCT01314872|50116966|FG011|Period 2|Adverse event, non-fatal|13|||
25020781|NCT01314872|50116967|FG012|Period 2|Adverse event, non-fatal|16|||
25020782|NCT01314872|50116968|FG013|Period 2|Adverse event, non-fatal|24|||
25020783|NCT01314872|50116969|FG014|Period 2|Adverse event, non-fatal|9|||
25020784|NCT01314872|50116955|FG000|Period 2|Withdrawal by Subject|0|||
25020785|NCT01314872|50116956|FG001|Period 2|Withdrawal by Subject|0|||
25020786|NCT01314872|50116957|FG002|Period 2|Withdrawal by Subject|0|||
25020787|NCT01314872|50116958|FG003|Period 2|Withdrawal by Subject|0|||
25020788|NCT01314872|50116959|FG004|Period 2|Withdrawal by Subject|0|||
25020789|NCT01314872|50116960|FG005|Period 2|Withdrawal by Subject|0|||
25020790|NCT01314872|50116961|FG006|Period 2|Withdrawal by Subject|0|||
25020791|NCT01314872|50116962|FG007|Period 2|Withdrawal by Subject|0|||
25020792|NCT01314872|50116963|FG008|Period 2|Withdrawal by Subject|0|||
25020793|NCT01314872|50116964|FG009|Period 2|Withdrawal by Subject|0|||
25020794|NCT01314872|50116965|FG010|Period 2|Withdrawal by Subject|0|||
25020795|NCT01314872|50116966|FG011|Period 2|Withdrawal by Subject|14|||
25020796|NCT01314872|50116967|FG012|Period 2|Withdrawal by Subject|17|||
25020797|NCT01314872|50116968|FG013|Period 2|Withdrawal by Subject|12|||
25020798|NCT01314872|50116969|FG014|Period 2|Withdrawal by Subject|4|||
25020799|NCT01314872|50116955|FG000|Period 2|Lost to Follow-up|0|||
25020800|NCT01314872|50116956|FG001|Period 2|Lost to Follow-up|0|||
25020801|NCT01314872|50116957|FG002|Period 2|Lost to Follow-up|0|||
25020802|NCT01314872|50116958|FG003|Period 2|Lost to Follow-up|0|||
25020803|NCT01314872|50116959|FG004|Period 2|Lost to Follow-up|0|||
25020804|NCT01314872|50116960|FG005|Period 2|Lost to Follow-up|0|||
25020805|NCT01314872|50116961|FG006|Period 2|Lost to Follow-up|0|||
25020806|NCT01314872|50116962|FG007|Period 2|Lost to Follow-up|0|||
25020807|NCT01314872|50116963|FG008|Period 2|Lost to Follow-up|0|||
25020808|NCT01314872|50116964|FG009|Period 2|Lost to Follow-up|0|||
25020809|NCT01314872|50116965|FG010|Period 2|Lost to Follow-up|0|||
25020810|NCT01314872|50116966|FG011|Period 2|Lost to Follow-up|6|||
25020811|NCT01314872|50116967|FG012|Period 2|Lost to Follow-up|7|||
25020812|NCT01314872|50116968|FG013|Period 2|Lost to Follow-up|2|||
25020813|NCT01314872|50116969|FG014|Period 2|Lost to Follow-up|6|||
25020814|NCT00703924|50117003|FG000|Overall Study|Withdrawal by Subject|1|||
25020815|NCT00703924|50117004|FG001|Overall Study|Withdrawal by Subject|1|||
25020816|NCT03152526|50117016|FG000|Overall Study|Withdrawal by Subject|0|||
25184982|NCT04115748|50334082|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
25274956|NCT00905437|50589052|FG000|Overall Study|Withdrawal by Subject|0|||
25020817|NCT03152526|50117017|FG001|Overall Study|Withdrawal by Subject|1|||
25020818|NCT03149328|50117025|FG000|Overall Study|Withdrawal by Subject|30|||
25020819|NCT03149328|50117026|FG001|Overall Study|Withdrawal by Subject|26|||
25020820|NCT03149328|50117025|FG000|Overall Study|Changed Dialysis Modality|18|||
25020821|NCT03149328|50117026|FG001|Overall Study|Changed Dialysis Modality|1|||
25020822|NCT03149328|50117025|FG000|Overall Study|Transplant|9|||
25020823|NCT03149328|50117026|FG001|Overall Study|Transplant|1|||
25020824|NCT03149328|50117025|FG000|Overall Study|Lost to Follow-up|25|||
25020825|NCT03149328|50117026|FG001|Overall Study|Lost to Follow-up|16|||
25020826|NCT03149328|50117025|FG000|Overall Study|Left Study Site|1|||
25020827|NCT03149328|50117026|FG001|Overall Study|Left Study Site|2|||
25020828|NCT03149328|50117025|FG000|Overall Study|Language Barrier|1|||
25020829|NCT03149328|50117026|FG001|Overall Study|Language Barrier|0|||
25020830|NCT04296942|50117075|FG000|Overall Study|Study closure by sponsor|1|||
25020831|NCT04296942|50117076|FG001|Overall Study|Study closure by sponsor|0|||
25020832|NCT04296942|50117077|FG002|Overall Study|Study closure by sponsor|0|||
25274957|NCT00905437|50589053|FG001|Overall Study|Withdrawal by Subject|1|||
25020834|NCT01315028|50117148|FG000|Overall Study|Lost to Follow-up|1|||
25020835|NCT01315028|50117149|FG001|Overall Study|Lost to Follow-up|0|||
25020836|NCT01315028|50117148|FG000|Overall Study|Death|0|||
25020837|NCT01315028|50117149|FG001|Overall Study|Death|1|||
25020838|NCT02720536|50117155|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
25020839|NCT02720536|50117155|FG000|Overall Study|PR - pregnancy|2|||
25020840|NCT02720536|50117155|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
25020841|NCT02720536|50117155|FG000|Overall Study|PR - death|1|||
25020842|NCT02720536|50117155|FG000|Overall Study|PR - adverse event|1|||
25020843|NCT02720536|50117155|FG000|Overall Study|PR - abnormal lab value(s)|1|||
25020844|NCT02720536|50117155|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
25020845|NCT03168438|50117167|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
25020846|NCT03168438|50117168|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
25020847|NCT03137784|50117175|FG000|Overall Study|Adverse Event|1|||
25020848|NCT03137784|50117176|FG001|Overall Study|Adverse Event|1|||
25020849|NCT03137784|50117177|FG002|Overall Study|Adverse Event|0|||
25020850|NCT03137784|50117178|FG003|Overall Study|Adverse Event|0|||
25020851|NCT03137784|50117179|FG004|Overall Study|Adverse Event|0|||
25020852|NCT03137784|50117180|FG005|Overall Study|Adverse Event|0|||
25020853|NCT03137784|50117175|FG000|Overall Study|Subject/guardian decision|1|||
25020854|NCT03137784|50117176|FG001|Overall Study|Subject/guardian decision|0|||
25020855|NCT03137784|50117177|FG002|Overall Study|Subject/guardian decision|0|||
25020856|NCT03137784|50117178|FG003|Overall Study|Subject/guardian decision|0|||
25020857|NCT03137784|50117179|FG004|Overall Study|Subject/guardian decision|0|||
25020858|NCT03137784|50117180|FG005|Overall Study|Subject/guardian decision|0|||
25020859|NCT03137784|50117175|FG000|Overall Study|Non-compliance with study treatment|0|||
24914838|NCT00289783|50009205|FG000|Primary Phase|Protocol Violation|27|||
24914839|NCT00289783|50009206|FG001|Primary Phase|Protocol Violation|6|||
24914840|NCT00289783|50009205|FG000|Primary Phase|Withdrawal by Subject|93|||
24914841|NCT00289783|50009206|FG001|Primary Phase|Withdrawal by Subject|40|||
24914842|NCT00289783|50009205|FG000|Primary Phase|Lost to Follow-up|60|||
24914843|NCT00289783|50009206|FG001|Primary Phase|Lost to Follow-up|14|||
24914844|NCT00289783|50009205|FG000|Primary Phase|Migration from the study area|26|||
24914845|NCT00289783|50009206|FG001|Primary Phase|Migration from the study area|10|||
24914846|NCT00289783|50009205|FG000|Primary Phase|Other|32|||
24914847|NCT00289783|50009206|FG001|Primary Phase|Other|12|||
24914848|NCT00289783|50009205|FG000|Fourth Dose Phase|Adverse Event|1|||
24914849|NCT00289783|50009206|FG001|Fourth Dose Phase|Adverse Event|0|||
24914850|NCT00289783|50009205|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
24914851|NCT00289783|50009206|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
24914852|NCT00289783|50009205|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
24914853|NCT00289783|50009206|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
24914854|NCT00289783|50009205|FG000|Fourth Dose Phase|Migration from the study area|1|||
24914855|NCT00289783|50009206|FG001|Fourth Dose Phase|Migration from the study area|1|||
24914856|NCT00289783|50009205|FG000|Fourth Dose Phase|Other|22|||
24914857|NCT00289783|50009206|FG001|Fourth Dose Phase|Other|10|||
24914858|NCT00574080|50009222|FG000|Overall Study|Death|10|||
24914859|NCT00574080|50009223|FG001|Overall Study|Death|10|||
24914860|NCT00546351|50009229|FG000|Overall Study|Adverse Event|76|||
24914861|NCT00546351|50009229|FG000|Overall Study|Lack of Efficacy|15|||
24914862|NCT00546351|50009229|FG000|Overall Study|Withdrawal by Subject|109|||
24914863|NCT00546351|50009229|FG000|Overall Study|Lost to Follow-up|9|||
24914864|NCT00546351|50009229|FG000|Overall Study|Protocol Deviation|1|||
24914865|NCT00546351|50009229|FG000|Overall Study|Unsatisfactory compliance|9|||
24914866|NCT00546351|50009229|FG000|Overall Study|Other reasons for premature termination|17|||
24914867|NCT00267865|50009233|FG000|Induction Treatment|Died before completing.|2|||
24914868|NCT00267865|50009233|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
24914869|NCT00546117|50009239|FG000|Overall Study|Withdrawal by Subject|3|||
24914870|NCT00546117|50009240|FG001|Overall Study|Withdrawal by Subject|0|||
24914871|NCT00546117|50009239|FG000|Overall Study|Inability to schedule follow-up visit|1|||
24914872|NCT00546117|50009240|FG001|Overall Study|Inability to schedule follow-up visit|0|||
24914873|NCT00251719|50009251|FG000|Overall Study|Adverse Event|14|||
25020860|NCT03137784|50117176|FG001|Overall Study|Non-compliance with study treatment|0|||
25020861|NCT03137784|50117177|FG002|Overall Study|Non-compliance with study treatment|0|||
25020862|NCT03137784|50117178|FG003|Overall Study|Non-compliance with study treatment|0|||
25274958|NCT00905437|50589052|FG000|Overall Study|Other|5|||
24914874|NCT00251719|50009252|FG001|Overall Study|Adverse Event|8|||
24914875|NCT00251719|50009253|FG002|Overall Study|Adverse Event|7|||
24914876|NCT00251719|50009251|FG000|Overall Study|Protocol Violation|1|||
24914877|NCT00251719|50009252|FG001|Overall Study|Protocol Violation|1|||
24914878|NCT00251719|50009253|FG002|Overall Study|Protocol Violation|1|||
24914879|NCT00251719|50009251|FG000|Overall Study|Lost to Follow-up|5|||
24914880|NCT00251719|50009252|FG001|Overall Study|Lost to Follow-up|11|||
24914881|NCT00251719|50009253|FG002|Overall Study|Lost to Follow-up|8|||
24914882|NCT00251719|50009251|FG000|Overall Study|Withdrawal by Subject|14|||
24914883|NCT00251719|50009252|FG001|Overall Study|Withdrawal by Subject|12|||
25020863|NCT03137784|50117179|FG004|Overall Study|Non-compliance with study treatment|1|||
25020864|NCT03137784|50117180|FG005|Overall Study|Non-compliance with study treatment|0|||
25020865|NCT01314716|50117190|FG000|Double-Blind Phase|Randomized but not treated|1|||
25020866|NCT01314716|50117191|FG001|Double-Blind Phase|Randomized but not treated|1|||
25020867|NCT01314716|50117190|FG000|Double-Blind Phase|Adverse Event|10|||
25020868|NCT01314716|50117191|FG001|Double-Blind Phase|Adverse Event|4|||
25020869|NCT01314716|50117190|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
25020870|NCT01314716|50117191|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
25020871|NCT01314716|50117190|FG000|Double-Blind Phase|Lost to Follow-up|0|||
25020872|NCT01314716|50117191|FG001|Double-Blind Phase|Lost to Follow-up|1|||
25020873|NCT01314716|50117190|FG000|Double-Blind Phase|Sponsor request|1|||
25020874|NCT01314716|50117191|FG001|Double-Blind Phase|Sponsor request|2|||
25020875|NCT01314716|50117190|FG000|Double-Blind Phase|Physician Decision|0|||
25020876|NCT01314716|50117191|FG001|Double-Blind Phase|Physician Decision|1|||
25020877|NCT01314716|50117190|FG000|Open-Label Phase|Adverse Event|4|||
25020878|NCT01314716|50117191|FG001|Open-Label Phase|Adverse Event|6|||
25020879|NCT01314716|50117190|FG000|Open-Label Phase|Withdrawal by Subject|1|||
25020880|NCT01314716|50117191|FG001|Open-Label Phase|Withdrawal by Subject|2|||
25020881|NCT01314716|50117190|FG000|Open-Label Phase|Physician Decision|5|||
25020882|NCT01314716|50117191|FG001|Open-Label Phase|Physician Decision|4|||
25020883|NCT03144180|50117201|FG000|Overall Study|STAT Delivery|1|||
25020884|NCT03144180|50117202|FG001|Overall Study|STAT Delivery|1|||
25020885|NCT03144180|50117201|FG000|Overall Study|Provider forgot to fill out forms|1|||
25020886|NCT03144180|50117202|FG001|Overall Study|Provider forgot to fill out forms|3|||
25020887|NCT03144180|50117201|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
25020888|NCT03144180|50117202|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
25020889|NCT03144180|50117201|FG000|Overall Study|Scrub tech removed tube cap|0|||
25020890|NCT03144180|50117202|FG001|Overall Study|Scrub tech removed tube cap|1|||
25020891|NCT01465334|50117212|FG000|Overall Study|Disease Progression|1|||
25020892|NCT01465334|50117213|FG001|Overall Study|Disease Progression|0|||
25020893|NCT01465334|50117212|FG000|Overall Study|Adverse Event|1|||
25020894|NCT01465334|50117213|FG001|Overall Study|Adverse Event|0|||
25020895|NCT01465334|50117212|FG000|Overall Study|Richter's transformation|0|||
25020896|NCT01465334|50117213|FG001|Overall Study|Richter's transformation|3|||
24914884|NCT00251719|50009253|FG002|Overall Study|Withdrawal by Subject|11|||
24914885|NCT00251719|50009251|FG000|Overall Study|Lack of Efficacy|2|||
24914886|NCT00251719|50009252|FG001|Overall Study|Lack of Efficacy|1|||
24914887|NCT00251719|50009253|FG002|Overall Study|Lack of Efficacy|0|||
24914888|NCT00251719|50009251|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
24914889|NCT00251719|50009252|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
24914890|NCT00251719|50009253|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
24914891|NCT00251719|50009251|FG000|Overall Study|Investigator decision|1|||
24914892|NCT00251719|50009252|FG001|Overall Study|Investigator decision|1|||
24914893|NCT00251719|50009253|FG002|Overall Study|Investigator decision|0|||
24914894|NCT00251719|50009251|FG000|Overall Study|Noncompliance|2|||
24914895|NCT00251719|50009252|FG001|Overall Study|Noncompliance|3|||
24914896|NCT00251719|50009253|FG002|Overall Study|Noncompliance|1|||
24914897|NCT00251719|50009251|FG000|Overall Study|Barrett's esophagus|2|||
24914898|NCT00251719|50009252|FG001|Overall Study|Barrett's esophagus|2|||
24914899|NCT00251719|50009253|FG002|Overall Study|Barrett's esophagus|0|||
24914900|NCT03952143|50009263|FG000|Lead-In Period|Adverse Event|2|||
24914901|NCT03952143|50009264|FG001|Lead-In Period|Adverse Event|0|||
24914902|NCT03952143|50009265|FG002|Lead-In Period|Adverse Event|0|||
24914903|NCT03952143|50009263|FG000|Lead-In Period|Lack of Efficacy|2|||
24914904|NCT03952143|50009264|FG001|Lead-In Period|Lack of Efficacy|0|||
24914905|NCT03952143|50009265|FG002|Lead-In Period|Lack of Efficacy|0|||
24914906|NCT03952143|50009263|FG000|Lead-In Period|Physician Decision|5|||
24914907|NCT03952143|50009264|FG001|Lead-In Period|Physician Decision|0|||
24914908|NCT03952143|50009265|FG002|Lead-In Period|Physician Decision|0|||
25020897|NCT01465334|50117212|FG000|Overall Study|Refractory Disease|0|||
25020898|NCT01465334|50117213|FG001|Overall Study|Refractory Disease|3|||
25020899|NCT00702208|50117219|FG000|Overall Study|Lost to Follow-up|28|||
25020900|NCT00702208|50117219|FG000|Overall Study|Did not self-lavage|1|||
25020901|NCT00702208|50117219|FG000|Overall Study|Unsatisfactory colposcopy|2|||
25153367|NCT01555125|50268492|FG000|Maintenance Period|Subject / guardian decision|1|||
24914909|NCT03952143|50009263|FG000|Lead-In Period|Protocol Violation|5|||
24914910|NCT03952143|50009264|FG001|Lead-In Period|Protocol Violation|0|||
24914911|NCT03952143|50009265|FG002|Lead-In Period|Protocol Violation|0|||
24914912|NCT03952143|50009263|FG000|Lead-In Period|Withdrawal by Subject|19|||
24914913|NCT03952143|50009264|FG001|Lead-In Period|Withdrawal by Subject|0|||
24914914|NCT03952143|50009265|FG002|Lead-In Period|Withdrawal by Subject|0|||
24914915|NCT03952143|50009263|FG000|Treatment Period|Adverse Event|0|||
24914916|NCT03952143|50009264|FG001|Treatment Period|Adverse Event|0|||
24914917|NCT03952143|50009265|FG002|Treatment Period|Adverse Event|1|||
24914918|NCT03952143|50009263|FG000|Treatment Period|Lost to Follow-up|0|||
24914919|NCT03952143|50009264|FG001|Treatment Period|Lost to Follow-up|2|||
24914920|NCT03952143|50009265|FG002|Treatment Period|Lost to Follow-up|0|||
24914921|NCT03952143|50009263|FG000|Treatment Period|Physician Decision|0|||
24914922|NCT03952143|50009264|FG001|Treatment Period|Physician Decision|0|||
24914923|NCT03952143|50009265|FG002|Treatment Period|Physician Decision|2|||
24914924|NCT03952143|50009263|FG000|Treatment Period|Protocol Violation|0|||
24914925|NCT03952143|50009264|FG001|Treatment Period|Protocol Violation|0|||
24914926|NCT03952143|50009265|FG002|Treatment Period|Protocol Violation|1|||
24914927|NCT03952143|50009263|FG000|Treatment Period|Withdrawal by Subject|0|||
24914928|NCT03952143|50009264|FG001|Treatment Period|Withdrawal by Subject|5|||
24914929|NCT03952143|50009265|FG002|Treatment Period|Withdrawal by Subject|26|||
24914930|NCT03952143|50009263|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
24914931|NCT03952143|50009264|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
24914932|NCT03952143|50009265|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
24914933|NCT03952143|50009263|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
24914934|NCT03952143|50009264|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
25020902|NCT02718898|50117236|FG000|Blinded Treatment Period|Adverse Event|5|||
25020903|NCT02718898|50117237|FG001|Blinded Treatment Period|Adverse Event|1|||
25020904|NCT02718898|50117238|FG002|Blinded Treatment Period|Adverse Event|0|||
25020905|NCT02718898|50117239|FG003|Blinded Treatment Period|Adverse Event|0|||
25020906|NCT02718898|50117240|FG004|Blinded Treatment Period|Adverse Event|0|||
25020907|NCT02718898|50117241|FG005|Blinded Treatment Period|Adverse Event|0|||
25020908|NCT02718898|50117242|FG006|Blinded Treatment Period|Adverse Event|0|||
25020909|NCT02718898|50117236|FG000|Blinded Treatment Period|Physician Decision|1|||
25020910|NCT02718898|50117237|FG001|Blinded Treatment Period|Physician Decision|0|||
25020911|NCT02718898|50117238|FG002|Blinded Treatment Period|Physician Decision|0|||
25020912|NCT02718898|50117239|FG003|Blinded Treatment Period|Physician Decision|0|||
25153368|NCT01555125|50268493|FG001|Maintenance Period|Subject / guardian decision|2|||
25153369|NCT01555125|50268494|FG002|Maintenance Period|Subject / guardian decision|0|||
25153370|NCT01555125|50268495|FG003|Maintenance Period|Subject / guardian decision|0|||
25153371|NCT01555125|50268496|FG004|Maintenance Period|Subject / guardian decision|0|||
25153372|NCT01555125|50268492|FG000|Maintenance Period|Lost to Follow-up|2|||
25153373|NCT01555125|50268493|FG001|Maintenance Period|Lost to Follow-up|0|||
25153374|NCT01555125|50268494|FG002|Maintenance Period|Lost to Follow-up|0|||
25153375|NCT01555125|50268495|FG003|Maintenance Period|Lost to Follow-up|1|||
25153376|NCT01555125|50268496|FG004|Maintenance Period|Lost to Follow-up|0|||
25153377|NCT01555125|50268492|FG000|Maintenance Period|Lack of Efficacy|6|||
25153378|NCT01555125|50268493|FG001|Maintenance Period|Lack of Efficacy|1|||
25153379|NCT01555125|50268494|FG002|Maintenance Period|Lack of Efficacy|3|||
25153380|NCT01555125|50268495|FG003|Maintenance Period|Lack of Efficacy|0|||
25153381|NCT01555125|50268496|FG004|Maintenance Period|Lack of Efficacy|0|||
25153382|NCT01555125|50268492|FG000|Maintenance Period|Physician Decision|0|||
25020913|NCT02718898|50117240|FG004|Blinded Treatment Period|Physician Decision|0|||
25020914|NCT02718898|50117241|FG005|Blinded Treatment Period|Physician Decision|0|||
25020915|NCT02718898|50117242|FG006|Blinded Treatment Period|Physician Decision|0|||
25020916|NCT02718898|50117236|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
25020917|NCT02718898|50117237|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
25020918|NCT02718898|50117238|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
25020919|NCT02718898|50117239|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
25020920|NCT02718898|50117240|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
25020921|NCT02718898|50117241|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
25020922|NCT02718898|50117242|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
24914935|NCT03952143|50009265|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
25020923|NCT02718898|50117236|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
25020924|NCT02718898|50117237|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
25020925|NCT02718898|50117238|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
25020926|NCT02718898|50117239|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
25020927|NCT02718898|50117240|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
24914936|NCT00267007|50009274|FG000|Overall Study|Withdrawal by Subject|6|||
24914937|NCT00267007|50009275|FG001|Overall Study|Withdrawal by Subject|0|||
24914938|NCT00267007|50009274|FG000|Overall Study|Lost to Follow-up|1|||
24914939|NCT00267007|50009275|FG001|Overall Study|Lost to Follow-up|0|||
24914940|NCT00267007|50009274|FG000|Overall Study|Non-compliance|0|||
24914941|NCT00267007|50009275|FG001|Overall Study|Non-compliance|1|||
24914942|NCT00267007|50009274|FG000|Overall Study|Adverse Event|1|||
24914943|NCT00267007|50009275|FG001|Overall Study|Adverse Event|0|||
24914944|NCT03943095|50009283|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
24914945|NCT03943095|50009284|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
24914946|NCT03943095|50009283|FG000|Overall Study|Withdrawal by Subject|1|||
24914947|NCT03943095|50009284|FG001|Overall Study|Withdrawal by Subject|0|||
24914948|NCT00251641|50009293|FG000|Overall Study|Adverse Event|80|||
24914949|NCT00251641|50009294|FG001|Overall Study|Adverse Event|8|||
24914950|NCT00251641|50009293|FG000|Overall Study|Lack of Efficacy|2|||
24914951|NCT00251641|50009294|FG001|Overall Study|Lack of Efficacy|1|||
24914952|NCT00251641|50009293|FG000|Overall Study|Progression of Disease|0|||
24914953|NCT00251641|50009294|FG001|Overall Study|Progression of Disease|2|||
25020928|NCT02718898|50117241|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
24914954|NCT00251641|50009293|FG000|Overall Study|Lost to Follow-up|3|||
24914955|NCT00251641|50009294|FG001|Overall Study|Lost to Follow-up|3|||
24914956|NCT00251641|50009293|FG000|Overall Study|Withdrawal by Subject|6|||
24914957|NCT00251641|50009294|FG001|Overall Study|Withdrawal by Subject|8|||
24914958|NCT00251641|50009293|FG000|Overall Study|Protocol Violation|10|||
24914959|NCT00251641|50009294|FG001|Overall Study|Protocol Violation|2|||
24914960|NCT00251641|50009293|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
25020929|NCT02718898|50117242|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
25153383|NCT01555125|50268493|FG001|Maintenance Period|Physician Decision|0|||
25153384|NCT01555125|50268494|FG002|Maintenance Period|Physician Decision|1|||
25153385|NCT01555125|50268495|FG003|Maintenance Period|Physician Decision|0|||
25153386|NCT01555125|50268496|FG004|Maintenance Period|Physician Decision|0|||
25153387|NCT01555125|50268492|FG000|Maintenance Period|Death|0|||
25153388|NCT01555125|50268493|FG001|Maintenance Period|Death|0|||
25153389|NCT01555125|50268494|FG002|Maintenance Period|Death|0|||
25153390|NCT01555125|50268495|FG003|Maintenance Period|Death|1|||
25153391|NCT01555125|50268496|FG004|Maintenance Period|Death|0|||
25153392|NCT01555125|50268492|FG000|Extension|Adverse Event|1|||
25153393|NCT01555125|50268493|FG001|Extension|Adverse Event|2|||
25153394|NCT01555125|50268494|FG002|Extension|Adverse Event|1|||
25153395|NCT01555125|50268495|FG003|Extension|Adverse Event|1|||
25153396|NCT01555125|50268496|FG004|Extension|Adverse Event|0|||
25153397|NCT01555125|50268492|FG000|Extension|Protocol deviation|1|||
25020930|NCT02718898|50117236|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
25020931|NCT02718898|50117237|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
25020932|NCT02718898|50117238|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
25020933|NCT02718898|50117239|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
25020934|NCT02718898|50117240|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
25020935|NCT02718898|50117241|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
25020936|NCT02718898|50117242|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
25020937|NCT02718898|50117236|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
25020938|NCT02718898|50117237|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
25020939|NCT02718898|50117238|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
25020940|NCT02718898|50117239|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
25020941|NCT02718898|50117240|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
25020942|NCT02718898|50117241|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
25020943|NCT02718898|50117242|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
25020944|NCT02718898|50117236|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
25020945|NCT02718898|50117237|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
25153398|NCT01555125|50268493|FG001|Extension|Protocol deviation|0|||
25153399|NCT01555125|50268494|FG002|Extension|Protocol deviation|0|||
25153400|NCT01555125|50268495|FG003|Extension|Protocol deviation|0|||
25153401|NCT01555125|50268496|FG004|Extension|Protocol deviation|0|||
25274959|NCT00905437|50589053|FG001|Overall Study|Other|6|||
25274960|NCT01238861|50589065|FG000|Overall Study|Lost to Follow-up|4|||
24914961|NCT00251641|50009294|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
25153402|NCT01555125|50268492|FG000|Extension|Lack of Efficacy|7|||
24914962|NCT00251641|50009293|FG000|Overall Study|Switched Treatment|9|||
24914963|NCT00251641|50009294|FG001|Overall Study|Switched Treatment|63|||
25274961|NCT01238861|50589066|FG001|Overall Study|Lost to Follow-up|2|||
24914964|NCT00250705|50009302|FG000|Overall Study|Lack of Efficacy|2|||
24914965|NCT00266695|50009308|FG000|Overall Study|Adverse Event|1|||
25153403|NCT01555125|50268493|FG001|Extension|Lack of Efficacy|6|||
25153404|NCT01555125|50268494|FG002|Extension|Lack of Efficacy|3|||
25020946|NCT02718898|50117238|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
24914966|NCT00266695|50009308|FG000|Overall Study|Death|9|||
24914967|NCT00266695|50009308|FG000|Overall Study|Physician Decision|1|||
24914968|NCT00266695|50009308|FG000|Overall Study|Lost to Follow-up|3|||
24914969|NCT00266695|50009308|FG000|Overall Study|Withdrawal by Subject|15|||
24914970|NCT00620022|50009312|FG000|Treatment Period 1|Adverse Event|4|||
24914971|NCT00620022|50009313|FG001|Treatment Period 1|Adverse Event|6|||
24914972|NCT00620022|50009312|FG000|Treatment Period 1|Subject withdrew consent|1|||
24914973|NCT00620022|50009313|FG001|Treatment Period 1|Subject withdrew consent|0|||
24914974|NCT00620022|50009312|FG000|Treatment Period 2|Adverse Event|2|||
24914975|NCT00620022|50009313|FG001|Treatment Period 2|Adverse Event|2|||
24914976|NCT00547521|50009321|FG000|Short Term Study (4 Months)|Adverse Event|1|||
24914977|NCT00547521|50009322|FG001|Short Term Study (4 Months)|Adverse Event|0|||
24914978|NCT00547521|50009321|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
24914979|NCT00547521|50009322|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
24914980|NCT00547521|50009321|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
24914981|NCT00547521|50009322|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
24914982|NCT00547521|50009321|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
24914983|NCT00547521|50009322|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
24914984|NCT00547521|50009321|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
24914985|NCT00547521|50009322|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
24914986|NCT00547521|50009321|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
24914987|NCT00547521|50009322|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
24914988|NCT00547521|50009321|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
24914989|NCT00547521|50009322|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
24914990|NCT00547521|50009321|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
24914991|NCT00547521|50009322|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
24914992|NCT00547521|50009321|FG000|Long Term Extension (LTE) Study|Other|0|||
24914993|NCT00547521|50009322|FG001|Long Term Extension (LTE) Study|Other|2|||
24914994|NCT00547521|50009321|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
24914995|NCT00547521|50009322|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
24914996|NCT00266227|50009337|FG000|Initial Treatment|Adverse Event|0|||
24914997|NCT00266227|50009338|FG001|Initial Treatment|Adverse Event|0|||
24914998|NCT00266227|50009339|FG002|Initial Treatment|Adverse Event|13|||
24914999|NCT00266227|50009337|FG000|Initial Treatment|Lost to Follow-up|0|||
24915000|NCT00266227|50009338|FG001|Initial Treatment|Lost to Follow-up|0|||
24915001|NCT00266227|50009339|FG002|Initial Treatment|Lost to Follow-up|6|||
24915002|NCT00266227|50009337|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
24915003|NCT00266227|50009338|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
24915004|NCT00266227|50009339|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
24915005|NCT00266227|50009337|FG000|Initial Treatment|Physician decision to withdraw|0|||
24915006|NCT00266227|50009338|FG001|Initial Treatment|Physician decision to withdraw|0|||
24915007|NCT00266227|50009339|FG002|Initial Treatment|Physician decision to withdraw|12|||
24915008|NCT00266227|50009337|FG000|Initial Treatment|Pregnancy|0|||
24915009|NCT00266227|50009338|FG001|Initial Treatment|Pregnancy|0|||
24915010|NCT00266227|50009339|FG002|Initial Treatment|Pregnancy|1|||
24915011|NCT00266227|50009337|FG000|Retreatment: Up to Week 48|Death|1|||
24915012|NCT00266227|50009338|FG001|Retreatment: Up to Week 48|Death|0|||
24915013|NCT00266227|50009339|FG002|Retreatment: Up to Week 48|Death|0|||
24915014|NCT00266227|50009337|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
24915015|NCT00266227|50009338|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
24915016|NCT00266227|50009339|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
24915017|NCT00266227|50009337|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
24915018|NCT00266227|50009338|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
24915019|NCT00266227|50009339|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
24915020|NCT00266227|50009337|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
24915021|NCT00266227|50009338|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
24915022|NCT00266227|50009339|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
24915023|NCT00266227|50009337|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
24915024|NCT00266227|50009338|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
24915025|NCT00266227|50009339|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
24915026|NCT00266227|50009337|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
24915027|NCT00266227|50009338|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
24915028|NCT00266227|50009339|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
24915029|NCT00266227|50009337|FG000|Retreatment: Week 48 to Week 72|Death|1|||
24915030|NCT00266227|50009338|FG001|Retreatment: Week 48 to Week 72|Death|1|||
24915031|NCT00266227|50009339|FG002|Retreatment: Week 48 to Week 72|Death|0|||
24915032|NCT00266227|50009337|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
24915033|NCT00266227|50009338|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
24915034|NCT00266227|50009339|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
25020947|NCT02718898|50117239|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
25153405|NCT01555125|50268495|FG003|Extension|Lack of Efficacy|0|||
24915035|NCT00266227|50009337|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
24915036|NCT00266227|50009338|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
24915037|NCT00266227|50009339|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
24915038|NCT00266227|50009337|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
24915039|NCT00266227|50009338|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
24915040|NCT00266227|50009339|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
24915041|NCT00266227|50009337|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
24915042|NCT00266227|50009338|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
24915043|NCT00266227|50009339|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
24915044|NCT00287365|50009348|FG000|Overall Study|sample not acquired|13|||
24915045|NCT00573768|50009356|FG000|Overall Study|Adverse Event|1|||
24915046|NCT00573768|50009357|FG001|Overall Study|Adverse Event|1|||
24915047|NCT00573768|50009358|FG002|Overall Study|Adverse Event|2|||
24915048|NCT00573768|50009356|FG000|Overall Study|Protocol Violation|1|||
24915049|NCT00573768|50009357|FG001|Overall Study|Protocol Violation|0|||
24915050|NCT00573768|50009358|FG002|Overall Study|Protocol Violation|1|||
24915051|NCT00573768|50009356|FG000|Overall Study|Withdrawal by Subject|0|||
24915052|NCT00573768|50009357|FG001|Overall Study|Withdrawal by Subject|1|||
24915053|NCT00573768|50009358|FG002|Overall Study|Withdrawal by Subject|0|||
24915054|NCT00573768|50009356|FG000|Overall Study|Lost to Follow-up|0|||
24915055|NCT00573768|50009357|FG001|Overall Study|Lost to Follow-up|0|||
24915056|NCT00573768|50009358|FG002|Overall Study|Lost to Follow-up|1|||
24915057|NCT00547365|50009366|FG000|Overall Study|Physician Decision|1|||
24915058|NCT00547365|50009366|FG000|Overall Study|Lost to Follow-up|1|||
24915059|NCT00547365|50009366|FG000|Overall Study|Protocol Violation|2|||
24915060|NCT00547365|50009366|FG000|Overall Study|death (not related to study)|4|||
24915061|NCT00619866|50009374|FG000|Weeks 1 - 12|Adverse Event|0|||
24915062|NCT00619866|50009375|FG001|Weeks 1 - 12|Adverse Event|1|||
24915063|NCT00619866|50009376|FG002|Weeks 1 - 12|Adverse Event|2|||
24915064|NCT00619866|50009377|FG003|Weeks 1 - 12|Adverse Event|0|||
24915065|NCT00619866|50009378|FG004|Weeks 1 - 12|Adverse Event|0|||
24915066|NCT00619866|50009374|FG000|Weeks 1 - 12|Non-compliance|0|||
24915067|NCT00619866|50009375|FG001|Weeks 1 - 12|Non-compliance|0|||
24915068|NCT00619866|50009376|FG002|Weeks 1 - 12|Non-compliance|1|||
24915069|NCT00619866|50009377|FG003|Weeks 1 - 12|Non-compliance|0|||
24915070|NCT00619866|50009378|FG004|Weeks 1 - 12|Non-compliance|0|||
24915071|NCT00619866|50009374|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
24915072|NCT00619866|50009375|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
24915073|NCT00619866|50009376|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
24915074|NCT00619866|50009377|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
24915075|NCT00619866|50009378|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
24915076|NCT00619866|50009374|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
24915077|NCT00619866|50009375|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
24915078|NCT00619866|50009376|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
24915079|NCT00619866|50009377|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
24915080|NCT00619866|50009378|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
24915081|NCT00619866|50009374|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
24915082|NCT00619866|50009375|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
24915083|NCT00619866|50009376|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
25153406|NCT01555125|50268496|FG004|Extension|Lack of Efficacy|0|||
25153407|NCT01555125|50268492|FG000|Extension|Lost to Follow-up|2|||
25153408|NCT01555125|50268493|FG001|Extension|Lost to Follow-up|1|||
25153409|NCT01555125|50268494|FG002|Extension|Lost to Follow-up|2|||
25153410|NCT01555125|50268495|FG003|Extension|Lost to Follow-up|0|||
25153411|NCT01555125|50268496|FG004|Extension|Lost to Follow-up|0|||
25153412|NCT01555125|50268492|FG000|Extension|Study terminated by sponsor|32|||
25153413|NCT01555125|50268493|FG001|Extension|Study terminated by sponsor|33|||
25153414|NCT01555125|50268494|FG002|Extension|Study terminated by sponsor|16|||
25153415|NCT01555125|50268495|FG003|Extension|Study terminated by sponsor|20|||
25153416|NCT01555125|50268496|FG004|Extension|Study terminated by sponsor|0|||
24915084|NCT00619866|50009377|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
24915085|NCT00619866|50009378|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
25153417|NCT01555125|50268492|FG000|Extension|Subject/guardian decision|1|||
24915086|NCT00619866|50009374|FG000|Weeks 1 - 12|Sponsor Decision|0|||
24915087|NCT00619866|50009375|FG001|Weeks 1 - 12|Sponsor Decision|1|||
24915088|NCT00619866|50009376|FG002|Weeks 1 - 12|Sponsor Decision|0|||
24915089|NCT00619866|50009377|FG003|Weeks 1 - 12|Sponsor Decision|0|||
24915090|NCT00619866|50009378|FG004|Weeks 1 - 12|Sponsor Decision|0|||
24915091|NCT00619866|50009374|FG000|Weeks 13 - 24|Adverse Event|0|||
24915092|NCT00619866|50009375|FG001|Weeks 13 - 24|Adverse Event|0|||
24915093|NCT00619866|50009376|FG002|Weeks 13 - 24|Adverse Event|2|||
24915094|NCT00619866|50009377|FG003|Weeks 13 - 24|Adverse Event|1|||
24915095|NCT00619866|50009378|FG004|Weeks 13 - 24|Adverse Event|0|||
24915096|NCT00619866|50009374|FG000|Weeks 13 - 24|Protocol Deviation|0|||
24915097|NCT00619866|50009375|FG001|Weeks 13 - 24|Protocol Deviation|0|||
25153418|NCT01555125|50268493|FG001|Extension|Subject/guardian decision|9|||
25153419|NCT01555125|50268494|FG002|Extension|Subject/guardian decision|1|||
24915098|NCT00619866|50009376|FG002|Weeks 13 - 24|Protocol Deviation|0|||
24915099|NCT00619866|50009377|FG003|Weeks 13 - 24|Protocol Deviation|1|||
24915100|NCT00619866|50009378|FG004|Weeks 13 - 24|Protocol Deviation|0|||
24915101|NCT00619866|50009374|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
24915102|NCT00619866|50009375|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
24915103|NCT00619866|50009376|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
24915104|NCT00619866|50009377|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
24915105|NCT00619866|50009378|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
24915106|NCT00619866|50009374|FG000|Weeks 13 - 24|Non-compliance|0|||
24915107|NCT00619866|50009375|FG001|Weeks 13 - 24|Non-compliance|1|||
24915108|NCT00619866|50009376|FG002|Weeks 13 - 24|Non-compliance|1|||
24915109|NCT00619866|50009377|FG003|Weeks 13 - 24|Non-compliance|0|||
24915110|NCT00619866|50009378|FG004|Weeks 13 - 24|Non-compliance|0|||
24915111|NCT00619866|50009374|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
24915112|NCT00619866|50009375|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
24915113|NCT00619866|50009376|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
24915114|NCT00619866|50009377|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
24915115|NCT00619866|50009378|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
24915116|NCT03937479|50009406|FG000|Overall Study|Adverse Event|2|||
24915117|NCT03937479|50009407|FG001|Overall Study|Adverse Event|3|||
24915118|NCT03937479|50009408|FG002|Overall Study|Adverse Event|0|||
24915119|NCT03937479|50009409|FG003|Overall Study|Adverse Event|0|||
24915120|NCT03937479|50009410|FG004|Overall Study|Adverse Event|1|||
24915121|NCT03937479|50009406|FG000|Overall Study|Withdrawal by Subject|3|||
24915122|NCT03937479|50009407|FG001|Overall Study|Withdrawal by Subject|5|||
24915123|NCT03937479|50009408|FG002|Overall Study|Withdrawal by Subject|2|||
24915124|NCT03937479|50009409|FG003|Overall Study|Withdrawal by Subject|2|||
25020948|NCT02718898|50117240|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
25020949|NCT02718898|50117241|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
25020950|NCT02718898|50117242|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
25020951|NCT02718898|50117236|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
25020952|NCT02718898|50117237|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
25020953|NCT02718898|50117238|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
25020954|NCT02718898|50117239|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
25020955|NCT02718898|50117240|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
25020956|NCT02718898|50117241|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
25020957|NCT02718898|50117242|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
25020958|NCT02718898|50117236|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
25020959|NCT02718898|50117237|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
25020960|NCT02718898|50117238|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
25020961|NCT02718898|50117239|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
25020962|NCT02718898|50117240|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
25020963|NCT02718898|50117241|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
25020964|NCT02718898|50117242|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
25020965|NCT02718898|50117236|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
25067415|NCT02397460|50173039|FG002|Treatment Period 4|Physician Decision|0|||
25153420|NCT01555125|50268495|FG003|Extension|Subject/guardian decision|0|||
25153421|NCT01555125|50268496|FG004|Extension|Subject/guardian decision|0|||
25153422|NCT01555125|50268492|FG000|Extension|Technical Problems|1|||
24915125|NCT03937479|50009410|FG004|Overall Study|Withdrawal by Subject|1|||
24915126|NCT03937479|50009406|FG000|Overall Study|Protocol Violation|5|||
24915127|NCT03937479|50009407|FG001|Overall Study|Protocol Violation|6|||
24915128|NCT03937479|50009408|FG002|Overall Study|Protocol Violation|4|||
24915129|NCT03937479|50009409|FG003|Overall Study|Protocol Violation|3|||
24915130|NCT03937479|50009410|FG004|Overall Study|Protocol Violation|2|||
24915131|NCT03937479|50009406|FG000|Overall Study|Lost to Follow-up|0|||
24915132|NCT03937479|50009407|FG001|Overall Study|Lost to Follow-up|1|||
24915133|NCT03937479|50009408|FG002|Overall Study|Lost to Follow-up|0|||
24915134|NCT03937479|50009409|FG003|Overall Study|Lost to Follow-up|1|||
24915135|NCT03937479|50009410|FG004|Overall Study|Lost to Follow-up|0|||
24915136|NCT03937479|50009406|FG000|Overall Study|Physician Decision|0|||
24915137|NCT03937479|50009407|FG001|Overall Study|Physician Decision|0|||
24915138|NCT03937479|50009408|FG002|Overall Study|Physician Decision|1|||
24915139|NCT03937479|50009409|FG003|Overall Study|Physician Decision|0|||
24915140|NCT03937479|50009410|FG004|Overall Study|Physician Decision|1|||
24915141|NCT00619476|50009426|FG000|Overall Study|Adverse Event|12|||
24915142|NCT00619476|50009427|FG001|Overall Study|Adverse Event|6|||
24915143|NCT00619476|50009428|FG002|Overall Study|Adverse Event|12|||
24915144|NCT00619476|50009429|FG003|Overall Study|Adverse Event|16|||
24915145|NCT00619476|50009426|FG000|Overall Study|Lack of Efficacy|6|||
24915146|NCT00619476|50009427|FG001|Overall Study|Lack of Efficacy|1|||
24915147|NCT00619476|50009428|FG002|Overall Study|Lack of Efficacy|1|||
24915148|NCT00619476|50009429|FG003|Overall Study|Lack of Efficacy|4|||
24915149|NCT00619476|50009426|FG000|Overall Study|Protocol Violation|5|||
24915150|NCT00619476|50009427|FG001|Overall Study|Protocol Violation|4|||
25020966|NCT02718898|50117237|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
25020967|NCT02718898|50117238|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
25020968|NCT02718898|50117239|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
25020969|NCT02718898|50117240|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
25020970|NCT02718898|50117241|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
25020971|NCT02718898|50117242|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
25020972|NCT02718898|50117236|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
25020973|NCT02718898|50117237|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
24915151|NCT00619476|50009428|FG002|Overall Study|Protocol Violation|4|||
24915152|NCT00619476|50009429|FG003|Overall Study|Protocol Violation|9|||
24915153|NCT00619476|50009426|FG000|Overall Study|Lost to Follow-up|1|||
24915154|NCT00619476|50009427|FG001|Overall Study|Lost to Follow-up|2|||
24915155|NCT00619476|50009428|FG002|Overall Study|Lost to Follow-up|0|||
24915156|NCT00619476|50009429|FG003|Overall Study|Lost to Follow-up|1|||
24915157|NCT00619476|50009426|FG000|Overall Study|Investigator Discretion|2|||
24915158|NCT00619476|50009427|FG001|Overall Study|Investigator Discretion|2|||
24915159|NCT00619476|50009428|FG002|Overall Study|Investigator Discretion|2|||
24915160|NCT00619476|50009429|FG003|Overall Study|Investigator Discretion|0|||
24915161|NCT00619476|50009426|FG000|Overall Study|Withdrawal by Subject|5|||
24915162|NCT00619476|50009427|FG001|Overall Study|Withdrawal by Subject|7|||
24915163|NCT00619476|50009428|FG002|Overall Study|Withdrawal by Subject|5|||
24915164|NCT00619476|50009429|FG003|Overall Study|Withdrawal by Subject|4|||
24915165|NCT00618072|50009442|FG000|Overall Study|Lost to Follow-up|2|||
24915166|NCT00618072|50009443|FG001|Overall Study|Lost to Follow-up|0|||
24915167|NCT00618072|50009444|FG002|Overall Study|Lost to Follow-up|3|||
24915168|NCT00618072|50009442|FG000|Overall Study|Physician Decision|0|||
25153423|NCT01555125|50268493|FG001|Extension|Technical Problems|0|||
25153424|NCT01555125|50268494|FG002|Extension|Technical Problems|0|||
25153425|NCT01555125|50268495|FG003|Extension|Technical Problems|1|||
25153426|NCT01555125|50268496|FG004|Extension|Technical Problems|0|||
25153427|NCT01555125|50268492|FG000|Follow-Up Period|Lost to Follow-up|1|||
25153428|NCT01555125|50268493|FG001|Follow-Up Period|Lost to Follow-up|0|||
25153429|NCT01555125|50268494|FG002|Follow-Up Period|Lost to Follow-up|0|||
25153430|NCT01555125|50268495|FG003|Follow-Up Period|Lost to Follow-up|0|||
25153431|NCT01555125|50268496|FG004|Follow-Up Period|Lost to Follow-up|0|||
25153432|NCT01555125|50268492|FG000|Follow-Up Period|Subject / guardian decision|3|||
25153433|NCT01555125|50268493|FG001|Follow-Up Period|Subject / guardian decision|1|||
25153434|NCT01555125|50268494|FG002|Follow-Up Period|Subject / guardian decision|1|||
25153435|NCT01555125|50268495|FG003|Follow-Up Period|Subject / guardian decision|1|||
25153436|NCT01555125|50268496|FG004|Follow-Up Period|Subject / guardian decision|0|||
25153437|NCT01768286|50268515|FG000|Overall Study|Randomized But Not Treated|0|||
25153438|NCT01768286|50268516|FG001|Overall Study|Randomized But Not Treated|0|||
25153439|NCT01768286|50268517|FG002|Overall Study|Randomized But Not Treated|1|||
25153440|NCT01768286|50268518|FG003|Overall Study|Randomized But Not Treated|0|||
25153441|NCT01768286|50268515|FG000|Overall Study|Lack of Efficacy|7|||
25153442|NCT01768286|50268516|FG001|Overall Study|Lack of Efficacy|4|||
24915169|NCT00618072|50009443|FG001|Overall Study|Physician Decision|1|||
24915170|NCT00618072|50009444|FG002|Overall Study|Physician Decision|1|||
24915171|NCT00666926|50009452|FG000|Overall Study|Adverse Event|0|||
24915172|NCT00666926|50009453|FG001|Overall Study|Adverse Event|0|||
24915173|NCT00666926|50009454|FG002|Overall Study|Adverse Event|0|||
24915174|NCT00666926|50009455|FG003|Overall Study|Adverse Event|0|||
24915175|NCT00666926|50009456|FG004|Overall Study|Adverse Event|0|||
24915176|NCT00666926|50009457|FG005|Overall Study|Adverse Event|0|||
25020974|NCT02718898|50117238|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
25020975|NCT02718898|50117239|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
25020976|NCT02718898|50117240|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
25020977|NCT02718898|50117241|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
25020978|NCT02718898|50117242|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
25020979|NCT02718898|50117236|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
25020980|NCT02718898|50117237|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
25153443|NCT01768286|50268517|FG002|Overall Study|Lack of Efficacy|0|||
25153444|NCT01768286|50268518|FG003|Overall Study|Lack of Efficacy|1|||
24915177|NCT00666926|50009458|FG006|Overall Study|Adverse Event|0|||
24915178|NCT00666926|50009459|FG007|Overall Study|Adverse Event|0|||
24915179|NCT00666926|50009460|FG008|Overall Study|Adverse Event|0|||
24915180|NCT00666926|50009461|FG009|Overall Study|Adverse Event|2|||
24915181|NCT00666926|50009462|FG010|Overall Study|Adverse Event|2|||
24915182|NCT00666926|50009463|FG011|Overall Study|Adverse Event|2|||
24915183|NCT00666926|50009464|FG012|Overall Study|Adverse Event|0|||
25153445|NCT01768286|50268515|FG000|Overall Study|Withdrew Consent|0|||
25153446|NCT01768286|50268516|FG001|Overall Study|Withdrew Consent|0|||
25153447|NCT01768286|50268517|FG002|Overall Study|Withdrew Consent|1|||
24915184|NCT00666926|50009465|FG013|Overall Study|Adverse Event|1|||
24915185|NCT00666926|50009466|FG014|Overall Study|Adverse Event|0|||
24915186|NCT00666926|50009467|FG015|Overall Study|Adverse Event|0|||
24915187|NCT00666926|50009452|FG000|Overall Study|Laboratory abnormality|0|||
24915188|NCT00666926|50009453|FG001|Overall Study|Laboratory abnormality|0|||
24915189|NCT00666926|50009454|FG002|Overall Study|Laboratory abnormality|0|||
24915190|NCT00666926|50009455|FG003|Overall Study|Laboratory abnormality|0|||
24915191|NCT00666926|50009456|FG004|Overall Study|Laboratory abnormality|0|||
24915192|NCT00666926|50009457|FG005|Overall Study|Laboratory abnormality|0|||
24915193|NCT00666926|50009458|FG006|Overall Study|Laboratory abnormality|0|||
24915194|NCT00666926|50009459|FG007|Overall Study|Laboratory abnormality|0|||
24915195|NCT00666926|50009460|FG008|Overall Study|Laboratory abnormality|0|||
24915196|NCT00666926|50009461|FG009|Overall Study|Laboratory abnormality|0|||
24915197|NCT00666926|50009462|FG010|Overall Study|Laboratory abnormality|1|||
24915198|NCT00666926|50009463|FG011|Overall Study|Laboratory abnormality|0|||
24915199|NCT00666926|50009464|FG012|Overall Study|Laboratory abnormality|0|||
24915200|NCT00666926|50009465|FG013|Overall Study|Laboratory abnormality|0|||
24915201|NCT00666926|50009466|FG014|Overall Study|Laboratory abnormality|0|||
24915202|NCT00666926|50009467|FG015|Overall Study|Laboratory abnormality|1|||
24915203|NCT00666926|50009452|FG000|Overall Study|Lack of Efficacy|0|||
24915204|NCT00666926|50009453|FG001|Overall Study|Lack of Efficacy|0|||
24915205|NCT00666926|50009454|FG002|Overall Study|Lack of Efficacy|0|||
24915206|NCT00666926|50009455|FG003|Overall Study|Lack of Efficacy|0|||
24915207|NCT00666926|50009456|FG004|Overall Study|Lack of Efficacy|0|||
24915208|NCT00666926|50009457|FG005|Overall Study|Lack of Efficacy|1|||
24915209|NCT00666926|50009458|FG006|Overall Study|Lack of Efficacy|0|||
24915210|NCT00666926|50009459|FG007|Overall Study|Lack of Efficacy|0|||
24915211|NCT00666926|50009460|FG008|Overall Study|Lack of Efficacy|0|||
24915212|NCT00666926|50009461|FG009|Overall Study|Lack of Efficacy|0|||
24915213|NCT00666926|50009462|FG010|Overall Study|Lack of Efficacy|0|||
24915214|NCT00666926|50009463|FG011|Overall Study|Lack of Efficacy|1|||
24915215|NCT00666926|50009464|FG012|Overall Study|Lack of Efficacy|0|||
24915216|NCT00666926|50009465|FG013|Overall Study|Lack of Efficacy|0|||
24915217|NCT00666926|50009466|FG014|Overall Study|Lack of Efficacy|0|||
24915218|NCT00666926|50009467|FG015|Overall Study|Lack of Efficacy|0|||
24915219|NCT00666926|50009452|FG000|Overall Study|Lost to Follow-up|0|||
24915220|NCT00666926|50009453|FG001|Overall Study|Lost to Follow-up|0|||
24915221|NCT00666926|50009454|FG002|Overall Study|Lost to Follow-up|0|||
24915222|NCT00666926|50009455|FG003|Overall Study|Lost to Follow-up|1|||
24915223|NCT00666926|50009456|FG004|Overall Study|Lost to Follow-up|0|||
24915224|NCT00666926|50009457|FG005|Overall Study|Lost to Follow-up|0|||
24915225|NCT00666926|50009458|FG006|Overall Study|Lost to Follow-up|0|||
24915226|NCT00666926|50009459|FG007|Overall Study|Lost to Follow-up|0|||
24915227|NCT00666926|50009460|FG008|Overall Study|Lost to Follow-up|0|||
24915228|NCT00666926|50009461|FG009|Overall Study|Lost to Follow-up|0|||
24915229|NCT00666926|50009462|FG010|Overall Study|Lost to Follow-up|0|||
24915230|NCT00666926|50009463|FG011|Overall Study|Lost to Follow-up|0|||
24915231|NCT00666926|50009464|FG012|Overall Study|Lost to Follow-up|0|||
24915232|NCT00666926|50009465|FG013|Overall Study|Lost to Follow-up|0|||
24915233|NCT00666926|50009466|FG014|Overall Study|Lost to Follow-up|0|||
24915234|NCT00666926|50009467|FG015|Overall Study|Lost to Follow-up|0|||
24915235|NCT00666926|50009452|FG000|Overall Study|Other|2|||
24915236|NCT00666926|50009453|FG001|Overall Study|Other|4|||
24915237|NCT00666926|50009454|FG002|Overall Study|Other|3|||
24915238|NCT00666926|50009455|FG003|Overall Study|Other|3|||
24915239|NCT00666926|50009456|FG004|Overall Study|Other|3|||
24915240|NCT00666926|50009457|FG005|Overall Study|Other|3|||
24915241|NCT00666926|50009458|FG006|Overall Study|Other|4|||
24915242|NCT00666926|50009459|FG007|Overall Study|Other|0|||
24915243|NCT00666926|50009460|FG008|Overall Study|Other|3|||
24915244|NCT00666926|50009461|FG009|Overall Study|Other|5|||
24915245|NCT00666926|50009462|FG010|Overall Study|Other|3|||
24915246|NCT00666926|50009463|FG011|Overall Study|Other|26|||
24915247|NCT00666926|50009464|FG012|Overall Study|Other|3|||
24915248|NCT00666926|50009465|FG013|Overall Study|Other|2|||
24915249|NCT00666926|50009466|FG014|Overall Study|Other|4|||
24915250|NCT00666926|50009467|FG015|Overall Study|Other|4|||
24915251|NCT00666926|50009452|FG000|Overall Study|Withdrawal by Subject|0|||
24915252|NCT00666926|50009453|FG001|Overall Study|Withdrawal by Subject|0|||
24915253|NCT00666926|50009454|FG002|Overall Study|Withdrawal by Subject|0|||
24915254|NCT00666926|50009455|FG003|Overall Study|Withdrawal by Subject|0|||
24915255|NCT00666926|50009456|FG004|Overall Study|Withdrawal by Subject|0|||
24915256|NCT00666926|50009457|FG005|Overall Study|Withdrawal by Subject|0|||
24915257|NCT00666926|50009458|FG006|Overall Study|Withdrawal by Subject|0|||
24915258|NCT00666926|50009459|FG007|Overall Study|Withdrawal by Subject|1|||
24915259|NCT00666926|50009460|FG008|Overall Study|Withdrawal by Subject|0|||
24915260|NCT00666926|50009461|FG009|Overall Study|Withdrawal by Subject|3|||
24915261|NCT00666926|50009462|FG010|Overall Study|Withdrawal by Subject|0|||
24915262|NCT00666926|50009463|FG011|Overall Study|Withdrawal by Subject|3|||
24915263|NCT00666926|50009464|FG012|Overall Study|Withdrawal by Subject|0|||
24915264|NCT00666926|50009465|FG013|Overall Study|Withdrawal by Subject|1|||
24915265|NCT00666926|50009466|FG014|Overall Study|Withdrawal by Subject|3|||
24915266|NCT00666926|50009467|FG015|Overall Study|Withdrawal by Subject|3|||
24915267|NCT00666926|50009452|FG000|Overall Study|Death|0|||
24915268|NCT00666926|50009453|FG001|Overall Study|Death|0|||
24915269|NCT00666926|50009454|FG002|Overall Study|Death|0|||
24915270|NCT00666926|50009455|FG003|Overall Study|Death|0|||
24915271|NCT00666926|50009456|FG004|Overall Study|Death|0|||
24915272|NCT00666926|50009457|FG005|Overall Study|Death|0|||
24915273|NCT00666926|50009458|FG006|Overall Study|Death|0|||
24915274|NCT00666926|50009459|FG007|Overall Study|Death|0|||
24915275|NCT00666926|50009460|FG008|Overall Study|Death|0|||
24915276|NCT00666926|50009461|FG009|Overall Study|Death|0|||
24915277|NCT00666926|50009462|FG010|Overall Study|Death|0|||
24915278|NCT00666926|50009463|FG011|Overall Study|Death|1|||
24915279|NCT00666926|50009464|FG012|Overall Study|Death|0|||
24915280|NCT00666926|50009465|FG013|Overall Study|Death|0|||
24915281|NCT00666926|50009466|FG014|Overall Study|Death|0|||
24915282|NCT00666926|50009467|FG015|Overall Study|Death|0|||
24915283|NCT03861052|50009522|FG000|Overall Study|Adverse Event|1|||
24915284|NCT03861052|50009523|FG001|Overall Study|Adverse Event|1|||
24915285|NCT03861052|50009524|FG002|Overall Study|Adverse Event|2|||
24915286|NCT03861052|50009525|FG003|Overall Study|Adverse Event|4|||
24915287|NCT03861052|50009522|FG000|Overall Study|Lost to Follow-up|0|||
24915288|NCT03861052|50009523|FG001|Overall Study|Lost to Follow-up|0|||
24915289|NCT03861052|50009524|FG002|Overall Study|Lost to Follow-up|0|||
24915290|NCT03861052|50009525|FG003|Overall Study|Lost to Follow-up|1|||
24915291|NCT03861052|50009522|FG000|Overall Study|Physician Decision|0|||
24915292|NCT03861052|50009523|FG001|Overall Study|Physician Decision|1|||
24915293|NCT03861052|50009524|FG002|Overall Study|Physician Decision|0|||
24915294|NCT03861052|50009525|FG003|Overall Study|Physician Decision|0|||
24915295|NCT03861052|50009522|FG000|Overall Study|Withdrawal by Subject|2|||
24915296|NCT03861052|50009523|FG001|Overall Study|Withdrawal by Subject|5|||
24915297|NCT03861052|50009524|FG002|Overall Study|Withdrawal by Subject|3|||
24915298|NCT03861052|50009525|FG003|Overall Study|Withdrawal by Subject|0|||
24915299|NCT03861052|50009522|FG000|Overall Study|Relocation to other city|1|||
24915300|NCT03861052|50009523|FG001|Overall Study|Relocation to other city|0|||
24915301|NCT03861052|50009524|FG002|Overall Study|Relocation to other city|0|||
24915302|NCT03861052|50009525|FG003|Overall Study|Relocation to other city|0|||
24915303|NCT00664742|50009540|FG000|Overall Study|Withdrawn due to adverse events|3|||
24915304|NCT00664742|50009540|FG000|Overall Study|Withdrawal by Subject|31|||
24915305|NCT00664742|50009540|FG000|Overall Study|Lost to Follow-up|92|||
24915306|NCT00511342|50009546|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
24915307|NCT00511342|50009547|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
24915308|NCT00511342|50009546|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
24915309|NCT00511342|50009547|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
24915310|NCT00511342|50009546|FG000|Overall Study|Pregnancy|0|||
24915311|NCT00511342|50009547|FG001|Overall Study|Pregnancy|1|||
24915312|NCT00511342|50009546|FG000|Overall Study|Pregnancy wish|0|||
24915313|NCT00511342|50009547|FG001|Overall Study|Pregnancy wish|1|||
24915314|NCT00511342|50009546|FG000|Overall Study|Lost to Follow-up|1|||
24915315|NCT00511342|50009547|FG001|Overall Study|Lost to Follow-up|5|||
24915316|NCT00511342|50009546|FG000|Overall Study|Other Reason|2|||
24915317|NCT00511342|50009547|FG001|Overall Study|Other Reason|2|||
24915318|NCT03931785|50009557|FG000|Overall Study|Lost to Follow-up|4|||
24915319|NCT03931785|50009558|FG001|Overall Study|Lost to Follow-up|1|||
24915320|NCT03931785|50009559|FG002|Overall Study|Lost to Follow-up|4|||
24915321|NCT03931785|50009560|FG003|Overall Study|Lost to Follow-up|3|||
24915322|NCT03931785|50009557|FG000|Overall Study|Adverse Event|1|||
24915323|NCT03931785|50009558|FG001|Overall Study|Adverse Event|0|||
24915324|NCT03931785|50009559|FG002|Overall Study|Adverse Event|3|||
24915325|NCT03931785|50009560|FG003|Overall Study|Adverse Event|4|||
24915326|NCT03931785|50009557|FG000|Overall Study|Protocol Violation|0|||
24915327|NCT03931785|50009558|FG001|Overall Study|Protocol Violation|1|||
24915328|NCT03931785|50009559|FG002|Overall Study|Protocol Violation|0|||
24915329|NCT03931785|50009560|FG003|Overall Study|Protocol Violation|0|||
24915330|NCT03931785|50009557|FG000|Overall Study|Noncompliance With Study drug|0|||
24915331|NCT03931785|50009558|FG001|Overall Study|Noncompliance With Study drug|1|||
24915332|NCT03931785|50009559|FG002|Overall Study|Noncompliance With Study drug|0|||
24915333|NCT03931785|50009560|FG003|Overall Study|Noncompliance With Study drug|0|||
24915334|NCT03931785|50009557|FG000|Overall Study|Other Not specified|0|||
24915335|NCT03931785|50009558|FG001|Overall Study|Other Not specified|2|||
24915336|NCT03931785|50009559|FG002|Overall Study|Other Not specified|2|||
24915337|NCT03931785|50009560|FG003|Overall Study|Other Not specified|2|||
24915338|NCT03931785|50009557|FG000|Overall Study|Withdrawal by Subject|0|||
24915339|NCT03931785|50009558|FG001|Overall Study|Withdrawal by Subject|2|||
24915340|NCT03931785|50009559|FG002|Overall Study|Withdrawal by Subject|4|||
24915341|NCT03931785|50009560|FG003|Overall Study|Withdrawal by Subject|1|||
24915342|NCT03931785|50009557|FG000|Overall Study|Pregnancy|0|||
24915343|NCT03931785|50009558|FG001|Overall Study|Pregnancy|0|||
24915344|NCT03931785|50009559|FG002|Overall Study|Pregnancy|0|||
24915345|NCT03931785|50009560|FG003|Overall Study|Pregnancy|1|||
24915346|NCT00666536|50009572|FG000|Overall Study|Adverse Event|9|||
24915347|NCT00666536|50009573|FG001|Overall Study|Adverse Event|19|||
24915348|NCT00666536|50009572|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
24915349|NCT00666536|50009573|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
24915350|NCT00666536|50009572|FG000|Overall Study|Protocol deviation(s)|8|||
24915351|NCT00666536|50009573|FG001|Overall Study|Protocol deviation(s)|6|||
25020981|NCT02718898|50117238|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
25020982|NCT02718898|50117239|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
25020983|NCT02718898|50117240|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
25020984|NCT02718898|50117241|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
25020985|NCT02718898|50117242|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
25020986|NCT02718898|50117236|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
25020987|NCT02718898|50117237|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
25020988|NCT02718898|50117238|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
24915352|NCT00666536|50009572|FG000|Overall Study|Withdrawal by Subject|10|||
25020989|NCT02718898|50117239|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
25020990|NCT02718898|50117240|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
25020991|NCT02718898|50117241|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
25020992|NCT02718898|50117242|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
25020993|NCT03143166|50117259|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
25020994|NCT02879994|50117265|FG000|Overall Study|off treatment early|7|||
25274962|NCT01238861|50589067|FG002|Overall Study|Lost to Follow-up|3|||
25274963|NCT01238861|50589068|FG003|Overall Study|Lost to Follow-up|1|||
25274964|NCT01238861|50589069|FG004|Overall Study|Lost to Follow-up|1|||
25274965|NCT01238861|50589070|FG005|Overall Study|Lost to Follow-up|2|||
24915353|NCT00666536|50009573|FG001|Overall Study|Withdrawal by Subject|9|||
24915354|NCT00666536|50009572|FG000|Overall Study|Lost to Follow-up|4|||
24915355|NCT00666536|50009573|FG001|Overall Study|Lost to Follow-up|3|||
24915356|NCT00519532|50009579|FG000|Overall Study|Adverse Event|11|||
24915357|NCT00519532|50009579|FG000|Overall Study|Withdrawal by Subject|5|||
24915358|NCT00519532|50009579|FG000|Overall Study|Lost to Follow-up|2|||
24915359|NCT00666458|50009585|FG000|Overall Study|Adverse Event|8|||
24915360|NCT00666458|50009586|FG001|Overall Study|Adverse Event|7|||
25020995|NCT02879994|50117265|FG000|Overall Study|Adverse Event|2|||
25020996|NCT02879994|50117265|FG000|Overall Study|Death|2|||
25020997|NCT03142932|50117271|FG000|Overall Study|Lost to Follow-up|2|||
25020998|NCT03142932|50117272|FG001|Overall Study|Lost to Follow-up|11|||
25020999|NCT00702052|50117278|FG000|Overall Study|Adverse Event|23|||
25021000|NCT00702052|50117278|FG000|Overall Study|Disease Progression|30|||
25021001|NCT00702052|50117278|FG000|Overall Study|Withdrawal by Subject|5|||
25021002|NCT03140280|50117282|FG000|Overall Study|Physician Decision|5|||
25021003|NCT03136380|50117288|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
25021004|NCT03136380|50117289|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
25021005|NCT03136380|50117290|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
25021006|NCT03136380|50117291|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
25021007|NCT03136380|50117292|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
25021008|NCT03136068|50117312|FG000|Overall Study|Lost to Follow-up|1|||
25021009|NCT03136068|50117313|FG001|Overall Study|Lost to Follow-up|1|||
25021010|NCT03136068|50117312|FG000|Overall Study|Protocol Violation|1|||
24915361|NCT00666458|50009585|FG000|Overall Study|Withdrawal by Subject|5|||
24915362|NCT00666458|50009586|FG001|Overall Study|Withdrawal by Subject|4|||
24915363|NCT00666458|50009585|FG000|Overall Study|Lost to Follow-up|0|||
24915364|NCT00666458|50009586|FG001|Overall Study|Lost to Follow-up|3|||
24915365|NCT00666458|50009585|FG000|Overall Study|Administrative reason by sponsor|1|||
24915366|NCT00666458|50009586|FG001|Overall Study|Administrative reason by sponsor|1|||
24915367|NCT00666458|50009585|FG000|Overall Study|Incorrect enrollment|7|||
24915368|NCT00666458|50009586|FG001|Overall Study|Incorrect enrollment|1|||
24915369|NCT00666458|50009585|FG000|Overall Study|Study specific discontinuation criteria|14|||
24915370|NCT00666458|50009586|FG001|Overall Study|Study specific discontinuation criteria|7|||
24915371|NCT00666458|50009585|FG000|Overall Study|Severe non-compliance to the protocol|1|||
24915372|NCT00666458|50009586|FG001|Overall Study|Severe non-compliance to the protocol|1|||
24915373|NCT00666458|50009585|FG000|Overall Study|Safety reasons|1|||
24915374|NCT00666458|50009586|FG001|Overall Study|Safety reasons|0|||
24915375|NCT00666458|50009585|FG000|Overall Study|Medical history of anemia|1|||
24915376|NCT00666458|50009586|FG001|Overall Study|Medical history of anemia|0|||
24915377|NCT00511108|50009596|FG000|Overall Study|Adverse Event|2|||
24915378|NCT00511108|50009597|FG001|Overall Study|Adverse Event|0|||
24915379|NCT00511108|50009598|FG002|Overall Study|Adverse Event|1|||
24915380|NCT00511108|50009599|FG003|Overall Study|Adverse Event|2|||
24915381|NCT00511108|50009596|FG000|Overall Study|Lost to Follow-up|0|||
24915382|NCT00511108|50009597|FG001|Overall Study|Lost to Follow-up|2|||
24915383|NCT00511108|50009598|FG002|Overall Study|Lost to Follow-up|1|||
24915384|NCT00511108|50009599|FG003|Overall Study|Lost to Follow-up|0|||
24915385|NCT00511108|50009596|FG000|Overall Study|Physician Decision|0|||
24915386|NCT00511108|50009597|FG001|Overall Study|Physician Decision|0|||
24915387|NCT00511108|50009598|FG002|Overall Study|Physician Decision|0|||
24915388|NCT00511108|50009599|FG003|Overall Study|Physician Decision|1|||
24915389|NCT00511108|50009596|FG000|Overall Study|Withdrawal by Subject|4|||
24915390|NCT00511108|50009597|FG001|Overall Study|Withdrawal by Subject|0|||
24915391|NCT00511108|50009598|FG002|Overall Study|Withdrawal by Subject|3|||
24915392|NCT00511108|50009599|FG003|Overall Study|Withdrawal by Subject|2|||
24915393|NCT00510952|50009611|FG000|Overall Study|Adverse Event|1|||
24915394|NCT00510952|50009612|FG001|Overall Study|Adverse Event|0|||
24915395|NCT00510952|50009611|FG000|Overall Study|Entry Criteria Not Met|3|||
24915396|NCT00510952|50009612|FG001|Overall Study|Entry Criteria Not Met|1|||
24915397|NCT00510952|50009611|FG000|Overall Study|Lost to Follow-up|5|||
24915398|NCT00510952|50009612|FG001|Overall Study|Lost to Follow-up|3|||
24915399|NCT00510952|50009611|FG000|Overall Study|Physician Decision|1|||
24915400|NCT00510952|50009612|FG001|Overall Study|Physician Decision|1|||
24915401|NCT00510952|50009611|FG000|Overall Study|Protocol Violation|7|||
24915402|NCT00510952|50009612|FG001|Overall Study|Protocol Violation|4|||
25021011|NCT03136068|50117313|FG001|Overall Study|Protocol Violation|0|||
25021012|NCT02585232|50117321|FG000|Overall Study|Lost to Follow-up|8|||
25021013|NCT02585232|50117322|FG001|Overall Study|Lost to Follow-up|8|||
25021014|NCT02585232|50117321|FG000|Overall Study|Withdrawal by Subject|4|||
25021015|NCT02585232|50117322|FG001|Overall Study|Withdrawal by Subject|8|||
25021016|NCT03377790|50117351|FG000|Overall Study|Withdrawal by Subject|1|||
25021017|NCT03377790|50117352|FG001|Overall Study|Withdrawal by Subject|0|||
25021018|NCT03377790|50117351|FG000|Overall Study|Adverse Event|1|||
25021019|NCT03377790|50117352|FG001|Overall Study|Adverse Event|0|||
25274966|NCT01238861|50589065|FG000|Overall Study|Unplanned surgery|1|||
25274967|NCT01238861|50589066|FG001|Overall Study|Unplanned surgery|0|||
24915403|NCT00510952|50009611|FG000|Overall Study|Sponsor Decision|1|||
24915404|NCT00510952|50009612|FG001|Overall Study|Sponsor Decision|0|||
24915405|NCT00510952|50009611|FG000|Overall Study|Withdrawal by Subject|6|||
24915406|NCT00510952|50009612|FG001|Overall Study|Withdrawal by Subject|7|||
25021020|NCT03377790|50117351|FG000|Overall Study|Lost to Follow-up|0|||
24915407|NCT00510952|50009611|FG000|Overall Study|Did Not Receive Study Drug|2|||
24915408|NCT00510952|50009612|FG001|Overall Study|Did Not Receive Study Drug|0|||
24915409|NCT00617604|50009620|FG000|Overall Study|Death|2|||
25021021|NCT03377790|50117352|FG001|Overall Study|Lost to Follow-up|2|||
25021022|NCT03377790|50117351|FG000|Overall Study|Randomized but not treated|1|||
25021023|NCT03377790|50117352|FG001|Overall Study|Randomized but not treated|0|||
25021024|NCT03377790|50117351|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
25021025|NCT03377790|50117352|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
25021026|NCT02717494|50117361|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
25021027|NCT02717494|50117362|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
25021028|NCT02717494|50117363|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
25021029|NCT02717494|50117361|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
25021030|NCT02717494|50117362|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
25021031|NCT02717494|50117363|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
25021032|NCT02717494|50117361|FG000|First Intervention (Step 1)|Death|0|||
25021033|NCT02717494|50117362|FG001|First Intervention (Step 1)|Death|0|||
25021034|NCT02717494|50117363|FG002|First Intervention (Step 1)|Death|1|||
25021035|NCT02717494|50117361|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
25021036|NCT02717494|50117362|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
25021037|NCT02717494|50117363|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
25021038|NCT01844856|50117391|FG000|Overall Study|Lost to Follow-up|15|||
25021039|NCT01844856|50117392|FG001|Overall Study|Lost to Follow-up|3|||
25021040|NCT01844856|50117391|FG000|Overall Study|Adverse Event|3|||
25021041|NCT01844856|50117392|FG001|Overall Study|Adverse Event|6|||
25021042|NCT01844856|50117391|FG000|Overall Study|Withdrawal by Subject|3|||
25021043|NCT01844856|50117392|FG001|Overall Study|Withdrawal by Subject|2|||
25021044|NCT01844856|50117391|FG000|Overall Study|Noncompliance|2|||
25021045|NCT01844856|50117392|FG001|Overall Study|Noncompliance|3|||
25021046|NCT01844856|50117391|FG000|Overall Study|Enterococcus Resistant|0|||
25021047|NCT01844856|50117392|FG001|Overall Study|Enterococcus Resistant|1|||
25021048|NCT01844856|50117391|FG000|Overall Study|Inadvertently Not Scheduled|1|||
25021049|NCT01844856|50117392|FG001|Overall Study|Inadvertently Not Scheduled|0|||
25021050|NCT01844856|50117391|FG000|Overall Study|Randomized but was a Screen Failure|0|||
25021051|NCT01844856|50117392|FG001|Overall Study|Randomized but was a Screen Failure|1|||
25021052|NCT03135210|50117428|FG000|Overall Study|Death|0|||
25021053|NCT03135210|50117429|FG001|Overall Study|Death|1|||
25274968|NCT01238861|50589067|FG002|Overall Study|Unplanned surgery|0|||
25274969|NCT01238861|50589068|FG003|Overall Study|Unplanned surgery|0|||
25274970|NCT01238861|50589069|FG004|Overall Study|Unplanned surgery|0|||
25274971|NCT01238861|50589070|FG005|Overall Study|Unplanned surgery|0|||
25274972|NCT01238861|50589065|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
25274973|NCT01238861|50589066|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
25274974|NCT01238861|50589067|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
25274975|NCT01238861|50589068|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
25274976|NCT01238861|50589069|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
25274977|NCT01238861|50589070|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
25274978|NCT01238861|50589065|FG000|Overall Study|Incorrect enrollment/randomization|0|||
25021066|NCT00701662|50117444|FG000|Overall Study|Lack of Efficacy|1|||
25021067|NCT02878590|50117448|FG000|Overall Study|Withdrawal by Subject|2|||
25021068|NCT04634409|50117479|FG000|Overall Study|Death|0|||
25021069|NCT04634409|50117480|FG001|Overall Study|Death|0|||
25021070|NCT04634409|50117481|FG002|Overall Study|Death|0|||
25021071|NCT04634409|50117482|FG003|Overall Study|Death|0|||
25021072|NCT04634409|50117483|FG004|Overall Study|Death|0|||
25021073|NCT04634409|50117484|FG005|Overall Study|Death|0|||
25021074|NCT04634409|50117485|FG006|Overall Study|Death|0|||
25021075|NCT04634409|50117486|FG007|Overall Study|Death|0|||
25021076|NCT04634409|50117487|FG008|Overall Study|Death|0|||
25021077|NCT04634409|50117488|FG009|Overall Study|Death|0|||
25021078|NCT04634409|50117489|FG010|Overall Study|Death|1|||
25021079|NCT04634409|50117490|FG011|Overall Study|Death|0|||
25021080|NCT04634409|50117491|FG012|Overall Study|Death|1|||
25021081|NCT04634409|50117492|FG013|Overall Study|Death|0|||
25021082|NCT04634409|50117493|FG014|Overall Study|Death|0|||
25021083|NCT04634409|50117494|FG015|Overall Study|Death|0|||
25021084|NCT04634409|50117495|FG016|Overall Study|Death|0|||
25021085|NCT04634409|50117496|FG017|Overall Study|Death|0|||
25021086|NCT04634409|50117497|FG018|Overall Study|Death|0|||
25021087|NCT04634409|50117498|FG019|Overall Study|Death|0|||
25021088|NCT04634409|50117499|FG020|Overall Study|Death|0|||
25021089|NCT04634409|50117500|FG021|Overall Study|Death|0|||
25021090|NCT04634409|50117501|FG022|Overall Study|Death|0|||
25021091|NCT04634409|50117502|FG023|Overall Study|Death|0|||
25021092|NCT04634409|50117503|FG024|Overall Study|Death|0|||
25021093|NCT04634409|50117504|FG025|Overall Study|Death|0|||
25021094|NCT04634409|50117505|FG026|Overall Study|Death|0|||
25021095|NCT04634409|50117479|FG000|Overall Study|Adverse Event|0|||
25021096|NCT04634409|50117480|FG001|Overall Study|Adverse Event|0|||
25021097|NCT04634409|50117481|FG002|Overall Study|Adverse Event|1|||
25021098|NCT04634409|50117482|FG003|Overall Study|Adverse Event|0|||
25021099|NCT04634409|50117483|FG004|Overall Study|Adverse Event|0|||
25021100|NCT04634409|50117484|FG005|Overall Study|Adverse Event|1|||
25021101|NCT04634409|50117485|FG006|Overall Study|Adverse Event|0|||
25021102|NCT04634409|50117486|FG007|Overall Study|Adverse Event|0|||
25021103|NCT04634409|50117487|FG008|Overall Study|Adverse Event|0|||
25021104|NCT04634409|50117488|FG009|Overall Study|Adverse Event|0|||
24915410|NCT00617604|50009621|FG001|Overall Study|Death|1|||
24915411|NCT00617604|50009620|FG000|Overall Study|Lost to Follow-up|1|||
24915412|NCT00617604|50009621|FG001|Overall Study|Lost to Follow-up|0|||
24915413|NCT00617604|50009620|FG000|Overall Study|Miscellaneous Reasons|8|||
24915414|NCT00617604|50009621|FG001|Overall Study|Miscellaneous Reasons|10|||
24915415|NCT00617604|50009620|FG000|Overall Study|Withdrawal by Subject|4|||
24915416|NCT00617604|50009621|FG001|Overall Study|Withdrawal by Subject|6|||
24915417|NCT00617604|50009620|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
24915418|NCT00617604|50009621|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
24915419|NCT00661622|50009629|FG000|Overall Study|Protocol Violation|1|||
24915420|NCT00661622|50009630|FG001|Overall Study|Protocol Violation|0|||
24915421|NCT04093752|50009641|FG000|Overall Study|Adverse Event|7|||
24915422|NCT04093752|50009642|FG001|Overall Study|Adverse Event|19|||
25021105|NCT04634409|50117489|FG010|Overall Study|Adverse Event|0|||
25021106|NCT04634409|50117490|FG011|Overall Study|Adverse Event|0|||
25021107|NCT04634409|50117491|FG012|Overall Study|Adverse Event|0|||
25021108|NCT04634409|50117492|FG013|Overall Study|Adverse Event|0|||
25021109|NCT04634409|50117493|FG014|Overall Study|Adverse Event|0|||
25021110|NCT04634409|50117494|FG015|Overall Study|Adverse Event|0|||
25021111|NCT04634409|50117495|FG016|Overall Study|Adverse Event|0|||
25021112|NCT04634409|50117496|FG017|Overall Study|Adverse Event|0|||
25021113|NCT04634409|50117497|FG018|Overall Study|Adverse Event|0|||
25021114|NCT04634409|50117498|FG019|Overall Study|Adverse Event|0|||
25021115|NCT04634409|50117499|FG020|Overall Study|Adverse Event|0|||
25021116|NCT04634409|50117500|FG021|Overall Study|Adverse Event|0|||
25021117|NCT04634409|50117501|FG022|Overall Study|Adverse Event|0|||
25021118|NCT04634409|50117502|FG023|Overall Study|Adverse Event|0|||
25021119|NCT04634409|50117503|FG024|Overall Study|Adverse Event|0|||
25021120|NCT04634409|50117504|FG025|Overall Study|Adverse Event|0|||
25021121|NCT04634409|50117505|FG026|Overall Study|Adverse Event|0|||
25021122|NCT04634409|50117479|FG000|Overall Study|Lost to Follow-up|3|||
25021123|NCT04634409|50117480|FG001|Overall Study|Lost to Follow-up|1|||
25021124|NCT04634409|50117481|FG002|Overall Study|Lost to Follow-up|1|||
25021125|NCT04634409|50117482|FG003|Overall Study|Lost to Follow-up|3|||
25021126|NCT04634409|50117483|FG004|Overall Study|Lost to Follow-up|1|||
25021127|NCT04634409|50117484|FG005|Overall Study|Lost to Follow-up|1|||
25021128|NCT04634409|50117485|FG006|Overall Study|Lost to Follow-up|1|||
25021129|NCT04634409|50117486|FG007|Overall Study|Lost to Follow-up|3|||
25021130|NCT04634409|50117487|FG008|Overall Study|Lost to Follow-up|3|||
25021131|NCT04634409|50117488|FG009|Overall Study|Lost to Follow-up|11|||
25021132|NCT04634409|50117489|FG010|Overall Study|Lost to Follow-up|8|||
25021133|NCT04634409|50117490|FG011|Overall Study|Lost to Follow-up|15|||
25021134|NCT04634409|50117491|FG012|Overall Study|Lost to Follow-up|3|||
25021135|NCT04634409|50117492|FG013|Overall Study|Lost to Follow-up|2|||
25021136|NCT04634409|50117493|FG014|Overall Study|Lost to Follow-up|7|||
25021137|NCT04634409|50117494|FG015|Overall Study|Lost to Follow-up|0|||
25021138|NCT04634409|50117495|FG016|Overall Study|Lost to Follow-up|0|||
25021139|NCT04634409|50117496|FG017|Overall Study|Lost to Follow-up|0|||
25021140|NCT04634409|50117497|FG018|Overall Study|Lost to Follow-up|0|||
25021141|NCT04634409|50117498|FG019|Overall Study|Lost to Follow-up|0|||
25021142|NCT04634409|50117499|FG020|Overall Study|Lost to Follow-up|0|||
25021143|NCT04634409|50117500|FG021|Overall Study|Lost to Follow-up|0|||
25021144|NCT04634409|50117501|FG022|Overall Study|Lost to Follow-up|0|||
25021145|NCT04634409|50117502|FG023|Overall Study|Lost to Follow-up|0|||
25021146|NCT04634409|50117503|FG024|Overall Study|Lost to Follow-up|0|||
25021147|NCT04634409|50117504|FG025|Overall Study|Lost to Follow-up|0|||
25021148|NCT04634409|50117505|FG026|Overall Study|Lost to Follow-up|0|||
25021149|NCT04634409|50117479|FG000|Overall Study|Withdrawal by Subject|3|||
25021150|NCT04634409|50117480|FG001|Overall Study|Withdrawal by Subject|1|||
25021151|NCT04634409|50117481|FG002|Overall Study|Withdrawal by Subject|6|||
25021152|NCT04634409|50117482|FG003|Overall Study|Withdrawal by Subject|4|||
25021153|NCT04634409|50117483|FG004|Overall Study|Withdrawal by Subject|2|||
25021154|NCT04634409|50117484|FG005|Overall Study|Withdrawal by Subject|0|||
25021155|NCT04634409|50117485|FG006|Overall Study|Withdrawal by Subject|0|||
25274979|NCT01238861|50589066|FG001|Overall Study|Incorrect enrollment/randomization|0|||
24915423|NCT04093752|50009643|FG002|Overall Study|Adverse Event|18|||
24915424|NCT04093752|50009644|FG003|Overall Study|Adverse Event|4|||
25021156|NCT04634409|50117486|FG007|Overall Study|Withdrawal by Subject|2|||
25021157|NCT04634409|50117487|FG008|Overall Study|Withdrawal by Subject|3|||
25021158|NCT04634409|50117488|FG009|Overall Study|Withdrawal by Subject|2|||
25021159|NCT04634409|50117489|FG010|Overall Study|Withdrawal by Subject|3|||
25021160|NCT04634409|50117490|FG011|Overall Study|Withdrawal by Subject|2|||
25021161|NCT04634409|50117491|FG012|Overall Study|Withdrawal by Subject|2|||
25274980|NCT01238861|50589067|FG002|Overall Study|Incorrect enrollment/randomization|1|||
25021162|NCT04634409|50117492|FG013|Overall Study|Withdrawal by Subject|1|||
24915425|NCT04093752|50009641|FG000|Overall Study|Withdrawal by Subject|6|||
24915426|NCT04093752|50009642|FG001|Overall Study|Withdrawal by Subject|6|||
25153448|NCT01768286|50268518|FG003|Overall Study|Withdrew Consent|0|||
25153449|NCT01800968|50268530|FG000|Overall Study|Death|23|||
25153450|NCT01800968|50268531|FG001|Overall Study|Death|16|||
25153451|NCT01800968|50268530|FG000|Overall Study|Lost to Follow-up|5|||
25153452|NCT01800968|50268531|FG001|Overall Study|Lost to Follow-up|7|||
25153453|NCT01800968|50268530|FG000|Overall Study|Withdrawal by Subject|7|||
25153454|NCT01800968|50268531|FG001|Overall Study|Withdrawal by Subject|9|||
25153455|NCT01800968|50268530|FG000|Overall Study|Physician Decision|1|||
25153456|NCT01800968|50268531|FG001|Overall Study|Physician Decision|0|||
25153457|NCT01799720|50268540|FG000|Overall Study|Withdrawal by Subject|3|||
25153458|NCT01799720|50268541|FG001|Overall Study|Withdrawal by Subject|0|||
25153459|NCT01799720|50268542|FG002|Overall Study|Withdrawal by Subject|0|||
25153460|NCT01799720|50268540|FG000|Overall Study|Protocol Violation|0|||
25153461|NCT01799720|50268541|FG001|Overall Study|Protocol Violation|1|||
25153462|NCT01799720|50268542|FG002|Overall Study|Protocol Violation|0|||
25153463|NCT01799720|50268540|FG000|Overall Study|Pregnancy|0|||
25153464|NCT01799720|50268541|FG001|Overall Study|Pregnancy|0|||
25153465|NCT01799720|50268542|FG002|Overall Study|Pregnancy|1|||
25153466|NCT01687257|50268552|FG000|Overall Study|Efficacy Failure|6|||
25153467|NCT01687257|50268553|FG001|Overall Study|Efficacy Failure|0|||
24915427|NCT04093752|50009643|FG002|Overall Study|Withdrawal by Subject|8|||
24915428|NCT04093752|50009644|FG003|Overall Study|Withdrawal by Subject|20|||
25184983|NCT04115748|50334083|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
25184984|NCT04115748|50334084|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
24915429|NCT04093752|50009641|FG000|Overall Study|Lost to Follow-up|2|||
24915430|NCT04093752|50009642|FG001|Overall Study|Lost to Follow-up|1|||
24915431|NCT04093752|50009643|FG002|Overall Study|Lost to Follow-up|1|||
24915432|NCT04093752|50009644|FG003|Overall Study|Lost to Follow-up|1|||
24915433|NCT04093752|50009641|FG000|Overall Study|Death|0|||
24915434|NCT04093752|50009642|FG001|Overall Study|Death|0|||
24915435|NCT04093752|50009643|FG002|Overall Study|Death|1|||
24915436|NCT04093752|50009644|FG003|Overall Study|Death|2|||
24915437|NCT04093752|50009641|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
24915438|NCT04093752|50009642|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
25021163|NCT04634409|50117493|FG014|Overall Study|Withdrawal by Subject|5|||
25021164|NCT04634409|50117494|FG015|Overall Study|Withdrawal by Subject|0|||
25021165|NCT04634409|50117495|FG016|Overall Study|Withdrawal by Subject|0|||
25021166|NCT04634409|50117496|FG017|Overall Study|Withdrawal by Subject|1|||
25021167|NCT04634409|50117497|FG018|Overall Study|Withdrawal by Subject|0|||
25021168|NCT04634409|50117498|FG019|Overall Study|Withdrawal by Subject|0|||
25021169|NCT04634409|50117499|FG020|Overall Study|Withdrawal by Subject|0|||
25021170|NCT04634409|50117500|FG021|Overall Study|Withdrawal by Subject|0|||
25021171|NCT04634409|50117501|FG022|Overall Study|Withdrawal by Subject|0|||
25021172|NCT04634409|50117502|FG023|Overall Study|Withdrawal by Subject|1|||
25021173|NCT04634409|50117503|FG024|Overall Study|Withdrawal by Subject|0|||
25021174|NCT04634409|50117504|FG025|Overall Study|Withdrawal by Subject|0|||
25021175|NCT04634409|50117505|FG026|Overall Study|Withdrawal by Subject|0|||
25021176|NCT04634409|50117479|FG000|Overall Study|Other - As reported by Investigator|1|||
24915439|NCT04093752|50009643|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
24915440|NCT04093752|50009644|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
25021177|NCT04634409|50117480|FG001|Overall Study|Other - As reported by Investigator|0|||
25021178|NCT04634409|50117481|FG002|Overall Study|Other - As reported by Investigator|0|||
24915441|NCT04093752|50009641|FG000|Overall Study|Covid 19|0|||
24915442|NCT04093752|50009642|FG001|Overall Study|Covid 19|0|||
24915443|NCT04093752|50009643|FG002|Overall Study|Covid 19|0|||
24915444|NCT04093752|50009644|FG003|Overall Study|Covid 19|1|||
24915445|NCT04093752|50009641|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
24915446|NCT04093752|50009642|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
24915447|NCT04093752|50009643|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
24915448|NCT04093752|50009644|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
24915449|NCT04093752|50009641|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
24915450|NCT04093752|50009642|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
24915451|NCT04093752|50009643|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
24915452|NCT04093752|50009644|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
25021179|NCT04634409|50117482|FG003|Overall Study|Other - As reported by Investigator|0|||
25021180|NCT04634409|50117483|FG004|Overall Study|Other - As reported by Investigator|0|||
25021181|NCT04634409|50117484|FG005|Overall Study|Other - As reported by Investigator|0|||
25153468|NCT01687257|50268554|FG002|Overall Study|Efficacy Failure|5|||
25153469|NCT01687257|50268552|FG000|Overall Study|Subject Withdrew Consent|1|||
25153470|NCT01687257|50268553|FG001|Overall Study|Subject Withdrew Consent|1|||
25153471|NCT01687257|50268554|FG002|Overall Study|Subject Withdrew Consent|1|||
25153472|NCT01687257|50268552|FG000|Overall Study|Adverse Event|1|||
25021182|NCT04634409|50117485|FG006|Overall Study|Other - As reported by Investigator|0|||
25021183|NCT04634409|50117486|FG007|Overall Study|Other - As reported by Investigator|6|||
25021184|NCT04634409|50117487|FG008|Overall Study|Other - As reported by Investigator|4|||
25021185|NCT04634409|50117488|FG009|Overall Study|Other - As reported by Investigator|0|||
25021186|NCT04634409|50117489|FG010|Overall Study|Other - As reported by Investigator|1|||
25021187|NCT04634409|50117490|FG011|Overall Study|Other - As reported by Investigator|2|||
25021188|NCT04634409|50117491|FG012|Overall Study|Other - As reported by Investigator|2|||
25021189|NCT04634409|50117492|FG013|Overall Study|Other - As reported by Investigator|1|||
25021190|NCT04634409|50117493|FG014|Overall Study|Other - As reported by Investigator|0|||
25021191|NCT04634409|50117494|FG015|Overall Study|Other - As reported by Investigator|0|||
25021192|NCT04634409|50117495|FG016|Overall Study|Other - As reported by Investigator|0|||
25021193|NCT04634409|50117496|FG017|Overall Study|Other - As reported by Investigator|0|||
25021194|NCT04634409|50117497|FG018|Overall Study|Other - As reported by Investigator|0|||
24915453|NCT04093752|50009641|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
24915454|NCT04093752|50009642|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
24915455|NCT04093752|50009643|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
24915456|NCT04093752|50009644|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
24915457|NCT03928821|50009662|FG000|Overall Study|Death|0|||
24915458|NCT03928821|50009663|FG001|Overall Study|Death|1|||
24915459|NCT03928821|50009664|FG002|Overall Study|Death|0|||
25021195|NCT04634409|50117498|FG019|Overall Study|Other - As reported by Investigator|0|||
25274981|NCT01238861|50589068|FG003|Overall Study|Incorrect enrollment/randomization|0|||
24915460|NCT03928821|50009665|FG003|Overall Study|Death|0|||
24915461|NCT03928821|50009662|FG000|Overall Study|Lost to Follow-up|0|||
24915462|NCT03928821|50009663|FG001|Overall Study|Lost to Follow-up|2|||
24915463|NCT03928821|50009664|FG002|Overall Study|Lost to Follow-up|3|||
24915464|NCT03928821|50009665|FG003|Overall Study|Lost to Follow-up|0|||
24915465|NCT03928821|50009662|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
24915466|NCT03928821|50009663|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
24915467|NCT03928821|50009664|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
24915468|NCT03928821|50009665|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
24915469|NCT00666224|50009677|FG000|Double-Blind|Adverse Event|15|||
24915470|NCT00666224|50009678|FG001|Double-Blind|Adverse Event|5|||
24915471|NCT00666224|50009677|FG000|Double-Blind|Lost to Follow-up|2|||
24915472|NCT00666224|50009678|FG001|Double-Blind|Lost to Follow-up|2|||
24915473|NCT00666224|50009677|FG000|Double-Blind|Withdrawal by Subject|18|||
24915474|NCT00666224|50009678|FG001|Double-Blind|Withdrawal by Subject|14|||
24915475|NCT00666224|50009677|FG000|Double-Blind|Physician Decision|0|||
24915476|NCT00666224|50009678|FG001|Double-Blind|Physician Decision|3|||
24915477|NCT00666224|50009677|FG000|Double-Blind|Sponsor decision|1|||
24915478|NCT00666224|50009678|FG001|Double-Blind|Sponsor decision|0|||
24915479|NCT00666224|50009677|FG000|Double-Blind|Pregnancy|3|||
24915480|NCT00666224|50009678|FG001|Double-Blind|Pregnancy|2|||
24915481|NCT00666224|50009677|FG000|Double-Blind|Noncompliance|1|||
24915482|NCT00666224|50009678|FG001|Double-Blind|Noncompliance|0|||
24915483|NCT00666224|50009677|FG000|Double-Blind|Death|1|||
24915484|NCT00666224|50009678|FG001|Double-Blind|Death|0|||
24915485|NCT00666224|50009677|FG000|Double-Blind|Undefined/Unknown|4|||
24915486|NCT00666224|50009678|FG001|Double-Blind|Undefined/Unknown|1|||
24915487|NCT00666224|50009677|FG000|Open-Label|Adverse Event|8|||
24915488|NCT00666224|50009678|FG001|Open-Label|Adverse Event|43|||
24915489|NCT00666224|50009677|FG000|Open-Label|Lost to Follow-up|4|||
24915490|NCT00666224|50009678|FG001|Open-Label|Lost to Follow-up|5|||
24915491|NCT00666224|50009677|FG000|Open-Label|Withdrawal by Subject|12|||
24915492|NCT00666224|50009678|FG001|Open-Label|Withdrawal by Subject|25|||
24915493|NCT00666224|50009677|FG000|Open-Label|Physician Decision|7|||
24915494|NCT00666224|50009678|FG001|Open-Label|Physician Decision|5|||
24915495|NCT00666224|50009677|FG000|Open-Label|Pregnancy|1|||
24915496|NCT00666224|50009678|FG001|Open-Label|Pregnancy|5|||
24915497|NCT00666224|50009677|FG000|Open-Label|Noncompliance|2|||
24915498|NCT00666224|50009678|FG001|Open-Label|Noncompliance|1|||
24915499|NCT00666224|50009677|FG000|Open-Label|Undefined/Unknown|1|||
24915500|NCT00666224|50009678|FG001|Open-Label|Undefined/Unknown|1|||
24915501|NCT00663962|50009687|FG000|Overall Study|somnolence|1|||
24915502|NCT00663962|50009688|FG001|Overall Study|somnolence|0|||
24915503|NCT00265759|50009700|FG000|Overall Study|Withdrawal by Subject|0|||
24915504|NCT00265759|50009701|FG001|Overall Study|Withdrawal by Subject|1|||
24915505|NCT00265759|50009702|FG002|Overall Study|Withdrawal by Subject|2|||
24915506|NCT00265759|50009703|FG003|Overall Study|Withdrawal by Subject|2|||
24915507|NCT00265759|50009700|FG000|Overall Study|Cancel|0|||
24915508|NCT00265759|50009701|FG001|Overall Study|Cancel|0|||
24915509|NCT00265759|50009702|FG002|Overall Study|Cancel|0|||
24915510|NCT00265759|50009703|FG003|Overall Study|Cancel|3|||
24915511|NCT00265759|50009700|FG000|Overall Study|Ineligible|0|||
24915512|NCT00265759|50009701|FG001|Overall Study|Ineligible|0|||
24915513|NCT00265759|50009702|FG002|Overall Study|Ineligible|0|||
24915514|NCT00265759|50009703|FG003|Overall Study|Ineligible|1|||
24915515|NCT00265759|50009700|FG000|Overall Study|Bilateral disease|0|||
24915516|NCT00265759|50009701|FG001|Overall Study|Bilateral disease|0|||
24915517|NCT00265759|50009702|FG002|Overall Study|Bilateral disease|0|||
24915518|NCT00265759|50009703|FG003|Overall Study|Bilateral disease|2|||
24915519|NCT00265759|50009700|FG000|Overall Study|Discontinued due to intolerability|0|||
24915520|NCT00265759|50009701|FG001|Overall Study|Discontinued due to intolerability|0|||
24915521|NCT00265759|50009702|FG002|Overall Study|Discontinued due to intolerability|0|||
24915522|NCT00265759|50009703|FG003|Overall Study|Discontinued due to intolerability|1|||
24915523|NCT00744263|50009716|FG000|Overall Study|Death|3006|||
24915524|NCT00744263|50009717|FG001|Overall Study|Death|3005|||
24915525|NCT00744263|50009716|FG000|Overall Study|Lost to Follow-up|2038|||
24915526|NCT00744263|50009717|FG001|Overall Study|Lost to Follow-up|2135|||
24915527|NCT00744263|50009716|FG000|Overall Study|Withdrawal by Subject|166|||
24915528|NCT00744263|50009717|FG001|Overall Study|Withdrawal by Subject|150|||
24915529|NCT00744263|50009716|FG000|Overall Study|Physician Decision|20|||
24915530|NCT00744263|50009717|FG001|Overall Study|Physician Decision|23|||
24915531|NCT00744263|50009716|FG000|Overall Study|Protocol Violation|3|||
24915532|NCT00744263|50009717|FG001|Overall Study|Protocol Violation|5|||
24915533|NCT00744263|50009716|FG000|Overall Study|Adverse Event|1|||
25021196|NCT04634409|50117499|FG020|Overall Study|Other - As reported by Investigator|0|||
25021197|NCT04634409|50117500|FG021|Overall Study|Other - As reported by Investigator|0|||
25021198|NCT04634409|50117501|FG022|Overall Study|Other - As reported by Investigator|0|||
25021199|NCT04634409|50117502|FG023|Overall Study|Other - As reported by Investigator|0|||
25021200|NCT04634409|50117503|FG024|Overall Study|Other - As reported by Investigator|0|||
25021201|NCT04634409|50117504|FG025|Overall Study|Other - As reported by Investigator|0|||
25021202|NCT04634409|50117505|FG026|Overall Study|Other - As reported by Investigator|0|||
25021203|NCT00005780|50117583|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
25021204|NCT01978938|50117592|FG000|Overall Study|Lost to Follow-up|12|||
24915534|NCT00744263|50009717|FG001|Overall Study|Adverse Event|0|||
24915535|NCT00744263|50009716|FG000|Overall Study|Other|2|||
24915536|NCT00744263|50009717|FG001|Overall Study|Other|2|||
24915537|NCT00618774|50009727|FG000|Overall Study|Adverse Event|5|||
24915538|NCT00618774|50009728|FG001|Overall Study|Adverse Event|3|||
24915539|NCT00618774|50009727|FG000|Overall Study|Withdrawal by Subject|1|||
24915540|NCT00618774|50009728|FG001|Overall Study|Withdrawal by Subject|0|||
24915541|NCT00545571|50009734|FG000|Overall Study|Administrative Reasons|1|||
24915542|NCT00545571|50009734|FG000|Overall Study|Adverse Event|2|||
24915543|NCT00545571|50009734|FG000|Overall Study|Death|5|||
24915544|NCT00545571|50009734|FG000|Overall Study|Lack of Efficacy|1|||
24915545|NCT00545571|50009734|FG000|Overall Study|Protocol Violation|2|||
24915546|NCT00545571|50009734|FG000|Overall Study|Refused Treatment|1|||
24915547|NCT00545571|50009734|FG000|Overall Study|Screen Failure|16|||
24915548|NCT00545571|50009734|FG000|Overall Study|Transfusion|12|||
24915549|NCT00545571|50009734|FG000|Overall Study|Early Termination of Study|24|||
24915550|NCT00545571|50009734|FG000|Overall Study|Kidney Transplantation|3|||
24915551|NCT00748709|50009738|FG000|Overall Study|Progressive disease|15|||
24915552|NCT00748709|50009738|FG000|Overall Study|Drug reducing Toxity|2|||
24915553|NCT00748709|50009738|FG000|Overall Study|Other Adverse Event|1|||
24915554|NCT00748709|50009738|FG000|Overall Study|Withdrawal by Subject|1|||
24915555|NCT00748709|50009738|FG000|Overall Study|Other Reasons|1|||
24915556|NCT00263887|50009744|FG000|Overall Study|Withdrawal by Subject|1|||
24915557|NCT00263887|50009745|FG001|Overall Study|Withdrawal by Subject|1|||
24915558|NCT00263887|50009744|FG000|Overall Study|Lung transplantation|1|||
24915559|NCT00263887|50009745|FG001|Overall Study|Lung transplantation|2|||
24915560|NCT00263887|50009744|FG000|Overall Study|Too ill to attend visit|1|||
24915561|NCT00263887|50009745|FG001|Overall Study|Too ill to attend visit|0|||
24915562|NCT00263887|50009744|FG000|Overall Study|Adverse Event|0|||
24915563|NCT00263887|50009745|FG001|Overall Study|Adverse Event|2|||
24915564|NCT00263887|50009744|FG000|Overall Study|Disease progression|0|||
24915565|NCT00263887|50009745|FG001|Overall Study|Disease progression|1|||
24915566|NCT00263887|50009744|FG000|Overall Study|Lack of Efficacy|0|||
24915567|NCT00263887|50009745|FG001|Overall Study|Lack of Efficacy|1|||
24915568|NCT00748553|50009753|FG000|Overall Study|Adverse Event|0|||
25021205|NCT01978938|50117593|FG001|Overall Study|Lost to Follow-up|6|||
24915569|NCT00748553|50009754|FG001|Overall Study|Adverse Event|1|||
24915570|NCT00748553|50009753|FG000|Overall Study|disease progression|2|||
24915571|NCT00748553|50009754|FG001|Overall Study|disease progression|0|||
24915572|NCT00748553|50009753|FG000|Overall Study|noncompliance|1|||
24915573|NCT00748553|50009754|FG001|Overall Study|noncompliance|0|||
24915574|NCT00661388|50009759|FG000|Overall Study|Adverse Event|14|||
24915575|NCT00661388|50009759|FG000|Overall Study|Protocol Violation|7|||
24915576|NCT00661388|50009759|FG000|Overall Study|Renal transplantation|1|||
25021206|NCT01978938|50117592|FG000|Overall Study|Withdrawal by Subject|8|||
24915577|NCT00661388|50009759|FG000|Overall Study|Dialysis initiation|1|||
24915578|NCT00661388|50009759|FG000|Overall Study|Administrative reasons|1|||
24915579|NCT00743483|50009763|FG000|Baseline Period|Physician Decision|1|||
24915580|NCT00743483|50009763|FG000|Treatment Period|Adverse Event|1|||
24915581|NCT00263575|50009767|FG000|Titration Period|Adverse Event|14|||
24915582|NCT00263575|50009767|FG000|Titration Period|Withdrawal by Subject|10|||
24915583|NCT00263575|50009767|FG000|Titration Period|Protocol Violation|9|||
24915584|NCT00263575|50009767|FG000|Titration Period|Sponsor Decision|2|||
24915585|NCT00263575|50009767|FG000|Titration Period|Other|2|||
24915586|NCT00263575|50009767|FG000|Titration Period|Lack of Efficacy|6|||
24915587|NCT00263575|50009767|FG000|Maintence Period|Adverse Event|23|||
24915588|NCT00263575|50009767|FG000|Maintence Period|Withdrawal by Subject|8|||
24915589|NCT00263575|50009767|FG000|Maintence Period|Protocol Violation|4|||
24915590|NCT00263575|50009767|FG000|Maintence Period|Lack of Efficacy|4|||
24915591|NCT00263575|50009767|FG000|Maintence Period|Physician Decision|6|||
24915592|NCT00263575|50009767|FG000|Maintence Period|Lost to Follow-up|1|||
24915593|NCT00263575|50009767|FG000|Maintence Period|Sponsor Decision|24|||
24915594|NCT00263575|50009767|FG000|Maintence Period|Other|7|||
24915595|NCT00748241|50009773|FG000|Overall Study|Implant failure|1|||
24915596|NCT00748241|50009773|FG000|Overall Study|Lost to Follow-up|5|||
25021207|NCT01978938|50117593|FG001|Overall Study|Withdrawal by Subject|4|||
25021208|NCT01978938|50117592|FG000|Overall Study|Adverse Event, non-fatal|2|||
25021209|NCT01978938|50117593|FG001|Overall Study|Adverse Event, non-fatal|1|||
25021210|NCT01978938|50117592|FG000|Overall Study|Participant noncompliance|1|||
25021211|NCT01978938|50117593|FG001|Overall Study|Participant noncompliance|1|||
25021212|NCT01978938|50117592|FG000|Overall Study|Did not meet inclusion criteria|0|||
25021213|NCT01978938|50117593|FG001|Overall Study|Did not meet inclusion criteria|1|||
25021214|NCT01978938|50117592|FG000|Overall Study|Previously scheduled procedure|0|||
24915597|NCT00748241|50009773|FG000|Overall Study|Death|2|||
24915598|NCT00570128|50009779|FG000|Overall Study|Adverse Event|1|||
24915599|NCT00570128|50009780|FG001|Overall Study|Adverse Event|0|||
25153473|NCT01687257|50268553|FG001|Overall Study|Adverse Event|0|||
25153474|NCT01687257|50268554|FG002|Overall Study|Adverse Event|0|||
25153475|NCT01687257|50268552|FG000|Overall Study|Investigator's Discretion|0|||
25153476|NCT01687257|50268553|FG001|Overall Study|Investigator's Discretion|3|||
24915600|NCT00570128|50009779|FG000|Overall Study|Lost to Follow-up|1|||
24915601|NCT00570128|50009780|FG001|Overall Study|Lost to Follow-up|0|||
24915602|NCT00570128|50009779|FG000|Overall Study|Withdrawal by Subject|2|||
24915603|NCT00570128|50009780|FG001|Overall Study|Withdrawal by Subject|0|||
24915604|NCT00743249|50009788|FG000|Overall Study|Adverse Event|0|||
24915605|NCT00743249|50009789|FG001|Overall Study|Adverse Event|4|||
24915606|NCT00743249|50009788|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
24915607|NCT00743249|50009789|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
24915608|NCT00743249|50009788|FG000|Overall Study|Unsuccessful insertion of stent|2|||
24915609|NCT00743249|50009789|FG001|Overall Study|Unsuccessful insertion of stent|1|||
24915610|NCT00262951|50009795|FG000|Overall Study|Progressive disease/relapse|3|||
24915611|NCT00262951|50009795|FG000|Overall Study|Adverse Event|7|||
24915612|NCT00262951|50009795|FG000|Overall Study|Death|1|||
24915613|NCT00262951|50009795|FG000|Overall Study|Withdrawal by Subject|1|||
24915614|NCT00262951|50009795|FG000|Overall Study|Alternative treatment|3|||
24915615|NCT00262951|50009795|FG000|Overall Study|Off treatment for other disease|1|||
24915616|NCT00262873|50009799|FG000|Overall Study|Adverse Event|3|||
24915617|NCT00262873|50009799|FG000|Overall Study|Withdrawal by Subject|5|||
24915618|NCT00573534|50009803|FG000|Overall Study|oppositional behavior|3|||
24915619|NCT00260533|50009810|FG000|Overall Study|Other|3|||
25153477|NCT01687257|50268554|FG002|Overall Study|Investigator's Discretion|0|||
25153478|NCT01806740|50268568|FG000|Overall Study|Withdrawal by Subject|4|||
25153479|NCT01806740|50268568|FG000|Overall Study|Physician Decision|1|||
25021215|NCT01978938|50117593|FG001|Overall Study|Previously scheduled procedure|1|||
25021216|NCT03041090|50117601|FG000|Overall Study|technical error|0|||
25153480|NCT01806740|50268568|FG000|Overall Study|Patient's refusal of treatment|1|||
24915620|NCT00260533|50009811|FG001|Overall Study|Other|3|||
24915621|NCT03945981|50009817|FG000|Overall Study|Lost to Follow-up|12|||
24915622|NCT03945981|50009817|FG000|Overall Study|Physician Decision|4|||
24915623|NCT03945981|50009817|FG000|Overall Study|Withdrawal by Subject|6|||
24915624|NCT03945981|50009817|FG000|Overall Study|Protocol Violation|1|||
24915625|NCT00745901|50009844|FG000|Overall Study|Adverse Event|3|||
24915626|NCT00745901|50009845|FG001|Overall Study|Adverse Event|4|||
24915627|NCT00745901|50009844|FG000|Overall Study|Protocol Violation|0|||
24915628|NCT00745901|50009845|FG001|Overall Study|Protocol Violation|1|||
24915629|NCT00745901|50009844|FG000|Overall Study|Withdrawal by Subject|1|||
24915630|NCT00745901|50009845|FG001|Overall Study|Withdrawal by Subject|0|||
24915631|NCT00745901|50009844|FG000|Overall Study|Lost to Follow-up|7|||
24915632|NCT00745901|50009845|FG001|Overall Study|Lost to Follow-up|4|||
24915633|NCT00745901|50009844|FG000|Overall Study|Pregnancy|2|||
24915634|NCT00745901|50009845|FG001|Overall Study|Pregnancy|4|||
24915635|NCT00745901|50009844|FG000|Overall Study|Lack of compliance|2|||
24915636|NCT00745901|50009845|FG001|Overall Study|Lack of compliance|2|||
24915637|NCT00745901|50009844|FG000|Overall Study|Patient's next menses did not start with|1|||
24915638|NCT00745901|50009845|FG001|Overall Study|Patient's next menses did not start with|0|||
24915639|NCT00745901|50009844|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
24915640|NCT00745901|50009845|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
24915641|NCT00745901|50009844|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
24915642|NCT00745901|50009845|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
24915643|NCT00745901|50009844|FG000|Overall Study|Patient didn't take any study medication|7|||
24915644|NCT00745901|50009845|FG001|Overall Study|Patient didn't take any study medication|3|||
24915645|NCT00286429|50009854|FG000|Overall Study|Adverse Event|4|||
24915646|NCT00286429|50009855|FG001|Overall Study|Adverse Event|1|||
24915647|NCT00286429|50009856|FG002|Overall Study|Adverse Event|6|||
24915648|NCT00286429|50009854|FG000|Overall Study|Lack of Efficacy|52|||
24915649|NCT00286429|50009855|FG001|Overall Study|Lack of Efficacy|27|||
24915650|NCT00286429|50009856|FG002|Overall Study|Lack of Efficacy|25|||
24915651|NCT00286429|50009854|FG000|Overall Study|Lost to Follow-up|2|||
24915652|NCT00286429|50009855|FG001|Overall Study|Lost to Follow-up|4|||
24915653|NCT00286429|50009856|FG002|Overall Study|Lost to Follow-up|3|||
24915654|NCT00286429|50009854|FG000|Overall Study|Physician Decision|10|||
24915655|NCT00286429|50009855|FG001|Overall Study|Physician Decision|7|||
24915656|NCT00286429|50009856|FG002|Overall Study|Physician Decision|7|||
24915657|NCT00286429|50009854|FG000|Overall Study|Protocol Violation|3|||
24915658|NCT00286429|50009855|FG001|Overall Study|Protocol Violation|5|||
24915659|NCT00286429|50009856|FG002|Overall Study|Protocol Violation|4|||
24915660|NCT00286429|50009854|FG000|Overall Study|Withdrawal by Subject|3|||
24915661|NCT00286429|50009855|FG001|Overall Study|Withdrawal by Subject|2|||
24915662|NCT00286429|50009856|FG002|Overall Study|Withdrawal by Subject|6|||
24915663|NCT00286429|50009854|FG000|Overall Study|Administrative Error|1|||
24915664|NCT00286429|50009855|FG001|Overall Study|Administrative Error|1|||
24915665|NCT00286429|50009856|FG002|Overall Study|Administrative Error|1|||
24915666|NCT00286429|50009854|FG000|Overall Study|Administrative Decision|0|||
24915667|NCT00286429|50009855|FG001|Overall Study|Administrative Decision|1|||
24915668|NCT00286429|50009856|FG002|Overall Study|Administrative Decision|0|||
24915669|NCT00665444|50009864|FG000|Overall Study|Physician Decision|1|||
24915670|NCT00665444|50009864|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
24915671|NCT03926169|50009871|FG000|Period A|Adverse Event|2|||
24915672|NCT03926169|50009872|FG001|Period A|Adverse Event|2|||
24915673|NCT03926169|50009873|FG002|Period A|Adverse Event|1|||
24915674|NCT03926169|50009871|FG000|Period A|Withdrawal by Subject|2|||
24915675|NCT03926169|50009872|FG001|Period A|Withdrawal by Subject|2|||
24915676|NCT03926169|50009873|FG002|Period A|Withdrawal by Subject|2|||
24915677|NCT03926169|50009871|FG000|Period A|Lost to Follow-up|3|||
24915678|NCT03926169|50009872|FG001|Period A|Lost to Follow-up|1|||
24915679|NCT03926169|50009873|FG002|Period A|Lost to Follow-up|0|||
24915680|NCT03926169|50009871|FG000|Period A|Lack of Efficacy|0|||
24915681|NCT03926169|50009872|FG001|Period A|Lack of Efficacy|2|||
24915682|NCT03926169|50009873|FG002|Period A|Lack of Efficacy|2|||
24915683|NCT03926169|50009871|FG000|Period A|COVID-19 Infection|0|||
24915684|NCT03926169|50009872|FG001|Period A|COVID-19 Infection|1|||
24915685|NCT03926169|50009873|FG002|Period A|COVID-19 Infection|0|||
24915686|NCT03926169|50009871|FG000|Period A|COVID-19 Logistical Restrictions|0|||
24915687|NCT03926169|50009872|FG001|Period A|COVID-19 Logistical Restrictions|2|||
24915688|NCT03926169|50009873|FG002|Period A|COVID-19 Logistical Restrictions|1|||
24915689|NCT03926169|50009871|FG000|Period A|Other, Not Specified|1|||
24915690|NCT03926169|50009872|FG001|Period A|Other, Not Specified|0|||
24915691|NCT03926169|50009873|FG002|Period A|Other, Not Specified|0|||
24915692|NCT03926169|50009871|FG000|Period B|Adverse Event|3|||
24915693|NCT03926169|50009872|FG001|Period B|Adverse Event|1|||
24915694|NCT03926169|50009873|FG002|Period B|Adverse Event|1|||
24915695|NCT03926169|50009871|FG000|Period B|Withdrawal by Subject|1|||
24915696|NCT03926169|50009872|FG001|Period B|Withdrawal by Subject|3|||
24915697|NCT03926169|50009873|FG002|Period B|Withdrawal by Subject|0|||
24915698|NCT03926169|50009871|FG000|Period B|Lack of Efficacy|3|||
24915699|NCT03926169|50009872|FG001|Period B|Lack of Efficacy|1|||
24915700|NCT03926169|50009873|FG002|Period B|Lack of Efficacy|1|||
24915701|NCT03926169|50009871|FG000|Period B|Lost to Follow-up|1|||
24915702|NCT03926169|50009872|FG001|Period B|Lost to Follow-up|1|||
24915703|NCT03926169|50009873|FG002|Period B|Lost to Follow-up|4|||
24915704|NCT03926169|50009871|FG000|Period B|Other, Not Specified|62|||
24915705|NCT03926169|50009872|FG001|Period B|Other, Not Specified|57|||
24915706|NCT03926169|50009873|FG002|Period B|Other, Not Specified|65|||
24915707|NCT00285649|50009887|FG000|Overall Study|Lost to Follow-up|6|||
24915708|NCT00285649|50009888|FG001|Overall Study|Lost to Follow-up|4|||
25021217|NCT03041090|50117602|FG001|Overall Study|technical error|3|||
25021218|NCT00116142|50117610|FG000|Overall Study|Adverse Event|8|||
25021219|NCT00116142|50117611|FG001|Overall Study|Adverse Event|7|||
25021220|NCT00116142|50117610|FG000|Overall Study|Protocol Violation|2|||
25021221|NCT00116142|50117611|FG001|Overall Study|Protocol Violation|1|||
25021222|NCT00116142|50117610|FG000|Overall Study|Withdrawal by Subject|5|||
25021223|NCT00116142|50117611|FG001|Overall Study|Withdrawal by Subject|5|||
25021224|NCT00116142|50117610|FG000|Overall Study|Physician Decision|3|||
24915709|NCT00285649|50009889|FG002|Overall Study|Lost to Follow-up|4|||
24915710|NCT00285649|50009887|FG000|Overall Study|Withdrawal by Subject|3|||
24915711|NCT00285649|50009888|FG001|Overall Study|Withdrawal by Subject|2|||
24915712|NCT00285649|50009889|FG002|Overall Study|Withdrawal by Subject|2|||
24915713|NCT00745823|50009899|FG000|Overall Study|Adverse Event|5|||
25021225|NCT00116142|50117611|FG001|Overall Study|Physician Decision|1|||
25021226|NCT00116142|50117610|FG000|Overall Study|Delayed Radiation Therapy|1|||
25021227|NCT00116142|50117611|FG001|Overall Study|Delayed Radiation Therapy|0|||
25021228|NCT00116142|50117610|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
25021229|NCT00116142|50117611|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
25021230|NCT00116142|50117610|FG000|Overall Study|Patient stopped due to depression|0|||
25021231|NCT00116142|50117611|FG001|Overall Study|Patient stopped due to depression|1|||
25021232|NCT00116142|50117610|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
25021233|NCT00116142|50117611|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
25021234|NCT00116142|50117610|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
25021235|NCT00116142|50117611|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
25021236|NCT00116142|50117610|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
25021237|NCT00116142|50117611|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
25021238|NCT03135522|50117622|FG000|Overall Study|Adverse Event|1|||
25021239|NCT03135522|50117623|FG001|Overall Study|Adverse Event|0|||
25021240|NCT02875080|50117646|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
25021241|NCT02875080|50117647|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
25021242|NCT02875080|50117648|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
25021243|NCT03129360|50117659|FG000|Overall Study|Did not meet entry criteria|0|||
25021244|NCT03129360|50117660|FG001|Overall Study|Did not meet entry criteria|2|||
25021245|NCT03129360|50117661|FG002|Overall Study|Did not meet entry criteria|1|||
25021246|NCT03129360|50117659|FG000|Overall Study|Excluded due to motion in scanner|1|||
25021247|NCT03129360|50117660|FG001|Overall Study|Excluded due to motion in scanner|0|||
25021248|NCT03129360|50117661|FG002|Overall Study|Excluded due to motion in scanner|0|||
25021249|NCT03165045|50117669|FG000|Visit 1|No registration after visit 1|9|||
25021250|NCT03165045|50117669|FG000|Visit 1|No treatment documented|10|||
25021251|NCT03165045|50117669|FG000|Visit 1|No visit 1|10|||
25021252|NCT03165045|50117669|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
25021253|NCT03165045|50117669|FG000|Visit 2|No available total CCQ score at all|29|||
25021254|NCT03165045|50117669|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
25021255|NCT01928199|50117677|FG000|Overall Study|Lost to Follow-up|2|||
25021256|NCT01928199|50117678|FG001|Overall Study|Lost to Follow-up|1|||
25021257|NCT01928199|50117677|FG000|Overall Study|Withdrawal by Subject|3|||
25021258|NCT01928199|50117678|FG001|Overall Study|Withdrawal by Subject|5|||
25021259|NCT03128892|50117684|FG000|Overall Study|Withdrawal by Subject|2|||
25021260|NCT03128892|50117684|FG000|Overall Study|Physician Decision|1|||
24915714|NCT00745823|50009900|FG001|Overall Study|Adverse Event|3|||
24915715|NCT00745823|50009899|FG000|Overall Study|Lack of Efficacy|20|||
24915716|NCT00745823|50009900|FG001|Overall Study|Lack of Efficacy|6|||
24915717|NCT00745823|50009899|FG000|Overall Study|Lost to Follow-up|10|||
24915718|NCT00745823|50009900|FG001|Overall Study|Lost to Follow-up|11|||
24915719|NCT00745823|50009899|FG000|Overall Study|Physician Decision|10|||
24915720|NCT00745823|50009900|FG001|Overall Study|Physician Decision|5|||
24915721|NCT00745823|50009899|FG000|Overall Study|Pregnancy|0|||
24915722|NCT00745823|50009900|FG001|Overall Study|Pregnancy|4|||
24915723|NCT00745823|50009899|FG000|Overall Study|Withdrawal by Subject|14|||
24915724|NCT00745823|50009900|FG001|Overall Study|Withdrawal by Subject|8|||
24915725|NCT00745823|50009899|FG000|Overall Study|Study Terminated by Sponsor|326|||
24915726|NCT00745823|50009900|FG001|Overall Study|Study Terminated by Sponsor|349|||
24915727|NCT00663260|50009911|FG000|Overall Study|Lack of Efficacy|2|||
25021261|NCT03039686|50117700|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
25021262|NCT03039686|50117701|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
25153481|NCT01687101|50268575|FG000|Overall Study|Lost to Follow-up|7|||
24915728|NCT00663260|50009912|FG001|Overall Study|Lack of Efficacy|0|||
24915729|NCT00663260|50009913|FG002|Overall Study|Lack of Efficacy|0|||
24915730|NCT00663260|50009911|FG000|Overall Study|Adverse Event|12|||
24915731|NCT00663260|50009912|FG001|Overall Study|Adverse Event|7|||
24915732|NCT00663260|50009913|FG002|Overall Study|Adverse Event|6|||
24915733|NCT00663260|50009911|FG000|Overall Study|Withdrawal by Subject|3|||
24915734|NCT00663260|50009912|FG001|Overall Study|Withdrawal by Subject|1|||
24915735|NCT00663260|50009913|FG002|Overall Study|Withdrawal by Subject|6|||
24915736|NCT00663260|50009911|FG000|Overall Study|Death|1|||
24915737|NCT00663260|50009912|FG001|Overall Study|Death|0|||
24915738|NCT00663260|50009913|FG002|Overall Study|Death|1|||
24915739|NCT00663260|50009911|FG000|Overall Study|Lost to Follow-up|0|||
24915740|NCT00663260|50009912|FG001|Overall Study|Lost to Follow-up|1|||
24915741|NCT00663260|50009913|FG002|Overall Study|Lost to Follow-up|0|||
24915742|NCT00663260|50009911|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
24915743|NCT00663260|50009912|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
24915744|NCT00663260|50009913|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
24915745|NCT00740597|50009921|FG000|Overall Study|insurance would not cover treatment|1|||
24915746|NCT00284089|50009929|FG000|Multiple Dose Phase|Adverse Event|1|||
25021263|NCT03039686|50117702|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
24915747|NCT00284089|50009930|FG001|Multiple Dose Phase|Adverse Event|0|||
24915748|NCT00284089|50009931|FG002|Multiple Dose Phase|Adverse Event|1|||
24915749|NCT00284089|50009932|FG003|Multiple Dose Phase|Adverse Event|1|||
24915750|NCT00284089|50009929|FG000|Multiple Dose Phase|Protocol Violation|0|||
24915751|NCT00284089|50009930|FG001|Multiple Dose Phase|Protocol Violation|0|||
24915752|NCT00284089|50009931|FG002|Multiple Dose Phase|Protocol Violation|1|||
24915753|NCT00284089|50009932|FG003|Multiple Dose Phase|Protocol Violation|0|||
24915754|NCT00284089|50009929|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
24915755|NCT00284089|50009930|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
24915756|NCT00284089|50009931|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
24915757|NCT00284089|50009932|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
24915758|NCT00284089|50009929|FG000|Multiple Dose Phase|Death|0|||
24915759|NCT00284089|50009930|FG001|Multiple Dose Phase|Death|0|||
24915760|NCT00284089|50009931|FG002|Multiple Dose Phase|Death|1|||
24915761|NCT00284089|50009932|FG003|Multiple Dose Phase|Death|1|||
24915762|NCT00284089|50009929|FG000|Extension Phase|Adverse Event|0|||
24915763|NCT00284089|50009930|FG001|Extension Phase|Adverse Event|0|||
24915764|NCT00284089|50009931|FG002|Extension Phase|Adverse Event|2|||
25021264|NCT03039686|50117700|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
25153482|NCT01968967|50268581|FG000|Treatment Period|Other|22|||
24915765|NCT00284089|50009932|FG003|Extension Phase|Adverse Event|2|||
24915766|NCT00284089|50009929|FG000|Extension Phase|condition no longer requires study drug|2|||
24915767|NCT00284089|50009930|FG001|Extension Phase|condition no longer requires study drug|0|||
24915768|NCT00284089|50009931|FG002|Extension Phase|condition no longer requires study drug|2|||
24915769|NCT00284089|50009932|FG003|Extension Phase|condition no longer requires study drug|7|||
24915770|NCT00284089|50009929|FG000|Extension Phase|Protocol Violation|0|||
24915771|NCT00284089|50009930|FG001|Extension Phase|Protocol Violation|0|||
24915772|NCT00284089|50009931|FG002|Extension Phase|Protocol Violation|1|||
24915773|NCT00284089|50009932|FG003|Extension Phase|Protocol Violation|0|||
24915774|NCT00284089|50009929|FG000|Extension Phase|Withdrawal by Subject|0|||
24915775|NCT00284089|50009930|FG001|Extension Phase|Withdrawal by Subject|0|||
24915776|NCT00284089|50009931|FG002|Extension Phase|Withdrawal by Subject|1|||
24915777|NCT00284089|50009932|FG003|Extension Phase|Withdrawal by Subject|3|||
24915778|NCT00659984|50009942|FG000|Overall Study|Adverse Event|1|||
24915779|NCT00283387|50009956|FG000|First Intervention|Subject non-compliant|1|||
24915780|NCT00283387|50009957|FG001|First Intervention|Subject non-compliant|1|||
24915781|NCT00283387|50009956|FG000|First Intervention|Withdrawal by Subject|0|||
24915782|NCT00283387|50009957|FG001|First Intervention|Withdrawal by Subject|1|||
24915783|NCT00282919|50009963|FG000|Overall Study|Lack of Efficacy|4|||
24915784|NCT00282919|50009963|FG000|Overall Study|Withdrawal by Subject|1|||
24915785|NCT00282919|50009963|FG000|Overall Study|Asymptomatic Parasitemia|2|||
24915786|NCT00742859|50009971|FG000|Overall Study|Adverse Event|5|||
24915787|NCT00742859|50009972|FG001|Overall Study|Adverse Event|6|||
24915788|NCT00742859|50009973|FG002|Overall Study|Adverse Event|3|||
24915789|NCT00742859|50009974|FG003|Overall Study|Adverse Event|1|||
24915790|NCT00742859|50009971|FG000|Overall Study|Death|1|||
24915791|NCT00742859|50009972|FG001|Overall Study|Death|0|||
24915792|NCT00742859|50009973|FG002|Overall Study|Death|0|||
24915793|NCT00742859|50009974|FG003|Overall Study|Death|1|||
24915794|NCT00742859|50009971|FG000|Overall Study|Physician Decision|1|||
25153483|NCT01968967|50268582|FG001|Treatment Period|Other|22|||
24915795|NCT00742859|50009972|FG001|Overall Study|Physician Decision|2|||
24915796|NCT00742859|50009973|FG002|Overall Study|Physician Decision|0|||
24915797|NCT00742859|50009974|FG003|Overall Study|Physician Decision|0|||
24915798|NCT00742859|50009971|FG000|Overall Study|Withdrawal by Subject|4|||
24915799|NCT00742859|50009972|FG001|Overall Study|Withdrawal by Subject|2|||
25153484|NCT01968967|50268583|FG002|Treatment Period|Other|0|||
24915800|NCT00742859|50009973|FG002|Overall Study|Withdrawal by Subject|4|||
24915801|NCT00742859|50009974|FG003|Overall Study|Withdrawal by Subject|1|||
24915802|NCT00742859|50009971|FG000|Overall Study|Endpoint|0|||
24915803|NCT00742859|50009972|FG001|Overall Study|Endpoint|1|||
24915804|NCT00742859|50009973|FG002|Overall Study|Endpoint|1|||
24915805|NCT00742859|50009974|FG003|Overall Study|Endpoint|2|||
24915806|NCT00742859|50009971|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
24915807|NCT00742859|50009972|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
24915808|NCT00742859|50009973|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
24915809|NCT00742859|50009974|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
24915810|NCT00742859|50009971|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
24915811|NCT00742859|50009972|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
24915812|NCT00742859|50009973|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
24915813|NCT00742859|50009974|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
25153485|NCT01968967|50268584|FG003|Treatment Period|Other|0|||
24915814|NCT00742859|50009971|FG000|Overall Study|Sponsor request patient out of town|0|||
24915815|NCT00742859|50009972|FG001|Overall Study|Sponsor request patient out of town|0|||
24915816|NCT00742859|50009973|FG002|Overall Study|Sponsor request patient out of town|1|||
24915817|NCT00742859|50009974|FG003|Overall Study|Sponsor request patient out of town|1|||
24915818|NCT00742859|50009971|FG000|Overall Study|Site error|0|||
24915819|NCT00742859|50009972|FG001|Overall Study|Site error|0|||
24915820|NCT00742859|50009973|FG002|Overall Study|Site error|1|||
24915821|NCT00742859|50009974|FG003|Overall Study|Site error|1|||
24915822|NCT00282295|50009987|FG000|Overall Study|Adverse Event|0|||
24915823|NCT00282295|50009988|FG001|Overall Study|Adverse Event|1|||
24915824|NCT00282295|50009989|FG002|Overall Study|Adverse Event|0|||
24915825|NCT00282295|50009987|FG000|Overall Study|Serious Adverse Events|0|||
24915826|NCT00282295|50009988|FG001|Overall Study|Serious Adverse Events|0|||
24915827|NCT00282295|50009989|FG002|Overall Study|Serious Adverse Events|1|||
24915828|NCT00282295|50009987|FG000|Overall Study|Protocol Violation|0|||
24915829|NCT00282295|50009988|FG001|Overall Study|Protocol Violation|2|||
24915830|NCT00282295|50009989|FG002|Overall Study|Protocol Violation|1|||
24915831|NCT00282295|50009987|FG000|Overall Study|Withdrawal by Subject|2|||
24915832|NCT00282295|50009988|FG001|Overall Study|Withdrawal by Subject|6|||
24915833|NCT00282295|50009989|FG002|Overall Study|Withdrawal by Subject|4|||
24915834|NCT00282295|50009987|FG000|Overall Study|Lost to Follow-up|1|||
24915835|NCT00282295|50009988|FG001|Overall Study|Lost to Follow-up|7|||
24915836|NCT00282295|50009989|FG002|Overall Study|Lost to Follow-up|2|||
24915837|NCT00282295|50009987|FG000|Overall Study|Other|0|||
25153486|NCT01968967|50268585|FG004|Treatment Period|Other|0|||
25153487|NCT01968967|50268581|FG000|Treatment Period|Withdrawal by Subject|71|||
24915838|NCT00282295|50009988|FG001|Overall Study|Other|1|||
24915839|NCT00282295|50009989|FG002|Overall Study|Other|0|||
24915840|NCT00742781|50010002|FG000|Overall Study|Withdrawal by Subject|3|||
24915841|NCT00663026|50010010|FG000|Overall Study|Lost to Follow-up|1|||
25153488|NCT01968967|50268582|FG001|Treatment Period|Withdrawal by Subject|61|||
25153489|NCT01968967|50268583|FG002|Treatment Period|Withdrawal by Subject|0|||
25153490|NCT01968967|50268584|FG003|Treatment Period|Withdrawal by Subject|0|||
25153491|NCT01968967|50268585|FG004|Treatment Period|Withdrawal by Subject|0|||
25153492|NCT01968967|50268581|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
25153493|NCT01968967|50268582|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
25153494|NCT01968967|50268583|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
25153495|NCT01968967|50268584|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
24915842|NCT00663026|50010011|FG001|Overall Study|Lost to Follow-up|0|||
24915843|NCT00663026|50010012|FG002|Overall Study|Lost to Follow-up|0|||
24915844|NCT00663026|50010010|FG000|Overall Study|Other|1|||
24915845|NCT00663026|50010011|FG001|Overall Study|Other|2|||
24915846|NCT00663026|50010012|FG002|Overall Study|Other|0|||
24915847|NCT00663026|50010010|FG000|Overall Study|Adverse Event|0|||
24915848|NCT00663026|50010011|FG001|Overall Study|Adverse Event|2|||
24915849|NCT00663026|50010012|FG002|Overall Study|Adverse Event|3|||
24915850|NCT00663026|50010010|FG000|Overall Study|Caregiver Request|0|||
24915851|NCT00663026|50010011|FG001|Overall Study|Caregiver Request|2|||
24915852|NCT00663026|50010012|FG002|Overall Study|Caregiver Request|0|||
24915853|NCT00663026|50010010|FG000|Overall Study|Withdrawal by Subject|0|||
24915854|NCT00663026|50010011|FG001|Overall Study|Withdrawal by Subject|0|||
25153496|NCT01968967|50268585|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
24915855|NCT00663026|50010012|FG002|Overall Study|Withdrawal by Subject|1|||
24915856|NCT00280735|50010022|FG000|Overall Study|Adverse Event|5|||
24915857|NCT00280735|50010022|FG000|Overall Study|Lack of Efficacy|3|||
24915858|NCT00280735|50010022|FG000|Overall Study|Withdrawal by Subject|8|||
24915859|NCT00280735|50010022|FG000|Overall Study|Intercurrent Illness|2|||
24915860|NCT00260065|50010030|FG000|Overall Study|Progressive Disease|22|||
24915861|NCT00260065|50010030|FG000|Overall Study|Adverse Event|17|||
24915862|NCT00260065|50010030|FG000|Overall Study|Death|13|||
24915863|NCT00260065|50010030|FG000|Overall Study|Withdrawal by Subject|13|||
24915864|NCT00260065|50010030|FG000|Overall Study|Physician Decision|19|||
24915865|NCT00260065|50010030|FG000|Overall Study|Not otherwise specified|8|||
24915866|NCT00260065|50010030|FG000|Overall Study|Medication Noncompliance|1|||
25153497|NCT01968967|50268581|FG000|Treatment Period|Lost to Follow-up|26|||
24915867|NCT00506350|50010043|FG000|Overall Study|Serious Adverse Event|1|||
24915868|NCT00506350|50010044|FG001|Overall Study|Serious Adverse Event|0|||
24915869|NCT00506350|50010045|FG002|Overall Study|Serious Adverse Event|0|||
24915870|NCT00506350|50010046|FG003|Overall Study|Serious Adverse Event|0|||
24915871|NCT00506350|50010047|FG004|Overall Study|Serious Adverse Event|0|||
24915872|NCT00506350|50010048|FG005|Overall Study|Serious Adverse Event|0|||
24915873|NCT00506350|50010049|FG006|Overall Study|Serious Adverse Event|0|||
24915874|NCT00506350|50010050|FG007|Overall Study|Serious Adverse Event|0|||
24915875|NCT00506350|50010051|FG008|Overall Study|Serious Adverse Event|0|||
24915876|NCT00506350|50010043|FG000|Overall Study|Adverse Event|0|||
24915877|NCT00506350|50010044|FG001|Overall Study|Adverse Event|0|||
24915878|NCT00506350|50010045|FG002|Overall Study|Adverse Event|0|||
24915879|NCT00506350|50010046|FG003|Overall Study|Adverse Event|0|||
24915880|NCT00506350|50010047|FG004|Overall Study|Adverse Event|0|||
24915881|NCT00506350|50010048|FG005|Overall Study|Adverse Event|0|||
24915882|NCT00506350|50010049|FG006|Overall Study|Adverse Event|0|||
24915883|NCT00506350|50010050|FG007|Overall Study|Adverse Event|1|||
24915884|NCT00506350|50010051|FG008|Overall Study|Adverse Event|1|||
25153498|NCT01968967|50268582|FG001|Treatment Period|Lost to Follow-up|31|||
25153499|NCT01968967|50268583|FG002|Treatment Period|Lost to Follow-up|0|||
25153500|NCT01968967|50268584|FG003|Treatment Period|Lost to Follow-up|0|||
24915885|NCT00506350|50010043|FG000|Overall Study|Protocol Violation|0|||
24915886|NCT00506350|50010044|FG001|Overall Study|Protocol Violation|0|||
24915887|NCT00506350|50010045|FG002|Overall Study|Protocol Violation|1|||
24915888|NCT00506350|50010046|FG003|Overall Study|Protocol Violation|0|||
24915889|NCT00506350|50010047|FG004|Overall Study|Protocol Violation|0|||
24915890|NCT00506350|50010048|FG005|Overall Study|Protocol Violation|0|||
24915891|NCT00506350|50010049|FG006|Overall Study|Protocol Violation|1|||
24915892|NCT00506350|50010050|FG007|Overall Study|Protocol Violation|0|||
24915893|NCT00506350|50010051|FG008|Overall Study|Protocol Violation|0|||
24915894|NCT00506350|50010043|FG000|Overall Study|Withdrawal by Subject|0|||
24915895|NCT00506350|50010044|FG001|Overall Study|Withdrawal by Subject|1|||
24915896|NCT00506350|50010045|FG002|Overall Study|Withdrawal by Subject|1|||
24915897|NCT00506350|50010046|FG003|Overall Study|Withdrawal by Subject|1|||
24915898|NCT00506350|50010047|FG004|Overall Study|Withdrawal by Subject|4|||
24915899|NCT00506350|50010048|FG005|Overall Study|Withdrawal by Subject|1|||
24915900|NCT00506350|50010049|FG006|Overall Study|Withdrawal by Subject|1|||
24915901|NCT00506350|50010050|FG007|Overall Study|Withdrawal by Subject|2|||
24915902|NCT00506350|50010051|FG008|Overall Study|Withdrawal by Subject|0|||
24915903|NCT00506350|50010043|FG000|Overall Study|Lost to Follow-up|1|||
24915904|NCT00506350|50010044|FG001|Overall Study|Lost to Follow-up|1|||
24915905|NCT00506350|50010045|FG002|Overall Study|Lost to Follow-up|1|||
24915906|NCT00506350|50010046|FG003|Overall Study|Lost to Follow-up|1|||
25153501|NCT01968967|50268585|FG004|Treatment Period|Lost to Follow-up|0|||
25153502|NCT01968967|50268581|FG000|Treatment Period|Protocol Violation|1|||
25153503|NCT01968967|50268582|FG001|Treatment Period|Protocol Violation|2|||
25153504|NCT01968967|50268583|FG002|Treatment Period|Protocol Violation|0|||
25153505|NCT01968967|50268584|FG003|Treatment Period|Protocol Violation|0|||
25153506|NCT01968967|50268585|FG004|Treatment Period|Protocol Violation|0|||
25153507|NCT01968967|50268581|FG000|Treatment Period|Adverse Event|9|||
25153508|NCT01968967|50268582|FG001|Treatment Period|Adverse Event|8|||
25153509|NCT01968967|50268583|FG002|Treatment Period|Adverse Event|0|||
24915907|NCT00506350|50010047|FG004|Overall Study|Lost to Follow-up|2|||
25153510|NCT01968967|50268584|FG003|Treatment Period|Adverse Event|0|||
25153511|NCT01968967|50268585|FG004|Treatment Period|Adverse Event|0|||
25153512|NCT01968967|50268581|FG000|Treatment Period|Death|9|||
24915908|NCT00506350|50010048|FG005|Overall Study|Lost to Follow-up|1|||
24915909|NCT00506350|50010049|FG006|Overall Study|Lost to Follow-up|0|||
24915910|NCT00506350|50010050|FG007|Overall Study|Lost to Follow-up|0|||
24915911|NCT00506350|50010051|FG008|Overall Study|Lost to Follow-up|2|||
24915912|NCT00506350|50010043|FG000|Overall Study|Medical Reason|0|||
24915913|NCT00506350|50010044|FG001|Overall Study|Medical Reason|0|||
24915914|NCT00506350|50010045|FG002|Overall Study|Medical Reason|0|||
24915915|NCT00506350|50010046|FG003|Overall Study|Medical Reason|0|||
24915916|NCT00506350|50010047|FG004|Overall Study|Medical Reason|1|||
25021265|NCT03039686|50117701|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
25021266|NCT03039686|50117702|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
25274982|NCT01238861|50589069|FG004|Overall Study|Incorrect enrollment/randomization|1|||
24915917|NCT00506350|50010048|FG005|Overall Study|Medical Reason|0|||
24915918|NCT00506350|50010049|FG006|Overall Study|Medical Reason|0|||
24915919|NCT00506350|50010050|FG007|Overall Study|Medical Reason|0|||
24915920|NCT00506350|50010051|FG008|Overall Study|Medical Reason|0|||
24915921|NCT00506350|50010043|FG000|Overall Study|Other|1|||
24915922|NCT00506350|50010044|FG001|Overall Study|Other|1|||
24915923|NCT00506350|50010045|FG002|Overall Study|Other|3|||
25153513|NCT01968967|50268582|FG001|Treatment Period|Death|2|||
25153514|NCT01968967|50268583|FG002|Treatment Period|Death|0|||
24915924|NCT00506350|50010046|FG003|Overall Study|Other|0|||
24915925|NCT00506350|50010047|FG004|Overall Study|Other|3|||
24915926|NCT00506350|50010048|FG005|Overall Study|Other|0|||
24915927|NCT00506350|50010049|FG006|Overall Study|Other|0|||
24915928|NCT00506350|50010050|FG007|Overall Study|Other|2|||
24915929|NCT00506350|50010051|FG008|Overall Study|Other|2|||
24915930|NCT00258895|50010080|FG000|Overall Study|Lost to Follow-up|3|||
24915931|NCT00258895|50010081|FG001|Overall Study|Lost to Follow-up|1|||
24915932|NCT00258895|50010080|FG000|Overall Study|Protocol Violation|6|||
24915933|NCT00258895|50010081|FG001|Overall Study|Protocol Violation|2|||
24915934|NCT00258895|50010080|FG000|Overall Study|Withdrawal by Subject|1|||
24915935|NCT00258895|50010081|FG001|Overall Study|Withdrawal by Subject|0|||
24915936|NCT00742625|50010087|FG000|Remission Induction|Progression|6|||
24915937|NCT00742625|50010087|FG000|Remission Induction|Failed induction|8|||
24915938|NCT00742625|50010087|FG000|Remission Induction|Adverse Event|3|||
24915939|NCT00742625|50010087|FG000|Remission Induction|Death|10|||
24915940|NCT00742625|50010087|FG000|Remission Induction|Refusal|5|||
24915941|NCT00742625|50010087|FG000|Remission Induction|Non protocol treatment|17|||
24915942|NCT00742625|50010087|FG000|Remission Induction|Other, not specified|5|||
24915943|NCT00742625|50010087|FG000|Consolidation|Progression|5|||
24915944|NCT00742625|50010087|FG000|Consolidation|Adverse Event|1|||
24915945|NCT00742625|50010087|FG000|Consolidation|Death|1|||
24915946|NCT00742625|50010087|FG000|Consolidation|Refused|1|||
24915947|NCT00742625|50010087|FG000|Consolidation|Non protocol therapy|13|||
24915948|NCT00618618|50010098|FG000|Overall Study|Patient Request|0|||
24915949|NCT00618618|50010099|FG001|Overall Study|Patient Request|0|||
24915950|NCT00618618|50010100|FG002|Overall Study|Patient Request|2|||
24915951|NCT00618618|50010101|FG003|Overall Study|Patient Request|0|||
24915952|NCT00618618|50010098|FG000|Overall Study|Inability to Complete Study Procedures|0|||
24915953|NCT00618618|50010099|FG001|Overall Study|Inability to Complete Study Procedures|1|||
24915954|NCT00618618|50010100|FG002|Overall Study|Inability to Complete Study Procedures|0|||
24915955|NCT00618618|50010101|FG003|Overall Study|Inability to Complete Study Procedures|0|||
24915956|NCT00618618|50010098|FG000|Overall Study|Lost to Follow-up|3|||
25021267|NCT03039686|50117700|FG000|Double-blind Period|Withdrawal by Subject|2|||
25021268|NCT03039686|50117701|FG001|Double-blind Period|Withdrawal by Subject|2|||
25021269|NCT03039686|50117702|FG002|Double-blind Period|Withdrawal by Subject|1|||
25021270|NCT03039686|50117700|FG000|Double-blind Period|Death|0|||
24915957|NCT00618618|50010099|FG001|Overall Study|Lost to Follow-up|0|||
24915958|NCT00618618|50010100|FG002|Overall Study|Lost to Follow-up|0|||
24915959|NCT00618618|50010101|FG003|Overall Study|Lost to Follow-up|1|||
24915960|NCT00618618|50010098|FG000|Overall Study|Non-compliance|1|||
24915961|NCT00618618|50010099|FG001|Overall Study|Non-compliance|1|||
25021271|NCT03039686|50117701|FG001|Double-blind Period|Death|0|||
25021272|NCT03039686|50117702|FG002|Double-blind Period|Death|1|||
25021273|NCT03039686|50117700|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
25021274|NCT03039686|50117701|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
25021275|NCT03039686|50117702|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
25153515|NCT01968967|50268584|FG003|Treatment Period|Death|0|||
25021276|NCT03039686|50117700|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
25021277|NCT03039686|50117701|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
25021278|NCT03039686|50117702|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
25021279|NCT03039686|50117700|FG000|Open Label Period|Withdrawal by Subject|0|||
25021280|NCT03039686|50117701|FG001|Open Label Period|Withdrawal by Subject|3|||
25021281|NCT03039686|50117702|FG002|Open Label Period|Withdrawal by Subject|1|||
25021282|NCT01822275|50117720|FG000|Overall Study|Withdrawal by Subject|3|||
25021283|NCT01822275|50117720|FG000|Overall Study|Adverse Event|3|||
25021284|NCT01822275|50117720|FG000|Overall Study|Progression|14|||
25021285|NCT01822275|50117720|FG000|Overall Study|Physician Decision|2|||
25021286|NCT01656434|50117732|FG000|Overall Study|Adverse Event|199|||
25021287|NCT01656434|50117733|FG001|Overall Study|Adverse Event|63|||
25021288|NCT01656434|50117732|FG000|Overall Study|Enrollment terminated at trial site|2|||
25021289|NCT01656434|50117733|FG001|Overall Study|Enrollment terminated at trial site|0|||
25021290|NCT01656434|50117732|FG000|Overall Study|Lost to Follow-up|309|||
25021291|NCT01656434|50117733|FG001|Overall Study|Lost to Follow-up|76|||
25021292|NCT01656434|50117732|FG000|Overall Study|Site discontinued study participation|24|||
25021293|NCT01656434|50117733|FG001|Overall Study|Site discontinued study participation|9|||
25021294|NCT01656434|50117732|FG000|Overall Study|Screen failure|2|||
24915962|NCT00618618|50010100|FG002|Overall Study|Non-compliance|0|||
24915963|NCT00618618|50010101|FG003|Overall Study|Non-compliance|0|||
25021295|NCT01656434|50117733|FG001|Overall Study|Screen failure|0|||
25021296|NCT01656434|50117732|FG000|Overall Study|Protocol Violation|7|||
25021297|NCT01656434|50117733|FG001|Overall Study|Protocol Violation|0|||
25153516|NCT01968967|50268585|FG004|Treatment Period|Death|0|||
24915964|NCT00618618|50010098|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
24915965|NCT00618618|50010099|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
24915966|NCT00618618|50010100|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
24915967|NCT00618618|50010101|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
24915968|NCT00618618|50010098|FG000|Overall Study|Death|0|||
25021298|NCT01656434|50117732|FG000|Overall Study|Pregnancy wish|18|||
25021299|NCT01656434|50117733|FG001|Overall Study|Pregnancy wish|6|||
25021300|NCT01656434|50117732|FG000|Overall Study|Pregnancy|45|||
25021301|NCT01656434|50117733|FG001|Overall Study|Pregnancy|10|||
25021302|NCT01656434|50117732|FG000|Overall Study|Physician Decision|7|||
25021303|NCT01656434|50117733|FG001|Overall Study|Physician Decision|2|||
25021304|NCT01656434|50117732|FG000|Overall Study|Non-compliance with study drug|48|||
25021305|NCT01656434|50117733|FG001|Overall Study|Non-compliance with study drug|9|||
25021306|NCT01656434|50117732|FG000|Overall Study|Study terminated by sponsor|1501|||
25021307|NCT01656434|50117733|FG001|Overall Study|Study terminated by sponsor|348|||
25021308|NCT01656434|50117732|FG000|Overall Study|Participant discontinued; drug related|13|||
25021309|NCT01656434|50117733|FG001|Overall Study|Participant discontinued; drug related|4|||
25021310|NCT01656434|50117732|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
25021311|NCT01656434|50117733|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
25021312|NCT01656434|50117732|FG000|Overall Study|Non-compliance with protocol|39|||
25021313|NCT01656434|50117733|FG001|Overall Study|Non-compliance with protocol|15|||
25021314|NCT01656434|50117732|FG000|Overall Study|Participant moved|40|||
25021315|NCT01656434|50117733|FG001|Overall Study|Participant moved|12|||
25021316|NCT01656434|50117732|FG000|Overall Study|Participant withdrew consent|28|||
25021317|NCT01656434|50117733|FG001|Overall Study|Participant withdrew consent|9|||
25021318|NCT01656434|50117732|FG000|Overall Study|Withdrawal by Subject|64|||
25021319|NCT01656434|50117733|FG001|Overall Study|Withdrawal by Subject|7|||
25021320|NCT02931396|50117741|FG000|Overall Study|Lost to Follow-up|3|||
25021321|NCT02931396|50117742|FG001|Overall Study|Lost to Follow-up|0|||
25021322|NCT02931396|50117741|FG000|Overall Study|Withdrawal by Subject|2|||
25021323|NCT02931396|50117742|FG001|Overall Study|Withdrawal by Subject|0|||
25021324|NCT03037580|50117750|FG000|Overall Study|Withdrawal by Subject|3|||
24915969|NCT00618618|50010099|FG001|Overall Study|Death|1|||
24915970|NCT00618618|50010100|FG002|Overall Study|Death|0|||
24915971|NCT00618618|50010101|FG003|Overall Study|Death|0|||
24915972|NCT00246805|50010114|FG000|Phase 1|Lost to Follow-up|1|||
24915973|NCT00246805|50010115|FG001|Phase 1|Lost to Follow-up|0|||
24915974|NCT00519376|50010121|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
24915975|NCT00519376|50010122|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
24915976|NCT00519376|50010123|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
24915977|NCT00519376|50010124|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
24915978|NCT00519376|50010125|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
24915979|NCT00519376|50010126|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
24915980|NCT00519376|50010127|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
24915981|NCT00519376|50010128|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
24915982|NCT00519376|50010129|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
24915983|NCT00519376|50010130|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
24915984|NCT00519376|50010131|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
24915985|NCT00519376|50010132|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
24915986|NCT00519376|50010133|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
25021325|NCT03037580|50117751|FG001|Overall Study|Withdrawal by Subject|0|||
25021326|NCT03037580|50117750|FG000|Overall Study|Adverse Event|1|||
25021327|NCT03037580|50117751|FG001|Overall Study|Adverse Event|0|||
25021328|NCT03037580|50117750|FG000|Overall Study|Study Terminated by Sponsor|12|||
25021329|NCT03037580|50117751|FG001|Overall Study|Study Terminated by Sponsor|15|||
25021330|NCT03037580|50117750|FG000|Overall Study|Death|0|||
25184985|NCT04115748|50334075|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
25184986|NCT04115748|50334076|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
25184987|NCT04115748|50334077|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
24915987|NCT00519376|50010134|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
25184988|NCT04115748|50334078|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
25184989|NCT04115748|50334079|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
25184990|NCT04115748|50334080|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
25184991|NCT04115748|50334081|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
25184992|NCT04115748|50334082|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
25184993|NCT04115748|50334083|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
25184994|NCT04115748|50334084|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
25184995|NCT04115748|50334075|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
25184996|NCT04115748|50334076|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
25184997|NCT04115748|50334077|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
25184998|NCT04115748|50334078|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
25274983|NCT01238861|50589070|FG005|Overall Study|Incorrect enrollment/randomization|0|||
25021331|NCT03037580|50117751|FG001|Overall Study|Death|1|||
25021332|NCT01755195|50117757|FG000|Overall Study|Participant noncompliance|2|||
25021333|NCT01755195|50117757|FG000|Overall Study|Switched to alternative treatment|4|||
25021334|NCT01755195|50117757|FG000|Overall Study|Withdrawal by Subject|1|||
24915988|NCT00519376|50010135|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
24915989|NCT00519376|50010136|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
24915990|NCT00519376|50010121|FG000|Treatment Period 4|Lost to Follow-up|0|||
24915991|NCT00519376|50010122|FG001|Treatment Period 4|Lost to Follow-up|0|||
24915992|NCT00519376|50010123|FG002|Treatment Period 4|Lost to Follow-up|1|||
24915993|NCT00519376|50010124|FG003|Treatment Period 4|Lost to Follow-up|0|||
24915994|NCT00519376|50010125|FG004|Treatment Period 4|Lost to Follow-up|0|||
24915995|NCT00519376|50010126|FG005|Treatment Period 4|Lost to Follow-up|0|||
24915996|NCT00519376|50010127|FG006|Treatment Period 4|Lost to Follow-up|0|||
24915997|NCT00519376|50010128|FG007|Treatment Period 4|Lost to Follow-up|0|||
24915998|NCT00519376|50010129|FG008|Treatment Period 4|Lost to Follow-up|0|||
24915999|NCT00519376|50010130|FG009|Treatment Period 4|Lost to Follow-up|0|||
24916000|NCT00519376|50010131|FG010|Treatment Period 4|Lost to Follow-up|0|||
24916001|NCT00519376|50010132|FG011|Treatment Period 4|Lost to Follow-up|0|||
24916002|NCT00519376|50010133|FG012|Treatment Period 4|Lost to Follow-up|0|||
24916003|NCT00519376|50010134|FG013|Treatment Period 4|Lost to Follow-up|0|||
24916004|NCT00519376|50010135|FG014|Treatment Period 4|Lost to Follow-up|0|||
24916005|NCT00519376|50010136|FG015|Treatment Period 4|Lost to Follow-up|0|||
24916006|NCT00745121|50010150|FG000|Overall Study|Death|3|||
24916007|NCT00745121|50010151|FG001|Overall Study|Death|0|||
24916008|NCT00745121|50010150|FG000|Overall Study|Adverse Event|1|||
24916009|NCT00745121|50010151|FG001|Overall Study|Adverse Event|0|||
24916010|NCT00745121|50010150|FG000|Overall Study|Lost to Follow-up|1|||
24916011|NCT00745121|50010151|FG001|Overall Study|Lost to Follow-up|0|||
24916012|NCT00745121|50010150|FG000|Overall Study|Withdrawal by Subject|4|||
24916013|NCT00745121|50010151|FG001|Overall Study|Withdrawal by Subject|2|||
25184999|NCT04115748|50334079|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
25185000|NCT04115748|50334080|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
25185001|NCT04115748|50334081|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
25185002|NCT04115748|50334082|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
25185003|NCT04115748|50334083|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
25185004|NCT04115748|50334084|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
25185005|NCT04115748|50334075|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
25185006|NCT04115748|50334076|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
25185007|NCT04115748|50334077|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
24916014|NCT00740051|50010159|FG000|Overall Study|Lack of Efficacy|2|||
25021335|NCT01755195|50117757|FG000|Overall Study|Participant refused to start treatment|1|||
25021336|NCT01755195|50117757|FG000|Overall Study|Participant has been consented for another trial|1|||
25021337|NCT01755195|50117757|FG000|Overall Study|Refused further treatment|3|||
25021338|NCT01755195|50117757|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
25021339|NCT00897104|50117764|FG000|Overall Study|Lost to Follow-up|12|||
25021340|NCT00897104|50117765|FG001|Overall Study|Lost to Follow-up|17|||
25021341|NCT00897104|50117766|FG002|Overall Study|Lost to Follow-up|2|||
25021342|NCT00897104|50117764|FG000|Overall Study|Pregnancy|0|||
25021343|NCT00897104|50117765|FG001|Overall Study|Pregnancy|1|||
25021344|NCT00897104|50117766|FG002|Overall Study|Pregnancy|0|||
25021345|NCT00897104|50117764|FG000|Overall Study|Protocol Violation|0|||
25021346|NCT00897104|50117765|FG001|Overall Study|Protocol Violation|1|||
25021347|NCT00897104|50117766|FG002|Overall Study|Protocol Violation|0|||
25021348|NCT00897104|50117764|FG000|Overall Study|Withdrawal by Subject|23|||
25021349|NCT00897104|50117765|FG001|Overall Study|Withdrawal by Subject|27|||
25021350|NCT00897104|50117766|FG002|Overall Study|Withdrawal by Subject|3|||
25021351|NCT00897104|50117764|FG000|Overall Study|Abnormal Prestudy Labs|2|||
25021352|NCT00897104|50117765|FG001|Overall Study|Abnormal Prestudy Labs|0|||
25021353|NCT00897104|50117766|FG002|Overall Study|Abnormal Prestudy Labs|0|||
25021354|NCT00897104|50117764|FG000|Overall Study|Abnormal Baseline ECG|2|||
25021355|NCT00897104|50117765|FG001|Overall Study|Abnormal Baseline ECG|2|||
25021356|NCT00897104|50117766|FG002|Overall Study|Abnormal Baseline ECG|0|||
25021357|NCT00897104|50117764|FG000|Overall Study|Need for Concom. Med.|0|||
24916015|NCT00740051|50010160|FG001|Overall Study|Lack of Efficacy|5|||
24916016|NCT00740051|50010159|FG000|Overall Study|Adverse Event|1|||
24916017|NCT00740051|50010160|FG001|Overall Study|Adverse Event|4|||
25021358|NCT00897104|50117765|FG001|Overall Study|Need for Concom. Med.|1|||
24916018|NCT00740051|50010159|FG000|Overall Study|Protocol Violation|2|||
24916019|NCT00740051|50010160|FG001|Overall Study|Protocol Violation|6|||
24916020|NCT00740051|50010159|FG000|Overall Study|Lost to Follow-up|3|||
24916021|NCT00740051|50010160|FG001|Overall Study|Lost to Follow-up|8|||
24916022|NCT00740051|50010159|FG000|Overall Study|Withdrawal by Subject|6|||
24916023|NCT00740051|50010160|FG001|Overall Study|Withdrawal by Subject|8|||
24916024|NCT00740051|50010159|FG000|Overall Study|Other reason (not specified)|4|||
24916025|NCT00740051|50010160|FG001|Overall Study|Other reason (not specified)|1|||
24916026|NCT00518986|50010169|FG000|Overall Study|Adverse Event|12|||
25021359|NCT00897104|50117766|FG002|Overall Study|Need for Concom. Med.|1|||
25021360|NCT00897104|50117764|FG000|Overall Study|Lack of Migraine Attack|20|||
24916027|NCT00518986|50010170|FG001|Overall Study|Adverse Event|7|||
25021361|NCT00897104|50117765|FG001|Overall Study|Lack of Migraine Attack|22|||
25021362|NCT00897104|50117766|FG002|Overall Study|Lack of Migraine Attack|1|||
25021363|NCT00897104|50117764|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
25021364|NCT00897104|50117765|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
25021365|NCT00897104|50117766|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
25021366|NCT00897104|50117764|FG000|Overall Study|Other|3|||
25153517|NCT01968967|50268581|FG000|Treatment Period|Randomized Not Treated|6|||
25153518|NCT01968967|50268582|FG001|Treatment Period|Randomized Not Treated|5|||
24916028|NCT00518986|50010169|FG000|Overall Study|Lack of Efficacy|0|||
24916029|NCT00518986|50010170|FG001|Overall Study|Lack of Efficacy|2|||
24916030|NCT00518986|50010169|FG000|Overall Study|Lost to Follow-up|3|||
24916031|NCT00518986|50010170|FG001|Overall Study|Lost to Follow-up|2|||
24916032|NCT00518986|50010169|FG000|Overall Study|Physician Decision|0|||
24916033|NCT00518986|50010170|FG001|Overall Study|Physician Decision|3|||
24916034|NCT00518986|50010169|FG000|Overall Study|Protocol Violation|5|||
24916035|NCT00518986|50010170|FG001|Overall Study|Protocol Violation|7|||
24916036|NCT00518986|50010169|FG000|Overall Study|Withdrawal by Subject|4|||
24916037|NCT00518986|50010170|FG001|Overall Study|Withdrawal by Subject|4|||
24916038|NCT00518986|50010169|FG000|Overall Study|Non-Specific|2|||
24916039|NCT00518986|50010170|FG001|Overall Study|Non-Specific|1|||
24916040|NCT00742391|50010178|FG000|Overall Study|Adverse Event|2|||
24916041|NCT00742391|50010179|FG001|Overall Study|Adverse Event|1|||
24916042|NCT00742391|50010178|FG000|Overall Study|Lost to Follow-up|1|||
24916043|NCT00742391|50010179|FG001|Overall Study|Lost to Follow-up|0|||
24916044|NCT00742391|50010178|FG000|Overall Study|Protocol Violation|1|||
24916045|NCT00742391|50010179|FG001|Overall Study|Protocol Violation|0|||
24916046|NCT00742235|50010187|FG000|Overall Study|Lost to Follow-up|0|||
24916047|NCT00742235|50010188|FG001|Overall Study|Lost to Follow-up|31|||
24916048|NCT00742079|50010196|FG000|Overall Study|Lost to Follow-up|0|||
24916049|NCT00742079|50010197|FG001|Overall Study|Lost to Follow-up|1|||
24916050|NCT00662792|50010203|FG000|Period 1|Personal Reasons|0|||
24916051|NCT00662792|50010204|FG001|Period 1|Personal Reasons|0|||
24916052|NCT00662792|50010205|FG002|Period 1|Personal Reasons|1|||
24916053|NCT00662792|50010206|FG003|Period 1|Personal Reasons|0|||
24916054|NCT00662792|50010203|FG000|Period 1|Refused continuing medication|0|||
24916055|NCT00662792|50010204|FG001|Period 1|Refused continuing medication|1|||
25153519|NCT01968967|50268583|FG002|Treatment Period|Randomized Not Treated|0|||
25153520|NCT01968967|50268584|FG003|Treatment Period|Randomized Not Treated|0|||
24916056|NCT00662792|50010205|FG002|Period 1|Refused continuing medication|1|||
24916057|NCT00662792|50010206|FG003|Period 1|Refused continuing medication|0|||
24916058|NCT00662792|50010203|FG000|Period 1|Lost to Follow-up|1|||
24916059|NCT00662792|50010204|FG001|Period 1|Lost to Follow-up|0|||
24916060|NCT00662792|50010205|FG002|Period 1|Lost to Follow-up|0|||
24916061|NCT00662792|50010206|FG003|Period 1|Lost to Follow-up|0|||
24916062|NCT00662792|50010203|FG000|Period 1|Other adverse event (AE)|0|||
24916063|NCT00662792|50010204|FG001|Period 1|Other adverse event (AE)|2|||
24916064|NCT00662792|50010205|FG002|Period 1|Other adverse event (AE)|0|||
24916065|NCT00662792|50010206|FG003|Period 1|Other adverse event (AE)|0|||
24916066|NCT00662792|50010203|FG000|Period 1|Worsening of disease under study (AE)|1|||
24916067|NCT00662792|50010204|FG001|Period 1|Worsening of disease under study (AE)|3|||
25153521|NCT01968967|50268585|FG004|Treatment Period|Randomized Not Treated|0|||
25153522|NCT01968967|50268581|FG000|Extension Period|Withdrew Consent|0|||
25153523|NCT01968967|50268582|FG001|Extension Period|Withdrew Consent|0|||
24916068|NCT00662792|50010205|FG002|Period 1|Worsening of disease under study (AE)|2|||
24916069|NCT00662792|50010206|FG003|Period 1|Worsening of disease under study (AE)|0|||
24916070|NCT00662792|50010203|FG000|Period 1|Not treated|0|||
24916071|NCT00662792|50010204|FG001|Period 1|Not treated|1|||
24916072|NCT00662792|50010205|FG002|Period 1|Not treated|0|||
24916073|NCT00662792|50010206|FG003|Period 1|Not treated|0|||
24916074|NCT00662792|50010203|FG000|Period 2|Worsening of disease under study|1|||
24916075|NCT00662792|50010204|FG001|Period 2|Worsening of disease under study|0|||
24916076|NCT00662792|50010205|FG002|Period 2|Worsening of disease under study|0|||
24916077|NCT00662792|50010206|FG003|Period 2|Worsening of disease under study|3|||
24916078|NCT00662792|50010203|FG000|Period 3|Refused continuing medication|1|||
24916079|NCT00662792|50010204|FG001|Period 3|Refused continuing medication|0|||
24916080|NCT00662792|50010205|FG002|Period 3|Refused continuing medication|1|||
24916081|NCT00662792|50010206|FG003|Period 3|Refused continuing medication|0|||
24916082|NCT00662792|50010203|FG000|Period 3|Other adverse event (AE)|0|||
24916083|NCT00662792|50010204|FG001|Period 3|Other adverse event (AE)|0|||
24916084|NCT00662792|50010205|FG002|Period 3|Other adverse event (AE)|1|||
24916085|NCT00662792|50010206|FG003|Period 3|Other adverse event (AE)|1|||
24916086|NCT00662792|50010203|FG000|Period 4|Refused continuing medication|0|||
25153524|NCT01968967|50268583|FG002|Extension Period|Withdrew Consent|2|||
24916087|NCT00662792|50010204|FG001|Period 4|Refused continuing medication|1|||
24916088|NCT00662792|50010205|FG002|Period 4|Refused continuing medication|0|||
24916089|NCT00662792|50010206|FG003|Period 4|Refused continuing medication|0|||
24916090|NCT00662792|50010203|FG000|Period 4|Other adverse event (AE)|1|||
25153525|NCT01968967|50268584|FG003|Extension Period|Withdrew Consent|0|||
25153526|NCT01968967|50268585|FG004|Extension Period|Withdrew Consent|5|||
25153527|NCT01554579|50268601|FG000|Overall Study|Adverse Event|6|||
25153528|NCT01554579|50268602|FG001|Overall Study|Adverse Event|25|||
25153529|NCT01554579|50268601|FG000|Overall Study|Lack of Efficacy|2|||
25153530|NCT01554579|50268602|FG001|Overall Study|Lack of Efficacy|1|||
25153531|NCT01554579|50268601|FG000|Overall Study|Withdrawal by Subject|2|||
25153532|NCT01554579|50268602|FG001|Overall Study|Withdrawal by Subject|1|||
25153533|NCT01806662|50268609|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
25153534|NCT01806662|50268610|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
25153535|NCT01806662|50268609|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
25153536|NCT01806662|50268610|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
24916091|NCT00662792|50010204|FG001|Period 4|Other adverse event (AE)|0|||
24916092|NCT00662792|50010205|FG002|Period 4|Other adverse event (AE)|0|||
24916093|NCT00662792|50010206|FG003|Period 4|Other adverse event (AE)|0|||
24916094|NCT00662792|50010203|FG000|Period 4|Worsening of disease under study (AE)|0|||
24916095|NCT00662792|50010204|FG001|Period 4|Worsening of disease under study (AE)|0|||
24916096|NCT00662792|50010205|FG002|Period 4|Worsening of disease under study (AE)|0|||
24916097|NCT00662792|50010206|FG003|Period 4|Worsening of disease under study (AE)|1|||
25153537|NCT01806662|50268609|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
25153538|NCT01806662|50268610|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
25153539|NCT01806662|50268609|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
25153540|NCT01806662|50268610|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
25153541|NCT01930123|50268618|FG000|Overall Study|Adverse Event|1|||
25153542|NCT01930123|50268619|FG001|Overall Study|Adverse Event|0|||
25153543|NCT01930123|50268618|FG000|Overall Study|Physician Decision|21|||
25153544|NCT01930123|50268619|FG001|Overall Study|Physician Decision|8|||
24916098|NCT00742001|50010221|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
24916099|NCT00742001|50010222|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
24916100|NCT00742001|50010223|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
24916101|NCT00616902|50010236|FG000|Overall Study|Termination of study|6|||
24916102|NCT00616902|50010237|FG001|Overall Study|Termination of study|6|||
24916103|NCT00741611|50010246|FG000|Overall Study|Death|0|||
24916104|NCT00741611|50010247|FG001|Overall Study|Death|0|||
24916105|NCT00741611|50010248|FG002|Overall Study|Death|1|||
24916106|NCT00741611|50010246|FG000|Overall Study|Withdrawal by Subject|0|||
24916107|NCT00741611|50010247|FG001|Overall Study|Withdrawal by Subject|2|||
25153545|NCT01930123|50268618|FG000|Overall Study|Withdrawal by Subject|1|||
25153546|NCT01930123|50268619|FG001|Overall Study|Withdrawal by Subject|0|||
24916108|NCT00741611|50010248|FG002|Overall Study|Withdrawal by Subject|2|||
24916109|NCT00662558|50010259|FG000|Overall Study|Adverse Event|21|||
24916110|NCT00662558|50010260|FG001|Overall Study|Adverse Event|59|||
24916111|NCT00662558|50010259|FG000|Overall Study|Lack of Efficacy|4|||
24916112|NCT00662558|50010260|FG001|Overall Study|Lack of Efficacy|7|||
24916113|NCT00662558|50010259|FG000|Overall Study|Lost to Follow-up|13|||
24916114|NCT00662558|50010260|FG001|Overall Study|Lost to Follow-up|10|||
24916115|NCT00662558|50010259|FG000|Overall Study|Other|9|||
24916116|NCT00662558|50010260|FG001|Overall Study|Other|14|||
24916117|NCT00662558|50010259|FG000|Overall Study|Withdrawal by Subject|7|||
24916118|NCT00662558|50010260|FG001|Overall Study|Withdrawal by Subject|12|||
24916119|NCT00662558|50010259|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
24916120|NCT00662558|50010260|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
24916121|NCT00739973|50010275|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
24916122|NCT00739973|50010276|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
24916123|NCT00739973|50010277|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
24916124|NCT00739973|50010278|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
24916125|NCT00739973|50010279|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
25153547|NCT01930045|50268625|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
24916126|NCT00739973|50010280|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
24916127|NCT00739973|50010281|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
24916128|NCT00739973|50010282|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
24916129|NCT00739973|50010283|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
25153548|NCT01930045|50268626|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
24916130|NCT00739973|50010275|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
25153549|NCT01930045|50268627|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
24916131|NCT00739973|50010276|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
24916132|NCT00739973|50010277|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
24916133|NCT00739973|50010278|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
24916134|NCT00739973|50010279|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
24916135|NCT00739973|50010280|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
24916136|NCT00739973|50010281|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
25153550|NCT01930045|50268628|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
25153551|NCT01930045|50268629|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
24916137|NCT00739973|50010282|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
24916138|NCT00739973|50010283|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
24916139|NCT00739973|50010275|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
24916140|NCT00739973|50010276|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
24916141|NCT00739973|50010277|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
24916142|NCT00739973|50010278|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
24916143|NCT00739973|50010279|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
24916144|NCT00739973|50010280|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
24916145|NCT00739973|50010281|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
24916146|NCT00739973|50010282|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
24916147|NCT00739973|50010283|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
24916148|NCT00739973|50010275|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
24916149|NCT00739973|50010276|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
24916150|NCT00739973|50010277|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
24916151|NCT00739973|50010278|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
24916152|NCT00739973|50010279|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
24916153|NCT00739973|50010280|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
24916154|NCT00739973|50010281|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
24916155|NCT00739973|50010282|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
25153552|NCT01930045|50268630|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
25153553|NCT01930045|50268625|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
25153554|NCT01930045|50268626|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
25153555|NCT01930045|50268627|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
25153556|NCT01930045|50268628|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
24916156|NCT00739973|50010283|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
24916157|NCT00739973|50010275|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
24916158|NCT00739973|50010276|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
24916159|NCT00739973|50010277|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
24916160|NCT00739973|50010278|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
24916161|NCT00739973|50010279|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
24916162|NCT00739973|50010280|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
25153557|NCT01930045|50268629|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
25153558|NCT01930045|50268630|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
24916163|NCT00739973|50010281|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
24916164|NCT00739973|50010282|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
24916165|NCT00739973|50010283|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
24916166|NCT00739973|50010275|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
24916167|NCT00739973|50010276|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
24916168|NCT00739973|50010277|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
24916169|NCT00739973|50010278|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
24916170|NCT00739973|50010279|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
24916171|NCT00739973|50010280|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
24916172|NCT00739973|50010281|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
24916173|NCT00739973|50010282|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
25021367|NCT00897104|50117765|FG001|Overall Study|Other|0|||
25153559|NCT01929343|50268645|FG000|Overall Study|Physician Decision|0|||
25153560|NCT01929343|50268646|FG001|Overall Study|Physician Decision|2|||
25153561|NCT01929343|50268647|FG002|Overall Study|Physician Decision|0|||
25153562|NCT01929343|50268645|FG000|Overall Study|Withdrawal by Subject|1|||
25153563|NCT01929343|50268646|FG001|Overall Study|Withdrawal by Subject|0|||
25153564|NCT01929343|50268647|FG002|Overall Study|Withdrawal by Subject|0|||
25153565|NCT01968811|50268655|FG000|Overall Study|Protocol Violation|4|||
25153566|NCT01968811|50268655|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
25153567|NCT01806584|50268661|FG000|Overall Study|Adverse Event|2|||
25185008|NCT04115748|50334078|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
24916174|NCT00739973|50010283|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
24916175|NCT00739973|50010275|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
24916176|NCT00739973|50010276|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
24916177|NCT00739973|50010277|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
24916178|NCT00739973|50010278|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
24916179|NCT00739973|50010279|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
24916180|NCT00739973|50010280|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
24916181|NCT00739973|50010281|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
25153568|NCT01806584|50268662|FG001|Overall Study|Adverse Event|1|||
25153569|NCT01806584|50268661|FG000|Overall Study|Death|1|||
25153570|NCT01806584|50268662|FG001|Overall Study|Death|0|||
25153571|NCT01806584|50268661|FG000|Overall Study|Lost to Follow-up|0|||
24916182|NCT00739973|50010282|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
24916183|NCT00739973|50010283|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
24916184|NCT00739973|50010275|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
24916185|NCT00739973|50010276|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
24916186|NCT00739973|50010277|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
24916187|NCT00739973|50010278|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
24916188|NCT00739973|50010279|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
24916189|NCT00739973|50010280|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
24916190|NCT00739973|50010281|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
24916191|NCT00739973|50010282|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
25153572|NCT01806584|50268662|FG001|Overall Study|Lost to Follow-up|2|||
25153573|NCT01806584|50268661|FG000|Overall Study|Study terminated by sponsor|9|||
25153574|NCT01806584|50268662|FG001|Overall Study|Study terminated by sponsor|14|||
25153575|NCT01806584|50268661|FG000|Overall Study|Withdrawal by Subject|1|||
25153576|NCT01806584|50268662|FG001|Overall Study|Withdrawal by Subject|1|||
25153577|NCT01806584|50268661|FG000|Overall Study|Other unspecified|1|||
25153578|NCT01806584|50268662|FG001|Overall Study|Other unspecified|0|||
25153579|NCT01798706|50268670|FG000|Overall Study|Adverse Event|15|||
25153580|NCT01798706|50268671|FG001|Overall Study|Adverse Event|10|||
25153581|NCT01798706|50268670|FG000|Overall Study|Lack of Efficacy|0|||
25153582|NCT01798706|50268671|FG001|Overall Study|Lack of Efficacy|2|||
25153583|NCT01798706|50268670|FG000|Overall Study|Poor compliance to protocol|1|||
25153584|NCT01798706|50268671|FG001|Overall Study|Poor compliance to protocol|0|||
25153585|NCT01798706|50268670|FG000|Overall Study|Other than specified above|5|||
25021368|NCT00897104|50117766|FG002|Overall Study|Other|0|||
25153586|NCT01798706|50268671|FG001|Overall Study|Other than specified above|9|||
25153587|NCT01767194|50268679|FG000|Overall Study|Adverse Event|1|||
25274984|NCT01238861|50589065|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
24916192|NCT00739973|50010283|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
24916193|NCT00739973|50010275|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
24916194|NCT00739973|50010276|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
25153588|NCT01767194|50268680|FG001|Overall Study|Adverse Event|1|||
25153589|NCT01767194|50268679|FG000|Overall Study|Death|0|||
25153590|NCT01767194|50268680|FG001|Overall Study|Death|1|||
25153591|NCT01767194|50268679|FG000|Overall Study|Lack of Efficacy|12|||
25153592|NCT01767194|50268680|FG001|Overall Study|Lack of Efficacy|11|||
25153593|NCT01767194|50268679|FG000|Overall Study|Physician Decision|2|||
25153594|NCT01767194|50268680|FG001|Overall Study|Physician Decision|23|||
25153595|NCT01767194|50268679|FG000|Overall Study|Withdrawal by Subject|0|||
25153596|NCT01767194|50268680|FG001|Overall Study|Withdrawal by Subject|1|||
24916195|NCT00739973|50010277|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
24916196|NCT00739973|50010278|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
24916197|NCT00739973|50010279|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
24916198|NCT00739973|50010280|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
24916199|NCT00739973|50010281|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
24916200|NCT00739973|50010282|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
24916201|NCT00739973|50010283|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
24916202|NCT00739973|50010275|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
24916203|NCT00739973|50010276|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
25153597|NCT01767194|50268679|FG000|Overall Study|Ineligible|1|||
25153598|NCT01767194|50268680|FG001|Overall Study|Ineligible|1|||
25153599|NCT01767194|50268679|FG000|Overall Study|Refusal by patient/parent|2|||
25153600|NCT01767194|50268680|FG001|Overall Study|Refusal by patient/parent|4|||
25153601|NCT01767194|50268679|FG000|Overall Study|Criteria not met on time for next cycle|0|||
25153602|NCT01767194|50268680|FG001|Overall Study|Criteria not met on time for next cycle|1|||
25153603|NCT01575873|50268691|FG000|Overall Study|Withdrawal by Subject|15|||
25153604|NCT01575873|50268692|FG001|Overall Study|Withdrawal by Subject|20|||
25153605|NCT01575873|50268693|FG002|Overall Study|Withdrawal by Subject|34|||
25153606|NCT01575873|50268694|FG003|Overall Study|Withdrawal by Subject|34|||
25153607|NCT01575873|50268691|FG000|Overall Study|Adverse Event|7|||
25153608|NCT01575873|50268692|FG001|Overall Study|Adverse Event|7|||
25153609|NCT01575873|50268693|FG002|Overall Study|Adverse Event|9|||
25153610|NCT01575873|50268694|FG003|Overall Study|Adverse Event|12|||
25153611|NCT01575873|50268691|FG000|Overall Study|Lost to Follow-up|1|||
24916204|NCT00739973|50010277|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
25153612|NCT01575873|50268692|FG001|Overall Study|Lost to Follow-up|3|||
24916205|NCT00739973|50010278|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
24916206|NCT00739973|50010279|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
24916207|NCT00739973|50010280|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
25021369|NCT00897104|50117764|FG000|Overall Study|Protocol Violation|1|||
25021370|NCT00897104|50117765|FG001|Overall Study|Protocol Violation|0|||
25021371|NCT00897104|50117766|FG002|Overall Study|Protocol Violation|0|||
25021372|NCT00897104|50117764|FG000|Overall Study|Withdrawal by Subject|0|||
25021373|NCT00897104|50117765|FG001|Overall Study|Withdrawal by Subject|0|||
25021374|NCT00897104|50117766|FG002|Overall Study|Withdrawal by Subject|1|||
25021375|NCT01339689|50117776|FG000|Overall Study|Adverse Event|1|||
25021376|NCT01339689|50117777|FG001|Overall Study|Adverse Event|2|||
25021377|NCT01339689|50117776|FG000|Overall Study|Lost to Follow-up|9|||
25021378|NCT01339689|50117777|FG001|Overall Study|Lost to Follow-up|3|||
25021379|NCT01339689|50117776|FG000|Overall Study|Withdrawal by Subject|3|||
25021380|NCT01339689|50117777|FG001|Overall Study|Withdrawal by Subject|0|||
25021381|NCT01339689|50117776|FG000|Overall Study|Noncompliance|1|||
25021382|NCT01339689|50117777|FG001|Overall Study|Noncompliance|0|||
24916208|NCT00739973|50010281|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
25021383|NCT01339689|50117776|FG000|Overall Study|Relocated out of area|0|||
25021384|NCT01339689|50117777|FG001|Overall Study|Relocated out of area|1|||
25153613|NCT01575873|50268693|FG002|Overall Study|Lost to Follow-up|13|||
25153614|NCT01575873|50268694|FG003|Overall Study|Lost to Follow-up|5|||
25274985|NCT01238861|50589066|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
25153615|NCT01575873|50268691|FG000|Overall Study|Death|3|||
25153616|NCT01575873|50268692|FG001|Overall Study|Death|2|||
24916209|NCT00739973|50010282|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
24916210|NCT00739973|50010283|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
24916211|NCT00739973|50010275|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
24916212|NCT00739973|50010276|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
24916213|NCT00739973|50010277|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
24916214|NCT00739973|50010278|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
25153617|NCT01575873|50268693|FG002|Overall Study|Death|8|||
25153618|NCT01575873|50268694|FG003|Overall Study|Death|9|||
24916215|NCT00739973|50010279|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
24916216|NCT00739973|50010280|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
24916217|NCT00739973|50010281|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
24916218|NCT00739973|50010282|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
24916219|NCT00739973|50010283|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
24916220|NCT00739973|50010275|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
24916221|NCT00739973|50010276|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
24916222|NCT00739973|50010277|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
24916223|NCT00739973|50010278|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
24916224|NCT00739973|50010279|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
24916225|NCT00739973|50010280|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
24916226|NCT00739973|50010281|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
24916227|NCT00739973|50010282|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
24916228|NCT00739973|50010283|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
24916229|NCT00739973|50010275|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
24916230|NCT00739973|50010276|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
24916231|NCT00739973|50010277|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
24916232|NCT00739973|50010278|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
24916233|NCT00739973|50010279|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
24916234|NCT00739973|50010280|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
24916235|NCT00739973|50010281|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
24916236|NCT00739973|50010282|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
24916237|NCT00739973|50010283|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
25153619|NCT01575873|50268691|FG000|Overall Study|Noncompliance|1|||
25153620|NCT01575873|50268692|FG001|Overall Study|Noncompliance|2|||
25153621|NCT01575873|50268693|FG002|Overall Study|Noncompliance|4|||
25153622|NCT01575873|50268694|FG003|Overall Study|Noncompliance|3|||
25153623|NCT01575873|50268691|FG000|Overall Study|Administrative decision|1|||
24916238|NCT00739973|50010275|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
24916239|NCT00739973|50010276|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
25153624|NCT01575873|50268692|FG001|Overall Study|Administrative decision|1|||
25153625|NCT01575873|50268693|FG002|Overall Study|Administrative decision|1|||
25153626|NCT01575873|50268694|FG003|Overall Study|Administrative decision|0|||
25153627|NCT01575873|50268691|FG000|Overall Study|Protocol deviation|0|||
25153628|NCT01575873|50268692|FG001|Overall Study|Protocol deviation|1|||
25153629|NCT01575873|50268693|FG002|Overall Study|Protocol deviation|0|||
24916240|NCT00739973|50010277|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
24916241|NCT00739973|50010278|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
24916242|NCT00739973|50010279|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
25274986|NCT01238861|50589067|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
24916243|NCT00739973|50010280|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
24916244|NCT00739973|50010281|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
24916245|NCT00739973|50010282|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
24916246|NCT00739973|50010283|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
24916247|NCT00739973|50010275|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
24916248|NCT00739973|50010276|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
24916249|NCT00739973|50010277|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
24916250|NCT00739973|50010278|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
24916251|NCT00739973|50010279|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
24916252|NCT00739973|50010280|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
24916253|NCT00739973|50010281|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
24916254|NCT00739973|50010282|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
25153630|NCT01575873|50268694|FG003|Overall Study|Protocol deviation|1|||
25153631|NCT01575873|50268691|FG000|Overall Study|Requirement for Alternative Therapy|0|||
25153632|NCT01575873|50268692|FG001|Overall Study|Requirement for Alternative Therapy|0|||
24916255|NCT00739973|50010283|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
24916256|NCT00739973|50010275|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
24916257|NCT00739973|50010276|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
24916258|NCT00739973|50010277|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
25153633|NCT01575873|50268693|FG002|Overall Study|Requirement for Alternative Therapy|1|||
25153634|NCT01575873|50268694|FG003|Overall Study|Requirement for Alternative Therapy|1|||
25153635|NCT01575873|50268691|FG000|Overall Study|Other|0|||
25153636|NCT01575873|50268692|FG001|Overall Study|Other|0|||
25153637|NCT01575873|50268693|FG002|Overall Study|Other|4|||
25153638|NCT01575873|50268694|FG003|Overall Study|Other|2|||
24916259|NCT00739973|50010278|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
24916260|NCT00739973|50010279|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
24916261|NCT00739973|50010280|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
24916262|NCT00739973|50010281|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
24916263|NCT00739973|50010282|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
24916264|NCT00739973|50010283|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
25153639|NCT01575561|50268702|FG000|Overall Study|Adverse Event|9|||
25153640|NCT01575561|50268702|FG000|Overall Study|Lack of Efficacy|8|||
25153641|NCT01575561|50268702|FG000|Overall Study|Lost to Follow-up|6|||
25153642|NCT01575561|50268702|FG000|Overall Study|Protocol Violation|4|||
25153643|NCT01575561|50268702|FG000|Overall Study|Withdrawal by Subject|11|||
25153644|NCT01575561|50268702|FG000|Overall Study|administration|1|||
25153645|NCT01609790|50268709|FG000|Overall Study|Protocol Violation|1|||
25153646|NCT01609790|50268710|FG001|Overall Study|Protocol Violation|7|||
25153647|NCT01609790|50268711|FG002|Overall Study|Protocol Violation|8|||
25153648|NCT01767116|50268721|FG000|Overall Study|Lost to Follow-up|2|||
25153649|NCT01767116|50268722|FG001|Overall Study|Lost to Follow-up|2|||
25153650|NCT01574703|50268732|FG000|Overall Study|Adverse Event|0|||
25153651|NCT01574703|50268733|FG001|Overall Study|Adverse Event|2|||
25153652|NCT01574703|50268734|FG002|Overall Study|Adverse Event|1|||
25153653|NCT01574703|50268735|FG003|Overall Study|Adverse Event|1|||
25153654|NCT01574703|50268732|FG000|Overall Study|Protocol Violation|0|||
25153655|NCT01574703|50268733|FG001|Overall Study|Protocol Violation|0|||
25153656|NCT01574703|50268734|FG002|Overall Study|Protocol Violation|0|||
25153657|NCT01574703|50268735|FG003|Overall Study|Protocol Violation|1|||
25153658|NCT01574703|50268732|FG000|Overall Study|Unspecified Reason|27|||
25153659|NCT01574703|50268733|FG001|Overall Study|Unspecified Reason|15|||
25153660|NCT01574703|50268734|FG002|Overall Study|Unspecified Reason|20|||
25153661|NCT01574703|50268735|FG003|Overall Study|Unspecified Reason|16|||
25153662|NCT01574703|50268732|FG000|Overall Study|Withdrawal by Subject|53|||
25153663|NCT01574703|50268733|FG001|Overall Study|Withdrawal by Subject|52|||
25153664|NCT01574703|50268734|FG002|Overall Study|Withdrawal by Subject|36|||
25153665|NCT01574703|50268735|FG003|Overall Study|Withdrawal by Subject|61|||
25153666|NCT01574703|50268732|FG000|Overall Study|Met Withdrawal Criteria|0|||
25153667|NCT01574703|50268733|FG001|Overall Study|Met Withdrawal Criteria|1|||
25153668|NCT01574703|50268734|FG002|Overall Study|Met Withdrawal Criteria|1|||
25153669|NCT01574703|50268735|FG003|Overall Study|Met Withdrawal Criteria|0|||
25153670|NCT01574703|50268732|FG000|Overall Study|Lost to Follow-up|43|||
25153671|NCT01574703|50268733|FG001|Overall Study|Lost to Follow-up|41|||
25153672|NCT01574703|50268734|FG002|Overall Study|Lost to Follow-up|46|||
25153673|NCT01574703|50268735|FG003|Overall Study|Lost to Follow-up|35|||
25153674|NCT01574703|50268732|FG000|Overall Study|Death|2|||
25153675|NCT01574703|50268733|FG001|Overall Study|Death|1|||
25153676|NCT01574703|50268734|FG002|Overall Study|Death|1|||
25153677|NCT01574703|50268735|FG003|Overall Study|Death|0|||
25153678|NCT01686633|50268748|FG000|Overall Study|Lack of Efficacy|33|||
25153679|NCT01686633|50268749|FG001|Overall Study|Lack of Efficacy|13|||
25153680|NCT01686633|50268750|FG002|Overall Study|Lack of Efficacy|11|||
25153681|NCT01686633|50268748|FG000|Overall Study|Withdrawal by Subject|8|||
25153682|NCT01686633|50268749|FG001|Overall Study|Withdrawal by Subject|8|||
25153683|NCT01686633|50268750|FG002|Overall Study|Withdrawal by Subject|5|||
25153684|NCT01686633|50268748|FG000|Overall Study|Physician Decision|3|||
25153685|NCT01686633|50268749|FG001|Overall Study|Physician Decision|4|||
25153686|NCT01686633|50268750|FG002|Overall Study|Physician Decision|4|||
25153687|NCT01686633|50268748|FG000|Overall Study|Adverse Event|4|||
25153688|NCT01686633|50268749|FG001|Overall Study|Adverse Event|3|||
25153689|NCT01686633|50268750|FG002|Overall Study|Adverse Event|3|||
25153690|NCT01686633|50268748|FG000|Overall Study|Protocol Violation|2|||
25153691|NCT01686633|50268749|FG001|Overall Study|Protocol Violation|3|||
25153692|NCT01686633|50268750|FG002|Overall Study|Protocol Violation|0|||
25153693|NCT01686633|50268748|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
25153694|NCT01686633|50268749|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
25153695|NCT01686633|50268750|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
25153696|NCT01686633|50268748|FG000|Overall Study|Lost to Follow-up|0|||
25153697|NCT01686633|50268749|FG001|Overall Study|Lost to Follow-up|1|||
25153698|NCT01686633|50268750|FG002|Overall Study|Lost to Follow-up|1|||
25153699|NCT02511106|50268760|FG000|Overall Study|Lost to Follow-up|1|||
25153700|NCT02511106|50268761|FG001|Overall Study|Lost to Follow-up|2|||
25153701|NCT02511106|50268760|FG000|Overall Study|Withdrawal by Subject|19|||
25153702|NCT02511106|50268761|FG001|Overall Study|Withdrawal by Subject|14|||
25153703|NCT02511106|50268760|FG000|Overall Study|Ongoing study at data cut-off|309|||
25021385|NCT01339689|50117776|FG000|Overall Study|Other|2|||
25153704|NCT02511106|50268761|FG001|Overall Study|Ongoing study at data cut-off|307|||
25153705|NCT02511106|50268760|FG000|Overall Study|Without specified reason|1|||
25153706|NCT02511106|50268761|FG001|Overall Study|Without specified reason|0|||
25153707|NCT02511106|50268760|FG000|Overall Study|Missing|1|||
25153708|NCT02511106|50268761|FG001|Overall Study|Missing|0|||
25153709|NCT01685697|50268771|FG000|Overall Study|Protocol Violation|3|||
25153710|NCT01685697|50268772|FG001|Overall Study|Protocol Violation|3|||
25153711|NCT02395120|50268783|FG000|Overall Study|Missed follow-up dental exam|57|||
25021386|NCT01339689|50117777|FG001|Overall Study|Other|2|||
25021387|NCT01339689|50117776|FG000|Overall Study|multiple reasons|1|||
25021388|NCT01339689|50117777|FG001|Overall Study|multiple reasons|1|||
25153712|NCT02395120|50268784|FG001|Overall Study|Missed follow-up dental exam|62|||
25153713|NCT02395120|50268785|FG002|Overall Study|Missed follow-up dental exam|6|||
25153714|NCT02395120|50268786|FG003|Overall Study|Missed follow-up dental exam|6|||
25153715|NCT02395120|50268787|FG004|Overall Study|Missed follow-up dental exam|51|||
25153716|NCT01685229|50268801|FG000|Overall Study|Subjects missing Study Exit form|3|||
25153717|NCT01685229|50268802|FG001|Overall Study|Subjects missing Study Exit form|1|||
25153718|NCT01685229|50268801|FG000|Overall Study|Lost to Follow-up|16|||
25153719|NCT01685229|50268802|FG001|Overall Study|Lost to Follow-up|10|||
25153720|NCT01685229|50268801|FG000|Overall Study|Withdrawal by Subject|6|||
25153721|NCT01685229|50268802|FG001|Overall Study|Withdrawal by Subject|5|||
25153722|NCT01685229|50268801|FG000|Overall Study|Death|1|||
25021389|NCT03038126|50117785|FG000|Overall Study|Death|1|||
25021390|NCT03038126|50117786|FG001|Overall Study|Death|1|||
25021391|NCT03038126|50117785|FG000|Overall Study|Withdrawal by Subject|5|||
25021392|NCT03038126|50117786|FG001|Overall Study|Withdrawal by Subject|0|||
25021393|NCT03038126|50117785|FG000|Overall Study|Lost to Follow-up|0|||
25021394|NCT03038126|50117786|FG001|Overall Study|Lost to Follow-up|1|||
25021395|NCT03038126|50117785|FG000|Overall Study|Long Term Hospitalization|2|||
25021396|NCT03038126|50117786|FG001|Overall Study|Long Term Hospitalization|0|||
25021397|NCT03038126|50117785|FG000|Overall Study|Too Ill to Participate|1|||
25021398|NCT03038126|50117786|FG001|Overall Study|Too Ill to Participate|2|||
25021399|NCT00696878|50117804|FG000|Overall Study|Adverse Event|8|||
25021400|NCT00696878|50117804|FG000|Overall Study|Withdrawal by Subject|87|||
25021401|NCT00696878|50117804|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
25021402|NCT00696878|50117804|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
25021403|NCT00696878|50117804|FG000|Overall Study|Trial stopped|32|||
25021404|NCT00696878|50117804|FG000|Overall Study|Other reason (not specified)|55|||
25021405|NCT00696800|50117810|FG000|Overall Study|Adverse Event|16|||
25021406|NCT00696800|50117811|FG001|Overall Study|Adverse Event|3|||
25021407|NCT00696800|50117810|FG000|Overall Study|Insufficient compliance with medication|2|||
25021408|NCT00696800|50117811|FG001|Overall Study|Insufficient compliance with medication|1|||
25021409|NCT00696800|50117810|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
25153723|NCT01685229|50268802|FG001|Overall Study|Death|0|||
25153724|NCT01551693|50268813|FG000|Overall Study|Disease Progression|1|||
25153725|NCT01551693|50268814|FG001|Overall Study|Disease Progression|0|||
25153726|NCT01551693|50268813|FG000|Overall Study|Adverse Event|0|||
25153727|NCT01551693|50268814|FG001|Overall Study|Adverse Event|1|||
25021410|NCT00696800|50117811|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
25021411|NCT00696800|50117810|FG000|Overall Study|Insufficient ovarian response|4|||
25021412|NCT00696800|50117811|FG001|Overall Study|Insufficient ovarian response|1|||
25021413|NCT00696800|50117810|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
25021414|NCT00696800|50117811|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
24916265|NCT00739973|50010275|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
24916266|NCT00739973|50010276|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
24916267|NCT00739973|50010277|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
24916268|NCT00739973|50010278|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
24916269|NCT00739973|50010279|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
24916270|NCT00739973|50010280|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
24916271|NCT00739973|50010281|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
24916272|NCT00739973|50010282|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
24916273|NCT00739973|50010283|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
24916274|NCT00510874|50010318|FG000|Overall Study|Withdrawal by Subject|1|||
24916275|NCT00510874|50010319|FG001|Overall Study|Withdrawal by Subject|1|||
24916276|NCT00510874|50010320|FG002|Overall Study|Withdrawal by Subject|0|||
24916277|NCT00510874|50010321|FG003|Overall Study|Withdrawal by Subject|0|||
24916278|NCT00510874|50010322|FG004|Overall Study|Withdrawal by Subject|3|||
24916279|NCT00510874|50010323|FG005|Overall Study|Withdrawal by Subject|0|||
24916280|NCT00510874|50010324|FG006|Overall Study|Withdrawal by Subject|0|||
24916281|NCT00510874|50010318|FG000|Overall Study|Lost to Follow-up|2|||
24916282|NCT00510874|50010319|FG001|Overall Study|Lost to Follow-up|3|||
24916283|NCT00510874|50010320|FG002|Overall Study|Lost to Follow-up|1|||
24916284|NCT00510874|50010321|FG003|Overall Study|Lost to Follow-up|3|||
24916285|NCT00510874|50010322|FG004|Overall Study|Lost to Follow-up|4|||
24916286|NCT00510874|50010323|FG005|Overall Study|Lost to Follow-up|0|||
24916287|NCT00510874|50010324|FG006|Overall Study|Lost to Follow-up|1|||
24916288|NCT00739661|50010343|FG000|Overall Study|Adverse Event|2|||
24916289|NCT00739661|50010344|FG001|Overall Study|Adverse Event|0|||
24916290|NCT00739661|50010343|FG000|Overall Study|Physician decision to withdraw patient|1|||
24916291|NCT00739661|50010344|FG001|Overall Study|Physician decision to withdraw patient|0|||
24916292|NCT00739661|50010343|FG000|Overall Study|Patient decision to withdraw|9|||
24916293|NCT00739661|50010344|FG001|Overall Study|Patient decision to withdraw|4|||
24916294|NCT00739661|50010343|FG000|Overall Study|Disease progression, radiographic|33|||
24916295|NCT00739661|50010344|FG001|Overall Study|Disease progression, radiographic|37|||
24916296|NCT00739661|50010343|FG000|Overall Study|Reason for discontinuation not available|1|||
24916297|NCT00739661|50010344|FG001|Overall Study|Reason for discontinuation not available|1|||
24916298|NCT00615030|50010350|FG000|Period I|Administrative problem|0|||
24916299|NCT00615030|50010351|FG001|Period I|Administrative problem|0|||
24916300|NCT00615030|50010352|FG002|Period I|Administrative problem|0|||
24916301|NCT00615030|50010353|FG003|Period I|Administrative problem|0|||
24916302|NCT00615030|50010354|FG004|Period I|Administrative problem|1|||
24916303|NCT00615030|50010355|FG005|Period I|Administrative problem|0|||
24916304|NCT00615030|50010356|FG006|Period I|Administrative problem|0|||
24916305|NCT00615030|50010357|FG007|Period I|Administrative problem|0|||
24916306|NCT00615030|50010358|FG008|Period I|Administrative problem|0|||
24916307|NCT00615030|50010359|FG009|Period I|Administrative problem|0|||
24916308|NCT00615030|50010360|FG010|Period I|Administrative problem|0|||
24916309|NCT00615030|50010361|FG011|Period I|Administrative problem|0|||
24916310|NCT00615030|50010350|FG000|Period I|Protocol deviation|1|||
24916311|NCT00615030|50010351|FG001|Period I|Protocol deviation|0|||
24916312|NCT00615030|50010352|FG002|Period I|Protocol deviation|0|||
24916313|NCT00615030|50010353|FG003|Period I|Protocol deviation|0|||
24916314|NCT00615030|50010354|FG004|Period I|Protocol deviation|0|||
24916315|NCT00615030|50010355|FG005|Period I|Protocol deviation|0|||
24916316|NCT00615030|50010356|FG006|Period I|Protocol deviation|0|||
24916317|NCT00615030|50010357|FG007|Period I|Protocol deviation|0|||
24916318|NCT00615030|50010358|FG008|Period I|Protocol deviation|0|||
24916319|NCT00615030|50010359|FG009|Period I|Protocol deviation|0|||
24916320|NCT00615030|50010360|FG010|Period I|Protocol deviation|0|||
24916321|NCT00615030|50010361|FG011|Period I|Protocol deviation|0|||
24916322|NCT00615030|50010350|FG000|Period I|Subject withdrew consent|0|||
25021415|NCT00696800|50117810|FG000|Overall Study|Too high ovarian response|6|||
25153728|NCT01551693|50268813|FG000|Overall Study|Withdrawal by Subject|0|||
24916323|NCT00615030|50010351|FG001|Period I|Subject withdrew consent|0|||
24916324|NCT00615030|50010352|FG002|Period I|Subject withdrew consent|0|||
24916325|NCT00615030|50010353|FG003|Period I|Subject withdrew consent|0|||
24916326|NCT00615030|50010354|FG004|Period I|Subject withdrew consent|0|||
24916327|NCT00615030|50010355|FG005|Period I|Subject withdrew consent|0|||
24916328|NCT00615030|50010356|FG006|Period I|Subject withdrew consent|0|||
24916329|NCT00615030|50010357|FG007|Period I|Subject withdrew consent|0|||
24916330|NCT00615030|50010358|FG008|Period I|Subject withdrew consent|1|||
24916331|NCT00615030|50010359|FG009|Period I|Subject withdrew consent|0|||
24916332|NCT00615030|50010360|FG010|Period I|Subject withdrew consent|1|||
24916333|NCT00615030|50010361|FG011|Period I|Subject withdrew consent|1|||
25021416|NCT00696800|50117811|FG001|Overall Study|Too high ovarian response|1|||
25021417|NCT00696800|50117810|FG000|Overall Study|No/too few/bad quality oocytes|4|||
25021418|NCT00696800|50117811|FG001|Overall Study|No/too few/bad quality oocytes|3|||
25021419|NCT00696800|50117810|FG000|Overall Study|No/abnormal fertilization|11|||
25021420|NCT00696800|50117811|FG001|Overall Study|No/abnormal fertilization|13|||
25021421|NCT00696800|50117810|FG000|Overall Study|No/too few/bad quality embryos|24|||
24916334|NCT00615030|50010350|FG000|Period I|Abnormal laboratory value(s)|0|||
24916335|NCT00615030|50010351|FG001|Period I|Abnormal laboratory value(s)|0|||
24916336|NCT00615030|50010352|FG002|Period I|Abnormal laboratory value(s)|0|||
24916337|NCT00615030|50010353|FG003|Period I|Abnormal laboratory value(s)|0|||
24916338|NCT00615030|50010354|FG004|Period I|Abnormal laboratory value(s)|0|||
24916339|NCT00615030|50010355|FG005|Period I|Abnormal laboratory value(s)|1|||
24916340|NCT00615030|50010356|FG006|Period I|Abnormal laboratory value(s)|0|||
24916341|NCT00615030|50010357|FG007|Period I|Abnormal laboratory value(s)|0|||
24916342|NCT00615030|50010358|FG008|Period I|Abnormal laboratory value(s)|0|||
24916343|NCT00615030|50010359|FG009|Period I|Abnormal laboratory value(s)|0|||
24916344|NCT00615030|50010360|FG010|Period I|Abnormal laboratory value(s)|0|||
24916345|NCT00615030|50010361|FG011|Period I|Abnormal laboratory value(s)|0|||
25021422|NCT00696800|50117811|FG001|Overall Study|No/too few/bad quality embryos|18|||
25021423|NCT00696800|50117810|FG000|Overall Study|Other Reasons|5|||
25021424|NCT00696800|50117811|FG001|Overall Study|Other Reasons|3|||
24916346|NCT00615030|50010350|FG000|Period II|Adverse Event|0|||
24916347|NCT00615030|50010351|FG001|Period II|Adverse Event|0|||
24916348|NCT00615030|50010352|FG002|Period II|Adverse Event|1|||
24916349|NCT00615030|50010353|FG003|Period II|Adverse Event|0|||
24916350|NCT00615030|50010354|FG004|Period II|Adverse Event|0|||
24916351|NCT00615030|50010355|FG005|Period II|Adverse Event|0|||
24916352|NCT00615030|50010356|FG006|Period II|Adverse Event|0|||
24916353|NCT00615030|50010357|FG007|Period II|Adverse Event|0|||
24916354|NCT00615030|50010358|FG008|Period II|Adverse Event|1|||
24916355|NCT00615030|50010359|FG009|Period II|Adverse Event|0|||
24916356|NCT00615030|50010360|FG010|Period II|Adverse Event|0|||
24916357|NCT00615030|50010361|FG011|Period II|Adverse Event|0|||
24916358|NCT00615030|50010350|FG000|Period II|Subject withdrew consent|0|||
24916359|NCT00615030|50010351|FG001|Period II|Subject withdrew consent|0|||
24916360|NCT00615030|50010352|FG002|Period II|Subject withdrew consent|0|||
24916361|NCT00615030|50010353|FG003|Period II|Subject withdrew consent|1|||
24916362|NCT00615030|50010354|FG004|Period II|Subject withdrew consent|0|||
24916363|NCT00615030|50010355|FG005|Period II|Subject withdrew consent|0|||
24916364|NCT00615030|50010356|FG006|Period II|Subject withdrew consent|1|||
24916365|NCT00615030|50010357|FG007|Period II|Subject withdrew consent|0|||
24916366|NCT00615030|50010358|FG008|Period II|Subject withdrew consent|0|||
24916367|NCT00615030|50010359|FG009|Period II|Subject withdrew consent|0|||
24916368|NCT00615030|50010360|FG010|Period II|Subject withdrew consent|0|||
24916369|NCT00615030|50010361|FG011|Period II|Subject withdrew consent|0|||
24916370|NCT00615030|50010350|FG000|Period III|Administrative problems|1|||
24916371|NCT00615030|50010351|FG001|Period III|Administrative problems|0|||
24916372|NCT00615030|50010352|FG002|Period III|Administrative problems|0|||
24916373|NCT00615030|50010353|FG003|Period III|Administrative problems|1|||
24916374|NCT00615030|50010354|FG004|Period III|Administrative problems|0|||
24916375|NCT00615030|50010355|FG005|Period III|Administrative problems|0|||
24916376|NCT00615030|50010356|FG006|Period III|Administrative problems|0|||
24916377|NCT00615030|50010357|FG007|Period III|Administrative problems|0|||
24916378|NCT00615030|50010358|FG008|Period III|Administrative problems|0|||
24916379|NCT00615030|50010359|FG009|Period III|Administrative problems|0|||
24916380|NCT00615030|50010360|FG010|Period III|Administrative problems|0|||
24916381|NCT00615030|50010361|FG011|Period III|Administrative problems|0|||
24916382|NCT00518284|50010379|FG000|Overall Study|Adverse Event|0|||
24916383|NCT00518284|50010380|FG001|Overall Study|Adverse Event|1|||
24916384|NCT00518284|50010381|FG002|Overall Study|Adverse Event|0|||
24916385|NCT00518284|50010382|FG003|Overall Study|Adverse Event|0|||
24916386|NCT00518284|50010379|FG000|Overall Study|Study Termination|0|||
24916387|NCT00518284|50010380|FG001|Overall Study|Study Termination|2|||
24916388|NCT00518284|50010381|FG002|Overall Study|Study Termination|1|||
25021425|NCT00696800|50117810|FG000|Overall Study|Not treated|1|||
24916389|NCT00518284|50010382|FG003|Overall Study|Study Termination|2|||
24916390|NCT00614874|50010392|FG000|Overall Study|Protocol Violation|1|||
24916391|NCT00614874|50010392|FG000|Overall Study|Withdrawal by Subject|1|||
24916392|NCT00727415|50010396|FG000|Phase I|Dose Limiting Toxicity|2|||
24916393|NCT00544557|50010400|FG000|Overall Study|Adverse Event|140|||
24916394|NCT00544557|50010400|FG000|Overall Study|Lack of Efficacy|196|||
24916395|NCT00544557|50010400|FG000|Overall Study|Other|98|||
25021426|NCT00696800|50117811|FG001|Overall Study|Not treated|2|||
24916396|NCT00727259|50010404|FG000|Overall Study|Not all questionnaires completed|1055|||
24916397|NCT00735371|50010413|FG000|Overall Study|Adverse Event|3|||
24916398|NCT00735371|50010414|FG001|Overall Study|Adverse Event|3|||
24916399|NCT00735371|50010415|FG002|Overall Study|Adverse Event|4|||
24916400|NCT00735371|50010416|FG003|Overall Study|Adverse Event|1|||
24916401|NCT00735371|50010413|FG000|Overall Study|Protocol Violation|2|||
24916402|NCT00735371|50010414|FG001|Overall Study|Protocol Violation|2|||
24916403|NCT00735371|50010415|FG002|Overall Study|Protocol Violation|0|||
24916404|NCT00735371|50010416|FG003|Overall Study|Protocol Violation|3|||
24916405|NCT00735371|50010413|FG000|Overall Study|Withdrawal by Subject|0|||
24916406|NCT00735371|50010414|FG001|Overall Study|Withdrawal by Subject|2|||
24916407|NCT00735371|50010415|FG002|Overall Study|Withdrawal by Subject|2|||
24916408|NCT00735371|50010416|FG003|Overall Study|Withdrawal by Subject|0|||
24916409|NCT00735371|50010413|FG000|Overall Study|Lost to Follow-up|1|||
24916410|NCT00735371|50010414|FG001|Overall Study|Lost to Follow-up|1|||
24916411|NCT00735371|50010415|FG002|Overall Study|Lost to Follow-up|3|||
24916412|NCT00735371|50010416|FG003|Overall Study|Lost to Follow-up|1|||
24916413|NCT00735371|50010413|FG000|Overall Study|Lack of Efficacy|4|||
24916414|NCT00735371|50010414|FG001|Overall Study|Lack of Efficacy|2|||
24916415|NCT00735371|50010415|FG002|Overall Study|Lack of Efficacy|0|||
24916416|NCT00735371|50010416|FG003|Overall Study|Lack of Efficacy|4|||
24916417|NCT00735371|50010413|FG000|Overall Study|Sponsor Decision|3|||
24916418|NCT00735371|50010414|FG001|Overall Study|Sponsor Decision|1|||
24916419|NCT00735371|50010415|FG002|Overall Study|Sponsor Decision|0|||
24916420|NCT00735371|50010416|FG003|Overall Study|Sponsor Decision|1|||
24916421|NCT00735371|50010413|FG000|Overall Study|Protocol Violation|0|||
24916422|NCT00735371|50010414|FG001|Overall Study|Protocol Violation|1|||
25021427|NCT00289874|50117819|FG000|Overall Study|Adverse Event|1|||
25021428|NCT00289874|50117820|FG001|Overall Study|Adverse Event|5|||
25021429|NCT00289874|50117819|FG000|Overall Study|Lost to Follow-up|1|||
25021430|NCT00289874|50117820|FG001|Overall Study|Lost to Follow-up|1|||
25021431|NCT00289874|50117819|FG000|Overall Study|Protocol Violation|3|||
25021432|NCT00289874|50117820|FG001|Overall Study|Protocol Violation|2|||
25021433|NCT00289874|50117819|FG000|Overall Study|Did not meet eligibility|1|||
25021434|NCT00289874|50117820|FG001|Overall Study|Did not meet eligibility|0|||
25021435|NCT00245570|50117826|FG000|Washout Between Periods III and IV|Adverse Event|0|||
25021436|NCT00245570|50117827|FG001|Washout Between Periods III and IV|Adverse Event|1|||
25021437|NCT00245570|50117828|FG002|Washout Between Periods III and IV|Adverse Event|0|||
25021438|NCT00245570|50117829|FG003|Washout Between Periods III and IV|Adverse Event|0|||
24916423|NCT00735371|50010415|FG002|Overall Study|Protocol Violation|2|||
24916424|NCT00735371|50010416|FG003|Overall Study|Protocol Violation|0|||
25021439|NCT00245570|50117830|FG004|Washout Between Periods III and IV|Adverse Event|0|||
25021440|NCT00245570|50117831|FG005|Washout Between Periods III and IV|Adverse Event|0|||
24916425|NCT00735371|50010413|FG000|Overall Study|Prior Vyvanse Exposure|1|||
24916426|NCT00735371|50010414|FG001|Overall Study|Prior Vyvanse Exposure|1|||
24916427|NCT00735371|50010415|FG002|Overall Study|Prior Vyvanse Exposure|0|||
24916428|NCT00735371|50010416|FG003|Overall Study|Prior Vyvanse Exposure|0|||
24916429|NCT00735371|50010413|FG000|Overall Study|Exclusion criteria|1|||
24916430|NCT00735371|50010414|FG001|Overall Study|Exclusion criteria|0|||
24916431|NCT00735371|50010415|FG002|Overall Study|Exclusion criteria|0|||
24916432|NCT00735371|50010416|FG003|Overall Study|Exclusion criteria|0|||
24916433|NCT00518206|50010428|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
24916434|NCT00518206|50010429|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
24916435|NCT00518206|50010428|FG000|Overall Study|Withdrawal by Subject|2|||
24916436|NCT00518206|50010429|FG001|Overall Study|Withdrawal by Subject|0|||
24916437|NCT00518206|50010428|FG000|Overall Study|Drug Supply Issue|1|||
24916438|NCT00518206|50010429|FG001|Overall Study|Drug Supply Issue|0|||
24916439|NCT00518206|50010428|FG000|Overall Study|Reason Unknown|1|||
24916440|NCT00518206|50010429|FG001|Overall Study|Reason Unknown|0|||
24916441|NCT00518206|50010428|FG000|Overall Study|Completion Status Unknown|1|||
24916442|NCT00518206|50010429|FG001|Overall Study|Completion Status Unknown|0|||
24916443|NCT00586313|50010435|FG000|Overall Study|Lack of Efficacy|2|||
24916444|NCT00727025|50010439|FG000|Overall Study|Physician Decision|23|||
24916445|NCT00734747|50010447|FG000|SRS Procedure|No staples placed|3|||
24916446|NCT00734747|50010447|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
24916447|NCT00726557|50010451|FG000|Overall Study|Screening failure|4|||
24916448|NCT00726557|50010451|FG000|Overall Study|No end of treatment documentation|37|||
24916449|NCT00726557|50010451|FG000|Overall Study|No follow-up documentation available|55|||
24916450|NCT00726557|50010451|FG000|Overall Study|Treatment less than 3 months|17|||
24916451|NCT00726557|50010451|FG000|Overall Study|Inclusion criteria not met|15|||
24916452|NCT00738881|50010458|FG000|Overall Study|Withdrawal by Subject|0|||
24916453|NCT00738881|50010459|FG001|Overall Study|Withdrawal by Subject|2|||
24916454|NCT00657020|50010465|FG000|PERIOD 1|Adverse Event|0|||
25021441|NCT03512210|50117859|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
25021442|NCT03512210|50117859|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
24916455|NCT00657020|50010466|FG001|PERIOD 1|Adverse Event|1|||
24916456|NCT03921723|50010478|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
24916457|NCT03921723|50010478|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
25021443|NCT03512210|50117859|FG000|Step 2:Post-MINMON|Death|2|||
24916458|NCT00544167|50010486|FG000|Overall Study|Adverse Event|21|||
24916459|NCT00544167|50010486|FG000|Overall Study|Physician Decision|8|||
24916460|NCT00659438|50010492|FG000|Overall Study|Withdrawal by Subject|2|||
24916461|NCT00659438|50010493|FG001|Overall Study|Withdrawal by Subject|2|||
24916462|NCT00659438|50010492|FG000|Overall Study|Death|11|||
24916463|NCT00659438|50010493|FG001|Overall Study|Death|6|||
24916464|NCT00659438|50010492|FG000|Overall Study|Lost to Follow-up|1|||
24916465|NCT00659438|50010493|FG001|Overall Study|Lost to Follow-up|0|||
24916466|NCT00543855|50010503|FG000|Overall Study|Adverse Event|3|||
24916467|NCT00543855|50010504|FG001|Overall Study|Adverse Event|1|||
24916468|NCT00543855|50010505|FG002|Overall Study|Adverse Event|3|||
24916469|NCT00543855|50010506|FG003|Overall Study|Adverse Event|4|||
24916470|NCT00543855|50010503|FG000|Overall Study|Lost to Follow-up|0|||
24916471|NCT00543855|50010504|FG001|Overall Study|Lost to Follow-up|0|||
24916472|NCT00543855|50010505|FG002|Overall Study|Lost to Follow-up|1|||
24916473|NCT00543855|50010506|FG003|Overall Study|Lost to Follow-up|0|||
24916474|NCT00543855|50010503|FG000|Overall Study|Withdrawal by Subject|0|||
24916475|NCT00543855|50010504|FG001|Overall Study|Withdrawal by Subject|1|||
24916476|NCT00543855|50010505|FG002|Overall Study|Withdrawal by Subject|2|||
24916477|NCT00543855|50010506|FG003|Overall Study|Withdrawal by Subject|0|||
24916478|NCT00543855|50010503|FG000|Overall Study|Protocol Violation|1|||
24916479|NCT00543855|50010504|FG001|Overall Study|Protocol Violation|0|||
24916480|NCT00543855|50010505|FG002|Overall Study|Protocol Violation|0|||
24916481|NCT00543855|50010506|FG003|Overall Study|Protocol Violation|0|||
24916482|NCT00656474|50010516|FG000|Overall Study|Other Reason|1|||
24916483|NCT00656084|50010521|FG000|Overall Study|Adverse Event|4|||
24916484|NCT00656084|50010521|FG000|Overall Study|Withdrawal by Subject|1|||
24916485|NCT00656084|50010521|FG000|Overall Study|Patient Request|1|||
24916486|NCT00656084|50010521|FG000|Overall Study|Investigator Request|1|||
24916487|NCT00613938|50010529|FG000|Overall Study|Withdrawal by Subject|2|||
24916488|NCT00613938|50010530|FG001|Overall Study|Withdrawal by Subject|4|||
24916489|NCT00613938|50010531|FG002|Overall Study|Withdrawal by Subject|9|||
24916490|NCT00613938|50010532|FG003|Overall Study|Withdrawal by Subject|9|||
24916491|NCT00613938|50010529|FG000|Overall Study|Adverse Event|1|||
24916492|NCT00613938|50010530|FG001|Overall Study|Adverse Event|4|||
24916493|NCT00613938|50010531|FG002|Overall Study|Adverse Event|8|||
24916494|NCT00613938|50010532|FG003|Overall Study|Adverse Event|5|||
24916495|NCT00613938|50010529|FG000|Overall Study|Lack of Efficacy|16|||
24916496|NCT00613938|50010530|FG001|Overall Study|Lack of Efficacy|18|||
24916497|NCT00613938|50010531|FG002|Overall Study|Lack of Efficacy|5|||
24916498|NCT00613938|50010532|FG003|Overall Study|Lack of Efficacy|9|||
24916499|NCT00613938|50010529|FG000|Overall Study|Other|1|||
24916500|NCT00613938|50010530|FG001|Overall Study|Other|2|||
24916501|NCT00613938|50010531|FG002|Overall Study|Other|1|||
24916502|NCT00613938|50010532|FG003|Overall Study|Other|3|||
24916503|NCT00655928|50010544|FG000|Overall Study|Withdrawal by Subject|2|||
24916504|NCT00655928|50010545|FG001|Overall Study|Withdrawal by Subject|1|||
24916505|NCT00655928|50010544|FG000|Overall Study|Physician Decision|1|||
24916506|NCT00655928|50010545|FG001|Overall Study|Physician Decision|1|||
24916507|NCT00655850|50010551|FG000|Overall Study|Death|2|||
24916508|NCT00655850|50010551|FG000|Overall Study|Withdrawal by Subject|1|||
24916509|NCT00726323|50010559|FG000|Overall Study|Withdrawal by Subject|3|||
24916510|NCT00726323|50010560|FG001|Overall Study|Withdrawal by Subject|1|||
24916511|NCT00726323|50010559|FG000|Overall Study|Physician Decision|1|||
24916512|NCT00726323|50010560|FG001|Overall Study|Physician Decision|0|||
24916513|NCT00726323|50010559|FG000|Overall Study|Progressive disease|23|||
24916514|NCT00726323|50010560|FG001|Overall Study|Progressive disease|16|||
24916515|NCT00726323|50010559|FG000|Overall Study|Clinical progression|0|||
24916516|NCT00726323|50010560|FG001|Overall Study|Clinical progression|3|||
24916517|NCT00726323|50010559|FG000|Overall Study|Adverse Event|9|||
24916518|NCT00726323|50010560|FG001|Overall Study|Adverse Event|9|||
24916519|NCT00726323|50010559|FG000|Overall Study|Death|1|||
24916520|NCT00726323|50010560|FG001|Overall Study|Death|0|||
24916521|NCT00726323|50010559|FG000|Overall Study|Participant wished to discontinue|0|||
24916522|NCT00726323|50010560|FG001|Overall Study|Participant wished to discontinue|1|||
24916523|NCT00726323|50010559|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
25274987|NCT01238861|50589068|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
24916524|NCT00726323|50010560|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
25274988|NCT01238861|50589069|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
24916525|NCT00246571|50010568|FG000|Overall Study|Adverse Event|7|||
24916526|NCT00246571|50010569|FG001|Overall Study|Adverse Event|0|||
24916527|NCT00246571|50010568|FG000|Overall Study|Protocol Violation|0|||
24916528|NCT00246571|50010569|FG001|Overall Study|Protocol Violation|1|||
24916529|NCT00246571|50010568|FG000|Overall Study|Withdrawal by Subject|2|||
24916530|NCT00246571|50010569|FG001|Overall Study|Withdrawal by Subject|3|||
24916531|NCT00246571|50010568|FG000|Overall Study|Lack of Efficacy|84|||
24916532|NCT00246571|50010569|FG001|Overall Study|Lack of Efficacy|21|||
24916533|NCT00246571|50010568|FG000|Overall Study|Death|17|||
24916534|NCT00246571|50010569|FG001|Overall Study|Death|3|||
24916535|NCT00246571|50010568|FG000|Overall Study|Sponsor|0|||
24916536|NCT00246571|50010569|FG001|Overall Study|Sponsor|1|||
24916537|NCT00246571|50010568|FG000|Overall Study|Did not meet entrance criteria|2|||
24916538|NCT00246571|50010569|FG001|Overall Study|Did not meet entrance criteria|1|||
24916539|NCT00246571|50010568|FG000|Overall Study|Laboratory abnormalities|1|||
24916540|NCT00246571|50010569|FG001|Overall Study|Laboratory abnormalities|0|||
24916541|NCT00246571|50010568|FG000|Overall Study|Crossover participants|0|||
24916542|NCT00246571|50010569|FG001|Overall Study|Crossover participants|74|||
24916543|NCT00734591|50010577|FG000|Screening for Prospective Period|Site did not participate|1604|||
24916544|NCT00734591|50010578|FG001|Screening for Prospective Period|Site did not participate|1488|||
24916545|NCT00734591|50010577|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
24916546|NCT00734591|50010578|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
24916547|NCT00734591|50010577|FG000|Prospective Period|Withdrawal by Subject|11|||
24916548|NCT00734591|50010578|FG001|Prospective Period|Withdrawal by Subject|9|||
24916549|NCT00734591|50010577|FG000|Prospective Period|Lost to Follow-up|37|||
24916550|NCT00734591|50010578|FG001|Prospective Period|Lost to Follow-up|33|||
24916551|NCT00734591|50010577|FG000|Prospective Period|Study Terminated|1|||
24916552|NCT00734591|50010578|FG001|Prospective Period|Study Terminated|0|||
24916553|NCT00734591|50010577|FG000|Prospective Period|Other|2|||
24916554|NCT00734591|50010578|FG001|Prospective Period|Other|2|||
24916555|NCT00569270|50010584|FG000|Period: First Intervention|Protocol Violation|0|||
24916556|NCT00569270|50010585|FG001|Period: First Intervention|Protocol Violation|1|||
24916557|NCT00545103|50010604|FG000|Overall Study|Lack of Efficacy|48|||
24916558|NCT00545103|50010605|FG001|Overall Study|Lack of Efficacy|45|||
24916559|NCT00545103|50010606|FG002|Overall Study|Lack of Efficacy|31|||
24916560|NCT00545103|50010607|FG003|Overall Study|Lack of Efficacy|27|||
24916561|NCT00545103|50010604|FG000|Overall Study|Withdrawal by Subject|6|||
24916562|NCT00545103|50010605|FG001|Overall Study|Withdrawal by Subject|10|||
24916563|NCT00545103|50010606|FG002|Overall Study|Withdrawal by Subject|18|||
24916564|NCT00545103|50010607|FG003|Overall Study|Withdrawal by Subject|22|||
24916565|NCT00545103|50010604|FG000|Overall Study|Adverse Event|11|||
24916566|NCT00545103|50010605|FG001|Overall Study|Adverse Event|12|||
24916567|NCT00545103|50010606|FG002|Overall Study|Adverse Event|17|||
24916568|NCT00545103|50010607|FG003|Overall Study|Adverse Event|10|||
24916569|NCT00545103|50010604|FG000|Overall Study|Lost to Follow-up|4|||
24916570|NCT00545103|50010605|FG001|Overall Study|Lost to Follow-up|6|||
24916571|NCT00545103|50010606|FG002|Overall Study|Lost to Follow-up|3|||
24916572|NCT00545103|50010607|FG003|Overall Study|Lost to Follow-up|4|||
24916573|NCT00545103|50010604|FG000|Overall Study|Protocol Violation|1|||
24916574|NCT00545103|50010605|FG001|Overall Study|Protocol Violation|2|||
24916575|NCT00545103|50010606|FG002|Overall Study|Protocol Violation|3|||
24916576|NCT00545103|50010607|FG003|Overall Study|Protocol Violation|0|||
24916577|NCT00545103|50010604|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
24916578|NCT00545103|50010605|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
24916579|NCT00545103|50010606|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
24916580|NCT00545103|50010607|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
24916581|NCT00545103|50010604|FG000|Overall Study|Difficult to open package|0|||
24916582|NCT00545103|50010605|FG001|Overall Study|Difficult to open package|0|||
24916583|NCT00545103|50010606|FG002|Overall Study|Difficult to open package|0|||
24916584|NCT00545103|50010607|FG003|Overall Study|Difficult to open package|1|||
24916585|NCT00545103|50010604|FG000|Overall Study|Investigational product not taken|1|||
24916586|NCT00545103|50010605|FG001|Overall Study|Investigational product not taken|0|||
24916587|NCT00545103|50010606|FG002|Overall Study|Investigational product not taken|0|||
24916588|NCT00545103|50010607|FG003|Overall Study|Investigational product not taken|1|||
24916589|NCT00545103|50010604|FG000|Overall Study|Wish to start a family|0|||
24916590|NCT00545103|50010605|FG001|Overall Study|Wish to start a family|0|||
24916591|NCT00545103|50010606|FG002|Overall Study|Wish to start a family|0|||
24916592|NCT00545103|50010607|FG003|Overall Study|Wish to start a family|1|||
24916593|NCT00545103|50010604|FG000|Overall Study|Diverticulitis crisis|0|||
24916594|NCT00545103|50010605|FG001|Overall Study|Diverticulitis crisis|0|||
24916595|NCT00545103|50010606|FG002|Overall Study|Diverticulitis crisis|0|||
24916596|NCT00545103|50010607|FG003|Overall Study|Diverticulitis crisis|1|||
24916597|NCT00545103|50010604|FG000|Overall Study|Personal reasons|1|||
24916598|NCT00545103|50010605|FG001|Overall Study|Personal reasons|0|||
24916599|NCT00545103|50010606|FG002|Overall Study|Personal reasons|0|||
24916600|NCT00545103|50010607|FG003|Overall Study|Personal reasons|0|||
24916601|NCT00545103|50010604|FG000|Overall Study|Subject's decision|1|||
24916602|NCT00545103|50010605|FG001|Overall Study|Subject's decision|0|||
24916603|NCT00545103|50010606|FG002|Overall Study|Subject's decision|0|||
25274989|NCT01238861|50589070|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
25274990|NCT01238861|50589065|FG000|Overall Study|Subject moved out of state/area|0|||
25274991|NCT01238861|50589066|FG001|Overall Study|Subject moved out of state/area|0|||
25274992|NCT01238861|50589067|FG002|Overall Study|Subject moved out of state/area|1|||
25274993|NCT01238861|50589068|FG003|Overall Study|Subject moved out of state/area|1|||
25274994|NCT01238861|50589069|FG004|Overall Study|Subject moved out of state/area|0|||
24916604|NCT00545103|50010607|FG003|Overall Study|Subject's decision|0|||
24916605|NCT00545103|50010604|FG000|Overall Study|Noncompliance|0|||
24916606|NCT00545103|50010605|FG001|Overall Study|Noncompliance|1|||
24916607|NCT00545103|50010606|FG002|Overall Study|Noncompliance|0|||
24916608|NCT00545103|50010607|FG003|Overall Study|Noncompliance|0|||
24916609|NCT00545103|50010604|FG000|Overall Study|Investigator decision|0|||
24916610|NCT00545103|50010605|FG001|Overall Study|Investigator decision|0|||
24916611|NCT00545103|50010606|FG002|Overall Study|Investigator decision|1|||
24916612|NCT00545103|50010607|FG003|Overall Study|Investigator decision|0|||
24916613|NCT00545103|50010604|FG000|Overall Study|Subject moved|0|||
24916614|NCT00545103|50010605|FG001|Overall Study|Subject moved|1|||
24916615|NCT00545103|50010606|FG002|Overall Study|Subject moved|0|||
24916616|NCT00545103|50010607|FG003|Overall Study|Subject moved|0|||
24916617|NCT00545103|50010604|FG000|Overall Study|Use of prohibited medication|0|||
24916618|NCT00545103|50010605|FG001|Overall Study|Use of prohibited medication|0|||
24916619|NCT00545103|50010606|FG002|Overall Study|Use of prohibited medication|1|||
24916620|NCT00545103|50010607|FG003|Overall Study|Use of prohibited medication|0|||
24916621|NCT00545103|50010604|FG000|Overall Study|Does not want to take study drug anymore|1|||
24916622|NCT00545103|50010605|FG001|Overall Study|Does not want to take study drug anymore|0|||
24916623|NCT00545103|50010606|FG002|Overall Study|Does not want to take study drug anymore|1|||
24916624|NCT00545103|50010607|FG003|Overall Study|Does not want to take study drug anymore|0|||
24916625|NCT00545103|50010604|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
24916626|NCT00545103|50010605|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
24916627|NCT00545103|50010606|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
24916628|NCT00545103|50010607|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
24916629|NCT00545103|50010604|FG000|Overall Study|Death|0|||
24916630|NCT00545103|50010605|FG001|Overall Study|Death|1|||
24916631|NCT00545103|50010606|FG002|Overall Study|Death|0|||
24916632|NCT00545103|50010607|FG003|Overall Study|Death|0|||
24916633|NCT00586157|50010617|FG000|First Intervention|Worsening behavior|1|||
24916634|NCT00586157|50010618|FG001|First Intervention|Worsening behavior|0|||
24916635|NCT00586157|50010617|FG000|Second Intervention|Withdrawal by Subject|1|||
24916636|NCT00586157|50010618|FG001|Second Intervention|Withdrawal by Subject|0|||
24916637|NCT00586157|50010617|FG000|Second Intervention|Worsening behavior|1|||
24916638|NCT00586157|50010618|FG001|Second Intervention|Worsening behavior|0|||
24916639|NCT00586157|50010617|FG000|Second Intervention|Adverse Event|0|||
24916640|NCT00586157|50010618|FG001|Second Intervention|Adverse Event|1|||
24916641|NCT00246337|50010633|FG000|Overall Study|Lost to Follow-up|3|||
24916642|NCT00246337|50010634|FG001|Overall Study|Lost to Follow-up|0|||
24916643|NCT00246337|50010635|FG002|Overall Study|Lost to Follow-up|0|||
24916644|NCT00246337|50010636|FG003|Overall Study|Lost to Follow-up|0|||
24916645|NCT00246337|50010637|FG004|Overall Study|Lost to Follow-up|2|||
24916646|NCT00246337|50010638|FG005|Overall Study|Lost to Follow-up|2|||
24916647|NCT00246337|50010639|FG006|Overall Study|Lost to Follow-up|1|||
25021444|NCT03512210|50117859|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
25021445|NCT03512210|50117859|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
25021446|NCT00383721|50117868|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
25021447|NCT00383721|50117869|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
25021448|NCT00383721|50117870|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
25021449|NCT00383721|50117871|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
25021450|NCT00383721|50117872|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
25021451|NCT00383721|50117868|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
25021452|NCT00383721|50117869|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
25021453|NCT00383721|50117870|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
25021454|NCT00383721|50117871|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
25021455|NCT00383721|50117872|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
25021456|NCT00383721|50117868|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
25021457|NCT00383721|50117869|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
25021458|NCT00383721|50117870|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
25021459|NCT00383721|50117871|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
25021460|NCT00383721|50117872|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
25021461|NCT00383721|50117868|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
25021462|NCT00383721|50117869|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
25021463|NCT00383721|50117870|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
25021464|NCT00383721|50117871|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
25021465|NCT00383721|50117872|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
25021466|NCT00383721|50117868|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
25021467|NCT00383721|50117869|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
25021468|NCT00383721|50117870|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
25021469|NCT00383721|50117871|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
24916648|NCT00246337|50010640|FG007|Overall Study|Lost to Follow-up|2|||
24916649|NCT00246337|50010641|FG008|Overall Study|Lost to Follow-up|0|||
24916650|NCT00246337|50010633|FG000|Overall Study|Protocol Violation|1|||
24916651|NCT00246337|50010634|FG001|Overall Study|Protocol Violation|0|||
25021470|NCT00383721|50117872|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
25021471|NCT00383721|50117868|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
24916652|NCT00246337|50010635|FG002|Overall Study|Protocol Violation|0|||
24916653|NCT00246337|50010636|FG003|Overall Study|Protocol Violation|0|||
24916654|NCT00246337|50010637|FG004|Overall Study|Protocol Violation|1|||
24916655|NCT00246337|50010638|FG005|Overall Study|Protocol Violation|0|||
24916656|NCT00246337|50010639|FG006|Overall Study|Protocol Violation|1|||
24916657|NCT00246337|50010640|FG007|Overall Study|Protocol Violation|1|||
24916658|NCT00246337|50010641|FG008|Overall Study|Protocol Violation|0|||
24916659|NCT00246337|50010633|FG000|Overall Study|Withdrawal by Subject|2|||
24916660|NCT00246337|50010634|FG001|Overall Study|Withdrawal by Subject|0|||
24916661|NCT00246337|50010635|FG002|Overall Study|Withdrawal by Subject|0|||
24916662|NCT00246337|50010636|FG003|Overall Study|Withdrawal by Subject|0|||
24916663|NCT00246337|50010637|FG004|Overall Study|Withdrawal by Subject|0|||
24916664|NCT00246337|50010638|FG005|Overall Study|Withdrawal by Subject|0|||
24916665|NCT00246337|50010639|FG006|Overall Study|Withdrawal by Subject|1|||
24916666|NCT00246337|50010640|FG007|Overall Study|Withdrawal by Subject|1|||
24916667|NCT00246337|50010641|FG008|Overall Study|Withdrawal by Subject|0|||
24916668|NCT00246337|50010633|FG000|Overall Study|Lack of Qualifying Event|8|||
24916669|NCT00246337|50010634|FG001|Overall Study|Lack of Qualifying Event|2|||
24916670|NCT00246337|50010635|FG002|Overall Study|Lack of Qualifying Event|1|||
24916671|NCT00246337|50010636|FG003|Overall Study|Lack of Qualifying Event|1|||
24916672|NCT00246337|50010637|FG004|Overall Study|Lack of Qualifying Event|1|||
24916673|NCT00246337|50010638|FG005|Overall Study|Lack of Qualifying Event|3|||
24916674|NCT00246337|50010639|FG006|Overall Study|Lack of Qualifying Event|3|||
24916675|NCT00246337|50010640|FG007|Overall Study|Lack of Qualifying Event|2|||
24916676|NCT00246337|50010641|FG008|Overall Study|Lack of Qualifying Event|5|||
24916677|NCT00246337|50010633|FG000|Overall Study|Site Terminated|10|||
24916678|NCT00246337|50010634|FG001|Overall Study|Site Terminated|0|||
24916679|NCT00246337|50010635|FG002|Overall Study|Site Terminated|0|||
24916680|NCT00246337|50010636|FG003|Overall Study|Site Terminated|0|||
24916681|NCT00246337|50010637|FG004|Overall Study|Site Terminated|0|||
24916682|NCT00246337|50010638|FG005|Overall Study|Site Terminated|7|||
24916683|NCT00246337|50010639|FG006|Overall Study|Site Terminated|1|||
24916684|NCT00246337|50010640|FG007|Overall Study|Site Terminated|6|||
24916685|NCT00246337|50010641|FG008|Overall Study|Site Terminated|2|||
24916686|NCT00246337|50010633|FG000|Overall Study|Abnormal baseline lab values|7|||
24916687|NCT00246337|50010634|FG001|Overall Study|Abnormal baseline lab values|0|||
24916688|NCT00246337|50010635|FG002|Overall Study|Abnormal baseline lab values|2|||
24916689|NCT00246337|50010636|FG003|Overall Study|Abnormal baseline lab values|0|||
24916690|NCT00246337|50010637|FG004|Overall Study|Abnormal baseline lab values|0|||
24916691|NCT00246337|50010638|FG005|Overall Study|Abnormal baseline lab values|2|||
24916692|NCT00246337|50010639|FG006|Overall Study|Abnormal baseline lab values|2|||
24916693|NCT00246337|50010640|FG007|Overall Study|Abnormal baseline lab values|0|||
24916694|NCT00246337|50010641|FG008|Overall Study|Abnormal baseline lab values|4|||
24916695|NCT00246337|50010633|FG000|Overall Study|Overwhelmed|0|||
24916696|NCT00246337|50010634|FG001|Overall Study|Overwhelmed|0|||
24916697|NCT00246337|50010635|FG002|Overall Study|Overwhelmed|0|||
24916698|NCT00246337|50010636|FG003|Overall Study|Overwhelmed|0|||
24916699|NCT00246337|50010637|FG004|Overall Study|Overwhelmed|0|||
24916700|NCT00246337|50010638|FG005|Overall Study|Overwhelmed|1|||
24916701|NCT00246337|50010639|FG006|Overall Study|Overwhelmed|0|||
24916702|NCT00246337|50010640|FG007|Overall Study|Overwhelmed|0|||
24916703|NCT00246337|50010641|FG008|Overall Study|Overwhelmed|0|||
24916704|NCT00246337|50010633|FG000|Overall Study|Protocol Violator|1|||
25021472|NCT00383721|50117869|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
25021473|NCT00383721|50117870|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
25021474|NCT00383721|50117871|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
25021475|NCT00383721|50117872|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
25021476|NCT00383721|50117868|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
25021477|NCT00383721|50117869|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
25021478|NCT00383721|50117870|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
24916705|NCT00246337|50010634|FG001|Overall Study|Protocol Violator|0|||
24916706|NCT00246337|50010635|FG002|Overall Study|Protocol Violator|0|||
24916707|NCT00246337|50010636|FG003|Overall Study|Protocol Violator|0|||
24916708|NCT00246337|50010637|FG004|Overall Study|Protocol Violator|0|||
24916709|NCT00246337|50010638|FG005|Overall Study|Protocol Violator|0|||
24916710|NCT00246337|50010639|FG006|Overall Study|Protocol Violator|0|||
24916711|NCT00246337|50010640|FG007|Overall Study|Protocol Violator|0|||
24916712|NCT00246337|50010641|FG008|Overall Study|Protocol Violator|0|||
24916713|NCT00246337|50010633|FG000|Overall Study|Reported as completing trial in error|0|||
24916714|NCT00246337|50010634|FG001|Overall Study|Reported as completing trial in error|0|||
24916715|NCT00246337|50010635|FG002|Overall Study|Reported as completing trial in error|0|||
24916716|NCT00246337|50010636|FG003|Overall Study|Reported as completing trial in error|0|||
24916717|NCT00246337|50010637|FG004|Overall Study|Reported as completing trial in error|0|||
24916718|NCT00246337|50010638|FG005|Overall Study|Reported as completing trial in error|0|||
24916719|NCT00246337|50010639|FG006|Overall Study|Reported as completing trial in error|0|||
24916720|NCT00246337|50010640|FG007|Overall Study|Reported as completing trial in error|1|||
24916721|NCT00246337|50010641|FG008|Overall Study|Reported as completing trial in error|0|||
24916722|NCT00243919|50010664|FG000|Overall Study|Death|3|||
24916723|NCT00243919|50010665|FG001|Overall Study|Death|4|||
24916724|NCT00243919|50010666|FG002|Overall Study|Death|6|||
24916725|NCT00243919|50010664|FG000|Overall Study|Withdrawal by Subject|6|||
24916726|NCT00243919|50010665|FG001|Overall Study|Withdrawal by Subject|6|||
24916727|NCT00243919|50010666|FG002|Overall Study|Withdrawal by Subject|2|||
24916728|NCT00243919|50010664|FG000|Overall Study|Lost to Follow-up|6|||
24916729|NCT00243919|50010665|FG001|Overall Study|Lost to Follow-up|7|||
24916730|NCT00243919|50010666|FG002|Overall Study|Lost to Follow-up|3|||
24916731|NCT00243919|50010664|FG000|Overall Study|Administrative Error|1|||
24916732|NCT00243919|50010665|FG001|Overall Study|Administrative Error|0|||
24916733|NCT00243919|50010666|FG002|Overall Study|Administrative Error|0|||
24916734|NCT00243919|50010664|FG000|Overall Study|Physician Decision|1|||
24916735|NCT00243919|50010665|FG001|Overall Study|Physician Decision|1|||
24916736|NCT00243919|50010666|FG002|Overall Study|Physician Decision|0|||
24916737|NCT00725621|50010674|FG000|Overall Study|Adverse Event|25|||
24916738|NCT00725621|50010674|FG000|Overall Study|Lack of Efficacy|46|||
24916739|NCT00725621|50010674|FG000|Overall Study|Withdrawal by Subject|57|||
24916740|NCT00725621|50010674|FG000|Overall Study|Physician Decision|19|||
24916741|NCT00725621|50010674|FG000|Overall Study|Lost to Follow-up|52|||
24916742|NCT00725621|50010674|FG000|Overall Study|Non-compliance|8|||
24916743|NCT00725621|50010674|FG000|Overall Study|Continued treatment by other physician|6|||
24916744|NCT00725621|50010674|FG000|Overall Study|Switched to other study|1|||
24916745|NCT00725621|50010674|FG000|Overall Study|Switched to other drug|1|||
24916746|NCT00725621|50010674|FG000|Overall Study|Prepared for elective surgery|1|||
24916747|NCT00725621|50010674|FG000|Overall Study|Reason not specified|55|||
24916748|NCT00613626|50010685|FG000|Overall Study|Ineligible|0|||
24916749|NCT00613626|50010686|FG001|Overall Study|Ineligible|1|||
24916750|NCT00613626|50010687|FG002|Overall Study|Ineligible|0|||
24916751|NCT00725543|50010694|FG000|Overall Study|Adverse Event|10|||
24916752|NCT00725543|50010694|FG000|Overall Study|Lack of Efficacy|3|||
24916753|NCT00725543|50010694|FG000|Overall Study|Withdrawal by Subject|10|||
24916754|NCT00725543|50010694|FG000|Overall Study|Physician Decision|5|||
24916755|NCT00725543|50010694|FG000|Overall Study|Lost to Follow-up|4|||
24916756|NCT00725543|50010694|FG000|Overall Study|Non-compliance|2|||
24916757|NCT00725543|50010694|FG000|Overall Study|Other|119|||
24916758|NCT00239005|50010700|FG000|Overall Study|Adverse Event|6|||
24916759|NCT00239005|50010701|FG001|Overall Study|Adverse Event|6|||
24916760|NCT00239005|50010700|FG000|Overall Study|Withdrawal by Subject|3|||
24916761|NCT00239005|50010701|FG001|Overall Study|Withdrawal by Subject|4|||
24916762|NCT00239005|50010700|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
24916763|NCT00239005|50010701|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
24916764|NCT00239005|50010700|FG000|Overall Study|Protocol Violation|1|||
24916765|NCT00239005|50010701|FG001|Overall Study|Protocol Violation|0|||
24916766|NCT00239005|50010700|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
24916767|NCT00239005|50010701|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
24916768|NCT00239005|50010700|FG000|Overall Study|Lost to Follow-up|0|||
24916769|NCT00239005|50010701|FG001|Overall Study|Lost to Follow-up|1|||
24916770|NCT00616434|50010709|FG000|Overall Study|Adverse Event|5|||
24916771|NCT00616434|50010710|FG001|Overall Study|Adverse Event|2|||
24916772|NCT00616434|50010709|FG000|Overall Study|Physician Decision|0|||
24916773|NCT00616434|50010710|FG001|Overall Study|Physician Decision|4|||
24916774|NCT00616434|50010709|FG000|Overall Study|Withdrawal by Subject|1|||
24916775|NCT00616434|50010710|FG001|Overall Study|Withdrawal by Subject|1|||
24916776|NCT00616434|50010709|FG000|Overall Study|Protocol deviation|0|||
24916777|NCT00616434|50010710|FG001|Overall Study|Protocol deviation|1|||
24916778|NCT00652340|50010718|FG000|Overall Study|Had not progressed.|4|||
24916779|NCT00652340|50010719|FG001|Overall Study|Had not progressed.|3|||
24916780|NCT00613314|50010725|FG000|Overall Study|Adverse Event|5|||
24916781|NCT00613314|50010725|FG000|Overall Study|Protocol Violation|14|||
24916782|NCT00613314|50010725|FG000|Overall Study|Lost to Follow-up|46|||
25153729|NCT01551693|50268814|FG001|Overall Study|Withdrawal by Subject|1|||
24916783|NCT00613314|50010725|FG000|Overall Study|Other reason not defined above|90|||
24916784|NCT00257725|50010729|FG000|Overall Study|Adverse Event|3|||
24916785|NCT00544869|50010737|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
25274995|NCT01238861|50589070|FG005|Overall Study|Subject moved out of state/area|0|||
25153730|NCT01574157|50268822|FG000|Overall Study|Withdrawal by Subject|4|||
24916786|NCT00544869|50010738|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
24916787|NCT00544869|50010739|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
24916788|NCT00544869|50010737|FG000|Overall Study|Adverse Event|6|||
24916789|NCT00544869|50010738|FG001|Overall Study|Adverse Event|1|||
24916790|NCT00544869|50010739|FG002|Overall Study|Adverse Event|0|||
24916791|NCT00544869|50010737|FG000|Overall Study|Lack of Efficacy|1|||
24916792|NCT00544869|50010738|FG001|Overall Study|Lack of Efficacy|1|||
24916793|NCT00544869|50010739|FG002|Overall Study|Lack of Efficacy|0|||
24916794|NCT00544869|50010737|FG000|Overall Study|Physician Decision|2|||
24916795|NCT00544869|50010738|FG001|Overall Study|Physician Decision|0|||
24916796|NCT00544869|50010739|FG002|Overall Study|Physician Decision|0|||
24916797|NCT00725075|50010750|FG000|Overall Study|Use of Excluded Medication|0|||
24916798|NCT00725075|50010751|FG001|Overall Study|Use of Excluded Medication|1|||
24916799|NCT00725075|50010752|FG002|Overall Study|Use of Excluded Medication|0|||
24916800|NCT00725075|50010750|FG000|Overall Study|Protocol Violation|0|||
24916801|NCT00725075|50010751|FG001|Overall Study|Protocol Violation|0|||
24916802|NCT00725075|50010752|FG002|Overall Study|Protocol Violation|1|||
24916803|NCT00725075|50010750|FG000|Overall Study|Lost to Follow-up|1|||
24916804|NCT00725075|50010751|FG001|Overall Study|Lost to Follow-up|0|||
24916805|NCT00725075|50010752|FG002|Overall Study|Lost to Follow-up|0|||
24916806|NCT00725075|50010750|FG000|Overall Study|Withdrawal by Subject|4|||
24916807|NCT00725075|50010751|FG001|Overall Study|Withdrawal by Subject|5|||
24916808|NCT00725075|50010752|FG002|Overall Study|Withdrawal by Subject|4|||
24916809|NCT00725075|50010750|FG000|Overall Study|Adverse Event|2|||
24916810|NCT00725075|50010751|FG001|Overall Study|Adverse Event|1|||
24916811|NCT00725075|50010752|FG002|Overall Study|Adverse Event|1|||
24916812|NCT00725075|50010750|FG000|Overall Study|Worsening of Disease|2|||
24916813|NCT00725075|50010751|FG001|Overall Study|Worsening of Disease|1|||
24916814|NCT00725075|50010752|FG002|Overall Study|Worsening of Disease|2|||
24916815|NCT00725075|50010750|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
24916816|NCT00725075|50010751|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
24916817|NCT00725075|50010752|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
24916818|NCT00725075|50010750|FG000|Overall Study|Other|1|||
25021479|NCT00383721|50117871|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
25021480|NCT00383721|50117872|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
24916819|NCT00725075|50010751|FG001|Overall Study|Other|0|||
24916820|NCT00725075|50010752|FG002|Overall Study|Other|0|||
24916821|NCT00733499|50010762|FG000|Pre-operative|Protocol Violation|0|||
24916822|NCT00733499|50010763|FG001|Pre-operative|Protocol Violation|1|||
24916823|NCT00733499|50010762|FG000|3 Months Follow-up|Death|1|||
24916824|NCT00733499|50010763|FG001|3 Months Follow-up|Death|2|||
24916825|NCT00733499|50010762|FG000|6 Months Follow-up|Death|0|||
24916826|NCT00733499|50010763|FG001|6 Months Follow-up|Death|2|||
24916827|NCT00733499|50010762|FG000|6 Months Follow-up|Adverse Event|0|||
24916828|NCT00733499|50010763|FG001|6 Months Follow-up|Adverse Event|1|||
24916829|NCT00733499|50010762|FG000|12 Months Follow-up|Death|2|||
24916830|NCT00733499|50010763|FG001|12 Months Follow-up|Death|1|||
24916831|NCT00733499|50010762|FG000|24 Months Follow-up|Death|0|||
24916832|NCT00733499|50010763|FG001|24 Months Follow-up|Death|1|||
24916833|NCT00733499|50010762|FG000|5 Year Followup|Adverse Event|2|||
24916834|NCT00733499|50010763|FG001|5 Year Followup|Adverse Event|2|||
25021481|NCT00383721|50117868|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
25021482|NCT00383721|50117869|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
25021483|NCT00383721|50117870|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
25021484|NCT00383721|50117871|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
25021485|NCT00383721|50117872|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
24916835|NCT00733499|50010762|FG000|5 Year Followup|Non device related AE|0|||
24916836|NCT00733499|50010763|FG001|5 Year Followup|Non device related AE|1|||
24916837|NCT00733499|50010762|FG000|5 Year Followup|Revision of Study Implant|0|||
24916838|NCT00733499|50010763|FG001|5 Year Followup|Revision of Study Implant|1|||
24916839|NCT00733499|50010762|FG000|5 Year Followup|Lost to Follow-up|2|||
24916840|NCT00733499|50010763|FG001|5 Year Followup|Lost to Follow-up|0|||
24916841|NCT00733499|50010762|FG000|5 Year Followup|Death|13|||
24916842|NCT00733499|50010763|FG001|5 Year Followup|Death|19|||
24916843|NCT00733499|50010762|FG000|5 Year Followup|missing, unable to locate|0|||
24916844|NCT00733499|50010763|FG001|5 Year Followup|missing, unable to locate|1|||
24916845|NCT00733499|50010762|FG000|5 Year Followup|Withdrawal by Subject|4|||
24916846|NCT00733499|50010763|FG001|5 Year Followup|Withdrawal by Subject|1|||
24916847|NCT00733499|50010762|FG000|10 Year Followup|Death|9|||
24916848|NCT00733499|50010763|FG001|10 Year Followup|Death|7|||
24916849|NCT00733499|50010762|FG000|10 Year Followup|Adverse Event|3|||
24916850|NCT00733499|50010763|FG001|10 Year Followup|Adverse Event|3|||
24916851|NCT00733499|50010762|FG000|10 Year Followup|Lost to Follow-up|3|||
24916852|NCT00733499|50010763|FG001|10 Year Followup|Lost to Follow-up|2|||
24916853|NCT00733499|50010762|FG000|10 Year Followup|Withdrawal by Subject|5|||
24916854|NCT00733499|50010763|FG001|10 Year Followup|Withdrawal by Subject|5|||
24916855|NCT00733499|50010762|FG000|10 Year Followup|missing, unable to locate|0|||
24916856|NCT00733499|50010763|FG001|10 Year Followup|missing, unable to locate|2|||
24916857|NCT00652028|50010773|FG000|Overall Study|Adverse Event|1|||
24916858|NCT00652028|50010774|FG001|Overall Study|Adverse Event|0|||
24916859|NCT00652028|50010775|FG002|Overall Study|Adverse Event|0|||
24916860|NCT00652028|50010776|FG003|Overall Study|Adverse Event|0|||
24916861|NCT00652028|50010773|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
24916862|NCT00652028|50010774|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
24916863|NCT00652028|50010775|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
24916864|NCT00652028|50010776|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
24916865|NCT00652028|50010773|FG000|Overall Study|Physician Decision|0|||
24916866|NCT00652028|50010774|FG001|Overall Study|Physician Decision|0|||
24916867|NCT00652028|50010775|FG002|Overall Study|Physician Decision|1|||
24916868|NCT00652028|50010776|FG003|Overall Study|Physician Decision|0|||
24916869|NCT00738101|50010786|FG000|Overall Study|Physician Decision|5|||
24916870|NCT00738101|50010786|FG000|Overall Study|Death|1|||
24916871|NCT00738101|50010786|FG000|Overall Study|Repeat enrollment|1|||
24916872|NCT00733421|50010792|FG000|Overall Study|Withdrawal by Subject|1|||
24916873|NCT00733421|50010793|FG001|Overall Study|Withdrawal by Subject|1|||
24916874|NCT00613080|50010799|FG000|Overall Study|Ineligible / no protocol treatment|11|||
24916875|NCT00732875|50010803|FG000|Overall Study|Adverse Event|16|||
24916876|NCT00732875|50010803|FG000|Overall Study|Withdrawal by Subject|6|||
24916877|NCT00732875|50010803|FG000|Overall Study|Lack of Efficacy|13|||
24916878|NCT00615264|50010813|FG000|Overall Study|Withdrawal by Subject|17|||
24916879|NCT00615264|50010814|FG001|Overall Study|Withdrawal by Subject|19|||
24916880|NCT00615264|50010813|FG000|Overall Study|Lost to Follow-up|6|||
24916881|NCT00615264|50010814|FG001|Overall Study|Lost to Follow-up|13|||
24916882|NCT00615264|50010813|FG000|Overall Study|Adverse Event|8|||
24916883|NCT00615264|50010814|FG001|Overall Study|Adverse Event|5|||
24916884|NCT00615264|50010813|FG000|Overall Study|Death|1|||
24916885|NCT00615264|50010814|FG001|Overall Study|Death|1|||
24916886|NCT00615264|50010813|FG000|Overall Study|Protocol Violation|11|||
24916887|NCT00615264|50010814|FG001|Overall Study|Protocol Violation|7|||
24916888|NCT00615264|50010813|FG000|Overall Study|Not defined|7|||
24916889|NCT00615264|50010814|FG001|Overall Study|Not defined|4|||
24916890|NCT00615264|50010813|FG000|Overall Study|Dermal Hypersensitivity|0|||
24916891|NCT00615264|50010814|FG001|Overall Study|Dermal Hypersensitivity|3|||
24916892|NCT00732641|50010822|FG000|Overall Study|Relapse or Progressive Disease|65|||
25021486|NCT00383721|50117868|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
25021487|NCT00383721|50117869|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
25021488|NCT00383721|50117870|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
25021489|NCT00383721|50117871|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
25021490|NCT00383721|50117872|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
25021491|NCT00383721|50117868|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
25153731|NCT01574157|50268823|FG001|Overall Study|Withdrawal by Subject|5|||
25153732|NCT01574157|50268822|FG000|Overall Study|Lost to Follow-up|0|||
25153733|NCT01574157|50268823|FG001|Overall Study|Lost to Follow-up|3|||
25153734|NCT01574079|50268835|FG000|Overall Study|Physician Decision|0|||
25153735|NCT01574079|50268836|FG001|Overall Study|Physician Decision|2|||
25153736|NCT01574079|50268835|FG000|Overall Study|Lost to Follow-up|1|||
25153737|NCT01574079|50268836|FG001|Overall Study|Lost to Follow-up|0|||
25153738|NCT01573767|50268846|FG000|Overall Study|Adverse Event|0|||
25153739|NCT01573767|50268847|FG001|Overall Study|Adverse Event|1|||
25153740|NCT01573767|50268848|FG002|Overall Study|Adverse Event|0|||
25153741|NCT01573767|50268849|FG003|Overall Study|Adverse Event|1|||
25153742|NCT01573767|50268846|FG000|Overall Study|Lack of Efficacy|18|||
25153743|NCT01573767|50268847|FG001|Overall Study|Lack of Efficacy|15|||
25153744|NCT01573767|50268848|FG002|Overall Study|Lack of Efficacy|12|||
25153745|NCT01573767|50268849|FG003|Overall Study|Lack of Efficacy|17|||
25153746|NCT01573767|50268846|FG000|Overall Study|Protocol Violation|3|||
25153747|NCT01573767|50268847|FG001|Overall Study|Protocol Violation|1|||
25153748|NCT01573767|50268848|FG002|Overall Study|Protocol Violation|1|||
25153749|NCT01573767|50268849|FG003|Overall Study|Protocol Violation|3|||
25153750|NCT01573767|50268846|FG000|Overall Study|Lost to Follow-up|0|||
25153751|NCT01573767|50268847|FG001|Overall Study|Lost to Follow-up|1|||
25153752|NCT01573767|50268848|FG002|Overall Study|Lost to Follow-up|1|||
25153753|NCT01573767|50268849|FG003|Overall Study|Lost to Follow-up|1|||
25153754|NCT01573767|50268846|FG000|Overall Study|Physician Decision|1|||
25153755|NCT01573767|50268847|FG001|Overall Study|Physician Decision|2|||
25153756|NCT01573767|50268848|FG002|Overall Study|Physician Decision|0|||
25021492|NCT00383721|50117869|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
25021493|NCT00383721|50117870|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
25153757|NCT01573767|50268849|FG003|Overall Study|Physician Decision|2|||
25153758|NCT01573767|50268846|FG000|Overall Study|Withdrawal by Subject|0|||
25153759|NCT01573767|50268847|FG001|Overall Study|Withdrawal by Subject|1|||
25153760|NCT01573767|50268848|FG002|Overall Study|Withdrawal by Subject|0|||
25274996|NCT01238861|50589065|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
24916893|NCT00732641|50010823|FG001|Overall Study|Relapse or Progressive Disease|101|||
24916894|NCT00732641|50010822|FG000|Overall Study|Serious Adverse Events|12|||
25153761|NCT01573767|50268849|FG003|Overall Study|Withdrawal by Subject|0|||
24916895|NCT00732641|50010823|FG001|Overall Study|Serious Adverse Events|3|||
25021494|NCT00383721|50117871|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
25021495|NCT00383721|50117872|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
25153762|NCT01551303|50268861|FG000|Overall Study|failed awareness check on vision test|4|||
25153763|NCT01551303|50268862|FG001|Overall Study|failed awareness check on vision test|7|||
25153764|NCT00638404|50268870|FG000|Overall Study|Physician Decision|8|||
25153765|NCT00638404|50268871|FG001|Overall Study|Physician Decision|0|||
25153766|NCT01550757|50268885|FG000|Overall Study|Lost to Follow-up|21|||
25153767|NCT01550757|50268886|FG001|Overall Study|Lost to Follow-up|14|||
24916896|NCT00732641|50010822|FG000|Overall Study|Physician Decision|6|||
24916897|NCT00732641|50010823|FG001|Overall Study|Physician Decision|0|||
24916898|NCT00732641|50010822|FG000|Overall Study|Withdrawal by Subject|4|||
24916899|NCT00732641|50010823|FG001|Overall Study|Withdrawal by Subject|2|||
24916900|NCT00732641|50010822|FG000|Overall Study|Unable to Complete|1|||
24916901|NCT00732641|50010823|FG001|Overall Study|Unable to Complete|1|||
24916902|NCT00732641|50010822|FG000|Overall Study|Other|18|||
24916903|NCT00732641|50010823|FG001|Overall Study|Other|5|||
24916904|NCT00737711|50010829|FG000|Overall Study|Adverse Event|2|||
24916905|NCT00737711|50010829|FG000|Overall Study|Death|8|||
24916906|NCT00737711|50010829|FG000|Overall Study|Failure to return|4|||
24916907|NCT00737711|50010829|FG000|Overall Study|Protocol Violation|1|||
24916908|NCT00737711|50010829|FG000|Overall Study|Withdrawal by Subject|5|||
24916909|NCT00737711|50010829|FG000|Overall Study|Blood transfusion|6|||
24916910|NCT00737711|50010829|FG000|Overall Study|Other|5|||
24916911|NCT00615108|50010833|FG000|Overall Study|Adverse Event|122|||
24916912|NCT00615108|50010833|FG000|Overall Study|Other|370|||
24916913|NCT00615108|50010833|FG000|Overall Study|Lost to Follow-up|15|||
24916914|NCT00238303|50010842|FG000|Overall Study|Withdrawal by Subject|11|||
24916915|NCT00238303|50010843|FG001|Overall Study|Withdrawal by Subject|1|||
24916916|NCT00238303|50010844|FG002|Overall Study|Withdrawal by Subject|2|||
24916917|NCT00238303|50010842|FG000|Overall Study|Death|1|||
24916918|NCT00238303|50010843|FG001|Overall Study|Death|0|||
24916919|NCT00238303|50010844|FG002|Overall Study|Death|1|||
24916920|NCT00238303|50010842|FG000|Overall Study|Other Medical Problems|2|||
24916921|NCT00238303|50010843|FG001|Overall Study|Other Medical Problems|0|||
24916922|NCT00238303|50010844|FG002|Overall Study|Other Medical Problems|2|||
24916923|NCT00238303|50010842|FG000|Overall Study|Poor tolerance of study treatment|1|||
24916924|NCT00238303|50010843|FG001|Overall Study|Poor tolerance of study treatment|0|||
24916925|NCT00238303|50010844|FG002|Overall Study|Poor tolerance of study treatment|1|||
25153768|NCT01550757|50268887|FG002|Overall Study|Lost to Follow-up|42|||
25153769|NCT01550757|50268888|FG003|Overall Study|Lost to Follow-up|53|||
24916926|NCT00238303|50010842|FG000|Overall Study|Adverse Event|0|||
24916927|NCT00238303|50010843|FG001|Overall Study|Adverse Event|1|||
24916928|NCT00238303|50010844|FG002|Overall Study|Adverse Event|3|||
24916929|NCT00737633|50010855|FG000|Overall Study|Study terminated by sponsor|44|||
24916930|NCT00737633|50010856|FG001|Overall Study|Study terminated by sponsor|55|||
24916931|NCT00737633|50010855|FG000|Overall Study|Lost to Follow-up|0|||
24916932|NCT00737633|50010856|FG001|Overall Study|Lost to Follow-up|1|||
24916933|NCT00737633|50010855|FG000|Overall Study|protocol non-compliance|0|||
24916934|NCT00737633|50010856|FG001|Overall Study|protocol non-compliance|1|||
24916935|NCT00732251|50010862|FG000|Overall Study|Lost to Follow-up|3|||
24916936|NCT00732251|50010862|FG000|Overall Study|Withdrawal by Subject|3|||
24916937|NCT00732251|50010862|FG000|Overall Study|Early Term due to Site Closure|1|||
24916938|NCT00737477|50010866|FG000|Overall Study|Adverse Event|9|||
24916939|NCT00737477|50010866|FG000|Overall Study|Death|9|||
24916940|NCT00737477|50010866|FG000|Overall Study|Treatment Refusal|1|||
24916941|NCT00737477|50010866|FG000|Overall Study|Withdrawal by Subject|1|||
24916942|NCT00737477|50010866|FG000|Overall Study|Renal Transplantation|10|||
24916943|NCT00737477|50010866|FG000|Overall Study|Other|4|||
24916944|NCT00256867|50010878|FG000|Overall Study|Adverse Event|0|||
24916945|NCT00256867|50010879|FG001|Overall Study|Adverse Event|1|||
24916946|NCT00256867|50010880|FG002|Overall Study|Adverse Event|1|||
24916947|NCT00256867|50010881|FG003|Overall Study|Adverse Event|1|||
24916948|NCT00256867|50010882|FG004|Overall Study|Adverse Event|2|||
24916949|NCT00256867|50010883|FG005|Overall Study|Adverse Event|2|||
24916950|NCT00256867|50010884|FG006|Overall Study|Adverse Event|1|||
24916951|NCT00256867|50010885|FG007|Overall Study|Adverse Event|4|||
24916952|NCT00256867|50010878|FG000|Overall Study|Lost to Follow-up|2|||
24916953|NCT00256867|50010879|FG001|Overall Study|Lost to Follow-up|2|||
24916954|NCT00256867|50010880|FG002|Overall Study|Lost to Follow-up|2|||
24916955|NCT00256867|50010881|FG003|Overall Study|Lost to Follow-up|3|||
24916956|NCT00256867|50010882|FG004|Overall Study|Lost to Follow-up|2|||
24916957|NCT00256867|50010883|FG005|Overall Study|Lost to Follow-up|0|||
24916958|NCT00256867|50010884|FG006|Overall Study|Lost to Follow-up|1|||
25021496|NCT00383721|50117868|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
25021497|NCT00383721|50117869|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
25153770|NCT01550757|50268885|FG000|Overall Study|Withdrawal by Subject|2|||
24916959|NCT00256867|50010885|FG007|Overall Study|Lost to Follow-up|2|||
24916960|NCT00256867|50010878|FG000|Overall Study|Protocol Violation|0|||
24916961|NCT00256867|50010879|FG001|Overall Study|Protocol Violation|0|||
25153771|NCT01550757|50268886|FG001|Overall Study|Withdrawal by Subject|0|||
24916962|NCT00256867|50010880|FG002|Overall Study|Protocol Violation|0|||
24916963|NCT00256867|50010881|FG003|Overall Study|Protocol Violation|1|||
24916964|NCT00256867|50010882|FG004|Overall Study|Protocol Violation|0|||
24916965|NCT00256867|50010883|FG005|Overall Study|Protocol Violation|1|||
24916966|NCT00256867|50010884|FG006|Overall Study|Protocol Violation|0|||
24916967|NCT00256867|50010885|FG007|Overall Study|Protocol Violation|1|||
24916968|NCT00256867|50010878|FG000|Overall Study|Withdrawal by Subject|0|||
24916969|NCT00256867|50010879|FG001|Overall Study|Withdrawal by Subject|0|||
25153772|NCT01550757|50268887|FG002|Overall Study|Withdrawal by Subject|3|||
25153773|NCT01550757|50268888|FG003|Overall Study|Withdrawal by Subject|1|||
25153774|NCT01685073|50268900|FG000|Overall Study|Lost to Follow-up|6|||
25153775|NCT01685073|50268901|FG001|Overall Study|Lost to Follow-up|8|||
25153776|NCT01685073|50268900|FG000|Overall Study|Withdrawal by Subject|24|||
25153777|NCT01685073|50268901|FG001|Overall Study|Withdrawal by Subject|24|||
25153778|NCT01572909|50268909|FG000|Overall Study|Adverse Event|7|||
25153779|NCT01572909|50268910|FG001|Overall Study|Adverse Event|2|||
25153780|NCT01572909|50268909|FG000|Overall Study|Death|3|||
25153781|NCT01572909|50268910|FG001|Overall Study|Death|1|||
25153782|NCT01572909|50268909|FG000|Overall Study|Lost to Follow-up|8|||
25153783|NCT01572909|50268910|FG001|Overall Study|Lost to Follow-up|7|||
24916970|NCT00256867|50010880|FG002|Overall Study|Withdrawal by Subject|1|||
24916971|NCT00256867|50010881|FG003|Overall Study|Withdrawal by Subject|1|||
24916972|NCT00256867|50010882|FG004|Overall Study|Withdrawal by Subject|2|||
24916973|NCT00256867|50010883|FG005|Overall Study|Withdrawal by Subject|2|||
24916974|NCT00256867|50010884|FG006|Overall Study|Withdrawal by Subject|3|||
24916975|NCT00256867|50010885|FG007|Overall Study|Withdrawal by Subject|2|||
24916976|NCT00256867|50010878|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
24916977|NCT00256867|50010879|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
24916978|NCT00256867|50010880|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
24916979|NCT00256867|50010881|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
24916980|NCT00256867|50010882|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
24916981|NCT00256867|50010883|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
24916982|NCT00256867|50010884|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
25153784|NCT01572909|50268909|FG000|Overall Study|Physician Decision|1|||
25153785|NCT01572909|50268910|FG001|Overall Study|Physician Decision|1|||
25153786|NCT01572909|50268909|FG000|Overall Study|Technical Issues|1|||
24916983|NCT00256867|50010885|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
24916984|NCT00256867|50010878|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
24916985|NCT00256867|50010879|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
24916986|NCT00256867|50010880|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
24916987|NCT00256867|50010881|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
24916988|NCT00256867|50010882|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
24916989|NCT00256867|50010883|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
24916990|NCT00256867|50010884|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
24916991|NCT00256867|50010885|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
24916992|NCT00256867|50010878|FG000|Overall Study|Investigator's Decision|0|||
24916993|NCT00256867|50010879|FG001|Overall Study|Investigator's Decision|0|||
24916994|NCT00256867|50010880|FG002|Overall Study|Investigator's Decision|0|||
24916995|NCT00256867|50010881|FG003|Overall Study|Investigator's Decision|0|||
24916996|NCT00256867|50010882|FG004|Overall Study|Investigator's Decision|1|||
24916997|NCT00256867|50010883|FG005|Overall Study|Investigator's Decision|0|||
24916998|NCT00256867|50010884|FG006|Overall Study|Investigator's Decision|0|||
24916999|NCT00256867|50010885|FG007|Overall Study|Investigator's Decision|0|||
24917000|NCT00256867|50010878|FG000|Overall Study|Non-compliance with study medication|0|||
24917001|NCT00256867|50010879|FG001|Overall Study|Non-compliance with study medication|0|||
24917002|NCT00256867|50010880|FG002|Overall Study|Non-compliance with study medication|0|||
25153787|NCT01572909|50268910|FG001|Overall Study|Technical Issues|0|||
25153788|NCT01572909|50268909|FG000|Overall Study|Withdrawal by Subject|12|||
25274997|NCT01238861|50589066|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
25153789|NCT01572909|50268910|FG001|Overall Study|Withdrawal by Subject|11|||
25153790|NCT01572909|50268909|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
25153791|NCT01572909|50268910|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
25153792|NCT01572675|50268920|FG000|Overall Study|End of prescribed treatment|140|||
25153793|NCT01572675|50268921|FG001|Overall Study|End of prescribed treatment|118|||
25153794|NCT01572675|50268920|FG000|Overall Study|Recovery|16|||
25153795|NCT01572675|50268921|FG001|Overall Study|Recovery|23|||
25153796|NCT01572675|50268920|FG000|Overall Study|Lack of Efficacy|31|||
25153797|NCT01572675|50268921|FG001|Overall Study|Lack of Efficacy|31|||
24917003|NCT00256867|50010881|FG003|Overall Study|Non-compliance with study medication|0|||
24917004|NCT00256867|50010882|FG004|Overall Study|Non-compliance with study medication|0|||
24917005|NCT00256867|50010883|FG005|Overall Study|Non-compliance with study medication|0|||
24917006|NCT00256867|50010884|FG006|Overall Study|Non-compliance with study medication|0|||
25153798|NCT01572675|50268920|FG000|Overall Study|Intolerance|6|||
25153799|NCT01572675|50268921|FG001|Overall Study|Intolerance|5|||
25153800|NCT01572675|50268920|FG000|Overall Study|Improved symptoms|8|||
25153801|NCT01572675|50268921|FG001|Overall Study|Improved symptoms|2|||
24917007|NCT00256867|50010885|FG007|Overall Study|Non-compliance with study medication|1|||
24917008|NCT00256867|50010878|FG000|Overall Study|Participant travelled Overseas|0|||
24917009|NCT00256867|50010879|FG001|Overall Study|Participant travelled Overseas|1|||
24917010|NCT00256867|50010880|FG002|Overall Study|Participant travelled Overseas|0|||
24917011|NCT00256867|50010881|FG003|Overall Study|Participant travelled Overseas|0|||
25153802|NCT01572675|50268920|FG000|Overall Study|Surgical intervention|3|||
25153803|NCT01572675|50268921|FG001|Overall Study|Surgical intervention|6|||
25153804|NCT01572675|50268920|FG000|Overall Study|Withdrawal by Subject|5|||
25153805|NCT01572675|50268921|FG001|Overall Study|Withdrawal by Subject|1|||
24917012|NCT00256867|50010882|FG004|Overall Study|Participant travelled Overseas|0|||
24917013|NCT00256867|50010883|FG005|Overall Study|Participant travelled Overseas|0|||
24917014|NCT00256867|50010884|FG006|Overall Study|Participant travelled Overseas|0|||
24917015|NCT00256867|50010885|FG007|Overall Study|Participant travelled Overseas|0|||
24917016|NCT00256867|50010878|FG000|Overall Study|Participant out of assessment window|0|||
24917017|NCT00256867|50010879|FG001|Overall Study|Participant out of assessment window|0|||
24917018|NCT00256867|50010880|FG002|Overall Study|Participant out of assessment window|1|||
24917019|NCT00256867|50010881|FG003|Overall Study|Participant out of assessment window|0|||
24917020|NCT00256867|50010882|FG004|Overall Study|Participant out of assessment window|0|||
24917021|NCT00256867|50010883|FG005|Overall Study|Participant out of assessment window|0|||
24917022|NCT00256867|50010884|FG006|Overall Study|Participant out of assessment window|0|||
24917023|NCT00256867|50010885|FG007|Overall Study|Participant out of assessment window|0|||
24917024|NCT00256867|50010878|FG000|Overall Study|Withdrawal by participant|0|||
24917025|NCT00256867|50010879|FG001|Overall Study|Withdrawal by participant|0|||
24917026|NCT00256867|50010880|FG002|Overall Study|Withdrawal by participant|0|||
24917027|NCT00256867|50010881|FG003|Overall Study|Withdrawal by participant|0|||
24917028|NCT00256867|50010882|FG004|Overall Study|Withdrawal by participant|0|||
24917029|NCT00256867|50010883|FG005|Overall Study|Withdrawal by participant|1|||
24917030|NCT00256867|50010884|FG006|Overall Study|Withdrawal by participant|0|||
24917031|NCT00256867|50010885|FG007|Overall Study|Withdrawal by participant|0|||
24917032|NCT00731939|50010908|FG000|Overall Study|Adverse Event|6|||
24917033|NCT00731939|50010908|FG000|Overall Study|Lost to Follow-up|15|||
24917034|NCT00731939|50010908|FG000|Overall Study|Not implanted with study device|9|||
24917035|NCT00731939|50010908|FG000|Overall Study|Withdrawal by Subject|2|||
24917036|NCT00731939|50010908|FG000|Overall Study|Did not meet enrollment criteria|2|||
24917037|NCT00731783|50010914|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
24917038|NCT00731783|50010915|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
24917039|NCT00731783|50010914|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
24917040|NCT00731783|50010915|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
24917041|NCT00731783|50010914|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
24917042|NCT00731783|50010915|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
24917043|NCT00731783|50010914|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
24917044|NCT00731783|50010915|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
24917045|NCT00724451|50010921|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
24917046|NCT00724451|50010921|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
24917047|NCT00724451|50010921|FG000|Overall Study|Not Eligible for Treatment|431|||
24917048|NCT00724451|50010921|FG000|Overall Study|Participant Refused Treatment|89|||
24917049|NCT00724451|50010921|FG000|Overall Study|Never Started Treatment|89|||
24917050|NCT00724451|50010921|FG000|Overall Study|Unknown; No Data Sources Available|9|||
24917051|NCT00724451|50010921|FG000|Overall Study|Physician Decision|116|||
24917052|NCT00724451|50010921|FG000|Overall Study|Withdrawal by Subject|45|||
24917053|NCT00724451|50010921|FG000|Overall Study|Investigator + Participant Decision|13|||
24917054|NCT00724373|50010925|FG000|Overall Study|Adverse Event|41|||
24917055|NCT00724373|50010925|FG000|Overall Study|Lack of Efficacy|82|||
24917056|NCT00724373|50010925|FG000|Overall Study|Lost to Follow-up|7|||
24917057|NCT00724373|50010925|FG000|Overall Study|Non-compliance|2|||
24917058|NCT00724373|50010925|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
24917059|NCT00724373|50010925|FG000|Overall Study|Participant moved away|1|||
24917060|NCT00724373|50010925|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
24917061|NCT00724373|50010925|FG000|Overall Study|Only to have 24 week regimen|1|||
24917062|NCT00724373|50010925|FG000|Overall Study|Viral Relapse|1|||
24917063|NCT00724373|50010925|FG000|Overall Study|Acute HCV infection|1|||
24917064|NCT00724373|50010925|FG000|Overall Study|Drug Relapse|1|||
24917065|NCT00724373|50010925|FG000|Overall Study|Tolerability|23|||
24917066|NCT00724061|50010929|FG000|Dose Escalation Phase|Adverse Event|2|||
24917067|NCT00724061|50010929|FG000|Dose Escalation Phase|Disease Progression|3|||
24917068|NCT00731549|50010933|FG000|Overall Study|Lost to Follow-up|19|||
24917069|NCT00731549|50010933|FG000|Overall Study|Met withdrawal criteria|24|||
24917070|NCT00731549|50010933|FG000|Overall Study|Physician Decision|16|||
24917071|NCT00731549|50010933|FG000|Overall Study|Withdrawal by Subject|89|||
24917072|NCT00731549|50010933|FG000|Overall Study|Protocol deviation|1|||
24917073|NCT00731549|50010933|FG000|Overall Study|Adverse Event|31|||
25153806|NCT01572675|50268920|FG000|Overall Study|Physician Decision|2|||
25153807|NCT01572675|50268921|FG001|Overall Study|Physician Decision|2|||
25021498|NCT00383721|50117870|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
25021499|NCT00383721|50117871|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
25021500|NCT00383721|50117872|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
25021501|NCT00383721|50117868|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
25021502|NCT00383721|50117869|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
25021503|NCT00383721|50117870|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
25021504|NCT00383721|50117871|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
25021505|NCT00383721|50117872|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
25021506|NCT00383721|50117868|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
25021507|NCT00383721|50117869|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
25021508|NCT00383721|50117870|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
25021509|NCT00383721|50117871|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
25021510|NCT00383721|50117872|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
25021511|NCT00383721|50117868|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
25021512|NCT00383721|50117869|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
25021513|NCT00383721|50117870|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
25021514|NCT00383721|50117871|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
25021515|NCT00383721|50117872|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
25021516|NCT00383721|50117868|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
25021517|NCT00383721|50117869|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
25021518|NCT00383721|50117870|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
25021519|NCT00383721|50117871|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
25021520|NCT00383721|50117872|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
25021521|NCT00383721|50117868|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
25021522|NCT00383721|50117869|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
25021523|NCT00383721|50117870|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
25021524|NCT00383721|50117871|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
25021525|NCT00383721|50117872|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
25021526|NCT00383721|50117868|FG000|26-Week Treatment Safety Extension|Administrative|1|||
25021527|NCT00383721|50117869|FG001|26-Week Treatment Safety Extension|Administrative|2|||
25021528|NCT00383721|50117870|FG002|26-Week Treatment Safety Extension|Administrative|3|||
25021529|NCT00383721|50117871|FG003|26-Week Treatment Safety Extension|Administrative|1|||
25021530|NCT00383721|50117872|FG004|26-Week Treatment Safety Extension|Administrative|0|||
25021531|NCT03035942|50117900|FG000|Overall Study|Adverse Event|8|||
25021532|NCT03035942|50117901|FG001|Overall Study|Adverse Event|4|||
25021533|NCT03035942|50117902|FG002|Overall Study|Adverse Event|5|||
25021534|NCT02616146|50117914|FG000|Overall Study|Adverse Event|64|||
25021535|NCT02616146|50117915|FG001|Overall Study|Adverse Event|24|||
25021536|NCT02616146|50117914|FG000|Overall Study|Lost to Follow-up|23|||
25021537|NCT02616146|50117915|FG001|Overall Study|Lost to Follow-up|13|||
25021538|NCT02616146|50117914|FG000|Overall Study|Non-compliance with study protocol|2|||
25021539|NCT02616146|50117915|FG001|Overall Study|Non-compliance with study protocol|0|||
25021540|NCT02616146|50117914|FG000|Overall Study|Non-compliance with study drug|4|||
25021541|NCT02616146|50117915|FG001|Overall Study|Non-compliance with study drug|2|||
25153808|NCT01572675|50268920|FG000|Overall Study|Death unrelated to coxibs|1|||
25153809|NCT01572675|50268921|FG001|Overall Study|Death unrelated to coxibs|1|||
25153810|NCT01572675|50268920|FG000|Overall Study|Other disease detected|1|||
25274998|NCT01238861|50589067|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
25021542|NCT02616146|50117914|FG000|Overall Study|Pregnancy|2|||
24917074|NCT00731549|50010933|FG000|Overall Study|Lack of efficacy with AE|37|||
24917075|NCT00731549|50010933|FG000|Overall Study|Lack of efficacy without AE|6|||
24917076|NCT00730925|50010978|FG000|Overall Study|Progressive Disease|21|||
24917077|NCT00730925|50010978|FG000|Overall Study|Dose reducing Event|2|||
24917078|NCT00730925|50010978|FG000|Overall Study|Other Averse Event|7|||
24917079|NCT00730925|50010978|FG000|Overall Study|Protocol Violation|1|||
24917080|NCT00730925|50010978|FG000|Overall Study|Withdrawal by Subject|1|||
24917081|NCT00730925|50010978|FG000|Overall Study|Switch to combination therapy|8|||
24917082|NCT00730925|50010978|FG000|Overall Study|Other|1|||
24917083|NCT00236899|50010986|FG000|Overall Study|Adverse Event (Study Related)|1|||
24917084|NCT00236899|50010987|FG001|Overall Study|Adverse Event (Study Related)|1|||
24917085|NCT00236899|50010988|FG002|Overall Study|Adverse Event (Study Related)|2|||
24917086|NCT00236899|50010989|FG003|Overall Study|Adverse Event (Study Related)|1|||
24917087|NCT00236899|50010986|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
25021543|NCT02616146|50117915|FG001|Overall Study|Pregnancy|2|||
25021544|NCT02616146|50117914|FG000|Overall Study|Pregnancy wish|3|||
25021545|NCT02616146|50117915|FG001|Overall Study|Pregnancy wish|0|||
25021546|NCT02616146|50117914|FG000|Overall Study|Protocol Violation|6|||
25153811|NCT01572675|50268921|FG001|Overall Study|Other disease detected|1|||
25274999|NCT01238861|50589068|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
24917088|NCT00236899|50010987|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
24917089|NCT00236899|50010988|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
24917090|NCT00236899|50010989|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
24917091|NCT00236899|50010986|FG000|Overall Study|Death (Study Disease)|1|||
24917092|NCT00236899|50010987|FG001|Overall Study|Death (Study Disease)|4|||
24917093|NCT00236899|50010988|FG002|Overall Study|Death (Study Disease)|0|||
24917094|NCT00236899|50010989|FG003|Overall Study|Death (Study Disease)|0|||
24917095|NCT00236899|50010986|FG000|Overall Study|Death (Not Study Related)|2|||
24917096|NCT00236899|50010987|FG001|Overall Study|Death (Not Study Related)|0|||
24917097|NCT00236899|50010988|FG002|Overall Study|Death (Not Study Related)|0|||
24917098|NCT00236899|50010989|FG003|Overall Study|Death (Not Study Related)|0|||
24917099|NCT00236899|50010986|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
24917100|NCT00236899|50010987|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
24917101|NCT00236899|50010988|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
24917102|NCT00236899|50010989|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
24917103|NCT00236899|50010986|FG000|Overall Study|Lost to Follow-up|0|||
24917104|NCT00236899|50010987|FG001|Overall Study|Lost to Follow-up|1|||
24917105|NCT00236899|50010988|FG002|Overall Study|Lost to Follow-up|0|||
24917106|NCT00236899|50010989|FG003|Overall Study|Lost to Follow-up|0|||
24917107|NCT00236899|50010986|FG000|Overall Study|Entry Criteria Exclusion|0|||
24917108|NCT00236899|50010987|FG001|Overall Study|Entry Criteria Exclusion|1|||
24917109|NCT00236899|50010988|FG002|Overall Study|Entry Criteria Exclusion|1|||
24917110|NCT00236899|50010989|FG003|Overall Study|Entry Criteria Exclusion|0|||
24917111|NCT00236899|50010986|FG000|Overall Study|Protocol Violation|1|||
24917112|NCT00236899|50010987|FG001|Overall Study|Protocol Violation|0|||
24917113|NCT00236899|50010988|FG002|Overall Study|Protocol Violation|0|||
24917114|NCT00236899|50010989|FG003|Overall Study|Protocol Violation|0|||
24917115|NCT00236899|50010986|FG000|Overall Study|Withdrawal by Subject|6|||
24917116|NCT00236899|50010987|FG001|Overall Study|Withdrawal by Subject|4|||
24917117|NCT00236899|50010988|FG002|Overall Study|Withdrawal by Subject|5|||
24917118|NCT00236899|50010989|FG003|Overall Study|Withdrawal by Subject|2|||
24917119|NCT00236899|50010986|FG000|Overall Study|Physician Decision|7|||
24917120|NCT00236899|50010987|FG001|Overall Study|Physician Decision|8|||
24917121|NCT00236899|50010988|FG002|Overall Study|Physician Decision|7|||
24917122|NCT00236899|50010989|FG003|Overall Study|Physician Decision|6|||
24917123|NCT00236899|50010986|FG000|Overall Study|Satisfactory Response|2|||
24917124|NCT00236899|50010987|FG001|Overall Study|Satisfactory Response|0|||
24917125|NCT00236899|50010988|FG002|Overall Study|Satisfactory Response|0|||
24917126|NCT00236899|50010989|FG003|Overall Study|Satisfactory Response|1|||
24917127|NCT00236899|50010986|FG000|Overall Study|Lack of Efficacy|18|||
24917128|NCT00236899|50010987|FG001|Overall Study|Lack of Efficacy|18|||
24917129|NCT00236899|50010988|FG002|Overall Study|Lack of Efficacy|25|||
24917130|NCT00236899|50010989|FG003|Overall Study|Lack of Efficacy|23|||
24917131|NCT00611130|50011008|FG000|Overall Study|Lost to Follow-up|25|||
24917132|NCT00611130|50011009|FG001|Overall Study|Lost to Follow-up|29|||
24917133|NCT00611130|50011008|FG000|Overall Study|Protocol noncompliance|7|||
24917134|NCT00611130|50011009|FG001|Overall Study|Protocol noncompliance|6|||
24917135|NCT00611130|50011008|FG000|Overall Study|Withdrawal by Subject|6|||
24917136|NCT00611130|50011009|FG001|Overall Study|Withdrawal by Subject|5|||
24917137|NCT00611130|50011008|FG000|Overall Study|Other|5|||
24917138|NCT00611130|50011009|FG001|Overall Study|Other|4|||
24917139|NCT00611130|50011008|FG000|Overall Study|Incarceration|3|||
24917140|NCT00611130|50011009|FG001|Overall Study|Incarceration|2|||
24917141|NCT00611130|50011008|FG000|Overall Study|Administrative|1|||
24917142|NCT00611130|50011009|FG001|Overall Study|Administrative|1|||
24917143|NCT00611130|50011008|FG000|Overall Study|Adverse Event|1|||
24917144|NCT00611130|50011009|FG001|Overall Study|Adverse Event|0|||
24917145|NCT00611130|50011008|FG000|Overall Study|Death|1|||
24917146|NCT00611130|50011009|FG001|Overall Study|Death|0|||
24917147|NCT00256243|50011016|FG000|Overall Study|Lost to Follow-up|2|||
24917148|NCT00256243|50011016|FG000|Overall Study|Death|7|||
24917149|NCT00256243|50011016|FG000|Overall Study|Not treated|1|||
24917150|NCT00236197|50011023|FG000|Overall Study|Withdrawal by Subject|3|||
24917151|NCT00236197|50011024|FG001|Overall Study|Withdrawal by Subject|2|||
24917152|NCT00236197|50011023|FG000|Overall Study|Lost to Follow-up|1|||
24917153|NCT00236197|50011024|FG001|Overall Study|Lost to Follow-up|5|||
24917154|NCT00236197|50011023|FG000|Overall Study|Protocol Violation|0|||
24917155|NCT00236197|50011024|FG001|Overall Study|Protocol Violation|3|||
24917156|NCT00236197|50011023|FG000|Overall Study|Medication non-compliance|1|||
24917157|NCT00236197|50011024|FG001|Overall Study|Medication non-compliance|2|||
24917158|NCT00236197|50011023|FG000|Overall Study|Other|0|||
25021547|NCT02616146|50117915|FG001|Overall Study|Protocol Violation|3|||
24917159|NCT00236197|50011024|FG001|Overall Study|Other|2|||
24917160|NCT00278629|50011030|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
24917161|NCT00612690|50011037|FG000|Overall Study|Lost to Follow-up|72|||
24917162|NCT00612690|50011038|FG001|Overall Study|Lost to Follow-up|98|||
24917163|NCT00612690|50011037|FG000|Overall Study|Withdrawal by Subject|32|||
24917164|NCT00612690|50011038|FG001|Overall Study|Withdrawal by Subject|20|||
24917165|NCT00612690|50011037|FG000|Overall Study|Withdrawal by Site|11|||
24917166|NCT00612690|50011038|FG001|Overall Study|Withdrawal by Site|0|||
24917167|NCT00278473|50011048|FG000|Overall Study|drop out|4|||
24917168|NCT00278473|50011049|FG001|Overall Study|drop out|3|||
24917169|NCT00278395|50011055|FG000|Overall Study|Adverse Event|2|||
24917170|NCT00278395|50011055|FG000|Overall Study|Nonevaluable|1|||
24917171|NCT00612534|50011066|FG000|Overall Study|Adverse Event|0|||
24917172|NCT00612534|50011067|FG001|Overall Study|Adverse Event|4|||
24917173|NCT00612534|50011068|FG002|Overall Study|Adverse Event|2|||
24917174|NCT00612534|50011069|FG003|Overall Study|Adverse Event|1|||
24917175|NCT00612534|50011066|FG000|Overall Study|Lack of Efficacy|13|||
24917176|NCT00612534|50011067|FG001|Overall Study|Lack of Efficacy|12|||
24917177|NCT00612534|50011068|FG002|Overall Study|Lack of Efficacy|5|||
24917178|NCT00612534|50011069|FG003|Overall Study|Lack of Efficacy|16|||
24917179|NCT00612534|50011066|FG000|Overall Study|Other Reason|0|||
24917180|NCT00612534|50011067|FG001|Overall Study|Other Reason|1|||
24917181|NCT00612534|50011068|FG002|Overall Study|Other Reason|0|||
24917182|NCT00612534|50011069|FG003|Overall Study|Other Reason|0|||
24917183|NCT00736853|50011079|FG000|Open-Label Period|Physician Decision|2|||
24917184|NCT00736853|50011080|FG001|Open-Label Period|Physician Decision|0|||
24917185|NCT00736853|50011081|FG002|Open-Label Period|Physician Decision|0|||
24917186|NCT00736853|50011079|FG000|Open-Label Period|Adverse Event|31|||
24917187|NCT00736853|50011080|FG001|Open-Label Period|Adverse Event|0|||
24917188|NCT00736853|50011081|FG002|Open-Label Period|Adverse Event|0|||
24917189|NCT00736853|50011079|FG000|Open-Label Period|Withdrawal by Subject|16|||
24917190|NCT00736853|50011080|FG001|Open-Label Period|Withdrawal by Subject|0|||
24917191|NCT00736853|50011081|FG002|Open-Label Period|Withdrawal by Subject|0|||
24917192|NCT00736853|50011079|FG000|Open-Label Period|Started but not treated|42|||
24917193|NCT00736853|50011080|FG001|Open-Label Period|Started but not treated|0|||
24917194|NCT00736853|50011081|FG002|Open-Label Period|Started but not treated|0|||
24917195|NCT00736853|50011079|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
24917196|NCT00736853|50011080|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
24917197|NCT00736853|50011081|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
24917198|NCT00736853|50011079|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
24917199|NCT00736853|50011080|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
24917200|NCT00736853|50011081|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
24917201|NCT00736853|50011079|FG000|Double-Blind Period|Lack of Efficacy|0|||
24917202|NCT00736853|50011080|FG001|Double-Blind Period|Lack of Efficacy|19|||
24917203|NCT00736853|50011081|FG002|Double-Blind Period|Lack of Efficacy|42|||
24917204|NCT00736853|50011079|FG000|Double-Blind Period|Adverse Event|0|||
24917205|NCT00736853|50011080|FG001|Double-Blind Period|Adverse Event|3|||
24917206|NCT00736853|50011081|FG002|Double-Blind Period|Adverse Event|2|||
24917207|NCT00736853|50011079|FG000|Double-Blind Period|Withdrawal by Subject|0|||
24917208|NCT00736853|50011080|FG001|Double-Blind Period|Withdrawal by Subject|1|||
24917209|NCT00736853|50011081|FG002|Double-Blind Period|Withdrawal by Subject|4|||
24917210|NCT00736853|50011079|FG000|Double-Blind Period|Ineligible to participate the study|0|||
24917211|NCT00736853|50011080|FG001|Double-Blind Period|Ineligible to participate the study|1|||
24917212|NCT00736853|50011081|FG002|Double-Blind Period|Ineligible to participate the study|0|||
25021548|NCT02616146|50117914|FG000|Overall Study|Study terminated by sponsor|1372|||
25021549|NCT02616146|50117915|FG001|Overall Study|Study terminated by sponsor|432|||
25021550|NCT02616146|50117914|FG000|Overall Study|Participant moved|4|||
25021551|NCT02616146|50117915|FG001|Overall Study|Participant moved|3|||
25021552|NCT02616146|50117914|FG000|Overall Study|Withdrawal by Subject|30|||
25021553|NCT02616146|50117915|FG001|Overall Study|Withdrawal by Subject|24|||
25021554|NCT02616146|50117914|FG000|Overall Study|Physician Decision|2|||
25021555|NCT02616146|50117915|FG001|Overall Study|Physician Decision|1|||
25021556|NCT03035864|50117923|FG000|Treatment Period|Adverse Event|1|||
25021557|NCT03035864|50117924|FG001|Treatment Period|Adverse Event|0|||
25021558|NCT03035864|50117923|FG000|Treatment Period|Other|3|||
25021559|NCT03035864|50117924|FG001|Treatment Period|Other|1|||
25021560|NCT03035864|50117923|FG000|Follow-up Period|Adverse Event|1|||
25021561|NCT03035864|50117924|FG001|Follow-up Period|Adverse Event|0|||
25021562|NCT03035864|50117923|FG000|Follow-up Period|Lost to Follow-up|6|||
25021563|NCT03035864|50117924|FG001|Follow-up Period|Lost to Follow-up|2|||
25153812|NCT01572675|50268920|FG000|Overall Study|Unknown reason|1|||
25153813|NCT01572675|50268921|FG001|Overall Study|Unknown reason|1|||
25021564|NCT03035864|50117923|FG000|Follow-up Period|Physician Decision|1|||
25021565|NCT03035864|50117924|FG001|Follow-up Period|Physician Decision|0|||
25021566|NCT03035864|50117923|FG000|Follow-up Period|Other|3|||
25021567|NCT03035864|50117924|FG001|Follow-up Period|Other|2|||
25153814|NCT01572675|50268920|FG000|Overall Study|Rheumatologist new evaluation|0|||
25153815|NCT01572675|50268921|FG001|Overall Study|Rheumatologist new evaluation|1|||
25153816|NCT01572675|50268920|FG000|Overall Study|Missing data|1|||
25021568|NCT02885181|50117942|FG000|Overall Study|Investigator's Discretion|0|||
25153817|NCT01572675|50268921|FG001|Overall Study|Missing data|4|||
25153818|NCT01572675|50268920|FG000|Overall Study|Lost to Follow-up|22|||
24917213|NCT00730847|50011090|FG000|Overall Study|Adverse Event|1|||
25021569|NCT02885181|50117943|FG001|Overall Study|Investigator's Discretion|1|||
25021570|NCT02885181|50117944|FG002|Overall Study|Investigator's Discretion|0|||
25021571|NCT02885181|50117945|FG003|Overall Study|Investigator's Discretion|1|||
25021572|NCT02885181|50117942|FG000|Overall Study|Adverse Event|0|||
25021573|NCT02885181|50117943|FG001|Overall Study|Adverse Event|0|||
25153819|NCT01572675|50268921|FG001|Overall Study|Lost to Follow-up|27|||
25153820|NCT01550289|50268942|FG000|Overall Study|Protocol Violation|1|||
24917214|NCT00730847|50011090|FG000|Overall Study|Protocol Violation|2|||
24917215|NCT00730847|50011090|FG000|Overall Study|Withdrawal by Subject|16|||
24917216|NCT00730847|50011090|FG000|Overall Study|Lost to Follow-up|67|||
24917217|NCT00730847|50011090|FG000|Overall Study|Unknown completion status|21|||
24917218|NCT00730847|50011090|FG000|Overall Study|Other|24|||
24917219|NCT00573066|50011094|FG000|Overall Study|Exclusion criteria|18|||
24917220|NCT00573066|50011094|FG000|Overall Study|IV malfunction|1|||
24917221|NCT00573066|50011094|FG000|Overall Study|Postoperative bleeding|1|||
24917222|NCT00612456|50011101|FG000|Overall Study|Adverse Event|1|||
24917223|NCT00612456|50011102|FG001|Overall Study|Adverse Event|0|||
24917224|NCT00612456|50011103|FG002|Overall Study|Adverse Event|0|||
24917225|NCT00612456|50011101|FG000|Overall Study|Lack of Efficacy|1|||
24917226|NCT00612456|50011102|FG001|Overall Study|Lack of Efficacy|1|||
24917227|NCT00612456|50011103|FG002|Overall Study|Lack of Efficacy|0|||
24917228|NCT00612456|50011101|FG000|Overall Study|Withdrawal by Subject|0|||
24917229|NCT00612456|50011102|FG001|Overall Study|Withdrawal by Subject|1|||
24917230|NCT00612456|50011103|FG002|Overall Study|Withdrawal by Subject|0|||
24917231|NCT00730691|50011118|FG000|Overall Study|Adverse Event|4|||
24917232|NCT00730691|50011119|FG001|Overall Study|Adverse Event|8|||
24917233|NCT00730691|50011120|FG002|Overall Study|Adverse Event|11|||
24917234|NCT00730691|50011121|FG003|Overall Study|Adverse Event|11|||
24917235|NCT00730691|50011122|FG004|Overall Study|Adverse Event|23|||
24917236|NCT00730691|50011118|FG000|Overall Study|Lack of Efficacy|4|||
24917237|NCT00730691|50011119|FG001|Overall Study|Lack of Efficacy|4|||
24917238|NCT00730691|50011120|FG002|Overall Study|Lack of Efficacy|2|||
24917239|NCT00730691|50011121|FG003|Overall Study|Lack of Efficacy|1|||
24917240|NCT00730691|50011122|FG004|Overall Study|Lack of Efficacy|1|||
24917241|NCT00730691|50011118|FG000|Overall Study|Non-compliance with Study Drug|6|||
24917242|NCT00730691|50011119|FG001|Overall Study|Non-compliance with Study Drug|1|||
24917243|NCT00730691|50011120|FG002|Overall Study|Non-compliance with Study Drug|6|||
24917244|NCT00730691|50011121|FG003|Overall Study|Non-compliance with Study Drug|3|||
24917245|NCT00730691|50011122|FG004|Overall Study|Non-compliance with Study Drug|3|||
24917246|NCT00730691|50011118|FG000|Overall Study|Protocol Deviations|3|||
24917247|NCT00730691|50011119|FG001|Overall Study|Protocol Deviations|5|||
24917248|NCT00730691|50011120|FG002|Overall Study|Protocol Deviations|3|||
24917249|NCT00730691|50011121|FG003|Overall Study|Protocol Deviations|7|||
24917250|NCT00730691|50011122|FG004|Overall Study|Protocol Deviations|5|||
24917251|NCT00730691|50011118|FG000|Overall Study|Withdrawal of Consent|7|||
24917252|NCT00730691|50011119|FG001|Overall Study|Withdrawal of Consent|9|||
24917253|NCT00730691|50011120|FG002|Overall Study|Withdrawal of Consent|3|||
24917254|NCT00730691|50011121|FG003|Overall Study|Withdrawal of Consent|6|||
24917255|NCT00730691|50011122|FG004|Overall Study|Withdrawal of Consent|3|||
25021574|NCT02885181|50117944|FG002|Overall Study|Adverse Event|0|||
25153821|NCT01550289|50268943|FG001|Overall Study|Protocol Violation|0|||
25153822|NCT01550289|50268942|FG000|Overall Study|Lost to Follow-up|1|||
25153823|NCT01550289|50268943|FG001|Overall Study|Lost to Follow-up|1|||
25153824|NCT01550289|50268942|FG000|Overall Study|Withdrawal by Subject|11|||
25153825|NCT01550289|50268943|FG001|Overall Study|Withdrawal by Subject|3|||
25153826|NCT01968031|50268954|FG000|Overall Study|Adverse Event|13|||
25153827|NCT01968031|50268955|FG001|Overall Study|Adverse Event|10|||
25153828|NCT01968031|50268956|FG002|Overall Study|Adverse Event|22|||
25153829|NCT01968031|50268954|FG000|Overall Study|Withdrawal by Subject|3|||
25153830|NCT01968031|50268955|FG001|Overall Study|Withdrawal by Subject|7|||
25153831|NCT01968031|50268956|FG002|Overall Study|Withdrawal by Subject|3|||
25153832|NCT01968031|50268954|FG000|Overall Study|Did not meet entry criteria|1|||
25153833|NCT01968031|50268955|FG001|Overall Study|Did not meet entry criteria|1|||
25153834|NCT01968031|50268956|FG002|Overall Study|Did not meet entry criteria|1|||
25153835|NCT01968031|50268954|FG000|Overall Study|Noncompliance|0|||
25153836|NCT01968031|50268955|FG001|Overall Study|Noncompliance|0|||
24917256|NCT00730691|50011118|FG000|Overall Study|Lost to Follow-up|11|||
24917257|NCT00730691|50011119|FG001|Overall Study|Lost to Follow-up|8|||
24917258|NCT00730691|50011120|FG002|Overall Study|Lost to Follow-up|13|||
24917259|NCT00730691|50011121|FG003|Overall Study|Lost to Follow-up|15|||
25021575|NCT02885181|50117945|FG003|Overall Study|Adverse Event|1|||
25153837|NCT01968031|50268956|FG002|Overall Study|Noncompliance|2|||
24917260|NCT00730691|50011122|FG004|Overall Study|Lost to Follow-up|13|||
24917261|NCT00730691|50011118|FG000|Overall Study|Other|1|||
24917262|NCT00730691|50011119|FG001|Overall Study|Other|1|||
24917263|NCT00730691|50011120|FG002|Overall Study|Other|1|||
25153838|NCT01968031|50268954|FG000|Overall Study|Failed inclusion criteria|0|||
25153839|NCT01968031|50268955|FG001|Overall Study|Failed inclusion criteria|2|||
25153840|NCT01968031|50268956|FG002|Overall Study|Failed inclusion criteria|0|||
25185009|NCT04115748|50334079|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
25185010|NCT04115748|50334080|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
25185011|NCT04115748|50334081|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
25185012|NCT04115748|50334082|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
25185013|NCT04115748|50334083|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
25185014|NCT04115748|50334084|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
25185015|NCT02652624|50334141|FG000|Randomized Phase|Pregnancy|3|||
25185016|NCT02652624|50334142|FG001|Randomized Phase|Pregnancy|1|||
25185017|NCT02652624|50334141|FG000|Randomized Phase|Investigator's Discretion|0|||
25185018|NCT02652624|50334142|FG001|Randomized Phase|Investigator's Discretion|2|||
25185019|NCT02652624|50334141|FG000|Randomized Phase|Death|0|||
25185020|NCT02652624|50334142|FG001|Randomized Phase|Death|1|||
25185021|NCT02652624|50334141|FG000|Randomized Phase|Lost to Follow-up|0|||
25185022|NCT02652624|50334142|FG001|Randomized Phase|Lost to Follow-up|1|||
25185023|NCT02652624|50334141|FG000|Extension Phase|Lost to Follow-up|3|||
25185024|NCT02652624|50334142|FG001|Extension Phase|Lost to Follow-up|1|||
25185025|NCT02652624|50334141|FG000|Extension Phase|Pregnancy|1|||
25185026|NCT02652624|50334142|FG001|Extension Phase|Pregnancy|1|||
25185027|NCT02652624|50334141|FG000|Extension Phase|Adverse Event|0|||
25185028|NCT02652624|50334142|FG001|Extension Phase|Adverse Event|1|||
25185029|NCT02652624|50334141|FG000|Extension Phase|Withdrew Consent|0|||
25185030|NCT02652624|50334142|FG001|Extension Phase|Withdrew Consent|1|||
25185031|NCT00249795|50334152|FG000|Overall Study|Not treated|16|||
25185032|NCT00249795|50334153|FG001|Overall Study|Not treated|14|||
25185033|NCT00249795|50334152|FG000|Overall Study|Symptomatic hypotension|127|||
25275000|NCT01238861|50589069|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
24917264|NCT00730691|50011121|FG003|Overall Study|Other|2|||
24917265|NCT00730691|50011122|FG004|Overall Study|Other|2|||
24917266|NCT00235495|50011136|FG000|Overall Study|Death|52|||
24917267|NCT00235495|50011137|FG001|Overall Study|Death|42|||
24917268|NCT00235495|50011136|FG000|Overall Study|Withdrawal by Subject|5|||
24917269|NCT00235495|50011137|FG001|Overall Study|Withdrawal by Subject|3|||
24917270|NCT00235495|50011136|FG000|Overall Study|Lost to Follow-up|11|||
24917271|NCT00235495|50011137|FG001|Overall Study|Lost to Follow-up|13|||
24917272|NCT00235495|50011136|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
24917273|NCT00235495|50011137|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
24917274|NCT00278161|50011143|FG000|Overall Study|Death|11|||
24917275|NCT00255151|50011150|FG000|Overall Study|Adverse Event|10|||
24917276|NCT00255151|50011151|FG001|Overall Study|Adverse Event|6|||
24917277|NCT00255151|50011152|FG002|Overall Study|Adverse Event|9|||
24917278|NCT00255151|50011150|FG000|Overall Study|Lost to Follow-up|4|||
24917279|NCT00255151|50011151|FG001|Overall Study|Lost to Follow-up|3|||
24917280|NCT00255151|50011152|FG002|Overall Study|Lost to Follow-up|4|||
24917281|NCT00255151|50011150|FG000|Overall Study|Withdrawal by Subject|18|||
24917282|NCT00255151|50011151|FG001|Overall Study|Withdrawal by Subject|17|||
24917283|NCT00255151|50011152|FG002|Overall Study|Withdrawal by Subject|8|||
24917284|NCT00255151|50011150|FG000|Overall Study|Noncompliance|0|||
25153841|NCT01968031|50268954|FG000|Overall Study|Death|0|||
25153842|NCT01968031|50268955|FG001|Overall Study|Death|0|||
25153843|NCT01968031|50268956|FG002|Overall Study|Death|1|||
25153844|NCT01968031|50268954|FG000|Overall Study|Prohibited concomitant medication|1|||
25153845|NCT01968031|50268955|FG001|Overall Study|Prohibited concomitant medication|0|||
25153846|NCT01968031|50268956|FG002|Overall Study|Prohibited concomitant medication|0|||
25153847|NCT01684215|50268968|FG000|Phase 1, Part 1|Adverse Event|1|||
25153848|NCT01684215|50268969|FG001|Phase 1, Part 1|Adverse Event|0|||
25153849|NCT01684215|50268970|FG002|Phase 1, Part 1|Adverse Event|0|||
25153850|NCT01684215|50268971|FG003|Phase 1, Part 1|Adverse Event|0|||
25153851|NCT01684215|50268968|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
25153852|NCT01684215|50268969|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
25153853|NCT01684215|50268970|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
25153854|NCT01684215|50268971|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
25153855|NCT01684215|50268968|FG000|Phase 1, Part 2|Adverse Event|0|||
25153856|NCT01684215|50268969|FG001|Phase 1, Part 2|Adverse Event|0|||
25153857|NCT01684215|50268970|FG002|Phase 1, Part 2|Adverse Event|1|||
25153858|NCT01684215|50268971|FG003|Phase 1, Part 2|Adverse Event|0|||
24917285|NCT00255151|50011151|FG001|Overall Study|Noncompliance|1|||
24917286|NCT00255151|50011152|FG002|Overall Study|Noncompliance|2|||
24917287|NCT00255151|50011150|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
24917288|NCT00255151|50011151|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
25153859|NCT01684215|50268968|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
25153860|NCT01684215|50268969|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
25185034|NCT00249795|50334153|FG001|Overall Study|Symptomatic hypotension|64|||
25185035|NCT00249795|50334152|FG000|Overall Study|Other Serious Adverse Event|84|||
25185036|NCT00249795|50334153|FG001|Overall Study|Other Serious Adverse Event|93|||
25185037|NCT00249795|50334152|FG000|Overall Study|Qualifying condition not present|26|||
25185038|NCT00249795|50334153|FG001|Overall Study|Qualifying condition not present|29|||
25185039|NCT00249795|50334152|FG000|Overall Study|Withdrawal by Subject|678|||
24917289|NCT00255151|50011152|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
24917290|NCT00255151|50011150|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
24917291|NCT00255151|50011151|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
24917292|NCT00255151|50011152|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
24917293|NCT00255151|50011150|FG000|Overall Study|Possible Barrett's Esophagus|1|||
24917294|NCT00255151|50011151|FG001|Overall Study|Possible Barrett's Esophagus|3|||
24917295|NCT00255151|50011152|FG002|Overall Study|Possible Barrett's Esophagus|8|||
24917296|NCT00255151|50011150|FG000|Overall Study|Esophageal Stricture|0|||
24917297|NCT00255151|50011151|FG001|Overall Study|Esophageal Stricture|0|||
24917298|NCT00255151|50011152|FG002|Overall Study|Esophageal Stricture|1|||
24917299|NCT00255151|50011150|FG000|Overall Study|Therapeutic Failure|11|||
24917300|NCT00255151|50011151|FG001|Overall Study|Therapeutic Failure|2|||
24917301|NCT00255151|50011152|FG002|Overall Study|Therapeutic Failure|3|||
24917302|NCT00658658|50011165|FG000|Overall Study|Withdrawal by Subject|0|||
24917303|NCT00658658|50011166|FG001|Overall Study|Withdrawal by Subject|1|||
24917304|NCT00658658|50011167|FG002|Overall Study|Withdrawal by Subject|0|||
24917305|NCT00658658|50011168|FG003|Overall Study|Withdrawal by Subject|0|||
24917306|NCT00658658|50011169|FG004|Overall Study|Withdrawal by Subject|0|||
24917307|NCT00658658|50011165|FG000|Overall Study|Death|4|||
24917308|NCT00658658|50011166|FG001|Overall Study|Death|0|||
24917309|NCT00658658|50011167|FG002|Overall Study|Death|0|||
24917310|NCT00658658|50011168|FG003|Overall Study|Death|1|||
24917311|NCT00658658|50011169|FG004|Overall Study|Death|1|||
24917312|NCT00658658|50011165|FG000|Overall Study|Disease Progression|0|||
24917313|NCT00658658|50011166|FG001|Overall Study|Disease Progression|1|||
24917314|NCT00658658|50011167|FG002|Overall Study|Disease Progression|0|||
24917315|NCT00658658|50011168|FG003|Overall Study|Disease Progression|1|||
24917316|NCT00658658|50011169|FG004|Overall Study|Disease Progression|3|||
24917317|NCT00658658|50011165|FG000|Overall Study|Protocol-specified Criteria|1|||
24917318|NCT00658658|50011166|FG001|Overall Study|Protocol-specified Criteria|0|||
24917319|NCT00658658|50011167|FG002|Overall Study|Protocol-specified Criteria|0|||
25153861|NCT01684215|50268970|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
25153862|NCT01684215|50268971|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
25153863|NCT01684215|50268968|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
25153864|NCT01684215|50268969|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
25153865|NCT01684215|50268970|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
25153866|NCT01684215|50268971|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
25153867|NCT01684215|50268968|FG000|Phase 2|Death|0|||
25153868|NCT01684215|50268969|FG001|Phase 2|Death|0|||
25153869|NCT01684215|50268970|FG002|Phase 2|Death|0|||
24917320|NCT00658658|50011168|FG003|Overall Study|Protocol-specified Criteria|0|||
24917321|NCT00658658|50011169|FG004|Overall Study|Protocol-specified Criteria|0|||
24917322|NCT00658658|50011165|FG000|Overall Study|Other|0|||
24917323|NCT00658658|50011166|FG001|Overall Study|Other|0|||
24917324|NCT00658658|50011167|FG002|Overall Study|Other|0|||
24917325|NCT00658658|50011168|FG003|Overall Study|Other|0|||
24917326|NCT00658658|50011169|FG004|Overall Study|Other|1|||
24917327|NCT00723203|50011181|FG000|Overall Study|Withdrawal by Subject|3|||
25021576|NCT02885181|50117942|FG000|Overall Study|Withdrawal by Subject|0|||
25021577|NCT02885181|50117943|FG001|Overall Study|Withdrawal by Subject|0|||
25021578|NCT02885181|50117944|FG002|Overall Study|Withdrawal by Subject|0|||
25021579|NCT02885181|50117945|FG003|Overall Study|Withdrawal by Subject|1|||
25021580|NCT02884089|50117959|FG000|Period 1|Dosing error|2|||
25021581|NCT02884089|50117960|FG001|Period 1|Dosing error|2|||
25021582|NCT02884089|50117961|FG002|Period 1|Dosing error|0|||
25021583|NCT02884089|50117962|FG003|Period 1|Dosing error|0|||
25021584|NCT02884089|50117959|FG000|Washout Period 1|Lost to Follow-up|0|||
25021585|NCT02884089|50117960|FG001|Washout Period 1|Lost to Follow-up|1|||
25021586|NCT02884089|50117961|FG002|Washout Period 1|Lost to Follow-up|0|||
25021587|NCT02884089|50117962|FG003|Washout Period 1|Lost to Follow-up|1|||
25021588|NCT02884089|50117959|FG000|Washout Period 1|Withdrawal by Subject|0|||
25021589|NCT02884089|50117960|FG001|Washout Period 1|Withdrawal by Subject|1|||
25021590|NCT02884089|50117961|FG002|Washout Period 1|Withdrawal by Subject|0|||
25021591|NCT02884089|50117962|FG003|Washout Period 1|Withdrawal by Subject|0|||
25021592|NCT02884089|50117959|FG000|Period 2|Adverse Event|1|||
25021593|NCT02884089|50117960|FG001|Period 2|Adverse Event|0|||
25021594|NCT02884089|50117961|FG002|Period 2|Adverse Event|0|||
25021595|NCT02884089|50117962|FG003|Period 2|Adverse Event|0|||
25021596|NCT02884089|50117959|FG000|Period 3|Withdrawal by Subject|0|||
25021597|NCT02884089|50117960|FG001|Period 3|Withdrawal by Subject|0|||
24917328|NCT00233389|50011187|FG000|Overall Study|Adverse Event|5|||
24917329|NCT00233389|50011188|FG001|Overall Study|Adverse Event|5|||
24917330|NCT00233389|50011187|FG000|Overall Study|Lack of Efficacy|11|||
24917331|NCT00233389|50011188|FG001|Overall Study|Lack of Efficacy|8|||
24917332|NCT00233389|50011187|FG000|Overall Study|Lost to Follow-up|1|||
25021598|NCT02884089|50117961|FG002|Period 3|Withdrawal by Subject|1|||
25021599|NCT02884089|50117962|FG003|Period 3|Withdrawal by Subject|0|||
25153870|NCT01684215|50268971|FG003|Phase 2|Death|8|||
25153871|NCT01684215|50268968|FG000|Phase 2|Study terminated by sponsor|0|||
24917333|NCT00233389|50011188|FG001|Overall Study|Lost to Follow-up|1|||
24917334|NCT00233389|50011187|FG000|Overall Study|Physician Decision|1|||
24917335|NCT00233389|50011188|FG001|Overall Study|Physician Decision|0|||
24917336|NCT00233389|50011187|FG000|Overall Study|Protocol Violation|0|||
24917337|NCT00233389|50011188|FG001|Overall Study|Protocol Violation|1|||
24917338|NCT00233389|50011187|FG000|Overall Study|Withdrawal by Subject|0|||
24917339|NCT00233389|50011188|FG001|Overall Study|Withdrawal by Subject|1|||
25021600|NCT02884089|50117959|FG000|Washout Period 3|Withdrawal by Subject|0|||
25021601|NCT02884089|50117960|FG001|Washout Period 3|Withdrawal by Subject|0|||
25021602|NCT02884089|50117961|FG002|Washout Period 3|Withdrawal by Subject|1|||
25153872|NCT01684215|50268969|FG001|Phase 2|Study terminated by sponsor|0|||
24917340|NCT00649220|50011194|FG000|Overall Study|Adverse Event|2|||
24917341|NCT00649220|50011194|FG000|Overall Study|Withdrawal by Subject|1|||
24917342|NCT00654368|50011201|FG000|Overall Study|Ineligibility determined|6|||
24917343|NCT00654368|50011202|FG001|Overall Study|Ineligibility determined|0|||
24917344|NCT00654368|50011203|FG002|Overall Study|Ineligibility determined|0|||
24917345|NCT00654368|50011201|FG000|Overall Study|Protocol deviation|3|||
24917346|NCT00654368|50011202|FG001|Overall Study|Protocol deviation|2|||
24917347|NCT00654368|50011203|FG002|Overall Study|Protocol deviation|1|||
25153873|NCT01684215|50268970|FG002|Phase 2|Study terminated by sponsor|0|||
25153874|NCT01684215|50268971|FG003|Phase 2|Study terminated by sponsor|30|||
25153875|NCT01684215|50268968|FG000|Phase 2|Enrolled but not treated|0|||
25153876|NCT01684215|50268969|FG001|Phase 2|Enrolled but not treated|0|||
25153877|NCT01684215|50268970|FG002|Phase 2|Enrolled but not treated|0|||
25153878|NCT01684215|50268971|FG003|Phase 2|Enrolled but not treated|1|||
25153879|NCT01684215|50268968|FG000|Phase 2|Lost to Follow-up|0|||
25153880|NCT01684215|50268969|FG001|Phase 2|Lost to Follow-up|0|||
25153881|NCT01684215|50268970|FG002|Phase 2|Lost to Follow-up|0|||
25275001|NCT01238861|50589070|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
24917348|NCT00654368|50011201|FG000|Overall Study|Non-compliance|2|||
24917349|NCT00654368|50011202|FG001|Overall Study|Non-compliance|1|||
24917350|NCT00654368|50011203|FG002|Overall Study|Non-compliance|2|||
24917351|NCT00654368|50011201|FG000|Overall Study|Withdrawal by Subject|5|||
24917352|NCT00654368|50011202|FG001|Overall Study|Withdrawal by Subject|2|||
24917353|NCT00654368|50011203|FG002|Overall Study|Withdrawal by Subject|2|||
24917354|NCT00654368|50011201|FG000|Overall Study|Disease progression|21|||
24917355|NCT00654368|50011202|FG001|Overall Study|Disease progression|31|||
24917356|NCT00654368|50011203|FG002|Overall Study|Disease progression|13|||
24917357|NCT00654368|50011201|FG000|Overall Study|Requirement for alternative therapy|1|||
24917358|NCT00654368|50011202|FG001|Overall Study|Requirement for alternative therapy|1|||
24917359|NCT00654368|50011203|FG002|Overall Study|Requirement for alternative therapy|1|||
24917360|NCT00654368|50011201|FG000|Overall Study|Physician Decision|0|||
24917361|NCT00654368|50011202|FG001|Overall Study|Physician Decision|0|||
24917362|NCT00654368|50011203|FG002|Overall Study|Physician Decision|2|||
24917363|NCT00654368|50011201|FG000|Overall Study|Death|1|||
24917364|NCT00654368|50011202|FG001|Overall Study|Death|0|||
24917365|NCT00654368|50011203|FG002|Overall Study|Death|0|||
24917366|NCT00654368|50011201|FG000|Overall Study|Pregnancy|0|||
24917367|NCT00654368|50011202|FG001|Overall Study|Pregnancy|0|||
24917368|NCT00654368|50011203|FG002|Overall Study|Pregnancy|2|||
24917369|NCT00654368|50011201|FG000|Overall Study|Other|0|||
24917370|NCT00654368|50011202|FG001|Overall Study|Other|2|||
24917371|NCT00654368|50011203|FG002|Overall Study|Other|3|||
24917372|NCT00654368|50011201|FG000|Overall Study|Adverse Event|14|||
24917373|NCT00654368|50011202|FG001|Overall Study|Adverse Event|9|||
24917374|NCT00654368|50011203|FG002|Overall Study|Adverse Event|6|||
24917375|NCT00647426|50011210|FG000|Overall Study|Withdrawal by Subject|2|||
24917376|NCT00647348|50011217|FG000|Overall Study|Lost to Follow-up|3|||
24917377|NCT00647348|50011218|FG001|Overall Study|Lost to Follow-up|6|||
24917378|NCT00647270|50011227|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
24917379|NCT00647270|50011228|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
24917380|NCT00647270|50011229|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
24917381|NCT00647270|50011227|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
24917382|NCT00647270|50011228|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
25021603|NCT02884089|50117962|FG003|Washout Period 3|Withdrawal by Subject|0|||
24917383|NCT00647270|50011229|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
24917384|NCT00647270|50011227|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
24917385|NCT00647270|50011228|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
24917386|NCT00647270|50011229|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
24917387|NCT00647270|50011227|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
24917388|NCT00647270|50011228|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
24917389|NCT00647270|50011229|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
24917390|NCT00647270|50011227|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
24917391|NCT00647270|50011228|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
25153882|NCT01684215|50268971|FG003|Phase 2|Lost to Follow-up|4|||
25153883|NCT01549275|50268986|FG000|Overall Study|Lost to Follow-up|1|||
25153884|NCT01549275|50268987|FG001|Overall Study|Lost to Follow-up|0|||
25021604|NCT02884089|50117959|FG000|Washout Period 3|Lost to Follow-up|0|||
25021605|NCT02884089|50117960|FG001|Washout Period 3|Lost to Follow-up|0|||
24917392|NCT00647270|50011229|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
24917393|NCT00647270|50011227|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
25021606|NCT02884089|50117961|FG002|Washout Period 3|Lost to Follow-up|0|||
25021607|NCT02884089|50117962|FG003|Washout Period 3|Lost to Follow-up|1|||
25021608|NCT02884089|50117959|FG000|Period 4|Withdrawal by Subject|0|||
25021609|NCT02884089|50117960|FG001|Period 4|Withdrawal by Subject|1|||
25021610|NCT02884089|50117961|FG002|Period 4|Withdrawal by Subject|0|||
25021611|NCT02884089|50117962|FG003|Period 4|Withdrawal by Subject|0|||
25021612|NCT02884089|50117959|FG000|Period 4|Lost to Follow-up|1|||
25021613|NCT02884089|50117960|FG001|Period 4|Lost to Follow-up|0|||
25021614|NCT02884089|50117961|FG002|Period 4|Lost to Follow-up|0|||
24917394|NCT00647270|50011228|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
24917395|NCT00647270|50011229|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
24917396|NCT00647270|50011227|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
24917397|NCT00647270|50011228|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
24917398|NCT00647270|50011229|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
24917399|NCT00645944|50011242|FG000|Randomized|Withdrawal by Subject|1|||
24917400|NCT00645944|50011243|FG001|Randomized|Withdrawal by Subject|2|||
24917401|NCT00645944|50011242|FG000|Received Medication|Adverse Event|2|||
24917402|NCT00645944|50011243|FG001|Received Medication|Adverse Event|1|||
24917403|NCT00645944|50011242|FG000|Received Medication|Withdrawal by Subject|1|||
24917404|NCT00645944|50011243|FG001|Received Medication|Withdrawal by Subject|1|||
24917405|NCT00645944|50011242|FG000|Received Medication|Lost to Follow-up|1|||
24917406|NCT00645944|50011243|FG001|Received Medication|Lost to Follow-up|0|||
24917407|NCT00645944|50011242|FG000|Received Medication|Protocol Violation|2|||
24917408|NCT00645944|50011243|FG001|Received Medication|Protocol Violation|1|||
24917409|NCT00646958|50011252|FG000|Overall Study|Lack of Efficacy|1|||
24917410|NCT00646958|50011253|FG001|Overall Study|Lack of Efficacy|0|||
24917411|NCT00646958|50011254|FG002|Overall Study|Lack of Efficacy|0|||
24917412|NCT00646958|50011252|FG000|Overall Study|Adverse Event|4|||
24917413|NCT00646958|50011253|FG001|Overall Study|Adverse Event|0|||
24917414|NCT00646958|50011254|FG002|Overall Study|Adverse Event|0|||
24917415|NCT00646958|50011252|FG000|Overall Study|Lost to Follow-up|1|||
24917416|NCT00646958|50011253|FG001|Overall Study|Lost to Follow-up|5|||
24917417|NCT00646958|50011254|FG002|Overall Study|Lost to Follow-up|7|||
25021615|NCT02884089|50117962|FG003|Period 4|Lost to Follow-up|0|||
25021616|NCT02884089|50117959|FG000|Follow-up Visit|Withdrawal by Subject|1|||
25021617|NCT02884089|50117960|FG001|Follow-up Visit|Withdrawal by Subject|0|||
25021618|NCT02884089|50117961|FG002|Follow-up Visit|Withdrawal by Subject|0|||
25021619|NCT02884089|50117962|FG003|Follow-up Visit|Withdrawal by Subject|1|||
25021620|NCT02809677|50117972|FG000|Overall Study|Withdrawal by Subject|8|||
25021621|NCT02881047|50117977|FG000|Overall Study|Adverse Event|1|||
25021622|NCT02881047|50117977|FG000|Overall Study|Withdrawal by Subject|1|||
25021623|NCT03157089|50117983|FG000|Overall Study|Treated only with pembrolizumab|1|||
25021624|NCT03157089|50117984|FG001|Overall Study|Treated only with pembrolizumab|0|||
25021625|NCT03157089|50117983|FG000|Overall Study|Adverse Event|5|||
25021626|NCT03157089|50117984|FG001|Overall Study|Adverse Event|4|||
24917418|NCT00646958|50011252|FG000|Overall Study|Protocol Violation|1|||
25021627|NCT03157089|50117983|FG000|Overall Study|Progressive disease|6|||
25021628|NCT03157089|50117984|FG001|Overall Study|Progressive disease|8|||
25021629|NCT03158727|50117993|FG000|Overall Study|Withdrawal by Subject|2|||
25021630|NCT03158727|50117994|FG001|Overall Study|Withdrawal by Subject|6|||
24917419|NCT00646958|50011253|FG001|Overall Study|Protocol Violation|1|||
24917420|NCT00646958|50011254|FG002|Overall Study|Protocol Violation|0|||
24917421|NCT00646958|50011252|FG000|Overall Study|Abnormal screening lab tests|1|||
25021631|NCT03158727|50117993|FG000|Overall Study|Death|11|||
25021632|NCT03158727|50117994|FG001|Overall Study|Death|12|||
25021633|NCT03158727|50117993|FG000|Overall Study|Lost to Follow-up|1|||
24917422|NCT00646958|50011253|FG001|Overall Study|Abnormal screening lab tests|1|||
24917423|NCT00646958|50011254|FG002|Overall Study|Abnormal screening lab tests|0|||
24917424|NCT00646958|50011252|FG000|Overall Study|Withdrawal by Subject|1|||
24917425|NCT00646958|50011253|FG001|Overall Study|Withdrawal by Subject|2|||
24917426|NCT00646958|50011254|FG002|Overall Study|Withdrawal by Subject|0|||
24917427|NCT00646958|50011252|FG000|Overall Study|Did not receive study drug|2|||
24917428|NCT00646958|50011253|FG001|Overall Study|Did not receive study drug|0|||
24917429|NCT00646958|50011254|FG002|Overall Study|Did not receive study drug|2|||
24917430|NCT00642746|50011264|FG000|Overall Study|Patient unevaluable|1|||
24917431|NCT00642746|50011265|FG001|Overall Study|Patient unevaluable|0|||
24917432|NCT00642668|50011271|FG000|Overall Study|Lost to Follow-up|1|||
24917433|NCT00642668|50011271|FG000|Overall Study|Adverse Event|2|||
24917434|NCT00642668|50011271|FG000|Overall Study|Death|2|||
24917435|NCT00642668|50011271|FG000|Overall Study|Insufficient Therapeutic Response|1|||
24917436|NCT00642668|50011271|FG000|Overall Study|Failure to Return|1|||
24917437|NCT00642668|50011271|FG000|Overall Study|Dialysis Initiation|5|||
24917438|NCT00642668|50011271|FG000|Overall Study|Blood Transfusion|2|||
24917439|NCT00729833|50011275|FG000|Overall Study|Death|5|||
24917440|NCT00729833|50011276|FG001|Overall Study|Death|1|||
24917441|NCT00729833|50011277|FG002|Overall Study|Death|3|||
24917442|NCT00729833|50011278|FG003|Overall Study|Death|5|||
24917443|NCT00729833|50011275|FG000|Overall Study|Study Terminated by Sponsor|0|||
24917444|NCT00729833|50011276|FG001|Overall Study|Study Terminated by Sponsor|0|||
24917445|NCT00729833|50011277|FG002|Overall Study|Study Terminated by Sponsor|1|||
24917446|NCT00729833|50011278|FG003|Overall Study|Study Terminated by Sponsor|0|||
24917447|NCT00729833|50011275|FG000|Overall Study|Lost to Follow-up|1|||
24917448|NCT00729833|50011276|FG001|Overall Study|Lost to Follow-up|0|||
24917449|NCT00729833|50011277|FG002|Overall Study|Lost to Follow-up|0|||
24917450|NCT00729833|50011278|FG003|Overall Study|Lost to Follow-up|0|||
24917451|NCT00729833|50011275|FG000|Overall Study|Withdrawal by Subject|3|||
24917452|NCT00729833|50011276|FG001|Overall Study|Withdrawal by Subject|1|||
24917453|NCT00729833|50011277|FG002|Overall Study|Withdrawal by Subject|3|||
24917454|NCT00729833|50011278|FG003|Overall Study|Withdrawal by Subject|0|||
24917455|NCT00729833|50011275|FG000|Overall Study|Unspecified Reasons|11|||
24917456|NCT00729833|50011276|FG001|Overall Study|Unspecified Reasons|5|||
24917457|NCT00729833|50011277|FG002|Overall Study|Unspecified Reasons|5|||
24917458|NCT00729833|50011278|FG003|Overall Study|Unspecified Reasons|1|||
24917459|NCT00645788|50011293|FG000|Overall Study|Did not receive study drug|1|||
24917460|NCT00645788|50011294|FG001|Overall Study|Did not receive study drug|1|||
24917461|NCT00645788|50011295|FG002|Overall Study|Did not receive study drug|0|||
24917462|NCT00645788|50011296|FG003|Overall Study|Did not receive study drug|0|||
24917463|NCT00645788|50011293|FG000|Overall Study|Adverse Event|4|||
24917464|NCT00645788|50011294|FG001|Overall Study|Adverse Event|9|||
24917465|NCT00645788|50011295|FG002|Overall Study|Adverse Event|5|||
24917466|NCT00645788|50011296|FG003|Overall Study|Adverse Event|3|||
25021634|NCT03158727|50117994|FG001|Overall Study|Lost to Follow-up|0|||
25021635|NCT03158727|50117993|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
25021636|NCT03158727|50117994|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
25021637|NCT03158727|50117993|FG000|Overall Study|Visit 11 not done by mistake|0|||
25021638|NCT03158727|50117994|FG001|Overall Study|Visit 11 not done by mistake|1|||
25021639|NCT03158727|50117993|FG000|Overall Study|Enrolled, not treated|1|||
25021640|NCT03158727|50117994|FG001|Overall Study|Enrolled, not treated|0|||
25021641|NCT00089895|50118002|FG000|Overall Study|Consent Withdrawn|11|||
25021642|NCT00089895|50118003|FG001|Overall Study|Consent Withdrawn|14|||
25021643|NCT00089895|50118002|FG000|Overall Study|Technical reason|7|||
25153885|NCT01908205|50268999|FG000|Overall Study|Lost to Follow-up|2|||
25153886|NCT01908205|50269000|FG001|Overall Study|Lost to Follow-up|0|||
25153887|NCT01908205|50268999|FG000|Overall Study|Withdrawal by Subject|3|||
25153888|NCT01908205|50269000|FG001|Overall Study|Withdrawal by Subject|1|||
25153889|NCT01549041|50269021|FG000|Overall Study|Lack of Efficacy|2|||
25153890|NCT01549041|50269022|FG001|Overall Study|Lack of Efficacy|4|||
25153891|NCT01549041|50269021|FG000|Overall Study|Adverse Event|0|||
25153892|NCT01549041|50269022|FG001|Overall Study|Adverse Event|4|||
25153893|NCT01907815|50269030|FG000|Overall Study|Withdrawal by Subject|1|||
25153894|NCT01907815|50269031|FG001|Overall Study|Withdrawal by Subject|0|||
25153895|NCT01548573|50269039|FG000|Overall Study|Death|3|||
25153896|NCT01548573|50269039|FG000|Overall Study|Withdrawal by Subject|2|||
25153897|NCT01907737|50269044|FG000|Overall Study|Withdrawal by Subject|1|||
25153898|NCT01570491|50269056|FG000|Overall Study|Lost to Follow-up|3|||
25153899|NCT01570491|50269057|FG001|Overall Study|Lost to Follow-up|1|||
24917467|NCT00645788|50011293|FG000|Overall Study|Lost to Follow-up|1|||
24917468|NCT00645788|50011294|FG001|Overall Study|Lost to Follow-up|0|||
24917469|NCT00645788|50011295|FG002|Overall Study|Lost to Follow-up|0|||
24917470|NCT00645788|50011296|FG003|Overall Study|Lost to Follow-up|0|||
24917471|NCT00645788|50011293|FG000|Overall Study|Protocol Violation|1|||
24917472|NCT00645788|50011294|FG001|Overall Study|Protocol Violation|0|||
24917473|NCT00645788|50011295|FG002|Overall Study|Protocol Violation|2|||
25153900|NCT01570491|50269056|FG000|Overall Study|treatment: not given or discontinued|2|||
25153901|NCT01570491|50269057|FG001|Overall Study|treatment: not given or discontinued|0|||
25153902|NCT01929109|50269068|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
25153903|NCT01929109|50269069|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
25153904|NCT01929109|50269070|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
25153905|NCT01929109|50269071|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
25153906|NCT01929109|50269072|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
25153907|NCT01518153|50269087|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
25021644|NCT00089895|50118003|FG001|Overall Study|Technical reason|2|||
25153908|NCT01518153|50269088|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
25153909|NCT01518153|50269089|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
25153910|NCT01518153|50269087|FG000|Stem Cell Transplant|Death|2|||
25153911|NCT01518153|50269088|FG001|Stem Cell Transplant|Death|0|||
25153912|NCT01518153|50269089|FG002|Stem Cell Transplant|Death|0|||
25153913|NCT01518153|50269087|FG000|Stem Cell Transplant|Secondary graft failure|1|||
25153914|NCT01518153|50269088|FG001|Stem Cell Transplant|Secondary graft failure|0|||
25153915|NCT01518153|50269089|FG002|Stem Cell Transplant|Secondary graft failure|0|||
25153916|NCT01518153|50269087|FG000|Stem Cell Transplant|Adverse Event|1|||
25153917|NCT01518153|50269088|FG001|Stem Cell Transplant|Adverse Event|0|||
25153918|NCT01518153|50269089|FG002|Stem Cell Transplant|Adverse Event|0|||
25153919|NCT01518153|50269087|FG000|Donor Lymphocyte Infusion|Death|0|||
25153920|NCT01518153|50269088|FG001|Donor Lymphocyte Infusion|Death|2|||
25153921|NCT01518153|50269089|FG002|Donor Lymphocyte Infusion|Death|1|||
25153922|NCT01906489|50269099|FG000|Overall Study|Adverse Event|10|||
25153923|NCT01906489|50269100|FG001|Overall Study|Adverse Event|3|||
24917474|NCT00645788|50011296|FG003|Overall Study|Protocol Violation|0|||
24917475|NCT00645788|50011293|FG000|Overall Study|Withdrawal by Subject|0|||
24917476|NCT00645788|50011294|FG001|Overall Study|Withdrawal by Subject|1|||
24917477|NCT00645788|50011295|FG002|Overall Study|Withdrawal by Subject|0|||
24917478|NCT00645788|50011296|FG003|Overall Study|Withdrawal by Subject|2|||
24917479|NCT00645788|50011293|FG000|Overall Study|Pulmonary exacerbation|13|||
24917480|NCT00645788|50011294|FG001|Overall Study|Pulmonary exacerbation|16|||
24917481|NCT00645788|50011295|FG002|Overall Study|Pulmonary exacerbation|11|||
24917482|NCT00645788|50011296|FG003|Overall Study|Pulmonary exacerbation|9|||
24917483|NCT00642356|50011308|FG000|Overall Study|Adverse Event|1|||
24917484|NCT00642356|50011309|FG001|Overall Study|Adverse Event|0|||
24917485|NCT00642356|50011308|FG000|Overall Study|Protocol Violation|0|||
24917486|NCT00642356|50011309|FG001|Overall Study|Protocol Violation|3|||
24917487|NCT00642356|50011308|FG000|Overall Study|Lack of Efficacy|1|||
24917488|NCT00642356|50011309|FG001|Overall Study|Lack of Efficacy|0|||
24917489|NCT00642278|50011322|FG000|Overall Study|Adverse Event|2|||
24917490|NCT00642278|50011323|FG001|Overall Study|Adverse Event|1|||
24917491|NCT00642278|50011324|FG002|Overall Study|Adverse Event|3|||
24917492|NCT00642278|50011325|FG003|Overall Study|Adverse Event|1|||
24917493|NCT00642278|50011326|FG004|Overall Study|Adverse Event|2|||
24917494|NCT00642278|50011327|FG005|Overall Study|Adverse Event|2|||
24917495|NCT00642278|50011328|FG006|Overall Study|Adverse Event|0|||
24917496|NCT00642278|50011322|FG000|Overall Study|Lack of Efficacy|0|||
24917497|NCT00642278|50011323|FG001|Overall Study|Lack of Efficacy|1|||
24917498|NCT00642278|50011324|FG002|Overall Study|Lack of Efficacy|0|||
24917499|NCT00642278|50011325|FG003|Overall Study|Lack of Efficacy|0|||
24917500|NCT00642278|50011326|FG004|Overall Study|Lack of Efficacy|0|||
24917501|NCT00642278|50011327|FG005|Overall Study|Lack of Efficacy|0|||
24917502|NCT00642278|50011328|FG006|Overall Study|Lack of Efficacy|0|||
24917503|NCT00642278|50011322|FG000|Overall Study|Lost to Follow-up|5|||
24917504|NCT00642278|50011323|FG001|Overall Study|Lost to Follow-up|1|||
24917505|NCT00642278|50011324|FG002|Overall Study|Lost to Follow-up|0|||
24917506|NCT00642278|50011325|FG003|Overall Study|Lost to Follow-up|1|||
24917507|NCT00642278|50011326|FG004|Overall Study|Lost to Follow-up|0|||
24917508|NCT00642278|50011327|FG005|Overall Study|Lost to Follow-up|1|||
24917509|NCT00642278|50011328|FG006|Overall Study|Lost to Follow-up|1|||
24917510|NCT00642278|50011322|FG000|Overall Study|Physician Decision|0|||
24917511|NCT00642278|50011323|FG001|Overall Study|Physician Decision|0|||
24917512|NCT00642278|50011324|FG002|Overall Study|Physician Decision|0|||
24917513|NCT00642278|50011325|FG003|Overall Study|Physician Decision|1|||
24917514|NCT00642278|50011326|FG004|Overall Study|Physician Decision|0|||
24917515|NCT00642278|50011327|FG005|Overall Study|Physician Decision|0|||
24917516|NCT00642278|50011328|FG006|Overall Study|Physician Decision|0|||
25021645|NCT00089895|50118002|FG000|Overall Study|Surgery|0|||
25021646|NCT00089895|50118003|FG001|Overall Study|Surgery|1|||
25153924|NCT01906489|50269099|FG000|Overall Study|Worsening of CKD|6|||
25153925|NCT01906489|50269100|FG001|Overall Study|Worsening of CKD|4|||
25153926|NCT01906489|50269099|FG000|Overall Study|Withdrawal by Subject|5|||
25153927|NCT01906489|50269100|FG001|Overall Study|Withdrawal by Subject|0|||
24917517|NCT00642278|50011322|FG000|Overall Study|Protocol Violation|0|||
24917518|NCT00642278|50011323|FG001|Overall Study|Protocol Violation|0|||
24917519|NCT00642278|50011324|FG002|Overall Study|Protocol Violation|1|||
24917520|NCT00642278|50011325|FG003|Overall Study|Protocol Violation|1|||
24917521|NCT00642278|50011326|FG004|Overall Study|Protocol Violation|0|||
25021647|NCT00089895|50118002|FG000|Overall Study|Bleeding|0|||
24917522|NCT00642278|50011327|FG005|Overall Study|Protocol Violation|1|||
24917523|NCT00642278|50011328|FG006|Overall Study|Protocol Violation|2|||
24917524|NCT00642278|50011322|FG000|Overall Study|Withdrawal by Subject|1|||
24917525|NCT00642278|50011323|FG001|Overall Study|Withdrawal by Subject|1|||
24917526|NCT00642278|50011324|FG002|Overall Study|Withdrawal by Subject|1|||
24917527|NCT00642278|50011325|FG003|Overall Study|Withdrawal by Subject|3|||
24917528|NCT00642278|50011326|FG004|Overall Study|Withdrawal by Subject|6|||
24917529|NCT00642278|50011327|FG005|Overall Study|Withdrawal by Subject|2|||
24917530|NCT00642278|50011328|FG006|Overall Study|Withdrawal by Subject|2|||
24917531|NCT00642278|50011322|FG000|Overall Study|Noncompliance with study drug regimen|0|||
24917532|NCT00642278|50011323|FG001|Overall Study|Noncompliance with study drug regimen|0|||
24917533|NCT00642278|50011324|FG002|Overall Study|Noncompliance with study drug regimen|0|||
24917534|NCT00642278|50011325|FG003|Overall Study|Noncompliance with study drug regimen|1|||
24917535|NCT00642278|50011326|FG004|Overall Study|Noncompliance with study drug regimen|0|||
24917536|NCT00642278|50011327|FG005|Overall Study|Noncompliance with study drug regimen|0|||
24917537|NCT00642278|50011328|FG006|Overall Study|Noncompliance with study drug regimen|0|||
24917538|NCT00642278|50011322|FG000|Overall Study|Other|2|||
24917539|NCT00642278|50011323|FG001|Overall Study|Other|1|||
24917540|NCT00642278|50011324|FG002|Overall Study|Other|0|||
24917541|NCT00642278|50011325|FG003|Overall Study|Other|1|||
24917542|NCT00642278|50011326|FG004|Overall Study|Other|0|||
24917543|NCT00642278|50011327|FG005|Overall Study|Other|1|||
24917544|NCT00642278|50011328|FG006|Overall Study|Other|0|||
24917545|NCT00543543|50011348|FG000|Base Study|Adverse Event|1|||
24917546|NCT00543543|50011349|FG001|Base Study|Adverse Event|11|||
24917547|NCT00543543|50011350|FG002|Base Study|Adverse Event|0|||
24917548|NCT00543543|50011351|FG003|Base Study|Adverse Event|5|||
24917549|NCT00543543|50011348|FG000|Base Study|Lost to Follow-up|12|||
25021648|NCT00089895|50118003|FG001|Overall Study|Bleeding|2|||
25021649|NCT00089895|50118002|FG000|Overall Study|Physician Decision|3|||
24917550|NCT00543543|50011349|FG001|Base Study|Lost to Follow-up|749|||
24917551|NCT00543543|50011350|FG002|Base Study|Lost to Follow-up|9|||
24917552|NCT00543543|50011351|FG003|Base Study|Lost to Follow-up|701|||
24917553|NCT00543543|50011348|FG000|Base Study|Physician Decision|0|||
25021650|NCT00089895|50118003|FG001|Overall Study|Physician Decision|7|||
25021651|NCT00089895|50118002|FG000|Overall Study|Exclusion criteria met|6|||
25021652|NCT00089895|50118003|FG001|Overall Study|Exclusion criteria met|6|||
25021653|NCT00089895|50118002|FG000|Overall Study|Not otherwise specified|4|||
25021654|NCT00089895|50118003|FG001|Overall Study|Not otherwise specified|8|||
25021655|NCT00089895|50118002|FG000|Overall Study|Missing|4|||
25021656|NCT00089895|50118003|FG001|Overall Study|Missing|2|||
25021657|NCT02714218|50118012|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25021658|NCT02714218|50118013|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
25021659|NCT02714218|50118014|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25021660|NCT02714218|50118012|FG000|Pre-Treatment Period|Other reasons|0|||
25021661|NCT02714218|50118013|FG001|Pre-Treatment Period|Other reasons|1|||
25021662|NCT02714218|50118014|FG002|Pre-Treatment Period|Other reasons|0|||
25021663|NCT02714218|50118012|FG000|Treatment Period|Disease Progression|55|||
25021664|NCT02714218|50118013|FG001|Treatment Period|Disease Progression|52|||
25021665|NCT02714218|50118014|FG002|Treatment Period|Disease Progression|14|||
25021666|NCT02714218|50118012|FG000|Treatment Period|Study drug toxicity|46|||
25021667|NCT02714218|50118013|FG001|Treatment Period|Study drug toxicity|70|||
25021668|NCT02714218|50118014|FG002|Treatment Period|Study drug toxicity|6|||
25021669|NCT02714218|50118012|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
25153928|NCT01906489|50269099|FG000|Overall Study|Worsening of Anemia|1|||
24917554|NCT00543543|50011349|FG001|Base Study|Physician Decision|4|||
24917555|NCT00543543|50011350|FG002|Base Study|Physician Decision|0|||
24917556|NCT00543543|50011351|FG003|Base Study|Physician Decision|7|||
24917557|NCT00543543|50011348|FG000|Base Study|Protocol Violation|0|||
24917558|NCT00543543|50011349|FG001|Base Study|Protocol Violation|6|||
25021670|NCT02714218|50118013|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
25021671|NCT02714218|50118014|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
25021672|NCT02714218|50118012|FG000|Treatment Period|Request to discontinue treatment|1|||
25021673|NCT02714218|50118013|FG001|Treatment Period|Request to discontinue treatment|4|||
25021674|NCT02714218|50118014|FG002|Treatment Period|Request to discontinue treatment|1|||
25021675|NCT02714218|50118012|FG000|Treatment Period|Participant withdrew consent|2|||
25021676|NCT02714218|50118013|FG001|Treatment Period|Participant withdrew consent|2|||
25153929|NCT01906489|50269100|FG001|Overall Study|Worsening of Anemia|0|||
24917559|NCT00543543|50011350|FG002|Base Study|Protocol Violation|0|||
24917560|NCT00543543|50011351|FG003|Base Study|Protocol Violation|6|||
24917561|NCT00543543|50011348|FG000|Base Study|Withdrawal by Subject|7|||
24917562|NCT00543543|50011349|FG001|Base Study|Withdrawal by Subject|482|||
24917563|NCT00543543|50011350|FG002|Base Study|Withdrawal by Subject|5|||
24917564|NCT00543543|50011351|FG003|Base Study|Withdrawal by Subject|503|||
24917565|NCT00543543|50011348|FG000|Extension Study|Adverse Event|0|||
24917566|NCT00543543|50011349|FG001|Extension Study|Adverse Event|0|||
24917567|NCT00543543|50011350|FG002|Extension Study|Adverse Event|0|||
24917568|NCT00543543|50011351|FG003|Extension Study|Adverse Event|5|||
24917569|NCT00543543|50011348|FG000|Extension Study|Lost to Follow-up|0|||
24917570|NCT00543543|50011349|FG001|Extension Study|Lost to Follow-up|0|||
24917571|NCT00543543|50011350|FG002|Extension Study|Lost to Follow-up|0|||
24917572|NCT00543543|50011351|FG003|Extension Study|Lost to Follow-up|77|||
24917573|NCT00543543|50011348|FG000|Extension Study|Physician Decision|0|||
24917574|NCT00543543|50011349|FG001|Extension Study|Physician Decision|0|||
24917575|NCT00543543|50011350|FG002|Extension Study|Physician Decision|0|||
24917576|NCT00543543|50011351|FG003|Extension Study|Physician Decision|7|||
24917577|NCT00543543|50011348|FG000|Extension Study|Pregnancy|0|||
24917578|NCT00543543|50011349|FG001|Extension Study|Pregnancy|0|||
24917579|NCT00543543|50011350|FG002|Extension Study|Pregnancy|0|||
24917580|NCT00543543|50011351|FG003|Extension Study|Pregnancy|6|||
24917581|NCT00543543|50011348|FG000|Extension Study|Protocol Violation|0|||
24917582|NCT00543543|50011349|FG001|Extension Study|Protocol Violation|0|||
24917583|NCT00543543|50011350|FG002|Extension Study|Protocol Violation|0|||
24917584|NCT00543543|50011351|FG003|Extension Study|Protocol Violation|11|||
24917585|NCT00543543|50011348|FG000|Extension Study|Withdrawal by Subject|0|||
24917586|NCT00543543|50011349|FG001|Extension Study|Withdrawal by Subject|0|||
24917587|NCT00543543|50011350|FG002|Extension Study|Withdrawal by Subject|0|||
24917588|NCT00543543|50011351|FG003|Extension Study|Withdrawal by Subject|120|||
24917589|NCT00645164|50011366|FG000|Overall Study|Lost to Follow-up|2|||
24917590|NCT00645164|50011366|FG000|Overall Study|Withdrawal by Subject|4|||
24917591|NCT00645164|50011366|FG000|Overall Study|Protocol Violation|1|||
24917592|NCT00723125|50011372|FG000|Overall Study|Met Dx|1|||
24917593|NCT00723125|50011373|FG001|Overall Study|Met Dx|0|||
24917594|NCT00723125|50011372|FG000|Overall Study|Withdrawal by Subject|15|||
24917595|NCT00723125|50011373|FG001|Overall Study|Withdrawal by Subject|6|||
24917596|NCT00723125|50011372|FG000|Overall Study|Adverse Event|2|||
25021677|NCT02714218|50118014|FG002|Treatment Period|Participant withdrew consent|0|||
25021678|NCT02714218|50118012|FG000|Treatment Period|Maximum clinical benefit|4|||
25021679|NCT02714218|50118013|FG001|Treatment Period|Maximum clinical benefit|2|||
25021680|NCT02714218|50118014|FG002|Treatment Period|Maximum clinical benefit|0|||
25021681|NCT02714218|50118012|FG000|Treatment Period|Administrative reason by sponsor|2|||
25021682|NCT02714218|50118013|FG001|Treatment Period|Administrative reason by sponsor|1|||
25021683|NCT02714218|50118014|FG002|Treatment Period|Administrative reason by sponsor|0|||
25021684|NCT02714218|50118012|FG000|Treatment Period|Other reasons|6|||
24917597|NCT00723125|50011373|FG001|Overall Study|Adverse Event|0|||
24917598|NCT00722423|50011387|FG000|Overall Study|Protocol Violation|0|||
24917599|NCT00722423|50011388|FG001|Overall Study|Protocol Violation|1|||
24917600|NCT00640562|50011398|FG000|Overall Study|Adverse Event|8|||
24917601|NCT00640562|50011399|FG001|Overall Study|Adverse Event|5|||
24917602|NCT00640562|50011398|FG000|Overall Study|Lack of Efficacy|1|||
24917603|NCT00640562|50011399|FG001|Overall Study|Lack of Efficacy|4|||
24917604|NCT00640562|50011398|FG000|Overall Study|Protocol Violation|2|||
24917605|NCT00640562|50011399|FG001|Overall Study|Protocol Violation|4|||
24917606|NCT00640562|50011398|FG000|Overall Study|Withdrawal by Subject|6|||
24917607|NCT00640562|50011399|FG001|Overall Study|Withdrawal by Subject|10|||
24917608|NCT00640562|50011398|FG000|Overall Study|Known risperidone intolerance|0|||
24917609|NCT00640562|50011399|FG001|Overall Study|Known risperidone intolerance|1|||
24917610|NCT00640562|50011398|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
24917611|NCT00640562|50011399|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
24917612|NCT00640562|50011398|FG000|Overall Study|Low study drug dose|0|||
24917613|NCT00640562|50011399|FG001|Overall Study|Low study drug dose|1|||
25021685|NCT02714218|50118013|FG001|Treatment Period|Other reasons|6|||
25021686|NCT02714218|50118014|FG002|Treatment Period|Other reasons|0|||
25021687|NCT02714218|50118012|FG000|Treatment Period|Completed treatment as per protocol|36|||
25021688|NCT02714218|50118013|FG001|Treatment Period|Completed treatment as per protocol|27|||
24917614|NCT00640562|50011398|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
24917615|NCT00640562|50011399|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
24917616|NCT00585923|50011407|FG000|Overall Study|Physician decided not to continue|31|||
25021689|NCT02714218|50118014|FG002|Treatment Period|Completed treatment as per protocol|3|||
25021690|NCT02714218|50118012|FG000|Treatment Period|Not reported|9|||
25021691|NCT02714218|50118013|FG001|Treatment Period|Not reported|6|||
25021692|NCT02714218|50118014|FG002|Treatment Period|Not reported|0|||
25185040|NCT00249795|50334153|FG001|Overall Study|Withdrawal by Subject|742|||
25021693|NCT03154047|50118021|FG000|Overall Study|Death|1|||
24917617|NCT00585923|50011408|FG001|Overall Study|Physician decided not to continue|33|||
24917618|NCT00721955|50011417|FG000|Overall Study|Adverse Event|0|||
24917619|NCT00721955|50011418|FG001|Overall Study|Adverse Event|0|||
24917620|NCT00721955|50011419|FG002|Overall Study|Adverse Event|2|||
24917621|NCT00585689|50011427|FG000|Overall Study|Received different ABI-007 schedule|3|||
24917622|NCT00585689|50011427|FG000|Overall Study|Adverse Event|1|||
25021694|NCT03154047|50118021|FG000|Overall Study|Study terminated by sponsor|76|||
24917623|NCT00585689|50011427|FG000|Overall Study|Patient Declined Surgery|1|||
24917624|NCT00585689|50011427|FG000|Overall Study|Patient had unresectable disease|1|||
24917625|NCT00585689|50011427|FG000|Overall Study|Death|1|||
24917626|NCT00721799|50011431|FG000|Overall Study|Withdrawal by Subject|7|||
24917627|NCT00721799|50011431|FG000|Overall Study|withdraw by subject after scan 1|1|||
24917628|NCT00653432|50011437|FG000|Overall Study|Adverse Event|4|||
25153930|NCT01906489|50269099|FG000|Overall Study|Protocol Violation|0|||
25153931|NCT01906489|50269100|FG001|Overall Study|Protocol Violation|1|||
25153932|NCT01906489|50269099|FG000|Overall Study|Non- Compliance|1|||
24917629|NCT00653432|50011438|FG001|Overall Study|Adverse Event|1|||
24917630|NCT00653432|50011437|FG000|Overall Study|Withdrawal by Subject|4|||
24917631|NCT00653432|50011438|FG001|Overall Study|Withdrawal by Subject|5|||
24917632|NCT00653432|50011437|FG000|Overall Study|Lost to Follow-up|7|||
24917633|NCT00653432|50011438|FG001|Overall Study|Lost to Follow-up|6|||
24917634|NCT00653432|50011437|FG000|Overall Study|Use/Need of Con Therapy|2|||
24917635|NCT00653432|50011438|FG001|Overall Study|Use/Need of Con Therapy|1|||
24917636|NCT00653432|50011437|FG000|Overall Study|Other - Reason Not Provided|5|||
24917637|NCT00653432|50011438|FG001|Overall Study|Other - Reason Not Provided|3|||
24917638|NCT00729365|50011447|FG000|Overall Study|Physician Decision|33|||
24917639|NCT00729365|50011448|FG001|Overall Study|Physician Decision|6|||
24917640|NCT00729365|50011449|FG002|Overall Study|Physician Decision|7|||
24917641|NCT00254293|50011465|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
24917642|NCT00254293|50011466|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
24917643|NCT00254293|50011467|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
24917644|NCT00254293|50011468|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
24917645|NCT00254293|50011469|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
24917646|NCT00254293|50011470|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
24917647|NCT00254293|50011471|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
24917648|NCT00254293|50011465|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
24917649|NCT00254293|50011466|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
24917650|NCT00254293|50011467|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
24917651|NCT00254293|50011468|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
24917652|NCT00254293|50011469|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
24917653|NCT00254293|50011470|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
24917654|NCT00254293|50011471|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
24917655|NCT00254293|50011465|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
24917656|NCT00254293|50011466|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
24917657|NCT00254293|50011467|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
24917658|NCT00254293|50011468|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
24917659|NCT00254293|50011469|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
24917660|NCT00254293|50011470|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
24917661|NCT00254293|50011471|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
24917662|NCT00254293|50011465|FG000|LTE Open Label Variable SC Dosing|Death|0|||
24917663|NCT00254293|50011466|FG001|LTE Open Label Variable SC Dosing|Death|0|||
24917664|NCT00254293|50011467|FG002|LTE Open Label Variable SC Dosing|Death|1|||
24917665|NCT00254293|50011468|FG003|LTE Open Label Variable SC Dosing|Death|0|||
24917666|NCT00254293|50011469|FG004|LTE Open Label Variable SC Dosing|Death|0|||
24917667|NCT00254293|50011470|FG005|LTE Open Label Variable SC Dosing|Death|0|||
24917668|NCT00254293|50011471|FG006|LTE Open Label Variable SC Dosing|Death|0|||
24917669|NCT00254293|50011465|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
24917670|NCT00254293|50011466|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
24917671|NCT00254293|50011467|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
24917672|NCT00254293|50011468|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
24917673|NCT00254293|50011469|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
24917674|NCT00254293|50011470|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
24917675|NCT00254293|50011471|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
24917676|NCT00254293|50011465|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
24917677|NCT00254293|50011466|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
24917678|NCT00254293|50011467|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
24917679|NCT00254293|50011468|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
24917680|NCT00254293|50011469|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
24917681|NCT00254293|50011470|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
24917682|NCT00254293|50011471|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
25153933|NCT01906489|50269100|FG001|Overall Study|Non- Compliance|0|||
24917683|NCT00254293|50011465|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
24917684|NCT00254293|50011466|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
24917685|NCT00254293|50011467|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
24917686|NCT00254293|50011468|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
24917687|NCT00254293|50011469|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
24917688|NCT00254293|50011470|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
25021695|NCT03154047|50118021|FG000|Overall Study|Withdrawal by Subject|3|||
25021696|NCT03156621|50118027|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
25021697|NCT03156621|50118028|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
25021698|NCT03156621|50118027|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
25021699|NCT03156621|50118028|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
25021700|NCT03156543|50118039|FG000|Overall Study|Withdrawal by Subject|1|||
25021701|NCT03156543|50118040|FG001|Overall Study|Withdrawal by Subject|0|||
25021702|NCT02713594|50118048|FG000|Overall Study|Withdrawal by Subject|32|||
25021703|NCT02713594|50118049|FG001|Overall Study|Withdrawal by Subject|22|||
25021704|NCT02713594|50118048|FG000|Overall Study|Lost to Follow-up|358|||
25021705|NCT02713594|50118049|FG001|Overall Study|Lost to Follow-up|374|||
25021706|NCT03152019|50118059|FG000|Overall Study|Adverse Event|0|||
25021707|NCT03152019|50118060|FG001|Overall Study|Adverse Event|1|||
25021708|NCT02714062|50118073|FG000|Overall Study|Adverse Event|0|||
25021709|NCT02714062|50118074|FG001|Overall Study|Adverse Event|0|||
25021710|NCT02714062|50118075|FG002|Overall Study|Adverse Event|2|||
25021711|NCT02714062|50118073|FG000|Overall Study|Withdrawal by Subject|1|||
25153934|NCT01906489|50269099|FG000|Overall Study|Sponsor Decision|1|||
24917689|NCT00254293|50011471|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
24917690|NCT00254293|50011465|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
24917691|NCT00254293|50011466|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
24917692|NCT00254293|50011467|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
24917693|NCT00254293|50011468|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
24917694|NCT00254293|50011469|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
24917695|NCT00254293|50011470|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
24917696|NCT00254293|50011471|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
24917697|NCT00254293|50011465|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
24917698|NCT00254293|50011466|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
24917699|NCT00254293|50011467|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
24917700|NCT00254293|50011468|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
24917701|NCT00254293|50011469|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
24917702|NCT00254293|50011470|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
24917703|NCT00254293|50011471|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
24917704|NCT00254293|50011465|FG000|LTE Open Label Variable SC Dosing|Other|0|||
24917705|NCT00254293|50011466|FG001|LTE Open Label Variable SC Dosing|Other|0|||
24917706|NCT00254293|50011467|FG002|LTE Open Label Variable SC Dosing|Other|2|||
24917707|NCT00254293|50011468|FG003|LTE Open Label Variable SC Dosing|Other|0|||
24917708|NCT00254293|50011469|FG004|LTE Open Label Variable SC Dosing|Other|0|||
24917709|NCT00254293|50011470|FG005|LTE Open Label Variable SC Dosing|Other|0|||
24917710|NCT00254293|50011471|FG006|LTE Open Label Variable SC Dosing|Other|0|||
24917711|NCT00254293|50011465|FG000|LTE Open Label Fixed Dosing|Death|0|||
24917712|NCT00254293|50011466|FG001|LTE Open Label Fixed Dosing|Death|0|||
24917713|NCT00254293|50011467|FG002|LTE Open Label Fixed Dosing|Death|0|||
24917714|NCT00254293|50011468|FG003|LTE Open Label Fixed Dosing|Death|0|||
24917715|NCT00254293|50011469|FG004|LTE Open Label Fixed Dosing|Death|0|||
24917716|NCT00254293|50011470|FG005|LTE Open Label Fixed Dosing|Death|0|||
24917717|NCT00254293|50011471|FG006|LTE Open Label Fixed Dosing|Death|3|||
24917718|NCT00254293|50011465|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
24917719|NCT00254293|50011466|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
24917720|NCT00254293|50011467|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
24917721|NCT00254293|50011468|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
24917722|NCT00254293|50011469|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
24917723|NCT00254293|50011470|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
24917724|NCT00254293|50011471|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
24917725|NCT00254293|50011465|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
24917726|NCT00254293|50011466|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
24917727|NCT00254293|50011467|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
24917728|NCT00254293|50011468|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
24917729|NCT00254293|50011469|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
24917730|NCT00254293|50011470|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
25021712|NCT02714062|50118074|FG001|Overall Study|Withdrawal by Subject|0|||
25021713|NCT02714062|50118075|FG002|Overall Study|Withdrawal by Subject|1|||
25021714|NCT02714062|50118073|FG000|Overall Study|Protocol Violation|0|||
25021715|NCT02714062|50118074|FG001|Overall Study|Protocol Violation|1|||
25021716|NCT02714062|50118075|FG002|Overall Study|Protocol Violation|0|||
25021717|NCT03151395|50118085|FG000|Overall Study|Adverse Event|2|||
25153935|NCT01906489|50269100|FG001|Overall Study|Sponsor Decision|0|||
24917731|NCT00254293|50011471|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
24917732|NCT00254293|50011465|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
24917733|NCT00254293|50011466|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
24917734|NCT00254293|50011467|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
24917735|NCT00254293|50011468|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
24917736|NCT00254293|50011469|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
24917737|NCT00254293|50011470|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
24917738|NCT00254293|50011471|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
24917739|NCT00254293|50011465|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
24917740|NCT00254293|50011466|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
24917741|NCT00254293|50011467|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
24917742|NCT00254293|50011468|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
24917743|NCT00254293|50011469|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
24917744|NCT00254293|50011470|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
24917745|NCT00254293|50011471|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
24917746|NCT00254293|50011465|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
24917747|NCT00254293|50011466|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
24917748|NCT00254293|50011467|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
24917749|NCT00254293|50011468|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
24917750|NCT00254293|50011469|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
24917751|NCT00254293|50011470|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
24917752|NCT00254293|50011471|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
24917753|NCT00254293|50011465|FG000|LTE Open Label Fixed Dosing|Other|0|||
24917754|NCT00254293|50011466|FG001|LTE Open Label Fixed Dosing|Other|0|||
24917755|NCT00254293|50011467|FG002|LTE Open Label Fixed Dosing|Other|0|||
24917756|NCT00254293|50011468|FG003|LTE Open Label Fixed Dosing|Other|0|||
24917757|NCT00254293|50011469|FG004|LTE Open Label Fixed Dosing|Other|0|||
24917758|NCT00254293|50011470|FG005|LTE Open Label Fixed Dosing|Other|0|||
24917759|NCT00254293|50011471|FG006|LTE Open Label Fixed Dosing|Other|1|||
24917760|NCT00736385|50011516|FG000|Overall Study|Withdrawal by Subject|2|||
24917761|NCT00736385|50011517|FG001|Overall Study|Withdrawal by Subject|2|||
24917762|NCT00736385|50011516|FG000|Overall Study|Adverse Event|0|||
24917763|NCT00736385|50011517|FG001|Overall Study|Adverse Event|1|||
24917764|NCT00585221|50011523|FG000|Overall Study|Protocol Violation|8|||
24917765|NCT00253747|50011529|FG000|Overall Study|Lost to Follow-up|13|||
24917766|NCT00253747|50011530|FG001|Overall Study|Lost to Follow-up|14|||
24917767|NCT00253747|50011529|FG000|Overall Study|Withdrawal by Subject|10|||
24917768|NCT00253747|50011530|FG001|Overall Study|Withdrawal by Subject|11|||
24917769|NCT00253747|50011529|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
24917770|NCT00253747|50011530|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
24917771|NCT00252733|50011548|FG000|Overall Study|Withdrawal by Subject|73|||
24917772|NCT00252733|50011549|FG001|Overall Study|Withdrawal by Subject|67|||
24917773|NCT00252733|50011548|FG000|Overall Study|Death|7|||
24917774|NCT00252733|50011549|FG001|Overall Study|Death|5|||
24917775|NCT00252733|50011548|FG000|Overall Study|Lost to Follow-up|12|||
24917776|NCT00252733|50011549|FG001|Overall Study|Lost to Follow-up|6|||
24917777|NCT00252733|50011548|FG000|Overall Study|Multiple Reasons|14|||
24917778|NCT00252733|50011549|FG001|Overall Study|Multiple Reasons|14|||
24917779|NCT00275821|50011558|FG000|Overall Study|Adverse Event|4|||
24917780|NCT00275821|50011559|FG001|Overall Study|Adverse Event|12|||
24917781|NCT00275821|50011560|FG002|Overall Study|Adverse Event|5|||
24917782|NCT00275821|50011558|FG000|Overall Study|Administrative problems|3|||
24917783|NCT00275821|50011559|FG001|Overall Study|Administrative problems|4|||
24917784|NCT00275821|50011560|FG002|Overall Study|Administrative problems|4|||
24917785|NCT00275821|50011558|FG000|Overall Study|Withdrawal by Subject|0|||
24917786|NCT00275821|50011559|FG001|Overall Study|Withdrawal by Subject|2|||
24917787|NCT00275821|50011560|FG002|Overall Study|Withdrawal by Subject|1|||
24917788|NCT00275821|50011558|FG000|Overall Study|Lost to Follow-up|0|||
24917789|NCT00275821|50011559|FG001|Overall Study|Lost to Follow-up|1|||
24917790|NCT00275821|50011560|FG002|Overall Study|Lost to Follow-up|1|||
24917791|NCT00275821|50011558|FG000|Overall Study|Death|0|||
24917792|NCT00275821|50011559|FG001|Overall Study|Death|2|||
24917793|NCT00275821|50011560|FG002|Overall Study|Death|1|||
24917794|NCT00275821|50011558|FG000|Overall Study|Lack of Efficacy|2|||
24917795|NCT00275821|50011559|FG001|Overall Study|Lack of Efficacy|1|||
24917796|NCT00275821|50011560|FG002|Overall Study|Lack of Efficacy|0|||
24917797|NCT00275821|50011558|FG000|Overall Study|Protocol Violation|5|||
24917798|NCT00275821|50011559|FG001|Overall Study|Protocol Violation|1|||
24917799|NCT00275821|50011560|FG002|Overall Study|Protocol Violation|0|||
24917800|NCT00275509|50011570|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
24917801|NCT00275509|50011571|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
24917802|NCT00252577|50011577|FG000|Overall Study|Lost to Follow-up|20|||
24917803|NCT00252499|50011584|FG000|Overall Study|Lost to Follow-up|1|||
24917804|NCT00252499|50011585|FG001|Overall Study|Lost to Follow-up|0|||
24917805|NCT00252499|50011586|FG002|Overall Study|Lost to Follow-up|0|||
24917806|NCT00252187|50011596|FG000|Overall Study|Adverse Event|3|||
24917807|NCT00252187|50011597|FG001|Overall Study|Adverse Event|1|||
24917808|NCT00252187|50011596|FG000|Overall Study|Withdrawal by Subject|1|||
24917809|NCT00252187|50011597|FG001|Overall Study|Withdrawal by Subject|0|||
24917810|NCT00572910|50011609|FG000|Overall Study|Adverse Event|1|||
24917811|NCT00572910|50011610|FG001|Overall Study|Adverse Event|2|||
24917812|NCT00572910|50011611|FG002|Overall Study|Adverse Event|0|||
24917813|NCT00572910|50011612|FG003|Overall Study|Adverse Event|2|||
24917814|NCT00572910|50011613|FG004|Overall Study|Adverse Event|0|||
24917815|NCT00572910|50011614|FG005|Overall Study|Adverse Event|0|||
24917816|NCT00572910|50011615|FG006|Overall Study|Adverse Event|4|||
24917817|NCT00572910|50011616|FG007|Overall Study|Adverse Event|2|||
24917818|NCT00572910|50011617|FG008|Overall Study|Adverse Event|1|||
24917819|NCT00572910|50011618|FG009|Overall Study|Adverse Event|3|||
24917820|NCT00572910|50011619|FG010|Overall Study|Adverse Event|2|||
24917821|NCT00572910|50011609|FG000|Overall Study|Lost to Follow-up|0|||
24917822|NCT00572910|50011610|FG001|Overall Study|Lost to Follow-up|1|||
24917823|NCT00572910|50011611|FG002|Overall Study|Lost to Follow-up|1|||
24917824|NCT00572910|50011612|FG003|Overall Study|Lost to Follow-up|2|||
24917825|NCT00572910|50011613|FG004|Overall Study|Lost to Follow-up|1|||
24917826|NCT00572910|50011614|FG005|Overall Study|Lost to Follow-up|0|||
24917827|NCT00572910|50011615|FG006|Overall Study|Lost to Follow-up|0|||
24917828|NCT00572910|50011616|FG007|Overall Study|Lost to Follow-up|0|||
24917829|NCT00572910|50011617|FG008|Overall Study|Lost to Follow-up|0|||
24917830|NCT00572910|50011618|FG009|Overall Study|Lost to Follow-up|1|||
24917831|NCT00572910|50011619|FG010|Overall Study|Lost to Follow-up|0|||
24917832|NCT00572910|50011609|FG000|Overall Study|Withdrawal by Subject|3|||
24917833|NCT00572910|50011610|FG001|Overall Study|Withdrawal by Subject|0|||
24917834|NCT00572910|50011611|FG002|Overall Study|Withdrawal by Subject|1|||
24917835|NCT00572910|50011612|FG003|Overall Study|Withdrawal by Subject|0|||
24917836|NCT00572910|50011613|FG004|Overall Study|Withdrawal by Subject|1|||
24917837|NCT00572910|50011614|FG005|Overall Study|Withdrawal by Subject|3|||
24917838|NCT00572910|50011615|FG006|Overall Study|Withdrawal by Subject|0|||
24917839|NCT00572910|50011616|FG007|Overall Study|Withdrawal by Subject|2|||
24917840|NCT00572910|50011617|FG008|Overall Study|Withdrawal by Subject|2|||
24917841|NCT00572910|50011618|FG009|Overall Study|Withdrawal by Subject|2|||
24917842|NCT00572910|50011619|FG010|Overall Study|Withdrawal by Subject|1|||
24917843|NCT00163657|50011657|FG000|Overall Study|Death|12|||
24917844|NCT00163657|50011658|FG001|Overall Study|Death|14|||
24917845|NCT00163657|50011659|FG002|Overall Study|Death|19|||
24917846|NCT00163657|50011657|FG000|Overall Study|graft loss|4|||
24917847|NCT00163657|50011658|FG001|Overall Study|graft loss|1|||
24917848|NCT00163657|50011659|FG002|Overall Study|graft loss|2|||
24917849|NCT00163657|50011657|FG000|Overall Study|Withdrawal by Subject|2|||
24917850|NCT00163657|50011658|FG001|Overall Study|Withdrawal by Subject|3|||
24917851|NCT00163657|50011659|FG002|Overall Study|Withdrawal by Subject|2|||
24917852|NCT00163657|50011657|FG000|Overall Study|Physician Decision|0|||
24917853|NCT00163657|50011658|FG001|Overall Study|Physician Decision|1|||
24917854|NCT00163657|50011659|FG002|Overall Study|Physician Decision|1|||
24917855|NCT00163657|50011657|FG000|Overall Study|Non Compliance|1|||
24917856|NCT00163657|50011658|FG001|Overall Study|Non Compliance|0|||
24917857|NCT00163657|50011659|FG002|Overall Study|Non Compliance|0|||
24917858|NCT00163657|50011657|FG000|Overall Study|Lost to Follow-up|1|||
24917859|NCT00163657|50011658|FG001|Overall Study|Lost to Follow-up|3|||
24917860|NCT00163657|50011659|FG002|Overall Study|Lost to Follow-up|10|||
24917861|NCT00163657|50011657|FG000|Overall Study|Other reason|0|||
24917862|NCT00163657|50011658|FG001|Overall Study|Other reason|1|||
24917863|NCT00163657|50011659|FG002|Overall Study|Other reason|3|||
24917864|NCT00609492|50011670|FG000|Overall Study|Withdrawal by Subject|0|||
24917865|NCT00609492|50011671|FG001|Overall Study|Withdrawal by Subject|2|||
24917866|NCT00609492|50011672|FG002|Overall Study|Withdrawal by Subject|3|||
24917867|NCT00609492|50011670|FG000|Overall Study|Lost to Follow-up|1|||
24917868|NCT00609492|50011671|FG001|Overall Study|Lost to Follow-up|1|||
24917869|NCT00609492|50011672|FG002|Overall Study|Lost to Follow-up|4|||
24917870|NCT00230971|50011684|FG000|Randomization|No study drug administered|3|||
24917871|NCT00230971|50011685|FG001|Randomization|No study drug administered|3|||
24917872|NCT00230971|50011684|FG000|Baseline Participants|Lost to Follow-up|5|||
24917873|NCT00230971|50011685|FG001|Baseline Participants|Lost to Follow-up|12|||
24917874|NCT00230971|50011684|FG000|Baseline Participants|Death|6|||
24917875|NCT00230971|50011685|FG001|Baseline Participants|Death|5|||
24917876|NCT00230971|50011684|FG000|Baseline Participants|Withdrawal by Subject|7|||
24917877|NCT00230971|50011685|FG001|Baseline Participants|Withdrawal by Subject|1|||
24917878|NCT00230971|50011684|FG000|Baseline Participants|Adverse Event|1|||
24917879|NCT00230971|50011685|FG001|Baseline Participants|Adverse Event|0|||
24917880|NCT00230971|50011684|FG000|Baseline Participants|No bacteria observed|1|||
24917881|NCT00230971|50011685|FG001|Baseline Participants|No bacteria observed|0|||
24917882|NCT00230971|50011684|FG000|Baseline Participants|Failure to return|1|||
24917883|NCT00230971|50011685|FG001|Baseline Participants|Failure to return|1|||
24917884|NCT00230971|50011684|FG000|Baseline Participants|Reintervention|1|||
24917885|NCT00230971|50011685|FG001|Baseline Participants|Reintervention|0|||
24917886|NCT00211081|50011691|FG000|Overall Study|Withdrawal by Subject|2|||
24917887|NCT00609336|50011695|FG000|Overall Study|Protocol Violation|3|||
24917888|NCT00609336|50011695|FG000|Overall Study|Death|1|||
24917889|NCT00609336|50011695|FG000|Overall Study|LA or Met at Surgery|9|||
24917890|NCT00612066|50011700|FG000|Overall Study|Adverse Event|1|||
24917891|NCT00573144|50011706|FG000|Overall Study|Withdrawal by Subject|2|||
24917892|NCT00573144|50011707|FG001|Overall Study|Withdrawal by Subject|3|||
24917893|NCT00640328|50011719|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
24917894|NCT00640328|50011720|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
24917895|NCT00640328|50011721|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
24917896|NCT00640328|50011722|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
24917897|NCT00640328|50011723|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
24917898|NCT00640328|50011724|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
25153936|NCT01906489|50269099|FG000|Overall Study|Lost to Follow-up|1|||
25153937|NCT01906489|50269100|FG001|Overall Study|Lost to Follow-up|1|||
25153938|NCT01906489|50269099|FG000|Overall Study|Other|1|||
25153939|NCT01906489|50269100|FG001|Overall Study|Other|0|||
25153940|NCT01517373|50269111|FG000|Run-in Period|Death|1|||
25153941|NCT01517373|50269112|FG001|Run-in Period|Death|0|||
25153942|NCT01517373|50269113|FG002|Run-in Period|Death|0|||
25153943|NCT01517373|50269114|FG003|Run-in Period|Death|0|||
25153944|NCT01517373|50269115|FG004|Run-in Period|Death|0|||
25153945|NCT01517373|50269116|FG005|Run-in Period|Death|0|||
25153946|NCT01517373|50269111|FG000|Run-in Period|Adverse Event|5|||
25153947|NCT01517373|50269112|FG001|Run-in Period|Adverse Event|0|||
25153948|NCT01517373|50269113|FG002|Run-in Period|Adverse Event|0|||
25153949|NCT01517373|50269114|FG003|Run-in Period|Adverse Event|0|||
25153950|NCT01517373|50269115|FG004|Run-in Period|Adverse Event|0|||
25153951|NCT01517373|50269116|FG005|Run-in Period|Adverse Event|0|||
25153952|NCT01517373|50269111|FG000|Run-in Period|Did not meet eligibility criteria|34|||
25153953|NCT01517373|50269112|FG001|Run-in Period|Did not meet eligibility criteria|0|||
25153954|NCT01517373|50269113|FG002|Run-in Period|Did not meet eligibility criteria|0|||
24917899|NCT00640328|50011719|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
24917900|NCT00640328|50011720|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
24917901|NCT00640328|50011721|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
24917902|NCT00640328|50011722|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
25153955|NCT01517373|50269114|FG003|Run-in Period|Did not meet eligibility criteria|0|||
25153956|NCT01517373|50269115|FG004|Run-in Period|Did not meet eligibility criteria|0|||
25153957|NCT01517373|50269116|FG005|Run-in Period|Did not meet eligibility criteria|0|||
25153958|NCT01517373|50269111|FG000|Run-in Period|Lost to Follow-up|1|||
25153959|NCT01517373|50269112|FG001|Run-in Period|Lost to Follow-up|0|||
24917903|NCT00640328|50011723|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
24917904|NCT00640328|50011724|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
24917905|NCT00640328|50011719|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
24917906|NCT00640328|50011720|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
24917907|NCT00640328|50011721|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
24917908|NCT00640328|50011722|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
24917909|NCT00640328|50011723|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
24917910|NCT00640328|50011724|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
24917911|NCT00640328|50011719|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
24917912|NCT00640328|50011720|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
24917913|NCT00640328|50011721|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
24917914|NCT00640328|50011722|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
24917915|NCT00640328|50011723|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
24917916|NCT00640328|50011724|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
24917917|NCT00163189|50011745|FG000|Overall Study|Other|6|||
24917918|NCT00163189|50011745|FG000|Overall Study|Lost to Follow-up|1|||
25153960|NCT01517373|50269113|FG002|Run-in Period|Lost to Follow-up|0|||
25153961|NCT01517373|50269114|FG003|Run-in Period|Lost to Follow-up|0|||
24917919|NCT00163189|50011745|FG000|Overall Study|Protocol Violation|2|||
24917920|NCT00163189|50011745|FG000|Overall Study|Death|3|||
24917921|NCT00163189|50011745|FG000|Overall Study|Adverse Event|6|||
24917922|NCT00163189|50011745|FG000|Overall Study|Lack of Efficacy|7|||
24917923|NCT00163189|50011745|FG000|Overall Study|Study terminated by sponsor|11|||
24917924|NCT00163189|50011745|FG000|Overall Study|Withdrawal by Subject|11|||
24917925|NCT00163189|50011745|FG000|Overall Study|Did not meet continuation criterion|16|||
24917926|NCT00162097|50011753|FG000|Overall Study|Participant no longer met study criteria|0|||
24917927|NCT00162097|50011754|FG001|Overall Study|Participant no longer met study criteria|0|||
24917928|NCT00162097|50011755|FG002|Overall Study|Participant no longer met study criteria|0|||
24917929|NCT00162097|50011756|FG003|Overall Study|Participant no longer met study criteria|1|||
24917930|NCT00640016|50011776|FG000|Overall Study|Withdrawal by Subject|0|||
24917931|NCT00640016|50011777|FG001|Overall Study|Withdrawal by Subject|1|||
24917932|NCT00640016|50011778|FG002|Overall Study|Withdrawal by Subject|0|||
24917933|NCT00640016|50011779|FG003|Overall Study|Withdrawal by Subject|0|||
25153962|NCT01517373|50269115|FG004|Run-in Period|Lost to Follow-up|0|||
25153963|NCT01517373|50269116|FG005|Run-in Period|Lost to Follow-up|0|||
25153964|NCT01517373|50269111|FG000|Run-in Period|Withdrawal by Subject|12|||
25153965|NCT01517373|50269112|FG001|Run-in Period|Withdrawal by Subject|0|||
24917934|NCT00640016|50011776|FG000|Overall Study|Study termination|2|||
24917935|NCT00640016|50011777|FG001|Overall Study|Study termination|1|||
24917936|NCT00640016|50011778|FG002|Overall Study|Study termination|3|||
24917937|NCT00640016|50011779|FG003|Overall Study|Study termination|2|||
24917938|NCT00640016|50011776|FG000|Overall Study|Adverse Event|0|||
24917939|NCT00640016|50011777|FG001|Overall Study|Adverse Event|0|||
24917940|NCT00640016|50011778|FG002|Overall Study|Adverse Event|0|||
24917941|NCT00640016|50011779|FG003|Overall Study|Adverse Event|1|||
24917942|NCT00608868|50011796|FG000|Overall Study|Withdrawal by Subject|7|||
24917943|NCT00608868|50011796|FG000|Overall Study|Protocol Violation|3|||
24917944|NCT00608868|50011796|FG000|Overall Study|Lost to Follow-up|2|||
25153966|NCT01517373|50269113|FG002|Run-in Period|Withdrawal by Subject|0|||
25153967|NCT01517373|50269114|FG003|Run-in Period|Withdrawal by Subject|0|||
24917945|NCT00608868|50011796|FG000|Overall Study|Adverse Event|1|||
24917946|NCT00608868|50011796|FG000|Overall Study|Physician Decision|2|||
24917947|NCT00608322|50011802|FG000|Overall Study|Death|2|||
24917948|NCT00608322|50011803|FG001|Overall Study|Death|1|||
25275002|NCT01238861|50589065|FG000|Overall Study|Personal problems|0|||
25275003|NCT01238861|50589066|FG001|Overall Study|Personal problems|0|||
24917951|NCT00608244|50011818|FG000|Overall Study|Adverse Event|1|||
24917952|NCT00608244|50011818|FG000|Overall Study|Low trough levels|1|||
24917953|NCT00605280|50011828|FG000|Year 1|Protocol Violation|0|||
24917954|NCT00605280|50011829|FG001|Year 1|Protocol Violation|0|||
24917955|NCT00605280|50011830|FG002|Year 1|Protocol Violation|0|||
24917956|NCT00605280|50011831|FG003|Year 1|Protocol Violation|1|||
24917957|NCT00605280|50011828|FG000|Year 1|Adverse Event|3|||
24917958|NCT00605280|50011829|FG001|Year 1|Adverse Event|1|||
24917959|NCT00605280|50011830|FG002|Year 1|Adverse Event|1|||
24917960|NCT00605280|50011831|FG003|Year 1|Adverse Event|5|||
24917961|NCT00605280|50011828|FG000|Year 1|Physician Decision|7|||
24917962|NCT00605280|50011829|FG001|Year 1|Physician Decision|4|||
24917963|NCT00605280|50011830|FG002|Year 1|Physician Decision|0|||
24917964|NCT00605280|50011831|FG003|Year 1|Physician Decision|6|||
24917965|NCT00605280|50011828|FG000|Year 1|Withdrawal by Subject|2|||
24917966|NCT00605280|50011829|FG001|Year 1|Withdrawal by Subject|4|||
24917967|NCT00605280|50011830|FG002|Year 1|Withdrawal by Subject|0|||
24917968|NCT00605280|50011831|FG003|Year 1|Withdrawal by Subject|4|||
24917969|NCT00605280|50011828|FG000|Year 1|Other|2|||
24917970|NCT00605280|50011829|FG001|Year 1|Other|1|||
24917971|NCT00605280|50011830|FG002|Year 1|Other|0|||
24917972|NCT00605280|50011831|FG003|Year 1|Other|1|||
24917973|NCT00605280|50011828|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
24917974|NCT00605280|50011829|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
24917975|NCT00605280|50011830|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
25275004|NCT01238861|50589067|FG002|Overall Study|Personal problems|0|||
25275005|NCT01238861|50589068|FG003|Overall Study|Personal problems|1|||
24917976|NCT00605280|50011831|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
24917977|NCT00605280|50011828|FG000|Year 2|Adverse Event|4|||
24917978|NCT00605280|50011829|FG001|Year 2|Adverse Event|0|||
24917979|NCT00605280|50011830|FG002|Year 2|Adverse Event|2|||
24917980|NCT00605280|50011831|FG003|Year 2|Adverse Event|4|||
24917981|NCT00605280|50011828|FG000|Year 2|Physician Decision|11|||
24917982|NCT00605280|50011829|FG001|Year 2|Physician Decision|6|||
24917983|NCT00605280|50011830|FG002|Year 2|Physician Decision|4|||
24917984|NCT00605280|50011831|FG003|Year 2|Physician Decision|11|||
24917985|NCT00605280|50011828|FG000|Year 2|Withdrawal by Subject|4|||
24917986|NCT00605280|50011829|FG001|Year 2|Withdrawal by Subject|0|||
24917987|NCT00605280|50011830|FG002|Year 2|Withdrawal by Subject|0|||
24917988|NCT00605280|50011831|FG003|Year 2|Withdrawal by Subject|4|||
24917989|NCT00605280|50011828|FG000|Year 2|Other|1|||
24917990|NCT00605280|50011829|FG001|Year 2|Other|0|||
24917991|NCT00605280|50011830|FG002|Year 2|Other|0|||
24917992|NCT00605280|50011831|FG003|Year 2|Other|1|||
25153968|NCT01517373|50269115|FG004|Run-in Period|Withdrawal by Subject|0|||
24917993|NCT00605280|50011828|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
24917994|NCT00605280|50011829|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
24917995|NCT00605280|50011830|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
24917996|NCT00605280|50011831|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
24917997|NCT00605280|50011828|FG000|Year 3 Extension|Adverse Event|2|||
25153969|NCT01517373|50269116|FG005|Run-in Period|Withdrawal by Subject|0|||
24917998|NCT00605280|50011829|FG001|Year 3 Extension|Adverse Event|0|||
24917999|NCT00605280|50011830|FG002|Year 3 Extension|Adverse Event|0|||
24918000|NCT00605280|50011831|FG003|Year 3 Extension|Adverse Event|2|||
24918001|NCT00605280|50011828|FG000|Year 3 Extension|Physician Decision|0|||
24918002|NCT00605280|50011829|FG001|Year 3 Extension|Physician Decision|0|||
24918003|NCT00605280|50011830|FG002|Year 3 Extension|Physician Decision|0|||
24918004|NCT00605280|50011831|FG003|Year 3 Extension|Physician Decision|2|||
24918005|NCT00605280|50011828|FG000|Year 3 Extension|Withdrawal by Subject|2|||
24918006|NCT00605280|50011829|FG001|Year 3 Extension|Withdrawal by Subject|0|||
24918007|NCT00605280|50011830|FG002|Year 3 Extension|Withdrawal by Subject|0|||
24918008|NCT00605280|50011831|FG003|Year 3 Extension|Withdrawal by Subject|5|||
24918009|NCT00605280|50011828|FG000|Year 3 Extension|Other|2|||
24918010|NCT00605280|50011829|FG001|Year 3 Extension|Other|0|||
24918011|NCT00605280|50011830|FG002|Year 3 Extension|Other|0|||
24918012|NCT00605280|50011831|FG003|Year 3 Extension|Other|0|||
24918013|NCT00605280|50011828|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
24918014|NCT00605280|50011829|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
24918015|NCT00605280|50011830|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
24918016|NCT00605280|50011831|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
24918017|NCT00607386|50011841|FG000|Overall Study|Physician Decision|1|||
24918018|NCT00638690|50011847|FG000|Overall Study|Death|655|||
24918019|NCT00638690|50011848|FG001|Overall Study|Death|335|||
24918020|NCT00638690|50011847|FG000|Overall Study|Withdrawal by Subject|22|||
24918021|NCT00638690|50011848|FG001|Overall Study|Withdrawal by Subject|5|||
24918022|NCT00638690|50011847|FG000|Overall Study|Lost to Follow-up|4|||
24918023|NCT00638690|50011848|FG001|Overall Study|Lost to Follow-up|2|||
24918024|NCT00543387|50011864|FG000|Panel 1 + Panel 2|Adverse Event|0|||
24918025|NCT00543387|50011865|FG001|Panel 1 + Panel 2|Adverse Event|1|||
24918026|NCT00543387|50011866|FG002|Panel 1 + Panel 2|Adverse Event|0|||
24918027|NCT00543387|50011867|FG003|Panel 1 + Panel 2|Adverse Event|0|||
24918028|NCT00543387|50011868|FG004|Panel 1 + Panel 2|Adverse Event|0|||
24918029|NCT00543387|50011869|FG005|Panel 1 + Panel 2|Adverse Event|0|||
25021718|NCT03151395|50118085|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
25021719|NCT03151395|50118085|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
25021720|NCT03151395|50118085|FG000|Overall Study|Unspecified reason|4|||
25021721|NCT02713828|50118091|FG000|Overall Study|Death|2|||
25021722|NCT02713828|50118092|FG001|Overall Study|Death|0|||
25021723|NCT02713828|50118091|FG000|Overall Study|Withdrawal by Subject|1|||
24918030|NCT00543387|50011870|FG006|Panel 1 + Panel 2|Adverse Event|0|||
24918031|NCT00543387|50011871|FG007|Panel 1 + Panel 2|Adverse Event|1|||
24918032|NCT00543387|50011872|FG008|Panel 1 + Panel 2|Adverse Event|1|||
24918033|NCT00543387|50011873|FG009|Panel 1 + Panel 2|Adverse Event|0|||
24918034|NCT00543387|50011874|FG010|Panel 1 + Panel 2|Adverse Event|0|||
25021724|NCT02713828|50118092|FG001|Overall Study|Withdrawal by Subject|0|||
25021725|NCT02713828|50118091|FG000|Overall Study|study terminated but patient allowed to|2|||
25021726|NCT02713828|50118092|FG001|Overall Study|study terminated but patient allowed to|0|||
25021727|NCT02876328|50118121|FG000|Overall Study|Death|2|||
25021728|NCT02876328|50118122|FG001|Overall Study|Death|1|||
25021729|NCT02876328|50118123|FG002|Overall Study|Death|3|||
24918035|NCT00543387|50011864|FG000|Panel 1 + Panel 2|Physician Decision|0|||
25021730|NCT02876328|50118124|FG003|Overall Study|Death|0|||
24918036|NCT00543387|50011865|FG001|Panel 1 + Panel 2|Physician Decision|0|||
24918037|NCT00543387|50011866|FG002|Panel 1 + Panel 2|Physician Decision|1|||
24918038|NCT00543387|50011867|FG003|Panel 1 + Panel 2|Physician Decision|0|||
24918039|NCT00543387|50011868|FG004|Panel 1 + Panel 2|Physician Decision|0|||
25021731|NCT02876328|50118125|FG004|Overall Study|Death|0|||
25021732|NCT02876328|50118126|FG005|Overall Study|Death|0|||
25021733|NCT02876328|50118127|FG006|Overall Study|Death|1|||
25021734|NCT02876328|50118128|FG007|Overall Study|Death|3|||
25021735|NCT02876328|50118129|FG008|Overall Study|Death|0|||
25021736|NCT02876328|50118130|FG009|Overall Study|Death|1|||
25021737|NCT02876328|50118131|FG010|Overall Study|Death|1|||
25021738|NCT02876328|50118132|FG011|Overall Study|Death|0|||
25021739|NCT02876328|50118133|FG012|Overall Study|Death|0|||
25021740|NCT02876328|50118134|FG013|Overall Study|Death|0|||
25021741|NCT02876328|50118135|FG014|Overall Study|Death|0|||
25021742|NCT02876328|50118136|FG015|Overall Study|Death|0|||
25021743|NCT02876328|50118137|FG016|Overall Study|Death|1|||
25021744|NCT02876328|50118138|FG017|Overall Study|Death|1|||
25021745|NCT02876328|50118139|FG018|Overall Study|Death|0|||
25021746|NCT02876328|50118140|FG019|Overall Study|Death|0|||
25021747|NCT02876328|50118141|FG020|Overall Study|Death|0|||
25021748|NCT02876328|50118142|FG021|Overall Study|Death|1|||
25021749|NCT02876328|50118143|FG022|Overall Study|Death|0|||
25021750|NCT02876328|50118144|FG023|Overall Study|Death|0|||
25021751|NCT02876328|50118121|FG000|Overall Study|Withdrawal by Subject|0|||
25021752|NCT02876328|50118122|FG001|Overall Study|Withdrawal by Subject|2|||
25021753|NCT02876328|50118123|FG002|Overall Study|Withdrawal by Subject|3|||
25021754|NCT02876328|50118124|FG003|Overall Study|Withdrawal by Subject|3|||
25021755|NCT02876328|50118125|FG004|Overall Study|Withdrawal by Subject|0|||
25021756|NCT02876328|50118126|FG005|Overall Study|Withdrawal by Subject|1|||
25021757|NCT02876328|50118127|FG006|Overall Study|Withdrawal by Subject|0|||
25021758|NCT02876328|50118128|FG007|Overall Study|Withdrawal by Subject|1|||
25021759|NCT02876328|50118129|FG008|Overall Study|Withdrawal by Subject|1|||
25021760|NCT02876328|50118130|FG009|Overall Study|Withdrawal by Subject|2|||
25021761|NCT02876328|50118131|FG010|Overall Study|Withdrawal by Subject|0|||
25021762|NCT02876328|50118132|FG011|Overall Study|Withdrawal by Subject|0|||
25021763|NCT02876328|50118133|FG012|Overall Study|Withdrawal by Subject|0|||
25021764|NCT02876328|50118134|FG013|Overall Study|Withdrawal by Subject|0|||
25021765|NCT02876328|50118135|FG014|Overall Study|Withdrawal by Subject|0|||
25021766|NCT02876328|50118136|FG015|Overall Study|Withdrawal by Subject|0|||
25021767|NCT02876328|50118137|FG016|Overall Study|Withdrawal by Subject|1|||
25021768|NCT02876328|50118138|FG017|Overall Study|Withdrawal by Subject|3|||
25021769|NCT02876328|50118139|FG018|Overall Study|Withdrawal by Subject|0|||
25021770|NCT02876328|50118140|FG019|Overall Study|Withdrawal by Subject|0|||
25021771|NCT02876328|50118141|FG020|Overall Study|Withdrawal by Subject|1|||
25021772|NCT02876328|50118142|FG021|Overall Study|Withdrawal by Subject|0|||
25021773|NCT02876328|50118143|FG022|Overall Study|Withdrawal by Subject|0|||
25021774|NCT02876328|50118144|FG023|Overall Study|Withdrawal by Subject|0|||
25021775|NCT02876328|50118121|FG000|Overall Study|Missed 12 Month Visit|15|||
25021776|NCT02876328|50118122|FG001|Overall Study|Missed 12 Month Visit|10|||
25021777|NCT02876328|50118123|FG002|Overall Study|Missed 12 Month Visit|11|||
25021778|NCT02876328|50118124|FG003|Overall Study|Missed 12 Month Visit|6|||
25021779|NCT02876328|50118125|FG004|Overall Study|Missed 12 Month Visit|10|||
25021780|NCT02876328|50118126|FG005|Overall Study|Missed 12 Month Visit|14|||
25021781|NCT02876328|50118127|FG006|Overall Study|Missed 12 Month Visit|3|||
25021782|NCT02876328|50118128|FG007|Overall Study|Missed 12 Month Visit|8|||
25021783|NCT02876328|50118129|FG008|Overall Study|Missed 12 Month Visit|9|||
25021784|NCT02876328|50118130|FG009|Overall Study|Missed 12 Month Visit|5|||
25021785|NCT02876328|50118131|FG010|Overall Study|Missed 12 Month Visit|4|||
25021786|NCT02876328|50118132|FG011|Overall Study|Missed 12 Month Visit|1|||
25021787|NCT02876328|50118133|FG012|Overall Study|Missed 12 Month Visit|5|||
25021788|NCT02876328|50118134|FG013|Overall Study|Missed 12 Month Visit|4|||
25021789|NCT02876328|50118135|FG014|Overall Study|Missed 12 Month Visit|4|||
25021790|NCT02876328|50118136|FG015|Overall Study|Missed 12 Month Visit|4|||
25021791|NCT02876328|50118137|FG016|Overall Study|Missed 12 Month Visit|3|||
25021792|NCT02876328|50118138|FG017|Overall Study|Missed 12 Month Visit|6|||
25021793|NCT02876328|50118139|FG018|Overall Study|Missed 12 Month Visit|2|||
25021794|NCT02876328|50118140|FG019|Overall Study|Missed 12 Month Visit|2|||
25021795|NCT02876328|50118141|FG020|Overall Study|Missed 12 Month Visit|11|||
25021796|NCT02876328|50118142|FG021|Overall Study|Missed 12 Month Visit|7|||
25021797|NCT02876328|50118143|FG022|Overall Study|Missed 12 Month Visit|1|||
25021798|NCT02876328|50118144|FG023|Overall Study|Missed 12 Month Visit|0|||
25021799|NCT02875860|50118172|FG000|Overall Study|Withdrawal by Subject|0|||
25021800|NCT02875860|50118173|FG001|Overall Study|Withdrawal by Subject|1|||
25021801|NCT02875392|50118181|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
25021802|NCT02875392|50118182|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
25021803|NCT03127644|50118191|FG000|Overall Study|Study-specific withdrawal criteria|0|||
25021804|NCT03127644|50118192|FG001|Overall Study|Study-specific withdrawal criteria|0|||
25021805|NCT03127644|50118193|FG002|Overall Study|Study-specific withdrawal criteria|2|||
25021806|NCT03965962|50118207|FG000|Overall Study|Adverse Event|1|||
25021807|NCT03965962|50118208|FG001|Overall Study|Adverse Event|0|||
25021808|NCT03965962|50118209|FG002|Overall Study|Adverse Event|0|||
25021809|NCT03965962|50118210|FG003|Overall Study|Adverse Event|0|||
25021810|NCT03965962|50118207|FG000|Overall Study|Protocol Violation|21|||
25021811|NCT03965962|50118208|FG001|Overall Study|Protocol Violation|4|||
25021812|NCT03965962|50118209|FG002|Overall Study|Protocol Violation|10|||
25021813|NCT03965962|50118210|FG003|Overall Study|Protocol Violation|5|||
24918040|NCT00543387|50011869|FG005|Panel 1 + Panel 2|Physician Decision|0|||
24918041|NCT00543387|50011870|FG006|Panel 1 + Panel 2|Physician Decision|0|||
24918042|NCT00543387|50011871|FG007|Panel 1 + Panel 2|Physician Decision|1|||
24918043|NCT00543387|50011872|FG008|Panel 1 + Panel 2|Physician Decision|0|||
24918044|NCT00543387|50011873|FG009|Panel 1 + Panel 2|Physician Decision|0|||
24918045|NCT00543387|50011874|FG010|Panel 1 + Panel 2|Physician Decision|0|||
24918046|NCT00543387|50011864|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
24918047|NCT00543387|50011865|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
24918048|NCT00543387|50011866|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
24918049|NCT00543387|50011867|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
24918050|NCT00543387|50011868|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
24918051|NCT00543387|50011869|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
24918052|NCT00543387|50011870|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
24918053|NCT00543387|50011871|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
24918054|NCT00543387|50011872|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
24918055|NCT00543387|50011873|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
24918056|NCT00543387|50011874|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
24918057|NCT00543387|50011864|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
24918058|NCT00543387|50011865|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
24918059|NCT00543387|50011866|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
24918060|NCT00543387|50011867|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
24918061|NCT00543387|50011868|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
24918062|NCT00543387|50011869|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
24918063|NCT00543387|50011870|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
24918064|NCT00543387|50011871|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
24918065|NCT00543387|50011872|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
24918066|NCT00543387|50011873|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
24918067|NCT00543387|50011874|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
24918068|NCT00543387|50011864|FG000|Crossover Participants|Progressive Disease|0|||
24918069|NCT00543387|50011865|FG001|Crossover Participants|Progressive Disease|0|||
24918070|NCT00543387|50011866|FG002|Crossover Participants|Progressive Disease|0|||
24918071|NCT00543387|50011867|FG003|Crossover Participants|Progressive Disease|0|||
24918072|NCT00543387|50011868|FG004|Crossover Participants|Progressive Disease|0|||
24918073|NCT00543387|50011869|FG005|Crossover Participants|Progressive Disease|0|||
24918074|NCT00543387|50011870|FG006|Crossover Participants|Progressive Disease|0|||
24918075|NCT00543387|50011871|FG007|Crossover Participants|Progressive Disease|0|||
24918076|NCT00543387|50011872|FG008|Crossover Participants|Progressive Disease|0|||
24918077|NCT00543387|50011873|FG009|Crossover Participants|Progressive Disease|1|||
24918078|NCT00543387|50011874|FG010|Crossover Participants|Progressive Disease|2|||
24918079|NCT00543387|50011864|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
24918080|NCT00543387|50011865|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
24918081|NCT00543387|50011866|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
24918082|NCT00543387|50011867|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
24918083|NCT00543387|50011868|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
24918084|NCT00543387|50011869|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
24918085|NCT00543387|50011870|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
25021814|NCT03965962|50118207|FG000|Overall Study|Lost to Follow-up|0|||
25021815|NCT03965962|50118208|FG001|Overall Study|Lost to Follow-up|1|||
25021816|NCT03965962|50118209|FG002|Overall Study|Lost to Follow-up|0|||
25021817|NCT03965962|50118210|FG003|Overall Study|Lost to Follow-up|0|||
24918086|NCT00543387|50011871|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
24918087|NCT00543387|50011872|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
25275006|NCT01238861|50589069|FG004|Overall Study|Personal problems|0|||
25275007|NCT01238861|50589070|FG005|Overall Study|Personal problems|0|||
25275008|NCT01238861|50589065|FG000|Overall Study|Unable to continue visits|0|||
25275009|NCT01238861|50589066|FG001|Overall Study|Unable to continue visits|0|||
25275010|NCT01238861|50589067|FG002|Overall Study|Unable to continue visits|0|||
25275011|NCT01238861|50589068|FG003|Overall Study|Unable to continue visits|1|||
25275012|NCT01238861|50589069|FG004|Overall Study|Unable to continue visits|0|||
25275013|NCT01238861|50589070|FG005|Overall Study|Unable to continue visits|1|||
25275014|NCT01238861|50589065|FG000|Overall Study|Serious adverse event|0|||
25275015|NCT01238861|50589066|FG001|Overall Study|Serious adverse event|0|||
25275016|NCT01238861|50589067|FG002|Overall Study|Serious adverse event|0|||
25275017|NCT01238861|50589068|FG003|Overall Study|Serious adverse event|0|||
25275018|NCT01238861|50589069|FG004|Overall Study|Serious adverse event|0|||
25275019|NCT01238861|50589070|FG005|Overall Study|Serious adverse event|1|||
25275020|NCT01238861|50589065|FG000|Overall Study|Lack of compliance|0|||
25275021|NCT01238861|50589066|FG001|Overall Study|Lack of compliance|0|||
24918088|NCT00543387|50011873|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
24918089|NCT00543387|50011874|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
24918090|NCT00635570|50011904|FG000|Overall Study|Lost to Follow-up|8|||
25021818|NCT03965962|50118207|FG000|Overall Study|Withdrawal by Subject|3|||
25021819|NCT03965962|50118208|FG001|Overall Study|Withdrawal by Subject|0|||
24918091|NCT00635570|50011905|FG001|Overall Study|Lost to Follow-up|8|||
24918092|NCT00635570|50011904|FG000|Overall Study|Withdrawal by Subject|1|||
24918093|NCT00635570|50011905|FG001|Overall Study|Withdrawal by Subject|1|||
24918094|NCT00635570|50011904|FG000|Overall Study|Adverse Event|2|||
24918095|NCT00635570|50011905|FG001|Overall Study|Adverse Event|0|||
24918096|NCT00635570|50011904|FG000|Overall Study|Physician Decision|1|||
24918097|NCT00635570|50011905|FG001|Overall Study|Physician Decision|0|||
24918098|NCT00635570|50011904|FG000|Overall Study|Did not complete survey|2|||
24918099|NCT00635570|50011905|FG001|Overall Study|Did not complete survey|1|||
24918100|NCT00635570|50011904|FG000|Overall Study|Early termination(No sexual activity)|1|||
24918101|NCT00635570|50011905|FG001|Overall Study|Early termination(No sexual activity)|1|||
24918102|NCT00635492|50011913|FG000|Overall Study|Death|12|||
24918103|NCT00635492|50011914|FG001|Overall Study|Death|40|||
24918104|NCT00635492|50011913|FG000|Overall Study|Lost to Follow-up|151|||
24918105|NCT00635492|50011914|FG001|Overall Study|Lost to Follow-up|172|||
24918106|NCT00635492|50011913|FG000|Overall Study|Physician Decision|32|||
24918107|NCT00635492|50011914|FG001|Overall Study|Physician Decision|22|||
25021820|NCT03965962|50118209|FG002|Overall Study|Withdrawal by Subject|0|||
25021821|NCT03965962|50118210|FG003|Overall Study|Withdrawal by Subject|1|||
25021822|NCT03151551|50118222|FG000|Open-Label Treatment Period|Adverse Event|0|||
25021823|NCT03151551|50118223|FG001|Open-Label Treatment Period|Adverse Event|2|||
25021824|NCT03151551|50118222|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
25021825|NCT03151551|50118223|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
24918108|NCT00635492|50011913|FG000|Overall Study|Sponsor decision|2|||
24918109|NCT00635492|50011914|FG001|Overall Study|Sponsor decision|3|||
24918110|NCT00635492|50011913|FG000|Overall Study|Withdrawal by Subject|82|||
24918111|NCT00635492|50011914|FG001|Overall Study|Withdrawal by Subject|45|||
24918112|NCT00543309|50011927|FG000|Overall Study|Physician Decision|0|||
24918113|NCT00543309|50011928|FG001|Overall Study|Physician Decision|1|||
24918114|NCT00543309|50011929|FG002|Overall Study|Physician Decision|0|||
24918115|NCT00569582|50011938|FG000|Overall Study|Withdrawal by Subject|5|||
24918116|NCT00569582|50011938|FG000|Overall Study|Death|2|||
24918117|NCT00569582|50011938|FG000|Overall Study|Adverse Event|7|||
24918118|NCT00569582|50011938|FG000|Overall Study|Subject was too ill to travel.|1|||
24918119|NCT00569582|50011938|FG000|Overall Study|Subject was non-compliant.|1|||
24918120|NCT00721409|50011945|FG000|Overall Study|Global deterioration of health status|2|||
24918121|NCT00721409|50011946|FG001|Overall Study|Global deterioration of health status|6|||
24918122|NCT00721409|50011947|FG002|Overall Study|Global deterioration of health status|3|||
25021826|NCT03151551|50118222|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
25021827|NCT03151551|50118223|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
25021828|NCT03151551|50118222|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
25021829|NCT03151551|50118223|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
25021830|NCT03151551|50118222|FG000|Open-Label Treatment Period|Physician Decision|3|||
25021831|NCT03151551|50118223|FG001|Open-Label Treatment Period|Physician Decision|0|||
25021832|NCT03151551|50118222|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
25021833|NCT03151551|50118223|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
25021834|NCT03151551|50118222|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
25021835|NCT03151551|50118223|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
25021836|NCT03151551|50118222|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
25021837|NCT03151551|50118223|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
25021838|NCT03151551|50118222|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
25021839|NCT03151551|50118223|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
25275022|NCT01238861|50589067|FG002|Overall Study|Lack of compliance|0|||
24918123|NCT00721409|50011945|FG000|Overall Study|Death|0|||
24918124|NCT00721409|50011946|FG001|Overall Study|Death|1|||
24918125|NCT00721409|50011947|FG002|Overall Study|Death|0|||
24918126|NCT00721409|50011945|FG000|Overall Study|Randomized not Treated|0|||
24918127|NCT00721409|50011946|FG001|Overall Study|Randomized not Treated|1|||
24918128|NCT00721409|50011947|FG002|Overall Study|Randomized not Treated|4|||
24918129|NCT00721409|50011945|FG000|Overall Study|Reason not specified|1|||
24918130|NCT00721409|50011946|FG001|Overall Study|Reason not specified|0|||
24918131|NCT00721409|50011947|FG002|Overall Study|Reason not specified|2|||
24918132|NCT00721409|50011945|FG000|Overall Study|Adverse Event|0|||
24918133|NCT00721409|50011946|FG001|Overall Study|Adverse Event|13|||
24918134|NCT00721409|50011947|FG002|Overall Study|Adverse Event|2|||
24918135|NCT00721409|50011945|FG000|Overall Study|Lost to Follow-up|0|||
24918136|NCT00721409|50011946|FG001|Overall Study|Lost to Follow-up|0|||
24918137|NCT00721409|50011947|FG002|Overall Study|Lost to Follow-up|1|||
24918138|NCT00721409|50011945|FG000|Overall Study|Withdrawal by Subject|1|||
24918139|NCT00721409|50011946|FG001|Overall Study|Withdrawal by Subject|6|||
24918140|NCT00721409|50011947|FG002|Overall Study|Withdrawal by Subject|5|||
24918141|NCT00721409|50011945|FG000|Overall Study|Objective progression or relapse|8|||
24918142|NCT00721409|50011946|FG001|Overall Study|Objective progression or relapse|55|||
24918143|NCT00721409|50011947|FG002|Overall Study|Objective progression or relapse|62|||
24918144|NCT00542997|50011971|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
24918145|NCT00542997|50011971|FG000|Wash in / Wash Out Period|Adverse Event|3|||
24918146|NCT00542997|50011971|FG000|Efficacy Period|Adverse Event|3|||
24918147|NCT00572832|50011980|FG000|Overall Study|Lost to Follow-up|0|||
24918148|NCT00572832|50011981|FG001|Overall Study|Lost to Follow-up|11|||
24918149|NCT00572832|50011980|FG000|Overall Study|Pregnancy|0|||
25153970|NCT01517373|50269111|FG000|Run-in Period|Sponsor Decision|3|||
25153971|NCT01517373|50269112|FG001|Run-in Period|Sponsor Decision|0|||
25153972|NCT01517373|50269113|FG002|Run-in Period|Sponsor Decision|0|||
25153973|NCT01517373|50269114|FG003|Run-in Period|Sponsor Decision|0|||
25153974|NCT01517373|50269115|FG004|Run-in Period|Sponsor Decision|0|||
25153975|NCT01517373|50269116|FG005|Run-in Period|Sponsor Decision|0|||
25153976|NCT01517373|50269111|FG000|Run-in Period|Other|1|||
25153977|NCT01517373|50269112|FG001|Run-in Period|Other|0|||
25153978|NCT01517373|50269113|FG002|Run-in Period|Other|0|||
25153979|NCT01517373|50269114|FG003|Run-in Period|Other|0|||
25153980|NCT01517373|50269115|FG004|Run-in Period|Other|0|||
25153981|NCT01517373|50269116|FG005|Run-in Period|Other|0|||
25153982|NCT01517373|50269111|FG000|Treatment Period|Adverse Event|0|||
25153983|NCT01517373|50269112|FG001|Treatment Period|Adverse Event|0|||
25153984|NCT01517373|50269113|FG002|Treatment Period|Adverse Event|0|||
25153985|NCT01517373|50269114|FG003|Treatment Period|Adverse Event|0|||
25153986|NCT01517373|50269115|FG004|Treatment Period|Adverse Event|0|||
25153987|NCT01517373|50269116|FG005|Treatment Period|Adverse Event|2|||
25153988|NCT01517373|50269111|FG000|Treatment Period|Lost to Follow-up|0|||
25185041|NCT00249795|50334152|FG000|Overall Study|Thromboembolic / outcome event|39|||
24918150|NCT00572832|50011981|FG001|Overall Study|Pregnancy|1|||
24918151|NCT03917823|50011989|FG000|Overall Study|Lost to Follow-up|1|||
24918152|NCT03917823|50011990|FG001|Overall Study|Lost to Follow-up|1|||
25153989|NCT01517373|50269112|FG001|Treatment Period|Lost to Follow-up|0|||
25153990|NCT01517373|50269113|FG002|Treatment Period|Lost to Follow-up|1|||
25185042|NCT00249795|50334153|FG001|Overall Study|Thromboembolic / outcome event|45|||
24918153|NCT03917823|50011989|FG000|Overall Study|Withdrawal by Subject|0|||
25153991|NCT01517373|50269114|FG003|Treatment Period|Lost to Follow-up|1|||
25185043|NCT00249795|50334152|FG000|Overall Study|Oral anticoagulant required|2|||
25153992|NCT01517373|50269115|FG004|Treatment Period|Lost to Follow-up|0|||
25153993|NCT01517373|50269116|FG005|Treatment Period|Lost to Follow-up|0|||
25153994|NCT01517373|50269111|FG000|Treatment Period|Withdrawal by Subject|0|||
25153995|NCT01517373|50269112|FG001|Treatment Period|Withdrawal by Subject|3|||
25153996|NCT01517373|50269113|FG002|Treatment Period|Withdrawal by Subject|2|||
25153997|NCT01517373|50269114|FG003|Treatment Period|Withdrawal by Subject|2|||
25153998|NCT01517373|50269115|FG004|Treatment Period|Withdrawal by Subject|2|||
25153999|NCT01517373|50269116|FG005|Treatment Period|Withdrawal by Subject|3|||
25154000|NCT01517373|50269111|FG000|Treatment Period|Other|0|||
25154001|NCT01517373|50269112|FG001|Treatment Period|Other|0|||
25154002|NCT01517373|50269113|FG002|Treatment Period|Other|0|||
25154003|NCT01517373|50269114|FG003|Treatment Period|Other|0|||
25154004|NCT01517373|50269115|FG004|Treatment Period|Other|1|||
25154005|NCT01517373|50269116|FG005|Treatment Period|Other|0|||
25154006|NCT01517373|50269111|FG000|Treatment Period|Protocol Violation|0|||
25154007|NCT01517373|50269112|FG001|Treatment Period|Protocol Violation|0|||
25154008|NCT01517373|50269113|FG002|Treatment Period|Protocol Violation|0|||
24918154|NCT03917823|50011990|FG001|Overall Study|Withdrawal by Subject|1|||
24918155|NCT00229723|50012003|FG000|Concomitant Phase|Adverse Event|4|||
24918156|NCT00229723|50012004|FG001|Concomitant Phase|Adverse Event|2|||
24918157|NCT00229723|50012005|FG002|Concomitant Phase|Adverse Event|5|||
24918158|NCT00229723|50012006|FG003|Concomitant Phase|Adverse Event|2|||
24918159|NCT00229723|50012007|FG004|Concomitant Phase|Adverse Event|0|||
24918160|NCT00229723|50012008|FG005|Concomitant Phase|Adverse Event|1|||
24918161|NCT00229723|50012009|FG006|Concomitant Phase|Adverse Event|2|||
24918162|NCT00229723|50012003|FG000|Concomitant Phase|Objective disease progression|0|||
24918163|NCT00229723|50012004|FG001|Concomitant Phase|Objective disease progression|0|||
24918164|NCT00229723|50012005|FG002|Concomitant Phase|Objective disease progression|0|||
24918165|NCT00229723|50012006|FG003|Concomitant Phase|Objective disease progression|0|||
24918166|NCT00229723|50012007|FG004|Concomitant Phase|Objective disease progression|0|||
24918167|NCT00229723|50012008|FG005|Concomitant Phase|Objective disease progression|0|||
24918168|NCT00229723|50012009|FG006|Concomitant Phase|Objective disease progression|0|||
24918169|NCT00229723|50012003|FG000|Concomitant Phase|Clinical progression|0|||
24918170|NCT00229723|50012004|FG001|Concomitant Phase|Clinical progression|0|||
24918171|NCT00229723|50012005|FG002|Concomitant Phase|Clinical progression|0|||
24918172|NCT00229723|50012006|FG003|Concomitant Phase|Clinical progression|0|||
24918173|NCT00229723|50012007|FG004|Concomitant Phase|Clinical progression|0|||
24918174|NCT00229723|50012008|FG005|Concomitant Phase|Clinical progression|0|||
24918175|NCT00229723|50012009|FG006|Concomitant Phase|Clinical progression|1|||
24918176|NCT00229723|50012003|FG000|Concomitant Phase|Lost to Follow-up|0|||
24918177|NCT00229723|50012004|FG001|Concomitant Phase|Lost to Follow-up|0|||
24918178|NCT00229723|50012005|FG002|Concomitant Phase|Lost to Follow-up|0|||
24918179|NCT00229723|50012006|FG003|Concomitant Phase|Lost to Follow-up|0|||
24918180|NCT00229723|50012007|FG004|Concomitant Phase|Lost to Follow-up|1|||
24918181|NCT00229723|50012008|FG005|Concomitant Phase|Lost to Follow-up|0|||
24918182|NCT00229723|50012009|FG006|Concomitant Phase|Lost to Follow-up|0|||
24918183|NCT00229723|50012003|FG000|Concomitant Phase|Informed consent withdrawn|3|||
24918184|NCT00229723|50012004|FG001|Concomitant Phase|Informed consent withdrawn|2|||
24918185|NCT00229723|50012005|FG002|Concomitant Phase|Informed consent withdrawn|0|||
24918186|NCT00229723|50012006|FG003|Concomitant Phase|Informed consent withdrawn|2|||
24918187|NCT00229723|50012007|FG004|Concomitant Phase|Informed consent withdrawn|0|||
24918188|NCT00229723|50012008|FG005|Concomitant Phase|Informed consent withdrawn|0|||
24918189|NCT00229723|50012009|FG006|Concomitant Phase|Informed consent withdrawn|0|||
24918190|NCT00229723|50012003|FG000|Concomitant Phase|Severe non-compliance|0|||
24918191|NCT00229723|50012004|FG001|Concomitant Phase|Severe non-compliance|1|||
24918192|NCT00229723|50012005|FG002|Concomitant Phase|Severe non-compliance|0|||
24918193|NCT00229723|50012006|FG003|Concomitant Phase|Severe non-compliance|0|||
24918194|NCT00229723|50012007|FG004|Concomitant Phase|Severe non-compliance|1|||
24918195|NCT00229723|50012008|FG005|Concomitant Phase|Severe non-compliance|0|||
24918196|NCT00229723|50012009|FG006|Concomitant Phase|Severe non-compliance|0|||
25154009|NCT01517373|50269114|FG003|Treatment Period|Protocol Violation|0|||
25154010|NCT01517373|50269115|FG004|Treatment Period|Protocol Violation|1|||
25154011|NCT01517373|50269116|FG005|Treatment Period|Protocol Violation|0|||
25154012|NCT01517373|50269111|FG000|Treatment Period|Lack of Efficacy|0|||
24918197|NCT00229723|50012003|FG000|Concomitant Phase|Other|3|||
24918198|NCT00229723|50012004|FG001|Concomitant Phase|Other|0|||
24918199|NCT00229723|50012005|FG002|Concomitant Phase|Other|1|||
24918200|NCT00229723|50012006|FG003|Concomitant Phase|Other|1|||
24918201|NCT00229723|50012007|FG004|Concomitant Phase|Other|0|||
24918202|NCT00229723|50012008|FG005|Concomitant Phase|Other|2|||
24918203|NCT00229723|50012009|FG006|Concomitant Phase|Other|0|||
24918204|NCT00229723|50012003|FG000|Maintenance Phase|Adverse Event|7|||
24918205|NCT00229723|50012004|FG001|Maintenance Phase|Adverse Event|2|||
24918206|NCT00229723|50012005|FG002|Maintenance Phase|Adverse Event|1|||
24918207|NCT00229723|50012006|FG003|Maintenance Phase|Adverse Event|4|||
24918208|NCT00229723|50012007|FG004|Maintenance Phase|Adverse Event|7|||
24918209|NCT00229723|50012008|FG005|Maintenance Phase|Adverse Event|5|||
24918210|NCT00229723|50012009|FG006|Maintenance Phase|Adverse Event|2|||
24918211|NCT00229723|50012003|FG000|Maintenance Phase|Objective disease progression|5|||
24918212|NCT00229723|50012004|FG001|Maintenance Phase|Objective disease progression|5|||
24918213|NCT00229723|50012005|FG002|Maintenance Phase|Objective disease progression|3|||
24918214|NCT00229723|50012006|FG003|Maintenance Phase|Objective disease progression|6|||
24918215|NCT00229723|50012007|FG004|Maintenance Phase|Objective disease progression|2|||
24918216|NCT00229723|50012008|FG005|Maintenance Phase|Objective disease progression|9|||
24918217|NCT00229723|50012009|FG006|Maintenance Phase|Objective disease progression|5|||
24918218|NCT00229723|50012003|FG000|Maintenance Phase|Clinical progression|4|||
24918219|NCT00229723|50012004|FG001|Maintenance Phase|Clinical progression|1|||
24918220|NCT00229723|50012005|FG002|Maintenance Phase|Clinical progression|2|||
24918221|NCT00229723|50012006|FG003|Maintenance Phase|Clinical progression|2|||
24918222|NCT00229723|50012007|FG004|Maintenance Phase|Clinical progression|1|||
24918223|NCT00229723|50012008|FG005|Maintenance Phase|Clinical progression|1|||
24918224|NCT00229723|50012009|FG006|Maintenance Phase|Clinical progression|1|||
24918225|NCT00229723|50012003|FG000|Maintenance Phase|Lost to Follow-up|0|||
24918226|NCT00229723|50012004|FG001|Maintenance Phase|Lost to Follow-up|1|||
24918227|NCT00229723|50012005|FG002|Maintenance Phase|Lost to Follow-up|2|||
24918228|NCT00229723|50012006|FG003|Maintenance Phase|Lost to Follow-up|2|||
24918229|NCT00229723|50012007|FG004|Maintenance Phase|Lost to Follow-up|0|||
24918230|NCT00229723|50012008|FG005|Maintenance Phase|Lost to Follow-up|0|||
24918231|NCT00229723|50012009|FG006|Maintenance Phase|Lost to Follow-up|1|||
24918232|NCT00229723|50012003|FG000|Maintenance Phase|Informed consent withdrawn|1|||
24918233|NCT00229723|50012004|FG001|Maintenance Phase|Informed consent withdrawn|0|||
24918234|NCT00229723|50012005|FG002|Maintenance Phase|Informed consent withdrawn|0|||
24918235|NCT00229723|50012006|FG003|Maintenance Phase|Informed consent withdrawn|1|||
24918236|NCT00229723|50012007|FG004|Maintenance Phase|Informed consent withdrawn|1|||
24918237|NCT00229723|50012008|FG005|Maintenance Phase|Informed consent withdrawn|1|||
24918238|NCT00229723|50012009|FG006|Maintenance Phase|Informed consent withdrawn|0|||
24918239|NCT00229723|50012003|FG000|Maintenance Phase|Severe non-compliance|3|||
24918240|NCT00229723|50012004|FG001|Maintenance Phase|Severe non-compliance|1|||
24918241|NCT00229723|50012005|FG002|Maintenance Phase|Severe non-compliance|0|||
24918242|NCT00229723|50012006|FG003|Maintenance Phase|Severe non-compliance|0|||
24918243|NCT00229723|50012007|FG004|Maintenance Phase|Severe non-compliance|1|||
24918244|NCT00229723|50012008|FG005|Maintenance Phase|Severe non-compliance|0|||
24918245|NCT00229723|50012009|FG006|Maintenance Phase|Severe non-compliance|0|||
24918246|NCT00229723|50012003|FG000|Maintenance Phase|Other|5|||
24918247|NCT00229723|50012004|FG001|Maintenance Phase|Other|4|||
24918248|NCT00229723|50012005|FG002|Maintenance Phase|Other|1|||
24918249|NCT00229723|50012006|FG003|Maintenance Phase|Other|2|||
24918250|NCT00229723|50012007|FG004|Maintenance Phase|Other|3|||
24918251|NCT00229723|50012008|FG005|Maintenance Phase|Other|3|||
24918252|NCT00229723|50012009|FG006|Maintenance Phase|Other|1|||
24918253|NCT00606684|50012031|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
24918254|NCT00606684|50012032|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
24918255|NCT00606684|50012033|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
24918256|NCT00606684|50012034|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
24918257|NCT00606684|50012035|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
24918258|NCT00606684|50012036|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
24918259|NCT00606684|50012037|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
24918260|NCT00606684|50012031|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
24918261|NCT00606684|50012032|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
24918262|NCT00606684|50012033|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
24918263|NCT00606684|50012034|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
24918264|NCT00606684|50012035|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
24918265|NCT00606684|50012036|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
24918266|NCT00606684|50012037|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
24918267|NCT00606684|50012031|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
24918268|NCT00606684|50012032|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
24918269|NCT00606684|50012033|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
24918270|NCT00606684|50012034|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
24918271|NCT00606684|50012035|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
24918272|NCT00606684|50012036|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
24918273|NCT00606684|50012037|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
24918274|NCT00606684|50012031|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
24918275|NCT00606684|50012032|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
24918276|NCT00606684|50012033|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
24918277|NCT00606684|50012034|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
24918278|NCT00606684|50012035|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
24918279|NCT00606684|50012036|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
24918280|NCT00606684|50012037|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
24918281|NCT00606684|50012031|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
24918282|NCT00606684|50012032|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
24918283|NCT00606684|50012033|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
24918284|NCT00606684|50012034|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
24918285|NCT00606684|50012035|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
24918286|NCT00606684|50012036|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
24918287|NCT00606684|50012037|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
24918288|NCT00606684|50012031|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
24918289|NCT00606684|50012032|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
24918290|NCT00606684|50012033|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
24918291|NCT00606684|50012034|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
24918292|NCT00606684|50012035|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
24918293|NCT00606684|50012036|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
24918294|NCT00606684|50012037|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
24918295|NCT00606684|50012031|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
25154013|NCT01517373|50269112|FG001|Treatment Period|Lack of Efficacy|1|||
25154014|NCT01517373|50269113|FG002|Treatment Period|Lack of Efficacy|1|||
25154015|NCT01517373|50269114|FG003|Treatment Period|Lack of Efficacy|3|||
25154016|NCT01517373|50269115|FG004|Treatment Period|Lack of Efficacy|2|||
25154017|NCT01517373|50269116|FG005|Treatment Period|Lack of Efficacy|0|||
25154018|NCT01517373|50269111|FG000|Treatment Period|Medication error without AEs|0|||
25154019|NCT01517373|50269112|FG001|Treatment Period|Medication error without AEs|0|||
24918296|NCT00606684|50012032|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
24918297|NCT00606684|50012033|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
24918298|NCT00606684|50012034|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
24918299|NCT00606684|50012035|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
24918300|NCT00606684|50012036|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
24918301|NCT00606684|50012037|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
24918302|NCT00606684|50012031|FG000|Double-Blind Treatment Period|Adverse Event|0|||
24918303|NCT00606684|50012032|FG001|Double-Blind Treatment Period|Adverse Event|3|||
24918304|NCT00606684|50012033|FG002|Double-Blind Treatment Period|Adverse Event|2|||
24918305|NCT00606684|50012034|FG003|Double-Blind Treatment Period|Adverse Event|4|||
24918306|NCT00606684|50012035|FG004|Double-Blind Treatment Period|Adverse Event|2|||
25021840|NCT03151551|50118222|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
25021841|NCT03151551|50118223|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
25021842|NCT03147495|50118233|FG000|Overall Study|Physician Decision|0|||
25021843|NCT03147495|50118234|FG001|Overall Study|Physician Decision|6|||
24918307|NCT00606684|50012036|FG005|Double-Blind Treatment Period|Adverse Event|0|||
24918308|NCT00606684|50012037|FG006|Double-Blind Treatment Period|Adverse Event|1|||
24918309|NCT00606684|50012031|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
24918310|NCT00606684|50012032|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
24918311|NCT00606684|50012033|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
24918312|NCT00606684|50012034|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
24918313|NCT00606684|50012035|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
24918314|NCT00606684|50012036|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
24918315|NCT00606684|50012037|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
24918316|NCT00606684|50012031|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
24918317|NCT00606684|50012032|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
24918318|NCT00606684|50012033|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
24918319|NCT00606684|50012034|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
24918320|NCT00606684|50012035|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
24918321|NCT00606684|50012036|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
24918322|NCT00606684|50012037|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
24918323|NCT00606684|50012031|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
24918324|NCT00606684|50012032|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
24918325|NCT00606684|50012033|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
24918326|NCT00606684|50012034|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
24918327|NCT00606684|50012035|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
24918328|NCT00606684|50012036|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
24918329|NCT00606684|50012037|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
24918330|NCT00606684|50012031|FG000|Double-Blind Treatment Period|Physician Decision|0|||
24918331|NCT00606684|50012032|FG001|Double-Blind Treatment Period|Physician Decision|5|||
24918332|NCT00606684|50012033|FG002|Double-Blind Treatment Period|Physician Decision|1|||
24918333|NCT00606684|50012034|FG003|Double-Blind Treatment Period|Physician Decision|0|||
24918334|NCT00606684|50012035|FG004|Double-Blind Treatment Period|Physician Decision|3|||
24918335|NCT00606684|50012036|FG005|Double-Blind Treatment Period|Physician Decision|1|||
24918336|NCT00606684|50012037|FG006|Double-Blind Treatment Period|Physician Decision|2|||
24918337|NCT00606684|50012031|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
24918338|NCT00606684|50012032|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
24918339|NCT00606684|50012033|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
24918340|NCT00606684|50012034|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
24918341|NCT00606684|50012035|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
25021844|NCT03126786|50118242|FG000|Overall Study|Adverse Event|3|||
25021845|NCT03126786|50118243|FG001|Overall Study|Adverse Event|0|||
25021846|NCT03126786|50118242|FG000|Overall Study|Lost to Follow-up|0|||
24918342|NCT00606684|50012036|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
24918343|NCT00606684|50012037|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
24918344|NCT00627926|50012054|FG000|Overall Study|Adverse Event|26|||
24918345|NCT00627926|50012055|FG001|Overall Study|Adverse Event|37|||
24918346|NCT00627926|50012056|FG002|Overall Study|Adverse Event|36|||
24918347|NCT00627926|50012054|FG000|Overall Study|Death|1|||
24918348|NCT00627926|50012055|FG001|Overall Study|Death|0|||
24918349|NCT00627926|50012056|FG002|Overall Study|Death|0|||
24918350|NCT00627926|50012054|FG000|Overall Study|Lost to Follow-up|4|||
24918351|NCT00627926|50012055|FG001|Overall Study|Lost to Follow-up|3|||
24918352|NCT00627926|50012056|FG002|Overall Study|Lost to Follow-up|4|||
24918353|NCT00627926|50012054|FG000|Overall Study|Withdrawal by Subject|2|||
24918354|NCT00627926|50012055|FG001|Overall Study|Withdrawal by Subject|1|||
24918355|NCT00627926|50012056|FG002|Overall Study|Withdrawal by Subject|0|||
24918356|NCT00627926|50012054|FG000|Overall Study|Lack of Efficacy|118|||
24918357|NCT00627926|50012055|FG001|Overall Study|Lack of Efficacy|40|||
24918358|NCT00627926|50012056|FG002|Overall Study|Lack of Efficacy|38|||
24918359|NCT00627926|50012054|FG000|Overall Study|Noncompliance/unspecified|8|||
24918360|NCT00627926|50012055|FG001|Overall Study|Noncompliance/unspecified|23|||
24918361|NCT00627926|50012056|FG002|Overall Study|Noncompliance/unspecified|17|||
24918362|NCT00228553|50012064|FG000|Overall Study|Adverse Event|112|||
25021847|NCT03126786|50118243|FG001|Overall Study|Lost to Follow-up|1|||
25021848|NCT03126786|50118242|FG000|Overall Study|Withdrawal by Subject|3|||
25021849|NCT03126786|50118243|FG001|Overall Study|Withdrawal by Subject|1|||
25021850|NCT03146403|50118251|FG000|Overall Study|Withdrawal by Subject|0|||
25021851|NCT03146403|50118252|FG001|Overall Study|Withdrawal by Subject|3|||
25021852|NCT03146403|50118251|FG000|Overall Study|Lost to Follow-up|2|||
25021853|NCT03146403|50118252|FG001|Overall Study|Lost to Follow-up|0|||
25021854|NCT02713204|50118261|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
25021855|NCT02713204|50118262|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
25021856|NCT02713204|50118263|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
25021857|NCT02713204|50118264|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
25021858|NCT02713204|50118265|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
25021859|NCT02713204|50118266|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
25021860|NCT02713204|50118267|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
25021861|NCT02713204|50118268|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
25021862|NCT02713204|50118261|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
25021863|NCT02713204|50118262|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
25154020|NCT01517373|50269113|FG002|Treatment Period|Medication error without AEs|2|||
25154021|NCT01517373|50269114|FG003|Treatment Period|Medication error without AEs|1|||
25154022|NCT01517373|50269115|FG004|Treatment Period|Medication error without AEs|0|||
25154023|NCT01517373|50269116|FG005|Treatment Period|Medication error without AEs|2|||
25154024|NCT01517295|50269131|FG000|Overall Study|Physician Decision|1|||
25154025|NCT01517295|50269132|FG001|Overall Study|Physician Decision|0|||
25154026|NCT01541865|50269138|FG000|Overall Study|Lost to Follow-up|11|||
25154027|NCT01541865|50269138|FG000|Overall Study|Withdrawal by Subject|9|||
25154028|NCT01541865|50269138|FG000|Overall Study|Adverse Event|1|||
25154029|NCT01541865|50269138|FG000|Overall Study|Protocol Violation|1|||
25154030|NCT01541397|50269144|FG000|Overall Study|Study ended prior to data collection|4|||
25154031|NCT01541397|50269145|FG001|Overall Study|Study ended prior to data collection|2|||
25154032|NCT01548417|50269153|FG000|Overall Study|Withdrawal by Subject|0|||
25154033|NCT01548417|50269154|FG001|Overall Study|Withdrawal by Subject|2|||
25154034|NCT01546857|50269162|FG000|Overall Study|Withdrawal by Subject|2|||
25154035|NCT01546857|50269163|FG001|Overall Study|Withdrawal by Subject|3|||
25154036|NCT01540851|50269172|FG000|Overall Study|Lost to Follow-up|14|||
25021864|NCT02713204|50118263|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
25021865|NCT02713204|50118264|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
25154037|NCT01540851|50269173|FG001|Overall Study|Lost to Follow-up|15|||
24918363|NCT00228553|50012064|FG000|Overall Study|Lack of Efficacy|34|||
24918364|NCT00228553|50012064|FG000|Overall Study|Lost to Follow-up|67|||
25154038|NCT01540851|50269172|FG000|Overall Study|Withdrawal by Subject|7|||
24918365|NCT00228553|50012064|FG000|Overall Study|Physician Decision|48|||
24918366|NCT00228553|50012064|FG000|Overall Study|Protocol Violation|6|||
24918367|NCT00228553|50012064|FG000|Overall Study|Withdrawal by Subject|115|||
25021866|NCT02713204|50118265|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
25021867|NCT02713204|50118266|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
25021868|NCT02713204|50118267|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
25021869|NCT02713204|50118268|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
24918368|NCT00228553|50012064|FG000|Overall Study|Pregnancy|2|||
24918369|NCT00228553|50012064|FG000|Overall Study|Miscellaneous|46|||
24918370|NCT00643916|50012074|FG000|Overall Study|Protocol Violation|0|||
24918371|NCT00643916|50012075|FG001|Overall Study|Protocol Violation|1|||
24918372|NCT00643916|50012076|FG002|Overall Study|Protocol Violation|1|||
24918373|NCT00643916|50012077|FG003|Overall Study|Protocol Violation|1|||
24918374|NCT00643916|50012078|FG004|Overall Study|Protocol Violation|0|||
25154039|NCT01540851|50269173|FG001|Overall Study|Withdrawal by Subject|3|||
25154040|NCT01516749|50269181|FG000|Active Therapy|Lost to Follow-up|1|||
24918375|NCT00643916|50012079|FG005|Overall Study|Protocol Violation|0|||
25154041|NCT01516749|50269181|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
25154042|NCT01516437|50269189|FG000|Overall Study|Reason not specified|0|||
25154043|NCT01516437|50269190|FG001|Overall Study|Reason not specified|0|||
25154044|NCT01516437|50269191|FG002|Overall Study|Reason not specified|1|||
24918376|NCT00643916|50012074|FG000|Overall Study|Lost to Follow-up|0|||
24918377|NCT00643916|50012075|FG001|Overall Study|Lost to Follow-up|1|||
24918378|NCT00643916|50012076|FG002|Overall Study|Lost to Follow-up|0|||
24918379|NCT00643916|50012077|FG003|Overall Study|Lost to Follow-up|0|||
24918380|NCT00643916|50012078|FG004|Overall Study|Lost to Follow-up|0|||
24918381|NCT00643916|50012079|FG005|Overall Study|Lost to Follow-up|0|||
24918382|NCT00643916|50012074|FG000|Overall Study|Withdrawal by Subject|2|||
24918383|NCT00643916|50012075|FG001|Overall Study|Withdrawal by Subject|2|||
24918384|NCT00643916|50012076|FG002|Overall Study|Withdrawal by Subject|2|||
24918385|NCT00643916|50012077|FG003|Overall Study|Withdrawal by Subject|1|||
25021870|NCT02713204|50118261|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
25154045|NCT01516437|50269192|FG003|Overall Study|Reason not specified|1|||
24918386|NCT00643916|50012078|FG004|Overall Study|Withdrawal by Subject|0|||
24918387|NCT00643916|50012079|FG005|Overall Study|Withdrawal by Subject|1|||
24918388|NCT00643916|50012074|FG000|Overall Study|Not Vaccinated|2|||
24918389|NCT00643916|50012075|FG001|Overall Study|Not Vaccinated|2|||
24918390|NCT00643916|50012076|FG002|Overall Study|Not Vaccinated|3|||
24918391|NCT00643916|50012077|FG003|Overall Study|Not Vaccinated|0|||
24918392|NCT00643916|50012078|FG004|Overall Study|Not Vaccinated|2|||
24918393|NCT00643916|50012079|FG005|Overall Study|Not Vaccinated|0|||
24918394|NCT00160693|50012093|FG000|Overall Study|Adverse Event|97|||
24918395|NCT00160693|50012093|FG000|Overall Study|Lack of Efficacy|30|||
24918396|NCT00160693|50012093|FG000|Overall Study|Protocol Violation|24|||
24918397|NCT00160693|50012093|FG000|Overall Study|Lost to Follow-up|15|||
24918398|NCT00160693|50012093|FG000|Overall Study|Withdrawal by Subject|54|||
24918399|NCT00160693|50012093|FG000|Overall Study|Study terminated by sponsor|15|||
24918400|NCT00643760|50012102|FG000|Overall Study|Adverse Event|11|||
24918401|NCT00643760|50012103|FG001|Overall Study|Adverse Event|5|||
24918402|NCT00643760|50012104|FG002|Overall Study|Adverse Event|12|||
25154046|NCT01515423|50269206|FG000|Open Label Phase|Adverse Event|57|||
24918403|NCT00643760|50012105|FG003|Overall Study|Adverse Event|21|||
24918404|NCT00643760|50012106|FG004|Overall Study|Adverse Event|6|||
24918405|NCT00643760|50012102|FG000|Overall Study|Lack of Efficacy|3|||
25154047|NCT01515423|50269207|FG001|Open Label Phase|Adverse Event|0|||
24918406|NCT00643760|50012103|FG001|Overall Study|Lack of Efficacy|1|||
24918407|NCT00643760|50012104|FG002|Overall Study|Lack of Efficacy|0|||
24918408|NCT00643760|50012105|FG003|Overall Study|Lack of Efficacy|4|||
24918409|NCT00643760|50012106|FG004|Overall Study|Lack of Efficacy|3|||
24918410|NCT00643760|50012102|FG000|Overall Study|Protocol Violation|7|||
24918411|NCT00643760|50012103|FG001|Overall Study|Protocol Violation|6|||
25154048|NCT01515423|50269208|FG002|Open Label Phase|Adverse Event|0|||
25154049|NCT01515423|50269206|FG000|Open Label Phase|Death|2|||
25154050|NCT01515423|50269207|FG001|Open Label Phase|Death|0|||
25154051|NCT01515423|50269208|FG002|Open Label Phase|Death|0|||
25154052|NCT01515423|50269206|FG000|Open Label Phase|Lack of Efficacy|117|||
25154053|NCT01515423|50269207|FG001|Open Label Phase|Lack of Efficacy|0|||
25154054|NCT01515423|50269208|FG002|Open Label Phase|Lack of Efficacy|0|||
25154055|NCT01515423|50269206|FG000|Open Label Phase|Lost to Follow-up|21|||
24918412|NCT00643760|50012104|FG002|Overall Study|Protocol Violation|4|||
24918413|NCT00643760|50012105|FG003|Overall Study|Protocol Violation|4|||
24918414|NCT00643760|50012106|FG004|Overall Study|Protocol Violation|6|||
24918415|NCT00643760|50012102|FG000|Overall Study|Lost to Follow-up|6|||
24918416|NCT00643760|50012103|FG001|Overall Study|Lost to Follow-up|2|||
24918417|NCT00643760|50012104|FG002|Overall Study|Lost to Follow-up|1|||
24918418|NCT00643760|50012105|FG003|Overall Study|Lost to Follow-up|3|||
24918419|NCT00643760|50012106|FG004|Overall Study|Lost to Follow-up|3|||
25021871|NCT02713204|50118262|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
25021872|NCT02713204|50118263|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
25021873|NCT02713204|50118264|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
25021874|NCT02713204|50118265|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
25021875|NCT02713204|50118266|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
25021876|NCT02713204|50118267|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
25021877|NCT02713204|50118268|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
24918420|NCT00643760|50012102|FG000|Overall Study|Investigator Discretion|0|||
24918421|NCT00643760|50012103|FG001|Overall Study|Investigator Discretion|0|||
24918422|NCT00643760|50012104|FG002|Overall Study|Investigator Discretion|0|||
24918423|NCT00643760|50012105|FG003|Overall Study|Investigator Discretion|2|||
24918424|NCT00643760|50012106|FG004|Overall Study|Investigator Discretion|0|||
24918425|NCT00643760|50012102|FG000|Overall Study|Withdrawal by Subject|3|||
24918426|NCT00643760|50012103|FG001|Overall Study|Withdrawal by Subject|1|||
24918427|NCT00643760|50012104|FG002|Overall Study|Withdrawal by Subject|2|||
24918428|NCT00643760|50012105|FG003|Overall Study|Withdrawal by Subject|4|||
24918429|NCT00643760|50012106|FG004|Overall Study|Withdrawal by Subject|1|||
24918430|NCT00643682|50012120|FG000|Overall Study|did not keep appointment|522|||
24918431|NCT00643682|50012121|FG001|Overall Study|did not keep appointment|509|||
24918432|NCT00643604|50012127|FG000|Overall Study|Death|1|||
24918433|NCT00603798|50012134|FG000|Overall Study|Adverse Event|4|||
24918434|NCT00603798|50012135|FG001|Overall Study|Adverse Event|2|||
24918435|NCT00603798|50012136|FG002|Overall Study|Adverse Event|1|||
24918436|NCT00603798|50012134|FG000|Overall Study|Withdrawal by Subject|4|||
24918437|NCT00603798|50012135|FG001|Overall Study|Withdrawal by Subject|3|||
24918438|NCT00603798|50012136|FG002|Overall Study|Withdrawal by Subject|4|||
24918439|NCT00603798|50012134|FG000|Overall Study|Lost to Follow-up|1|||
24918440|NCT00603798|50012135|FG001|Overall Study|Lost to Follow-up|0|||
24918441|NCT00603798|50012136|FG002|Overall Study|Lost to Follow-up|1|||
25021878|NCT02713204|50118261|FG000|From Week 12 up to Week 36|Adverse Event|1|||
25154056|NCT01515423|50269207|FG001|Open Label Phase|Lost to Follow-up|0|||
25154057|NCT01515423|50269208|FG002|Open Label Phase|Lost to Follow-up|0|||
24918442|NCT00603798|50012134|FG000|Overall Study|Non-compliance with study procedures|0|||
24918443|NCT00603798|50012135|FG001|Overall Study|Non-compliance with study procedures|1|||
24918444|NCT00603798|50012136|FG002|Overall Study|Non-compliance with study procedures|0|||
24918445|NCT00603798|50012134|FG000|Overall Study|Not due to AE|1|||
24918446|NCT00603798|50012135|FG001|Overall Study|Not due to AE|1|||
24918447|NCT00603798|50012136|FG002|Overall Study|Not due to AE|4|||
24918448|NCT00630812|50012146|FG000|Randomisation to First Dose|Adverse Event|1|||
24918449|NCT00630812|50012147|FG001|Randomisation to First Dose|Adverse Event|1|||
24918450|NCT00630812|50012146|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
24918451|NCT00630812|50012147|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
24918452|NCT00630812|50012146|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
24918453|NCT00630812|50012147|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
24918454|NCT00630812|50012146|FG000|Randomisation to First Dose|Protocol Violation|4|||
24918455|NCT00630812|50012147|FG001|Randomisation to First Dose|Protocol Violation|1|||
24918456|NCT00630812|50012146|FG000|Double Blind Treatment Period|Adverse Event|13|||
24918457|NCT00630812|50012147|FG001|Double Blind Treatment Period|Adverse Event|5|||
24918458|NCT00630812|50012146|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
24918459|NCT00630812|50012147|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
24918460|NCT00630812|50012146|FG000|Double Blind Treatment Period|Physician Decision|2|||
24918461|NCT00630812|50012147|FG001|Double Blind Treatment Period|Physician Decision|1|||
24918462|NCT00630812|50012146|FG000|Double Blind Treatment Period|Protocol Violation|1|||
24918463|NCT00630812|50012147|FG001|Double Blind Treatment Period|Protocol Violation|0|||
24918464|NCT00630812|50012146|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
24918465|NCT00630812|50012147|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
24918466|NCT00630812|50012146|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
24918467|NCT00630812|50012147|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
24918468|NCT00630812|50012146|FG000|Double Blind Treatment Period|Non-compliance|0|||
24918469|NCT00630812|50012147|FG001|Double Blind Treatment Period|Non-compliance|1|||
24918470|NCT00629798|50012153|FG000|Overall Study|Not Treated|4|||
24918471|NCT00160615|50012159|FG000|Overall Study|Adverse Event|5|||
24918472|NCT00160615|50012160|FG001|Overall Study|Adverse Event|12|||
24918473|NCT00160615|50012159|FG000|Overall Study|Withdrawal by Subject|0|||
24918474|NCT00160615|50012160|FG001|Overall Study|Withdrawal by Subject|2|||
24918475|NCT00160615|50012159|FG000|Overall Study|Lack of Efficacy|11|||
24918476|NCT00160615|50012160|FG001|Overall Study|Lack of Efficacy|23|||
24918477|NCT00160615|50012159|FG000|Overall Study|Patient decision|1|||
24918478|NCT00160615|50012160|FG001|Overall Study|Patient decision|2|||
24918479|NCT00160615|50012159|FG000|Overall Study|Investigator decision|1|||
24918480|NCT00160615|50012160|FG001|Overall Study|Investigator decision|1|||
24918481|NCT00160615|50012159|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
24918482|NCT00160615|50012160|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
24918483|NCT00160615|50012159|FG000|Overall Study|Switch to surgical treatment|0|||
24918484|NCT00160615|50012160|FG001|Overall Study|Switch to surgical treatment|2|||
24918485|NCT00160615|50012159|FG000|Overall Study|Non-compliance was suspected|0|||
24918486|NCT00160615|50012160|FG001|Overall Study|Non-compliance was suspected|1|||
24918487|NCT00160615|50012159|FG000|Overall Study|Poor compliance|0|||
24918488|NCT00160615|50012160|FG001|Overall Study|Poor compliance|1|||
24918489|NCT00643448|50012171|FG000|Overall Study|Lack of Efficacy|2|||
24918490|NCT00643448|50012172|FG001|Overall Study|Lack of Efficacy|0|||
24918491|NCT00643448|50012173|FG002|Overall Study|Lack of Efficacy|4|||
24918492|NCT00643448|50012171|FG000|Overall Study|Adverse Event|2|||
24918493|NCT00643448|50012172|FG001|Overall Study|Adverse Event|2|||
24918494|NCT00643448|50012173|FG002|Overall Study|Adverse Event|2|||
24918495|NCT00643448|50012171|FG000|Overall Study|QTcF>550 ms|0|||
24918496|NCT00643448|50012172|FG001|Overall Study|QTcF>550 ms|3|||
24918497|NCT00643448|50012173|FG002|Overall Study|QTcF>550 ms|0|||
24918498|NCT00604500|50012183|FG000|Overall Study|Adverse Event|2|||
24918499|NCT00604500|50012183|FG000|Overall Study|Protocol Violation|2|||
24918500|NCT00604500|50012183|FG000|Overall Study|Treatment Failure|1|||
24918501|NCT00604500|50012183|FG000|Overall Study|Withdrawal by Subject|4|||
24918502|NCT00604500|50012183|FG000|Overall Study|Administrative|1|||
24918503|NCT00604500|50012183|FG000|Overall Study|Did not meet protocol eligibility|1|||
24918504|NCT00627458|50012190|FG000|Overall Study|Migrated from study area|1|||
24918505|NCT00627458|50012191|FG001|Overall Study|Migrated from study area|0|||
24918506|NCT00627458|50012192|FG002|Overall Study|Migrated from study area|1|||
24918507|NCT00627458|50012190|FG000|Overall Study|Withdrawal by Subject|2|||
25021879|NCT02713204|50118262|FG001|From Week 12 up to Week 36|Adverse Event|0|||
25021880|NCT02713204|50118263|FG002|From Week 12 up to Week 36|Adverse Event|0|||
24918508|NCT00627458|50012191|FG001|Overall Study|Withdrawal by Subject|6|||
24918509|NCT00627458|50012192|FG002|Overall Study|Withdrawal by Subject|5|||
24918510|NCT00627458|50012190|FG000|Overall Study|Lost to Follow-up|1|||
24918511|NCT00627458|50012191|FG001|Overall Study|Lost to Follow-up|1|||
25021881|NCT02713204|50118264|FG003|From Week 12 up to Week 36|Adverse Event|1|||
24918512|NCT00627458|50012192|FG002|Overall Study|Lost to Follow-up|0|||
24918513|NCT00542919|50012204|FG000|Overall Study|Adverse Event|1|||
24918514|NCT00542919|50012205|FG001|Overall Study|Adverse Event|5|||
24918515|NCT00542919|50012206|FG002|Overall Study|Adverse Event|1|||
24918516|NCT00542919|50012204|FG000|Overall Study|Withdrawal by Subject|1|||
24918517|NCT00542919|50012205|FG001|Overall Study|Withdrawal by Subject|0|||
24918518|NCT00542919|50012206|FG002|Overall Study|Withdrawal by Subject|3|||
24918519|NCT00542919|50012204|FG000|Overall Study|Physician Decision|2|||
24918520|NCT00542919|50012205|FG001|Overall Study|Physician Decision|2|||
24918521|NCT00542919|50012206|FG002|Overall Study|Physician Decision|1|||
24918522|NCT00542919|50012204|FG000|Overall Study|Sponsor Decision|1|||
24918523|NCT00542919|50012205|FG001|Overall Study|Sponsor Decision|0|||
24918524|NCT00542919|50012206|FG002|Overall Study|Sponsor Decision|0|||
24918525|NCT00542919|50012204|FG000|Overall Study|Lost to Follow-up|2|||
24918526|NCT00542919|50012205|FG001|Overall Study|Lost to Follow-up|0|||
25021882|NCT02713204|50118265|FG004|From Week 12 up to Week 36|Adverse Event|1|||
25021883|NCT02713204|50118266|FG005|From Week 12 up to Week 36|Adverse Event|0|||
25021884|NCT02713204|50118267|FG006|From Week 12 up to Week 36|Adverse Event|2|||
25021885|NCT02713204|50118268|FG007|From Week 12 up to Week 36|Adverse Event|1|||
25021886|NCT02713204|50118261|FG000|From Week 12 up to Week 36|Death|0|||
25021887|NCT02713204|50118262|FG001|From Week 12 up to Week 36|Death|0|||
24918527|NCT00542919|50012206|FG002|Overall Study|Lost to Follow-up|1|||
24918528|NCT00159913|50012233|FG000|Overall Study|Adverse Event|1|||
24918529|NCT00159913|50012234|FG001|Overall Study|Adverse Event|0|||
24918530|NCT00159913|50012235|FG002|Overall Study|Adverse Event|1|||
24918531|NCT00159913|50012236|FG003|Overall Study|Adverse Event|0|||
24918532|NCT00159913|50012233|FG000|Overall Study|Withdrawal by Subject|0|||
24918533|NCT00159913|50012234|FG001|Overall Study|Withdrawal by Subject|0|||
24918534|NCT00159913|50012235|FG002|Overall Study|Withdrawal by Subject|0|||
24918535|NCT00159913|50012236|FG003|Overall Study|Withdrawal by Subject|1|||
24918536|NCT00159913|50012233|FG000|Overall Study|Lost to Follow-up|0|||
24918537|NCT00159913|50012234|FG001|Overall Study|Lost to Follow-up|0|||
24918538|NCT00159913|50012235|FG002|Overall Study|Lost to Follow-up|0|||
24918539|NCT00159913|50012236|FG003|Overall Study|Lost to Follow-up|1|||
24918540|NCT00159913|50012233|FG000|Overall Study|Protocol Violation|1|||
24918541|NCT00159913|50012234|FG001|Overall Study|Protocol Violation|0|||
24918542|NCT00159913|50012235|FG002|Overall Study|Protocol Violation|1|||
24918543|NCT00159913|50012236|FG003|Overall Study|Protocol Violation|0|||
24918544|NCT00604188|50012250|FG000|Overall Study|Adverse Event|1|||
24918545|NCT00604188|50012251|FG001|Overall Study|Adverse Event|4|||
24918546|NCT00604188|50012250|FG000|Overall Study|Lost to Follow-up|17|||
24918547|NCT00604188|50012251|FG001|Overall Study|Lost to Follow-up|15|||
24918548|NCT00604188|50012250|FG000|Overall Study|Withdrawal by Subject|5|||
24918549|NCT00604188|50012251|FG001|Overall Study|Withdrawal by Subject|1|||
24918550|NCT00604188|50012250|FG000|Overall Study|Non-compliance with protocol|4|||
24918551|NCT00604188|50012251|FG001|Overall Study|Non-compliance with protocol|4|||
25021888|NCT02713204|50118263|FG002|From Week 12 up to Week 36|Death|0|||
25021889|NCT02713204|50118264|FG003|From Week 12 up to Week 36|Death|1|||
25021890|NCT02713204|50118265|FG004|From Week 12 up to Week 36|Death|0|||
25021891|NCT02713204|50118266|FG005|From Week 12 up to Week 36|Death|1|||
24918552|NCT00604188|50012250|FG000|Overall Study|Did not receive study drug|0|||
24918553|NCT00604188|50012251|FG001|Overall Study|Did not receive study drug|1|||
24918554|NCT03913377|50012259|FG000|Period 1|Test Article no longer available|0|||
24918555|NCT03913377|50012260|FG001|Period 1|Test Article no longer available|1|||
24918556|NCT03913377|50012261|FG002|Period 1|Test Article no longer available|0|||
24918557|NCT03913377|50012259|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
24918558|NCT03913377|50012260|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
24918559|NCT03913377|50012261|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
24918560|NCT00227539|50012268|FG000|Overall Study|Protocol Violation|1|||
24918561|NCT00227305|50012272|FG000|Overall Study|Adverse Event|40|||
24918562|NCT00227305|50012272|FG000|Overall Study|Withdrawal by Subject|42|||
24918563|NCT00227305|50012272|FG000|Overall Study|Lost to Follow-up|33|||
24918564|NCT00227305|50012272|FG000|Overall Study|Study specific discontinuation|13|||
24918565|NCT00227305|50012272|FG000|Overall Study|MOVED OUT OF AREA|3|||
24918566|NCT00227305|50012272|FG000|Overall Study|Lack of Efficacy|7|||
24918567|NCT00227305|50012272|FG000|Overall Study|Physician Decision|3|||
24918568|NCT00227305|50012272|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
24918569|NCT00227305|50012272|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
24918570|NCT00227305|50012272|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
24918571|NCT00720941|50012278|FG000|Overall Study|Death|334|||
24918572|NCT00720941|50012279|FG001|Overall Study|Death|335|||
24918573|NCT00720941|50012278|FG000|Overall Study|Protocol Violation|0|||
24918574|NCT00720941|50012279|FG001|Overall Study|Protocol Violation|2|||
25021892|NCT02713204|50118267|FG006|From Week 12 up to Week 36|Death|0|||
25021893|NCT02713204|50118268|FG007|From Week 12 up to Week 36|Death|3|||
25275023|NCT01238861|50589068|FG003|Overall Study|Lack of compliance|0|||
24918575|NCT00720941|50012278|FG000|Overall Study|Lost to Follow-up|17|||
24918576|NCT00720941|50012279|FG001|Overall Study|Lost to Follow-up|15|||
24918577|NCT00720941|50012278|FG000|Overall Study|Physician Decision|1|||
24918578|NCT00720941|50012279|FG001|Overall Study|Physician Decision|5|||
24918579|NCT00720941|50012278|FG000|Overall Study|Withdrawal by Subject|27|||
24918580|NCT00720941|50012279|FG001|Overall Study|Withdrawal by Subject|35|||
25021894|NCT02713204|50118261|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
24918581|NCT00720941|50012278|FG000|Overall Study|Ongoing|34|||
24918582|NCT00720941|50012279|FG001|Overall Study|Ongoing|23|||
24918583|NCT00585533|50012285|FG000|Overall Study|objective or symptomatic progression|9|||
24918584|NCT00628862|50012292|FG000|Overall Study|Adverse Event|6|||
24918585|NCT00628862|50012293|FG001|Overall Study|Adverse Event|8|||
24918586|NCT00628862|50012294|FG002|Overall Study|Adverse Event|10|||
24918587|NCT00628862|50012292|FG000|Overall Study|Withdrawal by Subject|4|||
24918588|NCT00628862|50012293|FG001|Overall Study|Withdrawal by Subject|6|||
24918589|NCT00628862|50012294|FG002|Overall Study|Withdrawal by Subject|11|||
24918590|NCT00628862|50012292|FG000|Overall Study|Lost to Follow-up|0|||
24918591|NCT00628862|50012293|FG001|Overall Study|Lost to Follow-up|2|||
24918592|NCT00628862|50012294|FG002|Overall Study|Lost to Follow-up|1|||
24918593|NCT00628862|50012292|FG000|Overall Study|Protocol Violation|1|||
24918594|NCT00628862|50012293|FG001|Overall Study|Protocol Violation|0|||
24918595|NCT00628862|50012294|FG002|Overall Study|Protocol Violation|0|||
24918596|NCT00628862|50012292|FG000|Overall Study|COPD Exacerbation|0|||
24918597|NCT00628862|50012293|FG001|Overall Study|COPD Exacerbation|1|||
24918598|NCT00628862|50012294|FG002|Overall Study|COPD Exacerbation|0|||
24918599|NCT00584987|50012306|FG000|Overall Study|Protocol Violation|1|||
24918600|NCT00584987|50012307|FG001|Overall Study|Protocol Violation|1|||
24918601|NCT00584987|50012308|FG002|Overall Study|Protocol Violation|1|||
24918602|NCT00584987|50012309|FG003|Overall Study|Protocol Violation|0|||
24918603|NCT00584987|50012306|FG000|Overall Study|Adverse Event|0|||
24918604|NCT00584987|50012307|FG001|Overall Study|Adverse Event|0|||
24918605|NCT00584987|50012308|FG002|Overall Study|Adverse Event|0|||
24918606|NCT00584987|50012309|FG003|Overall Study|Adverse Event|1|||
24918607|NCT00727961|50012319|FG000|Overall Study|Lost to Follow-up|1|||
24918608|NCT00727961|50012319|FG000|Overall Study|Adverse Event|4|||
24918609|NCT00727961|50012319|FG000|Overall Study|Patient's refusal|2|||
24918610|NCT00727961|50012319|FG000|Overall Study|Progression|30|||
24918611|NCT00568958|50012325|FG000|Allocation|Withdrawal by Subject|7|||
24918612|NCT00568958|50012326|FG001|Allocation|Withdrawal by Subject|3|||
25021895|NCT02713204|50118262|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
25021896|NCT02713204|50118263|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
24918613|NCT00568958|50012325|FG000|Allocation|Physician Decision|2|||
24918614|NCT00568958|50012326|FG001|Allocation|Physician Decision|0|||
24918615|NCT00568958|50012325|FG000|Follow-Up|Withdrawal by Subject|6|||
24918616|NCT00568958|50012326|FG001|Follow-Up|Withdrawal by Subject|6|||
24918617|NCT00568958|50012325|FG000|Follow-Up|Physician Decision|1|||
24918618|NCT00568958|50012326|FG001|Follow-Up|Physician Decision|1|||
24918619|NCT00568958|50012325|FG000|Follow-Up|Family Emergency|1|||
24918620|NCT00568958|50012326|FG001|Follow-Up|Family Emergency|0|||
24918621|NCT00568958|50012325|FG000|Follow-Up|Adverse Event|1|||
24918622|NCT00568958|50012326|FG001|Follow-Up|Adverse Event|0|||
24918623|NCT00727649|50012334|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
24918624|NCT00727649|50012335|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
24918625|NCT00727649|50012334|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
24918626|NCT00727649|50012335|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
24918627|NCT00727649|50012334|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
24918628|NCT00727649|50012335|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
24918629|NCT00727649|50012334|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
24918630|NCT00727649|50012335|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
24918631|NCT00727649|50012334|FG000|Second Intervention (4-weeks)|Death|1|||
25021897|NCT02713204|50118264|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
25021898|NCT02713204|50118265|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
25021899|NCT02713204|50118266|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
25021900|NCT02713204|50118267|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
25021901|NCT02713204|50118268|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
25021902|NCT02713204|50118261|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
25021903|NCT02713204|50118262|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
25021904|NCT02713204|50118263|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
25021905|NCT02713204|50118264|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
24918632|NCT00727649|50012335|FG001|Second Intervention (4-weeks)|Death|0|||
24918633|NCT00727649|50012334|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
24918634|NCT00727649|50012335|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
24918635|NCT00727649|50012334|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
25021906|NCT02713204|50118265|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
25275024|NCT01238861|50589069|FG004|Overall Study|Lack of compliance|0|||
24918636|NCT00727649|50012335|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
24918637|NCT00568334|50012345|FG000|Overall Study|Withdrawal by Subject|0|||
24918638|NCT00568334|50012346|FG001|Overall Study|Withdrawal by Subject|1|||
24918639|NCT00568334|50012345|FG000|Overall Study|Lost to Follow-up|1|||
24918640|NCT00568334|50012346|FG001|Overall Study|Lost to Follow-up|0|||
24918641|NCT00727571|50012356|FG000|Overall Study|Ineligibility determined|1|||
24918642|NCT00727571|50012357|FG001|Overall Study|Ineligibility determined|1|||
24918643|NCT00727571|50012358|FG002|Overall Study|Ineligibility determined|1|||
24918644|NCT00727571|50012359|FG003|Overall Study|Ineligibility determined|0|||
25021907|NCT02713204|50118266|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
25021908|NCT02713204|50118267|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
25021909|NCT02713204|50118268|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
25021910|NCT03695172|50118288|FG000|Overall Study|Withdrawal by Subject|1|||
25021911|NCT03695172|50118289|FG001|Overall Study|Withdrawal by Subject|1|||
25021912|NCT03695172|50118290|FG002|Overall Study|Withdrawal by Subject|0|||
25021913|NCT03721107|50118302|FG000|Overall Study|Adverse Event|1|||
25021914|NCT03721107|50118303|FG001|Overall Study|Adverse Event|1|||
25021915|NCT03721107|50118304|FG002|Overall Study|Adverse Event|6|||
25021916|NCT03721107|50118305|FG003|Overall Study|Adverse Event|5|||
25021917|NCT03721107|50118302|FG000|Overall Study|Lost to Follow-up|2|||
25021918|NCT03721107|50118303|FG001|Overall Study|Lost to Follow-up|0|||
25021919|NCT03721107|50118304|FG002|Overall Study|Lost to Follow-up|3|||
25021920|NCT03721107|50118305|FG003|Overall Study|Lost to Follow-up|0|||
25021921|NCT03721107|50118302|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
25021922|NCT03721107|50118303|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
25021923|NCT03721107|50118304|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
25021924|NCT03721107|50118305|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
25021925|NCT03721107|50118302|FG000|Overall Study|Physician Decision|0|||
25021926|NCT03721107|50118303|FG001|Overall Study|Physician Decision|1|||
25021927|NCT03721107|50118304|FG002|Overall Study|Physician Decision|0|||
25021928|NCT03721107|50118305|FG003|Overall Study|Physician Decision|0|||
25021929|NCT03721107|50118302|FG000|Overall Study|Pregnancy|0|||
25021930|NCT03721107|50118303|FG001|Overall Study|Pregnancy|0|||
25021931|NCT03721107|50118304|FG002|Overall Study|Pregnancy|1|||
25021932|NCT03721107|50118305|FG003|Overall Study|Pregnancy|0|||
25021933|NCT03721107|50118302|FG000|Overall Study|Withdrawal by Subject|1|||
25021934|NCT03721107|50118303|FG001|Overall Study|Withdrawal by Subject|1|||
25021935|NCT03721107|50118304|FG002|Overall Study|Withdrawal by Subject|5|||
25021936|NCT03721107|50118305|FG003|Overall Study|Withdrawal by Subject|5|||
25021937|NCT03721107|50118302|FG000|Overall Study|Other|1|||
25021938|NCT03721107|50118303|FG001|Overall Study|Other|0|||
25021939|NCT03721107|50118304|FG002|Overall Study|Other|0|||
25021940|NCT03721107|50118305|FG003|Overall Study|Other|1|||
25021941|NCT03052920|50118324|FG000|Overall Study|Withdrawal by Subject|1|||
25021942|NCT02930226|50118334|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
25021943|NCT02930226|50118335|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
25021944|NCT02930226|50118336|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
25021945|NCT02930226|50118337|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
25021946|NCT02930226|50118338|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
25021947|NCT02930226|50118339|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
25021948|NCT02722434|50118376|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
25021949|NCT02722434|50118377|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
25021950|NCT02722434|50118376|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
25154058|NCT01515423|50269206|FG000|Open Label Phase|Withdrawal by Subject|118|||
25154059|NCT01515423|50269207|FG001|Open Label Phase|Withdrawal by Subject|0|||
25154060|NCT01515423|50269208|FG002|Open Label Phase|Withdrawal by Subject|0|||
25154061|NCT01515423|50269206|FG000|Open Label Phase|excluded from DB Phase|70|||
25154062|NCT01515423|50269207|FG001|Open Label Phase|excluded from DB Phase|0|||
25154063|NCT01515423|50269208|FG002|Open Label Phase|excluded from DB Phase|0|||
25021951|NCT02722434|50118377|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
25021952|NCT03539601|50118387|FG000|Overall Study|Withdraw by parent/guardian|1|||
25021953|NCT03539601|50118388|FG001|Overall Study|Withdraw by parent/guardian|0|||
25021954|NCT03539601|50118389|FG002|Overall Study|Withdraw by parent/guardian|1|||
25021955|NCT03539601|50118390|FG003|Overall Study|Withdraw by parent/guardian|0|||
25021956|NCT03539601|50118387|FG000|Overall Study|Adverse Event|0|||
25021957|NCT03539601|50118388|FG001|Overall Study|Adverse Event|2|||
25154064|NCT01515423|50269206|FG000|Open Label Phase|Other|28|||
24918645|NCT00727571|50012356|FG000|Overall Study|Death|0|||
24918646|NCT00727571|50012357|FG001|Overall Study|Death|19|||
24918647|NCT00727571|50012358|FG002|Overall Study|Death|5|||
24918648|NCT00727571|50012359|FG003|Overall Study|Death|1|||
24918649|NCT00727571|50012356|FG000|Overall Study|Physician Decision|0|||
24918650|NCT00727571|50012357|FG001|Overall Study|Physician Decision|5|||
24918651|NCT00727571|50012358|FG002|Overall Study|Physician Decision|0|||
24918652|NCT00727571|50012359|FG003|Overall Study|Physician Decision|0|||
25021958|NCT03539601|50118389|FG002|Overall Study|Adverse Event|0|||
25021959|NCT03539601|50118390|FG003|Overall Study|Adverse Event|0|||
25021960|NCT03539601|50118387|FG000|Overall Study|Lost to Follow-up|2|||
25021961|NCT03539601|50118388|FG001|Overall Study|Lost to Follow-up|4|||
25021962|NCT03539601|50118389|FG002|Overall Study|Lost to Follow-up|5|||
25021963|NCT03539601|50118390|FG003|Overall Study|Lost to Follow-up|0|||
25021964|NCT03539601|50118387|FG000|Overall Study|Withdrawal by Subject|2|||
25021965|NCT03539601|50118388|FG001|Overall Study|Withdrawal by Subject|0|||
25021966|NCT03539601|50118389|FG002|Overall Study|Withdrawal by Subject|0|||
25021967|NCT03539601|50118390|FG003|Overall Study|Withdrawal by Subject|1|||
25021968|NCT03539601|50118387|FG000|Overall Study|Randomized but not treated|1|||
25021969|NCT03539601|50118388|FG001|Overall Study|Randomized but not treated|1|||
24918653|NCT00727571|50012356|FG000|Overall Study|Withdrawal by Subject|0|||
24918654|NCT00727571|50012357|FG001|Overall Study|Withdrawal by Subject|10|||
24918655|NCT00727571|50012358|FG002|Overall Study|Withdrawal by Subject|11|||
24918656|NCT00727571|50012359|FG003|Overall Study|Withdrawal by Subject|0|||
24918657|NCT00727571|50012356|FG000|Overall Study|Subject Non Compliance|0|||
24918658|NCT00727571|50012357|FG001|Overall Study|Subject Non Compliance|6|||
24918659|NCT00727571|50012358|FG002|Overall Study|Subject Non Compliance|0|||
24918660|NCT00727571|50012359|FG003|Overall Study|Subject Non Compliance|4|||
24918661|NCT00727571|50012356|FG000|Overall Study|Dismissed from nursing home|0|||
24918662|NCT00727571|50012357|FG001|Overall Study|Dismissed from nursing home|9|||
25185044|NCT00249795|50334153|FG001|Overall Study|Oral anticoagulant required|0|||
25185045|NCT00249795|50334152|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
25185046|NCT00249795|50334153|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
25185047|NCT00249795|50334152|FG000|Overall Study|Non-compliance|71|||
25185048|NCT00249795|50334153|FG001|Overall Study|Non-compliance|69|||
25185049|NCT00249795|50334152|FG000|Overall Study|Study drug intolerance|3|||
25185050|NCT00249795|50334153|FG001|Overall Study|Study drug intolerance|3|||
25275025|NCT01238861|50589070|FG005|Overall Study|Lack of compliance|1|||
24918663|NCT00727571|50012358|FG002|Overall Study|Dismissed from nursing home|5|||
24918664|NCT00727571|50012359|FG003|Overall Study|Dismissed from nursing home|0|||
24918665|NCT00727571|50012356|FG000|Overall Study|Hospitalization|0|||
24918666|NCT00727571|50012357|FG001|Overall Study|Hospitalization|1|||
24918667|NCT00727571|50012358|FG002|Overall Study|Hospitalization|0|||
24918668|NCT00727571|50012359|FG003|Overall Study|Hospitalization|1|||
24918669|NCT00727571|50012356|FG000|Overall Study|AE not leading to hospitalization|0|||
24918670|NCT00727571|50012357|FG001|Overall Study|AE not leading to hospitalization|0|||
24918671|NCT00727571|50012358|FG002|Overall Study|AE not leading to hospitalization|2|||
24918672|NCT00727571|50012359|FG003|Overall Study|AE not leading to hospitalization|0|||
24918673|NCT00727571|50012356|FG000|Overall Study|Other|0|||
24918674|NCT00727571|50012357|FG001|Overall Study|Other|4|||
24918675|NCT00727571|50012358|FG002|Overall Study|Other|6|||
24918676|NCT00727571|50012359|FG003|Overall Study|Other|0|||
24918677|NCT00225277|50012371|FG000|Overall Study|Adverse Event|30|||
24918678|NCT00225277|50012372|FG001|Overall Study|Adverse Event|34|||
24918679|NCT00225277|50012371|FG000|Overall Study|Lack of Efficacy|4|||
24918680|NCT00225277|50012372|FG001|Overall Study|Lack of Efficacy|1|||
24918681|NCT00225277|50012371|FG000|Overall Study|Lost to Follow-up|4|||
24918682|NCT00225277|50012372|FG001|Overall Study|Lost to Follow-up|6|||
24918683|NCT00225277|50012371|FG000|Overall Study|Physician Decision|6|||
25154065|NCT01515423|50269207|FG001|Open Label Phase|Other|0|||
25154066|NCT01515423|50269208|FG002|Open Label Phase|Other|0|||
25154067|NCT01515423|50269206|FG000|DOUBLE BLIND|Adverse Event|0|||
25154068|NCT01515423|50269207|FG001|DOUBLE BLIND|Adverse Event|15|||
25154069|NCT01515423|50269208|FG002|DOUBLE BLIND|Adverse Event|13|||
25154070|NCT01515423|50269206|FG000|DOUBLE BLIND|Death|0|||
25154071|NCT01515423|50269207|FG001|DOUBLE BLIND|Death|1|||
25154072|NCT01515423|50269208|FG002|DOUBLE BLIND|Death|2|||
24918684|NCT00225277|50012372|FG001|Overall Study|Physician Decision|8|||
24918685|NCT00225277|50012371|FG000|Overall Study|Protocol Violation|6|||
24918686|NCT00225277|50012372|FG001|Overall Study|Protocol Violation|3|||
25021970|NCT03539601|50118389|FG002|Overall Study|Randomized but not treated|0|||
25021971|NCT03539601|50118390|FG003|Overall Study|Randomized but not treated|0|||
25154073|NCT01515423|50269206|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
24918687|NCT00225277|50012371|FG000|Overall Study|Withdrawal by Subject|40|||
24918688|NCT00225277|50012372|FG001|Overall Study|Withdrawal by Subject|34|||
25154074|NCT01515423|50269207|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
24918689|NCT00225277|50012371|FG000|Overall Study|Other|7|||
24918690|NCT00225277|50012372|FG001|Overall Study|Other|9|||
25154075|NCT01515423|50269208|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
24918691|NCT00567996|50012381|FG000|Overall Study|Adverse Event|18|||
24918692|NCT00567996|50012382|FG001|Overall Study|Adverse Event|16|||
24918693|NCT00567996|50012383|FG002|Overall Study|Adverse Event|13|||
24918694|NCT00567996|50012381|FG000|Overall Study|Protocol Deviation|9|||
24918695|NCT00567996|50012382|FG001|Overall Study|Protocol Deviation|11|||
24918696|NCT00567996|50012383|FG002|Overall Study|Protocol Deviation|13|||
24918697|NCT00567996|50012381|FG000|Overall Study|Withdrawal by Subject|8|||
24918698|NCT00567996|50012382|FG001|Overall Study|Withdrawal by Subject|12|||
24918699|NCT00567996|50012383|FG002|Overall Study|Withdrawal by Subject|22|||
24918700|NCT00567996|50012381|FG000|Overall Study|Abnormal Lab value(s)|2|||
24918701|NCT00567996|50012382|FG001|Overall Study|Abnormal Lab value(s)|1|||
24918702|NCT00567996|50012383|FG002|Overall Study|Abnormal Lab value(s)|2|||
24918703|NCT00567996|50012381|FG000|Overall Study|Abnormal test procedure result(s)|2|||
24918704|NCT00567996|50012382|FG001|Overall Study|Abnormal test procedure result(s)|1|||
24918705|NCT00567996|50012383|FG002|Overall Study|Abnormal test procedure result(s)|1|||
24918706|NCT00567996|50012381|FG000|Overall Study|Lost to Follow-up|2|||
24918707|NCT00567996|50012382|FG001|Overall Study|Lost to Follow-up|5|||
24918708|NCT00567996|50012383|FG002|Overall Study|Lost to Follow-up|2|||
24918709|NCT00567996|50012381|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
24918710|NCT00567996|50012382|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
24918711|NCT00567996|50012383|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
24918712|NCT00567996|50012381|FG000|Overall Study|Administrative problems|1|||
24918713|NCT00567996|50012382|FG001|Overall Study|Administrative problems|1|||
24918714|NCT00567996|50012383|FG002|Overall Study|Administrative problems|0|||
24918715|NCT00567996|50012381|FG000|Overall Study|Death|1|||
24918716|NCT00567996|50012382|FG001|Overall Study|Death|0|||
25021972|NCT00700804|50118410|FG000|Overall Study|Withdrawal by Subject|1|||
25021973|NCT00700804|50118411|FG001|Overall Study|Withdrawal by Subject|2|||
25021974|NCT00700804|50118410|FG000|Overall Study|Protocol Violation|1|||
25021975|NCT00700804|50118411|FG001|Overall Study|Protocol Violation|1|||
25021976|NCT00700804|50118410|FG000|Overall Study|Loose Stools|1|||
25021977|NCT00700804|50118411|FG001|Overall Study|Loose Stools|1|||
25021978|NCT02903823|50118417|FG000|Overall Study|Physician Decision|5|||
25021979|NCT02903823|50118417|FG000|Overall Study|Could not advance catheter|1|||
25021980|NCT02903823|50118417|FG000|Overall Study|Catheter dislodgement|1|||
24918717|NCT00567996|50012383|FG002|Overall Study|Death|2|||
24918718|NCT00567996|50012381|FG000|Overall Study|Patient's inability to use the device|0|||
24918719|NCT00567996|50012382|FG001|Overall Study|Patient's inability to use the device|1|||
24918720|NCT00567996|50012383|FG002|Overall Study|Patient's inability to use the device|0|||
24918721|NCT00224887|50012397|FG000|Overall Study|Pregnancy|6|||
24918722|NCT00224887|50012398|FG001|Overall Study|Pregnancy|6|||
24918723|NCT00148759|50012406|FG000|Overall Study|Withdrawal by Subject|1|||
24918724|NCT00148759|50012407|FG001|Overall Study|Withdrawal by Subject|1|||
24918725|NCT00148759|50012406|FG000|Overall Study|Lost to Follow-up|1|||
24918726|NCT00148759|50012407|FG001|Overall Study|Lost to Follow-up|0|||
24918727|NCT00717275|50012413|FG000|Overall Study|Premature study termination.|3|||
24918728|NCT00584909|50012417|FG000|Overall Study|Adverse Event|4|||
24918729|NCT00147823|50012423|FG000|Overall Study|Lost to Follow-up|6|||
24918730|NCT00147823|50012424|FG001|Overall Study|Lost to Follow-up|12|||
24918731|NCT00147823|50012423|FG000|Overall Study|Physician Decision|1|||
24918732|NCT00147823|50012424|FG001|Overall Study|Physician Decision|0|||
24918733|NCT00147823|50012423|FG000|Overall Study|Withdrawal by Subject|0|||
24918734|NCT00147823|50012424|FG001|Overall Study|Withdrawal by Subject|1|||
24918735|NCT00147823|50012423|FG000|Overall Study|Did not receive vitoss due to infection|6|||
24918736|NCT00147823|50012424|FG001|Overall Study|Did not receive vitoss due to infection|2|||
24918737|NCT00717197|50012430|FG000|Overall Study|Unable to purchase study drug|5|||
24918738|NCT00717197|50012430|FG000|Overall Study|Tumor Progression|1|||
24918739|NCT00717197|50012430|FG000|Overall Study|Physician Decision|1|||
24918740|NCT00147745|50012437|FG000|Overall Study|Withdrawal by Subject|1|||
24918741|NCT00147745|50012438|FG001|Overall Study|Withdrawal by Subject|0|||
24918742|NCT00147745|50012439|FG002|Overall Study|Withdrawal by Subject|0|||
24918743|NCT00642902|50012451|FG000|Overall Study|Adverse Event|0|||
24918744|NCT00642902|50012452|FG001|Overall Study|Adverse Event|1|||
24918745|NCT00642902|50012453|FG002|Overall Study|Adverse Event|3|||
24918746|NCT00642902|50012454|FG003|Overall Study|Adverse Event|1|||
25021981|NCT00832455|50118446|FG000|Overall Study|Adverse Event|13|||
25021982|NCT00832455|50118446|FG000|Overall Study|Lost to Follow-up|26|||
24918747|NCT00642902|50012451|FG000|Overall Study|Lost to Follow-up|1|||
24918748|NCT00642902|50012452|FG001|Overall Study|Lost to Follow-up|1|||
24918749|NCT00642902|50012453|FG002|Overall Study|Lost to Follow-up|0|||
24918750|NCT00642902|50012454|FG003|Overall Study|Lost to Follow-up|0|||
24918751|NCT00642902|50012451|FG000|Overall Study|Lack of Efficacy|0|||
24918752|NCT00642902|50012452|FG001|Overall Study|Lack of Efficacy|3|||
25021983|NCT00832455|50118446|FG000|Overall Study|Protocol Violation|4|||
24918753|NCT00642902|50012453|FG002|Overall Study|Lack of Efficacy|3|||
24918754|NCT00642902|50012454|FG003|Overall Study|Lack of Efficacy|0|||
25154076|NCT01515423|50269206|FG000|DOUBLE BLIND|Pregnancy|0|||
24918755|NCT00642902|50012451|FG000|Overall Study|Death|1|||
24918756|NCT00642902|50012452|FG001|Overall Study|Death|0|||
24918757|NCT00642902|50012453|FG002|Overall Study|Death|0|||
24918758|NCT00642902|50012454|FG003|Overall Study|Death|0|||
24918759|NCT00642902|50012451|FG000|Overall Study|Premature termination of clinical trial|37|||
24918760|NCT00642902|50012452|FG001|Overall Study|Premature termination of clinical trial|32|||
24918761|NCT00642902|50012453|FG002|Overall Study|Premature termination of clinical trial|35|||
24918762|NCT00642902|50012454|FG003|Overall Study|Premature termination of clinical trial|35|||
24918763|NCT00642902|50012451|FG000|Overall Study|Randomized, but not treated|0|||
24918764|NCT00642902|50012452|FG001|Overall Study|Randomized, but not treated|0|||
24918765|NCT00642902|50012453|FG002|Overall Study|Randomized, but not treated|1|||
24918766|NCT00642902|50012454|FG003|Overall Study|Randomized, but not treated|0|||
24918767|NCT00642902|50012451|FG000|Overall Study|Other|1|||
24918768|NCT00642902|50012452|FG001|Overall Study|Other|5|||
24918769|NCT00642902|50012453|FG002|Overall Study|Other|1|||
24918770|NCT00642902|50012454|FG003|Overall Study|Other|4|||
24918771|NCT00224107|50012466|FG000|Overall Study|Adverse Event|20|||
24918772|NCT00224107|50012467|FG001|Overall Study|Adverse Event|6|||
24918773|NCT00224107|50012466|FG000|Overall Study|Protocol Violation|2|||
24918774|NCT00224107|50012467|FG001|Overall Study|Protocol Violation|3|||
24918775|NCT00224107|50012466|FG000|Overall Study|Withdrawal by Subject|1|||
24918776|NCT00224107|50012467|FG001|Overall Study|Withdrawal by Subject|4|||
24918777|NCT00224107|50012466|FG000|Overall Study|Lack of Efficacy|2|||
24918778|NCT00224107|50012467|FG001|Overall Study|Lack of Efficacy|0|||
24918779|NCT00224107|50012466|FG000|Overall Study|Lost to Follow-up|4|||
24918780|NCT00224107|50012467|FG001|Overall Study|Lost to Follow-up|0|||
24918781|NCT00224107|50012466|FG000|Overall Study|Physician Decision|1|||
24918782|NCT00224107|50012467|FG001|Overall Study|Physician Decision|0|||
24918783|NCT00224107|50012466|FG000|Overall Study|Other|1|||
24918784|NCT00224107|50012467|FG001|Overall Study|Other|1|||
24918785|NCT00720083|50012475|FG000|Overall Study|Ineligible|1|||
24918786|NCT00720083|50012476|FG001|Overall Study|Ineligible|2|||
24918787|NCT00209131|50012484|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
24918788|NCT00209131|50012485|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
24918789|NCT00224029|50012491|FG000|Overall Study|Lost to Follow-up|1|||
24918790|NCT00224029|50012491|FG000|Overall Study|Withdrawal by Subject|4|||
24918791|NCT00224029|50012491|FG000|Overall Study|Other|1|||
24918792|NCT00223795|50012495|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
24918793|NCT00223795|50012496|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
24918794|NCT00223795|50012495|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
24918795|NCT00223795|50012496|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
24918796|NCT00719849|50012505|FG000|Overall Study|Death|0|||
24918797|NCT00719849|50012506|FG001|Overall Study|Death|1|||
24918798|NCT03907683|50012512|FG000|Overall Study|Pregnancy|1|||
24918799|NCT03907683|50012512|FG000|Overall Study|Withdrawal by Subject|1|||
24918800|NCT00626522|50012522|FG000|Overall Study|Protocol Violation|0|||
24918801|NCT00626522|50012523|FG001|Overall Study|Protocol Violation|0|||
24918802|NCT00626522|50012524|FG002|Overall Study|Protocol Violation|0|||
24918803|NCT00626522|50012525|FG003|Overall Study|Protocol Violation|0|||
24918804|NCT00626522|50012526|FG004|Overall Study|Protocol Violation|1|||
24918805|NCT00626522|50012527|FG005|Overall Study|Protocol Violation|0|||
24918806|NCT00626522|50012522|FG000|Overall Study|Adverse Event|2|||
24918807|NCT00626522|50012523|FG001|Overall Study|Adverse Event|1|||
24918808|NCT00626522|50012524|FG002|Overall Study|Adverse Event|2|||
24918809|NCT00626522|50012525|FG003|Overall Study|Adverse Event|0|||
24918810|NCT00626522|50012526|FG004|Overall Study|Adverse Event|1|||
24918811|NCT00626522|50012527|FG005|Overall Study|Adverse Event|1|||
24918812|NCT00626522|50012522|FG000|Overall Study|Withdrawal by Subject|2|||
24918813|NCT00626522|50012523|FG001|Overall Study|Withdrawal by Subject|5|||
24918814|NCT00626522|50012524|FG002|Overall Study|Withdrawal by Subject|5|||
24918815|NCT00626522|50012525|FG003|Overall Study|Withdrawal by Subject|0|||
24918816|NCT00626522|50012526|FG004|Overall Study|Withdrawal by Subject|4|||
24918817|NCT00626522|50012527|FG005|Overall Study|Withdrawal by Subject|1|||
24918818|NCT00626522|50012522|FG000|Overall Study|COPD exacerbation|0|||
24918819|NCT00626522|50012523|FG001|Overall Study|COPD exacerbation|0|||
24918820|NCT00626522|50012524|FG002|Overall Study|COPD exacerbation|0|||
24918821|NCT00626522|50012525|FG003|Overall Study|COPD exacerbation|1|||
24918822|NCT00626522|50012526|FG004|Overall Study|COPD exacerbation|1|||
24918823|NCT00626522|50012527|FG005|Overall Study|COPD exacerbation|0|||
24918824|NCT00626522|50012522|FG000|Overall Study|Lost to Follow-up|0|||
24918825|NCT00626522|50012523|FG001|Overall Study|Lost to Follow-up|1|||
24918826|NCT00626522|50012524|FG002|Overall Study|Lost to Follow-up|0|||
25021984|NCT00832455|50118446|FG000|Overall Study|Withdrawal by Subject|17|||
24918827|NCT00626522|50012525|FG003|Overall Study|Lost to Follow-up|0|||
24918828|NCT00626522|50012526|FG004|Overall Study|Lost to Follow-up|0|||
24918829|NCT00626522|50012527|FG005|Overall Study|Lost to Follow-up|0|||
24918830|NCT00626522|50012522|FG000|Overall Study|Inconsistent reason reported|1|||
24918831|NCT00626522|50012523|FG001|Overall Study|Inconsistent reason reported|0|||
24918832|NCT00626522|50012524|FG002|Overall Study|Inconsistent reason reported|0|||
24918833|NCT00626522|50012525|FG003|Overall Study|Inconsistent reason reported|0|||
24918834|NCT00626522|50012526|FG004|Overall Study|Inconsistent reason reported|0|||
24918835|NCT00626522|50012527|FG005|Overall Study|Inconsistent reason reported|0|||
24918836|NCT00626522|50012522|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
24918837|NCT00626522|50012523|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
24918838|NCT00626522|50012524|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
24918839|NCT00626522|50012525|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
24918840|NCT00626522|50012526|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
24918841|NCT00626522|50012527|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
24918842|NCT00540423|50012552|FG000|Double-Blind Treatment Period|Adverse Event|0|||
24918843|NCT00540423|50012553|FG001|Double-Blind Treatment Period|Adverse Event|1|||
24918844|NCT00540423|50012554|FG002|Double-Blind Treatment Period|Adverse Event|0|||
24918845|NCT00540423|50012552|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
24918846|NCT00540423|50012553|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
24918847|NCT00540423|50012554|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
24918848|NCT00566982|50012574|FG000|Overall Study|Adverse Event|6|||
24918849|NCT00566982|50012575|FG001|Overall Study|Adverse Event|48|||
24918850|NCT00566982|50012574|FG000|Overall Study|Withdrawal by Subject|1|||
24918851|NCT00566982|50012575|FG001|Overall Study|Withdrawal by Subject|14|||
24918852|NCT00566982|50012574|FG000|Overall Study|Protocol Violation|1|||
24918853|NCT00566982|50012575|FG001|Overall Study|Protocol Violation|4|||
24918854|NCT00566982|50012574|FG000|Overall Study|Lost to Follow-up|0|||
24918855|NCT00566982|50012575|FG001|Overall Study|Lost to Follow-up|1|||
24918856|NCT00566982|50012574|FG000|Overall Study|Other-family problems & doctor's request|0|||
25021985|NCT00832455|50118446|FG000|Overall Study|Screening Failure|2|||
25021986|NCT00832455|50118446|FG000|Overall Study|Stopped Medication|4|||
25021987|NCT00832455|50118446|FG000|Overall Study|Parent misunderstood study|1|||
25021988|NCT00832455|50118446|FG000|Overall Study|Parent dissatisfied|1|||
25021989|NCT00832455|50118446|FG000|Overall Study|No improvement|3|||
25021990|NCT00832455|50118446|FG000|Overall Study|Patient moved|1|||
25021991|NCT00687531|50118459|FG000|Overall Study|Did not meet protocol eligibility|104|||
25021992|NCT00687531|50118459|FG000|Overall Study|Adverse Event|5|||
24918857|NCT00566982|50012575|FG001|Overall Study|Other-family problems & doctor's request|2|||
24918858|NCT00624338|50012587|FG000|Overall Study|Adverse Event|14|||
24918859|NCT00624338|50012588|FG001|Overall Study|Adverse Event|14|||
24918860|NCT00624338|50012589|FG002|Overall Study|Adverse Event|18|||
25021993|NCT00687531|50118459|FG000|Overall Study|Lost to Follow-up|26|||
24918861|NCT00624338|50012587|FG000|Overall Study|Lost to Follow-up|1|||
24918862|NCT00624338|50012588|FG001|Overall Study|Lost to Follow-up|0|||
24918863|NCT00624338|50012589|FG002|Overall Study|Lost to Follow-up|0|||
24918864|NCT00624338|50012587|FG000|Overall Study|Lack of Efficacy|11|||
24918865|NCT00624338|50012588|FG001|Overall Study|Lack of Efficacy|3|||
24918866|NCT00624338|50012589|FG002|Overall Study|Lack of Efficacy|14|||
24918867|NCT00624338|50012587|FG000|Overall Study|Protocol Violation|3|||
24918868|NCT00624338|50012588|FG001|Overall Study|Protocol Violation|3|||
24918869|NCT00624338|50012589|FG002|Overall Study|Protocol Violation|2|||
24918870|NCT00624338|50012587|FG000|Overall Study|Death|0|||
25021994|NCT00423579|50118465|FG000|Overall Study|Lost to Follow-up|3|||
25021995|NCT00423579|50118466|FG001|Overall Study|Lost to Follow-up|0|||
25021996|NCT00423579|50118465|FG000|Overall Study|Protocol Violation|1|||
25021997|NCT00423579|50118466|FG001|Overall Study|Protocol Violation|3|||
25021998|NCT00423579|50118465|FG000|Overall Study|Diagnosis of diabetes|0|||
25021999|NCT00423579|50118466|FG001|Overall Study|Diagnosis of diabetes|1|||
25022000|NCT03268005|50118474|FG000|Overall Study|Death|2|||
24918871|NCT00624338|50012588|FG001|Overall Study|Death|2|||
24918872|NCT00624338|50012589|FG002|Overall Study|Death|0|||
24918873|NCT00624338|50012587|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
25022001|NCT03268005|50118475|FG001|Overall Study|Death|1|||
25022002|NCT03268005|50118474|FG000|Overall Study|Lost to Follow-up|2|||
25022003|NCT03268005|50118475|FG001|Overall Study|Lost to Follow-up|2|||
25275026|NCT01238861|50589065|FG000|Overall Study|Adverse Event|0|||
25022004|NCT03268005|50118474|FG000|Overall Study|Withdrawal by Subject|11|||
24918874|NCT00624338|50012588|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
24918875|NCT00624338|50012589|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
24918876|NCT00624338|50012587|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
25022005|NCT03268005|50118475|FG001|Overall Study|Withdrawal by Subject|11|||
25022006|NCT03149055|50118481|FG000|Overall Study|Not treated|4|||
25022007|NCT03137121|50118496|FG000|Overall Study|Withdrawal by Subject|0|||
24918877|NCT00624338|50012588|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
24918878|NCT00624338|50012589|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
24918879|NCT00624338|50012587|FG000|Overall Study|Other|15|||
24918880|NCT00624338|50012588|FG001|Overall Study|Other|5|||
24918881|NCT00624338|50012589|FG002|Overall Study|Other|9|||
24918882|NCT00624338|50012587|FG000|Overall Study|Randomized but not treated|2|||
24918883|NCT00624338|50012588|FG001|Overall Study|Randomized but not treated|1|||
24918884|NCT00624338|50012589|FG002|Overall Study|Randomized but not treated|3|||
24918885|NCT03977454|50012599|FG000|Overall Study|immediate postoperative revision|2|||
24918886|NCT03977454|50012600|FG001|Overall Study|immediate postoperative revision|2|||
24918887|NCT00538785|50012608|FG000|Overall Study|Death|9|||
25022008|NCT03137121|50118497|FG001|Overall Study|Withdrawal by Subject|1|||
25022009|NCT00700570|50118540|FG000|Overall Study|Adverse Event|2|||
25022010|NCT00700570|50118541|FG001|Overall Study|Adverse Event|6|||
25022011|NCT00700570|50118540|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
25022012|NCT00700570|50118541|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
25022013|NCT00700570|50118540|FG000|Overall Study|Disease Progression|8|||
25022014|NCT00700570|50118541|FG001|Overall Study|Disease Progression|11|||
25022015|NCT00700570|50118540|FG000|Overall Study|Withdrawal by Subject|1|||
25022016|NCT00700570|50118541|FG001|Overall Study|Withdrawal by Subject|6|||
25022017|NCT02874924|50118559|FG000|Overall Study|Adverse Event|2|||
25022018|NCT02874924|50118560|FG001|Overall Study|Adverse Event|0|||
25022019|NCT02874924|50118561|FG002|Overall Study|Adverse Event|0|||
25022020|NCT02874924|50118559|FG000|Overall Study|Withdrawal by Subject|1|||
25022021|NCT02874924|50118560|FG001|Overall Study|Withdrawal by Subject|0|||
25022022|NCT02874924|50118561|FG002|Overall Study|Withdrawal by Subject|0|||
25022023|NCT04425863|50118572|FG000|Overall Study|Death|0|||
25022024|NCT04425863|50118573|FG001|Overall Study|Death|0|||
25022025|NCT04425863|50118574|FG002|Overall Study|Death|1|||
25022026|NCT04360187|50118596|FG000|Double-Blind Treatment|Adverse Event|9|||
25022027|NCT04360187|50118597|FG001|Double-Blind Treatment|Adverse Event|11|||
25022028|NCT04360187|50118596|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
25022029|NCT04360187|50118597|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
25022030|NCT04360187|50118596|FG000|Double-Blind Treatment|Physician Decision|1|||
25022031|NCT04360187|50118597|FG001|Double-Blind Treatment|Physician Decision|0|||
25022032|NCT04360187|50118596|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
25022033|NCT04360187|50118597|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
25154077|NCT01515423|50269207|FG001|DOUBLE BLIND|Pregnancy|2|||
25154078|NCT01515423|50269208|FG002|DOUBLE BLIND|Pregnancy|0|||
25154079|NCT01515423|50269206|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
25154080|NCT01515423|50269207|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
25154081|NCT01515423|50269208|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
25154082|NCT01515423|50269206|FG000|DOUBLE BLIND|Other|0|||
25154083|NCT01515423|50269207|FG001|DOUBLE BLIND|Other|6|||
25154084|NCT01515423|50269208|FG002|DOUBLE BLIND|Other|12|||
25154085|NCT01515423|50269206|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
25154086|NCT01515423|50269207|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
25154087|NCT01515423|50269208|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
25154088|NCT00637156|50269217|FG000|Overall Study|Withdrawal by Subject|0|||
24918888|NCT00538785|50012609|FG001|Overall Study|Death|10|||
24918889|NCT00538785|50012608|FG000|Overall Study|Withdrawal of consent|9|||
24918890|NCT00538785|50012609|FG001|Overall Study|Withdrawal of consent|7|||
24918891|NCT00538785|50012608|FG000|Overall Study|Lost to Follow-up|1|||
24918892|NCT00538785|50012609|FG001|Overall Study|Lost to Follow-up|0|||
25022034|NCT04360187|50118596|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
25022035|NCT04360187|50118597|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
25022036|NCT04360187|50118596|FG000|Follow-Up|Lost to Follow-up|1|||
25154089|NCT00637156|50269218|FG001|Overall Study|Withdrawal by Subject|7|||
25154090|NCT00637156|50269217|FG000|Overall Study|Death|0|||
24918893|NCT00538629|50012615|FG000|Overall Study|At subject's request|1|||
25154091|NCT00637156|50269218|FG001|Overall Study|Death|1|||
24918894|NCT00538629|50012615|FG000|Overall Study|Adverse Event|2|||
25154092|NCT00637156|50269217|FG000|Overall Study|Lost to Follow-up|10|||
24918895|NCT00538629|50012615|FG000|Overall Study|Lack of Efficacy|12|||
24918896|NCT00538629|50012615|FG000|Overall Study|Lost to Follow-up|6|||
24918897|NCT00538629|50012615|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
24918898|NCT00622700|50012622|FG000|Core Treatment Period|Randomized but Not Treated|0|||
24918899|NCT00622700|50012623|FG001|Core Treatment Period|Randomized but Not Treated|2|||
24918900|NCT00622700|50012624|FG002|Core Treatment Period|Randomized but Not Treated|2|||
24918901|NCT00622700|50012625|FG003|Core Treatment Period|Randomized but Not Treated|0|||
24918902|NCT00622700|50012626|FG004|Core Treatment Period|Randomized but Not Treated|0|||
24918903|NCT00622700|50012627|FG005|Core Treatment Period|Randomized but Not Treated|0|||
25022037|NCT04360187|50118597|FG001|Follow-Up|Lost to Follow-up|0|||
25022038|NCT04498169|50118605|FG000|Study Completion|Adverse Event|1|||
25022039|NCT04498169|50118606|FG001|Study Completion|Adverse Event|1|||
25022040|NCT03695393|50118614|FG000|Overall Study|Death|3|||
25022041|NCT03695393|50118615|FG001|Overall Study|Death|1|||
25022042|NCT03695393|50118614|FG000|Overall Study|Lost to Follow-up|0|||
25022043|NCT03695393|50118615|FG001|Overall Study|Lost to Follow-up|1|||
25022044|NCT03694925|50118624|FG000|Overall Study|Inadequate laboratory testing|0|||
25022045|NCT03694925|50118625|FG001|Overall Study|Inadequate laboratory testing|3|||
25022046|NCT03694925|50118626|FG002|Overall Study|Inadequate laboratory testing|0|||
25022047|NCT04495829|50118636|FG000|Overall Study|Lost to Follow-up|2|||
25022048|NCT04495829|50118636|FG000|Overall Study|Inclusion criterion not met|3|||
25022049|NCT04258020|50118642|FG000|Overall Study|Withdrawal by Subject|1|||
25022050|NCT04258020|50118643|FG001|Overall Study|Withdrawal by Subject|0|||
25022051|NCT04495283|50118652|FG000|Overall Study|Physician Decision|0|||
25022052|NCT04495283|50118653|FG001|Overall Study|Physician Decision|0|||
24918904|NCT00622700|50012628|FG006|Core Treatment Period|Randomized but Not Treated|0|||
25022053|NCT04495283|50118654|FG002|Overall Study|Physician Decision|1|||
25022054|NCT04495283|50118652|FG000|Overall Study|Withdrawal by Subject|0|||
25022055|NCT04495283|50118653|FG001|Overall Study|Withdrawal by Subject|1|||
25022056|NCT04495283|50118654|FG002|Overall Study|Withdrawal by Subject|1|||
25022057|NCT04495283|50118652|FG000|Overall Study|Other|1|||
25022058|NCT04495283|50118653|FG001|Overall Study|Other|0|||
25022059|NCT04495283|50118654|FG002|Overall Study|Other|1|||
25022060|NCT03117738|50118667|FG000|Overall Study|Withdrawal by Subject|3|||
25022061|NCT03117738|50118668|FG001|Overall Study|Withdrawal by Subject|1|||
25022062|NCT03117738|50118667|FG000|Overall Study|Lost to Follow-up|1|||
25022063|NCT03117738|50118668|FG001|Overall Study|Lost to Follow-up|4|||
25022064|NCT04234464|50118676|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
25022065|NCT04234464|50118677|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
25022066|NCT03123588|50118685|FG000|Overall Study|Study Terminated by Sponsor|2|||
25022067|NCT03123588|50118686|FG001|Overall Study|Study Terminated by Sponsor|5|||
25022068|NCT03123588|50118685|FG000|Overall Study|Withdrawal by Subject|1|||
25022069|NCT03123588|50118686|FG001|Overall Study|Withdrawal by Subject|0|||
25022070|NCT03123588|50118685|FG000|Overall Study|Adverse Event|1|||
25022071|NCT03123588|50118686|FG001|Overall Study|Adverse Event|0|||
25022072|NCT03123588|50118685|FG000|Overall Study|Physician Decision|2|||
25022073|NCT03123588|50118686|FG001|Overall Study|Physician Decision|1|||
25022074|NCT03123354|50118693|FG000|Overall Study|Physician Decision|6|||
25022075|NCT04421027|50118699|FG000|Treatment Period|Adverse Event|5|||
24918905|NCT00622700|50012622|FG000|Core Treatment Period|Adverse Event|18|||
24918906|NCT00622700|50012623|FG001|Core Treatment Period|Adverse Event|25|||
24918907|NCT00622700|50012624|FG002|Core Treatment Period|Adverse Event|18|||
24918908|NCT00622700|50012625|FG003|Core Treatment Period|Adverse Event|0|||
24918909|NCT00622700|50012626|FG004|Core Treatment Period|Adverse Event|0|||
24918910|NCT00622700|50012627|FG005|Core Treatment Period|Adverse Event|0|||
24918911|NCT00622700|50012628|FG006|Core Treatment Period|Adverse Event|0|||
24918912|NCT00622700|50012622|FG000|Core Treatment Period|Lack of Efficacy|19|||
24918913|NCT00622700|50012623|FG001|Core Treatment Period|Lack of Efficacy|6|||
24918914|NCT00622700|50012624|FG002|Core Treatment Period|Lack of Efficacy|12|||
24918915|NCT00622700|50012625|FG003|Core Treatment Period|Lack of Efficacy|0|||
24918916|NCT00622700|50012626|FG004|Core Treatment Period|Lack of Efficacy|0|||
24918917|NCT00622700|50012627|FG005|Core Treatment Period|Lack of Efficacy|0|||
24918918|NCT00622700|50012628|FG006|Core Treatment Period|Lack of Efficacy|0|||
25022076|NCT04421027|50118700|FG001|Treatment Period|Adverse Event|3|||
25022077|NCT04421027|50118701|FG002|Treatment Period|Adverse Event|0|||
25022078|NCT04421027|50118702|FG003|Treatment Period|Adverse Event|0|||
25022079|NCT04421027|50118699|FG000|Treatment Period|Death|98|||
25022080|NCT04421027|50118700|FG001|Treatment Period|Death|61|||
25022081|NCT04421027|50118701|FG002|Treatment Period|Death|0|||
25022082|NCT04421027|50118702|FG003|Treatment Period|Death|0|||
24918919|NCT00622700|50012622|FG000|Core Treatment Period|Lost to Follow-up|1|||
24918920|NCT00622700|50012623|FG001|Core Treatment Period|Lost to Follow-up|1|||
24918921|NCT00622700|50012624|FG002|Core Treatment Period|Lost to Follow-up|1|||
24918922|NCT00622700|50012625|FG003|Core Treatment Period|Lost to Follow-up|0|||
24918923|NCT00622700|50012626|FG004|Core Treatment Period|Lost to Follow-up|0|||
24918924|NCT00622700|50012627|FG005|Core Treatment Period|Lost to Follow-up|0|||
24918925|NCT00622700|50012628|FG006|Core Treatment Period|Lost to Follow-up|0|||
24918926|NCT00622700|50012622|FG000|Core Treatment Period|Death|1|||
25022083|NCT04421027|50118699|FG000|Treatment Period|Lost to Follow-up|22|||
25022084|NCT04421027|50118700|FG001|Treatment Period|Lost to Follow-up|20|||
25022085|NCT04421027|50118701|FG002|Treatment Period|Lost to Follow-up|0|||
25022086|NCT04421027|50118702|FG003|Treatment Period|Lost to Follow-up|0|||
25022087|NCT04421027|50118699|FG000|Treatment Period|Other-Unknown|15|||
25022088|NCT04421027|50118700|FG001|Treatment Period|Other-Unknown|9|||
25022089|NCT04421027|50118701|FG002|Treatment Period|Other-Unknown|0|||
25022090|NCT04421027|50118702|FG003|Treatment Period|Other-Unknown|0|||
25022091|NCT04421027|50118699|FG000|Treatment Period|Physician Decision|1|||
25022092|NCT04421027|50118700|FG001|Treatment Period|Physician Decision|1|||
25022093|NCT04421027|50118701|FG002|Treatment Period|Physician Decision|0|||
25022094|NCT04421027|50118702|FG003|Treatment Period|Physician Decision|0|||
25022095|NCT04421027|50118699|FG000|Treatment Period|Withdrawal by Subject|7|||
25022096|NCT04421027|50118700|FG001|Treatment Period|Withdrawal by Subject|12|||
25022097|NCT04421027|50118701|FG002|Treatment Period|Withdrawal by Subject|0|||
25022098|NCT04421027|50118702|FG003|Treatment Period|Withdrawal by Subject|0|||
25022099|NCT04421027|50118699|FG000|Treatment Period|Randomized Not Dosed|9|||
25022100|NCT04421027|50118700|FG001|Treatment Period|Randomized Not Dosed|14|||
25022101|NCT04421027|50118701|FG002|Treatment Period|Randomized Not Dosed|0|||
25022102|NCT04421027|50118702|FG003|Treatment Period|Randomized Not Dosed|0|||
25022103|NCT04421027|50118699|FG000|Follow-Up Period|Adverse Event|0|||
25022104|NCT04421027|50118700|FG001|Follow-Up Period|Adverse Event|0|||
25022105|NCT04421027|50118701|FG002|Follow-Up Period|Adverse Event|0|||
25022106|NCT04421027|50118702|FG003|Follow-Up Period|Adverse Event|3|||
24918927|NCT00622700|50012623|FG001|Core Treatment Period|Death|0|||
24918928|NCT00622700|50012624|FG002|Core Treatment Period|Death|0|||
24918929|NCT00622700|50012625|FG003|Core Treatment Period|Death|0|||
24918930|NCT00622700|50012626|FG004|Core Treatment Period|Death|0|||
24918931|NCT00622700|50012627|FG005|Core Treatment Period|Death|0|||
24918932|NCT00622700|50012628|FG006|Core Treatment Period|Death|0|||
24918933|NCT00622700|50012622|FG000|Core Treatment Period|Progressive Disease|3|||
25022107|NCT04421027|50118699|FG000|Follow-Up Period|Death|0|||
25022108|NCT04421027|50118700|FG001|Follow-Up Period|Death|0|||
25022109|NCT04421027|50118701|FG002|Follow-Up Period|Death|16|||
25022110|NCT04421027|50118702|FG003|Follow-Up Period|Death|17|||
25022111|NCT04421027|50118699|FG000|Follow-Up Period|Lost to Follow-up|0|||
25022112|NCT04421027|50118700|FG001|Follow-Up Period|Lost to Follow-up|0|||
25022113|NCT04421027|50118701|FG002|Follow-Up Period|Lost to Follow-up|7|||
25022114|NCT04421027|50118702|FG003|Follow-Up Period|Lost to Follow-up|7|||
25022115|NCT04421027|50118699|FG000|Follow-Up Period|Protocol Deviation|0|||
25022116|NCT04421027|50118700|FG001|Follow-Up Period|Protocol Deviation|0|||
25022117|NCT04421027|50118701|FG002|Follow-Up Period|Protocol Deviation|1|||
25154093|NCT00637156|50269218|FG001|Overall Study|Lost to Follow-up|16|||
25154094|NCT00637000|50269226|FG000|Overall Study|Withdrawal by Subject|4|||
25154095|NCT00637000|50269227|FG001|Overall Study|Withdrawal by Subject|3|||
24918934|NCT00622700|50012623|FG001|Core Treatment Period|Progressive Disease|1|||
24918935|NCT00622700|50012624|FG002|Core Treatment Period|Progressive Disease|0|||
24918936|NCT00622700|50012625|FG003|Core Treatment Period|Progressive Disease|0|||
24918937|NCT00622700|50012626|FG004|Core Treatment Period|Progressive Disease|0|||
24918938|NCT00622700|50012627|FG005|Core Treatment Period|Progressive Disease|0|||
25154096|NCT01515189|50269235|FG000|Induction|Disease Progression|109|||
25154097|NCT01515189|50269236|FG001|Induction|Disease Progression|155|||
25154098|NCT01515189|50269235|FG000|Induction|Study drug toxicity|86|||
25154099|NCT01515189|50269236|FG001|Induction|Study drug toxicity|36|||
25154100|NCT01515189|50269235|FG000|Induction|Death|24|||
25154101|NCT01515189|50269236|FG001|Induction|Death|17|||
25154102|NCT01515189|50269235|FG000|Induction|Adverse Event|14|||
24918939|NCT00622700|50012628|FG006|Core Treatment Period|Progressive Disease|0|||
24918940|NCT00622700|50012622|FG000|Core Treatment Period|Withdrawal by Subject|12|||
24918941|NCT00622700|50012623|FG001|Core Treatment Period|Withdrawal by Subject|18|||
24918942|NCT00622700|50012624|FG002|Core Treatment Period|Withdrawal by Subject|15|||
24918943|NCT00622700|50012625|FG003|Core Treatment Period|Withdrawal by Subject|0|||
24918944|NCT00622700|50012626|FG004|Core Treatment Period|Withdrawal by Subject|0|||
24918945|NCT00622700|50012627|FG005|Core Treatment Period|Withdrawal by Subject|0|||
24918946|NCT00622700|50012628|FG006|Core Treatment Period|Withdrawal by Subject|0|||
24918947|NCT00622700|50012622|FG000|Core Treatment Period|Other than specified above|2|||
24918948|NCT00622700|50012623|FG001|Core Treatment Period|Other than specified above|2|||
24918949|NCT00622700|50012624|FG002|Core Treatment Period|Other than specified above|5|||
24918950|NCT00622700|50012625|FG003|Core Treatment Period|Other than specified above|0|||
25022118|NCT04421027|50118702|FG003|Follow-Up Period|Protocol Deviation|0|||
25022119|NCT04421027|50118699|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
25022120|NCT04421027|50118700|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
25022121|NCT04421027|50118701|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
25154103|NCT01515189|50269236|FG001|Induction|Adverse Event|9|||
25154104|NCT01515189|50269235|FG000|Induction|Withdrawal by Subject|3|||
25022122|NCT04421027|50118702|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
25022123|NCT04421027|50118699|FG000|Follow-Up Period|Left message, participant did not call back|0|||
25022124|NCT04421027|50118700|FG001|Follow-Up Period|Left message, participant did not call back|0|||
25022125|NCT04421027|50118701|FG002|Follow-Up Period|Left message, participant did not call back|0|||
25022126|NCT04421027|50118702|FG003|Follow-Up Period|Left message, participant did not call back|1|||
25022127|NCT04421027|50118699|FG000|Follow-Up Period|Participant died|0|||
25022128|NCT04421027|50118700|FG001|Follow-Up Period|Participant died|0|||
25022129|NCT04421027|50118701|FG002|Follow-Up Period|Participant died|0|||
25022130|NCT04421027|50118702|FG003|Follow-Up Period|Participant died|1|||
25022131|NCT04421027|50118699|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
25022132|NCT04421027|50118700|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
25022133|NCT04421027|50118701|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
25022134|NCT04421027|50118702|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
25022135|NCT04419311|50118712|FG000|Overall Study|Lost to Follow-up|1|||
25022136|NCT04419311|50118713|FG001|Overall Study|Lost to Follow-up|0|||
25022137|NCT04411667|50118723|FG000|Overall Study|Physician Decision|1|||
25022138|NCT04411667|50118724|FG001|Overall Study|Physician Decision|0|||
25022139|NCT04358549|50118732|FG000|Overall Study|Adverse Event|0|||
25022140|NCT04358549|50118733|FG001|Overall Study|Adverse Event|1|||
25022141|NCT04358549|50118732|FG000|Overall Study|Death|1|||
25022142|NCT04358549|50118733|FG001|Overall Study|Death|0|||
25022143|NCT04358549|50118732|FG000|Overall Study|Lost to Follow-up|2|||
25022144|NCT04358549|50118733|FG001|Overall Study|Lost to Follow-up|1|||
25022145|NCT04358549|50118732|FG000|Overall Study|Withdrawal by Subject|6|||
25022146|NCT04358549|50118733|FG001|Overall Study|Withdrawal by Subject|6|||
25022147|NCT04358549|50118732|FG000|Overall Study|Start remdesivir|1|||
25022148|NCT04358549|50118733|FG001|Overall Study|Start remdesivir|0|||
25022149|NCT00700180|50118741|FG000|Overall Study|Death|99|||
25022150|NCT00700180|50118742|FG001|Overall Study|Death|114|||
25022151|NCT00700180|50118741|FG000|Overall Study|Alive on treatment|5|||
25022152|NCT00700180|50118742|FG001|Overall Study|Alive on treatment|3|||
25022153|NCT00700180|50118741|FG000|Overall Study|Alive in follow-up|46|||
25022154|NCT00700180|50118742|FG001|Overall Study|Alive in follow-up|27|||
25022155|NCT00700180|50118741|FG000|Overall Study|Lost to Follow-up|4|||
25022156|NCT00700180|50118742|FG001|Overall Study|Lost to Follow-up|5|||
25022157|NCT00238420|50118750|FG000|Overall Study|Protocol Violation|1|||
25022158|NCT00238420|50118751|FG001|Overall Study|Protocol Violation|1|||
25022159|NCT04492475|50118759|FG000|Overall Study|Enrolled but not treated|8|||
25022160|NCT04492475|50118760|FG001|Overall Study|Enrolled but not treated|8|||
25022161|NCT04492475|50118759|FG000|Overall Study|Withdrawal by Subject|4|||
25154105|NCT01515189|50269236|FG001|Induction|Withdrawal by Subject|9|||
25154106|NCT01515189|50269235|FG000|Induction|No longer meets study criteria|0|||
25154107|NCT01515189|50269236|FG001|Induction|No longer meets study criteria|2|||
25154108|NCT01515189|50269235|FG000|Induction|Lost to Follow-up|1|||
25154109|NCT01515189|50269236|FG001|Induction|Lost to Follow-up|0|||
25154110|NCT01515189|50269235|FG000|Induction|Other|0|||
25154111|NCT01515189|50269236|FG001|Induction|Other|4|||
25185051|NCT00249795|50334152|FG000|Overall Study|Other adverse events (non-serious)|188|||
25185052|NCT00249795|50334153|FG001|Overall Study|Other adverse events (non-serious)|159|||
25185053|NCT00249795|50334152|FG000|Overall Study|Physician withdrew consent|71|||
25185054|NCT00249795|50334153|FG001|Overall Study|Physician withdrew consent|63|||
25154112|NCT01515189|50269235|FG000|First Re-Induction Phase|Disease progression|6|||
25185055|NCT00249795|50334152|FG000|Overall Study|Surgery / procedure|4|||
25022162|NCT04492475|50118760|FG001|Overall Study|Withdrawal by Subject|0|||
25022163|NCT04492475|50118759|FG000|Overall Study|Became ineligible after enrollment|2|||
25022164|NCT04492475|50118760|FG001|Overall Study|Became ineligible after enrollment|0|||
25022165|NCT04486235|50118775|FG000|Overall Study|Pregnancy|1|||
24918951|NCT00622700|50012626|FG004|Core Treatment Period|Other than specified above|0|||
24918952|NCT00622700|50012627|FG005|Core Treatment Period|Other than specified above|0|||
24918953|NCT00622700|50012628|FG006|Core Treatment Period|Other than specified above|0|||
24918954|NCT00622700|50012622|FG000|Extension Treatment Period|Adverse Event|0|||
24918955|NCT00622700|50012623|FG001|Extension Treatment Period|Adverse Event|0|||
24918956|NCT00622700|50012624|FG002|Extension Treatment Period|Adverse Event|0|||
24918957|NCT00622700|50012625|FG003|Extension Treatment Period|Adverse Event|5|||
24918958|NCT00622700|50012626|FG004|Extension Treatment Period|Adverse Event|9|||
24918959|NCT00622700|50012627|FG005|Extension Treatment Period|Adverse Event|6|||
24918960|NCT00622700|50012628|FG006|Extension Treatment Period|Adverse Event|8|||
24918961|NCT00622700|50012622|FG000|Extension Treatment Period|Lack of Efficacy|0|||
24918962|NCT00622700|50012623|FG001|Extension Treatment Period|Lack of Efficacy|0|||
24918963|NCT00622700|50012624|FG002|Extension Treatment Period|Lack of Efficacy|0|||
24918964|NCT00622700|50012625|FG003|Extension Treatment Period|Lack of Efficacy|2|||
24918965|NCT00622700|50012626|FG004|Extension Treatment Period|Lack of Efficacy|8|||
24918966|NCT00622700|50012627|FG005|Extension Treatment Period|Lack of Efficacy|1|||
24918967|NCT00622700|50012628|FG006|Extension Treatment Period|Lack of Efficacy|9|||
24918968|NCT00622700|50012622|FG000|Extension Treatment Period|Protocol Violation|0|||
24918969|NCT00622700|50012623|FG001|Extension Treatment Period|Protocol Violation|0|||
24918970|NCT00622700|50012624|FG002|Extension Treatment Period|Protocol Violation|0|||
25022166|NCT04486235|50118776|FG001|Overall Study|Pregnancy|0|||
25022167|NCT04486235|50118775|FG000|Overall Study|Lost to Follow-up|1|||
25022168|NCT04486235|50118776|FG001|Overall Study|Lost to Follow-up|0|||
25022169|NCT04358081|50118786|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
25022170|NCT04358081|50118787|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
25022171|NCT04358081|50118788|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
24918971|NCT00622700|50012625|FG003|Extension Treatment Period|Protocol Violation|0|||
24918972|NCT00622700|50012626|FG004|Extension Treatment Period|Protocol Violation|0|||
24918973|NCT00622700|50012627|FG005|Extension Treatment Period|Protocol Violation|2|||
24918974|NCT00622700|50012628|FG006|Extension Treatment Period|Protocol Violation|0|||
24918975|NCT00622700|50012622|FG000|Extension Treatment Period|Lost to Follow-up|0|||
24918976|NCT00622700|50012623|FG001|Extension Treatment Period|Lost to Follow-up|0|||
24918977|NCT00622700|50012624|FG002|Extension Treatment Period|Lost to Follow-up|0|||
24918978|NCT00622700|50012625|FG003|Extension Treatment Period|Lost to Follow-up|0|||
24918979|NCT00622700|50012626|FG004|Extension Treatment Period|Lost to Follow-up|1|||
24918980|NCT00622700|50012627|FG005|Extension Treatment Period|Lost to Follow-up|0|||
24918981|NCT00622700|50012628|FG006|Extension Treatment Period|Lost to Follow-up|0|||
24918982|NCT00622700|50012622|FG000|Extension Treatment Period|Progressive Disease|0|||
24918983|NCT00622700|50012623|FG001|Extension Treatment Period|Progressive Disease|0|||
24918984|NCT00622700|50012624|FG002|Extension Treatment Period|Progressive Disease|0|||
24918985|NCT00622700|50012625|FG003|Extension Treatment Period|Progressive Disease|1|||
24918986|NCT00622700|50012626|FG004|Extension Treatment Period|Progressive Disease|2|||
24918987|NCT00622700|50012627|FG005|Extension Treatment Period|Progressive Disease|0|||
24918988|NCT00622700|50012628|FG006|Extension Treatment Period|Progressive Disease|2|||
24918989|NCT00622700|50012622|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
24918990|NCT00622700|50012623|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
25022172|NCT04358081|50118786|FG000|Treatment Phase of Study|Adverse Event|1|||
25022173|NCT04358081|50118787|FG001|Treatment Phase of Study|Adverse Event|0|||
25022174|NCT04358081|50118788|FG002|Treatment Phase of Study|Adverse Event|1|||
25022175|NCT04358081|50118786|FG000|Treatment Phase of Study|Physician Decision|2|||
25022176|NCT04358081|50118787|FG001|Treatment Phase of Study|Physician Decision|0|||
25022177|NCT04358081|50118788|FG002|Treatment Phase of Study|Physician Decision|1|||
25022178|NCT04358081|50118786|FG000|Treatment Phase of Study|Protocol Violation|1|||
25022179|NCT04358081|50118787|FG001|Treatment Phase of Study|Protocol Violation|0|||
25022180|NCT04358081|50118788|FG002|Treatment Phase of Study|Protocol Violation|0|||
25022181|NCT04358081|50118786|FG000|Study Completion Phase|Death|0|||
25022182|NCT04358081|50118787|FG001|Study Completion Phase|Death|0|||
25022183|NCT04358081|50118788|FG002|Study Completion Phase|Death|1|||
25022184|NCT04358081|50118786|FG000|Study Completion Phase|Lost to Follow-up|1|||
25022185|NCT04358081|50118787|FG001|Study Completion Phase|Lost to Follow-up|0|||
25022186|NCT04358081|50118788|FG002|Study Completion Phase|Lost to Follow-up|1|||
25022187|NCT04355663|50118801|FG000|Overall Study|Physician Decision|2|||
25022188|NCT04355663|50118802|FG001|Overall Study|Physician Decision|7|||
25022189|NCT04355663|50118803|FG002|Overall Study|Physician Decision|0|||
24918991|NCT00622700|50012624|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
25022190|NCT04355663|50118801|FG000|Overall Study|Adverse Event|0|||
24918992|NCT00622700|50012625|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
24918993|NCT00622700|50012626|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
24918994|NCT00622700|50012627|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
24918995|NCT00622700|50012628|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
24918996|NCT00622700|50012622|FG000|Extension Treatment Period|Missing|0|||
25022191|NCT04355663|50118802|FG001|Overall Study|Adverse Event|0|||
25022192|NCT04355663|50118803|FG002|Overall Study|Adverse Event|1|||
24918997|NCT00622700|50012623|FG001|Extension Treatment Period|Missing|0|||
24918998|NCT00622700|50012624|FG002|Extension Treatment Period|Missing|0|||
24918999|NCT00622700|50012625|FG003|Extension Treatment Period|Missing|2|||
24919000|NCT00622700|50012626|FG004|Extension Treatment Period|Missing|3|||
24919001|NCT00622700|50012627|FG005|Extension Treatment Period|Missing|1|||
24919002|NCT00622700|50012628|FG006|Extension Treatment Period|Missing|0|||
24919003|NCT00622700|50012622|FG000|Extension Treatment Period|Other than specified above|0|||
24919004|NCT00622700|50012623|FG001|Extension Treatment Period|Other than specified above|0|||
24919005|NCT00622700|50012624|FG002|Extension Treatment Period|Other than specified above|0|||
24919006|NCT00622700|50012625|FG003|Extension Treatment Period|Other than specified above|0|||
24919007|NCT00622700|50012626|FG004|Extension Treatment Period|Other than specified above|0|||
24919008|NCT00622700|50012627|FG005|Extension Treatment Period|Other than specified above|1|||
24919009|NCT00622700|50012628|FG006|Extension Treatment Period|Other than specified above|1|||
24919010|NCT00538473|50012647|FG000|Overall Study|Adverse Event|1|||
24919011|NCT00538473|50012648|FG001|Overall Study|Adverse Event|0|||
24919012|NCT00622466|50012654|FG000|Overall Study|Death|1|||
24919013|NCT00622466|50012654|FG000|Overall Study|Adverse Event|1|||
24919014|NCT00622466|50012654|FG000|Overall Study|Withdrawal by Subject|2|||
24919015|NCT00537771|50012660|FG000|Overall Study|Withdrawal by Subject|6|||
24919016|NCT00537771|50012661|FG001|Overall Study|Withdrawal by Subject|23|||
24919017|NCT00537771|50012660|FG000|Overall Study|Adverse Event|8|||
24919018|NCT00537771|50012661|FG001|Overall Study|Adverse Event|15|||
25022193|NCT04355663|50118801|FG000|Overall Study|Withdrawal by Subject|0|||
25022194|NCT04355663|50118802|FG001|Overall Study|Withdrawal by Subject|8|||
24919019|NCT00537771|50012660|FG000|Overall Study|Lost to Follow-up|9|||
24919020|NCT00537771|50012661|FG001|Overall Study|Lost to Follow-up|15|||
24919021|NCT00537771|50012660|FG000|Overall Study|Protocol Violation|2|||
24919022|NCT00537771|50012661|FG001|Overall Study|Protocol Violation|6|||
25022195|NCT04355663|50118803|FG002|Overall Study|Withdrawal by Subject|3|||
25022196|NCT04345367|50118813|FG000|Overall Study|Other|3|||
25022197|NCT04345367|50118814|FG001|Overall Study|Other|4|||
25022198|NCT04345367|50118813|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
25022199|NCT04345367|50118814|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
25022200|NCT04345367|50118813|FG000|Overall Study|Withdrawal by Subject|11|||
25022201|NCT04345367|50118814|FG001|Overall Study|Withdrawal by Subject|11|||
25022202|NCT04345367|50118813|FG000|Overall Study|Protocol Violation|4|||
25022203|NCT04345367|50118814|FG001|Overall Study|Protocol Violation|3|||
25022204|NCT04345367|50118813|FG000|Overall Study|Lost to Follow-up|2|||
25022205|NCT04345367|50118814|FG001|Overall Study|Lost to Follow-up|4|||
25022206|NCT04345367|50118813|FG000|Overall Study|Lack of Efficacy|2|||
25022207|NCT04345367|50118814|FG001|Overall Study|Lack of Efficacy|0|||
25022208|NCT04345367|50118813|FG000|Overall Study|Death|2|||
25022209|NCT04345367|50118814|FG001|Overall Study|Death|0|||
25022210|NCT04345367|50118813|FG000|Overall Study|Adverse Event|10|||
25022211|NCT04345367|50118814|FG001|Overall Study|Adverse Event|9|||
25022212|NCT04404725|50118820|FG000|First Intervention|Withdrawal by Subject|0|||
25022213|NCT04404725|50118821|FG001|First Intervention|Withdrawal by Subject|2|||
25022214|NCT04404725|50118820|FG000|Second Intervention|Adverse Event|1|||
25022215|NCT04404725|50118821|FG001|Second Intervention|Adverse Event|1|||
25022216|NCT04404725|50118820|FG000|Second Intervention|Withdrawal by Subject|0|||
25022217|NCT04404725|50118821|FG001|Second Intervention|Withdrawal by Subject|1|||
25022218|NCT04343261|50118827|FG000|Overall Study|Adverse Event|1|||
25022219|NCT04343261|50118827|FG000|Overall Study|received inadequate amount of antibodies|7|||
25022220|NCT04336475|50118833|FG000|Overall Study|pain|1|||
25022221|NCT04336475|50118834|FG001|Overall Study|pain|0|||
25022222|NCT04336475|50118833|FG000|Overall Study|upper respiratory infection|1|||
25022223|NCT04336475|50118834|FG001|Overall Study|upper respiratory infection|0|||
25022224|NCT04336475|50118833|FG000|Overall Study|Lost to Follow-up|0|||
25022225|NCT04336475|50118834|FG001|Overall Study|Lost to Follow-up|2|||
25022226|NCT04335929|50118840|FG000|Overall Study|Lost to Follow-up|10|||
25022227|NCT04333199|50118847|FG000|Evaluated Patients|Lost to Follow-up|0|||
25022228|NCT04333199|50118848|FG001|Evaluated Patients|Lost to Follow-up|1|||
25022229|NCT04333199|50118849|FG002|Evaluated Patients|Lost to Follow-up|2|||
25022230|NCT04332419|50118858|FG000|Overall Study|Withdrawal by Subject|1|||
25022231|NCT04330157|50118862|FG000|Overall Study|Protocol Violation|4|||
24919023|NCT00537771|50012660|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
24919024|NCT00537771|50012661|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
24919025|NCT00623480|50012669|FG000|Overall Study|Lost to Follow-up|0|||
24919026|NCT00623480|50012670|FG001|Overall Study|Lost to Follow-up|1|||
24919027|NCT00623480|50012669|FG000|Overall Study|Withdrawal by Subject|2|||
24919028|NCT00623480|50012670|FG001|Overall Study|Withdrawal by Subject|4|||
24919029|NCT00623480|50012669|FG000|Overall Study|Lack of Efficacy|1|||
24919030|NCT00623480|50012670|FG001|Overall Study|Lack of Efficacy|0|||
24919031|NCT00623480|50012669|FG000|Overall Study|Non-compliant with study medication|4|||
25022232|NCT04330157|50118862|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
25022233|NCT04329923|50118877|FG000|Overall Study|Withdrawal by Subject|1|||
25022234|NCT04329923|50118878|FG001|Overall Study|Withdrawal by Subject|4|||
25022235|NCT04329923|50118879|FG002|Overall Study|Withdrawal by Subject|1|||
25022236|NCT04329923|50118880|FG003|Overall Study|Withdrawal by Subject|1|||
25022237|NCT04329923|50118881|FG004|Overall Study|Withdrawal by Subject|1|||
25022238|NCT04329923|50118882|FG005|Overall Study|Withdrawal by Subject|1|||
25022239|NCT04329923|50118877|FG000|Overall Study|early termination of study|0|||
25022240|NCT04329923|50118878|FG001|Overall Study|early termination of study|0|||
25022241|NCT04329923|50118879|FG002|Overall Study|early termination of study|0|||
24919032|NCT00623480|50012670|FG001|Overall Study|Non-compliant with study medication|0|||
24919033|NCT00623480|50012669|FG000|Overall Study|Protocol Violation|0|||
24919034|NCT00623480|50012670|FG001|Overall Study|Protocol Violation|1|||
24919035|NCT00623480|50012669|FG000|Overall Study|Site closed by sponsor|0|||
24919036|NCT00623480|50012670|FG001|Overall Study|Site closed by sponsor|1|||
24919037|NCT02513667|50012678|FG000|Overall Study|Withdrawal by Subject|0|||
24919038|NCT02513667|50012679|FG001|Overall Study|Withdrawal by Subject|1|||
24919039|NCT03823911|50012688|FG000|Overall Study|Lost to Follow-up|1|||
24919040|NCT03823911|50012689|FG001|Overall Study|Lost to Follow-up|5|||
24919041|NCT03823911|50012690|FG002|Overall Study|Lost to Follow-up|2|||
24919042|NCT03823911|50012688|FG000|Overall Study|Did not meet eligibility criteria|13|||
24919043|NCT03823911|50012689|FG001|Overall Study|Did not meet eligibility criteria|7|||
24919044|NCT03823911|50012690|FG002|Overall Study|Did not meet eligibility criteria|4|||
24919045|NCT03823911|50012688|FG000|Overall Study|Death|0|||
24919046|NCT03823911|50012689|FG001|Overall Study|Death|1|||
24919047|NCT03823911|50012690|FG002|Overall Study|Death|0|||
24919048|NCT00621764|50012701|FG000|Overall Study|Protocol Violation|0|||
24919049|NCT00621764|50012702|FG001|Overall Study|Protocol Violation|0|||
24919050|NCT00621764|50012703|FG002|Overall Study|Protocol Violation|0|||
24919051|NCT00621764|50012704|FG003|Overall Study|Protocol Violation|1|||
24919052|NCT00510718|50012722|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
24919053|NCT00510718|50012723|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
24919054|NCT00510718|50012722|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
24919055|NCT00510718|50012723|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
25022242|NCT04329923|50118880|FG003|Overall Study|early termination of study|0|||
25022243|NCT04329923|50118881|FG004|Overall Study|early termination of study|1|||
25022244|NCT04329923|50118882|FG005|Overall Study|early termination of study|2|||
25022245|NCT04329923|50118877|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
25022246|NCT04329923|50118878|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
25022247|NCT04329923|50118879|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
25185056|NCT00249795|50334153|FG001|Overall Study|Surgery / procedure|5|||
24919056|NCT00510718|50012722|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
24919057|NCT00510718|50012723|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
24919058|NCT00510718|50012722|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
24919059|NCT00510718|50012723|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
24919060|NCT00510718|50012722|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
24919061|NCT00510718|50012723|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
24919062|NCT00510718|50012722|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
24919063|NCT00510718|50012723|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
24919064|NCT00537381|50012744|FG000|Overall Study|Adverse Event|13|||
24919065|NCT00537381|50012745|FG001|Overall Study|Adverse Event|9|||
24919066|NCT00537381|50012744|FG000|Overall Study|Death|3|||
24919067|NCT00537381|50012745|FG001|Overall Study|Death|3|||
24919068|NCT00537381|50012744|FG000|Overall Study|Withdrawal by Subject|5|||
24919069|NCT00537381|50012745|FG001|Overall Study|Withdrawal by Subject|14|||
24919070|NCT00537381|50012744|FG000|Overall Study|Physician Decision|7|||
24919071|NCT00537381|50012745|FG001|Overall Study|Physician Decision|6|||
24919072|NCT00537381|50012744|FG000|Overall Study|Disease Progression|9|||
24919073|NCT00537381|50012745|FG001|Overall Study|Disease Progression|18|||
24919074|NCT00537381|50012744|FG000|Overall Study|Sponsor decision|14|||
24919075|NCT00537381|50012745|FG001|Overall Study|Sponsor decision|9|||
24919076|NCT00537381|50012744|FG000|Overall Study|Other|5|||
24919077|NCT00537381|50012745|FG001|Overall Study|Other|3|||
24919078|NCT03791398|50012756|FG000|Overall Study|Progression of Disease Under Study|2|||
24919079|NCT03791398|50012757|FG001|Overall Study|Progression of Disease Under Study|0|||
25022248|NCT04329923|50118880|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
24919080|NCT03791398|50012758|FG002|Overall Study|Progression of Disease Under Study|0|||
24919081|NCT00517192|50012764|FG000|Overall Study|Adverse Event|1|||
24919082|NCT00517192|50012765|FG001|Overall Study|Adverse Event|1|||
24919083|NCT00517192|50012764|FG000|Overall Study|Lost to Follow-up|1|||
24919084|NCT00517192|50012765|FG001|Overall Study|Lost to Follow-up|1|||
24919085|NCT00517192|50012764|FG000|Overall Study|Withdrawal by Subject|1|||
24919086|NCT00517192|50012765|FG001|Overall Study|Withdrawal by Subject|0|||
24919087|NCT00517192|50012764|FG000|Overall Study|Early termination of the trial|16|||
25022249|NCT04329923|50118881|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
25022250|NCT04329923|50118882|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
25185057|NCT00249795|50334152|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
24919088|NCT00517192|50012765|FG001|Overall Study|Early termination of the trial|18|||
24919089|NCT00625820|50012771|FG000|Overall Study|Withdrawal by Subject|1|||
24919090|NCT00145327|50012779|FG000|Overall Study|Withdrawal by Subject|77|||
24919091|NCT00145327|50012780|FG001|Overall Study|Withdrawal by Subject|72|||
24919092|NCT00145327|50012781|FG002|Overall Study|Withdrawal by Subject|164|||
24919093|NCT00145327|50012779|FG000|Overall Study|Death|26|||
24919094|NCT00145327|50012780|FG001|Overall Study|Death|18|||
24919095|NCT00145327|50012781|FG002|Overall Study|Death|30|||
24919096|NCT00145327|50012779|FG000|Overall Study|Adverse Event|14|||
24919097|NCT00145327|50012780|FG001|Overall Study|Adverse Event|11|||
24919098|NCT00145327|50012781|FG002|Overall Study|Adverse Event|22|||
24919099|NCT00145327|50012779|FG000|Overall Study|Lost to Follow-up|9|||
24919100|NCT00145327|50012780|FG001|Overall Study|Lost to Follow-up|14|||
24919101|NCT00145327|50012781|FG002|Overall Study|Lost to Follow-up|14|||
24919102|NCT00145327|50012779|FG000|Overall Study|Administrative problems|12|||
24919103|NCT00145327|50012780|FG001|Overall Study|Administrative problems|9|||
24919104|NCT00145327|50012781|FG002|Overall Study|Administrative problems|13|||
24919105|NCT00145327|50012779|FG000|Overall Study|Protocol Violation|2|||
24919106|NCT00145327|50012780|FG001|Overall Study|Protocol Violation|0|||
24919107|NCT00145327|50012781|FG002|Overall Study|Protocol Violation|2|||
24919108|NCT00145327|50012779|FG000|Overall Study|Abnormal laboratory value(s)|1|||
24919109|NCT00145327|50012780|FG001|Overall Study|Abnormal laboratory value(s)|0|||
24919110|NCT00145327|50012781|FG002|Overall Study|Abnormal laboratory value(s)|2|||
24919111|NCT00145327|50012779|FG000|Overall Study|Missing - not stated|1|||
24919112|NCT00145327|50012780|FG001|Overall Study|Missing - not stated|0|||
24919113|NCT00145327|50012781|FG002|Overall Study|Missing - not stated|1|||
24919114|NCT00510484|50012791|FG000|Wash-out Period|Adverse Event|0|||
25022251|NCT04403399|50118898|FG000|Period 2|Physician Decision|0|||
25022252|NCT04403399|50118899|FG001|Period 2|Physician Decision|1|||
25022253|NCT04401293|50118907|FG000|Overall Study|Withdrawal by Subject|1|||
25022254|NCT04401293|50118908|FG001|Overall Study|Withdrawal by Subject|3|||
25022255|NCT04319159|50118916|FG000|Overall Study|Screening failure|13|||
25022256|NCT04319159|50118916|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
25022257|NCT04319159|50118916|FG000|Overall Study|Withdrawal by Subject|1|||
25022258|NCT04318535|50118922|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
25022259|NCT04318535|50118923|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
25022260|NCT04318535|50118924|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
25022261|NCT04454567|50118935|FG000|Overall Study|Study Terminated by Sponsor|1|||
25022262|NCT04454567|50118936|FG001|Overall Study|Study Terminated by Sponsor|1|||
25022263|NCT04449341|50118944|FG000|Overall Study|Protocol Violation|1|||
25022264|NCT04449341|50118945|FG001|Overall Study|Protocol Violation|0|||
24919115|NCT00510484|50012792|FG001|Wash-out Period|Adverse Event|1|||
24919116|NCT00622388|50012798|FG000|Overall Study|Disease Progression|47|||
24919117|NCT00622388|50012798|FG000|Overall Study|Adverse Event|6|||
24919118|NCT00622388|50012798|FG000|Overall Study|Protocol Violation|3|||
24919119|NCT00622388|50012798|FG000|Overall Study|Participant Refusal|1|||
24919120|NCT00622388|50012798|FG000|Overall Study|Death|3|||
24919121|NCT00622388|50012798|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
24919122|NCT00622388|50012798|FG000|Overall Study|Took Prohibited Medication|2|||
24919123|NCT00622388|50012798|FG000|Overall Study|Withdrew Consent|1|||
24919124|NCT00622388|50012798|FG000|Overall Study|Insurance Expired|1|||
24919125|NCT01156389|50012805|FG000|Overall Study|Elevated liver enzymes|4|||
24919126|NCT01156389|50012806|FG001|Overall Study|Elevated liver enzymes|0|||
24919127|NCT01156389|50012805|FG000|Overall Study|Vomiting|0|||
24919128|NCT01156389|50012806|FG001|Overall Study|Vomiting|1|||
24919129|NCT01105767|50012815|FG000|Overall Study|Lost to Follow-up|1160|||
25022265|NCT04448561|50118953|FG000|Overall Study|Noncompliance|1|||
25022266|NCT04448561|50118954|FG001|Overall Study|Noncompliance|0|||
25022267|NCT04308239|50118970|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
25022268|NCT04308239|50118971|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
25022269|NCT04308239|50118970|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
24919130|NCT01105767|50012816|FG001|Overall Study|Lost to Follow-up|1614|||
24919131|NCT01105767|50012817|FG002|Overall Study|Lost to Follow-up|1184|||
24919132|NCT03693430|50012827|FG000|Overall Study|Lost to Follow-up|3|||
24919133|NCT03693430|50012828|FG001|Overall Study|Lost to Follow-up|14|||
25022270|NCT04308239|50118971|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
25022271|NCT04308239|50118970|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
25022272|NCT04308239|50118971|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
25154113|NCT01515189|50269236|FG001|First Re-Induction Phase|Disease progression|14|||
25154114|NCT01515189|50269235|FG000|First Re-Induction Phase|Study drug toxicity|5|||
25154115|NCT01515189|50269236|FG001|First Re-Induction Phase|Study drug toxicity|0|||
24919134|NCT03693430|50012827|FG000|Overall Study|Death|1|||
24919135|NCT03693430|50012828|FG001|Overall Study|Death|0|||
24919136|NCT03693430|50012827|FG000|Overall Study|Withdrawal by Subject|0|||
24919137|NCT03693430|50012828|FG001|Overall Study|Withdrawal by Subject|4|||
24919138|NCT00625742|50012834|FG000|Overall Study|Disease Progression|2|||
24919139|NCT00625742|50012834|FG000|Overall Study|Withdrawal by Subject|1|||
24919140|NCT00625742|50012834|FG000|Overall Study|Adverse Event|4|||
24919141|NCT00625742|50012834|FG000|Overall Study|Lost to Follow-up|4|||
24919142|NCT00625742|50012834|FG000|Overall Study|Ineligible|1|||
24919143|NCT00621296|50012847|FG000|Overall Study|Adverse Event|2|||
24919144|NCT00621296|50012847|FG000|Overall Study|Lack of Efficacy|1|||
24919145|NCT00621296|50012847|FG000|Overall Study|Physician Decision|7|||
24919146|NCT00621296|50012847|FG000|Overall Study|Unmatch Criteria|1|||
24919147|NCT00621296|50012847|FG000|Overall Study|Stopping Criteria|3|||
24919148|NCT00537303|50012853|FG000|Overall Study|Adverse Event|1|||
24919149|NCT00537303|50012854|FG001|Overall Study|Adverse Event|4|||
24919150|NCT00537303|50012853|FG000|Overall Study|Lack of Efficacy|6|||
24919151|NCT00537303|50012854|FG001|Overall Study|Lack of Efficacy|7|||
24919152|NCT00537303|50012853|FG000|Overall Study|Protocol Violation|8|||
24919153|NCT00537303|50012854|FG001|Overall Study|Protocol Violation|4|||
25185058|NCT00249795|50334153|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
24919154|NCT00537303|50012853|FG000|Overall Study|Withdrawal criteria|3|||
24919155|NCT00537303|50012854|FG001|Overall Study|Withdrawal criteria|3|||
24919156|NCT00537303|50012853|FG000|Overall Study|Unclassified|8|||
24919157|NCT00537303|50012854|FG001|Overall Study|Unclassified|7|||
24919158|NCT00505414|50012862|FG000|Titration Phase|Adverse Event|0|||
24919159|NCT00505414|50012863|FG001|Titration Phase|Adverse Event|0|||
24919160|NCT00505414|50012864|FG002|Titration Phase|Adverse Event|0|||
24919161|NCT00505414|50012865|FG003|Titration Phase|Adverse Event|8|||
24919162|NCT00505414|50012866|FG004|Titration Phase|Adverse Event|3|||
24919163|NCT00505414|50012862|FG000|Titration Phase|Death|0|||
24919164|NCT00505414|50012863|FG001|Titration Phase|Death|0|||
24919165|NCT00505414|50012864|FG002|Titration Phase|Death|0|||
24919166|NCT00505414|50012865|FG003|Titration Phase|Death|2|||
24919167|NCT00505414|50012866|FG004|Titration Phase|Death|0|||
24919168|NCT00505414|50012862|FG000|Titration Phase|Lack of Efficacy|0|||
25022273|NCT04308239|50118970|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
24919169|NCT00505414|50012863|FG001|Titration Phase|Lack of Efficacy|0|||
24919170|NCT00505414|50012864|FG002|Titration Phase|Lack of Efficacy|0|||
24919171|NCT00505414|50012865|FG003|Titration Phase|Lack of Efficacy|10|||
24919172|NCT00505414|50012866|FG004|Titration Phase|Lack of Efficacy|1|||
25154116|NCT01515189|50269235|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
24919173|NCT00505414|50012862|FG000|Titration Phase|Protocol Violation|0|||
24919174|NCT00505414|50012863|FG001|Titration Phase|Protocol Violation|0|||
24919175|NCT00505414|50012864|FG002|Titration Phase|Protocol Violation|0|||
24919176|NCT00505414|50012865|FG003|Titration Phase|Protocol Violation|0|||
24919177|NCT00505414|50012866|FG004|Titration Phase|Protocol Violation|1|||
24919178|NCT00505414|50012862|FG000|Titration Phase|Withdrawal by Subject|0|||
24919179|NCT00505414|50012863|FG001|Titration Phase|Withdrawal by Subject|0|||
24919180|NCT00505414|50012864|FG002|Titration Phase|Withdrawal by Subject|0|||
24919181|NCT00505414|50012865|FG003|Titration Phase|Withdrawal by Subject|3|||
24919182|NCT00505414|50012866|FG004|Titration Phase|Withdrawal by Subject|4|||
24919183|NCT00505414|50012862|FG000|Titration Phase|Underlying disease and therapy required|0|||
24919184|NCT00505414|50012863|FG001|Titration Phase|Underlying disease and therapy required|0|||
24919185|NCT00505414|50012864|FG002|Titration Phase|Underlying disease and therapy required|0|||
24919186|NCT00505414|50012865|FG003|Titration Phase|Underlying disease and therapy required|7|||
24919187|NCT00505414|50012866|FG004|Titration Phase|Underlying disease and therapy required|3|||
24919188|NCT00505414|50012862|FG000|Maintenance Phase|Adverse Event|2|||
24919189|NCT00505414|50012863|FG001|Maintenance Phase|Adverse Event|2|||
24919190|NCT00505414|50012864|FG002|Maintenance Phase|Adverse Event|3|||
24919191|NCT00505414|50012865|FG003|Maintenance Phase|Adverse Event|0|||
24919192|NCT00505414|50012866|FG004|Maintenance Phase|Adverse Event|0|||
24919193|NCT00505414|50012862|FG000|Maintenance Phase|Death|2|||
24919194|NCT00505414|50012863|FG001|Maintenance Phase|Death|0|||
24919195|NCT00505414|50012864|FG002|Maintenance Phase|Death|1|||
24919196|NCT00505414|50012865|FG003|Maintenance Phase|Death|0|||
24919197|NCT00505414|50012866|FG004|Maintenance Phase|Death|0|||
24919198|NCT00505414|50012862|FG000|Maintenance Phase|Lack of Efficacy|2|||
24919199|NCT00505414|50012863|FG001|Maintenance Phase|Lack of Efficacy|1|||
24919200|NCT00505414|50012864|FG002|Maintenance Phase|Lack of Efficacy|1|||
24919201|NCT00505414|50012865|FG003|Maintenance Phase|Lack of Efficacy|0|||
24919202|NCT00505414|50012866|FG004|Maintenance Phase|Lack of Efficacy|0|||
24919203|NCT00505414|50012862|FG000|Maintenance Phase|Withdrawal by Subject|0|||
24919204|NCT00505414|50012863|FG001|Maintenance Phase|Withdrawal by Subject|0|||
24919205|NCT00505414|50012864|FG002|Maintenance Phase|Withdrawal by Subject|1|||
24919206|NCT00505414|50012865|FG003|Maintenance Phase|Withdrawal by Subject|0|||
24919207|NCT00505414|50012866|FG004|Maintenance Phase|Withdrawal by Subject|0|||
25022274|NCT04308239|50118971|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
25275027|NCT01238861|50589066|FG001|Overall Study|Adverse Event|1|||
24919208|NCT00505414|50012862|FG000|Maintenance Phase|underlying disease and therapy required|0|||
24919209|NCT00505414|50012863|FG001|Maintenance Phase|underlying disease and therapy required|2|||
24919210|NCT00505414|50012864|FG002|Maintenance Phase|underlying disease and therapy required|2|||
24919211|NCT00505414|50012865|FG003|Maintenance Phase|underlying disease and therapy required|0|||
25022275|NCT04302545|50118983|FG000|Overall Study|Lost to Follow-up|3|||
24919212|NCT00505414|50012866|FG004|Maintenance Phase|underlying disease and therapy required|0|||
24919213|NCT00625586|50012882|FG000|Overall Study|Adverse Event|1|||
24919214|NCT00144781|50012904|FG000|Overall Study|Adverse Event|0|||
25022276|NCT04302545|50118984|FG001|Overall Study|Lost to Follow-up|4|||
25022277|NCT04297241|50119001|FG000|Overall Study|Withdrawal by Subject|1|||
24919215|NCT00144781|50012905|FG001|Overall Study|Adverse Event|1|||
24919216|NCT00144781|50012906|FG002|Overall Study|Adverse Event|0|||
24919217|NCT00144781|50012907|FG003|Overall Study|Adverse Event|0|||
24919218|NCT00144781|50012904|FG000|Overall Study|Non-compliant|0|||
24919219|NCT00144781|50012905|FG001|Overall Study|Non-compliant|1|||
24919220|NCT00144781|50012906|FG002|Overall Study|Non-compliant|0|||
24919221|NCT00144781|50012907|FG003|Overall Study|Non-compliant|0|||
24919222|NCT00621140|50012923|FG000|Overall Study|Adverse Event|4|||
24919223|NCT00621140|50012924|FG001|Overall Study|Adverse Event|5|||
24919224|NCT00621140|50012923|FG000|Overall Study|Lost to Follow-up|1|||
24919225|NCT00621140|50012924|FG001|Overall Study|Lost to Follow-up|2|||
24919226|NCT00621140|50012923|FG000|Overall Study|Withdrawal by Subject|4|||
24919227|NCT00621140|50012924|FG001|Overall Study|Withdrawal by Subject|6|||
24919228|NCT00621140|50012923|FG000|Overall Study|Other incl. lack of efficacy|6|||
24919229|NCT00621140|50012924|FG001|Overall Study|Other incl. lack of efficacy|5|||
24919230|NCT00207727|50012935|FG000|Overall Study|Withdrawal by Subject|0|||
24919231|NCT00207727|50012936|FG001|Overall Study|Withdrawal by Subject|0|||
24919232|NCT00207727|50012937|FG002|Overall Study|Withdrawal by Subject|0|||
24919233|NCT00207727|50012938|FG003|Overall Study|Withdrawal by Subject|0|||
24919234|NCT00207727|50012939|FG004|Overall Study|Withdrawal by Subject|1|||
24919235|NCT00207727|50012935|FG000|Overall Study|Lost to Follow-up|0|||
24919236|NCT00207727|50012936|FG001|Overall Study|Lost to Follow-up|1|||
24919237|NCT00207727|50012937|FG002|Overall Study|Lost to Follow-up|0|||
24919238|NCT00207727|50012938|FG003|Overall Study|Lost to Follow-up|0|||
24919239|NCT00207727|50012939|FG004|Overall Study|Lost to Follow-up|0|||
24919240|NCT00207727|50012935|FG000|Overall Study|Other|38|||
24919241|NCT00207727|50012936|FG001|Overall Study|Other|41|||
24919242|NCT00207727|50012937|FG002|Overall Study|Other|41|||
24919243|NCT00207727|50012938|FG003|Overall Study|Other|37|||
24919244|NCT00207727|50012939|FG004|Overall Study|Other|33|||
24919245|NCT00504556|50012956|FG000|Overall Study|Adverse Event|11|||
24919246|NCT00504556|50012957|FG001|Overall Study|Adverse Event|11|||
24919247|NCT00504556|50012958|FG002|Overall Study|Adverse Event|14|||
24919248|NCT00504556|50012959|FG003|Overall Study|Adverse Event|13|||
24919249|NCT00504556|50012960|FG004|Overall Study|Adverse Event|5|||
24919250|NCT00504556|50012956|FG000|Overall Study|Death|3|||
24919251|NCT00504556|50012957|FG001|Overall Study|Death|3|||
24919252|NCT00504556|50012958|FG002|Overall Study|Death|1|||
24919253|NCT00504556|50012959|FG003|Overall Study|Death|0|||
24919254|NCT00504556|50012960|FG004|Overall Study|Death|2|||
24919255|NCT00504556|50012956|FG000|Overall Study|Protocol Violation|1|||
24919256|NCT00504556|50012957|FG001|Overall Study|Protocol Violation|3|||
24919257|NCT00504556|50012958|FG002|Overall Study|Protocol Violation|2|||
24919258|NCT00504556|50012959|FG003|Overall Study|Protocol Violation|1|||
24919259|NCT00504556|50012960|FG004|Overall Study|Protocol Violation|2|||
24919260|NCT00504556|50012956|FG000|Overall Study|Lost to Follow-up|0|||
24919261|NCT00504556|50012957|FG001|Overall Study|Lost to Follow-up|0|||
24919262|NCT00504556|50012958|FG002|Overall Study|Lost to Follow-up|1|||
24919263|NCT00504556|50012959|FG003|Overall Study|Lost to Follow-up|1|||
24919264|NCT00504556|50012960|FG004|Overall Study|Lost to Follow-up|1|||
24919265|NCT00504556|50012956|FG000|Overall Study|Withdrawal by Subject|16|||
24919266|NCT00504556|50012957|FG001|Overall Study|Withdrawal by Subject|16|||
24919267|NCT00504556|50012958|FG002|Overall Study|Withdrawal by Subject|7|||
24919268|NCT00504556|50012959|FG003|Overall Study|Withdrawal by Subject|8|||
24919269|NCT00504556|50012960|FG004|Overall Study|Withdrawal by Subject|12|||
24919270|NCT00504556|50012956|FG000|Overall Study|administrative reasons|0|||
24919271|NCT00504556|50012957|FG001|Overall Study|administrative reasons|2|||
24919272|NCT00504556|50012958|FG002|Overall Study|administrative reasons|2|||
24919273|NCT00504556|50012959|FG003|Overall Study|administrative reasons|1|||
24919274|NCT00504556|50012960|FG004|Overall Study|administrative reasons|2|||
24919275|NCT00504556|50012956|FG000|Overall Study|did not meet entry criteria|2|||
24919276|NCT00504556|50012957|FG001|Overall Study|did not meet entry criteria|0|||
25022278|NCT04297241|50119001|FG000|Overall Study|Adverse Event|1|||
24919277|NCT00504556|50012958|FG002|Overall Study|did not meet entry criteria|1|||
24919278|NCT00504556|50012959|FG003|Overall Study|did not meet entry criteria|1|||
24919279|NCT00504556|50012960|FG004|Overall Study|did not meet entry criteria|0|||
25022279|NCT04297241|50119001|FG000|Overall Study|Physician Decision|3|||
25022280|NCT04292171|50119017|FG000|Overall Study|Pharmacy error|2|||
24919280|NCT00504556|50012956|FG000|Overall Study|data monitor committee decision|0|||
24919281|NCT00504556|50012957|FG001|Overall Study|data monitor committee decision|0|||
24919282|NCT00504556|50012958|FG002|Overall Study|data monitor committee decision|0|||
24919283|NCT00504556|50012959|FG003|Overall Study|data monitor committee decision|100|||
24919284|NCT00504556|50012960|FG004|Overall Study|data monitor committee decision|0|||
25022281|NCT04292171|50119018|FG001|Overall Study|Pharmacy error|0|||
24919285|NCT00504556|50012956|FG000|Overall Study|Other|2|||
24919286|NCT00504556|50012957|FG001|Overall Study|Other|2|||
24919287|NCT00504556|50012958|FG002|Overall Study|Other|2|||
24919288|NCT00504556|50012959|FG003|Overall Study|Other|3|||
24919289|NCT00504556|50012960|FG004|Overall Study|Other|0|||
24919290|NCT00504556|50012956|FG000|Overall Study|not in safety analysis set|0|||
24919291|NCT00504556|50012957|FG001|Overall Study|not in safety analysis set|1|||
24919292|NCT00504556|50012958|FG002|Overall Study|not in safety analysis set|1|||
24919293|NCT00504556|50012959|FG003|Overall Study|not in safety analysis set|0|||
24919294|NCT00504556|50012960|FG004|Overall Study|not in safety analysis set|1|||
24919295|NCT00206323|50012974|FG000|Overall Study|Lack of Efficacy|4|||
24919296|NCT00206323|50012975|FG001|Overall Study|Lack of Efficacy|1|||
24919297|NCT00206323|50012974|FG000|Overall Study|Adverse Event|1|||
24919298|NCT00206323|50012975|FG001|Overall Study|Adverse Event|1|||
24919299|NCT00206323|50012974|FG000|Overall Study|Lost to Follow-up|1|||
24919300|NCT00206323|50012975|FG001|Overall Study|Lost to Follow-up|1|||
24919301|NCT03903159|50012981|FG000|Overall Study|Discharged with Staff Approval|2|||
24919302|NCT03903159|50012981|FG000|Overall Study|Discharged at Staff Request|2|||
24919303|NCT03903159|50012981|FG000|Overall Study|Discharged Against Staff Advice|1|||
24919304|NCT00205855|50012985|FG000|Overall Study|Only received temporary implants|16|||
24919305|NCT00205855|50012985|FG000|Overall Study|Withdrawal by Subject|5|||
24919306|NCT00536991|50012989|FG000|Overall Study|Withdrawal by Subject|10|||
24919307|NCT00536991|50012989|FG000|Overall Study|Physician Decision|1|||
24919308|NCT00536991|50012989|FG000|Overall Study|patient ineligible|2|||
24919309|NCT03902613|50012994|FG000|Overall Study|Physician Decision|1|||
24919310|NCT00504166|50013000|FG000|Overall Study|Adverse Event|1|||
24919311|NCT00504166|50013001|FG001|Overall Study|Adverse Event|4|||
24919312|NCT00504166|50013000|FG000|Overall Study|Withdrawal by Subject|3|||
24919313|NCT00504166|50013001|FG001|Overall Study|Withdrawal by Subject|6|||
24919314|NCT00504166|50013000|FG000|Overall Study|Physician Decision|1|||
24919315|NCT00504166|50013001|FG001|Overall Study|Physician Decision|1|||
24919316|NCT00504166|50013000|FG000|Overall Study|Lost to Follow-up|1|||
24919317|NCT00504166|50013001|FG001|Overall Study|Lost to Follow-up|3|||
24919318|NCT00509236|50013009|FG000|Overall Study|Adverse Event|7|||
24919319|NCT00509236|50013010|FG001|Overall Study|Adverse Event|9|||
24919320|NCT00509236|50013009|FG000|Overall Study|Withdrawal by Subject|5|||
25022282|NCT04292171|50119017|FG000|Overall Study|Delivered prior to procedure|0|||
24919321|NCT00509236|50013010|FG001|Overall Study|Withdrawal by Subject|10|||
24919322|NCT00509236|50013009|FG000|Overall Study|Protocol Violation|3|||
24919323|NCT00509236|50013010|FG001|Overall Study|Protocol Violation|0|||
24919324|NCT00509236|50013009|FG000|Overall Study|Excluded Medication|1|||
24919325|NCT00509236|50013010|FG001|Overall Study|Excluded Medication|1|||
24919326|NCT00509236|50013009|FG000|Overall Study|Scheduled Kidney Transplant|1|||
24919327|NCT00509236|50013010|FG001|Overall Study|Scheduled Kidney Transplant|0|||
25275028|NCT01238861|50589067|FG002|Overall Study|Adverse Event|0|||
25275029|NCT01238861|50589068|FG003|Overall Study|Adverse Event|0|||
25275030|NCT01238861|50589069|FG004|Overall Study|Adverse Event|0|||
25275031|NCT01238861|50589070|FG005|Overall Study|Adverse Event|0|||
24919332|NCT00508924|50013034|FG000|Overall Study|Protocol Violation|0|||
24919333|NCT00508924|50013035|FG001|Overall Study|Protocol Violation|0|||
24919334|NCT00508924|50013036|FG002|Overall Study|Protocol Violation|1|||
24919335|NCT00508924|50013037|FG003|Overall Study|Protocol Violation|1|||
24919336|NCT00620750|50013047|FG000|Overall Study|Lost to Follow-up|25|||
24919337|NCT00508144|50013051|FG000|Overall Study|Not eligible|6|||
24919338|NCT00508144|50013051|FG000|Overall Study|Death|5|||
24919339|NCT00621842|50013055|FG000|Overall Study|Adverse Event|6|||
24919340|NCT00621842|50013055|FG000|Overall Study|Withdrawal by Subject|7|||
24919341|NCT00621842|50013055|FG000|Overall Study|Protocol Violation|4|||
24919342|NCT00621842|50013055|FG000|Overall Study|Lack of Efficacy|2|||
24919343|NCT00503776|50013063|FG000|Overall Study|Withdrawal by Subject|1|||
24919344|NCT00503776|50013064|FG001|Overall Study|Withdrawal by Subject|0|||
24919345|NCT00503776|50013065|FG002|Overall Study|Withdrawal by Subject|1|||
24919346|NCT00503776|50013066|FG003|Overall Study|Withdrawal by Subject|1|||
24919347|NCT00503776|50013063|FG000|Overall Study|Physician Decision|0|||
24919348|NCT00503776|50013064|FG001|Overall Study|Physician Decision|0|||
24919349|NCT00503776|50013065|FG002|Overall Study|Physician Decision|1|||
24919350|NCT00503776|50013066|FG003|Overall Study|Physician Decision|1|||
24919351|NCT00619112|50013083|FG000|Overall Study|Adverse Event|1|||
25022283|NCT04292171|50119018|FG001|Overall Study|Delivered prior to procedure|1|||
24919352|NCT00619112|50013084|FG001|Overall Study|Adverse Event|2|||
24919353|NCT00619502|50013095|FG000|Overall Study|Lost to Follow-up|8|||
24919354|NCT00619502|50013096|FG001|Overall Study|Lost to Follow-up|10|||
24919355|NCT00618956|50013106|FG000|Overall Study|Adverse Event|10|||
24919356|NCT00618956|50013107|FG001|Overall Study|Adverse Event|34|||
24919357|NCT00618956|50013106|FG000|Overall Study|Lack of Efficacy|2|||
24919358|NCT00618956|50013107|FG001|Overall Study|Lack of Efficacy|1|||
24919359|NCT00618956|50013106|FG000|Overall Study|Withdrawal by Subject|5|||
24919360|NCT00618956|50013107|FG001|Overall Study|Withdrawal by Subject|7|||
24919361|NCT00618956|50013106|FG000|Overall Study|Lost to Follow-up|4|||
24919362|NCT00618956|50013107|FG001|Overall Study|Lost to Follow-up|5|||
25022284|NCT04393493|50119026|FG000|First 4 Days of Intervention|Early improvement|5|||
25022285|NCT04393493|50119027|FG001|First 4 Days of Intervention|Early improvement|7|||
25022286|NCT04280705|50119037|FG000|Overall Study|Enrolled but not treated|4|||
24919363|NCT00618956|50013106|FG000|Overall Study|Protocol Violation|2|||
24919364|NCT00618956|50013107|FG001|Overall Study|Protocol Violation|2|||
24919365|NCT00618956|50013106|FG000|Overall Study|did not meet criteria, non-compliance|2|||
24919366|NCT00618956|50013107|FG001|Overall Study|did not meet criteria, non-compliance|1|||
24919367|NCT00716417|50013129|FG000|Overall Study|Adverse Event|0|||
24919368|NCT00716417|50013130|FG001|Overall Study|Adverse Event|0|||
24919369|NCT00716417|50013131|FG002|Overall Study|Adverse Event|2|||
24919370|NCT00716417|50013132|FG003|Overall Study|Adverse Event|1|||
24919371|NCT00716417|50013133|FG004|Overall Study|Adverse Event|0|||
24919372|NCT00716417|50013134|FG005|Overall Study|Adverse Event|0|||
24919373|NCT00716417|50013135|FG006|Overall Study|Adverse Event|3|||
24919374|NCT00716417|50013136|FG007|Overall Study|Adverse Event|1|||
24919375|NCT00716417|50013137|FG008|Overall Study|Adverse Event|0|||
24919376|NCT00716417|50013138|FG009|Overall Study|Adverse Event|3|||
24919377|NCT00716417|50013129|FG000|Overall Study|Withdrawal by Subject|0|||
24919378|NCT00716417|50013130|FG001|Overall Study|Withdrawal by Subject|1|||
24919379|NCT00716417|50013131|FG002|Overall Study|Withdrawal by Subject|0|||
24919380|NCT00716417|50013132|FG003|Overall Study|Withdrawal by Subject|2|||
24919381|NCT00716417|50013133|FG004|Overall Study|Withdrawal by Subject|0|||
24919382|NCT00716417|50013134|FG005|Overall Study|Withdrawal by Subject|0|||
24919383|NCT00716417|50013135|FG006|Overall Study|Withdrawal by Subject|1|||
24919384|NCT00716417|50013136|FG007|Overall Study|Withdrawal by Subject|0|||
24919385|NCT00716417|50013137|FG008|Overall Study|Withdrawal by Subject|0|||
24919386|NCT00716417|50013138|FG009|Overall Study|Withdrawal by Subject|0|||
24919387|NCT00716417|50013129|FG000|Overall Study|Progressive disease|3|||
24919388|NCT00716417|50013130|FG001|Overall Study|Progressive disease|5|||
24919389|NCT00716417|50013131|FG002|Overall Study|Progressive disease|3|||
24919390|NCT00716417|50013132|FG003|Overall Study|Progressive disease|8|||
24919391|NCT00716417|50013133|FG004|Overall Study|Progressive disease|0|||
24919392|NCT00716417|50013134|FG005|Overall Study|Progressive disease|3|||
24919393|NCT00716417|50013135|FG006|Overall Study|Progressive disease|3|||
24919394|NCT00716417|50013136|FG007|Overall Study|Progressive disease|1|||
24919395|NCT00716417|50013137|FG008|Overall Study|Progressive disease|5|||
24919396|NCT00716417|50013138|FG009|Overall Study|Progressive disease|0|||
24919397|NCT00716417|50013129|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
24919398|NCT00716417|50013130|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
24919399|NCT00716417|50013131|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
24919400|NCT00716417|50013132|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
24919401|NCT00716417|50013133|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
24919402|NCT00716417|50013134|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
24919403|NCT00716417|50013135|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
24919404|NCT00716417|50013136|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
24919405|NCT00716417|50013137|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
24919406|NCT00716417|50013138|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
24919407|NCT00716417|50013129|FG000|Overall Study|On patient request due to toxicities|0|||
24919408|NCT00716417|50013130|FG001|Overall Study|On patient request due to toxicities|0|||
24919409|NCT00716417|50013131|FG002|Overall Study|On patient request due to toxicities|0|||
24919410|NCT00716417|50013132|FG003|Overall Study|On patient request due to toxicities|0|||
24919411|NCT00716417|50013133|FG004|Overall Study|On patient request due to toxicities|0|||
24919412|NCT00716417|50013134|FG005|Overall Study|On patient request due to toxicities|0|||
24919413|NCT00716417|50013135|FG006|Overall Study|On patient request due to toxicities|0|||
24919414|NCT00716417|50013136|FG007|Overall Study|On patient request due to toxicities|1|||
25022287|NCT04280705|50119038|FG001|Overall Study|Enrolled but not treated|10|||
25022288|NCT04280705|50119037|FG000|Overall Study|Physician Decision|1|||
25022289|NCT04280705|50119038|FG001|Overall Study|Physician Decision|0|||
25022290|NCT04280705|50119037|FG000|Overall Study|Withdrawal by Subject|7|||
25022291|NCT04280705|50119038|FG001|Overall Study|Withdrawal by Subject|9|||
25022292|NCT04280705|50119037|FG000|Overall Study|Adverse Event|0|||
25022293|NCT04280705|50119038|FG001|Overall Study|Adverse Event|4|||
25022294|NCT04280705|50119037|FG000|Overall Study|Transferred to another hospital|1|||
24919415|NCT00716417|50013137|FG008|Overall Study|On patient request due to toxicities|0|||
24919416|NCT00716417|50013138|FG009|Overall Study|On patient request due to toxicities|0|||
25022295|NCT04280705|50119038|FG001|Overall Study|Transferred to another hospital|1|||
25022296|NCT02077166|50119051|FG000|Overall Study|Death|6|||
25022297|NCT02077166|50119052|FG001|Overall Study|Death|7|||
25022298|NCT02077166|50119053|FG002|Overall Study|Death|5|||
25022299|NCT02077166|50119054|FG003|Overall Study|Death|6|||
25022300|NCT02077166|50119055|FG004|Overall Study|Death|4|||
25022301|NCT02077166|50119056|FG005|Overall Study|Death|32|||
25022302|NCT02077166|50119057|FG006|Overall Study|Death|22|||
24919417|NCT00719537|50013164|FG000|Overall Study|Withdrawal by Subject|1|||
24919418|NCT00719537|50013165|FG001|Overall Study|Withdrawal by Subject|0|||
24919419|NCT00719537|50013164|FG000|Overall Study|Lost to Follow-up|0|||
24919420|NCT00719537|50013165|FG001|Overall Study|Lost to Follow-up|1|||
24919421|NCT00715949|50013171|FG000|Overall Study|could not finish first test|4|||
24919422|NCT00503698|50013177|FG000|Overall Study|Protocol Violation|5|||
24919423|NCT00503698|50013178|FG001|Overall Study|Protocol Violation|6|||
24919424|NCT00503698|50013177|FG000|Overall Study|Adverse Event|52|||
24919425|NCT00503698|50013178|FG001|Overall Study|Adverse Event|41|||
24919426|NCT00503698|50013177|FG000|Overall Study|Death|1|||
24919427|NCT00503698|50013178|FG001|Overall Study|Death|0|||
24919428|NCT00503698|50013177|FG000|Overall Study|Lack of Efficacy|3|||
24919429|NCT00503698|50013178|FG001|Overall Study|Lack of Efficacy|4|||
24919430|NCT00503698|50013177|FG000|Overall Study|Trial terminated|216|||
24919431|NCT00503698|50013178|FG001|Overall Study|Trial terminated|253|||
24919432|NCT00503698|50013177|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
24919433|NCT00503698|50013178|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
24919434|NCT00503698|50013177|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
24919435|NCT00503698|50013178|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
24919436|NCT00503698|50013177|FG000|Overall Study|Any condition in exclusion criteria|4|||
24919437|NCT00503698|50013178|FG001|Overall Study|Any condition in exclusion criteria|6|||
24919438|NCT00503698|50013177|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
24919439|NCT00503698|50013178|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
24919440|NCT00503698|50013177|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
25022303|NCT02077166|50119051|FG000|Overall Study|Study Closure by Sponsor|3|||
25022304|NCT02077166|50119052|FG001|Overall Study|Study Closure by Sponsor|0|||
24919441|NCT00503698|50013178|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
24919442|NCT00503698|50013177|FG000|Overall Study|Critically ill|2|||
24919443|NCT00503698|50013178|FG001|Overall Study|Critically ill|0|||
25022305|NCT02077166|50119053|FG002|Overall Study|Study Closure by Sponsor|2|||
25022306|NCT02077166|50119054|FG003|Overall Study|Study Closure by Sponsor|2|||
25022307|NCT02077166|50119055|FG004|Overall Study|Study Closure by Sponsor|2|||
25022308|NCT02077166|50119056|FG005|Overall Study|Study Closure by Sponsor|12|||
25022309|NCT02077166|50119057|FG006|Overall Study|Study Closure by Sponsor|4|||
25022310|NCT02077166|50119051|FG000|Overall Study|Lost to Follow-up|0|||
24919444|NCT00503698|50013177|FG000|Overall Study|Unclassified|48|||
24919445|NCT00503698|50013178|FG001|Overall Study|Unclassified|32|||
24919446|NCT00503698|50013177|FG000|Overall Study|Not exposed to trial drug|11|||
24919447|NCT00503698|50013178|FG001|Overall Study|Not exposed to trial drug|6|||
24919448|NCT00573794|50013193|FG000|Overall Study|Adverse Event|81|||
24919449|NCT00573794|50013193|FG000|Overall Study|Withdrew Consent|90|||
24919450|NCT00573794|50013193|FG000|Overall Study|Lost to Follow-up|13|||
24919451|NCT00573794|50013193|FG000|Overall Study|Protocol Violation|6|||
24919452|NCT00573794|50013193|FG000|Overall Study|Lack of Efficacy|94|||
24919453|NCT00573794|50013193|FG000|Overall Study|Other|46|||
25022311|NCT02077166|50119052|FG001|Overall Study|Lost to Follow-up|0|||
25022312|NCT02077166|50119053|FG002|Overall Study|Lost to Follow-up|0|||
25022313|NCT02077166|50119054|FG003|Overall Study|Lost to Follow-up|0|||
25022314|NCT02077166|50119055|FG004|Overall Study|Lost to Follow-up|0|||
25022315|NCT02077166|50119056|FG005|Overall Study|Lost to Follow-up|1|||
25022316|NCT02077166|50119057|FG006|Overall Study|Lost to Follow-up|0|||
25022317|NCT02077166|50119051|FG000|Overall Study|Withdrawal by Subject|3|||
25022318|NCT02077166|50119052|FG001|Overall Study|Withdrawal by Subject|0|||
25022319|NCT02077166|50119053|FG002|Overall Study|Withdrawal by Subject|1|||
25022320|NCT02077166|50119054|FG003|Overall Study|Withdrawal by Subject|1|||
25022321|NCT02077166|50119055|FG004|Overall Study|Withdrawal by Subject|1|||
25022322|NCT02077166|50119056|FG005|Overall Study|Withdrawal by Subject|3|||
25022323|NCT02077166|50119057|FG006|Overall Study|Withdrawal by Subject|0|||
24919454|NCT00715793|50013197|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
24919455|NCT00715793|50013198|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
24919456|NCT00715793|50013197|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
24919457|NCT00715793|50013198|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
24919458|NCT00718523|50013207|FG000|Overall Study|Withdrawal by Subject|5|||
25022324|NCT02077166|50119051|FG000|Overall Study|Other, Not Specified|0|||
25022325|NCT02077166|50119052|FG001|Overall Study|Other, Not Specified|0|||
25022326|NCT02077166|50119053|FG002|Overall Study|Other, Not Specified|1|||
25022327|NCT02077166|50119054|FG003|Overall Study|Other, Not Specified|0|||
25022328|NCT02077166|50119055|FG004|Overall Study|Other, Not Specified|1|||
24919459|NCT00718523|50013208|FG001|Overall Study|Withdrawal by Subject|7|||
24919460|NCT00718523|50013207|FG000|Overall Study|Death|13|||
24919461|NCT00718523|50013208|FG001|Overall Study|Death|17|||
24919462|NCT00715559|50013214|FG000|Overall Study|medication not tolerated - nausea|1|||
24919463|NCT00620282|50013230|FG000|Overall Study|Adverse Event|0|||
24919464|NCT00620282|50013231|FG001|Overall Study|Adverse Event|1|||
24919465|NCT00620282|50013232|FG002|Overall Study|Adverse Event|0|||
24919466|NCT00620282|50013230|FG000|Overall Study|Arterial line unable to be placed|0|||
25022329|NCT02077166|50119056|FG005|Overall Study|Other, Not Specified|7|||
25022330|NCT02077166|50119057|FG006|Overall Study|Other, Not Specified|8|||
24919467|NCT00620282|50013231|FG001|Overall Study|Arterial line unable to be placed|0|||
25022331|NCT04273217|50119084|FG000|Overall Study|Lost to Follow-up|0|||
24919468|NCT00620282|50013232|FG002|Overall Study|Arterial line unable to be placed|1|||
24919469|NCT00620282|50013230|FG000|Overall Study|Withdrawal by Subject|0|||
24919470|NCT00620282|50013231|FG001|Overall Study|Withdrawal by Subject|1|||
24919471|NCT00620282|50013232|FG002|Overall Study|Withdrawal by Subject|0|||
24919472|NCT00515086|50013244|FG000|Overall Study|Adverse Event|1|||
24919473|NCT00515086|50013245|FG001|Overall Study|Adverse Event|1|||
24919474|NCT00515086|50013246|FG002|Overall Study|Adverse Event|2|||
24919475|NCT00515086|50013247|FG003|Overall Study|Adverse Event|3|||
24919476|NCT00515086|50013244|FG000|Overall Study|Administrative|1|||
24919477|NCT00515086|50013245|FG001|Overall Study|Administrative|1|||
24919478|NCT00515086|50013246|FG002|Overall Study|Administrative|0|||
24919479|NCT00515086|50013247|FG003|Overall Study|Administrative|0|||
24919480|NCT00515086|50013244|FG000|Overall Study|Withdrawal by Subject|1|||
24919481|NCT00515086|50013245|FG001|Overall Study|Withdrawal by Subject|0|||
24919482|NCT00515086|50013246|FG002|Overall Study|Withdrawal by Subject|0|||
24919483|NCT00515086|50013247|FG003|Overall Study|Withdrawal by Subject|1|||
24919484|NCT00515086|50013244|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
24919485|NCT00515086|50013245|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
24919486|NCT00515086|50013246|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
24919487|NCT00515086|50013247|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
24919488|NCT00515086|50013244|FG000|Overall Study|Lost to Follow-up|1|||
24919489|NCT00515086|50013245|FG001|Overall Study|Lost to Follow-up|0|||
24919490|NCT00515086|50013246|FG002|Overall Study|Lost to Follow-up|0|||
24919491|NCT00515086|50013247|FG003|Overall Study|Lost to Follow-up|0|||
24919492|NCT00515086|50013244|FG000|Overall Study|Study drug no longer required|0|||
24919493|NCT00515086|50013245|FG001|Overall Study|Study drug no longer required|1|||
24919494|NCT00515086|50013246|FG002|Overall Study|Study drug no longer required|0|||
24919495|NCT00515086|50013247|FG003|Overall Study|Study drug no longer required|0|||
24919496|NCT00515086|50013244|FG000|Overall Study|Death|2|||
24919497|NCT00515086|50013245|FG001|Overall Study|Death|0|||
24919498|NCT00515086|50013246|FG002|Overall Study|Death|0|||
24919499|NCT00515086|50013247|FG003|Overall Study|Death|0|||
24919500|NCT00618410|50013263|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
24919501|NCT00618410|50013264|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
24919502|NCT00618722|50013274|FG000|Overall Study|Refusal of Treatment|0|||
24919503|NCT00618722|50013275|FG001|Overall Study|Refusal of Treatment|0|||
24919504|NCT00618722|50013276|FG002|Overall Study|Refusal of Treatment|1|||
24919505|NCT00618722|50013277|FG003|Overall Study|Refusal of Treatment|0|||
24919506|NCT00618722|50013274|FG000|Overall Study|Patient Request|1|||
24919507|NCT00618722|50013275|FG001|Overall Study|Patient Request|1|||
24919508|NCT00618722|50013276|FG002|Overall Study|Patient Request|1|||
24919509|NCT00618722|50013277|FG003|Overall Study|Patient Request|1|||
24919510|NCT00618722|50013274|FG000|Overall Study|Inability to Complete Study Procedure|0|||
24919511|NCT00618722|50013275|FG001|Overall Study|Inability to Complete Study Procedure|1|||
24919512|NCT00618722|50013276|FG002|Overall Study|Inability to Complete Study Procedure|0|||
24919513|NCT00618722|50013277|FG003|Overall Study|Inability to Complete Study Procedure|0|||
24919514|NCT00618722|50013274|FG000|Overall Study|Lost to Follow-up|2|||
24919515|NCT00618722|50013275|FG001|Overall Study|Lost to Follow-up|0|||
24919516|NCT00618722|50013276|FG002|Overall Study|Lost to Follow-up|0|||
24919517|NCT00618722|50013277|FG003|Overall Study|Lost to Follow-up|2|||
24919518|NCT00618722|50013274|FG000|Overall Study|Miscellaneous Reasons|0|||
24919519|NCT00618722|50013275|FG001|Overall Study|Miscellaneous Reasons|0|||
24919520|NCT00618722|50013276|FG002|Overall Study|Miscellaneous Reasons|1|||
25022332|NCT04273217|50119085|FG001|Overall Study|Lost to Follow-up|0|||
25154117|NCT01515189|50269236|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
25154118|NCT01515189|50269235|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
24919521|NCT00618722|50013277|FG003|Overall Study|Miscellaneous Reasons|1|||
24919522|NCT00507442|50013291|FG000|Overall Study|Adverse Event|8|||
24919523|NCT00507442|50013292|FG001|Overall Study|Adverse Event|11|||
24919524|NCT00507442|50013293|FG002|Overall Study|Adverse Event|4|||
24919525|NCT00507442|50013294|FG003|Overall Study|Adverse Event|1|||
24919526|NCT00507442|50013291|FG000|Overall Study|Protocol Violation|0|||
24919527|NCT00507442|50013292|FG001|Overall Study|Protocol Violation|1|||
25022333|NCT04273217|50119086|FG002|Overall Study|Lost to Follow-up|0|||
24919528|NCT00507442|50013293|FG002|Overall Study|Protocol Violation|0|||
24919529|NCT00507442|50013294|FG003|Overall Study|Protocol Violation|0|||
24919530|NCT00507442|50013291|FG000|Overall Study|Lost to Follow-up|0|||
24919531|NCT00507442|50013292|FG001|Overall Study|Lost to Follow-up|0|||
24919532|NCT00507442|50013293|FG002|Overall Study|Lost to Follow-up|1|||
24919533|NCT00507442|50013294|FG003|Overall Study|Lost to Follow-up|0|||
24919534|NCT00507442|50013291|FG000|Overall Study|Physician Decision|0|||
24919535|NCT00507442|50013292|FG001|Overall Study|Physician Decision|2|||
24919536|NCT00507442|50013293|FG002|Overall Study|Physician Decision|4|||
24919537|NCT00507442|50013294|FG003|Overall Study|Physician Decision|1|||
24919538|NCT00507442|50013291|FG000|Overall Study|Progressive Disease|2|||
24919539|NCT00507442|50013292|FG001|Overall Study|Progressive Disease|4|||
24919540|NCT00507442|50013293|FG002|Overall Study|Progressive Disease|2|||
24919541|NCT00507442|50013294|FG003|Overall Study|Progressive Disease|0|||
24919542|NCT00507442|50013291|FG000|Overall Study|Withdrawal by Subject|4|||
24919543|NCT00507442|50013292|FG001|Overall Study|Withdrawal by Subject|4|||
24919544|NCT00507442|50013293|FG002|Overall Study|Withdrawal by Subject|2|||
24919545|NCT00507442|50013294|FG003|Overall Study|Withdrawal by Subject|1|||
24919546|NCT00507442|50013291|FG000|Overall Study|Other|2|||
24919547|NCT00507442|50013292|FG001|Overall Study|Other|5|||
24919548|NCT00507442|50013293|FG002|Overall Study|Other|2|||
24919549|NCT00507442|50013294|FG003|Overall Study|Other|2|||
24919550|NCT00619892|50013310|FG000|Overall Study|Adverse Event|3|||
24919551|NCT00619892|50013311|FG001|Overall Study|Adverse Event|0|||
24919552|NCT00619892|50013310|FG000|Overall Study|Lost to Follow-up|0|||
24919553|NCT00619892|50013311|FG001|Overall Study|Lost to Follow-up|1|||
24919554|NCT00619892|50013310|FG000|Overall Study|Intercurrent illness|0|||
24919555|NCT00619892|50013311|FG001|Overall Study|Intercurrent illness|1|||
24919556|NCT00507130|50013323|FG000|Overall Study|Lost to Follow-up|0|||
24919557|NCT00507130|50013324|FG001|Overall Study|Lost to Follow-up|0|||
24919558|NCT00507130|50013325|FG002|Overall Study|Lost to Follow-up|1|||
24919559|NCT00507130|50013326|FG003|Overall Study|Lost to Follow-up|1|||
24919560|NCT00507130|50013323|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
24919561|NCT00507130|50013324|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
24919562|NCT00507130|50013325|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
24919563|NCT00507130|50013326|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
24919564|NCT00503308|50013338|FG000|Overall Study|Protocol Violation|2|||
24919565|NCT00503308|50013339|FG001|Overall Study|Protocol Violation|1|||
24919566|NCT03893565|50013350|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
24919567|NCT03893565|50013351|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
24919568|NCT03893565|50013352|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
24919569|NCT03893565|50013353|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
24919570|NCT03893565|50013354|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
24919571|NCT03893565|50013355|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
24919572|NCT03893565|50013356|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
24919573|NCT03893565|50013357|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
24919574|NCT03893565|50013358|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
25154119|NCT01515189|50269236|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
24919575|NCT03893565|50013350|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
25154120|NCT01515189|50269235|FG000|First Re-Induction Phase|Other|1|||
25154121|NCT01515189|50269236|FG001|First Re-Induction Phase|Other|0|||
25154122|NCT01546623|50269244|FG000|Overall Study|Adverse Event|2|||
25154123|NCT01546623|50269245|FG001|Overall Study|Adverse Event|3|||
25154124|NCT01546623|50269244|FG000|Overall Study|Major Protocol Deviation|1|||
24919576|NCT03893565|50013351|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
24919577|NCT03893565|50013352|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
24919578|NCT03893565|50013353|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
24919579|NCT03893565|50013354|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
24919580|NCT03893565|50013355|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
25022334|NCT04273217|50119087|FG003|Overall Study|Lost to Follow-up|0|||
25022335|NCT04273217|50119088|FG004|Overall Study|Lost to Follow-up|0|||
25022336|NCT04273217|50119089|FG005|Overall Study|Lost to Follow-up|1|||
25022337|NCT04273217|50119084|FG000|Overall Study|Participant non-compliance|0|||
24919581|NCT03893565|50013356|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
24919582|NCT03893565|50013357|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
24919583|NCT03893565|50013358|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
24919584|NCT03893565|50013350|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
24919585|NCT03893565|50013351|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
24919586|NCT03893565|50013352|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
24919587|NCT03893565|50013353|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
24919588|NCT03893565|50013354|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
24919589|NCT03893565|50013355|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
24919590|NCT03893565|50013356|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
24919591|NCT03893565|50013357|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
24919592|NCT03893565|50013358|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
24919593|NCT03893565|50013350|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
24919594|NCT03893565|50013351|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
24919595|NCT03893565|50013352|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
24919596|NCT03893565|50013353|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
24919597|NCT03893565|50013354|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
24919598|NCT03893565|50013355|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
24919599|NCT03893565|50013356|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
24919600|NCT03893565|50013357|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
24919601|NCT03893565|50013358|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
24919602|NCT03893565|50013350|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
24919603|NCT03893565|50013351|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
24919604|NCT03893565|50013352|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
24919605|NCT03893565|50013353|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
24919606|NCT03893565|50013354|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
24919607|NCT03893565|50013355|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
24919608|NCT03893565|50013356|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
24919609|NCT03893565|50013357|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
24919610|NCT03893565|50013358|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
24919611|NCT03893565|50013350|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
24919612|NCT03893565|50013351|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
24919613|NCT03893565|50013352|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
24919614|NCT03893565|50013353|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
24919615|NCT03893565|50013354|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
24919616|NCT03893565|50013355|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
24919617|NCT03893565|50013356|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
24919618|NCT03893565|50013357|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
24919619|NCT03893565|50013358|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
24919620|NCT03893565|50013350|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
24919621|NCT03893565|50013351|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
24919622|NCT03893565|50013352|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
24919623|NCT03893565|50013353|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
24919624|NCT03893565|50013354|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
24919625|NCT03893565|50013355|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
24919626|NCT03893565|50013356|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
24919627|NCT03893565|50013357|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
25022338|NCT04273217|50119085|FG001|Overall Study|Participant non-compliance|0|||
25022339|NCT04273217|50119086|FG002|Overall Study|Participant non-compliance|0|||
25022340|NCT04273217|50119087|FG003|Overall Study|Participant non-compliance|0|||
25022341|NCT04273217|50119088|FG004|Overall Study|Participant non-compliance|1|||
25022342|NCT04273217|50119089|FG005|Overall Study|Participant non-compliance|0|||
25022343|NCT04273217|50119084|FG000|Overall Study|Positive urine drug screen|1|||
25022344|NCT04273217|50119085|FG001|Overall Study|Positive urine drug screen|0|||
25022345|NCT04273217|50119086|FG002|Overall Study|Positive urine drug screen|1|||
25022346|NCT04273217|50119087|FG003|Overall Study|Positive urine drug screen|0|||
25022347|NCT04273217|50119088|FG004|Overall Study|Positive urine drug screen|0|||
25022348|NCT04273217|50119089|FG005|Overall Study|Positive urine drug screen|1|||
25154125|NCT01546623|50269245|FG001|Overall Study|Major Protocol Deviation|1|||
25022349|NCT04384523|50119109|FG000|Overall Study|Lost to Follow-up|0|||
25022350|NCT04384523|50119110|FG001|Overall Study|Lost to Follow-up|0|||
25022351|NCT04384523|50119111|FG002|Overall Study|Lost to Follow-up|0|||
25022352|NCT04384523|50119112|FG003|Overall Study|Lost to Follow-up|0|||
25022353|NCT04384523|50119113|FG004|Overall Study|Lost to Follow-up|0|||
25022354|NCT04384523|50119114|FG005|Overall Study|Lost to Follow-up|1|||
25022355|NCT04384523|50119109|FG000|Overall Study|Protocol Violation|0|||
24919628|NCT03893565|50013358|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
24919629|NCT03893565|50013350|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
24919630|NCT03893565|50013351|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
24919631|NCT03893565|50013352|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
24919632|NCT03893565|50013353|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
24919633|NCT03893565|50013354|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
24919634|NCT03893565|50013355|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
24919635|NCT03893565|50013356|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
24919636|NCT03893565|50013357|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
24919637|NCT03893565|50013358|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
24919638|NCT03893565|50013350|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
24919639|NCT03893565|50013351|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
24919640|NCT03893565|50013352|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
24919641|NCT03893565|50013353|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
24919642|NCT03893565|50013354|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
24919643|NCT03893565|50013355|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
24919644|NCT03893565|50013356|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
24919645|NCT03893565|50013357|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
24919646|NCT03893565|50013358|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
24919647|NCT03893565|50013350|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
24919648|NCT03893565|50013351|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
24919649|NCT03893565|50013352|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
24919650|NCT03893565|50013353|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
24919651|NCT03893565|50013354|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
24919652|NCT03893565|50013355|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
24919653|NCT03893565|50013356|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
24919654|NCT03893565|50013357|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
24919655|NCT03893565|50013358|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
24919656|NCT03893565|50013350|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
24919657|NCT03893565|50013351|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
25022356|NCT04384523|50119110|FG001|Overall Study|Protocol Violation|1|||
25022357|NCT04384523|50119111|FG002|Overall Study|Protocol Violation|0|||
25022358|NCT04384523|50119112|FG003|Overall Study|Protocol Violation|0|||
25275032|NCT01238861|50589065|FG000|Overall Study|Withdrawal by Subject|6|||
24919658|NCT03893565|50013352|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
24919659|NCT03893565|50013353|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
24919660|NCT03893565|50013354|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
24919661|NCT03893565|50013355|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
24919662|NCT03893565|50013356|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
24919663|NCT03893565|50013357|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
24919664|NCT03893565|50013358|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
24919665|NCT03893565|50013350|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
24919666|NCT03893565|50013351|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
24919667|NCT03893565|50013352|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
24919668|NCT03893565|50013353|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
24919669|NCT03893565|50013354|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
24919670|NCT03893565|50013355|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
24919671|NCT03893565|50013356|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
24919672|NCT03893565|50013357|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
24919673|NCT03893565|50013358|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
24919674|NCT03893565|50013350|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
24919675|NCT03893565|50013351|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
24919676|NCT03893565|50013352|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
24919677|NCT03893565|50013353|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
24919678|NCT03893565|50013354|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
24919679|NCT03893565|50013355|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
24919680|NCT03893565|50013356|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
25022359|NCT04384523|50119113|FG004|Overall Study|Protocol Violation|0|||
25022360|NCT04384523|50119114|FG005|Overall Study|Protocol Violation|0|||
25022361|NCT04384523|50119109|FG000|Overall Study|Withdrawal by Subject|1|||
25022362|NCT04384523|50119110|FG001|Overall Study|Withdrawal by Subject|0|||
24919681|NCT03893565|50013357|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
24919682|NCT03893565|50013358|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
24919683|NCT03893565|50013350|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
24919684|NCT03893565|50013351|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
24919685|NCT03893565|50013352|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
24919686|NCT03893565|50013353|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
24919687|NCT03893565|50013354|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
24919688|NCT03893565|50013355|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
24919689|NCT03893565|50013356|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
24919690|NCT03893565|50013357|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
24919691|NCT03893565|50013358|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
24919692|NCT03893565|50013350|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
24919693|NCT03893565|50013351|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
24919694|NCT03893565|50013352|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
24919695|NCT03893565|50013353|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
24919696|NCT03893565|50013354|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
24919697|NCT03893565|50013355|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
24919698|NCT03893565|50013356|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
24919699|NCT03893565|50013357|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
24919700|NCT03893565|50013358|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
24919701|NCT03893565|50013350|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
24919702|NCT03893565|50013351|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
24919703|NCT03893565|50013352|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
24919704|NCT03893565|50013353|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
24919705|NCT03893565|50013354|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
24919706|NCT03893565|50013355|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
24919707|NCT03893565|50013356|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
24919708|NCT03893565|50013357|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
24919709|NCT03893565|50013358|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
24919710|NCT00502996|50013377|FG000|Overall Study|Lost to Follow-up|9|||
24919711|NCT00502996|50013377|FG000|Overall Study|Protocol Violation|2|||
24919712|NCT00502996|50013377|FG000|Overall Study|Treatment failure|25|||
24919713|NCT00502996|50013377|FG000|Overall Study|Withdrawal Informed Consent|6|||
24919714|NCT00502996|50013377|FG000|Overall Study|Adverse Event|2|||
24919715|NCT00715403|50013388|FG000|Overall Study|Progressive disease|0|||
24919716|NCT00715403|50013389|FG001|Overall Study|Progressive disease|1|||
24919717|NCT00715403|50013390|FG002|Overall Study|Progressive disease|3|||
24919718|NCT00715403|50013391|FG003|Overall Study|Progressive disease|9|||
24919719|NCT00715403|50013392|FG004|Overall Study|Progressive disease|5|||
24919720|NCT00715403|50013393|FG005|Overall Study|Progressive disease|14|||
24919721|NCT00715403|50013394|FG006|Overall Study|Progressive disease|1|||
24919722|NCT00715403|50013388|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
24919723|NCT00715403|50013389|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
24919724|NCT00715403|50013390|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
24919725|NCT00715403|50013391|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
24919726|NCT00715403|50013392|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
24919727|NCT00715403|50013393|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
24919728|NCT00715403|50013394|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
24919729|NCT00715403|50013388|FG000|Overall Study|Other Adverse Event than DLT|1|||
24919730|NCT00715403|50013389|FG001|Overall Study|Other Adverse Event than DLT|0|||
24919731|NCT00715403|50013390|FG002|Overall Study|Other Adverse Event than DLT|0|||
24919732|NCT00715403|50013391|FG003|Overall Study|Other Adverse Event than DLT|0|||
24919733|NCT00715403|50013392|FG004|Overall Study|Other Adverse Event than DLT|0|||
24919734|NCT00715403|50013393|FG005|Overall Study|Other Adverse Event than DLT|2|||
24919735|NCT00715403|50013394|FG006|Overall Study|Other Adverse Event than DLT|0|||
24919736|NCT00715403|50013388|FG000|Overall Study|Protocol Violation|0|||
24919737|NCT00715403|50013389|FG001|Overall Study|Protocol Violation|0|||
25022363|NCT04384523|50119111|FG002|Overall Study|Withdrawal by Subject|0|||
24919738|NCT00715403|50013390|FG002|Overall Study|Protocol Violation|0|||
24919739|NCT00715403|50013391|FG003|Overall Study|Protocol Violation|0|||
24919740|NCT00715403|50013392|FG004|Overall Study|Protocol Violation|0|||
24919741|NCT00715403|50013393|FG005|Overall Study|Protocol Violation|1|||
24919742|NCT00715403|50013394|FG006|Overall Study|Protocol Violation|0|||
24919743|NCT00715403|50013388|FG000|Overall Study|Other reason not defined above|0|||
24919744|NCT00715403|50013389|FG001|Overall Study|Other reason not defined above|0|||
24919745|NCT00715403|50013390|FG002|Overall Study|Other reason not defined above|1|||
24919746|NCT00715403|50013391|FG003|Overall Study|Other reason not defined above|0|||
24919747|NCT00715403|50013392|FG004|Overall Study|Other reason not defined above|1|||
24919748|NCT00715403|50013393|FG005|Overall Study|Other reason not defined above|1|||
24919749|NCT00715403|50013394|FG006|Overall Study|Other reason not defined above|0|||
24919750|NCT00502840|50013410|FG000|Overall Study|Adverse Event|5|||
24919751|NCT00502840|50013410|FG000|Overall Study|Additional or changed therapy|48|||
24919752|NCT00502840|50013410|FG000|Overall Study|Lack of Efficacy|11|||
24919753|NCT00502840|50013410|FG000|Overall Study|Protocol Violation|4|||
24919754|NCT00502840|50013410|FG000|Overall Study|Withdrawal by Subject|5|||
24919755|NCT00502840|50013410|FG000|Overall Study|Lost to Follow-up|6|||
24919756|NCT00502840|50013410|FG000|Overall Study|Administrative problems|1|||
24919757|NCT00502840|50013410|FG000|Overall Study|Other|20|||
24919758|NCT00515008|50013417|FG000|Overall Study|Lost to Follow-up|1|||
24919759|NCT00515008|50013418|FG001|Overall Study|Lost to Follow-up|0|||
24919760|NCT00515008|50013417|FG000|Overall Study|Declined|0|||
24919761|NCT00515008|50013418|FG001|Overall Study|Declined|3|||
24919762|NCT00515008|50013417|FG000|Overall Study|Left the Boston Area|1|||
24919763|NCT00515008|50013418|FG001|Overall Study|Left the Boston Area|1|||
24919764|NCT00515008|50013417|FG000|Overall Study|Scheduling conflict|1|||
24919765|NCT00515008|50013418|FG001|Overall Study|Scheduling conflict|0|||
24919766|NCT00514540|50013427|FG000|First-Line Chemo|Withdrawal by Subject|1|||
24919767|NCT00514540|50013427|FG000|First-Line Chemo|Protocol Violation|7|||
24919768|NCT00514540|50013427|FG000|Second-Line|Physician/Patient Decision|31|||
24919769|NCT00506662|50013437|FG000|Overall Study|Adverse Event|0|||
24919770|NCT00506662|50013438|FG001|Overall Study|Adverse Event|2|||
24919771|NCT00506662|50013437|FG000|Overall Study|Lack of Efficacy|1|||
24919772|NCT00506662|50013438|FG001|Overall Study|Lack of Efficacy|0|||
24919773|NCT00506662|50013437|FG000|Overall Study|Protocol Violation|2|||
24919774|NCT00506662|50013438|FG001|Overall Study|Protocol Violation|4|||
24919775|NCT00506662|50013437|FG000|Overall Study|Trial terminated|10|||
24919776|NCT00506662|50013438|FG001|Overall Study|Trial terminated|16|||
24919777|NCT00506662|50013437|FG000|Overall Study|Not recorded|4|||
24919778|NCT00506662|50013438|FG001|Overall Study|Not recorded|6|||
24919779|NCT00713609|50013454|FG000|Overall Study|Adverse Event|2|||
24919780|NCT00713609|50013455|FG001|Overall Study|Adverse Event|0|||
24919781|NCT00713609|50013456|FG002|Overall Study|Adverse Event|2|||
24919782|NCT00713609|50013457|FG003|Overall Study|Adverse Event|2|||
25022364|NCT04384523|50119112|FG003|Overall Study|Withdrawal by Subject|0|||
25022365|NCT04384523|50119113|FG004|Overall Study|Withdrawal by Subject|0|||
24919783|NCT00713609|50013458|FG004|Overall Study|Adverse Event|3|||
24919784|NCT00713609|50013459|FG005|Overall Study|Adverse Event|1|||
24919785|NCT00713609|50013454|FG000|Overall Study|Lost to Follow-up|5|||
24919786|NCT00713609|50013455|FG001|Overall Study|Lost to Follow-up|7|||
24919787|NCT00713609|50013456|FG002|Overall Study|Lost to Follow-up|5|||
24919788|NCT00713609|50013457|FG003|Overall Study|Lost to Follow-up|5|||
24919789|NCT00713609|50013458|FG004|Overall Study|Lost to Follow-up|7|||
24919790|NCT00713609|50013459|FG005|Overall Study|Lost to Follow-up|0|||
24919791|NCT00713609|50013454|FG000|Overall Study|Lack of Efficacy|1|||
24919792|NCT00713609|50013455|FG001|Overall Study|Lack of Efficacy|3|||
24919793|NCT00713609|50013456|FG002|Overall Study|Lack of Efficacy|0|||
24919794|NCT00713609|50013457|FG003|Overall Study|Lack of Efficacy|0|||
24919795|NCT00713609|50013458|FG004|Overall Study|Lack of Efficacy|1|||
24919796|NCT00713609|50013459|FG005|Overall Study|Lack of Efficacy|0|||
25022366|NCT04384523|50119114|FG005|Overall Study|Withdrawal by Subject|0|||
25022367|NCT04382651|50119149|FG000|Overall Study|Death|26|||
24919797|NCT00713609|50013454|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
24919798|NCT00713609|50013455|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
24919799|NCT00713609|50013456|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
24919800|NCT00713609|50013457|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
24919801|NCT00713609|50013458|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
24919802|NCT00713609|50013459|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
24919803|NCT00713609|50013454|FG000|Overall Study|Withdrawal by Subject|6|||
24919804|NCT00713609|50013455|FG001|Overall Study|Withdrawal by Subject|1|||
24919805|NCT00713609|50013456|FG002|Overall Study|Withdrawal by Subject|5|||
24919806|NCT00713609|50013457|FG003|Overall Study|Withdrawal by Subject|1|||
24919807|NCT00713609|50013458|FG004|Overall Study|Withdrawal by Subject|5|||
24919808|NCT00713609|50013459|FG005|Overall Study|Withdrawal by Subject|7|||
24919809|NCT00713609|50013454|FG000|Overall Study|Protocol Violation|6|||
24919810|NCT00713609|50013455|FG001|Overall Study|Protocol Violation|3|||
24919811|NCT00713609|50013456|FG002|Overall Study|Protocol Violation|1|||
24919812|NCT00713609|50013457|FG003|Overall Study|Protocol Violation|1|||
24919813|NCT00713609|50013458|FG004|Overall Study|Protocol Violation|2|||
24919814|NCT00713609|50013459|FG005|Overall Study|Protocol Violation|0|||
24919815|NCT00513682|50013473|FG000|Washout Phase|Adverse Event|2|||
24919816|NCT00493012|50013482|FG000|Overall Study|Lost to Follow-up|18|||
24919817|NCT00493012|50013483|FG001|Overall Study|Lost to Follow-up|17|||
24919818|NCT05144477|50013491|FG000|Overall Study|Withdrawal by Subject|1|||
24919819|NCT05144477|50013492|FG001|Overall Study|Withdrawal by Subject|1|||
24919820|NCT00617708|50013508|FG000|Overall Study|Adverse Event|0|||
24919821|NCT00617708|50013509|FG001|Overall Study|Adverse Event|6|||
24919822|NCT00617708|50013510|FG002|Overall Study|Adverse Event|9|||
24919823|NCT00617708|50013508|FG000|Overall Study|Withdrawal by Subject|1|||
24919824|NCT00617708|50013509|FG001|Overall Study|Withdrawal by Subject|1|||
24919825|NCT00617708|50013510|FG002|Overall Study|Withdrawal by Subject|7|||
24919826|NCT00617708|50013508|FG000|Overall Study|Death|0|||
24919827|NCT00617708|50013509|FG001|Overall Study|Death|6|||
24919828|NCT00617708|50013510|FG002|Overall Study|Death|5|||
24919829|NCT00617708|50013508|FG000|Overall Study|Progression/Relapse|7|||
24919830|NCT00617708|50013509|FG001|Overall Study|Progression/Relapse|40|||
24919831|NCT00617708|50013510|FG002|Overall Study|Progression/Relapse|36|||
24919832|NCT00617708|50013508|FG000|Overall Study|Not protocol specified|1|||
24919833|NCT00617708|50013509|FG001|Overall Study|Not protocol specified|4|||
24919834|NCT00617708|50013510|FG002|Overall Study|Not protocol specified|2|||
24919835|NCT00617708|50013508|FG000|Overall Study|Not eligible|1|||
24919836|NCT00617708|50013509|FG001|Overall Study|Not eligible|3|||
24919837|NCT00617708|50013510|FG002|Overall Study|Not eligible|5|||
24919838|NCT03894969|50013525|FG000|Overall Study|Adverse Event|0|||
24919839|NCT03894969|50013526|FG001|Overall Study|Adverse Event|2|||
24919840|NCT03894969|50013527|FG002|Overall Study|Adverse Event|0|||
24919841|NCT03894969|50013528|FG003|Overall Study|Adverse Event|1|||
24919842|NCT03894969|50013529|FG004|Overall Study|Adverse Event|2|||
24919843|NCT03894969|50013525|FG000|Overall Study|Lost to Follow-up|3|||
24919844|NCT03894969|50013526|FG001|Overall Study|Lost to Follow-up|1|||
24919845|NCT03894969|50013527|FG002|Overall Study|Lost to Follow-up|1|||
24919846|NCT03894969|50013528|FG003|Overall Study|Lost to Follow-up|0|||
24919847|NCT03894969|50013529|FG004|Overall Study|Lost to Follow-up|0|||
24919848|NCT03894969|50013525|FG000|Overall Study|Withdrawal by Subject|2|||
24919849|NCT03894969|50013526|FG001|Overall Study|Withdrawal by Subject|1|||
24919850|NCT03894969|50013527|FG002|Overall Study|Withdrawal by Subject|3|||
24919851|NCT03894969|50013528|FG003|Overall Study|Withdrawal by Subject|4|||
24919852|NCT03894969|50013529|FG004|Overall Study|Withdrawal by Subject|8|||
24919853|NCT03894969|50013525|FG000|Overall Study|Other|0|||
24919854|NCT03894969|50013526|FG001|Overall Study|Other|0|||
24919855|NCT03894969|50013527|FG002|Overall Study|Other|0|||
24919856|NCT03894969|50013528|FG003|Overall Study|Other|0|||
24919857|NCT03894969|50013529|FG004|Overall Study|Other|3|||
24919858|NCT03894969|50013525|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
24919859|NCT03894969|50013526|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
24919860|NCT03894969|50013527|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
24919861|NCT03894969|50013528|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
24919862|NCT03894969|50013529|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
24919863|NCT03894969|50013525|FG000|Overall Study|Solicited Adverse Event|0|||
24919864|NCT03894969|50013526|FG001|Overall Study|Solicited Adverse Event|1|||
24919865|NCT03894969|50013527|FG002|Overall Study|Solicited Adverse Event|0|||
24919866|NCT03894969|50013528|FG003|Overall Study|Solicited Adverse Event|0|||
24919867|NCT03894969|50013529|FG004|Overall Study|Solicited Adverse Event|0|||
24919868|NCT03894813|50013545|FG000|Overall Study|Adverse Event|1|||
24919869|NCT03894813|50013546|FG001|Overall Study|Adverse Event|1|||
24919870|NCT03894813|50013545|FG000|Overall Study|Lack of Efficacy|3|||
24919871|NCT03894813|50013546|FG001|Overall Study|Lack of Efficacy|3|||
24919872|NCT03894813|50013545|FG000|Overall Study|Lost to Follow-up|1|||
24919873|NCT03894813|50013546|FG001|Overall Study|Lost to Follow-up|0|||
24919874|NCT03894813|50013545|FG000|Overall Study|Pregnancy|2|||
24919875|NCT03894813|50013546|FG001|Overall Study|Pregnancy|1|||
24919876|NCT03894813|50013545|FG000|Overall Study|Protocol Violation|3|||
24919877|NCT03894813|50013546|FG001|Overall Study|Protocol Violation|7|||
24919878|NCT03894813|50013545|FG000|Overall Study|Withdrawal by Subject|1|||
24919879|NCT03894813|50013546|FG001|Overall Study|Withdrawal by Subject|3|||
24919880|NCT03894813|50013545|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
24919881|NCT03894813|50013546|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
24919882|NCT00615992|50013552|FG000|Overall Study|Protocol Violation|67|||
24919883|NCT03892707|50013558|FG000|Overall Study|Screen failure|6|||
24919884|NCT03892707|50013559|FG001|Overall Study|Screen failure|0|||
24919885|NCT03892707|50013558|FG000|Overall Study|Pain resolution|0|||
24919886|NCT03892707|50013559|FG001|Overall Study|Pain resolution|4|||
24919887|NCT03892707|50013558|FG000|Overall Study|Withdrawal by Subject|0|||
24919888|NCT03892707|50013559|FG001|Overall Study|Withdrawal by Subject|1|||
24919889|NCT03892707|50013558|FG000|Overall Study|Other (long business trip)|0|||
24919890|NCT03892707|50013559|FG001|Overall Study|Other (long business trip)|1|||
24919891|NCT00615914|50013566|FG000|Overall Study|Adverse Event|274|||
24919892|NCT00615914|50013566|FG000|Overall Study|Death|20|||
24919893|NCT00615914|50013566|FG000|Overall Study|Lack of Efficacy|59|||
24919894|NCT00615914|50013566|FG000|Overall Study|Lost to Follow-up|187|||
24919895|NCT00615914|50013566|FG000|Overall Study|Withdrawal by Subject|16|||
24919896|NCT00615914|50013566|FG000|Overall Study|Physician Decision|4|||
24919897|NCT00615914|50013566|FG000|Overall Study|No data was collected.|65|||
24919898|NCT00615914|50013566|FG000|Overall Study|No treatment|2|||
24919899|NCT00615914|50013566|FG000|Overall Study|Irregularly enrolled patients|10|||
24919900|NCT00513604|50013576|FG000|Overall Study|Not treated|2|||
24919901|NCT00513604|50013577|FG001|Overall Study|Not treated|0|||
24919902|NCT00513604|50013578|FG002|Overall Study|Not treated|1|||
24919903|NCT00513604|50013579|FG003|Overall Study|Not treated|0|||
24919904|NCT00513604|50013580|FG004|Overall Study|Not treated|0|||
24919905|NCT00513604|50013576|FG000|Overall Study|Death during treatment|0|||
24919906|NCT00513604|50013577|FG001|Overall Study|Death during treatment|3|||
24919907|NCT00513604|50013578|FG002|Overall Study|Death during treatment|2|||
24919908|NCT00513604|50013579|FG003|Overall Study|Death during treatment|0|||
24919909|NCT00513604|50013580|FG004|Overall Study|Death during treatment|0|||
24919910|NCT00534105|50013594|FG000|Overall Study|Lost to Follow-up|23|||
24919911|NCT00534105|50013595|FG001|Overall Study|Lost to Follow-up|39|||
24919912|NCT00573248|50013610|FG000|Overall Study|scheduling conflicts|15|||
24919913|NCT00573248|50013611|FG001|Overall Study|scheduling conflicts|11|||
24919914|NCT00532935|50013619|FG000|Overall Study|Adverse Event|11|||
24919915|NCT00532935|50013620|FG001|Overall Study|Adverse Event|12|||
24919916|NCT00532935|50013619|FG000|Overall Study|Lack of Efficacy|0|||
24919917|NCT00532935|50013620|FG001|Overall Study|Lack of Efficacy|3|||
24919918|NCT00532935|50013619|FG000|Overall Study|Lost to Follow-up|10|||
24919919|NCT00532935|50013620|FG001|Overall Study|Lost to Follow-up|6|||
24919920|NCT00532935|50013619|FG000|Overall Study|Physician Decision|4|||
24919921|NCT00532935|50013620|FG001|Overall Study|Physician Decision|5|||
24919922|NCT00532935|50013619|FG000|Overall Study|Pregnancy|1|||
24919923|NCT00532935|50013620|FG001|Overall Study|Pregnancy|0|||
24919924|NCT00532935|50013619|FG000|Overall Study|Protocol Violation|4|||
24919925|NCT00532935|50013620|FG001|Overall Study|Protocol Violation|2|||
24919926|NCT00532935|50013619|FG000|Overall Study|Withdrawal by Subject|10|||
24919927|NCT00532935|50013620|FG001|Overall Study|Withdrawal by Subject|9|||
24919928|NCT00532935|50013619|FG000|Overall Study|Protocol Specific Criteria|11|||
24919929|NCT00532935|50013620|FG001|Overall Study|Protocol Specific Criteria|15|||
24919930|NCT03016312|50013628|FG000|Overall Study|Death|194|||
24919931|NCT03016312|50013629|FG001|Overall Study|Death|164|||
24919932|NCT03016312|50013628|FG000|Overall Study|Lost to Follow-up|11|||
24919933|NCT03016312|50013629|FG001|Overall Study|Lost to Follow-up|12|||
24919934|NCT03016312|50013628|FG000|Overall Study|Started new therapy, loss of contact|2|||
24919935|NCT03016312|50013629|FG001|Overall Study|Started new therapy, loss of contact|1|||
24919936|NCT03016312|50013628|FG000|Overall Study|Physician Decision|0|||
24919937|NCT03016312|50013629|FG001|Overall Study|Physician Decision|2|||
24919938|NCT03016312|50013628|FG000|Overall Study|Withdrawal by Subject|34|||
24919939|NCT03016312|50013629|FG001|Overall Study|Withdrawal by Subject|39|||
24919940|NCT00512902|50013635|FG000|Overall Study|Adverse Event|7|||
24919941|NCT00512902|50013635|FG000|Overall Study|Lost to Follow-up|1|||
24919942|NCT00492232|50013641|FG000|Placebo Run-in|Adverse Event|0|||
24919943|NCT00492232|50013642|FG001|Placebo Run-in|Adverse Event|2|||
24919944|NCT00492232|50013641|FG000|Placebo Run-in|Protocol Violation|0|||
24919945|NCT00492232|50013642|FG001|Placebo Run-in|Protocol Violation|3|||
24919946|NCT00492232|50013641|FG000|Placebo Run-in|Lost to Follow-up|0|||
24919947|NCT00492232|50013642|FG001|Placebo Run-in|Lost to Follow-up|3|||
24919948|NCT00492232|50013641|FG000|Placebo Run-in|Withdrawal by Subject|0|||
24919949|NCT00492232|50013642|FG001|Placebo Run-in|Withdrawal by Subject|8|||
24919950|NCT00492232|50013641|FG000|Placebo Run-in|Pregnancy|0|||
24919951|NCT00492232|50013642|FG001|Placebo Run-in|Pregnancy|1|||
24919952|NCT00492232|50013641|FG000|Placebo Run-in|Entrance criteria not met|0|||
24919953|NCT00492232|50013642|FG001|Placebo Run-in|Entrance criteria not met|45|||
24919954|NCT00492232|50013641|FG000|Placebo Run-in|Other|0|||
24919955|NCT00492232|50013642|FG001|Placebo Run-in|Other|6|||
24919956|NCT00492232|50013641|FG000|Placebo Run-in|Missing|0|||
24919957|NCT00492232|50013642|FG001|Placebo Run-in|Missing|2|||
24919958|NCT00492232|50013641|FG000|Double-Blind Treatment|Adverse Event|1|||
24919959|NCT00492232|50013642|FG001|Double-Blind Treatment|Adverse Event|2|||
24919960|NCT00492232|50013641|FG000|Double-Blind Treatment|Protocol Violation|3|||
24919961|NCT00492232|50013642|FG001|Double-Blind Treatment|Protocol Violation|7|||
24919962|NCT00492232|50013641|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
24919963|NCT00492232|50013642|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
24919964|NCT00492232|50013641|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
24919965|NCT00492232|50013642|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
24919966|NCT00492232|50013641|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
24919967|NCT00492232|50013642|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
24919968|NCT00492232|50013641|FG000|Double-Blind Treatment|Other|6|||
24919969|NCT00492232|50013642|FG001|Double-Blind Treatment|Other|5|||
24919970|NCT00492232|50013641|FG000|Double-Blind Treatment|Randomized not treated|1|||
24919971|NCT00492232|50013642|FG001|Double-Blind Treatment|Randomized not treated|0|||
24919972|NCT00492232|50013641|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
24919973|NCT00492232|50013642|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
24919974|NCT00491764|50013654|FG000|Overall Study|Adverse Event|1|||
24919975|NCT00491764|50013655|FG001|Overall Study|Adverse Event|2|||
24919976|NCT00491764|50013656|FG002|Overall Study|Adverse Event|4|||
24919977|NCT00491764|50013657|FG003|Overall Study|Adverse Event|4|||
24919978|NCT00491764|50013658|FG004|Overall Study|Adverse Event|0|||
24919979|NCT00491764|50013659|FG005|Overall Study|Adverse Event|1|||
24919980|NCT00491764|50013654|FG000|Overall Study|Lost to Follow-up|0|||
24919981|NCT00491764|50013655|FG001|Overall Study|Lost to Follow-up|1|||
24919982|NCT00491764|50013656|FG002|Overall Study|Lost to Follow-up|0|||
24919983|NCT00491764|50013657|FG003|Overall Study|Lost to Follow-up|1|||
24919984|NCT00491764|50013658|FG004|Overall Study|Lost to Follow-up|0|||
24919985|NCT00491764|50013659|FG005|Overall Study|Lost to Follow-up|3|||
24919986|NCT00491764|50013654|FG000|Overall Study|Withdrawal by Subject|2|||
24919987|NCT00491764|50013655|FG001|Overall Study|Withdrawal by Subject|3|||
24919988|NCT00491764|50013656|FG002|Overall Study|Withdrawal by Subject|1|||
24919989|NCT00491764|50013657|FG003|Overall Study|Withdrawal by Subject|2|||
24919990|NCT00491764|50013658|FG004|Overall Study|Withdrawal by Subject|2|||
24919991|NCT00491764|50013659|FG005|Overall Study|Withdrawal by Subject|4|||
24919992|NCT00491764|50013654|FG000|Overall Study|Non Compliance with the Protocol|1|||
25022368|NCT04382651|50119150|FG001|Overall Study|Death|23|||
25022369|NCT04382651|50119149|FG000|Overall Study|Lost to Follow-up|3|||
25022370|NCT04382651|50119150|FG001|Overall Study|Lost to Follow-up|4|||
25022371|NCT04382651|50119149|FG000|Overall Study|Withdrawal by Subject|2|||
25022372|NCT04382651|50119150|FG001|Overall Study|Withdrawal by Subject|0|||
25022373|NCT04382651|50119149|FG000|Overall Study|Physician Decision|0|||
25022374|NCT04382651|50119150|FG001|Overall Study|Physician Decision|1|||
25022375|NCT04238663|50119165|FG000|Overall Study|Lost to Follow-up|0|||
25022376|NCT04238663|50119166|FG001|Overall Study|Lost to Follow-up|1|||
25022377|NCT04238663|50119167|FG002|Overall Study|Lost to Follow-up|0|||
25022378|NCT03442088|50119175|FG000|Overall Study|Adverse Event|1|||
25022379|NCT03442088|50119175|FG000|Overall Study|Lack of Efficacy|2|||
25022380|NCT03442088|50119175|FG000|Overall Study|Lost to Follow-up|2|||
25022381|NCT04223687|50119181|FG000|Overall Study|Missing primary outcome|1|||
25022382|NCT04223687|50119182|FG001|Overall Study|Missing primary outcome|0|||
25022383|NCT03722576|50119188|FG000|Overall Study|Withdrawal by Subject|3|||
25022384|NCT03722576|50119188|FG000|Overall Study|Adverse Event|2|||
25022385|NCT03722576|50119188|FG000|Overall Study|Physician Decision|1|||
25022386|NCT03722576|50119188|FG000|Overall Study|Lost to Follow-up|1|||
25022387|NCT03693989|50119194|FG000|Overall Study|Protocol Violation|3|||
25022388|NCT03693989|50119195|FG001|Overall Study|Protocol Violation|4|||
25022389|NCT04206293|50119201|FG000|Overall Study|Consent withdrawal|1|||
25022390|NCT02727998|50119208|FG000|Overall Study|Lost to Follow-up|3|||
25022391|NCT02727998|50119209|FG001|Overall Study|Lost to Follow-up|3|||
25022392|NCT02727998|50119208|FG000|Overall Study|Withdrawal by Subject|0|||
25022393|NCT02727998|50119209|FG001|Overall Study|Withdrawal by Subject|1|||
25022394|NCT04366349|50119221|FG000|Overall Study|Withdrawal by Subject|1|||
25022395|NCT04366349|50119222|FG001|Overall Study|Withdrawal by Subject|0|||
25022396|NCT04366349|50119223|FG002|Overall Study|Withdrawal by Subject|0|||
25022397|NCT04366349|50119224|FG003|Overall Study|Withdrawal by Subject|0|||
25022398|NCT04366349|50119225|FG004|Overall Study|Withdrawal by Subject|0|||
25022399|NCT04366349|50119226|FG005|Overall Study|Withdrawal by Subject|0|||
25022400|NCT04179461|50119244|FG000|Overall Study|Lost to Follow-up|4|||
25022401|NCT04017611|50119248|FG000|Overall Study|Withdrawn prior to completion|1|||
25022402|NCT04172831|50119263|FG000|Overall Study|Adverse Event|21|||
25022403|NCT04172831|50119264|FG001|Overall Study|Adverse Event|9|||
25022404|NCT04172831|50119263|FG000|Overall Study|Lack of Efficacy|2|||
25022405|NCT04172831|50119264|FG001|Overall Study|Lack of Efficacy|8|||
25022406|NCT04172831|50119263|FG000|Overall Study|Physician Decision|0|||
25022407|NCT04172831|50119264|FG001|Overall Study|Physician Decision|1|||
25022408|NCT04172831|50119263|FG000|Overall Study|Withdrawal by Subject|12|||
25022409|NCT04172831|50119264|FG001|Overall Study|Withdrawal by Subject|11|||
25022410|NCT04172831|50119263|FG000|Overall Study|Lost to Follow-up|4|||
25022411|NCT04172831|50119264|FG001|Overall Study|Lost to Follow-up|9|||
24919993|NCT00491764|50013655|FG001|Overall Study|Non Compliance with the Protocol|0|||
24919994|NCT00491764|50013656|FG002|Overall Study|Non Compliance with the Protocol|0|||
25022412|NCT04172831|50119263|FG000|Overall Study|COVID-19 related crisis|3|||
25022413|NCT04172831|50119264|FG001|Overall Study|COVID-19 related crisis|3|||
25022414|NCT04172831|50119263|FG000|Overall Study|Subject non-compliance|1|||
25022415|NCT04172831|50119264|FG001|Overall Study|Subject non-compliance|1|||
25022416|NCT04172831|50119263|FG000|Overall Study|Family emergency|1|||
25022417|NCT04172831|50119264|FG001|Overall Study|Family emergency|0|||
24919995|NCT00491764|50013657|FG003|Overall Study|Non Compliance with the Protocol|0|||
24919996|NCT00491764|50013658|FG004|Overall Study|Non Compliance with the Protocol|0|||
24919997|NCT00491764|50013659|FG005|Overall Study|Non Compliance with the Protocol|0|||
24919998|NCT00491764|50013654|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
24919999|NCT00491764|50013655|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
24920000|NCT00491764|50013656|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
24920001|NCT00491764|50013657|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
24920002|NCT00491764|50013658|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
24920003|NCT00491764|50013659|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
24920004|NCT00491764|50013654|FG000|Overall Study|Administrative|1|||
24920005|NCT00491764|50013655|FG001|Overall Study|Administrative|0|||
24920006|NCT00491764|50013656|FG002|Overall Study|Administrative|2|||
24920007|NCT00491764|50013657|FG003|Overall Study|Administrative|1|||
24920008|NCT00491764|50013658|FG004|Overall Study|Administrative|0|||
24920009|NCT00491764|50013659|FG005|Overall Study|Administrative|0|||
24920010|NCT00491608|50013673|FG000|Overall Study|Death|2|||
24920011|NCT00491608|50013673|FG000|Overall Study|Withdrawal by Subject|1|||
24920012|NCT00615836|50013681|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
24920013|NCT00615836|50013682|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
24920014|NCT00615836|50013683|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
24920015|NCT00615836|50013684|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
24920016|NCT00615836|50013685|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
24920017|NCT00615836|50013681|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
24920018|NCT00615836|50013682|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
24920019|NCT00615836|50013683|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
25022418|NCT04165031|50119281|FG000|Overall Study|Adverse Event|1|||
24920020|NCT00615836|50013684|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
24920021|NCT00615836|50013685|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
24920022|NCT00615836|50013681|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
24920023|NCT00615836|50013682|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
24920024|NCT00615836|50013683|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
24920025|NCT00615836|50013684|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
24920026|NCT00615836|50013685|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
24920027|NCT00615836|50013681|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
24920028|NCT00615836|50013682|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
24920029|NCT00615836|50013683|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
24920030|NCT00615836|50013684|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
24920031|NCT00615836|50013685|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
24920032|NCT00615836|50013681|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
24920033|NCT00615836|50013682|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
24920034|NCT00615836|50013683|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
25275033|NCT01238861|50589066|FG001|Overall Study|Withdrawal by Subject|5|||
25275034|NCT01238861|50589067|FG002|Overall Study|Withdrawal by Subject|4|||
25275035|NCT01238861|50589068|FG003|Overall Study|Withdrawal by Subject|8|||
25275036|NCT01238861|50589069|FG004|Overall Study|Withdrawal by Subject|10|||
24920035|NCT00615836|50013684|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
24920036|NCT00615836|50013685|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
24920037|NCT00615836|50013681|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
24920038|NCT00615836|50013682|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
24920039|NCT00615836|50013683|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
24920040|NCT00615836|50013684|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
24920041|NCT00615836|50013685|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
24920042|NCT00615836|50013681|FG000|Extension Study (FE992026 CS31)|Other|10|||
24920043|NCT00615836|50013682|FG001|Extension Study (FE992026 CS31)|Other|7|||
24920044|NCT00615836|50013683|FG002|Extension Study (FE992026 CS31)|Other|8|||
24920045|NCT00615836|50013684|FG003|Extension Study (FE992026 CS31)|Other|8|||
24920046|NCT00615836|50013685|FG004|Extension Study (FE992026 CS31)|Other|0|||
24920047|NCT00615836|50013681|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
24920048|NCT00615836|50013682|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
24920049|NCT00615836|50013683|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
24920050|NCT00615836|50013684|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
24920051|NCT00615836|50013685|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
24920052|NCT00615836|50013681|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
25022419|NCT04165031|50119282|FG001|Overall Study|Adverse Event|1|||
25275037|NCT01238861|50589070|FG005|Overall Study|Withdrawal by Subject|9|||
24920053|NCT00615836|50013682|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
24920054|NCT00615836|50013683|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
24920055|NCT00615836|50013684|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
24920056|NCT00615836|50013685|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
24920057|NCT00491530|50013704|FG000|Overall Study|Adverse Event|6|||
24920058|NCT00491530|50013705|FG001|Overall Study|Adverse Event|1|||
24920059|NCT00491530|50013706|FG002|Overall Study|Adverse Event|2|||
24920060|NCT00491530|50013704|FG000|Overall Study|Withdrawal by Subject|3|||
24920061|NCT00491530|50013705|FG001|Overall Study|Withdrawal by Subject|0|||
24920062|NCT00491530|50013706|FG002|Overall Study|Withdrawal by Subject|0|||
24920063|NCT00491530|50013704|FG000|Overall Study|Lost to Follow-up|3|||
24920064|NCT00491530|50013705|FG001|Overall Study|Lost to Follow-up|2|||
24920065|NCT00491530|50013706|FG002|Overall Study|Lost to Follow-up|2|||
24920066|NCT00491530|50013704|FG000|Overall Study|Lack of Efficacy|0|||
24920067|NCT00491530|50013705|FG001|Overall Study|Lack of Efficacy|1|||
24920068|NCT00491530|50013706|FG002|Overall Study|Lack of Efficacy|0|||
24920069|NCT00491530|50013704|FG000|Overall Study|Investigator Discretion|0|||
24920070|NCT00491530|50013705|FG001|Overall Study|Investigator Discretion|1|||
24920071|NCT00491530|50013706|FG002|Overall Study|Investigator Discretion|0|||
24920072|NCT00491530|50013704|FG000|Overall Study|Patient Request|0|||
24920073|NCT00491530|50013705|FG001|Overall Study|Patient Request|1|||
24920074|NCT00491530|50013706|FG002|Overall Study|Patient Request|0|||
24920075|NCT00491530|50013704|FG000|Overall Study|Use of Prohibited Medication|0|||
24920076|NCT00491530|50013705|FG001|Overall Study|Use of Prohibited Medication|0|||
24920077|NCT00491530|50013706|FG002|Overall Study|Use of Prohibited Medication|1|||
24920078|NCT00617240|50013716|FG000|Overall Study|Lack of Efficacy|1|||
24920079|NCT00617240|50013717|FG001|Overall Study|Lack of Efficacy|0|||
24920080|NCT00615290|50013723|FG000|Overall Study|Adverse Event|2|||
24920081|NCT00615290|50013723|FG000|Overall Study|Lost to Follow-up|3|||
24920082|NCT00615290|50013723|FG000|Overall Study|Withdrawal by Subject|1|||
24920083|NCT00615290|50013723|FG000|Overall Study|Other|2|||
24920084|NCT00501046|50013729|FG000|Overall Study|Adverse Event|21|||
24920085|NCT00501046|50013730|FG001|Overall Study|Adverse Event|25|||
24920086|NCT00501046|50013729|FG000|Overall Study|Death|23|||
24920087|NCT00501046|50013730|FG001|Overall Study|Death|30|||
24920088|NCT00501046|50013729|FG000|Overall Study|Lost to Follow-up|14|||
24920089|NCT00501046|50013730|FG001|Overall Study|Lost to Follow-up|13|||
24920090|NCT00501046|50013729|FG000|Overall Study|Physician Decision|7|||
24920091|NCT00501046|50013730|FG001|Overall Study|Physician Decision|2|||
24920092|NCT00501046|50013729|FG000|Overall Study|Pregnancy|0|||
24920093|NCT00501046|50013730|FG001|Overall Study|Pregnancy|3|||
24920094|NCT00501046|50013729|FG000|Overall Study|Protocol Violation|2|||
25022420|NCT04165031|50119283|FG002|Overall Study|Adverse Event|0|||
25022421|NCT04165031|50119284|FG003|Overall Study|Adverse Event|0|||
25022422|NCT04165031|50119285|FG004|Overall Study|Adverse Event|0|||
25022423|NCT04165031|50119286|FG005|Overall Study|Adverse Event|0|||
25022424|NCT04165031|50119281|FG000|Overall Study|Withdrawal by Subject|0|||
25022425|NCT04165031|50119282|FG001|Overall Study|Withdrawal by Subject|0|||
25022426|NCT04165031|50119283|FG002|Overall Study|Withdrawal by Subject|1|||
25022427|NCT04165031|50119284|FG003|Overall Study|Withdrawal by Subject|0|||
25022428|NCT04165031|50119285|FG004|Overall Study|Withdrawal by Subject|0|||
25022429|NCT04165031|50119286|FG005|Overall Study|Withdrawal by Subject|0|||
25022430|NCT02712424|50119303|FG000|Overall Study|Lost to Follow-up|34|||
25022431|NCT02712424|50119304|FG001|Overall Study|Lost to Follow-up|32|||
25022432|NCT02968004|50119312|FG000|Overall Study|Adverse Event|1|||
25022433|NCT02968004|50119313|FG001|Overall Study|Adverse Event|0|||
25022434|NCT02968004|50119312|FG000|Overall Study|Withdrawal by Subject|0|||
25022435|NCT02968004|50119313|FG001|Overall Study|Withdrawal by Subject|1|||
25022436|NCT03034772|50119321|FG000|Overall Study|Adverse Event|0|||
24920095|NCT00501046|50013730|FG001|Overall Study|Protocol Violation|1|||
25022437|NCT03034772|50119322|FG001|Overall Study|Adverse Event|1|||
25022438|NCT03034772|50119321|FG000|Overall Study|Withdrawal by Subject|0|||
24920096|NCT00501046|50013729|FG000|Overall Study|Withdrawal by Subject|84|||
24920097|NCT00501046|50013730|FG001|Overall Study|Withdrawal by Subject|83|||
24920098|NCT00501046|50013729|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
24920099|NCT00501046|50013730|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
25022439|NCT03034772|50119322|FG001|Overall Study|Withdrawal by Subject|1|||
25022440|NCT03032198|50119328|FG000|Overall Study|Screen Fail|1|||
25022441|NCT02431364|50119337|FG000|Overall Study|Adverse Event|0|||
25022442|NCT02431364|50119338|FG001|Overall Study|Adverse Event|1|||
25022443|NCT02431364|50119339|FG002|Overall Study|Adverse Event|0|||
25022444|NCT02431364|50119340|FG003|Overall Study|Adverse Event|0|||
25022445|NCT02431364|50119341|FG004|Overall Study|Adverse Event|0|||
24920100|NCT00533949|50013740|FG000|Overall Study|Protocol Violation|12|||
24920101|NCT00533949|50013741|FG001|Overall Study|Protocol Violation|12|||
24920102|NCT00533949|50013742|FG002|Overall Study|Protocol Violation|9|||
24920103|NCT00533949|50013743|FG003|Overall Study|Protocol Violation|9|||
24920104|NCT00533949|50013740|FG000|Overall Study|Withdrawal by Subject|3|||
24920105|NCT00533949|50013741|FG001|Overall Study|Withdrawal by Subject|2|||
24920106|NCT00533949|50013742|FG002|Overall Study|Withdrawal by Subject|1|||
24920107|NCT00533949|50013743|FG003|Overall Study|Withdrawal by Subject|1|||
24920108|NCT00485134|50013769|FG000|Overall Study|Lost to Follow-up|1|||
24920109|NCT00485134|50013770|FG001|Overall Study|Lost to Follow-up|0|||
24920110|NCT00485134|50013771|FG002|Overall Study|Lost to Follow-up|0|||
24920111|NCT00485134|50013772|FG003|Overall Study|Lost to Follow-up|0|||
24920112|NCT00485134|50013773|FG004|Overall Study|Lost to Follow-up|0|||
24920113|NCT00485134|50013774|FG005|Overall Study|Lost to Follow-up|0|||
24920114|NCT00485134|50013775|FG006|Overall Study|Lost to Follow-up|0|||
24920115|NCT00485134|50013776|FG007|Overall Study|Lost to Follow-up|0|||
24920116|NCT00485134|50013769|FG000|Overall Study|Withdrawal by Subject|0|||
24920117|NCT00485134|50013770|FG001|Overall Study|Withdrawal by Subject|1|||
24920118|NCT00485134|50013771|FG002|Overall Study|Withdrawal by Subject|0|||
24920119|NCT00485134|50013772|FG003|Overall Study|Withdrawal by Subject|0|||
24920120|NCT00485134|50013773|FG004|Overall Study|Withdrawal by Subject|0|||
24920121|NCT00485134|50013774|FG005|Overall Study|Withdrawal by Subject|0|||
24920122|NCT00485134|50013775|FG006|Overall Study|Withdrawal by Subject|0|||
24920123|NCT00485134|50013776|FG007|Overall Study|Withdrawal by Subject|0|||
24920124|NCT00485134|50013769|FG000|Overall Study|Change in health status|0|||
24920125|NCT00485134|50013770|FG001|Overall Study|Change in health status|1|||
24920126|NCT00485134|50013771|FG002|Overall Study|Change in health status|2|||
24920127|NCT00485134|50013772|FG003|Overall Study|Change in health status|1|||
24920128|NCT00485134|50013773|FG004|Overall Study|Change in health status|0|||
24920129|NCT00485134|50013774|FG005|Overall Study|Change in health status|1|||
24920130|NCT00485134|50013775|FG006|Overall Study|Change in health status|0|||
24920131|NCT00485134|50013776|FG007|Overall Study|Change in health status|0|||
24920132|NCT00485134|50013769|FG000|Overall Study|Withdrew for adverse event|0|||
24920133|NCT00485134|50013770|FG001|Overall Study|Withdrew for adverse event|0|||
24920134|NCT00485134|50013771|FG002|Overall Study|Withdrew for adverse event|1|||
24920135|NCT00485134|50013772|FG003|Overall Study|Withdrew for adverse event|0|||
24920136|NCT00485134|50013773|FG004|Overall Study|Withdrew for adverse event|0|||
24920137|NCT00485134|50013774|FG005|Overall Study|Withdrew for adverse event|0|||
24920138|NCT00485134|50013775|FG006|Overall Study|Withdrew for adverse event|0|||
24920139|NCT00485134|50013776|FG007|Overall Study|Withdrew for adverse event|0|||
24920140|NCT00485134|50013769|FG000|Overall Study|Positive drug test|0|||
24920141|NCT00485134|50013770|FG001|Overall Study|Positive drug test|0|||
24920142|NCT00485134|50013771|FG002|Overall Study|Positive drug test|0|||
25022446|NCT02431364|50119337|FG000|Overall Study|Randomized but never treated|0|||
24920143|NCT00485134|50013772|FG003|Overall Study|Positive drug test|0|||
24920144|NCT00485134|50013773|FG004|Overall Study|Positive drug test|2|||
24920145|NCT00485134|50013774|FG005|Overall Study|Positive drug test|1|||
24920146|NCT00485134|50013775|FG006|Overall Study|Positive drug test|0|||
24920147|NCT00485134|50013776|FG007|Overall Study|Positive drug test|0|||
24920148|NCT00485134|50013769|FG000|Overall Study|Non-compliance|0|||
25154126|NCT01546623|50269244|FG000|Overall Study|High Prostate specific antigen|2|||
24920149|NCT00485134|50013770|FG001|Overall Study|Non-compliance|0|||
24920150|NCT00485134|50013771|FG002|Overall Study|Non-compliance|0|||
24920151|NCT00485134|50013772|FG003|Overall Study|Non-compliance|0|||
24920152|NCT00485134|50013773|FG004|Overall Study|Non-compliance|1|||
24920153|NCT00485134|50013774|FG005|Overall Study|Non-compliance|2|||
25022447|NCT02431364|50119338|FG001|Overall Study|Randomized but never treated|0|||
25154127|NCT01546623|50269245|FG001|Overall Study|High Prostate specific antigen|1|||
24920154|NCT00485134|50013775|FG006|Overall Study|Non-compliance|2|||
24920155|NCT00485134|50013776|FG007|Overall Study|Non-compliance|0|||
24920156|NCT00485134|50013769|FG000|Overall Study|Unable to comply with study schedule|0|||
24920157|NCT00485134|50013770|FG001|Overall Study|Unable to comply with study schedule|0|||
24920158|NCT00485134|50013771|FG002|Overall Study|Unable to comply with study schedule|0|||
24920159|NCT00485134|50013772|FG003|Overall Study|Unable to comply with study schedule|0|||
24920160|NCT00485134|50013773|FG004|Overall Study|Unable to comply with study schedule|0|||
24920161|NCT00485134|50013774|FG005|Overall Study|Unable to comply with study schedule|0|||
24920162|NCT00485134|50013775|FG006|Overall Study|Unable to comply with study schedule|0|||
24920163|NCT00485134|50013776|FG007|Overall Study|Unable to comply with study schedule|1|||
24920164|NCT00485134|50013769|FG000|Overall Study|Pregnancy|0|||
24920165|NCT00485134|50013770|FG001|Overall Study|Pregnancy|0|||
24920166|NCT00485134|50013771|FG002|Overall Study|Pregnancy|0|||
24920167|NCT00485134|50013772|FG003|Overall Study|Pregnancy|0|||
24920168|NCT00485134|50013773|FG004|Overall Study|Pregnancy|0|||
24920169|NCT00485134|50013774|FG005|Overall Study|Pregnancy|0|||
24920170|NCT00485134|50013775|FG006|Overall Study|Pregnancy|1|||
24920171|NCT00485134|50013776|FG007|Overall Study|Pregnancy|0|||
24920172|NCT03890367|50013791|FG000|Overall Study|Withdrawal by parent/guardian|1|||
24920173|NCT03890367|50013792|FG001|Overall Study|Withdrawal by parent/guardian|3|||
24920174|NCT03890367|50013793|FG002|Overall Study|Withdrawal by parent/guardian|0|||
24920175|NCT03890367|50013791|FG000|Overall Study|Protocol deviation|2|||
24920176|NCT03890367|50013792|FG001|Overall Study|Protocol deviation|2|||
24920177|NCT03890367|50013793|FG002|Overall Study|Protocol deviation|1|||
24920178|NCT03890367|50013791|FG000|Overall Study|Lost to Follow-up|1|||
24920179|NCT03890367|50013792|FG001|Overall Study|Lost to Follow-up|1|||
24920180|NCT03890367|50013793|FG002|Overall Study|Lost to Follow-up|0|||
24920181|NCT00583115|50013801|FG000|Overall Study|Death|1|||
24920182|NCT00532779|50013808|FG000|Overall Study|Adverse Event|122|||
24920183|NCT00532779|50013809|FG001|Overall Study|Adverse Event|112|||
24920184|NCT00532779|50013810|FG002|Overall Study|Adverse Event|56|||
24920185|NCT00532779|50013808|FG000|Overall Study|Lost to Follow-up|76|||
24920186|NCT00532779|50013809|FG001|Overall Study|Lost to Follow-up|65|||
24920187|NCT00532779|50013810|FG002|Overall Study|Lost to Follow-up|66|||
24920188|NCT00532779|50013808|FG000|Overall Study|Withdrawal by Subject|63|||
24920189|NCT00532779|50013809|FG001|Overall Study|Withdrawal by Subject|60|||
24920190|NCT00532779|50013810|FG002|Overall Study|Withdrawal by Subject|90|||
24920191|NCT00532779|50013808|FG000|Overall Study|Lack of Efficacy|12|||
24920192|NCT00532779|50013809|FG001|Overall Study|Lack of Efficacy|12|||
24920193|NCT00532779|50013810|FG002|Overall Study|Lack of Efficacy|40|||
24920194|NCT00532779|50013808|FG000|Overall Study|Protocol Violation|5|||
24920195|NCT00532779|50013809|FG001|Overall Study|Protocol Violation|9|||
24920196|NCT00532779|50013810|FG002|Overall Study|Protocol Violation|7|||
24920197|NCT00532779|50013808|FG000|Overall Study|Pregnancy|2|||
24920198|NCT00532779|50013809|FG001|Overall Study|Pregnancy|5|||
24920199|NCT00532779|50013810|FG002|Overall Study|Pregnancy|3|||
24920200|NCT00532779|50013808|FG000|Overall Study|Death|0|||
24920201|NCT00532779|50013809|FG001|Overall Study|Death|1|||
24920202|NCT00532779|50013810|FG002|Overall Study|Death|0|||
24920203|NCT00532779|50013808|FG000|Overall Study|Drug noncompliance, moved, other|14|||
24920204|NCT00532779|50013809|FG001|Overall Study|Drug noncompliance, moved, other|23|||
24920205|NCT00532779|50013810|FG002|Overall Study|Drug noncompliance, moved, other|29|||
24920206|NCT00500266|50013818|FG000|Overall Study|Death|3|||
24920207|NCT00500266|50013818|FG000|Overall Study|Lost to Follow-up|3|||
24920208|NCT00500266|50013818|FG000|Overall Study|Withdrawal by Subject|3|||
24920209|NCT00500266|50013818|FG000|Overall Study|Assigned, not treated|4|||
24920210|NCT00500110|50013823|FG000|Overall Study|Withdrawal by Subject|3|||
24920211|NCT00534495|50013829|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
24920212|NCT00534495|50013830|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
24920213|NCT00534495|50013831|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
24920214|NCT00534495|50013829|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
24920215|NCT00534495|50013830|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
25022448|NCT02431364|50119339|FG002|Overall Study|Randomized but never treated|0|||
25022449|NCT02431364|50119340|FG003|Overall Study|Randomized but never treated|1|||
24920216|NCT00534495|50013831|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
24920217|NCT00534495|50013829|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
24920218|NCT00534495|50013830|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
24920219|NCT00534495|50013831|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
24920220|NCT00534495|50013829|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
24920221|NCT00534495|50013830|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
24920222|NCT00534495|50013831|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
24920223|NCT00534495|50013829|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
24920224|NCT00534495|50013830|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
25275038|NCT00903409|50589093|FG000|Overall Study|Adverse Event|11|||
24920225|NCT00534495|50013831|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
24920226|NCT00534495|50013829|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
24920227|NCT00534495|50013830|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
24920228|NCT00534495|50013831|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
24920229|NCT00534495|50013829|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
24920230|NCT00534495|50013830|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
24920231|NCT00534495|50013831|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
24920232|NCT00534495|50013829|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
24920233|NCT00534495|50013830|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
24920234|NCT00534495|50013831|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
24920235|NCT00534495|50013829|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
24920236|NCT00534495|50013830|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
24920237|NCT00534495|50013831|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
24920238|NCT00484198|50013855|FG000|Overall Study|Participant Withdrew Consent|12|||
24920239|NCT00484198|50013856|FG001|Overall Study|Participant Withdrew Consent|21|||
24920240|NCT00484198|50013857|FG002|Overall Study|Participant Withdrew Consent|47|||
24920241|NCT00484198|50013858|FG003|Overall Study|Participant Withdrew Consent|59|||
24920242|NCT00484198|50013855|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
24920243|NCT00484198|50013856|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
24920244|NCT00484198|50013857|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
25154128|NCT01546623|50269244|FG000|Overall Study|Did Not Receive Study Drug|1|||
25154129|NCT01546623|50269245|FG001|Overall Study|Did Not Receive Study Drug|1|||
25154130|NCT01546155|50269251|FG000|Overall Study|could not tolerate long scan duration|3|||
25154131|NCT00636610|50269257|FG000|Overall Study|Adverse Event|4|||
25154132|NCT00636610|50269258|FG001|Overall Study|Adverse Event|4|||
25154133|NCT00636610|50269257|FG000|Overall Study|Death|6|||
25154134|NCT00636610|50269258|FG001|Overall Study|Death|3|||
25154135|NCT00636610|50269257|FG000|Overall Study|Physician decision to withdraw patient|15|||
25154136|NCT00636610|50269258|FG001|Overall Study|Physician decision to withdraw patient|9|||
25154137|NCT00636610|50269257|FG000|Overall Study|Subject decision to withdraw|15|||
25154138|NCT00636610|50269258|FG001|Overall Study|Subject decision to withdraw|11|||
25154139|NCT00636610|50269257|FG000|Overall Study|Disease progression - radiographic|41|||
25154140|NCT00636610|50269258|FG001|Overall Study|Disease progression - radiographic|51|||
25154141|NCT00636610|50269257|FG000|Overall Study|Disease progression - clinical|8|||
25154142|NCT00636610|50269258|FG001|Overall Study|Disease progression - clinical|3|||
25154143|NCT00636610|50269257|FG000|Overall Study|Reason for discontinuation not available|3|||
25154144|NCT00636610|50269258|FG001|Overall Study|Reason for discontinuation not available|2|||
25154145|NCT00635050|50269266|FG000|Overall Study|Withdrawal by Subject|1|||
25154146|NCT00634504|50269275|FG000|Overall Study|Protocol Violation|1|||
25154147|NCT00634504|50269276|FG001|Overall Study|Protocol Violation|0|||
25154148|NCT00634114|50269285|FG000|Overall Study|Adverse Event|6|||
25154149|NCT00634114|50269286|FG001|Overall Study|Adverse Event|8|||
25154150|NCT00634114|50269287|FG002|Overall Study|Adverse Event|3|||
25154151|NCT00634114|50269285|FG000|Overall Study|Withdrawal by Subject|9|||
25154152|NCT00634114|50269286|FG001|Overall Study|Withdrawal by Subject|6|||
25154153|NCT00634114|50269287|FG002|Overall Study|Withdrawal by Subject|11|||
25154154|NCT00634114|50269285|FG000|Overall Study|Lost to Follow-up|0|||
25154155|NCT00634114|50269286|FG001|Overall Study|Lost to Follow-up|0|||
25154156|NCT00634114|50269287|FG002|Overall Study|Lost to Follow-up|1|||
24920245|NCT00484198|50013858|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
24920246|NCT00484198|50013855|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
24920247|NCT00484198|50013856|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
24920248|NCT00484198|50013857|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
24920249|NCT00484198|50013858|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
24920250|NCT00484198|50013855|FG000|Overall Study|Adverse Event|3|||
24920251|NCT00484198|50013856|FG001|Overall Study|Adverse Event|11|||
24920252|NCT00484198|50013857|FG002|Overall Study|Adverse Event|32|||
24920253|NCT00484198|50013858|FG003|Overall Study|Adverse Event|31|||
24920254|NCT00484198|50013855|FG000|Overall Study|Protocol Violation|0|||
24920255|NCT00484198|50013856|FG001|Overall Study|Protocol Violation|5|||
25022450|NCT02431364|50119341|FG004|Overall Study|Randomized but never treated|0|||
25154157|NCT00634114|50269285|FG000|Overall Study|Protocol Violation|3|||
25154158|NCT00634114|50269286|FG001|Overall Study|Protocol Violation|3|||
25154159|NCT00634114|50269287|FG002|Overall Study|Protocol Violation|1|||
25154160|NCT00634114|50269285|FG000|Overall Study|Pregnancy|1|||
25154161|NCT00634114|50269286|FG001|Overall Study|Pregnancy|0|||
25154162|NCT00634114|50269287|FG002|Overall Study|Pregnancy|0|||
25154163|NCT00634114|50269285|FG000|Overall Study|Incorrect enrolment|0|||
24920256|NCT00484198|50013857|FG002|Overall Study|Protocol Violation|6|||
24920257|NCT00484198|50013858|FG003|Overall Study|Protocol Violation|8|||
24920258|NCT00484198|50013855|FG000|Overall Study|Other|7|||
25154164|NCT00634114|50269286|FG001|Overall Study|Incorrect enrolment|1|||
24920259|NCT00484198|50013856|FG001|Overall Study|Other|10|||
24920260|NCT00484198|50013857|FG002|Overall Study|Other|31|||
25154165|NCT00634114|50269287|FG002|Overall Study|Incorrect enrolment|0|||
25154166|NCT00634114|50269285|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
25154167|NCT00634114|50269286|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
24920261|NCT00484198|50013858|FG003|Overall Study|Other|28|||
24920262|NCT00499486|50013873|FG000|Overall Study|Withdrawal by Subject|16|||
24920263|NCT00499252|50013877|FG000|Overall Study|Adverse Event|3|||
24920264|NCT00499252|50013877|FG000|Overall Study|Refused further treatment|2|||
24920265|NCT00499252|50013877|FG000|Overall Study|Ineligible|4|||
24920266|NCT00499252|50013877|FG000|Overall Study|<no further label>|3|||
24920267|NCT00499174|50013887|FG000|Overall Study|Physician Decision|78|||
24920268|NCT00499174|50013888|FG001|Overall Study|Physician Decision|9|||
24920269|NCT03775421|50013896|FG000|Overall Study|Lost to Follow-up|2|||
24920270|NCT03775421|50013896|FG000|Overall Study|Withdrawal by Subject|10|||
24920271|NCT03775421|50013896|FG000|Overall Study|Physician Decision|3|||
24920272|NCT03775421|50013896|FG000|Overall Study|Death|1|||
24920273|NCT03775421|50013896|FG000|Overall Study|Study Terminated by Sponsor|94|||
24920274|NCT00532155|50013902|FG000|Overall Study|Adverse Event|66|||
25154168|NCT00634114|50269287|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
25154169|NCT00634114|50269285|FG000|Overall Study|Difficult to continue|3|||
24920275|NCT00532155|50013903|FG001|Overall Study|Adverse Event|123|||
25154170|NCT00634114|50269286|FG001|Overall Study|Difficult to continue|1|||
25154171|NCT00634114|50269287|FG002|Overall Study|Difficult to continue|1|||
24920276|NCT00532155|50013902|FG000|Overall Study|Lack of Efficacy|332|||
24920277|NCT00532155|50013903|FG001|Overall Study|Lack of Efficacy|255|||
24920278|NCT00532155|50013902|FG000|Overall Study|Protocol Violation|1|||
24920279|NCT00532155|50013903|FG001|Overall Study|Protocol Violation|3|||
24920280|NCT00532155|50013902|FG000|Overall Study|Lost to Follow-up|2|||
24920281|NCT00532155|50013903|FG001|Overall Study|Lost to Follow-up|0|||
24920282|NCT00532155|50013902|FG000|Overall Study|Physician Decision|16|||
24920283|NCT00532155|50013903|FG001|Overall Study|Physician Decision|15|||
24920284|NCT00532155|50013902|FG000|Overall Study|Withdrawal by Subject|23|||
24920285|NCT00532155|50013903|FG001|Overall Study|Withdrawal by Subject|44|||
24920286|NCT00532155|50013902|FG000|Overall Study|Consent withdrawn|5|||
24920287|NCT00532155|50013903|FG001|Overall Study|Consent withdrawn|7|||
24920288|NCT00532155|50013902|FG000|Overall Study|Moved|1|||
24920289|NCT00532155|50013903|FG001|Overall Study|Moved|0|||
24920290|NCT00532155|50013902|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
24920291|NCT00532155|50013903|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
24920292|NCT00532155|50013902|FG000|Overall Study|Occurence of a second cancer|0|||
24920293|NCT00532155|50013903|FG001|Overall Study|Occurence of a second cancer|1|||
24920294|NCT00532155|50013902|FG000|Overall Study|Occurence of a secondary cancer|0|||
24920295|NCT00532155|50013903|FG001|Overall Study|Occurence of a secondary cancer|1|||
24920296|NCT00532155|50013902|FG000|Overall Study|Promotor ended study|1|||
24920297|NCT00532155|50013903|FG001|Overall Study|Promotor ended study|0|||
24920298|NCT00532155|50013902|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
24920299|NCT00532155|50013903|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
24920300|NCT00532155|50013902|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
24920301|NCT00532155|50013903|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
24920302|NCT00532155|50013902|FG000|Overall Study|Study stopped|1|||
24920303|NCT00532155|50013903|FG001|Overall Study|Study stopped|0|||
25154172|NCT00634114|50269285|FG000|Overall Study|Other reason|1|||
24920304|NCT00532155|50013902|FG000|Overall Study|Study terminated by sponsor|1|||
24920305|NCT00532155|50013903|FG001|Overall Study|Study terminated by sponsor|0|||
24920306|NCT00532155|50013902|FG000|Overall Study|Study termination stop further treatment|4|||
24920307|NCT00532155|50013903|FG001|Overall Study|Study termination stop further treatment|0|||
24920308|NCT00532155|50013902|FG000|Overall Study|Did not receive study medication|2|||
24920309|NCT00532155|50013903|FG001|Overall Study|Did not receive study medication|6|||
24920310|NCT00205777|50013913|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
24920311|NCT00205777|50013914|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
24920312|NCT00205777|50013915|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
24920313|NCT00205777|50013916|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
24920314|NCT00205777|50013917|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
25154173|NCT00634114|50269286|FG001|Overall Study|Other reason|1|||
25154174|NCT00634114|50269287|FG002|Overall Study|Other reason|1|||
24920315|NCT00205777|50013918|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
24920316|NCT00205777|50013913|FG000|Core Study (Up to 3 Years)|Death|9|||
24920317|NCT00205777|50013914|FG001|Core Study (Up to 3 Years)|Death|7|||
24920318|NCT00205777|50013915|FG002|Core Study (Up to 3 Years)|Death|14|||
24920319|NCT00205777|50013916|FG003|Core Study (Up to 3 Years)|Death|7|||
24920320|NCT00205777|50013917|FG004|Core Study (Up to 3 Years)|Death|0|||
24920321|NCT00205777|50013918|FG005|Core Study (Up to 3 Years)|Death|0|||
24920322|NCT00205777|50013913|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
24920323|NCT00205777|50013914|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
24920324|NCT00205777|50013915|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
24920325|NCT00205777|50013916|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
25022451|NCT03034460|50119359|FG000|Overall Study|Adverse Event|0|||
24920326|NCT00205777|50013917|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
24920327|NCT00205777|50013918|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
24920328|NCT00205777|50013913|FG000|Core Study (Up to 3 Years)|Other Event|49|||
24920329|NCT00205777|50013914|FG001|Core Study (Up to 3 Years)|Other Event|52|||
24920330|NCT00205777|50013915|FG002|Core Study (Up to 3 Years)|Other Event|41|||
24920331|NCT00205777|50013916|FG003|Core Study (Up to 3 Years)|Other Event|58|||
24920332|NCT00205777|50013917|FG004|Core Study (Up to 3 Years)|Other Event|0|||
24920333|NCT00205777|50013918|FG005|Core Study (Up to 3 Years)|Other Event|0|||
24920334|NCT00205777|50013913|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
24920335|NCT00205777|50013914|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
24920336|NCT00205777|50013915|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
24920337|NCT00205777|50013916|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
24920338|NCT00205777|50013917|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
24920339|NCT00205777|50013918|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
24920340|NCT00205777|50013913|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
24920341|NCT00205777|50013914|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
24920342|NCT00205777|50013915|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
24920343|NCT00205777|50013916|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
24920344|NCT00205777|50013917|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
24920345|NCT00205777|50013918|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
24920346|NCT00205777|50013913|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
24920347|NCT00205777|50013914|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
24920348|NCT00205777|50013915|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
24920349|NCT00205777|50013916|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
24920350|NCT00205777|50013917|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
24920351|NCT00205777|50013918|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
24920352|NCT00205777|50013913|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
24920353|NCT00205777|50013914|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
24920354|NCT00205777|50013915|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
24920355|NCT00205777|50013916|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
24920356|NCT00205777|50013917|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
24920357|NCT00205777|50013918|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
24920358|NCT00205777|50013913|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
24920359|NCT00205777|50013914|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
24920360|NCT00205777|50013915|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
24920361|NCT00205777|50013916|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
24920362|NCT00205777|50013917|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
25022452|NCT03034460|50119360|FG001|Overall Study|Adverse Event|1|||
25154175|NCT00634036|50269297|FG000|Overall Study|Lost to Follow-up|1|||
25154176|NCT00634036|50269298|FG001|Overall Study|Lost to Follow-up|1|||
25154177|NCT00634036|50269297|FG000|Overall Study|Withdrawal by Subject|1|||
25154178|NCT00634036|50269298|FG001|Overall Study|Withdrawal by Subject|1|||
25154179|NCT01545375|50269306|FG000|Overall Study|Adverse Event|2|||
25154180|NCT01545375|50269307|FG001|Overall Study|Adverse Event|1|||
25154181|NCT01545375|50269306|FG000|Overall Study|Lost to Follow-up|34|||
25154182|NCT01545375|50269307|FG001|Overall Study|Lost to Follow-up|31|||
25154183|NCT01545375|50269306|FG000|Overall Study|Protocol Violation|3|||
25154184|NCT01545375|50269307|FG001|Overall Study|Protocol Violation|3|||
25154185|NCT01545375|50269306|FG000|Overall Study|Withdrawal by Subject|58|||
25154186|NCT01545375|50269307|FG001|Overall Study|Withdrawal by Subject|55|||
25154187|NCT01539837|50269316|FG000|Overall Study|reduce neutrophil level|0|||
25154188|NCT01539837|50269317|FG001|Overall Study|reduce neutrophil level|1|||
25154189|NCT01539837|50269318|FG002|Overall Study|reduce neutrophil level|1|||
25154190|NCT01539837|50269316|FG000|Overall Study|bad compliance|0|||
25154191|NCT01539837|50269317|FG001|Overall Study|bad compliance|0|||
25154192|NCT01539837|50269318|FG002|Overall Study|bad compliance|1|||
25154193|NCT01539759|50269328|FG000|Overall Study|Lost to Follow-up|6|||
25154194|NCT01539759|50269329|FG001|Overall Study|Lost to Follow-up|8|||
25154195|NCT00633022|50269338|FG000|Overall Study|Adverse Event|1|||
25154196|NCT00633022|50269339|FG001|Overall Study|Adverse Event|0|||
25154197|NCT00633022|50269340|FG002|Overall Study|Adverse Event|5|||
25154198|NCT00633022|50269338|FG000|Overall Study|Physician Decision|0|||
25154199|NCT00633022|50269339|FG001|Overall Study|Physician Decision|1|||
25154200|NCT00633022|50269340|FG002|Overall Study|Physician Decision|0|||
25154201|NCT00630994|50269348|FG000|Overall Study|Adverse Event|1|||
25154202|NCT00630994|50269348|FG000|Overall Study|Disease Progression|1|||
25154203|NCT00630994|50269348|FG000|Overall Study|Lack of Efficacy|1|||
25154204|NCT00630994|50269348|FG000|Overall Study|Other|1|||
25154205|NCT00630838|50269354|FG000|Overall Study|Death|0|||
25154206|NCT00630838|50269355|FG001|Overall Study|Death|1|||
25154207|NCT00630838|50269354|FG000|Overall Study|Lost to Follow-up|0|||
25154208|NCT00630838|50269355|FG001|Overall Study|Lost to Follow-up|1|||
25154209|NCT00630058|50269365|FG000|Overall Study|Adverse Event|1|||
25154210|NCT00630058|50269366|FG001|Overall Study|Adverse Event|1|||
25275039|NCT00903409|50589094|FG001|Overall Study|Adverse Event|9|||
24920363|NCT00205777|50013918|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
24920364|NCT00205777|50013913|FG000|Completed Core Study, Entered SE I|Other Event|52|||
25154211|NCT00630058|50269365|FG000|Overall Study|Withdrawal by Subject|0|||
24920365|NCT00205777|50013914|FG001|Completed Core Study, Entered SE I|Other Event|46|||
24920366|NCT00205777|50013915|FG002|Completed Core Study, Entered SE I|Other Event|47|||
24920367|NCT00205777|50013916|FG003|Completed Core Study, Entered SE I|Other Event|50|||
24920368|NCT00205777|50013917|FG004|Completed Core Study, Entered SE I|Other Event|0|||
24920369|NCT00205777|50013918|FG005|Completed Core Study, Entered SE I|Other Event|0|||
24920370|NCT00205777|50013913|FG000|Study Extension I|Adverse Event|57|||
24920371|NCT00205777|50013914|FG001|Study Extension I|Adverse Event|0|||
24920372|NCT00205777|50013915|FG002|Study Extension I|Adverse Event|0|||
24920373|NCT00205777|50013916|FG003|Study Extension I|Adverse Event|61|||
24920374|NCT00205777|50013917|FG004|Study Extension I|Adverse Event|58|||
24920375|NCT00205777|50013918|FG005|Study Extension I|Adverse Event|0|||
24920376|NCT00205777|50013913|FG000|Study Extension I|Death|5|||
24920377|NCT00205777|50013914|FG001|Study Extension I|Death|0|||
24920378|NCT00205777|50013915|FG002|Study Extension I|Death|0|||
24920379|NCT00205777|50013916|FG003|Study Extension I|Death|1|||
24920380|NCT00205777|50013917|FG004|Study Extension I|Death|2|||
24920381|NCT00205777|50013918|FG005|Study Extension I|Death|0|||
24920382|NCT00205777|50013913|FG000|Study Extension I|Withdrawal by Subject|99|||
24920383|NCT00205777|50013914|FG001|Study Extension I|Withdrawal by Subject|0|||
24920384|NCT00205777|50013915|FG002|Study Extension I|Withdrawal by Subject|0|||
24920385|NCT00205777|50013916|FG003|Study Extension I|Withdrawal by Subject|106|||
24920386|NCT00205777|50013917|FG004|Study Extension I|Withdrawal by Subject|89|||
24920387|NCT00205777|50013918|FG005|Study Extension I|Withdrawal by Subject|0|||
24920388|NCT00205777|50013913|FG000|Study Extension I|Protocol Violation|4|||
24920389|NCT00205777|50013914|FG001|Study Extension I|Protocol Violation|0|||
24920390|NCT00205777|50013915|FG002|Study Extension I|Protocol Violation|0|||
24920391|NCT00205777|50013916|FG003|Study Extension I|Protocol Violation|8|||
24920392|NCT00205777|50013917|FG004|Study Extension I|Protocol Violation|8|||
24920393|NCT00205777|50013918|FG005|Study Extension I|Protocol Violation|0|||
24920394|NCT00205777|50013913|FG000|Study Extension I|Lack of Efficacy|0|||
24920395|NCT00205777|50013914|FG001|Study Extension I|Lack of Efficacy|0|||
24920396|NCT00205777|50013915|FG002|Study Extension I|Lack of Efficacy|0|||
24920397|NCT00205777|50013916|FG003|Study Extension I|Lack of Efficacy|1|||
24920398|NCT00205777|50013917|FG004|Study Extension I|Lack of Efficacy|2|||
24920399|NCT00205777|50013918|FG005|Study Extension I|Lack of Efficacy|0|||
24920400|NCT00205777|50013913|FG000|Study Extension I|Failed to return|15|||
24920401|NCT00205777|50013914|FG001|Study Extension I|Failed to return|0|||
24920402|NCT00205777|50013915|FG002|Study Extension I|Failed to return|0|||
24920403|NCT00205777|50013916|FG003|Study Extension I|Failed to return|17|||
24920404|NCT00205777|50013917|FG004|Study Extension I|Failed to return|13|||
24920405|NCT00205777|50013918|FG005|Study Extension I|Failed to return|0|||
24920406|NCT00205777|50013913|FG000|Study Extension I|Other Event|34|||
24920407|NCT00205777|50013914|FG001|Study Extension I|Other Event|0|||
24920408|NCT00205777|50013915|FG002|Study Extension I|Other Event|0|||
24920409|NCT00205777|50013916|FG003|Study Extension I|Other Event|34|||
24920410|NCT00205777|50013917|FG004|Study Extension I|Other Event|29|||
24920411|NCT00205777|50013918|FG005|Study Extension I|Other Event|0|||
24920412|NCT00205777|50013913|FG000|Study Extension I|Withdrawn as per protocol|0|||
24920413|NCT00205777|50013914|FG001|Study Extension I|Withdrawn as per protocol|0|||
24920414|NCT00205777|50013915|FG002|Study Extension I|Withdrawn as per protocol|1070|||
24920415|NCT00205777|50013916|FG003|Study Extension I|Withdrawn as per protocol|0|||
25022453|NCT03034460|50119359|FG000|Overall Study|Withdrawal by Subject|2|||
25022454|NCT03034460|50119360|FG001|Overall Study|Withdrawal by Subject|2|||
25022455|NCT03034460|50119359|FG000|Overall Study|Personal Reasons|1|||
25022456|NCT03034460|50119360|FG001|Overall Study|Personal Reasons|0|||
25022457|NCT04162769|50119373|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
25022458|NCT04162769|50119374|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
25022459|NCT04162769|50119375|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
25022460|NCT04162769|50119376|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
25022461|NCT04162769|50119373|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
25022462|NCT04162769|50119374|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
25022463|NCT04162769|50119375|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
25022464|NCT04162769|50119376|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
25154212|NCT00630058|50269366|FG001|Overall Study|Withdrawal by Subject|1|||
24920416|NCT00205777|50013917|FG004|Study Extension I|Withdrawn as per protocol|0|||
24920417|NCT00205777|50013918|FG005|Study Extension I|Withdrawn as per protocol|0|||
24920418|NCT00205777|50013913|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
24920419|NCT00205777|50013914|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
24920420|NCT00205777|50013915|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
24920421|NCT00205777|50013916|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
24920422|NCT00205777|50013917|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
24920423|NCT00205777|50013918|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
24920424|NCT00205777|50013913|FG000|Study Extension II|Adverse Event|0|||
24920425|NCT00205777|50013914|FG001|Study Extension II|Adverse Event|0|||
24920426|NCT00205777|50013915|FG002|Study Extension II|Adverse Event|0|||
24920427|NCT00205777|50013916|FG003|Study Extension II|Adverse Event|14|||
24920428|NCT00205777|50013917|FG004|Study Extension II|Adverse Event|0|||
24920429|NCT00205777|50013918|FG005|Study Extension II|Adverse Event|30|||
24920430|NCT00205777|50013913|FG000|Study Extension II|Death|0|||
24920431|NCT00205777|50013914|FG001|Study Extension II|Death|0|||
24920432|NCT00205777|50013915|FG002|Study Extension II|Death|0|||
24920433|NCT00205777|50013916|FG003|Study Extension II|Death|2|||
24920434|NCT00205777|50013917|FG004|Study Extension II|Death|0|||
24920435|NCT00205777|50013918|FG005|Study Extension II|Death|5|||
24920436|NCT00205777|50013913|FG000|Study Extension II|Withdrawal by Subject|0|||
24920437|NCT00205777|50013914|FG001|Study Extension II|Withdrawal by Subject|0|||
24920438|NCT00205777|50013915|FG002|Study Extension II|Withdrawal by Subject|0|||
24920439|NCT00205777|50013916|FG003|Study Extension II|Withdrawal by Subject|35|||
24920440|NCT00205777|50013917|FG004|Study Extension II|Withdrawal by Subject|0|||
24920441|NCT00205777|50013918|FG005|Study Extension II|Withdrawal by Subject|59|||
24920442|NCT00205777|50013913|FG000|Study Extension II|Protocol Violation|0|||
24920443|NCT00205777|50013914|FG001|Study Extension II|Protocol Violation|0|||
24920444|NCT00205777|50013915|FG002|Study Extension II|Protocol Violation|0|||
24920445|NCT00205777|50013916|FG003|Study Extension II|Protocol Violation|1|||
24920446|NCT00205777|50013917|FG004|Study Extension II|Protocol Violation|0|||
24920447|NCT00205777|50013918|FG005|Study Extension II|Protocol Violation|10|||
24920448|NCT00205777|50013913|FG000|Study Extension II|Lack of Efficacy|0|||
24920449|NCT00205777|50013914|FG001|Study Extension II|Lack of Efficacy|0|||
24920450|NCT00205777|50013915|FG002|Study Extension II|Lack of Efficacy|0|||
24920451|NCT00205777|50013916|FG003|Study Extension II|Lack of Efficacy|0|||
24920452|NCT00205777|50013917|FG004|Study Extension II|Lack of Efficacy|0|||
24920453|NCT00205777|50013918|FG005|Study Extension II|Lack of Efficacy|1|||
24920454|NCT00205777|50013913|FG000|Study Extension II|Failed to return|0|||
24920455|NCT00205777|50013914|FG001|Study Extension II|Failed to return|0|||
24920456|NCT00205777|50013915|FG002|Study Extension II|Failed to return|0|||
24920457|NCT00205777|50013916|FG003|Study Extension II|Failed to return|14|||
24920458|NCT00205777|50013917|FG004|Study Extension II|Failed to return|0|||
24920459|NCT00205777|50013918|FG005|Study Extension II|Failed to return|26|||
24920460|NCT00205777|50013913|FG000|Study Extension II|Other Event|0|||
24920461|NCT00205777|50013914|FG001|Study Extension II|Other Event|0|||
24920462|NCT00205777|50013915|FG002|Study Extension II|Other Event|0|||
24920463|NCT00205777|50013916|FG003|Study Extension II|Other Event|12|||
24920464|NCT00205777|50013917|FG004|Study Extension II|Other Event|0|||
24920465|NCT00205777|50013918|FG005|Study Extension II|Other Event|20|||
24920466|NCT00205777|50013913|FG000|Study Extension II|Enrolled but not treated|0|||
24920467|NCT00205777|50013914|FG001|Study Extension II|Enrolled but not treated|0|||
24920468|NCT00205777|50013915|FG002|Study Extension II|Enrolled but not treated|0|||
24920469|NCT00205777|50013916|FG003|Study Extension II|Enrolled but not treated|71|||
24920470|NCT00205777|50013917|FG004|Study Extension II|Enrolled but not treated|0|||
24920471|NCT00205777|50013918|FG005|Study Extension II|Enrolled but not treated|131|||
24920472|NCT00483652|50013935|FG000|Double-blind Treatment Period|Protocol Violation|2|||
24920473|NCT00483652|50013936|FG001|Double-blind Treatment Period|Protocol Violation|1|||
24920474|NCT00483652|50013935|FG000|Double-blind Treatment Period|Adverse Event|3|||
24920475|NCT00483652|50013936|FG001|Double-blind Treatment Period|Adverse Event|4|||
24920476|NCT00483652|50013935|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
24920477|NCT00483652|50013936|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
24920478|NCT00483652|50013935|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
24920479|NCT00483652|50013936|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
24920480|NCT00483574|50013944|FG000|Overall Study|Adverse Event|6|||
24920481|NCT00483574|50013945|FG001|Overall Study|Adverse Event|0|||
24920482|NCT00483574|50013944|FG000|Overall Study|Protocol Violation|28|||
24920483|NCT00483574|50013945|FG001|Overall Study|Protocol Violation|9|||
24920484|NCT00483574|50013944|FG000|Overall Study|Lost to Follow-up|16|||
24920485|NCT00483574|50013945|FG001|Overall Study|Lost to Follow-up|4|||
24920486|NCT00483574|50013944|FG000|Overall Study|Withdrawal by Subject|52|||
24920487|NCT00483574|50013945|FG001|Overall Study|Withdrawal by Subject|0|||
24920488|NCT00483184|50013956|FG000|Overall Study|Withdrawal by Subject|2|||
24920489|NCT00483184|50013957|FG001|Overall Study|Withdrawal by Subject|2|||
24920490|NCT00483184|50013958|FG002|Overall Study|Withdrawal by Subject|0|||
24920491|NCT00483184|50013956|FG000|Overall Study|Lost to Follow-up|1|||
24920492|NCT00483184|50013957|FG001|Overall Study|Lost to Follow-up|0|||
24920493|NCT00483184|50013958|FG002|Overall Study|Lost to Follow-up|0|||
24920494|NCT00483184|50013956|FG000|Overall Study|Adverse Event|1|||
24920495|NCT00483184|50013957|FG001|Overall Study|Adverse Event|2|||
24920496|NCT00483184|50013958|FG002|Overall Study|Adverse Event|2|||
24920497|NCT00483184|50013956|FG000|Overall Study|Protocol Violation|1|||
24920498|NCT00483184|50013957|FG001|Overall Study|Protocol Violation|0|||
24920499|NCT00483184|50013958|FG002|Overall Study|Protocol Violation|1|||
24920500|NCT00482170|50013968|FG000|Overall Study|Adverse Event|5|||
24920501|NCT00482170|50013969|FG001|Overall Study|Adverse Event|14|||
24920502|NCT00482170|50013968|FG000|Overall Study|Withdrawal by Subject|6|||
24920503|NCT00482170|50013969|FG001|Overall Study|Withdrawal by Subject|1|||
24920504|NCT00482170|50013968|FG000|Overall Study|Protocol Violation|2|||
24920505|NCT00482170|50013969|FG001|Overall Study|Protocol Violation|3|||
24920506|NCT00482170|50013968|FG000|Overall Study|Lost to Follow-up|2|||
24920507|NCT00482170|50013969|FG001|Overall Study|Lost to Follow-up|0|||
24920508|NCT00482170|50013968|FG000|Overall Study|Unspecified reason|0|||
24920509|NCT00482170|50013969|FG001|Overall Study|Unspecified reason|2|||
24920510|NCT03883113|50013977|FG000|Overall Study|Physician Decision|4|||
24920511|NCT03883113|50013978|FG001|Overall Study|Physician Decision|2|||
24920512|NCT03883113|50013977|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
24920513|NCT03883113|50013978|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
24920514|NCT03883113|50013977|FG000|Overall Study|Pregnancy|1|||
24920515|NCT03883113|50013978|FG001|Overall Study|Pregnancy|0|||
24920516|NCT03883113|50013977|FG000|Overall Study|Adverse Event|0|||
24920517|NCT03883113|50013978|FG001|Overall Study|Adverse Event|1|||
24920518|NCT03883113|50013977|FG000|Overall Study|Withdrawal by Subject|1|||
24920519|NCT03883113|50013978|FG001|Overall Study|Withdrawal by Subject|2|||
24920520|NCT03883113|50013977|FG000|Overall Study|Lost to Follow-up|1|||
24920521|NCT03883113|50013978|FG001|Overall Study|Lost to Follow-up|0|||
24920522|NCT04218695|50014000|FG000|Overall Study|Adverse Event|1|||
24920523|NCT04218695|50014001|FG001|Overall Study|Adverse Event|0|||
24920524|NCT00490282|50014007|FG000|Overall Study|Withdrawal by Subject|3|||
24920525|NCT00615056|50014016|FG000|Overall Study|Death|31|||
24920526|NCT00615056|50014017|FG001|Overall Study|Death|31|||
24920527|NCT00615056|50014018|FG002|Overall Study|Death|21|||
24920528|NCT00615056|50014019|FG003|Overall Study|Death|23|||
24920529|NCT00615056|50014016|FG000|Overall Study|Lost to Follow-up|1|||
24920530|NCT00615056|50014017|FG001|Overall Study|Lost to Follow-up|2|||
24920531|NCT00615056|50014018|FG002|Overall Study|Lost to Follow-up|4|||
24920532|NCT00615056|50014019|FG003|Overall Study|Lost to Follow-up|5|||
24920533|NCT00615056|50014016|FG000|Overall Study|Other|13|||
24920534|NCT00615056|50014017|FG001|Overall Study|Other|15|||
24920535|NCT00615056|50014018|FG002|Overall Study|Other|10|||
24920536|NCT00615056|50014019|FG003|Overall Study|Other|7|||
24920537|NCT00615056|50014016|FG000|Overall Study|Objective progression or relapse|0|||
24920538|NCT00615056|50014017|FG001|Overall Study|Objective progression or relapse|2|||
24920539|NCT00615056|50014018|FG002|Overall Study|Objective progression or relapse|0|||
24920540|NCT00615056|50014019|FG003|Overall Study|Objective progression or relapse|0|||
24920541|NCT00615056|50014016|FG000|Overall Study|Withdrawal by Subject|0|||
24920542|NCT00615056|50014017|FG001|Overall Study|Withdrawal by Subject|1|||
24920543|NCT00615056|50014018|FG002|Overall Study|Withdrawal by Subject|1|||
24920544|NCT00615056|50014019|FG003|Overall Study|Withdrawal by Subject|0|||
24920545|NCT00615056|50014016|FG000|Overall Study|Discontinued by Sponsor|1|||
24920546|NCT00615056|50014017|FG001|Overall Study|Discontinued by Sponsor|0|||
24920547|NCT00615056|50014018|FG002|Overall Study|Discontinued by Sponsor|0|||
24920548|NCT00615056|50014019|FG003|Overall Study|Discontinued by Sponsor|0|||
24920549|NCT00615056|50014016|FG000|Overall Study|Randomized but not treated|3|||
24920550|NCT00615056|50014017|FG001|Overall Study|Randomized but not treated|0|||
24920551|NCT00615056|50014018|FG002|Overall Study|Randomized but not treated|0|||
24920552|NCT00615056|50014019|FG003|Overall Study|Randomized but not treated|0|||
24920553|NCT00482014|50014033|FG000|Overall Study|Withdrawal by Subject|1|||
24920554|NCT00482014|50014034|FG001|Overall Study|Withdrawal by Subject|2|||
24920555|NCT00482014|50014035|FG002|Overall Study|Withdrawal by Subject|3|||
25154213|NCT00630058|50269365|FG000|Overall Study|stopping criteria|3|||
25154214|NCT00630058|50269366|FG001|Overall Study|stopping criteria|2|||
25154215|NCT01925794|50269372|FG000|180 Days|Death|2|||
25022465|NCT04162769|50119373|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
25022466|NCT04162769|50119374|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
25022467|NCT04162769|50119375|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
25022468|NCT04162769|50119376|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
25022469|NCT04162769|50119373|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
25185059|NCT00249795|50334152|FG000|Overall Study|Lightheadedness / dizziness|15|||
24920556|NCT00482014|50014036|FG003|Overall Study|Withdrawal by Subject|4|||
24920557|NCT00482014|50014033|FG000|Overall Study|Adverse Event|3|||
24920558|NCT00482014|50014034|FG001|Overall Study|Adverse Event|0|||
24920559|NCT00482014|50014035|FG002|Overall Study|Adverse Event|2|||
24920560|NCT00482014|50014036|FG003|Overall Study|Adverse Event|8|||
24920561|NCT00482014|50014033|FG000|Overall Study|Death|1|||
24920562|NCT00482014|50014034|FG001|Overall Study|Death|2|||
24920563|NCT00482014|50014035|FG002|Overall Study|Death|1|||
24920564|NCT00482014|50014036|FG003|Overall Study|Death|4|||
24920565|NCT00482014|50014033|FG000|Overall Study|Lack of Efficacy|1|||
24920566|NCT00482014|50014034|FG001|Overall Study|Lack of Efficacy|0|||
24920567|NCT00482014|50014035|FG002|Overall Study|Lack of Efficacy|4|||
24920568|NCT00482014|50014036|FG003|Overall Study|Lack of Efficacy|6|||
24920569|NCT00482014|50014033|FG000|Overall Study|Sponsor Decision|1|||
24920570|NCT00482014|50014034|FG001|Overall Study|Sponsor Decision|2|||
24920571|NCT00482014|50014035|FG002|Overall Study|Sponsor Decision|1|||
24920572|NCT00482014|50014036|FG003|Overall Study|Sponsor Decision|1|||
24920573|NCT03595553|50014050|FG000|Overall Study|Withdrawal by Subject|20|||
24920574|NCT03595553|50014051|FG001|Overall Study|Withdrawal by Subject|8|||
24920575|NCT03595553|50014050|FG000|Overall Study|Physician Decision|3|||
24920576|NCT03595553|50014051|FG001|Overall Study|Physician Decision|2|||
24920577|NCT03595553|50014050|FG000|Overall Study|Adverse Event|2|||
24920578|NCT03595553|50014051|FG001|Overall Study|Adverse Event|5|||
24920579|NCT03595553|50014050|FG000|Overall Study|Death|24|||
24920580|NCT03595553|50014051|FG001|Overall Study|Death|22|||
24920581|NCT03595553|50014050|FG000|Overall Study|Lost to Follow-up|6|||
24920582|NCT03595553|50014051|FG001|Overall Study|Lost to Follow-up|7|||
24920583|NCT03595553|50014050|FG000|Overall Study|Other as indicated in CSR|3|||
24920584|NCT03595553|50014051|FG001|Overall Study|Other as indicated in CSR|3|||
24920585|NCT03595553|50014050|FG000|Overall Study|Sponsor Decision|0|||
24920586|NCT03595553|50014051|FG001|Overall Study|Sponsor Decision|1|||
24920587|NCT00614822|50014057|FG000|Overall Study|Adverse Event|3|||
24920588|NCT00529659|50014064|FG000|Overall Study|Adverse Event|8|||
24920589|NCT00529659|50014065|FG001|Overall Study|Adverse Event|7|||
24920590|NCT00529659|50014064|FG000|Overall Study|Lost to Follow-up|0|||
24920591|NCT00529659|50014065|FG001|Overall Study|Lost to Follow-up|2|||
24920592|NCT00529659|50014064|FG000|Overall Study|Physician Decision|0|||
24920593|NCT00529659|50014065|FG001|Overall Study|Physician Decision|2|||
24920594|NCT00529659|50014064|FG000|Overall Study|Protocol Violation|2|||
24920595|NCT00529659|50014065|FG001|Overall Study|Protocol Violation|6|||
24920596|NCT00529659|50014064|FG000|Overall Study|Withdrawal by Subject|1|||
24920597|NCT00529659|50014065|FG001|Overall Study|Withdrawal by Subject|6|||
24920598|NCT03569891|50014071|FG000|Lead-in|Ineligible during lead-in|8|||
24920599|NCT03569891|50014071|FG000|Lead-in|Withdrawal by Subject|3|||
24920600|NCT03569891|50014071|FG000|Lead-in|Risks related to COVID-19|2|||
24920601|NCT03569891|50014071|FG000|AMT-061|Adverse Event|1|||
24920602|NCT00143455|50014084|FG000|Cohort 1|Adverse Event|8|||
24920603|NCT00143455|50014085|FG001|Cohort 1|Adverse Event|4|||
24920604|NCT00143455|50014086|FG002|Cohort 1|Adverse Event|0|||
24920605|NCT00143455|50014087|FG003|Cohort 1|Adverse Event|0|||
24920606|NCT00143455|50014084|FG000|Cohort 1|Death|5|||
24920607|NCT00143455|50014085|FG001|Cohort 1|Death|2|||
24920608|NCT00143455|50014086|FG002|Cohort 1|Death|0|||
25022470|NCT04162769|50119374|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
25022471|NCT04162769|50119375|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
25022472|NCT04162769|50119376|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
25022473|NCT04162769|50119373|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
24920609|NCT00143455|50014087|FG003|Cohort 1|Death|0|||
24920610|NCT00143455|50014084|FG000|Cohort 1|Progressive Disease|0|||
24920611|NCT00143455|50014085|FG001|Cohort 1|Progressive Disease|6|||
24920612|NCT00143455|50014086|FG002|Cohort 1|Progressive Disease|0|||
24920613|NCT00143455|50014087|FG003|Cohort 1|Progressive Disease|0|||
24920614|NCT00143455|50014084|FG000|Cohort 1|Withdrawal by Subject|1|||
24920615|NCT00143455|50014085|FG001|Cohort 1|Withdrawal by Subject|4|||
24920616|NCT00143455|50014086|FG002|Cohort 1|Withdrawal by Subject|0|||
24920617|NCT00143455|50014087|FG003|Cohort 1|Withdrawal by Subject|0|||
24920618|NCT00143455|50014084|FG000|Cohort 1|Randomized But Not Treated|0|||
24920619|NCT00143455|50014085|FG001|Cohort 1|Randomized But Not Treated|1|||
24920620|NCT00143455|50014086|FG002|Cohort 1|Randomized But Not Treated|0|||
25022474|NCT04162769|50119374|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
25022475|NCT04162769|50119375|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
25022476|NCT04162769|50119376|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
25022477|NCT04162769|50119373|FG000|Double-blind Treatment (12-Week)|Other|0|||
25022478|NCT04162769|50119374|FG001|Double-blind Treatment (12-Week)|Other|1|||
25022479|NCT04162769|50119375|FG002|Double-blind Treatment (12-Week)|Other|1|||
25022480|NCT04162769|50119376|FG003|Double-blind Treatment (12-Week)|Other|0|||
25022481|NCT04162769|50119373|FG000|OLE Period (52-Week)|Adverse Event|0|||
25022482|NCT04162769|50119374|FG001|OLE Period (52-Week)|Adverse Event|0|||
25022483|NCT04162769|50119375|FG002|OLE Period (52-Week)|Adverse Event|0|||
25022484|NCT04162769|50119376|FG003|OLE Period (52-Week)|Adverse Event|5|||
25022485|NCT04162769|50119373|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
24920621|NCT00143455|50014087|FG003|Cohort 1|Randomized But Not Treated|0|||
24920622|NCT00143455|50014084|FG000|Cohort 2|Adverse Event|0|||
24920623|NCT00143455|50014085|FG001|Cohort 2|Adverse Event|0|||
24920624|NCT00143455|50014086|FG002|Cohort 2|Adverse Event|42|||
24920625|NCT00143455|50014087|FG003|Cohort 2|Adverse Event|30|||
24920626|NCT00143455|50014084|FG000|Cohort 2|No Longer Required Study Treatment|0|||
24920627|NCT00143455|50014085|FG001|Cohort 2|No Longer Required Study Treatment|0|||
25022486|NCT04162769|50119374|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
24920628|NCT00143455|50014086|FG002|Cohort 2|No Longer Required Study Treatment|1|||
24920629|NCT00143455|50014087|FG003|Cohort 2|No Longer Required Study Treatment|0|||
24920630|NCT00143455|50014084|FG000|Cohort 2|Protocol Violation|0|||
24920631|NCT00143455|50014085|FG001|Cohort 2|Protocol Violation|0|||
24920632|NCT00143455|50014086|FG002|Cohort 2|Protocol Violation|1|||
24920633|NCT00143455|50014087|FG003|Cohort 2|Protocol Violation|1|||
24920634|NCT00143455|50014084|FG000|Cohort 2|Lost to Follow-up|0|||
24920635|NCT00143455|50014085|FG001|Cohort 2|Lost to Follow-up|0|||
24920636|NCT00143455|50014086|FG002|Cohort 2|Lost to Follow-up|1|||
24920637|NCT00143455|50014087|FG003|Cohort 2|Lost to Follow-up|4|||
24920638|NCT00143455|50014084|FG000|Cohort 2|Death|0|||
24920639|NCT00143455|50014085|FG001|Cohort 2|Death|0|||
24920640|NCT00143455|50014086|FG002|Cohort 2|Death|20|||
24920641|NCT00143455|50014087|FG003|Cohort 2|Death|12|||
24920642|NCT00143455|50014084|FG000|Cohort 2|Progressive Disease|0|||
24920643|NCT00143455|50014085|FG001|Cohort 2|Progressive Disease|0|||
24920644|NCT00143455|50014086|FG002|Cohort 2|Progressive Disease|20|||
24920645|NCT00143455|50014087|FG003|Cohort 2|Progressive Disease|27|||
24920646|NCT00143455|50014084|FG000|Cohort 2|Withdrawal by Subject|0|||
24920647|NCT00143455|50014085|FG001|Cohort 2|Withdrawal by Subject|0|||
24920648|NCT00143455|50014086|FG002|Cohort 2|Withdrawal by Subject|13|||
24920649|NCT00143455|50014087|FG003|Cohort 2|Withdrawal by Subject|12|||
24920650|NCT00143455|50014084|FG000|Cohort 2|Other|0|||
24920651|NCT00143455|50014085|FG001|Cohort 2|Other|0|||
24920652|NCT00143455|50014086|FG002|Cohort 2|Other|7|||
24920653|NCT00143455|50014087|FG003|Cohort 2|Other|6|||
24920654|NCT00143455|50014084|FG000|Cohort 2|Randomized But Not Treated|0|||
24920655|NCT00143455|50014085|FG001|Cohort 2|Randomized But Not Treated|0|||
24920656|NCT00143455|50014086|FG002|Cohort 2|Randomized But Not Treated|1|||
24920657|NCT00143455|50014087|FG003|Cohort 2|Randomized But Not Treated|1|||
24920658|NCT03529955|50014099|FG000|Overall Study|Adverse Event|1|||
24920659|NCT03529955|50014099|FG000|Overall Study|Lack of Efficacy|1|||
24920660|NCT00142909|50014115|FG000|Randomization|Various Reasons|7|||
24920661|NCT00142909|50014116|FG001|Randomization|Various Reasons|10|||
24920662|NCT00142909|50014115|FG000|Medications Begin|Protocol Violation|2|||
24920663|NCT00142909|50014116|FG001|Medications Begin|Protocol Violation|0|||
24920664|NCT00142909|50014115|FG000|Medications Begin|Withdrawal by Subject|5|||
24920665|NCT00142909|50014116|FG001|Medications Begin|Withdrawal by Subject|3|||
24920666|NCT00142909|50014115|FG000|Medications Begin|Withdrawal by Subject|2|||
24920667|NCT00142909|50014116|FG001|Medications Begin|Withdrawal by Subject|0|||
24920668|NCT00205699|50014125|FG000|Overall Study|Lost to Follow-up|1|||
24920669|NCT00205699|50014126|FG001|Overall Study|Lost to Follow-up|3|||
24920670|NCT00205699|50014127|FG002|Overall Study|Lost to Follow-up|5|||
24920671|NCT00205699|50014125|FG000|Overall Study|Adverse Event|1|||
24920672|NCT00205699|50014126|FG001|Overall Study|Adverse Event|0|||
24920673|NCT00205699|50014127|FG002|Overall Study|Adverse Event|0|||
24920674|NCT00205699|50014125|FG000|Overall Study|Withdrawal by Subject|1|||
24920675|NCT00205699|50014126|FG001|Overall Study|Withdrawal by Subject|2|||
24920676|NCT00205699|50014127|FG002|Overall Study|Withdrawal by Subject|1|||
24920677|NCT00205699|50014125|FG000|Overall Study|Lack of Efficacy|0|||
24920678|NCT00205699|50014126|FG001|Overall Study|Lack of Efficacy|1|||
24920679|NCT00205699|50014127|FG002|Overall Study|Lack of Efficacy|0|||
24920680|NCT03882801|50014140|FG000|Period 1|Adverse Event|0|||
24920681|NCT03882801|50014141|FG001|Period 1|Adverse Event|1|||
24920682|NCT03882801|50014140|FG000|Period 1|Non-compliance with study drug|1|||
24920683|NCT03882801|50014141|FG001|Period 1|Non-compliance with study drug|1|||
24920684|NCT03882801|50014140|FG000|Period 1|Never treated with study drug|1|||
24920685|NCT03882801|50014141|FG001|Period 1|Never treated with study drug|0|||
24920686|NCT03882801|50014140|FG000|Washout Period|Physician Decision|0|||
24920687|NCT03882801|50014141|FG001|Washout Period|Physician Decision|1|||
24920688|NCT03882801|50014140|FG000|Period 2|Non-compliance with study drug|0|||
24920689|NCT03882801|50014141|FG001|Period 2|Non-compliance with study drug|1|||
24920690|NCT03880227|50014151|FG000|First Visit|Withdrawal by Subject|1|||
24920691|NCT03880227|50014152|FG001|First Visit|Withdrawal by Subject|0|||
24920692|NCT03880227|50014153|FG002|First Visit|Withdrawal by Subject|0|||
24920693|NCT03880227|50014154|FG003|First Visit|Withdrawal by Subject|0|||
24920694|NCT03880227|50014151|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
24920695|NCT03880227|50014152|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
24920696|NCT03880227|50014153|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
24920697|NCT03880227|50014154|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
24920698|NCT03880227|50014151|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
24920699|NCT03880227|50014152|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
24920700|NCT03880227|50014153|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
24920701|NCT03880227|50014154|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
24920702|NCT03880227|50014151|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
24920703|NCT03880227|50014152|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
24920704|NCT03880227|50014153|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
24920705|NCT03880227|50014154|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
24920706|NCT00530439|50014178|FG000|Overall Study|GDM|9|||
24920707|NCT00530439|50014179|FG001|Overall Study|GDM|3|||
24920708|NCT00530439|50014178|FG000|Overall Study|Withdraw|18|||
24920709|NCT00530439|50014179|FG001|Overall Study|Withdraw|14|||
24920710|NCT00530439|50014178|FG000|Overall Study|Missed abortion|1|||
24920711|NCT00530439|50014179|FG001|Overall Study|Missed abortion|4|||
24920712|NCT00530439|50014178|FG000|Overall Study|Misclassification|2|||
24920713|NCT00530439|50014179|FG001|Overall Study|Misclassification|0|||
24920714|NCT00530439|50014178|FG000|Overall Study|Twin pregnancy|0|||
24920715|NCT00530439|50014179|FG001|Overall Study|Twin pregnancy|2|||
24920716|NCT00530439|50014178|FG000|Overall Study|Severe malformation/abortion|0|||
24920717|NCT00530439|50014179|FG001|Overall Study|Severe malformation/abortion|3|||
24920718|NCT00497146|50014187|FG000|Treatment Period|Adverse Event|6|||
24920719|NCT00497146|50014188|FG001|Treatment Period|Adverse Event|2|||
24920720|NCT00497146|50014187|FG000|Treatment Period|Withdrawal by Subject|5|||
24920721|NCT00497146|50014188|FG001|Treatment Period|Withdrawal by Subject|9|||
24920722|NCT00497146|50014187|FG000|Treatment Period|Lost to Follow-up|1|||
24920723|NCT00497146|50014188|FG001|Treatment Period|Lost to Follow-up|3|||
24920724|NCT00497146|50014187|FG000|Treatment Period|Required dialysis|4|||
24920725|NCT00497146|50014188|FG001|Treatment Period|Required dialysis|1|||
24920726|NCT00497146|50014187|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
24920727|NCT00497146|50014188|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
24920728|NCT00497146|50014187|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
24920729|NCT00497146|50014188|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
24920730|NCT00497146|50014187|FG000|Treatment Period|Other Reason|2|||
24920731|NCT00497146|50014188|FG001|Treatment Period|Other Reason|3|||
24920732|NCT00497146|50014187|FG000|Long-term Follow-up Period|Adverse Event|2|||
24920733|NCT00497146|50014188|FG001|Long-term Follow-up Period|Adverse Event|2|||
24920734|NCT00497146|50014187|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
24920735|NCT00497146|50014188|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
24920736|NCT00497146|50014187|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
24920737|NCT00497146|50014188|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
24920738|NCT00497146|50014187|FG000|Long-term Follow-up Period|Other|0|||
24920739|NCT00497146|50014188|FG001|Long-term Follow-up Period|Other|1|||
24920740|NCT00489970|50014199|FG000|Persistence Year 9|Lost to Follow-up|2|||
24920741|NCT00489970|50014200|FG001|Persistence Year 9|Lost to Follow-up|2|||
24920742|NCT00489970|50014201|FG002|Persistence Year 9|Lost to Follow-up|3|||
24920743|NCT00489970|50014199|FG000|Persistence Year 9|Other|1|||
24920744|NCT00489970|50014200|FG001|Persistence Year 9|Other|0|||
24920745|NCT00489970|50014201|FG002|Persistence Year 9|Other|2|||
24920746|NCT02798471|50014214|FG000|Overall Study|Adverse Event|7|||
24920747|NCT02798471|50014215|FG001|Overall Study|Adverse Event|2|||
24920748|NCT02798471|50014214|FG000|Overall Study|Physician Decision|3|||
24920749|NCT02798471|50014215|FG001|Overall Study|Physician Decision|7|||
24920750|NCT02798471|50014214|FG000|Overall Study|Death|2|||
24920751|NCT02798471|50014215|FG001|Overall Study|Death|3|||
24920752|NCT02798471|50014214|FG000|Overall Study|Lost to Follow-up|0|||
24920753|NCT02798471|50014215|FG001|Overall Study|Lost to Follow-up|1|||
24920754|NCT02798471|50014214|FG000|Overall Study|Other|5|||
24920755|NCT02798471|50014215|FG001|Overall Study|Other|3|||
24920756|NCT02798471|50014214|FG000|Overall Study|Subject withdrew consent|0|||
24920757|NCT02798471|50014215|FG001|Overall Study|Subject withdrew consent|6|||
24920758|NCT02798471|50014214|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
24920759|NCT02798471|50014215|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
24920760|NCT02798471|50014214|FG000|Overall Study|Randomized, but not treated|0|||
24920761|NCT02798471|50014215|FG001|Overall Study|Randomized, but not treated|2|||
24920762|NCT00489736|50014223|FG000|Overall Study|Lack of Efficacy|53|||
24920763|NCT00489736|50014224|FG001|Overall Study|Lack of Efficacy|14|||
24920764|NCT00489736|50014223|FG000|Overall Study|Adverse Event|32|||
24920765|NCT00489736|50014224|FG001|Overall Study|Adverse Event|45|||
24920766|NCT00489736|50014223|FG000|Overall Study|Poor compliance|6|||
24920767|NCT00489736|50014224|FG001|Overall Study|Poor compliance|2|||
24920768|NCT00489736|50014223|FG000|Overall Study|Not coded/ Not pre-specified|5|||
24920769|NCT00489736|50014224|FG001|Overall Study|Not coded/ Not pre-specified|8|||
24920770|NCT00617084|50014232|FG000|Overall Study|Withdrawal by Subject|5|||
24920771|NCT00617084|50014233|FG001|Overall Study|Withdrawal by Subject|7|||
24920772|NCT00617084|50014232|FG000|Overall Study|Missed 12 Months visit|16|||
24920773|NCT00617084|50014233|FG001|Overall Study|Missed 12 Months visit|19|||
24920774|NCT00489424|50014242|FG000|Overall Study|Adverse Event|3|||
24920775|NCT00489424|50014243|FG001|Overall Study|Adverse Event|3|||
24920776|NCT00489424|50014244|FG002|Overall Study|Adverse Event|4|||
24920777|NCT00489424|50014242|FG000|Overall Study|Lack of Efficacy|1|||
24920778|NCT00489424|50014243|FG001|Overall Study|Lack of Efficacy|0|||
24920779|NCT00489424|50014244|FG002|Overall Study|Lack of Efficacy|0|||
24920780|NCT00489424|50014242|FG000|Overall Study|Administrative problems|0|||
24920781|NCT00489424|50014243|FG001|Overall Study|Administrative problems|2|||
24920782|NCT00489424|50014244|FG002|Overall Study|Administrative problems|1|||
24920783|NCT00614744|50014254|FG000|Overall Study|Lost to Follow-up|5|||
24920784|NCT00614744|50014255|FG001|Overall Study|Lost to Follow-up|4|||
24920785|NCT00614744|50014254|FG000|Overall Study|Incomplete for Behavior Issues|0|||
24920786|NCT00614744|50014255|FG001|Overall Study|Incomplete for Behavior Issues|2|||
24920787|NCT00565812|50014264|FG000|Overall Study|Death|2|||
24920788|NCT00565812|50014265|FG001|Overall Study|Death|1|||
24920789|NCT00565812|50014266|FG002|Overall Study|Death|3|||
24920790|NCT00565812|50014264|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
24920791|NCT00565812|50014265|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
24920792|NCT00565812|50014266|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
24920793|NCT00565812|50014264|FG000|Overall Study|Lost to Follow-up|10|||
24920794|NCT00565812|50014265|FG001|Overall Study|Lost to Follow-up|8|||
24920795|NCT00565812|50014266|FG002|Overall Study|Lost to Follow-up|8|||
24920796|NCT00565812|50014264|FG000|Overall Study|Withdrawal by Subject|58|||
24920797|NCT00565812|50014265|FG001|Overall Study|Withdrawal by Subject|47|||
24920798|NCT00565812|50014266|FG002|Overall Study|Withdrawal by Subject|48|||
24920799|NCT00565812|50014264|FG000|Overall Study|Work Schedule|5|||
24920800|NCT00565812|50014265|FG001|Overall Study|Work Schedule|3|||
24920801|NCT00565812|50014266|FG002|Overall Study|Work Schedule|1|||
24920802|NCT00565812|50014264|FG000|Overall Study|Protocol Violation|2|||
24920803|NCT00565812|50014265|FG001|Overall Study|Protocol Violation|6|||
24920804|NCT00565812|50014266|FG002|Overall Study|Protocol Violation|4|||
24920805|NCT00565812|50014264|FG000|Overall Study|Adverse Event|41|||
24920806|NCT00565812|50014265|FG001|Overall Study|Adverse Event|54|||
24920807|NCT00565812|50014266|FG002|Overall Study|Adverse Event|40|||
24920808|NCT00565812|50014264|FG000|Overall Study|Jury Duty|1|||
24920809|NCT00565812|50014265|FG001|Overall Study|Jury Duty|0|||
24920810|NCT00565812|50014266|FG002|Overall Study|Jury Duty|0|||
24920811|NCT00565812|50014264|FG000|Overall Study|Relocated Out of Area|5|||
24920812|NCT00565812|50014265|FG001|Overall Study|Relocated Out of Area|8|||
24920813|NCT00565812|50014266|FG002|Overall Study|Relocated Out of Area|9|||
24920814|NCT00565812|50014264|FG000|Overall Study|Sponsor Decision|1|||
24920815|NCT00565812|50014265|FG001|Overall Study|Sponsor Decision|5|||
24920816|NCT00565812|50014266|FG002|Overall Study|Sponsor Decision|1|||
24920817|NCT00565812|50014264|FG000|Overall Study|Domestic Reasons|7|||
24920818|NCT00565812|50014265|FG001|Overall Study|Domestic Reasons|1|||
24920819|NCT00565812|50014266|FG002|Overall Study|Domestic Reasons|3|||
24920820|NCT00565812|50014264|FG000|Overall Study|Research Site Closure|6|||
24920821|NCT00565812|50014265|FG001|Overall Study|Research Site Closure|1|||
24920822|NCT00565812|50014266|FG002|Overall Study|Research Site Closure|8|||
24920823|NCT00565812|50014264|FG000|Overall Study|Surgical Intervention|0|||
24920824|NCT00565812|50014265|FG001|Overall Study|Surgical Intervention|1|||
24920825|NCT00565812|50014266|FG002|Overall Study|Surgical Intervention|2|||
24920826|NCT00565812|50014264|FG000|Overall Study|Low Compliance|1|||
24920827|NCT00565812|50014265|FG001|Overall Study|Low Compliance|0|||
24920828|NCT00565812|50014266|FG002|Overall Study|Low Compliance|1|||
24920829|NCT00565812|50014264|FG000|Overall Study|Follow-up Visit Not Completed|2|||
24920830|NCT00565812|50014265|FG001|Overall Study|Follow-up Visit Not Completed|0|||
24920831|NCT00565812|50014266|FG002|Overall Study|Follow-up Visit Not Completed|1|||
24920832|NCT00565812|50014264|FG000|Overall Study|Physician Decision|2|||
24920833|NCT00565812|50014265|FG001|Overall Study|Physician Decision|0|||
24920834|NCT00565812|50014266|FG002|Overall Study|Physician Decision|0|||
24920835|NCT03974334|50014274|FG000|Overall Study|Lost to Follow-up|1|||
24920836|NCT03970824|50014281|FG000|Overall Study|Withdrawal by Subject|1|||
24920837|NCT03970824|50014282|FG001|Overall Study|Withdrawal by Subject|1|||
24920838|NCT03970824|50014283|FG002|Overall Study|Withdrawal by Subject|3|||
24920839|NCT03970824|50014281|FG000|Overall Study|Lost to Follow-up|0|||
24920840|NCT03970824|50014282|FG001|Overall Study|Lost to Follow-up|2|||
24920841|NCT03970824|50014283|FG002|Overall Study|Lost to Follow-up|1|||
24920842|NCT03970824|50014281|FG000|Overall Study|Adverse Event|1|||
24920843|NCT03970824|50014282|FG001|Overall Study|Adverse Event|0|||
24920844|NCT03970824|50014283|FG002|Overall Study|Adverse Event|0|||
24920845|NCT00564486|50014294|FG000|Overall Study|Adverse Event|0|||
24920846|NCT00564486|50014295|FG001|Overall Study|Adverse Event|1|||
24920847|NCT00564486|50014296|FG002|Overall Study|Adverse Event|0|||
24920848|NCT00564486|50014297|FG003|Overall Study|Adverse Event|0|||
24920849|NCT00564486|50014294|FG000|Overall Study|Withdrawal by Subject|4|||
24920850|NCT00564486|50014295|FG001|Overall Study|Withdrawal by Subject|0|||
24920851|NCT00564486|50014296|FG002|Overall Study|Withdrawal by Subject|0|||
24920852|NCT00564486|50014297|FG003|Overall Study|Withdrawal by Subject|5|||
24920853|NCT00564486|50014294|FG000|Overall Study|Subject refused to have blood drawn|0|||
24920854|NCT00564486|50014295|FG001|Overall Study|Subject refused to have blood drawn|0|||
24920855|NCT00564486|50014296|FG002|Overall Study|Subject refused to have blood drawn|1|||
24920856|NCT00564486|50014297|FG003|Overall Study|Subject refused to have blood drawn|0|||
24920857|NCT00564486|50014294|FG000|Overall Study|Lost to Follow-up|3|||
24920858|NCT00564486|50014295|FG001|Overall Study|Lost to Follow-up|0|||
24920859|NCT00564486|50014296|FG002|Overall Study|Lost to Follow-up|2|||
25022487|NCT04162769|50119375|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
25022488|NCT04162769|50119376|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
25022489|NCT04162769|50119373|FG000|OLE Period (52-Week)|Physician Decision|0|||
25022490|NCT04162769|50119374|FG001|OLE Period (52-Week)|Physician Decision|0|||
25022491|NCT04162769|50119375|FG002|OLE Period (52-Week)|Physician Decision|0|||
25022492|NCT04162769|50119376|FG003|OLE Period (52-Week)|Physician Decision|1|||
25022493|NCT04162769|50119373|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
25022494|NCT04162769|50119374|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
25022495|NCT04162769|50119375|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
25022496|NCT04162769|50119376|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
25022497|NCT04162769|50119373|FG000|OLE Period (52-Week)|Protocol deviation|0|||
25022498|NCT04162769|50119374|FG001|OLE Period (52-Week)|Protocol deviation|0|||
25022499|NCT04162769|50119375|FG002|OLE Period (52-Week)|Protocol deviation|0|||
25022500|NCT04162769|50119376|FG003|OLE Period (52-Week)|Protocol deviation|2|||
25022501|NCT04161131|50119387|FG000|Overall Study|Ineligible|2|||
25022502|NCT04161131|50119387|FG000|Overall Study|Lost to Follow-up|4|||
25022503|NCT04155047|50119393|FG000|Overall Study|Adverse Event|1|||
25022504|NCT04155047|50119394|FG001|Overall Study|Adverse Event|0|||
25022505|NCT04155047|50119393|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
25022506|NCT04155047|50119394|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
24920860|NCT00564486|50014297|FG003|Overall Study|Lost to Follow-up|2|||
24920861|NCT00481078|50014313|FG000|Overall Study|Progression of disease|11|||
25022507|NCT04152083|50119402|FG000|Overall Study|Lost to Follow-up|2|||
25022508|NCT04152083|50119403|FG001|Overall Study|Lost to Follow-up|1|||
25022509|NCT04152083|50119402|FG000|Overall Study|Adverse Event|1|||
25022510|NCT04152083|50119403|FG001|Overall Study|Adverse Event|0|||
25022511|NCT04152083|50119402|FG000|Overall Study|Randomized but not treated|3|||
25022512|NCT04152083|50119403|FG001|Overall Study|Randomized but not treated|2|||
25022513|NCT02711956|50119424|FG000|Overall Study|Adverse Event|0|||
25022514|NCT02711956|50119425|FG001|Overall Study|Adverse Event|0|||
25022515|NCT02711956|50119426|FG002|Overall Study|Adverse Event|0|||
25022516|NCT02711956|50119427|FG003|Overall Study|Adverse Event|1|||
25022517|NCT02711956|50119428|FG004|Overall Study|Adverse Event|2|||
25022518|NCT02711956|50119429|FG005|Overall Study|Adverse Event|0|||
25022519|NCT02711956|50119430|FG006|Overall Study|Adverse Event|0|||
25022520|NCT02711956|50119431|FG007|Overall Study|Adverse Event|1|||
25022521|NCT02711956|50119432|FG008|Overall Study|Adverse Event|1|||
25022522|NCT02711956|50119433|FG009|Overall Study|Adverse Event|1|||
24920862|NCT00481078|50014314|FG001|Overall Study|Progression of disease|11|||
24920863|NCT00481078|50014313|FG000|Overall Study|Adverse Event|15|||
24920864|NCT00481078|50014314|FG001|Overall Study|Adverse Event|3|||
24920865|NCT00481078|50014313|FG000|Overall Study|Death|5|||
24920866|NCT00481078|50014314|FG001|Overall Study|Death|3|||
24920867|NCT00481078|50014313|FG000|Overall Study|Intercurrent illness|1|||
24920868|NCT00481078|50014314|FG001|Overall Study|Intercurrent illness|0|||
24920869|NCT00481078|50014313|FG000|Overall Study|Withdrawal by Subject|7|||
25022523|NCT02711956|50119434|FG010|Overall Study|Adverse Event|1|||
25022524|NCT02711956|50119435|FG011|Overall Study|Adverse Event|0|||
24920870|NCT00481078|50014314|FG001|Overall Study|Withdrawal by Subject|1|||
24920871|NCT00481078|50014313|FG000|Overall Study|Information not available|1|||
24920872|NCT00481078|50014314|FG001|Overall Study|Information not available|0|||
24920873|NCT00481078|50014313|FG000|Overall Study|Received other treatment|2|||
24920874|NCT00481078|50014314|FG001|Overall Study|Received other treatment|1|||
25022525|NCT02711956|50119436|FG012|Overall Study|Adverse Event|0|||
25022526|NCT02711956|50119437|FG013|Overall Study|Adverse Event|0|||
25022527|NCT02711956|50119438|FG014|Overall Study|Adverse Event|2|||
25022528|NCT02711956|50119424|FG000|Overall Study|Physician Decision|0|||
25022529|NCT02711956|50119425|FG001|Overall Study|Physician Decision|0|||
24920875|NCT00481078|50014313|FG000|Overall Study|Brain metastasis|0|||
24920876|NCT00481078|50014314|FG001|Overall Study|Brain metastasis|1|||
24920877|NCT00480532|50014324|FG000|Overall Study|Withdrawal by Subject|2|||
24920878|NCT00480532|50014325|FG001|Overall Study|Withdrawal by Subject|4|||
24920879|NCT00480532|50014326|FG002|Overall Study|Withdrawal by Subject|3|||
24920880|NCT00480532|50014327|FG003|Overall Study|Withdrawal by Subject|1|||
25154216|NCT01925794|50269372|FG000|180 Days|Withdrawal by Subject|2|||
25154217|NCT01925794|50269372|FG000|270 Days|Death|2|||
25154218|NCT01925794|50269372|FG000|270 Days|Protocol Violation|3|||
25154219|NCT00989950|50269384|FG000|Randomized Phase|Protocol Violation|1|||
25154220|NCT00989950|50269385|FG001|Randomized Phase|Protocol Violation|0|||
25154221|NCT00989950|50269386|FG002|Randomized Phase|Protocol Violation|0|||
25154222|NCT00989950|50269387|FG003|Randomized Phase|Protocol Violation|0|||
25154223|NCT00989950|50269384|FG000|Randomized Phase|Adverse Event|0|||
25154224|NCT00989950|50269385|FG001|Randomized Phase|Adverse Event|1|||
25154225|NCT00989950|50269386|FG002|Randomized Phase|Adverse Event|0|||
25154226|NCT00989950|50269387|FG003|Randomized Phase|Adverse Event|0|||
25154227|NCT01905943|50269397|FG000|Overall Study|Withdrawal of consent|90|||
25154228|NCT01905943|50269397|FG000|Overall Study|Lost to Follow-up|16|||
25154229|NCT01905943|50269397|FG000|Overall Study|Investigator discretion|7|||
25154230|NCT01905943|50269397|FG000|Overall Study|Death|186|||
25154231|NCT01905943|50269397|FG000|Overall Study|Adverse Event|3|||
25154232|NCT01905943|50269397|FG000|Overall Study|Other|12|||
25154233|NCT01905553|50269418|FG000|Period 2|Adverse Event|1|||
25154234|NCT01905553|50269419|FG001|Period 2|Adverse Event|0|||
25154235|NCT01929031|50269429|FG000|Overall Study|Adverse Event|3|||
25154236|NCT01929031|50269430|FG001|Overall Study|Adverse Event|1|||
25154237|NCT01929031|50269431|FG002|Overall Study|Adverse Event|1|||
25154238|NCT01929031|50269432|FG003|Overall Study|Adverse Event|0|||
25154239|NCT01929031|50269433|FG004|Overall Study|Adverse Event|0|||
25154240|NCT01929031|50269434|FG005|Overall Study|Adverse Event|0|||
25154241|NCT01929031|50269429|FG000|Overall Study|Protocol Violation|1|||
25154242|NCT01929031|50269430|FG001|Overall Study|Protocol Violation|0|||
25154243|NCT01929031|50269431|FG002|Overall Study|Protocol Violation|0|||
25154244|NCT01929031|50269432|FG003|Overall Study|Protocol Violation|0|||
25185060|NCT00249795|50334153|FG001|Overall Study|Lightheadedness / dizziness|11|||
24920881|NCT00480532|50014324|FG000|Overall Study|Protocol Violation|0|||
24920882|NCT00480532|50014325|FG001|Overall Study|Protocol Violation|0|||
24920883|NCT00480532|50014326|FG002|Overall Study|Protocol Violation|1|||
24920884|NCT00480532|50014327|FG003|Overall Study|Protocol Violation|0|||
24920885|NCT00496366|50014337|FG000|Overall Study|Death|1|||
24920886|NCT00488644|50014341|FG000|Overall Study|Not Eligible|1|||
24920887|NCT00488644|50014341|FG000|Overall Study|Not Evaluable|1|||
24920888|NCT00564018|50014348|FG000|Overall Study|Withdrawal by Subject|2|||
25022530|NCT02711956|50119426|FG002|Overall Study|Physician Decision|0|||
25022531|NCT02711956|50119427|FG003|Overall Study|Physician Decision|2|||
25022532|NCT02711956|50119428|FG004|Overall Study|Physician Decision|0|||
25022533|NCT02711956|50119429|FG005|Overall Study|Physician Decision|0|||
25022534|NCT02711956|50119430|FG006|Overall Study|Physician Decision|0|||
25022535|NCT02711956|50119431|FG007|Overall Study|Physician Decision|0|||
25022536|NCT02711956|50119432|FG008|Overall Study|Physician Decision|0|||
25022537|NCT02711956|50119433|FG009|Overall Study|Physician Decision|0|||
25022538|NCT02711956|50119434|FG010|Overall Study|Physician Decision|0|||
25022539|NCT02711956|50119435|FG011|Overall Study|Physician Decision|0|||
25022540|NCT02711956|50119436|FG012|Overall Study|Physician Decision|0|||
25022541|NCT02711956|50119437|FG013|Overall Study|Physician Decision|0|||
25022542|NCT02711956|50119438|FG014|Overall Study|Physician Decision|0|||
25022543|NCT02711956|50119424|FG000|Overall Study|Withdrawal by Subject|0|||
25022544|NCT02711956|50119425|FG001|Overall Study|Withdrawal by Subject|0|||
25022545|NCT02711956|50119426|FG002|Overall Study|Withdrawal by Subject|0|||
25022546|NCT02711956|50119427|FG003|Overall Study|Withdrawal by Subject|0|||
25022547|NCT02711956|50119428|FG004|Overall Study|Withdrawal by Subject|0|||
25022548|NCT02711956|50119429|FG005|Overall Study|Withdrawal by Subject|0|||
25022549|NCT02711956|50119430|FG006|Overall Study|Withdrawal by Subject|1|||
25022550|NCT02711956|50119431|FG007|Overall Study|Withdrawal by Subject|0|||
25022551|NCT02711956|50119432|FG008|Overall Study|Withdrawal by Subject|0|||
25022552|NCT02711956|50119433|FG009|Overall Study|Withdrawal by Subject|0|||
25022553|NCT02711956|50119434|FG010|Overall Study|Withdrawal by Subject|0|||
25154245|NCT01929031|50269433|FG004|Overall Study|Protocol Violation|0|||
25154246|NCT01929031|50269434|FG005|Overall Study|Protocol Violation|1|||
25154247|NCT01929031|50269429|FG000|Overall Study|Reason other than specified above|0|||
25154248|NCT01929031|50269430|FG001|Overall Study|Reason other than specified above|1|||
25154249|NCT01929031|50269431|FG002|Overall Study|Reason other than specified above|0|||
25154250|NCT01929031|50269432|FG003|Overall Study|Reason other than specified above|0|||
24920889|NCT00564018|50014349|FG001|Overall Study|Withdrawal by Subject|3|||
24920890|NCT00564018|50014350|FG002|Overall Study|Withdrawal by Subject|1|||
24920891|NCT03381287|50014362|FG000|Overall Study|Withdrawal by Subject|0|||
25022554|NCT02711956|50119435|FG011|Overall Study|Withdrawal by Subject|1|||
25022555|NCT02711956|50119436|FG012|Overall Study|Withdrawal by Subject|6|||
25022556|NCT02711956|50119437|FG013|Overall Study|Withdrawal by Subject|0|||
25022557|NCT02711956|50119438|FG014|Overall Study|Withdrawal by Subject|1|||
25022558|NCT02711956|50119424|FG000|Overall Study|Clinical progression|1|||
25022559|NCT02711956|50119425|FG001|Overall Study|Clinical progression|0|||
25022560|NCT02711956|50119426|FG002|Overall Study|Clinical progression|0|||
25022561|NCT02711956|50119427|FG003|Overall Study|Clinical progression|0|||
25022562|NCT02711956|50119428|FG004|Overall Study|Clinical progression|0|||
25022563|NCT02711956|50119429|FG005|Overall Study|Clinical progression|0|||
25022564|NCT02711956|50119430|FG006|Overall Study|Clinical progression|1|||
25022565|NCT02711956|50119431|FG007|Overall Study|Clinical progression|0|||
25022566|NCT02711956|50119432|FG008|Overall Study|Clinical progression|1|||
25022567|NCT02711956|50119433|FG009|Overall Study|Clinical progression|0|||
25022568|NCT02711956|50119434|FG010|Overall Study|Clinical progression|0|||
25022569|NCT02711956|50119435|FG011|Overall Study|Clinical progression|2|||
25022570|NCT02711956|50119436|FG012|Overall Study|Clinical progression|4|||
25022571|NCT02711956|50119437|FG013|Overall Study|Clinical progression|1|||
25022572|NCT02711956|50119438|FG014|Overall Study|Clinical progression|1|||
25022573|NCT02711956|50119424|FG000|Overall Study|Radiographic progression|1|||
25154251|NCT01929031|50269433|FG004|Overall Study|Reason other than specified above|1|||
25154252|NCT01929031|50269434|FG005|Overall Study|Reason other than specified above|0|||
25154253|NCT00989092|50269446|FG000|Overall Study|Physician Decision|9|||
25154254|NCT00989092|50269447|FG001|Overall Study|Physician Decision|6|||
25154255|NCT00989092|50269446|FG000|Overall Study|Adverse Event|20|||
25154256|NCT00989092|50269447|FG001|Overall Study|Adverse Event|1|||
25154257|NCT00989092|50269446|FG000|Overall Study|Chemotherapy initiated|12|||
25154258|NCT00989092|50269447|FG001|Overall Study|Chemotherapy initiated|4|||
25154259|NCT00989092|50269446|FG000|Overall Study|Withdrawal by Subject|17|||
25154260|NCT00989092|50269447|FG001|Overall Study|Withdrawal by Subject|9|||
25022574|NCT02711956|50119425|FG001|Overall Study|Radiographic progression|1|||
25022575|NCT02711956|50119426|FG002|Overall Study|Radiographic progression|2|||
25022576|NCT02711956|50119427|FG003|Overall Study|Radiographic progression|0|||
25022577|NCT02711956|50119428|FG004|Overall Study|Radiographic progression|1|||
25022578|NCT02711956|50119429|FG005|Overall Study|Radiographic progression|0|||
25022579|NCT02711956|50119430|FG006|Overall Study|Radiographic progression|0|||
25022580|NCT02711956|50119431|FG007|Overall Study|Radiographic progression|0|||
25022581|NCT02711956|50119432|FG008|Overall Study|Radiographic progression|2|||
25022582|NCT02711956|50119433|FG009|Overall Study|Radiographic progression|1|||
25022583|NCT02711956|50119434|FG010|Overall Study|Radiographic progression|0|||
25022584|NCT02711956|50119435|FG011|Overall Study|Radiographic progression|5|||
25022585|NCT02711956|50119436|FG012|Overall Study|Radiographic progression|3|||
25022586|NCT02711956|50119437|FG013|Overall Study|Radiographic progression|0|||
25022587|NCT02711956|50119438|FG014|Overall Study|Radiographic progression|1|||
25022588|NCT02711956|50119424|FG000|Overall Study|PSA progression with clinical progression|0|||
25022589|NCT02711956|50119425|FG001|Overall Study|PSA progression with clinical progression|0|||
25022590|NCT02711956|50119426|FG002|Overall Study|PSA progression with clinical progression|0|||
25022591|NCT02711956|50119427|FG003|Overall Study|PSA progression with clinical progression|0|||
25022592|NCT02711956|50119428|FG004|Overall Study|PSA progression with clinical progression|1|||
25022593|NCT02711956|50119429|FG005|Overall Study|PSA progression with clinical progression|0|||
25022594|NCT02711956|50119430|FG006|Overall Study|PSA progression with clinical progression|0|||
25022595|NCT02711956|50119431|FG007|Overall Study|PSA progression with clinical progression|0|||
25022596|NCT02711956|50119432|FG008|Overall Study|PSA progression with clinical progression|0|||
25022597|NCT02711956|50119433|FG009|Overall Study|PSA progression with clinical progression|0|||
25022598|NCT02711956|50119434|FG010|Overall Study|PSA progression with clinical progression|0|||
25022599|NCT02711956|50119435|FG011|Overall Study|PSA progression with clinical progression|0|||
25022600|NCT02711956|50119436|FG012|Overall Study|PSA progression with clinical progression|1|||
25022601|NCT02711956|50119437|FG013|Overall Study|PSA progression with clinical progression|1|||
25022602|NCT02711956|50119438|FG014|Overall Study|PSA progression with clinical progression|0|||
25022603|NCT02711956|50119424|FG000|Overall Study|PSA progression with radiographic progression|0|||
25022604|NCT02711956|50119425|FG001|Overall Study|PSA progression with radiographic progression|1|||
25022605|NCT02711956|50119426|FG002|Overall Study|PSA progression with radiographic progression|0|||
25022606|NCT02711956|50119427|FG003|Overall Study|PSA progression with radiographic progression|0|||
25022607|NCT02711956|50119428|FG004|Overall Study|PSA progression with radiographic progression|0|||
25022608|NCT02711956|50119429|FG005|Overall Study|PSA progression with radiographic progression|2|||
25154261|NCT00989092|50269446|FG000|Overall Study|Death|14|||
25154262|NCT00989092|50269447|FG001|Overall Study|Death|2|||
25154263|NCT00989092|50269446|FG000|Overall Study|Ineligibility determined|3|||
25022609|NCT02711956|50119430|FG006|Overall Study|PSA progression with radiographic progression|2|||
25154264|NCT00989092|50269447|FG001|Overall Study|Ineligibility determined|3|||
25022610|NCT02711956|50119431|FG007|Overall Study|PSA progression with radiographic progression|1|||
25022611|NCT02711956|50119432|FG008|Overall Study|PSA progression with radiographic progression|0|||
25022612|NCT02711956|50119433|FG009|Overall Study|PSA progression with radiographic progression|1|||
25022613|NCT02711956|50119434|FG010|Overall Study|PSA progression with radiographic progression|0|||
25022614|NCT02711956|50119435|FG011|Overall Study|PSA progression with radiographic progression|1|||
25022615|NCT02711956|50119436|FG012|Overall Study|PSA progression with radiographic progression|2|||
25022616|NCT02711956|50119437|FG013|Overall Study|PSA progression with radiographic progression|3|||
25022617|NCT02711956|50119438|FG014|Overall Study|PSA progression with radiographic progression|3|||
25022618|NCT04149353|50119479|FG000|Overall Study|Study terminated|1|||
25022619|NCT02711800|50119484|FG000|Overall Study|Lost to Follow-up|1|||
25022620|NCT02711800|50119484|FG000|Overall Study|Withdrawal by Subject|1|||
25022621|NCT03031496|50119488|FG000|Period 1|Adverse Event|2|||
25022622|NCT03031496|50119489|FG001|Period 1|Adverse Event|0|||
25022623|NCT03031496|50119488|FG000|Period 1|Withdrawal by Subject|0|||
25022624|NCT03031496|50119489|FG001|Period 1|Withdrawal by Subject|2|||
25022625|NCT02659020|50119502|FG000|Overall Study|Adverse Event|0|||
25022626|NCT02659020|50119503|FG001|Overall Study|Adverse Event|0|||
25022627|NCT02659020|50119504|FG002|Overall Study|Adverse Event|0|||
25022628|NCT02659020|50119505|FG003|Overall Study|Adverse Event|2|||
25022629|NCT02659020|50119506|FG004|Overall Study|Adverse Event|0|||
25022630|NCT02659020|50119507|FG005|Overall Study|Adverse Event|0|||
25022631|NCT02659020|50119508|FG006|Overall Study|Adverse Event|2|||
25022632|NCT02659020|50119502|FG000|Overall Study|Lost to Follow-up|1|||
25022633|NCT02659020|50119503|FG001|Overall Study|Lost to Follow-up|2|||
25022634|NCT02659020|50119504|FG002|Overall Study|Lost to Follow-up|1|||
25022635|NCT02659020|50119505|FG003|Overall Study|Lost to Follow-up|6|||
25022636|NCT02659020|50119506|FG004|Overall Study|Lost to Follow-up|1|||
25022637|NCT02659020|50119507|FG005|Overall Study|Lost to Follow-up|5|||
25022638|NCT02659020|50119508|FG006|Overall Study|Lost to Follow-up|0|||
25022639|NCT02659020|50119502|FG000|Overall Study|Physician Decision|0|||
25022640|NCT02659020|50119503|FG001|Overall Study|Physician Decision|0|||
25022641|NCT02659020|50119504|FG002|Overall Study|Physician Decision|0|||
25022642|NCT02659020|50119505|FG003|Overall Study|Physician Decision|1|||
25022643|NCT02659020|50119506|FG004|Overall Study|Physician Decision|1|||
25022644|NCT02659020|50119507|FG005|Overall Study|Physician Decision|0|||
25022645|NCT02659020|50119508|FG006|Overall Study|Physician Decision|1|||
25022646|NCT02659020|50119502|FG000|Overall Study|Withdrawal by Subject|2|||
25022647|NCT02659020|50119503|FG001|Overall Study|Withdrawal by Subject|1|||
25022648|NCT02659020|50119504|FG002|Overall Study|Withdrawal by Subject|0|||
25022649|NCT02659020|50119505|FG003|Overall Study|Withdrawal by Subject|3|||
25022650|NCT02659020|50119506|FG004|Overall Study|Withdrawal by Subject|3|||
25022651|NCT02659020|50119507|FG005|Overall Study|Withdrawal by Subject|6|||
25022652|NCT02659020|50119508|FG006|Overall Study|Withdrawal by Subject|3|||
25022653|NCT02659020|50119502|FG000|Overall Study|Progressive Disease|0|||
25022654|NCT02659020|50119503|FG001|Overall Study|Progressive Disease|0|||
25022655|NCT02659020|50119504|FG002|Overall Study|Progressive Disease|0|||
25022656|NCT02659020|50119505|FG003|Overall Study|Progressive Disease|4|||
25022657|NCT02659020|50119506|FG004|Overall Study|Progressive Disease|1|||
25022658|NCT02659020|50119507|FG005|Overall Study|Progressive Disease|0|||
25022659|NCT02659020|50119508|FG006|Overall Study|Progressive Disease|2|||
25022660|NCT03482011|50119533|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
25022661|NCT03482011|50119534|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
25022662|NCT03482011|50119535|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
25022663|NCT03482011|50119536|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
25022664|NCT03482011|50119537|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
25022665|NCT03482011|50119538|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
25022666|NCT03482011|50119539|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
25022667|NCT03482011|50119540|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
25022668|NCT03482011|50119533|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
25022669|NCT03482011|50119534|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
25022670|NCT03482011|50119535|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
25022671|NCT03482011|50119536|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
25022672|NCT03482011|50119537|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
25022673|NCT03482011|50119538|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
25022674|NCT03482011|50119539|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
25154265|NCT00989092|50269446|FG000|Overall Study|Lost to Follow-up|6|||
25154266|NCT00989092|50269447|FG001|Overall Study|Lost to Follow-up|2|||
25022675|NCT03482011|50119540|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
25022676|NCT03482011|50119533|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
25022677|NCT03482011|50119534|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
25022678|NCT03482011|50119535|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
25022679|NCT03482011|50119536|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
25022680|NCT03482011|50119537|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
25022681|NCT03482011|50119538|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
25022682|NCT03482011|50119539|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
25022683|NCT03482011|50119540|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
25022684|NCT03482011|50119533|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
25022685|NCT03482011|50119534|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
25022686|NCT03482011|50119535|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
25022687|NCT03482011|50119536|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
25022688|NCT03482011|50119537|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
25022689|NCT03482011|50119538|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
25022690|NCT03482011|50119539|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
25022691|NCT03482011|50119540|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
25022692|NCT03482011|50119533|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
25022693|NCT03482011|50119534|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
25022694|NCT03482011|50119535|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
25022695|NCT03482011|50119536|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
25022696|NCT03482011|50119537|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
25022697|NCT03482011|50119538|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
25022698|NCT03482011|50119539|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
25022699|NCT03482011|50119540|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
25022700|NCT03482011|50119533|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
25022701|NCT03482011|50119534|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
25022702|NCT03482011|50119535|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
25022703|NCT03482011|50119536|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
25022704|NCT03482011|50119537|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
25022705|NCT03482011|50119538|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
25022706|NCT03482011|50119539|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
25022707|NCT03482011|50119540|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
25022708|NCT03482011|50119533|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
25022709|NCT03482011|50119534|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
25022710|NCT03482011|50119535|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
25022711|NCT03482011|50119536|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
25022712|NCT03482011|50119537|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
25022713|NCT03482011|50119538|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
25022714|NCT03482011|50119539|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
25022715|NCT03482011|50119540|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
25022716|NCT03482011|50119533|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
25022717|NCT03482011|50119534|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
25022718|NCT03482011|50119535|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
25022719|NCT03482011|50119536|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
25022720|NCT03482011|50119537|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
25022721|NCT03482011|50119538|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
25022722|NCT03482011|50119539|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
25022723|NCT03482011|50119540|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
25022724|NCT03482011|50119533|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
25022725|NCT03482011|50119534|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
25022726|NCT03482011|50119535|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
25022727|NCT03482011|50119536|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
25022728|NCT03482011|50119537|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
25022729|NCT03482011|50119538|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
25022730|NCT03482011|50119539|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
25022731|NCT03482011|50119540|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
25022732|NCT03482011|50119533|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
25022733|NCT03482011|50119534|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
25022734|NCT03482011|50119535|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
25022735|NCT03482011|50119536|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
25022736|NCT03482011|50119537|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
25022737|NCT03482011|50119538|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
25022738|NCT03482011|50119539|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
25022739|NCT03482011|50119540|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
25022740|NCT03482011|50119533|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
25022741|NCT03482011|50119534|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
25022742|NCT03482011|50119535|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
25022743|NCT03482011|50119536|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
25022744|NCT03482011|50119537|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
25022745|NCT03482011|50119538|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
25022746|NCT03482011|50119539|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
25022747|NCT03482011|50119540|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
25022748|NCT03482011|50119533|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
25022749|NCT03482011|50119534|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
25022750|NCT03482011|50119535|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
25022751|NCT03482011|50119536|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
25022752|NCT03482011|50119537|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
25022753|NCT03482011|50119538|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
25022754|NCT03482011|50119539|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
25022755|NCT03482011|50119540|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
25022756|NCT03482011|50119533|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
25022757|NCT03482011|50119534|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
25022758|NCT03482011|50119535|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
25022759|NCT03482011|50119536|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
25022760|NCT03482011|50119537|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
25022761|NCT03482011|50119538|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
25022762|NCT03482011|50119539|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
25022763|NCT03482011|50119540|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
25022764|NCT03482011|50119533|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
25022765|NCT03482011|50119534|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
25022766|NCT03482011|50119535|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
25022767|NCT03482011|50119536|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
25022768|NCT03482011|50119537|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
25022769|NCT03482011|50119538|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
25022770|NCT03482011|50119539|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
25022771|NCT03482011|50119540|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
25022772|NCT03482011|50119533|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
25022773|NCT03482011|50119534|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
25022774|NCT03482011|50119535|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
25022775|NCT03482011|50119536|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
25022776|NCT03482011|50119537|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
25022777|NCT03482011|50119538|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
25022778|NCT03482011|50119539|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
25022779|NCT03482011|50119540|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
25022780|NCT03481309|50119571|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
25022781|NCT03481309|50119572|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
25022782|NCT03481309|50119573|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
25022783|NCT03481309|50119574|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
25022784|NCT03481309|50119575|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
25022785|NCT03481309|50119576|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
25022786|NCT03480841|50119584|FG000|Overall Study|Lost to Follow-up|2|||
25022787|NCT02709538|50119591|FG000|Overall Study|Adverse Event|13|||
25022788|NCT02709538|50119592|FG001|Overall Study|Adverse Event|2|||
25022789|NCT02709538|50119593|FG002|Overall Study|Adverse Event|3|||
25022790|NCT02709538|50119591|FG000|Overall Study|Lack of Efficacy|1|||
25022791|NCT02709538|50119592|FG001|Overall Study|Lack of Efficacy|0|||
25022792|NCT02709538|50119593|FG002|Overall Study|Lack of Efficacy|0|||
25022793|NCT02709538|50119591|FG000|Overall Study|Lost to Follow-up|24|||
25022794|NCT02709538|50119592|FG001|Overall Study|Lost to Follow-up|8|||
25022795|NCT02709538|50119593|FG002|Overall Study|Lost to Follow-up|4|||
25022796|NCT02709538|50119591|FG000|Overall Study|Physician Decision|1|||
25022797|NCT02709538|50119592|FG001|Overall Study|Physician Decision|0|||
25022798|NCT02709538|50119593|FG002|Overall Study|Physician Decision|0|||
25022799|NCT02709538|50119591|FG000|Overall Study|Withdrawal by Subject|40|||
25022800|NCT02709538|50119592|FG001|Overall Study|Withdrawal by Subject|7|||
25022801|NCT02709538|50119593|FG002|Overall Study|Withdrawal by Subject|4|||
25154267|NCT00989092|50269446|FG000|Overall Study|Other|3|||
25154268|NCT00989092|50269447|FG001|Overall Study|Other|1|||
25154269|NCT00989092|50269446|FG000|Overall Study|Protocol deviation|2|||
25154270|NCT00989092|50269447|FG001|Overall Study|Protocol deviation|0|||
25154271|NCT00989092|50269446|FG000|Overall Study|Erythropoietin therapy initiated|2|||
25154272|NCT00989092|50269447|FG001|Overall Study|Erythropoietin therapy initiated|0|||
25154273|NCT00989092|50269446|FG000|Overall Study|Did not receive study drug|2|||
25154274|NCT00989092|50269447|FG001|Overall Study|Did not receive study drug|0|||
25154275|NCT00988858|50269454|FG000|Overall Study|Adverse Event|7|||
25154276|NCT00988858|50269454|FG000|Overall Study|Death|1|||
25154277|NCT00988858|50269454|FG000|Overall Study|Physician Decision|1|||
25154278|NCT00988858|50269454|FG000|Overall Study|Sponsor Decision|1|||
25154279|NCT00986986|50269460|FG000|Overall Study|Lost to Follow-up|0|||
25154280|NCT00986986|50269461|FG001|Overall Study|Lost to Follow-up|1|||
25154281|NCT01904773|50269468|FG000|Screen|Screen failure|3|||
25154282|NCT01904773|50269469|FG001|Screen|Screen failure|0|||
25154283|NCT01904773|50269470|FG002|Screen|Screen failure|0|||
25154284|NCT01904773|50269471|FG003|Screen|Screen failure|0|||
25154285|NCT01904773|50269472|FG004|Screen|Screen failure|0|||
25154286|NCT01904773|50269473|FG005|Screen|Screen failure|0|||
25154287|NCT01904773|50269474|FG006|Screen|Screen failure|0|||
25022802|NCT02709538|50119591|FG000|Overall Study|Non-compliance with study procedures|5|||
25022803|NCT02709538|50119592|FG001|Overall Study|Non-compliance with study procedures|0|||
25022804|NCT02709538|50119593|FG002|Overall Study|Non-compliance with study procedures|0|||
25022805|NCT02709538|50119591|FG000|Overall Study|Non-compliance with study drug|2|||
25022806|NCT02709538|50119592|FG001|Overall Study|Non-compliance with study drug|0|||
25154288|NCT01904773|50269475|FG007|Screen|Screen failure|0|||
25154289|NCT01904773|50269476|FG008|Screen|Screen failure|0|||
25154290|NCT01904773|50269468|FG000|Screen|Withdrawal by Subject|1|||
25022807|NCT02709538|50119593|FG002|Overall Study|Non-compliance with study drug|0|||
25022808|NCT02709538|50119591|FG000|Overall Study|Protocol deviation|10|||
25022809|NCT02709538|50119592|FG001|Overall Study|Protocol deviation|4|||
25022810|NCT02709538|50119593|FG002|Overall Study|Protocol deviation|4|||
25022811|NCT02709538|50119591|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
25022812|NCT02709538|50119592|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
25022813|NCT02709538|50119593|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
25022814|NCT02709538|50119591|FG000|Overall Study|Other|16|||
25022815|NCT02709538|50119592|FG001|Overall Study|Other|7|||
25022816|NCT02709538|50119593|FG002|Overall Study|Other|5|||
25022817|NCT03789318|50119606|FG000|Overall Study|Adverse Event|0|||
25022818|NCT03789318|50119607|FG001|Overall Study|Adverse Event|0|||
25022819|NCT03789318|50119608|FG002|Overall Study|Adverse Event|1|||
25022820|NCT03789318|50119609|FG003|Overall Study|Adverse Event|1|||
25022821|NCT03789318|50119610|FG004|Overall Study|Adverse Event|0|||
25022822|NCT03789318|50119606|FG000|Overall Study|Lost to Follow-up|0|||
25022823|NCT03789318|50119607|FG001|Overall Study|Lost to Follow-up|0|||
25022824|NCT03789318|50119608|FG002|Overall Study|Lost to Follow-up|1|||
25022825|NCT03789318|50119609|FG003|Overall Study|Lost to Follow-up|0|||
25022826|NCT03789318|50119610|FG004|Overall Study|Lost to Follow-up|0|||
25022827|NCT03789318|50119606|FG000|Overall Study|Withdrawal by Subject|0|||
25022828|NCT03789318|50119607|FG001|Overall Study|Withdrawal by Subject|0|||
25022829|NCT03789318|50119608|FG002|Overall Study|Withdrawal by Subject|1|||
25022830|NCT03789318|50119609|FG003|Overall Study|Withdrawal by Subject|0|||
25022831|NCT03789318|50119610|FG004|Overall Study|Withdrawal by Subject|0|||
25022832|NCT00511134|50119628|FG000|Overall Study|Withdrawal by Subject|0|||
25022833|NCT00511134|50119629|FG001|Overall Study|Withdrawal by Subject|2|||
25022834|NCT01372384|50119635|FG000|Overall Study|Progression of disease|3|||
25022835|NCT03115476|50119642|FG000|LP0084-1369|Death|1|||
25022836|NCT03115476|50119643|FG001|LP0084-1369|Death|0|||
25022837|NCT03115476|50119644|FG002|LP0084-1369|Death|2|||
25022838|NCT03115476|50119642|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
25022839|NCT03115476|50119643|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
25022840|NCT03115476|50119644|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
25022841|NCT03480763|50119654|FG000|Overall Study|Withdrawal by Subject|18|||
25022842|NCT03480763|50119655|FG001|Overall Study|Withdrawal by Subject|10|||
25022843|NCT03480763|50119654|FG000|Overall Study|Lost to Follow-up|4|||
25022844|NCT03480763|50119655|FG001|Overall Study|Lost to Follow-up|7|||
25022845|NCT03480763|50119654|FG000|Overall Study|non-study pneumococcal vaccine|1|||
25022846|NCT03480763|50119655|FG001|Overall Study|non-study pneumococcal vaccine|0|||
25022847|NCT03480763|50119654|FG000|Overall Study|oncological treatment|0|||
25022848|NCT03480763|50119655|FG001|Overall Study|oncological treatment|2|||
25022849|NCT03480763|50119654|FG000|Overall Study|pain with vaccination|1|||
25022850|NCT03480763|50119655|FG001|Overall Study|pain with vaccination|0|||
25022851|NCT03123120|50119669|FG000|Overall Study|Lost to Follow-up|0|||
25022852|NCT03123120|50119670|FG001|Overall Study|Lost to Follow-up|1|||
25022853|NCT03123120|50119669|FG000|Overall Study|Withdrawal by Subject|0|||
25022854|NCT03123120|50119670|FG001|Overall Study|Withdrawal by Subject|1|||
25022855|NCT01319994|50119680|FG000|Overall Study|Protocol Violation|7|||
25022856|NCT01319994|50119681|FG001|Overall Study|Protocol Violation|6|||
25022857|NCT03453151|50119691|FG000|Overall Study|Withdrawal by Subject|1|||
25022858|NCT03453151|50119691|FG000|Overall Study|Physician Decision|3|||
25022859|NCT02887248|50119695|FG000|Overall Study|Withdrawal by Subject|1|||
25022860|NCT02887248|50119695|FG000|Overall Study|Adverse Event|1|||
25022861|NCT02887248|50119695|FG000|Overall Study|Progressive Disease|1|||
25022862|NCT03452527|50119701|FG000|Overall Study|Withdrawal by Subject|1|||
25022863|NCT03452527|50119702|FG001|Overall Study|Withdrawal by Subject|1|||
25022864|NCT03452527|50119701|FG000|Overall Study|Study Terminated|2|||
25022865|NCT03452527|50119702|FG001|Overall Study|Study Terminated|3|||
25022866|NCT03028142|50119708|FG000|Overall Study|Adverse Event|1|||
25022867|NCT03028142|50119709|FG001|Overall Study|Adverse Event|1|||
25022868|NCT03028142|50119710|FG002|Overall Study|Adverse Event|0|||
25022869|NCT03028142|50119711|FG003|Overall Study|Adverse Event|0|||
25022870|NCT03028142|50119712|FG004|Overall Study|Adverse Event|0|||
25022871|NCT03028142|50119713|FG005|Overall Study|Adverse Event|1|||
25022872|NCT03028142|50119708|FG000|Overall Study|Withdrawal by Subject|0|||
25022873|NCT03028142|50119709|FG001|Overall Study|Withdrawal by Subject|0|||
25022874|NCT03028142|50119710|FG002|Overall Study|Withdrawal by Subject|0|||
25154291|NCT01904773|50269469|FG001|Screen|Withdrawal by Subject|0|||
25022875|NCT03028142|50119711|FG003|Overall Study|Withdrawal by Subject|0|||
25022876|NCT03028142|50119712|FG004|Overall Study|Withdrawal by Subject|1|||
25154292|NCT01904773|50269470|FG002|Screen|Withdrawal by Subject|0|||
25154293|NCT01904773|50269471|FG003|Screen|Withdrawal by Subject|0|||
25022877|NCT03028142|50119713|FG005|Overall Study|Withdrawal by Subject|0|||
25022878|NCT02708524|50119726|FG000|Overall Study|Adverse Event|0|||
25022879|NCT02708524|50119727|FG001|Overall Study|Adverse Event|1|||
25022880|NCT02708524|50119728|FG002|Overall Study|Adverse Event|0|||
25022881|NCT02708524|50119729|FG003|Overall Study|Adverse Event|0|||
25022882|NCT02708524|50119726|FG000|Overall Study|Lens Discomfort|1|||
25022883|NCT02708524|50119727|FG001|Overall Study|Lens Discomfort|0|||
25022884|NCT02708524|50119728|FG002|Overall Study|Lens Discomfort|1|||
25022885|NCT02708524|50119729|FG003|Overall Study|Lens Discomfort|0|||
25022886|NCT02708524|50119726|FG000|Overall Study|Lost to Follow-up|1|||
25022887|NCT02708524|50119727|FG001|Overall Study|Lost to Follow-up|1|||
25022888|NCT02708524|50119728|FG002|Overall Study|Lost to Follow-up|1|||
25022889|NCT02708524|50119729|FG003|Overall Study|Lost to Follow-up|0|||
25022890|NCT02708524|50119726|FG000|Overall Study|Protocol Violation|0|||
25022891|NCT02708524|50119727|FG001|Overall Study|Protocol Violation|1|||
25022892|NCT02708524|50119728|FG002|Overall Study|Protocol Violation|0|||
25022893|NCT02708524|50119729|FG003|Overall Study|Protocol Violation|0|||
25022894|NCT02708524|50119726|FG000|Overall Study|Withdrawal by Subject|1|||
25022895|NCT02708524|50119727|FG001|Overall Study|Withdrawal by Subject|1|||
25022896|NCT02708524|50119728|FG002|Overall Study|Withdrawal by Subject|0|||
25022897|NCT02708524|50119729|FG003|Overall Study|Withdrawal by Subject|0|||
25022898|NCT02708524|50119726|FG000|Overall Study|Dispensed incorrect study lens|0|||
25022899|NCT02708524|50119727|FG001|Overall Study|Dispensed incorrect study lens|1|||
25022900|NCT02708524|50119728|FG002|Overall Study|Dispensed incorrect study lens|1|||
25022901|NCT02708524|50119729|FG003|Overall Study|Dispensed incorrect study lens|0|||
25022902|NCT02708524|50119726|FG000|Overall Study|Did not wear lens at final visit|0|||
25022903|NCT02708524|50119727|FG001|Overall Study|Did not wear lens at final visit|1|||
25022904|NCT02708524|50119728|FG002|Overall Study|Did not wear lens at final visit|0|||
25022905|NCT02708524|50119729|FG003|Overall Study|Did not wear lens at final visit|0|||
25022906|NCT02708524|50119726|FG000|Overall Study|Subject lost study lens|1|||
25022907|NCT02708524|50119727|FG001|Overall Study|Subject lost study lens|0|||
25022908|NCT02708524|50119728|FG002|Overall Study|Subject lost study lens|0|||
25022909|NCT02708524|50119729|FG003|Overall Study|Subject lost study lens|0|||
25022910|NCT03418675|50119741|FG000|Overall Study|Lost to Follow-up|13|||
25022911|NCT03418675|50119742|FG001|Overall Study|Lost to Follow-up|10|||
25022912|NCT03418675|50119741|FG000|Overall Study|Adverse Event|2|||
25022913|NCT03418675|50119742|FG001|Overall Study|Adverse Event|0|||
25022914|NCT03417505|50119759|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
25022915|NCT03417505|50119760|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
25022916|NCT02953639|50119769|FG000|Overall Study|Adverse Event|2|||
25022917|NCT02953639|50119770|FG001|Overall Study|Adverse Event|0|||
25022918|NCT02953639|50119771|FG002|Overall Study|Adverse Event|1|||
25022919|NCT02953639|50119769|FG000|Overall Study|Lost to Follow-up|8|||
25022920|NCT02953639|50119770|FG001|Overall Study|Lost to Follow-up|4|||
25022921|NCT02953639|50119771|FG002|Overall Study|Lost to Follow-up|3|||
25022922|NCT02953639|50119769|FG000|Overall Study|Non-Compliance With Study Drug|0|||
25022923|NCT02953639|50119770|FG001|Overall Study|Non-Compliance With Study Drug|2|||
25022924|NCT02953639|50119771|FG002|Overall Study|Non-Compliance With Study Drug|1|||
25022925|NCT02953639|50119769|FG000|Overall Study|Multiple Reasons|1|||
25022926|NCT02953639|50119770|FG001|Overall Study|Multiple Reasons|0|||
25022927|NCT02953639|50119771|FG002|Overall Study|Multiple Reasons|1|||
25022928|NCT02953639|50119769|FG000|Overall Study|Physician Decision|1|||
25022929|NCT02953639|50119770|FG001|Overall Study|Physician Decision|0|||
25022930|NCT02953639|50119771|FG002|Overall Study|Physician Decision|0|||
25022931|NCT02953639|50119769|FG000|Overall Study|Withdrawal by Subject|7|||
25022932|NCT02953639|50119770|FG001|Overall Study|Withdrawal by Subject|8|||
25022933|NCT02953639|50119771|FG002|Overall Study|Withdrawal by Subject|10|||
25022934|NCT02953639|50119769|FG000|Overall Study|Completed or Discontinued information is missing|1|||
25022935|NCT02953639|50119770|FG001|Overall Study|Completed or Discontinued information is missing|0|||
25022936|NCT02953639|50119771|FG002|Overall Study|Completed or Discontinued information is missing|0|||
25022937|NCT04147715|50119793|FG000|Overall Study|Adverse Event|0|||
25022938|NCT04147715|50119794|FG001|Overall Study|Adverse Event|0|||
25022939|NCT04147715|50119795|FG002|Overall Study|Adverse Event|0|||
25022940|NCT04147715|50119796|FG003|Overall Study|Adverse Event|0|||
25022941|NCT04147715|50119797|FG004|Overall Study|Adverse Event|0|||
25022942|NCT04147715|50119798|FG005|Overall Study|Adverse Event|0|||
25022943|NCT04147715|50119799|FG006|Overall Study|Adverse Event|0|||
25022944|NCT04147715|50119800|FG007|Overall Study|Adverse Event|2|||
25022945|NCT04147715|50119801|FG008|Overall Study|Adverse Event|1|||
25022946|NCT04147715|50119802|FG009|Overall Study|Adverse Event|0|||
25022947|NCT04147715|50119803|FG010|Overall Study|Adverse Event|0|||
25022948|NCT04147715|50119804|FG011|Overall Study|Adverse Event|0|||
25022949|NCT02452554|50119891|FG000|Overall Study|Death|2|||
25022950|NCT02452554|50119892|FG001|Overall Study|Death|1|||
25022951|NCT02452554|50119893|FG002|Overall Study|Death|0|||
25022952|NCT02452554|50119894|FG003|Overall Study|Death|0|||
25022953|NCT02452554|50119895|FG004|Overall Study|Death|0|||
25022954|NCT02452554|50119896|FG005|Overall Study|Death|0|||
25022955|NCT02452554|50119891|FG000|Overall Study|Lack of Efficacy|13|||
25022956|NCT02452554|50119892|FG001|Overall Study|Lack of Efficacy|14|||
25022957|NCT02452554|50119893|FG002|Overall Study|Lack of Efficacy|9|||
25022958|NCT02452554|50119894|FG003|Overall Study|Lack of Efficacy|1|||
25022959|NCT02452554|50119895|FG004|Overall Study|Lack of Efficacy|5|||
25022960|NCT02452554|50119896|FG005|Overall Study|Lack of Efficacy|8|||
25022961|NCT02452554|50119891|FG000|Overall Study|Physician Decision|0|||
25022962|NCT02452554|50119892|FG001|Overall Study|Physician Decision|1|||
25022963|NCT02452554|50119893|FG002|Overall Study|Physician Decision|0|||
25022964|NCT02452554|50119894|FG003|Overall Study|Physician Decision|0|||
25022965|NCT02452554|50119895|FG004|Overall Study|Physician Decision|0|||
25022966|NCT02452554|50119896|FG005|Overall Study|Physician Decision|0|||
25022967|NCT02452554|50119891|FG000|Overall Study|Withdrawal by Subject|1|||
25022968|NCT02452554|50119892|FG001|Overall Study|Withdrawal by Subject|0|||
25022969|NCT02452554|50119893|FG002|Overall Study|Withdrawal by Subject|2|||
25022970|NCT02452554|50119894|FG003|Overall Study|Withdrawal by Subject|0|||
25022971|NCT02452554|50119895|FG004|Overall Study|Withdrawal by Subject|0|||
25022972|NCT02452554|50119896|FG005|Overall Study|Withdrawal by Subject|1|||
25022973|NCT02452554|50119891|FG000|Overall Study|Ineligible|0|||
25022974|NCT02452554|50119892|FG001|Overall Study|Ineligible|1|||
25022975|NCT02452554|50119893|FG002|Overall Study|Ineligible|0|||
25022976|NCT02452554|50119894|FG003|Overall Study|Ineligible|0|||
25022977|NCT02452554|50119895|FG004|Overall Study|Ineligible|0|||
25022978|NCT02452554|50119896|FG005|Overall Study|Ineligible|0|||
25022979|NCT02452554|50119891|FG000|Overall Study|Never Received Treatment|1|||
25022980|NCT02452554|50119892|FG001|Overall Study|Never Received Treatment|0|||
25022981|NCT02452554|50119893|FG002|Overall Study|Never Received Treatment|0|||
25022982|NCT02452554|50119894|FG003|Overall Study|Never Received Treatment|0|||
25022983|NCT02452554|50119895|FG004|Overall Study|Never Received Treatment|0|||
25022984|NCT02452554|50119896|FG005|Overall Study|Never Received Treatment|0|||
25022985|NCT04009577|50119915|FG000|Core Study|Adverse Event|1|||
25022986|NCT04009577|50119916|FG001|Core Study|Adverse Event|0|||
25022987|NCT04009577|50119917|FG002|Core Study|Adverse Event|2|||
25022988|NCT04009577|50119918|FG003|Core Study|Adverse Event|4|||
25022989|NCT04009577|50119915|FG000|Core Study|Withdrawal by Subject|0|||
25022990|NCT04009577|50119916|FG001|Core Study|Withdrawal by Subject|0|||
25022991|NCT04009577|50119917|FG002|Core Study|Withdrawal by Subject|2|||
25022992|NCT04009577|50119918|FG003|Core Study|Withdrawal by Subject|0|||
25022993|NCT04009577|50119915|FG000|Core Study|Other|0|||
25022994|NCT04009577|50119916|FG001|Core Study|Other|0|||
25022995|NCT04009577|50119917|FG002|Core Study|Other|0|||
25022996|NCT04009577|50119918|FG003|Core Study|Other|1|||
25022997|NCT04009577|50119915|FG000|Extension Phase|Adverse Event|0|||
25022998|NCT04009577|50119916|FG001|Extension Phase|Adverse Event|0|||
25022999|NCT04009577|50119917|FG002|Extension Phase|Adverse Event|0|||
25023000|NCT04009577|50119918|FG003|Extension Phase|Adverse Event|1|||
25023001|NCT04009577|50119915|FG000|Extension Phase|Inadequate therapeutic effect|0|||
25023002|NCT04009577|50119916|FG001|Extension Phase|Inadequate therapeutic effect|0|||
25023003|NCT04009577|50119917|FG002|Extension Phase|Inadequate therapeutic effect|1|||
25023004|NCT04009577|50119918|FG003|Extension Phase|Inadequate therapeutic effect|0|||
25023005|NCT04009577|50119915|FG000|Extension Phase|Withdrawal by Subject|0|||
25023006|NCT04009577|50119916|FG001|Extension Phase|Withdrawal by Subject|0|||
25023007|NCT04009577|50119917|FG002|Extension Phase|Withdrawal by Subject|1|||
25023008|NCT04009577|50119918|FG003|Extension Phase|Withdrawal by Subject|0|||
25023009|NCT04009577|50119915|FG000|Extension Phase|Not Treated|0|||
25023010|NCT04009577|50119916|FG001|Extension Phase|Not Treated|0|||
25023011|NCT04009577|50119917|FG002|Extension Phase|Not Treated|2|||
25023012|NCT04009577|50119918|FG003|Extension Phase|Not Treated|0|||
25023013|NCT04146467|50119946|FG000|Overall Study|Adverse Event|0|||
25023014|NCT04146467|50119947|FG001|Overall Study|Adverse Event|1|||
25023015|NCT04146467|50119946|FG000|Overall Study|Lost to Follow-up|0|||
25023016|NCT04146467|50119947|FG001|Overall Study|Lost to Follow-up|2|||
25023017|NCT02705716|50119958|FG000|Overall Study|Adverse Event|0|||
25023018|NCT02705716|50119959|FG001|Overall Study|Adverse Event|1|||
25023019|NCT02705716|50119958|FG000|Overall Study|Protocol Violation|3|||
25023020|NCT02705716|50119959|FG001|Overall Study|Protocol Violation|0|||
25023021|NCT02705716|50119958|FG000|Overall Study|Withdrawal of Consent|1|||
25023022|NCT02705716|50119959|FG001|Overall Study|Withdrawal of Consent|1|||
25023023|NCT04138043|50119967|FG000|Overall Study|Withdrawal by Subject|0|||
25023024|NCT04138043|50119968|FG001|Overall Study|Withdrawal by Subject|1|||
25023025|NCT04135937|50119984|FG000|Overall Study|Lost to Follow-up|2|||
25023026|NCT04135937|50119984|FG000|Overall Study|Withdrawal by Subject|1|||
25023027|NCT03443713|50119991|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
25023028|NCT03443713|50119992|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
25023029|NCT03443713|50119993|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
25023030|NCT04133519|50120007|FG000|Overall Study|Withdrawal by Subject|5|||
25023031|NCT04133519|50120008|FG001|Overall Study|Withdrawal by Subject|4|||
25023032|NCT04133519|50120007|FG000|Overall Study|Protocol Violation|0|||
25023033|NCT04133519|50120008|FG001|Overall Study|Protocol Violation|1|||
25023034|NCT04133519|50120007|FG000|Overall Study|Never started treatment|1|||
25023035|NCT04133519|50120008|FG001|Overall Study|Never started treatment|1|||
25023036|NCT04007159|50120014|FG000|Induction Phase|(missed study visits)|16|||
25023037|NCT04007159|50120014|FG000|Induction Phase|Withdrawal by Subject|4|||
25023038|NCT04007159|50120014|FG000|Induction Phase|Adverse Event|2|||
25023039|NCT04007159|50120014|FG000|Challenge Phase|missed study visits|3|||
25023040|NCT03119688|50120025|FG000|Overall Study|Adverse Event|4|||
25023041|NCT03389893|50120044|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
25023042|NCT03389893|50120045|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
25023043|NCT03389893|50120046|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
25023044|NCT03389893|50120047|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
25023045|NCT03389893|50120044|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
25023046|NCT03389893|50120045|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
25023047|NCT03389893|50120046|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
25023048|NCT03389893|50120047|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
25023049|NCT03389893|50120044|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
25023050|NCT03389893|50120045|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
25023051|NCT03389893|50120046|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
25023052|NCT03389893|50120047|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
25023053|NCT03389893|50120044|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
25023054|NCT03389893|50120045|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
25023055|NCT03389893|50120046|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
25023056|NCT03389893|50120047|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
25023057|NCT04128293|50120057|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
25023058|NCT04128293|50120058|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
25023059|NCT04128293|50120059|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
25023060|NCT04128293|50120060|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
25023061|NCT00787176|50120079|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
25023062|NCT00787176|50120080|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
25023063|NCT00787176|50120081|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
25023064|NCT00787176|50120082|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
25023065|NCT03691571|50120095|FG000|Overall Study|Withdrawal by Subject|9|||
25023066|NCT03691571|50120096|FG001|Overall Study|Withdrawal by Subject|2|||
25023067|NCT03113916|50120105|FG000|Overall Study|Withdrawal by Subject|9|||
25023068|NCT03113916|50120106|FG001|Overall Study|Withdrawal by Subject|7|||
25023069|NCT03113916|50120105|FG000|Overall Study|Pregnancy|1|||
25023070|NCT03113916|50120106|FG001|Overall Study|Pregnancy|3|||
25023071|NCT03113916|50120105|FG000|Overall Study|Lost to Follow-up|1|||
25023072|NCT03113916|50120106|FG001|Overall Study|Lost to Follow-up|2|||
25023073|NCT02925494|50120121|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
25023074|NCT02925494|50120122|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
25023075|NCT02925494|50120123|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
25023076|NCT02925494|50120124|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
25023077|NCT02925494|50120121|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
25023078|NCT02925494|50120122|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
25023079|NCT02925494|50120123|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
25023080|NCT02925494|50120124|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
25023081|NCT02925494|50120121|FG000|Post-Treatment Follow-Up Period|Other|1|||
25023082|NCT02925494|50120122|FG001|Post-Treatment Follow-Up Period|Other|4|||
25023083|NCT02925494|50120123|FG002|Post-Treatment Follow-Up Period|Other|3|||
25023084|NCT02925494|50120124|FG003|Post-Treatment Follow-Up Period|Other|6|||
25023085|NCT02925494|50120121|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
25023086|NCT02925494|50120122|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
25023087|NCT02925494|50120123|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
25023088|NCT02925494|50120124|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
25023089|NCT02925494|50120121|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
25023090|NCT02925494|50120122|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
25023091|NCT02925494|50120123|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
25023092|NCT02925494|50120124|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
25023093|NCT02925494|50120121|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
25023094|NCT02925494|50120122|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
25023095|NCT02925494|50120123|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
25023096|NCT02925494|50120124|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
25023097|NCT02925494|50120121|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
25023098|NCT02925494|50120122|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
25023099|NCT02925494|50120123|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
25023100|NCT02925494|50120124|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
25023101|NCT04006145|50120137|FG000|Overall Study|Lost to Follow-up|0|||
25023102|NCT04006145|50120138|FG001|Overall Study|Lost to Follow-up|1|||
25023103|NCT04006145|50120137|FG000|Overall Study|Other|1|||
25023104|NCT04006145|50120138|FG001|Overall Study|Other|2|||
25023105|NCT03386773|50120146|FG000|Overall Study|Lost to Follow-up|24|||
25023106|NCT03386773|50120147|FG001|Overall Study|Lost to Follow-up|33|||
25023107|NCT03386773|50120146|FG000|Overall Study|Withdrawal by Subject|3|||
25023108|NCT03386773|50120147|FG001|Overall Study|Withdrawal by Subject|2|||
25023109|NCT04126343|50120159|FG000|Overall Study|Adverse Event|0|||
25023110|NCT04126343|50120160|FG001|Overall Study|Adverse Event|0|||
25023111|NCT04126343|50120161|FG002|Overall Study|Adverse Event|0|||
25023112|NCT04126343|50120162|FG003|Overall Study|Adverse Event|0|||
25023113|NCT04126343|50120163|FG004|Overall Study|Adverse Event|0|||
25023114|NCT04126343|50120164|FG005|Overall Study|Adverse Event|1|||
25023115|NCT04126343|50120159|FG000|Overall Study|Withdrawal by Subject|0|||
25023116|NCT04126343|50120160|FG001|Overall Study|Withdrawal by Subject|0|||
25023117|NCT04126343|50120161|FG002|Overall Study|Withdrawal by Subject|0|||
25023118|NCT04126343|50120162|FG003|Overall Study|Withdrawal by Subject|1|||
25023119|NCT04126343|50120163|FG004|Overall Study|Withdrawal by Subject|0|||
25023120|NCT04126343|50120164|FG005|Overall Study|Withdrawal by Subject|0|||
25023121|NCT04126343|50120159|FG000|Overall Study|Related to COVID-19 pandemic|3|||
25023122|NCT04126343|50120160|FG001|Overall Study|Related to COVID-19 pandemic|4|||
25023123|NCT04126343|50120161|FG002|Overall Study|Related to COVID-19 pandemic|3|||
25023124|NCT04126343|50120162|FG003|Overall Study|Related to COVID-19 pandemic|3|||
25023125|NCT04126343|50120163|FG004|Overall Study|Related to COVID-19 pandemic|3|||
25023126|NCT04126343|50120164|FG005|Overall Study|Related to COVID-19 pandemic|3|||
25023127|NCT02952313|50120179|FG000|Primary Endpoint|Lost to Follow-up|4|||
25023128|NCT02952313|50120179|FG000|Primary Endpoint|Withdrawal by Subject|1|||
25023129|NCT02952313|50120179|FG000|Primary Endpoint|Lack of Efficacy|1|||
25023130|NCT02952313|50120179|FG000|Primary Endpoint|Missed visit|1|||
25023131|NCT02952313|50120179|FG000|Long-term Follow-up|Lost to Follow-up|12|||
25023132|NCT02952313|50120179|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
25023133|NCT02952313|50120179|FG000|Long-term Follow-up|Lack of Efficacy|6|||
25023134|NCT02952313|50120179|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
25023135|NCT02952313|50120179|FG000|Long-term Follow-up|Physician Decision|1|||
25023136|NCT02952313|50120179|FG000|Long-term Follow-up|Death|1|||
25023137|NCT03119610|50120186|FG000|Overall Study|Adverse Event|1|||
25023138|NCT03119610|50120187|FG001|Overall Study|Adverse Event|0|||
25023139|NCT03119610|50120186|FG000|Overall Study|Lost to Follow-up|0|||
25023140|NCT03119610|50120187|FG001|Overall Study|Lost to Follow-up|1|||
25023141|NCT04005755|50120193|FG000|Overall Study|Adverse Event|6|||
25023142|NCT04005755|50120193|FG000|Overall Study|Physician Decision|3|||
25023143|NCT04005755|50120193|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
25023144|NCT04005755|50120193|FG000|Overall Study|Withdrawal by Subject|3|||
25023145|NCT04005755|50120193|FG000|Overall Study|Lost to Follow-up|1|||
25023146|NCT03442777|50120200|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
25023147|NCT03442777|50120201|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
25023148|NCT03442777|50120202|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
25023149|NCT03401749|50120211|FG000|Overall Study|Lost to Follow-up|20|||
25023150|NCT03401749|50120212|FG001|Overall Study|Lost to Follow-up|16|||
25023151|NCT03401749|50120213|FG002|Overall Study|Lost to Follow-up|26|||
25023152|NCT03029624|50120221|FG000|Overall Study|Adverse Event|1|||
25023153|NCT03029624|50120221|FG000|Overall Study|Withdrawal by Subject|1|||
25023154|NCT03029624|50120221|FG000|Overall Study|Lack of Efficacy|1|||
25023155|NCT03029624|50120221|FG000|Overall Study|MRI need|2|||
25023156|NCT02952001|50120229|FG000|Overall Study|Adverse Event|3|||
25023157|NCT02952001|50120230|FG001|Overall Study|Adverse Event|0|||
25023158|NCT02952001|50120229|FG000|Overall Study|Prohibited therapy|10|||
25023159|NCT02952001|50120230|FG001|Overall Study|Prohibited therapy|3|||
25023160|NCT02952001|50120229|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
25023161|NCT02952001|50120230|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
25023162|NCT04123067|50120239|FG000|Overall Study|Lost to Follow-up|0|||
25023163|NCT04123067|50120240|FG001|Overall Study|Lost to Follow-up|1|||
25023164|NCT04117607|50120249|FG000|Overall Study|Early Termination|0|||
25023165|NCT04117607|50120250|FG001|Overall Study|Early Termination|1|||
25023166|NCT04117607|50120251|FG002|Overall Study|Early Termination|0|||
25023167|NCT04117607|50120252|FG003|Overall Study|Early Termination|0|||
25023168|NCT04117607|50120253|FG004|Overall Study|Early Termination|0|||
25023169|NCT04117607|50120254|FG005|Overall Study|Early Termination|0|||
25023170|NCT04117607|50120255|FG006|Overall Study|Early Termination|1|||
25023171|NCT04117607|50120256|FG007|Overall Study|Early Termination|0|||
25023172|NCT04117607|50120257|FG008|Overall Study|Early Termination|0|||
25023173|NCT04117607|50120258|FG009|Overall Study|Early Termination|0|||
25023174|NCT04117607|50120259|FG010|Overall Study|Early Termination|0|||
25023175|NCT04117607|50120260|FG011|Overall Study|Early Termination|0|||
25023176|NCT04117607|50120261|FG012|Overall Study|Early Termination|0|||
25023177|NCT04117607|50120262|FG013|Overall Study|Early Termination|0|||
25023178|NCT04112303|50120278|FG000|Overall Study|Death|1|||
25023179|NCT03998189|50120284|FG000|Overall Study|Lack of Efficacy|0|||
25023180|NCT03998189|50120285|FG001|Overall Study|Lack of Efficacy|1|||
25154294|NCT01904773|50269472|FG004|Screen|Withdrawal by Subject|0|||
25154295|NCT01904773|50269473|FG005|Screen|Withdrawal by Subject|0|||
25154296|NCT01904773|50269474|FG006|Screen|Withdrawal by Subject|0|||
25154297|NCT01904773|50269475|FG007|Screen|Withdrawal by Subject|0|||
25154298|NCT01904773|50269476|FG008|Screen|Withdrawal by Subject|0|||
25154299|NCT01904773|50269468|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
25154300|NCT01904773|50269469|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
25023181|NCT04099277|50120291|FG000|Overall Study|Physician Decision|1|||
25023182|NCT04099277|50120291|FG000|Overall Study|Withdrawal by Subject|1|||
25023183|NCT03990389|50120297|FG000|Overall Study|Lost to Follow-up|3|||
25154301|NCT01904773|50269470|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
25023184|NCT03990389|50120298|FG001|Overall Study|Lost to Follow-up|0|||
25023185|NCT03988907|50120306|FG000|Overall Study|Unable to complete visit|0|||
25154302|NCT01904773|50269471|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
25154303|NCT01904773|50269472|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
24920892|NCT03381287|50014363|FG001|Overall Study|Withdrawal by Subject|1|||
24920893|NCT03381287|50014364|FG002|Overall Study|Withdrawal by Subject|0|||
24920894|NCT03381287|50014365|FG003|Overall Study|Withdrawal by Subject|0|||
25023186|NCT03988907|50120307|FG001|Overall Study|Unable to complete visit|1|||
25023187|NCT03987191|50120321|FG000|Overall Study|COVID-19 related research disruption|0|||
25023188|NCT03987191|50120322|FG001|Overall Study|COVID-19 related research disruption|2|||
25023189|NCT04098809|50120330|FG000|Overall Study|Withdrawal by Subject|1|||
25023190|NCT04098809|50120331|FG001|Overall Study|Withdrawal by Subject|3|||
25023191|NCT04098809|50120330|FG000|Overall Study|Physician Decision|2|||
25023192|NCT04098809|50120331|FG001|Overall Study|Physician Decision|1|||
25023193|NCT03122184|50120339|FG000|Overall Study|Lost to Follow-up|4|||
25023194|NCT03122184|50120340|FG001|Overall Study|Lost to Follow-up|6|||
25023195|NCT03122184|50120339|FG000|Overall Study|Withdrawal by Subject|3|||
25023196|NCT03122184|50120340|FG001|Overall Study|Withdrawal by Subject|0|||
25023197|NCT03122184|50120339|FG000|Overall Study|Terminated due to cognitive problem|1|||
25023198|NCT03122184|50120340|FG001|Overall Study|Terminated due to cognitive problem|0|||
25023199|NCT04091087|50120365|FG000|Overall Study|Not treated|1|||
25023200|NCT04091087|50120366|FG001|Overall Study|Not treated|0|||
25023201|NCT04091087|50120365|FG000|Overall Study|Adverse Event|4|||
25023202|NCT04091087|50120366|FG001|Overall Study|Adverse Event|4|||
25023203|NCT04091087|50120365|FG000|Overall Study|Protocol Violation|0|||
25023204|NCT04091087|50120366|FG001|Overall Study|Protocol Violation|1|||
25023205|NCT04091087|50120365|FG000|Overall Study|Withdrawal by Subject|5|||
25023206|NCT04091087|50120366|FG001|Overall Study|Withdrawal by Subject|2|||
25023207|NCT03400033|50120384|FG000|Overall Study|Withdrawal by Subject|1|||
25023208|NCT03400033|50120385|FG001|Overall Study|Withdrawal by Subject|2|||
25023209|NCT04089761|50120400|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
25023210|NCT04089761|50120400|FG000|"Run In Phase"|Lost to Follow-up|1|||
25023211|NCT04089761|50120400|FG000|"Treatment Phase"|No evaluable data|5|||
25023212|NCT04089761|50120400|FG000|"Treatment Phase"|Lost to Follow-up|1|||
25023213|NCT03118518|50120406|FG000|Overall Study|Early Exit after treatment|2|||
25023214|NCT03118518|50120407|FG001|Overall Study|Early Exit after treatment|8|||
25023215|NCT03118518|50120406|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
25023216|NCT03118518|50120407|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
24920895|NCT03381287|50014362|FG000|Overall Study|Adverse Event|0|||
25023217|NCT03984305|50120415|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
25023218|NCT03984305|50120416|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
25023219|NCT03984305|50120415|FG000|Overall Study|Withdrawal by Subject|3|||
25023220|NCT03984305|50120416|FG001|Overall Study|Withdrawal by Subject|3|||
25023221|NCT03984305|50120415|FG000|Overall Study|Lost to Follow-up|1|||
25023222|NCT03984305|50120416|FG001|Overall Study|Lost to Follow-up|0|||
25023223|NCT03397771|50120424|FG000|Overall Study|2 erroneously randomized, never treated|3|||
25023224|NCT03397771|50120425|FG001|Overall Study|2 erroneously randomized, never treated|1|||
25023225|NCT03397771|50120424|FG000|Overall Study|Withdrawal by Subject|1|||
25023226|NCT03397771|50120425|FG001|Overall Study|Withdrawal by Subject|3|||
24920896|NCT03381287|50014363|FG001|Overall Study|Adverse Event|0|||
25023227|NCT03397771|50120424|FG000|Overall Study|Protocol Violation|2|||
24920897|NCT03381287|50014364|FG002|Overall Study|Adverse Event|0|||
24920898|NCT03381287|50014365|FG003|Overall Study|Adverse Event|1|||
25023228|NCT03397771|50120425|FG001|Overall Study|Protocol Violation|2|||
25154304|NCT01904773|50269473|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
25154305|NCT01904773|50269474|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
24920899|NCT03381287|50014362|FG000|Overall Study|Physician Decision|0|||
25023229|NCT03397771|50120424|FG000|Overall Study|Adverse Event|2|||
25023230|NCT03397771|50120425|FG001|Overall Study|Adverse Event|1|||
25023231|NCT02876835|50120433|FG000|Treatment Period (51.1 Month)|Other|1|||
25023232|NCT02876835|50120434|FG001|Treatment Period (51.1 Month)|Other|0|||
25023233|NCT02876835|50120433|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
25023234|NCT02876835|50120434|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
25023235|NCT02876835|50120433|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
25023236|NCT02876835|50120434|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
25023237|NCT02876835|50120433|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
25023238|NCT02876835|50120434|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
25023239|NCT04086641|50120443|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
25023240|NCT04086641|50120444|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
25023241|NCT03503318|50120453|FG000|Overall Study|Death|1|||
25023242|NCT03503318|50120454|FG001|Overall Study|Death|0|||
25023243|NCT03503318|50120455|FG002|Overall Study|Death|4|||
25023244|NCT03503318|50120453|FG000|Overall Study|Adverse Event|3|||
25023245|NCT03503318|50120454|FG001|Overall Study|Adverse Event|4|||
25023246|NCT03503318|50120455|FG002|Overall Study|Adverse Event|2|||
25023247|NCT03503318|50120453|FG000|Overall Study|Withdrawal by Subject|12|||
25023248|NCT03503318|50120454|FG001|Overall Study|Withdrawal by Subject|17|||
25023249|NCT03503318|50120455|FG002|Overall Study|Withdrawal by Subject|16|||
25023250|NCT03503318|50120453|FG000|Overall Study|Protocol Violation|5|||
25023251|NCT03503318|50120454|FG001|Overall Study|Protocol Violation|0|||
25023252|NCT03503318|50120455|FG002|Overall Study|Protocol Violation|3|||
25023253|NCT03503318|50120453|FG000|Overall Study|Lost to Follow-up|17|||
25023254|NCT03503318|50120454|FG001|Overall Study|Lost to Follow-up|15|||
25023255|NCT03503318|50120455|FG002|Overall Study|Lost to Follow-up|12|||
25023256|NCT03503318|50120453|FG000|Overall Study|Other than specified|1|||
25023257|NCT03503318|50120454|FG001|Overall Study|Other than specified|3|||
25023258|NCT03503318|50120455|FG002|Overall Study|Other than specified|3|||
25023259|NCT03396913|50120465|FG000|Overall Study|Lost to Follow-up|0|||
25023260|NCT03396913|50120466|FG001|Overall Study|Lost to Follow-up|6|||
25023261|NCT03982433|50120472|FG000|Overall Study|Lost to Follow-up|1|||
25023262|NCT03396835|50120476|FG000|Overall Study|Withdrawn prior to completion|1|||
25023263|NCT03396835|50120476|FG000|Overall Study|Did not meet criteria for data analysis|1|||
25023264|NCT03122106|50120480|FG000|Overall Study|Not enough tissue|1|||
25023265|NCT03122106|50120480|FG000|Overall Study|Disease progression during screening|2|||
25023266|NCT03122106|50120480|FG000|Overall Study|Poor RNA quality for vaccine|1|||
25023267|NCT04084769|50120488|FG000|Overall Study|Protocol Violation|1|||
25023268|NCT04084769|50120489|FG001|Overall Study|Protocol Violation|3|||
25023269|NCT04084769|50120490|FG002|Overall Study|Protocol Violation|0|||
25023270|NCT04084769|50120491|FG003|Overall Study|Protocol Violation|1|||
25023271|NCT04084769|50120488|FG000|Overall Study|Withdrawal by Subject|0|||
25023272|NCT04084769|50120489|FG001|Overall Study|Withdrawal by Subject|1|||
25023273|NCT04084769|50120490|FG002|Overall Study|Withdrawal by Subject|0|||
25023274|NCT04084769|50120491|FG003|Overall Study|Withdrawal by Subject|0|||
25023275|NCT04084769|50120488|FG000|Overall Study|Withdrawal by parent/guardian|1|||
25023276|NCT04084769|50120489|FG001|Overall Study|Withdrawal by parent/guardian|0|||
25023277|NCT04084769|50120490|FG002|Overall Study|Withdrawal by parent/guardian|0|||
25023278|NCT04084769|50120491|FG003|Overall Study|Withdrawal by parent/guardian|1|||
25023279|NCT04084769|50120488|FG000|Overall Study|Lost to Follow-up|2|||
25023280|NCT04084769|50120489|FG001|Overall Study|Lost to Follow-up|0|||
25023281|NCT04084769|50120490|FG002|Overall Study|Lost to Follow-up|0|||
25023282|NCT04084769|50120491|FG003|Overall Study|Lost to Follow-up|0|||
25023283|NCT03121950|50120508|FG000|Overall Study|Withdrawal by Subject|11|||
25023284|NCT03121950|50120509|FG001|Overall Study|Withdrawal by Subject|2|||
25023285|NCT03395353|50120517|FG000|Overall Study|Adverse Event|20|||
25023286|NCT03395353|50120517|FG000|Overall Study|Protocol Violation|1|||
25023287|NCT03395353|50120517|FG000|Overall Study|Lack of Efficacy|3|||
25023288|NCT03395353|50120517|FG000|Overall Study|Withdrawal by Subject|24|||
25023289|NCT03395353|50120517|FG000|Overall Study|Discontinued visit|1|||
25023290|NCT03395353|50120517|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
25023291|NCT03395353|50120517|FG000|Overall Study|Physician Decision|4|||
25023292|NCT03395353|50120517|FG000|Overall Study|Early termination of overall study|33|||
25023293|NCT04082663|50120525|FG000|Overall Study|Adverse Event|6|||
25023294|NCT04082663|50120525|FG000|Overall Study|Lost to Follow-up|1|||
25023295|NCT03682367|50120531|FG000|Overall Study|Protocol Violation|2|||
25023296|NCT03682367|50120532|FG001|Overall Study|Protocol Violation|1|||
25023297|NCT03682367|50120531|FG000|Overall Study|Closed Study Early|0|||
25023298|NCT03682367|50120532|FG001|Overall Study|Closed Study Early|3|||
25023299|NCT03681353|50120538|FG000|Overall Study|Lost to Follow-up|2|||
25023300|NCT03681353|50120538|FG000|Overall Study|Withdrawal by Subject|3|||
25023301|NCT03681353|50120538|FG000|Overall Study|withdrawn by PI|2|||
25023302|NCT03394885|50120542|FG000|Overall Study|Adverse Event|4|||
25023303|NCT03394885|50120542|FG000|Overall Study|Lack of Efficacy|1|||
25023304|NCT03394885|50120542|FG000|Overall Study|Physician Decision|1|||
25023305|NCT03394885|50120542|FG000|Overall Study|Withdrawal by Subject|8|||
25023306|NCT03394885|50120542|FG000|Overall Study|Alternative Therapy|1|||
25023307|NCT02877927|50120548|FG000|Overall Study|Adverse Event|1|||
25023308|NCT02877927|50120549|FG001|Overall Study|Adverse Event|0|||
25023309|NCT02877927|50120548|FG000|Overall Study|Lost to Follow-up|37|||
25023310|NCT02877927|50120549|FG001|Overall Study|Lost to Follow-up|38|||
25023311|NCT02877927|50120548|FG000|Overall Study|Withdrawal by Subject|11|||
25154306|NCT01904773|50269475|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
25154307|NCT01904773|50269476|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
25154308|NCT01904773|50269468|FG000|First Intervention|Adverse Event|0|||
25154309|NCT01904773|50269469|FG001|First Intervention|Adverse Event|0|||
25154310|NCT01904773|50269470|FG002|First Intervention|Adverse Event|0|||
25154311|NCT01904773|50269471|FG003|First Intervention|Adverse Event|0|||
25154312|NCT01904773|50269472|FG004|First Intervention|Adverse Event|0|||
25154313|NCT01904773|50269473|FG005|First Intervention|Adverse Event|0|||
25154314|NCT01904773|50269474|FG006|First Intervention|Adverse Event|1|||
25154315|NCT01904773|50269475|FG007|First Intervention|Adverse Event|0|||
25154316|NCT01904773|50269476|FG008|First Intervention|Adverse Event|0|||
24920900|NCT03381287|50014363|FG001|Overall Study|Physician Decision|0|||
24920901|NCT03381287|50014364|FG002|Overall Study|Physician Decision|0|||
24920902|NCT03381287|50014365|FG003|Overall Study|Physician Decision|1|||
24920903|NCT00616928|50014389|FG000|Overall Study|Adverse Event|6|||
24920904|NCT00616928|50014390|FG001|Overall Study|Adverse Event|3|||
24920905|NCT00616928|50014391|FG002|Overall Study|Adverse Event|2|||
24920906|NCT00616928|50014392|FG003|Overall Study|Adverse Event|2|||
24920907|NCT00616928|50014389|FG000|Overall Study|Other|51|||
24920908|NCT00616928|50014390|FG001|Overall Study|Other|8|||
24920909|NCT00616928|50014391|FG002|Overall Study|Other|15|||
24920910|NCT00616928|50014392|FG003|Overall Study|Other|5|||
24920911|NCT00616928|50014389|FG000|Overall Study|Lost to Follow-up|5|||
24920912|NCT00616928|50014390|FG001|Overall Study|Lost to Follow-up|7|||
24920913|NCT00616928|50014391|FG002|Overall Study|Lost to Follow-up|0|||
24920914|NCT00616928|50014392|FG003|Overall Study|Lost to Follow-up|0|||
24920915|NCT00563784|50014414|FG000|Overall Study|Withdrawal by Subject|2|||
24920916|NCT00563784|50014414|FG000|Overall Study|Screen Failures|20|||
24920917|NCT00203047|50014429|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
24920918|NCT00203047|50014430|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
24920919|NCT00203047|50014429|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
24920920|NCT00203047|50014430|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
24920921|NCT00203047|50014429|FG000|Overall Study|Withdrawal by Subject|13|||
24920922|NCT00203047|50014430|FG001|Overall Study|Withdrawal by Subject|47|||
24920923|NCT00203047|50014429|FG000|Overall Study|Teva requested participant withdrawal|1|||
24920924|NCT00203047|50014430|FG001|Overall Study|Teva requested participant withdrawal|1|||
24920925|NCT00203047|50014429|FG000|Overall Study|Physician Decision|8|||
24920926|NCT00203047|50014430|FG001|Overall Study|Physician Decision|7|||
24920927|NCT00203047|50014429|FG000|Overall Study|Non-compliance|4|||
24920928|NCT00203047|50014430|FG001|Overall Study|Non-compliance|8|||
24920929|NCT00203047|50014429|FG000|Overall Study|Protocol Violation|1|||
24920930|NCT00203047|50014430|FG001|Overall Study|Protocol Violation|0|||
24920931|NCT00203047|50014429|FG000|Overall Study|Lost to Follow-up|11|||
24920932|NCT00203047|50014430|FG001|Overall Study|Lost to Follow-up|5|||
24920933|NCT00203047|50014429|FG000|Overall Study|Adverse Event|8|||
24920934|NCT00203047|50014430|FG001|Overall Study|Adverse Event|18|||
24920935|NCT00203047|50014429|FG000|Overall Study|Death|1|||
24920936|NCT00203047|50014430|FG001|Overall Study|Death|2|||
24920937|NCT00203047|50014429|FG000|Overall Study|Pregnancy|3|||
24920938|NCT00203047|50014430|FG001|Overall Study|Pregnancy|0|||
24920939|NCT00203047|50014429|FG000|Overall Study|Other|5|||
24920940|NCT00203047|50014430|FG001|Overall Study|Other|5|||
24920941|NCT00142519|50014438|FG000|Overall Study|Not Treated|7|||
24920942|NCT00142519|50014439|FG001|Overall Study|Not Treated|9|||
24920943|NCT00142519|50014438|FG000|Overall Study|Protocol Violation|1|||
24920944|NCT00142519|50014439|FG001|Overall Study|Protocol Violation|0|||
24920945|NCT00142519|50014438|FG000|Overall Study|Withdrawal by Subject|10|||
24920946|NCT00142519|50014439|FG001|Overall Study|Withdrawal by Subject|7|||
24920947|NCT00141817|50014458|FG000|Overall Study|Protocol Violation|0|||
24920948|NCT00141817|50014459|FG001|Overall Study|Protocol Violation|0|||
24920949|NCT00141817|50014460|FG002|Overall Study|Protocol Violation|1|||
24920950|NCT00141817|50014461|FG003|Overall Study|Protocol Violation|0|||
24920951|NCT00141817|50014458|FG000|Overall Study|Parent request|1|||
24920952|NCT00141817|50014459|FG001|Overall Study|Parent request|0|||
24920953|NCT00141817|50014460|FG002|Overall Study|Parent request|0|||
25154317|NCT01904773|50269468|FG000|Placebo Washout First Intervention|Condition worsened|0|||
25154318|NCT01904773|50269469|FG001|Placebo Washout First Intervention|Condition worsened|1|||
24920954|NCT00141817|50014461|FG003|Overall Study|Parent request|0|||
24920955|NCT00573170|50014471|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
24920956|NCT00573170|50014472|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
24920957|NCT00573170|50014473|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
24920958|NCT00573170|50014474|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
24920959|NCT00573170|50014475|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
24920960|NCT00573170|50014476|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
24920961|NCT00573170|50014471|FG000|First Washout Period|Adverse Event|1|||
24920962|NCT00573170|50014472|FG001|First Washout Period|Adverse Event|1|||
24920963|NCT00573170|50014473|FG002|First Washout Period|Adverse Event|0|||
24920964|NCT00573170|50014474|FG003|First Washout Period|Adverse Event|0|||
24920965|NCT00573170|50014475|FG004|First Washout Period|Adverse Event|0|||
24920966|NCT00573170|50014476|FG005|First Washout Period|Adverse Event|1|||
24920967|NCT00573170|50014471|FG000|First Washout Period|Lack of Efficacy|0|||
24920968|NCT00573170|50014472|FG001|First Washout Period|Lack of Efficacy|0|||
24920969|NCT00573170|50014473|FG002|First Washout Period|Lack of Efficacy|0|||
24920970|NCT00573170|50014474|FG003|First Washout Period|Lack of Efficacy|0|||
24920971|NCT00573170|50014475|FG004|First Washout Period|Lack of Efficacy|0|||
24920972|NCT00573170|50014476|FG005|First Washout Period|Lack of Efficacy|1|||
24920973|NCT00573170|50014471|FG000|First Washout Period|Lost to Follow-up|1|||
24920974|NCT00573170|50014472|FG001|First Washout Period|Lost to Follow-up|1|||
24920975|NCT00573170|50014473|FG002|First Washout Period|Lost to Follow-up|0|||
25023312|NCT02877927|50120549|FG001|Overall Study|Withdrawal by Subject|12|||
25023313|NCT02877927|50120548|FG000|Overall Study|Physician Decision|0|||
25023314|NCT02877927|50120549|FG001|Overall Study|Physician Decision|1|||
25023315|NCT02877927|50120548|FG000|Overall Study|Missed EOT/PTE Visit|5|||
25023316|NCT02877927|50120549|FG001|Overall Study|Missed EOT/PTE Visit|6|||
25023317|NCT02706886|50120564|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
25023318|NCT02706886|50120565|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
25023319|NCT02706886|50120566|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
25023320|NCT02706886|50120567|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
25023321|NCT02706886|50120568|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
25023322|NCT02706886|50120569|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
25023323|NCT02706886|50120570|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
25023324|NCT02706886|50120571|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
25023325|NCT02706886|50120572|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
25023326|NCT04069715|50120626|FG000|Overall Study|Lost to Follow-up|1|||
25023327|NCT04069715|50120627|FG001|Overall Study|Lost to Follow-up|1|||
25023328|NCT04069715|50120626|FG000|Overall Study|Physician Decision|1|||
25023329|NCT04069715|50120627|FG001|Overall Study|Physician Decision|1|||
25023330|NCT04069715|50120626|FG000|Overall Study|Withdrawal by Subject|3|||
24920976|NCT00573170|50014474|FG003|First Washout Period|Lost to Follow-up|2|||
24920977|NCT00573170|50014475|FG004|First Washout Period|Lost to Follow-up|0|||
24920978|NCT00573170|50014476|FG005|First Washout Period|Lost to Follow-up|2|||
24920979|NCT00573170|50014471|FG000|First Washout Period|Withdrawal by Subject|2|||
24920980|NCT00573170|50014472|FG001|First Washout Period|Withdrawal by Subject|0|||
24920981|NCT00573170|50014473|FG002|First Washout Period|Withdrawal by Subject|0|||
24920982|NCT00573170|50014474|FG003|First Washout Period|Withdrawal by Subject|2|||
24920983|NCT00573170|50014475|FG004|First Washout Period|Withdrawal by Subject|3|||
24920984|NCT00573170|50014476|FG005|First Washout Period|Withdrawal by Subject|3|||
24920985|NCT00573170|50014471|FG000|First Washout Period|Other|4|||
24920986|NCT00573170|50014472|FG001|First Washout Period|Other|0|||
24920987|NCT00573170|50014473|FG002|First Washout Period|Other|1|||
24920988|NCT00573170|50014474|FG003|First Washout Period|Other|1|||
24920989|NCT00573170|50014475|FG004|First Washout Period|Other|0|||
24920990|NCT00573170|50014476|FG005|First Washout Period|Other|0|||
24920991|NCT00573170|50014471|FG000|Second Washout Period|Adverse Event|1|||
24920992|NCT00573170|50014472|FG001|Second Washout Period|Adverse Event|0|||
24920993|NCT00573170|50014473|FG002|Second Washout Period|Adverse Event|0|||
24920994|NCT00573170|50014474|FG003|Second Washout Period|Adverse Event|0|||
24920995|NCT00573170|50014475|FG004|Second Washout Period|Adverse Event|1|||
24920996|NCT00573170|50014476|FG005|Second Washout Period|Adverse Event|0|||
24920997|NCT00573170|50014471|FG000|Second Washout Period|Protocol Violation|2|||
24920998|NCT00573170|50014472|FG001|Second Washout Period|Protocol Violation|1|||
24920999|NCT00573170|50014473|FG002|Second Washout Period|Protocol Violation|1|||
24921000|NCT00573170|50014474|FG003|Second Washout Period|Protocol Violation|0|||
24921001|NCT00573170|50014475|FG004|Second Washout Period|Protocol Violation|0|||
24921002|NCT00573170|50014476|FG005|Second Washout Period|Protocol Violation|0|||
24921003|NCT00573170|50014471|FG000|Second Washout Period|Withdrawal by Subject|1|||
24921004|NCT00573170|50014472|FG001|Second Washout Period|Withdrawal by Subject|1|||
24921005|NCT00573170|50014473|FG002|Second Washout Period|Withdrawal by Subject|2|||
24921006|NCT00573170|50014474|FG003|Second Washout Period|Withdrawal by Subject|0|||
24921007|NCT00573170|50014475|FG004|Second Washout Period|Withdrawal by Subject|1|||
24921008|NCT00573170|50014476|FG005|Second Washout Period|Withdrawal by Subject|0|||
24921009|NCT00573170|50014471|FG000|Second Washout Period|Lost to Follow-up|0|||
24921010|NCT00573170|50014472|FG001|Second Washout Period|Lost to Follow-up|0|||
25023331|NCT04069715|50120627|FG001|Overall Study|Withdrawal by Subject|3|||
24921011|NCT00573170|50014473|FG002|Second Washout Period|Lost to Follow-up|0|||
24921012|NCT00573170|50014474|FG003|Second Washout Period|Lost to Follow-up|1|||
24921013|NCT00573170|50014475|FG004|Second Washout Period|Lost to Follow-up|0|||
24921014|NCT00573170|50014476|FG005|Second Washout Period|Lost to Follow-up|0|||
24921015|NCT00573170|50014471|FG000|Second Washout Period|Other|1|||
24921016|NCT00573170|50014472|FG001|Second Washout Period|Other|2|||
25023332|NCT03681119|50120635|FG000|Overall Study|No specific reason|4|||
25023333|NCT03681119|50120636|FG001|Overall Study|No specific reason|0|||
25023334|NCT03681119|50120635|FG000|Overall Study|Sickness|2|||
25023335|NCT03681119|50120636|FG001|Overall Study|Sickness|0|||
24921017|NCT00573170|50014473|FG002|Second Washout Period|Other|1|||
24921018|NCT00573170|50014474|FG003|Second Washout Period|Other|4|||
24921019|NCT00573170|50014475|FG004|Second Washout Period|Other|6|||
24921020|NCT00573170|50014476|FG005|Second Washout Period|Other|2|||
24921021|NCT00573170|50014471|FG000|Third Treatment Period|Withdrawal by Subject|1|||
24921022|NCT00573170|50014472|FG001|Third Treatment Period|Withdrawal by Subject|0|||
24921023|NCT00573170|50014473|FG002|Third Treatment Period|Withdrawal by Subject|0|||
24921024|NCT00573170|50014474|FG003|Third Treatment Period|Withdrawal by Subject|0|||
24921025|NCT00573170|50014475|FG004|Third Treatment Period|Withdrawal by Subject|0|||
24921026|NCT00573170|50014476|FG005|Third Treatment Period|Withdrawal by Subject|0|||
24921027|NCT00573170|50014471|FG000|Third Treatment Period|Lost to Follow-up|0|||
24921028|NCT00573170|50014472|FG001|Third Treatment Period|Lost to Follow-up|0|||
24921029|NCT00573170|50014473|FG002|Third Treatment Period|Lost to Follow-up|0|||
24921030|NCT00573170|50014474|FG003|Third Treatment Period|Lost to Follow-up|0|||
24921031|NCT00573170|50014475|FG004|Third Treatment Period|Lost to Follow-up|0|||
24921032|NCT00573170|50014476|FG005|Third Treatment Period|Lost to Follow-up|2|||
24921033|NCT00201643|50014495|FG000|Overall Study|Withdrawal by Subject|5|||
24921034|NCT00201643|50014496|FG001|Overall Study|Withdrawal by Subject|4|||
24921035|NCT00130039|50014504|FG000|Overall Study|Withdrawal by Subject|15|||
24921036|NCT00130039|50014505|FG001|Overall Study|Withdrawal by Subject|11|||
24921037|NCT00130039|50014504|FG000|Overall Study|Lost to Follow-up|3|||
24921038|NCT00130039|50014505|FG001|Overall Study|Lost to Follow-up|1|||
24921039|NCT00130039|50014504|FG000|Overall Study|Adverse Event|4|||
24921040|NCT00130039|50014505|FG001|Overall Study|Adverse Event|2|||
24921041|NCT00130039|50014504|FG000|Overall Study|Physician Decision|3|||
25154319|NCT01904773|50269470|FG002|Placebo Washout First Intervention|Condition worsened|0|||
25154320|NCT01904773|50269471|FG003|Placebo Washout First Intervention|Condition worsened|0|||
25154321|NCT01904773|50269472|FG004|Placebo Washout First Intervention|Condition worsened|0|||
25154322|NCT01904773|50269473|FG005|Placebo Washout First Intervention|Condition worsened|0|||
25154323|NCT01904773|50269474|FG006|Placebo Washout First Intervention|Condition worsened|0|||
25154324|NCT01904773|50269475|FG007|Placebo Washout First Intervention|Condition worsened|0|||
25154325|NCT01904773|50269476|FG008|Placebo Washout First Intervention|Condition worsened|0|||
25154326|NCT01904773|50269468|FG000|Fifth Intervention|Adverse Event|0|||
25154327|NCT01904773|50269469|FG001|Fifth Intervention|Adverse Event|0|||
25154328|NCT01904773|50269470|FG002|Fifth Intervention|Adverse Event|0|||
25154329|NCT01904773|50269471|FG003|Fifth Intervention|Adverse Event|0|||
25154330|NCT01904773|50269472|FG004|Fifth Intervention|Adverse Event|0|||
25154331|NCT01904773|50269473|FG005|Fifth Intervention|Adverse Event|0|||
25154332|NCT01904773|50269474|FG006|Fifth Intervention|Adverse Event|0|||
25154333|NCT01904773|50269475|FG007|Fifth Intervention|Adverse Event|1|||
25154334|NCT01904773|50269476|FG008|Fifth Intervention|Adverse Event|0|||
25154335|NCT01904773|50269468|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
25154336|NCT01904773|50269469|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
25154337|NCT01904773|50269470|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
25154338|NCT01904773|50269471|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
24921042|NCT00130039|50014505|FG001|Overall Study|Physician Decision|0|||
24921043|NCT00130039|50014504|FG000|Overall Study|clinical events without follow up MRI|5|||
24921044|NCT00130039|50014505|FG001|Overall Study|clinical events without follow up MRI|4|||
24921045|NCT00475852|50014513|FG000|Overall Study|Death|444|||
24921046|NCT00475852|50014514|FG001|Overall Study|Death|456|||
24921047|NCT00475852|50014513|FG000|Overall Study|Withdrawal by Subject|19|||
24921048|NCT00475852|50014514|FG001|Overall Study|Withdrawal by Subject|24|||
24921049|NCT00475852|50014513|FG000|Overall Study|Lost to Follow-up|54|||
24921050|NCT00475852|50014514|FG001|Overall Study|Lost to Follow-up|68|||
24921051|NCT00141271|50014523|FG000|Overall Study|Adverse Event|31|||
24921052|NCT00141271|50014524|FG001|Overall Study|Adverse Event|19|||
24921053|NCT00141271|50014525|FG002|Overall Study|Adverse Event|17|||
24921054|NCT00141271|50014523|FG000|Overall Study|Laboratory Abnormality|2|||
24921055|NCT00141271|50014524|FG001|Overall Study|Laboratory Abnormality|1|||
25154339|NCT01904773|50269472|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
25154340|NCT01904773|50269473|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
25154341|NCT01904773|50269474|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
25154342|NCT01904773|50269475|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
24921056|NCT00141271|50014525|FG002|Overall Study|Laboratory Abnormality|1|||
24921057|NCT00141271|50014523|FG000|Overall Study|Lack of Efficacy|7|||
24921058|NCT00141271|50014524|FG001|Overall Study|Lack of Efficacy|7|||
24921059|NCT00141271|50014525|FG002|Overall Study|Lack of Efficacy|3|||
24921060|NCT00141271|50014523|FG000|Overall Study|Lost to Follow-up|15|||
24921061|NCT00141271|50014524|FG001|Overall Study|Lost to Follow-up|15|||
24921062|NCT00141271|50014525|FG002|Overall Study|Lost to Follow-up|21|||
24921063|NCT00141271|50014523|FG000|Overall Study|Withdrawal by Subject|14|||
24921064|NCT00141271|50014524|FG001|Overall Study|Withdrawal by Subject|9|||
25023336|NCT03111108|50120642|FG000|Overall Study|Death|0|||
25154343|NCT01904773|50269476|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
25154344|NCT01928719|50269490|FG000|Overall Study|Lost to Follow-up|26|||
24921065|NCT00141271|50014525|FG002|Overall Study|Withdrawal by Subject|10|||
24921066|NCT00141271|50014523|FG000|Overall Study|Other|11|||
24921067|NCT00141271|50014524|FG001|Overall Study|Other|12|||
24921068|NCT00141271|50014525|FG002|Overall Study|Other|5|||
24921069|NCT00614120|50014537|FG000|Overall Study|Adverse Event|9|||
24921070|NCT00614120|50014538|FG001|Overall Study|Adverse Event|22|||
24921071|NCT00614120|50014539|FG002|Overall Study|Adverse Event|30|||
24921072|NCT00614120|50014540|FG003|Overall Study|Adverse Event|3|||
24921073|NCT00614120|50014537|FG000|Overall Study|Lack of Efficacy|3|||
24921074|NCT00614120|50014538|FG001|Overall Study|Lack of Efficacy|3|||
24921075|NCT00614120|50014539|FG002|Overall Study|Lack of Efficacy|2|||
24921076|NCT00614120|50014540|FG003|Overall Study|Lack of Efficacy|2|||
24921077|NCT00614120|50014537|FG000|Overall Study|Protocol Violation|2|||
24921078|NCT00614120|50014538|FG001|Overall Study|Protocol Violation|5|||
24921079|NCT00614120|50014539|FG002|Overall Study|Protocol Violation|3|||
25154345|NCT01928719|50269491|FG001|Overall Study|Lost to Follow-up|11|||
25154346|NCT01928719|50269490|FG000|Overall Study|Withdrawal by Subject|22|||
24921080|NCT00614120|50014540|FG003|Overall Study|Protocol Violation|1|||
24921081|NCT00614120|50014537|FG000|Overall Study|Withdrawal criteria|1|||
25154347|NCT01928719|50269491|FG001|Overall Study|Withdrawal by Subject|7|||
25154348|NCT01928719|50269490|FG000|Overall Study|Protocol Violation|3|||
25154349|NCT01928719|50269491|FG001|Overall Study|Protocol Violation|1|||
25154350|NCT01928719|50269490|FG000|Overall Study|Adverse Event|1|||
25154351|NCT01928719|50269491|FG001|Overall Study|Adverse Event|0|||
25154352|NCT00986674|50269502|FG000|Overall Study|Lack of Efficacy|28|||
24921082|NCT00614120|50014538|FG001|Overall Study|Withdrawal criteria|0|||
24921083|NCT00614120|50014539|FG002|Overall Study|Withdrawal criteria|0|||
24921084|NCT00614120|50014540|FG003|Overall Study|Withdrawal criteria|0|||
24921085|NCT00614120|50014537|FG000|Overall Study|Withdrawal by Subject|9|||
24921086|NCT00614120|50014538|FG001|Overall Study|Withdrawal by Subject|10|||
24921087|NCT00614120|50014539|FG002|Overall Study|Withdrawal by Subject|16|||
24921088|NCT00614120|50014540|FG003|Overall Study|Withdrawal by Subject|3|||
24921089|NCT00614120|50014537|FG000|Overall Study|Did not meet trial criteria|0|||
24921090|NCT00614120|50014538|FG001|Overall Study|Did not meet trial criteria|1|||
24921091|NCT00614120|50014539|FG002|Overall Study|Did not meet trial criteria|1|||
24921092|NCT00614120|50014540|FG003|Overall Study|Did not meet trial criteria|1|||
24921093|NCT00614120|50014537|FG000|Overall Study|hCG positive (not pregnant)|0|||
24921094|NCT00614120|50014538|FG001|Overall Study|hCG positive (not pregnant)|0|||
24921095|NCT00614120|50014539|FG002|Overall Study|hCG positive (not pregnant)|1|||
24921096|NCT00614120|50014540|FG003|Overall Study|hCG positive (not pregnant)|0|||
24921097|NCT00614120|50014537|FG000|Overall Study|Hypoglycaemia|0|||
24921098|NCT00614120|50014538|FG001|Overall Study|Hypoglycaemia|0|||
24921099|NCT00614120|50014539|FG002|Overall Study|Hypoglycaemia|0|||
24921100|NCT00614120|50014540|FG003|Overall Study|Hypoglycaemia|1|||
24921101|NCT00614120|50014537|FG000|Overall Study|Lack of trial product|3|||
24921102|NCT00614120|50014538|FG001|Overall Study|Lack of trial product|3|||
24921103|NCT00614120|50014539|FG002|Overall Study|Lack of trial product|2|||
24921104|NCT00614120|50014540|FG003|Overall Study|Lack of trial product|0|||
24921105|NCT00614120|50014537|FG000|Overall Study|Late syphilis, latent|1|||
24921106|NCT00614120|50014538|FG001|Overall Study|Late syphilis, latent|0|||
24921107|NCT00614120|50014539|FG002|Overall Study|Late syphilis, latent|0|||
25154353|NCT00986674|50269503|FG001|Overall Study|Lack of Efficacy|25|||
25154354|NCT00986674|50269504|FG002|Overall Study|Lack of Efficacy|23|||
24921108|NCT00614120|50014540|FG003|Overall Study|Late syphilis, latent|0|||
24921109|NCT00614120|50014537|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
24921110|NCT00614120|50014538|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
24921111|NCT00614120|50014539|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
25154355|NCT00986674|50269502|FG000|Overall Study|Adverse Event|4|||
25154356|NCT00986674|50269503|FG001|Overall Study|Adverse Event|8|||
24921112|NCT00614120|50014540|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
24921113|NCT00614120|50014537|FG000|Overall Study|Lost to Follow-up|1|||
24921114|NCT00614120|50014538|FG001|Overall Study|Lost to Follow-up|2|||
24921115|NCT00614120|50014539|FG002|Overall Study|Lost to Follow-up|3|||
24921116|NCT00614120|50014540|FG003|Overall Study|Lost to Follow-up|4|||
24921117|NCT00496054|50014550|FG000|Overall Study|Adverse Event|1|||
24921118|NCT00496054|50014550|FG000|Overall Study|Lost to Follow-up|7|||
24921119|NCT00495820|50014556|FG000|Overall Study|Adverse Event|1|||
24921120|NCT00495820|50014557|FG001|Overall Study|Adverse Event|1|||
24921121|NCT00495586|50014565|FG000|Overall Study|Withdrawal by Subject|4|||
24921122|NCT00495586|50014566|FG001|Overall Study|Withdrawal by Subject|4|||
25154357|NCT00986674|50269504|FG002|Overall Study|Adverse Event|9|||
25154358|NCT00986674|50269502|FG000|Overall Study|Death|5|||
25154359|NCT00986674|50269503|FG001|Overall Study|Death|0|||
25154360|NCT00986674|50269504|FG002|Overall Study|Death|4|||
25154361|NCT00986674|50269502|FG000|Overall Study|Withdrawal by Subject|6|||
24921123|NCT00613730|50014574|FG000|Overall Study|Disease progression|2|||
24921124|NCT00613730|50014574|FG000|Overall Study|Administrative decision|1|||
24921125|NCT00613574|50014578|FG000|Overall Study|Adverse Event|3|||
24921126|NCT00613574|50014578|FG000|Overall Study|Lost to Follow-up|2|||
24921127|NCT00613574|50014578|FG000|Overall Study|Other|1|||
24921128|NCT00613106|50014584|FG000|Overall Study|Adverse Event|3|||
24921129|NCT00613106|50014585|FG001|Overall Study|Adverse Event|1|||
24921130|NCT00613106|50014584|FG000|Overall Study|Withdrawal by Subject|6|||
24921131|NCT00613106|50014585|FG001|Overall Study|Withdrawal by Subject|3|||
24921132|NCT00613106|50014584|FG000|Overall Study|Lost to Follow-up|7|||
24921133|NCT00613106|50014585|FG001|Overall Study|Lost to Follow-up|2|||
24921134|NCT00613106|50014584|FG000|Overall Study|misc|4|||
24921135|NCT00613106|50014585|FG001|Overall Study|misc|3|||
24921136|NCT00141037|50014593|FG000|Overall Study|Physician Decision|1|||
24921137|NCT00141037|50014594|FG001|Overall Study|Physician Decision|2|||
24921138|NCT00141037|50014593|FG000|Overall Study|Lost to Follow-up|3|||
24921139|NCT00141037|50014594|FG001|Overall Study|Lost to Follow-up|1|||
24921140|NCT00141037|50014593|FG000|Overall Study|Protocol Violation|0|||
24921141|NCT00141037|50014594|FG001|Overall Study|Protocol Violation|2|||
24921142|NCT00141037|50014593|FG000|Overall Study|Withdrawal by Subject|2|||
24921143|NCT00141037|50014594|FG001|Overall Study|Withdrawal by Subject|1|||
24921144|NCT00141037|50014593|FG000|Overall Study|Other|0|||
24921145|NCT00141037|50014594|FG001|Overall Study|Other|1|||
24921146|NCT00141037|50014593|FG000|Overall Study|Moved from area|1|||
24921147|NCT00141037|50014594|FG001|Overall Study|Moved from area|7|||
24921148|NCT00141037|50014593|FG000|Overall Study|Graft Failure|3|||
24921149|NCT00141037|50014594|FG001|Overall Study|Graft Failure|4|||
24921150|NCT00140413|50014603|FG000|Overall Study|Lost to Follow-up|1|||
24921151|NCT00140413|50014604|FG001|Overall Study|Lost to Follow-up|0|||
24921152|NCT00140413|50014603|FG000|Overall Study|Withdrawal by Subject|2|||
24921153|NCT00140413|50014604|FG001|Overall Study|Withdrawal by Subject|0|||
24921154|NCT00563706|50014620|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
24921155|NCT00563706|50014621|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
24921156|NCT00563706|50014622|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
24921157|NCT00563706|50014623|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
24921158|NCT00563706|50014624|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
24921159|NCT00563706|50014625|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
24921160|NCT00563706|50014626|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
24921161|NCT00563706|50014627|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
24921162|NCT00563706|50014628|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
24921163|NCT00563706|50014620|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
24921164|NCT00563706|50014621|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
24921165|NCT00563706|50014622|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
24921166|NCT00563706|50014623|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
24921167|NCT00563706|50014624|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
24921168|NCT00563706|50014625|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
24921169|NCT00563706|50014626|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
24921170|NCT00563706|50014627|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
24921171|NCT00563706|50014628|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
24921172|NCT00563706|50014620|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
24921173|NCT00563706|50014621|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
24921174|NCT00563706|50014622|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
24921175|NCT00563706|50014623|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
24921176|NCT00563706|50014624|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
24921177|NCT00563706|50014625|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
24921178|NCT00563706|50014626|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
24921179|NCT00563706|50014627|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
24921180|NCT00563706|50014628|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
24921181|NCT00563706|50014620|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
24921182|NCT00563706|50014621|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
25023337|NCT03111108|50120643|FG001|Overall Study|Death|1|||
25023338|NCT03111108|50120642|FG000|Overall Study|Withdrawal by Subject|1|||
24921183|NCT00563706|50014622|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
24921184|NCT00563706|50014623|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
24921185|NCT00563706|50014624|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
24921186|NCT00563706|50014625|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
24921187|NCT00563706|50014626|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
24921188|NCT00563706|50014627|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
24921189|NCT00563706|50014628|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
24921190|NCT00563706|50014620|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
25023339|NCT03111108|50120643|FG001|Overall Study|Withdrawal by Subject|0|||
25023340|NCT03677375|50120649|FG000|Overall Study|Incomplete procedure|8|||
25023341|NCT03677375|50120649|FG000|Overall Study|Adverse Event|3|||
25023342|NCT03677375|50120649|FG000|Overall Study|Physician Decision|1|||
25023343|NCT00702520|50120655|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
25023344|NCT00702520|50120656|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
25023345|NCT00702520|50120657|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
25023346|NCT00702520|50120658|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
25023347|NCT00702520|50120655|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
25023348|NCT00702520|50120656|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
25023349|NCT00702520|50120657|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
25023350|NCT00702520|50120658|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
25023351|NCT00702520|50120655|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
25023352|NCT00702520|50120656|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
25023353|NCT00702520|50120657|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
25023354|NCT00702520|50120658|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
25023355|NCT04067141|50120668|FG000|First Intervention|Withdrawal by Subject|0|||
25023356|NCT04067141|50120669|FG001|First Intervention|Withdrawal by Subject|1|||
25023357|NCT04067141|50120668|FG000|Second Intervention|Adverse Event|0|||
25023358|NCT04067141|50120669|FG001|Second Intervention|Adverse Event|2|||
25023359|NCT02876601|50120679|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
25023360|NCT02876601|50120680|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
25023361|NCT02876601|50120681|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
25023362|NCT02876601|50120682|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
25023363|NCT04054193|50120727|FG000|Cycle 1|Physician Decision|1|||
25023364|NCT04054193|50120727|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
25023365|NCT04054193|50120727|FG000|Cycle 1|Allocated but not treated|3|||
25023366|NCT04054193|50120727|FG000|Cycles 2-3|Physician Decision|2|||
25023367|NCT04054193|50120727|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
25023368|NCT04054193|50120727|FG000|Cycles 2-3|Various reasons|17|||
25023369|NCT03394027|50120735|FG000|Overall Study|Ineligible|3|||
25023370|NCT03394027|50120736|FG001|Overall Study|Ineligible|1|||
25023371|NCT03394027|50120737|FG002|Overall Study|Ineligible|3|||
25023372|NCT03394027|50120735|FG000|Overall Study|Participant declined to participate before treatment started|0|||
24921191|NCT00563706|50014621|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
24921192|NCT00563706|50014622|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
24921193|NCT00563706|50014623|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
24921194|NCT00563706|50014624|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
24921195|NCT00563706|50014625|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
24921196|NCT00563706|50014626|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
24921197|NCT00563706|50014627|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
24921198|NCT00563706|50014628|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
25023373|NCT03394027|50120736|FG001|Overall Study|Participant declined to participate before treatment started|0|||
25154362|NCT00986674|50269503|FG001|Overall Study|Withdrawal by Subject|2|||
25023374|NCT03394027|50120737|FG002|Overall Study|Participant declined to participate before treatment started|1|||
25023375|NCT03136107|50120763|FG000|Overall Study|Other (Not specified)|1|||
25023376|NCT02916056|50120771|FG000|Overall Study|Adverse Event|6|||
25023377|NCT02916056|50120771|FG000|Overall Study|Lost to Follow-up|1|||
25023378|NCT02916056|50120771|FG000|Overall Study|Other|12|||
25023379|NCT02916056|50120771|FG000|Overall Study|Protocol Violation|1|||
25023380|NCT02916056|50120771|FG000|Overall Study|Withdrawal by Subject|8|||
25023381|NCT02916056|50120771|FG000|Overall Study|Study Terminated by Sponsor|269|||
25023382|NCT04854642|50120775|FG000|Overall Study|Adverse Event|1|||
25023383|NCT04854642|50120776|FG001|Overall Study|Adverse Event|2|||
25023384|NCT04854642|50120775|FG000|Overall Study|Withdrawal by Subject|0|||
25023385|NCT04854642|50120776|FG001|Overall Study|Withdrawal by Subject|1|||
25023386|NCT03689712|50120786|FG000|Overall Study|Adverse Event|1|||
25023387|NCT03689712|50120787|FG001|Overall Study|Adverse Event|0|||
25023388|NCT03689712|50120786|FG000|Overall Study|Death|20|||
25023389|NCT03689712|50120787|FG001|Overall Study|Death|10|||
25023390|NCT03689712|50120786|FG000|Overall Study|Lost to Follow-up|6|||
25154363|NCT00986674|50269504|FG002|Overall Study|Withdrawal by Subject|1|||
24921199|NCT00129961|50014650|FG000|Overall Study|Adverse Event|1|||
25023391|NCT03689712|50120787|FG001|Overall Study|Lost to Follow-up|6|||
25023392|NCT03689712|50120786|FG000|Overall Study|Other|1|||
25023393|NCT03689712|50120787|FG001|Overall Study|Other|0|||
25023394|NCT03689712|50120786|FG000|Overall Study|Patient Non-Compliance|0|||
25023395|NCT03689712|50120787|FG001|Overall Study|Patient Non-Compliance|1|||
25023396|NCT03689712|50120786|FG000|Overall Study|Withdrawal by Subject|20|||
25023397|NCT03689712|50120787|FG001|Overall Study|Withdrawal by Subject|4|||
25023398|NCT03689712|50120786|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
25023399|NCT03689712|50120787|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
25023400|NCT03689712|50120786|FG000|Overall Study|Randomized but not Treated|13|||
25023401|NCT03689712|50120787|FG001|Overall Study|Randomized but not Treated|7|||
25023402|NCT03689712|50120786|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
25023403|NCT03689712|50120787|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
25023404|NCT03384745|50120799|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
25023405|NCT03384745|50120800|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
25023406|NCT03384745|50120801|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
25023407|NCT03384745|50120802|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
25023408|NCT03384745|50120803|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
25023409|NCT03384745|50120804|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
25023410|NCT03384745|50120799|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
25023411|NCT03384745|50120800|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
25023412|NCT03384745|50120801|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
25023413|NCT03384745|50120802|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
25023414|NCT03384745|50120803|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
25023415|NCT03384745|50120804|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
25023416|NCT03384745|50120799|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
25023417|NCT03384745|50120800|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
25023418|NCT03384745|50120801|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
25023419|NCT03384745|50120802|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
25023420|NCT03384745|50120803|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
24921200|NCT00129961|50014651|FG001|Overall Study|Adverse Event|0|||
24921201|NCT00129961|50014650|FG000|Overall Study|Death|1|||
24921202|NCT00129961|50014651|FG001|Overall Study|Death|1|||
24921203|NCT00129961|50014650|FG000|Overall Study|Withdrawal by Sponsor|14|||
24921204|NCT00129961|50014651|FG001|Overall Study|Withdrawal by Sponsor|20|||
24921205|NCT00129961|50014650|FG000|Overall Study|Physician Decision|1|||
24921206|NCT00129961|50014651|FG001|Overall Study|Physician Decision|0|||
24921207|NCT00129961|50014650|FG000|Overall Study|Withdrawal by Subject|2|||
24921208|NCT00129961|50014651|FG001|Overall Study|Withdrawal by Subject|1|||
24921209|NCT00129961|50014650|FG000|Overall Study|Missing Record|0|||
24921210|NCT00129961|50014651|FG001|Overall Study|Missing Record|1|||
24921211|NCT00528567|50014659|FG000|Overall Study|Death|4|||
24921212|NCT00528567|50014660|FG001|Overall Study|Death|5|||
24921213|NCT00528567|50014659|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
24921214|NCT00528567|50014660|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
24921215|NCT00528567|50014659|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
24921216|NCT00528567|50014660|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
24921217|NCT00528567|50014659|FG000|Overall Study|Violation Criteria at Entry|3|||
24921218|NCT00528567|50014660|FG001|Overall Study|Violation Criteria at Entry|17|||
24921219|NCT00528567|50014659|FG000|Overall Study|Withdrew Consent|59|||
24921220|NCT00528567|50014660|FG001|Overall Study|Withdrew Consent|55|||
24921221|NCT00528567|50014659|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
24921222|NCT00528567|50014660|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
24921223|NCT00528567|50014659|FG000|Overall Study|Failure to Return|1|||
24921224|NCT00528567|50014660|FG001|Overall Study|Failure to Return|4|||
24921225|NCT00528567|50014659|FG000|Overall Study|Other Protocol Violation|5|||
24921226|NCT00528567|50014660|FG001|Overall Study|Other Protocol Violation|21|||
24921227|NCT00528567|50014659|FG000|Overall Study|Administrative/Other|22|||
24921228|NCT00528567|50014660|FG001|Overall Study|Administrative/Other|75|||
24921229|NCT00138151|50014673|FG000|Overall Study|Withdrawal by Subject|3|||
24921230|NCT00138151|50014673|FG000|Overall Study|Physician Decision|1|||
24921231|NCT00138073|50014677|FG000|Overall Study|lack of resources|55|||
24921232|NCT02581631|50014686|FG000|Overall Study|Disease progression|29|||
24921233|NCT02581631|50014687|FG001|Overall Study|Disease progression|19|||
24921234|NCT02581631|50014688|FG002|Overall Study|Disease progression|13|||
24921235|NCT02581631|50014689|FG003|Overall Study|Disease progression|5|||
24921236|NCT02581631|50014690|FG004|Overall Study|Disease progression|8|||
24921237|NCT02581631|50014686|FG000|Overall Study|Study drug toxicity|4|||
24921238|NCT02581631|50014687|FG001|Overall Study|Study drug toxicity|6|||
24921239|NCT02581631|50014688|FG002|Overall Study|Study drug toxicity|7|||
24921240|NCT02581631|50014689|FG003|Overall Study|Study drug toxicity|0|||
24921241|NCT02581631|50014690|FG004|Overall Study|Study drug toxicity|3|||
24921242|NCT02581631|50014686|FG000|Overall Study|AE unrelated to study drug|3|||
24921243|NCT02581631|50014687|FG001|Overall Study|AE unrelated to study drug|1|||
25023421|NCT03384745|50120804|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
24921244|NCT02581631|50014688|FG002|Overall Study|AE unrelated to study drug|1|||
24921245|NCT02581631|50014689|FG003|Overall Study|AE unrelated to study drug|0|||
24921246|NCT02581631|50014690|FG004|Overall Study|AE unrelated to study drug|2|||
24921247|NCT02581631|50014686|FG000|Overall Study|Request to discontinue|1|||
24921248|NCT02581631|50014687|FG001|Overall Study|Request to discontinue|0|||
24921249|NCT02581631|50014688|FG002|Overall Study|Request to discontinue|3|||
24921250|NCT02581631|50014689|FG003|Overall Study|Request to discontinue|0|||
24921251|NCT02581631|50014690|FG004|Overall Study|Request to discontinue|1|||
24921252|NCT02581631|50014686|FG000|Overall Study|participant withdrew consent|3|||
24921253|NCT02581631|50014687|FG001|Overall Study|participant withdrew consent|0|||
24921254|NCT02581631|50014688|FG002|Overall Study|participant withdrew consent|1|||
24921255|NCT02581631|50014689|FG003|Overall Study|participant withdrew consent|0|||
24921256|NCT02581631|50014690|FG004|Overall Study|participant withdrew consent|0|||
24921257|NCT02581631|50014686|FG000|Overall Study|Maximum clinical benefit|1|||
24921258|NCT02581631|50014687|FG001|Overall Study|Maximum clinical benefit|7|||
24921259|NCT02581631|50014688|FG002|Overall Study|Maximum clinical benefit|1|||
24921260|NCT02581631|50014689|FG003|Overall Study|Maximum clinical benefit|3|||
24921261|NCT02581631|50014690|FG004|Overall Study|Maximum clinical benefit|13|||
24921262|NCT02581631|50014686|FG000|Overall Study|Other Reasons|1|||
24921263|NCT02581631|50014687|FG001|Overall Study|Other Reasons|0|||
24921264|NCT02581631|50014688|FG002|Overall Study|Other Reasons|2|||
24921265|NCT02581631|50014689|FG003|Overall Study|Other Reasons|2|||
24921266|NCT02581631|50014690|FG004|Overall Study|Other Reasons|3|||
24921267|NCT02581631|50014686|FG000|Overall Study|Poor/Non-Compliance|0|||
24921268|NCT02581631|50014687|FG001|Overall Study|Poor/Non-Compliance|0|||
24921269|NCT02581631|50014688|FG002|Overall Study|Poor/Non-Compliance|1|||
24921270|NCT02581631|50014689|FG003|Overall Study|Poor/Non-Compliance|0|||
24921271|NCT02581631|50014690|FG004|Overall Study|Poor/Non-Compliance|0|||
24921272|NCT00529035|50014702|FG000|Overall Study|Withdrawal by Subject|1|||
24921273|NCT00609674|50014715|FG000|Overall Study|Adverse Event|1|||
24921274|NCT00609674|50014716|FG001|Overall Study|Adverse Event|1|||
24921275|NCT00609674|50014715|FG000|Overall Study|Protocol Violation|3|||
24921276|NCT00609674|50014716|FG001|Overall Study|Protocol Violation|5|||
24921277|NCT00609674|50014715|FG000|Overall Study|Lost to Follow-up|1|||
24921278|NCT00609674|50014716|FG001|Overall Study|Lost to Follow-up|0|||
24921279|NCT00609674|50014715|FG000|Overall Study|Withdrew consent|2|||
24921280|NCT00609674|50014716|FG001|Overall Study|Withdrew consent|1|||
24921281|NCT00137839|50014722|FG000|Overall Study|Adverse Event|7|||
24921282|NCT00137839|50014722|FG000|Overall Study|Physician Decision|7|||
24921283|NCT00137839|50014722|FG000|Overall Study|Death|8|||
24921284|NCT00137839|50014722|FG000|Overall Study|Disease Progression|60|||
24921285|NCT00137839|50014722|FG000|Overall Study|Not Start Treatment|1|||
24921286|NCT00137839|50014722|FG000|Overall Study|Prolonged Treatment Delay|1|||
24921287|NCT00563316|50014729|FG000|Overall Study|Adverse Event|2|||
24921288|NCT00563316|50014729|FG000|Overall Study|Physician Decision|1|||
24921289|NCT00563316|50014729|FG000|Overall Study|Lost to Follow-up|2|||
24921290|NCT00563316|50014729|FG000|Overall Study|Death|1|||
24921291|NCT00563316|50014729|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
24921292|NCT00563316|50014729|FG000|Overall Study|Other|1|||
24921293|NCT03178487|50014739|FG000|Period 1|Adverse Event|1|||
24921294|NCT03178487|50014740|FG001|Period 1|Adverse Event|2|||
24921295|NCT03178487|50014739|FG000|Period 1|Withdrawal by Subject|2|||
24921296|NCT03178487|50014740|FG001|Period 1|Withdrawal by Subject|1|||
24921297|NCT03178487|50014739|FG000|Period 1|Lost to Follow-up|1|||
24921298|NCT03178487|50014740|FG001|Period 1|Lost to Follow-up|0|||
24921299|NCT03178487|50014739|FG000|Period 1|Other|0|||
24921300|NCT03178487|50014740|FG001|Period 1|Other|1|||
24921301|NCT03178487|50014739|FG000|Period 2|Adverse Event|4|||
24921302|NCT03178487|50014740|FG001|Period 2|Adverse Event|4|||
24921303|NCT03178487|50014739|FG000|Period 2|Withdrawal by Subject|6|||
24921304|NCT03178487|50014740|FG001|Period 2|Withdrawal by Subject|6|||
24921305|NCT03178487|50014739|FG000|Period 2|Lost to Follow-up|2|||
24921306|NCT03178487|50014740|FG001|Period 2|Lost to Follow-up|2|||
24921307|NCT03178487|50014739|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
24921308|NCT03178487|50014740|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
24921309|NCT03178487|50014739|FG000|Period 2|Other|8|||
24921310|NCT03178487|50014740|FG001|Period 2|Other|7|||
24921311|NCT00528957|50014749|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
24921312|NCT00528957|50014750|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
24921313|NCT00528957|50014749|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
24921314|NCT00528957|50014750|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
24921315|NCT00528957|50014749|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
24921316|NCT00528957|50014750|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
24921317|NCT00528957|50014749|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
24921318|NCT00528957|50014750|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
24921319|NCT00528957|50014749|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
24921320|NCT00528957|50014750|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
24921321|NCT00528957|50014749|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
24921322|NCT00528957|50014750|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
24921323|NCT00528957|50014749|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
24921324|NCT00528957|50014750|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
24921325|NCT00528957|50014749|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
24921326|NCT00528957|50014750|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
24921327|NCT00528957|50014749|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
24921328|NCT00528957|50014750|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
24921329|NCT00528957|50014749|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
24921330|NCT00528957|50014750|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
24921331|NCT00528957|50014749|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
24921332|NCT00528957|50014750|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
24921333|NCT00528957|50014749|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
24921334|NCT00528957|50014750|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
24921335|NCT00528957|50014749|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
24921336|NCT00528957|50014750|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
24921337|NCT00528957|50014749|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
24921338|NCT00528957|50014750|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
24921339|NCT00528957|50014749|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
24921340|NCT00528957|50014750|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
24921341|NCT00528957|50014749|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
24921342|NCT00528957|50014750|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
24921343|NCT00560508|50014768|FG000|12 Week Double-blind Period|Adverse Event|3|||
24921344|NCT00560508|50014769|FG001|12 Week Double-blind Period|Adverse Event|2|||
24921345|NCT00560508|50014768|FG000|12 Week Double-blind Period|Protocol Violation|1|||
24921346|NCT00560508|50014769|FG001|12 Week Double-blind Period|Protocol Violation|0|||
24921347|NCT00560508|50014768|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
24921348|NCT00560508|50014769|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
24921349|NCT00560508|50014768|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
24921350|NCT00560508|50014769|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
25023422|NCT03384745|50120799|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
24921351|NCT00560508|50014768|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
24921352|NCT00560508|50014769|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
24921353|NCT00560508|50014768|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
24921354|NCT00560508|50014769|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
24921355|NCT00560508|50014768|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
24921356|NCT00560508|50014769|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
24921357|NCT03962790|50014780|FG000|Period 1|Adverse Event|0|||
24921358|NCT03962790|50014781|FG001|Period 1|Adverse Event|1|||
24921359|NCT03962790|50014780|FG000|Period 1|Failed to meet all eligibility criteria|1|||
24921360|NCT03962790|50014781|FG001|Period 1|Failed to meet all eligibility criteria|1|||
24921361|NCT03962790|50014780|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
24921362|NCT03962790|50014781|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
24921363|NCT03962790|50014780|FG000|Period 1|Withdrawal by Subject|1|||
24921364|NCT03962790|50014781|FG001|Period 1|Withdrawal by Subject|0|||
24921365|NCT00609518|50014789|FG000|Overall Study|Death from Study Disease|32|||
24921366|NCT00609518|50014790|FG001|Overall Study|Death from Study Disease|32|||
24921367|NCT00609518|50014789|FG000|Overall Study|Withdrawal by Subject|5|||
25154364|NCT00986674|50269502|FG000|Overall Study|alternative therapy|0|||
25154365|NCT00986674|50269503|FG001|Overall Study|alternative therapy|0|||
24921368|NCT00609518|50014790|FG001|Overall Study|Withdrawal by Subject|3|||
24921369|NCT00609518|50014789|FG000|Overall Study|Lost to Follow-up|3|||
24921370|NCT00609518|50014790|FG001|Overall Study|Lost to Follow-up|0|||
24921371|NCT00609518|50014789|FG000|Overall Study|Physician Decision|1|||
24921372|NCT00609518|50014790|FG001|Overall Study|Physician Decision|3|||
24921373|NCT00609518|50014789|FG000|Overall Study|Death from Adverse Event|2|||
24921374|NCT00609518|50014790|FG001|Overall Study|Death from Adverse Event|2|||
24921375|NCT00609362|50014798|FG000|Overall Study|Withdrawal by Subject|2|||
24921376|NCT00609362|50014799|FG001|Overall Study|Withdrawal by Subject|1|||
24921377|NCT00609362|50014798|FG000|Overall Study|Adverse Event|1|||
24921378|NCT00609362|50014799|FG001|Overall Study|Adverse Event|0|||
24921379|NCT00611858|50014805|FG000|Overall Study|Adverse Event|2|||
24921380|NCT00611858|50014805|FG000|Overall Study|Withdrawal by Subject|2|||
24921381|NCT00137449|50014813|FG000|Overall Study|Disease Progression|8|||
24921382|NCT00137449|50014814|FG001|Overall Study|Disease Progression|13|||
24921383|NCT00137449|50014813|FG000|Overall Study|Death|4|||
24921384|NCT00137449|50014814|FG001|Overall Study|Death|3|||
24921385|NCT00137449|50014813|FG000|Overall Study|Adverse Event|3|||
24921386|NCT00137449|50014814|FG001|Overall Study|Adverse Event|1|||
24921387|NCT00137449|50014813|FG000|Overall Study|Withdrawal by Subject|1|||
25023423|NCT03384745|50120800|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
25154366|NCT00986674|50269504|FG002|Overall Study|alternative therapy|1|||
25154367|NCT00986674|50269502|FG000|Overall Study|not start protocol therapy|4|||
25154368|NCT00986674|50269503|FG001|Overall Study|not start protocol therapy|3|||
25154369|NCT00986674|50269504|FG002|Overall Study|not start protocol therapy|1|||
24921388|NCT00137449|50014814|FG001|Overall Study|Withdrawal by Subject|1|||
24921389|NCT00528879|50014825|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
24921390|NCT00528879|50014826|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
24921391|NCT00528879|50014827|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
24921392|NCT00528879|50014828|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
24921393|NCT00528879|50014825|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
24921394|NCT00528879|50014826|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
24921395|NCT00528879|50014827|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
24921396|NCT00528879|50014828|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
24921397|NCT00528879|50014825|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
24921398|NCT00528879|50014826|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
24921399|NCT00528879|50014827|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
24921400|NCT00528879|50014828|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
24921401|NCT00528879|50014825|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
24921402|NCT00528879|50014826|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
24921403|NCT00528879|50014827|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
24921404|NCT00528879|50014828|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
24921405|NCT00528879|50014825|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
24921406|NCT00528879|50014826|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
24921407|NCT00528879|50014827|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
25023424|NCT03384745|50120801|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
24921408|NCT00528879|50014828|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
24921409|NCT00528879|50014825|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
24921410|NCT00528879|50014826|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
24921411|NCT00528879|50014827|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
24921412|NCT00528879|50014828|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
24921413|NCT00528879|50014825|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
24921414|NCT00528879|50014826|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
24921415|NCT00528879|50014827|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
24921416|NCT00528879|50014828|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
24921417|NCT00528879|50014825|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
24921418|NCT00528879|50014826|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
24921419|NCT00528879|50014827|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
24921420|NCT00528879|50014828|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
24921421|NCT00528879|50014825|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
24921422|NCT00528879|50014826|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
24921423|NCT00528879|50014827|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
24921424|NCT00528879|50014828|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
24921425|NCT00528879|50014825|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
24921426|NCT00528879|50014826|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
25023425|NCT03384745|50120802|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
25023426|NCT03384745|50120803|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
25023427|NCT03384745|50120804|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
25023428|NCT03384745|50120799|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
25023429|NCT03384745|50120800|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
25023430|NCT03384745|50120801|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
25023431|NCT03384745|50120802|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
24921427|NCT00528879|50014827|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
24921428|NCT00528879|50014828|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
24921429|NCT00528879|50014825|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
24921430|NCT00528879|50014826|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
24921431|NCT00528879|50014827|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
24921432|NCT00528879|50014828|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
24921433|NCT00528879|50014825|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
24921434|NCT00528879|50014826|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
24921435|NCT00528879|50014827|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
24921436|NCT00528879|50014828|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
24921437|NCT00528879|50014825|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
24921438|NCT00528879|50014826|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
24921439|NCT00528879|50014827|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
24921440|NCT00528879|50014828|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
24921441|NCT00528879|50014825|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
24921442|NCT00528879|50014826|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
24921443|NCT00528879|50014827|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
25023432|NCT03384745|50120803|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
24921444|NCT00528879|50014828|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
24921445|NCT00528879|50014825|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
24921446|NCT00528879|50014826|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
24921447|NCT00528879|50014827|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
24921448|NCT00528879|50014828|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
24921449|NCT00528879|50014825|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
24921450|NCT00528879|50014826|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
24921451|NCT00528879|50014827|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
24921452|NCT00528879|50014828|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
24921453|NCT00608894|50014840|FG000|Overall Study|Withdrawal by Subject|0|||
24921454|NCT00608894|50014841|FG001|Overall Study|Withdrawal by Subject|2|||
24921455|NCT00557856|50014849|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
24921456|NCT00557856|50014850|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
24921457|NCT00557856|50014851|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
24921458|NCT00557856|50014852|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
24921459|NCT00557856|50014853|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
24921460|NCT00557856|50014854|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
24921461|NCT00557856|50014855|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
24921462|NCT00557856|50014856|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
24921463|NCT00557856|50014857|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
24921464|NCT00557856|50014849|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
24921465|NCT00557856|50014850|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
24921466|NCT00557856|50014851|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
24921467|NCT00557856|50014852|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
24921468|NCT00557856|50014853|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
24921469|NCT00557856|50014854|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
24921470|NCT00557856|50014855|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
24921471|NCT00557856|50014856|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
24921472|NCT00557856|50014857|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
24921473|NCT00557856|50014849|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
24921474|NCT00557856|50014850|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
24921475|NCT00557856|50014851|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
24921476|NCT00557856|50014852|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
25154370|NCT00986674|50269502|FG000|Overall Study|unknown/not specify|0|||
25154371|NCT00986674|50269503|FG001|Overall Study|unknown/not specify|7|||
24921477|NCT00557856|50014853|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
24921478|NCT00557856|50014854|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
24921479|NCT00557856|50014855|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
24921480|NCT00557856|50014856|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
24921481|NCT00557856|50014857|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
24921482|NCT00557856|50014849|FG000|Part 1: Dose Escalation Phase|Other|0|||
24921483|NCT00557856|50014850|FG001|Part 1: Dose Escalation Phase|Other|0|||
24921484|NCT00557856|50014851|FG002|Part 1: Dose Escalation Phase|Other|1|||
24921485|NCT00557856|50014852|FG003|Part 1: Dose Escalation Phase|Other|1|||
24921486|NCT00557856|50014853|FG004|Part 1: Dose Escalation Phase|Other|0|||
24921487|NCT00557856|50014854|FG005|Part 1: Dose Escalation Phase|Other|0|||
24921488|NCT00557856|50014855|FG006|Part 1: Dose Escalation Phase|Other|0|||
24921489|NCT00557856|50014856|FG007|Part 1: Dose Escalation Phase|Other|1|||
24921490|NCT00557856|50014857|FG008|Part 1: Dose Escalation Phase|Other|0|||
24921491|NCT00557856|50014849|FG000|Part 1: Dose Escalation Phase|Death|0|||
24921492|NCT00557856|50014850|FG001|Part 1: Dose Escalation Phase|Death|0|||
24921493|NCT00557856|50014851|FG002|Part 1: Dose Escalation Phase|Death|0|||
24921494|NCT00557856|50014852|FG003|Part 1: Dose Escalation Phase|Death|0|||
24921495|NCT00557856|50014853|FG004|Part 1: Dose Escalation Phase|Death|0|||
24921496|NCT00557856|50014854|FG005|Part 1: Dose Escalation Phase|Death|1|||
24921497|NCT00557856|50014855|FG006|Part 1: Dose Escalation Phase|Death|0|||
24921498|NCT00557856|50014856|FG007|Part 1: Dose Escalation Phase|Death|0|||
24921499|NCT00557856|50014857|FG008|Part 1: Dose Escalation Phase|Death|0|||
24921500|NCT00557856|50014849|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
24921501|NCT00557856|50014850|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
24921502|NCT00557856|50014851|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
24921503|NCT00557856|50014852|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
24921504|NCT00557856|50014853|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
24921505|NCT00557856|50014854|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
25154372|NCT00986674|50269504|FG002|Overall Study|unknown/not specify|9|||
24921506|NCT00557856|50014855|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
25154373|NCT00986440|50269514|FG000|Overall Study|Progressive disease|27|||
25154374|NCT00986440|50269515|FG001|Overall Study|Progressive disease|37|||
24921507|NCT00557856|50014856|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
24921508|NCT00557856|50014857|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
24921509|NCT00557856|50014849|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
24921510|NCT00557856|50014850|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
24921511|NCT00557856|50014851|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
24921512|NCT00557856|50014852|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
24921513|NCT00557856|50014853|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
24921514|NCT00557856|50014854|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
24921515|NCT00557856|50014855|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
24921516|NCT00557856|50014856|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
24921517|NCT00557856|50014857|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
24921518|NCT00557856|50014849|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
24921519|NCT00557856|50014850|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
24921520|NCT00557856|50014851|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
24921521|NCT00557856|50014852|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
24921522|NCT00557856|50014853|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
24921523|NCT00557856|50014854|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
24921524|NCT00557856|50014855|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
24921525|NCT00557856|50014856|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
24921526|NCT00557856|50014857|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
24921527|NCT00557856|50014849|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
24921528|NCT00557856|50014850|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
24921529|NCT00557856|50014851|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
24921530|NCT00557856|50014852|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
24921531|NCT00557856|50014853|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
24921532|NCT00557856|50014854|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
24921533|NCT00557856|50014855|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
24921534|NCT00557856|50014856|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
24921535|NCT00557856|50014857|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
24921536|NCT00557856|50014849|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
24921537|NCT00557856|50014850|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
24921538|NCT00557856|50014851|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
24921539|NCT00557856|50014852|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
24921540|NCT00557856|50014853|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
24921541|NCT00557856|50014854|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
24921542|NCT00557856|50014855|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
24921543|NCT00557856|50014856|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
24921544|NCT00557856|50014857|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
24921545|NCT00557856|50014849|FG000|Part 2: Exploratory Phase|Other|0|||
24921546|NCT00557856|50014850|FG001|Part 2: Exploratory Phase|Other|0|||
24921547|NCT00557856|50014851|FG002|Part 2: Exploratory Phase|Other|0|||
24921548|NCT00557856|50014852|FG003|Part 2: Exploratory Phase|Other|0|||
24921549|NCT00557856|50014853|FG004|Part 2: Exploratory Phase|Other|0|||
24921550|NCT00557856|50014854|FG005|Part 2: Exploratory Phase|Other|0|||
24921551|NCT00557856|50014855|FG006|Part 2: Exploratory Phase|Other|0|||
24921552|NCT00557856|50014856|FG007|Part 2: Exploratory Phase|Other|0|||
24921553|NCT00557856|50014857|FG008|Part 2: Exploratory Phase|Other|1|||
24921554|NCT00557856|50014849|FG000|Part 2: Exploratory Phase|Death|0|||
24921555|NCT00557856|50014850|FG001|Part 2: Exploratory Phase|Death|0|||
24921556|NCT00557856|50014851|FG002|Part 2: Exploratory Phase|Death|0|||
24921557|NCT00557856|50014852|FG003|Part 2: Exploratory Phase|Death|0|||
24921558|NCT00557856|50014853|FG004|Part 2: Exploratory Phase|Death|0|||
24921559|NCT00557856|50014854|FG005|Part 2: Exploratory Phase|Death|0|||
24921560|NCT00557856|50014855|FG006|Part 2: Exploratory Phase|Death|0|||
24921561|NCT00557856|50014856|FG007|Part 2: Exploratory Phase|Death|0|||
24921562|NCT00557856|50014857|FG008|Part 2: Exploratory Phase|Death|2|||
24921563|NCT00557856|50014849|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
24921564|NCT00557856|50014850|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
24921565|NCT00557856|50014851|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
25023433|NCT03384745|50120804|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
25023434|NCT03384745|50120799|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
25023435|NCT03384745|50120800|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
25023436|NCT03384745|50120801|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
25023437|NCT03384745|50120802|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
25023438|NCT03384745|50120803|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
25023439|NCT03384745|50120804|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
25023440|NCT03384745|50120799|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
25023441|NCT03384745|50120800|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
24921566|NCT00557856|50014852|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
25023442|NCT03384745|50120801|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
25023443|NCT03384745|50120802|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
25023444|NCT03384745|50120803|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
25023445|NCT03384745|50120804|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
25023446|NCT03384745|50120799|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
25154375|NCT00986440|50269514|FG000|Overall Study|Serious adverse event or adverse event|9|||
25154376|NCT00986440|50269515|FG001|Overall Study|Serious adverse event or adverse event|2|||
25154377|NCT00986440|50269514|FG000|Overall Study|Withdrawal by Subject|1|||
25154378|NCT00986440|50269515|FG001|Overall Study|Withdrawal by Subject|2|||
25154379|NCT00986440|50269514|FG000|Overall Study|Screen failure (not dosed)|4|||
25154380|NCT00986440|50269515|FG001|Overall Study|Screen failure (not dosed)|2|||
25154381|NCT01904383|50269521|FG000|Overall Study|CRF not collected|117|||
25154382|NCT01904383|50269521|FG000|Overall Study|Reason not listed|147|||
25154383|NCT01904383|50269521|FG000|Overall Study|Lost to Follow-up|674|||
25154384|NCT01904383|50269521|FG000|Overall Study|Lack of Efficacy|370|||
25154385|NCT01904383|50269521|FG000|Overall Study|Improvement|141|||
25154386|NCT01904383|50269521|FG000|Overall Study|Adverse Event|271|||
25154387|NCT01904383|50269521|FG000|Overall Study|No patient visit after entry|54|||
25154388|NCT01904149|50269531|FG000|Overall Study|Adverse Event|3|||
25154389|NCT01904149|50269532|FG001|Overall Study|Adverse Event|4|||
25154390|NCT01904149|50269533|FG002|Overall Study|Adverse Event|0|||
25154391|NCT01904149|50269534|FG003|Overall Study|Adverse Event|1|||
25154392|NCT01904149|50269535|FG004|Overall Study|Adverse Event|1|||
25154393|NCT01904149|50269536|FG005|Overall Study|Adverse Event|2|||
25154394|NCT01904149|50269531|FG000|Overall Study|Lack of Efficacy|0|||
25154395|NCT01904149|50269532|FG001|Overall Study|Lack of Efficacy|3|||
25154396|NCT01904149|50269533|FG002|Overall Study|Lack of Efficacy|1|||
25154397|NCT01904149|50269534|FG003|Overall Study|Lack of Efficacy|3|||
25154398|NCT01904149|50269535|FG004|Overall Study|Lack of Efficacy|3|||
25154399|NCT01904149|50269536|FG005|Overall Study|Lack of Efficacy|1|||
25154400|NCT01904149|50269531|FG000|Overall Study|Withdrawal by Subject|1|||
25154401|NCT01904149|50269532|FG001|Overall Study|Withdrawal by Subject|3|||
25154402|NCT01904149|50269533|FG002|Overall Study|Withdrawal by Subject|1|||
25154403|NCT01904149|50269534|FG003|Overall Study|Withdrawal by Subject|0|||
25154404|NCT01904149|50269535|FG004|Overall Study|Withdrawal by Subject|1|||
25154405|NCT01904149|50269536|FG005|Overall Study|Withdrawal by Subject|0|||
25154406|NCT01904149|50269531|FG000|Overall Study|Protocol Violation|0|||
25154407|NCT01904149|50269532|FG001|Overall Study|Protocol Violation|1|||
25154408|NCT01904149|50269533|FG002|Overall Study|Protocol Violation|0|||
25154409|NCT01904149|50269534|FG003|Overall Study|Protocol Violation|0|||
25154410|NCT01904149|50269535|FG004|Overall Study|Protocol Violation|0|||
25185061|NCT00249795|50334152|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
25154411|NCT01904149|50269536|FG005|Overall Study|Protocol Violation|0|||
25154412|NCT01904149|50269531|FG000|Overall Study|non compliance with study drug|1|||
25154413|NCT01904149|50269532|FG001|Overall Study|non compliance with study drug|0|||
25154414|NCT01904149|50269533|FG002|Overall Study|non compliance with study drug|0|||
25154415|NCT01904149|50269534|FG003|Overall Study|non compliance with study drug|0|||
25154416|NCT01904149|50269535|FG004|Overall Study|non compliance with study drug|0|||
25154417|NCT01904149|50269536|FG005|Overall Study|non compliance with study drug|0|||
25185062|NCT00249795|50334153|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
25185063|NCT00249795|50334152|FG000|Overall Study|Other contraindicated medication|1|||
25185064|NCT00249795|50334153|FG001|Overall Study|Other contraindicated medication|1|||
25185065|NCT00249795|50334152|FG000|Overall Study|Event related to cardiac condition|17|||
25185066|NCT00249795|50334153|FG001|Overall Study|Event related to cardiac condition|16|||
25185067|NCT00249795|50334152|FG000|Overall Study|Patient not wish to continue after May08|4|||
25185068|NCT00249795|50334153|FG001|Overall Study|Patient not wish to continue after May08|6|||
25185069|NCT00249795|50334152|FG000|Overall Study|Site not agree to continue after May08|1|||
25185070|NCT00249795|50334153|FG001|Overall Study|Site not agree to continue after May08|1|||
25185071|NCT00249795|50334152|FG000|Overall Study|Lost to Follow-up|0|||
25185072|NCT00249795|50334153|FG001|Overall Study|Lost to Follow-up|2|||
25185073|NCT00249795|50334152|FG000|Overall Study|Missing|0|||
25185074|NCT00249795|50334153|FG001|Overall Study|Missing|1|||
25185075|NCT02651220|50334162|FG000|Overall Study|Adverse Event|1|||
24921567|NCT00557856|50014853|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
25154418|NCT00986362|50269554|FG000|Overall Study|Death|2|||
25154419|NCT00986362|50269555|FG001|Overall Study|Death|0|||
25154420|NCT00986362|50269554|FG000|Overall Study|Lost to Follow-up|0|||
25185076|NCT02651220|50334163|FG001|Overall Study|Adverse Event|5|||
25185077|NCT02651220|50334164|FG002|Overall Study|Adverse Event|1|||
25185078|NCT02651220|50334162|FG000|Overall Study|Lost to Follow-up|8|||
24921568|NCT00557856|50014854|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
24921569|NCT00557856|50014855|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
24921570|NCT00557856|50014856|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
25154421|NCT00986362|50269555|FG001|Overall Study|Lost to Follow-up|1|||
25154422|NCT01890421|50269561|FG000|Overall Study|Adverse Event|1|||
25154423|NCT01890421|50269561|FG000|Overall Study|Other reason|10|||
24921571|NCT00557856|50014857|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
24921572|NCT00191113|50014874|FG000|Core Study|Withdrawal by Subject|25|||
24921573|NCT00191113|50014875|FG001|Core Study|Withdrawal by Subject|9|||
24921574|NCT00191113|50014874|FG000|Core Study|Protocol Violation|6|||
24921575|NCT00191113|50014875|FG001|Core Study|Protocol Violation|2|||
24921576|NCT00191113|50014874|FG000|Core Study|Lost to Follow-up|3|||
24921577|NCT00191113|50014875|FG001|Core Study|Lost to Follow-up|0|||
24921578|NCT00191113|50014874|FG000|Core Study|Adverse Event|0|||
24921579|NCT00191113|50014875|FG001|Core Study|Adverse Event|2|||
24921580|NCT00191113|50014874|FG000|Core Study|Lack of Efficacy|0|||
24921581|NCT00191113|50014875|FG001|Core Study|Lack of Efficacy|2|||
24921582|NCT00191113|50014874|FG000|Core Study|Death|1|||
24921583|NCT00191113|50014875|FG001|Core Study|Death|0|||
24921584|NCT00608582|50014889|FG000|Overall Study|Lost to Follow-up|2|||
24921585|NCT00608582|50014890|FG001|Overall Study|Lost to Follow-up|0|||
24921586|NCT00608582|50014889|FG000|Overall Study|No Best Response in Phase 1 located|1|||
24921587|NCT00608582|50014890|FG001|Overall Study|No Best Response in Phase 1 located|1|||
24921588|NCT00608582|50014889|FG000|Overall Study|Illicit Drug Use|1|||
24921589|NCT00608582|50014890|FG001|Overall Study|Illicit Drug Use|0|||
24921590|NCT00608582|50014889|FG000|Overall Study|Early stage Design Change|0|||
24921591|NCT00608582|50014890|FG001|Overall Study|Early stage Design Change|3|||
24921592|NCT03965052|50014900|FG000|Overall Study|Protocol Violation|1|||
24921593|NCT03965052|50014901|FG001|Overall Study|Protocol Violation|0|||
24921594|NCT03964974|50014909|FG000|Overall Study|Lost to Follow-up|3|||
24921595|NCT03964974|50014910|FG001|Overall Study|Lost to Follow-up|2|||
24921596|NCT03964974|50014909|FG000|Overall Study|Withdrawal by Subject|0|||
24921597|NCT03964974|50014910|FG001|Overall Study|Withdrawal by Subject|3|||
24921598|NCT00606320|50014916|FG000|Overall Study|Adverse Event|3|||
24921599|NCT00606320|50014916|FG000|Overall Study|Lack of Efficacy|5|||
24921600|NCT00606320|50014916|FG000|Overall Study|Physician Decision|7|||
24921601|NCT00606320|50014916|FG000|Overall Study|Protocol Violation|8|||
24921602|NCT00606320|50014916|FG000|Overall Study|Withdrawal by Subject|10|||
24921603|NCT00606320|50014916|FG000|Overall Study|Progression to depressive phase|4|||
24921604|NCT00528411|50014923|FG000|Overall Study|Adverse Event|4|||
24921605|NCT00528411|50014924|FG001|Overall Study|Adverse Event|0|||
24921606|NCT00528411|50014925|FG002|Overall Study|Adverse Event|1|||
25185079|NCT02651220|50334163|FG001|Overall Study|Lost to Follow-up|14|||
24921607|NCT00528411|50014923|FG000|Overall Study|Incorrect Enrolment|1|||
25185080|NCT02651220|50334164|FG002|Overall Study|Lost to Follow-up|14|||
24921608|NCT00528411|50014924|FG001|Overall Study|Incorrect Enrolment|1|||
24921609|NCT00528411|50014925|FG002|Overall Study|Incorrect Enrolment|0|||
24921610|NCT00528411|50014923|FG000|Overall Study|Severe non-compliance to protocol|0|||
24921611|NCT00528411|50014924|FG001|Overall Study|Severe non-compliance to protocol|1|||
24921612|NCT00528411|50014925|FG002|Overall Study|Severe non-compliance to protocol|0|||
24921613|NCT00528411|50014923|FG000|Overall Study|Prior commitment medication|0|||
24921614|NCT00528411|50014924|FG001|Overall Study|Prior commitment medication|1|||
24921615|NCT00528411|50014925|FG002|Overall Study|Prior commitment medication|0|||
24921616|NCT00136357|50014935|FG000|Overall Study|Withdrawal by Subject|3|||
24921617|NCT00136357|50014936|FG001|Overall Study|Withdrawal by Subject|2|||
24921618|NCT00129649|50014944|FG000|Overall Study|Withdrawal by Subject|76|||
24921619|NCT00129649|50014945|FG001|Overall Study|Withdrawal by Subject|65|||
24921620|NCT00187135|50014957|FG000|Visit One|Withdrawal by Subject|1|||
24921621|NCT00187135|50014958|FG001|Visit One|Withdrawal by Subject|0|||
24921622|NCT00187135|50014959|FG002|Visit One|Withdrawal by Subject|0|||
24921623|NCT00187135|50014960|FG003|Visit One|Withdrawal by Subject|0|||
24921624|NCT00187135|50014961|FG004|Visit One|Withdrawal by Subject|0|||
24921625|NCT00187135|50014962|FG005|Visit One|Withdrawal by Subject|1|||
24921626|NCT00187135|50014957|FG000|Visit One|Physician Decision|3|||
24921627|NCT00187135|50014958|FG001|Visit One|Physician Decision|1|||
24921628|NCT00187135|50014959|FG002|Visit One|Physician Decision|0|||
24921629|NCT00187135|50014960|FG003|Visit One|Physician Decision|0|||
24921630|NCT00187135|50014961|FG004|Visit One|Physician Decision|0|||
24921631|NCT00187135|50014962|FG005|Visit One|Physician Decision|1|||
24921632|NCT00187135|50014957|FG000|Visit Two|Death|0|||
24921633|NCT00187135|50014958|FG001|Visit Two|Death|0|||
24921634|NCT00187135|50014959|FG002|Visit Two|Death|0|||
24921635|NCT00187135|50014960|FG003|Visit Two|Death|1|||
24921636|NCT00187135|50014961|FG004|Visit Two|Death|0|||
24921637|NCT00187135|50014962|FG005|Visit Two|Death|1|||
24921638|NCT00187135|50014957|FG000|Visit Two|Physician Decision|1|||
24921639|NCT00187135|50014958|FG001|Visit Two|Physician Decision|0|||
24921640|NCT00187135|50014959|FG002|Visit Two|Physician Decision|0|||
24921641|NCT00187135|50014960|FG003|Visit Two|Physician Decision|0|||
24921642|NCT00187135|50014961|FG004|Visit Two|Physician Decision|0|||
24921643|NCT00187135|50014962|FG005|Visit Two|Physician Decision|0|||
24921644|NCT00187135|50014957|FG000|Visit Two|Withdrawal by Subject|1|||
24921645|NCT00187135|50014958|FG001|Visit Two|Withdrawal by Subject|1|||
24921646|NCT00187135|50014959|FG002|Visit Two|Withdrawal by Subject|1|||
24921647|NCT00187135|50014960|FG003|Visit Two|Withdrawal by Subject|0|||
24921648|NCT00187135|50014961|FG004|Visit Two|Withdrawal by Subject|1|||
24921649|NCT00187135|50014962|FG005|Visit Two|Withdrawal by Subject|1|||
24921650|NCT00187135|50014957|FG000|Visit Two|Study Discontinued|3|||
24921651|NCT00187135|50014958|FG001|Visit Two|Study Discontinued|2|||
24921652|NCT00187135|50014959|FG002|Visit Two|Study Discontinued|1|||
24921653|NCT00187135|50014960|FG003|Visit Two|Study Discontinued|7|||
24921654|NCT00187135|50014961|FG004|Visit Two|Study Discontinued|5|||
24921655|NCT00187135|50014962|FG005|Visit Two|Study Discontinued|6|||
24921656|NCT00187135|50014957|FG000|Visit Three|Death|0|||
24921657|NCT00187135|50014958|FG001|Visit Three|Death|0|||
24921658|NCT00187135|50014959|FG002|Visit Three|Death|1|||
24921659|NCT00187135|50014960|FG003|Visit Three|Death|0|||
24921660|NCT00187135|50014961|FG004|Visit Three|Death|1|||
24921661|NCT00187135|50014962|FG005|Visit Three|Death|0|||
24921662|NCT00187135|50014957|FG000|Visit Three|Withdrawal by Subject|0|||
24921663|NCT00187135|50014958|FG001|Visit Three|Withdrawal by Subject|1|||
24921664|NCT00187135|50014959|FG002|Visit Three|Withdrawal by Subject|1|||
24921665|NCT00187135|50014960|FG003|Visit Three|Withdrawal by Subject|2|||
24921666|NCT00187135|50014961|FG004|Visit Three|Withdrawal by Subject|0|||
24921667|NCT00187135|50014962|FG005|Visit Three|Withdrawal by Subject|0|||
24921668|NCT00187135|50014957|FG000|Visit Three|Study Discontinued|7|||
24921669|NCT00187135|50014958|FG001|Visit Three|Study Discontinued|6|||
24921670|NCT00187135|50014959|FG002|Visit Three|Study Discontinued|7|||
24921671|NCT00187135|50014960|FG003|Visit Three|Study Discontinued|7|||
24921672|NCT00187135|50014961|FG004|Visit Three|Study Discontinued|7|||
24921673|NCT00187135|50014962|FG005|Visit Three|Study Discontinued|6|||
24921674|NCT00528021|50014978|FG000|Overall Study|Lack of Efficacy|17|||
24921675|NCT00528021|50014979|FG001|Overall Study|Lack of Efficacy|13|||
24921676|NCT00528021|50014980|FG002|Overall Study|Lack of Efficacy|7|||
24921677|NCT00528021|50014981|FG003|Overall Study|Lack of Efficacy|9|||
24921678|NCT00560352|50014994|FG000|Overall Study|Adverse event unrelated to study drug|2|||
24921679|NCT00560352|50014995|FG001|Overall Study|Adverse event unrelated to study drug|1|||
24921680|NCT00560352|50014996|FG002|Overall Study|Adverse event unrelated to study drug|1|||
24921681|NCT00560352|50014994|FG000|Overall Study|Study drug toxicity|3|||
24921682|NCT00560352|50014995|FG001|Overall Study|Study drug toxicity|0|||
24921683|NCT00560352|50014996|FG002|Overall Study|Study drug toxicity|1|||
24921684|NCT00560352|50014994|FG000|Overall Study|Disease progression|0|||
24921685|NCT00560352|50014995|FG001|Overall Study|Disease progression|1|||
24921686|NCT00560352|50014996|FG002|Overall Study|Disease progression|1|||
25023447|NCT03384745|50120800|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
24921687|NCT00560352|50014994|FG000|Overall Study|Withdrawal by Subject|1|||
24921688|NCT00560352|50014995|FG001|Overall Study|Withdrawal by Subject|1|||
24921689|NCT00560352|50014996|FG002|Overall Study|Withdrawal by Subject|1|||
24921690|NCT00560352|50014994|FG000|Overall Study|Maximum clinical benefit|1|||
24921691|NCT00560352|50014995|FG001|Overall Study|Maximum clinical benefit|0|||
24921692|NCT00560352|50014996|FG002|Overall Study|Maximum clinical benefit|0|||
24921693|NCT00527787|50015010|FG000|Overall Study|Adverse Event|14|||
24921694|NCT00527787|50015011|FG001|Overall Study|Adverse Event|24|||
24921695|NCT00527787|50015010|FG000|Overall Study|Withdrawal by Subject|13|||
24921696|NCT00527787|50015011|FG001|Overall Study|Withdrawal by Subject|25|||
24921697|NCT00527787|50015010|FG000|Overall Study|Lost to Follow-up|5|||
24921698|NCT00527787|50015011|FG001|Overall Study|Lost to Follow-up|2|||
24921699|NCT00527787|50015010|FG000|Overall Study|Duodenal Ulcer|1|||
24921700|NCT00527787|50015011|FG001|Overall Study|Duodenal Ulcer|10|||
24921701|NCT00527787|50015010|FG000|Overall Study|misc|5|||
24921702|NCT00527787|50015011|FG001|Overall Study|misc|2|||
24921703|NCT00608426|50015019|FG000|Overall Study|Death|32|||
25023448|NCT03384745|50120801|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
25023449|NCT03384745|50120802|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
25023450|NCT03384745|50120803|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
25154424|NCT00985738|50269567|FG000|Overall Study|Study closed prematurely|8|||
24921704|NCT00608426|50015020|FG001|Overall Study|Death|36|||
24921705|NCT00608426|50015019|FG000|Overall Study|Lost to Follow-up|485|||
24921706|NCT00608426|50015020|FG001|Overall Study|Lost to Follow-up|521|||
24921707|NCT00608426|50015019|FG000|Overall Study|refused, health issues, wrong address|319|||
24921708|NCT00608426|50015020|FG001|Overall Study|refused, health issues, wrong address|348|||
24921709|NCT00557076|50015028|FG000|Overall Study|Unblinding|0|||
24921710|NCT00557076|50015029|FG001|Overall Study|Unblinding|1|||
24921711|NCT00129259|50015037|FG000|Overall Study|Lost to Follow-up|1|||
24921712|NCT00129259|50015038|FG001|Overall Study|Lost to Follow-up|1|||
24921713|NCT00129259|50015037|FG000|Overall Study|Withdrawal by Subject|2|||
24921714|NCT00129259|50015038|FG001|Overall Study|Withdrawal by Subject|1|||
24921715|NCT00129259|50015037|FG000|Overall Study|Only available minimal phone assessments|0|||
24921716|NCT00129259|50015038|FG001|Overall Study|Only available minimal phone assessments|1|||
24921717|NCT00186901|50015047|FG000|Overall Study|Pregnancy|6|||
24921718|NCT00186901|50015048|FG001|Overall Study|Pregnancy|3|||
24921719|NCT00186901|50015049|FG002|Overall Study|Pregnancy|0|||
24921720|NCT00186901|50015047|FG000|Overall Study|Lost to Follow-up|6|||
24921721|NCT00186901|50015048|FG001|Overall Study|Lost to Follow-up|3|||
24921722|NCT00186901|50015049|FG002|Overall Study|Lost to Follow-up|0|||
24921723|NCT00186901|50015047|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
24921724|NCT00186901|50015048|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
24921725|NCT00186901|50015049|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
24921726|NCT00186901|50015047|FG000|Overall Study|ALL relapse or second malignancy|1|||
25154425|NCT00985738|50269568|FG001|Overall Study|Study closed prematurely|8|||
24921727|NCT00186901|50015048|FG001|Overall Study|ALL relapse or second malignancy|2|||
24921728|NCT00186901|50015049|FG002|Overall Study|ALL relapse or second malignancy|0|||
25154426|NCT01928485|50269576|FG000|Overall Study|Physician Decision|0|||
25154427|NCT01928485|50269577|FG001|Overall Study|Physician Decision|1|||
25154428|NCT00985504|50269585|FG000|Acute Treatment Period|Adverse Event|3|||
25154429|NCT00985504|50269586|FG001|Acute Treatment Period|Adverse Event|4|||
25154430|NCT00985504|50269585|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
25154431|NCT00985504|50269586|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
25154432|NCT00985504|50269585|FG000|Acute Treatment Period|Protocol Violation|2|||
24921729|NCT00186901|50015047|FG000|Overall Study|Withdrawal by Subject|4|||
24921730|NCT00186901|50015048|FG001|Overall Study|Withdrawal by Subject|5|||
25154433|NCT00985504|50269586|FG001|Acute Treatment Period|Protocol Violation|0|||
25154434|NCT00985504|50269585|FG000|Acute Treatment Period|Sponsor Decision|0|||
25154435|NCT00985504|50269586|FG001|Acute Treatment Period|Sponsor Decision|1|||
25154436|NCT00985504|50269585|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
25154437|NCT00985504|50269586|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
25154438|NCT00985504|50269585|FG000|Optimization Period|Adverse Event|7|||
25154439|NCT00985504|50269586|FG001|Optimization Period|Adverse Event|9|||
25154440|NCT00985504|50269585|FG000|Optimization Period|Death|0|||
25154441|NCT00985504|50269586|FG001|Optimization Period|Death|1|||
25154442|NCT00985504|50269585|FG000|Optimization Period|Lack of Efficacy|5|||
25185081|NCT02651220|50334162|FG000|Overall Study|Non-Compliance with Study Drug|4|||
24921731|NCT00186901|50015049|FG002|Overall Study|Withdrawal by Subject|0|||
24921732|NCT00186901|50015047|FG000|Overall Study|Open label|3|||
24921733|NCT00186901|50015048|FG001|Overall Study|Open label|2|||
24921734|NCT00186901|50015049|FG002|Overall Study|Open label|0|||
24921735|NCT00186901|50015047|FG000|Overall Study|Limited adherence to study requirements|20|||
24921736|NCT00186901|50015048|FG001|Overall Study|Limited adherence to study requirements|23|||
24921737|NCT00186901|50015049|FG002|Overall Study|Limited adherence to study requirements|0|||
25154443|NCT00985504|50269586|FG001|Optimization Period|Lack of Efficacy|3|||
25154444|NCT00985504|50269585|FG000|Optimization Period|Lost to Follow-up|0|||
25154445|NCT00985504|50269586|FG001|Optimization Period|Lost to Follow-up|1|||
25154446|NCT00985504|50269585|FG000|Optimization Period|Physician Decision|1|||
25154447|NCT00985504|50269586|FG001|Optimization Period|Physician Decision|0|||
24921738|NCT00186901|50015047|FG000|Overall Study|Bone Mineral Density > 0|0|||
24921739|NCT00186901|50015048|FG001|Overall Study|Bone Mineral Density > 0|0|||
24921740|NCT00186901|50015049|FG002|Overall Study|Bone Mineral Density > 0|149|||
24921741|NCT00186121|50015086|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
25185082|NCT02651220|50334163|FG001|Overall Study|Non-Compliance with Study Drug|0|||
25185083|NCT02651220|50334164|FG002|Overall Study|Non-Compliance with Study Drug|1|||
25185084|NCT02651220|50334162|FG000|Overall Study|Pregnancy|1|||
25185085|NCT02651220|50334163|FG001|Overall Study|Pregnancy|0|||
25185086|NCT02651220|50334164|FG002|Overall Study|Pregnancy|1|||
25185087|NCT02651220|50334162|FG000|Overall Study|Protocol Violation|0|||
25185088|NCT02651220|50334163|FG001|Overall Study|Protocol Violation|0|||
25185089|NCT02651220|50334164|FG002|Overall Study|Protocol Violation|1|||
25185090|NCT02651220|50334162|FG000|Overall Study|Withdrawal by Subject|5|||
25154448|NCT00985504|50269585|FG000|Optimization Period|Protocol Violation|3|||
25154449|NCT00985504|50269586|FG001|Optimization Period|Protocol Violation|1|||
25154450|NCT00985504|50269585|FG000|Optimization Period|Withdrawal by Subject|10|||
25154451|NCT00985504|50269586|FG001|Optimization Period|Withdrawal by Subject|8|||
25154452|NCT00985426|50269594|FG000|Overall Study|Adverse Event|0|||
25154453|NCT00985426|50269595|FG001|Overall Study|Adverse Event|1|||
25154454|NCT00985426|50269594|FG000|Overall Study|Subject Non-Compliance|3|||
25154455|NCT00985426|50269595|FG001|Overall Study|Subject Non-Compliance|3|||
25154456|NCT00985426|50269594|FG000|Overall Study|Withdrawal by Subject|12|||
25154457|NCT00985426|50269595|FG001|Overall Study|Withdrawal by Subject|16|||
25154458|NCT00985426|50269594|FG000|Overall Study|Lost to Follow-up|8|||
25154459|NCT00985426|50269595|FG001|Overall Study|Lost to Follow-up|10|||
25154460|NCT00985426|50269594|FG000|Overall Study|Death|7|||
25154461|NCT00985426|50269595|FG001|Overall Study|Death|3|||
25154462|NCT00985426|50269594|FG000|Overall Study|Protocol Violation|2|||
25154463|NCT00985426|50269595|FG001|Overall Study|Protocol Violation|0|||
25154464|NCT00985426|50269594|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
25154465|NCT00985426|50269595|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
25154466|NCT00985192|50269601|FG000|Overall Study|Withdrawal by Subject|1|||
25154467|NCT00985192|50269601|FG000|Overall Study|Disease Progression|1|||
25154468|NCT00985192|50269601|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
25154469|NCT00985114|50269607|FG000|Overall Study|Adverse Event|1|||
25154470|NCT00985114|50269608|FG001|Overall Study|Adverse Event|0|||
25154471|NCT00985114|50269607|FG000|Overall Study|Withdrawal by Subject|0|||
25154472|NCT00985114|50269608|FG001|Overall Study|Withdrawal by Subject|2|||
25154473|NCT00984568|50269616|FG000|Overall Study|Withdrawal by Subject|1|||
25154474|NCT00984568|50269617|FG001|Overall Study|Withdrawal by Subject|2|||
25154475|NCT00984568|50269616|FG000|Overall Study|Lack of Efficacy|2|||
25154476|NCT00984568|50269617|FG001|Overall Study|Lack of Efficacy|0|||
25154477|NCT00984568|50269616|FG000|Overall Study|Adverse Event|2|||
25154478|NCT00984568|50269617|FG001|Overall Study|Adverse Event|0|||
25185091|NCT02651220|50334163|FG001|Overall Study|Withdrawal by Subject|6|||
25185092|NCT02651220|50334164|FG002|Overall Study|Withdrawal by Subject|8|||
25185093|NCT02651220|50334162|FG000|Overall Study|Miscellaneous|4|||
25185094|NCT02651220|50334163|FG001|Overall Study|Miscellaneous|1|||
24921742|NCT00186121|50015086|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
24921743|NCT00186121|50015086|FG000|Overall Study|Not eligible (no treatment)|1|||
24921744|NCT00186043|50015092|FG000|Overall Study|Lack of Efficacy|1|||
24921745|NCT00186043|50015093|FG001|Overall Study|Lack of Efficacy|3|||
24921746|NCT00186043|50015092|FG000|Overall Study|Lost to Follow-up|4|||
24921747|NCT00186043|50015093|FG001|Overall Study|Lost to Follow-up|6|||
24921748|NCT00186043|50015092|FG000|Overall Study|Withdrawal by Subject|1|||
24921749|NCT00186043|50015093|FG001|Overall Study|Withdrawal by Subject|0|||
24921750|NCT00186043|50015092|FG000|Overall Study|Adverse Event|7|||
24921751|NCT00186043|50015093|FG001|Overall Study|Adverse Event|3|||
24921752|NCT00186043|50015092|FG000|Overall Study|Protocol Violation|2|||
24921753|NCT00186043|50015093|FG001|Overall Study|Protocol Violation|1|||
24921754|NCT00185965|50015101|FG000|Overall Study|Adverse Event|0|||
24921755|NCT00185965|50015102|FG001|Overall Study|Adverse Event|1|||
24921756|NCT00607880|50015110|FG000|Overall Study|Unable to place port due to occlusion|1|||
24921757|NCT00607880|50015111|FG001|Overall Study|Unable to place port due to occlusion|0|||
24921758|NCT00127933|50015119|FG000|Overall Study|Randomized but not dosed|1|||
24921759|NCT00127933|50015120|FG001|Overall Study|Randomized but not dosed|0|||
24921760|NCT03875313|50015131|FG000|Overall Study|Withdrawal by Subject|1|||
24921761|NCT03875313|50015132|FG001|Overall Study|Withdrawal by Subject|3|||
24921762|NCT03875313|50015133|FG002|Overall Study|Withdrawal by Subject|0|||
24921763|NCT03875313|50015134|FG003|Overall Study|Withdrawal by Subject|0|||
24921764|NCT03875313|50015135|FG004|Overall Study|Withdrawal by Subject|0|||
24921765|NCT03875313|50015131|FG000|Overall Study|Death|0|||
25154479|NCT00984568|50269616|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
25154480|NCT00984568|50269617|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
25154481|NCT00984568|50269616|FG000|Overall Study|Lost to Follow-up|0|||
25154482|NCT00984568|50269617|FG001|Overall Study|Lost to Follow-up|1|||
25154483|NCT00984568|50269616|FG000|Overall Study|Opportunistic Infection|1|||
25154484|NCT00984568|50269617|FG001|Overall Study|Opportunistic Infection|0|||
25185095|NCT02651220|50334164|FG002|Overall Study|Miscellaneous|2|||
24921766|NCT03875313|50015132|FG001|Overall Study|Death|0|||
24921767|NCT03875313|50015133|FG002|Overall Study|Death|0|||
24921768|NCT03875313|50015134|FG003|Overall Study|Death|0|||
24921769|NCT03875313|50015135|FG004|Overall Study|Death|1|||
24921770|NCT03875313|50015131|FG000|Overall Study|Lost to Follow-up|0|||
24921771|NCT03875313|50015132|FG001|Overall Study|Lost to Follow-up|0|||
24921772|NCT03875313|50015133|FG002|Overall Study|Lost to Follow-up|0|||
24921773|NCT03875313|50015134|FG003|Overall Study|Lost to Follow-up|0|||
24921774|NCT03875313|50015135|FG004|Overall Study|Lost to Follow-up|1|||
24921775|NCT03875313|50015131|FG000|Overall Study|Study Termination by Sponsor|0|||
24921776|NCT03875313|50015132|FG001|Overall Study|Study Termination by Sponsor|1|||
24921777|NCT03875313|50015133|FG002|Overall Study|Study Termination by Sponsor|1|||
24921778|NCT03875313|50015134|FG003|Overall Study|Study Termination by Sponsor|0|||
24921779|NCT03875313|50015135|FG004|Overall Study|Study Termination by Sponsor|1|||
24921780|NCT03875313|50015131|FG000|Overall Study|New Anticancer Treatment|0|||
24921781|NCT03875313|50015132|FG001|Overall Study|New Anticancer Treatment|1|||
24921782|NCT03875313|50015133|FG002|Overall Study|New Anticancer Treatment|2|||
24921783|NCT03875313|50015134|FG003|Overall Study|New Anticancer Treatment|1|||
24921784|NCT03875313|50015135|FG004|Overall Study|New Anticancer Treatment|0|||
24921785|NCT03875313|50015131|FG000|Overall Study|Other, Not Specified|2|||
24921786|NCT03875313|50015132|FG001|Overall Study|Other, Not Specified|11|||
24921787|NCT03875313|50015133|FG002|Overall Study|Other, Not Specified|3|||
24921788|NCT03875313|50015134|FG003|Overall Study|Other, Not Specified|3|||
24921789|NCT03875313|50015135|FG004|Overall Study|Other, Not Specified|1|||
24921790|NCT00556998|50015147|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
24921791|NCT00556998|50015147|FG000|Voriconazole Intravenous (IV)|Other|4|||
24921792|NCT00556998|50015147|FG000|Voriconazole Oral|Adverse Event|1|||
25023451|NCT03384745|50120804|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
25023452|NCT03384745|50120799|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
25023453|NCT03384745|50120800|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
25023454|NCT03384745|50120801|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
25023455|NCT03384745|50120802|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
25023456|NCT03384745|50120803|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
24921793|NCT00556998|50015147|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
24921794|NCT00528801|50015157|FG000|Overall Study|Withdrawal by Subject|1|||
24921795|NCT00528801|50015158|FG001|Overall Study|Withdrawal by Subject|1|||
24921796|NCT00528801|50015157|FG000|Overall Study|Protocol Violation|11|||
24921797|NCT00528801|50015158|FG001|Overall Study|Protocol Violation|5|||
24921798|NCT00528801|50015157|FG000|Overall Study|Lost to Follow-up|15|||
24921799|NCT00528801|50015158|FG001|Overall Study|Lost to Follow-up|4|||
24921800|NCT00528801|50015157|FG000|Overall Study|Administrative Reasons|0|||
24921801|NCT00528801|50015158|FG001|Overall Study|Administrative Reasons|1|||
24921802|NCT00527397|50015164|FG000|Overall Study|Adverse Event|3|||
25023457|NCT03384745|50120804|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
25023458|NCT03384745|50120799|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
25023459|NCT03384745|50120800|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
25023460|NCT03384745|50120801|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
25023461|NCT03384745|50120802|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
24921803|NCT00527397|50015164|FG000|Overall Study|Lack of Efficacy|1|||
24921804|NCT00527397|50015164|FG000|Overall Study|Protocol Violation|1|||
24921805|NCT00527397|50015164|FG000|Overall Study|Withdrawal by Subject|6|||
24921806|NCT00527397|50015164|FG000|Overall Study|Study terminated by sponsor|13|||
24921807|NCT00527319|50015174|FG000|Overall Study|Withdrawal by Subject|5|||
24921808|NCT00527319|50015175|FG001|Overall Study|Withdrawal by Subject|0|||
24921809|NCT00527319|50015176|FG002|Overall Study|Withdrawal by Subject|1|||
24921810|NCT00527319|50015174|FG000|Overall Study|Lost to Follow-up|1|||
24921811|NCT00527319|50015175|FG001|Overall Study|Lost to Follow-up|0|||
24921812|NCT00527319|50015176|FG002|Overall Study|Lost to Follow-up|0|||
24921813|NCT00527319|50015174|FG000|Overall Study|Death|0|||
24921814|NCT00527319|50015175|FG001|Overall Study|Death|3|||
24921815|NCT00527319|50015176|FG002|Overall Study|Death|1|||
24921816|NCT00527319|50015174|FG000|Overall Study|Intercurrent Medical Illness|0|||
24921817|NCT00527319|50015175|FG001|Overall Study|Intercurrent Medical Illness|1|||
24921818|NCT00527319|50015176|FG002|Overall Study|Intercurrent Medical Illness|3|||
24921819|NCT00527319|50015174|FG000|Overall Study|Adverse Event|0|||
24921820|NCT00527319|50015175|FG001|Overall Study|Adverse Event|0|||
24921821|NCT00527319|50015176|FG002|Overall Study|Adverse Event|1|||
24921822|NCT00562302|50015186|FG000|Overall Study|Lost to Follow-up|3|||
24921823|NCT00562302|50015187|FG001|Overall Study|Lost to Follow-up|3|||
24921824|NCT00562302|50015186|FG000|Overall Study|Adverse Event|0|||
24921825|NCT00562302|50015187|FG001|Overall Study|Adverse Event|6|||
24921826|NCT00562302|50015186|FG000|Overall Study|Non-compliance|1|||
25023462|NCT03384745|50120803|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
24921827|NCT00562302|50015187|FG001|Overall Study|Non-compliance|2|||
24921828|NCT00562302|50015186|FG000|Overall Study|Withdrawal by Subject|7|||
24921829|NCT00562302|50015187|FG001|Overall Study|Withdrawal by Subject|8|||
24921830|NCT00562302|50015186|FG000|Overall Study|Death|1|||
24921831|NCT00562302|50015187|FG001|Overall Study|Death|2|||
24921832|NCT00562302|50015186|FG000|Overall Study|Lung resection prior to study completion|7|||
24921833|NCT00562302|50015187|FG001|Overall Study|Lung resection prior to study completion|7|||
24921834|NCT00562302|50015186|FG000|Overall Study|Not stated|1|||
24921835|NCT00562302|50015187|FG001|Overall Study|Not stated|4|||
24921836|NCT00134719|50015196|FG000|Primary Vaccination Phase|Adverse Event|4|||
24921837|NCT00134719|50015197|FG001|Primary Vaccination Phase|Adverse Event|0|||
24921838|NCT00134719|50015198|FG002|Primary Vaccination Phase|Adverse Event|0|||
24921839|NCT00134719|50015196|FG000|Primary Vaccination Phase|Protocol Violation|1|||
24921840|NCT00134719|50015197|FG001|Primary Vaccination Phase|Protocol Violation|0|||
24921841|NCT00134719|50015198|FG002|Primary Vaccination Phase|Protocol Violation|0|||
24921842|NCT00134719|50015196|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
24921843|NCT00134719|50015197|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
24921844|NCT00134719|50015198|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
24921845|NCT00134719|50015196|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
24921846|NCT00134719|50015197|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
24921847|NCT00134719|50015198|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
24921848|NCT00134719|50015196|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
24921849|NCT00134719|50015197|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
24921850|NCT00134719|50015198|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
24921851|NCT00134719|50015196|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
24921852|NCT00134719|50015197|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
24921853|NCT00134719|50015198|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
24921854|NCT00526071|50015215|FG000|Overall Study|Adverse Event|1|||
24921855|NCT00526071|50015215|FG000|Overall Study|Withdrawal by Subject|1|||
24921856|NCT00526071|50015215|FG000|Overall Study|Lack of Response to Study Drug|4|||
24921857|NCT00525915|50015225|FG000|Overall Study|Non-Compliance|0|||
24921858|NCT00525915|50015226|FG001|Overall Study|Non-Compliance|1|||
25023463|NCT03384745|50120804|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
25023464|NCT03384745|50120799|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
25023465|NCT03384745|50120800|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
25023466|NCT03384745|50120801|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
25023467|NCT03384745|50120802|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
25023468|NCT03384745|50120803|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
25023469|NCT03384745|50120804|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
25023470|NCT03383887|50120824|FG000|Overall Study|Lost to Follow-up|0|||
25023471|NCT03383887|50120825|FG001|Overall Study|Lost to Follow-up|1|||
25023472|NCT03379753|50120833|FG000|Overall Study|Withdrawal by Subject|2|||
25023473|NCT03379753|50120834|FG001|Overall Study|Withdrawal by Subject|1|||
25023474|NCT03379753|50120833|FG000|Overall Study|not having correct procedure|1|||
25023475|NCT03379753|50120834|FG001|Overall Study|not having correct procedure|2|||
25023476|NCT03379753|50120833|FG000|Overall Study|No primary outcome|12|||
25023477|NCT03379753|50120834|FG001|Overall Study|No primary outcome|22|||
25023478|NCT03548064|50120848|FG000|Overall Study|Withdrawal by Subject|0|||
25023479|NCT03548064|50120849|FG001|Overall Study|Withdrawal by Subject|0|||
25023480|NCT03548064|50120850|FG002|Overall Study|Withdrawal by Subject|0|||
25023481|NCT03548064|50120851|FG003|Overall Study|Withdrawal by Subject|1|||
25023482|NCT03548064|50120852|FG004|Overall Study|Withdrawal by Subject|0|||
24921859|NCT00525915|50015225|FG000|Overall Study|Disease Progression|5|||
24921860|NCT00525915|50015226|FG001|Overall Study|Disease Progression|6|||
24921861|NCT00525915|50015225|FG000|Overall Study|Withdrawal by Subject|1|||
24921862|NCT00525915|50015226|FG001|Overall Study|Withdrawal by Subject|0|||
24921863|NCT00525915|50015225|FG000|Overall Study|Refused Surgery|1|||
24921864|NCT00525915|50015226|FG001|Overall Study|Refused Surgery|2|||
24921865|NCT00525915|50015225|FG000|Overall Study|Unrelated illness|1|||
24921866|NCT00525915|50015226|FG001|Overall Study|Unrelated illness|0|||
24921867|NCT00521079|50015234|FG000|Overall Study|Adverse Event|7|||
25023483|NCT03548064|50120853|FG005|Overall Study|Withdrawal by Subject|0|||
25023484|NCT03548064|50120854|FG006|Overall Study|Withdrawal by Subject|0|||
25023485|NCT03548064|50120855|FG007|Overall Study|Withdrawal by Subject|0|||
24921868|NCT00521079|50015235|FG001|Overall Study|Adverse Event|1|||
24921869|NCT00521079|50015234|FG000|Overall Study|Lost to Follow-up|2|||
24921870|NCT00521079|50015235|FG001|Overall Study|Lost to Follow-up|1|||
24921871|NCT00521079|50015234|FG000|Overall Study|Withdrawal by Subject|5|||
24921872|NCT00521079|50015235|FG001|Overall Study|Withdrawal by Subject|3|||
24921873|NCT00521001|50015241|FG000|Overall Study|Ineligible|1|||
24921874|NCT00134563|50015248|FG000|Overall Study|Not treated due to protocol violation|0|||
24921875|NCT00134563|50015249|FG001|Overall Study|Not treated due to protocol violation|1|||
24921876|NCT00134563|50015250|FG002|Overall Study|Not treated due to protocol violation|1|||
24921877|NCT00134563|50015248|FG000|Overall Study|Adverse Event|29|||
24921878|NCT00134563|50015249|FG001|Overall Study|Adverse Event|37|||
24921879|NCT00134563|50015250|FG002|Overall Study|Adverse Event|38|||
24921880|NCT00134563|50015248|FG000|Overall Study|Lack of Efficacy|24|||
24921881|NCT00134563|50015249|FG001|Overall Study|Lack of Efficacy|14|||
24921882|NCT00134563|50015250|FG002|Overall Study|Lack of Efficacy|17|||
24921883|NCT00134563|50015248|FG000|Overall Study|Protocol Violation|3|||
24921884|NCT00134563|50015249|FG001|Overall Study|Protocol Violation|2|||
24921885|NCT00134563|50015250|FG002|Overall Study|Protocol Violation|5|||
24921886|NCT00134563|50015248|FG000|Overall Study|Lost to Follow-up|4|||
24921887|NCT00134563|50015249|FG001|Overall Study|Lost to Follow-up|0|||
24921888|NCT00134563|50015250|FG002|Overall Study|Lost to Follow-up|2|||
24921889|NCT00134563|50015248|FG000|Overall Study|progressive disease|11|||
24921890|NCT00134563|50015249|FG001|Overall Study|progressive disease|4|||
24921891|NCT00134563|50015250|FG002|Overall Study|progressive disease|2|||
24921892|NCT00134563|50015248|FG000|Overall Study|did not wish to continue|33|||
24921893|NCT00134563|50015249|FG001|Overall Study|did not wish to continue|32|||
24921894|NCT00134563|50015250|FG002|Overall Study|did not wish to continue|26|||
24921895|NCT00134563|50015248|FG000|Overall Study|Reason other than above|0|||
24921896|NCT00134563|50015249|FG001|Overall Study|Reason other than above|2|||
24921897|NCT00134563|50015250|FG002|Overall Study|Reason other than above|5|||
24921898|NCT00520845|50015258|FG000|Overall Study|Death|3|||
24921899|NCT00520845|50015258|FG000|Overall Study|Adverse Event|4|||
24921900|NCT00520845|50015258|FG000|Overall Study|Disease Progression, relapse|13|||
24921901|NCT00520845|50015258|FG000|Overall Study|Withdrawal by Subject|1|||
24921902|NCT00520845|50015258|FG000|Overall Study|Alternative Therapy|1|||
24921903|NCT00185731|50015262|FG000|Overall Study|Withdrawal by Subject|1|||
24921904|NCT00185731|50015262|FG000|Overall Study|Not Eligible|1|||
24921905|NCT00582491|50015270|FG000|Overall Study|Withdrawal by Subject|1|||
24921906|NCT00582491|50015271|FG001|Overall Study|Withdrawal by Subject|0|||
24921907|NCT00520767|50015277|FG000|Overall Study|Death|2|||
24921908|NCT04679051|50015283|FG000|Overall Study|felt tired after restricted time in bed|3|||
24921909|NCT04679051|50015284|FG001|Overall Study|felt tired after restricted time in bed|0|||
24921910|NCT04679051|50015283|FG000|Overall Study|discomfort with blood pressure cuff|2|||
24921911|NCT04679051|50015284|FG001|Overall Study|discomfort with blood pressure cuff|0|||
24921912|NCT04679051|50015283|FG000|Overall Study|scheduling conflict|1|||
24921913|NCT04679051|50015284|FG001|Overall Study|scheduling conflict|1|||
24921914|NCT04679051|50015283|FG000|Overall Study|Protocol Violation|0|||
24921915|NCT04679051|50015284|FG001|Overall Study|Protocol Violation|4|||
24921916|NCT03873987|50015295|FG000|Overall Study|Adverse Event|1|||
24921917|NCT03873987|50015296|FG001|Overall Study|Adverse Event|0|||
24921918|NCT03873987|50015295|FG000|Overall Study|staff was unable to start a new IV line|1|||
24921919|NCT03873987|50015296|FG001|Overall Study|staff was unable to start a new IV line|0|||
24921920|NCT03873987|50015295|FG000|Overall Study|Lost to Follow-up|0|||
24921921|NCT03873987|50015296|FG001|Overall Study|Lost to Follow-up|1|||
24921922|NCT00474760|50015314|FG000|Overall Study|Death|0|||
24921923|NCT00474760|50015315|FG001|Overall Study|Death|0|||
24921924|NCT00474760|50015316|FG002|Overall Study|Death|0|||
24921925|NCT00474760|50015317|FG003|Overall Study|Death|0|||
24921926|NCT00474760|50015318|FG004|Overall Study|Death|2|||
24921927|NCT00474760|50015319|FG005|Overall Study|Death|0|||
24921928|NCT00474760|50015320|FG006|Overall Study|Death|0|||
24921929|NCT00474760|50015314|FG000|Overall Study|Adverse Event|0|||
24921930|NCT00474760|50015315|FG001|Overall Study|Adverse Event|0|||
24921931|NCT00474760|50015316|FG002|Overall Study|Adverse Event|0|||
24921932|NCT00474760|50015317|FG003|Overall Study|Adverse Event|0|||
24921933|NCT00474760|50015318|FG004|Overall Study|Adverse Event|1|||
24921934|NCT00474760|50015319|FG005|Overall Study|Adverse Event|7|||
24921935|NCT00474760|50015320|FG006|Overall Study|Adverse Event|0|||
24921936|NCT00474760|50015314|FG000|Overall Study|Laboratory abnormality|0|||
24921937|NCT00474760|50015315|FG001|Overall Study|Laboratory abnormality|0|||
24921938|NCT00474760|50015316|FG002|Overall Study|Laboratory abnormality|0|||
24921939|NCT00474760|50015317|FG003|Overall Study|Laboratory abnormality|0|||
24921940|NCT00474760|50015318|FG004|Overall Study|Laboratory abnormality|0|||
24921941|NCT00474760|50015319|FG005|Overall Study|Laboratory abnormality|1|||
24921942|NCT00474760|50015320|FG006|Overall Study|Laboratory abnormality|0|||
24921943|NCT00474760|50015314|FG000|Overall Study|Withdrawal by Subject|0|||
24921944|NCT00474760|50015315|FG001|Overall Study|Withdrawal by Subject|0|||
24921945|NCT00474760|50015316|FG002|Overall Study|Withdrawal by Subject|0|||
24921946|NCT00474760|50015317|FG003|Overall Study|Withdrawal by Subject|1|||
24921947|NCT00474760|50015318|FG004|Overall Study|Withdrawal by Subject|0|||
24921948|NCT00474760|50015319|FG005|Overall Study|Withdrawal by Subject|1|||
24921949|NCT00474760|50015320|FG006|Overall Study|Withdrawal by Subject|1|||
24921950|NCT00474760|50015314|FG000|Overall Study|Other|0|||
24921951|NCT00474760|50015315|FG001|Overall Study|Other|1|||
24921952|NCT00474760|50015316|FG002|Overall Study|Other|0|||
24921953|NCT00474760|50015317|FG003|Overall Study|Other|0|||
24921954|NCT00474760|50015318|FG004|Overall Study|Other|1|||
24921955|NCT00474760|50015319|FG005|Overall Study|Other|0|||
24921956|NCT00474760|50015320|FG006|Overall Study|Other|0|||
24921957|NCT00474760|50015314|FG000|Overall Study|Progressive disease|3|||
24921958|NCT00474760|50015315|FG001|Overall Study|Progressive disease|2|||
24921959|NCT00474760|50015316|FG002|Overall Study|Progressive disease|3|||
24921960|NCT00474760|50015317|FG003|Overall Study|Progressive disease|2|||
24921961|NCT00474760|50015318|FG004|Overall Study|Progressive disease|8|||
24921962|NCT00474760|50015319|FG005|Overall Study|Progressive disease|20|||
24921963|NCT00474760|50015320|FG006|Overall Study|Progressive disease|7|||
24921964|NCT00474760|50015314|FG000|Overall Study|Terminated by sponsor|0|||
24921965|NCT00474760|50015315|FG001|Overall Study|Terminated by sponsor|0|||
24921966|NCT00474760|50015316|FG002|Overall Study|Terminated by sponsor|0|||
24921967|NCT00474760|50015317|FG003|Overall Study|Terminated by sponsor|0|||
24921968|NCT00474760|50015318|FG004|Overall Study|Terminated by sponsor|0|||
24921969|NCT00474760|50015319|FG005|Overall Study|Terminated by sponsor|0|||
24921970|NCT00474760|50015320|FG006|Overall Study|Terminated by sponsor|2|||
24921971|NCT00528645|50015343|FG000|Overall Study|Adverse Event|3|||
24921972|NCT00524745|50015352|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
24921973|NCT00524745|50015353|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
24921974|NCT00524745|50015354|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
24921975|NCT00524745|50015355|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
24921976|NCT00495040|50015365|FG000|Overall Study|Withdrawal by Subject|3|||
24921977|NCT00494026|50015373|FG000|Overall Study|Sponsor Decision|4|||
24921978|NCT00524589|50015377|FG000|Overall Study|Withdrawal by Subject|2|||
24921979|NCT00524589|50015377|FG000|Overall Study|Disease Progression|16|||
24921980|NCT00472030|50015383|FG000|Overall Study|Physician Decision|1|||
24921981|NCT00472030|50015384|FG001|Overall Study|Physician Decision|0|||
25154485|NCT00984568|50269616|FG000|Overall Study|Unknown Reason|1|||
25154486|NCT00984568|50269617|FG001|Overall Study|Unknown Reason|3|||
24921982|NCT00127855|50015399|FG000|Primary Vaccination Course|Adverse Event|0|||
24921983|NCT00127855|50015400|FG001|Primary Vaccination Course|Adverse Event|0|||
24921984|NCT00127855|50015401|FG002|Primary Vaccination Course|Adverse Event|1|||
24921985|NCT00127855|50015402|FG003|Primary Vaccination Course|Adverse Event|0|||
25023486|NCT03548064|50120848|FG000|Overall Study|Lost to Follow-up|0|||
25023487|NCT03548064|50120849|FG001|Overall Study|Lost to Follow-up|0|||
25023488|NCT03548064|50120850|FG002|Overall Study|Lost to Follow-up|0|||
25023489|NCT03548064|50120851|FG003|Overall Study|Lost to Follow-up|0|||
25023490|NCT03548064|50120852|FG004|Overall Study|Lost to Follow-up|2|||
25023491|NCT03548064|50120853|FG005|Overall Study|Lost to Follow-up|0|||
25023492|NCT03548064|50120854|FG006|Overall Study|Lost to Follow-up|0|||
25023493|NCT03548064|50120855|FG007|Overall Study|Lost to Follow-up|0|||
25023494|NCT03548064|50120848|FG000|Overall Study|Covid-19 Pandemic|0|||
25023495|NCT03548064|50120849|FG001|Overall Study|Covid-19 Pandemic|0|||
25023496|NCT03548064|50120850|FG002|Overall Study|Covid-19 Pandemic|0|||
25023497|NCT03548064|50120851|FG003|Overall Study|Covid-19 Pandemic|0|||
25023498|NCT03548064|50120852|FG004|Overall Study|Covid-19 Pandemic|10|||
25023499|NCT03548064|50120853|FG005|Overall Study|Covid-19 Pandemic|3|||
25023500|NCT03548064|50120854|FG006|Overall Study|Covid-19 Pandemic|0|||
25023501|NCT03548064|50120855|FG007|Overall Study|Covid-19 Pandemic|0|||
25154487|NCT00984256|50269625|FG000|Overall Study|Withdrawal by Subject|0|||
25154488|NCT00984256|50269626|FG001|Overall Study|Withdrawal by Subject|1|||
24921986|NCT00127855|50015403|FG004|Primary Vaccination Course|Adverse Event|0|||
24921987|NCT00127855|50015399|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
24921988|NCT00127855|50015400|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
24921989|NCT00127855|50015401|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
24921990|NCT00127855|50015402|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
24921991|NCT00127855|50015403|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
24921992|NCT00127855|50015399|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
24921993|NCT00127855|50015400|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
24921994|NCT00127855|50015401|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
25185096|NCT02651220|50334162|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
25185097|NCT02651220|50334163|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
25185098|NCT02651220|50334164|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
25185099|NCT00247611|50334212|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
25185100|NCT00247611|50334213|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
25185101|NCT00247611|50334212|FG000|Baselined|Completed baseline only|9|||
25154489|NCT00984022|50269643|FG000|Overall Study|Lost to Follow-up|10|||
25154490|NCT00984022|50269644|FG001|Overall Study|Lost to Follow-up|14|||
25185102|NCT00247611|50334213|FG001|Baselined|Completed baseline only|8|||
25185103|NCT00246753|50334229|FG000|Overall Study|Withdrawal by Subject|2|||
25185104|NCT00246753|50334229|FG000|Overall Study|Physician Decision|2|||
25185105|NCT00246753|50334229|FG000|Overall Study|Adverse Event|2|||
25185106|NCT00246753|50334229|FG000|Overall Study|Unacceptable toxicity|2|||
25185107|NCT00246129|50334246|FG000|Overall Study|Lost to Follow-up|1|||
25185108|NCT00246129|50334247|FG001|Overall Study|Lost to Follow-up|0|||
25154491|NCT01890265|50269656|FG000|Overall Study|Other (Unspecified reason)|0|||
24921995|NCT00127855|50015402|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
25154492|NCT01890265|50269657|FG001|Overall Study|Other (Unspecified reason)|1|||
25154493|NCT01890265|50269658|FG002|Overall Study|Other (Unspecified reason)|0|||
25154494|NCT01890265|50269659|FG003|Overall Study|Other (Unspecified reason)|0|||
25154495|NCT01890265|50269660|FG004|Overall Study|Other (Unspecified reason)|0|||
25154496|NCT01890265|50269661|FG005|Overall Study|Other (Unspecified reason)|0|||
25154497|NCT01890265|50269656|FG000|Overall Study|Progressive disease|6|||
25185109|NCT00246129|50334246|FG000|Overall Study|Death|2|||
25185110|NCT00246129|50334247|FG001|Overall Study|Death|1|||
25185111|NCT00246129|50334246|FG000|Overall Study|suffered primary non-function|1|||
24921996|NCT00127855|50015403|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
24921997|NCT00127855|50015399|FG000|Primary Vaccination Course|Other|0|||
25023502|NCT03379675|50120882|FG000|Overall Study|Lost to Follow-up|0|||
25023503|NCT03379675|50120883|FG001|Overall Study|Lost to Follow-up|1|||
25154498|NCT01890265|50269657|FG001|Overall Study|Progressive disease|6|||
25023504|NCT03379675|50120884|FG002|Overall Study|Lost to Follow-up|0|||
25023505|NCT03379675|50120882|FG000|Overall Study|Adverse Event|2|||
25023506|NCT03379675|50120883|FG001|Overall Study|Adverse Event|0|||
25185112|NCT00246129|50334247|FG001|Overall Study|suffered primary non-function|0|||
25185113|NCT00246129|50334246|FG000|Overall Study|grafts failed|3|||
25185114|NCT00246129|50334247|FG001|Overall Study|grafts failed|1|||
25185115|NCT03182868|50334270|FG000|Overall Study|Protocol Violation|3|||
25185116|NCT03182868|50334271|FG001|Overall Study|Protocol Violation|0|||
25185117|NCT03182868|50334272|FG002|Overall Study|Protocol Violation|4|||
25185118|NCT03182868|50334273|FG003|Overall Study|Protocol Violation|1|||
25185119|NCT03182868|50334274|FG004|Overall Study|Protocol Violation|8|||
25185120|NCT00245583|50334298|FG000|Overall Study|Lost to Follow-up|1|||
24921998|NCT00127855|50015400|FG001|Primary Vaccination Course|Other|0|||
24921999|NCT00127855|50015401|FG002|Primary Vaccination Course|Other|0|||
24922000|NCT00127855|50015402|FG003|Primary Vaccination Course|Other|0|||
24922001|NCT00127855|50015403|FG004|Primary Vaccination Course|Other|1|||
24922002|NCT00493636|50015417|FG000|Overall Study|Withdrawal by Subject|1|||
24922003|NCT00493636|50015418|FG001|Overall Study|Withdrawal by Subject|0|||
24922004|NCT00493636|50015417|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
24922005|NCT00493636|50015418|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
24922006|NCT00493636|50015417|FG000|Overall Study|Mis-randomization|1|||
24922007|NCT00493636|50015418|FG001|Overall Study|Mis-randomization|1|||
24922008|NCT00524121|50015424|FG000|Overall Study|Disease progression|6|||
24922009|NCT00524121|50015424|FG000|Overall Study|Adverse Event|4|||
24922010|NCT00524121|50015424|FG000|Overall Study|Patient refused|2|||
24922011|NCT00524121|50015424|FG000|Overall Study|Other|1|||
24922012|NCT00524121|50015424|FG000|Overall Study|Death|1|||
24922013|NCT00524121|50015424|FG000|Overall Study|Not treated (became ineligible)|4|||
24922014|NCT00524121|50015424|FG000|Overall Study|Not treated (changed mind)|1|||
24922015|NCT00470626|50015439|FG000|Overall Study|Lost to Follow-up|10|||
24922016|NCT00470626|50015439|FG000|Overall Study|Withdrawal by Subject|7|||
24922017|NCT00133705|50015445|FG000|Overall Study|Withdrawal by Subject|2|||
24922018|NCT00133705|50015446|FG001|Overall Study|Withdrawal by Subject|3|||
24922019|NCT00132769|50015454|FG000|Overall Study|Withdrawal by Subject|1|||
24922020|NCT00132769|50015455|FG001|Overall Study|Withdrawal by Subject|3|||
24922021|NCT00132769|50015454|FG000|Overall Study|Lack of Efficacy|7|||
24922022|NCT00132769|50015455|FG001|Overall Study|Lack of Efficacy|6|||
24922023|NCT00132769|50015454|FG000|Overall Study|Adverse Event|2|||
24922024|NCT00132769|50015455|FG001|Overall Study|Adverse Event|1|||
24922025|NCT00132769|50015454|FG000|Overall Study|Protocol Violation|1|||
24922026|NCT00132769|50015455|FG001|Overall Study|Protocol Violation|1|||
24922027|NCT00520299|50015464|FG000|Overall Study|Withdrawal by Subject|0|||
24922028|NCT00520299|50015465|FG001|Overall Study|Withdrawal by Subject|0|||
24922029|NCT00520299|50015466|FG002|Overall Study|Withdrawal by Subject|2|||
24922030|NCT00520299|50015464|FG000|Overall Study|Progressive disease|0|||
24922031|NCT00520299|50015465|FG001|Overall Study|Progressive disease|3|||
24922032|NCT00520299|50015466|FG002|Overall Study|Progressive disease|4|||
24922033|NCT02478255|50015476|FG000|Overall Study|Physician Decision|6|||
24922034|NCT02478255|50015477|FG001|Overall Study|Physician Decision|0|||
24922035|NCT02478255|50015476|FG000|Overall Study|Withdrawal by Subject|2|||
24922036|NCT02478255|50015477|FG001|Overall Study|Withdrawal by Subject|0|||
24922037|NCT00132691|50015485|FG000|Overall Study|Lost to Follow-up|5|||
24922038|NCT00132691|50015486|FG001|Overall Study|Lost to Follow-up|8|||
24922039|NCT00132691|50015485|FG000|Overall Study|Missed 2-year visit|4|||
24922040|NCT00132691|50015486|FG001|Overall Study|Missed 2-year visit|4|||
24922041|NCT00132691|50015485|FG000|Overall Study|Death|2|||
24922042|NCT00132691|50015486|FG001|Overall Study|Death|0|||
24922043|NCT00125359|50015497|FG000|Overall Study|Death|4|||
24922044|NCT00125359|50015497|FG000|Overall Study|Adverse Event|5|||
24922045|NCT00125359|50015497|FG000|Overall Study|Physician Decision|14|||
24922046|NCT00524043|50015504|FG000|Overall Study|Lack of Efficacy|15|||
24922047|NCT00524043|50015505|FG001|Overall Study|Lack of Efficacy|13|||
24922048|NCT00524043|50015506|FG002|Overall Study|Lack of Efficacy|14|||
24922049|NCT00524043|50015504|FG000|Overall Study|Withdrawal by Subject|5|||
24922050|NCT00524043|50015505|FG001|Overall Study|Withdrawal by Subject|7|||
24922051|NCT00524043|50015506|FG002|Overall Study|Withdrawal by Subject|7|||
24922052|NCT00524043|50015504|FG000|Overall Study|Adverse Event|5|||
24922053|NCT00524043|50015505|FG001|Overall Study|Adverse Event|2|||
24922054|NCT00524043|50015506|FG002|Overall Study|Adverse Event|7|||
24922055|NCT00524043|50015504|FG000|Overall Study|Lost to Follow-up|3|||
24922056|NCT00524043|50015505|FG001|Overall Study|Lost to Follow-up|5|||
25185121|NCT00245583|50334299|FG001|Overall Study|Lost to Follow-up|5|||
24922057|NCT00524043|50015506|FG002|Overall Study|Lost to Follow-up|3|||
24922058|NCT00524043|50015504|FG000|Overall Study|Various (eg, incarceration)|2|||
24922059|NCT00524043|50015505|FG001|Overall Study|Various (eg, incarceration)|1|||
24922060|NCT00524043|50015506|FG002|Overall Study|Various (eg, incarceration)|0|||
24922061|NCT00523419|50015514|FG000|Overall Study|Adverse Event|1|||
24922062|NCT00523419|50015514|FG000|Overall Study|Withdrawal by Subject|1|||
25154499|NCT01890265|50269658|FG002|Overall Study|Progressive disease|0|||
24922063|NCT00523419|50015514|FG000|Overall Study|Physician Decision|2|||
25154500|NCT01890265|50269659|FG003|Overall Study|Progressive disease|0|||
25154501|NCT01890265|50269660|FG004|Overall Study|Progressive disease|0|||
25154502|NCT01890265|50269661|FG005|Overall Study|Progressive disease|0|||
25154503|NCT01890265|50269656|FG000|Overall Study|Adverse Event|2|||
24922064|NCT00523419|50015514|FG000|Overall Study|Progressive Disease|22|||
24922065|NCT00523419|50015514|FG000|Overall Study|Death due to Study Disease|4|||
24922066|NCT00523419|50015514|FG000|Overall Study|Death due to Adverse Event|2|||
24922067|NCT03868059|50015518|FG000|Overall Study|Adverse Event|3|||
24922068|NCT03868059|50015518|FG000|Overall Study|Lost to Follow-up|3|||
24922069|NCT03868059|50015518|FG000|Overall Study|Withdrawal by Subject|6|||
24922070|NCT00522951|50015522|FG000|Period 1|body motion|0|||
25154504|NCT01890265|50269657|FG001|Overall Study|Adverse Event|1|||
25154505|NCT01890265|50269658|FG002|Overall Study|Adverse Event|0|||
25154506|NCT01890265|50269659|FG003|Overall Study|Adverse Event|0|||
25154507|NCT01890265|50269660|FG004|Overall Study|Adverse Event|0|||
25154508|NCT01890265|50269661|FG005|Overall Study|Adverse Event|0|||
25154509|NCT01890265|50269656|FG000|Overall Study|Death|2|||
25154510|NCT01890265|50269657|FG001|Overall Study|Death|3|||
25154511|NCT01890265|50269658|FG002|Overall Study|Death|1|||
25154512|NCT01890265|50269659|FG003|Overall Study|Death|0|||
25154513|NCT01890265|50269660|FG004|Overall Study|Death|0|||
25154514|NCT01890265|50269661|FG005|Overall Study|Death|0|||
25154515|NCT01890265|50269656|FG000|Overall Study|Withdrawal by Subject|0|||
25154516|NCT01890265|50269657|FG001|Overall Study|Withdrawal by Subject|2|||
25154517|NCT01890265|50269658|FG002|Overall Study|Withdrawal by Subject|3|||
25154518|NCT01890265|50269659|FG003|Overall Study|Withdrawal by Subject|0|||
25154519|NCT01890265|50269660|FG004|Overall Study|Withdrawal by Subject|2|||
25154520|NCT01890265|50269661|FG005|Overall Study|Withdrawal by Subject|0|||
25154521|NCT01928329|50269682|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
25154522|NCT01928329|50269683|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
25154523|NCT01928329|50269682|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
25154524|NCT01928329|50269683|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
24922071|NCT00522951|50015523|FG001|Period 1|body motion|1|||
24922072|NCT00522951|50015522|FG000|Washout Period|Adverse Event|0|||
24922073|NCT00522951|50015523|FG001|Washout Period|Adverse Event|1|||
24922074|NCT00522951|50015522|FG000|Washout Period|Death|0|||
24922075|NCT00522951|50015523|FG001|Washout Period|Death|1|||
24922076|NCT00522951|50015522|FG000|Period 2|Withdrawal by Subject|1|||
24922077|NCT00522951|50015523|FG001|Period 2|Withdrawal by Subject|0|||
24922078|NCT00522951|50015522|FG000|Period 2|residual contrast medium|1|||
24922079|NCT00522951|50015523|FG001|Period 2|residual contrast medium|1|||
24922080|NCT03865953|50015535|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
24922081|NCT03865953|50015536|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
24922082|NCT03865953|50015535|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
24922083|NCT03865953|50015536|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
24922084|NCT03865953|50015535|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
24922085|NCT03865953|50015536|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
24922086|NCT03865407|50015544|FG000|Overall Study|Adverse Event|1|||
24922087|NCT03865407|50015545|FG001|Overall Study|Adverse Event|0|||
24922088|NCT03865407|50015544|FG000|Overall Study|Withdrawal by Subject|1|||
24922089|NCT03865407|50015545|FG001|Overall Study|Withdrawal by Subject|0|||
24922090|NCT03865407|50015544|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
24922091|NCT03865407|50015545|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
24922092|NCT00487942|50015555|FG000|Overall Study|Adverse Event|1|||
24922093|NCT00487942|50015556|FG001|Overall Study|Adverse Event|1|||
24922094|NCT00487942|50015557|FG002|Overall Study|Adverse Event|1|||
24922095|NCT00487942|50015558|FG003|Overall Study|Adverse Event|1|||
24922096|NCT00487942|50015555|FG000|Overall Study|Lost to Follow-up|1|||
24922097|NCT00487942|50015556|FG001|Overall Study|Lost to Follow-up|0|||
24922098|NCT00487942|50015557|FG002|Overall Study|Lost to Follow-up|0|||
24922099|NCT00487942|50015558|FG003|Overall Study|Lost to Follow-up|1|||
24922100|NCT00487942|50015555|FG000|Overall Study|Protocol Violation|1|||
24922101|NCT00487942|50015556|FG001|Overall Study|Protocol Violation|1|||
24922102|NCT00487942|50015557|FG002|Overall Study|Protocol Violation|0|||
24922103|NCT00487942|50015558|FG003|Overall Study|Protocol Violation|0|||
25154525|NCT01928329|50269682|FG000|Overall Study|Adverse Event|5|||
25154526|NCT01928329|50269683|FG001|Overall Study|Adverse Event|3|||
25154527|NCT01928329|50269682|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
24922104|NCT00487942|50015555|FG000|Overall Study|Withdrawal by Subject|0|||
25154528|NCT01928329|50269683|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
25154529|NCT01928329|50269682|FG000|Overall Study|Withdrawal by Subject|1|||
24922105|NCT00487942|50015556|FG001|Overall Study|Withdrawal by Subject|1|||
24922106|NCT00487942|50015557|FG002|Overall Study|Withdrawal by Subject|2|||
24922107|NCT00487942|50015558|FG003|Overall Study|Withdrawal by Subject|0|||
24922108|NCT00132301|50015570|FG000|Overall Study|Death|7|||
24922109|NCT00132301|50015571|FG001|Overall Study|Death|6|||
24922110|NCT00132301|50015570|FG000|Overall Study|Withdrawal by Subject|5|||
24922111|NCT00132301|50015571|FG001|Overall Study|Withdrawal by Subject|2|||
24922112|NCT00132301|50015570|FG000|Overall Study|Physician Decision|1|||
24922113|NCT00132301|50015571|FG001|Overall Study|Physician Decision|1|||
24922114|NCT00132301|50015570|FG000|Overall Study|Lost to Follow-up|5|||
24922115|NCT00132301|50015571|FG001|Overall Study|Lost to Follow-up|3|||
24922116|NCT00132301|50015570|FG000|Overall Study|Other|1|||
24922117|NCT00132301|50015571|FG001|Overall Study|Other|1|||
24922118|NCT00132301|50015570|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
24922119|NCT00132301|50015571|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
24922120|NCT00522873|50015579|FG000|Overall Study|Adverse Event|41|||
24922121|NCT00522873|50015580|FG001|Overall Study|Adverse Event|26|||
24922122|NCT00522873|50015579|FG000|Overall Study|Withdrawal by Subject|20|||
24922123|NCT00522873|50015580|FG001|Overall Study|Withdrawal by Subject|9|||
24922124|NCT00522873|50015579|FG000|Overall Study|Protocol Violation|14|||
24922125|NCT00522873|50015580|FG001|Overall Study|Protocol Violation|4|||
24922126|NCT00522873|50015579|FG000|Overall Study|Lost to Follow-up|11|||
24922127|NCT00522873|50015580|FG001|Overall Study|Lost to Follow-up|3|||
24922128|NCT00522873|50015579|FG000|Overall Study|Personal Reasons|8|||
24922129|NCT00522873|50015580|FG001|Overall Study|Personal Reasons|1|||
24922130|NCT00522873|50015579|FG000|Overall Study|Medication Errors|1|||
24922131|NCT00522873|50015580|FG001|Overall Study|Medication Errors|1|||
24922132|NCT00522873|50015579|FG000|Overall Study|Never Received Medication|1|||
24922133|NCT00522873|50015580|FG001|Overall Study|Never Received Medication|0|||
24922134|NCT03684057|50015588|FG000|Overall Study|Withdrawal by Subject|4|||
24922135|NCT03684057|50015589|FG001|Overall Study|Withdrawal by Subject|5|||
24922136|NCT03864627|50015598|FG000|Overall Study|Adverse Event|0|||
24922137|NCT03864627|50015599|FG001|Overall Study|Adverse Event|1|||
24922138|NCT03864627|50015598|FG000|Overall Study|Lack of Efficacy|0|||
24922139|NCT03864627|50015599|FG001|Overall Study|Lack of Efficacy|1|||
24922140|NCT03864627|50015598|FG000|Overall Study|Lost to Follow-up|0|||
24922141|NCT03864627|50015599|FG001|Overall Study|Lost to Follow-up|1|||
24922142|NCT03864627|50015598|FG000|Overall Study|Withdrawal by Subject|4|||
24922143|NCT03864627|50015599|FG001|Overall Study|Withdrawal by Subject|8|||
24922144|NCT03864627|50015598|FG000|Overall Study|Study terminated by sponsor|0|||
24922145|NCT03864627|50015599|FG001|Overall Study|Study terminated by sponsor|1|||
24922146|NCT00519831|50015606|FG000|Overall Study|Adverse Event|3|||
24922147|NCT00131911|50015616|FG000|Overall Study|Withdrawal by Subject|1|||
24922148|NCT00131911|50015617|FG001|Overall Study|Withdrawal by Subject|0|||
24922149|NCT00184093|50015622|FG000|Overall Study|Adverse Event|3|||
24922150|NCT00184093|50015622|FG000|Overall Study|Lost to Follow-up|3|||
24922151|NCT00184093|50015622|FG000|Overall Study|Physician Decision|1|||
24922152|NCT00184093|50015622|FG000|Overall Study|Withdrawal by Subject|2|||
24922153|NCT00183625|50015628|FG000|Overall Study|Withdrawal by Subject|18|||
24922154|NCT00183625|50015629|FG001|Overall Study|Withdrawal by Subject|18|||
24922155|NCT00183625|50015630|FG002|Overall Study|Withdrawal by Subject|19|||
24922156|NCT00183625|50015631|FG003|Overall Study|Withdrawal by Subject|14|||
24922157|NCT00511875|50015641|FG000|Overall Study|Lost to Follow-up|4|||
24922158|NCT00511875|50015642|FG001|Overall Study|Lost to Follow-up|0|||
24922159|NCT00511875|50015641|FG000|Overall Study|Missing variables|1|||
24922160|NCT00511875|50015642|FG001|Overall Study|Missing variables|0|||
24922161|NCT00183391|50015650|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
24922162|NCT00183391|50015651|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
24922163|NCT00183391|50015650|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
24922164|NCT00183391|50015651|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
24922165|NCT00493246|50015667|FG000|Overall Study|Withdrawal by Subject|0|||
24922166|NCT00493246|50015668|FG001|Overall Study|Withdrawal by Subject|0|||
24922167|NCT00493246|50015669|FG002|Overall Study|Withdrawal by Subject|0|||
24922168|NCT00493246|50015670|FG003|Overall Study|Withdrawal by Subject|0|||
24922169|NCT00493246|50015671|FG004|Overall Study|Withdrawal by Subject|1|||
24922170|NCT00493246|50015672|FG005|Overall Study|Withdrawal by Subject|0|||
24922171|NCT00493246|50015673|FG006|Overall Study|Withdrawal by Subject|0|||
24922172|NCT00493246|50015674|FG007|Overall Study|Withdrawal by Subject|0|||
24922173|NCT00493246|50015667|FG000|Overall Study|No access to draw blood|0|||
24922174|NCT00493246|50015668|FG001|Overall Study|No access to draw blood|0|||
24922175|NCT00493246|50015669|FG002|Overall Study|No access to draw blood|0|||
24922176|NCT00493246|50015670|FG003|Overall Study|No access to draw blood|0|||
24922177|NCT00493246|50015671|FG004|Overall Study|No access to draw blood|0|||
24922178|NCT00493246|50015672|FG005|Overall Study|No access to draw blood|1|||
24922179|NCT00493246|50015673|FG006|Overall Study|No access to draw blood|0|||
24922180|NCT00493246|50015674|FG007|Overall Study|No access to draw blood|0|||
24922181|NCT00493246|50015667|FG000|Overall Study|Lost to Follow-up|0|||
24922182|NCT00493246|50015668|FG001|Overall Study|Lost to Follow-up|0|||
24922183|NCT00493246|50015669|FG002|Overall Study|Lost to Follow-up|0|||
24922184|NCT00493246|50015670|FG003|Overall Study|Lost to Follow-up|0|||
24922185|NCT00493246|50015671|FG004|Overall Study|Lost to Follow-up|0|||
24922186|NCT00493246|50015672|FG005|Overall Study|Lost to Follow-up|0|||
24922187|NCT00493246|50015673|FG006|Overall Study|Lost to Follow-up|1|||
24922188|NCT00493246|50015674|FG007|Overall Study|Lost to Follow-up|0|||
24922189|NCT02281955|50015692|FG000|Overall Study|Death|1|||
24922190|NCT00511797|50015700|FG000|Overall Study|Adverse Event|1|||
24922191|NCT00511797|50015701|FG001|Overall Study|Adverse Event|2|||
24922192|NCT00511797|50015702|FG002|Overall Study|Adverse Event|2|||
24922193|NCT00511797|50015703|FG003|Overall Study|Adverse Event|2|||
24922194|NCT00511797|50015700|FG000|Overall Study|Lost to Follow-up|1|||
24922195|NCT00511797|50015701|FG001|Overall Study|Lost to Follow-up|0|||
24922196|NCT00511797|50015702|FG002|Overall Study|Lost to Follow-up|0|||
24922197|NCT00511797|50015703|FG003|Overall Study|Lost to Follow-up|1|||
24922198|NCT00511797|50015700|FG000|Overall Study|Pregnancy|0|||
24922199|NCT00511797|50015701|FG001|Overall Study|Pregnancy|0|||
24922200|NCT00511797|50015702|FG002|Overall Study|Pregnancy|0|||
24922201|NCT00511797|50015703|FG003|Overall Study|Pregnancy|1|||
24922202|NCT00511797|50015700|FG000|Overall Study|Protocol Violation|0|||
24922203|NCT00511797|50015701|FG001|Overall Study|Protocol Violation|2|||
24922204|NCT00511797|50015702|FG002|Overall Study|Protocol Violation|2|||
24922205|NCT00511797|50015703|FG003|Overall Study|Protocol Violation|3|||
24922206|NCT00511797|50015700|FG000|Overall Study|Withdrawal by Subject|3|||
24922207|NCT00511797|50015701|FG001|Overall Study|Withdrawal by Subject|3|||
24922208|NCT00511797|50015702|FG002|Overall Study|Withdrawal by Subject|4|||
24922209|NCT00511797|50015703|FG003|Overall Study|Withdrawal by Subject|2|||
24922210|NCT00511797|50015700|FG000|Overall Study|Never dispensed|1|||
24922211|NCT00511797|50015701|FG001|Overall Study|Never dispensed|0|||
24922212|NCT00511797|50015702|FG002|Overall Study|Never dispensed|1|||
24922213|NCT00511797|50015703|FG003|Overall Study|Never dispensed|3|||
24922214|NCT00511797|50015700|FG000|Overall Study|Study drug not taken|0|||
24922215|NCT00511797|50015701|FG001|Overall Study|Study drug not taken|1|||
24922216|NCT00511797|50015702|FG002|Overall Study|Study drug not taken|0|||
24922217|NCT00511797|50015703|FG003|Overall Study|Study drug not taken|1|||
24922218|NCT00511797|50015700|FG000|Overall Study|Partially missing diary|0|||
24922219|NCT00511797|50015701|FG001|Overall Study|Partially missing diary|0|||
24922220|NCT00511797|50015702|FG002|Overall Study|Partially missing diary|1|||
24922221|NCT00511797|50015703|FG003|Overall Study|Partially missing diary|0|||
24922222|NCT00511797|50015700|FG000|Overall Study|Other (moving etc)|1|||
24922223|NCT00511797|50015701|FG001|Overall Study|Other (moving etc)|0|||
24922224|NCT00511797|50015702|FG002|Overall Study|Other (moving etc)|1|||
24922225|NCT00511797|50015703|FG003|Overall Study|Other (moving etc)|2|||
24922226|NCT00487552|50015713|FG000|Overall Study|Unsuccessful magnet placements|3|||
24922227|NCT00487552|50015713|FG000|Overall Study|Death due to progressive malignancy|2|||
24922228|NCT00487552|50015713|FG000|Overall Study|Stent not placed|1|||
24922229|NCT00182689|50015720|FG000|Overall Study|Adverse Event|8|||
24922230|NCT00182689|50015721|FG001|Overall Study|Adverse Event|11|||
24922231|NCT00182689|50015720|FG000|Overall Study|Withdrawal by Subject|2|||
24922232|NCT00182689|50015721|FG001|Overall Study|Withdrawal by Subject|2|||
24922233|NCT00182689|50015720|FG000|Overall Study|Progression|27|||
24922234|NCT00182689|50015721|FG001|Overall Study|Progression|29|||
24922235|NCT00182689|50015720|FG000|Overall Study|Death|1|||
24922236|NCT00182689|50015721|FG001|Overall Study|Death|0|||
24922237|NCT00182689|50015720|FG000|Overall Study|not protocol specified|0|||
24922238|NCT00182689|50015721|FG001|Overall Study|not protocol specified|3|||
24922239|NCT00182689|50015720|FG000|Overall Study|Ineligible|1|||
24922240|NCT00182689|50015721|FG001|Overall Study|Ineligible|4|||
24922241|NCT00182689|50015720|FG000|Overall Study|Never received treatment|1|||
24922242|NCT00182689|50015721|FG001|Overall Study|Never received treatment|0|||
24922243|NCT03860259|50015733|FG000|Overall Study|Lost to Follow-up|5|||
24922244|NCT03860259|50015734|FG001|Overall Study|Lost to Follow-up|5|||
24922245|NCT03860259|50015733|FG000|Overall Study|Protocol Violation|1|||
25023507|NCT03379675|50120884|FG002|Overall Study|Adverse Event|0|||
25023508|NCT03379675|50120882|FG000|Overall Study|Withdrawal by Subject|2|||
25023509|NCT03379675|50120883|FG001|Overall Study|Withdrawal by Subject|1|||
25023510|NCT03379675|50120884|FG002|Overall Study|Withdrawal by Subject|2|||
25023511|NCT02930889|50120892|FG000|Overall Study|Lost to Follow-up|2|||
24922246|NCT03860259|50015734|FG001|Overall Study|Protocol Violation|0|||
24922247|NCT00131365|50015740|FG000|Overall Study|Withdrawal by Subject|1|||
24922248|NCT00131365|50015740|FG000|Overall Study|Alternative treatment|3|||
24922249|NCT00487240|50015747|FG000|Overall Study|Withdrawal by Subject|12|||
24922250|NCT00487240|50015748|FG001|Overall Study|Withdrawal by Subject|6|||
24922251|NCT00487240|50015747|FG000|Overall Study|Lost to Follow-up|7|||
24922252|NCT00487240|50015748|FG001|Overall Study|Lost to Follow-up|6|||
25023512|NCT02930889|50120892|FG000|Overall Study|Withdrawal by Subject|6|||
24922253|NCT00487240|50015747|FG000|Overall Study|Adverse Event|0|||
24922254|NCT00487240|50015748|FG001|Overall Study|Adverse Event|4|||
25185122|NCT00245583|50334298|FG000|Overall Study|Adverse Event|2|||
24922255|NCT00487240|50015747|FG000|Overall Study|Protocol Violation|5|||
24922256|NCT00487240|50015748|FG001|Overall Study|Protocol Violation|5|||
24922257|NCT00487240|50015747|FG000|Overall Study|Entry Criteria Not Met|3|||
24922258|NCT00487240|50015748|FG001|Overall Study|Entry Criteria Not Met|4|||
24922259|NCT00487240|50015747|FG000|Overall Study|Sponsor Decision|2|||
24922260|NCT00487240|50015748|FG001|Overall Study|Sponsor Decision|1|||
24922261|NCT00487240|50015747|FG000|Overall Study|Physician Decision|2|||
24922262|NCT00487240|50015748|FG001|Overall Study|Physician Decision|0|||
24922263|NCT02224391|50015756|FG000|Overall Study|Lost to Follow-up|26|||
24922264|NCT02224391|50015757|FG001|Overall Study|Lost to Follow-up|19|||
24922265|NCT02224391|50015756|FG000|Overall Study|Withdrawal by Subject|6|||
24922266|NCT02224391|50015757|FG001|Overall Study|Withdrawal by Subject|5|||
24922267|NCT00487162|50015765|FG000|Overall Study|Adverse Event|0|||
24922268|NCT00487162|50015766|FG001|Overall Study|Adverse Event|1|||
24922269|NCT00487162|50015765|FG000|Overall Study|Physician Decision|0|||
24922270|NCT00487162|50015766|FG001|Overall Study|Physician Decision|1|||
24922271|NCT00487162|50015765|FG000|Overall Study|Withdrawal by Subject|2|||
24922272|NCT00487162|50015766|FG001|Overall Study|Withdrawal by Subject|3|||
24922273|NCT00487084|50015775|FG000|Overall Study|Did not receive intervention|4|||
24922274|NCT00487084|50015776|FG001|Overall Study|Did not receive intervention|3|||
24922275|NCT00487084|50015777|FG002|Overall Study|Did not receive intervention|5|||
24922276|NCT00466726|50015785|FG000|Overall Study|Not evaluable for response|14|||
24922277|NCT01721291|50015791|FG000|Overall Study|Withdrawal by Subject|1|||
24922278|NCT01721291|50015792|FG001|Overall Study|Withdrawal by Subject|0|||
24922279|NCT01721291|50015791|FG000|Overall Study|did not like the treatment|1|||
24922280|NCT01721291|50015792|FG001|Overall Study|did not like the treatment|0|||
24922281|NCT00486226|50015818|FG000|Overall Study|Death|3|||
24922282|NCT00486226|50015818|FG000|Overall Study|Adverse Event|1|||
24922283|NCT00486226|50015818|FG000|Overall Study|Withdrawal by Subject|1|||
24922284|NCT00486226|50015818|FG000|Overall Study|Lost to Follow-up|8|||
24922285|NCT00485758|50015827|FG000|Overall Study|Adverse Event|102|||
24922286|NCT00485758|50015828|FG001|Overall Study|Adverse Event|31|||
24922287|NCT00485758|50015827|FG000|Overall Study|Death|0|||
24922288|NCT00485758|50015828|FG001|Overall Study|Death|1|||
24922289|NCT00485758|50015827|FG000|Overall Study|Lost to Follow-up|5|||
24922290|NCT00485758|50015828|FG001|Overall Study|Lost to Follow-up|1|||
24922291|NCT00485758|50015827|FG000|Overall Study|Physician Decision|3|||
24922292|NCT00485758|50015828|FG001|Overall Study|Physician Decision|3|||
24922293|NCT00485758|50015827|FG000|Overall Study|Protocol Violation|11|||
24922294|NCT00485758|50015828|FG001|Overall Study|Protocol Violation|2|||
24922295|NCT00485758|50015827|FG000|Overall Study|Withdrawal by Subject|32|||
24922296|NCT00485758|50015828|FG001|Overall Study|Withdrawal by Subject|27|||
24922297|NCT00485758|50015827|FG000|Overall Study|Study Terminated by Sponsor|3|||
24922298|NCT00485758|50015828|FG001|Overall Study|Study Terminated by Sponsor|0|||
24922299|NCT03850444|50015836|FG000|Overall Study|Adverse Event|12|||
24922300|NCT03850444|50015837|FG001|Overall Study|Adverse Event|9|||
24922301|NCT03850444|50015836|FG000|Overall Study|Death|38|||
24922302|NCT03850444|50015837|FG001|Overall Study|Death|64|||
24922303|NCT03850444|50015836|FG000|Overall Study|Lost to Follow-up|0|||
24922304|NCT03850444|50015837|FG001|Overall Study|Lost to Follow-up|1|||
24922305|NCT03850444|50015836|FG000|Overall Study|Withdrawal by Subject|0|||
24922306|NCT03850444|50015837|FG001|Overall Study|Withdrawal by Subject|1|||
24922307|NCT03850444|50015836|FG000|Overall Study|Ongoing in Study|78|||
24922308|NCT03850444|50015837|FG001|Overall Study|Ongoing in Study|59|||
24922309|NCT00469612|50015845|FG000|Overall Study|Study terminated before data collected|2|||
24922310|NCT00469612|50015846|FG001|Overall Study|Study terminated before data collected|0|||
24922311|NCT00469456|50015854|FG000|Overall Study|Adverse Event|4|||
24922312|NCT00469456|50015855|FG001|Overall Study|Adverse Event|3|||
24922313|NCT00469456|50015854|FG000|Overall Study|Protocol Violation|1|||
24922314|NCT00469456|50015855|FG001|Overall Study|Protocol Violation|0|||
24922315|NCT00469456|50015854|FG000|Overall Study|Withdrawal by Subject|4|||
24922316|NCT00469456|50015855|FG001|Overall Study|Withdrawal by Subject|1|||
24922317|NCT00581555|50015863|FG000|Overall Study|Adverse Event|4|||
24922318|NCT00581555|50015864|FG001|Overall Study|Adverse Event|3|||
24922319|NCT00581555|50015863|FG000|Overall Study|Physician Decision|3|||
24922320|NCT00581555|50015864|FG001|Overall Study|Physician Decision|2|||
24922321|NCT00581555|50015863|FG000|Overall Study|Withdrawal by Subject|18|||
24922322|NCT00581555|50015864|FG001|Overall Study|Withdrawal by Subject|9|||
24922323|NCT00581555|50015863|FG000|Overall Study|Lost to Follow-up|2|||
24922324|NCT00581555|50015864|FG001|Overall Study|Lost to Follow-up|2|||
25023513|NCT02930889|50120892|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
24922325|NCT00581555|50015863|FG000|Overall Study|Other reasons|16|||
24922326|NCT00581555|50015864|FG001|Overall Study|Other reasons|4|||
24922327|NCT00469144|50015872|FG000|Overall Study|Death|0|||
24922328|NCT00469144|50015873|FG001|Overall Study|Death|1|||
24922329|NCT00469144|50015872|FG000|Overall Study|No Response|5|||
24922330|NCT00469144|50015873|FG001|Overall Study|No Response|5|||
24922331|NCT00469144|50015872|FG000|Overall Study|Progressive Disease|1|||
24922332|NCT00469144|50015873|FG001|Overall Study|Progressive Disease|0|||
24922333|NCT00468910|50015885|FG000|Overall Study|Lost to Follow-up|2|||
24922334|NCT00468910|50015886|FG001|Overall Study|Lost to Follow-up|1|||
24922335|NCT00468910|50015885|FG000|Overall Study|Withdrawal by Subject|2|||
24922336|NCT00468910|50015886|FG001|Overall Study|Withdrawal by Subject|1|||
24922337|NCT00468910|50015885|FG000|Overall Study|Medical Contraindication|0|||
24922338|NCT00468910|50015886|FG001|Overall Study|Medical Contraindication|1|||
24922339|NCT01412333|50015895|FG000|Overall Study|Death|1|||
24922340|NCT01412333|50015896|FG001|Overall Study|Death|1|||
24922341|NCT01412333|50015895|FG000|Overall Study|Physician Decision|0|||
24922342|NCT01412333|50015896|FG001|Overall Study|Physician Decision|1|||
24922343|NCT01412333|50015895|FG000|Overall Study|Reason not specified|16|||
24922344|NCT01412333|50015896|FG001|Overall Study|Reason not specified|10|||
24922345|NCT01412333|50015895|FG000|Overall Study|Non-compliance with study drug|1|||
24922346|NCT01412333|50015896|FG001|Overall Study|Non-compliance with study drug|1|||
24922347|NCT01412333|50015895|FG000|Overall Study|Protocol Violation|1|||
24922348|NCT01412333|50015896|FG001|Overall Study|Protocol Violation|1|||
24922349|NCT01412333|50015895|FG000|Overall Study|Non-compliance|1|||
24922350|NCT01412333|50015896|FG001|Overall Study|Non-compliance|3|||
24922351|NCT01412333|50015895|FG000|Overall Study|Lack of Efficacy|15|||
24922352|NCT01412333|50015896|FG001|Overall Study|Lack of Efficacy|6|||
24922353|NCT01412333|50015895|FG000|Overall Study|Pregnancy|3|||
24922354|NCT01412333|50015896|FG001|Overall Study|Pregnancy|0|||
24922355|NCT01412333|50015895|FG000|Overall Study|Consent withdrawn by participant|25|||
24922356|NCT01412333|50015896|FG001|Overall Study|Consent withdrawn by participant|12|||
24922357|NCT01412333|50015895|FG000|Overall Study|Adverse Event|25|||
24922358|NCT01412333|50015896|FG001|Overall Study|Adverse Event|16|||
24922359|NCT01412333|50015895|FG000|Overall Study|Lost to Follow-up|10|||
24922360|NCT01412333|50015896|FG001|Overall Study|Lost to Follow-up|6|||
25154530|NCT01928329|50269683|FG001|Overall Study|Withdrawal by Subject|5|||
24922361|NCT00519285|50015905|FG000|Overall Study|Adverse Event|127|||
24922362|NCT00519285|50015906|FG001|Overall Study|Adverse Event|266|||
24922363|NCT00519285|50015905|FG000|Overall Study|Disease progression|334|||
24922364|NCT00519285|50015906|FG001|Overall Study|Disease progression|186|||
24922365|NCT00519285|50015905|FG000|Overall Study|Physician Decision|75|||
24922366|NCT00519285|50015906|FG001|Overall Study|Physician Decision|47|||
24922367|NCT00519285|50015905|FG000|Overall Study|Participant's request|53|||
24922368|NCT00519285|50015906|FG001|Overall Study|Participant's request|84|||
24922369|NCT00519285|50015905|FG000|Overall Study|Consent withdrawn|4|||
24922370|NCT00519285|50015906|FG001|Overall Study|Consent withdrawn|5|||
24922371|NCT00519285|50015905|FG000|Overall Study|Poor compliance to protocol|5|||
24922372|NCT00519285|50015906|FG001|Overall Study|Poor compliance to protocol|7|||
24922373|NCT00519285|50015905|FG000|Overall Study|Reason unspecified|5|||
24922374|NCT00519285|50015906|FG001|Overall Study|Reason unspecified|8|||
24922375|NCT00519285|50015905|FG000|Overall Study|Not treated|8|||
24922376|NCT00519285|50015906|FG001|Overall Study|Not treated|7|||
24922377|NCT00519285|50015905|FG000|Overall Study|Treatment ongoing|1|||
24922378|NCT00519285|50015906|FG001|Overall Study|Treatment ongoing|2|||
24922379|NCT00464620|50015912|FG000|Overall Study|Physician Decision|1|||
24922380|NCT00464620|50015913|FG001|Overall Study|Physician Decision|0|||
24922381|NCT00464620|50015914|FG002|Overall Study|Physician Decision|0|||
24922382|NCT00464620|50015912|FG000|Overall Study|Withdrawal by Subject|1|||
25154531|NCT01928329|50269682|FG000|Overall Study|Physician Decision|1|||
25154532|NCT01928329|50269683|FG001|Overall Study|Physician Decision|1|||
25154533|NCT01890109|50269691|FG000|Overall Study|Withdrawal by Subject|0|||
25154534|NCT01890109|50269692|FG001|Overall Study|Withdrawal by Subject|3|||
25154535|NCT01890109|50269691|FG000|Overall Study|Lost to Follow-up|1|||
25154536|NCT01890109|50269692|FG001|Overall Study|Lost to Follow-up|2|||
25154537|NCT00982930|50269699|FG000|Overall Study|Adverse Event|1|||
25154538|NCT00982930|50269699|FG000|Overall Study|Withdrawal by Subject|1|||
25154539|NCT00982930|50269699|FG000|Overall Study|Administrative Problems|2|||
25154540|NCT00981682|50269703|FG000|Overall Study|Adverse Event|48|||
25154541|NCT00981682|50269703|FG000|Overall Study|Withdrawal by Subject|52|||
25154542|NCT00981682|50269703|FG000|Overall Study|Lost to Follow-up|14|||
24922383|NCT00464620|50015913|FG001|Overall Study|Withdrawal by Subject|0|||
24922384|NCT00464620|50015914|FG002|Overall Study|Withdrawal by Subject|3|||
24922385|NCT00464620|50015912|FG000|Overall Study|Ineligible sarcoma subtype|0|||
24922386|NCT00464620|50015913|FG001|Overall Study|Ineligible sarcoma subtype|2|||
24922387|NCT00464620|50015914|FG002|Overall Study|Ineligible sarcoma subtype|2|||
24922388|NCT00464620|50015912|FG000|Overall Study|Use of prohibited concomitant medication|0|||
24922389|NCT00464620|50015913|FG001|Overall Study|Use of prohibited concomitant medication|0|||
24922390|NCT00464620|50015914|FG002|Overall Study|Use of prohibited concomitant medication|2|||
24922391|NCT00464542|50015927|FG000|Pre-treatment|Withdrawal by Subject|2|||
24922392|NCT00468676|50015933|FG000|Overall Study|Lost to Follow-up|14|||
24922393|NCT00468676|50015934|FG001|Overall Study|Lost to Follow-up|11|||
24922394|NCT00468676|50015933|FG000|Overall Study|Death|2|||
25023514|NCT02875977|50120898|FG000|Overall Study|Lost to Follow-up|42|||
24922395|NCT00468676|50015934|FG001|Overall Study|Death|1|||
25154543|NCT00981682|50269703|FG000|Overall Study|Lack of Efficacy|13|||
25154544|NCT00981682|50269703|FG000|Overall Study|Protocol Violation|6|||
25154545|NCT00981682|50269703|FG000|Overall Study|administrative|9|||
25154546|NCT01903993|50269709|FG000|Overall Study|Death|118|||
25154547|NCT01903993|50269710|FG001|Overall Study|Death|121|||
25154548|NCT01903993|50269709|FG000|Overall Study|Withdrawal by Subject|15|||
25154549|NCT01903993|50269710|FG001|Overall Study|Withdrawal by Subject|4|||
25154550|NCT01903993|50269709|FG000|Overall Study|Lost to Follow-up|2|||
25154551|NCT01903993|50269710|FG001|Overall Study|Lost to Follow-up|3|||
25154552|NCT01903993|50269709|FG000|Overall Study|Study Terminated by Sponsor|8|||
25154553|NCT01903993|50269710|FG001|Overall Study|Study Terminated by Sponsor|14|||
25154554|NCT01903993|50269709|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
25154555|NCT01903993|50269710|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
25154556|NCT00981292|50269723|FG000|Day 1|Protocol Violation|1|||
25154557|NCT00981292|50269724|FG001|Day 1|Protocol Violation|0|||
25154558|NCT00981292|50269725|FG002|Day 1|Protocol Violation|0|||
25154559|NCT00981292|50269726|FG003|Day 1|Protocol Violation|0|||
25154560|NCT00981292|50269727|FG004|Day 1|Protocol Violation|0|||
25154561|NCT00981292|50269728|FG005|Day 1|Protocol Violation|2|||
25154562|NCT00981292|50269723|FG000|Day 2|Protocol Violation|2|||
25154563|NCT00981292|50269724|FG001|Day 2|Protocol Violation|0|||
25154564|NCT00981292|50269725|FG002|Day 2|Protocol Violation|0|||
25154565|NCT00981292|50269726|FG003|Day 2|Protocol Violation|0|||
25154566|NCT00981292|50269727|FG004|Day 2|Protocol Violation|0|||
25154567|NCT00981292|50269728|FG005|Day 2|Protocol Violation|0|||
25154568|NCT00981292|50269723|FG000|Day 3|Protocol Violation|0|||
25154569|NCT00981292|50269724|FG001|Day 3|Protocol Violation|0|||
25154570|NCT00981292|50269725|FG002|Day 3|Protocol Violation|0|||
25154571|NCT00981292|50269726|FG003|Day 3|Protocol Violation|0|||
25154572|NCT00981292|50269727|FG004|Day 3|Protocol Violation|0|||
25185123|NCT00245583|50334299|FG001|Overall Study|Adverse Event|1|||
24922396|NCT00464308|50015945|FG000|Overall Study|Adverse Event|22|||
24922397|NCT00464308|50015946|FG001|Overall Study|Adverse Event|27|||
24922398|NCT00464308|50015947|FG002|Overall Study|Adverse Event|16|||
24922399|NCT00464308|50015945|FG000|Overall Study|Lost to Follow-up|29|||
24922400|NCT00464308|50015946|FG001|Overall Study|Lost to Follow-up|19|||
24922401|NCT00464308|50015947|FG002|Overall Study|Lost to Follow-up|20|||
24922402|NCT00464308|50015945|FG000|Overall Study|Patient discontinued and other reasons|17|||
24922403|NCT00464308|50015946|FG001|Overall Study|Patient discontinued and other reasons|17|||
24922404|NCT00464308|50015947|FG002|Overall Study|Patient discontinued and other reasons|23|||
24922405|NCT00464308|50015945|FG000|Overall Study|Physician Decision|1|||
24922406|NCT00464308|50015946|FG001|Overall Study|Physician Decision|0|||
24922407|NCT00464308|50015947|FG002|Overall Study|Physician Decision|0|||
24922408|NCT00468286|50015957|FG000|Overall Study|Adverse Event|1|||
24922409|NCT00468286|50015958|FG001|Overall Study|Adverse Event|6|||
24922410|NCT00468286|50015957|FG000|Overall Study|Protocol Violation|2|||
24922411|NCT00468286|50015958|FG001|Overall Study|Protocol Violation|2|||
24922412|NCT00468286|50015957|FG000|Overall Study|Withdrawal by Subject|4|||
24922413|NCT00468286|50015958|FG001|Overall Study|Withdrawal by Subject|3|||
24922414|NCT00468286|50015957|FG000|Overall Study|Physician Decision|0|||
25154573|NCT00981292|50269728|FG005|Day 3|Protocol Violation|1|||
25154574|NCT00980044|50269743|FG000|Overall Study|Withdrawal by Subject|5|||
24922415|NCT00468286|50015958|FG001|Overall Study|Physician Decision|1|||
25185124|NCT00245583|50334298|FG000|Overall Study|Lack of Efficacy|1|||
24922416|NCT00463840|50015964|FG000|Overall Study|Disease progression|7|||
24922417|NCT00463840|50015964|FG000|Overall Study|Withdrawal by Subject|2|||
24922418|NCT00463840|50015964|FG000|Overall Study|Adverse Event|3|||
25154575|NCT00980044|50269744|FG001|Overall Study|Withdrawal by Subject|7|||
25154576|NCT00980044|50269745|FG002|Overall Study|Withdrawal by Subject|3|||
25154577|NCT00980044|50269743|FG000|Overall Study|Protocol Violation|0|||
25154578|NCT00980044|50269744|FG001|Overall Study|Protocol Violation|0|||
25154579|NCT00980044|50269745|FG002|Overall Study|Protocol Violation|2|||
25185125|NCT00245583|50334299|FG001|Overall Study|Lack of Efficacy|0|||
24922419|NCT00129389|50015970|FG000|Overall Study|Adverse Event|19|||
24922420|NCT00129389|50015971|FG001|Overall Study|Adverse Event|87|||
24922421|NCT00129389|50015970|FG000|Overall Study|Death|0|||
24922422|NCT00129389|50015971|FG001|Overall Study|Death|1|||
24922423|NCT00129389|50015970|FG000|Overall Study|Lost to Follow-up|2|||
24922424|NCT00129389|50015971|FG001|Overall Study|Lost to Follow-up|1|||
24922425|NCT00129389|50015970|FG000|Overall Study|Physician Decision|0|||
24922426|NCT00129389|50015971|FG001|Overall Study|Physician Decision|4|||
24922427|NCT00129389|50015970|FG000|Overall Study|Protocol Violation|0|||
24922428|NCT00129389|50015971|FG001|Overall Study|Protocol Violation|6|||
24922429|NCT00129389|50015970|FG000|Overall Study|Withdrawal by Subject|9|||
24922430|NCT00129389|50015971|FG001|Overall Study|Withdrawal by Subject|23|||
24922431|NCT00129389|50015970|FG000|Overall Study|Relapse|1|||
24922432|NCT00129389|50015971|FG001|Overall Study|Relapse|0|||
24922433|NCT00129389|50015970|FG000|Overall Study|Not eligible|1|||
24922434|NCT00129389|50015971|FG001|Overall Study|Not eligible|2|||
24922435|NCT00129389|50015970|FG000|Overall Study|Crossed to the other arm|1|||
24922436|NCT00129389|50015971|FG001|Overall Study|Crossed to the other arm|16|||
24922437|NCT00468052|50015979|FG000|Overall Study|Protocol Violation|7|||
24922438|NCT00468052|50015980|FG001|Overall Study|Protocol Violation|8|||
24922439|NCT00453310|50015988|FG000|Overall Study|Progression of Disease|10|||
24922440|NCT00124657|50015995|FG000|Overall Study|Toxicity|0|||
24922441|NCT00124657|50015996|FG001|Overall Study|Toxicity|0|||
24922442|NCT00124657|50015997|FG002|Overall Study|Toxicity|1|||
24922443|NCT00124657|50015995|FG000|Overall Study|Non-compliance|1|||
24922444|NCT00124657|50015996|FG001|Overall Study|Non-compliance|0|||
24922445|NCT00124657|50015997|FG002|Overall Study|Non-compliance|4|||
24922446|NCT00124657|50015995|FG000|Overall Study|Progressive disease|14|||
24922447|NCT00124657|50015996|FG001|Overall Study|Progressive disease|5|||
24922448|NCT00124657|50015997|FG002|Overall Study|Progressive disease|27|||
24922449|NCT00124657|50015995|FG000|Overall Study|Intercurrent illness|1|||
24922450|NCT00124657|50015996|FG001|Overall Study|Intercurrent illness|0|||
24922451|NCT00124657|50015997|FG002|Overall Study|Intercurrent illness|0|||
24922452|NCT00581945|50016020|FG000|Overall Study|Adverse Event|4|||
24922453|NCT00581945|50016021|FG001|Overall Study|Adverse Event|4|||
24922454|NCT00581945|50016020|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
24922455|NCT00581945|50016021|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
24922456|NCT00581945|50016020|FG000|Overall Study|Withdrawal by Subject|2|||
24922457|NCT00581945|50016021|FG001|Overall Study|Withdrawal by Subject|6|||
24922458|NCT00581945|50016020|FG000|Overall Study|Death|1|||
24922459|NCT00581945|50016021|FG001|Overall Study|Death|0|||
24922460|NCT00555906|50016030|FG000|Phase 1|Objective Progression or Relapse|3|||
24922461|NCT00555906|50016031|FG001|Phase 1|Objective Progression or Relapse|5|||
24922462|NCT00555906|50016032|FG002|Phase 1|Objective Progression or Relapse|3|||
24922463|NCT00555906|50016033|FG003|Phase 1|Objective Progression or Relapse|1|||
24922464|NCT00555906|50016034|FG004|Phase 1|Objective Progression or Relapse|0|||
24922465|NCT00555906|50016030|FG000|Phase 1|Global Deterioration of Health Status|0|||
24922466|NCT00555906|50016031|FG001|Phase 1|Global Deterioration of Health Status|1|||
24922467|NCT00555906|50016032|FG002|Phase 1|Global Deterioration of Health Status|1|||
24922468|NCT00555906|50016033|FG003|Phase 1|Global Deterioration of Health Status|1|||
24922469|NCT00555906|50016034|FG004|Phase 1|Global Deterioration of Health Status|0|||
24922470|NCT00555906|50016030|FG000|Phase 1|Adverse Event|0|||
24922471|NCT00555906|50016031|FG001|Phase 1|Adverse Event|0|||
24922472|NCT00555906|50016032|FG002|Phase 1|Adverse Event|3|||
24922473|NCT00555906|50016033|FG003|Phase 1|Adverse Event|2|||
24922474|NCT00555906|50016034|FG004|Phase 1|Adverse Event|0|||
24922475|NCT00555906|50016030|FG000|Phase 1|Withdrawal by Subject|0|||
24922476|NCT00555906|50016031|FG001|Phase 1|Withdrawal by Subject|0|||
24922477|NCT00555906|50016032|FG002|Phase 1|Withdrawal by Subject|0|||
24922478|NCT00555906|50016033|FG003|Phase 1|Withdrawal by Subject|1|||
24922479|NCT00555906|50016034|FG004|Phase 1|Withdrawal by Subject|0|||
24922480|NCT00555906|50016030|FG000|Phase 2|Adverse Event|0|||
24922481|NCT00555906|50016031|FG001|Phase 2|Adverse Event|0|||
24922482|NCT00555906|50016032|FG002|Phase 2|Adverse Event|0|||
24922483|NCT00555906|50016033|FG003|Phase 2|Adverse Event|0|||
24922484|NCT00555906|50016034|FG004|Phase 2|Adverse Event|4|||
24922485|NCT00555906|50016030|FG000|Phase 2|Global Deterioration of Health Status|0|||
24922486|NCT00555906|50016031|FG001|Phase 2|Global Deterioration of Health Status|0|||
24922487|NCT00555906|50016032|FG002|Phase 2|Global Deterioration of Health Status|0|||
24922488|NCT00555906|50016033|FG003|Phase 2|Global Deterioration of Health Status|0|||
24922489|NCT00555906|50016034|FG004|Phase 2|Global Deterioration of Health Status|2|||
24922490|NCT00555906|50016030|FG000|Phase 2|Objective Progression or Relapse|0|||
24922491|NCT00555906|50016031|FG001|Phase 2|Objective Progression or Relapse|0|||
24922492|NCT00555906|50016032|FG002|Phase 2|Objective Progression or Relapse|0|||
24922493|NCT00555906|50016033|FG003|Phase 2|Objective Progression or Relapse|0|||
24922494|NCT00555906|50016034|FG004|Phase 2|Objective Progression or Relapse|16|||
24922495|NCT00555906|50016030|FG000|Phase 2|Withdrawal by Subject|0|||
24922496|NCT00555906|50016031|FG001|Phase 2|Withdrawal by Subject|0|||
24922497|NCT00555906|50016032|FG002|Phase 2|Withdrawal by Subject|0|||
24922498|NCT00555906|50016033|FG003|Phase 2|Withdrawal by Subject|0|||
24922499|NCT00555906|50016034|FG004|Phase 2|Withdrawal by Subject|2|||
24922500|NCT00555906|50016030|FG000|Phase 2|Other|0|||
24922501|NCT00555906|50016031|FG001|Phase 2|Other|0|||
24922502|NCT00555906|50016032|FG002|Phase 2|Other|0|||
24922503|NCT00555906|50016033|FG003|Phase 2|Other|0|||
24922504|NCT00555906|50016034|FG004|Phase 2|Other|6|||
24922505|NCT00555906|50016030|FG000|Phase 2|Randomized but not Treated|0|||
24922506|NCT00555906|50016031|FG001|Phase 2|Randomized but not Treated|0|||
24922507|NCT00555906|50016032|FG002|Phase 2|Randomized but not Treated|0|||
24922508|NCT00555906|50016033|FG003|Phase 2|Randomized but not Treated|0|||
24922509|NCT00555906|50016034|FG004|Phase 2|Randomized but not Treated|2|||
24922510|NCT03817879|50016051|FG000|Overall Study|Drop out|5|||
24922511|NCT03817879|50016052|FG001|Overall Study|Drop out|12|||
24922512|NCT03817879|50016051|FG000|Overall Study|Withdrawal by Subject|0|||
24922513|NCT03817879|50016052|FG001|Overall Study|Withdrawal by Subject|1|||
24922514|NCT00555672|50016060|FG000|Overall Study|Death|0|||
24922515|NCT00555672|50016061|FG001|Overall Study|Death|2|||
24922516|NCT00555672|50016060|FG000|Overall Study|Adverse Event|8|||
24922517|NCT00555672|50016061|FG001|Overall Study|Adverse Event|2|||
24922518|NCT00555672|50016060|FG000|Overall Study|Objective progression or relapse|11|||
24922519|NCT00555672|50016061|FG001|Overall Study|Objective progression or relapse|5|||
24922520|NCT00555672|50016060|FG000|Overall Study|Other|3|||
24922521|NCT00555672|50016061|FG001|Overall Study|Other|1|||
24922522|NCT00555672|50016060|FG000|Overall Study|Participant refused|2|||
24922523|NCT00555672|50016061|FG001|Overall Study|Participant refused|0|||
24922524|NCT03958656|50016071|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
24922525|NCT03958656|50016072|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
24922526|NCT03958656|50016073|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
24922527|NCT03958656|50016074|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
24922528|NCT03958656|50016071|FG000|Overall Study|No longer meets eligibility criteria|0|||
24922529|NCT03958656|50016072|FG001|Overall Study|No longer meets eligibility criteria|0|||
24922530|NCT03958656|50016073|FG002|Overall Study|No longer meets eligibility criteria|1|||
24922531|NCT03958656|50016074|FG003|Overall Study|No longer meets eligibility criteria|0|||
24922532|NCT03958656|50016071|FG000|Overall Study|Started anti-cancer treatment|0|||
24922533|NCT03958656|50016072|FG001|Overall Study|Started anti-cancer treatment|0|||
24922534|NCT03958656|50016073|FG002|Overall Study|Started anti-cancer treatment|1|||
24922535|NCT03958656|50016074|FG003|Overall Study|Started anti-cancer treatment|0|||
24922536|NCT00561912|50016084|FG000|Overall Study|ineligible|1|||
24922537|NCT00561678|50016090|FG000|Overall Study|Withdrawal by Subject|4|||
24922538|NCT00561678|50016091|FG001|Overall Study|Withdrawal by Subject|3|||
24922539|NCT00561678|50016090|FG000|Overall Study|surgery cancelled|1|||
24922540|NCT00561678|50016091|FG001|Overall Study|surgery cancelled|1|||
24922541|NCT00561678|50016090|FG000|Overall Study|surgery rescheduled to different site|2|||
24922542|NCT00561678|50016091|FG001|Overall Study|surgery rescheduled to different site|2|||
24922543|NCT00561678|50016090|FG000|Overall Study|anesthesia provider refusal|1|||
24922544|NCT00561678|50016091|FG001|Overall Study|anesthesia provider refusal|0|||
24922545|NCT00463684|50016097|FG000|Overall Study|Withdrawal by Subject|1|||
24922546|NCT00463684|50016097|FG000|Overall Study|Lost to Follow-up|3|||
24922547|NCT00463606|50016104|FG000|Overall Study|Adverse Event|21|||
24922548|NCT00463606|50016105|FG001|Overall Study|Adverse Event|18|||
24922549|NCT00463606|50016106|FG002|Overall Study|Adverse Event|11|||
24922550|NCT00463606|50016104|FG000|Overall Study|Withdrawal by Subject|11|||
24922551|NCT00463606|50016105|FG001|Overall Study|Withdrawal by Subject|11|||
24922552|NCT00463606|50016106|FG002|Overall Study|Withdrawal by Subject|5|||
24922553|NCT00463606|50016104|FG000|Overall Study|Lost to Follow-up|2|||
24922554|NCT00463606|50016105|FG001|Overall Study|Lost to Follow-up|2|||
24922555|NCT00463606|50016106|FG002|Overall Study|Lost to Follow-up|3|||
24922556|NCT00463606|50016104|FG000|Overall Study|Subject noncompliance|1|||
24922557|NCT00463606|50016105|FG001|Overall Study|Subject noncompliance|1|||
24922558|NCT00463606|50016106|FG002|Overall Study|Subject noncompliance|0|||
24922559|NCT00463606|50016104|FG000|Overall Study|Subject moved out of town|1|||
24922560|NCT00463606|50016105|FG001|Overall Study|Subject moved out of town|0|||
24922561|NCT00463606|50016106|FG002|Overall Study|Subject moved out of town|0|||
24922562|NCT00463606|50016104|FG000|Overall Study|Physician Decision|0|||
24922563|NCT00463606|50016105|FG001|Overall Study|Physician Decision|1|||
24922564|NCT00463606|50016106|FG002|Overall Study|Physician Decision|0|||
24922565|NCT00463606|50016104|FG000|Overall Study|Sponsor request|0|||
24922566|NCT00463606|50016105|FG001|Overall Study|Sponsor request|1|||
24922567|NCT00463606|50016106|FG002|Overall Study|Sponsor request|0|||
25023515|NCT02875977|50120899|FG001|Overall Study|Lost to Follow-up|29|||
24922568|NCT00463606|50016104|FG000|Overall Study|Exclusion criteria violation|2|||
24922569|NCT00463606|50016105|FG001|Overall Study|Exclusion criteria violation|0|||
24922570|NCT00463606|50016106|FG002|Overall Study|Exclusion criteria violation|0|||
24922571|NCT00463606|50016104|FG000|Overall Study|Coordinator error|1|||
24922572|NCT00463606|50016105|FG001|Overall Study|Coordinator error|0|||
24922573|NCT00463606|50016106|FG002|Overall Study|Coordinator error|0|||
24922574|NCT00463606|50016104|FG000|Overall Study|Patient randomized in error|1|||
24922575|NCT00463606|50016105|FG001|Overall Study|Patient randomized in error|0|||
24922576|NCT00463606|50016106|FG002|Overall Study|Patient randomized in error|0|||
24922577|NCT00463606|50016104|FG000|Overall Study|Participation in another ABT-335 trial|1|||
24922578|NCT00463606|50016105|FG001|Overall Study|Participation in another ABT-335 trial|0|||
24922579|NCT00463606|50016106|FG002|Overall Study|Participation in another ABT-335 trial|0|||
24922580|NCT00463606|50016104|FG000|Overall Study|Protocol Violation|0|||
24922581|NCT00463606|50016105|FG001|Overall Study|Protocol Violation|0|||
24922582|NCT00463606|50016106|FG002|Overall Study|Protocol Violation|1|||
24922583|NCT03961308|50016116|FG000|Overall Study|Withdrawal by Subject|1|||
24922584|NCT03961308|50016117|FG001|Overall Study|Withdrawal by Subject|0|||
24922585|NCT03961308|50016116|FG000|Overall Study|Other|1|||
24922586|NCT03961308|50016117|FG001|Overall Study|Other|0|||
24922587|NCT03961308|50016116|FG000|Overall Study|Lost to Follow-up|0|||
24922588|NCT03961308|50016117|FG001|Overall Study|Lost to Follow-up|1|||
24922589|NCT03961308|50016116|FG000|Overall Study|Adverse Event|0|||
24922590|NCT03961308|50016117|FG001|Overall Study|Adverse Event|1|||
24922591|NCT00174187|50016125|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
24922592|NCT00174187|50016126|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
24922593|NCT00174187|50016127|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
24922594|NCT00174187|50016125|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
24922595|NCT00174187|50016126|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
24922596|NCT00174187|50016127|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
24922597|NCT00174187|50016125|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
24922598|NCT00174187|50016126|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
24922599|NCT00174187|50016127|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
24922600|NCT00174187|50016125|FG000|Period 1 (up to 3 Years)|Other|0|||
24922601|NCT00174187|50016126|FG001|Period 1 (up to 3 Years)|Other|1|||
24922602|NCT00174187|50016127|FG002|Period 1 (up to 3 Years)|Other|0|||
24922603|NCT00174187|50016125|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
24922604|NCT00174187|50016126|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
24922605|NCT00174187|50016127|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
24922606|NCT00174187|50016125|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
24922607|NCT00174187|50016126|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
24922608|NCT00174187|50016127|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
24922609|NCT00174187|50016125|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
24922610|NCT00174187|50016126|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
24922611|NCT00174187|50016127|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
24922612|NCT00174187|50016125|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
24922613|NCT00174187|50016126|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
24922614|NCT00174187|50016127|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
24922615|NCT00174187|50016125|FG000|Period 2 (After 3 Years)|Other|0|||
24922616|NCT00174187|50016126|FG001|Period 2 (After 3 Years)|Other|0|||
24922617|NCT00174187|50016127|FG002|Period 2 (After 3 Years)|Other|5|||
24922618|NCT01011335|50016139|FG000|Overall Study|Lost to Follow-up|0|||
24922619|NCT01011335|50016140|FG001|Overall Study|Lost to Follow-up|0|||
24922620|NCT01011335|50016141|FG002|Overall Study|Lost to Follow-up|1|||
24922621|NCT01011335|50016142|FG003|Overall Study|Lost to Follow-up|1|||
24922622|NCT01011335|50016143|FG004|Overall Study|Lost to Follow-up|1|||
24922623|NCT01011335|50016144|FG005|Overall Study|Lost to Follow-up|1|||
24922624|NCT01011335|50016145|FG006|Overall Study|Lost to Follow-up|2|||
24922625|NCT01011335|50016146|FG007|Overall Study|Lost to Follow-up|2|||
24922626|NCT01011335|50016147|FG008|Overall Study|Lost to Follow-up|1|||
24922627|NCT01011335|50016148|FG009|Overall Study|Lost to Follow-up|0|||
24922628|NCT01011335|50016149|FG010|Overall Study|Lost to Follow-up|0|||
24922629|NCT01011335|50016150|FG011|Overall Study|Lost to Follow-up|1|||
24922630|NCT01011335|50016151|FG012|Overall Study|Lost to Follow-up|2|||
24922631|NCT01011335|50016139|FG000|Overall Study|Protocol Violation|0|||
24922632|NCT01011335|50016140|FG001|Overall Study|Protocol Violation|1|||
24922633|NCT01011335|50016141|FG002|Overall Study|Protocol Violation|0|||
25023516|NCT02703532|50120918|FG000|Overall Study|Withdrawal by Subject|0|||
25023517|NCT02703532|50120919|FG001|Overall Study|Withdrawal by Subject|1|||
25185126|NCT00245583|50334298|FG000|Overall Study|Withdrawal by Subject|2|||
24922634|NCT01011335|50016142|FG003|Overall Study|Protocol Violation|0|||
25185127|NCT00245583|50334299|FG001|Overall Study|Withdrawal by Subject|3|||
24922635|NCT01011335|50016143|FG004|Overall Study|Protocol Violation|0|||
24922636|NCT01011335|50016144|FG005|Overall Study|Protocol Violation|0|||
24922637|NCT01011335|50016145|FG006|Overall Study|Protocol Violation|0|||
24922638|NCT01011335|50016146|FG007|Overall Study|Protocol Violation|0|||
24922639|NCT01011335|50016147|FG008|Overall Study|Protocol Violation|0|||
24922640|NCT01011335|50016148|FG009|Overall Study|Protocol Violation|0|||
24922641|NCT01011335|50016149|FG010|Overall Study|Protocol Violation|0|||
24922642|NCT01011335|50016150|FG011|Overall Study|Protocol Violation|0|||
24922643|NCT01011335|50016151|FG012|Overall Study|Protocol Violation|0|||
24922644|NCT01011335|50016139|FG000|Overall Study|Moved/deployed or no booster|1|||
25023518|NCT02703532|50120920|FG002|Overall Study|Withdrawal by Subject|0|||
25023519|NCT02703532|50120921|FG003|Overall Study|Withdrawal by Subject|1|||
25023520|NCT02703532|50120918|FG000|Overall Study|Lost to Follow-up|2|||
25023521|NCT02703532|50120919|FG001|Overall Study|Lost to Follow-up|0|||
25023522|NCT02703532|50120920|FG002|Overall Study|Lost to Follow-up|2|||
25023523|NCT02703532|50120921|FG003|Overall Study|Lost to Follow-up|0|||
25023524|NCT02930343|50120954|FG000|Overall Study|Lost to Follow-up|9|||
25023525|NCT02930343|50120955|FG001|Overall Study|Lost to Follow-up|7|||
25023526|NCT02703454|50120963|FG000|Overall Study|Not treated|1|||
25023527|NCT02703454|50120964|FG001|Overall Study|Not treated|3|||
25023528|NCT02703454|50120963|FG000|Overall Study|Withdrawal by Subject|4|||
25023529|NCT02703454|50120964|FG001|Overall Study|Withdrawal by Subject|3|||
25023530|NCT02703454|50120963|FG000|Overall Study|Lost to Follow-up|1|||
25023531|NCT02703454|50120964|FG001|Overall Study|Lost to Follow-up|2|||
25023532|NCT02703454|50120963|FG000|Overall Study|Study discontinuation|5|||
25023533|NCT02703454|50120964|FG001|Overall Study|Study discontinuation|8|||
25023534|NCT03103542|50120970|FG000|Overall Study|Physician Decision|2|||
25023535|NCT03103542|50120970|FG000|Overall Study|Adverse Event|2|||
25023536|NCT03103542|50120970|FG000|Overall Study|Other|2|||
25023537|NCT03103542|50120970|FG000|Overall Study|Withdrawal by Subject|1|||
25023538|NCT03376321|50120997|FG000|Overall Study|Other|5|||
25023539|NCT03376321|50120998|FG001|Overall Study|Other|1|||
25023540|NCT03376321|50120997|FG000|Overall Study|Withdrawal by Subject|8|||
25023541|NCT03376321|50120998|FG001|Overall Study|Withdrawal by Subject|14|||
25023542|NCT03376321|50120997|FG000|Overall Study|Lost to Follow-up|1|||
25023543|NCT03376321|50120998|FG001|Overall Study|Lost to Follow-up|7|||
25023544|NCT03376321|50120997|FG000|Overall Study|Death|4|||
25023545|NCT03376321|50120998|FG001|Overall Study|Death|0|||
25023546|NCT03376321|50120997|FG000|Overall Study|Randomized, not treated|5|||
25023547|NCT03376321|50120998|FG001|Overall Study|Randomized, not treated|3|||
25023548|NCT03374995|50121006|FG000|Overall Study|Withdrawal by Subject|0|||
25023549|NCT03374995|50121007|FG001|Overall Study|Withdrawal by Subject|1|||
25023550|NCT02828982|50121013|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
25023551|NCT02828982|50121014|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
25023552|NCT03133767|50121024|FG000|Overall Study|Lost to Follow-up|38|||
25023553|NCT03133767|50121025|FG001|Overall Study|Lost to Follow-up|24|||
25023554|NCT03133767|50121024|FG000|Overall Study|Protocol Violation|0|||
25023555|NCT03133767|50121025|FG001|Overall Study|Protocol Violation|1|||
25023556|NCT03391765|50121035|FG000|Overall Study|Adverse Event|2|||
25023557|NCT03391765|50121036|FG001|Overall Study|Adverse Event|0|||
25023558|NCT03391765|50121037|FG002|Overall Study|Adverse Event|0|||
25023559|NCT03391765|50121038|FG003|Overall Study|Adverse Event|2|||
25023560|NCT03391765|50121035|FG000|Overall Study|Withdrew consent|5|||
25023561|NCT03391765|50121036|FG001|Overall Study|Withdrew consent|7|||
25023562|NCT03391765|50121037|FG002|Overall Study|Withdrew consent|2|||
25023563|NCT03391765|50121038|FG003|Overall Study|Withdrew consent|5|||
25023564|NCT03391765|50121035|FG000|Overall Study|Other, not specified|44|||
25023565|NCT03391765|50121036|FG001|Overall Study|Other, not specified|38|||
25023566|NCT03391765|50121037|FG002|Overall Study|Other, not specified|21|||
25023567|NCT03391765|50121038|FG003|Overall Study|Other, not specified|16|||
25023568|NCT02802228|50121050|FG000|Overall Study|Withdrawal by Subject|2|||
25023569|NCT02802228|50121051|FG001|Overall Study|Withdrawal by Subject|0|||
25023570|NCT02802228|50121050|FG000|Overall Study|Lost to Follow-up|1|||
25023571|NCT02802228|50121051|FG001|Overall Study|Lost to Follow-up|0|||
25023572|NCT02802228|50121050|FG000|Overall Study|Adverse Event|1|||
25023573|NCT02802228|50121051|FG001|Overall Study|Adverse Event|0|||
25023574|NCT02802228|50121050|FG000|Overall Study|Physician Decision|1|||
25023575|NCT02802228|50121051|FG001|Overall Study|Physician Decision|0|||
25023576|NCT03130257|50121060|FG000|Overall Study|Withdrawal by Subject|1|||
25023577|NCT03130257|50121061|FG001|Overall Study|Withdrawal by Subject|0|||
25023578|NCT03130257|50121062|FG002|Overall Study|Withdrawal by Subject|2|||
25023579|NCT03674177|50121074|FG000|Overall Study|Lost to Follow-up|2|||
25023580|NCT03674177|50121075|FG001|Overall Study|Lost to Follow-up|1|||
25023581|NCT03674177|50121076|FG002|Overall Study|Lost to Follow-up|0|||
25023582|NCT03674177|50121077|FG003|Overall Study|Lost to Follow-up|2|||
25023583|NCT03354637|50121103|FG000|Double-blind Period|Protocol Violation|2|||
25023584|NCT03354637|50121104|FG001|Double-blind Period|Protocol Violation|0|||
25023585|NCT03354637|50121105|FG002|Double-blind Period|Protocol Violation|0|||
25023586|NCT03354637|50121103|FG000|Double-blind Period|Adverse Event|1|||
25023587|NCT03354637|50121104|FG001|Double-blind Period|Adverse Event|2|||
25023588|NCT03354637|50121105|FG002|Double-blind Period|Adverse Event|0|||
25023589|NCT03354637|50121103|FG000|Double-blind Period|Lost to Follow-up|3|||
25023590|NCT03354637|50121104|FG001|Double-blind Period|Lost to Follow-up|4|||
25023591|NCT03354637|50121105|FG002|Double-blind Period|Lost to Follow-up|3|||
25023592|NCT03354637|50121103|FG000|Double-blind Period|Withdrawal by Subject|10|||
25023593|NCT03354637|50121104|FG001|Double-blind Period|Withdrawal by Subject|6|||
25023594|NCT03354637|50121105|FG002|Double-blind Period|Withdrawal by Subject|4|||
25023595|NCT03354637|50121103|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
25023596|NCT03354637|50121104|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
25023597|NCT03354637|50121105|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
25023598|NCT03354637|50121103|FG000|Open Label Extension|Adverse Event|0|||
25023599|NCT03354637|50121104|FG001|Open Label Extension|Adverse Event|0|||
25023600|NCT03354637|50121105|FG002|Open Label Extension|Adverse Event|1|||
25023601|NCT03354637|50121103|FG000|Open Label Extension|Lost to Follow-up|0|||
25023602|NCT03354637|50121104|FG001|Open Label Extension|Lost to Follow-up|0|||
25023603|NCT03354637|50121105|FG002|Open Label Extension|Lost to Follow-up|2|||
25023604|NCT03354637|50121103|FG000|Open Label Extension|Withdrawal by Subject|0|||
25023605|NCT03354637|50121104|FG001|Open Label Extension|Withdrawal by Subject|0|||
25023606|NCT03354637|50121105|FG002|Open Label Extension|Withdrawal by Subject|5|||
25023607|NCT03354637|50121103|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
25023608|NCT03354637|50121104|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
25023609|NCT03354637|50121105|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
25023610|NCT03354637|50121103|FG000|Open Label Extension|Subject Noncompliance|0|||
25023611|NCT03354637|50121104|FG001|Open Label Extension|Subject Noncompliance|0|||
25023612|NCT03354637|50121105|FG002|Open Label Extension|Subject Noncompliance|1|||
25023613|NCT03354637|50121103|FG000|Open Label Extension|Lack of Efficacy|0|||
25023614|NCT03354637|50121104|FG001|Open Label Extension|Lack of Efficacy|0|||
25023615|NCT03354637|50121105|FG002|Open Label Extension|Lack of Efficacy|1|||
25023616|NCT03354637|50121103|FG000|Open Label Extension|Physician Decision|0|||
25023617|NCT03354637|50121104|FG001|Open Label Extension|Physician Decision|0|||
25023618|NCT03354637|50121105|FG002|Open Label Extension|Physician Decision|1|||
25023619|NCT04053023|50121116|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
25023620|NCT04053023|50121117|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
25023621|NCT03352453|50121129|FG000|Overall Study|Miscellaneous Reasons|1|||
25023622|NCT03352453|50121130|FG001|Overall Study|Miscellaneous Reasons|2|||
25023623|NCT03352453|50121129|FG000|Overall Study|Lack of Efficacy|1|||
25023624|NCT03352453|50121130|FG001|Overall Study|Lack of Efficacy|0|||
25023625|NCT03352453|50121129|FG000|Overall Study|Withdrawal by Subject|8|||
25023626|NCT03352453|50121130|FG001|Overall Study|Withdrawal by Subject|14|||
25023627|NCT03352453|50121129|FG000|Overall Study|Study Terminated by Sponsor|2|||
25023628|NCT03352453|50121130|FG001|Overall Study|Study Terminated by Sponsor|1|||
25023629|NCT03352453|50121129|FG000|Overall Study|Protocol Deviation|1|||
25023630|NCT03352453|50121130|FG001|Overall Study|Protocol Deviation|0|||
25023631|NCT03352453|50121129|FG000|Overall Study|Lost to Follow-up|7|||
25023632|NCT03352453|50121130|FG001|Overall Study|Lost to Follow-up|6|||
25023633|NCT03352453|50121129|FG000|Overall Study|Adverse Event|2|||
25023634|NCT03352453|50121130|FG001|Overall Study|Adverse Event|9|||
25023635|NCT03128931|50121136|FG000|Overall Study|Physician Decision|1|||
25023636|NCT03128931|50121136|FG000|Overall Study|Equipment Issues|3|||
25023637|NCT03107052|50121143|FG000|Overall Study|Adverse Event|6|||
25023638|NCT03107052|50121144|FG001|Overall Study|Adverse Event|1|||
25023639|NCT03107052|50121145|FG002|Overall Study|Adverse Event|2|||
25023640|NCT03107052|50121143|FG000|Overall Study|Withdrawal by Subject|9|||
25023641|NCT03107052|50121144|FG001|Overall Study|Withdrawal by Subject|5|||
25023642|NCT03107052|50121145|FG002|Overall Study|Withdrawal by Subject|8|||
25023643|NCT03107052|50121143|FG000|Overall Study|Protocol Violation|6|||
25023644|NCT03107052|50121144|FG001|Overall Study|Protocol Violation|0|||
25023645|NCT03107052|50121145|FG002|Overall Study|Protocol Violation|3|||
25023646|NCT03107052|50121143|FG000|Overall Study|Lost to Follow-up|4|||
25185128|NCT02652156|50334319|FG000|Overall Study|Physician Decision|1|||
25185129|NCT02652156|50334320|FG001|Overall Study|Physician Decision|0|||
25185130|NCT02652156|50334321|FG002|Overall Study|Physician Decision|0|||
25185131|NCT01675050|50334368|FG000|Period One Treatment|Withdrawal by Subject|1|||
25023647|NCT03107052|50121144|FG001|Overall Study|Lost to Follow-up|0|||
25023648|NCT03107052|50121145|FG002|Overall Study|Lost to Follow-up|1|||
25023649|NCT03107052|50121143|FG000|Overall Study|Lack of Efficacy|23|||
25023650|NCT03107052|50121144|FG001|Overall Study|Lack of Efficacy|7|||
25023651|NCT03107052|50121145|FG002|Overall Study|Lack of Efficacy|4|||
25023652|NCT03107052|50121143|FG000|Overall Study|Other than specified|4|||
25023653|NCT03107052|50121144|FG001|Overall Study|Other than specified|2|||
25023654|NCT03107052|50121145|FG002|Overall Study|Other than specified|0|||
25023655|NCT03107052|50121143|FG000|Overall Study|Study terminated due to futility|67|||
25023656|NCT03107052|50121144|FG001|Overall Study|Study terminated due to futility|31|||
25023657|NCT03107052|50121145|FG002|Overall Study|Study terminated due to futility|23|||
25023658|NCT04050371|50121155|FG000|Overall Study|Withdrawal by Subject|1|||
25023659|NCT04050371|50121156|FG001|Overall Study|Withdrawal by Subject|0|||
25023660|NCT04447287|50121165|FG000|Period 1: Run-in Period|Adverse Event|3|||
25185132|NCT01675050|50334369|FG001|Period One Treatment|Withdrawal by Subject|0|||
25185133|NCT00244881|50334388|FG000|Overall Study|Withdrawal by Subject|3|||
25023661|NCT04447287|50121166|FG001|Period 1: Run-in Period|Adverse Event|0|||
25023662|NCT04447287|50121167|FG002|Period 1: Run-in Period|Adverse Event|0|||
25023663|NCT04447287|50121165|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
25023664|NCT04447287|50121166|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
25023665|NCT04447287|50121167|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
25023666|NCT04447287|50121165|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
25023667|NCT04447287|50121166|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
25023668|NCT04447287|50121167|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
25023669|NCT01879319|50121188|FG000|Overall Study|Withdrawal by Subject|1|||
25023670|NCT01879319|50121189|FG001|Overall Study|Withdrawal by Subject|0|||
25023671|NCT01879319|50121188|FG000|Overall Study|Lost to Follow-up|1|||
25023672|NCT01879319|50121189|FG001|Overall Study|Lost to Follow-up|5|||
25023673|NCT03102918|50121197|FG000|Overall Study|Protocol Violation|1|||
25023674|NCT03102918|50121198|FG001|Overall Study|Protocol Violation|0|||
25023675|NCT03128307|50121204|FG000|Overall Study|Lost to Follow-up|29|||
25023676|NCT03128307|50121204|FG000|Overall Study|Withdrawal by Subject|5|||
25023677|NCT03102762|50121210|FG000|Overall Study|Lost to Follow-up|1|||
25023678|NCT03102762|50121211|FG001|Overall Study|Lost to Follow-up|0|||
25023679|NCT01346475|50121224|FG000|First Intervention|Lost to Follow-up|4|||
25023680|NCT01346475|50121225|FG001|First Intervention|Lost to Follow-up|3|||
25023681|NCT01338636|50121231|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
25023682|NCT00322218|50121237|FG000|Overall Study|Death|3|||
25023683|NCT00322218|50121238|FG001|Overall Study|Death|6|||
25023684|NCT02873754|50121244|FG000|Overall Study|Lost to Follow-up|5|||
25023685|NCT02873754|50121244|FG000|Overall Study|Couldn't complete study procedures|1|||
25023686|NCT03287414|50121250|FG000|Treatment Epoch|Adverse Event|0|||
25023687|NCT03287414|50121251|FG001|Treatment Epoch|Adverse Event|1|||
25023688|NCT03287414|50121250|FG000|Treatment Epoch|Study terminated by sponsor|2|||
25023689|NCT03287414|50121251|FG001|Treatment Epoch|Study terminated by sponsor|2|||
25023690|NCT03287414|50121250|FG000|Treatment Epoch|Subject/Guardian decision|4|||
25023691|NCT03287414|50121251|FG001|Treatment Epoch|Subject/Guardian decision|0|||
25023692|NCT03287414|50121250|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
25023693|NCT03287414|50121251|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
25023694|NCT03287414|50121250|FG000|Treatment Epoch|Withdrawal by Subject|1|||
25023695|NCT03287414|50121251|FG001|Treatment Epoch|Withdrawal by Subject|0|||
25023696|NCT03287414|50121250|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
25023697|NCT03287414|50121251|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
25023698|NCT03287414|50121250|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
25023699|NCT03287414|50121251|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
25023700|NCT03101592|50121281|FG000|Overall Study|participant files could not be located|111|||
25023701|NCT03101592|50121282|FG001|Overall Study|participant files could not be located|170|||
25023702|NCT03101592|50121283|FG002|Overall Study|participant files could not be located|118|||
25023703|NCT04046939|50121301|FG000|Primary Assessment Period|Adverse Event|1|||
25023704|NCT04046939|50121302|FG001|Primary Assessment Period|Adverse Event|0|||
25023705|NCT04046939|50121303|FG002|Primary Assessment Period|Adverse Event|0|||
25023706|NCT04046939|50121304|FG003|Primary Assessment Period|Adverse Event|0|||
25023707|NCT04046939|50121301|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
25023708|NCT04046939|50121302|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
25023709|NCT04046939|50121303|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
25023710|NCT04046939|50121304|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
25023711|NCT04046939|50121301|FG000|Primary Assessment Period|Physician Decision|0|||
25023712|NCT04046939|50121302|FG001|Primary Assessment Period|Physician Decision|0|||
25023713|NCT04046939|50121303|FG002|Primary Assessment Period|Physician Decision|1|||
25023714|NCT04046939|50121304|FG003|Primary Assessment Period|Physician Decision|0|||
25023715|NCT04046939|50121301|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
25023716|NCT04046939|50121302|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
25023717|NCT04046939|50121303|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
25023718|NCT04046939|50121304|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
25023719|NCT04042103|50121320|FG000|Overall Study|Lost to Follow-up|1|||
25023720|NCT04042103|50121320|FG000|Overall Study|Withdrawal by Subject|1|||
25023721|NCT02955797|50121328|FG000|Overall Study|Protocol Violation|1|||
25023722|NCT02955797|50121329|FG001|Overall Study|Protocol Violation|0|||
25023723|NCT02955797|50121330|FG002|Overall Study|Protocol Violation|0|||
25023724|NCT02955797|50121331|FG003|Overall Study|Protocol Violation|1|||
25023725|NCT02955797|50121328|FG000|Overall Study|Withdrawal by Subject|2|||
25023726|NCT02955797|50121329|FG001|Overall Study|Withdrawal by Subject|2|||
25023727|NCT02955797|50121330|FG002|Overall Study|Withdrawal by Subject|0|||
25023728|NCT02955797|50121331|FG003|Overall Study|Withdrawal by Subject|1|||
25023729|NCT02955797|50121328|FG000|Overall Study|Lost to Follow-up|0|||
25023730|NCT02955797|50121329|FG001|Overall Study|Lost to Follow-up|1|||
25154580|NCT01903837|50269760|FG000|Part A|Withdrawal by Subject|4|||
25154581|NCT01903837|50269761|FG001|Part A|Withdrawal by Subject|9|||
25154582|NCT01903837|50269762|FG002|Part A|Withdrawal by Subject|8|||
25154583|NCT01903837|50269763|FG003|Part A|Withdrawal by Subject|5|||
25023731|NCT02955797|50121330|FG002|Overall Study|Lost to Follow-up|0|||
25023732|NCT02955797|50121331|FG003|Overall Study|Lost to Follow-up|0|||
25023733|NCT03101514|50121344|FG000|Overall Study|Withdrawal by Subject|4|||
25023734|NCT03101514|50121344|FG000|Overall Study|Protocol Violation|2|||
25023735|NCT03101514|50121344|FG000|Overall Study|patient's information was incomplete|1|||
25023736|NCT04040933|50121348|FG000|Overall Study|Protocol Violation|1|||
25023737|NCT04040933|50121348|FG000|Overall Study|Withdrawal by Subject|2|||
25023738|NCT02702518|50121361|FG000|Overall Study|Lost to Follow-up|3|||
25023739|NCT02702518|50121362|FG001|Overall Study|Lost to Follow-up|4|||
25023740|NCT04039503|50121372|FG000|Overall Study|Adverse Event|3|||
25023741|NCT04039503|50121373|FG001|Overall Study|Adverse Event|0|||
25023742|NCT04039503|50121374|FG002|Overall Study|Adverse Event|2|||
25023743|NCT04039503|50121375|FG003|Overall Study|Adverse Event|0|||
25023744|NCT04039503|50121372|FG000|Overall Study|Lost to Follow-up|0|||
25023745|NCT04039503|50121373|FG001|Overall Study|Lost to Follow-up|0|||
25023746|NCT04039503|50121374|FG002|Overall Study|Lost to Follow-up|1|||
25023747|NCT04039503|50121375|FG003|Overall Study|Lost to Follow-up|0|||
25023748|NCT04039503|50121372|FG000|Overall Study|Protocol Violation|0|||
25023749|NCT04039503|50121373|FG001|Overall Study|Protocol Violation|1|||
25023750|NCT04039503|50121374|FG002|Overall Study|Protocol Violation|2|||
25023751|NCT04039503|50121375|FG003|Overall Study|Protocol Violation|1|||
25023752|NCT04039503|50121372|FG000|Overall Study|Withdrawal by Subject|4|||
25023753|NCT04039503|50121373|FG001|Overall Study|Withdrawal by Subject|3|||
25023754|NCT04039503|50121374|FG002|Overall Study|Withdrawal by Subject|5|||
25023755|NCT04039503|50121375|FG003|Overall Study|Withdrawal by Subject|2|||
25023756|NCT03131895|50121412|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
25023757|NCT03131895|50121413|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
25023758|NCT03131895|50121414|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
25023759|NCT03131895|50121415|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
25023760|NCT03131895|50121412|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
25023761|NCT03131895|50121413|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
25023762|NCT03131895|50121414|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
25023763|NCT03131895|50121415|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
25023764|NCT03131895|50121412|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
25023765|NCT03131895|50121413|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
25023766|NCT03131895|50121414|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
25023767|NCT03131895|50121415|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
25023768|NCT03131895|50121412|FG000|Washout Period (at Least 5 Days)|Other|0|||
25023769|NCT03131895|50121413|FG001|Washout Period (at Least 5 Days)|Other|0|||
25023770|NCT03131895|50121414|FG002|Washout Period (at Least 5 Days)|Other|2|||
25023771|NCT03131895|50121415|FG003|Washout Period (at Least 5 Days)|Other|0|||
25023772|NCT03131895|50121412|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
25023773|NCT03131895|50121413|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
25023774|NCT03131895|50121414|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
25023775|NCT03131895|50121415|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
25023776|NCT03131895|50121412|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
25023777|NCT03131895|50121413|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
25023778|NCT03131895|50121414|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
25023779|NCT03131895|50121415|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
25023780|NCT04039919|50121430|FG000|Treatment Period 1|Withdrawal by Subject|1|||
25023781|NCT04039919|50121431|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25023782|NCT04039919|50121432|FG002|Treatment Period 1|Withdrawal by Subject|0|||
25023783|NCT04039919|50121433|FG003|Treatment Period 1|Withdrawal by Subject|0|||
25023784|NCT04039919|50121434|FG004|Treatment Period 1|Withdrawal by Subject|0|||
25023785|NCT04039919|50121430|FG000|Treatment Period 1|Sponsor's decision|0|||
25023786|NCT04039919|50121431|FG001|Treatment Period 1|Sponsor's decision|0|||
25023787|NCT04039919|50121432|FG002|Treatment Period 1|Sponsor's decision|0|||
25023788|NCT04039919|50121433|FG003|Treatment Period 1|Sponsor's decision|0|||
25023789|NCT04039919|50121434|FG004|Treatment Period 1|Sponsor's decision|16|||
25023790|NCT04039919|50121430|FG000|Treatment Period 5|Withdrawal by Subject|1|||
25023791|NCT04039919|50121431|FG001|Treatment Period 5|Withdrawal by Subject|0|||
25023792|NCT04039919|50121432|FG002|Treatment Period 5|Withdrawal by Subject|0|||
25154584|NCT01903837|50269760|FG000|Part A|Adverse Event|3|||
25154585|NCT01903837|50269761|FG001|Part A|Adverse Event|6|||
25023793|NCT04039919|50121433|FG003|Treatment Period 5|Withdrawal by Subject|0|||
25023794|NCT04039919|50121434|FG004|Treatment Period 5|Withdrawal by Subject|0|||
25023795|NCT04035473|50121470|FG000|Screening/Baseline|Death|0|||
25023796|NCT04035473|50121471|FG001|Screening/Baseline|Death|1|||
25023797|NCT04035473|50121470|FG000|Screening/Baseline|Adverse Event|0|||
25023798|NCT04035473|50121471|FG001|Screening/Baseline|Adverse Event|1|||
25023799|NCT04035473|50121470|FG000|Follow-up Period|Adverse Event|2|||
25023800|NCT04035473|50121471|FG001|Follow-up Period|Adverse Event|0|||
25023801|NCT04032977|50121479|FG000|Overall Study|Withdrawal by Subject|6|||
25154586|NCT01903837|50269762|FG002|Part A|Adverse Event|9|||
25185134|NCT00244725|50334419|FG000|Overall Study|Lost to Follow-up|3|||
25023802|NCT04032977|50121480|FG001|Overall Study|Withdrawal by Subject|1|||
25023803|NCT04032977|50121479|FG000|Overall Study|Lost to Follow-up|2|||
25023804|NCT04032977|50121480|FG001|Overall Study|Lost to Follow-up|7|||
25023805|NCT04032977|50121479|FG000|Overall Study|Pregnancy|1|||
25023806|NCT04032977|50121480|FG001|Overall Study|Pregnancy|0|||
25023807|NCT04030247|50121486|FG000|Overall Study|Withdrawal by Subject|4|||
25023808|NCT04030247|50121486|FG000|Overall Study|Lost to Follow-up|13|||
25023809|NCT02915978|50121493|FG000|Overall Study|Adverse Event|2|||
25023810|NCT02915978|50121494|FG001|Overall Study|Adverse Event|1|||
25023811|NCT02915978|50121495|FG002|Overall Study|Adverse Event|0|||
25023812|NCT02701192|50121503|FG000|Overall Study|Protocol Violation|2|||
25023813|NCT02701192|50121503|FG000|Overall Study|Lost to Follow-up|4|||
25023814|NCT03101358|50121511|FG000|Overall Study|Non-compliance with study schedule|1|||
25023815|NCT03101358|50121512|FG001|Overall Study|Non-compliance with study schedule|0|||
25023816|NCT03101358|50121513|FG002|Overall Study|Non-compliance with study schedule|0|||
25023817|NCT03101358|50121514|FG003|Overall Study|Non-compliance with study schedule|1|||
25023818|NCT03101358|50121511|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
25023819|NCT03101358|50121512|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
25023820|NCT03101358|50121513|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
25023821|NCT03101358|50121514|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
25023822|NCT03101358|50121511|FG000|Overall Study|Physician Decision|1|||
25023823|NCT03101358|50121512|FG001|Overall Study|Physician Decision|0|||
25023824|NCT03101358|50121513|FG002|Overall Study|Physician Decision|0|||
25023825|NCT03101358|50121514|FG003|Overall Study|Physician Decision|3|||
25023826|NCT03101358|50121511|FG000|Overall Study|Adverse Event|0|||
25023827|NCT03101358|50121512|FG001|Overall Study|Adverse Event|0|||
25023828|NCT03101358|50121513|FG002|Overall Study|Adverse Event|1|||
25023829|NCT03101358|50121514|FG003|Overall Study|Adverse Event|0|||
25023830|NCT03101358|50121511|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
25023831|NCT03101358|50121512|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
25023832|NCT03101358|50121513|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
25023833|NCT03101358|50121514|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
25023834|NCT03101358|50121511|FG000|Overall Study|Lost to Follow-up|1|||
25023835|NCT03101358|50121512|FG001|Overall Study|Lost to Follow-up|0|||
25023836|NCT03101358|50121513|FG002|Overall Study|Lost to Follow-up|0|||
25023837|NCT03101358|50121514|FG003|Overall Study|Lost to Follow-up|1|||
25023838|NCT03657095|50121527|FG000|Overall Study|Withdrawal by Subject|1|||
25023839|NCT03657095|50121528|FG001|Overall Study|Withdrawal by Subject|1|||
25023840|NCT03657095|50121527|FG000|Overall Study|Adverse Event|0|||
25023841|NCT03657095|50121528|FG001|Overall Study|Adverse Event|3|||
25023842|NCT03657095|50121527|FG000|Overall Study|Study Terminated by Sponsor|58|||
25023843|NCT03657095|50121528|FG001|Overall Study|Study Terminated by Sponsor|49|||
25023844|NCT03100344|50121538|FG000|Overall Study|Adverse Event|0|||
25023845|NCT03100344|50121539|FG001|Overall Study|Adverse Event|3|||
25023846|NCT03100344|50121540|FG002|Overall Study|Adverse Event|2|||
25023847|NCT03100344|50121541|FG003|Overall Study|Adverse Event|3|||
25023848|NCT03100344|50121538|FG000|Overall Study|Lack of Efficacy|2|||
25023849|NCT03100344|50121539|FG001|Overall Study|Lack of Efficacy|0|||
25023850|NCT03100344|50121540|FG002|Overall Study|Lack of Efficacy|0|||
25023851|NCT03100344|50121541|FG003|Overall Study|Lack of Efficacy|0|||
25023852|NCT03100344|50121538|FG000|Overall Study|Protocol Violation|1|||
25023853|NCT03100344|50121539|FG001|Overall Study|Protocol Violation|0|||
25023854|NCT03100344|50121540|FG002|Overall Study|Protocol Violation|0|||
25023855|NCT03100344|50121541|FG003|Overall Study|Protocol Violation|0|||
25023856|NCT03100344|50121538|FG000|Overall Study|Withdrawal by Subject|10|||
25023857|NCT03100344|50121539|FG001|Overall Study|Withdrawal by Subject|7|||
25023858|NCT03100344|50121540|FG002|Overall Study|Withdrawal by Subject|4|||
25023859|NCT03100344|50121541|FG003|Overall Study|Withdrawal by Subject|8|||
25023860|NCT03100344|50121538|FG000|Overall Study|Lost to Follow-up|1|||
25023861|NCT03100344|50121539|FG001|Overall Study|Lost to Follow-up|1|||
25023862|NCT03100344|50121540|FG002|Overall Study|Lost to Follow-up|1|||
25023863|NCT03100344|50121541|FG003|Overall Study|Lost to Follow-up|1|||
25023864|NCT02951533|50121554|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
25023865|NCT02951533|50121555|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
25023866|NCT02951533|50121556|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
25023867|NCT02951533|50121554|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
25023868|NCT02951533|50121555|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
25023869|NCT02951533|50121556|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
25023870|NCT02951533|50121554|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
25023871|NCT02951533|50121555|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
25023872|NCT02951533|50121556|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
25023873|NCT02951533|50121554|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
25023874|NCT02951533|50121555|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
25023875|NCT02951533|50121556|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
25023876|NCT02951533|50121554|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
25023877|NCT02951533|50121555|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
25023878|NCT02951533|50121556|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
25023879|NCT02951533|50121554|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
25023880|NCT02951533|50121555|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
25023881|NCT02951533|50121556|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
25023882|NCT02951533|50121554|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
25023883|NCT02951533|50121555|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
25023884|NCT02951533|50121556|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
25023885|NCT02951533|50121554|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
25023886|NCT02951533|50121555|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
25023887|NCT02951533|50121556|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
25023888|NCT02951533|50121554|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
25023889|NCT02951533|50121555|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
25023890|NCT02951533|50121556|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
25023891|NCT02951533|50121554|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
25023892|NCT02951533|50121555|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
25023893|NCT02951533|50121556|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
25023894|NCT02951533|50121554|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
25023895|NCT02951533|50121555|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
25023896|NCT02951533|50121556|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
25023897|NCT02700412|50121573|FG000|Overall Study|Adverse Event|6|||
25023898|NCT02700412|50121573|FG000|Overall Study|Death|1|||
25023899|NCT02700412|50121573|FG000|Overall Study|Lack of Efficacy|19|||
25023900|NCT02700412|50121573|FG000|Overall Study|Protocol Violation|5|||
25023901|NCT02700412|50121573|FG000|Overall Study|Withdrawal by Subject|2|||
25023902|NCT03665441|50121579|FG000|Overall Study|survival follow up ongoing|23|||
25023903|NCT03665441|50121580|FG001|Overall Study|survival follow up ongoing|0|||
25023904|NCT03665441|50121579|FG000|Overall Study|Patients ongoing on treatment|9|||
25023905|NCT03665441|50121580|FG001|Overall Study|Patients ongoing on treatment|6|||
25023906|NCT03665441|50121579|FG000|Overall Study|Randomized but not treated|7|||
25023907|NCT03665441|50121580|FG001|Overall Study|Randomized but not treated|11|||
25023908|NCT02699866|50121586|FG000|Overall Study|Withdrawal by Subject|3|||
25023909|NCT02699866|50121586|FG000|Overall Study|Physician Decision|2|||
25023910|NCT02699866|50121586|FG000|Overall Study|Adverse Event|3|||
25023911|NCT03663569|50121590|FG000|Overall Study|Discontinuation of study|11|||
25023912|NCT03663569|50121590|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
25023913|NCT03663569|50121590|FG000|Overall Study|Deceased patient|6|||
25023914|NCT03663569|50121590|FG000|Overall Study|Lost to Follow-up|18|||
25023915|NCT03663569|50121590|FG000|Overall Study|Withdrawal of consent|5|||
25023916|NCT03663569|50121590|FG000|Overall Study|Patient's request|11|||
25023917|NCT03663569|50121590|FG000|Overall Study|Adverse Event|4|||
25023918|NCT03663569|50121590|FG000|Overall Study|Not come to second visit|3|||
25023919|NCT03663569|50121590|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
25023920|NCT03663569|50121590|FG000|Overall Study|Serious adverse event|1|||
25023921|NCT03596762|50121599|FG000|Overall Study|Protocol Violation|0|||
25023922|NCT03596762|50121600|FG001|Overall Study|Protocol Violation|0|||
25023923|NCT03596762|50121601|FG002|Overall Study|Protocol Violation|0|||
25023924|NCT03596762|50121602|FG003|Overall Study|Protocol Violation|0|||
25023925|NCT03596762|50121603|FG004|Overall Study|Protocol Violation|1|||
25023926|NCT03596762|50121599|FG000|Overall Study|Adverse Event|2|||
25023927|NCT03596762|50121600|FG001|Overall Study|Adverse Event|0|||
25023928|NCT03596762|50121601|FG002|Overall Study|Adverse Event|1|||
25185135|NCT00244725|50334420|FG001|Overall Study|Lost to Follow-up|4|||
25185136|NCT00244725|50334421|FG002|Overall Study|Lost to Follow-up|9|||
25185137|NCT00244725|50334422|FG003|Overall Study|Lost to Follow-up|2|||
25023929|NCT03596762|50121602|FG003|Overall Study|Adverse Event|0|||
25023930|NCT03596762|50121603|FG004|Overall Study|Adverse Event|5|||
25023931|NCT03596762|50121599|FG000|Overall Study|Withdrawal by Subject|2|||
25023932|NCT03596762|50121600|FG001|Overall Study|Withdrawal by Subject|1|||
25023933|NCT03596762|50121601|FG002|Overall Study|Withdrawal by Subject|0|||
25185138|NCT00244725|50334419|FG000|Overall Study|Withdrawal by Subject|9|||
25185139|NCT00244725|50334420|FG001|Overall Study|Withdrawal by Subject|7|||
25185140|NCT00244725|50334421|FG002|Overall Study|Withdrawal by Subject|7|||
25185141|NCT00244725|50334422|FG003|Overall Study|Withdrawal by Subject|8|||
25185142|NCT00244725|50334419|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
25185143|NCT00244725|50334420|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
25185144|NCT00244725|50334421|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
25023934|NCT03596762|50121602|FG003|Overall Study|Withdrawal by Subject|1|||
25023935|NCT03596762|50121603|FG004|Overall Study|Withdrawal by Subject|1|||
25023936|NCT03663179|50121621|FG000|Overall Study|Withdrawal by Subject|2|||
25023937|NCT03663179|50121622|FG001|Overall Study|Withdrawal by Subject|0|||
25023938|NCT03663179|50121621|FG000|Overall Study|Lost to Follow-up|1|||
25023939|NCT03663179|50121622|FG001|Overall Study|Lost to Follow-up|1|||
25023940|NCT03663179|50121621|FG000|Overall Study|Revealed exclusionary condition|1|||
25023941|NCT03663179|50121622|FG001|Overall Study|Revealed exclusionary condition|0|||
25023942|NCT03662789|50121630|FG000|Overall Study|Lost to Follow-up|1|||
25023943|NCT03662789|50121631|FG001|Overall Study|Lost to Follow-up|2|||
25023944|NCT03662789|50121630|FG000|Overall Study|Could not perform treadmill test|4|||
25023945|NCT03662789|50121631|FG001|Overall Study|Could not perform treadmill test|4|||
25023946|NCT03662789|50121630|FG000|Overall Study|Death|0|||
25023947|NCT03662789|50121631|FG001|Overall Study|Death|1|||
25023948|NCT03658889|50121639|FG000|Overall Study|Protocol Violation|2|||
25023949|NCT03658889|50121640|FG001|Overall Study|Protocol Violation|0|||
25185145|NCT00244725|50334422|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
25185146|NCT00244725|50334419|FG000|Overall Study|Physician Decision|3|||
24922645|NCT01011335|50016140|FG001|Overall Study|Moved/deployed or no booster|0|||
24922646|NCT01011335|50016141|FG002|Overall Study|Moved/deployed or no booster|0|||
24922647|NCT01011335|50016142|FG003|Overall Study|Moved/deployed or no booster|1|||
24922648|NCT01011335|50016143|FG004|Overall Study|Moved/deployed or no booster|0|||
24922649|NCT01011335|50016144|FG005|Overall Study|Moved/deployed or no booster|0|||
24922650|NCT01011335|50016145|FG006|Overall Study|Moved/deployed or no booster|1|||
24922651|NCT01011335|50016146|FG007|Overall Study|Moved/deployed or no booster|0|||
24922652|NCT01011335|50016147|FG008|Overall Study|Moved/deployed or no booster|1|||
24922653|NCT01011335|50016148|FG009|Overall Study|Moved/deployed or no booster|0|||
24922654|NCT01011335|50016149|FG010|Overall Study|Moved/deployed or no booster|2|||
24922655|NCT01011335|50016150|FG011|Overall Study|Moved/deployed or no booster|0|||
24922656|NCT01011335|50016151|FG012|Overall Study|Moved/deployed or no booster|0|||
24922657|NCT01011335|50016139|FG000|Overall Study|Adverse Event|0|||
24922658|NCT01011335|50016140|FG001|Overall Study|Adverse Event|0|||
24922659|NCT01011335|50016141|FG002|Overall Study|Adverse Event|0|||
24922660|NCT01011335|50016142|FG003|Overall Study|Adverse Event|0|||
24922661|NCT01011335|50016143|FG004|Overall Study|Adverse Event|0|||
24922662|NCT01011335|50016144|FG005|Overall Study|Adverse Event|0|||
24922663|NCT01011335|50016145|FG006|Overall Study|Adverse Event|0|||
24922664|NCT01011335|50016146|FG007|Overall Study|Adverse Event|0|||
24922665|NCT01011335|50016147|FG008|Overall Study|Adverse Event|0|||
24922666|NCT01011335|50016148|FG009|Overall Study|Adverse Event|0|||
24922667|NCT01011335|50016149|FG010|Overall Study|Adverse Event|4|||
24922668|NCT01011335|50016150|FG011|Overall Study|Adverse Event|0|||
24922669|NCT01011335|50016151|FG012|Overall Study|Adverse Event|1|||
24922670|NCT00467896|50016188|FG000|Overall Study|Consent Withdrawal|18|||
24922671|NCT00467896|50016188|FG000|Overall Study|Adverse Event|7|||
24922672|NCT00467896|50016188|FG000|Overall Study|Serious Adverse Event|13|||
24922673|NCT00467896|50016188|FG000|Overall Study|Non-compliance|3|||
24922674|NCT00467896|50016188|FG000|Overall Study|Changed therapy|2|||
24922675|NCT00467896|50016188|FG000|Overall Study|Patient received transplant|2|||
25023950|NCT03655691|50121648|FG000|Overall Study|Adverse Event|0|||
25023951|NCT03655691|50121649|FG001|Overall Study|Adverse Event|0|||
25023952|NCT03655691|50121650|FG002|Overall Study|Adverse Event|1|||
25023953|NCT03655691|50121648|FG000|Overall Study|Lost to Follow-up|1|||
24922676|NCT00467896|50016188|FG000|Overall Study|Patient had atrial septostomy|1|||
25185147|NCT00244725|50334420|FG001|Overall Study|Physician Decision|0|||
24922677|NCT00467896|50016188|FG000|Overall Study|Patient weaned off iloprost|1|||
24922678|NCT00467896|50016188|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
24922679|NCT00467896|50016188|FG000|Overall Study|Started intravenous prostacyclin|1|||
25023954|NCT03655691|50121649|FG001|Overall Study|Lost to Follow-up|1|||
24922680|NCT00467896|50016188|FG000|Overall Study|Started inhaled Remodulin|1|||
24922681|NCT00467896|50016188|FG000|Overall Study|Patient had no improvement|1|||
24922682|NCT00579059|50016196|FG000|Overall Study|Study Canceled at 1 Year|21|||
24922683|NCT00579059|50016197|FG001|Overall Study|Study Canceled at 1 Year|10|||
24922684|NCT00467818|50016205|FG000|Overall Study|Adverse Event|1|||
24922685|NCT00467818|50016206|FG001|Overall Study|Adverse Event|0|||
24922686|NCT00467818|50016205|FG000|Overall Study|Lost to Follow-up|2|||
24922687|NCT00467818|50016206|FG001|Overall Study|Lost to Follow-up|2|||
24922688|NCT00467740|50016219|FG000|Overall Study|Adverse Event|0|||
24922689|NCT00467740|50016220|FG001|Overall Study|Adverse Event|0|||
24922690|NCT00467740|50016221|FG002|Overall Study|Adverse Event|1|||
24922691|NCT00467740|50016222|FG003|Overall Study|Adverse Event|0|||
24922692|NCT00467740|50016223|FG004|Overall Study|Adverse Event|0|||
24922693|NCT00467740|50016219|FG000|Overall Study|Protocol Violation|0|||
24922694|NCT00467740|50016220|FG001|Overall Study|Protocol Violation|0|||
24922695|NCT00467740|50016221|FG002|Overall Study|Protocol Violation|1|||
24922696|NCT00467740|50016222|FG003|Overall Study|Protocol Violation|0|||
24922697|NCT00467740|50016223|FG004|Overall Study|Protocol Violation|0|||
24922698|NCT00467740|50016219|FG000|Overall Study|Lost to Follow-up|0|||
24922699|NCT00467740|50016220|FG001|Overall Study|Lost to Follow-up|1|||
24922700|NCT00467740|50016221|FG002|Overall Study|Lost to Follow-up|0|||
24922701|NCT00467740|50016222|FG003|Overall Study|Lost to Follow-up|0|||
24922702|NCT00467740|50016223|FG004|Overall Study|Lost to Follow-up|0|||
24922703|NCT00467740|50016219|FG000|Overall Study|Withdrawal by Subject|1|||
24922704|NCT00467740|50016220|FG001|Overall Study|Withdrawal by Subject|1|||
24922705|NCT00467740|50016221|FG002|Overall Study|Withdrawal by Subject|0|||
24922706|NCT00467740|50016222|FG003|Overall Study|Withdrawal by Subject|1|||
24922707|NCT00467740|50016223|FG004|Overall Study|Withdrawal by Subject|0|||
24922708|NCT00467740|50016219|FG000|Overall Study|Lack of Efficacy|0|||
24922709|NCT00467740|50016220|FG001|Overall Study|Lack of Efficacy|1|||
24922710|NCT00467740|50016221|FG002|Overall Study|Lack of Efficacy|0|||
24922711|NCT00467740|50016222|FG003|Overall Study|Lack of Efficacy|0|||
24922712|NCT00467740|50016223|FG004|Overall Study|Lack of Efficacy|0|||
24922713|NCT00553254|50016237|FG000|Overall Study|Death|3|||
24922714|NCT00553254|50016238|FG001|Overall Study|Death|6|||
24922715|NCT00553254|50016239|FG002|Overall Study|Death|25|||
24922716|NCT00553254|50016237|FG000|Overall Study|Lost to Follow-up|0|||
24922717|NCT00553254|50016238|FG001|Overall Study|Lost to Follow-up|0|||
24922718|NCT00553254|50016239|FG002|Overall Study|Lost to Follow-up|2|||
24922719|NCT00553254|50016237|FG000|Overall Study|Withdrawal by Subject|2|||
24922720|NCT00553254|50016238|FG001|Overall Study|Withdrawal by Subject|0|||
24922721|NCT00553254|50016239|FG002|Overall Study|Withdrawal by Subject|2|||
24922722|NCT00553254|50016237|FG000|Overall Study|Study terminated by Sponsor|0|||
24922723|NCT00553254|50016238|FG001|Overall Study|Study terminated by Sponsor|0|||
24922724|NCT00553254|50016239|FG002|Overall Study|Study terminated by Sponsor|1|||
24922725|NCT00553254|50016237|FG000|Overall Study|Other|1|||
24922726|NCT00553254|50016238|FG001|Overall Study|Other|0|||
24922727|NCT00553254|50016239|FG002|Overall Study|Other|13|||
25154587|NCT01903837|50269763|FG003|Part A|Adverse Event|6|||
25154588|NCT01903837|50269760|FG000|Part A|Lost to Follow-up|9|||
25154589|NCT01903837|50269761|FG001|Part A|Lost to Follow-up|7|||
25154590|NCT01903837|50269762|FG002|Part A|Lost to Follow-up|7|||
25154591|NCT01903837|50269763|FG003|Part A|Lost to Follow-up|2|||
25154592|NCT01903837|50269760|FG000|Part A|Non-compliance with study drug|1|||
25154593|NCT01903837|50269761|FG001|Part A|Non-compliance with study drug|4|||
25154594|NCT01903837|50269762|FG002|Part A|Non-compliance with study drug|4|||
25154595|NCT01903837|50269763|FG003|Part A|Non-compliance with study drug|0|||
25154596|NCT01903837|50269760|FG000|Part A|Physician Decision|1|||
25154597|NCT01903837|50269761|FG001|Part A|Physician Decision|1|||
25154598|NCT01903837|50269762|FG002|Part A|Physician Decision|0|||
25154599|NCT01903837|50269763|FG003|Part A|Physician Decision|0|||
24922728|NCT00168805|50016254|FG000|Overall Study|Adverse Event|7|||
24922729|NCT00168805|50016255|FG001|Overall Study|Adverse Event|11|||
24922730|NCT00168805|50016256|FG002|Overall Study|Adverse Event|16|||
24922731|NCT00168805|50016254|FG000|Overall Study|Protocol Violation|12|||
25154600|NCT01903837|50269760|FG000|Part A|Protocol Violation|1|||
25154601|NCT01903837|50269761|FG001|Part A|Protocol Violation|1|||
24922732|NCT00168805|50016255|FG001|Overall Study|Protocol Violation|11|||
24922733|NCT00168805|50016256|FG002|Overall Study|Protocol Violation|8|||
24922734|NCT00168805|50016254|FG000|Overall Study|Lost to Follow-up|12|||
24922735|NCT00168805|50016255|FG001|Overall Study|Lost to Follow-up|17|||
24922736|NCT00168805|50016256|FG002|Overall Study|Lost to Follow-up|11|||
24922737|NCT00168805|50016254|FG000|Overall Study|Withdrawal by Subject|16|||
24922738|NCT00168805|50016255|FG001|Overall Study|Withdrawal by Subject|18|||
24922739|NCT00168805|50016256|FG002|Overall Study|Withdrawal by Subject|21|||
24922740|NCT00168805|50016254|FG000|Overall Study|Other|24|||
24922741|NCT00168805|50016255|FG001|Overall Study|Other|21|||
25154602|NCT01903837|50269762|FG002|Part A|Protocol Violation|0|||
25154603|NCT01903837|50269763|FG003|Part A|Protocol Violation|0|||
25154604|NCT01903837|50269760|FG000|Part B|Lost to Follow-up|0|||
25154605|NCT01903837|50269761|FG001|Part B|Lost to Follow-up|3|||
24922742|NCT00168805|50016256|FG002|Overall Study|Other|22|||
24922743|NCT00168805|50016254|FG000|Treatment|Adverse Event|25|||
24922744|NCT00168805|50016255|FG001|Treatment|Adverse Event|26|||
24922745|NCT00168805|50016256|FG002|Treatment|Adverse Event|32|||
24922746|NCT00168805|50016254|FG000|Treatment|Protocol Violation|3|||
24922747|NCT00168805|50016255|FG001|Treatment|Protocol Violation|5|||
24922748|NCT00168805|50016256|FG002|Treatment|Protocol Violation|5|||
24922749|NCT00168805|50016254|FG000|Treatment|Withdrawal by Subject|3|||
24922750|NCT00168805|50016255|FG001|Treatment|Withdrawal by Subject|7|||
24922751|NCT00168805|50016256|FG002|Treatment|Withdrawal by Subject|8|||
24922752|NCT00168805|50016254|FG000|Treatment|Other|18|||
24922753|NCT00168805|50016255|FG001|Treatment|Other|18|||
24922754|NCT00168805|50016256|FG002|Treatment|Other|17|||
24922755|NCT00467584|50016267|FG000|Overall Study|Withdrawal by Subject|4|||
24922756|NCT00467584|50016268|FG001|Overall Study|Withdrawal by Subject|5|||
24922757|NCT00467584|50016269|FG002|Overall Study|Withdrawal by Subject|1|||
24922758|NCT03839212|50016277|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
24922759|NCT00168103|50016284|FG000|Overall Study|Withdrawal by Subject|1|||
24922760|NCT00168103|50016285|FG001|Overall Study|Withdrawal by Subject|2|||
24922761|NCT00168103|50016286|FG002|Overall Study|Withdrawal by Subject|1|||
24922762|NCT00168103|50016287|FG003|Overall Study|Withdrawal by Subject|0|||
24922763|NCT00168103|50016284|FG000|Overall Study|Lost to Follow-up|1|||
24922764|NCT00168103|50016285|FG001|Overall Study|Lost to Follow-up|3|||
24922765|NCT00168103|50016286|FG002|Overall Study|Lost to Follow-up|0|||
24922766|NCT00168103|50016287|FG003|Overall Study|Lost to Follow-up|0|||
24922767|NCT00463060|50016297|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
24922768|NCT00463060|50016297|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
24922769|NCT00462982|50016306|FG000|Overall Study|Adverse Event|1|||
24922770|NCT00462982|50016306|FG000|Overall Study|Patient Not Treated|2|||
24922771|NCT00462904|50016327|FG000|Overall Study|Lost to Follow-up|1|||
24922772|NCT00467272|50016331|FG000|Overall Study|Pneumonia|2|||
24922773|NCT00467272|50016331|FG000|Overall Study|Thrombophlebitis|1|||
24922774|NCT00462826|50016335|FG000|Overall Study|Ineligible - second primary|1|||
24922775|NCT00462826|50016335|FG000|Overall Study|Ineligible - wrong cell type|1|||
24922776|NCT00462826|50016335|FG000|Overall Study|Ineligible - wrong primary|2|||
24922777|NCT00462826|50016335|FG000|Overall Study|Never treated|1|||
24922778|NCT00551616|50016347|FG000|Overall Study|Lost to Follow-up|48|||
24922779|NCT00551616|50016348|FG001|Overall Study|Lost to Follow-up|40|||
24922780|NCT00452530|50016356|FG000|Overall Study|Death|1|||
24922781|NCT00452530|50016357|FG001|Overall Study|Death|0|||
24922782|NCT00452530|50016356|FG000|Overall Study|Adverse Event|40|||
24922783|NCT00452530|50016357|FG001|Overall Study|Adverse Event|44|||
24922784|NCT00452530|50016356|FG000|Overall Study|Withdrawal by Subject|68|||
24922785|NCT00452530|50016357|FG001|Overall Study|Withdrawal by Subject|57|||
24922786|NCT00452530|50016356|FG000|Overall Study|Lost to Follow-up|1|||
24922787|NCT00452530|50016357|FG001|Overall Study|Lost to Follow-up|0|||
24922788|NCT00452530|50016356|FG000|Overall Study|Poor compliance/noncompliance|1|||
24922789|NCT00452530|50016357|FG001|Overall Study|Poor compliance/noncompliance|2|||
24922790|NCT00452530|50016356|FG000|Overall Study|No longer met study criteria|18|||
24922791|NCT00452530|50016357|FG001|Overall Study|No longer met study criteria|22|||
24922792|NCT00452530|50016356|FG000|Overall Study|Other|7|||
24922793|NCT00452530|50016357|FG001|Overall Study|Other|11|||
24922794|NCT00549198|50016369|FG000|Overall Study|Adverse Event|28|||
24922795|NCT00549198|50016370|FG001|Overall Study|Adverse Event|26|||
24922796|NCT00549198|50016369|FG000|Overall Study|Insufficient Viral Load Response|4|||
24922797|NCT00549198|50016370|FG001|Overall Study|Insufficient Viral Load Response|2|||
24922798|NCT00549198|50016369|FG000|Overall Study|Protocol-defined Virological Failure|7|||
24922799|NCT00549198|50016370|FG001|Overall Study|Protocol-defined Virological Failure|0|||
24922800|NCT00549198|50016369|FG000|Overall Study|Non-compliance|2|||
24922801|NCT00549198|50016370|FG001|Overall Study|Non-compliance|4|||
24922802|NCT00549198|50016369|FG000|Overall Study|Lost to Follow-up|7|||
24922803|NCT00549198|50016370|FG001|Overall Study|Lost to Follow-up|8|||
24922804|NCT00549198|50016369|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
24922805|NCT00549198|50016370|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
24922806|NCT00549198|50016369|FG000|Overall Study|Protocol Violation|7|||
24922807|NCT00549198|50016370|FG001|Overall Study|Protocol Violation|2|||
24922808|NCT00549198|50016369|FG000|Overall Study|Investigator Decision|4|||
24922809|NCT00549198|50016370|FG001|Overall Study|Investigator Decision|3|||
24922810|NCT00549198|50016369|FG000|Overall Study|Withdrawal by Subject|7|||
24922811|NCT00549198|50016370|FG001|Overall Study|Withdrawal by Subject|7|||
24922812|NCT00549198|50016369|FG000|Overall Study|Disease Progression|1|||
24922813|NCT00549198|50016370|FG001|Overall Study|Disease Progression|0|||
24922814|NCT00549198|50016369|FG000|Overall Study|Participant Moved|2|||
24922815|NCT00549198|50016370|FG001|Overall Study|Participant Moved|0|||
24922816|NCT00549198|50016369|FG000|Overall Study|Participant not able to perform Week 96|1|||
24922817|NCT00549198|50016370|FG001|Overall Study|Participant not able to perform Week 96|0|||
24922818|NCT00549198|50016369|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
25023955|NCT03655691|50121650|FG002|Overall Study|Lost to Follow-up|2|||
24922819|NCT00549198|50016370|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
24922820|NCT00549198|50016369|FG000|Overall Study|Prohibited Medication|1|||
24922821|NCT00549198|50016370|FG001|Overall Study|Prohibited Medication|2|||
24922822|NCT00549198|50016369|FG000|Overall Study|Participant planning pregnancy|1|||
24922823|NCT00549198|50016370|FG001|Overall Study|Participant planning pregnancy|0|||
24922824|NCT00549198|50016369|FG000|Overall Study|Participant overweight, no scan possible|1|||
24922825|NCT00549198|50016370|FG001|Overall Study|Participant overweight, no scan possible|0|||
24922826|NCT00549198|50016369|FG000|Overall Study|No scan facilities|0|||
24922827|NCT00549198|50016370|FG001|Overall Study|No scan facilities|2|||
24922828|NCT00549198|50016369|FG000|Overall Study|Pregnancy|0|||
24922829|NCT00549198|50016370|FG001|Overall Study|Pregnancy|3|||
24922830|NCT00549198|50016369|FG000|Overall Study|Not Exposed to Study Drug|3|||
24922831|NCT00549198|50016370|FG001|Overall Study|Not Exposed to Study Drug|4|||
24922832|NCT00607724|50016383|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
24922833|NCT00607724|50016384|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
24922834|NCT00607724|50016385|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
24922835|NCT00607724|50016386|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
24922836|NCT00607724|50016387|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
24922837|NCT00607724|50016388|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
24922838|NCT00607724|50016389|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
24922839|NCT00607724|50016383|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
24922840|NCT00607724|50016384|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
24922841|NCT00607724|50016385|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
24922842|NCT00607724|50016386|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
24922843|NCT00607724|50016387|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
24922844|NCT00607724|50016388|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
25023956|NCT03655691|50121648|FG000|Overall Study|Protocol Violation|0|||
24922845|NCT00607724|50016389|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
24922846|NCT00607724|50016383|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
24922847|NCT00607724|50016384|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
24922848|NCT00607724|50016385|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
24922849|NCT00607724|50016386|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
24922850|NCT00607724|50016387|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
24922851|NCT00607724|50016388|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
24922852|NCT00607724|50016389|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
24922853|NCT00607724|50016383|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
24922854|NCT00607724|50016384|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
24922855|NCT00607724|50016385|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
24922856|NCT00607724|50016386|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
24922857|NCT00607724|50016387|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
24922858|NCT00607724|50016388|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
24922859|NCT00607724|50016389|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
24922860|NCT00607724|50016383|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
24922861|NCT00607724|50016384|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
24922862|NCT00607724|50016385|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
24922863|NCT00607724|50016386|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
24922864|NCT00607724|50016387|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
24922865|NCT00607724|50016388|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
24922866|NCT00607724|50016389|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
24922867|NCT00506415|50016413|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
24922868|NCT00506415|50016414|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
25023957|NCT03655691|50121649|FG001|Overall Study|Protocol Violation|1|||
25023958|NCT03655691|50121650|FG002|Overall Study|Protocol Violation|0|||
24922869|NCT00506415|50016415|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
24922870|NCT00506415|50016416|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
24922871|NCT00506415|50016413|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
24922872|NCT00506415|50016414|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
24922873|NCT00506415|50016415|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
24922874|NCT00506415|50016416|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
24922875|NCT00506415|50016413|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
24922876|NCT00506415|50016414|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
24922877|NCT00506415|50016415|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
24922878|NCT00506415|50016416|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
24922879|NCT00506415|50016413|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
24922880|NCT00506415|50016414|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
24922881|NCT00506415|50016415|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
24922882|NCT00506415|50016416|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
24922883|NCT00506415|50016413|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
24922884|NCT00506415|50016414|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
24922885|NCT00506415|50016415|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
24922886|NCT00506415|50016416|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
24922887|NCT00506415|50016413|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
24922888|NCT00506415|50016414|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
24922889|NCT00506415|50016415|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
24922890|NCT00506415|50016416|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
24922891|NCT00506415|50016413|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
24922892|NCT00506415|50016414|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
24922893|NCT00506415|50016415|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
24922894|NCT00506415|50016416|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
24922895|NCT00506415|50016413|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
24922896|NCT00506415|50016414|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
24922897|NCT00506415|50016415|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
24922898|NCT00506415|50016416|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
24922899|NCT00506415|50016413|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
25154606|NCT01903837|50269762|FG002|Part B|Lost to Follow-up|3|||
25154607|NCT01903837|50269763|FG003|Part B|Lost to Follow-up|4|||
25154608|NCT01903837|50269760|FG000|Part B|Withdrawal by Subject|1|||
25154609|NCT01903837|50269761|FG001|Part B|Withdrawal by Subject|2|||
25154610|NCT01903837|50269762|FG002|Part B|Withdrawal by Subject|0|||
25154611|NCT01903837|50269763|FG003|Part B|Withdrawal by Subject|3|||
25154612|NCT01903837|50269760|FG000|Part B|Adverse Event|3|||
25154613|NCT01903837|50269761|FG001|Part B|Adverse Event|0|||
25154614|NCT01903837|50269762|FG002|Part B|Adverse Event|2|||
25154615|NCT01903837|50269763|FG003|Part B|Adverse Event|0|||
25154616|NCT01903837|50269760|FG000|Part B|Non-compliance with study drug|2|||
25154617|NCT01903837|50269761|FG001|Part B|Non-compliance with study drug|0|||
25154618|NCT01903837|50269762|FG002|Part B|Non-compliance with study drug|0|||
25154619|NCT01903837|50269763|FG003|Part B|Non-compliance with study drug|1|||
25154620|NCT01903837|50269760|FG000|Part B|Incarceration|2|||
25154621|NCT01903837|50269761|FG001|Part B|Incarceration|0|||
25154622|NCT01903837|50269762|FG002|Part B|Incarceration|0|||
25154623|NCT01903837|50269763|FG003|Part B|Incarceration|1|||
25154624|NCT01903837|50269760|FG000|Part B|Physician Decision|1|||
25154625|NCT01903837|50269761|FG001|Part B|Physician Decision|0|||
25154626|NCT01903837|50269762|FG002|Part B|Physician Decision|0|||
25154627|NCT01903837|50269763|FG003|Part B|Physician Decision|2|||
25154628|NCT01903837|50269760|FG000|Part B|Lack of Efficacy|0|||
25154629|NCT01903837|50269761|FG001|Part B|Lack of Efficacy|1|||
25154630|NCT01903837|50269762|FG002|Part B|Lack of Efficacy|0|||
25154631|NCT01903837|50269763|FG003|Part B|Lack of Efficacy|0|||
25154632|NCT01903525|50269796|FG000|Overall Study|Lost to Follow-up|5|||
25154633|NCT01903525|50269797|FG001|Overall Study|Lost to Follow-up|9|||
25154634|NCT01903525|50269796|FG000|Overall Study|Adverse Event|0|||
25154635|NCT01903525|50269797|FG001|Overall Study|Adverse Event|1|||
25154636|NCT00981526|50269805|FG000|Overall Study|Withdrawal by Subject|0|||
25154637|NCT00981526|50269806|FG001|Overall Study|Withdrawal by Subject|2|||
25154638|NCT00981526|50269805|FG000|Overall Study|Physician Decision|4|||
25154639|NCT00981526|50269806|FG001|Overall Study|Physician Decision|4|||
25154640|NCT01927861|50269816|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
25154641|NCT01927861|50269817|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
25154642|NCT01927861|50269816|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
25154643|NCT01927861|50269817|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
25154644|NCT01927627|50269823|FG000|Overall Study|Adverse Event|3|||
25154645|NCT01927627|50269823|FG000|Overall Study|Lack of Efficacy|1|||
25154646|NCT01927627|50269823|FG000|Overall Study|Financial Concerns|1|||
25154647|NCT01889251|50269829|FG000|Overall Study|Adverse Event|1|||
25154648|NCT01889251|50269830|FG001|Overall Study|Adverse Event|0|||
25154649|NCT01616563|50269836|FG000|Overall Study|Lost to Follow-up|40|||
25154650|NCT01616173|50269844|FG000|Overall Study|Lost to Follow-up|0|||
25154651|NCT01616173|50269845|FG001|Overall Study|Lost to Follow-up|2|||
25154652|NCT01616173|50269846|FG002|Overall Study|Lost to Follow-up|0|||
25154653|NCT01544595|50269860|FG000|Status at Week 68|Adverse Event|3|||
24922900|NCT00506415|50016414|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
24922901|NCT00506415|50016415|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
24922902|NCT00506415|50016416|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
24922903|NCT00506415|50016413|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
25154654|NCT01544595|50269861|FG001|Status at Week 68|Adverse Event|2|||
25154655|NCT01544595|50269862|FG002|Status at Week 68|Adverse Event|1|||
25154656|NCT01544595|50269863|FG003|Status at Week 68|Adverse Event|0|||
25185148|NCT00244725|50334421|FG002|Overall Study|Physician Decision|1|||
25185149|NCT00244725|50334422|FG003|Overall Study|Physician Decision|2|||
25154657|NCT01544595|50269864|FG004|Status at Week 68|Adverse Event|0|||
25154658|NCT01544595|50269865|FG005|Status at Week 68|Adverse Event|0|||
24922904|NCT00506415|50016414|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
25154659|NCT01544595|50269860|FG000|Status at Week 68|Lack of Efficacy|1|||
24922905|NCT00506415|50016415|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
24922906|NCT00506415|50016416|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
24922907|NCT00506415|50016413|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
24922908|NCT00506415|50016414|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
24922909|NCT00506415|50016415|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
24922910|NCT00506415|50016416|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
24922911|NCT00506415|50016413|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
24922912|NCT00506415|50016414|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
24922913|NCT00506415|50016415|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
24922914|NCT00506415|50016416|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
24922915|NCT00506415|50016413|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
24922916|NCT00506415|50016414|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
24922917|NCT00506415|50016415|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
24922918|NCT00506415|50016416|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
24922919|NCT00506415|50016413|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
24922920|NCT00506415|50016414|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
24922921|NCT00506415|50016415|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
24922922|NCT00506415|50016416|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
24922923|NCT00506415|50016413|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
24922924|NCT00506415|50016414|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
24922925|NCT00506415|50016415|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
24922926|NCT00506415|50016416|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
24922927|NCT00506415|50016413|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
24922928|NCT00506415|50016414|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
24922929|NCT00506415|50016415|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
24922930|NCT00506415|50016416|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
24922931|NCT00506415|50016413|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
24922932|NCT00506415|50016414|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
24922933|NCT00506415|50016415|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
24922934|NCT00506415|50016416|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
24922935|NCT00506415|50016413|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
24922936|NCT00506415|50016414|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
24922937|NCT00506415|50016415|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
24922938|NCT00506415|50016416|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
24922939|NCT00506415|50016413|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
24922940|NCT00506415|50016414|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
24922941|NCT00506415|50016415|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
24922942|NCT00506415|50016416|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
24922943|NCT00506415|50016413|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
25023959|NCT03655691|50121648|FG000|Overall Study|Withdrawal by Subject|1|||
25185150|NCT00244725|50334419|FG000|Overall Study|Adverse Events|3|||
25185151|NCT00244725|50334420|FG001|Overall Study|Adverse Events|1|||
25185152|NCT00244725|50334421|FG002|Overall Study|Adverse Events|4|||
25185153|NCT00244725|50334422|FG003|Overall Study|Adverse Events|4|||
25023960|NCT03655691|50121649|FG001|Overall Study|Withdrawal by Subject|1|||
25154660|NCT01544595|50269861|FG001|Status at Week 68|Lack of Efficacy|0|||
25154661|NCT01544595|50269862|FG002|Status at Week 68|Lack of Efficacy|0|||
25154662|NCT01544595|50269863|FG003|Status at Week 68|Lack of Efficacy|0|||
25185154|NCT00244725|50334419|FG000|Overall Study|Withdrwal by participant|1|||
24922944|NCT00506415|50016414|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
24922945|NCT00506415|50016415|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
24922946|NCT00506415|50016416|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
24922947|NCT00506415|50016413|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
24922948|NCT00506415|50016414|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
24922949|NCT00506415|50016415|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
24922950|NCT00506415|50016416|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
24922951|NCT00506415|50016413|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
24922952|NCT00506415|50016414|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
24922953|NCT00506415|50016415|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
24922954|NCT00506415|50016416|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
24922955|NCT00506415|50016413|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
24922956|NCT00506415|50016414|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
24922957|NCT00506415|50016415|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
24922958|NCT00506415|50016416|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
24922959|NCT00506415|50016413|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
24922960|NCT00506415|50016414|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
24922961|NCT00506415|50016415|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
24922962|NCT00506415|50016416|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
25185155|NCT00244725|50334420|FG001|Overall Study|Withdrwal by participant|0|||
25185156|NCT00244725|50334421|FG002|Overall Study|Withdrwal by participant|0|||
25185157|NCT00244725|50334422|FG003|Overall Study|Withdrwal by participant|1|||
25185158|NCT00244725|50334419|FG000|Overall Study|Liver function test abnormality|2|||
25185159|NCT00244725|50334420|FG001|Overall Study|Liver function test abnormality|0|||
25185160|NCT00244725|50334421|FG002|Overall Study|Liver function test abnormality|0|||
25185161|NCT00244725|50334422|FG003|Overall Study|Liver function test abnormality|1|||
25185162|NCT00244725|50334419|FG000|Overall Study|Sponsor withdrew the participant|1|||
25185163|NCT00244725|50334420|FG001|Overall Study|Sponsor withdrew the participant|0|||
25185164|NCT00244725|50334421|FG002|Overall Study|Sponsor withdrew the participant|0|||
25185165|NCT00244725|50334422|FG003|Overall Study|Sponsor withdrew the participant|1|||
25185166|NCT00244725|50334419|FG000|Overall Study|Mediciation Error|0|||
24922963|NCT00452452|50016432|FG000|Overall Study|Protocol Violation|0|||
24922964|NCT00452452|50016433|FG001|Overall Study|Protocol Violation|0|||
24922965|NCT00452452|50016434|FG002|Overall Study|Protocol Violation|1|||
24922966|NCT00452452|50016432|FG000|Overall Study|Withdrawal by Subject|1|||
24922967|NCT00452452|50016433|FG001|Overall Study|Withdrawal by Subject|0|||
24922968|NCT00452452|50016434|FG002|Overall Study|Withdrawal by Subject|0|||
24922969|NCT00452452|50016432|FG000|Overall Study|Lost to Follow-up|1|||
24922970|NCT00452452|50016433|FG001|Overall Study|Lost to Follow-up|0|||
24922971|NCT00452452|50016434|FG002|Overall Study|Lost to Follow-up|0|||
24922972|NCT00510783|50016450|FG000|Overall Study|Lost to Follow-up|29|||
24922973|NCT00510783|50016451|FG001|Overall Study|Lost to Follow-up|25|||
24922974|NCT00510783|50016450|FG000|Overall Study|Withdrawal by Subject|2|||
24922975|NCT00510783|50016451|FG001|Overall Study|Withdrawal by Subject|3|||
24922976|NCT00510783|50016450|FG000|Overall Study|Protocol Violation|0|||
24922977|NCT00510783|50016451|FG001|Overall Study|Protocol Violation|1|||
24922978|NCT00518973|50016459|FG000|Overall Study|Withdrawal by Subject|3|||
24922979|NCT00518973|50016460|FG001|Overall Study|Withdrawal by Subject|2|||
24922980|NCT00462670|50016468|FG000|Overall Study|Adverse Event|3|||
24922981|NCT00462670|50016469|FG001|Overall Study|Adverse Event|5|||
24922982|NCT00462670|50016468|FG000|Overall Study|Lack of Efficacy|1|||
24922983|NCT00462670|50016469|FG001|Overall Study|Lack of Efficacy|0|||
24922984|NCT00462670|50016468|FG000|Overall Study|Protocol Violation|1|||
24922985|NCT00462670|50016469|FG001|Overall Study|Protocol Violation|0|||
24922986|NCT00462670|50016468|FG000|Overall Study|Resolution of signs and symptoms|0|||
24922987|NCT00462670|50016469|FG001|Overall Study|Resolution of signs and symptoms|2|||
24922988|NCT00606086|50016477|FG000|Overall Study|Adverse Event|1|||
24922989|NCT00606086|50016478|FG001|Overall Study|Adverse Event|1|||
24922990|NCT00606086|50016477|FG000|Overall Study|Lost to Follow-up|4|||
24922991|NCT00606086|50016478|FG001|Overall Study|Lost to Follow-up|8|||
24922992|NCT00606086|50016477|FG000|Overall Study|Protocol Violation|1|||
24922993|NCT00606086|50016478|FG001|Overall Study|Protocol Violation|0|||
25185167|NCT00244725|50334420|FG001|Overall Study|Mediciation Error|1|||
24922994|NCT00606086|50016477|FG000|Overall Study|Withdrawal by Subject|5|||
24922995|NCT00606086|50016478|FG001|Overall Study|Withdrawal by Subject|3|||
24922996|NCT00606086|50016477|FG000|Overall Study|Non-compliance|0|||
24922997|NCT00606086|50016478|FG001|Overall Study|Non-compliance|1|||
24922998|NCT00606086|50016477|FG000|Overall Study|Randomized, not treated|1|||
24922999|NCT00606086|50016478|FG001|Overall Study|Randomized, not treated|2|||
24923000|NCT00609986|50016486|FG000|Overall Study|Did not receive transplant or treatment|8|||
25185168|NCT00244725|50334421|FG002|Overall Study|Mediciation Error|0|||
25185169|NCT00244725|50334422|FG003|Overall Study|Mediciation Error|0|||
24923001|NCT00609986|50016487|FG001|Overall Study|Did not receive transplant or treatment|3|||
24923002|NCT00451906|50016493|FG000|Overall Study|Adverse Event|515|||
24923003|NCT00451906|50016493|FG000|Overall Study|Lost to Follow-up|31|||
24923004|NCT00451906|50016493|FG000|Overall Study|Withdrawal by Subject|111|||
24923005|NCT00451906|50016493|FG000|Overall Study|Protocol Violation|21|||
24923006|NCT00451906|50016493|FG000|Overall Study|Progressive disease|1328|||
24923007|NCT00451906|50016493|FG000|Overall Study|Termination of the study|108|||
24923008|NCT00451906|50016493|FG000|Overall Study|Other Reasons|121|||
24923009|NCT00451906|50016493|FG000|Overall Study|Did not complete final visit|4|||
24923010|NCT00451282|50016499|FG000|Overall Study|Lost to Follow-up|6|||
24923011|NCT00451282|50016500|FG001|Overall Study|Lost to Follow-up|5|||
24923012|NCT03838198|50016508|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
24923013|NCT03838198|50016509|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
24923014|NCT03838198|50016510|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
24923015|NCT03838198|50016511|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
24923016|NCT03838198|50016508|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
24923017|NCT03838198|50016509|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
24923018|NCT03838198|50016510|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
24923019|NCT03838198|50016511|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
24923020|NCT00115765|50016526|FG000|Overall Study|Withdrawal by Subject|22|||
24923021|NCT00115765|50016527|FG001|Overall Study|Withdrawal by Subject|53|||
24923022|NCT00115765|50016528|FG002|Overall Study|Withdrawal by Subject|76|||
24923023|NCT00115765|50016529|FG003|Overall Study|Withdrawal by Subject|15|||
24923024|NCT00115765|50016526|FG000|Overall Study|Physician Decision|4|||
24923025|NCT00115765|50016527|FG001|Overall Study|Physician Decision|15|||
24923026|NCT00115765|50016528|FG002|Overall Study|Physician Decision|18|||
24923027|NCT00115765|50016529|FG003|Overall Study|Physician Decision|13|||
24923028|NCT00115765|50016526|FG000|Overall Study|Lost to Follow-up|3|||
24923029|NCT00115765|50016527|FG001|Overall Study|Lost to Follow-up|20|||
24923030|NCT00115765|50016528|FG002|Overall Study|Lost to Follow-up|18|||
24923031|NCT00115765|50016529|FG003|Overall Study|Lost to Follow-up|1|||
24923032|NCT00115765|50016526|FG000|Overall Study|Other|6|||
24923033|NCT00115765|50016527|FG001|Overall Study|Other|12|||
24923034|NCT00115765|50016528|FG002|Overall Study|Other|9|||
24923035|NCT00115765|50016529|FG003|Overall Study|Other|2|||
24923036|NCT00606008|50016537|FG000|Overall Study|Adverse Event|1|||
24923037|NCT00606008|50016537|FG000|Overall Study|Withdrawal by Subject|4|||
24923038|NCT00461812|50016549|FG000|Overall Study|study terminated|10|||
24923039|NCT00123955|50016556|FG000|Overall Study|Adverse Event|1|||
24923040|NCT00123955|50016557|FG001|Overall Study|Adverse Event|0|||
24923041|NCT00123955|50016556|FG000|Overall Study|Withdrawal by Subject|4|||
24923042|NCT00123955|50016557|FG001|Overall Study|Withdrawal by Subject|3|||
24923043|NCT00123955|50016556|FG000|Overall Study|Death|0|||
24923044|NCT00123955|50016557|FG001|Overall Study|Death|1|||
24923045|NCT03837028|50016567|FG000|Overall Study|Lost to Follow-up|4|||
24923046|NCT03837028|50016568|FG001|Overall Study|Lost to Follow-up|0|||
24923047|NCT03837028|50016569|FG002|Overall Study|Lost to Follow-up|2|||
24923048|NCT03837028|50016570|FG003|Overall Study|Lost to Follow-up|0|||
24923049|NCT03837028|50016567|FG000|Overall Study|Withdrawal by Subject|12|||
24923050|NCT03837028|50016568|FG001|Overall Study|Withdrawal by Subject|11|||
25154663|NCT01544595|50269864|FG004|Status at Week 68|Lack of Efficacy|0|||
25154664|NCT01544595|50269865|FG005|Status at Week 68|Lack of Efficacy|0|||
25154665|NCT01544595|50269860|FG000|Status at Week 68|Lost to Follow-up|1|||
25154666|NCT01544595|50269861|FG001|Status at Week 68|Lost to Follow-up|1|||
25154667|NCT01544595|50269862|FG002|Status at Week 68|Lost to Follow-up|0|||
25154668|NCT01544595|50269863|FG003|Status at Week 68|Lost to Follow-up|0|||
25154669|NCT01544595|50269864|FG004|Status at Week 68|Lost to Follow-up|0|||
25154670|NCT01544595|50269865|FG005|Status at Week 68|Lost to Follow-up|0|||
25154671|NCT01544595|50269860|FG000|Status at Week 68|Non-compliance with study treatment|1|||
24923051|NCT03837028|50016569|FG002|Overall Study|Withdrawal by Subject|11|||
24923052|NCT03837028|50016570|FG003|Overall Study|Withdrawal by Subject|7|||
24923053|NCT00115063|50016582|FG000|Overall Study|Lost to Follow-up|98|||
24923054|NCT00115063|50016583|FG001|Overall Study|Lost to Follow-up|104|||
24923055|NCT00115063|50016582|FG000|Overall Study|Death|1|||
24923056|NCT00115063|50016583|FG001|Overall Study|Death|0|||
24923057|NCT00461500|50016591|FG000|Overall Study|Adverse Event|1|||
24923058|NCT00461500|50016592|FG001|Overall Study|Adverse Event|0|||
24923059|NCT00461500|50016591|FG000|Overall Study|Lack of Efficacy|0|||
24923060|NCT00461500|50016592|FG001|Overall Study|Lack of Efficacy|1|||
24923061|NCT00461500|50016591|FG000|Overall Study|Expired Drug Treatment|1|||
24923062|NCT00461500|50016592|FG001|Overall Study|Expired Drug Treatment|1|||
24923063|NCT00461500|50016591|FG000|Overall Study|Study Stopped|1|||
24923064|NCT00461500|50016592|FG001|Overall Study|Study Stopped|2|||
24923065|NCT00461500|50016591|FG000|Overall Study|Drug Treatment Misuse|1|||
24923066|NCT00461500|50016592|FG001|Overall Study|Drug Treatment Misuse|0|||
25154672|NCT01544595|50269861|FG001|Status at Week 68|Non-compliance with study treatment|0|||
24923067|NCT00461500|50016591|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
24923068|NCT00461500|50016592|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
24923069|NCT00461500|50016591|FG000|Overall Study|Lost to Follow-up|2|||
24923070|NCT00461500|50016592|FG001|Overall Study|Lost to Follow-up|2|||
24923071|NCT00167245|50016600|FG000|Overall Study|Lost to Follow-up|20|||
24923072|NCT00167245|50016601|FG001|Overall Study|Lost to Follow-up|31|||
24923073|NCT00167245|50016600|FG000|Overall Study|Withdrawal by Subject|5|||
24923074|NCT00167245|50016601|FG001|Overall Study|Withdrawal by Subject|8|||
24923075|NCT00167245|50016600|FG000|Overall Study|Incarcerated|3|||
24923076|NCT00167245|50016601|FG001|Overall Study|Incarcerated|2|||
24923077|NCT00167245|50016600|FG000|Overall Study|Drowsy|1|||
24923078|NCT00167245|50016601|FG001|Overall Study|Drowsy|0|||
24923079|NCT00443560|50016612|FG000|Overall Study|No intrathecal dose|58|||
24923080|NCT00443560|50016613|FG001|Overall Study|No intrathecal dose|26|||
24923081|NCT00443560|50016612|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
24923082|NCT00443560|50016613|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
24923083|NCT00451204|50016621|FG000|Overall Study|Adverse Event|4|||
24923084|NCT00451204|50016622|FG001|Overall Study|Adverse Event|6|||
25023961|NCT03655691|50121650|FG002|Overall Study|Withdrawal by Subject|0|||
25023962|NCT03658811|50121658|FG000|Overall Study|Lost to Follow-up|3|||
25023963|NCT03631355|50121668|FG000|Overall Study|Lost to Follow-up|1|||
24923085|NCT00451204|50016621|FG000|Overall Study|Lack of Efficacy|4|||
24923086|NCT00451204|50016622|FG001|Overall Study|Lack of Efficacy|4|||
24923087|NCT00451204|50016621|FG000|Overall Study|Lost to Follow-up|4|||
24923088|NCT00451204|50016622|FG001|Overall Study|Lost to Follow-up|4|||
24923089|NCT00451204|50016621|FG000|Overall Study|Protocol Violation|1|||
24923090|NCT00451204|50016622|FG001|Overall Study|Protocol Violation|0|||
24923091|NCT00451204|50016621|FG000|Overall Study|Patient refusal|8|||
24923092|NCT00451204|50016622|FG001|Overall Study|Patient refusal|4|||
24923093|NCT00451204|50016621|FG000|Overall Study|Other|1|||
24923094|NCT00451204|50016622|FG001|Overall Study|Other|2|||
24923095|NCT00605540|50016631|FG000|Overall Study|Death|15|||
24923096|NCT00605540|50016631|FG000|Overall Study|Lost to Follow-up|23|||
24923097|NCT00605306|50016637|FG000|Overall Study|Adverse Event|0|||
24923098|NCT00605306|50016638|FG001|Overall Study|Adverse Event|1|||
24923099|NCT00607022|50016647|FG000|Overall Study|Withdrawal by Subject|1|||
24923100|NCT00607022|50016648|FG001|Overall Study|Withdrawal by Subject|0|||
24923101|NCT00607022|50016649|FG002|Overall Study|Withdrawal by Subject|0|||
24923102|NCT00606632|50016657|FG000|Overall Study|Withdrawal by Subject|13|||
24923103|NCT00606632|50016657|FG000|Overall Study|Miscellaneous reasons|9|||
24923104|NCT00450814|50016676|FG000|Overall Study|Failed to complete the initial therapy|0|||
24923105|NCT00450814|50016677|FG001|Overall Study|Failed to complete the initial therapy|0|||
24923106|NCT00450814|50016678|FG002|Overall Study|Failed to complete the initial therapy|0|||
24923107|NCT00450814|50016679|FG003|Overall Study|Failed to complete the initial therapy|1|||
24923108|NCT00450814|50016680|FG004|Overall Study|Failed to complete the initial therapy|1|||
24923109|NCT00450814|50016681|FG005|Overall Study|Failed to complete the initial therapy|1|||
24923110|NCT00450814|50016682|FG006|Overall Study|Failed to complete the initial therapy|0|||
24923111|NCT00450814|50016683|FG007|Overall Study|Failed to complete the initial therapy|0|||
24923112|NCT00450814|50016684|FG008|Overall Study|Failed to complete the initial therapy|0|||
24923113|NCT00450814|50016685|FG009|Overall Study|Failed to complete the initial therapy|0|||
24923114|NCT00450814|50016686|FG010|Overall Study|Failed to complete the initial therapy|0|||
24923115|NCT00450814|50016676|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
24923116|NCT00450814|50016677|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
24923117|NCT00450814|50016678|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
24923118|NCT00450814|50016679|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
24923119|NCT00450814|50016680|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
24923120|NCT00450814|50016681|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
24923121|NCT00450814|50016682|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
24923122|NCT00450814|50016683|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
24923123|NCT00450814|50016684|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
24923124|NCT00450814|50016685|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
24923125|NCT00450814|50016686|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
24923126|NCT00518115|50016721|FG000|Overall Study|Adverse Event|6|||
24923127|NCT00518115|50016722|FG001|Overall Study|Adverse Event|1|||
24923128|NCT00518115|50016723|FG002|Overall Study|Adverse Event|5|||
24923129|NCT00518115|50016724|FG003|Overall Study|Adverse Event|6|||
24923130|NCT00518115|50016725|FG004|Overall Study|Adverse Event|5|||
24923131|NCT00518115|50016726|FG005|Overall Study|Adverse Event|5|||
24923132|NCT00518115|50016727|FG006|Overall Study|Adverse Event|5|||
24923133|NCT00518115|50016728|FG007|Overall Study|Adverse Event|10|||
24923134|NCT00518115|50016729|FG008|Overall Study|Adverse Event|2|||
24923135|NCT00518115|50016730|FG009|Overall Study|Adverse Event|9|||
24923136|NCT00518115|50016721|FG000|Overall Study|Lost to Follow-up|0|||
24923137|NCT00518115|50016722|FG001|Overall Study|Lost to Follow-up|0|||
24923138|NCT00518115|50016723|FG002|Overall Study|Lost to Follow-up|2|||
24923139|NCT00518115|50016724|FG003|Overall Study|Lost to Follow-up|3|||
24923140|NCT00518115|50016725|FG004|Overall Study|Lost to Follow-up|1|||
24923141|NCT00518115|50016726|FG005|Overall Study|Lost to Follow-up|3|||
24923142|NCT00518115|50016727|FG006|Overall Study|Lost to Follow-up|0|||
24923143|NCT00518115|50016728|FG007|Overall Study|Lost to Follow-up|1|||
24923144|NCT00518115|50016729|FG008|Overall Study|Lost to Follow-up|1|||
24923145|NCT00518115|50016730|FG009|Overall Study|Lost to Follow-up|1|||
24923146|NCT00518115|50016721|FG000|Overall Study|Protocol Violation|1|||
24923147|NCT00518115|50016722|FG001|Overall Study|Protocol Violation|3|||
24923148|NCT00518115|50016723|FG002|Overall Study|Protocol Violation|1|||
24923149|NCT00518115|50016724|FG003|Overall Study|Protocol Violation|0|||
24923150|NCT00518115|50016725|FG004|Overall Study|Protocol Violation|0|||
24923151|NCT00518115|50016726|FG005|Overall Study|Protocol Violation|0|||
24923152|NCT00518115|50016727|FG006|Overall Study|Protocol Violation|0|||
24923153|NCT00518115|50016728|FG007|Overall Study|Protocol Violation|0|||
24923154|NCT00518115|50016729|FG008|Overall Study|Protocol Violation|0|||
24923155|NCT00518115|50016730|FG009|Overall Study|Protocol Violation|0|||
24923156|NCT00518115|50016721|FG000|Overall Study|Withdrawal by Subject|1|||
24923157|NCT00518115|50016722|FG001|Overall Study|Withdrawal by Subject|1|||
24923158|NCT00518115|50016723|FG002|Overall Study|Withdrawal by Subject|5|||
24923159|NCT00518115|50016724|FG003|Overall Study|Withdrawal by Subject|0|||
24923160|NCT00518115|50016725|FG004|Overall Study|Withdrawal by Subject|2|||
24923161|NCT00518115|50016726|FG005|Overall Study|Withdrawal by Subject|1|||
24923162|NCT00518115|50016727|FG006|Overall Study|Withdrawal by Subject|0|||
24923163|NCT00518115|50016728|FG007|Overall Study|Withdrawal by Subject|2|||
24923164|NCT00518115|50016729|FG008|Overall Study|Withdrawal by Subject|1|||
24923165|NCT00518115|50016730|FG009|Overall Study|Withdrawal by Subject|3|||
24923166|NCT00518115|50016721|FG000|Overall Study|Lack of Efficacy|1|||
24923167|NCT00518115|50016722|FG001|Overall Study|Lack of Efficacy|0|||
24923168|NCT00518115|50016723|FG002|Overall Study|Lack of Efficacy|1|||
24923169|NCT00518115|50016724|FG003|Overall Study|Lack of Efficacy|1|||
24923170|NCT00518115|50016725|FG004|Overall Study|Lack of Efficacy|0|||
25023964|NCT03631355|50121669|FG001|Overall Study|Lost to Follow-up|2|||
25023965|NCT03629249|50121678|FG000|Overall Study|Study terminated by sponsor|197|||
25023966|NCT03629249|50121679|FG001|Overall Study|Study terminated by sponsor|197|||
25023967|NCT03629249|50121680|FG002|Overall Study|Study terminated by sponsor|194|||
25023968|NCT03629249|50121678|FG000|Overall Study|Protocol deviation|0|||
25023969|NCT03629249|50121679|FG001|Overall Study|Protocol deviation|2|||
25185170|NCT00244725|50334419|FG000|Overall Study|Rehab Refused to allow participantion|0|||
25185171|NCT00244725|50334420|FG001|Overall Study|Rehab Refused to allow participantion|1|||
25185172|NCT00244725|50334421|FG002|Overall Study|Rehab Refused to allow participantion|0|||
25185173|NCT00244725|50334422|FG003|Overall Study|Rehab Refused to allow participantion|0|||
25185174|NCT00244725|50334419|FG000|Overall Study|Headache|0|||
25185175|NCT00244725|50334420|FG001|Overall Study|Headache|1|||
25185176|NCT00244725|50334421|FG002|Overall Study|Headache|0|||
25185177|NCT00244725|50334422|FG003|Overall Study|Headache|0|||
25185178|NCT00244725|50334419|FG000|Overall Study|Received prohibited medication|0|||
25185179|NCT00244725|50334420|FG001|Overall Study|Received prohibited medication|1|||
25185180|NCT00244725|50334421|FG002|Overall Study|Received prohibited medication|0|||
25185181|NCT00244725|50334422|FG003|Overall Study|Received prohibited medication|1|||
25023970|NCT03629249|50121680|FG002|Overall Study|Protocol deviation|5|||
25023971|NCT03629249|50121678|FG000|Overall Study|Subject decision|1|||
25185182|NCT00244725|50334419|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
25185183|NCT00244725|50334420|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
25185184|NCT00244725|50334421|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
25185185|NCT00244725|50334422|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
25185186|NCT00244725|50334419|FG000|Overall Study|Administrative reason|0|||
25185187|NCT00244725|50334420|FG001|Overall Study|Administrative reason|0|||
25185188|NCT00244725|50334421|FG002|Overall Study|Administrative reason|1|||
25185189|NCT00244725|50334422|FG003|Overall Study|Administrative reason|0|||
25185190|NCT00244725|50334419|FG000|Overall Study|Vomit|0|||
25185191|NCT00244725|50334420|FG001|Overall Study|Vomit|0|||
24923171|NCT00518115|50016726|FG005|Overall Study|Lack of Efficacy|0|||
24923172|NCT00518115|50016727|FG006|Overall Study|Lack of Efficacy|0|||
24923173|NCT00518115|50016728|FG007|Overall Study|Lack of Efficacy|1|||
24923174|NCT00518115|50016729|FG008|Overall Study|Lack of Efficacy|0|||
24923175|NCT00518115|50016730|FG009|Overall Study|Lack of Efficacy|0|||
24923176|NCT00518115|50016721|FG000|Overall Study|Non-Compliance|1|||
24923177|NCT00518115|50016722|FG001|Overall Study|Non-Compliance|0|||
24923178|NCT00518115|50016723|FG002|Overall Study|Non-Compliance|1|||
24923179|NCT00518115|50016724|FG003|Overall Study|Non-Compliance|0|||
24923180|NCT00518115|50016725|FG004|Overall Study|Non-Compliance|1|||
24923181|NCT00518115|50016726|FG005|Overall Study|Non-Compliance|1|||
24923182|NCT00518115|50016727|FG006|Overall Study|Non-Compliance|1|||
24923183|NCT00518115|50016728|FG007|Overall Study|Non-Compliance|1|||
24923184|NCT00518115|50016729|FG008|Overall Study|Non-Compliance|0|||
24923185|NCT00518115|50016730|FG009|Overall Study|Non-Compliance|1|||
24923186|NCT00518115|50016721|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
24923187|NCT00518115|50016722|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
24923188|NCT00518115|50016723|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
24923189|NCT00518115|50016724|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
24923190|NCT00518115|50016725|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
24923191|NCT00518115|50016726|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
24923192|NCT00518115|50016727|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
24923193|NCT00518115|50016728|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
24923194|NCT00518115|50016729|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
24923195|NCT00518115|50016730|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
24923196|NCT00518115|50016721|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
24923197|NCT00518115|50016722|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
24923198|NCT00518115|50016723|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
24923199|NCT00518115|50016724|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
24923200|NCT00518115|50016725|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
24923201|NCT00518115|50016726|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
24923202|NCT00518115|50016727|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
24923203|NCT00518115|50016728|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
24923204|NCT00518115|50016729|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
24923205|NCT00518115|50016730|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
24923206|NCT00518115|50016721|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
24923207|NCT00518115|50016722|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
24923208|NCT00518115|50016723|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
24923209|NCT00518115|50016724|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
24923210|NCT00518115|50016725|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
24923211|NCT00518115|50016726|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
24923212|NCT00518115|50016727|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
24923213|NCT00518115|50016728|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
24923214|NCT00518115|50016729|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
24923215|NCT00518115|50016730|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
24923216|NCT00518115|50016721|FG000|Overall Study|Wrong Monotherapy Administered|0|||
24923217|NCT00518115|50016722|FG001|Overall Study|Wrong Monotherapy Administered|0|||
24923218|NCT00518115|50016723|FG002|Overall Study|Wrong Monotherapy Administered|1|||
24923219|NCT00518115|50016724|FG003|Overall Study|Wrong Monotherapy Administered|0|||
24923220|NCT00518115|50016725|FG004|Overall Study|Wrong Monotherapy Administered|0|||
24923221|NCT00518115|50016726|FG005|Overall Study|Wrong Monotherapy Administered|0|||
24923222|NCT00518115|50016727|FG006|Overall Study|Wrong Monotherapy Administered|1|||
24923223|NCT00518115|50016728|FG007|Overall Study|Wrong Monotherapy Administered|0|||
24923224|NCT00518115|50016729|FG008|Overall Study|Wrong Monotherapy Administered|0|||
24923225|NCT00518115|50016730|FG009|Overall Study|Wrong Monotherapy Administered|0|||
25185192|NCT00244725|50334421|FG002|Overall Study|Vomit|1|||
25185193|NCT00244725|50334422|FG003|Overall Study|Vomit|0|||
25185194|NCT00244725|50334419|FG000|Overall Study|Failed to follow-up|0|||
25185195|NCT00244725|50334420|FG001|Overall Study|Failed to follow-up|0|||
24923226|NCT00518115|50016721|FG000|Overall Study|Violation of Exclusion Criteria|0|||
25185196|NCT00244725|50334421|FG002|Overall Study|Failed to follow-up|1|||
25185197|NCT00244725|50334422|FG003|Overall Study|Failed to follow-up|1|||
24923227|NCT00518115|50016722|FG001|Overall Study|Violation of Exclusion Criteria|0|||
24923228|NCT00518115|50016723|FG002|Overall Study|Violation of Exclusion Criteria|0|||
24923229|NCT00518115|50016724|FG003|Overall Study|Violation of Exclusion Criteria|1|||
24923230|NCT00518115|50016725|FG004|Overall Study|Violation of Exclusion Criteria|0|||
24923231|NCT00518115|50016726|FG005|Overall Study|Violation of Exclusion Criteria|0|||
24923232|NCT00518115|50016727|FG006|Overall Study|Violation of Exclusion Criteria|1|||
24923233|NCT00518115|50016728|FG007|Overall Study|Violation of Exclusion Criteria|0|||
24923234|NCT00518115|50016729|FG008|Overall Study|Violation of Exclusion Criteria|0|||
24923235|NCT00518115|50016730|FG009|Overall Study|Violation of Exclusion Criteria|0|||
24923236|NCT00518115|50016721|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
24923237|NCT00518115|50016722|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
25023972|NCT03629249|50121679|FG001|Overall Study|Subject decision|1|||
25023973|NCT03629249|50121680|FG002|Overall Study|Subject decision|3|||
25023974|NCT03629249|50121678|FG000|Overall Study|Adverse Event|1|||
25154673|NCT01544595|50269862|FG002|Status at Week 68|Non-compliance with study treatment|0|||
25023975|NCT03629249|50121679|FG001|Overall Study|Adverse Event|1|||
25154674|NCT01544595|50269863|FG003|Status at Week 68|Non-compliance with study treatment|1|||
25154675|NCT01544595|50269864|FG004|Status at Week 68|Non-compliance with study treatment|0|||
24923238|NCT00518115|50016723|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
24923239|NCT00518115|50016724|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
25154676|NCT01544595|50269865|FG005|Status at Week 68|Non-compliance with study treatment|0|||
24923240|NCT00518115|50016725|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
24923241|NCT00518115|50016726|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
24923242|NCT00518115|50016727|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
24923243|NCT00518115|50016728|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
24923244|NCT00518115|50016729|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
24923245|NCT00518115|50016730|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
24923246|NCT00518115|50016721|FG000|Overall Study|Withdrew Consent|0|||
24923247|NCT00518115|50016722|FG001|Overall Study|Withdrew Consent|0|||
24923248|NCT00518115|50016723|FG002|Overall Study|Withdrew Consent|0|||
24923249|NCT00518115|50016724|FG003|Overall Study|Withdrew Consent|0|||
24923250|NCT00518115|50016725|FG004|Overall Study|Withdrew Consent|0|||
24923251|NCT00518115|50016726|FG005|Overall Study|Withdrew Consent|1|||
24923252|NCT00518115|50016727|FG006|Overall Study|Withdrew Consent|0|||
24923253|NCT00518115|50016728|FG007|Overall Study|Withdrew Consent|0|||
24923254|NCT00518115|50016729|FG008|Overall Study|Withdrew Consent|0|||
24923255|NCT00518115|50016730|FG009|Overall Study|Withdrew Consent|0|||
24923256|NCT00518115|50016721|FG000|Overall Study|Moved Out of State|0|||
24923257|NCT00518115|50016722|FG001|Overall Study|Moved Out of State|0|||
24923258|NCT00518115|50016723|FG002|Overall Study|Moved Out of State|0|||
24923259|NCT00518115|50016724|FG003|Overall Study|Moved Out of State|0|||
24923260|NCT00518115|50016725|FG004|Overall Study|Moved Out of State|0|||
24923261|NCT00518115|50016726|FG005|Overall Study|Moved Out of State|0|||
24923262|NCT00518115|50016727|FG006|Overall Study|Moved Out of State|0|||
24923263|NCT00518115|50016728|FG007|Overall Study|Moved Out of State|0|||
24923264|NCT00518115|50016729|FG008|Overall Study|Moved Out of State|0|||
25154677|NCT01544595|50269860|FG000|Status at Week 68|Protocol Violation|2|||
25154678|NCT01544595|50269861|FG001|Status at Week 68|Protocol Violation|0|||
25154679|NCT01544595|50269862|FG002|Status at Week 68|Protocol Violation|1|||
25154680|NCT01544595|50269863|FG003|Status at Week 68|Protocol Violation|1|||
24923265|NCT00518115|50016730|FG009|Overall Study|Moved Out of State|1|||
24923266|NCT00450658|50016755|FG000|Overall Study|Adverse Event|24|||
24923267|NCT00450658|50016756|FG001|Overall Study|Adverse Event|15|||
24923268|NCT00450658|50016755|FG000|Overall Study|Withdrawal by Subject|43|||
24923269|NCT00450658|50016756|FG001|Overall Study|Withdrawal by Subject|26|||
24923270|NCT00450658|50016755|FG000|Overall Study|Lost to Follow-up|22|||
24923271|NCT00450658|50016756|FG001|Overall Study|Lost to Follow-up|5|||
25023976|NCT03629249|50121680|FG002|Overall Study|Adverse Event|0|||
25023977|NCT03629249|50121678|FG000|Overall Study|Death|1|||
25154681|NCT01544595|50269864|FG004|Status at Week 68|Protocol Violation|0|||
25185198|NCT02649894|50334434|FG000|Overall Study|Adverse Event|1|||
24923272|NCT00450658|50016755|FG000|Overall Study|UGI ulcer|33|||
24923273|NCT00450658|50016756|FG001|Overall Study|UGI ulcer|34|||
24923274|NCT00450658|50016755|FG000|Overall Study|misc|21|||
24923275|NCT00450658|50016756|FG001|Overall Study|misc|10|||
24923276|NCT00517881|50016762|FG000|Overall Study|Protocol Violation|2|||
24923277|NCT00517881|50016762|FG000|Overall Study|Adverse Event|1|||
24923278|NCT00517881|50016762|FG000|Overall Study|Renal transplantation|2|||
24923279|NCT00517413|50016783|FG000|Overall Study|Adverse Event|7|||
24923280|NCT00517413|50016783|FG000|Overall Study|Death|13|||
24923281|NCT00517413|50016783|FG000|Overall Study|Protocol Violation|15|||
24923282|NCT00517413|50016783|FG000|Overall Study|Withdrawal by Subject|2|||
24923283|NCT00517413|50016783|FG000|Overall Study|Failure to return|1|||
24923284|NCT00517413|50016783|FG000|Overall Study|Other-Reasons|23|||
24923285|NCT00604214|50016797|FG000|Baseline to Day 28|Death|223|||
24923286|NCT00604214|50016798|FG001|Baseline to Day 28|Death|202|||
24923287|NCT00604214|50016797|FG000|Baseline to Day 28|Lost to Follow-up|2|||
24923288|NCT00604214|50016798|FG001|Baseline to Day 28|Lost to Follow-up|4|||
24923289|NCT00604214|50016797|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
24923290|NCT00604214|50016798|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
24923291|NCT00604214|50016797|FG000|Day 29 to Day 90|Death|64|||
24923292|NCT00604214|50016798|FG001|Day 29 to Day 90|Death|67|||
24923293|NCT00604214|50016797|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
24923294|NCT00604214|50016798|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
24923295|NCT00604214|50016797|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
24923296|NCT00604214|50016798|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
24923297|NCT00604214|50016797|FG000|Day 91 to Day 180|Death|19|||
24923298|NCT00604214|50016798|FG001|Day 91 to Day 180|Death|23|||
24923299|NCT00604214|50016797|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
24923300|NCT00604214|50016798|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
24923301|NCT00604214|50016797|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
24923302|NCT00604214|50016798|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
24923303|NCT00450580|50016806|FG000|Overall Study|Adverse Event|5|||
24923304|NCT00450580|50016807|FG001|Overall Study|Adverse Event|7|||
24923305|NCT00450580|50016806|FG000|Overall Study|Lost to Follow-up|4|||
24923306|NCT00450580|50016807|FG001|Overall Study|Lost to Follow-up|5|||
24923307|NCT00450580|50016806|FG000|Overall Study|Withdrawal by Subject|2|||
24923308|NCT00450580|50016807|FG001|Overall Study|Withdrawal by Subject|2|||
24923309|NCT00450580|50016806|FG000|Overall Study|Protocol Violation|1|||
24923310|NCT00450580|50016807|FG001|Overall Study|Protocol Violation|1|||
24923311|NCT00450580|50016806|FG000|Overall Study|Protocol-defined virologic failure|1|||
24923312|NCT00450580|50016807|FG001|Overall Study|Protocol-defined virologic failure|0|||
24923313|NCT00450580|50016806|FG000|Overall Study|Could not comply with scheduled visits|1|||
24923314|NCT00450580|50016807|FG001|Overall Study|Could not comply with scheduled visits|0|||
24923315|NCT00450580|50016806|FG000|Overall Study|Patient went to Brazil|1|||
24923316|NCT00450580|50016807|FG001|Overall Study|Patient went to Brazil|0|||
24923317|NCT00450580|50016806|FG000|Overall Study|Patient could not swallow Norvir|1|||
24923318|NCT00450580|50016807|FG001|Overall Study|Patient could not swallow Norvir|0|||
24923319|NCT00450580|50016806|FG000|Overall Study|Withdrawal due to pregnancy|0|||
24923320|NCT00450580|50016807|FG001|Overall Study|Withdrawal due to pregnancy|1|||
24923321|NCT00123487|50016815|FG000|Randomized|Death prior to starting treatment|0|||
25023978|NCT03629249|50121679|FG001|Overall Study|Death|0|||
25023979|NCT03629249|50121680|FG002|Overall Study|Death|0|||
25023980|NCT03629249|50121678|FG000|Overall Study|Physician Decision|1|||
25023981|NCT03629249|50121679|FG001|Overall Study|Physician Decision|0|||
25023982|NCT03629249|50121680|FG002|Overall Study|Physician Decision|0|||
25023983|NCT03628781|50121690|FG000|Overall Study|Lost to Follow-up|16|||
25023984|NCT03628781|50121691|FG001|Overall Study|Lost to Follow-up|8|||
25023985|NCT03628781|50121690|FG000|Overall Study|Withdrawal by Subject|16|||
25023986|NCT03628781|50121691|FG001|Overall Study|Withdrawal by Subject|1|||
25023987|NCT03371251|50121703|FG000|Overall Study|Withdrawal by Subject|1|||
25023988|NCT03371251|50121704|FG001|Overall Study|Withdrawal by Subject|0|||
25023989|NCT03371251|50121705|FG002|Overall Study|Withdrawal by Subject|1|||
25023990|NCT03371251|50121706|FG003|Overall Study|Withdrawal by Subject|0|||
25023991|NCT03371251|50121707|FG004|Overall Study|Withdrawal by Subject|2|||
25023992|NCT03371251|50121708|FG005|Overall Study|Withdrawal by Subject|2|||
25023993|NCT03371251|50121703|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
25023994|NCT03371251|50121704|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
25023995|NCT03371251|50121705|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
25023996|NCT03371251|50121706|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
25023997|NCT03371251|50121707|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
25023998|NCT03371251|50121708|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
25023999|NCT03371251|50121703|FG000|Overall Study|Adverse Event|0|||
25024000|NCT03371251|50121704|FG001|Overall Study|Adverse Event|0|||
25024001|NCT03371251|50121705|FG002|Overall Study|Adverse Event|0|||
25024002|NCT03371251|50121706|FG003|Overall Study|Adverse Event|0|||
25024003|NCT03371251|50121707|FG004|Overall Study|Adverse Event|1|||
25024004|NCT03371251|50121708|FG005|Overall Study|Adverse Event|0|||
25024005|NCT03371251|50121703|FG000|Overall Study|Decision by Sponsor|0|||
25024006|NCT03371251|50121704|FG001|Overall Study|Decision by Sponsor|0|||
25024007|NCT03371251|50121705|FG002|Overall Study|Decision by Sponsor|0|||
25024008|NCT03371251|50121706|FG003|Overall Study|Decision by Sponsor|0|||
25024009|NCT03371251|50121707|FG004|Overall Study|Decision by Sponsor|2|||
25024010|NCT03371251|50121708|FG005|Overall Study|Decision by Sponsor|0|||
25024011|NCT03370471|50121727|FG000|Overall Study|Withdrawal by Subject|6|||
24923322|NCT00123487|50016816|FG001|Randomized|Death prior to starting treatment|1|||
25024012|NCT03370471|50121728|FG001|Overall Study|Withdrawal by Subject|1|||
24923323|NCT00123487|50016815|FG000|Randomized|SAE prior to starting treatment|1|||
24923324|NCT00123487|50016816|FG001|Randomized|SAE prior to starting treatment|0|||
24923325|NCT00123487|50016815|FG000|Treated With Study Drug|Adverse Event|23|||
25024013|NCT03370471|50121727|FG000|Overall Study|Unable to access veins for blood draw|0|||
25024014|NCT03370471|50121728|FG001|Overall Study|Unable to access veins for blood draw|1|||
25024015|NCT03370471|50121727|FG000|Overall Study|Screen fail|1|||
25024016|NCT03370471|50121728|FG001|Overall Study|Screen fail|0|||
25024017|NCT03349645|50121736|FG000|Overall Study|Sponsor Terminated Study|75|||
25024018|NCT03349645|50121736|FG000|Overall Study|Withdrawal by Subject|4|||
25024019|NCT03349645|50121736|FG000|Overall Study|Protocol Violation|1|||
25024020|NCT03349645|50121736|FG000|Overall Study|Other|2|||
25024021|NCT03349333|50121740|FG000|Overall Study|Progression of Disease|36|||
25024022|NCT03349333|50121740|FG000|Overall Study|Adverse Event|11|||
25024023|NCT03349333|50121740|FG000|Overall Study|Other|6|||
25024024|NCT03349333|50121740|FG000|Overall Study|Withdrawal by Subject|5|||
24923326|NCT00123487|50016816|FG001|Treated With Study Drug|Adverse Event|22|||
24923327|NCT00123487|50016815|FG000|Treated With Study Drug|Disease Progression|141|||
24923328|NCT00123487|50016816|FG001|Treated With Study Drug|Disease Progression|122|||
24923329|NCT00123487|50016815|FG000|Treated With Study Drug|Physician Decision|8|||
24923330|NCT00123487|50016816|FG001|Treated With Study Drug|Physician Decision|9|||
24923331|NCT00123487|50016815|FG000|Treated With Study Drug|Other|59|||
24923332|NCT00123487|50016816|FG001|Treated With Study Drug|Other|58|||
24923333|NCT00123487|50016815|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
24923334|NCT00123487|50016816|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
24923335|NCT00123487|50016815|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
24923336|NCT00123487|50016816|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
24923337|NCT00123487|50016815|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
24923338|NCT00123487|50016816|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
24923339|NCT00509925|50016823|FG000|Overall Study|Personal reasons|0|||
24923340|NCT00509925|50016824|FG001|Overall Study|Personal reasons|1|||
24923341|NCT00504777|50016832|FG000|Overall Study|Adverse Event|1|||
24923342|NCT00509769|50016836|FG000|Overall Study|Progressive disease|77|||
24923343|NCT00509769|50016836|FG000|Overall Study|Adverse Event|4|||
24923344|NCT00509769|50016836|FG000|Overall Study|Patient's decision|1|||
24923345|NCT00509769|50016836|FG000|Overall Study|Physician Decision|8|||
24923346|NCT00509769|50016836|FG000|Overall Study|Use of prohibited therapies during study|1|||
24923347|NCT00114127|50016842|FG000|Overall Study|Adverse Event|2|||
24923348|NCT00114127|50016843|FG001|Overall Study|Adverse Event|1|||
24923349|NCT00114127|50016842|FG000|Overall Study|Lost to Follow-up|1|||
24923350|NCT00114127|50016843|FG001|Overall Study|Lost to Follow-up|0|||
24923351|NCT00114127|50016842|FG000|Overall Study|Withdrawal by Subject|1|||
24923352|NCT00114127|50016843|FG001|Overall Study|Withdrawal by Subject|3|||
24923353|NCT00572624|50016851|FG000|Overall Study|Lost to Follow-up|10|||
24923354|NCT00572624|50016852|FG001|Overall Study|Lost to Follow-up|4|||
24923355|NCT00572624|50016851|FG000|Overall Study|Wanted to do a different diet program|1|||
24923356|NCT00572624|50016852|FG001|Overall Study|Wanted to do a different diet program|0|||
24923357|NCT00572624|50016851|FG000|Overall Study|Medication change|1|||
24923358|NCT00572624|50016852|FG001|Overall Study|Medication change|0|||
24923359|NCT00572624|50016851|FG000|Overall Study|Started a new job-- no time for study|1|||
24923360|NCT00572624|50016852|FG001|Overall Study|Started a new job-- no time for study|0|||
24923361|NCT00572624|50016851|FG000|Overall Study|Admitted to being a smoker|1|||
24923362|NCT00572624|50016852|FG001|Overall Study|Admitted to being a smoker|0|||
24923363|NCT00572624|50016851|FG000|Overall Study|Refused to do the stress test|1|||
24923364|NCT00572624|50016852|FG001|Overall Study|Refused to do the stress test|0|||
24923365|NCT00572624|50016851|FG000|Overall Study|Problem with vascular access|1|||
24923366|NCT00572624|50016852|FG001|Overall Study|Problem with vascular access|0|||
24923367|NCT00572624|50016851|FG000|Overall Study|Health issues unrelated to the study|1|||
24923368|NCT00572624|50016852|FG001|Overall Study|Health issues unrelated to the study|0|||
24923369|NCT00122317|50016858|FG000|Overall Study|Death|3|||
24923370|NCT00122317|50016858|FG000|Overall Study|Adverse Event|4|||
24923371|NCT00122317|50016858|FG000|Overall Study|Physician Decision|2|||
24923372|NCT00122317|50016858|FG000|Overall Study|patient non-compliance|1|||
24923373|NCT00122317|50016858|FG000|Overall Study|Withdrawal by Subject|1|||
25024025|NCT03349333|50121740|FG000|Overall Study|Conditions interfere with participation|2|||
25024026|NCT03349333|50121740|FG000|Overall Study|Physician Decision|2|||
25024027|NCT03349333|50121740|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
24923374|NCT03870555|50016865|FG000|Period 3 (2 Days)|Adverse Event|1|||
24923375|NCT03870555|50016866|FG001|Period 3 (2 Days)|Adverse Event|0|||
24923376|NCT03870555|50016867|FG002|Period 3 (2 Days)|Adverse Event|0|||
24923377|NCT03870477|50016878|FG000|Overall Study|Early Study Termination|1|||
24923378|NCT00165841|50016884|FG000|Overall Study|Adverse Event|2|||
25024028|NCT03349333|50121740|FG000|Overall Study|Patients in treatment less than 24 month|8|||
25024029|NCT03349099|50121746|FG000|Overall Study|Physician Decision|3|||
25024030|NCT03349099|50121747|FG001|Overall Study|Physician Decision|4|||
25024031|NCT03349099|50121746|FG000|Overall Study|Stone migrated from the kidney|1|||
24923379|NCT00165841|50016885|FG001|Overall Study|Adverse Event|3|||
24923380|NCT00165841|50016884|FG000|Overall Study|Lack of Efficacy|6|||
24923381|NCT00165841|50016885|FG001|Overall Study|Lack of Efficacy|33|||
24923382|NCT00165841|50016884|FG000|Overall Study|Lost to Follow-up|4|||
24923383|NCT00165841|50016885|FG001|Overall Study|Lost to Follow-up|4|||
24923384|NCT00165841|50016884|FG000|Overall Study|Withdrawal by Subject|7|||
24923385|NCT00165841|50016885|FG001|Overall Study|Withdrawal by Subject|8|||
24923386|NCT00165841|50016884|FG000|Overall Study|Physician Decision|1|||
24923387|NCT00165841|50016885|FG001|Overall Study|Physician Decision|0|||
24923388|NCT00165841|50016884|FG000|Overall Study|Protocol Violation|6|||
24923389|NCT00165841|50016885|FG001|Overall Study|Protocol Violation|8|||
24923390|NCT00165841|50016884|FG000|Overall Study|Other|3|||
24923391|NCT00165841|50016885|FG001|Overall Study|Other|5|||
24923392|NCT00165841|50016884|FG000|Overall Study|Medication Noncompliance|1|||
24923393|NCT00165841|50016885|FG001|Overall Study|Medication Noncompliance|1|||
24923394|NCT00509223|50016893|FG000|Overall Study|Lost to Follow-up|1|||
24923395|NCT00509223|50016894|FG001|Overall Study|Lost to Follow-up|1|||
24923396|NCT00509223|50016893|FG000|Overall Study|Adverse Event|1|||
24923397|NCT00509223|50016894|FG001|Overall Study|Adverse Event|1|||
24923398|NCT00509223|50016893|FG000|Overall Study|Withdrawal by Subject|25|||
24923399|NCT00509223|50016894|FG001|Overall Study|Withdrawal by Subject|6|||
24923400|NCT00509223|50016893|FG000|Overall Study|Including: subject change of address|5|||
24923401|NCT00509223|50016894|FG001|Overall Study|Including: subject change of address|2|||
24923402|NCT00509223|50016893|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
24923403|NCT00509223|50016894|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
24923404|NCT00460798|50016900|FG000|Overall Study|Death|59|||
24923405|NCT00460798|50016900|FG000|Overall Study|Adverse Event|27|||
24923406|NCT00460798|50016900|FG000|Overall Study|Lost to Follow-up|19|||
24923407|NCT00460798|50016900|FG000|Overall Study|Progressive Disease|99|||
24923408|NCT00460798|50016900|FG000|Overall Study|Other|27|||
24923409|NCT00460798|50016900|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
24923410|NCT00460798|50016900|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
24923411|NCT00603980|50016904|FG000|Study Qualification|Protocol Violation|3|||
24923412|NCT00603980|50016904|FG000|Study Qualification|Inconsistent data reporting|13|||
24923413|NCT00603980|50016904|FG000|Main Study|14th subject completed trial|1|||
24923414|NCT00450190|50016924|FG000|Overall Study|Withdrawal by Subject|2|||
24923415|NCT00450112|50016930|FG000|Overall Study|Other Treatment Required|5|||
25154682|NCT01544595|50269865|FG005|Status at Week 68|Protocol Violation|0|||
25154683|NCT01544595|50269860|FG000|Status at Week 68|Technical problems|1|||
25154684|NCT01544595|50269861|FG001|Status at Week 68|Technical problems|0|||
25154685|NCT01544595|50269862|FG002|Status at Week 68|Technical problems|0|||
25154686|NCT01544595|50269863|FG003|Status at Week 68|Technical problems|1|||
25154687|NCT01544595|50269864|FG004|Status at Week 68|Technical problems|0|||
25154688|NCT01544595|50269865|FG005|Status at Week 68|Technical problems|0|||
25154689|NCT01544595|50269860|FG000|Status at Week 68|Withdrawal by Subject|0|||
25154690|NCT01544595|50269861|FG001|Status at Week 68|Withdrawal by Subject|1|||
25185199|NCT02649894|50334435|FG001|Overall Study|Adverse Event|0|||
25185200|NCT02649894|50334434|FG000|Overall Study|Physician Decision|0|||
25185201|NCT02649894|50334435|FG001|Overall Study|Physician Decision|1|||
25185202|NCT02649894|50334434|FG000|Overall Study|Withdrawal by Subject|5|||
25185203|NCT02649894|50334435|FG001|Overall Study|Withdrawal by Subject|2|||
25185204|NCT02649894|50334434|FG000|Overall Study|Lost to Follow-up|2|||
25185205|NCT02649894|50334435|FG001|Overall Study|Lost to Follow-up|1|||
25185206|NCT02649894|50334434|FG000|Overall Study|Death|30|||
25185207|NCT02649894|50334435|FG001|Overall Study|Death|7|||
25154691|NCT01544595|50269862|FG002|Status at Week 68|Withdrawal by Subject|1|||
25154692|NCT01544595|50269863|FG003|Status at Week 68|Withdrawal by Subject|2|||
24923416|NCT00450112|50016931|FG001|Overall Study|Other Treatment Required|1|||
25185208|NCT02649894|50334434|FG000|Overall Study|Other, not specified|6|||
25185209|NCT02649894|50334435|FG001|Overall Study|Other, not specified|0|||
25185210|NCT01278615|50334441|FG000|Overall Study|Withdrawal by Subject|2|||
25185211|NCT01505114|50334467|FG000|Overall Study|Withdrawal by Subject|5|||
25185212|NCT01505114|50334468|FG001|Overall Study|Withdrawal by Subject|4|||
25185213|NCT01505114|50334469|FG002|Overall Study|Withdrawal by Subject|4|||
25185214|NCT01505114|50334470|FG003|Overall Study|Withdrawal by Subject|7|||
25185215|NCT01505114|50334467|FG000|Overall Study|Death|1|||
25185216|NCT01505114|50334468|FG001|Overall Study|Death|0|||
25154693|NCT01544595|50269864|FG004|Status at Week 68|Withdrawal by Subject|0|||
25154694|NCT01544595|50269865|FG005|Status at Week 68|Withdrawal by Subject|0|||
25154695|NCT01544595|50269860|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
25154696|NCT01544595|50269861|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
25154697|NCT01544595|50269862|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
25154698|NCT01544595|50269863|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
25154699|NCT01544595|50269864|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
25154700|NCT01544595|50269865|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
25154701|NCT01544595|50269860|FG000|Status at Week 156|Withdrawal by Subject|9|||
25154702|NCT01544595|50269861|FG001|Status at Week 156|Withdrawal by Subject|10|||
25154703|NCT01544595|50269862|FG002|Status at Week 156|Withdrawal by Subject|4|||
25154704|NCT01544595|50269863|FG003|Status at Week 156|Withdrawal by Subject|9|||
25154705|NCT01544595|50269864|FG004|Status at Week 156|Withdrawal by Subject|20|||
25154706|NCT01544595|50269865|FG005|Status at Week 156|Withdrawal by Subject|6|||
25154707|NCT01544595|50269860|FG000|Status at Week 156|Adverse Event|9|||
25154708|NCT01544595|50269861|FG001|Status at Week 156|Adverse Event|11|||
25154709|NCT01544595|50269862|FG002|Status at Week 156|Adverse Event|1|||
25154710|NCT01544595|50269863|FG003|Status at Week 156|Adverse Event|3|||
25154711|NCT01544595|50269864|FG004|Status at Week 156|Adverse Event|4|||
25154712|NCT01544595|50269865|FG005|Status at Week 156|Adverse Event|2|||
25154713|NCT01544595|50269860|FG000|Status at Week 156|Lost to Follow-up|4|||
25185217|NCT01505114|50334469|FG002|Overall Study|Death|0|||
25185218|NCT01505114|50334470|FG003|Overall Study|Death|1|||
25154714|NCT01544595|50269861|FG001|Status at Week 156|Lost to Follow-up|4|||
25154715|NCT01544595|50269862|FG002|Status at Week 156|Lost to Follow-up|0|||
24923417|NCT00450112|50016930|FG000|Overall Study|Withdrawal by Subject|4|||
24923418|NCT00450112|50016931|FG001|Overall Study|Withdrawal by Subject|1|||
24923419|NCT00450112|50016930|FG000|Overall Study|Lost to Follow-up|2|||
24923420|NCT00450112|50016931|FG001|Overall Study|Lost to Follow-up|1|||
24923421|NCT00450112|50016930|FG000|Overall Study|Others|2|||
24923422|NCT00450112|50016931|FG001|Overall Study|Others|3|||
24923423|NCT00449956|50016940|FG000|Overall Study|Adverse Event|7|||
24923424|NCT00449956|50016941|FG001|Overall Study|Adverse Event|1|||
24923425|NCT00449956|50016942|FG002|Overall Study|Adverse Event|6|||
25154716|NCT01544595|50269863|FG003|Status at Week 156|Lost to Follow-up|1|||
25154717|NCT01544595|50269864|FG004|Status at Week 156|Lost to Follow-up|4|||
25154718|NCT01544595|50269865|FG005|Status at Week 156|Lost to Follow-up|1|||
25154719|NCT01544595|50269860|FG000|Status at Week 156|Non-compliance with study treatement|0|||
25154720|NCT01544595|50269861|FG001|Status at Week 156|Non-compliance with study treatement|1|||
25154721|NCT01544595|50269862|FG002|Status at Week 156|Non-compliance with study treatement|0|||
25154722|NCT01544595|50269863|FG003|Status at Week 156|Non-compliance with study treatement|1|||
25154723|NCT01544595|50269864|FG004|Status at Week 156|Non-compliance with study treatement|0|||
25154724|NCT01544595|50269865|FG005|Status at Week 156|Non-compliance with study treatement|1|||
25154725|NCT01544595|50269860|FG000|Status at Week 156|Physician Decision|0|||
25185219|NCT01505114|50334467|FG000|Overall Study|unable to adhere to visit schedule|3|||
25185220|NCT01505114|50334468|FG001|Overall Study|unable to adhere to visit schedule|2|||
25185221|NCT01505114|50334469|FG002|Overall Study|unable to adhere to visit schedule|3|||
25185222|NCT01505114|50334470|FG003|Overall Study|unable to adhere to visit schedule|3|||
25185223|NCT01505114|50334467|FG000|Overall Study|Lost to Follow-up|11|||
25185224|NCT01505114|50334468|FG001|Overall Study|Lost to Follow-up|5|||
25185225|NCT01505114|50334469|FG002|Overall Study|Lost to Follow-up|8|||
25185226|NCT01505114|50334470|FG003|Overall Study|Lost to Follow-up|7|||
25185227|NCT01505114|50334467|FG000|Overall Study|relocated|4|||
25185228|NCT01505114|50334468|FG001|Overall Study|relocated|2|||
25185229|NCT01505114|50334469|FG002|Overall Study|relocated|2|||
25185230|NCT01505114|50334470|FG003|Overall Study|relocated|3|||
25185231|NCT01505114|50334467|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
25154726|NCT01544595|50269861|FG001|Status at Week 156|Physician Decision|3|||
25154727|NCT01544595|50269862|FG002|Status at Week 156|Physician Decision|1|||
25154728|NCT01544595|50269863|FG003|Status at Week 156|Physician Decision|0|||
25185232|NCT01505114|50334468|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
25185233|NCT01505114|50334469|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
25185234|NCT01505114|50334470|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
25185235|NCT01505114|50334467|FG000|Overall Study|staff safety concerns|0|||
25185236|NCT01505114|50334468|FG001|Overall Study|staff safety concerns|0|||
25185237|NCT01505114|50334469|FG002|Overall Study|staff safety concerns|0|||
24923426|NCT00449956|50016940|FG000|Overall Study|Lack of Efficacy|0|||
24923427|NCT00449956|50016941|FG001|Overall Study|Lack of Efficacy|0|||
25185238|NCT01505114|50334470|FG003|Overall Study|staff safety concerns|1|||
25185239|NCT01505114|50334467|FG000|Overall Study|investigator decision|1|||
25185240|NCT01505114|50334468|FG001|Overall Study|investigator decision|0|||
25185241|NCT01505114|50334469|FG002|Overall Study|investigator decision|1|||
25185242|NCT01505114|50334470|FG003|Overall Study|investigator decision|0|||
25185243|NCT02651922|50334502|FG000|Overall Study|due to exclusion criteria|2|||
25185244|NCT01277757|50334506|FG000|Overall Study|Disease Progression|1|||
25185245|NCT01277757|50334506|FG000|Overall Study|Withdrawal by Subject|1|||
25185246|NCT01276821|50334512|FG000|Overall Study|Protocol Violation|0|||
25185247|NCT01276821|50334513|FG001|Overall Study|Protocol Violation|1|||
25185248|NCT00245037|50334519|FG000|Overall Study|Death|17|||
25185249|NCT00241839|50334525|FG000|Overall Study|Withdrawal by Subject|18|||
25185250|NCT00241839|50334526|FG001|Overall Study|Withdrawal by Subject|17|||
25154729|NCT01544595|50269864|FG004|Status at Week 156|Physician Decision|0|||
25154730|NCT01544595|50269865|FG005|Status at Week 156|Physician Decision|0|||
25185251|NCT00241839|50334525|FG000|Overall Study|Adverse Event|1|||
25185252|NCT00241839|50334526|FG001|Overall Study|Adverse Event|1|||
25185253|NCT02651688|50334535|FG000|Overall Study|Non-compliance|0|||
25185254|NCT02651688|50334536|FG001|Overall Study|Non-compliance|0|||
25185255|NCT02651688|50334537|FG002|Overall Study|Non-compliance|1|||
25185256|NCT02651688|50334535|FG000|Overall Study|Principal Investigator (PI) decision|0|||
25185257|NCT02651688|50334536|FG001|Overall Study|Principal Investigator (PI) decision|2|||
25185258|NCT02651688|50334537|FG002|Overall Study|Principal Investigator (PI) decision|0|||
25185259|NCT02651688|50334535|FG000|Overall Study|Lost to Follow-up|1|||
25185260|NCT02651688|50334536|FG001|Overall Study|Lost to Follow-up|3|||
25185261|NCT02651688|50334537|FG002|Overall Study|Lost to Follow-up|0|||
25185262|NCT02651688|50334535|FG000|Overall Study|Withdrawal by Subject|1|||
25185263|NCT02651688|50334536|FG001|Overall Study|Withdrawal by Subject|0|||
25185264|NCT02651688|50334537|FG002|Overall Study|Withdrawal by Subject|2|||
25185265|NCT01276353|50334547|FG000|Double-blind|Adverse Event|2|||
25185266|NCT01276353|50334548|FG001|Double-blind|Adverse Event|0|||
25185267|NCT01276353|50334547|FG000|Double-blind|Withdrawal by Subject|1|||
25185268|NCT01276353|50334548|FG001|Double-blind|Withdrawal by Subject|0|||
25185269|NCT01276353|50334547|FG000|Extension|Adverse Event|2|||
25185270|NCT01276353|50334548|FG001|Extension|Adverse Event|5|||
25185271|NCT01276353|50334547|FG000|Extension|Withdrawal by Subject|1|||
25185272|NCT01276353|50334548|FG001|Extension|Withdrawal by Subject|2|||
25185273|NCT01276353|50334547|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
25185274|NCT01276353|50334548|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
25185275|NCT01276353|50334547|FG000|Extension|Physician Decision|1|||
25185276|NCT01276353|50334548|FG001|Extension|Physician Decision|0|||
25185277|NCT01276353|50334547|FG000|Extension|Prohibited concomitant medications|0|||
25185278|NCT01276353|50334548|FG001|Extension|Prohibited concomitant medications|1|||
25185279|NCT02536794|50334583|FG000|Reached 1st Response Assessment|Adverse Event|2|||
25185280|NCT02536794|50334583|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
25185281|NCT02536794|50334583|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
25185282|NCT02536794|50334583|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
25185283|NCT02536794|50334583|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
25154731|NCT01544595|50269860|FG000|Status at Week 156|Pregnancy|2|||
25154732|NCT01544595|50269861|FG001|Status at Week 156|Pregnancy|3|||
25154733|NCT01544595|50269862|FG002|Status at Week 156|Pregnancy|0|||
25154734|NCT01544595|50269863|FG003|Status at Week 156|Pregnancy|0|||
25154735|NCT01544595|50269864|FG004|Status at Week 156|Pregnancy|0|||
25154736|NCT01544595|50269865|FG005|Status at Week 156|Pregnancy|0|||
25154737|NCT01544595|50269860|FG000|Status at Week 156|Protocol Violation|3|||
25154738|NCT01544595|50269861|FG001|Status at Week 156|Protocol Violation|1|||
25154739|NCT01544595|50269862|FG002|Status at Week 156|Protocol Violation|2|||
25154740|NCT01544595|50269863|FG003|Status at Week 156|Protocol Violation|2|||
25154741|NCT01544595|50269864|FG004|Status at Week 156|Protocol Violation|0|||
25154742|NCT01544595|50269865|FG005|Status at Week 156|Protocol Violation|0|||
25154743|NCT01544595|50269860|FG000|Status at Week 156|Technical problems|3|||
25154744|NCT01544595|50269861|FG001|Status at Week 156|Technical problems|1|||
25154745|NCT01544595|50269862|FG002|Status at Week 156|Technical problems|0|||
25154746|NCT01544595|50269863|FG003|Status at Week 156|Technical problems|1|||
25154747|NCT01544595|50269864|FG004|Status at Week 156|Technical problems|0|||
25154748|NCT01544595|50269865|FG005|Status at Week 156|Technical problems|0|||
25154749|NCT01544595|50269860|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
25154750|NCT01544595|50269861|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
25154751|NCT01544595|50269862|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
25154752|NCT01544595|50269863|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
25154753|NCT01544595|50269864|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
25154754|NCT01544595|50269865|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
25154755|NCT01544595|50269860|FG000|Status at Week 156|Lack of Efficacy|1|||
25154756|NCT01544595|50269861|FG001|Status at Week 156|Lack of Efficacy|0|||
25185284|NCT02536794|50334583|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
25185285|NCT01480076|50334662|FG000|Overall Study|Run-in Failure|52|||
25185286|NCT01480076|50334662|FG000|Overall Study|Adverse Event|39|||
25185287|NCT01480076|50334662|FG000|Overall Study|Death|2|||
25185288|NCT01480076|50334662|FG000|Overall Study|Disease Progression|5|||
25185289|NCT01480076|50334662|FG000|Overall Study|Non-compliance With Study Protocol|15|||
25185290|NCT01480076|50334662|FG000|Overall Study|Withdrawal by Subject|105|||
25185291|NCT01480076|50334662|FG000|Overall Study|Lost to Follow-up|7|||
25185292|NCT01480076|50334662|FG000|Overall Study|Investigator Decision|13|||
25185293|NCT01480076|50334662|FG000|Overall Study|Other|52|||
25185294|NCT02650128|50334750|FG000|Overall Study|Death|2|||
25185295|NCT01362270|50334765|FG000|Overall Study|Withdrawal by Subject|1|||
25185296|NCT01362270|50334766|FG001|Overall Study|Withdrawal by Subject|0|||
25185297|NCT01362270|50334765|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
25185298|NCT01362270|50334766|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
25185299|NCT01362270|50334765|FG000|Overall Study|Met excl. criteria before 1st session|1|||
25185300|NCT01362270|50334766|FG001|Overall Study|Met excl. criteria before 1st session|1|||
25185301|NCT00089479|50334787|FG000|Overall Study|Death|108|||
25185302|NCT00089479|50334788|FG001|Overall Study|Death|75|||
25185303|NCT00089479|50334787|FG000|Overall Study|Withdrawal by Subject|86|||
25185304|NCT00089479|50334788|FG001|Overall Study|Withdrawal by Subject|107|||
25185305|NCT00089479|50334787|FG000|Overall Study|Lost to Follow-up|137|||
25185306|NCT00089479|50334788|FG001|Overall Study|Lost to Follow-up|107|||
25185307|NCT01463306|50334797|FG000|Overall Study|Adverse Event|6|||
25185308|NCT01463306|50334798|FG001|Overall Study|Adverse Event|9|||
25185309|NCT01463306|50334799|FG002|Overall Study|Adverse Event|3|||
25185310|NCT01463306|50334797|FG000|Overall Study|Death|3|||
25185311|NCT01463306|50334798|FG001|Overall Study|Death|3|||
25185312|NCT01463306|50334799|FG002|Overall Study|Death|0|||
25185313|NCT01463306|50334797|FG000|Overall Study|Lack of Efficacy|22|||
25185314|NCT01463306|50334798|FG001|Overall Study|Lack of Efficacy|16|||
25185315|NCT01463306|50334799|FG002|Overall Study|Lack of Efficacy|1|||
25185316|NCT01463306|50334797|FG000|Overall Study|Lost to Follow-up|5|||
25185317|NCT01463306|50334798|FG001|Overall Study|Lost to Follow-up|2|||
25185318|NCT01463306|50334799|FG002|Overall Study|Lost to Follow-up|0|||
25185319|NCT01463306|50334797|FG000|Overall Study|Protocol Violation|4|||
25185320|NCT01463306|50334798|FG001|Overall Study|Protocol Violation|0|||
25185321|NCT01463306|50334799|FG002|Overall Study|Protocol Violation|0|||
25185322|NCT01463306|50334797|FG000|Overall Study|Withdrawal by Subject|19|||
25185323|NCT01463306|50334798|FG001|Overall Study|Withdrawal by Subject|9|||
25185324|NCT01463306|50334799|FG002|Overall Study|Withdrawal by Subject|1|||
25185325|NCT01463306|50334797|FG000|Overall Study|Other|26|||
25185326|NCT01463306|50334798|FG001|Overall Study|Other|13|||
25185327|NCT01463306|50334799|FG002|Overall Study|Other|0|||
25185328|NCT01463306|50334797|FG000|Overall Study|Approval expiry at site|1|||
25154757|NCT01544595|50269862|FG002|Status at Week 156|Lack of Efficacy|1|||
25154758|NCT01544595|50269863|FG003|Status at Week 156|Lack of Efficacy|4|||
25154759|NCT01544595|50269864|FG004|Status at Week 156|Lack of Efficacy|10|||
25154760|NCT01544595|50269865|FG005|Status at Week 156|Lack of Efficacy|5|||
25154761|NCT01539525|50269886|FG000|Overall Study|Lost to Follow-up|19|||
25154762|NCT01539525|50269887|FG001|Overall Study|Lost to Follow-up|12|||
25154763|NCT01539525|50269888|FG002|Overall Study|Lost to Follow-up|11|||
25154764|NCT01539525|50269886|FG000|Overall Study|Withdrawal by Subject|0|||
25154765|NCT01539525|50269887|FG001|Overall Study|Withdrawal by Subject|3|||
25154766|NCT01539525|50269888|FG002|Overall Study|Withdrawal by Subject|2|||
25154767|NCT01539525|50269886|FG000|Overall Study|Protocol Violation|1|||
25154768|NCT01539525|50269887|FG001|Overall Study|Protocol Violation|1|||
25154769|NCT01539525|50269888|FG002|Overall Study|Protocol Violation|4|||
25154770|NCT01513551|50269902|FG000|Overall Study|Death|0|||
25154771|NCT01513551|50269903|FG001|Overall Study|Death|1|||
25154772|NCT01513551|50269904|FG002|Overall Study|Death|0|||
25154773|NCT01513551|50269902|FG000|Overall Study|Lost to Follow-up|3|||
25154774|NCT01513551|50269903|FG001|Overall Study|Lost to Follow-up|5|||
25185329|NCT01463306|50334798|FG001|Overall Study|Approval expiry at site|0|||
25185330|NCT01463306|50334799|FG002|Overall Study|Approval expiry at site|0|||
25185331|NCT01504412|50334828|FG000|Overall Study|Adverse Event|1|||
25154775|NCT01513551|50269904|FG002|Overall Study|Lost to Follow-up|2|||
25154776|NCT01513551|50269902|FG000|Overall Study|Withdrawal by Subject|1|||
25154777|NCT01513551|50269903|FG001|Overall Study|Withdrawal by Subject|0|||
25154778|NCT01513551|50269904|FG002|Overall Study|Withdrawal by Subject|2|||
25185332|NCT01504412|50334829|FG001|Overall Study|Adverse Event|8|||
25185333|NCT01504412|50334830|FG002|Overall Study|Adverse Event|1|||
25185334|NCT01504412|50334831|FG003|Overall Study|Adverse Event|7|||
25185335|NCT01504412|50334832|FG004|Overall Study|Adverse Event|10|||
25185336|NCT01504412|50334828|FG000|Overall Study|Withdrawal by Subject|2|||
25154779|NCT01513551|50269902|FG000|Overall Study|Randomized but not vaccinated|0|||
25185337|NCT01504412|50334829|FG001|Overall Study|Withdrawal by Subject|1|||
25185338|NCT01504412|50334830|FG002|Overall Study|Withdrawal by Subject|1|||
25185339|NCT01504412|50334831|FG003|Overall Study|Withdrawal by Subject|5|||
25185340|NCT01504412|50334832|FG004|Overall Study|Withdrawal by Subject|1|||
25185341|NCT01504412|50334828|FG000|Overall Study|Other|2|||
25185342|NCT01504412|50334829|FG001|Overall Study|Other|1|||
25185343|NCT01504412|50334830|FG002|Overall Study|Other|1|||
25185344|NCT01504412|50334831|FG003|Overall Study|Other|6|||
25185345|NCT01504412|50334832|FG004|Overall Study|Other|1|||
25185346|NCT01504412|50334828|FG000|Overall Study|Lost to Follow-up|0|||
25185347|NCT01504412|50334829|FG001|Overall Study|Lost to Follow-up|2|||
25185348|NCT01504412|50334830|FG002|Overall Study|Lost to Follow-up|0|||
25185349|NCT01504412|50334831|FG003|Overall Study|Lost to Follow-up|0|||
25185350|NCT01504412|50334832|FG004|Overall Study|Lost to Follow-up|0|||
25185351|NCT01504412|50334828|FG000|Overall Study|Lack of Efficacy|0|||
25185352|NCT01504412|50334829|FG001|Overall Study|Lack of Efficacy|0|||
25185353|NCT01504412|50334830|FG002|Overall Study|Lack of Efficacy|1|||
25185354|NCT01504412|50334831|FG003|Overall Study|Lack of Efficacy|0|||
25185355|NCT01504412|50334832|FG004|Overall Study|Lack of Efficacy|1|||
25185356|NCT01504412|50334828|FG000|Overall Study|Death|0|||
25185357|NCT01504412|50334829|FG001|Overall Study|Death|0|||
25185358|NCT01504412|50334830|FG002|Overall Study|Death|0|||
25185359|NCT01504412|50334831|FG003|Overall Study|Death|1|||
25185360|NCT01504412|50334832|FG004|Overall Study|Death|0|||
25185361|NCT01503164|50334862|FG000|Overall Study|Withdrawal by Subject|2|||
25185362|NCT01503164|50334863|FG001|Overall Study|Withdrawal by Subject|1|||
25185363|NCT00088465|50334869|FG000|Overall Study|Withdrawal by Subject|290|||
25185364|NCT00088465|50334869|FG000|Overall Study|Adverse Event|77|||
25185365|NCT00088465|50334869|FG000|Overall Study|Lost to Follow-up|57|||
25185366|NCT00088465|50334869|FG000|Overall Study|Physician Decision|45|||
25185367|NCT00088465|50334869|FG000|Overall Study|Sponsor Decision|37|||
25185368|NCT00088465|50334869|FG000|Overall Study|Lack of Efficacy|27|||
25185369|NCT00088465|50334869|FG000|Overall Study|Protocol Violation|17|||
25185370|NCT00088465|50334869|FG000|Overall Study|Death|11|||
25185371|NCT00088153|50334897|FG000|Overall Study|Physician Decision|3|||
25185372|NCT00088153|50334898|FG001|Overall Study|Physician Decision|3|||
25185373|NCT00088153|50334897|FG000|Overall Study|Withdrawal by Subject|10|||
25185374|NCT00088153|50334898|FG001|Overall Study|Withdrawal by Subject|10|||
25185375|NCT00088153|50334897|FG000|Overall Study|Lost to Follow-up|11|||
25185376|NCT00088153|50334898|FG001|Overall Study|Lost to Follow-up|12|||
25185377|NCT00087685|50334917|FG000|Overall Study|Adverse Event|5|||
25185378|NCT00087685|50334917|FG000|Overall Study|Non-Compliance|1|||
25185379|NCT00087685|50334917|FG000|Overall Study|Progressive Disease|5|||
25154780|NCT01513551|50269903|FG001|Overall Study|Randomized but not vaccinated|0|||
25154781|NCT01513551|50269904|FG002|Overall Study|Randomized but not vaccinated|1|||
25154782|NCT01513473|50269914|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
25154783|NCT01513473|50269915|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
25154784|NCT01513473|50269914|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
25154785|NCT01513473|50269915|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
25154786|NCT01513473|50269914|FG000|Main Trial (26 Weeks)|Unclassified|0|||
25154787|NCT01513473|50269915|FG001|Main Trial (26 Weeks)|Unclassified|2|||
25154788|NCT01513473|50269914|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
25154789|NCT01513473|50269915|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
25154790|NCT01513473|50269914|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
25154791|NCT01513473|50269915|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
25154792|NCT01513317|50269923|FG000|Overall Study|Withdrawal by Subject|15|||
25154793|NCT01513317|50269924|FG001|Overall Study|Withdrawal by Subject|4|||
25154794|NCT01513317|50269923|FG000|Overall Study|Death|1|||
25154795|NCT01513317|50269924|FG001|Overall Study|Death|1|||
25185380|NCT00087685|50334917|FG000|Overall Study|Withdrawal by Subject|3|||
24923428|NCT00449956|50016942|FG002|Overall Study|Lack of Efficacy|1|||
25185381|NCT01502228|50334921|FG000|Overall Study|Death|1|||
25185382|NCT01502072|50334928|FG000|Overall Study|Withdrawal by Subject|1|||
25185383|NCT01502072|50334929|FG001|Overall Study|Withdrawal by Subject|0|||
25185384|NCT01502072|50334930|FG002|Overall Study|Withdrawal by Subject|0|||
25185385|NCT01502072|50334928|FG000|Overall Study|Death|0|||
24923429|NCT00449956|50016940|FG000|Overall Study|Protocol Violation|1|||
24923430|NCT00449956|50016941|FG001|Overall Study|Protocol Violation|1|||
24923431|NCT00449956|50016942|FG002|Overall Study|Protocol Violation|1|||
25154796|NCT01513317|50269923|FG000|Overall Study|Study terminated by sponsor|18|||
24923432|NCT00449956|50016940|FG000|Overall Study|Withdrawal by Subject|0|||
25185386|NCT01502072|50334929|FG001|Overall Study|Death|1|||
25185387|NCT01502072|50334930|FG002|Overall Study|Death|0|||
25185388|NCT01462370|50334938|FG000|Overall Study|Lack of Qualifying Event|1|||
25185389|NCT01462370|50334939|FG001|Overall Study|Lack of Qualifying Event|1|||
25185390|NCT01462370|50334938|FG000|Overall Study|Physician Decision|0|||
24923433|NCT00449956|50016941|FG001|Overall Study|Withdrawal by Subject|1|||
25154797|NCT01513317|50269924|FG001|Overall Study|Study terminated by sponsor|18|||
25185391|NCT01462370|50334939|FG001|Overall Study|Physician Decision|1|||
25185392|NCT01462370|50334938|FG000|Overall Study|Withdrawal by Subject|0|||
25185393|NCT01462370|50334939|FG001|Overall Study|Withdrawal by Subject|3|||
24923434|NCT00449956|50016942|FG002|Overall Study|Withdrawal by Subject|0|||
25185394|NCT01479764|50334947|FG000|Randomized|Adverse Event|1|||
25185395|NCT01479764|50334948|FG001|Randomized|Adverse Event|1|||
25185396|NCT01479764|50334947|FG000|Randomized|Withdrawal by Subject|1|||
25185397|NCT01479764|50334948|FG001|Randomized|Withdrawal by Subject|0|||
25185398|NCT01479764|50334947|FG000|Treated|Lost to Follow-up|0|||
25185399|NCT01479764|50334948|FG001|Treated|Lost to Follow-up|2|||
25185400|NCT01479530|50334956|FG000|Overall Study|Adverse Event|5|||
25185401|NCT01479530|50334957|FG001|Overall Study|Adverse Event|6|||
25185402|NCT01479530|50334956|FG000|Overall Study|Lack of Efficacy|0|||
25185403|NCT01479530|50334957|FG001|Overall Study|Lack of Efficacy|1|||
25185404|NCT01479530|50334956|FG000|Overall Study|Protocol Violation|2|||
25185405|NCT01479530|50334957|FG001|Overall Study|Protocol Violation|3|||
25185406|NCT01479530|50334956|FG000|Overall Study|Withdrawal of Consent|3|||
25185407|NCT01479530|50334957|FG001|Overall Study|Withdrawal of Consent|2|||
25185408|NCT01479374|50334966|FG000|Overall Study|Adverse Event|2|||
25185409|NCT01479374|50334967|FG001|Overall Study|Adverse Event|1|||
25185410|NCT01479374|50334968|FG002|Overall Study|Adverse Event|0|||
25185411|NCT01479374|50334966|FG000|Overall Study|Lost to Follow-up|1|||
25185412|NCT01479374|50334967|FG001|Overall Study|Lost to Follow-up|2|||
25185413|NCT01479374|50334968|FG002|Overall Study|Lost to Follow-up|0|||
25185414|NCT01479374|50334966|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
25185415|NCT01479374|50334967|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
25185416|NCT01479374|50334968|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
25185417|NCT01479374|50334966|FG000|Overall Study|Other|0|||
25185418|NCT01479374|50334967|FG001|Overall Study|Other|4|||
25185419|NCT01479374|50334968|FG002|Overall Study|Other|5|||
25185420|NCT00087529|50334978|FG000|Overall Study|Death|1|||
25185421|NCT00087529|50334979|FG001|Overall Study|Death|0|||
25185422|NCT00087529|50334978|FG000|Overall Study|Adverse Event|0|||
25185423|NCT00087529|50334979|FG001|Overall Study|Adverse Event|8|||
25185424|NCT00087529|50334978|FG000|Overall Study|Pregnancy|0|||
25185425|NCT00087529|50334979|FG001|Overall Study|Pregnancy|1|||
25185426|NCT00087529|50334978|FG000|Overall Study|Lost to Follow-up|2|||
25185427|NCT00087529|50334979|FG001|Overall Study|Lost to Follow-up|3|||
25185428|NCT00087529|50334978|FG000|Overall Study|Participant Decision|14|||
25185429|NCT00087529|50334979|FG001|Overall Study|Participant Decision|37|||
25185430|NCT00087529|50334978|FG000|Overall Study|Physician Decision|4|||
25185431|NCT00087529|50334979|FG001|Overall Study|Physician Decision|8|||
25185432|NCT00087529|50334978|FG000|Overall Study|Initiation of Excluded Therapy|0|||
25185433|NCT00087529|50334979|FG001|Overall Study|Initiation of Excluded Therapy|1|||
25185434|NCT00087529|50334978|FG000|Overall Study|Participant Noncompliance|0|||
25185435|NCT00087529|50334979|FG001|Overall Study|Participant Noncompliance|1|||
25185436|NCT00087529|50334978|FG000|Overall Study|Disease Progression|5|||
25185437|NCT00087529|50334979|FG001|Overall Study|Disease Progression|4|||
25185438|NCT00087529|50334978|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
25185439|NCT00087529|50334979|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
25185440|NCT01500434|50335002|FG000|Overall Study|Death|1|||
25185441|NCT01500434|50335002|FG000|Overall Study|Withdrawal by Subject|1|||
25185442|NCT01500434|50335002|FG000|Overall Study|Missed 12-month follow-up|5|||
25185443|NCT00087139|50335009|FG000|Overall Study|Adverse Event|18|||
25185444|NCT00087139|50335010|FG001|Overall Study|Adverse Event|17|||
25185445|NCT00087139|50335011|FG002|Overall Study|Adverse Event|13|||
25185446|NCT00087139|50335009|FG000|Overall Study|Death|2|||
25185447|NCT00087139|50335010|FG001|Overall Study|Death|1|||
25185448|NCT00087139|50335011|FG002|Overall Study|Death|0|||
25185449|NCT00087139|50335009|FG000|Overall Study|Withdrawal by Subject|3|||
25185450|NCT00087139|50335010|FG001|Overall Study|Withdrawal by Subject|2|||
25185451|NCT00087139|50335011|FG002|Overall Study|Withdrawal by Subject|2|||
25185452|NCT00087139|50335009|FG000|Overall Study|Physician Decision|1|||
25154798|NCT01513317|50269923|FG000|Overall Study|Other|0|||
25185453|NCT00087139|50335010|FG001|Overall Study|Physician Decision|1|||
25154799|NCT01513317|50269924|FG001|Overall Study|Other|1|||
25154800|NCT01901653|50269943|FG000|Overall Study|Death|2|||
25154801|NCT01901653|50269944|FG001|Overall Study|Death|1|||
25154802|NCT01901653|50269945|FG002|Overall Study|Death|8|||
25154803|NCT01901653|50269946|FG003|Overall Study|Death|3|||
25154804|NCT01901653|50269947|FG004|Overall Study|Death|2|||
25154805|NCT01901653|50269948|FG005|Overall Study|Death|2|||
25154806|NCT01901653|50269949|FG006|Overall Study|Death|6|||
25185454|NCT00087139|50335011|FG002|Overall Study|Physician Decision|1|||
25185455|NCT00087139|50335009|FG000|Overall Study|Disease progression|9|||
25154807|NCT01901653|50269950|FG007|Overall Study|Death|9|||
25154808|NCT01901653|50269951|FG008|Overall Study|Death|1|||
25185456|NCT00087139|50335010|FG001|Overall Study|Disease progression|19|||
25154809|NCT01901653|50269952|FG009|Overall Study|Death|16|||
25154810|NCT01901653|50269953|FG010|Overall Study|Death|2|||
25154811|NCT01901653|50269954|FG011|Overall Study|Death|15|||
25185457|NCT00087139|50335011|FG002|Overall Study|Disease progression|12|||
25185458|NCT00087139|50335009|FG000|Overall Study|Ineligible|4|||
25185459|NCT00087139|50335010|FG001|Overall Study|Ineligible|7|||
25185460|NCT00087139|50335011|FG002|Overall Study|Ineligible|4|||
25185461|NCT00087139|50335009|FG000|Overall Study|Symptomatic deterioration|1|||
25185462|NCT00087139|50335010|FG001|Overall Study|Symptomatic deterioration|1|||
25185463|NCT00087139|50335011|FG002|Overall Study|Symptomatic deterioration|3|||
25185464|NCT00087139|50335009|FG000|Overall Study|Use of coumadin|1|||
25185465|NCT00087139|50335010|FG001|Overall Study|Use of coumadin|0|||
25185466|NCT00087139|50335011|FG002|Overall Study|Use of coumadin|0|||
25185467|NCT00087139|50335009|FG000|Overall Study|Response achieved|0|||
25154812|NCT01901653|50269955|FG012|Overall Study|Death|4|||
25154813|NCT01901653|50269943|FG000|Overall Study|Lost to Follow-up|1|||
25154814|NCT01901653|50269944|FG001|Overall Study|Lost to Follow-up|0|||
25154815|NCT01901653|50269945|FG002|Overall Study|Lost to Follow-up|2|||
25154816|NCT01901653|50269946|FG003|Overall Study|Lost to Follow-up|0|||
25154817|NCT01901653|50269947|FG004|Overall Study|Lost to Follow-up|0|||
25154818|NCT01901653|50269948|FG005|Overall Study|Lost to Follow-up|1|||
25154819|NCT01901653|50269949|FG006|Overall Study|Lost to Follow-up|0|||
25154820|NCT01901653|50269950|FG007|Overall Study|Lost to Follow-up|1|||
25154821|NCT01901653|50269951|FG008|Overall Study|Lost to Follow-up|0|||
25154822|NCT01901653|50269952|FG009|Overall Study|Lost to Follow-up|0|||
25154823|NCT01901653|50269953|FG010|Overall Study|Lost to Follow-up|0|||
25154824|NCT01901653|50269954|FG011|Overall Study|Lost to Follow-up|0|||
25154825|NCT01901653|50269955|FG012|Overall Study|Lost to Follow-up|0|||
25154826|NCT01901653|50269943|FG000|Overall Study|Withdrawal by Subject|0|||
25154827|NCT01901653|50269944|FG001|Overall Study|Withdrawal by Subject|0|||
25185468|NCT00087139|50335010|FG001|Overall Study|Response achieved|1|||
25185469|NCT00087139|50335011|FG002|Overall Study|Response achieved|0|||
25185470|NCT00087139|50335009|FG000|Overall Study|Extradural disease|0|||
25185471|NCT00087139|50335010|FG001|Overall Study|Extradural disease|0|||
25185472|NCT00087139|50335011|FG002|Overall Study|Extradural disease|1|||
25185473|NCT01500278|50335063|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
25185474|NCT01500278|50335064|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
25185475|NCT01500278|50335063|FG000|Week 0 - Week 12|Protocol Violation|10|||
25185476|NCT01500278|50335064|FG001|Week 0 - Week 12|Protocol Violation|16|||
25185477|NCT01500278|50335063|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
25185478|NCT01500278|50335064|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
25185479|NCT01500278|50335063|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
25185480|NCT01500278|50335064|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
25185481|NCT01500278|50335063|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
25185482|NCT01500278|50335064|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
25185483|NCT01500278|50335063|FG000|Week 0 - Week 12|Patient decision|1|||
25185484|NCT01500278|50335064|FG001|Week 0 - Week 12|Patient decision|0|||
25185485|NCT01500278|50335063|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
25185486|NCT01500278|50335064|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
25024032|NCT03349099|50121747|FG001|Overall Study|Stone migrated from the kidney|0|||
25154828|NCT01901653|50269945|FG002|Overall Study|Withdrawal by Subject|0|||
25154829|NCT01901653|50269946|FG003|Overall Study|Withdrawal by Subject|0|||
25154830|NCT01901653|50269947|FG004|Overall Study|Withdrawal by Subject|0|||
25154831|NCT01901653|50269948|FG005|Overall Study|Withdrawal by Subject|0|||
25154832|NCT01901653|50269949|FG006|Overall Study|Withdrawal by Subject|1|||
25154833|NCT01901653|50269950|FG007|Overall Study|Withdrawal by Subject|0|||
25154834|NCT01901653|50269951|FG008|Overall Study|Withdrawal by Subject|0|||
25154835|NCT01901653|50269952|FG009|Overall Study|Withdrawal by Subject|0|||
25154836|NCT01901653|50269953|FG010|Overall Study|Withdrawal by Subject|0|||
25154837|NCT01901653|50269954|FG011|Overall Study|Withdrawal by Subject|0|||
25154838|NCT01901653|50269955|FG012|Overall Study|Withdrawal by Subject|0|||
25154839|NCT01901653|50269943|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
25154840|NCT01901653|50269944|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
25154841|NCT01901653|50269945|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
25154842|NCT01901653|50269946|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
25154843|NCT01901653|50269947|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
25154844|NCT01901653|50269948|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
25154845|NCT01901653|50269949|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
25154846|NCT01901653|50269950|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
25154847|NCT01901653|50269951|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
25154848|NCT01901653|50269952|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
25154849|NCT01901653|50269953|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
25154850|NCT01901653|50269954|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
25154851|NCT01901653|50269955|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
25154852|NCT01925989|50269983|FG000|Period 1|Sponsor Decision|1|||
25185487|NCT01500278|50335063|FG000|Week 0 - Week 12|Investigator decision|1|||
25185488|NCT01500278|50335064|FG001|Week 0 - Week 12|Investigator decision|0|||
25185489|NCT01500278|50335063|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
25275040|NCT00903409|50589093|FG000|Overall Study|Non-compliance with Protocol|1|||
25154853|NCT01925989|50269984|FG001|Period 1|Sponsor Decision|1|||
25185490|NCT01500278|50335064|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
25275041|NCT00903409|50589094|FG001|Overall Study|Non-compliance with Protocol|1|||
25154854|NCT01925989|50269985|FG002|Period 1|Sponsor Decision|0|||
25185491|NCT01500278|50335063|FG000|Week 0 - Week 12|Sponsor decision|1|||
25185492|NCT01500278|50335064|FG001|Week 0 - Week 12|Sponsor decision|0|||
25185493|NCT01500278|50335063|FG000|Week 0 - Week 12|Personal reason|0|||
25185494|NCT01500278|50335064|FG001|Week 0 - Week 12|Personal reason|1|||
25185495|NCT01500278|50335063|FG000|Week 0 - Week 12|Other serious disease|0|||
25185496|NCT01500278|50335064|FG001|Week 0 - Week 12|Other serious disease|1|||
25185497|NCT01500278|50335063|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
25185498|NCT01500278|50335064|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
25185499|NCT01500278|50335063|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
25185500|NCT01500278|50335064|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
25185501|NCT01500278|50335063|FG000|Week 13 - Week 104|Protocol Violation|6|||
25185502|NCT01500278|50335064|FG001|Week 13 - Week 104|Protocol Violation|6|||
25185503|NCT01500278|50335063|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
25185504|NCT01500278|50335064|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
25185505|NCT01500278|50335063|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
25185506|NCT01500278|50335064|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
25185507|NCT01500278|50335063|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
25185508|NCT01500278|50335064|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
25185509|NCT01500278|50335063|FG000|Week 13 - Week 104|Non/bad compliance|7|||
25185510|NCT01500278|50335064|FG001|Week 13 - Week 104|Non/bad compliance|5|||
25185511|NCT01500278|50335063|FG000|Week 13 - Week 104|Recurrent infections|1|||
25185512|NCT01500278|50335064|FG001|Week 13 - Week 104|Recurrent infections|0|||
25185513|NCT01500278|50335063|FG000|Week 13 - Week 104|False positive test|1|||
25185514|NCT01500278|50335064|FG001|Week 13 - Week 104|False positive test|2|||
25185515|NCT01500278|50335063|FG000|Week 13 - Week 104|Sponsor request|4|||
25185516|NCT01500278|50335064|FG001|Week 13 - Week 104|Sponsor request|0|||
25185517|NCT01500278|50335063|FG000|Week 13 - Week 104|Withdrawn in error|1|||
25185518|NCT01500278|50335064|FG001|Week 13 - Week 104|Withdrawn in error|0|||
25185519|NCT01500278|50335063|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
25185520|NCT01500278|50335064|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
24923435|NCT00449956|50016940|FG000|Overall Study|Physician Decision|2|||
24923436|NCT00449956|50016941|FG001|Overall Study|Physician Decision|1|||
24923437|NCT00449956|50016942|FG002|Overall Study|Physician Decision|1|||
24923438|NCT00509145|50016952|FG000|Overall Study|Death|0|||
24923439|NCT00509145|50016953|FG001|Overall Study|Death|2|||
25185521|NCT01500278|50335063|FG000|Week 13 - Week 104|Protocol deviation|1|||
25185522|NCT01500278|50335064|FG001|Week 13 - Week 104|Protocol deviation|0|||
25185523|NCT01500278|50335063|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
25185524|NCT01500278|50335064|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
25185525|NCT01500278|50335063|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
24923440|NCT00509145|50016952|FG000|Overall Study|Adverse Event|42|||
24923441|NCT00509145|50016953|FG001|Overall Study|Adverse Event|28|||
24923442|NCT00509145|50016952|FG000|Overall Study|Withdrawal by Subject|32|||
24923443|NCT00509145|50016953|FG001|Overall Study|Withdrawal by Subject|38|||
24923444|NCT00509145|50016952|FG000|Overall Study|Physician Decision|11|||
24923445|NCT00509145|50016953|FG001|Overall Study|Physician Decision|14|||
24923446|NCT00509145|50016952|FG000|Overall Study|Protocol Violation|1|||
24923447|NCT00509145|50016953|FG001|Overall Study|Protocol Violation|6|||
24923448|NCT00509145|50016952|FG000|Overall Study|Pregnancy|3|||
24923449|NCT00509145|50016953|FG001|Overall Study|Pregnancy|8|||
24923450|NCT00509145|50016952|FG000|Overall Study|Lost to Follow-up|6|||
24923451|NCT00509145|50016953|FG001|Overall Study|Lost to Follow-up|5|||
24923452|NCT00509145|50016952|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
24923453|NCT00509145|50016953|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
24923454|NCT00509145|50016952|FG000|Overall Study|Other|6|||
24923455|NCT00509145|50016953|FG001|Overall Study|Other|6|||
24923456|NCT00509067|50016961|FG000|Overall Study|Lost to Follow-up|1|||
24923457|NCT00509067|50016962|FG001|Overall Study|Lost to Follow-up|1|||
24923458|NCT00509067|50016961|FG000|Overall Study|Adverse Event|3|||
24923459|NCT00509067|50016962|FG001|Overall Study|Adverse Event|1|||
24923460|NCT00509067|50016961|FG000|Overall Study|Protocol Violation|0|||
24923461|NCT00509067|50016962|FG001|Overall Study|Protocol Violation|3|||
24923462|NCT00504309|50016978|FG000|Overall Study|Death|0|||
24923463|NCT00504309|50016979|FG001|Overall Study|Death|0|||
24923464|NCT00504309|50016980|FG002|Overall Study|Death|0|||
24923465|NCT00504309|50016981|FG003|Overall Study|Death|0|||
24923466|NCT00504309|50016982|FG004|Overall Study|Death|1|||
25024033|NCT03348163|50121755|FG000|Overall Study|Withdrawal by Subject|2|||
25024034|NCT03348163|50121756|FG001|Overall Study|Withdrawal by Subject|0|||
25024035|NCT03347695|50121764|FG000|Overall Study|Death|0|||
24923467|NCT00504309|50016983|FG005|Overall Study|Death|0|||
24923468|NCT00504309|50016978|FG000|Overall Study|Withdrawal by Subject|0|||
24923469|NCT00504309|50016979|FG001|Overall Study|Withdrawal by Subject|0|||
24923470|NCT00504309|50016980|FG002|Overall Study|Withdrawal by Subject|1|||
24923471|NCT00504309|50016981|FG003|Overall Study|Withdrawal by Subject|0|||
24923472|NCT00504309|50016982|FG004|Overall Study|Withdrawal by Subject|0|||
24923473|NCT00504309|50016983|FG005|Overall Study|Withdrawal by Subject|0|||
24923474|NCT00508755|50016995|FG000|Overall Study|Withdrawal by Subject|1|||
24923475|NCT00504231|50017005|FG000|Overall Study|Discrepant chart documentation re route|0|||
24923476|NCT00504231|50017006|FG001|Overall Study|Discrepant chart documentation re route|0|||
24923477|NCT00504231|50017007|FG002|Overall Study|Discrepant chart documentation re route|1|||
24923478|NCT00504231|50017008|FG003|Overall Study|Discrepant chart documentation re route|0|||
24923479|NCT00568178|50017060|FG000|Double Blind Base Study|Adverse Event|0|||
24923480|NCT00568178|50017061|FG001|Double Blind Base Study|Adverse Event|2|||
24923481|NCT00568178|50017062|FG002|Double Blind Base Study|Adverse Event|1|||
24923482|NCT00568178|50017063|FG003|Double Blind Base Study|Adverse Event|2|||
24923483|NCT00568178|50017064|FG004|Double Blind Base Study|Adverse Event|0|||
24923484|NCT00568178|50017065|FG005|Double Blind Base Study|Adverse Event|0|||
24923485|NCT00568178|50017060|FG000|Double Blind Base Study|Lost to Follow-up|1|||
24923486|NCT00568178|50017061|FG001|Double Blind Base Study|Lost to Follow-up|0|||
24923487|NCT00568178|50017062|FG002|Double Blind Base Study|Lost to Follow-up|0|||
24923488|NCT00568178|50017063|FG003|Double Blind Base Study|Lost to Follow-up|1|||
24923489|NCT00568178|50017064|FG004|Double Blind Base Study|Lost to Follow-up|0|||
24923490|NCT00568178|50017065|FG005|Double Blind Base Study|Lost to Follow-up|0|||
24923491|NCT00568178|50017060|FG000|Double Blind Base Study|Physician Decision|1|||
24923492|NCT00568178|50017061|FG001|Double Blind Base Study|Physician Decision|1|||
24923493|NCT00568178|50017062|FG002|Double Blind Base Study|Physician Decision|0|||
24923494|NCT00568178|50017063|FG003|Double Blind Base Study|Physician Decision|1|||
24923495|NCT00568178|50017064|FG004|Double Blind Base Study|Physician Decision|0|||
24923496|NCT00568178|50017065|FG005|Double Blind Base Study|Physician Decision|0|||
24923497|NCT00568178|50017060|FG000|Double Blind Base Study|Protocol Violation|3|||
24923498|NCT00568178|50017061|FG001|Double Blind Base Study|Protocol Violation|2|||
24923499|NCT00568178|50017062|FG002|Double Blind Base Study|Protocol Violation|0|||
25024036|NCT03347695|50121765|FG001|Overall Study|Death|4|||
25024037|NCT03347695|50121764|FG000|Overall Study|Lost to Follow-up|0|||
24923500|NCT00568178|50017063|FG003|Double Blind Base Study|Protocol Violation|0|||
24923501|NCT00568178|50017064|FG004|Double Blind Base Study|Protocol Violation|0|||
25024038|NCT03347695|50121765|FG001|Overall Study|Lost to Follow-up|1|||
24923502|NCT00568178|50017065|FG005|Double Blind Base Study|Protocol Violation|0|||
24923503|NCT00568178|50017060|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
24923504|NCT00568178|50017061|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
24923505|NCT00568178|50017062|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
24923506|NCT00568178|50017063|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
24923507|NCT00568178|50017064|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
24923508|NCT00568178|50017065|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
24923509|NCT00568178|50017060|FG000|Double Blind Base Study|Progressive Disease|0|||
25024039|NCT02892019|50121775|FG000|Overall Study|randomized but not treated|0|||
24923510|NCT00568178|50017061|FG001|Double Blind Base Study|Progressive Disease|0|||
24923511|NCT00568178|50017062|FG002|Double Blind Base Study|Progressive Disease|0|||
24923512|NCT00568178|50017063|FG003|Double Blind Base Study|Progressive Disease|1|||
24923513|NCT00568178|50017064|FG004|Double Blind Base Study|Progressive Disease|0|||
24923514|NCT00568178|50017065|FG005|Double Blind Base Study|Progressive Disease|0|||
24923515|NCT00568178|50017060|FG000|Open Label Extension|Adverse Event|0|||
24923516|NCT00568178|50017061|FG001|Open Label Extension|Adverse Event|0|||
24923517|NCT00568178|50017062|FG002|Open Label Extension|Adverse Event|0|||
24923518|NCT00568178|50017063|FG003|Open Label Extension|Adverse Event|0|||
24923519|NCT00568178|50017064|FG004|Open Label Extension|Adverse Event|11|||
24923520|NCT00568178|50017065|FG005|Open Label Extension|Adverse Event|8|||
24923521|NCT00568178|50017060|FG000|Open Label Extension|Protocol Violation|0|||
24923522|NCT00568178|50017061|FG001|Open Label Extension|Protocol Violation|0|||
24923523|NCT00568178|50017062|FG002|Open Label Extension|Protocol Violation|0|||
24923524|NCT00568178|50017063|FG003|Open Label Extension|Protocol Violation|0|||
24923525|NCT00568178|50017064|FG004|Open Label Extension|Protocol Violation|1|||
24923526|NCT00568178|50017065|FG005|Open Label Extension|Protocol Violation|0|||
24923527|NCT00568178|50017060|FG000|Open Label Extension|Lost to Follow-up|0|||
24923528|NCT00568178|50017061|FG001|Open Label Extension|Lost to Follow-up|0|||
24923529|NCT00568178|50017062|FG002|Open Label Extension|Lost to Follow-up|0|||
24923530|NCT00568178|50017063|FG003|Open Label Extension|Lost to Follow-up|0|||
24923531|NCT00568178|50017064|FG004|Open Label Extension|Lost to Follow-up|6|||
24923532|NCT00568178|50017065|FG005|Open Label Extension|Lost to Follow-up|11|||
24923533|NCT00568178|50017060|FG000|Open Label Extension|Physician Decision|0|||
24923534|NCT00568178|50017061|FG001|Open Label Extension|Physician Decision|0|||
24923535|NCT00568178|50017062|FG002|Open Label Extension|Physician Decision|0|||
24923536|NCT00568178|50017063|FG003|Open Label Extension|Physician Decision|0|||
24923537|NCT00568178|50017064|FG004|Open Label Extension|Physician Decision|9|||
24923538|NCT00568178|50017065|FG005|Open Label Extension|Physician Decision|8|||
24923539|NCT00568178|50017060|FG000|Open Label Extension|Pregnancy|0|||
24923540|NCT00568178|50017061|FG001|Open Label Extension|Pregnancy|0|||
24923541|NCT00568178|50017062|FG002|Open Label Extension|Pregnancy|0|||
24923542|NCT00568178|50017063|FG003|Open Label Extension|Pregnancy|0|||
25154855|NCT01925989|50269983|FG000|Period 1|Withdrawal by Subject|0|||
25154856|NCT01925989|50269984|FG001|Period 1|Withdrawal by Subject|1|||
24923543|NCT00568178|50017064|FG004|Open Label Extension|Pregnancy|0|||
24923544|NCT00568178|50017065|FG005|Open Label Extension|Pregnancy|1|||
24923545|NCT00568178|50017060|FG000|Open Label Extension|Progressive Disease|0|||
24923546|NCT00568178|50017061|FG001|Open Label Extension|Progressive Disease|0|||
24923547|NCT00568178|50017062|FG002|Open Label Extension|Progressive Disease|0|||
24923548|NCT00568178|50017063|FG003|Open Label Extension|Progressive Disease|0|||
24923549|NCT00568178|50017064|FG004|Open Label Extension|Progressive Disease|3|||
24923550|NCT00568178|50017065|FG005|Open Label Extension|Progressive Disease|1|||
24923551|NCT00568178|50017060|FG000|Open Label Extension|Termination of Trial|0|||
24923552|NCT00568178|50017061|FG001|Open Label Extension|Termination of Trial|0|||
24923553|NCT00568178|50017062|FG002|Open Label Extension|Termination of Trial|0|||
24923554|NCT00568178|50017063|FG003|Open Label Extension|Termination of Trial|0|||
24923555|NCT00568178|50017064|FG004|Open Label Extension|Termination of Trial|45|||
24923556|NCT00568178|50017065|FG005|Open Label Extension|Termination of Trial|47|||
24923557|NCT00568178|50017060|FG000|Open Label Extension|Withdrawal by Subject|0|||
24923558|NCT00568178|50017061|FG001|Open Label Extension|Withdrawal by Subject|0|||
24923559|NCT00568178|50017062|FG002|Open Label Extension|Withdrawal by Subject|0|||
24923560|NCT00568178|50017063|FG003|Open Label Extension|Withdrawal by Subject|0|||
24923561|NCT00568178|50017064|FG004|Open Label Extension|Withdrawal by Subject|4|||
24923562|NCT00568178|50017065|FG005|Open Label Extension|Withdrawal by Subject|4|||
24923563|NCT00577889|50017082|FG000|Overall Study|Withdrawal by Subject|1|||
24923564|NCT00577889|50017083|FG001|Overall Study|Withdrawal by Subject|0|||
24923565|NCT00577889|50017084|FG002|Overall Study|Withdrawal by Subject|0|||
24923566|NCT00460564|50017096|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
24923567|NCT00460564|50017097|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
24923568|NCT00460564|50017098|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
24923569|NCT00460564|50017099|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
24923570|NCT00460564|50017100|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
24923571|NCT00460564|50017101|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
24923572|NCT00460564|50017102|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
24923573|NCT00460564|50017103|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
24923574|NCT00460564|50017096|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
24923575|NCT00460564|50017097|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
24923576|NCT00460564|50017098|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
24923577|NCT00460564|50017099|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
24923578|NCT00460564|50017100|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
24923579|NCT00460564|50017101|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
24923580|NCT00460564|50017102|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
24923581|NCT00460564|50017103|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
24923582|NCT00460564|50017096|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
24923583|NCT00460564|50017097|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
24923584|NCT00460564|50017098|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
24923585|NCT00460564|50017099|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
24923586|NCT00460564|50017100|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
25024040|NCT02892019|50121776|FG001|Overall Study|randomized but not treated|1|||
25024041|NCT02892019|50121775|FG000|Overall Study|Withdrawal by Subject|0|||
25024042|NCT02892019|50121776|FG001|Overall Study|Withdrawal by Subject|1|||
25024043|NCT02892019|50121775|FG000|Overall Study|Adverse Event|1|||
24923587|NCT00460564|50017101|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
24923588|NCT00460564|50017102|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
24923589|NCT00460564|50017103|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
24923590|NCT00460564|50017096|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
24923591|NCT00460564|50017097|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
24923592|NCT00460564|50017098|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
25024044|NCT02892019|50121776|FG001|Overall Study|Adverse Event|1|||
25024045|NCT03365791|50121782|FG000|Overall Study|Adverse Event|5|||
25024046|NCT03365791|50121782|FG000|Overall Study|Death|1|||
25024047|NCT03365791|50121782|FG000|Overall Study|Lost to Follow-up|1|||
25024048|NCT03365791|50121782|FG000|Overall Study|Physician Decision|9|||
24923593|NCT00460564|50017099|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
24923594|NCT00460564|50017100|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
24923595|NCT00460564|50017101|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
24923596|NCT00460564|50017102|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
24923597|NCT00460564|50017103|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
24923598|NCT00460564|50017096|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
24923599|NCT00460564|50017097|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
24923600|NCT00460564|50017098|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
24923601|NCT00460564|50017099|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
24923602|NCT00460564|50017100|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
24923603|NCT00460564|50017101|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
24923604|NCT00460564|50017102|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
24923605|NCT00460564|50017103|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
24923606|NCT00567476|50017125|FG000|Overall Study|Adverse Event|2|||
24923607|NCT00567476|50017126|FG001|Overall Study|Adverse Event|0|||
24923608|NCT00567476|50017125|FG000|Overall Study|Pregnancy|1|||
24923609|NCT00567476|50017126|FG001|Overall Study|Pregnancy|0|||
24923610|NCT00567476|50017125|FG000|Overall Study|Protocol Violation|4|||
24923611|NCT00567476|50017126|FG001|Overall Study|Protocol Violation|1|||
24923612|NCT00567476|50017125|FG000|Overall Study|Lost to Follow-up|0|||
24923613|NCT00567476|50017126|FG001|Overall Study|Lost to Follow-up|1|||
24923614|NCT00567476|50017125|FG000|Overall Study|Administrative issues|1|||
24923615|NCT00567476|50017126|FG001|Overall Study|Administrative issues|0|||
24923616|NCT00567476|50017125|FG000|Overall Study|Medical Decision|0|||
24923617|NCT00567476|50017126|FG001|Overall Study|Medical Decision|1|||
24923618|NCT00567476|50017125|FG000|Overall Study|Non-adherence to protocol|0|||
24923619|NCT00567476|50017126|FG001|Overall Study|Non-adherence to protocol|1|||
24923620|NCT00516321|50017134|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
24923621|NCT00516321|50017135|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
24923622|NCT00516321|50017136|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
24923623|NCT00516321|50017134|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
24923624|NCT00516321|50017135|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
24923625|NCT00516321|50017136|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
24923626|NCT00516321|50017134|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
24923627|NCT00516321|50017135|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
24923628|NCT00516321|50017136|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
24923629|NCT00516321|50017134|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
24923630|NCT00516321|50017135|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
24923631|NCT00516321|50017136|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
24923632|NCT00516321|50017134|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
24923633|NCT00516321|50017135|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
24923634|NCT00516321|50017136|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
24923635|NCT00516321|50017134|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
24923636|NCT00516321|50017135|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
24923637|NCT00516321|50017136|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
25024049|NCT03365791|50121782|FG000|Overall Study|Progressive disease|51|||
25024050|NCT03365791|50121782|FG000|Overall Study|Subject/guardian decision|5|||
25024051|NCT03365011|50121789|FG000|Overall Study|Withdrawal by Subject|1|||
25024052|NCT03365011|50121790|FG001|Overall Study|Withdrawal by Subject|2|||
25024053|NCT03627767|50121799|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
24923638|NCT00516321|50017134|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
24923639|NCT00516321|50017135|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
24923640|NCT00516321|50017136|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
24923641|NCT00516321|50017134|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
24923642|NCT00516321|50017135|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
24923643|NCT00516321|50017136|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
24923644|NCT00516321|50017134|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
24923645|NCT00516321|50017135|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
24923646|NCT00516321|50017136|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
24923647|NCT00516321|50017134|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
24923648|NCT00516321|50017135|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
24923649|NCT00516321|50017136|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
24923650|NCT00516321|50017134|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
24923651|NCT00516321|50017135|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
24923652|NCT00516321|50017136|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
24923653|NCT00460408|50017148|FG000|Overall Study|Adverse Event|1|||
24923654|NCT00460408|50017149|FG001|Overall Study|Adverse Event|0|||
24923655|NCT00460408|50017150|FG002|Overall Study|Adverse Event|0|||
24923656|NCT00460408|50017151|FG003|Overall Study|Adverse Event|0|||
24923657|NCT00460408|50017148|FG000|Overall Study|Death|7|||
24923658|NCT00460408|50017149|FG001|Overall Study|Death|0|||
24923659|NCT00460408|50017150|FG002|Overall Study|Death|0|||
24923660|NCT00460408|50017151|FG003|Overall Study|Death|0|||
24923661|NCT00460408|50017148|FG000|Overall Study|Lost to Follow-up|11|||
24923662|NCT00460408|50017149|FG001|Overall Study|Lost to Follow-up|0|||
24923663|NCT00460408|50017150|FG002|Overall Study|Lost to Follow-up|1|||
24923664|NCT00460408|50017151|FG003|Overall Study|Lost to Follow-up|0|||
24923665|NCT00460408|50017148|FG000|Overall Study|Withdrawal by Subject|31|||
24923666|NCT00460408|50017149|FG001|Overall Study|Withdrawal by Subject|0|||
24923667|NCT00460408|50017150|FG002|Overall Study|Withdrawal by Subject|0|||
24923668|NCT00460408|50017151|FG003|Overall Study|Withdrawal by Subject|0|||
24923669|NCT00460408|50017148|FG000|Overall Study|Insufficient clinical response|5|||
24923670|NCT00460408|50017149|FG001|Overall Study|Insufficient clinical response|1|||
24923671|NCT00460408|50017150|FG002|Overall Study|Insufficient clinical response|5|||
25024054|NCT03627767|50121800|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
25024055|NCT03627767|50121801|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
25024056|NCT03627767|50121802|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
25024057|NCT03627767|50121803|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
25024058|NCT03627767|50121799|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
25024059|NCT03627767|50121800|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
25024060|NCT03627767|50121801|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
25024061|NCT03627767|50121802|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
25024062|NCT03627767|50121803|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
25024063|NCT03627767|50121799|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
25024064|NCT03627767|50121800|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
25024065|NCT03627767|50121801|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
25024066|NCT03627767|50121802|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
25024067|NCT03627767|50121803|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
25024068|NCT03627767|50121799|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
25024069|NCT03627767|50121800|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
24923672|NCT00460408|50017151|FG003|Overall Study|Insufficient clinical response|0|||
24923673|NCT00460408|50017148|FG000|Overall Study|Other|12|||
24923674|NCT00460408|50017149|FG001|Overall Study|Other|2|||
24923675|NCT00460408|50017150|FG002|Overall Study|Other|0|||
24923676|NCT00460408|50017151|FG003|Overall Study|Other|0|||
24923677|NCT00507819|50017161|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
24923678|NCT00507819|50017162|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
25024070|NCT03627767|50121801|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
25024071|NCT03627767|50121802|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
25024072|NCT03627767|50121803|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
25024073|NCT03627767|50121799|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
25024074|NCT03627767|50121800|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
24923679|NCT00442936|50017192|FG000|Overall Study|Protocol Violation|1|||
24923680|NCT00442936|50017193|FG001|Overall Study|Protocol Violation|0|||
25024075|NCT03627767|50121801|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
25024076|NCT03627767|50121802|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
24923681|NCT00442936|50017194|FG002|Overall Study|Protocol Violation|1|||
24923682|NCT00442936|50017195|FG003|Overall Study|Protocol Violation|1|||
24923683|NCT00577655|50017207|FG000|Overall Study|Patient Request|0|||
24923684|NCT00577655|50017208|FG001|Overall Study|Patient Request|2|||
24923685|NCT00577655|50017207|FG000|Overall Study|Protocol Violation|0|||
25024077|NCT03627767|50121803|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
25024078|NCT03627767|50121799|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
25024079|NCT03627767|50121800|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
25024080|NCT03627767|50121801|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
25024081|NCT03627767|50121802|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
25024082|NCT03627767|50121803|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
25024083|NCT03627767|50121799|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
25024084|NCT03627767|50121800|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
25024085|NCT03627767|50121801|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
25024086|NCT03627767|50121802|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
25024087|NCT03627767|50121803|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
25024088|NCT03627767|50121799|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
25024089|NCT03627767|50121800|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
25024090|NCT03627767|50121801|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
25024091|NCT03627767|50121802|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
25024092|NCT03627767|50121803|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
25024093|NCT03627767|50121799|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
25024094|NCT03627767|50121800|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
25024095|NCT03627767|50121801|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
25024096|NCT03627767|50121802|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
25024097|NCT03627767|50121803|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
25024098|NCT03627767|50121799|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
25024099|NCT03627767|50121800|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
25024100|NCT03627767|50121801|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
24923686|NCT00577655|50017208|FG001|Overall Study|Protocol Violation|1|||
24923687|NCT00577655|50017207|FG000|Overall Study|Lost to Follow-up|1|||
24923688|NCT00577655|50017208|FG001|Overall Study|Lost to Follow-up|1|||
24923689|NCT00113269|50017219|FG000|Overall Study|Not transplanted, donor issues|4|||
24923690|NCT00113269|50017220|FG001|Overall Study|Not transplanted, donor issues|0|||
24923691|NCT00113269|50017221|FG002|Overall Study|Not transplanted, donor issues|2|||
24923692|NCT00113269|50017222|FG003|Overall Study|Not transplanted, donor issues|2|||
24923693|NCT00113269|50017219|FG000|Overall Study|Not transplanted, recipient issues|2|||
25024101|NCT03627767|50121802|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
25024102|NCT03627767|50121803|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
25024103|NCT03627767|50121799|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
25024104|NCT03627767|50121800|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
25024105|NCT03627767|50121801|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
25024106|NCT03627767|50121802|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
25024107|NCT03627767|50121803|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
25024108|NCT03627767|50121799|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
25024109|NCT03627767|50121800|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
25024110|NCT03627767|50121801|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
25024111|NCT03627767|50121802|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
25024112|NCT03627767|50121803|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
25024113|NCT03627767|50121799|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
25024114|NCT03627767|50121800|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
25024115|NCT03627767|50121801|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
25024116|NCT03627767|50121802|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
25024117|NCT03627767|50121803|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
25185526|NCT01500278|50335064|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
24923694|NCT00113269|50017220|FG001|Overall Study|Not transplanted, recipient issues|1|||
24923695|NCT00113269|50017221|FG002|Overall Study|Not transplanted, recipient issues|7|||
24923696|NCT00113269|50017222|FG003|Overall Study|Not transplanted, recipient issues|4|||
25024118|NCT03627767|50121799|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
25024119|NCT03627767|50121800|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
25024120|NCT03627767|50121801|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
25024121|NCT03627767|50121802|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
25024122|NCT03627767|50121803|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
25024123|NCT03627767|50121799|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
25024124|NCT03627767|50121800|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
25024125|NCT03627767|50121801|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
25024126|NCT03627767|50121802|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
25024127|NCT03627767|50121803|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
25024128|NCT03627767|50121799|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
25024129|NCT03627767|50121800|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
25024130|NCT03627767|50121801|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
25024131|NCT03627767|50121802|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
25024132|NCT03627767|50121803|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
25024133|NCT03627767|50121799|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
25024134|NCT03627767|50121800|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
25024135|NCT03627767|50121801|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
25024136|NCT03627767|50121802|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
25024137|NCT03627767|50121803|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
25024138|NCT03627767|50121799|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
25024139|NCT03627767|50121800|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
25024140|NCT03627767|50121801|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
25024141|NCT03627767|50121802|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
25024142|NCT03627767|50121803|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
25024143|NCT03627767|50121799|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
25024144|NCT03627767|50121800|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
25024145|NCT03627767|50121801|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
25024146|NCT03627767|50121802|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
25024147|NCT03627767|50121803|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
25024148|NCT03627767|50121799|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
25024149|NCT03627767|50121800|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
25024150|NCT03627767|50121801|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
25024151|NCT03627767|50121802|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
25024152|NCT03627767|50121803|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
25024153|NCT03627065|50121814|FG000|Overall Study|Study Terminated by sponsor|1|||
25024154|NCT03627065|50121814|FG000|Overall Study|Withdrawal by Subject|2|||
25024155|NCT03624881|50121820|FG000|Overall Study|Screen Failure|14|||
25024156|NCT03624881|50121821|FG001|Overall Study|Screen Failure|0|||
25024157|NCT03624881|50121820|FG000|Overall Study|No Catheter Inserted|6|||
25024158|NCT03624881|50121821|FG001|Overall Study|No Catheter Inserted|1|||
25024159|NCT03624881|50121820|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
25024160|NCT03624881|50121821|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
25024161|NCT03624881|50121820|FG000|Overall Study|Death|2|||
25024162|NCT03624881|50121821|FG001|Overall Study|Death|0|||
25024163|NCT03624881|50121820|FG000|Overall Study|Lost to Follow-up|10|||
25024164|NCT03624881|50121821|FG001|Overall Study|Lost to Follow-up|4|||
25024165|NCT03624881|50121820|FG000|Overall Study|Withdrawal by Subject|12|||
25024166|NCT03624881|50121821|FG001|Overall Study|Withdrawal by Subject|1|||
25024167|NCT02142738|50121829|FG000|Overall Study|Adverse Event|13|||
25024168|NCT02142738|50121830|FG001|Overall Study|Adverse Event|9|||
25024169|NCT02142738|50121829|FG000|Overall Study|Death|92|||
25024170|NCT02142738|50121830|FG001|Overall Study|Death|112|||
25024171|NCT02142738|50121829|FG000|Overall Study|Lost to Follow-up|0|||
25024172|NCT02142738|50121830|FG001|Overall Study|Lost to Follow-up|3|||
25024173|NCT02142738|50121829|FG000|Overall Study|Withdrawal by Subject|6|||
25024174|NCT02142738|50121830|FG001|Overall Study|Withdrawal by Subject|7|||
24923697|NCT00113269|50017219|FG000|Overall Study|Early graft loss, technical|0|||
24923698|NCT00113269|50017220|FG001|Overall Study|Early graft loss, technical|0|||
24923699|NCT00113269|50017221|FG002|Overall Study|Early graft loss, technical|2|||
24923700|NCT00113269|50017222|FG003|Overall Study|Early graft loss, technical|0|||
24923701|NCT00113269|50017219|FG000|Overall Study|Death in operating room|0|||
24923702|NCT00113269|50017220|FG001|Overall Study|Death in operating room|0|||
24923703|NCT00113269|50017221|FG002|Overall Study|Death in operating room|0|||
24923704|NCT00113269|50017222|FG003|Overall Study|Death in operating room|1|||
24923705|NCT00113269|50017219|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
25024175|NCT02142738|50121829|FG000|Overall Study|Follow up ended by sponsor|43|||
25024176|NCT02142738|50121830|FG001|Overall Study|Follow up ended by sponsor|20|||
25024177|NCT03617861|50121841|FG000|Second Intervention (1 Day)|Adverse Event|0|||
25024178|NCT03617861|50121842|FG001|Second Intervention (1 Day)|Adverse Event|0|||
24923706|NCT00113269|50017220|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
24923707|NCT00113269|50017221|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
24923708|NCT00113269|50017222|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
24923709|NCT00113269|50017219|FG000|Overall Study|Adverse Event|2|||
24923710|NCT00113269|50017220|FG001|Overall Study|Adverse Event|7|||
24923711|NCT00113269|50017221|FG002|Overall Study|Adverse Event|11|||
24923712|NCT00113269|50017222|FG003|Overall Study|Adverse Event|7|||
24923713|NCT00113269|50017219|FG000|Overall Study|Withdrawal by Subject|4|||
24923714|NCT00113269|50017220|FG001|Overall Study|Withdrawal by Subject|3|||
24923715|NCT00113269|50017221|FG002|Overall Study|Withdrawal by Subject|4|||
24923716|NCT00113269|50017222|FG003|Overall Study|Withdrawal by Subject|2|||
24923717|NCT00113269|50017219|FG000|Overall Study|Graft loss|6|||
24923718|NCT00113269|50017220|FG001|Overall Study|Graft loss|6|||
24923719|NCT00113269|50017221|FG002|Overall Study|Graft loss|4|||
24923720|NCT00113269|50017222|FG003|Overall Study|Graft loss|9|||
24923721|NCT00113269|50017219|FG000|Overall Study|Protocol Violation|1|||
24923722|NCT00113269|50017220|FG001|Overall Study|Protocol Violation|0|||
24923723|NCT00113269|50017221|FG002|Overall Study|Protocol Violation|4|||
24923724|NCT00113269|50017222|FG003|Overall Study|Protocol Violation|2|||
24923725|NCT00113269|50017219|FG000|Overall Study|Lost to Follow-up|2|||
24923726|NCT00113269|50017220|FG001|Overall Study|Lost to Follow-up|3|||
24923727|NCT00113269|50017221|FG002|Overall Study|Lost to Follow-up|6|||
24923728|NCT00113269|50017222|FG003|Overall Study|Lost to Follow-up|3|||
24923729|NCT00113269|50017219|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
24923730|NCT00113269|50017220|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
24923731|NCT00113269|50017221|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
24923732|NCT00113269|50017222|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
24923733|NCT00113269|50017219|FG000|Overall Study|Discontinued due to rejection|0|||
24923734|NCT00113269|50017220|FG001|Overall Study|Discontinued due to rejection|0|||
24923735|NCT00113269|50017221|FG002|Overall Study|Discontinued due to rejection|1|||
24923736|NCT00113269|50017222|FG003|Overall Study|Discontinued due to rejection|0|||
24923737|NCT00113269|50017219|FG000|Overall Study|Moved|0|||
24923738|NCT00113269|50017220|FG001|Overall Study|Moved|1|||
24923739|NCT00113269|50017221|FG002|Overall Study|Moved|0|||
24923740|NCT00113269|50017222|FG003|Overall Study|Moved|3|||
24923741|NCT00113269|50017219|FG000|Overall Study|Received pancreas transplant|0|||
24923742|NCT00113269|50017220|FG001|Overall Study|Received pancreas transplant|0|||
24923743|NCT00113269|50017221|FG002|Overall Study|Received pancreas transplant|0|||
24923744|NCT00113269|50017222|FG003|Overall Study|Received pancreas transplant|2|||
24923745|NCT00113269|50017219|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
24923746|NCT00113269|50017220|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
24923747|NCT00113269|50017221|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
24923748|NCT00113269|50017222|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
24923749|NCT00113269|50017219|FG000|Overall Study|Did not meet eligibility criteria|1|||
24923750|NCT00113269|50017220|FG001|Overall Study|Did not meet eligibility criteria|0|||
24923751|NCT00113269|50017221|FG002|Overall Study|Did not meet eligibility criteria|0|||
24923752|NCT00113269|50017222|FG003|Overall Study|Did not meet eligibility criteria|1|||
24923753|NCT00113269|50017219|FG000|Overall Study|Unable to return for follow up|2|||
24923754|NCT00113269|50017220|FG001|Overall Study|Unable to return for follow up|1|||
25024179|NCT03617861|50121843|FG002|Second Intervention (1 Day)|Adverse Event|1|||
25024180|NCT03617861|50121844|FG003|Second Intervention (1 Day)|Adverse Event|0|||
24923755|NCT00113269|50017221|FG002|Overall Study|Unable to return for follow up|0|||
24923756|NCT00113269|50017222|FG003|Overall Study|Unable to return for follow up|0|||
24923757|NCT00515619|50017232|FG000|Overall Study|Adverse Event|34|||
24923758|NCT00515619|50017232|FG000|Overall Study|Lack of Efficacy|92|||
24923759|NCT00515619|50017232|FG000|Overall Study|Withdrawal by Subject|66|||
24923760|NCT00515619|50017232|FG000|Overall Study|Protocol Violation|3|||
24923761|NCT00515619|50017232|FG000|Overall Study|Lost to Follow-up|4|||
24923762|NCT00515619|50017232|FG000|Overall Study|Unsatisfactory compliance|6|||
24923763|NCT00515619|50017232|FG000|Overall Study|Other: Site discontinuing trials|2|||
24923764|NCT00515619|50017232|FG000|Overall Study|Other: Subject cannot attend visits|2|||
24923765|NCT00515619|50017232|FG000|Overall Study|Other: Subject required surgery|1|||
24923766|NCT00515619|50017232|FG000|Overall Study|Other: Subject moved to another country|1|||
25275042|NCT00903409|50589093|FG000|Overall Study|Laboratory Abnormality|2|||
25275043|NCT00903409|50589094|FG001|Overall Study|Laboratory Abnormality|0|||
24923767|NCT00515619|50017232|FG000|Overall Study|Other: Investigator decision|1|||
24923768|NCT00515619|50017232|FG000|Overall Study|Other: Subject became pregnant|1|||
24923769|NCT00515619|50017232|FG000|Overall Study|Other: Request from sponsor|1|||
24923770|NCT00515619|50017232|FG000|Overall Study|Other: Drug available on license|1|||
24923771|NCT00515619|50017232|FG000|Overall Study|Other: Subject interested in other AED|1|||
24923772|NCT00449644|50017240|FG000|Overall Study|Adverse Event|0|||
24923773|NCT00449644|50017241|FG001|Overall Study|Adverse Event|0|||
24923774|NCT00449644|50017242|FG002|Overall Study|Adverse Event|3|||
24923775|NCT00449644|50017243|FG003|Overall Study|Adverse Event|5|||
24923776|NCT00449644|50017240|FG000|Overall Study|Death|1|||
24923777|NCT00449644|50017241|FG001|Overall Study|Death|0|||
24923778|NCT00449644|50017242|FG002|Overall Study|Death|6|||
24923779|NCT00449644|50017243|FG003|Overall Study|Death|1|||
24923780|NCT00449644|50017240|FG000|Overall Study|Lost to Follow-up|1|||
24923781|NCT00449644|50017241|FG001|Overall Study|Lost to Follow-up|1|||
24923782|NCT00449644|50017242|FG002|Overall Study|Lost to Follow-up|5|||
24923783|NCT00449644|50017243|FG003|Overall Study|Lost to Follow-up|3|||
24923784|NCT00449644|50017240|FG000|Overall Study|Pregnancy|0|||
24923785|NCT00449644|50017241|FG001|Overall Study|Pregnancy|0|||
24923786|NCT00449644|50017242|FG002|Overall Study|Pregnancy|3|||
24923787|NCT00449644|50017243|FG003|Overall Study|Pregnancy|2|||
24923788|NCT00449644|50017240|FG000|Overall Study|Protocol Violation|4|||
24923789|NCT00449644|50017241|FG001|Overall Study|Protocol Violation|4|||
24923790|NCT00449644|50017242|FG002|Overall Study|Protocol Violation|3|||
24923791|NCT00449644|50017243|FG003|Overall Study|Protocol Violation|7|||
24923792|NCT00449644|50017240|FG000|Overall Study|Withdrawal by Subject|3|||
24923793|NCT00449644|50017241|FG001|Overall Study|Withdrawal by Subject|4|||
24923794|NCT00449644|50017242|FG002|Overall Study|Withdrawal by Subject|6|||
24923795|NCT00449644|50017243|FG003|Overall Study|Withdrawal by Subject|7|||
24923796|NCT00449644|50017240|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
25154857|NCT01925989|50269985|FG002|Period 1|Withdrawal by Subject|0|||
25154858|NCT01901419|50269999|FG000|Overall Study|Protocol Violation|2|||
25154859|NCT01901419|50270000|FG001|Overall Study|Protocol Violation|6|||
25154860|NCT01901419|50269999|FG000|Overall Study|unavailable researchers|6|||
25154861|NCT01901419|50270000|FG001|Overall Study|unavailable researchers|3|||
25154862|NCT01901341|50270027|FG000|Overall Study|Adverse Event|4|||
25154863|NCT01901341|50270028|FG001|Overall Study|Adverse Event|2|||
25154864|NCT01901341|50270027|FG000|Overall Study|Lack of Efficacy|0|||
25154865|NCT01901341|50270028|FG001|Overall Study|Lack of Efficacy|2|||
25154866|NCT01901341|50270027|FG000|Overall Study|Lost to Follow-up|0|||
25154867|NCT01901341|50270028|FG001|Overall Study|Lost to Follow-up|1|||
25154868|NCT01901341|50270027|FG000|Overall Study|Protocol Violation|2|||
25154869|NCT01901341|50270028|FG001|Overall Study|Protocol Violation|0|||
25154870|NCT01901341|50270027|FG000|Overall Study|Study Terminated by Sponsor|13|||
24923797|NCT00449644|50017241|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
24923798|NCT00449644|50017242|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
24923799|NCT00449644|50017243|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
24923800|NCT00449644|50017240|FG000|Overall Study|Other|1|||
24923801|NCT00449644|50017241|FG001|Overall Study|Other|4|||
24923802|NCT00449644|50017242|FG002|Overall Study|Other|1|||
25024183|NCT03614975|50121860|FG000|Overall Study|Physician Decision|7|||
25024184|NCT03614975|50121861|FG001|Overall Study|Physician Decision|5|||
25024185|NCT03614975|50121860|FG000|Overall Study|Withdrawal by Subject|2|||
25154871|NCT01901341|50270028|FG001|Overall Study|Study Terminated by Sponsor|15|||
25154872|NCT01901341|50270027|FG000|Overall Study|Withdrawal by Subject|1|||
25154873|NCT01901341|50270028|FG001|Overall Study|Withdrawal by Subject|1|||
24923803|NCT00449644|50017243|FG003|Overall Study|Other|0|||
24923804|NCT00449644|50017240|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
24923805|NCT00449644|50017241|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
24923806|NCT00449644|50017242|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
24923807|NCT00449644|50017243|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
24923808|NCT00515541|50017260|FG000|Overall Study|Physician Decision|0|||
24923809|NCT00515541|50017261|FG001|Overall Study|Physician Decision|2|||
25024186|NCT03614975|50121861|FG001|Overall Study|Withdrawal by Subject|2|||
24923810|NCT00515541|50017262|FG002|Overall Study|Physician Decision|0|||
24923811|NCT00515541|50017263|FG003|Overall Study|Physician Decision|1|||
24923812|NCT00515541|50017260|FG000|Overall Study|No show for appointments|0|||
25154874|NCT01615939|50270037|FG000|Overall Study|Lost to Follow-up|5|||
24923813|NCT00515541|50017261|FG001|Overall Study|No show for appointments|1|||
24923814|NCT00515541|50017262|FG002|Overall Study|No show for appointments|0|||
24923815|NCT00515541|50017263|FG003|Overall Study|No show for appointments|2|||
24923816|NCT00515541|50017260|FG000|Overall Study|Withdrawal by Subject|0|||
24923817|NCT00515541|50017261|FG001|Overall Study|Withdrawal by Subject|2|||
24923818|NCT00515541|50017262|FG002|Overall Study|Withdrawal by Subject|0|||
24923819|NCT00515541|50017263|FG003|Overall Study|Withdrawal by Subject|2|||
24923820|NCT00112489|50017273|FG000|Overall Study|Refused further treatment|8|||
24923821|NCT00112489|50017273|FG000|Overall Study|Adverse Event|12|||
24923822|NCT00112489|50017273|FG000|Overall Study|Death|2|||
24923823|NCT00112489|50017273|FG000|Overall Study|Other, Not Specified|9|||
24923824|NCT00112489|50017273|FG000|Overall Study|Patient never treated|2|||
24923825|NCT00112489|50017273|FG000|Overall Study|Ineligible|7|||
24923826|NCT00711971|50017286|FG000|Overall Study|Lost to Follow-up|3|||
24923827|NCT00711971|50017287|FG001|Overall Study|Lost to Follow-up|4|||
24923828|NCT00711971|50017288|FG002|Overall Study|Lost to Follow-up|1|||
25024187|NCT03614975|50121860|FG000|Overall Study|Specimens not in lab batch shipment|1|||
25024188|NCT03614975|50121861|FG001|Overall Study|Specimens not in lab batch shipment|1|||
25024189|NCT03613649|50121879|FG000|Second Treatment|Lost to Follow-up|0|||
24923829|NCT00515463|50017302|FG000|Overall Study|Physician Decision|4|||
24923830|NCT00515463|50017303|FG001|Overall Study|Physician Decision|2|||
24923831|NCT00515463|50017302|FG000|Overall Study|Adverse Event|1|||
24923832|NCT00515463|50017303|FG001|Overall Study|Adverse Event|2|||
24923833|NCT00515463|50017302|FG000|Overall Study|Withdrawal by Subject|3|||
24923834|NCT00515463|50017303|FG001|Overall Study|Withdrawal by Subject|4|||
24923835|NCT00515463|50017302|FG000|Overall Study|Lost to Follow-up|6|||
24923836|NCT00515463|50017303|FG001|Overall Study|Lost to Follow-up|5|||
24923837|NCT00515463|50017302|FG000|Overall Study|Other|0|||
24923838|NCT00515463|50017303|FG001|Overall Study|Other|1|||
24923839|NCT00507507|50017312|FG000|Treatment Period|Lost to Follow-up|0|||
24923840|NCT00507507|50017313|FG001|Treatment Period|Lost to Follow-up|2|||
24923841|NCT00507507|50017312|FG000|Treatment Period|Physician Decision|4|||
24923842|NCT00507507|50017313|FG001|Treatment Period|Physician Decision|1|||
24923843|NCT00507507|50017312|FG000|Treatment Period|Protocol Violation|1|||
25024190|NCT03613649|50121880|FG001|Second Treatment|Lost to Follow-up|0|||
25024191|NCT03613649|50121881|FG002|Second Treatment|Lost to Follow-up|1|||
25024192|NCT03613649|50121882|FG003|Second Treatment|Lost to Follow-up|0|||
25024193|NCT03613649|50121883|FG004|Second Treatment|Lost to Follow-up|0|||
24923844|NCT00507507|50017313|FG001|Treatment Period|Protocol Violation|2|||
24923845|NCT00507507|50017312|FG000|Treatment Period|Adverse Event|1|||
24923846|NCT00507507|50017313|FG001|Treatment Period|Adverse Event|1|||
24923847|NCT00507507|50017312|FG000|Treatment Period|Withdrawal by Subject|46|||
24923848|NCT00507507|50017313|FG001|Treatment Period|Withdrawal by Subject|47|||
24923849|NCT00507507|50017312|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
24923850|NCT00507507|50017313|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
24923851|NCT00507507|50017312|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
25024194|NCT03613649|50121884|FG005|Second Treatment|Lost to Follow-up|0|||
25024195|NCT03613649|50121885|FG006|Second Treatment|Lost to Follow-up|0|||
25024196|NCT03613649|50121886|FG007|Second Treatment|Lost to Follow-up|0|||
25024197|NCT03613649|50121887|FG008|Second Treatment|Lost to Follow-up|0|||
25024198|NCT03613649|50121888|FG009|Second Treatment|Lost to Follow-up|0|||
25024199|NCT03613649|50121889|FG010|Second Treatment|Lost to Follow-up|0|||
25024200|NCT03613649|50121890|FG011|Second Treatment|Lost to Follow-up|0|||
25024201|NCT03613649|50121879|FG000|Second Treatment|Withdrawal by Subject|0|||
25024202|NCT03613649|50121880|FG001|Second Treatment|Withdrawal by Subject|0|||
25024203|NCT03613649|50121881|FG002|Second Treatment|Withdrawal by Subject|0|||
25024204|NCT03613649|50121882|FG003|Second Treatment|Withdrawal by Subject|0|||
25024205|NCT03613649|50121883|FG004|Second Treatment|Withdrawal by Subject|1|||
25024206|NCT03613649|50121884|FG005|Second Treatment|Withdrawal by Subject|0|||
25024207|NCT03613649|50121885|FG006|Second Treatment|Withdrawal by Subject|0|||
25024208|NCT03613649|50121886|FG007|Second Treatment|Withdrawal by Subject|0|||
24923852|NCT00507507|50017313|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
24923853|NCT00507507|50017312|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
24923854|NCT00507507|50017313|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
24923855|NCT00459706|50017323|FG000|Overall Study|Adverse Event|19|||
24923856|NCT00459706|50017324|FG001|Overall Study|Adverse Event|13|||
24923857|NCT00459706|50017323|FG000|Overall Study|Withdrawal by Subject|1|||
24923858|NCT00459706|50017324|FG001|Overall Study|Withdrawal by Subject|6|||
24923859|NCT00459706|50017323|FG000|Overall Study|Physician Decision|2|||
24923860|NCT00459706|50017324|FG001|Overall Study|Physician Decision|0|||
24923861|NCT00459706|50017323|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
24923862|NCT00459706|50017324|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
24923863|NCT00459706|50017323|FG000|Overall Study|Protocol Violation|2|||
24923864|NCT00459706|50017324|FG001|Overall Study|Protocol Violation|1|||
25024209|NCT03613649|50121887|FG008|Second Treatment|Withdrawal by Subject|0|||
25024210|NCT03613649|50121888|FG009|Second Treatment|Withdrawal by Subject|0|||
24923865|NCT00459706|50017323|FG000|Overall Study|Failed to Return|1|||
24923866|NCT00459706|50017324|FG001|Overall Study|Failed to Return|0|||
24923867|NCT00459706|50017323|FG000|Overall Study|Other|0|||
24923868|NCT00459706|50017324|FG001|Overall Study|Other|1|||
24923869|NCT00507429|50017332|FG000|Treatment Phase|Disease Progression|12|||
25024211|NCT03613649|50121889|FG010|Second Treatment|Withdrawal by Subject|0|||
25024212|NCT03613649|50121890|FG011|Second Treatment|Withdrawal by Subject|0|||
24923870|NCT00507429|50017333|FG001|Treatment Phase|Disease Progression|5|||
24923871|NCT00507429|50017332|FG000|Treatment Phase|Adverse Event|12|||
24923872|NCT00507429|50017333|FG001|Treatment Phase|Adverse Event|5|||
24923873|NCT00507429|50017332|FG000|Treatment Phase|Withdrawal by Subject|3|||
24923874|NCT00507429|50017333|FG001|Treatment Phase|Withdrawal by Subject|3|||
24923875|NCT00507429|50017332|FG000|Treatment Phase|Physician Decision|4|||
24923876|NCT00507429|50017333|FG001|Treatment Phase|Physician Decision|2|||
24923877|NCT00507429|50017332|FG000|Treatment Phase|Other|6|||
24923878|NCT00507429|50017333|FG001|Treatment Phase|Other|3|||
24923879|NCT00507429|50017332|FG000|Maintenance Phase|Progressive Disease|14|||
25024213|NCT03613649|50121879|FG000|Third Treatment|Lost to Follow-up|0|||
25024214|NCT03613649|50121880|FG001|Third Treatment|Lost to Follow-up|0|||
24923880|NCT00507429|50017333|FG001|Maintenance Phase|Progressive Disease|0|||
24923881|NCT00449176|50017344|FG000|Overall Study|Withdrawal by Subject|39|||
24923882|NCT00449176|50017345|FG001|Overall Study|Withdrawal by Subject|43|||
24923883|NCT00449176|50017346|FG002|Overall Study|Withdrawal by Subject|59|||
24923884|NCT00449176|50017344|FG000|Overall Study|Lost to Follow-up|13|||
24923885|NCT00449176|50017345|FG001|Overall Study|Lost to Follow-up|8|||
24923886|NCT00449176|50017346|FG002|Overall Study|Lost to Follow-up|12|||
24923887|NCT00449176|50017344|FG000|Overall Study|Adverse Event|51|||
24923888|NCT00449176|50017345|FG001|Overall Study|Adverse Event|107|||
24923889|NCT00449176|50017346|FG002|Overall Study|Adverse Event|15|||
24923890|NCT00449176|50017344|FG000|Overall Study|Lack of Efficacy|13|||
24923891|NCT00449176|50017345|FG001|Overall Study|Lack of Efficacy|7|||
24923892|NCT00449176|50017346|FG002|Overall Study|Lack of Efficacy|50|||
24923893|NCT00449176|50017344|FG000|Overall Study|Study drug non-compliant|14|||
24923894|NCT00449176|50017345|FG001|Overall Study|Study drug non-compliant|11|||
24923895|NCT00449176|50017346|FG002|Overall Study|Study drug non-compliant|11|||
24923896|NCT00449176|50017344|FG000|Overall Study|all other|22|||
24923897|NCT00449176|50017345|FG001|Overall Study|all other|19|||
25024215|NCT03613649|50121881|FG002|Third Treatment|Lost to Follow-up|0|||
25024216|NCT03613649|50121882|FG003|Third Treatment|Lost to Follow-up|0|||
25024217|NCT03613649|50121883|FG004|Third Treatment|Lost to Follow-up|1|||
25024218|NCT03613649|50121884|FG005|Third Treatment|Lost to Follow-up|0|||
25024219|NCT03613649|50121885|FG006|Third Treatment|Lost to Follow-up|0|||
25024220|NCT03613649|50121886|FG007|Third Treatment|Lost to Follow-up|0|||
25024221|NCT03613649|50121887|FG008|Third Treatment|Lost to Follow-up|0|||
25024222|NCT03613649|50121888|FG009|Third Treatment|Lost to Follow-up|0|||
25024223|NCT03613649|50121889|FG010|Third Treatment|Lost to Follow-up|0|||
25024224|NCT03613649|50121890|FG011|Third Treatment|Lost to Follow-up|1|||
25024225|NCT03613649|50121879|FG000|Third Treatment|Protocol Violation|0|||
25024226|NCT03613649|50121880|FG001|Third Treatment|Protocol Violation|0|||
24923898|NCT00449176|50017346|FG002|Overall Study|all other|20|||
24923899|NCT00515073|50017354|FG000|Overall Study|Withdrawal by Subject|1|||
24923900|NCT00515073|50017354|FG000|Overall Study|Physician Decision|1|||
24923901|NCT00710021|50017361|FG000|Overall Study|Lost to Follow-up|1|||
24923902|NCT00710021|50017362|FG001|Overall Study|Lost to Follow-up|0|||
24923903|NCT00710021|50017363|FG002|Overall Study|Lost to Follow-up|0|||
24923904|NCT00710021|50017361|FG000|Overall Study|Subject's Decision|0|||
24923905|NCT00710021|50017362|FG001|Overall Study|Subject's Decision|1|||
24923906|NCT00710021|50017363|FG002|Overall Study|Subject's Decision|0|||
24923907|NCT00710021|50017361|FG000|Overall Study|Subject misrandomized|0|||
24923908|NCT00710021|50017362|FG001|Overall Study|Subject misrandomized|1|||
24923909|NCT00710021|50017363|FG002|Overall Study|Subject misrandomized|1|||
24923910|NCT00710021|50017361|FG000|Overall Study|Physician Decision|0|||
24923911|NCT00710021|50017362|FG001|Overall Study|Physician Decision|1|||
24923912|NCT00710021|50017363|FG002|Overall Study|Physician Decision|0|||
24923913|NCT00504153|50017372|FG000|Overall Study|Withdrawal by Subject|1|||
24923914|NCT00504153|50017372|FG000|Overall Study|Adverse Event|4|||
24923915|NCT00504153|50017372|FG000|Overall Study|Death|1|||
24923916|NCT00442702|50017378|FG000|Titration Period|Adverse Event|2|||
24923917|NCT00442702|50017379|FG001|Titration Period|Adverse Event|0|||
24923918|NCT00442702|50017378|FG000|Titration Period|Death|3|||
24923919|NCT00442702|50017379|FG001|Titration Period|Death|2|||
24923920|NCT00442702|50017378|FG000|Titration Period|Insufficient Therapeutic Response|1|||
24923921|NCT00442702|50017379|FG001|Titration Period|Insufficient Therapeutic Response|0|||
24923922|NCT00442702|50017378|FG000|Titration Period|Refused Treatment|4|||
24923923|NCT00442702|50017379|FG001|Titration Period|Refused Treatment|1|||
24923924|NCT00442702|50017378|FG000|Titration Period|Failure to return|1|||
24923925|NCT00442702|50017379|FG001|Titration Period|Failure to return|0|||
24923926|NCT00442702|50017378|FG000|Titration Period|Hospitalized in another hospital|1|||
24923927|NCT00442702|50017379|FG001|Titration Period|Hospitalized in another hospital|0|||
24923928|NCT00442702|50017378|FG000|Evaluation Period|Adverse Event|1|||
24923929|NCT00442702|50017379|FG001|Evaluation Period|Adverse Event|0|||
24923930|NCT00442702|50017378|FG000|Evaluation Period|Death|1|||
24923931|NCT00442702|50017379|FG001|Evaluation Period|Death|1|||
24923932|NCT00442702|50017378|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
24923933|NCT00442702|50017379|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
25024227|NCT03613649|50121881|FG002|Third Treatment|Protocol Violation|0|||
25024228|NCT03613649|50121882|FG003|Third Treatment|Protocol Violation|0|||
25024229|NCT03613649|50121883|FG004|Third Treatment|Protocol Violation|0|||
25024230|NCT03613649|50121884|FG005|Third Treatment|Protocol Violation|0|||
24923934|NCT00442702|50017378|FG000|Evaluation Period|Refused treatment|1|||
24923935|NCT00442702|50017379|FG001|Evaluation Period|Refused treatment|1|||
24923936|NCT00442702|50017378|FG000|Evaluation Period|Renal transplant|0|||
24923937|NCT00442702|50017379|FG001|Evaluation Period|Renal transplant|1|||
24923938|NCT00442702|50017378|FG000|Evaluation Period|Failure to return|1|||
24923939|NCT00442702|50017379|FG001|Evaluation Period|Failure to return|0|||
24923940|NCT00442702|50017378|FG000|Evaluation Period|Site closure|0|||
25024231|NCT03613649|50121885|FG006|Third Treatment|Protocol Violation|1|||
24923941|NCT00442702|50017379|FG001|Evaluation Period|Site closure|1|||
24923942|NCT00514917|50017387|FG000|Overall Study|Death|4|||
24923943|NCT00514917|50017388|FG001|Overall Study|Death|10|||
24923944|NCT00514917|50017387|FG000|Overall Study|Protocol Violation|1|||
24923945|NCT00514917|50017388|FG001|Overall Study|Protocol Violation|0|||
24923946|NCT00514917|50017387|FG000|Overall Study|Lost to Follow-up|4|||
24923947|NCT00514917|50017388|FG001|Overall Study|Lost to Follow-up|3|||
24923948|NCT00514917|50017387|FG000|Overall Study|Withdrawal by Subject|18|||
24923949|NCT00514917|50017388|FG001|Overall Study|Withdrawal by Subject|16|||
24923950|NCT00514917|50017387|FG000|Overall Study|Discontinued due to study closure|88|||
24923951|NCT00514917|50017388|FG001|Overall Study|Discontinued due to study closure|81|||
24923952|NCT00514917|50017387|FG000|Overall Study|Undefined|11|||
24923953|NCT00514917|50017388|FG001|Overall Study|Undefined|5|||
24923954|NCT00711425|50017396|FG000|Overall Study|Protocol Violation|1|||
24923955|NCT00711425|50017396|FG000|Overall Study|Death|2|||
24923956|NCT00711425|50017396|FG000|Overall Study|Lost to Follow-up|1|||
24923957|NCT00504075|50017400|FG000|Overall Study|Adverse Event|1|||
24923958|NCT00504075|50017400|FG000|Overall Study|Lost to Follow-up|5|||
24923959|NCT00504075|50017400|FG000|Overall Study|Withdrawal by Subject|1|||
24923960|NCT00504075|50017400|FG000|Overall Study|Required other therapeutic intervention|1|||
24923961|NCT00503997|50017405|FG000|Overall Study|disease progression|1|||
24923962|NCT00503997|50017405|FG000|Overall Study|Adverse Event|5|||
24923963|NCT00503997|50017405|FG000|Overall Study|Death|1|||
24923964|NCT00503997|50017405|FG000|Overall Study|Withdrawal by Subject|1|||
24923965|NCT00096265|50017412|FG000|Overall Study|Ineligible|1|||
24923966|NCT00096265|50017413|FG001|Overall Study|Ineligible|0|||
24923967|NCT00096265|50017414|FG002|Overall Study|Ineligible|0|||
24923968|NCT00711191|50017426|FG000|Overall Study|Adverse Event|1|||
24923969|NCT00711191|50017427|FG001|Overall Study|Adverse Event|1|||
24923970|NCT00711191|50017428|FG002|Overall Study|Adverse Event|2|||
24923971|NCT00711191|50017426|FG000|Overall Study|Objective progression or relapse|2|||
24923972|NCT00711191|50017427|FG001|Overall Study|Objective progression or relapse|3|||
24923973|NCT00711191|50017428|FG002|Overall Study|Objective progression or relapse|7|||
24923974|NCT00711191|50017426|FG000|Overall Study|Withdrawal by Subject|0|||
24923975|NCT00711191|50017427|FG001|Overall Study|Withdrawal by Subject|1|||
24923976|NCT00711191|50017428|FG002|Overall Study|Withdrawal by Subject|3|||
25024232|NCT03613649|50121886|FG007|Third Treatment|Protocol Violation|0|||
25154875|NCT01615939|50270038|FG001|Overall Study|Lost to Follow-up|0|||
25154876|NCT01901185|50270044|FG000|Overall Study|Withdrawal by Subject|2|||
24923977|NCT00706511|50017443|FG000|Overall Study|Withdrawal by Subject|1|||
24923978|NCT00706511|50017444|FG001|Overall Study|Withdrawal by Subject|0|||
24923979|NCT00706511|50017445|FG002|Overall Study|Withdrawal by Subject|0|||
24923980|NCT00706511|50017446|FG003|Overall Study|Withdrawal by Subject|0|||
24923981|NCT00448864|50017457|FG000|Overall Study|Death|1|||
24923982|NCT00448864|50017458|FG001|Overall Study|Death|0|||
24923983|NCT00448864|50017459|FG002|Overall Study|Death|0|||
24923984|NCT00448864|50017457|FG000|Overall Study|Lost to Follow-up|3|||
24923985|NCT00448864|50017458|FG001|Overall Study|Lost to Follow-up|1|||
24923986|NCT00448864|50017459|FG002|Overall Study|Lost to Follow-up|0|||
24923987|NCT00448864|50017457|FG000|Overall Study|Physician Decision|1|||
24923988|NCT00448864|50017458|FG001|Overall Study|Physician Decision|0|||
24923989|NCT00448864|50017459|FG002|Overall Study|Physician Decision|1|||
24923990|NCT00448864|50017457|FG000|Overall Study|Withdrawal by Subject|0|||
24923991|NCT00448864|50017458|FG001|Overall Study|Withdrawal by Subject|2|||
24923992|NCT00448864|50017459|FG002|Overall Study|Withdrawal by Subject|0|||
24923993|NCT00448864|50017457|FG000|Overall Study|Protocol Violation|0|||
24923994|NCT00448864|50017458|FG001|Overall Study|Protocol Violation|2|||
24923995|NCT00448864|50017459|FG002|Overall Study|Protocol Violation|0|||
24923996|NCT00567398|50017471|FG000|Overall Study|Adverse Event|6|||
24923997|NCT00567398|50017472|FG001|Overall Study|Adverse Event|14|||
24923998|NCT00567398|50017471|FG000|Overall Study|Physician Decision|0|||
24923999|NCT00567398|50017472|FG001|Overall Study|Physician Decision|4|||
24924000|NCT00567398|50017471|FG000|Overall Study|Withdrawal by Subject|0|||
24924001|NCT00567398|50017472|FG001|Overall Study|Withdrawal by Subject|2|||
24924002|NCT00567398|50017471|FG000|Overall Study|Renal Transplantation|0|||
24924003|NCT00567398|50017472|FG001|Overall Study|Renal Transplantation|3|||
24924004|NCT00567398|50017471|FG000|Overall Study|Other|1|||
24924005|NCT00567398|50017472|FG001|Overall Study|Other|0|||
25154877|NCT01888003|50270051|FG000|Overall Study|Study Terminated|5|||
24924006|NCT00448708|50017480|FG000|Overall Study|Death|21|||
24924007|NCT00448708|50017481|FG001|Overall Study|Death|17|||
24924008|NCT00448708|50017480|FG000|Overall Study|Withdrawal by Subject|8|||
24924009|NCT00448708|50017481|FG001|Overall Study|Withdrawal by Subject|4|||
24924010|NCT00448708|50017480|FG000|Overall Study|Lost to Follow-up|6|||
24924011|NCT00448708|50017481|FG001|Overall Study|Lost to Follow-up|8|||
24924012|NCT00448708|50017480|FG000|Overall Study|not listed|0|||
24924013|NCT00448708|50017481|FG001|Overall Study|not listed|2|||
24924014|NCT00706355|50017491|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
24924015|NCT00706355|50017492|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
25154878|NCT01888003|50270052|FG001|Overall Study|Study Terminated|6|||
24924016|NCT00706355|50017493|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
24924017|NCT00706355|50017494|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
24924018|NCT00706355|50017491|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
24924019|NCT00706355|50017492|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
24924020|NCT00706355|50017493|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
24924021|NCT00706355|50017494|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
24924022|NCT00706355|50017491|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
24924023|NCT00706355|50017492|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
24924024|NCT00706355|50017493|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
24924025|NCT00706355|50017494|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
24924026|NCT00706355|50017491|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
24924027|NCT00706355|50017492|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
24924028|NCT00706355|50017493|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
24924029|NCT00706355|50017494|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
24924030|NCT00706355|50017491|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
25154879|NCT01888003|50270053|FG002|Overall Study|Study Terminated|40|||
25154880|NCT01925209|50270119|FG000|Treatment Epoch|Physician Decision|1|||
25154881|NCT01925209|50270120|FG001|Treatment Epoch|Physician Decision|0|||
25154882|NCT01925209|50270121|FG002|Treatment Epoch|Physician Decision|0|||
25154883|NCT01925209|50270122|FG003|Treatment Epoch|Physician Decision|0|||
24924031|NCT00706355|50017492|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
24924032|NCT00706355|50017493|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
24924033|NCT00706355|50017494|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
24924034|NCT00706355|50017491|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
24924035|NCT00706355|50017492|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
25024233|NCT03613649|50121887|FG008|Third Treatment|Protocol Violation|0|||
25024234|NCT03613649|50121888|FG009|Third Treatment|Protocol Violation|0|||
25024235|NCT03613649|50121889|FG010|Third Treatment|Protocol Violation|0|||
25024236|NCT03613649|50121890|FG011|Third Treatment|Protocol Violation|1|||
25024237|NCT03613649|50121879|FG000|Fourth Treatment|Protocol Violation|1|||
25024238|NCT03613649|50121880|FG001|Fourth Treatment|Protocol Violation|0|||
25024239|NCT03613649|50121881|FG002|Fourth Treatment|Protocol Violation|0|||
25024240|NCT03613649|50121882|FG003|Fourth Treatment|Protocol Violation|0|||
25154884|NCT01925209|50270119|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
24924036|NCT00706355|50017493|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
24924037|NCT00706355|50017494|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
24924038|NCT00706355|50017491|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
24924039|NCT00706355|50017492|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
24924040|NCT00706355|50017493|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
24924041|NCT00706355|50017494|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
24924042|NCT00706355|50017491|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
24924043|NCT00706355|50017492|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
24924044|NCT00706355|50017493|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
24924045|NCT00706355|50017494|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
24924046|NCT00706355|50017491|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
24924047|NCT00706355|50017492|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
24924048|NCT00706355|50017493|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
24924049|NCT00706355|50017494|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
24924050|NCT00711113|50017506|FG000|Overall Study|Lost to Follow-up|9|||
24924051|NCT00711113|50017506|FG000|Overall Study|Implant lost|2|||
24924052|NCT00710879|50017516|FG000|Overall Study|Lost to Follow-up|2|||
24924053|NCT00710879|50017517|FG001|Overall Study|Lost to Follow-up|1|||
24924054|NCT00710879|50017516|FG000|Overall Study|Protocol Violation|0|||
24924055|NCT00710879|50017517|FG001|Overall Study|Protocol Violation|3|||
24924056|NCT03979274|50017523|FG000|Treatment Period 2|Withdrawal by Subject|0|||
24924057|NCT03979274|50017524|FG001|Treatment Period 2|Withdrawal by Subject|1|||
24924058|NCT00459316|50017534|FG000|Steps 1 & 2|Other eligibility failure|1|||
24924059|NCT00459316|50017535|FG001|Steps 1 & 2|Other eligibility failure|1|||
24924060|NCT00459316|50017536|FG002|Steps 1 & 2|Other eligibility failure|0|||
24924061|NCT00459316|50017534|FG000|Steps 1 & 2|Death|1|||
25024241|NCT03613649|50121883|FG004|Fourth Treatment|Protocol Violation|1|||
25024242|NCT03613649|50121884|FG005|Fourth Treatment|Protocol Violation|0|||
25024243|NCT03613649|50121885|FG006|Fourth Treatment|Protocol Violation|0|||
25154885|NCT01925209|50270120|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
24924062|NCT00459316|50017535|FG001|Steps 1 & 2|Death|1|||
24924063|NCT00459316|50017536|FG002|Steps 1 & 2|Death|0|||
24924064|NCT00459316|50017534|FG000|Steps 1 & 2|Not able to get to clinic|7|||
24924065|NCT00459316|50017535|FG001|Steps 1 & 2|Not able to get to clinic|4|||
24924066|NCT00459316|50017536|FG002|Steps 1 & 2|Not able to get to clinic|0|||
24924067|NCT00459316|50017534|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
24924068|NCT00459316|50017535|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
24924069|NCT00459316|50017536|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
24924070|NCT00459316|50017534|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
24924071|NCT00459316|50017535|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
24924072|NCT00459316|50017536|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
24924073|NCT00459316|50017534|FG000|Steps 1 & 2|Lost to Follow-up|5|||
24924074|NCT00459316|50017535|FG001|Steps 1 & 2|Lost to Follow-up|0|||
24924075|NCT00459316|50017536|FG002|Steps 1 & 2|Lost to Follow-up|2|||
24924076|NCT00459316|50017534|FG000|Step 3|Withdrawal by Subject|3|||
24924077|NCT00459316|50017535|FG001|Step 3|Withdrawal by Subject|0|||
24924078|NCT00459316|50017536|FG002|Step 3|Withdrawal by Subject|1|||
24924079|NCT00567164|50017562|FG000|Overall Study|Withdrawal by Subject|171|||
24924080|NCT00567164|50017563|FG001|Overall Study|Withdrawal by Subject|21|||
24924081|NCT00567164|50017564|FG002|Overall Study|Withdrawal by Subject|17|||
24924082|NCT00567164|50017562|FG000|Overall Study|Protocol Violation|23|||
24924083|NCT00567164|50017563|FG001|Overall Study|Protocol Violation|4|||
24924084|NCT00567164|50017564|FG002|Overall Study|Protocol Violation|2|||
24924085|NCT00567164|50017562|FG000|Overall Study|Adverse Event|92|||
24924086|NCT00567164|50017563|FG001|Overall Study|Adverse Event|13|||
24924087|NCT00567164|50017564|FG002|Overall Study|Adverse Event|9|||
24924088|NCT00567164|50017562|FG000|Overall Study|Death|0|||
24924089|NCT00567164|50017563|FG001|Overall Study|Death|0|||
24924090|NCT00567164|50017564|FG002|Overall Study|Death|1|||
24924091|NCT00567164|50017562|FG000|Overall Study|Lost to Follow-up|202|||
24924092|NCT00567164|50017563|FG001|Overall Study|Lost to Follow-up|23|||
24924093|NCT00567164|50017564|FG002|Overall Study|Lost to Follow-up|21|||
24924094|NCT00567164|50017562|FG000|Overall Study|Pregnancy|20|||
24924095|NCT00567164|50017563|FG001|Overall Study|Pregnancy|4|||
24924096|NCT00567164|50017564|FG002|Overall Study|Pregnancy|6|||
24924097|NCT00567164|50017562|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
24924098|NCT00567164|50017563|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
24924099|NCT00567164|50017564|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
24924100|NCT00567164|50017562|FG000|Overall Study|Missing|1|||
24924101|NCT00567164|50017563|FG001|Overall Study|Missing|0|||
24924102|NCT00567164|50017564|FG002|Overall Study|Missing|0|||
24924103|NCT00713219|50017576|FG000|Overall Study|Death|1|||
24924104|NCT00713219|50017576|FG000|Overall Study|Protocol Violation|1|||
24924105|NCT00712985|50017580|FG000|Overall Study|1 withdrew prior to start of drug|1|||
24924106|NCT00712985|50017580|FG000|Overall Study|1 patient moved out of state|1|||
24924107|NCT00712985|50017580|FG000|Overall Study|Lack of Efficacy|3|||
24924108|NCT00700115|50017586|FG000|Overall Study|Withdrawal by Subject|1|||
24924109|NCT00700115|50017587|FG001|Overall Study|Withdrawal by Subject|0|||
24924110|NCT00700115|50017586|FG000|Overall Study|Lost to Follow-up|0|||
24924111|NCT00700115|50017587|FG001|Overall Study|Lost to Follow-up|1|||
24924112|NCT00566852|50017595|FG000|Overall Study|Protocol Violation|22|||
24924113|NCT00566852|50017596|FG001|Overall Study|Protocol Violation|24|||
24924114|NCT00566852|50017595|FG000|Overall Study|Death|95|||
24924115|NCT00566852|50017596|FG001|Overall Study|Death|78|||
24924116|NCT00566852|50017595|FG000|Overall Study|Withdrawal by Subject|30|||
24924117|NCT00566852|50017596|FG001|Overall Study|Withdrawal by Subject|25|||
24924118|NCT00566852|50017595|FG000|Overall Study|Patient refusal|37|||
24924119|NCT00566852|50017596|FG001|Overall Study|Patient refusal|37|||
24924120|NCT00566852|50017595|FG000|Overall Study|Not tested due to disability|6|||
24924121|NCT00566852|50017596|FG001|Overall Study|Not tested due to disability|12|||
24924122|NCT00566852|50017595|FG000|Overall Study|Missing reason not specified|1|||
24924123|NCT00566852|50017596|FG001|Overall Study|Missing reason not specified|2|||
24924124|NCT00566852|50017595|FG000|Overall Study|Missing reason not reported|16|||
24924125|NCT00566852|50017596|FG001|Overall Study|Missing reason not reported|20|||
24924126|NCT00442546|50017605|FG000|Overall Study|Adverse Event|11|||
24924127|NCT00442546|50017606|FG001|Overall Study|Adverse Event|17|||
24924128|NCT00442546|50017607|FG002|Overall Study|Adverse Event|13|||
24924129|NCT00442546|50017605|FG000|Overall Study|Lost to Follow-up|1|||
24924130|NCT00442546|50017606|FG001|Overall Study|Lost to Follow-up|2|||
24924131|NCT00442546|50017607|FG002|Overall Study|Lost to Follow-up|1|||
24924132|NCT00442546|50017605|FG000|Overall Study|Other|4|||
24924133|NCT00442546|50017606|FG001|Overall Study|Other|9|||
24924134|NCT00442546|50017607|FG002|Overall Study|Other|6|||
24924135|NCT00442546|50017605|FG000|Overall Study|Withdrawal by Subject|5|||
24924136|NCT00442546|50017606|FG001|Overall Study|Withdrawal by Subject|5|||
24924137|NCT00442546|50017607|FG002|Overall Study|Withdrawal by Subject|7|||
24924138|NCT00442546|50017605|FG000|Overall Study|Randomized But Not Treated|5|||
24924139|NCT00442546|50017606|FG001|Overall Study|Randomized But Not Treated|4|||
24924140|NCT00442546|50017607|FG002|Overall Study|Randomized But Not Treated|6|||
24924141|NCT00514683|50017622|FG000|Overall Study|Not treated|2|||
24924142|NCT00514683|50017623|FG001|Overall Study|Not treated|1|||
24924143|NCT00514683|50017624|FG002|Overall Study|Not treated|0|||
24924144|NCT00514683|50017625|FG003|Overall Study|Not treated|0|||
24924145|NCT00514683|50017626|FG004|Overall Study|Not treated|1|||
24924146|NCT00514683|50017622|FG000|Overall Study|Adverse Event|21|||
24924147|NCT00514683|50017623|FG001|Overall Study|Adverse Event|20|||
24924148|NCT00514683|50017624|FG002|Overall Study|Adverse Event|15|||
24924149|NCT00514683|50017625|FG003|Overall Study|Adverse Event|13|||
25024244|NCT03613649|50121886|FG007|Fourth Treatment|Protocol Violation|0|||
25024245|NCT03613649|50121887|FG008|Fourth Treatment|Protocol Violation|0|||
25024246|NCT03613649|50121888|FG009|Fourth Treatment|Protocol Violation|0|||
25024247|NCT03613649|50121889|FG010|Fourth Treatment|Protocol Violation|0|||
25024248|NCT03613649|50121890|FG011|Fourth Treatment|Protocol Violation|0|||
25024249|NCT03613649|50121879|FG000|Fourth Treatment|Physician Decision|0|||
25024250|NCT03613649|50121880|FG001|Fourth Treatment|Physician Decision|0|||
25024251|NCT03613649|50121881|FG002|Fourth Treatment|Physician Decision|0|||
25024252|NCT03613649|50121882|FG003|Fourth Treatment|Physician Decision|0|||
25024253|NCT03613649|50121883|FG004|Fourth Treatment|Physician Decision|0|||
25024254|NCT03613649|50121884|FG005|Fourth Treatment|Physician Decision|0|||
25024255|NCT03613649|50121885|FG006|Fourth Treatment|Physician Decision|1|||
25024256|NCT03613649|50121886|FG007|Fourth Treatment|Physician Decision|0|||
25024257|NCT03613649|50121887|FG008|Fourth Treatment|Physician Decision|0|||
25024258|NCT03613649|50121888|FG009|Fourth Treatment|Physician Decision|0|||
25024259|NCT03613649|50121889|FG010|Fourth Treatment|Physician Decision|0|||
25024260|NCT03613649|50121890|FG011|Fourth Treatment|Physician Decision|0|||
25024261|NCT03096288|50121912|FG000|Overall Study|Withdrawal by Subject|0|||
25024262|NCT03096288|50121913|FG001|Overall Study|Withdrawal by Subject|1|||
25024263|NCT03096288|50121914|FG002|Overall Study|Withdrawal by Subject|0|||
25024264|NCT03096288|50121915|FG003|Overall Study|Withdrawal by Subject|1|||
25024265|NCT03611075|50121934|FG000|Overall Study|Physician Decision|0|||
25024266|NCT03611075|50121935|FG001|Overall Study|Physician Decision|1|||
25024267|NCT03611075|50121936|FG002|Overall Study|Physician Decision|1|||
25024268|NCT03611075|50121937|FG003|Overall Study|Physician Decision|0|||
25024269|NCT03611075|50121938|FG004|Overall Study|Physician Decision|0|||
25024270|NCT03611075|50121939|FG005|Overall Study|Physician Decision|0|||
25024271|NCT03611075|50121940|FG006|Overall Study|Physician Decision|0|||
25024272|NCT03611075|50121941|FG007|Overall Study|Physician Decision|0|||
24924150|NCT00514683|50017626|FG004|Overall Study|Adverse Event|27|||
24924151|NCT00514683|50017622|FG000|Overall Study|Protocol Violation|1|||
24924152|NCT00514683|50017623|FG001|Overall Study|Protocol Violation|1|||
24924153|NCT00514683|50017624|FG002|Overall Study|Protocol Violation|0|||
25024273|NCT03611075|50121942|FG008|Overall Study|Physician Decision|0|||
25024274|NCT03611075|50121934|FG000|Overall Study|Lost to Follow-up|1|||
25024275|NCT03611075|50121935|FG001|Overall Study|Lost to Follow-up|0|||
25024276|NCT03611075|50121936|FG002|Overall Study|Lost to Follow-up|0|||
25024277|NCT03611075|50121937|FG003|Overall Study|Lost to Follow-up|2|||
25024278|NCT03611075|50121938|FG004|Overall Study|Lost to Follow-up|0|||
25024279|NCT03611075|50121939|FG005|Overall Study|Lost to Follow-up|0|||
25024280|NCT03611075|50121940|FG006|Overall Study|Lost to Follow-up|0|||
25024281|NCT03611075|50121941|FG007|Overall Study|Lost to Follow-up|0|||
24924154|NCT00514683|50017625|FG003|Overall Study|Protocol Violation|1|||
24924155|NCT00514683|50017626|FG004|Overall Study|Protocol Violation|0|||
24924156|NCT00514683|50017622|FG000|Overall Study|Withdrawal by Subject|2|||
24924157|NCT00514683|50017623|FG001|Overall Study|Withdrawal by Subject|2|||
24924158|NCT00514683|50017624|FG002|Overall Study|Withdrawal by Subject|1|||
24924159|NCT00514683|50017625|FG003|Overall Study|Withdrawal by Subject|0|||
24924160|NCT00514683|50017626|FG004|Overall Study|Withdrawal by Subject|4|||
24924161|NCT00514683|50017622|FG000|Overall Study|Reason other than listed above|0|||
24924162|NCT00514683|50017623|FG001|Overall Study|Reason other than listed above|1|||
24924163|NCT00514683|50017624|FG002|Overall Study|Reason other than listed above|2|||
24924164|NCT00514683|50017625|FG003|Overall Study|Reason other than listed above|0|||
24924165|NCT00514683|50017626|FG004|Overall Study|Reason other than listed above|1|||
24924166|NCT00566696|50017642|FG000|Overall Study|Met Exclusion Criteria|2|||
24924167|NCT00566696|50017642|FG000|Overall Study|Muromonab not available|1|||
24924168|NCT00566696|50017642|FG000|Overall Study|Health Status Change|1|||
24924169|NCT00566696|50017642|FG000|Overall Study|Physician Decision|1|||
24924170|NCT00566696|50017642|FG000|Overall Study|Non-Patient Donors|37|||
24924171|NCT00503841|50017646|FG000|Overall Study|All screen failures|44|||
24924172|NCT00442468|50017652|FG000|Overall Study|Adverse Event|4|||
24924173|NCT00442468|50017652|FG000|Overall Study|Withdrawal by Subject|91|||
24924174|NCT00442468|50017652|FG000|Overall Study|Did not complete all study procedures|88|||
24924175|NCT00506883|50017659|FG000|Overall Study|Lost to Follow-up|1|||
24924176|NCT00506883|50017660|FG001|Overall Study|Lost to Follow-up|1|||
24924177|NCT00506883|50017661|FG002|Overall Study|Lost to Follow-up|1|||
24924178|NCT00506883|50017659|FG000|Overall Study|Withdrawal by Subject|1|||
24924179|NCT00506883|50017660|FG001|Overall Study|Withdrawal by Subject|0|||
24924180|NCT00506883|50017661|FG002|Overall Study|Withdrawal by Subject|1|||
24924181|NCT00506883|50017659|FG000|Overall Study|Lack of Efficacy|0|||
24924182|NCT00506883|50017660|FG001|Overall Study|Lack of Efficacy|1|||
24924183|NCT00506883|50017661|FG002|Overall Study|Lack of Efficacy|1|||
24924184|NCT00506883|50017659|FG000|Overall Study|Other|5|||
24924185|NCT00506883|50017660|FG001|Overall Study|Other|1|||
24924186|NCT00506883|50017661|FG002|Overall Study|Other|1|||
24924187|NCT00503685|50017672|FG000|Overall Study|Adverse Event|0|||
24924188|NCT00503685|50017673|FG001|Overall Study|Adverse Event|0|||
24924189|NCT00503685|50017674|FG002|Overall Study|Adverse Event|2|||
24924190|NCT00503685|50017672|FG000|Overall Study|Withdrawal by Subject|0|||
24924191|NCT00503685|50017673|FG001|Overall Study|Withdrawal by Subject|1|||
24924192|NCT00503685|50017674|FG002|Overall Study|Withdrawal by Subject|0|||
24924193|NCT00503685|50017672|FG000|Overall Study|Protocol Violation|0|||
24924194|NCT00503685|50017673|FG001|Overall Study|Protocol Violation|1|||
24924195|NCT00503685|50017674|FG002|Overall Study|Protocol Violation|0|||
24924196|NCT00503685|50017672|FG000|Overall Study|Eligibility Criteria Not Met|0|||
24924197|NCT00503685|50017673|FG001|Overall Study|Eligibility Criteria Not Met|1|||
24924198|NCT00503685|50017674|FG002|Overall Study|Eligibility Criteria Not Met|0|||
24924199|NCT00712673|50017686|FG000|Overall Study|Adverse Event|3|||
24924200|NCT00712673|50017687|FG001|Overall Study|Adverse Event|3|||
24924201|NCT00712673|50017688|FG002|Overall Study|Adverse Event|21|||
24924202|NCT00712673|50017689|FG003|Overall Study|Adverse Event|26|||
24924203|NCT00712673|50017686|FG000|Overall Study|Lack of Efficacy|2|||
25024282|NCT03611075|50121942|FG008|Overall Study|Lost to Follow-up|0|||
25024283|NCT03611075|50121934|FG000|Overall Study|Withdrawal by Subject|0|||
25024284|NCT03611075|50121935|FG001|Overall Study|Withdrawal by Subject|1|||
24924204|NCT00712673|50017687|FG001|Overall Study|Lack of Efficacy|8|||
24924205|NCT00712673|50017688|FG002|Overall Study|Lack of Efficacy|8|||
25024285|NCT03611075|50121936|FG002|Overall Study|Withdrawal by Subject|1|||
25024286|NCT03611075|50121937|FG003|Overall Study|Withdrawal by Subject|1|||
25024287|NCT03611075|50121938|FG004|Overall Study|Withdrawal by Subject|0|||
24924206|NCT00712673|50017689|FG003|Overall Study|Lack of Efficacy|6|||
24924207|NCT00712673|50017686|FG000|Overall Study|Poor Compliance to Protocol|3|||
24924208|NCT00712673|50017687|FG001|Overall Study|Poor Compliance to Protocol|3|||
24924209|NCT00712673|50017688|FG002|Overall Study|Poor Compliance to Protocol|4|||
24924210|NCT00712673|50017689|FG003|Overall Study|Poor Compliance to Protocol|16|||
24924211|NCT00712673|50017686|FG000|Overall Study|Lost to Follow-up|1|||
24924212|NCT00712673|50017687|FG001|Overall Study|Lost to Follow-up|0|||
24924213|NCT00712673|50017688|FG002|Overall Study|Lost to Follow-up|2|||
24924214|NCT00712673|50017689|FG003|Overall Study|Lost to Follow-up|0|||
24924215|NCT00712673|50017686|FG000|Overall Study|Withdrawal by Subject|6|||
24924216|NCT00712673|50017687|FG001|Overall Study|Withdrawal by Subject|7|||
25024288|NCT03611075|50121939|FG005|Overall Study|Withdrawal by Subject|0|||
25024289|NCT03611075|50121940|FG006|Overall Study|Withdrawal by Subject|1|||
24924217|NCT00712673|50017688|FG002|Overall Study|Withdrawal by Subject|15|||
24924218|NCT00712673|50017689|FG003|Overall Study|Withdrawal by Subject|20|||
24924219|NCT00712673|50017686|FG000|Overall Study|Familial and Personal Reasons|5|||
24924220|NCT00712673|50017687|FG001|Overall Study|Familial and Personal Reasons|0|||
24924221|NCT00712673|50017688|FG002|Overall Study|Familial and Personal Reasons|5|||
24924222|NCT00712673|50017689|FG003|Overall Study|Familial and Personal Reasons|2|||
24924223|NCT00712673|50017686|FG000|Overall Study|Investigator's Decision|1|||
24924224|NCT00712673|50017687|FG001|Overall Study|Investigator's Decision|0|||
24924225|NCT00712673|50017688|FG002|Overall Study|Investigator's Decision|0|||
24924226|NCT00712673|50017689|FG003|Overall Study|Investigator's Decision|0|||
24924227|NCT00712673|50017686|FG000|Overall Study|Protocol Violation|0|||
24924228|NCT00712673|50017687|FG001|Overall Study|Protocol Violation|0|||
24924229|NCT00712673|50017688|FG002|Overall Study|Protocol Violation|2|||
24924230|NCT00712673|50017689|FG003|Overall Study|Protocol Violation|0|||
24924231|NCT03976466|50017710|FG000|Overall Study|Lost to Follow-up|1|||
24924232|NCT03976466|50017711|FG001|Overall Study|Lost to Follow-up|3|||
24924233|NCT02536755|50017719|FG000|Overall Study|Adverse Event|4|||
24924234|NCT03303105|50017728|FG000|Overall Study|Adverse Event|0|||
24924235|NCT03303105|50017729|FG001|Overall Study|Adverse Event|2|||
24924236|NCT03303105|50017728|FG000|Overall Study|Lack of Efficacy|1|||
24924237|NCT03303105|50017729|FG001|Overall Study|Lack of Efficacy|0|||
24924238|NCT03303105|50017728|FG000|Overall Study|Protocol Violation|1|||
24924239|NCT03303105|50017729|FG001|Overall Study|Protocol Violation|0|||
24924240|NCT03303105|50017728|FG000|Overall Study|Withdrawal by Subject|0|||
24924241|NCT03303105|50017729|FG001|Overall Study|Withdrawal by Subject|2|||
24924242|NCT00447694|50017735|FG000|Overall Study|Adverse Event|2|||
25024290|NCT03611075|50121941|FG007|Overall Study|Withdrawal by Subject|0|||
25024291|NCT03611075|50121942|FG008|Overall Study|Withdrawal by Subject|0|||
25024292|NCT03611075|50121934|FG000|Overall Study|Reason unknown|0|||
25024293|NCT03611075|50121935|FG001|Overall Study|Reason unknown|0|||
25024294|NCT03611075|50121936|FG002|Overall Study|Reason unknown|0|||
25024295|NCT03611075|50121937|FG003|Overall Study|Reason unknown|1|||
25024296|NCT03611075|50121938|FG004|Overall Study|Reason unknown|0|||
25024297|NCT03611075|50121939|FG005|Overall Study|Reason unknown|0|||
25024298|NCT03611075|50121940|FG006|Overall Study|Reason unknown|1|||
25024299|NCT03611075|50121941|FG007|Overall Study|Reason unknown|0|||
25024300|NCT03611075|50121942|FG008|Overall Study|Reason unknown|0|||
25024301|NCT03095508|50121987|FG000|Overall Study|Adverse Event|0|||
25024302|NCT03095508|50121988|FG001|Overall Study|Adverse Event|1|||
25024303|NCT03607487|50121998|FG000|Overall Study|Withdrawal by Subject|2|||
25024304|NCT03607487|50121999|FG001|Overall Study|Withdrawal by Subject|0|||
25024305|NCT03607487|50122000|FG002|Overall Study|Withdrawal by Subject|0|||
25024306|NCT03607487|50122001|FG003|Overall Study|Withdrawal by Subject|1|||
25024307|NCT03605693|50122015|FG000|Overall Study|Lost to Follow-up|4|||
25024308|NCT03605693|50122016|FG001|Overall Study|Lost to Follow-up|0|||
25024309|NCT03605693|50122015|FG000|Overall Study|Physician Decision|1|||
25024310|NCT03605693|50122016|FG001|Overall Study|Physician Decision|0|||
25024311|NCT03605303|50122022|FG000|Period 1|Study Terminated|2|||
25024312|NCT03605303|50122023|FG001|Period 1|Study Terminated|1|||
25024313|NCT03604523|50122031|FG000|Overall Study|Physician Decision|1|||
25024314|NCT03604523|50122032|FG001|Overall Study|Physician Decision|0|||
25024315|NCT03602339|50122038|FG000|Overall Study|Withdrawal by Subject|9|||
25024316|NCT03602339|50122038|FG000|Overall Study|Physician Decision|2|||
25024317|NCT03602339|50122038|FG000|Overall Study|Other reason|4|||
25024318|NCT03653429|50122047|FG000|Overall Study|Physician Decision|4|||
25024319|NCT03653429|50122048|FG001|Overall Study|Physician Decision|10|||
25024320|NCT03601715|50122057|FG000|Second Intervention|Lost to Follow-up|1|||
25024321|NCT03601715|50122058|FG001|Second Intervention|Lost to Follow-up|1|||
25024322|NCT03601715|50122059|FG002|Second Intervention|Lost to Follow-up|0|||
25024323|NCT03594227|50122071|FG000|Overall Study|Adverse Event|2|||
25024324|NCT03594227|50122072|FG001|Overall Study|Adverse Event|1|||
25024325|NCT03594227|50122073|FG002|Overall Study|Adverse Event|0|||
25024326|NCT03594227|50122074|FG003|Overall Study|Adverse Event|2|||
25024327|NCT03594227|50122071|FG000|Overall Study|Lost to Follow-up|1|||
25185527|NCT01500278|50335063|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
24924243|NCT00447694|50017735|FG000|Overall Study|Abnormal laboratory value|1|||
24924244|NCT00447694|50017735|FG000|Overall Study|Abnormal test procedure result|1|||
24924245|NCT00447694|50017735|FG000|Overall Study|Withdrawal by Subject|2|||
24924246|NCT00564278|50017741|FG000|Overall Study|Lost to Follow-up|35|||
24924247|NCT00564278|50017742|FG001|Overall Study|Lost to Follow-up|33|||
24924248|NCT00564278|50017741|FG000|Overall Study|Physician Decision|1|||
24924249|NCT00564278|50017742|FG001|Overall Study|Physician Decision|2|||
25024328|NCT03594227|50122072|FG001|Overall Study|Lost to Follow-up|1|||
25024329|NCT03594227|50122073|FG002|Overall Study|Lost to Follow-up|1|||
25024330|NCT03594227|50122074|FG003|Overall Study|Lost to Follow-up|0|||
25024331|NCT03594227|50122071|FG000|Overall Study|Withdrawal by Subject|1|||
25024332|NCT03594227|50122072|FG001|Overall Study|Withdrawal by Subject|1|||
25024333|NCT03594227|50122073|FG002|Overall Study|Withdrawal by Subject|1|||
25024334|NCT03594227|50122074|FG003|Overall Study|Withdrawal by Subject|1|||
25024335|NCT03594227|50122071|FG000|Overall Study|Pregnancy|0|||
24924250|NCT00564278|50017741|FG000|Overall Study|Withdrawal by Subject|11|||
24924251|NCT00564278|50017742|FG001|Overall Study|Withdrawal by Subject|7|||
25024336|NCT03594227|50122072|FG001|Overall Study|Pregnancy|1|||
25024337|NCT03594227|50122073|FG002|Overall Study|Pregnancy|0|||
25024338|NCT03594227|50122074|FG003|Overall Study|Pregnancy|0|||
25024339|NCT03594227|50122071|FG000|Overall Study|Sponsor Decision|0|||
25024340|NCT03594227|50122072|FG001|Overall Study|Sponsor Decision|0|||
25024341|NCT03594227|50122073|FG002|Overall Study|Sponsor Decision|0|||
25024342|NCT03594227|50122074|FG003|Overall Study|Sponsor Decision|1|||
25024343|NCT03594227|50122071|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
25024344|NCT03594227|50122072|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
25024345|NCT03594227|50122073|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
25024346|NCT03594227|50122074|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
25024347|NCT03098550|50122098|FG000|Overall Study|Disease Progression|30|||
24924252|NCT00565604|50017748|FG000|Overall Study|Failure to treat|2|||
24924253|NCT00565604|50017748|FG000|Overall Study|Lost to Follow-up|2|||
24924254|NCT00447382|50017754|FG000|Overall Study|Adverse Event|1|||
24924255|NCT00447382|50017755|FG001|Overall Study|Adverse Event|1|||
24924256|NCT00447382|50017754|FG000|Overall Study|Lack of Efficacy|1|||
24924257|NCT00447382|50017755|FG001|Overall Study|Lack of Efficacy|0|||
24924258|NCT00447382|50017754|FG000|Overall Study|Protocol Violation|2|||
24924259|NCT00447382|50017755|FG001|Overall Study|Protocol Violation|0|||
24924260|NCT00447382|50017754|FG000|Overall Study|Unclassified|2|||
24924261|NCT00447382|50017755|FG001|Overall Study|Unclassified|5|||
24924262|NCT00447226|50017761|FG000|12-Week Open-label Phase|Adverse Event|0|||
24924263|NCT00447226|50017762|FG001|12-Week Open-label Phase|Adverse Event|3|||
24924264|NCT00447226|50017761|FG000|12-Week Open-label Phase|Protocol Violation|0|||
24924265|NCT00447226|50017762|FG001|12-Week Open-label Phase|Protocol Violation|1|||
24924266|NCT00447226|50017761|FG000|12-Week Open-label Phase|Disease Progression|0|||
24924267|NCT00447226|50017762|FG001|12-Week Open-label Phase|Disease Progression|20|||
24924268|NCT00447226|50017761|FG000|12-Week Open-label Phase|Physician Decision|0|||
24924269|NCT00447226|50017762|FG001|12-Week Open-label Phase|Physician Decision|1|||
24924270|NCT00447226|50017761|FG000|Double-blind Phase|Disease Progression|4|||
24924271|NCT00447226|50017762|FG001|Double-blind Phase|Disease Progression|3|||
24924272|NCT00446992|50017777|FG000|Overall Study|Adverse Event|11|||
24924273|NCT00446992|50017777|FG000|Overall Study|Lost to Follow-up|5|||
24924274|NCT00503139|50017781|FG000|Overall Study|Case Report Forms were not collected|4|||
24924275|NCT00503139|50017781|FG000|Overall Study|Protocol Violation|4|||
24924276|NCT00577031|50017785|FG000|Overall Study|Adverse Event|52|||
24924277|NCT00577031|50017785|FG000|Overall Study|Progression of disease|93|||
24924278|NCT00577031|50017785|FG000|Overall Study|Protocol Violation|5|||
24924279|NCT00577031|50017785|FG000|Overall Study|Participant withdrew consent|13|||
24924280|NCT00577031|50017785|FG000|Overall Study|Participant non-compliance|5|||
24924281|NCT00577031|50017785|FG000|Overall Study|Need for surgery|17|||
24924282|NCT00577031|50017785|FG000|Overall Study|Medical decision|14|||
24924283|NCT00577031|50017785|FG000|Overall Study|Death|6|||
24924284|NCT00565448|50017794|FG000|Overall Study|Adverse Event|1|||
24924285|NCT00565448|50017795|FG001|Overall Study|Adverse Event|2|||
24924286|NCT00565448|50017794|FG000|Overall Study|Disease progression|1|||
24924287|NCT00565448|50017795|FG001|Overall Study|Disease progression|0|||
24924288|NCT00565448|50017794|FG000|Overall Study|Withdrawal by Subject|1|||
24924289|NCT00565448|50017795|FG001|Overall Study|Withdrawal by Subject|0|||
24924290|NCT00446446|50017804|FG000|Overall Study|Death|10|||
24924291|NCT00446446|50017804|FG000|Overall Study|Withdrawal by Subject|6|||
24924292|NCT00446446|50017804|FG000|Overall Study|Other|4|||
24924293|NCT00446446|50017804|FG000|Overall Study|Disease Progession|2|||
24924294|NCT00446446|50017804|FG000|Overall Study|Adverse Event|1|||
24924295|NCT00446446|50017804|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
24924296|NCT00506493|50017808|FG000|Overall Study|Death|6|||
24924297|NCT00506493|50017808|FG000|Overall Study|Withdrawal by Subject|5|||
24924298|NCT00514449|50017816|FG000|Overall Study|Withdrawal by Subject|1|||
24924299|NCT00514449|50017817|FG001|Overall Study|Withdrawal by Subject|2|||
24924300|NCT00514449|50017816|FG000|Overall Study|Protocol Violation|1|||
24924301|NCT00514449|50017817|FG001|Overall Study|Protocol Violation|2|||
24924302|NCT00514449|50017816|FG000|Overall Study|Lost to Follow-up|1|||
25024348|NCT03098550|50122099|FG001|Overall Study|Disease Progression|19|||
25024349|NCT03098550|50122100|FG002|Overall Study|Disease Progression|41|||
25024350|NCT03098550|50122098|FG000|Overall Study|Study Drug Toxicity|2|||
25024351|NCT03098550|50122099|FG001|Overall Study|Study Drug Toxicity|1|||
25024352|NCT03098550|50122100|FG002|Overall Study|Study Drug Toxicity|0|||
24924303|NCT00514449|50017817|FG001|Overall Study|Lost to Follow-up|0|||
24924304|NCT00565136|50017826|FG000|Overall Study|Lost to Follow-up|1|||
24924305|NCT00565136|50017826|FG000|Overall Study|Withdrawal by Subject|1|||
25024353|NCT03098550|50122098|FG000|Overall Study|Death|1|||
25024354|NCT03098550|50122099|FG001|Overall Study|Death|0|||
25024355|NCT03098550|50122100|FG002|Overall Study|Death|0|||
25024356|NCT03098550|50122098|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
25024357|NCT03098550|50122099|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
25024358|NCT03098550|50122100|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
24924306|NCT00565136|50017826|FG000|Overall Study|Protocol Violation|1|||
24924307|NCT00492921|50017830|FG000|Overall Study|Death|1|||
24924308|NCT00492921|50017831|FG001|Overall Study|Death|0|||
24924309|NCT00492921|50017832|FG002|Overall Study|Death|1|||
24924310|NCT00502671|50017840|FG000|Overall Study|Disease Progression|13|||
24924311|NCT00502671|50017840|FG000|Overall Study|Personal Reasons|22|||
24924312|NCT00502671|50017840|FG000|Overall Study|Lost to Follow-up|7|||
24924313|NCT00502671|50017840|FG000|Overall Study|Protocol Violation|16|||
24924314|NCT00502671|50017840|FG000|Overall Study|Adverse Event|19|||
24924315|NCT00697463|50017844|FG000|Overall Study|Withdrawal by Subject|1|||
24924316|NCT00492531|50017850|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
24924317|NCT00492531|50017851|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
24924318|NCT00111475|50017867|FG000|Overall Study|Lost to Follow-up|0|||
24924319|NCT00111475|50017868|FG001|Overall Study|Lost to Follow-up|0|||
24924320|NCT00111475|50017869|FG002|Overall Study|Lost to Follow-up|0|||
24924321|NCT00111475|50017870|FG003|Overall Study|Lost to Follow-up|0|||
24924322|NCT00111475|50017871|FG004|Overall Study|Lost to Follow-up|0|||
24924323|NCT00111475|50017872|FG005|Overall Study|Lost to Follow-up|1|||
24924324|NCT00111475|50017873|FG006|Overall Study|Lost to Follow-up|0|||
24924325|NCT00111475|50017874|FG007|Overall Study|Lost to Follow-up|0|||
24924326|NCT00111475|50017875|FG008|Overall Study|Lost to Follow-up|0|||
24924327|NCT00111475|50017876|FG009|Overall Study|Lost to Follow-up|0|||
24924328|NCT00111241|50017905|FG000|Overall Study|Lost to Follow-up|1|||
24924329|NCT00111241|50017906|FG001|Overall Study|Lost to Follow-up|0|||
25024359|NCT03098550|50122098|FG000|Overall Study|Administrative reason by sponsor|0|||
25024360|NCT03098550|50122099|FG001|Overall Study|Administrative reason by sponsor|0|||
25024361|NCT03098550|50122100|FG002|Overall Study|Administrative reason by sponsor|1|||
25024362|NCT03098550|50122098|FG000|Overall Study|Other reasons|2|||
25024363|NCT03098550|50122099|FG001|Overall Study|Other reasons|0|||
25024364|NCT03098550|50122100|FG002|Overall Study|Other reasons|0|||
25024365|NCT03095118|50122112|FG000|Overall Study|Adverse Event|1|||
25024366|NCT03095118|50122112|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
25024367|NCT03594071|50122116|FG000|Overall Study|Re-operation|3|||
25024368|NCT03594071|50122116|FG000|Overall Study|Missed visit|2|||
25154886|NCT01925209|50270121|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
25154887|NCT01925209|50270122|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
24924330|NCT00111241|50017905|FG000|Overall Study|Withdrawal by Subject|4|||
24924331|NCT00111241|50017906|FG001|Overall Study|Withdrawal by Subject|0|||
24924332|NCT00111241|50017905|FG000|Overall Study|Protocol Violation|9|||
24924333|NCT00111241|50017906|FG001|Overall Study|Protocol Violation|8|||
24924334|NCT00111241|50017905|FG000|Overall Study|Adverse Event|1|||
24924335|NCT00111241|50017906|FG001|Overall Study|Adverse Event|0|||
24924336|NCT00492297|50017914|FG000|Treatment|Death|2|||
24924337|NCT00492297|50017914|FG000|Treatment|Study terminated by sponsor|3|||
25024369|NCT02696902|50122123|FG000|Overall Study|Lost to Follow-up|0|||
25154888|NCT01925209|50270119|FG000|Treatment Epoch|Death|1|||
24924338|NCT00492297|50017914|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
24924339|NCT00492297|50017914|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
24924340|NCT00492297|50017914|FG000|Survival Only Follow-up|Death|46|||
24924341|NCT00492297|50017914|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
24924342|NCT00492297|50017914|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
25024370|NCT02696902|50122124|FG001|Overall Study|Lost to Follow-up|1|||
25024371|NCT02696902|50122125|FG002|Overall Study|Lost to Follow-up|1|||
25024372|NCT02696902|50122123|FG000|Overall Study|Withdrawal by Subject|0|||
25024373|NCT02696902|50122124|FG001|Overall Study|Withdrawal by Subject|0|||
24924343|NCT00565058|50017920|FG000|Overall Study|Adverse Event|1|||
24924344|NCT00565058|50017921|FG001|Overall Study|Adverse Event|0|||
24924345|NCT00564902|50017930|FG000|Overall Study|Withdrawal by Subject|0|||
24924346|NCT00564902|50017931|FG001|Overall Study|Withdrawal by Subject|3|||
24924347|NCT00564902|50017932|FG002|Overall Study|Withdrawal by Subject|4|||
24924348|NCT00564902|50017930|FG000|Overall Study|Death|1|||
24924349|NCT00564902|50017931|FG001|Overall Study|Death|1|||
24924350|NCT00564902|50017932|FG002|Overall Study|Death|0|||
25024374|NCT02696902|50122125|FG002|Overall Study|Withdrawal by Subject|1|||
25024375|NCT02696902|50122123|FG000|Overall Study|Death|19|||
25154889|NCT01925209|50270120|FG001|Treatment Epoch|Death|0|||
25154890|NCT01925209|50270121|FG002|Treatment Epoch|Death|0|||
25154891|NCT01925209|50270122|FG003|Treatment Epoch|Death|0|||
25154892|NCT01925209|50270119|FG000|Treatment Epoch|Protocol deviation|0|||
25154893|NCT01925209|50270120|FG001|Treatment Epoch|Protocol deviation|0|||
25154894|NCT01925209|50270121|FG002|Treatment Epoch|Protocol deviation|1|||
25154895|NCT01925209|50270122|FG003|Treatment Epoch|Protocol deviation|1|||
25154896|NCT01925209|50270119|FG000|Treatment Epoch|Withdrawal by Subject|4|||
25154897|NCT01925209|50270120|FG001|Treatment Epoch|Withdrawal by Subject|3|||
25154898|NCT01925209|50270121|FG002|Treatment Epoch|Withdrawal by Subject|3|||
25154899|NCT01925209|50270122|FG003|Treatment Epoch|Withdrawal by Subject|2|||
25154900|NCT01925209|50270119|FG000|Treatment Epoch|Adverse Event|3|||
25154901|NCT01925209|50270120|FG001|Treatment Epoch|Adverse Event|5|||
25154902|NCT01925209|50270121|FG002|Treatment Epoch|Adverse Event|3|||
25154903|NCT01925209|50270122|FG003|Treatment Epoch|Adverse Event|1|||
25154904|NCT01925209|50270119|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
25154905|NCT01925209|50270120|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
25154906|NCT01925209|50270121|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
25154907|NCT01925209|50270122|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
25154908|NCT01925209|50270119|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
25024376|NCT02696902|50122124|FG001|Overall Study|Death|3|||
25024377|NCT02696902|50122125|FG002|Overall Study|Death|24|||
25024378|NCT02696902|50122123|FG000|Overall Study|Participant not fit post-randomization|0|||
25024379|NCT02696902|50122124|FG001|Overall Study|Participant not fit post-randomization|0|||
25024380|NCT02696902|50122125|FG002|Overall Study|Participant not fit post-randomization|1|||
25024381|NCT02696902|50122123|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
25024382|NCT02696902|50122124|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
25024383|NCT02696902|50122125|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
25154909|NCT01925209|50270120|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
25154910|NCT01925209|50270121|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
24924351|NCT00446134|50017944|FG000|Overall Study|Adverse Event|7|||
24924352|NCT00446134|50017945|FG001|Overall Study|Adverse Event|17|||
24924353|NCT00446134|50017946|FG002|Overall Study|Adverse Event|13|||
25024384|NCT02696902|50122123|FG000|Overall Study|Principal investigator's decision|1|||
25154911|NCT01925209|50270122|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
25154912|NCT01925209|50270119|FG000|Follow-up|Adverse Event|1|||
25154913|NCT01925209|50270120|FG001|Follow-up|Adverse Event|4|||
25154914|NCT01925209|50270121|FG002|Follow-up|Adverse Event|0|||
24924354|NCT00446134|50017947|FG003|Overall Study|Adverse Event|18|||
24924355|NCT00446134|50017944|FG000|Overall Study|Lack of Efficacy|19|||
24924356|NCT00446134|50017945|FG001|Overall Study|Lack of Efficacy|19|||
24924357|NCT00446134|50017946|FG002|Overall Study|Lack of Efficacy|24|||
24924358|NCT00446134|50017947|FG003|Overall Study|Lack of Efficacy|19|||
24924359|NCT00446134|50017944|FG000|Overall Study|Protocol Violation|0|||
24924360|NCT00446134|50017945|FG001|Overall Study|Protocol Violation|2|||
24924361|NCT00446134|50017946|FG002|Overall Study|Protocol Violation|1|||
24924362|NCT00446134|50017947|FG003|Overall Study|Protocol Violation|0|||
24924363|NCT00446134|50017944|FG000|Overall Study|Lost to Follow-up|1|||
24924364|NCT00446134|50017945|FG001|Overall Study|Lost to Follow-up|3|||
24924365|NCT00446134|50017946|FG002|Overall Study|Lost to Follow-up|1|||
24924366|NCT00446134|50017947|FG003|Overall Study|Lost to Follow-up|1|||
24924367|NCT00446134|50017944|FG000|Overall Study|Withdrawal by Subject|3|||
24924368|NCT00446134|50017945|FG001|Overall Study|Withdrawal by Subject|3|||
24924369|NCT00446134|50017946|FG002|Overall Study|Withdrawal by Subject|1|||
24924370|NCT00446134|50017947|FG003|Overall Study|Withdrawal by Subject|3|||
24924371|NCT00446134|50017944|FG000|Overall Study|Physician Decision|0|||
24924372|NCT00446134|50017945|FG001|Overall Study|Physician Decision|0|||
24924373|NCT00446134|50017946|FG002|Overall Study|Physician Decision|0|||
24924374|NCT00446134|50017947|FG003|Overall Study|Physician Decision|2|||
24924375|NCT00446134|50017944|FG000|Overall Study|Adverse Event-Diarrhea|1|||
24924376|NCT00446134|50017945|FG001|Overall Study|Adverse Event-Diarrhea|1|||
24924377|NCT00446134|50017946|FG002|Overall Study|Adverse Event-Diarrhea|2|||
24924378|NCT00446134|50017947|FG003|Overall Study|Adverse Event-Diarrhea|0|||
24924379|NCT00446134|50017944|FG000|Overall Study|Reason Not Completed|3|||
24924380|NCT00446134|50017945|FG001|Overall Study|Reason Not Completed|0|||
24924381|NCT00446134|50017946|FG002|Overall Study|Reason Not Completed|1|||
24924382|NCT00446134|50017947|FG003|Overall Study|Reason Not Completed|2|||
24924383|NCT00563186|50017959|FG000|Overall Study|LOS<48 hours|97|||
24924384|NCT00563186|50017960|FG001|Overall Study|LOS<48 hours|74|||
24924385|NCT00563186|50017959|FG000|Overall Study|Incomplete data|1|||
24924386|NCT00563186|50017960|FG001|Overall Study|Incomplete data|1|||
24924387|NCT00699413|50017971|FG000|Overall Study|Withdrawal by Subject|0|||
24924388|NCT00699413|50017972|FG001|Overall Study|Withdrawal by Subject|2|||
24924389|NCT00699413|50017971|FG000|Overall Study|Study terminated by sponsor|4|||
24924390|NCT00699413|50017972|FG001|Overall Study|Study terminated by sponsor|2|||
24924391|NCT04808609|50017980|FG000|Overall Study|Lost to Follow-up|0|||
24924392|NCT04808609|50017981|FG001|Overall Study|Lost to Follow-up|2|||
25024385|NCT02696902|50122124|FG001|Overall Study|Principal investigator's decision|0|||
25154915|NCT01925209|50270122|FG003|Follow-up|Adverse Event|1|||
24924393|NCT04808609|50017980|FG000|Overall Study|Administrative Withdrawal|0|||
24924394|NCT04808609|50017981|FG001|Overall Study|Administrative Withdrawal|1|||
24924395|NCT00111007|50017989|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
24924396|NCT00111007|50017990|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
24924397|NCT00111007|50017989|FG000|Double-blind (DB) Treatment|Death|5|||
24924398|NCT00111007|50017990|FG001|Double-blind (DB) Treatment|Death|2|||
24924399|NCT00111007|50017989|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
24924400|NCT00111007|50017990|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
24924401|NCT00111007|50017989|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
24924402|NCT00111007|50017990|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
24924403|NCT00111007|50017989|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
24924404|NCT00111007|50017990|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
24924405|NCT00111007|50017989|FG000|Double-blind (DB) Treatment|Relapse|1|||
24924406|NCT00111007|50017990|FG001|Double-blind (DB) Treatment|Relapse|0|||
24924407|NCT00111007|50017989|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
24924408|NCT00111007|50017990|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
25154916|NCT01925209|50270119|FG000|Follow-up|Physician Decision|0|||
25154917|NCT01925209|50270120|FG001|Follow-up|Physician Decision|0|||
25024386|NCT02696902|50122125|FG002|Overall Study|Principal investigator's decision|0|||
25024387|NCT02696902|50122123|FG000|Overall Study|Sponsor's decision|1|||
25024388|NCT02696902|50122124|FG001|Overall Study|Sponsor's decision|0|||
25024389|NCT02696902|50122125|FG002|Overall Study|Sponsor's decision|0|||
25024390|NCT02696902|50122123|FG000|Overall Study|Transferred to other hospital|1|||
25024391|NCT02696902|50122124|FG001|Overall Study|Transferred to other hospital|0|||
25024392|NCT02696902|50122125|FG002|Overall Study|Transferred to other hospital|0|||
25024393|NCT02694562|50122135|FG000|Overall Study|Death|8|||
25024394|NCT02694562|50122135|FG000|Overall Study|Protocol Violation|4|||
25024395|NCT02694562|50122135|FG000|Overall Study|Lost to Follow-up|3|||
25024396|NCT02694562|50122135|FG000|Overall Study|Screen Failure|2|||
25024397|NCT02694562|50122135|FG000|Overall Study|Physician Decision|1|||
25024398|NCT02874534|50122141|FG000|Overall Study|Withdrawal by Subject|5|||
25024399|NCT02874534|50122142|FG001|Overall Study|Withdrawal by Subject|8|||
25024400|NCT02874534|50122141|FG000|Overall Study|Lost to Follow-up|2|||
25024401|NCT02874534|50122142|FG001|Overall Study|Lost to Follow-up|2|||
25024402|NCT02874534|50122141|FG000|Overall Study|Ongoing in study|1|||
25024403|NCT02874534|50122142|FG001|Overall Study|Ongoing in study|1|||
25024404|NCT03097614|50122148|FG000|Overall Study|Adverse Event|3|||
25024405|NCT03364309|50122155|FG000|Induction Period|Adverse Event|4|||
25024406|NCT03364309|50122156|FG001|Induction Period|Adverse Event|0|||
25024407|NCT03364309|50122157|FG002|Induction Period|Adverse Event|1|||
25024408|NCT03364309|50122158|FG003|Induction Period|Adverse Event|0|||
25024409|NCT03364309|50122159|FG004|Induction Period|Adverse Event|0|||
25024410|NCT03364309|50122160|FG005|Induction Period|Adverse Event|0|||
25024411|NCT03364309|50122161|FG006|Induction Period|Adverse Event|0|||
25024412|NCT03364309|50122162|FG007|Induction Period|Adverse Event|0|||
25024413|NCT03364309|50122163|FG008|Induction Period|Adverse Event|0|||
25024414|NCT03364309|50122164|FG009|Induction Period|Adverse Event|0|||
25024415|NCT03364309|50122165|FG010|Induction Period|Adverse Event|0|||
25024416|NCT03364309|50122166|FG011|Induction Period|Adverse Event|0|||
25024417|NCT03364309|50122167|FG012|Induction Period|Adverse Event|0|||
25024418|NCT03364309|50122168|FG013|Induction Period|Adverse Event|0|||
25024419|NCT03364309|50122169|FG014|Induction Period|Adverse Event|0|||
25024420|NCT03364309|50122170|FG015|Induction Period|Adverse Event|0|||
25024421|NCT03364309|50122171|FG016|Induction Period|Adverse Event|0|||
25024422|NCT03364309|50122172|FG017|Induction Period|Adverse Event|0|||
25024423|NCT03364309|50122173|FG018|Induction Period|Adverse Event|0|||
25024424|NCT03364309|50122155|FG000|Induction Period|Withdrawal by Subject|1|||
25024425|NCT03364309|50122156|FG001|Induction Period|Withdrawal by Subject|3|||
25024426|NCT03364309|50122157|FG002|Induction Period|Withdrawal by Subject|0|||
25024427|NCT03364309|50122158|FG003|Induction Period|Withdrawal by Subject|0|||
25024428|NCT03364309|50122159|FG004|Induction Period|Withdrawal by Subject|0|||
25024429|NCT03364309|50122160|FG005|Induction Period|Withdrawal by Subject|0|||
25024430|NCT03364309|50122161|FG006|Induction Period|Withdrawal by Subject|0|||
25024431|NCT03364309|50122162|FG007|Induction Period|Withdrawal by Subject|0|||
25024432|NCT03364309|50122163|FG008|Induction Period|Withdrawal by Subject|0|||
25024433|NCT03364309|50122164|FG009|Induction Period|Withdrawal by Subject|0|||
25024434|NCT03364309|50122165|FG010|Induction Period|Withdrawal by Subject|0|||
25024435|NCT03364309|50122166|FG011|Induction Period|Withdrawal by Subject|0|||
25024436|NCT03364309|50122167|FG012|Induction Period|Withdrawal by Subject|0|||
25024437|NCT03364309|50122168|FG013|Induction Period|Withdrawal by Subject|0|||
25024438|NCT03364309|50122169|FG014|Induction Period|Withdrawal by Subject|0|||
25024439|NCT03364309|50122170|FG015|Induction Period|Withdrawal by Subject|0|||
25024440|NCT03364309|50122171|FG016|Induction Period|Withdrawal by Subject|0|||
25024441|NCT03364309|50122172|FG017|Induction Period|Withdrawal by Subject|0|||
25024442|NCT03364309|50122173|FG018|Induction Period|Withdrawal by Subject|0|||
25024443|NCT03364309|50122155|FG000|Induction Period|Lost to Follow-up|1|||
25024444|NCT03364309|50122156|FG001|Induction Period|Lost to Follow-up|0|||
25024445|NCT03364309|50122157|FG002|Induction Period|Lost to Follow-up|0|||
25024446|NCT03364309|50122158|FG003|Induction Period|Lost to Follow-up|0|||
25024447|NCT03364309|50122159|FG004|Induction Period|Lost to Follow-up|0|||
25024448|NCT03364309|50122160|FG005|Induction Period|Lost to Follow-up|0|||
25024449|NCT03364309|50122161|FG006|Induction Period|Lost to Follow-up|0|||
25024450|NCT03364309|50122162|FG007|Induction Period|Lost to Follow-up|0|||
25024451|NCT03364309|50122163|FG008|Induction Period|Lost to Follow-up|0|||
25024452|NCT03364309|50122164|FG009|Induction Period|Lost to Follow-up|0|||
25024453|NCT03364309|50122165|FG010|Induction Period|Lost to Follow-up|0|||
25024454|NCT03364309|50122166|FG011|Induction Period|Lost to Follow-up|0|||
25024455|NCT03364309|50122167|FG012|Induction Period|Lost to Follow-up|0|||
25024456|NCT03364309|50122168|FG013|Induction Period|Lost to Follow-up|0|||
25024457|NCT03364309|50122169|FG014|Induction Period|Lost to Follow-up|0|||
25024458|NCT03364309|50122170|FG015|Induction Period|Lost to Follow-up|0|||
25024459|NCT03364309|50122171|FG016|Induction Period|Lost to Follow-up|0|||
25024460|NCT03364309|50122172|FG017|Induction Period|Lost to Follow-up|0|||
25024461|NCT03364309|50122173|FG018|Induction Period|Lost to Follow-up|0|||
25024462|NCT03364309|50122155|FG000|Induction Period|Physician Decision|0|||
25154918|NCT01925209|50270121|FG002|Follow-up|Physician Decision|1|||
25154919|NCT01925209|50270122|FG003|Follow-up|Physician Decision|0|||
24924409|NCT00111007|50017989|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
24924410|NCT00111007|50017990|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
24924411|NCT00111007|50017989|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
24924412|NCT00111007|50017990|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
24924413|NCT00111007|50017989|FG000|Active Follow-up|Adverse Event|1|||
24924414|NCT00111007|50017990|FG001|Active Follow-up|Adverse Event|0|||
24924415|NCT00111007|50017989|FG000|Active Follow-up|Death|2|||
24924416|NCT00111007|50017990|FG001|Active Follow-up|Death|0|||
24924417|NCT00111007|50017989|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
24924418|NCT00111007|50017990|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
24924419|NCT00111007|50017989|FG000|Long Term Follow-up|Death|34|||
24924420|NCT00111007|50017990|FG001|Long Term Follow-up|Death|39|||
24924421|NCT00111007|50017989|FG000|Long Term Follow-up|Lost to Follow-up|1|||
24924422|NCT00111007|50017990|FG001|Long Term Follow-up|Lost to Follow-up|1|||
24924423|NCT00111007|50017989|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
24924424|NCT00111007|50017990|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
24924425|NCT00111007|50017989|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
24924426|NCT00111007|50017990|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
24924427|NCT00111007|50017989|FG000|Long Term Follow-up|Missing|10|||
24924428|NCT00111007|50017990|FG001|Long Term Follow-up|Missing|3|||
24924429|NCT03975920|50017998|FG000|Overall Study|Lost to Follow-up|1|||
24924430|NCT03975920|50017999|FG001|Overall Study|Lost to Follow-up|2|||
24924431|NCT03975920|50017998|FG000|Overall Study|Protocol Violation|1|||
24924432|NCT03975920|50017999|FG001|Overall Study|Protocol Violation|1|||
24924433|NCT03975920|50017998|FG000|Overall Study|Did not complete survey|2|||
24924434|NCT03975920|50017999|FG001|Overall Study|Did not complete survey|1|||
24924435|NCT00699335|50018005|FG000|Overall Study|Combination of multiple reasons|176|||
24924436|NCT00699335|50018005|FG000|Overall Study|Missing data|52|||
24924437|NCT00445978|50018012|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
24924438|NCT00445978|50018012|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
24924439|NCT00445978|50018012|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
24924440|NCT00445978|50018012|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
24924441|NCT00445978|50018012|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
24924442|NCT00445978|50018012|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
24924443|NCT00445978|50018012|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
24924444|NCT00445978|50018012|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
24924445|NCT00445978|50018012|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
24924446|NCT00566228|50018025|FG000|Overall Study|Withdrawal by Subject|1|||
24924447|NCT00566228|50018026|FG001|Overall Study|Withdrawal by Subject|0|||
24924448|NCT00566228|50018025|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
24924449|NCT00566228|50018026|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
24924450|NCT00566228|50018025|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
24924451|NCT00566228|50018026|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
24924452|NCT00566228|50018025|FG000|Overall Study|progressed before infusion could occur|0|||
24924453|NCT00566228|50018026|FG001|Overall Study|progressed before infusion could occur|1|||
24924454|NCT00698009|50018032|FG000|Overall Study|Withdrawal by Subject|1|||
24924455|NCT03968978|50018038|FG000|Overall Study|Adverse Event|1|||
24924456|NCT03968978|50018039|FG001|Overall Study|Adverse Event|0|||
24924457|NCT00562718|50018045|FG000|Overall Study|Death|1|||
24924458|NCT00562718|50018045|FG000|Overall Study|Withdrawal by Subject|3|||
24924459|NCT00562718|50018045|FG000|Overall Study|Adverse Event|4|||
24924460|NCT00562718|50018045|FG000|Overall Study|Lack of Efficacy|2|||
24924461|NCT00562718|50018045|FG000|Overall Study|not stated|1|||
24924462|NCT00697619|50018051|FG000|Overall Study|Lack of Efficacy|2|||
25154920|NCT01925209|50270119|FG000|Follow-up|Non-compliance with study treatment|0|||
25154921|NCT01925209|50270120|FG001|Follow-up|Non-compliance with study treatment|0|||
25154922|NCT01925209|50270121|FG002|Follow-up|Non-compliance with study treatment|0|||
25154923|NCT01925209|50270122|FG003|Follow-up|Non-compliance with study treatment|1|||
25154924|NCT01925209|50270119|FG000|Follow-up|Withdrawal by Subject|0|||
24924463|NCT00697619|50018052|FG001|Overall Study|Lack of Efficacy|2|||
24924464|NCT00697619|50018051|FG000|Overall Study|Adverse Event|4|||
24924465|NCT00697619|50018052|FG001|Overall Study|Adverse Event|6|||
24924466|NCT00445432|50018061|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
25154925|NCT01925209|50270120|FG001|Follow-up|Withdrawal by Subject|2|||
25154926|NCT01925209|50270121|FG002|Follow-up|Withdrawal by Subject|0|||
25154927|NCT01925209|50270122|FG003|Follow-up|Withdrawal by Subject|2|||
25154928|NCT01614925|50270134|FG000|Overall Study|Withdrawal by Subject|1|||
25154929|NCT01614925|50270135|FG001|Overall Study|Withdrawal by Subject|0|||
25154930|NCT01614925|50270134|FG000|Overall Study|Protocol Violation|3|||
25154931|NCT01614925|50270135|FG001|Overall Study|Protocol Violation|2|||
25154932|NCT01886833|50270141|FG000|Overall Study|IgA not available from both periods|204|||
25154933|NCT01898923|50270150|FG000|Overall Study|Lack of Efficacy|5|||
25154934|NCT01898923|50270151|FG001|Overall Study|Lack of Efficacy|6|||
24924467|NCT00445432|50018062|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
24924468|NCT00445432|50018063|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
24924469|NCT00445432|50018064|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
24924470|NCT00445432|50018061|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
24924471|NCT00445432|50018062|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
24924472|NCT00445432|50018063|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
24924473|NCT00445432|50018064|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
24924474|NCT00445432|50018061|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
24924475|NCT00445432|50018062|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
24924476|NCT00445432|50018063|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
24924477|NCT00445432|50018064|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
24924478|NCT00445432|50018061|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
24924479|NCT00445432|50018062|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
24924480|NCT00445432|50018063|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
24924481|NCT00445432|50018064|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
24924482|NCT00445432|50018061|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
24924483|NCT00445432|50018062|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
24924484|NCT00445432|50018063|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
24924485|NCT00445432|50018064|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
24924486|NCT00445432|50018061|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
24924487|NCT00445432|50018062|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
24924488|NCT00445432|50018063|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
24924489|NCT00445432|50018064|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
24924490|NCT00445432|50018061|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
24924491|NCT00445432|50018062|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
24924492|NCT00445432|50018063|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
24924493|NCT00445432|50018064|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
24924494|NCT03370133|50018078|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
25024463|NCT03364309|50122156|FG001|Induction Period|Physician Decision|1|||
25024464|NCT03364309|50122157|FG002|Induction Period|Physician Decision|0|||
24924495|NCT03370133|50018079|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
24924496|NCT03370133|50018080|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
24924497|NCT03370133|50018081|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
24924498|NCT03370133|50018082|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
24924499|NCT03370133|50018083|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
24924500|NCT03370133|50018078|FG000|Initial Treatment Period (WK 16)|Death|1|||
24924501|NCT03370133|50018079|FG001|Initial Treatment Period (WK 16)|Death|1|||
24924502|NCT03370133|50018080|FG002|Initial Treatment Period (WK 16)|Death|1|||
24924503|NCT03370133|50018081|FG003|Initial Treatment Period (WK 16)|Death|0|||
24924504|NCT03370133|50018082|FG004|Initial Treatment Period (WK 16)|Death|0|||
24924505|NCT03370133|50018083|FG005|Initial Treatment Period (WK 16)|Death|0|||
24924506|NCT03370133|50018078|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
24924507|NCT03370133|50018079|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
24924508|NCT03370133|50018080|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
24924509|NCT03370133|50018081|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
24924510|NCT03370133|50018082|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
24924511|NCT03370133|50018083|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
24924512|NCT03370133|50018078|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
24924513|NCT03370133|50018079|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
25024465|NCT03364309|50122158|FG003|Induction Period|Physician Decision|0|||
25154935|NCT01898923|50270150|FG000|Overall Study|Adverse Event|3|||
25154936|NCT01898923|50270151|FG001|Overall Study|Adverse Event|1|||
24924514|NCT03370133|50018080|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
24924515|NCT03370133|50018081|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
24924516|NCT03370133|50018082|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
24924517|NCT03370133|50018083|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
24924518|NCT03370133|50018078|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
25024466|NCT03364309|50122159|FG004|Induction Period|Physician Decision|0|||
25154937|NCT01898923|50270150|FG000|Overall Study|Lost to Follow-up|0|||
25154938|NCT01898923|50270151|FG001|Overall Study|Lost to Follow-up|1|||
25154939|NCT01898923|50270150|FG000|Overall Study|Withdrawal by Subject|4|||
24924519|NCT03370133|50018079|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
25024467|NCT03364309|50122160|FG005|Induction Period|Physician Decision|0|||
25024468|NCT03364309|50122161|FG006|Induction Period|Physician Decision|0|||
25024469|NCT03364309|50122162|FG007|Induction Period|Physician Decision|0|||
25024470|NCT03364309|50122163|FG008|Induction Period|Physician Decision|0|||
25024471|NCT03364309|50122164|FG009|Induction Period|Physician Decision|0|||
25024472|NCT03364309|50122165|FG010|Induction Period|Physician Decision|0|||
25024473|NCT03364309|50122166|FG011|Induction Period|Physician Decision|0|||
25024474|NCT03364309|50122167|FG012|Induction Period|Physician Decision|0|||
24924520|NCT03370133|50018080|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
24924521|NCT03370133|50018081|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
24924522|NCT03370133|50018082|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
24924523|NCT03370133|50018083|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
24924524|NCT03370133|50018078|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
24924525|NCT03370133|50018079|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
24924526|NCT03370133|50018080|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
24924527|NCT03370133|50018081|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
24924528|NCT03370133|50018082|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
24924529|NCT03370133|50018083|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
24924530|NCT03370133|50018078|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
24924531|NCT03370133|50018079|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
24924532|NCT03370133|50018080|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
24924533|NCT03370133|50018081|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
24924534|NCT03370133|50018082|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
24924535|NCT03370133|50018083|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
24924536|NCT03370133|50018078|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
24924537|NCT03370133|50018079|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
24924538|NCT03370133|50018080|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
24924539|NCT03370133|50018081|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
24924540|NCT03370133|50018082|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
24924541|NCT03370133|50018083|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
24924542|NCT03370133|50018078|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
24924543|NCT03370133|50018079|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
24924544|NCT03370133|50018080|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
24924545|NCT03370133|50018081|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
24924546|NCT03370133|50018082|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
24924547|NCT03370133|50018083|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
24924548|NCT03370133|50018078|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
24924549|NCT03370133|50018079|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
24924550|NCT03370133|50018080|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
24924551|NCT03370133|50018081|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
24924552|NCT03370133|50018082|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
24924553|NCT03370133|50018083|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
24924554|NCT03370133|50018078|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
24924555|NCT03370133|50018079|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
24924556|NCT03370133|50018080|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
24924557|NCT03370133|50018081|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
24924558|NCT03370133|50018082|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
24924559|NCT03370133|50018083|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
24924560|NCT03370133|50018078|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
24924561|NCT03370133|50018079|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
24924562|NCT03370133|50018080|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
24924563|NCT03370133|50018081|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
24924564|NCT03370133|50018082|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
24924565|NCT03370133|50018083|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
25024475|NCT03364309|50122168|FG013|Induction Period|Physician Decision|0|||
25024476|NCT03364309|50122169|FG014|Induction Period|Physician Decision|0|||
25024477|NCT03364309|50122170|FG015|Induction Period|Physician Decision|0|||
25024478|NCT03364309|50122171|FG016|Induction Period|Physician Decision|0|||
25024479|NCT03364309|50122172|FG017|Induction Period|Physician Decision|0|||
25024480|NCT03364309|50122173|FG018|Induction Period|Physician Decision|0|||
25024481|NCT03364309|50122155|FG000|Maintenance Period|Withdrawal by Subject|0|||
25024482|NCT03364309|50122156|FG001|Maintenance Period|Withdrawal by Subject|0|||
25024483|NCT03364309|50122157|FG002|Maintenance Period|Withdrawal by Subject|0|||
25024484|NCT03364309|50122158|FG003|Maintenance Period|Withdrawal by Subject|1|||
25024485|NCT03364309|50122159|FG004|Maintenance Period|Withdrawal by Subject|3|||
25024486|NCT03364309|50122160|FG005|Maintenance Period|Withdrawal by Subject|1|||
25024487|NCT03364309|50122161|FG006|Maintenance Period|Withdrawal by Subject|3|||
25024488|NCT03364309|50122162|FG007|Maintenance Period|Withdrawal by Subject|0|||
24924566|NCT03370133|50018078|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
24924567|NCT03370133|50018079|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
24924568|NCT03370133|50018080|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
24924569|NCT03370133|50018081|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
24924570|NCT03370133|50018082|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
24924571|NCT03370133|50018083|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
24924572|NCT03370133|50018078|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
24924573|NCT03370133|50018079|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
24924574|NCT03370133|50018080|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
24924575|NCT03370133|50018081|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
24924576|NCT03370133|50018082|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
24924577|NCT03370133|50018083|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
24924578|NCT03370133|50018078|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
24924579|NCT03370133|50018079|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
24924580|NCT03370133|50018080|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
24924581|NCT03370133|50018081|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
24924582|NCT03370133|50018082|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
24924583|NCT03370133|50018083|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
24924584|NCT00696137|50018101|FG000|Overall Study|Withdrawal by Subject|2|||
24924585|NCT00441142|50018109|FG000|Overall Study|Adverse Event|2|||
24924586|NCT00441142|50018110|FG001|Overall Study|Adverse Event|3|||
24924587|NCT00441142|50018111|FG002|Overall Study|Adverse Event|3|||
24924588|NCT00441142|50018112|FG003|Overall Study|Adverse Event|22|||
24924589|NCT00441142|50018109|FG000|Overall Study|Lack of Efficacy|3|||
24924590|NCT00441142|50018110|FG001|Overall Study|Lack of Efficacy|3|||
24924591|NCT00441142|50018111|FG002|Overall Study|Lack of Efficacy|17|||
24924592|NCT00441142|50018112|FG003|Overall Study|Lack of Efficacy|32|||
24924593|NCT00441142|50018109|FG000|Overall Study|Withdrawal by Subject|0|||
25024489|NCT03364309|50122163|FG008|Maintenance Period|Withdrawal by Subject|1|||
25024490|NCT03364309|50122164|FG009|Maintenance Period|Withdrawal by Subject|1|||
25024491|NCT03364309|50122165|FG010|Maintenance Period|Withdrawal by Subject|2|||
25024492|NCT03364309|50122166|FG011|Maintenance Period|Withdrawal by Subject|0|||
25024493|NCT03364309|50122167|FG012|Maintenance Period|Withdrawal by Subject|0|||
25024494|NCT03364309|50122168|FG013|Maintenance Period|Withdrawal by Subject|0|||
25024495|NCT03364309|50122169|FG014|Maintenance Period|Withdrawal by Subject|0|||
25024496|NCT03364309|50122170|FG015|Maintenance Period|Withdrawal by Subject|0|||
25024497|NCT03364309|50122171|FG016|Maintenance Period|Withdrawal by Subject|0|||
25024498|NCT03364309|50122172|FG017|Maintenance Period|Withdrawal by Subject|0|||
25024499|NCT03364309|50122173|FG018|Maintenance Period|Withdrawal by Subject|0|||
25024500|NCT03364309|50122155|FG000|Maintenance Period|Adverse Event|0|||
25024501|NCT03364309|50122156|FG001|Maintenance Period|Adverse Event|0|||
25024502|NCT03364309|50122157|FG002|Maintenance Period|Adverse Event|0|||
25024503|NCT03364309|50122158|FG003|Maintenance Period|Adverse Event|0|||
24924594|NCT00441142|50018110|FG001|Overall Study|Withdrawal by Subject|0|||
24924595|NCT00441142|50018111|FG002|Overall Study|Withdrawal by Subject|2|||
24924596|NCT00441142|50018112|FG003|Overall Study|Withdrawal by Subject|10|||
24924597|NCT00441142|50018109|FG000|Overall Study|Patient still receiving active study tx|1|||
24924598|NCT00441142|50018110|FG001|Overall Study|Patient still receiving active study tx|0|||
24924599|NCT00441142|50018111|FG002|Overall Study|Patient still receiving active study tx|0|||
24924600|NCT00441142|50018112|FG003|Overall Study|Patient still receiving active study tx|2|||
24924601|NCT00441142|50018109|FG000|Overall Study|Physician Decision|0|||
24924602|NCT00441142|50018110|FG001|Overall Study|Physician Decision|1|||
24924603|NCT00441142|50018111|FG002|Overall Study|Physician Decision|0|||
24924604|NCT00441142|50018112|FG003|Overall Study|Physician Decision|1|||
24924605|NCT00441142|50018109|FG000|Overall Study|Death|0|||
24924606|NCT00441142|50018110|FG001|Overall Study|Death|0|||
24924607|NCT00441142|50018111|FG002|Overall Study|Death|0|||
24924608|NCT00441142|50018112|FG003|Overall Study|Death|1|||
24924609|NCT04025021|50018126|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
24924610|NCT04025021|50018127|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
24924611|NCT03848416|50018137|FG000|Overall Study|Withdrawal by Subject|1|||
24924612|NCT03848416|50018138|FG001|Overall Study|Withdrawal by Subject|0|||
24924613|NCT03848416|50018139|FG002|Overall Study|Withdrawal by Subject|0|||
24924614|NCT03848416|50018137|FG000|Overall Study|Death|0|||
24924615|NCT03848416|50018138|FG001|Overall Study|Death|0|||
24924616|NCT03848416|50018139|FG002|Overall Study|Death|1|||
24924617|NCT00458302|50018149|FG000|Overall Study|Adverse Event|4|||
24924618|NCT00458302|50018150|FG001|Overall Study|Adverse Event|14|||
25024504|NCT03364309|50122159|FG004|Maintenance Period|Adverse Event|2|||
25024505|NCT03364309|50122160|FG005|Maintenance Period|Adverse Event|0|||
25024506|NCT03364309|50122161|FG006|Maintenance Period|Adverse Event|3|||
25024507|NCT03364309|50122162|FG007|Maintenance Period|Adverse Event|0|||
24924619|NCT00458302|50018149|FG000|Overall Study|Pregnancy|2|||
25024508|NCT03364309|50122163|FG008|Maintenance Period|Adverse Event|1|||
25024509|NCT03364309|50122164|FG009|Maintenance Period|Adverse Event|0|||
25024510|NCT03364309|50122165|FG010|Maintenance Period|Adverse Event|2|||
25024511|NCT03364309|50122166|FG011|Maintenance Period|Adverse Event|0|||
25024512|NCT03364309|50122167|FG012|Maintenance Period|Adverse Event|0|||
25024513|NCT03364309|50122168|FG013|Maintenance Period|Adverse Event|0|||
25024514|NCT03364309|50122169|FG014|Maintenance Period|Adverse Event|0|||
25024515|NCT03364309|50122170|FG015|Maintenance Period|Adverse Event|0|||
25024516|NCT03364309|50122171|FG016|Maintenance Period|Adverse Event|0|||
25024517|NCT03364309|50122172|FG017|Maintenance Period|Adverse Event|0|||
25024518|NCT03364309|50122173|FG018|Maintenance Period|Adverse Event|0|||
25024519|NCT03364309|50122155|FG000|Maintenance Period|Relapsed|0|||
25024520|NCT03364309|50122156|FG001|Maintenance Period|Relapsed|0|||
25024521|NCT03364309|50122157|FG002|Maintenance Period|Relapsed|0|||
25024522|NCT03364309|50122158|FG003|Maintenance Period|Relapsed|43|||
25024523|NCT03364309|50122159|FG004|Maintenance Period|Relapsed|7|||
25024524|NCT03364309|50122160|FG005|Maintenance Period|Relapsed|45|||
25024525|NCT03364309|50122161|FG006|Maintenance Period|Relapsed|10|||
25024526|NCT03364309|50122162|FG007|Maintenance Period|Relapsed|2|||
25024527|NCT03364309|50122163|FG008|Maintenance Period|Relapsed|0|||
25024528|NCT03364309|50122164|FG009|Maintenance Period|Relapsed|0|||
25024529|NCT03364309|50122165|FG010|Maintenance Period|Relapsed|0|||
25024530|NCT03364309|50122166|FG011|Maintenance Period|Relapsed|0|||
25024531|NCT03364309|50122167|FG012|Maintenance Period|Relapsed|0|||
24924620|NCT00458302|50018150|FG001|Overall Study|Pregnancy|1|||
24924621|NCT00458302|50018149|FG000|Overall Study|Protocol Violation|0|||
24924622|NCT00458302|50018150|FG001|Overall Study|Protocol Violation|2|||
24924623|NCT00458302|50018149|FG000|Overall Study|Withdrawal by Subject|6|||
24924624|NCT00458302|50018150|FG001|Overall Study|Withdrawal by Subject|4|||
24924625|NCT00458302|50018149|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
24924626|NCT00458302|50018150|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
24924627|NCT00458302|50018149|FG000|Overall Study|Study Termination By Sponsor|1|||
24924628|NCT00458302|50018150|FG001|Overall Study|Study Termination By Sponsor|0|||
24924629|NCT00458302|50018149|FG000|Overall Study|Lost to Follow-up|2|||
24924630|NCT00458302|50018150|FG001|Overall Study|Lost to Follow-up|0|||
24924631|NCT00458302|50018149|FG000|Overall Study|Other|4|||
24924632|NCT00458302|50018150|FG001|Overall Study|Other|2|||
24924633|NCT00444106|50018160|FG000|Overall Study|Lost to Follow-up|2|||
24924634|NCT00444106|50018161|FG001|Overall Study|Lost to Follow-up|1|||
24924635|NCT00444106|50018162|FG002|Overall Study|Lost to Follow-up|0|||
24924636|NCT00444106|50018160|FG000|Overall Study|Abnormal Test Procedure Results|0|||
24924637|NCT00444106|50018161|FG001|Overall Study|Abnormal Test Procedure Results|0|||
24924638|NCT00444106|50018162|FG002|Overall Study|Abnormal Test Procedure Results|1|||
24924639|NCT00561470|50018175|FG000|Overall Study|Adverse Event|74|||
24924640|NCT00561470|50018176|FG001|Overall Study|Adverse Event|163|||
24924641|NCT00561470|50018175|FG000|Overall Study|Disease progression|437|||
24924642|NCT00561470|50018176|FG001|Overall Study|Disease progression|305|||
24924643|NCT00561470|50018175|FG000|Overall Study|poor compliance to protocol|4|||
24924644|NCT00561470|50018176|FG001|Overall Study|poor compliance to protocol|4|||
24924645|NCT00561470|50018175|FG000|Overall Study|Lost to Follow-up|2|||
24924646|NCT00561470|50018176|FG001|Overall Study|Lost to Follow-up|0|||
24924647|NCT00561470|50018175|FG000|Overall Study|Physician Decision|21|||
24924648|NCT00561470|50018176|FG001|Overall Study|Physician Decision|20|||
24924649|NCT00561470|50018175|FG000|Overall Study|Consent Withdrawn|2|||
24924650|NCT00561470|50018176|FG001|Overall Study|Consent Withdrawn|6|||
24924651|NCT00561470|50018175|FG000|Overall Study|Subject request|43|||
24924652|NCT00561470|50018176|FG001|Overall Study|Subject request|77|||
24924653|NCT00561470|50018175|FG000|Overall Study|Metastatic surgery|10|||
24924654|NCT00561470|50018176|FG001|Overall Study|Metastatic surgery|12|||
24924655|NCT00561470|50018175|FG000|Overall Study|Unauthorized procedure|3|||
24924656|NCT00561470|50018176|FG001|Overall Study|Unauthorized procedure|1|||
24924657|NCT00561470|50018175|FG000|Overall Study|Randomized but not treated|5|||
24924658|NCT00561470|50018176|FG001|Overall Study|Randomized but not treated|5|||
24924659|NCT00561470|50018175|FG000|Overall Study|Missed visit window|1|||
25024532|NCT03364309|50122168|FG013|Maintenance Period|Relapsed|0|||
24924660|NCT00561470|50018176|FG001|Overall Study|Missed visit window|4|||
24924661|NCT00561470|50018175|FG000|Overall Study|Planning surgery|1|||
24924662|NCT00561470|50018176|FG001|Overall Study|Planning surgery|1|||
24924663|NCT00561470|50018175|FG000|Overall Study|Ongoing Treatment|11|||
24924664|NCT00561470|50018176|FG001|Overall Study|Ongoing Treatment|14|||
24924665|NCT00443872|50018184|FG000|Overall Study|Protocol Violation|7|||
24924666|NCT00443872|50018184|FG000|Overall Study|Lost to Follow-up|2|||
24924667|NCT00443872|50018184|FG000|Overall Study|Adverse Event|8|||
24924668|NCT00441064|50018199|FG000|Overall Study|Adverse Event|1|||
25024533|NCT03364309|50122169|FG014|Maintenance Period|Relapsed|0|||
25024534|NCT03364309|50122170|FG015|Maintenance Period|Relapsed|0|||
25024535|NCT03364309|50122171|FG016|Maintenance Period|Relapsed|0|||
25024536|NCT03364309|50122172|FG017|Maintenance Period|Relapsed|0|||
25024537|NCT03364309|50122173|FG018|Maintenance Period|Relapsed|0|||
24924669|NCT00441064|50018200|FG001|Overall Study|Adverse Event|0|||
24924670|NCT00441064|50018199|FG000|Overall Study|Abnormal laboratory values|0|||
24924671|NCT00441064|50018200|FG001|Overall Study|Abnormal laboratory values|2|||
24924672|NCT00441064|50018199|FG000|Overall Study|Abnormal test procedure results|0|||
24924673|NCT00441064|50018200|FG001|Overall Study|Abnormal test procedure results|1|||
24924674|NCT00441064|50018199|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
24924675|NCT00441064|50018200|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
24924676|NCT00441064|50018199|FG000|Overall Study|Protocol Deviation|3|||
24924677|NCT00441064|50018200|FG001|Overall Study|Protocol Deviation|2|||
24924678|NCT00441064|50018199|FG000|Overall Study|Patient withdrew consent|5|||
24924679|NCT00441064|50018200|FG001|Overall Study|Patient withdrew consent|2|||
24924680|NCT03962738|50018210|FG000|Overall Study|Protocol Deviation|3|||
24924681|NCT03962738|50018211|FG001|Overall Study|Protocol Deviation|0|||
24924682|NCT03962738|50018212|FG002|Overall Study|Protocol Deviation|1|||
24924683|NCT03962738|50018213|FG003|Overall Study|Protocol Deviation|1|||
24924684|NCT03962738|50018210|FG000|Overall Study|Withdrawal by Subject|4|||
24924685|NCT03962738|50018211|FG001|Overall Study|Withdrawal by Subject|0|||
24924686|NCT03962738|50018212|FG002|Overall Study|Withdrawal by Subject|0|||
24924687|NCT03962738|50018213|FG003|Overall Study|Withdrawal by Subject|0|||
24924688|NCT03962738|50018210|FG000|Overall Study|Lost to Follow-up|0|||
24924689|NCT03962738|50018211|FG001|Overall Study|Lost to Follow-up|0|||
24924690|NCT03962738|50018212|FG002|Overall Study|Lost to Follow-up|1|||
24924691|NCT03962738|50018213|FG003|Overall Study|Lost to Follow-up|0|||
24924692|NCT00561392|50018231|FG000|Overall Study|Adverse Event|38|||
24924693|NCT00561392|50018231|FG000|Overall Study|Lack of Efficacy|2|||
24924694|NCT00561392|50018231|FG000|Overall Study|Protocol Violation|1|||
24924695|NCT00561392|50018231|FG000|Overall Study|Withdrawal by Subject|8|||
24924696|NCT00561392|50018231|FG000|Overall Study|Administrative problems|4|||
24924697|NCT00694109|50018235|FG000|Overall Study|Physician Decision|3|||
24924698|NCT00694109|50018235|FG000|Overall Study|Adverse Event|74|||
24924699|NCT00694109|50018235|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
24924700|NCT00694109|50018235|FG000|Overall Study|Lack of Efficacy|2|||
24924701|NCT00694109|50018235|FG000|Overall Study|Withdrawal by Subject|13|||
24924702|NCT00694109|50018235|FG000|Overall Study|Pregnancy|1|||
24924703|NCT00694109|50018235|FG000|Overall Study|Enrolled but not treated|1|||
24924704|NCT00694109|50018235|FG000|Overall Study|Other|2|||
24924705|NCT00694109|50018235|FG000|Overall Study|Consented but no additional treatment|3|||
24924706|NCT00562484|50018246|FG000|Overall Study|Adverse Event|6|||
24924707|NCT00562484|50018247|FG001|Overall Study|Adverse Event|1|||
24924708|NCT00562484|50018246|FG000|Overall Study|Protocol Violation|11|||
24924709|NCT00562484|50018247|FG001|Overall Study|Protocol Violation|2|||
24924710|NCT00562484|50018246|FG000|Overall Study|Withdrawal by Subject|12|||
24924711|NCT00562484|50018247|FG001|Overall Study|Withdrawal by Subject|9|||
24924712|NCT00562484|50018246|FG000|Overall Study|Moved away from the study area|20|||
24924713|NCT00562484|50018247|FG001|Overall Study|Moved away from the study area|9|||
24924714|NCT00562484|50018246|FG000|Overall Study|Lost to Follow-up|132|||
24924715|NCT00562484|50018247|FG001|Overall Study|Lost to Follow-up|71|||
24924716|NCT00562484|50018246|FG000|Overall Study|Reason not provided or not specified|25|||
24924717|NCT00562484|50018247|FG001|Overall Study|Reason not provided or not specified|12|||
24924718|NCT00561080|50018256|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
24924719|NCT00561080|50018257|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
24924720|NCT00561080|50018258|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
24924721|NCT00561080|50018256|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
24924722|NCT00561080|50018257|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
24924723|NCT00561080|50018258|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
24924724|NCT00561080|50018256|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
24924725|NCT00561080|50018257|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
24924726|NCT00561080|50018258|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
24924727|NCT00561080|50018256|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
24924728|NCT00561080|50018257|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
24924729|NCT00561080|50018258|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
24924730|NCT00561080|50018256|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
24924731|NCT00561080|50018257|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
24924732|NCT00561080|50018258|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
24924733|NCT00561080|50018256|FG000|Vaccination Period (up to Month 4)|Other|0|||
24924734|NCT00561080|50018257|FG001|Vaccination Period (up to Month 4)|Other|2|||
24924735|NCT00561080|50018258|FG002|Vaccination Period (up to Month 4)|Other|1|||
24924736|NCT00561080|50018256|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
24924737|NCT00561080|50018257|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
24924738|NCT00561080|50018258|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
24924739|NCT00561080|50018256|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
24924740|NCT00561080|50018257|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
24924741|NCT00561080|50018258|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
24924742|NCT00561080|50018256|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
24924743|NCT00561080|50018257|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
24924744|NCT00561080|50018258|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
24924745|NCT00561080|50018256|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
24924746|NCT00561080|50018257|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
24924747|NCT00561080|50018258|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
24924748|NCT00562094|50018268|FG000|Overall Study|Lost to Follow-up|62|||
24924749|NCT03817853|50018276|FG000|Induction Phase|Adverse Event|5|||
24924750|NCT03817853|50018277|FG001|Induction Phase|Adverse Event|0|||
24924751|NCT03817853|50018278|FG002|Induction Phase|Adverse Event|0|||
24924752|NCT03817853|50018276|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
24924753|NCT03817853|50018277|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
24924754|NCT03817853|50018278|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
24924755|NCT03817853|50018276|FG000|Induction Phase|Physician Decision|2|||
24924756|NCT03817853|50018277|FG001|Induction Phase|Physician Decision|0|||
24924757|NCT03817853|50018278|FG002|Induction Phase|Physician Decision|0|||
24924758|NCT03817853|50018276|FG000|Induction Phase|Progressive Disease|4|||
24924759|NCT03817853|50018277|FG001|Induction Phase|Progressive Disease|0|||
24924760|NCT03817853|50018278|FG002|Induction Phase|Progressive Disease|0|||
24924761|NCT03817853|50018276|FG000|Induction Phase|Withdrawal by Subject|3|||
24924762|NCT03817853|50018277|FG001|Induction Phase|Withdrawal by Subject|0|||
24924763|NCT03817853|50018278|FG002|Induction Phase|Withdrawal by Subject|0|||
24924764|NCT03817853|50018276|FG000|Induction Phase|Continuing on Study|34|||
24924765|NCT03817853|50018277|FG001|Induction Phase|Continuing on Study|0|||
24924766|NCT03817853|50018278|FG002|Induction Phase|Continuing on Study|0|||
24924767|NCT03817853|50018276|FG000|Maintenance/ Follow-up Phase|Adverse Event|0|||
24924768|NCT03817853|50018277|FG001|Maintenance/ Follow-up Phase|Adverse Event|1|||
24924769|NCT03817853|50018278|FG002|Maintenance/ Follow-up Phase|Adverse Event|0|||
24924770|NCT03817853|50018276|FG000|Maintenance/ Follow-up Phase|Death|0|||
24924771|NCT03817853|50018277|FG001|Maintenance/ Follow-up Phase|Death|1|||
24924772|NCT03817853|50018278|FG002|Maintenance/ Follow-up Phase|Death|1|||
24924773|NCT03817853|50018276|FG000|Maintenance/ Follow-up Phase|Progressive Disease|0|||
24924774|NCT03817853|50018277|FG001|Maintenance/ Follow-up Phase|Progressive Disease|1|||
24924775|NCT03817853|50018278|FG002|Maintenance/ Follow-up Phase|Progressive Disease|3|||
24924776|NCT03817853|50018276|FG000|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
24924777|NCT03817853|50018277|FG001|Maintenance/ Follow-up Phase|Withdrawal by Subject|1|||
24924778|NCT03817853|50018278|FG002|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
24924779|NCT03817853|50018276|FG000|Maintenance/ Follow-up Phase|Continuing on Study|0|||
24924780|NCT03817853|50018277|FG001|Maintenance/ Follow-up Phase|Continuing on Study|52|||
24924781|NCT03817853|50018278|FG002|Maintenance/ Follow-up Phase|Continuing on Study|2|||
24924782|NCT00439270|50018291|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
24924783|NCT00439270|50018292|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
24924784|NCT00439270|50018293|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
24924785|NCT00439270|50018294|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
24924786|NCT00439270|50018295|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
25154940|NCT01898923|50270151|FG001|Overall Study|Withdrawal by Subject|7|||
25154941|NCT01898923|50270150|FG000|Overall Study|Physician Decision|3|||
25154942|NCT01898923|50270151|FG001|Overall Study|Physician Decision|4|||
25154943|NCT01898923|50270150|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
25154944|NCT01898923|50270151|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
25154945|NCT01924429|50270159|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
25154946|NCT01924429|50270160|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
24924787|NCT00439270|50018291|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
24924788|NCT00439270|50018292|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
24924789|NCT00439270|50018293|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
24924790|NCT00439270|50018294|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
24924791|NCT00439270|50018295|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
24924792|NCT00439270|50018291|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
24924793|NCT00439270|50018292|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
24924794|NCT00439270|50018293|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
24924795|NCT00439270|50018294|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
24924796|NCT00439270|50018295|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
24924797|NCT00439270|50018291|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
24924798|NCT00439270|50018292|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
24924799|NCT00439270|50018293|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
24924800|NCT00439270|50018294|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
24924801|NCT00439270|50018295|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
24924802|NCT00439270|50018291|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
24924803|NCT00439270|50018292|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
24924804|NCT00439270|50018293|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
24924805|NCT00439270|50018294|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
24924806|NCT00439270|50018295|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
24924807|NCT00439270|50018291|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
24924808|NCT00439270|50018292|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
24924809|NCT00439270|50018293|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
24924810|NCT00439270|50018294|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
24924811|NCT00439270|50018295|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
24924812|NCT00439270|50018291|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
24924813|NCT00439270|50018292|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
24924814|NCT00439270|50018293|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
24924815|NCT00439270|50018294|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
24924816|NCT00439270|50018295|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
24924817|NCT00439270|50018291|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
24924818|NCT00439270|50018292|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
24924819|NCT00439270|50018293|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
24924820|NCT00439270|50018294|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
24924821|NCT00439270|50018295|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
24924822|NCT00439270|50018291|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
24924823|NCT00439270|50018292|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
24924824|NCT00439270|50018293|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
24924825|NCT00439270|50018294|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
24924826|NCT00439270|50018295|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
24924827|NCT00439270|50018291|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
24924828|NCT00439270|50018292|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
24924829|NCT00439270|50018293|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
24924830|NCT00439270|50018294|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
24924831|NCT00439270|50018295|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
24924832|NCT00553280|50018314|FG000|Overall Study|Adverse Event|19|||
24924833|NCT00553280|50018314|FG000|Overall Study|Lack of Efficacy|3|||
24924834|NCT00553280|50018314|FG000|Overall Study|Withdrawal by Subject|3|||
24924835|NCT00553280|50018314|FG000|Overall Study|Physician Decision|1|||
24924836|NCT00440518|50018321|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
24924837|NCT00440518|50018322|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
24924838|NCT00440518|50018323|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
24924839|NCT00440518|50018321|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
24924840|NCT00440518|50018322|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
24924841|NCT00440518|50018323|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
24924842|NCT00440518|50018321|FG000|Randomized /Titration Period|Protocol Deviation|1|||
24924843|NCT00440518|50018322|FG001|Randomized /Titration Period|Protocol Deviation|0|||
24924844|NCT00440518|50018323|FG002|Randomized /Titration Period|Protocol Deviation|0|||
24924845|NCT00440518|50018321|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
24924846|NCT00440518|50018322|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
24924847|NCT00440518|50018323|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
24924848|NCT00440518|50018321|FG000|Randomized /Titration Period|Other|1|||
24924849|NCT00440518|50018322|FG001|Randomized /Titration Period|Other|0|||
24924850|NCT00440518|50018323|FG002|Randomized /Titration Period|Other|0|||
25024538|NCT03364309|50122155|FG000|Maintenance Period|Lack of Efficacy|0|||
24924851|NCT00440518|50018321|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
24924852|NCT00440518|50018322|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
25024539|NCT03364309|50122156|FG001|Maintenance Period|Lack of Efficacy|0|||
25024540|NCT03364309|50122157|FG002|Maintenance Period|Lack of Efficacy|0|||
24924853|NCT00440518|50018323|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
25154947|NCT01898299|50270170|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
25154948|NCT01898299|50270171|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
25154949|NCT01886287|50270177|FG000|Overall Study|Radiographic disease progression|1|||
25154950|NCT01886287|50270177|FG000|Overall Study|Clinical progression due to disease|1|||
25154951|NCT01885195|50270181|FG000|Overall Study|Adverse Event|29|||
25154952|NCT01885195|50270181|FG000|Overall Study|Death|1|||
25154953|NCT01885195|50270181|FG000|Overall Study|Disease Progression|67|||
25154954|NCT01885195|50270181|FG000|Overall Study|Protocol Deviation|2|||
25154955|NCT01885195|50270181|FG000|Overall Study|Physician Decision|3|||
25154956|NCT01885195|50270181|FG000|Overall Study|Patient/guardian decision|8|||
25154957|NCT01896895|50270188|FG000|Double-blind MP|Physician Decision|0|||
25154958|NCT01896895|50270189|FG001|Double-blind MP|Physician Decision|0|||
25154959|NCT01896895|50270190|FG002|Double-blind MP|Physician Decision|1|||
25154960|NCT01896895|50270191|FG003|Double-blind MP|Physician Decision|0|||
25154961|NCT01896895|50270188|FG000|Double-blind MP|Withdrawal by Subject|0|||
25154962|NCT01896895|50270189|FG001|Double-blind MP|Withdrawal by Subject|2|||
25154963|NCT01896895|50270190|FG002|Double-blind MP|Withdrawal by Subject|1|||
25154964|NCT01896895|50270191|FG003|Double-blind MP|Withdrawal by Subject|0|||
25154965|NCT01896895|50270188|FG000|Double-blind MP|Lost to Follow-up|1|||
25154966|NCT01896895|50270189|FG001|Double-blind MP|Lost to Follow-up|0|||
25154967|NCT01896895|50270190|FG002|Double-blind MP|Lost to Follow-up|1|||
25154968|NCT01896895|50270191|FG003|Double-blind MP|Lost to Follow-up|0|||
25154969|NCT01923181|50270234|FG000|Overall Study|Protocol Violation|2|||
25154970|NCT01923181|50270235|FG001|Overall Study|Protocol Violation|2|||
25154971|NCT01923181|50270236|FG002|Overall Study|Protocol Violation|0|||
25154972|NCT01923181|50270237|FG003|Overall Study|Protocol Violation|2|||
25154973|NCT01923181|50270238|FG004|Overall Study|Protocol Violation|2|||
25154974|NCT01923181|50270239|FG005|Overall Study|Protocol Violation|1|||
25154975|NCT01923181|50270240|FG006|Overall Study|Protocol Violation|1|||
25154976|NCT01923181|50270241|FG007|Overall Study|Protocol Violation|2|||
25154977|NCT01923181|50270242|FG008|Overall Study|Protocol Violation|1|||
25154978|NCT01923181|50270234|FG000|Overall Study|Withdrawal by Subject|0|||
25154979|NCT01923181|50270235|FG001|Overall Study|Withdrawal by Subject|1|||
25154980|NCT01923181|50270236|FG002|Overall Study|Withdrawal by Subject|0|||
25154981|NCT01923181|50270237|FG003|Overall Study|Withdrawal by Subject|1|||
25154982|NCT01923181|50270238|FG004|Overall Study|Withdrawal by Subject|4|||
25154983|NCT01923181|50270239|FG005|Overall Study|Withdrawal by Subject|2|||
25154984|NCT01923181|50270240|FG006|Overall Study|Withdrawal by Subject|4|||
25154985|NCT01923181|50270241|FG007|Overall Study|Withdrawal by Subject|3|||
25154986|NCT01923181|50270242|FG008|Overall Study|Withdrawal by Subject|1|||
25154987|NCT01923181|50270234|FG000|Overall Study|Other|1|||
25154988|NCT01923181|50270235|FG001|Overall Study|Other|0|||
25154989|NCT01923181|50270236|FG002|Overall Study|Other|0|||
25154990|NCT01923181|50270237|FG003|Overall Study|Other|1|||
25154991|NCT01923181|50270238|FG004|Overall Study|Other|0|||
25154992|NCT01923181|50270239|FG005|Overall Study|Other|0|||
25154993|NCT01923181|50270240|FG006|Overall Study|Other|0|||
25154994|NCT01923181|50270241|FG007|Overall Study|Other|0|||
25154995|NCT01923181|50270242|FG008|Overall Study|Other|0|||
24924854|NCT00440518|50018321|FG000|Randomized /Titration Period|Adverse Event|2|||
24924855|NCT00440518|50018322|FG001|Randomized /Titration Period|Adverse Event|3|||
24924856|NCT00440518|50018323|FG002|Randomized /Titration Period|Adverse Event|0|||
24924857|NCT00440518|50018321|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
24924858|NCT00440518|50018322|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
24924859|NCT00440518|50018323|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
24924860|NCT00440518|50018321|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
24924861|NCT00440518|50018322|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
24924862|NCT00440518|50018323|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
24924863|NCT00440518|50018321|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
24924864|NCT00440518|50018322|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
24924865|NCT00440518|50018323|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
24924866|NCT00440518|50018321|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
24924867|NCT00440518|50018322|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
24924868|NCT00440518|50018323|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
24924869|NCT00440518|50018321|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
24924870|NCT00440518|50018322|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
24924871|NCT00440518|50018323|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
24924872|NCT00440518|50018321|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
24924873|NCT00440518|50018322|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
24924874|NCT00440518|50018323|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
24924875|NCT00438256|50018331|FG000|Overall Study|Ineligible for Resection|2|||
24924876|NCT00438256|50018332|FG001|Overall Study|Ineligible for Resection|1|||
24924877|NCT00438256|50018333|FG002|Overall Study|Ineligible for Resection|1|||
24924878|NCT00438256|50018334|FG003|Overall Study|Ineligible for Resection|7|||
24924879|NCT00438256|50018331|FG000|Overall Study|Excluded final Diagnosis|0|||
24924880|NCT00438256|50018332|FG001|Overall Study|Excluded final Diagnosis|0|||
24924881|NCT00438256|50018333|FG002|Overall Study|Excluded final Diagnosis|0|||
24924882|NCT00438256|50018334|FG003|Overall Study|Excluded final Diagnosis|2|||
24924883|NCT00436852|50018353|FG000|Overall Study|Death|23|||
24924884|NCT00436852|50018354|FG001|Overall Study|Death|34|||
24924885|NCT00436852|50018353|FG000|Overall Study|Lack of Efficacy|9|||
24924886|NCT00436852|50018354|FG001|Overall Study|Lack of Efficacy|7|||
24924887|NCT00436852|50018353|FG000|Overall Study|Withdrawal by Subject|2|||
24924888|NCT00436852|50018354|FG001|Overall Study|Withdrawal by Subject|4|||
24924889|NCT00436852|50018353|FG000|Overall Study|Ineligible|1|||
24924890|NCT00436852|50018354|FG001|Overall Study|Ineligible|0|||
24924891|NCT00120289|50018365|FG000|Overall Study|Death|96|||
25024541|NCT03364309|50122158|FG003|Maintenance Period|Lack of Efficacy|0|||
25024542|NCT03364309|50122159|FG004|Maintenance Period|Lack of Efficacy|0|||
25154996|NCT01923181|50270234|FG000|Overall Study|Lost to Follow-up|0|||
25154997|NCT01923181|50270235|FG001|Overall Study|Lost to Follow-up|3|||
25154998|NCT01923181|50270236|FG002|Overall Study|Lost to Follow-up|2|||
25154999|NCT01923181|50270237|FG003|Overall Study|Lost to Follow-up|1|||
25155000|NCT01923181|50270238|FG004|Overall Study|Lost to Follow-up|2|||
25155001|NCT01923181|50270239|FG005|Overall Study|Lost to Follow-up|1|||
25155002|NCT01923181|50270240|FG006|Overall Study|Lost to Follow-up|3|||
25155003|NCT01923181|50270241|FG007|Overall Study|Lost to Follow-up|3|||
24924892|NCT00120289|50018366|FG001|Overall Study|Death|82|||
24924893|NCT00120289|50018365|FG000|Overall Study|Lost to Follow-up|11|||
24924894|NCT00120289|50018366|FG001|Overall Study|Lost to Follow-up|14|||
24924895|NCT00120289|50018365|FG000|Overall Study|Withdrawal by Subject|14|||
24924896|NCT00120289|50018366|FG001|Overall Study|Withdrawal by Subject|13|||
24924897|NCT00550446|50018379|FG000|Up To Week 12|Adverse Event|2|||
24924898|NCT00550446|50018380|FG001|Up To Week 12|Adverse Event|2|||
24924899|NCT00550446|50018381|FG002|Up To Week 12|Adverse Event|0|||
24924900|NCT00550446|50018382|FG003|Up To Week 12|Adverse Event|0|||
24924901|NCT00550446|50018383|FG004|Up To Week 12|Adverse Event|2|||
24924902|NCT00550446|50018384|FG005|Up To Week 12|Adverse Event|2|||
24924903|NCT00550446|50018385|FG006|Up To Week 12|Adverse Event|1|||
24924904|NCT00550446|50018386|FG007|Up To Week 12|Adverse Event|0|||
24924905|NCT00550446|50018387|FG008|Up To Week 12|Adverse Event|0|||
24924906|NCT00550446|50018388|FG009|Up To Week 12|Adverse Event|0|||
24924907|NCT00550446|50018389|FG010|Up To Week 12|Adverse Event|0|||
24924908|NCT00550446|50018379|FG000|Up To Week 12|Lack of Efficacy|3|||
24924909|NCT00550446|50018380|FG001|Up To Week 12|Lack of Efficacy|1|||
24924910|NCT00550446|50018381|FG002|Up To Week 12|Lack of Efficacy|0|||
24924911|NCT00550446|50018382|FG003|Up To Week 12|Lack of Efficacy|1|||
24924912|NCT00550446|50018383|FG004|Up To Week 12|Lack of Efficacy|0|||
24924913|NCT00550446|50018384|FG005|Up To Week 12|Lack of Efficacy|3|||
24924914|NCT00550446|50018385|FG006|Up To Week 12|Lack of Efficacy|3|||
24924915|NCT00550446|50018386|FG007|Up To Week 12|Lack of Efficacy|0|||
24924916|NCT00550446|50018387|FG008|Up To Week 12|Lack of Efficacy|0|||
24924917|NCT00550446|50018388|FG009|Up To Week 12|Lack of Efficacy|0|||
24924918|NCT00550446|50018389|FG010|Up To Week 12|Lack of Efficacy|0|||
24924919|NCT00550446|50018379|FG000|Up To Week 12|Lost to Follow-up|0|||
24924920|NCT00550446|50018380|FG001|Up To Week 12|Lost to Follow-up|1|||
24924921|NCT00550446|50018381|FG002|Up To Week 12|Lost to Follow-up|0|||
24924922|NCT00550446|50018382|FG003|Up To Week 12|Lost to Follow-up|0|||
24924923|NCT00550446|50018383|FG004|Up To Week 12|Lost to Follow-up|1|||
24924924|NCT00550446|50018384|FG005|Up To Week 12|Lost to Follow-up|1|||
24924925|NCT00550446|50018385|FG006|Up To Week 12|Lost to Follow-up|2|||
24924926|NCT00550446|50018386|FG007|Up To Week 12|Lost to Follow-up|0|||
24924927|NCT00550446|50018387|FG008|Up To Week 12|Lost to Follow-up|0|||
24924928|NCT00550446|50018388|FG009|Up To Week 12|Lost to Follow-up|0|||
24924929|NCT00550446|50018389|FG010|Up To Week 12|Lost to Follow-up|0|||
24924930|NCT00550446|50018379|FG000|Up To Week 12|Withdrawal by Subject|2|||
24924931|NCT00550446|50018380|FG001|Up To Week 12|Withdrawal by Subject|0|||
24924932|NCT00550446|50018381|FG002|Up To Week 12|Withdrawal by Subject|3|||
24924933|NCT00550446|50018382|FG003|Up To Week 12|Withdrawal by Subject|2|||
24924934|NCT00550446|50018383|FG004|Up To Week 12|Withdrawal by Subject|0|||
24924935|NCT00550446|50018384|FG005|Up To Week 12|Withdrawal by Subject|1|||
24924936|NCT00550446|50018385|FG006|Up To Week 12|Withdrawal by Subject|3|||
24924937|NCT00550446|50018386|FG007|Up To Week 12|Withdrawal by Subject|0|||
24924938|NCT00550446|50018387|FG008|Up To Week 12|Withdrawal by Subject|0|||
24924939|NCT00550446|50018388|FG009|Up To Week 12|Withdrawal by Subject|0|||
24924940|NCT00550446|50018389|FG010|Up To Week 12|Withdrawal by Subject|0|||
24924941|NCT00550446|50018379|FG000|Up To Week 12|Other|3|||
24924942|NCT00550446|50018380|FG001|Up To Week 12|Other|0|||
24924943|NCT00550446|50018381|FG002|Up To Week 12|Other|0|||
24924944|NCT00550446|50018382|FG003|Up To Week 12|Other|0|||
24924945|NCT00550446|50018383|FG004|Up To Week 12|Other|0|||
24924946|NCT00550446|50018384|FG005|Up To Week 12|Other|1|||
24924947|NCT00550446|50018385|FG006|Up To Week 12|Other|4|||
24924948|NCT00550446|50018386|FG007|Up To Week 12|Other|0|||
24924949|NCT00550446|50018387|FG008|Up To Week 12|Other|0|||
24924950|NCT00550446|50018388|FG009|Up To Week 12|Other|0|||
24924951|NCT00550446|50018389|FG010|Up To Week 12|Other|0|||
24924952|NCT00550446|50018379|FG000|Up To Week 12|Randomized not treated|0|||
24924953|NCT00550446|50018380|FG001|Up To Week 12|Randomized not treated|1|||
24924954|NCT00550446|50018381|FG002|Up To Week 12|Randomized not treated|1|||
24924955|NCT00550446|50018382|FG003|Up To Week 12|Randomized not treated|0|||
24924956|NCT00550446|50018383|FG004|Up To Week 12|Randomized not treated|0|||
24924957|NCT00550446|50018384|FG005|Up To Week 12|Randomized not treated|0|||
25155004|NCT01923181|50270242|FG008|Overall Study|Lost to Follow-up|1|||
24924958|NCT00550446|50018385|FG006|Up To Week 12|Randomized not treated|0|||
24924959|NCT00550446|50018386|FG007|Up To Week 12|Randomized not treated|0|||
25155005|NCT01896271|50270265|FG000|Overall Study|Physician Decision|10|||
25155006|NCT01884571|50270278|FG000|Overall Study|Adverse Event|1|||
24924960|NCT00550446|50018387|FG008|Up To Week 12|Randomized not treated|0|||
24924961|NCT00550446|50018388|FG009|Up To Week 12|Randomized not treated|0|||
24924962|NCT00550446|50018389|FG010|Up To Week 12|Randomized not treated|0|||
24924963|NCT00550446|50018379|FG000|Post Week 12|Adverse Event|2|||
24924964|NCT00550446|50018380|FG001|Post Week 12|Adverse Event|1|||
24924965|NCT00550446|50018381|FG002|Post Week 12|Adverse Event|1|||
24924966|NCT00550446|50018382|FG003|Post Week 12|Adverse Event|1|||
24924967|NCT00550446|50018383|FG004|Post Week 12|Adverse Event|1|||
24924968|NCT00550446|50018384|FG005|Post Week 12|Adverse Event|1|||
24924969|NCT00550446|50018385|FG006|Post Week 12|Adverse Event|0|||
24924970|NCT00550446|50018386|FG007|Post Week 12|Adverse Event|0|||
24924971|NCT00550446|50018387|FG008|Post Week 12|Adverse Event|0|||
24924972|NCT00550446|50018388|FG009|Post Week 12|Adverse Event|4|||
24924973|NCT00550446|50018389|FG010|Post Week 12|Adverse Event|0|||
24924974|NCT00550446|50018379|FG000|Post Week 12|Lack of Efficacy|0|||
24924975|NCT00550446|50018380|FG001|Post Week 12|Lack of Efficacy|0|||
24924976|NCT00550446|50018381|FG002|Post Week 12|Lack of Efficacy|1|||
24924977|NCT00550446|50018382|FG003|Post Week 12|Lack of Efficacy|0|||
24924978|NCT00550446|50018383|FG004|Post Week 12|Lack of Efficacy|0|||
24924979|NCT00550446|50018384|FG005|Post Week 12|Lack of Efficacy|0|||
24924980|NCT00550446|50018385|FG006|Post Week 12|Lack of Efficacy|0|||
24924981|NCT00550446|50018386|FG007|Post Week 12|Lack of Efficacy|1|||
24924982|NCT00550446|50018387|FG008|Post Week 12|Lack of Efficacy|1|||
24924983|NCT00550446|50018388|FG009|Post Week 12|Lack of Efficacy|2|||
24924984|NCT00550446|50018389|FG010|Post Week 12|Lack of Efficacy|1|||
24924985|NCT00550446|50018379|FG000|Post Week 12|Lost to Follow-up|0|||
24924986|NCT00550446|50018380|FG001|Post Week 12|Lost to Follow-up|0|||
24924987|NCT00550446|50018381|FG002|Post Week 12|Lost to Follow-up|1|||
24924988|NCT00550446|50018382|FG003|Post Week 12|Lost to Follow-up|1|||
24924989|NCT00550446|50018383|FG004|Post Week 12|Lost to Follow-up|0|||
24924990|NCT00550446|50018384|FG005|Post Week 12|Lost to Follow-up|0|||
24924991|NCT00550446|50018385|FG006|Post Week 12|Lost to Follow-up|1|||
24924992|NCT00550446|50018386|FG007|Post Week 12|Lost to Follow-up|0|||
24924993|NCT00550446|50018387|FG008|Post Week 12|Lost to Follow-up|0|||
24924994|NCT00550446|50018388|FG009|Post Week 12|Lost to Follow-up|0|||
24924995|NCT00550446|50018389|FG010|Post Week 12|Lost to Follow-up|0|||
24924996|NCT00550446|50018379|FG000|Post Week 12|Withdrawal by Subject|0|||
24924997|NCT00550446|50018380|FG001|Post Week 12|Withdrawal by Subject|0|||
24924998|NCT00550446|50018381|FG002|Post Week 12|Withdrawal by Subject|0|||
24924999|NCT00550446|50018382|FG003|Post Week 12|Withdrawal by Subject|0|||
24925000|NCT00550446|50018383|FG004|Post Week 12|Withdrawal by Subject|1|||
24925001|NCT00550446|50018384|FG005|Post Week 12|Withdrawal by Subject|0|||
24925002|NCT00550446|50018385|FG006|Post Week 12|Withdrawal by Subject|0|||
24925003|NCT00550446|50018386|FG007|Post Week 12|Withdrawal by Subject|0|||
24925004|NCT00550446|50018387|FG008|Post Week 12|Withdrawal by Subject|0|||
24925005|NCT00550446|50018388|FG009|Post Week 12|Withdrawal by Subject|0|||
24925006|NCT00550446|50018389|FG010|Post Week 12|Withdrawal by Subject|0|||
24925007|NCT00550446|50018379|FG000|Post Week 12|Other|1|||
24925008|NCT00550446|50018380|FG001|Post Week 12|Other|1|||
24925009|NCT00550446|50018381|FG002|Post Week 12|Other|0|||
24925010|NCT00550446|50018382|FG003|Post Week 12|Other|1|||
24925011|NCT00550446|50018383|FG004|Post Week 12|Other|0|||
24925012|NCT00550446|50018384|FG005|Post Week 12|Other|0|||
24925013|NCT00550446|50018385|FG006|Post Week 12|Other|1|||
24925014|NCT00550446|50018386|FG007|Post Week 12|Other|0|||
24925015|NCT00550446|50018387|FG008|Post Week 12|Other|1|||
24925016|NCT00550446|50018388|FG009|Post Week 12|Other|1|||
24925017|NCT00550446|50018389|FG010|Post Week 12|Other|0|||
24925018|NCT00436618|50018430|FG000|Overall Study|Withdrawal by Subject|5|||
24925019|NCT00436618|50018431|FG001|Overall Study|Withdrawal by Subject|8|||
24925020|NCT00436618|50018432|FG002|Overall Study|Withdrawal by Subject|11|||
24925021|NCT00436618|50018430|FG000|Overall Study|Adverse Event|8|||
24925022|NCT00436618|50018431|FG001|Overall Study|Adverse Event|8|||
24925023|NCT00436618|50018432|FG002|Overall Study|Adverse Event|9|||
24925024|NCT00436618|50018430|FG000|Overall Study|Alternate Treatment|3|||
24925025|NCT00436618|50018431|FG001|Overall Study|Alternate Treatment|4|||
24925026|NCT00436618|50018432|FG002|Overall Study|Alternate Treatment|12|||
24925027|NCT00436618|50018430|FG000|Overall Study|Other Medical Problems|3|||
24925028|NCT00436618|50018431|FG001|Overall Study|Other Medical Problems|1|||
24925029|NCT00436618|50018432|FG002|Overall Study|Other Medical Problems|7|||
24925030|NCT00436618|50018430|FG000|Overall Study|Death|4|||
24925031|NCT00436618|50018431|FG001|Overall Study|Death|2|||
24925032|NCT00436618|50018432|FG002|Overall Study|Death|3|||
24925033|NCT00436618|50018430|FG000|Overall Study|New Primary or Other Reasons|6|||
24925034|NCT00436618|50018431|FG001|Overall Study|New Primary or Other Reasons|2|||
24925035|NCT00436618|50018432|FG002|Overall Study|New Primary or Other Reasons|12|||
24925036|NCT00436618|50018430|FG000|Overall Study|Still on treatment|1|||
24925037|NCT00436618|50018431|FG001|Overall Study|Still on treatment|2|||
24925038|NCT00436618|50018432|FG002|Overall Study|Still on treatment|7|||
24925039|NCT00548808|50018469|FG000|Overall Study|Lost to Follow-up|9|||
24925040|NCT00548808|50018470|FG001|Overall Study|Lost to Follow-up|3|||
24925041|NCT00548808|50018469|FG000|Overall Study|Protocol Violation|8|||
24925042|NCT00548808|50018470|FG001|Overall Study|Protocol Violation|8|||
24925043|NCT00548808|50018469|FG000|Overall Study|Withdrawal by Subject|8|||
25024543|NCT03364309|50122160|FG005|Maintenance Period|Lack of Efficacy|0|||
24925044|NCT00548808|50018470|FG001|Overall Study|Withdrawal by Subject|4|||
24925045|NCT00548808|50018469|FG000|Overall Study|Physician Decision|6|||
24925046|NCT00548808|50018470|FG001|Overall Study|Physician Decision|3|||
24925047|NCT00548808|50018469|FG000|Overall Study|Adverse Event|4|||
24925048|NCT00548808|50018470|FG001|Overall Study|Adverse Event|5|||
24925049|NCT00548808|50018469|FG000|Overall Study|Death|2|||
24925050|NCT00548808|50018470|FG001|Overall Study|Death|0|||
24925051|NCT00548808|50018469|FG000|Overall Study|Entry Criteria Not Met|2|||
24925052|NCT00548808|50018470|FG001|Overall Study|Entry Criteria Not Met|2|||
24925053|NCT00548808|50018469|FG000|Overall Study|Lack of Efficacy|2|||
24925054|NCT00548808|50018470|FG001|Overall Study|Lack of Efficacy|0|||
24925055|NCT00548808|50018469|FG000|Overall Study|Sponsor Decision|1|||
24925056|NCT00548808|50018470|FG001|Overall Study|Sponsor Decision|1|||
24925057|NCT00110617|50018478|FG000|Overall Study|Adverse Event|2|||
24925058|NCT00110617|50018479|FG001|Overall Study|Adverse Event|4|||
24925059|NCT00110617|50018478|FG000|Overall Study|Abnormal Laboratory Value|4|||
24925060|NCT00110617|50018479|FG001|Overall Study|Abnormal Laboratory Value|2|||
24925061|NCT00110617|50018478|FG000|Overall Study|Lack of Efficacy|1|||
24925062|NCT00110617|50018479|FG001|Overall Study|Lack of Efficacy|0|||
24925063|NCT00110617|50018478|FG000|Overall Study|Patient no longer requires study drug|1|||
24925064|NCT00110617|50018479|FG001|Overall Study|Patient no longer requires study drug|0|||
24925065|NCT00110617|50018478|FG000|Overall Study|Protocol Violation|5|||
25155007|NCT01884571|50270278|FG000|Overall Study|Death|2|||
24925066|NCT00110617|50018479|FG001|Overall Study|Protocol Violation|0|||
24925067|NCT00110617|50018478|FG000|Overall Study|Withdrawal by Subject|10|||
24925068|NCT00110617|50018479|FG001|Overall Study|Withdrawal by Subject|4|||
24925069|NCT00110617|50018478|FG000|Overall Study|Lost to Follow-up|9|||
24925070|NCT00110617|50018479|FG001|Overall Study|Lost to Follow-up|1|||
24925071|NCT00110617|50018478|FG000|Overall Study|Administrative problems|6|||
24925072|NCT00110617|50018479|FG001|Overall Study|Administrative problems|5|||
24925073|NCT00110617|50018478|FG000|Overall Study|Death|1|||
24925074|NCT00110617|50018479|FG001|Overall Study|Death|1|||
24925075|NCT00110617|50018478|FG000|Overall Study|Did not receive study drug|0|||
24925076|NCT00110617|50018479|FG001|Overall Study|Did not receive study drug|12|||
24925077|NCT03956862|50018489|FG000|Overall Study|Lost to Follow-up|1|||
24925078|NCT03956862|50018490|FG001|Overall Study|Lost to Follow-up|1|||
24925079|NCT03956862|50018489|FG000|Overall Study|Withdrawal by Subject|1|||
24925080|NCT03956862|50018490|FG001|Overall Study|Withdrawal by Subject|1|||
24925081|NCT00550238|50018496|FG000|Overall Study|Adverse Event|88|||
24925082|NCT00550238|50018496|FG000|Overall Study|Death|34|||
24925083|NCT00550238|50018496|FG000|Overall Study|Disease progression|46|||
24925084|NCT00550238|50018496|FG000|Overall Study|Withdrawal by Subject|167|||
24925085|NCT00550238|50018496|FG000|Overall Study|Physician Decision|31|||
24925086|NCT00550238|50018496|FG000|Overall Study|Patient noncompliance|25|||
24925087|NCT00550238|50018496|FG000|Overall Study|Lost to Follow-up|13|||
24925088|NCT00550238|50018496|FG000|Overall Study|Sponsor decision|55|||
24925089|NCT03956550|50018503|FG000|Overall Study|Sponsor decision|65|||
24925090|NCT03956550|50018504|FG001|Overall Study|Sponsor decision|66|||
25155008|NCT01884571|50270278|FG000|Overall Study|Withdrawal by Subject|2|||
25155009|NCT01884571|50270278|FG000|Overall Study|Disease progression|3|||
25155010|NCT01884337|50270284|FG000|Treatment|Adverse Event|2|||
25155011|NCT01884337|50270285|FG001|Treatment|Adverse Event|2|||
25155012|NCT01884337|50270284|FG000|Treatment|Subj. request to discont. treatment|2|||
25155013|NCT01884337|50270285|FG001|Treatment|Subj. request to discont. treatment|0|||
25155014|NCT01884337|50270284|FG000|Follow-up Period|Lost to Follow-up|1|||
25155015|NCT01884337|50270285|FG001|Follow-up Period|Lost to Follow-up|1|||
25155016|NCT01922089|50270293|FG000|Overall Study|Adverse Event|18|||
24925091|NCT03956550|50018505|FG002|Overall Study|Sponsor decision|64|||
24925092|NCT03956550|50018503|FG000|Overall Study|Adverse Event|0|||
24925093|NCT03956550|50018504|FG001|Overall Study|Adverse Event|1|||
24925094|NCT03956550|50018505|FG002|Overall Study|Adverse Event|0|||
24925095|NCT03956550|50018503|FG000|Overall Study|Withdrawal by Subject|5|||
24925096|NCT03956550|50018504|FG001|Overall Study|Withdrawal by Subject|5|||
24925097|NCT03956550|50018505|FG002|Overall Study|Withdrawal by Subject|6|||
24925098|NCT00110305|50018517|FG000|Overall Study|Adverse Event|46|||
24925099|NCT00110305|50018518|FG001|Overall Study|Adverse Event|13|||
24925100|NCT00110305|50018517|FG000|Overall Study|Sponsors Decision|1|||
24925101|NCT00110305|50018518|FG001|Overall Study|Sponsors Decision|0|||
24925102|NCT00110305|50018517|FG000|Overall Study|Subject Non-Compliant|9|||
24925103|NCT00110305|50018518|FG001|Overall Study|Subject Non-Compliant|2|||
24925104|NCT00110305|50018517|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
24925105|NCT00110305|50018518|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
25155017|NCT01922089|50270294|FG001|Overall Study|Adverse Event|13|||
25155018|NCT01922089|50270293|FG000|Overall Study|Protocol Deviation|10|||
25155019|NCT01922089|50270294|FG001|Overall Study|Protocol Deviation|7|||
25155020|NCT01922089|50270293|FG000|Overall Study|Withdrawal by Subject|3|||
24925106|NCT00110305|50018517|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
24925107|NCT00110305|50018518|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
24925108|NCT00110305|50018517|FG000|Overall Study|Protocol Violation|0|||
24925109|NCT00110305|50018518|FG001|Overall Study|Protocol Violation|1|||
24925110|NCT00110305|50018517|FG000|Overall Study|Withdrawal by Subject|7|||
25155021|NCT01922089|50270294|FG001|Overall Study|Withdrawal by Subject|4|||
25155022|NCT01922089|50270293|FG000|Overall Study|administrative problems|4|||
25155023|NCT01922089|50270294|FG001|Overall Study|administrative problems|1|||
25155024|NCT01922089|50270293|FG000|Overall Study|Physician Decision|2|||
25155025|NCT01922089|50270294|FG001|Overall Study|Physician Decision|3|||
25155026|NCT01922089|50270293|FG000|Overall Study|Death|2|||
25155027|NCT01922089|50270294|FG001|Overall Study|Death|1|||
25155028|NCT01922089|50270293|FG000|Overall Study|Lost to Follow-up|0|||
25155029|NCT01922089|50270294|FG001|Overall Study|Lost to Follow-up|1|||
25155030|NCT01884025|50270302|FG000|Overall Study|Lost to Follow-up|3|||
25155031|NCT01884025|50270303|FG001|Overall Study|Lost to Follow-up|4|||
25155032|NCT01896193|50270313|FG000|Overall Study|Lack of Efficacy|20|||
25155033|NCT01896193|50270314|FG001|Overall Study|Lack of Efficacy|11|||
25155034|NCT01896193|50270313|FG000|Overall Study|Protocol Violation|0|||
25155035|NCT01896193|50270314|FG001|Overall Study|Protocol Violation|1|||
25155036|NCT01896193|50270313|FG000|Overall Study|Withdrew Consent|1|||
25155037|NCT01896193|50270314|FG001|Overall Study|Withdrew Consent|0|||
25155038|NCT01922011|50270324|FG000|Overall Study|Protocol Violation|0|||
25024544|NCT03364309|50122161|FG006|Maintenance Period|Lack of Efficacy|0|||
25024545|NCT03364309|50122162|FG007|Maintenance Period|Lack of Efficacy|0|||
25024546|NCT03364309|50122163|FG008|Maintenance Period|Lack of Efficacy|1|||
25024547|NCT03364309|50122164|FG009|Maintenance Period|Lack of Efficacy|3|||
25024548|NCT03364309|50122165|FG010|Maintenance Period|Lack of Efficacy|2|||
25024549|NCT03364309|50122166|FG011|Maintenance Period|Lack of Efficacy|0|||
25024550|NCT03364309|50122167|FG012|Maintenance Period|Lack of Efficacy|0|||
25024551|NCT03364309|50122168|FG013|Maintenance Period|Lack of Efficacy|0|||
25024552|NCT03364309|50122169|FG014|Maintenance Period|Lack of Efficacy|0|||
25024553|NCT03364309|50122170|FG015|Maintenance Period|Lack of Efficacy|0|||
25024554|NCT03364309|50122171|FG016|Maintenance Period|Lack of Efficacy|0|||
25024555|NCT03364309|50122172|FG017|Maintenance Period|Lack of Efficacy|0|||
25024556|NCT03364309|50122173|FG018|Maintenance Period|Lack of Efficacy|0|||
25024557|NCT03364309|50122155|FG000|Maintenance Period|Death|0|||
25024558|NCT03364309|50122156|FG001|Maintenance Period|Death|0|||
25024559|NCT03364309|50122157|FG002|Maintenance Period|Death|0|||
25024560|NCT03364309|50122158|FG003|Maintenance Period|Death|0|||
25024561|NCT03364309|50122159|FG004|Maintenance Period|Death|0|||
25024562|NCT03364309|50122160|FG005|Maintenance Period|Death|0|||
25024563|NCT03364309|50122161|FG006|Maintenance Period|Death|0|||
25024564|NCT03364309|50122162|FG007|Maintenance Period|Death|0|||
25024565|NCT03364309|50122163|FG008|Maintenance Period|Death|1|||
25024566|NCT03364309|50122164|FG009|Maintenance Period|Death|0|||
25024567|NCT03364309|50122165|FG010|Maintenance Period|Death|0|||
25024568|NCT03364309|50122166|FG011|Maintenance Period|Death|0|||
25024569|NCT03364309|50122167|FG012|Maintenance Period|Death|0|||
25024570|NCT03364309|50122168|FG013|Maintenance Period|Death|0|||
25024571|NCT03364309|50122169|FG014|Maintenance Period|Death|0|||
25024572|NCT03364309|50122170|FG015|Maintenance Period|Death|0|||
25155039|NCT01922011|50270325|FG001|Overall Study|Protocol Violation|1|||
25155040|NCT01922011|50270324|FG000|Overall Study|Physician Decision|0|||
24925111|NCT00110305|50018518|FG001|Overall Study|Withdrawal by Subject|7|||
24925112|NCT00110305|50018517|FG000|Overall Study|Lost to Follow-up|20|||
24925113|NCT00110305|50018518|FG001|Overall Study|Lost to Follow-up|3|||
24925114|NCT00110305|50018517|FG000|Overall Study|Other|8|||
24925115|NCT00110305|50018518|FG001|Overall Study|Other|2|||
24925116|NCT00428116|50018537|FG000|Overall Study|Death|1|||
24925117|NCT00428116|50018538|FG001|Overall Study|Death|0|||
24925118|NCT00428116|50018537|FG000|Overall Study|Withdrawal by Subject|1|||
24925119|NCT00428116|50018538|FG001|Overall Study|Withdrawal by Subject|0|||
24925120|NCT00428116|50018537|FG000|Overall Study|Lost to Follow-up|1|||
24925121|NCT00428116|50018538|FG001|Overall Study|Lost to Follow-up|0|||
25024573|NCT03364309|50122171|FG016|Maintenance Period|Death|0|||
25024574|NCT03364309|50122172|FG017|Maintenance Period|Death|0|||
25024575|NCT03364309|50122173|FG018|Maintenance Period|Death|0|||
25024576|NCT03364309|50122155|FG000|Maintenance Period|Lost to Follow-up|0|||
25024577|NCT03364309|50122156|FG001|Maintenance Period|Lost to Follow-up|0|||
25024578|NCT03364309|50122157|FG002|Maintenance Period|Lost to Follow-up|0|||
25024579|NCT03364309|50122158|FG003|Maintenance Period|Lost to Follow-up|0|||
25024580|NCT03364309|50122159|FG004|Maintenance Period|Lost to Follow-up|0|||
25155041|NCT01922011|50270325|FG001|Overall Study|Physician Decision|1|||
25155042|NCT01922011|50270324|FG000|Overall Study|Parent/Guardian Decision|3|||
25155043|NCT01922011|50270325|FG001|Overall Study|Parent/Guardian Decision|0|||
25024581|NCT03364309|50122160|FG005|Maintenance Period|Lost to Follow-up|0|||
25024582|NCT03364309|50122161|FG006|Maintenance Period|Lost to Follow-up|0|||
25024583|NCT03364309|50122162|FG007|Maintenance Period|Lost to Follow-up|0|||
25024584|NCT03364309|50122163|FG008|Maintenance Period|Lost to Follow-up|1|||
25024585|NCT03364309|50122164|FG009|Maintenance Period|Lost to Follow-up|0|||
25024586|NCT03364309|50122165|FG010|Maintenance Period|Lost to Follow-up|0|||
25024587|NCT03364309|50122166|FG011|Maintenance Period|Lost to Follow-up|0|||
25024588|NCT03364309|50122167|FG012|Maintenance Period|Lost to Follow-up|0|||
25024589|NCT03364309|50122168|FG013|Maintenance Period|Lost to Follow-up|0|||
25024590|NCT03364309|50122169|FG014|Maintenance Period|Lost to Follow-up|0|||
25024591|NCT03364309|50122170|FG015|Maintenance Period|Lost to Follow-up|0|||
25024592|NCT03364309|50122171|FG016|Maintenance Period|Lost to Follow-up|0|||
25024593|NCT03364309|50122172|FG017|Maintenance Period|Lost to Follow-up|0|||
25024594|NCT03364309|50122173|FG018|Maintenance Period|Lost to Follow-up|0|||
25024595|NCT03364309|50122155|FG000|Maintenance Period|Miscellaneous|0|||
25024596|NCT03364309|50122156|FG001|Maintenance Period|Miscellaneous|0|||
25024597|NCT03364309|50122157|FG002|Maintenance Period|Miscellaneous|0|||
25024598|NCT03364309|50122158|FG003|Maintenance Period|Miscellaneous|0|||
25024599|NCT03364309|50122159|FG004|Maintenance Period|Miscellaneous|0|||
25024600|NCT03364309|50122160|FG005|Maintenance Period|Miscellaneous|0|||
25024601|NCT03364309|50122161|FG006|Maintenance Period|Miscellaneous|0|||
25024602|NCT03364309|50122162|FG007|Maintenance Period|Miscellaneous|0|||
25024603|NCT03364309|50122163|FG008|Maintenance Period|Miscellaneous|1|||
25024604|NCT03364309|50122164|FG009|Maintenance Period|Miscellaneous|0|||
25024605|NCT03364309|50122165|FG010|Maintenance Period|Miscellaneous|0|||
25024606|NCT03364309|50122166|FG011|Maintenance Period|Miscellaneous|0|||
24925122|NCT00560066|50018547|FG000|Overall Study|Death|2|||
24925123|NCT00560066|50018548|FG001|Overall Study|Death|1|||
25024607|NCT03364309|50122167|FG012|Maintenance Period|Miscellaneous|0|||
25024608|NCT03364309|50122168|FG013|Maintenance Period|Miscellaneous|0|||
25024609|NCT03364309|50122169|FG014|Maintenance Period|Miscellaneous|0|||
25024610|NCT03364309|50122170|FG015|Maintenance Period|Miscellaneous|0|||
25024611|NCT03364309|50122171|FG016|Maintenance Period|Miscellaneous|0|||
25024612|NCT03364309|50122172|FG017|Maintenance Period|Miscellaneous|0|||
24925124|NCT00560066|50018547|FG000|Overall Study|Withdrawal by Subject|0|||
24925125|NCT00560066|50018548|FG001|Overall Study|Withdrawal by Subject|3|||
24925126|NCT00560066|50018547|FG000|Overall Study|Lost to Follow-up|4|||
24925127|NCT00560066|50018548|FG001|Overall Study|Lost to Follow-up|10|||
24925128|NCT00560066|50018547|FG000|Overall Study|Protocol Violation|0|||
24925129|NCT00560066|50018548|FG001|Overall Study|Protocol Violation|1|||
24925130|NCT00560066|50018547|FG000|Overall Study|Administrative reason|0|||
24925131|NCT00560066|50018548|FG001|Overall Study|Administrative reason|5|||
24925132|NCT00560066|50018547|FG000|Overall Study|Missing primary reason|0|||
24925133|NCT00560066|50018548|FG001|Overall Study|Missing primary reason|2|||
24925134|NCT00549900|50018559|FG000|Overall Study|Adverse Event|1|||
24925135|NCT00435994|50018566|FG000|Overall Study|Lost to Follow-up|7|||
24925136|NCT00435994|50018567|FG001|Overall Study|Lost to Follow-up|0|||
24925137|NCT00435994|50018568|FG002|Overall Study|Lost to Follow-up|0|||
24925138|NCT00435370|50018579|FG000|Overall Study|Adverse Event|8|||
24925139|NCT00435370|50018580|FG001|Overall Study|Adverse Event|8|||
24925140|NCT00435370|50018579|FG000|Overall Study|Withdrawal by Subject|10|||
24925141|NCT00435370|50018580|FG001|Overall Study|Withdrawal by Subject|10|||
24925142|NCT00435370|50018579|FG000|Overall Study|Antipsychotic medication changed|4|||
24925143|NCT00435370|50018580|FG001|Overall Study|Antipsychotic medication changed|2|||
24925144|NCT00096031|50018586|FG000|Overall Study|Adverse Event|3|||
24925145|NCT00096031|50018586|FG000|Overall Study|Lack of Efficacy|42|||
24925146|NCT00096031|50018586|FG000|Overall Study|Death|4|||
24925147|NCT00096031|50018586|FG000|Overall Study|Withdrawal by Subject|1|||
24925148|NCT00096031|50018586|FG000|Overall Study|Ineligible|8|||
24925149|NCT00096031|50018586|FG000|Overall Study|Not protocol specified|5|||
24925150|NCT00118417|50018590|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
24925151|NCT00118417|50018591|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
24925152|NCT00118417|50018590|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
24925153|NCT00118417|50018591|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
24925154|NCT00118417|50018590|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
24925155|NCT00118417|50018591|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
24925156|NCT00118417|50018590|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
24925157|NCT00118417|50018591|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
24925158|NCT00118417|50018590|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
24925159|NCT00118417|50018591|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
24925160|NCT00549848|50018604|FG000|Overall Study|Death|1|||
25024613|NCT03364309|50122173|FG018|Maintenance Period|Miscellaneous|0|||
25024614|NCT03364309|50122155|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
25024615|NCT03364309|50122156|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
25024616|NCT03364309|50122157|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
25024617|NCT03364309|50122158|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
25024618|NCT03364309|50122159|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
24925161|NCT00549848|50018605|FG001|Overall Study|Death|4|||
24925162|NCT00549848|50018606|FG002|Overall Study|Death|13|||
24925163|NCT00549848|50018604|FG000|Overall Study|Physician Decision|0|||
24925164|NCT00549848|50018605|FG001|Overall Study|Physician Decision|0|||
24925165|NCT00549848|50018606|FG002|Overall Study|Physician Decision|4|||
24925166|NCT00549848|50018604|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
24925167|NCT00549848|50018605|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
24925168|NCT00549848|50018606|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
24925169|NCT00549848|50018604|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
24925170|NCT00549848|50018605|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
24925171|NCT00549848|50018606|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
24925172|NCT00549848|50018604|FG000|Overall Study|Participant/Family Withdraw|2|||
24925173|NCT00549848|50018605|FG001|Overall Study|Participant/Family Withdraw|3|||
24925174|NCT00549848|50018606|FG002|Overall Study|Participant/Family Withdraw|5|||
24925175|NCT00549848|50018604|FG000|Overall Study|Second Malignancy|1|||
24925176|NCT00549848|50018605|FG001|Overall Study|Second Malignancy|0|||
24925177|NCT00549848|50018606|FG002|Overall Study|Second Malignancy|0|||
24925178|NCT00549848|50018604|FG000|Overall Study|Transplant|3|||
24925179|NCT00549848|50018605|FG001|Overall Study|Transplant|3|||
24925180|NCT00549848|50018606|FG002|Overall Study|Transplant|18|||
24925181|NCT00549848|50018604|FG000|Overall Study|Unacceptable Toxicity|1|||
24925182|NCT00549848|50018605|FG001|Overall Study|Unacceptable Toxicity|6|||
24925183|NCT00549848|50018606|FG002|Overall Study|Unacceptable Toxicity|6|||
24925184|NCT00549770|50018630|FG000|Overall Study|Protocol deviation|1|||
24925185|NCT00549770|50018631|FG001|Overall Study|Protocol deviation|1|||
24925186|NCT00549770|50018632|FG002|Overall Study|Protocol deviation|1|||
24925187|NCT00549770|50018633|FG003|Overall Study|Protocol deviation|2|||
24925188|NCT00549770|50018634|FG004|Overall Study|Protocol deviation|2|||
24925189|NCT00549770|50018635|FG005|Overall Study|Protocol deviation|2|||
24925190|NCT00549770|50018636|FG006|Overall Study|Protocol deviation|1|||
24925191|NCT00549770|50018637|FG007|Overall Study|Protocol deviation|2|||
24925192|NCT00549770|50018630|FG000|Overall Study|Administrative problems|0|||
24925193|NCT00549770|50018631|FG001|Overall Study|Administrative problems|1|||
24925194|NCT00549770|50018632|FG002|Overall Study|Administrative problems|0|||
24925195|NCT00549770|50018633|FG003|Overall Study|Administrative problems|0|||
24925196|NCT00549770|50018634|FG004|Overall Study|Administrative problems|0|||
24925197|NCT00549770|50018635|FG005|Overall Study|Administrative problems|0|||
24925198|NCT00549770|50018636|FG006|Overall Study|Administrative problems|0|||
24925199|NCT00549770|50018637|FG007|Overall Study|Administrative problems|1|||
24925200|NCT00549770|50018630|FG000|Overall Study|Lost to Follow-up|0|||
24925201|NCT00549770|50018631|FG001|Overall Study|Lost to Follow-up|0|||
24925202|NCT00549770|50018632|FG002|Overall Study|Lost to Follow-up|2|||
24925203|NCT00549770|50018633|FG003|Overall Study|Lost to Follow-up|2|||
24925204|NCT00549770|50018634|FG004|Overall Study|Lost to Follow-up|3|||
24925205|NCT00549770|50018635|FG005|Overall Study|Lost to Follow-up|2|||
24925206|NCT00549770|50018636|FG006|Overall Study|Lost to Follow-up|0|||
24925207|NCT00549770|50018637|FG007|Overall Study|Lost to Follow-up|0|||
24925208|NCT00549770|50018630|FG000|Overall Study|Withdrawal by Subject|4|||
24925209|NCT00549770|50018631|FG001|Overall Study|Withdrawal by Subject|6|||
24925210|NCT00549770|50018632|FG002|Overall Study|Withdrawal by Subject|4|||
24925211|NCT00549770|50018633|FG003|Overall Study|Withdrawal by Subject|5|||
24925212|NCT00549770|50018634|FG004|Overall Study|Withdrawal by Subject|6|||
24925213|NCT00549770|50018635|FG005|Overall Study|Withdrawal by Subject|6|||
24925214|NCT00549770|50018636|FG006|Overall Study|Withdrawal by Subject|4|||
24925215|NCT00549770|50018637|FG007|Overall Study|Withdrawal by Subject|9|||
24925216|NCT00549770|50018630|FG000|Overall Study|Lack of Efficacy|1|||
24925217|NCT00549770|50018631|FG001|Overall Study|Lack of Efficacy|0|||
24925218|NCT00549770|50018632|FG002|Overall Study|Lack of Efficacy|2|||
24925219|NCT00549770|50018633|FG003|Overall Study|Lack of Efficacy|3|||
24925220|NCT00549770|50018634|FG004|Overall Study|Lack of Efficacy|5|||
24925221|NCT00549770|50018635|FG005|Overall Study|Lack of Efficacy|1|||
24925222|NCT00549770|50018636|FG006|Overall Study|Lack of Efficacy|3|||
24925223|NCT00549770|50018637|FG007|Overall Study|Lack of Efficacy|8|||
24925224|NCT00549770|50018630|FG000|Overall Study|Abnormal test procedure results|0|||
24925225|NCT00549770|50018631|FG001|Overall Study|Abnormal test procedure results|0|||
24925226|NCT00549770|50018632|FG002|Overall Study|Abnormal test procedure results|0|||
24925227|NCT00549770|50018633|FG003|Overall Study|Abnormal test procedure results|2|||
24925228|NCT00549770|50018634|FG004|Overall Study|Abnormal test procedure results|0|||
24925229|NCT00549770|50018635|FG005|Overall Study|Abnormal test procedure results|1|||
24925230|NCT00549770|50018636|FG006|Overall Study|Abnormal test procedure results|1|||
24925231|NCT00549770|50018637|FG007|Overall Study|Abnormal test procedure results|1|||
24925232|NCT00549770|50018630|FG000|Overall Study|Abnormal laboratory values|0|||
24925233|NCT00549770|50018631|FG001|Overall Study|Abnormal laboratory values|0|||
24925234|NCT00549770|50018632|FG002|Overall Study|Abnormal laboratory values|0|||
24925235|NCT00549770|50018633|FG003|Overall Study|Abnormal laboratory values|0|||
24925236|NCT00549770|50018634|FG004|Overall Study|Abnormal laboratory values|0|||
24925237|NCT00549770|50018635|FG005|Overall Study|Abnormal laboratory values|1|||
24925238|NCT00549770|50018636|FG006|Overall Study|Abnormal laboratory values|0|||
24925239|NCT00549770|50018637|FG007|Overall Study|Abnormal laboratory values|0|||
24925240|NCT00549770|50018630|FG000|Overall Study|Adverse Event|1|||
24925241|NCT00549770|50018631|FG001|Overall Study|Adverse Event|3|||
24925242|NCT00549770|50018632|FG002|Overall Study|Adverse Event|1|||
24925243|NCT00549770|50018633|FG003|Overall Study|Adverse Event|2|||
24925244|NCT00549770|50018634|FG004|Overall Study|Adverse Event|1|||
24925245|NCT00549770|50018635|FG005|Overall Study|Adverse Event|0|||
24925246|NCT00549770|50018636|FG006|Overall Study|Adverse Event|5|||
24925247|NCT00549770|50018637|FG007|Overall Study|Adverse Event|4|||
24925248|NCT00548184|50018655|FG000|Overall Study|Adverse Event|3|||
24925249|NCT00548184|50018655|FG000|Overall Study|took other drug|1|||
24925250|NCT00548184|50018655|FG000|Overall Study|Found Her2 negative|1|||
24925251|NCT00454636|50018663|FG000|Overall Study|Adverse Event|10|||
24925252|NCT00454636|50018664|FG001|Overall Study|Adverse Event|6|||
24925253|NCT00454636|50018665|FG002|Overall Study|Adverse Event|9|||
24925254|NCT00454636|50018666|FG003|Overall Study|Adverse Event|15|||
24925255|NCT00454636|50018663|FG000|Overall Study|Disease Progression|11|||
24925256|NCT00454636|50018664|FG001|Overall Study|Disease Progression|12|||
24925257|NCT00454636|50018665|FG002|Overall Study|Disease Progression|4|||
24925258|NCT00454636|50018666|FG003|Overall Study|Disease Progression|11|||
24925259|NCT00454636|50018663|FG000|Overall Study|Protocol Violation|3|||
24925260|NCT00454636|50018664|FG001|Overall Study|Protocol Violation|2|||
24925261|NCT00454636|50018665|FG002|Overall Study|Protocol Violation|3|||
24925262|NCT00454636|50018666|FG003|Overall Study|Protocol Violation|3|||
24925263|NCT00454636|50018663|FG000|Overall Study|Death|6|||
24925264|NCT00454636|50018664|FG001|Overall Study|Death|1|||
24925265|NCT00454636|50018665|FG002|Overall Study|Death|1|||
24925266|NCT00454636|50018666|FG003|Overall Study|Death|1|||
24925267|NCT00454636|50018663|FG000|Overall Study|Patient refusal|1|||
24925268|NCT00454636|50018664|FG001|Overall Study|Patient refusal|1|||
24925269|NCT00454636|50018665|FG002|Overall Study|Patient refusal|3|||
24925270|NCT00454636|50018666|FG003|Overall Study|Patient refusal|2|||
24925271|NCT00454636|50018663|FG000|Overall Study|Lost to Follow-up|0|||
24925272|NCT00454636|50018664|FG001|Overall Study|Lost to Follow-up|1|||
24925273|NCT00454636|50018665|FG002|Overall Study|Lost to Follow-up|0|||
24925274|NCT00454636|50018666|FG003|Overall Study|Lost to Follow-up|0|||
24925275|NCT00427960|50018678|FG000|Overall Study|Adverse Event|2|||
24925276|NCT00427960|50018679|FG001|Overall Study|Adverse Event|0|||
24925277|NCT00427960|50018678|FG000|Overall Study|Withdrawal by Subject|0|||
24925278|NCT00427960|50018679|FG001|Overall Study|Withdrawal by Subject|3|||
24925279|NCT00427960|50018678|FG000|Overall Study|Other|0|||
24925280|NCT00427960|50018679|FG001|Overall Study|Other|1|||
24925281|NCT00548340|50018688|FG000|Overall Study|Protocol Violation|2|||
24925282|NCT00548340|50018689|FG001|Overall Study|Protocol Violation|3|||
24925283|NCT00548340|50018690|FG002|Overall Study|Protocol Violation|3|||
24925284|NCT00548340|50018688|FG000|Overall Study|Adverse Event|2|||
24925285|NCT00548340|50018689|FG001|Overall Study|Adverse Event|2|||
24925286|NCT00548340|50018690|FG002|Overall Study|Adverse Event|2|||
24925287|NCT00548340|50018688|FG000|Overall Study|Lost to Follow-up|1|||
24925288|NCT00548340|50018689|FG001|Overall Study|Lost to Follow-up|1|||
24925289|NCT00548340|50018690|FG002|Overall Study|Lost to Follow-up|0|||
24925290|NCT00548340|50018688|FG000|Overall Study|Withdrawal by Subject|2|||
24925291|NCT00548340|50018689|FG001|Overall Study|Withdrawal by Subject|4|||
24925292|NCT00548340|50018690|FG002|Overall Study|Withdrawal by Subject|3|||
24925293|NCT00548340|50018688|FG000|Overall Study|Other|1|||
24925294|NCT00548340|50018689|FG001|Overall Study|Other|1|||
24925295|NCT00548340|50018690|FG002|Overall Study|Other|1|||
24925296|NCT00454246|50018701|FG000|Overall Study|Adverse Event|2|||
24925297|NCT00454246|50018702|FG001|Overall Study|Adverse Event|2|||
24925298|NCT00454246|50018703|FG002|Overall Study|Adverse Event|0|||
24925299|NCT00454246|50018701|FG000|Overall Study|Violation of selection criteria at entry|6|||
24925300|NCT00454246|50018702|FG001|Overall Study|Violation of selection criteria at entry|0|||
24925301|NCT00454246|50018703|FG002|Overall Study|Violation of selection criteria at entry|0|||
24925302|NCT00454246|50018701|FG000|Overall Study|Protocol Violation|1|||
24925303|NCT00454246|50018702|FG001|Overall Study|Protocol Violation|0|||
24925304|NCT00454246|50018703|FG002|Overall Study|Protocol Violation|0|||
24925305|NCT00454246|50018701|FG000|Overall Study|Refused Treatment|1|||
24925306|NCT00454246|50018702|FG001|Overall Study|Refused Treatment|1|||
24925307|NCT00454246|50018703|FG002|Overall Study|Refused Treatment|0|||
24925308|NCT00454246|50018701|FG000|Overall Study|Failure to return|1|||
24925309|NCT00454246|50018702|FG001|Overall Study|Failure to return|0|||
24925310|NCT00454246|50018703|FG002|Overall Study|Failure to return|0|||
24925311|NCT00454246|50018701|FG000|Overall Study|Early termination of study|62|||
25185528|NCT01500278|50335064|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
24925312|NCT00454246|50018702|FG001|Overall Study|Early termination of study|26|||
24925313|NCT00454246|50018703|FG002|Overall Study|Early termination of study|9|||
24925314|NCT00434590|50018713|FG000|Overall Study|Administrative problems|5|||
24925315|NCT00434590|50018714|FG001|Overall Study|Administrative problems|5|||
24925316|NCT02891837|50018722|FG000|Overall Study|Lost to Follow-up|2|||
24925317|NCT02891837|50018723|FG001|Overall Study|Lost to Follow-up|0|||
24925318|NCT02891837|50018722|FG000|Overall Study|Withdrawal by Subject|1|||
24925319|NCT02891837|50018723|FG001|Overall Study|Withdrawal by Subject|0|||
24925320|NCT00695903|50018747|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
24925321|NCT00695903|50018748|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
24925322|NCT00695903|50018747|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
24925323|NCT00695903|50018748|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
24925324|NCT00695903|50018747|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
24925325|NCT00695903|50018748|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
24925326|NCT00695903|50018747|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
24925327|NCT00695903|50018748|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
24925328|NCT00695903|50018747|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
24925329|NCT00695903|50018748|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
24925330|NCT00695903|50018747|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
24925331|NCT00695903|50018748|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
24925332|NCT00695903|50018747|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
24925333|NCT00695903|50018748|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
24925334|NCT00695903|50018747|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
24925335|NCT00695903|50018748|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
24925336|NCT00695903|50018747|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
24925337|NCT00695903|50018748|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
24925338|NCT02759861|50018754|FG000|Overall Study|Death|1|||
24925339|NCT00548262|50018759|FG000|Overall Study|Death|21|||
24925340|NCT00548262|50018759|FG000|Overall Study|Adverse Event|2|||
24925341|NCT00548262|50018759|FG000|Overall Study|Lack of Efficacy|4|||
24925342|NCT00548262|50018759|FG000|Overall Study|Lost to Follow-up|1|||
24925343|NCT00548262|50018759|FG000|Overall Study|Other|3|||
24925344|NCT00548262|50018759|FG000|Overall Study|Withdrawal by Subject|1|||
24925345|NCT00095173|50018763|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
24925346|NCT00095173|50018764|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
24925347|NCT00095173|50018765|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
24925348|NCT00095173|50018766|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
24925349|NCT00095173|50018767|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
24925350|NCT00095173|50018768|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
24925351|NCT00095173|50018763|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
24925352|NCT00095173|50018764|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
24925353|NCT00095173|50018765|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
24925354|NCT00095173|50018766|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
24925355|NCT00095173|50018767|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
24925356|NCT00095173|50018768|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
24925357|NCT00095173|50018763|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
24925358|NCT00095173|50018764|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
24925359|NCT00095173|50018765|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
24925360|NCT00095173|50018766|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
24925361|NCT00095173|50018767|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
24925362|NCT00095173|50018768|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
24925363|NCT00095173|50018763|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
24925364|NCT00095173|50018764|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
24925365|NCT00095173|50018765|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
24925366|NCT00095173|50018766|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
24925367|NCT00095173|50018767|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
25024619|NCT03364309|50122160|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
25185529|NCT01500278|50335063|FG000|Week 13 - Week 104|Relocation|0|||
25185530|NCT01500278|50335064|FG001|Week 13 - Week 104|Relocation|1|||
25185531|NCT01500278|50335063|FG000|Week 13 - Week 104|Sponsor decision|0|||
24925368|NCT00095173|50018768|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
24925369|NCT00095173|50018763|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
24925370|NCT00095173|50018764|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
24925371|NCT00095173|50018765|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
24925372|NCT00095173|50018766|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
24925373|NCT00095173|50018767|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
24925374|NCT00095173|50018768|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
24925375|NCT00095173|50018763|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
24925376|NCT00095173|50018764|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
24925377|NCT00095173|50018765|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
24925378|NCT00095173|50018766|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
24925379|NCT00095173|50018767|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
24925380|NCT00095173|50018768|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
24925381|NCT00095173|50018763|FG000|Open-Label Extension Phase (Period C)|Death|0|||
24925382|NCT00095173|50018764|FG001|Open-Label Extension Phase (Period C)|Death|0|||
25024620|NCT03364309|50122161|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
25024621|NCT03364309|50122162|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
25024622|NCT03364309|50122163|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
25024623|NCT03364309|50122164|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
25024624|NCT03364309|50122165|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
25024625|NCT03364309|50122166|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
25024626|NCT03364309|50122167|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
25024627|NCT03364309|50122168|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
25024628|NCT03364309|50122169|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
25024629|NCT03364309|50122170|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
25024630|NCT03364309|50122171|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
25024631|NCT03364309|50122172|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
25024632|NCT03364309|50122173|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
25024633|NCT03364309|50122155|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024634|NCT03364309|50122156|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024635|NCT03364309|50122157|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024636|NCT03364309|50122158|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024637|NCT03364309|50122159|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024638|NCT03364309|50122160|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024639|NCT03364309|50122161|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024640|NCT03364309|50122162|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024641|NCT03364309|50122163|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024642|NCT03364309|50122164|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024643|NCT03364309|50122165|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024644|NCT03364309|50122166|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024645|NCT03364309|50122167|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024646|NCT03364309|50122168|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024647|NCT03364309|50122169|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
25024648|NCT03364309|50122170|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024649|NCT03364309|50122171|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024650|NCT03364309|50122172|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024651|NCT03364309|50122173|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
25024652|NCT03364309|50122155|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
25024653|NCT03364309|50122156|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
25024654|NCT03364309|50122157|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
25024655|NCT03364309|50122158|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
25024656|NCT03364309|50122159|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
25024657|NCT03364309|50122160|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
25024658|NCT03364309|50122161|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
25024659|NCT03364309|50122162|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
25024660|NCT03364309|50122163|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
25024661|NCT03364309|50122164|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
25024662|NCT03364309|50122165|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
25024663|NCT03364309|50122166|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
25024664|NCT03364309|50122167|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
25024665|NCT03364309|50122168|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
25024666|NCT03364309|50122169|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
25024667|NCT03364309|50122170|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
25024668|NCT03364309|50122171|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
25024669|NCT03364309|50122172|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
25024670|NCT03364309|50122173|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
25024671|NCT03364309|50122155|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
25024672|NCT03364309|50122156|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
25024673|NCT03364309|50122157|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
25024674|NCT03364309|50122158|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
25024675|NCT03364309|50122159|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
25024676|NCT03364309|50122160|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
25024677|NCT03364309|50122161|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
25024678|NCT03364309|50122162|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
25024679|NCT03364309|50122163|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
25024680|NCT03364309|50122164|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
25024681|NCT03364309|50122165|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
25024682|NCT03364309|50122166|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
25024683|NCT03364309|50122167|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
25024684|NCT03364309|50122168|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
25024685|NCT03364309|50122169|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
25024686|NCT03364309|50122170|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
25024687|NCT03364309|50122171|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
25024688|NCT03364309|50122172|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
25024689|NCT03364309|50122173|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
25024690|NCT03364309|50122155|FG000|Post-Treatment Followup Period|Adverse Event|0|||
25024691|NCT03364309|50122156|FG001|Post-Treatment Followup Period|Adverse Event|0|||
25024692|NCT03364309|50122157|FG002|Post-Treatment Followup Period|Adverse Event|0|||
25024693|NCT03364309|50122158|FG003|Post-Treatment Followup Period|Adverse Event|0|||
25024694|NCT03364309|50122159|FG004|Post-Treatment Followup Period|Adverse Event|0|||
25024695|NCT03364309|50122160|FG005|Post-Treatment Followup Period|Adverse Event|0|||
25024696|NCT03364309|50122161|FG006|Post-Treatment Followup Period|Adverse Event|0|||
25024697|NCT03364309|50122162|FG007|Post-Treatment Followup Period|Adverse Event|0|||
25024698|NCT03364309|50122163|FG008|Post-Treatment Followup Period|Adverse Event|0|||
25024699|NCT03364309|50122164|FG009|Post-Treatment Followup Period|Adverse Event|0|||
25024700|NCT03364309|50122165|FG010|Post-Treatment Followup Period|Adverse Event|0|||
25024701|NCT03364309|50122166|FG011|Post-Treatment Followup Period|Adverse Event|0|||
25024702|NCT03364309|50122167|FG012|Post-Treatment Followup Period|Adverse Event|0|||
24925383|NCT00095173|50018765|FG002|Open-Label Extension Phase (Period C)|Death|0|||
24925384|NCT00095173|50018766|FG003|Open-Label Extension Phase (Period C)|Death|0|||
24925385|NCT00095173|50018767|FG004|Open-Label Extension Phase (Period C)|Death|0|||
24925386|NCT00095173|50018768|FG005|Open-Label Extension Phase (Period C)|Death|1|||
24925387|NCT00095173|50018763|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
24925388|NCT00095173|50018764|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
24925389|NCT00095173|50018765|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
24925390|NCT00095173|50018766|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
24925391|NCT00095173|50018767|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
24925392|NCT00095173|50018768|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
24925393|NCT00095173|50018763|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
24925394|NCT00095173|50018764|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
24925395|NCT00095173|50018765|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
24925396|NCT00095173|50018766|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
24925397|NCT00095173|50018767|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
24925398|NCT00095173|50018768|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
24925399|NCT00095173|50018763|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
24925400|NCT00095173|50018764|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
24925401|NCT00095173|50018765|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
24925402|NCT00095173|50018766|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
24925403|NCT00095173|50018767|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
24925404|NCT00095173|50018768|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
24925405|NCT00095173|50018763|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
24925406|NCT00095173|50018764|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
24925407|NCT00095173|50018765|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
24925408|NCT00095173|50018766|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
24925409|NCT00095173|50018767|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
24925410|NCT00095173|50018768|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
24925411|NCT00095173|50018763|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
24925412|NCT00095173|50018764|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
25024703|NCT03364309|50122168|FG013|Post-Treatment Followup Period|Adverse Event|0|||
25024704|NCT03364309|50122169|FG014|Post-Treatment Followup Period|Adverse Event|0|||
25024705|NCT03364309|50122170|FG015|Post-Treatment Followup Period|Adverse Event|0|||
25024706|NCT03364309|50122171|FG016|Post-Treatment Followup Period|Adverse Event|2|||
25024707|NCT03364309|50122172|FG017|Post-Treatment Followup Period|Adverse Event|6|||
25024708|NCT03364309|50122173|FG018|Post-Treatment Followup Period|Adverse Event|1|||
25024709|NCT03364309|50122155|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
25024710|NCT03364309|50122156|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
24925413|NCT00095173|50018765|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
24925414|NCT00095173|50018766|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
24925415|NCT00095173|50018767|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
24925416|NCT00095173|50018768|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
24925417|NCT00095173|50018763|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
24925418|NCT00095173|50018764|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
24925419|NCT00095173|50018765|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
24925420|NCT00095173|50018766|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
24925421|NCT00095173|50018767|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
24925422|NCT00095173|50018768|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
25024711|NCT03364309|50122157|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
25024712|NCT03364309|50122158|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
25024713|NCT03364309|50122159|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
24925423|NCT00095173|50018763|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
24925424|NCT00095173|50018764|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
24925425|NCT00095173|50018765|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
24925426|NCT00095173|50018766|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
24925427|NCT00095173|50018767|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
24925428|NCT00095173|50018768|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
24925429|NCT00095173|50018763|FG000|Open-Label Extension Phase (Period C)|Other|0|||
24925430|NCT00095173|50018764|FG001|Open-Label Extension Phase (Period C)|Other|0|||
24925431|NCT00095173|50018765|FG002|Open-Label Extension Phase (Period C)|Other|0|||
24925432|NCT00095173|50018766|FG003|Open-Label Extension Phase (Period C)|Other|4|||
24925433|NCT00095173|50018767|FG004|Open-Label Extension Phase (Period C)|Other|6|||
24925434|NCT00095173|50018768|FG005|Open-Label Extension Phase (Period C)|Other|8|||
24925435|NCT00690443|50018784|FG000|Overall Study|Adverse Event|1|||
24925436|NCT00690443|50018785|FG001|Overall Study|Adverse Event|2|||
24925437|NCT03954834|50018795|FG000|Overall Study|Adverse Event|1|||
24925438|NCT03954834|50018796|FG001|Overall Study|Adverse Event|3|||
24925439|NCT03954834|50018797|FG002|Overall Study|Adverse Event|1|||
24925440|NCT03954834|50018798|FG003|Overall Study|Adverse Event|1|||
24925441|NCT03954834|50018795|FG000|Overall Study|Death|0|||
24925442|NCT03954834|50018796|FG001|Overall Study|Death|0|||
24925443|NCT03954834|50018797|FG002|Overall Study|Death|0|||
24925444|NCT03954834|50018798|FG003|Overall Study|Death|1|||
24925445|NCT03954834|50018795|FG000|Overall Study|Physician Decision|0|||
24925446|NCT03954834|50018796|FG001|Overall Study|Physician Decision|1|||
24925447|NCT03954834|50018797|FG002|Overall Study|Physician Decision|0|||
24925448|NCT03954834|50018798|FG003|Overall Study|Physician Decision|2|||
24925449|NCT03954834|50018795|FG000|Overall Study|Protocol Violation|1|||
24925450|NCT03954834|50018796|FG001|Overall Study|Protocol Violation|0|||
24925451|NCT03954834|50018797|FG002|Overall Study|Protocol Violation|0|||
24925452|NCT03954834|50018798|FG003|Overall Study|Protocol Violation|1|||
25024714|NCT03364309|50122160|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
25024715|NCT03364309|50122161|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
24925453|NCT03954834|50018795|FG000|Overall Study|Withdrawal by Subject|2|||
24925454|NCT03954834|50018796|FG001|Overall Study|Withdrawal by Subject|3|||
24925455|NCT03954834|50018797|FG002|Overall Study|Withdrawal by Subject|13|||
24925456|NCT03954834|50018798|FG003|Overall Study|Withdrawal by Subject|6|||
24925457|NCT03954834|50018795|FG000|Overall Study|Participant left the country|0|||
24925458|NCT03954834|50018796|FG001|Overall Study|Participant left the country|0|||
24925459|NCT03954834|50018797|FG002|Overall Study|Participant left the country|1|||
24925460|NCT03954834|50018798|FG003|Overall Study|Participant left the country|0|||
24925461|NCT03954834|50018795|FG000|Overall Study|Lost to Follow-up|3|||
24925462|NCT03954834|50018796|FG001|Overall Study|Lost to Follow-up|2|||
24925463|NCT03954834|50018797|FG002|Overall Study|Lost to Follow-up|3|||
24925464|NCT03954834|50018798|FG003|Overall Study|Lost to Follow-up|5|||
24925465|NCT00693017|50018810|FG000|Overall Study|Sponsor Decision|2|||
24925466|NCT00693017|50018811|FG001|Overall Study|Sponsor Decision|1|||
24925467|NCT00693017|50018810|FG000|Overall Study|Death|0|||
24925468|NCT00693017|50018811|FG001|Overall Study|Death|1|||
24925469|NCT00692237|50018819|FG000|Overall Study|Withdrawal by Subject|1|||
24925470|NCT00692237|50018820|FG001|Overall Study|Withdrawal by Subject|3|||
24925471|NCT00692237|50018819|FG000|Overall Study|Adverse Event|0|||
24925472|NCT00692237|50018820|FG001|Overall Study|Adverse Event|1|||
24925473|NCT00110149|50018826|FG000|Overall Study|Physician Decision|3|||
24925474|NCT03954444|50018834|FG000|Overall Study|Withdrawal by Subject|5|||
24925475|NCT03954444|50018835|FG001|Overall Study|Withdrawal by Subject|5|||
24925476|NCT03954444|50018836|FG002|Overall Study|Withdrawal by Subject|5|||
24925477|NCT03954444|50018834|FG000|Overall Study|Adverse Event|1|||
24925478|NCT03954444|50018835|FG001|Overall Study|Adverse Event|3|||
24925479|NCT03954444|50018836|FG002|Overall Study|Adverse Event|2|||
24925480|NCT03954444|50018834|FG000|Overall Study|Protocol Violation|0|||
24925481|NCT03954444|50018835|FG001|Overall Study|Protocol Violation|3|||
24925482|NCT03954444|50018836|FG002|Overall Study|Protocol Violation|5|||
25024716|NCT03364309|50122162|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
25024717|NCT03364309|50122163|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
25024718|NCT03364309|50122164|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
25155044|NCT01922011|50270324|FG000|Overall Study|Lost to Follow-up|0|||
25155045|NCT01922011|50270325|FG001|Overall Study|Lost to Follow-up|1|||
25155046|NCT01922011|50270324|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
24925483|NCT03954444|50018834|FG000|Overall Study|Use of prohibited therapy|1|||
24925484|NCT03954444|50018835|FG001|Overall Study|Use of prohibited therapy|1|||
24925485|NCT03954444|50018836|FG002|Overall Study|Use of prohibited therapy|2|||
24925486|NCT03954444|50018834|FG000|Overall Study|Lost to Follow-up|1|||
24925487|NCT03954444|50018835|FG001|Overall Study|Lost to Follow-up|0|||
24925488|NCT03954444|50018836|FG002|Overall Study|Lost to Follow-up|1|||
24925489|NCT03954444|50018834|FG000|Overall Study|Non-compliant with study drug application|2|||
24925490|NCT03954444|50018835|FG001|Overall Study|Non-compliant with study drug application|2|||
24925491|NCT03954444|50018836|FG002|Overall Study|Non-compliant with study drug application|0|||
25155047|NCT01922011|50270325|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
25024719|NCT03364309|50122165|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
24925492|NCT03954444|50018834|FG000|Overall Study|Administrative reasons|0|||
24925493|NCT03954444|50018835|FG001|Overall Study|Administrative reasons|0|||
24925494|NCT03954444|50018836|FG002|Overall Study|Administrative reasons|1|||
24925495|NCT03954444|50018834|FG000|Overall Study|Miscellaneous|3|||
24925496|NCT03954444|50018835|FG001|Overall Study|Miscellaneous|2|||
24925497|NCT03954444|50018836|FG002|Overall Study|Miscellaneous|1|||
24925498|NCT03953820|50018844|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
24925499|NCT03953820|50018845|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
24925500|NCT03953820|50018846|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
24925501|NCT03953820|50018844|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
24925502|NCT03953820|50018845|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
24925503|NCT03953820|50018846|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
24925504|NCT00117949|50018863|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
24925505|NCT00117949|50018864|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
24925506|NCT00117949|50018865|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
24925507|NCT00117949|50018866|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
24925508|NCT00117949|50018863|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
24925509|NCT00117949|50018864|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
24925510|NCT00117949|50018865|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
24925511|NCT00117949|50018866|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
25024720|NCT03364309|50122166|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
25024721|NCT03364309|50122167|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
25024722|NCT03364309|50122168|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
24925512|NCT00117949|50018863|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
24925513|NCT00117949|50018864|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
24925514|NCT00117949|50018865|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
24925515|NCT00117949|50018866|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
24925516|NCT00117949|50018863|FG000|Overall Study|PSA increase >=10ng/mL|0|||
24925517|NCT00117949|50018864|FG001|Overall Study|PSA increase >=10ng/mL|1|||
24925518|NCT00117949|50018865|FG002|Overall Study|PSA increase >=10ng/mL|1|||
24925519|NCT00117949|50018866|FG003|Overall Study|PSA increase >=10ng/mL|0|||
24925520|NCT00117949|50018863|FG000|Overall Study|PSA reduction <=50%|0|||
24925521|NCT00117949|50018864|FG001|Overall Study|PSA reduction <=50%|2|||
24925522|NCT00117949|50018865|FG002|Overall Study|PSA reduction <=50%|2|||
24925523|NCT00117949|50018866|FG003|Overall Study|PSA reduction <=50%|4|||
24925524|NCT00117949|50018863|FG000|Overall Study|Hepatic abnormalities|0|||
24925525|NCT00117949|50018864|FG001|Overall Study|Hepatic abnormalities|1|||
24925526|NCT00117949|50018865|FG002|Overall Study|Hepatic abnormalities|0|||
24925527|NCT00117949|50018866|FG003|Overall Study|Hepatic abnormalities|1|||
24925528|NCT02611037|50018876|FG000|Overall Study|Withdrawal prior to treatment|2|||
24925529|NCT02611037|50018877|FG001|Overall Study|Withdrawal prior to treatment|0|||
24925530|NCT00117793|50018882|FG000|Overall Study|Withdrawal by Subject|12|||
24925531|NCT00695669|50018891|FG000|Overall Study|Adverse Event|0|||
24925532|NCT00695669|50018892|FG001|Overall Study|Adverse Event|0|||
24925533|NCT00695669|50018893|FG002|Overall Study|Adverse Event|2|||
24925534|NCT00695669|50018894|FG003|Overall Study|Adverse Event|0|||
24925535|NCT00695669|50018891|FG000|Overall Study|Lost to Follow-up|4|||
24925536|NCT00695669|50018892|FG001|Overall Study|Lost to Follow-up|4|||
24925537|NCT00695669|50018893|FG002|Overall Study|Lost to Follow-up|1|||
24925538|NCT00695669|50018894|FG003|Overall Study|Lost to Follow-up|4|||
24925539|NCT03671369|50018907|FG000|Overall Study|Other|1|||
24925540|NCT03671369|50018907|FG000|Overall Study|Withdrawal by Subject|289|||
24925541|NCT03671369|50018907|FG000|Overall Study|Not willing to be vaccinated|1|||
24925542|NCT00692003|50018913|FG000|Overall Study|Sponsor Decision|5|||
24925543|NCT00692003|50018914|FG001|Overall Study|Sponsor Decision|1|||
24925544|NCT00434512|50018926|FG000|Overall Study|Migrated/moved from study area|0|||
24925545|NCT00434512|50018927|FG001|Overall Study|Migrated/moved from study area|0|||
24925546|NCT00434512|50018928|FG002|Overall Study|Migrated/moved from study area|0|||
24925547|NCT00434512|50018929|FG003|Overall Study|Migrated/moved from study area|1|||
24925548|NCT00434512|50018930|FG004|Overall Study|Migrated/moved from study area|1|||
24925549|NCT00434512|50018931|FG005|Overall Study|Migrated/moved from study area|1|||
24925550|NCT00434512|50018926|FG000|Overall Study|Other|0|||
24925551|NCT00434512|50018927|FG001|Overall Study|Other|1|||
24925552|NCT00434512|50018928|FG002|Overall Study|Other|0|||
24925553|NCT00434512|50018929|FG003|Overall Study|Other|0|||
24925554|NCT00434512|50018930|FG004|Overall Study|Other|0|||
24925555|NCT00434512|50018931|FG005|Overall Study|Other|0|||
24925556|NCT00427648|50018951|FG000|Overall Study|Protocol Violation|1|||
24925557|NCT00427648|50018952|FG001|Overall Study|Protocol Violation|2|||
24925558|NCT00427648|50018951|FG000|Overall Study|Adverse Event|0|||
24925559|NCT00427648|50018952|FG001|Overall Study|Adverse Event|1|||
24925560|NCT00416884|50018960|FG000|Overall Study|Study terminated due to low accrual|1|||
24925561|NCT00434122|50018966|FG000|Overall Study|Non-compliance with protocol|0|||
24925562|NCT00434122|50018967|FG001|Overall Study|Non-compliance with protocol|1|||
24925563|NCT00434122|50018966|FG000|Overall Study|loss of subject contact|1|||
24925564|NCT00434122|50018967|FG001|Overall Study|loss of subject contact|1|||
24925565|NCT00434122|50018966|FG000|Overall Study|Personal reasons|1|||
24925566|NCT00434122|50018967|FG001|Overall Study|Personal reasons|1|||
24925567|NCT00434122|50018966|FG000|Overall Study|Large follicle size|2|||
24925568|NCT00434122|50018967|FG001|Overall Study|Large follicle size|2|||
24925569|NCT00434122|50018966|FG000|Overall Study|Low follicular response.|1|||
24925570|NCT00434122|50018967|FG001|Overall Study|Low follicular response.|2|||
24925571|NCT00434122|50018966|FG000|Overall Study|Travelling of subject.|1|||
25024723|NCT03364309|50122169|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
25024724|NCT03364309|50122170|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
25024725|NCT03364309|50122171|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
25024726|NCT03364309|50122172|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
25155048|NCT01922011|50270324|FG000|Overall Study|Not Treated|1|||
25155049|NCT01922011|50270325|FG001|Overall Study|Not Treated|0|||
25155050|NCT01922011|50270324|FG000|Overall Study|Lack of willing home health agency|1|||
25155051|NCT01922011|50270325|FG001|Overall Study|Lack of willing home health agency|0|||
25155052|NCT01922011|50270324|FG000|Overall Study|Randomized in error|1|||
25155053|NCT01922011|50270325|FG001|Overall Study|Randomized in error|0|||
25155054|NCT01883635|50270339|FG000|Overall Study|Withdrawal by Subject|4|||
25155055|NCT01883635|50270340|FG001|Overall Study|Withdrawal by Subject|0|||
25155056|NCT01921387|50270348|FG000|Overall Study|Adverse Event|1|||
25155057|NCT01895335|50270352|FG000|Overall Study|Adverse Event|106|||
25155058|NCT01895335|50270352|FG000|Overall Study|Lack of Efficacy|53|||
25155059|NCT01895335|50270352|FG000|Overall Study|Poor Compliance to Protocol|11|||
25155060|NCT01895335|50270352|FG000|Overall Study|Included But Not treated|1|||
25155061|NCT01895335|50270352|FG000|Overall Study|Other than Specified Above|44|||
25155062|NCT01617655|50270358|FG000|Overall Study|Adverse Event|2|||
25155063|NCT01617655|50270359|FG001|Overall Study|Adverse Event|3|||
25155064|NCT01617655|50270358|FG000|Overall Study|Poor compliance to protocol|1|||
25155065|NCT01617655|50270359|FG001|Overall Study|Poor compliance to protocol|4|||
25155066|NCT01617655|50270358|FG000|Overall Study|Participants moved|0|||
25155067|NCT01617655|50270359|FG001|Overall Study|Participants moved|4|||
25155068|NCT01617655|50270358|FG000|Overall Study|Consent withdrawn by participant|1|||
25155069|NCT01617655|50270359|FG001|Overall Study|Consent withdrawn by participant|1|||
25155070|NCT01617655|50270358|FG000|Overall Study|Last visit outside protocol visit window|1|||
25155071|NCT01617655|50270359|FG001|Overall Study|Last visit outside protocol visit window|10|||
25155072|NCT01617655|50270358|FG000|Overall Study|Site closure|3|||
25155073|NCT01617655|50270359|FG001|Overall Study|Site closure|5|||
25155074|NCT01617655|50270358|FG000|Overall Study|Other than specified above|1|||
25024727|NCT03364309|50122173|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
25024728|NCT03364309|50122155|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
25024729|NCT03364309|50122156|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
25024730|NCT03364309|50122157|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
25155075|NCT01617655|50270359|FG001|Overall Study|Other than specified above|2|||
25155076|NCT01895101|50270370|FG000|Overall Study|OPCAB procedure|1|||
25155077|NCT01895101|50270371|FG001|Overall Study|OPCAB procedure|1|||
25155078|NCT01895101|50270372|FG002|Overall Study|OPCAB procedure|3|||
25155079|NCT01895101|50270370|FG000|Overall Study|Withdrawal by Subject|0|||
25155080|NCT01895101|50270371|FG001|Overall Study|Withdrawal by Subject|1|||
25155081|NCT01895101|50270372|FG002|Overall Study|Withdrawal by Subject|2|||
25155082|NCT01895101|50270370|FG000|Overall Study|another study, enrolled in other study|0|||
25155083|NCT01895101|50270371|FG001|Overall Study|another study, enrolled in other study|1|||
25155084|NCT01895101|50270372|FG002|Overall Study|another study, enrolled in other study|0|||
25155085|NCT01895101|50270370|FG000|Overall Study|Death|0|||
25155086|NCT01895101|50270371|FG001|Overall Study|Death|1|||
25155087|NCT01895101|50270372|FG002|Overall Study|Death|0|||
25155088|NCT01895101|50270370|FG000|Overall Study|coagulation disorder|0|||
25155089|NCT01895101|50270371|FG001|Overall Study|coagulation disorder|1|||
25155090|NCT01895101|50270372|FG002|Overall Study|coagulation disorder|0|||
25155091|NCT01894477|50270382|FG000|Overall Study|Protocol Violation|0|||
25155092|NCT01894477|50270383|FG001|Overall Study|Protocol Violation|1|||
25155093|NCT01894477|50270382|FG000|Overall Study|protocol changed due SC changed to cord|0|||
25155094|NCT01894477|50270383|FG001|Overall Study|protocol changed due SC changed to cord|1|||
25155095|NCT01894243|50270392|FG000|Overall Study|Adverse Event|0|||
25155096|NCT01894243|50270393|FG001|Overall Study|Adverse Event|1|||
25155097|NCT01894243|50270394|FG002|Overall Study|Adverse Event|2|||
25024731|NCT03364309|50122158|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
25024732|NCT03364309|50122159|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
25024733|NCT03364309|50122160|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
25024734|NCT03364309|50122161|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
25024735|NCT03364309|50122162|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
25024736|NCT03364309|50122163|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
25024737|NCT03364309|50122164|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
25024738|NCT03364309|50122165|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
25024739|NCT03364309|50122166|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
25024740|NCT03364309|50122167|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
25024741|NCT03364309|50122168|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
25024742|NCT03364309|50122169|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
25024743|NCT03364309|50122170|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
25024744|NCT03364309|50122171|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
25024745|NCT03364309|50122172|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
24925572|NCT00434122|50018967|FG001|Overall Study|Travelling of subject.|0|||
24925573|NCT00555620|50018981|FG000|Overall Study|Death|0|||
24925574|NCT00555620|50018982|FG001|Overall Study|Death|1|||
25024746|NCT03364309|50122173|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
25024747|NCT03334903|50122199|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
25024748|NCT03334903|50122200|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
25024749|NCT03334903|50122199|FG000|Overall Study|Protocol Violation|1|||
25024750|NCT03334903|50122200|FG001|Overall Study|Protocol Violation|3|||
25024751|NCT03334903|50122199|FG000|Overall Study|Surgery postponed|1|||
24925575|NCT00555620|50018983|FG002|Overall Study|Death|0|||
24925576|NCT00555620|50018984|FG003|Overall Study|Death|0|||
24925577|NCT00555620|50018985|FG004|Overall Study|Death|0|||
24925578|NCT00555620|50018986|FG005|Overall Study|Death|1|||
24925579|NCT00555620|50018981|FG000|Overall Study|Study terminated by sponsor|0|||
24925580|NCT00555620|50018982|FG001|Overall Study|Study terminated by sponsor|0|||
24925581|NCT00555620|50018983|FG002|Overall Study|Study terminated by sponsor|1|||
24925582|NCT00555620|50018984|FG003|Overall Study|Study terminated by sponsor|0|||
24925583|NCT00555620|50018985|FG004|Overall Study|Study terminated by sponsor|0|||
24925584|NCT00555620|50018986|FG005|Overall Study|Study terminated by sponsor|0|||
24925585|NCT00555620|50018981|FG000|Overall Study|Adverse Event|0|||
24925586|NCT00555620|50018982|FG001|Overall Study|Adverse Event|0|||
24925587|NCT00555620|50018983|FG002|Overall Study|Adverse Event|1|||
24925588|NCT00555620|50018984|FG003|Overall Study|Adverse Event|5|||
24925589|NCT00555620|50018985|FG004|Overall Study|Adverse Event|0|||
24925590|NCT00555620|50018986|FG005|Overall Study|Adverse Event|1|||
24925591|NCT00555620|50018981|FG000|Overall Study|Objective progression or relapse|6|||
24925592|NCT00555620|50018982|FG001|Overall Study|Objective progression or relapse|5|||
24925593|NCT00555620|50018983|FG002|Overall Study|Objective progression or relapse|12|||
24925594|NCT00555620|50018984|FG003|Overall Study|Objective progression or relapse|17|||
24925595|NCT00555620|50018985|FG004|Overall Study|Objective progression or relapse|3|||
24925596|NCT00555620|50018986|FG005|Overall Study|Objective progression or relapse|16|||
24925597|NCT00555620|50018981|FG000|Overall Study|Participant refused treatment|0|||
24925598|NCT00555620|50018982|FG001|Overall Study|Participant refused treatment|1|||
24925599|NCT00555620|50018983|FG002|Overall Study|Participant refused treatment|1|||
24925600|NCT00555620|50018984|FG003|Overall Study|Participant refused treatment|0|||
24925601|NCT00555620|50018985|FG004|Overall Study|Participant refused treatment|0|||
24925602|NCT00555620|50018986|FG005|Overall Study|Participant refused treatment|1|||
24925603|NCT00555620|50018981|FG000|Overall Study|Other|0|||
24925604|NCT00555620|50018982|FG001|Overall Study|Other|0|||
25024752|NCT03334903|50122200|FG001|Overall Study|Surgery postponed|0|||
25024753|NCT03334903|50122199|FG000|Overall Study|Adverse Event|1|||
25024754|NCT03334903|50122200|FG001|Overall Study|Adverse Event|1|||
25024755|NCT03334903|50122199|FG000|Overall Study|Withdrawal by Subject|0|||
25024756|NCT03334903|50122200|FG001|Overall Study|Withdrawal by Subject|1|||
25024757|NCT01353664|50122206|FG000|Overall Study|Other|3|||
25024758|NCT01353664|50122206|FG000|Overall Study|Disease Progression|16|||
25024759|NCT02694328|50122212|FG000|Overall Study|Adverse Event|27|||
25155098|NCT01894243|50270392|FG000|Overall Study|Death|0|||
25024760|NCT02694328|50122213|FG001|Overall Study|Adverse Event|33|||
24925605|NCT00555620|50018983|FG002|Overall Study|Other|0|||
24925606|NCT00555620|50018984|FG003|Overall Study|Other|1|||
24925607|NCT00555620|50018985|FG004|Overall Study|Other|0|||
24925608|NCT00555620|50018986|FG005|Overall Study|Other|3|||
24925609|NCT00433966|50019006|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
24925610|NCT00433966|50019007|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
25024761|NCT02694328|50122212|FG000|Overall Study|Withdrawal by Subject|27|||
25024762|NCT02694328|50122213|FG001|Overall Study|Withdrawal by Subject|23|||
25024763|NCT02694328|50122212|FG000|Overall Study|Lost to Follow-up|26|||
25024764|NCT02694328|50122213|FG001|Overall Study|Lost to Follow-up|22|||
25024765|NCT02694328|50122212|FG000|Overall Study|Noncompliant with study drug|11|||
25024766|NCT02694328|50122213|FG001|Overall Study|Noncompliant with study drug|8|||
25024767|NCT02694328|50122212|FG000|Overall Study|Incarceration|1|||
25024768|NCT02694328|50122213|FG001|Overall Study|Incarceration|1|||
25024769|NCT02694328|50122212|FG000|Overall Study|Lack of Efficacy|1|||
24925611|NCT00433966|50019008|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
25024770|NCT02694328|50122213|FG001|Overall Study|Lack of Efficacy|2|||
25024771|NCT02694328|50122212|FG000|Overall Study|Pregnancy|1|||
24925612|NCT00433966|50019009|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
24925613|NCT00433966|50019006|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
24925614|NCT00433966|50019007|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
24925615|NCT00433966|50019008|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
24925616|NCT00433966|50019009|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
24925617|NCT00433966|50019006|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
24925618|NCT00433966|50019007|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
24925619|NCT00433966|50019008|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
24925620|NCT00433966|50019009|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
24925621|NCT00433966|50019006|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
24925622|NCT00433966|50019007|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
24925623|NCT00433966|50019008|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
24925624|NCT00433966|50019009|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
24925625|NCT00433966|50019006|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
24925626|NCT00433966|50019007|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
24925627|NCT00433966|50019008|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
24925628|NCT00433966|50019009|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
24925629|NCT03952650|50019026|FG000|Overall Study|TRAVEL|0|||
24925630|NCT03952650|50019027|FG001|Overall Study|TRAVEL|4|||
24925631|NCT03952650|50019028|FG002|Overall Study|TRAVEL|0|||
24925632|NCT03952650|50019029|FG003|Overall Study|TRAVEL|4|||
24925633|NCT03952650|50019030|FG004|Overall Study|TRAVEL|0|||
24925634|NCT03952650|50019031|FG005|Overall Study|TRAVEL|3|||
24925635|NCT03952650|50019032|FG006|Overall Study|TRAVEL|2|||
24925636|NCT03952650|50019026|FG000|Overall Study|Withdrawal by Subject|0|||
24925637|NCT03952650|50019027|FG001|Overall Study|Withdrawal by Subject|2|||
24925638|NCT03952650|50019028|FG002|Overall Study|Withdrawal by Subject|0|||
24925639|NCT03952650|50019029|FG003|Overall Study|Withdrawal by Subject|3|||
24925640|NCT03952650|50019030|FG004|Overall Study|Withdrawal by Subject|0|||
24925641|NCT03952650|50019031|FG005|Overall Study|Withdrawal by Subject|1|||
24925642|NCT03952650|50019032|FG006|Overall Study|Withdrawal by Subject|1|||
24925643|NCT03952650|50019026|FG000|Overall Study|Lost to Follow-up|0|||
24925644|NCT03952650|50019027|FG001|Overall Study|Lost to Follow-up|1|||
24925645|NCT03952650|50019028|FG002|Overall Study|Lost to Follow-up|0|||
24925646|NCT03952650|50019029|FG003|Overall Study|Lost to Follow-up|0|||
24925647|NCT03952650|50019030|FG004|Overall Study|Lost to Follow-up|0|||
24925648|NCT03952650|50019031|FG005|Overall Study|Lost to Follow-up|1|||
24925649|NCT03952650|50019032|FG006|Overall Study|Lost to Follow-up|1|||
24925650|NCT03952650|50019026|FG000|Overall Study|Received wrong vaccine and travelled|0|||
24925651|NCT03952650|50019027|FG001|Overall Study|Received wrong vaccine and travelled|0|||
24925652|NCT03952650|50019028|FG002|Overall Study|Received wrong vaccine and travelled|0|||
24925653|NCT03952650|50019029|FG003|Overall Study|Received wrong vaccine and travelled|0|||
24925654|NCT03952650|50019030|FG004|Overall Study|Received wrong vaccine and travelled|0|||
24925655|NCT03952650|50019031|FG005|Overall Study|Received wrong vaccine and travelled|1|||
24925656|NCT03952650|50019032|FG006|Overall Study|Received wrong vaccine and travelled|0|||
24925657|NCT03952650|50019026|FG000|Overall Study|Unable to make study visit|0|||
24925658|NCT03952650|50019027|FG001|Overall Study|Unable to make study visit|0|||
24925659|NCT03952650|50019028|FG002|Overall Study|Unable to make study visit|0|||
24925660|NCT03952650|50019029|FG003|Overall Study|Unable to make study visit|0|||
24925661|NCT03952650|50019030|FG004|Overall Study|Unable to make study visit|0|||
24925662|NCT03952650|50019031|FG005|Overall Study|Unable to make study visit|1|||
24925663|NCT03952650|50019032|FG006|Overall Study|Unable to make study visit|0|||
25024772|NCT02694328|50122213|FG001|Overall Study|Pregnancy|1|||
25024773|NCT02694328|50122212|FG000|Overall Study|Protocol Violation|6|||
25024774|NCT02694328|50122213|FG001|Overall Study|Protocol Violation|5|||
25024775|NCT02694328|50122212|FG000|Overall Study|Abnormal Laboratory Value|0|||
24925664|NCT00691301|50019048|FG000|Overall Study|Adverse Event|10|||
24925665|NCT00691301|50019048|FG000|Overall Study|Death|2|||
24925666|NCT00691301|50019048|FG000|Overall Study|Lack of Efficacy|32|||
24925667|NCT00691301|50019048|FG000|Overall Study|Withdrawal by Subject|4|||
24925668|NCT00691301|50019048|FG000|Overall Study|Concurrent illness|2|||
25024776|NCT02694328|50122213|FG001|Overall Study|Abnormal Laboratory Value|3|||
24925669|NCT00691301|50019048|FG000|Overall Study|other reason|3|||
24925670|NCT00691301|50019048|FG000|Overall Study|Did not initiate study treatment|1|||
24925671|NCT00927563|50019058|FG000|Overall Study|Lost to Follow-up|1|||
24925672|NCT00927563|50019058|FG000|Overall Study|Withdrawal by Subject|1|||
24925673|NCT00653159|50019073|FG000|Overall Study|Adverse Event|4|||
24925674|NCT00653159|50019074|FG001|Overall Study|Adverse Event|1|||
24925675|NCT00653159|50019073|FG000|Overall Study|Lost to Follow-up|1|||
24925676|NCT00653159|50019074|FG001|Overall Study|Lost to Follow-up|2|||
24964543|NCT00433199|50054371|FG000|Double-Blind Period|Lack of Efficacy|0|||
24964544|NCT00433199|50054372|FG001|Double-Blind Period|Lack of Efficacy|2|||
24964545|NCT00433199|50054371|FG000|Double-Blind Period|Lost to Follow-up|2|||
24964546|NCT00433199|50054372|FG001|Double-Blind Period|Lost to Follow-up|5|||
24964547|NCT00433199|50054371|FG000|Double-Blind Period|Withdrawal by Subject|8|||
24964548|NCT00433199|50054372|FG001|Double-Blind Period|Withdrawal by Subject|19|||
24964549|NCT00433199|50054371|FG000|Double-Blind Period|Protocol Violation|1|||
24964550|NCT00433199|50054372|FG001|Double-Blind Period|Protocol Violation|10|||
24964551|NCT00433199|50054371|FG000|Double-Blind Period|Administrative|1|||
24964552|NCT00433199|50054372|FG001|Double-Blind Period|Administrative|5|||
24964553|NCT00433199|50054371|FG000|Open-Label Period|Adverse Event|0|||
24964554|NCT00433199|50054372|FG001|Open-Label Period|Adverse Event|19|||
24964555|NCT00433199|50054371|FG000|Open-Label Period|Lack of Efficacy|0|||
24964556|NCT00433199|50054372|FG001|Open-Label Period|Lack of Efficacy|2|||
24964557|NCT00433199|50054371|FG000|Open-Label Period|Lost to Follow-up|0|||
24964558|NCT00433199|50054372|FG001|Open-Label Period|Lost to Follow-up|3|||
24964559|NCT00433199|50054371|FG000|Open-Label Period|Withdrawal by Subject|0|||
24964560|NCT00433199|50054372|FG001|Open-Label Period|Withdrawal by Subject|7|||
24964561|NCT00433199|50054371|FG000|Open-Label Period|Protocol Violation|0|||
24964562|NCT00433199|50054372|FG001|Open-Label Period|Protocol Violation|2|||
24964563|NCT00433199|50054371|FG000|Open-Label Period|Administrative|0|||
24964564|NCT00433199|50054372|FG001|Open-Label Period|Administrative|1|||
24964565|NCT00006046|50054388|FG000|Overall Study|Adverse Event|3|||
24964566|NCT00006046|50054389|FG001|Overall Study|Adverse Event|0|||
24964567|NCT00006046|50054390|FG002|Overall Study|Adverse Event|0|||
24964568|NCT00006046|50054391|FG003|Overall Study|Adverse Event|0|||
24964569|NCT00006046|50054392|FG004|Overall Study|Adverse Event|0|||
24964570|NCT00006046|50054388|FG000|Overall Study|Disease Progression|2|||
24964571|NCT00006046|50054389|FG001|Overall Study|Disease Progression|0|||
24964572|NCT00006046|50054390|FG002|Overall Study|Disease Progression|0|||
24964573|NCT00006046|50054391|FG003|Overall Study|Disease Progression|0|||
24964574|NCT00006046|50054392|FG004|Overall Study|Disease Progression|0|||
24964575|NCT00005908|50054404|FG000|Overall Study|Withdrawal by Subject|1|||
24964576|NCT00005908|50054405|FG001|Overall Study|Withdrawal by Subject|0|||
24964577|NCT00432965|50054416|FG000|Overall Study|Lost to Follow-up|22|||
24964578|NCT00432965|50054417|FG001|Overall Study|Lost to Follow-up|19|||
24964579|NCT00432965|50054416|FG000|Overall Study|Withdrawal by Subject|13|||
24964580|NCT00432965|50054417|FG001|Overall Study|Withdrawal by Subject|13|||
24964581|NCT00432965|50054416|FG000|Overall Study|Physician Decision|14|||
24964582|NCT00432965|50054417|FG001|Overall Study|Physician Decision|13|||
24964583|NCT00432965|50054416|FG000|Overall Study|Lack of Efficacy|8|||
24964584|NCT00432965|50054417|FG001|Overall Study|Lack of Efficacy|13|||
24964585|NCT00432965|50054416|FG000|Overall Study|Non-compliance|7|||
24964586|NCT00432965|50054417|FG001|Overall Study|Non-compliance|0|||
24964587|NCT00432965|50054416|FG000|Overall Study|Adverse Event|22|||
24964588|NCT00432965|50054417|FG001|Overall Study|Adverse Event|19|||
24964589|NCT00432965|50054416|FG000|Overall Study|Death|3|||
24964590|NCT00432965|50054417|FG001|Overall Study|Death|4|||
24964591|NCT00432965|50054416|FG000|Overall Study|Exclusionary Methods|1|||
24964592|NCT00432965|50054417|FG001|Overall Study|Exclusionary Methods|2|||
25024777|NCT03334747|50122228|FG000|Treatment Phase|Technical problems|0|||
25024778|NCT03334747|50122229|FG001|Treatment Phase|Technical problems|0|||
25024779|NCT03334747|50122230|FG002|Treatment Phase|Technical problems|0|||
25024780|NCT03334747|50122231|FG003|Treatment Phase|Technical problems|0|||
25024781|NCT03334747|50122232|FG004|Treatment Phase|Technical problems|1|||
25024782|NCT03334747|50122233|FG005|Treatment Phase|Technical problems|0|||
24964593|NCT00432965|50054416|FG000|Overall Study|Incomplete Data|4|||
24964594|NCT00432965|50054417|FG001|Overall Study|Incomplete Data|3|||
24964595|NCT00440297|50054425|FG000|Overall Study|Adverse Event|8|||
24964596|NCT00440297|50054426|FG001|Overall Study|Adverse Event|5|||
24964597|NCT00440297|50054425|FG000|Overall Study|Lost to Follow-up|1|||
24964598|NCT00440297|50054426|FG001|Overall Study|Lost to Follow-up|0|||
24964599|NCT00440297|50054425|FG000|Overall Study|Physician Decision|1|||
24964600|NCT00440297|50054426|FG001|Overall Study|Physician Decision|0|||
24964601|NCT00440297|50054425|FG000|Overall Study|Protocol Violation|11|||
24964602|NCT00440297|50054426|FG001|Overall Study|Protocol Violation|7|||
25024783|NCT03334747|50122234|FG006|Treatment Phase|Technical problems|0|||
24964603|NCT00440297|50054425|FG000|Overall Study|Withdrawal by Subject|1|||
24964604|NCT00440297|50054426|FG001|Overall Study|Withdrawal by Subject|6|||
24964605|NCT00440297|50054425|FG000|Overall Study|Randomized by mistake|1|||
25024784|NCT03334747|50122235|FG007|Treatment Phase|Technical problems|0|||
25024785|NCT03334747|50122236|FG008|Treatment Phase|Technical problems|0|||
25024786|NCT03334747|50122228|FG000|Treatment Phase|Subject/guardian decision|1|||
25024787|NCT03334747|50122229|FG001|Treatment Phase|Subject/guardian decision|0|||
24925677|NCT00117637|50019082|FG000|First Intervention (Period 1)|Adverse Event|11|||
24925678|NCT00117637|50019083|FG001|First Intervention (Period 1)|Adverse Event|16|||
25024788|NCT03334747|50122230|FG002|Treatment Phase|Subject/guardian decision|0|||
25024789|NCT03334747|50122231|FG003|Treatment Phase|Subject/guardian decision|0|||
25024790|NCT03334747|50122232|FG004|Treatment Phase|Subject/guardian decision|0|||
25024791|NCT03334747|50122233|FG005|Treatment Phase|Subject/guardian decision|1|||
25024792|NCT03334747|50122234|FG006|Treatment Phase|Subject/guardian decision|0|||
25024793|NCT03334747|50122235|FG007|Treatment Phase|Subject/guardian decision|0|||
25024794|NCT03334747|50122236|FG008|Treatment Phase|Subject/guardian decision|0|||
25024795|NCT03334747|50122228|FG000|Follow-Up Phase|Subject/guardian decision|0|||
25024796|NCT03334747|50122229|FG001|Follow-Up Phase|Subject/guardian decision|0|||
25024797|NCT03334747|50122230|FG002|Follow-Up Phase|Subject/guardian decision|0|||
25024798|NCT03334747|50122231|FG003|Follow-Up Phase|Subject/guardian decision|0|||
25024799|NCT03334747|50122232|FG004|Follow-Up Phase|Subject/guardian decision|0|||
24925679|NCT00117637|50019082|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
24925680|NCT00117637|50019083|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
24925681|NCT00117637|50019082|FG000|First Intervention (Period 1)|Protocol Violation|1|||
24925682|NCT00117637|50019083|FG001|First Intervention (Period 1)|Protocol Violation|0|||
24925683|NCT00117637|50019082|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
24925684|NCT00117637|50019083|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
24925685|NCT00117637|50019082|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
24925686|NCT00117637|50019083|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
24925687|NCT00117637|50019082|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
24925688|NCT00117637|50019083|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
24925689|NCT00117637|50019082|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
24925690|NCT00117637|50019083|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
24925691|NCT00117637|50019082|FG000|First Intervention (Period 1)|reason not reported|0|||
24925692|NCT00117637|50019083|FG001|First Intervention (Period 1)|reason not reported|1|||
24925693|NCT00117637|50019082|FG000|Second Intervention (Period 2)|Adverse Event|0|||
24925694|NCT00117637|50019083|FG001|Second Intervention (Period 2)|Adverse Event|9|||
24925695|NCT00117637|50019082|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
24925696|NCT00117637|50019083|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
24925697|NCT00117637|50019082|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
24925698|NCT00117637|50019083|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
24925699|NCT00117637|50019082|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
24925700|NCT00117637|50019083|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
24925701|NCT00117637|50019082|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
24925702|NCT00117637|50019083|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
24925703|NCT00117637|50019082|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
24925704|NCT00117637|50019083|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
24925705|NCT00117637|50019082|FG000|Second Intervention (Period 2)|reason not reported|1|||
24925706|NCT00117637|50019083|FG001|Second Intervention (Period 2)|reason not reported|0|||
24925707|NCT00690755|50019103|FG000|Overall Study|Physician Decision|2|||
24925708|NCT00690755|50019104|FG001|Overall Study|Physician Decision|0|||
24925709|NCT00690755|50019105|FG002|Overall Study|Physician Decision|46|||
24925710|NCT00690755|50019106|FG003|Overall Study|Physician Decision|5|||
24925711|NCT00690755|50019107|FG004|Overall Study|Physician Decision|0|||
24925712|NCT00690755|50019108|FG005|Overall Study|Physician Decision|4|||
24925713|NCT00690755|50019109|FG006|Overall Study|Physician Decision|0|||
24925714|NCT00549302|50019127|FG000|Double-Blind|Death|2|||
24925715|NCT00549302|50019128|FG001|Double-Blind|Death|9|||
24925716|NCT00549302|50019129|FG002|Double-Blind|Death|0|||
24925717|NCT00549302|50019127|FG000|Double-Blind|Adverse Event|3|||
24925718|NCT00549302|50019128|FG001|Double-Blind|Adverse Event|16|||
24925719|NCT00549302|50019129|FG002|Double-Blind|Adverse Event|0|||
24925720|NCT00549302|50019127|FG000|Double-Blind|Withdrawal by Subject|3|||
24925721|NCT00549302|50019128|FG001|Double-Blind|Withdrawal by Subject|8|||
24925722|NCT00549302|50019129|FG002|Double-Blind|Withdrawal by Subject|0|||
24925723|NCT00549302|50019127|FG000|Double-Blind|Investigator Decision|1|||
24925724|NCT00549302|50019128|FG001|Double-Blind|Investigator Decision|5|||
24925725|NCT00549302|50019129|FG002|Double-Blind|Investigator Decision|0|||
24925726|NCT00549302|50019127|FG000|Double-Blind|Sponsor Decision|0|||
24925727|NCT00549302|50019128|FG001|Double-Blind|Sponsor Decision|1|||
24925728|NCT00549302|50019129|FG002|Double-Blind|Sponsor Decision|0|||
24925729|NCT00549302|50019127|FG000|Double-Blind|Lost to Follow-up|1|||
25024800|NCT03334747|50122233|FG005|Follow-Up Phase|Subject/guardian decision|0|||
25024801|NCT03334747|50122234|FG006|Follow-Up Phase|Subject/guardian decision|1|||
25024802|NCT03334747|50122235|FG007|Follow-Up Phase|Subject/guardian decision|0|||
24925730|NCT00549302|50019128|FG001|Double-Blind|Lost to Follow-up|2|||
24925731|NCT00549302|50019129|FG002|Double-Blind|Lost to Follow-up|0|||
24925732|NCT00549302|50019127|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
24925733|NCT00549302|50019128|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
24925734|NCT00549302|50019129|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
24925735|NCT00549302|50019127|FG000|Double-Blind|New condition or starts new therapy|0|||
24925736|NCT00549302|50019128|FG001|Double-Blind|New condition or starts new therapy|2|||
24925737|NCT00549302|50019129|FG002|Double-Blind|New condition or starts new therapy|0|||
24925738|NCT00549302|50019127|FG000|Open-Label|Adverse Event|0|||
24925739|NCT00549302|50019128|FG001|Open-Label|Adverse Event|0|||
24925740|NCT00549302|50019129|FG002|Open-Label|Adverse Event|11|||
24925741|NCT00549302|50019127|FG000|Open-Label|Death|0|||
24925742|NCT00549302|50019128|FG001|Open-Label|Death|0|||
24925743|NCT00549302|50019129|FG002|Open-Label|Death|40|||
24925744|NCT00549302|50019127|FG000|Open-Label|Investigator Decision|0|||
24925745|NCT00549302|50019128|FG001|Open-Label|Investigator Decision|0|||
24925746|NCT00549302|50019129|FG002|Open-Label|Investigator Decision|5|||
24925747|NCT00549302|50019127|FG000|Open-Label|Lost to Follow-up|0|||
24925748|NCT00549302|50019128|FG001|Open-Label|Lost to Follow-up|0|||
24925749|NCT00549302|50019129|FG002|Open-Label|Lost to Follow-up|2|||
24925750|NCT00549302|50019127|FG000|Open-Label|Other|0|||
24925751|NCT00549302|50019128|FG001|Open-Label|Other|0|||
24925752|NCT00549302|50019129|FG002|Open-Label|Other|3|||
24925753|NCT00549302|50019127|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
24925754|NCT00549302|50019128|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
24925755|NCT00549302|50019129|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
24925756|NCT00549302|50019127|FG000|Open-Label|Withdrawal by Subject|0|||
24925757|NCT00549302|50019128|FG001|Open-Label|Withdrawal by Subject|0|||
24925758|NCT00549302|50019129|FG002|Open-Label|Withdrawal by Subject|6|||
25024803|NCT03334747|50122236|FG008|Follow-Up Phase|Subject/guardian decision|1|||
25024804|NCT03346759|50122258|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
25024805|NCT03346759|50122259|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
25024806|NCT03346759|50122258|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
25024807|NCT03346759|50122259|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
25024808|NCT03346759|50122258|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
24925759|NCT00117325|50019139|FG000|Overall Study|Adverse Event|3|||
24925760|NCT00117325|50019140|FG001|Overall Study|Adverse Event|3|||
24925761|NCT00117325|50019139|FG000|Overall Study|Lost to Follow-up|1|||
24925762|NCT00117325|50019140|FG001|Overall Study|Lost to Follow-up|1|||
24925763|NCT00117325|50019139|FG000|Overall Study|Protocol Violation|2|||
24925764|NCT00117325|50019140|FG001|Overall Study|Protocol Violation|3|||
24925765|NCT00117325|50019139|FG000|Overall Study|Withdrawal by Subject|3|||
24925766|NCT00117325|50019140|FG001|Overall Study|Withdrawal by Subject|2|||
24925767|NCT00117325|50019139|FG000|Overall Study|Lack of Efficacy|1|||
24925768|NCT00117325|50019140|FG001|Overall Study|Lack of Efficacy|0|||
24925769|NCT00117325|50019139|FG000|Overall Study|Use of prohibited medicine|1|||
24925770|NCT00117325|50019140|FG001|Overall Study|Use of prohibited medicine|2|||
24925771|NCT00117325|50019139|FG000|Overall Study|Early termination|1|||
24925772|NCT00117325|50019140|FG001|Overall Study|Early termination|1|||
24925773|NCT00117325|50019139|FG000|Overall Study|Admisnitrative|1|||
24925774|NCT00117325|50019140|FG001|Overall Study|Admisnitrative|0|||
24925775|NCT00108433|50019149|FG000|Overall Study|Lack of Efficacy|1|||
24925776|NCT00108433|50019150|FG001|Overall Study|Lack of Efficacy|2|||
24925777|NCT00108433|50019149|FG000|Overall Study|Death|3|||
24925778|NCT00108433|50019150|FG001|Overall Study|Death|0|||
24925779|NCT00108433|50019149|FG000|Overall Study|Adverse Event|3|||
24925780|NCT00108433|50019150|FG001|Overall Study|Adverse Event|1|||
24925781|NCT00108433|50019149|FG000|Overall Study|Other|14|||
24925782|NCT00108433|50019150|FG001|Overall Study|Other|14|||
24925783|NCT00116779|50019158|FG000|Overall Study|Adverse Event|4|||
24925784|NCT00116779|50019159|FG001|Overall Study|Adverse Event|2|||
24925785|NCT00116779|50019158|FG000|Overall Study|Protocol Violation|1|||
24925786|NCT00116779|50019159|FG001|Overall Study|Protocol Violation|4|||
24925787|NCT00116779|50019158|FG000|Overall Study|Withdrawal by Subject|4|||
24925788|NCT00116779|50019159|FG001|Overall Study|Withdrawal by Subject|1|||
24925789|NCT00116779|50019158|FG000|Overall Study|Inadequate testosterone suppression|7|||
24925790|NCT00116779|50019159|FG001|Overall Study|Inadequate testosterone suppression|9|||
25024809|NCT03346759|50122259|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
24925791|NCT00116779|50019158|FG000|Overall Study|Physician Decision|3|||
24925792|NCT00116779|50019159|FG001|Overall Study|Physician Decision|1|||
25024810|NCT03361423|50122268|FG000|Overall Study|Withdrawal by Subject|4|||
24925793|NCT00116779|50019158|FG000|Overall Study|Elevated PSA levels|2|||
24925794|NCT00116779|50019159|FG001|Overall Study|Elevated PSA levels|2|||
24925795|NCT03943290|50019174|FG000|Overall Study|Sponsor Terminated Study|6|||
24925796|NCT03943290|50019175|FG001|Overall Study|Sponsor Terminated Study|1|||
24925797|NCT03943290|50019176|FG002|Overall Study|Sponsor Terminated Study|11|||
24925798|NCT03943290|50019177|FG003|Overall Study|Sponsor Terminated Study|6|||
24925799|NCT03943290|50019178|FG004|Overall Study|Sponsor Terminated Study|7|||
24925800|NCT03943290|50019179|FG005|Overall Study|Sponsor Terminated Study|6|||
24925801|NCT03943290|50019180|FG006|Overall Study|Sponsor Terminated Study|6|||
24925802|NCT03943290|50019181|FG007|Overall Study|Sponsor Terminated Study|7|||
24925803|NCT03943290|50019182|FG008|Overall Study|Sponsor Terminated Study|8|||
24925804|NCT03943290|50019174|FG000|Overall Study|Lost to Follow-up|1|||
24925805|NCT03943290|50019175|FG001|Overall Study|Lost to Follow-up|0|||
24925806|NCT03943290|50019176|FG002|Overall Study|Lost to Follow-up|1|||
25024811|NCT03361423|50122269|FG001|Overall Study|Withdrawal by Subject|3|||
25024812|NCT03361423|50122268|FG000|Overall Study|Did not treat|19|||
25024813|NCT03361423|50122269|FG001|Overall Study|Did not treat|18|||
25024814|NCT03361423|50122268|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
25024815|NCT03361423|50122269|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
25024816|NCT03361423|50122268|FG000|Overall Study|Missing data|4|||
25024817|NCT03361423|50122269|FG001|Overall Study|Missing data|1|||
25024818|NCT02693002|50122277|FG000|Overall Study|Withdrawal by Subject|1|||
25024819|NCT02693002|50122278|FG001|Overall Study|Withdrawal by Subject|0|||
24925807|NCT03943290|50019177|FG003|Overall Study|Lost to Follow-up|0|||
24925808|NCT03943290|50019178|FG004|Overall Study|Lost to Follow-up|0|||
24925809|NCT03943290|50019179|FG005|Overall Study|Lost to Follow-up|0|||
24925810|NCT03943290|50019180|FG006|Overall Study|Lost to Follow-up|0|||
24925811|NCT03943290|50019181|FG007|Overall Study|Lost to Follow-up|1|||
24925812|NCT03943290|50019182|FG008|Overall Study|Lost to Follow-up|0|||
24925813|NCT03943290|50019174|FG000|Overall Study|Withdrawal by Subject|0|||
24925814|NCT03943290|50019175|FG001|Overall Study|Withdrawal by Subject|0|||
24925815|NCT03943290|50019176|FG002|Overall Study|Withdrawal by Subject|1|||
24925816|NCT03943290|50019177|FG003|Overall Study|Withdrawal by Subject|0|||
24925817|NCT03943290|50019178|FG004|Overall Study|Withdrawal by Subject|0|||
24925818|NCT03943290|50019179|FG005|Overall Study|Withdrawal by Subject|0|||
24925819|NCT03943290|50019180|FG006|Overall Study|Withdrawal by Subject|0|||
24925820|NCT03943290|50019181|FG007|Overall Study|Withdrawal by Subject|0|||
24925821|NCT03943290|50019182|FG008|Overall Study|Withdrawal by Subject|0|||
24925822|NCT00108355|50019217|FG000|Overall Study|Peritonitis at index paracentesis|1|||
24925823|NCT00108355|50019218|FG001|Overall Study|Peritonitis at index paracentesis|1|||
24925824|NCT00108355|50019217|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
24925825|NCT00108355|50019218|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
24925826|NCT00094861|50019239|FG000|Overall Study|Adverse Event|5|||
24925827|NCT00094861|50019240|FG001|Overall Study|Adverse Event|2|||
24925828|NCT00094861|50019239|FG000|Overall Study|Withdrawal by Subject|5|||
24925829|NCT00094861|50019240|FG001|Overall Study|Withdrawal by Subject|3|||
24925830|NCT00094861|50019239|FG000|Overall Study|Physician Decision|1|||
24925831|NCT00094861|50019240|FG001|Overall Study|Physician Decision|1|||
24925832|NCT00094861|50019239|FG000|Overall Study|Lost to Follow-up|0|||
24925833|NCT00094861|50019240|FG001|Overall Study|Lost to Follow-up|1|||
24925834|NCT00094861|50019239|FG000|Overall Study|Death|4|||
24925835|NCT00094861|50019240|FG001|Overall Study|Death|2|||
24925836|NCT00094861|50019239|FG000|Overall Study|Other|3|||
24925837|NCT00094861|50019240|FG001|Overall Study|Other|0|||
24925838|NCT00426556|50019250|FG000|Phase I - Core Phase|Disease Progression|0|||
24925839|NCT00426556|50019251|FG001|Phase I - Core Phase|Disease Progression|6|||
24925840|NCT00426556|50019252|FG002|Phase I - Core Phase|Disease Progression|2|||
24925841|NCT00426556|50019253|FG003|Phase I - Core Phase|Disease Progression|0|||
24925842|NCT00426556|50019250|FG000|Phase I - Core Phase|Adverse Event|1|||
24925843|NCT00426556|50019251|FG001|Phase I - Core Phase|Adverse Event|3|||
24925844|NCT00426556|50019252|FG002|Phase I - Core Phase|Adverse Event|1|||
24925845|NCT00426556|50019253|FG003|Phase I - Core Phase|Adverse Event|0|||
24925846|NCT00426556|50019250|FG000|Phase I - Core Phase|Death|0|||
24925847|NCT00426556|50019251|FG001|Phase I - Core Phase|Death|1|||
25024820|NCT03093870|50122287|FG000|Overall Study|Withdrawal by Subject|2|||
24925848|NCT00426556|50019252|FG002|Phase I - Core Phase|Death|0|||
24925849|NCT00426556|50019253|FG003|Phase I - Core Phase|Death|0|||
24925850|NCT00426556|50019250|FG000|Phase I - Extension Phase|Adverse Event|0|||
24925851|NCT00426556|50019251|FG001|Phase I - Extension Phase|Adverse Event|1|||
24925852|NCT00426556|50019252|FG002|Phase I - Extension Phase|Adverse Event|1|||
24925853|NCT00426556|50019253|FG003|Phase I - Extension Phase|Adverse Event|0|||
24925854|NCT00426556|50019250|FG000|Phase I - Extension Phase|Disease Progression|5|||
24925855|NCT00426556|50019251|FG001|Phase I - Extension Phase|Disease Progression|5|||
24925856|NCT00426556|50019252|FG002|Phase I - Extension Phase|Disease Progression|6|||
24925857|NCT00426556|50019253|FG003|Phase I - Extension Phase|Disease Progression|0|||
24925858|NCT00426556|50019250|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
24925859|NCT00426556|50019251|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
24925860|NCT00426556|50019252|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
24925861|NCT00426556|50019253|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
24925862|NCT00426556|50019250|FG000|Phase II - Core Phase|Disease Progression|0|||
24925863|NCT00426556|50019251|FG001|Phase II - Core Phase|Disease Progression|0|||
24925864|NCT00426556|50019252|FG002|Phase II - Core Phase|Disease Progression|0|||
24925865|NCT00426556|50019253|FG003|Phase II - Core Phase|Disease Progression|16|||
24925866|NCT00426556|50019250|FG000|Phase II - Core Phase|Adverse Event|0|||
24925867|NCT00426556|50019251|FG001|Phase II - Core Phase|Adverse Event|0|||
24925868|NCT00426556|50019252|FG002|Phase II - Core Phase|Adverse Event|0|||
25185532|NCT01500278|50335064|FG001|Week 13 - Week 104|Sponsor decision|2|||
25185533|NCT01500278|50335063|FG000|Week 13 - Week 104|Medical monitor decision|0|||
25185534|NCT01500278|50335064|FG001|Week 13 - Week 104|Medical monitor decision|2|||
24925869|NCT00426556|50019253|FG003|Phase II - Core Phase|Adverse Event|8|||
24925870|NCT00426556|50019250|FG000|Phase II - Extension Phase|Disease Progression|0|||
24925871|NCT00426556|50019251|FG001|Phase II - Extension Phase|Disease Progression|0|||
24925872|NCT00426556|50019252|FG002|Phase II - Extension Phase|Disease Progression|0|||
24925873|NCT00426556|50019253|FG003|Phase II - Extension Phase|Disease Progression|21|||
24925874|NCT00426556|50019250|FG000|Phase II - Extension Phase|Adverse Event|0|||
24925875|NCT00426556|50019251|FG001|Phase II - Extension Phase|Adverse Event|0|||
24925876|NCT00426556|50019252|FG002|Phase II - Extension Phase|Adverse Event|0|||
24925877|NCT00426556|50019253|FG003|Phase II - Extension Phase|Adverse Event|2|||
24925878|NCT00107653|50019265|FG000|Overall Study|Adverse Event|24|||
24925879|NCT00107653|50019266|FG001|Overall Study|Adverse Event|43|||
24925880|NCT00107653|50019265|FG000|Overall Study|Insufficient Therapeutic Response|25|||
25024821|NCT03093870|50122288|FG001|Overall Study|Withdrawal by Subject|6|||
24925881|NCT00107653|50019266|FG001|Overall Study|Insufficient Therapeutic Response|11|||
24925882|NCT00107653|50019265|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
24925883|NCT00107653|50019266|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
24925884|NCT00107653|50019265|FG000|Overall Study|Protocol Violation|1|||
24925885|NCT00107653|50019266|FG001|Overall Study|Protocol Violation|0|||
24925886|NCT00107653|50019265|FG000|Overall Study|Withdrawal by Subject|12|||
24925887|NCT00107653|50019266|FG001|Overall Study|Withdrawal by Subject|13|||
24925888|NCT00107653|50019265|FG000|Overall Study|Lost to Follow-up|13|||
24925889|NCT00107653|50019266|FG001|Overall Study|Lost to Follow-up|5|||
24925890|NCT00107653|50019265|FG000|Overall Study|Administrative Reasons|3|||
24925891|NCT00107653|50019266|FG001|Overall Study|Administrative Reasons|3|||
24925892|NCT03950856|50019276|FG000|Overall Study|Death|1|||
24925893|NCT03950856|50019277|FG001|Overall Study|Death|2|||
24925894|NCT03950856|50019278|FG002|Overall Study|Death|0|||
24925895|NCT03950856|50019279|FG003|Overall Study|Death|0|||
24925896|NCT03950856|50019276|FG000|Overall Study|Lost to Follow-up|5|||
24925897|NCT03950856|50019277|FG001|Overall Study|Lost to Follow-up|6|||
24925898|NCT03950856|50019278|FG002|Overall Study|Lost to Follow-up|8|||
24925899|NCT03950856|50019279|FG003|Overall Study|Lost to Follow-up|2|||
24925900|NCT03950856|50019276|FG000|Overall Study|Protocol Violation|2|||
24925901|NCT03950856|50019277|FG001|Overall Study|Protocol Violation|0|||
24925902|NCT03950856|50019278|FG002|Overall Study|Protocol Violation|0|||
24925903|NCT03950856|50019279|FG003|Overall Study|Protocol Violation|1|||
24925904|NCT03950856|50019276|FG000|Overall Study|Withdrawal by Subject|4|||
24925905|NCT03950856|50019277|FG001|Overall Study|Withdrawal by Subject|1|||
24925906|NCT03950856|50019278|FG002|Overall Study|Withdrawal by Subject|3|||
25185535|NCT01500278|50335063|FG000|Week 13 - Week 104|Personal reason|0|||
24925907|NCT03950856|50019279|FG003|Overall Study|Withdrawal by Subject|1|||
24925908|NCT03950856|50019276|FG000|Overall Study|Unable to phone|7|||
24925909|NCT03950856|50019277|FG001|Overall Study|Unable to phone|6|||
24925910|NCT03950856|50019278|FG002|Overall Study|Unable to phone|7|||
24925911|NCT03950856|50019279|FG003|Overall Study|Unable to phone|2|||
24925912|NCT00433654|50019293|FG000|Overall Study|Death|4|||
24925913|NCT00433654|50019294|FG001|Overall Study|Death|0|||
24925914|NCT00433654|50019293|FG000|Overall Study|Missed visit|6|||
24925915|NCT00433654|50019294|FG001|Overall Study|Missed visit|3|||
24925916|NCT00433654|50019293|FG000|Overall Study|Subject not yet due for visit|4|||
24925917|NCT00433654|50019294|FG001|Overall Study|Subject not yet due for visit|0|||
24925918|NCT00433654|50019293|FG000|Overall Study|Withdrawal by Subject|1|||
24925919|NCT00433654|50019294|FG001|Overall Study|Withdrawal by Subject|2|||
24925920|NCT00689351|50019308|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
24925921|NCT00689351|50019309|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
24925922|NCT00689351|50019308|FG000|Infant Series of Dosing|Adverse Event|1|||
24925923|NCT00689351|50019309|FG001|Infant Series of Dosing|Adverse Event|0|||
24925924|NCT00689351|50019308|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
24925925|NCT00689351|50019309|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
24925926|NCT00689351|50019308|FG000|After Infant Series|Parent/legal guardian request|1|||
24925927|NCT00689351|50019309|FG001|After Infant Series|Parent/legal guardian request|0|||
24925928|NCT03950622|50019321|FG000|Overall Study|Withdrawal by Subject|1|||
24925929|NCT03950622|50019322|FG001|Overall Study|Withdrawal by Subject|0|||
24925930|NCT03950622|50019321|FG000|Overall Study|Protocol Deviation|0|||
24925931|NCT03950622|50019322|FG001|Overall Study|Protocol Deviation|1|||
24925932|NCT03950622|50019321|FG000|Overall Study|Physician Decision|1|||
24925933|NCT03950622|50019322|FG001|Overall Study|Physician Decision|0|||
24925934|NCT03950622|50019321|FG000|Overall Study|Lost to Follow-up|5|||
24925935|NCT03950622|50019322|FG001|Overall Study|Lost to Follow-up|5|||
24925936|NCT03950622|50019321|FG000|Overall Study|Death|1|||
24925937|NCT03950622|50019322|FG001|Overall Study|Death|1|||
24925938|NCT03937908|50019328|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
24925939|NCT03937908|50019329|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
25024822|NCT03093870|50122289|FG002|Overall Study|Withdrawal by Subject|5|||
25024823|NCT03093870|50122287|FG000|Overall Study|Death|1|||
25024824|NCT03093870|50122288|FG001|Overall Study|Death|35|||
25024825|NCT03093870|50122289|FG002|Overall Study|Death|35|||
25024826|NCT03093870|50122287|FG000|Overall Study|Radiographic disease progression|10|||
24925940|NCT00689273|50019337|FG000|Overall Study|Adverse Event|3|||
24925941|NCT00689273|50019338|FG001|Overall Study|Adverse Event|1|||
24925942|NCT00689273|50019337|FG000|Overall Study|Lack of Efficacy|3|||
24925943|NCT00689273|50019338|FG001|Overall Study|Lack of Efficacy|0|||
24925944|NCT00689273|50019337|FG000|Overall Study|Lost to Follow-up|0|||
24925945|NCT00689273|50019338|FG001|Overall Study|Lost to Follow-up|2|||
24925946|NCT00689273|50019337|FG000|Overall Study|Other|6|||
24925947|NCT00689273|50019338|FG001|Overall Study|Other|2|||
24925948|NCT00689273|50019337|FG000|Overall Study|Randomized but not Treated|1|||
24925949|NCT00689273|50019338|FG001|Overall Study|Randomized but not Treated|0|||
24925950|NCT00553358|50019347|FG000|Overall Study|Randomized but did not receive treatment|3|||
24925951|NCT00553358|50019348|FG001|Overall Study|Randomized but did not receive treatment|3|||
24925952|NCT00553358|50019349|FG002|Overall Study|Randomized but did not receive treatment|1|||
24925953|NCT00553358|50019347|FG000|Overall Study|Lost to Follow-up|22|||
24925954|NCT00553358|50019348|FG001|Overall Study|Lost to Follow-up|26|||
24925955|NCT00553358|50019349|FG002|Overall Study|Lost to Follow-up|18|||
24925956|NCT00553358|50019347|FG000|Overall Study|Withdrew completely|23|||
24925957|NCT00553358|50019348|FG001|Overall Study|Withdrew completely|33|||
24925958|NCT00553358|50019349|FG002|Overall Study|Withdrew completely|34|||
24925959|NCT00553358|50019347|FG000|Overall Study|Died during clinical follow-up|25|||
24925960|NCT00553358|50019348|FG001|Overall Study|Died during clinical follow-up|29|||
24925961|NCT00553358|50019349|FG002|Overall Study|Died during clinical follow-up|32|||
24925962|NCT00553358|50019347|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
24925963|NCT00553358|50019348|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
24925964|NCT00553358|50019349|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
24925965|NCT00553358|50019347|FG000|Overall Study|Died after clinical follow-up ended|1|||
24925966|NCT00553358|50019348|FG001|Overall Study|Died after clinical follow-up ended|2|||
24925967|NCT00553358|50019349|FG002|Overall Study|Died after clinical follow-up ended|0|||
24925968|NCT00553358|50019347|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
24925969|NCT00553358|50019348|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
24925970|NCT00553358|50019349|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
24925971|NCT00688259|50019365|FG000|Overall Study|Lost to Follow-up|2|||
24925972|NCT00688259|50019366|FG001|Overall Study|Lost to Follow-up|4|||
24925973|NCT00688259|50019365|FG000|Overall Study|Physician Decision|1|||
24925974|NCT00688259|50019366|FG001|Overall Study|Physician Decision|0|||
24925975|NCT00688259|50019365|FG000|Overall Study|Withdrawal by Subject|2|||
24925976|NCT00688259|50019366|FG001|Overall Study|Withdrawal by Subject|0|||
24925977|NCT00688259|50019365|FG000|Overall Study|Declined Interview|2|||
24925978|NCT00688259|50019366|FG001|Overall Study|Declined Interview|3|||
24925979|NCT00688259|50019365|FG000|Overall Study|Hospitalized at Follow-up|0|||
24925980|NCT00688259|50019366|FG001|Overall Study|Hospitalized at Follow-up|1|||
24925981|NCT00688181|50019372|FG000|Overall Study|Lost to Follow-up|17|||
24925982|NCT00688181|50019372|FG000|Overall Study|Unknown Reason|4|||
24925983|NCT00688181|50019372|FG000|Overall Study|Non-clinical Reason|2|||
24925984|NCT00689117|50019391|FG000|Overall Study|Adverse Event|6|||
24925985|NCT00689117|50019392|FG001|Overall Study|Adverse Event|0|||
24925986|NCT00689117|50019393|FG002|Overall Study|Adverse Event|5|||
24925987|NCT00689117|50019394|FG003|Overall Study|Adverse Event|0|||
24925988|NCT00689117|50019391|FG000|Overall Study|Lost to Follow-up|26|||
24925989|NCT00689117|50019392|FG001|Overall Study|Lost to Follow-up|19|||
24925990|NCT00689117|50019393|FG002|Overall Study|Lost to Follow-up|17|||
24925991|NCT00689117|50019394|FG003|Overall Study|Lost to Follow-up|11|||
24925992|NCT00689117|50019391|FG000|Overall Study|Lack of Efficacy|1|||
24925993|NCT00689117|50019392|FG001|Overall Study|Lack of Efficacy|2|||
24925994|NCT00689117|50019393|FG002|Overall Study|Lack of Efficacy|2|||
24925995|NCT00689117|50019394|FG003|Overall Study|Lack of Efficacy|2|||
24925996|NCT00689117|50019391|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
24925997|NCT00689117|50019392|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
24925998|NCT00689117|50019393|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
24925999|NCT00689117|50019394|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
24926000|NCT00689117|50019391|FG000|Overall Study|Withdrawal by Subject|19|||
24926001|NCT00689117|50019392|FG001|Overall Study|Withdrawal by Subject|18|||
24926002|NCT00689117|50019393|FG002|Overall Study|Withdrawal by Subject|26|||
24926003|NCT00689117|50019394|FG003|Overall Study|Withdrawal by Subject|13|||
24926004|NCT00689117|50019391|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
24926005|NCT00689117|50019392|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
24926006|NCT00689117|50019393|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
24926007|NCT00689117|50019394|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
24926008|NCT00689117|50019391|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
24926009|NCT00689117|50019392|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
25024827|NCT03093870|50122288|FG001|Overall Study|Radiographic disease progression|0|||
25024828|NCT03093870|50122289|FG002|Overall Study|Radiographic disease progression|0|||
25024829|NCT03093870|50122287|FG000|Overall Study|Clinical disease progression|1|||
25024830|NCT03093870|50122288|FG001|Overall Study|Clinical disease progression|0|||
25024831|NCT03093870|50122289|FG002|Overall Study|Clinical disease progression|0|||
25024832|NCT03093870|50122287|FG000|Overall Study|Physician Decision|2|||
25024833|NCT03093870|50122288|FG001|Overall Study|Physician Decision|0|||
25024834|NCT03093870|50122289|FG002|Overall Study|Physician Decision|0|||
25024835|NCT03093870|50122287|FG000|Overall Study|Adverse Event|7|||
25024836|NCT03093870|50122288|FG001|Overall Study|Adverse Event|0|||
25024837|NCT03093870|50122289|FG002|Overall Study|Adverse Event|0|||
24926010|NCT00689117|50019393|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
24926011|NCT00689117|50019394|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
24926012|NCT00689117|50019391|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
24926013|NCT00689117|50019392|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
24926014|NCT00689117|50019393|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
24926015|NCT00689117|50019394|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
25024838|NCT03093870|50122287|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
25024839|NCT03093870|50122288|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
24926016|NCT00689117|50019391|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
24926017|NCT00689117|50019392|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
24926018|NCT00689117|50019393|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
24926019|NCT00689117|50019394|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
24926020|NCT00689117|50019391|FG000|Overall Study|Use of Prohibitive Medication|2|||
24926021|NCT00689117|50019392|FG001|Overall Study|Use of Prohibitive Medication|1|||
24926022|NCT00689117|50019393|FG002|Overall Study|Use of Prohibitive Medication|3|||
24926023|NCT00689117|50019394|FG003|Overall Study|Use of Prohibitive Medication|0|||
24926024|NCT00689117|50019391|FG000|Overall Study|Pregnancy|0|||
24926025|NCT00689117|50019392|FG001|Overall Study|Pregnancy|2|||
24926026|NCT00689117|50019393|FG002|Overall Study|Pregnancy|0|||
24926027|NCT00689117|50019394|FG003|Overall Study|Pregnancy|2|||
24926028|NCT00689117|50019391|FG000|Overall Study|Incarceration|2|||
24926029|NCT00689117|50019392|FG001|Overall Study|Incarceration|0|||
25024840|NCT03093870|50122289|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
25024841|NCT03093870|50122287|FG000|Overall Study|Lost to Follow-up|0|||
25024842|NCT03093870|50122288|FG001|Overall Study|Lost to Follow-up|0|||
25024843|NCT03093870|50122289|FG002|Overall Study|Lost to Follow-up|1|||
24926030|NCT00689117|50019393|FG002|Overall Study|Incarceration|0|||
24926031|NCT00689117|50019394|FG003|Overall Study|Incarceration|0|||
24926032|NCT00689117|50019391|FG000|Overall Study|Fear of Birth Defects|0|||
24926033|NCT00689117|50019392|FG001|Overall Study|Fear of Birth Defects|0|||
24926034|NCT00689117|50019393|FG002|Overall Study|Fear of Birth Defects|1|||
24926035|NCT00689117|50019394|FG003|Overall Study|Fear of Birth Defects|0|||
24926036|NCT00689117|50019391|FG000|Overall Study|Transportation|1|||
24926037|NCT00689117|50019392|FG001|Overall Study|Transportation|0|||
25024844|NCT03346057|50122312|FG000|Overall Study|Death|1|||
25024845|NCT03346057|50122313|FG001|Overall Study|Death|2|||
25024846|NCT03346057|50122314|FG002|Overall Study|Death|0|||
25024847|NCT03346057|50122315|FG003|Overall Study|Death|0|||
25024848|NCT03346057|50122312|FG000|Overall Study|Lost to Follow-up|0|||
25024849|NCT03346057|50122313|FG001|Overall Study|Lost to Follow-up|2|||
25024850|NCT03346057|50122314|FG002|Overall Study|Lost to Follow-up|1|||
25024851|NCT03346057|50122315|FG003|Overall Study|Lost to Follow-up|0|||
25024852|NCT03346057|50122312|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
25024853|NCT03346057|50122313|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
25024854|NCT03346057|50122314|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
25024855|NCT03346057|50122315|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
25024856|NCT03346057|50122312|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
25024857|NCT03346057|50122313|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
25024858|NCT03346057|50122314|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
24926038|NCT00689117|50019393|FG002|Overall Study|Transportation|0|||
24926039|NCT00689117|50019394|FG003|Overall Study|Transportation|0|||
24926040|NCT00689117|50019391|FG000|Overall Study|Patient Withdrew from Study|0|||
24926041|NCT00689117|50019392|FG001|Overall Study|Patient Withdrew from Study|0|||
24926042|NCT00689117|50019393|FG002|Overall Study|Patient Withdrew from Study|0|||
24926043|NCT00689117|50019394|FG003|Overall Study|Patient Withdrew from Study|1|||
25024859|NCT03346057|50122315|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
24926044|NCT00689117|50019391|FG000|Overall Study|Personal Reason|0|||
24926045|NCT00689117|50019392|FG001|Overall Study|Personal Reason|1|||
25024860|NCT03346057|50122312|FG000|Overall Study|Physician Decision|3|||
25024861|NCT03346057|50122313|FG001|Overall Study|Physician Decision|2|||
24926046|NCT00689117|50019393|FG002|Overall Study|Personal Reason|0|||
24926047|NCT00689117|50019394|FG003|Overall Study|Personal Reason|0|||
24926048|NCT00689117|50019391|FG000|Overall Study|Dispensing Error|0|||
24926049|NCT00689117|50019392|FG001|Overall Study|Dispensing Error|1|||
24926050|NCT00689117|50019393|FG002|Overall Study|Dispensing Error|0|||
24926051|NCT00689117|50019394|FG003|Overall Study|Dispensing Error|0|||
24926052|NCT00547248|50019408|FG000|Overall Study|Protocol Violation|0|||
24926053|NCT00547248|50019409|FG001|Overall Study|Protocol Violation|0|||
24926054|NCT00547248|50019410|FG002|Overall Study|Protocol Violation|1|||
24926055|NCT00547248|50019411|FG003|Overall Study|Protocol Violation|1|||
24926056|NCT00547248|50019408|FG000|Overall Study|Migrated/moved from study area|0|||
24926057|NCT00547248|50019409|FG001|Overall Study|Migrated/moved from study area|0|||
24926058|NCT00547248|50019410|FG002|Overall Study|Migrated/moved from study area|2|||
24926059|NCT00547248|50019411|FG003|Overall Study|Migrated/moved from study area|0|||
24926060|NCT00547248|50019408|FG000|Overall Study|Withdrawal by Subject|0|||
24926061|NCT00547248|50019409|FG001|Overall Study|Withdrawal by Subject|0|||
24926062|NCT00547248|50019410|FG002|Overall Study|Withdrawal by Subject|7|||
24926063|NCT00547248|50019411|FG003|Overall Study|Withdrawal by Subject|1|||
24926064|NCT00688103|50019426|FG000|Overall Study|Adverse Event|4|||
24926065|NCT00688103|50019427|FG001|Overall Study|Adverse Event|1|||
24926066|NCT00688103|50019426|FG000|Overall Study|Lack of Efficacy|11|||
24926067|NCT00688103|50019427|FG001|Overall Study|Lack of Efficacy|1|||
24926068|NCT00688103|50019426|FG000|Overall Study|Withdrawal by Subject|4|||
24926069|NCT00688103|50019427|FG001|Overall Study|Withdrawal by Subject|2|||
24926070|NCT00688103|50019426|FG000|Overall Study|complex reasons|11|||
24926071|NCT00688103|50019427|FG001|Overall Study|complex reasons|9|||
24926072|NCT00686855|50019437|FG000|Overall Study|Lost to Follow-up|1|||
24926073|NCT00686855|50019438|FG001|Overall Study|Lost to Follow-up|0|||
25155099|NCT01894243|50270393|FG001|Overall Study|Death|0|||
25155100|NCT01894243|50270394|FG002|Overall Study|Death|3|||
25155101|NCT01894243|50270392|FG000|Overall Study|Lack of Efficacy|3|||
25155102|NCT01894243|50270393|FG001|Overall Study|Lack of Efficacy|3|||
25155103|NCT01894243|50270394|FG002|Overall Study|Lack of Efficacy|1|||
25155104|NCT01894243|50270392|FG000|Overall Study|Condition under investigation worsened|8|||
25155105|NCT01894243|50270393|FG001|Overall Study|Condition under investigation worsened|6|||
25155106|NCT01894243|50270394|FG002|Overall Study|Condition under investigation worsened|2|||
25155107|NCT01894243|50270392|FG000|Overall Study|Subject decision|1|||
25155108|NCT01894243|50270393|FG001|Overall Study|Subject decision|0|||
25155109|NCT01894243|50270394|FG002|Overall Study|Subject decision|0|||
25155110|NCT01894243|50270392|FG000|Overall Study|Other|1|||
25155111|NCT01894243|50270393|FG001|Overall Study|Other|0|||
25155112|NCT01894243|50270394|FG002|Overall Study|Other|0|||
25155113|NCT03822832|50270411|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
24926074|NCT00686855|50019437|FG000|Overall Study|Progressive GVHD|0|||
24926075|NCT00686855|50019438|FG001|Overall Study|Progressive GVHD|1|||
24926076|NCT00686777|50019444|FG000|Overall Study|Adverse Event|2|||
24926077|NCT00686777|50019444|FG000|Overall Study|Pregnancy|1|||
24926078|NCT00686777|50019444|FG000|Overall Study|Withdrawal by Subject|2|||
24926079|NCT00686777|50019444|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
24926080|NCT00686777|50019444|FG000|Overall Study|No Visit|1|||
24926081|NCT00686699|50019450|FG000|Treatment Period 1|Adverse Event|0|||
24926082|NCT00686699|50019451|FG001|Treatment Period 1|Adverse Event|2|||
24926083|NCT00106639|50019460|FG000|Overall Study|Adverse Event|3|||
24926084|NCT00106639|50019461|FG001|Overall Study|Adverse Event|4|||
24926085|NCT00106639|50019462|FG002|Overall Study|Adverse Event|1|||
24926086|NCT00106639|50019460|FG000|Overall Study|Protocol Violation|0|||
24926087|NCT00106639|50019461|FG001|Overall Study|Protocol Violation|1|||
24926088|NCT00106639|50019462|FG002|Overall Study|Protocol Violation|0|||
24926089|NCT00106639|50019460|FG000|Overall Study|Withdrawal by Subject|0|||
24926090|NCT00106639|50019461|FG001|Overall Study|Withdrawal by Subject|1|||
24926091|NCT00106639|50019462|FG002|Overall Study|Withdrawal by Subject|0|||
25155114|NCT03822832|50270412|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
25155115|NCT03822832|50270411|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
25155116|NCT03822832|50270412|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
25155117|NCT03822832|50270411|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
24926092|NCT00106639|50019460|FG000|Overall Study|Participant defaulted|0|||
24926093|NCT00106639|50019461|FG001|Overall Study|Participant defaulted|1|||
24926094|NCT00106639|50019462|FG002|Overall Study|Participant defaulted|1|||
24926095|NCT00106249|50019473|FG000|Overall Study|Lost to Follow-up|3|||
24926096|NCT00106249|50019474|FG001|Overall Study|Lost to Follow-up|2|||
24926097|NCT00105469|50019482|FG000|Overall Study|Adverse Event|9|||
24926098|NCT00105469|50019483|FG001|Overall Study|Adverse Event|8|||
24926099|NCT00105469|50019482|FG000|Overall Study|Protocol Violation|4|||
24926100|NCT00105469|50019483|FG001|Overall Study|Protocol Violation|0|||
24926101|NCT00105469|50019482|FG000|Overall Study|Withdrawal by Subject|2|||
24926102|NCT00105469|50019483|FG001|Overall Study|Withdrawal by Subject|3|||
24926103|NCT00105469|50019482|FG000|Overall Study|Lost to Follow-up|1|||
24926104|NCT00105469|50019483|FG001|Overall Study|Lost to Follow-up|0|||
24926105|NCT00105469|50019482|FG000|Overall Study|Lack of Efficacy|2|||
24926106|NCT00105469|50019483|FG001|Overall Study|Lack of Efficacy|0|||
24926107|NCT00105469|50019482|FG000|Overall Study|Other Reason|4|||
24926108|NCT00105469|50019483|FG001|Overall Study|Other Reason|0|||
24926109|NCT00105235|50019489|FG000|Overall Study|Death|4|||
24926110|NCT00105235|50019489|FG000|Overall Study|Physician Decision|1|||
24926111|NCT00105235|50019489|FG000|Overall Study|Withdrawal by Subject|2|||
24926112|NCT00547118|50019499|FG000|Overall Study|Did not qualify prior to starting drug|1|||
24926113|NCT00547118|50019500|FG001|Overall Study|Did not qualify prior to starting drug|1|||
24926114|NCT00547118|50019499|FG000|Overall Study|Study suspended|7|||
24926115|NCT00547118|50019500|FG001|Overall Study|Study suspended|8|||
24926116|NCT00502593|50019520|FG000|Overall Study|Withdrawn unspecified reason|1|||
24926117|NCT00502593|50019521|FG001|Overall Study|Withdrawn unspecified reason|1|||
24926118|NCT00502593|50019522|FG002|Overall Study|Withdrawn unspecified reason|3|||
24926119|NCT00502593|50019523|FG003|Overall Study|Withdrawn unspecified reason|1|||
24926120|NCT00502593|50019524|FG004|Overall Study|Withdrawn unspecified reason|2|||
24926121|NCT00502593|50019525|FG005|Overall Study|Withdrawn unspecified reason|0|||
24926122|NCT00502593|50019526|FG006|Overall Study|Withdrawn unspecified reason|2|||
24926123|NCT00502593|50019527|FG007|Overall Study|Withdrawn unspecified reason|0|||
24926124|NCT00502593|50019528|FG008|Overall Study|Withdrawn unspecified reason|0|||
24926125|NCT00502593|50019529|FG009|Overall Study|Withdrawn unspecified reason|0|||
24926126|NCT00502593|50019530|FG010|Overall Study|Withdrawn unspecified reason|0|||
24926127|NCT00502593|50019531|FG011|Overall Study|Withdrawn unspecified reason|0|||
24926128|NCT00502593|50019520|FG000|Overall Study|Withdrawal by Subject|0|||
24926129|NCT00502593|50019521|FG001|Overall Study|Withdrawal by Subject|0|||
24926130|NCT00502593|50019522|FG002|Overall Study|Withdrawal by Subject|6|||
24926131|NCT00502593|50019523|FG003|Overall Study|Withdrawal by Subject|2|||
24926132|NCT00502593|50019524|FG004|Overall Study|Withdrawal by Subject|2|||
24926133|NCT00502593|50019525|FG005|Overall Study|Withdrawal by Subject|0|||
24926134|NCT00502593|50019526|FG006|Overall Study|Withdrawal by Subject|3|||
24926135|NCT00502593|50019527|FG007|Overall Study|Withdrawal by Subject|0|||
24926136|NCT00502593|50019528|FG008|Overall Study|Withdrawal by Subject|3|||
24926137|NCT00502593|50019529|FG009|Overall Study|Withdrawal by Subject|0|||
24926138|NCT00502593|50019530|FG010|Overall Study|Withdrawal by Subject|1|||
24926139|NCT00502593|50019531|FG011|Overall Study|Withdrawal by Subject|0|||
24926140|NCT00502593|50019520|FG000|Overall Study|Lost to Follow-up|2|||
24926141|NCT00502593|50019521|FG001|Overall Study|Lost to Follow-up|1|||
24926142|NCT00502593|50019522|FG002|Overall Study|Lost to Follow-up|1|||
24926143|NCT00502593|50019523|FG003|Overall Study|Lost to Follow-up|1|||
24926144|NCT00502593|50019524|FG004|Overall Study|Lost to Follow-up|0|||
24926145|NCT00502593|50019525|FG005|Overall Study|Lost to Follow-up|0|||
24926146|NCT00502593|50019526|FG006|Overall Study|Lost to Follow-up|0|||
24926147|NCT00502593|50019527|FG007|Overall Study|Lost to Follow-up|0|||
24926148|NCT00502593|50019528|FG008|Overall Study|Lost to Follow-up|3|||
24926149|NCT00502593|50019529|FG009|Overall Study|Lost to Follow-up|0|||
24926150|NCT00502593|50019530|FG010|Overall Study|Lost to Follow-up|1|||
24926151|NCT00502593|50019531|FG011|Overall Study|Lost to Follow-up|0|||
24926152|NCT00686543|50019584|FG000|Overall Study|Adverse Event|9|||
24926153|NCT00686543|50019585|FG001|Overall Study|Adverse Event|1|||
24926154|NCT00686543|50019586|FG002|Overall Study|Adverse Event|3|||
24926155|NCT00686543|50019587|FG003|Overall Study|Adverse Event|2|||
24926156|NCT00686543|50019584|FG000|Overall Study|Withdrawal by Subject|2|||
24926157|NCT00686543|50019585|FG001|Overall Study|Withdrawal by Subject|0|||
24926158|NCT00686543|50019586|FG002|Overall Study|Withdrawal by Subject|0|||
24926159|NCT00686543|50019587|FG003|Overall Study|Withdrawal by Subject|0|||
24926160|NCT00686543|50019584|FG000|Overall Study|Protocol Violation|3|||
24926161|NCT00686543|50019585|FG001|Overall Study|Protocol Violation|0|||
24926162|NCT00686543|50019586|FG002|Overall Study|Protocol Violation|2|||
24926163|NCT00686543|50019587|FG003|Overall Study|Protocol Violation|1|||
24926164|NCT00545688|50019601|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
24926165|NCT00545688|50019602|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
24926166|NCT00545688|50019603|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
24926167|NCT00545688|50019604|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
24926168|NCT00545688|50019601|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
24926169|NCT00545688|50019602|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
24926170|NCT00545688|50019603|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
24926171|NCT00545688|50019604|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
24926172|NCT00545688|50019601|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
24926173|NCT00545688|50019602|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
24926174|NCT00545688|50019603|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
24926175|NCT00545688|50019604|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
24926176|NCT00545688|50019601|FG000|Neo-Adjuvant Treatment Period|Death|0|||
24926177|NCT00545688|50019602|FG001|Neo-Adjuvant Treatment Period|Death|1|||
24926178|NCT00545688|50019603|FG002|Neo-Adjuvant Treatment Period|Death|0|||
24926179|NCT00545688|50019604|FG003|Neo-Adjuvant Treatment Period|Death|0|||
24926180|NCT00545688|50019601|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
24926181|NCT00545688|50019602|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
24926182|NCT00545688|50019603|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
24926183|NCT00545688|50019604|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
24926184|NCT00545688|50019601|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
24926185|NCT00545688|50019602|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
24926186|NCT00545688|50019603|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
24926187|NCT00545688|50019604|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
24926188|NCT00545688|50019601|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
24926189|NCT00545688|50019602|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
24926190|NCT00545688|50019603|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
24926191|NCT00545688|50019604|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
24926192|NCT00545688|50019601|FG000|Adjuvant Treatment Period|Disease Progression|3|||
24926193|NCT00545688|50019602|FG001|Adjuvant Treatment Period|Disease Progression|3|||
24926194|NCT00545688|50019603|FG002|Adjuvant Treatment Period|Disease Progression|0|||
24926195|NCT00545688|50019604|FG003|Adjuvant Treatment Period|Disease Progression|7|||
24926196|NCT00545688|50019601|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
24926197|NCT00545688|50019602|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
24926198|NCT00545688|50019603|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
24926199|NCT00545688|50019604|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
24926200|NCT00545688|50019601|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
24926201|NCT00545688|50019602|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
24926202|NCT00545688|50019603|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
24926203|NCT00545688|50019604|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
24926204|NCT00545688|50019601|FG000|Adjuvant Treatment Period|Adverse Event|0|||
24926205|NCT00545688|50019602|FG001|Adjuvant Treatment Period|Adverse Event|3|||
24926206|NCT00545688|50019603|FG002|Adjuvant Treatment Period|Adverse Event|2|||
24926207|NCT00545688|50019604|FG003|Adjuvant Treatment Period|Adverse Event|2|||
24926208|NCT00545688|50019601|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
24926209|NCT00545688|50019602|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
24926210|NCT00545688|50019603|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
24926211|NCT00545688|50019604|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
24926212|NCT00545688|50019601|FG000|Follow-Up Period|Death|4|||
24926213|NCT00545688|50019602|FG001|Follow-Up Period|Death|2|||
24926214|NCT00545688|50019603|FG002|Follow-Up Period|Death|2|||
24926215|NCT00545688|50019604|FG003|Follow-Up Period|Death|6|||
25024862|NCT03346057|50122314|FG002|Overall Study|Physician Decision|0|||
25024863|NCT03346057|50122315|FG003|Overall Study|Physician Decision|2|||
25024864|NCT03346057|50122312|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
25024865|NCT03346057|50122313|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
25024866|NCT03346057|50122314|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
25024867|NCT03346057|50122315|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
25024868|NCT03346057|50122312|FG000|Overall Study|Withdrawal by Subject|1|||
25024869|NCT03346057|50122313|FG001|Overall Study|Withdrawal by Subject|0|||
25024870|NCT03346057|50122314|FG002|Overall Study|Withdrawal by Subject|0|||
25024871|NCT03346057|50122315|FG003|Overall Study|Withdrawal by Subject|0|||
24926216|NCT00545688|50019601|FG000|Follow-Up Period|Disease Progression|6|||
24926217|NCT00545688|50019602|FG001|Follow-Up Period|Disease Progression|5|||
24926218|NCT00545688|50019603|FG002|Follow-Up Period|Disease Progression|9|||
24926219|NCT00545688|50019604|FG003|Follow-Up Period|Disease Progression|9|||
25024872|NCT03345979|50122327|FG000|Overall Study|Withdrawal by Subject|20|||
25024873|NCT03345979|50122328|FG001|Overall Study|Withdrawal by Subject|31|||
24926220|NCT00545688|50019601|FG000|Follow-Up Period|Refused Treatment|6|||
24926221|NCT00545688|50019602|FG001|Follow-Up Period|Refused Treatment|2|||
24926222|NCT00545688|50019603|FG002|Follow-Up Period|Refused Treatment|0|||
24926223|NCT00545688|50019604|FG003|Follow-Up Period|Refused Treatment|2|||
24926224|NCT00545688|50019601|FG000|Follow-Up Period|Lost to Follow-up|3|||
24926225|NCT00545688|50019602|FG001|Follow-Up Period|Lost to Follow-up|3|||
24926226|NCT00545688|50019603|FG002|Follow-Up Period|Lost to Follow-up|3|||
24926227|NCT00545688|50019604|FG003|Follow-Up Period|Lost to Follow-up|1|||
25024874|NCT03345979|50122327|FG000|Overall Study|Adverse Event|10|||
25024875|NCT03345979|50122328|FG001|Overall Study|Adverse Event|11|||
25024876|NCT03345979|50122327|FG000|Overall Study|Lost to Follow-up|8|||
25024877|NCT03345979|50122328|FG001|Overall Study|Lost to Follow-up|9|||
25024878|NCT03345979|50122327|FG000|Overall Study|Lack of Efficacy|4|||
24926228|NCT00545688|50019601|FG000|Follow-Up Period|Unspecified Reason|2|||
24926229|NCT00545688|50019602|FG001|Follow-Up Period|Unspecified Reason|5|||
24926230|NCT00545688|50019603|FG002|Follow-Up Period|Unspecified Reason|6|||
24926231|NCT00545688|50019604|FG003|Follow-Up Period|Unspecified Reason|8|||
24926232|NCT00545688|50019601|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
24926233|NCT00545688|50019602|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
24926234|NCT00545688|50019603|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
24926235|NCT00545688|50019604|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
24926236|NCT00502203|50019617|FG000|Overall Study|Inevaluable|1|||
24926237|NCT00546078|50019623|FG000|Overall Study|Lost to Follow-up|1|||
24926238|NCT00546078|50019624|FG001|Overall Study|Lost to Follow-up|3|||
24926239|NCT00546078|50019623|FG000|Overall Study|Withdrawal by Subject|2|||
24926240|NCT00546078|50019624|FG001|Overall Study|Withdrawal by Subject|3|||
24926241|NCT00546078|50019623|FG000|Overall Study|Other reason|1|||
25024879|NCT03345979|50122328|FG001|Overall Study|Lack of Efficacy|2|||
25024880|NCT03345979|50122327|FG000|Overall Study|Protocol Violation|1|||
24926242|NCT00546078|50019624|FG001|Overall Study|Other reason|1|||
24926243|NCT00546000|50019630|FG000|Overall Study|Adverse Event|1|||
24926244|NCT00546000|50019630|FG000|Overall Study|Lost to Follow-up|1|||
24926245|NCT00546000|50019630|FG000|Overall Study|Baseline HPA Axis Supression|2|||
24926246|NCT00501969|50019634|FG000|Overall Study|Major Protocol Violation|4|||
24926247|NCT00501969|50019634|FG000|Overall Study|Lack of Efficacy|29|||
24926248|NCT00501969|50019634|FG000|Overall Study|Adverse Event|76|||
24926249|NCT00501969|50019634|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
24926250|NCT00501969|50019634|FG000|Overall Study|Subject withdrew consent|51|||
24926251|NCT00501969|50019634|FG000|Overall Study|Lost to Follow-up|4|||
24926252|NCT00501969|50019634|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
24926253|NCT00501969|50019634|FG000|Overall Study|Other: Sponsors Request|10|||
24926254|NCT00501969|50019634|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
24926255|NCT00501969|50019634|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
24926256|NCT00501969|50019634|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
24926257|NCT00501969|50019634|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
24926258|NCT00501969|50019634|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
24926259|NCT00501969|50019634|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
24926260|NCT00501969|50019634|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
24926261|NCT00501969|50019634|FG000|Overall Study|Other: As Required by Local EC|2|||
24926262|NCT00501969|50019634|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
24926263|NCT00501969|50019634|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
24926264|NCT03942042|50019640|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
24926265|NCT03942042|50019641|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
24926266|NCT03942042|50019640|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
24926267|NCT03942042|50019641|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
24926268|NCT00104299|50019653|FG000|Overall Study|Adverse Event|3|||
24926269|NCT00104299|50019654|FG001|Overall Study|Adverse Event|1|||
24926270|NCT00104299|50019653|FG000|Overall Study|Death|2|||
24926271|NCT00104299|50019654|FG001|Overall Study|Death|2|||
24926272|NCT00104299|50019653|FG000|Overall Study|Withdrawal by Subject|2|||
25024881|NCT03345979|50122328|FG001|Overall Study|Protocol Violation|3|||
25024882|NCT03345979|50122327|FG000|Overall Study|Physician Decision|0|||
25024883|NCT03345979|50122328|FG001|Overall Study|Physician Decision|2|||
25024884|NCT02696434|50122336|FG000|Overall Study|Adverse Event|3|||
25024885|NCT02696434|50122337|FG001|Overall Study|Adverse Event|1|||
25024886|NCT02696434|50122336|FG000|Overall Study|Lost to Follow-up|5|||
24926273|NCT00104299|50019654|FG001|Overall Study|Withdrawal by Subject|6|||
24926274|NCT00104299|50019653|FG000|Overall Study|Physician Decision|1|||
24926275|NCT00104299|50019654|FG001|Overall Study|Physician Decision|1|||
25024887|NCT02696434|50122337|FG001|Overall Study|Lost to Follow-up|4|||
25024888|NCT02696434|50122336|FG000|Overall Study|Withdrawal by Subject|14|||
24926276|NCT00104299|50019653|FG000|Overall Study|To have renal transplant|1|||
24926277|NCT00104299|50019654|FG001|Overall Study|To have renal transplant|0|||
25024889|NCT02696434|50122337|FG001|Overall Study|Withdrawal by Subject|12|||
25024890|NCT02696434|50122336|FG000|Overall Study|Physician Decision|0|||
24926278|NCT03939312|50019660|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
25024891|NCT02696434|50122337|FG001|Overall Study|Physician Decision|1|||
24926279|NCT03939312|50019660|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
24926280|NCT03939312|50019660|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
24926281|NCT03939312|50019660|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
25024892|NCT03345901|50122343|FG000|Overall Study|The study was terminated|18|||
25024893|NCT02950831|50122348|FG000|Overall Study|Lost to Follow-up|1|||
24926282|NCT03939312|50019660|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
24926283|NCT03939312|50019660|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
24926284|NCT03939312|50019660|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
24926285|NCT03939312|50019660|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
24926286|NCT03939312|50019660|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
24926287|NCT03939312|50019660|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
24926288|NCT03939312|50019660|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
24926289|NCT03939312|50019660|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
24926290|NCT00082381|50019668|FG000|Overall Study|Adverse Event|27|||
24926291|NCT00082381|50019669|FG001|Overall Study|Adverse Event|2|||
24926292|NCT00082381|50019668|FG000|Overall Study|Lost to Follow-up|5|||
24926293|NCT00082381|50019669|FG001|Overall Study|Lost to Follow-up|7|||
24926294|NCT00082381|50019668|FG000|Overall Study|Patient Decision|8|||
24926295|NCT00082381|50019669|FG001|Overall Study|Patient Decision|4|||
24926296|NCT00082381|50019668|FG000|Overall Study|Physician Decision|1|||
24926297|NCT00082381|50019669|FG001|Overall Study|Physician Decision|2|||
24926298|NCT00082381|50019668|FG000|Overall Study|Protocol Violation|10|||
24926299|NCT00082381|50019669|FG001|Overall Study|Protocol Violation|11|||
24926300|NCT00082381|50019668|FG000|Overall Study|Loss of Glucose Control|4|||
24926301|NCT00082381|50019669|FG001|Overall Study|Loss of Glucose Control|0|||
24926302|NCT00545844|50019675|FG000|Overall Study|Lost to Follow-up|9|||
24926303|NCT00545844|50019675|FG000|Overall Study|Protocol Violation|1|||
24926304|NCT00545844|50019675|FG000|Overall Study|Withdrawal by Subject|2|||
24926305|NCT00492063|50019685|FG000|Overall Study|Death|0|||
25024894|NCT02950831|50122348|FG000|Overall Study|Withdrawal by Subject|3|||
25024895|NCT02950831|50122348|FG000|Overall Study|stimulation trail failure|5|||
25024896|NCT03593915|50122358|FG000|Overall Study|Adverse Event|0|||
25024897|NCT03593915|50122359|FG001|Overall Study|Adverse Event|0|||
25024898|NCT03593915|50122360|FG002|Overall Study|Adverse Event|0|||
25024899|NCT03593915|50122361|FG003|Overall Study|Adverse Event|1|||
25024900|NCT03593915|50122362|FG004|Overall Study|Adverse Event|0|||
25024901|NCT03593915|50122363|FG005|Overall Study|Adverse Event|0|||
25024902|NCT03593915|50122358|FG000|Overall Study|Physician Decision|0|||
25024903|NCT03593915|50122359|FG001|Overall Study|Physician Decision|0|||
25024904|NCT03593915|50122360|FG002|Overall Study|Physician Decision|0|||
25024905|NCT03593915|50122361|FG003|Overall Study|Physician Decision|0|||
25024906|NCT03593915|50122362|FG004|Overall Study|Physician Decision|0|||
25024907|NCT03593915|50122363|FG005|Overall Study|Physician Decision|1|||
25024908|NCT03593681|50122377|FG000|Overall Study|Inadequate sample collected|12|||
25024909|NCT03593681|50122377|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
25024910|NCT03593681|50122377|FG000|Overall Study|Protocol Violation|3|||
25024911|NCT03593681|50122377|FG000|Overall Study|Withdrawal by Subject|3|||
25024912|NCT03593681|50122377|FG000|Overall Study|Procedure not attempted|3|||
25024913|NCT03593681|50122377|FG000|Overall Study|Adverse Event|2|||
25024914|NCT03593681|50122377|FG000|Overall Study|Physician Decision|1|||
25024915|NCT03592745|50122400|FG000|Overall Study|Adverse Event|0|||
25024916|NCT03592745|50122401|FG001|Overall Study|Adverse Event|2|||
25024917|NCT03592745|50122400|FG000|Overall Study|Lost to Follow-up|2|||
25024918|NCT03592745|50122401|FG001|Overall Study|Lost to Follow-up|0|||
25024919|NCT03592745|50122400|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
25024920|NCT03592745|50122401|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
25024921|NCT03592277|50122409|FG000|Overall Study|Withdrawal by Subject|6|||
25024922|NCT03592277|50122410|FG001|Overall Study|Withdrawal by Subject|8|||
25024923|NCT03401112|50122421|FG000|Overall Study|Adverse Event|1|||
25024924|NCT03401112|50122422|FG001|Overall Study|Adverse Event|2|||
25024925|NCT03401112|50122423|FG002|Overall Study|Adverse Event|3|||
25024926|NCT03401112|50122424|FG003|Overall Study|Adverse Event|2|||
25024927|NCT03401112|50122425|FG004|Overall Study|Adverse Event|0|||
25024928|NCT03401112|50122421|FG000|Overall Study|Lost to Follow-up|1|||
25024929|NCT03401112|50122422|FG001|Overall Study|Lost to Follow-up|0|||
25024930|NCT03401112|50122423|FG002|Overall Study|Lost to Follow-up|0|||
25024931|NCT03401112|50122424|FG003|Overall Study|Lost to Follow-up|0|||
25024932|NCT03401112|50122425|FG004|Overall Study|Lost to Follow-up|0|||
25024933|NCT03401112|50122421|FG000|Overall Study|Noncompliance|1|||
25024934|NCT03401112|50122422|FG001|Overall Study|Noncompliance|2|||
25024935|NCT03401112|50122423|FG002|Overall Study|Noncompliance|3|||
24926306|NCT00492063|50019686|FG001|Overall Study|Death|0|||
25024936|NCT03401112|50122424|FG003|Overall Study|Noncompliance|0|||
25024937|NCT03401112|50122425|FG004|Overall Study|Noncompliance|0|||
24926307|NCT00492063|50019687|FG002|Overall Study|Death|1|||
24926308|NCT00492063|50019688|FG003|Overall Study|Death|2|||
24926309|NCT00492063|50019685|FG000|Overall Study|Withdrawal by Subject|4|||
25024938|NCT03401112|50122421|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
25024939|NCT03401112|50122422|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
25024940|NCT03401112|50122423|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
25024941|NCT03401112|50122424|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
25024942|NCT03401112|50122425|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
25024943|NCT03401112|50122421|FG000|Overall Study|Withdrawal by Subject|0|||
25155118|NCT03822832|50270412|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
24926310|NCT00492063|50019686|FG001|Overall Study|Withdrawal by Subject|3|||
24926311|NCT00492063|50019687|FG002|Overall Study|Withdrawal by Subject|5|||
24926312|NCT00492063|50019688|FG003|Overall Study|Withdrawal by Subject|4|||
24926313|NCT00492063|50019685|FG000|Overall Study|Lost to Follow-up|6|||
24926314|NCT00492063|50019686|FG001|Overall Study|Lost to Follow-up|11|||
24926315|NCT00492063|50019687|FG002|Overall Study|Lost to Follow-up|5|||
24926316|NCT00492063|50019688|FG003|Overall Study|Lost to Follow-up|3|||
24926317|NCT00492063|50019685|FG000|Overall Study|Protocol Violation|0|||
24926318|NCT00492063|50019686|FG001|Overall Study|Protocol Violation|0|||
24926319|NCT00492063|50019687|FG002|Overall Study|Protocol Violation|0|||
24926320|NCT00492063|50019688|FG003|Overall Study|Protocol Violation|1|||
24926321|NCT00093145|50019698|FG000|Overall Study|Unacceptable Toxicity Only|2|||
24926322|NCT00093145|50019698|FG000|Overall Study|Physician Decision|5|||
24926323|NCT00093145|50019698|FG000|Overall Study|Withdrawal by Subject|9|||
24926324|NCT00093145|50019698|FG000|Overall Study|Other|1|||
24926325|NCT00513357|50019704|FG000|Overall Study|did not receive allocated placebo|2|||
24926326|NCT00513357|50019705|FG001|Overall Study|did not receive allocated placebo|3|||
24926327|NCT00513357|50019704|FG000|Overall Study|Adverse Event|4|||
24926328|NCT00513357|50019705|FG001|Overall Study|Adverse Event|2|||
24926329|NCT00513357|50019704|FG000|Overall Study|Death|2|||
24926330|NCT00513357|50019705|FG001|Overall Study|Death|0|||
24926331|NCT00513357|50019704|FG000|Overall Study|Withdrawal by Subject|5|||
24926332|NCT00513357|50019705|FG001|Overall Study|Withdrawal by Subject|4|||
24926333|NCT00513357|50019704|FG000|Overall Study|Disease Progression|2|||
24926334|NCT00513357|50019705|FG001|Overall Study|Disease Progression|1|||
24926335|NCT03933462|50019711|FG000|Overall Study|Adverse Event|2|||
24926336|NCT03933462|50019712|FG001|Overall Study|Adverse Event|0|||
24926337|NCT03929562|50019720|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
24926338|NCT03929562|50019721|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
24926339|NCT03929562|50019720|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
24926340|NCT03929562|50019721|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
24926341|NCT03929562|50019720|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
24926342|NCT03929562|50019721|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
24926343|NCT00415636|50019735|FG000|Overall Study|Symptomatic deterioration|1|||
25155119|NCT03822832|50270411|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
25155120|NCT03822832|50270412|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
25155121|NCT03822832|50270411|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
25155122|NCT03822832|50270412|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
25155123|NCT03822832|50270411|FG000|Re-allocation|Not re-allocated to open label period|2|||
25155124|NCT03822832|50270412|FG001|Re-allocation|Not re-allocated to open label period|6|||
25155125|NCT03822832|50270411|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
25155126|NCT03822832|50270412|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
24926344|NCT00415636|50019736|FG001|Overall Study|Symptomatic deterioration|0|||
24926345|NCT00415636|50019737|FG002|Overall Study|Symptomatic deterioration|1|||
24926346|NCT00415636|50019738|FG003|Overall Study|Symptomatic deterioration|2|||
24926347|NCT00415636|50019739|FG004|Overall Study|Symptomatic deterioration|0|||
24926348|NCT00415636|50019740|FG005|Overall Study|Symptomatic deterioration|1|||
24926349|NCT00415636|50019735|FG000|Overall Study|Adverse Event|0|||
24926350|NCT00415636|50019736|FG001|Overall Study|Adverse Event|0|||
24926351|NCT00415636|50019737|FG002|Overall Study|Adverse Event|0|||
24926352|NCT00415636|50019738|FG003|Overall Study|Adverse Event|1|||
24926353|NCT00415636|50019739|FG004|Overall Study|Adverse Event|1|||
24926354|NCT00415636|50019740|FG005|Overall Study|Adverse Event|0|||
24926355|NCT00415636|50019735|FG000|Overall Study|Withdrawal by Subject|0|||
24926356|NCT00415636|50019736|FG001|Overall Study|Withdrawal by Subject|0|||
24926357|NCT00415636|50019737|FG002|Overall Study|Withdrawal by Subject|0|||
24926358|NCT00415636|50019738|FG003|Overall Study|Withdrawal by Subject|0|||
24926359|NCT00415636|50019739|FG004|Overall Study|Withdrawal by Subject|1|||
24926360|NCT00415636|50019740|FG005|Overall Study|Withdrawal by Subject|0|||
25155127|NCT03822832|50270411|FG000|Period 2 - Open Label Period|Adverse Event|0|||
25185536|NCT01500278|50335064|FG001|Week 13 - Week 104|Personal reason|1|||
24926361|NCT00415636|50019735|FG000|Overall Study|Disease progression|0|||
24926362|NCT00415636|50019736|FG001|Overall Study|Disease progression|0|||
24926363|NCT00415636|50019737|FG002|Overall Study|Disease progression|0|||
24926364|NCT00415636|50019738|FG003|Overall Study|Disease progression|3|||
24926365|NCT00415636|50019739|FG004|Overall Study|Disease progression|0|||
24926366|NCT00415636|50019740|FG005|Overall Study|Disease progression|1|||
24926367|NCT00425854|50019764|FG000|Overall Study|Progressive Disease|19|||
24926368|NCT00425854|50019765|FG001|Overall Study|Progressive Disease|12|||
24926369|NCT00425854|50019764|FG000|Overall Study|Dose reduction toxicity AE|8|||
24926370|NCT00425854|50019765|FG001|Overall Study|Dose reduction toxicity AE|7|||
24926371|NCT00425854|50019764|FG000|Overall Study|Other Adverse Event|2|||
24926372|NCT00425854|50019765|FG001|Overall Study|Other Adverse Event|2|||
24926373|NCT00425698|50019774|FG000|Overall Study|Adverse Event|3|||
24926374|NCT00425698|50019775|FG001|Overall Study|Adverse Event|1|||
24926375|NCT00425698|50019774|FG000|Overall Study|Withdrawal by Subject|0|||
24926376|NCT00425698|50019775|FG001|Overall Study|Withdrawal by Subject|1|||
24926377|NCT00425308|50019783|FG000|Overall Study|Adverse Event|2|||
24926378|NCT00425308|50019784|FG001|Overall Study|Adverse Event|1|||
24926379|NCT00425308|50019783|FG000|Overall Study|Withdrawal by Subject|1|||
24926380|NCT00425308|50019784|FG001|Overall Study|Withdrawal by Subject|0|||
24926381|NCT00425308|50019783|FG000|Overall Study|Death|1|||
24926382|NCT00425308|50019784|FG001|Overall Study|Death|0|||
24926383|NCT00545064|50019790|FG000|Overall Study|Lost to Follow-up|3|||
24926384|NCT00545064|50019790|FG000|Overall Study|Withdrawal by Subject|2|||
24926385|NCT00545064|50019790|FG000|Overall Study|did not complete course of treatment|1|||
24926386|NCT00545064|50019790|FG000|Overall Study|cancel all appointments, no rebooking|1|||
24926387|NCT00545064|50019790|FG000|Overall Study|inclement weather|1|||
24926388|NCT00432562|50019798|FG000|Overall Study|Death|3|||
24926389|NCT00432562|50019799|FG001|Overall Study|Death|0|||
24926390|NCT00432172|50019809|FG000|Overall Study|Physician Decision|0|||
24926391|NCT00432172|50019810|FG001|Overall Study|Physician Decision|0|||
24926392|NCT00432172|50019811|FG002|Overall Study|Physician Decision|2|||
24926393|NCT00432172|50019812|FG003|Overall Study|Physician Decision|0|||
24926394|NCT00432172|50019809|FG000|Overall Study|Adverse Event|4|||
24926395|NCT00432172|50019810|FG001|Overall Study|Adverse Event|2|||
24926396|NCT00432172|50019811|FG002|Overall Study|Adverse Event|4|||
24926397|NCT00432172|50019812|FG003|Overall Study|Adverse Event|3|||
24926398|NCT00432172|50019809|FG000|Overall Study|Disease progression|0|||
24926399|NCT00432172|50019810|FG001|Overall Study|Disease progression|2|||
24926400|NCT00432172|50019811|FG002|Overall Study|Disease progression|5|||
24926401|NCT00432172|50019812|FG003|Overall Study|Disease progression|1|||
24926402|NCT00432172|50019809|FG000|Overall Study|Withdrawal by Subject|0|||
24926403|NCT00432172|50019810|FG001|Overall Study|Withdrawal by Subject|1|||
24926404|NCT00432172|50019811|FG002|Overall Study|Withdrawal by Subject|0|||
24926405|NCT00432172|50019812|FG003|Overall Study|Withdrawal by Subject|2|||
24926406|NCT00432172|50019809|FG000|Overall Study|No treatment received|2|||
24926407|NCT00432172|50019810|FG001|Overall Study|No treatment received|2|||
24926408|NCT00432172|50019811|FG002|Overall Study|No treatment received|0|||
24926409|NCT00432172|50019812|FG003|Overall Study|No treatment received|1|||
24926410|NCT00415168|50019824|FG000|Overall Study|Death|26|||
24926411|NCT00415168|50019824|FG000|Overall Study|Lost to Follow-up|3|||
24926412|NCT00415168|50019824|FG000|Overall Study|Physician Decision|13|||
24926413|NCT00415168|50019824|FG000|Overall Study|Sponsor Decision|4|||
24926414|NCT00415168|50019824|FG000|Overall Study|Withdrawal by Subject|6|||
25024944|NCT03401112|50122422|FG001|Overall Study|Withdrawal by Subject|3|||
25024945|NCT03401112|50122423|FG002|Overall Study|Withdrawal by Subject|2|||
24926415|NCT00424762|50019830|FG000|Overall Study|Withdrawal by Subject|18|||
24926416|NCT00424762|50019831|FG001|Overall Study|Withdrawal by Subject|19|||
24926417|NCT00424762|50019830|FG000|Overall Study|Lost to Follow-up|2|||
24926418|NCT00424762|50019831|FG001|Overall Study|Lost to Follow-up|3|||
24926419|NCT00414544|50019837|FG000|Overall Study|Lost to Follow-up|14|||
24926420|NCT00414466|50019847|FG000|Overall Study|Adverse Event|0|||
24926421|NCT00414466|50019848|FG001|Overall Study|Adverse Event|0|||
24926422|NCT00414466|50019849|FG002|Overall Study|Adverse Event|1|||
25024946|NCT03401112|50122424|FG003|Overall Study|Withdrawal by Subject|1|||
25024947|NCT03401112|50122425|FG004|Overall Study|Withdrawal by Subject|0|||
25024948|NCT03401112|50122421|FG000|Overall Study|Physician Decision|0|||
25155128|NCT03822832|50270412|FG001|Period 2 - Open Label Period|Adverse Event|3|||
25155129|NCT01513239|50270422|FG000|Period 1: Main Phase|Adverse Event|1|||
25155130|NCT01513239|50270423|FG001|Period 1: Main Phase|Adverse Event|1|||
25155131|NCT01513239|50270424|FG002|Period 1: Main Phase|Adverse Event|2|||
25155132|NCT01513239|50270425|FG003|Period 1: Main Phase|Adverse Event|0|||
25155133|NCT01513239|50270426|FG004|Period 1: Main Phase|Adverse Event|0|||
25155134|NCT01513239|50270427|FG005|Period 1: Main Phase|Adverse Event|0|||
25155135|NCT01513239|50270422|FG000|Period 1: Main Phase|Death|29|||
25155136|NCT01513239|50270423|FG001|Period 1: Main Phase|Death|22|||
24926423|NCT00414466|50019850|FG003|Overall Study|Adverse Event|1|||
24926424|NCT00414466|50019847|FG000|Overall Study|Lack of Efficacy|1|||
25155137|NCT01513239|50270424|FG002|Period 1: Main Phase|Death|32|||
24926425|NCT00414466|50019848|FG001|Overall Study|Lack of Efficacy|0|||
24926426|NCT00414466|50019849|FG002|Overall Study|Lack of Efficacy|0|||
24926427|NCT00414466|50019850|FG003|Overall Study|Lack of Efficacy|0|||
24926428|NCT00414466|50019847|FG000|Overall Study|Withdrawn by Sponsor|1|||
24926429|NCT00414466|50019848|FG001|Overall Study|Withdrawn by Sponsor|0|||
25024949|NCT03401112|50122422|FG001|Overall Study|Physician Decision|0|||
25155138|NCT01513239|50270425|FG003|Period 1: Main Phase|Death|0|||
25155139|NCT01513239|50270426|FG004|Period 1: Main Phase|Death|0|||
25155140|NCT01513239|50270427|FG005|Period 1: Main Phase|Death|0|||
25155141|NCT01513239|50270422|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
25155142|NCT01513239|50270423|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
25155143|NCT01513239|50270424|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
25155144|NCT01513239|50270425|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
25155145|NCT01513239|50270426|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
25155146|NCT01513239|50270427|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
25155147|NCT01513239|50270422|FG000|Period 1: Main Phase|Physician Decision|4|||
25155148|NCT01513239|50270423|FG001|Period 1: Main Phase|Physician Decision|4|||
25155149|NCT01513239|50270424|FG002|Period 1: Main Phase|Physician Decision|4|||
25155150|NCT01513239|50270425|FG003|Period 1: Main Phase|Physician Decision|0|||
25155151|NCT01513239|50270426|FG004|Period 1: Main Phase|Physician Decision|0|||
25155152|NCT01513239|50270427|FG005|Period 1: Main Phase|Physician Decision|0|||
25155153|NCT01513239|50270422|FG000|Period 1: Main Phase|Protocol Violation|2|||
25155154|NCT01513239|50270423|FG001|Period 1: Main Phase|Protocol Violation|2|||
25155155|NCT01513239|50270424|FG002|Period 1: Main Phase|Protocol Violation|2|||
25155156|NCT01513239|50270425|FG003|Period 1: Main Phase|Protocol Violation|0|||
25155157|NCT01513239|50270426|FG004|Period 1: Main Phase|Protocol Violation|0|||
25155158|NCT01513239|50270427|FG005|Period 1: Main Phase|Protocol Violation|0|||
25155159|NCT01513239|50270422|FG000|Period 1: Main Phase|Technical Problems|1|||
25155160|NCT01513239|50270423|FG001|Period 1: Main Phase|Technical Problems|2|||
25155161|NCT01513239|50270424|FG002|Period 1: Main Phase|Technical Problems|0|||
24926430|NCT00414466|50019849|FG002|Overall Study|Withdrawn by Sponsor|0|||
24926431|NCT00414466|50019850|FG003|Overall Study|Withdrawn by Sponsor|0|||
24926432|NCT00424528|50019866|FG000|Overall Study|Adverse Event|2|||
24926433|NCT00424528|50019867|FG001|Overall Study|Adverse Event|1|||
24926434|NCT00424528|50019868|FG002|Overall Study|Adverse Event|2|||
24926435|NCT00424528|50019866|FG000|Overall Study|Protocol Violation|1|||
24926436|NCT00424528|50019867|FG001|Overall Study|Protocol Violation|1|||
24926437|NCT00424528|50019868|FG002|Overall Study|Protocol Violation|0|||
24926438|NCT00424528|50019866|FG000|Overall Study|Lost to Follow-up|0|||
24926439|NCT00424528|50019867|FG001|Overall Study|Lost to Follow-up|1|||
24926440|NCT00424528|50019868|FG002|Overall Study|Lost to Follow-up|0|||
24926441|NCT00424528|50019866|FG000|Overall Study|noncompliance with study requirements|2|||
24926442|NCT00424528|50019867|FG001|Overall Study|noncompliance with study requirements|1|||
24926443|NCT00424528|50019868|FG002|Overall Study|noncompliance with study requirements|2|||
24926444|NCT00545532|50019878|FG000|Overall Study|Withdrawal by Subject|1|||
24926445|NCT00545532|50019879|FG001|Overall Study|Withdrawal by Subject|3|||
24926446|NCT00545532|50019878|FG000|Overall Study|Lost to Follow-up|5|||
24926447|NCT00545532|50019879|FG001|Overall Study|Lost to Follow-up|6|||
24926448|NCT00545532|50019878|FG000|Overall Study|Death|0|||
24926449|NCT00545532|50019879|FG001|Overall Study|Death|1|||
24926450|NCT00544440|50019887|FG000|Overall Study|Other|1|||
24926451|NCT00544440|50019887|FG000|Overall Study|Adverse Event|1|||
24926452|NCT00544440|50019887|FG000|Overall Study|Withdrawal by Subject|2|||
24926453|NCT00544440|50019887|FG000|Overall Study|Subject Non-compliance|1|||
24926454|NCT00544440|50019887|FG000|Overall Study|Progressive Disease|47|||
25024950|NCT03401112|50122423|FG002|Overall Study|Physician Decision|0|||
25024951|NCT03401112|50122424|FG003|Overall Study|Physician Decision|2|||
25024952|NCT03401112|50122425|FG004|Overall Study|Physician Decision|0|||
25024953|NCT03401112|50122421|FG000|Overall Study|Study was Terminated by Sponsor|0|||
25024954|NCT03401112|50122422|FG001|Overall Study|Study was Terminated by Sponsor|0|||
25024955|NCT03401112|50122423|FG002|Overall Study|Study was Terminated by Sponsor|0|||
25024956|NCT03401112|50122424|FG003|Overall Study|Study was Terminated by Sponsor|1|||
25024957|NCT03401112|50122425|FG004|Overall Study|Study was Terminated by Sponsor|0|||
24926455|NCT00544440|50019887|FG000|Overall Study|Other|5|||
24926456|NCT03920670|50019893|FG000|Overall Study|Protocol Violation|2|||
24926457|NCT03920670|50019894|FG001|Overall Study|Protocol Violation|2|||
24926458|NCT03920670|50019893|FG000|Overall Study|Adverse Event|1|||
24926459|NCT03920670|50019894|FG001|Overall Study|Adverse Event|0|||
24926460|NCT00430300|50019904|FG000|Overall Study|Adverse Event|0|||
24926461|NCT00430300|50019905|FG001|Overall Study|Adverse Event|2|||
25024958|NCT03401112|50122421|FG000|Overall Study|Day 1 Assessment not Done|1|||
25024959|NCT03401112|50122422|FG001|Overall Study|Day 1 Assessment not Done|0|||
25024960|NCT03401112|50122423|FG002|Overall Study|Day 1 Assessment not Done|0|||
25155162|NCT01513239|50270425|FG003|Period 1: Main Phase|Technical Problems|0|||
25155163|NCT01513239|50270426|FG004|Period 1: Main Phase|Technical Problems|0|||
24926462|NCT00430300|50019906|FG002|Overall Study|Adverse Event|1|||
24926463|NCT00430300|50019907|FG003|Overall Study|Adverse Event|1|||
24926464|NCT00430300|50019904|FG000|Overall Study|Withdrawal by Subject|1|||
24926465|NCT00430300|50019905|FG001|Overall Study|Withdrawal by Subject|0|||
25024961|NCT03401112|50122424|FG003|Overall Study|Day 1 Assessment not Done|0|||
25024962|NCT03401112|50122425|FG004|Overall Study|Day 1 Assessment not Done|0|||
25024963|NCT03401112|50122421|FG000|Overall Study|Not Dosed|0|||
25155164|NCT01513239|50270427|FG005|Period 1: Main Phase|Technical Problems|0|||
25155165|NCT01513239|50270422|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
24926466|NCT00430300|50019906|FG002|Overall Study|Withdrawal by Subject|5|||
24926467|NCT00430300|50019907|FG003|Overall Study|Withdrawal by Subject|0|||
24926468|NCT00430300|50019904|FG000|Overall Study|Laboratory abnormality|1|||
24926469|NCT00430300|50019905|FG001|Overall Study|Laboratory abnormality|0|||
24926470|NCT00430300|50019906|FG002|Overall Study|Laboratory abnormality|0|||
24926471|NCT00430300|50019907|FG003|Overall Study|Laboratory abnormality|0|||
24926472|NCT00430300|50019904|FG000|Overall Study|Other|0|||
24926473|NCT00430300|50019905|FG001|Overall Study|Other|0|||
24926474|NCT00430300|50019906|FG002|Overall Study|Other|0|||
24926475|NCT00430300|50019907|FG003|Overall Study|Other|1|||
24926476|NCT03927846|50019919|FG000|Overall Study|Lost to Follow-up|10|||
24926477|NCT03927846|50019920|FG001|Overall Study|Lost to Follow-up|11|||
24926478|NCT03927144|50019928|FG000|Overall Study|Adverse Event|9|||
24926479|NCT03927144|50019929|FG001|Overall Study|Adverse Event|5|||
24926480|NCT03927144|50019928|FG000|Overall Study|Lost to Follow-up|3|||
24926481|NCT03927144|50019929|FG001|Overall Study|Lost to Follow-up|2|||
24926482|NCT03927144|50019928|FG000|Overall Study|New Therapy for Study Indication|0|||
24926483|NCT03927144|50019929|FG001|Overall Study|New Therapy for Study Indication|1|||
24926484|NCT03927144|50019928|FG000|Overall Study|No Longer Clinically Benefiting|4|||
24926485|NCT03927144|50019929|FG001|Overall Study|No Longer Clinically Benefiting|4|||
24926486|NCT03927144|50019928|FG000|Overall Study|Physician Decision|2|||
24926487|NCT03927144|50019929|FG001|Overall Study|Physician Decision|8|||
24926488|NCT03927144|50019928|FG000|Overall Study|Protocol Violation|2|||
24926489|NCT03927144|50019929|FG001|Overall Study|Protocol Violation|2|||
24926490|NCT03927144|50019928|FG000|Overall Study|Withdrawal by Subject|16|||
24926491|NCT03927144|50019929|FG001|Overall Study|Withdrawal by Subject|40|||
24926492|NCT00545298|50019938|FG000|Overall Study|Issues with Standard of Care|2|||
24926493|NCT00545298|50019939|FG001|Overall Study|Issues with Standard of Care|0|||
25024964|NCT03401112|50122422|FG001|Overall Study|Not Dosed|0|||
25024965|NCT03401112|50122423|FG002|Overall Study|Not Dosed|1|||
25275044|NCT00903409|50589093|FG000|Overall Study|Withdrawal by Subject|8|||
25275045|NCT00903409|50589094|FG001|Overall Study|Withdrawal by Subject|8|||
24926494|NCT00545298|50019940|FG002|Overall Study|Issues with Standard of Care|1|||
24926495|NCT00429364|50019953|FG000|Overall Study|Withdrawal by Subject|11|||
24926496|NCT00429364|50019954|FG001|Overall Study|Withdrawal by Subject|5|||
24926497|NCT00429364|50019953|FG000|Overall Study|Physician Decision|4|||
24926498|NCT00429364|50019954|FG001|Overall Study|Physician Decision|2|||
24926499|NCT00429364|50019953|FG000|Overall Study|Lost to Follow-up|7|||
24926500|NCT00429364|50019954|FG001|Overall Study|Lost to Follow-up|6|||
24926501|NCT00429364|50019953|FG000|Overall Study|Death|0|||
24926502|NCT00429364|50019954|FG001|Overall Study|Death|1|||
24926503|NCT00429364|50019953|FG000|Overall Study|Underwent aortic root surgery|10|||
24926504|NCT00429364|50019954|FG001|Overall Study|Underwent aortic root surgery|18|||
24926505|NCT00429364|50019953|FG000|Overall Study|Pregnancy|0|||
24926506|NCT00429364|50019954|FG001|Overall Study|Pregnancy|1|||
24926507|NCT00414388|50019960|FG000|Overall Study|Adverse Event|1|||
24926508|NCT03920280|50019967|FG000|Overall Study|Adverse Event|2|||
24926509|NCT03920280|50019968|FG001|Overall Study|Adverse Event|3|||
24926510|NCT03920280|50019967|FG000|Overall Study|Lost to Follow-up|0|||
24926511|NCT03920280|50019968|FG001|Overall Study|Lost to Follow-up|1|||
25275046|NCT00903409|50589093|FG000|Overall Study|Other|2|||
25275047|NCT00903409|50589094|FG001|Overall Study|Other|3|||
25275048|NCT00903409|50589093|FG000|Overall Study|Lost to Follow-up|2|||
25275049|NCT00903409|50589094|FG001|Overall Study|Lost to Follow-up|6|||
25275050|NCT01237223|50589108|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
25275051|NCT01237223|50589109|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
25275052|NCT01237223|50589110|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
25275053|NCT01237223|50589111|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
24926512|NCT03920280|50019967|FG000|Overall Study|Withdrawal by Subject|1|||
24926513|NCT03920280|50019968|FG001|Overall Study|Withdrawal by Subject|1|||
24926514|NCT03920280|50019967|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
24926515|NCT03920280|50019968|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
24926516|NCT00424372|50019977|FG000|Overall Study|Death|1|||
24926517|NCT00424372|50019977|FG000|Overall Study|Adverse Event|18|||
24926518|NCT00424372|50019977|FG000|Overall Study|Lack of Efficacy|6|||
25275054|NCT01237223|50589112|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
24926519|NCT00424372|50019977|FG000|Overall Study|Withdrawal by Subject|4|||
24926520|NCT00424372|50019977|FG000|Overall Study|Protocol Violation|1|||
24926521|NCT00424372|50019977|FG000|Overall Study|Health deterioration|1|||
24926522|NCT00414310|50019983|FG000|Overall Study|Not treated|1|||
24926523|NCT00414310|50019984|FG001|Overall Study|Not treated|0|||
24926524|NCT00542880|50019994|FG000|Period 1|Eligibility criteria not fulfilled|2|||
24926525|NCT00542880|50019995|FG001|Period 1|Eligibility criteria not fulfilled|6|||
24926526|NCT00542880|50019994|FG000|Period 1|Adverse Event|2|||
24926527|NCT00542880|50019995|FG001|Period 1|Adverse Event|2|||
25024966|NCT03401112|50122424|FG003|Overall Study|Not Dosed|0|||
25275055|NCT01237223|50589113|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
24926528|NCT00542880|50019994|FG000|Period 1|Development of study-specific criteria|1|||
24926529|NCT00542880|50019995|FG001|Period 1|Development of study-specific criteria|2|||
24926530|NCT00542880|50019994|FG000|Period 1|Withdrawal by Subject|1|||
24926531|NCT00542880|50019995|FG001|Period 1|Withdrawal by Subject|1|||
24926532|NCT00542880|50019994|FG000|Period 1|Protocol Violation|0|||
24926533|NCT00542880|50019995|FG001|Period 1|Protocol Violation|1|||
24926534|NCT00542880|50019994|FG000|Period 2|Adverse Event|5|||
24926535|NCT00542880|50019995|FG001|Period 2|Adverse Event|7|||
24926536|NCT00542880|50019994|FG000|Period 2|Eligibility not fulfilled|0|||
24926537|NCT00542880|50019995|FG001|Period 2|Eligibility not fulfilled|1|||
24926538|NCT00542880|50019994|FG000|Period 2|Discontinuation criteria|2|||
24926539|NCT00542880|50019995|FG001|Period 2|Discontinuation criteria|0|||
24926540|NCT00542880|50019994|FG000|Period 2|Severe non-compliance|0|||
24926541|NCT00542880|50019995|FG001|Period 2|Severe non-compliance|1|||
24926542|NCT00542880|50019994|FG000|Period 2|Other|0|||
24926543|NCT00542880|50019995|FG001|Period 2|Other|1|||
24926544|NCT00542880|50019994|FG000|Period 3|Adverse Event|0|||
24926545|NCT00542880|50019995|FG001|Period 3|Adverse Event|2|||
24926546|NCT00414076|50020004|FG000|Overall Study|Progression|1|||
24926547|NCT00414076|50020005|FG001|Overall Study|Progression|2|||
24926548|NCT00414076|50020004|FG000|Overall Study|Withdrawal by Subject|1|||
24926549|NCT00414076|50020005|FG001|Overall Study|Withdrawal by Subject|3|||
24926550|NCT00414076|50020004|FG000|Overall Study|Adverse Event|1|||
24926551|NCT00414076|50020005|FG001|Overall Study|Adverse Event|0|||
24926552|NCT00092677|50020013|FG000|Overall Study|Lost to Follow-up|0|||
24926553|NCT00092677|50020014|FG001|Overall Study|Lost to Follow-up|2|||
24926554|NCT00092677|50020013|FG000|Overall Study|Adminstrative|5|||
24926555|NCT00092677|50020014|FG001|Overall Study|Adminstrative|9|||
24926556|NCT00542178|50020026|FG000|Overall Study|did not complete year 4 follow-up|75|||
24926557|NCT00542178|50020027|FG001|Overall Study|did not complete year 4 follow-up|80|||
24926558|NCT00542178|50020028|FG002|Overall Study|did not complete year 4 follow-up|74|||
24926559|NCT00542178|50020029|FG003|Overall Study|did not complete year 4 follow-up|62|||
24926560|NCT00542178|50020030|FG004|Overall Study|did not complete year 4 follow-up|64|||
24926561|NCT00542178|50020031|FG005|Overall Study|did not complete year 4 follow-up|89|||
24926562|NCT00542178|50020032|FG006|Overall Study|did not complete year 4 follow-up|87|||
24926563|NCT00542178|50020033|FG007|Overall Study|did not complete year 4 follow-up|85|||
24926564|NCT00424294|50020049|FG000|Overall Study|Adverse Event|4|||
24926565|NCT00424294|50020050|FG001|Overall Study|Adverse Event|10|||
24926566|NCT00424294|50020049|FG000|Overall Study|Lack of Efficacy|2|||
24926567|NCT00424294|50020050|FG001|Overall Study|Lack of Efficacy|1|||
24926568|NCT00424294|50020049|FG000|Overall Study|Withdrawal by Subject|1|||
24926569|NCT00424294|50020050|FG001|Overall Study|Withdrawal by Subject|2|||
24926570|NCT00424294|50020049|FG000|Overall Study|Other|0|||
24926571|NCT00424294|50020050|FG001|Overall Study|Other|2|||
24926572|NCT00424294|50020049|FG000|Overall Study|Randomized but not Treated|1|||
24926573|NCT00424294|50020050|FG001|Overall Study|Randomized but not Treated|0|||
24926574|NCT00092521|50020059|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
24926575|NCT00092521|50020060|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
24926576|NCT00092521|50020061|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
24926577|NCT00092521|50020062|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
24926578|NCT00092521|50020059|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
24926579|NCT00092521|50020060|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
24926580|NCT00092521|50020061|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
24926581|NCT00092521|50020062|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
24926582|NCT00092521|50020059|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
24926583|NCT00092521|50020060|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
25024967|NCT03401112|50122425|FG004|Overall Study|Not Dosed|0|||
25024968|NCT03401112|50122421|FG000|Overall Study|Missed Clinical Visit|0|||
25024969|NCT03401112|50122422|FG001|Overall Study|Missed Clinical Visit|0|||
25024970|NCT03401112|50122423|FG002|Overall Study|Missed Clinical Visit|1|||
25024971|NCT03401112|50122424|FG003|Overall Study|Missed Clinical Visit|0|||
25024972|NCT03401112|50122425|FG004|Overall Study|Missed Clinical Visit|0|||
25024973|NCT03401112|50122421|FG000|Overall Study|Missed Doses|0|||
25024974|NCT03401112|50122422|FG001|Overall Study|Missed Doses|0|||
25024975|NCT03401112|50122423|FG002|Overall Study|Missed Doses|1|||
24926584|NCT00092521|50020061|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
24926585|NCT00092521|50020062|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
24926586|NCT00092521|50020059|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
24926587|NCT00092521|50020060|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
24926588|NCT00092521|50020061|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
24926589|NCT00092521|50020062|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
24926590|NCT00092521|50020059|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
24926591|NCT00092521|50020060|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
24926592|NCT00092521|50020061|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
25024976|NCT03401112|50122424|FG003|Overall Study|Missed Doses|0|||
25024977|NCT03401112|50122425|FG004|Overall Study|Missed Doses|0|||
24926593|NCT00092521|50020062|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
24926594|NCT00092521|50020059|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
24926595|NCT00092521|50020060|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
24926596|NCT00092521|50020061|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
24926597|NCT00092521|50020062|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
24926598|NCT00092521|50020059|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
24926599|NCT00092521|50020060|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
24926600|NCT00092521|50020061|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
24926601|NCT00092521|50020062|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
24926602|NCT00092521|50020059|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
24926603|NCT00092521|50020060|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
24926604|NCT00092521|50020061|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
24926605|NCT00092521|50020062|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
24926606|NCT00092521|50020059|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
24926607|NCT00092521|50020060|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
24926608|NCT00092521|50020061|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
24926609|NCT00092521|50020062|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
24926610|NCT00092521|50020059|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
24926611|NCT00092521|50020060|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
24926612|NCT00092521|50020061|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
24926613|NCT00092521|50020062|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
24926614|NCT00092521|50020059|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
24926615|NCT00092521|50020060|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
24926616|NCT00092521|50020061|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
24926617|NCT00092521|50020062|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
24926618|NCT00092521|50020059|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
24926619|NCT00092521|50020060|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
24926620|NCT00092521|50020061|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
24926621|NCT00092521|50020062|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
24926622|NCT00092521|50020059|FG000|Follow-Up (After Month 7)|Death|2|||
24926623|NCT00092521|50020060|FG001|Follow-Up (After Month 7)|Death|0|||
24926624|NCT00092521|50020061|FG002|Follow-Up (After Month 7)|Death|1|||
24926625|NCT00092521|50020062|FG003|Follow-Up (After Month 7)|Death|0|||
24926626|NCT00092521|50020059|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
24926627|NCT00092521|50020060|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
24926628|NCT00092521|50020061|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
24926629|NCT00092521|50020062|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
24926630|NCT00092521|50020059|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
24926631|NCT00092521|50020060|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
24926632|NCT00092521|50020061|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
24926633|NCT00092521|50020062|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
24926634|NCT00092521|50020059|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
24926635|NCT00092521|50020060|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
24926636|NCT00092521|50020061|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
24926637|NCT00092521|50020062|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
24926638|NCT00092521|50020059|FG000|Follow-Up (After Month 7)|Moved|32|||
25024978|NCT02697916|50122454|FG000|Overall Study|Death|357|||
25024979|NCT02697916|50122455|FG001|Overall Study|Death|315|||
25024980|NCT02697916|50122454|FG000|Overall Study|Withdrawal by Subject|221|||
25024981|NCT02697916|50122455|FG001|Overall Study|Withdrawal by Subject|393|||
25024982|NCT03650387|50122461|FG000|Overall Study|Withdrawal by Subject|13|||
25024983|NCT03650387|50122461|FG000|Overall Study|Lost to Follow-up|12|||
25024984|NCT03650387|50122461|FG000|Overall Study|Adverse Event (Not related)|1|||
25024985|NCT03650387|50122461|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
25024986|NCT03359473|50122487|FG000|Overall Study|Adverse Event|0|||
25024987|NCT03359473|50122488|FG001|Overall Study|Adverse Event|2|||
25024988|NCT03359473|50122489|FG002|Overall Study|Adverse Event|5|||
25024989|NCT03359473|50122490|FG003|Overall Study|Adverse Event|3|||
25024990|NCT03359473|50122487|FG000|Overall Study|Lost to Follow-up|0|||
25024991|NCT03359473|50122488|FG001|Overall Study|Lost to Follow-up|1|||
25024992|NCT03359473|50122489|FG002|Overall Study|Lost to Follow-up|0|||
25024993|NCT03359473|50122490|FG003|Overall Study|Lost to Follow-up|0|||
25024994|NCT03359473|50122487|FG000|Overall Study|Physician Decision|0|||
25024995|NCT03359473|50122488|FG001|Overall Study|Physician Decision|1|||
24926639|NCT00092521|50020060|FG001|Follow-Up (After Month 7)|Moved|2|||
24926640|NCT00092521|50020061|FG002|Follow-Up (After Month 7)|Moved|28|||
25024996|NCT03359473|50122489|FG002|Overall Study|Physician Decision|0|||
25024997|NCT03359473|50122490|FG003|Overall Study|Physician Decision|1|||
25024998|NCT03359473|50122487|FG000|Overall Study|Withdrawal by Subject|1|||
24926641|NCT00092521|50020062|FG003|Follow-Up (After Month 7)|Moved|0|||
24926642|NCT00092521|50020059|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
25024999|NCT03359473|50122488|FG001|Overall Study|Withdrawal by Subject|2|||
25025000|NCT03359473|50122489|FG002|Overall Study|Withdrawal by Subject|1|||
25025001|NCT03359473|50122490|FG003|Overall Study|Withdrawal by Subject|0|||
25025002|NCT03359473|50122487|FG000|Overall Study|Protocol-defined stopping criteria|1|||
25025003|NCT03359473|50122488|FG001|Overall Study|Protocol-defined stopping criteria|0|||
25025004|NCT03359473|50122489|FG002|Overall Study|Protocol-defined stopping criteria|0|||
25025005|NCT03359473|50122490|FG003|Overall Study|Protocol-defined stopping criteria|1|||
25025006|NCT03589469|50122503|FG000|Overall Study|Ongoing in study|58|||
25025007|NCT03589469|50122503|FG000|Overall Study|Withdrawal by Subject|6|||
25025008|NCT03589469|50122503|FG000|Overall Study|Physician Decision|1|||
25025009|NCT03589469|50122503|FG000|Overall Study|Death|77|||
25025010|NCT03589469|50122503|FG000|Overall Study|Lost to Follow-up|3|||
25025011|NCT03359395|50122509|FG000|First Intervention A / B|Withdrawal by Subject|1|||
25025012|NCT03359395|50122510|FG001|First Intervention A / B|Withdrawal by Subject|0|||
25025013|NCT03359395|50122509|FG000|First Intervention A / B|Lost to Follow-up|2|||
25025014|NCT03359395|50122510|FG001|First Intervention A / B|Lost to Follow-up|3|||
25025015|NCT03359395|50122509|FG000|Second Intervention B/A|Exclusion criteria|0|||
25025016|NCT03359395|50122510|FG001|Second Intervention B/A|Exclusion criteria|1|||
25025017|NCT03359395|50122509|FG000|Second Intervention B/A|Lost to Follow-up|3|||
25025018|NCT03359395|50122510|FG001|Second Intervention B/A|Lost to Follow-up|2|||
25025019|NCT03586427|50122521|FG000|Overall Study|Lost to Follow-up|0|||
25025020|NCT03586427|50122522|FG001|Overall Study|Lost to Follow-up|3|||
25025021|NCT03586427|50122523|FG002|Overall Study|Lost to Follow-up|1|||
25025022|NCT03586427|50122524|FG003|Overall Study|Lost to Follow-up|3|||
25025023|NCT03586427|50122525|FG004|Overall Study|Lost to Follow-up|3|||
25025024|NCT03586427|50122521|FG000|Overall Study|Withdrawal by Subject|0|||
25025025|NCT03586427|50122522|FG001|Overall Study|Withdrawal by Subject|1|||
25025026|NCT03586427|50122523|FG002|Overall Study|Withdrawal by Subject|2|||
25025027|NCT03586427|50122524|FG003|Overall Study|Withdrawal by Subject|1|||
25025028|NCT03586427|50122525|FG004|Overall Study|Withdrawal by Subject|1|||
25025029|NCT03586427|50122521|FG000|Overall Study|Adverse Event|0|||
25025030|NCT03586427|50122522|FG001|Overall Study|Adverse Event|0|||
24926643|NCT00092521|50020060|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
24926644|NCT00092521|50020061|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
24926645|NCT00092521|50020062|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
24926646|NCT00092521|50020059|FG000|Follow-Up (After Month 7)|Travel|2|||
24926647|NCT00092521|50020060|FG001|Follow-Up (After Month 7)|Travel|0|||
24926648|NCT00092521|50020061|FG002|Follow-Up (After Month 7)|Travel|0|||
24926649|NCT00092521|50020062|FG003|Follow-Up (After Month 7)|Travel|0|||
24926650|NCT00092521|50020059|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
24926651|NCT00092521|50020060|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
24926652|NCT00092521|50020061|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
24926653|NCT00092521|50020062|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
24926654|NCT00092521|50020059|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
24926655|NCT00092521|50020060|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
24926656|NCT00092521|50020061|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
24926657|NCT00092521|50020062|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
24926658|NCT00092521|50020059|FG000|Extension Study (Group 4)|Adverse Event|0|||
24926659|NCT00092521|50020060|FG001|Extension Study (Group 4)|Adverse Event|0|||
24926660|NCT00092521|50020061|FG002|Extension Study (Group 4)|Adverse Event|0|||
24926661|NCT00092521|50020062|FG003|Extension Study (Group 4)|Adverse Event|2|||
24926662|NCT00092521|50020059|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
24926663|NCT00092521|50020060|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
24926664|NCT00092521|50020061|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
24926665|NCT00092521|50020062|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
24926666|NCT00092521|50020059|FG000|Extension Study (Group 4)|Pregnancy|0|||
24926667|NCT00092521|50020060|FG001|Extension Study (Group 4)|Pregnancy|0|||
24926668|NCT00092521|50020061|FG002|Extension Study (Group 4)|Pregnancy|0|||
24926669|NCT00092521|50020062|FG003|Extension Study (Group 4)|Pregnancy|4|||
24926670|NCT00092521|50020059|FG000|Extension Study (Group 4)|Protocol Violation|0|||
24926671|NCT00092521|50020060|FG001|Extension Study (Group 4)|Protocol Violation|0|||
24926672|NCT00092521|50020061|FG002|Extension Study (Group 4)|Protocol Violation|0|||
24926673|NCT00092521|50020062|FG003|Extension Study (Group 4)|Protocol Violation|2|||
24926674|NCT00092521|50020059|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
24926675|NCT00092521|50020060|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
24926676|NCT00092521|50020061|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
24926677|NCT00092521|50020062|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
24926678|NCT00092521|50020059|FG000|Extension Study (Group 4)|Moved|0|||
24926679|NCT00092521|50020060|FG001|Extension Study (Group 4)|Moved|0|||
25025031|NCT03586427|50122523|FG002|Overall Study|Adverse Event|1|||
25025032|NCT03586427|50122524|FG003|Overall Study|Adverse Event|0|||
25025033|NCT03586427|50122525|FG004|Overall Study|Adverse Event|0|||
25025034|NCT03586427|50122521|FG000|Overall Study|Protocol Violation|0|||
25025035|NCT03586427|50122522|FG001|Overall Study|Protocol Violation|0|||
24926680|NCT00092521|50020061|FG002|Extension Study (Group 4)|Moved|0|||
25025036|NCT03586427|50122523|FG002|Overall Study|Protocol Violation|1|||
25025037|NCT03586427|50122524|FG003|Overall Study|Protocol Violation|0|||
24926681|NCT00092521|50020062|FG003|Extension Study (Group 4)|Moved|16|||
24926682|NCT00092521|50020059|FG000|Extension Study (Group 4)|Site Terminated|0|||
24926683|NCT00092521|50020060|FG001|Extension Study (Group 4)|Site Terminated|0|||
24926684|NCT00092521|50020061|FG002|Extension Study (Group 4)|Site Terminated|0|||
24926685|NCT00092521|50020062|FG003|Extension Study (Group 4)|Site Terminated|4|||
24926686|NCT00092521|50020059|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
24926687|NCT00092521|50020060|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
24926688|NCT00092521|50020061|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
24926689|NCT00092521|50020062|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
24926690|NCT03908970|50020072|FG000|Overall Study|Adverse Event|7|||
24926691|NCT03908970|50020073|FG001|Overall Study|Adverse Event|21|||
24926692|NCT03908970|50020072|FG000|Overall Study|Physician Decision|1|||
24926693|NCT03908970|50020073|FG001|Overall Study|Physician Decision|4|||
24926694|NCT03908970|50020072|FG000|Overall Study|Withdrawal by Subject|9|||
24926695|NCT03908970|50020073|FG001|Overall Study|Withdrawal by Subject|22|||
24926696|NCT00092443|50020081|FG000|Overall Study|Adverse Event|9|||
24926697|NCT00092443|50020082|FG001|Overall Study|Adverse Event|13|||
24926698|NCT00092443|50020081|FG000|Overall Study|Lost to Follow-up|7|||
24926699|NCT00092443|50020082|FG001|Overall Study|Lost to Follow-up|3|||
24926700|NCT00092443|50020081|FG000|Overall Study|Protocol Violation|11|||
24926701|NCT00092443|50020082|FG001|Overall Study|Protocol Violation|9|||
24926702|NCT00092443|50020081|FG000|Overall Study|Withdrawal by Subject|9|||
24926703|NCT00092443|50020082|FG001|Overall Study|Withdrawal by Subject|11|||
24926704|NCT00092443|50020081|FG000|Overall Study|Moved|5|||
24926705|NCT00092443|50020082|FG001|Overall Study|Moved|5|||
24926706|NCT00092443|50020081|FG000|Overall Study|Other|17|||
24926707|NCT00092443|50020082|FG001|Overall Study|Other|13|||
24926708|NCT00413920|50020100|FG000|Overall Study|Adverse Event|9|||
24926709|NCT00413920|50020101|FG001|Overall Study|Adverse Event|11|||
24926710|NCT00413920|50020100|FG000|Overall Study|Lack of Efficacy|11|||
24926711|NCT00413920|50020101|FG001|Overall Study|Lack of Efficacy|9|||
24926712|NCT00413920|50020100|FG000|Overall Study|Death|3|||
24926713|NCT00413920|50020101|FG001|Overall Study|Death|5|||
24926714|NCT00413920|50020100|FG000|Overall Study|Graft Loss|5|||
24926715|NCT00413920|50020101|FG001|Overall Study|Graft Loss|3|||
24926716|NCT00091819|50020109|FG000|Overall Study|Adverse Event|1|||
24926717|NCT00091819|50020110|FG001|Overall Study|Adverse Event|1|||
24926718|NCT00091819|50020109|FG000|Overall Study|Death|4|||
24926719|NCT00091819|50020110|FG001|Overall Study|Death|5|||
24926720|NCT00091819|50020109|FG000|Overall Study|Lost to Follow-up|26|||
24926721|NCT00091819|50020110|FG001|Overall Study|Lost to Follow-up|23|||
24926722|NCT00091819|50020109|FG000|Overall Study|Withdrawal by Subject|5|||
24926723|NCT00091819|50020110|FG001|Overall Study|Withdrawal by Subject|8|||
24926724|NCT00091819|50020109|FG000|Overall Study|Protocol Violation|1|||
24926725|NCT00091819|50020110|FG001|Overall Study|Protocol Violation|2|||
24926726|NCT00091819|50020109|FG000|Overall Study|Other|2|||
24926727|NCT00091819|50020110|FG001|Overall Study|Other|3|||
24926728|NCT00091819|50020109|FG000|Overall Study|Never received study treatment|3|||
25025038|NCT03586427|50122525|FG004|Overall Study|Protocol Violation|1|||
25025039|NCT03586427|50122521|FG000|Overall Study|Noncompliance with study drug|0|||
25025040|NCT03586427|50122522|FG001|Overall Study|Noncompliance with study drug|0|||
25025041|NCT03586427|50122523|FG002|Overall Study|Noncompliance with study drug|1|||
25025042|NCT03586427|50122524|FG003|Overall Study|Noncompliance with study drug|0|||
25025043|NCT03586427|50122525|FG004|Overall Study|Noncompliance with study drug|0|||
25025044|NCT03648983|50122542|FG000|Overall Study|Study was terminated due to PI departure|95|||
25025045|NCT02695420|50122551|FG000|Overall Study|Death|0|||
25025046|NCT02695420|50122552|FG001|Overall Study|Death|1|||
25025047|NCT02695420|50122553|FG002|Overall Study|Death|0|||
25025048|NCT02695420|50122554|FG003|Overall Study|Death|0|||
25025049|NCT03358147|50122572|FG000|Overall Study|Withdrawal by Subject|13|||
25025050|NCT03358147|50122573|FG001|Overall Study|Withdrawal by Subject|19|||
24926729|NCT00091819|50020110|FG001|Overall Study|Never received study treatment|4|||
24926730|NCT00540228|50020121|FG000|Overall Study|Adverse Event|2|||
24926731|NCT00540228|50020122|FG001|Overall Study|Adverse Event|0|||
24926732|NCT00540228|50020123|FG002|Overall Study|Adverse Event|0|||
24926733|NCT00540228|50020124|FG003|Overall Study|Adverse Event|0|||
24926734|NCT00540228|50020125|FG004|Overall Study|Adverse Event|0|||
24926735|NCT00540228|50020121|FG000|Overall Study|Lost to Follow-up|1|||
24926736|NCT00540228|50020122|FG001|Overall Study|Lost to Follow-up|1|||
24926737|NCT00540228|50020123|FG002|Overall Study|Lost to Follow-up|0|||
24926738|NCT00540228|50020124|FG003|Overall Study|Lost to Follow-up|0|||
25025051|NCT03358147|50122574|FG002|Overall Study|Withdrawal by Subject|16|||
25025052|NCT03358147|50122575|FG003|Overall Study|Withdrawal by Subject|10|||
24926739|NCT00540228|50020125|FG004|Overall Study|Lost to Follow-up|0|||
24926740|NCT05013385|50020150|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
24926741|NCT04474366|50020166|FG000|Overall Study|Lost to Follow-up|2|||
24926742|NCT04474366|50020167|FG001|Overall Study|Lost to Follow-up|5|||
24926743|NCT04250636|50020191|FG000|Overall Study|Lost to Follow-up|2|||
24926744|NCT03989115|50020203|FG000|Overall Study|Withdrawal by Subject|2|||
25025053|NCT03358147|50122576|FG004|Overall Study|Withdrawal by Subject|5|||
25025054|NCT03358147|50122572|FG000|Overall Study|Adverse Event|3|||
25025055|NCT03358147|50122573|FG001|Overall Study|Adverse Event|9|||
25025056|NCT03358147|50122574|FG002|Overall Study|Adverse Event|7|||
25025057|NCT03358147|50122575|FG003|Overall Study|Adverse Event|5|||
25025058|NCT03358147|50122576|FG004|Overall Study|Adverse Event|2|||
25025059|NCT03358147|50122572|FG000|Overall Study|Lost to Follow-up|4|||
25025060|NCT03358147|50122573|FG001|Overall Study|Lost to Follow-up|3|||
25025061|NCT03358147|50122574|FG002|Overall Study|Lost to Follow-up|7|||
25025062|NCT03358147|50122575|FG003|Overall Study|Lost to Follow-up|6|||
25025063|NCT03358147|50122576|FG004|Overall Study|Lost to Follow-up|4|||
25025064|NCT03358147|50122572|FG000|Overall Study|Major Protocol Deviation|11|||
25025065|NCT03358147|50122573|FG001|Overall Study|Major Protocol Deviation|3|||
25025066|NCT03358147|50122574|FG002|Overall Study|Major Protocol Deviation|2|||
25025067|NCT03358147|50122575|FG003|Overall Study|Major Protocol Deviation|3|||
25025068|NCT03358147|50122576|FG004|Overall Study|Major Protocol Deviation|1|||
25025069|NCT03358147|50122572|FG000|Overall Study|Protocol specified criteria|2|||
25025070|NCT03358147|50122573|FG001|Overall Study|Protocol specified criteria|3|||
25025071|NCT03358147|50122574|FG002|Overall Study|Protocol specified criteria|0|||
25025072|NCT03358147|50122575|FG003|Overall Study|Protocol specified criteria|3|||
25025073|NCT03358147|50122576|FG004|Overall Study|Protocol specified criteria|1|||
25025074|NCT03358147|50122572|FG000|Overall Study|Physician Decision|1|||
25025075|NCT03358147|50122573|FG001|Overall Study|Physician Decision|0|||
25025076|NCT03358147|50122574|FG002|Overall Study|Physician Decision|1|||
25025077|NCT03358147|50122575|FG003|Overall Study|Physician Decision|6|||
25025078|NCT03358147|50122576|FG004|Overall Study|Physician Decision|1|||
25025079|NCT03358147|50122572|FG000|Overall Study|Administrative reasons|0|||
25025080|NCT03358147|50122573|FG001|Overall Study|Administrative reasons|1|||
25025081|NCT03358147|50122574|FG002|Overall Study|Administrative reasons|0|||
25025082|NCT03358147|50122575|FG003|Overall Study|Administrative reasons|3|||
25025083|NCT03358147|50122576|FG004|Overall Study|Administrative reasons|0|||
25025084|NCT03358147|50122572|FG000|Overall Study|Lack of Efficacy|0|||
25025085|NCT03358147|50122573|FG001|Overall Study|Lack of Efficacy|1|||
25025086|NCT03358147|50122574|FG002|Overall Study|Lack of Efficacy|1|||
25025087|NCT03358147|50122575|FG003|Overall Study|Lack of Efficacy|0|||
25025088|NCT03358147|50122576|FG004|Overall Study|Lack of Efficacy|0|||
25025089|NCT03093402|50122592|FG000|Overall Study|Lost to Follow-up|1|||
25025090|NCT03093402|50122593|FG001|Overall Study|Lost to Follow-up|0|||
25025091|NCT03093402|50122594|FG002|Overall Study|Lost to Follow-up|0|||
25025092|NCT03093402|50122595|FG003|Overall Study|Lost to Follow-up|0|||
25025093|NCT03093402|50122592|FG000|Overall Study|Withdrawal by Subject|3|||
25025094|NCT03093402|50122593|FG001|Overall Study|Withdrawal by Subject|3|||
25025095|NCT03093402|50122594|FG002|Overall Study|Withdrawal by Subject|0|||
25025096|NCT03093402|50122595|FG003|Overall Study|Withdrawal by Subject|1|||
25025097|NCT03093402|50122592|FG000|Overall Study|Withdrew prior to dosing|2|||
25025098|NCT03093402|50122593|FG001|Overall Study|Withdrew prior to dosing|1|||
25025099|NCT03093402|50122594|FG002|Overall Study|Withdrew prior to dosing|2|||
25025100|NCT03093402|50122595|FG003|Overall Study|Withdrew prior to dosing|3|||
25025101|NCT03093402|50122592|FG000|Overall Study|Ineligible for study|1|||
25025102|NCT03093402|50122593|FG001|Overall Study|Ineligible for study|0|||
25025103|NCT03093402|50122594|FG002|Overall Study|Ineligible for study|0|||
25025104|NCT03093402|50122595|FG003|Overall Study|Ineligible for study|0|||
25025105|NCT03093402|50122592|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
25025106|NCT03093402|50122593|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
25025107|NCT03093402|50122594|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
24926745|NCT03989115|50020204|FG001|Overall Study|Withdrawal by Subject|1|||
24926746|NCT03989115|50020205|FG002|Overall Study|Withdrawal by Subject|3|||
24926747|NCT03989115|50020206|FG003|Overall Study|Withdrawal by Subject|0|||
24926748|NCT03989115|50020207|FG004|Overall Study|Withdrawal by Subject|17|||
24926749|NCT03989115|50020208|FG005|Overall Study|Withdrawal by Subject|1|||
24926750|NCT03989115|50020209|FG006|Overall Study|Withdrawal by Subject|0|||
24926751|NCT03989115|50020210|FG007|Overall Study|Withdrawal by Subject|0|||
24926752|NCT03989115|50020203|FG000|Overall Study|Sponsor decision to terminate the study|1|||
24926753|NCT03989115|50020204|FG001|Overall Study|Sponsor decision to terminate the study|1|||
24926754|NCT03989115|50020205|FG002|Overall Study|Sponsor decision to terminate the study|0|||
25025108|NCT03093402|50122595|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
25025109|NCT03585959|50122605|FG000|Overall Study|Physician Decision|1|||
25025110|NCT03585959|50122605|FG000|Overall Study|Unsuccessful Procedure|2|||
25025111|NCT03584789|50122614|FG000|Overall Study|refused EHR permission|19|||
24926755|NCT03989115|50020206|FG003|Overall Study|Sponsor decision to terminate the study|1|||
25025112|NCT03584789|50122615|FG001|Overall Study|refused EHR permission|28|||
25025113|NCT03584789|50122616|FG002|Overall Study|refused EHR permission|23|||
25025114|NCT03584789|50122614|FG000|Overall Study|patients tied to a provider who retired|0|||
25025115|NCT03584789|50122615|FG001|Overall Study|patients tied to a provider who retired|0|||
24926756|NCT03989115|50020207|FG004|Overall Study|Sponsor decision to terminate the study|11|||
24926757|NCT03989115|50020208|FG005|Overall Study|Sponsor decision to terminate the study|0|||
24926758|NCT03989115|50020209|FG006|Overall Study|Sponsor decision to terminate the study|2|||
24926759|NCT03989115|50020210|FG007|Overall Study|Sponsor decision to terminate the study|1|||
24926760|NCT03989115|50020203|FG000|Overall Study|Lost to Follow-up|2|||
24926761|NCT03989115|50020204|FG001|Overall Study|Lost to Follow-up|0|||
24926762|NCT03989115|50020205|FG002|Overall Study|Lost to Follow-up|0|||
24926763|NCT03989115|50020206|FG003|Overall Study|Lost to Follow-up|0|||
24926764|NCT03989115|50020207|FG004|Overall Study|Lost to Follow-up|1|||
24926765|NCT03989115|50020208|FG005|Overall Study|Lost to Follow-up|0|||
24926766|NCT03989115|50020209|FG006|Overall Study|Lost to Follow-up|0|||
24926767|NCT03989115|50020210|FG007|Overall Study|Lost to Follow-up|0|||
24926768|NCT03989115|50020203|FG000|Overall Study|Death|2|||
24926769|NCT03989115|50020204|FG001|Overall Study|Death|2|||
24926770|NCT03989115|50020205|FG002|Overall Study|Death|9|||
24926771|NCT03989115|50020206|FG003|Overall Study|Death|6|||
24926772|NCT03989115|50020207|FG004|Overall Study|Death|31|||
24926773|NCT03989115|50020208|FG005|Overall Study|Death|6|||
24926774|NCT03989115|50020209|FG006|Overall Study|Death|2|||
24926775|NCT03989115|50020210|FG007|Overall Study|Death|3|||
24926776|NCT03989115|50020203|FG000|Overall Study|Other|1|||
24926777|NCT03989115|50020204|FG001|Overall Study|Other|2|||
24926778|NCT03989115|50020205|FG002|Overall Study|Other|0|||
24926779|NCT03989115|50020206|FG003|Overall Study|Other|0|||
24926780|NCT03989115|50020207|FG004|Overall Study|Other|5|||
24926781|NCT03989115|50020208|FG005|Overall Study|Other|0|||
25025116|NCT03584789|50122616|FG002|Overall Study|patients tied to a provider who retired|3|||
25025117|NCT03343639|50122626|FG000|Overall Study|Withdrawal by Subject|10|||
25025118|NCT03343639|50122627|FG001|Overall Study|Withdrawal by Subject|6|||
25025119|NCT03343639|50122626|FG000|Overall Study|Lost to Follow-up|4|||
25025120|NCT03343639|50122627|FG001|Overall Study|Lost to Follow-up|5|||
25155166|NCT01513239|50270423|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
25155167|NCT01513239|50270424|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
25155168|NCT01513239|50270425|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
24926782|NCT03989115|50020209|FG006|Overall Study|Other|0|||
24926783|NCT03989115|50020210|FG007|Overall Study|Other|0|||
24926784|NCT03797898|50020239|FG000|Overall Study|Lost to Follow-up|60|||
24926785|NCT03797898|50020240|FG001|Overall Study|Lost to Follow-up|69|||
24926786|NCT03797898|50020239|FG000|Overall Study|Withdrawal by Subject|9|||
24926787|NCT03797898|50020240|FG001|Overall Study|Withdrawal by Subject|7|||
25025121|NCT03343639|50122626|FG000|Overall Study|Protocol Violation|0|||
24926788|NCT03797898|50020239|FG000|Overall Study|Became ineligible|5|||
24926789|NCT03797898|50020240|FG001|Overall Study|Became ineligible|2|||
24926790|NCT03559192|50020271|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
24926791|NCT03559192|50020272|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
24926792|NCT03559192|50020273|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
24926793|NCT03559192|50020271|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
24926794|NCT03559192|50020272|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
24926795|NCT03559192|50020273|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
24926796|NCT03559192|50020271|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
24926797|NCT03559192|50020272|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
24926798|NCT03559192|50020273|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
24926799|NCT03559192|50020271|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
24926800|NCT03559192|50020272|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
24926801|NCT03559192|50020273|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
24926802|NCT03559192|50020271|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
24926803|NCT03559192|50020272|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
24926804|NCT03559192|50020273|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
24926805|NCT03559192|50020271|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
24926806|NCT03559192|50020272|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
24926807|NCT03559192|50020273|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
24926808|NCT03559192|50020271|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
24926809|NCT03559192|50020272|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
24926810|NCT03559192|50020273|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
24926811|NCT03559192|50020271|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
24926812|NCT03559192|50020272|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
24926813|NCT03559192|50020273|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
24926814|NCT03559192|50020271|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
24926815|NCT03559192|50020272|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
24926816|NCT03559192|50020273|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
24926817|NCT03523585|50020284|FG000|Overall Study|Progressive Disease|174|||
24926818|NCT03523585|50020285|FG001|Overall Study|Progressive Disease|64|||
24926819|NCT03523585|50020286|FG002|Overall Study|Progressive Disease|77|||
24926820|NCT03523585|50020284|FG000|Overall Study|Adverse Event|74|||
24926821|NCT03523585|50020285|FG001|Overall Study|Adverse Event|5|||
24926822|NCT03523585|50020286|FG002|Overall Study|Adverse Event|9|||
24926823|NCT03523585|50020284|FG000|Overall Study|Withdrawal by Subject|30|||
24926824|NCT03523585|50020285|FG001|Overall Study|Withdrawal by Subject|11|||
24926825|NCT03523585|50020286|FG002|Overall Study|Withdrawal by Subject|6|||
24926826|NCT03523585|50020284|FG000|Overall Study|Clinical Progression|23|||
24926827|NCT03523585|50020285|FG001|Overall Study|Clinical Progression|5|||
24926828|NCT03523585|50020286|FG002|Overall Study|Clinical Progression|10|||
24926829|NCT03523585|50020284|FG000|Overall Study|Death|4|||
24926830|NCT03523585|50020285|FG001|Overall Study|Death|0|||
24926831|NCT03523585|50020286|FG002|Overall Study|Death|1|||
24926832|NCT03523585|50020284|FG000|Overall Study|Physician Decision|2|||
24926833|NCT03523585|50020285|FG001|Overall Study|Physician Decision|1|||
24926834|NCT03523585|50020286|FG002|Overall Study|Physician Decision|0|||
24926835|NCT03523585|50020284|FG000|Overall Study|Lost to Follow-up|1|||
24926836|NCT03523585|50020285|FG001|Overall Study|Lost to Follow-up|0|||
24926837|NCT03523585|50020286|FG002|Overall Study|Lost to Follow-up|0|||
24926838|NCT03523585|50020284|FG000|Overall Study|Miscellaneous|1|||
24926839|NCT03523585|50020285|FG001|Overall Study|Miscellaneous|0|||
24926840|NCT03523585|50020286|FG002|Overall Study|Miscellaneous|0|||
24926841|NCT03523585|50020284|FG000|Overall Study|Protocol Deviation|1|||
24926842|NCT03523585|50020285|FG001|Overall Study|Protocol Deviation|0|||
24926843|NCT03523585|50020286|FG002|Overall Study|Protocol Deviation|1|||
24926844|NCT03523585|50020284|FG000|Overall Study|Randomized But Not Treated|2|||
24926845|NCT03523585|50020285|FG001|Overall Study|Randomized But Not Treated|4|||
24926846|NCT03523585|50020286|FG002|Overall Study|Randomized But Not Treated|3|||
24926847|NCT03485911|50020296|FG000|Part 1|Perceived lack of efficacy|1|||
24926848|NCT03485911|50020297|FG001|Part 1|Perceived lack of efficacy|1|||
24926849|NCT03485911|50020298|FG002|Part 1|Perceived lack of efficacy|2|||
24926850|NCT03485911|50020299|FG003|Part 1|Perceived lack of efficacy|0|||
25185537|NCT01500278|50335063|FG000|Week 13 - Week 104|Not completed|0|||
24926851|NCT03485911|50020296|FG000|Part 1|Subject withdrew consent|0|||
24926852|NCT03485911|50020297|FG001|Part 1|Subject withdrew consent|1|||
24926853|NCT03485911|50020298|FG002|Part 1|Subject withdrew consent|0|||
24926854|NCT03485911|50020299|FG003|Part 1|Subject withdrew consent|1|||
24926855|NCT03485911|50020296|FG000|Part 1|Lab abnormalities/AEs|3|||
24926856|NCT03485911|50020297|FG001|Part 1|Lab abnormalities/AEs|1|||
24926857|NCT03485911|50020298|FG002|Part 1|Lab abnormalities/AEs|1|||
24926858|NCT03485911|50020299|FG003|Part 1|Lab abnormalities/AEs|0|||
24926859|NCT03485911|50020296|FG000|Part 1|Withdrew Consent prior to dosing|0|||
24926860|NCT03485911|50020297|FG001|Part 1|Withdrew Consent prior to dosing|0|||
24926861|NCT03485911|50020298|FG002|Part 1|Withdrew Consent prior to dosing|0|||
24926862|NCT03485911|50020299|FG003|Part 1|Withdrew Consent prior to dosing|1|||
24926863|NCT03485911|50020296|FG000|Part 1|Other NOS|0|||
24926864|NCT03485911|50020297|FG001|Part 1|Other NOS|0|||
24926865|NCT03485911|50020298|FG002|Part 1|Other NOS|0|||
24926866|NCT03485911|50020299|FG003|Part 1|Other NOS|1|||
24926867|NCT03485911|50020296|FG000|Part 2|Perceived lack of efficacy|5|||
24926868|NCT03485911|50020297|FG001|Part 2|Perceived lack of efficacy|3|||
24926869|NCT03485911|50020298|FG002|Part 2|Perceived lack of efficacy|0|||
24926870|NCT03485911|50020299|FG003|Part 2|Perceived lack of efficacy|2|||
24926871|NCT03485911|50020296|FG000|Part 2|Subject withdrew consent|1|||
25025122|NCT03343639|50122627|FG001|Overall Study|Protocol Violation|1|||
25025123|NCT03647267|50122635|FG000|Overall Study|Lost to Follow-up|1|||
25025124|NCT03647267|50122636|FG001|Overall Study|Lost to Follow-up|0|||
25025125|NCT03356977|50122644|FG000|Overall Study|Lost to Follow-up|3|||
25025126|NCT03356977|50122644|FG000|Overall Study|Withdrawal by parent/guardian|2|||
25025127|NCT02690974|50122648|FG000|Overall Study|Adverse Event|16|||
25025128|NCT02690974|50122648|FG000|Overall Study|Death|9|||
25025129|NCT02690974|50122648|FG000|Overall Study|Subject/guardian decision|4|||
25025130|NCT02690974|50122648|FG000|Overall Study|Lost to Follow-up|3|||
25025131|NCT02690974|50122648|FG000|Overall Study|Withdrawal of Informed Consent|3|||
25025132|NCT02690974|50122648|FG000|Overall Study|Physician Decision|2|||
25025133|NCT02690974|50122648|FG000|Overall Study|Non-compliance with study treatment|1|||
25025134|NCT02690974|50122648|FG000|Overall Study|Protocol-defined stopping criteria|1|||
25025135|NCT02690974|50122648|FG000|Overall Study|Protocol Deviation|1|||
25025136|NCT03093324|50122654|FG000|Overall Study|Adverse Event|4|||
25025137|NCT03093324|50122655|FG001|Overall Study|Adverse Event|15|||
25025138|NCT03093324|50122654|FG000|Overall Study|Lost to Follow-up|1|||
25025139|NCT03093324|50122655|FG001|Overall Study|Lost to Follow-up|0|||
25025140|NCT03093324|50122654|FG000|Overall Study|Protocol Deviation|2|||
25025141|NCT03093324|50122655|FG001|Overall Study|Protocol Deviation|2|||
25025142|NCT03093324|50122654|FG000|Overall Study|Withdrawal by Subject|2|||
25025143|NCT03093324|50122655|FG001|Overall Study|Withdrawal by Subject|2|||
25155169|NCT01513239|50270426|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
25155170|NCT01513239|50270427|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
25155171|NCT01513239|50270422|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
25155172|NCT01513239|50270423|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
25155173|NCT01513239|50270424|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
25155174|NCT01513239|50270425|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
25155175|NCT01513239|50270426|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
25155176|NCT01513239|50270427|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
25155177|NCT01513239|50270422|FG000|Period 2: 9 Month Extension Phase|Death|0|||
25155178|NCT01513239|50270423|FG001|Period 2: 9 Month Extension Phase|Death|0|||
25155179|NCT01513239|50270424|FG002|Period 2: 9 Month Extension Phase|Death|0|||
25155180|NCT01513239|50270425|FG003|Period 2: 9 Month Extension Phase|Death|2|||
25155181|NCT01513239|50270426|FG004|Period 2: 9 Month Extension Phase|Death|5|||
25155182|NCT01513239|50270427|FG005|Period 2: 9 Month Extension Phase|Death|2|||
25155183|NCT01513239|50270422|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
25155184|NCT01513239|50270423|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
25155185|NCT01513239|50270424|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
25155186|NCT01513239|50270425|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
25155187|NCT01513239|50270426|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
25155188|NCT01513239|50270427|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
25155189|NCT01513239|50270422|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
25155190|NCT01513239|50270423|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
25155191|NCT01513239|50270424|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
25155192|NCT01513239|50270425|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
25155193|NCT01513239|50270426|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
25155194|NCT01513239|50270427|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
24926872|NCT03485911|50020297|FG001|Part 2|Subject withdrew consent|0|||
24926873|NCT03485911|50020298|FG002|Part 2|Subject withdrew consent|2|||
24926874|NCT03485911|50020299|FG003|Part 2|Subject withdrew consent|1|||
24926875|NCT03485911|50020296|FG000|Part 2|Lab abnormalities/AEs|1|||
24926876|NCT03485911|50020297|FG001|Part 2|Lab abnormalities/AEs|2|||
24926877|NCT03485911|50020298|FG002|Part 2|Lab abnormalities/AEs|0|||
24926878|NCT03485911|50020299|FG003|Part 2|Lab abnormalities/AEs|0|||
24926879|NCT03485911|50020296|FG000|Part 2|Other NOS|0|||
25025144|NCT03584009|50122663|FG000|Overall Study|Death|25|||
24926880|NCT03485911|50020297|FG001|Part 2|Other NOS|1|||
25025145|NCT03584009|50122664|FG001|Overall Study|Death|18|||
25025146|NCT03584009|50122663|FG000|Overall Study|Lost to Follow-up|0|||
25025147|NCT03584009|50122664|FG001|Overall Study|Lost to Follow-up|1|||
24926881|NCT03485911|50020298|FG002|Part 2|Other NOS|0|||
24926882|NCT03485911|50020299|FG003|Part 2|Other NOS|0|||
24926883|NCT03485911|50020296|FG000|Part 2|Intercurrent illness/new medical condition|1|||
25025148|NCT03584009|50122663|FG000|Overall Study|Physician Decision|1|||
25155195|NCT01513239|50270422|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
25155196|NCT01513239|50270423|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
24926884|NCT03485911|50020297|FG001|Part 2|Intercurrent illness/new medical condition|0|||
24926885|NCT03485911|50020298|FG002|Part 2|Intercurrent illness/new medical condition|0|||
24926886|NCT03485911|50020299|FG003|Part 2|Intercurrent illness/new medical condition|0|||
24926887|NCT03485911|50020296|FG000|Part 2|Investigator judgement|1|||
25155197|NCT01513239|50270424|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
25185538|NCT01500278|50335064|FG001|Week 13 - Week 104|Not completed|1|||
25185539|NCT01500278|50335063|FG000|Week 13 - Week 104|Death|2|||
25185540|NCT01500278|50335064|FG001|Week 13 - Week 104|Death|4|||
25185541|NCT01500278|50335063|FG000|Week 13 - Week 104|Adverse Event|54|||
25185542|NCT01500278|50335064|FG001|Week 13 - Week 104|Adverse Event|54|||
25185543|NCT00086281|50335087|FG000|Phase 1|Adverse Event|0|||
25185544|NCT00086281|50335088|FG001|Phase 1|Adverse Event|0|||
25185545|NCT00086281|50335089|FG002|Phase 1|Adverse Event|0|||
25185546|NCT00086281|50335090|FG003|Phase 1|Adverse Event|0|||
25185547|NCT00086281|50335091|FG004|Phase 1|Adverse Event|0|||
25185548|NCT00086281|50335092|FG005|Phase 1|Adverse Event|0|||
25185549|NCT00086281|50335093|FG006|Phase 1|Adverse Event|0|||
25185550|NCT00086281|50335094|FG007|Phase 1|Adverse Event|0|||
25185551|NCT00086281|50335095|FG008|Phase 1|Adverse Event|0|||
25185552|NCT00086281|50335096|FG009|Phase 1|Adverse Event|1|||
25185553|NCT00086281|50335097|FG010|Phase 1|Adverse Event|2|||
25185554|NCT00086281|50335098|FG011|Phase 1|Adverse Event|1|||
25185555|NCT00086281|50335099|FG012|Phase 1|Adverse Event|1|||
25185556|NCT00086281|50335100|FG013|Phase 1|Adverse Event|1|||
25185557|NCT00086281|50335101|FG014|Phase 1|Adverse Event|2|||
25185558|NCT00086281|50335087|FG000|Phase 1|Protocol Violation|0|||
25185559|NCT00086281|50335088|FG001|Phase 1|Protocol Violation|0|||
25185560|NCT00086281|50335089|FG002|Phase 1|Protocol Violation|0|||
25185561|NCT00086281|50335090|FG003|Phase 1|Protocol Violation|0|||
25185562|NCT00086281|50335091|FG004|Phase 1|Protocol Violation|0|||
25185563|NCT00086281|50335092|FG005|Phase 1|Protocol Violation|0|||
25185564|NCT00086281|50335093|FG006|Phase 1|Protocol Violation|0|||
25185565|NCT00086281|50335094|FG007|Phase 1|Protocol Violation|0|||
25155198|NCT01513239|50270425|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
25155199|NCT01513239|50270426|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
25155200|NCT01513239|50270427|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
25155201|NCT01544127|50270442|FG000|Overall Study|Lost to Follow-up|4|||
25155202|NCT01544127|50270443|FG001|Overall Study|Lost to Follow-up|2|||
25185566|NCT00086281|50335095|FG008|Phase 1|Protocol Violation|0|||
25185567|NCT00086281|50335096|FG009|Phase 1|Protocol Violation|0|||
25185568|NCT00086281|50335097|FG010|Phase 1|Protocol Violation|1|||
25185569|NCT00086281|50335098|FG011|Phase 1|Protocol Violation|0|||
25155203|NCT01544127|50270444|FG002|Overall Study|Lost to Follow-up|9|||
25155204|NCT01544127|50270442|FG000|Overall Study|Withdrawal by Subject|2|||
25155205|NCT01544127|50270443|FG001|Overall Study|Withdrawal by Subject|2|||
25155206|NCT01544127|50270444|FG002|Overall Study|Withdrawal by Subject|1|||
25155207|NCT01544127|50270442|FG000|Overall Study|Discharged out of catchment area|1|||
25155208|NCT01544127|50270443|FG001|Overall Study|Discharged out of catchment area|1|||
25155209|NCT01544127|50270444|FG002|Overall Study|Discharged out of catchment area|1|||
25155210|NCT01544127|50270442|FG000|Overall Study|Death|1|||
25155211|NCT01544127|50270443|FG001|Overall Study|Death|0|||
25275056|NCT01237223|50589108|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
24926888|NCT03485911|50020297|FG001|Part 2|Investigator judgement|0|||
24926889|NCT03485911|50020298|FG002|Part 2|Investigator judgement|0|||
25155212|NCT01544127|50270444|FG002|Overall Study|Death|0|||
25155213|NCT01544127|50270442|FG000|Overall Study|Jail or Prison|1|||
25155214|NCT01544127|50270443|FG001|Overall Study|Jail or Prison|1|||
25185570|NCT00086281|50335099|FG012|Phase 1|Protocol Violation|0|||
25185571|NCT00086281|50335100|FG013|Phase 1|Protocol Violation|0|||
25185572|NCT00086281|50335101|FG014|Phase 1|Protocol Violation|0|||
25185573|NCT00086281|50335087|FG000|Phase 1|Serious Adverse Event|0|||
25185574|NCT00086281|50335088|FG001|Phase 1|Serious Adverse Event|0|||
25185575|NCT00086281|50335089|FG002|Phase 1|Serious Adverse Event|0|||
25185576|NCT00086281|50335090|FG003|Phase 1|Serious Adverse Event|0|||
25185577|NCT00086281|50335091|FG004|Phase 1|Serious Adverse Event|0|||
25185578|NCT00086281|50335092|FG005|Phase 1|Serious Adverse Event|0|||
24926890|NCT03485911|50020299|FG003|Part 2|Investigator judgement|0|||
24926891|NCT03485911|50020296|FG000|Part 3|Perceived lack of efficacy|2|||
24926892|NCT03485911|50020297|FG001|Part 3|Perceived lack of efficacy|2|||
24926893|NCT03485911|50020298|FG002|Part 3|Perceived lack of efficacy|2|||
24926894|NCT03485911|50020299|FG003|Part 3|Perceived lack of efficacy|0|||
24926895|NCT03485911|50020296|FG000|Part 3|Subject withdrew consent|1|||
24926896|NCT03485911|50020297|FG001|Part 3|Subject withdrew consent|4|||
24926897|NCT03485911|50020298|FG002|Part 3|Subject withdrew consent|0|||
24926898|NCT03485911|50020299|FG003|Part 3|Subject withdrew consent|1|||
24926899|NCT03485911|50020296|FG000|Part 3|Lab abnormalities/AEs|1|||
24926900|NCT03485911|50020297|FG001|Part 3|Lab abnormalities/AEs|1|||
24926901|NCT03485911|50020298|FG002|Part 3|Lab abnormalities/AEs|0|||
24926902|NCT03485911|50020299|FG003|Part 3|Lab abnormalities/AEs|2|||
24926903|NCT03485911|50020296|FG000|Part 3|Other NOS|1|||
24926904|NCT03485911|50020297|FG001|Part 3|Other NOS|1|||
24926905|NCT03485911|50020298|FG002|Part 3|Other NOS|0|||
24926906|NCT03485911|50020299|FG003|Part 3|Other NOS|0|||
24926907|NCT03485911|50020296|FG000|Part 3|Intercurrent illness/new medical condition|0|||
24926908|NCT03485911|50020297|FG001|Part 3|Intercurrent illness/new medical condition|1|||
24926909|NCT03485911|50020298|FG002|Part 3|Intercurrent illness/new medical condition|1|||
24926910|NCT03485911|50020299|FG003|Part 3|Intercurrent illness/new medical condition|0|||
24926911|NCT03485911|50020296|FG000|Part 3|Sponsor discontinuation|1|||
24926912|NCT03485911|50020297|FG001|Part 3|Sponsor discontinuation|0|||
24926913|NCT03485911|50020298|FG002|Part 3|Sponsor discontinuation|0|||
24926914|NCT03485911|50020299|FG003|Part 3|Sponsor discontinuation|0|||
24926915|NCT03485911|50020296|FG000|Part 3|Berotralstat provided by alternative means|13|||
24926916|NCT03485911|50020297|FG001|Part 3|Berotralstat provided by alternative means|13|||
24926917|NCT03485911|50020298|FG002|Part 3|Berotralstat provided by alternative means|7|||
24926918|NCT03485911|50020299|FG003|Part 3|Berotralstat provided by alternative means|7|||
24926919|NCT02933489|50020358|FG000|Overall Study|Ineligible|3|||
24926920|NCT02933489|50020359|FG001|Overall Study|Ineligible|3|||
24926921|NCT02933489|50020358|FG000|Overall Study|Withdrawal by Subject|27|||
24926922|NCT02933489|50020359|FG001|Overall Study|Withdrawal by Subject|18|||
24926923|NCT02933489|50020358|FG000|Overall Study|Unable to complete exams (other)|14|||
24926924|NCT02933489|50020359|FG001|Overall Study|Unable to complete exams (other)|7|||
24926925|NCT02886936|50020395|FG000|Overall Study|Lost to Follow-up|4|||
24926926|NCT02886936|50020396|FG001|Overall Study|Lost to Follow-up|3|||
24926927|NCT02886936|50020397|FG002|Overall Study|Lost to Follow-up|0|||
24926928|NCT02589522|50020410|FG000|Overall Study|Physician Decision|1|||
24926929|NCT02589522|50020411|FG001|Overall Study|Physician Decision|2|||
24926930|NCT02589522|50020412|FG002|Overall Study|Physician Decision|0|||
24926931|NCT02589522|50020410|FG000|Overall Study|Did not start treatment|1|||
24926932|NCT02589522|50020411|FG001|Overall Study|Did not start treatment|0|||
24926933|NCT02589522|50020412|FG002|Overall Study|Did not start treatment|0|||
24926934|NCT02542293|50020422|FG000|Overall Study|Death|367|||
24926935|NCT02542293|50020423|FG001|Overall Study|Death|377|||
24926936|NCT02542293|50020422|FG000|Overall Study|Withdrawal by Subject|8|||
24926937|NCT02542293|50020423|FG001|Overall Study|Withdrawal by Subject|19|||
24926938|NCT02453282|50020439|FG000|Overall Study|Death|275|||
24926939|NCT02453282|50020440|FG001|Overall Study|Death|277|||
24926940|NCT02453282|50020441|FG002|Overall Study|Death|296|||
24926941|NCT02453282|50020439|FG000|Overall Study|Lost to Follow-up|1|||
24926942|NCT02453282|50020440|FG001|Overall Study|Lost to Follow-up|0|||
24926943|NCT02453282|50020441|FG002|Overall Study|Lost to Follow-up|2|||
24926944|NCT02453282|50020439|FG000|Overall Study|Withdrawal by Subject|12|||
24926945|NCT02453282|50020440|FG001|Overall Study|Withdrawal by Subject|10|||
24926946|NCT02453282|50020441|FG002|Overall Study|Withdrawal by Subject|11|||
24926947|NCT02453282|50020439|FG000|Overall Study|Participants ongoing at data cut-off|85|||
24926948|NCT02453282|50020440|FG001|Overall Study|Participants ongoing at data cut-off|84|||
24926949|NCT02453282|50020441|FG002|Overall Study|Participants ongoing at data cut-off|62|||
24926950|NCT02453282|50020439|FG000|Overall Study|Other|1|||
24926951|NCT02453282|50020440|FG001|Overall Study|Other|1|||
24926952|NCT02453282|50020441|FG002|Overall Study|Other|1|||
24926953|NCT02393859|50020453|FG000|Overall Study|Decision by Sponsor|2|||
24926954|NCT02393859|50020454|FG001|Overall Study|Decision by Sponsor|4|||
25155215|NCT01544127|50270444|FG002|Overall Study|Jail or Prison|2|||
25155216|NCT01544127|50270442|FG000|Overall Study|Became Psychotic|1|||
24926955|NCT02393859|50020453|FG000|Overall Study|Withdrawal by Subject|11|||
24926956|NCT02393859|50020454|FG001|Overall Study|Withdrawal by Subject|6|||
24926957|NCT02393859|50020453|FG000|Overall Study|Death|27|||
25155217|NCT01544127|50270443|FG001|Overall Study|Became Psychotic|0|||
25185579|NCT00086281|50335093|FG006|Phase 1|Serious Adverse Event|0|||
24926958|NCT02393859|50020454|FG001|Overall Study|Death|10|||
24926959|NCT02393859|50020453|FG000|Overall Study|Lost to Follow-up|1|||
24926960|NCT02393859|50020454|FG001|Overall Study|Lost to Follow-up|1|||
24926961|NCT02242942|50020477|FG000|Overall Study|Death|17|||
25155218|NCT01544127|50270444|FG002|Overall Study|Became Psychotic|0|||
25185580|NCT00086281|50335094|FG007|Phase 1|Serious Adverse Event|0|||
24926962|NCT02242942|50020478|FG001|Overall Study|Death|20|||
25185581|NCT00086281|50335095|FG008|Phase 1|Serious Adverse Event|0|||
24926963|NCT02242942|50020479|FG002|Overall Study|Death|2|||
24926964|NCT02242942|50020477|FG000|Overall Study|Physician Decision|1|||
24926965|NCT02242942|50020478|FG001|Overall Study|Physician Decision|0|||
24926966|NCT02242942|50020479|FG002|Overall Study|Physician Decision|0|||
24926967|NCT02242942|50020477|FG000|Overall Study|Withdrawal by Subject|8|||
24926968|NCT02242942|50020478|FG001|Overall Study|Withdrawal by Subject|10|||
24926969|NCT02242942|50020479|FG002|Overall Study|Withdrawal by Subject|0|||
24926970|NCT02242942|50020477|FG000|Overall Study|On-going in Study|190|||
24926971|NCT02242942|50020478|FG001|Overall Study|On-going in Study|186|||
24926972|NCT02242942|50020479|FG002|Overall Study|On-going in Study|11|||
24926973|NCT02162511|50020501|FG000|Overall Study|Lack of Efficacy|0|||
24926974|NCT02162511|50020502|FG001|Overall Study|Lack of Efficacy|0|||
24926975|NCT02162511|50020503|FG002|Overall Study|Lack of Efficacy|2|||
24926976|NCT02065869|50020507|FG000|Overall Study|Death|7|||
24926977|NCT02065869|50020507|FG000|Overall Study|Disease relapse|16|||
24926978|NCT02065869|50020507|FG000|Overall Study|Lost to Follow-up|4|||
24926979|NCT02065869|50020507|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
24926980|NCT02065869|50020507|FG000|Overall Study|Withdrawal by Subject|1|||
24964606|NCT00440297|50054426|FG001|Overall Study|Randomized by mistake|0|||
24964607|NCT00432809|50054435|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
25025149|NCT03584009|50122664|FG001|Overall Study|Physician Decision|1|||
25025150|NCT03584009|50122663|FG000|Overall Study|Study Terminated by Sponsor|22|||
25025151|NCT03584009|50122664|FG001|Overall Study|Study Terminated by Sponsor|30|||
25025152|NCT03584009|50122663|FG000|Overall Study|Withdrawal by Subject|3|||
25025153|NCT03584009|50122664|FG001|Overall Study|Withdrawal by Subject|2|||
25025154|NCT04167462|50122675|FG000|Overall Study|Other reasons|3|||
25025155|NCT04167462|50122676|FG001|Overall Study|Other reasons|2|||
25025156|NCT04167462|50122675|FG000|Overall Study|Withdrawal by Subject|6|||
25025157|NCT04167462|50122676|FG001|Overall Study|Withdrawal by Subject|7|||
25025158|NCT04167462|50122675|FG000|Overall Study|Adverse Event|4|||
25025159|NCT04167462|50122676|FG001|Overall Study|Adverse Event|0|||
25025160|NCT04167462|50122675|FG000|Overall Study|Pregnancy|1|||
25025161|NCT04167462|50122676|FG001|Overall Study|Pregnancy|0|||
25025162|NCT04167462|50122675|FG000|Overall Study|Lack of Efficacy|0|||
25025163|NCT04167462|50122676|FG001|Overall Study|Lack of Efficacy|1|||
25025164|NCT03583385|50122683|FG000|Treatment Period 1|Withdrawal by Subject|1|||
25025165|NCT03583385|50122684|FG001|Treatment Period 1|Withdrawal by Subject|1|||
25155219|NCT01544127|50270442|FG000|Overall Study|Researcher withdrew|1|||
25155220|NCT01544127|50270443|FG001|Overall Study|Researcher withdrew|0|||
25155221|NCT01544127|50270444|FG002|Overall Study|Researcher withdrew|0|||
25155222|NCT01544127|50270442|FG000|Overall Study|Went active duty|0|||
25155223|NCT01544127|50270443|FG001|Overall Study|Went active duty|0|||
25155224|NCT01544127|50270444|FG002|Overall Study|Went active duty|1|||
25155225|NCT01512693|50270455|FG000|Overall Study|Withdrawal by Subject|0|||
25155226|NCT01512693|50270456|FG001|Overall Study|Withdrawal by Subject|1|||
25155227|NCT01458340|50270465|FG000|Overall Study|Adverse Event|5|||
25155228|NCT01458340|50270466|FG001|Overall Study|Adverse Event|4|||
25155229|NCT01458340|50270467|FG002|Overall Study|Adverse Event|2|||
25155230|NCT01458340|50270465|FG000|Overall Study|Lost to Follow-up|3|||
25155231|NCT01458340|50270466|FG001|Overall Study|Lost to Follow-up|3|||
25155232|NCT01458340|50270467|FG002|Overall Study|Lost to Follow-up|10|||
25155233|NCT01458340|50270465|FG000|Overall Study|Miscellaneous|0|||
25155234|NCT01458340|50270466|FG001|Overall Study|Miscellaneous|1|||
25275057|NCT01237223|50589109|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
25025166|NCT03583385|50122683|FG000|Treatment Period 2|Adverse Event|1|||
25025167|NCT03583385|50122684|FG001|Treatment Period 2|Adverse Event|0|||
25025168|NCT04350372|50122690|FG000|Overall Study|Death|1|||
25155235|NCT01458340|50270467|FG002|Overall Study|Miscellaneous|0|||
25155236|NCT01458340|50270465|FG000|Overall Study|Physician Decision|1|||
25155237|NCT01458340|50270466|FG001|Overall Study|Physician Decision|1|||
25155238|NCT01458340|50270467|FG002|Overall Study|Physician Decision|2|||
24926981|NCT00539994|50020576|FG000|Overall Study|Lost to Follow-up|2|||
24926982|NCT00539994|50020577|FG001|Overall Study|Lost to Follow-up|1|||
24926983|NCT00539994|50020578|FG002|Overall Study|Lost to Follow-up|0|||
24926984|NCT00539994|50020576|FG000|Overall Study|Withdrawal by Subject|1|||
24926985|NCT00539994|50020577|FG001|Overall Study|Withdrawal by Subject|0|||
24926986|NCT00539994|50020578|FG002|Overall Study|Withdrawal by Subject|1|||
24926987|NCT00539994|50020576|FG000|Overall Study|Physician Decision|0|||
24926988|NCT00539994|50020577|FG001|Overall Study|Physician Decision|0|||
24926989|NCT00539994|50020578|FG002|Overall Study|Physician Decision|1|||
24926990|NCT00098839|50020595|FG000|Overall Study|Adverse Event|5|||
24926991|NCT00098839|50020596|FG001|Overall Study|Adverse Event|2|||
24926992|NCT00098839|50020595|FG000|Overall Study|Death|1|||
25025169|NCT02949973|50122694|FG000|Overall Study|Physician Decision|1|||
25025170|NCT02948959|50122700|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
25025171|NCT02948959|50122701|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
25025172|NCT02948959|50122700|FG000|52 Weeks Treatment Period|Adverse Event|2|||
25025173|NCT02948959|50122701|FG001|52 Weeks Treatment Period|Adverse Event|5|||
25025174|NCT02948959|50122700|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
25025175|NCT02948959|50122701|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
25025176|NCT02948959|50122700|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
25025177|NCT02948959|50122701|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
25025178|NCT02948959|50122700|FG000|52 Weeks Treatment Period|Randomized by error|0|||
25025179|NCT02948959|50122701|FG001|52 Weeks Treatment Period|Randomized by error|5|||
25025180|NCT02948959|50122700|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
25025181|NCT02948959|50122701|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
25025182|NCT02948959|50122700|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
25025183|NCT02948959|50122701|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
25025184|NCT02948959|50122700|FG000|52 Weeks Treatment Period|Change of residence location|0|||
25025185|NCT02948959|50122701|FG001|52 Weeks Treatment Period|Change of residence location|1|||
25025186|NCT02948959|50122700|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
25025187|NCT02948959|50122701|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
25025188|NCT02948959|50122700|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
25025189|NCT02948959|50122701|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
25025190|NCT02948959|50122700|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
25155239|NCT01458340|50270465|FG000|Overall Study|Protocol Violation|6|||
25155240|NCT01458340|50270466|FG001|Overall Study|Protocol Violation|6|||
25155241|NCT01458340|50270467|FG002|Overall Study|Protocol Violation|5|||
24926993|NCT00098839|50020596|FG001|Overall Study|Death|2|||
24926994|NCT00098839|50020595|FG000|Overall Study|Physician Decision|4|||
24926995|NCT00098839|50020596|FG001|Overall Study|Physician Decision|14|||
24926996|NCT00098839|50020595|FG000|Overall Study|Withdrawal by Subject|1|||
24926997|NCT00098839|50020596|FG001|Overall Study|Withdrawal by Subject|0|||
24926998|NCT00098839|50020595|FG000|Overall Study|Refusal of further protocol therapy|3|||
24926999|NCT00098839|50020596|FG001|Overall Study|Refusal of further protocol therapy|1|||
24927000|NCT00098839|50020595|FG000|Overall Study|Relapse|6|||
25025191|NCT02948959|50122701|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
25155242|NCT01458340|50270465|FG000|Overall Study|Withdrawal by Subject|12|||
25155243|NCT01458340|50270466|FG001|Overall Study|Withdrawal by Subject|6|||
24927001|NCT00098839|50020596|FG001|Overall Study|Relapse|3|||
24927002|NCT00098839|50020595|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
24927003|NCT00098839|50020596|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
24927004|NCT00098839|50020595|FG000|Overall Study|Ineligible|2|||
25025192|NCT02948959|50122700|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
25025193|NCT02948959|50122701|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
25025194|NCT02948959|50122700|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
25025195|NCT02948959|50122701|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
24927005|NCT00098839|50020596|FG001|Overall Study|Ineligible|0|||
24927006|NCT03811093|50020605|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
24927007|NCT03811093|50020606|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
24927008|NCT03811093|50020605|FG000|Overall Study|Unable to measure body fat percentage|2|||
24927009|NCT03811093|50020606|FG001|Overall Study|Unable to measure body fat percentage|0|||
24927010|NCT00485589|50020618|FG000|Overall Study|Death|2|||
24927011|NCT00485589|50020619|FG001|Overall Study|Death|2|||
25025196|NCT02948959|50122700|FG000|12 Weeks Follow-up Period|Study site closure|1|||
25025197|NCT02948959|50122701|FG001|12 Weeks Follow-up Period|Study site closure|0|||
25025198|NCT03582215|50122723|FG000|Overall Study|Adverse Event|1|||
24927012|NCT00485589|50020620|FG002|Overall Study|Death|0|||
24927013|NCT00485589|50020618|FG000|Overall Study|Failure to return|6|||
24927014|NCT00485589|50020619|FG001|Overall Study|Failure to return|5|||
24927015|NCT00485589|50020620|FG002|Overall Study|Failure to return|1|||
24927016|NCT00485589|50020618|FG000|Overall Study|Protocol Violation|1|||
24927017|NCT00485589|50020619|FG001|Overall Study|Protocol Violation|0|||
24927018|NCT00485589|50020620|FG002|Overall Study|Protocol Violation|0|||
24927019|NCT00485589|50020618|FG000|Overall Study|Violation of selection criteria at entry|0|||
24927020|NCT00485589|50020619|FG001|Overall Study|Violation of selection criteria at entry|3|||
24927021|NCT00485589|50020620|FG002|Overall Study|Violation of selection criteria at entry|1|||
24927022|NCT00485589|50020618|FG000|Overall Study|Administrative/Other|1|||
24927023|NCT00485589|50020619|FG001|Overall Study|Administrative/Other|2|||
24927024|NCT00485589|50020620|FG002|Overall Study|Administrative/Other|1|||
24927025|NCT00485589|50020618|FG000|Overall Study|Insufficient therapeutic response|10|||
24927026|NCT00485589|50020619|FG001|Overall Study|Insufficient therapeutic response|3|||
24927027|NCT00485589|50020620|FG002|Overall Study|Insufficient therapeutic response|1|||
24927028|NCT00485589|50020618|FG000|Overall Study|Refused treatment/did not cooperate|1|||
24927029|NCT00485589|50020619|FG001|Overall Study|Refused treatment/did not cooperate|0|||
24927030|NCT00485589|50020620|FG002|Overall Study|Refused treatment/did not cooperate|2|||
24927031|NCT00485589|50020618|FG000|Overall Study|Withdrawal by Subject|3|||
24927032|NCT00485589|50020619|FG001|Overall Study|Withdrawal by Subject|2|||
24927033|NCT00485589|50020620|FG002|Overall Study|Withdrawal by Subject|2|||
24927034|NCT00485589|50020618|FG000|Overall Study|Adverse Event|3|||
24927035|NCT00485589|50020619|FG001|Overall Study|Adverse Event|3|||
24927036|NCT00485589|50020620|FG002|Overall Study|Adverse Event|10|||
24927037|NCT00490971|50020639|FG000|Acute/Continuation|Adverse Event|62|||
24927038|NCT00490971|50020640|FG001|Acute/Continuation|Adverse Event|13|||
24927039|NCT00490971|50020641|FG002|Acute/Continuation|Adverse Event|0|||
24927040|NCT00490971|50020642|FG003|Acute/Continuation|Adverse Event|0|||
24927041|NCT00490971|50020643|FG004|Acute/Continuation|Adverse Event|0|||
24927042|NCT00490971|50020639|FG000|Acute/Continuation|Death|2|||
24927043|NCT00490971|50020640|FG001|Acute/Continuation|Death|0|||
24927044|NCT00490971|50020641|FG002|Acute/Continuation|Death|0|||
24927045|NCT00490971|50020642|FG003|Acute/Continuation|Death|0|||
24927046|NCT00490971|50020643|FG004|Acute/Continuation|Death|0|||
24927047|NCT00490971|50020639|FG000|Acute/Continuation|Lack of Efficacy|106|||
24927048|NCT00490971|50020640|FG001|Acute/Continuation|Lack of Efficacy|12|||
24927049|NCT00490971|50020641|FG002|Acute/Continuation|Lack of Efficacy|0|||
24927050|NCT00490971|50020642|FG003|Acute/Continuation|Lack of Efficacy|0|||
24927051|NCT00490971|50020643|FG004|Acute/Continuation|Lack of Efficacy|0|||
24927052|NCT00490971|50020639|FG000|Acute/Continuation|Lost to Follow-up|23|||
24927053|NCT00490971|50020640|FG001|Acute/Continuation|Lost to Follow-up|7|||
24927054|NCT00490971|50020641|FG002|Acute/Continuation|Lost to Follow-up|0|||
24927055|NCT00490971|50020642|FG003|Acute/Continuation|Lost to Follow-up|0|||
24927056|NCT00490971|50020643|FG004|Acute/Continuation|Lost to Follow-up|0|||
24927057|NCT00490971|50020639|FG000|Acute/Continuation|Protocol Violation|10|||
24927058|NCT00490971|50020640|FG001|Acute/Continuation|Protocol Violation|2|||
24927059|NCT00490971|50020641|FG002|Acute/Continuation|Protocol Violation|0|||
24927060|NCT00490971|50020642|FG003|Acute/Continuation|Protocol Violation|0|||
24927061|NCT00490971|50020643|FG004|Acute/Continuation|Protocol Violation|0|||
24927062|NCT00490971|50020639|FG000|Acute/Continuation|Withdrawal by Subject|92|||
24927063|NCT00490971|50020640|FG001|Acute/Continuation|Withdrawal by Subject|24|||
25025199|NCT03582215|50122724|FG001|Overall Study|Adverse Event|0|||
24927064|NCT00490971|50020641|FG002|Acute/Continuation|Withdrawal by Subject|0|||
24927065|NCT00490971|50020642|FG003|Acute/Continuation|Withdrawal by Subject|0|||
24927066|NCT00490971|50020643|FG004|Acute/Continuation|Withdrawal by Subject|0|||
24927067|NCT00490971|50020639|FG000|Acute/Continuation|Other|11|||
24927068|NCT00490971|50020640|FG001|Acute/Continuation|Other|4|||
24927069|NCT00490971|50020641|FG002|Acute/Continuation|Other|0|||
24927070|NCT00490971|50020642|FG003|Acute/Continuation|Other|0|||
24927071|NCT00490971|50020643|FG004|Acute/Continuation|Other|0|||
24927072|NCT00490971|50020639|FG000|Maintenance|Adverse Event|0|||
24927073|NCT00490971|50020640|FG001|Maintenance|Adverse Event|0|||
24927074|NCT00490971|50020641|FG002|Maintenance|Adverse Event|4|||
24927075|NCT00490971|50020642|FG003|Maintenance|Adverse Event|5|||
24927076|NCT00490971|50020643|FG004|Maintenance|Adverse Event|7|||
24927077|NCT00490971|50020639|FG000|Maintenance|Death|0|||
24927078|NCT00490971|50020640|FG001|Maintenance|Death|0|||
24927079|NCT00490971|50020641|FG002|Maintenance|Death|0|||
24927080|NCT00490971|50020642|FG003|Maintenance|Death|2|||
24927081|NCT00490971|50020643|FG004|Maintenance|Death|0|||
25025200|NCT03582215|50122725|FG002|Overall Study|Adverse Event|0|||
25025201|NCT03582215|50122726|FG003|Overall Study|Adverse Event|0|||
25025202|NCT03582215|50122727|FG004|Overall Study|Adverse Event|0|||
25025203|NCT03582215|50122728|FG005|Overall Study|Adverse Event|0|||
25025204|NCT03582215|50122729|FG006|Overall Study|Adverse Event|2|||
25025205|NCT03582215|50122730|FG007|Overall Study|Adverse Event|2|||
25025206|NCT03089580|50122759|FG000|Overall Study|Lost to Follow-up|2|||
25025207|NCT03645395|50122769|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
25025208|NCT03645395|50122770|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
25025209|NCT03645395|50122771|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
25025210|NCT03645395|50122772|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
25025211|NCT03645395|50122769|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
25025212|NCT03645395|50122770|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
25025213|NCT03645395|50122771|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
25025214|NCT03645395|50122772|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
25025215|NCT03645395|50122769|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
25025216|NCT03645395|50122770|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
25025217|NCT03645395|50122771|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
25025218|NCT03645395|50122772|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
25025219|NCT03645395|50122769|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
25025220|NCT03645395|50122770|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
25025221|NCT03645395|50122771|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
25025222|NCT03645395|50122772|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
25025223|NCT03342469|50122785|FG000|Overall Study|Withdrawal by Subject|0|||
25025224|NCT03342469|50122786|FG001|Overall Study|Withdrawal by Subject|1|||
25025225|NCT03342469|50122787|FG002|Overall Study|Withdrawal by Subject|0|||
25025226|NCT03342469|50122788|FG003|Overall Study|Withdrawal by Subject|0|||
25025227|NCT03581825|50122799|FG000|Period 1|Lens Discomfort|1|||
24927082|NCT00490971|50020639|FG000|Maintenance|Lost to Follow-up|0|||
24927083|NCT00490971|50020640|FG001|Maintenance|Lost to Follow-up|0|||
24927084|NCT00490971|50020641|FG002|Maintenance|Lost to Follow-up|5|||
24927085|NCT00490971|50020642|FG003|Maintenance|Lost to Follow-up|8|||
24927086|NCT00490971|50020643|FG004|Maintenance|Lost to Follow-up|10|||
24927087|NCT00490971|50020639|FG000|Maintenance|Pregnancy|0|||
24927088|NCT00490971|50020640|FG001|Maintenance|Pregnancy|0|||
24927089|NCT00490971|50020641|FG002|Maintenance|Pregnancy|1|||
24927090|NCT00490971|50020642|FG003|Maintenance|Pregnancy|0|||
24927091|NCT00490971|50020643|FG004|Maintenance|Pregnancy|0|||
24927092|NCT00490971|50020639|FG000|Maintenance|Protocol Violation|0|||
24927093|NCT00490971|50020640|FG001|Maintenance|Protocol Violation|0|||
24927094|NCT00490971|50020641|FG002|Maintenance|Protocol Violation|4|||
24927095|NCT00490971|50020642|FG003|Maintenance|Protocol Violation|1|||
24927096|NCT00490971|50020643|FG004|Maintenance|Protocol Violation|1|||
24927097|NCT00490971|50020639|FG000|Maintenance|Withdrawal by Subject|0|||
24927098|NCT00490971|50020640|FG001|Maintenance|Withdrawal by Subject|0|||
25025228|NCT03581825|50122800|FG001|Period 1|Lens Discomfort|0|||
25025229|NCT03581825|50122799|FG000|Period 2|Unsatisfactory Vision to Test|0|||
25025230|NCT03581825|50122800|FG001|Period 2|Unsatisfactory Vision to Test|1|||
25025231|NCT03342001|50122806|FG000|Overall Study|Adverse Event|1|||
24927099|NCT00490971|50020641|FG002|Maintenance|Withdrawal by Subject|26|||
24927100|NCT00490971|50020642|FG003|Maintenance|Withdrawal by Subject|28|||
24927101|NCT00490971|50020643|FG004|Maintenance|Withdrawal by Subject|18|||
24927102|NCT00490971|50020639|FG000|Maintenance|Other|0|||
24927103|NCT00490971|50020640|FG001|Maintenance|Other|0|||
24927104|NCT00490971|50020641|FG002|Maintenance|Other|11|||
24927105|NCT00490971|50020642|FG003|Maintenance|Other|9|||
24927106|NCT00490971|50020643|FG004|Maintenance|Other|3|||
24927107|NCT00686075|50020665|FG000|Overall Study|Withdrawal by Subject|4|||
24927108|NCT00686075|50020666|FG001|Overall Study|Withdrawal by Subject|3|||
24927109|NCT00686075|50020667|FG002|Overall Study|Withdrawal by Subject|3|||
24927110|NCT00686075|50020668|FG003|Overall Study|Withdrawal by Subject|7|||
24927111|NCT00686075|50020669|FG004|Overall Study|Withdrawal by Subject|1|||
24927112|NCT00686075|50020670|FG005|Overall Study|Withdrawal by Subject|0|||
24927113|NCT00686075|50020671|FG006|Overall Study|Withdrawal by Subject|0|||
24927114|NCT00686075|50020672|FG007|Overall Study|Withdrawal by Subject|2|||
24927115|NCT00686075|50020673|FG008|Overall Study|Withdrawal by Subject|4|||
24927116|NCT00686075|50020674|FG009|Overall Study|Withdrawal by Subject|6|||
24927117|NCT00686075|50020665|FG000|Overall Study|Lost to Follow-up|3|||
24927118|NCT00686075|50020666|FG001|Overall Study|Lost to Follow-up|6|||
24927119|NCT00686075|50020667|FG002|Overall Study|Lost to Follow-up|3|||
24927120|NCT00686075|50020668|FG003|Overall Study|Lost to Follow-up|2|||
24927121|NCT00686075|50020669|FG004|Overall Study|Lost to Follow-up|3|||
24927122|NCT00686075|50020670|FG005|Overall Study|Lost to Follow-up|3|||
24927123|NCT00686075|50020671|FG006|Overall Study|Lost to Follow-up|0|||
24927124|NCT00686075|50020672|FG007|Overall Study|Lost to Follow-up|0|||
24927125|NCT00686075|50020673|FG008|Overall Study|Lost to Follow-up|2|||
24927126|NCT00686075|50020674|FG009|Overall Study|Lost to Follow-up|3|||
24927127|NCT00686075|50020665|FG000|Overall Study|Other|1|||
24927128|NCT00686075|50020666|FG001|Overall Study|Other|1|||
24927129|NCT00686075|50020667|FG002|Overall Study|Other|0|||
24927130|NCT00686075|50020668|FG003|Overall Study|Other|0|||
24927131|NCT00686075|50020669|FG004|Overall Study|Other|0|||
24927132|NCT00686075|50020670|FG005|Overall Study|Other|0|||
24927133|NCT00686075|50020671|FG006|Overall Study|Other|0|||
24927134|NCT00686075|50020672|FG007|Overall Study|Other|0|||
24927135|NCT00686075|50020673|FG008|Overall Study|Other|0|||
24927136|NCT00686075|50020674|FG009|Overall Study|Other|1|||
24927137|NCT00685763|50020696|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
24927138|NCT00685763|50020696|FG000|Overall Study|Protocol Violation|1|||
24927139|NCT00098293|50020703|FG000|Double-blind (DB) Phase|Adverse Event|14|||
24927140|NCT00098293|50020704|FG001|Double-blind (DB) Phase|Adverse Event|27|||
24927141|NCT00098293|50020705|FG002|Double-blind (DB) Phase|Adverse Event|60|||
24927142|NCT00098293|50020706|FG003|Double-blind (DB) Phase|Adverse Event|0|||
24927143|NCT00098293|50020707|FG004|Double-blind (DB) Phase|Adverse Event|0|||
24927144|NCT00098293|50020703|FG000|Double-blind (DB) Phase|Pregnancy|0|||
24927145|NCT00098293|50020704|FG001|Double-blind (DB) Phase|Pregnancy|7|||
24927146|NCT00098293|50020705|FG002|Double-blind (DB) Phase|Pregnancy|9|||
24927147|NCT00098293|50020706|FG003|Double-blind (DB) Phase|Pregnancy|0|||
24927148|NCT00098293|50020707|FG004|Double-blind (DB) Phase|Pregnancy|0|||
24927149|NCT00098293|50020703|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
24927150|NCT00098293|50020704|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
24927151|NCT00098293|50020705|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
24927152|NCT00098293|50020706|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
24927153|NCT00098293|50020707|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
24927154|NCT00098293|50020703|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
24927155|NCT00098293|50020704|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
24927156|NCT00098293|50020705|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
24927157|NCT00098293|50020706|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
24927158|NCT00098293|50020707|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
24927159|NCT00098293|50020703|FG000|Double-blind (DB) Phase|Death|1|||
24927160|NCT00098293|50020704|FG001|Double-blind (DB) Phase|Death|2|||
24927161|NCT00098293|50020705|FG002|Double-blind (DB) Phase|Death|2|||
24927162|NCT00098293|50020706|FG003|Double-blind (DB) Phase|Death|0|||
24927163|NCT00098293|50020707|FG004|Double-blind (DB) Phase|Death|0|||
24927164|NCT00098293|50020703|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
25025232|NCT03342001|50122806|FG000|Overall Study|Lost to Follow-up|1|||
25025233|NCT03341923|50122810|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
25025234|NCT03341923|50122811|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
25025235|NCT03579719|50122819|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
25025236|NCT03341533|50122825|FG000|Overall Study|Withdrawal by Subject|1|||
24927165|NCT00098293|50020704|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
24927166|NCT00098293|50020705|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
24927167|NCT00098293|50020706|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
24927168|NCT00098293|50020707|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
25025237|NCT03341533|50122826|FG001|Overall Study|Withdrawal by Subject|1|||
25025238|NCT03341533|50122825|FG000|Overall Study|Not eligible after randomization|2|||
24927169|NCT00098293|50020703|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
24927170|NCT00098293|50020704|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
24927171|NCT00098293|50020705|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
24927172|NCT00098293|50020706|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
24927173|NCT00098293|50020707|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
24927174|NCT00098293|50020703|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
24927175|NCT00098293|50020704|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
24927176|NCT00098293|50020705|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
24927177|NCT00098293|50020706|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
24927178|NCT00098293|50020707|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
24927179|NCT00098293|50020703|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
24927180|NCT00098293|50020704|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
24927181|NCT00098293|50020705|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
24927182|NCT00098293|50020706|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
24927183|NCT00098293|50020707|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
24927184|NCT00098293|50020703|FG000|Open-label (OL) Phase|Adverse Event|0|||
24927185|NCT00098293|50020704|FG001|Open-label (OL) Phase|Adverse Event|3|||
24927186|NCT00098293|50020705|FG002|Open-label (OL) Phase|Adverse Event|7|||
24927187|NCT00098293|50020706|FG003|Open-label (OL) Phase|Adverse Event|6|||
24927188|NCT00098293|50020707|FG004|Open-label (OL) Phase|Adverse Event|0|||
25025239|NCT03341533|50122826|FG001|Overall Study|Not eligible after randomization|1|||
25025240|NCT02688088|50122832|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
24927189|NCT00098293|50020703|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
24927190|NCT00098293|50020704|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
24927191|NCT00098293|50020705|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
24927192|NCT00098293|50020706|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
25025241|NCT02688088|50122833|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
25025242|NCT02688088|50122834|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
25025243|NCT02688088|50122835|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
24927193|NCT00098293|50020707|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
24927194|NCT00098293|50020703|FG000|Open-label (OL) Phase|Pregnancy|0|||
24927195|NCT00098293|50020704|FG001|Open-label (OL) Phase|Pregnancy|1|||
24927196|NCT00098293|50020705|FG002|Open-label (OL) Phase|Pregnancy|0|||
24927197|NCT00098293|50020706|FG003|Open-label (OL) Phase|Pregnancy|3|||
24927198|NCT00098293|50020707|FG004|Open-label (OL) Phase|Pregnancy|0|||
24927199|NCT00098293|50020703|FG000|Open-label (OL) Phase|Protocol Violation|0|||
24927200|NCT00098293|50020704|FG001|Open-label (OL) Phase|Protocol Violation|6|||
24927201|NCT00098293|50020705|FG002|Open-label (OL) Phase|Protocol Violation|13|||
24927202|NCT00098293|50020706|FG003|Open-label (OL) Phase|Protocol Violation|16|||
24927203|NCT00098293|50020707|FG004|Open-label (OL) Phase|Protocol Violation|0|||
24927204|NCT00098293|50020703|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
24927205|NCT00098293|50020704|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
24927206|NCT00098293|50020705|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
24927207|NCT00098293|50020706|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
24927208|NCT00098293|50020707|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
24927209|NCT00098293|50020703|FG000|Open-label (OL) Phase|Death|0|||
24927210|NCT00098293|50020704|FG001|Open-label (OL) Phase|Death|2|||
24927211|NCT00098293|50020705|FG002|Open-label (OL) Phase|Death|3|||
24927212|NCT00098293|50020706|FG003|Open-label (OL) Phase|Death|0|||
24927213|NCT00098293|50020707|FG004|Open-label (OL) Phase|Death|0|||
24927214|NCT00098293|50020703|FG000|Supplemental Phase (SP)|Death|0|||
24927215|NCT00098293|50020704|FG001|Supplemental Phase (SP)|Death|0|||
24927216|NCT00098293|50020705|FG002|Supplemental Phase (SP)|Death|0|||
24927217|NCT00098293|50020706|FG003|Supplemental Phase (SP)|Death|0|||
24927218|NCT00098293|50020707|FG004|Supplemental Phase (SP)|Death|1|||
24927219|NCT00098293|50020703|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
24927220|NCT00098293|50020704|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
24927221|NCT00098293|50020705|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
24927222|NCT00098293|50020706|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
24927223|NCT00098293|50020707|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
24927224|NCT00098293|50020703|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
24927225|NCT00098293|50020704|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
24927226|NCT00098293|50020705|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
24927227|NCT00098293|50020706|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
24927228|NCT00098293|50020707|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
24927229|NCT00098293|50020703|FG000|Supplemental Phase (SP)|Other|0|||
24927230|NCT00098293|50020704|FG001|Supplemental Phase (SP)|Other|0|||
24927231|NCT00098293|50020705|FG002|Supplemental Phase (SP)|Other|0|||
24927232|NCT00098293|50020706|FG003|Supplemental Phase (SP)|Other|0|||
24927233|NCT00098293|50020707|FG004|Supplemental Phase (SP)|Other|22|||
24927234|NCT00685685|50020718|FG000|Washout Period of 7 Days|Adverse Event|2|||
24927235|NCT00685685|50020719|FG001|Washout Period of 7 Days|Adverse Event|0|||
24927236|NCT00685685|50020718|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
24927237|NCT00685685|50020719|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
24927238|NCT00684671|50020728|FG000|Overall Study|Adverse Event|1|||
24927239|NCT00684671|50020729|FG001|Overall Study|Adverse Event|0|||
24927240|NCT00684671|50020730|FG002|Overall Study|Adverse Event|0|||
24927241|NCT00684671|50020728|FG000|Overall Study|Lost to Follow-up|1|||
24927242|NCT00684671|50020729|FG001|Overall Study|Lost to Follow-up|0|||
24927243|NCT00684671|50020730|FG002|Overall Study|Lost to Follow-up|0|||
24927244|NCT00684671|50020728|FG000|Overall Study|Alcoholic dependance|1|||
24927245|NCT00684671|50020729|FG001|Overall Study|Alcoholic dependance|0|||
24927246|NCT00684671|50020730|FG002|Overall Study|Alcoholic dependance|0|||
24927247|NCT03859323|50020751|FG000|Overall Study|Lost to Follow-up|0|||
24927248|NCT03859323|50020752|FG001|Overall Study|Lost to Follow-up|0|||
24927249|NCT03859323|50020753|FG002|Overall Study|Lost to Follow-up|0|||
24927250|NCT03859323|50020754|FG003|Overall Study|Lost to Follow-up|0|||
24927251|NCT03859323|50020755|FG004|Overall Study|Lost to Follow-up|0|||
24927252|NCT03859323|50020756|FG005|Overall Study|Lost to Follow-up|0|||
24927253|NCT03859323|50020757|FG006|Overall Study|Lost to Follow-up|1|||
24927254|NCT03859323|50020758|FG007|Overall Study|Lost to Follow-up|0|||
24927255|NCT03859323|50020759|FG008|Overall Study|Lost to Follow-up|0|||
24927256|NCT03859323|50020760|FG009|Overall Study|Lost to Follow-up|0|||
24927257|NCT03859323|50020761|FG010|Overall Study|Lost to Follow-up|0|||
24927258|NCT03859323|50020762|FG011|Overall Study|Lost to Follow-up|0|||
24927259|NCT03859323|50020763|FG012|Overall Study|Lost to Follow-up|0|||
24927260|NCT03859323|50020751|FG000|Overall Study|Withdrawal by Subject|0|||
25155244|NCT01458340|50270467|FG002|Overall Study|Withdrawal by Subject|4|||
24927261|NCT03859323|50020752|FG001|Overall Study|Withdrawal by Subject|0|||
24927262|NCT03859323|50020753|FG002|Overall Study|Withdrawal by Subject|1|||
24927263|NCT03859323|50020754|FG003|Overall Study|Withdrawal by Subject|0|||
24927264|NCT03859323|50020755|FG004|Overall Study|Withdrawal by Subject|0|||
24927265|NCT03859323|50020756|FG005|Overall Study|Withdrawal by Subject|1|||
24927266|NCT03859323|50020757|FG006|Overall Study|Withdrawal by Subject|0|||
24927267|NCT03859323|50020758|FG007|Overall Study|Withdrawal by Subject|0|||
24927268|NCT03859323|50020759|FG008|Overall Study|Withdrawal by Subject|0|||
24927269|NCT03859323|50020760|FG009|Overall Study|Withdrawal by Subject|1|||
24927270|NCT03859323|50020761|FG010|Overall Study|Withdrawal by Subject|1|||
24927271|NCT03859323|50020762|FG011|Overall Study|Withdrawal by Subject|2|||
24927272|NCT03859323|50020763|FG012|Overall Study|Withdrawal by Subject|1|||
24927273|NCT03859323|50020751|FG000|Overall Study|Pregnancy|0|||
24927274|NCT03859323|50020752|FG001|Overall Study|Pregnancy|0|||
24927275|NCT03859323|50020753|FG002|Overall Study|Pregnancy|0|||
24927276|NCT03859323|50020754|FG003|Overall Study|Pregnancy|0|||
24927277|NCT03859323|50020755|FG004|Overall Study|Pregnancy|0|||
24927278|NCT03859323|50020756|FG005|Overall Study|Pregnancy|0|||
24927279|NCT03859323|50020757|FG006|Overall Study|Pregnancy|0|||
24927280|NCT03859323|50020758|FG007|Overall Study|Pregnancy|0|||
24927281|NCT03859323|50020759|FG008|Overall Study|Pregnancy|0|||
24927282|NCT03859323|50020760|FG009|Overall Study|Pregnancy|1|||
24927283|NCT03859323|50020761|FG010|Overall Study|Pregnancy|0|||
24927284|NCT03859323|50020762|FG011|Overall Study|Pregnancy|0|||
24927285|NCT03859323|50020763|FG012|Overall Study|Pregnancy|0|||
24927286|NCT03857841|50020806|FG000|Overall Study|Death|1|||
24927287|NCT03857841|50020807|FG001|Overall Study|Death|0|||
24927288|NCT03857841|50020808|FG002|Overall Study|Death|0|||
24927289|NCT03857841|50020809|FG003|Overall Study|Death|0|||
24927290|NCT03857841|50020806|FG000|Overall Study|Study Terminated by Sponsor|1|||
24927291|NCT03857841|50020807|FG001|Overall Study|Study Terminated by Sponsor|0|||
24927292|NCT03857841|50020808|FG002|Overall Study|Study Terminated by Sponsor|0|||
24927293|NCT03857841|50020809|FG003|Overall Study|Study Terminated by Sponsor|0|||
24927294|NCT00500331|50020826|FG000|Overall Study|Adverse Event|0|||
24927295|NCT00500331|50020827|FG001|Overall Study|Adverse Event|2|||
24927296|NCT00500331|50020828|FG002|Overall Study|Adverse Event|0|||
25155245|NCT01539291|50270522|FG000|Study GS-US-312-0116|Adverse Event|9|||
25155246|NCT01539291|50270523|FG001|Study GS-US-312-0116|Adverse Event|0|||
25155247|NCT01539291|50270524|FG002|Study GS-US-312-0116|Adverse Event|0|||
25155248|NCT01539291|50270525|FG003|Study GS-US-312-0116|Adverse Event|0|||
25155249|NCT01539291|50270522|FG000|Study GS-US-312-0116|Physician Decision|1|||
25155250|NCT01539291|50270523|FG001|Study GS-US-312-0116|Physician Decision|0|||
25155251|NCT01539291|50270524|FG002|Study GS-US-312-0116|Physician Decision|0|||
25155252|NCT01539291|50270525|FG003|Study GS-US-312-0116|Physician Decision|0|||
25155253|NCT01539291|50270522|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
25155254|NCT01539291|50270523|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
25155255|NCT01539291|50270524|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
24927297|NCT00500331|50020829|FG003|Overall Study|Adverse Event|1|||
24927298|NCT00500331|50020830|FG004|Overall Study|Adverse Event|2|||
24927299|NCT00500331|50020831|FG005|Overall Study|Adverse Event|2|||
24927300|NCT00500331|50020832|FG006|Overall Study|Adverse Event|0|||
24927301|NCT00500331|50020826|FG000|Overall Study|Lost to Follow-up|1|||
24927302|NCT00500331|50020827|FG001|Overall Study|Lost to Follow-up|1|||
25155256|NCT01539291|50270525|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
24927303|NCT00500331|50020828|FG002|Overall Study|Lost to Follow-up|1|||
25155257|NCT01539291|50270522|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
24927304|NCT00500331|50020829|FG003|Overall Study|Lost to Follow-up|2|||
24927305|NCT00500331|50020830|FG004|Overall Study|Lost to Follow-up|1|||
24927306|NCT00500331|50020831|FG005|Overall Study|Lost to Follow-up|0|||
24927307|NCT00500331|50020832|FG006|Overall Study|Lost to Follow-up|0|||
24927308|NCT00500331|50020826|FG000|Overall Study|Protocol Violation|3|||
24927309|NCT00500331|50020827|FG001|Overall Study|Protocol Violation|1|||
25185582|NCT00086281|50335096|FG009|Phase 1|Serious Adverse Event|0|||
24927310|NCT00500331|50020828|FG002|Overall Study|Protocol Violation|1|||
24927311|NCT00500331|50020829|FG003|Overall Study|Protocol Violation|0|||
24927312|NCT00500331|50020830|FG004|Overall Study|Protocol Violation|1|||
24927313|NCT00500331|50020831|FG005|Overall Study|Protocol Violation|1|||
24927314|NCT00500331|50020832|FG006|Overall Study|Protocol Violation|1|||
24927315|NCT00500331|50020826|FG000|Overall Study|Withdrawal by Subject|4|||
24927316|NCT00500331|50020827|FG001|Overall Study|Withdrawal by Subject|0|||
24927317|NCT00500331|50020828|FG002|Overall Study|Withdrawal by Subject|1|||
24927318|NCT00500331|50020829|FG003|Overall Study|Withdrawal by Subject|5|||
24927319|NCT00500331|50020830|FG004|Overall Study|Withdrawal by Subject|0|||
24927320|NCT00500331|50020831|FG005|Overall Study|Withdrawal by Subject|1|||
24927321|NCT00500331|50020832|FG006|Overall Study|Withdrawal by Subject|1|||
25025244|NCT02688088|50122836|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
25025245|NCT02688088|50122832|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
25025246|NCT02688088|50122833|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
25025247|NCT02688088|50122834|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
25025248|NCT02688088|50122835|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
25025249|NCT02688088|50122836|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
25025250|NCT02688088|50122832|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
25025251|NCT02688088|50122833|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
25025252|NCT02688088|50122834|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
25025253|NCT02688088|50122835|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
25025254|NCT02688088|50122836|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
25025255|NCT02688088|50122832|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
25025256|NCT02688088|50122833|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
25025257|NCT02688088|50122834|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
25025258|NCT02688088|50122835|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
24927322|NCT00500331|50020826|FG000|Overall Study|Lack of Efficacy|3|||
24927323|NCT00500331|50020827|FG001|Overall Study|Lack of Efficacy|1|||
24927324|NCT00500331|50020828|FG002|Overall Study|Lack of Efficacy|0|||
24927325|NCT00500331|50020829|FG003|Overall Study|Lack of Efficacy|0|||
24927326|NCT00500331|50020830|FG004|Overall Study|Lack of Efficacy|0|||
24927327|NCT00500331|50020831|FG005|Overall Study|Lack of Efficacy|0|||
24927328|NCT00500331|50020832|FG006|Overall Study|Lack of Efficacy|0|||
24927329|NCT00500331|50020826|FG000|Overall Study|Liver function test abnormality|0|||
24927330|NCT00500331|50020827|FG001|Overall Study|Liver function test abnormality|0|||
24927331|NCT00500331|50020828|FG002|Overall Study|Liver function test abnormality|1|||
24927332|NCT00500331|50020829|FG003|Overall Study|Liver function test abnormality|0|||
24927333|NCT00500331|50020830|FG004|Overall Study|Liver function test abnormality|0|||
24927334|NCT00500331|50020831|FG005|Overall Study|Liver function test abnormality|0|||
24927335|NCT00500331|50020832|FG006|Overall Study|Liver function test abnormality|0|||
24927336|NCT00500331|50020826|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
24927337|NCT00500331|50020827|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
24927338|NCT00500331|50020828|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
24927339|NCT00500331|50020829|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
24927340|NCT00500331|50020830|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
24927341|NCT00500331|50020831|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
24927342|NCT00500331|50020832|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
24927343|NCT00500331|50020826|FG000|Overall Study|Didn't return for continuation of study|1|||
24927344|NCT00500331|50020827|FG001|Overall Study|Didn't return for continuation of study|0|||
24927345|NCT00500331|50020828|FG002|Overall Study|Didn't return for continuation of study|0|||
24927346|NCT00500331|50020829|FG003|Overall Study|Didn't return for continuation of study|0|||
24927347|NCT00500331|50020830|FG004|Overall Study|Didn't return for continuation of study|0|||
24927348|NCT00500331|50020831|FG005|Overall Study|Didn't return for continuation of study|0|||
24927349|NCT00500331|50020832|FG006|Overall Study|Didn't return for continuation of study|0|||
24927350|NCT00500331|50020826|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
24927351|NCT00500331|50020827|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
24927352|NCT00500331|50020828|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
24927353|NCT00500331|50020829|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
24927354|NCT00500331|50020830|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
24927355|NCT00500331|50020831|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
24927356|NCT00500331|50020832|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
24927357|NCT00500331|50020826|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
24927358|NCT00500331|50020827|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
24927359|NCT00500331|50020828|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
24927360|NCT00500331|50020829|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
25025259|NCT02688088|50122836|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
25025260|NCT02688088|50122832|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
25185583|NCT00086281|50335097|FG010|Phase 1|Serious Adverse Event|0|||
25185584|NCT00086281|50335098|FG011|Phase 1|Serious Adverse Event|0|||
24927361|NCT00500331|50020830|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
24927362|NCT00500331|50020831|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
24927363|NCT00500331|50020832|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
24927364|NCT00500331|50020826|FG000|Overall Study|Participant was randomized by mistake|1|||
24927365|NCT00500331|50020827|FG001|Overall Study|Participant was randomized by mistake|0|||
24927366|NCT00500331|50020828|FG002|Overall Study|Participant was randomized by mistake|0|||
24927367|NCT00500331|50020829|FG003|Overall Study|Participant was randomized by mistake|0|||
24927368|NCT00500331|50020830|FG004|Overall Study|Participant was randomized by mistake|0|||
24927369|NCT00500331|50020831|FG005|Overall Study|Participant was randomized by mistake|0|||
24927370|NCT00500331|50020832|FG006|Overall Study|Participant was randomized by mistake|0|||
24927371|NCT00500331|50020826|FG000|Overall Study|Diabetologist nurse in the study|0|||
24927372|NCT00500331|50020827|FG001|Overall Study|Diabetologist nurse in the study|0|||
24927373|NCT00500331|50020828|FG002|Overall Study|Diabetologist nurse in the study|1|||
24927374|NCT00500331|50020829|FG003|Overall Study|Diabetologist nurse in the study|0|||
24927375|NCT00500331|50020830|FG004|Overall Study|Diabetologist nurse in the study|0|||
24927376|NCT00500331|50020831|FG005|Overall Study|Diabetologist nurse in the study|0|||
25025261|NCT02688088|50122833|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
25025262|NCT02688088|50122834|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
25025263|NCT02688088|50122835|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
25025264|NCT02688088|50122836|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
25025265|NCT02688088|50122832|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
25025266|NCT02688088|50122833|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
25025267|NCT02688088|50122834|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
25025268|NCT02688088|50122835|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
25025269|NCT02688088|50122836|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
25025270|NCT02688088|50122832|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
25025271|NCT02688088|50122833|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
25155258|NCT01539291|50270523|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
25155259|NCT01539291|50270524|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
25155260|NCT01539291|50270525|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
25155261|NCT01539291|50270522|FG000|Study GS-US-312-0116|Other|1|||
25155262|NCT01539291|50270523|FG001|Study GS-US-312-0116|Other|0|||
25155263|NCT01539291|50270524|FG002|Study GS-US-312-0116|Other|0|||
25155264|NCT01539291|50270525|FG003|Study GS-US-312-0116|Other|0|||
25155265|NCT01539291|50270522|FG000|Study GS-US-312-0117|Adverse Event|22|||
25155266|NCT01539291|50270523|FG001|Study GS-US-312-0117|Adverse Event|1|||
25155267|NCT01539291|50270524|FG002|Study GS-US-312-0117|Adverse Event|9|||
25155268|NCT01539291|50270525|FG003|Study GS-US-312-0117|Adverse Event|12|||
25155269|NCT01539291|50270522|FG000|Study GS-US-312-0117|Physician Decision|9|||
25155270|NCT01539291|50270523|FG001|Study GS-US-312-0117|Physician Decision|0|||
25155271|NCT01539291|50270524|FG002|Study GS-US-312-0117|Physician Decision|6|||
25155272|NCT01539291|50270525|FG003|Study GS-US-312-0117|Physician Decision|4|||
25155273|NCT01539291|50270522|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
25155274|NCT01539291|50270523|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
25155275|NCT01539291|50270524|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
25155276|NCT01539291|50270525|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
24927377|NCT00500331|50020832|FG006|Overall Study|Diabetologist nurse in the study|0|||
24927378|NCT00500331|50020826|FG000|Overall Study|State ban of biological samples export|0|||
24927379|NCT00500331|50020827|FG001|Overall Study|State ban of biological samples export|0|||
24927380|NCT00500331|50020828|FG002|Overall Study|State ban of biological samples export|0|||
24927381|NCT00500331|50020829|FG003|Overall Study|State ban of biological samples export|1|||
24927382|NCT00500331|50020830|FG004|Overall Study|State ban of biological samples export|0|||
24927383|NCT00500331|50020831|FG005|Overall Study|State ban of biological samples export|0|||
24927384|NCT00500331|50020832|FG006|Overall Study|State ban of biological samples export|0|||
24927385|NCT00500331|50020826|FG000|Overall Study|Protocol violated|0|||
24927386|NCT00500331|50020827|FG001|Overall Study|Protocol violated|0|||
24927387|NCT00500331|50020828|FG002|Overall Study|Protocol violated|0|||
24927388|NCT00500331|50020829|FG003|Overall Study|Protocol violated|1|||
24927389|NCT00500331|50020830|FG004|Overall Study|Protocol violated|0|||
24927390|NCT00500331|50020831|FG005|Overall Study|Protocol violated|0|||
24927391|NCT00500331|50020832|FG006|Overall Study|Protocol violated|0|||
24927392|NCT00499863|50020851|FG000|Overall Study|Lack of Efficacy|21|||
24927393|NCT00499863|50020852|FG001|Overall Study|Lack of Efficacy|27|||
24927394|NCT00499863|50020851|FG000|Overall Study|Protocol Violation|12|||
24927395|NCT00499863|50020852|FG001|Overall Study|Protocol Violation|7|||
24927396|NCT00499863|50020851|FG000|Overall Study|Withdrawal by Subject|6|||
24927397|NCT00499863|50020852|FG001|Overall Study|Withdrawal by Subject|4|||
24927398|NCT00499863|50020851|FG000|Overall Study|Adverse Event|8|||
24927399|NCT00499863|50020852|FG001|Overall Study|Adverse Event|2|||
24927400|NCT00499863|50020851|FG000|Overall Study|Sponsor decision|2|||
24927401|NCT00499863|50020852|FG001|Overall Study|Sponsor decision|2|||
24927402|NCT00499863|50020851|FG000|Overall Study|Lost to Follow-up|1|||
24927403|NCT00499863|50020852|FG001|Overall Study|Lost to Follow-up|1|||
24927404|NCT00484185|50020858|FG000|Overall Study|Lost to Follow-up|44|||
24927405|NCT00484185|50020858|FG000|Overall Study|Other|20|||
24927406|NCT00484185|50020858|FG000|Overall Study|Randomized but not treated|5|||
24927407|NCT00484185|50020858|FG000|Overall Study|Death|2|||
24927408|NCT00097981|50020864|FG000|Overall Study|Adverse Event|31|||
24927409|NCT00097981|50020865|FG001|Overall Study|Adverse Event|44|||
24927410|NCT00097981|50020864|FG000|Overall Study|Withdrawal by Subject|10|||
24927411|NCT00097981|50020865|FG001|Overall Study|Withdrawal by Subject|8|||
24927412|NCT00097981|50020864|FG000|Overall Study|Protocol Violation|1|||
24927413|NCT00097981|50020865|FG001|Overall Study|Protocol Violation|1|||
24927414|NCT00097981|50020864|FG000|Overall Study|Death|2|||
24927415|NCT00097981|50020865|FG001|Overall Study|Death|4|||
24927416|NCT00097981|50020864|FG000|Overall Study|Physician Decision|7|||
24927417|NCT00097981|50020865|FG001|Overall Study|Physician Decision|1|||
24927418|NCT00097981|50020864|FG000|Overall Study|Disease Progression|8|||
25185585|NCT00086281|50335099|FG012|Phase 1|Serious Adverse Event|0|||
25185586|NCT00086281|50335100|FG013|Phase 1|Serious Adverse Event|0|||
24927419|NCT00097981|50020865|FG001|Overall Study|Disease Progression|2|||
24927420|NCT00097981|50020864|FG000|Overall Study|Transplant planned|28|||
24927421|NCT00097981|50020865|FG001|Overall Study|Transplant planned|27|||
24927422|NCT00097981|50020864|FG000|Overall Study|Other|19|||
24927423|NCT00097981|50020865|FG001|Overall Study|Other|13|||
24927424|NCT00499083|50020871|FG000|Overall Study|Not evaluable|3|||
25185587|NCT00086281|50335101|FG014|Phase 1|Serious Adverse Event|1|||
25025272|NCT02688088|50122834|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
25025273|NCT02688088|50122835|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
25025274|NCT02688088|50122836|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
25025275|NCT02688088|50122832|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
25025276|NCT02688088|50122833|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
25025277|NCT02688088|50122834|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
25025278|NCT02688088|50122835|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
25025279|NCT02688088|50122836|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
25025280|NCT02688088|50122832|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
25025281|NCT02688088|50122833|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
25025282|NCT02688088|50122834|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
25025283|NCT02688088|50122835|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
25025284|NCT02688088|50122836|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
25025285|NCT03641651|50122861|FG000|Overall Study|organizational issues at one study site|1|||
25025286|NCT03341299|50122865|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
24927425|NCT00572195|50020875|FG000|Overall Study|Withdrawal by Subject|50|||
24927426|NCT00572195|50020875|FG000|Overall Study|Death|9|||
24927427|NCT00572195|50020875|FG000|Overall Study|Adverse Event|4|||
24927428|NCT00572195|50020875|FG000|Overall Study|Lost to Follow-up|5|||
24927429|NCT00572039|50020881|FG000|Overall Study|Withdrawal by Subject|9|||
24927430|NCT00572039|50020882|FG001|Overall Study|Withdrawal by Subject|6|||
24927431|NCT00572039|50020881|FG000|Overall Study|Death|2|||
24927432|NCT00572039|50020882|FG001|Overall Study|Death|3|||
24927433|NCT00572039|50020881|FG000|Overall Study|Ill|5|||
24927434|NCT00572039|50020882|FG001|Overall Study|Ill|1|||
24927435|NCT00684593|50020892|FG000|Overall Study|Adverse Event|0|||
24927436|NCT00684593|50020893|FG001|Overall Study|Adverse Event|2|||
24927437|NCT00685373|50020899|FG000|Overall Study|Adverse Event|3|||
24927438|NCT00685373|50020899|FG000|Overall Study|Withdrawal by Subject|5|||
24927439|NCT00685373|50020899|FG000|Overall Study|Lack of Efficacy|3|||
24927440|NCT00685373|50020899|FG000|Overall Study|Condition no longer requires study drug|1|||
24927441|NCT00685373|50020899|FG000|Overall Study|Lost to Follow-up|2|||
24927442|NCT00685373|50020899|FG000|Overall Study|Protocol Violation|1|||
24927443|NCT00684515|50020906|FG000|Overall Study|Adverse Event|3|||
24927444|NCT00684515|50020907|FG001|Overall Study|Adverse Event|3|||
24927445|NCT00684515|50020908|FG002|Overall Study|Adverse Event|1|||
25025287|NCT03341299|50122866|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
25025288|NCT03341299|50122867|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
25025289|NCT03341299|50122868|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
25025290|NCT02949271|50122882|FG000|Overall Study|Lack of Efficacy|5|||
25025291|NCT02949271|50122883|FG001|Overall Study|Lack of Efficacy|4|||
25025292|NCT02949271|50122882|FG000|Overall Study|Lost to Follow-up|3|||
25025293|NCT02949271|50122883|FG001|Overall Study|Lost to Follow-up|6|||
25025294|NCT02949271|50122882|FG000|Overall Study|Physician Decision|5|||
25025295|NCT02949271|50122883|FG001|Overall Study|Physician Decision|5|||
25025296|NCT02949271|50122882|FG000|Overall Study|Protocol Violation|6|||
25025297|NCT02949271|50122883|FG001|Overall Study|Protocol Violation|3|||
25025298|NCT02949271|50122882|FG000|Overall Study|Withdrawal by Subject|1|||
25025299|NCT02949271|50122883|FG001|Overall Study|Withdrawal by Subject|0|||
25025300|NCT02949271|50122882|FG000|Overall Study|Delivered prior to intervention|7|||
25025301|NCT02949271|50122883|FG001|Overall Study|Delivered prior to intervention|9|||
25025302|NCT02949271|50122882|FG000|Overall Study|Outside the window for cervical dilation|2|||
25025303|NCT02949271|50122883|FG001|Overall Study|Outside the window for cervical dilation|3|||
25155277|NCT01539291|50270522|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
25155278|NCT01539291|50270523|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
25155279|NCT01539291|50270524|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
25155280|NCT01539291|50270525|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
25155281|NCT01539291|50270522|FG000|Study GS-US-312-0117|Other|2|||
24927446|NCT00684515|50020906|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
24927447|NCT00684515|50020907|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
25155282|NCT01539291|50270523|FG001|Study GS-US-312-0117|Other|1|||
24927448|NCT00684515|50020908|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
24927449|NCT00490815|50020918|FG000|Overall Study|Adverse Event|2|||
24927450|NCT00490815|50020919|FG001|Overall Study|Adverse Event|3|||
24927451|NCT00490815|50020918|FG000|Overall Study|Withdrawal by Subject|4|||
24927452|NCT00490815|50020919|FG001|Overall Study|Withdrawal by Subject|0|||
24927453|NCT00490815|50020918|FG000|Overall Study|Lost to Follow-up|1|||
25025304|NCT03640559|50122891|FG000|Overall Study|Physician Decision|1|||
24927454|NCT00490815|50020919|FG001|Overall Study|Lost to Follow-up|3|||
25155283|NCT01539291|50270524|FG002|Study GS-US-312-0117|Other|1|||
24927455|NCT00490815|50020918|FG000|Overall Study|Death|1|||
24927456|NCT00490815|50020919|FG001|Overall Study|Death|3|||
24927457|NCT03855189|50020928|FG000|Overall Study|Adverse Event|5|||
25155284|NCT01539291|50270525|FG003|Study GS-US-312-0117|Other|1|||
24927458|NCT03855189|50020929|FG001|Overall Study|Adverse Event|2|||
24927459|NCT03855189|50020930|FG002|Overall Study|Adverse Event|4|||
24927460|NCT03855189|50020928|FG000|Overall Study|Treatment Failure|1|||
24927461|NCT03855189|50020929|FG001|Overall Study|Treatment Failure|1|||
24927462|NCT03855189|50020930|FG002|Overall Study|Treatment Failure|2|||
24927463|NCT03855189|50020928|FG000|Overall Study|Noncompliance with Protocol|0|||
24927464|NCT03855189|50020929|FG001|Overall Study|Noncompliance with Protocol|1|||
24927465|NCT03855189|50020930|FG002|Overall Study|Noncompliance with Protocol|0|||
24927466|NCT03855189|50020928|FG000|Overall Study|Did Not Return|4|||
24927467|NCT03855189|50020929|FG001|Overall Study|Did Not Return|3|||
24927468|NCT03855189|50020930|FG002|Overall Study|Did Not Return|0|||
25155285|NCT01538199|50270548|FG000|Overall Study|Lost to Follow-up|1|||
25275058|NCT01237223|50589110|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
25275059|NCT01237223|50589111|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
25275060|NCT01237223|50589112|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
25275061|NCT01237223|50589113|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
25275062|NCT01237223|50589108|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
25275063|NCT01237223|50589109|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
25275064|NCT01237223|50589110|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
25275065|NCT01237223|50589111|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
25275066|NCT01237223|50589112|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
25275067|NCT01237223|50589113|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
25275068|NCT01237223|50589108|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
25275069|NCT01237223|50589109|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
24927469|NCT03853551|50020938|FG000|Overall Study|Death|2|||
24927470|NCT03853551|50020938|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
24927471|NCT00423670|50020949|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
24927472|NCT00423670|50020950|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
24927473|NCT00423670|50020951|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
24927474|NCT00423670|50020952|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
24927475|NCT00423670|50020953|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
24927476|NCT00423670|50020954|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
24927477|NCT00423670|50020955|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
24927478|NCT00423670|50020956|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
24927479|NCT00423670|50020949|FG000|Treatment Period|Adverse Event|8|||
24927480|NCT00423670|50020950|FG001|Treatment Period|Adverse Event|12|||
24927481|NCT00423670|50020951|FG002|Treatment Period|Adverse Event|15|||
24927482|NCT00423670|50020952|FG003|Treatment Period|Adverse Event|20|||
24927483|NCT00423670|50020953|FG004|Treatment Period|Adverse Event|9|||
24927484|NCT00423670|50020954|FG005|Treatment Period|Adverse Event|4|||
24927485|NCT00423670|50020955|FG006|Treatment Period|Adverse Event|7|||
24927486|NCT00423670|50020956|FG007|Treatment Period|Adverse Event|2|||
24927487|NCT00423670|50020949|FG000|Treatment Period|Protocol-defined clinical event|0|||
24927488|NCT00423670|50020950|FG001|Treatment Period|Protocol-defined clinical event|7|||
24927489|NCT00423670|50020951|FG002|Treatment Period|Protocol-defined clinical event|4|||
24927490|NCT00423670|50020952|FG003|Treatment Period|Protocol-defined clinical event|12|||
24927491|NCT00423670|50020953|FG004|Treatment Period|Protocol-defined clinical event|5|||
24927492|NCT00423670|50020954|FG005|Treatment Period|Protocol-defined clinical event|4|||
24927493|NCT00423670|50020955|FG006|Treatment Period|Protocol-defined clinical event|16|||
24927494|NCT00423670|50020956|FG007|Treatment Period|Protocol-defined clinical event|15|||
24927495|NCT00423670|50020949|FG000|Treatment Period|Lost to Follow-up|2|||
24927496|NCT00423670|50020950|FG001|Treatment Period|Lost to Follow-up|1|||
24927497|NCT00423670|50020951|FG002|Treatment Period|Lost to Follow-up|3|||
24927498|NCT00423670|50020952|FG003|Treatment Period|Lost to Follow-up|1|||
24927499|NCT00423670|50020953|FG004|Treatment Period|Lost to Follow-up|6|||
24927500|NCT00423670|50020954|FG005|Treatment Period|Lost to Follow-up|0|||
24927501|NCT00423670|50020955|FG006|Treatment Period|Lost to Follow-up|3|||
24927502|NCT00423670|50020956|FG007|Treatment Period|Lost to Follow-up|1|||
24927503|NCT00423670|50020949|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
24927504|NCT00423670|50020950|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
24927505|NCT00423670|50020951|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
24927506|NCT00423670|50020952|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
24927507|NCT00423670|50020953|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
24927508|NCT00423670|50020954|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
24927509|NCT00423670|50020955|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
24927510|NCT00423670|50020956|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
24927511|NCT00423670|50020949|FG000|Treatment Period|Investigator decision|0|||
24927512|NCT00423670|50020950|FG001|Treatment Period|Investigator decision|0|||
24927513|NCT00423670|50020951|FG002|Treatment Period|Investigator decision|0|||
24927514|NCT00423670|50020952|FG003|Treatment Period|Investigator decision|0|||
25155286|NCT01538199|50270549|FG001|Overall Study|Lost to Follow-up|2|||
24927515|NCT00423670|50020953|FG004|Treatment Period|Investigator decision|0|||
24927516|NCT00423670|50020954|FG005|Treatment Period|Investigator decision|0|||
24927517|NCT00423670|50020955|FG006|Treatment Period|Investigator decision|0|||
24927518|NCT00423670|50020956|FG007|Treatment Period|Investigator decision|1|||
24927519|NCT00423670|50020949|FG000|Treatment Period|Non-compliance with protocol|3|||
24927520|NCT00423670|50020950|FG001|Treatment Period|Non-compliance with protocol|1|||
24927521|NCT00423670|50020951|FG002|Treatment Period|Non-compliance with protocol|1|||
24927522|NCT00423670|50020952|FG003|Treatment Period|Non-compliance with protocol|3|||
24927523|NCT00423670|50020953|FG004|Treatment Period|Non-compliance with protocol|2|||
24927524|NCT00423670|50020954|FG005|Treatment Period|Non-compliance with protocol|0|||
24927525|NCT00423670|50020955|FG006|Treatment Period|Non-compliance with protocol|2|||
24927526|NCT00423670|50020956|FG007|Treatment Period|Non-compliance with protocol|2|||
24927527|NCT00423670|50020949|FG000|Follow-up Period|Lost to Follow-up|0|||
24927528|NCT00423670|50020950|FG001|Follow-up Period|Lost to Follow-up|12|||
24927529|NCT00423670|50020951|FG002|Follow-up Period|Lost to Follow-up|8|||
24927530|NCT00423670|50020952|FG003|Follow-up Period|Lost to Follow-up|3|||
24927531|NCT00423670|50020953|FG004|Follow-up Period|Lost to Follow-up|1|||
24927532|NCT00423670|50020954|FG005|Follow-up Period|Lost to Follow-up|0|||
24927533|NCT00423670|50020955|FG006|Follow-up Period|Lost to Follow-up|5|||
24927534|NCT00423670|50020956|FG007|Follow-up Period|Lost to Follow-up|0|||
24927535|NCT00423670|50020949|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
24927536|NCT00423670|50020950|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
24927537|NCT00423670|50020951|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
24927538|NCT00423670|50020952|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
24927539|NCT00423670|50020953|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
24927540|NCT00423670|50020954|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
24927541|NCT00423670|50020955|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
24927542|NCT00423670|50020956|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
24927543|NCT00423670|50020949|FG000|Follow-up Period|Non-compliance with protocol|2|||
24927544|NCT00423670|50020950|FG001|Follow-up Period|Non-compliance with protocol|0|||
24927545|NCT00423670|50020951|FG002|Follow-up Period|Non-compliance with protocol|1|||
24927546|NCT00423670|50020952|FG003|Follow-up Period|Non-compliance with protocol|1|||
24927547|NCT00423670|50020953|FG004|Follow-up Period|Non-compliance with protocol|0|||
24927548|NCT00423670|50020954|FG005|Follow-up Period|Non-compliance with protocol|0|||
24927549|NCT00423670|50020955|FG006|Follow-up Period|Non-compliance with protocol|3|||
24927550|NCT00423670|50020956|FG007|Follow-up Period|Non-compliance with protocol|2|||
24927551|NCT00483717|50020979|FG000|Overall Study|Protocol Violation|5|||
24927552|NCT00483717|50020980|FG001|Overall Study|Protocol Violation|7|||
24927553|NCT00483717|50020979|FG000|Overall Study|Time of dosing missing|1|||
25275070|NCT01237223|50589110|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
25275071|NCT01237223|50589111|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
25275072|NCT01237223|50589112|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
25025305|NCT03640559|50122892|FG001|Overall Study|Physician Decision|1|||
25025306|NCT03640559|50122891|FG000|Overall Study|Withdrawal by Subject|1|||
25025307|NCT03640559|50122892|FG001|Overall Study|Withdrawal by Subject|0|||
25025308|NCT03339583|50122900|FG000|First Intervention (14 Days)|Adverse Event|1|||
25025309|NCT03339583|50122901|FG001|First Intervention (14 Days)|Adverse Event|0|||
25025310|NCT03339583|50122900|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
25025311|NCT03339583|50122901|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
25025312|NCT03339583|50122900|FG000|Second Intervention (14 Days)|Adverse Event|0|||
25025313|NCT03339583|50122901|FG001|Second Intervention (14 Days)|Adverse Event|1|||
25025314|NCT03339583|50122900|FG000|Follow-up (14 Days)|Physician Decision|6|||
25025315|NCT03339583|50122901|FG001|Follow-up (14 Days)|Physician Decision|3|||
25025316|NCT03639779|50122909|FG000|Overall Study|Lost to Follow-up|1|||
25025317|NCT03575975|50122918|FG000|Overall Study|Lost to Follow-up|1|||
25025318|NCT03575975|50122919|FG001|Overall Study|Lost to Follow-up|0|||
25025319|NCT03575975|50122920|FG002|Overall Study|Lost to Follow-up|0|||
25025320|NCT03636893|50122928|FG000|Overall Study|Death|0|||
25025321|NCT03636893|50122929|FG001|Overall Study|Death|1|||
25025322|NCT03636893|50122928|FG000|Overall Study|Protocol Violation|0|||
25025323|NCT03636893|50122929|FG001|Overall Study|Protocol Violation|3|||
25025324|NCT03636893|50122928|FG000|Overall Study|Withdrawal by Subject|1|||
25025325|NCT03636893|50122929|FG001|Overall Study|Withdrawal by Subject|2|||
25025326|NCT03636893|50122928|FG000|Overall Study|Refusal to surgery|4|||
25025327|NCT03636893|50122929|FG001|Overall Study|Refusal to surgery|3|||
25275073|NCT01237223|50589113|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
24927554|NCT00483717|50020980|FG001|Overall Study|Time of dosing missing|1|||
25025328|NCT03636893|50122928|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
25025329|NCT03636893|50122929|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
25025330|NCT03636893|50122928|FG000|Overall Study|Adverse Event|1|||
25025331|NCT03636893|50122929|FG001|Overall Study|Adverse Event|1|||
25025332|NCT01353586|50122937|FG000|Overall Study|Procedure terminated prior to ablation|3|||
24927555|NCT00483717|50020979|FG000|Overall Study|No treatment for migraine|16|||
24927556|NCT00483717|50020980|FG001|Overall Study|No treatment for migraine|13|||
24927557|NCT00483717|50020979|FG000|Overall Study|Lost to Follow-up|1|||
24927558|NCT00483717|50020980|FG001|Overall Study|Lost to Follow-up|0|||
24927559|NCT00483717|50020979|FG000|Overall Study|Withdrawal by Subject|1|||
24927560|NCT00483717|50020980|FG001|Overall Study|Withdrawal by Subject|0|||
24927561|NCT00406354|50020989|FG000|All Randomized Patients|Protocol Violation|0|||
24927562|NCT00406354|50020990|FG001|All Randomized Patients|Protocol Violation|0|||
24927563|NCT00406354|50020991|FG002|All Randomized Patients|Protocol Violation|1|||
24927564|NCT00406354|50020989|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
24927565|NCT00406354|50020990|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
24927566|NCT00406354|50020991|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
24927567|NCT00406354|50020989|FG000|All Randomized and Treated Patients|Adverse Event|6|||
24927568|NCT00406354|50020990|FG001|All Randomized and Treated Patients|Adverse Event|2|||
24927569|NCT00406354|50020991|FG002|All Randomized and Treated Patients|Adverse Event|1|||
24927570|NCT00406354|50020989|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
24927571|NCT00406354|50020990|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
25025333|NCT01353586|50122938|FG001|Overall Study|Procedure terminated prior to ablation|0|||
25025334|NCT01353586|50122937|FG000|Overall Study|Never had insertion of study catheter|4|||
25025335|NCT01353586|50122938|FG001|Overall Study|Never had insertion of study catheter|1|||
24927572|NCT00406354|50020991|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
24927573|NCT00406354|50020989|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
24927574|NCT00406354|50020990|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
24927575|NCT00406354|50020991|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
24927576|NCT00406354|50020989|FG000|All Randomized and Treated Patients|Physician Decision|0|||
24927577|NCT00406354|50020990|FG001|All Randomized and Treated Patients|Physician Decision|0|||
25025336|NCT01353586|50122937|FG000|Overall Study|Neurological exam not done|0|||
25025337|NCT01353586|50122938|FG001|Overall Study|Neurological exam not done|1|||
25025338|NCT03091920|50122950|FG000|Overall Study|Adverse Event|0|||
25025339|NCT03091920|50122951|FG001|Overall Study|Adverse Event|1|||
25025340|NCT03091920|50122952|FG002|Overall Study|Adverse Event|0|||
25025341|NCT03338569|50122968|FG000|Overall Study|Physician Decision|8|||
25025342|NCT03338569|50122969|FG001|Overall Study|Physician Decision|3|||
25025343|NCT03338569|50122968|FG000|Overall Study|Withdrawal by Subject|0|||
25025344|NCT03338569|50122969|FG001|Overall Study|Withdrawal by Subject|1|||
25025345|NCT03338569|50122968|FG000|Overall Study|Lost to Follow-up|0|||
25025346|NCT03338569|50122969|FG001|Overall Study|Lost to Follow-up|1|||
25025347|NCT03338023|50122977|FG000|Overall Study|Withdrawal by Subject|3|||
25025348|NCT03338023|50122978|FG001|Overall Study|Withdrawal by Subject|4|||
24927578|NCT00406354|50020991|FG002|All Randomized and Treated Patients|Physician Decision|1|||
24927579|NCT00483405|50020999|FG000|Overall Study|Adverse Event|8|||
24927580|NCT00483405|50020999|FG000|Overall Study|Lack of Efficacy|14|||
24927581|NCT00483405|50020999|FG000|Overall Study|Death|3|||
24927582|NCT00483405|50020999|FG000|Overall Study|Withdrawal by Subject|2|||
24927583|NCT00483405|50020999|FG000|Overall Study|Other complicating disease|1|||
24927584|NCT00483327|50021007|FG000|Overall Study|Adverse Event|1|||
24927585|NCT00483327|50021007|FG000|Overall Study|Withdrawal by Subject|3|||
24927586|NCT00483327|50021007|FG000|Overall Study|Lost to Follow-up|4|||
24927587|NCT00483327|50021007|FG000|Overall Study|Patient Non Compliance|2|||
25025349|NCT03338023|50122977|FG000|Overall Study|Protocol Violation|3|||
25025350|NCT03338023|50122978|FG001|Overall Study|Protocol Violation|3|||
25025351|NCT03338023|50122977|FG000|Overall Study|Lost to Follow-up|2|||
25155287|NCT01538199|50270550|FG002|Overall Study|Lost to Follow-up|1|||
24927588|NCT00684203|50021019|FG000|Overall Study|Adverse Event|6|||
25025352|NCT03338023|50122978|FG001|Overall Study|Lost to Follow-up|1|||
25025353|NCT03338023|50122977|FG000|Overall Study|Physician Decision|1|||
25025354|NCT03338023|50122978|FG001|Overall Study|Physician Decision|2|||
25155288|NCT01538199|50270551|FG003|Overall Study|Lost to Follow-up|0|||
24927589|NCT00684203|50021020|FG001|Overall Study|Adverse Event|4|||
24927590|NCT00684203|50021021|FG002|Overall Study|Adverse Event|8|||
24927591|NCT00684203|50021022|FG003|Overall Study|Adverse Event|0|||
24927592|NCT00684203|50021023|FG004|Overall Study|Adverse Event|0|||
25155289|NCT01538199|50270548|FG000|Overall Study|participant did not have time|1|||
25155290|NCT01538199|50270549|FG001|Overall Study|participant did not have time|0|||
25155291|NCT01538199|50270550|FG002|Overall Study|participant did not have time|0|||
25155292|NCT01538199|50270551|FG003|Overall Study|participant did not have time|2|||
24927593|NCT00684203|50021024|FG005|Overall Study|Adverse Event|0|||
24927594|NCT00684203|50021019|FG000|Overall Study|Protocol-defined clinical event|3|||
24927595|NCT00684203|50021020|FG001|Overall Study|Protocol-defined clinical event|1|||
24927596|NCT00684203|50021021|FG002|Overall Study|Protocol-defined clinical event|0|||
24927597|NCT00684203|50021022|FG003|Overall Study|Protocol-defined clinical event|0|||
24927598|NCT00684203|50021023|FG004|Overall Study|Protocol-defined clinical event|0|||
24927599|NCT00684203|50021024|FG005|Overall Study|Protocol-defined clinical event|0|||
24927600|NCT00684203|50021019|FG000|Overall Study|Withdrawal by Subject|0|||
24927601|NCT00684203|50021020|FG001|Overall Study|Withdrawal by Subject|2|||
24927602|NCT00684203|50021021|FG002|Overall Study|Withdrawal by Subject|1|||
24927603|NCT00684203|50021022|FG003|Overall Study|Withdrawal by Subject|0|||
24927604|NCT00684203|50021023|FG004|Overall Study|Withdrawal by Subject|0|||
24927605|NCT00684203|50021024|FG005|Overall Study|Withdrawal by Subject|0|||
24927606|NCT00684203|50021019|FG000|Overall Study|Did not meet protocol eligibility|0|||
24927607|NCT00684203|50021020|FG001|Overall Study|Did not meet protocol eligibility|1|||
24927608|NCT00684203|50021021|FG002|Overall Study|Did not meet protocol eligibility|0|||
24927609|NCT00684203|50021022|FG003|Overall Study|Did not meet protocol eligibility|0|||
24927610|NCT00684203|50021023|FG004|Overall Study|Did not meet protocol eligibility|0|||
24927611|NCT00684203|50021024|FG005|Overall Study|Did not meet protocol eligibility|0|||
24927612|NCT00423592|50021045|FG000|Overall Study|Adverse Event (through Week 12)|2|||
24927613|NCT00423592|50021045|FG000|Overall Study|Adverse Event (post Week 12)|5|||
24927614|NCT00683657|50021051|FG000|Overall Study|Adverse Event|0|||
24927615|NCT00683657|50021052|FG001|Overall Study|Adverse Event|1|||
24927616|NCT00683657|50021051|FG000|Overall Study|Subject Withdrew Consent|1|||
24927617|NCT00683657|50021052|FG001|Overall Study|Subject Withdrew Consent|0|||
24927618|NCT00680771|50021060|FG000|Overall Study|Withdrawal by Subject|1|||
24927619|NCT00680771|50021061|FG001|Overall Study|Withdrawal by Subject|0|||
24927620|NCT00680771|50021060|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
25155293|NCT01538199|50270548|FG000|Overall Study|Lack of Efficacy|0|||
25155294|NCT01538199|50270549|FG001|Overall Study|Lack of Efficacy|1|||
25155295|NCT01538199|50270550|FG002|Overall Study|Lack of Efficacy|0|||
25155296|NCT01538199|50270551|FG003|Overall Study|Lack of Efficacy|0|||
25155297|NCT01511445|50270570|FG000|Overall Study|Lost to Follow-up|3|||
24927621|NCT00680771|50021061|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
24927622|NCT00680771|50021060|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
25025355|NCT03337477|50122986|FG000|Overall Study|not categorized into the listed ones|11|||
25155298|NCT01511445|50270571|FG001|Overall Study|Lost to Follow-up|1|||
25155299|NCT01511445|50270570|FG000|Overall Study|Protocol Violation|1|||
25155300|NCT01511445|50270571|FG001|Overall Study|Protocol Violation|3|||
25155301|NCT01511445|50270570|FG000|Overall Study|Protocol Violation|1|||
25155302|NCT01511445|50270571|FG001|Overall Study|Protocol Violation|0|||
25155303|NCT01543503|50270579|FG000|Overall Study|Lost to Follow-up|32|||
25155304|NCT01543503|50270580|FG001|Overall Study|Lost to Follow-up|36|||
25155305|NCT01543503|50270579|FG000|Overall Study|Adverse Event|9|||
25185588|NCT00086281|50335087|FG000|Phase 2|Adverse Event|0|||
24927623|NCT00680771|50021061|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
24927624|NCT00482703|50021069|FG000|Overall Study|Poor compliance|1|||
24927625|NCT00482703|50021070|FG001|Overall Study|Poor compliance|0|||
24927626|NCT00482391|50021083|FG000|Overall Study|Withdrawal by Subject|1|||
24927627|NCT00482391|50021083|FG000|Overall Study|Adverse Event|1|||
24927628|NCT00482391|50021083|FG000|Overall Study|Death|1|||
24927629|NCT00423046|50021090|FG000|Overall Study|Other|340|||
24927630|NCT00423046|50021091|FG001|Overall Study|Other|345|||
24927631|NCT00496587|50021099|FG000|Overall Study|Adverse Event|2|||
24927632|NCT00496587|50021099|FG000|Overall Study|Progressive Disease|24|||
24927633|NCT00496587|50021099|FG000|Overall Study|Withdrawal by Subject|2|||
24927634|NCT00496587|50021099|FG000|Overall Study|Death|1|||
24927635|NCT00496587|50021099|FG000|Overall Study|Complications unrelated|2|||
25155306|NCT01543503|50270580|FG001|Overall Study|Adverse Event|13|||
25155307|NCT01543503|50270579|FG000|Overall Study|Lack of Efficacy|4|||
25155308|NCT01543503|50270580|FG001|Overall Study|Lack of Efficacy|16|||
25155309|NCT01543503|50270579|FG000|Overall Study|Participant withdrew informed consent|8|||
25155310|NCT01543503|50270580|FG001|Overall Study|Participant withdrew informed consent|10|||
25155311|NCT01543503|50270579|FG000|Overall Study|Change of jobs|0|||
25155312|NCT01543503|50270580|FG001|Overall Study|Change of jobs|1|||
25185589|NCT00086281|50335088|FG001|Phase 2|Adverse Event|0|||
24927636|NCT00405652|50021103|FG000|Overall Study|Adverse Event|4|||
24927637|NCT00422734|50021109|FG000|Overall Study|Physician Decision|1|||
24927638|NCT00422734|50021110|FG001|Overall Study|Physician Decision|1|||
24927639|NCT00422734|50021109|FG000|Overall Study|Protocol Violation|1|||
24927640|NCT00422734|50021110|FG001|Overall Study|Protocol Violation|6|||
24927641|NCT00422734|50021109|FG000|Overall Study|Withdrawal by Subject|12|||
24927642|NCT00422734|50021110|FG001|Overall Study|Withdrawal by Subject|8|||
24927643|NCT00422734|50021109|FG000|Overall Study|Adverse Event|0|||
24927644|NCT00422734|50021110|FG001|Overall Study|Adverse Event|3|||
24927645|NCT00422734|50021109|FG000|Overall Study|Partner Decision|0|||
24927646|NCT00422734|50021110|FG001|Overall Study|Partner Decision|3|||
24927647|NCT00422422|50021116|FG000|Overall Study|Lack of Efficacy|1|||
24927648|NCT00422422|50021116|FG000|Overall Study|Protocol Violation|1|||
24927649|NCT00422422|50021116|FG000|Overall Study|Withdrawal by Subject|2|||
24927650|NCT00422422|50021116|FG000|Overall Study|SAE, non-fatal|1|||
24927651|NCT00422422|50021116|FG000|Overall Study|AE, non-serious non-fatal|5|||
24927652|NCT00413374|50021124|FG000|Overall Study|Ineligible due to screening criteria.|3|||
24927653|NCT00413374|50021125|FG001|Overall Study|Ineligible due to screening criteria.|0|||
24927654|NCT00413374|50021124|FG000|Overall Study|Adverse Event|1|||
24927655|NCT00413374|50021125|FG001|Overall Study|Adverse Event|0|||
24927656|NCT00413374|50021124|FG000|Overall Study|Lost to Follow-up|1|||
24927657|NCT00413374|50021125|FG001|Overall Study|Lost to Follow-up|0|||
24927658|NCT00413374|50021124|FG000|Overall Study|Surgery|1|||
24927659|NCT00413374|50021125|FG001|Overall Study|Surgery|0|||
24927660|NCT00682643|50021136|FG000|Overall Study|Adverse Event|12|||
24927661|NCT00682643|50021137|FG001|Overall Study|Adverse Event|23|||
24927662|NCT00682643|50021136|FG000|Overall Study|Lack of Efficacy|2|||
24927663|NCT00682643|50021137|FG001|Overall Study|Lack of Efficacy|0|||
24927664|NCT00682643|50021136|FG000|Overall Study|Protocol Violation|38|||
24927665|NCT00682643|50021137|FG001|Overall Study|Protocol Violation|76|||
24927666|NCT00682643|50021136|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
24927667|NCT00682643|50021137|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
24927668|NCT00682643|50021136|FG000|Overall Study|Lost to Follow-up|1|||
24927669|NCT00682643|50021137|FG001|Overall Study|Lost to Follow-up|6|||
24927670|NCT00682643|50021136|FG000|Overall Study|Physician Decision|2|||
24927671|NCT00682643|50021137|FG001|Overall Study|Physician Decision|6|||
24927672|NCT00682643|50021136|FG000|Overall Study|Withdrawal by Subject|19|||
24927673|NCT00682643|50021137|FG001|Overall Study|Withdrawal by Subject|53|||
24927674|NCT00682643|50021136|FG000|Overall Study|Did Not Receive Study Drug|1|||
24927675|NCT00682643|50021137|FG001|Overall Study|Did Not Receive Study Drug|1|||
24927676|NCT00421408|50021146|FG000|Overall Study|Lost to Follow-up|30|||
24927677|NCT00421408|50021147|FG001|Overall Study|Lost to Follow-up|20|||
24927678|NCT00421408|50021146|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
24927679|NCT00421408|50021147|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
24927680|NCT00679913|50021155|FG000|Overall Study|Protocol Violation|18|||
24927681|NCT00679913|50021156|FG001|Overall Study|Protocol Violation|13|||
24927682|NCT00482001|50021173|FG000|Overall Study|Protocol Violation|1|||
24927683|NCT00482001|50021174|FG001|Overall Study|Protocol Violation|1|||
24927684|NCT00490035|50021186|FG000|Overall Study|AE, non-serious non-fatal|3|||
24927685|NCT00490035|50021187|FG001|Overall Study|AE, non-serious non-fatal|4|||
24927686|NCT00490035|50021188|FG002|Overall Study|AE, non-serious non-fatal|4|||
24927687|NCT00490035|50021189|FG003|Overall Study|AE, non-serious non-fatal|5|||
24927688|NCT00490035|50021186|FG000|Overall Study|Lost to Follow-up|2|||
24927689|NCT00490035|50021187|FG001|Overall Study|Lost to Follow-up|0|||
24927690|NCT00490035|50021188|FG002|Overall Study|Lost to Follow-up|1|||
24927691|NCT00490035|50021189|FG003|Overall Study|Lost to Follow-up|0|||
24927692|NCT00490035|50021186|FG000|Overall Study|Withdrawal by Subject|2|||
24927693|NCT00490035|50021187|FG001|Overall Study|Withdrawal by Subject|1|||
24927694|NCT00490035|50021188|FG002|Overall Study|Withdrawal by Subject|1|||
24927695|NCT00490035|50021189|FG003|Overall Study|Withdrawal by Subject|0|||
24927696|NCT00490035|50021186|FG000|Overall Study|Other reason|0|||
24927697|NCT00490035|50021187|FG001|Overall Study|Other reason|1|||
24927698|NCT00490035|50021188|FG002|Overall Study|Other reason|3|||
24927699|NCT00490035|50021189|FG003|Overall Study|Other reason|1|||
24927700|NCT00490035|50021186|FG000|Overall Study|AE, serious fatal|1|||
24927701|NCT00490035|50021187|FG001|Overall Study|AE, serious fatal|0|||
24927702|NCT00490035|50021188|FG002|Overall Study|AE, serious fatal|0|||
24927703|NCT00490035|50021189|FG003|Overall Study|AE, serious fatal|0|||
24927704|NCT00490035|50021186|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
24927705|NCT00490035|50021187|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
24927706|NCT00490035|50021188|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
24927707|NCT00490035|50021189|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
24927708|NCT00490035|50021186|FG000|Overall Study|AE of unknown type|0|||
24927709|NCT00490035|50021187|FG001|Overall Study|AE of unknown type|0|||
24927710|NCT00490035|50021188|FG002|Overall Study|AE of unknown type|2|||
24927711|NCT00490035|50021189|FG003|Overall Study|AE of unknown type|0|||
24927712|NCT00404248|50021202|FG000|Overall Study|pts declining status|0|||
24927713|NCT00404248|50021203|FG001|Overall Study|pts declining status|1|||
24927714|NCT00404248|50021204|FG002|Overall Study|pts declining status|0|||
24927715|NCT00404248|50021205|FG003|Overall Study|pts declining status|0|||
24927716|NCT00404248|50021206|FG004|Overall Study|pts declining status|0|||
24927717|NCT00404248|50021207|FG005|Overall Study|pts declining status|0|||
24927718|NCT00404248|50021208|FG006|Overall Study|pts declining status|0|||
24927719|NCT00404248|50021209|FG007|Overall Study|pts declining status|0|||
24927720|NCT00404248|50021210|FG008|Overall Study|pts declining status|0|||
24927721|NCT00421174|50021238|FG000|Overall Study|Withdrawal by Subject|0|||
24927722|NCT00421174|50021239|FG001|Overall Study|Withdrawal by Subject|1|||
24927723|NCT00421174|50021238|FG000|Overall Study|Ineligible due to infection|2|||
24927724|NCT00421174|50021239|FG001|Overall Study|Ineligible due to infection|0|||
24927725|NCT00496197|50021245|FG000|Overall Study|Discontinued study due to death|43|||
24927726|NCT00496197|50021245|FG000|Overall Study|Adverse Event|13|||
24927727|NCT00496197|50021245|FG000|Overall Study|Does not meet entrance criteria|5|||
24927728|NCT00496197|50021245|FG000|Overall Study|Insufficient clinical response|3|||
24927729|NCT00496197|50021245|FG000|Overall Study|Insufficient bacteriological response|10|||
24927730|NCT00496197|50021245|FG000|Overall Study|Lost to Follow-up|11|||
24927731|NCT00496197|50021245|FG000|Overall Study|Withdrawal by Subject|11|||
24927732|NCT00496197|50021245|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
24927733|NCT00496197|50021245|FG000|Overall Study|Other|14|||
24927734|NCT00496197|50021245|FG000|Overall Study|Protocol Violation|8|||
24927735|NCT00495495|50021249|FG000|Overall Study|Protocol Violation|99|||
24927736|NCT00404092|50021258|FG000|Overall Study|Death|1|||
24927737|NCT00404092|50021259|FG001|Overall Study|Death|0|||
24927738|NCT00404092|50021260|FG002|Overall Study|Death|0|||
24927739|NCT00404092|50021261|FG003|Overall Study|Death|0|||
24927740|NCT00404092|50021258|FG000|Overall Study|Adverse Event|0|||
24927741|NCT00404092|50021259|FG001|Overall Study|Adverse Event|0|||
24927742|NCT00404092|50021260|FG002|Overall Study|Adverse Event|1|||
24927743|NCT00404092|50021261|FG003|Overall Study|Adverse Event|0|||
24927744|NCT00481767|50021273|FG000|Overall Study|Withdrawal by Subject|16|||
24927745|NCT00481767|50021274|FG001|Overall Study|Withdrawal by Subject|11|||
24927746|NCT00481767|50021273|FG000|Overall Study|Lost to Follow-up|16|||
24927747|NCT00481767|50021274|FG001|Overall Study|Lost to Follow-up|10|||
24927748|NCT00489489|50021283|FG000|Overall Study|Not treated due to protocol violation|0|||
24927749|NCT00489489|50021284|FG001|Overall Study|Not treated due to protocol violation|1|||
24927750|NCT00489489|50021285|FG002|Overall Study|Not treated due to protocol violation|1|||
24927751|NCT00489489|50021283|FG000|Overall Study|Adverse Event|1|||
24927752|NCT00489489|50021284|FG001|Overall Study|Adverse Event|1|||
24927753|NCT00489489|50021285|FG002|Overall Study|Adverse Event|1|||
24927754|NCT00489489|50021283|FG000|Overall Study|Protocol Violation|1|||
24927755|NCT00489489|50021284|FG001|Overall Study|Protocol Violation|0|||
24927756|NCT00489489|50021285|FG002|Overall Study|Protocol Violation|1|||
24927757|NCT00489489|50021283|FG000|Overall Study|Progressive disease|0|||
24927758|NCT00489489|50021284|FG001|Overall Study|Progressive disease|1|||
24927759|NCT00489489|50021285|FG002|Overall Study|Progressive disease|0|||
24927760|NCT00489489|50021283|FG000|Overall Study|Participant did not wish to continue|1|||
24927761|NCT00489489|50021284|FG001|Overall Study|Participant did not wish to continue|1|||
24927762|NCT00489489|50021285|FG002|Overall Study|Participant did not wish to continue|0|||
24927763|NCT00489489|50021283|FG000|Overall Study|Other than above|0|||
24927764|NCT00489489|50021284|FG001|Overall Study|Other than above|1|||
24927765|NCT00489489|50021285|FG002|Overall Study|Other than above|0|||
24927766|NCT00489411|50021297|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
24927767|NCT00489411|50021298|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
25185590|NCT00086281|50335089|FG002|Phase 2|Adverse Event|0|||
24927768|NCT00489411|50021297|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
25185591|NCT00086281|50335090|FG003|Phase 2|Adverse Event|0|||
25185592|NCT00086281|50335091|FG004|Phase 2|Adverse Event|0|||
24927769|NCT00489411|50021298|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
24927770|NCT00489411|50021297|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
24927771|NCT00489411|50021298|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
24927772|NCT00489411|50021297|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
24927773|NCT00489411|50021298|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
24927774|NCT00489411|50021297|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
24927775|NCT00489411|50021298|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
24927776|NCT00420784|50021308|FG000|Overall Study|Adverse Event|11|||
24927777|NCT00420784|50021309|FG001|Overall Study|Adverse Event|29|||
25025356|NCT03337477|50122987|FG001|Overall Study|not categorized into the listed ones|9|||
25025357|NCT03337477|50122986|FG000|Overall Study|Withdrawal by Subject|0|||
25025358|NCT03337477|50122987|FG001|Overall Study|Withdrawal by Subject|1|||
25025359|NCT03337477|50122986|FG000|Overall Study|Death|0|||
25025360|NCT03337477|50122987|FG001|Overall Study|Death|1|||
25025361|NCT03337477|50122986|FG000|Overall Study|Lost to Follow-up|0|||
25025362|NCT03337477|50122987|FG001|Overall Study|Lost to Follow-up|2|||
25025363|NCT02687542|50123000|FG000|Overall Study|Medication error without associated AEs|0|||
25025364|NCT02687542|50123001|FG001|Overall Study|Medication error without associated AEs|0|||
24927778|NCT00420784|50021310|FG002|Overall Study|Adverse Event|10|||
24927779|NCT00420784|50021311|FG003|Overall Study|Adverse Event|5|||
25025365|NCT02687542|50123002|FG002|Overall Study|Medication error without associated AEs|0|||
25025366|NCT02687542|50123003|FG003|Overall Study|Medication error without associated AEs|0|||
25025367|NCT02687542|50123004|FG004|Overall Study|Medication error without associated AEs|1|||
25025368|NCT02687542|50123000|FG000|Overall Study|Lost to Follow-up|0|||
25025369|NCT02687542|50123001|FG001|Overall Study|Lost to Follow-up|0|||
25025370|NCT02687542|50123002|FG002|Overall Study|Lost to Follow-up|0|||
25025371|NCT02687542|50123003|FG003|Overall Study|Lost to Follow-up|0|||
25025372|NCT02687542|50123004|FG004|Overall Study|Lost to Follow-up|1|||
25025373|NCT02687542|50123000|FG000|Overall Study|Protocol Violation|0|||
25025374|NCT02687542|50123001|FG001|Overall Study|Protocol Violation|1|||
25025375|NCT02687542|50123002|FG002|Overall Study|Protocol Violation|0|||
25025376|NCT02687542|50123003|FG003|Overall Study|Protocol Violation|0|||
25025377|NCT02687542|50123004|FG004|Overall Study|Protocol Violation|0|||
24927780|NCT00420784|50021308|FG000|Overall Study|Withdrawal by Subject|0|||
24927781|NCT00420784|50021309|FG001|Overall Study|Withdrawal by Subject|1|||
24927782|NCT00420784|50021310|FG002|Overall Study|Withdrawal by Subject|0|||
24927783|NCT00420784|50021311|FG003|Overall Study|Withdrawal by Subject|0|||
24927784|NCT00420784|50021308|FG000|Overall Study|Lost to Follow-up|0|||
24927785|NCT00420784|50021309|FG001|Overall Study|Lost to Follow-up|0|||
24927786|NCT00420784|50021310|FG002|Overall Study|Lost to Follow-up|2|||
24927787|NCT00420784|50021311|FG003|Overall Study|Lost to Follow-up|1|||
24927788|NCT00420784|50021308|FG000|Overall Study|Virologic Stopping Rule|17|||
24927789|NCT00420784|50021309|FG001|Overall Study|Virologic Stopping Rule|26|||
24927790|NCT00420784|50021310|FG002|Overall Study|Virologic Stopping Rule|41|||
24927791|NCT00420784|50021311|FG003|Overall Study|Virologic Stopping Rule|67|||
24927792|NCT00420784|50021308|FG000|Overall Study|Other|1|||
24927793|NCT00420784|50021309|FG001|Overall Study|Other|2|||
24927794|NCT00420784|50021310|FG002|Overall Study|Other|0|||
24927795|NCT00420784|50021311|FG003|Overall Study|Other|5|||
24927796|NCT00420628|50021324|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
24927797|NCT00420628|50021325|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
24927798|NCT00420628|50021324|FG000|Overall Study|Lost to Follow-up|3|||
24927799|NCT00420628|50021325|FG001|Overall Study|Lost to Follow-up|2|||
24927800|NCT00420628|50021324|FG000|Overall Study|Adverse Event|1|||
24927801|NCT00420628|50021325|FG001|Overall Study|Adverse Event|0|||
24927802|NCT00489255|50021333|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
24927803|NCT00489255|50021334|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
24927804|NCT00489255|50021333|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
24927805|NCT00489255|50021334|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
24927806|NCT00489255|50021333|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
24927807|NCT00489255|50021334|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
24927808|NCT00489255|50021333|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
24927809|NCT00489255|50021334|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
24927810|NCT00489255|50021333|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
24927811|NCT00489255|50021334|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
24927812|NCT00489255|50021333|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
24927813|NCT00489255|50021334|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
24927814|NCT00489255|50021333|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
24927815|NCT00489255|50021334|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
25025378|NCT02687542|50123000|FG000|Overall Study|Other|5|||
25025379|NCT02687542|50123001|FG001|Overall Study|Other|9|||
25025380|NCT02687542|50123002|FG002|Overall Study|Other|10|||
25025381|NCT02687542|50123003|FG003|Overall Study|Other|6|||
24927816|NCT00489255|50021333|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
24927817|NCT00489255|50021334|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
24927818|NCT00489255|50021333|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
24927819|NCT00489255|50021334|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
24927820|NCT00489255|50021333|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
24927821|NCT00489255|50021334|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
24927822|NCT00413218|50021342|FG000|Overall Study|Randomized but didn't receive study drug|2|||
24927823|NCT00413218|50021343|FG001|Overall Study|Randomized but didn't receive study drug|8|||
24927824|NCT00413218|50021342|FG000|Overall Study|Death|57|||
25025382|NCT02687542|50123004|FG004|Overall Study|Other|5|||
25025383|NCT02687542|50123000|FG000|Overall Study|Adverse Event|3|||
24927825|NCT00413218|50021343|FG001|Overall Study|Death|56|||
24927826|NCT00413218|50021342|FG000|Overall Study|Lost to Follow-up|14|||
24927827|NCT00413218|50021343|FG001|Overall Study|Lost to Follow-up|17|||
24927828|NCT00413218|50021342|FG000|Overall Study|Admin|20|||
24927829|NCT00413218|50021343|FG001|Overall Study|Admin|14|||
24927830|NCT00413218|50021342|FG000|Overall Study|Missing|1|||
24927831|NCT00413218|50021343|FG001|Overall Study|Missing|0|||
24927832|NCT00413218|50021342|FG000|Overall Study|Withdrawal by Subject|9|||
24927833|NCT00413218|50021343|FG001|Overall Study|Withdrawal by Subject|1|||
24927834|NCT00420316|50021352|FG000|Overall Study|Withdrawal by Subject|0|||
24927835|NCT00420316|50021353|FG001|Overall Study|Withdrawal by Subject|1|||
25155313|NCT01543503|50270579|FG000|Overall Study|Intolerance to the biologic treatment|0|||
25155314|NCT01543503|50270580|FG001|Overall Study|Intolerance to the biologic treatment|1|||
25155315|NCT01543503|50270579|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
25155316|NCT01543503|50270580|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
25155317|NCT01543503|50270579|FG000|Overall Study|Participant did not complete last visit|0|||
24927836|NCT00420316|50021352|FG000|Overall Study|Lost to Follow-up|12|||
24927837|NCT00420316|50021353|FG001|Overall Study|Lost to Follow-up|8|||
24927838|NCT00494871|50021361|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
24927839|NCT00494871|50021362|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
24927840|NCT00494871|50021361|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
25155318|NCT01543503|50270580|FG001|Overall Study|Participant did not complete last visit|2|||
25155319|NCT01543503|50270579|FG000|Overall Study|Refused to continue treatment|7|||
25155320|NCT01543503|50270580|FG001|Overall Study|Refused to continue treatment|0|||
25155321|NCT01543503|50270579|FG000|Overall Study|Incorrect medication received|1|||
25155322|NCT01543503|50270580|FG001|Overall Study|Incorrect medication received|0|||
25155323|NCT01543503|50270579|FG000|Overall Study|Participant moved to another city|2|||
25155324|NCT01543503|50270580|FG001|Overall Study|Participant moved to another city|0|||
25155325|NCT01543503|50270579|FG000|Overall Study|Participant will not return for visits|0|||
25185593|NCT00086281|50335092|FG005|Phase 2|Adverse Event|0|||
25185594|NCT00086281|50335093|FG006|Phase 2|Adverse Event|0|||
24927841|NCT00494871|50021362|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
24927842|NCT00494871|50021361|FG000|Double-blind (DB) Treatment Period|Death|8|||
24927843|NCT00494871|50021362|FG001|Double-blind (DB) Treatment Period|Death|3|||
24927844|NCT00494871|50021361|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
24927845|NCT00494871|50021362|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
24927846|NCT00494871|50021361|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
24927847|NCT00494871|50021362|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
24927848|NCT00494871|50021361|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
24927849|NCT00494871|50021362|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
24927850|NCT00494871|50021361|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
24927851|NCT00494871|50021362|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
24927852|NCT00494871|50021361|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
24927853|NCT00494871|50021362|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
24927854|NCT00494871|50021361|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
24927855|NCT00494871|50021362|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
24927856|NCT00494871|50021361|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
24927857|NCT00494871|50021362|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
24927858|NCT00494871|50021361|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
24927859|NCT00494871|50021362|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
24927860|NCT00494871|50021361|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
24927861|NCT00494871|50021362|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
25155326|NCT01543503|50270580|FG001|Overall Study|Participant will not return for visits|2|||
25185595|NCT00086281|50335094|FG007|Phase 2|Adverse Event|0|||
24927862|NCT00494871|50021361|FG000|Follow-up (FU) Period|Adverse Event|1|||
24927863|NCT00494871|50021362|FG001|Follow-up (FU) Period|Adverse Event|1|||
24927864|NCT00494871|50021361|FG000|Follow-up (FU) Period|Death|13|||
24927865|NCT00494871|50021362|FG001|Follow-up (FU) Period|Death|12|||
24927866|NCT00494871|50021361|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
24927867|NCT00494871|50021362|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
24927868|NCT00494871|50021361|FG000|Follow-up (FU) Period|Physician Decision|0|||
24927869|NCT00494871|50021362|FG001|Follow-up (FU) Period|Physician Decision|1|||
24927870|NCT00494871|50021361|FG000|Follow-up (FU) Period|Protocol Violation|1|||
25025384|NCT02687542|50123001|FG001|Overall Study|Adverse Event|1|||
25025385|NCT02687542|50123002|FG002|Overall Study|Adverse Event|3|||
25025386|NCT02687542|50123003|FG003|Overall Study|Adverse Event|2|||
25025387|NCT02687542|50123004|FG004|Overall Study|Adverse Event|9|||
25025388|NCT02687542|50123000|FG000|Overall Study|Withdrawal by Subject|0|||
25025389|NCT02687542|50123001|FG001|Overall Study|Withdrawal by Subject|1|||
25025390|NCT02687542|50123002|FG002|Overall Study|Withdrawal by Subject|1|||
25025391|NCT02687542|50123003|FG003|Overall Study|Withdrawal by Subject|2|||
25025392|NCT02687542|50123004|FG004|Overall Study|Withdrawal by Subject|4|||
25025393|NCT03336619|50123018|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
25275074|NCT01237223|50589108|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
25275075|NCT01237223|50589109|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
24927871|NCT00494871|50021362|FG001|Follow-up (FU) Period|Protocol Violation|0|||
25025394|NCT03336619|50123019|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
25025395|NCT03336619|50123018|FG000|Overall Study|Withdrawal by Subject|17|||
24927872|NCT00494871|50021361|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
24927873|NCT00494871|50021362|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
24927874|NCT00494871|50021361|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
24927875|NCT00494871|50021362|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
24927876|NCT00420238|50021372|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
24927877|NCT00420238|50021373|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
24927878|NCT00420238|50021372|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
24927879|NCT00420238|50021373|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
24927880|NCT00420238|50021372|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
24927881|NCT00420238|50021373|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
24927882|NCT00420238|50021372|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
24927883|NCT00420238|50021373|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
24927884|NCT00420238|50021372|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
24927885|NCT00420238|50021373|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
24927886|NCT00420238|50021372|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
24927887|NCT00420238|50021373|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
24927888|NCT00420004|50021388|FG000|Overall Study|Adverse Event|4|||
24927889|NCT00420004|50021389|FG001|Overall Study|Adverse Event|1|||
24927890|NCT00420004|50021390|FG002|Overall Study|Adverse Event|1|||
24927891|NCT00420004|50021388|FG000|Overall Study|Lack of Efficacy|5|||
24927892|NCT00420004|50021389|FG001|Overall Study|Lack of Efficacy|4|||
24927893|NCT00420004|50021390|FG002|Overall Study|Lack of Efficacy|1|||
24927894|NCT00420004|50021388|FG000|Overall Study|Lost to Follow-up|31|||
24927895|NCT00420004|50021389|FG001|Overall Study|Lost to Follow-up|12|||
24927896|NCT00420004|50021390|FG002|Overall Study|Lost to Follow-up|10|||
24927897|NCT00420004|50021388|FG000|Overall Study|Entry Criteria Not Met|0|||
24927898|NCT00420004|50021389|FG001|Overall Study|Entry Criteria Not Met|1|||
24927899|NCT00420004|50021390|FG002|Overall Study|Entry Criteria Not Met|0|||
24927900|NCT00420004|50021388|FG000|Overall Study|Physician Decision|14|||
24927901|NCT00420004|50021389|FG001|Overall Study|Physician Decision|4|||
24927902|NCT00420004|50021390|FG002|Overall Study|Physician Decision|2|||
24927903|NCT00420004|50021388|FG000|Overall Study|Protocol Violation|5|||
24927904|NCT00420004|50021389|FG001|Overall Study|Protocol Violation|4|||
24927905|NCT00420004|50021390|FG002|Overall Study|Protocol Violation|3|||
24927906|NCT00420004|50021388|FG000|Overall Study|Withdrawal by Subject|67|||
24927907|NCT00420004|50021389|FG001|Overall Study|Withdrawal by Subject|42|||
24927908|NCT00420004|50021390|FG002|Overall Study|Withdrawal by Subject|14|||
24927909|NCT00420004|50021388|FG000|Overall Study|Sponsor Decision|3|||
24927910|NCT00420004|50021389|FG001|Overall Study|Sponsor Decision|3|||
24927911|NCT00420004|50021390|FG002|Overall Study|Sponsor Decision|1|||
24927912|NCT00494481|50021404|FG000|Overall Study|Condition under investigation worsened|11|||
24927913|NCT00494481|50021405|FG001|Overall Study|Condition under investigation worsened|13|||
24927914|NCT00494481|50021404|FG000|Overall Study|Adverse Event|15|||
24927915|NCT00494481|50021405|FG001|Overall Study|Adverse Event|11|||
24927916|NCT00494481|50021404|FG000|Overall Study|Other|1|||
24927917|NCT00494481|50021405|FG001|Overall Study|Other|0|||
24927918|NCT00494481|50021404|FG000|Overall Study|Never received IP|2|||
24927919|NCT00494481|50021405|FG001|Overall Study|Never received IP|0|||
24927920|NCT00097591|50021413|FG000|Overall Study|Withdrawal of consent|342|||
24927921|NCT00097591|50021414|FG001|Overall Study|Withdrawal of consent|323|||
24927922|NCT00097591|50021413|FG000|Overall Study|Less than 6 months on study drug|9|||
24927923|NCT00097591|50021414|FG001|Overall Study|Less than 6 months on study drug|7|||
24927924|NCT00097591|50021413|FG000|Overall Study|Unable to attend termination visit|53|||
24927925|NCT00097591|50021414|FG001|Overall Study|Unable to attend termination visit|51|||
24927926|NCT00097591|50021413|FG000|Overall Study|Lost to follow up|6|||
24927927|NCT00097591|50021414|FG001|Overall Study|Lost to follow up|10|||
24927928|NCT00097591|50021413|FG000|Overall Study|Other|0|||
24927929|NCT00097591|50021414|FG001|Overall Study|Other|3|||
24927930|NCT00419926|50021422|FG000|Overall Study|Withdrawal by Subject|7|||
24927931|NCT00419926|50021423|FG001|Overall Study|Withdrawal by Subject|3|||
24927932|NCT00419926|50021422|FG000|Overall Study|Administrative Problem|4|||
24927933|NCT00419926|50021423|FG001|Overall Study|Administrative Problem|4|||
24927934|NCT00419926|50021422|FG000|Overall Study|Lost to Follow-up|1|||
24927935|NCT00419926|50021423|FG001|Overall Study|Lost to Follow-up|2|||
24927936|NCT00419926|50021422|FG000|Overall Study|Death|2|||
24927937|NCT00419926|50021423|FG001|Overall Study|Death|1|||
24927938|NCT00419770|50021431|FG000|Overall Study|Withdrawal by Subject|5|||
24927939|NCT00419770|50021432|FG001|Overall Study|Withdrawal by Subject|1|||
24927940|NCT00080119|50021442|FG000|Overall Study|Discontinued because of study closure|0|||
24927941|NCT00080119|50021443|FG001|Overall Study|Discontinued because of study closure|0|||
24927942|NCT00080119|50021444|FG002|Overall Study|Discontinued because of study closure|130|||
24927943|NCT00080119|50021445|FG003|Overall Study|Discontinued because of study closure|141|||
24927944|NCT00080119|50021442|FG000|Overall Study|Unable to get to clinic|24|||
24927945|NCT00080119|50021443|FG001|Overall Study|Unable to get to clinic|24|||
24927946|NCT00080119|50021444|FG002|Overall Study|Unable to get to clinic|7|||
24927947|NCT00080119|50021445|FG003|Overall Study|Unable to get to clinic|1|||
25155327|NCT01543503|50270579|FG000|Overall Study|Participant transferred to another city|1|||
25155328|NCT01543503|50270580|FG001|Overall Study|Participant transferred to another city|0|||
25155329|NCT01543503|50270579|FG000|Overall Study|Participant moved to Scotland|1|||
25155330|NCT01543503|50270580|FG001|Overall Study|Participant moved to Scotland|0|||
25155331|NCT01543503|50270579|FG000|Overall Study|Participant decision to stop treatment|1|||
25155332|NCT01543503|50270580|FG001|Overall Study|Participant decision to stop treatment|0|||
25155333|NCT01543503|50270579|FG000|Overall Study|Investigator did not wish to participate|1|||
24927948|NCT00080119|50021442|FG000|Overall Study|Consent withdrawn|13|||
24927949|NCT00080119|50021443|FG001|Overall Study|Consent withdrawn|17|||
24927950|NCT00080119|50021444|FG002|Overall Study|Consent withdrawn|4|||
24927951|NCT00080119|50021445|FG003|Overall Study|Consent withdrawn|6|||
24927952|NCT00080119|50021442|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
24927953|NCT00080119|50021443|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
24927954|NCT00080119|50021444|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
24927955|NCT00080119|50021445|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
24927956|NCT00080119|50021442|FG000|Overall Study|Lost to Follow-up|16|||
24927957|NCT00080119|50021443|FG001|Overall Study|Lost to Follow-up|19|||
24927958|NCT00080119|50021444|FG002|Overall Study|Lost to Follow-up|19|||
24927959|NCT00080119|50021445|FG003|Overall Study|Lost to Follow-up|14|||
24927960|NCT00419380|50021459|FG000|Overall Study|Lack of Efficacy|1|||
24927961|NCT00419380|50021460|FG001|Overall Study|Lack of Efficacy|7|||
25025396|NCT03336619|50123019|FG001|Overall Study|Withdrawal by Subject|16|||
25155334|NCT01543503|50270580|FG001|Overall Study|Investigator did not wish to participate|1|||
25155335|NCT01543503|50270579|FG000|Overall Study|Participant recruited after closing date|0|||
24927962|NCT00419380|50021459|FG000|Overall Study|Physician Decision|0|||
24927963|NCT00419380|50021460|FG001|Overall Study|Physician Decision|1|||
24927964|NCT00419380|50021459|FG000|Overall Study|Lost to Follow-up|0|||
24927965|NCT00419380|50021460|FG001|Overall Study|Lost to Follow-up|1|||
24927966|NCT00419380|50021459|FG000|Overall Study|Withdrawal by Subject|0|||
24927967|NCT00419380|50021460|FG001|Overall Study|Withdrawal by Subject|1|||
24927968|NCT00413062|50021468|FG000|Overall Study|Adverse event/serious adverse event|289|||
24927969|NCT00413062|50021469|FG001|Overall Study|Adverse event/serious adverse event|56|||
24927970|NCT00413062|50021468|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
25025397|NCT03336619|50123018|FG000|Overall Study|Adverse Event|2|||
24927971|NCT00413062|50021469|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
24927972|NCT00413062|50021468|FG000|Overall Study|Withdrawal of informed consent|111|||
24927973|NCT00413062|50021469|FG001|Overall Study|Withdrawal of informed consent|36|||
24927974|NCT00413062|50021468|FG000|Overall Study|Pregnancy|15|||
24927975|NCT00413062|50021469|FG001|Overall Study|Pregnancy|5|||
24927976|NCT00413062|50021468|FG000|Overall Study|Pregnancy wish|17|||
24927977|NCT00413062|50021469|FG001|Overall Study|Pregnancy wish|6|||
24927978|NCT00413062|50021468|FG000|Overall Study|Lost to Follow-up|175|||
24927979|NCT00413062|50021469|FG001|Overall Study|Lost to Follow-up|73|||
24927980|NCT00413062|50021468|FG000|Overall Study|Other reason|70|||
24927981|NCT00413062|50021469|FG001|Overall Study|Other reason|34|||
24927982|NCT00494091|50021479|FG000|Overall Study|Death|5|||
24927983|NCT00494091|50021480|FG001|Overall Study|Death|54|||
24927984|NCT00494091|50021479|FG000|Overall Study|Lost to Follow-up|0|||
25025398|NCT03336619|50123019|FG001|Overall Study|Adverse Event|5|||
25025399|NCT03336619|50123018|FG000|Overall Study|Physician Decision|3|||
25025400|NCT03336619|50123019|FG001|Overall Study|Physician Decision|0|||
25025401|NCT01353508|50123041|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
25025402|NCT01353508|50123042|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
25025403|NCT01353508|50123043|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
25025404|NCT01353508|50123044|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
25025405|NCT01353508|50123041|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
25025406|NCT01353508|50123042|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
25025407|NCT01353508|50123043|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
24927985|NCT00494091|50021480|FG001|Overall Study|Lost to Follow-up|4|||
24927986|NCT00494091|50021479|FG000|Overall Study|Other|1|||
24927987|NCT00494091|50021480|FG001|Overall Study|Other|11|||
24927988|NCT00494091|50021479|FG000|Overall Study|Withdrawal by Subject|0|||
24927989|NCT00494091|50021480|FG001|Overall Study|Withdrawal by Subject|7|||
24927990|NCT00494013|50021489|FG000|Overall Study|Adverse Event|0|||
24927991|NCT00494013|50021490|FG001|Overall Study|Adverse Event|1|||
24927992|NCT00494013|50021489|FG000|Overall Study|Entry Criteria Not Met|1|||
24927993|NCT00494013|50021490|FG001|Overall Study|Entry Criteria Not Met|4|||
24927994|NCT00494013|50021489|FG000|Overall Study|Lost to Follow-up|5|||
24927995|NCT00494013|50021490|FG001|Overall Study|Lost to Follow-up|6|||
24927996|NCT00494013|50021489|FG000|Overall Study|Physician Decision|3|||
24927997|NCT00494013|50021490|FG001|Overall Study|Physician Decision|5|||
25025408|NCT01353508|50123044|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
25025409|NCT03636269|50123056|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
25025410|NCT03636269|50123057|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
25025411|NCT03636269|50123058|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
25025412|NCT03636269|50123056|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
25025413|NCT03636269|50123057|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
25025414|NCT03636269|50123058|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
25025415|NCT03636269|50123056|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
25185596|NCT00086281|50335095|FG008|Phase 2|Adverse Event|0|||
24927998|NCT00494013|50021489|FG000|Overall Study|Protocol Violation|8|||
24927999|NCT00494013|50021490|FG001|Overall Study|Protocol Violation|5|||
24928000|NCT00494013|50021489|FG000|Overall Study|Withdrawal by Subject|13|||
24928001|NCT00494013|50021490|FG001|Overall Study|Withdrawal by Subject|14|||
24928002|NCT00494013|50021489|FG000|Overall Study|Sponsor Decision|0|||
24928003|NCT00494013|50021490|FG001|Overall Study|Sponsor Decision|1|||
24928004|NCT00079339|50021499|FG000|Overall Study|Adverse Event|1|||
24928005|NCT00079339|50021500|FG001|Overall Study|Adverse Event|7|||
24928006|NCT00079339|50021501|FG002|Overall Study|Adverse Event|2|||
24928007|NCT00079339|50021499|FG000|Overall Study|Death|1|||
24928008|NCT00079339|50021500|FG001|Overall Study|Death|0|||
24928009|NCT00079339|50021501|FG002|Overall Study|Death|0|||
24928010|NCT00079339|50021499|FG000|Overall Study|Non-compliance|0|||
24928011|NCT00079339|50021500|FG001|Overall Study|Non-compliance|0|||
24928012|NCT00079339|50021501|FG002|Overall Study|Non-compliance|1|||
24928013|NCT00079339|50021499|FG000|Overall Study|Withdrawal by Subject|0|||
24928014|NCT00079339|50021500|FG001|Overall Study|Withdrawal by Subject|4|||
24928015|NCT00079339|50021501|FG002|Overall Study|Withdrawal by Subject|1|||
25025416|NCT03636269|50123057|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
25025417|NCT03636269|50123058|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
25025418|NCT03636269|50123056|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
25025419|NCT03636269|50123057|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
24928016|NCT00079339|50021499|FG000|Overall Study|Disease progression|3|||
24928017|NCT00079339|50021500|FG001|Overall Study|Disease progression|28|||
24928018|NCT00079339|50021501|FG002|Overall Study|Disease progression|2|||
24928019|NCT00493779|50021514|FG000|Overall Study|Logistical issue at site|1|||
24928020|NCT00541866|50021524|FG000|Overall Study|Adverse Event|3|||
24928021|NCT00541866|50021525|FG001|Overall Study|Adverse Event|0|||
24928022|NCT00541866|50021526|FG002|Overall Study|Adverse Event|0|||
24928023|NCT00541866|50021527|FG003|Overall Study|Adverse Event|0|||
24928024|NCT00541866|50021528|FG004|Overall Study|Adverse Event|0|||
24928025|NCT00541866|50021524|FG000|Overall Study|Death|1|||
24928026|NCT00541866|50021525|FG001|Overall Study|Death|0|||
24928027|NCT00541866|50021526|FG002|Overall Study|Death|0|||
24928028|NCT00541866|50021527|FG003|Overall Study|Death|0|||
24928029|NCT00541866|50021528|FG004|Overall Study|Death|0|||
24928030|NCT00541866|50021524|FG000|Overall Study|Lack of Efficacy|19|||
24928031|NCT00541866|50021525|FG001|Overall Study|Lack of Efficacy|15|||
24928032|NCT00541866|50021526|FG002|Overall Study|Lack of Efficacy|10|||
24928033|NCT00541866|50021527|FG003|Overall Study|Lack of Efficacy|12|||
24928034|NCT00541866|50021528|FG004|Overall Study|Lack of Efficacy|14|||
24928035|NCT00541866|50021524|FG000|Overall Study|Not Reported or Other|11|||
24928036|NCT00541866|50021525|FG001|Overall Study|Not Reported or Other|3|||
24928037|NCT00541866|50021526|FG002|Overall Study|Not Reported or Other|3|||
24928038|NCT00541866|50021527|FG003|Overall Study|Not Reported or Other|3|||
24928039|NCT00541866|50021528|FG004|Overall Study|Not Reported or Other|1|||
24928040|NCT00541866|50021524|FG000|Overall Study|Physician Decision|0|||
24928041|NCT00541866|50021525|FG001|Overall Study|Physician Decision|0|||
24928042|NCT00541866|50021526|FG002|Overall Study|Physician Decision|2|||
24928043|NCT00541866|50021527|FG003|Overall Study|Physician Decision|1|||
24928044|NCT00541866|50021528|FG004|Overall Study|Physician Decision|0|||
24928045|NCT00493467|50021556|FG000|Overall Study|Death|1|||
24928046|NCT00090493|50021560|FG000|Overall Study|Physician Decision|2|||
24928047|NCT04329702|50021567|FG000|Overall Study|illness|3|||
25025420|NCT03636269|50123058|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
24928048|NCT04329702|50021568|FG001|Overall Study|illness|4|||
24928049|NCT04329702|50021569|FG002|Overall Study|illness|0|||
24928050|NCT04329702|50021567|FG000|Overall Study|Lost to Follow-up|0|||
24928051|NCT04329702|50021568|FG001|Overall Study|Lost to Follow-up|0|||
24928052|NCT04329702|50021569|FG002|Overall Study|Lost to Follow-up|2|||
24928053|NCT04329702|50021567|FG000|Overall Study|Death|0|||
24928054|NCT04329702|50021568|FG001|Overall Study|Death|2|||
24928055|NCT04329702|50021569|FG002|Overall Study|Death|0|||
24928056|NCT00481065|50021590|FG000|Overall Study|Adverse event or death|1|||
24928057|NCT00481065|50021591|FG001|Overall Study|Adverse event or death|1|||
24928058|NCT00481065|50021592|FG002|Overall Study|Adverse event or death|3|||
24928059|NCT00481065|50021593|FG003|Overall Study|Adverse event or death|0|||
24928060|NCT00481065|50021594|FG004|Overall Study|Adverse event or death|2|||
24928061|NCT00481065|50021595|FG005|Overall Study|Adverse event or death|0|||
24928062|NCT00481065|50021596|FG006|Overall Study|Adverse event or death|1|||
24928063|NCT00481065|50021597|FG007|Overall Study|Adverse event or death|1|||
24928064|NCT00481065|50021590|FG000|Overall Study|Withdrawal by Subject|11|||
24928065|NCT00481065|50021591|FG001|Overall Study|Withdrawal by Subject|12|||
24928066|NCT00481065|50021592|FG002|Overall Study|Withdrawal by Subject|7|||
24928067|NCT00481065|50021593|FG003|Overall Study|Withdrawal by Subject|11|||
24928068|NCT00481065|50021594|FG004|Overall Study|Withdrawal by Subject|13|||
24928069|NCT00481065|50021595|FG005|Overall Study|Withdrawal by Subject|12|||
24928070|NCT00481065|50021596|FG006|Overall Study|Withdrawal by Subject|9|||
24928071|NCT00481065|50021597|FG007|Overall Study|Withdrawal by Subject|10|||
24928072|NCT00481065|50021590|FG000|Overall Study|Lost to Follow-up|4|||
24928073|NCT00481065|50021591|FG001|Overall Study|Lost to Follow-up|2|||
24928074|NCT00481065|50021592|FG002|Overall Study|Lost to Follow-up|4|||
24928075|NCT00481065|50021593|FG003|Overall Study|Lost to Follow-up|3|||
24928076|NCT00481065|50021594|FG004|Overall Study|Lost to Follow-up|3|||
24928077|NCT00481065|50021595|FG005|Overall Study|Lost to Follow-up|3|||
24928078|NCT00481065|50021596|FG006|Overall Study|Lost to Follow-up|2|||
24928079|NCT00481065|50021597|FG007|Overall Study|Lost to Follow-up|5|||
24928080|NCT00481065|50021590|FG000|Overall Study|Inappropriate enrollment|4|||
24928081|NCT00481065|50021591|FG001|Overall Study|Inappropriate enrollment|0|||
24928082|NCT00481065|50021592|FG002|Overall Study|Inappropriate enrollment|2|||
24928083|NCT00481065|50021593|FG003|Overall Study|Inappropriate enrollment|0|||
24928084|NCT00481065|50021594|FG004|Overall Study|Inappropriate enrollment|2|||
24928085|NCT00481065|50021595|FG005|Overall Study|Inappropriate enrollment|1|||
24928086|NCT00481065|50021596|FG006|Overall Study|Inappropriate enrollment|0|||
24928087|NCT00481065|50021597|FG007|Overall Study|Inappropriate enrollment|1|||
24928088|NCT00481065|50021590|FG000|Overall Study|Administrative reason|0|||
24928089|NCT00481065|50021591|FG001|Overall Study|Administrative reason|0|||
24928090|NCT00481065|50021592|FG002|Overall Study|Administrative reason|0|||
24928091|NCT00481065|50021593|FG003|Overall Study|Administrative reason|0|||
24928092|NCT00481065|50021594|FG004|Overall Study|Administrative reason|0|||
24928093|NCT00481065|50021595|FG005|Overall Study|Administrative reason|2|||
25185597|NCT00086281|50335096|FG009|Phase 2|Adverse Event|0|||
25185598|NCT00086281|50335097|FG010|Phase 2|Adverse Event|0|||
25185599|NCT00086281|50335098|FG011|Phase 2|Adverse Event|0|||
24928094|NCT00481065|50021596|FG006|Overall Study|Administrative reason|1|||
24928095|NCT00481065|50021597|FG007|Overall Study|Administrative reason|0|||
24928096|NCT00481065|50021590|FG000|Overall Study|Protocol Violation|2|||
24928097|NCT00481065|50021591|FG001|Overall Study|Protocol Violation|1|||
24928098|NCT00481065|50021592|FG002|Overall Study|Protocol Violation|1|||
24928099|NCT00481065|50021593|FG003|Overall Study|Protocol Violation|1|||
24928100|NCT00481065|50021594|FG004|Overall Study|Protocol Violation|2|||
24928101|NCT00481065|50021595|FG005|Overall Study|Protocol Violation|6|||
24928102|NCT00481065|50021596|FG006|Overall Study|Protocol Violation|3|||
24928103|NCT00481065|50021597|FG007|Overall Study|Protocol Violation|2|||
24928104|NCT00481065|50021590|FG000|Overall Study|Unable to classify|0|||
24928105|NCT00481065|50021591|FG001|Overall Study|Unable to classify|1|||
25025421|NCT03636269|50123056|FG000|Period 1: Double-blind Phase|Other|6|||
25185600|NCT00086281|50335099|FG012|Phase 2|Adverse Event|1|||
24928106|NCT00481065|50021592|FG002|Overall Study|Unable to classify|2|||
24928107|NCT00481065|50021593|FG003|Overall Study|Unable to classify|0|||
24928108|NCT00481065|50021594|FG004|Overall Study|Unable to classify|1|||
24928109|NCT00481065|50021595|FG005|Overall Study|Unable to classify|0|||
24928110|NCT00481065|50021596|FG006|Overall Study|Unable to classify|0|||
24928111|NCT00481065|50021597|FG007|Overall Study|Unable to classify|0|||
24928112|NCT00493311|50021619|FG000|Overall Study|Need for rescue medication|2|||
24928113|NCT00493311|50021620|FG001|Overall Study|Need for rescue medication|2|||
24928114|NCT00571649|50021628|FG000|Treatment Period|Adverse Event|438|||
24928115|NCT00571649|50021629|FG001|Treatment Period|Adverse Event|385|||
24928116|NCT00571649|50021628|FG000|Treatment Period|Clinical endpoint reached|50|||
25025422|NCT03636269|50123057|FG001|Period 1: Double-blind Phase|Other|3|||
24928117|NCT00571649|50021629|FG001|Treatment Period|Clinical endpoint reached|56|||
24928118|NCT00571649|50021628|FG000|Treatment Period|Withdrawal by Subject|285|||
24928119|NCT00571649|50021629|FG001|Treatment Period|Withdrawal by Subject|255|||
24928120|NCT00571649|50021628|FG000|Treatment Period|Death|76|||
24928121|NCT00571649|50021629|FG001|Treatment Period|Death|59|||
24928122|NCT00571649|50021628|FG000|Treatment Period|Physician Decision|8|||
24928123|NCT00571649|50021629|FG001|Treatment Period|Physician Decision|9|||
24928124|NCT00571649|50021628|FG000|Treatment Period|Lost to Follow-up|43|||
24928125|NCT00571649|50021629|FG001|Treatment Period|Lost to Follow-up|41|||
24928126|NCT00571649|50021628|FG000|Treatment Period|Non-compliant with study medication|88|||
24928127|NCT00571649|50021629|FG001|Treatment Period|Non-compliant with study medication|89|||
24928128|NCT00571649|50021628|FG000|Treatment Period|Patient convenience|11|||
24928129|NCT00571649|50021629|FG001|Treatment Period|Patient convenience|13|||
24928130|NCT00571649|50021628|FG000|Treatment Period|Protocol Violation|90|||
25185601|NCT00086281|50335100|FG013|Phase 2|Adverse Event|1|||
24928131|NCT00571649|50021629|FG001|Treatment Period|Protocol Violation|92|||
24928132|NCT00571649|50021628|FG000|Treatment Period|Technical problems|3|||
24928133|NCT00571649|50021629|FG001|Treatment Period|Technical problems|5|||
24928134|NCT00571649|50021628|FG000|Follow-up Period|Adverse Event|46|||
24928135|NCT00571649|50021629|FG001|Follow-up Period|Adverse Event|40|||
24928136|NCT00571649|50021628|FG000|Follow-up Period|Clinical endpoint reached|5|||
24928137|NCT00571649|50021629|FG001|Follow-up Period|Clinical endpoint reached|2|||
24928138|NCT00571649|50021628|FG000|Follow-up Period|Withdrawal by Subject|119|||
24928139|NCT00571649|50021629|FG001|Follow-up Period|Withdrawal by Subject|115|||
25025423|NCT03636269|50123058|FG002|Period 1: Double-blind Phase|Other|0|||
25025424|NCT03636269|50123056|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
25025425|NCT03636269|50123057|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
25025426|NCT03636269|50123058|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
25025427|NCT03636269|50123056|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
25025428|NCT03636269|50123057|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
25025429|NCT03636269|50123058|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
25025430|NCT03636269|50123056|FG000|Period 2: Open-label Phase|Adverse Event|0|||
25025431|NCT03636269|50123057|FG001|Period 2: Open-label Phase|Adverse Event|0|||
25025432|NCT03636269|50123058|FG002|Period 2: Open-label Phase|Adverse Event|21|||
25025433|NCT03636269|50123056|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
25025434|NCT03636269|50123057|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
25025435|NCT03636269|50123058|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
25025436|NCT03636269|50123056|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
25025437|NCT03636269|50123057|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
25025438|NCT03636269|50123058|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
25025439|NCT03636269|50123056|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
25025440|NCT03636269|50123057|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
25155336|NCT01543503|50270580|FG001|Overall Study|Participant recruited after closing date|1|||
25155337|NCT01543503|50270579|FG000|Overall Study|Site stopped participation|5|||
25155338|NCT01543503|50270580|FG001|Overall Study|Site stopped participation|1|||
25155339|NCT01543503|50270579|FG000|Overall Study|Participant did not attend a visit|1|||
25155340|NCT01543503|50270580|FG001|Overall Study|Participant did not attend a visit|0|||
24928140|NCT00571649|50021628|FG000|Follow-up Period|Death|132|||
24928141|NCT00571649|50021629|FG001|Follow-up Period|Death|133|||
24928142|NCT00571649|50021628|FG000|Follow-up Period|Physician Decision|7|||
24928143|NCT00571649|50021629|FG001|Follow-up Period|Physician Decision|13|||
24928144|NCT00571649|50021628|FG000|Follow-up Period|Lost to Follow-up|95|||
24928145|NCT00571649|50021629|FG001|Follow-up Period|Lost to Follow-up|92|||
24928146|NCT00571649|50021628|FG000|Follow-up Period|Patient convenience|136|||
24928147|NCT00571649|50021629|FG001|Follow-up Period|Patient convenience|121|||
24928148|NCT00571649|50021628|FG000|Follow-up Period|Protocol Violation|5|||
24928149|NCT00571649|50021629|FG001|Follow-up Period|Protocol Violation|12|||
24928150|NCT00546572|50021637|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
24928151|NCT00546572|50021638|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
24928152|NCT00546572|50021637|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
24928153|NCT00546572|50021638|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
24928154|NCT00546572|50021637|FG000|Vax 1 / Year 0|Protocol Violation|3|||
24928155|NCT00546572|50021638|FG001|Vax 1 / Year 0|Protocol Violation|4|||
24928156|NCT00546572|50021637|FG000|Vax 1 / Year 0|Death|2|||
24928157|NCT00546572|50021638|FG001|Vax 1 / Year 0|Death|2|||
24928158|NCT00546572|50021637|FG000|Vax 1 / Year 0|Adverse Event|0|||
24928159|NCT00546572|50021638|FG001|Vax 1 / Year 0|Adverse Event|1|||
24928160|NCT00546572|50021637|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
24928161|NCT00546572|50021638|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
24928162|NCT00546572|50021637|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
24928163|NCT00546572|50021638|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
24928164|NCT00546572|50021637|FG000|Vax 2 / Year 1|Other|1|||
24928165|NCT00546572|50021638|FG001|Vax 2 / Year 1|Other|1|||
24928166|NCT00546572|50021637|FG000|Vax 2 / Year 1|Adverse Event|1|||
24928167|NCT00546572|50021638|FG001|Vax 2 / Year 1|Adverse Event|0|||
24928168|NCT00546572|50021637|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
24928169|NCT00546572|50021638|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
24928170|NCT03917472|50021657|FG000|Overall Study|Physician Decision|4|||
24928171|NCT03917472|50021658|FG001|Overall Study|Physician Decision|0|||
24928172|NCT03917472|50021657|FG000|Overall Study|Adverse Event|3|||
24928173|NCT03917472|50021658|FG001|Overall Study|Adverse Event|1|||
25025441|NCT03636269|50123058|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
25025442|NCT03636269|50123056|FG000|Period 2: Open-label Phase|Administrative|0|||
24928174|NCT03917472|50021657|FG000|Overall Study|Death|7|||
24928175|NCT03917472|50021658|FG001|Overall Study|Death|5|||
24928176|NCT03917472|50021657|FG000|Overall Study|Withdrawal by Subject|11|||
24928177|NCT03917472|50021658|FG001|Overall Study|Withdrawal by Subject|4|||
24928178|NCT03917472|50021657|FG000|Overall Study|Lost to Follow-up|10|||
24928179|NCT03917472|50021658|FG001|Overall Study|Lost to Follow-up|5|||
25155341|NCT01543503|50270579|FG000|Overall Study|Moved to other rheumatologic site|0|||
25155342|NCT01543503|50270580|FG001|Overall Study|Moved to other rheumatologic site|1|||
25155343|NCT01543503|50270579|FG000|Overall Study|Participant consented to another study|0|||
25155344|NCT01543503|50270580|FG001|Overall Study|Participant consented to another study|2|||
25155345|NCT01543503|50270579|FG000|Overall Study|Participant went to United States|1|||
25155346|NCT01543503|50270580|FG001|Overall Study|Participant went to United States|0|||
25025443|NCT03636269|50123057|FG001|Period 2: Open-label Phase|Administrative|0|||
25025444|NCT03636269|50123058|FG002|Period 2: Open-label Phase|Administrative|36|||
25025445|NCT03636269|50123056|FG000|Period 2: Open-label Phase|Other|0|||
25025446|NCT03636269|50123057|FG001|Period 2: Open-label Phase|Other|0|||
25025447|NCT03636269|50123058|FG002|Period 2: Open-label Phase|Other|9|||
25025448|NCT03636269|50123056|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
25025449|NCT03636269|50123057|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
25025450|NCT03636269|50123058|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
25025451|NCT02685202|50123067|FG000|Overall Study|Lost to Follow-up|9|||
25025452|NCT03087786|50123073|FG000|Overall Study|Withdrawal by Subject|2|||
25025453|NCT03087786|50123074|FG001|Overall Study|Withdrawal by Subject|0|||
25155347|NCT01543503|50270579|FG000|Overall Study|Screen failure|1|||
25155348|NCT01543503|50270580|FG001|Overall Study|Screen failure|0|||
25025454|NCT03635957|50123080|FG000|Run-In Period|Lost to Follow-up|1|||
25025455|NCT03635957|50123080|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
25025456|NCT01353274|50123085|FG000|Overall Study|No case report form (CRF) collected|28|||
25025457|NCT02690194|50123092|FG000|Overall Study|Withdrawal by Subject|1|||
25025458|NCT02690194|50123093|FG001|Overall Study|Withdrawal by Subject|4|||
25025459|NCT02690194|50123094|FG002|Overall Study|Withdrawal by Subject|0|||
25025460|NCT02684344|50123104|FG000|Overall Study|Withdrawal by Subject|0|||
25025461|NCT02684344|50123105|FG001|Overall Study|Withdrawal by Subject|1|||
25025462|NCT02683876|50123113|FG000|Overall Study|samples damaged during shipping|2|||
25025463|NCT02683876|50123114|FG001|Overall Study|samples damaged during shipping|0|||
25025464|NCT03974100|50123124|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
25025465|NCT03974100|50123125|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
25025466|NCT03974100|50123126|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
25025467|NCT03974100|50123127|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
25025468|NCT03974100|50123128|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
25025469|NCT03974100|50123124|FG000|TP1 - Day 1 to Week 52|Death|1|||
25025470|NCT03974100|50123125|FG001|TP1 - Day 1 to Week 52|Death|0|||
25025471|NCT03974100|50123126|FG002|TP1 - Day 1 to Week 52|Death|0|||
25025472|NCT03974100|50123127|FG003|TP1 - Day 1 to Week 52|Death|0|||
25025473|NCT03974100|50123128|FG004|TP1 - Day 1 to Week 52|Death|0|||
25025474|NCT03974100|50123124|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
25025475|NCT03974100|50123125|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
25025476|NCT03974100|50123126|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
25025477|NCT03974100|50123127|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
25025478|NCT03974100|50123128|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
25025479|NCT03974100|50123124|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
24928180|NCT00681863|50021665|FG000|Overall Study|Adverse Event|1|||
24928181|NCT00681863|50021665|FG000|Overall Study|Lost to Follow-up|2|||
24928182|NCT00681863|50021665|FG000|Overall Study|Lack of Efficacy|2|||
24928183|NCT00681863|50021665|FG000|Overall Study|Other|18|||
24928184|NCT00681629|50021671|FG000|Overall Study|Study termination|4|||
24928185|NCT00681629|50021672|FG001|Overall Study|Study termination|2|||
25155349|NCT01511055|50270586|FG000|Overall Study|Withdrawal by Subject|6|||
25155350|NCT01537887|50270599|FG000|Period 1|Physician Decision|0|||
25155351|NCT01537887|50270600|FG001|Period 1|Physician Decision|0|||
24928186|NCT00681629|50021671|FG000|Overall Study|Adverse Event|1|||
24928187|NCT00681629|50021672|FG001|Overall Study|Adverse Event|0|||
24928188|NCT00546260|50021680|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
24928189|NCT00546260|50021681|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
24928190|NCT00679367|50021687|FG000|Overall Study|Adverse Event|7|||
24928191|NCT00679367|50021687|FG000|Overall Study|inability to swallow oral drugs|1|||
24928192|NCT00679367|50021687|FG000|Overall Study|Lack of Efficacy|3|||
24928193|NCT00679367|50021687|FG000|Overall Study|Withdrawal by Subject|1|||
24928194|NCT03937778|50021692|FG000|Overall Study|Withdrawal by Subject|1|||
24928195|NCT03937778|50021692|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
24928196|NCT03935126|50021696|FG000|Overall Study|Study termination by sponsor|3|||
24928197|NCT00545714|50021700|FG000|Induction Phase (6 Months)|Physician Decision|3|||
24928198|NCT00545714|50021700|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
25025480|NCT03974100|50123125|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
25025481|NCT03974100|50123126|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
25155352|NCT01537887|50270601|FG002|Period 1|Physician Decision|0|||
25025482|NCT03974100|50123127|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
24928199|NCT00545714|50021700|FG000|Induction Phase (6 Months)|Disease Progression|1|||
24928200|NCT00545714|50021700|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
25025483|NCT03974100|50123128|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
25025484|NCT03974100|50123124|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
24928201|NCT00545714|50021700|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
24928202|NCT00545714|50021700|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
24928203|NCT00545714|50021700|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
24928204|NCT00545714|50021700|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
24928205|NCT00545714|50021700|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
24928206|NCT00545714|50021700|FG000|Maintenance Phase (36 Months)|Death|2|||
24928207|NCT00539838|50021707|FG000|Overall Study|Fail to return|2|||
24928208|NCT00539838|50021708|FG001|Overall Study|Fail to return|0|||
24928209|NCT00539838|50021709|FG002|Overall Study|Fail to return|0|||
24928210|NCT00539838|50021707|FG000|Overall Study|Withdrawal by Subject|0|||
24928211|NCT00539838|50021708|FG001|Overall Study|Withdrawal by Subject|4|||
24928212|NCT00539838|50021709|FG002|Overall Study|Withdrawal by Subject|0|||
24928213|NCT00539838|50021707|FG000|Overall Study|Death|0|||
24928214|NCT00539838|50021708|FG001|Overall Study|Death|2|||
24928215|NCT00539838|50021709|FG002|Overall Study|Death|0|||
24928216|NCT00539838|50021707|FG000|Overall Study|Did not cooperate|1|||
25025485|NCT03974100|50123125|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
25025486|NCT03974100|50123126|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
25025487|NCT03974100|50123127|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
25025488|NCT03974100|50123128|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
25025489|NCT03974100|50123124|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
25025490|NCT03974100|50123125|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
25025491|NCT03974100|50123126|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
25025492|NCT03974100|50123127|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
25025493|NCT03974100|50123128|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
25025494|NCT03974100|50123124|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
25025495|NCT03974100|50123125|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
25025496|NCT03974100|50123126|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
25025497|NCT03974100|50123127|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
25025498|NCT03974100|50123128|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
25025499|NCT02689804|50123142|FG000|Overall Study|Withdrawal by Subject|2|||
25025500|NCT02689804|50123143|FG001|Overall Study|Withdrawal by Subject|0|||
25025501|NCT02946931|50123152|FG000|Overall Study|Did not require collection of CRFs|588|||
25025502|NCT02946931|50123152|FG000|Overall Study|Other than listed|37|||
25025503|NCT02946931|50123152|FG000|Overall Study|Discharge from hospital|118|||
25025504|NCT02946931|50123152|FG000|Overall Study|Adverse Event|81|||
25025505|NCT02946931|50123152|FG000|Overall Study|CRFs not valid|1|||
25025506|NCT02946931|50123152|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
24928217|NCT00539838|50021708|FG001|Overall Study|Did not cooperate|0|||
24928218|NCT00539838|50021709|FG002|Overall Study|Did not cooperate|1|||
24928219|NCT00539838|50021707|FG000|Overall Study|Administrative|4|||
24928220|NCT00539838|50021708|FG001|Overall Study|Administrative|0|||
24928221|NCT00539838|50021709|FG002|Overall Study|Administrative|8|||
24928222|NCT00679289|50021722|FG000|Overall Study|Progressive disease|4|||
24928223|NCT00679289|50021723|FG001|Overall Study|Progressive disease|5|||
24928224|NCT00679289|50021724|FG002|Overall Study|Progressive disease|18|||
24928225|NCT00679289|50021722|FG000|Overall Study|Withdrawal by Subject|0|||
24928226|NCT00679289|50021723|FG001|Overall Study|Withdrawal by Subject|1|||
24928227|NCT00679289|50021724|FG002|Overall Study|Withdrawal by Subject|1|||
24928228|NCT00679289|50021722|FG000|Overall Study|Adverse Event|0|||
24928229|NCT00679289|50021723|FG001|Overall Study|Adverse Event|0|||
24928230|NCT00679289|50021724|FG002|Overall Study|Adverse Event|3|||
24928231|NCT00679289|50021722|FG000|Overall Study|Physician Decision|1|||
24928232|NCT00679289|50021723|FG001|Overall Study|Physician Decision|0|||
24928233|NCT00679289|50021724|FG002|Overall Study|Physician Decision|1|||
24928234|NCT00679211|50021734|FG000|Overall Study|Progressive disease|82|||
24928235|NCT00679211|50021734|FG000|Overall Study|Adverse Event|7|||
24928236|NCT00679211|50021734|FG000|Overall Study|Withdrawal by Subject|2|||
25025507|NCT02689492|50123156|FG000|Overall Study|Lost to Follow-up|61|||
25025508|NCT02689492|50123156|FG000|Overall Study|Withdrawal by Subject|11|||
25025509|NCT02689492|50123156|FG000|Overall Study|Death|9|||
25025510|NCT02689492|50123156|FG000|Overall Study|Physician Decision|2|||
25025511|NCT02689492|50123156|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
25025512|NCT02689492|50123156|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
24928237|NCT00679211|50021734|FG000|Overall Study|Physician Decision|5|||
24928238|NCT00679211|50021734|FG000|Overall Study|Refused to undergo protocol procedures|1|||
24928239|NCT00679211|50021734|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
24928240|NCT00679211|50021734|FG000|Overall Study|Other|1|||
24928241|NCT00545948|50021743|FG000|Overall Study|Not Treated|1|||
24928242|NCT00545948|50021744|FG001|Overall Study|Not Treated|1|||
24928243|NCT00545948|50021745|FG002|Overall Study|Not Treated|7|||
24928244|NCT00679055|50021756|FG000|Overall Study|Adverse Event|0|||
25025513|NCT02689492|50123156|FG000|Overall Study|Other than listed|1|||
25025514|NCT01374568|50123174|FG000|Overall Study|Lab unable to analyze BTM|0|||
25025515|NCT01374568|50123175|FG001|Overall Study|Lab unable to analyze BTM|2|||
25025516|NCT02682784|50123185|FG000|Overall Study|Withdrawal by Subject|0|||
25025517|NCT02682784|50123186|FG001|Overall Study|Withdrawal by Subject|2|||
24928245|NCT00679055|50021757|FG001|Overall Study|Adverse Event|1|||
24928246|NCT00679055|50021756|FG000|Overall Study|Other|0|||
24928247|NCT00679055|50021757|FG001|Overall Study|Other|3|||
24928248|NCT00679055|50021756|FG000|Overall Study|Study Terminated|2|||
24928249|NCT00679055|50021757|FG001|Overall Study|Study Terminated|1|||
24928250|NCT03927950|50021763|FG000|Overall Study|Adverse Event|9|||
24928251|NCT00678899|50021768|FG000|Overall Study|Adverse Event|1|||
24928252|NCT00678587|50021775|FG000|Overall Study|Adverse Event|3|||
24928253|NCT00678587|50021776|FG001|Overall Study|Adverse Event|3|||
24928254|NCT00678587|50021775|FG000|Overall Study|Lack of Efficacy|1|||
24928255|NCT00678587|50021776|FG001|Overall Study|Lack of Efficacy|0|||
24928256|NCT00678587|50021775|FG000|Overall Study|Protocol Violation|2|||
24928257|NCT00678587|50021776|FG001|Overall Study|Protocol Violation|1|||
24928258|NCT00678587|50021775|FG000|Overall Study|Study Closed/Terminated|1|||
24928259|NCT00678587|50021776|FG001|Overall Study|Study Closed/Terminated|0|||
24928260|NCT00678587|50021775|FG000|Overall Study|Lost to Follow-up|3|||
24928261|NCT00678587|50021776|FG001|Overall Study|Lost to Follow-up|5|||
24928262|NCT00678587|50021775|FG000|Overall Study|Investigator Discretion|2|||
24928263|NCT00678587|50021776|FG001|Overall Study|Investigator Discretion|6|||
24928264|NCT00678587|50021775|FG000|Overall Study|Withdrew Consent|8|||
24928265|NCT00678587|50021776|FG001|Overall Study|Withdrew Consent|3|||
24928266|NCT03523728|50021788|FG000|Stage 1 (24 Months)|Adverse Event|2|||
24928267|NCT03523728|50021789|FG001|Stage 1 (24 Months)|Adverse Event|2|||
24928268|NCT03523728|50021790|FG002|Stage 1 (24 Months)|Adverse Event|4|||
24928269|NCT03523728|50021791|FG003|Stage 1 (24 Months)|Adverse Event|0|||
24928270|NCT03523728|50021792|FG004|Stage 1 (24 Months)|Adverse Event|0|||
24928271|NCT03523728|50021788|FG000|Stage 1 (24 Months)|Progressive disease|0|||
24928272|NCT03523728|50021789|FG001|Stage 1 (24 Months)|Progressive disease|0|||
24928273|NCT03523728|50021790|FG002|Stage 1 (24 Months)|Progressive disease|1|||
24928274|NCT03523728|50021791|FG003|Stage 1 (24 Months)|Progressive disease|0|||
24928275|NCT03523728|50021792|FG004|Stage 1 (24 Months)|Progressive disease|0|||
24928276|NCT03523728|50021788|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
25155353|NCT01537887|50270602|FG003|Period 1|Physician Decision|0|||
25155354|NCT01537887|50270603|FG004|Period 1|Physician Decision|1|||
25155355|NCT01537887|50270604|FG005|Period 1|Physician Decision|1|||
25155356|NCT01537887|50270599|FG000|Period 1|Did not receive treatment|0|||
25155357|NCT01537887|50270600|FG001|Period 1|Did not receive treatment|0|||
24928277|NCT03523728|50021789|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
24928278|NCT03523728|50021790|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
24928279|NCT03523728|50021791|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
24928280|NCT03523728|50021792|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
24928281|NCT03523728|50021788|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
24928282|NCT03523728|50021789|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
24928283|NCT03523728|50021790|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
24928284|NCT03523728|50021791|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
24928285|NCT03523728|50021792|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
25155358|NCT01537887|50270601|FG002|Period 1|Did not receive treatment|1|||
24928286|NCT03523728|50021788|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
24928287|NCT03523728|50021789|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
24928288|NCT03523728|50021790|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
24928289|NCT03523728|50021791|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
24928290|NCT03523728|50021792|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
24928291|NCT03523728|50021788|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
24928292|NCT03523728|50021789|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
24928293|NCT03523728|50021790|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
24928294|NCT03523728|50021791|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
24928295|NCT03523728|50021792|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
24928296|NCT03523728|50021788|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
24928297|NCT03523728|50021789|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
24928298|NCT03523728|50021790|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
24928299|NCT03523728|50021791|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
24928300|NCT03523728|50021792|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
24928301|NCT03523728|50021788|FG000|Stage 2 (24 Months)|Adverse Event|0|||
24928302|NCT03523728|50021789|FG001|Stage 2 (24 Months)|Adverse Event|0|||
24928303|NCT03523728|50021790|FG002|Stage 2 (24 Months)|Adverse Event|0|||
24928304|NCT03523728|50021791|FG003|Stage 2 (24 Months)|Adverse Event|1|||
24928305|NCT03523728|50021792|FG004|Stage 2 (24 Months)|Adverse Event|2|||
24928306|NCT03523728|50021788|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
24928307|NCT03523728|50021789|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
24928308|NCT03523728|50021790|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
24928309|NCT03523728|50021791|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
25025518|NCT02682784|50123187|FG002|Overall Study|Withdrawal by Subject|1|||
24928310|NCT03523728|50021792|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
24928311|NCT03523728|50021788|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
24928312|NCT03523728|50021789|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
24928313|NCT03523728|50021790|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
24928314|NCT03523728|50021791|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
24928315|NCT03523728|50021792|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
24928316|NCT03523728|50021788|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
24928317|NCT03523728|50021789|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
24928318|NCT03523728|50021790|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
24928319|NCT03523728|50021791|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
24928320|NCT03523728|50021792|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
24928321|NCT03523728|50021788|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
24928322|NCT03523728|50021789|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
24928323|NCT03523728|50021790|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
24928324|NCT03523728|50021791|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
24928325|NCT03523728|50021792|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
24928326|NCT00538590|50021811|FG000|Overall Study|Death|1|||
24928327|NCT00538590|50021812|FG001|Overall Study|Death|0|||
24928328|NCT00466947|50021820|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
24928329|NCT00466947|50021821|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
24928330|NCT00466947|50021820|FG000|Study End Analysis Period|Adverse Event|35|||
24928331|NCT00466947|50021821|FG001|Study End Analysis Period|Adverse Event|43|||
24928332|NCT00466947|50021820|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
24928333|NCT00466947|50021821|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
24928334|NCT00466947|50021820|FG000|Study End Analysis Period|Physician Decision|29|||
24928335|NCT00466947|50021821|FG001|Study End Analysis Period|Physician Decision|29|||
24928336|NCT00466947|50021820|FG000|Study End Analysis Period|Protocol Violation|9|||
24928337|NCT00466947|50021821|FG001|Study End Analysis Period|Protocol Violation|17|||
24928338|NCT00466947|50021820|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
24928339|NCT00466947|50021821|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
24928340|NCT00466947|50021820|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
24928341|NCT00466947|50021821|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
24928342|NCT00466947|50021820|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
24928343|NCT00466947|50021821|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
24928344|NCT00466947|50021820|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
24928345|NCT00466947|50021821|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
24928346|NCT00537810|50021832|FG000|Overall Study|Withdrawal by Subject|4|||
24928347|NCT00537810|50021833|FG001|Overall Study|Withdrawal by Subject|11|||
24928348|NCT00537810|50021834|FG002|Overall Study|Withdrawal by Subject|4|||
24928349|NCT00537810|50021835|FG003|Overall Study|Withdrawal by Subject|3|||
24928350|NCT00537810|50021832|FG000|Overall Study|Medically withdrawn|2|||
24928351|NCT00537810|50021833|FG001|Overall Study|Medically withdrawn|2|||
24928352|NCT00537810|50021834|FG002|Overall Study|Medically withdrawn|0|||
24928353|NCT00537810|50021835|FG003|Overall Study|Medically withdrawn|1|||
24928354|NCT01287936|50021848|FG000|Overall Study|Lost to Follow-up|0|||
24928355|NCT01287936|50021849|FG001|Overall Study|Lost to Follow-up|1|||
24928356|NCT01287936|50021850|FG002|Overall Study|Lost to Follow-up|1|||
25025519|NCT02682784|50123188|FG003|Overall Study|Withdrawal by Subject|2|||
25025520|NCT02682784|50123185|FG000|Overall Study|Physician Decision|1|||
25025521|NCT02682784|50123186|FG001|Overall Study|Physician Decision|0|||
24928357|NCT00090259|50021860|FG000|Overall Study|Lost to Follow-up|30|||
25025522|NCT02682784|50123187|FG002|Overall Study|Physician Decision|1|||
25155359|NCT01537887|50270602|FG003|Period 1|Did not receive treatment|0|||
25155360|NCT01537887|50270603|FG004|Period 1|Did not receive treatment|0|||
25025523|NCT02682784|50123188|FG003|Overall Study|Physician Decision|1|||
24928358|NCT00090259|50021861|FG001|Overall Study|Lost to Follow-up|26|||
24928359|NCT00090259|50021860|FG000|Overall Study|Withdrawal by Subject|21|||
24928360|NCT00090259|50021861|FG001|Overall Study|Withdrawal by Subject|15|||
24928361|NCT00090259|50021860|FG000|Overall Study|Investigator site closed|11|||
24928362|NCT00090259|50021861|FG001|Overall Study|Investigator site closed|7|||
24928363|NCT00079183|50021867|FG000|Overall Study|Withdrawal by Subject|4|||
24928364|NCT00079183|50021867|FG000|Overall Study|Study medication non-compliance|2|||
24928365|NCT00079183|50021867|FG000|Overall Study|Specimen collection non-compliance|1|||
24928366|NCT00676403|50021878|FG000|Overall Study|Adverse Event|1|||
24928367|NCT00676403|50021879|FG001|Overall Study|Adverse Event|2|||
24928368|NCT00676403|50021880|FG002|Overall Study|Adverse Event|0|||
24928369|NCT00676403|50021881|FG003|Overall Study|Adverse Event|5|||
24928370|NCT00676403|50021882|FG004|Overall Study|Adverse Event|1|||
25155361|NCT01537887|50270604|FG005|Period 1|Did not receive treatment|0|||
24928371|NCT00676403|50021883|FG005|Overall Study|Adverse Event|2|||
24928372|NCT00676403|50021878|FG000|Overall Study|Lost to Follow-up|0|||
24928373|NCT00676403|50021879|FG001|Overall Study|Lost to Follow-up|0|||
24928374|NCT00676403|50021880|FG002|Overall Study|Lost to Follow-up|0|||
24928375|NCT00676403|50021881|FG003|Overall Study|Lost to Follow-up|0|||
24928376|NCT00676403|50021882|FG004|Overall Study|Lost to Follow-up|0|||
24928377|NCT00676403|50021883|FG005|Overall Study|Lost to Follow-up|1|||
24928378|NCT00676403|50021878|FG000|Overall Study|Reason Unspecified|1|||
25155362|NCT01537887|50270599|FG000|Period 2|Withdrawal by Subject|0|||
24928379|NCT00676403|50021879|FG001|Overall Study|Reason Unspecified|0|||
24928380|NCT00676403|50021880|FG002|Overall Study|Reason Unspecified|1|||
24928381|NCT00676403|50021881|FG003|Overall Study|Reason Unspecified|0|||
24928382|NCT00676403|50021882|FG004|Overall Study|Reason Unspecified|0|||
24928383|NCT00676403|50021883|FG005|Overall Study|Reason Unspecified|1|||
24928384|NCT00676403|50021878|FG000|Overall Study|Withdrawal by Subject|0|||
24928385|NCT00676403|50021879|FG001|Overall Study|Withdrawal by Subject|0|||
24928386|NCT00676403|50021880|FG002|Overall Study|Withdrawal by Subject|0|||
24928387|NCT00676403|50021881|FG003|Overall Study|Withdrawal by Subject|0|||
24928388|NCT00676403|50021882|FG004|Overall Study|Withdrawal by Subject|0|||
24928389|NCT00676403|50021883|FG005|Overall Study|Withdrawal by Subject|1|||
25275076|NCT01237223|50589110|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
25275077|NCT01237223|50589111|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
24928394|NCT00078325|50021925|FG000|Overall Study|Adverse Event|15|||
24928395|NCT00078325|50021926|FG001|Overall Study|Adverse Event|10|||
24928396|NCT00078325|50021927|FG002|Overall Study|Adverse Event|5|||
24928397|NCT00078325|50021925|FG000|Overall Study|Protocol Violation|2|||
24928398|NCT00078325|50021926|FG001|Overall Study|Protocol Violation|2|||
24928399|NCT00078325|50021927|FG002|Overall Study|Protocol Violation|0|||
24928400|NCT00078325|50021925|FG000|Overall Study|Withdrawal by Subject|1|||
24928401|NCT00078325|50021926|FG001|Overall Study|Withdrawal by Subject|5|||
24928402|NCT00078325|50021927|FG002|Overall Study|Withdrawal by Subject|3|||
24928403|NCT00078325|50021925|FG000|Overall Study|Lost to Follow-up|0|||
24928404|NCT00078325|50021926|FG001|Overall Study|Lost to Follow-up|1|||
24928405|NCT00078325|50021927|FG002|Overall Study|Lost to Follow-up|1|||
24928406|NCT00078325|50021925|FG000|Overall Study|Physician Decision|2|||
24928407|NCT00078325|50021926|FG001|Overall Study|Physician Decision|0|||
24928408|NCT00078325|50021927|FG002|Overall Study|Physician Decision|1|||
24928409|NCT00078325|50021925|FG000|Overall Study|Miscellaneous|1|||
24928410|NCT00078325|50021926|FG001|Overall Study|Miscellaneous|1|||
24928411|NCT00078325|50021927|FG002|Overall Study|Miscellaneous|1|||
24928412|NCT00077857|50021937|FG000|Overall Study|Adverse Event|30|||
24928413|NCT00077857|50021938|FG001|Overall Study|Adverse Event|32|||
24928414|NCT00077857|50021937|FG000|Overall Study|Death|7|||
24928415|NCT00077857|50021938|FG001|Overall Study|Death|3|||
24928416|NCT00077857|50021937|FG000|Overall Study|Insufficient therapeutic response|112|||
24928417|NCT00077857|50021938|FG001|Overall Study|Insufficient therapeutic response|128|||
24928418|NCT00077857|50021937|FG000|Overall Study|Violation of selection criteria at entry|3|||
24928419|NCT00077857|50021938|FG001|Overall Study|Violation of selection criteria at entry|1|||
24928420|NCT00077857|50021937|FG000|Overall Study|Other protocol violation|0|||
24928421|NCT00077857|50021938|FG001|Overall Study|Other protocol violation|1|||
24928422|NCT00077857|50021937|FG000|Overall Study|Refused treatment|29|||
24928423|NCT00077857|50021938|FG001|Overall Study|Refused treatment|21|||
24928424|NCT00077857|50021937|FG000|Overall Study|Failure to return|5|||
24928425|NCT00077857|50021938|FG001|Overall Study|Failure to return|5|||
24928426|NCT00077857|50021937|FG000|Overall Study|Other|15|||
24928427|NCT00077857|50021938|FG001|Overall Study|Other|13|||
24928428|NCT00545402|50021946|FG000|Overall Study|Discontinuation of treatment|17|||
24928429|NCT00545402|50021947|FG001|Overall Study|Discontinuation of treatment|9|||
25025524|NCT03387852|50123202|FG000|Overall Study|Adverse event (AE)|3|||
24928430|NCT00545402|50021946|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
24928431|NCT00545402|50021947|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
24928432|NCT00545402|50021946|FG000|Overall Study|Death|5|||
25025525|NCT03387852|50123203|FG001|Overall Study|Adverse event (AE)|0|||
24928433|NCT00545402|50021947|FG001|Overall Study|Death|7|||
25155363|NCT01537887|50270600|FG001|Period 2|Withdrawal by Subject|1|||
24928434|NCT00545402|50021946|FG000|Overall Study|Graft loss|2|||
24928435|NCT00545402|50021947|FG001|Overall Study|Graft loss|4|||
24928436|NCT00545402|50021946|FG000|Overall Study|Withdrawal by Subject|0|||
24928437|NCT00545402|50021947|FG001|Overall Study|Withdrawal by Subject|1|||
24928438|NCT00545402|50021946|FG000|Overall Study|Protocol Violation|1|||
24928439|NCT00545402|50021947|FG001|Overall Study|Protocol Violation|0|||
24928440|NCT00545402|50021946|FG000|Overall Study|Reason not specified|1|||
24928441|NCT00545402|50021947|FG001|Overall Study|Reason not specified|1|||
24928442|NCT00545792|50021953|FG000|Overall Study|Withdrawal by Subject|1|||
24928443|NCT00545168|50021960|FG000|Overall Study|Lost to Follow-up|5|||
24928444|NCT00545168|50021961|FG001|Overall Study|Lost to Follow-up|5|||
24928445|NCT00545168|50021962|FG002|Overall Study|Lost to Follow-up|5|||
24928446|NCT00545168|50021960|FG000|Overall Study|Withdrawal by Subject|9|||
24928447|NCT00545168|50021961|FG001|Overall Study|Withdrawal by Subject|0|||
24928448|NCT00545168|50021962|FG002|Overall Study|Withdrawal by Subject|13|||
24928449|NCT00545168|50021960|FG000|Overall Study|Protocol Violation|1|||
24928450|NCT00545168|50021961|FG001|Overall Study|Protocol Violation|0|||
24928451|NCT00545168|50021962|FG002|Overall Study|Protocol Violation|1|||
24928452|NCT00545168|50021960|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
24928453|NCT00545168|50021961|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
24928454|NCT00545168|50021962|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
24928455|NCT00544544|50021971|FG000|Overall Study|Withdrawal by Subject|1|||
24928456|NCT00544544|50021971|FG000|Overall Study|Adverse Event|1|||
24928457|NCT00544544|50021971|FG000|Overall Study|Lost to Follow-up|1|||
24928458|NCT00541346|50021975|FG000|Follow-up|Adverse Event|1|||
24928459|NCT00077623|50021982|FG000|Overall Study|Adverse Event|1|||
24928460|NCT00077623|50021983|FG001|Overall Study|Adverse Event|0|||
24928461|NCT00077623|50021984|FG002|Overall Study|Adverse Event|1|||
24928462|NCT00077623|50021982|FG000|Overall Study|Withdrawal by Subject|2|||
24928463|NCT00077623|50021983|FG001|Overall Study|Withdrawal by Subject|10|||
24928464|NCT00077623|50021984|FG002|Overall Study|Withdrawal by Subject|1|||
24928465|NCT00077623|50021982|FG000|Overall Study|Other-Non safety reason|18|||
24928466|NCT00077623|50021983|FG001|Overall Study|Other-Non safety reason|15|||
24928467|NCT00077623|50021984|FG002|Overall Study|Other-Non safety reason|19|||
24928468|NCT00077623|50021982|FG000|Overall Study|Insufficient therapeutic response|2|||
24928469|NCT00077623|50021983|FG001|Overall Study|Insufficient therapeutic response|0|||
24928470|NCT00077623|50021984|FG002|Overall Study|Insufficient therapeutic response|0|||
24928471|NCT00077623|50021982|FG000|Overall Study|Death|12|||
25155364|NCT01537887|50270601|FG002|Period 2|Withdrawal by Subject|0|||
25155365|NCT01537887|50270602|FG003|Period 2|Withdrawal by Subject|0|||
25155366|NCT01537887|50270603|FG004|Period 2|Withdrawal by Subject|0|||
25155367|NCT01537887|50270604|FG005|Period 2|Withdrawal by Subject|0|||
25155368|NCT01537887|50270599|FG000|Period 3|Adverse Event|0|||
25155369|NCT01537887|50270600|FG001|Period 3|Adverse Event|0|||
25155370|NCT01537887|50270601|FG002|Period 3|Adverse Event|1|||
25155371|NCT01537887|50270602|FG003|Period 3|Adverse Event|0|||
25155372|NCT01537887|50270603|FG004|Period 3|Adverse Event|0|||
25155373|NCT01537887|50270604|FG005|Period 3|Adverse Event|0|||
25155374|NCT01537887|50270599|FG000|Period 3|Withdrawal by Subject|0|||
25155375|NCT01537887|50270600|FG001|Period 3|Withdrawal by Subject|1|||
25155376|NCT01537887|50270601|FG002|Period 3|Withdrawal by Subject|0|||
25155377|NCT01537887|50270602|FG003|Period 3|Withdrawal by Subject|0|||
25155378|NCT01537887|50270603|FG004|Period 3|Withdrawal by Subject|0|||
25155379|NCT01537887|50270604|FG005|Period 3|Withdrawal by Subject|0|||
25155380|NCT01489527|50270614|FG000|Overall Study|Pregnancy|9|||
25155381|NCT01489527|50270615|FG001|Overall Study|Pregnancy|14|||
25155382|NCT01489527|50270614|FG000|Overall Study|Participant moved|6|||
25155383|NCT01489527|50270615|FG001|Overall Study|Participant moved|7|||
25155384|NCT01489527|50270614|FG000|Overall Study|Withdrawal by Subject|0|||
25155385|NCT01489527|50270615|FG001|Overall Study|Withdrawal by Subject|4|||
25155386|NCT01489527|50270614|FG000|Overall Study|Lost to Follow-up|5|||
25155387|NCT01489527|50270615|FG001|Overall Study|Lost to Follow-up|1|||
25155388|NCT01489527|50270614|FG000|Overall Study|Procedures|1|||
25155389|NCT01489527|50270615|FG001|Overall Study|Procedures|0|||
25155390|NCT01489527|50270614|FG000|Overall Study|Not compliant|1|||
25155391|NCT01489527|50270615|FG001|Overall Study|Not compliant|0|||
24928472|NCT00077623|50021983|FG001|Overall Study|Death|18|||
24928473|NCT00077623|50021984|FG002|Overall Study|Death|11|||
24928474|NCT00077623|50021982|FG000|Overall Study|Failure to return|1|||
24928475|NCT00077623|50021983|FG001|Overall Study|Failure to return|0|||
24928476|NCT00077623|50021984|FG002|Overall Study|Failure to return|0|||
24928477|NCT00541034|50021992|FG000|Overall Study|Non-Compliance|3|||
24928478|NCT00540644|50021998|FG000|Overall Study|Adverse Event|3|||
24928479|NCT00540644|50021999|FG001|Overall Study|Adverse Event|1|||
25155392|NCT01487577|50270628|FG000|Overall Study|Became ineligible after signing consent|1|||
24928480|NCT00540644|50021998|FG000|Overall Study|Disease Progression|3|||
24928481|NCT00540644|50021999|FG001|Overall Study|Disease Progression|1|||
25185602|NCT00086281|50335101|FG014|Phase 2|Adverse Event|0|||
24928482|NCT00540644|50021998|FG000|Overall Study|Physician Decision|0|||
24928483|NCT00540644|50021999|FG001|Overall Study|Physician Decision|5|||
24928484|NCT00540644|50021998|FG000|Overall Study|Withdrawal by Subject|2|||
24928485|NCT00540644|50021999|FG001|Overall Study|Withdrawal by Subject|2|||
25155393|NCT01536951|50270634|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
24928486|NCT00540644|50021998|FG000|Overall Study|Noncomplilance|1|||
24928487|NCT00540644|50021999|FG001|Overall Study|Noncomplilance|0|||
24928488|NCT00543296|50022005|FG000|Overall Study|Physician Decision|7|||
24928489|NCT00543140|50022009|FG000|Overall Study|Lost to Follow-up|33|||
24928490|NCT00543140|50022009|FG000|Overall Study|Withdrawal by Subject|13|||
24928491|NCT00543140|50022009|FG000|Overall Study|Protocol Violation|10|||
24928492|NCT00543140|50022009|FG000|Overall Study|Insufficient weight loss|10|||
24928493|NCT00543140|50022009|FG000|Overall Study|SAE leading to explant of SAGB|3|||
24928494|NCT00543140|50022009|FG000|Overall Study|Death|1|||
24928495|NCT00543140|50022009|FG000|Overall Study|Subject moved|1|||
24928496|NCT00543140|50022009|FG000|Overall Study|Conversion to different procedure|1|||
24928497|NCT00543062|50022013|FG000|Overall Study|Withdrawal by Subject|1|||
24928498|NCT00543062|50022014|FG001|Overall Study|Withdrawal by Subject|0|||
24928499|NCT00543062|50022015|FG002|Overall Study|Withdrawal by Subject|2|||
24928500|NCT00543062|50022016|FG003|Overall Study|Withdrawal by Subject|0|||
24928501|NCT00543062|50022013|FG000|Overall Study|Adverse Event|0|||
24928502|NCT00543062|50022014|FG001|Overall Study|Adverse Event|1|||
24928503|NCT00543062|50022015|FG002|Overall Study|Adverse Event|1|||
24928504|NCT00543062|50022016|FG003|Overall Study|Adverse Event|1|||
24928505|NCT00543062|50022013|FG000|Overall Study|Protocol Violation|1|||
24928506|NCT00543062|50022014|FG001|Overall Study|Protocol Violation|0|||
24928507|NCT00543062|50022015|FG002|Overall Study|Protocol Violation|0|||
24928508|NCT00543062|50022016|FG003|Overall Study|Protocol Violation|0|||
25155394|NCT01536951|50270635|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
24928509|NCT03911960|50022036|FG000|Overall Study|Lost to Follow-up|5|||
24928510|NCT03911960|50022037|FG001|Overall Study|Lost to Follow-up|3|||
24928511|NCT00676091|50022046|FG000|Infant Series|Parent or legal guardian request|10|||
24928512|NCT00676091|50022047|FG001|Infant Series|Parent or legal guardian request|8|||
24928513|NCT00676091|50022046|FG000|Infant Series|Protocol Violation|6|||
24928514|NCT00676091|50022047|FG001|Infant Series|Protocol Violation|3|||
24928515|NCT00676091|50022046|FG000|Infant Series|Adverse Event|2|||
24928516|NCT00676091|50022047|FG001|Infant Series|Adverse Event|3|||
24928517|NCT00676091|50022046|FG000|Infant Series|Failed to return|1|||
24928518|NCT00676091|50022047|FG001|Infant Series|Failed to return|3|||
24928519|NCT00676091|50022046|FG000|Infant Series|Lost to Follow-up|1|||
24928520|NCT00676091|50022047|FG001|Infant Series|Lost to Follow-up|0|||
24928521|NCT00676091|50022046|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
24928522|NCT00676091|50022047|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
24928523|NCT00676091|50022046|FG000|After Infant Series|Adverse Event|0|||
24928524|NCT00676091|50022047|FG001|After Infant Series|Adverse Event|1|||
25025526|NCT03387852|50123204|FG002|Overall Study|Adverse event (AE)|2|||
25025527|NCT03387852|50123205|FG003|Overall Study|Adverse event (AE)|0|||
25025528|NCT03387852|50123202|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
25025529|NCT03387852|50123203|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
25025530|NCT03387852|50123204|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
25025531|NCT03387852|50123205|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
25025532|NCT03387852|50123202|FG000|Overall Study|Withdrawal by participant|1|||
25025533|NCT03387852|50123203|FG001|Overall Study|Withdrawal by participant|1|||
25025534|NCT03387852|50123204|FG002|Overall Study|Withdrawal by participant|3|||
25025535|NCT03387852|50123205|FG003|Overall Study|Withdrawal by participant|2|||
25025536|NCT03387852|50123202|FG000|Overall Study|Other- Unspecified|1|||
25025537|NCT03387852|50123203|FG001|Overall Study|Other- Unspecified|1|||
24928525|NCT00676091|50022046|FG000|After Infant Series|Protocol Violation|0|||
24928526|NCT00676091|50022047|FG001|After Infant Series|Protocol Violation|1|||
24928527|NCT00676091|50022046|FG000|After Infant Series|Failed to return|1|||
24928528|NCT00676091|50022047|FG001|After Infant Series|Failed to return|1|||
24928529|NCT00676091|50022046|FG000|Toddler Dose|Failed to return|2|||
24928530|NCT00676091|50022047|FG001|Toddler Dose|Failed to return|0|||
24928531|NCT00676091|50022046|FG000|Toddler Dose|Parent or legal guardian request|1|||
24928532|NCT00676091|50022047|FG001|Toddler Dose|Parent or legal guardian request|0|||
24928533|NCT00678041|50022059|FG000|Overall Study|Physician Decision|5|||
25025538|NCT03387852|50123204|FG002|Overall Study|Other- Unspecified|2|||
25025539|NCT03387852|50123205|FG003|Overall Study|Other- Unspecified|1|||
25025540|NCT03387852|50123202|FG000|Overall Study|Poor compliance to protocol|0|||
25025541|NCT03387852|50123203|FG001|Overall Study|Poor compliance to protocol|0|||
25155395|NCT01536951|50270636|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
25185603|NCT00086047|50335113|FG000|Overall Study|Lost to Follow-up|7|||
24928534|NCT00678041|50022060|FG001|Overall Study|Physician Decision|5|||
24928535|NCT03903822|50022075|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
24928536|NCT03903822|50022076|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
24928537|NCT03903822|50022077|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
25025542|NCT03387852|50123204|FG002|Overall Study|Poor compliance to protocol|0|||
25025543|NCT03387852|50123205|FG003|Overall Study|Poor compliance to protocol|1|||
25025544|NCT03387852|50123202|FG000|Overall Study|Randomized and not treated|0|||
25025545|NCT03387852|50123203|FG001|Overall Study|Randomized and not treated|0|||
25025546|NCT03387852|50123204|FG002|Overall Study|Randomized and not treated|0|||
25025547|NCT03387852|50123205|FG003|Overall Study|Randomized and not treated|1|||
25025548|NCT02679274|50123218|FG000|Overall Study|Withdrawal by Subject|1|||
25025549|NCT02679274|50123219|FG001|Overall Study|Withdrawal by Subject|0|||
25025550|NCT04969861|50123227|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
25025551|NCT04969861|50123228|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
25025552|NCT02678416|50123236|FG000|Part 1|Withdrawal by Subject|1|||
25025553|NCT02678416|50123236|FG000|Part 2|Adverse Event|2|||
25025554|NCT02678416|50123236|FG000|Part 2|Withdrawal by Subject|1|||
24928538|NCT03903822|50022078|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
24928539|NCT03903822|50022079|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
24928540|NCT03903822|50022080|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
24928541|NCT03903822|50022081|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
24928542|NCT03903822|50022082|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
24928543|NCT03903822|50022075|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
24928544|NCT03903822|50022076|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
24928545|NCT03903822|50022077|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
24928546|NCT03903822|50022078|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
24928547|NCT03903822|50022079|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
24928548|NCT03903822|50022080|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
24928549|NCT03903822|50022081|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
24928550|NCT03903822|50022082|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
24928551|NCT03903822|50022075|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
24928552|NCT03903822|50022076|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
24928553|NCT03903822|50022077|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
24928554|NCT03903822|50022078|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
24928555|NCT03903822|50022079|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
24928556|NCT03903822|50022080|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
24928557|NCT03903822|50022081|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
24928558|NCT03903822|50022082|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
24928559|NCT03903822|50022075|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
24928560|NCT03903822|50022076|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
24928561|NCT03903822|50022077|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
24928562|NCT03903822|50022078|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
24928563|NCT03903822|50022079|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
24928564|NCT03903822|50022080|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
24928565|NCT03903822|50022081|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
24928566|NCT03903822|50022082|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
24928567|NCT03903822|50022075|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
24928568|NCT03903822|50022076|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
25025555|NCT02680834|50123256|FG000|Overall Study|Physician Decision|5|||
25025556|NCT02680834|50123257|FG001|Overall Study|Physician Decision|2|||
25025557|NCT02680834|50123256|FG000|Overall Study|Withdrawal by Subject|6|||
25025558|NCT02680834|50123257|FG001|Overall Study|Withdrawal by Subject|0|||
25025559|NCT02680834|50123256|FG000|Overall Study|Lost to Follow-up|0|||
25025560|NCT02680834|50123257|FG001|Overall Study|Lost to Follow-up|1|||
24928569|NCT03903822|50022077|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
24928570|NCT03903822|50022078|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
24928571|NCT03903822|50022079|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
24928572|NCT03903822|50022080|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
24928573|NCT03903822|50022081|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
24928574|NCT03903822|50022082|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
24928575|NCT03903822|50022075|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
24928576|NCT03903822|50022076|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
24928577|NCT03903822|50022077|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
24928578|NCT03903822|50022078|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
24928579|NCT03903822|50022079|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
25155396|NCT01536951|50270637|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
25155397|NCT01536951|50270638|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
25155398|NCT01536951|50270639|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
25155399|NCT01536951|50270640|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
25155400|NCT01536951|50270641|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
25155401|NCT01536951|50270642|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
25155402|NCT01536951|50270634|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
25155403|NCT01536951|50270635|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
25155404|NCT01536951|50270636|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
25155405|NCT01536951|50270637|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
25155406|NCT01536951|50270638|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
25155407|NCT01536951|50270639|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
25155408|NCT01536951|50270640|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
25155409|NCT01536951|50270641|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
25155410|NCT01536951|50270642|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
25155411|NCT01536795|50270667|FG000|Overall Study|Lost to Follow-up|0|||
25155412|NCT01536795|50270668|FG001|Overall Study|Lost to Follow-up|2|||
25155413|NCT01536795|50270667|FG000|Overall Study|Lack of Efficacy|1|||
25155414|NCT01536795|50270668|FG001|Overall Study|Lack of Efficacy|0|||
25155415|NCT01536561|50270678|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
25155416|NCT01536561|50270678|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
25155417|NCT01536561|50270678|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
25155418|NCT01536561|50270678|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
25155419|NCT01536561|50270678|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
25155420|NCT01536561|50270678|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
25155421|NCT01536405|50270696|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
25155422|NCT01536405|50270697|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
24928580|NCT03903822|50022080|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
24928581|NCT03903822|50022081|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
24928582|NCT03903822|50022082|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
25155423|NCT01536405|50270696|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
25155424|NCT01536405|50270697|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
25155425|NCT01536405|50270696|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
25155426|NCT01536405|50270697|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
25155427|NCT01536405|50270696|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
25155428|NCT01536405|50270697|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
25155429|NCT01536405|50270696|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
25155430|NCT01536405|50270697|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
25155431|NCT01536405|50270696|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
25155432|NCT01536405|50270697|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
25155433|NCT01536405|50270696|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
25155434|NCT01536405|50270697|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
25155435|NCT01536405|50270696|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
25155436|NCT01536405|50270697|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
25155437|NCT01536405|50270696|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
25155438|NCT01536405|50270697|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
25155439|NCT01536405|50270696|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
25155440|NCT01536405|50270697|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
25155441|NCT01536405|50270696|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
25155442|NCT01536405|50270697|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
25155443|NCT01536405|50270696|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
25155444|NCT01536405|50270697|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
25155445|NCT01536405|50270696|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
25155446|NCT01536405|50270697|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
25155447|NCT01487265|50270703|FG000|Overall Study|Adverse Event|8|||
25155448|NCT01487265|50270703|FG000|Overall Study|Withdrawal by Subject|5|||
25155449|NCT01487265|50270703|FG000|Overall Study|Disease Progression|21|||
25155450|NCT01487265|50270703|FG000|Overall Study|Death|2|||
25155451|NCT01487265|50270703|FG000|Overall Study|Still on Treatment|1|||
25155452|NCT01485627|50270709|FG000|Overall Study|Patient withdrew|6|||
25155453|NCT01485627|50270710|FG001|Overall Study|Patient withdrew|5|||
25155454|NCT01485627|50270709|FG000|Overall Study|Patient died|3|||
25155455|NCT01485627|50270710|FG001|Overall Study|Patient died|1|||
25155456|NCT01485627|50270709|FG000|Overall Study|Patient lost to followup|0|||
25155457|NCT01485627|50270710|FG001|Overall Study|Patient lost to followup|1|||
25155458|NCT01485627|50270709|FG000|Overall Study|Caregiver withdrew|3|||
25155459|NCT01485627|50270710|FG001|Overall Study|Caregiver withdrew|3|||
25155460|NCT01485627|50270709|FG000|Overall Study|Caregiver lost to follow up|11|||
25155461|NCT01485627|50270710|FG001|Overall Study|Caregiver lost to follow up|12|||
25155462|NCT01485627|50270709|FG000|Overall Study|Caregiver died|1|||
25155463|NCT01485627|50270710|FG001|Overall Study|Caregiver died|0|||
25155464|NCT01485627|50270709|FG000|Overall Study|caregiver was not bereaved|42|||
25155465|NCT01485627|50270710|FG001|Overall Study|caregiver was not bereaved|35|||
25155466|NCT01508325|50270733|FG000|Overall Study|Withdrawal by Subject|8|||
25155467|NCT01508325|50270734|FG001|Overall Study|Withdrawal by Subject|9|||
25155468|NCT01508325|50270733|FG000|Overall Study|Protocol Violation|0|||
25155469|NCT01508325|50270734|FG001|Overall Study|Protocol Violation|3|||
25155470|NCT01508325|50270733|FG000|Overall Study|Physician Decision|2|||
25155471|NCT01508325|50270734|FG001|Overall Study|Physician Decision|1|||
25155472|NCT01508325|50270733|FG000|Overall Study|Adverse Event|1|||
25155473|NCT01508325|50270734|FG001|Overall Study|Adverse Event|0|||
25275078|NCT01237223|50589112|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
25155474|NCT01508325|50270733|FG000|Overall Study|Lost to Follow-up|5|||
25155475|NCT01508325|50270734|FG001|Overall Study|Lost to Follow-up|6|||
25155476|NCT01508325|50270733|FG000|Overall Study|Other|2|||
25155477|NCT01508325|50270734|FG001|Overall Study|Other|2|||
25155478|NCT01508169|50270742|FG000|Overall Study|Adverse Event|1|||
25155479|NCT01508169|50270743|FG001|Overall Study|Adverse Event|0|||
24928583|NCT03903822|50022075|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
24928584|NCT03903822|50022076|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
24928585|NCT03903822|50022077|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
24928586|NCT03903822|50022078|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
24928587|NCT03903822|50022079|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
24928588|NCT03903822|50022080|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
24928589|NCT03903822|50022081|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
24928590|NCT03903822|50022082|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
24928591|NCT03903822|50022075|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
24928592|NCT03903822|50022076|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
24928593|NCT03903822|50022077|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
24928594|NCT03903822|50022078|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
24928595|NCT03903822|50022079|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
24928596|NCT03903822|50022080|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
24928597|NCT03903822|50022081|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
24928598|NCT03903822|50022082|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
24928599|NCT03903822|50022075|FG000|Treatment Phase (6 Weeks)|Other|2|||
24928600|NCT03903822|50022076|FG001|Treatment Phase (6 Weeks)|Other|1|||
24928601|NCT03903822|50022077|FG002|Treatment Phase (6 Weeks)|Other|0|||
24928602|NCT03903822|50022078|FG003|Treatment Phase (6 Weeks)|Other|0|||
24928603|NCT03903822|50022079|FG004|Treatment Phase (6 Weeks)|Other|1|||
24928604|NCT03903822|50022080|FG005|Treatment Phase (6 Weeks)|Other|1|||
24928605|NCT03903822|50022081|FG006|Treatment Phase (6 Weeks)|Other|0|||
24928606|NCT03903822|50022082|FG007|Treatment Phase (6 Weeks)|Other|0|||
24928607|NCT03903822|50022075|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
24928608|NCT03903822|50022076|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
24928609|NCT03903822|50022077|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
24928610|NCT03903822|50022078|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
24928611|NCT03903822|50022079|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
24928612|NCT03903822|50022080|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
24928613|NCT03903822|50022081|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
24928614|NCT03903822|50022082|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
24928615|NCT03903822|50022075|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
24928616|NCT03903822|50022076|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
24928617|NCT03903822|50022077|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
24928618|NCT03903822|50022078|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
24928619|NCT03903822|50022079|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
24928620|NCT03903822|50022080|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
24928621|NCT03903822|50022081|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
24928622|NCT03903822|50022082|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
24928623|NCT03903822|50022075|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
24928624|NCT03903822|50022076|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
24928625|NCT03903822|50022077|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
24928626|NCT03903822|50022078|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
25025561|NCT03343704|50123265|FG000|Overall Study|Refused to complete follow up|0|||
25025562|NCT03343704|50123266|FG001|Overall Study|Refused to complete follow up|1|||
25025563|NCT03343704|50123265|FG000|Overall Study|Death|0|||
25025564|NCT03343704|50123266|FG001|Overall Study|Death|1|||
25025565|NCT03343704|50123265|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
25025566|NCT03343704|50123266|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
25025567|NCT02680756|50123276|FG000|Overall Study|Adverse Event|10|||
25025568|NCT02680756|50123277|FG001|Overall Study|Adverse Event|2|||
25025569|NCT02680756|50123276|FG000|Overall Study|Lost to Follow-up|7|||
25025570|NCT02680756|50123277|FG001|Overall Study|Lost to Follow-up|6|||
25025571|NCT02680756|50123276|FG000|Overall Study|Withdrawal by Subject|5|||
25025572|NCT02680756|50123277|FG001|Overall Study|Withdrawal by Subject|5|||
25025573|NCT02680756|50123276|FG000|Overall Study|Physician Decision|4|||
25025574|NCT02680756|50123277|FG001|Overall Study|Physician Decision|1|||
25025575|NCT02680756|50123276|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
25025576|NCT02680756|50123277|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
25155480|NCT01508169|50270742|FG000|Overall Study|Withdrawal by Subject|1|||
25025577|NCT02680756|50123276|FG000|Overall Study|Blood transfusion for any reason|0|||
25025578|NCT02680756|50123277|FG001|Overall Study|Blood transfusion for any reason|1|||
24928627|NCT03903822|50022079|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
24928628|NCT03903822|50022080|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
24928629|NCT03903822|50022081|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
24928630|NCT03903822|50022082|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
24928631|NCT03903822|50022075|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
25025579|NCT02680756|50123276|FG000|Overall Study|Death|1|||
25025580|NCT02680756|50123277|FG001|Overall Study|Death|0|||
25025581|NCT02680756|50123276|FG000|Overall Study|Protocol Violation|1|||
25025582|NCT02680756|50123277|FG001|Overall Study|Protocol Violation|0|||
25025583|NCT02680756|50123276|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
25025584|NCT02680756|50123277|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
25025585|NCT02680756|50123276|FG000|Overall Study|None of above or not recorded|3|||
25025586|NCT02680756|50123277|FG001|Overall Study|None of above or not recorded|2|||
25025587|NCT03086460|50123283|FG000|Study Participants|Lost to Follow-up|2|||
25025588|NCT03086460|50123283|FG000|Study Participants|Protocol Violation|1|||
25025589|NCT03086460|50123283|FG000|Study Participants|Withdrawal by Subject|6|||
25155481|NCT01508169|50270743|FG001|Overall Study|Withdrawal by Subject|0|||
25025590|NCT03086460|50123283|FG000|Treatment A|Lost to Follow-up|1|||
25025591|NCT03086460|50123283|FG000|Treatment A|Protocol Violation|1|||
25025592|NCT03086460|50123283|FG000|Treatment A|Withdrawal by Subject|2|||
25025593|NCT03086460|50123283|FG000|Treatment C|Withdrawal by Subject|2|||
25025594|NCT03086460|50123283|FG000|Treatment E|Lost to Follow-up|1|||
25025595|NCT03086460|50123283|FG000|Treatment E|Withdrawal by Subject|3|||
25025596|NCT02677714|50123309|FG000|Overall Study|Withdrawal by Subject|2|||
25025597|NCT02677714|50123310|FG001|Overall Study|Withdrawal by Subject|0|||
25025598|NCT02677324|50123316|FG000|Overall Study|Disease Progression|6|||
25025599|NCT02677324|50123316|FG000|Overall Study|Inability to Swallow pills|1|||
25025600|NCT02677324|50123316|FG000|Overall Study|Non-compliance|1|||
25025601|NCT02677324|50123316|FG000|Overall Study|Lack of Efficacy|1|||
25025602|NCT02677324|50123316|FG000|Overall Study|Medical insurance coverage|1|||
24928632|NCT03903822|50022076|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
24928633|NCT03903822|50022077|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
24928634|NCT03903822|50022078|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
24928635|NCT03903822|50022079|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
24928636|NCT03903822|50022080|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
24928637|NCT03903822|50022081|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
24928638|NCT03903822|50022082|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
24928639|NCT03903822|50022075|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
24928640|NCT03903822|50022076|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
24928641|NCT03903822|50022077|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
24928642|NCT03903822|50022078|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
24928643|NCT03903822|50022079|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
24928644|NCT03903822|50022080|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
24928645|NCT03903822|50022081|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
24928646|NCT03903822|50022082|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
24928647|NCT03903822|50022075|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
24928648|NCT03903822|50022076|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
24928649|NCT03903822|50022077|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
24928650|NCT03903822|50022078|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
24928651|NCT03903822|50022079|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
24928652|NCT03903822|50022080|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
24928653|NCT03903822|50022081|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
24928654|NCT03903822|50022082|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
24928655|NCT03903822|50022075|FG000|Follow up Phase (4 Weeks)|Other|1|||
24928656|NCT03903822|50022076|FG001|Follow up Phase (4 Weeks)|Other|1|||
24928657|NCT03903822|50022077|FG002|Follow up Phase (4 Weeks)|Other|0|||
24928658|NCT03903822|50022078|FG003|Follow up Phase (4 Weeks)|Other|0|||
24928659|NCT03903822|50022079|FG004|Follow up Phase (4 Weeks)|Other|0|||
24928660|NCT03903822|50022080|FG005|Follow up Phase (4 Weeks)|Other|0|||
24928661|NCT03903822|50022081|FG006|Follow up Phase (4 Weeks)|Other|0|||
24928662|NCT03903822|50022082|FG007|Follow up Phase (4 Weeks)|Other|0|||
24928663|NCT00677807|50022103|FG000|Overall Study|Adverse Event|4|||
24928664|NCT00677807|50022104|FG001|Overall Study|Adverse Event|1|||
24928665|NCT00677807|50022105|FG002|Overall Study|Adverse Event|6|||
24928666|NCT00677807|50022103|FG000|Overall Study|Lack of Efficacy|0|||
24928667|NCT00677807|50022104|FG001|Overall Study|Lack of Efficacy|0|||
24928668|NCT00677807|50022105|FG002|Overall Study|Lack of Efficacy|2|||
24928669|NCT00677807|50022103|FG000|Overall Study|Participant no longer needs study drug|0|||
24928670|NCT00677807|50022104|FG001|Overall Study|Participant no longer needs study drug|0|||
24928671|NCT00677807|50022105|FG002|Overall Study|Participant no longer needs study drug|1|||
24928672|NCT00677807|50022103|FG000|Overall Study|Withdrawal by Subject|10|||
24928673|NCT00677807|50022104|FG001|Overall Study|Withdrawal by Subject|3|||
24928674|NCT00677807|50022105|FG002|Overall Study|Withdrawal by Subject|6|||
25155482|NCT01508169|50270742|FG000|Overall Study|Lost to Follow-up|1|||
25275079|NCT01237223|50589113|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
24928675|NCT00677807|50022103|FG000|Overall Study|Lost to Follow-up|2|||
24928676|NCT00677807|50022104|FG001|Overall Study|Lost to Follow-up|2|||
24928677|NCT00677807|50022105|FG002|Overall Study|Lost to Follow-up|2|||
24928678|NCT00677807|50022103|FG000|Overall Study|Administrative problems|1|||
25025603|NCT02677324|50123316|FG000|Overall Study|Adverse Event|1|||
25025604|NCT02677324|50123316|FG000|Overall Study|IgM Myeloma diagnosis|1|||
25025605|NCT01971008|50123324|FG000|Overall Study|Protocol Violation|2|||
24928679|NCT00677807|50022104|FG001|Overall Study|Administrative problems|1|||
25025606|NCT01971008|50123325|FG001|Overall Study|Protocol Violation|1|||
25025607|NCT01374178|50123334|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
24928680|NCT00677807|50022105|FG002|Overall Study|Administrative problems|2|||
24928681|NCT00677807|50022103|FG000|Overall Study|Death|0|||
24928682|NCT00677807|50022104|FG001|Overall Study|Death|1|||
24928683|NCT00677807|50022105|FG002|Overall Study|Death|1|||
24928684|NCT00677807|50022103|FG000|Overall Study|Protocol Deviation|1|||
24928685|NCT00677807|50022104|FG001|Overall Study|Protocol Deviation|3|||
24928686|NCT00677807|50022105|FG002|Overall Study|Protocol Deviation|0|||
24928687|NCT00687401|50022113|FG000|Overall Study|Protocol Violation|7|||
24928688|NCT00687401|50022113|FG000|Overall Study|Adverse Event|6|||
24928689|NCT00687401|50022113|FG000|Overall Study|Lack of Efficacy|6|||
24928690|NCT00687401|50022113|FG000|Overall Study|Withdrawal by Subject|4|||
24928691|NCT00687401|50022113|FG000|Overall Study|Did not return for visit|3|||
24928692|NCT00687401|50022113|FG000|Overall Study|For reasons different from those above|4|||
24928693|NCT00538902|50022133|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
24928694|NCT00538902|50022134|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
24928695|NCT00538902|50022135|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
24928696|NCT00538902|50022133|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
24928697|NCT00538902|50022134|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
24928698|NCT00538902|50022135|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
24928699|NCT00538902|50022133|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
24928700|NCT00538902|50022134|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
24928701|NCT00538902|50022135|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
24928702|NCT00538902|50022133|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
25155483|NCT01508169|50270743|FG001|Overall Study|Lost to Follow-up|2|||
25155484|NCT01536171|50270755|FG000|Overall Study|Withdrawal by Subject|1|||
25155485|NCT01536093|50270762|FG000|Overall Study|Death|1|||
25275080|NCT01237223|50589108|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
24928703|NCT00538902|50022134|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
24928704|NCT00538902|50022135|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
24928705|NCT00538902|50022133|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
24928706|NCT00538902|50022134|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
24928707|NCT00538902|50022135|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
24928708|NCT00538902|50022133|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
24928709|NCT00538902|50022134|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
24928710|NCT00538902|50022135|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
24928711|NCT00538902|50022133|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
24928712|NCT00538902|50022134|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
24928713|NCT00538902|50022135|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
24928714|NCT00538902|50022133|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
24928715|NCT00538902|50022134|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
24928716|NCT00538902|50022135|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
24928717|NCT00541970|50022149|FG000|Month 7|Protocol Violation|9|||
24928718|NCT00541970|50022150|FG001|Month 7|Protocol Violation|13|||
24928719|NCT00541970|50022151|FG002|Month 7|Protocol Violation|11|||
24928720|NCT00541970|50022152|FG003|Month 7|Protocol Violation|5|||
24928721|NCT00541970|50022149|FG000|Month 12|Adverse Event|0|||
24928722|NCT00541970|50022150|FG001|Month 12|Adverse Event|1|||
24928723|NCT00541970|50022151|FG002|Month 12|Adverse Event|1|||
24928724|NCT00541970|50022152|FG003|Month 12|Adverse Event|1|||
25025608|NCT01374178|50123335|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
25025609|NCT01374178|50123334|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
25025610|NCT01374178|50123335|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
25025611|NCT03025542|50123343|FG000|Overall Study|Adverse Event|0|||
25025612|NCT03025542|50123344|FG001|Overall Study|Adverse Event|2|||
25025613|NCT03025542|50123343|FG000|Overall Study|Lost to Follow-up|1|||
25025614|NCT03025542|50123344|FG001|Overall Study|Lost to Follow-up|0|||
25025615|NCT03025542|50123343|FG000|Overall Study|Withdrawal by Subject|1|||
25025616|NCT03025542|50123344|FG001|Overall Study|Withdrawal by Subject|0|||
25025617|NCT03022370|50123358|FG000|Overall Study|Death|6|||
25025618|NCT03022370|50123359|FG001|Overall Study|Death|12|||
24928725|NCT00541970|50022149|FG000|Month 12|Protocol Violation|12|||
24928726|NCT00541970|50022150|FG001|Month 12|Protocol Violation|21|||
24928727|NCT00541970|50022151|FG002|Month 12|Protocol Violation|20|||
25025619|NCT03022370|50123358|FG000|Overall Study|Lost to Follow-up|174|||
25025620|NCT03022370|50123359|FG001|Overall Study|Lost to Follow-up|109|||
25025621|NCT03021668|50123371|FG000|Overall Study|Physician Decision|0|||
25025622|NCT03021668|50123372|FG001|Overall Study|Physician Decision|1|||
25025623|NCT03020888|50123378|FG000|Overall Study|Physician Decision|4|||
25275081|NCT01237223|50589109|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
25025624|NCT03020888|50123378|FG000|Overall Study|Withdrawal by Subject|6|||
24928728|NCT00541970|50022152|FG003|Month 12|Protocol Violation|15|||
24928729|NCT00541970|50022149|FG000|Month 18|Adverse Event|0|||
24928730|NCT00541970|50022150|FG001|Month 18|Adverse Event|1|||
24928731|NCT00541970|50022151|FG002|Month 18|Adverse Event|1|||
24928732|NCT00541970|50022152|FG003|Month 18|Adverse Event|1|||
24928733|NCT00541970|50022149|FG000|Month 18|Protocol Violation|14|||
24928734|NCT00541970|50022150|FG001|Month 18|Protocol Violation|23|||
24928735|NCT00541970|50022151|FG002|Month 18|Protocol Violation|24|||
24928736|NCT00541970|50022152|FG003|Month 18|Protocol Violation|16|||
24928737|NCT00541970|50022149|FG000|Month 24|Adverse Event|0|||
24928738|NCT00541970|50022150|FG001|Month 24|Adverse Event|1|||
24928739|NCT00541970|50022151|FG002|Month 24|Adverse Event|1|||
24928740|NCT00541970|50022152|FG003|Month 24|Adverse Event|1|||
24928741|NCT00541970|50022149|FG000|Month 24|Protocol Violation|29|||
24928742|NCT00541970|50022150|FG001|Month 24|Protocol Violation|31|||
24928743|NCT00541970|50022151|FG002|Month 24|Protocol Violation|31|||
24928744|NCT00541970|50022152|FG003|Month 24|Protocol Violation|21|||
24928745|NCT00541970|50022149|FG000|Month 36|Protocol Violation|61|||
24928746|NCT00541970|50022150|FG001|Month 36|Protocol Violation|66|||
24928747|NCT00541970|50022151|FG002|Month 36|Protocol Violation|66|||
24928748|NCT00541970|50022152|FG003|Month 36|Protocol Violation|60|||
24928749|NCT00541970|50022149|FG000|Month 48|Withdrawal by Subject|2|||
24928750|NCT00541970|50022150|FG001|Month 48|Withdrawal by Subject|4|||
24928751|NCT00541970|50022151|FG002|Month 48|Withdrawal by Subject|4|||
24928752|NCT00541970|50022152|FG003|Month 48|Withdrawal by Subject|2|||
24928753|NCT00541970|50022149|FG000|Month 48|Other|3|||
24928754|NCT00541970|50022150|FG001|Month 48|Other|1|||
24928755|NCT00541970|50022151|FG002|Month 48|Other|1|||
24928756|NCT00541970|50022152|FG003|Month 48|Other|0|||
24928757|NCT00541970|50022149|FG000|Month 48|Lost to Follow-up|66|||
24928758|NCT00541970|50022150|FG001|Month 48|Lost to Follow-up|68|||
24928759|NCT00541970|50022151|FG002|Month 48|Lost to Follow-up|68|||
24928760|NCT00541970|50022152|FG003|Month 48|Lost to Follow-up|73|||
24928761|NCT00541970|50022149|FG000|Month 60|Protocol Violation|78|||
24928762|NCT00541970|50022150|FG001|Month 60|Protocol Violation|77|||
24928763|NCT00541970|50022151|FG002|Month 60|Protocol Violation|82|||
24928764|NCT00541970|50022152|FG003|Month 60|Protocol Violation|72|||
24928765|NCT00687323|50022162|FG000|Overall Study|Death|25|||
24928766|NCT00687323|50022162|FG000|Overall Study|Withdrawal by Subject|1|||
24928767|NCT00687323|50022162|FG000|Overall Study|Excluded from efficacy evaluations|6|||
24928768|NCT00687323|50022162|FG000|Overall Study|Screen failure|148|||
24928769|NCT03899064|50022179|FG000|Overall Study|Lost to Follow-up|1|||
24928770|NCT03899064|50022179|FG000|Overall Study|Protocol Violation|2|||
24928771|NCT03899064|50022179|FG000|Overall Study|Withdrawal by Subject|2|||
24928772|NCT03899064|50022179|FG000|Overall Study|Other|2|||
24928773|NCT03902574|50022186|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
24928774|NCT03902574|50022187|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
24928775|NCT03902574|50022188|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
24928776|NCT00542828|50022200|FG000|Overall Study|Physician Decision|1|||
24928777|NCT00542828|50022200|FG000|Overall Study|Need for Prohibited Treatment|3|||
24928778|NCT00542828|50022200|FG000|Overall Study|Study Prematurely Discontinued|7|||
24928779|NCT00542828|50022200|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
24928780|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
24928781|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
24928782|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
24928783|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
24928784|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
24928785|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
24928786|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
24928787|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
24928788|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
24928789|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
24928790|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
24928791|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
24928792|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
24928793|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
24928794|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
24928795|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
24928796|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
24928797|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
24928798|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
25025625|NCT03020888|50123378|FG000|Overall Study|Insurance coverage|2|||
24928799|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
25025626|NCT03020888|50123378|FG000|Overall Study|Lost to Follow-up|1|||
25025627|NCT02250300|50123386|FG000|Expansion Phase|Death|6|||
25025628|NCT02250300|50123387|FG001|Expansion Phase|Death|7|||
25025629|NCT02250300|50123388|FG002|Expansion Phase|Death|0|||
25025630|NCT02250300|50123389|FG003|Expansion Phase|Death|0|||
25025631|NCT03020966|50123402|FG000|Overall Study|Withdrawal by Subject|2|||
25025632|NCT03020966|50123403|FG001|Overall Study|Withdrawal by Subject|0|||
25025633|NCT03020576|50123411|FG000|Overall Study|Withdrawal by Subject|1|||
25025634|NCT03020576|50123412|FG001|Overall Study|Withdrawal by Subject|2|||
25025635|NCT03017612|50123418|FG000|Overall Study|Adverse Event|2|||
25025636|NCT03635099|50123430|FG000|Period 1|Adverse Event|1|||
25025637|NCT03635099|50123431|FG001|Period 1|Adverse Event|0|||
25025638|NCT03635099|50123432|FG002|Period 1|Adverse Event|0|||
25025639|NCT03635099|50123433|FG003|Period 1|Adverse Event|1|||
25025640|NCT03635099|50123434|FG004|Period 1|Adverse Event|0|||
24928800|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
24928801|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
24928802|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
24928803|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
24928804|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
24928805|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
24928806|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
24928807|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
25275082|NCT01237223|50589110|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
25275083|NCT01237223|50589111|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
24928808|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
24928809|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
24928810|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
24928811|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
24928812|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
24928813|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
24928814|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
24928815|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
24928816|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
24928817|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
24928818|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
24928819|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
24928820|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
24928821|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
24928822|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
24928823|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
24928824|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
25025641|NCT03635099|50123435|FG005|Period 1|Adverse Event|0|||
25025642|NCT03635099|50123436|FG006|Period 1|Adverse Event|0|||
25275084|NCT01237223|50589112|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
25275085|NCT01237223|50589113|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
25275086|NCT01237223|50589108|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
25275087|NCT01237223|50589109|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
25275088|NCT01237223|50589110|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
25275089|NCT01237223|50589111|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
25275090|NCT01237223|50589112|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
25275091|NCT01237223|50589113|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
25275092|NCT01237223|50589108|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
25275093|NCT01237223|50589109|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
25275094|NCT01237223|50589110|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
25275095|NCT01237223|50589111|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
25275096|NCT01237223|50589112|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
25275097|NCT01237223|50589113|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
25275098|NCT01237223|50589108|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
25275099|NCT01237223|50589109|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
25275100|NCT01237223|50589110|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
25275101|NCT01237223|50589111|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
25025643|NCT03635099|50123437|FG007|Period 1|Adverse Event|0|||
25025644|NCT03635099|50123430|FG000|Period 1|Protocol Violation|0|||
24928825|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
24928826|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
24928827|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
24928828|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
24928829|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
24928830|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
24928831|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
24928832|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
24928833|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
24928834|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
24928835|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
24928836|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
24928837|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
24928838|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
24928839|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
24928840|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
24928841|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
24928842|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
24928843|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
24928844|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
24928845|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
24928846|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
24928847|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
24928848|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
24928849|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
24928850|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
24928851|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
24928852|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
24928853|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
24928854|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
24928855|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
24928856|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
24928857|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
24928858|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
24928859|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
24928860|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
24928861|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
24928862|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
24928863|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
24928864|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
24928865|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
24928866|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
25155486|NCT01536093|50270763|FG001|Overall Study|Death|2|||
25155487|NCT01536093|50270762|FG000|Overall Study|absence of maternal colostrum|2|||
25155488|NCT01536093|50270763|FG001|Overall Study|absence of maternal colostrum|0|||
24928867|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
25025645|NCT03635099|50123431|FG001|Period 1|Protocol Violation|0|||
25025646|NCT03635099|50123432|FG002|Period 1|Protocol Violation|1|||
25025647|NCT03635099|50123433|FG003|Period 1|Protocol Violation|0|||
25025648|NCT03635099|50123434|FG004|Period 1|Protocol Violation|0|||
25025649|NCT03635099|50123435|FG005|Period 1|Protocol Violation|0|||
25025650|NCT03635099|50123436|FG006|Period 1|Protocol Violation|0|||
25185604|NCT00086047|50335114|FG001|Overall Study|Lost to Follow-up|6|||
25025651|NCT03635099|50123437|FG007|Period 1|Protocol Violation|0|||
25025652|NCT03635099|50123430|FG000|Period 1|Lost to Follow-up|0|||
25025653|NCT03635099|50123431|FG001|Period 1|Lost to Follow-up|0|||
25155489|NCT01536093|50270762|FG000|Overall Study|Withdrawal by Subject|0|||
25155490|NCT01536093|50270763|FG001|Overall Study|Withdrawal by Subject|1|||
25155491|NCT01536015|50270771|FG000|Overall Study|Adverse Event|1|||
25155492|NCT01536015|50270772|FG001|Overall Study|Adverse Event|4|||
25155493|NCT01536015|50270771|FG000|Overall Study|Lost to Follow-up|0|||
25155494|NCT01536015|50270772|FG001|Overall Study|Lost to Follow-up|1|||
25155495|NCT01536015|50270771|FG000|Overall Study|Inclusion Criterion not met|2|||
25155496|NCT01536015|50270772|FG001|Overall Study|Inclusion Criterion not met|0|||
25155497|NCT01536015|50270771|FG000|Overall Study|Study closure|5|||
25155498|NCT01536015|50270772|FG001|Overall Study|Study closure|5|||
25155499|NCT01484691|50270781|FG000|Overall Study|Withdrawal by Subject|1|||
24928868|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
24928869|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
24928870|NCT00090103|50022207|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
24928871|NCT00090103|50022208|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
24928872|NCT00090103|50022209|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
24928873|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
24928874|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
24928875|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
24928876|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
24928877|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
24928878|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
24928879|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
24928880|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
24928881|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
24928882|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
24928883|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
24928884|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
24928885|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
24928886|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
24928887|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
24928888|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
24928889|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
24928890|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
24928891|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
24928892|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
24928893|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
24928894|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
24928895|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
24928896|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
24928897|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
24928898|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
24928899|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
24928900|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
24928901|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
24928902|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
24928903|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
24928904|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
24928905|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
24928906|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
24928907|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
24928908|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
24928909|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
24928910|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
24928911|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
24928912|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
24928913|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
24928914|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
24928915|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
24928916|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
25025654|NCT03635099|50123432|FG002|Period 1|Lost to Follow-up|1|||
25025655|NCT03635099|50123433|FG003|Period 1|Lost to Follow-up|2|||
25025656|NCT03635099|50123434|FG004|Period 1|Lost to Follow-up|1|||
25025657|NCT03635099|50123435|FG005|Period 1|Lost to Follow-up|0|||
24928917|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
24928918|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
24928919|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
24928920|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
24928921|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Death|1|||
24928922|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Death|0|||
24928923|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Death|1|||
24928924|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
24928925|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
24928926|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
25025658|NCT03635099|50123436|FG006|Period 1|Lost to Follow-up|1|||
25025659|NCT03635099|50123437|FG007|Period 1|Lost to Follow-up|2|||
25025660|NCT03635099|50123430|FG000|Period 1|Withdrawal by Subject|3|||
24928927|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
24928928|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
24928929|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
24928930|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
24928931|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
24928932|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
24928933|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
24928934|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
24928935|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
24928936|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
24928937|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
24928938|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
24928939|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
24928940|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
24928941|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
24928942|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
24928943|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
24928944|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
24928945|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Depression|0|||
24928946|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Depression|1|||
24928947|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Depression|0|||
24928948|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
24928949|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
24928950|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
24928951|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Jailed|0|||
24928952|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Jailed|1|||
24928953|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Jailed|0|||
24928954|NCT00090103|50022207|FG000|16-Week Safety Follow-up Period|Other|0|||
24928955|NCT00090103|50022208|FG001|16-Week Safety Follow-up Period|Other|1|||
24928956|NCT00090103|50022209|FG002|16-Week Safety Follow-up Period|Other|0|||
24928957|NCT00087607|50022219|FG000|Overall Study|Adverse Event|14|||
24928958|NCT00087607|50022220|FG001|Overall Study|Adverse Event|24|||
24928959|NCT00087607|50022219|FG000|Overall Study|Death|0|||
24928960|NCT00087607|50022220|FG001|Overall Study|Death|1|||
24928961|NCT00087607|50022219|FG000|Overall Study|Insufficient Therapeutic Response|53|||
24928962|NCT00087607|50022220|FG001|Overall Study|Insufficient Therapeutic Response|42|||
25025661|NCT03635099|50123431|FG001|Period 1|Withdrawal by Subject|3|||
25025662|NCT03635099|50123432|FG002|Period 1|Withdrawal by Subject|5|||
25025663|NCT03635099|50123433|FG003|Period 1|Withdrawal by Subject|2|||
25025664|NCT03635099|50123434|FG004|Period 1|Withdrawal by Subject|2|||
25025665|NCT03635099|50123435|FG005|Period 1|Withdrawal by Subject|0|||
25025666|NCT03635099|50123436|FG006|Period 1|Withdrawal by Subject|3|||
25025667|NCT03635099|50123437|FG007|Period 1|Withdrawal by Subject|0|||
25025668|NCT03635099|50123430|FG000|Period 1|History of suicidal ideation|0|||
24928963|NCT00087607|50022219|FG000|Overall Study|Failure to return|21|||
24928964|NCT00087607|50022220|FG001|Overall Study|Failure to return|17|||
24928965|NCT00087607|50022219|FG000|Overall Study|Withdrew Consent|12|||
24928966|NCT00087607|50022220|FG001|Overall Study|Withdrew Consent|16|||
25025669|NCT03635099|50123431|FG001|Period 1|History of suicidal ideation|0|||
25025670|NCT03635099|50123432|FG002|Period 1|History of suicidal ideation|1|||
25025671|NCT03635099|50123433|FG003|Period 1|History of suicidal ideation|0|||
25025672|NCT03635099|50123434|FG004|Period 1|History of suicidal ideation|0|||
25025673|NCT03635099|50123435|FG005|Period 1|History of suicidal ideation|0|||
25025674|NCT03635099|50123436|FG006|Period 1|History of suicidal ideation|0|||
25025675|NCT03635099|50123437|FG007|Period 1|History of suicidal ideation|0|||
25025676|NCT03635099|50123430|FG000|Period 1|pursue other treatment options|0|||
25025677|NCT03635099|50123431|FG001|Period 1|pursue other treatment options|0|||
25025678|NCT03635099|50123432|FG002|Period 1|pursue other treatment options|0|||
25025679|NCT03635099|50123433|FG003|Period 1|pursue other treatment options|0|||
25025680|NCT03635099|50123434|FG004|Period 1|pursue other treatment options|0|||
25025681|NCT03635099|50123435|FG005|Period 1|pursue other treatment options|1|||
25025682|NCT03635099|50123436|FG006|Period 1|pursue other treatment options|0|||
25025683|NCT03635099|50123437|FG007|Period 1|pursue other treatment options|0|||
25025684|NCT03635099|50123430|FG000|Not Eligible for Period 2|Pregnancy|0|||
25025685|NCT03635099|50123431|FG001|Not Eligible for Period 2|Pregnancy|0|||
25155500|NCT01484691|50270782|FG001|Overall Study|Withdrawal by Subject|1|||
24928967|NCT00087607|50022219|FG000|Overall Study|Administrative|12|||
24928968|NCT00087607|50022220|FG001|Overall Study|Administrative|12|||
24928969|NCT00087607|50022219|FG000|Overall Study|Refused Treatment|5|||
25025686|NCT03635099|50123432|FG002|Not Eligible for Period 2|Pregnancy|0|||
25025687|NCT03635099|50123433|FG003|Not Eligible for Period 2|Pregnancy|1|||
25025688|NCT03635099|50123434|FG004|Not Eligible for Period 2|Pregnancy|0|||
25025689|NCT03635099|50123435|FG005|Not Eligible for Period 2|Pregnancy|0|||
24928970|NCT00087607|50022220|FG001|Overall Study|Refused Treatment|7|||
24928971|NCT00087607|50022219|FG000|Overall Study|Other Protocol Violation|5|||
24928972|NCT00087607|50022220|FG001|Overall Study|Other Protocol Violation|2|||
24928973|NCT00087607|50022219|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
24928974|NCT00087607|50022220|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
24928975|NCT00069823|50022232|FG000|Overall Study|Did not have follow-up diary cards|6|||
24928976|NCT00069823|50022233|FG001|Overall Study|Did not have follow-up diary cards|3|||
24928977|NCT00086515|50022245|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
24928978|NCT00086515|50022246|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
24928979|NCT00086515|50022245|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
24928980|NCT00086515|50022246|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
24928981|NCT00086515|50022245|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
24928982|NCT00086515|50022246|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
24928983|NCT00086515|50022245|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
24928984|NCT00086515|50022246|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
24928985|NCT00086515|50022245|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
24928986|NCT00086515|50022246|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
24928987|NCT00086515|50022245|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
24928988|NCT00086515|50022246|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
24928989|NCT00086515|50022245|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
24928990|NCT00086515|50022246|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
24928991|NCT00086515|50022245|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
24928992|NCT00086515|50022246|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
24928993|NCT00086515|50022245|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
24928994|NCT00086515|50022246|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
24928995|NCT00086515|50022245|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
25025690|NCT03635099|50123436|FG006|Not Eligible for Period 2|Pregnancy|0|||
25025691|NCT03635099|50123437|FG007|Not Eligible for Period 2|Pregnancy|0|||
25025692|NCT03635099|50123430|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
25025693|NCT03635099|50123431|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
25025694|NCT03635099|50123432|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
25025695|NCT03635099|50123433|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
25025696|NCT03635099|50123434|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
25025697|NCT03635099|50123435|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
25025698|NCT03635099|50123436|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
25025699|NCT03635099|50123437|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
25025700|NCT03635099|50123430|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
25025701|NCT03635099|50123431|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
25025702|NCT03635099|50123432|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
25025703|NCT03635099|50123433|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
25025704|NCT03635099|50123434|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
25025705|NCT03635099|50123435|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
25025706|NCT03635099|50123436|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
25025707|NCT03635099|50123437|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
25025708|NCT03635099|50123430|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
25025709|NCT03635099|50123431|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
25025710|NCT03635099|50123432|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
25025711|NCT03635099|50123433|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
25025712|NCT03635099|50123434|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
24928996|NCT00086515|50022246|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
25025713|NCT03635099|50123435|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
25025714|NCT03635099|50123436|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
25025715|NCT03635099|50123437|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
25025716|NCT03635099|50123430|FG000|Period 2|Adverse Event|0|||
25025717|NCT03635099|50123431|FG001|Period 2|Adverse Event|0|||
25025718|NCT03635099|50123432|FG002|Period 2|Adverse Event|1|||
25025719|NCT03635099|50123433|FG003|Period 2|Adverse Event|0|||
25025720|NCT03635099|50123434|FG004|Period 2|Adverse Event|1|||
25025721|NCT03635099|50123435|FG005|Period 2|Adverse Event|0|||
25025722|NCT03635099|50123436|FG006|Period 2|Adverse Event|0|||
25025723|NCT03635099|50123437|FG007|Period 2|Adverse Event|0|||
25025724|NCT03635099|50123430|FG000|Period 2|Lost to Follow-up|0|||
25025725|NCT03635099|50123431|FG001|Period 2|Lost to Follow-up|0|||
25025726|NCT03635099|50123432|FG002|Period 2|Lost to Follow-up|1|||
25025727|NCT03635099|50123433|FG003|Period 2|Lost to Follow-up|0|||
25025728|NCT03635099|50123434|FG004|Period 2|Lost to Follow-up|4|||
24928997|NCT00086515|50022245|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
24928998|NCT00086515|50022246|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
24928999|NCT00086515|50022245|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
24929000|NCT00086515|50022246|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
24929001|NCT00086515|50022245|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
24929002|NCT00086515|50022246|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
24929003|NCT00086515|50022245|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
24929004|NCT00086515|50022246|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
24929005|NCT00086515|50022245|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
24929006|NCT00086515|50022246|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
24929007|NCT00086515|50022245|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
24929008|NCT00086515|50022246|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
24929009|NCT00086515|50022245|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
24929010|NCT00086515|50022246|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
24929011|NCT00086515|50022245|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
24929012|NCT00086515|50022246|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
24929013|NCT00086515|50022245|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
24929014|NCT00086515|50022246|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
24929015|NCT00086515|50022245|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
24929016|NCT00086515|50022246|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
24929017|NCT00086515|50022245|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
24929018|NCT00086515|50022246|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
24929019|NCT00086515|50022245|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
24929020|NCT00086515|50022246|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
24929021|NCT00086515|50022245|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
25155501|NCT01484691|50270783|FG002|Overall Study|Withdrawal by Subject|1|||
24929022|NCT00086515|50022246|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
24929023|NCT00086515|50022245|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
24929024|NCT00086515|50022246|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
24929025|NCT00086515|50022245|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
25155502|NCT01484691|50270781|FG000|Overall Study|Physician Decision|0|||
24929026|NCT00086515|50022246|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
24929027|NCT00086515|50022245|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
24929028|NCT00086515|50022246|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
24929029|NCT00086515|50022245|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
24929030|NCT00086515|50022246|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
24929031|NCT00086515|50022245|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
24929032|NCT00086515|50022246|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
24929033|NCT00086515|50022245|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
24929034|NCT00086515|50022246|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
24929035|NCT00086515|50022245|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
25155503|NCT01484691|50270782|FG001|Overall Study|Physician Decision|2|||
24929036|NCT00086515|50022246|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
24929037|NCT00086515|50022245|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
24929038|NCT00086515|50022246|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
24929039|NCT00541658|50022255|FG000|Overall Study|Adverse Event|28|||
24929040|NCT00541658|50022256|FG001|Overall Study|Adverse Event|37|||
24929041|NCT00541658|50022257|FG002|Overall Study|Adverse Event|25|||
24929042|NCT00541658|50022255|FG000|Overall Study|Physician Decision|0|||
24929043|NCT00541658|50022256|FG001|Overall Study|Physician Decision|0|||
24929044|NCT00541658|50022257|FG002|Overall Study|Physician Decision|4|||
24929045|NCT00541658|50022255|FG000|Overall Study|Lost to Follow-up|3|||
24929046|NCT00541658|50022256|FG001|Overall Study|Lost to Follow-up|3|||
24929047|NCT00541658|50022257|FG002|Overall Study|Lost to Follow-up|6|||
24929048|NCT00541658|50022255|FG000|Overall Study|Protocol Violation|0|||
25025729|NCT03635099|50123435|FG005|Period 2|Lost to Follow-up|0|||
24929049|NCT00541658|50022256|FG001|Overall Study|Protocol Violation|1|||
24929050|NCT00541658|50022257|FG002|Overall Study|Protocol Violation|1|||
24929051|NCT00541658|50022255|FG000|Overall Study|Withdrawal by Subject|28|||
24929052|NCT00541658|50022256|FG001|Overall Study|Withdrawal by Subject|32|||
24929053|NCT00541658|50022257|FG002|Overall Study|Withdrawal by Subject|32|||
24929054|NCT00541658|50022255|FG000|Overall Study|Took No Study Drug|1|||
24929055|NCT00541658|50022256|FG001|Overall Study|Took No Study Drug|0|||
24929056|NCT00541658|50022257|FG002|Overall Study|Took No Study Drug|0|||
25025730|NCT03635099|50123436|FG006|Period 2|Lost to Follow-up|0|||
25025731|NCT03635099|50123437|FG007|Period 2|Lost to Follow-up|0|||
25025732|NCT03635099|50123430|FG000|Period 2|Withdrawal by Subject|0|||
25025733|NCT03635099|50123431|FG001|Period 2|Withdrawal by Subject|0|||
25025734|NCT03635099|50123432|FG002|Period 2|Withdrawal by Subject|7|||
25155504|NCT01484691|50270783|FG002|Overall Study|Physician Decision|1|||
24929057|NCT03907280|50022281|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
24929058|NCT03907280|50022282|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
24964608|NCT00432809|50054436|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
25025735|NCT03635099|50123433|FG003|Period 2|Withdrawal by Subject|4|||
25155505|NCT01535235|50270794|FG000|Overall Study|Adverse Event|1|||
24929059|NCT03907280|50022283|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
25025736|NCT03635099|50123434|FG004|Period 2|Withdrawal by Subject|7|||
25025737|NCT03635099|50123435|FG005|Period 2|Withdrawal by Subject|0|||
24929060|NCT04120376|50022295|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
24929061|NCT04120376|50022296|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
24929062|NCT03905642|50022303|FG000|Overall Study|Withdrawal by Subject|3|||
24929063|NCT03905642|50022303|FG000|Overall Study|Pregnancy|1|||
24929064|NCT03905642|50022303|FG000|Overall Study|Adverse Event|1|||
24929065|NCT03905642|50022303|FG000|Overall Study|Lack of Efficacy|1|||
24929066|NCT03905642|50022303|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
24929067|NCT00412984|50022343|FG000|Overall Study|Death|331|||
24929068|NCT00412984|50022344|FG001|Overall Study|Death|349|||
24929069|NCT00412984|50022343|FG000|Overall Study|Adverse Event|679|||
24929070|NCT00412984|50022344|FG001|Overall Study|Adverse Event|738|||
24929071|NCT00412984|50022343|FG000|Overall Study|Withdrawal by Subject|921|||
24929072|NCT00412984|50022344|FG001|Overall Study|Withdrawal by Subject|989|||
24929073|NCT00412984|50022343|FG000|Overall Study|Lost to Follow-up|51|||
24929074|NCT00412984|50022344|FG001|Overall Study|Lost to Follow-up|39|||
24929075|NCT00412984|50022343|FG000|Overall Study|Poor/Noncompliance|57|||
24929076|NCT00412984|50022344|FG001|Overall Study|Poor/Noncompliance|77|||
24929077|NCT00412984|50022343|FG000|Overall Study|Pregnancy|1|||
24929078|NCT00412984|50022344|FG001|Overall Study|Pregnancy|0|||
24929079|NCT00412984|50022343|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
24929080|NCT00412984|50022344|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
24929081|NCT00412984|50022343|FG000|Overall Study|Administrative Reason by Sponsor|11|||
24929082|NCT00412984|50022344|FG001|Overall Study|Administrative Reason by Sponsor|8|||
24929083|NCT00412984|50022343|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
24929084|NCT00412984|50022344|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
24929085|NCT00412984|50022343|FG000|Overall Study|Other Reason|80|||
24929086|NCT00412984|50022344|FG001|Overall Study|Other Reason|92|||
24929087|NCT00412984|50022343|FG000|Overall Study|Not Reported|11|||
24929088|NCT00412984|50022344|FG001|Overall Study|Not Reported|12|||
24929089|NCT00539864|50022352|FG000|Overall Study|Lost to Follow-up|0|||
24929090|NCT00539864|50022353|FG001|Overall Study|Lost to Follow-up|1|||
24929091|NCT00539864|50022352|FG000|Overall Study|Withdrawal by Subject|1|||
24929092|NCT00539864|50022353|FG001|Overall Study|Withdrawal by Subject|1|||
24929093|NCT00673049|50022361|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
24929094|NCT00673049|50022362|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
24929095|NCT00673049|50022363|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
24929096|NCT00673049|50022364|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
24929097|NCT00673049|50022361|FG000|Before Progression on Erlotinib|Death|235|||
24929098|NCT00673049|50022362|FG001|Before Progression on Erlotinib|Death|167|||
24929099|NCT00673049|50022363|FG002|Before Progression on Erlotinib|Death|1|||
24929100|NCT00673049|50022364|FG003|Before Progression on Erlotinib|Death|0|||
24929101|NCT00673049|50022361|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
24929102|NCT00673049|50022362|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
24929103|NCT00673049|50022363|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
24929104|NCT00673049|50022364|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
24929105|NCT00673049|50022361|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
24929106|NCT00673049|50022362|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
24929107|NCT00673049|50022363|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
24929108|NCT00673049|50022364|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
24929109|NCT00673049|50022361|FG000|Before Progression on Erlotinib|Other|1|||
24929110|NCT00673049|50022362|FG001|Before Progression on Erlotinib|Other|2|||
24929111|NCT00673049|50022363|FG002|Before Progression on Erlotinib|Other|0|||
24929112|NCT00673049|50022364|FG003|Before Progression on Erlotinib|Other|0|||
24929113|NCT00673049|50022361|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
24929114|NCT00673049|50022362|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
24929115|NCT00673049|50022363|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
25025738|NCT03635099|50123436|FG006|Period 2|Withdrawal by Subject|0|||
25025739|NCT03635099|50123437|FG007|Period 2|Withdrawal by Subject|0|||
24929116|NCT00673049|50022364|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
24929117|NCT00673049|50022361|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
24929118|NCT00673049|50022362|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
24929119|NCT00673049|50022363|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
24929120|NCT00673049|50022364|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
24929121|NCT00673049|50022361|FG000|After Progression on Erlotinib|Death|0|||
24929122|NCT00673049|50022362|FG001|After Progression on Erlotinib|Death|0|||
24929123|NCT00673049|50022363|FG002|After Progression on Erlotinib|Death|0|||
24929124|NCT00673049|50022364|FG003|After Progression on Erlotinib|Death|71|||
24929125|NCT00673049|50022361|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
25025740|NCT02108652|50123463|FG000|Overall Study|Death|226|||
24929126|NCT00673049|50022362|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
24929127|NCT00673049|50022363|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
24929128|NCT00673049|50022364|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
24929129|NCT00673049|50022361|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
24929130|NCT00673049|50022362|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
24929131|NCT00673049|50022363|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
24929132|NCT00673049|50022364|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
24929133|NCT00673049|50022361|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
24929134|NCT00673049|50022362|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
24929135|NCT00673049|50022363|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
24929136|NCT00673049|50022364|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
24929137|NCT00412750|50022375|FG000|Overall Study|Abnormal laboratory value(s)|1|||
24929138|NCT00412750|50022376|FG001|Overall Study|Abnormal laboratory value(s)|0|||
24929139|NCT00412750|50022377|FG002|Overall Study|Abnormal laboratory value(s)|0|||
24929140|NCT00412750|50022375|FG000|Overall Study|Administrative problems|21|||
24929141|NCT00412750|50022376|FG001|Overall Study|Administrative problems|17|||
24929142|NCT00412750|50022377|FG002|Overall Study|Administrative problems|14|||
24929143|NCT00412750|50022375|FG000|Overall Study|Adverse Event|8|||
24929144|NCT00412750|50022376|FG001|Overall Study|Adverse Event|3|||
24929145|NCT00412750|50022377|FG002|Overall Study|Adverse Event|3|||
24929146|NCT00412750|50022375|FG000|Overall Study|Lost to Follow-up|1|||
25025741|NCT02108652|50123463|FG000|Overall Study|Lost to Follow-up|2|||
25025742|NCT02108652|50123463|FG000|Overall Study|Withdrawal by Subject|8|||
25025743|NCT02108652|50123463|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|74|||
25025744|NCT03634085|50123469|FG000|Overall Study|Adverse Event|1|||
25025745|NCT03634085|50123470|FG001|Overall Study|Adverse Event|0|||
25025746|NCT03634085|50123469|FG000|Overall Study|Withdrawal by Subject|0|||
25025747|NCT03634085|50123470|FG001|Overall Study|Withdrawal by Subject|2|||
25155506|NCT01535235|50270795|FG001|Overall Study|Adverse Event|0|||
25155507|NCT01483599|50270839|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
25155508|NCT01483599|50270840|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
25155509|NCT01483599|50270841|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
25155510|NCT01483599|50270842|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
25155511|NCT01483599|50270843|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
25155512|NCT01483599|50270844|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
25155513|NCT01483599|50270845|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
25155514|NCT01483599|50270846|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
25155515|NCT01483599|50270847|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
25155516|NCT01483599|50270848|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
25155517|NCT01483599|50270849|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
25155518|NCT01483599|50270850|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
25155519|NCT01483599|50270851|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
25155520|NCT01483599|50270852|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
25155521|NCT01483599|50270839|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
25155522|NCT01483599|50270840|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
25155523|NCT01483599|50270841|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
25155524|NCT01483599|50270842|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
25155525|NCT01483599|50270843|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
25155526|NCT01483599|50270844|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
25155527|NCT01483599|50270845|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
25155528|NCT01483599|50270846|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
25155529|NCT01483599|50270847|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
25155530|NCT01483599|50270848|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
25155531|NCT01483599|50270849|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
25155532|NCT01483599|50270850|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
25155533|NCT01483599|50270851|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
25155534|NCT01483599|50270852|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
25185605|NCT00086047|50335113|FG000|Overall Study|Physician Decision|0|||
25185606|NCT00086047|50335114|FG001|Overall Study|Physician Decision|1|||
25025748|NCT02676778|50123486|FG000|Overall Study|Disease Progression|7|||
25025749|NCT02676778|50123487|FG001|Overall Study|Disease Progression|3|||
25025750|NCT02676778|50123488|FG002|Overall Study|Disease Progression|1|||
25025751|NCT02676778|50123486|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
25025752|NCT02676778|50123487|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
24929147|NCT00412750|50022376|FG001|Overall Study|Lost to Follow-up|0|||
24929148|NCT00412750|50022377|FG002|Overall Study|Lost to Follow-up|1|||
24929149|NCT00412750|50022375|FG000|Overall Study|Withdrawal by Subject|0|||
24929150|NCT00412750|50022376|FG001|Overall Study|Withdrawal by Subject|1|||
25185607|NCT01478828|50335126|FG000|Overall Study|Adverse Event|1|||
25025753|NCT02676778|50123488|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
25025754|NCT02676778|50123486|FG000|Overall Study|Withdrawal by Subject|3|||
25025755|NCT02676778|50123487|FG001|Overall Study|Withdrawal by Subject|2|||
25025756|NCT02676778|50123488|FG002|Overall Study|Withdrawal by Subject|0|||
25025757|NCT02676778|50123486|FG000|Overall Study|Other|4|||
25025758|NCT02676778|50123487|FG001|Overall Study|Other|3|||
25025759|NCT02676778|50123488|FG002|Overall Study|Other|0|||
25025760|NCT02676778|50123486|FG000|Overall Study|Adverse Event|2|||
25025761|NCT02676778|50123487|FG001|Overall Study|Adverse Event|3|||
25025762|NCT02676778|50123488|FG002|Overall Study|Adverse Event|0|||
25025763|NCT02946385|50123503|FG000|Overall Study|Lost to Follow-up|0|||
25025764|NCT02946385|50123504|FG001|Overall Study|Lost to Follow-up|0|||
25025765|NCT02946385|50123505|FG002|Overall Study|Lost to Follow-up|3|||
25025766|NCT02946385|50123506|FG003|Overall Study|Lost to Follow-up|0|||
24929151|NCT00412750|50022377|FG002|Overall Study|Withdrawal by Subject|2|||
24929152|NCT00412750|50022375|FG000|Overall Study|Lack of Efficacy|0|||
24929153|NCT00412750|50022376|FG001|Overall Study|Lack of Efficacy|0|||
24929154|NCT00412750|50022377|FG002|Overall Study|Lack of Efficacy|3|||
24929155|NCT00076999|50022391|FG000|Overall Study|Adverse Event|2|||
24929156|NCT00076999|50022392|FG001|Overall Study|Adverse Event|8|||
24929157|NCT00076999|50022393|FG002|Overall Study|Adverse Event|6|||
24929158|NCT00076999|50022394|FG003|Overall Study|Adverse Event|0|||
24929159|NCT00076999|50022395|FG004|Overall Study|Adverse Event|2|||
24929160|NCT00076999|50022391|FG000|Overall Study|Protocol Violation|0|||
24929161|NCT00076999|50022392|FG001|Overall Study|Protocol Violation|3|||
24929162|NCT00076999|50022393|FG002|Overall Study|Protocol Violation|4|||
24929163|NCT00076999|50022394|FG003|Overall Study|Protocol Violation|0|||
24929164|NCT00076999|50022395|FG004|Overall Study|Protocol Violation|9|||
24929165|NCT00076999|50022391|FG000|Overall Study|Lost to Follow-up|2|||
24929166|NCT00076999|50022392|FG001|Overall Study|Lost to Follow-up|1|||
24929167|NCT00076999|50022393|FG002|Overall Study|Lost to Follow-up|0|||
24929168|NCT00076999|50022394|FG003|Overall Study|Lost to Follow-up|0|||
24929169|NCT00076999|50022395|FG004|Overall Study|Lost to Follow-up|0|||
24929170|NCT00076999|50022391|FG000|Overall Study|Withdrawal by Subject|0|||
24929171|NCT00076999|50022392|FG001|Overall Study|Withdrawal by Subject|4|||
24929172|NCT00076999|50022393|FG002|Overall Study|Withdrawal by Subject|3|||
24929173|NCT00076999|50022394|FG003|Overall Study|Withdrawal by Subject|0|||
24929174|NCT00076999|50022395|FG004|Overall Study|Withdrawal by Subject|1|||
24929175|NCT00076999|50022391|FG000|Overall Study|Other reason (not specified)|8|||
24929176|NCT00076999|50022392|FG001|Overall Study|Other reason (not specified)|8|||
24929177|NCT00076999|50022393|FG002|Overall Study|Other reason (not specified)|4|||
24929178|NCT00076999|50022394|FG003|Overall Study|Other reason (not specified)|1|||
24929179|NCT00076999|50022395|FG004|Overall Study|Other reason (not specified)|13|||
24929180|NCT03905096|50022410|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
24929181|NCT03905096|50022411|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
24929182|NCT00412360|50022426|FG000|Overall Study|Lost to Follow-up|0|||
24929183|NCT00412360|50022427|FG001|Overall Study|Lost to Follow-up|1|||
24929184|NCT00412360|50022426|FG000|Overall Study|Not Transplanted|1|||
24929185|NCT00412360|50022427|FG001|Overall Study|Not Transplanted|2|||
24929186|NCT00571103|50022433|FG000|Overall Study|Withdrawal by Subject|1|||
24929187|NCT00571103|50022433|FG000|Overall Study|Lost to Follow-up|1|||
24929188|NCT00084799|50022439|FG000|Overall Study|Disease Progression|1|||
24929189|NCT00084799|50022440|FG001|Overall Study|Disease Progression|0|||
24929190|NCT00069277|50022446|FG000|Overall Study|Adverse Event|3|||
24929191|NCT00069277|50022446|FG000|Overall Study|Withdrawal by Subject|1|||
24929192|NCT00069277|50022446|FG000|Overall Study|Progressive Disease|15|||
24929193|NCT00069277|50022446|FG000|Overall Study|Physician Decision|2|||
24929194|NCT00418522|50022452|FG000|Overall Study|Adverse Event|7|||
24929195|NCT00418522|50022453|FG001|Overall Study|Adverse Event|1|||
24929196|NCT00418522|50022452|FG000|Overall Study|Lack of Efficacy|1|||
24929197|NCT00418522|50022453|FG001|Overall Study|Lack of Efficacy|3|||
24929198|NCT00418522|50022452|FG000|Overall Study|Lost to Follow-up|10|||
24929199|NCT00418522|50022453|FG001|Overall Study|Lost to Follow-up|4|||
24929200|NCT00418522|50022452|FG000|Overall Study|Withdrawal by Subject|31|||
24929201|NCT00418522|50022453|FG001|Overall Study|Withdrawal by Subject|7|||
24929202|NCT00418522|50022452|FG000|Overall Study|Other|27|||
24929203|NCT00418522|50022453|FG001|Overall Study|Other|23|||
24929204|NCT00418522|50022452|FG000|Overall Study|Randomized but did not receive treatment|7|||
24929205|NCT00418522|50022453|FG001|Overall Study|Randomized but did not receive treatment|4|||
25025767|NCT02946385|50123507|FG004|Overall Study|Lost to Follow-up|2|||
25025768|NCT02946385|50123508|FG005|Overall Study|Lost to Follow-up|1|||
25025769|NCT02694718|50123528|FG000|Overall Study|Death|1|||
24929206|NCT00403546|50022461|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
24929207|NCT00403546|50022462|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
24929208|NCT00403546|50022463|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
24929209|NCT00403546|50022461|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
25025770|NCT02694718|50123528|FG000|Overall Study|Withdrawal by Subject|1|||
25025771|NCT02944513|50123534|FG000|Overall Study|Withdrawal by Subject|4|||
24929210|NCT00403546|50022462|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
24929211|NCT00403546|50022463|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
24929212|NCT00403546|50022461|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
24929213|NCT00403546|50022462|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
24929214|NCT00403546|50022463|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
24929215|NCT00403546|50022461|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
24929216|NCT00403546|50022462|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
24929217|NCT00403546|50022463|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
24929218|NCT00403546|50022461|FG000|Screening Phase|Screening Failure|22|||
24929219|NCT00403546|50022462|FG001|Screening Phase|Screening Failure|0|||
24929220|NCT00403546|50022463|FG002|Screening Phase|Screening Failure|0|||
24929221|NCT00403546|50022461|FG000|Screening Phase|Adverse Event|1|||
24929222|NCT00403546|50022462|FG001|Screening Phase|Adverse Event|0|||
24929223|NCT00403546|50022463|FG002|Screening Phase|Adverse Event|0|||
24929224|NCT00403546|50022461|FG000|Screening Phase|Terminated Prior to Randomization|5|||
24929225|NCT00403546|50022462|FG001|Screening Phase|Terminated Prior to Randomization|0|||
24929226|NCT00403546|50022463|FG002|Screening Phase|Terminated Prior to Randomization|0|||
24929227|NCT00403546|50022461|FG000|Randomized Trial|Early Terminations|0|||
24929228|NCT00403546|50022462|FG001|Randomized Trial|Early Terminations|17|||
24929229|NCT00403546|50022463|FG002|Randomized Trial|Early Terminations|16|||
24929230|NCT00403390|50022474|FG000|Overall Study|Withdrawal by Subject|1|||
24929231|NCT00403390|50022475|FG001|Overall Study|Withdrawal by Subject|0|||
24929232|NCT00403390|50022474|FG000|Overall Study|samples lost|1|||
24929233|NCT00403390|50022475|FG001|Overall Study|samples lost|0|||
24929234|NCT00403390|50022474|FG000|Overall Study|non-compliant|1|||
24929235|NCT00403390|50022475|FG001|Overall Study|non-compliant|0|||
24929236|NCT00403234|50022485|FG000|Overall Study|Withdrawal by Subject|0|||
24929237|NCT00403234|50022486|FG001|Overall Study|Withdrawal by Subject|1|||
24929238|NCT00403234|50022487|FG002|Overall Study|Withdrawal by Subject|0|||
24929239|NCT00403234|50022488|FG003|Overall Study|Withdrawal by Subject|0|||
24929240|NCT00403234|50022485|FG000|Overall Study|Adverse Event|1|||
24929241|NCT00403234|50022486|FG001|Overall Study|Adverse Event|0|||
24929242|NCT00403234|50022487|FG002|Overall Study|Adverse Event|1|||
24929243|NCT00403234|50022488|FG003|Overall Study|Adverse Event|0|||
24929244|NCT00402688|50022501|FG000|Overall Study|Adverse Event|12|||
24929245|NCT00402688|50022502|FG001|Overall Study|Adverse Event|9|||
24929246|NCT00402688|50022503|FG002|Overall Study|Adverse Event|3|||
24929247|NCT00402688|50022501|FG000|Overall Study|Withdrawal by Subject|3|||
24929248|NCT00402688|50022502|FG001|Overall Study|Withdrawal by Subject|1|||
24929249|NCT00402688|50022503|FG002|Overall Study|Withdrawal by Subject|1|||
24929250|NCT00402688|50022501|FG000|Overall Study|Physician Decision|0|||
24929251|NCT00402688|50022502|FG001|Overall Study|Physician Decision|0|||
24929252|NCT00402688|50022503|FG002|Overall Study|Physician Decision|1|||
24929253|NCT00402688|50022501|FG000|Overall Study|Lack of Efficacy|4|||
24929254|NCT00402688|50022502|FG001|Overall Study|Lack of Efficacy|4|||
24929255|NCT00402688|50022503|FG002|Overall Study|Lack of Efficacy|5|||
24929256|NCT00402688|50022501|FG000|Overall Study|Protocol Violation|1|||
24929257|NCT00402688|50022502|FG001|Overall Study|Protocol Violation|1|||
24929258|NCT00402688|50022503|FG002|Overall Study|Protocol Violation|1|||
24929259|NCT00402688|50022501|FG000|Overall Study|Lost to Follow-up|1|||
24929260|NCT00402688|50022502|FG001|Overall Study|Lost to Follow-up|0|||
24929261|NCT00402688|50022503|FG002|Overall Study|Lost to Follow-up|2|||
24929262|NCT00402688|50022501|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
24929263|NCT00402688|50022502|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
24929264|NCT00402688|50022503|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
24929265|NCT00402688|50022501|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
24929266|NCT00402688|50022502|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
24929267|NCT00402688|50022503|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
24929268|NCT00402688|50022501|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
24929269|NCT00402688|50022502|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
25155535|NCT01483599|50270839|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
24929270|NCT00402688|50022503|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
24929271|NCT00671879|50022514|FG000|Overall Study|Withdrawal by Subject|0|||
24929272|NCT00671879|50022515|FG001|Overall Study|Withdrawal by Subject|4|||
24929273|NCT00671879|50022516|FG002|Overall Study|Withdrawal by Subject|6|||
24929274|NCT00402298|50022527|FG000|Overall Study|Withdrawal by Subject|1|||
24929275|NCT00402298|50022528|FG001|Overall Study|Withdrawal by Subject|0|||
24929276|NCT00401830|50022536|FG000|Overall Study|Adverse Event|10|||
24929277|NCT00401830|50022537|FG001|Overall Study|Adverse Event|18|||
25025772|NCT02944513|50123535|FG001|Overall Study|Withdrawal by Subject|1|||
24929278|NCT00401830|50022536|FG000|Overall Study|Lack of Efficacy|11|||
24929279|NCT00401830|50022537|FG001|Overall Study|Lack of Efficacy|5|||
24929280|NCT00401830|50022536|FG000|Overall Study|Withdrawal by Subject|4|||
24929281|NCT00401830|50022537|FG001|Overall Study|Withdrawal by Subject|3|||
24929282|NCT00401830|50022536|FG000|Overall Study|Protocol Violation|3|||
24929283|NCT00401830|50022537|FG001|Overall Study|Protocol Violation|3|||
24929284|NCT00401830|50022536|FG000|Overall Study|Non-compliance with drug study|1|||
24929285|NCT00401830|50022537|FG001|Overall Study|Non-compliance with drug study|0|||
24929286|NCT00401830|50022536|FG000|Overall Study|Lost to Follow-up|1|||
25155536|NCT01483599|50270840|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
25155537|NCT01483599|50270841|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
25155538|NCT01483599|50270842|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
25155539|NCT01483599|50270843|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
25155540|NCT01483599|50270844|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
25155541|NCT01483599|50270845|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
25155542|NCT01483599|50270846|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
25155543|NCT01483599|50270847|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
25155544|NCT01483599|50270848|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
25155545|NCT01483599|50270849|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
25155546|NCT01483599|50270850|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
25155547|NCT01483599|50270851|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
25155548|NCT01483599|50270852|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
25155549|NCT01483599|50270839|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
25155550|NCT01483599|50270840|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
25155551|NCT01483599|50270841|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
25155552|NCT01483599|50270842|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
25155553|NCT01483599|50270843|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
25155554|NCT01483599|50270844|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
25155555|NCT01483599|50270845|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
25155556|NCT01483599|50270846|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
25155557|NCT01483599|50270847|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
25155558|NCT01483599|50270848|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
25155559|NCT01483599|50270849|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
25155560|NCT01483599|50270850|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
25155561|NCT01483599|50270851|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
25155562|NCT01483599|50270852|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
25155563|NCT01483599|50270839|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
25155564|NCT01483599|50270840|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
25155565|NCT01483599|50270841|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
25155566|NCT01483599|50270842|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
25155567|NCT01483599|50270843|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
25155568|NCT01483599|50270844|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
25155569|NCT01483599|50270845|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
25155570|NCT01483599|50270846|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
25155571|NCT01483599|50270847|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
25155572|NCT01483599|50270848|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
25155573|NCT01483599|50270849|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
25155574|NCT01483599|50270850|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
25155575|NCT01483599|50270851|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
24929287|NCT00401830|50022537|FG001|Overall Study|Lost to Follow-up|3|||
24929288|NCT00401830|50022536|FG000|Overall Study|Other: Personal / Family problems|1|||
24929289|NCT00401830|50022537|FG001|Overall Study|Other: Personal / Family problems|0|||
24929290|NCT02471144|50022547|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
24929291|NCT02471144|50022548|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
24929292|NCT02471144|50022549|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
24929293|NCT02471144|50022550|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
25155576|NCT01483599|50270852|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
25155577|NCT01483599|50270839|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
25155578|NCT01483599|50270840|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
25155579|NCT01483599|50270841|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
25155580|NCT01483599|50270842|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
25155581|NCT01483599|50270843|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
25185608|NCT00085423|50335131|FG000|Overall Study|Withdrawal by Subject|1|||
24929294|NCT02471144|50022551|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
24929295|NCT02471144|50022552|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
24929296|NCT02471144|50022553|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
24929297|NCT02471144|50022554|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
24929298|NCT02471144|50022555|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
24929299|NCT02471144|50022556|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
24929300|NCT02471144|50022557|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
24929301|NCT02471144|50022547|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
24929302|NCT02471144|50022548|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
24929303|NCT02471144|50022549|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
24929304|NCT02471144|50022550|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
25155582|NCT01483599|50270844|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
25155583|NCT01483599|50270845|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
24929305|NCT02471144|50022551|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
24929306|NCT02471144|50022552|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
24929307|NCT02471144|50022553|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
24929308|NCT02471144|50022554|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
24929309|NCT02471144|50022555|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
24929310|NCT02471144|50022556|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
24929311|NCT02471144|50022557|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
24929312|NCT02471144|50022547|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
24929313|NCT02471144|50022548|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
24929314|NCT02471144|50022549|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
24929315|NCT02471144|50022550|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
24929316|NCT02471144|50022551|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
24929317|NCT02471144|50022552|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
24929318|NCT02471144|50022553|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
24929319|NCT02471144|50022554|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
24929320|NCT02471144|50022555|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
24929321|NCT02471144|50022556|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
25025773|NCT03018938|50123550|FG000|Overall Study|Death|0|||
25025774|NCT03018938|50123551|FG001|Overall Study|Death|1|||
25025775|NCT03018938|50123550|FG000|Overall Study|Lost to Follow-up|21|||
25025776|NCT03018938|50123551|FG001|Overall Study|Lost to Follow-up|32|||
25025777|NCT03018938|50123550|FG000|Overall Study|Withdrawal by Subject|38|||
25025778|NCT03018938|50123551|FG001|Overall Study|Withdrawal by Subject|45|||
24929322|NCT02471144|50022557|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
24929323|NCT02471144|50022547|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
24929324|NCT02471144|50022548|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
24929325|NCT02471144|50022549|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
24929326|NCT02471144|50022550|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
25025779|NCT03018938|50123550|FG000|Overall Study|Physician Decision|3|||
25025780|NCT03018938|50123551|FG001|Overall Study|Physician Decision|2|||
25025781|NCT03018938|50123550|FG000|Overall Study|Sponsor Decision|0|||
25025782|NCT03018938|50123551|FG001|Overall Study|Sponsor Decision|1|||
25025783|NCT03018938|50123550|FG000|Overall Study|Screen failure-After randomization|4|||
25025784|NCT03018938|50123551|FG001|Overall Study|Screen failure-After randomization|2|||
25025785|NCT03018938|50123550|FG000|Overall Study|Not recorded|0|||
25155584|NCT01483599|50270846|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
24929327|NCT02471144|50022551|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
24929328|NCT02471144|50022552|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
24929329|NCT02471144|50022553|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
24929330|NCT02471144|50022554|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
24929331|NCT02471144|50022555|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
24929332|NCT02471144|50022556|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
25025786|NCT03018938|50123551|FG001|Overall Study|Not recorded|2|||
25025787|NCT02943577|50123559|FG000|Overall Study|Protocol Violation|0|||
25025788|NCT02943577|50123560|FG001|Overall Study|Protocol Violation|1|||
25025789|NCT02943577|50123559|FG000|Overall Study|Adverse Event|3|||
25025790|NCT02943577|50123560|FG001|Overall Study|Adverse Event|2|||
25025791|NCT02943577|50123559|FG000|Overall Study|Lost to Follow-up|0|||
25025792|NCT02943577|50123560|FG001|Overall Study|Lost to Follow-up|1|||
24929333|NCT02471144|50022557|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
24929334|NCT02471144|50022547|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
24929335|NCT02471144|50022548|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
24929336|NCT02471144|50022549|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
24929337|NCT02471144|50022550|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
24929338|NCT02471144|50022551|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
24929339|NCT02471144|50022552|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
24929340|NCT02471144|50022553|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
24929341|NCT02471144|50022554|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
24929342|NCT02471144|50022555|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
24929343|NCT02471144|50022556|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
24929344|NCT02471144|50022557|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
24929345|NCT02471144|50022547|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
24929346|NCT02471144|50022548|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
24929347|NCT02471144|50022549|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
24929348|NCT02471144|50022550|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
24929349|NCT02471144|50022551|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
24929350|NCT02471144|50022552|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
24929351|NCT02471144|50022553|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
24929352|NCT02471144|50022554|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
24929353|NCT02471144|50022555|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
24929354|NCT02471144|50022556|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
24929355|NCT02471144|50022557|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
24929356|NCT02471144|50022547|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
24929357|NCT02471144|50022548|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
24929358|NCT02471144|50022549|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
24929359|NCT02471144|50022550|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
24929360|NCT02471144|50022551|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
24929361|NCT02471144|50022552|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
24929362|NCT02471144|50022553|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
24929363|NCT02471144|50022554|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
24929364|NCT02471144|50022555|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
24929365|NCT02471144|50022556|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
24929366|NCT02471144|50022557|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
24929367|NCT02471144|50022547|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
24929368|NCT02471144|50022548|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
24929369|NCT02471144|50022549|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
24929370|NCT02471144|50022550|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
24929371|NCT02471144|50022551|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
24929372|NCT02471144|50022552|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
24929373|NCT02471144|50022553|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
24929374|NCT02471144|50022554|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
24929375|NCT02471144|50022555|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
24929376|NCT02471144|50022556|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
24929377|NCT02471144|50022557|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
24929378|NCT02471144|50022547|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
24929379|NCT02471144|50022548|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
24929380|NCT02471144|50022549|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
24929381|NCT02471144|50022550|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
24929382|NCT02471144|50022551|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
24929383|NCT02471144|50022552|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
24929384|NCT02471144|50022553|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
24929385|NCT02471144|50022554|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
24929386|NCT02471144|50022555|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
24929387|NCT02471144|50022556|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|5|||
24929388|NCT02471144|50022557|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|2|||
24929389|NCT02471144|50022547|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
24929390|NCT02471144|50022548|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
24929391|NCT02471144|50022549|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
24929392|NCT02471144|50022550|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
24929393|NCT02471144|50022551|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
24929394|NCT02471144|50022552|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
24929395|NCT02471144|50022553|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
24929396|NCT02471144|50022554|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
24929397|NCT02471144|50022555|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
24929398|NCT02471144|50022556|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
24929399|NCT02471144|50022557|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
24929400|NCT02471144|50022547|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
24929401|NCT02471144|50022548|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
24929402|NCT02471144|50022549|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
24929403|NCT02471144|50022550|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
24929404|NCT02471144|50022551|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
24929405|NCT02471144|50022552|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
24929406|NCT02471144|50022553|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
24929407|NCT02471144|50022554|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
24929408|NCT02471144|50022555|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
24929409|NCT02471144|50022556|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
24929410|NCT02471144|50022557|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
24929411|NCT00401752|50022575|FG000|Overall Study|Adverse Event|2|||
24929412|NCT00401752|50022576|FG001|Overall Study|Adverse Event|5|||
24929413|NCT00401752|50022575|FG000|Overall Study|Withdrawal by Subject|2|||
24929414|NCT00401752|50022576|FG001|Overall Study|Withdrawal by Subject|6|||
25025793|NCT02943577|50123559|FG000|Overall Study|Withdrawal by Subject|1|||
25025794|NCT02943577|50123560|FG001|Overall Study|Withdrawal by Subject|1|||
24929415|NCT00401752|50022575|FG000|Overall Study|Lost to Follow-up|1|||
24929416|NCT00401752|50022576|FG001|Overall Study|Lost to Follow-up|4|||
24929417|NCT00401752|50022575|FG000|Overall Study|Development of any exclusion criteria|4|||
24929418|NCT00401752|50022576|FG001|Overall Study|Development of any exclusion criteria|2|||
25025795|NCT02943577|50123559|FG000|Overall Study|Pregnancy|1|||
25025796|NCT02943577|50123560|FG001|Overall Study|Pregnancy|0|||
25025797|NCT03016598|50123568|FG000|Overall Study|Lost to Follow-up|0|||
25025798|NCT03016598|50123569|FG001|Overall Study|Lost to Follow-up|2|||
25275102|NCT01237223|50589112|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
25275103|NCT01237223|50589113|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
25275104|NCT01237223|50589108|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
25275105|NCT01237223|50589109|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
25275106|NCT01237223|50589110|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
25025805|NCT03017846|50123584|FG000|Overall Study|Lost to Follow-up|3|||
25025806|NCT03017846|50123584|FG000|Overall Study|Adverse Event|2|||
25025807|NCT03014180|50123590|FG000|Overall Study|Protocol Violation|2|||
25025808|NCT03011840|50123600|FG000|Overall Study|Not received PIL in post PIL phase|0|||
25025809|NCT03011840|50123601|FG001|Overall Study|Not received PIL in post PIL phase|21|||
24929419|NCT00401752|50022575|FG000|Overall Study|Physician Decision|1|||
24929420|NCT00401752|50022576|FG001|Overall Study|Physician Decision|1|||
24929421|NCT00539240|50022585|FG000|Overall Study|Withdrawal by Subject|0|||
24929422|NCT00539240|50022586|FG001|Overall Study|Withdrawal by Subject|2|||
24929423|NCT00539240|50022587|FG002|Overall Study|Withdrawal by Subject|0|||
24929424|NCT00539240|50022585|FG000|Overall Study|Protocol Violation|1|||
24929425|NCT00539240|50022586|FG001|Overall Study|Protocol Violation|1|||
24929426|NCT00539240|50022587|FG002|Overall Study|Protocol Violation|4|||
24929427|NCT00539240|50022585|FG000|Overall Study|Lost to Follow-up|2|||
24929428|NCT00539240|50022586|FG001|Overall Study|Lost to Follow-up|3|||
24929429|NCT00539240|50022587|FG002|Overall Study|Lost to Follow-up|1|||
24929430|NCT00539240|50022585|FG000|Overall Study|Adverse Event|3|||
24929431|NCT00539240|50022586|FG001|Overall Study|Adverse Event|1|||
24929432|NCT00539240|50022587|FG002|Overall Study|Adverse Event|10|||
24929433|NCT00417976|50022595|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
24929434|NCT00417976|50022595|FG000|Overall Study|Treatment -related toxicity|2|||
24929435|NCT00673673|50022600|FG000|Overall Study|Progressive disease|27|||
24929436|NCT00673673|50022600|FG000|Overall Study|Adverse Event|4|||
24929437|NCT00673673|50022600|FG000|Overall Study|Withdrawal by Subject|3|||
24929438|NCT00673673|50022600|FG000|Overall Study|Investigators' discretion|2|||
24929439|NCT00069121|50022606|FG000|Overall Study|Death|286|||
24929440|NCT00069121|50022607|FG001|Overall Study|Death|242|||
24929441|NCT00069121|50022606|FG000|Overall Study|Withdrawal by Subject|18|||
25025810|NCT02942485|50123609|FG000|Overall Study|Lost to Follow-up|1|||
25025811|NCT02942485|50123610|FG001|Overall Study|Lost to Follow-up|0|||
25025812|NCT02942407|50123618|FG000|Overall Study|Lost to Follow-up|3|||
25025813|NCT02942407|50123619|FG001|Overall Study|Lost to Follow-up|2|||
24929442|NCT00069121|50022607|FG001|Overall Study|Withdrawal by Subject|20|||
24929443|NCT00069121|50022606|FG000|Overall Study|Lost to Follow-up|63|||
24929444|NCT00069121|50022607|FG001|Overall Study|Lost to Follow-up|63|||
24929445|NCT00399802|50022619|FG000|Overall Study|Adverse Event|0|||
24929446|NCT00399802|50022620|FG001|Overall Study|Adverse Event|2|||
24929447|NCT00399802|50022619|FG000|Overall Study|Participant discontinued by mistake|0|||
25025814|NCT02942407|50123618|FG000|Overall Study|Withdrawal by Subject|7|||
25025815|NCT02942407|50123619|FG001|Overall Study|Withdrawal by Subject|9|||
24929448|NCT00399802|50022620|FG001|Overall Study|Participant discontinued by mistake|1|||
24929449|NCT00399568|50022628|FG000|Overall Study|Adverse Event|1|||
24929450|NCT00399568|50022629|FG001|Overall Study|Adverse Event|2|||
25025816|NCT02942407|50123618|FG000|Overall Study|Death|16|||
24929451|NCT00399568|50022628|FG000|Overall Study|Withdrawal by Subject|7|||
24929452|NCT00399568|50022629|FG001|Overall Study|Withdrawal by Subject|3|||
24929453|NCT00399568|50022628|FG000|Overall Study|Protocol non-compliance|2|||
24929454|NCT00399568|50022629|FG001|Overall Study|Protocol non-compliance|2|||
24929455|NCT00399568|50022628|FG000|Overall Study|Lost to Follow-up|2|||
24929456|NCT00399568|50022629|FG001|Overall Study|Lost to Follow-up|2|||
24929457|NCT03900728|50022640|FG000|Overall Study|No text responses|0|||
24929458|NCT03900728|50022641|FG001|Overall Study|No text responses|0|||
24929459|NCT03900728|50022642|FG002|Overall Study|No text responses|4|||
24929460|NCT00068419|50022650|FG000|Overall Study|Adverse Event|3|||
24929461|NCT00068419|50022650|FG000|Overall Study|Lack of Efficacy|24|||
24929462|NCT00068419|50022650|FG000|Overall Study|Lost to Follow-up|1|||
24929463|NCT00068419|50022650|FG000|Overall Study|Physician Decision|7|||
24929464|NCT00068419|50022650|FG000|Overall Study|Withdrawal by Subject|14|||
24929465|NCT00068419|50022650|FG000|Overall Study|Ineligible|11|||
24929466|NCT00068107|50022654|FG000|Overall Study|end-stage renal disease|6|||
24929467|NCT00068107|50022654|FG000|Overall Study|Death|2|||
24929468|NCT00068107|50022654|FG000|Overall Study|Withdrawal by Subject|1|||
24929469|NCT00394654|50022663|FG000|Overall Study|Lost to Follow-up|1|||
24929470|NCT00394654|50022664|FG001|Overall Study|Lost to Follow-up|0|||
24929471|NCT00394654|50022663|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
24929472|NCT00394654|50022664|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
24929473|NCT03900416|50022672|FG000|Six Week Follow-up|Lost to Follow-up|1|||
24929474|NCT03900416|50022673|FG001|Six Week Follow-up|Lost to Follow-up|0|||
24929475|NCT03900416|50022672|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
24929476|NCT03900416|50022673|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
24929477|NCT03900416|50022672|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
25025817|NCT02942407|50123619|FG001|Overall Study|Death|13|||
25025818|NCT03009344|50123633|FG000|Overall Study|Lack of Efficacy|5|||
24929478|NCT03900416|50022673|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
24929479|NCT03900416|50022672|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
24929480|NCT03900416|50022673|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
24929481|NCT03900416|50022672|FG000|Twelve Week Follow-up|Adverse Event|1|||
24929482|NCT03900416|50022673|FG001|Twelve Week Follow-up|Adverse Event|1|||
24929483|NCT03900416|50022672|FG000|Six Month Follow-up|Lost to Follow-up|4|||
24929484|NCT03900416|50022673|FG001|Six Month Follow-up|Lost to Follow-up|3|||
24929485|NCT03900416|50022672|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
25025819|NCT03009344|50123633|FG000|Overall Study|Withdrawal by Subject|1|||
25025820|NCT03009344|50123633|FG000|Overall Study|Adverse Event|1|||
25025821|NCT03322423|50123637|FG000|Period 1|Subject no longer eligible|0|||
25025822|NCT03322423|50123638|FG001|Period 1|Subject no longer eligible|1|||
25025823|NCT03322423|50123637|FG000|Period 1|Withdrawal by Subject|0|||
25025824|NCT03322423|50123638|FG001|Period 1|Withdrawal by Subject|1|||
25025825|NCT03322423|50123637|FG000|Period 1|Incorrect Lens Dispensed|1|||
25025826|NCT03322423|50123638|FG001|Period 1|Incorrect Lens Dispensed|0|||
25025827|NCT03322423|50123637|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
25025828|NCT03322423|50123638|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
25025829|NCT03322423|50123637|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
25025830|NCT03322423|50123638|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
25025831|NCT03322423|50123637|FG000|Period 2|Protocol Violation|1|||
25025832|NCT03322423|50123638|FG001|Period 2|Protocol Violation|0|||
25025833|NCT03322423|50123637|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
25025834|NCT03322423|50123638|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
25025835|NCT03007472|50123644|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
25025836|NCT03007472|50123644|FG000|Overall Study|Death|2|||
25025837|NCT03007472|50123644|FG000|Overall Study|Loss to Follow Up|1|||
25025838|NCT03321721|50123651|FG000|Overall Study|Lost to Follow-up|4|||
25025839|NCT03321721|50123652|FG001|Overall Study|Lost to Follow-up|8|||
25025840|NCT03321721|50123653|FG002|Overall Study|Lost to Follow-up|11|||
25025841|NCT03015116|50123665|FG000|Overall Study|Lost to Follow-up|3|||
25025842|NCT03015116|50123666|FG001|Overall Study|Lost to Follow-up|0|||
25025843|NCT03015116|50123667|FG002|Overall Study|Lost to Follow-up|2|||
25025844|NCT03015116|50123665|FG000|Overall Study|Withdrawal by Subject|3|||
25025845|NCT03015116|50123666|FG001|Overall Study|Withdrawal by Subject|1|||
25025846|NCT03015116|50123667|FG002|Overall Study|Withdrawal by Subject|0|||
25155585|NCT01483599|50270847|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
25155586|NCT01483599|50270848|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
24929486|NCT03900416|50022673|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
24929487|NCT00399490|50022679|FG000|Overall Study|Adverse Event|19|||
24929488|NCT00399490|50022679|FG000|Overall Study|Lack of Efficacy|31|||
24929489|NCT00399490|50022679|FG000|Overall Study|Lost to Follow-up|5|||
24929490|NCT00399490|50022679|FG000|Overall Study|Withdrawal by Subject|18|||
25025847|NCT03015116|50123665|FG000|Overall Study|Subject has New Medical Status|1|||
25025848|NCT03015116|50123666|FG001|Overall Study|Subject has New Medical Status|0|||
25025849|NCT03015116|50123667|FG002|Overall Study|Subject has New Medical Status|0|||
25025850|NCT03015116|50123665|FG000|Overall Study|Physician Decision|0|||
24929491|NCT00399490|50022679|FG000|Overall Study|Other|25|||
24929492|NCT00398866|50022688|FG000|Overall Study|Adverse Event|1|||
24929493|NCT00398866|50022689|FG001|Overall Study|Adverse Event|0|||
24929494|NCT00398866|50022690|FG002|Overall Study|Adverse Event|0|||
24929495|NCT00398866|50022688|FG000|Overall Study|Lack of Efficacy|0|||
24929496|NCT00398866|50022689|FG001|Overall Study|Lack of Efficacy|0|||
24929497|NCT00398866|50022690|FG002|Overall Study|Lack of Efficacy|1|||
24929498|NCT00398866|50022688|FG000|Overall Study|Lost to Follow-up|7|||
24929499|NCT00398866|50022689|FG001|Overall Study|Lost to Follow-up|6|||
24929500|NCT00398866|50022690|FG002|Overall Study|Lost to Follow-up|4|||
24929501|NCT00398866|50022688|FG000|Overall Study|Withdrawal by Subject|5|||
24929502|NCT00398866|50022689|FG001|Overall Study|Withdrawal by Subject|1|||
24929503|NCT00398866|50022690|FG002|Overall Study|Withdrawal by Subject|2|||
25025851|NCT03015116|50123666|FG001|Overall Study|Physician Decision|1|||
25025852|NCT03015116|50123667|FG002|Overall Study|Physician Decision|0|||
25025853|NCT03006848|50123677|FG000|Overall Study|Adverse Event|1|||
25025854|NCT03006848|50123677|FG000|Overall Study|Physician Decision|1|||
25025855|NCT03006848|50123677|FG000|Overall Study|Lack of Efficacy|16|||
25025856|NCT03006458|50123688|FG000|First Intervention|Unsatisfied Vision|0|||
25025857|NCT03006458|50123689|FG001|First Intervention|Unsatisfied Vision|3|||
25025858|NCT03320941|50123700|FG000|Overall Study|subject/guardian decision|0|||
25025859|NCT03320941|50123701|FG001|Overall Study|subject/guardian decision|0|||
25025860|NCT03320941|50123702|FG002|Overall Study|subject/guardian decision|0|||
25025861|NCT03320941|50123703|FG003|Overall Study|subject/guardian decision|1|||
25025862|NCT03320941|50123704|FG004|Overall Study|subject/guardian decision|0|||
25155587|NCT01483599|50270849|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
24929504|NCT00398866|50022688|FG000|Overall Study|Unable to complete requirements of study|1|||
24929505|NCT00398866|50022689|FG001|Overall Study|Unable to complete requirements of study|1|||
24929506|NCT00398866|50022690|FG002|Overall Study|Unable to complete requirements of study|1|||
24929507|NCT00398632|50022699|FG000|Overall Study|Withdrawal by Subject|1|||
24929508|NCT00398632|50022699|FG000|Overall Study|Lack of Efficacy|1|||
24929509|NCT00673361|50022704|FG000|Overall Study|Screen Failure|2|||
24929510|NCT00393718|50022710|FG000|Overall Study|Adverse Event|20|||
24929511|NCT00393718|50022711|FG001|Overall Study|Adverse Event|8|||
24929512|NCT00393718|50022710|FG000|Overall Study|Protocol Violation|1|||
24929513|NCT00393718|50022711|FG001|Overall Study|Protocol Violation|2|||
24929514|NCT00393718|50022710|FG000|Overall Study|Lack of Efficacy|10|||
24929515|NCT00393718|50022711|FG001|Overall Study|Lack of Efficacy|9|||
24929516|NCT00393718|50022710|FG000|Overall Study|Hypoglycaemia|3|||
24929517|NCT00393718|50022711|FG001|Overall Study|Hypoglycaemia|2|||
24929518|NCT00393718|50022710|FG000|Overall Study|Subject decision|5|||
24929519|NCT00393718|50022711|FG001|Overall Study|Subject decision|0|||
24929520|NCT00393718|50022710|FG000|Overall Study|Withdrawal of consent|2|||
24929521|NCT00393718|50022711|FG001|Overall Study|Withdrawal of consent|1|||
24929522|NCT00393718|50022710|FG000|Overall Study|Missed measurement|1|||
24929523|NCT00393718|50022711|FG001|Overall Study|Missed measurement|0|||
24929524|NCT00393718|50022710|FG000|Overall Study|Move|1|||
25155588|NCT01483599|50270850|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
25155589|NCT01483599|50270851|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
25155590|NCT01483599|50270852|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
25155591|NCT01483599|50270839|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
25155592|NCT01483599|50270840|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
25155593|NCT01483599|50270841|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
25155594|NCT01483599|50270842|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
25155595|NCT01483599|50270843|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
25155596|NCT01483599|50270844|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
25155597|NCT01483599|50270845|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
25155598|NCT01483599|50270846|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
25185609|NCT00085423|50335131|FG000|Overall Study|screen failure|1|||
24929525|NCT00393718|50022711|FG001|Overall Study|Move|0|||
24929526|NCT00669071|50022717|FG000|Overall Study|Lost to Follow-up|3|||
24929527|NCT00669071|50022717|FG000|Overall Study|Final visit 40 days out of window|1|||
24929528|NCT00398320|50022723|FG000|Overall Study|Death|1|||
24929529|NCT00398320|50022723|FG000|Overall Study|Adverse Event|4|||
24929530|NCT00398320|50022723|FG000|Overall Study|Physician Decision|1|||
24929531|NCT00670007|50022727|FG000|Overall Study|Drug abuse|1|||
25025863|NCT03005288|50123718|FG000|Overall Study|Withdrawal by Subject|7|||
24929532|NCT00670007|50022727|FG000|Overall Study|Lung transplant|1|||
24929533|NCT00670007|50022727|FG000|Overall Study|Travel/Vacation|1|||
24929534|NCT00670007|50022727|FG000|Overall Study|Adverse event, serious fatal|1|||
24929535|NCT00670007|50022727|FG000|Overall Study|Adverse Event|1|||
24929536|NCT00670007|50022727|FG000|Overall Study|Withdrawal by Subject|4|||
24929537|NCT00535496|50022734|FG000|Overall Study|Lost to Follow-up|0|||
24929538|NCT00535496|50022735|FG001|Overall Study|Lost to Follow-up|1|||
24929539|NCT00535496|50022736|FG002|Overall Study|Lost to Follow-up|0|||
24929540|NCT00535496|50022737|FG003|Overall Study|Lost to Follow-up|0|||
25025864|NCT03005288|50123719|FG001|Overall Study|Withdrawal by Subject|5|||
24929541|NCT00535496|50022734|FG000|Overall Study|Not treated with sugammadex|0|||
24929542|NCT00535496|50022735|FG001|Overall Study|Not treated with sugammadex|1|||
24929543|NCT00535496|50022736|FG002|Overall Study|Not treated with sugammadex|0|||
24929544|NCT00535496|50022737|FG003|Overall Study|Not treated with sugammadex|0|||
24929545|NCT00539006|50022748|FG000|Pre-treatment|Other|0|||
24929546|NCT00539006|50022749|FG001|Pre-treatment|Other|1|||
24929547|NCT00539006|50022750|FG002|Pre-treatment|Other|0|||
24929548|NCT00539006|50022751|FG003|Pre-treatment|Other|0|||
24929549|NCT00539006|50022748|FG000|Treatment Period 1|Lost to Follow-up|0|||
24929550|NCT00539006|50022749|FG001|Treatment Period 1|Lost to Follow-up|0|||
24929551|NCT00539006|50022750|FG002|Treatment Period 1|Lost to Follow-up|1|||
24929552|NCT00539006|50022751|FG003|Treatment Period 1|Lost to Follow-up|0|||
24929553|NCT00539006|50022748|FG000|Treatment Period 1|Protocol Violation|0|||
24929554|NCT00539006|50022749|FG001|Treatment Period 1|Protocol Violation|0|||
24929555|NCT00539006|50022750|FG002|Treatment Period 1|Protocol Violation|1|||
24929556|NCT00539006|50022751|FG003|Treatment Period 1|Protocol Violation|0|||
24929557|NCT00539006|50022748|FG000|Treatment Period 1|Lack of Efficacy|0|||
24929558|NCT00539006|50022749|FG001|Treatment Period 1|Lack of Efficacy|0|||
24929559|NCT00539006|50022750|FG002|Treatment Period 1|Lack of Efficacy|0|||
24929560|NCT00539006|50022751|FG003|Treatment Period 1|Lack of Efficacy|1|||
24929561|NCT00539006|50022748|FG000|Washout|Adverse Event|2|||
24929562|NCT00539006|50022749|FG001|Washout|Adverse Event|1|||
24929563|NCT00539006|50022750|FG002|Washout|Adverse Event|0|||
24929564|NCT00539006|50022751|FG003|Washout|Adverse Event|0|||
24929565|NCT00539006|50022748|FG000|Washout|Protocol Violation|1|||
24929566|NCT00539006|50022749|FG001|Washout|Protocol Violation|1|||
24929567|NCT00539006|50022750|FG002|Washout|Protocol Violation|0|||
24929568|NCT00539006|50022751|FG003|Washout|Protocol Violation|0|||
24929569|NCT00539006|50022748|FG000|Washout|Withdrawal by Subject|0|||
24929570|NCT00539006|50022749|FG001|Washout|Withdrawal by Subject|2|||
24929571|NCT00539006|50022750|FG002|Washout|Withdrawal by Subject|0|||
24929572|NCT00539006|50022751|FG003|Washout|Withdrawal by Subject|0|||
25025865|NCT03005288|50123718|FG000|Overall Study|Lost to Follow-up|0|||
25025866|NCT03005288|50123719|FG001|Overall Study|Lost to Follow-up|1|||
25025867|NCT03005288|50123718|FG000|Overall Study|Adverse Event|5|||
24929573|NCT00539006|50022748|FG000|Washout|Failed to meet continuation criteria|16|||
24929574|NCT00539006|50022749|FG001|Washout|Failed to meet continuation criteria|5|||
25025868|NCT03005288|50123719|FG001|Overall Study|Adverse Event|0|||
25025869|NCT03005288|50123718|FG000|Overall Study|Protocol deviation|0|||
24929575|NCT00539006|50022750|FG002|Washout|Failed to meet continuation criteria|14|||
24929576|NCT00539006|50022751|FG003|Washout|Failed to meet continuation criteria|6|||
24929577|NCT00539006|50022748|FG000|Washout|Other|1|||
24929578|NCT00539006|50022749|FG001|Washout|Other|1|||
24929579|NCT00539006|50022750|FG002|Washout|Other|2|||
24929580|NCT00539006|50022751|FG003|Washout|Other|3|||
24929581|NCT00539006|50022748|FG000|Treatment Period 2|Protocol Violation|1|||
24929582|NCT00539006|50022749|FG001|Treatment Period 2|Protocol Violation|0|||
24929583|NCT00539006|50022750|FG002|Treatment Period 2|Protocol Violation|0|||
24929584|NCT00539006|50022751|FG003|Treatment Period 2|Protocol Violation|0|||
24929585|NCT00539006|50022748|FG000|Treatment Period 2|Other|0|||
24929586|NCT00539006|50022749|FG001|Treatment Period 2|Other|1|||
25025870|NCT03005288|50123719|FG001|Overall Study|Protocol deviation|1|||
25025871|NCT03005288|50123718|FG000|Overall Study|Physician Decision|0|||
25025872|NCT03005288|50123719|FG001|Overall Study|Physician Decision|1|||
25025873|NCT03003494|50123725|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
25025874|NCT03559699|50123729|FG000|Overall Study|Withdrawal by Subject|6|||
25025875|NCT03559699|50123729|FG000|Overall Study|Lost to Follow-up|1|||
25025876|NCT03085758|50123736|FG000|Overall Study|Death|26|||
25025877|NCT03085758|50123737|FG001|Overall Study|Death|24|||
25025878|NCT03085758|50123738|FG002|Overall Study|Death|53|||
25155599|NCT01483599|50270847|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
24929587|NCT00539006|50022750|FG002|Treatment Period 2|Other|0|||
24929588|NCT00539006|50022751|FG003|Treatment Period 2|Other|0|||
24929589|NCT00537056|50022767|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
24929590|NCT00535262|50022773|FG000|Overall Study|No funding|3|||
24929591|NCT00074581|50022779|FG000|Overall Study|Death|15|||
25025879|NCT03085758|50123736|FG000|Overall Study|Lost to Follow-up|1|||
24929592|NCT00074581|50022780|FG001|Overall Study|Death|16|||
24929593|NCT00074581|50022779|FG000|Overall Study|Withdrawal by Subject|50|||
24929594|NCT00074581|50022780|FG001|Overall Study|Withdrawal by Subject|49|||
24929595|NCT00074581|50022779|FG000|Overall Study|Unable to adhere to visit schedule|13|||
24929596|NCT00074581|50022780|FG001|Overall Study|Unable to adhere to visit schedule|14|||
24929597|NCT00074581|50022779|FG000|Overall Study|Relocated|14|||
24929598|NCT00074581|50022780|FG001|Overall Study|Relocated|9|||
24929599|NCT00074581|50022779|FG000|Overall Study|Were withdrawn by investigator|5|||
24929600|NCT00074581|50022780|FG001|Overall Study|Were withdrawn by investigator|2|||
24929601|NCT00074581|50022779|FG000|Overall Study|Lost to Follow-up|16|||
24929602|NCT00074581|50022780|FG001|Overall Study|Lost to Follow-up|11|||
24929603|NCT00074581|50022779|FG000|Overall Study|Ended relationship w. index participant|117|||
24929604|NCT00074581|50022780|FG001|Overall Study|Ended relationship w. index participant|106|||
24929605|NCT00074581|50022779|FG000|Overall Study|Other|14|||
24929606|NCT00074581|50022780|FG001|Overall Study|Other|19|||
24929607|NCT03895034|50022786|FG000|Overall Study|Lost to Follow-up|2|||
24929608|NCT00536978|50022790|FG000|Overall Study|Not eligible for Adback Infusion|22|||
24929609|NCT03809611|50022796|FG000|Overall Study|Withdrawal by Subject|1|||
24929610|NCT03809611|50022797|FG001|Overall Study|Withdrawal by Subject|1|||
24929611|NCT03807739|50022808|FG000|Overall Study|Adverse Event|1|||
24929612|NCT03807739|50022809|FG001|Overall Study|Adverse Event|0|||
24929613|NCT03807739|50022810|FG002|Overall Study|Adverse Event|0|||
24929614|NCT03807739|50022811|FG003|Overall Study|Adverse Event|0|||
24929615|NCT03807739|50022808|FG000|Overall Study|Withdrawal by Subject|1|||
24929616|NCT03807739|50022809|FG001|Overall Study|Withdrawal by Subject|0|||
24929617|NCT03807739|50022810|FG002|Overall Study|Withdrawal by Subject|0|||
24929618|NCT03807739|50022811|FG003|Overall Study|Withdrawal by Subject|0|||
24929619|NCT00536744|50022823|FG000|Overall Study|Adverse Event|13|||
24929620|NCT00536744|50022824|FG001|Overall Study|Adverse Event|10|||
24929621|NCT00536744|50022823|FG000|Overall Study|Death|2|||
24929622|NCT00536744|50022824|FG001|Overall Study|Death|1|||
24929623|NCT00536744|50022823|FG000|Overall Study|Physician Decision|3|||
24929624|NCT00536744|50022824|FG001|Overall Study|Physician Decision|1|||
24929625|NCT00536744|50022823|FG000|Overall Study|Lost to Follow-up|3|||
24929626|NCT00536744|50022824|FG001|Overall Study|Lost to Follow-up|5|||
24929627|NCT00536744|50022823|FG000|Overall Study|Withdrawal by Subject|7|||
24929628|NCT00536744|50022824|FG001|Overall Study|Withdrawal by Subject|8|||
25025880|NCT03085758|50123737|FG001|Overall Study|Lost to Follow-up|1|||
25025881|NCT03085758|50123738|FG002|Overall Study|Lost to Follow-up|1|||
25025882|NCT03085758|50123736|FG000|Overall Study|Withdrawal by Subject|2|||
25025883|NCT03085758|50123737|FG001|Overall Study|Withdrawal by Subject|2|||
25025884|NCT03085758|50123738|FG002|Overall Study|Withdrawal by Subject|1|||
25025885|NCT03085758|50123736|FG000|Overall Study|Refusal to recall it up to day 90|0|||
25025886|NCT03085758|50123737|FG001|Overall Study|Refusal to recall it up to day 90|0|||
25025887|NCT03085758|50123738|FG002|Overall Study|Refusal to recall it up to day 90|1|||
25025888|NCT03085758|50123736|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
25025889|NCT03085758|50123737|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
25025890|NCT03085758|50123738|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
25025891|NCT03935880|50123762|FG000|Overall Study|Lost to Follow-up|0|||
25025892|NCT03935880|50123763|FG001|Overall Study|Lost to Follow-up|1|||
25025893|NCT03315793|50123771|FG000|Overall Study|Adverse Event|4|||
25025894|NCT03315793|50123772|FG001|Overall Study|Adverse Event|2|||
25025895|NCT03315793|50123771|FG000|Overall Study|Protocol Deviation|1|||
25025896|NCT03315793|50123772|FG001|Overall Study|Protocol Deviation|0|||
25025897|NCT03315793|50123771|FG000|Overall Study|Difficult for regular visit|0|||
25025898|NCT03315793|50123772|FG001|Overall Study|Difficult for regular visit|1|||
25025899|NCT02676466|50123788|FG000|Overall Study|Death|0|||
25025900|NCT02676466|50123789|FG001|Overall Study|Death|2|||
25025901|NCT02676466|50123790|FG002|Overall Study|Death|1|||
25025902|NCT02676466|50123791|FG003|Overall Study|Death|0|||
25025903|NCT02676466|50123792|FG004|Overall Study|Death|0|||
25025904|NCT02676466|50123793|FG005|Overall Study|Death|0|||
25025905|NCT02676466|50123794|FG006|Overall Study|Death|0|||
25155600|NCT01483599|50270848|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
25155601|NCT01483599|50270849|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
24929629|NCT00536744|50022823|FG000|Overall Study|PI tried alternative treatment|1|||
24929630|NCT00536744|50022824|FG001|Overall Study|PI tried alternative treatment|3|||
25025906|NCT02676466|50123795|FG007|Overall Study|Death|0|||
24929631|NCT00536510|50022841|FG000|Overall Study|Adverse Event|27|||
24929632|NCT00536510|50022842|FG001|Overall Study|Adverse Event|4|||
24929633|NCT00536510|50022841|FG000|Overall Study|Lost to Follow-up|11|||
24929634|NCT00536510|50022842|FG001|Overall Study|Lost to Follow-up|8|||
25025907|NCT02676466|50123788|FG000|Overall Study|Withdrawal by Subject|4|||
24929635|NCT00536510|50022841|FG000|Overall Study|Protocol Violation|4|||
24929636|NCT00536510|50022842|FG001|Overall Study|Protocol Violation|5|||
24929637|NCT00536510|50022841|FG000|Overall Study|Withdrawal by Subject|16|||
24929638|NCT00536510|50022842|FG001|Overall Study|Withdrawal by Subject|9|||
24929639|NCT00536510|50022841|FG000|Overall Study|Flushing with Product|20|||
24929640|NCT00536510|50022842|FG001|Overall Study|Flushing with Product|0|||
24929641|NCT00536510|50022841|FG000|Overall Study|Laboratory Adverse Event|2|||
24929642|NCT00536510|50022842|FG001|Overall Study|Laboratory Adverse Event|1|||
24929643|NCT00536510|50022841|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
24929644|NCT00536510|50022842|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
24929645|NCT00398086|50022851|FG000|Overall Study|Unacceptable Toxicity|2|||
24929646|NCT00398086|50022852|FG001|Overall Study|Unacceptable Toxicity|8|||
24929647|NCT00398086|50022853|FG002|Overall Study|Unacceptable Toxicity|2|||
24929648|NCT00398086|50022851|FG000|Overall Study|Adverse Event|1|||
24929649|NCT00398086|50022852|FG001|Overall Study|Adverse Event|4|||
24929650|NCT00398086|50022853|FG002|Overall Study|Adverse Event|0|||
24929651|NCT00398086|50022851|FG000|Overall Study|Physician Decision|1|||
24929652|NCT00398086|50022852|FG001|Overall Study|Physician Decision|4|||
24929653|NCT00398086|50022853|FG002|Overall Study|Physician Decision|0|||
24929654|NCT00398086|50022851|FG000|Overall Study|Withdrawal by Subject|5|||
24929655|NCT00398086|50022852|FG001|Overall Study|Withdrawal by Subject|7|||
24929656|NCT00398086|50022853|FG002|Overall Study|Withdrawal by Subject|0|||
24929657|NCT00536198|50022863|FG000|Overall Study|Lost to Follow-up|15|||
25155602|NCT01483599|50270850|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
25155603|NCT01483599|50270851|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
24929658|NCT00536198|50022864|FG001|Overall Study|Lost to Follow-up|14|||
24929659|NCT00536198|50022863|FG000|Overall Study|Withdrawal by Subject|16|||
24929660|NCT00536198|50022864|FG001|Overall Study|Withdrawal by Subject|12|||
24929661|NCT00536198|50022863|FG000|Overall Study|Adverse Event|2|||
24929662|NCT00536198|50022864|FG001|Overall Study|Adverse Event|2|||
24929663|NCT00536198|50022863|FG000|Overall Study|Rescue|3|||
24929664|NCT00536198|50022864|FG001|Overall Study|Rescue|9|||
24929665|NCT00536198|50022863|FG000|Overall Study|Pregnancy|1|||
24929666|NCT00536198|50022864|FG001|Overall Study|Pregnancy|1|||
24929667|NCT00536198|50022863|FG000|Overall Study|Protocol Violation|0|||
24929668|NCT00536198|50022864|FG001|Overall Study|Protocol Violation|1|||
24929669|NCT00393484|50022874|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
24929670|NCT00393484|50022875|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
24929671|NCT00393484|50022874|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
24929672|NCT00393484|50022875|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
25155604|NCT01483599|50270852|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
25155605|NCT01483599|50270839|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
25155606|NCT01483599|50270840|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
25155607|NCT01483599|50270841|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
25155608|NCT01483599|50270842|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
25155609|NCT01483599|50270843|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
25155610|NCT01483599|50270844|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
25155611|NCT01483599|50270845|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
24929673|NCT00393484|50022874|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
24929674|NCT00393484|50022875|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
24929675|NCT00393484|50022874|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
24929676|NCT00393484|50022875|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
24929677|NCT00393484|50022874|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
24929678|NCT00393484|50022875|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
24929679|NCT00393484|50022874|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
25025908|NCT02676466|50123789|FG001|Overall Study|Withdrawal by Subject|3|||
25025909|NCT02676466|50123790|FG002|Overall Study|Withdrawal by Subject|1|||
25025910|NCT02676466|50123791|FG003|Overall Study|Withdrawal by Subject|0|||
25025911|NCT02676466|50123792|FG004|Overall Study|Withdrawal by Subject|3|||
25025912|NCT02676466|50123793|FG005|Overall Study|Withdrawal by Subject|1|||
25025913|NCT02676466|50123794|FG006|Overall Study|Withdrawal by Subject|1|||
25025914|NCT02676466|50123795|FG007|Overall Study|Withdrawal by Subject|1|||
25025915|NCT03314857|50123817|FG000|Overall Study|Death|4|||
25025916|NCT03314857|50123817|FG000|Overall Study|Physician Decision|1|||
25025917|NCT03633695|50123823|FG000|Overall Study|Lost to Follow-up|4|||
25025918|NCT03633695|50123824|FG001|Overall Study|Lost to Follow-up|5|||
25025919|NCT03633695|50123823|FG000|Overall Study|Discontinued|8|||
25025920|NCT03633695|50123824|FG001|Overall Study|Discontinued|4|||
25025921|NCT03314233|50123846|FG000|Overall Study|No longer eligible at time of delivery|1|||
25025922|NCT02675998|50123854|FG000|8-Week Treatment Period|Adverse Event|6|||
25025923|NCT02675998|50123855|FG001|8-Week Treatment Period|Adverse Event|5|||
25025924|NCT02675998|50123856|FG002|8-Week Treatment Period|Adverse Event|6|||
25155612|NCT01483599|50270846|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
25155613|NCT01483599|50270847|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
25155614|NCT01483599|50270848|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
25155615|NCT01483599|50270849|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
25155616|NCT01483599|50270850|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
25155617|NCT01483599|50270851|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
25025925|NCT02675998|50123857|FG003|8-Week Treatment Period|Adverse Event|0|||
25025926|NCT02675998|50123854|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
25025927|NCT02675998|50123855|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
25025928|NCT02675998|50123856|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
25025929|NCT02675998|50123857|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
25025930|NCT02675998|50123854|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
25025931|NCT02675998|50123855|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
25025932|NCT02675998|50123856|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
25025933|NCT02675998|50123857|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
25025934|NCT02675998|50123854|FG000|8-Week Treatment Period|Physician Decision|1|||
25025935|NCT02675998|50123855|FG001|8-Week Treatment Period|Physician Decision|0|||
25025936|NCT02675998|50123856|FG002|8-Week Treatment Period|Physician Decision|2|||
25025937|NCT02675998|50123857|FG003|8-Week Treatment Period|Physician Decision|0|||
25025938|NCT02675998|50123854|FG000|8-Week Treatment Period|GI side Effects|1|||
25025939|NCT02675998|50123855|FG001|8-Week Treatment Period|GI side Effects|4|||
25025940|NCT02675998|50123856|FG002|8-Week Treatment Period|GI side Effects|2|||
25025941|NCT02675998|50123857|FG003|8-Week Treatment Period|GI side Effects|0|||
25025942|NCT02675998|50123854|FG000|8-Week Treatment Period|Protocol Violation|1|||
25025943|NCT02675998|50123855|FG001|8-Week Treatment Period|Protocol Violation|1|||
25025944|NCT02675998|50123856|FG002|8-Week Treatment Period|Protocol Violation|1|||
25025945|NCT02675998|50123857|FG003|8-Week Treatment Period|Protocol Violation|0|||
25025946|NCT02675998|50123854|FG000|8-Week Treatment Period|Other|3|||
25025947|NCT02675998|50123855|FG001|8-Week Treatment Period|Other|1|||
25025948|NCT02675998|50123856|FG002|8-Week Treatment Period|Other|2|||
25025949|NCT02675998|50123857|FG003|8-Week Treatment Period|Other|0|||
25025950|NCT02675998|50123854|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
25025951|NCT02675998|50123855|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
25025952|NCT02675998|50123856|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
25025953|NCT02675998|50123857|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
25025954|NCT02675998|50123854|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
25025955|NCT02675998|50123855|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
25025956|NCT02675998|50123856|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
25025957|NCT02675998|50123857|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
25025958|NCT02675998|50123854|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
25025959|NCT02675998|50123855|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
25025960|NCT02675998|50123856|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
25025961|NCT02675998|50123857|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
25025962|NCT02675998|50123854|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
25155618|NCT01483599|50270852|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
25025963|NCT02675998|50123855|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
25025964|NCT02675998|50123856|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
25025965|NCT02675998|50123857|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
25025966|NCT02675998|50123854|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
25025967|NCT02675998|50123855|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
25025968|NCT02675998|50123856|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
25025969|NCT02675998|50123857|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
25025970|NCT02674204|50123873|FG000|Overall Study|Adverse Event|1|||
25025971|NCT02674204|50123874|FG001|Overall Study|Adverse Event|0|||
25025972|NCT02941627|50123880|FG000|Overall Study|Death|1|||
25025973|NCT02941627|50123880|FG000|Overall Study|Surgical failure|1|||
25025974|NCT02941627|50123880|FG000|Overall Study|cholesteatoma prevented implantation|1|||
25025975|NCT03521934|50123892|FG000|Overall Study|Death|65|||
25025976|NCT03521934|50123893|FG001|Overall Study|Death|73|||
25025977|NCT03521934|50123892|FG000|Overall Study|Withdrawal by Subject|18|||
25025978|NCT03521934|50123893|FG001|Overall Study|Withdrawal by Subject|23|||
25025979|NCT03521934|50123892|FG000|Overall Study|Site Terminated by Sponsor|39|||
25025980|NCT03521934|50123893|FG001|Overall Study|Site Terminated by Sponsor|35|||
25025981|NCT03521934|50123892|FG000|Overall Study|Study Terminated by Sponsor|483|||
25155619|NCT01483599|50270839|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
25155620|NCT01483599|50270840|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
25155621|NCT01483599|50270841|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
25155622|NCT01483599|50270842|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
24929680|NCT00393484|50022875|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
24929681|NCT00393484|50022874|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
24929682|NCT00393484|50022875|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
24929683|NCT00393484|50022874|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
25155623|NCT01483599|50270843|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
24929684|NCT00393484|50022875|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
24929685|NCT00393484|50022874|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
24929686|NCT00393484|50022875|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
24929687|NCT00393484|50022874|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
24929688|NCT00393484|50022875|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
24929689|NCT00667823|50022883|FG000|Overall Study|Lost to Follow-up|5|||
24929690|NCT00667823|50022883|FG000|Overall Study|Adverse Event|7|||
24929691|NCT00667823|50022883|FG000|Overall Study|Death|182|||
24929692|NCT00667823|50022883|FG000|Overall Study|Withdrawal by Subject|12|||
24929693|NCT00667823|50022883|FG000|Overall Study|Other|8|||
24929694|NCT00667823|50022883|FG000|Overall Study|Missing (completion page missing)|2|||
24929695|NCT00397930|50022889|FG000|Overall Study|Personal reasons|14|||
24929696|NCT00397930|50022890|FG001|Overall Study|Personal reasons|8|||
24929697|NCT00397930|50022889|FG000|Overall Study|Other medical|9|||
24929698|NCT00397930|50022890|FG001|Overall Study|Other medical|4|||
24929699|NCT00397930|50022889|FG000|Overall Study|Unknown reasons|9|||
24929700|NCT00397930|50022890|FG001|Overall Study|Unknown reasons|14|||
25155624|NCT01483599|50270844|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
24929701|NCT00397930|50022889|FG000|Overall Study|Noncompliant|3|||
24929702|NCT00397930|50022890|FG001|Overall Study|Noncompliant|2|||
24929703|NCT00397930|50022889|FG000|Overall Study|Too time-consuming|2|||
24929704|NCT00397930|50022890|FG001|Overall Study|Too time-consuming|9|||
24929705|NCT00397930|50022889|FG000|Overall Study|Started own yoga program|1|||
24929706|NCT00397930|50022890|FG001|Overall Study|Started own yoga program|1|||
24929707|NCT00397930|50022889|FG000|Overall Study|Did not want to be in control group|0|||
24929708|NCT00397930|50022890|FG001|Overall Study|Did not want to be in control group|1|||
24929709|NCT00397930|50022889|FG000|Overall Study|Withdrawal by Subject|0|||
24929710|NCT00397930|50022890|FG001|Overall Study|Withdrawal by Subject|8|||
24929711|NCT00397930|50022889|FG000|Overall Study|Missing data|0|||
24929712|NCT00397930|50022890|FG001|Overall Study|Missing data|4|||
24929713|NCT00397540|50022898|FG000|Overall Study|short follow-up duration < 12 months|1|||
24929714|NCT00397540|50022899|FG001|Overall Study|short follow-up duration < 12 months|0|||
24929715|NCT00536120|50022908|FG000|Overall Study|Lost to Follow-up|1|||
24929716|NCT00536120|50022909|FG001|Overall Study|Lost to Follow-up|0|||
24929717|NCT00536120|50022908|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
24929718|NCT00536120|50022909|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
25155625|NCT01483599|50270845|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
24929719|NCT00536120|50022908|FG000|Overall Study|Non-compliance|1|||
24929720|NCT00536120|50022909|FG001|Overall Study|Non-compliance|0|||
24929721|NCT00536120|50022908|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
24929722|NCT00536120|50022909|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
24929723|NCT00536120|50022908|FG000|Overall Study|Steroid Use|0|||
24929724|NCT00536120|50022909|FG001|Overall Study|Steroid Use|2|||
24929725|NCT00536120|50022908|FG000|Overall Study|Missed Study Visit|0|||
24929726|NCT00536120|50022909|FG001|Overall Study|Missed Study Visit|1|||
25025982|NCT03521934|50123893|FG001|Overall Study|Study Terminated by Sponsor|477|||
25025983|NCT03521934|50123892|FG000|Overall Study|Reason not Specified|3|||
24929727|NCT00057811|50022917|FG000|Overall Study|Lack of Efficacy|1|||
24929728|NCT00057811|50022918|FG001|Overall Study|Lack of Efficacy|4|||
24929729|NCT00057811|50022917|FG000|Overall Study|Physician Decision|1|||
24929730|NCT00057811|50022918|FG001|Overall Study|Physician Decision|0|||
24929731|NCT00057811|50022917|FG000|Overall Study|Withdrawal by Subject|3|||
24929732|NCT00057811|50022918|FG001|Overall Study|Withdrawal by Subject|4|||
24929733|NCT00057811|50022917|FG000|Overall Study|Ineligible|4|||
24929734|NCT00057811|50022918|FG001|Overall Study|Ineligible|2|||
24929735|NCT00057811|50022917|FG000|Overall Study|Inevaluable|1|||
24929736|NCT00057811|50022918|FG001|Overall Study|Inevaluable|2|||
24929737|NCT02866682|50022931|FG000|Overall Study|Death|0|||
24929738|NCT02866682|50022932|FG001|Overall Study|Death|1|||
24929739|NCT02866682|50022931|FG000|Overall Study|Lost to Follow-up|0|||
24929740|NCT02866682|50022932|FG001|Overall Study|Lost to Follow-up|4|||
24929741|NCT02866682|50022931|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
24929742|NCT02866682|50022932|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
24929743|NCT02866682|50022931|FG000|Overall Study|Other|0|||
24929744|NCT02866682|50022932|FG001|Overall Study|Other|1|||
24929745|NCT00570713|50022949|FG000|Overall Study|Adverse Event|16|||
24929746|NCT00570713|50022950|FG001|Overall Study|Adverse Event|9|||
24929747|NCT00570713|50022949|FG000|Overall Study|Death|7|||
24929748|NCT00570713|50022950|FG001|Overall Study|Death|7|||
24929749|NCT00570713|50022949|FG000|Overall Study|Lack of Efficacy|40|||
24929750|NCT00570713|50022950|FG001|Overall Study|Lack of Efficacy|49|||
24929751|NCT00570713|50022949|FG000|Overall Study|Physician Decision|2|||
24929752|NCT00570713|50022950|FG001|Overall Study|Physician Decision|2|||
24929753|NCT00570713|50022949|FG000|Overall Study|Withdrawal by Subject|3|||
24929754|NCT00570713|50022950|FG001|Overall Study|Withdrawal by Subject|3|||
24929755|NCT00570713|50022949|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
24929756|NCT00570713|50022950|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
24929757|NCT00669617|50022960|FG000|Period 1|Withdrawal by Subject|0|||
24929758|NCT00669617|50022961|FG001|Period 1|Withdrawal by Subject|0|||
24929759|NCT00669617|50022962|FG002|Period 1|Withdrawal by Subject|1|||
24929760|NCT00669617|50022963|FG003|Period 1|Withdrawal by Subject|0|||
24929761|NCT00669617|50022964|FG004|Period 1|Withdrawal by Subject|0|||
24929762|NCT00669617|50022960|FG000|Period 1|Protocol Deviation|0|||
24929763|NCT00669617|50022961|FG001|Period 1|Protocol Deviation|0|||
24929764|NCT00669617|50022962|FG002|Period 1|Protocol Deviation|0|||
24929765|NCT00669617|50022963|FG003|Period 1|Protocol Deviation|0|||
24929766|NCT00669617|50022964|FG004|Period 1|Protocol Deviation|1|||
24929767|NCT00669617|50022960|FG000|Period 3|Lost to Follow-up|1|||
24929768|NCT00669617|50022961|FG001|Period 3|Lost to Follow-up|0|||
24929769|NCT00669617|50022962|FG002|Period 3|Lost to Follow-up|0|||
24929770|NCT00669617|50022963|FG003|Period 3|Lost to Follow-up|0|||
24929771|NCT00669617|50022964|FG004|Period 3|Lost to Follow-up|0|||
25025984|NCT03521934|50123893|FG001|Overall Study|Reason not Specified|6|||
25025985|NCT03434353|50123904|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
25025986|NCT03434353|50123905|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
25025987|NCT03434353|50123906|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
25025988|NCT03434353|50123907|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
25025989|NCT03434353|50123908|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
25025990|NCT03434353|50123904|FG000|Overall Study|Withdrew consent|1|||
25025991|NCT03434353|50123905|FG001|Overall Study|Withdrew consent|0|||
25025992|NCT03434353|50123906|FG002|Overall Study|Withdrew consent|3|||
25025993|NCT03434353|50123907|FG003|Overall Study|Withdrew consent|0|||
25025994|NCT03434353|50123908|FG004|Overall Study|Withdrew consent|0|||
25025995|NCT03434353|50123904|FG000|Overall Study|Adverse Event|1|||
25025996|NCT03434353|50123905|FG001|Overall Study|Adverse Event|0|||
25025997|NCT03434353|50123906|FG002|Overall Study|Adverse Event|0|||
25025998|NCT03434353|50123907|FG003|Overall Study|Adverse Event|0|||
25025999|NCT03434353|50123908|FG004|Overall Study|Adverse Event|1|||
25026000|NCT03434353|50123904|FG000|Overall Study|Lost to Follow-up|2|||
25026001|NCT03434353|50123905|FG001|Overall Study|Lost to Follow-up|0|||
25026002|NCT03434353|50123906|FG002|Overall Study|Lost to Follow-up|0|||
25026003|NCT03434353|50123907|FG003|Overall Study|Lost to Follow-up|0|||
25026004|NCT03434353|50123908|FG004|Overall Study|Lost to Follow-up|0|||
24929772|NCT00535730|50022978|FG000|Overall Study|Adverse Event|1|||
24929773|NCT00535730|50022979|FG001|Overall Study|Adverse Event|1|||
24929774|NCT00535730|50022978|FG000|Overall Study|Lost to Follow-up|0|||
24929775|NCT00535730|50022979|FG001|Overall Study|Lost to Follow-up|1|||
24929776|NCT00535730|50022978|FG000|Overall Study|Physician Decision|0|||
25026005|NCT02914184|50123924|FG000|Overall Study|Lost to Follow-up|7|||
25026006|NCT02914184|50123925|FG001|Overall Study|Lost to Follow-up|10|||
25026007|NCT02914184|50123926|FG002|Overall Study|Lost to Follow-up|8|||
25026008|NCT02914184|50123927|FG003|Overall Study|Lost to Follow-up|7|||
24929777|NCT00535730|50022979|FG001|Overall Study|Physician Decision|1|||
24929778|NCT00535730|50022978|FG000|Overall Study|Protocol Violation|1|||
24929779|NCT00535730|50022979|FG001|Overall Study|Protocol Violation|0|||
24929780|NCT00535730|50022978|FG000|Overall Study|Withdrawal by Subject|0|||
24929781|NCT00535730|50022979|FG001|Overall Study|Withdrawal by Subject|4|||
24929782|NCT00666965|50022990|FG000|Overall Study|Adverse Event|0|||
24929783|NCT00666965|50022991|FG001|Overall Study|Adverse Event|2|||
24929784|NCT00666965|50022992|FG002|Overall Study|Adverse Event|1|||
24929785|NCT00666965|50022993|FG003|Overall Study|Adverse Event|9|||
25026009|NCT02914184|50123924|FG000|Overall Study|Withdrawal by Subject|4|||
25026010|NCT02914184|50123925|FG001|Overall Study|Withdrawal by Subject|2|||
25026011|NCT02914184|50123926|FG002|Overall Study|Withdrawal by Subject|7|||
25026012|NCT02914184|50123927|FG003|Overall Study|Withdrawal by Subject|3|||
25155626|NCT01483599|50270846|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
24929786|NCT00666965|50022990|FG000|Overall Study|Lack of Efficacy|1|||
24929787|NCT00666965|50022991|FG001|Overall Study|Lack of Efficacy|1|||
24929788|NCT00666965|50022992|FG002|Overall Study|Lack of Efficacy|0|||
24929789|NCT00666965|50022993|FG003|Overall Study|Lack of Efficacy|0|||
24929790|NCT00666965|50022990|FG000|Overall Study|Protocol Violation|0|||
24929791|NCT00666965|50022991|FG001|Overall Study|Protocol Violation|0|||
24929792|NCT00666965|50022992|FG002|Overall Study|Protocol Violation|0|||
24929793|NCT00666965|50022993|FG003|Overall Study|Protocol Violation|2|||
24929794|NCT00666965|50022990|FG000|Overall Study|Discontinuation criteria|2|||
24929795|NCT00666965|50022991|FG001|Overall Study|Discontinuation criteria|1|||
24929796|NCT00666965|50022992|FG002|Overall Study|Discontinuation criteria|1|||
24929797|NCT00666965|50022993|FG003|Overall Study|Discontinuation criteria|2|||
24929798|NCT00666965|50022990|FG000|Overall Study|Withdrawal by Subject|0|||
24929799|NCT00666965|50022991|FG001|Overall Study|Withdrawal by Subject|0|||
24929800|NCT00666965|50022992|FG002|Overall Study|Withdrawal by Subject|0|||
24929801|NCT00666965|50022993|FG003|Overall Study|Withdrawal by Subject|2|||
24929802|NCT03889886|50023007|FG000|Overall Study|Other|0|||
24929803|NCT03889886|50023008|FG001|Overall Study|Other|1|||
24929804|NCT03889886|50023009|FG002|Overall Study|Other|0|||
24929805|NCT03889886|50023010|FG003|Overall Study|Other|1|||
24929806|NCT03889886|50023007|FG000|Overall Study|Withdrawal by Subject|0|||
24929807|NCT03889886|50023008|FG001|Overall Study|Withdrawal by Subject|0|||
24929808|NCT03889886|50023009|FG002|Overall Study|Withdrawal by Subject|1|||
24929809|NCT03889886|50023010|FG003|Overall Study|Withdrawal by Subject|0|||
24929810|NCT03889886|50023007|FG000|Overall Study|Adverse Event|0|||
24929811|NCT03889886|50023008|FG001|Overall Study|Adverse Event|0|||
24929812|NCT03889886|50023009|FG002|Overall Study|Adverse Event|0|||
24929813|NCT03889886|50023010|FG003|Overall Study|Adverse Event|6|||
24929814|NCT03888482|50023022|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
24929815|NCT03888482|50023023|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
24929816|NCT03888482|50023022|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
24929817|NCT03888482|50023023|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
24929818|NCT00667355|50023031|FG000|Overall Study|Adverse Event|5|||
24929819|NCT00667355|50023031|FG000|Overall Study|Lost to Follow-up|1|||
24929820|NCT00667355|50023031|FG000|Overall Study|Other reason was not specified|5|||
24929821|NCT00532844|50023037|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
24929822|NCT00532844|50023038|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
24929823|NCT00532844|50023037|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
25026013|NCT02914184|50123924|FG000|Overall Study|Other|1|||
25155627|NCT01483599|50270847|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
25155628|NCT01483599|50270848|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
24929824|NCT00532844|50023038|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
24929825|NCT00532844|50023037|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
24929826|NCT00532844|50023038|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
24929827|NCT00532844|50023037|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
24929828|NCT00532844|50023038|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
24929829|NCT00532844|50023037|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
24929830|NCT00532844|50023038|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
24929831|NCT00666263|50023066|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
24929832|NCT00666263|50023067|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
24929833|NCT00666263|50023066|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
24929834|NCT00666263|50023067|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
24929835|NCT00666263|50023066|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
25026014|NCT02914184|50123925|FG001|Overall Study|Other|0|||
25026015|NCT02914184|50123926|FG002|Overall Study|Other|0|||
25185610|NCT00084487|50335135|FG000|Overall Study|Death|1|||
24929836|NCT00666263|50023067|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
24929837|NCT00667277|50023112|FG000|Overall Study|Withdrawal by Subject|2|||
24929838|NCT00534638|50023118|FG000|Overall Study|Withdrawal by Subject|3|||
24929839|NCT00534638|50023119|FG001|Overall Study|Withdrawal by Subject|4|||
24929840|NCT00534638|50023118|FG000|Overall Study|Migrated/moved from study area|13|||
24929841|NCT00534638|50023119|FG001|Overall Study|Migrated/moved from study area|11|||
24929842|NCT00534638|50023118|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
24929843|NCT00534638|50023119|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
24929844|NCT00534638|50023118|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
24929845|NCT00534638|50023119|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
24929846|NCT00534638|50023118|FG000|Overall Study|Other|1685|||
24929847|NCT00534638|50023119|FG001|Overall Study|Other|902|||
24929848|NCT00662129|50023130|FG000|Overall Study|Protocol Violation|1|||
24929849|NCT00662129|50023130|FG000|Overall Study|Cancel prior to beginning treatment|1|||
24929850|NCT00662129|50023130|FG000|Overall Study|Ineligible|1|||
24929851|NCT00664859|50023137|FG000|Overall Study|Adverse Event|2|||
24929852|NCT00664859|50023138|FG001|Overall Study|Adverse Event|1|||
24929853|NCT00664859|50023139|FG002|Overall Study|Adverse Event|3|||
24929854|NCT00664859|50023137|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
24929855|NCT00664859|50023138|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
24929856|NCT00664859|50023139|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
24929857|NCT00664859|50023137|FG000|Overall Study|Noncompliance with protocol|1|||
24929858|NCT00664859|50023138|FG001|Overall Study|Noncompliance with protocol|0|||
25026016|NCT02914184|50123927|FG003|Overall Study|Other|0|||
25155629|NCT01483599|50270849|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
25155630|NCT01483599|50270850|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
25155631|NCT01483599|50270851|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
24929859|NCT00664859|50023139|FG002|Overall Study|Noncompliance with protocol|4|||
24929860|NCT00664859|50023137|FG000|Overall Study|Laboratory abnormality|2|||
24929861|NCT00664859|50023138|FG001|Overall Study|Laboratory abnormality|1|||
24929862|NCT00664859|50023139|FG002|Overall Study|Laboratory abnormality|4|||
24929863|NCT00664859|50023137|FG000|Overall Study|Withdrawal by Subject|4|||
24929864|NCT00664859|50023138|FG001|Overall Study|Withdrawal by Subject|1|||
24929865|NCT00664859|50023139|FG002|Overall Study|Withdrawal by Subject|3|||
24929866|NCT00664859|50023137|FG000|Overall Study|Lost to Follow-up|2|||
24929867|NCT00664859|50023138|FG001|Overall Study|Lost to Follow-up|2|||
24929868|NCT00664859|50023139|FG002|Overall Study|Lost to Follow-up|1|||
24929869|NCT00664859|50023137|FG000|Overall Study|Other|0|||
24929870|NCT00664859|50023138|FG001|Overall Study|Other|1|||
24929871|NCT00664859|50023139|FG002|Overall Study|Other|2|||
24929872|NCT00570401|50023147|FG000|Overall Study|Adverse Event|2|||
24929873|NCT00532298|50023157|FG000|Overall Study|Adverse Event|1|||
24929874|NCT00532298|50023158|FG001|Overall Study|Adverse Event|0|||
24929875|NCT00532298|50023159|FG002|Overall Study|Adverse Event|0|||
24929876|NCT00532298|50023160|FG003|Overall Study|Adverse Event|0|||
24929877|NCT00532298|50023161|FG004|Overall Study|Adverse Event|1|||
24929878|NCT00532298|50023162|FG005|Overall Study|Adverse Event|1|||
24929879|NCT00532298|50023157|FG000|Overall Study|Lost to Follow-up|1|||
24929880|NCT00532298|50023158|FG001|Overall Study|Lost to Follow-up|1|||
24929881|NCT00532298|50023159|FG002|Overall Study|Lost to Follow-up|1|||
24929882|NCT00532298|50023160|FG003|Overall Study|Lost to Follow-up|0|||
24929883|NCT00532298|50023161|FG004|Overall Study|Lost to Follow-up|0|||
24929884|NCT00532298|50023162|FG005|Overall Study|Lost to Follow-up|1|||
24929885|NCT00410410|50023182|FG000|Induction Period (IP)|Death|1|||
24929886|NCT00410410|50023183|FG001|Induction Period (IP)|Death|0|||
24929887|NCT00410410|50023184|FG002|Induction Period (IP)|Death|0|||
24929888|NCT00410410|50023185|FG003|Induction Period (IP)|Death|0|||
25155632|NCT01483599|50270852|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
25155633|NCT01483599|50270839|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
25155634|NCT01483599|50270840|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
24929889|NCT00410410|50023186|FG004|Induction Period (IP)|Death|0|||
24929890|NCT00410410|50023187|FG005|Induction Period (IP)|Death|0|||
24929891|NCT00410410|50023188|FG006|Induction Period (IP)|Death|0|||
24929892|NCT00410410|50023189|FG007|Induction Period (IP)|Death|0|||
24929893|NCT00410410|50023190|FG008|Induction Period (IP)|Death|0|||
24929894|NCT00410410|50023182|FG000|Induction Period (IP)|Adverse Event|3|||
24929895|NCT00410410|50023183|FG001|Induction Period (IP)|Adverse Event|4|||
24929896|NCT00410410|50023184|FG002|Induction Period (IP)|Adverse Event|2|||
24929897|NCT00410410|50023185|FG003|Induction Period (IP)|Adverse Event|4|||
24929898|NCT00410410|50023186|FG004|Induction Period (IP)|Adverse Event|1|||
24929899|NCT00410410|50023187|FG005|Induction Period (IP)|Adverse Event|0|||
24929900|NCT00410410|50023188|FG006|Induction Period (IP)|Adverse Event|0|||
24929901|NCT00410410|50023189|FG007|Induction Period (IP)|Adverse Event|0|||
24929902|NCT00410410|50023190|FG008|Induction Period (IP)|Adverse Event|0|||
24929903|NCT00410410|50023182|FG000|Induction Period (IP)|Lack of Efficacy|26|||
24929904|NCT00410410|50023183|FG001|Induction Period (IP)|Lack of Efficacy|24|||
24929905|NCT00410410|50023184|FG002|Induction Period (IP)|Lack of Efficacy|8|||
24929906|NCT00410410|50023185|FG003|Induction Period (IP)|Lack of Efficacy|8|||
24929907|NCT00410410|50023186|FG004|Induction Period (IP)|Lack of Efficacy|7|||
24929908|NCT00410410|50023187|FG005|Induction Period (IP)|Lack of Efficacy|7|||
24929909|NCT00410410|50023188|FG006|Induction Period (IP)|Lack of Efficacy|0|||
24929910|NCT00410410|50023189|FG007|Induction Period (IP)|Lack of Efficacy|0|||
24929911|NCT00410410|50023190|FG008|Induction Period (IP)|Lack of Efficacy|0|||
24929912|NCT00410410|50023182|FG000|Induction Period (IP)|Lost to Follow-up|2|||
24929913|NCT00410410|50023183|FG001|Induction Period (IP)|Lost to Follow-up|2|||
24929914|NCT00410410|50023184|FG002|Induction Period (IP)|Lost to Follow-up|2|||
24929915|NCT00410410|50023185|FG003|Induction Period (IP)|Lost to Follow-up|3|||
24929916|NCT00410410|50023186|FG004|Induction Period (IP)|Lost to Follow-up|0|||
24929917|NCT00410410|50023187|FG005|Induction Period (IP)|Lost to Follow-up|1|||
24929918|NCT00410410|50023188|FG006|Induction Period (IP)|Lost to Follow-up|0|||
24929919|NCT00410410|50023189|FG007|Induction Period (IP)|Lost to Follow-up|0|||
24929920|NCT00410410|50023190|FG008|Induction Period (IP)|Lost to Follow-up|0|||
24929921|NCT00410410|50023182|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
24929922|NCT00410410|50023183|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
24929923|NCT00410410|50023184|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
24929924|NCT00410410|50023185|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
24929925|NCT00410410|50023186|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
24929926|NCT00410410|50023187|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
24929927|NCT00410410|50023188|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
24929928|NCT00410410|50023189|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
24929929|NCT00410410|50023190|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
24929930|NCT00410410|50023182|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
24929931|NCT00410410|50023183|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
24929932|NCT00410410|50023184|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
24929933|NCT00410410|50023185|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
24929934|NCT00410410|50023186|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
24929935|NCT00410410|50023187|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
24929936|NCT00410410|50023188|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
24929937|NCT00410410|50023189|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
25026017|NCT02914184|50123924|FG000|Overall Study|Migrated/moved from the study area|2|||
24929938|NCT00410410|50023190|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
24929939|NCT00410410|50023182|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
24929940|NCT00410410|50023183|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
24929941|NCT00410410|50023184|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
24929942|NCT00410410|50023185|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
24929943|NCT00410410|50023186|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
24929944|NCT00410410|50023187|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
24929945|NCT00410410|50023188|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
24929946|NCT00410410|50023189|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
24929947|NCT00410410|50023190|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
24929948|NCT00410410|50023182|FG000|Induction Period (IP)|Other|0|||
24929949|NCT00410410|50023183|FG001|Induction Period (IP)|Other|0|||
24929950|NCT00410410|50023184|FG002|Induction Period (IP)|Other|1|||
24929951|NCT00410410|50023185|FG003|Induction Period (IP)|Other|0|||
24929952|NCT00410410|50023186|FG004|Induction Period (IP)|Other|0|||
24929953|NCT00410410|50023187|FG005|Induction Period (IP)|Other|0|||
24929954|NCT00410410|50023188|FG006|Induction Period (IP)|Other|0|||
25026018|NCT02914184|50123925|FG001|Overall Study|Migrated/moved from the study area|1|||
24929955|NCT00410410|50023189|FG007|Induction Period (IP)|Other|0|||
24929956|NCT00410410|50023190|FG008|Induction Period (IP)|Other|0|||
24929957|NCT00410410|50023182|FG000|Maintenance Period (MP)|Death|0|||
24929958|NCT00410410|50023183|FG001|Maintenance Period (MP)|Death|0|||
24929959|NCT00410410|50023184|FG002|Maintenance Period (MP)|Death|0|||
25026019|NCT02914184|50123926|FG002|Overall Study|Migrated/moved from the study area|2|||
24929960|NCT00410410|50023185|FG003|Maintenance Period (MP)|Death|0|||
24929961|NCT00410410|50023186|FG004|Maintenance Period (MP)|Death|0|||
24929962|NCT00410410|50023187|FG005|Maintenance Period (MP)|Death|0|||
24929963|NCT00410410|50023188|FG006|Maintenance Period (MP)|Death|1|||
24929964|NCT00410410|50023189|FG007|Maintenance Period (MP)|Death|0|||
24929965|NCT00410410|50023190|FG008|Maintenance Period (MP)|Death|0|||
24929966|NCT00410410|50023182|FG000|Maintenance Period (MP)|Adverse Event|0|||
24929967|NCT00410410|50023183|FG001|Maintenance Period (MP)|Adverse Event|0|||
24929968|NCT00410410|50023184|FG002|Maintenance Period (MP)|Adverse Event|0|||
24929969|NCT00410410|50023185|FG003|Maintenance Period (MP)|Adverse Event|0|||
24929970|NCT00410410|50023186|FG004|Maintenance Period (MP)|Adverse Event|0|||
24929971|NCT00410410|50023187|FG005|Maintenance Period (MP)|Adverse Event|0|||
24929972|NCT00410410|50023188|FG006|Maintenance Period (MP)|Adverse Event|1|||
24929973|NCT00410410|50023189|FG007|Maintenance Period (MP)|Adverse Event|3|||
24929974|NCT00410410|50023190|FG008|Maintenance Period (MP)|Adverse Event|0|||
24929975|NCT00410410|50023182|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
24929976|NCT00410410|50023183|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
24929977|NCT00410410|50023184|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
24929978|NCT00410410|50023185|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
24929979|NCT00410410|50023186|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
24929980|NCT00410410|50023187|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
24929981|NCT00410410|50023188|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
24929982|NCT00410410|50023189|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
24929983|NCT00410410|50023190|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
24929984|NCT00410410|50023182|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
24929985|NCT00410410|50023183|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
24929986|NCT00410410|50023184|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
24929987|NCT00410410|50023185|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
24929988|NCT00410410|50023186|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
24929989|NCT00410410|50023187|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
24929990|NCT00410410|50023188|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
24929991|NCT00410410|50023189|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
24929992|NCT00410410|50023190|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
24929993|NCT00410410|50023182|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
24929994|NCT00410410|50023183|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
24929995|NCT00410410|50023184|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
24929996|NCT00410410|50023185|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
24929997|NCT00410410|50023186|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
24929998|NCT00410410|50023187|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
24929999|NCT00410410|50023188|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
24930000|NCT00410410|50023189|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
24930001|NCT00410410|50023190|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
24930002|NCT00410410|50023182|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
24930003|NCT00410410|50023183|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
24930004|NCT00410410|50023184|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
24930005|NCT00410410|50023185|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
24930006|NCT00410410|50023186|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
24930007|NCT00410410|50023187|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
24930008|NCT00410410|50023188|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
24930009|NCT00410410|50023189|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
24930010|NCT00410410|50023190|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
24930011|NCT00410410|50023182|FG000|Open-Label Period (OL)|Death|0|||
24930012|NCT00410410|50023183|FG001|Open-Label Period (OL)|Death|0|||
24930013|NCT00410410|50023184|FG002|Open-Label Period (OL)|Death|0|||
24930014|NCT00410410|50023185|FG003|Open-Label Period (OL)|Death|0|||
24930015|NCT00410410|50023186|FG004|Open-Label Period (OL)|Death|0|||
24930016|NCT00410410|50023187|FG005|Open-Label Period (OL)|Death|0|||
24930017|NCT00410410|50023188|FG006|Open-Label Period (OL)|Death|0|||
24930018|NCT00410410|50023189|FG007|Open-Label Period (OL)|Death|0|||
24930019|NCT00410410|50023190|FG008|Open-Label Period (OL)|Death|1|||
24930020|NCT00410410|50023182|FG000|Open-Label Period (OL)|Adverse Event|0|||
24930021|NCT00410410|50023183|FG001|Open-Label Period (OL)|Adverse Event|0|||
24930022|NCT00410410|50023184|FG002|Open-Label Period (OL)|Adverse Event|0|||
24930023|NCT00410410|50023185|FG003|Open-Label Period (OL)|Adverse Event|0|||
24930024|NCT00410410|50023186|FG004|Open-Label Period (OL)|Adverse Event|0|||
24930025|NCT00410410|50023187|FG005|Open-Label Period (OL)|Adverse Event|0|||
24930026|NCT00410410|50023188|FG006|Open-Label Period (OL)|Adverse Event|0|||
24930027|NCT00410410|50023189|FG007|Open-Label Period (OL)|Adverse Event|0|||
24930028|NCT00410410|50023190|FG008|Open-Label Period (OL)|Adverse Event|10|||
24930029|NCT00410410|50023182|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
24930030|NCT00410410|50023183|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
24930031|NCT00410410|50023184|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
24930032|NCT00410410|50023185|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
24930033|NCT00410410|50023186|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
24930034|NCT00410410|50023187|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
24930035|NCT00410410|50023188|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
24930036|NCT00410410|50023189|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
24930037|NCT00410410|50023190|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
24930038|NCT00410410|50023182|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
24930039|NCT00410410|50023183|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
24930040|NCT00410410|50023184|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
24930041|NCT00410410|50023185|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
24930042|NCT00410410|50023186|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
24930043|NCT00410410|50023187|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
24930044|NCT00410410|50023188|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
24930045|NCT00410410|50023189|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
24930046|NCT00410410|50023190|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
24930047|NCT00410410|50023182|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
24930048|NCT00410410|50023183|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
24930049|NCT00410410|50023184|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
24930050|NCT00410410|50023185|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
24930051|NCT00410410|50023186|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
24930052|NCT00410410|50023187|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
24930053|NCT00410410|50023188|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
24930054|NCT00410410|50023189|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
24930055|NCT00410410|50023190|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
24930056|NCT00410410|50023182|FG000|Open-Label Period (OL)|Pregnancy|0|||
24930057|NCT00410410|50023183|FG001|Open-Label Period (OL)|Pregnancy|0|||
24930058|NCT00410410|50023184|FG002|Open-Label Period (OL)|Pregnancy|0|||
24930059|NCT00410410|50023185|FG003|Open-Label Period (OL)|Pregnancy|0|||
24930060|NCT00410410|50023186|FG004|Open-Label Period (OL)|Pregnancy|0|||
24930061|NCT00410410|50023187|FG005|Open-Label Period (OL)|Pregnancy|0|||
24930062|NCT00410410|50023188|FG006|Open-Label Period (OL)|Pregnancy|0|||
24930063|NCT00410410|50023189|FG007|Open-Label Period (OL)|Pregnancy|0|||
24930064|NCT00410410|50023190|FG008|Open-Label Period (OL)|Pregnancy|1|||
24930065|NCT00410410|50023182|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
24930066|NCT00410410|50023183|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
24930067|NCT00410410|50023184|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
24930068|NCT00410410|50023185|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
24930069|NCT00410410|50023186|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
24930070|NCT00410410|50023187|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
24930071|NCT00410410|50023188|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
24930072|NCT00410410|50023189|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
24930073|NCT00410410|50023190|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
24930074|NCT00410410|50023182|FG000|Open-Label Period (OL)|Other|0|||
24930075|NCT00410410|50023183|FG001|Open-Label Period (OL)|Other|0|||
24930076|NCT00410410|50023184|FG002|Open-Label Period (OL)|Other|0|||
24930077|NCT00410410|50023185|FG003|Open-Label Period (OL)|Other|0|||
24930078|NCT00410410|50023186|FG004|Open-Label Period (OL)|Other|0|||
24930079|NCT00410410|50023187|FG005|Open-Label Period (OL)|Other|0|||
24930080|NCT00410410|50023188|FG006|Open-Label Period (OL)|Other|0|||
24930081|NCT00410410|50023189|FG007|Open-Label Period (OL)|Other|0|||
24930082|NCT00410410|50023190|FG008|Open-Label Period (OL)|Other|7|||
24930083|NCT00534404|50023228|FG000|Overall Study|Death|0|||
24930084|NCT00534404|50023229|FG001|Overall Study|Death|0|||
24930085|NCT00534404|50023230|FG002|Overall Study|Death|2|||
24930086|NCT00534404|50023228|FG000|Overall Study|Withdrawal by Subject|8|||
24930087|NCT00534404|50023229|FG001|Overall Study|Withdrawal by Subject|2|||
24930088|NCT00534404|50023230|FG002|Overall Study|Withdrawal by Subject|38|||
24930089|NCT00534404|50023228|FG000|Overall Study|Removed by study staff|2|||
24930090|NCT00534404|50023229|FG001|Overall Study|Removed by study staff|3|||
24930091|NCT00534404|50023230|FG002|Overall Study|Removed by study staff|1|||
24930092|NCT00534404|50023228|FG000|Overall Study|Lost to Follow-up|170|||
24930093|NCT00534404|50023229|FG001|Overall Study|Lost to Follow-up|138|||
24930094|NCT00534404|50023230|FG002|Overall Study|Lost to Follow-up|201|||
24930095|NCT00393094|50023238|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
25026020|NCT02914184|50123927|FG003|Overall Study|Migrated/moved from the study area|1|||
25026021|NCT03633227|50123941|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
25026022|NCT03633227|50123942|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
24930096|NCT00393094|50023238|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
24930097|NCT00409786|50023244|FG000|Overall Study|Withdrawal by Subject|3|||
24930098|NCT00409708|50023250|FG000|Treatment|Abnormal test procedure result(s)|1|||
24930099|NCT00409708|50023251|FG001|Treatment|Abnormal test procedure result(s)|0|||
24930100|NCT00409708|50023250|FG000|Treatment|Lack of Efficacy|0|||
24930101|NCT00409708|50023251|FG001|Treatment|Lack of Efficacy|1|||
24930102|NCT00409708|50023250|FG000|Treatment|Protocol Violation|6|||
24930103|NCT00409708|50023251|FG001|Treatment|Protocol Violation|2|||
24930104|NCT00409708|50023250|FG000|Treatment|Withdrawal by Subject|3|||
25026023|NCT03633227|50123941|FG000|Double Blind (DB), up to Week 48|Death|2|||
24930105|NCT00409708|50023251|FG001|Treatment|Withdrawal by Subject|8|||
24930106|NCT00409708|50023250|FG000|Treatment|Lost to Follow-up|0|||
24930107|NCT00409708|50023251|FG001|Treatment|Lost to Follow-up|6|||
24930108|NCT00409708|50023250|FG000|Treatment|Administrative problems|5|||
24930109|NCT00409708|50023251|FG001|Treatment|Administrative problems|0|||
24930110|NCT00409708|50023250|FG000|Washout|Lack of Efficacy|9|||
24930111|NCT00409708|50023251|FG001|Washout|Lack of Efficacy|1|||
24930112|NCT00409708|50023250|FG000|Washout|Protocol Violation|0|||
24930113|NCT00409708|50023251|FG001|Washout|Protocol Violation|1|||
24930114|NCT00409708|50023250|FG000|Washout|Withdrawal by Subject|11|||
24930115|NCT00409708|50023251|FG001|Washout|Withdrawal by Subject|5|||
24930116|NCT00409708|50023250|FG000|Washout|Lost to Follow-up|1|||
24930117|NCT00409708|50023251|FG001|Washout|Lost to Follow-up|3|||
24930118|NCT00391846|50023268|FG000|Overall Study|Adverse Event|4|||
24930119|NCT00391846|50023269|FG001|Overall Study|Adverse Event|1|||
24930120|NCT00391846|50023268|FG000|Overall Study|Did not meet the required elig. crit|2|||
24930121|NCT00391846|50023269|FG001|Overall Study|Did not meet the required elig. crit|2|||
24930122|NCT00391846|50023268|FG000|Overall Study|Withdrawal by Subject|2|||
24930123|NCT00391846|50023269|FG001|Overall Study|Withdrawal by Subject|3|||
24930124|NCT00391846|50023268|FG000|Overall Study|Developed study specific DC criteria|0|||
24930125|NCT00391846|50023269|FG001|Overall Study|Developed study specific DC criteria|1|||
24930126|NCT00534248|50023294|FG000|Overall Study|Adverse Event|19|||
24930127|NCT00534248|50023295|FG001|Overall Study|Adverse Event|29|||
25026024|NCT03633227|50123942|FG001|Double Blind (DB), up to Week 48|Death|1|||
25026025|NCT03633227|50123941|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
25026026|NCT03633227|50123942|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
25026027|NCT03633227|50123941|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
25026028|NCT03633227|50123942|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
24930128|NCT00534248|50023294|FG000|Overall Study|Lost to Follow-up|353|||
24930129|NCT00534248|50023295|FG001|Overall Study|Lost to Follow-up|375|||
24930130|NCT00534248|50023294|FG000|Overall Study|Other protocol specified criteria|13|||
24930131|NCT00534248|50023295|FG001|Overall Study|Other protocol specified criteria|3|||
24930132|NCT00534248|50023294|FG000|Overall Study|Physician Decision|10|||
24930133|NCT00534248|50023295|FG001|Overall Study|Physician Decision|7|||
24930134|NCT00534248|50023294|FG000|Overall Study|Protocol Violation|3|||
24930135|NCT00534248|50023295|FG001|Overall Study|Protocol Violation|4|||
24930136|NCT00534248|50023294|FG000|Overall Study|Withdrawal by Subject|263|||
24930137|NCT00534248|50023295|FG001|Overall Study|Withdrawal by Subject|255|||
24930138|NCT00391768|50023308|FG000|Overall Study|Withdrawal by Subject|0|||
24930139|NCT00391768|50023309|FG001|Overall Study|Withdrawal by Subject|0|||
24930140|NCT00391768|50023310|FG002|Overall Study|Withdrawal by Subject|1|||
24930141|NCT00391768|50023311|FG003|Overall Study|Withdrawal by Subject|0|||
24930142|NCT00391768|50023312|FG004|Overall Study|Withdrawal by Subject|0|||
24930143|NCT00391768|50023313|FG005|Overall Study|Withdrawal by Subject|1|||
24930144|NCT00391768|50023314|FG006|Overall Study|Withdrawal by Subject|1|||
24930145|NCT00391768|50023308|FG000|Overall Study|Lost to Follow-up|0|||
24930146|NCT00391768|50023309|FG001|Overall Study|Lost to Follow-up|0|||
24930147|NCT00391768|50023310|FG002|Overall Study|Lost to Follow-up|0|||
24930148|NCT00391768|50023311|FG003|Overall Study|Lost to Follow-up|1|||
24930149|NCT00391768|50023312|FG004|Overall Study|Lost to Follow-up|2|||
24930150|NCT00391768|50023313|FG005|Overall Study|Lost to Follow-up|2|||
24930151|NCT00391768|50023314|FG006|Overall Study|Lost to Follow-up|3|||
24930152|NCT00391222|50023351|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
24930153|NCT00391222|50023352|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
24930154|NCT00391222|50023353|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
24930155|NCT00391222|50023354|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
24930156|NCT00391222|50023351|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
24930157|NCT00391222|50023352|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
24930158|NCT00391222|50023353|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
25026029|NCT03633227|50123941|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
25155635|NCT01483599|50270841|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
25155636|NCT01483599|50270842|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
24930159|NCT00391222|50023354|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
24930160|NCT00391222|50023351|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
24930161|NCT00391222|50023352|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
24930162|NCT00391222|50023353|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
25026030|NCT03633227|50123942|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
25026031|NCT03633227|50123941|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
24930163|NCT00391222|50023354|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
24930164|NCT00391222|50023351|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
24930165|NCT00391222|50023352|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
24930166|NCT00391222|50023353|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
24930167|NCT00391222|50023354|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
24930168|NCT00391222|50023351|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
24930169|NCT00391222|50023352|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
24930170|NCT00391222|50023353|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
24930171|NCT00391222|50023354|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
24930172|NCT00391222|50023351|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
24930173|NCT00391222|50023352|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
24930174|NCT00391222|50023353|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
24930175|NCT00391222|50023354|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
24930176|NCT00391222|50023351|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
24930177|NCT00391222|50023352|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
24930178|NCT00391222|50023353|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
24930179|NCT00391222|50023354|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
24930180|NCT00391222|50023351|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
24930181|NCT00391222|50023352|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
24930182|NCT00391222|50023353|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
24930183|NCT00391222|50023354|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
24930184|NCT00391222|50023351|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
24930185|NCT00391222|50023352|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
24930186|NCT00391222|50023353|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
24930187|NCT00391222|50023354|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
24930188|NCT00391222|50023351|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
24930189|NCT00391222|50023352|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
24930190|NCT00391222|50023353|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
24930191|NCT00391222|50023354|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
24930192|NCT00391222|50023351|FG000|Period III (Double-Blind Treatment)|Other|6|||
24930193|NCT00391222|50023352|FG001|Period III (Double-Blind Treatment)|Other|1|||
24930194|NCT00391222|50023353|FG002|Period III (Double-Blind Treatment)|Other|6|||
24930195|NCT00391222|50023354|FG003|Period III (Double-Blind Treatment)|Other|0|||
25026032|NCT03633227|50123942|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
25026033|NCT03633227|50123941|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
25155637|NCT01483599|50270843|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
25155638|NCT01483599|50270844|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
24930196|NCT00409006|50023366|FG000|Overall Study|Death|15|||
24930197|NCT00409006|50023367|FG001|Overall Study|Death|6|||
24930198|NCT00409006|50023366|FG000|Overall Study|Lost to Follow-up|1|||
24930199|NCT00409006|50023367|FG001|Overall Study|Lost to Follow-up|2|||
24930200|NCT00409006|50023366|FG000|Overall Study|Withdrawal by Subject|3|||
24930201|NCT00409006|50023367|FG001|Overall Study|Withdrawal by Subject|2|||
24930202|NCT00409006|50023366|FG000|Overall Study|Physician Decision|1|||
24930203|NCT00409006|50023367|FG001|Overall Study|Physician Decision|2|||
24930204|NCT00534092|50023375|FG000|Overall Study|Lost to Follow-up|1|||
24930205|NCT00534092|50023376|FG001|Overall Study|Lost to Follow-up|0|||
24930206|NCT00534092|50023375|FG000|Overall Study|personal reasons/family concerns|1|||
24930207|NCT00534092|50023376|FG001|Overall Study|personal reasons/family concerns|0|||
24930208|NCT00408928|50023384|FG000|Overall Study|Withdrawal by Subject|1|||
25155639|NCT01483599|50270845|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
25155640|NCT01483599|50270846|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
25155641|NCT01483599|50270847|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
25155642|NCT01483599|50270848|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
25155643|NCT01483599|50270849|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
25155644|NCT01483599|50270850|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
25155645|NCT01483599|50270851|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
25155646|NCT01483599|50270852|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
25155647|NCT01507545|50270945|FG000|Overall Study|Withdrawal by Subject|6|||
25155648|NCT01507545|50270946|FG001|Overall Study|Withdrawal by Subject|2|||
25155649|NCT01507545|50270945|FG000|Overall Study|Lost to Follow-up|1|||
25155650|NCT01507545|50270946|FG001|Overall Study|Lost to Follow-up|0|||
25155651|NCT01507545|50270945|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
25155652|NCT01507545|50270946|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
24930209|NCT00408928|50023384|FG000|Overall Study|Death|1|||
24930210|NCT00408928|50023384|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
24930211|NCT00390910|50023391|FG000|Overall Study|Adverse Event|1|||
24930212|NCT00390910|50023392|FG001|Overall Study|Adverse Event|0|||
24930213|NCT00390910|50023393|FG002|Overall Study|Adverse Event|0|||
24930214|NCT00390910|50023391|FG000|Overall Study|Lost to Follow-up|0|||
24930215|NCT00390910|50023392|FG001|Overall Study|Lost to Follow-up|1|||
24930216|NCT00390910|50023393|FG002|Overall Study|Lost to Follow-up|5|||
25155653|NCT01507545|50270945|FG000|Overall Study|Progressive disease|60|||
24930217|NCT00390910|50023391|FG000|Overall Study|Withdrawal by Subject|1|||
25026034|NCT03633227|50123942|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
24930218|NCT00390910|50023392|FG001|Overall Study|Withdrawal by Subject|3|||
24930219|NCT00390910|50023393|FG002|Overall Study|Withdrawal by Subject|2|||
24930220|NCT00390910|50023391|FG000|Overall Study|Migrated/moved from study area|0|||
24930221|NCT00390910|50023392|FG001|Overall Study|Migrated/moved from study area|0|||
24930222|NCT00390910|50023393|FG002|Overall Study|Migrated/moved from study area|3|||
24930223|NCT00533702|50023405|FG000|Overall Study|Withdrawal by Subject|3|||
25026035|NCT03633227|50123941|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
25026036|NCT03633227|50123942|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
25026037|NCT03633227|50123941|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
25026038|NCT03633227|50123942|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
25026039|NCT03633227|50123941|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
25026040|NCT03633227|50123942|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
24930224|NCT00533702|50023406|FG001|Overall Study|Withdrawal by Subject|1|||
24930225|NCT00533702|50023405|FG000|Overall Study|Found ineligible after randomization|2|||
24930226|NCT00533702|50023406|FG001|Overall Study|Found ineligible after randomization|1|||
24930227|NCT00408694|50023412|FG000|Overall Study|Ineligible|1|||
24930228|NCT00408694|50023412|FG000|Overall Study|No protocol treatment|1|||
24930229|NCT00396136|50023416|FG000|Overall Study|Death|43|||
24930230|NCT00396136|50023416|FG000|Overall Study|Withdrawal by Subject|59|||
24930231|NCT00396136|50023416|FG000|Overall Study|Lost to Follow-up|15|||
24930232|NCT00396136|50023416|FG000|Overall Study|Study device explanted|8|||
24930233|NCT00530894|50023424|FG000|Overall Study|Death|84|||
24930234|NCT00530894|50023425|FG001|Overall Study|Death|89|||
24930235|NCT00530894|50023426|FG002|Overall Study|Death|55|||
24930236|NCT00530894|50023427|FG003|Overall Study|Death|89|||
24930237|NCT00530894|50023424|FG000|Overall Study|Lost to Follow-up|1|||
24930238|NCT00530894|50023425|FG001|Overall Study|Lost to Follow-up|3|||
24930239|NCT00530894|50023426|FG002|Overall Study|Lost to Follow-up|0|||
24930240|NCT00530894|50023427|FG003|Overall Study|Lost to Follow-up|0|||
24930241|NCT00530894|50023424|FG000|Overall Study|Withdrawal by Subject|1|||
24930242|NCT00530894|50023425|FG001|Overall Study|Withdrawal by Subject|23|||
24930243|NCT00530894|50023426|FG002|Overall Study|Withdrawal by Subject|0|||
24930244|NCT00530894|50023427|FG003|Overall Study|Withdrawal by Subject|5|||
24930245|NCT00530894|50023424|FG000|Overall Study|Alive and censored prior to 1 year|2|||
24930246|NCT00530894|50023425|FG001|Overall Study|Alive and censored prior to 1 year|0|||
24930247|NCT00530894|50023426|FG002|Overall Study|Alive and censored prior to 1 year|0|||
24930248|NCT00530894|50023427|FG003|Overall Study|Alive and censored prior to 1 year|0|||
24930249|NCT00056407|50023441|FG000|Overall Study|Adverse Event|282|||
24930250|NCT00056407|50023442|FG001|Overall Study|Adverse Event|364|||
24930251|NCT00056407|50023441|FG000|Overall Study|Withdrawal by Subject|377|||
24930252|NCT00056407|50023442|FG001|Overall Study|Withdrawal by Subject|361|||
24930253|NCT00056407|50023441|FG000|Overall Study|Lost to Follow-up|123|||
24930254|NCT00056407|50023442|FG001|Overall Study|Lost to Follow-up|113|||
24930255|NCT00056407|50023441|FG000|Overall Study|Protocol Violation|104|||
24930256|NCT00056407|50023442|FG001|Overall Study|Protocol Violation|95|||
24930257|NCT00056407|50023441|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
24930258|NCT00056407|50023442|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
24930259|NCT00056407|50023441|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
24930260|NCT00056407|50023442|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
24930261|NCT00056407|50023441|FG000|Overall Study|Missing|25|||
24930262|NCT00056407|50023442|FG001|Overall Study|Missing|34|||
24930263|NCT00388726|50023450|FG000|Overall Study|Adverse Event|50|||
24930264|NCT00388726|50023451|FG001|Overall Study|Adverse Event|24|||
25026041|NCT03633227|50123941|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
25026042|NCT03633227|50123942|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
25155654|NCT01507545|50270946|FG001|Overall Study|Progressive disease|27|||
24930265|NCT00388726|50023450|FG000|Overall Study|Progressive Disease|336|||
24930266|NCT00388726|50023451|FG001|Overall Study|Progressive Disease|153|||
24930267|NCT00388726|50023450|FG000|Overall Study|Clinical Progression|61|||
24930268|NCT00388726|50023451|FG001|Overall Study|Clinical Progression|36|||
24930269|NCT00388726|50023450|FG000|Overall Study|Withdrawal by Subject|10|||
24930270|NCT00388726|50023451|FG001|Overall Study|Withdrawal by Subject|7|||
24930271|NCT00388726|50023450|FG000|Overall Study|Administrative|6|||
24930272|NCT00388726|50023451|FG001|Overall Study|Administrative|9|||
24930273|NCT00388726|50023450|FG000|Overall Study|Physician Decision|18|||
24930274|NCT00388726|50023451|FG001|Overall Study|Physician Decision|13|||
24930275|NCT00388726|50023450|FG000|Overall Study|Death|3|||
24930276|NCT00388726|50023451|FG001|Overall Study|Death|2|||
24930277|NCT00387790|50023457|FG000|Overall Study|Adverse Event|5|||
25155655|NCT01507545|50270945|FG000|Overall Study|Other|6|||
25185611|NCT01425281|50335175|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
24930278|NCT00387790|50023457|FG000|Overall Study|Lack of Efficacy|2|||
24930279|NCT00387790|50023457|FG000|Overall Study|Physician Decision|2|||
24930280|NCT00387790|50023457|FG000|Overall Study|Withdrawal by Subject|3|||
24930281|NCT00387790|50023457|FG000|Overall Study|Ineligible for study|2|||
24930282|NCT00073021|50023463|FG000|Overall Study|Protocol Violation|2|||
25026043|NCT03633227|50123941|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
25026044|NCT03633227|50123942|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
25026045|NCT02913326|50123955|FG000|Overall Study|Reason not listed|0|||
25026046|NCT02913326|50123956|FG001|Overall Study|Reason not listed|1|||
25026047|NCT02913326|50123955|FG000|Overall Study|Lost to Follow-up|0|||
25026048|NCT02913326|50123956|FG001|Overall Study|Lost to Follow-up|1|||
25026049|NCT02913326|50123955|FG000|Overall Study|Adverse Event|1|||
25026050|NCT02913326|50123956|FG001|Overall Study|Adverse Event|0|||
25026051|NCT02912468|50123964|FG000|Overall Study|Adverse Event|3|||
25026052|NCT02912468|50123965|FG001|Overall Study|Adverse Event|2|||
25026053|NCT02912468|50123964|FG000|Overall Study|Withdrawal by Subject|6|||
25026054|NCT02912468|50123965|FG001|Overall Study|Withdrawal by Subject|2|||
25026055|NCT02912468|50123964|FG000|Overall Study|Randomized and not treated|0|||
25026056|NCT02912468|50123965|FG001|Overall Study|Randomized and not treated|1|||
25026057|NCT04438499|50123972|FG000|Overall Study|Lack of Efficacy|2|||
25026058|NCT00002874|50123978|FG000|Overall Study|Withdrawal by Subject|1|||
25026059|NCT00002874|50123979|FG001|Overall Study|Withdrawal by Subject|1|||
25026060|NCT00002874|50123978|FG000|Overall Study|Protocol Violation|44|||
25026061|NCT00002874|50123979|FG001|Overall Study|Protocol Violation|34|||
25026062|NCT03001076|50123987|FG000|Overall Study|Withdrawal by patient|2|||
25026063|NCT03001076|50123988|FG001|Overall Study|Withdrawal by patient|0|||
25026064|NCT03001076|50123987|FG000|Overall Study|Other|1|||
25026065|NCT03001076|50123988|FG001|Overall Study|Other|0|||
25026066|NCT03001076|50123987|FG000|Overall Study|Adverse Event|3|||
25026067|NCT03001076|50123988|FG001|Overall Study|Adverse Event|3|||
25026068|NCT03001076|50123987|FG000|Overall Study|Sponsor decision|1|||
25026069|NCT03001076|50123988|FG001|Overall Study|Sponsor decision|0|||
25026070|NCT03001076|50123987|FG000|Overall Study|Lost to Follow-up|0|||
25026071|NCT03001076|50123988|FG001|Overall Study|Lost to Follow-up|2|||
25026072|NCT03555305|50123994|FG000|Period 1|Physician Decision|0|||
25026073|NCT03555305|50123995|FG001|Period 1|Physician Decision|1|||
25026074|NCT03555305|50123994|FG000|Period 1|Adverse Event|0|||
25026075|NCT03555305|50123995|FG001|Period 1|Adverse Event|1|||
25026076|NCT03553823|50124003|FG000|Overall Study|Physician Decision|0|||
25026077|NCT03553823|50124004|FG001|Overall Study|Physician Decision|1|||
25026078|NCT03000686|50124012|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
25026079|NCT03000686|50124013|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
25026080|NCT03000686|50124014|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
25026081|NCT03000686|50124015|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
25026082|NCT02493660|50124033|FG000|Overall Study|Physician Decision|0|||
25026083|NCT02493660|50124034|FG001|Overall Study|Physician Decision|1|||
25026084|NCT02493660|50124033|FG000|Overall Study|Adverse Event|4|||
25026085|NCT02493660|50124034|FG001|Overall Study|Adverse Event|2|||
25026086|NCT02493660|50124033|FG000|Overall Study|Withdrawal by Subject|2|||
25026087|NCT02493660|50124034|FG001|Overall Study|Withdrawal by Subject|3|||
25026088|NCT02493660|50124033|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
25026089|NCT02493660|50124034|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
25026090|NCT02493660|50124033|FG000|Overall Study|Protocol Violation|0|||
25026091|NCT02493660|50124034|FG001|Overall Study|Protocol Violation|1|||
25026092|NCT02493660|50124033|FG000|Overall Study|Death|0|||
25026093|NCT02493660|50124034|FG001|Overall Study|Death|1|||
25026094|NCT02493660|50124033|FG000|Overall Study|Lost to Follow-up|2|||
25026095|NCT02493660|50124034|FG001|Overall Study|Lost to Follow-up|4|||
25026096|NCT03552029|50124044|FG000|Overall Study|Death|3|||
25026097|NCT03552029|50124045|FG001|Overall Study|Death|0|||
25026098|NCT03552029|50124044|FG000|Overall Study|Adverse Event|1|||
25026099|NCT03552029|50124045|FG001|Overall Study|Adverse Event|0|||
25026100|NCT03552029|50124044|FG000|Overall Study|Lack of Efficacy|0|||
25026101|NCT03552029|50124045|FG001|Overall Study|Lack of Efficacy|2|||
25026102|NCT03552029|50124044|FG000|Overall Study|Physician Decision|0|||
25026103|NCT03552029|50124045|FG001|Overall Study|Physician Decision|1|||
25026104|NCT03552029|50124044|FG000|Overall Study|Study terminated by Sponsor|0|||
25026105|NCT03552029|50124045|FG001|Overall Study|Study terminated by Sponsor|1|||
25026106|NCT03552029|50124044|FG000|Overall Study|Other|0|||
25026107|NCT03552029|50124045|FG001|Overall Study|Other|2|||
25026108|NCT03521141|50124054|FG000|Overall Study|Death|1|||
25026109|NCT03521141|50124055|FG001|Overall Study|Death|0|||
25026110|NCT03521141|50124056|FG002|Overall Study|Death|1|||
25026111|NCT02997176|50124068|FG000|Overall Study|Adverse Event|0|||
25026112|NCT02997176|50124069|FG001|Overall Study|Adverse Event|0|||
25026113|NCT02997176|50124070|FG002|Overall Study|Adverse Event|0|||
25026114|NCT02997176|50124071|FG003|Overall Study|Adverse Event|8|||
25026115|NCT02997176|50124068|FG000|Overall Study|Progressive Disease|1|||
25026116|NCT02997176|50124069|FG001|Overall Study|Progressive Disease|0|||
25026117|NCT02997176|50124070|FG002|Overall Study|Progressive Disease|1|||
25026118|NCT02997176|50124071|FG003|Overall Study|Progressive Disease|1|||
25026119|NCT02997176|50124068|FG000|Overall Study|Death|0|||
25026120|NCT02997176|50124069|FG001|Overall Study|Death|0|||
25026121|NCT02997176|50124070|FG002|Overall Study|Death|1|||
25026122|NCT02997176|50124071|FG003|Overall Study|Death|1|||
25026123|NCT02997176|50124068|FG000|Overall Study|Withdrawal by Subject|0|||
25026124|NCT02997176|50124069|FG001|Overall Study|Withdrawal by Subject|2|||
25026125|NCT02997176|50124070|FG002|Overall Study|Withdrawal by Subject|0|||
25026126|NCT02997176|50124071|FG003|Overall Study|Withdrawal by Subject|1|||
25026127|NCT03000452|50124081|FG000|Treatment Period|Death|1|||
25026128|NCT03000452|50124081|FG000|Treatment Period|Progressive Disease (PD)|14|||
25026129|NCT03000452|50124081|FG000|Treatment Period|Physician Decision|1|||
25026130|NCT03000452|50124081|FG000|Treatment Period|Miscellaneous|2|||
25026131|NCT03000452|50124081|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
25026132|NCT03000452|50124081|FG000|Follow-Up Period|Death|3|||
25026133|NCT03000452|50124081|FG000|Follow-Up Period|Withdrawal by Subject|3|||
25026134|NCT01373164|50124090|FG000|Overall Study|Lost to Follow-up|0|||
25026135|NCT01373164|50124091|FG001|Overall Study|Lost to Follow-up|0|||
25026136|NCT01373164|50124092|FG002|Overall Study|Lost to Follow-up|1|||
25026137|NCT01373164|50124093|FG003|Overall Study|Lost to Follow-up|2|||
25026138|NCT01373164|50124094|FG004|Overall Study|Lost to Follow-up|0|||
25026139|NCT01373164|50124090|FG000|Overall Study|Withdrawal by Subject|0|||
25026140|NCT01373164|50124091|FG001|Overall Study|Withdrawal by Subject|1|||
25026141|NCT01373164|50124092|FG002|Overall Study|Withdrawal by Subject|0|||
25026142|NCT01373164|50124093|FG003|Overall Study|Withdrawal by Subject|10|||
25026143|NCT01373164|50124094|FG004|Overall Study|Withdrawal by Subject|2|||
25026144|NCT02999984|50124109|FG000|Overall Study|Treatment Failure|1|||
25026145|NCT03550313|50124116|FG000|Overall Study|Adverse Event|0|||
25026146|NCT03550313|50124117|FG001|Overall Study|Adverse Event|1|||
25026147|NCT03550313|50124118|FG002|Overall Study|Adverse Event|0|||
25026148|NCT03550313|50124116|FG000|Overall Study|Lost to Follow-up|5|||
25026149|NCT03550313|50124117|FG001|Overall Study|Lost to Follow-up|7|||
25026150|NCT03550313|50124118|FG002|Overall Study|Lost to Follow-up|12|||
25026151|NCT03550313|50124116|FG000|Overall Study|Study terminated by sponsor|44|||
25026152|NCT03550313|50124117|FG001|Overall Study|Study terminated by sponsor|37|||
25026153|NCT03550313|50124118|FG002|Overall Study|Study terminated by sponsor|48|||
25026154|NCT03550313|50124116|FG000|Overall Study|No longer met eligibility criteria|3|||
25026155|NCT03550313|50124117|FG001|Overall Study|No longer met eligibility criteria|5|||
25026156|NCT03550313|50124118|FG002|Overall Study|No longer met eligibility criteria|6|||
25026157|NCT03550313|50124116|FG000|Overall Study|Withdrawal by parent/guardian|20|||
25026158|NCT03550313|50124117|FG001|Overall Study|Withdrawal by parent/guardian|18|||
25026159|NCT03550313|50124118|FG002|Overall Study|Withdrawal by parent/guardian|26|||
25026160|NCT03550313|50124116|FG000|Overall Study|Other|4|||
25026161|NCT03550313|50124117|FG001|Overall Study|Other|2|||
25026162|NCT03550313|50124118|FG002|Overall Study|Other|2|||
25026163|NCT03550313|50124116|FG000|Overall Study|Randomized but not vaccinated|3|||
25026164|NCT03550313|50124117|FG001|Overall Study|Randomized but not vaccinated|23|||
25026165|NCT03550313|50124118|FG002|Overall Study|Randomized but not vaccinated|2|||
25026166|NCT03550313|50124116|FG000|Overall Study|Sites terminated due to quality issues|18|||
25026167|NCT03550313|50124117|FG001|Overall Study|Sites terminated due to quality issues|17|||
25026168|NCT03550313|50124118|FG002|Overall Study|Sites terminated due to quality issues|18|||
25026169|NCT03312907|50124130|FG000|Overall Study|Adverse Event|1|||
25026170|NCT03312907|50124131|FG001|Overall Study|Adverse Event|6|||
25026171|NCT03312907|50124132|FG002|Overall Study|Adverse Event|1|||
25026172|NCT03312907|50124130|FG000|Overall Study|Protocol Violation|2|||
25026173|NCT03312907|50124131|FG001|Overall Study|Protocol Violation|3|||
25026174|NCT03312907|50124132|FG002|Overall Study|Protocol Violation|4|||
25026175|NCT03312907|50124130|FG000|Overall Study|Lost to Follow-up|2|||
25026176|NCT03312907|50124131|FG001|Overall Study|Lost to Follow-up|3|||
25026177|NCT03312907|50124132|FG002|Overall Study|Lost to Follow-up|2|||
25026178|NCT03312907|50124130|FG000|Overall Study|Physician Decision|3|||
25026179|NCT03312907|50124131|FG001|Overall Study|Physician Decision|4|||
25026180|NCT03312907|50124132|FG002|Overall Study|Physician Decision|2|||
25026181|NCT03312907|50124130|FG000|Overall Study|Withdrawal by Subject|9|||
25026182|NCT03312907|50124131|FG001|Overall Study|Withdrawal by Subject|14|||
25026183|NCT03312907|50124132|FG002|Overall Study|Withdrawal by Subject|10|||
25026184|NCT02999672|50124142|FG000|Overall Study|Death|0|||
25026185|NCT02999672|50124143|FG001|Overall Study|Death|1|||
25026186|NCT02999672|50124142|FG000|Overall Study|Study Terminated by Sponsor|0|||
25026187|NCT02999672|50124143|FG001|Overall Study|Study Terminated by Sponsor|1|||
25026188|NCT02999672|50124142|FG000|Overall Study|Progressive Disease|9|||
25026189|NCT02999672|50124143|FG001|Overall Study|Progressive Disease|5|||
25026190|NCT02999672|50124142|FG000|Overall Study|Adverse Event|4|||
25026191|NCT02999672|50124143|FG001|Overall Study|Adverse Event|0|||
25026192|NCT01911676|50124153|FG000|Period 1 of Study|Withdrawal by Subject|4|||
25026193|NCT01911676|50124154|FG001|Period 1 of Study|Withdrawal by Subject|2|||
25026194|NCT01911676|50124155|FG002|Period 1 of Study|Withdrawal by Subject|1|||
25026195|NCT01911676|50124156|FG003|Period 1 of Study|Withdrawal by Subject|2|||
25026196|NCT01911676|50124153|FG000|Period 1 of Study|Physician Decision|2|||
25026197|NCT01911676|50124154|FG001|Period 1 of Study|Physician Decision|0|||
25026198|NCT01911676|50124155|FG002|Period 1 of Study|Physician Decision|0|||
25026199|NCT01911676|50124156|FG003|Period 1 of Study|Physician Decision|1|||
25026200|NCT01911676|50124153|FG000|Period 2 of Study|Physician Decision|2|||
25026201|NCT01911676|50124154|FG001|Period 2 of Study|Physician Decision|0|||
25026202|NCT01911676|50124155|FG002|Period 2 of Study|Physician Decision|0|||
25026203|NCT01911676|50124156|FG003|Period 2 of Study|Physician Decision|1|||
25026204|NCT01911676|50124153|FG000|Period 2 of Study|Lost to Follow-up|0|||
25026205|NCT01911676|50124154|FG001|Period 2 of Study|Lost to Follow-up|0|||
25026206|NCT01911676|50124155|FG002|Period 2 of Study|Lost to Follow-up|0|||
25026207|NCT01911676|50124156|FG003|Period 2 of Study|Lost to Follow-up|1|||
25026208|NCT03573323|50124173|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
25026209|NCT03573323|50124174|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
25026210|NCT03573323|50124173|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
25026211|NCT03573323|50124174|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
25026212|NCT03573323|50124173|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
25026213|NCT03573323|50124174|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
25026214|NCT03573323|50124173|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
25026215|NCT03573323|50124174|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
25026216|NCT03573323|50124173|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
25026217|NCT03573323|50124174|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
25026218|NCT03573323|50124173|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
25026219|NCT03573323|50124174|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
25026220|NCT03573323|50124173|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
25026221|NCT03573323|50124174|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
25026222|NCT03573323|50124173|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
25026223|NCT03573323|50124174|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
25026224|NCT03573323|50124173|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
25026225|NCT03573323|50124174|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
25026226|NCT03573323|50124173|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
25026227|NCT03573323|50124174|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
25026228|NCT03573323|50124173|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
25026229|NCT03573323|50124174|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
25026230|NCT03573323|50124173|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
25026231|NCT03573323|50124174|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
25026232|NCT03573323|50124173|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
25026233|NCT03573323|50124174|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
25026234|NCT03573323|50124173|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
25026235|NCT03573323|50124174|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
25026236|NCT03573323|50124173|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
25026237|NCT03573323|50124174|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
25026238|NCT03573323|50124173|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
25026239|NCT03573323|50124174|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
25026240|NCT03573323|50124173|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
25026241|NCT03573323|50124174|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
25026242|NCT03573323|50124173|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
25026243|NCT03573323|50124174|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
25026244|NCT03573323|50124173|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
25026245|NCT03573323|50124174|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
25026246|NCT03306043|50124200|FG000|Overall Study|Adverse Event|1|||
25026247|NCT03306043|50124200|FG000|Overall Study|Lost to Follow-up|1|||
25026248|NCT03306043|50124200|FG000|Overall Study|Withdrawal by Subject|2|||
25026249|NCT01069172|50124204|FG000|Overall Study|Withdrawal by Subject|1|||
25026250|NCT01069172|50124205|FG001|Overall Study|Withdrawal by Subject|0|||
25026251|NCT02911688|50124214|FG000|Washout|Lost to Follow-up|1|||
25026252|NCT02911688|50124215|FG001|Washout|Lost to Follow-up|1|||
25026253|NCT02911688|50124214|FG000|Washout|Withdrawal by Subject|0|||
25026254|NCT02911688|50124215|FG001|Washout|Withdrawal by Subject|1|||
25026255|NCT02670928|50124225|FG000|Overall Study|Adverse Event|3|||
25026256|NCT02670928|50124226|FG001|Overall Study|Adverse Event|1|||
25026257|NCT02670928|50124225|FG000|Overall Study|Withdrawal by Subject|4|||
25026258|NCT02670928|50124226|FG001|Overall Study|Withdrawal by Subject|0|||
25026259|NCT02670928|50124225|FG000|Overall Study|Lost to Follow-up|1|||
25026260|NCT02670928|50124226|FG001|Overall Study|Lost to Follow-up|0|||
25026261|NCT02670928|50124225|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
25026262|NCT02670928|50124226|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
25026263|NCT03305809|50124236|FG000|Overall Study|Adverse Event|2|||
25026264|NCT03305809|50124237|FG001|Overall Study|Adverse Event|2|||
25026265|NCT03305809|50124238|FG002|Overall Study|Adverse Event|6|||
25026266|NCT03305809|50124239|FG003|Overall Study|Adverse Event|6|||
25026267|NCT03305809|50124236|FG000|Overall Study|Death|0|||
25026268|NCT03305809|50124237|FG001|Overall Study|Death|0|||
25026269|NCT03305809|50124238|FG002|Overall Study|Death|1|||
25026270|NCT03305809|50124239|FG003|Overall Study|Death|1|||
25026271|NCT03305809|50124236|FG000|Overall Study|Lost to Follow-up|1|||
25026272|NCT03305809|50124237|FG001|Overall Study|Lost to Follow-up|2|||
25026273|NCT03305809|50124238|FG002|Overall Study|Lost to Follow-up|0|||
25026274|NCT03305809|50124239|FG003|Overall Study|Lost to Follow-up|0|||
25026275|NCT03305809|50124236|FG000|Overall Study|Sponsor Decision|1|||
25026276|NCT03305809|50124237|FG001|Overall Study|Sponsor Decision|0|||
25026277|NCT03305809|50124238|FG002|Overall Study|Sponsor Decision|1|||
25026278|NCT03305809|50124239|FG003|Overall Study|Sponsor Decision|8|||
25026279|NCT03305809|50124236|FG000|Overall Study|Physician Decision|0|||
25026280|NCT03305809|50124237|FG001|Overall Study|Physician Decision|0|||
25026281|NCT03305809|50124238|FG002|Overall Study|Physician Decision|2|||
25026282|NCT03305809|50124239|FG003|Overall Study|Physician Decision|4|||
25026283|NCT03305809|50124236|FG000|Overall Study|Progressive Disease|0|||
25026284|NCT03305809|50124237|FG001|Overall Study|Progressive Disease|0|||
25026285|NCT03305809|50124238|FG002|Overall Study|Progressive Disease|1|||
25026286|NCT03305809|50124239|FG003|Overall Study|Progressive Disease|0|||
25026287|NCT03305809|50124236|FG000|Overall Study|Protocol Violation|1|||
25026288|NCT03305809|50124237|FG001|Overall Study|Protocol Violation|0|||
25026289|NCT03305809|50124238|FG002|Overall Study|Protocol Violation|2|||
25026290|NCT03305809|50124239|FG003|Overall Study|Protocol Violation|3|||
25026291|NCT03305809|50124236|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
25026292|NCT03305809|50124237|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
25026293|NCT03305809|50124238|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
25026294|NCT03305809|50124239|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
25026295|NCT03305809|50124236|FG000|Overall Study|Withdrawal by Subject|2|||
25026296|NCT03305809|50124237|FG001|Overall Study|Withdrawal by Subject|4|||
25026297|NCT03305809|50124238|FG002|Overall Study|Withdrawal by Subject|5|||
25026298|NCT03305809|50124239|FG003|Overall Study|Withdrawal by Subject|2|||
25026299|NCT03305809|50124236|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
25026300|NCT03305809|50124237|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
25026301|NCT03305809|50124238|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
25026302|NCT03305809|50124239|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
25026303|NCT02994056|50124252|FG000|Overall Study|Death|8|||
25026304|NCT02994056|50124252|FG000|Overall Study|Withdrew Consent|1|||
25026305|NCT03548051|50124271|FG000|Overall Study|Death|1|||
25026306|NCT03548051|50124272|FG001|Overall Study|Death|1|||
25026307|NCT03548051|50124271|FG000|Overall Study|Withdrawal by Subject|1|||
25026308|NCT03548051|50124272|FG001|Overall Study|Withdrawal by Subject|0|||
25026309|NCT03305731|50124278|FG000|Overall Study|Protocol Violation|1|||
25026310|NCT03305575|50124284|FG000|Overall Study|Physician Decision|1|||
25026311|NCT03305575|50124285|FG001|Overall Study|Physician Decision|0|||
25026312|NCT02993822|50124295|FG000|Overall Study|Lack of Efficacy|1|||
25026313|NCT02993822|50124296|FG001|Overall Study|Lack of Efficacy|1|||
25026314|NCT02993822|50124297|FG002|Overall Study|Lack of Efficacy|0|||
25026315|NCT02993822|50124298|FG003|Overall Study|Lack of Efficacy|0|||
25026316|NCT02993822|50124295|FG000|Overall Study|Protocol Violation|1|||
25026317|NCT02993822|50124296|FG001|Overall Study|Protocol Violation|0|||
25026318|NCT02993822|50124297|FG002|Overall Study|Protocol Violation|0|||
25026319|NCT02993822|50124298|FG003|Overall Study|Protocol Violation|0|||
25026320|NCT02993822|50124295|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
25026321|NCT02993822|50124296|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
25026322|NCT02993822|50124297|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
25026323|NCT02993822|50124298|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
25026324|NCT02993822|50124295|FG000|Overall Study|Adverse Event|3|||
25026325|NCT02993822|50124296|FG001|Overall Study|Adverse Event|1|||
25026326|NCT02993822|50124297|FG002|Overall Study|Adverse Event|7|||
25026327|NCT02993822|50124298|FG003|Overall Study|Adverse Event|0|||
25026328|NCT02993822|50124295|FG000|Overall Study|Withdrawal by Subject|4|||
25026329|NCT02993822|50124296|FG001|Overall Study|Withdrawal by Subject|2|||
25026330|NCT02993822|50124297|FG002|Overall Study|Withdrawal by Subject|2|||
25026331|NCT02993822|50124298|FG003|Overall Study|Withdrawal by Subject|3|||
25026332|NCT02993822|50124295|FG000|Overall Study|Lost to Follow-up|1|||
25185612|NCT01425281|50335176|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
25026333|NCT02993822|50124296|FG001|Overall Study|Lost to Follow-up|0|||
25026334|NCT02993822|50124297|FG002|Overall Study|Lost to Follow-up|1|||
25185613|NCT01425281|50335175|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
25026335|NCT02993822|50124298|FG003|Overall Study|Lost to Follow-up|0|||
25026336|NCT01068860|50124318|FG000|Overall Study|Withdrawal by Subject|0|||
25155656|NCT01507545|50270946|FG001|Overall Study|Other|4|||
25026337|NCT01068860|50124319|FG001|Overall Study|Withdrawal by Subject|0|||
25026338|NCT01068860|50124320|FG002|Overall Study|Withdrawal by Subject|0|||
25026339|NCT01068860|50124321|FG003|Overall Study|Withdrawal by Subject|0|||
25026340|NCT01068860|50124322|FG004|Overall Study|Withdrawal by Subject|0|||
25026341|NCT01068860|50124323|FG005|Overall Study|Withdrawal by Subject|2|||
25026342|NCT01068860|50124324|FG006|Overall Study|Withdrawal by Subject|0|||
25026343|NCT01068860|50124325|FG007|Overall Study|Withdrawal by Subject|0|||
25026344|NCT01068860|50124326|FG008|Overall Study|Withdrawal by Subject|0|||
25026345|NCT01068860|50124327|FG009|Overall Study|Withdrawal by Subject|3|||
25026346|NCT01068860|50124318|FG000|Overall Study|Administrative problems; misrandomized|0|||
25026347|NCT01068860|50124319|FG001|Overall Study|Administrative problems; misrandomized|0|||
25026348|NCT01068860|50124320|FG002|Overall Study|Administrative problems; misrandomized|0|||
25026349|NCT01068860|50124321|FG003|Overall Study|Administrative problems; misrandomized|1|||
25026350|NCT01068860|50124322|FG004|Overall Study|Administrative problems; misrandomized|0|||
25026351|NCT01068860|50124323|FG005|Overall Study|Administrative problems; misrandomized|0|||
25026352|NCT01068860|50124324|FG006|Overall Study|Administrative problems; misrandomized|0|||
25026353|NCT01068860|50124325|FG007|Overall Study|Administrative problems; misrandomized|0|||
25026354|NCT01068860|50124326|FG008|Overall Study|Administrative problems; misrandomized|0|||
25026355|NCT01068860|50124327|FG009|Overall Study|Administrative problems; misrandomized|1|||
25026356|NCT01068860|50124318|FG000|Overall Study|Lost to Follow-up|0|||
25026357|NCT01068860|50124319|FG001|Overall Study|Lost to Follow-up|1|||
25026358|NCT01068860|50124320|FG002|Overall Study|Lost to Follow-up|0|||
25026359|NCT01068860|50124321|FG003|Overall Study|Lost to Follow-up|0|||
25026360|NCT01068860|50124322|FG004|Overall Study|Lost to Follow-up|0|||
25026361|NCT01068860|50124323|FG005|Overall Study|Lost to Follow-up|0|||
25026362|NCT01068860|50124324|FG006|Overall Study|Lost to Follow-up|0|||
25026363|NCT01068860|50124325|FG007|Overall Study|Lost to Follow-up|0|||
25026364|NCT01068860|50124326|FG008|Overall Study|Lost to Follow-up|0|||
25026365|NCT01068860|50124327|FG009|Overall Study|Lost to Follow-up|0|||
25026366|NCT02989610|50124349|FG000|Overall Study|Withdrawal/Other reasons|39|||
25026367|NCT01372774|50124355|FG000|Overall Study|Withdrawal prior to treatment|4|||
25026368|NCT01372774|50124356|FG001|Overall Study|Withdrawal prior to treatment|5|||
25026369|NCT02670538|50124367|FG000|Overall Study|Withdrawal of Consent|8|||
25026370|NCT02670538|50124368|FG001|Overall Study|Withdrawal of Consent|6|||
25026371|NCT02670538|50124369|FG002|Overall Study|Withdrawal of Consent|5|||
25026372|NCT02670538|50124367|FG000|Overall Study|Lost to Follow-up|8|||
25026373|NCT02670538|50124368|FG001|Overall Study|Lost to Follow-up|12|||
25026374|NCT02670538|50124369|FG002|Overall Study|Lost to Follow-up|7|||
25026375|NCT02670538|50124367|FG000|Overall Study|Adverse Event|5|||
25026376|NCT02670538|50124368|FG001|Overall Study|Adverse Event|5|||
25026377|NCT02670538|50124369|FG002|Overall Study|Adverse Event|11|||
25026378|NCT02670538|50124367|FG000|Overall Study|Lack of Efficacy|7|||
25026379|NCT02670538|50124368|FG001|Overall Study|Lack of Efficacy|1|||
25026380|NCT02670538|50124369|FG002|Overall Study|Lack of Efficacy|2|||
25026381|NCT02670538|50124367|FG000|Overall Study|Protocol Violation|3|||
25026382|NCT02670538|50124368|FG001|Overall Study|Protocol Violation|4|||
25026383|NCT02670538|50124369|FG002|Overall Study|Protocol Violation|1|||
25026384|NCT02670538|50124367|FG000|Overall Study|Noncompliance with Study Drug|1|||
25026385|NCT02670538|50124368|FG001|Overall Study|Noncompliance with Study Drug|3|||
25026386|NCT02670538|50124369|FG002|Overall Study|Noncompliance with Study Drug|2|||
25026387|NCT02670538|50124367|FG000|Overall Study|Other Miscellaneous Reasons|0|||
25026388|NCT02670538|50124368|FG001|Overall Study|Other Miscellaneous Reasons|1|||
25026389|NCT02670538|50124369|FG002|Overall Study|Other Miscellaneous Reasons|2|||
25026390|NCT03547583|50124380|FG000|Overall Study|Adverse Event|16|||
25155657|NCT01482819|50270952|FG000|Overall Study|Lost to Follow-up|2|||
25155658|NCT01534533|50270964|FG000|Overall Study|Lost to Follow-up|3|||
25155659|NCT01534533|50270965|FG001|Overall Study|Lost to Follow-up|0|||
24930283|NCT00073021|50023464|FG001|Overall Study|Protocol Violation|1|||
24930284|NCT00073021|50023463|FG000|Overall Study|Adverse Event|4|||
24930285|NCT00073021|50023464|FG001|Overall Study|Adverse Event|4|||
24930286|NCT00073021|50023463|FG000|Overall Study|Withdrawal by Subject|6|||
24930287|NCT00073021|50023464|FG001|Overall Study|Withdrawal by Subject|5|||
24930288|NCT00073021|50023463|FG000|Overall Study|Physician Decision|3|||
24930289|NCT00073021|50023464|FG001|Overall Study|Physician Decision|1|||
24930290|NCT00073021|50023463|FG000|Overall Study|Lack of Efficacy|11|||
24930291|NCT00073021|50023464|FG001|Overall Study|Lack of Efficacy|5|||
24930292|NCT00407758|50023470|FG000|Overall Study|ineligible -improper prior treatment|1|||
24930293|NCT00531752|50023478|FG000|First Double-blind Intervention Period|Adverse Event|2|||
25026391|NCT03547583|50124381|FG001|Overall Study|Adverse Event|11|||
25155660|NCT01534533|50270966|FG002|Overall Study|Lost to Follow-up|4|||
24930294|NCT00531752|50023479|FG001|First Double-blind Intervention Period|Adverse Event|0|||
25026392|NCT03547583|50124382|FG002|Overall Study|Adverse Event|10|||
25026393|NCT03547583|50124380|FG000|Overall Study|Death|11|||
25026394|NCT03547583|50124381|FG001|Overall Study|Death|7|||
25026395|NCT03547583|50124382|FG002|Overall Study|Death|4|||
25026396|NCT03547583|50124380|FG000|Overall Study|Lost to Follow-up|1|||
25026397|NCT03547583|50124381|FG001|Overall Study|Lost to Follow-up|0|||
25026398|NCT03547583|50124382|FG002|Overall Study|Lost to Follow-up|0|||
25185614|NCT01425281|50335176|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
25185615|NCT01425281|50335175|FG000|At 180-day Clinical Follow-up|Death|0|||
25185616|NCT01425281|50335176|FG001|At 180-day Clinical Follow-up|Death|1|||
25185617|NCT01425281|50335175|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
25185618|NCT01425281|50335176|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
25185619|NCT01425281|50335175|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
25185620|NCT01425281|50335176|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
25185621|NCT01425281|50335175|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
25185622|NCT01425281|50335176|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
25185623|NCT01425281|50335175|FG000|At 2-year Clinical Follow-up|Death|2|||
25185624|NCT01425281|50335176|FG001|At 2-year Clinical Follow-up|Death|0|||
25185625|NCT01425281|50335175|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
25185626|NCT01425281|50335176|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
25185627|NCT01425281|50335175|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
25185628|NCT01425281|50335176|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
25185629|NCT01425281|50335175|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
25185630|NCT01425281|50335176|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
25185631|NCT01425281|50335175|FG000|At 3-year Clinical Follow-up|Death|2|||
25185632|NCT01425281|50335176|FG001|At 3-year Clinical Follow-up|Death|3|||
25185633|NCT01425281|50335175|FG000|At 4-year Clinical Follow-up|Death|7|||
25185634|NCT01425281|50335176|FG001|At 4-year Clinical Follow-up|Death|3|||
25185635|NCT01425281|50335175|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
25185636|NCT01425281|50335176|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
25185637|NCT01425281|50335175|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
25185638|NCT01425281|50335176|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
25185639|NCT01425281|50335175|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
25185640|NCT01425281|50335176|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
25185641|NCT01425281|50335175|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
25185642|NCT01425281|50335176|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
25185643|NCT01425281|50335175|FG000|At 5-year Clinical Follow-up|Death|2|||
25185644|NCT01425281|50335176|FG001|At 5-year Clinical Follow-up|Death|0|||
25185645|NCT01425281|50335175|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
25185646|NCT01425281|50335176|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
25185647|NCT01425281|50335175|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
25185648|NCT01425281|50335176|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
25185649|NCT01425281|50335175|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
25185650|NCT01425281|50335176|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
25185651|NCT02648724|50335204|FG000|Overall Study|Withdrawal by Subject|0|||
25185652|NCT02648724|50335205|FG001|Overall Study|Withdrawal by Subject|1|||
25185653|NCT02648724|50335206|FG002|Overall Study|Withdrawal by Subject|1|||
25185654|NCT02648724|50335207|FG003|Overall Study|Withdrawal by Subject|0|||
25185655|NCT02648724|50335208|FG004|Overall Study|Withdrawal by Subject|1|||
25185656|NCT02648724|50335209|FG005|Overall Study|Withdrawal by Subject|0|||
25185657|NCT02648724|50335210|FG006|Overall Study|Withdrawal by Subject|0|||
25185658|NCT02648724|50335204|FG000|Overall Study|Progressive disease|2|||
25185659|NCT02648724|50335205|FG001|Overall Study|Progressive disease|2|||
25185660|NCT02648724|50335206|FG002|Overall Study|Progressive disease|2|||
25185661|NCT02648724|50335207|FG003|Overall Study|Progressive disease|3|||
25185662|NCT02648724|50335208|FG004|Overall Study|Progressive disease|22|||
25185663|NCT02648724|50335209|FG005|Overall Study|Progressive disease|7|||
25185664|NCT02648724|50335210|FG006|Overall Study|Progressive disease|8|||
25185665|NCT02648724|50335204|FG000|Overall Study|Other reason (unknown)|1|||
25185666|NCT02648724|50335205|FG001|Overall Study|Other reason (unknown)|0|||
25185667|NCT02648724|50335206|FG002|Overall Study|Other reason (unknown)|0|||
25185668|NCT02648724|50335207|FG003|Overall Study|Other reason (unknown)|0|||
25185669|NCT02648724|50335208|FG004|Overall Study|Other reason (unknown)|0|||
25185670|NCT02648724|50335209|FG005|Overall Study|Other reason (unknown)|0|||
25185671|NCT02648724|50335210|FG006|Overall Study|Other reason (unknown)|0|||
25026399|NCT03547583|50124380|FG000|Overall Study|Non-compliance with study drug|0|||
25185672|NCT02648724|50335204|FG000|Overall Study|Protocol Violation|0|||
25185673|NCT02648724|50335205|FG001|Overall Study|Protocol Violation|0|||
25185674|NCT02648724|50335206|FG002|Overall Study|Protocol Violation|0|||
24930295|NCT00531752|50023480|FG002|First Double-blind Intervention Period|Adverse Event|1|||
24930296|NCT00531752|50023481|FG003|First Double-blind Intervention Period|Adverse Event|1|||
24930297|NCT00531752|50023478|FG000|First Double-blind Intervention Period|Other|1|||
24930298|NCT00531752|50023479|FG001|First Double-blind Intervention Period|Other|4|||
24930299|NCT00531752|50023480|FG002|First Double-blind Intervention Period|Other|4|||
25026400|NCT03547583|50124381|FG001|Overall Study|Non-compliance with study drug|0|||
24930300|NCT00531752|50023481|FG003|First Double-blind Intervention Period|Other|0|||
24930301|NCT00531752|50023478|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
24930302|NCT00531752|50023479|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
24930303|NCT00531752|50023480|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
24930304|NCT00531752|50023481|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
24930305|NCT00531752|50023478|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
24930306|NCT00531752|50023479|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
25026401|NCT03547583|50124382|FG002|Overall Study|Non-compliance with study drug|1|||
25026402|NCT03547583|50124380|FG000|Overall Study|Physician Decision|1|||
25026403|NCT03547583|50124381|FG001|Overall Study|Physician Decision|0|||
25026404|NCT03547583|50124382|FG002|Overall Study|Physician Decision|3|||
24930307|NCT00531752|50023480|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
24930308|NCT00531752|50023481|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
24930309|NCT00531752|50023478|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
24930310|NCT00531752|50023479|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
24930311|NCT00531752|50023480|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
24930312|NCT00531752|50023481|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
24930313|NCT00531752|50023478|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
24930314|NCT00531752|50023479|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
24930315|NCT00531752|50023480|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
24930316|NCT00531752|50023481|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
25026405|NCT03547583|50124380|FG000|Overall Study|Protocol Violation|2|||
24930317|NCT00531752|50023478|FG000|Second Double-blind Intervention Period|Other|1|||
24930318|NCT00531752|50023479|FG001|Second Double-blind Intervention Period|Other|1|||
24930319|NCT00531752|50023480|FG002|Second Double-blind Intervention Period|Other|0|||
24930320|NCT00531752|50023481|FG003|Second Double-blind Intervention Period|Other|0|||
24930321|NCT00531752|50023478|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
24930322|NCT00531752|50023479|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
24930323|NCT00531752|50023480|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
24930324|NCT00531752|50023481|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
24930325|NCT00531752|50023478|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
24930326|NCT00531752|50023479|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
24930327|NCT00531752|50023480|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
24930328|NCT00531752|50023481|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
24930329|NCT00395746|50023492|FG000|Overall Study|Adverse Event|5|||
24930330|NCT00395746|50023493|FG001|Overall Study|Adverse Event|2|||
24930331|NCT00395746|50023494|FG002|Overall Study|Adverse Event|2|||
24930332|NCT00395746|50023492|FG000|Overall Study|Protocol Violation|0|||
24930333|NCT00395746|50023493|FG001|Overall Study|Protocol Violation|1|||
24930334|NCT00395746|50023494|FG002|Overall Study|Protocol Violation|0|||
24930335|NCT00395746|50023492|FG000|Overall Study|Lack of Efficacy|2|||
24930336|NCT00395746|50023493|FG001|Overall Study|Lack of Efficacy|0|||
24930337|NCT00395746|50023494|FG002|Overall Study|Lack of Efficacy|17|||
24930338|NCT00395746|50023492|FG000|Overall Study|Hypoglycaemia|2|||
24930339|NCT00395746|50023493|FG001|Overall Study|Hypoglycaemia|1|||
24930340|NCT00395746|50023494|FG002|Overall Study|Hypoglycaemia|0|||
24930341|NCT00395746|50023492|FG000|Overall Study|Subject decision|0|||
24930342|NCT00395746|50023493|FG001|Overall Study|Subject decision|0|||
24930343|NCT00395746|50023494|FG002|Overall Study|Subject decision|1|||
25026406|NCT03547583|50124381|FG001|Overall Study|Protocol Violation|1|||
25155661|NCT01534533|50270967|FG003|Overall Study|Lost to Follow-up|3|||
25155662|NCT01534533|50270964|FG000|Overall Study|Withdrawal by Subject|5|||
25155663|NCT01534533|50270965|FG001|Overall Study|Withdrawal by Subject|3|||
25155664|NCT01534533|50270966|FG002|Overall Study|Withdrawal by Subject|4|||
25155665|NCT01534533|50270967|FG003|Overall Study|Withdrawal by Subject|1|||
25155666|NCT01506609|50271101|FG000|Overall Study|Adverse Event Related to Progression|0|||
25155667|NCT01506609|50271102|FG001|Overall Study|Adverse Event Related to Progression|0|||
25155668|NCT01506609|50271103|FG002|Overall Study|Adverse Event Related to Progression|0|||
25155669|NCT01506609|50271104|FG003|Overall Study|Adverse Event Related to Progression|3|||
25155670|NCT01506609|50271105|FG004|Overall Study|Adverse Event Related to Progression|7|||
25155671|NCT01506609|50271106|FG005|Overall Study|Adverse Event Related to Progression|3|||
25155672|NCT01506609|50271101|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
25155673|NCT01506609|50271102|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
25155674|NCT01506609|50271103|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
24930344|NCT00395746|50023492|FG000|Overall Study|Withdrawal of consent|0|||
24930345|NCT00395746|50023493|FG001|Overall Study|Withdrawal of consent|0|||
24930346|NCT00395746|50023494|FG002|Overall Study|Withdrawal of consent|1|||
24930347|NCT00395746|50023492|FG000|Overall Study|Difficultulty in use of device|0|||
25026407|NCT03547583|50124382|FG002|Overall Study|Protocol Violation|1|||
25026408|NCT03547583|50124380|FG000|Overall Study|Withdrawal by Subject|12|||
25026409|NCT03547583|50124381|FG001|Overall Study|Withdrawal by Subject|19|||
25026410|NCT03547583|50124382|FG002|Overall Study|Withdrawal by Subject|10|||
25026411|NCT03547583|50124380|FG000|Overall Study|Other|2|||
25026412|NCT03547583|50124381|FG001|Overall Study|Other|2|||
25026413|NCT03547583|50124382|FG002|Overall Study|Other|3|||
25026414|NCT02670382|50124393|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
25026415|NCT02670382|50124394|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
25026416|NCT02991482|50124404|FG000|Overall Study|Disease progression|56|||
25026417|NCT02991482|50124405|FG001|Overall Study|Disease progression|47|||
25026418|NCT02991482|50124404|FG000|Overall Study|Death|4|||
25026419|NCT02991482|50124405|FG001|Overall Study|Death|4|||
25026420|NCT02991482|50124404|FG000|Overall Study|Adverse Event|1|||
25026421|NCT02991482|50124405|FG001|Overall Study|Adverse Event|6|||
25026422|NCT02991482|50124404|FG000|Overall Study|Patient decision|1|||
25026423|NCT02991482|50124405|FG001|Overall Study|Patient decision|1|||
25026424|NCT02991482|50124404|FG000|Overall Study|Physician Decision|0|||
25026425|NCT02991482|50124405|FG001|Overall Study|Physician Decision|6|||
25026426|NCT02991482|50124404|FG000|Overall Study|Clinical deterioration|1|||
25026427|NCT02991482|50124405|FG001|Overall Study|Clinical deterioration|0|||
25026428|NCT02991482|50124404|FG000|Overall Study|Patient feeling too unwell|1|||
25026429|NCT02991482|50124405|FG001|Overall Study|Patient feeling too unwell|0|||
25026430|NCT02991482|50124404|FG000|Overall Study|Worsening of performance status|0|||
25026431|NCT02991482|50124405|FG001|Overall Study|Worsening of performance status|1|||
25026432|NCT02991482|50124404|FG000|Overall Study|Death prior to study drug initiation|1|||
25026433|NCT02991482|50124405|FG001|Overall Study|Death prior to study drug initiation|0|||
25026434|NCT02991482|50124404|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
25026435|NCT02991482|50124405|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
25026436|NCT02674750|50124414|FG000|Overall Study|Death|4|||
25026437|NCT02674750|50124415|FG001|Overall Study|Death|5|||
25026438|NCT02674750|50124416|FG002|Overall Study|Death|8|||
25026439|NCT02674750|50124414|FG000|Overall Study|Lost to Follow-up|0|||
25026440|NCT02674750|50124415|FG001|Overall Study|Lost to Follow-up|8|||
25026441|NCT02674750|50124416|FG002|Overall Study|Lost to Follow-up|0|||
25026442|NCT02674750|50124414|FG000|Overall Study|Lack of Efficacy|1|||
25026443|NCT02674750|50124415|FG001|Overall Study|Lack of Efficacy|17|||
25026444|NCT02674750|50124416|FG002|Overall Study|Lack of Efficacy|3|||
25026445|NCT02674750|50124414|FG000|Overall Study|Withdrawal by Subject|0|||
25026446|NCT02674750|50124415|FG001|Overall Study|Withdrawal by Subject|7|||
25026447|NCT02674750|50124416|FG002|Overall Study|Withdrawal by Subject|1|||
25026448|NCT02674750|50124414|FG000|Overall Study|Other|0|||
25026449|NCT02674750|50124415|FG001|Overall Study|Other|8|||
25026450|NCT02674750|50124416|FG002|Overall Study|Other|0|||
25026451|NCT02987972|50124445|FG000|Overall Study|Adverse Event|1|||
25026452|NCT02987972|50124446|FG001|Overall Study|Adverse Event|1|||
25026453|NCT02987972|50124447|FG002|Overall Study|Adverse Event|0|||
25026454|NCT02987972|50124445|FG000|Overall Study|Death|1|||
25026455|NCT02987972|50124446|FG001|Overall Study|Death|0|||
25026456|NCT02987972|50124447|FG002|Overall Study|Death|0|||
25026457|NCT02987972|50124445|FG000|Overall Study|Lack of Efficacy|9|||
25026458|NCT02987972|50124446|FG001|Overall Study|Lack of Efficacy|12|||
25026459|NCT02987972|50124447|FG002|Overall Study|Lack of Efficacy|12|||
25026460|NCT02987972|50124445|FG000|Overall Study|Lost to Follow-up|7|||
25026461|NCT02987972|50124446|FG001|Overall Study|Lost to Follow-up|8|||
25026462|NCT02987972|50124447|FG002|Overall Study|Lost to Follow-up|4|||
25026463|NCT02987972|50124445|FG000|Overall Study|Physician Decision|1|||
25026464|NCT02987972|50124446|FG001|Overall Study|Physician Decision|6|||
25026465|NCT02987972|50124447|FG002|Overall Study|Physician Decision|0|||
24930348|NCT00395746|50023493|FG001|Overall Study|Difficultulty in use of device|0|||
24930349|NCT00395746|50023494|FG002|Overall Study|Difficultulty in use of device|1|||
25026466|NCT02987972|50124445|FG000|Overall Study|Protocol Violation|2|||
25026467|NCT02987972|50124446|FG001|Overall Study|Protocol Violation|1|||
25026468|NCT02987972|50124447|FG002|Overall Study|Protocol Violation|5|||
25026469|NCT02987972|50124445|FG000|Overall Study|Withdrawal by Subject|22|||
25026470|NCT02987972|50124446|FG001|Overall Study|Withdrawal by Subject|17|||
25026471|NCT02987972|50124447|FG002|Overall Study|Withdrawal by Subject|21|||
25026472|NCT03305419|50124463|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
24930350|NCT00395746|50023492|FG000|Overall Study|Unable to visit site on schedule|1|||
25026473|NCT03305419|50124464|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
25026474|NCT03305419|50124465|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
25026475|NCT03305419|50124466|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
25026476|NCT03305419|50124467|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
24930351|NCT00395746|50023493|FG001|Overall Study|Unable to visit site on schedule|0|||
24930352|NCT00395746|50023494|FG002|Overall Study|Unable to visit site on schedule|0|||
24930353|NCT00055471|50023505|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
24930354|NCT00055471|50023506|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
24930355|NCT00055471|50023507|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
24930356|NCT00055471|50023505|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
24930357|NCT00055471|50023506|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
24930358|NCT00055471|50023507|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
24930359|NCT00055471|50023505|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
24930360|NCT00055471|50023506|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
24930361|NCT00055471|50023507|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
24930362|NCT00395512|50023519|FG000|Overall Study|Adverse Event|3|||
24930363|NCT00395512|50023520|FG001|Overall Study|Adverse Event|8|||
24930364|NCT00395512|50023521|FG002|Overall Study|Adverse Event|6|||
24930365|NCT00395512|50023522|FG003|Overall Study|Adverse Event|6|||
24930366|NCT00395512|50023519|FG000|Overall Study|Protocol Violation|2|||
24930367|NCT00395512|50023520|FG001|Overall Study|Protocol Violation|3|||
24930368|NCT00395512|50023521|FG002|Overall Study|Protocol Violation|6|||
24930369|NCT00395512|50023522|FG003|Overall Study|Protocol Violation|7|||
24930370|NCT00395512|50023519|FG000|Overall Study|Lost to Follow-up|2|||
24930371|NCT00395512|50023520|FG001|Overall Study|Lost to Follow-up|6|||
24930372|NCT00395512|50023521|FG002|Overall Study|Lost to Follow-up|5|||
24930373|NCT00395512|50023522|FG003|Overall Study|Lost to Follow-up|5|||
24930374|NCT00395512|50023519|FG000|Overall Study|Withdrawal by Subject|6|||
24930375|NCT00395512|50023520|FG001|Overall Study|Withdrawal by Subject|5|||
24930376|NCT00395512|50023521|FG002|Overall Study|Withdrawal by Subject|5|||
24930377|NCT00395512|50023522|FG003|Overall Study|Withdrawal by Subject|12|||
24930378|NCT00395512|50023519|FG000|Overall Study|Physician Decision|6|||
24930379|NCT00395512|50023520|FG001|Overall Study|Physician Decision|4|||
24930380|NCT00395512|50023521|FG002|Overall Study|Physician Decision|2|||
24930381|NCT00395512|50023522|FG003|Overall Study|Physician Decision|2|||
24930382|NCT00395512|50023519|FG000|Overall Study|Other|1|||
24930383|NCT00395512|50023520|FG001|Overall Study|Other|1|||
24930384|NCT00395512|50023521|FG002|Overall Study|Other|0|||
24930385|NCT00395512|50023522|FG003|Overall Study|Other|0|||
24930386|NCT00395512|50023519|FG000|Overall Study|Hyperglycemic Rescue|18|||
24930387|NCT00395512|50023520|FG001|Overall Study|Hyperglycemic Rescue|10|||
24930388|NCT00395512|50023521|FG002|Overall Study|Hyperglycemic Rescue|4|||
24930389|NCT00395512|50023522|FG003|Overall Study|Hyperglycemic Rescue|6|||
24930390|NCT00054691|50023532|FG000|Overall Study|Unmeasurable Disease|2|||
24930391|NCT00054691|50023532|FG000|Overall Study|Noncompliant|1|||
24930392|NCT00387712|50023538|FG000|Overall Study|Physician Decision|6|||
24930393|NCT00387712|50023539|FG001|Overall Study|Physician Decision|4|||
24930394|NCT00387712|50023538|FG000|Overall Study|Lost to Follow-up|17|||
24930395|NCT00387712|50023539|FG001|Overall Study|Lost to Follow-up|20|||
24930396|NCT00387712|50023538|FG000|Overall Study|Withdrawal by Subject|6|||
24930397|NCT00387712|50023539|FG001|Overall Study|Withdrawal by Subject|12|||
24930398|NCT00066703|50023547|FG000|Overall Study|Adverse Event|80|||
24930399|NCT00066703|50023548|FG001|Overall Study|Adverse Event|111|||
24930400|NCT00066703|50023547|FG000|Overall Study|Death|3|||
24930401|NCT00066703|50023548|FG001|Overall Study|Death|0|||
24930402|NCT00066703|50023547|FG000|Overall Study|Lack of Efficacy|114|||
24930403|NCT00066703|50023548|FG001|Overall Study|Lack of Efficacy|69|||
24930404|NCT00066703|50023547|FG000|Overall Study|Lost to Follow-up|31|||
24930405|NCT00066703|50023548|FG001|Overall Study|Lost to Follow-up|28|||
24930406|NCT00066703|50023547|FG000|Overall Study|Withdrawal by Subject|38|||
24930407|NCT00066703|50023548|FG001|Overall Study|Withdrawal by Subject|63|||
24930408|NCT00066703|50023547|FG000|Overall Study|Treatment ongoing|346|||
24930409|NCT00066703|50023548|FG001|Overall Study|Treatment ongoing|311|||
24930410|NCT00072475|50023554|FG000|Overall Study|Adverse Event|44|||
24930411|NCT00072475|50023554|FG000|Overall Study|Death|3|||
24930412|NCT00072475|50023554|FG000|Overall Study|Withdrawal by Subject|46|||
24930413|NCT00072475|50023554|FG000|Overall Study|Patient/Investigator Decision|4|||
24930414|NCT00066469|50023558|FG000|Overall Study|Death|3|||
24930415|NCT00066469|50023558|FG000|Overall Study|Lack of Efficacy|9|||
24930416|NCT00066469|50023558|FG000|Overall Study|Lost to Follow-up|1|||
24930417|NCT00066469|50023558|FG000|Overall Study|Physician Decision|1|||
24930418|NCT00066469|50023558|FG000|Overall Study|Withdrawal by Subject|1|||
24930419|NCT00066469|50023558|FG000|Overall Study|ineligible|1|||
24930420|NCT00387088|50023564|FG000|Overall Study|Adverse Event|143|||
24930421|NCT00387088|50023565|FG001|Overall Study|Adverse Event|156|||
24930422|NCT00387088|50023564|FG000|Overall Study|Protocol Violation|47|||
24930423|NCT00387088|50023565|FG001|Overall Study|Protocol Violation|35|||
24930424|NCT00387088|50023564|FG000|Overall Study|Withdrawal by Subject|20|||
24930425|NCT00387088|50023565|FG001|Overall Study|Withdrawal by Subject|35|||
24930426|NCT00387088|50023564|FG000|Overall Study|Lack of Efficacy|28|||
24930427|NCT00387088|50023565|FG001|Overall Study|Lack of Efficacy|67|||
24930428|NCT00387088|50023564|FG000|Overall Study|Lost to Follow-up|22|||
24930429|NCT00387088|50023565|FG001|Overall Study|Lost to Follow-up|28|||
24930430|NCT00387088|50023564|FG000|Overall Study|Other|58|||
24930431|NCT00387088|50023565|FG001|Overall Study|Other|52|||
25275107|NCT01237223|50589111|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
25275108|NCT01237223|50589112|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
24930435|NCT00053365|50023575|FG000|Overall Study|Incorrect cell type|1|||
24930436|NCT00053365|50023575|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
24930437|NCT00053365|50023575|FG000|Overall Study|Never treated|4|||
24930438|NCT00387010|50023581|FG000|Dose Titration Period|Adverse Event|12|||
24930439|NCT00387010|50023581|FG000|Dose Titration Period|Lack of Efficacy|5|||
24930440|NCT00387010|50023581|FG000|Dose Titration Period|Withdrawal by Subject|3|||
24930441|NCT00387010|50023581|FG000|Dose Titration Period|Protocol Violation|1|||
24930442|NCT00387010|50023581|FG000|Dose Titration Period|Lost to Follow-up|2|||
24930443|NCT00387010|50023581|FG000|Dose Titration Period|Noncompliance with study medication|8|||
24930444|NCT00387010|50023581|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
24930445|NCT00387010|50023581|FG000|Treatment Period|Adverse Event|4|||
24930446|NCT00387010|50023581|FG000|Treatment Period|Withdrawal by Subject|1|||
24930447|NCT00387010|50023581|FG000|Treatment Period|Noncompliance with study medication|2|||
24930448|NCT00387010|50023581|FG000|Treatment Period|Noncompliance with study procedures|3|||
24930449|NCT00387010|50023581|FG000|Treatment Period|Participant reported study drug stolen|1|||
24930450|NCT00386776|50023585|FG000|Overall Study|Withdrawal by Subject|8|||
24930451|NCT00065065|50023593|FG000|Overall Study|Adverse Event|3|||
24930452|NCT00065065|50023594|FG001|Overall Study|Adverse Event|2|||
24930453|NCT00065065|50023593|FG000|Overall Study|Withdrawal by Subject|1|||
24930454|NCT00065065|50023594|FG001|Overall Study|Withdrawal by Subject|5|||
24930455|NCT00065065|50023593|FG000|Overall Study|Lack of Efficacy|4|||
24930456|NCT00065065|50023594|FG001|Overall Study|Lack of Efficacy|11|||
24930457|NCT00065065|50023593|FG000|Overall Study|Other|2|||
24930458|NCT00065065|50023594|FG001|Overall Study|Other|2|||
24930459|NCT00386308|50023604|FG000|Overall Study|Adverse Event|3|||
24930460|NCT00386308|50023605|FG001|Overall Study|Adverse Event|3|||
24930461|NCT00386308|50023604|FG000|Overall Study|Protocol Violation|2|||
24930462|NCT00386308|50023605|FG001|Overall Study|Protocol Violation|5|||
24930463|NCT00386308|50023604|FG000|Overall Study|Lack of Efficacy|0|||
24930464|NCT00386308|50023605|FG001|Overall Study|Lack of Efficacy|2|||
24930465|NCT00386308|50023604|FG000|Overall Study|Lost to Follow-up|10|||
24930466|NCT00386308|50023605|FG001|Overall Study|Lost to Follow-up|6|||
24930467|NCT00386308|50023604|FG000|Overall Study|Withdrawal by Subject|6|||
24930468|NCT00386308|50023605|FG001|Overall Study|Withdrawal by Subject|2|||
24930469|NCT00386308|50023604|FG000|Overall Study|Other Event|8|||
24930470|NCT00386308|50023605|FG001|Overall Study|Other Event|1|||
24930471|NCT00064987|50023613|FG000|Overall Study|Physician Decision|3|||
24930472|NCT00064987|50023614|FG001|Overall Study|Physician Decision|0|||
24930473|NCT00374452|50023622|FG000|Overall Study|Left clinic before intervention started|4|||
24930474|NCT00374452|50023623|FG001|Overall Study|Left clinic before intervention started|1|||
24930475|NCT00374452|50023622|FG000|Overall Study|Change in job role before intervention|0|||
24930476|NCT00374452|50023623|FG001|Overall Study|Change in job role before intervention|1|||
24930477|NCT00374452|50023622|FG000|Overall Study|Left clinic after intervention started|1|||
24930478|NCT00374452|50023623|FG001|Overall Study|Left clinic after intervention started|1|||
24930479|NCT00374452|50023622|FG000|Overall Study|Withdrawal by Subject|0|||
24930480|NCT00374452|50023623|FG001|Overall Study|Withdrawal by Subject|2|||
24930481|NCT00064753|50023631|FG000|Overall Study|Death|251|||
24930482|NCT00064753|50023632|FG001|Overall Study|Death|242|||
24930483|NCT00064753|50023631|FG000|Overall Study|Withdrawal by Subject|198|||
24930484|NCT00064753|50023632|FG001|Overall Study|Withdrawal by Subject|171|||
24930485|NCT00064753|50023631|FG000|Overall Study|Lost to Follow-up|225|||
24930486|NCT00064753|50023632|FG001|Overall Study|Lost to Follow-up|235|||
24930487|NCT00374140|50023638|FG000|Overall Study|Lost to Follow-up|1|||
24930488|NCT00374140|50023638|FG000|Overall Study|Protocol Violation|1|||
25026477|NCT03305419|50124468|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
24930489|NCT00665561|50023644|FG000|Overall Study|Death recorded on subject summary pages|75|||
24930490|NCT00665561|50023645|FG001|Overall Study|Death recorded on subject summary pages|75|||
25185675|NCT02648724|50335207|FG003|Overall Study|Protocol Violation|0|||
24930491|NCT00665561|50023644|FG000|Overall Study|Does not meet entrance criteria|19|||
24930492|NCT00665561|50023645|FG001|Overall Study|Does not meet entrance criteria|21|||
24930493|NCT00665561|50023644|FG000|Overall Study|Lost to Follow-up|203|||
24930494|NCT00665561|50023645|FG001|Overall Study|Lost to Follow-up|264|||
24930495|NCT00665561|50023644|FG000|Overall Study|Withdrawal by Subject|74|||
24930496|NCT00665561|50023645|FG001|Overall Study|Withdrawal by Subject|65|||
24930497|NCT00665561|50023644|FG000|Overall Study|Other|123|||
24930498|NCT00665561|50023645|FG001|Overall Study|Other|108|||
24930499|NCT00665561|50023644|FG000|Overall Study|Site closed|8|||
24930500|NCT00665561|50023645|FG001|Overall Study|Site closed|0|||
24930501|NCT00665561|50023644|FG000|Overall Study|Withdrawn due to pregnancy|0|||
24930502|NCT00665561|50023645|FG001|Overall Study|Withdrawn due to pregnancy|1|||
24930503|NCT00663923|50023651|FG000|Overall Study|Lost to Follow-up|2|||
24930504|NCT00386152|50023660|FG000|Overall Study|Adverse Event|6|||
24930505|NCT00386152|50023661|FG001|Overall Study|Adverse Event|5|||
24930506|NCT00386152|50023662|FG002|Overall Study|Adverse Event|4|||
24930507|NCT00386152|50023660|FG000|Overall Study|Chang from original chemo stratification|4|||
24930508|NCT00386152|50023661|FG001|Overall Study|Chang from original chemo stratification|5|||
24930509|NCT00386152|50023662|FG002|Overall Study|Chang from original chemo stratification|6|||
24930510|NCT00386152|50023660|FG000|Overall Study|Death|3|||
24930511|NCT00386152|50023661|FG001|Overall Study|Death|0|||
24930512|NCT00386152|50023662|FG002|Overall Study|Death|1|||
24930513|NCT00386152|50023660|FG000|Overall Study|Disease progression|7|||
24930514|NCT00386152|50023661|FG001|Overall Study|Disease progression|4|||
24930515|NCT00386152|50023662|FG002|Overall Study|Disease progression|5|||
24930516|NCT00386152|50023660|FG000|Overall Study|Physician Decision|13|||
24930517|NCT00386152|50023661|FG001|Overall Study|Physician Decision|10|||
24930518|NCT00386152|50023662|FG002|Overall Study|Physician Decision|4|||
24930519|NCT00386152|50023660|FG000|Overall Study|Lost to Follow-up|1|||
24930520|NCT00386152|50023661|FG001|Overall Study|Lost to Follow-up|0|||
24930521|NCT00386152|50023662|FG002|Overall Study|Lost to Follow-up|0|||
24930522|NCT00386152|50023660|FG000|Overall Study|Completed chemotherapy|4|||
24930523|NCT00386152|50023661|FG001|Overall Study|Completed chemotherapy|5|||
24930524|NCT00386152|50023662|FG002|Overall Study|Completed chemotherapy|1|||
24930525|NCT00386152|50023660|FG000|Overall Study|Protocol Violation|3|||
24930526|NCT00386152|50023661|FG001|Overall Study|Protocol Violation|5|||
24930527|NCT00386152|50023662|FG002|Overall Study|Protocol Violation|2|||
24930528|NCT00386152|50023660|FG000|Overall Study|Withdrawal by Subject|3|||
24930529|NCT00386152|50023661|FG001|Overall Study|Withdrawal by Subject|6|||
24930530|NCT00386152|50023662|FG002|Overall Study|Withdrawal by Subject|10|||
25026478|NCT03305419|50124469|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
25026479|NCT03305419|50124470|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
25026480|NCT03305419|50124463|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
25026481|NCT03305419|50124464|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
25026482|NCT03305419|50124465|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
25026483|NCT03305419|50124466|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
25026484|NCT03305419|50124467|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
25026485|NCT03305419|50124468|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
25026486|NCT03305419|50124469|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
25026487|NCT03305419|50124470|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
25026488|NCT03305419|50124463|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
25026489|NCT03305419|50124464|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
25026490|NCT03305419|50124465|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
25026491|NCT03305419|50124466|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
25026492|NCT03305419|50124467|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
25026493|NCT03305419|50124468|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
25026494|NCT03305419|50124469|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
25026495|NCT03305419|50124470|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
25026496|NCT03305419|50124463|FG000|Part B (14 Days)|Adverse Event|0|||
25026497|NCT03305419|50124464|FG001|Part B (14 Days)|Adverse Event|0|||
25155675|NCT01506609|50271104|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
24930531|NCT00385918|50023672|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
25026498|NCT03305419|50124465|FG002|Part B (14 Days)|Adverse Event|0|||
25026499|NCT03305419|50124466|FG003|Part B (14 Days)|Adverse Event|0|||
25026500|NCT03305419|50124467|FG004|Part B (14 Days)|Adverse Event|1|||
25026501|NCT03305419|50124468|FG005|Part B (14 Days)|Adverse Event|2|||
24930532|NCT00385918|50023673|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
24930533|NCT00385918|50023674|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
24930534|NCT00385918|50023672|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
25026502|NCT03305419|50124469|FG006|Part B (14 Days)|Adverse Event|4|||
25026503|NCT03305419|50124470|FG007|Part B (14 Days)|Adverse Event|0|||
25026504|NCT03305419|50124463|FG000|Part B (14 Days)|Physician Decision|0|||
25026505|NCT03305419|50124464|FG001|Part B (14 Days)|Physician Decision|0|||
25026506|NCT03305419|50124465|FG002|Part B (14 Days)|Physician Decision|0|||
25026507|NCT03305419|50124466|FG003|Part B (14 Days)|Physician Decision|0|||
25026508|NCT03305419|50124467|FG004|Part B (14 Days)|Physician Decision|2|||
25026509|NCT03305419|50124468|FG005|Part B (14 Days)|Physician Decision|8|||
25026510|NCT03305419|50124469|FG006|Part B (14 Days)|Physician Decision|1|||
25026511|NCT03305419|50124470|FG007|Part B (14 Days)|Physician Decision|0|||
25026512|NCT01372618|50124493|FG000|Overall Study|PI Died. Study Terminated|9|||
25026513|NCT03304873|50124499|FG000|Overall Study|Lost to Follow-up|1|||
25155676|NCT01506609|50271105|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
25026514|NCT03304873|50124500|FG001|Overall Study|Lost to Follow-up|8|||
25026515|NCT02669758|50124506|FG000|Overall Study|Withdrawal by Subject|43|||
25026516|NCT02669758|50124506|FG000|Overall Study|Lost to Follow-up|19|||
25026517|NCT02669758|50124506|FG000|Overall Study|Adverse Event|16|||
25026518|NCT02669758|50124506|FG000|Overall Study|Non-Compliance with Study Drug|8|||
25026519|NCT02669758|50124506|FG000|Overall Study|Lack of Efficacy|5|||
25026520|NCT02669758|50124506|FG000|Overall Study|Pregnancy|1|||
25026521|NCT02669758|50124506|FG000|Overall Study|Study noncompliance|1|||
25026522|NCT02669758|50124506|FG000|Overall Study|Protocol Violation|1|||
25026523|NCT02987660|50124512|FG000|Overall Study|Study terminated by sponsor|10|||
25155677|NCT01506609|50271106|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
25026524|NCT02987660|50124513|FG001|Overall Study|Study terminated by sponsor|10|||
25026525|NCT04528069|50124519|FG000|Overall Study|Adverse Event|1|||
25026526|NCT04528069|50124519|FG000|Overall Study|Lost to Follow-up|1|||
25026527|NCT04528069|50124519|FG000|Overall Study|Patient Unable to Come|1|||
25026528|NCT04528069|50124519|FG000|Overall Study|Patient Unable to Attend|1|||
25026529|NCT03303469|50124535|FG000|Overall Study|Lost to Follow-up|2|||
25155678|NCT01506609|50271101|FG000|Overall Study|Withdrawal by Subject|0|||
24930535|NCT00385918|50023673|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
24930536|NCT00385918|50023674|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
24930537|NCT00385918|50023672|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
24930538|NCT00385918|50023673|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
24930539|NCT00385918|50023674|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
24930540|NCT00385918|50023672|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
24930541|NCT00385918|50023673|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
24930542|NCT00385918|50023674|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
24930543|NCT00385918|50023672|FG000|Intervention Phase After Randomization|Physician Decision|1|||
24930544|NCT00385918|50023673|FG001|Intervention Phase After Randomization|Physician Decision|0|||
24930545|NCT00385918|50023674|FG002|Intervention Phase After Randomization|Physician Decision|0|||
24930546|NCT00385918|50023672|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
24930547|NCT00385918|50023673|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
24930548|NCT00385918|50023674|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
25155679|NCT01506609|50271102|FG001|Overall Study|Withdrawal by Subject|0|||
25155680|NCT01506609|50271103|FG002|Overall Study|Withdrawal by Subject|0|||
25155681|NCT01506609|50271104|FG003|Overall Study|Withdrawal by Subject|9|||
25155682|NCT01506609|50271105|FG004|Overall Study|Withdrawal by Subject|7|||
25155683|NCT01506609|50271106|FG005|Overall Study|Withdrawal by Subject|7|||
25155684|NCT01506609|50271101|FG000|Overall Study|Lost to Follow-up|0|||
25155685|NCT01506609|50271102|FG001|Overall Study|Lost to Follow-up|0|||
25155686|NCT01506609|50271103|FG002|Overall Study|Lost to Follow-up|0|||
25155687|NCT01506609|50271104|FG003|Overall Study|Lost to Follow-up|1|||
25155688|NCT01506609|50271105|FG004|Overall Study|Lost to Follow-up|2|||
24930549|NCT00385840|50023683|FG000|Overall Study|Adverse Event|1|||
24930550|NCT00385840|50023684|FG001|Overall Study|Adverse Event|1|||
24930551|NCT00385840|50023683|FG000|Overall Study|Lost to Follow-up|3|||
24930552|NCT00385840|50023684|FG001|Overall Study|Lost to Follow-up|13|||
24930553|NCT00385762|50023690|FG000|Overall Study|Adverse Event|1|||
24930554|NCT00385762|50023690|FG000|Overall Study|Lost to Follow-up|1|||
25155689|NCT01506609|50271106|FG005|Overall Study|Lost to Follow-up|0|||
25155690|NCT01506609|50271101|FG000|Overall Study|Sponsor Discontinued Study|0|||
25155691|NCT01506609|50271102|FG001|Overall Study|Sponsor Discontinued Study|0|||
25155692|NCT01506609|50271103|FG002|Overall Study|Sponsor Discontinued Study|0|||
25155693|NCT01506609|50271104|FG003|Overall Study|Sponsor Discontinued Study|2|||
25155694|NCT01506609|50271105|FG004|Overall Study|Sponsor Discontinued Study|2|||
25155695|NCT01506609|50271106|FG005|Overall Study|Sponsor Discontinued Study|0|||
25155696|NCT01506609|50271101|FG000|Overall Study|Progressive Disease per Protocol|1|||
25155697|NCT01506609|50271102|FG001|Overall Study|Progressive Disease per Protocol|0|||
24930555|NCT00385684|50023694|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
25026530|NCT02990000|50124541|FG000|Overall Study|Failed to provide data beyond baseline|36|||
25026531|NCT02990000|50124542|FG001|Overall Study|Failed to provide data beyond baseline|34|||
25026532|NCT01068626|50124550|FG000|Overall Study|Adverse Event|3|||
25185676|NCT02648724|50335208|FG004|Overall Study|Protocol Violation|1|||
24930556|NCT00385684|50023695|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
25026533|NCT01068626|50124551|FG001|Overall Study|Adverse Event|0|||
25026534|NCT01068626|50124550|FG000|Overall Study|Withdrawal by Subject|0|||
25155698|NCT01506609|50271103|FG002|Overall Study|Progressive Disease per Protocol|0|||
25155699|NCT01506609|50271104|FG003|Overall Study|Progressive Disease per Protocol|64|||
25155700|NCT01506609|50271105|FG004|Overall Study|Progressive Disease per Protocol|57|||
25155701|NCT01506609|50271106|FG005|Overall Study|Progressive Disease per Protocol|74|||
25155702|NCT01506609|50271101|FG000|Overall Study|Other, Not Specified|0|||
25155703|NCT01506609|50271102|FG001|Overall Study|Other, Not Specified|0|||
25155704|NCT01506609|50271103|FG002|Overall Study|Other, Not Specified|0|||
25155705|NCT01506609|50271104|FG003|Overall Study|Other, Not Specified|10|||
25155706|NCT01506609|50271105|FG004|Overall Study|Other, Not Specified|7|||
25155707|NCT01506609|50271106|FG005|Overall Study|Other, Not Specified|3|||
25155708|NCT01506609|50271101|FG000|Overall Study|Missing / Unknown Reason|1|||
25155709|NCT01506609|50271102|FG001|Overall Study|Missing / Unknown Reason|0|||
25155710|NCT01506609|50271103|FG002|Overall Study|Missing / Unknown Reason|1|||
24930557|NCT00385684|50023694|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
24930558|NCT00385684|50023695|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
24930559|NCT00385684|50023694|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
24930560|NCT00385684|50023695|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
24930561|NCT00661661|50023703|FG000|Overall Study|Adverse Event|99|||
24930562|NCT00661661|50023704|FG001|Overall Study|Adverse Event|24|||
24930563|NCT00661661|50023703|FG000|Overall Study|Lack of Efficacy|3|||
24930564|NCT00661661|50023704|FG001|Overall Study|Lack of Efficacy|2|||
24930565|NCT00661661|50023703|FG000|Overall Study|Lost to Follow-up|0|||
24930566|NCT00661661|50023704|FG001|Overall Study|Lost to Follow-up|1|||
24930567|NCT00661661|50023703|FG000|Overall Study|Withdrawal by Subject|15|||
24930568|NCT00661661|50023704|FG001|Overall Study|Withdrawal by Subject|5|||
24930569|NCT00661661|50023703|FG000|Overall Study|Other|22|||
24930570|NCT00661661|50023704|FG001|Overall Study|Other|7|||
24930571|NCT00661661|50023703|FG000|Overall Study|Not assigned treatment|1|||
24930572|NCT00661661|50023704|FG001|Overall Study|Not assigned treatment|0|||
24930573|NCT00038467|50023714|FG000|Overall Study|Adverse Event|170|||
24930574|NCT00038467|50023715|FG001|Overall Study|Adverse Event|145|||
24930575|NCT00038467|50023714|FG000|Overall Study|Withdrawal by Subject|150|||
24930576|NCT00038467|50023715|FG001|Overall Study|Withdrawal by Subject|107|||
24930577|NCT00038467|50023714|FG000|Overall Study|Protocol Violation|19|||
24930578|NCT00038467|50023715|FG001|Overall Study|Protocol Violation|22|||
24930579|NCT00038467|50023714|FG000|Overall Study|Death|22|||
24930580|NCT00038467|50023715|FG001|Overall Study|Death|16|||
24930581|NCT00038467|50023714|FG000|Overall Study|Lost to Follow-up|15|||
24930582|NCT00038467|50023715|FG001|Overall Study|Lost to Follow-up|10|||
24930583|NCT00038467|50023714|FG000|Overall Study|Recurrence|109|||
24930584|NCT00038467|50023715|FG001|Overall Study|Recurrence|179|||
24930585|NCT00038467|50023714|FG000|Overall Study|Randomized, but not treated|31|||
24930586|NCT00038467|50023715|FG001|Overall Study|Randomized, but not treated|35|||
24930587|NCT00038467|50023714|FG000|Overall Study|Other|26|||
24930588|NCT00038467|50023715|FG001|Overall Study|Other|28|||
24930589|NCT00051025|50023723|FG000|Overall Study|Progressive Disease|1|||
24930590|NCT00051025|50023724|FG001|Overall Study|Progressive Disease|1|||
24930591|NCT00051025|50023723|FG000|Overall Study|Adverse Event|1|||
24930592|NCT00051025|50023724|FG001|Overall Study|Adverse Event|1|||
24930593|NCT00051025|50023723|FG000|Overall Study|Withdrawal by Subject|0|||
24930594|NCT00051025|50023724|FG001|Overall Study|Withdrawal by Subject|1|||
24930595|NCT00051025|50023723|FG000|Overall Study|Death|0|||
25155711|NCT01506609|50271104|FG003|Overall Study|Missing / Unknown Reason|4|||
25155712|NCT01506609|50271105|FG004|Overall Study|Missing / Unknown Reason|4|||
25155713|NCT01506609|50271106|FG005|Overall Study|Missing / Unknown Reason|2|||
25155714|NCT01506453|50271130|FG000|Overall Study|Withdrawal prior to treatment|0|||
25155715|NCT01506453|50271131|FG001|Overall Study|Withdrawal prior to treatment|2|||
25155716|NCT01482429|50271139|FG000|Care Usual|Protocol Violation|0|||
24930596|NCT00051025|50023724|FG001|Overall Study|Death|1|||
24930597|NCT00660179|50023733|FG000|Overall Study|Death|44|||
24930598|NCT00660179|50023734|FG001|Overall Study|Death|47|||
24930599|NCT00660179|50023735|FG002|Overall Study|Death|34|||
24930600|NCT00660179|50023733|FG000|Overall Study|Withdrawal of consent|4|||
24930601|NCT00660179|50023734|FG001|Overall Study|Withdrawal of consent|6|||
24930602|NCT00660179|50023735|FG002|Overall Study|Withdrawal of consent|4|||
24930603|NCT00660179|50023733|FG000|Overall Study|Lost to Follow-up|7|||
24930604|NCT00660179|50023734|FG001|Overall Study|Lost to Follow-up|5|||
24930605|NCT00660179|50023735|FG002|Overall Study|Lost to Follow-up|2|||
25155717|NCT01482429|50271140|FG001|Care Usual|Protocol Violation|172|||
24930606|NCT00660179|50023733|FG000|Overall Study|Administrative reason|0|||
24930607|NCT00660179|50023734|FG001|Overall Study|Administrative reason|0|||
24930608|NCT00660179|50023735|FG002|Overall Study|Administrative reason|1|||
24930609|NCT00660179|50023733|FG000|Overall Study|Incorrect randomization|1|||
24930610|NCT00660179|50023734|FG001|Overall Study|Incorrect randomization|0|||
24930611|NCT00660179|50023735|FG002|Overall Study|Incorrect randomization|0|||
24930612|NCT00050167|50023745|FG000|Overall Study|not eligible not invasive|1|||
24930613|NCT00050167|50023746|FG001|Overall Study|not eligible not invasive|1|||
24930614|NCT00660023|50023752|FG000|Overall Study|Adverse Event|2|||
24930615|NCT00660023|50023752|FG000|Overall Study|Death|8|||
24930616|NCT00660023|50023752|FG000|Overall Study|Blood Transfusion|5|||
24930617|NCT00660023|50023752|FG000|Overall Study|Renal Transplantation|3|||
24930618|NCT00660023|50023752|FG000|Overall Study|Withdrawal by Subject|1|||
24930619|NCT00660023|50023752|FG000|Overall Study|Missed Pregnancy Test|1|||
24930620|NCT00660023|50023752|FG000|Overall Study|Other Screening Failure|9|||
24930621|NCT00062647|50023758|FG000|Overall Study|Death|2|||
24930622|NCT00062647|50023759|FG001|Overall Study|Death|2|||
24930623|NCT00062647|50023758|FG000|Overall Study|Adverse Event|1|||
24930624|NCT00062647|50023759|FG001|Overall Study|Adverse Event|1|||
24930625|NCT00062647|50023758|FG000|Overall Study|Withdrawal by Subject|2|||
24930626|NCT00062647|50023759|FG001|Overall Study|Withdrawal by Subject|1|||
24930627|NCT00062647|50023758|FG000|Overall Study|Protocol Violation|1|||
24930628|NCT00062647|50023759|FG001|Overall Study|Protocol Violation|0|||
24930629|NCT00062647|50023758|FG000|Overall Study|Lost to Follow-up|1|||
24930630|NCT00062647|50023759|FG001|Overall Study|Lost to Follow-up|2|||
25155718|NCT01482429|50271139|FG000|Care Usual|Lost to Follow-up|0|||
25155719|NCT01482429|50271140|FG001|Care Usual|Lost to Follow-up|1|||
24930631|NCT00062647|50023758|FG000|Overall Study|Failed continuation criteria|4|||
24930632|NCT00062647|50023759|FG001|Overall Study|Failed continuation criteria|2|||
24930633|NCT00062647|50023758|FG000|Overall Study|Other|4|||
24930634|NCT00062647|50023759|FG001|Overall Study|Other|4|||
24930635|NCT00062647|50023758|FG000|Overall Study|Never received study treatment|1|||
25155720|NCT01482429|50271139|FG000|Protocol|Protocol Violation|275|||
25155721|NCT01482429|50271140|FG001|Protocol|Protocol Violation|0|||
25155722|NCT01504971|50271146|FG000|Overall Study|Physician Decision|13|||
25155723|NCT01479777|50271154|FG000|Overall Study|Physician Decision|2|||
25155724|NCT01479621|50271164|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
24930636|NCT00062647|50023759|FG001|Overall Study|Never received study treatment|1|||
24930637|NCT00570323|50023767|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
24930638|NCT00570323|50023768|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
24930639|NCT00570323|50023767|FG000|Started Treatment After Randomization|Protocol Violation|1|||
24930640|NCT00570323|50023768|FG001|Started Treatment After Randomization|Protocol Violation|0|||
24930641|NCT00570323|50023767|FG000|Started Treatment After Randomization|Physician Decision|1|||
24930642|NCT00570323|50023768|FG001|Started Treatment After Randomization|Physician Decision|0|||
24930643|NCT00570323|50023767|FG000|Complete Study After Start|Lost to Follow-up|0|||
24930644|NCT00570323|50023768|FG001|Complete Study After Start|Lost to Follow-up|1|||
25155725|NCT01479621|50271165|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
24930645|NCT00570323|50023767|FG000|Complete Study After Start|Withdrawal by Subject|2|||
24930646|NCT00570323|50023768|FG001|Complete Study After Start|Withdrawal by Subject|0|||
24930647|NCT00570323|50023767|FG000|Complete Study After Start|Physician Decision|1|||
24930648|NCT00570323|50023768|FG001|Complete Study After Start|Physician Decision|0|||
24930649|NCT00661505|50023776|FG000|Overall Study|Adverse Event|3|||
24930650|NCT00661505|50023776|FG000|Overall Study|Protocol Violation|14|||
24930651|NCT00661505|50023776|FG000|Overall Study|Withdrawal by Subject|8|||
24930652|NCT00661505|50023776|FG000|Overall Study|Lost to Follow-up|3|||
24930653|NCT00661505|50023776|FG000|Overall Study|Other|2|||
24930654|NCT00662909|50023784|FG000|Overall Study|Adverse Event|17|||
24930655|NCT00662909|50023785|FG001|Overall Study|Adverse Event|18|||
24930656|NCT00662909|50023786|FG002|Overall Study|Adverse Event|19|||
24930657|NCT00662909|50023784|FG000|Overall Study|Lack of Efficacy|9|||
24930658|NCT00662909|50023785|FG001|Overall Study|Lack of Efficacy|1|||
24930659|NCT00662909|50023786|FG002|Overall Study|Lack of Efficacy|5|||
24930660|NCT00662909|50023784|FG000|Overall Study|Withdrawal by Subject|29|||
24930661|NCT00662909|50023785|FG001|Overall Study|Withdrawal by Subject|22|||
24930662|NCT00662909|50023786|FG002|Overall Study|Withdrawal by Subject|16|||
24930663|NCT00662909|50023784|FG000|Overall Study|Lost to Follow-up|2|||
24930664|NCT00662909|50023785|FG001|Overall Study|Lost to Follow-up|9|||
24930665|NCT00662909|50023786|FG002|Overall Study|Lost to Follow-up|3|||
24930666|NCT00662909|50023784|FG000|Overall Study|Protocol Violation|7|||
24930667|NCT00662909|50023785|FG001|Overall Study|Protocol Violation|4|||
25155726|NCT01479621|50271166|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
24930668|NCT00662909|50023786|FG002|Overall Study|Protocol Violation|5|||
24930669|NCT00662909|50023784|FG000|Overall Study|Randomized- never received study drug|1|||
24930670|NCT00662909|50023785|FG001|Overall Study|Randomized- never received study drug|0|||
24930671|NCT00662909|50023786|FG002|Overall Study|Randomized- never received study drug|0|||
24930672|NCT00662909|50023784|FG000|Overall Study|Non-compliance with study procedures|3|||
24930673|NCT00662909|50023785|FG001|Overall Study|Non-compliance with study procedures|3|||
24930674|NCT00662909|50023786|FG002|Overall Study|Non-compliance with study procedures|2|||
24930675|NCT00662909|50023784|FG000|Overall Study|Physician Decision|1|||
25155727|NCT01479621|50271167|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
24930676|NCT00662909|50023785|FG001|Overall Study|Physician Decision|1|||
24930677|NCT00662909|50023786|FG002|Overall Study|Physician Decision|2|||
24930678|NCT00662909|50023784|FG000|Overall Study|Eligibility criterion not met|0|||
24930679|NCT00662909|50023785|FG001|Overall Study|Eligibility criterion not met|1|||
24930680|NCT00662909|50023786|FG002|Overall Study|Eligibility criterion not met|1|||
24930681|NCT00050011|50023796|FG000|Overall Study|Adverse Event|41|||
24930682|NCT00050011|50023797|FG001|Overall Study|Adverse Event|46|||
24930683|NCT00050011|50023796|FG000|Overall Study|Abnormal laboratory value(s)|1|||
24930684|NCT00050011|50023797|FG001|Overall Study|Abnormal laboratory value(s)|1|||
24930685|NCT00050011|50023796|FG000|Overall Study|Abnormal test procedure results|0|||
24930686|NCT00050011|50023797|FG001|Overall Study|Abnormal test procedure results|1|||
24930687|NCT00050011|50023796|FG000|Overall Study|Lack of Efficacy|16|||
24930688|NCT00050011|50023797|FG001|Overall Study|Lack of Efficacy|21|||
24930689|NCT00050011|50023796|FG000|Overall Study|Participant condition no longer required|1|||
24930690|NCT00050011|50023797|FG001|Overall Study|Participant condition no longer required|0|||
24930691|NCT00050011|50023796|FG000|Overall Study|Protocol Violation|4|||
24930692|NCT00050011|50023797|FG001|Overall Study|Protocol Violation|10|||
24930693|NCT00050011|50023796|FG000|Overall Study|Withdrawal by Subject|34|||
24930694|NCT00050011|50023797|FG001|Overall Study|Withdrawal by Subject|26|||
24930695|NCT00050011|50023796|FG000|Overall Study|Lost to Follow-up|7|||
24930696|NCT00050011|50023797|FG001|Overall Study|Lost to Follow-up|9|||
24930697|NCT00050011|50023796|FG000|Overall Study|Administrative problems|10|||
24930698|NCT00050011|50023797|FG001|Overall Study|Administrative problems|6|||
24930699|NCT00050011|50023796|FG000|Overall Study|Death|7|||
24930700|NCT00050011|50023797|FG001|Overall Study|Death|4|||
24930701|NCT00050011|50023796|FG000|Overall Study|Unknown - Reason is missing|0|||
24930702|NCT00050011|50023797|FG001|Overall Study|Unknown - Reason is missing|2|||
24930703|NCT00661427|50023806|FG000|Overall Study|Adverse Event|5|||
24930704|NCT00661427|50023807|FG001|Overall Study|Adverse Event|5|||
24930705|NCT00661427|50023806|FG000|Overall Study|Patient not treated|0|||
24930706|NCT00661427|50023807|FG001|Overall Study|Patient not treated|2|||
25155728|NCT01479621|50271168|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
25155729|NCT01479621|50271169|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
25155730|NCT01479621|50271170|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
25155731|NCT01479621|50271164|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
25155732|NCT01479621|50271165|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
25155733|NCT01479621|50271166|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
25155734|NCT01479621|50271167|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
24930707|NCT00049543|50023815|FG000|Overall Study|still on treatment|2|||
24930708|NCT00049543|50023816|FG001|Overall Study|still on treatment|9|||
24930709|NCT00048997|50023824|FG000|Overall Study|Protocol Violation|7|||
24930710|NCT00048997|50023825|FG001|Overall Study|Protocol Violation|2|||
24930711|NCT00048997|50023824|FG000|Overall Study|Withdrawal by Subject|6|||
24930712|NCT00048997|50023825|FG001|Overall Study|Withdrawal by Subject|1|||
24930713|NCT00035815|50023832|FG000|Overall Study|Withdrawal by Subject|17|||
24930714|NCT00035815|50023833|FG001|Overall Study|Withdrawal by Subject|11|||
24930715|NCT00662831|50023841|FG000|Overall Study|Death|4|||
24930716|NCT00662831|50023842|FG001|Overall Study|Death|1|||
25155735|NCT01479621|50271168|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
25155736|NCT01479621|50271169|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
25155737|NCT01479621|50271170|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
25155738|NCT01479621|50271164|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
25155739|NCT01479621|50271165|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
24930717|NCT00662831|50023841|FG000|Overall Study|Lack of Efficacy|6|||
24930718|NCT00662831|50023842|FG001|Overall Study|Lack of Efficacy|6|||
24930719|NCT00662831|50023841|FG000|Overall Study|Lost to Follow-up|1|||
24930720|NCT00662831|50023842|FG001|Overall Study|Lost to Follow-up|0|||
24930721|NCT00662831|50023841|FG000|Overall Study|Withdrawal by Subject|2|||
24930722|NCT00662831|50023842|FG001|Overall Study|Withdrawal by Subject|1|||
24930723|NCT00662831|50023841|FG000|Overall Study|Other|62|||
24930724|NCT00662831|50023842|FG001|Overall Study|Other|31|||
24930725|NCT00662831|50023841|FG000|Overall Study|Protocol Violation|8|||
24930726|NCT00662831|50023842|FG001|Overall Study|Protocol Violation|4|||
24930727|NCT00662831|50023841|FG000|Overall Study|Adverse Event|23|||
24930728|NCT00662831|50023842|FG001|Overall Study|Adverse Event|16|||
24930729|NCT00662363|50023850|FG000|Overall Study|Withdrawal by Subject|6|||
24930730|NCT00662363|50023851|FG001|Overall Study|Withdrawal by Subject|5|||
24930731|NCT00662363|50023850|FG000|Overall Study|Adverse Event|0|||
24930732|NCT00662363|50023851|FG001|Overall Study|Adverse Event|3|||
24930733|NCT00662363|50023850|FG000|Overall Study|Discharged early from rehab|4|||
25026535|NCT01068626|50124551|FG001|Overall Study|Withdrawal by Subject|2|||
25026536|NCT02921750|50124559|FG000|Overall Study|Adverse Event|1|||
25026537|NCT02921750|50124560|FG001|Overall Study|Adverse Event|2|||
25026538|NCT02921750|50124559|FG000|Overall Study|Withdrawal by Subject|1|||
25026539|NCT02921750|50124560|FG001|Overall Study|Withdrawal by Subject|1|||
25026540|NCT02921750|50124559|FG000|Overall Study|Lost to Follow-up|3|||
25026541|NCT02921750|50124560|FG001|Overall Study|Lost to Follow-up|3|||
25026542|NCT02921750|50124559|FG000|Overall Study|Wound healed|3|||
25026543|NCT02921750|50124560|FG001|Overall Study|Wound healed|3|||
25026544|NCT02921750|50124559|FG000|Overall Study|Serious Adverse Event|1|||
25026545|NCT02921750|50124560|FG001|Overall Study|Serious Adverse Event|2|||
25026546|NCT02920970|50124569|FG000|First Intervention|Protocol Violation|0|||
25026547|NCT02920970|50124570|FG001|First Intervention|Protocol Violation|1|||
25026548|NCT02920970|50124569|FG000|First Intervention|Adverse Event|0|||
24930734|NCT00662363|50023851|FG001|Overall Study|Discharged early from rehab|1|||
24930735|NCT00662363|50023850|FG000|Overall Study|Protocol Violation|1|||
24930736|NCT00662363|50023851|FG001|Overall Study|Protocol Violation|1|||
24930737|NCT00661271|50023861|FG000|Overall Study|Lost to Follow-up|28|||
24930738|NCT00661271|50023862|FG001|Overall Study|Lost to Follow-up|25|||
24930739|NCT00661193|50023870|FG000|Overall Study|Adverse Event|2|||
24930740|NCT00661193|50023871|FG001|Overall Study|Adverse Event|1|||
24930741|NCT00661193|50023870|FG000|Overall Study|Withdrawal by Subject|3|||
24930742|NCT00661193|50023871|FG001|Overall Study|Withdrawal by Subject|1|||
24930743|NCT00661193|50023870|FG000|Overall Study|Progression|27|||
24930744|NCT00661193|50023871|FG001|Overall Study|Progression|24|||
24930745|NCT00661193|50023870|FG000|Overall Study|Not protocol specified|1|||
24930746|NCT00661193|50023871|FG001|Overall Study|Not protocol specified|0|||
24930747|NCT00658541|50023877|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
24930748|NCT00658541|50023878|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
24930749|NCT00658541|50023877|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
24930750|NCT00658541|50023878|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
24930751|NCT00048061|50023888|FG000|Overall Study|Adverse Event|41|||
25026549|NCT02920970|50124570|FG001|First Intervention|Adverse Event|1|||
25026550|NCT02920970|50124569|FG000|Second Intervention|Poor Lens Fit|1|||
25026551|NCT02920970|50124570|FG001|Second Intervention|Poor Lens Fit|0|||
25026552|NCT01068158|50124580|FG000|Overall Study|Withdrawal by Subject|1|||
25026553|NCT01068158|50124581|FG001|Overall Study|Withdrawal by Subject|2|||
25026554|NCT01068158|50124580|FG000|Overall Study|Lost to Follow-up|7|||
25026555|NCT01068158|50124581|FG001|Overall Study|Lost to Follow-up|0|||
25155740|NCT01479621|50271166|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
25155741|NCT01479621|50271167|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
24930752|NCT00048061|50023889|FG001|Overall Study|Adverse Event|32|||
24930753|NCT00048061|50023890|FG002|Overall Study|Adverse Event|44|||
24930754|NCT00048061|50023891|FG003|Overall Study|Adverse Event|37|||
25026556|NCT01068158|50124580|FG000|Overall Study|Protocol Violation|0|||
25026557|NCT01068158|50124581|FG001|Overall Study|Protocol Violation|2|||
25026558|NCT03303079|50124590|FG000|Overall Study|Adverse Event|0|||
25026559|NCT03303079|50124591|FG001|Overall Study|Adverse Event|1|||
24930755|NCT00048061|50023888|FG000|Overall Study|Lost to Follow-up|3|||
24930756|NCT00048061|50023889|FG001|Overall Study|Lost to Follow-up|2|||
24930757|NCT00048061|50023890|FG002|Overall Study|Lost to Follow-up|4|||
24930758|NCT00048061|50023891|FG003|Overall Study|Lost to Follow-up|5|||
24930759|NCT00048061|50023888|FG000|Overall Study|Withdrawal by Subject|20|||
24930760|NCT00048061|50023889|FG001|Overall Study|Withdrawal by Subject|29|||
25026560|NCT03303079|50124592|FG002|Overall Study|Adverse Event|3|||
24930761|NCT00048061|50023890|FG002|Overall Study|Withdrawal by Subject|29|||
24930762|NCT00048061|50023891|FG003|Overall Study|Withdrawal by Subject|32|||
25026561|NCT03303079|50124590|FG000|Overall Study|Protocol Violation|5|||
25026562|NCT03303079|50124591|FG001|Overall Study|Protocol Violation|4|||
25026563|NCT03303079|50124592|FG002|Overall Study|Protocol Violation|7|||
25026564|NCT03303079|50124590|FG000|Overall Study|Withdrawal by Subject|2|||
25026565|NCT03303079|50124591|FG001|Overall Study|Withdrawal by Subject|4|||
25026566|NCT03303079|50124592|FG002|Overall Study|Withdrawal by Subject|2|||
25026567|NCT03303079|50124590|FG000|Overall Study|Other than specified|0|||
25026568|NCT03303079|50124591|FG001|Overall Study|Other than specified|2|||
25026569|NCT03303079|50124592|FG002|Overall Study|Other than specified|0|||
25026570|NCT01067846|50124602|FG000|Overall Study|Lost to Follow-up|17|||
24930763|NCT00048061|50023888|FG000|Overall Study|Did not follow-up|5|||
24930764|NCT00048061|50023889|FG001|Overall Study|Did not follow-up|5|||
24930765|NCT00048061|50023890|FG002|Overall Study|Did not follow-up|4|||
24930766|NCT00048061|50023891|FG003|Overall Study|Did not follow-up|5|||
24930767|NCT00048061|50023888|FG000|Overall Study|Early improvement|6|||
24930768|NCT00048061|50023889|FG001|Overall Study|Early improvement|5|||
24930769|NCT00048061|50023890|FG002|Overall Study|Early improvement|3|||
24930770|NCT00048061|50023891|FG003|Overall Study|Early improvement|0|||
24930771|NCT00656513|50023904|FG000|Overall Study|Protocol Violation|1|||
24930772|NCT00656513|50023905|FG001|Overall Study|Protocol Violation|0|||
24930773|NCT00656513|50023906|FG002|Overall Study|Protocol Violation|2|||
24930774|NCT00656513|50023904|FG000|Overall Study|Withdrawal by Subject|0|||
24930775|NCT00656513|50023905|FG001|Overall Study|Withdrawal by Subject|11|||
24930776|NCT00656513|50023906|FG002|Overall Study|Withdrawal by Subject|4|||
24930777|NCT00656513|50023904|FG000|Overall Study|Death|0|||
24930778|NCT00656513|50023905|FG001|Overall Study|Death|0|||
25026571|NCT01067846|50124603|FG001|Overall Study|Lost to Follow-up|19|||
24930779|NCT00656513|50023906|FG002|Overall Study|Death|1|||
24930780|NCT00656513|50023904|FG000|Overall Study|Missing data|0|||
24930781|NCT00656513|50023905|FG001|Overall Study|Missing data|11|||
24930782|NCT00656513|50023906|FG002|Overall Study|Missing data|9|||
24930783|NCT00656513|50023904|FG000|Overall Study|Incomplete treatment|3|||
24930784|NCT00656513|50023905|FG001|Overall Study|Incomplete treatment|0|||
24930785|NCT00656513|50023906|FG002|Overall Study|Incomplete treatment|0|||
24930786|NCT00656513|50023904|FG000|Overall Study|Treatment completed outside of timeframe|0|||
24930787|NCT00656513|50023905|FG001|Overall Study|Treatment completed outside of timeframe|3|||
24930788|NCT00656513|50023906|FG002|Overall Study|Treatment completed outside of timeframe|1|||
24930789|NCT00656513|50023904|FG000|Overall Study|Missing baseline form|0|||
24930790|NCT00656513|50023905|FG001|Overall Study|Missing baseline form|5|||
24930791|NCT00656513|50023906|FG002|Overall Study|Missing baseline form|5|||
24930792|NCT00655889|50023914|FG000|Overall Study|Inadequate cell growth|1|||
24930793|NCT00655889|50023914|FG000|Overall Study|Protocol Violation|1|||
24930794|NCT00655733|50023920|FG000|Overall Study|Lost to Follow-up|2|||
24930795|NCT00655733|50023921|FG001|Overall Study|Lost to Follow-up|2|||
24930796|NCT00655733|50023920|FG000|Overall Study|Adverse Event|2|||
24930797|NCT00655733|50023921|FG001|Overall Study|Adverse Event|2|||
24930798|NCT00655733|50023920|FG000|Overall Study|Withdrawal by Subject|3|||
24930799|NCT00655733|50023921|FG001|Overall Study|Withdrawal by Subject|3|||
24930800|NCT00655733|50023920|FG000|Overall Study|Physician Decision|0|||
24930801|NCT00655733|50023921|FG001|Overall Study|Physician Decision|1|||
25026572|NCT01067846|50124602|FG000|Overall Study|Withdrawal by Subject|1|||
25026573|NCT01067846|50124603|FG001|Overall Study|Withdrawal by Subject|0|||
25026574|NCT01067846|50124602|FG000|Overall Study|participation in other tx study|1|||
25026575|NCT01067846|50124603|FG001|Overall Study|participation in other tx study|0|||
25026576|NCT03311659|50124609|FG000|Overall Study|Protocol Violation|1|||
25026577|NCT03874234|50124626|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
25026578|NCT03874234|50124627|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
25026579|NCT03874234|50124628|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
25026580|NCT03874234|50124629|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
25026581|NCT03874234|50124630|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
25026582|NCT03874234|50124631|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
25026583|NCT03874234|50124632|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
25026584|NCT03874234|50124633|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
25026585|NCT03874234|50124634|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
25026586|NCT03874234|50124635|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
25026587|NCT03874234|50124636|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
25026588|NCT03874234|50124637|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
24930802|NCT00657371|50023929|FG000|Overall Study|Poor bowel preparation|15|||
24930803|NCT00657371|50023929|FG000|Overall Study|Unable to intubate the cecum|5|||
24930804|NCT00657371|50023929|FG000|Overall Study|Protocol Violation|2|||
24930805|NCT00657371|50023929|FG000|Overall Study|Device- related reasons|13|||
25026589|NCT03874234|50124638|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
25026590|NCT03874234|50124626|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
25026591|NCT03874234|50124627|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
25026592|NCT03874234|50124628|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
25026593|NCT03874234|50124629|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
25026594|NCT03874234|50124630|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
25026595|NCT03874234|50124631|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
25026596|NCT03874234|50124632|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
25026597|NCT03874234|50124633|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
25026598|NCT03874234|50124634|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
25155742|NCT01479621|50271168|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
24930806|NCT00657371|50023929|FG000|Overall Study|Pre-existing medical condition|4|||
24930807|NCT00658775|50023935|FG000|Overall Study|Adverse Event|4|||
24930808|NCT00658775|50023936|FG001|Overall Study|Adverse Event|6|||
24930809|NCT00658775|50023935|FG000|Overall Study|Lost to Follow-up|17|||
24930810|NCT00658775|50023936|FG001|Overall Study|Lost to Follow-up|18|||
24930811|NCT00658775|50023935|FG000|Overall Study|Withdrawal by Subject|6|||
24930812|NCT00658775|50023936|FG001|Overall Study|Withdrawal by Subject|4|||
24930813|NCT00658775|50023935|FG000|Overall Study|Withdrawal of consent|8|||
24930814|NCT00658775|50023936|FG001|Overall Study|Withdrawal of consent|7|||
24930815|NCT00658775|50023935|FG000|Overall Study|Other|7|||
24930816|NCT00658775|50023936|FG001|Overall Study|Other|8|||
24930817|NCT00488631|50023948|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
24930818|NCT00488631|50023949|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
24930819|NCT00488631|50023950|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
24930820|NCT00488631|50023951|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
24930821|NCT00488631|50023952|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
24930822|NCT00488631|50023953|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
24930823|NCT00488631|50023954|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
24930824|NCT00488631|50023955|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
24930825|NCT00488631|50023956|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
24930826|NCT00488631|50023957|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
24930827|NCT00488631|50023948|FG000|Double Blind Period (Week 0-54)|Death|0|||
24930828|NCT00488631|50023949|FG001|Double Blind Period (Week 0-54)|Death|0|||
24930829|NCT00488631|50023950|FG002|Double Blind Period (Week 0-54)|Death|0|||
24930830|NCT00488631|50023951|FG003|Double Blind Period (Week 0-54)|Death|0|||
24930831|NCT00488631|50023952|FG004|Double Blind Period (Week 0-54)|Death|0|||
24930832|NCT00488631|50023953|FG005|Double Blind Period (Week 0-54)|Death|1|||
24930833|NCT00488631|50023954|FG006|Double Blind Period (Week 0-54)|Death|0|||
24930834|NCT00488631|50023955|FG007|Double Blind Period (Week 0-54)|Death|0|||
24930835|NCT00488631|50023956|FG008|Double Blind Period (Week 0-54)|Death|0|||
24930836|NCT00488631|50023957|FG009|Double Blind Period (Week 0-54)|Death|0|||
24930837|NCT00488631|50023948|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
24930838|NCT00488631|50023949|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
24930839|NCT00488631|50023950|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
24930840|NCT00488631|50023951|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
24930841|NCT00488631|50023952|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
24930842|NCT00488631|50023953|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
24930843|NCT00488631|50023954|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
24930844|NCT00488631|50023955|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
24930845|NCT00488631|50023956|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
24930846|NCT00488631|50023957|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
24930847|NCT00488631|50023948|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
24930848|NCT00488631|50023949|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
24930849|NCT00488631|50023950|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
24930850|NCT00488631|50023951|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
24930851|NCT00488631|50023952|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
24930852|NCT00488631|50023953|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
24930853|NCT00488631|50023954|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
24930854|NCT00488631|50023955|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
24930855|NCT00488631|50023956|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
24930856|NCT00488631|50023957|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
24930857|NCT00488631|50023948|FG000|Double Blind Period (Week 0-54)|Other|6|||
24930858|NCT00488631|50023949|FG001|Double Blind Period (Week 0-54)|Other|12|||
24930859|NCT00488631|50023950|FG002|Double Blind Period (Week 0-54)|Other|10|||
24930860|NCT00488631|50023951|FG003|Double Blind Period (Week 0-54)|Other|11|||
24930861|NCT00488631|50023952|FG004|Double Blind Period (Week 0-54)|Other|14|||
24930862|NCT00488631|50023953|FG005|Double Blind Period (Week 0-54)|Other|34|||
24930863|NCT00488631|50023954|FG006|Double Blind Period (Week 0-54)|Other|0|||
24930864|NCT00488631|50023955|FG007|Double Blind Period (Week 0-54)|Other|0|||
24930865|NCT00488631|50023956|FG008|Double Blind Period (Week 0-54)|Other|0|||
25155743|NCT01479621|50271169|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
24930866|NCT00488631|50023957|FG009|Double Blind Period (Week 0-54)|Other|0|||
24930867|NCT00488631|50023948|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
24930868|NCT00488631|50023949|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
24930869|NCT00488631|50023950|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
24930870|NCT00488631|50023951|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
24930871|NCT00488631|50023952|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
24930872|NCT00488631|50023953|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
24930873|NCT00488631|50023954|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
24930874|NCT00488631|50023955|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
24930875|NCT00488631|50023956|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
24930876|NCT00488631|50023957|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
24930877|NCT00488631|50023948|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
24930878|NCT00488631|50023949|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
24930879|NCT00488631|50023950|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
24930880|NCT00488631|50023951|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
24930881|NCT00488631|50023952|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
24930882|NCT00488631|50023953|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
24930883|NCT00488631|50023954|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
24930884|NCT00488631|50023955|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
24930885|NCT00488631|50023956|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
24930886|NCT00488631|50023957|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
24930887|NCT00488631|50023948|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
24930888|NCT00488631|50023949|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
24930889|NCT00488631|50023950|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
24930890|NCT00488631|50023951|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
24930891|NCT00488631|50023952|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
24930892|NCT00488631|50023953|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
24930893|NCT00488631|50023954|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
24930894|NCT00488631|50023955|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
24930895|NCT00488631|50023956|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
24930896|NCT00488631|50023957|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
24930897|NCT00488631|50023948|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
24930898|NCT00488631|50023949|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
24930899|NCT00488631|50023950|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
24930900|NCT00488631|50023951|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
25026599|NCT03874234|50124635|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
25026600|NCT03874234|50124636|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
25026601|NCT03874234|50124637|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
25026602|NCT03874234|50124638|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
25026603|NCT03874234|50124626|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
25026604|NCT03874234|50124627|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
25026605|NCT03874234|50124628|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
25026606|NCT03874234|50124629|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
25026607|NCT03874234|50124630|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
25026608|NCT03874234|50124631|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
25026609|NCT03874234|50124632|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
25026610|NCT03874234|50124633|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
25026611|NCT03874234|50124634|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
24930901|NCT00488631|50023952|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
24930902|NCT00488631|50023953|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
24930903|NCT00488631|50023954|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
24930904|NCT00488631|50023955|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
24930905|NCT00488631|50023956|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
24930906|NCT00488631|50023957|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
24930907|NCT00488631|50023948|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
24930908|NCT00488631|50023949|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
24930909|NCT00488631|50023950|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
24930910|NCT00488631|50023951|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
24930911|NCT00488631|50023952|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
24930912|NCT00488631|50023953|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
24930913|NCT00488631|50023954|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
24930914|NCT00488631|50023955|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
25026612|NCT03874234|50124635|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
25026613|NCT03874234|50124636|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
24930915|NCT00488631|50023956|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
24930916|NCT00488631|50023957|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
24930917|NCT00655499|50023980|FG000|Overall Study|not eligible|4|||
24930918|NCT00654875|50023987|FG000|Overall Study|Adverse Event|5|||
24930919|NCT00654875|50023988|FG001|Overall Study|Adverse Event|5|||
24930920|NCT00654875|50023987|FG000|Overall Study|Withdrawal by Subject|4|||
24930921|NCT00654875|50023988|FG001|Overall Study|Withdrawal by Subject|4|||
24930922|NCT00654875|50023987|FG000|Overall Study|Protocol Violation|3|||
24930923|NCT00654875|50023988|FG001|Overall Study|Protocol Violation|3|||
24930924|NCT00654875|50023987|FG000|Overall Study|Lack of Efficacy|2|||
24930925|NCT00654875|50023988|FG001|Overall Study|Lack of Efficacy|2|||
24930926|NCT00654875|50023987|FG000|Overall Study|Lost to Follow-up|1|||
24930927|NCT00654875|50023988|FG001|Overall Study|Lost to Follow-up|3|||
24930928|NCT00654875|50023987|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
24930929|NCT00654875|50023988|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
24930930|NCT00654875|50023987|FG000|Overall Study|Administrative Problems|1|||
24930931|NCT00654875|50023988|FG001|Overall Study|Administrative Problems|0|||
25026614|NCT03874234|50124637|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
25026615|NCT03874234|50124638|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
25026616|NCT03874234|50124626|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
25026617|NCT03874234|50124627|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
25026618|NCT03874234|50124628|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
25026619|NCT03874234|50124629|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
24930932|NCT00651755|50023994|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
25026620|NCT03874234|50124630|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
25026621|NCT03874234|50124631|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
25026622|NCT03874234|50124632|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
25026623|NCT03874234|50124633|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
24930933|NCT00651755|50023995|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
24930934|NCT00651755|50023994|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
24930935|NCT00651755|50023995|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
24930936|NCT00654641|50024004|FG000|Overall Study|Lost to Follow-up|2|||
24930937|NCT00654641|50024005|FG001|Overall Study|Lost to Follow-up|3|||
24930938|NCT00569777|50024013|FG000|Overall Study|Withdrawal by Subject|4|||
25026624|NCT03874234|50124634|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
25026625|NCT03874234|50124635|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
25026626|NCT03874234|50124636|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
25026627|NCT03874234|50124637|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
25026628|NCT03874234|50124638|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
25026629|NCT03874234|50124626|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
25026630|NCT03874234|50124627|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
25185677|NCT02648724|50335209|FG005|Overall Study|Protocol Violation|0|||
25185678|NCT02648724|50335210|FG006|Overall Study|Protocol Violation|0|||
25185679|NCT02648724|50335204|FG000|Overall Study|Death|0|||
25185680|NCT02648724|50335205|FG001|Overall Study|Death|0|||
25185681|NCT02648724|50335206|FG002|Overall Study|Death|0|||
24930939|NCT00569777|50024014|FG001|Overall Study|Withdrawal by Subject|0|||
24930940|NCT00569777|50024013|FG000|Overall Study|Adverse Event|3|||
24930941|NCT00569777|50024014|FG001|Overall Study|Adverse Event|0|||
24930942|NCT00569777|50024013|FG000|Overall Study|Lost to Follow-up|1|||
24930943|NCT00569777|50024014|FG001|Overall Study|Lost to Follow-up|0|||
25185682|NCT02648724|50335207|FG003|Overall Study|Death|0|||
25185683|NCT02648724|50335208|FG004|Overall Study|Death|0|||
25185684|NCT02648724|50335209|FG005|Overall Study|Death|0|||
25185685|NCT02648724|50335210|FG006|Overall Study|Death|3|||
25185686|NCT02648724|50335204|FG000|Overall Study|Physician Decision|0|||
25185687|NCT02648724|50335205|FG001|Overall Study|Physician Decision|0|||
25185688|NCT02648724|50335206|FG002|Overall Study|Physician Decision|0|||
25275109|NCT01237223|50589113|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
24930944|NCT00569777|50024013|FG000|Overall Study|scheduled eye surgery|0|||
24930945|NCT00569777|50024014|FG001|Overall Study|scheduled eye surgery|1|||
24930946|NCT00569777|50024013|FG000|Overall Study|did not meet exclusion criteria|1|||
24930947|NCT00569777|50024014|FG001|Overall Study|did not meet exclusion criteria|2|||
24930948|NCT00569777|50024013|FG000|Overall Study|pregnant|1|||
24930949|NCT00569777|50024014|FG001|Overall Study|pregnant|0|||
24930950|NCT00569231|50024020|FG000|Overall Study|Study unrelated surgery|1|||
24930951|NCT00569231|50024020|FG000|Overall Study|Airfare expense|2|||
24930952|NCT00569231|50024020|FG000|Overall Study|Withdrawal by Subject|1|||
24930953|NCT00569231|50024020|FG000|Overall Study|Car accident injury|1|||
24930954|NCT00569231|50024020|FG000|Overall Study|Non-compliance|2|||
24930955|NCT00654095|50024024|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
25185689|NCT02648724|50335207|FG003|Overall Study|Physician Decision|0|||
25185690|NCT02648724|50335208|FG004|Overall Study|Physician Decision|1|||
25275110|NCT01236755|50589129|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
24930956|NCT00654095|50024024|FG000|Overall Study|Elevated triglyceride level (2)|1|||
25026631|NCT03874234|50124628|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
25026632|NCT03874234|50124629|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
24930957|NCT00654095|50024024|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
24930958|NCT00654095|50024024|FG000|Overall Study|Adverse Event|11|||
24930959|NCT00654095|50024024|FG000|Overall Study|Withdrawal by Subject|5|||
24930960|NCT00654095|50024024|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
24930961|NCT00654095|50024024|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
24930962|NCT00654095|50024024|FG000|Overall Study|Did not meet inclusion criteria|1|||
24930963|NCT00650585|50024030|FG000|Overall Study|Lost to Follow-up|505|||
24930964|NCT00650585|50024031|FG001|Overall Study|Lost to Follow-up|482|||
24930965|NCT00650585|50024030|FG000|Overall Study|No parental consent|935|||
24930966|NCT00650585|50024031|FG001|Overall Study|No parental consent|866|||
24930967|NCT00650585|50024030|FG000|Overall Study|Excluded/ruled ineligible|357|||
24930968|NCT00650585|50024031|FG001|Overall Study|Excluded/ruled ineligible|129|||
24930969|NCT00653939|50024039|FG000|Overall Study|Adverse Event|1|||
24930970|NCT00653939|50024040|FG001|Overall Study|Adverse Event|3|||
24930971|NCT00653939|50024039|FG000|Overall Study|Withdrawal by Subject|3|||
25026633|NCT03874234|50124630|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
25026634|NCT03874234|50124631|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
25026635|NCT03874234|50124632|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
25026636|NCT03874234|50124633|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
25026637|NCT03874234|50124634|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
25026638|NCT03874234|50124635|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
25026639|NCT03874234|50124636|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
25026640|NCT03874234|50124637|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
25026641|NCT03874234|50124638|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
25026642|NCT03874234|50124626|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
25026643|NCT03874234|50124627|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
25026644|NCT03874234|50124628|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
25155744|NCT01479621|50271170|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
25155745|NCT01479621|50271164|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
24930972|NCT00653939|50024040|FG001|Overall Study|Withdrawal by Subject|3|||
24930973|NCT00653939|50024039|FG000|Overall Study|Physician Decision|4|||
24930974|NCT00653939|50024040|FG001|Overall Study|Physician Decision|0|||
24930975|NCT00653939|50024039|FG000|Overall Study|Disease Progression|2|||
24930976|NCT00653939|50024040|FG001|Overall Study|Disease Progression|3|||
24930977|NCT00653939|50024039|FG000|Overall Study|Other|2|||
24930978|NCT00653939|50024040|FG001|Overall Study|Other|6|||
24930979|NCT00646451|50024048|FG000|Overall Study|Adverse Event|3|||
24930980|NCT00646451|50024049|FG001|Overall Study|Adverse Event|0|||
24930981|NCT00646451|50024048|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
24930982|NCT00646451|50024049|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
24930983|NCT00642707|50024061|FG000|Overall Study|Adverse Event|0|||
24930984|NCT00642707|50024062|FG001|Overall Study|Adverse Event|0|||
24930985|NCT00642707|50024063|FG002|Overall Study|Adverse Event|0|||
24930986|NCT00642707|50024064|FG003|Overall Study|Adverse Event|2|||
24930987|NCT00642707|50024061|FG000|Overall Study|Withdrawal by Subject|1|||
25185691|NCT02648724|50335209|FG005|Overall Study|Physician Decision|0|||
24930988|NCT00642707|50024062|FG001|Overall Study|Withdrawal by Subject|0|||
24930989|NCT00642707|50024063|FG002|Overall Study|Withdrawal by Subject|0|||
24930990|NCT00642707|50024064|FG003|Overall Study|Withdrawal by Subject|0|||
24930991|NCT00568685|50024077|FG000|Overall Study|Adverse Event|2|||
24930992|NCT00568685|50024078|FG001|Overall Study|Adverse Event|3|||
24930993|NCT00568685|50024079|FG002|Overall Study|Adverse Event|3|||
24930994|NCT00568685|50024077|FG000|Overall Study|Withdrawal by Subject|7|||
24930995|NCT00568685|50024078|FG001|Overall Study|Withdrawal by Subject|2|||
24930996|NCT00568685|50024079|FG002|Overall Study|Withdrawal by Subject|2|||
24930997|NCT00568685|50024077|FG000|Overall Study|Protocol Violation|1|||
24930998|NCT00568685|50024078|FG001|Overall Study|Protocol Violation|0|||
24930999|NCT00568685|50024079|FG002|Overall Study|Protocol Violation|0|||
24931000|NCT00061945|50024093|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
24931001|NCT00061945|50024094|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
24931002|NCT00061945|50024093|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
24931003|NCT00061945|50024094|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
24931004|NCT00061945|50024093|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
24931005|NCT00061945|50024094|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
24931006|NCT00061945|50024093|FG000|Course IV: Alemtuzumab|Early exits|6|||
25026645|NCT03874234|50124629|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
25026646|NCT03874234|50124630|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
25026647|NCT03874234|50124631|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
25026648|NCT03874234|50124632|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
25026649|NCT03874234|50124633|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
25026650|NCT03874234|50124634|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
25026651|NCT03874234|50124635|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
25026652|NCT03874234|50124636|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
24931007|NCT00061945|50024094|FG001|Course IV: Alemtuzumab|Early exits|15|||
24931008|NCT00642473|50024105|FG000|Overall Study|Withdrawal by Subject|0|||
24931009|NCT00642473|50024106|FG001|Overall Study|Withdrawal by Subject|5|||
24931010|NCT00642473|50024105|FG000|Overall Study|Progression or death|2|||
24931011|NCT00642473|50024106|FG001|Overall Study|Progression or death|4|||
24931012|NCT00642473|50024105|FG000|Overall Study|Other|2|||
24931013|NCT00642473|50024106|FG001|Overall Study|Other|2|||
24931014|NCT00645671|50024117|FG000|Overall Study|Protocol Violation|1|||
24931015|NCT00645671|50024118|FG001|Overall Study|Protocol Violation|0|||
24931016|NCT00645671|50024117|FG000|Overall Study|Withdrawal by Subject|0|||
24931017|NCT00645671|50024118|FG001|Overall Study|Withdrawal by Subject|4|||
24931018|NCT00645671|50024117|FG000|Overall Study|Adverse Event|0|||
24931019|NCT00645671|50024118|FG001|Overall Study|Adverse Event|1|||
24931020|NCT00645671|50024117|FG000|Overall Study|Physician Decision|0|||
24931021|NCT00645671|50024118|FG001|Overall Study|Physician Decision|1|||
24931022|NCT00366340|50024126|FG000|Infant Series|Protocol Violation|3|||
24931023|NCT00366340|50024127|FG001|Infant Series|Protocol Violation|4|||
24931024|NCT00366340|50024126|FG000|Infant Series|Withdrawal by Subject|3|||
24931025|NCT00366340|50024127|FG001|Infant Series|Withdrawal by Subject|3|||
24931026|NCT00366340|50024126|FG000|Infant Series|Adverse Event|0|||
24931027|NCT00366340|50024127|FG001|Infant Series|Adverse Event|2|||
24931028|NCT00366340|50024126|FG000|Infant Series|Lost to Follow-up|1|||
24931029|NCT00366340|50024127|FG001|Infant Series|Lost to Follow-up|1|||
24931030|NCT00366340|50024126|FG000|Infant Series|Failure to return|1|||
24931031|NCT00366340|50024127|FG001|Infant Series|Failure to return|0|||
25026653|NCT03874234|50124637|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
25026654|NCT03874234|50124638|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
25026655|NCT03874234|50124626|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
25026656|NCT03874234|50124627|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
25026657|NCT03874234|50124628|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
25026658|NCT03874234|50124629|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
25026659|NCT03874234|50124630|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
25026660|NCT03874234|50124631|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
25155746|NCT01479621|50271165|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
25185692|NCT02648724|50335210|FG006|Overall Study|Physician Decision|1|||
25026661|NCT03874234|50124632|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
25026662|NCT03874234|50124633|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
24931032|NCT00366340|50024126|FG000|After the Infant Series|Parent/legal guardian request|1|||
24931033|NCT00366340|50024127|FG001|After the Infant Series|Parent/legal guardian request|1|||
24931034|NCT00366340|50024126|FG000|After the Infant Series|Failed to return|0|||
24931035|NCT00366340|50024127|FG001|After the Infant Series|Failed to return|1|||
24931036|NCT00366340|50024126|FG000|After the Infant Series|Protocol Violation|2|||
24931037|NCT00366340|50024127|FG001|After the Infant Series|Protocol Violation|2|||
24931038|NCT00366340|50024126|FG000|After the Infant Series|Adverse Event|0|||
24931039|NCT00366340|50024127|FG001|After the Infant Series|Adverse Event|1|||
24931040|NCT00366340|50024126|FG000|After the Infant Series|Lost to Follow-up|0|||
24931041|NCT00366340|50024127|FG001|After the Infant Series|Lost to Follow-up|1|||
24931042|NCT00366340|50024126|FG000|Toddler Dose|Failed to return|1|||
24931043|NCT00366340|50024127|FG001|Toddler Dose|Failed to return|0|||
24931044|NCT00366340|50024126|FG000|Toddler Dose|Parent/legal guardian request|0|||
24931045|NCT00366340|50024127|FG001|Toddler Dose|Parent/legal guardian request|1|||
24931046|NCT00061633|50024159|FG000|Overall Study|Adverse Event|1|||
24931047|NCT00061633|50024160|FG001|Overall Study|Adverse Event|2|||
24931048|NCT00061633|50024159|FG000|Overall Study|Withdrawal by Subject|2|||
24931049|NCT00061633|50024160|FG001|Overall Study|Withdrawal by Subject|2|||
24931050|NCT00061633|50024159|FG000|Overall Study|Lost to Follow-up|1|||
24931051|NCT00061633|50024160|FG001|Overall Study|Lost to Follow-up|4|||
24931052|NCT00061633|50024159|FG000|Overall Study|Other|1|||
24931053|NCT00061633|50024160|FG001|Overall Study|Other|1|||
24931054|NCT00061633|50024159|FG000|Overall Study|Never received study treatment|0|||
24931055|NCT00061633|50024160|FG001|Overall Study|Never received study treatment|2|||
24931056|NCT00645593|50024168|FG000|Overall Study|Later found to be ineligible|1|||
25026663|NCT03874234|50124634|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
25026664|NCT03874234|50124635|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
25026665|NCT03874234|50124636|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
25026666|NCT03874234|50124637|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
25026667|NCT03874234|50124638|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
25026668|NCT03874234|50124626|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
25026669|NCT03874234|50124627|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
25026670|NCT03874234|50124628|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
24931057|NCT00645593|50024169|FG001|Overall Study|Later found to be ineligible|0|||
24931058|NCT03832738|50024178|FG000|Overall Study|Withdrawal by Subject|6|||
24931059|NCT03832738|50024179|FG001|Overall Study|Withdrawal by Subject|7|||
24931060|NCT03832738|50024180|FG002|Overall Study|Withdrawal by Subject|16|||
24931061|NCT03832738|50024178|FG000|Overall Study|Physician Decision|0|||
24931062|NCT03832738|50024179|FG001|Overall Study|Physician Decision|1|||
24931063|NCT03832738|50024180|FG002|Overall Study|Physician Decision|2|||
24931064|NCT03832738|50024178|FG000|Overall Study|Adverse Event|2|||
24931065|NCT03832738|50024179|FG001|Overall Study|Adverse Event|3|||
24931066|NCT03832738|50024180|FG002|Overall Study|Adverse Event|1|||
24931067|NCT03832738|50024178|FG000|Overall Study|Pregnancy|0|||
24931068|NCT03832738|50024179|FG001|Overall Study|Pregnancy|1|||
24931069|NCT03832738|50024180|FG002|Overall Study|Pregnancy|0|||
24931070|NCT00046891|50024190|FG000|Overall Study|Cancels|5|||
24931071|NCT00046891|50024191|FG001|Overall Study|Cancels|9|||
24931072|NCT00046891|50024190|FG000|Overall Study|Ineligible|1|||
24931073|NCT00046891|50024191|FG001|Overall Study|Ineligible|1|||
24931074|NCT00046891|50024190|FG000|Overall Study|Withdrawal by Subject|18|||
24931075|NCT00046891|50024191|FG001|Overall Study|Withdrawal by Subject|15|||
24931076|NCT00046891|50024190|FG000|Overall Study|Adverse Event|5|||
24931077|NCT00046891|50024191|FG001|Overall Study|Adverse Event|5|||
24931078|NCT00365794|50024205|FG000|Overall Study|Withdrawal by Subject|2|||
24931079|NCT00383500|50024213|FG000|Overall Study|Withdrawal by Subject|8|||
24931080|NCT00383500|50024214|FG001|Overall Study|Withdrawal by Subject|3|||
24931081|NCT00383500|50024215|FG002|Overall Study|Withdrawal by Subject|0|||
24931082|NCT00383500|50024213|FG000|Overall Study|Lost to Follow-up|0|||
24931083|NCT00383500|50024214|FG001|Overall Study|Lost to Follow-up|0|||
25026671|NCT03874234|50124629|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
25155747|NCT01479621|50271166|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
25155748|NCT01479621|50271167|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
25155749|NCT01479621|50271168|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
25155750|NCT01479621|50271169|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
25155751|NCT01479621|50271170|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
25155752|NCT01479621|50271164|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
25155753|NCT01479621|50271165|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
25155754|NCT01479621|50271166|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
25155755|NCT01479621|50271167|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
25155756|NCT01479621|50271168|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
25155757|NCT01479621|50271169|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
25155758|NCT01479621|50271170|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
25155759|NCT01479621|50271164|FG000|Treatment Period|Adverse Event|0|||
24931084|NCT00383500|50024215|FG002|Overall Study|Lost to Follow-up|2|||
24931085|NCT00365716|50024229|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
24931086|NCT00365716|50024230|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
24931087|NCT00365716|50024231|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
24931088|NCT00365716|50024232|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
24931089|NCT00365716|50024233|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
24931090|NCT00365716|50024234|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
24931091|NCT00365716|50024235|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
24931092|NCT00365716|50024229|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
24931093|NCT00365716|50024230|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
24931094|NCT00365716|50024231|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
24931095|NCT00365716|50024232|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
24931096|NCT00365716|50024233|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
24931097|NCT00365716|50024234|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
24931098|NCT00365716|50024235|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
24931099|NCT00365716|50024229|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
24931100|NCT00365716|50024230|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
24931101|NCT00365716|50024231|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
24931102|NCT00365716|50024232|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
24931103|NCT00365716|50024233|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
24931104|NCT00365716|50024234|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
24931105|NCT00365716|50024235|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
24931106|NCT00365716|50024229|FG000|Base Study (Day 1 to Month 7)|Other|0|||
24931107|NCT00365716|50024230|FG001|Base Study (Day 1 to Month 7)|Other|1|||
24931108|NCT00365716|50024231|FG002|Base Study (Day 1 to Month 7)|Other|0|||
24931109|NCT00365716|50024232|FG003|Base Study (Day 1 to Month 7)|Other|0|||
24931110|NCT00365716|50024233|FG004|Base Study (Day 1 to Month 7)|Other|0|||
24931111|NCT00365716|50024234|FG005|Base Study (Day 1 to Month 7)|Other|0|||
24931112|NCT00365716|50024235|FG006|Base Study (Day 1 to Month 7)|Other|0|||
24931113|NCT00365716|50024229|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
24931114|NCT00365716|50024230|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
24931115|NCT00365716|50024231|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
24931116|NCT00365716|50024232|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
24931117|NCT00365716|50024233|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
24931118|NCT00365716|50024234|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
24931119|NCT00365716|50024235|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
24931120|NCT00365716|50024229|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
24931121|NCT00365716|50024230|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
24931122|NCT00365716|50024231|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
24931123|NCT00365716|50024232|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
25026672|NCT03874234|50124630|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
25026673|NCT03874234|50124631|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
25026674|NCT03874234|50124632|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
25026675|NCT03874234|50124633|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
25026676|NCT03874234|50124634|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
25026677|NCT03874234|50124635|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
25026678|NCT03874234|50124636|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
24931124|NCT00365716|50024233|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
24931125|NCT00365716|50024234|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
24931126|NCT00365716|50024235|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
24931127|NCT00365716|50024229|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
24931128|NCT00365716|50024230|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
24931129|NCT00365716|50024231|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
24931130|NCT00365716|50024232|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
24931131|NCT00365716|50024233|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
24931132|NCT00365716|50024234|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
24931133|NCT00365716|50024235|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
24931134|NCT00365716|50024229|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
24931135|NCT00365716|50024230|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
24931136|NCT00365716|50024231|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
24931137|NCT00365716|50024232|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
24931138|NCT00365716|50024233|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
24931139|NCT00365716|50024234|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
24931140|NCT00365716|50024235|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
24931141|NCT00365716|50024229|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
24931142|NCT00365716|50024230|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
24931143|NCT00365716|50024231|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
24931144|NCT00365716|50024232|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
24931145|NCT00365716|50024233|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
24931146|NCT00365716|50024234|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
24931147|NCT00365716|50024235|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
24931148|NCT00365716|50024229|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
24931149|NCT00365716|50024230|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
24931150|NCT00365716|50024231|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
24931151|NCT00365716|50024232|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
24931152|NCT00365716|50024233|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
24931153|NCT00365716|50024234|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
24931154|NCT00365716|50024235|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
24931155|NCT00365716|50024229|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
25026679|NCT03874234|50124637|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
25026680|NCT03874234|50124638|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
24931156|NCT00365716|50024230|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
24931157|NCT00365716|50024231|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
24931158|NCT00365716|50024232|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
24931159|NCT00365716|50024233|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
24931160|NCT00365716|50024234|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
24931161|NCT00365716|50024235|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
24931162|NCT00365716|50024229|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
24931163|NCT00365716|50024230|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
25026681|NCT02985398|50124674|FG000|Overall Study|Adverse Event|1|||
25026682|NCT02985398|50124674|FG000|Overall Study|Lost to Follow-up|4|||
25026683|NCT02985398|50124674|FG000|Overall Study|Withdrawal by Subject|8|||
25026684|NCT02985398|50124674|FG000|Overall Study|Study Burden|9|||
25026685|NCT03310723|50124680|FG000|Overall Study|Withdrawal by Subject|0|||
25026686|NCT03310723|50124681|FG001|Overall Study|Withdrawal by Subject|1|||
25026687|NCT03310723|50124680|FG000|Overall Study|Protocol Violation|0|||
25026688|NCT03310723|50124681|FG001|Overall Study|Protocol Violation|2|||
25026689|NCT02663674|50124689|FG000|Overall Study|Lost to Follow-up|5|||
25026690|NCT02663674|50124690|FG001|Overall Study|Lost to Follow-up|4|||
25026691|NCT02663674|50124689|FG000|Overall Study|Withdrawal by Subject|1|||
25026692|NCT02663674|50124690|FG001|Overall Study|Withdrawal by Subject|4|||
25026693|NCT02663674|50124689|FG000|Overall Study|Physician Decision|1|||
25026694|NCT02663674|50124690|FG001|Overall Study|Physician Decision|1|||
25026695|NCT02663674|50124689|FG000|Overall Study|Other Event (Health Related)|0|||
25026696|NCT02663674|50124690|FG001|Overall Study|Other Event (Health Related)|1|||
25026697|NCT02908880|50124696|FG000|Overall Study|Lost to Follow-up|4|||
24931164|NCT00365716|50024231|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
24931165|NCT00365716|50024232|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
24931166|NCT00365716|50024233|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
24931167|NCT00365716|50024234|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
24931168|NCT00365716|50024235|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
25026698|NCT02908880|50124696|FG000|Overall Study|Explantation of the device|1|||
25026699|NCT02908880|50124696|FG000|Overall Study|Withdrawal by Subject|17|||
25026700|NCT02908880|50124696|FG000|Overall Study|Death|5|||
24931169|NCT00365716|50024229|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
25026701|NCT03310411|50124700|FG000|Period 1|Adverse Event|0|||
24931170|NCT00365716|50024230|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
24931171|NCT00365716|50024231|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
24931172|NCT00365716|50024232|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
24931173|NCT00365716|50024233|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
24931174|NCT00365716|50024234|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
24931175|NCT00365716|50024235|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
24931176|NCT00365716|50024229|FG000|Extension 1|Lost to Follow-up|0|||
25026702|NCT03310411|50124701|FG001|Period 1|Adverse Event|0|||
25026703|NCT03310411|50124702|FG002|Period 1|Adverse Event|0|||
25026704|NCT03310411|50124703|FG003|Period 1|Adverse Event|1|||
25026705|NCT03301831|50124721|FG000|Overall Study|Lost to Follow-up|5|||
25026706|NCT03301831|50124722|FG001|Overall Study|Lost to Follow-up|3|||
25026707|NCT03301831|50124721|FG000|Overall Study|Protocol Violation|4|||
25026708|NCT03301831|50124722|FG001|Overall Study|Protocol Violation|0|||
25026709|NCT03301831|50124721|FG000|Overall Study|Withdrawal by Subject|11|||
25026710|NCT03301831|50124722|FG001|Overall Study|Withdrawal by Subject|0|||
25026711|NCT02909504|50124728|FG000|Overall Study|Adverse Event|2|||
25026712|NCT02909504|50124728|FG000|Overall Study|Lack of Efficacy|3|||
25155760|NCT01479621|50271165|FG001|Treatment Period|Adverse Event|0|||
25155761|NCT01479621|50271166|FG002|Treatment Period|Adverse Event|0|||
25155762|NCT01479621|50271167|FG003|Treatment Period|Adverse Event|0|||
25155763|NCT01479621|50271168|FG004|Treatment Period|Adverse Event|1|||
25155764|NCT01479621|50271169|FG005|Treatment Period|Adverse Event|2|||
25155765|NCT01479621|50271170|FG006|Treatment Period|Adverse Event|2|||
25155766|NCT01479621|50271164|FG000|Treatment Period|Withdrawal by Subject|0|||
25155767|NCT01479621|50271165|FG001|Treatment Period|Withdrawal by Subject|4|||
25155768|NCT01479621|50271166|FG002|Treatment Period|Withdrawal by Subject|2|||
25155769|NCT01479621|50271167|FG003|Treatment Period|Withdrawal by Subject|2|||
25155770|NCT01479621|50271168|FG004|Treatment Period|Withdrawal by Subject|5|||
25155771|NCT01479621|50271169|FG005|Treatment Period|Withdrawal by Subject|5|||
25155772|NCT01479621|50271170|FG006|Treatment Period|Withdrawal by Subject|1|||
25155773|NCT01479621|50271164|FG000|Treatment Period|Physician Decision|0|||
25026713|NCT02909504|50124728|FG000|Overall Study|Withdrawal by Subject|4|||
25026714|NCT02909504|50124728|FG000|Overall Study|Pregnancy|1|||
25026715|NCT02909504|50124728|FG000|Overall Study|Subject moved|1|||
25026716|NCT02909504|50124728|FG000|Overall Study|Lost to Follow-up|1|||
25026717|NCT02199691|50124737|FG000|Overall Study|Protocol Violation|3|||
25026718|NCT02199691|50124738|FG001|Overall Study|Protocol Violation|3|||
25026719|NCT02199691|50124739|FG002|Overall Study|Protocol Violation|6|||
25026720|NCT02199691|50124740|FG003|Overall Study|Protocol Violation|7|||
25026721|NCT02199691|50124737|FG000|Overall Study|Withdrawal by Subject|5|||
25026722|NCT02199691|50124738|FG001|Overall Study|Withdrawal by Subject|3|||
25026723|NCT02199691|50124739|FG002|Overall Study|Withdrawal by Subject|12|||
25026724|NCT02199691|50124740|FG003|Overall Study|Withdrawal by Subject|13|||
25026725|NCT02199691|50124737|FG000|Overall Study|Lost to Follow-up|2|||
25026726|NCT02199691|50124738|FG001|Overall Study|Lost to Follow-up|1|||
25026727|NCT02199691|50124739|FG002|Overall Study|Lost to Follow-up|9|||
25026728|NCT02199691|50124740|FG003|Overall Study|Lost to Follow-up|10|||
25026729|NCT03299881|50124754|FG000|Overall Study|Study Termination|17|||
25026730|NCT03299881|50124755|FG001|Overall Study|Study Termination|13|||
25026731|NCT03299101|50124761|FG000|Overall Study|Lost to Follow-up|1|||
25026732|NCT03299101|50124761|FG000|Overall Study|Withdrawal by Subject|5|||
25026733|NCT03299101|50124761|FG000|Overall Study|Surgery was changed|3|||
25026734|NCT03299101|50124761|FG000|Overall Study|Not enough time to complete prehab|1|||
25026735|NCT02663128|50124767|FG000|Period 2|Physician Decision|0|||
25026736|NCT02663128|50124768|FG001|Period 2|Physician Decision|0|||
25026737|NCT02663128|50124769|FG002|Period 2|Physician Decision|0|||
25026738|NCT02663128|50124770|FG003|Period 2|Physician Decision|0|||
25026739|NCT02663128|50124771|FG004|Period 2|Physician Decision|1|||
25026740|NCT02663128|50124772|FG005|Period 2|Physician Decision|0|||
25026741|NCT03298867|50124783|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
25026742|NCT03298867|50124784|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
25026743|NCT03298867|50124783|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
24931177|NCT00365716|50024230|FG001|Extension 1|Lost to Follow-up|0|||
24931178|NCT00365716|50024231|FG002|Extension 1|Lost to Follow-up|0|||
24931179|NCT00365716|50024232|FG003|Extension 1|Lost to Follow-up|0|||
25026744|NCT03298867|50124784|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
25026745|NCT03298867|50124783|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
25026746|NCT03298867|50124784|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
25026747|NCT03298867|50124783|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
25026748|NCT03298867|50124784|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
25155774|NCT01479621|50271165|FG001|Treatment Period|Physician Decision|0|||
25155775|NCT01479621|50271166|FG002|Treatment Period|Physician Decision|0|||
24931180|NCT00365716|50024233|FG004|Extension 1|Lost to Follow-up|0|||
24931181|NCT00365716|50024234|FG005|Extension 1|Lost to Follow-up|1|||
24931182|NCT00365716|50024235|FG006|Extension 1|Lost to Follow-up|0|||
24931183|NCT00365716|50024229|FG000|Extension 1|Other|0|||
24931184|NCT00365716|50024230|FG001|Extension 1|Other|0|||
24931185|NCT00365716|50024231|FG002|Extension 1|Other|0|||
25155776|NCT01479621|50271167|FG003|Treatment Period|Physician Decision|0|||
24931186|NCT00365716|50024232|FG003|Extension 1|Other|0|||
24931187|NCT00365716|50024233|FG004|Extension 1|Other|0|||
24931188|NCT00365716|50024234|FG005|Extension 1|Other|9|||
24931189|NCT00365716|50024235|FG006|Extension 1|Other|0|||
24931190|NCT00365716|50024229|FG000|Extension 1|Moved|0|||
24931191|NCT00365716|50024230|FG001|Extension 1|Moved|0|||
24931192|NCT00365716|50024231|FG002|Extension 1|Moved|0|||
25275111|NCT01236755|50589129|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
24931193|NCT00365716|50024232|FG003|Extension 1|Moved|0|||
25155777|NCT01479621|50271168|FG004|Treatment Period|Physician Decision|1|||
25155778|NCT01479621|50271169|FG005|Treatment Period|Physician Decision|1|||
25155779|NCT01479621|50271170|FG006|Treatment Period|Physician Decision|0|||
24931194|NCT00365716|50024233|FG004|Extension 1|Moved|0|||
25155780|NCT01479621|50271164|FG000|Treatment Period|Non-compliance to study drug|0|||
25155781|NCT01479621|50271165|FG001|Treatment Period|Non-compliance to study drug|1|||
25155782|NCT01479621|50271166|FG002|Treatment Period|Non-compliance to study drug|0|||
25155783|NCT01479621|50271167|FG003|Treatment Period|Non-compliance to study drug|0|||
25155784|NCT01479621|50271168|FG004|Treatment Period|Non-compliance to study drug|0|||
25155785|NCT01479621|50271169|FG005|Treatment Period|Non-compliance to study drug|0|||
25155786|NCT01479621|50271170|FG006|Treatment Period|Non-compliance to study drug|1|||
25155787|NCT01479621|50271164|FG000|Treatment Period|Protocol Violation|0|||
25155788|NCT01479621|50271165|FG001|Treatment Period|Protocol Violation|9|||
25155789|NCT01479621|50271166|FG002|Treatment Period|Protocol Violation|6|||
25155790|NCT01479621|50271167|FG003|Treatment Period|Protocol Violation|5|||
25155791|NCT01479621|50271168|FG004|Treatment Period|Protocol Violation|2|||
25155792|NCT01479621|50271169|FG005|Treatment Period|Protocol Violation|10|||
25155793|NCT01479621|50271170|FG006|Treatment Period|Protocol Violation|6|||
25155794|NCT01479621|50271164|FG000|Treatment Period|Pregnancy|0|||
25155795|NCT01479621|50271165|FG001|Treatment Period|Pregnancy|0|||
25155796|NCT01479621|50271166|FG002|Treatment Period|Pregnancy|2|||
25155797|NCT01479621|50271167|FG003|Treatment Period|Pregnancy|0|||
24931195|NCT00365716|50024234|FG005|Extension 1|Moved|4|||
24931196|NCT00365716|50024235|FG006|Extension 1|Moved|0|||
24931197|NCT00365716|50024229|FG000|Extension 1|Withdrawal by Subject|0|||
24931198|NCT00365716|50024230|FG001|Extension 1|Withdrawal by Subject|0|||
24931199|NCT00365716|50024231|FG002|Extension 1|Withdrawal by Subject|0|||
24931200|NCT00365716|50024232|FG003|Extension 1|Withdrawal by Subject|0|||
24931201|NCT00365716|50024233|FG004|Extension 1|Withdrawal by Subject|0|||
24931202|NCT00365716|50024234|FG005|Extension 1|Withdrawal by Subject|3|||
24931203|NCT00365716|50024235|FG006|Extension 1|Withdrawal by Subject|0|||
24931204|NCT00365716|50024229|FG000|Extension 1|Pregnancy|0|||
24931205|NCT00365716|50024230|FG001|Extension 1|Pregnancy|0|||
24931206|NCT00365716|50024231|FG002|Extension 1|Pregnancy|0|||
24931207|NCT00365716|50024232|FG003|Extension 1|Pregnancy|0|||
24931208|NCT00365716|50024233|FG004|Extension 1|Pregnancy|0|||
24931209|NCT00365716|50024234|FG005|Extension 1|Pregnancy|4|||
24931210|NCT00365716|50024235|FG006|Extension 1|Pregnancy|0|||
24931211|NCT00365716|50024229|FG000|Extension 1|Protocol Violation|0|||
24931212|NCT00365716|50024230|FG001|Extension 1|Protocol Violation|0|||
24931213|NCT00365716|50024231|FG002|Extension 1|Protocol Violation|0|||
24931214|NCT00365716|50024232|FG003|Extension 1|Protocol Violation|0|||
24931215|NCT00365716|50024233|FG004|Extension 1|Protocol Violation|0|||
24931216|NCT00365716|50024234|FG005|Extension 1|Protocol Violation|1|||
24931217|NCT00365716|50024235|FG006|Extension 1|Protocol Violation|0|||
24931218|NCT00365716|50024229|FG000|Extension 2|Lost to Follow-up|0|||
24931219|NCT00365716|50024230|FG001|Extension 2|Lost to Follow-up|0|||
24931220|NCT00365716|50024231|FG002|Extension 2|Lost to Follow-up|0|||
25155798|NCT01479621|50271168|FG004|Treatment Period|Pregnancy|0|||
25155799|NCT01479621|50271169|FG005|Treatment Period|Pregnancy|0|||
25155800|NCT01479621|50271170|FG006|Treatment Period|Pregnancy|0|||
24931221|NCT00365716|50024232|FG003|Extension 2|Lost to Follow-up|0|||
24931222|NCT00365716|50024233|FG004|Extension 2|Lost to Follow-up|0|||
24931223|NCT00365716|50024234|FG005|Extension 2|Lost to Follow-up|0|||
24931224|NCT00365716|50024235|FG006|Extension 2|Lost to Follow-up|2|||
25155801|NCT01479621|50271164|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
25155802|NCT01479621|50271165|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
24931225|NCT00365716|50024229|FG000|Extension 2|Other|0|||
24931226|NCT00365716|50024230|FG001|Extension 2|Other|0|||
24931227|NCT00365716|50024231|FG002|Extension 2|Other|0|||
24931228|NCT00365716|50024232|FG003|Extension 2|Other|0|||
24931229|NCT00365716|50024233|FG004|Extension 2|Other|0|||
24931230|NCT00365716|50024234|FG005|Extension 2|Other|0|||
24931231|NCT00365716|50024235|FG006|Extension 2|Other|3|||
24931232|NCT00365716|50024229|FG000|Extension 2|Withdrawal by Subject|0|||
24931233|NCT00365716|50024230|FG001|Extension 2|Withdrawal by Subject|0|||
24931234|NCT00365716|50024231|FG002|Extension 2|Withdrawal by Subject|0|||
24931235|NCT00365716|50024232|FG003|Extension 2|Withdrawal by Subject|0|||
25155803|NCT01479621|50271166|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
25155804|NCT01479621|50271167|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
24931236|NCT00365716|50024233|FG004|Extension 2|Withdrawal by Subject|0|||
24931237|NCT00365716|50024234|FG005|Extension 2|Withdrawal by Subject|0|||
24931238|NCT00365716|50024235|FG006|Extension 2|Withdrawal by Subject|5|||
24931239|NCT00059839|50024251|FG000|Overall Study|Death|1|||
24931240|NCT00059839|50024252|FG001|Overall Study|Death|1|||
24931241|NCT00059839|50024251|FG000|Overall Study|Lack of Efficacy|6|||
24931242|NCT00059839|50024252|FG001|Overall Study|Lack of Efficacy|5|||
24931243|NCT00059839|50024251|FG000|Overall Study|Lost to Follow-up|2|||
24931244|NCT00059839|50024252|FG001|Overall Study|Lost to Follow-up|0|||
24931245|NCT00059839|50024251|FG000|Overall Study|Physician Decision|1|||
24931246|NCT00059839|50024252|FG001|Overall Study|Physician Decision|2|||
24931247|NCT00059839|50024251|FG000|Overall Study|Withdrawal by Subject|1|||
24931248|NCT00059839|50024252|FG001|Overall Study|Withdrawal by Subject|6|||
24931249|NCT00059839|50024251|FG000|Overall Study|Ineligible|1|||
24931250|NCT00059839|50024252|FG001|Overall Study|Ineligible|3|||
24931251|NCT00059215|50024262|FG000|Overall Study|Adverse Event|5|||
24931252|NCT00059215|50024263|FG001|Overall Study|Adverse Event|5|||
24931253|NCT00059215|50024264|FG002|Overall Study|Adverse Event|9|||
24931254|NCT00059215|50024265|FG003|Overall Study|Adverse Event|9|||
24931255|NCT00059215|50024262|FG000|Overall Study|Death|0|||
24931256|NCT00059215|50024263|FG001|Overall Study|Death|0|||
24931257|NCT00059215|50024264|FG002|Overall Study|Death|3|||
24931258|NCT00059215|50024265|FG003|Overall Study|Death|0|||
24931259|NCT00059215|50024262|FG000|Overall Study|Lost to Follow-up|1|||
24931260|NCT00059215|50024263|FG001|Overall Study|Lost to Follow-up|2|||
24931261|NCT00059215|50024264|FG002|Overall Study|Lost to Follow-up|0|||
24931262|NCT00059215|50024265|FG003|Overall Study|Lost to Follow-up|0|||
24931263|NCT00059215|50024262|FG000|Overall Study|Withdrawal by Subject|4|||
24931264|NCT00059215|50024263|FG001|Overall Study|Withdrawal by Subject|4|||
24931265|NCT00059215|50024264|FG002|Overall Study|Withdrawal by Subject|1|||
25155805|NCT01479621|50271168|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
25155806|NCT01479621|50271169|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
25155807|NCT01479621|50271170|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
25155808|NCT01479621|50271164|FG000|Treatment Period|Lost to Follow-up|0|||
25155809|NCT01479621|50271165|FG001|Treatment Period|Lost to Follow-up|0|||
25155810|NCT01479621|50271166|FG002|Treatment Period|Lost to Follow-up|1|||
25155811|NCT01479621|50271167|FG003|Treatment Period|Lost to Follow-up|0|||
24931266|NCT00059215|50024265|FG003|Overall Study|Withdrawal by Subject|3|||
24931267|NCT00059215|50024262|FG000|Overall Study|Protocol Violation|1|||
24931268|NCT00059215|50024263|FG001|Overall Study|Protocol Violation|0|||
24931269|NCT00059215|50024264|FG002|Overall Study|Protocol Violation|1|||
24931270|NCT00059215|50024265|FG003|Overall Study|Protocol Violation|0|||
24931271|NCT00059215|50024262|FG000|Overall Study|Protocol entry criteria not met|1|||
24931272|NCT00059215|50024263|FG001|Overall Study|Protocol entry criteria not met|1|||
24931273|NCT00059215|50024264|FG002|Overall Study|Protocol entry criteria not met|0|||
24931274|NCT00059215|50024265|FG003|Overall Study|Protocol entry criteria not met|2|||
25026749|NCT03298867|50124783|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
25026750|NCT03298867|50124784|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
25026751|NCT03298867|50124783|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
25026752|NCT03298867|50124784|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
25026753|NCT03298867|50124783|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
25026754|NCT03298867|50124784|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
25026755|NCT03298867|50124783|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
25026756|NCT03298867|50124784|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
24931275|NCT00059215|50024262|FG000|Overall Study|Physician Decision|1|||
24931276|NCT00059215|50024263|FG001|Overall Study|Physician Decision|2|||
24931277|NCT00059215|50024264|FG002|Overall Study|Physician Decision|1|||
24931278|NCT00059215|50024265|FG003|Overall Study|Physician Decision|1|||
24931279|NCT00058825|50024276|FG000|Overall Study|Relapse|9|||
24931280|NCT00058825|50024276|FG000|Overall Study|Progressive Disease|5|||
25155812|NCT01479621|50271168|FG004|Treatment Period|Lost to Follow-up|2|||
24931281|NCT00058825|50024276|FG000|Overall Study|Graft Failure|5|||
24931282|NCT00058825|50024276|FG000|Overall Study|Death|3|||
24931283|NCT00364858|50024284|FG000|Overall Study|Adverse Event|1|||
24931284|NCT00364858|50024285|FG001|Overall Study|Adverse Event|5|||
24931285|NCT00364858|50024284|FG000|Overall Study|Withdrawal by Subject|1|||
24931286|NCT00364858|50024285|FG001|Overall Study|Withdrawal by Subject|1|||
24931287|NCT00364858|50024284|FG000|Overall Study|Pregnancy|1|||
24931288|NCT00364858|50024285|FG001|Overall Study|Pregnancy|1|||
24931289|NCT00364858|50024284|FG000|Overall Study|Clinical failure|2|||
24931290|NCT00364858|50024285|FG001|Overall Study|Clinical failure|13|||
24931291|NCT00364858|50024284|FG000|Overall Study|Discontinuation at baseline|1|||
24931292|NCT00364858|50024285|FG001|Overall Study|Discontinuation at baseline|0|||
24931293|NCT00364858|50024284|FG000|Overall Study|Non-compliant|1|||
24931294|NCT00364858|50024285|FG001|Overall Study|Non-compliant|0|||
24931295|NCT00364858|50024284|FG000|Overall Study|Return to Q2 regimen|0|||
24931296|NCT00364858|50024285|FG001|Overall Study|Return to Q2 regimen|1|||
24931297|NCT00364858|50024284|FG000|Overall Study|Clinical baseline issue|0|||
24931298|NCT00364858|50024285|FG001|Overall Study|Clinical baseline issue|1|||
24931299|NCT03803059|50024292|FG000|Overall Study|Protocol Violation|2|||
24931300|NCT03803059|50024292|FG000|Overall Study|Lost to Follow-up|1|||
24931301|NCT00372424|50024297|FG000|Overall Study|Adverse Event|2|||
24931302|NCT00372424|50024297|FG000|Overall Study|Withdrawal by Subject|1|||
24931303|NCT00372424|50024297|FG000|Overall Study|Death|1|||
24931304|NCT00372424|50024297|FG000|Overall Study|Objective Progression or Relapse|14|||
24931305|NCT00372424|50024297|FG000|Overall Study|Other|7|||
24931306|NCT00372424|50024297|FG000|Overall Study|Enrolled, Not Treated|1|||
24931307|NCT00372190|50024303|FG000|Overall Study|Lost to Follow-up|3|||
24931308|NCT00372190|50024304|FG001|Overall Study|Lost to Follow-up|1|||
24931309|NCT00044083|50024314|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
24931310|NCT00044083|50024315|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
24931311|NCT00044083|50024314|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
24931312|NCT00044083|50024315|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
24931313|NCT00044083|50024314|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
24931314|NCT00044083|50024315|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
24931315|NCT00044083|50024314|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
24931316|NCT00044083|50024315|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
24931317|NCT00044083|50024314|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
24931318|NCT00044083|50024315|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
24931319|NCT00044083|50024314|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
24931320|NCT00044083|50024315|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
24931321|NCT00044083|50024314|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
24931322|NCT00044083|50024315|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
24931323|NCT00044083|50024314|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
24931324|NCT00044083|50024315|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
24931325|NCT00044083|50024314|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
24931326|NCT00044083|50024315|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
24931327|NCT00044083|50024314|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
24931328|NCT00044083|50024315|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
24931329|NCT00058123|50024348|FG000|Overall Study|Wrong histology|9|||
24931330|NCT00058123|50024348|FG000|Overall Study|Received >3 prior treatments|1|||
24931331|NCT00022633|50024355|FG000|Overall Study|Adverse Event|11|||
24931332|NCT00022633|50024356|FG001|Overall Study|Adverse Event|1|||
24931333|NCT00022633|50024355|FG000|Overall Study|Refusal unrelated to adverse event|1|||
24931334|NCT00022633|50024356|FG001|Overall Study|Refusal unrelated to adverse event|0|||
24931335|NCT00022633|50024355|FG000|Overall Study|Progression/relapse|9|||
24931336|NCT00022633|50024356|FG001|Overall Study|Progression/relapse|2|||
24931337|NCT00022633|50024355|FG000|Overall Study|Death|4|||
24931338|NCT00022633|50024356|FG001|Overall Study|Death|0|||
24931339|NCT00022633|50024355|FG000|Overall Study|Other - not protocol specified|3|||
24931340|NCT00022633|50024356|FG001|Overall Study|Other - not protocol specified|2|||
24931341|NCT00022633|50024355|FG000|Overall Study|Ineligible|4|||
24931342|NCT00022633|50024356|FG001|Overall Study|Ineligible|0|||
24931343|NCT00021541|50024363|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
24931344|NCT00021541|50024364|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
25155813|NCT01479621|50271169|FG005|Treatment Period|Lost to Follow-up|2|||
25155814|NCT01479621|50271170|FG006|Treatment Period|Lost to Follow-up|1|||
25155815|NCT01479621|50271164|FG000|Treatment Period|Met stopping criteria|0|||
24931345|NCT00021541|50024363|FG000|Period 1-First Treatment|Adverse Event|2|||
24931346|NCT00021541|50024364|FG001|Period 1-First Treatment|Adverse Event|1|||
24931347|NCT00021541|50024363|FG000|Period 1-First Treatment|non-adherence|3|||
24931348|NCT00021541|50024364|FG001|Period 1-First Treatment|non-adherence|0|||
24931349|NCT00021541|50024363|FG000|Period 1-First Treatment|Death|1|||
24931350|NCT00021541|50024364|FG001|Period 1-First Treatment|Death|0|||
24931351|NCT00021541|50024363|FG000|Period 1-First Treatment|Pts that did not progress|2|||
24931352|NCT00021541|50024364|FG001|Period 1-First Treatment|Pts that did not progress|2|||
24931353|NCT00021541|50024363|FG000|Period 1-First Treatment|Ineligible|0|||
24931354|NCT00021541|50024364|FG001|Period 1-First Treatment|Ineligible|2|||
24931355|NCT00021541|50024363|FG000|Period 2-crossover|refused phase B|2|||
24931356|NCT00021541|50024364|FG001|Period 2-crossover|refused phase B|2|||
24931357|NCT00021541|50024363|FG000|Period 2-crossover|Withdrawal by Subject|3|||
24931358|NCT00021541|50024364|FG001|Period 2-crossover|Withdrawal by Subject|4|||
24931359|NCT00021541|50024363|FG000|Period 2-crossover|Adverse Event|2|||
24931360|NCT00021541|50024364|FG001|Period 2-crossover|Adverse Event|2|||
24931361|NCT00021541|50024363|FG000|Period 2-crossover|non-adherence|1|||
24931362|NCT00021541|50024364|FG001|Period 2-crossover|non-adherence|0|||
24931363|NCT00021541|50024363|FG000|Period 2-crossover|Pts that did not progress|2|||
24931364|NCT00021541|50024364|FG001|Period 2-crossover|Pts that did not progress|3|||
24931365|NCT00021229|50024375|FG000|Overall Study|Adverse Event|10|||
24931366|NCT00021229|50024376|FG001|Overall Study|Adverse Event|5|||
24931367|NCT00021229|50024377|FG002|Overall Study|Adverse Event|2|||
24931368|NCT00021229|50024375|FG000|Overall Study|Death|0|||
24931369|NCT00021229|50024376|FG001|Overall Study|Death|1|||
24931370|NCT00021229|50024377|FG002|Overall Study|Death|0|||
24931371|NCT00021229|50024375|FG000|Overall Study|Withdrawal by Subject|7|||
24931372|NCT00021229|50024376|FG001|Overall Study|Withdrawal by Subject|7|||
24931373|NCT00021229|50024377|FG002|Overall Study|Withdrawal by Subject|1|||
25026757|NCT03298867|50124783|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
25026758|NCT03298867|50124784|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
25026759|NCT02906930|50124794|FG000|Overall Study|Withdrawal by Subject|0|||
25026760|NCT02906930|50124795|FG001|Overall Study|Withdrawal by Subject|5|||
25026761|NCT02906930|50124796|FG002|Overall Study|Withdrawal by Subject|5|||
25026762|NCT02906930|50124797|FG003|Overall Study|Withdrawal by Subject|4|||
25026763|NCT02906930|50124794|FG000|Overall Study|Lost to Follow-up|5|||
25026764|NCT02906930|50124795|FG001|Overall Study|Lost to Follow-up|7|||
25026765|NCT02906930|50124796|FG002|Overall Study|Lost to Follow-up|5|||
25026766|NCT02906930|50124797|FG003|Overall Study|Lost to Follow-up|2|||
25026767|NCT02906930|50124794|FG000|Overall Study|Death|0|||
25026768|NCT02906930|50124795|FG001|Overall Study|Death|0|||
25026769|NCT02906930|50124796|FG002|Overall Study|Death|1|||
25026770|NCT02906930|50124797|FG003|Overall Study|Death|0|||
25026771|NCT02906930|50124794|FG000|Overall Study|Other|1|||
25026772|NCT02906930|50124795|FG001|Overall Study|Other|2|||
25026773|NCT02906930|50124796|FG002|Overall Study|Other|1|||
25026774|NCT02906930|50124797|FG003|Overall Study|Other|2|||
25026775|NCT02983604|50124811|FG000|Overall Study|Enrolled but not Treated|0|||
24931374|NCT00021229|50024375|FG000|Overall Study|Progressive Disease|15|||
24931375|NCT00021229|50024376|FG001|Overall Study|Progressive Disease|19|||
24931376|NCT00021229|50024377|FG002|Overall Study|Progressive Disease|12|||
24931377|NCT00021229|50024375|FG000|Overall Study|Protocol Violation|1|||
24931378|NCT00021229|50024376|FG001|Overall Study|Protocol Violation|1|||
24931379|NCT00021229|50024377|FG002|Overall Study|Protocol Violation|0|||
24931380|NCT00021229|50024375|FG000|Overall Study|Physician Decision|0|||
24931381|NCT00021229|50024376|FG001|Overall Study|Physician Decision|0|||
24931382|NCT00021229|50024377|FG002|Overall Study|Physician Decision|1|||
24931383|NCT00021229|50024375|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
24931384|NCT00021229|50024376|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
24931385|NCT00021229|50024377|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
24931386|NCT00372112|50024391|FG000|Overall Study|Adverse Event|0|||
24931387|NCT00372112|50024392|FG001|Overall Study|Adverse Event|1|||
24931388|NCT00372112|50024393|FG002|Overall Study|Adverse Event|1|||
24931389|NCT00372112|50024394|FG003|Overall Study|Adverse Event|1|||
24931390|NCT00372112|50024391|FG000|Overall Study|Withdrawal by Subject|0|||
24931391|NCT00372112|50024392|FG001|Overall Study|Withdrawal by Subject|0|||
24931392|NCT00372112|50024393|FG002|Overall Study|Withdrawal by Subject|2|||
24931393|NCT00372112|50024394|FG003|Overall Study|Withdrawal by Subject|1|||
24931394|NCT00372112|50024391|FG000|Overall Study|Exacerbation|0|||
24931395|NCT00372112|50024392|FG001|Overall Study|Exacerbation|0|||
24931396|NCT00372112|50024393|FG002|Overall Study|Exacerbation|0|||
24931397|NCT00372112|50024394|FG003|Overall Study|Exacerbation|1|||
24931398|NCT00372112|50024391|FG000|Overall Study|PR >240 at Visit 3|0|||
25026776|NCT02983604|50124812|FG001|Overall Study|Enrolled but not Treated|0|||
25026777|NCT02983604|50124813|FG002|Overall Study|Enrolled but not Treated|1|||
25185693|NCT02648724|50335204|FG000|Overall Study|Transferred to named patient program|0|||
25026778|NCT02983604|50124814|FG003|Overall Study|Enrolled but not Treated|0|||
25026779|NCT02662582|50124826|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
24931399|NCT00372112|50024392|FG001|Overall Study|PR >240 at Visit 3|0|||
24931400|NCT00372112|50024393|FG002|Overall Study|PR >240 at Visit 3|0|||
24931401|NCT00372112|50024394|FG003|Overall Study|PR >240 at Visit 3|1|||
24931402|NCT00372112|50024391|FG000|Overall Study|Hepatitis B|1|||
24931403|NCT00372112|50024392|FG001|Overall Study|Hepatitis B|0|||
24931404|NCT00372112|50024393|FG002|Overall Study|Hepatitis B|0|||
24931405|NCT00372112|50024394|FG003|Overall Study|Hepatitis B|0|||
24931406|NCT00372112|50024391|FG000|Overall Study|Other-protocol violation|0|||
24931407|NCT00372112|50024392|FG001|Overall Study|Other-protocol violation|0|||
24931408|NCT00372112|50024393|FG002|Overall Study|Other-protocol violation|1|||
24931409|NCT00372112|50024394|FG003|Overall Study|Other-protocol violation|0|||
24931410|NCT00488475|50024407|FG000|Overall Study|Other|1754|||
24931411|NCT00042991|50024418|FG000|Overall Study|Adverse Event|1|||
24931412|NCT00042991|50024419|FG001|Overall Study|Adverse Event|4|||
24931413|NCT00042991|50024420|FG002|Overall Study|Adverse Event|2|||
24931414|NCT00042991|50024421|FG003|Overall Study|Adverse Event|0|||
24931415|NCT00042991|50024422|FG004|Overall Study|Adverse Event|0|||
24931416|NCT00042991|50024423|FG005|Overall Study|Adverse Event|1|||
24931417|NCT00042991|50024424|FG006|Overall Study|Adverse Event|0|||
24931418|NCT00042991|50024418|FG000|Overall Study|Withdrawal by Subject|0|||
24931419|NCT00042991|50024419|FG001|Overall Study|Withdrawal by Subject|7|||
24931420|NCT00042991|50024420|FG002|Overall Study|Withdrawal by Subject|2|||
24931421|NCT00042991|50024421|FG003|Overall Study|Withdrawal by Subject|0|||
24931422|NCT00042991|50024422|FG004|Overall Study|Withdrawal by Subject|1|||
24931423|NCT00042991|50024423|FG005|Overall Study|Withdrawal by Subject|0|||
24931424|NCT00042991|50024424|FG006|Overall Study|Withdrawal by Subject|0|||
24931425|NCT00042991|50024418|FG000|Overall Study|Disease Progression|5|||
24931426|NCT00042991|50024419|FG001|Overall Study|Disease Progression|29|||
24931427|NCT00042991|50024420|FG002|Overall Study|Disease Progression|2|||
24931428|NCT00042991|50024421|FG003|Overall Study|Disease Progression|2|||
24931429|NCT00042991|50024422|FG004|Overall Study|Disease Progression|1|||
24931430|NCT00042991|50024423|FG005|Overall Study|Disease Progression|4|||
24931431|NCT00042991|50024424|FG006|Overall Study|Disease Progression|2|||
24931432|NCT00042991|50024418|FG000|Overall Study|Alternative Therapy|0|||
24931433|NCT00042991|50024419|FG001|Overall Study|Alternative Therapy|0|||
24931434|NCT00042991|50024420|FG002|Overall Study|Alternative Therapy|0|||
24931435|NCT00042991|50024421|FG003|Overall Study|Alternative Therapy|0|||
24931436|NCT00042991|50024422|FG004|Overall Study|Alternative Therapy|1|||
24931437|NCT00042991|50024423|FG005|Overall Study|Alternative Therapy|0|||
24931438|NCT00042991|50024424|FG006|Overall Study|Alternative Therapy|0|||
24931439|NCT00466167|50024445|FG000|Overall Study|Adverse Event|8|||
24931440|NCT00466167|50024446|FG001|Overall Study|Adverse Event|8|||
24931441|NCT00466167|50024447|FG002|Overall Study|Adverse Event|7|||
24931442|NCT00466167|50024445|FG000|Overall Study|Lack of Efficacy|2|||
25026780|NCT02662582|50124827|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
25026781|NCT02662582|50124826|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
25026782|NCT02662582|50124827|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
25026783|NCT02662582|50124826|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
25026784|NCT02662582|50124827|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
25026785|NCT02662582|50124826|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
25026786|NCT02662582|50124827|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
24931443|NCT00466167|50024446|FG001|Overall Study|Lack of Efficacy|0|||
24931444|NCT00466167|50024447|FG002|Overall Study|Lack of Efficacy|3|||
24931445|NCT00466167|50024445|FG000|Overall Study|Protocol Violation|1|||
24931446|NCT00466167|50024446|FG001|Overall Study|Protocol Violation|1|||
24931447|NCT00466167|50024447|FG002|Overall Study|Protocol Violation|2|||
24931448|NCT00466167|50024445|FG000|Overall Study|Lost to Follow-up|3|||
24931449|NCT00466167|50024446|FG001|Overall Study|Lost to Follow-up|2|||
24931450|NCT00466167|50024447|FG002|Overall Study|Lost to Follow-up|2|||
24931451|NCT00466167|50024445|FG000|Overall Study|Withdrawal by Subject|4|||
24931452|NCT00466167|50024446|FG001|Overall Study|Withdrawal by Subject|1|||
24931453|NCT00466167|50024447|FG002|Overall Study|Withdrawal by Subject|6|||
24931454|NCT00466167|50024445|FG000|Overall Study|patient did not meet inclusion criteria|1|||
24931455|NCT00466167|50024446|FG001|Overall Study|patient did not meet inclusion criteria|0|||
24931456|NCT00466167|50024447|FG002|Overall Study|patient did not meet inclusion criteria|1|||
24931457|NCT00466167|50024445|FG000|Overall Study|Not treated|1|||
25026787|NCT02908100|50124837|FG000|Overall Study|Adverse Event|7|||
25026788|NCT02908100|50124838|FG001|Overall Study|Adverse Event|6|||
24931458|NCT00466167|50024446|FG001|Overall Study|Not treated|0|||
24931459|NCT00466167|50024447|FG002|Overall Study|Not treated|0|||
24931460|NCT00480441|50024457|FG000|Screening|Not Eligible|37|||
24931461|NCT00480441|50024458|FG001|Screening|Not Eligible|0|||
24931462|NCT00480441|50024459|FG002|Screening|Not Eligible|0|||
24931463|NCT00480441|50024457|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
24931464|NCT00480441|50024458|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
24931465|NCT00480441|50024459|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
24931466|NCT00480441|50024457|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
24931467|NCT00480441|50024458|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
24931468|NCT00480441|50024459|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
24931469|NCT00480441|50024457|FG000|Baseline Functional MRI|physical contraindication|4|||
24931470|NCT00480441|50024458|FG001|Baseline Functional MRI|physical contraindication|0|||
24931471|NCT00480441|50024459|FG002|Baseline Functional MRI|physical contraindication|0|||
24931472|NCT00480441|50024457|FG000|Randomization|Lost to Follow-up|0|||
24931473|NCT00480441|50024458|FG001|Randomization|Lost to Follow-up|7|||
24931474|NCT00480441|50024459|FG002|Randomization|Lost to Follow-up|2|||
24931475|NCT00488319|50024469|FG000|Overall Study|Adverse Event|1|||
24931476|NCT00488319|50024470|FG001|Overall Study|Adverse Event|2|||
24931477|NCT00488319|50024471|FG002|Overall Study|Adverse Event|23|||
24931478|NCT00488319|50024469|FG000|Overall Study|Lack of Efficacy|6|||
24931479|NCT00488319|50024470|FG001|Overall Study|Lack of Efficacy|12|||
24931480|NCT00488319|50024471|FG002|Overall Study|Lack of Efficacy|27|||
24931481|NCT00488319|50024469|FG000|Overall Study|Lost to Follow-up|3|||
24931482|NCT00488319|50024470|FG001|Overall Study|Lost to Follow-up|5|||
24931483|NCT00488319|50024471|FG002|Overall Study|Lost to Follow-up|16|||
24931484|NCT00488319|50024469|FG000|Overall Study|Withdrawal by Subject|5|||
24931485|NCT00488319|50024470|FG001|Overall Study|Withdrawal by Subject|20|||
24931486|NCT00488319|50024471|FG002|Overall Study|Withdrawal by Subject|44|||
24931487|NCT00488319|50024469|FG000|Overall Study|Other reasons for withdrawal|0|||
24931488|NCT00488319|50024470|FG001|Overall Study|Other reasons for withdrawal|4|||
24931489|NCT00488319|50024471|FG002|Overall Study|Other reasons for withdrawal|12|||
24931490|NCT00463047|50024480|FG000|Titration Period 1|Adverse Event|10|||
24931491|NCT00463047|50024481|FG001|Titration Period 1|Adverse Event|8|||
24931492|NCT00463047|50024480|FG000|Titration Period 1|Lack of Efficacy|10|||
24931493|NCT00463047|50024481|FG001|Titration Period 1|Lack of Efficacy|4|||
24931494|NCT00463047|50024480|FG000|Titration Period 1|Lost to Follow-up|2|||
24931495|NCT00463047|50024481|FG001|Titration Period 1|Lost to Follow-up|0|||
25026789|NCT02908100|50124839|FG002|Overall Study|Adverse Event|9|||
25026790|NCT02908100|50124837|FG000|Overall Study|Death|2|||
25026791|NCT02908100|50124838|FG001|Overall Study|Death|0|||
25026792|NCT02908100|50124839|FG002|Overall Study|Death|0|||
25026793|NCT02908100|50124837|FG000|Overall Study|Lack of Efficacy|2|||
25026794|NCT02908100|50124838|FG001|Overall Study|Lack of Efficacy|3|||
25026795|NCT02908100|50124839|FG002|Overall Study|Lack of Efficacy|3|||
25026796|NCT02908100|50124837|FG000|Overall Study|Lost to Follow-up|0|||
25026797|NCT02908100|50124838|FG001|Overall Study|Lost to Follow-up|1|||
25026798|NCT02908100|50124839|FG002|Overall Study|Lost to Follow-up|2|||
25026799|NCT02908100|50124837|FG000|Overall Study|Non-Compliance With Study Drug|1|||
25026800|NCT02908100|50124838|FG001|Overall Study|Non-Compliance With Study Drug|1|||
25026801|NCT02908100|50124839|FG002|Overall Study|Non-Compliance With Study Drug|2|||
25026802|NCT02908100|50124837|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
25026803|NCT02908100|50124838|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
25026804|NCT02908100|50124839|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
25026805|NCT02908100|50124837|FG000|Overall Study|Physician Decision|0|||
25026806|NCT02908100|50124838|FG001|Overall Study|Physician Decision|1|||
24931496|NCT00463047|50024480|FG000|Titration Period 1|Non-compliance with study medication|3|||
24931497|NCT00463047|50024481|FG001|Titration Period 1|Non-compliance with study medication|5|||
24931498|NCT00463047|50024480|FG000|Titration Period 1|Protocol Violation|5|||
24931499|NCT00463047|50024481|FG001|Titration Period 1|Protocol Violation|5|||
24931500|NCT00463047|50024480|FG000|Titration Period 1|Withdrawal by Subject|3|||
24931501|NCT00463047|50024481|FG001|Titration Period 1|Withdrawal by Subject|5|||
24931502|NCT00463047|50024480|FG000|Titration Period 1|Non-compliance procedures|4|||
25026807|NCT02908100|50124839|FG002|Overall Study|Physician Decision|0|||
24931503|NCT00463047|50024481|FG001|Titration Period 1|Non-compliance procedures|10|||
24931504|NCT00463047|50024480|FG000|Titration Period 1|Other|0|||
25026808|NCT02908100|50124837|FG000|Overall Study|Pregnancy|1|||
25026809|NCT02908100|50124838|FG001|Overall Study|Pregnancy|2|||
25026810|NCT02908100|50124839|FG002|Overall Study|Pregnancy|0|||
25026811|NCT02908100|50124837|FG000|Overall Study|Withdrawal by Subject|8|||
25026812|NCT02908100|50124838|FG001|Overall Study|Withdrawal by Subject|7|||
24931505|NCT00463047|50024481|FG001|Titration Period 1|Other|2|||
24931506|NCT00463047|50024480|FG000|Titration Period 2|Adverse Event|9|||
24931507|NCT00463047|50024481|FG001|Titration Period 2|Adverse Event|9|||
24931508|NCT00463047|50024480|FG000|Titration Period 2|Lack of Efficacy|6|||
25185694|NCT02648724|50335205|FG001|Overall Study|Transferred to named patient program|0|||
25185695|NCT02648724|50335206|FG002|Overall Study|Transferred to named patient program|0|||
25185696|NCT02648724|50335207|FG003|Overall Study|Transferred to named patient program|0|||
25185697|NCT02648724|50335208|FG004|Overall Study|Transferred to named patient program|0|||
25185698|NCT02648724|50335209|FG005|Overall Study|Transferred to named patient program|1|||
25185699|NCT02648724|50335210|FG006|Overall Study|Transferred to named patient program|0|||
25185700|NCT01402817|50335242|FG000|Overall Study|Withdrawal by Subject|3|||
25185701|NCT01402817|50335242|FG000|Overall Study|Study Suspended by FDA|8|||
25185702|NCT01425203|50335249|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
25185703|NCT01425203|50335250|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
25185704|NCT01425203|50335251|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
25026813|NCT02908100|50124839|FG002|Overall Study|Withdrawal by Subject|5|||
25026814|NCT02908100|50124837|FG000|Overall Study|Randomised in Error|1|||
25026815|NCT02908100|50124838|FG001|Overall Study|Randomised in Error|0|||
25026816|NCT02908100|50124839|FG002|Overall Study|Randomised in Error|0|||
25026817|NCT02982590|50124863|FG000|Overall Study|Lost to Follow-up|0|||
25026818|NCT02982590|50124864|FG001|Overall Study|Lost to Follow-up|1|||
25026819|NCT02982590|50124863|FG000|Overall Study|Death|4|||
25026820|NCT02982590|50124864|FG001|Overall Study|Death|0|||
25185705|NCT01425203|50335249|FG000|Treatment Phase|Failure at futility timepoint|8|||
25185706|NCT01425203|50335250|FG001|Treatment Phase|Failure at futility timepoint|27|||
25185707|NCT01425203|50335251|FG002|Treatment Phase|Failure at futility timepoint|0|||
24931509|NCT00463047|50024481|FG001|Titration Period 2|Lack of Efficacy|4|||
24931510|NCT00463047|50024480|FG000|Titration Period 2|Withdrawal by Subject|1|||
24931511|NCT00463047|50024481|FG001|Titration Period 2|Withdrawal by Subject|0|||
24931512|NCT00463047|50024480|FG000|Titration Period 2|Protocol Violation|2|||
24931513|NCT00463047|50024481|FG001|Titration Period 2|Protocol Violation|3|||
24931514|NCT00463047|50024480|FG000|Titration Period 2|Lost to Follow-up|1|||
24931515|NCT00463047|50024481|FG001|Titration Period 2|Lost to Follow-up|2|||
24931516|NCT00463047|50024480|FG000|Titration Period 2|Non-compliance study medication|4|||
24931517|NCT00463047|50024481|FG001|Titration Period 2|Non-compliance study medication|2|||
24931518|NCT00463047|50024480|FG000|Titration Period 2|Non-compliance procedures|4|||
24931519|NCT00463047|50024481|FG001|Titration Period 2|Non-compliance procedures|1|||
24931520|NCT00463047|50024480|FG000|Titration Period 2|Other|3|||
25155816|NCT01479621|50271165|FG001|Treatment Period|Met stopping criteria|8|||
24931521|NCT00463047|50024481|FG001|Titration Period 2|Other|2|||
25026821|NCT03310021|50124890|FG000|Overall Study|Withdrawal by Subject|0|||
25026822|NCT03310021|50124891|FG001|Overall Study|Withdrawal by Subject|0|||
25155817|NCT01479621|50271166|FG002|Treatment Period|Met stopping criteria|7|||
25155818|NCT01479621|50271167|FG003|Treatment Period|Met stopping criteria|4|||
25155819|NCT01479621|50271168|FG004|Treatment Period|Met stopping criteria|9|||
25155820|NCT01479621|50271169|FG005|Treatment Period|Met stopping criteria|20|||
25155821|NCT01479621|50271170|FG006|Treatment Period|Met stopping criteria|6|||
25155822|NCT01479465|50271218|FG000|Overall Study|Disease Progression|9|||
25155823|NCT01479465|50271219|FG001|Overall Study|Disease Progression|61|||
25155824|NCT01479465|50271220|FG002|Overall Study|Disease Progression|65|||
25155825|NCT01479465|50271221|FG003|Overall Study|Disease Progression|70|||
25155826|NCT01479465|50271218|FG000|Overall Study|Study Discontinued by Sponsor|0|||
25155827|NCT01479465|50271219|FG001|Overall Study|Study Discontinued by Sponsor|7|||
25155828|NCT01479465|50271220|FG002|Overall Study|Study Discontinued by Sponsor|5|||
25155829|NCT01479465|50271221|FG003|Overall Study|Study Discontinued by Sponsor|3|||
24931522|NCT00463047|50024480|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
24931523|NCT00463047|50024481|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
24931524|NCT00463047|50024480|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
24931525|NCT00463047|50024481|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
24931526|NCT00463047|50024480|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
24931527|NCT00463047|50024481|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
24931528|NCT00463047|50024480|FG000|Double-Blind Treatment Period 1|Other|1|||
24931529|NCT00463047|50024481|FG001|Double-Blind Treatment Period 1|Other|0|||
24931530|NCT00463047|50024480|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
24931531|NCT00463047|50024481|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
24931532|NCT00463047|50024480|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
24931533|NCT00463047|50024481|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
24931534|NCT00463047|50024480|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
24931535|NCT00463047|50024481|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
24931536|NCT00487695|50024488|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
24931537|NCT00487695|50024489|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
24931538|NCT00487695|50024488|FG000|First Procedure|active wheezing (did not have procedure)|1|||
24931539|NCT00487695|50024489|FG001|First Procedure|active wheezing (did not have procedure)|0|||
24931540|NCT00487695|50024488|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
24931541|NCT00487695|50024489|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
24931542|NCT00487695|50024488|FG000|Second Procedure|active wheezing|0|||
24931543|NCT00487695|50024489|FG001|Second Procedure|active wheezing|1|||
24931544|NCT00487695|50024488|FG000|Second Procedure|Withdrawal by Subject|1|||
24931545|NCT00487695|50024489|FG001|Second Procedure|Withdrawal by Subject|2|||
24931546|NCT00487539|50024499|FG000|Overall Study|Adverse Event|3|||
24931547|NCT00487539|50024500|FG001|Overall Study|Adverse Event|2|||
24931548|NCT00487539|50024501|FG002|Overall Study|Adverse Event|1|||
24931549|NCT00487539|50024502|FG003|Overall Study|Adverse Event|1|||
24931550|NCT00487539|50024499|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
24931551|NCT00487539|50024500|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
25026823|NCT03310021|50124892|FG002|Overall Study|Withdrawal by Subject|0|||
25026824|NCT03310021|50124893|FG003|Overall Study|Withdrawal by Subject|0|||
25026825|NCT03310021|50124894|FG004|Overall Study|Withdrawal by Subject|0|||
25026826|NCT03310021|50124895|FG005|Overall Study|Withdrawal by Subject|0|||
25026827|NCT03310021|50124896|FG006|Overall Study|Withdrawal by Subject|1|||
25155830|NCT01479465|50271218|FG000|Overall Study|Adverse Event|0|||
25155831|NCT01479465|50271219|FG001|Overall Study|Adverse Event|3|||
24931552|NCT00487539|50024501|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
24931553|NCT00487539|50024502|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
24931554|NCT00487539|50024499|FG000|Overall Study|Other|3|||
24931555|NCT00487539|50024500|FG001|Overall Study|Other|1|||
24931556|NCT00487539|50024501|FG002|Overall Study|Other|2|||
24931557|NCT00487539|50024502|FG003|Overall Study|Other|2|||
24931558|NCT00486837|50024513|FG000|Overall Study|Withdrawal by Subject|1|||
24931559|NCT00486837|50024514|FG001|Overall Study|Withdrawal by Subject|0|||
24931560|NCT00486837|50024513|FG000|Overall Study|Adverse Event|1|||
24931561|NCT00486837|50024514|FG001|Overall Study|Adverse Event|1|||
24931562|NCT00486837|50024513|FG000|Overall Study|Protocol Violation|4|||
24931563|NCT00486837|50024514|FG001|Overall Study|Protocol Violation|2|||
24931564|NCT00486837|50024513|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
24931565|NCT00486837|50024514|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
24931566|NCT00486759|50024524|FG000|Treatment|Adverse event/intercurrent illness|86|||
24931567|NCT00486759|50024525|FG001|Treatment|Adverse event/intercurrent illness|39|||
24931568|NCT00486759|50024524|FG000|Treatment|Insufficient therapeutic response|37|||
24931569|NCT00486759|50024525|FG001|Treatment|Insufficient therapeutic response|39|||
24931570|NCT00486759|50024524|FG000|Treatment|Death|17|||
25026828|NCT03310021|50124897|FG007|Overall Study|Withdrawal by Subject|0|||
25026829|NCT03310021|50124898|FG008|Overall Study|Withdrawal by Subject|0|||
24931571|NCT00486759|50024525|FG001|Treatment|Death|10|||
24931572|NCT00486759|50024524|FG000|Treatment|Withdrew consent|15|||
24931573|NCT00486759|50024525|FG001|Treatment|Withdrew consent|12|||
24931574|NCT00486759|50024524|FG000|Treatment|Administrative/reason not specified|17|||
25026830|NCT03310021|50124899|FG009|Overall Study|Withdrawal by Subject|0|||
25026831|NCT03310021|50124900|FG010|Overall Study|Withdrawal by Subject|0|||
25026832|NCT03310021|50124901|FG011|Overall Study|Withdrawal by Subject|0|||
24931575|NCT00486759|50024525|FG001|Treatment|Administrative/reason not specified|21|||
24931576|NCT00486759|50024524|FG000|Treatment|Refused treatment|10|||
24931577|NCT00486759|50024525|FG001|Treatment|Refused treatment|7|||
24931578|NCT00486759|50024524|FG000|Treatment|Violation of selection criteria at entry|3|||
24931579|NCT00486759|50024525|FG001|Treatment|Violation of selection criteria at entry|3|||
24931580|NCT00486759|50024524|FG000|Treatment|Other protocol violation|1|||
24931581|NCT00486759|50024525|FG001|Treatment|Other protocol violation|5|||
24931582|NCT00486759|50024524|FG000|Treatment|Failure to return|1|||
24931583|NCT00486759|50024525|FG001|Treatment|Failure to return|1|||
24931584|NCT00486759|50024524|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
24931585|NCT00486759|50024525|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
24931586|NCT00486759|50024524|FG000|Safety Follow-up|Death|40|||
24931587|NCT00486759|50024525|FG001|Safety Follow-up|Death|29|||
24931588|NCT00486759|50024524|FG000|Safety Follow-up|Withdrew consent|32|||
24931589|NCT00486759|50024525|FG001|Safety Follow-up|Withdrew consent|23|||
24931590|NCT00486759|50024524|FG000|Safety Follow-up|Failure to return|9|||
24931591|NCT00486759|50024525|FG001|Safety Follow-up|Failure to return|6|||
24931592|NCT00486759|50024524|FG000|Safety Follow-up|Administrative/not specified|8|||
24931593|NCT00486759|50024525|FG001|Safety Follow-up|Administrative/not specified|6|||
24931594|NCT00486759|50024524|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
24931595|NCT00486759|50024525|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
24931596|NCT00486759|50024524|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
24931597|NCT00486759|50024525|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
24931598|NCT00486603|50024533|FG000|Overall Study|Withdrawal by Subject|1|||
24931599|NCT00486603|50024534|FG001|Overall Study|Withdrawal by Subject|0|||
24931600|NCT00486603|50024535|FG002|Overall Study|Withdrawal by Subject|0|||
24931601|NCT00486603|50024536|FG003|Overall Study|Withdrawal by Subject|0|||
24931602|NCT00486603|50024537|FG004|Overall Study|Withdrawal by Subject|0|||
24931603|NCT00486603|50024533|FG000|Overall Study|Physician Decision|0|||
24931604|NCT00486603|50024534|FG001|Overall Study|Physician Decision|1|||
25026833|NCT03310021|50124902|FG012|Overall Study|Withdrawal by Subject|0|||
25026834|NCT03310021|50124903|FG013|Overall Study|Withdrawal by Subject|0|||
25026835|NCT03310021|50124904|FG014|Overall Study|Withdrawal by Subject|0|||
25026836|NCT03310021|50124905|FG015|Overall Study|Withdrawal by Subject|0|||
25026837|NCT03310021|50124906|FG016|Overall Study|Withdrawal by Subject|0|||
25026838|NCT03310021|50124907|FG017|Overall Study|Withdrawal by Subject|0|||
25026839|NCT03310021|50124908|FG018|Overall Study|Withdrawal by Subject|0|||
25026840|NCT03310021|50124909|FG019|Overall Study|Withdrawal by Subject|0|||
25026841|NCT03310021|50124890|FG000|Overall Study|Lost to Follow-up|0|||
25026842|NCT03310021|50124891|FG001|Overall Study|Lost to Follow-up|0|||
25026843|NCT03310021|50124892|FG002|Overall Study|Lost to Follow-up|0|||
25026844|NCT03310021|50124893|FG003|Overall Study|Lost to Follow-up|0|||
25026845|NCT03310021|50124894|FG004|Overall Study|Lost to Follow-up|0|||
25026846|NCT03310021|50124895|FG005|Overall Study|Lost to Follow-up|0|||
25026847|NCT03310021|50124896|FG006|Overall Study|Lost to Follow-up|0|||
25026848|NCT03310021|50124897|FG007|Overall Study|Lost to Follow-up|0|||
25026849|NCT03310021|50124898|FG008|Overall Study|Lost to Follow-up|0|||
25026850|NCT03310021|50124899|FG009|Overall Study|Lost to Follow-up|0|||
25026851|NCT03310021|50124900|FG010|Overall Study|Lost to Follow-up|1|||
25026852|NCT03310021|50124901|FG011|Overall Study|Lost to Follow-up|0|||
25026853|NCT03310021|50124902|FG012|Overall Study|Lost to Follow-up|0|||
25026854|NCT03310021|50124903|FG013|Overall Study|Lost to Follow-up|0|||
25026855|NCT03310021|50124904|FG014|Overall Study|Lost to Follow-up|0|||
25026856|NCT03310021|50124905|FG015|Overall Study|Lost to Follow-up|0|||
25026857|NCT03310021|50124906|FG016|Overall Study|Lost to Follow-up|0|||
25026858|NCT03310021|50124907|FG017|Overall Study|Lost to Follow-up|0|||
25026859|NCT03310021|50124908|FG018|Overall Study|Lost to Follow-up|0|||
24931605|NCT00486603|50024535|FG002|Overall Study|Physician Decision|0|||
24931606|NCT00486603|50024536|FG003|Overall Study|Physician Decision|0|||
24931607|NCT00486603|50024537|FG004|Overall Study|Physician Decision|0|||
24931608|NCT00486291|50024554|FG000|Overall Study|Adverse Event|3|||
25026860|NCT03310021|50124909|FG019|Overall Study|Lost to Follow-up|0|||
25026861|NCT03333109|50124954|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
25026862|NCT03333109|50124955|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
25026863|NCT03333109|50124956|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
25026864|NCT03333109|50124954|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
25026865|NCT03333109|50124955|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
25026866|NCT03333109|50124956|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
24931609|NCT00486291|50024555|FG001|Overall Study|Adverse Event|4|||
24931610|NCT00486291|50024554|FG000|Overall Study|Lost to Follow-up|3|||
24931611|NCT00486291|50024555|FG001|Overall Study|Lost to Follow-up|7|||
25026867|NCT03333109|50124954|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
25026868|NCT03333109|50124955|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
25155832|NCT01479465|50271220|FG002|Overall Study|Adverse Event|6|||
24931612|NCT00486291|50024554|FG000|Overall Study|protocol non-compliance|10|||
24931613|NCT00486291|50024555|FG001|Overall Study|protocol non-compliance|15|||
24931614|NCT00486291|50024554|FG000|Overall Study|requirement for restricted medication|0|||
24931615|NCT00486291|50024555|FG001|Overall Study|requirement for restricted medication|3|||
24931616|NCT00474045|50024563|FG000|Overall Study|Adverse Event|18|||
24931617|NCT00474045|50024564|FG001|Overall Study|Adverse Event|8|||
24931618|NCT00474045|50024563|FG000|Overall Study|Unclassified|1|||
24931619|NCT00474045|50024564|FG001|Overall Study|Unclassified|3|||
24931620|NCT00474045|50024563|FG000|Overall Study|Lack of Efficacy|0|||
24931621|NCT00474045|50024564|FG001|Overall Study|Lack of Efficacy|9|||
24931622|NCT00474045|50024563|FG000|Overall Study|Lost to Follow-up|1|||
24931623|NCT00474045|50024564|FG001|Overall Study|Lost to Follow-up|1|||
24931624|NCT00474045|50024563|FG000|Overall Study|Protocol Violation|10|||
24931625|NCT00474045|50024564|FG001|Overall Study|Protocol Violation|12|||
24931626|NCT00474045|50024563|FG000|Overall Study|Withdrawal by Subject|16|||
24931627|NCT00474045|50024564|FG001|Overall Study|Withdrawal by Subject|18|||
24931628|NCT00474045|50024563|FG000|Overall Study|Withdrawal criteria|60|||
24931629|NCT00474045|50024564|FG001|Overall Study|Withdrawal criteria|50|||
24931630|NCT00462501|50024570|FG000|Overall Study|Not treated|3|||
24931631|NCT00462501|50024570|FG000|Overall Study|Adverse Event|2|||
24931632|NCT00383188|50024579|FG000|Overall Study|Adverse Event|4|||
24931633|NCT00383188|50024580|FG001|Overall Study|Adverse Event|7|||
24931634|NCT00383188|50024581|FG002|Overall Study|Adverse Event|9|||
24931635|NCT00383188|50024582|FG003|Overall Study|Adverse Event|8|||
24931636|NCT00383188|50024583|FG004|Overall Study|Adverse Event|8|||
24931637|NCT00383188|50024579|FG000|Overall Study|Lack of Efficacy|9|||
24931638|NCT00383188|50024580|FG001|Overall Study|Lack of Efficacy|3|||
24931639|NCT00383188|50024581|FG002|Overall Study|Lack of Efficacy|3|||
24931640|NCT00383188|50024582|FG003|Overall Study|Lack of Efficacy|2|||
24931641|NCT00383188|50024583|FG004|Overall Study|Lack of Efficacy|6|||
24931642|NCT00383188|50024579|FG000|Overall Study|Other|3|||
24931643|NCT00383188|50024580|FG001|Overall Study|Other|1|||
24931644|NCT00383188|50024581|FG002|Overall Study|Other|0|||
24931645|NCT00383188|50024582|FG003|Overall Study|Other|2|||
24931646|NCT00383188|50024583|FG004|Overall Study|Other|6|||
24931647|NCT00383188|50024579|FG000|Overall Study|No longer willing to participate|1|||
24931648|NCT00383188|50024580|FG001|Overall Study|No longer willing to participate|0|||
24931649|NCT00383188|50024581|FG002|Overall Study|No longer willing to participate|1|||
24931650|NCT00383188|50024582|FG003|Overall Study|No longer willing to participate|0|||
24931651|NCT00383188|50024583|FG004|Overall Study|No longer willing to participate|2|||
24931652|NCT00383188|50024579|FG000|Overall Study|Lost to Follow-up|0|||
24931653|NCT00383188|50024580|FG001|Overall Study|Lost to Follow-up|0|||
24931654|NCT00383188|50024581|FG002|Overall Study|Lost to Follow-up|0|||
24931655|NCT00383188|50024582|FG003|Overall Study|Lost to Follow-up|0|||
24931656|NCT00383188|50024583|FG004|Overall Study|Lost to Follow-up|1|||
24931657|NCT00462345|50024597|FG000|Overall Study|Withdrawal by Subject|2|||
24931658|NCT00462345|50024597|FG000|Overall Study|Did not complete second course|1|||
24931659|NCT00453999|50024604|FG000|Overall Study|Adverse Event|1|||
24931660|NCT00453999|50024605|FG001|Overall Study|Adverse Event|2|||
24931661|NCT00453999|50024606|FG002|Overall Study|Adverse Event|1|||
24931662|NCT00453999|50024604|FG000|Overall Study|Lost to Follow-up|0|||
24931663|NCT00453999|50024605|FG001|Overall Study|Lost to Follow-up|1|||
24931664|NCT00453999|50024606|FG002|Overall Study|Lost to Follow-up|1|||
24931665|NCT00453999|50024604|FG000|Overall Study|Withdrawal by Subject|2|||
24931666|NCT00453999|50024605|FG001|Overall Study|Withdrawal by Subject|1|||
24931667|NCT00453999|50024606|FG002|Overall Study|Withdrawal by Subject|1|||
24931668|NCT00453999|50024604|FG000|Overall Study|Subject Request|2|||
24931669|NCT00453999|50024605|FG001|Overall Study|Subject Request|1|||
24931670|NCT00453999|50024606|FG002|Overall Study|Subject Request|0|||
25026869|NCT03333109|50124956|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
24931671|NCT00453921|50024619|FG000|Overall Study|Withdrawal by Subject|1|||
24931672|NCT00453921|50024620|FG001|Overall Study|Withdrawal by Subject|1|||
24931673|NCT00453921|50024621|FG002|Overall Study|Withdrawal by Subject|1|||
24931674|NCT00453921|50024622|FG003|Overall Study|Withdrawal by Subject|1|||
24931675|NCT00453921|50024619|FG000|Overall Study|Lost to Follow-up|0|||
24931676|NCT00453921|50024620|FG001|Overall Study|Lost to Follow-up|0|||
24931677|NCT00453921|50024621|FG002|Overall Study|Lost to Follow-up|1|||
24931678|NCT00453921|50024622|FG003|Overall Study|Lost to Follow-up|0|||
24931679|NCT00382720|50024639|FG000|Overall Study|Adverse Event|21|||
24931680|NCT00382720|50024640|FG001|Overall Study|Adverse Event|23|||
24931681|NCT00382720|50024641|FG002|Overall Study|Adverse Event|15|||
24931682|NCT00382720|50024639|FG000|Overall Study|Protocol Violation|2|||
25026870|NCT03333109|50124954|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
25026871|NCT03333109|50124955|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
25026872|NCT03333109|50124956|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
24931683|NCT00382720|50024640|FG001|Overall Study|Protocol Violation|5|||
24931684|NCT00382720|50024641|FG002|Overall Study|Protocol Violation|1|||
24931685|NCT00382720|50024639|FG000|Overall Study|Death|0|||
24931686|NCT00382720|50024640|FG001|Overall Study|Death|1|||
24931687|NCT00382720|50024641|FG002|Overall Study|Death|2|||
24931688|NCT00382720|50024639|FG000|Overall Study|Progressive disease|37|||
24931689|NCT00382720|50024640|FG001|Overall Study|Progressive disease|28|||
24931690|NCT00382720|50024641|FG002|Overall Study|Progressive disease|38|||
24931691|NCT00382720|50024639|FG000|Overall Study|Withdrew consent|1|||
24931692|NCT00382720|50024640|FG001|Overall Study|Withdrew consent|1|||
24931693|NCT00382720|50024641|FG002|Overall Study|Withdrew consent|2|||
24931694|NCT00382720|50024639|FG000|Overall Study|Withdrawal by Subject|11|||
24931695|NCT00382720|50024640|FG001|Overall Study|Withdrawal by Subject|20|||
24931696|NCT00382720|50024641|FG002|Overall Study|Withdrawal by Subject|12|||
24931697|NCT00382720|50024639|FG000|Overall Study|Surgery|1|||
24931698|NCT00382720|50024640|FG001|Overall Study|Surgery|1|||
24931699|NCT00382720|50024641|FG002|Overall Study|Surgery|4|||
24931700|NCT00382720|50024639|FG000|Overall Study|Patient did not receive study medication|1|||
24931701|NCT00382720|50024640|FG001|Overall Study|Patient did not receive study medication|1|||
24931702|NCT00382720|50024641|FG002|Overall Study|Patient did not receive study medication|4|||
24931703|NCT00382720|50024639|FG000|Overall Study|Clinically progressive disease|0|||
24931704|NCT00382720|50024640|FG001|Overall Study|Clinically progressive disease|1|||
24931705|NCT00382720|50024641|FG002|Overall Study|Clinically progressive disease|0|||
24931706|NCT00382720|50024639|FG000|Overall Study|Good prognosis|0|||
24931707|NCT00382720|50024640|FG001|Overall Study|Good prognosis|1|||
24931708|NCT00382720|50024641|FG002|Overall Study|Good prognosis|0|||
24931709|NCT00382720|50024639|FG000|Overall Study|Investigator/Clinical decision|5|||
24931710|NCT00382720|50024640|FG001|Overall Study|Investigator/Clinical decision|6|||
24931711|NCT00382720|50024641|FG002|Overall Study|Investigator/Clinical decision|6|||
24931712|NCT00382720|50024639|FG000|Overall Study|Discontinued at end of study|0|||
24931713|NCT00382720|50024640|FG001|Overall Study|Discontinued at end of study|1|||
24931714|NCT00382720|50024641|FG002|Overall Study|Discontinued at end of study|2|||
24931715|NCT00453063|50024651|FG000|Overall Study|Adverse Event|1|||
24931716|NCT00453063|50024652|FG001|Overall Study|Adverse Event|2|||
24931717|NCT00453063|50024651|FG000|Overall Study|Withdrawal by Subject|1|||
24931718|NCT00453063|50024652|FG001|Overall Study|Withdrawal by Subject|1|||
24931719|NCT00453063|50024651|FG000|Overall Study|Protocol Violation|1|||
24931720|NCT00453063|50024652|FG001|Overall Study|Protocol Violation|0|||
24931721|NCT00371566|50024660|FG000|Treatment Phase|Withdrawal by Subject|0|||
24931722|NCT00371566|50024661|FG001|Treatment Phase|Withdrawal by Subject|1|||
25026873|NCT03333109|50124954|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
25026874|NCT03333109|50124955|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
25275112|NCT01236755|50589129|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
24931723|NCT00371566|50024660|FG000|Treatment Phase|Adverse Event|0|||
24931724|NCT00371566|50024661|FG001|Treatment Phase|Adverse Event|1|||
24931725|NCT00371566|50024660|FG000|Treatment Phase|Protocol Violation|0|||
24931726|NCT00371566|50024661|FG001|Treatment Phase|Protocol Violation|1|||
24931727|NCT00371566|50024660|FG000|Chemoradiation Phase|Physician Decision|2|||
24931728|NCT00371566|50024661|FG001|Chemoradiation Phase|Physician Decision|0|||
24931729|NCT00371566|50024660|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
24931730|NCT00371566|50024661|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
24931731|NCT00371566|50024660|FG000|Chemoradiation Phase|Non compliant|0|||
24931732|NCT00371566|50024661|FG001|Chemoradiation Phase|Non compliant|1|||
24931733|NCT00371566|50024660|FG000|Chemoradiation Phase|Progressive Disease|1|||
24931734|NCT00371566|50024661|FG001|Chemoradiation Phase|Progressive Disease|1|||
24931735|NCT00371566|50024660|FG000|Chemoradiation Phase|Death|2|||
24931736|NCT00371566|50024661|FG001|Chemoradiation Phase|Death|0|||
24931737|NCT00371566|50024660|FG000|Follow Up Phase|Death|0|||
24931738|NCT00371566|50024661|FG001|Follow Up Phase|Death|5|||
24931739|NCT00371566|50024660|FG000|Follow Up Phase|Disease progression|1|||
24931740|NCT00371566|50024661|FG001|Follow Up Phase|Disease progression|0|||
25155833|NCT01479465|50271221|FG003|Overall Study|Adverse Event|4|||
24931741|NCT00371566|50024660|FG000|Follow Up Phase|Withdrawal by Subject|0|||
24931742|NCT00371566|50024661|FG001|Follow Up Phase|Withdrawal by Subject|1|||
24931743|NCT00371566|50024660|FG000|Follow Up Phase|Physician Decision|1|||
24931744|NCT00371566|50024661|FG001|Follow Up Phase|Physician Decision|1|||
24931745|NCT00371566|50024660|FG000|Follow Up Phase|Lost to Follow-up|1|||
24931746|NCT00371566|50024661|FG001|Follow Up Phase|Lost to Follow-up|0|||
24931747|NCT00382408|50024669|FG000|Overall Study|Did not meet protocol requirement|3|||
24931748|NCT00382408|50024670|FG001|Overall Study|Did not meet protocol requirement|3|||
24931749|NCT00382408|50024669|FG000|Overall Study|Protocol Violation|2|||
24931750|NCT00382408|50024670|FG001|Overall Study|Protocol Violation|2|||
24931751|NCT00382408|50024669|FG000|Overall Study|Physician Decision|1|||
24931752|NCT00382408|50024670|FG001|Overall Study|Physician Decision|0|||
24931753|NCT00382408|50024669|FG000|Overall Study|Withdrawal by Subject|17|||
24931754|NCT00382408|50024670|FG001|Overall Study|Withdrawal by Subject|6|||
24931755|NCT00382408|50024669|FG000|Overall Study|Pregnancy|2|||
24931756|NCT00382408|50024670|FG001|Overall Study|Pregnancy|0|||
24931757|NCT00382408|50024669|FG000|Overall Study|Lost to Follow-up|19|||
24931758|NCT00382408|50024670|FG001|Overall Study|Lost to Follow-up|8|||
24931759|NCT00382408|50024669|FG000|Overall Study|Other|100|||
24931760|NCT00382408|50024670|FG001|Overall Study|Other|35|||
24931761|NCT00371254|50024678|FG000|Overall Study|Disease progression|13|||
24931762|NCT00371254|50024679|FG001|Overall Study|Disease progression|13|||
24931763|NCT00371254|50024678|FG000|Overall Study|Study drug toxicity|3|||
24931764|NCT00371254|50024679|FG001|Overall Study|Study drug toxicity|5|||
24931765|NCT00371254|50024678|FG000|Overall Study|Subject request|5|||
24931766|NCT00371254|50024679|FG001|Overall Study|Subject request|0|||
24931767|NCT00371254|50024678|FG000|Overall Study|Investigator Decision|2|||
24931768|NCT00371254|50024679|FG001|Overall Study|Investigator Decision|0|||
24931769|NCT00371254|50024678|FG000|Overall Study|Adverse event unrelated to study drug|0|||
24931770|NCT00371254|50024679|FG001|Overall Study|Adverse event unrelated to study drug|1|||
24931771|NCT00371254|50024678|FG000|Overall Study|Lost to Follow-up|0|||
24931772|NCT00371254|50024679|FG001|Overall Study|Lost to Follow-up|1|||
24931773|NCT00371254|50024678|FG000|Overall Study|Withdrawal by Subject|0|||
24931774|NCT00371254|50024679|FG001|Overall Study|Withdrawal by Subject|1|||
24931775|NCT00452673|50024689|FG000|Dose Escalation Period|Disease Progression|6|||
24931776|NCT00452673|50024690|FG001|Dose Escalation Period|Disease Progression|6|||
24931777|NCT00452673|50024691|FG002|Dose Escalation Period|Disease Progression|2|||
24931778|NCT00452673|50024692|FG003|Dose Escalation Period|Disease Progression|6|||
24931779|NCT00452673|50024693|FG004|Dose Escalation Period|Disease Progression|0|||
24931780|NCT00452673|50024689|FG000|Dose Escalation Period|study drug toxicity|1|||
24931781|NCT00452673|50024690|FG001|Dose Escalation Period|study drug toxicity|3|||
24931782|NCT00452673|50024691|FG002|Dose Escalation Period|study drug toxicity|3|||
24931783|NCT00452673|50024692|FG003|Dose Escalation Period|study drug toxicity|1|||
24931784|NCT00452673|50024693|FG004|Dose Escalation Period|study drug toxicity|0|||
24931785|NCT00452673|50024689|FG000|Dose Escalation Period|Other|0|||
24931786|NCT00452673|50024690|FG001|Dose Escalation Period|Other|0|||
24931787|NCT00452673|50024691|FG002|Dose Escalation Period|Other|1|||
24931788|NCT00452673|50024692|FG003|Dose Escalation Period|Other|0|||
24931789|NCT00452673|50024693|FG004|Dose Escalation Period|Other|0|||
24931790|NCT00452673|50024689|FG000|Dose Escalation Period|Adverse Event|0|||
24931791|NCT00452673|50024690|FG001|Dose Escalation Period|Adverse Event|0|||
24931792|NCT00452673|50024691|FG002|Dose Escalation Period|Adverse Event|0|||
24931793|NCT00452673|50024692|FG003|Dose Escalation Period|Adverse Event|1|||
24931794|NCT00452673|50024693|FG004|Dose Escalation Period|Adverse Event|0|||
24931795|NCT00452673|50024689|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
24931796|NCT00452673|50024690|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
24931797|NCT00452673|50024691|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
24931798|NCT00452673|50024692|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
24931799|NCT00452673|50024693|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
24931800|NCT00452673|50024689|FG000|Dose Expansion Period|Disease Progression|0|||
24931801|NCT00452673|50024690|FG001|Dose Expansion Period|Disease Progression|0|||
24931802|NCT00452673|50024691|FG002|Dose Expansion Period|Disease Progression|0|||
24931803|NCT00452673|50024692|FG003|Dose Expansion Period|Disease Progression|0|||
24931804|NCT00452673|50024693|FG004|Dose Expansion Period|Disease Progression|19|||
24931805|NCT00452673|50024689|FG000|Dose Expansion Period|Other|0|||
24931806|NCT00452673|50024690|FG001|Dose Expansion Period|Other|0|||
24931807|NCT00452673|50024691|FG002|Dose Expansion Period|Other|0|||
24931808|NCT00452673|50024692|FG003|Dose Expansion Period|Other|0|||
24931809|NCT00452673|50024693|FG004|Dose Expansion Period|Other|2|||
24931810|NCT00461253|50024706|FG000|Overall Study|Death|985|||
24931811|NCT00461253|50024707|FG001|Overall Study|Death|0|||
24931812|NCT00461253|50024706|FG000|Overall Study|Protocol Violation|613|||
24931813|NCT00461253|50024707|FG001|Overall Study|Protocol Violation|236|||
24931814|NCT00461253|50024706|FG000|Overall Study|no response|2609|||
24931815|NCT00461253|50024707|FG001|Overall Study|no response|11789|||
24931816|NCT00461253|50024706|FG000|Overall Study|administrative|773|||
24931817|NCT00461253|50024707|FG001|Overall Study|administrative|7773|||
24931818|NCT00469833|50024713|FG000|Overall Study|No IV access|2|||
24931819|NCT00382174|50024725|FG000|Overall Study|Lost to Follow-up|1|||
24931820|NCT00382174|50024726|FG001|Overall Study|Lost to Follow-up|4|||
24931821|NCT00382174|50024727|FG002|Overall Study|Lost to Follow-up|5|||
24931822|NCT00382174|50024725|FG000|Overall Study|Adverse Event|1|||
24931823|NCT00382174|50024726|FG001|Overall Study|Adverse Event|4|||
24931824|NCT00382174|50024727|FG002|Overall Study|Adverse Event|5|||
24931825|NCT00382174|50024725|FG000|Overall Study|Withdrawal by Subject|1|||
24931826|NCT00382174|50024726|FG001|Overall Study|Withdrawal by Subject|4|||
24931827|NCT00382174|50024727|FG002|Overall Study|Withdrawal by Subject|5|||
24931828|NCT00382174|50024725|FG000|Overall Study|Non compliance|1|||
24931829|NCT00382174|50024726|FG001|Overall Study|Non compliance|0|||
24931830|NCT00382174|50024727|FG002|Overall Study|Non compliance|1|||
24931831|NCT00382174|50024725|FG000|Overall Study|Physician Decision|0|||
24931832|NCT00382174|50024726|FG001|Overall Study|Physician Decision|2|||
24931833|NCT00382174|50024727|FG002|Overall Study|Physician Decision|2|||
24931834|NCT00382174|50024725|FG000|Overall Study|Failed to meet criteria|0|||
24931835|NCT00382174|50024726|FG001|Overall Study|Failed to meet criteria|1|||
24931836|NCT00382174|50024727|FG002|Overall Study|Failed to meet criteria|1|||
24931837|NCT00382174|50024725|FG000|Overall Study|Wounds merged|0|||
24931838|NCT00382174|50024726|FG001|Overall Study|Wounds merged|2|||
24931839|NCT00382174|50024727|FG002|Overall Study|Wounds merged|2|||
24931840|NCT00641537|50024740|FG000|96-week Period|Adverse Event|0|||
24931841|NCT00641537|50024741|FG001|96-week Period|Adverse Event|1|||
24931842|NCT00641537|50024742|FG002|96-week Period|Adverse Event|3|||
24931843|NCT00641537|50024743|FG003|96-week Period|Adverse Event|0|||
24931844|NCT00641537|50024744|FG004|96-week Period|Adverse Event|2|||
24931845|NCT00641537|50024745|FG005|96-week Period|Adverse Event|0|||
24931846|NCT00641537|50024746|FG006|96-week Period|Adverse Event|0|||
24931847|NCT00641537|50024747|FG007|96-week Period|Adverse Event|0|||
24931848|NCT00641537|50024740|FG000|96-week Period|Lost to Follow-up|3|||
24931849|NCT00641537|50024741|FG001|96-week Period|Lost to Follow-up|1|||
24931850|NCT00641537|50024742|FG002|96-week Period|Lost to Follow-up|2|||
24931851|NCT00641537|50024743|FG003|96-week Period|Lost to Follow-up|2|||
24931852|NCT00641537|50024744|FG004|96-week Period|Lost to Follow-up|4|||
24931853|NCT00641537|50024745|FG005|96-week Period|Lost to Follow-up|0|||
24931854|NCT00641537|50024746|FG006|96-week Period|Lost to Follow-up|1|||
24931855|NCT00641537|50024747|FG007|96-week Period|Lost to Follow-up|0|||
24931856|NCT00641537|50024740|FG000|96-week Period|Protocol Violation|0|||
24931857|NCT00641537|50024741|FG001|96-week Period|Protocol Violation|1|||
24931858|NCT00641537|50024742|FG002|96-week Period|Protocol Violation|0|||
24931859|NCT00641537|50024743|FG003|96-week Period|Protocol Violation|1|||
24931860|NCT00641537|50024744|FG004|96-week Period|Protocol Violation|0|||
24931861|NCT00641537|50024745|FG005|96-week Period|Protocol Violation|1|||
24931862|NCT00641537|50024746|FG006|96-week Period|Protocol Violation|0|||
24931863|NCT00641537|50024747|FG007|96-week Period|Protocol Violation|0|||
24931864|NCT00641537|50024740|FG000|96-week Period|Death|2|||
24931865|NCT00641537|50024741|FG001|96-week Period|Death|0|||
24931866|NCT00641537|50024742|FG002|96-week Period|Death|1|||
24931867|NCT00641537|50024743|FG003|96-week Period|Death|0|||
24931868|NCT00641537|50024744|FG004|96-week Period|Death|0|||
24931869|NCT00641537|50024745|FG005|96-week Period|Death|0|||
24931870|NCT00641537|50024746|FG006|96-week Period|Death|0|||
24931871|NCT00641537|50024747|FG007|96-week Period|Death|0|||
24931872|NCT00641537|50024740|FG000|96-week Period|Other|4|||
24931873|NCT00641537|50024741|FG001|96-week Period|Other|7|||
24931874|NCT00641537|50024742|FG002|96-week Period|Other|14|||
24931875|NCT00641537|50024743|FG003|96-week Period|Other|9|||
24931876|NCT00641537|50024744|FG004|96-week Period|Other|11|||
24931877|NCT00641537|50024745|FG005|96-week Period|Other|6|||
24931878|NCT00641537|50024746|FG006|96-week Period|Other|4|||
24931879|NCT00641537|50024747|FG007|96-week Period|Other|6|||
24931880|NCT00641537|50024740|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
24931881|NCT00641537|50024741|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
24931882|NCT00641537|50024742|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
24931883|NCT00641537|50024743|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
25026875|NCT03333109|50124956|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
25026876|NCT03333109|50124954|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
25155834|NCT01479465|50271218|FG000|Overall Study|Investigator Discretion|1|||
24931884|NCT00641537|50024744|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
24931885|NCT00641537|50024745|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
24931886|NCT00641537|50024746|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
24931887|NCT00641537|50024747|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
24931888|NCT00641537|50024740|FG000|24-Week Supplemental Follow-up Period|Other|0|||
25155835|NCT01479465|50271219|FG001|Overall Study|Investigator Discretion|4|||
25155836|NCT01479465|50271220|FG002|Overall Study|Investigator Discretion|2|||
25155837|NCT01479465|50271221|FG003|Overall Study|Investigator Discretion|4|||
24931889|NCT00641537|50024741|FG001|24-Week Supplemental Follow-up Period|Other|2|||
24931890|NCT00641537|50024742|FG002|24-Week Supplemental Follow-up Period|Other|2|||
24931891|NCT00641537|50024743|FG003|24-Week Supplemental Follow-up Period|Other|1|||
24931892|NCT00641537|50024744|FG004|24-Week Supplemental Follow-up Period|Other|3|||
24931893|NCT00641537|50024745|FG005|24-Week Supplemental Follow-up Period|Other|0|||
24931894|NCT00641537|50024746|FG006|24-Week Supplemental Follow-up Period|Other|1|||
24931895|NCT00641537|50024747|FG007|24-Week Supplemental Follow-up Period|Other|1|||
24931896|NCT03840135|50024767|FG000|Overall Study|Protocol Violation|6|||
24931897|NCT03840135|50024768|FG001|Overall Study|Protocol Violation|1|||
24931898|NCT03840135|50024767|FG000|Overall Study|Withdrawal by Subject|1|||
24931899|NCT03840135|50024768|FG001|Overall Study|Withdrawal by Subject|0|||
24931900|NCT00461175|50024780|FG000|Overall Study|Protocol Violation|522|||
24931901|NCT00461175|50024781|FG001|Overall Study|Protocol Violation|365|||
24931902|NCT00641147|50024789|FG000|Completed 4 Months.|Physician Decision|1|||
24931903|NCT00641147|50024790|FG001|Completed 4 Months.|Physician Decision|0|||
24931904|NCT00641147|50024789|FG000|Completed 4 Months.|Adverse Event|1|||
24931905|NCT00641147|50024790|FG001|Completed 4 Months.|Adverse Event|0|||
24931906|NCT00641147|50024789|FG000|Completed 8 Months.|Physician Decision|2|||
24931907|NCT00641147|50024790|FG001|Completed 8 Months.|Physician Decision|1|||
24931908|NCT00641147|50024789|FG000|Completed 8 Months.|non compliance|1|||
24931909|NCT00641147|50024790|FG001|Completed 8 Months.|non compliance|0|||
24931910|NCT00641147|50024789|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
24931911|NCT00641147|50024790|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
24931912|NCT00641147|50024789|FG000|Completed 12 Months.|Physician Decision|1|||
24931913|NCT00641147|50024790|FG001|Completed 12 Months.|Physician Decision|1|||
24931914|NCT00641147|50024789|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
24931915|NCT00641147|50024790|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
24931916|NCT00641147|50024789|FG000|Completed 16 Months.|Physician Decision|1|||
24931917|NCT00641147|50024790|FG001|Completed 16 Months.|Physician Decision|0|||
24931918|NCT00641147|50024789|FG000|Completed 16 Months.|Lost to Follow-up|1|||
24931919|NCT00641147|50024790|FG001|Completed 16 Months.|Lost to Follow-up|0|||
24931920|NCT00460239|50024800|FG000|Overall Study|Physician Decision|0|||
24931921|NCT00460239|50024801|FG001|Overall Study|Physician Decision|1|||
24931922|NCT00460239|50024802|FG002|Overall Study|Physician Decision|0|||
24931923|NCT00460239|50024803|FG003|Overall Study|Physician Decision|0|||
24931924|NCT00460239|50024804|FG004|Overall Study|Physician Decision|0|||
24931925|NCT00460239|50024805|FG005|Overall Study|Physician Decision|2|||
24931926|NCT00460239|50024806|FG006|Overall Study|Physician Decision|0|||
24931927|NCT00460239|50024807|FG007|Overall Study|Physician Decision|0|||
24931928|NCT00460239|50024808|FG008|Overall Study|Physician Decision|0|||
24931929|NCT00460239|50024800|FG000|Overall Study|Withdrawal by Subject|0|||
24931930|NCT00460239|50024801|FG001|Overall Study|Withdrawal by Subject|0|||
24931931|NCT00460239|50024802|FG002|Overall Study|Withdrawal by Subject|0|||
24931932|NCT00460239|50024803|FG003|Overall Study|Withdrawal by Subject|0|||
24931933|NCT00460239|50024804|FG004|Overall Study|Withdrawal by Subject|0|||
25155838|NCT01479465|50271218|FG000|Overall Study|Subject Request|1|||
25155839|NCT01479465|50271219|FG001|Overall Study|Subject Request|3|||
24931934|NCT00460239|50024805|FG005|Overall Study|Withdrawal by Subject|1|||
24931935|NCT00460239|50024806|FG006|Overall Study|Withdrawal by Subject|0|||
24931936|NCT00460239|50024807|FG007|Overall Study|Withdrawal by Subject|0|||
24931937|NCT00460239|50024808|FG008|Overall Study|Withdrawal by Subject|0|||
24931938|NCT00640835|50024823|FG000|Overall Study|Adverse Event|5|||
24931939|NCT00640835|50024824|FG001|Overall Study|Adverse Event|3|||
24931940|NCT00640835|50024823|FG000|Overall Study|Withdrawal by Subject|12|||
24931941|NCT00640835|50024824|FG001|Overall Study|Withdrawal by Subject|14|||
24931942|NCT00640835|50024823|FG000|Overall Study|Physician Decision|10|||
24931943|NCT00640835|50024824|FG001|Overall Study|Physician Decision|14|||
24931944|NCT00640835|50024823|FG000|Overall Study|Sponsor's Decision|11|||
24931945|NCT00640835|50024824|FG001|Overall Study|Sponsor's Decision|7|||
24931946|NCT00640835|50024823|FG000|Overall Study|Protocol Violation|2|||
24931947|NCT00640835|50024824|FG001|Overall Study|Protocol Violation|2|||
24931948|NCT00640835|50024823|FG000|Overall Study|Lost to Follow-up|17|||
24931949|NCT00640835|50024824|FG001|Overall Study|Lost to Follow-up|13|||
24931950|NCT00640835|50024823|FG000|Overall Study|Other Reason|19|||
25155840|NCT01479465|50271220|FG002|Overall Study|Subject Request|4|||
24931951|NCT00640835|50024824|FG001|Overall Study|Other Reason|4|||
25026877|NCT03333109|50124955|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
25026878|NCT03333109|50124956|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
25026879|NCT03333109|50124954|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
25026880|NCT03333109|50124955|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
25026881|NCT03333109|50124956|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
25026882|NCT03333109|50124954|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
25026883|NCT03333109|50124955|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
25026884|NCT03333109|50124956|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
25026885|NCT02940223|50124966|FG000|Overall Study|Failed Requirement|2|||
25026886|NCT02940223|50124967|FG001|Overall Study|Failed Requirement|0|||
25026887|NCT03296527|50124975|FG000|Overall Study|Adverse Event|15|||
25026888|NCT03296527|50124976|FG001|Overall Study|Adverse Event|33|||
25026889|NCT03296527|50124975|FG000|Overall Study|Protocol Deviation|4|||
25026890|NCT03296527|50124976|FG001|Overall Study|Protocol Deviation|0|||
25026891|NCT03296527|50124975|FG000|Overall Study|Subject withdrew consent|3|||
25026892|NCT03296527|50124976|FG001|Overall Study|Subject withdrew consent|1|||
25026893|NCT03296527|50124975|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
25026894|NCT03296527|50124976|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
25026895|NCT03296527|50124975|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
25026896|NCT03296527|50124976|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
25026897|NCT03296527|50124975|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
25026898|NCT03296527|50124976|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
25026899|NCT03296527|50124975|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
25026900|NCT03296527|50124976|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
25026901|NCT03296527|50124975|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
25026902|NCT03296527|50124976|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
25026903|NCT03295201|50124985|FG000|Overall Study|Lost to Follow-up|1|||
25026904|NCT03295201|50124986|FG001|Overall Study|Lost to Follow-up|1|||
25026905|NCT03295201|50124985|FG000|Overall Study|Hospital admission|0|||
25026906|NCT03295201|50124986|FG001|Overall Study|Hospital admission|1|||
25155841|NCT01479465|50271221|FG003|Overall Study|Subject Request|2|||
25155842|NCT01479465|50271218|FG000|Overall Study|Subject Withdrew Consent|0|||
25155843|NCT01479465|50271219|FG001|Overall Study|Subject Withdrew Consent|5|||
25155844|NCT01479465|50271220|FG002|Overall Study|Subject Withdrew Consent|2|||
25155845|NCT01479465|50271221|FG003|Overall Study|Subject Withdrew Consent|1|||
24931952|NCT03839355|50024832|FG000|Overall Study|Withdrawal by Subject|1|||
24931953|NCT03839355|50024833|FG001|Overall Study|Withdrawal by Subject|0|||
24931954|NCT00382018|50024843|FG000|Overall Study|Progression|0|||
24931955|NCT00382018|50024844|FG001|Overall Study|Progression|136|||
24931956|NCT00382018|50024845|FG002|Overall Study|Progression|51|||
24931957|NCT00382018|50024846|FG003|Overall Study|Progression|43|||
24931958|NCT00382018|50024843|FG000|Overall Study|Death|0|||
24931959|NCT00382018|50024844|FG001|Overall Study|Death|9|||
24931960|NCT00382018|50024845|FG002|Overall Study|Death|7|||
24931961|NCT00382018|50024846|FG003|Overall Study|Death|11|||
24931962|NCT00382018|50024843|FG000|Overall Study|Withdrawal by Subject|0|||
24931963|NCT00382018|50024844|FG001|Overall Study|Withdrawal by Subject|4|||
25026907|NCT03293485|50124992|FG000|Overall Study|Death|1|||
25026908|NCT03293485|50124992|FG000|Overall Study|Screen Failure|2|||
24931964|NCT00382018|50024845|FG002|Overall Study|Withdrawal by Subject|3|||
25026909|NCT03293485|50124992|FG000|Overall Study|Withdrawal by Subject|2|||
24931965|NCT00382018|50024846|FG003|Overall Study|Withdrawal by Subject|4|||
24931966|NCT00382018|50024843|FG000|Overall Study|Other, not protocol specified|0|||
25026910|NCT03309943|50125000|FG000|Overall Study|Withdrawal by Subject|0|||
25026911|NCT03309943|50125001|FG001|Overall Study|Withdrawal by Subject|1|||
25026912|NCT03309943|50125000|FG000|Overall Study|Inappropriate behavior towards staff|0|||
25155846|NCT01479465|50271218|FG000|Overall Study|Protocol Violation|0|||
24931967|NCT00382018|50024844|FG001|Overall Study|Other, not protocol specified|16|||
24931968|NCT00382018|50024845|FG002|Overall Study|Other, not protocol specified|3|||
24931969|NCT00382018|50024846|FG003|Overall Study|Other, not protocol specified|1|||
24931970|NCT00640601|50024859|FG000|Overall Study|Adverse Event|43|||
24931971|NCT00640601|50024859|FG000|Overall Study|Withdrawal by Subject|20|||
24931972|NCT00640601|50024859|FG000|Overall Study|Protocol Violation|6|||
24931973|NCT00640601|50024859|FG000|Overall Study|Lack of Efficacy|16|||
24931974|NCT00640601|50024859|FG000|Overall Study|Lost to Follow-up|9|||
24931975|NCT00640601|50024859|FG000|Overall Study|Physician Decision|8|||
24931976|NCT00640601|50024859|FG000|Overall Study|treatment naive, combination therapy|10|||
24931977|NCT03838731|50024865|FG000|Overall Study|Pregnancy|0|||
24931978|NCT03838731|50024866|FG001|Overall Study|Pregnancy|1|||
24931979|NCT03838731|50024865|FG000|Overall Study|Withdrawal of consent|1|||
24931980|NCT03838731|50024866|FG001|Overall Study|Withdrawal of consent|0|||
24931981|NCT00452439|50024874|FG000|Overall Study|Lost to Follow-up|1|||
24931982|NCT00452439|50024875|FG001|Overall Study|Lost to Follow-up|1|||
24931983|NCT00452439|50024874|FG000|Overall Study|Refused Treatment|4|||
24931984|NCT00452439|50024875|FG001|Overall Study|Refused Treatment|3|||
24931985|NCT00452439|50024874|FG000|Overall Study|Death|3|||
24931986|NCT00452439|50024875|FG001|Overall Study|Death|1|||
24931987|NCT00452439|50024874|FG000|Overall Study|Bone Marrow Transplant|0|||
24931988|NCT00452439|50024875|FG001|Overall Study|Bone Marrow Transplant|1|||
25026913|NCT03309943|50125001|FG001|Overall Study|Inappropriate behavior towards staff|1|||
25026914|NCT01732627|50125009|FG000|Overall Study|Withdrawal by Subject|1|||
25026915|NCT01732627|50125010|FG001|Overall Study|Withdrawal by Subject|0|||
25026916|NCT03307837|50125022|FG000|Overall Study|Withdrawal by Subject|0|||
24931989|NCT00452439|50024874|FG000|Overall Study|Too Ill to Continue|0|||
24931990|NCT00452439|50024875|FG001|Overall Study|Too Ill to Continue|1|||
24931991|NCT00452439|50024874|FG000|Overall Study|Failed to achieve complete response|2|||
24931992|NCT00452439|50024875|FG001|Overall Study|Failed to achieve complete response|0|||
24931993|NCT00452439|50024874|FG000|Overall Study|Relapse|3|||
24931994|NCT00452439|50024875|FG001|Overall Study|Relapse|0|||
24931995|NCT00452439|50024874|FG000|Overall Study|Fracture|1|||
24931996|NCT00452439|50024875|FG001|Overall Study|Fracture|0|||
24931997|NCT00381940|50024881|FG000|Overall Study|Lack of Efficacy|3|||
24931998|NCT00381940|50024881|FG000|Overall Study|Protocol Violation|1|||
24931999|NCT00381940|50024881|FG000|Overall Study|Ineligible|1|||
24932000|NCT00364156|50024887|FG000|Overall Study|Withdrawal by Subject|73|||
24932001|NCT00364156|50024888|FG001|Overall Study|Withdrawal by Subject|80|||
24932002|NCT00364156|50024887|FG000|Overall Study|Protocol Violation|6|||
24932003|NCT00364156|50024888|FG001|Overall Study|Protocol Violation|1|||
24932004|NCT00452361|50024896|FG000|Overall Study|Adverse Event|8|||
25155847|NCT01479465|50271219|FG001|Overall Study|Protocol Violation|1|||
25155848|NCT01479465|50271220|FG002|Overall Study|Protocol Violation|1|||
25155849|NCT01479465|50271221|FG003|Overall Study|Protocol Violation|0|||
25155850|NCT01479465|50271218|FG000|Overall Study|Death|0|||
24932005|NCT00452361|50024897|FG001|Overall Study|Adverse Event|0|||
24932006|NCT00452361|50024896|FG000|Overall Study|Withdrawal by Subject|0|||
24932007|NCT00452361|50024897|FG001|Overall Study|Withdrawal by Subject|1|||
24932008|NCT00452361|50024896|FG000|Overall Study|Premature termination|13|||
24932009|NCT00452361|50024897|FG001|Overall Study|Premature termination|9|||
24932010|NCT00640289|50024903|FG000|Overall Study|Death|3|||
24932011|NCT00640289|50024903|FG000|Overall Study|Withdrawal by Subject|1|||
24932012|NCT00640289|50024903|FG000|Overall Study|Lost to Follow-up|1|||
24932013|NCT00640289|50024903|FG000|Overall Study|Data collected under different amendment|2|||
24932014|NCT00640289|50024903|FG000|Overall Study|Transferred to another center|1|||
24932015|NCT00640289|50024903|FG000|Overall Study|Missing status|5|||
25026917|NCT03307837|50125023|FG001|Overall Study|Withdrawal by Subject|0|||
25155851|NCT01479465|50271219|FG001|Overall Study|Death|0|||
24932016|NCT00568451|50024911|FG000|Overall Study|Disease Progression|0|||
24932017|NCT00568451|50024912|FG001|Overall Study|Disease Progression|0|||
24932018|NCT00568451|50024913|FG002|Overall Study|Disease Progression|2|||
24932019|NCT00568451|50024914|FG003|Overall Study|Disease Progression|7|||
24932020|NCT00459537|50024927|FG000|Overall Study|Adverse Event|1|||
24932021|NCT00459537|50024928|FG001|Overall Study|Adverse Event|6|||
24932022|NCT00459537|50024927|FG000|Overall Study|Lack of Efficacy|10|||
24932023|NCT00459537|50024928|FG001|Overall Study|Lack of Efficacy|11|||
24932024|NCT00459537|50024927|FG000|Overall Study|Withdrawal by Subject|20|||
24932025|NCT00459537|50024928|FG001|Overall Study|Withdrawal by Subject|26|||
25026918|NCT03307837|50125024|FG002|Overall Study|Withdrawal by Subject|1|||
25155852|NCT01479465|50271220|FG002|Overall Study|Death|0|||
24932026|NCT00459537|50024927|FG000|Overall Study|Lost to Follow-up|27|||
24932027|NCT00459537|50024928|FG001|Overall Study|Lost to Follow-up|30|||
24932028|NCT00459537|50024927|FG000|Overall Study|Administrative problems|3|||
24932029|NCT00459537|50024928|FG001|Overall Study|Administrative problems|0|||
24932030|NCT00459537|50024927|FG000|Overall Study|Protocol Violation|4|||
24932031|NCT00459537|50024928|FG001|Overall Study|Protocol Violation|3|||
24932032|NCT00459537|50024927|FG000|Overall Study|Missing|1|||
25155853|NCT01479465|50271221|FG003|Overall Study|Death|1|||
25155854|NCT01479465|50271218|FG000|Overall Study|Lost to Follow-up|0|||
24932033|NCT00459537|50024928|FG001|Overall Study|Missing|0|||
24932034|NCT03850509|50024936|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
24932035|NCT03850509|50024937|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
24932036|NCT00635999|50024946|FG000|Overall Study|Withdrawal by Subject|4|||
24932037|NCT00635999|50024947|FG001|Overall Study|Withdrawal by Subject|2|||
24932038|NCT00635999|50024948|FG002|Overall Study|Withdrawal by Subject|1|||
24932039|NCT00469209|50024959|FG000|Overall Study|Adverse Event|1|||
24932040|NCT00469209|50024960|FG001|Overall Study|Adverse Event|0|||
24932041|NCT00469209|50024961|FG002|Overall Study|Adverse Event|1|||
24932042|NCT00635219|50024974|FG000|Overall Study|Adverse Event|12|||
24932043|NCT00635219|50024975|FG001|Overall Study|Adverse Event|10|||
24932044|NCT00635219|50024976|FG002|Overall Study|Adverse Event|18|||
24932045|NCT00635219|50024977|FG003|Overall Study|Adverse Event|15|||
24932046|NCT00635219|50024978|FG004|Overall Study|Adverse Event|19|||
24932047|NCT00635219|50024974|FG000|Overall Study|Lack of Efficacy|5|||
24932048|NCT00635219|50024975|FG001|Overall Study|Lack of Efficacy|6|||
24932049|NCT00635219|50024976|FG002|Overall Study|Lack of Efficacy|3|||
24932050|NCT00635219|50024977|FG003|Overall Study|Lack of Efficacy|4|||
24932051|NCT00635219|50024978|FG004|Overall Study|Lack of Efficacy|6|||
24932052|NCT00635219|50024974|FG000|Overall Study|Non-compliance With Study Product|0|||
24932053|NCT00635219|50024975|FG001|Overall Study|Non-compliance With Study Product|0|||
24932054|NCT00635219|50024976|FG002|Overall Study|Non-compliance With Study Product|0|||
24932055|NCT00635219|50024977|FG003|Overall Study|Non-compliance With Study Product|2|||
24932056|NCT00635219|50024978|FG004|Overall Study|Non-compliance With Study Product|1|||
24932057|NCT00635219|50024974|FG000|Overall Study|Protocol Violation|0|||
24932058|NCT00635219|50024975|FG001|Overall Study|Protocol Violation|2|||
24932059|NCT00635219|50024976|FG002|Overall Study|Protocol Violation|3|||
24932060|NCT00635219|50024977|FG003|Overall Study|Protocol Violation|2|||
24932061|NCT00635219|50024978|FG004|Overall Study|Protocol Violation|4|||
24932062|NCT00635219|50024974|FG000|Overall Study|Withdrawal of Consent|8|||
24932063|NCT00635219|50024975|FG001|Overall Study|Withdrawal of Consent|6|||
24932064|NCT00635219|50024976|FG002|Overall Study|Withdrawal of Consent|8|||
24932065|NCT00635219|50024977|FG003|Overall Study|Withdrawal of Consent|11|||
24932066|NCT00635219|50024978|FG004|Overall Study|Withdrawal of Consent|8|||
24932067|NCT00635219|50024974|FG000|Overall Study|Lost to Follow-up|0|||
24932068|NCT00635219|50024975|FG001|Overall Study|Lost to Follow-up|0|||
24932069|NCT00635219|50024976|FG002|Overall Study|Lost to Follow-up|2|||
24932070|NCT00635219|50024977|FG003|Overall Study|Lost to Follow-up|0|||
24932071|NCT00635219|50024978|FG004|Overall Study|Lost to Follow-up|3|||
24932072|NCT00635219|50024974|FG000|Overall Study|Administrative or Other Reasons|0|||
24932073|NCT00635219|50024975|FG001|Overall Study|Administrative or Other Reasons|1|||
24932074|NCT00635219|50024976|FG002|Overall Study|Administrative or Other Reasons|1|||
24932075|NCT00635219|50024977|FG003|Overall Study|Administrative or Other Reasons|0|||
24932076|NCT00635219|50024978|FG004|Overall Study|Administrative or Other Reasons|1|||
24932077|NCT00363766|50024992|FG000|Overall Study|Progressive Disease|15|||
24932078|NCT00363766|50024993|FG001|Overall Study|Progressive Disease|9|||
24932079|NCT00363766|50024992|FG000|Overall Study|Adverse Event|10|||
24932080|NCT00363766|50024993|FG001|Overall Study|Adverse Event|2|||
24932081|NCT00363766|50024992|FG000|Overall Study|Disease Related Death|1|||
24932082|NCT00363766|50024993|FG001|Overall Study|Disease Related Death|3|||
24932083|NCT00363766|50024992|FG000|Overall Study|Not Disease Related Death|3|||
24932084|NCT00363766|50024993|FG001|Overall Study|Not Disease Related Death|4|||
24932085|NCT00363766|50024992|FG000|Overall Study|Withdrawal by Subject|2|||
24932086|NCT00363766|50024993|FG001|Overall Study|Withdrawal by Subject|0|||
24932087|NCT00363766|50024992|FG000|Overall Study|Physician Decision|1|||
24932088|NCT00363766|50024993|FG001|Overall Study|Physician Decision|2|||
24932089|NCT00468819|50025003|FG000|Overall Study|Withdrawal by Subject|4|||
24932090|NCT00468819|50025004|FG001|Overall Study|Withdrawal by Subject|0|||
24932091|NCT00468819|50025005|FG002|Overall Study|Withdrawal by Subject|1|||
24932092|NCT00468819|50025003|FG000|Overall Study|Lost to Follow-up|0|||
24932093|NCT00468819|50025004|FG001|Overall Study|Lost to Follow-up|0|||
24932094|NCT00468819|50025005|FG002|Overall Study|Lost to Follow-up|1|||
24932095|NCT00468819|50025003|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
24932096|NCT00468819|50025004|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
24932097|NCT00468819|50025005|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
24932098|NCT00451191|50025017|FG000|Overall Study|withdrawal or received alternate tx|15|||
24932099|NCT00451191|50025018|FG001|Overall Study|withdrawal or received alternate tx|11|||
24932100|NCT00451035|50025024|FG000|Overall Study|Disease progression|11|||
24932101|NCT00451035|50025024|FG000|Overall Study|Death|3|||
24932102|NCT00451035|50025024|FG000|Overall Study|New anti-neoplastic therapy|3|||
24932103|NCT00468585|50025033|FG000|Overall Study|Patient not treated|1|||
24932104|NCT00468585|50025034|FG001|Overall Study|Patient not treated|0|||
24932105|NCT00468585|50025035|FG002|Overall Study|Patient not treated|1|||
24932106|NCT00468585|50025036|FG003|Overall Study|Patient not treated|0|||
24932107|NCT00468585|50025033|FG000|Overall Study|Patient found to be ineligible|0|||
24932108|NCT00468585|50025034|FG001|Overall Study|Patient found to be ineligible|0|||
24932109|NCT00468585|50025035|FG002|Overall Study|Patient found to be ineligible|1|||
24932110|NCT00468585|50025036|FG003|Overall Study|Patient found to be ineligible|0|||
24932111|NCT00468585|50025033|FG000|Overall Study|Adverse Event|0|||
24932112|NCT00468585|50025034|FG001|Overall Study|Adverse Event|0|||
24932113|NCT00468585|50025035|FG002|Overall Study|Adverse Event|1|||
24932114|NCT00468585|50025036|FG003|Overall Study|Adverse Event|0|||
24932115|NCT00468585|50025033|FG000|Overall Study|Withdrawal by Subject|0|||
24932116|NCT00468585|50025034|FG001|Overall Study|Withdrawal by Subject|0|||
24932117|NCT00468585|50025035|FG002|Overall Study|Withdrawal by Subject|2|||
24932118|NCT00468585|50025036|FG003|Overall Study|Withdrawal by Subject|1|||
24932119|NCT00450801|50025046|FG000|Overall Study|Death|1|||
24932120|NCT00458211|50025055|FG000|Overall Study|Lack of Efficacy|12|||
24932121|NCT00458211|50025055|FG000|Overall Study|Withdrawal by Subject|2|||
24932122|NCT00458211|50025055|FG000|Overall Study|Protocol Violation|2|||
24932123|NCT00450723|50025063|FG000|Overall Study|Physician Decision|5|||
24932124|NCT00467961|50025068|FG000|Overall Study|Technical Failures|5|||
24932125|NCT00467961|50025068|FG000|Overall Study|Disease Progression|2|||
24932126|NCT00457821|50025080|FG000|Part 2|Withdrawal by Subject|0|||
24932127|NCT00457821|50025081|FG001|Part 2|Withdrawal by Subject|0|||
24932128|NCT00457821|50025082|FG002|Part 2|Withdrawal by Subject|0|||
24932129|NCT00457821|50025083|FG003|Part 2|Withdrawal by Subject|0|||
24932130|NCT00457821|50025084|FG004|Part 2|Withdrawal by Subject|0|||
24932131|NCT00457821|50025085|FG005|Part 2|Withdrawal by Subject|0|||
24932132|NCT00457821|50025086|FG006|Part 2|Withdrawal by Subject|0|||
24932133|NCT00457821|50025087|FG007|Part 2|Withdrawal by Subject|1|||
24932134|NCT00633893|50025107|FG000|Overall Study|Death|1|||
24932135|NCT00633893|50025108|FG001|Overall Study|Death|3|||
24932136|NCT00633893|50025109|FG002|Overall Study|Death|9|||
24932137|NCT00633893|50025107|FG000|Overall Study|Adverse Event|65|||
24932138|NCT00633893|50025108|FG001|Overall Study|Adverse Event|58|||
24932139|NCT00633893|50025109|FG002|Overall Study|Adverse Event|126|||
24932140|NCT00633893|50025107|FG000|Overall Study|Withdrawal by Subject|7|||
24932141|NCT00633893|50025108|FG001|Overall Study|Withdrawal by Subject|12|||
24932142|NCT00633893|50025109|FG002|Overall Study|Withdrawal by Subject|6|||
24932143|NCT00633893|50025107|FG000|Overall Study|Lost to Follow-up|2|||
24932144|NCT00633893|50025108|FG001|Overall Study|Lost to Follow-up|4|||
24932145|NCT00633893|50025109|FG002|Overall Study|Lost to Follow-up|8|||
24932146|NCT00633893|50025107|FG000|Overall Study|Poor/non-compliance|5|||
24932147|NCT00633893|50025108|FG001|Overall Study|Poor/non-compliance|12|||
24932148|NCT00633893|50025109|FG002|Overall Study|Poor/non-compliance|3|||
24932149|NCT00633893|50025107|FG000|Overall Study|Pregnancy|2|||
24932150|NCT00633893|50025108|FG001|Overall Study|Pregnancy|1|||
24932151|NCT00633893|50025109|FG002|Overall Study|Pregnancy|1|||
24932152|NCT00633893|50025107|FG000|Overall Study|Not meet/no longer meets criteria|4|||
24932153|NCT00633893|50025108|FG001|Overall Study|Not meet/no longer meets criteria|6|||
24932154|NCT00633893|50025109|FG002|Overall Study|Not meet/no longer meets criteria|4|||
24932155|NCT00633893|50025107|FG000|Overall Study|Other|28|||
24932156|NCT00633893|50025108|FG001|Overall Study|Other|33|||
24932157|NCT00633893|50025109|FG002|Overall Study|Other|31|||
24932158|NCT00457743|50025120|FG000|Overall Study|Adverse Event|0|||
24932159|NCT00457743|50025121|FG001|Overall Study|Adverse Event|4|||
24932160|NCT00457743|50025122|FG002|Overall Study|Adverse Event|0|||
24932161|NCT00457743|50025120|FG000|Overall Study|Lack of Efficacy|3|||
24932162|NCT00457743|50025121|FG001|Overall Study|Lack of Efficacy|23|||
24932163|NCT00457743|50025122|FG002|Overall Study|Lack of Efficacy|3|||
24932164|NCT00450411|50025131|FG000|Overall Study|Protocol Violation|6|||
24932165|NCT00450411|50025131|FG000|Overall Study|No protocol treatment|2|||
24932166|NCT00644969|50025137|FG000|Treatment Phase|Randomized, not treated|1|||
24932167|NCT00644969|50025138|FG001|Treatment Phase|Randomized, not treated|0|||
24932168|NCT00644969|50025137|FG000|Treatment Phase|Adverse Event|3|||
24932169|NCT00644969|50025138|FG001|Treatment Phase|Adverse Event|0|||
24932170|NCT00644969|50025137|FG000|Treatment Phase|Withdrawal by Subject|4|||
24932171|NCT00644969|50025138|FG001|Treatment Phase|Withdrawal by Subject|0|||
24932172|NCT00644969|50025137|FG000|Treatment Phase|Lost to Follow-up|2|||
25026919|NCT03307837|50125025|FG003|Overall Study|Withdrawal by Subject|0|||
24932173|NCT00644969|50025138|FG001|Treatment Phase|Lost to Follow-up|2|||
24932174|NCT00644969|50025137|FG000|Treatment Phase|Other|4|||
24932175|NCT00644969|50025138|FG001|Treatment Phase|Other|1|||
24932176|NCT00644969|50025137|FG000|Post Treatment Phase|Death|1|||
24932177|NCT00644969|50025138|FG001|Post Treatment Phase|Death|0|||
25026920|NCT03307837|50125026|FG004|Overall Study|Withdrawal by Subject|0|||
25026921|NCT03307837|50125027|FG005|Overall Study|Withdrawal by Subject|1|||
25155855|NCT01479465|50271219|FG001|Overall Study|Lost to Follow-up|0|||
24932178|NCT00644969|50025137|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
24932179|NCT00644969|50025138|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
24932180|NCT00644969|50025137|FG000|Post Treatment Phase|Lost to Follow-up|4|||
24932181|NCT00644969|50025138|FG001|Post Treatment Phase|Lost to Follow-up|1|||
24932182|NCT00644969|50025137|FG000|Post Treatment Phase|Other|1|||
24932183|NCT00644969|50025138|FG001|Post Treatment Phase|Other|0|||
25155856|NCT01479465|50271220|FG002|Overall Study|Lost to Follow-up|1|||
24932184|NCT00644423|50025146|FG000|Overall Study|Lost to Follow-up|1|||
24932185|NCT00644423|50025147|FG001|Overall Study|Lost to Follow-up|1|||
24932186|NCT00628355|50025155|FG000|Overall Study|Withdrawal by Subject|1|||
24932187|NCT00628355|50025156|FG001|Overall Study|Withdrawal by Subject|1|||
24932188|NCT00627497|50025167|FG000|Overall Study|Lost to Follow-up|1|||
24932189|NCT00627497|50025168|FG001|Overall Study|Lost to Follow-up|1|||
24932190|NCT00627497|50025169|FG002|Overall Study|Lost to Follow-up|0|||
24932191|NCT00627497|50025170|FG003|Overall Study|Lost to Follow-up|0|||
24932192|NCT00648167|50025180|FG000|Overall Study|Adverse Event|6|||
24932193|NCT00648167|50025180|FG000|Overall Study|unable to swallow tablets|1|||
24932194|NCT00647699|50025214|FG000|Overall Study|Lost to Follow-up|5|||
24932195|NCT00647699|50025215|FG001|Overall Study|Lost to Follow-up|4|||
24932196|NCT00647699|50025214|FG000|Overall Study|Withdrawal by Subject|3|||
24932197|NCT00647699|50025215|FG001|Overall Study|Withdrawal by Subject|8|||
24932198|NCT00467649|50025223|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
24932199|NCT00467649|50025224|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
24932200|NCT00467649|50025225|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
24932201|NCT00467649|50025226|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
24932202|NCT00467649|50025227|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
24932203|NCT00467649|50025228|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
24932204|NCT00467649|50025223|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
24932205|NCT00467649|50025224|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
24932206|NCT00467649|50025225|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
24932207|NCT00467649|50025226|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
24932208|NCT00467649|50025227|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
24932209|NCT00467649|50025228|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
24932210|NCT00467649|50025223|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
24932211|NCT00467649|50025224|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
24932212|NCT00467649|50025225|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
24932213|NCT00467649|50025226|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
24932214|NCT00467649|50025227|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
24932215|NCT00467649|50025228|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
24932216|NCT00467649|50025223|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
24932217|NCT00467649|50025224|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
24932218|NCT00467649|50025225|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
24932219|NCT00467649|50025226|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
24932220|NCT00467649|50025227|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
24932221|NCT00467649|50025228|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
24932222|NCT00467649|50025223|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
25026922|NCT03307837|50125022|FG000|Overall Study|Lost to Follow-up|1|||
25026923|NCT03307837|50125023|FG001|Overall Study|Lost to Follow-up|1|||
25026924|NCT03307837|50125024|FG002|Overall Study|Lost to Follow-up|0|||
25026925|NCT03307837|50125025|FG003|Overall Study|Lost to Follow-up|0|||
25026926|NCT03307837|50125026|FG004|Overall Study|Lost to Follow-up|0|||
25026927|NCT03307837|50125027|FG005|Overall Study|Lost to Follow-up|1|||
24932223|NCT00467649|50025224|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
24932224|NCT00467649|50025225|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
24932225|NCT00467649|50025226|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
24932226|NCT00467649|50025227|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
24932227|NCT00467649|50025228|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
24932228|NCT00467649|50025223|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
24932229|NCT00467649|50025224|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
24932230|NCT00467649|50025225|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
24932231|NCT00467649|50025226|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
24932232|NCT00467649|50025227|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
24932233|NCT00467649|50025228|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
24932234|NCT00467649|50025223|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
24932235|NCT00467649|50025224|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
24932236|NCT00467649|50025225|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
24932237|NCT00467649|50025226|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
24932238|NCT00467649|50025227|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
24932239|NCT00467649|50025228|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
24932240|NCT00450333|50025250|FG000|Overall Study|Study terminated|47|||
24932241|NCT00450333|50025251|FG001|Overall Study|Study terminated|54|||
24932242|NCT00450333|50025252|FG002|Overall Study|Study terminated|16|||
24932243|NCT00450333|50025253|FG003|Overall Study|Study terminated|21|||
25026928|NCT03331315|50125048|FG000|Overall Study|Physician Decision|18|||
25026929|NCT03331315|50125049|FG001|Overall Study|Physician Decision|14|||
24932244|NCT00450333|50025250|FG000|Overall Study|Adverse Event|1|||
24932245|NCT00450333|50025251|FG001|Overall Study|Adverse Event|7|||
25026930|NCT03329989|50125057|FG000|Overall Study|Withdrawal by Subject|9|||
25026931|NCT03329989|50125057|FG000|Overall Study|Lost to Follow-up|8|||
25026932|NCT03329989|50125057|FG000|Overall Study|Adverse Event|5|||
25026933|NCT03329989|50125057|FG000|Overall Study|Protocol Violation|1|||
25026934|NCT03287869|50125063|FG000|Overall Study|Adverse Event|14|||
25026935|NCT03287869|50125064|FG001|Overall Study|Adverse Event|12|||
25026936|NCT03287869|50125063|FG000|Overall Study|Lack of Efficacy|1|||
25026937|NCT03287869|50125064|FG001|Overall Study|Lack of Efficacy|0|||
25155857|NCT01479465|50271221|FG003|Overall Study|Lost to Follow-up|0|||
25155858|NCT01503021|50271285|FG000|Overall Study|Adverse Event|7|||
24932246|NCT00450333|50025252|FG002|Overall Study|Adverse Event|2|||
24932247|NCT00450333|50025253|FG003|Overall Study|Adverse Event|2|||
24932248|NCT00450333|50025250|FG000|Overall Study|Protocol Violation|1|||
24932249|NCT00450333|50025251|FG001|Overall Study|Protocol Violation|0|||
24932250|NCT00450333|50025252|FG002|Overall Study|Protocol Violation|1|||
24932251|NCT00450333|50025253|FG003|Overall Study|Protocol Violation|0|||
24932252|NCT00450333|50025250|FG000|Overall Study|Withdrawal by Subject|1|||
24932253|NCT00450333|50025251|FG001|Overall Study|Withdrawal by Subject|0|||
24932254|NCT00450333|50025252|FG002|Overall Study|Withdrawal by Subject|3|||
24932255|NCT00450333|50025253|FG003|Overall Study|Withdrawal by Subject|0|||
24932256|NCT00450333|50025250|FG000|Overall Study|Kidney transplant|1|||
24932257|NCT00450333|50025251|FG001|Overall Study|Kidney transplant|0|||
24932258|NCT00450333|50025252|FG002|Overall Study|Kidney transplant|1|||
24932259|NCT00450333|50025253|FG003|Overall Study|Kidney transplant|3|||
24932260|NCT00450333|50025250|FG000|Overall Study|Death|3|||
24932261|NCT00450333|50025251|FG001|Overall Study|Death|2|||
24932262|NCT00450333|50025252|FG002|Overall Study|Death|2|||
24932263|NCT00450333|50025253|FG003|Overall Study|Death|2|||
24932264|NCT00643565|50025265|FG000|Overall Study|Death|12|||
24932265|NCT00643565|50025266|FG001|Overall Study|Death|11|||
24932266|NCT00643565|50025265|FG000|Overall Study|Withdrawal by Subject|4|||
24932267|NCT00643565|50025266|FG001|Overall Study|Withdrawal by Subject|1|||
24932268|NCT00643565|50025265|FG000|Overall Study|Lost to Follow-up|0|||
24932269|NCT00643565|50025266|FG001|Overall Study|Lost to Follow-up|6|||
24932270|NCT00643565|50025265|FG000|Overall Study|Other|7|||
24932271|NCT00643565|50025266|FG001|Overall Study|Other|8|||
24932272|NCT00643565|50025265|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
24932273|NCT00643565|50025266|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
24932274|NCT00643565|50025265|FG000|Overall Study|Recurrence of Disease|2|||
24932275|NCT00643565|50025266|FG001|Overall Study|Recurrence of Disease|1|||
24932276|NCT00643565|50025265|FG000|Overall Study|Progression of Disease|18|||
24932277|NCT00643565|50025266|FG001|Overall Study|Progression of Disease|14|||
24932278|NCT00643565|50025265|FG000|Overall Study|Protocol Violation|3|||
24932279|NCT00643565|50025266|FG001|Overall Study|Protocol Violation|0|||
24932280|NCT00643565|50025265|FG000|Overall Study|Did Not Cooperate|0|||
24932281|NCT00643565|50025266|FG001|Overall Study|Did Not Cooperate|1|||
24932282|NCT00643565|50025265|FG000|Overall Study|Administrative|22|||
24932283|NCT00643565|50025266|FG001|Overall Study|Administrative|16|||
24932284|NCT00643565|50025265|FG000|Overall Study|Adverse Event|5|||
24932285|NCT00643565|50025266|FG001|Overall Study|Adverse Event|8|||
24932286|NCT00643487|50025273|FG000|Overall Study|Technical difficulty|3|||
24932287|NCT00450255|50025277|FG000|Overall Study|Prior RFA ablation of liver|1|||
24932288|NCT00450177|50025284|FG000|Overall Study|Adverse Event|7|||
24932289|NCT00450177|50025285|FG001|Overall Study|Adverse Event|4|||
24932290|NCT00450177|50025284|FG000|Overall Study|Withdrawal by Subject|1|||
24932291|NCT00450177|50025285|FG001|Overall Study|Withdrawal by Subject|6|||
24932292|NCT00450177|50025284|FG000|Overall Study|Withdrawal by Primary Team|1|||
24932293|NCT00450177|50025285|FG001|Overall Study|Withdrawal by Primary Team|1|||
24932294|NCT03848949|50025293|FG000|Overall Study|Lost to Follow-up|5|||
24932295|NCT03848949|50025294|FG001|Overall Study|Lost to Follow-up|7|||
24932296|NCT00467259|50025302|FG000|Overall Study|Adverse Event|24|||
24932297|NCT00467259|50025303|FG001|Overall Study|Adverse Event|90|||
24932298|NCT00467259|50025302|FG000|Overall Study|Protocol Violation|1|||
24932299|NCT00467259|50025303|FG001|Overall Study|Protocol Violation|7|||
24932300|NCT00467259|50025302|FG000|Overall Study|Withdrawal by Subject|34|||
24932301|NCT00467259|50025303|FG001|Overall Study|Withdrawal by Subject|108|||
24932302|NCT00467259|50025302|FG000|Overall Study|Physician Decision|0|||
24932303|NCT00467259|50025303|FG001|Overall Study|Physician Decision|2|||
24932304|NCT00467259|50025302|FG000|Overall Study|Lost to Follow-up|14|||
24932305|NCT00467259|50025303|FG001|Overall Study|Lost to Follow-up|34|||
24932306|NCT00467259|50025302|FG000|Overall Study|Site Closed|2|||
24932307|NCT00467259|50025303|FG001|Overall Study|Site Closed|1|||
24932308|NCT00449865|50025311|FG000|Overall Study|Withdrawal by Subject|110|||
24932309|NCT00449865|50025312|FG001|Overall Study|Withdrawal by Subject|110|||
24932310|NCT00449865|50025311|FG000|Overall Study|Lost to Follow-up|36|||
24932311|NCT00449865|50025312|FG001|Overall Study|Lost to Follow-up|37|||
24932312|NCT00449865|50025311|FG000|Overall Study|Physician Decision|13|||
24932313|NCT00449865|50025312|FG001|Overall Study|Physician Decision|12|||
25026938|NCT03287869|50125063|FG000|Overall Study|Lost to Follow-up|13|||
25026939|NCT03287869|50125064|FG001|Overall Study|Lost to Follow-up|19|||
24932314|NCT00449865|50025311|FG000|Overall Study|Death|31|||
24932315|NCT00449865|50025312|FG001|Overall Study|Death|40|||
24932316|NCT00449865|50025311|FG000|Overall Study|Protocol Violation|8|||
24932317|NCT00449865|50025312|FG001|Overall Study|Protocol Violation|7|||
24932318|NCT00449865|50025311|FG000|Overall Study|Study was stopped|324|||
24932319|NCT00449865|50025312|FG001|Overall Study|Study was stopped|328|||
24932320|NCT00449787|50025320|FG000|Overall Study|Lost to Follow-up|10|||
24932321|NCT00449787|50025321|FG001|Overall Study|Lost to Follow-up|8|||
24932322|NCT00449787|50025320|FG000|Overall Study|Did not require medication|95|||
24932323|NCT00449787|50025321|FG001|Overall Study|Did not require medication|92|||
24932324|NCT00449163|50025329|FG000|Overall Study|Physician Decision|3|||
24932325|NCT00448539|50025335|FG000|Overall Study|Medication non-compliance|4|||
24932326|NCT00448539|50025336|FG001|Overall Study|Medication non-compliance|1|||
24932327|NCT00448539|50025335|FG000|Overall Study|Protocol Violation|1|||
24932328|NCT00448539|50025336|FG001|Overall Study|Protocol Violation|0|||
24932329|NCT00448539|50025335|FG000|Overall Study|Request of the investigator or sponsor|67|||
24932330|NCT00448539|50025336|FG001|Overall Study|Request of the investigator or sponsor|54|||
24932331|NCT00448539|50025335|FG000|Overall Study|Withdrawal by Subject|20|||
24932332|NCT00448539|50025336|FG001|Overall Study|Withdrawal by Subject|24|||
24932333|NCT00448539|50025335|FG000|Overall Study|Diary non-compliance|1|||
24932334|NCT00448539|50025336|FG001|Overall Study|Diary non-compliance|0|||
24932335|NCT00448539|50025335|FG000|Overall Study|Adverse Event|9|||
24932336|NCT00448539|50025336|FG001|Overall Study|Adverse Event|26|||
24932337|NCT00448539|50025335|FG000|Overall Study|Lack of Efficacy|27|||
24932338|NCT00448539|50025336|FG001|Overall Study|Lack of Efficacy|40|||
24932339|NCT00448539|50025335|FG000|Overall Study|Miscellaneous|2|||
24932340|NCT00448539|50025336|FG001|Overall Study|Miscellaneous|1|||
24932341|NCT00448539|50025335|FG000|Overall Study|Change of meds|2|||
24932342|NCT00448539|50025336|FG001|Overall Study|Change of meds|3|||
24932343|NCT00448539|50025335|FG000|Overall Study|Lost to Follow-up|1|||
24932344|NCT00448539|50025336|FG001|Overall Study|Lost to Follow-up|3|||
24932345|NCT00457665|50025344|FG000|12 Months|Drug allergy|1|||
24932346|NCT00457665|50025345|FG001|12 Months|Drug allergy|1|||
24932347|NCT00457665|50025344|FG000|12 Months|High HIV viral load|5|||
24932348|NCT00457665|50025345|FG001|12 Months|High HIV viral load|1|||
24932349|NCT00457665|50025344|FG000|12 Months|Lipodystrophy|2|||
24932350|NCT00457665|50025345|FG001|12 Months|Lipodystrophy|0|||
24932351|NCT00457665|50025344|FG000|12 Months|Withdrawal by Subject|0|||
24932352|NCT00457665|50025345|FG001|12 Months|Withdrawal by Subject|2|||
24932353|NCT00457665|50025344|FG000|12 Months|Abnormal Liver function tests|0|||
24932354|NCT00457665|50025345|FG001|12 Months|Abnormal Liver function tests|5|||
24932355|NCT00457665|50025344|FG000|24 Months|Withdrawal by Subject|3|||
24932356|NCT00457665|50025345|FG001|24 Months|Withdrawal by Subject|2|||
24932357|NCT00457665|50025344|FG000|24 Months|Lipodystrophy|1|||
24932358|NCT00457665|50025345|FG001|24 Months|Lipodystrophy|1|||
24932359|NCT00457665|50025344|FG000|24 Months|Abnormal liver function tests|1|||
24932360|NCT00457665|50025345|FG001|24 Months|Abnormal liver function tests|5|||
24932361|NCT00447603|50025351|FG000|Screening|Withdrawal by Subject|1|||
24932362|NCT00447603|50025352|FG001|Screening|Withdrawal by Subject|0|||
24932363|NCT00447603|50025353|FG002|Screening|Withdrawal by Subject|0|||
24932364|NCT00447603|50025351|FG000|Screening|Protocol Violation|1|||
24932365|NCT00447603|50025352|FG001|Screening|Protocol Violation|0|||
24932366|NCT00447603|50025353|FG002|Screening|Protocol Violation|0|||
24932367|NCT00447603|50025351|FG000|Screening|Screen Failure|4|||
24932368|NCT00447603|50025352|FG001|Screening|Screen Failure|0|||
24932369|NCT00447603|50025353|FG002|Screening|Screen Failure|0|||
24932370|NCT00447603|50025351|FG000|Screening|Study Terminated by Sponsor|15|||
24932371|NCT00447603|50025352|FG001|Screening|Study Terminated by Sponsor|0|||
25026940|NCT03287869|50125063|FG000|Overall Study|Non-Compliance With Study Drug|5|||
25026941|NCT03287869|50125064|FG001|Overall Study|Non-Compliance With Study Drug|9|||
25026942|NCT03287869|50125063|FG000|Overall Study|Progressive Disease|1|||
25026943|NCT03287869|50125064|FG001|Overall Study|Progressive Disease|0|||
25026944|NCT03287869|50125063|FG000|Overall Study|Protocol Deviation|2|||
25026945|NCT03287869|50125064|FG001|Overall Study|Protocol Deviation|1|||
25026946|NCT03287869|50125063|FG000|Overall Study|Withdrawal by Subject|36|||
25026947|NCT03287869|50125064|FG001|Overall Study|Withdrawal by Subject|43|||
25026948|NCT03287869|50125063|FG000|Overall Study|Early Closure of the Site|0|||
24932372|NCT00447603|50025353|FG002|Screening|Study Terminated by Sponsor|0|||
24932373|NCT00447603|50025351|FG000|Filter Period|Adverse Event|0|||
24932374|NCT00447603|50025352|FG001|Filter Period|Adverse Event|0|||
24932375|NCT00447603|50025353|FG002|Filter Period|Adverse Event|1|||
24932376|NCT00447603|50025351|FG000|Filter Period|Screen Failure|0|||
24932377|NCT00447603|50025352|FG001|Filter Period|Screen Failure|3|||
24932378|NCT00447603|50025353|FG002|Filter Period|Screen Failure|4|||
25155859|NCT01503021|50271286|FG001|Overall Study|Adverse Event|6|||
24932379|NCT00447603|50025351|FG000|Filter Period|Study terminated by Sponsor|0|||
24932380|NCT00447603|50025352|FG001|Filter Period|Study terminated by Sponsor|1|||
24932381|NCT00447603|50025353|FG002|Filter Period|Study terminated by Sponsor|10|||
25155860|NCT01503021|50271285|FG000|Overall Study|Death|0|||
24932382|NCT00447057|50025365|FG000|Overall Study|Adverse Event|4|||
24932383|NCT00447057|50025366|FG001|Overall Study|Adverse Event|10|||
24932384|NCT00447057|50025367|FG002|Overall Study|Adverse Event|0|||
24932385|NCT00447057|50025368|FG003|Overall Study|Adverse Event|3|||
24932386|NCT00447057|50025365|FG000|Overall Study|Death due to study disease|6|||
24932387|NCT00447057|50025366|FG001|Overall Study|Death due to study disease|4|||
24932388|NCT00447057|50025367|FG002|Overall Study|Death due to study disease|1|||
24932389|NCT00447057|50025368|FG003|Overall Study|Death due to study disease|1|||
24932390|NCT00447057|50025365|FG000|Overall Study|Lost to Follow-up|0|||
24932391|NCT00447057|50025366|FG001|Overall Study|Lost to Follow-up|1|||
24932392|NCT00447057|50025367|FG002|Overall Study|Lost to Follow-up|0|||
24932393|NCT00447057|50025368|FG003|Overall Study|Lost to Follow-up|0|||
24932394|NCT00447057|50025365|FG000|Overall Study|Entry criteria not met|1|||
24932395|NCT00447057|50025366|FG001|Overall Study|Entry criteria not met|1|||
24932396|NCT00447057|50025367|FG002|Overall Study|Entry criteria not met|0|||
24932397|NCT00447057|50025368|FG003|Overall Study|Entry criteria not met|0|||
24932398|NCT00447057|50025365|FG000|Overall Study|Protocol Violation|0|||
24932399|NCT00447057|50025366|FG001|Overall Study|Protocol Violation|1|||
24932400|NCT00447057|50025367|FG002|Overall Study|Protocol Violation|0|||
24932401|NCT00447057|50025368|FG003|Overall Study|Protocol Violation|0|||
24932402|NCT00447057|50025365|FG000|Overall Study|Withdrawal by Subject|4|||
24932403|NCT00447057|50025366|FG001|Overall Study|Withdrawal by Subject|5|||
24932404|NCT00447057|50025367|FG002|Overall Study|Withdrawal by Subject|1|||
24932405|NCT00447057|50025368|FG003|Overall Study|Withdrawal by Subject|1|||
24932406|NCT00447057|50025365|FG000|Overall Study|Physician Decision|9|||
24932407|NCT00447057|50025366|FG001|Overall Study|Physician Decision|6|||
24932408|NCT00447057|50025367|FG002|Overall Study|Physician Decision|3|||
24932409|NCT00447057|50025368|FG003|Overall Study|Physician Decision|1|||
24932410|NCT00447057|50025365|FG000|Overall Study|Sponsor decision|1|||
24932411|NCT00447057|50025366|FG001|Overall Study|Sponsor decision|1|||
24932412|NCT00447057|50025367|FG002|Overall Study|Sponsor decision|0|||
24932413|NCT00447057|50025368|FG003|Overall Study|Sponsor decision|0|||
24932414|NCT00447057|50025365|FG000|Overall Study|Progressive disease|58|||
24932415|NCT00447057|50025366|FG001|Overall Study|Progressive disease|43|||
24932416|NCT00447057|50025367|FG002|Overall Study|Progressive disease|13|||
24932417|NCT00447057|50025368|FG003|Overall Study|Progressive disease|18|||
24932418|NCT00447057|50025365|FG000|Overall Study|Death due to adverse event|0|||
24932419|NCT00447057|50025366|FG001|Overall Study|Death due to adverse event|0|||
24932420|NCT00447057|50025367|FG002|Overall Study|Death due to adverse event|1|||
24932421|NCT00447057|50025368|FG003|Overall Study|Death due to adverse event|2|||
24932422|NCT00447057|50025365|FG000|Overall Study|Death, study drug related|0|||
24932423|NCT00447057|50025366|FG001|Overall Study|Death, study drug related|1|||
24932424|NCT00447057|50025367|FG002|Overall Study|Death, study drug related|0|||
24932425|NCT00447057|50025368|FG003|Overall Study|Death, study drug related|0|||
24932426|NCT00446511|50025380|FG000|Overall Study|Adverse Event|7|||
24932427|NCT00446511|50025381|FG001|Overall Study|Adverse Event|2|||
24932428|NCT00446511|50025382|FG002|Overall Study|Adverse Event|3|||
24932429|NCT00446511|50025383|FG003|Overall Study|Adverse Event|1|||
24932430|NCT00446511|50025380|FG000|Overall Study|Protocol Violation|0|||
24932431|NCT00446511|50025381|FG001|Overall Study|Protocol Violation|0|||
24932432|NCT00446511|50025382|FG002|Overall Study|Protocol Violation|0|||
24932433|NCT00446511|50025383|FG003|Overall Study|Protocol Violation|1|||
24932434|NCT00446511|50025380|FG000|Overall Study|Withdrawal by Subject|0|||
24932435|NCT00446511|50025381|FG001|Overall Study|Withdrawal by Subject|0|||
24932436|NCT00446511|50025382|FG002|Overall Study|Withdrawal by Subject|0|||
24932437|NCT00446511|50025383|FG003|Overall Study|Withdrawal by Subject|3|||
24932438|NCT00446511|50025380|FG000|Overall Study|Administrative Problems|3|||
24932439|NCT00446511|50025381|FG001|Overall Study|Administrative Problems|0|||
24932440|NCT00446511|50025382|FG002|Overall Study|Administrative Problems|4|||
24932441|NCT00446511|50025383|FG003|Overall Study|Administrative Problems|1|||
24932442|NCT00446199|50025399|FG000|Overall Study|Adverse Event|7|||
24932443|NCT00446199|50025400|FG001|Overall Study|Adverse Event|4|||
24932444|NCT00446199|50025401|FG002|Overall Study|Adverse Event|6|||
24932445|NCT00446199|50025402|FG003|Overall Study|Adverse Event|4|||
24932446|NCT00446199|50025399|FG000|Overall Study|Lost to Follow-up|4|||
24932447|NCT00446199|50025400|FG001|Overall Study|Lost to Follow-up|5|||
24932448|NCT00446199|50025401|FG002|Overall Study|Lost to Follow-up|2|||
24932449|NCT00446199|50025402|FG003|Overall Study|Lost to Follow-up|6|||
24932450|NCT00446199|50025399|FG000|Overall Study|Protocol Violation|1|||
24932451|NCT00446199|50025400|FG001|Overall Study|Protocol Violation|2|||
24932452|NCT00446199|50025401|FG002|Overall Study|Protocol Violation|1|||
24932453|NCT00446199|50025402|FG003|Overall Study|Protocol Violation|3|||
24932454|NCT00446199|50025399|FG000|Overall Study|Withdrawal by Subject|2|||
24932455|NCT00446199|50025400|FG001|Overall Study|Withdrawal by Subject|5|||
24932456|NCT00446199|50025401|FG002|Overall Study|Withdrawal by Subject|9|||
24932457|NCT00446199|50025402|FG003|Overall Study|Withdrawal by Subject|10|||
24932458|NCT00446199|50025399|FG000|Overall Study|Site termination|2|||
24932459|NCT00446199|50025400|FG001|Overall Study|Site termination|0|||
24932460|NCT00446199|50025401|FG002|Overall Study|Site termination|0|||
24932461|NCT00446199|50025402|FG003|Overall Study|Site termination|1|||
24932462|NCT00446199|50025399|FG000|Overall Study|Randomization in Error|2|||
24932463|NCT00446199|50025400|FG001|Overall Study|Randomization in Error|0|||
24932464|NCT00446199|50025401|FG002|Overall Study|Randomization in Error|1|||
24932465|NCT00446199|50025402|FG003|Overall Study|Randomization in Error|1|||
24932466|NCT00446199|50025399|FG000|Overall Study|Lack of Efficacy|1|||
24932467|NCT00446199|50025400|FG001|Overall Study|Lack of Efficacy|0|||
24932468|NCT00446199|50025401|FG002|Overall Study|Lack of Efficacy|0|||
24932469|NCT00446199|50025402|FG003|Overall Study|Lack of Efficacy|1|||
24932470|NCT00446199|50025399|FG000|Overall Study|Non-compliant with study drug|1|||
25026949|NCT03287869|50125064|FG001|Overall Study|Early Closure of the Site|1|||
25026950|NCT03287869|50125063|FG000|Overall Study|Physician Decision|5|||
25026951|NCT03287869|50125064|FG001|Overall Study|Physician Decision|5|||
25026952|NCT03287869|50125063|FG000|Overall Study|Reason not Specified|6|||
25026953|NCT03287869|50125064|FG001|Overall Study|Reason not Specified|3|||
25026954|NCT02661490|50125075|FG000|Overall Study|Lost to Follow-up|0|||
25026955|NCT02661490|50125076|FG001|Overall Study|Lost to Follow-up|1|||
25026956|NCT02661490|50125077|FG002|Overall Study|Lost to Follow-up|0|||
25026957|NCT02661490|50125078|FG003|Overall Study|Lost to Follow-up|0|||
25026958|NCT02661490|50125079|FG004|Overall Study|Lost to Follow-up|2|||
25026959|NCT02661490|50125075|FG000|Overall Study|Withdrawal by Subject|2|||
25026960|NCT02661490|50125076|FG001|Overall Study|Withdrawal by Subject|0|||
25026961|NCT02661490|50125077|FG002|Overall Study|Withdrawal by Subject|2|||
25026962|NCT02661490|50125078|FG003|Overall Study|Withdrawal by Subject|0|||
25026963|NCT02661490|50125079|FG004|Overall Study|Withdrawal by Subject|0|||
25026964|NCT02661490|50125075|FG000|Overall Study|Death|1|||
25026965|NCT02661490|50125076|FG001|Overall Study|Death|1|||
25026966|NCT02661490|50125077|FG002|Overall Study|Death|0|||
25026967|NCT02661490|50125078|FG003|Overall Study|Death|1|||
25026968|NCT02661490|50125079|FG004|Overall Study|Death|0|||
25026969|NCT02661490|50125075|FG000|Overall Study|Reason not Specified|0|||
25026970|NCT02661490|50125076|FG001|Overall Study|Reason not Specified|0|||
25026971|NCT02661490|50125077|FG002|Overall Study|Reason not Specified|0|||
24932471|NCT00446199|50025400|FG001|Overall Study|Non-compliant with study drug|0|||
24932472|NCT00446199|50025401|FG002|Overall Study|Non-compliant with study drug|5|||
24932473|NCT00446199|50025402|FG003|Overall Study|Non-compliant with study drug|0|||
24932474|NCT00446199|50025399|FG000|Overall Study|Non-compliant with visit schedule|1|||
24932475|NCT00446199|50025400|FG001|Overall Study|Non-compliant with visit schedule|1|||
25026972|NCT02661490|50125078|FG003|Overall Study|Reason not Specified|0|||
25155861|NCT01503021|50271286|FG001|Overall Study|Death|2|||
24932476|NCT00446199|50025401|FG002|Overall Study|Non-compliant with visit schedule|1|||
24932477|NCT00446199|50025402|FG003|Overall Study|Non-compliant with visit schedule|2|||
24932478|NCT00446199|50025399|FG000|Overall Study|Hormone fear|0|||
24932479|NCT00446199|50025400|FG001|Overall Study|Hormone fear|0|||
24932480|NCT00446199|50025401|FG002|Overall Study|Hormone fear|0|||
24932481|NCT00446199|50025402|FG003|Overall Study|Hormone fear|1|||
24932482|NCT00446199|50025399|FG000|Overall Study|Lost interest in study participation|0|||
24932483|NCT00446199|50025400|FG001|Overall Study|Lost interest in study participation|1|||
24932484|NCT00446199|50025401|FG002|Overall Study|Lost interest in study participation|0|||
24932485|NCT00446199|50025402|FG003|Overall Study|Lost interest in study participation|0|||
24932486|NCT00446199|50025399|FG000|Overall Study|In-/Exclusion criterion violated|2|||
25026973|NCT02661490|50125079|FG004|Overall Study|Reason not Specified|1|||
25026974|NCT03287791|50125094|FG000|Overall Study|Insufficient Therapeutic Response|0|||
25026975|NCT03287791|50125095|FG001|Overall Study|Insufficient Therapeutic Response|0|||
25026976|NCT03287791|50125096|FG002|Overall Study|Insufficient Therapeutic Response|1|||
25026977|NCT03287791|50125094|FG000|Overall Study|Adverse Event|0|||
25026978|NCT03287791|50125095|FG001|Overall Study|Adverse Event|4|||
25026979|NCT03287791|50125096|FG002|Overall Study|Adverse Event|3|||
25155862|NCT01503021|50271285|FG000|Overall Study|Lost to Follow-up|2|||
25026980|NCT03287791|50125094|FG000|Overall Study|Withdrawal by Subject|12|||
25026981|NCT03287791|50125095|FG001|Overall Study|Withdrawal by Subject|12|||
25026982|NCT03287791|50125096|FG002|Overall Study|Withdrawal by Subject|17|||
25155863|NCT01503021|50271286|FG001|Overall Study|Lost to Follow-up|0|||
24932487|NCT00446199|50025400|FG001|Overall Study|In-/Exclusion criterion violated|1|||
24932488|NCT00446199|50025401|FG002|Overall Study|In-/Exclusion criterion violated|2|||
24932489|NCT00446199|50025402|FG003|Overall Study|In-/Exclusion criterion violated|1|||
24932490|NCT00446199|50025399|FG000|Overall Study|Move|0|||
24932491|NCT00446199|50025400|FG001|Overall Study|Move|1|||
24932492|NCT00446199|50025401|FG002|Overall Study|Move|0|||
24932493|NCT00446199|50025402|FG003|Overall Study|Move|0|||
24932494|NCT00456495|50025412|FG000|Overall Study|Physician Decision|2|||
24932495|NCT00445341|50025417|FG000|Overall Study|refused further treatment|1|||
24932496|NCT00445341|50025417|FG000|Overall Study|taken off treatment too early|1|||
24932497|NCT03846453|50025423|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
24932498|NCT03846453|50025424|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
24932499|NCT03846453|50025425|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
24932500|NCT03846453|50025423|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
24932501|NCT03846453|50025424|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
24932502|NCT03846453|50025425|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
24932503|NCT03846453|50025423|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
24932504|NCT03846453|50025424|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
24932505|NCT03846453|50025425|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
24932506|NCT03846453|50025423|FG000|Placebo Run-in (14 Days)|Other|2|||
24932507|NCT03846453|50025424|FG001|Placebo Run-in (14 Days)|Other|0|||
24932508|NCT03846453|50025425|FG002|Placebo Run-in (14 Days)|Other|0|||
24932509|NCT03846453|50025423|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
24932510|NCT03846453|50025424|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
24932511|NCT03846453|50025425|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
24932512|NCT03846453|50025423|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
24932513|NCT03846453|50025424|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
24932514|NCT03846453|50025425|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
24932515|NCT03846453|50025423|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
24932516|NCT03846453|50025424|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
24932517|NCT03846453|50025425|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
24932518|NCT03846453|50025423|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
24932519|NCT03846453|50025424|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
24932520|NCT03846453|50025425|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
24932521|NCT03846453|50025423|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
24932522|NCT03846453|50025424|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
24932523|NCT03846453|50025425|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
24932524|NCT00444951|50025436|FG000|Overall Study|Lost to Follow-up|1|||
24932525|NCT00444951|50025437|FG001|Overall Study|Lost to Follow-up|1|||
24932526|NCT00444951|50025438|FG002|Overall Study|Lost to Follow-up|0|||
25026983|NCT03287791|50125094|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
25026984|NCT03287791|50125095|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
25026985|NCT03287791|50125096|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
25026986|NCT03287791|50125094|FG000|Overall Study|Lost to Follow-up|8|||
25026987|NCT03287791|50125095|FG001|Overall Study|Lost to Follow-up|14|||
25026988|NCT03287791|50125096|FG002|Overall Study|Lost to Follow-up|11|||
25026989|NCT03287791|50125094|FG000|Overall Study|Protocol Violation|7|||
25026990|NCT03287791|50125095|FG001|Overall Study|Protocol Violation|2|||
25026991|NCT03287791|50125096|FG002|Overall Study|Protocol Violation|1|||
25026992|NCT03287791|50125094|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
25026993|NCT03287791|50125095|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
25026994|NCT03287791|50125096|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
25026995|NCT03287791|50125094|FG000|Overall Study|Too much time between 2 visits|0|||
25026996|NCT03287791|50125095|FG001|Overall Study|Too much time between 2 visits|1|||
25026997|NCT03287791|50125096|FG002|Overall Study|Too much time between 2 visits|0|||
25026998|NCT03287791|50125094|FG000|Overall Study|Non-compliance|0|||
25026999|NCT03287791|50125095|FG001|Overall Study|Non-compliance|1|||
25027000|NCT03287791|50125096|FG002|Overall Study|Non-compliance|0|||
25027001|NCT03287791|50125094|FG000|Overall Study|Did not meet inclusion criteria|1|||
25027002|NCT03287791|50125095|FG001|Overall Study|Did not meet inclusion criteria|0|||
25155864|NCT01503021|50271285|FG000|Overall Study|Physician Decision|3|||
24932527|NCT00444951|50025436|FG000|Overall Study|Withdrawal by Subject|4|||
24932528|NCT00444951|50025437|FG001|Overall Study|Withdrawal by Subject|5|||
24932529|NCT00444951|50025438|FG002|Overall Study|Withdrawal by Subject|3|||
24932530|NCT00444795|50025446|FG000|Overall Study|Not Treated|1|||
24932531|NCT00444795|50025446|FG000|Overall Study|Treated Prior to the Contract Date|2|||
24932532|NCT03846219|50025453|FG000|Overall Study|Withdrawal by Subject|3|||
24932533|NCT03846219|50025454|FG001|Overall Study|Withdrawal by Subject|2|||
24932534|NCT03846219|50025455|FG002|Overall Study|Withdrawal by Subject|2|||
24932535|NCT03846219|50025453|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
24932536|NCT03846219|50025454|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
24932537|NCT03846219|50025455|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
24932538|NCT03846219|50025453|FG000|Overall Study|Physician Decision|0|||
24932539|NCT03846219|50025454|FG001|Overall Study|Physician Decision|0|||
24932540|NCT03846219|50025455|FG002|Overall Study|Physician Decision|2|||
24932541|NCT00455325|50025471|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
24932542|NCT00455325|50025472|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
24932543|NCT00455325|50025473|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
24932544|NCT00455325|50025474|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
24932545|NCT00455325|50025471|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
24932546|NCT00455325|50025472|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
24932547|NCT00455325|50025473|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
24932548|NCT00455325|50025474|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
24932549|NCT00455325|50025471|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
24932550|NCT00455325|50025472|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
24932551|NCT00455325|50025473|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
24932552|NCT00455325|50025474|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
24932553|NCT00455325|50025471|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
24932554|NCT00455325|50025472|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
24932555|NCT00455325|50025473|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
24932556|NCT00455325|50025474|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
24932557|NCT00455325|50025471|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
24932558|NCT00455325|50025472|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
24932559|NCT00455325|50025473|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
24932560|NCT00455325|50025474|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
24932561|NCT00455325|50025471|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
24932562|NCT00455325|50025472|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
24932563|NCT00455325|50025473|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
24932564|NCT00455325|50025474|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
24932565|NCT00455325|50025471|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
24932566|NCT00455325|50025472|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
24932567|NCT00455325|50025473|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
24932568|NCT00455325|50025474|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
24932569|NCT00443781|50025485|FG000|Overall Study|Lost to Follow-up|10|||
24932570|NCT00443781|50025485|FG000|Overall Study|Physician Decision|2|||
24932571|NCT00443781|50025485|FG000|Overall Study|Protocol Violation|1|||
25027003|NCT03287791|50125096|FG002|Overall Study|Did not meet inclusion criteria|0|||
25027004|NCT03287635|50125104|FG000|Overall Study|Lost to Follow-up|5|||
25027005|NCT03287635|50125104|FG000|Overall Study|Withdrawal by Subject|1|||
24932572|NCT00443781|50025485|FG000|Overall Study|Withdrawal by Subject|6|||
24932573|NCT00443781|50025485|FG000|Overall Study|Unable to comply with study follow up|2|||
24932574|NCT00443781|50025485|FG000|Overall Study|Investigator terminated participation|1|||
24932575|NCT00443781|50025485|FG000|Overall Study|Insurance not covered|2|||
24932576|NCT00443781|50025485|FG000|Overall Study|PD/FAD not done|1|||
24932577|NCT00443703|50025491|FG000|Overall Study|Never Treated|3|||
24932578|NCT00443703|50025492|FG001|Overall Study|Never Treated|1|||
24932579|NCT00443703|50025491|FG000|Overall Study|Adverse Event|7|||
24932580|NCT00443703|50025492|FG001|Overall Study|Adverse Event|3|||
24932581|NCT00443703|50025491|FG000|Overall Study|Lack of Efficacy|3|||
24932582|NCT00443703|50025492|FG001|Overall Study|Lack of Efficacy|1|||
25027006|NCT03287635|50125104|FG000|Overall Study|Physician Decision|1|||
25027007|NCT03287089|50125110|FG000|Overall Study|Lost to Follow-up|0|||
24932583|NCT00443703|50025491|FG000|Overall Study|Lost to Follow-up|0|||
25027008|NCT03287089|50125111|FG001|Overall Study|Lost to Follow-up|2|||
24932584|NCT00443703|50025492|FG001|Overall Study|Lost to Follow-up|4|||
24932585|NCT00443703|50025491|FG000|Overall Study|Physician Decision|4|||
24932586|NCT00443703|50025492|FG001|Overall Study|Physician Decision|2|||
24932587|NCT00443703|50025491|FG000|Overall Study|Protocol Violation|1|||
24932588|NCT00443703|50025492|FG001|Overall Study|Protocol Violation|1|||
24932589|NCT00443703|50025491|FG000|Overall Study|Withdrawal by Subject|9|||
24932590|NCT00443703|50025492|FG001|Overall Study|Withdrawal by Subject|6|||
24932591|NCT00443703|50025491|FG000|Overall Study|Progressive Disease|1|||
24932592|NCT00443703|50025492|FG001|Overall Study|Progressive Disease|0|||
24932593|NCT00381706|50025504|FG000|Overall Study|Never treated|7|||
24932594|NCT00381706|50025505|FG001|Overall Study|Never treated|2|||
24932595|NCT00381706|50025506|FG002|Overall Study|Never treated|1|||
24932596|NCT00535236|50025530|FG000|Overall Study|Adverse Event|1|||
25155865|NCT01503021|50271286|FG001|Overall Study|Physician Decision|0|||
25155866|NCT01503021|50271285|FG000|Overall Study|Protocol Violation|1|||
24932597|NCT00535236|50025531|FG001|Overall Study|Adverse Event|0|||
24932598|NCT00535236|50025532|FG002|Overall Study|Adverse Event|9|||
24932599|NCT00535236|50025533|FG003|Overall Study|Adverse Event|3|||
24932600|NCT00535236|50025534|FG004|Overall Study|Adverse Event|3|||
24932601|NCT00535236|50025535|FG005|Overall Study|Adverse Event|0|||
24932602|NCT00535236|50025536|FG006|Overall Study|Adverse Event|5|||
24932603|NCT00535236|50025537|FG007|Overall Study|Adverse Event|1|||
24932604|NCT00535236|50025538|FG008|Overall Study|Adverse Event|2|||
24932605|NCT00535236|50025539|FG009|Overall Study|Adverse Event|1|||
24932606|NCT00535236|50025530|FG000|Overall Study|Lost to Follow-up|1|||
24932607|NCT00535236|50025531|FG001|Overall Study|Lost to Follow-up|2|||
24932608|NCT00535236|50025532|FG002|Overall Study|Lost to Follow-up|0|||
24932609|NCT00535236|50025533|FG003|Overall Study|Lost to Follow-up|0|||
24932610|NCT00535236|50025534|FG004|Overall Study|Lost to Follow-up|2|||
24932611|NCT00535236|50025535|FG005|Overall Study|Lost to Follow-up|0|||
24932612|NCT00535236|50025536|FG006|Overall Study|Lost to Follow-up|0|||
24932613|NCT00535236|50025537|FG007|Overall Study|Lost to Follow-up|0|||
24932614|NCT00535236|50025538|FG008|Overall Study|Lost to Follow-up|6|||
24932615|NCT00535236|50025539|FG009|Overall Study|Lost to Follow-up|1|||
24932616|NCT00535236|50025530|FG000|Overall Study|Physician Decision|0|||
24932617|NCT00535236|50025531|FG001|Overall Study|Physician Decision|0|||
24932618|NCT00535236|50025532|FG002|Overall Study|Physician Decision|0|||
24932619|NCT00535236|50025533|FG003|Overall Study|Physician Decision|0|||
24932620|NCT00535236|50025534|FG004|Overall Study|Physician Decision|1|||
24932621|NCT00535236|50025535|FG005|Overall Study|Physician Decision|0|||
24932622|NCT00535236|50025536|FG006|Overall Study|Physician Decision|1|||
24932623|NCT00535236|50025537|FG007|Overall Study|Physician Decision|0|||
24932624|NCT00535236|50025538|FG008|Overall Study|Physician Decision|0|||
24932625|NCT00535236|50025539|FG009|Overall Study|Physician Decision|0|||
24932626|NCT00535236|50025530|FG000|Overall Study|Protocol Violation|2|||
24932627|NCT00535236|50025531|FG001|Overall Study|Protocol Violation|0|||
24932628|NCT00535236|50025532|FG002|Overall Study|Protocol Violation|1|||
24932629|NCT00535236|50025533|FG003|Overall Study|Protocol Violation|0|||
24932630|NCT00535236|50025534|FG004|Overall Study|Protocol Violation|0|||
24932631|NCT00535236|50025535|FG005|Overall Study|Protocol Violation|0|||
24932632|NCT00535236|50025536|FG006|Overall Study|Protocol Violation|0|||
24932633|NCT00535236|50025537|FG007|Overall Study|Protocol Violation|0|||
25027009|NCT03287089|50125110|FG000|Overall Study|Physician Decision|0|||
25027010|NCT03287089|50125111|FG001|Overall Study|Physician Decision|2|||
25027011|NCT03287089|50125110|FG000|Overall Study|Withdrawal by Subject|0|||
25027012|NCT03287089|50125111|FG001|Overall Study|Withdrawal by Subject|2|||
25027013|NCT03286543|50125119|FG000|Consented|Screen failure before randomization|2|||
25027014|NCT03286543|50125120|FG001|Consented|Screen failure before randomization|0|||
25155867|NCT01503021|50271286|FG001|Overall Study|Protocol Violation|3|||
25155868|NCT01503021|50271285|FG000|Overall Study|Withdrawal by Subject|9|||
25155869|NCT01503021|50271286|FG001|Overall Study|Withdrawal by Subject|8|||
25155870|NCT01503021|50271285|FG000|Overall Study|Moved, received transplant, etc.|5|||
25155871|NCT01503021|50271286|FG001|Overall Study|Moved, received transplant, etc.|7|||
25155872|NCT01531725|50271297|FG000|Overall Study|Protocol Violation|5|||
25027015|NCT03286543|50125121|FG002|Consented|Screen failure before randomization|0|||
25027016|NCT03286543|50125119|FG000|Consented|Screen failure before enrollment|4|||
25027017|NCT03286543|50125120|FG001|Consented|Screen failure before enrollment|0|||
25155873|NCT01478373|50271301|FG000|Treatment Phase|Protocol Violation|1|||
25155874|NCT01478373|50271301|FG000|Survival Phase|Adverse Event|8|||
25155875|NCT01478373|50271301|FG000|Survival Phase|Protocol Violation|1|||
24932634|NCT00535236|50025538|FG008|Overall Study|Protocol Violation|1|||
25155876|NCT01478373|50271301|FG000|Survival Phase|crossover to another study|2|||
24932635|NCT00535236|50025539|FG009|Overall Study|Protocol Violation|0|||
24932636|NCT00535236|50025530|FG000|Overall Study|Withdrawal by Subject|3|||
24932637|NCT00535236|50025531|FG001|Overall Study|Withdrawal by Subject|0|||
24932638|NCT00535236|50025532|FG002|Overall Study|Withdrawal by Subject|2|||
24932639|NCT00535236|50025533|FG003|Overall Study|Withdrawal by Subject|1|||
25027018|NCT03286543|50125121|FG002|Consented|Screen failure before enrollment|0|||
25155877|NCT01478373|50271301|FG000|Survival Phase|Progressive Disease|27|||
25155878|NCT01502709|50271307|FG000|Overall Study|Lost to Follow-up|4|||
25155879|NCT01502709|50271308|FG001|Overall Study|Lost to Follow-up|0|||
25155880|NCT01477749|50271315|FG000|Overall Study|Physician Decision|4|||
25155881|NCT01502631|50271345|FG000|Overall Study|Adverse Event|5|||
25155882|NCT01502631|50271346|FG001|Overall Study|Adverse Event|8|||
25155883|NCT01502631|50271345|FG000|Overall Study|Lost to Follow-up|2|||
25155884|NCT01502631|50271346|FG001|Overall Study|Lost to Follow-up|2|||
25155885|NCT01502631|50271345|FG000|Overall Study|Participant withdrew consent|2|||
25155886|NCT01502631|50271346|FG001|Overall Study|Participant withdrew consent|4|||
25155887|NCT01502631|50271345|FG000|Overall Study|Participant non-compliant|1|||
25155888|NCT01502631|50271346|FG001|Overall Study|Participant non-compliant|0|||
25155889|NCT01502631|50271345|FG000|Overall Study|Investigator's decision|0|||
25155890|NCT01502631|50271346|FG001|Overall Study|Investigator's decision|1|||
25155891|NCT01502631|50271345|FG000|Overall Study|Other|10|||
25155892|NCT01502631|50271346|FG001|Overall Study|Other|5|||
25155893|NCT01475721|50271406|FG000|Overall Study|Death|3|||
25155894|NCT01475721|50271407|FG001|Overall Study|Death|6|||
25155895|NCT01475721|50271406|FG000|Overall Study|Withdrawal by Subject|8|||
25155896|NCT01475721|50271407|FG001|Overall Study|Withdrawal by Subject|8|||
25027019|NCT03286543|50125119|FG000|Consented|TKA cancelled after enrollment|1|||
25027020|NCT03286543|50125120|FG001|Consented|TKA cancelled after enrollment|0|||
25027021|NCT03286543|50125121|FG002|Consented|TKA cancelled after enrollment|0|||
25027022|NCT03286543|50125119|FG000|Consented|Withdrawn from study|12|||
25027023|NCT03286543|50125120|FG001|Consented|Withdrawn from study|0|||
25027024|NCT03286543|50125121|FG002|Consented|Withdrawn from study|0|||
25027025|NCT03286543|50125119|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
25027026|NCT03286543|50125120|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
25027027|NCT03286543|50125121|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
25027028|NCT03286543|50125119|FG000|Study Enrollment|Withdrawn from study|0|||
25027029|NCT03286543|50125120|FG001|Study Enrollment|Withdrawn from study|6|||
25027030|NCT03286543|50125121|FG002|Study Enrollment|Withdrawn from study|6|||
25027031|NCT03306433|50125127|FG000|Overall Study|Lost to Follow-up|3|||
25027032|NCT03306433|50125127|FG000|Overall Study|Patient did not have teeth extracted|1|||
25027033|NCT03306433|50125127|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
25027034|NCT02940691|50125135|FG000|Overall Study|Lost to Follow-up|5|||
25027035|NCT02940691|50125135|FG000|Overall Study|Incarceration|1|||
25027036|NCT03306277|50125173|FG000|Overall Study|Death|1|||
25027037|NCT03306277|50125173|FG000|Overall Study|Adverse Event|1|||
24932640|NCT00535236|50025534|FG004|Overall Study|Withdrawal by Subject|6|||
24932641|NCT00535236|50025535|FG005|Overall Study|Withdrawal by Subject|1|||
24932642|NCT00535236|50025536|FG006|Overall Study|Withdrawal by Subject|5|||
24932643|NCT00535236|50025537|FG007|Overall Study|Withdrawal by Subject|0|||
24932644|NCT00535236|50025538|FG008|Overall Study|Withdrawal by Subject|4|||
24932645|NCT00535236|50025539|FG009|Overall Study|Withdrawal by Subject|2|||
24932646|NCT00370552|50025567|FG000|Overall Study|Adverse Event|2|||
24932647|NCT00370552|50025568|FG001|Overall Study|Adverse Event|2|||
24932648|NCT00370552|50025569|FG002|Overall Study|Adverse Event|2|||
24932649|NCT00370552|50025567|FG000|Overall Study|Disease progression|23|||
24932650|NCT00370552|50025568|FG001|Overall Study|Disease progression|23|||
24932651|NCT00370552|50025569|FG002|Overall Study|Disease progression|15|||
24932652|NCT00370552|50025567|FG000|Overall Study|Maximum clinical benefit|3|||
24932653|NCT00370552|50025568|FG001|Overall Study|Maximum clinical benefit|5|||
24932654|NCT00370552|50025569|FG002|Overall Study|Maximum clinical benefit|5|||
25027038|NCT03306277|50125173|FG000|Overall Study|Withdrawal by Subject|1|||
25027039|NCT03130959|50125187|FG000|Overall Study|Disease progression|19|||
25027040|NCT03130959|50125188|FG001|Overall Study|Disease progression|7|||
25027041|NCT03130959|50125189|FG002|Overall Study|Disease progression|12|||
25027042|NCT03130959|50125190|FG003|Overall Study|Disease progression|7|||
25027043|NCT03130959|50125191|FG004|Overall Study|Disease progression|12|||
25027044|NCT03130959|50125192|FG005|Overall Study|Disease progression|3|||
25027045|NCT03130959|50125193|FG006|Overall Study|Disease progression|6|||
25155897|NCT01530087|50271431|FG000|Overall Study|Physician Decision|2|||
25155898|NCT01475487|50271449|FG000|Overall Study|had to leave early for personal reasons|2|||
25155899|NCT01475487|50271450|FG001|Overall Study|had to leave early for personal reasons|1|||
24932655|NCT00370552|50025567|FG000|Overall Study|Poor or noncompliance|0|||
24932656|NCT00370552|50025568|FG001|Overall Study|Poor or noncompliance|0|||
25027046|NCT03130959|50125194|FG007|Overall Study|Disease progression|3|||
25027047|NCT03130959|50125195|FG008|Overall Study|Disease progression|15|||
25155900|NCT01475331|50271458|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
25027048|NCT03130959|50125196|FG009|Overall Study|Disease progression|8|||
25027049|NCT03130959|50125187|FG000|Overall Study|Study drug toxicity|2|||
25027050|NCT03130959|50125188|FG001|Overall Study|Study drug toxicity|2|||
25027051|NCT03130959|50125189|FG002|Overall Study|Study drug toxicity|1|||
25027052|NCT03130959|50125190|FG003|Overall Study|Study drug toxicity|2|||
25155901|NCT01475331|50271459|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
25155902|NCT01475331|50271458|FG000|Overall Study|excessive main duct communication|1|||
25155903|NCT01475331|50271459|FG001|Overall Study|excessive main duct communication|1|||
25027053|NCT03130959|50125191|FG004|Overall Study|Study drug toxicity|1|||
25027054|NCT03130959|50125192|FG005|Overall Study|Study drug toxicity|1|||
25027055|NCT03130959|50125193|FG006|Overall Study|Study drug toxicity|3|||
25027056|NCT03130959|50125194|FG007|Overall Study|Study drug toxicity|0|||
25027057|NCT03130959|50125195|FG008|Overall Study|Study drug toxicity|3|||
25027058|NCT03130959|50125196|FG009|Overall Study|Study drug toxicity|3|||
25027059|NCT03130959|50125187|FG000|Overall Study|Other reasons|0|||
25027060|NCT03130959|50125188|FG001|Overall Study|Other reasons|0|||
25027061|NCT03130959|50125189|FG002|Overall Study|Other reasons|0|||
25027062|NCT03130959|50125190|FG003|Overall Study|Other reasons|0|||
25027063|NCT03130959|50125191|FG004|Overall Study|Other reasons|0|||
25027064|NCT03130959|50125192|FG005|Overall Study|Other reasons|1|||
25027065|NCT03130959|50125193|FG006|Overall Study|Other reasons|1|||
25027066|NCT03130959|50125194|FG007|Overall Study|Other reasons|0|||
25027067|NCT03130959|50125195|FG008|Overall Study|Other reasons|0|||
24932657|NCT00370552|50025569|FG002|Overall Study|Poor or noncompliance|1|||
24932658|NCT00370552|50025567|FG000|Overall Study|Study drug toxicity|11|||
24932659|NCT00370552|50025568|FG001|Overall Study|Study drug toxicity|8|||
24932660|NCT00370552|50025569|FG002|Overall Study|Study drug toxicity|6|||
24932661|NCT00370552|50025567|FG000|Overall Study|Withdrawal by Subject|2|||
24932662|NCT00370552|50025568|FG001|Overall Study|Withdrawal by Subject|0|||
24932663|NCT00370552|50025569|FG002|Overall Study|Withdrawal by Subject|1|||
24932664|NCT00370552|50025567|FG000|Overall Study|Still on treatment|1|||
24932665|NCT00370552|50025568|FG001|Overall Study|Still on treatment|3|||
24932666|NCT00370552|50025569|FG002|Overall Study|Still on treatment|2|||
24932667|NCT00370552|50025567|FG000|Overall Study|Never treated|1|||
24932668|NCT00370552|50025568|FG001|Overall Study|Never treated|0|||
24932669|NCT00370552|50025569|FG002|Overall Study|Never treated|0|||
24932670|NCT00370552|50025567|FG000|Overall Study|Physician Decision|1|||
24932671|NCT00370552|50025568|FG001|Overall Study|Physician Decision|1|||
24932672|NCT00370552|50025569|FG002|Overall Study|Physician Decision|0|||
24932673|NCT00370552|50025567|FG000|Overall Study|Investigator decision|2|||
24932674|NCT00370552|50025568|FG001|Overall Study|Investigator decision|1|||
24932675|NCT00370552|50025569|FG002|Overall Study|Investigator decision|0|||
24932676|NCT00370552|50025567|FG000|Overall Study|High risk of allergic reaction|0|||
24932677|NCT00370552|50025568|FG001|Overall Study|High risk of allergic reaction|1|||
24932678|NCT00370552|50025569|FG002|Overall Study|High risk of allergic reaction|0|||
24932679|NCT00370552|50025567|FG000|Overall Study|Planned radiation for palliation|0|||
24932680|NCT00370552|50025568|FG001|Overall Study|Planned radiation for palliation|1|||
24932681|NCT00370552|50025569|FG002|Overall Study|Planned radiation for palliation|0|||
24932682|NCT00537030|50025577|FG000|Overall Study|Physician Decision|2|||
24932683|NCT00537030|50025577|FG000|Overall Study|Withdrawal by Subject|2|||
24932684|NCT00537030|50025577|FG000|Overall Study|≥ Grade 2 allergy|7|||
24932685|NCT00537030|50025577|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
24932686|NCT00537030|50025577|FG000|Overall Study|Ineligible|2|||
24932687|NCT00537030|50025577|FG000|Overall Study|Inevaluable|2|||
24932688|NCT00381238|50025581|FG000|Overall Study|Adverse Event|3|||
24932689|NCT00381238|50025581|FG000|Overall Study|Protocol Violation|1|||
24932690|NCT00381238|50025581|FG000|Overall Study|Withdrawal by Subject|4|||
24932691|NCT00381238|50025581|FG000|Overall Study|Lack of Efficacy|2|||
24932692|NCT00381238|50025581|FG000|Overall Study|Withdrew by physician|1|||
24932693|NCT00381238|50025581|FG000|Overall Study|Disease progression|1|||
24932694|NCT03896022|50025588|FG000|Overall Study|Withdrawal by Subject|1|||
24932695|NCT03896022|50025589|FG001|Overall Study|Withdrawal by Subject|0|||
24932696|NCT03896022|50025590|FG002|Overall Study|Withdrawal by Subject|0|||
24932697|NCT03896022|50025588|FG000|Overall Study|Did not have procedure|3|||
24932698|NCT03896022|50025589|FG001|Overall Study|Did not have procedure|0|||
24932699|NCT03896022|50025590|FG002|Overall Study|Did not have procedure|0|||
24932700|NCT03831880|50025602|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
24932701|NCT03831880|50025603|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
24932702|NCT03831880|50025602|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
24932703|NCT03831880|50025603|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
24932704|NCT00380692|50025626|FG000|Study Period II - Double Blind|Adverse Event|1|||
24932705|NCT00380692|50025627|FG001|Study Period II - Double Blind|Adverse Event|0|||
24932706|NCT00380692|50025626|FG000|Study Period II - Double Blind|Protocol Violation|2|||
24932707|NCT00380692|50025627|FG001|Study Period II - Double Blind|Protocol Violation|2|||
24932708|NCT00380692|50025626|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
25027068|NCT03130959|50125196|FG009|Overall Study|Other reasons|0|||
24932709|NCT00380692|50025627|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
24932710|NCT00380692|50025626|FG000|Study Period II - Double Blind|Physician Decision|0|||
24932711|NCT00380692|50025627|FG001|Study Period II - Double Blind|Physician Decision|1|||
24932712|NCT00380692|50025626|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
24932713|NCT00380692|50025627|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
25027069|NCT03130959|50125187|FG000|Overall Study|Subject request to discontinue therapy|0|||
25027070|NCT03130959|50125188|FG001|Overall Study|Subject request to discontinue therapy|0|||
25027071|NCT03130959|50125189|FG002|Overall Study|Subject request to discontinue therapy|1|||
24932714|NCT00380692|50025626|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
24932715|NCT00380692|50025627|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
24932716|NCT00380692|50025626|FG000|Study Period III - Open Label|Adverse Event|5|||
24932717|NCT00380692|50025627|FG001|Study Period III - Open Label|Adverse Event|3|||
24932718|NCT00380692|50025626|FG000|Study Period III - Open Label|Protocol Violation|0|||
24932719|NCT00380692|50025627|FG001|Study Period III - Open Label|Protocol Violation|0|||
24932720|NCT00380692|50025626|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
24932721|NCT00380692|50025627|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
24932722|NCT00380692|50025626|FG000|Study Period III - Open Label|Physician Decision|0|||
24932723|NCT00380692|50025627|FG001|Study Period III - Open Label|Physician Decision|3|||
24932724|NCT00380692|50025626|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
24932725|NCT00380692|50025627|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
24932726|NCT00380692|50025626|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
24932727|NCT00380692|50025627|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
24932728|NCT00536874|50025633|FG000|Overall Study|Adverse Event|1|||
24932729|NCT00536874|50025633|FG000|Overall Study|Death|2|||
24932730|NCT00536874|50025633|FG000|Overall Study|Withdrawal by Subject|1|||
24932731|NCT00380068|50025637|FG000|Overall Study|Adverse Event|40|||
24932732|NCT00380068|50025637|FG000|Overall Study|Withdrawal by Subject|10|||
24932733|NCT00380068|50025637|FG000|Overall Study|Not compliant|6|||
24932734|NCT00380068|50025637|FG000|Overall Study|Lost to Follow-up|1|||
24932735|NCT00380068|50025637|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
24932736|NCT00380068|50025637|FG000|Overall Study|Lung transplant|3|||
24932737|NCT00380068|50025637|FG000|Overall Study|Physician Decision|2|||
24932738|NCT00380068|50025637|FG000|Overall Study|Partipant moved away|1|||
24932739|NCT00380068|50025637|FG000|Overall Study|Lack of Efficacy|5|||
24932740|NCT00536484|50025643|FG000|Overall Study|Adverse Event|21|||
24932741|NCT00536484|50025644|FG001|Overall Study|Adverse Event|34|||
24932742|NCT00536484|50025643|FG000|Overall Study|Withdrawal by Subject|11|||
24932743|NCT00536484|50025644|FG001|Overall Study|Withdrawal by Subject|11|||
24932744|NCT00536484|50025643|FG000|Overall Study|Lost to Follow-up|8|||
24932745|NCT00536484|50025644|FG001|Overall Study|Lost to Follow-up|6|||
24932746|NCT00536484|50025643|FG000|Overall Study|Lack of Efficacy|16|||
24932747|NCT00536484|50025644|FG001|Overall Study|Lack of Efficacy|5|||
24932748|NCT00536484|50025643|FG000|Overall Study|Other|4|||
24932749|NCT00536484|50025644|FG001|Overall Study|Other|0|||
24932750|NCT00370396|50025653|FG000|Overall Study|Withdrawal by Subject|0|||
24932751|NCT00370396|50025654|FG001|Overall Study|Withdrawal by Subject|0|||
24932752|NCT00370396|50025655|FG002|Overall Study|Withdrawal by Subject|1|||
24932753|NCT00370396|50025653|FG000|Overall Study|Lost to Follow-up|11|||
24932754|NCT00370396|50025654|FG001|Overall Study|Lost to Follow-up|1|||
24932755|NCT00370396|50025655|FG002|Overall Study|Lost to Follow-up|0|||
24932756|NCT00455013|50025666|FG000|Short Term Period|Adverse Event|2|||
24932757|NCT00455013|50025667|FG001|Short Term Period|Adverse Event|5|||
24932758|NCT00455013|50025668|FG002|Short Term Period|Adverse Event|0|||
24932759|NCT00455013|50025666|FG000|Short Term Period|Withdrawal by Subject|0|||
24932760|NCT00455013|50025667|FG001|Short Term Period|Withdrawal by Subject|0|||
24932761|NCT00455013|50025668|FG002|Short Term Period|Withdrawal by Subject|1|||
24932762|NCT00455013|50025666|FG000|Short Term Period|Lack of Efficacy|4|||
24932763|NCT00455013|50025667|FG001|Short Term Period|Lack of Efficacy|0|||
24932764|NCT00455013|50025668|FG002|Short Term Period|Lack of Efficacy|0|||
24932765|NCT00455013|50025666|FG000|Short Term Period|Other|0|||
24932766|NCT00455013|50025667|FG001|Short Term Period|Other|0|||
24932767|NCT00455013|50025668|FG002|Short Term Period|Other|1|||
24932768|NCT00455013|50025666|FG000|Long Term Extension (LTE)|Adverse Event|0|||
24932769|NCT00455013|50025667|FG001|Long Term Extension (LTE)|Adverse Event|1|||
24932770|NCT00455013|50025668|FG002|Long Term Extension (LTE)|Adverse Event|1|||
24932771|NCT00455013|50025666|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
24932772|NCT00455013|50025667|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
24932773|NCT00455013|50025668|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
24932774|NCT00455013|50025666|FG000|Long Term Extension (LTE)|Death|1|||
24932775|NCT00455013|50025667|FG001|Long Term Extension (LTE)|Death|1|||
24932776|NCT00455013|50025668|FG002|Long Term Extension (LTE)|Death|0|||
24932777|NCT00455013|50025666|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
24932778|NCT00455013|50025667|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
24932779|NCT00455013|50025668|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
24932780|NCT00455013|50025666|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
24932781|NCT00455013|50025667|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
24932782|NCT00455013|50025668|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
24932783|NCT00455013|50025666|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
24932784|NCT00455013|50025667|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
24932785|NCT00455013|50025668|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
24932786|NCT00455013|50025666|FG000|Long Term Extension (LTE)|non-specified|0|||
24932787|NCT00455013|50025667|FG001|Long Term Extension (LTE)|non-specified|0|||
24932788|NCT00455013|50025668|FG002|Long Term Extension (LTE)|non-specified|1|||
24932789|NCT00363298|50025678|FG000|First Study Week|Lack of Efficacy|6|||
24932790|NCT00363298|50025679|FG001|First Study Week|Lack of Efficacy|5|||
24932791|NCT00363298|50025678|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
24932792|NCT00363298|50025679|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
24932793|NCT00363142|50025688|FG000|Overall Study|Adverse Event|2|||
24932794|NCT00363142|50025689|FG001|Overall Study|Adverse Event|0|||
24932795|NCT00363142|50025688|FG000|Overall Study|Lack of Efficacy|0|||
24932796|NCT00363142|50025689|FG001|Overall Study|Lack of Efficacy|1|||
24932797|NCT00363142|50025688|FG000|Overall Study|Lost to Follow-up|1|||
24932798|NCT00363142|50025689|FG001|Overall Study|Lost to Follow-up|0|||
24932799|NCT00363142|50025688|FG000|Overall Study|Non-compliance|1|||
24932800|NCT00363142|50025689|FG001|Overall Study|Non-compliance|1|||
24932801|NCT00363142|50025688|FG000|Overall Study|Withdrawal by Subject|3|||
24932802|NCT00363142|50025689|FG001|Overall Study|Withdrawal by Subject|1|||
24932803|NCT00454857|50025698|FG000|Overall Study|Withdrawal by Subject|15|||
24932804|NCT00454857|50025698|FG000|Overall Study|Lost to Follow-up|16|||
24932805|NCT00454857|50025698|FG000|Overall Study|Noncompliance|6|||
24932806|NCT00454857|50025698|FG000|Overall Study|Death|5|||
24932807|NCT00454857|50025698|FG000|Overall Study|Other|11|||
24932808|NCT00454857|50025698|FG000|Overall Study|Reason unknown|1|||
24932809|NCT00379912|50025704|FG000|Overall Study|Lack of Efficacy|1|||
24932810|NCT00379912|50025705|FG001|Overall Study|Lack of Efficacy|0|||
24932811|NCT00379834|50025717|FG000|Overall Study|Time constraints|2|||
24932812|NCT00379210|50025723|FG000|Overall Study|Withdrawal by Subject|10|||
24932813|NCT00379210|50025724|FG001|Overall Study|Withdrawal by Subject|7|||
24932814|NCT00378898|50025732|FG000|Overall Study|Withdrawal by Subject|10|||
24932815|NCT00378898|50025733|FG001|Overall Study|Withdrawal by Subject|5|||
24932816|NCT00378898|50025732|FG000|Overall Study|Protocol Violation|1|||
24932817|NCT00378898|50025733|FG001|Overall Study|Protocol Violation|1|||
24932818|NCT00378508|50025743|FG000|Overall Study|Withdrawal by Subject|1|||
24932819|NCT00378508|50025744|FG001|Overall Study|Withdrawal by Subject|3|||
24932820|NCT00378508|50025743|FG000|Overall Study|Lost to Follow-up|1|||
24932821|NCT00378508|50025744|FG001|Overall Study|Lost to Follow-up|0|||
24932822|NCT00454779|50025753|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
24932823|NCT00454779|50025754|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
25155904|NCT01475331|50271458|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
25155905|NCT01475331|50271459|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
24932824|NCT00454779|50025753|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
24932825|NCT00454779|50025754|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
24932826|NCT00454779|50025753|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
24932827|NCT00454779|50025754|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
24932828|NCT00454779|50025753|FG000|First-line Treatment Phase|Protocol Violation|0|||
25185708|NCT01425203|50335249|FG000|Treatment Phase|Other virologic failure criteria|5|||
24932829|NCT00454779|50025754|FG001|First-line Treatment Phase|Protocol Violation|1|||
24932830|NCT00454779|50025753|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
24932831|NCT00454779|50025754|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
24932832|NCT00454779|50025753|FG000|First-line Treatment Phase|Ongoing|1|||
25027072|NCT03130959|50125190|FG003|Overall Study|Subject request to discontinue therapy|1|||
25027073|NCT03130959|50125191|FG004|Overall Study|Subject request to discontinue therapy|0|||
24932833|NCT00454779|50025754|FG001|First-line Treatment Phase|Ongoing|0|||
24932834|NCT00454779|50025753|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
24932835|NCT00454779|50025754|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
24932836|NCT00454779|50025753|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
24932837|NCT00454779|50025754|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
24932838|NCT00454779|50025753|FG000|Second-line Treatment Phase|Ongoing|0|||
24932839|NCT00454779|50025754|FG001|Second-line Treatment Phase|Ongoing|1|||
24932840|NCT00439569|50025764|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
24932841|NCT00439569|50025764|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
24932842|NCT00439569|50025764|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
24932843|NCT00443079|50025770|FG000|Overall Study|Lost to Follow-up|0|||
24932844|NCT00443079|50025771|FG001|Overall Study|Lost to Follow-up|1|||
24932845|NCT00427635|50025807|FG000|Treatment Phase|Withdrawal by Subject|1|||
24932846|NCT00427635|50025808|FG001|Treatment Phase|Withdrawal by Subject|0|||
24932847|NCT00427635|50025807|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
24932848|NCT00427635|50025808|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
24932849|NCT00427011|50025814|FG000|Overall Study|Adverse Event|10|||
24932850|NCT00427011|50025814|FG000|Overall Study|Withdrawal by Subject|1|||
24932851|NCT00427011|50025814|FG000|Overall Study|Lack of Efficacy|2|||
24932852|NCT00427011|50025814|FG000|Overall Study|Other|12|||
24932853|NCT03891264|50025819|FG000|Overall Study|Adverse Event|1|||
24932854|NCT03891264|50025819|FG000|Overall Study|Withdrawal by Subject|2|||
24932855|NCT03891264|50025819|FG000|Overall Study|Physician Decision|2|||
24932856|NCT00439179|50025827|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
24932857|NCT00439179|50025828|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
24932858|NCT00439179|50025829|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
24932859|NCT00439179|50025830|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
24932860|NCT00438633|50025845|FG000|Overall Study|Withdrawal by Subject|1|||
24932861|NCT00438633|50025846|FG001|Overall Study|Withdrawal by Subject|0|||
24932862|NCT00438633|50025845|FG000|Overall Study|Lost to Follow-up|15|||
24932863|NCT00438633|50025846|FG001|Overall Study|Lost to Follow-up|17|||
24932864|NCT00438399|50025855|FG000|Overall Study|Lost to Follow-up|2|||
24932865|NCT00438399|50025856|FG001|Overall Study|Lost to Follow-up|2|||
24932866|NCT00438399|50025857|FG002|Overall Study|Lost to Follow-up|1|||
24932867|NCT00438399|50025858|FG003|Overall Study|Lost to Follow-up|1|||
24932868|NCT00438399|50025859|FG004|Overall Study|Lost to Follow-up|1|||
24932869|NCT00438399|50025860|FG005|Overall Study|Lost to Follow-up|1|||
24932870|NCT00438399|50025855|FG000|Overall Study|Adverse Event|0|||
24932871|NCT00438399|50025856|FG001|Overall Study|Adverse Event|0|||
24932872|NCT00438399|50025857|FG002|Overall Study|Adverse Event|1|||
24932873|NCT00438399|50025858|FG003|Overall Study|Adverse Event|1|||
24932874|NCT00438399|50025859|FG004|Overall Study|Adverse Event|0|||
24932875|NCT00438399|50025860|FG005|Overall Study|Adverse Event|1|||
24932876|NCT00438399|50025855|FG000|Overall Study|Withdrawal by Subject|5|||
24932877|NCT00438399|50025856|FG001|Overall Study|Withdrawal by Subject|6|||
24932878|NCT00438399|50025857|FG002|Overall Study|Withdrawal by Subject|3|||
24932879|NCT00438399|50025858|FG003|Overall Study|Withdrawal by Subject|2|||
24932880|NCT00438399|50025859|FG004|Overall Study|Withdrawal by Subject|2|||
24932881|NCT00438399|50025860|FG005|Overall Study|Withdrawal by Subject|2|||
24932882|NCT00438399|50025855|FG000|Overall Study|Protocol Violation|0|||
24932883|NCT00438399|50025856|FG001|Overall Study|Protocol Violation|0|||
24932884|NCT00438399|50025857|FG002|Overall Study|Protocol Violation|1|||
24932885|NCT00438399|50025858|FG003|Overall Study|Protocol Violation|0|||
24932886|NCT00438399|50025859|FG004|Overall Study|Protocol Violation|0|||
24932887|NCT00438399|50025860|FG005|Overall Study|Protocol Violation|1|||
24932888|NCT00438399|50025855|FG000|Overall Study|Subje stopped study|0|||
24932889|NCT00438399|50025856|FG001|Overall Study|Subje stopped study|0|||
24932890|NCT00438399|50025857|FG002|Overall Study|Subje stopped study|1|||
24932891|NCT00438399|50025858|FG003|Overall Study|Subje stopped study|0|||
24932892|NCT00438399|50025859|FG004|Overall Study|Subje stopped study|0|||
24932893|NCT00438399|50025860|FG005|Overall Study|Subje stopped study|0|||
24932894|NCT00438399|50025855|FG000|Overall Study|Pregnancy|0|||
24932895|NCT00438399|50025856|FG001|Overall Study|Pregnancy|0|||
24932896|NCT00438399|50025857|FG002|Overall Study|Pregnancy|0|||
24932897|NCT00438399|50025858|FG003|Overall Study|Pregnancy|0|||
24932898|NCT00438399|50025859|FG004|Overall Study|Pregnancy|0|||
24932899|NCT00438399|50025860|FG005|Overall Study|Pregnancy|1|||
24932900|NCT00438399|50025855|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
24932901|NCT00438399|50025856|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
24932902|NCT00438399|50025857|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
24932903|NCT00438399|50025858|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
25027074|NCT03130959|50125192|FG005|Overall Study|Subject request to discontinue therapy|0|||
25027075|NCT03130959|50125193|FG006|Overall Study|Subject request to discontinue therapy|1|||
25027076|NCT03130959|50125194|FG007|Overall Study|Subject request to discontinue therapy|1|||
25027077|NCT03130959|50125195|FG008|Overall Study|Subject request to discontinue therapy|0|||
25027078|NCT03130959|50125196|FG009|Overall Study|Subject request to discontinue therapy|0|||
25027079|NCT03130959|50125187|FG000|Overall Study|Not reported|0|||
24932904|NCT00438399|50025859|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
24932905|NCT00438399|50025860|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
24932906|NCT00426231|50025871|FG000|Overall Study|Withdrawal by Subject|9|||
24932907|NCT00426231|50025872|FG001|Overall Study|Withdrawal by Subject|12|||
24932908|NCT00425607|50025878|FG000|Overall Study|Death|1|||
24932909|NCT00425607|50025878|FG000|Overall Study|Withdrawal by Subject|1|||
24932910|NCT00437073|50025884|FG000|Overall Study|Sponsor Terminated Study|1|||
24932911|NCT00437073|50025885|FG001|Overall Study|Sponsor Terminated Study|0|||
24932912|NCT00437073|50025884|FG000|Overall Study|Physician Decision|0|||
24932913|NCT00437073|50025885|FG001|Overall Study|Physician Decision|1|||
24932914|NCT00425373|50025900|FG000|Overall Study|Adverse Event|2|||
24932915|NCT00425373|50025901|FG001|Overall Study|Adverse Event|2|||
24932916|NCT00425373|50025902|FG002|Overall Study|Adverse Event|0|||
24932917|NCT00425373|50025903|FG003|Overall Study|Adverse Event|1|||
24932918|NCT00425373|50025904|FG004|Overall Study|Adverse Event|4|||
24932919|NCT00425373|50025905|FG005|Overall Study|Adverse Event|6|||
24932920|NCT00425373|50025906|FG006|Overall Study|Adverse Event|2|||
24932921|NCT00425373|50025907|FG007|Overall Study|Adverse Event|3|||
24932922|NCT00425373|50025908|FG008|Overall Study|Adverse Event|8|||
24932923|NCT00425373|50025900|FG000|Overall Study|Lost to Follow-up|0|||
25185709|NCT01425203|50335250|FG001|Treatment Phase|Other virologic failure criteria|3|||
25185710|NCT01425203|50335251|FG002|Treatment Phase|Other virologic failure criteria|0|||
25185711|NCT01425203|50335249|FG000|Treatment Phase|Unidentified reasons|11|||
24932924|NCT00425373|50025901|FG001|Overall Study|Lost to Follow-up|1|||
24932925|NCT00425373|50025902|FG002|Overall Study|Lost to Follow-up|0|||
24932926|NCT00425373|50025903|FG003|Overall Study|Lost to Follow-up|0|||
24932927|NCT00425373|50025904|FG004|Overall Study|Lost to Follow-up|1|||
24932928|NCT00425373|50025905|FG005|Overall Study|Lost to Follow-up|0|||
24932929|NCT00425373|50025906|FG006|Overall Study|Lost to Follow-up|0|||
24932930|NCT00425373|50025907|FG007|Overall Study|Lost to Follow-up|0|||
24932931|NCT00425373|50025908|FG008|Overall Study|Lost to Follow-up|0|||
24932932|NCT00425373|50025900|FG000|Overall Study|Protocol Violation|1|||
24932933|NCT00425373|50025901|FG001|Overall Study|Protocol Violation|0|||
24932934|NCT00425373|50025902|FG002|Overall Study|Protocol Violation|1|||
24932935|NCT00425373|50025903|FG003|Overall Study|Protocol Violation|0|||
24932936|NCT00425373|50025904|FG004|Overall Study|Protocol Violation|0|||
24932937|NCT00425373|50025905|FG005|Overall Study|Protocol Violation|0|||
24932938|NCT00425373|50025906|FG006|Overall Study|Protocol Violation|0|||
24932939|NCT00425373|50025907|FG007|Overall Study|Protocol Violation|5|||
24932940|NCT00425373|50025908|FG008|Overall Study|Protocol Violation|3|||
24932941|NCT00425373|50025900|FG000|Overall Study|Withdrawal by Subject|2|||
24932942|NCT00425373|50025901|FG001|Overall Study|Withdrawal by Subject|0|||
24932943|NCT00425373|50025902|FG002|Overall Study|Withdrawal by Subject|2|||
24932944|NCT00425373|50025903|FG003|Overall Study|Withdrawal by Subject|1|||
24932945|NCT00425373|50025904|FG004|Overall Study|Withdrawal by Subject|4|||
24932946|NCT00425373|50025905|FG005|Overall Study|Withdrawal by Subject|0|||
24932947|NCT00425373|50025906|FG006|Overall Study|Withdrawal by Subject|2|||
24932948|NCT00425373|50025907|FG007|Overall Study|Withdrawal by Subject|2|||
24932949|NCT00425373|50025908|FG008|Overall Study|Withdrawal by Subject|2|||
25027080|NCT03130959|50125188|FG001|Overall Study|Not reported|0|||
24932950|NCT00425373|50025900|FG000|Overall Study|Lack of Efficacy|0|||
24932951|NCT00425373|50025901|FG001|Overall Study|Lack of Efficacy|0|||
24932952|NCT00425373|50025902|FG002|Overall Study|Lack of Efficacy|0|||
24932953|NCT00425373|50025903|FG003|Overall Study|Lack of Efficacy|0|||
24932954|NCT00425373|50025904|FG004|Overall Study|Lack of Efficacy|1|||
24932955|NCT00425373|50025905|FG005|Overall Study|Lack of Efficacy|3|||
24932956|NCT00425373|50025906|FG006|Overall Study|Lack of Efficacy|3|||
24932957|NCT00425373|50025907|FG007|Overall Study|Lack of Efficacy|0|||
24932958|NCT00425373|50025908|FG008|Overall Study|Lack of Efficacy|5|||
24932959|NCT03894540|50025934|FG000|Overall Study|Adverse Event|0|||
24932960|NCT03894540|50025935|FG001|Overall Study|Adverse Event|0|||
24932961|NCT03894540|50025936|FG002|Overall Study|Adverse Event|0|||
24932962|NCT03894540|50025937|FG003|Overall Study|Adverse Event|0|||
24932963|NCT03894540|50025938|FG004|Overall Study|Adverse Event|1|||
24932964|NCT03894540|50025939|FG005|Overall Study|Adverse Event|0|||
24932965|NCT03894540|50025934|FG000|Overall Study|Withdrawal by Subject|0|||
24932966|NCT03894540|50025935|FG001|Overall Study|Withdrawal by Subject|0|||
24932967|NCT03894540|50025936|FG002|Overall Study|Withdrawal by Subject|0|||
24932968|NCT03894540|50025937|FG003|Overall Study|Withdrawal by Subject|0|||
24932969|NCT03894540|50025938|FG004|Overall Study|Withdrawal by Subject|1|||
24932970|NCT03894540|50025939|FG005|Overall Study|Withdrawal by Subject|0|||
24932971|NCT03894540|50025934|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
24932972|NCT03894540|50025935|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
24932973|NCT03894540|50025936|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
24932974|NCT03894540|50025937|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
24932975|NCT03894540|50025938|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
24932976|NCT03894540|50025939|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
24932977|NCT03894540|50025934|FG000|Overall Study|Progressive Disease Clinical|1|||
24932978|NCT03894540|50025935|FG001|Overall Study|Progressive Disease Clinical|1|||
24932979|NCT03894540|50025936|FG002|Overall Study|Progressive Disease Clinical|0|||
24932980|NCT03894540|50025937|FG003|Overall Study|Progressive Disease Clinical|1|||
24932981|NCT03894540|50025938|FG004|Overall Study|Progressive Disease Clinical|5|||
24932982|NCT03894540|50025939|FG005|Overall Study|Progressive Disease Clinical|1|||
24932983|NCT03894540|50025934|FG000|Overall Study|Study termination by sponsor|0|||
24932984|NCT03894540|50025935|FG001|Overall Study|Study termination by sponsor|0|||
24932985|NCT03894540|50025936|FG002|Overall Study|Study termination by sponsor|0|||
24932986|NCT03894540|50025937|FG003|Overall Study|Study termination by sponsor|0|||
24932987|NCT03894540|50025938|FG004|Overall Study|Study termination by sponsor|2|||
24932988|NCT03894540|50025939|FG005|Overall Study|Study termination by sponsor|0|||
24932989|NCT00535626|50025957|FG000|Overall Study|Death|15|||
24932990|NCT00535626|50025957|FG000|Overall Study|Lost to Follow-up|29|||
24932991|NCT00535626|50025957|FG000|Overall Study|Withdrawal by Subject|20|||
24932992|NCT00535626|50025957|FG000|Overall Study|Removal/revision of study component|8|||
24932993|NCT00535626|50025957|FG000|Overall Study|Subject terminated|31|||
24932994|NCT00535626|50025957|FG000|Overall Study|Unable to return|2|||
24932995|NCT03889704|50025980|FG000|Overall Study|Study terminated due to pandemic|1|||
24932996|NCT03887442|50025986|FG000|Overall Study|Adverse Event|1|||
24932997|NCT03887442|50025987|FG001|Overall Study|Adverse Event|0|||
24932998|NCT00425061|50026002|FG000|Overall Study|Adverse Event|1|||
24932999|NCT00425061|50026003|FG001|Overall Study|Adverse Event|0|||
24933000|NCT00425061|50026004|FG002|Overall Study|Adverse Event|0|||
24933001|NCT00425061|50026005|FG003|Overall Study|Adverse Event|2|||
24933002|NCT00425061|50026006|FG004|Overall Study|Adverse Event|2|||
24933003|NCT00425061|50026007|FG005|Overall Study|Adverse Event|0|||
24933004|NCT00425061|50026008|FG006|Overall Study|Adverse Event|0|||
24933005|NCT00425061|50026002|FG000|Overall Study|Lost to Follow-up|0|||
24933006|NCT00425061|50026003|FG001|Overall Study|Lost to Follow-up|1|||
24933007|NCT00425061|50026004|FG002|Overall Study|Lost to Follow-up|0|||
24933008|NCT00425061|50026005|FG003|Overall Study|Lost to Follow-up|0|||
24933009|NCT00425061|50026006|FG004|Overall Study|Lost to Follow-up|0|||
24933010|NCT00425061|50026007|FG005|Overall Study|Lost to Follow-up|0|||
24933011|NCT00425061|50026008|FG006|Overall Study|Lost to Follow-up|0|||
24933012|NCT00425061|50026002|FG000|Overall Study|Protocol Violation|1|||
24933013|NCT00425061|50026003|FG001|Overall Study|Protocol Violation|0|||
24933014|NCT00425061|50026004|FG002|Overall Study|Protocol Violation|0|||
24933015|NCT00425061|50026005|FG003|Overall Study|Protocol Violation|0|||
24933016|NCT00425061|50026006|FG004|Overall Study|Protocol Violation|0|||
24933017|NCT00425061|50026007|FG005|Overall Study|Protocol Violation|0|||
24933018|NCT00425061|50026008|FG006|Overall Study|Protocol Violation|0|||
24933019|NCT00425061|50026002|FG000|Overall Study|Withdrawal by Subject|0|||
24933020|NCT00425061|50026003|FG001|Overall Study|Withdrawal by Subject|1|||
24933021|NCT00425061|50026004|FG002|Overall Study|Withdrawal by Subject|0|||
24933022|NCT00425061|50026005|FG003|Overall Study|Withdrawal by Subject|0|||
24933023|NCT00425061|50026006|FG004|Overall Study|Withdrawal by Subject|1|||
24933024|NCT00425061|50026007|FG005|Overall Study|Withdrawal by Subject|0|||
24933025|NCT00425061|50026008|FG006|Overall Study|Withdrawal by Subject|3|||
24933026|NCT00425061|50026002|FG000|Overall Study|Sponsor's request|0|||
24933027|NCT00425061|50026003|FG001|Overall Study|Sponsor's request|0|||
24933028|NCT00425061|50026004|FG002|Overall Study|Sponsor's request|0|||
24933029|NCT00425061|50026005|FG003|Overall Study|Sponsor's request|0|||
24933030|NCT00425061|50026006|FG004|Overall Study|Sponsor's request|19|||
24933031|NCT00425061|50026007|FG005|Overall Study|Sponsor's request|4|||
24933032|NCT00425061|50026008|FG006|Overall Study|Sponsor's request|15|||
24933033|NCT00425061|50026002|FG000|Overall Study|Physician Decision|0|||
24933034|NCT00425061|50026003|FG001|Overall Study|Physician Decision|0|||
24933035|NCT00425061|50026004|FG002|Overall Study|Physician Decision|0|||
24933036|NCT00425061|50026005|FG003|Overall Study|Physician Decision|0|||
24933037|NCT00425061|50026006|FG004|Overall Study|Physician Decision|1|||
24933038|NCT00425061|50026007|FG005|Overall Study|Physician Decision|0|||
24933039|NCT00425061|50026008|FG006|Overall Study|Physician Decision|0|||
24933040|NCT00425061|50026002|FG000|Overall Study|Other|0|||
24933041|NCT00425061|50026003|FG001|Overall Study|Other|0|||
24933042|NCT00425061|50026004|FG002|Overall Study|Other|0|||
24933043|NCT00425061|50026005|FG003|Overall Study|Other|0|||
24933044|NCT00425061|50026006|FG004|Overall Study|Other|3|||
24933045|NCT00425061|50026007|FG005|Overall Study|Other|0|||
24933046|NCT00425061|50026008|FG006|Overall Study|Other|1|||
24933047|NCT00424827|50026026|FG000|Overall Study|Adverse Event|1|||
24933048|NCT03885726|50026031|FG000|Overall Study|Staffing issues/lost interest|1|||
25027081|NCT03130959|50125189|FG002|Overall Study|Not reported|0|||
25027082|NCT03130959|50125190|FG003|Overall Study|Not reported|1|||
25027083|NCT03130959|50125191|FG004|Overall Study|Not reported|0|||
25027084|NCT03130959|50125192|FG005|Overall Study|Not reported|1|||
25027085|NCT03130959|50125193|FG006|Overall Study|Not reported|0|||
25027086|NCT03130959|50125194|FG007|Overall Study|Not reported|0|||
25027087|NCT03130959|50125195|FG008|Overall Study|Not reported|0|||
25027088|NCT03130959|50125196|FG009|Overall Study|Not reported|1|||
24933049|NCT03885726|50026031|FG000|Overall Study|Early discharge from hospital|3|||
24933050|NCT00377962|50026041|FG000|Core Study: 0-12 Months|Adverse Event|18|||
24933051|NCT00377962|50026042|FG001|Core Study: 0-12 Months|Adverse Event|2|||
24933052|NCT00377962|50026041|FG000|Core Study: 0-12 Months|Death|3|||
24933053|NCT00377962|50026042|FG001|Core Study: 0-12 Months|Death|0|||
24933054|NCT00377962|50026041|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
24933055|NCT00377962|50026042|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
24933056|NCT00377962|50026041|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
24933057|NCT00377962|50026042|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
24933058|NCT00377962|50026041|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
24933059|NCT00377962|50026042|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
24933060|NCT00377962|50026041|FG000|Extension Study: 12-24 Months|Death|1|||
25027089|NCT03130959|50125187|FG000|Overall Study|Adverse Event unrelated to drug|0|||
25027090|NCT03130959|50125188|FG001|Overall Study|Adverse Event unrelated to drug|0|||
25027091|NCT03130959|50125189|FG002|Overall Study|Adverse Event unrelated to drug|1|||
25027092|NCT03130959|50125190|FG003|Overall Study|Adverse Event unrelated to drug|1|||
25027093|NCT03130959|50125191|FG004|Overall Study|Adverse Event unrelated to drug|1|||
25027094|NCT03130959|50125192|FG005|Overall Study|Adverse Event unrelated to drug|0|||
25027095|NCT03130959|50125193|FG006|Overall Study|Adverse Event unrelated to drug|1|||
25027096|NCT03130959|50125194|FG007|Overall Study|Adverse Event unrelated to drug|0|||
25027097|NCT03130959|50125195|FG008|Overall Study|Adverse Event unrelated to drug|1|||
25027098|NCT03130959|50125196|FG009|Overall Study|Adverse Event unrelated to drug|1|||
25027099|NCT03130959|50125187|FG000|Overall Study|Participant withdrew consent|0|||
25027100|NCT03130959|50125188|FG001|Overall Study|Participant withdrew consent|1|||
25155906|NCT01475331|50271458|FG000|Overall Study|Sign of malignancy during the procedure|2|||
25155907|NCT01475331|50271459|FG001|Overall Study|Sign of malignancy during the procedure|0|||
25155908|NCT01475331|50271458|FG000|Overall Study|cyst found to be prohibitively small|0|||
25155909|NCT01475331|50271459|FG001|Overall Study|cyst found to be prohibitively small|1|||
25155910|NCT01500213|50271467|FG000|Overall Study|Adverse Event|35|||
25155911|NCT01500213|50271468|FG001|Overall Study|Adverse Event|35|||
25155912|NCT01500213|50271467|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
25275113|NCT01236755|50589129|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
24933061|NCT00377962|50026042|FG001|Extension Study: 12-24 Months|Death|1|||
24933062|NCT00377962|50026041|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
24933063|NCT00377962|50026042|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
24933064|NCT00377962|50026041|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
24933065|NCT00377962|50026042|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
25027101|NCT03130959|50125189|FG002|Overall Study|Participant withdrew consent|0|||
25027102|NCT03130959|50125190|FG003|Overall Study|Participant withdrew consent|2|||
25027103|NCT03130959|50125191|FG004|Overall Study|Participant withdrew consent|1|||
25027104|NCT03130959|50125192|FG005|Overall Study|Participant withdrew consent|0|||
25155913|NCT01500213|50271468|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
25155914|NCT01500213|50271467|FG000|Overall Study|Withdrawal by Subject|28|||
25155915|NCT01500213|50271468|FG001|Overall Study|Withdrawal by Subject|37|||
25155916|NCT01500213|50271467|FG000|Overall Study|Death|7|||
25155917|NCT01500213|50271468|FG001|Overall Study|Death|3|||
25155918|NCT01500213|50271467|FG000|Overall Study|Disease Progression|13|||
25155919|NCT01500213|50271468|FG001|Overall Study|Disease Progression|21|||
25155920|NCT01500213|50271467|FG000|Overall Study|Protocol Violation|19|||
24933066|NCT00377962|50026041|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
24933067|NCT00377962|50026042|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
24933068|NCT00424749|50026054|FG000|Overall Study|Withdrawal by Subject|1|||
24933069|NCT00424593|50026060|FG000|Acute Double-Blind Period|Adverse Event|16|||
24933070|NCT00424593|50026061|FG001|Acute Double-Blind Period|Adverse Event|7|||
24933071|NCT00424593|50026060|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
24933072|NCT00424593|50026061|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
24933073|NCT00424593|50026060|FG000|Acute Double-Blind Period|Protocol Violation|2|||
24933074|NCT00424593|50026061|FG001|Acute Double-Blind Period|Protocol Violation|2|||
24933075|NCT00424593|50026060|FG000|Acute Double-Blind Period|Physician Decision|1|||
24933076|NCT00424593|50026061|FG001|Acute Double-Blind Period|Physician Decision|2|||
24933077|NCT00424593|50026060|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
24933078|NCT00424593|50026061|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
24933079|NCT00424593|50026060|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
24933080|NCT00424593|50026061|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
24933081|NCT00424593|50026060|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
24933082|NCT00424593|50026061|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
24933083|NCT00424593|50026060|FG000|Dose-Blind Extension Period|Adverse Event|18|||
24933084|NCT00424593|50026061|FG001|Dose-Blind Extension Period|Adverse Event|0|||
24933085|NCT00424593|50026060|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
24933086|NCT00424593|50026061|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
24933087|NCT00424593|50026060|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
24933088|NCT00424593|50026061|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
24933089|NCT00424593|50026060|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
24933090|NCT00424593|50026061|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
24933091|NCT00424593|50026060|FG000|Dose-Blind Extension Period|Physician Decision|3|||
24933092|NCT00424593|50026061|FG001|Dose-Blind Extension Period|Physician Decision|0|||
24933093|NCT00369382|50026069|FG000|Overall Study|Death|0|||
24933094|NCT00369382|50026070|FG001|Overall Study|Death|2|||
24933095|NCT00369382|50026069|FG000|Overall Study|Physician Decision|2|||
24933096|NCT00369382|50026070|FG001|Overall Study|Physician Decision|1|||
24933097|NCT00369382|50026069|FG000|Overall Study|Withdrawal by Subject|5|||
24933098|NCT00369382|50026070|FG001|Overall Study|Withdrawal by Subject|0|||
24933099|NCT00369382|50026069|FG000|Overall Study|Randomized, not treated|2|||
24933100|NCT00369382|50026070|FG001|Overall Study|Randomized, not treated|0|||
24933101|NCT00369382|50026069|FG000|Overall Study|Other|1|||
24933102|NCT00369382|50026070|FG001|Overall Study|Other|0|||
24933103|NCT00424515|50026079|FG000|Overall Study|Progressive Disease|10|||
24933104|NCT00424515|50026080|FG001|Overall Study|Progressive Disease|11|||
24933105|NCT00424515|50026079|FG000|Overall Study|Adverse Event|0|||
24933106|NCT00424515|50026080|FG001|Overall Study|Adverse Event|1|||
24933107|NCT00424515|50026079|FG000|Overall Study|Intercurrent Illness|0|||
24933108|NCT00424515|50026080|FG001|Overall Study|Intercurrent Illness|1|||
24933109|NCT00424515|50026079|FG000|Overall Study|Withdrawal by Subject|1|||
24933110|NCT00424515|50026080|FG001|Overall Study|Withdrawal by Subject|0|||
24933111|NCT00377260|50026088|FG000|Overall Study|Lost to Follow-up|0|||
24933112|NCT00377260|50026089|FG001|Overall Study|Lost to Follow-up|1|||
24933113|NCT00377260|50026088|FG000|Overall Study|Withdrawal by Subject|2|||
24933114|NCT00377260|50026089|FG001|Overall Study|Withdrawal by Subject|4|||
24933115|NCT00441441|50026097|FG000|Overall Study|Adverse Event|2|||
24933116|NCT00441441|50026098|FG001|Overall Study|Adverse Event|1|||
24933117|NCT00441441|50026097|FG000|Overall Study|Protocol Violation|4|||
24933118|NCT00441441|50026098|FG001|Overall Study|Protocol Violation|6|||
24933119|NCT00441441|50026097|FG000|Overall Study|Exacerbation of asthma|1|||
24933120|NCT00441441|50026098|FG001|Overall Study|Exacerbation of asthma|2|||
24933121|NCT00441441|50026097|FG000|Overall Study|Withdrawal by Subject|1|||
24933122|NCT00441441|50026098|FG001|Overall Study|Withdrawal by Subject|2|||
24933123|NCT00441441|50026097|FG000|Overall Study|Other|3|||
24933124|NCT00441441|50026098|FG001|Overall Study|Other|3|||
24933125|NCT00436917|50026118|FG000|Overall Study|Withdrawal by Subject|13|||
24933126|NCT00436917|50026118|FG000|Overall Study|Adverse Event|2|||
24933127|NCT00436917|50026118|FG000|Overall Study|Physician Decision|1|||
24933128|NCT00436917|50026118|FG000|Overall Study|Death|1|||
24933129|NCT00436917|50026118|FG000|Overall Study|Lost to Follow-up|1|||
24933130|NCT00436917|50026118|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
24933131|NCT00436917|50026118|FG000|Overall Study|Increased creatinine|1|||
24933132|NCT00436917|50026118|FG000|Overall Study|Personal conflicts of patient|1|||
25155921|NCT01500213|50271468|FG001|Overall Study|Protocol Violation|19|||
25155922|NCT01500213|50271467|FG000|Overall Study|Physician Decision|12|||
24933133|NCT00436605|50026122|FG000|Overall Study|Protocol Violation|3|||
24933134|NCT00368992|50026126|FG000|Overall Study|Ineligible|5|||
24933135|NCT00368992|50026126|FG000|Overall Study|Refused treatment|3|||
24933136|NCT00368992|50026126|FG000|Overall Study|Lack of Efficacy|63|||
24933137|NCT00368992|50026126|FG000|Overall Study|Adverse Event|26|||
24933138|NCT00368992|50026126|FG000|Overall Study|Death|4|||
24933139|NCT00368992|50026126|FG000|Overall Study|Other|9|||
24933140|NCT00376246|50026131|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
24933141|NCT00376246|50026132|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
24933142|NCT00376246|50026131|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
24933143|NCT00376246|50026132|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
24933144|NCT00376246|50026131|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
24933145|NCT00376246|50026132|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
24933146|NCT00368836|50026142|FG000|Phase II|Screen Failure|1|||
24933147|NCT00368836|50026142|FG000|Phase II|Withdrawal by Subject|1|||
24933148|NCT00368836|50026142|FG000|Phase II|unable to collect blood and/or breath|17|||
24933149|NCT00368836|50026142|FG000|Phase II|Protocol Violation|2|||
24933150|NCT00376168|50026151|FG000|Overall Study|Adverse Event|1|||
24933151|NCT00376168|50026152|FG001|Overall Study|Adverse Event|1|||
24933152|NCT00376168|50026151|FG000|Overall Study|Pregnancy|1|||
24933153|NCT00376168|50026152|FG001|Overall Study|Pregnancy|0|||
24933154|NCT00375934|50026160|FG000|Overall Study|Adverse Event|1|||
24933155|NCT00375934|50026161|FG001|Overall Study|Adverse Event|1|||
24933156|NCT00375934|50026160|FG000|Overall Study|Withdrawal by Subject|2|||
24933157|NCT00375934|50026161|FG001|Overall Study|Withdrawal by Subject|2|||
24933158|NCT00375934|50026160|FG000|Overall Study|Lack of Efficacy|0|||
24933159|NCT00375934|50026161|FG001|Overall Study|Lack of Efficacy|2|||
24933160|NCT00375934|50026160|FG000|Overall Study|Physician Decision|0|||
24933161|NCT00375934|50026161|FG001|Overall Study|Physician Decision|1|||
24933162|NCT00642941|50026179|FG000|Overall Study|Physician Decision|3|||
24933163|NCT00642941|50026180|FG001|Overall Study|Physician Decision|1|||
24933164|NCT00642941|50026181|FG002|Overall Study|Physician Decision|0|||
24933165|NCT00642941|50026182|FG003|Overall Study|Physician Decision|0|||
24933166|NCT00642941|50026183|FG004|Overall Study|Physician Decision|0|||
24933167|NCT00642941|50026184|FG005|Overall Study|Physician Decision|0|||
24933168|NCT00642941|50026185|FG006|Overall Study|Physician Decision|1|||
24933169|NCT00642941|50026186|FG007|Overall Study|Physician Decision|0|||
24933170|NCT00642941|50026187|FG008|Overall Study|Physician Decision|0|||
24933171|NCT00642941|50026188|FG009|Overall Study|Physician Decision|1|||
24933172|NCT00642941|50026189|FG010|Overall Study|Physician Decision|0|||
24933173|NCT00642941|50026190|FG011|Overall Study|Physician Decision|1|||
24933174|NCT00642941|50026179|FG000|Overall Study|Death|4|||
24933175|NCT00642941|50026180|FG001|Overall Study|Death|0|||
24933176|NCT00642941|50026181|FG002|Overall Study|Death|1|||
24933177|NCT00642941|50026182|FG003|Overall Study|Death|1|||
24933178|NCT00642941|50026183|FG004|Overall Study|Death|2|||
24933179|NCT00642941|50026184|FG005|Overall Study|Death|1|||
24933180|NCT00642941|50026185|FG006|Overall Study|Death|0|||
24933181|NCT00642941|50026186|FG007|Overall Study|Death|0|||
24933182|NCT00642941|50026187|FG008|Overall Study|Death|0|||
24933183|NCT00642941|50026188|FG009|Overall Study|Death|0|||
24933184|NCT00642941|50026189|FG010|Overall Study|Death|0|||
24933185|NCT00642941|50026190|FG011|Overall Study|Death|1|||
24933186|NCT00642941|50026179|FG000|Overall Study|Study closed by Sponsor|0|||
24933187|NCT00642941|50026180|FG001|Overall Study|Study closed by Sponsor|1|||
24933188|NCT00642941|50026181|FG002|Overall Study|Study closed by Sponsor|0|||
24933189|NCT00642941|50026182|FG003|Overall Study|Study closed by Sponsor|0|||
24933190|NCT00642941|50026183|FG004|Overall Study|Study closed by Sponsor|0|||
24933191|NCT00642941|50026184|FG005|Overall Study|Study closed by Sponsor|0|||
24933192|NCT00642941|50026185|FG006|Overall Study|Study closed by Sponsor|0|||
24933193|NCT00642941|50026186|FG007|Overall Study|Study closed by Sponsor|0|||
24933194|NCT00642941|50026187|FG008|Overall Study|Study closed by Sponsor|0|||
24933195|NCT00642941|50026188|FG009|Overall Study|Study closed by Sponsor|0|||
24933196|NCT00642941|50026189|FG010|Overall Study|Study closed by Sponsor|0|||
24933197|NCT00642941|50026190|FG011|Overall Study|Study closed by Sponsor|0|||
24933198|NCT00642941|50026179|FG000|Overall Study|Withdrawal by Subject|1|||
24933199|NCT00642941|50026180|FG001|Overall Study|Withdrawal by Subject|0|||
24933200|NCT00642941|50026181|FG002|Overall Study|Withdrawal by Subject|0|||
24933201|NCT00642941|50026182|FG003|Overall Study|Withdrawal by Subject|2|||
24933202|NCT00642941|50026183|FG004|Overall Study|Withdrawal by Subject|0|||
24933203|NCT00642941|50026184|FG005|Overall Study|Withdrawal by Subject|0|||
24933204|NCT00642941|50026185|FG006|Overall Study|Withdrawal by Subject|2|||
24933205|NCT00642941|50026186|FG007|Overall Study|Withdrawal by Subject|0|||
24933206|NCT00642941|50026187|FG008|Overall Study|Withdrawal by Subject|1|||
24933207|NCT00642941|50026188|FG009|Overall Study|Withdrawal by Subject|0|||
24933208|NCT00642941|50026189|FG010|Overall Study|Withdrawal by Subject|0|||
24933209|NCT00642941|50026190|FG011|Overall Study|Withdrawal by Subject|1|||
24933210|NCT00642941|50026179|FG000|Overall Study|Protocol Violation|0|||
24933211|NCT00642941|50026180|FG001|Overall Study|Protocol Violation|0|||
24933212|NCT00642941|50026181|FG002|Overall Study|Protocol Violation|0|||
24933213|NCT00642941|50026182|FG003|Overall Study|Protocol Violation|0|||
24933214|NCT00642941|50026183|FG004|Overall Study|Protocol Violation|0|||
24933215|NCT00642941|50026184|FG005|Overall Study|Protocol Violation|0|||
25027105|NCT03130959|50125193|FG006|Overall Study|Participant withdrew consent|0|||
25027106|NCT03130959|50125194|FG007|Overall Study|Participant withdrew consent|0|||
25027107|NCT03130959|50125195|FG008|Overall Study|Participant withdrew consent|0|||
25027108|NCT03130959|50125196|FG009|Overall Study|Participant withdrew consent|2|||
24933216|NCT00642941|50026185|FG006|Overall Study|Protocol Violation|1|||
24933217|NCT00642941|50026186|FG007|Overall Study|Protocol Violation|0|||
24933218|NCT00642941|50026187|FG008|Overall Study|Protocol Violation|0|||
24933219|NCT00642941|50026188|FG009|Overall Study|Protocol Violation|0|||
24933220|NCT00642941|50026189|FG010|Overall Study|Protocol Violation|0|||
24933221|NCT00642941|50026190|FG011|Overall Study|Protocol Violation|0|||
24933222|NCT00642941|50026179|FG000|Overall Study|Adverse Event|1|||
24933223|NCT00642941|50026180|FG001|Overall Study|Adverse Event|1|||
24933224|NCT00642941|50026181|FG002|Overall Study|Adverse Event|0|||
24933225|NCT00642941|50026182|FG003|Overall Study|Adverse Event|0|||
24933226|NCT00642941|50026183|FG004|Overall Study|Adverse Event|0|||
24933227|NCT00642941|50026184|FG005|Overall Study|Adverse Event|0|||
24933228|NCT00642941|50026185|FG006|Overall Study|Adverse Event|1|||
24933229|NCT00642941|50026186|FG007|Overall Study|Adverse Event|1|||
24933230|NCT00642941|50026187|FG008|Overall Study|Adverse Event|0|||
24933231|NCT00642941|50026188|FG009|Overall Study|Adverse Event|1|||
24933232|NCT00642941|50026189|FG010|Overall Study|Adverse Event|0|||
24933233|NCT00642941|50026190|FG011|Overall Study|Adverse Event|0|||
24933234|NCT00642941|50026179|FG000|Overall Study|Other|1|||
24933235|NCT00642941|50026180|FG001|Overall Study|Other|1|||
24933236|NCT00642941|50026181|FG002|Overall Study|Other|1|||
24933237|NCT00642941|50026182|FG003|Overall Study|Other|1|||
24933238|NCT00642941|50026183|FG004|Overall Study|Other|0|||
24933239|NCT00642941|50026184|FG005|Overall Study|Other|1|||
24933240|NCT00642941|50026185|FG006|Overall Study|Other|0|||
25027109|NCT03130959|50125187|FG000|Overall Study|Administrative reason by sponsor|1|||
24933241|NCT00642941|50026186|FG007|Overall Study|Other|1|||
24933242|NCT00642941|50026187|FG008|Overall Study|Other|0|||
24933243|NCT00642941|50026188|FG009|Overall Study|Other|0|||
24933244|NCT00642941|50026189|FG010|Overall Study|Other|0|||
24933245|NCT00642941|50026190|FG011|Overall Study|Other|1|||
24933246|NCT00642941|50026179|FG000|Overall Study|Disease progression|60|||
24933247|NCT00642941|50026180|FG001|Overall Study|Disease progression|50|||
24933248|NCT00642941|50026181|FG002|Overall Study|Disease progression|5|||
24933249|NCT00642941|50026182|FG003|Overall Study|Disease progression|36|||
24933250|NCT00642941|50026183|FG004|Overall Study|Disease progression|23|||
24933251|NCT00642941|50026184|FG005|Overall Study|Disease progression|39|||
24933252|NCT00642941|50026185|FG006|Overall Study|Disease progression|18|||
24933253|NCT00642941|50026186|FG007|Overall Study|Disease progression|12|||
24933254|NCT00642941|50026187|FG008|Overall Study|Disease progression|10|||
24933255|NCT00642941|50026188|FG009|Overall Study|Disease progression|7|||
24933256|NCT00642941|50026189|FG010|Overall Study|Disease progression|12|||
25027110|NCT03130959|50125188|FG001|Overall Study|Administrative reason by sponsor|0|||
25027111|NCT03130959|50125189|FG002|Overall Study|Administrative reason by sponsor|1|||
25027112|NCT03130959|50125190|FG003|Overall Study|Administrative reason by sponsor|0|||
25027113|NCT03130959|50125191|FG004|Overall Study|Administrative reason by sponsor|0|||
25027114|NCT03130959|50125192|FG005|Overall Study|Administrative reason by sponsor|0|||
25027115|NCT03130959|50125193|FG006|Overall Study|Administrative reason by sponsor|0|||
25027116|NCT03130959|50125194|FG007|Overall Study|Administrative reason by sponsor|0|||
25027117|NCT03130959|50125195|FG008|Overall Study|Administrative reason by sponsor|0|||
25027118|NCT03130959|50125196|FG009|Overall Study|Administrative reason by sponsor|0|||
25027119|NCT03130959|50125187|FG000|Overall Study|Lost to Follow-up|1|||
25027120|NCT03130959|50125188|FG001|Overall Study|Lost to Follow-up|0|||
25027121|NCT03130959|50125189|FG002|Overall Study|Lost to Follow-up|0|||
25027122|NCT03130959|50125190|FG003|Overall Study|Lost to Follow-up|0|||
24933257|NCT00642941|50026190|FG011|Overall Study|Disease progression|7|||
24933258|NCT00531960|50026239|FG000|Overall Study|Adverse Event|5|||
24933259|NCT00531960|50026240|FG001|Overall Study|Adverse Event|4|||
24933260|NCT00531960|50026239|FG000|Overall Study|Death|3|||
24933261|NCT00531960|50026240|FG001|Overall Study|Death|2|||
24933262|NCT00531960|50026239|FG000|Overall Study|Lack of Efficacy|42|||
24933263|NCT00531960|50026240|FG001|Overall Study|Lack of Efficacy|41|||
24933264|NCT00531960|50026239|FG000|Overall Study|Violation of Selection Criteria|2|||
24933265|NCT00531960|50026240|FG001|Overall Study|Violation of Selection Criteria|0|||
24933266|NCT00531960|50026239|FG000|Overall Study|Refused Treatment|5|||
25027123|NCT03130959|50125191|FG004|Overall Study|Lost to Follow-up|0|||
25027124|NCT03130959|50125192|FG005|Overall Study|Lost to Follow-up|0|||
25027125|NCT03130959|50125193|FG006|Overall Study|Lost to Follow-up|0|||
25027126|NCT03130959|50125194|FG007|Overall Study|Lost to Follow-up|0|||
24933267|NCT00531960|50026240|FG001|Overall Study|Refused Treatment|6|||
24933268|NCT00531960|50026239|FG000|Overall Study|Other|4|||
24933269|NCT00531960|50026240|FG001|Overall Study|Other|10|||
24933270|NCT00361504|50026248|FG000|Overall Study|Withdrawal by Subject|94|||
24933271|NCT00361504|50026249|FG001|Overall Study|Withdrawal by Subject|31|||
24933272|NCT00361504|50026248|FG000|Overall Study|Lost to Follow-up|40|||
24933273|NCT00361504|50026249|FG001|Overall Study|Lost to Follow-up|7|||
24933274|NCT00361504|50026248|FG000|Overall Study|Adverse Event|203|||
24933275|NCT00361504|50026249|FG001|Overall Study|Adverse Event|82|||
24933276|NCT00361504|50026248|FG000|Overall Study|Lack of Efficacy|72|||
24933277|NCT00361504|50026249|FG001|Overall Study|Lack of Efficacy|7|||
24933278|NCT00361504|50026248|FG000|Overall Study|Resolution of Pain|2|||
24933279|NCT00361504|50026249|FG001|Overall Study|Resolution of Pain|0|||
24933280|NCT00361504|50026248|FG000|Overall Study|Study medication non compliant|42|||
24933281|NCT00361504|50026249|FG001|Overall Study|Study medication non compliant|15|||
24933282|NCT00361504|50026248|FG000|Overall Study|All other|28|||
24933283|NCT00361504|50026249|FG001|Overall Study|All other|3|||
24933284|NCT00361270|50026259|FG000|Overall Study|Death|0|||
24933285|NCT00361270|50026260|FG001|Overall Study|Death|0|||
24933286|NCT00361270|50026261|FG002|Overall Study|Death|0|||
24933287|NCT00361270|50026262|FG003|Overall Study|Death|2|||
24933288|NCT00361270|50026259|FG000|Overall Study|Lost to Follow-up|4|||
24933289|NCT00361270|50026260|FG001|Overall Study|Lost to Follow-up|1|||
24933290|NCT00361270|50026261|FG002|Overall Study|Lost to Follow-up|0|||
24933291|NCT00361270|50026262|FG003|Overall Study|Lost to Follow-up|0|||
24933292|NCT00361270|50026259|FG000|Overall Study|Physician Decision|0|||
24933293|NCT00361270|50026260|FG001|Overall Study|Physician Decision|0|||
24933294|NCT00361270|50026261|FG002|Overall Study|Physician Decision|1|||
24933295|NCT00361270|50026262|FG003|Overall Study|Physician Decision|0|||
24933296|NCT00361270|50026259|FG000|Overall Study|Protocol Violation|9|||
24933297|NCT00361270|50026260|FG001|Overall Study|Protocol Violation|4|||
24933298|NCT00361270|50026261|FG002|Overall Study|Protocol Violation|5|||
24933299|NCT00361270|50026262|FG003|Overall Study|Protocol Violation|4|||
24933300|NCT00361270|50026259|FG000|Overall Study|Withdrawal by Subject|6|||
24933301|NCT00361270|50026260|FG001|Overall Study|Withdrawal by Subject|6|||
24933302|NCT00361270|50026261|FG002|Overall Study|Withdrawal by Subject|3|||
24933303|NCT00361270|50026262|FG003|Overall Study|Withdrawal by Subject|7|||
24933304|NCT00361270|50026259|FG000|Overall Study|Afraid of Hypnosis|1|||
24933305|NCT00361270|50026260|FG001|Overall Study|Afraid of Hypnosis|2|||
24933306|NCT00361270|50026261|FG002|Overall Study|Afraid of Hypnosis|0|||
24933307|NCT00361270|50026262|FG003|Overall Study|Afraid of Hypnosis|0|||
24933308|NCT00361270|50026259|FG000|Overall Study|Problems with Transportation|4|||
24933309|NCT00361270|50026260|FG001|Overall Study|Problems with Transportation|0|||
24933310|NCT00361270|50026261|FG002|Overall Study|Problems with Transportation|0|||
24933311|NCT00361270|50026262|FG003|Overall Study|Problems with Transportation|0|||
24933312|NCT00361270|50026259|FG000|Overall Study|Adverse Event|0|||
24933313|NCT00361270|50026260|FG001|Overall Study|Adverse Event|1|||
24933314|NCT00361270|50026261|FG002|Overall Study|Adverse Event|1|||
24933315|NCT00361270|50026262|FG003|Overall Study|Adverse Event|0|||
24933316|NCT00367744|50026281|FG000|Overall Study|Lost to Follow-up|4|||
24933317|NCT00367744|50026282|FG001|Overall Study|Lost to Follow-up|5|||
24933318|NCT03883386|50026291|FG000|First Assignment|Lost to Follow-up|1|||
24933319|NCT03883386|50026292|FG001|First Assignment|Lost to Follow-up|0|||
24933320|NCT03883386|50026291|FG000|First Assignment|Withdrawal by Subject|1|||
24933321|NCT03883386|50026292|FG001|First Assignment|Withdrawal by Subject|1|||
24933322|NCT00530946|50026302|FG000|Overall Study|Adverse Event|1|||
24933323|NCT00530946|50026303|FG001|Overall Study|Adverse Event|2|||
24933324|NCT00530946|50026304|FG002|Overall Study|Adverse Event|1|||
24933325|NCT00530946|50026305|FG003|Overall Study|Adverse Event|1|||
24933326|NCT00530946|50026302|FG000|Overall Study|Protocol Violation|0|||
24933327|NCT00530946|50026303|FG001|Overall Study|Protocol Violation|0|||
24933328|NCT00530946|50026304|FG002|Overall Study|Protocol Violation|0|||
24933329|NCT00530946|50026305|FG003|Overall Study|Protocol Violation|1|||
24933330|NCT00530946|50026302|FG000|Overall Study|Noncompliance|1|||
24933331|NCT00530946|50026303|FG001|Overall Study|Noncompliance|0|||
24933332|NCT00530946|50026304|FG002|Overall Study|Noncompliance|0|||
24933333|NCT00530946|50026305|FG003|Overall Study|Noncompliance|0|||
24933334|NCT00424047|50026317|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
24933335|NCT00424047|50026318|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
24933336|NCT00424047|50026317|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
24933337|NCT00424047|50026318|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
24933338|NCT00424047|50026317|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
24933339|NCT00424047|50026318|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
24933340|NCT00424047|50026317|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
24933341|NCT00424047|50026318|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
24933342|NCT00424047|50026317|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
24933343|NCT00424047|50026318|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
24933344|NCT00424047|50026317|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
25185712|NCT01425203|50335250|FG001|Treatment Phase|Unidentified reasons|5|||
24933345|NCT00424047|50026318|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
24933346|NCT00424047|50026317|FG000|On Study at Time of Unblinding|Adverse Event|22|||
24933347|NCT00424047|50026318|FG001|On Study at Time of Unblinding|Adverse Event|12|||
24933348|NCT00424047|50026317|FG000|On Study at Time of Unblinding|Progression of disease|92|||
24933349|NCT00424047|50026318|FG001|On Study at Time of Unblinding|Progression of disease|128|||
24933350|NCT00424047|50026317|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
24933351|NCT00424047|50026318|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
24933352|NCT00424047|50026317|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
24933353|NCT00424047|50026318|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
24933354|NCT00424047|50026317|FG000|On Study at Time of Unblinding|Death|11|||
24933355|NCT00424047|50026318|FG001|On Study at Time of Unblinding|Death|11|||
24933356|NCT00424047|50026317|FG000|On Study at Time of Unblinding|Other|5|||
24933357|NCT00424047|50026318|FG001|On Study at Time of Unblinding|Other|4|||
24933358|NCT00424047|50026317|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
24933359|NCT00424047|50026318|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
24933360|NCT00424047|50026317|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
24933361|NCT00424047|50026318|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
24933362|NCT00424047|50026317|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
24933363|NCT00424047|50026318|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
24933364|NCT00424047|50026317|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
24933365|NCT00424047|50026318|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
24933366|NCT00424047|50026317|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
24933367|NCT00424047|50026318|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
24933368|NCT00530790|50026329|FG000|Overall Study|Adverse Event|2|||
24933369|NCT00530790|50026329|FG000|Overall Study|Withdrawal by Subject|2|||
24933370|NCT00530790|50026329|FG000|Overall Study|Physician Decision|1|||
24933371|NCT00530088|50026333|FG000|Overall Study|Disease Progression|4|||
24933372|NCT00530088|50026333|FG000|Overall Study|Physician Decision|4|||
24933373|NCT00530088|50026333|FG000|Overall Study|Other Not Specified|2|||
24933374|NCT00360568|50026339|FG000|Overall Study|Adverse Event|1|||
24933375|NCT00360568|50026340|FG001|Overall Study|Adverse Event|2|||
24933376|NCT00360568|50026339|FG000|Overall Study|Lack of Efficacy|1|||
24933377|NCT00360568|50026340|FG001|Overall Study|Lack of Efficacy|0|||
24933378|NCT00360568|50026339|FG000|Overall Study|Withdrawal by Subject|0|||
24933379|NCT00360568|50026340|FG001|Overall Study|Withdrawal by Subject|3|||
24933380|NCT00436215|50026348|FG000|Overall Study|Refused further treatment|3|||
24933381|NCT00436215|50026348|FG000|Overall Study|Small bowel obstruction|1|||
24933382|NCT00441363|50026354|FG000|Overall Study|Adverse Event|4|||
24933383|NCT00441363|50026355|FG001|Overall Study|Adverse Event|2|||
24933384|NCT00441363|50026354|FG000|Overall Study|Withdrawal by Subject|3|||
25027127|NCT03130959|50125195|FG008|Overall Study|Lost to Follow-up|0|||
25027128|NCT03130959|50125196|FG009|Overall Study|Lost to Follow-up|0|||
25027129|NCT03124407|50125235|FG000|Overall Study|Lost to Follow-up|1|||
25027130|NCT03124407|50125236|FG001|Overall Study|Lost to Follow-up|0|||
25027131|NCT03124407|50125237|FG002|Overall Study|Lost to Follow-up|0|||
25027132|NCT03124407|50125238|FG003|Overall Study|Lost to Follow-up|0|||
25027133|NCT03124407|50125235|FG000|Overall Study|Adverse Event|0|||
25275114|NCT01236365|50589136|FG000|Overall Study|Lost to Follow-up|0|||
24933385|NCT00441363|50026355|FG001|Overall Study|Withdrawal by Subject|4|||
24933386|NCT00441363|50026354|FG000|Overall Study|Physician Decision|6|||
24933387|NCT00441363|50026355|FG001|Overall Study|Physician Decision|7|||
24933388|NCT00441363|50026354|FG000|Overall Study|Lost to Follow-up|2|||
24933389|NCT00441363|50026355|FG001|Overall Study|Lost to Follow-up|2|||
24933390|NCT00441363|50026354|FG000|Overall Study|Other|2|||
24933391|NCT00441363|50026355|FG001|Overall Study|Other|0|||
24933392|NCT00530712|50026361|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
24933393|NCT00530712|50026361|FG000|30 Day Follow-up Visit|Missed Visit|5|||
24933394|NCT00530712|50026361|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
24933395|NCT00530712|50026361|FG000|6 Month Follow-up Visit|Missed Visit|3|||
24933396|NCT00530712|50026361|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
24933397|NCT00530712|50026361|FG000|6 Month Follow-up Visit|Death|2|||
24933398|NCT00530712|50026361|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
24933399|NCT00530712|50026361|FG000|12 Month Follow-up Visit|Missed Visit|3|||
24933400|NCT00530712|50026361|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
24933401|NCT00530712|50026361|FG000|12 Month Follow-up Visit|Death|9|||
25275115|NCT01236365|50589137|FG001|Overall Study|Lost to Follow-up|2|||
24933402|NCT00626795|50026369|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
24933403|NCT00626795|50026370|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
24933404|NCT00626795|50026371|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
24933405|NCT00626795|50026369|FG000|Blinded Treatment|Lack of Efficacy|2|||
24933406|NCT00626795|50026370|FG001|Blinded Treatment|Lack of Efficacy|0|||
24933407|NCT00626795|50026371|FG002|Blinded Treatment|Lack of Efficacy|0|||
24933408|NCT00626795|50026369|FG000|Blinded Treatment|Unacceptable adverse event|0|||
25027134|NCT03124407|50125236|FG001|Overall Study|Adverse Event|0|||
25027135|NCT03124407|50125237|FG002|Overall Study|Adverse Event|1|||
24933409|NCT00626795|50026370|FG001|Blinded Treatment|Unacceptable adverse event|0|||
24933410|NCT00626795|50026371|FG002|Blinded Treatment|Unacceptable adverse event|1|||
24933411|NCT00626795|50026369|FG000|Blinded Treatment|Protocol Violation|0|||
24933412|NCT00626795|50026370|FG001|Blinded Treatment|Protocol Violation|1|||
24933413|NCT00626795|50026371|FG002|Blinded Treatment|Protocol Violation|1|||
24933414|NCT00626795|50026369|FG000|Blinded Treatment|Withdrawal by Subject|1|||
24933415|NCT00626795|50026370|FG001|Blinded Treatment|Withdrawal by Subject|1|||
24933416|NCT00626795|50026371|FG002|Blinded Treatment|Withdrawal by Subject|0|||
24933417|NCT00626795|50026369|FG000|Blinded Treatment|Other reasons|2|||
24933418|NCT00626795|50026370|FG001|Blinded Treatment|Other reasons|0|||
24933419|NCT00626795|50026371|FG002|Blinded Treatment|Other reasons|2|||
24933420|NCT00626795|50026369|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
24933421|NCT00626795|50026370|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
24933422|NCT00626795|50026371|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
24933423|NCT00626639|50026385|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
24933424|NCT00626639|50026386|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
24933425|NCT00626561|50026394|FG000|Overall Study|Withdrawal by Subject|2|||
24933426|NCT00626561|50026394|FG000|Overall Study|Disease Progression|2|||
24933427|NCT03880266|50026406|FG000|Overall Study|Withdrawal by Subject|0|||
24933428|NCT03880266|50026407|FG001|Overall Study|Withdrawal by Subject|1|||
24933429|NCT03880266|50026408|FG002|Overall Study|Withdrawal by Subject|1|||
24933430|NCT03880266|50026409|FG003|Overall Study|Withdrawal by Subject|0|||
24933431|NCT03880266|50026410|FG004|Overall Study|Withdrawal by Subject|0|||
24933432|NCT03880266|50026411|FG005|Overall Study|Withdrawal by Subject|0|||
24933433|NCT03880266|50026412|FG006|Overall Study|Withdrawal by Subject|0|||
24933434|NCT03880266|50026413|FG007|Overall Study|Withdrawal by Subject|0|||
24933435|NCT00423891|50026434|FG000|Enrolled|Withdrawal by Subject|0|||
24933436|NCT00423891|50026435|FG001|Enrolled|Withdrawal by Subject|0|||
24933437|NCT00423891|50026436|FG002|Enrolled|Withdrawal by Subject|1|||
24933438|NCT00423891|50026434|FG000|Enrolled|Lost to Follow-up|0|||
24933439|NCT00423891|50026435|FG001|Enrolled|Lost to Follow-up|0|||
25155923|NCT01500213|50271468|FG001|Overall Study|Physician Decision|10|||
25155924|NCT01500213|50271467|FG000|Overall Study|Lack of Efficacy|9|||
25155925|NCT01500213|50271468|FG001|Overall Study|Lack of Efficacy|7|||
25155926|NCT01500213|50271467|FG000|Overall Study|Lost to Follow-up|3|||
25155927|NCT01500213|50271468|FG001|Overall Study|Lost to Follow-up|6|||
25155928|NCT01500213|50271467|FG000|Overall Study|Other Reasons|7|||
25155929|NCT01500213|50271468|FG001|Overall Study|Other Reasons|5|||
25155930|NCT01475253|50271498|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
25155931|NCT01475253|50271499|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
25155932|NCT01475253|50271500|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
25155933|NCT01475253|50271501|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
25155934|NCT01475253|50271498|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
25155935|NCT01475253|50271499|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
25155936|NCT01475253|50271500|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
25155937|NCT01475253|50271501|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
25155938|NCT01500135|50271559|FG000|Overall Study|Withdrawal of Consent|4|||
25155939|NCT01500135|50271560|FG001|Overall Study|Withdrawal of Consent|0|||
25155940|NCT01500135|50271559|FG000|Overall Study|Lost to Follow-up|6|||
25155941|NCT01500135|50271560|FG001|Overall Study|Lost to Follow-up|4|||
25155942|NCT01500135|50271559|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
25155943|NCT01500135|50271560|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
25155944|NCT01500135|50271559|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
25155945|NCT01500135|50271560|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
25155946|NCT01500135|50271559|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
25155947|NCT01500135|50271560|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
25155948|NCT01500135|50271559|FG000|Overall Study|Participant was a Safety Concern|1|||
25155949|NCT01500135|50271560|FG001|Overall Study|Participant was a Safety Concern|0|||
25155950|NCT01500135|50271559|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
25155951|NCT01500135|50271560|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
25155952|NCT01475097|50271572|FG000|Overall Study|Protocol Violation|1|||
25155953|NCT01475097|50271573|FG001|Overall Study|Protocol Violation|1|||
24933440|NCT00423891|50026436|FG002|Enrolled|Lost to Follow-up|1|||
24933441|NCT00423891|50026434|FG000|Enrolled|No longer met criteria|11|||
24933442|NCT00423891|50026435|FG001|Enrolled|No longer met criteria|2|||
25155954|NCT01529385|50271581|FG000|Overall Study|Lost to Follow-up|2|||
25155955|NCT01529385|50271582|FG001|Overall Study|Lost to Follow-up|1|||
25155956|NCT01474551|50271588|FG000|Overall Study|Death|1|||
25155957|NCT01500057|50271623|FG000|Overall Study|Lost to Follow-up|6|||
25155958|NCT01500057|50271624|FG001|Overall Study|Lost to Follow-up|4|||
25155959|NCT01499667|50271642|FG000|Overall Study|administrative problems|4|||
25155960|NCT01499667|50271643|FG001|Overall Study|administrative problems|5|||
25155961|NCT01499667|50271644|FG002|Overall Study|administrative problems|5|||
25155962|NCT01499667|50271642|FG000|Overall Study|Protocol Violation|1|||
25155963|NCT01499667|50271643|FG001|Overall Study|Protocol Violation|3|||
25155964|NCT01499667|50271644|FG002|Overall Study|Protocol Violation|2|||
25155965|NCT01499667|50271642|FG000|Overall Study|Adverse Event|0|||
25155966|NCT01499667|50271643|FG001|Overall Study|Adverse Event|2|||
25155967|NCT01499667|50271644|FG002|Overall Study|Adverse Event|2|||
25155968|NCT01499667|50271642|FG000|Overall Study|Withdrawal by Subject|2|||
24933443|NCT00423891|50026436|FG002|Enrolled|No longer met criteria|1|||
24933444|NCT00423891|50026434|FG000|Treatment|Withdrawal by Subject|1|||
24933445|NCT00423891|50026435|FG001|Treatment|Withdrawal by Subject|0|||
24933446|NCT00423891|50026436|FG002|Treatment|Withdrawal by Subject|0|||
24933447|NCT00423891|50026434|FG000|Treatment|Lost to Follow-up|1|||
24933448|NCT00423891|50026435|FG001|Treatment|Lost to Follow-up|0|||
24933449|NCT00423891|50026436|FG002|Treatment|Lost to Follow-up|0|||
24933450|NCT00423891|50026434|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
24933451|NCT00423891|50026435|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
24933452|NCT00423891|50026436|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
24933453|NCT00423891|50026434|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
25027136|NCT03124407|50125238|FG003|Overall Study|Adverse Event|0|||
25027137|NCT02929407|50125252|FG000|Overall Study|Adverse Event|1|||
25027138|NCT03123939|50125256|FG000|Overall Study|Lack of Efficacy|6|||
25027139|NCT03123939|50125256|FG000|Overall Study|Death|5|||
25027140|NCT03123939|50125256|FG000|Overall Study|Physician Decision|2|||
25027141|NCT03123939|50125256|FG000|Overall Study|Subject/guardian decision|2|||
25027142|NCT03123939|50125256|FG000|Overall Study|Lost to Follow-up|1|||
25027143|NCT03123939|50125256|FG000|Overall Study|New therapy for study indication|1|||
25027144|NCT03123939|50125256|FG000|Overall Study|Protocol deviation|1|||
25027145|NCT03123939|50125256|FG000|Overall Study|Progressive disease|18|||
24933454|NCT00423891|50026435|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
24933455|NCT00423891|50026436|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
25027146|NCT03123939|50125256|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
25027147|NCT03123939|50125256|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
25027148|NCT03123861|50125271|FG000|Overall Study|Protocol Violation|1|||
25027149|NCT03123861|50125272|FG001|Overall Study|Protocol Violation|1|||
25027150|NCT03123861|50125271|FG000|Overall Study|Withdrawal by Subject|2|||
25027151|NCT03123861|50125272|FG001|Overall Study|Withdrawal by Subject|2|||
25027152|NCT03123471|50125280|FG000|Placebo-controlled Phase|Adverse Event|3|||
25027153|NCT03123471|50125281|FG001|Placebo-controlled Phase|Adverse Event|8|||
25027154|NCT03123471|50125280|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
25027155|NCT03123471|50125281|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
25027156|NCT03123471|50125280|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
25027157|NCT03123471|50125281|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
25027158|NCT03123471|50125280|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
25027159|NCT03123471|50125281|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
25027160|NCT03123471|50125280|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
25027161|NCT03123471|50125281|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
25027162|NCT03123471|50125280|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
25027163|NCT03123471|50125281|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
25027164|NCT03123471|50125280|FG000|Placebo-controlled Phase|Miscellaneous|0|||
25027165|NCT03123471|50125281|FG001|Placebo-controlled Phase|Miscellaneous|1|||
25027166|NCT03123471|50125280|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
25027167|NCT03123471|50125281|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
25027168|NCT03123471|50125280|FG000|Apremilast Extension Phase|Adverse Event|1|||
25027169|NCT03123471|50125281|FG001|Apremilast Extension Phase|Adverse Event|5|||
24933456|NCT00423813|50026449|FG000|Overall Study|Adverse Event|11|||
24933457|NCT00423813|50026450|FG001|Overall Study|Adverse Event|30|||
24933458|NCT00423813|50026451|FG002|Overall Study|Adverse Event|40|||
24933459|NCT00423813|50026449|FG000|Overall Study|Withdrawal by Subject|6|||
24933460|NCT00423813|50026450|FG001|Overall Study|Withdrawal by Subject|8|||
25027170|NCT03123471|50125280|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
25027171|NCT03123471|50125281|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
25027172|NCT03123471|50125280|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
25027173|NCT03123471|50125281|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
25027174|NCT02661178|50125308|FG000|Part 1|Protocol Violation|1|||
25027175|NCT02661178|50125309|FG001|Part 1|Protocol Violation|0|||
25027176|NCT02661178|50125310|FG002|Part 1|Protocol Violation|0|||
25027177|NCT02661178|50125311|FG003|Part 1|Protocol Violation|0|||
24933461|NCT00423813|50026451|FG002|Overall Study|Withdrawal by Subject|5|||
24933462|NCT00423813|50026449|FG000|Overall Study|Lost to Follow-up|5|||
25027178|NCT02661178|50125312|FG004|Part 1|Protocol Violation|0|||
25027179|NCT02661178|50125313|FG005|Part 1|Protocol Violation|0|||
25027180|NCT02661178|50125314|FG006|Part 1|Protocol Violation|0|||
25027181|NCT02661178|50125315|FG007|Part 1|Protocol Violation|0|||
25027182|NCT02661178|50125316|FG008|Part 1|Protocol Violation|0|||
25027183|NCT02661178|50125317|FG009|Part 1|Protocol Violation|0|||
25155969|NCT01499667|50271643|FG001|Overall Study|Withdrawal by Subject|1|||
25155970|NCT01499667|50271644|FG002|Overall Study|Withdrawal by Subject|1|||
25155971|NCT01499667|50271642|FG000|Overall Study|Lack of Efficacy|2|||
25155972|NCT01499667|50271643|FG001|Overall Study|Lack of Efficacy|0|||
24933463|NCT00423813|50026450|FG001|Overall Study|Lost to Follow-up|4|||
24933464|NCT00423813|50026451|FG002|Overall Study|Lost to Follow-up|4|||
24933465|NCT00423813|50026449|FG000|Overall Study|Lack of Efficacy|23|||
24933466|NCT00423813|50026450|FG001|Overall Study|Lack of Efficacy|18|||
24933467|NCT00423813|50026451|FG002|Overall Study|Lack of Efficacy|19|||
24933468|NCT00423813|50026449|FG000|Overall Study|Physician Decision|2|||
24933469|NCT00423813|50026450|FG001|Overall Study|Physician Decision|0|||
24933470|NCT00423813|50026451|FG002|Overall Study|Physician Decision|0|||
24933471|NCT00423813|50026449|FG000|Overall Study|Sponsor Decision|0|||
24933472|NCT00423813|50026450|FG001|Overall Study|Sponsor Decision|1|||
24933473|NCT00423813|50026451|FG002|Overall Study|Sponsor Decision|0|||
24933474|NCT00423813|50026449|FG000|Overall Study|Protocol Violation|9|||
24933475|NCT00423813|50026450|FG001|Overall Study|Protocol Violation|4|||
24933476|NCT00423813|50026451|FG002|Overall Study|Protocol Violation|4|||
24933477|NCT00423813|50026449|FG000|Overall Study|Pregnancy|0|||
24933478|NCT00423813|50026450|FG001|Overall Study|Pregnancy|0|||
24933479|NCT00423813|50026451|FG002|Overall Study|Pregnancy|1|||
24933480|NCT00423813|50026449|FG000|Overall Study|Subject started night shift work|1|||
24933481|NCT00423813|50026450|FG001|Overall Study|Subject started night shift work|0|||
24933482|NCT00423813|50026451|FG002|Overall Study|Subject started night shift work|0|||
24933483|NCT00423813|50026449|FG000|Overall Study|Will start exclusionary medications|0|||
24933484|NCT00423813|50026450|FG001|Overall Study|Will start exclusionary medications|1|||
24933485|NCT00423813|50026451|FG002|Overall Study|Will start exclusionary medications|0|||
24933486|NCT00423813|50026449|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
24933487|NCT00423813|50026450|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
25155973|NCT01499667|50271644|FG002|Overall Study|Lack of Efficacy|0|||
25155974|NCT01499511|50271654|FG000|Overall Study|Death|1|||
25155975|NCT01499511|50271655|FG001|Overall Study|Death|0|||
25155976|NCT01474317|50271675|FG000|Overall Study|Adverse Event|1|||
25155977|NCT01474317|50271675|FG000|Overall Study|Subject ineligible for study|1|||
25155978|NCT01499355|50271771|FG000|Run-In Period|Study Termination|15|||
25155979|NCT01499355|50271772|FG001|Run-In Period|Study Termination|0|||
25155980|NCT01499355|50271773|FG002|Run-In Period|Study Termination|0|||
25155981|NCT01499355|50271774|FG003|Run-In Period|Study Termination|0|||
25155982|NCT01499355|50271771|FG000|Run-In Period|Other|3|||
25155983|NCT01499355|50271772|FG001|Run-In Period|Other|0|||
25155984|NCT01499355|50271773|FG002|Run-In Period|Other|0|||
25155985|NCT01499355|50271774|FG003|Run-In Period|Other|0|||
25155986|NCT01499355|50271771|FG000|Run-In Period|Death|2|||
25155987|NCT01499355|50271772|FG001|Run-In Period|Death|0|||
25155988|NCT01499355|50271773|FG002|Run-In Period|Death|0|||
25155989|NCT01499355|50271774|FG003|Run-In Period|Death|0|||
25155990|NCT01499355|50271771|FG000|Run-In Period|Investigator Decision|2|||
25155991|NCT01499355|50271772|FG001|Run-In Period|Investigator Decision|0|||
25155992|NCT01499355|50271773|FG002|Run-In Period|Investigator Decision|0|||
25155993|NCT01499355|50271774|FG003|Run-In Period|Investigator Decision|0|||
25155994|NCT01499355|50271771|FG000|Run-In Period|Consent Withdrawn|1|||
25155995|NCT01499355|50271772|FG001|Run-In Period|Consent Withdrawn|0|||
25155996|NCT01499355|50271773|FG002|Run-In Period|Consent Withdrawn|0|||
25155997|NCT01499355|50271774|FG003|Run-In Period|Consent Withdrawn|0|||
25155998|NCT01499355|50271771|FG000|Run-In Period|Adverse Event|8|||
24933488|NCT00423813|50026451|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
24933489|NCT03687372|50026461|FG000|Overall Study|Lost to Follow-up|12|||
24933490|NCT03687372|50026462|FG001|Overall Study|Lost to Follow-up|21|||
24933491|NCT03687372|50026461|FG000|Overall Study|Withdrawal by Subject|4|||
24933492|NCT03687372|50026462|FG001|Overall Study|Withdrawal by Subject|17|||
24933493|NCT03687372|50026461|FG000|Overall Study|Investigator Decision|1|||
24933494|NCT03687372|50026462|FG001|Overall Study|Investigator Decision|1|||
24933495|NCT00626405|50026472|FG000|Overall Study|Deemed Ineligible|1|||
24933496|NCT00626405|50026473|FG001|Overall Study|Deemed Ineligible|0|||
24933497|NCT00626405|50026472|FG000|Overall Study|Withdrawal by Subject|0|||
24933498|NCT00626405|50026473|FG001|Overall Study|Withdrawal by Subject|1|||
24933499|NCT00358150|50026479|FG000|Overall Study|Adverse Event|3|||
24933500|NCT00358150|50026479|FG000|Overall Study|Withdrawal by Subject|1|||
25027184|NCT02661178|50125318|FG010|Part 1|Protocol Violation|0|||
24933501|NCT00358150|50026479|FG000|Overall Study|Undefined|3|||
24933502|NCT05061966|50026506|FG000|Overall Study|Lost to Follow-up|13|||
25027185|NCT02661178|50125319|FG011|Part 1|Protocol Violation|0|||
25155999|NCT01499355|50271772|FG001|Run-In Period|Adverse Event|0|||
25156000|NCT01499355|50271773|FG002|Run-In Period|Adverse Event|0|||
25156001|NCT01499355|50271774|FG003|Run-In Period|Adverse Event|0|||
25156002|NCT01499355|50271771|FG000|Double-Blind Period|Adverse Event|0|||
25156003|NCT01499355|50271772|FG001|Double-Blind Period|Adverse Event|2|||
25156004|NCT01499355|50271773|FG002|Double-Blind Period|Adverse Event|3|||
25156005|NCT01499355|50271774|FG003|Double-Blind Period|Adverse Event|2|||
25156006|NCT01499355|50271771|FG000|Double-Blind Period|Study Termination|0|||
24933503|NCT05061966|50026507|FG001|Overall Study|Lost to Follow-up|13|||
25156007|NCT01499355|50271772|FG001|Double-Blind Period|Study Termination|18|||
25156008|NCT01499355|50271773|FG002|Double-Blind Period|Study Termination|16|||
25275116|NCT01236365|50589136|FG000|Overall Study|Moved Out of State|1|||
24933504|NCT05027815|50026515|FG000|Overall Study|Death|2|||
24933505|NCT05027815|50026516|FG001|Overall Study|Death|1|||
24933506|NCT04827134|50026526|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
24933507|NCT04827134|50026527|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
24933508|NCT04827134|50026528|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
24933509|NCT04827134|50026529|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
25027186|NCT02661178|50125320|FG012|Part 1|Protocol Violation|0|||
25027187|NCT02661178|50125321|FG013|Part 1|Protocol Violation|0|||
25027188|NCT02661178|50125322|FG014|Part 1|Protocol Violation|0|||
25027189|NCT02660944|50125374|FG000|Overall Study|Adverse Event|3|||
24933510|NCT04818593|50026543|FG000|Overall Study|Low Oocyte Yield|8|||
24933511|NCT04818593|50026544|FG001|Overall Study|Low Oocyte Yield|8|||
24933512|NCT04818593|50026543|FG000|Overall Study|Not ICSI Insemination|7|||
24933513|NCT04818593|50026544|FG001|Overall Study|Not ICSI Insemination|7|||
24933514|NCT04818593|50026543|FG000|Overall Study|Poor Sperm Quality|2|||
24933515|NCT04818593|50026544|FG001|Overall Study|Poor Sperm Quality|2|||
24933516|NCT04818593|50026543|FG000|Overall Study|Withdrawal by Subject|2|||
24933517|NCT04818593|50026544|FG001|Overall Study|Withdrawal by Subject|2|||
24933518|NCT04818593|50026543|FG000|Overall Study|Conversion to IUI due to low response|1|||
24933519|NCT04818593|50026544|FG001|Overall Study|Conversion to IUI due to low response|1|||
24933520|NCT04680975|50026550|FG000|Overall Study|Adverse Event|3|||
24933521|NCT04680975|50026550|FG000|Overall Study|Death|1|||
24933522|NCT04680975|50026550|FG000|Overall Study|Progressive Disease|1|||
24933523|NCT04680975|50026550|FG000|Overall Study|Withdrawal by Subject|1|||
24933524|NCT04673786|50026556|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
24933525|NCT04673786|50026557|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
24933526|NCT04673786|50026558|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
25156009|NCT01499355|50271774|FG003|Double-Blind Period|Study Termination|14|||
25156010|NCT01499355|50271771|FG000|Double-Blind Period|Other|0|||
25156011|NCT01499355|50271772|FG001|Double-Blind Period|Other|1|||
25156012|NCT01499355|50271773|FG002|Double-Blind Period|Other|2|||
25156013|NCT01499355|50271774|FG003|Double-Blind Period|Other|2|||
25156014|NCT01499355|50271771|FG000|Double-Blind Period|Death|0|||
25156015|NCT01499355|50271772|FG001|Double-Blind Period|Death|1|||
25156016|NCT01499355|50271773|FG002|Double-Blind Period|Death|0|||
25156017|NCT01499355|50271774|FG003|Double-Blind Period|Death|0|||
25156018|NCT01499355|50271771|FG000|Double-Blind Period|Investigator Decision|0|||
25156019|NCT01499355|50271772|FG001|Double-Blind Period|Investigator Decision|0|||
25156020|NCT01499355|50271773|FG002|Double-Blind Period|Investigator Decision|3|||
25156021|NCT01499355|50271774|FG003|Double-Blind Period|Investigator Decision|3|||
25156022|NCT01499355|50271771|FG000|Double-Blind Period|Consent Withdrawn|0|||
25156023|NCT01499355|50271772|FG001|Double-Blind Period|Consent Withdrawn|0|||
25156024|NCT01499355|50271773|FG002|Double-Blind Period|Consent Withdrawn|1|||
24933527|NCT04673786|50026556|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
24933528|NCT04673786|50026557|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
24933529|NCT04673786|50026558|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
24933530|NCT04673786|50026556|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
24933531|NCT04673786|50026557|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
25027190|NCT02660944|50125375|FG001|Overall Study|Adverse Event|4|||
25027191|NCT02660944|50125374|FG000|Overall Study|Physician Decision|3|||
25027192|NCT02660944|50125375|FG001|Overall Study|Physician Decision|1|||
25027193|NCT02660944|50125374|FG000|Overall Study|Withdrawal by Subject|5|||
25027194|NCT02660944|50125375|FG001|Overall Study|Withdrawal by Subject|3|||
25027195|NCT02660944|50125374|FG000|Overall Study|Lost to Follow-up|4|||
25027196|NCT02660944|50125375|FG001|Overall Study|Lost to Follow-up|1|||
24933532|NCT04673786|50026558|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
24933533|NCT04673786|50026556|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
25027197|NCT02660944|50125374|FG000|Overall Study|Subject schedule|0|||
25027198|NCT02660944|50125375|FG001|Overall Study|Subject schedule|1|||
25027199|NCT02660944|50125374|FG000|Overall Study|Exclusion criteria met|2|||
25156025|NCT01499355|50271774|FG003|Double-Blind Period|Consent Withdrawn|2|||
25156026|NCT01499355|50271771|FG000|Double-Blind Period|Lost to Follow-up|0|||
25156027|NCT01499355|50271772|FG001|Double-Blind Period|Lost to Follow-up|1|||
25156028|NCT01499355|50271773|FG002|Double-Blind Period|Lost to Follow-up|0|||
25156029|NCT01499355|50271774|FG003|Double-Blind Period|Lost to Follow-up|0|||
25156030|NCT01474239|50271795|FG000|Overall Study|Disease Progression|37|||
25156031|NCT01474239|50271796|FG001|Overall Study|Disease Progression|25|||
25156032|NCT01474239|50271795|FG000|Overall Study|Adverse Event|12|||
25156033|NCT01474239|50271796|FG001|Overall Study|Adverse Event|3|||
25156034|NCT01474239|50271795|FG000|Overall Study|Withdrawal by Subject|1|||
25156035|NCT01474239|50271796|FG001|Overall Study|Withdrawal by Subject|2|||
25156036|NCT01474239|50271795|FG000|Overall Study|Death|1|||
25156037|NCT01474239|50271796|FG001|Overall Study|Death|1|||
25156038|NCT01474239|50271795|FG000|Overall Study|Clinical Disease Progression|7|||
24933534|NCT04673786|50026557|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
24933535|NCT04673786|50026558|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
24933536|NCT04673786|50026556|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
25156039|NCT01474239|50271796|FG001|Overall Study|Clinical Disease Progression|1|||
24933537|NCT04673786|50026557|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
24933538|NCT04673786|50026558|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
24933539|NCT04673786|50026556|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
24933540|NCT04673786|50026557|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
24933541|NCT04673786|50026558|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
24933542|NCT04583969|50026582|FG000|Overall Study|Death|31|||
25156040|NCT01474239|50271795|FG000|Overall Study|Withdrawal for Economic Reason|1|||
25156041|NCT01474239|50271796|FG001|Overall Study|Withdrawal for Economic Reason|0|||
25156042|NCT01473381|50271806|FG000|Overall Study|Adverse Event|8|||
25156043|NCT01473381|50271807|FG001|Overall Study|Adverse Event|20|||
25156044|NCT01473381|50271808|FG002|Overall Study|Adverse Event|25|||
25156045|NCT01473381|50271809|FG003|Overall Study|Adverse Event|17|||
25156046|NCT01473381|50271806|FG000|Overall Study|Insufficient Therapeutic Response|10|||
25156047|NCT01473381|50271807|FG001|Overall Study|Insufficient Therapeutic Response|1|||
25156048|NCT01473381|50271808|FG002|Overall Study|Insufficient Therapeutic Response|2|||
25156049|NCT01473381|50271809|FG003|Overall Study|Insufficient Therapeutic Response|3|||
25156050|NCT01473381|50271806|FG000|Overall Study|Protocol Violation|17|||
25156051|NCT01473381|50271807|FG001|Overall Study|Protocol Violation|23|||
25156052|NCT01473381|50271808|FG002|Overall Study|Protocol Violation|19|||
25156053|NCT01473381|50271809|FG003|Overall Study|Protocol Violation|17|||
25156054|NCT01473381|50271806|FG000|Overall Study|Withdrawal of Consent|20|||
25156055|NCT01473381|50271807|FG001|Overall Study|Withdrawal of Consent|21|||
25156056|NCT01473381|50271808|FG002|Overall Study|Withdrawal of Consent|20|||
25156057|NCT01473381|50271809|FG003|Overall Study|Withdrawal of Consent|26|||
25156058|NCT01473381|50271806|FG000|Overall Study|Lost to Follow-up|25|||
25156059|NCT01473381|50271807|FG001|Overall Study|Lost to Follow-up|28|||
25156060|NCT01473381|50271808|FG002|Overall Study|Lost to Follow-up|35|||
25156061|NCT01473381|50271809|FG003|Overall Study|Lost to Follow-up|23|||
25156062|NCT01473381|50271806|FG000|Overall Study|Other Reasons|0|||
25156063|NCT01473381|50271807|FG001|Overall Study|Other Reasons|0|||
25156064|NCT01473381|50271808|FG002|Overall Study|Other Reasons|1|||
25156065|NCT01473381|50271809|FG003|Overall Study|Other Reasons|3|||
25156066|NCT01499277|50271851|FG000|Overall Study|Adverse Event|3|||
25156067|NCT01499277|50271852|FG001|Overall Study|Adverse Event|6|||
25156068|NCT01499277|50271851|FG000|Overall Study|Death|3|||
25156069|NCT01499277|50271852|FG001|Overall Study|Death|2|||
24933543|NCT04583969|50026583|FG001|Overall Study|Death|38|||
24933544|NCT04583969|50026582|FG000|Overall Study|Lost to Follow-up|16|||
24933545|NCT04583969|50026583|FG001|Overall Study|Lost to Follow-up|13|||
24933546|NCT04583969|50026582|FG000|Overall Study|Protocol Violation|1|||
24933547|NCT04583969|50026583|FG001|Overall Study|Protocol Violation|0|||
24933548|NCT04583969|50026582|FG000|Overall Study|Withdrawal by Subject|3|||
24933549|NCT04583969|50026583|FG001|Overall Study|Withdrawal by Subject|3|||
24933550|NCT04583969|50026582|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
24933551|NCT04583969|50026583|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
24933552|NCT04583969|50026582|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
25156070|NCT01499277|50271851|FG000|Overall Study|Lost to Follow-up|15|||
25156071|NCT01499277|50271852|FG001|Overall Study|Lost to Follow-up|8|||
25156072|NCT01499277|50271851|FG000|Overall Study|Protocol Violation|2|||
25156073|NCT01499277|50271852|FG001|Overall Study|Protocol Violation|3|||
25156074|NCT01499277|50271851|FG000|Overall Study|Withdrawal by Subject|16|||
25156075|NCT01499277|50271852|FG001|Overall Study|Withdrawal by Subject|6|||
25156076|NCT01499277|50271851|FG000|Overall Study|Lack of therapeutic response and other|8|||
25156077|NCT01499277|50271852|FG001|Overall Study|Lack of therapeutic response and other|7|||
25156078|NCT01499199|50271877|FG000|Overall Study|Adverse Event|1|||
25156079|NCT01499199|50271877|FG000|Overall Study|Lack of Efficacy|1|||
25156080|NCT01499043|50271881|FG000|Overall Study|Progressive disease (radiographic)|2|||
24933553|NCT04583969|50026583|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
24933554|NCT04583969|50026582|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
25156081|NCT01499043|50271881|FG000|Overall Study|Progressive disease (clinical)|1|||
25156082|NCT01499043|50271881|FG000|Overall Study|Withdrawal by Subject|2|||
24933555|NCT04583969|50026583|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
24933556|NCT04583969|50026582|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
24933557|NCT04583969|50026583|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
24933558|NCT04583969|50026582|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
25027200|NCT02660944|50125375|FG001|Overall Study|Exclusion criteria met|0|||
25027201|NCT02975336|50125385|FG000|DBPC (52 Weeks)|Adverse Event|16|||
25027202|NCT02975336|50125386|FG001|DBPC (52 Weeks)|Adverse Event|17|||
25027203|NCT02975336|50125387|FG002|DBPC (52 Weeks)|Adverse Event|13|||
25027204|NCT02975336|50125388|FG003|DBPC (52 Weeks)|Adverse Event|18|||
25027205|NCT02975336|50125389|FG004|DBPC (52 Weeks)|Adverse Event|0|||
25027206|NCT02975336|50125390|FG005|DBPC (52 Weeks)|Adverse Event|0|||
25027207|NCT02975336|50125391|FG006|DBPC (52 Weeks)|Adverse Event|0|||
24933559|NCT04583969|50026583|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
24933560|NCT04561115|50026589|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
24933561|NCT04561115|50026590|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
24933562|NCT04561115|50026589|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
24933563|NCT04561115|50026590|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
24933564|NCT04561115|50026589|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
24933565|NCT04561115|50026590|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
24933566|NCT04546425|50026598|FG000|Overall Study|Protocol Violation|2|||
24933567|NCT04546425|50026599|FG001|Overall Study|Protocol Violation|1|||
24933568|NCT04546425|50026598|FG000|Overall Study|Adverse Event|3|||
24933569|NCT04546425|50026599|FG001|Overall Study|Adverse Event|0|||
24933570|NCT04546425|50026598|FG000|Overall Study|No Longer met eligibility criteria|3|||
25027208|NCT02975336|50125392|FG007|DBPC (52 Weeks)|Adverse Event|0|||
24933571|NCT04546425|50026599|FG001|Overall Study|No Longer met eligibility criteria|3|||
24933572|NCT04546425|50026598|FG000|Overall Study|Withdrawal by parent/guardian|7|||
24933573|NCT04546425|50026599|FG001|Overall Study|Withdrawal by parent/guardian|5|||
24933574|NCT04546425|50026598|FG000|Overall Study|Lost to Follow-up|5|||
25027209|NCT02975336|50125385|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
25027210|NCT02975336|50125386|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
25027211|NCT02975336|50125387|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
25027212|NCT02975336|50125388|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
25027213|NCT02975336|50125389|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
25027214|NCT02975336|50125390|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
24933575|NCT04546425|50026599|FG001|Overall Study|Lost to Follow-up|4|||
24933576|NCT04546425|50026598|FG000|Overall Study|Other|0|||
24933577|NCT04546425|50026599|FG001|Overall Study|Other|1|||
24933578|NCT04366258|50026605|FG000|Baseline Assessments|Screen Failure|21|||
24933579|NCT04366258|50026605|FG000|Baseline Assessments|Early Termination|3|||
24933580|NCT04101331|50026653|FG000|Overall Study|Adverse Event|7|||
24933581|NCT04101331|50026653|FG000|Overall Study|Disease progression|79|||
24933582|NCT04101331|50026653|FG000|Overall Study|Withdrawal by Subject|1|||
24933583|NCT04101331|50026653|FG000|Overall Study|Investigator decision|6|||
24933584|NCT04101331|50026653|FG000|Overall Study|Death|6|||
24933585|NCT04101331|50026653|FG000|Overall Study|Allogenic transplant|1|||
24933586|NCT04082884|50026657|FG000|Overall Study|Withdrawal by Subject|1|||
24933587|NCT03891667|50026674|FG000|Overall Study|Physician Decision|1|||
24933588|NCT03891667|50026675|FG001|Overall Study|Physician Decision|0|||
24933589|NCT03891667|50026674|FG000|Overall Study|COVID related pause|1|||
24933590|NCT03891667|50026675|FG001|Overall Study|COVID related pause|1|||
24933591|NCT03891667|50026674|FG000|Overall Study|Withdrawal by Subject|0|||
24933592|NCT03891667|50026675|FG001|Overall Study|Withdrawal by Subject|1|||
24933593|NCT03891667|50026674|FG000|Overall Study|Adverse Event|0|||
24933594|NCT03891667|50026675|FG001|Overall Study|Adverse Event|1|||
24933595|NCT03864926|50026683|FG000|Overall Study|Death|0|||
24933596|NCT03864926|50026684|FG001|Overall Study|Death|2|||
24933597|NCT03715153|50026708|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
24933598|NCT03715153|50026709|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
24933599|NCT03715153|50026708|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
24933600|NCT03715153|50026709|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
24933601|NCT03715153|50026708|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
24933602|NCT03715153|50026709|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
24933603|NCT03715153|50026708|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
24933604|NCT03715153|50026709|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
24933605|NCT03715153|50026708|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
24933606|NCT03715153|50026709|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
24933607|NCT03715153|50026708|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
25027215|NCT02975336|50125391|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
25027216|NCT02975336|50125392|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
25027217|NCT02975336|50125385|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
25027218|NCT02975336|50125386|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
24933608|NCT03715153|50026709|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
24933609|NCT03569293|50026738|FG000|Overall Study|Adverse Event|4|||
24933610|NCT03569293|50026739|FG001|Overall Study|Adverse Event|1|||
24933611|NCT03569293|50026740|FG002|Overall Study|Adverse Event|5|||
24933612|NCT03569293|50026741|FG003|Overall Study|Adverse Event|1|||
24933613|NCT03569293|50026742|FG004|Overall Study|Adverse Event|0|||
25027219|NCT02975336|50125387|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
25027220|NCT02975336|50125388|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
25027221|NCT02975336|50125389|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
25027222|NCT02975336|50125390|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
25027223|NCT02975336|50125391|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
25027224|NCT02975336|50125392|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
25027225|NCT02975336|50125385|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
25027226|NCT02975336|50125386|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
25027227|NCT02975336|50125387|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
25027228|NCT02975336|50125388|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
25027229|NCT02975336|50125389|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
25027230|NCT02975336|50125390|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
25027231|NCT02975336|50125391|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
25027232|NCT02975336|50125392|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
25027233|NCT02975336|50125385|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
25027234|NCT02975336|50125386|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
25027235|NCT02975336|50125387|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
25027236|NCT02975336|50125388|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
25027237|NCT02975336|50125389|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
25027238|NCT02975336|50125390|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
25027239|NCT02975336|50125391|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
25027240|NCT02975336|50125392|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
25027241|NCT02975336|50125385|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
25027242|NCT02975336|50125386|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
25027243|NCT02975336|50125387|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
25027244|NCT02975336|50125388|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
25156083|NCT01499043|50271881|FG000|Overall Study|Adverse Event|1|||
25156084|NCT01498887|50271955|FG000|Overall Study|Administrative problems|1|||
25156085|NCT01498887|50271956|FG001|Overall Study|Administrative problems|0|||
25156086|NCT01498887|50271955|FG000|Overall Study|Lost to Follow-up|1|||
25156087|NCT01498887|50271956|FG001|Overall Study|Lost to Follow-up|1|||
25156088|NCT01498887|50271955|FG000|Overall Study|Withdrawal by Subject|1|||
25156089|NCT01498887|50271956|FG001|Overall Study|Withdrawal by Subject|0|||
25156090|NCT01498887|50271955|FG000|Overall Study|Protocol Violation|1|||
24933614|NCT03569293|50026743|FG005|Overall Study|Adverse Event|0|||
24933615|NCT03569293|50026738|FG000|Overall Study|Withdrawal by Subject|16|||
24933616|NCT03569293|50026739|FG001|Overall Study|Withdrawal by Subject|2|||
24933617|NCT03569293|50026740|FG002|Overall Study|Withdrawal by Subject|4|||
24933618|NCT03569293|50026741|FG003|Overall Study|Withdrawal by Subject|1|||
24933619|NCT03569293|50026742|FG004|Overall Study|Withdrawal by Subject|0|||
24933620|NCT03569293|50026743|FG005|Overall Study|Withdrawal by Subject|0|||
24933621|NCT03569293|50026738|FG000|Overall Study|Lost to Follow-up|1|||
24933622|NCT03569293|50026739|FG001|Overall Study|Lost to Follow-up|3|||
24933623|NCT03569293|50026740|FG002|Overall Study|Lost to Follow-up|1|||
24933624|NCT03569293|50026741|FG003|Overall Study|Lost to Follow-up|1|||
24933625|NCT03569293|50026742|FG004|Overall Study|Lost to Follow-up|0|||
24933626|NCT03569293|50026743|FG005|Overall Study|Lost to Follow-up|0|||
24933627|NCT03569293|50026738|FG000|Overall Study|Other|8|||
24933628|NCT03569293|50026739|FG001|Overall Study|Other|2|||
24933629|NCT03569293|50026740|FG002|Overall Study|Other|1|||
24933630|NCT03569293|50026741|FG003|Overall Study|Other|1|||
24933631|NCT03569293|50026742|FG004|Overall Study|Other|0|||
24933632|NCT03569293|50026743|FG005|Overall Study|Other|0|||
24933633|NCT03569293|50026738|FG000|Overall Study|Ongoing at Time of Analysis|8|||
24933634|NCT03569293|50026739|FG001|Overall Study|Ongoing at Time of Analysis|1|||
24933635|NCT03569293|50026740|FG002|Overall Study|Ongoing at Time of Analysis|3|||
24933636|NCT03569293|50026741|FG003|Overall Study|Ongoing at Time of Analysis|0|||
24933637|NCT03569293|50026742|FG004|Overall Study|Ongoing at Time of Analysis|0|||
24933638|NCT03569293|50026743|FG005|Overall Study|Ongoing at Time of Analysis|0|||
24933639|NCT03464136|50026759|FG000|Overall Study|Lost to Follow-up|5|||
24933640|NCT03464136|50026760|FG001|Overall Study|Lost to Follow-up|8|||
24933641|NCT03464136|50026759|FG000|Overall Study|Withdrawal by Subject|16|||
24933642|NCT03464136|50026760|FG001|Overall Study|Withdrawal by Subject|13|||
25027245|NCT02975336|50125389|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
25027246|NCT02975336|50125390|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
25027247|NCT02975336|50125391|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
25027248|NCT02975336|50125392|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
25027249|NCT02975336|50125385|FG000|LTE (104 Weeks)|Adverse Event|0|||
25027250|NCT02975336|50125386|FG001|LTE (104 Weeks)|Adverse Event|0|||
25156091|NCT01498887|50271956|FG001|Overall Study|Protocol Violation|3|||
25156092|NCT01498887|50271955|FG000|Overall Study|Lack of Efficacy|5|||
24933643|NCT03464136|50026759|FG000|Overall Study|Death|1|||
24933644|NCT03464136|50026760|FG001|Overall Study|Death|0|||
24933645|NCT03464136|50026759|FG000|Overall Study|Other|8|||
24933646|NCT03464136|50026760|FG001|Overall Study|Other|4|||
24933647|NCT03361306|50026766|FG000|Overall Study|Death|5|||
24933648|NCT03361306|50026766|FG000|Overall Study|Still On Study (on study treatment)|3|||
24933649|NCT03361306|50026766|FG000|Overall Study|Still On Study (in follow up)|7|||
24933650|NCT03020823|50026788|FG000|Overall Study|Physician Decision|4|||
24933651|NCT03020823|50026788|FG000|Overall Study|Lack of Efficacy|4|||
24933652|NCT03020823|50026788|FG000|Overall Study|Adverse Event|2|||
24933653|NCT02998528|50026797|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
24933654|NCT02998528|50026798|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
24933655|NCT02998528|50026799|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
24933656|NCT02998528|50026797|FG000|Randomization Period|Participant withdrew consent|0|||
24933657|NCT02998528|50026798|FG001|Randomization Period|Participant withdrew consent|3|||
24933658|NCT02998528|50026799|FG002|Randomization Period|Participant withdrew consent|0|||
24933659|NCT02998528|50026797|FG000|Randomization Period|Participant no longer meets study criteria|1|||
24933660|NCT02998528|50026798|FG001|Randomization Period|Participant no longer meets study criteria|3|||
24933661|NCT02998528|50026799|FG002|Randomization Period|Participant no longer meets study criteria|2|||
24933662|NCT02998528|50026797|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
24933663|NCT02998528|50026798|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
24933664|NCT02998528|50026799|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
24933665|NCT02998528|50026797|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
24933666|NCT02998528|50026798|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
24933667|NCT02998528|50026799|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
24933668|NCT02998528|50026797|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
24933669|NCT02998528|50026798|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
24933670|NCT02998528|50026799|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
24933671|NCT02998528|50026797|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
24933672|NCT02998528|50026798|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
24933673|NCT02998528|50026799|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
24933674|NCT02998528|50026797|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
24933675|NCT02998528|50026798|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
24933676|NCT02998528|50026799|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
24933677|NCT02998528|50026797|FG000|Neoadjuvant Treatment Period|Death|1|||
24933678|NCT02998528|50026798|FG001|Neoadjuvant Treatment Period|Death|0|||
24933679|NCT02998528|50026799|FG002|Neoadjuvant Treatment Period|Death|0|||
25027251|NCT02975336|50125387|FG002|LTE (104 Weeks)|Adverse Event|0|||
25027252|NCT02975336|50125388|FG003|LTE (104 Weeks)|Adverse Event|0|||
24933680|NCT02998528|50026797|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
24933681|NCT02998528|50026798|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
24933682|NCT02998528|50026799|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
24933683|NCT02998528|50026797|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
24933684|NCT02998528|50026798|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
25156093|NCT01498887|50271956|FG001|Overall Study|Lack of Efficacy|3|||
25156094|NCT01498887|50271955|FG000|Overall Study|Abnormal result from test procedure|1|||
24933685|NCT02998528|50026799|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
24933686|NCT02998528|50026797|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
24933687|NCT02998528|50026798|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
24933688|NCT02998528|50026799|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
24933689|NCT02998528|50026797|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
24933690|NCT02998528|50026798|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
24933691|NCT02998528|50026799|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
25027253|NCT02975336|50125389|FG004|LTE (104 Weeks)|Adverse Event|7|||
25027254|NCT02975336|50125390|FG005|LTE (104 Weeks)|Adverse Event|4|||
25027255|NCT02975336|50125391|FG006|LTE (104 Weeks)|Adverse Event|2|||
24933692|NCT02998528|50026797|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
24933693|NCT02998528|50026798|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
24933694|NCT02998528|50026799|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
24933695|NCT02998528|50026797|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
24933696|NCT02998528|50026798|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
24933697|NCT02998528|50026799|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
24933698|NCT02969369|50026808|FG000|Study|Adverse Event|1|||
24933699|NCT02969369|50026809|FG001|Study|Adverse Event|6|||
24933700|NCT02969369|50026808|FG000|Study|Lack of Efficacy|0|||
24933701|NCT02969369|50026809|FG001|Study|Lack of Efficacy|1|||
24933702|NCT02969369|50026808|FG000|Study|Lost to Follow-up|0|||
24933703|NCT02969369|50026809|FG001|Study|Lost to Follow-up|1|||
24933704|NCT02969369|50026808|FG000|Study|Withdrawal by Subject|3|||
25027256|NCT02975336|50125392|FG007|LTE (104 Weeks)|Adverse Event|0|||
25027257|NCT02975336|50125385|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
24933705|NCT02969369|50026809|FG001|Study|Withdrawal by Subject|5|||
24933706|NCT02969369|50026808|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
24933707|NCT02969369|50026809|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
24933708|NCT02969369|50026808|FG000|Double-blind Period|Adverse Event|1|||
24933709|NCT02969369|50026809|FG001|Double-blind Period|Adverse Event|5|||
24933710|NCT02969369|50026808|FG000|Double-blind Period|Lost to Follow-up|0|||
24933711|NCT02969369|50026809|FG001|Double-blind Period|Lost to Follow-up|1|||
24933712|NCT02969369|50026808|FG000|Double-blind Period|Withdrawal by Subject|2|||
24933713|NCT02969369|50026809|FG001|Double-blind Period|Withdrawal by Subject|3|||
24933714|NCT02969369|50026808|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
24933715|NCT02969369|50026809|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
24933716|NCT02969369|50026808|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
24933717|NCT02969369|50026809|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
24933718|NCT02969369|50026808|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
24933719|NCT02969369|50026809|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
24933720|NCT02969369|50026808|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
24933721|NCT02969369|50026809|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
24933722|NCT02583269|50026838|FG000|Overall Study|Patient hospitalized prior to start|1|||
24933723|NCT02583269|50026839|FG001|Overall Study|Patient hospitalized prior to start|0|||
24933724|NCT02583269|50026840|FG002|Overall Study|Patient hospitalized prior to start|0|||
24933725|NCT02583269|50026841|FG003|Overall Study|Patient hospitalized prior to start|0|||
24933726|NCT02583269|50026842|FG004|Overall Study|Patient hospitalized prior to start|0|||
24933727|NCT02546921|50026862|FG000|Overall Study|Adverse Event|0|||
24933728|NCT02546921|50026863|FG001|Overall Study|Adverse Event|5|||
24933729|NCT02546921|50026864|FG002|Overall Study|Adverse Event|2|||
24933730|NCT02546921|50026865|FG003|Overall Study|Adverse Event|0|||
24933731|NCT02546921|50026866|FG004|Overall Study|Adverse Event|0|||
24933732|NCT02546921|50026867|FG005|Overall Study|Adverse Event|0|||
24933733|NCT02546921|50026868|FG006|Overall Study|Adverse Event|0|||
24933734|NCT02546921|50026862|FG000|Overall Study|Evidence of Disease Progression|1|||
24933735|NCT02546921|50026863|FG001|Overall Study|Evidence of Disease Progression|0|||
24933736|NCT02546921|50026864|FG002|Overall Study|Evidence of Disease Progression|0|||
24933737|NCT02546921|50026865|FG003|Overall Study|Evidence of Disease Progression|0|||
24933738|NCT02546921|50026866|FG004|Overall Study|Evidence of Disease Progression|1|||
24933739|NCT02546921|50026867|FG005|Overall Study|Evidence of Disease Progression|0|||
24933740|NCT02546921|50026868|FG006|Overall Study|Evidence of Disease Progression|0|||
24933741|NCT02546921|50026862|FG000|Overall Study|Patient Choice|0|||
24933742|NCT02546921|50026863|FG001|Overall Study|Patient Choice|1|||
24933743|NCT02546921|50026864|FG002|Overall Study|Patient Choice|0|||
24933744|NCT02546921|50026865|FG003|Overall Study|Patient Choice|0|||
24933745|NCT02546921|50026866|FG004|Overall Study|Patient Choice|0|||
24933746|NCT02546921|50026867|FG005|Overall Study|Patient Choice|1|||
24933747|NCT02546921|50026868|FG006|Overall Study|Patient Choice|0|||
24933748|NCT02513329|50026902|FG000|Overall Study|Lost to Follow-up|5|||
24933749|NCT02513329|50026903|FG001|Overall Study|Lost to Follow-up|2|||
24933750|NCT02425826|50026913|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
24933751|NCT02425826|50026914|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
24933752|NCT02425826|50026915|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
24933753|NCT02425826|50026913|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
24933754|NCT02425826|50026914|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
24933755|NCT02425826|50026915|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
24933756|NCT02425826|50026913|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
24933757|NCT02425826|50026914|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
24933758|NCT02425826|50026915|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
24933759|NCT02425826|50026913|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
24933760|NCT02425826|50026914|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
24933761|NCT02425826|50026915|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
24933762|NCT02425826|50026913|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
24933763|NCT02425826|50026914|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
24933764|NCT02425826|50026915|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
24933765|NCT02425826|50026913|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
24933766|NCT02425826|50026914|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
24933767|NCT02425826|50026915|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
24933768|NCT02425826|50026913|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
24933769|NCT02425826|50026914|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
24933770|NCT02425826|50026915|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
24933771|NCT02425826|50026913|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
24933772|NCT02425826|50026914|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
24933773|NCT02425826|50026915|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
24933774|NCT02425826|50026913|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
24933775|NCT02425826|50026914|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
24933776|NCT02425826|50026915|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
24933777|NCT02425826|50026913|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
24933778|NCT02425826|50026914|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
24933779|NCT02425826|50026915|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
24933780|NCT02406027|50026928|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
24933781|NCT02406027|50026929|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
24933782|NCT02406027|50026930|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
24933783|NCT02406027|50026931|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
24933784|NCT02406027|50026932|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
24933785|NCT02406027|50026933|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
24933786|NCT02406027|50026934|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
24933787|NCT02406027|50026928|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
24933788|NCT02406027|50026929|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
24933789|NCT02406027|50026930|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
24933790|NCT02406027|50026931|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
24933791|NCT02406027|50026932|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
24933792|NCT02406027|50026933|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
24933793|NCT02406027|50026934|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
24933794|NCT02406027|50026928|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
24933795|NCT02406027|50026929|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
24933796|NCT02406027|50026930|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
24933797|NCT02406027|50026931|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
24933798|NCT02406027|50026932|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
24933799|NCT02406027|50026933|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
24933800|NCT02406027|50026934|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
24933801|NCT02406027|50026928|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
24933802|NCT02406027|50026929|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
24933803|NCT02406027|50026930|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
24933804|NCT02406027|50026931|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
24933805|NCT02406027|50026932|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
24933806|NCT02406027|50026933|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
24933807|NCT02406027|50026934|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
24933808|NCT02406027|50026928|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
24933809|NCT02406027|50026929|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
24933810|NCT02406027|50026930|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
24933811|NCT02406027|50026931|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
24933812|NCT02406027|50026932|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
24933813|NCT02406027|50026933|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
24933814|NCT02406027|50026934|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
24933815|NCT02406027|50026928|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
24933816|NCT02406027|50026929|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
24933817|NCT02406027|50026930|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
25156095|NCT01498887|50271956|FG001|Overall Study|Abnormal result from test procedure|1|||
24933818|NCT02406027|50026931|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
24933819|NCT02406027|50026932|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
24933820|NCT02406027|50026933|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
24933821|NCT02406027|50026934|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
24933822|NCT02406027|50026928|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
24933823|NCT02406027|50026929|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
24933824|NCT02406027|50026930|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
24933825|NCT02406027|50026931|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
24933826|NCT02406027|50026932|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
24933827|NCT02406027|50026933|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
24933828|NCT02406027|50026934|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
24933829|NCT02406027|50026928|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
24933830|NCT02406027|50026929|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
24933831|NCT02406027|50026930|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
24933832|NCT02406027|50026931|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
24933833|NCT02406027|50026932|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
24933834|NCT02406027|50026933|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
24933835|NCT02406027|50026934|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
24933836|NCT02406027|50026928|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
24933837|NCT02406027|50026929|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
24933838|NCT02406027|50026930|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
24933839|NCT02406027|50026931|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
24933840|NCT02406027|50026932|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
24933841|NCT02406027|50026933|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
24933842|NCT02406027|50026934|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
24933843|NCT02406027|50026928|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
24933844|NCT02406027|50026929|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
24933845|NCT02406027|50026930|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
24933846|NCT02406027|50026931|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
24933847|NCT02406027|50026932|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
24933848|NCT02406027|50026933|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
24933849|NCT02406027|50026934|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
24933850|NCT02354651|50026950|FG000|Overall Study|Withdrawal by Subject|2|||
24933851|NCT02354651|50026950|FG000|Overall Study|Physician Decision|1|||
24933852|NCT02278120|50026959|FG000|Overall Study|Progressive disease|122|||
24933853|NCT02278120|50026960|FG001|Overall Study|Progressive disease|174|||
24933854|NCT02278120|50026959|FG000|Overall Study|Patient/guardian decision|14|||
24933855|NCT02278120|50026960|FG001|Overall Study|Patient/guardian decision|8|||
24933856|NCT02278120|50026959|FG000|Overall Study|Adverse Event|12|||
24933857|NCT02278120|50026960|FG001|Overall Study|Adverse Event|10|||
24933858|NCT02278120|50026959|FG000|Overall Study|Physician Decision|8|||
24933859|NCT02278120|50026960|FG001|Overall Study|Physician Decision|19|||
24933860|NCT02278120|50026959|FG000|Overall Study|Death|3|||
24933861|NCT02278120|50026960|FG001|Overall Study|Death|3|||
24933862|NCT02278120|50026959|FG000|Overall Study|Lost to Follow-up|2|||
24933863|NCT02278120|50026960|FG001|Overall Study|Lost to Follow-up|0|||
24933864|NCT02278120|50026959|FG000|Overall Study|Protocol Violation|0|||
24933865|NCT02278120|50026960|FG001|Overall Study|Protocol Violation|2|||
24933866|NCT02255357|50026968|FG000|Overall Study|Physician Decision|10|||
24933867|NCT02255357|50026969|FG001|Overall Study|Physician Decision|24|||
24933868|NCT02211131|50026977|FG000|Overall Study|Death|26|||
24933869|NCT02211131|50026978|FG001|Overall Study|Death|16|||
24933870|NCT02211131|50026977|FG000|Overall Study|Lost to Follow-up|4|||
24933871|NCT02211131|50026978|FG001|Overall Study|Lost to Follow-up|3|||
24933872|NCT02211131|50026977|FG000|Overall Study|Decision by Sponsor|1|||
24933873|NCT02211131|50026978|FG001|Overall Study|Decision by Sponsor|1|||
24933874|NCT02211131|50026977|FG000|Overall Study|Withdrawal by Subject|3|||
24933875|NCT02211131|50026978|FG001|Overall Study|Withdrawal by Subject|8|||
24933876|NCT02155647|50026993|FG000|Overall Study|Still on Treatment|26|||
24933877|NCT02155647|50026994|FG001|Overall Study|Still on Treatment|26|||
24933878|NCT02155647|50026993|FG000|Overall Study|Off-Treatment, but follow up ongoing|15|||
24933879|NCT02155647|50026994|FG001|Overall Study|Off-Treatment, but follow up ongoing|26|||
24933880|NCT02134587|50027004|FG000|Overall Study|Did not completed all meetings|30|||
24933881|NCT01752920|50027021|FG000|Overall Study|Adverse Event|1|||
24933882|NCT01752920|50027022|FG001|Overall Study|Adverse Event|0|||
24933883|NCT01752920|50027023|FG002|Overall Study|Adverse Event|5|||
24933884|NCT01752920|50027024|FG003|Overall Study|Adverse Event|10|||
24933885|NCT01752920|50027021|FG000|Overall Study|Clinical Disease Progression|6|||
24933886|NCT01752920|50027022|FG001|Overall Study|Clinical Disease Progression|4|||
24933887|NCT01752920|50027023|FG002|Overall Study|Clinical Disease Progression|1|||
25156096|NCT01498887|50271955|FG000|Overall Study|Abnormal laboratory value|2|||
24933888|NCT01752920|50027024|FG003|Overall Study|Clinical Disease Progression|13|||
24933889|NCT01752920|50027021|FG000|Overall Study|Physician Decision|1|||
24933890|NCT01752920|50027022|FG001|Overall Study|Physician Decision|0|||
24933891|NCT01752920|50027023|FG002|Overall Study|Physician Decision|0|||
24933892|NCT01752920|50027024|FG003|Overall Study|Physician Decision|3|||
24933893|NCT01752920|50027021|FG000|Overall Study|Radiographic Disease Progression|20|||
24933894|NCT01752920|50027022|FG001|Overall Study|Radiographic Disease Progression|7|||
24933895|NCT01752920|50027023|FG002|Overall Study|Radiographic Disease Progression|12|||
24933896|NCT01752920|50027024|FG003|Overall Study|Radiographic Disease Progression|29|||
24933897|NCT01752920|50027021|FG000|Overall Study|Study Terminated by Sponsor|0|||
24933898|NCT01752920|50027022|FG001|Overall Study|Study Terminated by Sponsor|0|||
24933899|NCT01752920|50027023|FG002|Overall Study|Study Terminated by Sponsor|0|||
24933900|NCT01752920|50027024|FG003|Overall Study|Study Terminated by Sponsor|1|||
24933901|NCT01752920|50027021|FG000|Overall Study|Withdrawal by Subject|0|||
24933902|NCT01752920|50027022|FG001|Overall Study|Withdrawal by Subject|1|||
24933903|NCT01752920|50027023|FG002|Overall Study|Withdrawal by Subject|0|||
24933904|NCT01752920|50027024|FG003|Overall Study|Withdrawal by Subject|1|||
24933905|NCT01752920|50027021|FG000|Overall Study|Lack of clinical benefit|1|||
24933906|NCT01752920|50027022|FG001|Overall Study|Lack of clinical benefit|1|||
24933907|NCT01752920|50027023|FG002|Overall Study|Lack of clinical benefit|1|||
24933908|NCT01752920|50027024|FG003|Overall Study|Lack of clinical benefit|1|||
24933909|NCT00976963|50027038|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
24933910|NCT00976963|50027039|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
24933911|NCT00976963|50027038|FG000|Overall Study|administrative error|1|||
24933912|NCT00976963|50027039|FG001|Overall Study|administrative error|0|||
24933913|NCT00976963|50027038|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
24933914|NCT00976963|50027039|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
24933915|NCT00423735|50027056|FG000|Overall Study|Ineligible / No protocol treatment|8|||
24933916|NCT00423735|50027057|FG001|Overall Study|Ineligible / No protocol treatment|6|||
24933917|NCT00423735|50027058|FG002|Overall Study|Ineligible / No protocol treatment|0|||
24933918|NCT00626327|50027071|FG000|Overall Study|Withdrawal by Subject|21|||
24933919|NCT00626327|50027072|FG001|Overall Study|Withdrawal by Subject|29|||
24933920|NCT00626327|50027073|FG002|Overall Study|Withdrawal by Subject|30|||
24933921|NCT00626327|50027071|FG000|Overall Study|Adverse Event|1|||
24933922|NCT00626327|50027072|FG001|Overall Study|Adverse Event|0|||
24933923|NCT00626327|50027073|FG002|Overall Study|Adverse Event|0|||
25185713|NCT01425203|50335251|FG002|Treatment Phase|Unidentified reasons|0|||
24933924|NCT00626327|50027071|FG000|Overall Study|Lost to Follow-up|24|||
24933925|NCT00626327|50027072|FG001|Overall Study|Lost to Follow-up|21|||
24933926|NCT00626327|50027073|FG002|Overall Study|Lost to Follow-up|23|||
24933927|NCT00626327|50027071|FG000|Overall Study|Inappropriate enrollment|4|||
24933928|NCT00626327|50027072|FG001|Overall Study|Inappropriate enrollment|5|||
24933929|NCT00626327|50027073|FG002|Overall Study|Inappropriate enrollment|3|||
24933930|NCT00626327|50027071|FG000|Overall Study|Administrative Reason|2|||
24933931|NCT00626327|50027072|FG001|Overall Study|Administrative Reason|0|||
24933932|NCT00626327|50027073|FG002|Overall Study|Administrative Reason|6|||
24933933|NCT00626327|50027071|FG000|Overall Study|Protocol Violation|26|||
24933934|NCT00626327|50027072|FG001|Overall Study|Protocol Violation|4|||
24933935|NCT00626327|50027073|FG002|Overall Study|Protocol Violation|26|||
24933936|NCT00357994|50027091|FG000|Overall Study|Adverse Event|1|||
24933937|NCT00357994|50027092|FG001|Overall Study|Adverse Event|2|||
24933938|NCT00357994|50027091|FG000|Overall Study|Lack of Efficacy|0|||
24933939|NCT00357994|50027092|FG001|Overall Study|Lack of Efficacy|1|||
24933940|NCT00357994|50027091|FG000|Overall Study|Protocol Violation|1|||
24933941|NCT00357994|50027092|FG001|Overall Study|Protocol Violation|0|||
24933942|NCT00423657|50027100|FG000|Overall Study|Withdrew consent|10|||
24933943|NCT00423657|50027101|FG001|Overall Study|Withdrew consent|8|||
24933944|NCT00423657|50027100|FG000|Overall Study|Non-compliance|0|||
24933945|NCT00423657|50027101|FG001|Overall Study|Non-compliance|1|||
24933946|NCT00423657|50027100|FG000|Overall Study|Other|15|||
24933947|NCT00423657|50027101|FG001|Overall Study|Other|16|||
24933948|NCT00423657|50027100|FG000|Overall Study|Request of sponsor/investigator|1|||
24933949|NCT00423657|50027101|FG001|Overall Study|Request of sponsor/investigator|0|||
24933950|NCT00367432|50027107|FG000|First Period (16 Weeks)|Adverse Event|6|||
24933951|NCT00367432|50027108|FG001|First Period (16 Weeks)|Adverse Event|0|||
24933952|NCT00367432|50027107|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
24933953|NCT00367432|50027108|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
24933954|NCT00367432|50027107|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
24933955|NCT00367432|50027108|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
24933956|NCT00367432|50027107|FG000|First Period (16 Weeks)|Other Reason|2|||
24933957|NCT00367432|50027108|FG001|First Period (16 Weeks)|Other Reason|0|||
24933958|NCT00367432|50027107|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
24933959|NCT00367432|50027108|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
24933960|NCT00367432|50027107|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
24933961|NCT00367432|50027108|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
24933962|NCT00367432|50027107|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
24933963|NCT00367432|50027108|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
24933964|NCT00367432|50027107|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
24933965|NCT00367432|50027108|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
24933966|NCT00367432|50027107|FG000|Second Period (up to 54 Months)|Other Reason|6|||
24933967|NCT00367432|50027108|FG001|Second Period (up to 54 Months)|Other Reason|2|||
24933968|NCT00623363|50027114|FG000|Overall Study|Adverse Event|2|||
24933969|NCT00623363|50027115|FG001|Overall Study|Adverse Event|2|||
24933970|NCT00423267|50027124|FG000|Period A|Withdrawal by Subject|0|||
24933971|NCT00423267|50027125|FG001|Period A|Withdrawal by Subject|1|||
24933972|NCT00423267|50027124|FG000|Period A|Non-compliance with protocol|1|||
24933973|NCT00423267|50027125|FG001|Period A|Non-compliance with protocol|0|||
24933974|NCT00423267|50027124|FG000|Period A|Administrative|1|||
24933975|NCT00423267|50027125|FG001|Period A|Administrative|0|||
24933976|NCT00626093|50027133|FG000|Overall Study|Lost to Follow-up|5|||
24933977|NCT00626093|50027133|FG000|Overall Study|Death|1|||
24933978|NCT00626093|50027133|FG000|Overall Study|Physician Decision|4|||
24933979|NCT00626093|50027133|FG000|Overall Study|Withdrawal by Subject|6|||
24933980|NCT00626093|50027133|FG000|Overall Study|Protocol Violation|1|||
24933981|NCT00626093|50027133|FG000|Overall Study|One of the required devices not implante|6|||
24933982|NCT00357760|50027139|FG000|Overall Study|Disease progression|44|||
24933983|NCT00357760|50027140|FG001|Overall Study|Disease progression|17|||
24933984|NCT00357760|50027139|FG000|Overall Study|Adverse Event|10|||
24933985|NCT00357760|50027140|FG001|Overall Study|Adverse Event|7|||
24933986|NCT00357760|50027139|FG000|Overall Study|Death|0|||
24933987|NCT00357760|50027140|FG001|Overall Study|Death|3|||
24933988|NCT00357760|50027139|FG000|Overall Study|Alternative therapy|1|||
24933989|NCT00357760|50027140|FG001|Overall Study|Alternative therapy|0|||
24933990|NCT00357760|50027139|FG000|Overall Study|Withdrawal by Subject|0|||
24933991|NCT00357760|50027140|FG001|Overall Study|Withdrawal by Subject|2|||
24933992|NCT00357760|50027139|FG000|Overall Study|Never started treatment|2|||
24933993|NCT00357760|50027140|FG001|Overall Study|Never started treatment|1|||
24933994|NCT00357760|50027139|FG000|Overall Study|Ineligible|0|||
24933995|NCT00357760|50027140|FG001|Overall Study|Ineligible|2|||
25185714|NCT01425203|50335249|FG000|Treatment Phase|Did not receive treatment|0|||
25185715|NCT01425203|50335250|FG001|Treatment Phase|Did not receive treatment|1|||
25185716|NCT01425203|50335251|FG002|Treatment Phase|Did not receive treatment|0|||
25185717|NCT01425203|50335249|FG000|Crossover Phase|Failure at futility timepoint|0|||
25185718|NCT01425203|50335250|FG001|Crossover Phase|Failure at futility timepoint|0|||
25185719|NCT01425203|50335251|FG002|Crossover Phase|Failure at futility timepoint|3|||
25185720|NCT01425203|50335249|FG000|Crossover Phase|Other virologic failure criteria|0|||
25185721|NCT01425203|50335250|FG001|Crossover Phase|Other virologic failure criteria|0|||
24933996|NCT00357760|50027139|FG000|Overall Study|Physician Decision|2|||
24933997|NCT00357760|50027140|FG001|Overall Study|Physician Decision|1|||
24933998|NCT00357760|50027139|FG000|Overall Study|Protocol Violation|0|||
24933999|NCT00357760|50027140|FG001|Overall Study|Protocol Violation|1|||
24934000|NCT00357760|50027139|FG000|Overall Study|To receive hospice care|0|||
24934001|NCT00357760|50027140|FG001|Overall Study|To receive hospice care|1|||
24934002|NCT00622739|50027148|FG000|Overall Study|Physician Decision|1|||
24934003|NCT00622739|50027149|FG001|Overall Study|Physician Decision|0|||
24934004|NCT00622739|50027148|FG000|Overall Study|Adverse Event|1|||
24934005|NCT00622739|50027149|FG001|Overall Study|Adverse Event|2|||
24934006|NCT00622739|50027148|FG000|Overall Study|Lack of Efficacy|0|||
24934007|NCT00622739|50027149|FG001|Overall Study|Lack of Efficacy|2|||
24934008|NCT00622739|50027148|FG000|Overall Study|Withdrawal by Subject|0|||
24934009|NCT00622739|50027149|FG001|Overall Study|Withdrawal by Subject|1|||
24934010|NCT00622739|50027148|FG000|Overall Study|Lost to Follow-up|0|||
24934011|NCT00622739|50027149|FG001|Overall Study|Lost to Follow-up|1|||
24934012|NCT00435825|50027161|FG000|Overall Study|Abnormality of Laboratory Test|0|||
24934013|NCT00435825|50027162|FG001|Overall Study|Abnormality of Laboratory Test|1|||
24934014|NCT00435825|50027163|FG002|Overall Study|Abnormality of Laboratory Test|0|||
24934015|NCT00435825|50027164|FG003|Overall Study|Abnormality of Laboratory Test|0|||
24934016|NCT00435825|50027161|FG000|Overall Study|Insufficient Therapeutic Response|3|||
24934017|NCT00435825|50027162|FG001|Overall Study|Insufficient Therapeutic Response|1|||
24934018|NCT00435825|50027163|FG002|Overall Study|Insufficient Therapeutic Response|0|||
24934019|NCT00435825|50027164|FG003|Overall Study|Insufficient Therapeutic Response|3|||
24934020|NCT00435825|50027161|FG000|Overall Study|Other Protocol Violation|1|||
25185722|NCT01425203|50335251|FG002|Crossover Phase|Other virologic failure criteria|3|||
25275117|NCT01236365|50589137|FG001|Overall Study|Moved Out of State|0|||
24934021|NCT00435825|50027162|FG001|Overall Study|Other Protocol Violation|0|||
24934022|NCT00435825|50027163|FG002|Overall Study|Other Protocol Violation|0|||
24934023|NCT00435825|50027164|FG003|Overall Study|Other Protocol Violation|0|||
24934024|NCT00435825|50027161|FG000|Overall Study|Refused treatment|2|||
24934025|NCT00435825|50027162|FG001|Overall Study|Refused treatment|0|||
24934026|NCT00435825|50027163|FG002|Overall Study|Refused treatment|0|||
24934027|NCT00435825|50027164|FG003|Overall Study|Refused treatment|5|||
24934028|NCT00435825|50027161|FG000|Overall Study|Failure to return|5|||
24934029|NCT00435825|50027162|FG001|Overall Study|Failure to return|0|||
24934030|NCT00435825|50027163|FG002|Overall Study|Failure to return|4|||
24934031|NCT00435825|50027164|FG003|Overall Study|Failure to return|0|||
24934032|NCT00435825|50027161|FG000|Overall Study|Did not receive study drug|1|||
24934033|NCT00435825|50027162|FG001|Overall Study|Did not receive study drug|0|||
24934034|NCT00435825|50027163|FG002|Overall Study|Did not receive study drug|2|||
24934035|NCT00435825|50027164|FG003|Overall Study|Did not receive study drug|0|||
24934036|NCT00435825|50027161|FG000|Overall Study|Did not enter follow-up|0|||
24934037|NCT00435825|50027162|FG001|Overall Study|Did not enter follow-up|4|||
24934038|NCT00435825|50027163|FG002|Overall Study|Did not enter follow-up|1|||
24934039|NCT00435825|50027164|FG003|Overall Study|Did not enter follow-up|3|||
24934040|NCT00435825|50027161|FG000|Overall Study|Did not complete full follow-up period|6|||
24934041|NCT00435825|50027162|FG001|Overall Study|Did not complete full follow-up period|6|||
24934042|NCT00435825|50027163|FG002|Overall Study|Did not complete full follow-up period|4|||
24934043|NCT00435825|50027164|FG003|Overall Study|Did not complete full follow-up period|5|||
24934044|NCT00574145|50027176|FG000|Overall Study|Withdrawal by Subject|2|||
24934045|NCT00574145|50027177|FG001|Overall Study|Withdrawal by Subject|1|||
24934046|NCT00423189|50027186|FG000|Overall Study|Death|0|||
24934047|NCT00423189|50027187|FG001|Overall Study|Death|1|||
25156097|NCT01498887|50271956|FG001|Overall Study|Abnormal laboratory value|2|||
25156098|NCT01498887|50271955|FG000|Overall Study|Adverse Event|4|||
24934048|NCT00423189|50027188|FG002|Overall Study|Death|0|||
24934049|NCT00422799|50027201|FG000|Overall Study|Withdrawal by Subject|6|||
24934050|NCT00422799|50027201|FG000|Overall Study|Adverse Event|7|||
24934051|NCT00435045|50027207|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
24934052|NCT00435045|50027208|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
24934053|NCT00435045|50027207|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
24934054|NCT00435045|50027208|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
24934055|NCT00435045|50027207|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
24934056|NCT00435045|50027208|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
24934057|NCT00435045|50027207|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
24934058|NCT00435045|50027208|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
24934059|NCT00435045|50027207|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
24934060|NCT00435045|50027208|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
24934061|NCT00435045|50027207|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
24934062|NCT00435045|50027208|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
24934063|NCT00435045|50027207|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
24934064|NCT00435045|50027208|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
25156099|NCT01498887|50271956|FG001|Overall Study|Adverse Event|1|||
24934065|NCT00435045|50027207|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
24934066|NCT00435045|50027208|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
24934067|NCT00435045|50027207|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
24934068|NCT00435045|50027208|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
24934069|NCT00435045|50027207|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
24934070|NCT00435045|50027208|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
24934071|NCT00435045|50027207|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
24934072|NCT00435045|50027208|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
24934073|NCT00441129|50027216|FG000|Overall Study|Withdrawal by Subject|6|||
24934074|NCT00441129|50027217|FG001|Overall Study|Withdrawal by Subject|14|||
24934075|NCT00622505|50027225|FG000|Overall Study|Adverse Event|9|||
24934076|NCT00622505|50027226|FG001|Overall Study|Adverse Event|7|||
24934077|NCT00622505|50027225|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
24934078|NCT00622505|50027226|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
24934079|NCT00622505|50027225|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
24934080|NCT00622505|50027226|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
24934081|NCT00622505|50027225|FG000|Overall Study|Withdrawal by Subject|12|||
24934082|NCT00622505|50027226|FG001|Overall Study|Withdrawal by Subject|5|||
24934083|NCT00622505|50027225|FG000|Overall Study|Administrative Problems|2|||
24934084|NCT00622505|50027226|FG001|Overall Study|Administrative Problems|4|||
24934085|NCT00622505|50027225|FG000|Overall Study|Death|2|||
24934086|NCT00622505|50027226|FG001|Overall Study|Death|2|||
24934087|NCT00350272|50027234|FG000|Blinded 12 Week Treatment|Adverse Event|1|||
24934088|NCT00350272|50027235|FG001|Blinded 12 Week Treatment|Adverse Event|0|||
24934089|NCT00350272|50027234|FG000|Blinded 12 Week Treatment|Death|1|||
24934090|NCT00350272|50027235|FG001|Blinded 12 Week Treatment|Death|0|||
24934091|NCT00350272|50027234|FG000|Blinded 12 Week Treatment|Lost to Follow-up|2|||
24934092|NCT00350272|50027235|FG001|Blinded 12 Week Treatment|Lost to Follow-up|0|||
24934093|NCT00350272|50027234|FG000|Blinded 12 Week Treatment|Withdrawal by Subject|3|||
24934094|NCT00350272|50027235|FG001|Blinded 12 Week Treatment|Withdrawal by Subject|0|||
24934095|NCT00350272|50027234|FG000|Blinded 12 Week Treatment|Physician Decision|2|||
24934096|NCT00350272|50027235|FG001|Blinded 12 Week Treatment|Physician Decision|1|||
24934097|NCT00350272|50027234|FG000|Blinded 12 Week Treatment|Sponsor decision|0|||
24934098|NCT00350272|50027235|FG001|Blinded 12 Week Treatment|Sponsor decision|1|||
24934099|NCT00350272|50027234|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
24934100|NCT00350272|50027235|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
25156100|NCT01498653|50271965|FG000|Overall Study|Adverse Event|2|||
25156101|NCT01498653|50271966|FG001|Overall Study|Adverse Event|2|||
25156102|NCT01498653|50271965|FG000|Overall Study|Lack of Efficacy|12|||
25156103|NCT01498653|50271966|FG001|Overall Study|Lack of Efficacy|26|||
24934101|NCT00350272|50027234|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
24934102|NCT00350272|50027235|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
24934103|NCT00350272|50027234|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
24934104|NCT00350272|50027235|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
24934105|NCT00350272|50027234|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
24934106|NCT00350272|50027235|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
24934107|NCT00350272|50027234|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
24934108|NCT00350272|50027235|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
24934109|NCT00357370|50027246|FG000|Cohort 2|Lack of Efficacy|0|||
24934110|NCT00357370|50027247|FG001|Cohort 2|Lack of Efficacy|2|||
24934111|NCT00357370|50027248|FG002|Cohort 2|Lack of Efficacy|1|||
24934112|NCT00357370|50027246|FG000|Cohort 2|Adverse Event|1|||
24934113|NCT00357370|50027247|FG001|Cohort 2|Adverse Event|1|||
24934114|NCT00357370|50027248|FG002|Cohort 2|Adverse Event|1|||
24934115|NCT00357370|50027246|FG000|Cohort 2|Lost to Follow-up|0|||
24934116|NCT00357370|50027247|FG001|Cohort 2|Lost to Follow-up|1|||
24934117|NCT00357370|50027248|FG002|Cohort 2|Lost to Follow-up|0|||
24934118|NCT00357370|50027246|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
24934119|NCT00357370|50027247|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
24934120|NCT00357370|50027248|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
24934121|NCT00357370|50027246|FG000|Cohort 2|Withdrawal by Subject|0|||
25156104|NCT01498653|50271965|FG000|Overall Study|Protocol Violation|0|||
25156105|NCT01498653|50271966|FG001|Overall Study|Protocol Violation|4|||
25156106|NCT01498653|50271965|FG000|Overall Study|Lost to Follow-up|1|||
25156107|NCT01498653|50271966|FG001|Overall Study|Lost to Follow-up|0|||
24934122|NCT00357370|50027247|FG001|Cohort 2|Withdrawal by Subject|2|||
24934123|NCT00357370|50027248|FG002|Cohort 2|Withdrawal by Subject|0|||
24934124|NCT00574847|50027258|FG000|Overall Study|Adverse Event|2|||
24934125|NCT00574847|50027259|FG001|Overall Study|Adverse Event|0|||
24934126|NCT00574847|50027258|FG000|Overall Study|Death|1|||
24934127|NCT00574847|50027259|FG001|Overall Study|Death|0|||
24934128|NCT00574847|50027258|FG000|Overall Study|Withdrawal by Subject|2|||
24934129|NCT00574847|50027259|FG001|Overall Study|Withdrawal by Subject|2|||
25027258|NCT02975336|50125386|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
25027259|NCT02975336|50125387|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
25156108|NCT01498653|50271965|FG000|Overall Study|Physician Decision|2|||
25156109|NCT01498653|50271966|FG001|Overall Study|Physician Decision|0|||
24934130|NCT00574847|50027258|FG000|Overall Study|Physician Decision|1|||
24934131|NCT00574847|50027259|FG001|Overall Study|Physician Decision|0|||
24934132|NCT00574847|50027258|FG000|Overall Study|Did not receive medication (declined)|2|||
24934133|NCT00574847|50027259|FG001|Overall Study|Did not receive medication (declined)|5|||
24934134|NCT00348790|50027265|FG000|Completed Treatment|Withdrawal by Subject|4|||
24934135|NCT00348790|50027265|FG000|Completed Treatment|Disease progression|14|||
24934136|NCT00348790|50027265|FG000|Completed Treatment|Adverse Event|4|||
24934137|NCT00348790|50027265|FG000|Completed Treatment|Required surgery|2|||
24934138|NCT00348790|50027265|FG000|Completed Treatment|Unable to travel to study site|1|||
24934139|NCT00360490|50027272|FG000|Overall Study|Adverse Event|4|||
24934140|NCT00360490|50027273|FG001|Overall Study|Adverse Event|2|||
24934141|NCT00360490|50027272|FG000|Overall Study|Lost to Follow-up|2|||
24934142|NCT00360490|50027273|FG001|Overall Study|Lost to Follow-up|1|||
24934143|NCT00360490|50027272|FG000|Overall Study|Physician Decision|2|||
24934144|NCT00360490|50027273|FG001|Overall Study|Physician Decision|1|||
24934145|NCT00360490|50027272|FG000|Overall Study|Protocol Violation|0|||
24934146|NCT00360490|50027273|FG001|Overall Study|Protocol Violation|4|||
24934147|NCT00360490|50027272|FG000|Overall Study|Withdrawal by Subject|1|||
24934148|NCT00360490|50027273|FG001|Overall Study|Withdrawal by Subject|3|||
24934149|NCT00624377|50027279|FG000|Overall Study|Lost to Follow-up|355|||
24934150|NCT00624377|50027279|FG000|Overall Study|Withdrawal by Subject|100|||
24934151|NCT00624377|50027279|FG000|Overall Study|Adverse Event|14|||
24934152|NCT00624377|50027279|FG000|Overall Study|Other|91|||
24934153|NCT00624377|50027279|FG000|Overall Study|Non-evaluable population|84|||
24934154|NCT00624065|50027285|FG000|Overall Study|Adverse Event|5|||
24934155|NCT00624065|50027286|FG001|Overall Study|Adverse Event|6|||
24934156|NCT00624065|50027285|FG000|Overall Study|Lost to Follow-up|4|||
24934157|NCT00624065|50027286|FG001|Overall Study|Lost to Follow-up|1|||
24934158|NCT00624065|50027285|FG000|Overall Study|Consent withdrawn|6|||
24934159|NCT00624065|50027286|FG001|Overall Study|Consent withdrawn|5|||
24934160|NCT00624065|50027285|FG000|Overall Study|Lack of Efficacy|0|||
24934161|NCT00624065|50027286|FG001|Overall Study|Lack of Efficacy|3|||
24934162|NCT00624065|50027285|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
24934163|NCT00624065|50027286|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
24934164|NCT00360412|50027294|FG000|Overall Study|Adverse Event|37|||
24934165|NCT00360412|50027295|FG001|Overall Study|Adverse Event|65|||
24934166|NCT00360412|50027294|FG000|Overall Study|Protocol Violation|2|||
24934167|NCT00360412|50027295|FG001|Overall Study|Protocol Violation|5|||
24934168|NCT00360412|50027294|FG000|Overall Study|Patient withdrew consent|27|||
24934169|NCT00360412|50027295|FG001|Overall Study|Patient withdrew consent|52|||
24934170|NCT00360412|50027294|FG000|Overall Study|Lack of therapeutic efficacy|46|||
24934171|NCT00360412|50027295|FG001|Overall Study|Lack of therapeutic efficacy|61|||
24934172|NCT00360412|50027294|FG000|Overall Study|Physician Decision|2|||
24934173|NCT00360412|50027295|FG001|Overall Study|Physician Decision|4|||
24934174|NCT00360412|50027294|FG000|Overall Study|Other|5|||
24934175|NCT00360412|50027295|FG001|Overall Study|Other|6|||
24934176|NCT00360412|50027294|FG000|Overall Study|Study termination by Sponsor|214|||
24934177|NCT00360412|50027295|FG001|Overall Study|Study termination by Sponsor|469|||
24934178|NCT00623831|50027303|FG000|Overall Study|Withdrawal by Subject|1|||
24934179|NCT00623831|50027304|FG001|Overall Study|Withdrawal by Subject|0|||
24934180|NCT00623831|50027303|FG000|Overall Study|Progressive Disease|0|||
24934181|NCT00623831|50027304|FG001|Overall Study|Progressive Disease|1|||
24934182|NCT00360334|50027315|FG000|Overall Study|Adverse Event|7|||
24934183|NCT00360334|50027316|FG001|Overall Study|Adverse Event|4|||
24934184|NCT00360334|50027315|FG000|Overall Study|Protocol Violation|1|||
24934185|NCT00360334|50027316|FG001|Overall Study|Protocol Violation|1|||
24934186|NCT00360334|50027315|FG000|Overall Study|Physician Decision|2|||
24934187|NCT00360334|50027316|FG001|Overall Study|Physician Decision|3|||
24934188|NCT00360334|50027315|FG000|Overall Study|Lack of Efficacy|0|||
24934189|NCT00360334|50027316|FG001|Overall Study|Lack of Efficacy|1|||
24934190|NCT00360334|50027315|FG000|Overall Study|Entry criterion not met|1|||
24934191|NCT00360334|50027316|FG001|Overall Study|Entry criterion not met|2|||
24934192|NCT00360334|50027315|FG000|Overall Study|Subject decision|8|||
24934193|NCT00360334|50027316|FG001|Overall Study|Subject decision|2|||
25027260|NCT02975336|50125388|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
25027261|NCT02975336|50125389|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
24934194|NCT00422097|50027328|FG000|Dose Level 2|Still on treatment|0|||
24934195|NCT00422097|50027329|FG001|Dose Level 2|Still on treatment|1|||
24934196|NCT00422097|50027330|FG002|Dose Level 2|Still on treatment|0|||
24934197|NCT00422097|50027331|FG003|Dose Level 2|Still on treatment|0|||
24934198|NCT00422097|50027332|FG004|Dose Level 2|Still on treatment|0|||
24934199|NCT00422097|50027333|FG005|Dose Level 2|Still on treatment|0|||
24934200|NCT00422097|50027334|FG006|Dose Level 2|Still on treatment|0|||
24934201|NCT00422097|50027335|FG007|Dose Level 2|Still on treatment|0|||
24934202|NCT00348556|50027359|FG000|Overall Study|Adverse Event|1|||
24934203|NCT00434967|50027367|FG000|Overall Study|Adverse Event|2|||
24934204|NCT00434967|50027368|FG001|Overall Study|Adverse Event|4|||
24934205|NCT00434967|50027369|FG002|Overall Study|Adverse Event|3|||
24934206|NCT00434967|50027370|FG003|Overall Study|Adverse Event|3|||
24934207|NCT00434967|50027367|FG000|Overall Study|Lost to Follow-up|0|||
24934208|NCT00434967|50027368|FG001|Overall Study|Lost to Follow-up|0|||
24934209|NCT00434967|50027369|FG002|Overall Study|Lost to Follow-up|1|||
24934210|NCT00434967|50027370|FG003|Overall Study|Lost to Follow-up|0|||
24934211|NCT00434967|50027367|FG000|Overall Study|Withdrawal by Subject|2|||
24934212|NCT00434967|50027368|FG001|Overall Study|Withdrawal by Subject|2|||
24934213|NCT00434967|50027369|FG002|Overall Study|Withdrawal by Subject|4|||
25027262|NCT02975336|50125390|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
25027263|NCT02975336|50125391|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
25027264|NCT02975336|50125392|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
25027265|NCT02975336|50125385|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
25027266|NCT02975336|50125386|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
25027267|NCT02975336|50125387|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
25027268|NCT02975336|50125388|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
25027269|NCT02975336|50125389|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
25027270|NCT02975336|50125390|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
25027271|NCT02975336|50125391|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
25027272|NCT02975336|50125392|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
25027273|NCT02975336|50125385|FG000|LTE (104 Weeks)|Other|0|||
25027274|NCT02975336|50125386|FG001|LTE (104 Weeks)|Other|0|||
25027275|NCT02975336|50125387|FG002|LTE (104 Weeks)|Other|0|||
25027276|NCT02975336|50125388|FG003|LTE (104 Weeks)|Other|0|||
25027277|NCT02975336|50125389|FG004|LTE (104 Weeks)|Other|55|||
25027278|NCT02975336|50125390|FG005|LTE (104 Weeks)|Other|63|||
25027279|NCT02975336|50125391|FG006|LTE (104 Weeks)|Other|76|||
25027280|NCT02975336|50125392|FG007|LTE (104 Weeks)|Other|72|||
25027281|NCT03124563|50125408|FG000|Overall Study|Lost to Follow-up|1|||
24934214|NCT00434967|50027370|FG003|Overall Study|Withdrawal by Subject|6|||
24934215|NCT00434967|50027367|FG000|Overall Study|Randomized in error|0|||
24934216|NCT00434967|50027368|FG001|Overall Study|Randomized in error|0|||
24934217|NCT00434967|50027369|FG002|Overall Study|Randomized in error|0|||
24934218|NCT00434967|50027370|FG003|Overall Study|Randomized in error|1|||
24934219|NCT00434967|50027367|FG000|Overall Study|Protocol Violation|0|||
24934220|NCT00434967|50027368|FG001|Overall Study|Protocol Violation|1|||
24934221|NCT00434967|50027369|FG002|Overall Study|Protocol Violation|0|||
25027282|NCT03124563|50125409|FG001|Overall Study|Lost to Follow-up|1|||
25027283|NCT03124563|50125408|FG000|Overall Study|Withdrawal by Subject|1|||
25027284|NCT03124563|50125409|FG001|Overall Study|Withdrawal by Subject|1|||
25027285|NCT03079869|50125417|FG000|Overall Study|Adverse Event|6|||
25027286|NCT03079869|50125418|FG001|Overall Study|Adverse Event|8|||
25027287|NCT03079869|50125417|FG000|Overall Study|Withdrawal by Subject|4|||
25027288|NCT03079869|50125418|FG001|Overall Study|Withdrawal by Subject|1|||
24934222|NCT00434967|50027370|FG003|Overall Study|Protocol Violation|1|||
24934223|NCT00434967|50027367|FG000|Overall Study|Physician Decision|1|||
24934224|NCT00434967|50027368|FG001|Overall Study|Physician Decision|1|||
25027289|NCT03079869|50125417|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
24934225|NCT00434967|50027369|FG002|Overall Study|Physician Decision|1|||
24934226|NCT00434967|50027370|FG003|Overall Study|Physician Decision|0|||
24934227|NCT00434967|50027367|FG000|Overall Study|Patient Disposition Challenges|2|||
24934228|NCT00434967|50027368|FG001|Overall Study|Patient Disposition Challenges|0|||
24934229|NCT00434967|50027369|FG002|Overall Study|Patient Disposition Challenges|0|||
24934230|NCT00434967|50027370|FG003|Overall Study|Patient Disposition Challenges|3|||
24934231|NCT00356590|50027380|FG000|Overall Study|Adverse Event|54|||
24934232|NCT00356590|50027380|FG000|Overall Study|Death|10|||
24934233|NCT00356590|50027380|FG000|Overall Study|Lost to Follow-up|35|||
24934234|NCT00356590|50027380|FG000|Overall Study|Physician Decision|46|||
25027290|NCT03079869|50125418|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
25027291|NCT03085914|50125431|FG000|Overall Study|Death|6|||
25027292|NCT03085914|50125432|FG001|Overall Study|Death|6|||
25027293|NCT03085914|50125433|FG002|Overall Study|Death|4|||
25027294|NCT03085914|50125434|FG003|Overall Study|Death|1|||
24934235|NCT00356590|50027380|FG000|Overall Study|Withdrawal by Subject|41|||
24934236|NCT00356590|50027380|FG000|Overall Study|Completed month 12 only|2|||
24934237|NCT00356590|50027380|FG000|Overall Study|Protocol issues|6|||
24934238|NCT00356590|50027380|FG000|Overall Study|Response status|28|||
24934239|NCT00356590|50027380|FG000|Overall Study|Other|52|||
24934240|NCT00356278|50027387|FG000|Overall Study|Withdrawal by Subject|25|||
25027295|NCT03085914|50125435|FG004|Overall Study|Death|5|||
25027296|NCT03085914|50125436|FG005|Overall Study|Death|2|||
25027297|NCT03085914|50125437|FG006|Overall Study|Death|2|||
25027298|NCT03085914|50125431|FG000|Overall Study|Withdrawal by Subject|1|||
25027299|NCT03085914|50125432|FG001|Overall Study|Withdrawal by Subject|1|||
25027300|NCT03085914|50125433|FG002|Overall Study|Withdrawal by Subject|2|||
25027301|NCT03085914|50125434|FG003|Overall Study|Withdrawal by Subject|2|||
25027302|NCT03085914|50125435|FG004|Overall Study|Withdrawal by Subject|2|||
25027303|NCT03085914|50125436|FG005|Overall Study|Withdrawal by Subject|0|||
25156110|NCT01498653|50271965|FG000|Overall Study|Withdrawal by Subject|2|||
24934241|NCT00356278|50027388|FG001|Overall Study|Withdrawal by Subject|15|||
24934242|NCT00356278|50027389|FG002|Overall Study|Withdrawal by Subject|19|||
24934243|NCT00356200|50027399|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
24934244|NCT00356200|50027400|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
24934245|NCT00356200|50027399|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
24934246|NCT00356200|50027400|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
24934247|NCT00356122|50027412|FG000|TREATMENT|Lack of Efficacy|26|||
24934248|NCT00356122|50027412|FG000|TREATMENT|Adverse Event|10|||
24934249|NCT00356122|50027412|FG000|TREATMENT|Subject's request|4|||
24934250|NCT00356122|50027412|FG000|TREATMENT|Other|4|||
24934251|NCT00356122|50027412|FG000|TREATMENT|Did not receive study medication|1|||
24934252|NCT00356122|50027412|FG000|FOLLOW-UP|Death|37|||
24934253|NCT00356122|50027412|FG000|FOLLOW-UP|Lost to Follow-up|2|||
24934254|NCT00356122|50027412|FG000|FOLLOW-UP|Other|2|||
24934255|NCT00347932|50027418|FG000|Overall Study|Adverse Event|4|||
24934256|NCT00347932|50027419|FG001|Overall Study|Adverse Event|5|||
24934257|NCT00347932|50027418|FG000|Overall Study|Lack of Efficacy|3|||
24934258|NCT00347932|50027419|FG001|Overall Study|Lack of Efficacy|14|||
24934259|NCT00347932|50027418|FG000|Overall Study|Lost to Follow-up|10|||
24934260|NCT00347932|50027419|FG001|Overall Study|Lost to Follow-up|9|||
24934261|NCT00347932|50027418|FG000|Overall Study|Withdrawal by Subject|10|||
24934262|NCT00347932|50027419|FG001|Overall Study|Withdrawal by Subject|16|||
24934263|NCT00347932|50027418|FG000|Overall Study|Did not meet inclusion criteria|4|||
24934264|NCT00347932|50027419|FG001|Overall Study|Did not meet inclusion criteria|8|||
24934265|NCT00528996|50027430|FG000|Overall Study|Other reasons than listing|6|||
24934266|NCT00528996|50027431|FG001|Overall Study|Other reasons than listing|7|||
24934267|NCT00528996|50027432|FG002|Overall Study|Other reasons than listing|14|||
24934268|NCT00528996|50027433|FG003|Overall Study|Other reasons than listing|11|||
24934269|NCT00528996|50027434|FG004|Overall Study|Other reasons than listing|5|||
24934270|NCT00528996|50027430|FG000|Overall Study|Refused continue medication|16|||
24934271|NCT00528996|50027431|FG001|Overall Study|Refused continue medication|0|||
24934272|NCT00528996|50027432|FG002|Overall Study|Refused continue medication|3|||
24934273|NCT00528996|50027433|FG003|Overall Study|Refused continue medication|3|||
24934274|NCT00528996|50027434|FG004|Overall Study|Refused continue medication|6|||
24934275|NCT00528996|50027430|FG000|Overall Study|Lost to Follow-up|2|||
24934276|NCT00528996|50027431|FG001|Overall Study|Lost to Follow-up|0|||
25027304|NCT03085914|50125437|FG006|Overall Study|Withdrawal by Subject|1|||
25027305|NCT03085914|50125431|FG000|Overall Study|Lost to Follow-up|0|||
25027306|NCT03085914|50125432|FG001|Overall Study|Lost to Follow-up|0|||
25027307|NCT03085914|50125433|FG002|Overall Study|Lost to Follow-up|1|||
25027308|NCT03085914|50125434|FG003|Overall Study|Lost to Follow-up|0|||
25027309|NCT03085914|50125435|FG004|Overall Study|Lost to Follow-up|0|||
25027310|NCT03085914|50125436|FG005|Overall Study|Lost to Follow-up|1|||
24934277|NCT00528996|50027432|FG002|Overall Study|Lost to Follow-up|4|||
24934278|NCT00528996|50027433|FG003|Overall Study|Lost to Follow-up|1|||
24934279|NCT00528996|50027434|FG004|Overall Study|Lost to Follow-up|3|||
24934280|NCT00528996|50027430|FG000|Overall Study|Protocol Violation|1|||
24934281|NCT00528996|50027431|FG001|Overall Study|Protocol Violation|2|||
24934282|NCT00528996|50027432|FG002|Overall Study|Protocol Violation|3|||
24934283|NCT00528996|50027433|FG003|Overall Study|Protocol Violation|3|||
24934284|NCT00528996|50027434|FG004|Overall Study|Protocol Violation|2|||
24934285|NCT00528996|50027430|FG000|Overall Study|Lack of Efficacy|7|||
24934286|NCT00528996|50027431|FG001|Overall Study|Lack of Efficacy|2|||
24934287|NCT00528996|50027432|FG002|Overall Study|Lack of Efficacy|1|||
24934288|NCT00528996|50027433|FG003|Overall Study|Lack of Efficacy|3|||
24934289|NCT00528996|50027434|FG004|Overall Study|Lack of Efficacy|3|||
24934290|NCT00528996|50027430|FG000|Overall Study|Adverse Event|32|||
24934291|NCT00528996|50027431|FG001|Overall Study|Adverse Event|13|||
24934292|NCT00528996|50027432|FG002|Overall Study|Adverse Event|18|||
24934293|NCT00528996|50027433|FG003|Overall Study|Adverse Event|29|||
24934294|NCT00528996|50027434|FG004|Overall Study|Adverse Event|18|||
24934295|NCT00359788|50027451|FG000|Overall Study|Adverse Event|11|||
24934296|NCT00359788|50027452|FG001|Overall Study|Adverse Event|10|||
24934297|NCT00359788|50027451|FG000|Overall Study|Lack of Efficacy|1|||
24934298|NCT00359788|50027452|FG001|Overall Study|Lack of Efficacy|2|||
24934299|NCT00359788|50027451|FG000|Overall Study|Lost to Follow-up|3|||
24934300|NCT00359788|50027452|FG001|Overall Study|Lost to Follow-up|2|||
24934301|NCT00359788|50027451|FG000|Overall Study|Withdrawal by Subject|4|||
24934302|NCT00359788|50027452|FG001|Overall Study|Withdrawal by Subject|1|||
24934303|NCT00359788|50027451|FG000|Overall Study|Protocol Violation|4|||
24934304|NCT00359788|50027452|FG001|Overall Study|Protocol Violation|2|||
24934305|NCT03878160|50027461|FG000|Overall Study|Lost to Follow-up|1|||
24934306|NCT03878160|50027462|FG001|Overall Study|Lost to Follow-up|1|||
24934307|NCT03878160|50027463|FG002|Overall Study|Lost to Follow-up|1|||
24934308|NCT03878160|50027461|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
24934309|NCT03878160|50027462|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
24934310|NCT03878160|50027463|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
24934311|NCT00623597|50027473|FG000|Overall Study|Failed to return|1|||
24934312|NCT00623597|50027474|FG001|Overall Study|Failed to return|0|||
24934313|NCT00347776|50027485|FG000|1.5 Month Follow-up|Death|2|||
24934314|NCT00347776|50027486|FG001|1.5 Month Follow-up|Death|0|||
24934315|NCT00347776|50027487|FG002|1.5 Month Follow-up|Death|0|||
24934316|NCT00347776|50027485|FG000|1.5 Month Follow-up|reached the endpoint|12|||
24934317|NCT00347776|50027486|FG001|1.5 Month Follow-up|reached the endpoint|8|||
24934318|NCT00347776|50027487|FG002|1.5 Month Follow-up|reached the endpoint|12|||
24934319|NCT00347776|50027485|FG000|6 Month Follow-up|Death|2|||
24934320|NCT00347776|50027486|FG001|6 Month Follow-up|Death|1|||
24934321|NCT00347776|50027487|FG002|6 Month Follow-up|Death|3|||
24934322|NCT00347776|50027485|FG000|6 Month Follow-up|reached endpont|20|||
24934323|NCT00347776|50027486|FG001|6 Month Follow-up|reached endpont|12|||
24934324|NCT00347776|50027487|FG002|6 Month Follow-up|reached endpont|15|||
24934325|NCT00347776|50027485|FG000|12 Month Follow-up|Lost to Follow-up|7|||
24934326|NCT00347776|50027486|FG001|12 Month Follow-up|Lost to Follow-up|6|||
24934327|NCT00347776|50027487|FG002|12 Month Follow-up|Lost to Follow-up|6|||
24934328|NCT00347776|50027485|FG000|12 Month Follow-up|Death|3|||
24934329|NCT00347776|50027486|FG001|12 Month Follow-up|Death|4|||
24934330|NCT00347776|50027487|FG002|12 Month Follow-up|Death|4|||
24934331|NCT00347776|50027485|FG000|12 Month Follow-up|Reached endpoint|13|||
24934332|NCT00347776|50027486|FG001|12 Month Follow-up|Reached endpoint|6|||
24934333|NCT00347776|50027487|FG002|12 Month Follow-up|Reached endpoint|9|||
24934334|NCT03829228|50027495|FG000|Overall Study|Protocol Violation|1|||
24934335|NCT00529542|50027501|FG000|Overall Study|Withdrawal by Subject|1|||
24934336|NCT00529542|50027502|FG001|Overall Study|Withdrawal by Subject|0|||
24934337|NCT00529542|50027501|FG000|Overall Study|Lost to Follow-up|0|||
24934338|NCT00529542|50027502|FG001|Overall Study|Lost to Follow-up|1|||
24934339|NCT00621959|50027510|FG000|Overall Study|Adverse Event|4|||
24934340|NCT00621959|50027511|FG001|Overall Study|Adverse Event|2|||
24934341|NCT00621959|50027510|FG000|Overall Study|Lack of Efficacy|1|||
24934342|NCT00621959|50027511|FG001|Overall Study|Lack of Efficacy|1|||
24934343|NCT00621959|50027510|FG000|Overall Study|Lost to Follow-up|0|||
24934344|NCT00621959|50027511|FG001|Overall Study|Lost to Follow-up|2|||
24934345|NCT00621959|50027510|FG000|Overall Study|Withdrawal by Subject|1|||
24934346|NCT00621959|50027511|FG001|Overall Study|Withdrawal by Subject|1|||
25027311|NCT03085914|50125437|FG006|Overall Study|Lost to Follow-up|1|||
25027312|NCT03085914|50125431|FG000|Overall Study|Reason was not specified,|2|||
24934347|NCT00621959|50027510|FG000|Overall Study|Other|1|||
24934348|NCT00621959|50027511|FG001|Overall Study|Other|3|||
24934349|NCT03877224|50027519|FG000|Overall Study|Death|3|||
24934350|NCT03877224|50027520|FG001|Overall Study|Death|2|||
24934351|NCT03877224|50027519|FG000|Overall Study|Withdrawal by Subject|1|||
24934352|NCT03877224|50027520|FG001|Overall Study|Withdrawal by Subject|6|||
24934353|NCT03877224|50027519|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
24934354|NCT03877224|50027520|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
24934355|NCT00528606|50027528|FG000|Overall Study|Withdrew consent|4|||
24934356|NCT00528606|50027529|FG001|Overall Study|Withdrew consent|3|||
24934357|NCT00528606|50027528|FG000|Overall Study|Lost to Follow-up|4|||
24934358|NCT00528606|50027529|FG001|Overall Study|Lost to Follow-up|1|||
24934359|NCT00528606|50027528|FG000|Overall Study|Adverse Event|3|||
24934360|NCT00528606|50027529|FG001|Overall Study|Adverse Event|0|||
24934361|NCT00528606|50027528|FG000|Overall Study|Other|2|||
24934362|NCT00528606|50027529|FG001|Overall Study|Other|0|||
24934363|NCT00621257|50027540|FG000|Overall Study|Lost to Follow-up|4|||
24934364|NCT00621257|50027541|FG001|Overall Study|Lost to Follow-up|0|||
24934365|NCT00621257|50027542|FG002|Overall Study|Lost to Follow-up|2|||
24934366|NCT00621257|50027543|FG003|Overall Study|Lost to Follow-up|4|||
24934367|NCT00621257|50027544|FG004|Overall Study|Lost to Follow-up|7|||
24934368|NCT00621257|50027540|FG000|Overall Study|Adverse Event|0|||
24934369|NCT00621257|50027541|FG001|Overall Study|Adverse Event|1|||
24934370|NCT00621257|50027542|FG002|Overall Study|Adverse Event|1|||
24934371|NCT00621257|50027543|FG003|Overall Study|Adverse Event|0|||
24934372|NCT00621257|50027544|FG004|Overall Study|Adverse Event|0|||
24934373|NCT00621257|50027540|FG000|Overall Study|Physician Decision|0|||
24934374|NCT00621257|50027541|FG001|Overall Study|Physician Decision|2|||
25027313|NCT03085914|50125432|FG001|Overall Study|Reason was not specified,|2|||
24934375|NCT00621257|50027542|FG002|Overall Study|Physician Decision|0|||
24934376|NCT00621257|50027543|FG003|Overall Study|Physician Decision|1|||
24934377|NCT00621257|50027544|FG004|Overall Study|Physician Decision|1|||
24934378|NCT00621257|50027540|FG000|Overall Study|Withdrawal by Subject|0|||
25027314|NCT03085914|50125433|FG002|Overall Study|Reason was not specified,|2|||
25027315|NCT03085914|50125434|FG003|Overall Study|Reason was not specified,|3|||
25027316|NCT03085914|50125435|FG004|Overall Study|Reason was not specified,|3|||
25027317|NCT03085914|50125436|FG005|Overall Study|Reason was not specified,|3|||
25027318|NCT03085914|50125437|FG006|Overall Study|Reason was not specified,|6|||
25027319|NCT03085914|50125431|FG000|Overall Study|Progressive Disease|0|||
25027320|NCT03085914|50125432|FG001|Overall Study|Progressive Disease|0|||
25027321|NCT03085914|50125433|FG002|Overall Study|Progressive Disease|2|||
25027322|NCT03085914|50125434|FG003|Overall Study|Progressive Disease|2|||
25027323|NCT03085914|50125435|FG004|Overall Study|Progressive Disease|1|||
25027324|NCT03085914|50125436|FG005|Overall Study|Progressive Disease|1|||
25027325|NCT03085914|50125437|FG006|Overall Study|Progressive Disease|1|||
25027326|NCT03085914|50125431|FG000|Overall Study|Study Terminated by the Sponsor|0|||
25027327|NCT03085914|50125432|FG001|Overall Study|Study Terminated by the Sponsor|0|||
25027328|NCT03085914|50125433|FG002|Overall Study|Study Terminated by the Sponsor|0|||
24934379|NCT00621257|50027541|FG001|Overall Study|Withdrawal by Subject|0|||
24934380|NCT00621257|50027542|FG002|Overall Study|Withdrawal by Subject|0|||
24934381|NCT00621257|50027543|FG003|Overall Study|Withdrawal by Subject|1|||
24934382|NCT00621257|50027544|FG004|Overall Study|Withdrawal by Subject|1|||
24934383|NCT00528840|50027556|FG000|Overall Study|Lost to Follow-up|10|||
24934384|NCT00528840|50027556|FG000|Overall Study|Adverse Event|1|||
24934385|NCT00528840|50027556|FG000|Overall Study|Withdrawal by Subject|17|||
24934386|NCT00528840|50027556|FG000|Overall Study|Death|2|||
24934387|NCT00528840|50027556|FG000|Overall Study|Administrative Reasons|1|||
24934388|NCT00528840|50027556|FG000|Overall Study|Other|2|||
24934389|NCT00528528|50027564|FG000|Overall Study|Lost to Follow-up|0|||
24934390|NCT00528528|50027565|FG001|Overall Study|Lost to Follow-up|0|||
24934391|NCT00528528|50027566|FG002|Overall Study|Lost to Follow-up|1|||
24934392|NCT00528528|50027567|FG003|Overall Study|Lost to Follow-up|1|||
24934393|NCT00528528|50027564|FG000|Overall Study|Ineligible to continue the trial|0|||
24934394|NCT00528528|50027565|FG001|Overall Study|Ineligible to continue the trial|0|||
24934395|NCT00528528|50027566|FG002|Overall Study|Ineligible to continue the trial|0|||
24934396|NCT00528528|50027567|FG003|Overall Study|Ineligible to continue the trial|1|||
24934397|NCT00528528|50027564|FG000|Overall Study|Other|0|||
24934398|NCT00528528|50027565|FG001|Overall Study|Other|1|||
24934399|NCT00528528|50027566|FG002|Overall Study|Other|0|||
24934400|NCT00528528|50027567|FG003|Overall Study|Other|0|||
24934401|NCT00528528|50027564|FG000|Overall Study|Withdrawal by Subject|3|||
24934402|NCT00528528|50027565|FG001|Overall Study|Withdrawal by Subject|2|||
24934403|NCT00528528|50027566|FG002|Overall Study|Withdrawal by Subject|1|||
24934404|NCT00528528|50027567|FG003|Overall Study|Withdrawal by Subject|1|||
24934405|NCT00528528|50027564|FG000|Overall Study|Ongoing participant|0|||
24934406|NCT00528528|50027565|FG001|Overall Study|Ongoing participant|0|||
24934407|NCT00528528|50027566|FG002|Overall Study|Ongoing participant|1|||
24934408|NCT00528528|50027567|FG003|Overall Study|Ongoing participant|0|||
25027329|NCT03085914|50125434|FG003|Overall Study|Study Terminated by the Sponsor|1|||
25027330|NCT03085914|50125435|FG004|Overall Study|Study Terminated by the Sponsor|2|||
25027331|NCT03085914|50125436|FG005|Overall Study|Study Terminated by the Sponsor|1|||
25027332|NCT03085914|50125437|FG006|Overall Study|Study Terminated by the Sponsor|0|||
25027333|NCT03078582|50125465|FG000|Overall Study|Adverse Event|0|||
24934409|NCT00620555|50027579|FG000|Overall Study|Adverse Event|4|||
24934410|NCT00620555|50027579|FG000|Overall Study|Protocol Violation|2|||
24934411|NCT00620555|50027579|FG000|Overall Study|Lack of Efficacy|12|||
24934412|NCT00620555|50027579|FG000|Overall Study|Withdrawal by Subject|1|||
24934413|NCT00620555|50027579|FG000|Overall Study|Choice of other treatment|1|||
24934414|NCT00620555|50027579|FG000|Overall Study|Visit failure against planned|1|||
24934415|NCT00529386|50027583|FG000|Overall Study|Lost to Follow-up|1|||
24934416|NCT03875118|50027589|FG000|Overall Study|Withdrawal by Subject|4|||
24934417|NCT03875118|50027590|FG001|Overall Study|Withdrawal by Subject|4|||
24934418|NCT00529308|50027598|FG000|Overall Study|Withdrawal by Subject|1|||
24934419|NCT00529308|50027599|FG001|Overall Study|Withdrawal by Subject|1|||
24934420|NCT03875508|50027605|FG000|Overall Study|Adverse Event|1|||
24934421|NCT03875508|50027605|FG000|Overall Study|Lost to Follow-up|8|||
24934422|NCT03875508|50027605|FG000|Overall Study|Lack of Efficacy|1|||
24934423|NCT03875508|50027605|FG000|Overall Study|Other, not specified|2|||
24934424|NCT00620321|50027611|FG000|Overall Study|Adverse Event|1|||
24934425|NCT00620321|50027612|FG001|Overall Study|Adverse Event|1|||
24934426|NCT00620321|50027611|FG000|Overall Study|Death|1|||
24934427|NCT00620321|50027612|FG001|Overall Study|Death|1|||
24934428|NCT00620321|50027611|FG000|Overall Study|Physician Decision|0|||
24934429|NCT00620321|50027612|FG001|Overall Study|Physician Decision|7|||
24934430|NCT00620321|50027611|FG000|Overall Study|Progressive Disease|5|||
24934431|NCT00620321|50027612|FG001|Overall Study|Progressive Disease|5|||
24934432|NCT00620321|50027611|FG000|Overall Study|Sponsor Decision|0|||
24934433|NCT00620321|50027612|FG001|Overall Study|Sponsor Decision|1|||
24934434|NCT00620321|50027611|FG000|Overall Study|Withdrawal by Subject|1|||
24934435|NCT00620321|50027612|FG001|Overall Study|Withdrawal by Subject|1|||
24934436|NCT00621023|50027618|FG000|Overall Study|Death|5|||
24934437|NCT00621023|50027618|FG000|Overall Study|Follow up discontinued|1|||
24934438|NCT00528372|50027631|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
24934439|NCT00528372|50027632|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
24934440|NCT00528372|50027633|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
24934441|NCT00528372|50027634|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
24934442|NCT00528372|50027635|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
24934443|NCT00528372|50027636|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
24934444|NCT00528372|50027637|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
24934445|NCT00528372|50027638|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
24934446|NCT00528372|50027639|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
24934447|NCT00528372|50027631|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
24934448|NCT00528372|50027632|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
24934449|NCT00528372|50027633|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
24934450|NCT00528372|50027634|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
24934451|NCT00528372|50027635|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
24934452|NCT00528372|50027636|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
24934453|NCT00528372|50027637|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
24934454|NCT00528372|50027638|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
24934455|NCT00528372|50027639|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
24934456|NCT00528372|50027631|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
24934457|NCT00528372|50027632|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
24934458|NCT00528372|50027633|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
24934459|NCT00528372|50027634|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
24934460|NCT00528372|50027635|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
24934461|NCT00528372|50027636|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
24934462|NCT00528372|50027637|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
24934463|NCT00528372|50027638|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
24934464|NCT00528372|50027639|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
24934465|NCT00528372|50027631|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
24934466|NCT00528372|50027632|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
24934467|NCT00528372|50027633|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
24934468|NCT00528372|50027634|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
24934469|NCT00528372|50027635|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
24934470|NCT00528372|50027636|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
24934471|NCT00528372|50027637|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
24934472|NCT00528372|50027638|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
24934473|NCT00528372|50027639|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
24934474|NCT00528372|50027631|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
24934475|NCT00528372|50027632|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
24934476|NCT00528372|50027633|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
24934477|NCT00528372|50027634|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
24934478|NCT00528372|50027635|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
25156111|NCT01498653|50271966|FG001|Overall Study|Withdrawal by Subject|3|||
24934479|NCT00528372|50027636|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
24934480|NCT00528372|50027637|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
24934481|NCT00528372|50027638|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
24934482|NCT00528372|50027639|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
24934483|NCT00528372|50027631|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
24934484|NCT00528372|50027632|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
24934485|NCT00528372|50027633|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
24934486|NCT00528372|50027634|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
24934487|NCT00528372|50027635|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
24934488|NCT00528372|50027636|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
24934489|NCT00528372|50027637|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
24934490|NCT00528372|50027638|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
24934491|NCT00528372|50027639|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
24934492|NCT00528372|50027631|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
24934493|NCT00528372|50027632|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
24934494|NCT00528372|50027633|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
24934495|NCT00528372|50027634|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
24934496|NCT00528372|50027635|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
24934497|NCT00528372|50027636|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
24934498|NCT00528372|50027637|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
24934499|NCT00528372|50027638|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
24934500|NCT00528372|50027639|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
24934501|NCT00528372|50027631|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
24934502|NCT00528372|50027632|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
24934503|NCT00528372|50027633|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
24934504|NCT00528372|50027634|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
24934505|NCT00528372|50027635|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
24934506|NCT00528372|50027636|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
24934507|NCT00528372|50027637|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
24934508|NCT00528372|50027638|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
24934509|NCT00528372|50027639|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
24934510|NCT00528372|50027631|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
24934511|NCT00528372|50027632|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
24934512|NCT00528372|50027633|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
24934513|NCT00528372|50027634|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
24934514|NCT00528372|50027635|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
24934515|NCT00528372|50027636|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
24934516|NCT00528372|50027637|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
24934517|NCT00528372|50027638|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
24934518|NCT00528372|50027639|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
24934519|NCT00528372|50027631|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
24934520|NCT00528372|50027632|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
24934521|NCT00528372|50027633|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
24934522|NCT00528372|50027634|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
24934523|NCT00528372|50027635|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
24934524|NCT00528372|50027636|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
24934525|NCT00528372|50027637|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
24934526|NCT00528372|50027638|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
24934527|NCT00528372|50027639|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
24934528|NCT00528372|50027631|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
24934529|NCT00528372|50027632|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
24934530|NCT00528372|50027633|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
24934531|NCT00528372|50027634|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
24934532|NCT00528372|50027635|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
24934533|NCT00528372|50027636|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
24934534|NCT00528372|50027637|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
24934535|NCT00528372|50027638|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
24934536|NCT00528372|50027639|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
24934537|NCT00528372|50027631|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
24934538|NCT00528372|50027632|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
24934539|NCT00528372|50027633|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
24964609|NCT00432809|50054437|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
25156112|NCT01498575|50271974|FG000|Overall Sample|Withdrawal by Subject|60|||
25185723|NCT00081289|50335261|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
24934540|NCT00528372|50027634|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
24934541|NCT00528372|50027635|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
25027334|NCT03078582|50125466|FG001|Overall Study|Adverse Event|8|||
25027335|NCT03077724|50125474|FG000|Overall Study|Lost to Follow-up|5|||
25027336|NCT03077724|50125475|FG001|Overall Study|Lost to Follow-up|1|||
24934542|NCT00528372|50027636|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
24934543|NCT00528372|50027637|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
24934544|NCT00528372|50027638|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
24934545|NCT00528372|50027639|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
24934546|NCT00528372|50027631|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
24934547|NCT00528372|50027632|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
24934548|NCT00528372|50027633|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
24934549|NCT00528372|50027634|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
24934550|NCT00528372|50027635|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
24934551|NCT00528372|50027636|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
24934552|NCT00528372|50027637|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
24934553|NCT00528372|50027638|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
24934554|NCT00528372|50027639|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
24934555|NCT00528372|50027631|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
24934556|NCT00528372|50027632|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
24934557|NCT00528372|50027633|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
24934558|NCT00528372|50027634|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
24934559|NCT00528372|50027635|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
24934560|NCT00528372|50027636|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
24934561|NCT00528372|50027637|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
24934562|NCT00528372|50027638|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
24934563|NCT00528372|50027639|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
24934564|NCT00528372|50027631|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
24934565|NCT00528372|50027632|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
24934566|NCT00528372|50027633|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
24934567|NCT00528372|50027634|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
24934568|NCT00528372|50027635|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
24934569|NCT00528372|50027636|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
24934570|NCT00528372|50027637|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
24934571|NCT00528372|50027638|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
24934572|NCT00528372|50027639|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
24934573|NCT00527982|50027687|FG000|Overall Study|Physician Decision|1|||
24934574|NCT00527982|50027688|FG001|Overall Study|Physician Decision|0|||
24934575|NCT00527904|50027694|FG000|Overall Study|Adverse Event|45|||
24934576|NCT00527904|50027694|FG000|Overall Study|Withdrawal by Subject|21|||
24934577|NCT00527904|50027694|FG000|Overall Study|Lost to Follow-up|8|||
24934578|NCT00527904|50027694|FG000|Overall Study|misc|22|||
24934579|NCT00619619|50027706|FG000|Overall Study|Physician Decision|0|||
24934580|NCT00619619|50027707|FG001|Overall Study|Physician Decision|0|||
24934581|NCT00619619|50027708|FG002|Overall Study|Physician Decision|1|||
24934582|NCT00619619|50027709|FG003|Overall Study|Physician Decision|0|||
24934583|NCT00619619|50027710|FG004|Overall Study|Physician Decision|0|||
24934584|NCT00619619|50027711|FG005|Overall Study|Physician Decision|0|||
24934585|NCT00619619|50027712|FG006|Overall Study|Physician Decision|0|||
24934586|NCT00619619|50027713|FG007|Overall Study|Physician Decision|0|||
24934587|NCT00619619|50027706|FG000|Overall Study|Protocol Violation|0|||
24934588|NCT00619619|50027707|FG001|Overall Study|Protocol Violation|0|||
24934589|NCT00619619|50027708|FG002|Overall Study|Protocol Violation|0|||
24934590|NCT00619619|50027709|FG003|Overall Study|Protocol Violation|1|||
24934591|NCT00619619|50027710|FG004|Overall Study|Protocol Violation|0|||
24934592|NCT00619619|50027711|FG005|Overall Study|Protocol Violation|0|||
24934593|NCT00619619|50027712|FG006|Overall Study|Protocol Violation|1|||
24934594|NCT00619619|50027713|FG007|Overall Study|Protocol Violation|1|||
24934595|NCT00619619|50027706|FG000|Overall Study|Adverse Event|0|||
24934596|NCT00619619|50027707|FG001|Overall Study|Adverse Event|0|||
24934597|NCT00619619|50027708|FG002|Overall Study|Adverse Event|0|||
24934598|NCT00619619|50027709|FG003|Overall Study|Adverse Event|0|||
24934599|NCT00619619|50027710|FG004|Overall Study|Adverse Event|2|||
24934600|NCT00619619|50027711|FG005|Overall Study|Adverse Event|0|||
24934601|NCT00619619|50027712|FG006|Overall Study|Adverse Event|0|||
24934602|NCT00619619|50027713|FG007|Overall Study|Adverse Event|2|||
24934603|NCT00527826|50027736|FG000|Overall Study|Adverse Event|10|||
24934604|NCT00527826|50027737|FG001|Overall Study|Adverse Event|10|||
24934605|NCT00527826|50027736|FG000|Overall Study|Lost to Follow-up|3|||
24934606|NCT00527826|50027737|FG001|Overall Study|Lost to Follow-up|2|||
25027337|NCT03077724|50125474|FG000|Overall Study|Withdrawal by Subject|3|||
24934607|NCT00527826|50027736|FG000|Overall Study|Withdrawal by Subject|5|||
24934608|NCT00527826|50027737|FG001|Overall Study|Withdrawal by Subject|8|||
24934609|NCT00527826|50027736|FG000|Overall Study|Inclusion Criteria Not Met|3|||
24934610|NCT00527826|50027737|FG001|Overall Study|Inclusion Criteria Not Met|3|||
24934611|NCT00527826|50027736|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
24934612|NCT00527826|50027737|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
24934613|NCT00527826|50027736|FG000|Overall Study|Additional Intake of Viani forte|0|||
24934614|NCT00527826|50027737|FG001|Overall Study|Additional Intake of Viani forte|1|||
24934615|NCT00527826|50027736|FG000|Overall Study|Participant moved away|0|||
24934616|NCT00527826|50027737|FG001|Overall Study|Participant moved away|1|||
24934617|NCT00527748|50027755|FG000|Overall Study|Other|3|||
24934618|NCT00619385|50027762|FG000|Overall Study|Adverse Event|0|||
24934619|NCT00619385|50027763|FG001|Overall Study|Adverse Event|0|||
24934620|NCT00619385|50027764|FG002|Overall Study|Adverse Event|3|||
24934621|NCT00619385|50027762|FG000|Overall Study|Other|1|||
24934622|NCT00619385|50027763|FG001|Overall Study|Other|2|||
24934623|NCT00619385|50027764|FG002|Overall Study|Other|1|||
24934624|NCT00619307|50027777|FG000|Overall Study|Adverse Event|0|||
24934625|NCT00619307|50027778|FG001|Overall Study|Adverse Event|1|||
24934626|NCT00619307|50027777|FG000|Overall Study|Lost to Follow-up|0|||
24934627|NCT00619307|50027778|FG001|Overall Study|Lost to Follow-up|1|||
24934628|NCT00619307|50027777|FG000|Overall Study|Protocol Violation|3|||
24934629|NCT00619307|50027778|FG001|Overall Study|Protocol Violation|0|||
24934630|NCT00619307|50027777|FG000|Overall Study|Withdrew consent|1|||
24934631|NCT00619307|50027778|FG001|Overall Study|Withdrew consent|0|||
24934632|NCT00619307|50027777|FG000|Overall Study|Severe migraine|0|||
24934633|NCT00619307|50027778|FG001|Overall Study|Severe migraine|1|||
24934634|NCT00619307|50027777|FG000|Overall Study|MS attack plus steroids|0|||
24934635|NCT00619307|50027778|FG001|Overall Study|MS attack plus steroids|1|||
24934636|NCT00619229|50027786|FG000|Overall Study|Withdrawal by Subject|1|||
24934637|NCT00619229|50027787|FG001|Overall Study|Withdrawal by Subject|1|||
24934638|NCT00619229|50027786|FG000|Overall Study|Lost to Follow-up|1|||
24934639|NCT00619229|50027787|FG001|Overall Study|Lost to Follow-up|0|||
24934640|NCT00619229|50027786|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
24934641|NCT00619229|50027787|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
24934642|NCT00619229|50027786|FG000|Overall Study|Investigator planned Cataract Operation|1|||
24934643|NCT00619229|50027787|FG001|Overall Study|Investigator planned Cataract Operation|0|||
24934644|NCT00619151|50027795|FG000|Overall Study|Study terminated prior to followup|1|||
24934645|NCT00619151|50027796|FG001|Overall Study|Study terminated prior to followup|0|||
24934646|NCT00618995|50027802|FG000|Period 1|Adverse Event|0|||
24934647|NCT00618995|50027803|FG001|Period 1|Adverse Event|0|||
24934648|NCT00618995|50027804|FG002|Period 1|Adverse Event|1|||
24934649|NCT00618995|50027805|FG003|Period 1|Adverse Event|0|||
24934650|NCT00618995|50027802|FG000|Period 1|Protocol Violation|0|||
24934651|NCT00618995|50027803|FG001|Period 1|Protocol Violation|1|||
24934652|NCT00618995|50027804|FG002|Period 1|Protocol Violation|1|||
24934653|NCT00618995|50027805|FG003|Period 1|Protocol Violation|0|||
24934654|NCT00618995|50027802|FG000|Period 2|Protocol Violation|0|||
24934655|NCT00618995|50027803|FG001|Period 2|Protocol Violation|0|||
24934656|NCT00618995|50027804|FG002|Period 2|Protocol Violation|1|||
24934657|NCT00618995|50027805|FG003|Period 2|Protocol Violation|0|||
24934658|NCT00618995|50027802|FG000|Period 4|Adverse Event|1|||
24934659|NCT00618995|50027803|FG001|Period 4|Adverse Event|0|||
24934660|NCT00618995|50027804|FG002|Period 4|Adverse Event|0|||
24934661|NCT00618995|50027805|FG003|Period 4|Adverse Event|0|||
24934662|NCT03685344|50027819|FG000|Overall Study|Withdrawal by Subject|1|||
24934663|NCT03685344|50027820|FG001|Overall Study|Withdrawal by Subject|1|||
24934664|NCT03685344|50027821|FG002|Overall Study|Withdrawal by Subject|2|||
24934665|NCT03685344|50027822|FG003|Overall Study|Withdrawal by Subject|0|||
24934666|NCT03685344|50027819|FG000|Overall Study|Physician Decision|1|||
24934667|NCT03685344|50027820|FG001|Overall Study|Physician Decision|1|||
24934668|NCT03685344|50027821|FG002|Overall Study|Physician Decision|5|||
24934669|NCT03685344|50027822|FG003|Overall Study|Physician Decision|0|||
24934670|NCT03685344|50027819|FG000|Overall Study|Death|1|||
24934671|NCT03685344|50027820|FG001|Overall Study|Death|1|||
24934672|NCT03685344|50027821|FG002|Overall Study|Death|0|||
24934673|NCT03685344|50027822|FG003|Overall Study|Death|0|||
24934674|NCT00520572|50027838|FG000|Overall Study|Adverse Event|9|||
24934675|NCT00520572|50027839|FG001|Overall Study|Adverse Event|3|||
24934676|NCT00520572|50027840|FG002|Overall Study|Adverse Event|6|||
25156113|NCT01498575|50271975|FG001|Overall Sample|Withdrawal by Subject|14|||
25156114|NCT01498575|50271974|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
25156115|NCT01498575|50271975|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
25156116|NCT01498575|50271974|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
25156117|NCT01498575|50271975|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
25156118|NCT01498185|50271986|FG000|Overall Study|Adverse Event|0|||
25156119|NCT01498185|50271987|FG001|Overall Study|Adverse Event|0|||
25156120|NCT01498185|50271988|FG002|Overall Study|Adverse Event|0|||
25156121|NCT01498185|50271989|FG003|Overall Study|Adverse Event|1|||
25156122|NCT01498185|50271990|FG004|Overall Study|Adverse Event|0|||
25156123|NCT01498185|50271986|FG000|Overall Study|Withdrawal by Subject|1|||
25156124|NCT01498185|50271987|FG001|Overall Study|Withdrawal by Subject|1|||
25156125|NCT01498185|50271988|FG002|Overall Study|Withdrawal by Subject|0|||
25156126|NCT01498185|50271989|FG003|Overall Study|Withdrawal by Subject|2|||
25156127|NCT01498185|50271990|FG004|Overall Study|Withdrawal by Subject|1|||
25156128|NCT01498185|50271986|FG000|Overall Study|No longer met criteria, etc|0|||
25156129|NCT01498185|50271987|FG001|Overall Study|No longer met criteria, etc|0|||
25156130|NCT01498185|50271988|FG002|Overall Study|No longer met criteria, etc|0|||
25156131|NCT01498185|50271989|FG003|Overall Study|No longer met criteria, etc|0|||
25156132|NCT01498185|50271990|FG004|Overall Study|No longer met criteria, etc|2|||
25156133|NCT01528605|50272012|FG000|Overall Study|Lost to Follow-up|1|||
25156134|NCT01528605|50272013|FG001|Overall Study|Lost to Follow-up|0|||
25156135|NCT01528605|50272014|FG002|Overall Study|Lost to Follow-up|1|||
25156136|NCT01528605|50272015|FG003|Overall Study|Lost to Follow-up|1|||
25156137|NCT01528605|50272016|FG004|Overall Study|Lost to Follow-up|0|||
25156138|NCT01528605|50272017|FG005|Overall Study|Lost to Follow-up|0|||
25156139|NCT01528605|50272012|FG000|Overall Study|Death|1|||
25156140|NCT01528605|50272013|FG001|Overall Study|Death|0|||
25156141|NCT01528605|50272014|FG002|Overall Study|Death|0|||
25156142|NCT01528605|50272015|FG003|Overall Study|Death|0|||
25156143|NCT01528605|50272016|FG004|Overall Study|Death|0|||
25156144|NCT01528605|50272017|FG005|Overall Study|Death|0|||
25156145|NCT01528215|50272033|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
25156146|NCT01528215|50272034|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
25156147|NCT01528215|50272033|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
25156148|NCT01528215|50272034|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
25156149|NCT01528215|50272033|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
25156150|NCT01528215|50272034|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
25156151|NCT01528215|50272033|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
25156152|NCT01528215|50272034|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
25156153|NCT01527357|50272042|FG000|Overall Study|Death|8|||
24934677|NCT00520572|50027841|FG003|Overall Study|Adverse Event|9|||
24934678|NCT00520572|50027842|FG004|Overall Study|Adverse Event|7|||
24934679|NCT00520572|50027843|FG005|Overall Study|Adverse Event|2|||
24934680|NCT00520572|50027838|FG000|Overall Study|Withdrawal by Subject|0|||
24934681|NCT00520572|50027839|FG001|Overall Study|Withdrawal by Subject|9|||
24934682|NCT00520572|50027840|FG002|Overall Study|Withdrawal by Subject|5|||
24934683|NCT00520572|50027841|FG003|Overall Study|Withdrawal by Subject|2|||
24934684|NCT00520572|50027842|FG004|Overall Study|Withdrawal by Subject|2|||
24934685|NCT00520572|50027843|FG005|Overall Study|Withdrawal by Subject|0|||
24934686|NCT00520572|50027838|FG000|Overall Study|Protocol Violation|0|||
24934687|NCT00520572|50027839|FG001|Overall Study|Protocol Violation|0|||
24934688|NCT00520572|50027840|FG002|Overall Study|Protocol Violation|1|||
24934689|NCT00520572|50027841|FG003|Overall Study|Protocol Violation|0|||
24934690|NCT00520572|50027842|FG004|Overall Study|Protocol Violation|0|||
24934691|NCT00520572|50027843|FG005|Overall Study|Protocol Violation|0|||
24934692|NCT00520572|50027838|FG000|Overall Study|Lack of Efficacy|1|||
24934693|NCT00520572|50027839|FG001|Overall Study|Lack of Efficacy|1|||
24934694|NCT00520572|50027840|FG002|Overall Study|Lack of Efficacy|1|||
24934695|NCT00520572|50027841|FG003|Overall Study|Lack of Efficacy|2|||
24934696|NCT00520572|50027842|FG004|Overall Study|Lack of Efficacy|1|||
24934697|NCT00520572|50027843|FG005|Overall Study|Lack of Efficacy|0|||
24934698|NCT00520572|50027838|FG000|Overall Study|Lost to Follow-up|0|||
24934699|NCT00520572|50027839|FG001|Overall Study|Lost to Follow-up|0|||
24934700|NCT00520572|50027840|FG002|Overall Study|Lost to Follow-up|0|||
24934701|NCT00520572|50027841|FG003|Overall Study|Lost to Follow-up|0|||
24934702|NCT00520572|50027842|FG004|Overall Study|Lost to Follow-up|1|||
24934703|NCT00520572|50027843|FG005|Overall Study|Lost to Follow-up|0|||
24934704|NCT00520572|50027838|FG000|Overall Study|Incorrect enrollment|1|||
24934705|NCT00520572|50027839|FG001|Overall Study|Incorrect enrollment|0|||
24934706|NCT00520572|50027840|FG002|Overall Study|Incorrect enrollment|1|||
24934707|NCT00520572|50027841|FG003|Overall Study|Incorrect enrollment|0|||
24934708|NCT00520572|50027842|FG004|Overall Study|Incorrect enrollment|1|||
24934709|NCT00520572|50027843|FG005|Overall Study|Incorrect enrollment|0|||
24934710|NCT00520572|50027838|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
24934711|NCT00520572|50027839|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
24934712|NCT00520572|50027840|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
24934713|NCT00520572|50027841|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
24934714|NCT00520572|50027842|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
24934715|NCT00520572|50027843|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
24934716|NCT00520572|50027838|FG000|Overall Study|Long break in taking Medication|0|||
24934717|NCT00520572|50027839|FG001|Overall Study|Long break in taking Medication|0|||
24934718|NCT00520572|50027840|FG002|Overall Study|Long break in taking Medication|0|||
24934719|NCT00520572|50027841|FG003|Overall Study|Long break in taking Medication|1|||
24934720|NCT00520572|50027842|FG004|Overall Study|Long break in taking Medication|0|||
24934721|NCT00520572|50027843|FG005|Overall Study|Long break in taking Medication|0|||
24934722|NCT00520572|50027838|FG000|Overall Study|Did not receive Treatment|1|||
24934723|NCT00520572|50027839|FG001|Overall Study|Did not receive Treatment|0|||
24934724|NCT00520572|50027840|FG002|Overall Study|Did not receive Treatment|1|||
24934725|NCT00520572|50027841|FG003|Overall Study|Did not receive Treatment|0|||
24934726|NCT00520572|50027842|FG004|Overall Study|Did not receive Treatment|0|||
24934727|NCT00520572|50027843|FG005|Overall Study|Did not receive Treatment|0|||
24934728|NCT00573833|50027857|FG000|Overall Study|Not Treated|2|||
24934729|NCT00520494|50027861|FG000|Overall Study|Withdrawal by Subject|1|||
24934730|NCT00527514|50027865|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
24934731|NCT00527514|50027865|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
24934732|NCT00527514|50027865|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
24934733|NCT00527514|50027865|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
24934734|NCT00527514|50027865|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
24934735|NCT00527514|50027865|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
24934736|NCT00527514|50027865|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
24934737|NCT00618449|50027878|FG000|Overall Study|Lost to Follow-up|98|||
24934738|NCT00618449|50027879|FG001|Overall Study|Lost to Follow-up|110|||
24934739|NCT03684642|50027888|FG000|Overall Study|Adverse Event|6|||
24934740|NCT03684642|50027889|FG001|Overall Study|Adverse Event|15|||
24934741|NCT03684642|50027890|FG002|Overall Study|Adverse Event|11|||
24934742|NCT03684642|50027888|FG000|Overall Study|Withdrawal by Subject|35|||
24934743|NCT03684642|50027889|FG001|Overall Study|Withdrawal by Subject|53|||
24934744|NCT03684642|50027890|FG002|Overall Study|Withdrawal by Subject|23|||
24934745|NCT03684642|50027888|FG000|Overall Study|Lack of Efficacy|0|||
24934746|NCT03684642|50027889|FG001|Overall Study|Lack of Efficacy|0|||
24934747|NCT03684642|50027890|FG002|Overall Study|Lack of Efficacy|1|||
24934748|NCT03684642|50027888|FG000|Overall Study|Poor compliance to protocol|0|||
24934749|NCT03684642|50027889|FG001|Overall Study|Poor compliance to protocol|4|||
24934750|NCT03684642|50027890|FG002|Overall Study|Poor compliance to protocol|1|||
24934751|NCT03684642|50027888|FG000|Overall Study|Other than specified|62|||
24934752|NCT03684642|50027889|FG001|Overall Study|Other than specified|60|||
24934753|NCT03684642|50027890|FG002|Overall Study|Other than specified|67|||
24934754|NCT03684642|50027888|FG000|Overall Study|Randomized and not treated|0|||
25027338|NCT03077724|50125475|FG001|Overall Study|Withdrawal by Subject|1|||
25027339|NCT00979212|50125483|FG000|Overall Study|Protocol Violation|1|||
25027340|NCT00979212|50125484|FG001|Overall Study|Protocol Violation|8|||
25027341|NCT00979212|50125483|FG000|Overall Study|No protocol therapy received|1|||
25027342|NCT00979212|50125484|FG001|Overall Study|No protocol therapy received|0|||
25027343|NCT03080454|50125490|FG000|Baseline|Adverse Event|2|||
24934755|NCT03684642|50027889|FG001|Overall Study|Randomized and not treated|0|||
24934756|NCT03684642|50027890|FG002|Overall Study|Randomized and not treated|1|||
24934757|NCT03684642|50027888|FG000|Overall Study|Missing completion status but alive at last contact|0|||
24934758|NCT03684642|50027889|FG001|Overall Study|Missing completion status but alive at last contact|1|||
24934759|NCT03684642|50027890|FG002|Overall Study|Missing completion status but alive at last contact|2|||
24934760|NCT00519636|50027902|FG000|Treatment Period 1|Adverse Event|1|||
24934761|NCT00519636|50027903|FG001|Treatment Period 1|Adverse Event|0|||
24934762|NCT00519636|50027904|FG002|Treatment Period 1|Adverse Event|1|||
24934763|NCT00519636|50027905|FG003|Treatment Period 1|Adverse Event|0|||
24934764|NCT00519636|50027902|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
24934765|NCT00519636|50027903|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
24934766|NCT00519636|50027904|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
24934767|NCT00519636|50027905|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
24934768|NCT00519636|50027902|FG000|Washout Period|Adverse Event|2|||
24934769|NCT00519636|50027903|FG001|Washout Period|Adverse Event|1|||
24934770|NCT00519636|50027904|FG002|Washout Period|Adverse Event|1|||
24934771|NCT00519636|50027905|FG003|Washout Period|Adverse Event|0|||
24934772|NCT00519636|50027902|FG000|Washout Period|Lost to Follow-up|1|||
24934773|NCT00519636|50027903|FG001|Washout Period|Lost to Follow-up|0|||
24934774|NCT00519636|50027904|FG002|Washout Period|Lost to Follow-up|0|||
24934775|NCT00519636|50027905|FG003|Washout Period|Lost to Follow-up|0|||
24934776|NCT00519636|50027902|FG000|Washout Period|Protocol Violation|0|||
24934777|NCT00519636|50027903|FG001|Washout Period|Protocol Violation|0|||
24934778|NCT00519636|50027904|FG002|Washout Period|Protocol Violation|1|||
24934779|NCT00519636|50027905|FG003|Washout Period|Protocol Violation|2|||
24934780|NCT00519636|50027902|FG000|Washout Period|Withdrawal by Subject|1|||
24934781|NCT00519636|50027903|FG001|Washout Period|Withdrawal by Subject|0|||
24934782|NCT00519636|50027904|FG002|Washout Period|Withdrawal by Subject|1|||
24934783|NCT00519636|50027905|FG003|Washout Period|Withdrawal by Subject|0|||
24934784|NCT00519636|50027902|FG000|Washout Period|Failed to meet continuation criteria|14|||
24934785|NCT00519636|50027903|FG001|Washout Period|Failed to meet continuation criteria|11|||
24934786|NCT00519636|50027904|FG002|Washout Period|Failed to meet continuation criteria|9|||
24934787|NCT00519636|50027905|FG003|Washout Period|Failed to meet continuation criteria|3|||
24934788|NCT00519636|50027902|FG000|Washout Period|Out of pollen area > 48 hours|1|||
24934789|NCT00519636|50027903|FG001|Washout Period|Out of pollen area > 48 hours|0|||
24934790|NCT00519636|50027904|FG002|Washout Period|Out of pollen area > 48 hours|0|||
24934791|NCT00519636|50027905|FG003|Washout Period|Out of pollen area > 48 hours|0|||
24934792|NCT00519636|50027902|FG000|Washout Period|Participating in study at another site|1|||
24934793|NCT00519636|50027903|FG001|Washout Period|Participating in study at another site|0|||
24934794|NCT00519636|50027904|FG002|Washout Period|Participating in study at another site|0|||
24934795|NCT00519636|50027905|FG003|Washout Period|Participating in study at another site|0|||
24934796|NCT00519636|50027902|FG000|Washout Period|Non-compliant|0|||
24934797|NCT00519636|50027903|FG001|Washout Period|Non-compliant|1|||
25027344|NCT03080454|50125490|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
25027345|NCT03080454|50125490|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
24934798|NCT00519636|50027904|FG002|Washout Period|Non-compliant|0|||
24934799|NCT00519636|50027905|FG003|Washout Period|Non-compliant|0|||
24934800|NCT00519636|50027902|FG000|Washout Period|Per doctors request|0|||
24934801|NCT00519636|50027903|FG001|Washout Period|Per doctors request|1|||
24934802|NCT00519636|50027904|FG002|Washout Period|Per doctors request|0|||
24934803|NCT00519636|50027905|FG003|Washout Period|Per doctors request|0|||
24934804|NCT00519636|50027902|FG000|Washout Period|Subject randomized in error|0|||
24934805|NCT00519636|50027903|FG001|Washout Period|Subject randomized in error|0|||
24934806|NCT00519636|50027904|FG002|Washout Period|Subject randomized in error|1|||
24934807|NCT00519636|50027905|FG003|Washout Period|Subject randomized in error|0|||
24934808|NCT00519636|50027902|FG000|Washout Period|Prohibited medications|0|||
24934809|NCT00519636|50027903|FG001|Washout Period|Prohibited medications|0|||
24934810|NCT00519636|50027904|FG002|Washout Period|Prohibited medications|1|||
24934811|NCT00519636|50027905|FG003|Washout Period|Prohibited medications|0|||
24934812|NCT00519636|50027902|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
24934813|NCT00519636|50027903|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
24934814|NCT00519636|50027904|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
24934815|NCT00519636|50027905|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
24934816|NCT00519636|50027902|FG000|Treatment Period 2|Subject randomized in error|0|||
25027346|NCT02981342|50125514|FG000|Overall Study|Adverse Event|0|||
25027347|NCT02981342|50125515|FG001|Overall Study|Adverse Event|0|||
25027348|NCT02981342|50125516|FG002|Overall Study|Adverse Event|0|||
25027349|NCT02981342|50125517|FG003|Overall Study|Adverse Event|1|||
25027350|NCT02981342|50125514|FG000|Overall Study|Death|0|||
25027351|NCT02981342|50125515|FG001|Overall Study|Death|9|||
25027352|NCT02981342|50125516|FG002|Overall Study|Death|9|||
25027353|NCT02981342|50125517|FG003|Overall Study|Death|4|||
25027354|NCT02981342|50125514|FG000|Overall Study|Withdrawal by Subject|0|||
25027355|NCT02981342|50125515|FG001|Overall Study|Withdrawal by Subject|0|||
25027356|NCT02981342|50125516|FG002|Overall Study|Withdrawal by Subject|3|||
25027357|NCT02981342|50125517|FG003|Overall Study|Withdrawal by Subject|1|||
25027358|NCT02981342|50125514|FG000|Overall Study|Study closed by sponsor|0|||
25027359|NCT02981342|50125515|FG001|Overall Study|Study closed by sponsor|0|||
25027360|NCT02981342|50125516|FG002|Overall Study|Study closed by sponsor|1|||
25027361|NCT02981342|50125517|FG003|Overall Study|Study closed by sponsor|1|||
25027362|NCT02981342|50125514|FG000|Overall Study|Randomized, Never Treated|0|||
25027363|NCT02981342|50125515|FG001|Overall Study|Randomized, Never Treated|1|||
25027364|NCT02981342|50125516|FG002|Overall Study|Randomized, Never Treated|0|||
25027365|NCT02981342|50125517|FG003|Overall Study|Randomized, Never Treated|7|||
25027366|NCT02981342|50125514|FG000|Overall Study|Lost to Follow-up|0|||
25027367|NCT02981342|50125515|FG001|Overall Study|Lost to Follow-up|1|||
24934817|NCT00519636|50027903|FG001|Treatment Period 2|Subject randomized in error|1|||
24934818|NCT00519636|50027904|FG002|Treatment Period 2|Subject randomized in error|0|||
24934819|NCT00519636|50027905|FG003|Treatment Period 2|Subject randomized in error|0|||
24934820|NCT00519636|50027902|FG000|Treatment Period 2|Per doctors request|0|||
24934821|NCT00519636|50027903|FG001|Treatment Period 2|Per doctors request|0|||
24934822|NCT00519636|50027904|FG002|Treatment Period 2|Per doctors request|1|||
24934823|NCT00519636|50027905|FG003|Treatment Period 2|Per doctors request|0|||
24934824|NCT00519636|50027902|FG000|Treatment Period 2|Subject misrandomized|0|||
24934825|NCT00519636|50027903|FG001|Treatment Period 2|Subject misrandomized|0|||
24934826|NCT00519636|50027904|FG002|Treatment Period 2|Subject misrandomized|0|||
24934827|NCT00519636|50027905|FG003|Treatment Period 2|Subject misrandomized|1|||
24934828|NCT00519636|50027902|FG000|Post Study Period|Subject randomized in error|0|||
24934829|NCT00519636|50027903|FG001|Post Study Period|Subject randomized in error|0|||
24934830|NCT00519636|50027904|FG002|Post Study Period|Subject randomized in error|0|||
24934831|NCT00519636|50027905|FG003|Post Study Period|Subject randomized in error|1|||
24934832|NCT00618371|50027919|FG000|Overall Study|Withdrawal by Subject|2|||
24934833|NCT00526890|50027924|FG000|Overall Study|Adverse Event|2|||
24934834|NCT03864900|50027930|FG000|Overall Study|Withdrawal by Subject|1|||
24934835|NCT03864900|50027931|FG001|Overall Study|Withdrawal by Subject|1|||
25027368|NCT02981342|50125516|FG002|Overall Study|Lost to Follow-up|0|||
25027369|NCT02981342|50125517|FG003|Overall Study|Lost to Follow-up|0|||
25027370|NCT02794246|50125529|FG000|Overall Study|Withdrawal by Subject|2|||
25027371|NCT02794246|50125529|FG000|Overall Study|Physician Decision|4|||
25027372|NCT03428100|50125537|FG000|Overall Study|Adverse Event|1|||
25027373|NCT03428100|50125538|FG001|Overall Study|Adverse Event|0|||
25027374|NCT03428100|50125539|FG002|Overall Study|Adverse Event|3|||
25156154|NCT01527357|50272043|FG001|Overall Study|Death|2|||
25156155|NCT01527357|50272042|FG000|Overall Study|Lost to Follow-up|6|||
25156156|NCT01527357|50272043|FG001|Overall Study|Lost to Follow-up|4|||
25156157|NCT01527357|50272042|FG000|Overall Study|Withdrew Consent|1|||
25156158|NCT01527357|50272043|FG001|Overall Study|Withdrew Consent|1|||
25156159|NCT01527357|50272042|FG000|Overall Study|Non-compliance|0|||
25156160|NCT01527357|50272043|FG001|Overall Study|Non-compliance|1|||
25156161|NCT01527357|50272042|FG000|Overall Study|No Day 29 Visit|0|||
25156162|NCT01527357|50272043|FG001|Overall Study|No Day 29 Visit|1|||
25156163|NCT01527357|50272042|FG000|Overall Study|Did Not Receive Treatment|2|||
25156164|NCT01527357|50272043|FG001|Overall Study|Did Not Receive Treatment|0|||
25156165|NCT01526889|50272062|FG000|Treatment Period|Adverse Event|2|||
24934836|NCT03864900|50027930|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
24934837|NCT03864900|50027931|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
24934838|NCT00526656|50027937|FG000|Overall Study|Death|1|||
24934839|NCT00526656|50027937|FG000|Overall Study|Refused surgery|1|||
24934840|NCT00617903|50027944|FG000|Overall Study|Withdrawal by Subject|2|||
24934841|NCT00617903|50027945|FG001|Overall Study|Withdrawal by Subject|3|||
24934842|NCT00617903|50027944|FG000|Overall Study|Lost to Follow-up|1|||
24934843|NCT00617903|50027945|FG001|Overall Study|Lost to Follow-up|1|||
24934844|NCT00617903|50027944|FG000|Overall Study|Lack of Efficacy|0|||
24934845|NCT00617903|50027945|FG001|Overall Study|Lack of Efficacy|1|||
24934846|NCT00617903|50027944|FG000|Overall Study|Adverse Event|0|||
24934847|NCT00617903|50027945|FG001|Overall Study|Adverse Event|1|||
24934848|NCT00617903|50027944|FG000|Overall Study|noncompliance|0|||
24934849|NCT00617903|50027945|FG001|Overall Study|noncompliance|1|||
24934850|NCT00526110|50027953|FG000|Overall Study|Adverse Event|2|||
24934851|NCT00526110|50027954|FG001|Overall Study|Adverse Event|9|||
24934852|NCT00526110|50027953|FG000|Overall Study|Disease Progression|0|||
24934853|NCT00526110|50027954|FG001|Overall Study|Disease Progression|19|||
24934854|NCT00526110|50027953|FG000|Overall Study|Maximal Response|0|||
24934855|NCT00526110|50027954|FG001|Overall Study|Maximal Response|6|||
24934856|NCT00526110|50027953|FG000|Overall Study|Withdrawal by Subject|0|||
24934857|NCT00526110|50027954|FG001|Overall Study|Withdrawal by Subject|2|||
24934858|NCT00526110|50027953|FG000|Overall Study|Poor Tolerance|0|||
24934859|NCT00526110|50027954|FG001|Overall Study|Poor Tolerance|5|||
24934860|NCT00512148|50027960|FG000|Primay Study Period|Withdrawal by Subject|1|||
24934861|NCT00511836|50027968|FG000|Double-blind Period|Lost to Follow-up|1|||
24934862|NCT00511836|50027969|FG001|Double-blind Period|Lost to Follow-up|0|||
24934863|NCT00573755|50027978|FG000|Overall Study|Still receiving treatment|1|||
24934864|NCT00573755|50027979|FG001|Overall Study|Still receiving treatment|0|||
24934865|NCT00524316|50027985|FG000|Overall Study|Withdrawal by Subject|2|||
24934866|NCT00524316|50027985|FG000|Overall Study|Adverse Event|7|||
24934867|NCT00524316|50027985|FG000|Overall Study|Disease Progression|7|||
24934868|NCT03861936|50028002|FG000|Overall Study|Withdrawal by Subject|4|||
24934869|NCT03861936|50028003|FG001|Overall Study|Withdrawal by Subject|1|||
24934870|NCT03861936|50028004|FG002|Overall Study|Withdrawal by Subject|3|||
24934871|NCT03861936|50028002|FG000|Overall Study|Lost to Follow-up|5|||
24934872|NCT03861936|50028003|FG001|Overall Study|Lost to Follow-up|3|||
24934873|NCT03861936|50028004|FG002|Overall Study|Lost to Follow-up|3|||
25156166|NCT01526889|50272063|FG001|Treatment Period|Adverse Event|0|||
24934874|NCT03861936|50028002|FG000|Overall Study|Physician Decision|0|||
24934875|NCT03861936|50028003|FG001|Overall Study|Physician Decision|1|||
24934876|NCT03861936|50028004|FG002|Overall Study|Physician Decision|0|||
24934877|NCT03861936|50028002|FG000|Overall Study|Protocol Deviation|0|||
24934878|NCT03861936|50028003|FG001|Overall Study|Protocol Deviation|0|||
24934879|NCT03861936|50028004|FG002|Overall Study|Protocol Deviation|1|||
24934880|NCT03861936|50028002|FG000|Overall Study|Reason not Specified|5|||
24934881|NCT03861936|50028003|FG001|Overall Study|Reason not Specified|5|||
24934882|NCT03861936|50028004|FG002|Overall Study|Reason not Specified|3|||
25156167|NCT01526889|50272062|FG000|Treatment Extension Period|Administrative problems|1|||
25156168|NCT01526889|50272063|FG001|Treatment Extension Period|Administrative problems|0|||
25156169|NCT01472835|50272075|FG000|Overall Study|Lost to Follow-up|2|||
25156170|NCT01472835|50272076|FG001|Overall Study|Lost to Follow-up|0|||
25156171|NCT01526733|50272089|FG000|Phase 1|Protocol Violation|1|||
25156172|NCT01526733|50272090|FG001|Phase 1|Protocol Violation|0|||
25156173|NCT01526733|50272089|FG000|Phase 1|Withdrawal by Subject|1|||
25156174|NCT01526733|50272090|FG001|Phase 1|Withdrawal by Subject|1|||
25156175|NCT01472757|50272135|FG000|Overall Study|Withdrawal by Subject|1|||
25156176|NCT01472757|50272136|FG001|Overall Study|Withdrawal by Subject|2|||
25156177|NCT01472757|50272137|FG002|Overall Study|Withdrawal by Subject|2|||
25156178|NCT01472757|50272138|FG003|Overall Study|Withdrawal by Subject|0|||
25156179|NCT01472757|50272135|FG000|Overall Study|Asthma exacerbation|4|||
25156180|NCT01472757|50272136|FG001|Overall Study|Asthma exacerbation|1|||
25156181|NCT01472757|50272137|FG002|Overall Study|Asthma exacerbation|2|||
24934883|NCT00434577|50028017|FG000|Months 0-3|Serious Adverse Event|0|||
24934884|NCT00434577|50028018|FG001|Months 0-3|Serious Adverse Event|0|||
24934885|NCT00434577|50028019|FG002|Months 0-3|Serious Adverse Event|1|||
24934886|NCT00434577|50028020|FG003|Months 0-3|Serious Adverse Event|0|||
25027375|NCT03428100|50125540|FG003|Overall Study|Adverse Event|1|||
25156182|NCT01472757|50272138|FG003|Overall Study|Asthma exacerbation|1|||
25156183|NCT01472757|50272135|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
24934887|NCT00434577|50028021|FG004|Months 0-3|Serious Adverse Event|0|||
25156184|NCT01472757|50272136|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
25156185|NCT01472757|50272137|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
25156186|NCT01472757|50272138|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
25027376|NCT03428100|50125537|FG000|Overall Study|Lack of Efficacy|16|||
24934888|NCT00434577|50028017|FG000|Months 0-3|Adverse Event|0|||
24934889|NCT00434577|50028018|FG001|Months 0-3|Adverse Event|1|||
24934890|NCT00434577|50028019|FG002|Months 0-3|Adverse Event|1|||
24934891|NCT00434577|50028020|FG003|Months 0-3|Adverse Event|0|||
24934892|NCT00434577|50028021|FG004|Months 0-3|Adverse Event|0|||
25027377|NCT03428100|50125538|FG001|Overall Study|Lack of Efficacy|10|||
25027378|NCT03428100|50125539|FG002|Overall Study|Lack of Efficacy|7|||
25027379|NCT03428100|50125540|FG003|Overall Study|Lack of Efficacy|6|||
25027380|NCT03428100|50125537|FG000|Overall Study|Protocol Deviation|0|||
25027381|NCT03428100|50125538|FG001|Overall Study|Protocol Deviation|2|||
25027382|NCT03428100|50125539|FG002|Overall Study|Protocol Deviation|2|||
25027383|NCT03428100|50125540|FG003|Overall Study|Protocol Deviation|0|||
25027384|NCT03428100|50125537|FG000|Overall Study|Withdrawal by Subject|4|||
25027385|NCT03428100|50125538|FG001|Overall Study|Withdrawal by Subject|0|||
25027386|NCT03428100|50125539|FG002|Overall Study|Withdrawal by Subject|0|||
25027387|NCT03428100|50125540|FG003|Overall Study|Withdrawal by Subject|0|||
25027388|NCT03428100|50125537|FG000|Overall Study|Physician Decision|0|||
25156187|NCT01472757|50272135|FG000|Overall Study|Protocol Violation|3|||
25156188|NCT01472757|50272136|FG001|Overall Study|Protocol Violation|2|||
24934893|NCT00434577|50028017|FG000|Months 0-3|Lost to Follow-up|0|||
24934894|NCT00434577|50028018|FG001|Months 0-3|Lost to Follow-up|0|||
24934895|NCT00434577|50028019|FG002|Months 0-3|Lost to Follow-up|0|||
24934896|NCT00434577|50028020|FG003|Months 0-3|Lost to Follow-up|0|||
24934897|NCT00434577|50028021|FG004|Months 0-3|Lost to Follow-up|2|||
24934898|NCT00434577|50028017|FG000|Months 0-3|Protocol Violation|1|||
24934899|NCT00434577|50028018|FG001|Months 0-3|Protocol Violation|0|||
24934900|NCT00434577|50028019|FG002|Months 0-3|Protocol Violation|1|||
24934901|NCT00434577|50028020|FG003|Months 0-3|Protocol Violation|0|||
24934902|NCT00434577|50028021|FG004|Months 0-3|Protocol Violation|0|||
24934903|NCT00434577|50028017|FG000|Months 0-3|Withdrawal by Subject|2|||
24934904|NCT00434577|50028018|FG001|Months 0-3|Withdrawal by Subject|1|||
24934905|NCT00434577|50028019|FG002|Months 0-3|Withdrawal by Subject|1|||
24934906|NCT00434577|50028020|FG003|Months 0-3|Withdrawal by Subject|1|||
24934907|NCT00434577|50028021|FG004|Months 0-3|Withdrawal by Subject|1|||
24934908|NCT00434421|50028033|FG000|Overall Study|Withdrawal by Subject|1|||
24934909|NCT00434421|50028033|FG000|Overall Study|Non-compliance with study treatment|1|||
24934910|NCT00421707|50028039|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
24934911|NCT00421707|50028040|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
24934912|NCT00421707|50028039|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
24934913|NCT00421707|50028040|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
24934914|NCT00421707|50028039|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
24934915|NCT00421707|50028040|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
24934916|NCT00421707|50028039|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
24934917|NCT00421707|50028040|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
24934918|NCT00421707|50028039|FG000|Period 2: Washout|Adverse Event|1|||
24934919|NCT00421707|50028040|FG001|Period 2: Washout|Adverse Event|1|||
24934920|NCT00421707|50028039|FG000|Period 2: Washout|Withdrawal by Subject|0|||
24934921|NCT00421707|50028040|FG001|Period 2: Washout|Withdrawal by Subject|1|||
24934922|NCT00421707|50028039|FG000|Period 2: Washout|Lost to Follow-up|0|||
24934923|NCT00421707|50028040|FG001|Period 2: Washout|Lost to Follow-up|1|||
24934924|NCT00421707|50028039|FG000|Period 2: Washout|Other: Pregnancy|0|||
24934925|NCT00421707|50028040|FG001|Period 2: Washout|Other: Pregnancy|1|||
24934926|NCT00421707|50028039|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
24934927|NCT00421707|50028040|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
24934928|NCT00421707|50028039|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
24934929|NCT00421707|50028040|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
24934930|NCT00421707|50028039|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
24934931|NCT00421707|50028040|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
24934932|NCT00518622|50028066|FG000|Overall Study|Lost to Follow-up|0|||
24934933|NCT00518622|50028067|FG001|Overall Study|Lost to Follow-up|0|||
24934934|NCT00518622|50028068|FG002|Overall Study|Lost to Follow-up|1|||
24934935|NCT00518622|50028069|FG003|Overall Study|Lost to Follow-up|0|||
24934936|NCT00518622|50028070|FG004|Overall Study|Lost to Follow-up|0|||
24934937|NCT00518622|50028071|FG005|Overall Study|Lost to Follow-up|0|||
24934938|NCT00518622|50028072|FG006|Overall Study|Lost to Follow-up|0|||
24934939|NCT00518622|50028073|FG007|Overall Study|Lost to Follow-up|0|||
24934940|NCT00518622|50028066|FG000|Overall Study|Study medication taken incorrectly|0|||
24934941|NCT00518622|50028067|FG001|Overall Study|Study medication taken incorrectly|1|||
24934942|NCT00518622|50028068|FG002|Overall Study|Study medication taken incorrectly|0|||
24934943|NCT00518622|50028069|FG003|Overall Study|Study medication taken incorrectly|0|||
24934944|NCT00518622|50028070|FG004|Overall Study|Study medication taken incorrectly|0|||
24934945|NCT00518622|50028071|FG005|Overall Study|Study medication taken incorrectly|0|||
24934946|NCT00518622|50028072|FG006|Overall Study|Study medication taken incorrectly|0|||
24934947|NCT00518622|50028073|FG007|Overall Study|Study medication taken incorrectly|0|||
25027389|NCT03428100|50125538|FG001|Overall Study|Physician Decision|1|||
25027390|NCT03428100|50125539|FG002|Overall Study|Physician Decision|0|||
25027391|NCT03428100|50125540|FG003|Overall Study|Physician Decision|0|||
25156189|NCT01472757|50272137|FG002|Overall Study|Protocol Violation|4|||
24934948|NCT03783078|50028091|FG000|Overall Study|Participants Ongoing|29|||
24934949|NCT03783078|50028091|FG000|Overall Study|Death|26|||
24934950|NCT00517296|50028097|FG000|Overall Study|Withdrawal by Subject|1|||
24934951|NCT00517296|50028098|FG001|Overall Study|Withdrawal by Subject|0|||
24934952|NCT00516906|50028106|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
24934953|NCT00516906|50028107|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
24934954|NCT00523848|50028113|FG000|Overall Study|Adverse Event|11|||
24934955|NCT00523848|50028113|FG000|Overall Study|Withdrawal by Subject|2|||
24934956|NCT00523848|50028113|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
24934957|NCT00523848|50028113|FG000|Overall Study|Disease Progression|5|||
24934958|NCT00523848|50028113|FG000|Overall Study|Other, unspecified|4|||
24934959|NCT00617669|50028119|FG000|Overall Study|Withdrawal by Subject|71|||
24934960|NCT00617669|50028120|FG001|Overall Study|Withdrawal by Subject|77|||
24934961|NCT00617669|50028119|FG000|Overall Study|Lost to Follow-up|3|||
24934962|NCT00617669|50028120|FG001|Overall Study|Lost to Follow-up|2|||
24934963|NCT00617669|50028119|FG000|Overall Study|Adverse Event|87|||
24934964|NCT00617669|50028120|FG001|Overall Study|Adverse Event|76|||
24934965|NCT00617669|50028119|FG000|Overall Study|Protocol Violation|2|||
24934966|NCT00617669|50028120|FG001|Overall Study|Protocol Violation|3|||
24934967|NCT00617669|50028119|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
24934968|NCT00617669|50028120|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
24934969|NCT00617669|50028119|FG000|Overall Study|Patients randomized but not treated|2|||
24934970|NCT00617669|50028120|FG001|Overall Study|Patients randomized but not treated|3|||
24934971|NCT03682848|50028126|FG000|Overall Study|Withdrawal by Subject|2|||
25156190|NCT01472757|50272138|FG003|Overall Study|Protocol Violation|4|||
25156191|NCT01472757|50272135|FG000|Overall Study|Other reasons|1|||
25156192|NCT01472757|50272136|FG001|Overall Study|Other reasons|0|||
25156193|NCT01472757|50272137|FG002|Overall Study|Other reasons|2|||
25156194|NCT01472757|50272138|FG003|Overall Study|Other reasons|2|||
25156195|NCT01472289|50272157|FG000|Overall Study|Death|2|||
25156196|NCT01525875|50272176|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
25156197|NCT01525875|50272177|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
25156198|NCT01525875|50272176|FG000|Open-label Period|Lost to Follow-up|0|||
25156199|NCT01525875|50272177|FG001|Open-label Period|Lost to Follow-up|2|||
25156200|NCT01525641|50272183|FG000|Overall Study|Case report form not collected|25|||
25156201|NCT01525641|50272183|FG000|Overall Study|No visit since the first visit|16|||
25156202|NCT01525641|50272183|FG000|Overall Study|Adverse Event|73|||
25156203|NCT01525641|50272183|FG000|Overall Study|Lack of Efficacy|24|||
25156204|NCT01525641|50272183|FG000|Overall Study|Improvement|5|||
25156205|NCT01525641|50272183|FG000|Overall Study|Lost to follow-up (relocation)|1|||
25156206|NCT01525641|50272183|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
25156207|NCT01525641|50272183|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
25185724|NCT00081289|50335262|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
24934972|NCT03682848|50028126|FG000|Overall Study|Site closed|5|||
24934973|NCT03682848|50028126|FG000|Overall Study|Protocol Deviation|1|||
24934974|NCT03682848|50028126|FG000|Overall Study|Adverse Event|1|||
24934975|NCT00510510|50028133|FG000|Overall Study|Adverse Event|4|||
24934976|NCT00510510|50028134|FG001|Overall Study|Adverse Event|3|||
24934977|NCT00510510|50028135|FG002|Overall Study|Adverse Event|6|||
24934978|NCT00510510|50028133|FG000|Overall Study|Lack of Efficacy|0|||
24934979|NCT00510510|50028134|FG001|Overall Study|Lack of Efficacy|1|||
24934980|NCT00510510|50028135|FG002|Overall Study|Lack of Efficacy|1|||
24934981|NCT00510510|50028133|FG000|Overall Study|Subjects no longer requires study drug|0|||
24934982|NCT00510510|50028134|FG001|Overall Study|Subjects no longer requires study drug|0|||
24934983|NCT00510510|50028135|FG002|Overall Study|Subjects no longer requires study drug|2|||
24934984|NCT00510510|50028133|FG000|Overall Study|Withdrawal by Subject|1|||
24934985|NCT00510510|50028134|FG001|Overall Study|Withdrawal by Subject|2|||
24934986|NCT00510510|50028135|FG002|Overall Study|Withdrawal by Subject|3|||
24934987|NCT00510510|50028133|FG000|Overall Study|Lost to Follow-up|0|||
24934988|NCT00510510|50028134|FG001|Overall Study|Lost to Follow-up|0|||
24934989|NCT00510510|50028135|FG002|Overall Study|Lost to Follow-up|1|||
24934990|NCT00510510|50028133|FG000|Overall Study|Protocol Violation|0|||
24934991|NCT00510510|50028134|FG001|Overall Study|Protocol Violation|3|||
25027392|NCT02980874|50125562|FG000|Overall Study|Adverse Event|2|||
25027393|NCT02980874|50125563|FG001|Overall Study|Adverse Event|7|||
25156208|NCT01525641|50272183|FG000|Overall Study|Other than stated above|7|||
25156209|NCT01496469|50272198|FG000|Overall Study|Adverse Event|1|||
25156210|NCT01496469|50272199|FG001|Overall Study|Adverse Event|0|||
25156211|NCT01496469|50272198|FG000|Overall Study|Protocol Violation|2|||
25156212|NCT01496469|50272199|FG001|Overall Study|Protocol Violation|0|||
25156213|NCT01496469|50272198|FG000|Overall Study|Lost to Follow-up|1|||
24934992|NCT00510510|50028135|FG002|Overall Study|Protocol Violation|4|||
24934993|NCT00617591|50028143|FG000|Overall Study|Withdrew consent during Induction|4|||
24934994|NCT00617591|50028143|FG000|Overall Study|Withdrew consent during Maintenance|6|||
24934995|NCT00510276|50028150|FG000|Acute Double-Blind Phase|Adverse Event|21|||
24934996|NCT00510276|50028151|FG001|Acute Double-Blind Phase|Adverse Event|6|||
25027394|NCT02980874|50125562|FG000|Overall Study|Withdrawal by Subject|7|||
25027395|NCT02980874|50125563|FG001|Overall Study|Withdrawal by Subject|2|||
25027396|NCT02980874|50125562|FG000|Overall Study|Lost to Follow-up|5|||
25027397|NCT02980874|50125563|FG001|Overall Study|Lost to Follow-up|5|||
25027398|NCT02980874|50125562|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
25027399|NCT02980874|50125563|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
25027400|NCT02980874|50125562|FG000|Overall Study|Unknown study completion status|1|||
25027401|NCT02980874|50125563|FG001|Overall Study|Unknown study completion status|0|||
25027402|NCT01066052|50125571|FG000|Overall Study|Enrolled But Not Treated|3|||
25027403|NCT01066052|50125572|FG001|Overall Study|Enrolled But Not Treated|0|||
25027404|NCT03077646|50125580|FG000|Overall Study|Lost to Follow-up|29|||
25027405|NCT03077646|50125581|FG001|Overall Study|Lost to Follow-up|30|||
25156214|NCT01496469|50272199|FG001|Overall Study|Lost to Follow-up|1|||
25156215|NCT01496469|50272198|FG000|Overall Study|Withdrawal by Subject|4|||
24934997|NCT00510276|50028150|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
25027406|NCT03077646|50125582|FG002|Overall Study|Lost to Follow-up|31|||
25027407|NCT02892149|50125592|FG000|Overall Study|Death|262|||
25027408|NCT02892149|50125593|FG001|Overall Study|Death|278|||
25027409|NCT02892149|50125592|FG000|Overall Study|Withdrawal by Subject|53|||
25027410|NCT02892149|50125593|FG001|Overall Study|Withdrawal by Subject|47|||
25027411|NCT02892149|50125592|FG000|Overall Study|Lost to Follow-up|37|||
25027412|NCT02892149|50125593|FG001|Overall Study|Lost to Follow-up|31|||
25027413|NCT04187092|50125601|FG000|Overall Study|Lost to Follow-up|1|||
25027414|NCT04187092|50125602|FG001|Overall Study|Lost to Follow-up|1|||
25027415|NCT04187092|50125601|FG000|Overall Study|Withdrawal by Subject|1|||
25027416|NCT04187092|50125602|FG001|Overall Study|Withdrawal by Subject|1|||
25027417|NCT04187092|50125601|FG000|Overall Study|Adverse Event|0|||
25027418|NCT04187092|50125602|FG001|Overall Study|Adverse Event|1|||
24934998|NCT00510276|50028151|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
25027419|NCT02896127|50125610|FG000|COMPLETED WEEK 52|Adverse Event|9|||
25027420|NCT02896127|50125611|FG001|COMPLETED WEEK 52|Adverse Event|2|||
25027421|NCT02896127|50125610|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
25027422|NCT02896127|50125611|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
25027423|NCT02896127|50125610|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
25027424|NCT02896127|50125611|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
25027425|NCT02896127|50125610|FG000|COMPLETED WEEK 52|Physician Decision|1|||
25027426|NCT02896127|50125611|FG001|COMPLETED WEEK 52|Physician Decision|1|||
25027427|NCT02896127|50125610|FG000|COMPLETED WEEK 52|Pregnancy|2|||
25027428|NCT02896127|50125611|FG001|COMPLETED WEEK 52|Pregnancy|0|||
25027429|NCT02896127|50125610|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
25027430|NCT02896127|50125611|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
24934999|NCT00510276|50028150|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
25027431|NCT02896127|50125610|FG000|COMPLETED WEEK 52|Technical problems|1|||
25027432|NCT02896127|50125611|FG001|COMPLETED WEEK 52|Technical problems|0|||
24935000|NCT00510276|50028151|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
24935001|NCT00510276|50028150|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
24935002|NCT00510276|50028151|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
24935003|NCT00510276|50028150|FG000|Acute Double-Blind Phase|Physician Decision|0|||
24935004|NCT00510276|50028151|FG001|Acute Double-Blind Phase|Physician Decision|3|||
24935005|NCT00510276|50028150|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
24935006|NCT00510276|50028151|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
24935007|NCT00510276|50028150|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
24935008|NCT00510276|50028151|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
25027433|NCT02896127|50125610|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
25027434|NCT02896127|50125611|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
25027435|NCT02896127|50125610|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
25027436|NCT02896127|50125611|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
25027437|NCT02896127|50125610|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
25027438|NCT02896127|50125611|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
25027439|NCT02896127|50125610|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
25027440|NCT02896127|50125611|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
25027441|NCT02896127|50125610|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
25027442|NCT02896127|50125611|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
25027443|NCT03546647|50125617|FG000|Overall Study|Adverse Event|1|||
24935009|NCT00510276|50028150|FG000|Acute Double-Blind Phase|Subject Decision|26|||
24935010|NCT00510276|50028151|FG001|Acute Double-Blind Phase|Subject Decision|28|||
24935011|NCT00510276|50028150|FG000|Extension Open-Label Phase|Adverse Event|9|||
24935012|NCT00510276|50028151|FG001|Extension Open-Label Phase|Adverse Event|18|||
24935013|NCT00510276|50028150|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
24935014|NCT00510276|50028151|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
24935015|NCT00510276|50028150|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
24935016|NCT00510276|50028151|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
25185725|NCT00081289|50335261|FG000|Overall Study|Ineligible / no protocol treatment|3|||
25185726|NCT00081289|50335262|FG001|Overall Study|Ineligible / no protocol treatment|4|||
25185727|NCT01478594|50335271|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
25185728|NCT01478594|50335272|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
25185729|NCT01478594|50335271|FG000|Overall Study|Death|45|||
25185730|NCT01478594|50335272|FG001|Overall Study|Death|18|||
25185731|NCT01478594|50335271|FG000|Overall Study|Lost to Follow-up|3|||
25185732|NCT01478594|50335272|FG001|Overall Study|Lost to Follow-up|1|||
25185733|NCT01478594|50335271|FG000|Overall Study|Withdrawal by Subject|9|||
25027444|NCT03546647|50125618|FG001|Overall Study|Adverse Event|0|||
25185734|NCT01478594|50335272|FG001|Overall Study|Withdrawal by Subject|3|||
25185735|NCT01478594|50335271|FG000|Overall Study|Study Closed by Sponsor|8|||
25185736|NCT01478594|50335272|FG001|Overall Study|Study Closed by Sponsor|5|||
25156216|NCT01496469|50272199|FG001|Overall Study|Withdrawal by Subject|4|||
25156217|NCT01496469|50272198|FG000|Overall Study|BP exceeds protocol limits|1|||
25156218|NCT01496469|50272199|FG001|Overall Study|BP exceeds protocol limits|2|||
25156219|NCT01496469|50272198|FG000|Overall Study|Other|1|||
25185737|NCT01424813|50335333|FG000|Overall Study|Withdrawal by Subject|3|||
25185738|NCT01424813|50335334|FG001|Overall Study|Withdrawal by Subject|0|||
25185739|NCT01424813|50335333|FG000|Overall Study|Protocol Violation|1|||
25185740|NCT01424813|50335334|FG001|Overall Study|Protocol Violation|0|||
25185741|NCT01424813|50335333|FG000|Overall Study|Other|1|||
25185742|NCT01424813|50335334|FG001|Overall Study|Other|2|||
25185743|NCT00080899|50335340|FG000|Overall Study|Adverse Event|1|||
25185744|NCT00089635|50335344|FG000|Overall Study|Adverse Event|2|||
25185745|NCT00089635|50335344|FG000|Overall Study|Death|17|||
25185746|NCT00089635|50335344|FG000|Overall Study|Disease Progression|12|||
25185747|NCT00089635|50335344|FG000|Overall Study|Lost to Follow-up|3|||
25185748|NCT00089635|50335344|FG000|Overall Study|Withdrawal by Subject|6|||
25185749|NCT00089635|50335344|FG000|Overall Study|Ineligibility determined|1|||
25185750|NCT00089635|50335344|FG000|Overall Study|Other|2|||
25185751|NCT01500200|50335358|FG000|Stage 1|Adverse Event|1|||
25185752|NCT01500200|50335359|FG001|Stage 1|Adverse Event|4|||
25185753|NCT01500200|50335360|FG002|Stage 1|Adverse Event|5|||
25185754|NCT01500200|50335361|FG003|Stage 1|Adverse Event|0|||
25185755|NCT01500200|50335362|FG004|Stage 1|Adverse Event|0|||
25185756|NCT01500200|50335363|FG005|Stage 1|Adverse Event|0|||
25185757|NCT01500200|50335358|FG000|Stage 1|Lost to Follow-up|2|||
25185758|NCT01500200|50335359|FG001|Stage 1|Lost to Follow-up|2|||
25185759|NCT01500200|50335360|FG002|Stage 1|Lost to Follow-up|1|||
25185760|NCT01500200|50335361|FG003|Stage 1|Lost to Follow-up|0|||
25185761|NCT01500200|50335362|FG004|Stage 1|Lost to Follow-up|0|||
25185762|NCT01500200|50335363|FG005|Stage 1|Lost to Follow-up|0|||
25185763|NCT01500200|50335358|FG000|Stage 1|Withdrawal by Subject|3|||
25185764|NCT01500200|50335359|FG001|Stage 1|Withdrawal by Subject|0|||
25185765|NCT01500200|50335360|FG002|Stage 1|Withdrawal by Subject|0|||
25185766|NCT01500200|50335361|FG003|Stage 1|Withdrawal by Subject|0|||
25185767|NCT01500200|50335362|FG004|Stage 1|Withdrawal by Subject|0|||
25185768|NCT01500200|50335363|FG005|Stage 1|Withdrawal by Subject|0|||
25185769|NCT01500200|50335358|FG000|Stage 1|Noncompliance with Study Drug|1|||
25185770|NCT01500200|50335359|FG001|Stage 1|Noncompliance with Study Drug|0|||
25185771|NCT01500200|50335360|FG002|Stage 1|Noncompliance with Study Drug|0|||
25156220|NCT01496469|50272199|FG001|Overall Study|Other|1|||
25156221|NCT01471353|50272214|FG000|Overall Study|remain on study|3|||
25156222|NCT01525407|50272220|FG000|Overall Study|Change in recipient treatment plan|2|||
25156223|NCT01525407|50272221|FG001|Overall Study|Change in recipient treatment plan|2|||
25156224|NCT01525407|50272220|FG000|Overall Study|Withdrawal by Subject|0|||
25156225|NCT01525407|50272221|FG001|Overall Study|Withdrawal by Subject|1|||
25156226|NCT01525407|50272220|FG000|Overall Study|Transplant was delayed|0|||
25156227|NCT01525407|50272221|FG001|Overall Study|Transplant was delayed|1|||
25156228|NCT01525407|50272220|FG000|Overall Study|Delay in Transplant|1|||
25156229|NCT01525407|50272221|FG001|Overall Study|Delay in Transplant|0|||
25156230|NCT01471197|50272229|FG000|Overall Study|Disease Progression|4|||
25156231|NCT01471197|50272230|FG001|Overall Study|Disease Progression|2|||
25156232|NCT01471197|50272229|FG000|Overall Study|Death|1|||
25156233|NCT01471197|50272230|FG001|Overall Study|Death|0|||
25156234|NCT01471197|50272229|FG000|Overall Study|Study Drug Toxicity|1|||
25156235|NCT01471197|50272230|FG001|Overall Study|Study Drug Toxicity|0|||
25156236|NCT01524783|50272264|FG000|Blinded Period|Adverse Event|64|||
25185772|NCT01500200|50335361|FG003|Stage 1|Noncompliance with Study Drug|0|||
25185773|NCT01500200|50335362|FG004|Stage 1|Noncompliance with Study Drug|0|||
25185774|NCT01500200|50335363|FG005|Stage 1|Noncompliance with Study Drug|0|||
25185775|NCT01500200|50335358|FG000|Stage 1|Physician Decision|1|||
25185776|NCT01500200|50335359|FG001|Stage 1|Physician Decision|0|||
25156237|NCT01524783|50272265|FG001|Blinded Period|Adverse Event|7|||
25185777|NCT01500200|50335360|FG002|Stage 1|Physician Decision|0|||
25185778|NCT01500200|50335361|FG003|Stage 1|Physician Decision|0|||
25185779|NCT01500200|50335362|FG004|Stage 1|Physician Decision|0|||
25185780|NCT01500200|50335363|FG005|Stage 1|Physician Decision|0|||
25185781|NCT01500200|50335358|FG000|Stage 2|Adverse Event|0|||
25156238|NCT01524783|50272266|FG002|Blinded Period|Adverse Event|0|||
25156239|NCT01524783|50272264|FG000|Blinded Period|Disease Progression|89|||
25185782|NCT01500200|50335359|FG001|Stage 2|Adverse Event|0|||
25156240|NCT01524783|50272265|FG001|Blinded Period|Disease Progression|75|||
25156241|NCT01524783|50272266|FG002|Blinded Period|Disease Progression|0|||
25185783|NCT01500200|50335360|FG002|Stage 2|Adverse Event|0|||
25185784|NCT01500200|50335361|FG003|Stage 2|Adverse Event|0|||
25185785|NCT01500200|50335362|FG004|Stage 2|Adverse Event|5|||
25185786|NCT01500200|50335363|FG005|Stage 2|Adverse Event|4|||
25185787|NCT01478360|50335379|FG000|Overall Study|Lost to Follow-up|1|||
25185788|NCT01478360|50335380|FG001|Overall Study|Lost to Follow-up|0|||
25185789|NCT01478360|50335379|FG000|Overall Study|Adverse Event|0|||
25156242|NCT01524783|50272264|FG000|Blinded Period|Withdrawal by Subject|19|||
25156243|NCT01524783|50272265|FG001|Blinded Period|Withdrawal by Subject|6|||
25156244|NCT01524783|50272266|FG002|Blinded Period|Withdrawal by Subject|0|||
25156245|NCT01524783|50272264|FG000|Blinded Period|Protocol deviation|2|||
25156246|NCT01524783|50272265|FG001|Blinded Period|Protocol deviation|1|||
25156247|NCT01524783|50272266|FG002|Blinded Period|Protocol deviation|0|||
25156248|NCT01524783|50272264|FG000|Blinded Period|Death|5|||
25156249|NCT01524783|50272265|FG001|Blinded Period|Death|2|||
25156250|NCT01524783|50272266|FG002|Blinded Period|Death|0|||
25156251|NCT01524783|50272264|FG000|Open-label Period|Disease progression|13|||
25156252|NCT01524783|50272265|FG001|Open-label Period|Disease progression|0|||
25156253|NCT01524783|50272266|FG002|Open-label Period|Disease progression|2|||
25156254|NCT01524783|50272264|FG000|Open-label Period|Administrative problems|5|||
25156255|NCT01524783|50272265|FG001|Open-label Period|Administrative problems|0|||
25156256|NCT01524783|50272266|FG002|Open-label Period|Administrative problems|2|||
25156257|NCT01524783|50272264|FG000|Open-label Period|Adverse Event|5|||
25156258|NCT01524783|50272265|FG001|Open-label Period|Adverse Event|0|||
25156259|NCT01524783|50272266|FG002|Open-label Period|Adverse Event|1|||
25156260|NCT01524783|50272264|FG000|Open-label Period|Withdrawal by Subject|2|||
25156261|NCT01524783|50272265|FG001|Open-label Period|Withdrawal by Subject|0|||
25156262|NCT01524783|50272266|FG002|Open-label Period|Withdrawal by Subject|1|||
25156263|NCT01524783|50272264|FG000|Open-label Period|Protocol deviation|1|||
25156264|NCT01524783|50272265|FG001|Open-label Period|Protocol deviation|0|||
25156265|NCT01524783|50272266|FG002|Open-label Period|Protocol deviation|0|||
25156266|NCT01494987|50272280|FG000|Overall Study|Adverse Event|6|||
25185790|NCT01478360|50335380|FG001|Overall Study|Adverse Event|1|||
25156267|NCT01494987|50272281|FG001|Overall Study|Adverse Event|5|||
25156268|NCT01494987|50272280|FG000|Overall Study|Hyperglycemia|6|||
25156269|NCT01494987|50272281|FG001|Overall Study|Hyperglycemia|4|||
25156270|NCT01494987|50272280|FG000|Overall Study|Investigator's Discretion|1|||
25156271|NCT01494987|50272281|FG001|Overall Study|Investigator's Discretion|2|||
25156272|NCT01494987|50272280|FG000|Overall Study|Lost to Follow-up|1|||
25156273|NCT01494987|50272281|FG001|Overall Study|Lost to Follow-up|1|||
25156274|NCT01494987|50272280|FG000|Overall Study|Protocol Violation|3|||
25156275|NCT01494987|50272281|FG001|Overall Study|Protocol Violation|3|||
25156276|NCT01494987|50272280|FG000|Overall Study|Subject Non-Compliance|9|||
25156277|NCT01494987|50272281|FG001|Overall Study|Subject Non-Compliance|10|||
25156278|NCT01494987|50272280|FG000|Overall Study|Subject Withdrew Consent|2|||
25156279|NCT01494987|50272281|FG001|Overall Study|Subject Withdrew Consent|3|||
25156280|NCT01470417|50272289|FG000|Overall Study|Disease progression|0|||
25156281|NCT01470417|50272290|FG001|Overall Study|Disease progression|2|||
25185791|NCT01478360|50335379|FG000|Overall Study|Administrative problems|1|||
25185792|NCT01478360|50335380|FG001|Overall Study|Administrative problems|2|||
25185793|NCT01461980|50335398|FG000|Overall Study|Other|9|||
25185794|NCT01461980|50335399|FG001|Overall Study|Other|8|||
25185795|NCT01461980|50335400|FG002|Overall Study|Other|6|||
25185796|NCT01461980|50335398|FG000|Overall Study|Medication error|7|||
25185797|NCT01461980|50335399|FG001|Overall Study|Medication error|5|||
25027445|NCT03077412|50125627|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
25027446|NCT03077412|50125628|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
25185798|NCT01461980|50335400|FG002|Overall Study|Medication error|6|||
25185799|NCT01461980|50335398|FG000|Overall Study|Adverse Event|12|||
25185800|NCT01461980|50335399|FG001|Overall Study|Adverse Event|5|||
25156282|NCT01524627|50272298|FG000|Overall Study|Physician Decision|0|||
25156283|NCT01524627|50272299|FG001|Overall Study|Physician Decision|1|||
25156284|NCT01524627|50272298|FG000|Overall Study|Lost to Follow-up|1|||
25156285|NCT01524627|50272299|FG001|Overall Study|Lost to Follow-up|1|||
25156286|NCT01469637|50272307|FG000|First Intervention|Unacceptable behavior|0|||
25156287|NCT01469637|50272308|FG001|First Intervention|Unacceptable behavior|1|||
25156288|NCT01469637|50272307|FG000|Second Intervention|Incarcerated|1|||
25185801|NCT01461980|50335400|FG002|Overall Study|Adverse Event|6|||
25185802|NCT01461980|50335398|FG000|Overall Study|Protocol Violation|12|||
25185803|NCT01461980|50335399|FG001|Overall Study|Protocol Violation|19|||
25185804|NCT01461980|50335400|FG002|Overall Study|Protocol Violation|16|||
24935017|NCT00510276|50028150|FG000|Extension Open-Label Phase|Physician Decision|2|||
25185805|NCT01461980|50335398|FG000|Overall Study|No longer meets eligibility criteria|18|||
25185806|NCT01461980|50335399|FG001|Overall Study|No longer meets eligibility criteria|9|||
25185807|NCT01461980|50335400|FG002|Overall Study|No longer meets eligibility criteria|19|||
25185808|NCT01461980|50335398|FG000|Overall Study|Lost to Follow-up|52|||
25185809|NCT01461980|50335399|FG001|Overall Study|Lost to Follow-up|53|||
25185810|NCT01461980|50335400|FG002|Overall Study|Lost to Follow-up|51|||
25185811|NCT01461980|50335398|FG000|Overall Study|No longer willing to participate|52|||
25185812|NCT01461980|50335399|FG001|Overall Study|No longer willing to participate|38|||
25185813|NCT01461980|50335400|FG002|Overall Study|No longer willing to participate|54|||
25185814|NCT01461980|50335398|FG000|Overall Study|Randomized but not vaccinated|4|||
25185815|NCT01461980|50335399|FG001|Overall Study|Randomized but not vaccinated|8|||
25185816|NCT01461980|50335400|FG002|Overall Study|Randomized but not vaccinated|7|||
25185817|NCT01424501|50335415|FG000|Overall Study|Withdrawal by Subject|1|||
25185818|NCT01424501|50335416|FG001|Overall Study|Withdrawal by Subject|0|||
25185819|NCT01424501|50335417|FG002|Overall Study|Withdrawal by Subject|1|||
25185820|NCT01424501|50335418|FG003|Overall Study|Withdrawal by Subject|0|||
25027447|NCT03077412|50125629|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
25027448|NCT03077412|50125627|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
25027449|NCT03077412|50125628|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
25027450|NCT03077412|50125629|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
25027451|NCT03077412|50125627|FG000|Overall Study|Adverse Event|1|||
25027452|NCT03077412|50125628|FG001|Overall Study|Adverse Event|2|||
25027453|NCT03077412|50125629|FG002|Overall Study|Adverse Event|2|||
25027454|NCT03077412|50125627|FG000|Overall Study|Investigator's Discretion|0|||
25027455|NCT03077412|50125628|FG001|Overall Study|Investigator's Discretion|1|||
25027456|NCT03077412|50125629|FG002|Overall Study|Investigator's Discretion|1|||
25027457|NCT03077412|50125627|FG000|Overall Study|Withdrew Consent|0|||
25027458|NCT03077412|50125628|FG001|Overall Study|Withdrew Consent|2|||
25027459|NCT03077412|50125629|FG002|Overall Study|Withdrew Consent|0|||
25156289|NCT01469637|50272308|FG001|Second Intervention|Incarcerated|0|||
25156290|NCT04842747|50272728|FG000|Overall Study|Withdrawal by Subject|6|||
25156291|NCT04842747|50272729|FG001|Overall Study|Withdrawal by Subject|2|||
25156292|NCT04842747|50272728|FG000|Overall Study|Lost to Follow-up|1|||
25027460|NCT03544229|50125641|FG000|Overall Study|Adverse Event|1|||
25027461|NCT03544229|50125642|FG001|Overall Study|Adverse Event|0|||
25027462|NCT03544229|50125643|FG002|Overall Study|Adverse Event|1|||
25027463|NCT03544229|50125644|FG003|Overall Study|Adverse Event|0|||
25027464|NCT03544229|50125641|FG000|Overall Study|Protocol Deviation|0|||
25027465|NCT03544229|50125642|FG001|Overall Study|Protocol Deviation|0|||
25027466|NCT03544229|50125643|FG002|Overall Study|Protocol Deviation|1|||
25027467|NCT03544229|50125644|FG003|Overall Study|Protocol Deviation|0|||
25027468|NCT03544229|50125641|FG000|Overall Study|Lost to Follow-up|3|||
25027469|NCT03544229|50125642|FG001|Overall Study|Lost to Follow-up|0|||
25027470|NCT03544229|50125643|FG002|Overall Study|Lost to Follow-up|0|||
25027471|NCT03544229|50125644|FG003|Overall Study|Lost to Follow-up|2|||
25027472|NCT03544229|50125641|FG000|Overall Study|Voluntary Withdrawal|2|||
25027473|NCT03544229|50125642|FG001|Overall Study|Voluntary Withdrawal|1|||
25027474|NCT03544229|50125643|FG002|Overall Study|Voluntary Withdrawal|3|||
25027475|NCT03544229|50125644|FG003|Overall Study|Voluntary Withdrawal|0|||
25027476|NCT03544229|50125641|FG000|Overall Study|Lack of Efficacy|0|||
25027477|NCT03544229|50125642|FG001|Overall Study|Lack of Efficacy|1|||
25027478|NCT03544229|50125643|FG002|Overall Study|Lack of Efficacy|0|||
25027479|NCT03544229|50125644|FG003|Overall Study|Lack of Efficacy|0|||
25027480|NCT03078816|50125654|FG000|Overall Study|Withdrawal by Subject|1|||
25027481|NCT03510455|50125658|FG000|Overall Study|Physician Decision|1|||
25027482|NCT03509675|50125666|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
25027483|NCT03509675|50125667|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
25027484|NCT03509675|50125666|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
25027485|NCT03509675|50125667|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
25156293|NCT04842747|50272729|FG001|Overall Study|Lost to Follow-up|2|||
25156294|NCT04842747|50272728|FG000|Overall Study|Physician Decision|1|||
25156295|NCT04842747|50272729|FG001|Overall Study|Physician Decision|0|||
25156296|NCT04842747|50272728|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
25156297|NCT04842747|50272729|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
25156298|NCT04810481|50272737|FG000|Overall Study|Disqualified data sets|10|||
25156299|NCT04810481|50272738|FG001|Overall Study|Disqualified data sets|28|||
25156300|NCT04664400|50272757|FG000|Overall Study|Withdrawal by Subject|2|||
25156301|NCT04657770|50272762|FG000|Overall Study|Withdrawal by Subject|3|||
25156302|NCT04657770|50272762|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
25156303|NCT04496453|50272766|FG000|Overall Study|Lost to Follow-up|6|||
25027486|NCT03509675|50125666|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
25027487|NCT03509675|50125667|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
25027488|NCT03509675|50125666|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
25027489|NCT03509675|50125667|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
25027490|NCT03509207|50125673|FG000|Overall Study|Death|2|||
25027491|NCT03543137|50125677|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
25027492|NCT03543137|50125678|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
25027493|NCT03543137|50125677|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
25027494|NCT03543137|50125678|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
25027495|NCT03543137|50125677|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
25027496|NCT03543137|50125678|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
25027497|NCT02895347|50125688|FG000|Overall Study|Withdrawal by Subject|3|||
25027498|NCT02895347|50125689|FG001|Overall Study|Withdrawal by Subject|1|||
25027499|NCT03539549|50125696|FG000|Overall Study|Adverse Event|12|||
25027500|NCT03539549|50125696|FG000|Overall Study|Lost to Follow-up|1|||
25027501|NCT03539549|50125696|FG000|Overall Study|Death|2|||
25027502|NCT03539549|50125696|FG000|Overall Study|Progressive Disease|1|||
25027503|NCT03539549|50125696|FG000|Overall Study|Reason not Specified|1|||
25027504|NCT03506477|50125702|FG000|Overall Study|Withdrawal by Subject|1|||
25027505|NCT03506477|50125703|FG001|Overall Study|Withdrawal by Subject|0|||
25027506|NCT03073980|50125712|FG000|Overall Study|Lost to Follow-up|10|||
25027507|NCT03073980|50125713|FG001|Overall Study|Lost to Follow-up|2|||
25027508|NCT03073980|50125714|FG002|Overall Study|Lost to Follow-up|9|||
25027509|NCT03073980|50125712|FG000|Overall Study|No post-procedure data|0|||
25027510|NCT03073980|50125713|FG001|Overall Study|No post-procedure data|0|||
25027511|NCT03073980|50125714|FG002|Overall Study|No post-procedure data|2|||
25027512|NCT03930186|50125726|FG000|Weeks 0 to 16|Adverse Event|6|||
25027513|NCT03930186|50125726|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
25027514|NCT03930186|50125726|FG000|Weeks 16 to 32|Adverse Event|1|||
25027515|NCT03930186|50125726|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
25027516|NCT03504917|50125732|FG000|Blinded Treatment Period|Protocol Violation|1|||
25027517|NCT03504917|50125733|FG001|Blinded Treatment Period|Protocol Violation|0|||
25027518|NCT03504917|50125732|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
25027519|NCT03504917|50125733|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
25027520|NCT03504917|50125732|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
25027521|NCT03504917|50125733|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
25027522|NCT03504917|50125732|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
25027523|NCT03504917|50125733|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
25027524|NCT03504917|50125732|FG000|Blinded Treatment Period|Adverse Event|4|||
25027525|NCT03504917|50125733|FG001|Blinded Treatment Period|Adverse Event|4|||
25027526|NCT03504917|50125732|FG000|Blinded Treatment Period|Physician Decision|1|||
25027527|NCT03504917|50125733|FG001|Blinded Treatment Period|Physician Decision|0|||
25027528|NCT03504917|50125732|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
25027529|NCT03504917|50125733|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
25027530|NCT03504917|50125732|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
25027531|NCT03504917|50125733|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
25027532|NCT03504917|50125732|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
25027533|NCT03504917|50125733|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
25027534|NCT03504917|50125732|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
25027535|NCT03504917|50125733|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
25027536|NCT03504917|50125732|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
25027537|NCT03504917|50125733|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
25027538|NCT03504917|50125732|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
25027539|NCT03504917|50125733|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
25027540|NCT03504917|50125732|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
25027541|NCT03504917|50125733|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
25027542|NCT03504917|50125732|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
25027543|NCT03504917|50125733|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
25027544|NCT03504917|50125732|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
25027545|NCT03504917|50125733|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
25027546|NCT03504917|50125732|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
25027547|NCT03504917|50125733|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
25027548|NCT03536663|50125745|FG000|Endexo|Protocol Violation|1|||
25027549|NCT03565211|50125754|FG000|Overall Study|Withdrawal by Subject|2|||
25027550|NCT03565211|50125754|FG000|Overall Study|Lost to Follow-up|1|||
25027551|NCT03565211|50125754|FG000|Overall Study|Adverse Event|44|||
25027552|NCT03565211|50125754|FG000|Overall Study|Personal issues|1|||
25027553|NCT03740100|50125758|FG000|Overall Study|Adverse Event|1|||
25027554|NCT03740100|50125758|FG000|Overall Study|Death|1|||
25027555|NCT03531905|50125765|FG000|Overall Study|Withdrawal by Subject|3|||
25027556|NCT03531905|50125766|FG001|Overall Study|Withdrawal by Subject|3|||
25027557|NCT03531905|50125767|FG002|Overall Study|Withdrawal by Subject|2|||
25027558|NCT03531905|50125765|FG000|Overall Study|Lost to Follow-up|2|||
25027559|NCT03531905|50125766|FG001|Overall Study|Lost to Follow-up|2|||
25027560|NCT03531905|50125767|FG002|Overall Study|Lost to Follow-up|1|||
25185821|NCT01424501|50335419|FG004|Overall Study|Withdrawal by Subject|0|||
25185822|NCT01424501|50335420|FG005|Overall Study|Withdrawal by Subject|0|||
25027561|NCT03531905|50125765|FG000|Overall Study|Participant was out of town|1|||
25027562|NCT03531905|50125766|FG001|Overall Study|Participant was out of town|0|||
25027563|NCT03531905|50125767|FG002|Overall Study|Participant was out of town|0|||
25027564|NCT03531905|50125765|FG000|Overall Study|Could not speak with the participant|1|||
25027565|NCT03531905|50125766|FG001|Overall Study|Could not speak with the participant|0|||
25027566|NCT03531905|50125767|FG002|Overall Study|Could not speak with the participant|0|||
25027567|NCT03531827|50125777|FG000|Overall Study|Adverse Event|2|||
25027568|NCT03531827|50125778|FG001|Overall Study|Adverse Event|0|||
25027569|NCT03531827|50125777|FG000|Overall Study|Progressive disease|1|||
25027570|NCT03531827|50125778|FG001|Overall Study|Progressive disease|0|||
25027571|NCT03530345|50125807|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
25027572|NCT03530345|50125808|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
25027573|NCT03530345|50125807|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
25156304|NCT04482647|50272770|FG000|Overall Study|Time constraints|2|||
25156305|NCT04482647|50272770|FG000|Overall Study|Health issues|1|||
25185823|NCT01424501|50335415|FG000|Overall Study|Lost to Follow-up|0|||
25185824|NCT01424501|50335416|FG001|Overall Study|Lost to Follow-up|1|||
25185825|NCT01424501|50335417|FG002|Overall Study|Lost to Follow-up|1|||
25185826|NCT01424501|50335418|FG003|Overall Study|Lost to Follow-up|0|||
25185827|NCT01424501|50335419|FG004|Overall Study|Lost to Follow-up|0|||
25185828|NCT01424501|50335420|FG005|Overall Study|Lost to Follow-up|0|||
25185829|NCT01401959|50335501|FG000|Enrolled|Withdrawal by Subject|1|||
25185830|NCT01401959|50335502|FG001|Enrolled|Withdrawal by Subject|0|||
25185831|NCT01401959|50335503|FG002|Enrolled|Withdrawal by Subject|0|||
25185832|NCT01401959|50335501|FG000|Treated|Disease Progression|2|||
25185833|NCT01401959|50335502|FG001|Treated|Disease Progression|2|||
25185834|NCT01401959|50335503|FG002|Treated|Disease Progression|1|||
25185835|NCT01401959|50335501|FG000|Treated|Adverse Event|4|||
25185836|NCT01401959|50335502|FG001|Treated|Adverse Event|3|||
25185837|NCT01401959|50335503|FG002|Treated|Adverse Event|2|||
25185838|NCT01401959|50335501|FG000|Treated|Withdrawal by Subject|1|||
25185839|NCT01401959|50335502|FG001|Treated|Withdrawal by Subject|2|||
25185840|NCT01401959|50335503|FG002|Treated|Withdrawal by Subject|2|||
25185841|NCT01401959|50335501|FG000|Treated|Protocol Violation|0|||
25185842|NCT01401959|50335502|FG001|Treated|Protocol Violation|1|||
25185843|NCT01401959|50335503|FG002|Treated|Protocol Violation|0|||
25185844|NCT01478048|50335533|FG000|Overall Study|Disease Progression|52|||
25185845|NCT01478048|50335534|FG001|Overall Study|Disease Progression|35|||
25185846|NCT01478048|50335533|FG000|Overall Study|study drug toxicity|11|||
25185847|NCT01478048|50335534|FG001|Overall Study|study drug toxicity|14|||
25185848|NCT01478048|50335533|FG000|Overall Study|Adverse Event|2|||
25185849|NCT01478048|50335534|FG001|Overall Study|Adverse Event|11|||
25185850|NCT01478048|50335533|FG000|Overall Study|subject request to discontinue treatment|3|||
25185851|NCT01478048|50335534|FG001|Overall Study|subject request to discontinue treatment|5|||
25185852|NCT01478048|50335533|FG000|Overall Study|Withdrawal by Subject|2|||
25185853|NCT01478048|50335534|FG001|Overall Study|Withdrawal by Subject|5|||
25185854|NCT01478048|50335533|FG000|Overall Study|non-specified|6|||
25185855|NCT01478048|50335534|FG001|Overall Study|non-specified|4|||
25185856|NCT01478048|50335533|FG000|Overall Study|poor/non-compliance|0|||
25185857|NCT01478048|50335534|FG001|Overall Study|poor/non-compliance|1|||
25185858|NCT01478048|50335533|FG000|Overall Study|no longer meets study criteria|1|||
25185859|NCT01478048|50335534|FG001|Overall Study|no longer meets study criteria|0|||
25185860|NCT01424189|50335542|FG000|Overall Study|Adverse Event|1|||
25185861|NCT01424189|50335543|FG001|Overall Study|Adverse Event|0|||
25185862|NCT01424189|50335542|FG000|Overall Study|Lost to Follow-up|4|||
25185863|NCT01424189|50335543|FG001|Overall Study|Lost to Follow-up|1|||
25185864|NCT01424189|50335542|FG000|Overall Study|Withdrawal by Subject|4|||
25185865|NCT01424189|50335543|FG001|Overall Study|Withdrawal by Subject|4|||
25185866|NCT01424189|50335542|FG000|Overall Study|Subject moved|1|||
25185867|NCT01424189|50335543|FG001|Overall Study|Subject moved|0|||
25185868|NCT01424189|50335542|FG000|Overall Study|Death|3|||
25185869|NCT01424189|50335543|FG001|Overall Study|Death|1|||
25185870|NCT01401647|50335556|FG000|Overall Study|Withdrawal by Subject|1|||
25185871|NCT01401647|50335557|FG001|Overall Study|Withdrawal by Subject|5|||
25185872|NCT01401647|50335558|FG002|Overall Study|Withdrawal by Subject|2|||
25185873|NCT01401647|50335556|FG000|Overall Study|Lost to Follow-up|3|||
25185874|NCT01401647|50335557|FG001|Overall Study|Lost to Follow-up|3|||
25185875|NCT01401647|50335558|FG002|Overall Study|Lost to Follow-up|1|||
25156306|NCT04482647|50272770|FG000|Overall Study|Death in the family|1|||
25156307|NCT04482647|50272770|FG000|Overall Study|Disliked the intervention|1|||
25156308|NCT04482647|50272770|FG000|Overall Study|No reasons specified|7|||
25156309|NCT04440163|50272782|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
25156310|NCT04440163|50272783|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
25156311|NCT04440163|50272784|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
25156312|NCT04440163|50272785|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
25027574|NCT03530345|50125808|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
25027575|NCT03530345|50125807|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
25185876|NCT01499810|50335566|FG000|Overall Study|Lost to Follow-up|10|||
25185877|NCT01499810|50335566|FG000|Overall Study|Protocol Violation|1|||
25185878|NCT01499810|50335566|FG000|Overall Study|Withdrawal by Subject|1|||
25185879|NCT01423253|50335571|FG000|Overall Study|Adverse Event|2|||
25185880|NCT01423253|50335571|FG000|Overall Study|Lack of Efficacy|2|||
25185881|NCT01423253|50335571|FG000|Overall Study|Lost to Follow-up|1|||
25185882|NCT01423253|50335571|FG000|Overall Study|Protocol Violation|2|||
25185883|NCT01423253|50335571|FG000|Overall Study|Withdrawal by Subject|2|||
25185884|NCT01477892|50335577|FG000|Overall Study|Withdrawal by Subject|0|||
25185885|NCT01477892|50335578|FG001|Overall Study|Withdrawal by Subject|2|||
25185886|NCT01422239|50335591|FG000|Overall Study|Lost to Follow-up|4|||
25185887|NCT01422239|50335592|FG001|Overall Study|Lost to Follow-up|3|||
25185888|NCT01499576|50335598|FG000|Overall Study|Physician Decision|12|||
25185889|NCT01499576|50335598|FG000|Overall Study|Withdrawal by Subject|9|||
25185890|NCT01476722|50335612|FG000|Overall Study|Adverse Event|1|||
25185891|NCT01476644|50335625|FG000|Overall Study|Death|5|||
25185892|NCT01476644|50335625|FG000|Overall Study|moved to another state|2|||
25185893|NCT01476644|50335625|FG000|Overall Study|Lost to Follow-up|19|||
25185894|NCT01476644|50335625|FG000|Overall Study|Withdrawal by Subject|13|||
25027576|NCT03530345|50125808|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
25027577|NCT03530345|50125807|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
25027578|NCT03530345|50125808|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
25027579|NCT03500159|50125822|FG000|Overall Study|Study Terminated|2|||
25027580|NCT03500159|50125823|FG001|Overall Study|Study Terminated|1|||
25027581|NCT03785340|50125831|FG000|Overall Study|Lost to Follow-up|2|||
25027582|NCT03785340|50125832|FG001|Overall Study|Lost to Follow-up|0|||
25027583|NCT03785340|50125831|FG000|Overall Study|Adverse Event|1|||
25027584|NCT03785340|50125832|FG001|Overall Study|Adverse Event|0|||
25027585|NCT03499067|50125838|FG000|First Intervention|Physician Decision|2|||
25027586|NCT03499067|50125839|FG001|First Intervention|Physician Decision|1|||
25027587|NCT03499067|50125838|FG000|First Intervention|Withdrawal by Subject|3|||
25027588|NCT03499067|50125839|FG001|First Intervention|Withdrawal by Subject|6|||
25027589|NCT03562481|50125847|FG000|First Intervention|Lost to Follow-up|1|||
25027590|NCT03562481|50125848|FG001|First Intervention|Lost to Follow-up|0|||
25027591|NCT03529409|50125874|FG000|Randomized|Lost to Follow-up|0|||
25027592|NCT03529409|50125875|FG001|Randomized|Lost to Follow-up|0|||
25027593|NCT03529409|50125876|FG002|Randomized|Lost to Follow-up|4|||
25027594|NCT03529409|50125874|FG000|Randomized|Excluded|0|||
25027595|NCT03529409|50125875|FG001|Randomized|Excluded|0|||
25027596|NCT03529409|50125876|FG002|Randomized|Excluded|1|||
25027597|NCT03529409|50125874|FG000|Post-treatment Assessment|Death|1|||
25027598|NCT03529409|50125875|FG001|Post-treatment Assessment|Death|0|||
25027599|NCT03529409|50125876|FG002|Post-treatment Assessment|Death|0|||
25156313|NCT04440163|50272786|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
25156314|NCT04440163|50272787|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
25156315|NCT04440163|50272788|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
25156316|NCT04440163|50272789|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
25156317|NCT04440163|50272782|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
25156318|NCT04440163|50272783|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
25156319|NCT04440163|50272784|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
25156320|NCT04440163|50272785|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
25156321|NCT04440163|50272786|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
25156322|NCT04440163|50272787|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
25156323|NCT04440163|50272788|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
25156324|NCT04440163|50272789|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
25156325|NCT04440163|50272782|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
25156326|NCT04440163|50272783|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
25156327|NCT04440163|50272784|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
25156328|NCT04440163|50272785|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
25156329|NCT04440163|50272786|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
25156330|NCT04440163|50272787|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
25156331|NCT04440163|50272788|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
25156332|NCT04440163|50272789|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
25156333|NCT04440163|50272782|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
25185895|NCT01421459|50335649|FG000|Overall Study|Adverse Event|6|||
25185896|NCT01421459|50335650|FG001|Overall Study|Adverse Event|10|||
25027600|NCT03529409|50125874|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
25027601|NCT03529409|50125875|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
25027602|NCT03529409|50125876|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
25027603|NCT03529409|50125874|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
25027604|NCT03529409|50125875|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
25027605|NCT03529409|50125876|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
25027606|NCT03529409|50125874|FG000|Follow-up Assessment|Death|1|||
25027607|NCT03529409|50125875|FG001|Follow-up Assessment|Death|0|||
25156334|NCT04440163|50272783|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
25156335|NCT04440163|50272784|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
25156336|NCT04440163|50272785|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
25156337|NCT04440163|50272786|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
25156338|NCT04440163|50272787|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
25156339|NCT04440163|50272788|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
25156340|NCT04440163|50272789|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
25156341|NCT04440163|50272782|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
25156342|NCT04440163|50272783|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
25156343|NCT04440163|50272784|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
25156344|NCT04440163|50272785|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
25156345|NCT04440163|50272786|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
25156346|NCT04440163|50272787|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
25156347|NCT04440163|50272788|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
25156348|NCT04440163|50272789|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
25156349|NCT04440163|50272782|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
25027608|NCT03529409|50125876|FG002|Follow-up Assessment|Death|0|||
25027609|NCT03529409|50125874|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
25027610|NCT03529409|50125875|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
25156350|NCT04440163|50272783|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
25185897|NCT01421459|50335649|FG000|Overall Study|Death|1|||
25185898|NCT01421459|50335650|FG001|Overall Study|Death|1|||
25185899|NCT01421459|50335649|FG000|Overall Study|Lack of Efficacy|1|||
25185900|NCT01421459|50335650|FG001|Overall Study|Lack of Efficacy|2|||
25185901|NCT01421459|50335649|FG000|Overall Study|Lost to Follow-up|8|||
25185902|NCT01421459|50335650|FG001|Overall Study|Lost to Follow-up|9|||
25185903|NCT01421459|50335649|FG000|Overall Study|Physician Decision|9|||
25185904|NCT01421459|50335650|FG001|Overall Study|Physician Decision|9|||
25185905|NCT01421459|50335649|FG000|Overall Study|Protocol Violation|8|||
25185906|NCT01421459|50335650|FG001|Overall Study|Protocol Violation|5|||
25185907|NCT01421459|50335649|FG000|Overall Study|Withdrawal by Subject|12|||
25185908|NCT01421459|50335650|FG001|Overall Study|Withdrawal by Subject|16|||
25185909|NCT01498952|50335658|FG000|Overall Study|Death|2|||
25185910|NCT01498952|50335659|FG001|Overall Study|Death|2|||
25185911|NCT01498952|50335660|FG002|Overall Study|Death|0|||
25185912|NCT01498952|50335661|FG003|Overall Study|Death|0|||
25185913|NCT01498952|50335662|FG004|Overall Study|Death|0|||
25185914|NCT01461044|50335694|FG000|Overall Study|Death|58|||
25156351|NCT04440163|50272784|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
25156352|NCT04440163|50272785|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
25185915|NCT01461044|50335695|FG001|Overall Study|Death|35|||
25185916|NCT01461044|50335694|FG000|Overall Study|Lost to Follow-up|12|||
25185917|NCT01461044|50335695|FG001|Overall Study|Lost to Follow-up|5|||
25185918|NCT01421303|50335728|FG000|Overall Study|Lost to Follow-up|13|||
25185919|NCT01421303|50335728|FG000|Overall Study|Non compliance with study procedure|1|||
25185920|NCT01421303|50335728|FG000|Overall Study|Other|7|||
25185921|NCT01421303|50335728|FG000|Overall Study|Withdrawal by Subject|1|||
25185922|NCT01475474|50335732|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
25185923|NCT01475474|50335732|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
25185924|NCT01400243|50335739|FG000|Overall Study|Protocol Violation|8|||
25185925|NCT01400243|50335740|FG001|Overall Study|Protocol Violation|11|||
25185926|NCT01475162|50335757|FG000|Overall Study|Physician Decision|1|||
25185927|NCT01475162|50335757|FG000|Overall Study|Death|10|||
25185928|NCT01475162|50335757|FG000|Overall Study|Study closed for safety|3|||
25185929|NCT01421225|50335764|FG000|Overall Study|Withdrawal by Subject|0|||
25185930|NCT01421225|50335765|FG001|Overall Study|Withdrawal by Subject|1|||
25185931|NCT01498640|50335781|FG000|Overall Study|Lost to Follow-up|1|||
25185932|NCT01498640|50335781|FG000|Overall Study|Death|1|||
25185933|NCT01498640|50335781|FG000|Overall Study|Other|3|||
25185934|NCT01498484|50335793|FG000|Overall Study|Death|6|||
25185935|NCT01498484|50335794|FG001|Overall Study|Death|3|||
25185936|NCT01498484|50335795|FG002|Overall Study|Death|1|||
25185937|NCT01498484|50335796|FG003|Overall Study|Death|1|||
25185938|NCT01498484|50335797|FG004|Overall Study|Death|0|||
25185939|NCT01498484|50335798|FG005|Overall Study|Death|0|||
25185940|NCT01498484|50335799|FG006|Overall Study|Death|10|||
25185941|NCT01498484|50335800|FG007|Overall Study|Death|1|||
25185942|NCT01498484|50335801|FG008|Overall Study|Death|0|||
25185943|NCT01498484|50335793|FG000|Overall Study|Physician Decision|3|||
25185944|NCT01498484|50335794|FG001|Overall Study|Physician Decision|2|||
25185945|NCT01498484|50335795|FG002|Overall Study|Physician Decision|1|||
25185946|NCT01498484|50335796|FG003|Overall Study|Physician Decision|1|||
25027611|NCT03529409|50125876|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
25185947|NCT01498484|50335797|FG004|Overall Study|Physician Decision|0|||
25185948|NCT01498484|50335798|FG005|Overall Study|Physician Decision|0|||
25185949|NCT01498484|50335799|FG006|Overall Study|Physician Decision|8|||
25185950|NCT01498484|50335800|FG007|Overall Study|Physician Decision|13|||
25185951|NCT01498484|50335801|FG008|Overall Study|Physician Decision|1|||
25185952|NCT01498484|50335793|FG000|Overall Study|Adverse Event|0|||
25185953|NCT01498484|50335794|FG001|Overall Study|Adverse Event|0|||
25185954|NCT01498484|50335795|FG002|Overall Study|Adverse Event|0|||
25185955|NCT01498484|50335796|FG003|Overall Study|Adverse Event|0|||
25185956|NCT01498484|50335797|FG004|Overall Study|Adverse Event|0|||
25185957|NCT01498484|50335798|FG005|Overall Study|Adverse Event|1|||
25185958|NCT01498484|50335799|FG006|Overall Study|Adverse Event|0|||
25185959|NCT01498484|50335800|FG007|Overall Study|Adverse Event|0|||
25185960|NCT01498484|50335801|FG008|Overall Study|Adverse Event|0|||
25185961|NCT01498484|50335793|FG000|Overall Study|Withdrawal by Subject|0|||
25027612|NCT03498287|50125885|FG000|Overall Study|Withdrawal by Subject|3|||
25027613|NCT03498287|50125886|FG001|Overall Study|Withdrawal by Subject|0|||
25027614|NCT03498287|50125885|FG000|Overall Study|Protocol Violation|0|||
25027615|NCT03498287|50125886|FG001|Overall Study|Protocol Violation|4|||
25027616|NCT03498287|50125885|FG000|Overall Study|Adverse Event|0|||
25027617|NCT03498287|50125886|FG001|Overall Study|Adverse Event|1|||
25027618|NCT03497429|50125894|FG000|Overall Study|Progressive disease|3|||
25027619|NCT03497429|50125895|FG001|Overall Study|Progressive disease|4|||
25027620|NCT03497429|50125894|FG000|Overall Study|Adverse Event|0|||
25027621|NCT03497429|50125895|FG001|Overall Study|Adverse Event|2|||
25027622|NCT03497039|50125903|FG000|Overall Study|Withdrawal by Subject|1|||
25027623|NCT03497039|50125904|FG001|Overall Study|Withdrawal by Subject|0|||
25185962|NCT01498484|50335794|FG001|Overall Study|Withdrawal by Subject|0|||
25185963|NCT01498484|50335795|FG002|Overall Study|Withdrawal by Subject|0|||
25185964|NCT01498484|50335796|FG003|Overall Study|Withdrawal by Subject|1|||
25185965|NCT01498484|50335797|FG004|Overall Study|Withdrawal by Subject|0|||
25185966|NCT01498484|50335798|FG005|Overall Study|Withdrawal by Subject|0|||
25185967|NCT01498484|50335799|FG006|Overall Study|Withdrawal by Subject|1|||
25185968|NCT01498484|50335800|FG007|Overall Study|Withdrawal by Subject|0|||
25185969|NCT01498484|50335801|FG008|Overall Study|Withdrawal by Subject|0|||
25027624|NCT03497039|50125903|FG000|Overall Study|Protocol Violation|0|||
25027625|NCT03497039|50125904|FG001|Overall Study|Protocol Violation|1|||
25027626|NCT03495869|50125923|FG000|Overall Study|Lost to Follow-up|4|||
25185970|NCT01498484|50335793|FG000|Overall Study|Other|5|||
25185971|NCT01498484|50335794|FG001|Overall Study|Other|2|||
25185972|NCT01498484|50335795|FG002|Overall Study|Other|0|||
25185973|NCT01498484|50335796|FG003|Overall Study|Other|0|||
25185974|NCT01498484|50335797|FG004|Overall Study|Other|1|||
25185975|NCT01498484|50335798|FG005|Overall Study|Other|0|||
25185976|NCT01498484|50335799|FG006|Overall Study|Other|3|||
25185977|NCT01498484|50335800|FG007|Overall Study|Other|0|||
25185978|NCT01498484|50335801|FG008|Overall Study|Other|1|||
25185979|NCT01474772|50335810|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
25185980|NCT01474772|50335811|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
25185981|NCT01474772|50335810|FG000|Period 1|AE not Related to Study Drug|1|||
25185982|NCT01474772|50335811|FG001|Period 1|AE not Related to Study Drug|0|||
25185983|NCT01474772|50335810|FG000|Period 1|Withdrawal by Subject|3|||
25185984|NCT01474772|50335811|FG001|Period 1|Withdrawal by Subject|1|||
25185985|NCT01474772|50335810|FG000|Period 1|Lost to Follow-up|1|||
25185986|NCT01474772|50335811|FG001|Period 1|Lost to Follow-up|0|||
25185987|NCT01474772|50335810|FG000|Period 1|Reason not Specified|1|||
25185988|NCT01474772|50335811|FG001|Period 1|Reason not Specified|1|||
25185989|NCT01474772|50335810|FG000|Washout|AE not Related to Study Drug|2|||
25185990|NCT01474772|50335811|FG001|Washout|AE not Related to Study Drug|0|||
25185991|NCT01474772|50335810|FG000|Washout|Withdrawal by Subject|1|||
25185992|NCT01474772|50335811|FG001|Washout|Withdrawal by Subject|0|||
25185993|NCT01474772|50335810|FG000|Washout|Lost to Follow-up|0|||
25185994|NCT01474772|50335811|FG001|Washout|Lost to Follow-up|1|||
25185995|NCT01474772|50335810|FG000|Washout|Reason not Specified|0|||
25185996|NCT01474772|50335811|FG001|Washout|Reason not Specified|1|||
25185997|NCT01474772|50335810|FG000|Period 2|Death|0|||
25027627|NCT03495869|50125924|FG001|Overall Study|Lost to Follow-up|17|||
25027628|NCT03495869|50125925|FG002|Overall Study|Lost to Follow-up|8|||
25027629|NCT03495869|50125926|FG003|Overall Study|Lost to Follow-up|14|||
25027630|NCT03495869|50125923|FG000|Overall Study|Withdrawal by Subject|0|||
25185998|NCT01474772|50335811|FG001|Period 2|Death|1|||
25185999|NCT01474772|50335810|FG000|Period 2|AE Related to Study Drug|0|||
25186000|NCT01474772|50335811|FG001|Period 2|AE Related to Study Drug|1|||
25027631|NCT03495869|50125924|FG001|Overall Study|Withdrawal by Subject|3|||
25027632|NCT03495869|50125925|FG002|Overall Study|Withdrawal by Subject|0|||
25027633|NCT03495869|50125926|FG003|Overall Study|Withdrawal by Subject|3|||
25027634|NCT03495869|50125923|FG000|Overall Study|Dropped from study|0|||
25027635|NCT03495869|50125924|FG001|Overall Study|Dropped from study|7|||
25027636|NCT03495869|50125925|FG002|Overall Study|Dropped from study|2|||
24935018|NCT00510276|50028151|FG001|Extension Open-Label Phase|Physician Decision|3|||
24935019|NCT00510276|50028150|FG000|Extension Open-Label Phase|Protocol Violation|0|||
24935020|NCT00510276|50028151|FG001|Extension Open-Label Phase|Protocol Violation|1|||
24935021|NCT00510276|50028150|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
24935022|NCT00510276|50028151|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
24935023|NCT00510276|50028150|FG000|Extension Open-Label Phase|Subject Decision|7|||
24935024|NCT00510276|50028151|FG001|Extension Open-Label Phase|Subject Decision|9|||
24935025|NCT00616655|50028167|FG000|Overall Study|Adverse Event|10|||
24935026|NCT00616655|50028168|FG001|Overall Study|Adverse Event|7|||
24935027|NCT00616655|50028169|FG002|Overall Study|Adverse Event|12|||
24935028|NCT00616655|50028167|FG000|Overall Study|Lack of Efficacy|5|||
24935029|NCT00616655|50028168|FG001|Overall Study|Lack of Efficacy|5|||
24935030|NCT00616655|50028169|FG002|Overall Study|Lack of Efficacy|5|||
24935031|NCT00616655|50028167|FG000|Overall Study|Lost to Follow-up|3|||
24935032|NCT00616655|50028168|FG001|Overall Study|Lost to Follow-up|12|||
24935033|NCT00616655|50028169|FG002|Overall Study|Lost to Follow-up|10|||
25027637|NCT03495869|50125926|FG003|Overall Study|Dropped from study|4|||
24935034|NCT00616655|50028167|FG000|Overall Study|Protocol Violation|2|||
24935035|NCT00616655|50028168|FG001|Overall Study|Protocol Violation|4|||
24935036|NCT00616655|50028169|FG002|Overall Study|Protocol Violation|3|||
24935037|NCT00616655|50028167|FG000|Overall Study|Withdrawal by Subject|9|||
24935038|NCT00616655|50028168|FG001|Overall Study|Withdrawal by Subject|7|||
24935039|NCT00616655|50028169|FG002|Overall Study|Withdrawal by Subject|11|||
24935040|NCT00616655|50028167|FG000|Overall Study|Does not meet in/ex criteria|0|||
24935041|NCT00616655|50028168|FG001|Overall Study|Does not meet in/ex criteria|0|||
24935042|NCT00616655|50028169|FG002|Overall Study|Does not meet in/ex criteria|2|||
24935043|NCT00616655|50028167|FG000|Overall Study|Other|6|||
24935044|NCT00616655|50028168|FG001|Overall Study|Other|6|||
24935045|NCT00616655|50028169|FG002|Overall Study|Other|5|||
24935046|NCT00510198|50028179|FG000|Overall Study|Withdrawal by Subject|5|||
24935047|NCT00510198|50028180|FG001|Overall Study|Withdrawal by Subject|4|||
24935048|NCT00516048|50028190|FG000|Overall Study|Death|0|||
24935049|NCT00516048|50028191|FG001|Overall Study|Death|0|||
24935050|NCT00516048|50028192|FG002|Overall Study|Death|1|||
24935051|NCT00516048|50028190|FG000|Overall Study|Subject Decision|0|||
24935052|NCT00516048|50028191|FG001|Overall Study|Subject Decision|2|||
24935053|NCT00516048|50028192|FG002|Overall Study|Subject Decision|0|||
24935054|NCT00617357|50028200|FG000|Overall Study|Lost to Follow-up|7|||
24935055|NCT00617357|50028200|FG000|Overall Study|Death|5|||
24935056|NCT00617357|50028200|FG000|Overall Study|insurance concerns|2|||
24935057|NCT00617357|50028200|FG000|Overall Study|Withdrawal by Subject|1|||
24935058|NCT00617357|50028200|FG000|Overall Study|Physician Decision|1|||
24935059|NCT00420927|50028212|FG000|Period 1|Adverse Event|19|||
24935060|NCT00420927|50028213|FG001|Period 1|Adverse Event|15|||
24935061|NCT00420927|50028214|FG002|Period 1|Adverse Event|0|||
24935062|NCT00420927|50028215|FG003|Period 1|Adverse Event|0|||
24935063|NCT00420927|50028216|FG004|Period 1|Adverse Event|0|||
24935064|NCT00420927|50028217|FG005|Period 1|Adverse Event|0|||
24935065|NCT00420927|50028218|FG006|Period 1|Adverse Event|0|||
24935066|NCT00420927|50028212|FG000|Period 1|Withdrawal by Subject|7|||
24935067|NCT00420927|50028213|FG001|Period 1|Withdrawal by Subject|12|||
24935068|NCT00420927|50028214|FG002|Period 1|Withdrawal by Subject|0|||
24935069|NCT00420927|50028215|FG003|Period 1|Withdrawal by Subject|0|||
24935070|NCT00420927|50028216|FG004|Period 1|Withdrawal by Subject|0|||
24935071|NCT00420927|50028217|FG005|Period 1|Withdrawal by Subject|0|||
24935072|NCT00420927|50028218|FG006|Period 1|Withdrawal by Subject|0|||
24935073|NCT00420927|50028212|FG000|Period 1|Lost to Follow-up|8|||
24935074|NCT00420927|50028213|FG001|Period 1|Lost to Follow-up|6|||
24935075|NCT00420927|50028214|FG002|Period 1|Lost to Follow-up|0|||
24935076|NCT00420927|50028215|FG003|Period 1|Lost to Follow-up|0|||
24935077|NCT00420927|50028216|FG004|Period 1|Lost to Follow-up|0|||
24935078|NCT00420927|50028217|FG005|Period 1|Lost to Follow-up|0|||
24935079|NCT00420927|50028218|FG006|Period 1|Lost to Follow-up|0|||
24935080|NCT00420927|50028212|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
24935081|NCT00420927|50028213|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
24935082|NCT00420927|50028214|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
24935083|NCT00420927|50028215|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
24935084|NCT00420927|50028216|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
25027638|NCT03071094|50125947|FG000|Overall Study|Death|1|||
25027639|NCT03071094|50125948|FG001|Overall Study|Death|1|||
25027640|NCT03071094|50125947|FG000|Overall Study|Adverse Event|1|||
24935085|NCT00420927|50028217|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
24935086|NCT00420927|50028218|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
24935087|NCT00420927|50028212|FG000|Period 1|Death|2|||
24935088|NCT00420927|50028213|FG001|Period 1|Death|0|||
25027641|NCT03071094|50125948|FG001|Overall Study|Adverse Event|0|||
25027642|NCT03559517|50125957|FG000|Overall Study|Withdrawal by Subject|1|||
24935089|NCT00420927|50028214|FG002|Period 1|Death|0|||
24935090|NCT00420927|50028215|FG003|Period 1|Death|0|||
24935091|NCT00420927|50028216|FG004|Period 1|Death|0|||
24935092|NCT00420927|50028217|FG005|Period 1|Death|0|||
25027643|NCT03559517|50125958|FG001|Overall Study|Withdrawal by Subject|0|||
25027644|NCT03559517|50125959|FG002|Overall Study|Withdrawal by Subject|0|||
25027645|NCT02509494|50125976|FG000|Overall Study|Lost to Follow-up|8|||
25027646|NCT02509494|50125977|FG001|Overall Study|Lost to Follow-up|47|||
25027647|NCT02509494|50125978|FG002|Overall Study|Lost to Follow-up|19|||
24935093|NCT00420927|50028218|FG006|Period 1|Death|0|||
24935094|NCT00420927|50028212|FG000|Period 1|Subject moved/relocated|0|||
24935095|NCT00420927|50028213|FG001|Period 1|Subject moved/relocated|2|||
24935096|NCT00420927|50028214|FG002|Period 1|Subject moved/relocated|0|||
24935097|NCT00420927|50028215|FG003|Period 1|Subject moved/relocated|0|||
24935098|NCT00420927|50028216|FG004|Period 1|Subject moved/relocated|0|||
24935099|NCT00420927|50028217|FG005|Period 1|Subject moved/relocated|0|||
24935100|NCT00420927|50028218|FG006|Period 1|Subject moved/relocated|0|||
24935101|NCT00420927|50028212|FG000|Period 1|Noncompliant with study drug|1|||
24935102|NCT00420927|50028213|FG001|Period 1|Noncompliant with study drug|1|||
24935103|NCT00420927|50028214|FG002|Period 1|Noncompliant with study drug|0|||
24935104|NCT00420927|50028215|FG003|Period 1|Noncompliant with study drug|0|||
24935105|NCT00420927|50028216|FG004|Period 1|Noncompliant with study drug|0|||
24935106|NCT00420927|50028217|FG005|Period 1|Noncompliant with study drug|0|||
24935107|NCT00420927|50028218|FG006|Period 1|Noncompliant with study drug|0|||
24935108|NCT00420927|50028212|FG000|Period 1|Randomization error|1|||
24935109|NCT00420927|50028213|FG001|Period 1|Randomization error|0|||
24935110|NCT00420927|50028214|FG002|Period 1|Randomization error|0|||
24935111|NCT00420927|50028215|FG003|Period 1|Randomization error|0|||
24935112|NCT00420927|50028216|FG004|Period 1|Randomization error|0|||
24935113|NCT00420927|50028217|FG005|Period 1|Randomization error|0|||
24935114|NCT00420927|50028218|FG006|Period 1|Randomization error|0|||
24935115|NCT00420927|50028212|FG000|Period 1|Suspected tuberculosis/positive test|1|||
24935116|NCT00420927|50028213|FG001|Period 1|Suspected tuberculosis/positive test|1|||
24935117|NCT00420927|50028214|FG002|Period 1|Suspected tuberculosis/positive test|0|||
24935118|NCT00420927|50028215|FG003|Period 1|Suspected tuberculosis/positive test|0|||
24935119|NCT00420927|50028216|FG004|Period 1|Suspected tuberculosis/positive test|0|||
24935120|NCT00420927|50028217|FG005|Period 1|Suspected tuberculosis/positive test|0|||
24935121|NCT00420927|50028218|FG006|Period 1|Suspected tuberculosis/positive test|0|||
24935122|NCT00420927|50028212|FG000|Period 1|Study site closure|0|||
24935123|NCT00420927|50028213|FG001|Period 1|Study site closure|1|||
24935124|NCT00420927|50028214|FG002|Period 1|Study site closure|0|||
24935125|NCT00420927|50028215|FG003|Period 1|Study site closure|0|||
24935126|NCT00420927|50028216|FG004|Period 1|Study site closure|0|||
24935127|NCT00420927|50028217|FG005|Period 1|Study site closure|0|||
25027648|NCT02509494|50125979|FG003|Overall Study|Lost to Follow-up|6|||
24935128|NCT00420927|50028218|FG006|Period 1|Study site closure|0|||
24935129|NCT00420927|50028212|FG000|Period 1|Subject received new diagnosis|0|||
24935130|NCT00420927|50028213|FG001|Period 1|Subject received new diagnosis|2|||
24935131|NCT00420927|50028214|FG002|Period 1|Subject received new diagnosis|0|||
24935132|NCT00420927|50028215|FG003|Period 1|Subject received new diagnosis|0|||
24935133|NCT00420927|50028216|FG004|Period 1|Subject received new diagnosis|0|||
24935134|NCT00420927|50028217|FG005|Period 1|Subject received new diagnosis|0|||
24935135|NCT00420927|50028218|FG006|Period 1|Subject received new diagnosis|0|||
24935136|NCT00420927|50028212|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
24935137|NCT00420927|50028213|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
24935138|NCT00420927|50028214|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
24935139|NCT00420927|50028215|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
24935140|NCT00420927|50028216|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
24935141|NCT00420927|50028217|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
24935142|NCT00420927|50028218|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
24935143|NCT00420927|50028212|FG000|Period 1|Failed to meet entry criteria|8|||
24935144|NCT00420927|50028213|FG001|Period 1|Failed to meet entry criteria|7|||
24935145|NCT00420927|50028214|FG002|Period 1|Failed to meet entry criteria|0|||
24935146|NCT00420927|50028215|FG003|Period 1|Failed to meet entry criteria|0|||
24935147|NCT00420927|50028216|FG004|Period 1|Failed to meet entry criteria|0|||
25156353|NCT04440163|50272786|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
25186001|NCT01474772|50335810|FG000|Period 2|AE not Related to Study Drug|4|||
25186002|NCT01474772|50335811|FG001|Period 2|AE not Related to Study Drug|1|||
25186003|NCT01474772|50335810|FG000|Period 2|Lack of Efficacy|1|||
25186004|NCT01474772|50335811|FG001|Period 2|Lack of Efficacy|0|||
25186005|NCT01474772|50335810|FG000|Period 2|Withdrawal by Subject|3|||
25186006|NCT01474772|50335811|FG001|Period 2|Withdrawal by Subject|4|||
25186007|NCT01474772|50335810|FG000|Period 2|Lost to Follow-up|1|||
25156354|NCT04440163|50272787|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
25156355|NCT04440163|50272788|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
25156356|NCT04440163|50272789|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
25156357|NCT04440163|50272782|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
25156358|NCT04440163|50272783|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
25156359|NCT04440163|50272784|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
25186008|NCT01474772|50335811|FG001|Period 2|Lost to Follow-up|1|||
24935148|NCT00420927|50028217|FG005|Period 1|Failed to meet entry criteria|0|||
24935149|NCT00420927|50028218|FG006|Period 1|Failed to meet entry criteria|0|||
24935150|NCT00420927|50028212|FG000|Period 1|Took prohibited medication|1|||
25156360|NCT04440163|50272785|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
25156361|NCT04440163|50272786|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
25156362|NCT04440163|50272787|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
25156363|NCT04440163|50272788|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
25156364|NCT04440163|50272789|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
24935151|NCT00420927|50028213|FG001|Period 1|Took prohibited medication|3|||
24935152|NCT00420927|50028214|FG002|Period 1|Took prohibited medication|0|||
24935153|NCT00420927|50028215|FG003|Period 1|Took prohibited medication|0|||
24935154|NCT00420927|50028216|FG004|Period 1|Took prohibited medication|0|||
24935155|NCT00420927|50028217|FG005|Period 1|Took prohibited medication|0|||
24935156|NCT00420927|50028218|FG006|Period 1|Took prohibited medication|0|||
24935157|NCT00420927|50028212|FG000|Period 2|Adverse Event|0|||
24935158|NCT00420927|50028213|FG001|Period 2|Adverse Event|0|||
24935159|NCT00420927|50028214|FG002|Period 2|Adverse Event|7|||
24935160|NCT00420927|50028215|FG003|Period 2|Adverse Event|3|||
24935161|NCT00420927|50028216|FG004|Period 2|Adverse Event|17|||
24935162|NCT00420927|50028217|FG005|Period 2|Adverse Event|6|||
24935163|NCT00420927|50028218|FG006|Period 2|Adverse Event|20|||
24935164|NCT00420927|50028212|FG000|Period 2|Withdrawal by Subject|0|||
24935165|NCT00420927|50028213|FG001|Period 2|Withdrawal by Subject|0|||
24935166|NCT00420927|50028214|FG002|Period 2|Withdrawal by Subject|1|||
24935167|NCT00420927|50028215|FG003|Period 2|Withdrawal by Subject|3|||
24935168|NCT00420927|50028216|FG004|Period 2|Withdrawal by Subject|11|||
24935169|NCT00420927|50028217|FG005|Period 2|Withdrawal by Subject|2|||
24935170|NCT00420927|50028218|FG006|Period 2|Withdrawal by Subject|12|||
25027649|NCT02509494|50125980|FG004|Overall Study|Lost to Follow-up|3|||
25027650|NCT02509494|50125981|FG005|Overall Study|Lost to Follow-up|3|||
25027651|NCT02509494|50125982|FG006|Overall Study|Lost to Follow-up|1|||
25027652|NCT02509494|50125983|FG007|Overall Study|Lost to Follow-up|3|||
25027653|NCT02509494|50125984|FG008|Overall Study|Lost to Follow-up|1|||
25027654|NCT02509494|50125976|FG000|Overall Study|Physician Decision|2|||
25027655|NCT02509494|50125977|FG001|Overall Study|Physician Decision|1|||
25027656|NCT02509494|50125978|FG002|Overall Study|Physician Decision|0|||
25027657|NCT02509494|50125979|FG003|Overall Study|Physician Decision|0|||
25027658|NCT02509494|50125980|FG004|Overall Study|Physician Decision|0|||
25027659|NCT02509494|50125981|FG005|Overall Study|Physician Decision|0|||
24935171|NCT00420927|50028212|FG000|Period 2|Lost to Follow-up|0|||
24935172|NCT00420927|50028213|FG001|Period 2|Lost to Follow-up|0|||
24935173|NCT00420927|50028214|FG002|Period 2|Lost to Follow-up|2|||
24935174|NCT00420927|50028215|FG003|Period 2|Lost to Follow-up|2|||
24935175|NCT00420927|50028216|FG004|Period 2|Lost to Follow-up|6|||
24935176|NCT00420927|50028217|FG005|Period 2|Lost to Follow-up|3|||
24935177|NCT00420927|50028218|FG006|Period 2|Lost to Follow-up|9|||
24935178|NCT00420927|50028212|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
24935179|NCT00420927|50028213|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
24935180|NCT00420927|50028214|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
24935181|NCT00420927|50028215|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
24935182|NCT00420927|50028216|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
24935183|NCT00420927|50028217|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
24935184|NCT00420927|50028218|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
24935185|NCT00420927|50028212|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
24935186|NCT00420927|50028213|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
24935187|NCT00420927|50028214|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
24935188|NCT00420927|50028215|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
24935189|NCT00420927|50028216|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
24935190|NCT00420927|50028217|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
24935191|NCT00420927|50028218|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
24935192|NCT00420927|50028212|FG000|Period 2|Subject unable to find transportation|0|||
24935193|NCT00420927|50028213|FG001|Period 2|Subject unable to find transportation|0|||
24935194|NCT00420927|50028214|FG002|Period 2|Subject unable to find transportation|0|||
24935195|NCT00420927|50028215|FG003|Period 2|Subject unable to find transportation|0|||
24935196|NCT00420927|50028216|FG004|Period 2|Subject unable to find transportation|0|||
24935197|NCT00420927|50028217|FG005|Period 2|Subject unable to find transportation|0|||
24935198|NCT00420927|50028218|FG006|Period 2|Subject unable to find transportation|1|||
24935199|NCT00420927|50028212|FG000|Period 2|Physician Decision|0|||
24935200|NCT00420927|50028213|FG001|Period 2|Physician Decision|0|||
24935201|NCT00420927|50028214|FG002|Period 2|Physician Decision|0|||
24935202|NCT00420927|50028215|FG003|Period 2|Physician Decision|0|||
25027660|NCT02509494|50125982|FG006|Overall Study|Physician Decision|0|||
25027661|NCT02509494|50125983|FG007|Overall Study|Physician Decision|0|||
24935203|NCT00420927|50028216|FG004|Period 2|Physician Decision|1|||
24935204|NCT00420927|50028217|FG005|Period 2|Physician Decision|1|||
25027662|NCT02509494|50125984|FG008|Overall Study|Physician Decision|0|||
25027663|NCT02509494|50125976|FG000|Overall Study|Withdrawal by Subject|4|||
25027664|NCT02509494|50125977|FG001|Overall Study|Withdrawal by Subject|17|||
24935205|NCT00420927|50028218|FG006|Period 2|Physician Decision|0|||
24935206|NCT00420927|50028212|FG000|Period 2|Sponsor decision|0|||
24935207|NCT00420927|50028213|FG001|Period 2|Sponsor decision|0|||
24935208|NCT00420927|50028214|FG002|Period 2|Sponsor decision|1|||
24935209|NCT00420927|50028215|FG003|Period 2|Sponsor decision|0|||
24935210|NCT00420927|50028216|FG004|Period 2|Sponsor decision|0|||
24935211|NCT00420927|50028217|FG005|Period 2|Sponsor decision|0|||
24935212|NCT00420927|50028218|FG006|Period 2|Sponsor decision|1|||
24935213|NCT00420927|50028212|FG000|Period 2|Randomization error|0|||
24935214|NCT00420927|50028213|FG001|Period 2|Randomization error|0|||
24935215|NCT00420927|50028214|FG002|Period 2|Randomization error|0|||
24935216|NCT00420927|50028215|FG003|Period 2|Randomization error|0|||
24935217|NCT00420927|50028216|FG004|Period 2|Randomization error|1|||
24935218|NCT00420927|50028217|FG005|Period 2|Randomization error|1|||
24935219|NCT00420927|50028218|FG006|Period 2|Randomization error|0|||
24935220|NCT00420927|50028212|FG000|Period 2|Noncompliant with study drug|0|||
24935221|NCT00420927|50028213|FG001|Period 2|Noncompliant with study drug|0|||
24935222|NCT00420927|50028214|FG002|Period 2|Noncompliant with study drug|0|||
24935223|NCT00420927|50028215|FG003|Period 2|Noncompliant with study drug|1|||
24935224|NCT00420927|50028216|FG004|Period 2|Noncompliant with study drug|0|||
24935225|NCT00420927|50028217|FG005|Period 2|Noncompliant with study drug|0|||
24935226|NCT00420927|50028218|FG006|Period 2|Noncompliant with study drug|2|||
24935227|NCT00420927|50028212|FG000|Period 2|Methotrexate intolerance|0|||
24935228|NCT00420927|50028213|FG001|Period 2|Methotrexate intolerance|0|||
24935229|NCT00420927|50028214|FG002|Period 2|Methotrexate intolerance|0|||
24935230|NCT00420927|50028215|FG003|Period 2|Methotrexate intolerance|0|||
24935231|NCT00420927|50028216|FG004|Period 2|Methotrexate intolerance|0|||
24935232|NCT00420927|50028217|FG005|Period 2|Methotrexate intolerance|0|||
25156365|NCT04440163|50272782|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
25186009|NCT01474772|50335810|FG000|Period 2|Reason not Specified|0|||
24935233|NCT00420927|50028218|FG006|Period 2|Methotrexate intolerance|1|||
24935234|NCT00420927|50028212|FG000|Period 2|Took prohibited medication|0|||
24935235|NCT00420927|50028213|FG001|Period 2|Took prohibited medication|0|||
24935236|NCT00420927|50028214|FG002|Period 2|Took prohibited medication|0|||
24935237|NCT00420927|50028215|FG003|Period 2|Took prohibited medication|0|||
24935238|NCT00420927|50028216|FG004|Period 2|Took prohibited medication|1|||
24935239|NCT00420927|50028217|FG005|Period 2|Took prohibited medication|0|||
24935240|NCT00420927|50028218|FG006|Period 2|Took prohibited medication|0|||
25027665|NCT02509494|50125978|FG002|Overall Study|Withdrawal by Subject|7|||
25027666|NCT02509494|50125979|FG003|Overall Study|Withdrawal by Subject|5|||
25027667|NCT02509494|50125980|FG004|Overall Study|Withdrawal by Subject|0|||
25027668|NCT02509494|50125981|FG005|Overall Study|Withdrawal by Subject|6|||
25027669|NCT02509494|50125982|FG006|Overall Study|Withdrawal by Subject|1|||
25027670|NCT02509494|50125983|FG007|Overall Study|Withdrawal by Subject|2|||
25027671|NCT02509494|50125984|FG008|Overall Study|Withdrawal by Subject|1|||
25027672|NCT02509494|50125976|FG000|Overall Study|Death|0|||
25027673|NCT02509494|50125977|FG001|Overall Study|Death|1|||
25027674|NCT02509494|50125978|FG002|Overall Study|Death|0|||
25156366|NCT04440163|50272783|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
25156367|NCT04440163|50272784|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
24935241|NCT00573443|50028235|FG000|Double-Blind Phase|Lost to Follow-up|1|||
24935242|NCT00573443|50028236|FG001|Double-Blind Phase|Lost to Follow-up|3|||
24935243|NCT00573443|50028237|FG002|Double-Blind Phase|Lost to Follow-up|2|||
24935244|NCT00573443|50028235|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
24935245|NCT00573443|50028236|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
24935246|NCT00573443|50028237|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
24935247|NCT00573443|50028235|FG000|Double-Blind Phase|Adverse Event|1|||
24935248|NCT00573443|50028236|FG001|Double-Blind Phase|Adverse Event|5|||
24935249|NCT00573443|50028237|FG002|Double-Blind Phase|Adverse Event|0|||
24935250|NCT00573443|50028235|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
24935251|NCT00573443|50028236|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
24935252|NCT00573443|50028237|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
24935253|NCT00573443|50028235|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
24935254|NCT00573443|50028236|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
24935255|NCT00573443|50028237|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
24935256|NCT00573443|50028235|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
24935257|NCT00573443|50028236|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
24935258|NCT00573443|50028237|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
24935259|NCT00573443|50028235|FG000|Double-Blind Phase|Protocol Violation|0|||
25027675|NCT02509494|50125979|FG003|Overall Study|Death|0|||
24935260|NCT00573443|50028236|FG001|Double-Blind Phase|Protocol Violation|2|||
24935261|NCT00573443|50028237|FG002|Double-Blind Phase|Protocol Violation|1|||
24935262|NCT00573443|50028235|FG000|Double-Blind Phase|Other|0|||
25027676|NCT02509494|50125980|FG004|Overall Study|Death|1|||
25027677|NCT02509494|50125981|FG005|Overall Study|Death|0|||
25027678|NCT02509494|50125982|FG006|Overall Study|Death|0|||
25156368|NCT04440163|50272785|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
25156369|NCT04440163|50272786|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
25156370|NCT04440163|50272787|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
25156371|NCT04440163|50272788|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
25156372|NCT04440163|50272789|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
25156373|NCT04440163|50272782|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
25156374|NCT04440163|50272783|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
25156375|NCT04440163|50272784|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
25156376|NCT04440163|50272785|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
25156377|NCT04440163|50272786|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
25156378|NCT04440163|50272787|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
25156379|NCT04440163|50272788|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
25156380|NCT04440163|50272789|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
25156381|NCT04440163|50272782|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
25156382|NCT04440163|50272783|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
25156383|NCT04440163|50272784|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
25156384|NCT04440163|50272785|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
25156385|NCT04440163|50272786|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
25156386|NCT04440163|50272787|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
25156387|NCT04440163|50272788|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
25156388|NCT04440163|50272789|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
25156389|NCT04440163|50272782|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
25156390|NCT04440163|50272783|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
25156391|NCT04440163|50272784|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
25156392|NCT04440163|50272785|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
25156393|NCT04440163|50272786|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
25156394|NCT04440163|50272787|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
25156395|NCT04440163|50272788|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
25156396|NCT04440163|50272789|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
25156397|NCT04440163|50272782|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
25156398|NCT04440163|50272783|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
25156399|NCT04440163|50272784|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
25156400|NCT04440163|50272785|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
25156401|NCT04440163|50272786|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
25156402|NCT04440163|50272787|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
25156403|NCT04440163|50272788|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
24935263|NCT00573443|50028236|FG001|Double-Blind Phase|Other|2|||
24935264|NCT00573443|50028237|FG002|Double-Blind Phase|Other|3|||
24935265|NCT00573443|50028235|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
24935266|NCT00573443|50028236|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
24935267|NCT00573443|50028237|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
24935268|NCT00573443|50028235|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
24935269|NCT00573443|50028236|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
24935270|NCT00573443|50028237|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
24935271|NCT00573443|50028235|FG000|Open-Label Extension Phase|Adverse Event|3|||
24935272|NCT00573443|50028236|FG001|Open-Label Extension Phase|Adverse Event|0|||
24935273|NCT00573443|50028237|FG002|Open-Label Extension Phase|Adverse Event|0|||
24935274|NCT00573443|50028235|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
24935275|NCT00573443|50028236|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
24935276|NCT00573443|50028237|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
24935277|NCT00573443|50028235|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
24935278|NCT00573443|50028236|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
24935279|NCT00573443|50028237|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
24935280|NCT00573443|50028235|FG000|Open-Label Extension Phase|Protocol Violation|2|||
24935281|NCT00573443|50028236|FG001|Open-Label Extension Phase|Protocol Violation|0|||
24935282|NCT00573443|50028237|FG002|Open-Label Extension Phase|Protocol Violation|0|||
25027679|NCT02509494|50125983|FG007|Overall Study|Death|1|||
25027680|NCT02509494|50125984|FG008|Overall Study|Death|0|||
25275118|NCT01236365|50589136|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
25275119|NCT01236365|50589137|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
25275120|NCT01235975|50589157|FG000|Overall Study|Serious Adverse Event|0|||
25275121|NCT01235975|50589158|FG001|Overall Study|Serious Adverse Event|1|||
25275122|NCT01235975|50589157|FG000|Overall Study|Withdrawal by Subject|8|||
25275123|NCT01235975|50589158|FG001|Overall Study|Withdrawal by Subject|2|||
25156404|NCT04440163|50272789|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
25156405|NCT04304508|50272820|FG000|Overall Study|Subject Decision|29|||
25156406|NCT04304508|50272821|FG001|Overall Study|Subject Decision|39|||
25156407|NCT04304508|50272822|FG002|Overall Study|Subject Decision|37|||
25156408|NCT04304508|50272823|FG003|Overall Study|Subject Decision|48|||
25156409|NCT04304508|50272820|FG000|Overall Study|Death|6|||
25156410|NCT04304508|50272821|FG001|Overall Study|Death|1|||
25156411|NCT04304508|50272822|FG002|Overall Study|Death|8|||
25156412|NCT04304508|50272823|FG003|Overall Study|Death|5|||
25156413|NCT04304508|50272820|FG000|Overall Study|Non-compliance With Study Drug|3|||
25156414|NCT04304508|50272821|FG001|Overall Study|Non-compliance With Study Drug|1|||
25156415|NCT04304508|50272822|FG002|Overall Study|Non-compliance With Study Drug|2|||
25156416|NCT04304508|50272823|FG003|Overall Study|Non-compliance With Study Drug|0|||
25156417|NCT04304508|50272820|FG000|Overall Study|Switching To Other Therapy|1|||
25156418|NCT04304508|50272821|FG001|Overall Study|Switching To Other Therapy|1|||
25156419|NCT04304508|50272822|FG002|Overall Study|Switching To Other Therapy|1|||
25156420|NCT04304508|50272823|FG003|Overall Study|Switching To Other Therapy|2|||
25156421|NCT04304508|50272820|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
25186010|NCT01474772|50335811|FG001|Period 2|Reason not Specified|2|||
25156422|NCT04304508|50272821|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
25156423|NCT04304508|50272822|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
25275124|NCT01235975|50589157|FG000|Overall Study|Migrated/moved from study area|2|||
25275125|NCT01235975|50589158|FG001|Overall Study|Migrated/moved from study area|1|||
25275126|NCT01235975|50589157|FG000|Overall Study|Lost to Follow-up|7|||
25275127|NCT01235975|50589158|FG001|Overall Study|Lost to Follow-up|3|||
25275128|NCT00903331|50589166|FG000|Overall Study|Death|4|||
25027681|NCT02509494|50125976|FG000|Overall Study|Other|0|||
25027682|NCT02509494|50125977|FG001|Overall Study|Other|4|||
25156424|NCT04304508|50272823|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
25156425|NCT04304508|50272820|FG000|Overall Study|Withdrawal by Subject|7|||
25186011|NCT01474772|50335810|FG000|Follow-up|AE not Related to Study Drug|0|||
25186012|NCT01474772|50335811|FG001|Follow-up|AE not Related to Study Drug|1|||
25186013|NCT01421147|50335819|FG000|Treatment Period|Adverse Event|2|||
25186014|NCT01421147|50335820|FG001|Treatment Period|Adverse Event|3|||
25186015|NCT01421147|50335819|FG000|Treatment Period|Lost to Follow-up|2|||
25186016|NCT01421147|50335820|FG001|Treatment Period|Lost to Follow-up|1|||
25186017|NCT01421147|50335819|FG000|Treatment Period|Physician Decision|2|||
25186018|NCT01421147|50335820|FG001|Treatment Period|Physician Decision|2|||
25186019|NCT01421147|50335819|FG000|Treatment Period|Withdrawal by Subject|10|||
25186020|NCT01421147|50335820|FG001|Treatment Period|Withdrawal by Subject|5|||
25186021|NCT01421147|50335819|FG000|Extension Period|Adverse Event|0|||
24935283|NCT00573443|50028235|FG000|Open-Label Extension Phase|Other|2|||
25027683|NCT02509494|50125978|FG002|Overall Study|Other|5|||
25027684|NCT02509494|50125979|FG003|Overall Study|Other|0|||
24935284|NCT00573443|50028236|FG001|Open-Label Extension Phase|Other|0|||
24935285|NCT00573443|50028237|FG002|Open-Label Extension Phase|Other|0|||
25027685|NCT02509494|50125980|FG004|Overall Study|Other|0|||
25275129|NCT00903331|50589167|FG001|Overall Study|Death|8|||
25275130|NCT00903331|50589166|FG000|Overall Study|Withdrawal of consent|1|||
25275131|NCT00903331|50589167|FG001|Overall Study|Withdrawal of consent|8|||
25275132|NCT00903331|50589166|FG000|Overall Study|Lung transplant|0|||
25275133|NCT00903331|50589167|FG001|Overall Study|Lung transplant|2|||
25275134|NCT01235741|50589176|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
25275135|NCT01235741|50589177|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
25275136|NCT01235741|50589178|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
24935286|NCT00420849|50028259|FG000|Overall Study|Lack of Efficacy|154|||
24935287|NCT00420849|50028259|FG000|Overall Study|Adverse Event|107|||
24935288|NCT00420849|50028259|FG000|Overall Study|Withdrawal by Subject|28|||
24935289|NCT00420849|50028259|FG000|Overall Study|Death|18|||
24935290|NCT00420849|50028259|FG000|Overall Study|Other|14|||
24935291|NCT00420849|50028259|FG000|Overall Study|Transplant|8|||
24935292|NCT00420849|50028259|FG000|Overall Study|Protocol Violation|1|||
25027686|NCT02509494|50125981|FG005|Overall Study|Other|0|||
25156426|NCT04304508|50272821|FG001|Overall Study|Withdrawal by Subject|5|||
24935293|NCT00420849|50028259|FG000|Overall Study|Lost to Follow-up|1|||
24935294|NCT00617279|50028268|FG000|Overall Study|Study terminated by Sponsor|10|||
24935295|NCT00617279|50028269|FG001|Overall Study|Study terminated by Sponsor|15|||
24935296|NCT00617279|50028268|FG000|Overall Study|Graft abandonment|2|||
24935297|NCT00617279|50028269|FG001|Overall Study|Graft abandonment|0|||
24935298|NCT00617279|50028268|FG000|Overall Study|Lost to Follow-up|1|||
24935299|NCT00617279|50028269|FG001|Overall Study|Lost to Follow-up|0|||
24935300|NCT00617279|50028268|FG000|Overall Study|Death|1|||
24935301|NCT00617279|50028269|FG001|Overall Study|Death|2|||
24935302|NCT00420381|50028275|FG000|Overall Study|Protocol Violation|1|||
24935303|NCT00617201|50028281|FG000|Overall Study|Lost to Follow-up|9|||
24935304|NCT00617201|50028282|FG001|Overall Study|Lost to Follow-up|13|||
24935305|NCT00420303|50028292|FG000|Overall Study|Serious Adverse Event|1|||
24935306|NCT00420303|50028293|FG001|Overall Study|Serious Adverse Event|0|||
24935307|NCT00420303|50028292|FG000|Overall Study|Lack of Efficacy|0|||
24935308|NCT00420303|50028293|FG001|Overall Study|Lack of Efficacy|3|||
24935309|NCT00420303|50028292|FG000|Overall Study|Physician Decision|0|||
24935310|NCT00420303|50028293|FG001|Overall Study|Physician Decision|1|||
24935311|NCT00617123|50028301|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
24935312|NCT00617123|50028302|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
24935313|NCT00617123|50028301|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
24935314|NCT00617123|50028302|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
24935315|NCT00617123|50028301|FG000|Referral Screening Period|Adverse Event|0|||
24935316|NCT00617123|50028302|FG001|Referral Screening Period|Adverse Event|1|||
24935317|NCT00617123|50028301|FG000|Study Treatment Period|Withdrawal by Subject|8|||
24935318|NCT00617123|50028302|FG001|Study Treatment Period|Withdrawal by Subject|12|||
25156427|NCT04304508|50272822|FG002|Overall Study|Withdrawal by Subject|11|||
25156428|NCT04304508|50272823|FG003|Overall Study|Withdrawal by Subject|6|||
25156429|NCT04304508|50272820|FG000|Overall Study|Logistical Difficulties|2|||
24935319|NCT00617123|50028301|FG000|Study Treatment Period|Adverse Event|7|||
24935320|NCT00617123|50028302|FG001|Study Treatment Period|Adverse Event|3|||
24935321|NCT00617123|50028301|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
24935322|NCT00617123|50028302|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
24935323|NCT00617123|50028301|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
24935324|NCT00617123|50028302|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
24935325|NCT00419757|50028310|FG000|Overall Study|Adverse Event|1|||
24935326|NCT00419757|50028311|FG001|Overall Study|Adverse Event|4|||
24935327|NCT00419757|50028310|FG000|Overall Study|Lost to Follow-up|1|||
24935328|NCT00419757|50028311|FG001|Overall Study|Lost to Follow-up|4|||
25156430|NCT04304508|50272821|FG001|Overall Study|Logistical Difficulties|2|||
25156431|NCT04304508|50272822|FG002|Overall Study|Logistical Difficulties|3|||
25275137|NCT01235741|50589176|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
25275138|NCT01235741|50589177|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
25027687|NCT02509494|50125982|FG006|Overall Study|Other|0|||
25027688|NCT02509494|50125983|FG007|Overall Study|Other|0|||
25027689|NCT02509494|50125984|FG008|Overall Study|Other|0|||
25027690|NCT02509494|50125976|FG000|Overall Study|Non-Compliance With Study Drug|1|||
25027691|NCT02509494|50125977|FG001|Overall Study|Non-Compliance With Study Drug|11|||
25027692|NCT02509494|50125978|FG002|Overall Study|Non-Compliance With Study Drug|7|||
25156432|NCT04304508|50272823|FG003|Overall Study|Logistical Difficulties|2|||
24935329|NCT00419757|50028310|FG000|Overall Study|Withdrawal by Subject|7|||
24935330|NCT00419757|50028311|FG001|Overall Study|Withdrawal by Subject|1|||
24935331|NCT00419757|50028310|FG000|Overall Study|Protocol Violation|2|||
24935332|NCT00419757|50028311|FG001|Overall Study|Protocol Violation|3|||
24935333|NCT00419757|50028310|FG000|Overall Study|Study specific discontinuation criteria|4|||
24935334|NCT00419757|50028311|FG001|Overall Study|Study specific discontinuation criteria|8|||
25027693|NCT02509494|50125979|FG003|Overall Study|Non-Compliance With Study Drug|0|||
25027694|NCT02509494|50125980|FG004|Overall Study|Non-Compliance With Study Drug|1|||
25156433|NCT04304508|50272820|FG000|Overall Study|Missing Information|1|||
25156434|NCT04304508|50272821|FG001|Overall Study|Missing Information|2|||
25156435|NCT04304508|50272822|FG002|Overall Study|Missing Information|1|||
25156436|NCT04304508|50272823|FG003|Overall Study|Missing Information|3|||
24935335|NCT00419757|50028310|FG000|Overall Study|Multiple reasons|3|||
24935336|NCT00419757|50028311|FG001|Overall Study|Multiple reasons|1|||
25027695|NCT02509494|50125981|FG005|Overall Study|Non-Compliance With Study Drug|2|||
25027696|NCT02509494|50125982|FG006|Overall Study|Non-Compliance With Study Drug|1|||
25027697|NCT02509494|50125983|FG007|Overall Study|Non-Compliance With Study Drug|1|||
25027698|NCT02509494|50125984|FG008|Overall Study|Non-Compliance With Study Drug|0|||
25027699|NCT03493451|50126021|FG000|Overall Study|Death|11|||
25027700|NCT03493451|50126022|FG001|Overall Study|Death|26|||
25027701|NCT03493451|50126023|FG002|Overall Study|Death|3|||
25027702|NCT03493451|50126021|FG000|Overall Study|Lost to Follow-up|1|||
25027703|NCT03493451|50126022|FG001|Overall Study|Lost to Follow-up|4|||
25027704|NCT03493451|50126023|FG002|Overall Study|Lost to Follow-up|1|||
25027705|NCT03493451|50126021|FG000|Overall Study|Withdrawal by Subject|1|||
24935337|NCT00434109|50028319|FG000|Overall Study|Physician Decision|9|||
24935338|NCT00434109|50028319|FG000|Overall Study|Adverse Event|5|||
24935339|NCT00434109|50028319|FG000|Overall Study|Protocol Violation|1|||
24935340|NCT00434109|50028319|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
24935341|NCT00433329|50028323|FG000|Overall Study|Adverse Event|9|||
24935342|NCT00433329|50028323|FG000|Overall Study|Death|4|||
24935343|NCT00433329|50028323|FG000|Overall Study|Withdrew consent|3|||
24935344|NCT00433329|50028323|FG000|Overall Study|Discontinued sildenafil|2|||
24935345|NCT00433329|50028323|FG000|Overall Study|Moved out of state|1|||
24935346|NCT00433329|50028323|FG000|Overall Study|Lost to Follow-up|1|||
24935347|NCT00433329|50028323|FG000|Overall Study|Physician Decision|1|||
24935348|NCT00616421|50028330|FG000|Overall Study|Withdrawal by Subject|9|||
24935349|NCT00616421|50028331|FG001|Overall Study|Withdrawal by Subject|11|||
24935350|NCT00616421|50028332|FG002|Overall Study|Withdrawal by Subject|8|||
24935351|NCT00616421|50028330|FG000|Overall Study|Lost to Follow-up|12|||
24935352|NCT00616421|50028331|FG001|Overall Study|Lost to Follow-up|26|||
25027706|NCT03493451|50126022|FG001|Overall Study|Withdrawal by Subject|1|||
25027707|NCT03493451|50126023|FG002|Overall Study|Withdrawal by Subject|2|||
24935353|NCT00616421|50028332|FG002|Overall Study|Lost to Follow-up|30|||
24935354|NCT00616421|50028330|FG000|Overall Study|Inappropriate enrollment|3|||
24935355|NCT00616421|50028331|FG001|Overall Study|Inappropriate enrollment|0|||
24935356|NCT00616421|50028332|FG002|Overall Study|Inappropriate enrollment|1|||
24935357|NCT00616421|50028330|FG000|Overall Study|Administrative reason|1|||
24935358|NCT00616421|50028331|FG001|Overall Study|Administrative reason|0|||
24935359|NCT00616421|50028332|FG002|Overall Study|Administrative reason|0|||
24935360|NCT00616421|50028330|FG000|Overall Study|Protocol Violation|0|||
24935361|NCT00616421|50028331|FG001|Overall Study|Protocol Violation|1|||
24935362|NCT00616421|50028332|FG002|Overall Study|Protocol Violation|2|||
24935363|NCT00616421|50028330|FG000|Overall Study|Unable to classify|1|||
24935364|NCT00616421|50028331|FG001|Overall Study|Unable to classify|0|||
24935365|NCT00616421|50028332|FG002|Overall Study|Unable to classify|0|||
24935366|NCT00433017|50028356|FG000|Overall Study|Adverse Event|5|||
24935367|NCT00433017|50028357|FG001|Overall Study|Adverse Event|3|||
24935368|NCT00433017|50028356|FG000|Overall Study|Withdrawal by Subject|4|||
24935369|NCT00433017|50028357|FG001|Overall Study|Withdrawal by Subject|5|||
24935370|NCT00433017|50028356|FG000|Overall Study|Lost to Follow-up|3|||
24935371|NCT00433017|50028357|FG001|Overall Study|Lost to Follow-up|4|||
24935372|NCT00433017|50028356|FG000|Overall Study|Administrative problems|80|||
24935373|NCT00433017|50028357|FG001|Overall Study|Administrative problems|86|||
24935374|NCT00433017|50028356|FG000|Overall Study|Protocol Violation|1|||
24935375|NCT00433017|50028357|FG001|Overall Study|Protocol Violation|0|||
24935376|NCT00433017|50028356|FG000|Overall Study|Death|2|||
24935377|NCT00433017|50028357|FG001|Overall Study|Death|2|||
24935378|NCT00433017|50028356|FG000|Overall Study|Subject no longer requires study drug|1|||
25027708|NCT03493451|50126021|FG000|Overall Study|Progressive Disease|1|||
25156437|NCT04304508|50272820|FG000|Overall Study|Other|7|||
25156438|NCT04304508|50272821|FG001|Overall Study|Other|6|||
25156439|NCT04304508|50272822|FG002|Overall Study|Other|5|||
24935379|NCT00433017|50028357|FG001|Overall Study|Subject no longer requires study drug|1|||
24935380|NCT00615719|50028389|FG000|Overall Study|Physician Decision|5|||
24935381|NCT00418665|50028396|FG000|Treatment Period|Ineligibility determined|1|||
24935382|NCT00418665|50028397|FG001|Treatment Period|Ineligibility determined|1|||
25027709|NCT03493451|50126022|FG001|Overall Study|Progressive Disease|0|||
25027710|NCT03493451|50126023|FG002|Overall Study|Progressive Disease|0|||
25027711|NCT03493451|50126021|FG000|Overall Study|Transferred to long term extension study|8|||
24935383|NCT00418665|50028398|FG002|Treatment Period|Ineligibility determined|0|||
24935384|NCT00418665|50028396|FG000|Treatment Period|Adverse Event|2|||
24935385|NCT00418665|50028397|FG001|Treatment Period|Adverse Event|2|||
24935386|NCT00418665|50028398|FG002|Treatment Period|Adverse Event|0|||
25027712|NCT03493451|50126022|FG001|Overall Study|Transferred to long term extension study|13|||
24935387|NCT00418665|50028396|FG000|Treatment Period|Withdrawal by Subject|0|||
24935388|NCT00418665|50028397|FG001|Treatment Period|Withdrawal by Subject|3|||
24935389|NCT00418665|50028398|FG002|Treatment Period|Withdrawal by Subject|1|||
24935390|NCT00418665|50028396|FG000|Treatment Period|Requirement for alternative therapy|1|||
24935391|NCT00418665|50028397|FG001|Treatment Period|Requirement for alternative therapy|0|||
24935392|NCT00418665|50028398|FG002|Treatment Period|Requirement for alternative therapy|0|||
24935393|NCT00418665|50028396|FG000|Treatment Period|Physician Decision|1|||
24935394|NCT00418665|50028397|FG001|Treatment Period|Physician Decision|0|||
24935395|NCT00418665|50028398|FG002|Treatment Period|Physician Decision|3|||
24935396|NCT00418665|50028396|FG000|Treatment Extension|Adverse Event|1|||
24935397|NCT00418665|50028397|FG001|Treatment Extension|Adverse Event|0|||
24935398|NCT00418665|50028398|FG002|Treatment Extension|Adverse Event|0|||
24935399|NCT00418665|50028396|FG000|Treatment Extension|Withdrawal by Subject|1|||
24935400|NCT00418665|50028397|FG001|Treatment Extension|Withdrawal by Subject|0|||
24935401|NCT00418665|50028398|FG002|Treatment Extension|Withdrawal by Subject|0|||
24935402|NCT00418665|50028396|FG000|Treatment Extension|Requirement for alternative therapy|2|||
24935403|NCT00418665|50028397|FG001|Treatment Extension|Requirement for alternative therapy|2|||
24935404|NCT00418665|50028398|FG002|Treatment Extension|Requirement for alternative therapy|0|||
24935405|NCT00418665|50028396|FG000|Treatment Extension|Physician Decision|2|||
24935406|NCT00418665|50028397|FG001|Treatment Extension|Physician Decision|2|||
24935407|NCT00418665|50028398|FG002|Treatment Extension|Physician Decision|1|||
24935408|NCT00418665|50028396|FG000|Treatment Extension|Death|0|||
24935409|NCT00418665|50028397|FG001|Treatment Extension|Death|0|||
24935410|NCT00418665|50028398|FG002|Treatment Extension|Death|1|||
24935411|NCT00432237|50028410|FG000|Overall Study|Adverse Event|0|||
24935412|NCT00432237|50028411|FG001|Overall Study|Adverse Event|0|||
24935413|NCT00432237|50028412|FG002|Overall Study|Adverse Event|0|||
24935414|NCT00432237|50028413|FG003|Overall Study|Adverse Event|1|||
24935415|NCT00432237|50028410|FG000|Overall Study|Lack of Efficacy|0|||
24935416|NCT00432237|50028411|FG001|Overall Study|Lack of Efficacy|0|||
24935417|NCT00432237|50028412|FG002|Overall Study|Lack of Efficacy|0|||
24935418|NCT00432237|50028413|FG003|Overall Study|Lack of Efficacy|1|||
24935419|NCT00432237|50028410|FG000|Overall Study|Lost to Follow-up|10|||
24935420|NCT00432237|50028411|FG001|Overall Study|Lost to Follow-up|10|||
24935421|NCT00432237|50028412|FG002|Overall Study|Lost to Follow-up|18|||
24935422|NCT00432237|50028413|FG003|Overall Study|Lost to Follow-up|18|||
24935423|NCT00432237|50028410|FG000|Overall Study|Physician Decision|1|||
24935424|NCT00432237|50028411|FG001|Overall Study|Physician Decision|3|||
25156440|NCT04304508|50272823|FG003|Overall Study|Other|4|||
25156441|NCT04304508|50272820|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
25156442|NCT04304508|50272821|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
24935425|NCT00432237|50028412|FG002|Overall Study|Physician Decision|2|||
24935426|NCT00432237|50028413|FG003|Overall Study|Physician Decision|1|||
24935427|NCT00432237|50028410|FG000|Overall Study|Pregnancy|0|||
24935428|NCT00432237|50028411|FG001|Overall Study|Pregnancy|1|||
25156443|NCT04304508|50272822|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
25156444|NCT04304508|50272823|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
25156445|NCT04304508|50272820|FG000|Overall Study|Physician Decision|3|||
25156446|NCT04304508|50272821|FG001|Overall Study|Physician Decision|4|||
25156447|NCT04304508|50272822|FG002|Overall Study|Physician Decision|9|||
25156448|NCT04304508|50272823|FG003|Overall Study|Physician Decision|7|||
25156449|NCT04304508|50272820|FG000|Overall Study|Study drug never administered|10|||
25156450|NCT04304508|50272821|FG001|Overall Study|Study drug never administered|4|||
25156451|NCT04304508|50272822|FG002|Overall Study|Study drug never administered|4|||
25156452|NCT04304508|50272823|FG003|Overall Study|Study drug never administered|4|||
25156453|NCT04304508|50272820|FG000|Overall Study|Adverse Event|49|||
25156454|NCT04304508|50272821|FG001|Overall Study|Adverse Event|50|||
25156455|NCT04304508|50272822|FG002|Overall Study|Adverse Event|51|||
25156456|NCT04304508|50272823|FG003|Overall Study|Adverse Event|56|||
25156457|NCT04304508|50272820|FG000|Overall Study|Lost to Follow-up|1|||
24935429|NCT00432237|50028412|FG002|Overall Study|Pregnancy|0|||
24935430|NCT00432237|50028413|FG003|Overall Study|Pregnancy|0|||
24935431|NCT00432237|50028410|FG000|Overall Study|Protocol Violation|13|||
24935432|NCT00432237|50028411|FG001|Overall Study|Protocol Violation|10|||
24935433|NCT00432237|50028412|FG002|Overall Study|Protocol Violation|11|||
24935434|NCT00432237|50028413|FG003|Overall Study|Protocol Violation|8|||
24935435|NCT00432237|50028410|FG000|Overall Study|Withdrawal by Subject|5|||
24935436|NCT00432237|50028411|FG001|Overall Study|Withdrawal by Subject|6|||
24935437|NCT00432237|50028412|FG002|Overall Study|Withdrawal by Subject|9|||
24935438|NCT00432237|50028413|FG003|Overall Study|Withdrawal by Subject|11|||
24935439|NCT00432237|50028410|FG000|Overall Study|Lack of Qualifying Event|38|||
24935440|NCT00432237|50028411|FG001|Overall Study|Lack of Qualifying Event|71|||
24935441|NCT00432237|50028412|FG002|Overall Study|Lack of Qualifying Event|69|||
24935442|NCT00432237|50028413|FG003|Overall Study|Lack of Qualifying Event|84|||
24935443|NCT00531284|50028440|FG000|Overall Study|Progressive Disease|1|||
24935444|NCT00531284|50028441|FG001|Overall Study|Progressive Disease|3|||
24935445|NCT00531284|50028442|FG002|Overall Study|Progressive Disease|5|||
24935446|NCT00531284|50028443|FG003|Overall Study|Progressive Disease|42|||
24935447|NCT00531284|50028444|FG004|Overall Study|Progressive Disease|4|||
24935448|NCT00531284|50028445|FG005|Overall Study|Progressive Disease|4|||
24935449|NCT00531284|50028446|FG006|Overall Study|Progressive Disease|3|||
24935450|NCT00531284|50028447|FG007|Overall Study|Progressive Disease|8|||
24935451|NCT00531284|50028448|FG008|Overall Study|Progressive Disease|6|||
24935452|NCT00531284|50028449|FG009|Overall Study|Progressive Disease|3|||
24935453|NCT00531284|50028450|FG010|Overall Study|Progressive Disease|3|||
24935454|NCT00531284|50028451|FG011|Overall Study|Progressive Disease|14|||
24935455|NCT00531284|50028452|FG012|Overall Study|Progressive Disease|2|||
24935456|NCT00531284|50028453|FG013|Overall Study|Progressive Disease|1|||
24935457|NCT00531284|50028454|FG014|Overall Study|Progressive Disease|2|||
24935458|NCT00531284|50028455|FG015|Overall Study|Progressive Disease|11|||
24935459|NCT00531284|50028456|FG016|Overall Study|Progressive Disease|5|||
24935460|NCT00531284|50028440|FG000|Overall Study|Adverse Event|0|||
24935461|NCT00531284|50028441|FG001|Overall Study|Adverse Event|1|||
24935462|NCT00531284|50028442|FG002|Overall Study|Adverse Event|1|||
24935463|NCT00531284|50028443|FG003|Overall Study|Adverse Event|7|||
24935464|NCT00531284|50028444|FG004|Overall Study|Adverse Event|0|||
24935465|NCT00531284|50028445|FG005|Overall Study|Adverse Event|2|||
24935466|NCT00531284|50028446|FG006|Overall Study|Adverse Event|3|||
24935467|NCT00531284|50028447|FG007|Overall Study|Adverse Event|2|||
24935468|NCT00531284|50028448|FG008|Overall Study|Adverse Event|3|||
24935469|NCT00531284|50028449|FG009|Overall Study|Adverse Event|0|||
24935470|NCT00531284|50028450|FG010|Overall Study|Adverse Event|0|||
24935471|NCT00531284|50028451|FG011|Overall Study|Adverse Event|5|||
24935472|NCT00531284|50028452|FG012|Overall Study|Adverse Event|0|||
24935473|NCT00531284|50028453|FG013|Overall Study|Adverse Event|1|||
24935474|NCT00531284|50028454|FG014|Overall Study|Adverse Event|1|||
24935475|NCT00531284|50028455|FG015|Overall Study|Adverse Event|0|||
24935476|NCT00531284|50028456|FG016|Overall Study|Adverse Event|2|||
24935477|NCT00531284|50028440|FG000|Overall Study|Withdrawal by Subject|1|||
24935478|NCT00531284|50028441|FG001|Overall Study|Withdrawal by Subject|0|||
24935479|NCT00531284|50028442|FG002|Overall Study|Withdrawal by Subject|0|||
24935480|NCT00531284|50028443|FG003|Overall Study|Withdrawal by Subject|4|||
24935481|NCT00531284|50028444|FG004|Overall Study|Withdrawal by Subject|0|||
24935482|NCT00531284|50028445|FG005|Overall Study|Withdrawal by Subject|0|||
24935483|NCT00531284|50028446|FG006|Overall Study|Withdrawal by Subject|0|||
24935484|NCT00531284|50028447|FG007|Overall Study|Withdrawal by Subject|0|||
24935485|NCT00531284|50028448|FG008|Overall Study|Withdrawal by Subject|0|||
24935486|NCT00531284|50028449|FG009|Overall Study|Withdrawal by Subject|0|||
24935487|NCT00531284|50028450|FG010|Overall Study|Withdrawal by Subject|0|||
25156458|NCT04304508|50272821|FG001|Overall Study|Lost to Follow-up|5|||
25156459|NCT04304508|50272822|FG002|Overall Study|Lost to Follow-up|2|||
25156460|NCT04304508|50272823|FG003|Overall Study|Lost to Follow-up|3|||
24935488|NCT00531284|50028451|FG011|Overall Study|Withdrawal by Subject|3|||
24935489|NCT00531284|50028452|FG012|Overall Study|Withdrawal by Subject|0|||
24935490|NCT00531284|50028453|FG013|Overall Study|Withdrawal by Subject|1|||
24935491|NCT00531284|50028454|FG014|Overall Study|Withdrawal by Subject|0|||
24935492|NCT00531284|50028455|FG015|Overall Study|Withdrawal by Subject|1|||
24935493|NCT00531284|50028456|FG016|Overall Study|Withdrawal by Subject|1|||
25156461|NCT04206332|50272852|FG000|Part A|Lost to Follow-up|0|||
25156462|NCT04206332|50272853|FG001|Part A|Lost to Follow-up|1|||
25156463|NCT04206332|50272854|FG002|Part A|Lost to Follow-up|0|||
25156464|NCT04206332|50272855|FG003|Part A|Lost to Follow-up|0|||
25156465|NCT04206332|50272856|FG004|Part A|Lost to Follow-up|0|||
25156466|NCT04206332|50272857|FG005|Part A|Lost to Follow-up|0|||
25156467|NCT04206332|50272858|FG006|Part A|Lost to Follow-up|0|||
25156468|NCT04206332|50272859|FG007|Part A|Lost to Follow-up|0|||
25156469|NCT04206332|50272860|FG008|Part A|Lost to Follow-up|0|||
25156470|NCT04206332|50272861|FG009|Part A|Lost to Follow-up|0|||
25156471|NCT04206332|50272862|FG010|Part A|Lost to Follow-up|0|||
25156472|NCT04206332|50272863|FG011|Part A|Lost to Follow-up|0|||
25156473|NCT04206332|50272864|FG012|Part A|Lost to Follow-up|0|||
25156474|NCT04206332|50272865|FG013|Part A|Lost to Follow-up|0|||
25156475|NCT04206332|50272866|FG014|Part A|Lost to Follow-up|0|||
25156476|NCT04206332|50272867|FG015|Part A|Lost to Follow-up|0|||
25156477|NCT04206332|50272868|FG016|Part A|Lost to Follow-up|0|||
25186022|NCT01421147|50335820|FG001|Extension Period|Adverse Event|2|||
25186023|NCT01421147|50335819|FG000|Extension Period|Death|0|||
25156478|NCT04206332|50272852|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
25156479|NCT04206332|50272853|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
25186024|NCT01421147|50335820|FG001|Extension Period|Death|1|||
25186025|NCT01421147|50335819|FG000|Extension Period|Lost to Follow-up|2|||
25186026|NCT01421147|50335820|FG001|Extension Period|Lost to Follow-up|5|||
25186027|NCT01421147|50335819|FG000|Extension Period|Physician Decision|1|||
25186028|NCT01421147|50335820|FG001|Extension Period|Physician Decision|0|||
25186029|NCT01421147|50335819|FG000|Extension Period|Withdrawal by Subject|5|||
25186030|NCT01421147|50335820|FG001|Extension Period|Withdrawal by Subject|3|||
25186031|NCT01497938|50335837|FG000|Overall Study|Adverse Event|0|||
25186032|NCT01497938|50335838|FG001|Overall Study|Adverse Event|1|||
25156480|NCT04206332|50272854|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
25156481|NCT04206332|50272855|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
25156482|NCT04206332|50272856|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
25156483|NCT04206332|50272857|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
25156484|NCT04206332|50272858|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
25156485|NCT04206332|50272859|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
25156486|NCT04206332|50272860|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
25156487|NCT04206332|50272861|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
25156488|NCT04206332|50272862|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
25156489|NCT04206332|50272863|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
25156490|NCT04206332|50272864|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
25156491|NCT04206332|50272865|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
25156492|NCT04206332|50272866|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
25156493|NCT04206332|50272867|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
25156494|NCT04206332|50272868|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
25156495|NCT04206332|50272852|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156496|NCT04206332|50272853|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156497|NCT04206332|50272854|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156498|NCT04206332|50272855|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156499|NCT04206332|50272856|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156500|NCT04206332|50272857|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156501|NCT04206332|50272858|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156502|NCT04206332|50272859|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
25156503|NCT04206332|50272860|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156504|NCT04206332|50272861|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156505|NCT04206332|50272862|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
24935494|NCT00531284|50028440|FG000|Overall Study|Other|1|||
24935495|NCT00531284|50028441|FG001|Overall Study|Other|0|||
24935496|NCT00531284|50028442|FG002|Overall Study|Other|0|||
24935497|NCT00531284|50028443|FG003|Overall Study|Other|10|||
24935498|NCT00531284|50028444|FG004|Overall Study|Other|2|||
24935499|NCT00531284|50028445|FG005|Overall Study|Other|1|||
24935500|NCT00531284|50028446|FG006|Overall Study|Other|0|||
24935501|NCT00531284|50028447|FG007|Overall Study|Other|0|||
24935502|NCT00531284|50028448|FG008|Overall Study|Other|2|||
25027713|NCT03493451|50126023|FG002|Overall Study|Transferred to long term extension study|5|||
24935503|NCT00531284|50028449|FG009|Overall Study|Other|1|||
24935504|NCT00531284|50028450|FG010|Overall Study|Other|0|||
24935505|NCT00531284|50028451|FG011|Overall Study|Other|2|||
24935506|NCT00531284|50028452|FG012|Overall Study|Other|0|||
24935507|NCT00531284|50028453|FG013|Overall Study|Other|0|||
24935508|NCT00531284|50028454|FG014|Overall Study|Other|1|||
24935509|NCT00531284|50028455|FG015|Overall Study|Other|0|||
24935510|NCT00531284|50028456|FG016|Overall Study|Other|0|||
24935511|NCT00531206|50028512|FG000|Overall Study|Adverse Event related|5|||
24935512|NCT00531206|50028512|FG000|Overall Study|Lack of Efficacy|2|||
24935513|NCT00531206|50028512|FG000|Overall Study|Lost to Follow-up|5|||
24935514|NCT00531206|50028512|FG000|Overall Study|including non-related adverse events|8|||
24935515|NCT00530816|50028519|FG000|Overall Study|Progressive Disease|16|||
24935516|NCT00530816|50028520|FG001|Overall Study|Progressive Disease|24|||
24935517|NCT00530816|50028521|FG002|Overall Study|Progressive Disease|24|||
24935518|NCT00530816|50028519|FG000|Overall Study|Adverse Event|6|||
24935519|NCT00530816|50028520|FG001|Overall Study|Adverse Event|13|||
24935520|NCT00530816|50028521|FG002|Overall Study|Adverse Event|7|||
24935521|NCT00530816|50028519|FG000|Overall Study|Other|3|||
24935522|NCT00530816|50028520|FG001|Overall Study|Other|3|||
24935523|NCT00530816|50028521|FG002|Overall Study|Other|4|||
24935524|NCT00530816|50028519|FG000|Overall Study|Withdrawal by Subject|1|||
24935525|NCT00530816|50028520|FG001|Overall Study|Withdrawal by Subject|2|||
24935526|NCT00530816|50028521|FG002|Overall Study|Withdrawal by Subject|6|||
24935527|NCT00615017|50028535|FG000|Overall Study|Adverse Event|0|||
24935528|NCT00615017|50028536|FG001|Overall Study|Adverse Event|1|||
24935529|NCT00615017|50028537|FG002|Overall Study|Adverse Event|2|||
24935530|NCT00615017|50028538|FG003|Overall Study|Adverse Event|0|||
24935531|NCT00615017|50028539|FG004|Overall Study|Adverse Event|0|||
24935532|NCT00615017|50028540|FG005|Overall Study|Adverse Event|1|||
24935533|NCT00615017|50028535|FG000|Overall Study|Death|0|||
24935534|NCT00615017|50028536|FG001|Overall Study|Death|0|||
24935535|NCT00615017|50028537|FG002|Overall Study|Death|2|||
25156506|NCT04206332|50272863|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156507|NCT04206332|50272864|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156508|NCT04206332|50272865|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156509|NCT04206332|50272866|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156510|NCT04206332|50272867|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156511|NCT04206332|50272868|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156512|NCT04206332|50272852|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156513|NCT04206332|50272853|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156514|NCT04206332|50272854|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156515|NCT04206332|50272855|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156516|NCT04206332|50272856|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156517|NCT04206332|50272857|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156518|NCT04206332|50272858|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156519|NCT04206332|50272859|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156520|NCT04206332|50272860|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156521|NCT04206332|50272861|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156522|NCT04206332|50272862|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156523|NCT04206332|50272863|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156524|NCT04206332|50272864|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156525|NCT04206332|50272865|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156526|NCT04206332|50272866|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156527|NCT04206332|50272867|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
25156528|NCT04206332|50272868|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
25156529|NCT04206332|50272852|FG000|Part C|Withdrawal by Subject|0|||
25156530|NCT04206332|50272853|FG001|Part C|Withdrawal by Subject|0|||
25186033|NCT01497938|50335837|FG000|Overall Study|Physician Decision|0|||
25186034|NCT01497938|50335838|FG001|Overall Study|Physician Decision|1|||
24935536|NCT00615017|50028538|FG003|Overall Study|Death|0|||
24935537|NCT00615017|50028539|FG004|Overall Study|Death|1|||
24935538|NCT00615017|50028540|FG005|Overall Study|Death|1|||
24935539|NCT00615017|50028535|FG000|Overall Study|Sepsis resolved|0|||
24935540|NCT00615017|50028536|FG001|Overall Study|Sepsis resolved|0|||
24935541|NCT00615017|50028537|FG002|Overall Study|Sepsis resolved|1|||
24935542|NCT00615017|50028538|FG003|Overall Study|Sepsis resolved|0|||
24935543|NCT00615017|50028539|FG004|Overall Study|Sepsis resolved|0|||
24935544|NCT00615017|50028540|FG005|Overall Study|Sepsis resolved|0|||
24935545|NCT00615017|50028535|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
24935546|NCT00615017|50028536|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
24935547|NCT00615017|50028537|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
24935548|NCT00615017|50028538|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
24935549|NCT00615017|50028539|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
24935550|NCT00615017|50028540|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
24935551|NCT00615017|50028535|FG000|Overall Study|Physician discontinued drug|0|||
24935552|NCT00615017|50028536|FG001|Overall Study|Physician discontinued drug|0|||
24935553|NCT00615017|50028537|FG002|Overall Study|Physician discontinued drug|0|||
24935554|NCT00615017|50028538|FG003|Overall Study|Physician discontinued drug|0|||
24935555|NCT00615017|50028539|FG004|Overall Study|Physician discontinued drug|0|||
24935556|NCT00615017|50028540|FG005|Overall Study|Physician discontinued drug|1|||
24935557|NCT00614939|50028556|FG000|Overall Study|Withdrawal by Subject|10|||
24935558|NCT00614939|50028557|FG001|Overall Study|Withdrawal by Subject|17|||
24935559|NCT00614939|50028556|FG000|Overall Study|Study specific discontinuation criteris|13|||
24935560|NCT00614939|50028557|FG001|Overall Study|Study specific discontinuation criteris|16|||
24935561|NCT00614939|50028556|FG000|Overall Study|Adverse Event|2|||
24935562|NCT00614939|50028557|FG001|Overall Study|Adverse Event|5|||
25156531|NCT04206332|50272854|FG002|Part C|Withdrawal by Subject|0|||
25156532|NCT04206332|50272855|FG003|Part C|Withdrawal by Subject|0|||
25156533|NCT04206332|50272856|FG004|Part C|Withdrawal by Subject|0|||
25156534|NCT04206332|50272857|FG005|Part C|Withdrawal by Subject|0|||
25156535|NCT04206332|50272858|FG006|Part C|Withdrawal by Subject|0|||
25156536|NCT04206332|50272859|FG007|Part C|Withdrawal by Subject|0|||
25156537|NCT04206332|50272860|FG008|Part C|Withdrawal by Subject|0|||
25156538|NCT04206332|50272861|FG009|Part C|Withdrawal by Subject|0|||
25156539|NCT04206332|50272862|FG010|Part C|Withdrawal by Subject|0|||
25156540|NCT04206332|50272863|FG011|Part C|Withdrawal by Subject|0|||
25156541|NCT04206332|50272864|FG012|Part C|Withdrawal by Subject|0|||
25156542|NCT04206332|50272865|FG013|Part C|Withdrawal by Subject|0|||
25156543|NCT04206332|50272866|FG014|Part C|Withdrawal by Subject|2|||
25156544|NCT04206332|50272867|FG015|Part C|Withdrawal by Subject|0|||
25156545|NCT04206332|50272868|FG016|Part C|Withdrawal by Subject|0|||
25156546|NCT03830866|50272953|FG000|Overall Study|Ongoing study at DCO|312|||
24935563|NCT00614939|50028556|FG000|Overall Study|Incorrect enrollment|1|||
25156547|NCT03830866|50272954|FG001|Overall Study|Ongoing study at DCO|295|||
24935564|NCT00614939|50028557|FG001|Overall Study|Incorrect enrollment|2|||
24935565|NCT00614939|50028556|FG000|Overall Study|Death|4|||
24935566|NCT00614939|50028557|FG001|Overall Study|Death|3|||
24935567|NCT00614939|50028556|FG000|Overall Study|Poor/non-compliance|4|||
24935568|NCT00614939|50028557|FG001|Overall Study|Poor/non-compliance|0|||
24935569|NCT00614939|50028556|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
24935570|NCT00614939|50028557|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
24935571|NCT00530504|50028563|FG000|Overall Study|Death|54|||
24935572|NCT00530504|50028563|FG000|Overall Study|Lost to Follow-up|26|||
24935573|NCT00530504|50028563|FG000|Overall Study|Withdrawal by Subject|39|||
24935574|NCT00530504|50028563|FG000|Overall Study|Exited study due to other reasons|33|||
24935575|NCT05159362|50028570|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
24935576|NCT05159362|50028571|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
24935577|NCT05159362|50028572|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
24935578|NCT04975191|50028587|FG000|Overall Study|Protocol Violation|1|||
24935579|NCT04975191|50028588|FG001|Overall Study|Protocol Violation|2|||
24935580|NCT04975191|50028589|FG002|Overall Study|Protocol Violation|2|||
24935581|NCT04975191|50028590|FG003|Overall Study|Protocol Violation|2|||
24935582|NCT04975191|50028587|FG000|Overall Study|Lost to Follow-up|13|||
24935583|NCT04975191|50028588|FG001|Overall Study|Lost to Follow-up|3|||
24935584|NCT04975191|50028589|FG002|Overall Study|Lost to Follow-up|8|||
24935585|NCT04975191|50028590|FG003|Overall Study|Lost to Follow-up|8|||
25275139|NCT01235741|50589178|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
25275140|NCT01235741|50589176|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
25275141|NCT01235741|50589177|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
25275142|NCT01235741|50589178|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
25275143|NCT01235741|50589176|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
25275144|NCT01235741|50589177|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
25027714|NCT03492281|50126034|FG000|Overall Study|Withdrawal by Subject|21|||
25027715|NCT03492281|50126035|FG001|Overall Study|Withdrawal by Subject|14|||
25027716|NCT03492281|50126036|FG002|Overall Study|Withdrawal by Subject|13|||
25027717|NCT03492281|50126034|FG000|Overall Study|Lost to Follow-up|14|||
25027718|NCT03492281|50126035|FG001|Overall Study|Lost to Follow-up|15|||
25027719|NCT03492281|50126036|FG002|Overall Study|Lost to Follow-up|10|||
25027720|NCT03492281|50126034|FG000|Overall Study|Adverse Event|6|||
25027721|NCT03492281|50126035|FG001|Overall Study|Adverse Event|8|||
25027722|NCT03492281|50126036|FG002|Overall Study|Adverse Event|13|||
25156548|NCT03830866|50272953|FG000|Overall Study|Death|58|||
25156549|NCT03830866|50272954|FG001|Overall Study|Death|74|||
25156550|NCT03830866|50272953|FG000|Overall Study|Lost to Follow-up|0|||
25156551|NCT03830866|50272954|FG001|Overall Study|Lost to Follow-up|1|||
25027723|NCT03492281|50126034|FG000|Overall Study|Lack of Efficacy|3|||
25027724|NCT03492281|50126035|FG001|Overall Study|Lack of Efficacy|0|||
25027725|NCT03492281|50126036|FG002|Overall Study|Lack of Efficacy|1|||
25027726|NCT03492281|50126034|FG000|Overall Study|Physician Decision|1|||
25027727|NCT03492281|50126035|FG001|Overall Study|Physician Decision|0|||
25027728|NCT03492281|50126036|FG002|Overall Study|Physician Decision|3|||
25027729|NCT03492281|50126034|FG000|Overall Study|Protocol Violation|0|||
25027730|NCT03492281|50126035|FG001|Overall Study|Protocol Violation|2|||
25027731|NCT03492281|50126036|FG002|Overall Study|Protocol Violation|1|||
25027732|NCT03492281|50126034|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
25027733|NCT03492281|50126035|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
25027734|NCT03492281|50126036|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
25027735|NCT03492281|50126034|FG000|Overall Study|Death|0|||
25027736|NCT03492281|50126035|FG001|Overall Study|Death|0|||
25027737|NCT03492281|50126036|FG002|Overall Study|Death|1|||
25027738|NCT03492281|50126034|FG000|Overall Study|Captured as Other in Database|8|||
25027739|NCT03492281|50126035|FG001|Overall Study|Captured as Other in Database|6|||
25027740|NCT03492281|50126036|FG002|Overall Study|Captured as Other in Database|3|||
25027741|NCT03070782|50126053|FG000|Overall Study|Adverse Event|3|||
25027742|NCT03070782|50126054|FG001|Overall Study|Adverse Event|0|||
25027743|NCT03070782|50126055|FG002|Overall Study|Adverse Event|3|||
25027744|NCT03070782|50126056|FG003|Overall Study|Adverse Event|1|||
25027745|NCT03070782|50126057|FG004|Overall Study|Adverse Event|6|||
25027746|NCT03070782|50126058|FG005|Overall Study|Adverse Event|2|||
25027747|NCT03070782|50126053|FG000|Overall Study|Withdrawal by Subject|2|||
25027748|NCT03070782|50126054|FG001|Overall Study|Withdrawal by Subject|1|||
25027749|NCT03070782|50126055|FG002|Overall Study|Withdrawal by Subject|1|||
25027750|NCT03070782|50126056|FG003|Overall Study|Withdrawal by Subject|0|||
25027751|NCT03070782|50126057|FG004|Overall Study|Withdrawal by Subject|4|||
25027752|NCT03070782|50126058|FG005|Overall Study|Withdrawal by Subject|3|||
25027753|NCT03070782|50126053|FG000|Overall Study|Reason Not Specified|2|||
25027754|NCT03070782|50126054|FG001|Overall Study|Reason Not Specified|0|||
25027755|NCT03070782|50126055|FG002|Overall Study|Reason Not Specified|0|||
25027756|NCT03070782|50126056|FG003|Overall Study|Reason Not Specified|1|||
25027757|NCT03070782|50126057|FG004|Overall Study|Reason Not Specified|2|||
25027758|NCT03070782|50126058|FG005|Overall Study|Reason Not Specified|1|||
25027759|NCT03070782|50126053|FG000|Overall Study|Ineligibility|0|||
25027760|NCT03070782|50126054|FG001|Overall Study|Ineligibility|0|||
25027761|NCT03070782|50126055|FG002|Overall Study|Ineligibility|0|||
25027762|NCT03070782|50126056|FG003|Overall Study|Ineligibility|1|||
25027763|NCT03070782|50126057|FG004|Overall Study|Ineligibility|0|||
25027764|NCT03070782|50126058|FG005|Overall Study|Ineligibility|1|||
25027765|NCT03070782|50126053|FG000|Overall Study|Pregnancy|0|||
25027766|NCT03070782|50126054|FG001|Overall Study|Pregnancy|0|||
25027767|NCT03070782|50126055|FG002|Overall Study|Pregnancy|0|||
25027768|NCT03070782|50126056|FG003|Overall Study|Pregnancy|1|||
25027769|NCT03070782|50126057|FG004|Overall Study|Pregnancy|0|||
25027770|NCT03070782|50126058|FG005|Overall Study|Pregnancy|0|||
25027771|NCT03070782|50126053|FG000|Overall Study|Investigator Judgement|0|||
25027772|NCT03070782|50126054|FG001|Overall Study|Investigator Judgement|0|||
25027773|NCT03070782|50126055|FG002|Overall Study|Investigator Judgement|0|||
25027774|NCT03070782|50126056|FG003|Overall Study|Investigator Judgement|1|||
25027775|NCT03070782|50126057|FG004|Overall Study|Investigator Judgement|0|||
25027776|NCT03070782|50126058|FG005|Overall Study|Investigator Judgement|0|||
25027777|NCT03525119|50126094|FG000|Overall Study|Adverse Event|0|||
25027778|NCT03525119|50126095|FG001|Overall Study|Adverse Event|1|||
25027779|NCT03525119|50126096|FG002|Overall Study|Adverse Event|0|||
25027780|NCT03525119|50126094|FG000|Overall Study|Lost to Follow-up|32|||
25027781|NCT03525119|50126095|FG001|Overall Study|Lost to Follow-up|33|||
25027782|NCT03525119|50126096|FG002|Overall Study|Lost to Follow-up|37|||
25027783|NCT03525119|50126094|FG000|Overall Study|Withdrawal by Subject|5|||
25027784|NCT03525119|50126095|FG001|Overall Study|Withdrawal by Subject|4|||
25027785|NCT03525119|50126096|FG002|Overall Study|Withdrawal by Subject|2|||
25027786|NCT03525119|50126094|FG000|Overall Study|Reason not Specified|2|||
25027787|NCT03525119|50126095|FG001|Overall Study|Reason not Specified|1|||
25027788|NCT03525119|50126096|FG002|Overall Study|Reason not Specified|2|||
25027789|NCT03525119|50126094|FG000|Overall Study|Randomized but not Vaccinated|1|||
25027790|NCT03525119|50126095|FG001|Overall Study|Randomized but not Vaccinated|0|||
25027791|NCT03525119|50126096|FG002|Overall Study|Randomized but not Vaccinated|2|||
25027792|NCT03558503|50126104|FG000|Overall Study|Adverse Event|1|||
25027793|NCT03558503|50126104|FG000|Overall Study|Death|1|||
25027794|NCT03558503|50126104|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
25027795|NCT03489863|50126110|FG000|Overall Study|Withdrawal by Subject|0|||
25156552|NCT03830866|50272953|FG000|Overall Study|Withdrawal by Subject|15|||
25027796|NCT03489863|50126111|FG001|Overall Study|Withdrawal by Subject|1|||
25027797|NCT03489551|50126117|FG000|Overall Study|Withdrawal by Subject|2|||
25027798|NCT03557801|50126124|FG000|Overall Study|Protocol Violation|1|||
25027799|NCT03557801|50126125|FG001|Overall Study|Protocol Violation|0|||
25027800|NCT03557801|50126126|FG002|Overall Study|Protocol Violation|0|||
25027801|NCT03557801|50126124|FG000|Overall Study|Withdrawal by Subject|1|||
25027802|NCT03557801|50126125|FG001|Overall Study|Withdrawal by Subject|0|||
25027803|NCT03557801|50126126|FG002|Overall Study|Withdrawal by Subject|3|||
25027804|NCT03557801|50126124|FG000|Overall Study|Lost to Follow-up|0|||
25027805|NCT03557801|50126125|FG001|Overall Study|Lost to Follow-up|1|||
25027806|NCT03557801|50126126|FG002|Overall Study|Lost to Follow-up|0|||
25027807|NCT04210180|50126134|FG000|Overall Study|Withdrawal by Subject|2|||
25027808|NCT03523871|50126138|FG000|Overall Study|Death|1|||
25027809|NCT03523715|50126144|FG000|Overall Study|Lost to Follow-up|11|||
25027810|NCT03523715|50126145|FG001|Overall Study|Lost to Follow-up|14|||
25027811|NCT03523715|50126144|FG000|Overall Study|Did not meet inclusion criteria|1|||
25027812|NCT03523715|50126145|FG001|Overall Study|Did not meet inclusion criteria|0|||
25027813|NCT03523715|50126144|FG000|Overall Study|Internally inconsistent reporting|0|||
25027814|NCT03523715|50126145|FG001|Overall Study|Internally inconsistent reporting|2|||
25027815|NCT03980730|50126153|FG000|Overall Study|Study Terminated by Sponsor|0|||
25027816|NCT03980730|50126154|FG001|Overall Study|Study Terminated by Sponsor|3|||
25027817|NCT03980730|50126153|FG000|Overall Study|Adverse Event|2|||
25027818|NCT03980730|50126154|FG001|Overall Study|Adverse Event|0|||
25027819|NCT03980730|50126153|FG000|Overall Study|Sponsor Request|0|||
25027820|NCT03980730|50126154|FG001|Overall Study|Sponsor Request|1|||
25027821|NCT03523091|50126162|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
25027822|NCT03523091|50126163|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
25027823|NCT03523091|50126162|FG000|Overall Study|Withdrawal by Subject|0|||
25027824|NCT03523091|50126163|FG001|Overall Study|Withdrawal by Subject|3|||
25027825|NCT03523091|50126162|FG000|Overall Study|Increase Botox dose|0|||
25027826|NCT03523091|50126163|FG001|Overall Study|Increase Botox dose|1|||
25027827|NCT03438383|50126184|FG000|Overall Study|Protocol Violation|9|||
25027828|NCT03438383|50126185|FG001|Overall Study|Protocol Violation|3|||
25027829|NCT03478787|50126193|FG000|Overall Study|Adverse Event|5|||
25027830|NCT03478787|50126194|FG001|Overall Study|Adverse Event|1|||
25027831|NCT03478787|50126193|FG000|Overall Study|Protocol Violation|3|||
25027832|NCT03478787|50126194|FG001|Overall Study|Protocol Violation|0|||
25027833|NCT03478787|50126193|FG000|Overall Study|Lack of Efficacy|7|||
25027834|NCT03478787|50126194|FG001|Overall Study|Lack of Efficacy|1|||
25156553|NCT03830866|50272954|FG001|Overall Study|Withdrawal by Subject|13|||
25156554|NCT03830866|50272953|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
25027835|NCT03478787|50126193|FG000|Overall Study|Lost to Follow-up|9|||
25027836|NCT03478787|50126194|FG001|Overall Study|Lost to Follow-up|5|||
25156555|NCT03830866|50272954|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
25027837|NCT03478787|50126193|FG000|Overall Study|Withdrawal by Subject|2|||
25027838|NCT03478787|50126194|FG001|Overall Study|Withdrawal by Subject|6|||
25027839|NCT03478787|50126193|FG000|Overall Study|Other, Not Specified|3|||
25275145|NCT01235741|50589178|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
25275146|NCT01235741|50589176|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
25275147|NCT01235741|50589177|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
25275148|NCT01235741|50589178|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
25275149|NCT01235741|50589176|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
25275150|NCT01235741|50589177|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
25275151|NCT01235741|50589178|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
25275152|NCT01235741|50589176|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
25275153|NCT01235741|50589177|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
25275154|NCT01235741|50589178|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
25275155|NCT01235741|50589176|FG000|Randomized to Treatment|Adverse Event|0|||
25275156|NCT01235741|50589177|FG001|Randomized to Treatment|Adverse Event|1|||
25275157|NCT01235741|50589178|FG002|Randomized to Treatment|Adverse Event|1|||
25275158|NCT01235741|50589176|FG000|Randomized to Treatment|Sponsor terminated study|0|||
25275159|NCT01235741|50589177|FG001|Randomized to Treatment|Sponsor terminated study|35|||
25275160|NCT01235741|50589178|FG002|Randomized to Treatment|Sponsor terminated study|34|||
25275161|NCT01235741|50589176|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
25275162|NCT01235741|50589177|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
25275163|NCT01235741|50589178|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
25275164|NCT01235741|50589176|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
25275165|NCT01235741|50589177|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
25275166|NCT01235741|50589178|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
25275167|NCT01235741|50589176|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
25275168|NCT01235741|50589177|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
25275169|NCT01235741|50589178|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
25275170|NCT01235507|50589190|FG000|Overall Study|Adverse Event|1|||
25275171|NCT01235507|50589190|FG000|Overall Study|Withdrawal by Subject|1|||
25275172|NCT01235351|50589196|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
25275173|NCT01235351|50589197|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
25275174|NCT01076205|50589207|FG000|Overall Study|Adverse Drug Reaction|299|||
24935629|NCT04492020|50028672|FG000|Overall Study|Adverse Event|1|||
24935630|NCT04492020|50028673|FG001|Overall Study|Adverse Event|3|||
25027840|NCT03478787|50126194|FG001|Overall Study|Other, Not Specified|0|||
25027841|NCT03488927|50126203|FG000|Overall Study|Withdrawal by Subject|44|||
25027842|NCT03488927|50126204|FG001|Overall Study|Withdrawal by Subject|118|||
25027843|NCT03488927|50126205|FG002|Overall Study|Withdrawal by Subject|217|||
25027844|NCT03488225|50126213|FG000|Overall Study|Off Protocol Therapy|2|||
24935631|NCT04492020|50028672|FG000|Overall Study|Withdrawal by Subject|4|||
24935632|NCT04492020|50028673|FG001|Overall Study|Withdrawal by Subject|3|||
24935633|NCT04492020|50028672|FG000|Overall Study|Lost to Follow-up|4|||
24935634|NCT04492020|50028673|FG001|Overall Study|Lost to Follow-up|3|||
24935635|NCT04492020|50028672|FG000|Overall Study|Protocol Violation|5|||
24935636|NCT04492020|50028673|FG001|Overall Study|Protocol Violation|2|||
24935637|NCT04492020|50028672|FG000|Overall Study|Lack of Qualifying Event|25|||
24935638|NCT04492020|50028673|FG001|Overall Study|Lack of Qualifying Event|27|||
24935639|NCT04492020|50028672|FG000|Overall Study|Non-compliance with Study Drug|2|||
24935640|NCT04492020|50028673|FG001|Overall Study|Non-compliance with Study Drug|1|||
24935641|NCT04382911|50028679|FG000|Overall Study|unable to be imaged prior to surgery|2|||
24935644|NCT04072575|50028697|FG000|Overall Study|Physician Decision|1|||
24935645|NCT04072575|50028697|FG000|Overall Study|Adverse Event|7|||
24935646|NCT04072575|50028697|FG000|Overall Study|Withdrawal by Subject|14|||
24935647|NCT04072575|50028697|FG000|Overall Study|Other|2|||
24935648|NCT03956056|50028701|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
24935649|NCT03956056|50028701|FG000|Overall Study|Lack of Efficacy|1|||
24935650|NCT03911869|50028707|FG000|Safety Lead-in Phase|Death|7|||
24935651|NCT03911869|50028708|FG001|Safety Lead-in Phase|Death|0|||
24935652|NCT03911869|50028709|FG002|Safety Lead-in Phase|Death|0|||
24935653|NCT03911869|50028707|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
24935654|NCT03911869|50028708|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
24935655|NCT03911869|50028709|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
24935656|NCT03911869|50028707|FG000|Safety Lead-in Phase|Other|1|||
24935657|NCT03911869|50028708|FG001|Safety Lead-in Phase|Other|0|||
24935658|NCT03911869|50028709|FG002|Safety Lead-in Phase|Other|0|||
24935659|NCT03911869|50028707|FG000|Phase 2|Death|0|||
24935660|NCT03911869|50028708|FG001|Phase 2|Death|3|||
24935661|NCT03911869|50028709|FG002|Phase 2|Death|0|||
24935662|NCT03897088|50028718|FG000|Overall Study|Withdrawal by Subject|12|||
24935663|NCT03897088|50028719|FG001|Overall Study|Withdrawal by Subject|12|||
24935664|NCT03897088|50028718|FG000|Overall Study|Lost to Follow-up|7|||
24935665|NCT03897088|50028719|FG001|Overall Study|Lost to Follow-up|15|||
24935666|NCT03897088|50028718|FG000|Overall Study|Sponsor Decision|1|||
25027845|NCT03488225|50126213|FG000|Overall Study|Stem Cell Transplant|2|||
24935667|NCT03897088|50028719|FG001|Overall Study|Sponsor Decision|2|||
24935668|NCT03897088|50028718|FG000|Overall Study|COVID-19|2|||
24935669|NCT03897088|50028719|FG001|Overall Study|COVID-19|0|||
24935670|NCT03897088|50028718|FG000|Overall Study|Other|3|||
24935671|NCT03897088|50028719|FG001|Overall Study|Other|0|||
24935672|NCT03897088|50028718|FG000|Overall Study|Non-compliance with Study Drug|1|||
24935673|NCT03897088|50028719|FG001|Overall Study|Non-compliance with Study Drug|1|||
24935674|NCT03897088|50028718|FG000|Overall Study|Pregnancy|0|||
24935675|NCT03897088|50028719|FG001|Overall Study|Pregnancy|1|||
24935676|NCT03700684|50028747|FG000|Overall Study|COVID-19|0|||
24935677|NCT03700684|50028748|FG001|Overall Study|COVID-19|0|||
24935678|NCT03700684|50028749|FG002|Overall Study|COVID-19|2|||
24935679|NCT03659136|50028759|FG000|Overall Study|Not treated|2|||
24935680|NCT03659136|50028760|FG001|Overall Study|Not treated|0|||
24935681|NCT03659136|50028759|FG000|Overall Study|Covid-19 related|1|||
24935682|NCT03659136|50028760|FG001|Overall Study|Covid-19 related|1|||
24935683|NCT03659136|50028759|FG000|Overall Study|Withdrawal by Subject|1|||
24935684|NCT03659136|50028760|FG001|Overall Study|Withdrawal by Subject|6|||
24935685|NCT03659136|50028759|FG000|Overall Study|Adverse Event|4|||
24935686|NCT03659136|50028760|FG001|Overall Study|Adverse Event|6|||
24935687|NCT03659136|50028759|FG000|Overall Study|Progressive disease|37|||
24935688|NCT03659136|50028760|FG001|Overall Study|Progressive disease|31|||
24935689|NCT03659136|50028759|FG000|Overall Study|Study closure|2|||
24935690|NCT03659136|50028760|FG001|Overall Study|Study closure|2|||
24935691|NCT03659136|50028759|FG000|Overall Study|Sponsor decision/recommendation|3|||
25027846|NCT03437447|50126220|FG000|Treatment Period 1|Withdrawal by Subject|0|||
25027847|NCT03437447|50126221|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25027848|NCT03437447|50126222|FG002|Treatment Period 1|Withdrawal by Subject|1|||
25027849|NCT03487445|50126245|FG000|Randomization|Not treated for administrative reasons|1|||
25027850|NCT03487445|50126246|FG001|Randomization|Not treated for administrative reasons|0|||
25027851|NCT02109172|50126252|FG000|Overall Study|Withdrawal by Subject|1|||
25027852|NCT02109172|50126253|FG001|Overall Study|Withdrawal by Subject|0|||
25027853|NCT02109172|50126254|FG002|Overall Study|Withdrawal by Subject|0|||
25027854|NCT02109172|50126255|FG003|Overall Study|Withdrawal by Subject|1|||
25027855|NCT02109172|50126256|FG004|Overall Study|Withdrawal by Subject|0|||
25027856|NCT02109172|50126257|FG005|Overall Study|Withdrawal by Subject|0|||
25027857|NCT02109172|50126252|FG000|Overall Study|Adverse Event|0|||
25027858|NCT02109172|50126253|FG001|Overall Study|Adverse Event|0|||
25027859|NCT02109172|50126254|FG002|Overall Study|Adverse Event|1|||
25027860|NCT02109172|50126255|FG003|Overall Study|Adverse Event|0|||
24935692|NCT03659136|50028760|FG001|Overall Study|Sponsor decision/recommendation|2|||
24935693|NCT03659136|50028759|FG000|Overall Study|Switched to other drug/therapy|2|||
24935694|NCT03659136|50028760|FG001|Overall Study|Switched to other drug/therapy|2|||
24935695|NCT03659136|50028759|FG000|Overall Study|Lack of clinical benefit|0|||
24935696|NCT03659136|50028760|FG001|Overall Study|Lack of clinical benefit|1|||
24935697|NCT03390036|50028795|FG000|Overall Study|Lost to Follow-up|1|||
24935698|NCT03390036|50028796|FG001|Overall Study|Lost to Follow-up|0|||
24935699|NCT03390036|50028797|FG002|Overall Study|Lost to Follow-up|0|||
24935700|NCT03390036|50028795|FG000|Overall Study|Lack of Efficacy|1|||
24935701|NCT03390036|50028796|FG001|Overall Study|Lack of Efficacy|0|||
24935702|NCT03390036|50028797|FG002|Overall Study|Lack of Efficacy|0|||
24935703|NCT03366844|50028822|FG000|Overall Study|Physician Decision|1|||
24935704|NCT03366844|50028822|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
24935705|NCT03341936|50028828|FG000|Overall Study|Ineligible|1|||
25027861|NCT02109172|50126256|FG004|Overall Study|Adverse Event|0|||
25027862|NCT02109172|50126257|FG005|Overall Study|Adverse Event|1|||
25027863|NCT02109172|50126252|FG000|Overall Study|Death|0|||
25027864|NCT02109172|50126253|FG001|Overall Study|Death|0|||
24935706|NCT03341936|50028828|FG000|Overall Study|Disease Progression|2|||
24935707|NCT03341936|50028828|FG000|Overall Study|Withdrew Consent|4|||
24935708|NCT03341936|50028828|FG000|Overall Study|Non-Compliance|1|||
24935709|NCT03341936|50028828|FG000|Overall Study|Physician Decision|1|||
24935710|NCT03341936|50028828|FG000|Overall Study|Withdrawal by Subject|1|||
24935711|NCT03341936|50028828|FG000|Overall Study|Other|1|||
24935712|NCT03284203|50028832|FG000|Overall Study|Lost to Follow-up|3|||
24935713|NCT03233724|50028851|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
24935714|NCT03233724|50028852|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
25027865|NCT02109172|50126254|FG002|Overall Study|Death|0|||
25186035|NCT01497938|50335837|FG000|Overall Study|Withdrawal by Subject|4|||
24935715|NCT03233724|50028853|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
24935716|NCT03233724|50028854|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
24935717|NCT03233724|50028855|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
25027866|NCT02109172|50126255|FG003|Overall Study|Death|0|||
25027867|NCT02109172|50126256|FG004|Overall Study|Death|1|||
25027868|NCT02109172|50126257|FG005|Overall Study|Death|0|||
24935718|NCT03233724|50028851|FG000|Phase I Dose Escalation|Best interest of participant|1|||
24935719|NCT03233724|50028852|FG001|Phase I Dose Escalation|Best interest of participant|1|||
24935720|NCT03233724|50028853|FG002|Phase I Dose Escalation|Best interest of participant|1|||
24935721|NCT03233724|50028854|FG003|Phase I Dose Escalation|Best interest of participant|0|||
24935722|NCT03233724|50028855|FG004|Phase I Dose Escalation|Best interest of participant|0|||
24935723|NCT03233724|50028851|FG000|Phase I Dose Escalation|Physician Decision|0|||
24935724|NCT03233724|50028852|FG001|Phase I Dose Escalation|Physician Decision|0|||
24935725|NCT03233724|50028853|FG002|Phase I Dose Escalation|Physician Decision|1|||
24935726|NCT03233724|50028854|FG003|Phase I Dose Escalation|Physician Decision|0|||
24935727|NCT03233724|50028855|FG004|Phase I Dose Escalation|Physician Decision|0|||
24935728|NCT03233724|50028851|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
24935729|NCT03233724|50028852|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
24935730|NCT03233724|50028853|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
24935731|NCT03233724|50028854|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
24935732|NCT03233724|50028855|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
24935733|NCT03089606|50028878|FG000|Overall Study|Progression after Cycle 1|1|||
24935734|NCT03026283|50028890|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
24935735|NCT03026283|50028891|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
24935736|NCT03026283|50028892|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
25156556|NCT03830866|50272953|FG000|Overall Study|Other|0|||
25156557|NCT03830866|50272954|FG001|Overall Study|Other|1|||
25156558|NCT03790111|50272960|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
25156559|NCT03780543|50272967|FG000|Overall Study|Adverse Event|1|||
25156560|NCT03780543|50272968|FG001|Overall Study|Adverse Event|0|||
25156561|NCT03780543|50272969|FG002|Overall Study|Adverse Event|2|||
25156562|NCT03780543|50272967|FG000|Overall Study|Lost to Follow-up|2|||
25156563|NCT03780543|50272968|FG001|Overall Study|Lost to Follow-up|0|||
24935737|NCT03026283|50028893|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
24935738|NCT03026283|50028894|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
24935739|NCT03026283|50028895|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
24935740|NCT03026283|50028896|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
24935741|NCT03026283|50028897|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
24935742|NCT03026283|50028890|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
24935743|NCT03026283|50028891|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
24935744|NCT03026283|50028892|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
24935745|NCT03026283|50028893|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
24935746|NCT03026283|50028894|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
24935747|NCT03026283|50028895|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
24935748|NCT03026283|50028896|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
24935749|NCT03026283|50028897|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
24935750|NCT03026283|50028890|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
24935751|NCT03026283|50028891|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
24935752|NCT03026283|50028892|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
24935753|NCT03026283|50028893|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
24935754|NCT03026283|50028894|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
24935755|NCT03026283|50028895|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
24935756|NCT03026283|50028896|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
24935757|NCT03026283|50028897|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
25156564|NCT03780543|50272969|FG002|Overall Study|Lost to Follow-up|1|||
25156565|NCT03780543|50272967|FG000|Overall Study|Study terminated by Sponsor|8|||
25156566|NCT03780543|50272968|FG001|Overall Study|Study terminated by Sponsor|7|||
25156567|NCT03780543|50272969|FG002|Overall Study|Study terminated by Sponsor|13|||
24935758|NCT03026283|50028890|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
24935759|NCT03026283|50028891|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
24935760|NCT03026283|50028892|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
24935761|NCT03026283|50028893|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
24935762|NCT03026283|50028894|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
24935763|NCT03026283|50028895|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
24935764|NCT03026283|50028896|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
24935765|NCT03026283|50028897|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
24935766|NCT03026283|50028890|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
24935767|NCT03026283|50028891|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
24935768|NCT03026283|50028892|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
24935769|NCT03026283|50028893|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
24935770|NCT03026283|50028894|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
24935771|NCT03026283|50028895|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
24935772|NCT03026283|50028896|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
24935773|NCT03026283|50028897|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
24935774|NCT03026283|50028890|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
24935775|NCT03026283|50028891|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
24935776|NCT03026283|50028892|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
24935777|NCT03026283|50028893|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
24935778|NCT03026283|50028894|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
24935779|NCT03026283|50028895|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
24935780|NCT03026283|50028896|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
24935781|NCT03026283|50028897|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
24935782|NCT03026283|50028890|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
24935783|NCT03026283|50028891|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
24935784|NCT03026283|50028892|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
24935785|NCT03026283|50028893|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
24935786|NCT03026283|50028894|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
24935787|NCT03026283|50028895|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
24935788|NCT03026283|50028896|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
24935789|NCT03026283|50028897|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
24935790|NCT03026283|50028890|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
24935791|NCT03026283|50028891|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
24935792|NCT03026283|50028892|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
24935793|NCT03026283|50028893|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
24935794|NCT03026283|50028894|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
24935795|NCT03026283|50028895|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
24935796|NCT03026283|50028896|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
24935797|NCT03026283|50028897|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
24935798|NCT03026283|50028890|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
24935799|NCT03026283|50028891|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
24935800|NCT03026283|50028892|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
24935801|NCT03026283|50028893|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
24935802|NCT03026283|50028894|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
24935803|NCT03026283|50028895|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
24935804|NCT03026283|50028896|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
24935805|NCT03026283|50028897|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
24935806|NCT02764762|50028932|FG000|Overall Study|Adverse Event|5|||
24935807|NCT02764762|50028932|FG000|Overall Study|Voluntary Withdrawal|3|||
25027869|NCT02974868|50126268|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
25027870|NCT02974868|50126269|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
25027871|NCT02974868|50126270|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
25027872|NCT02974868|50126271|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
25027873|NCT02974868|50126268|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
25027874|NCT02974868|50126269|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
25027875|NCT02974868|50126270|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
25027876|NCT02974868|50126271|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
25027877|NCT02974868|50126268|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
25027878|NCT02974868|50126269|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
25027879|NCT02974868|50126270|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
25027880|NCT02974868|50126271|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
25275175|NCT01076205|50589207|FG000|Overall Study|Lack of Effectiveness|1423|||
25275176|NCT01076205|50589207|FG000|Overall Study|Other Reason|1075|||
25275177|NCT01076205|50589207|FG000|Overall Study|Unknown Reason|71|||
24935808|NCT02764762|50028932|FG000|Overall Study|Significant Deviation|1|||
24935809|NCT02701283|50028939|FG000|Overall Study|Death|25|||
24935810|NCT02701283|50028940|FG001|Overall Study|Death|29|||
24935811|NCT02701283|50028941|FG002|Overall Study|Death|19|||
24935812|NCT02701283|50028939|FG000|Overall Study|Lost to Follow-up|3|||
24935813|NCT02701283|50028940|FG001|Overall Study|Lost to Follow-up|8|||
24935814|NCT02701283|50028941|FG002|Overall Study|Lost to Follow-up|1|||
24935815|NCT02701283|50028939|FG000|Overall Study|Withdrawal by Subject|12|||
24935816|NCT02701283|50028940|FG001|Overall Study|Withdrawal by Subject|41|||
24935817|NCT02701283|50028941|FG002|Overall Study|Withdrawal by Subject|1|||
24935818|NCT02701283|50028939|FG000|Overall Study|Missed 2-year visit|22|||
24935819|NCT02701283|50028940|FG001|Overall Study|Missed 2-year visit|27|||
24935820|NCT02701283|50028941|FG002|Overall Study|Missed 2-year visit|0|||
24935821|NCT02701283|50028939|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
24935822|NCT02701283|50028940|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
25027881|NCT02974868|50126268|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
25027882|NCT02974868|50126269|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
25027883|NCT02974868|50126270|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
25027884|NCT02974868|50126271|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
25027885|NCT03486899|50126316|FG000|Overall Study|Lost to Follow-up|4|||
25027886|NCT03486899|50126317|FG001|Overall Study|Lost to Follow-up|1|||
25027887|NCT03486899|50126318|FG002|Overall Study|Lost to Follow-up|4|||
25027888|NCT03486899|50126319|FG003|Overall Study|Lost to Follow-up|3|||
25027889|NCT03486899|50126316|FG000|Overall Study|Death|1|||
25027890|NCT03486899|50126317|FG001|Overall Study|Death|0|||
25027891|NCT03486899|50126318|FG002|Overall Study|Death|0|||
25027892|NCT03486899|50126319|FG003|Overall Study|Death|1|||
25156568|NCT03780543|50272967|FG000|Overall Study|Withdrawal by Subject|1|||
25156569|NCT03780543|50272968|FG001|Overall Study|Withdrawal by Subject|8|||
25156570|NCT03780543|50272969|FG002|Overall Study|Withdrawal by Subject|1|||
25156571|NCT03780543|50272967|FG000|Overall Study|Noncompliance with study drug|1|||
25156572|NCT03780543|50272968|FG001|Overall Study|Noncompliance with study drug|0|||
25156573|NCT03780543|50272969|FG002|Overall Study|Noncompliance with study drug|0|||
25156574|NCT03745820|50272982|FG000|Overall Study|Adverse Event|0|||
25156575|NCT03745820|50272983|FG001|Overall Study|Adverse Event|3|||
25156576|NCT03745820|50272984|FG002|Overall Study|Adverse Event|2|||
25156577|NCT03745820|50272982|FG000|Overall Study|Non-Compliance with Study Drug|4|||
25156578|NCT03745820|50272983|FG001|Overall Study|Non-Compliance with Study Drug|3|||
25156579|NCT03745820|50272984|FG002|Overall Study|Non-Compliance with Study Drug|0|||
25156580|NCT03745820|50272982|FG000|Overall Study|Withdrawal by Subject|4|||
25027893|NCT03486899|50126316|FG000|Overall Study|Adverse Event|0|||
25027894|NCT03486899|50126317|FG001|Overall Study|Adverse Event|2|||
25027895|NCT03486899|50126318|FG002|Overall Study|Adverse Event|0|||
25027896|NCT03486899|50126319|FG003|Overall Study|Adverse Event|2|||
25027897|NCT03486899|50126316|FG000|Overall Study|Withdrawal by Subject|3|||
25027898|NCT03486899|50126317|FG001|Overall Study|Withdrawal by Subject|7|||
25027899|NCT03486899|50126318|FG002|Overall Study|Withdrawal by Subject|4|||
25027900|NCT03486899|50126319|FG003|Overall Study|Withdrawal by Subject|3|||
25027901|NCT03486899|50126316|FG000|Overall Study|Other Reasons|0|||
24935823|NCT02701283|50028941|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
25027902|NCT03486899|50126317|FG001|Overall Study|Other Reasons|1|||
25027903|NCT03486899|50126318|FG002|Overall Study|Other Reasons|0|||
25156581|NCT03745820|50272983|FG001|Overall Study|Withdrawal by Subject|4|||
25156582|NCT03745820|50272984|FG002|Overall Study|Withdrawal by Subject|4|||
25027904|NCT03486899|50126319|FG003|Overall Study|Other Reasons|1|||
25027905|NCT02918552|50126331|FG000|Overall Study|Failed Pharmacokinetics|1|||
25027906|NCT02918552|50126332|FG001|Overall Study|Failed Pharmacokinetics|0|||
25027907|NCT02918552|50126331|FG000|Overall Study|Withdrawal by Subject|0|||
25027908|NCT02918552|50126332|FG001|Overall Study|Withdrawal by Subject|1|||
25027909|NCT02918552|50126331|FG000|Overall Study|Lost to Follow-up|0|||
25027910|NCT02918552|50126332|FG001|Overall Study|Lost to Follow-up|1|||
25027911|NCT03485495|50126340|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
25027912|NCT03485495|50126341|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
25027913|NCT01065818|50126347|FG000|Overall Study|Withdrawal by Subject|1|||
25027914|NCT01065818|50126347|FG000|Overall Study|Not a candidate for surgery|1|||
25027915|NCT03483623|50126351|FG000|Overall Study|43 complete sets achieved|1|||
25027916|NCT02318277|50126363|FG000|Overall Study|Physician Decision|0|||
25027917|NCT02318277|50126364|FG001|Overall Study|Physician Decision|0|||
24935824|NCT02166463|50028988|FG000|Overall Study|Lost to Follow-up|0|||
24935825|NCT02166463|50028989|FG001|Overall Study|Lost to Follow-up|1|||
24935826|NCT02166463|50028988|FG000|Overall Study|Physician Decision|10|||
24935827|NCT02166463|50028989|FG001|Overall Study|Physician Decision|10|||
24935828|NCT02166463|50028988|FG000|Overall Study|Ineligible|11|||
24935829|NCT02166463|50028989|FG001|Overall Study|Ineligible|2|||
24935830|NCT02166463|50028988|FG000|Overall Study|Progressive Disease|9|||
24935831|NCT02166463|50028989|FG001|Overall Study|Progressive Disease|6|||
24935832|NCT02166463|50028988|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
24935833|NCT02166463|50028989|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
24935834|NCT02166463|50028988|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
24935835|NCT02166463|50028989|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
24935836|NCT02166463|50028988|FG000|Overall Study|Refusal of further protocol therapy|5|||
24935837|NCT02166463|50028989|FG001|Overall Study|Refusal of further protocol therapy|6|||
24935838|NCT01994954|50029006|FG000|Overall Study|Death|1|||
25027918|NCT02318277|50126365|FG002|Overall Study|Physician Decision|0|||
25027919|NCT02318277|50126366|FG003|Overall Study|Physician Decision|0|||
25027920|NCT02318277|50126367|FG004|Overall Study|Physician Decision|0|||
25027921|NCT02318277|50126368|FG005|Overall Study|Physician Decision|0|||
25027922|NCT02318277|50126369|FG006|Overall Study|Physician Decision|0|||
25027923|NCT02318277|50126370|FG007|Overall Study|Physician Decision|1|||
25027924|NCT02318277|50126363|FG000|Overall Study|Other|0|||
25027925|NCT02318277|50126364|FG001|Overall Study|Other|0|||
25027926|NCT02318277|50126365|FG002|Overall Study|Other|0|||
25027927|NCT02318277|50126366|FG003|Overall Study|Other|0|||
25027928|NCT02318277|50126367|FG004|Overall Study|Other|0|||
25027929|NCT02318277|50126368|FG005|Overall Study|Other|0|||
25027930|NCT02318277|50126369|FG006|Overall Study|Other|1|||
25156583|NCT03745820|50272982|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
25156584|NCT03745820|50272983|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
25156585|NCT03745820|50272984|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
25156586|NCT03745820|50272982|FG000|Overall Study|Lost to Follow-up|2|||
25156587|NCT03745820|50272983|FG001|Overall Study|Lost to Follow-up|0|||
25156588|NCT03745820|50272984|FG002|Overall Study|Lost to Follow-up|3|||
24935839|NCT01994954|50029007|FG001|Overall Study|Death|0|||
24935840|NCT01994954|50029006|FG000|Overall Study|Withdrawal by Subject|9|||
24935841|NCT01994954|50029007|FG001|Overall Study|Withdrawal by Subject|14|||
24935842|NCT01994954|50029006|FG000|Overall Study|Physician Decision|2|||
24935843|NCT01994954|50029007|FG001|Overall Study|Physician Decision|2|||
24935844|NCT01994954|50029006|FG000|Overall Study|Lost to Follow-up|8|||
24935845|NCT01994954|50029007|FG001|Overall Study|Lost to Follow-up|10|||
24935846|NCT01994954|50029006|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
24935847|NCT01994954|50029007|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
25156589|NCT03745820|50272982|FG000|Overall Study|Reason not Specified|2|||
25156590|NCT03745820|50272983|FG001|Overall Study|Reason not Specified|4|||
25156591|NCT03745820|50272984|FG002|Overall Study|Reason not Specified|1|||
25156592|NCT03699631|50272992|FG000|Overall Study|Adverse Event|3|||
24935848|NCT01909453|50029024|FG000|Overall Study|Ongoing|118|||
24935849|NCT01909453|50029025|FG001|Overall Study|Ongoing|103|||
24935850|NCT01909453|50029026|FG002|Overall Study|Ongoing|83|||
24935851|NCT01909453|50029027|FG003|Overall Study|Ongoing|164|||
24935852|NCT01909453|50029028|FG004|Overall Study|Ongoing|50|||
24935853|NCT01909453|50029024|FG000|Overall Study|Death|69|||
25027931|NCT02318277|50126370|FG007|Overall Study|Other|0|||
25027932|NCT02318277|50126363|FG000|Overall Study|Withdrawal by Subject|0|||
25027933|NCT02318277|50126364|FG001|Overall Study|Withdrawal by Subject|0|||
25027934|NCT02318277|50126365|FG002|Overall Study|Withdrawal by Subject|1|||
25156593|NCT03686150|50273006|FG000|Overall Study|Withdrawal by Subject|1|||
25156594|NCT03686150|50273007|FG001|Overall Study|Withdrawal by Subject|1|||
25027935|NCT02318277|50126366|FG003|Overall Study|Withdrawal by Subject|0|||
24935854|NCT01909453|50029025|FG001|Overall Study|Death|74|||
24935855|NCT01909453|50029026|FG002|Overall Study|Death|88|||
25027936|NCT02318277|50126367|FG004|Overall Study|Withdrawal by Subject|1|||
25156595|NCT03686150|50273008|FG002|Overall Study|Withdrawal by Subject|1|||
25156596|NCT03686150|50273009|FG003|Overall Study|Withdrawal by Subject|0|||
25156597|NCT03686150|50273010|FG004|Overall Study|Withdrawal by Subject|1|||
25156598|NCT03686150|50273011|FG005|Overall Study|Withdrawal by Subject|2|||
25156599|NCT03686150|50273006|FG000|Overall Study|Physician Decision|1|||
25156600|NCT03686150|50273007|FG001|Overall Study|Physician Decision|0|||
25156601|NCT03686150|50273008|FG002|Overall Study|Physician Decision|0|||
25156602|NCT03686150|50273009|FG003|Overall Study|Physician Decision|0|||
25156603|NCT03686150|50273010|FG004|Overall Study|Physician Decision|0|||
25156604|NCT03686150|50273011|FG005|Overall Study|Physician Decision|1|||
25156605|NCT03686150|50273006|FG000|Overall Study|Lost to Follow-up|0|||
25156606|NCT03686150|50273007|FG001|Overall Study|Lost to Follow-up|1|||
25156607|NCT03686150|50273008|FG002|Overall Study|Lost to Follow-up|0|||
25156608|NCT03686150|50273009|FG003|Overall Study|Lost to Follow-up|0|||
25156609|NCT03686150|50273010|FG004|Overall Study|Lost to Follow-up|0|||
25156610|NCT03686150|50273011|FG005|Overall Study|Lost to Follow-up|0|||
25156611|NCT03604172|50273028|FG000|Overall Study|Lost to Follow-up|1|||
25156612|NCT03604172|50273029|FG001|Overall Study|Lost to Follow-up|2|||
25156613|NCT03530124|50273054|FG000|Overall Study|Withdrawal by Subject|0|||
25156614|NCT03530124|50273055|FG001|Overall Study|Withdrawal by Subject|1|||
25156615|NCT03530124|50273054|FG000|Overall Study|Protocol Violation|1|||
25156616|NCT03530124|50273055|FG001|Overall Study|Protocol Violation|0|||
25156617|NCT03530124|50273054|FG000|Overall Study|Discharged prior to study completion|1|||
25156618|NCT03530124|50273055|FG001|Overall Study|Discharged prior to study completion|0|||
25156619|NCT03496207|50273064|FG000|Base Study|Adverse Event|0|||
25156620|NCT03496207|50273065|FG001|Base Study|Adverse Event|0|||
25156621|NCT03496207|50273066|FG002|Base Study|Adverse Event|1|||
25156622|NCT03496207|50273067|FG003|Base Study|Adverse Event|1|||
25156623|NCT03496207|50273068|FG004|Base Study|Adverse Event|4|||
25156624|NCT03496207|50273064|FG000|Base Study|Death|0|||
25156625|NCT03496207|50273065|FG001|Base Study|Death|0|||
25156626|NCT03496207|50273066|FG002|Base Study|Death|0|||
24935856|NCT01909453|50029027|FG003|Overall Study|Death|86|||
24935857|NCT01909453|50029028|FG004|Overall Study|Death|29|||
24935858|NCT01909453|50029024|FG000|Overall Study|Lost to Follow-up|3|||
24935859|NCT01909453|50029025|FG001|Overall Study|Lost to Follow-up|4|||
24935860|NCT01909453|50029026|FG002|Overall Study|Lost to Follow-up|4|||
24935861|NCT01909453|50029027|FG003|Overall Study|Lost to Follow-up|3|||
24935862|NCT01909453|50029028|FG004|Overall Study|Lost to Follow-up|3|||
24935863|NCT01909453|50029024|FG000|Overall Study|Withdrawal by Subject|2|||
25156627|NCT03496207|50273067|FG003|Base Study|Death|0|||
25156628|NCT03496207|50273068|FG004|Base Study|Death|1|||
24935864|NCT01909453|50029025|FG001|Overall Study|Withdrawal by Subject|13|||
24935865|NCT01909453|50029026|FG002|Overall Study|Withdrawal by Subject|16|||
24935866|NCT01909453|50029027|FG003|Overall Study|Withdrawal by Subject|5|||
24935867|NCT01909453|50029028|FG004|Overall Study|Withdrawal by Subject|4|||
25156629|NCT03496207|50273064|FG000|Base Study|Withdrawal by Subject|0|||
25156630|NCT03496207|50273065|FG001|Base Study|Withdrawal by Subject|0|||
25156631|NCT03496207|50273066|FG002|Base Study|Withdrawal by Subject|1|||
25156632|NCT03496207|50273067|FG003|Base Study|Withdrawal by Subject|0|||
25156633|NCT03496207|50273068|FG004|Base Study|Withdrawal by Subject|1|||
25156634|NCT03496207|50273064|FG000|Extension Period|Adverse Event|0|||
25156635|NCT03496207|50273065|FG001|Extension Period|Adverse Event|0|||
25156636|NCT03496207|50273066|FG002|Extension Period|Adverse Event|0|||
25156637|NCT03496207|50273067|FG003|Extension Period|Adverse Event|1|||
25156638|NCT03496207|50273068|FG004|Extension Period|Adverse Event|1|||
25156639|NCT03496207|50273064|FG000|Extension Period|Death|1|||
25156640|NCT03496207|50273065|FG001|Extension Period|Death|0|||
25156641|NCT03496207|50273066|FG002|Extension Period|Death|0|||
25156642|NCT03496207|50273067|FG003|Extension Period|Death|1|||
25156643|NCT03496207|50273068|FG004|Extension Period|Death|2|||
25156644|NCT03496207|50273064|FG000|Extension Period|Withdrawal by Subject|1|||
25156645|NCT03496207|50273065|FG001|Extension Period|Withdrawal by Subject|0|||
25156646|NCT03496207|50273066|FG002|Extension Period|Withdrawal by Subject|0|||
25156647|NCT03496207|50273067|FG003|Extension Period|Withdrawal by Subject|1|||
25156648|NCT03496207|50273068|FG004|Extension Period|Withdrawal by Subject|1|||
25156649|NCT03496207|50273064|FG000|Extension Period|Elevated hemoglobin levels|0|||
25156650|NCT03496207|50273065|FG001|Extension Period|Elevated hemoglobin levels|0|||
25156651|NCT03496207|50273066|FG002|Extension Period|Elevated hemoglobin levels|0|||
25186036|NCT01497938|50335838|FG001|Overall Study|Withdrawal by Subject|0|||
24935868|NCT01902173|50029052|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
24935869|NCT01902173|50029053|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
24935870|NCT01902173|50029054|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
24935871|NCT01902173|50029055|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
24935872|NCT01902173|50029056|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
24935873|NCT01902173|50029057|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
24935874|NCT01902173|50029052|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
24935875|NCT01902173|50029053|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
24935876|NCT01902173|50029054|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
24935877|NCT01902173|50029055|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
24935878|NCT01902173|50029056|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
24935879|NCT01902173|50029057|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
24935880|NCT01902173|50029052|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
24935881|NCT01902173|50029053|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
24935882|NCT01902173|50029054|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
24935883|NCT01902173|50029055|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
24935884|NCT01902173|50029056|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
24935885|NCT01902173|50029057|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
24935886|NCT01902173|50029052|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
24935887|NCT01902173|50029053|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
24935888|NCT01902173|50029054|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
24935889|NCT01902173|50029055|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
24935890|NCT01902173|50029056|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
24935891|NCT01902173|50029057|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
24935892|NCT01902173|50029052|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
24935893|NCT01902173|50029053|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
24935894|NCT01902173|50029054|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
24935895|NCT01902173|50029055|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
25156652|NCT03496207|50273067|FG003|Extension Period|Elevated hemoglobin levels|0|||
25156653|NCT03496207|50273068|FG004|Extension Period|Elevated hemoglobin levels|1|||
25186037|NCT01497938|50335837|FG000|Overall Study|Device Violation|1|||
25156654|NCT03204188|50273119|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
25156655|NCT03204188|50273119|FG000|Immunotherapy Phase (1 Year)|Death|1|||
24935896|NCT01902173|50029056|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
24935897|NCT01902173|50029057|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
24935898|NCT01902173|50029052|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
24935899|NCT01902173|50029053|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
24935900|NCT01902173|50029054|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
24935901|NCT01902173|50029055|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
24935902|NCT01902173|50029056|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
25027937|NCT02318277|50126368|FG005|Overall Study|Withdrawal by Subject|1|||
25027938|NCT02318277|50126369|FG006|Overall Study|Withdrawal by Subject|6|||
25027939|NCT02318277|50126370|FG007|Overall Study|Withdrawal by Subject|14|||
25027940|NCT02318277|50126363|FG000|Overall Study|Participant trial terminated by sponsor|0|||
25027941|NCT02318277|50126364|FG001|Overall Study|Participant trial terminated by sponsor|0|||
25027942|NCT02318277|50126365|FG002|Overall Study|Participant trial terminated by sponsor|1|||
25027943|NCT02318277|50126366|FG003|Overall Study|Participant trial terminated by sponsor|0|||
25027944|NCT02318277|50126367|FG004|Overall Study|Participant trial terminated by sponsor|1|||
25027945|NCT02318277|50126368|FG005|Overall Study|Participant trial terminated by sponsor|2|||
25027946|NCT02318277|50126369|FG006|Overall Study|Participant trial terminated by sponsor|5|||
25027947|NCT02318277|50126370|FG007|Overall Study|Participant trial terminated by sponsor|16|||
25027948|NCT02318277|50126363|FG000|Overall Study|Lost to Follow-up|1|||
24935903|NCT01902173|50029057|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
24935904|NCT01902173|50029052|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
24935905|NCT01902173|50029053|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
24935906|NCT01902173|50029054|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
24935907|NCT01902173|50029055|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
24935908|NCT01902173|50029056|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
24935909|NCT01902173|50029057|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
24935910|NCT01902173|50029052|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
25027949|NCT02318277|50126364|FG001|Overall Study|Lost to Follow-up|0|||
25027950|NCT02318277|50126365|FG002|Overall Study|Lost to Follow-up|1|||
25027951|NCT02318277|50126366|FG003|Overall Study|Lost to Follow-up|0|||
25027952|NCT02318277|50126367|FG004|Overall Study|Lost to Follow-up|0|||
25027953|NCT02318277|50126368|FG005|Overall Study|Lost to Follow-up|0|||
25027954|NCT02318277|50126369|FG006|Overall Study|Lost to Follow-up|3|||
25027955|NCT02318277|50126370|FG007|Overall Study|Lost to Follow-up|4|||
25027956|NCT02318277|50126363|FG000|Overall Study|Death|5|||
25027957|NCT02318277|50126364|FG001|Overall Study|Death|3|||
25027958|NCT02318277|50126365|FG002|Overall Study|Death|1|||
25027959|NCT02318277|50126366|FG003|Overall Study|Death|4|||
25027960|NCT02318277|50126367|FG004|Overall Study|Death|6|||
25027961|NCT02318277|50126368|FG005|Overall Study|Death|5|||
24935911|NCT01902173|50029053|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
24935912|NCT01902173|50029054|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
24935913|NCT01902173|50029055|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
24935914|NCT01902173|50029056|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
24935915|NCT01902173|50029057|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
24935916|NCT01902173|50029052|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
24935917|NCT01902173|50029053|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
24935918|NCT01902173|50029054|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
24935919|NCT01902173|50029055|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
24935920|NCT01902173|50029056|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
24935921|NCT01902173|50029057|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
24935922|NCT01902173|50029052|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
24935923|NCT01902173|50029053|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
24935924|NCT01902173|50029054|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
24935925|NCT01902173|50029055|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
24935926|NCT01902173|50029056|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
24935927|NCT01902173|50029057|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
24935928|NCT01902173|50029052|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
24935929|NCT01902173|50029053|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
24935930|NCT01902173|50029054|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
24935931|NCT01902173|50029055|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
24935932|NCT01902173|50029056|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
24935933|NCT01902173|50029057|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
24935934|NCT01902173|50029052|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
24935935|NCT01902173|50029053|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
25027962|NCT02318277|50126369|FG006|Overall Study|Death|34|||
25027963|NCT02318277|50126370|FG007|Overall Study|Death|58|||
25027964|NCT02318277|50126363|FG000|Overall Study|Transitioned to Hospice|0|||
25027965|NCT02318277|50126364|FG001|Overall Study|Transitioned to Hospice|0|||
25027966|NCT02318277|50126365|FG002|Overall Study|Transitioned to Hospice|0|||
24935936|NCT01902173|50029054|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
24935937|NCT01902173|50029055|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
24935938|NCT01902173|50029056|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
24935939|NCT01902173|50029057|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
24935940|NCT01902173|50029052|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
24935941|NCT01902173|50029053|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
25027967|NCT02318277|50126366|FG003|Overall Study|Transitioned to Hospice|0|||
25027968|NCT02318277|50126367|FG004|Overall Study|Transitioned to Hospice|0|||
25027969|NCT02318277|50126368|FG005|Overall Study|Transitioned to Hospice|1|||
25027970|NCT02318277|50126369|FG006|Overall Study|Transitioned to Hospice|0|||
24935942|NCT01902173|50029054|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
24935943|NCT01902173|50029055|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
24935944|NCT01902173|50029056|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
24935945|NCT01902173|50029057|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
24935946|NCT01902173|50029052|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
24935947|NCT01902173|50029053|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
24935948|NCT01902173|50029054|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
24935949|NCT01902173|50029055|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
24935950|NCT01902173|50029056|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
24935951|NCT01902173|50029057|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
24935952|NCT01772472|50029097|FG000|Overall Study|Death|56|||
24935953|NCT01772472|50029098|FG001|Overall Study|Death|42|||
24935954|NCT01772472|50029097|FG000|Overall Study|Physician Decision|1|||
24935955|NCT01772472|50029098|FG001|Overall Study|Physician Decision|3|||
24935956|NCT01772472|50029097|FG000|Overall Study|Other|5|||
24935957|NCT01772472|50029098|FG001|Overall Study|Other|5|||
24935958|NCT01772472|50029097|FG000|Overall Study|Lost to Follow-up|12|||
24935959|NCT01772472|50029098|FG001|Overall Study|Lost to Follow-up|8|||
24935960|NCT01772472|50029097|FG000|Overall Study|Withdrawal by Subject|72|||
24935961|NCT01772472|50029098|FG001|Overall Study|Withdrawal by Subject|50|||
24935962|NCT01772472|50029097|FG000|Overall Study|Ongoing|597|||
24935963|NCT01772472|50029098|FG001|Overall Study|Ongoing|635|||
24935964|NCT01522976|50029107|FG000|Overall Study|Ineligible|4|||
24935965|NCT01522976|50029108|FG001|Overall Study|Ineligible|0|||
24935966|NCT01522976|50029109|FG002|Overall Study|Ineligible|1|||
24935967|NCT01522976|50029107|FG000|Overall Study|Death|7|||
24935968|NCT01522976|50029108|FG001|Overall Study|Death|6|||
24935969|NCT01522976|50029109|FG002|Overall Study|Death|2|||
24935970|NCT01522976|50029107|FG000|Overall Study|Still on treatment|9|||
24935971|NCT01522976|50029108|FG001|Overall Study|Still on treatment|9|||
24935972|NCT01522976|50029109|FG002|Overall Study|Still on treatment|6|||
24935973|NCT01522976|50029107|FG000|Overall Study|Disease progression|28|||
24935974|NCT01522976|50029108|FG001|Overall Study|Disease progression|30|||
24935975|NCT01522976|50029109|FG002|Overall Study|Disease progression|25|||
24935976|NCT01522976|50029107|FG000|Overall Study|Adverse Event|17|||
24935977|NCT01522976|50029108|FG001|Overall Study|Adverse Event|7|||
24935978|NCT01522976|50029109|FG002|Overall Study|Adverse Event|18|||
24935979|NCT01522976|50029107|FG000|Overall Study|Refusal unrelated to adverse event|10|||
24935980|NCT01522976|50029108|FG001|Overall Study|Refusal unrelated to adverse event|13|||
24935981|NCT01522976|50029109|FG002|Overall Study|Refusal unrelated to adverse event|14|||
24935982|NCT01522976|50029107|FG000|Overall Study|Not protocol specified|22|||
25027971|NCT02318277|50126370|FG007|Overall Study|Transitioned to Hospice|0|||
25027972|NCT01063868|50126415|FG000|Overall Study|Adverse Event|9|||
24935983|NCT01522976|50029108|FG001|Overall Study|Not protocol specified|27|||
25027973|NCT01063868|50126416|FG001|Overall Study|Adverse Event|7|||
24935984|NCT01522976|50029109|FG002|Overall Study|Not protocol specified|27|||
24935985|NCT00861705|50029161|FG000|Overall Study|Never Began Treatment|7|||
24935986|NCT00861705|50029162|FG001|Overall Study|Never Began Treatment|3|||
24935987|NCT00861705|50029163|FG002|Overall Study|Never Began Treatment|0|||
24935988|NCT00861705|50029164|FG003|Overall Study|Never Began Treatment|1|||
24935989|NCT00380367|50029189|FG000|Overall Study|Lost to Follow-up|1|||
25027974|NCT01063868|50126415|FG000|Overall Study|Withdrawal by Subject|3|||
25027975|NCT01063868|50126416|FG001|Overall Study|Withdrawal by Subject|1|||
25027976|NCT01063868|50126415|FG000|Overall Study|Study Terminated By Sponsor|23|||
25027977|NCT01063868|50126416|FG001|Overall Study|Study Terminated By Sponsor|4|||
25027978|NCT02974088|50126424|FG000|Overall Study|Lost to Follow-up|0|||
25027979|NCT02974088|50126425|FG001|Overall Study|Lost to Follow-up|2|||
25027980|NCT02974088|50126424|FG000|Overall Study|Adverse Event|0|||
25027981|NCT02974088|50126425|FG001|Overall Study|Adverse Event|1|||
25156656|NCT03204188|50273119|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
25156657|NCT03204188|50273119|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
25156658|NCT03112590|50273126|FG000|Overall Study|Adverse Event|0|||
25156659|NCT03112590|50273127|FG001|Overall Study|Adverse Event|1|||
25156660|NCT03112590|50273128|FG002|Overall Study|Adverse Event|0|||
25156661|NCT03060629|50273138|FG000|Overall Study|Death|4|||
25156662|NCT03060629|50273139|FG001|Overall Study|Death|5|||
25156663|NCT03060629|50273138|FG000|Overall Study|Withdrawal by Subject|50|||
25156664|NCT03060629|50273139|FG001|Overall Study|Withdrawal by Subject|35|||
25156665|NCT03060629|50273138|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
25027982|NCT02385045|50126431|FG000|Overall Study|Endoscopy could not be completed|4|||
25027983|NCT02974010|50126439|FG000|Overall Study|Lost to Follow-up|3|||
25027984|NCT02974010|50126440|FG001|Overall Study|Lost to Follow-up|1|||
25027985|NCT02974010|50126441|FG002|Overall Study|Lost to Follow-up|0|||
25027986|NCT02974010|50126442|FG003|Overall Study|Lost to Follow-up|0|||
25027987|NCT02974010|50126439|FG000|Overall Study|Withdrawal by Subject|2|||
25027988|NCT02974010|50126440|FG001|Overall Study|Withdrawal by Subject|1|||
25027989|NCT02974010|50126441|FG002|Overall Study|Withdrawal by Subject|0|||
25027990|NCT02974010|50126442|FG003|Overall Study|Withdrawal by Subject|0|||
25027991|NCT02974010|50126439|FG000|Overall Study|Adverse Event|0|||
25027992|NCT02974010|50126440|FG001|Overall Study|Adverse Event|1|||
25027993|NCT02974010|50126441|FG002|Overall Study|Adverse Event|0|||
24935990|NCT00380367|50029189|FG000|Overall Study|Withdrawal by Subject|1|||
24935991|NCT00531050|50029199|FG000|Part 1: Period 1|Adverse Event|0|||
24935992|NCT00531050|50029200|FG001|Part 1: Period 1|Adverse Event|1|||
24935993|NCT00531050|50029201|FG002|Part 1: Period 1|Adverse Event|0|||
24935994|NCT00531050|50029202|FG003|Part 1: Period 1|Adverse Event|0|||
25027994|NCT02974010|50126442|FG003|Overall Study|Adverse Event|0|||
25027995|NCT02974010|50126439|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
25027996|NCT02974010|50126440|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
25027997|NCT02974010|50126441|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
25027998|NCT02974010|50126442|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
25027999|NCT02974010|50126439|FG000|Overall Study|Lack of Efficacy|0|||
25028000|NCT02974010|50126440|FG001|Overall Study|Lack of Efficacy|0|||
25028001|NCT02974010|50126441|FG002|Overall Study|Lack of Efficacy|1|||
25028002|NCT02974010|50126442|FG003|Overall Study|Lack of Efficacy|0|||
25028003|NCT02030938|50126452|FG000|Overall Study|Lost to Follow-up|4|||
25028004|NCT02030938|50126452|FG000|Overall Study|Withdrawal by Subject|1|||
25028005|NCT03122535|50126460|FG000|Overall Study|Lost to Follow-up|68|||
25028006|NCT03122535|50126461|FG001|Overall Study|Lost to Follow-up|68|||
25028007|NCT03122535|50126460|FG000|Overall Study|Physician Decision|3|||
25028008|NCT03122535|50126461|FG001|Overall Study|Physician Decision|3|||
25028009|NCT03122535|50126460|FG000|Overall Study|Withdrawal by Subject|2|||
25028010|NCT03122535|50126461|FG001|Overall Study|Withdrawal by Subject|2|||
25028011|NCT01061606|50126467|FG000|Overall Study|Adverse Event|1|||
25028012|NCT01061606|50126467|FG000|Overall Study|Death|1|||
25028013|NCT01061606|50126467|FG000|Overall Study|Disease Progression|4|||
25028014|NCT01061606|50126467|FG000|Overall Study|alternative therapy|2|||
25156666|NCT03060629|50273139|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
25156667|NCT03060629|50273138|FG000|Overall Study|Participant Relocate|15|||
25028015|NCT03122457|50126471|FG000|Overall Study|Withdrawal by Subject|6|||
25028016|NCT03482453|50126487|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
25028017|NCT03482453|50126488|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
25028018|NCT03482453|50126489|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
25028019|NCT03482453|50126490|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
25156668|NCT03060629|50273139|FG001|Overall Study|Participant Relocate|15|||
25156669|NCT03060629|50273138|FG000|Overall Study|Unable to Contact Participant|34|||
25156670|NCT03060629|50273139|FG001|Overall Study|Unable to Contact Participant|23|||
24935995|NCT00531050|50029203|FG004|Part 1: Period 1|Adverse Event|0|||
24935996|NCT00531050|50029204|FG005|Part 1: Period 1|Adverse Event|0|||
24935997|NCT00531050|50029199|FG000|Part 1: Period 1|Protocol Deviation|0|||
24935998|NCT00531050|50029200|FG001|Part 1: Period 1|Protocol Deviation|0|||
25028020|NCT03482453|50126491|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
25028021|NCT03482453|50126492|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
25028022|NCT03482453|50126493|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
25028023|NCT03482453|50126494|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
25028024|NCT03482453|50126495|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
25028025|NCT03482453|50126496|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
25028026|NCT03482453|50126497|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
25028027|NCT03482453|50126498|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
25028028|NCT03480425|50126534|FG000|Overall Study|Force transducer technical failure|1|||
25028029|NCT03472547|50126538|FG000|Overall Study|Withdrawal by Subject|30|||
25028030|NCT00799396|50126542|FG000|Clopidogrel Treatment|Adverse Event|6|||
25028031|NCT00799396|50126542|FG000|Clopidogrel Treatment|Physician Decision|5|||
25028032|NCT00799396|50126542|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
25028033|NCT00799396|50126542|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
25028034|NCT00799396|50126542|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
25028035|NCT03469349|50126548|FG000|Overall Study|Withdrawal by Subject|1|||
25028036|NCT03469349|50126549|FG001|Overall Study|Withdrawal by Subject|3|||
25028037|NCT03469349|50126548|FG000|Overall Study|Progressive Disease|0|||
25028038|NCT03469349|50126549|FG001|Overall Study|Progressive Disease|1|||
25028039|NCT03469349|50126548|FG000|Overall Study|Lost to Follow-up|2|||
25028040|NCT03469349|50126549|FG001|Overall Study|Lost to Follow-up|2|||
25028041|NCT03469349|50126548|FG000|Overall Study|Adverse Event|2|||
25028042|NCT03469349|50126549|FG001|Overall Study|Adverse Event|4|||
25028043|NCT03467945|50126559|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25028044|NCT03467945|50126560|FG001|Treatment Period 2|Withdrawal by Subject|1|||
25028045|NCT03467945|50126561|FG002|Treatment Period 2|Withdrawal by Subject|0|||
25028046|NCT03467945|50126562|FG003|Treatment Period 2|Withdrawal by Subject|0|||
25028047|NCT03467945|50126559|FG000|Treatment Period 3|Withdrawal by Subject|1|||
25028048|NCT03467945|50126560|FG001|Treatment Period 3|Withdrawal by Subject|0|||
25028049|NCT03467945|50126561|FG002|Treatment Period 3|Withdrawal by Subject|2|||
25028050|NCT03467945|50126562|FG003|Treatment Period 3|Withdrawal by Subject|1|||
25028051|NCT00069238|50126573|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
25028052|NCT00069238|50126574|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
25028053|NCT00069238|50126575|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
25028054|NCT00069238|50126573|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
25028055|NCT00069238|50126574|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
25028056|NCT00069238|50126575|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
25028057|NCT00069238|50126573|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
25028058|NCT00069238|50126574|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
25028059|NCT00069238|50126575|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
25028060|NCT03435497|50126582|FG000|Overall Study|Lost to Follow-up|1|||
25028061|NCT03435497|50126583|FG001|Overall Study|Lost to Follow-up|0|||
25028062|NCT03435497|50126582|FG000|Overall Study|Death|1|||
25028063|NCT03435497|50126583|FG001|Overall Study|Death|0|||
25028064|NCT03435497|50126582|FG000|Overall Study|Withdrawal by Subject|0|||
25028065|NCT03435497|50126583|FG001|Overall Study|Withdrawal by Subject|4|||
25028066|NCT03435497|50126582|FG000|Overall Study|Wrong survey administered|0|||
25028067|NCT03435497|50126583|FG001|Overall Study|Wrong survey administered|2|||
25028068|NCT03073200|50126592|FG000|Double Blind Treatment Period|Protocol Violation|1|||
25028069|NCT03073200|50126593|FG001|Double Blind Treatment Period|Protocol Violation|0|||
25028070|NCT03073200|50126594|FG002|Double Blind Treatment Period|Protocol Violation|0|||
25028071|NCT03073200|50126595|FG003|Double Blind Treatment Period|Protocol Violation|0|||
25028072|NCT03073200|50126596|FG004|Double Blind Treatment Period|Protocol Violation|0|||
25028073|NCT03073200|50126597|FG005|Double Blind Treatment Period|Protocol Violation|0|||
25028074|NCT03073200|50126598|FG006|Double Blind Treatment Period|Protocol Violation|0|||
25028075|NCT03073200|50126599|FG007|Double Blind Treatment Period|Protocol Violation|0|||
25028076|NCT03073200|50126600|FG008|Double Blind Treatment Period|Protocol Violation|0|||
25028077|NCT03073200|50126601|FG009|Double Blind Treatment Period|Protocol Violation|0|||
24935999|NCT00531050|50029201|FG002|Part 1: Period 1|Protocol Deviation|0|||
24936000|NCT00531050|50029202|FG003|Part 1: Period 1|Protocol Deviation|1|||
24936001|NCT00531050|50029203|FG004|Part 1: Period 1|Protocol Deviation|0|||
24936002|NCT00531050|50029204|FG005|Part 1: Period 1|Protocol Deviation|0|||
24936003|NCT00531050|50029199|FG000|Part 1: Period 3|Adverse Event|1|||
24936004|NCT00531050|50029200|FG001|Part 1: Period 3|Adverse Event|0|||
24936005|NCT00531050|50029201|FG002|Part 1: Period 3|Adverse Event|0|||
25028078|NCT03073200|50126602|FG010|Double Blind Treatment Period|Protocol Violation|0|||
25028079|NCT03073200|50126603|FG011|Double Blind Treatment Period|Protocol Violation|0|||
25028080|NCT03073200|50126604|FG012|Double Blind Treatment Period|Protocol Violation|0|||
25028081|NCT03073200|50126605|FG013|Double Blind Treatment Period|Protocol Violation|0|||
25028082|NCT03073200|50126606|FG014|Double Blind Treatment Period|Protocol Violation|0|||
24936006|NCT00531050|50029202|FG003|Part 1: Period 3|Adverse Event|0|||
24936007|NCT00531050|50029203|FG004|Part 1: Period 3|Adverse Event|0|||
24936008|NCT00531050|50029204|FG005|Part 1: Period 3|Adverse Event|0|||
24936009|NCT00531050|50029199|FG000|Part 2: Period 1|Adverse Event|0|||
24936010|NCT00531050|50029200|FG001|Part 2: Period 1|Adverse Event|0|||
24936011|NCT00531050|50029201|FG002|Part 2: Period 1|Adverse Event|0|||
24936012|NCT00531050|50029202|FG003|Part 2: Period 1|Adverse Event|0|||
24936013|NCT00531050|50029203|FG004|Part 2: Period 1|Adverse Event|0|||
24936014|NCT00531050|50029204|FG005|Part 2: Period 1|Adverse Event|1|||
24936015|NCT00531050|50029199|FG000|Part 2: Period 3|Abnormal test procedure|1|||
24936016|NCT00531050|50029200|FG001|Part 2: Period 3|Abnormal test procedure|0|||
24936017|NCT00531050|50029201|FG002|Part 2: Period 3|Abnormal test procedure|0|||
24936018|NCT00531050|50029202|FG003|Part 2: Period 3|Abnormal test procedure|0|||
24936019|NCT00531050|50029203|FG004|Part 2: Period 3|Abnormal test procedure|0|||
24936020|NCT00531050|50029204|FG005|Part 2: Period 3|Abnormal test procedure|1|||
24936021|NCT00530348|50029223|FG000|Overall Study|Adverse Event|5|||
24936022|NCT00530348|50029224|FG001|Overall Study|Adverse Event|1|||
24936023|NCT00530348|50029223|FG000|Overall Study|Death|0|||
24936024|NCT00530348|50029224|FG001|Overall Study|Death|1|||
24936025|NCT00530348|50029223|FG000|Overall Study|Lack of Efficacy|2|||
24936026|NCT00530348|50029224|FG001|Overall Study|Lack of Efficacy|0|||
24936027|NCT00530348|50029223|FG000|Overall Study|Lost to Follow-up|0|||
24936028|NCT00530348|50029224|FG001|Overall Study|Lost to Follow-up|2|||
24936029|NCT00530348|50029223|FG000|Overall Study|Physician Decision|1|||
24936030|NCT00530348|50029224|FG001|Overall Study|Physician Decision|2|||
24936031|NCT00530348|50029223|FG000|Overall Study|Pregnancy|1|||
24936032|NCT00530348|50029224|FG001|Overall Study|Pregnancy|0|||
24936033|NCT00530348|50029223|FG000|Overall Study|Withdrawal by Subject|12|||
24936034|NCT00530348|50029224|FG001|Overall Study|Withdrawal by Subject|12|||
24936035|NCT00530348|50029223|FG000|Overall Study|Randomised in error|1|||
24936036|NCT00530348|50029224|FG001|Overall Study|Randomised in error|0|||
24936037|NCT00530348|50029223|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
24936038|NCT00530348|50029224|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
24936039|NCT03886220|50029232|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
24936040|NCT03886220|50029233|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
24936041|NCT03886220|50029232|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
24936042|NCT03886220|50029233|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
24936043|NCT03886220|50029232|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
24936044|NCT03886220|50029233|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
24936045|NCT00530270|50029241|FG000|Overall Study|Protocol Violation|1|||
24936046|NCT00530270|50029242|FG001|Overall Study|Protocol Violation|0|||
24936047|NCT03885596|50029252|FG000|Overall Study|Withdrawal by Subject|2|||
25028083|NCT03073200|50126592|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
25028084|NCT03073200|50126593|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
25028085|NCT03073200|50126594|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
25028086|NCT03073200|50126595|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
25028087|NCT03073200|50126596|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
25028088|NCT03073200|50126597|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
25028089|NCT03073200|50126598|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
25028090|NCT03073200|50126599|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
25028091|NCT03073200|50126600|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
24936048|NCT03885596|50029253|FG001|Overall Study|Withdrawal by Subject|1|||
24936049|NCT03885596|50029254|FG002|Overall Study|Withdrawal by Subject|0|||
24936050|NCT03885596|50029255|FG003|Overall Study|Withdrawal by Subject|0|||
24936051|NCT00529100|50029271|FG000|Overall Study|Adverse Event|0|||
24936052|NCT00529100|50029272|FG001|Overall Study|Adverse Event|5|||
24936053|NCT00529100|50029271|FG000|Overall Study|Protocol Violation|0|||
24936054|NCT00529100|50029272|FG001|Overall Study|Protocol Violation|1|||
24936055|NCT00529100|50029271|FG000|Overall Study|Progressive Disease|0|||
24936056|NCT00529100|50029272|FG001|Overall Study|Progressive Disease|1|||
25028092|NCT03073200|50126601|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
25028093|NCT03073200|50126602|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
25028094|NCT03073200|50126603|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
25028095|NCT03073200|50126604|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
25028096|NCT03073200|50126605|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
24936057|NCT00529100|50029271|FG000|Overall Study|Withdrawal by Subject|0|||
24936058|NCT00529100|50029272|FG001|Overall Study|Withdrawal by Subject|1|||
24936059|NCT00529100|50029271|FG000|Overall Study|Participant Ineligibility|0|||
24936060|NCT00529100|50029272|FG001|Overall Study|Participant Ineligibility|1|||
24936061|NCT03878108|50029284|FG000|Overall Study|Adverse Event|1|||
24936062|NCT03878108|50029285|FG001|Overall Study|Adverse Event|0|||
24936063|NCT00529958|50029294|FG000|2-Year Follow-up|Lost to Follow-up|1|||
24936064|NCT00529958|50029295|FG001|2-Year Follow-up|Lost to Follow-up|2|||
24936065|NCT00529958|50029296|FG002|2-Year Follow-up|Lost to Follow-up|2|||
24936066|NCT00529958|50029294|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
24936067|NCT00529958|50029295|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
24936068|NCT00529958|50029296|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
24936069|NCT00529958|50029294|FG000|5-Year Follow-up|Lost to Follow-up|2|||
24936070|NCT00529958|50029295|FG001|5-Year Follow-up|Lost to Follow-up|3|||
24936071|NCT00529958|50029296|FG002|5-Year Follow-up|Lost to Follow-up|1|||
24936072|NCT00529958|50029294|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
24936073|NCT00529958|50029295|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
24936074|NCT00529958|50029296|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
24936075|NCT00529802|50029304|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
24936076|NCT00529802|50029304|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
24936077|NCT00529802|50029304|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
25156671|NCT03060629|50273138|FG000|Overall Study|Investigator Decision|7|||
25156672|NCT03060629|50273139|FG001|Overall Study|Investigator Decision|7|||
25156673|NCT03060629|50273138|FG000|Overall Study|Study Terminated by Sponsor|1100|||
25156674|NCT03060629|50273139|FG001|Overall Study|Study Terminated by Sponsor|1123|||
25156675|NCT03060629|50273138|FG000|Overall Study|Other|4|||
25156676|NCT03060629|50273139|FG001|Overall Study|Other|4|||
25156677|NCT03021486|50273148|FG000|Overall Study|Withdrawal by Subject|1|||
25156678|NCT03021486|50273149|FG001|Overall Study|Withdrawal by Subject|1|||
25156679|NCT03021486|50273150|FG002|Overall Study|Withdrawal by Subject|3|||
25156680|NCT03021486|50273148|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
25156681|NCT03021486|50273149|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
25156682|NCT03021486|50273150|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
25156683|NCT02999789|50273162|FG000|Overall Study|Withdrawal by Subject|0|||
25156684|NCT02999789|50273163|FG001|Overall Study|Withdrawal by Subject|1|||
25156685|NCT02999789|50273162|FG000|Overall Study|Became ineligible|1|||
25156686|NCT02999789|50273163|FG001|Overall Study|Became ineligible|2|||
25156687|NCT02949128|50273170|FG000|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2|||
25156688|NCT02949128|50273170|FG000|Initial Evaluation Period|Adverse Event|3|||
25156689|NCT02949128|50273170|FG000|Initial Evaluation Period|Death|2|||
25156690|NCT02949128|50273170|FG000|Initial Evaluation Period|Physician Decision|1|||
25156691|NCT02949128|50273170|FG000|Initial Evaluation Period|Protocol Violation|1|||
25156692|NCT02949128|50273170|FG000|Extension Period|Withdrawal by Subject|5|||
25156693|NCT02949128|50273170|FG000|Extension Period|Protocol Violation|1|||
25156694|NCT02949128|50273170|FG000|Extension Period|Physician Decision|2|||
25156695|NCT02949128|50273170|FG000|Extension Period|Ongoing in Extension Period as of 07/02/2019|41|||
25156696|NCT02923115|50273189|FG000|Overall Study|Lost to Follow-up|0|||
25156697|NCT02923115|50273190|FG001|Overall Study|Lost to Follow-up|0|||
25156698|NCT02923115|50273191|FG002|Overall Study|Lost to Follow-up|0|||
25156699|NCT02923115|50273192|FG003|Overall Study|Lost to Follow-up|1|||
25156700|NCT02923115|50273193|FG004|Overall Study|Lost to Follow-up|0|||
25156701|NCT02923115|50273194|FG005|Overall Study|Lost to Follow-up|0|||
25156702|NCT02923115|50273189|FG000|Overall Study|Withdrawal by Subject|0|||
25156703|NCT02923115|50273190|FG001|Overall Study|Withdrawal by Subject|1|||
25156704|NCT02923115|50273191|FG002|Overall Study|Withdrawal by Subject|0|||
25156705|NCT02923115|50273192|FG003|Overall Study|Withdrawal by Subject|0|||
25156706|NCT02923115|50273193|FG004|Overall Study|Withdrawal by Subject|0|||
25156707|NCT02923115|50273194|FG005|Overall Study|Withdrawal by Subject|0|||
25156708|NCT02923115|50273189|FG000|Overall Study|Randomized, but not dosed|0|||
25156709|NCT02923115|50273190|FG001|Overall Study|Randomized, but not dosed|0|||
25156710|NCT02923115|50273191|FG002|Overall Study|Randomized, but not dosed|3|||
25156711|NCT02923115|50273192|FG003|Overall Study|Randomized, but not dosed|1|||
24936078|NCT00529802|50029304|FG000|Evaluable for Primary Endpoint|Death|1|||
24936079|NCT00529802|50029304|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
24936080|NCT00529802|50029304|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
24936081|NCT00529802|50029304|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
25156712|NCT02923115|50273193|FG004|Overall Study|Randomized, but not dosed|5|||
25156713|NCT02923115|50273194|FG005|Overall Study|Randomized, but not dosed|0|||
25156714|NCT02910583|50273210|FG000|Overall Study|Withdrawal by Subject|6|||
25156715|NCT02910583|50273211|FG001|Overall Study|Withdrawal by Subject|7|||
25275178|NCT01076205|50589207|FG000|Overall Study|Lost to Follow-up|3151|||
25028097|NCT03073200|50126606|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
25028098|NCT03073200|50126592|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
25028099|NCT03073200|50126593|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
25028100|NCT03073200|50126594|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
25028101|NCT03073200|50126595|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
25028102|NCT03073200|50126596|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
25028103|NCT03073200|50126597|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
25028104|NCT03073200|50126598|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
25028105|NCT03073200|50126599|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
25028106|NCT03073200|50126600|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
25028107|NCT03073200|50126601|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
25028108|NCT03073200|50126602|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
25028109|NCT03073200|50126603|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
25028110|NCT03073200|50126604|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
25028111|NCT03073200|50126605|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
25028112|NCT03073200|50126606|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
25028113|NCT03073200|50126592|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
25028114|NCT03073200|50126593|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
25028115|NCT03073200|50126594|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
25156716|NCT02910583|50273210|FG000|Overall Study|Other, Not Specified|1|||
25156717|NCT02910583|50273211|FG001|Overall Study|Other, Not Specified|0|||
24936082|NCT00528866|50029310|FG000|Overall Study|Protocol Violation|6|||
24936083|NCT00614393|50029320|FG000|Overall Study|Adverse Event|20|||
24936084|NCT00614393|50029321|FG001|Overall Study|Adverse Event|2|||
24936085|NCT00614393|50029322|FG002|Overall Study|Adverse Event|3|||
24936086|NCT00614393|50029323|FG003|Overall Study|Adverse Event|13|||
24936087|NCT00614393|50029324|FG004|Overall Study|Adverse Event|21|||
24936088|NCT00614393|50029320|FG000|Overall Study|Lost to Follow-up|0|||
24936089|NCT00614393|50029321|FG001|Overall Study|Lost to Follow-up|0|||
24936090|NCT00614393|50029322|FG002|Overall Study|Lost to Follow-up|0|||
24936091|NCT00614393|50029323|FG003|Overall Study|Lost to Follow-up|1|||
24936092|NCT00614393|50029324|FG004|Overall Study|Lost to Follow-up|2|||
24936093|NCT00614393|50029320|FG000|Overall Study|Physician Decision|17|||
24936094|NCT00614393|50029321|FG001|Overall Study|Physician Decision|0|||
24936095|NCT00614393|50029322|FG002|Overall Study|Physician Decision|1|||
24936096|NCT00614393|50029323|FG003|Overall Study|Physician Decision|8|||
24936097|NCT00614393|50029324|FG004|Overall Study|Physician Decision|9|||
24936098|NCT00614393|50029320|FG000|Overall Study|Progressive Disease|118|||
24936099|NCT00614393|50029321|FG001|Overall Study|Progressive Disease|5|||
24936100|NCT00614393|50029322|FG002|Overall Study|Progressive Disease|5|||
24936101|NCT00614393|50029323|FG003|Overall Study|Progressive Disease|138|||
24936102|NCT00614393|50029324|FG004|Overall Study|Progressive Disease|130|||
24936103|NCT00614393|50029320|FG000|Overall Study|Protocol Violation|1|||
24936104|NCT00614393|50029321|FG001|Overall Study|Protocol Violation|0|||
24936105|NCT00614393|50029322|FG002|Overall Study|Protocol Violation|0|||
24936106|NCT00614393|50029323|FG003|Overall Study|Protocol Violation|0|||
24936107|NCT00614393|50029324|FG004|Overall Study|Protocol Violation|0|||
24936108|NCT00614393|50029320|FG000|Overall Study|Terminated by Sponsor|0|||
24936109|NCT00614393|50029321|FG001|Overall Study|Terminated by Sponsor|0|||
24936110|NCT00614393|50029322|FG002|Overall Study|Terminated by Sponsor|0|||
24936111|NCT00614393|50029323|FG003|Overall Study|Terminated by Sponsor|0|||
24936112|NCT00614393|50029324|FG004|Overall Study|Terminated by Sponsor|1|||
24936113|NCT00614393|50029320|FG000|Overall Study|Withdrawal by Subject|20|||
24936114|NCT00614393|50029321|FG001|Overall Study|Withdrawal by Subject|1|||
24936115|NCT00614393|50029322|FG002|Overall Study|Withdrawal by Subject|1|||
24936116|NCT00614393|50029323|FG003|Overall Study|Withdrawal by Subject|16|||
25156718|NCT02779855|50273248|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
25156719|NCT02779855|50273249|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
24936117|NCT00614393|50029324|FG004|Overall Study|Withdrawal by Subject|13|||
24936118|NCT00614393|50029320|FG000|Overall Study|Other|4|||
24936119|NCT00614393|50029321|FG001|Overall Study|Other|0|||
24936120|NCT00614393|50029322|FG002|Overall Study|Other|0|||
24936121|NCT00614393|50029323|FG003|Overall Study|Other|4|||
25156720|NCT02779855|50273250|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
24936122|NCT00614393|50029324|FG004|Overall Study|Other|2|||
24936123|NCT00614393|50029320|FG000|Overall Study|Not Treated|0|||
25028116|NCT03073200|50126595|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
25028117|NCT03073200|50126596|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
25028118|NCT03073200|50126597|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
24936124|NCT00614393|50029321|FG001|Overall Study|Not Treated|0|||
24936125|NCT00614393|50029322|FG002|Overall Study|Not Treated|0|||
24936126|NCT00614393|50029323|FG003|Overall Study|Not Treated|0|||
24936127|NCT00614393|50029324|FG004|Overall Study|Not Treated|2|||
24936128|NCT00612677|50029336|FG000|Overall Study|study closed before treatment started|1|||
24936129|NCT00613925|50029342|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
25156721|NCT02487394|50273270|FG000|Phase 1|Withdrawal by Subject|0|||
25156722|NCT02487394|50273271|FG001|Phase 1|Withdrawal by Subject|1|||
25156723|NCT02315703|50273285|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
25156724|NCT02315703|50273286|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
25156725|NCT02315703|50273287|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
25156726|NCT02315703|50273288|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
25156727|NCT02315703|50273289|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
25156728|NCT02315703|50273290|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
25156729|NCT02315703|50273291|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
25156730|NCT02315703|50273292|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
25156731|NCT02315703|50273285|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
25156732|NCT02315703|50273286|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
25156733|NCT02315703|50273287|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
25156734|NCT02315703|50273288|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
25156735|NCT02315703|50273289|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
25156736|NCT02315703|50273290|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
25156737|NCT02315703|50273291|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
24936130|NCT00613925|50029343|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
24936131|NCT00613301|50029349|FG000|Overall Study|Adverse Event|49|||
24936132|NCT00613301|50029349|FG000|Overall Study|Lost to Follow-up|88|||
24936133|NCT00613301|50029349|FG000|Overall Study|Withdrawal by Subject|5|||
24936134|NCT00613301|50029349|FG000|Overall Study|Death|6|||
24936135|NCT00613301|50029349|FG000|Overall Study|Lack of Efficacy|13|||
24936136|NCT00613301|50029349|FG000|Overall Study|Physician Decision|2|||
24936137|NCT00613301|50029349|FG000|Overall Study|No data was collected|53|||
24936138|NCT00613301|50029349|FG000|Overall Study|Irregularly enrolled patients|12|||
24936139|NCT00609947|50029354|FG000|Overall Study|Death|1|||
24936140|NCT00609869|50029359|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
24936141|NCT00609869|50029359|FG000|Overall Study|Severe hematologic toxicity|1|||
24936142|NCT00609869|50029359|FG000|Overall Study|Withdrawal by Subject|1|||
24936143|NCT00609869|50029359|FG000|Overall Study|Seizures|1|||
24936144|NCT00609869|50029359|FG000|Overall Study|Severe tumor flare reaction|1|||
24936145|NCT00609869|50029359|FG000|Overall Study|Hepatitis B infection|1|||
24936146|NCT00609869|50029359|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
24936147|NCT00609869|50029359|FG000|Overall Study|Mantle cell: not evaluable|4|||
24936148|NCT00529568|50029365|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
24936149|NCT00529568|50029366|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
24936150|NCT00529568|50029367|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
24936151|NCT00529568|50029365|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
24936152|NCT00529568|50029366|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
24936153|NCT00529568|50029367|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
24936154|NCT00529568|50029365|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
25028119|NCT03073200|50126598|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
25028120|NCT03073200|50126599|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
25028121|NCT03073200|50126600|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
25028122|NCT03073200|50126601|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
25028123|NCT03073200|50126602|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
25028124|NCT03073200|50126603|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
25028125|NCT03073200|50126604|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
25028126|NCT03073200|50126605|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
25028127|NCT03073200|50126606|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
25028128|NCT03073200|50126592|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
25028129|NCT03073200|50126593|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
25156738|NCT02315703|50273292|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
25156739|NCT02315703|50273285|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
25156740|NCT02315703|50273286|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
25186038|NCT01497938|50335838|FG001|Overall Study|Device Violation|0|||
24936155|NCT00529568|50029366|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
24936156|NCT00529568|50029367|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
24936157|NCT00529568|50029365|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
24936158|NCT00529568|50029366|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
24936159|NCT00529568|50029367|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
24936160|NCT00529568|50029365|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
24936161|NCT00529568|50029366|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
24936162|NCT00529568|50029367|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
25028130|NCT03073200|50126594|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
24936163|NCT00529568|50029365|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
24936164|NCT00529568|50029366|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
25028131|NCT03073200|50126595|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
25028132|NCT03073200|50126596|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
25028133|NCT03073200|50126597|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
25028134|NCT03073200|50126598|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
25028135|NCT03073200|50126599|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
24936165|NCT00529568|50029367|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
24936166|NCT00529568|50029365|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
25156741|NCT02315703|50273287|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
25156742|NCT02315703|50273288|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
25156743|NCT02315703|50273289|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
25156744|NCT02315703|50273290|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
25156745|NCT02315703|50273291|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
25156746|NCT02315703|50273292|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
25156747|NCT02315703|50273285|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
25156748|NCT02315703|50273286|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
25156749|NCT02315703|50273287|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
25156750|NCT02315703|50273288|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
25156751|NCT02315703|50273289|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
25156752|NCT02315703|50273290|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
25156753|NCT02315703|50273291|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
25156754|NCT02315703|50273292|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
25156755|NCT02315703|50273285|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
25156756|NCT02315703|50273286|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
24936167|NCT00529568|50029366|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
24936168|NCT00529568|50029367|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
24936169|NCT00529568|50029365|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
24936170|NCT00529568|50029366|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
24936171|NCT00529568|50029367|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
24936172|NCT00529568|50029365|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
24936173|NCT00529568|50029366|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
24936174|NCT00529568|50029367|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
24936175|NCT00529568|50029365|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
24936176|NCT00529568|50029366|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
24936177|NCT00529568|50029367|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
24936178|NCT00529568|50029365|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
24936179|NCT00529568|50029366|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
24936180|NCT00529568|50029367|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
24936181|NCT00611975|50029378|FG000|Overall Study|Withdrawal by Subject|3|||
24936182|NCT00611975|50029379|FG001|Overall Study|Withdrawal by Subject|7|||
24936183|NCT00611975|50029378|FG000|Overall Study|Pregnancy|2|||
24936184|NCT00611975|50029379|FG001|Overall Study|Pregnancy|1|||
24936185|NCT00573131|50029387|FG000|Overall Study|Withdrawal by Subject|10|||
24936186|NCT00573131|50029388|FG001|Overall Study|Withdrawal by Subject|8|||
24936187|NCT00521144|50029399|FG000|Overall Study|Not Treated|0|||
24936188|NCT00521144|50029400|FG001|Overall Study|Not Treated|0|||
24936189|NCT00521144|50029401|FG002|Overall Study|Not Treated|0|||
24936190|NCT00521144|50029402|FG003|Overall Study|Not Treated|1|||
24936191|NCT00521144|50029403|FG004|Overall Study|Not Treated|0|||
24936192|NCT00521144|50029399|FG000|Overall Study|Adverse Event|0|||
24936193|NCT00521144|50029400|FG001|Overall Study|Adverse Event|1|||
24936194|NCT00521144|50029401|FG002|Overall Study|Adverse Event|0|||
24936195|NCT00521144|50029402|FG003|Overall Study|Adverse Event|0|||
24936196|NCT00521144|50029403|FG004|Overall Study|Adverse Event|1|||
24936197|NCT00521144|50029399|FG000|Overall Study|Progressive Disease|4|||
24936198|NCT00521144|50029400|FG001|Overall Study|Progressive Disease|2|||
25028136|NCT03073200|50126600|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
25028137|NCT03073200|50126601|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
24936199|NCT00521144|50029401|FG002|Overall Study|Progressive Disease|2|||
24936200|NCT00521144|50029402|FG003|Overall Study|Progressive Disease|0|||
24936201|NCT00521144|50029403|FG004|Overall Study|Progressive Disease|6|||
24936202|NCT00520676|50029417|FG000|Overall Study|Death|84|||
24936203|NCT00520676|50029418|FG001|Overall Study|Death|81|||
24936204|NCT00520676|50029417|FG000|Overall Study|Lost to Follow-up|6|||
24936205|NCT00520676|50029418|FG001|Overall Study|Lost to Follow-up|10|||
24936206|NCT00520676|50029417|FG000|Overall Study|Physician Decision|4|||
24936207|NCT00520676|50029418|FG001|Overall Study|Physician Decision|1|||
24936208|NCT00520676|50029417|FG000|Overall Study|Withdrawal by Subject|7|||
25028138|NCT03073200|50126602|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
25028139|NCT03073200|50126603|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
25028140|NCT03073200|50126604|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
24936209|NCT00520676|50029418|FG001|Overall Study|Withdrawal by Subject|11|||
24936210|NCT00610649|50029435|FG000|Overall Study|Adverse Event|1|||
24936211|NCT00610649|50029436|FG001|Overall Study|Adverse Event|0|||
24936212|NCT00610649|50029437|FG002|Overall Study|Adverse Event|0|||
24936213|NCT00610649|50029438|FG003|Overall Study|Adverse Event|0|||
24936214|NCT00610649|50029439|FG004|Overall Study|Adverse Event|0|||
24936215|NCT00610649|50029440|FG005|Overall Study|Adverse Event|0|||
24936216|NCT00610649|50029441|FG006|Overall Study|Adverse Event|0|||
24936217|NCT00610649|50029442|FG007|Overall Study|Adverse Event|0|||
24936218|NCT00610649|50029443|FG008|Overall Study|Adverse Event|0|||
24936219|NCT00610649|50029444|FG009|Overall Study|Adverse Event|0|||
24936220|NCT00610649|50029445|FG010|Overall Study|Adverse Event|1|||
24936221|NCT00610649|50029435|FG000|Overall Study|Family Emergency|0|||
25028141|NCT03073200|50126605|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
25028142|NCT03073200|50126606|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
25028143|NCT03073200|50126592|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
25028144|NCT03073200|50126593|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
25028145|NCT03073200|50126594|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
25028146|NCT03073200|50126595|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
25028147|NCT03073200|50126596|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
25028148|NCT03073200|50126597|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
25028149|NCT03073200|50126598|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
25028150|NCT03073200|50126599|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
25028151|NCT03073200|50126600|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
24936222|NCT00610649|50029436|FG001|Overall Study|Family Emergency|1|||
24936223|NCT00610649|50029437|FG002|Overall Study|Family Emergency|0|||
24936224|NCT00610649|50029438|FG003|Overall Study|Family Emergency|0|||
24936225|NCT00610649|50029439|FG004|Overall Study|Family Emergency|0|||
24936226|NCT00610649|50029440|FG005|Overall Study|Family Emergency|0|||
24936227|NCT00610649|50029441|FG006|Overall Study|Family Emergency|0|||
24936228|NCT00610649|50029442|FG007|Overall Study|Family Emergency|0|||
24936229|NCT00610649|50029443|FG008|Overall Study|Family Emergency|0|||
25028152|NCT03073200|50126601|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
25028153|NCT03073200|50126602|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
25156757|NCT02315703|50273287|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
25156758|NCT02315703|50273288|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
25156759|NCT02315703|50273289|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
25156760|NCT02315703|50273290|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
25156761|NCT02315703|50273291|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
25156762|NCT02315703|50273292|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
25156763|NCT02315703|50273285|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
25156764|NCT02315703|50273286|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
25156765|NCT02315703|50273287|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
25156766|NCT02315703|50273288|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
25156767|NCT02315703|50273289|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
25156768|NCT02315703|50273290|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
25156769|NCT02315703|50273291|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
25156770|NCT02315703|50273292|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
25156771|NCT02315703|50273285|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
25156772|NCT02315703|50273286|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
25156773|NCT02315703|50273287|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
25156774|NCT02315703|50273288|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
25156775|NCT02315703|50273289|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
25156776|NCT02315703|50273290|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
25156777|NCT02315703|50273291|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
25156778|NCT02315703|50273292|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
25156779|NCT02315703|50273285|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
25156780|NCT02315703|50273286|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
25156781|NCT02315703|50273287|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
25156782|NCT02315703|50273288|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
25156783|NCT02315703|50273289|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
25156784|NCT02315703|50273290|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
25156785|NCT02315703|50273291|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
25156786|NCT02315703|50273292|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
25156787|NCT02315703|50273285|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
25156788|NCT02315703|50273286|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
25186039|NCT01460342|50335888|FG000|Overall Study|Adverse Event|5|||
24936230|NCT00610649|50029444|FG009|Overall Study|Family Emergency|0|||
24936231|NCT00610649|50029445|FG010|Overall Study|Family Emergency|0|||
24936232|NCT00610649|50029435|FG000|Overall Study|Withdrawal by Subject|0|||
24936233|NCT00610649|50029436|FG001|Overall Study|Withdrawal by Subject|0|||
24936234|NCT00610649|50029437|FG002|Overall Study|Withdrawal by Subject|0|||
24936235|NCT00610649|50029438|FG003|Overall Study|Withdrawal by Subject|0|||
24936236|NCT00610649|50029439|FG004|Overall Study|Withdrawal by Subject|0|||
24936237|NCT00610649|50029440|FG005|Overall Study|Withdrawal by Subject|0|||
24936238|NCT00610649|50029441|FG006|Overall Study|Withdrawal by Subject|0|||
24936239|NCT00610649|50029442|FG007|Overall Study|Withdrawal by Subject|0|||
24936240|NCT00610649|50029443|FG008|Overall Study|Withdrawal by Subject|0|||
24936241|NCT00610649|50029444|FG009|Overall Study|Withdrawal by Subject|1|||
24936242|NCT00610649|50029445|FG010|Overall Study|Withdrawal by Subject|0|||
24936243|NCT00608543|50029469|FG000|Overall Study|Adverse Event|4|||
24936244|NCT00520130|50029476|FG000|Overall Study|Disease progression on study|4|||
24936245|NCT00520130|50029477|FG001|Overall Study|Disease progression on study|0|||
25028154|NCT03073200|50126603|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
25028155|NCT03073200|50126604|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
25028156|NCT03073200|50126605|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
25028157|NCT03073200|50126606|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
25028158|NCT03073200|50126592|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
25028159|NCT03073200|50126593|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
25028160|NCT03073200|50126594|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
25028161|NCT03073200|50126595|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
25028162|NCT03073200|50126596|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
25028163|NCT03073200|50126597|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
25028164|NCT03073200|50126598|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
25028165|NCT03073200|50126599|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
25028166|NCT03073200|50126600|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
25028167|NCT03073200|50126601|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
25028168|NCT03073200|50126602|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
25028169|NCT03073200|50126603|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
25028170|NCT03073200|50126604|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
25028171|NCT03073200|50126605|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
25028172|NCT03073200|50126606|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
25028173|NCT03073200|50126592|FG000|Extension Period|Lost to Follow-up|0|||
25028174|NCT03073200|50126593|FG001|Extension Period|Lost to Follow-up|0|||
25028175|NCT03073200|50126594|FG002|Extension Period|Lost to Follow-up|0|||
25028176|NCT03073200|50126595|FG003|Extension Period|Lost to Follow-up|0|||
25028177|NCT03073200|50126596|FG004|Extension Period|Lost to Follow-up|0|||
25028178|NCT03073200|50126597|FG005|Extension Period|Lost to Follow-up|0|||
25028179|NCT03073200|50126598|FG006|Extension Period|Lost to Follow-up|1|||
25028180|NCT03073200|50126599|FG007|Extension Period|Lost to Follow-up|1|||
25028181|NCT03073200|50126600|FG008|Extension Period|Lost to Follow-up|0|||
25028182|NCT03073200|50126601|FG009|Extension Period|Lost to Follow-up|0|||
25028183|NCT03073200|50126602|FG010|Extension Period|Lost to Follow-up|0|||
25028184|NCT03073200|50126603|FG011|Extension Period|Lost to Follow-up|0|||
25028185|NCT03073200|50126604|FG012|Extension Period|Lost to Follow-up|0|||
25028186|NCT03073200|50126605|FG013|Extension Period|Lost to Follow-up|0|||
25028187|NCT03073200|50126606|FG014|Extension Period|Lost to Follow-up|0|||
25028188|NCT03073200|50126592|FG000|Extension Period|Sponsor Decision|0|||
25028189|NCT03073200|50126593|FG001|Extension Period|Sponsor Decision|0|||
25028190|NCT03073200|50126594|FG002|Extension Period|Sponsor Decision|0|||
25028191|NCT03073200|50126595|FG003|Extension Period|Sponsor Decision|0|||
25028192|NCT03073200|50126596|FG004|Extension Period|Sponsor Decision|0|||
25028193|NCT03073200|50126597|FG005|Extension Period|Sponsor Decision|0|||
25028194|NCT03073200|50126598|FG006|Extension Period|Sponsor Decision|0|||
25028195|NCT03073200|50126599|FG007|Extension Period|Sponsor Decision|0|||
25028196|NCT03073200|50126600|FG008|Extension Period|Sponsor Decision|1|||
25028197|NCT03073200|50126601|FG009|Extension Period|Sponsor Decision|0|||
25028198|NCT03073200|50126602|FG010|Extension Period|Sponsor Decision|0|||
25028199|NCT03073200|50126603|FG011|Extension Period|Sponsor Decision|0|||
25028200|NCT03073200|50126604|FG012|Extension Period|Sponsor Decision|0|||
25028201|NCT03073200|50126605|FG013|Extension Period|Sponsor Decision|0|||
25028202|NCT03073200|50126606|FG014|Extension Period|Sponsor Decision|0|||
25028203|NCT03073200|50126592|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
25028204|NCT03073200|50126593|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
25028205|NCT03073200|50126594|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
25028206|NCT03073200|50126595|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
25028207|NCT03073200|50126596|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
25028208|NCT03073200|50126597|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
25028209|NCT03073200|50126598|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
25028210|NCT03073200|50126599|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
25028211|NCT03073200|50126600|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
25028212|NCT03073200|50126601|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
25156789|NCT02315703|50273287|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
24936246|NCT00520130|50029476|FG000|Overall Study|Physician Decision|1|||
24936247|NCT00520130|50029477|FG001|Overall Study|Physician Decision|1|||
24936248|NCT00519896|50029487|FG000|Overall Study|Protocol Violation|1|||
24936249|NCT00519896|50029487|FG000|Overall Study|Adverse Event|1|||
24936250|NCT00527618|50029500|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
24936251|NCT00527618|50029501|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
24936252|NCT00527618|50029500|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
24936253|NCT00527618|50029501|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
24936254|NCT00527618|50029500|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
24936255|NCT00527618|50029501|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
24936256|NCT00527618|50029500|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
24936257|NCT00527618|50029501|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
24936258|NCT00527618|50029500|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
24936259|NCT00527618|50029501|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
24936260|NCT00527618|50029500|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
24936261|NCT00527618|50029501|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
24936262|NCT00527072|50029508|FG000|Overall Study|Adverse Event|13|||
24936263|NCT00527072|50029508|FG000|Overall Study|Lack of Efficacy|11|||
24936264|NCT00527072|50029508|FG000|Overall Study|Lost to Follow-up|3|||
24936265|NCT00527072|50029508|FG000|Overall Study|Protocol Violation|2|||
24936266|NCT00527072|50029508|FG000|Overall Study|Withdrawal by Subject|7|||
24936267|NCT00526994|50029516|FG000|Overall Study|Lost to Follow-up|98|||
24936268|NCT00526994|50029517|FG001|Overall Study|Lost to Follow-up|108|||
24936269|NCT00526994|50029518|FG002|Overall Study|Lost to Follow-up|96|||
24936270|NCT00526994|50029516|FG000|Overall Study|Death|4|||
24936271|NCT00526994|50029517|FG001|Overall Study|Death|3|||
24936272|NCT00526994|50029518|FG002|Overall Study|Death|3|||
24936273|NCT00526994|50029516|FG000|Overall Study|Withdrawal by Subject|2|||
24936274|NCT00526994|50029517|FG001|Overall Study|Withdrawal by Subject|7|||
24936275|NCT00526994|50029518|FG002|Overall Study|Withdrawal by Subject|5|||
24936276|NCT00526994|50029516|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
24936277|NCT00526994|50029517|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
24936278|NCT00526994|50029518|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
24936279|NCT00519428|50029529|FG000|Overall Study|Adverse Event|5|||
24936280|NCT00519428|50029530|FG001|Overall Study|Adverse Event|2|||
25028213|NCT03073200|50126602|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
25028214|NCT03073200|50126603|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
25028215|NCT03073200|50126604|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
24936281|NCT00519428|50029531|FG002|Overall Study|Adverse Event|10|||
24936282|NCT00519428|50029529|FG000|Overall Study|Lost to Follow-up|7|||
24936283|NCT00519428|50029530|FG001|Overall Study|Lost to Follow-up|7|||
24936284|NCT00519428|50029531|FG002|Overall Study|Lost to Follow-up|6|||
24936285|NCT00519428|50029529|FG000|Overall Study|Withdrawal by Subject|8|||
24936286|NCT00519428|50029530|FG001|Overall Study|Withdrawal by Subject|3|||
24936287|NCT00519428|50029531|FG002|Overall Study|Withdrawal by Subject|7|||
24936288|NCT00519428|50029529|FG000|Overall Study|unstated|1|||
24936289|NCT00519428|50029530|FG001|Overall Study|unstated|3|||
24936290|NCT00519428|50029531|FG002|Overall Study|unstated|2|||
24936291|NCT00432159|50029547|FG000|Overall Study|Death|0|||
24936292|NCT00432159|50029548|FG001|Overall Study|Death|1|||
24936293|NCT00432159|50029549|FG002|Overall Study|Death|0|||
24936294|NCT00432159|50029550|FG003|Overall Study|Death|0|||
24936295|NCT00432159|50029551|FG004|Overall Study|Death|0|||
24936296|NCT00432159|50029547|FG000|Overall Study|Failure|9|||
24936297|NCT00432159|50029548|FG001|Overall Study|Failure|5|||
24936298|NCT00432159|50029549|FG002|Overall Study|Failure|3|||
24936299|NCT00432159|50029550|FG003|Overall Study|Failure|2|||
24936300|NCT00432159|50029551|FG004|Overall Study|Failure|3|||
24936301|NCT00432159|50029547|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
24936302|NCT00432159|50029548|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
24936303|NCT00432159|50029549|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
24936304|NCT00432159|50029550|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
24936305|NCT00432159|50029551|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
24936306|NCT00519194|50029563|FG000|Overall Study|Withdrawal by Subject|9|||
24936307|NCT00519194|50029563|FG000|Overall Study|Death|9|||
24936308|NCT00519194|50029563|FG000|Overall Study|Lost to Follow-up|3|||
24936309|NCT00431847|50029571|FG000|Overall Study|completion of less than two study visits|6|||
24936310|NCT00431847|50029572|FG001|Overall Study|completion of less than two study visits|3|||
25028216|NCT03073200|50126605|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
24936311|NCT00431847|50029573|FG002|Overall Study|completion of less than two study visits|4|||
24936312|NCT00431847|50029574|FG003|Overall Study|completion of less than two study visits|14|||
24936313|NCT00431847|50029575|FG004|Overall Study|completion of less than two study visits|0|||
24936314|NCT00431847|50029571|FG000|Overall Study|Protocol Violation|0|||
25028217|NCT03073200|50126606|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
24936315|NCT00431847|50029572|FG001|Overall Study|Protocol Violation|0|||
24936316|NCT00431847|50029573|FG002|Overall Study|Protocol Violation|0|||
24936317|NCT00431847|50029574|FG003|Overall Study|Protocol Violation|0|||
24936318|NCT00431847|50029575|FG004|Overall Study|Protocol Violation|1|||
24936319|NCT00431067|50029585|FG000|Overall Study|Other Adverse Event|9|||
24936320|NCT00431067|50029585|FG000|Overall Study|Progressive disease|30|||
24936321|NCT00431067|50029585|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
24936322|NCT00430989|50029591|FG000|Overall Study|Lost to Follow-up|2|||
24936323|NCT00430989|50029592|FG001|Overall Study|Lost to Follow-up|3|||
24936324|NCT00430989|50029591|FG000|Overall Study|Withdrawal by Subject|15|||
24936325|NCT00430989|50029592|FG001|Overall Study|Withdrawal by Subject|14|||
24936326|NCT00430989|50029591|FG000|Overall Study|Protocol Violation|30|||
24936327|NCT00430989|50029592|FG001|Overall Study|Protocol Violation|37|||
24936328|NCT00430989|50029591|FG000|Overall Study|Not eligible|13|||
24936329|NCT00430989|50029592|FG001|Overall Study|Not eligible|6|||
24936330|NCT00430755|50029600|FG000|Overall Study|Withdrawal by Subject|53|||
24936331|NCT00518882|50029606|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
24936332|NCT00518882|50029607|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
24936333|NCT00518882|50029606|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
25156790|NCT02315703|50273288|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
25156791|NCT02315703|50273289|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
25156792|NCT02315703|50273290|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
25156793|NCT02315703|50273291|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
25156794|NCT02315703|50273292|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
25156795|NCT02063724|50273323|FG000|Overall Study|Disease progression|1|||
25156796|NCT02029846|50273329|FG000|Overall Study|n=1 each arm|1|||
25156797|NCT02029846|50273330|FG001|Overall Study|n=1 each arm|1|||
25156798|NCT02028884|50273339|FG000|Double-blind Period|Adverse Event|5|||
25156799|NCT02028884|50273340|FG001|Double-blind Period|Adverse Event|3|||
24936334|NCT00518882|50029607|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
24936335|NCT00518882|50029606|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
24936336|NCT00518882|50029607|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
24936337|NCT00518882|50029606|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
24936338|NCT00518882|50029607|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
24936339|NCT00518882|50029606|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
25028218|NCT03073200|50126592|FG000|Extension Period|Withdrawal by Subject|0|||
24936340|NCT00518882|50029607|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
24936341|NCT00518882|50029606|FG000|Double-Blind, Week 0-26|Subject decision|1|||
24936342|NCT00518882|50029607|FG001|Double-Blind, Week 0-26|Subject decision|1|||
25028219|NCT03073200|50126593|FG001|Extension Period|Withdrawal by Subject|0|||
24936343|NCT00518882|50029606|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
24936344|NCT00518882|50029607|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
25028220|NCT03073200|50126594|FG002|Extension Period|Withdrawal by Subject|0|||
25028221|NCT03073200|50126595|FG003|Extension Period|Withdrawal by Subject|0|||
25028222|NCT03073200|50126596|FG004|Extension Period|Withdrawal by Subject|0|||
25028223|NCT03073200|50126597|FG005|Extension Period|Withdrawal by Subject|0|||
25028224|NCT03073200|50126598|FG006|Extension Period|Withdrawal by Subject|1|||
25028225|NCT03073200|50126599|FG007|Extension Period|Withdrawal by Subject|2|||
25028226|NCT03073200|50126600|FG008|Extension Period|Withdrawal by Subject|0|||
25028227|NCT03073200|50126601|FG009|Extension Period|Withdrawal by Subject|0|||
25028228|NCT03073200|50126602|FG010|Extension Period|Withdrawal by Subject|0|||
25028229|NCT03073200|50126603|FG011|Extension Period|Withdrawal by Subject|0|||
25028230|NCT03073200|50126604|FG012|Extension Period|Withdrawal by Subject|0|||
25028231|NCT03073200|50126605|FG013|Extension Period|Withdrawal by Subject|0|||
25028232|NCT03073200|50126606|FG014|Extension Period|Withdrawal by Subject|0|||
25028233|NCT03073200|50126592|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
25156800|NCT02028884|50273341|FG002|Double-blind Period|Adverse Event|0|||
25156801|NCT02028884|50273339|FG000|Double-blind Period|Eligibility Violation|1|||
25156802|NCT02028884|50273340|FG001|Double-blind Period|Eligibility Violation|0|||
24936345|NCT00518882|50029606|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
24936346|NCT00518882|50029607|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
25156803|NCT02028884|50273341|FG002|Double-blind Period|Eligibility Violation|0|||
25156804|NCT02028884|50273339|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
25156805|NCT02028884|50273340|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
25186040|NCT01460342|50335889|FG001|Overall Study|Adverse Event|4|||
24936347|NCT00518882|50029606|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
25028234|NCT03073200|50126593|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
25028235|NCT03073200|50126594|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
25028236|NCT03073200|50126595|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
25028237|NCT03073200|50126596|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
25028238|NCT03073200|50126597|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
25028239|NCT03073200|50126598|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
25028240|NCT03073200|50126599|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
25028241|NCT03073200|50126600|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
25028242|NCT03073200|50126601|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
25028243|NCT03073200|50126602|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
25028244|NCT03073200|50126603|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
25028245|NCT03073200|50126604|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
25028246|NCT03073200|50126605|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
25028247|NCT03073200|50126606|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
25028248|NCT03073200|50126592|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
25028249|NCT03073200|50126593|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
25028250|NCT03073200|50126594|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
25028251|NCT03073200|50126595|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
25028252|NCT03073200|50126596|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
25028253|NCT03073200|50126597|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
25028254|NCT03073200|50126598|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
25028255|NCT03073200|50126599|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
24936348|NCT00518882|50029607|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
24936349|NCT00518882|50029606|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
24936350|NCT00518882|50029607|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
24936351|NCT00518882|50029606|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
24936352|NCT00518882|50029607|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
24936353|NCT00518882|50029606|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
24936354|NCT00518882|50029607|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
25156806|NCT02028884|50273341|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
25156807|NCT02028884|50273339|FG000|Double-blind Period|Withdrawal by Subject|2|||
25156808|NCT02028884|50273340|FG001|Double-blind Period|Withdrawal by Subject|0|||
25156809|NCT02028884|50273341|FG002|Double-blind Period|Withdrawal by Subject|0|||
25156810|NCT02028884|50273339|FG000|Open-label Extension Period|Adverse Event|3|||
25156811|NCT02028884|50273340|FG001|Open-label Extension Period|Adverse Event|1|||
25156812|NCT02028884|50273341|FG002|Open-label Extension Period|Adverse Event|0|||
25156813|NCT02028884|50273339|FG000|Open-label Extension Period|Lack of Efficacy|3|||
25156814|NCT02028884|50273340|FG001|Open-label Extension Period|Lack of Efficacy|0|||
25156815|NCT02028884|50273341|FG002|Open-label Extension Period|Lack of Efficacy|0|||
25156816|NCT02028884|50273339|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
25156817|NCT02028884|50273340|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
25156818|NCT02028884|50273341|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
25156819|NCT02028884|50273339|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
25156820|NCT02028884|50273340|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
25156821|NCT02028884|50273341|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
25156822|NCT02028884|50273339|FG000|Open-label Extension Period|Switched to another treatment option|3|||
25156823|NCT02028884|50273340|FG001|Open-label Extension Period|Switched to another treatment option|0|||
25156824|NCT02028884|50273341|FG002|Open-label Extension Period|Switched to another treatment option|0|||
25275179|NCT01234883|50589229|FG000|Overall Study|Early treatment release|8|||
25275180|NCT01234883|50589230|FG001|Overall Study|Early treatment release|10|||
25275181|NCT01234883|50589229|FG000|Overall Study|Parent/guardian withdrew consent|1|||
25275182|NCT01234883|50589230|FG001|Overall Study|Parent/guardian withdrew consent|2|||
25275183|NCT01234883|50589229|FG000|Overall Study|Technical difficulties with IV infusion|0|||
25275184|NCT01234883|50589230|FG001|Overall Study|Technical difficulties with IV infusion|1|||
25275185|NCT01234883|50589229|FG000|Overall Study|Inclusion/exclusion failure|1|||
25275186|NCT01234883|50589230|FG001|Overall Study|Inclusion/exclusion failure|0|||
25275187|NCT01234649|50589238|FG000|Overall Study|Withdrawal by Subject|32|||
25275188|NCT01234649|50589239|FG001|Overall Study|Withdrawal by Subject|26|||
25275189|NCT01234649|50589238|FG000|Overall Study|Pregnancy|6|||
25275190|NCT01234649|50589239|FG001|Overall Study|Pregnancy|6|||
25275191|NCT01234649|50589238|FG000|Overall Study|intolerant to side effects|4|||
25275192|NCT01234649|50589239|FG001|Overall Study|intolerant to side effects|3|||
25275193|NCT01234649|50589238|FG000|Overall Study|Allergic reaction|1|||
25275194|NCT01234649|50589239|FG001|Overall Study|Allergic reaction|0|||
25275195|NCT01234649|50589238|FG000|Overall Study|Lack of Efficacy|0|||
25275196|NCT01234649|50589239|FG001|Overall Study|Lack of Efficacy|3|||
25275197|NCT01075815|50589247|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
25275198|NCT01075815|50589248|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
25275199|NCT01075815|50589247|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
25275200|NCT01075815|50589248|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
25275201|NCT01075815|50589247|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
25275202|NCT01075815|50589248|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
25275203|NCT01075191|50589254|FG000|Overall Study|Death|1|||
25275204|NCT01075191|50589254|FG000|Overall Study|Intensification|3|||
25275205|NCT01075191|50589254|FG000|Overall Study|Co-morbidities|1|||
25275206|NCT01075191|50589254|FG000|Overall Study|Adverse Event|4|||
25275207|NCT01075191|50589254|FG000|Overall Study|Noncompliance|3|||
25028256|NCT03073200|50126600|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
25028257|NCT03073200|50126601|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
25028258|NCT03073200|50126602|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
25028259|NCT03073200|50126603|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
25028260|NCT03073200|50126604|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
25028261|NCT03073200|50126605|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
25028262|NCT03073200|50126606|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
25028263|NCT03073200|50126592|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
25028264|NCT03073200|50126593|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
25028265|NCT03073200|50126594|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
25028266|NCT03073200|50126595|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
25028267|NCT03073200|50126596|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
25028268|NCT03073200|50126597|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
25028269|NCT03073200|50126598|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
25028270|NCT03073200|50126599|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
25028271|NCT03073200|50126600|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
25028272|NCT03073200|50126601|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
25275208|NCT01075191|50589254|FG000|Overall Study|Therapy Break|3|||
25275209|NCT01075191|50589254|FG000|Overall Study|Patient's Wish|2|||
25275210|NCT01075191|50589254|FG000|Overall Study|Unknown Reasons|1|||
25275211|NCT00905359|50589260|FG000|Overall Study|Lost to Follow-up|17|||
25275212|NCT00905359|50589261|FG001|Overall Study|Lost to Follow-up|10|||
25186041|NCT01460342|50335888|FG000|Overall Study|Lost to Follow-up|1|||
25275213|NCT00905359|50589260|FG000|Overall Study|Death|2|||
25028273|NCT03073200|50126602|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
25028274|NCT03073200|50126603|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
25028275|NCT03073200|50126604|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
25028276|NCT03073200|50126605|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
25028277|NCT03073200|50126606|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
25028278|NCT03073200|50126592|FG000|Randomized Withdrawal Period|Adverse Event|0|||
25028279|NCT03073200|50126593|FG001|Randomized Withdrawal Period|Adverse Event|0|||
25028280|NCT03073200|50126594|FG002|Randomized Withdrawal Period|Adverse Event|0|||
25028281|NCT03073200|50126595|FG003|Randomized Withdrawal Period|Adverse Event|0|||
25028282|NCT03073200|50126596|FG004|Randomized Withdrawal Period|Adverse Event|0|||
25028283|NCT03073200|50126597|FG005|Randomized Withdrawal Period|Adverse Event|0|||
25028284|NCT03073200|50126598|FG006|Randomized Withdrawal Period|Adverse Event|0|||
25028285|NCT03073200|50126599|FG007|Randomized Withdrawal Period|Adverse Event|0|||
25028286|NCT03073200|50126600|FG008|Randomized Withdrawal Period|Adverse Event|0|||
25028287|NCT03073200|50126601|FG009|Randomized Withdrawal Period|Adverse Event|0|||
25028288|NCT03073200|50126602|FG010|Randomized Withdrawal Period|Adverse Event|1|||
25028289|NCT03073200|50126603|FG011|Randomized Withdrawal Period|Adverse Event|0|||
25028290|NCT03073200|50126604|FG012|Randomized Withdrawal Period|Adverse Event|0|||
25028291|NCT03073200|50126605|FG013|Randomized Withdrawal Period|Adverse Event|0|||
25028292|NCT03073200|50126606|FG014|Randomized Withdrawal Period|Adverse Event|0|||
25028293|NCT03073200|50126592|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
25028294|NCT03073200|50126593|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
25028295|NCT03073200|50126594|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
25028296|NCT03073200|50126595|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
25028297|NCT03073200|50126596|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
25028298|NCT03073200|50126597|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
25028299|NCT03073200|50126598|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
25028300|NCT03073200|50126599|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
25028301|NCT03073200|50126600|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
25275214|NCT00905359|50589261|FG001|Overall Study|Death|0|||
25275215|NCT00905359|50589260|FG000|Overall Study|Withdrawal consent|5|||
24936355|NCT00518882|50029606|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
24936356|NCT00518882|50029607|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
24936357|NCT00518882|50029606|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
24936358|NCT00518882|50029607|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
24936359|NCT00518882|50029606|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
24936360|NCT00518882|50029607|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
24936361|NCT00518882|50029606|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
24936362|NCT00518882|50029607|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
24936363|NCT00518882|50029606|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
24936364|NCT00518882|50029607|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
24936365|NCT00518882|50029606|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
24936366|NCT00518882|50029607|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
24936367|NCT00518882|50029606|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
24936368|NCT00518882|50029607|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
24936369|NCT00518882|50029606|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
25028302|NCT03073200|50126601|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
25028303|NCT03073200|50126602|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
25275216|NCT00905359|50589261|FG001|Overall Study|Withdrawal consent|6|||
24936370|NCT00518882|50029607|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
24936371|NCT00518882|50029606|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
24936372|NCT00518882|50029607|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
24936373|NCT00518882|50029606|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
24936374|NCT00518882|50029607|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
24936375|NCT00518882|50029606|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
24936376|NCT00518882|50029607|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
24936377|NCT00518882|50029606|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
24936378|NCT00518882|50029607|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
24936379|NCT00518336|50029615|FG000|Year 7|Lost to Follow-up|2|||
24936380|NCT00518336|50029616|FG001|Year 7|Lost to Follow-up|0|||
24936381|NCT00518336|50029615|FG000|Year 7|Could not attend in time|0|||
24936382|NCT00518336|50029616|FG001|Year 7|Could not attend in time|3|||
24936383|NCT00518336|50029615|FG000|Year 8|Lost to Follow-up|1|||
24936384|NCT00518336|50029616|FG001|Year 8|Lost to Follow-up|1|||
24936385|NCT00518336|50029615|FG000|Year 8|Could not attend in time|0|||
24936386|NCT00518336|50029616|FG001|Year 8|Could not attend in time|1|||
24936387|NCT00518336|50029615|FG000|Year 9|Migrated/moved from study area|1|||
24936388|NCT00518336|50029616|FG001|Year 9|Migrated/moved from study area|1|||
24936389|NCT00518336|50029615|FG000|Year 9|Lost to Follow-up|3|||
24936390|NCT00518336|50029616|FG001|Year 9|Lost to Follow-up|0|||
24936391|NCT00518336|50029615|FG000|Year 9|Personal reasons|1|||
24936392|NCT00518336|50029616|FG001|Year 9|Personal reasons|0|||
24936393|NCT00518180|50029625|FG000|Overall Study|Withdrawal by Subject|29|||
24936394|NCT00518180|50029626|FG001|Overall Study|Withdrawal by Subject|30|||
25028304|NCT03073200|50126603|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
25028305|NCT03073200|50126604|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
25028306|NCT03073200|50126605|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
25028307|NCT03073200|50126606|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
25028308|NCT03073200|50126592|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25028309|NCT03073200|50126593|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25028310|NCT03073200|50126594|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25028311|NCT03073200|50126595|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25275217|NCT01072149|50589267|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25275218|NCT01072149|50589268|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
24936395|NCT00518180|50029627|FG002|Overall Study|Withdrawal by Subject|42|||
24936396|NCT00518180|50029625|FG000|Overall Study|Lost to Follow-up|30|||
24936397|NCT00518180|50029626|FG001|Overall Study|Lost to Follow-up|28|||
24936398|NCT00518180|50029627|FG002|Overall Study|Lost to Follow-up|34|||
25275219|NCT01072149|50589269|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
24936399|NCT00518180|50029625|FG000|Overall Study|Administrative reason|0|||
24936400|NCT00518180|50029626|FG001|Overall Study|Administrative reason|2|||
24936401|NCT00518180|50029627|FG002|Overall Study|Administrative reason|2|||
24936402|NCT00518180|50029625|FG000|Overall Study|Protocol Violation|5|||
24936403|NCT00518180|50029626|FG001|Overall Study|Protocol Violation|7|||
25028312|NCT03073200|50126596|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25186042|NCT01460342|50335889|FG001|Overall Study|Lost to Follow-up|2|||
25275220|NCT01072149|50589270|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25275221|NCT01072149|50589271|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25275222|NCT01072149|50589272|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25275223|NCT01072149|50589273|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25275224|NCT01072149|50589274|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25275225|NCT01072149|50589275|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25275226|NCT01072149|50589276|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25275227|NCT01072149|50589277|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25275228|NCT01072149|50589278|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25275229|NCT01072149|50589279|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25275230|NCT01072149|50589280|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25275231|NCT01072149|50589281|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25275232|NCT01072149|50589282|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25275233|NCT01072149|50589283|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25275234|NCT01072149|50589284|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25275235|NCT01072149|50589267|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
25275236|NCT01072149|50589268|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
25275237|NCT01072149|50589269|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
25275238|NCT01072149|50589270|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
25275239|NCT01072149|50589271|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
25186043|NCT01460342|50335888|FG000|Overall Study|Protocol Violation|0|||
25186044|NCT01460342|50335889|FG001|Overall Study|Protocol Violation|1|||
25186045|NCT01460342|50335888|FG000|Overall Study|Withdrawal by Subject|3|||
25275240|NCT01072149|50589272|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
25275241|NCT01072149|50589273|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
25275242|NCT01072149|50589274|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
24936404|NCT00518180|50029627|FG002|Overall Study|Protocol Violation|4|||
25275243|NCT01072149|50589275|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
25275244|NCT01072149|50589276|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
25275245|NCT01072149|50589277|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
25275246|NCT01072149|50589278|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
25275247|NCT01072149|50589279|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
25275248|NCT01072149|50589280|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
25275249|NCT01072149|50589281|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
25275250|NCT01072149|50589282|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
25275251|NCT01072149|50589283|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
25275252|NCT01072149|50589284|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
25275253|NCT01072149|50589267|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25275254|NCT01072149|50589268|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25275255|NCT01072149|50589269|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25275256|NCT01072149|50589270|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25275257|NCT01072149|50589271|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25275258|NCT01072149|50589272|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25275259|NCT01072149|50589273|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25275260|NCT01072149|50589274|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25275261|NCT01072149|50589275|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25275262|NCT01072149|50589276|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25275263|NCT01072149|50589277|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
25275264|NCT01072149|50589278|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25275265|NCT01072149|50589279|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25275266|NCT01072149|50589280|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25275267|NCT01072149|50589281|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25275268|NCT01072149|50589282|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25275269|NCT01072149|50589283|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25186046|NCT01460342|50335889|FG001|Overall Study|Withdrawal by Subject|4|||
25186047|NCT01460342|50335888|FG000|Overall Study|Physician Decision|1|||
25186048|NCT01460342|50335889|FG001|Overall Study|Physician Decision|3|||
25186049|NCT01460342|50335888|FG000|Overall Study|Lack of Efficacy|1|||
24936405|NCT00518180|50029625|FG000|Overall Study|Unable to classify|0|||
24936406|NCT00518180|50029626|FG001|Overall Study|Unable to classify|2|||
25186050|NCT01460342|50335889|FG001|Overall Study|Lack of Efficacy|0|||
25186051|NCT01459796|50335921|FG000|Overall Study|Non compliance with protocol|2|||
25186052|NCT01459796|50335922|FG001|Overall Study|Non compliance with protocol|4|||
25186053|NCT01459796|50335921|FG000|Overall Study|Adverse Event|5|||
25186054|NCT01459796|50335922|FG001|Overall Study|Adverse Event|5|||
24936407|NCT00518180|50029627|FG002|Overall Study|Unable to classify|0|||
24936408|NCT00518180|50029625|FG000|Overall Study|Adverse Event|1|||
24936409|NCT00518180|50029626|FG001|Overall Study|Adverse Event|0|||
25186055|NCT01459796|50335921|FG000|Overall Study|Withdrawal by Subject|6|||
25186056|NCT01459796|50335922|FG001|Overall Study|Withdrawal by Subject|3|||
24936410|NCT00518180|50029627|FG002|Overall Study|Adverse Event|0|||
24936411|NCT00525902|50029644|FG000|Overall Study|Lack of Efficacy|1|||
24936412|NCT00525824|50029652|FG000|Overall Study|Adverse Event|7|||
24936413|NCT00525824|50029653|FG001|Overall Study|Adverse Event|11|||
24936414|NCT00525824|50029654|FG002|Overall Study|Adverse Event|6|||
24936415|NCT00525824|50029655|FG003|Overall Study|Adverse Event|7|||
24936416|NCT00525824|50029652|FG000|Overall Study|Withdrawal by Subject|5|||
24936417|NCT00525824|50029653|FG001|Overall Study|Withdrawal by Subject|9|||
24936418|NCT00525824|50029654|FG002|Overall Study|Withdrawal by Subject|3|||
24936419|NCT00525824|50029655|FG003|Overall Study|Withdrawal by Subject|4|||
24936420|NCT00525824|50029652|FG000|Overall Study|Lost to Follow-up|4|||
24936421|NCT00525824|50029653|FG001|Overall Study|Lost to Follow-up|2|||
24936422|NCT00525824|50029654|FG002|Overall Study|Lost to Follow-up|4|||
25275270|NCT01072149|50589284|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25275271|NCT01072149|50589267|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25275272|NCT01072149|50589268|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
25275273|NCT01072149|50589269|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25028313|NCT03073200|50126597|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25028314|NCT03073200|50126598|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25028315|NCT03073200|50126599|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25028316|NCT03073200|50126600|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25028317|NCT03073200|50126601|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25275274|NCT01072149|50589270|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25275275|NCT01072149|50589271|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25275276|NCT01072149|50589272|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25275277|NCT01072149|50589273|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25028318|NCT03073200|50126602|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25028319|NCT03073200|50126603|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25028320|NCT03073200|50126604|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25028321|NCT03073200|50126605|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
25028322|NCT03073200|50126606|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25028323|NCT03073200|50126592|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
25028324|NCT03073200|50126593|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
25028325|NCT03073200|50126594|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
25275278|NCT01072149|50589274|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
24936423|NCT00525824|50029655|FG003|Overall Study|Lost to Follow-up|0|||
24936424|NCT00525824|50029652|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
24936425|NCT00525824|50029653|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
24936426|NCT00525824|50029654|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
24936427|NCT00525824|50029655|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
24936428|NCT00525824|50029652|FG000|Overall Study|Severe non-compliance|0|||
24936429|NCT00525824|50029653|FG001|Overall Study|Severe non-compliance|1|||
24936430|NCT00525824|50029654|FG002|Overall Study|Severe non-compliance|1|||
24936431|NCT00525824|50029655|FG003|Overall Study|Severe non-compliance|1|||
24936432|NCT00525824|50029652|FG000|Overall Study|Safety reasons|1|||
24936433|NCT00525824|50029653|FG001|Overall Study|Safety reasons|0|||
24936434|NCT00525824|50029654|FG002|Overall Study|Safety reasons|1|||
24936435|NCT00525824|50029655|FG003|Overall Study|Safety reasons|0|||
24936436|NCT00525824|50029652|FG000|Overall Study|Other|1|||
24936437|NCT00525824|50029653|FG001|Overall Study|Other|3|||
24936438|NCT00525824|50029654|FG002|Overall Study|Other|3|||
24936439|NCT00525824|50029655|FG003|Overall Study|Other|1|||
24936440|NCT00525590|50029669|FG000|Overall Study|Adverse Event|3|||
24936441|NCT00525590|50029669|FG000|Overall Study|Physician Decision|3|||
24936442|NCT00525590|50029669|FG000|Overall Study|Withdrawal by Subject|16|||
24936443|NCT00525590|50029669|FG000|Overall Study|Lost to Follow-up|1|||
24936444|NCT00525590|50029669|FG000|Overall Study|Death|9|||
24936445|NCT00525590|50029669|FG000|Overall Study|Other|13|||
24936446|NCT00430677|50029676|FG000|Short-term Period|Death|1|||
24936447|NCT00430677|50029677|FG001|Short-term Period|Death|1|||
24936448|NCT00430677|50029678|FG002|Short-term Period|Death|5|||
24936449|NCT00430677|50029676|FG000|Short-term Period|Adverse Event|15|||
24936450|NCT00430677|50029677|FG001|Short-term Period|Adverse Event|13|||
24936451|NCT00430677|50029678|FG002|Short-term Period|Adverse Event|9|||
24936452|NCT00430677|50029676|FG000|Short-term Period|Lack of Efficacy|5|||
24936453|NCT00430677|50029677|FG001|Short-term Period|Lack of Efficacy|6|||
24936454|NCT00430677|50029678|FG002|Short-term Period|Lack of Efficacy|4|||
24936455|NCT00430677|50029676|FG000|Short-term Period|Withdrawal by Subject|1|||
24936456|NCT00430677|50029677|FG001|Short-term Period|Withdrawal by Subject|1|||
24936457|NCT00430677|50029678|FG002|Short-term Period|Withdrawal by Subject|2|||
24936458|NCT00430677|50029676|FG000|Short-term Period|Participant no longer met study criteria|1|||
24936459|NCT00430677|50029677|FG001|Short-term Period|Participant no longer met study criteria|1|||
24936460|NCT00430677|50029678|FG002|Short-term Period|Participant no longer met study criteria|2|||
24936461|NCT00430677|50029676|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
24936462|NCT00430677|50029677|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
24936463|NCT00430677|50029678|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
24936464|NCT00430677|50029676|FG000|Short-term Period|Pregnancy|0|||
24936465|NCT00430677|50029677|FG001|Short-term Period|Pregnancy|2|||
24936466|NCT00430677|50029678|FG002|Short-term Period|Pregnancy|0|||
24936467|NCT00430677|50029676|FG000|Long-term Extension Period|Death|1|||
25028326|NCT03073200|50126595|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
25028327|NCT03073200|50126596|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
25028328|NCT03073200|50126597|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
25028329|NCT03073200|50126598|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
25028330|NCT03073200|50126599|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
25028331|NCT03073200|50126600|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
25028332|NCT03073200|50126601|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
25028333|NCT03073200|50126602|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
25028334|NCT03073200|50126603|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
25028335|NCT03073200|50126604|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
25028336|NCT03073200|50126605|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
25028337|NCT03073200|50126606|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
25028338|NCT03073200|50126592|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25028339|NCT03073200|50126593|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25028340|NCT03073200|50126594|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25028341|NCT03073200|50126595|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25028342|NCT03073200|50126596|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25028343|NCT03073200|50126597|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25028344|NCT03073200|50126598|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25028345|NCT03073200|50126599|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25028346|NCT03073200|50126600|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25028347|NCT03073200|50126601|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25028348|NCT03073200|50126602|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25028349|NCT03073200|50126603|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25028350|NCT03073200|50126604|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25028351|NCT03073200|50126605|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
25028352|NCT03073200|50126606|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
25028353|NCT03073200|50126592|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
25275279|NCT01072149|50589275|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25275280|NCT01072149|50589276|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25275281|NCT01072149|50589277|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25275282|NCT01072149|50589278|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25275283|NCT01072149|50589279|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
24936468|NCT00430677|50029677|FG001|Long-term Extension Period|Death|0|||
24936469|NCT00430677|50029678|FG002|Long-term Extension Period|Death|0|||
24936470|NCT00430677|50029676|FG000|Long-term Extension Period|Adverse Event|3|||
24936471|NCT00430677|50029677|FG001|Long-term Extension Period|Adverse Event|2|||
24936472|NCT00430677|50029678|FG002|Long-term Extension Period|Adverse Event|5|||
24936473|NCT00430677|50029676|FG000|Long-term Extension Period|Lack of Efficacy|5|||
24936474|NCT00430677|50029677|FG001|Long-term Extension Period|Lack of Efficacy|3|||
24936475|NCT00430677|50029678|FG002|Long-term Extension Period|Lack of Efficacy|8|||
24936476|NCT00430677|50029676|FG000|Long-term Extension Period|Lost to Follow-up|1|||
24936477|NCT00430677|50029677|FG001|Long-term Extension Period|Lost to Follow-up|1|||
24936478|NCT00430677|50029678|FG002|Long-term Extension Period|Lost to Follow-up|1|||
24936479|NCT00430677|50029676|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
24936480|NCT00430677|50029677|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
24936481|NCT00430677|50029678|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
24936482|NCT00430677|50029676|FG000|Long-term Extension Period|Pregnancy|1|||
24936483|NCT00430677|50029677|FG001|Long-term Extension Period|Pregnancy|1|||
24936484|NCT00430677|50029678|FG002|Long-term Extension Period|Pregnancy|0|||
24936485|NCT00430677|50029676|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
25275284|NCT01072149|50589280|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25275285|NCT01072149|50589281|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25275286|NCT01072149|50589282|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25275287|NCT01072149|50589283|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
24936486|NCT00430677|50029677|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
24936487|NCT00430677|50029678|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
24936488|NCT00430677|50029676|FG000|Long-term Extension Period|Other|2|||
24936489|NCT00430677|50029677|FG001|Long-term Extension Period|Other|1|||
24936490|NCT00430677|50029678|FG002|Long-term Extension Period|Other|1|||
24936491|NCT00430677|50029676|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
25028354|NCT03073200|50126593|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
24936492|NCT00430677|50029677|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
24936493|NCT00430677|50029678|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
24936494|NCT00525512|50029706|FG000|Double-Blind Phase|Adverse Event|48|||
24936495|NCT00525512|50029707|FG001|Double-Blind Phase|Adverse Event|28|||
24936496|NCT00525512|50029708|FG002|Double-Blind Phase|Adverse Event|0|||
24936497|NCT00525512|50029709|FG003|Double-Blind Phase|Adverse Event|0|||
24936498|NCT00525512|50029706|FG000|Double-Blind Phase|Protocol Violation|3|||
24936499|NCT00525512|50029707|FG001|Double-Blind Phase|Protocol Violation|1|||
25186057|NCT01459796|50335921|FG000|Overall Study|Lost to Follow-up|5|||
25186058|NCT01459796|50335922|FG001|Overall Study|Lost to Follow-up|4|||
25186059|NCT01459796|50335921|FG000|Overall Study|Reason unspecified|1|||
25186060|NCT01459796|50335922|FG001|Overall Study|Reason unspecified|2|||
25186061|NCT01459796|50335921|FG000|Overall Study|Decision by the sponsor|75|||
25186062|NCT01459796|50335922|FG001|Overall Study|Decision by the sponsor|108|||
25186063|NCT01459718|50335932|FG000|Overall Study|Physician Decision|1|||
25186064|NCT01459718|50335932|FG000|Overall Study|Lost to Follow-up|1|||
25186065|NCT01459718|50335932|FG000|Overall Study|Adverse Event|1|||
25186066|NCT02970318|50335942|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
25186067|NCT02970318|50335943|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
25186068|NCT02970318|50335944|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
25186069|NCT02970318|50335945|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
25186070|NCT02970318|50335942|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
25186071|NCT02970318|50335943|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
25186072|NCT02970318|50335944|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
25186073|NCT02970318|50335945|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
25186074|NCT02970318|50335942|FG000|Overall for Arm A & Main for Arm B|Death|41|||
25186075|NCT02970318|50335943|FG001|Overall for Arm A & Main for Arm B|Death|33|||
25186076|NCT02970318|50335944|FG002|Overall for Arm A & Main for Arm B|Death|0|||
25186077|NCT02970318|50335945|FG003|Overall for Arm A & Main for Arm B|Death|0|||
25186078|NCT02970318|50335942|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
25186079|NCT02970318|50335943|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
25186080|NCT02970318|50335944|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
24936500|NCT00525512|50029708|FG002|Double-Blind Phase|Protocol Violation|0|||
24936501|NCT00525512|50029709|FG003|Double-Blind Phase|Protocol Violation|0|||
24936502|NCT00525512|50029706|FG000|Double-Blind Phase|Lost to Follow-up|3|||
24936503|NCT00525512|50029707|FG001|Double-Blind Phase|Lost to Follow-up|7|||
24936504|NCT00525512|50029708|FG002|Double-Blind Phase|Lost to Follow-up|0|||
24936505|NCT00525512|50029709|FG003|Double-Blind Phase|Lost to Follow-up|0|||
24936506|NCT00525512|50029706|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
24936507|NCT00525512|50029707|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
24936508|NCT00525512|50029708|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
24936509|NCT00525512|50029709|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
24936510|NCT00525512|50029706|FG000|Double-Blind Phase|Lack of Efficacy|13|||
24936511|NCT00525512|50029707|FG001|Double-Blind Phase|Lack of Efficacy|5|||
24936512|NCT00525512|50029708|FG002|Double-Blind Phase|Lack of Efficacy|0|||
24936513|NCT00525512|50029709|FG003|Double-Blind Phase|Lack of Efficacy|0|||
24936514|NCT00525512|50029706|FG000|Double-Blind Phase|Other reason (not specified)|12|||
24936515|NCT00525512|50029707|FG001|Double-Blind Phase|Other reason (not specified)|13|||
24936516|NCT00525512|50029708|FG002|Double-Blind Phase|Other reason (not specified)|0|||
24936517|NCT00525512|50029709|FG003|Double-Blind Phase|Other reason (not specified)|0|||
24936518|NCT00525512|50029706|FG000|Open-Label Phase|Adverse Event|0|||
24936519|NCT00525512|50029707|FG001|Open-Label Phase|Adverse Event|0|||
24936520|NCT00525512|50029708|FG002|Open-Label Phase|Adverse Event|1|||
24936521|NCT00525512|50029709|FG003|Open-Label Phase|Adverse Event|0|||
24936522|NCT00525512|50029706|FG000|Open-Label Phase|Lost to Follow-up|0|||
24936523|NCT00525512|50029707|FG001|Open-Label Phase|Lost to Follow-up|0|||
24936524|NCT00525512|50029708|FG002|Open-Label Phase|Lost to Follow-up|1|||
24936525|NCT00525512|50029709|FG003|Open-Label Phase|Lost to Follow-up|0|||
24936526|NCT00525512|50029706|FG000|Open-Label Phase|Other reason (not specified)|0|||
24936527|NCT00525512|50029707|FG001|Open-Label Phase|Other reason (not specified)|0|||
24936528|NCT00525512|50029708|FG002|Open-Label Phase|Other reason (not specified)|4|||
24936529|NCT00525512|50029709|FG003|Open-Label Phase|Other reason (not specified)|5|||
24936530|NCT00517634|50029721|FG000|Second Treatment Period|Withdrawal by Subject|0|||
24936531|NCT00517634|50029722|FG001|Second Treatment Period|Withdrawal by Subject|0|||
24936532|NCT00517634|50029723|FG002|Second Treatment Period|Withdrawal by Subject|0|||
25028355|NCT03073200|50126594|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
24936533|NCT00517634|50029724|FG003|Second Treatment Period|Withdrawal by Subject|0|||
24936534|NCT00517634|50029725|FG004|Second Treatment Period|Withdrawal by Subject|1|||
24936535|NCT00517634|50029726|FG005|Second Treatment Period|Withdrawal by Subject|0|||
24936536|NCT03683576|50029738|FG000|Overall Study|Withdrawal by Subject|2|||
24936537|NCT03683576|50029739|FG001|Overall Study|Withdrawal by Subject|0|||
24936538|NCT03683576|50029740|FG002|Overall Study|Withdrawal by Subject|8|||
24936539|NCT03683576|50029741|FG003|Overall Study|Withdrawal by Subject|3|||
24936540|NCT03683576|50029738|FG000|Overall Study|Adverse Event|3|||
24936541|NCT03683576|50029739|FG001|Overall Study|Adverse Event|0|||
24936542|NCT03683576|50029740|FG002|Overall Study|Adverse Event|0|||
24936543|NCT03683576|50029741|FG003|Overall Study|Adverse Event|4|||
24936544|NCT03683576|50029738|FG000|Overall Study|Lack of Efficacy|1|||
24936545|NCT03683576|50029739|FG001|Overall Study|Lack of Efficacy|0|||
24936546|NCT03683576|50029740|FG002|Overall Study|Lack of Efficacy|1|||
24936547|NCT03683576|50029741|FG003|Overall Study|Lack of Efficacy|1|||
24936548|NCT03683576|50029738|FG000|Overall Study|Lost to Follow-up|0|||
24936549|NCT03683576|50029739|FG001|Overall Study|Lost to Follow-up|1|||
24936550|NCT03683576|50029740|FG002|Overall Study|Lost to Follow-up|2|||
24936551|NCT03683576|50029741|FG003|Overall Study|Lost to Follow-up|0|||
24936552|NCT03683576|50029738|FG000|Overall Study|Other, Not Specified|0|||
24936553|NCT03683576|50029739|FG001|Overall Study|Other, Not Specified|2|||
24936554|NCT03683576|50029740|FG002|Overall Study|Other, Not Specified|0|||
24936555|NCT03683576|50029741|FG003|Overall Study|Other, Not Specified|0|||
24936556|NCT03683576|50029738|FG000|Overall Study|Protocol Violation|0|||
24936557|NCT03683576|50029739|FG001|Overall Study|Protocol Violation|1|||
24936558|NCT03683576|50029740|FG002|Overall Study|Protocol Violation|1|||
24936559|NCT03683576|50029741|FG003|Overall Study|Protocol Violation|0|||
24936560|NCT03863834|50029751|FG000|Overall Study|Lost to Follow-up|3|||
24936561|NCT00430521|50029763|FG000|Overall Study|Adverse Event|0|||
24936562|NCT00430521|50029764|FG001|Overall Study|Adverse Event|0|||
24936563|NCT00430521|50029765|FG002|Overall Study|Adverse Event|0|||
24936564|NCT00430521|50029766|FG003|Overall Study|Adverse Event|0|||
24936565|NCT00430521|50029767|FG004|Overall Study|Adverse Event|0|||
24936566|NCT00430521|50029768|FG005|Overall Study|Adverse Event|2|||
24936567|NCT00430521|50029769|FG006|Overall Study|Adverse Event|1|||
24936568|NCT00430521|50029770|FG007|Overall Study|Adverse Event|0|||
24936569|NCT00430521|50029763|FG000|Overall Study|Lost to Follow-up|7|||
24936570|NCT00430521|50029764|FG001|Overall Study|Lost to Follow-up|8|||
24936571|NCT00430521|50029765|FG002|Overall Study|Lost to Follow-up|3|||
24936572|NCT00430521|50029766|FG003|Overall Study|Lost to Follow-up|5|||
24936573|NCT00430521|50029767|FG004|Overall Study|Lost to Follow-up|5|||
24936574|NCT00430521|50029768|FG005|Overall Study|Lost to Follow-up|2|||
24936575|NCT00430521|50029769|FG006|Overall Study|Lost to Follow-up|8|||
24936576|NCT00430521|50029770|FG007|Overall Study|Lost to Follow-up|10|||
24936577|NCT00430521|50029763|FG000|Overall Study|Pregnancy|0|||
24936578|NCT00430521|50029764|FG001|Overall Study|Pregnancy|0|||
24936579|NCT00430521|50029765|FG002|Overall Study|Pregnancy|0|||
24936580|NCT00430521|50029766|FG003|Overall Study|Pregnancy|0|||
24936581|NCT00430521|50029767|FG004|Overall Study|Pregnancy|0|||
24936582|NCT00430521|50029768|FG005|Overall Study|Pregnancy|0|||
24936583|NCT00430521|50029769|FG006|Overall Study|Pregnancy|1|||
24936584|NCT00430521|50029770|FG007|Overall Study|Pregnancy|0|||
24936585|NCT00430521|50029763|FG000|Overall Study|Vaccine Expired|0|||
24936586|NCT00430521|50029764|FG001|Overall Study|Vaccine Expired|0|||
24936587|NCT00430521|50029765|FG002|Overall Study|Vaccine Expired|0|||
24936588|NCT00430521|50029766|FG003|Overall Study|Vaccine Expired|0|||
24936589|NCT00430521|50029767|FG004|Overall Study|Vaccine Expired|0|||
25028356|NCT03073200|50126595|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
25028357|NCT03073200|50126596|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
24936590|NCT00430521|50029768|FG005|Overall Study|Vaccine Expired|1|||
24936591|NCT00430521|50029769|FG006|Overall Study|Vaccine Expired|0|||
24936592|NCT00430521|50029770|FG007|Overall Study|Vaccine Expired|0|||
24936593|NCT00430521|50029763|FG000|Overall Study|Protocol Violation|1|||
24936594|NCT00430521|50029764|FG001|Overall Study|Protocol Violation|0|||
24936595|NCT00430521|50029765|FG002|Overall Study|Protocol Violation|0|||
24936596|NCT00430521|50029766|FG003|Overall Study|Protocol Violation|0|||
24936597|NCT00430521|50029767|FG004|Overall Study|Protocol Violation|0|||
24936598|NCT00430521|50029768|FG005|Overall Study|Protocol Violation|0|||
24936599|NCT00430521|50029769|FG006|Overall Study|Protocol Violation|0|||
24936600|NCT00430521|50029770|FG007|Overall Study|Protocol Violation|0|||
24936601|NCT00430521|50029763|FG000|Overall Study|Withdrawal by Subject|3|||
24936602|NCT00430521|50029764|FG001|Overall Study|Withdrawal by Subject|1|||
24936603|NCT00430521|50029765|FG002|Overall Study|Withdrawal by Subject|0|||
24936604|NCT00430521|50029766|FG003|Overall Study|Withdrawal by Subject|3|||
24936605|NCT00430521|50029767|FG004|Overall Study|Withdrawal by Subject|0|||
25028358|NCT03073200|50126597|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
25186081|NCT02970318|50335945|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
25186082|NCT02970318|50335942|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
25186083|NCT02970318|50335943|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
25186084|NCT02970318|50335944|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
25186085|NCT02970318|50335945|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
25186086|NCT02970318|50335942|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
25186087|NCT02970318|50335943|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
25186088|NCT02970318|50335944|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
24936606|NCT00430521|50029768|FG005|Overall Study|Withdrawal by Subject|0|||
24936607|NCT00430521|50029769|FG006|Overall Study|Withdrawal by Subject|0|||
24936608|NCT00430521|50029770|FG007|Overall Study|Withdrawal by Subject|2|||
24936609|NCT00429663|50029803|FG000|Overall Study|Lost to Follow-up|24|||
24936610|NCT00429663|50029804|FG001|Overall Study|Lost to Follow-up|31|||
24936611|NCT00429663|50029803|FG000|Overall Study|Physician Decision|6|||
24936612|NCT00429663|50029804|FG001|Overall Study|Physician Decision|3|||
24936613|NCT00429663|50029803|FG000|Overall Study|Withdrawal by Subject|2|||
24936614|NCT00429663|50029804|FG001|Overall Study|Withdrawal by Subject|5|||
24936615|NCT00429663|50029803|FG000|Overall Study|Death|4|||
24936616|NCT00429663|50029804|FG001|Overall Study|Death|0|||
24936617|NCT00429585|50029812|FG000|Overall Study|Death|1|||
24936618|NCT00429585|50029813|FG001|Overall Study|Death|0|||
24936619|NCT00429585|50029812|FG000|Overall Study|Lost to Follow-up|27|||
24936620|NCT00429585|50029813|FG001|Overall Study|Lost to Follow-up|20|||
24936621|NCT00429585|50029812|FG000|Overall Study|Physician Decision|2|||
24936622|NCT00429585|50029813|FG001|Overall Study|Physician Decision|0|||
24936623|NCT00440271|50029821|FG000|Overall Study|Protocol Violation|1|||
24936624|NCT00440271|50029822|FG001|Overall Study|Protocol Violation|1|||
24936625|NCT00440271|50029821|FG000|Overall Study|Adverse Event|0|||
24936626|NCT00440271|50029822|FG001|Overall Study|Adverse Event|1|||
24936627|NCT00440271|50029821|FG000|Overall Study|Lost to Follow-up|1|||
24936628|NCT00440271|50029822|FG001|Overall Study|Lost to Follow-up|0|||
24936629|NCT00440271|50029821|FG000|Overall Study|Withdrawal by Subject|0|||
24936630|NCT00440271|50029822|FG001|Overall Study|Withdrawal by Subject|2|||
24936631|NCT00440271|50029821|FG000|Overall Study|Lack of Efficacy|0|||
24936632|NCT00440271|50029822|FG001|Overall Study|Lack of Efficacy|1|||
24936633|NCT00440271|50029821|FG000|Overall Study|Due to closure of trial|8|||
24936634|NCT00440271|50029822|FG001|Overall Study|Due to closure of trial|10|||
25028359|NCT03073200|50126598|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
25028360|NCT03073200|50126599|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
25028361|NCT03073200|50126600|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
25028362|NCT03073200|50126601|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
25028363|NCT03073200|50126602|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
25028364|NCT03073200|50126603|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
25028365|NCT03073200|50126604|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
25028366|NCT03073200|50126605|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
25028367|NCT03073200|50126606|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
25028368|NCT03073200|50126592|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
25028369|NCT03073200|50126593|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
25028370|NCT03073200|50126594|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
25028371|NCT03073200|50126595|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
25028372|NCT03073200|50126596|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
25028373|NCT03073200|50126597|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
25028374|NCT03073200|50126598|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
25028375|NCT03073200|50126599|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
25275288|NCT01072149|50589284|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25275289|NCT01072149|50589267|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
25275290|NCT01072149|50589268|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
25275291|NCT01072149|50589269|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
25275292|NCT01072149|50589270|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
25275293|NCT01072149|50589271|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
25275294|NCT01072149|50589272|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
25275295|NCT01072149|50589273|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
24936635|NCT00440271|50029821|FG000|Overall Study|Other|2|||
24936636|NCT00440271|50029822|FG001|Overall Study|Other|0|||
24936637|NCT00346216|50029831|FG000|Overall Study|Other|181|||
24936638|NCT00346216|50029832|FG001|Overall Study|Other|231|||
24936639|NCT00346216|50029833|FG002|Overall Study|Other|205|||
24936640|NCT00346216|50029831|FG000|Overall Study|No longer willing to participate|600|||
25275296|NCT01072149|50589274|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
25275297|NCT01072149|50589275|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
25275298|NCT01072149|50589276|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
25275299|NCT01072149|50589277|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
25275300|NCT01072149|50589278|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
25275301|NCT01072149|50589279|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
25275302|NCT01072149|50589280|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
25275303|NCT01072149|50589281|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
25275304|NCT01072149|50589282|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
25275305|NCT01072149|50589283|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
25275306|NCT01072149|50589284|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
25275307|NCT01072149|50589267|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
25275308|NCT01072149|50589268|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
25275309|NCT01072149|50589269|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
25275310|NCT01072149|50589270|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
25275311|NCT01072149|50589271|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
25275312|NCT01072149|50589272|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
24936641|NCT00346216|50029832|FG001|Overall Study|No longer willing to participate|606|||
24936642|NCT00346216|50029833|FG002|Overall Study|No longer willing to participate|585|||
24936643|NCT00346216|50029831|FG000|Overall Study|Withdrawal by Subject|661|||
24936644|NCT00346216|50029832|FG001|Overall Study|Withdrawal by Subject|692|||
24936645|NCT00346216|50029833|FG002|Overall Study|Withdrawal by Subject|651|||
24936646|NCT00346216|50029831|FG000|Overall Study|Lost to Follow-up|611|||
24936647|NCT00346216|50029832|FG001|Overall Study|Lost to Follow-up|588|||
24936648|NCT00346216|50029833|FG002|Overall Study|Lost to Follow-up|542|||
24936649|NCT00346216|50029831|FG000|Overall Study|Physician Decision|80|||
24936650|NCT00346216|50029832|FG001|Overall Study|Physician Decision|76|||
24936651|NCT00346216|50029833|FG002|Overall Study|Physician Decision|59|||
24936652|NCT00346216|50029831|FG000|Overall Study|Does not meet entrance criteria|13|||
24936653|NCT00346216|50029832|FG001|Overall Study|Does not meet entrance criteria|10|||
24936654|NCT00346216|50029833|FG002|Overall Study|Does not meet entrance criteria|8|||
24936655|NCT00346216|50029831|FG000|Overall Study|Death|189|||
24936656|NCT00346216|50029832|FG001|Overall Study|Death|192|||
24936657|NCT00346216|50029833|FG002|Overall Study|Death|228|||
24936658|NCT00346216|50029831|FG000|Overall Study|Study terminated by sponsor|11|||
24936659|NCT00346216|50029832|FG001|Overall Study|Study terminated by sponsor|4|||
24936660|NCT00346216|50029833|FG002|Overall Study|Study terminated by sponsor|8|||
24936661|NCT00346216|50029831|FG000|Overall Study|Missing Subject Summary Status|62|||
24936662|NCT00346216|50029832|FG001|Overall Study|Missing Subject Summary Status|61|||
24936663|NCT00346216|50029833|FG002|Overall Study|Missing Subject Summary Status|62|||
24936664|NCT00417963|50029841|FG000|Overall Study|Lost to Follow-up|3|||
24936665|NCT00417963|50029841|FG000|Overall Study|Withdrawal by Subject|18|||
24936666|NCT00417963|50029841|FG000|Overall Study|Death|17|||
24936667|NCT00417963|50029841|FG000|Overall Study|Study device could not be deployed|3|||
24936668|NCT00429273|50029853|FG000|Overall Study|Lost to Follow-up|1|||
24936669|NCT00429273|50029854|FG001|Overall Study|Lost to Follow-up|2|||
24936670|NCT00429273|50029855|FG002|Overall Study|Lost to Follow-up|2|||
24936671|NCT00429273|50029853|FG000|Overall Study|Physician Decision|6|||
24936672|NCT00429273|50029854|FG001|Overall Study|Physician Decision|5|||
24936673|NCT00429273|50029855|FG002|Overall Study|Physician Decision|5|||
24936674|NCT00429273|50029853|FG000|Overall Study|Adverse Event|1|||
24936675|NCT00429273|50029854|FG001|Overall Study|Adverse Event|1|||
24936676|NCT00429273|50029855|FG002|Overall Study|Adverse Event|2|||
24936677|NCT00359632|50029865|FG000|Overall Study|Death|2|||
24936678|NCT00359632|50029866|FG001|Overall Study|Death|0|||
24936679|NCT00359632|50029865|FG000|Overall Study|Adverse Event|1|||
24936680|NCT00359632|50029866|FG001|Overall Study|Adverse Event|0|||
24936681|NCT00359632|50029865|FG000|Overall Study|Non-compliance with visit schedule|1|||
24936682|NCT00359632|50029866|FG001|Overall Study|Non-compliance with visit schedule|0|||
24936683|NCT00417885|50029872|FG000|Overall Study|Adverse Event|1|||
25028376|NCT03073200|50126600|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
24936684|NCT00417885|50029872|FG000|Overall Study|Objective Progression or Relapse|3|||
24936685|NCT00417885|50029872|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
24936686|NCT04488770|50029889|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
24936687|NCT04488770|50029890|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
24936688|NCT04488770|50029891|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
24936689|NCT04488770|50029892|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
24936690|NCT04488770|50029893|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
24936691|NCT04488770|50029894|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
24936692|NCT04488770|50029895|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
24936693|NCT04488770|50029896|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
24936694|NCT04488770|50029897|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
24936695|NCT04488770|50029898|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
24936696|NCT04488770|50029899|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
24936697|NCT04488770|50029900|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
24936698|NCT04488770|50029901|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
24936699|NCT04488770|50029889|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
24936700|NCT04488770|50029890|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
24936701|NCT04488770|50029891|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
24936702|NCT04488770|50029892|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
24936703|NCT04488770|50029893|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
24936704|NCT04488770|50029894|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
24936705|NCT04488770|50029895|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
24936706|NCT04488770|50029896|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
24936707|NCT04488770|50029897|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
24936708|NCT04488770|50029898|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
24936709|NCT04488770|50029899|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
25028377|NCT03073200|50126601|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
25028378|NCT03073200|50126602|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
25028379|NCT03073200|50126603|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
25028380|NCT03073200|50126604|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
25028381|NCT03073200|50126605|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
25028382|NCT03073200|50126606|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
25028383|NCT03073200|50126592|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25028384|NCT03073200|50126593|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25028385|NCT03073200|50126594|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25028386|NCT03073200|50126595|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25028387|NCT03073200|50126596|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25028388|NCT03073200|50126597|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25028389|NCT03073200|50126598|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25028390|NCT03073200|50126599|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25186089|NCT02970318|50335945|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
24936710|NCT04488770|50029900|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
24936711|NCT04488770|50029901|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
24936712|NCT04488770|50029889|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
24936713|NCT04488770|50029890|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
24936714|NCT04488770|50029891|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
24936715|NCT04488770|50029892|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
24936716|NCT04488770|50029893|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
24936717|NCT04488770|50029894|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
24936718|NCT04488770|50029895|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
24936719|NCT04488770|50029896|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
24936720|NCT04488770|50029897|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
24936721|NCT04488770|50029898|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
24936722|NCT04488770|50029899|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
24936723|NCT04488770|50029900|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
24936724|NCT04488770|50029901|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
24936725|NCT04488770|50029889|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
24936726|NCT04488770|50029890|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
25275313|NCT01072149|50589273|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
25275314|NCT01072149|50589274|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
25275315|NCT01072149|50589275|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
25275316|NCT01072149|50589276|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
25275317|NCT01072149|50589277|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
25275318|NCT01072149|50589278|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
25275319|NCT01072149|50589279|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
25275320|NCT01072149|50589280|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
25275321|NCT01072149|50589281|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
25275322|NCT01072149|50589282|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
25275323|NCT01072149|50589283|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
25275324|NCT01072149|50589284|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
25275325|NCT01072149|50589267|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
25275326|NCT01072149|50589268|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
25275327|NCT01072149|50589269|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
25275328|NCT01072149|50589270|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
25275329|NCT01072149|50589271|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
25275330|NCT01072149|50589272|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
25275331|NCT01072149|50589273|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
25275332|NCT01072149|50589274|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
25275333|NCT01072149|50589275|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
25275334|NCT01072149|50589276|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
24936727|NCT04488770|50029891|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
24936728|NCT04488770|50029892|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
24936729|NCT04488770|50029893|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
24936730|NCT04488770|50029894|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
25275335|NCT01072149|50589277|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
25275336|NCT01072149|50589278|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
25275337|NCT01072149|50589279|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
25275338|NCT01072149|50589280|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
25275339|NCT01072149|50589281|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
25275340|NCT01072149|50589282|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
25275341|NCT01072149|50589283|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
25275342|NCT01072149|50589284|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
25275343|NCT01072149|50589267|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
25275344|NCT01072149|50589268|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
25275345|NCT01072149|50589269|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
24936731|NCT04488770|50029895|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
25028391|NCT03073200|50126600|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25028392|NCT03073200|50126601|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25275346|NCT01072149|50589270|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
25275347|NCT01072149|50589271|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
25275348|NCT01072149|50589272|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
25275349|NCT01072149|50589273|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
25275350|NCT01072149|50589274|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
24936732|NCT04488770|50029896|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
24936733|NCT04488770|50029897|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
24936734|NCT04488770|50029898|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
24936735|NCT04488770|50029899|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
24936736|NCT04488770|50029900|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
24936737|NCT04488770|50029901|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
24936738|NCT00525044|50029947|FG000|Overall Study|Lost to Follow-up|0|||
24936739|NCT00525044|50029948|FG001|Overall Study|Lost to Follow-up|1|||
24936740|NCT00355342|50029956|FG000|Overall Study|Adverse Event|13|||
24936741|NCT00355342|50029957|FG001|Overall Study|Adverse Event|15|||
24936742|NCT00355342|50029956|FG000|Overall Study|Lost to Follow-up|4|||
24936743|NCT00355342|50029957|FG001|Overall Study|Lost to Follow-up|2|||
24936744|NCT00355342|50029956|FG000|Overall Study|Withdrawal by Subject|14|||
24936745|NCT00355342|50029957|FG001|Overall Study|Withdrawal by Subject|11|||
25275351|NCT01072149|50589275|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
25275352|NCT01072149|50589276|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
24936746|NCT00355342|50029956|FG000|Overall Study|Sponsor terminated study|2|||
24936747|NCT00355342|50029957|FG001|Overall Study|Sponsor terminated study|2|||
24936748|NCT00355342|50029956|FG000|Overall Study|Overcompliant-PI discretion|1|||
24936749|NCT00355342|50029957|FG001|Overall Study|Overcompliant-PI discretion|0|||
24936750|NCT00355342|50029956|FG000|Overall Study|Use of prohibited medication|1|||
24936751|NCT00355342|50029957|FG001|Overall Study|Use of prohibited medication|0|||
24936752|NCT00355342|50029956|FG000|Overall Study|COPD exacerbation|1|||
24936753|NCT00355342|50029957|FG001|Overall Study|COPD exacerbation|1|||
24936754|NCT00355342|50029956|FG000|Overall Study|Dispensed wrong study drug kit|1|||
24936755|NCT00355342|50029957|FG001|Overall Study|Dispensed wrong study drug kit|0|||
24936756|NCT00355342|50029956|FG000|Overall Study|Non-compliance with Dexa scans|1|||
24936757|NCT00355342|50029957|FG001|Overall Study|Non-compliance with Dexa scans|0|||
24936758|NCT00355342|50029956|FG000|Overall Study|Withdrawal by participant and physician|1|||
24936759|NCT00355342|50029957|FG001|Overall Study|Withdrawal by participant and physician|0|||
24936760|NCT00355342|50029956|FG000|Overall Study|Participant relocated|0|||
24936761|NCT00355342|50029957|FG001|Overall Study|Participant relocated|1|||
24936762|NCT00355342|50029956|FG000|Overall Study|Participant discontinued study drug|0|||
25275353|NCT01072149|50589277|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
24936763|NCT00355342|50029957|FG001|Overall Study|Participant discontinued study drug|1|||
24936764|NCT00355342|50029956|FG000|Overall Study|Study management|0|||
24936765|NCT00355342|50029957|FG001|Overall Study|Study management|1|||
24936766|NCT00355342|50029956|FG000|Overall Study|Protocol Violation|0|||
24936767|NCT00355342|50029957|FG001|Overall Study|Protocol Violation|1|||
24936768|NCT00355342|50029956|FG000|Overall Study|Use of protocol excluded medication|0|||
24936769|NCT00355342|50029957|FG001|Overall Study|Use of protocol excluded medication|1|||
24936770|NCT01573754|50029965|FG000|Overall Study|Noncompliance or remission not achieved|3|||
24936771|NCT01573754|50029966|FG001|Overall Study|Noncompliance or remission not achieved|15|||
24936772|NCT00355264|50029972|FG000|Extension (Variable Duration)|Adverse Event|1|||
24936773|NCT00355264|50029972|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
24936774|NCT00355030|50029983|FG000|Study Period 1 Treatment|Adverse Event|1|||
24936775|NCT00355030|50029984|FG001|Study Period 1 Treatment|Adverse Event|1|||
24936776|NCT00355030|50029983|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
24936777|NCT00355030|50029984|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
24936778|NCT00355030|50029983|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
24936779|NCT00355030|50029984|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
24936780|NCT00355030|50029983|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
24936781|NCT00355030|50029984|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
24936782|NCT00355030|50029983|FG000|Study Period 1 Treatment|Physician Decision|0|||
24936783|NCT00355030|50029984|FG001|Study Period 1 Treatment|Physician Decision|1|||
24936784|NCT00355030|50029983|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
24936785|NCT00355030|50029984|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
24936786|NCT00355030|50029983|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
24936787|NCT00355030|50029984|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
24936788|NCT00355030|50029983|FG000|Study Period 1 Treatment|Other|2|||
24936789|NCT00355030|50029984|FG001|Study Period 1 Treatment|Other|6|||
24936790|NCT00355030|50029983|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
24936791|NCT00355030|50029984|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
24936792|NCT00355030|50029983|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
24936793|NCT00355030|50029984|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
24936794|NCT00354172|50029990|FG000|Overall Study|Did not receive transplant|1|||
24936795|NCT00345592|50029996|FG000|Overall Study|Death|14|||
24936796|NCT00345592|50029997|FG001|Overall Study|Death|16|||
24936797|NCT00345592|50029996|FG000|Overall Study|Withdrawal by Subject|11|||
24936798|NCT00345592|50029997|FG001|Overall Study|Withdrawal by Subject|8|||
24936799|NCT00353704|50030005|FG000|Overall Study|Protocol Violation|3|||
24936800|NCT00353704|50030006|FG001|Overall Study|Protocol Violation|1|||
24936801|NCT00512252|50030015|FG000|Overall Study|Lost to Follow-up|0|||
24936802|NCT00512252|50030016|FG001|Overall Study|Lost to Follow-up|0|||
24936803|NCT00512252|50030017|FG002|Overall Study|Lost to Follow-up|1|||
24936804|NCT00512252|50030015|FG000|Overall Study|Protocol Violation|0|||
24936805|NCT00512252|50030016|FG001|Overall Study|Protocol Violation|0|||
24936806|NCT00512252|50030017|FG002|Overall Study|Protocol Violation|1|||
24936807|NCT00512252|50030015|FG000|Overall Study|Death|0|||
24936808|NCT00512252|50030016|FG001|Overall Study|Death|0|||
24936809|NCT00512252|50030017|FG002|Overall Study|Death|1|||
24936810|NCT00516386|50030032|FG000|Overall Study|not interested in the study|4|||
24936811|NCT00516386|50030032|FG000|Overall Study|Lost to Follow-up|2|||
24936812|NCT00524420|50030038|FG000|Overall Study|Lack of Efficacy|1|||
24936813|NCT00524420|50030039|FG001|Overall Study|Lack of Efficacy|0|||
24936814|NCT00512096|50030047|FG000|Overall Study|Adverse Event|2|||
24936815|NCT00512096|50030047|FG000|Overall Study|Withdrawal by Subject|2|||
24936816|NCT00512096|50030047|FG000|Overall Study|Lack of Efficacy|3|||
24936817|NCT00524030|50030053|FG000|Overall Study|Lack of Efficacy|10|||
24936818|NCT00524030|50030054|FG001|Overall Study|Lack of Efficacy|24|||
24936819|NCT00524030|50030053|FG000|Overall Study|Lost to Follow-up|0|||
24936820|NCT00524030|50030054|FG001|Overall Study|Lost to Follow-up|2|||
25028393|NCT03073200|50126602|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25028394|NCT03073200|50126603|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25028395|NCT03073200|50126604|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25028396|NCT03073200|50126605|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
25028397|NCT03073200|50126606|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
25028398|NCT03073200|50126592|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
25186090|NCT02970318|50335942|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
24936821|NCT00524030|50030053|FG000|Overall Study|Withdrawal by Subject|3|||
24936822|NCT00524030|50030054|FG001|Overall Study|Withdrawal by Subject|8|||
24936823|NCT00524030|50030053|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
24936824|NCT00524030|50030054|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
24936825|NCT00524030|50030053|FG000|Overall Study|Protocol Violation|0|||
24936826|NCT00524030|50030054|FG001|Overall Study|Protocol Violation|1|||
24936827|NCT00524030|50030053|FG000|Overall Study|Pregnancy|1|||
24936828|NCT00524030|50030054|FG001|Overall Study|Pregnancy|0|||
24936829|NCT00524030|50030053|FG000|Overall Study|Adverse Event|3|||
24936830|NCT00524030|50030054|FG001|Overall Study|Adverse Event|21|||
24936831|NCT00524030|50030053|FG000|Overall Study|Death|0|||
24936832|NCT00524030|50030054|FG001|Overall Study|Death|1|||
24936833|NCT00523718|50030063|FG000|Overall Study|Withdrawal by Subject|1|||
25028399|NCT03073200|50126593|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
25028400|NCT03073200|50126594|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
25028401|NCT03073200|50126595|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
25028402|NCT03073200|50126596|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
25028403|NCT03073200|50126597|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
25028404|NCT03073200|50126598|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
25028405|NCT03073200|50126599|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
25028406|NCT03073200|50126600|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
25028407|NCT03073200|50126601|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
25028408|NCT03073200|50126602|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
25028409|NCT03073200|50126603|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
25028410|NCT03073200|50126604|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
25028411|NCT03073200|50126605|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
24936834|NCT00523718|50030064|FG001|Overall Study|Withdrawal by Subject|0|||
24936835|NCT00523718|50030063|FG000|Overall Study|Protocol Violation|2|||
24936836|NCT00523718|50030064|FG001|Overall Study|Protocol Violation|0|||
24936837|NCT00523640|50030070|FG000|Overall Study|Death|1|||
24936838|NCT00345358|50030078|FG000|Primary Vaccination Phase|Other|0|||
24936839|NCT00345358|50030079|FG001|Primary Vaccination Phase|Other|1|||
24936840|NCT00345358|50030080|FG002|Primary Vaccination Phase|Other|1|||
24936841|NCT00345358|50030081|FG003|Primary Vaccination Phase|Other|0|||
24936842|NCT00345358|50030078|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
24936843|NCT00345358|50030079|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
24936844|NCT00345358|50030080|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
24936845|NCT00345358|50030081|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
24936846|NCT00345358|50030078|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
24936847|NCT00345358|50030079|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
24936848|NCT00345358|50030080|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
24936849|NCT00345358|50030081|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
24936850|NCT00345358|50030078|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
24936851|NCT00345358|50030079|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
24936852|NCT00345358|50030080|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
24936853|NCT00345358|50030081|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
24936854|NCT00345358|50030078|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
24936855|NCT00345358|50030079|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
24936856|NCT00345358|50030080|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
24936857|NCT00345358|50030081|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
24936858|NCT00345358|50030078|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
24936859|NCT00345358|50030079|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
24936860|NCT00345358|50030080|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
24936861|NCT00345358|50030081|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
24936862|NCT03869684|50030094|FG000|Overall Study|Adverse Event|0|||
24936863|NCT03869684|50030095|FG001|Overall Study|Adverse Event|3|||
24936864|NCT03869684|50030096|FG002|Overall Study|Adverse Event|1|||
24936865|NCT03869684|50030094|FG000|Overall Study|Withdrawal by Subject|1|||
24936866|NCT03869684|50030095|FG001|Overall Study|Withdrawal by Subject|0|||
24936867|NCT03869684|50030096|FG002|Overall Study|Withdrawal by Subject|0|||
24936868|NCT03869684|50030094|FG000|Overall Study|Lost to Follow-up|1|||
24936869|NCT03869684|50030095|FG001|Overall Study|Lost to Follow-up|0|||
24936870|NCT03869684|50030096|FG002|Overall Study|Lost to Follow-up|0|||
24936871|NCT03869684|50030094|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
24936872|NCT03869684|50030095|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
24936873|NCT03869684|50030096|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
24936874|NCT00516074|50030106|FG000|Overall Study|Adverse Event|0|||
24936875|NCT00516074|50030107|FG001|Overall Study|Adverse Event|1|||
24936876|NCT00516074|50030106|FG000|Overall Study|Subject Decision|4|||
24936877|NCT00516074|50030107|FG001|Overall Study|Subject Decision|2|||
24936878|NCT00516074|50030106|FG000|Overall Study|Loss of Glucose Control|2|||
24936879|NCT00516074|50030107|FG001|Overall Study|Loss of Glucose Control|0|||
24936880|NCT00515294|50030117|FG000|Overall Study|Lost to Follow-up|3|||
24936881|NCT00515294|50030118|FG001|Overall Study|Lost to Follow-up|2|||
24936882|NCT00515294|50030119|FG002|Overall Study|Lost to Follow-up|3|||
24936883|NCT00515294|50030120|FG003|Overall Study|Lost to Follow-up|1|||
24936884|NCT00515294|50030117|FG000|Overall Study|Driver simulator problems|1|||
24936885|NCT00515294|50030118|FG001|Overall Study|Driver simulator problems|1|||
24936886|NCT00515294|50030119|FG002|Overall Study|Driver simulator problems|1|||
25028412|NCT03073200|50126606|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
24936887|NCT00515294|50030120|FG003|Overall Study|Driver simulator problems|3|||
24936888|NCT00515294|50030117|FG000|Overall Study|Caffeine amount inaccurate|5|||
24936889|NCT00515294|50030118|FG001|Overall Study|Caffeine amount inaccurate|0|||
24936890|NCT00515294|50030119|FG002|Overall Study|Caffeine amount inaccurate|7|||
25028413|NCT03290781|50126635|FG000|Overall Study|Adverse Event|5|||
25028414|NCT03290781|50126636|FG001|Overall Study|Adverse Event|7|||
25028415|NCT03290781|50126637|FG002|Overall Study|Adverse Event|4|||
25028416|NCT03290781|50126638|FG003|Overall Study|Adverse Event|1|||
25028417|NCT03290781|50126639|FG004|Overall Study|Adverse Event|0|||
25028418|NCT03290781|50126640|FG005|Overall Study|Adverse Event|0|||
25028419|NCT03290781|50126641|FG006|Overall Study|Adverse Event|0|||
25028420|NCT03290781|50126635|FG000|Overall Study|Death|0|||
25028421|NCT03290781|50126636|FG001|Overall Study|Death|0|||
25028422|NCT03290781|50126637|FG002|Overall Study|Death|1|||
25028423|NCT03290781|50126638|FG003|Overall Study|Death|0|||
25028424|NCT03290781|50126639|FG004|Overall Study|Death|1|||
25028425|NCT03290781|50126640|FG005|Overall Study|Death|0|||
25028426|NCT03290781|50126641|FG006|Overall Study|Death|0|||
25028427|NCT03290781|50126635|FG000|Overall Study|Withdrawal by Subject|6|||
25028428|NCT03290781|50126636|FG001|Overall Study|Withdrawal by Subject|5|||
25028429|NCT03290781|50126637|FG002|Overall Study|Withdrawal by Subject|9|||
25028430|NCT03290781|50126638|FG003|Overall Study|Withdrawal by Subject|10|||
25028431|NCT03290781|50126639|FG004|Overall Study|Withdrawal by Subject|1|||
25028432|NCT03290781|50126640|FG005|Overall Study|Withdrawal by Subject|2|||
25028433|NCT03290781|50126641|FG006|Overall Study|Withdrawal by Subject|0|||
25028434|NCT03290781|50126635|FG000|Overall Study|Physician Decision|0|||
25028435|NCT03290781|50126636|FG001|Overall Study|Physician Decision|1|||
25028436|NCT03290781|50126637|FG002|Overall Study|Physician Decision|0|||
25028437|NCT03290781|50126638|FG003|Overall Study|Physician Decision|0|||
25028438|NCT03290781|50126639|FG004|Overall Study|Physician Decision|0|||
25028439|NCT03290781|50126640|FG005|Overall Study|Physician Decision|0|||
25028440|NCT03290781|50126641|FG006|Overall Study|Physician Decision|0|||
25028441|NCT03290781|50126635|FG000|Overall Study|Site Terminated by Sponsor|1|||
25028442|NCT03290781|50126636|FG001|Overall Study|Site Terminated by Sponsor|0|||
25028443|NCT03290781|50126637|FG002|Overall Study|Site Terminated by Sponsor|2|||
25028444|NCT03290781|50126638|FG003|Overall Study|Site Terminated by Sponsor|1|||
25028445|NCT03290781|50126639|FG004|Overall Study|Site Terminated by Sponsor|0|||
25028446|NCT03290781|50126640|FG005|Overall Study|Site Terminated by Sponsor|0|||
25028447|NCT03290781|50126641|FG006|Overall Study|Site Terminated by Sponsor|0|||
25028448|NCT03290781|50126635|FG000|Overall Study|Lost to Follow-up|0|||
25028449|NCT03290781|50126636|FG001|Overall Study|Lost to Follow-up|0|||
25028450|NCT03290781|50126637|FG002|Overall Study|Lost to Follow-up|0|||
25028451|NCT03290781|50126638|FG003|Overall Study|Lost to Follow-up|1|||
25028452|NCT03290781|50126639|FG004|Overall Study|Lost to Follow-up|0|||
25028453|NCT03290781|50126640|FG005|Overall Study|Lost to Follow-up|0|||
25028454|NCT03290781|50126641|FG006|Overall Study|Lost to Follow-up|0|||
25028455|NCT03290781|50126635|FG000|Overall Study|Protocol Deviation|2|||
25028456|NCT03290781|50126636|FG001|Overall Study|Protocol Deviation|0|||
25028457|NCT03290781|50126637|FG002|Overall Study|Protocol Deviation|0|||
25028458|NCT03290781|50126638|FG003|Overall Study|Protocol Deviation|1|||
25028459|NCT03290781|50126639|FG004|Overall Study|Protocol Deviation|0|||
25028460|NCT03290781|50126640|FG005|Overall Study|Protocol Deviation|0|||
25028461|NCT03290781|50126641|FG006|Overall Study|Protocol Deviation|0|||
25028462|NCT03290781|50126635|FG000|Overall Study|Disease Relapse|32|||
25028463|NCT03290781|50126636|FG001|Overall Study|Disease Relapse|5|||
25028464|NCT03290781|50126637|FG002|Overall Study|Disease Relapse|38|||
25028465|NCT03290781|50126638|FG003|Overall Study|Disease Relapse|7|||
25028466|NCT03290781|50126639|FG004|Overall Study|Disease Relapse|3|||
25028467|NCT03290781|50126640|FG005|Overall Study|Disease Relapse|1|||
25028468|NCT03290781|50126641|FG006|Overall Study|Disease Relapse|4|||
25275354|NCT01072149|50589278|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
24936891|NCT00515294|50030120|FG003|Overall Study|Caffeine amount inaccurate|0|||
24936892|NCT00345046|50030133|FG000|Overall Study|Protocol Violation|1|||
24936893|NCT00345046|50030134|FG001|Overall Study|Protocol Violation|1|||
24936894|NCT00345046|50030135|FG002|Overall Study|Protocol Violation|2|||
24936895|NCT00515216|50030143|FG000|Overall Study|Withdrawal by Subject|1|||
25028469|NCT03290781|50126635|FG000|Overall Study|Other|3|||
25028470|NCT03290781|50126636|FG001|Overall Study|Other|0|||
25028471|NCT03290781|50126637|FG002|Overall Study|Other|2|||
25028472|NCT03290781|50126638|FG003|Overall Study|Other|2|||
25275355|NCT01072149|50589279|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
24936896|NCT01004978|50030150|FG000|Overall Study|Disease progression|31|||
24936897|NCT01004978|50030151|FG001|Overall Study|Disease progression|48|||
25028473|NCT03290781|50126639|FG004|Overall Study|Other|0|||
25028474|NCT03290781|50126640|FG005|Overall Study|Other|0|||
24936898|NCT01004978|50030150|FG000|Overall Study|Adverse Event|42|||
25028475|NCT03290781|50126641|FG006|Overall Study|Other|0|||
25028476|NCT03466073|50126670|FG000|Overall Study|Death|1|||
25028477|NCT03466073|50126671|FG001|Overall Study|Death|0|||
25028478|NCT03466073|50126672|FG002|Overall Study|Death|0|||
25028479|NCT03466073|50126673|FG003|Overall Study|Death|0|||
25028480|NCT03466073|50126674|FG004|Overall Study|Death|0|||
24936899|NCT01004978|50030151|FG001|Overall Study|Adverse Event|22|||
24936900|NCT01004978|50030150|FG000|Overall Study|Death|3|||
24936901|NCT01004978|50030151|FG001|Overall Study|Death|2|||
24936902|NCT01004978|50030150|FG000|Overall Study|Withdrawal by Subject|16|||
24936903|NCT01004978|50030151|FG001|Overall Study|Withdrawal by Subject|16|||
24936904|NCT01004978|50030150|FG000|Overall Study|Alternative therapy|4|||
24936905|NCT01004978|50030151|FG001|Overall Study|Alternative therapy|8|||
24936906|NCT01004978|50030150|FG000|Overall Study|Physician Decision|6|||
24936907|NCT01004978|50030151|FG001|Overall Study|Physician Decision|3|||
24936908|NCT01004978|50030150|FG000|Overall Study|Other complicating disease|2|||
24936909|NCT01004978|50030151|FG001|Overall Study|Other complicating disease|2|||
24936910|NCT01004978|50030150|FG000|Overall Study|Protocol Violation|2|||
24936911|NCT01004978|50030151|FG001|Overall Study|Protocol Violation|3|||
24936912|NCT01004978|50030150|FG000|Overall Study|Non-compliance|3|||
24936913|NCT01004978|50030151|FG001|Overall Study|Non-compliance|2|||
24936914|NCT01004978|50030150|FG000|Overall Study|Ineligible|1|||
24936915|NCT01004978|50030151|FG001|Overall Study|Ineligible|0|||
24936916|NCT01004978|50030150|FG000|Overall Study|Unblinded|0|||
24936917|NCT01004978|50030151|FG001|Overall Study|Unblinded|1|||
24936918|NCT01004978|50030150|FG000|Overall Study|Performance status worsening|0|||
24936919|NCT01004978|50030151|FG001|Overall Study|Performance status worsening|1|||
24936920|NCT01004978|50030150|FG000|Overall Study|Never started treatment|8|||
24936921|NCT01004978|50030151|FG001|Overall Study|Never started treatment|9|||
24936922|NCT00522626|50030157|FG000|Overall Study|Lost to Follow-up|7|||
24936923|NCT00440193|50030163|FG000|Treatment Period|Adverse Event|74|||
24936924|NCT00440193|50030164|FG001|Treatment Period|Adverse Event|67|||
24936925|NCT00440193|50030163|FG000|Treatment Period|Death|19|||
24936926|NCT00440193|50030164|FG001|Treatment Period|Death|22|||
24936927|NCT00440193|50030163|FG000|Treatment Period|Lack of Efficacy|0|||
24936928|NCT00440193|50030164|FG001|Treatment Period|Lack of Efficacy|1|||
24936929|NCT00440193|50030163|FG000|Treatment Period|Lost to Follow-up|12|||
24936930|NCT00440193|50030164|FG001|Treatment Period|Lost to Follow-up|18|||
24936931|NCT00440193|50030163|FG000|Treatment Period|Physician Decision|3|||
24936932|NCT00440193|50030164|FG001|Treatment Period|Physician Decision|6|||
24936933|NCT00440193|50030163|FG000|Treatment Period|Protocol Violation|16|||
24936934|NCT00440193|50030164|FG001|Treatment Period|Protocol Violation|19|||
24936935|NCT00440193|50030163|FG000|Treatment Period|Withdrawal by Subject|36|||
24936936|NCT00440193|50030164|FG001|Treatment Period|Withdrawal by Subject|77|||
24936937|NCT00440193|50030163|FG000|Treatment Period|Clinical endpoint reached|28|||
24936938|NCT00440193|50030164|FG001|Treatment Period|Clinical endpoint reached|25|||
24936939|NCT00440193|50030163|FG000|Treatment Period|Study terminated by sponsor|102|||
24936940|NCT00440193|50030164|FG001|Treatment Period|Study terminated by sponsor|94|||
24936941|NCT00440193|50030163|FG000|Treatment Period|Protocol driven decision point|2|||
24936942|NCT00440193|50030164|FG001|Treatment Period|Protocol driven decision point|2|||
24936943|NCT00440193|50030163|FG000|Treatment Period|Switch to commercial drug|0|||
24936944|NCT00440193|50030164|FG001|Treatment Period|Switch to commercial drug|2|||
24936945|NCT00440193|50030163|FG000|Treatment Period|Technical problems|1|||
24936946|NCT00440193|50030164|FG001|Treatment Period|Technical problems|1|||
24936947|NCT00440193|50030163|FG000|Treatment Period|Participant convenience|5|||
24936948|NCT00440193|50030164|FG001|Treatment Period|Participant convenience|2|||
24936949|NCT00440193|50030163|FG000|Treatment Period|Participant did not receive treatment|7|||
24936950|NCT00440193|50030164|FG001|Treatment Period|Participant did not receive treatment|13|||
24936951|NCT00440193|50030163|FG000|Treatment Period|Site closed by investigator|0|||
24936952|NCT00440193|50030164|FG001|Treatment Period|Site closed by investigator|2|||
24936953|NCT00440193|50030163|FG000|Observational Period|Adverse Event|2|||
24936954|NCT00440193|50030164|FG001|Observational Period|Adverse Event|2|||
24936955|NCT00440193|50030163|FG000|Observational Period|Death|15|||
24936956|NCT00440193|50030164|FG001|Observational Period|Death|20|||
24936957|NCT00440193|50030163|FG000|Observational Period|Lost to Follow-up|12|||
24936958|NCT00440193|50030164|FG001|Observational Period|Lost to Follow-up|8|||
24936959|NCT00440193|50030163|FG000|Observational Period|Protocol Violation|1|||
25275356|NCT01072149|50589280|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
25275357|NCT01072149|50589281|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
24936960|NCT00440193|50030164|FG001|Observational Period|Protocol Violation|0|||
24936961|NCT00440193|50030163|FG000|Observational Period|Withdrawal by Subject|11|||
24936962|NCT00440193|50030164|FG001|Observational Period|Withdrawal by Subject|8|||
24936963|NCT00440193|50030163|FG000|Observational Period|Physician Decision|1|||
24936964|NCT00440193|50030164|FG001|Observational Period|Physician Decision|0|||
24936965|NCT00440193|50030163|FG000|Observational Period|Clinical endpoint reached|1|||
24936966|NCT00440193|50030164|FG001|Observational Period|Clinical endpoint reached|0|||
24936967|NCT00440193|50030163|FG000|Observational Period|Participant convenience|2|||
24936968|NCT00440193|50030164|FG001|Observational Period|Participant convenience|0|||
24936969|NCT00511472|50030172|FG000|Overall Study|Clinical Adverse Event|1|||
24936970|NCT00511472|50030173|FG001|Overall Study|Clinical Adverse Event|2|||
24936971|NCT00511472|50030172|FG000|Overall Study|Laboratory Adverse Event|0|||
24936972|NCT00511472|50030173|FG001|Overall Study|Laboratory Adverse Event|2|||
25275358|NCT01072149|50589282|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
25275359|NCT01072149|50589283|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
25275360|NCT01072149|50589284|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
25275361|NCT01072149|50589267|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
25275362|NCT01072149|50589268|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
25275363|NCT01072149|50589269|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
25275364|NCT01072149|50589270|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
25275365|NCT01072149|50589271|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
25275366|NCT01072149|50589272|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
25275367|NCT01072149|50589273|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
25275368|NCT01072149|50589274|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
25275369|NCT01072149|50589275|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
25275370|NCT01072149|50589276|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
25275371|NCT01072149|50589277|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
25275372|NCT01072149|50589278|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
25275373|NCT01072149|50589279|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
25275374|NCT01072149|50589280|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
25275375|NCT01072149|50589281|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
25275376|NCT01072149|50589282|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
25275377|NCT01072149|50589283|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
24936973|NCT00511472|50030172|FG000|Overall Study|Not reported|2|||
24936974|NCT00511472|50030173|FG001|Overall Study|Not reported|2|||
24936975|NCT00514904|50030190|FG000|Overall Study|Withdrawal by Subject|3|||
24936976|NCT00514904|50030191|FG001|Overall Study|Withdrawal by Subject|2|||
24936977|NCT00514904|50030190|FG000|Overall Study|Lost to Follow-up|21|||
24936978|NCT00514904|50030191|FG001|Overall Study|Lost to Follow-up|3|||
24936979|NCT00440115|50030200|FG000|Overall Study|Death|7|||
24936980|NCT00440115|50030201|FG001|Overall Study|Death|9|||
24936981|NCT00440115|50030202|FG002|Overall Study|Death|5|||
24936982|NCT00440115|50030200|FG000|Overall Study|Incarceration|0|||
24936983|NCT00440115|50030201|FG001|Overall Study|Incarceration|2|||
24936984|NCT00440115|50030202|FG002|Overall Study|Incarceration|1|||
24936985|NCT00440037|50030210|FG000|Overall Study|Withdrawal by Subject|6|||
24936986|NCT00440037|50030210|FG000|Overall Study|Administrative decision|3|||
24936987|NCT00417027|50030217|FG000|Overall Study|Protocol Violation|0|||
24936988|NCT00417027|50030218|FG001|Overall Study|Protocol Violation|5|||
24936989|NCT00417027|50030219|FG002|Overall Study|Protocol Violation|5|||
24936990|NCT00416949|50030227|FG000|Overall Study|Patients refused to participate|5|||
24936991|NCT00416715|50030231|FG000|Overall Study|Not evaluable for joint aches|7|||
24936992|NCT00416715|50030231|FG000|Overall Study|Vitamin D levels not evaluable|8|||
24936993|NCT00406029|50030243|FG000|Overall Study|Adverse Event|12|||
24936994|NCT00406029|50030244|FG001|Overall Study|Adverse Event|2|||
24936995|NCT00406029|50030245|FG002|Overall Study|Adverse Event|5|||
24936996|NCT00406029|50030246|FG003|Overall Study|Adverse Event|10|||
24936997|NCT00406029|50030247|FG004|Overall Study|Adverse Event|7|||
24936998|NCT00406029|50030243|FG000|Overall Study|Withdrawal by Subject|3|||
24936999|NCT00406029|50030244|FG001|Overall Study|Withdrawal by Subject|4|||
24937000|NCT00406029|50030245|FG002|Overall Study|Withdrawal by Subject|2|||
24937001|NCT00406029|50030246|FG003|Overall Study|Withdrawal by Subject|2|||
24937002|NCT00406029|50030247|FG004|Overall Study|Withdrawal by Subject|0|||
24937003|NCT00406029|50030243|FG000|Overall Study|Protocol Violation|1|||
24937004|NCT00406029|50030244|FG001|Overall Study|Protocol Violation|2|||
24937005|NCT00406029|50030245|FG002|Overall Study|Protocol Violation|0|||
24937006|NCT00406029|50030246|FG003|Overall Study|Protocol Violation|2|||
24937007|NCT00406029|50030247|FG004|Overall Study|Protocol Violation|0|||
24937008|NCT00406029|50030243|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
24937009|NCT00406029|50030244|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
24937010|NCT00406029|50030245|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
24937011|NCT00406029|50030246|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
24937012|NCT00406029|50030247|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
24937013|NCT00406029|50030243|FG000|Overall Study|Randomized in Error|0|||
24937014|NCT00406029|50030244|FG001|Overall Study|Randomized in Error|0|||
24937015|NCT00406029|50030245|FG002|Overall Study|Randomized in Error|2|||
24937016|NCT00406029|50030246|FG003|Overall Study|Randomized in Error|3|||
24937017|NCT00406029|50030247|FG004|Overall Study|Randomized in Error|1|||
24937018|NCT00514514|50030262|FG000|Pre-phase|Death|10|||
24937019|NCT00514514|50030263|FG001|Pre-phase|Death|0|||
24937020|NCT00514514|50030264|FG002|Pre-phase|Death|0|||
25275378|NCT01072149|50589284|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
25275379|NCT01072149|50589267|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
25275380|NCT01072149|50589268|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
24937021|NCT00514514|50030262|FG000|Pre-phase|administrative problems|2|||
25028481|NCT03466073|50126675|FG005|Overall Study|Death|1|||
25275381|NCT01072149|50589269|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
25275382|NCT01072149|50589270|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
24937022|NCT00514514|50030263|FG001|Pre-phase|administrative problems|0|||
24937023|NCT00514514|50030264|FG002|Pre-phase|administrative problems|0|||
24937024|NCT00514514|50030262|FG000|Pre-phase|Protocol Violation|6|||
24937025|NCT00514514|50030263|FG001|Pre-phase|Protocol Violation|0|||
24937026|NCT00514514|50030264|FG002|Pre-phase|Protocol Violation|0|||
24937027|NCT00514514|50030262|FG000|Pre-phase|condition no longer requires study drug|7|||
24937028|NCT00514514|50030263|FG001|Pre-phase|condition no longer requires study drug|0|||
24937029|NCT00514514|50030264|FG002|Pre-phase|condition no longer requires study drug|0|||
24937030|NCT00514514|50030262|FG000|Pre-phase|abnormal test procedure results|15|||
24937031|NCT00514514|50030263|FG001|Pre-phase|abnormal test procedure results|0|||
24937032|NCT00514514|50030264|FG002|Pre-phase|abnormal test procedure results|0|||
24937033|NCT00514514|50030262|FG000|Pre-phase|Lost to Follow-up|2|||
24937034|NCT00514514|50030263|FG001|Pre-phase|Lost to Follow-up|0|||
24937035|NCT00514514|50030264|FG002|Pre-phase|Lost to Follow-up|0|||
24937036|NCT00514514|50030262|FG000|Pre-phase|abnormal lab values|23|||
25028482|NCT03412019|50126698|FG000|Overall Study|Withdrawal by Subject|1|||
25028483|NCT03412019|50126699|FG001|Overall Study|Withdrawal by Subject|1|||
25028484|NCT03070002|50126705|FG000|Follow up for 2 Years|Death|1|||
25028485|NCT02918318|50126713|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
25028486|NCT02918318|50126714|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
25028487|NCT02918318|50126715|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
25028488|NCT02918318|50126716|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
25028489|NCT02918318|50126717|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
25028490|NCT02918318|50126713|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
25028491|NCT02918318|50126714|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
25028492|NCT02918318|50126715|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
25028493|NCT02918318|50126716|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
25028494|NCT02918318|50126717|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
25028495|NCT02918318|50126713|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
25028496|NCT02918318|50126714|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
25028497|NCT02918318|50126715|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
24937037|NCT00514514|50030263|FG001|Pre-phase|abnormal lab values|0|||
24937038|NCT00514514|50030264|FG002|Pre-phase|abnormal lab values|0|||
25275383|NCT01072149|50589271|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
25275384|NCT01072149|50589272|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
24937039|NCT00514514|50030262|FG000|Pre-phase|Lack of Efficacy|35|||
24937040|NCT00514514|50030263|FG001|Pre-phase|Lack of Efficacy|0|||
24937041|NCT00514514|50030264|FG002|Pre-phase|Lack of Efficacy|0|||
24937042|NCT00514514|50030262|FG000|Pre-phase|Adverse Event|137|||
25275385|NCT01072149|50589273|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
25275386|NCT01072149|50589274|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
25275387|NCT01072149|50589275|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
25275388|NCT01072149|50589276|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
25275389|NCT01072149|50589277|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
25275390|NCT01072149|50589278|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
25275391|NCT01072149|50589279|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
25275392|NCT01072149|50589280|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
25275393|NCT01072149|50589281|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
25275394|NCT01072149|50589282|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
25275395|NCT01072149|50589283|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
25275396|NCT01072149|50589284|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
25275397|NCT01072149|50589267|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
25275398|NCT01072149|50589268|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
25275399|NCT01072149|50589269|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
25275400|NCT01072149|50589270|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
25275401|NCT01072149|50589271|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
25275402|NCT01072149|50589272|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
25275403|NCT01072149|50589273|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
25275404|NCT01072149|50589274|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
25186091|NCT02970318|50335943|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
24937043|NCT00514514|50030263|FG001|Pre-phase|Adverse Event|0|||
24937044|NCT00514514|50030264|FG002|Pre-phase|Adverse Event|0|||
24937045|NCT00514514|50030262|FG000|Pre-phase|Withdrawal by Subject|66|||
25028498|NCT02918318|50126716|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
25028499|NCT02918318|50126717|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
25028500|NCT02918318|50126713|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
25275405|NCT01072149|50589275|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
24937046|NCT00514514|50030263|FG001|Pre-phase|Withdrawal by Subject|0|||
24937047|NCT00514514|50030264|FG002|Pre-phase|Withdrawal by Subject|0|||
24937048|NCT00514514|50030262|FG000|Randomized - 9 Month|Death|3|||
24937049|NCT00514514|50030263|FG001|Randomized - 9 Month|Death|2|||
25186092|NCT02970318|50335944|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
24937050|NCT00514514|50030264|FG002|Randomized - 9 Month|Death|2|||
25275406|NCT01072149|50589276|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
25275407|NCT01072149|50589277|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
25275408|NCT01072149|50589278|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
25275409|NCT01072149|50589279|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
25275410|NCT01072149|50589280|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
25275411|NCT01072149|50589281|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
25275412|NCT01072149|50589282|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
25275413|NCT01072149|50589283|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
25275414|NCT01072149|50589284|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
25186093|NCT02970318|50335945|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
24937051|NCT00514514|50030262|FG000|Randomized - 9 Month|Administrative problems|1|||
24937052|NCT00514514|50030263|FG001|Randomized - 9 Month|Administrative problems|1|||
24937053|NCT00514514|50030264|FG002|Randomized - 9 Month|Administrative problems|2|||
24937054|NCT00514514|50030262|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
24937055|NCT00514514|50030263|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
24937056|NCT00514514|50030264|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
24937057|NCT00514514|50030262|FG000|Randomized - 9 Month|Protocol Violation|1|||
25028501|NCT02918318|50126714|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
25028502|NCT02918318|50126715|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
25028503|NCT02918318|50126716|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
25028504|NCT02918318|50126717|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
25275415|NCT01071915|50589294|FG000|Overall Study|Adverse Event|3|||
24937058|NCT00514514|50030263|FG001|Randomized - 9 Month|Protocol Violation|1|||
24937059|NCT00514514|50030264|FG002|Randomized - 9 Month|Protocol Violation|0|||
24937060|NCT00514514|50030262|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
24937061|NCT00514514|50030263|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
24937062|NCT00514514|50030264|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
24937063|NCT00514514|50030262|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
24937064|NCT00514514|50030263|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
24937065|NCT00514514|50030264|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
24937066|NCT00514514|50030262|FG000|Randomized - 9 Month|Adverse Event|25|||
24937067|NCT00514514|50030263|FG001|Randomized - 9 Month|Adverse Event|44|||
24937068|NCT00514514|50030264|FG002|Randomized - 9 Month|Adverse Event|27|||
24937069|NCT00514514|50030262|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
24937070|NCT00514514|50030263|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
24937071|NCT00514514|50030264|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
24937072|NCT00514514|50030262|FG000|Extension - 4 Years|Lost to Follow-up|12|||
24937073|NCT00514514|50030263|FG001|Extension - 4 Years|Lost to Follow-up|10|||
24937074|NCT00514514|50030264|FG002|Extension - 4 Years|Lost to Follow-up|9|||
24937075|NCT00514514|50030262|FG000|Extension - 4 Years|Administrative problems|3|||
24937076|NCT00514514|50030263|FG001|Extension - 4 Years|Administrative problems|1|||
24937077|NCT00514514|50030264|FG002|Extension - 4 Years|Administrative problems|1|||
24937078|NCT00514514|50030262|FG000|Extension - 4 Years|Death|8|||
24937079|NCT00514514|50030263|FG001|Extension - 4 Years|Death|3|||
24937080|NCT00514514|50030264|FG002|Extension - 4 Years|Death|6|||
24937081|NCT00514514|50030262|FG000|Extension - 4 Years|Adverse Event|9|||
24937082|NCT00514514|50030263|FG001|Extension - 4 Years|Adverse Event|6|||
24937083|NCT00514514|50030264|FG002|Extension - 4 Years|Adverse Event|3|||
24937084|NCT00405639|50030274|FG000|Overall Study|Withdrawal by Subject|1|||
24937085|NCT00405639|50030275|FG001|Overall Study|Withdrawal by Subject|0|||
24937086|NCT00405639|50030274|FG000|Overall Study|Adverse Event|1|||
24937087|NCT00405639|50030275|FG001|Overall Study|Adverse Event|0|||
24937088|NCT00405639|50030274|FG000|Overall Study|Seizure prior to receiving BNP|1|||
24937089|NCT00405639|50030275|FG001|Overall Study|Seizure prior to receiving BNP|0|||
24937090|NCT00439725|50030283|FG000|Treatment Period|Withdrawal by Subject|22|||
24937091|NCT00439725|50030284|FG001|Treatment Period|Withdrawal by Subject|19|||
24937092|NCT00439725|50030283|FG000|Treatment Period|Study terminated by sponsor|156|||
24937093|NCT00439725|50030284|FG001|Treatment Period|Study terminated by sponsor|148|||
24937094|NCT00439725|50030283|FG000|Treatment Period|Site closed by investigator|1|||
24937095|NCT00439725|50030284|FG001|Treatment Period|Site closed by investigator|2|||
24937096|NCT00439725|50030283|FG000|Treatment Period|Adverse Event|39|||
24937097|NCT00439725|50030284|FG001|Treatment Period|Adverse Event|18|||
24937098|NCT00439725|50030283|FG000|Treatment Period|Physician Decision|1|||
24937099|NCT00439725|50030284|FG001|Treatment Period|Physician Decision|1|||
24937100|NCT00439725|50030283|FG000|Treatment Period|Protocol Violation|2|||
24937101|NCT00439725|50030284|FG001|Treatment Period|Protocol Violation|1|||
24937102|NCT00439725|50030283|FG000|Treatment Period|Clinical endpoint reached|6|||
24937103|NCT00439725|50030284|FG001|Treatment Period|Clinical endpoint reached|50|||
24937104|NCT00439725|50030283|FG000|Treatment Period|Technical problems|1|||
24937105|NCT00439725|50030284|FG001|Treatment Period|Technical problems|0|||
24937106|NCT00439725|50030283|FG000|Treatment Period|Lost to Follow-up|1|||
25028505|NCT02918318|50126713|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
25028506|NCT02918318|50126714|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
24937107|NCT00439725|50030284|FG001|Treatment Period|Lost to Follow-up|1|||
24937108|NCT00439725|50030283|FG000|Treatment Period|Participant convenience|1|||
24937109|NCT00439725|50030284|FG001|Treatment Period|Participant convenience|0|||
24937110|NCT00439725|50030283|FG000|Treatment Period|Protocol driven decision point|1|||
24937111|NCT00439725|50030284|FG001|Treatment Period|Protocol driven decision point|1|||
24937112|NCT00439725|50030283|FG000|Treatment Period|Death|1|||
24937113|NCT00439725|50030284|FG001|Treatment Period|Death|1|||
24937114|NCT00439725|50030283|FG000|Treatment Period|Participant did not receive treatment|4|||
24937115|NCT00439725|50030284|FG001|Treatment Period|Participant did not receive treatment|4|||
24937116|NCT00439725|50030283|FG000|Observational Period|Withdrawal by Subject|2|||
24937117|NCT00439725|50030284|FG001|Observational Period|Withdrawal by Subject|2|||
24937118|NCT00439725|50030283|FG000|Observational Period|Lost to Follow-up|0|||
24937119|NCT00439725|50030284|FG001|Observational Period|Lost to Follow-up|1|||
24937120|NCT00439725|50030283|FG000|Observational Period|Death|0|||
24937121|NCT00439725|50030284|FG001|Observational Period|Death|2|||
24937122|NCT00439725|50030283|FG000|Observational Period|Study termination by sponsor|1|||
24937123|NCT00439725|50030284|FG001|Observational Period|Study termination by sponsor|1|||
24937124|NCT00439725|50030283|FG000|Observational Period|Clinical endpoint reached|3|||
24937125|NCT00439725|50030284|FG001|Observational Period|Clinical endpoint reached|1|||
24937126|NCT00439725|50030283|FG000|Observational Period|Technical problems|1|||
24937127|NCT00439725|50030284|FG001|Observational Period|Technical problems|0|||
24937128|NCT00439725|50030283|FG000|Observational Period|Participant convenience|1|||
24937129|NCT00439725|50030284|FG001|Observational Period|Participant convenience|0|||
24937130|NCT00521586|50030292|FG000|Initial Vaccination (Year 0)|Subject request|8|||
24937131|NCT00521586|50030293|FG001|Initial Vaccination (Year 0)|Subject request|11|||
24937132|NCT00521586|50030292|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
24937133|NCT00521586|50030293|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
24937134|NCT00521586|50030292|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
24937135|NCT00521586|50030293|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
24937136|NCT00521586|50030292|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
24937137|NCT00521586|50030293|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
24937138|NCT00521586|50030292|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
25028507|NCT02918318|50126715|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
25028508|NCT02918318|50126716|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
24937139|NCT00521586|50030293|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
24937140|NCT00521586|50030292|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
24937141|NCT00521586|50030293|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
24937142|NCT00521586|50030292|FG000|Initial Vaccination (Year 0)|Death|1|||
25028509|NCT02918318|50126717|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
25028510|NCT02918318|50126713|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
25028511|NCT02918318|50126714|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
25275416|NCT01071915|50589294|FG000|Overall Study|Physician Decision|2|||
24937143|NCT00521586|50030293|FG001|Initial Vaccination (Year 0)|Death|0|||
25186094|NCT02900976|50335955|FG000|Overall Study|Adverse Event|0|||
25275417|NCT01071915|50589294|FG000|Overall Study|Withdrawal by Subject|2|||
25275418|NCT01071915|50589294|FG000|Overall Study|Miscellaneous Reasons|2|||
25275419|NCT00904969|50589298|FG000|Overall Study|Lost to Follow-up|4|||
25275420|NCT00904969|50589298|FG000|Overall Study|Withdrawal by Subject|3|||
25275421|NCT00904969|50589298|FG000|Overall Study|Additional Treatments|11|||
25275422|NCT00904969|50589298|FG000|Overall Study|Case Aborted; Subject Exited|1|||
25275423|NCT01070979|50589320|FG000|Overall Study|Adverse Event|2|||
25275424|NCT01070979|50589321|FG001|Overall Study|Adverse Event|3|||
25275425|NCT01070979|50589322|FG002|Overall Study|Adverse Event|3|||
25275426|NCT01070979|50589320|FG000|Overall Study|Lost to Follow-up|2|||
25275427|NCT01070979|50589321|FG001|Overall Study|Lost to Follow-up|1|||
25275428|NCT01070979|50589322|FG002|Overall Study|Lost to Follow-up|1|||
25275429|NCT01070979|50589320|FG000|Overall Study|Protocol Violation|0|||
25275430|NCT01070979|50589321|FG001|Overall Study|Protocol Violation|2|||
25275431|NCT01070979|50589322|FG002|Overall Study|Protocol Violation|6|||
25275432|NCT01070979|50589320|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
25275433|NCT01070979|50589321|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
25275434|NCT01070979|50589322|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
25275435|NCT01070979|50589320|FG000|Overall Study|Withdrawal by Subject|3|||
25275436|NCT01070979|50589321|FG001|Overall Study|Withdrawal by Subject|1|||
25275437|NCT01070979|50589322|FG002|Overall Study|Withdrawal by Subject|1|||
25275438|NCT01070979|50589320|FG000|Overall Study|No study drug taken|0|||
25275439|NCT01070979|50589321|FG001|Overall Study|No study drug taken|1|||
25275440|NCT01070979|50589322|FG002|Overall Study|No study drug taken|0|||
25275441|NCT01234337|50589332|FG000|Overall Study|Adverse Event|58|||
25275442|NCT01234337|50589333|FG001|Overall Study|Adverse Event|21|||
25275443|NCT01234337|50589332|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
25275444|NCT01234337|50589333|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
25275445|NCT01234337|50589332|FG000|Overall Study|Investi. decision not protocol driven|5|||
25275446|NCT01234337|50589333|FG001|Overall Study|Investi. decision not protocol driven|6|||
25275447|NCT01234337|50589332|FG000|Overall Study|Non-compliant with study medication|3|||
25275448|NCT01234337|50589333|FG001|Overall Study|Non-compliant with study medication|2|||
25275449|NCT01234337|50589332|FG000|Overall Study|Randomized but not treated|6|||
25275450|NCT01234337|50589333|FG001|Overall Study|Randomized but not treated|4|||
25275451|NCT01234337|50589332|FG000|Overall Study|Lost to Follow-up|0|||
25275452|NCT01234337|50589333|FG001|Overall Study|Lost to Follow-up|1|||
25275453|NCT01234337|50589332|FG000|Overall Study|Protocol Violation|2|||
25275454|NCT01234337|50589333|FG001|Overall Study|Protocol Violation|3|||
25275455|NCT01234337|50589332|FG000|Overall Study|Withdrawal by Subject|11|||
25275456|NCT01234337|50589333|FG001|Overall Study|Withdrawal by Subject|9|||
25275457|NCT01234337|50589332|FG000|Overall Study|Death|0|||
25275458|NCT01234337|50589333|FG001|Overall Study|Death|1|||
25275459|NCT01234337|50589332|FG000|Overall Study|Switch to commercial drug|0|||
25275460|NCT01234337|50589333|FG001|Overall Study|Switch to commercial drug|1|||
25275461|NCT01070043|50589341|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
25275462|NCT01070043|50589342|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
25275463|NCT01070043|50589343|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
25275464|NCT01070043|50589341|FG000|Double-Blind Treatment|Adverse Event|0|||
25186095|NCT02900976|50335956|FG001|Overall Study|Adverse Event|1|||
25275465|NCT01070043|50589342|FG001|Double-Blind Treatment|Adverse Event|0|||
25275466|NCT01070043|50589343|FG002|Double-Blind Treatment|Adverse Event|2|||
25275467|NCT01074255|50589349|FG000|Overall Study|Did not receive EMEND|2|||
25275468|NCT01073943|50589355|FG000|Overall Study|Withdrawal by Subject|8|||
25275469|NCT01073943|50589356|FG001|Overall Study|Withdrawal by Subject|2|||
25275470|NCT01073943|50589355|FG000|Overall Study|Protocol Violation|2|||
25275471|NCT01073943|50589356|FG001|Overall Study|Protocol Violation|1|||
25275472|NCT01073943|50589355|FG000|Overall Study|Adverse Event|1|||
25275473|NCT01073943|50589356|FG001|Overall Study|Adverse Event|1|||
25275474|NCT01073943|50589355|FG000|Overall Study|Lost to Follow-up|0|||
25275475|NCT01073943|50589356|FG001|Overall Study|Lost to Follow-up|2|||
25275476|NCT01073943|50589355|FG000|Overall Study|Power outage; colonoscopy not done|1|||
25275477|NCT01073943|50589356|FG001|Overall Study|Power outage; colonoscopy not done|0|||
25275478|NCT01073943|50589355|FG000|Overall Study|Subject forgot|0|||
25275479|NCT01073943|50589356|FG001|Overall Study|Subject forgot|1|||
25157147|NCT01701674|50273469|FG000|Overall Study|Unable to safely complete treatment|1|||
25157148|NCT01467427|50273490|FG000|Overall Study|Withdrawal by Subject|1|||
25157149|NCT01467427|50273491|FG001|Overall Study|Withdrawal by Subject|0|||
25157150|NCT01467427|50273490|FG000|Overall Study|Entered extension phase|11|||
25157151|NCT01467427|50273491|FG001|Overall Study|Entered extension phase|11|||
25157152|NCT01467427|50273490|FG000|Overall Study|Not continuing in extension phase|0|||
25157153|NCT01467427|50273491|FG001|Overall Study|Not continuing in extension phase|2|||
25157154|NCT01422187|50273500|FG000|Overall Study|Personal reason|1|||
25157155|NCT01422187|50273501|FG001|Overall Study|Personal reason|0|||
25157156|NCT01422187|50273502|FG002|Overall Study|Personal reason|0|||
25157157|NCT01422187|50273500|FG000|Overall Study|Lost to Follow-up|0|||
25275480|NCT01073943|50589355|FG000|Overall Study|Unable to return for follow-up|0|||
24937144|NCT00521586|50030292|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
24937145|NCT00521586|50030293|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
24937146|NCT00521586|50030292|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
24937147|NCT00521586|50030293|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
25028512|NCT02918318|50126715|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
25028513|NCT02918318|50126716|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
25028514|NCT02918318|50126717|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
25028515|NCT02918318|50126713|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
25028516|NCT02918318|50126714|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
24937148|NCT00521586|50030292|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
24937149|NCT00521586|50030293|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
24937150|NCT00521586|50030292|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
24937151|NCT00521586|50030293|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
24937152|NCT00521586|50030292|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
24937153|NCT00521586|50030293|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
24937154|NCT00521586|50030292|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
24937155|NCT00521586|50030293|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
25275481|NCT01073943|50589356|FG001|Overall Study|Unable to return for follow-up|1|||
25275482|NCT01073943|50589355|FG000|Overall Study|Could not tolerate prep|1|||
24937156|NCT00521586|50030292|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
24937157|NCT00521586|50030293|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
24937158|NCT00521586|50030292|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
24937159|NCT00521586|50030293|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
24937160|NCT00521586|50030292|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
24937161|NCT00521586|50030293|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
24937162|NCT00521586|50030292|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
24937163|NCT00521586|50030293|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
24937164|NCT00521586|50030292|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
24937165|NCT00521586|50030293|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
24937166|NCT00521586|50030292|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
24937167|NCT00521586|50030293|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
24937168|NCT00515502|50030311|FG000|Treatment Period 1|Adverse Event|0|||
24937169|NCT00515502|50030312|FG001|Treatment Period 1|Adverse Event|0|||
24937170|NCT00515502|50030313|FG002|Treatment Period 1|Adverse Event|0|||
24937171|NCT00515502|50030314|FG003|Treatment Period 1|Adverse Event|0|||
24937172|NCT00515502|50030315|FG004|Treatment Period 1|Adverse Event|0|||
24937173|NCT00515502|50030316|FG005|Treatment Period 1|Adverse Event|0|||
24937174|NCT00515502|50030317|FG006|Treatment Period 1|Adverse Event|1|||
24937175|NCT00515502|50030318|FG007|Treatment Period 1|Adverse Event|0|||
25028517|NCT02918318|50126715|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
24937176|NCT00515502|50030319|FG008|Treatment Period 1|Adverse Event|1|||
25157158|NCT01422187|50273501|FG001|Overall Study|Lost to Follow-up|1|||
25157159|NCT01422187|50273502|FG002|Overall Study|Lost to Follow-up|0|||
25157160|NCT00920621|50273514|FG000|Overall Study|Lost to Follow-up|16|||
25157161|NCT00920621|50273515|FG001|Overall Study|Lost to Follow-up|17|||
25157162|NCT00920621|50273516|FG002|Overall Study|Lost to Follow-up|19|||
25157163|NCT00920621|50273517|FG003|Overall Study|Lost to Follow-up|21|||
24937177|NCT00515502|50030320|FG009|Treatment Period 1|Adverse Event|0|||
24937178|NCT00515502|50030321|FG010|Treatment Period 1|Adverse Event|0|||
24937179|NCT00515502|50030322|FG011|Treatment Period 1|Adverse Event|1|||
24937180|NCT00515502|50030311|FG000|Treatment Period 2|Adverse Event|0|||
24937181|NCT00515502|50030312|FG001|Treatment Period 2|Adverse Event|1|||
24937182|NCT00515502|50030313|FG002|Treatment Period 2|Adverse Event|0|||
24937183|NCT00515502|50030314|FG003|Treatment Period 2|Adverse Event|0|||
24937184|NCT00515502|50030315|FG004|Treatment Period 2|Adverse Event|0|||
24937185|NCT00515502|50030316|FG005|Treatment Period 2|Adverse Event|0|||
24937186|NCT00515502|50030317|FG006|Treatment Period 2|Adverse Event|0|||
24937187|NCT00515502|50030318|FG007|Treatment Period 2|Adverse Event|0|||
24937188|NCT00515502|50030319|FG008|Treatment Period 2|Adverse Event|0|||
24937189|NCT00515502|50030320|FG009|Treatment Period 2|Adverse Event|0|||
24937190|NCT00515502|50030321|FG010|Treatment Period 2|Adverse Event|0|||
24937191|NCT00515502|50030322|FG011|Treatment Period 2|Adverse Event|0|||
24937192|NCT00439647|50030341|FG000|Overall Study|Withdrawal by Subject|25|||
24937193|NCT00439647|50030342|FG001|Overall Study|Withdrawal by Subject|22|||
24937194|NCT00439647|50030341|FG000|Overall Study|Death|15|||
24937195|NCT00439647|50030342|FG001|Overall Study|Death|18|||
24937196|NCT00439647|50030341|FG000|Overall Study|Adverse Event|11|||
24937197|NCT00439647|50030342|FG001|Overall Study|Adverse Event|11|||
25028518|NCT02918318|50126716|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
25028519|NCT02918318|50126717|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
25028520|NCT02918318|50126713|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
25028521|NCT02918318|50126714|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
24937198|NCT00439647|50030341|FG000|Overall Study|Lost to Follow-up|4|||
24937199|NCT00439647|50030342|FG001|Overall Study|Lost to Follow-up|12|||
24937200|NCT00439647|50030341|FG000|Overall Study|Protocol Violation|3|||
24937201|NCT00439647|50030342|FG001|Overall Study|Protocol Violation|4|||
24937202|NCT00439647|50030341|FG000|Overall Study|Lack of Efficacy|0|||
24937203|NCT00439647|50030342|FG001|Overall Study|Lack of Efficacy|4|||
24937204|NCT00515112|50030350|FG000|Overall Study|Death|0|||
24937205|NCT00515112|50030351|FG001|Overall Study|Death|1|||
24937206|NCT00515112|50030350|FG000|Overall Study|The study was terminated|3|||
24937207|NCT00515112|50030351|FG001|Overall Study|The study was terminated|2|||
24937208|NCT00404547|50030359|FG000|Overall Study|Adverse Event|39|||
24937209|NCT00404547|50030360|FG001|Overall Study|Adverse Event|6|||
24937210|NCT00404547|50030359|FG000|Overall Study|Withdrawal by Subject|19|||
24937211|NCT00404547|50030360|FG001|Overall Study|Withdrawal by Subject|2|||
24937212|NCT00404547|50030359|FG000|Overall Study|Protocol Violation|0|||
24937213|NCT00404547|50030360|FG001|Overall Study|Protocol Violation|1|||
24937214|NCT00404547|50030359|FG000|Overall Study|Lost to Follow-up|20|||
24937215|NCT00404547|50030360|FG001|Overall Study|Lost to Follow-up|9|||
24937216|NCT00404547|50030359|FG000|Overall Study|Lack of compliance|5|||
24937217|NCT00404547|50030360|FG001|Overall Study|Lack of compliance|1|||
24937218|NCT00404547|50030359|FG000|Overall Study|Other|4|||
24937219|NCT00404547|50030360|FG001|Overall Study|Other|0|||
24937220|NCT00404547|50030359|FG000|Overall Study|Reason not stated|3|||
24937221|NCT00404547|50030360|FG001|Overall Study|Reason not stated|6|||
24937222|NCT00515034|50030370|FG000|Overall Study|Adverse Event|2|||
24937223|NCT00515034|50030371|FG001|Overall Study|Adverse Event|0|||
24937224|NCT00515034|50030372|FG002|Overall Study|Adverse Event|1|||
24937225|NCT00515034|50030373|FG003|Overall Study|Adverse Event|0|||
24937226|NCT00515034|50030370|FG000|Overall Study|Death|4|||
24937227|NCT00515034|50030371|FG001|Overall Study|Death|2|||
24937228|NCT00515034|50030372|FG002|Overall Study|Death|1|||
24937229|NCT00515034|50030373|FG003|Overall Study|Death|3|||
24937230|NCT00515034|50030370|FG000|Overall Study|Withdrawal by Subject|1|||
25028522|NCT02918318|50126715|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
25028523|NCT02918318|50126716|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
25157164|NCT00920621|50273514|FG000|Overall Study|Fetal/neonatal deaths|16|||
24937231|NCT00515034|50030371|FG001|Overall Study|Withdrawal by Subject|0|||
24937232|NCT00515034|50030372|FG002|Overall Study|Withdrawal by Subject|3|||
24937233|NCT00515034|50030373|FG003|Overall Study|Withdrawal by Subject|0|||
24937234|NCT00515034|50030370|FG000|Overall Study|Physician Decision|0|||
24937235|NCT00515034|50030371|FG001|Overall Study|Physician Decision|0|||
24937236|NCT00515034|50030372|FG002|Overall Study|Physician Decision|1|||
24937237|NCT00515034|50030373|FG003|Overall Study|Physician Decision|1|||
24937238|NCT00515034|50030370|FG000|Overall Study|Other|1|||
24937239|NCT00515034|50030371|FG001|Overall Study|Other|0|||
24937240|NCT00515034|50030372|FG002|Overall Study|Other|2|||
24937241|NCT00515034|50030373|FG003|Overall Study|Other|1|||
24937242|NCT00404235|50030385|FG000|Overall Study|Withdrawal by Subject|1|||
24937243|NCT00404235|50030386|FG001|Overall Study|Withdrawal by Subject|2|||
24937244|NCT00404079|50030394|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
25157165|NCT00920621|50273515|FG001|Overall Study|Fetal/neonatal deaths|14|||
24937245|NCT00404079|50030395|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
24937246|NCT00403845|50030401|FG000|Treatment Period 1|Subject withdrew consent|1|||
24937247|NCT00403845|50030402|FG001|Treatment Period 1|Subject withdrew consent|0|||
24937248|NCT00403845|50030403|FG002|Treatment Period 1|Subject withdrew consent|0|||
24937249|NCT00403845|50030404|FG003|Treatment Period 1|Subject withdrew consent|0|||
24937250|NCT00403845|50030401|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
24937251|NCT00403845|50030402|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
24937252|NCT00403845|50030403|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
24937253|NCT00403845|50030404|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
24937254|NCT00403845|50030401|FG000|Treatment Period 2|Subject withdrew consent|1|||
24937255|NCT00403845|50030402|FG001|Treatment Period 2|Subject withdrew consent|0|||
24937256|NCT00403845|50030403|FG002|Treatment Period 2|Subject withdrew consent|0|||
24937257|NCT00403845|50030404|FG003|Treatment Period 2|Subject withdrew consent|0|||
24937258|NCT00403845|50030401|FG000|Treatment Period 3|Subject withdrew consent|0|||
24937259|NCT00403845|50030402|FG001|Treatment Period 3|Subject withdrew consent|0|||
24937260|NCT00403845|50030403|FG002|Treatment Period 3|Subject withdrew consent|0|||
24937261|NCT00403845|50030404|FG003|Treatment Period 3|Subject withdrew consent|1|||
24937262|NCT00403845|50030401|FG000|Treatment Period 3|Adverse Event|0|||
24937263|NCT00403845|50030402|FG001|Treatment Period 3|Adverse Event|0|||
24937264|NCT00403845|50030403|FG002|Treatment Period 3|Adverse Event|0|||
24937265|NCT00403845|50030404|FG003|Treatment Period 3|Adverse Event|1|||
24937266|NCT00509262|50030416|FG000|Overall Study|Adverse Event|16|||
24937267|NCT00509262|50030417|FG001|Overall Study|Adverse Event|18|||
24937268|NCT00509262|50030416|FG000|Overall Study|Other|2|||
24937269|NCT00509262|50030417|FG001|Overall Study|Other|2|||
24937270|NCT00509262|50030416|FG000|Overall Study|Lack of Efficacy|1|||
24937271|NCT00509262|50030417|FG001|Overall Study|Lack of Efficacy|0|||
24937272|NCT00509262|50030416|FG000|Overall Study|Lost to Follow-up|1|||
24937273|NCT00509262|50030417|FG001|Overall Study|Lost to Follow-up|6|||
24937274|NCT00509262|50030416|FG000|Overall Study|Physician Decision|1|||
24937275|NCT00509262|50030417|FG001|Overall Study|Physician Decision|3|||
24937276|NCT00509262|50030416|FG000|Overall Study|Protocol Violation|2|||
24937277|NCT00509262|50030417|FG001|Overall Study|Protocol Violation|2|||
24937278|NCT00509262|50030416|FG000|Overall Study|Withdrawal by Subject|24|||
24937279|NCT00509262|50030417|FG001|Overall Study|Withdrawal by Subject|11|||
24937280|NCT00607997|50030427|FG000|Overall Study|Lack of Efficacy|6|||
24937281|NCT00607997|50030428|FG001|Overall Study|Lack of Efficacy|20|||
24937282|NCT00607997|50030429|FG002|Overall Study|Lack of Efficacy|14|||
24937283|NCT00607997|50030430|FG003|Overall Study|Lack of Efficacy|10|||
24937284|NCT00607997|50030427|FG000|Overall Study|Death|8|||
24937285|NCT00607997|50030428|FG001|Overall Study|Death|5|||
24937286|NCT00607997|50030429|FG002|Overall Study|Death|2|||
24937287|NCT00607997|50030430|FG003|Overall Study|Death|5|||
25028524|NCT02918318|50126717|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
25028525|NCT02918318|50126713|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
25028526|NCT02918318|50126714|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
25028527|NCT02918318|50126715|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
25028528|NCT02918318|50126716|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
25028529|NCT02918318|50126717|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
25028530|NCT02918318|50126713|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
25028531|NCT02918318|50126714|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
25028532|NCT02918318|50126715|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
25028533|NCT02918318|50126716|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
24937288|NCT00607997|50030427|FG000|Overall Study|Adverse Event|3|||
24937289|NCT00607997|50030428|FG001|Overall Study|Adverse Event|1|||
24937290|NCT00607997|50030429|FG002|Overall Study|Adverse Event|2|||
24937291|NCT00607997|50030430|FG003|Overall Study|Adverse Event|0|||
24937292|NCT00607997|50030427|FG000|Overall Study|Physician Decision|4|||
24937293|NCT00607997|50030428|FG001|Overall Study|Physician Decision|1|||
24937294|NCT00607997|50030429|FG002|Overall Study|Physician Decision|0|||
24937295|NCT00607997|50030430|FG003|Overall Study|Physician Decision|0|||
24937296|NCT00607997|50030427|FG000|Overall Study|Relapse, recurrent illness|4|||
24937297|NCT00607997|50030428|FG001|Overall Study|Relapse, recurrent illness|0|||
24937298|NCT00607997|50030429|FG002|Overall Study|Relapse, recurrent illness|2|||
24937299|NCT00607997|50030430|FG003|Overall Study|Relapse, recurrent illness|0|||
24937300|NCT00607997|50030427|FG000|Overall Study|Other without explanation|2|||
24937301|NCT00607997|50030428|FG001|Overall Study|Other without explanation|0|||
24937302|NCT00607997|50030429|FG002|Overall Study|Other without explanation|4|||
24937303|NCT00607997|50030430|FG003|Overall Study|Other without explanation|1|||
24937304|NCT00509106|50030447|FG000|Overall Study|Adverse Event|3|||
24937305|NCT00509106|50030448|FG001|Overall Study|Adverse Event|2|||
24937306|NCT00509106|50030447|FG000|Overall Study|Noncompliance|0|||
24937307|NCT00509106|50030448|FG001|Overall Study|Noncompliance|1|||
25028534|NCT02918318|50126717|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
24937308|NCT00509106|50030447|FG000|Overall Study|At the request of sponsor/investigator|1|||
24937309|NCT00509106|50030448|FG001|Overall Study|At the request of sponsor/investigator|2|||
24937310|NCT00509106|50030447|FG000|Overall Study|Withdrew consent|4|||
25028535|NCT02918318|50126713|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
25028536|NCT02918318|50126714|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
24937311|NCT00509106|50030448|FG001|Overall Study|Withdrew consent|8|||
24937312|NCT00509106|50030447|FG000|Overall Study|Lost to Follow-up|16|||
24937313|NCT00509106|50030448|FG001|Overall Study|Lost to Follow-up|10|||
24937314|NCT00509106|50030447|FG000|Overall Study|Other|1|||
24937315|NCT00509106|50030448|FG001|Overall Study|Other|0|||
24937316|NCT00509106|50030447|FG000|Overall Study|Death|6|||
24937317|NCT00509106|50030448|FG001|Overall Study|Death|6|||
24937318|NCT00607919|50030456|FG000|Acute Phase|Adverse Event|9|||
24937319|NCT00607919|50030457|FG001|Acute Phase|Adverse Event|2|||
24937320|NCT00607919|50030456|FG000|Acute Phase|Entry Criteria Not Met|1|||
24937321|NCT00607919|50030457|FG001|Acute Phase|Entry Criteria Not Met|1|||
24937322|NCT00607919|50030456|FG000|Acute Phase|Lack of Efficacy|1|||
24937323|NCT00607919|50030457|FG001|Acute Phase|Lack of Efficacy|2|||
24937324|NCT00607919|50030456|FG000|Acute Phase|Lost to Follow-up|9|||
24937325|NCT00607919|50030457|FG001|Acute Phase|Lost to Follow-up|3|||
24937326|NCT00607919|50030456|FG000|Acute Phase|Parent/Caregiver Decision|6|||
24937327|NCT00607919|50030457|FG001|Acute Phase|Parent/Caregiver Decision|4|||
24937328|NCT00607919|50030456|FG000|Acute Phase|Protocol Violation|5|||
24937329|NCT00607919|50030457|FG001|Acute Phase|Protocol Violation|1|||
24937330|NCT00607919|50030456|FG000|Acute Phase|Withdrawal by Subject|3|||
24937331|NCT00607919|50030457|FG001|Acute Phase|Withdrawal by Subject|3|||
24937332|NCT00607919|50030456|FG000|Open-Label Phase|Adverse Event|1|||
24937333|NCT00607919|50030457|FG001|Open-Label Phase|Adverse Event|5|||
24937334|NCT00607919|50030456|FG000|Open-Label Phase|Lost to Follow-up|4|||
24937335|NCT00607919|50030457|FG001|Open-Label Phase|Lost to Follow-up|1|||
24937336|NCT00607919|50030456|FG000|Open-Label Phase|Protocol Violation|2|||
24937337|NCT00607919|50030457|FG001|Open-Label Phase|Protocol Violation|2|||
24937338|NCT00607919|50030456|FG000|Open-Label Phase|Withdrawal by Subject|2|||
24937339|NCT00607919|50030457|FG001|Open-Label Phase|Withdrawal by Subject|2|||
24937340|NCT00607919|50030456|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
24937341|NCT00607919|50030457|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
24937342|NCT00344968|50030468|FG000|Overall Study|Adverse Event|5|||
24937343|NCT00344968|50030469|FG001|Overall Study|Adverse Event|4|||
24937344|NCT00344968|50030470|FG002|Overall Study|Adverse Event|15|||
24937345|NCT00344968|50030468|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
24937346|NCT00344968|50030469|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
24937347|NCT00344968|50030470|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
24937348|NCT00344968|50030468|FG000|Overall Study|Protocol Violation|2|||
24937349|NCT00344968|50030469|FG001|Overall Study|Protocol Violation|2|||
24937350|NCT00344968|50030470|FG002|Overall Study|Protocol Violation|5|||
24937351|NCT00344968|50030468|FG000|Overall Study|Withdrawal by Subject|14|||
24937352|NCT00344968|50030469|FG001|Overall Study|Withdrawal by Subject|31|||
24937353|NCT00344968|50030470|FG002|Overall Study|Withdrawal by Subject|27|||
24937354|NCT00344968|50030468|FG000|Overall Study|Lost to Follow-up|24|||
24937355|NCT00344968|50030469|FG001|Overall Study|Lost to Follow-up|37|||
24937356|NCT00344968|50030470|FG002|Overall Study|Lost to Follow-up|37|||
24937357|NCT00344968|50030468|FG000|Overall Study|Death|11|||
24937358|NCT00344968|50030469|FG001|Overall Study|Death|27|||
25028537|NCT02918318|50126715|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
25028538|NCT02918318|50126716|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
24937359|NCT00344968|50030470|FG002|Overall Study|Death|31|||
24937360|NCT00344968|50030468|FG000|Overall Study|Other|0|||
24937361|NCT00344968|50030469|FG001|Overall Study|Other|1|||
24937362|NCT00344968|50030470|FG002|Overall Study|Other|0|||
24937363|NCT00509028|50030481|FG000|Overall Study|Adverse Event|2|||
24937364|NCT00509028|50030482|FG001|Overall Study|Adverse Event|0|||
24937365|NCT00509028|50030481|FG000|Overall Study|Withdrawal by Subject|4|||
24937366|NCT00509028|50030482|FG001|Overall Study|Withdrawal by Subject|3|||
24937367|NCT00509028|50030481|FG000|Overall Study|Lost to Follow-up|0|||
24937368|NCT00509028|50030482|FG001|Overall Study|Lost to Follow-up|1|||
24937369|NCT00509028|50030481|FG000|Overall Study|Protocol Violation|4|||
24937370|NCT00509028|50030482|FG001|Overall Study|Protocol Violation|2|||
24937371|NCT00509028|50030481|FG000|Overall Study|Non-compliance|2|||
24937372|NCT00509028|50030482|FG001|Overall Study|Non-compliance|1|||
24937373|NCT00352846|50030490|FG000|Overall Study|Disease progression|0|||
24937374|NCT00352846|50030491|FG001|Overall Study|Disease progression|2|||
25028539|NCT02918318|50126717|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
25028540|NCT02918318|50126713|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
24937375|NCT00352846|50030490|FG000|Overall Study|Withdrawal by Subject|3|||
24937376|NCT00352846|50030491|FG001|Overall Study|Withdrawal by Subject|8|||
24937377|NCT00352846|50030490|FG000|Overall Study|Ineligible|3|||
24937378|NCT00352846|50030491|FG001|Overall Study|Ineligible|2|||
24937379|NCT00352846|50030490|FG000|Overall Study|Non-compliance|2|||
24937380|NCT00352846|50030491|FG001|Overall Study|Non-compliance|0|||
24937381|NCT00352846|50030490|FG000|Overall Study|Death|0|||
24937382|NCT00352846|50030491|FG001|Overall Study|Death|1|||
24937383|NCT00508872|50030497|FG000|Overall Study|Lost to Follow-up|1|||
24937384|NCT00508872|50030497|FG000|Overall Study|Physician Decision|1|||
24937385|NCT00508482|50030504|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
24937386|NCT00508482|50030505|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
24937387|NCT00508482|50030506|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
24937388|NCT00508482|50030504|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
24937389|NCT00508482|50030505|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
24937390|NCT00508482|50030506|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
24937391|NCT00508482|50030504|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
24937392|NCT00508482|50030505|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
24937393|NCT00508482|50030506|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
24937394|NCT00344500|50030517|FG000|Overall Study|Adverse Event|6|||
24937395|NCT00344500|50030518|FG001|Overall Study|Adverse Event|2|||
24937396|NCT00344500|50030519|FG002|Overall Study|Adverse Event|0|||
24937397|NCT00344500|50030517|FG000|Overall Study|Lost to Follow-up|5|||
24937398|NCT00344500|50030518|FG001|Overall Study|Lost to Follow-up|13|||
24937399|NCT00344500|50030519|FG002|Overall Study|Lost to Follow-up|1|||
24937400|NCT00344500|50030517|FG000|Overall Study|Withdrawal by Subject|7|||
24937401|NCT00344500|50030518|FG001|Overall Study|Withdrawal by Subject|10|||
24937402|NCT00344500|50030519|FG002|Overall Study|Withdrawal by Subject|0|||
24937403|NCT00344500|50030517|FG000|Overall Study|Protocol Violation|4|||
24937404|NCT00344500|50030518|FG001|Overall Study|Protocol Violation|7|||
24937405|NCT00344500|50030519|FG002|Overall Study|Protocol Violation|1|||
24937406|NCT00344500|50030517|FG000|Overall Study|Not Noted|1|||
24937407|NCT00344500|50030518|FG001|Overall Study|Not Noted|3|||
24937408|NCT00344500|50030519|FG002|Overall Study|Not Noted|0|||
24937409|NCT00344032|50030528|FG000|Overall Study|Adverse Event|0|||
24937410|NCT00344032|50030529|FG001|Overall Study|Adverse Event|1|||
24937411|NCT00344032|50030528|FG000|Overall Study|Withdrawal by Subject|6|||
24937412|NCT00344032|50030529|FG001|Overall Study|Withdrawal by Subject|2|||
24937413|NCT00344032|50030528|FG000|Overall Study|Lost to Follow-up|4|||
24937414|NCT00344032|50030529|FG001|Overall Study|Lost to Follow-up|6|||
24937415|NCT00344032|50030528|FG000|Overall Study|Physician Decision|4|||
24937416|NCT00344032|50030529|FG001|Overall Study|Physician Decision|1|||
24937417|NCT00607373|50030537|FG000|Treatment Period|Adverse Event|0|||
24937418|NCT00607373|50030538|FG001|Treatment Period|Adverse Event|4|||
24937419|NCT00607373|50030537|FG000|Treatment Period|Physician Decision|0|||
24937420|NCT00607373|50030538|FG001|Treatment Period|Physician Decision|1|||
24937421|NCT00607373|50030537|FG000|Treatment Period|Withdrawal by Subject|0|||
24937422|NCT00607373|50030538|FG001|Treatment Period|Withdrawal by Subject|1|||
24937423|NCT00607373|50030537|FG000|Follow-up Period|Other|0|||
24937424|NCT00607373|50030538|FG001|Follow-up Period|Other|1|||
24937425|NCT00607373|50030537|FG000|Follow-up Period|Protocol Violation|0|||
24937426|NCT00607373|50030538|FG001|Follow-up Period|Protocol Violation|1|||
24937427|NCT00607373|50030537|FG000|Follow-up Period|Withdrawal by Subject|1|||
24937428|NCT00607373|50030538|FG001|Follow-up Period|Withdrawal by Subject|3|||
24937429|NCT00508404|50030544|FG000|Overall Study|Ongoing at Data Cut-off|12|||
24937430|NCT00508404|50030544|FG000|Overall Study|Adverse Event|2|||
24937431|NCT00508404|50030544|FG000|Overall Study|Death|16|||
24937432|NCT00508404|50030544|FG000|Overall Study|Physician Decision|2|||
24937433|NCT00508404|50030544|FG000|Overall Study|Withdrawal by Subject|3|||
24937434|NCT00508404|50030544|FG000|Overall Study|Protocol-specified Criteria|2|||
24937435|NCT00508404|50030544|FG000|Overall Study|Lost to Follow-up|2|||
24937436|NCT00508404|50030544|FG000|Overall Study|Other - Not Specified|3|||
24937437|NCT00352690|50030551|FG000|Overall Study|Determined to be ineligible|2|||
24937438|NCT00352690|50030552|FG001|Overall Study|Determined to be ineligible|0|||
24937439|NCT00609245|50030558|FG000|Overall Study|Adverse Event|1|||
24937440|NCT00343642|50030567|FG000|Overall Study|Lost to Follow-up|0|||
24937441|NCT00343642|50030568|FG001|Overall Study|Lost to Follow-up|1|||
24937442|NCT00343642|50030569|FG002|Overall Study|Lost to Follow-up|0|||
24937443|NCT00343642|50030567|FG000|Overall Study|Pregnancy|1|||
24937444|NCT00343642|50030568|FG001|Overall Study|Pregnancy|0|||
24937445|NCT00343642|50030569|FG002|Overall Study|Pregnancy|2|||
24937446|NCT00343642|50030567|FG000|Overall Study|Withdrawal by Subject|2|||
24937447|NCT00343642|50030568|FG001|Overall Study|Withdrawal by Subject|3|||
24937448|NCT00343642|50030569|FG002|Overall Study|Withdrawal by Subject|4|||
25028541|NCT02918318|50126714|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
25157166|NCT00920621|50273516|FG002|Overall Study|Fetal/neonatal deaths|16|||
24937449|NCT00343642|50030567|FG000|Overall Study|Adverse Event|0|||
24937450|NCT00343642|50030568|FG001|Overall Study|Adverse Event|0|||
24937451|NCT00343642|50030569|FG002|Overall Study|Adverse Event|1|||
24937452|NCT00343642|50030567|FG000|Overall Study|Flare up|6|||
24937453|NCT00343642|50030568|FG001|Overall Study|Flare up|4|||
24937454|NCT00343642|50030569|FG002|Overall Study|Flare up|0|||
24937455|NCT00609167|50030582|FG000|Overall Study|Withdrawal by Subject|1|||
24937456|NCT00609167|50030583|FG001|Overall Study|Withdrawal by Subject|0|||
24937457|NCT00609167|50030582|FG000|Overall Study|Lack of Efficacy|1|||
24937458|NCT00609167|50030583|FG001|Overall Study|Lack of Efficacy|0|||
24937459|NCT00609167|50030582|FG000|Overall Study|Adverse Event|5|||
24937460|NCT00609167|50030583|FG001|Overall Study|Adverse Event|1|||
24937461|NCT00609167|50030582|FG000|Overall Study|Disease Progression|1|||
24937462|NCT00609167|50030583|FG001|Overall Study|Disease Progression|0|||
24937463|NCT00609167|50030582|FG000|Overall Study|Stem Cell Transplant|0|||
24937464|NCT00609167|50030583|FG001|Overall Study|Stem Cell Transplant|6|||
24937465|NCT00606281|50030591|FG000|Overall Study|Adverse Event|11|||
24937466|NCT00606281|50030592|FG001|Overall Study|Adverse Event|12|||
24937467|NCT00606281|50030591|FG000|Overall Study|Death|1|||
25157167|NCT00920621|50273517|FG003|Overall Study|Fetal/neonatal deaths|14|||
25157168|NCT00920621|50273514|FG000|Overall Study|Blood sample not collected|22|||
25157169|NCT00920621|50273515|FG001|Overall Study|Blood sample not collected|14|||
24937468|NCT00606281|50030592|FG001|Overall Study|Death|0|||
24937469|NCT00606281|50030591|FG000|Overall Study|Lack of Efficacy|28|||
24937470|NCT00606281|50030592|FG001|Overall Study|Lack of Efficacy|35|||
24937471|NCT00606281|50030591|FG000|Overall Study|Physician Decision|0|||
24937472|NCT00606281|50030592|FG001|Overall Study|Physician Decision|1|||
24937473|NCT00606281|50030591|FG000|Overall Study|Protocol Violation|3|||
24937474|NCT00606281|50030592|FG001|Overall Study|Protocol Violation|3|||
25028542|NCT02918318|50126715|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
25028543|NCT02918318|50126716|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
24937475|NCT00606281|50030591|FG000|Overall Study|Withdrawal by Subject|11|||
24937476|NCT00606281|50030592|FG001|Overall Study|Withdrawal by Subject|13|||
24937477|NCT00606281|50030591|FG000|Overall Study|Progression to depressive phase|1|||
24937478|NCT00606281|50030592|FG001|Overall Study|Progression to depressive phase|1|||
24937479|NCT00606281|50030591|FG000|Overall Study|Change of residence or other commitments|1|||
24937480|NCT00606281|50030592|FG001|Overall Study|Change of residence or other commitments|1|||
24937481|NCT00506142|50030600|FG000|Overall Study|Adverse Event|8|||
24937482|NCT00506142|50030601|FG001|Overall Study|Adverse Event|7|||
24937483|NCT00506142|50030600|FG000|Overall Study|Lack of Efficacy|21|||
25157170|NCT00920621|50273516|FG002|Overall Study|Blood sample not collected|0|||
25157171|NCT00920621|50273517|FG003|Overall Study|Blood sample not collected|0|||
25157172|NCT00472212|50273530|FG000|Overall Study|Lost to Follow-up|6|||
25157173|NCT00472212|50273531|FG001|Overall Study|Lost to Follow-up|4|||
25157174|NCT00378105|50273539|FG000|Overall Study|Adverse Event|3|||
25157175|NCT00378105|50273540|FG001|Overall Study|Adverse Event|1|||
25157176|NCT00378105|50273539|FG000|Overall Study|Withdrawal by Subject|3|||
24937484|NCT00506142|50030601|FG001|Overall Study|Lack of Efficacy|7|||
24937485|NCT00506142|50030600|FG000|Overall Study|Withdrawal by Subject|4|||
24937486|NCT00506142|50030601|FG001|Overall Study|Withdrawal by Subject|5|||
24937487|NCT00506142|50030600|FG000|Overall Study|Physician Decision|1|||
24937488|NCT00506142|50030601|FG001|Overall Study|Physician Decision|0|||
24937489|NCT00506142|50030600|FG000|Overall Study|New health condition|1|||
24937490|NCT00506142|50030601|FG001|Overall Study|New health condition|0|||
24937491|NCT00514020|50030607|FG000|Overall Study|Adverse Event|6|||
24937492|NCT00514020|50030607|FG000|Overall Study|Withdrawal by Subject|3|||
24937493|NCT00514020|50030607|FG000|Overall Study|Physician Decision|1|||
24937494|NCT00514020|50030607|FG000|Overall Study|disease progression|9|||
25028544|NCT02918318|50126717|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
25028545|NCT03411863|50126762|FG000|Overall Study|Withdrawal by Subject|3|||
25028546|NCT03411863|50126763|FG001|Overall Study|Withdrawal by Subject|1|||
25028547|NCT03411863|50126762|FG000|Overall Study|Physician Decision|0|||
25028548|NCT03411863|50126763|FG001|Overall Study|Physician Decision|1|||
25028549|NCT01065350|50126772|FG000|Overall Study|Received incorrect drug allocation|0|||
25028550|NCT01065350|50126773|FG001|Overall Study|Received incorrect drug allocation|1|||
25028551|NCT03434249|50126781|FG000|Overall Study|Adverse Event|1|||
25028552|NCT03434249|50126782|FG001|Overall Study|Adverse Event|0|||
25157177|NCT00378105|50273540|FG001|Overall Study|Withdrawal by Subject|3|||
25157178|NCT00378105|50273539|FG000|Overall Study|Death|1|||
25157179|NCT00378105|50273540|FG001|Overall Study|Death|0|||
25157180|NCT00378105|50273539|FG000|Overall Study|Going to transplant|7|||
25157181|NCT00378105|50273540|FG001|Overall Study|Going to transplant|8|||
25157182|NCT00378105|50273539|FG000|Overall Study|Progressive disease|3|||
25186096|NCT02900976|50335955|FG000|Overall Study|Physician Decision|0|||
25186097|NCT02900976|50335956|FG001|Overall Study|Physician Decision|2|||
25186098|NCT02900976|50335955|FG000|Overall Study|Progressive disease|0|||
24937495|NCT00514020|50030607|FG000|Overall Study|other complicating disease|2|||
24937496|NCT00514020|50030607|FG000|Overall Study|patient went to radiation treatment|1|||
25028553|NCT03434249|50126781|FG000|Overall Study|Lost to Follow-up|0|||
25028554|NCT03434249|50126782|FG001|Overall Study|Lost to Follow-up|1|||
25028555|NCT03434249|50126781|FG000|Overall Study|Non-compliance of family|2|||
25157183|NCT00378105|50273540|FG001|Overall Study|Progressive disease|3|||
24937497|NCT00514020|50030607|FG000|Overall Study|"patients moved to the no tx group"|6|||
24937498|NCT00513708|50030614|FG000|Overall Study|Lost to Follow-up|4|||
24937499|NCT00513708|50030615|FG001|Overall Study|Lost to Follow-up|4|||
24937500|NCT00513708|50030616|FG002|Overall Study|Lost to Follow-up|4|||
24937501|NCT00513474|50030626|FG000|Overall Study|Death|6|||
24937502|NCT00513474|50030627|FG001|Overall Study|Death|9|||
25157184|NCT00378105|50273539|FG000|Overall Study|remain on study|3|||
25157185|NCT00378105|50273540|FG001|Overall Study|remain on study|11|||
25157186|NCT00378105|50273539|FG000|Overall Study|Physician Decision|0|||
25157187|NCT00378105|50273540|FG001|Overall Study|Physician Decision|2|||
25157188|NCT00378105|50273539|FG000|Overall Study|Going non-protocol therapy|0|||
25157189|NCT00378105|50273540|FG001|Overall Study|Going non-protocol therapy|1|||
25157190|NCT00378105|50273539|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
25157191|NCT00378105|50273540|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
25157192|NCT00139477|50273549|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
25157193|NCT00139477|50273550|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
25157194|NCT00139477|50273549|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
25157195|NCT00139477|50273550|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
25157196|NCT00139477|50273549|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
25157197|NCT00139477|50273550|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
25157198|NCT00139477|50273549|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
24937503|NCT00513474|50030626|FG000|Overall Study|Participant Withdrew Consent|1|||
24937504|NCT00513474|50030627|FG001|Overall Study|Participant Withdrew Consent|0|||
24937505|NCT00505752|50030637|FG000|Overall Study|Adverse Event|1|||
24937506|NCT00505752|50030638|FG001|Overall Study|Adverse Event|0|||
24937507|NCT00505752|50030639|FG002|Overall Study|Adverse Event|1|||
24937508|NCT00505752|50030640|FG003|Overall Study|Adverse Event|0|||
24937509|NCT00505752|50030637|FG000|Overall Study|Lost to Follow-up|1|||
24937510|NCT00505752|50030638|FG001|Overall Study|Lost to Follow-up|0|||
24937511|NCT00505752|50030639|FG002|Overall Study|Lost to Follow-up|0|||
24937512|NCT00505752|50030640|FG003|Overall Study|Lost to Follow-up|0|||
24937513|NCT00505752|50030637|FG000|Overall Study|Lack of ovarian response|1|||
24937514|NCT00505752|50030638|FG001|Overall Study|Lack of ovarian response|3|||
24937515|NCT00505752|50030639|FG002|Overall Study|Lack of ovarian response|0|||
24937516|NCT00505752|50030640|FG003|Overall Study|Lack of ovarian response|0|||
24937517|NCT00505752|50030637|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
24937518|NCT00505752|50030638|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
24937519|NCT00505752|50030639|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
24937520|NCT00505752|50030640|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
24937521|NCT00505752|50030637|FG000|Overall Study|No oocytes retrieved|0|||
24937522|NCT00505752|50030638|FG001|Overall Study|No oocytes retrieved|2|||
25028556|NCT03434249|50126782|FG001|Overall Study|Non-compliance of family|1|||
25028557|NCT03434249|50126781|FG000|Overall Study|Difficulties in completing daily diary|2|||
25028558|NCT03434249|50126782|FG001|Overall Study|Difficulties in completing daily diary|1|||
25028559|NCT03114969|50126797|FG000|Overall Study|Lost to Follow-up|0|||
25028560|NCT03114969|50126798|FG001|Overall Study|Lost to Follow-up|0|||
25028561|NCT03114969|50126799|FG002|Overall Study|Lost to Follow-up|3|||
24937523|NCT00505752|50030639|FG002|Overall Study|No oocytes retrieved|0|||
24937524|NCT00505752|50030640|FG003|Overall Study|No oocytes retrieved|1|||
24937525|NCT00505752|50030637|FG000|Overall Study|No Fertilization|1|||
24937526|NCT00505752|50030638|FG001|Overall Study|No Fertilization|1|||
24937527|NCT00505752|50030639|FG002|Overall Study|No Fertilization|2|||
24937528|NCT00505752|50030640|FG003|Overall Study|No Fertilization|1|||
24937529|NCT00505752|50030637|FG000|Overall Study|All embryos/blastocysts discarded|0|||
24937530|NCT00505752|50030638|FG001|Overall Study|All embryos/blastocysts discarded|0|||
24937531|NCT00505752|50030639|FG002|Overall Study|All embryos/blastocysts discarded|1|||
24937532|NCT00505752|50030640|FG003|Overall Study|All embryos/blastocysts discarded|1|||
24937533|NCT00505752|50030637|FG000|Overall Study|Other|1|||
24937534|NCT00505752|50030638|FG001|Overall Study|Other|2|||
24937535|NCT00505752|50030639|FG002|Overall Study|Other|1|||
25186099|NCT02900976|50335956|FG001|Overall Study|Progressive disease|6|||
24937536|NCT00505752|50030640|FG003|Overall Study|Other|2|||
24937537|NCT03601637|50030652|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
24937538|NCT03601637|50030653|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
24937539|NCT03601637|50030652|FG000|Overall Study|Adverse Event|1|||
24937540|NCT03601637|50030653|FG001|Overall Study|Adverse Event|1|||
24937541|NCT03601637|50030652|FG000|Overall Study|Other|0|||
24937542|NCT03601637|50030653|FG001|Overall Study|Other|1|||
24937543|NCT00343252|50030668|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
24937544|NCT00343252|50030669|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
24937545|NCT00343252|50030668|FG000|6 Months (All Treated Participants)|Death|0|||
24937546|NCT00343252|50030669|FG001|6 Months (All Treated Participants)|Death|2|||
24937547|NCT00343252|50030668|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
24937548|NCT00343252|50030669|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
25028562|NCT03114969|50126800|FG003|Overall Study|Lost to Follow-up|2|||
24937549|NCT00343252|50030668|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
24937550|NCT00343252|50030669|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
24937551|NCT00343252|50030668|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
24937552|NCT00343252|50030669|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
24937553|NCT00343252|50030668|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
24937554|NCT00343252|50030669|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
25028563|NCT03114969|50126801|FG004|Overall Study|Lost to Follow-up|0|||
24937555|NCT00343252|50030668|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
24937556|NCT00343252|50030669|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
24937557|NCT00343252|50030668|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
24937558|NCT00343252|50030669|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
24937559|NCT00343252|50030668|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
24937560|NCT00343252|50030669|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
25157199|NCT00139477|50273550|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
24937561|NCT00343252|50030668|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
24937562|NCT00343252|50030669|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
24937563|NCT00343252|50030668|FG000|12 Months (All Treated Participants)|Death|3|||
24937564|NCT00343252|50030669|FG001|12 Months (All Treated Participants)|Death|3|||
24937565|NCT00343252|50030668|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
24937566|NCT00343252|50030669|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
24937567|NCT00343252|50030668|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
24937568|NCT00343252|50030669|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
24937569|NCT00343252|50030668|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
24937570|NCT00343252|50030669|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
25028564|NCT03114969|50126802|FG005|Overall Study|Lost to Follow-up|0|||
24937571|NCT00343252|50030668|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
25157200|NCT00139477|50273549|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
25028565|NCT03114969|50126803|FG006|Overall Study|Lost to Follow-up|0|||
25157201|NCT00139477|50273550|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
24937572|NCT00343252|50030669|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
24937573|NCT00343252|50030668|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
24937574|NCT00343252|50030669|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
24937575|NCT00343252|50030668|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
24937576|NCT00343252|50030669|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
24937577|NCT00343252|50030668|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
24937578|NCT00343252|50030669|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
24937579|NCT00343252|50030668|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
24937580|NCT00343252|50030669|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
24937581|NCT00343252|50030668|FG000|18 Months (All Treated Participants)|Death|4|||
24937582|NCT00343252|50030669|FG001|18 Months (All Treated Participants)|Death|5|||
24937583|NCT00343252|50030668|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
24937584|NCT00343252|50030669|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
24937585|NCT00343252|50030668|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
24937586|NCT00343252|50030669|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
24937587|NCT00343252|50030668|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
24937588|NCT00343252|50030669|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
25157202|NCT00139477|50273549|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
25157203|NCT00139477|50273550|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
25157204|NCT00139477|50273549|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
25157205|NCT00139477|50273550|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
25157206|NCT01469013|50273870|FG000|Part A (Treatment Period)|Adverse Event|1|||
25157207|NCT01469013|50273871|FG001|Part A (Treatment Period)|Adverse Event|0|||
25157208|NCT01469013|50273872|FG002|Part A (Treatment Period)|Adverse Event|0|||
25157209|NCT01469013|50273873|FG003|Part A (Treatment Period)|Adverse Event|0|||
25157210|NCT01469013|50273874|FG004|Part A (Treatment Period)|Adverse Event|1|||
25157211|NCT01469013|50273875|FG005|Part A (Treatment Period)|Adverse Event|0|||
25157212|NCT01469013|50273876|FG006|Part A (Treatment Period)|Adverse Event|0|||
25157213|NCT01469013|50273877|FG007|Part A (Treatment Period)|Adverse Event|0|||
25157214|NCT01469013|50273878|FG008|Part A (Treatment Period)|Adverse Event|0|||
25157215|NCT01469013|50273879|FG009|Part A (Treatment Period)|Adverse Event|0|||
25157216|NCT01469013|50273880|FG010|Part A (Treatment Period)|Adverse Event|0|||
25157217|NCT01469013|50273881|FG011|Part A (Treatment Period)|Adverse Event|0|||
25157218|NCT01469013|50273882|FG012|Part A (Treatment Period)|Adverse Event|0|||
25157219|NCT01469013|50273870|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
25157220|NCT01469013|50273871|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
25157221|NCT01469013|50273872|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
25157222|NCT01469013|50273873|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
25157223|NCT01469013|50273874|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
25157224|NCT01469013|50273875|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
25157225|NCT01469013|50273876|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
25157226|NCT01469013|50273877|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
25157227|NCT01469013|50273878|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
25157228|NCT01469013|50273879|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
25157229|NCT01469013|50273880|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
25028566|NCT03114969|50126804|FG007|Overall Study|Lost to Follow-up|0|||
25157230|NCT01469013|50273881|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
25157231|NCT01469013|50273882|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
25157232|NCT01469013|50273870|FG000|Part B (Extension Period)|Adverse Event|0|||
25157233|NCT01469013|50273871|FG001|Part B (Extension Period)|Adverse Event|0|||
25157234|NCT01469013|50273872|FG002|Part B (Extension Period)|Adverse Event|0|||
25157235|NCT01469013|50273873|FG003|Part B (Extension Period)|Adverse Event|0|||
24937589|NCT00343252|50030668|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
24937590|NCT00343252|50030669|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
24937591|NCT00343252|50030668|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
24937592|NCT00343252|50030669|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
24937593|NCT00343252|50030668|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
25157236|NCT01469013|50273874|FG004|Part B (Extension Period)|Adverse Event|0|||
25157237|NCT01469013|50273875|FG005|Part B (Extension Period)|Adverse Event|2|||
24937594|NCT00343252|50030669|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
24937595|NCT00343252|50030668|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
25157238|NCT01469013|50273876|FG006|Part B (Extension Period)|Adverse Event|5|||
25157239|NCT01469013|50273877|FG007|Part B (Extension Period)|Adverse Event|5|||
25157240|NCT01469013|50273878|FG008|Part B (Extension Period)|Adverse Event|3|||
25157241|NCT01469013|50273879|FG009|Part B (Extension Period)|Adverse Event|3|||
24937596|NCT00343252|50030669|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
24937597|NCT00342628|50030678|FG000|Overall Study|Withdrawal by Subject|19|||
24937598|NCT00342628|50030679|FG001|Overall Study|Withdrawal by Subject|19|||
24937599|NCT00342628|50030680|FG002|Overall Study|Withdrawal by Subject|18|||
24937600|NCT00342628|50030678|FG000|Overall Study|Death|1|||
24937601|NCT00342628|50030679|FG001|Overall Study|Death|1|||
24937602|NCT00342628|50030680|FG002|Overall Study|Death|0|||
24937603|NCT00342628|50030678|FG000|Overall Study|moved residence|0|||
24937604|NCT00342628|50030679|FG001|Overall Study|moved residence|1|||
24937605|NCT00342628|50030680|FG002|Overall Study|moved residence|1|||
24937606|NCT00505284|50030693|FG000|Overall Study|Adverse Event|3|||
25157242|NCT01469013|50273880|FG010|Part B (Extension Period)|Adverse Event|1|||
25157243|NCT01469013|50273881|FG011|Part B (Extension Period)|Adverse Event|6|||
25028567|NCT03114969|50126805|FG008|Overall Study|Lost to Follow-up|0|||
25157244|NCT01469013|50273882|FG012|Part B (Extension Period)|Adverse Event|3|||
25157245|NCT01469013|50273870|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
24937607|NCT00505284|50030694|FG001|Overall Study|Adverse Event|7|||
24937608|NCT00505284|50030695|FG002|Overall Study|Adverse Event|9|||
25028568|NCT03114969|50126797|FG000|Overall Study|Adverse Event|0|||
25028569|NCT03114969|50126798|FG001|Overall Study|Adverse Event|0|||
24937609|NCT00505284|50030696|FG003|Overall Study|Adverse Event|14|||
24937610|NCT00505284|50030697|FG004|Overall Study|Adverse Event|22|||
24937611|NCT00505284|50030693|FG000|Overall Study|Protocol Violation|0|||
24937612|NCT00505284|50030694|FG001|Overall Study|Protocol Violation|1|||
24937613|NCT00505284|50030695|FG002|Overall Study|Protocol Violation|1|||
24937614|NCT00505284|50030696|FG003|Overall Study|Protocol Violation|0|||
24937615|NCT00505284|50030697|FG004|Overall Study|Protocol Violation|0|||
24937616|NCT00505284|50030693|FG000|Overall Study|Withdrawal by Subject|2|||
24937617|NCT00505284|50030694|FG001|Overall Study|Withdrawal by Subject|6|||
24937618|NCT00505284|50030695|FG002|Overall Study|Withdrawal by Subject|1|||
25028570|NCT03114969|50126799|FG002|Overall Study|Adverse Event|1|||
24937619|NCT00505284|50030696|FG003|Overall Study|Withdrawal by Subject|0|||
24937620|NCT00505284|50030697|FG004|Overall Study|Withdrawal by Subject|6|||
24937621|NCT00505284|50030693|FG000|Overall Study|Lack of Efficacy|0|||
24937622|NCT00505284|50030694|FG001|Overall Study|Lack of Efficacy|1|||
24937623|NCT00505284|50030695|FG002|Overall Study|Lack of Efficacy|1|||
24937624|NCT00505284|50030696|FG003|Overall Study|Lack of Efficacy|1|||
24937625|NCT00505284|50030697|FG004|Overall Study|Lack of Efficacy|1|||
24937626|NCT00505284|50030693|FG000|Overall Study|Physician Decision|0|||
24937627|NCT00505284|50030694|FG001|Overall Study|Physician Decision|1|||
24937628|NCT00505284|50030695|FG002|Overall Study|Physician Decision|0|||
24937629|NCT00505284|50030696|FG003|Overall Study|Physician Decision|0|||
24937630|NCT00505284|50030697|FG004|Overall Study|Physician Decision|0|||
25028571|NCT03114969|50126800|FG003|Overall Study|Adverse Event|0|||
25028572|NCT03114969|50126801|FG004|Overall Study|Adverse Event|0|||
25028573|NCT03114969|50126802|FG005|Overall Study|Adverse Event|1|||
25028574|NCT03114969|50126803|FG006|Overall Study|Adverse Event|1|||
24937631|NCT00505284|50030693|FG000|Overall Study|Other|5|||
24937632|NCT00505284|50030694|FG001|Overall Study|Other|0|||
24937633|NCT00505284|50030695|FG002|Overall Study|Other|0|||
24937634|NCT00505284|50030696|FG003|Overall Study|Other|4|||
24937635|NCT00505284|50030697|FG004|Overall Study|Other|4|||
24937636|NCT00337168|50030709|FG000|Overall Study|Death|5|||
25028575|NCT03114969|50126804|FG007|Overall Study|Adverse Event|0|||
25028576|NCT03114969|50126805|FG008|Overall Study|Adverse Event|2|||
24937637|NCT00337168|50030709|FG000|Overall Study|Not protocol specified|2|||
24937638|NCT00337168|50030709|FG000|Overall Study|Did not start therapy|1|||
25028577|NCT02046096|50126834|FG000|Overall Study|Death|28|||
25028578|NCT02046096|50126835|FG001|Overall Study|Death|45|||
24937639|NCT00606905|50030716|FG000|Overall Study|No Pregnancy|9|||
24937640|NCT00606905|50030717|FG001|Overall Study|No Pregnancy|6|||
24937641|NCT00606905|50030716|FG000|Overall Study|Non-Index Pregnancy|1|||
24937642|NCT00606905|50030717|FG001|Overall Study|Non-Index Pregnancy|4|||
24937643|NCT00606905|50030716|FG000|Overall Study|Withdrew|5|||
24937644|NCT00606905|50030717|FG001|Overall Study|Withdrew|5|||
24937645|NCT00606593|50030723|FG000|Overall Study|Adverse Event|0|||
24937646|NCT00606593|50030724|FG001|Overall Study|Adverse Event|0|||
24937647|NCT00606593|50030725|FG002|Overall Study|Adverse Event|0|||
24937648|NCT00606593|50030726|FG003|Overall Study|Adverse Event|1|||
24937649|NCT00606593|50030727|FG004|Overall Study|Adverse Event|1|||
24937650|NCT00606593|50030728|FG005|Overall Study|Adverse Event|0|||
24937651|NCT00606593|50030729|FG006|Overall Study|Adverse Event|1|||
25028579|NCT02046096|50126834|FG000|Overall Study|Lost to Follow-up|9|||
25028580|NCT02046096|50126835|FG001|Overall Study|Lost to Follow-up|20|||
25028581|NCT02046096|50126834|FG000|Overall Study|Withdrawal by Subject|5|||
25028582|NCT02046096|50126835|FG001|Overall Study|Withdrawal by Subject|17|||
25028583|NCT02046096|50126834|FG000|Overall Study|Other endpoint|2|||
25028584|NCT02046096|50126835|FG001|Overall Study|Other endpoint|19|||
25028585|NCT03463577|50126849|FG000|Overall Study|Lost to Follow-up|238|||
25028586|NCT03463577|50126850|FG001|Overall Study|Lost to Follow-up|435|||
25028587|NCT03463577|50126851|FG002|Overall Study|Lost to Follow-up|0|||
25028588|NCT03463577|50126852|FG003|Overall Study|Lost to Follow-up|0|||
25028589|NCT03463577|50126853|FG004|Overall Study|Lost to Follow-up|0|||
25028590|NCT03463577|50126854|FG005|Overall Study|Lost to Follow-up|0|||
25028591|NCT03463577|50126849|FG000|Overall Study|With unknown pregnancy outcome|0|||
25028592|NCT03463577|50126850|FG001|Overall Study|With unknown pregnancy outcome|5|||
25028593|NCT03463577|50126851|FG002|Overall Study|With unknown pregnancy outcome|0|||
25028594|NCT03463577|50126852|FG003|Overall Study|With unknown pregnancy outcome|0|||
25028595|NCT03463577|50126853|FG004|Overall Study|With unknown pregnancy outcome|0|||
25028596|NCT03463577|50126854|FG005|Overall Study|With unknown pregnancy outcome|0|||
25028597|NCT03463577|50126849|FG000|Overall Study|Maternal death|2|||
25028598|NCT03463577|50126850|FG001|Overall Study|Maternal death|0|||
25028599|NCT03463577|50126851|FG002|Overall Study|Maternal death|0|||
25028600|NCT03463577|50126852|FG003|Overall Study|Maternal death|0|||
25028601|NCT03463577|50126853|FG004|Overall Study|Maternal death|0|||
25028602|NCT03463577|50126854|FG005|Overall Study|Maternal death|0|||
25028603|NCT03463577|50126849|FG000|Overall Study|Neonatal death|0|||
25028604|NCT03463577|50126850|FG001|Overall Study|Neonatal death|0|||
25028605|NCT03463577|50126851|FG002|Overall Study|Neonatal death|0|||
25028606|NCT03463577|50126852|FG003|Overall Study|Neonatal death|15|||
25028607|NCT03463577|50126853|FG004|Overall Study|Neonatal death|17|||
25028608|NCT03463577|50126854|FG005|Overall Study|Neonatal death|0|||
25028609|NCT03122145|50126870|FG000|Overall Study|Concurrent respiratory disease|3|||
25028610|NCT03122145|50126871|FG001|Overall Study|Concurrent respiratory disease|0|||
25028611|NCT03114657|50126879|FG000|Overall Study|Adverse Event|9|||
25028612|NCT03114657|50126880|FG001|Overall Study|Adverse Event|6|||
25028613|NCT03114657|50126879|FG000|Overall Study|Death|4|||
25028614|NCT03114657|50126880|FG001|Overall Study|Death|0|||
25028615|NCT03114657|50126879|FG000|Overall Study|Multiple Reasons|1|||
25028616|NCT03114657|50126880|FG001|Overall Study|Multiple Reasons|2|||
25028617|NCT03114657|50126879|FG000|Overall Study|Physician Decision|2|||
25028618|NCT03114657|50126880|FG001|Overall Study|Physician Decision|2|||
25028619|NCT03114657|50126879|FG000|Overall Study|Study Terminated By Sponsor|355|||
25028620|NCT03114657|50126880|FG001|Overall Study|Study Terminated By Sponsor|374|||
25028621|NCT03114657|50126879|FG000|Overall Study|Symptomatic Deterioration|0|||
25028622|NCT03114657|50126880|FG001|Overall Study|Symptomatic Deterioration|1|||
25028623|NCT03114657|50126879|FG000|Overall Study|Withdrawal by Subject|28|||
25028624|NCT03114657|50126880|FG001|Overall Study|Withdrawal by Subject|22|||
25028625|NCT02926950|50126889|FG000|Overall Study|Adverse Event|4|||
25028626|NCT02926950|50126890|FG001|Overall Study|Adverse Event|6|||
25028627|NCT02926950|50126889|FG000|Overall Study|At the participant's own request|21|||
25028628|NCT02926950|50126890|FG001|Overall Study|At the participant's own request|25|||
25028629|NCT02926950|50126889|FG000|Overall Study|Reason not Specified|17|||
25028630|NCT02926950|50126890|FG001|Overall Study|Reason not Specified|9|||
25028631|NCT02926950|50126889|FG000|Overall Study|Lost to Follow-up|7|||
25028632|NCT02926950|50126890|FG001|Overall Study|Lost to Follow-up|8|||
25157246|NCT01469013|50273871|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
25028633|NCT03410693|50126899|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
25028634|NCT03410693|50126900|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
25028635|NCT03410693|50126899|FG000|Overall Study|Disc trt: Lost to follow up|0|||
25157247|NCT01469013|50273872|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
24937652|NCT00606593|50030730|FG007|Overall Study|Adverse Event|2|||
24937653|NCT00606593|50030731|FG008|Overall Study|Adverse Event|1|||
24937654|NCT00606593|50030732|FG009|Overall Study|Adverse Event|0|||
25157248|NCT01469013|50273873|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
25028636|NCT03410693|50126900|FG001|Overall Study|Disc trt: Lost to follow up|1|||
25028637|NCT03410693|50126899|FG000|Overall Study|Disc trt: radiological progression|58|||
25028638|NCT03410693|50126900|FG001|Overall Study|Disc trt: radiological progression|50|||
25028639|NCT03410693|50126899|FG000|Overall Study|Disc trt: Other|1|||
25028640|NCT03410693|50126900|FG001|Overall Study|Disc trt: Other|0|||
25028641|NCT03410693|50126899|FG000|Overall Study|Study drug never administered|1|||
25028642|NCT03410693|50126900|FG001|Overall Study|Study drug never administered|6|||
25028643|NCT03410693|50126899|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
25028644|NCT03410693|50126900|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
25028645|NCT03410693|50126899|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
24937655|NCT00606593|50030723|FG000|Overall Study|Withdrawal of consent|1|||
24937656|NCT00606593|50030724|FG001|Overall Study|Withdrawal of consent|0|||
24937657|NCT00606593|50030725|FG002|Overall Study|Withdrawal of consent|1|||
24937658|NCT00606593|50030726|FG003|Overall Study|Withdrawal of consent|0|||
24937659|NCT00606593|50030727|FG004|Overall Study|Withdrawal of consent|0|||
24937660|NCT00606593|50030728|FG005|Overall Study|Withdrawal of consent|0|||
24937661|NCT00606593|50030729|FG006|Overall Study|Withdrawal of consent|0|||
24937662|NCT00606593|50030730|FG007|Overall Study|Withdrawal of consent|0|||
24937663|NCT00606593|50030731|FG008|Overall Study|Withdrawal of consent|0|||
24937664|NCT00606593|50030732|FG009|Overall Study|Withdrawal of consent|0|||
24937665|NCT00606593|50030723|FG000|Overall Study|Administrative/Other|0|||
24937666|NCT00606593|50030724|FG001|Overall Study|Administrative/Other|0|||
24937667|NCT00606593|50030725|FG002|Overall Study|Administrative/Other|1|||
24937668|NCT00606593|50030726|FG003|Overall Study|Administrative/Other|0|||
24937669|NCT00606593|50030727|FG004|Overall Study|Administrative/Other|0|||
24937670|NCT00606593|50030728|FG005|Overall Study|Administrative/Other|0|||
24937671|NCT00606593|50030729|FG006|Overall Study|Administrative/Other|0|||
25028646|NCT03410693|50126900|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
25028647|NCT03410693|50126899|FG000|Overall Study|Disc trt: Physician decision|0|||
25028648|NCT03410693|50126900|FG001|Overall Study|Disc trt: Physician decision|5|||
25028649|NCT03410693|50126899|FG000|Overall Study|Disc trt: clinical progression|1|||
25157249|NCT01469013|50273874|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
25157250|NCT01469013|50273875|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
25157251|NCT01469013|50273876|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
25028650|NCT03410693|50126900|FG001|Overall Study|Disc trt: clinical progression|5|||
25028651|NCT03410693|50126899|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
25157252|NCT01469013|50273877|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
25157253|NCT01469013|50273878|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
25157254|NCT01469013|50273879|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
25157255|NCT01469013|50273880|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
25157256|NCT01469013|50273881|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
25157257|NCT01469013|50273882|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
25157258|NCT01493427|50273909|FG000|Overall Study|Adverse Event|10|||
25157259|NCT01493427|50273909|FG000|Overall Study|Personal Reasons|4|||
25157260|NCT01493427|50273909|FG000|Overall Study|Lost to Follow-up|2|||
25157261|NCT01493427|50273909|FG000|Overall Study|Inability to Follow Instructions|2|||
25157262|NCT01493427|50273909|FG000|Overall Study|Other|2|||
25157263|NCT01523457|50273915|FG000|Overall Study|Withdrawal by Subject|7|||
25157264|NCT01523457|50273916|FG001|Overall Study|Withdrawal by Subject|2|||
25157265|NCT01523301|50273924|FG000|Overall Study|Adverse Event|25|||
25157266|NCT01523301|50273925|FG001|Overall Study|Adverse Event|16|||
25157267|NCT01523301|50273924|FG000|Overall Study|Lack of Efficacy|0|||
25157268|NCT01523301|50273925|FG001|Overall Study|Lack of Efficacy|2|||
25157269|NCT01523301|50273924|FG000|Overall Study|Protocol Violation|3|||
25157270|NCT01523301|50273925|FG001|Overall Study|Protocol Violation|4|||
24937672|NCT00606593|50030730|FG007|Overall Study|Administrative/Other|0|||
24937673|NCT00606593|50030731|FG008|Overall Study|Administrative/Other|0|||
24937674|NCT00606593|50030732|FG009|Overall Study|Administrative/Other|0|||
24937675|NCT00605267|50030747|FG000|Overall Study|Adverse Event|0|||
24937676|NCT00605267|50030748|FG001|Overall Study|Adverse Event|1|||
25157271|NCT01523301|50273924|FG000|Overall Study|Lost to Follow-up|1|||
25157272|NCT01523301|50273925|FG001|Overall Study|Lost to Follow-up|0|||
25157273|NCT01523301|50273924|FG000|Overall Study|Withdrawal by Subject|6|||
25157274|NCT01523301|50273925|FG001|Overall Study|Withdrawal by Subject|8|||
25157275|NCT01523301|50273924|FG000|Overall Study|Other Reason|0|||
25157276|NCT01523301|50273925|FG001|Overall Study|Other Reason|2|||
25157277|NCT01806506|50273933|FG000|Overall Study|Lost to Follow-up|2|||
25157278|NCT01806506|50273934|FG001|Overall Study|Lost to Follow-up|1|||
25157279|NCT01766336|50273942|FG000|Overall Study|Adverse Event|11|||
25157280|NCT01766336|50273943|FG001|Overall Study|Adverse Event|8|||
25157281|NCT01766336|50273942|FG000|Overall Study|Death|4|||
24937677|NCT00605267|50030747|FG000|Overall Study|Lack of Efficacy|1|||
24937678|NCT00605267|50030748|FG001|Overall Study|Lack of Efficacy|5|||
24937679|NCT00605267|50030747|FG000|Overall Study|Withdrawal by Subject|2|||
24937680|NCT00605267|50030748|FG001|Overall Study|Withdrawal by Subject|3|||
24937681|NCT00605813|50030754|FG000|Overall Study|Protocol Violation|25|||
24937682|NCT00604721|50030767|FG000|Overall Study|Physician Decision|1|||
24937683|NCT00604721|50030767|FG000|Overall Study|Withdrawal by Subject|1|||
24937684|NCT00605657|50030772|FG000|Overall Study|Adverse Event|1|||
24937685|NCT00605657|50030772|FG000|Overall Study|Protocol Violation|1|||
24937686|NCT00604565|50030778|FG000|Overall Study|Study terminated|0|||
24937687|NCT00604565|50030779|FG001|Overall Study|Study terminated|3|||
24937688|NCT00605345|50030787|FG000|Overall Study|Withdrawal by Subject|1|||
24937689|NCT00605345|50030788|FG001|Overall Study|Withdrawal by Subject|0|||
24937690|NCT00605345|50030787|FG000|Overall Study|Adverse Event|0|||
24937691|NCT00605345|50030788|FG001|Overall Study|Adverse Event|1|||
24937692|NCT00605345|50030787|FG000|Overall Study|Protocol Violation|0|||
24937693|NCT00605345|50030788|FG001|Overall Study|Protocol Violation|2|||
24937694|NCT00604175|50030797|FG000|Entry Through Week 28|Death|2|||
24937695|NCT00604175|50030798|FG001|Entry Through Week 28|Death|0|||
24937696|NCT00604175|50030799|FG002|Entry Through Week 28|Death|0|||
24937697|NCT00604175|50030797|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
24937698|NCT00604175|50030798|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
24937699|NCT00604175|50030799|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
24937700|NCT00604175|50030797|FG000|Entry Through Week 28|Lost to Follow-up|4|||
24937701|NCT00604175|50030798|FG001|Entry Through Week 28|Lost to Follow-up|3|||
24937702|NCT00604175|50030799|FG002|Entry Through Week 28|Lost to Follow-up|0|||
24937703|NCT00604175|50030797|FG000|Entry Through Week 28|Ineligible|1|||
24937704|NCT00604175|50030798|FG001|Entry Through Week 28|Ineligible|0|||
24937705|NCT00604175|50030799|FG002|Entry Through Week 28|Ineligible|0|||
24937706|NCT00604175|50030797|FG000|Entry Through Week 28|Did not start intervention|2|||
24937707|NCT00604175|50030798|FG001|Entry Through Week 28|Did not start intervention|0|||
25157282|NCT01766336|50273943|FG001|Overall Study|Death|3|||
25157283|NCT01766336|50273942|FG000|Overall Study|Lost to Follow-up|1|||
25157284|NCT01766336|50273943|FG001|Overall Study|Lost to Follow-up|3|||
25157285|NCT01766336|50273942|FG000|Overall Study|Physician Decision|4|||
25157286|NCT01766336|50273943|FG001|Overall Study|Physician Decision|2|||
25157287|NCT01766336|50273942|FG000|Overall Study|Protocol Violation|0|||
25157288|NCT01766336|50273943|FG001|Overall Study|Protocol Violation|1|||
25157289|NCT01766336|50273942|FG000|Overall Study|Sponsor Decision|52|||
25157290|NCT01766336|50273943|FG001|Overall Study|Sponsor Decision|43|||
25157291|NCT01766336|50273942|FG000|Overall Study|Withdrawal by Subject|18|||
25157292|NCT01766336|50273943|FG001|Overall Study|Withdrawal by Subject|15|||
25157293|NCT01797536|50273953|FG000|Overall Study|Adverse Event|0|||
25157294|NCT01797536|50273954|FG001|Overall Study|Adverse Event|1|||
25157295|NCT01797536|50273955|FG002|Overall Study|Adverse Event|0|||
25157296|NCT01797536|50273956|FG003|Overall Study|Adverse Event|0|||
25157297|NCT01797302|50273969|FG000|Overall Study|Lost to Follow-up|16|||
25157298|NCT01797302|50273970|FG001|Overall Study|Lost to Follow-up|23|||
25157299|NCT01797302|50273971|FG002|Overall Study|Lost to Follow-up|22|||
25157300|NCT01797302|50273969|FG000|Overall Study|Withdrawal by Subject|1|||
25157301|NCT01797302|50273970|FG001|Overall Study|Withdrawal by Subject|3|||
25157302|NCT01797302|50273971|FG002|Overall Study|Withdrawal by Subject|4|||
25157303|NCT01805180|50273981|FG000|Lead-in Donor Phase|screen failure|1|||
25157304|NCT01805180|50273982|FG001|Lead-in Donor Phase|screen failure|0|||
25157305|NCT01805180|50273983|FG002|Lead-in Donor Phase|screen failure|0|||
25275483|NCT01073943|50589356|FG001|Overall Study|Could not tolerate prep|0|||
25275484|NCT01073865|50589364|FG000|Overall Study|Reasons other than below|19|||
25275485|NCT01073865|50589365|FG001|Overall Study|Reasons other than below|31|||
25275486|NCT01073865|50589364|FG000|Overall Study|Lost to Follow-up|1|||
24937708|NCT00604175|50030799|FG002|Entry Through Week 28|Did not start intervention|1|||
24937709|NCT00604175|50030797|FG000|Week 29 Through Week 72|Death|0|||
24937710|NCT00604175|50030798|FG001|Week 29 Through Week 72|Death|0|||
24937711|NCT00604175|50030799|FG002|Week 29 Through Week 72|Death|1|||
24937712|NCT00604175|50030797|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
24937713|NCT00604175|50030798|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
24937714|NCT00604175|50030799|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
25275487|NCT01073865|50589365|FG001|Overall Study|Lost to Follow-up|1|||
25275488|NCT01073865|50589364|FG000|Overall Study|Death|3|||
25157306|NCT01804946|50273993|FG000|Overall Study|Protocol Violation|1|||
25157307|NCT01804946|50273994|FG001|Overall Study|Protocol Violation|0|||
25157308|NCT01804946|50273993|FG000|Overall Study|Adverse Event|0|||
25157309|NCT01804946|50273994|FG001|Overall Study|Adverse Event|1|||
25157310|NCT01804946|50273993|FG000|Overall Study|Insufficient data available|0|||
25157311|NCT01804946|50273994|FG001|Overall Study|Insufficient data available|1|||
24937715|NCT00604175|50030797|FG000|Week 29 Through Week 72|Site closure|0|||
24937716|NCT00604175|50030798|FG001|Week 29 Through Week 72|Site closure|1|||
24937717|NCT00604175|50030799|FG002|Week 29 Through Week 72|Site closure|0|||
24937718|NCT00604175|50030797|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
24937719|NCT00604175|50030798|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
24937720|NCT00604175|50030799|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
24937721|NCT00605189|50030834|FG000|Overall Study|Adverse Event|1|||
24937722|NCT00605189|50030835|FG001|Overall Study|Adverse Event|0|||
24937723|NCT00605189|50030836|FG002|Overall Study|Adverse Event|0|||
24937724|NCT00605189|50030834|FG000|Overall Study|Other|2|||
24937725|NCT00605189|50030835|FG001|Overall Study|Other|2|||
25028652|NCT03410693|50126900|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
25157312|NCT01804946|50273993|FG000|Overall Study|Do not meet inclusion criteria|1|||
24937726|NCT00605189|50030836|FG002|Overall Study|Other|0|||
24937727|NCT00340834|50030849|FG000|Core Phase of Study|Adverse Event|26|||
24937728|NCT00340834|50030850|FG001|Core Phase of Study|Adverse Event|9|||
24937729|NCT00340834|50030851|FG002|Core Phase of Study|Adverse Event|9|||
24937730|NCT00340834|50030852|FG003|Core Phase of Study|Adverse Event|0|||
24937731|NCT00340834|50030853|FG004|Core Phase of Study|Adverse Event|0|||
24937732|NCT00340834|50030849|FG000|Core Phase of Study|Withdrawal by Subject|11|||
24937733|NCT00340834|50030850|FG001|Core Phase of Study|Withdrawal by Subject|9|||
24937734|NCT00340834|50030851|FG002|Core Phase of Study|Withdrawal by Subject|16|||
24937735|NCT00340834|50030852|FG003|Core Phase of Study|Withdrawal by Subject|0|||
24937736|NCT00340834|50030853|FG004|Core Phase of Study|Withdrawal by Subject|0|||
24937737|NCT00340834|50030849|FG000|Core Phase of Study|Administrative Problems|6|||
24937738|NCT00340834|50030850|FG001|Core Phase of Study|Administrative Problems|2|||
24937739|NCT00340834|50030851|FG002|Core Phase of Study|Administrative Problems|7|||
24937740|NCT00340834|50030852|FG003|Core Phase of Study|Administrative Problems|0|||
24937741|NCT00340834|50030853|FG004|Core Phase of Study|Administrative Problems|0|||
24937742|NCT00340834|50030849|FG000|Core Phase of Study|Lack of Efficacy|3|||
24937743|NCT00340834|50030850|FG001|Core Phase of Study|Lack of Efficacy|3|||
24937744|NCT00340834|50030851|FG002|Core Phase of Study|Lack of Efficacy|7|||
24937745|NCT00340834|50030852|FG003|Core Phase of Study|Lack of Efficacy|0|||
24937746|NCT00340834|50030853|FG004|Core Phase of Study|Lack of Efficacy|0|||
24937747|NCT00340834|50030849|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
24937748|NCT00340834|50030850|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
24937749|NCT00340834|50030851|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
25157313|NCT01804946|50273994|FG001|Overall Study|Do not meet inclusion criteria|2|||
25186100|NCT01474538|50335969|FG000|Treatment Period 1|Death|1|||
24937750|NCT00340834|50030852|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
24937751|NCT00340834|50030853|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
24937752|NCT00340834|50030849|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
24937753|NCT00340834|50030850|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
24937754|NCT00340834|50030851|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
24937755|NCT00340834|50030852|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
24937756|NCT00340834|50030853|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
24937757|NCT00340834|50030849|FG000|Core Phase of Study|Lost to Follow-up|1|||
24937758|NCT00340834|50030850|FG001|Core Phase of Study|Lost to Follow-up|1|||
24937759|NCT00340834|50030851|FG002|Core Phase of Study|Lost to Follow-up|4|||
24937760|NCT00340834|50030852|FG003|Core Phase of Study|Lost to Follow-up|0|||
24937761|NCT00340834|50030853|FG004|Core Phase of Study|Lost to Follow-up|0|||
24937762|NCT00340834|50030849|FG000|Core Phase of Study|Death|2|||
24937763|NCT00340834|50030850|FG001|Core Phase of Study|Death|0|||
24937764|NCT00340834|50030851|FG002|Core Phase of Study|Death|0|||
24937765|NCT00340834|50030852|FG003|Core Phase of Study|Death|0|||
24937766|NCT00340834|50030853|FG004|Core Phase of Study|Death|0|||
24937767|NCT00340834|50030849|FG000|Core Phase of Study|Protocol Violation|0|||
25028653|NCT01064414|50126915|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
25028654|NCT01064414|50126916|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
25028655|NCT01064414|50126917|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
25028656|NCT01064414|50126915|FG000|Core Period: Baseline to Week 26|Death|0|||
25028657|NCT01064414|50126916|FG001|Core Period: Baseline to Week 26|Death|1|||
25028658|NCT01064414|50126917|FG002|Core Period: Baseline to Week 26|Death|0|||
25028659|NCT01064414|50126915|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
25028660|NCT01064414|50126916|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
25028661|NCT01064414|50126917|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
25028662|NCT01064414|50126915|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
25028663|NCT01064414|50126916|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
25028664|NCT01064414|50126917|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
25028665|NCT01064414|50126915|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
25028666|NCT01064414|50126916|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
25028667|NCT01064414|50126917|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
25028668|NCT01064414|50126915|FG000|Core Period: Baseline to Week 26|Other|4|||
25028669|NCT01064414|50126916|FG001|Core Period: Baseline to Week 26|Other|7|||
25028670|NCT01064414|50126917|FG002|Core Period: Baseline to Week 26|Other|2|||
25028671|NCT01064414|50126915|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
25157314|NCT01737398|50274004|FG000|Overall Study|Adverse event or SAE|16|||
25157315|NCT01737398|50274005|FG001|Overall Study|Adverse event or SAE|1|||
25157316|NCT01737398|50274004|FG000|Overall Study|Stopping rule met|2|||
25157317|NCT01737398|50274005|FG001|Overall Study|Stopping rule met|1|||
25157318|NCT01737398|50274004|FG000|Overall Study|Voluntary withdrawal|2|||
24937768|NCT00340834|50030850|FG001|Core Phase of Study|Protocol Violation|0|||
24937769|NCT00340834|50030851|FG002|Core Phase of Study|Protocol Violation|2|||
25157319|NCT01737398|50274005|FG001|Overall Study|Voluntary withdrawal|3|||
25157320|NCT01737398|50274004|FG000|Overall Study|Ineligibility|1|||
24937770|NCT00340834|50030852|FG003|Core Phase of Study|Protocol Violation|0|||
24937771|NCT00340834|50030853|FG004|Core Phase of Study|Protocol Violation|0|||
24937772|NCT00340834|50030849|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
24937773|NCT00340834|50030850|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
24937774|NCT00340834|50030851|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
24937775|NCT00340834|50030852|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
24937776|NCT00340834|50030853|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
24937777|NCT00340834|50030849|FG000|Extension Phase of Study|Subject withdrew consent|26|||
24937778|NCT00340834|50030850|FG001|Extension Phase of Study|Subject withdrew consent|31|||
24937779|NCT00340834|50030851|FG002|Extension Phase of Study|Subject withdrew consent|0|||
24937780|NCT00340834|50030852|FG003|Extension Phase of Study|Subject withdrew consent|12|||
24937781|NCT00340834|50030853|FG004|Extension Phase of Study|Subject withdrew consent|15|||
24937782|NCT00340834|50030849|FG000|Extension Phase of Study|Adverse Event|21|||
25157321|NCT01737398|50274005|FG001|Overall Study|Ineligibility|0|||
25157322|NCT01737398|50274004|FG000|Overall Study|Liver transplant|1|||
25157323|NCT01737398|50274005|FG001|Overall Study|Liver transplant|0|||
25157324|NCT01737398|50274004|FG000|Overall Study|Disease progression|2|||
25157325|NCT01737398|50274005|FG001|Overall Study|Disease progression|3|||
25157326|NCT01737398|50274004|FG000|Overall Study|Sponsor's decision|2|||
25157327|NCT01737398|50274005|FG001|Overall Study|Sponsor's decision|0|||
25157328|NCT01795898|50274014|FG000|Overall Study|Adverse Event|27|||
25157329|NCT01795898|50274014|FG000|Overall Study|Lost to Follow-up|20|||
25157330|NCT01795898|50274014|FG000|Overall Study|Withdrawal of consent|6|||
25157331|NCT01795898|50274014|FG000|Overall Study|Diagnosed with metastasis|1|||
25157332|NCT01795898|50274014|FG000|Overall Study|No pain|1|||
25157333|NCT01795898|50274014|FG000|Overall Study|Death|1|||
24937783|NCT00340834|50030850|FG001|Extension Phase of Study|Adverse Event|22|||
25028672|NCT01064414|50126916|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
25028673|NCT01064414|50126917|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
25157334|NCT01795898|50274014|FG000|Overall Study|Withdrew consent & had adverse events|3|||
24937784|NCT00340834|50030851|FG002|Extension Phase of Study|Adverse Event|0|||
24937785|NCT00340834|50030852|FG003|Extension Phase of Study|Adverse Event|19|||
24937786|NCT00340834|50030853|FG004|Extension Phase of Study|Adverse Event|7|||
24937787|NCT00340834|50030849|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
24937788|NCT00340834|50030850|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
24937789|NCT00340834|50030851|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
24937790|NCT00340834|50030852|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
25157335|NCT01795898|50274014|FG000|Overall Study|Physician Decision|1|||
25157336|NCT01736696|50274025|FG000|Overall Study|Withdrawal by Subject|0|||
25157337|NCT01736696|50274026|FG001|Overall Study|Withdrawal by Subject|0|||
25157338|NCT01736696|50274027|FG002|Overall Study|Withdrawal by Subject|1|||
25157339|NCT01736696|50274028|FG003|Overall Study|Withdrawal by Subject|0|||
25157340|NCT01736696|50274029|FG004|Overall Study|Withdrawal by Subject|0|||
24937791|NCT00340834|50030853|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
24937792|NCT00340834|50030849|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
24937793|NCT00340834|50030850|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
24937794|NCT00340834|50030851|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
24937795|NCT00340834|50030852|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
24937796|NCT00340834|50030853|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
24937797|NCT00340834|50030849|FG000|Extension Phase of Study|Lost to Follow-up|1|||
24937798|NCT00340834|50030850|FG001|Extension Phase of Study|Lost to Follow-up|1|||
24937799|NCT00340834|50030851|FG002|Extension Phase of Study|Lost to Follow-up|0|||
24937800|NCT00340834|50030852|FG003|Extension Phase of Study|Lost to Follow-up|2|||
24937801|NCT00340834|50030853|FG004|Extension Phase of Study|Lost to Follow-up|3|||
24937802|NCT00340834|50030849|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
24937803|NCT00340834|50030850|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
24937804|NCT00340834|50030851|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
25028674|NCT01064414|50126915|FG000|Extension Period: Week 26 to Week 52|Death|0|||
25028675|NCT01064414|50126916|FG001|Extension Period: Week 26 to Week 52|Death|1|||
25028676|NCT01064414|50126917|FG002|Extension Period: Week 26 to Week 52|Death|0|||
25028677|NCT01064414|50126915|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
25157341|NCT01736696|50274030|FG005|Overall Study|Withdrawal by Subject|0|||
25157342|NCT01736696|50274031|FG006|Overall Study|Withdrawal by Subject|0|||
25157343|NCT01736540|50274055|FG000|Overall Study|Did not complete scan within 45 days|2|||
24937805|NCT00340834|50030852|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
24937806|NCT00340834|50030853|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
25028678|NCT01064414|50126916|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
25028679|NCT01064414|50126917|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
25028680|NCT01064414|50126915|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
25028681|NCT01064414|50126916|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
25028682|NCT01064414|50126917|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
25028683|NCT01064414|50126915|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
25028684|NCT01064414|50126916|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
25028685|NCT01064414|50126917|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
25028686|NCT01064414|50126915|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
25028687|NCT01064414|50126916|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
25028688|NCT01064414|50126917|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
25028689|NCT01064414|50126915|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
25028690|NCT01064414|50126916|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
25028691|NCT01064414|50126917|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
24937807|NCT00340834|50030849|FG000|Extension Phase of Study|Administrative problems|3|||
24937808|NCT00340834|50030850|FG001|Extension Phase of Study|Administrative problems|0|||
24937809|NCT00340834|50030851|FG002|Extension Phase of Study|Administrative problems|0|||
24937810|NCT00340834|50030852|FG003|Extension Phase of Study|Administrative problems|1|||
24937811|NCT00340834|50030853|FG004|Extension Phase of Study|Administrative problems|1|||
24937812|NCT00340834|50030849|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
25157344|NCT01736540|50274055|FG000|Overall Study|Death|1|||
25157345|NCT01736540|50274055|FG000|Overall Study|Abnormal test procedure|1|||
25157346|NCT01736540|50274055|FG000|Overall Study|Withdrawal by Subject|5|||
25157347|NCT01736540|50274055|FG000|Overall Study|Protocol Violation|1|||
25157348|NCT01736540|50274055|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
25157349|NCT01736540|50274055|FG000|Overall Study|No show for MRI appointment|1|||
25157350|NCT01736540|50274055|FG000|Overall Study|Unable to make MRI appointment|3|||
25157351|NCT01794338|50274068|FG000|Overall Study|Death|2|||
25157352|NCT01794338|50274069|FG001|Overall Study|Death|0|||
25157353|NCT01794338|50274068|FG000|Overall Study|Lost to Follow-up|6|||
25157354|NCT01794338|50274069|FG001|Overall Study|Lost to Follow-up|9|||
25186101|NCT01474538|50335970|FG001|Treatment Period 1|Death|0|||
24937813|NCT00340834|50030850|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
24937814|NCT00340834|50030851|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
24937815|NCT00340834|50030852|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
24937816|NCT00340834|50030853|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
24937817|NCT00340834|50030849|FG000|Extension Phase of Study|Protocol Violation|3|||
24937818|NCT00340834|50030850|FG001|Extension Phase of Study|Protocol Violation|0|||
24937819|NCT00340834|50030851|FG002|Extension Phase of Study|Protocol Violation|0|||
24937820|NCT00340834|50030852|FG003|Extension Phase of Study|Protocol Violation|0|||
24937821|NCT00340834|50030853|FG004|Extension Phase of Study|Protocol Violation|0|||
24937822|NCT00340834|50030849|FG000|Extension Phase of Study|Death|0|||
24937823|NCT00340834|50030850|FG001|Extension Phase of Study|Death|0|||
24937824|NCT00340834|50030851|FG002|Extension Phase of Study|Death|0|||
24937825|NCT00340834|50030852|FG003|Extension Phase of Study|Death|0|||
24937826|NCT00340834|50030853|FG004|Extension Phase of Study|Death|1|||
24937827|NCT00603941|50030866|FG000|Overall Study|Disease progression|6|||
24937828|NCT00603941|50030867|FG001|Overall Study|Disease progression|7|||
24937829|NCT00603941|50030868|FG002|Overall Study|Disease progression|1|||
24937830|NCT00603941|50030866|FG000|Overall Study|Adverse Event|1|||
24937831|NCT00603941|50030867|FG001|Overall Study|Adverse Event|0|||
24937832|NCT00603941|50030868|FG002|Overall Study|Adverse Event|1|||
24937833|NCT00603941|50030866|FG000|Overall Study|Physician Decision|0|||
24937834|NCT00603941|50030867|FG001|Overall Study|Physician Decision|1|||
24937835|NCT00603941|50030868|FG002|Overall Study|Physician Decision|0|||
24937836|NCT00603941|50030866|FG000|Overall Study|Withdrawal by Subject|0|||
24937837|NCT00603941|50030867|FG001|Overall Study|Withdrawal by Subject|2|||
24937838|NCT00603941|50030868|FG002|Overall Study|Withdrawal by Subject|0|||
24937839|NCT00340678|50030881|FG000|Overall Study|Lost to Follow-up|1|||
24937840|NCT00340678|50030882|FG001|Overall Study|Lost to Follow-up|0|||
24937841|NCT00340678|50030883|FG002|Overall Study|Lost to Follow-up|0|||
24937842|NCT00340678|50030884|FG003|Overall Study|Lost to Follow-up|0|||
24937843|NCT00336544|50030894|FG000|Overall Study|Lack of Efficacy|8|||
24937844|NCT00336544|50030895|FG001|Overall Study|Lack of Efficacy|5|||
24937845|NCT00336544|50030894|FG000|Overall Study|Adverse Event|4|||
24937846|NCT00336544|50030895|FG001|Overall Study|Adverse Event|9|||
24937847|NCT00336544|50030894|FG000|Overall Study|Withdrawal by Subject|4|||
24937848|NCT00336544|50030895|FG001|Overall Study|Withdrawal by Subject|3|||
24937849|NCT00336544|50030894|FG000|Overall Study|Other|3|||
24937850|NCT00336544|50030895|FG001|Overall Study|Other|5|||
24937851|NCT00605033|50030903|FG000|Overall Study|Adverse Event|2|||
24937852|NCT00605033|50030904|FG001|Overall Study|Adverse Event|2|||
25157355|NCT01609478|50274078|FG000|Overall Study|Adverse Event|3|||
25157356|NCT01609478|50274079|FG001|Overall Study|Adverse Event|1|||
25157357|NCT01609478|50274080|FG002|Overall Study|Adverse Event|5|||
25157358|NCT01609478|50274078|FG000|Overall Study|Protocol Deviation|0|||
25157359|NCT01609478|50274079|FG001|Overall Study|Protocol Deviation|1|||
24937853|NCT00605033|50030903|FG000|Overall Study|Lost to Follow-up|1|||
25157360|NCT01609478|50274080|FG002|Overall Study|Protocol Deviation|1|||
25157361|NCT01609478|50274078|FG000|Overall Study|Non-Compliance with study treatment|1|||
24937854|NCT00605033|50030904|FG001|Overall Study|Lost to Follow-up|1|||
24937855|NCT00605033|50030903|FG000|Overall Study|Withdrawal by Subject|3|||
24937856|NCT00605033|50030904|FG001|Overall Study|Withdrawal by Subject|4|||
24937857|NCT00605033|50030903|FG000|Overall Study|Protocol Violation|1|||
24937858|NCT00605033|50030904|FG001|Overall Study|Protocol Violation|1|||
24937859|NCT00339040|50030912|FG000|Stage I|Not able to attend clinic|1|||
24937860|NCT00339040|50030913|FG001|Stage I|Not able to attend clinic|0|||
24937861|NCT00339040|50030912|FG000|Stage I|Protocol Violation|1|||
24937862|NCT00339040|50030913|FG001|Stage I|Protocol Violation|1|||
24937863|NCT00339040|50030912|FG000|Stage II|Lost to Follow-up|3|||
24937864|NCT00339040|50030913|FG001|Stage II|Lost to Follow-up|0|||
24937865|NCT00339040|50030912|FG000|Stage II|Withdrawal by Subject|1|||
24937866|NCT00339040|50030913|FG001|Stage II|Withdrawal by Subject|2|||
24937867|NCT00339040|50030912|FG000|Stage II|Protocol Violation|3|||
24937868|NCT00339040|50030913|FG001|Stage II|Protocol Violation|0|||
24937869|NCT00339040|50030912|FG000|Stage II|Not able to attend clinic|1|||
24937870|NCT00339040|50030913|FG001|Stage II|Not able to attend clinic|0|||
24937871|NCT00339040|50030912|FG000|Stage II|Site closing|2|||
24937872|NCT00339040|50030913|FG001|Stage II|Site closing|0|||
24937873|NCT00338962|50030923|FG000|Overall Study|Lost to Follow-up|3|||
24937874|NCT00338962|50030924|FG001|Overall Study|Lost to Follow-up|3|||
24937875|NCT00338962|50030925|FG002|Overall Study|Lost to Follow-up|2|||
24937876|NCT00338962|50030926|FG003|Overall Study|Lost to Follow-up|3|||
24937877|NCT00338962|50030923|FG000|Overall Study|Withdrawal by Subject|1|||
24937878|NCT00338962|50030924|FG001|Overall Study|Withdrawal by Subject|0|||
24937879|NCT00338962|50030925|FG002|Overall Study|Withdrawal by Subject|0|||
24937880|NCT00338962|50030926|FG003|Overall Study|Withdrawal by Subject|0|||
24937881|NCT00338962|50030923|FG000|Overall Study|No Transportation|2|||
24937882|NCT00338962|50030924|FG001|Overall Study|No Transportation|0|||
24937883|NCT00338962|50030925|FG002|Overall Study|No Transportation|0|||
24937884|NCT00338962|50030926|FG003|Overall Study|No Transportation|0|||
24937885|NCT00338962|50030923|FG000|Overall Study|Time Constraint|2|||
24937886|NCT00338962|50030924|FG001|Overall Study|Time Constraint|0|||
24937887|NCT00338962|50030925|FG002|Overall Study|Time Constraint|0|||
24937888|NCT00338962|50030926|FG003|Overall Study|Time Constraint|0|||
24937889|NCT00338962|50030923|FG000|Overall Study|Moved|0|||
24937890|NCT00338962|50030924|FG001|Overall Study|Moved|1|||
24937891|NCT00338962|50030925|FG002|Overall Study|Moved|0|||
24937892|NCT00338962|50030926|FG003|Overall Study|Moved|0|||
24937893|NCT00338962|50030923|FG000|Overall Study|Adverse Event|0|||
24937894|NCT00338962|50030924|FG001|Overall Study|Adverse Event|0|||
24937895|NCT00338962|50030925|FG002|Overall Study|Adverse Event|2|||
24937896|NCT00338962|50030926|FG003|Overall Study|Adverse Event|0|||
24937897|NCT00338962|50030923|FG000|Overall Study|Poor Compliance|0|||
24937898|NCT00338962|50030924|FG001|Overall Study|Poor Compliance|0|||
24937899|NCT00338962|50030925|FG002|Overall Study|Poor Compliance|2|||
24937900|NCT00338962|50030926|FG003|Overall Study|Poor Compliance|0|||
24937901|NCT00568061|50030938|FG000|Overall Study|Inclusion / exclusion criteria|5|||
24937902|NCT00568061|50030939|FG001|Overall Study|Inclusion / exclusion criteria|1|||
24937903|NCT00568061|50030938|FG000|Overall Study|Adverse Event|0|||
24937904|NCT00568061|50030939|FG001|Overall Study|Adverse Event|1|||
24937905|NCT00338884|50030946|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
24937906|NCT00338884|50030946|FG000|Overall Study|Adverse Event|14|||
24937907|NCT00338884|50030946|FG000|Overall Study|Death|8|||
24937908|NCT00338884|50030946|FG000|Overall Study|Other|4|||
24937909|NCT00338884|50030946|FG000|Overall Study|Global Deterioration of Health Status|3|||
24937910|NCT00338884|50030946|FG000|Overall Study|Withdrawal by Subject|3|||
24937911|NCT00338884|50030946|FG000|Overall Study|Lost to Follow-up|1|||
24937912|NCT00338884|50030946|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
24937913|NCT00338806|50030952|FG000|Acute Phase|Withdrawal by Subject|0|||
24937914|NCT00338806|50030953|FG001|Acute Phase|Withdrawal by Subject|1|||
24937915|NCT00338806|50030952|FG000|Follow-up|Lost to Follow-up|1|||
24937916|NCT00338806|50030953|FG001|Follow-up|Lost to Follow-up|3|||
24937917|NCT03038100|50030963|FG000|Overall Study|Death|289|||
24937918|NCT03038100|50030964|FG001|Overall Study|Death|272|||
24937919|NCT03038100|50030963|FG000|Overall Study|Lost to Follow-up|9|||
24937920|NCT03038100|50030964|FG001|Overall Study|Lost to Follow-up|10|||
24937921|NCT03038100|50030963|FG000|Overall Study|Protocol Deviation|1|||
24937922|NCT03038100|50030964|FG001|Overall Study|Protocol Deviation|4|||
24937923|NCT03038100|50030963|FG000|Overall Study|Withdrawal by Subject|45|||
24937924|NCT03038100|50030964|FG001|Overall Study|Withdrawal by Subject|51|||
24937925|NCT03038100|50030963|FG000|Overall Study|Study Terminated By Sponsor|305|||
25028692|NCT01064414|50126915|FG000|Extension Period: Week 26 to Week 52|Other|5|||
25028693|NCT01064414|50126916|FG001|Extension Period: Week 26 to Week 52|Other|2|||
25028694|NCT01064414|50126917|FG002|Extension Period: Week 26 to Week 52|Other|1|||
25028695|NCT03433703|50126928|FG000|Overall Study|Study terminated by Sponsor|2|||
25028696|NCT03463031|50126938|FG000|Overall Study|Withdrawal by Subject|4|||
25028697|NCT03463031|50126939|FG001|Overall Study|Withdrawal by Subject|2|||
25028698|NCT03463031|50126938|FG000|Overall Study|Investigator/Sponsor Decision|0|||
25028699|NCT03463031|50126939|FG001|Overall Study|Investigator/Sponsor Decision|1|||
25028700|NCT03463031|50126938|FG000|Overall Study|Lost to Follow-up|1|||
25028701|NCT03463031|50126939|FG001|Overall Study|Lost to Follow-up|1|||
24937926|NCT03038100|50030964|FG001|Overall Study|Study Terminated By Sponsor|311|||
24937927|NCT03038100|50030963|FG000|Overall Study|Physician Decision|1|||
24937928|NCT03038100|50030964|FG001|Overall Study|Physician Decision|3|||
24937929|NCT00338728|50030971|FG000|Overall Study|Screen Failure|14|||
24937930|NCT00336856|50030975|FG000|Overall Study|Withdrawal by Subject|3|||
25028702|NCT03463031|50126938|FG000|Overall Study|Adverse Event|4|||
25028703|NCT03463031|50126939|FG001|Overall Study|Adverse Event|1|||
25028704|NCT03463031|50126938|FG000|Overall Study|Use of prohibited medication by subject|1|||
25028705|NCT03463031|50126939|FG001|Overall Study|Use of prohibited medication by subject|0|||
25028706|NCT03462641|50126947|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
25028707|NCT03462641|50126948|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
25028708|NCT03462641|50126947|FG000|Visit 2|Withdrawal by Subject|0|||
25028709|NCT03462641|50126948|FG001|Visit 2|Withdrawal by Subject|1|||
25028710|NCT02974634|50126958|FG000|Overall Study|Advanced disease|12|||
25028711|NCT02974634|50126959|FG001|Overall Study|Advanced disease|3|||
25028712|NCT02974634|50126958|FG000|Overall Study|Noncompliance|3|||
25028713|NCT02974634|50126959|FG001|Overall Study|Noncompliance|7|||
25028714|NCT02974634|50126958|FG000|Overall Study|intervention technology related issues|5|||
25028715|NCT02974634|50126959|FG001|Overall Study|intervention technology related issues|0|||
25028716|NCT02974634|50126958|FG000|Overall Study|Death|8|||
25028717|NCT02974634|50126959|FG001|Overall Study|Death|11|||
25028718|NCT01060670|50126968|FG000|Run In|screen failure|0|||
25028719|NCT01060670|50126969|FG001|Run In|screen failure|238|||
25028720|NCT02971670|50126981|FG000|Overall Study|Withdrawal by Subject|4|||
25028721|NCT02971670|50126982|FG001|Overall Study|Withdrawal by Subject|1|||
25028722|NCT02971670|50126983|FG002|Overall Study|Withdrawal by Subject|1|||
25028723|NCT02971670|50126984|FG003|Overall Study|Withdrawal by Subject|2|||
25028724|NCT02971202|50126997|FG000|Overall Study|Pregnancy|1|||
25028725|NCT02971202|50126998|FG001|Overall Study|Pregnancy|0|||
25028726|NCT02971202|50126999|FG002|Overall Study|Pregnancy|0|||
25028727|NCT02971202|50126997|FG000|Overall Study|screen fail after consent|1|||
25028728|NCT02971202|50126998|FG001|Overall Study|screen fail after consent|0|||
25028729|NCT02971202|50126999|FG002|Overall Study|screen fail after consent|1|||
25028730|NCT02926638|50127009|FG000|Overall Study|Progression|2|||
25028731|NCT02926638|50127010|FG001|Overall Study|Progression|5|||
25028732|NCT02926638|50127009|FG000|Overall Study|Ineligible|1|||
25028733|NCT02926638|50127010|FG001|Overall Study|Ineligible|0|||
25028734|NCT02926638|50127009|FG000|Overall Study|Not protocol specified|1|||
25028735|NCT02926638|50127010|FG001|Overall Study|Not protocol specified|0|||
25028736|NCT02903030|50127018|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
25028737|NCT02903030|50127019|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
25028738|NCT02969408|50127028|FG000|Overall Study|Adverse Event|2|||
25028739|NCT02969408|50127028|FG000|Overall Study|Withdrawal by Subject|8|||
25028740|NCT02969408|50127028|FG000|Overall Study|Lost to Follow-up|4|||
25028741|NCT02969408|50127028|FG000|Overall Study|Protocol Violation|1|||
25028742|NCT02969408|50127028|FG000|Overall Study|Other than specified|1|||
25028743|NCT03462563|50127034|FG000|Overall Study|Death|1|||
25028744|NCT03462563|50127035|FG001|Overall Study|Death|1|||
25028745|NCT03462563|50127034|FG000|Overall Study|Termination of study|2|||
25028746|NCT03462563|50127035|FG001|Overall Study|Termination of study|1|||
25028747|NCT03462563|50127034|FG000|Overall Study|Adverse Event|1|||
25028748|NCT03462563|50127035|FG001|Overall Study|Adverse Event|3|||
25028749|NCT03462563|50127034|FG000|Overall Study|Unspecified reason|10|||
25028750|NCT03462563|50127035|FG001|Overall Study|Unspecified reason|12|||
25028751|NCT03462563|50127034|FG000|Overall Study|Physician Decision|1|||
25028752|NCT03462563|50127035|FG001|Overall Study|Physician Decision|0|||
25028753|NCT01060124|50127041|FG000|Overall Study|Other|16|||
25028754|NCT01060124|50127041|FG000|Overall Study|Adverse Event|14|||
25028755|NCT01060124|50127041|FG000|Overall Study|Withdrawal by Subject|7|||
25028756|NCT03461003|50127047|FG000|Overall Study|Lost to Follow-up|2|||
25028757|NCT03461003|50127048|FG001|Overall Study|Lost to Follow-up|2|||
25028758|NCT03461003|50127047|FG000|Overall Study|Withdrawal by Subject|3|||
25157362|NCT01609478|50274079|FG001|Overall Study|Non-Compliance with study treatment|0|||
25028759|NCT03461003|50127048|FG001|Overall Study|Withdrawal by Subject|1|||
25028760|NCT02904902|50127054|FG000|Overall Study|Withdrawal by Subject|1|||
25028761|NCT04425720|50127060|FG000|Overall Study|Withdrawal by Subject|0|||
25028762|NCT04425720|50127061|FG001|Overall Study|Withdrawal by Subject|20|||
25028763|NCT03459443|50127068|FG000|Overall Study|Lack of Efficacy|3|||
25028764|NCT03459443|50127068|FG000|Overall Study|Adverse Event|1|||
25028765|NCT03459443|50127068|FG000|Overall Study|Sponsor's decision to close the study|18|||
25028766|NCT02904512|50127074|FG000|Overall Study|Withdrawal by Subject|1|||
25028767|NCT02904512|50127075|FG001|Overall Study|Withdrawal by Subject|0|||
25028768|NCT02904512|50127074|FG000|Overall Study|Transferred to ICU|1|||
25028769|NCT02904512|50127075|FG001|Overall Study|Transferred to ICU|0|||
25028770|NCT02904512|50127074|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
25028771|NCT02904512|50127075|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
25028772|NCT02904200|50127081|FG000|Overall Study|Withdrawal by Subject|1|||
24937931|NCT00336856|50030975|FG000|Overall Study|Found ineligible at time of analysis|1|||
24937932|NCT00566501|50030981|FG000|Overall Study|Adverse Event|68|||
24937933|NCT00566501|50030982|FG001|Overall Study|Adverse Event|59|||
24937934|NCT00566501|50030981|FG000|Overall Study|Medication Non-compliance|5|||
24937935|NCT00566501|50030982|FG001|Overall Study|Medication Non-compliance|0|||
24937936|NCT00566501|50030981|FG000|Overall Study|Protocol Violation|2|||
24937937|NCT00566501|50030982|FG001|Overall Study|Protocol Violation|2|||
25157363|NCT01609478|50274080|FG002|Overall Study|Non-Compliance with study treatment|0|||
25157364|NCT01609478|50274078|FG000|Overall Study|Physician Decision|1|||
25157365|NCT01609478|50274079|FG001|Overall Study|Physician Decision|0|||
25157366|NCT01609478|50274080|FG002|Overall Study|Physician Decision|1|||
25157367|NCT01609478|50274078|FG000|Overall Study|Withdrawal by Subject|2|||
25157368|NCT01609478|50274079|FG001|Overall Study|Withdrawal by Subject|0|||
25157369|NCT01609478|50274080|FG002|Overall Study|Withdrawal by Subject|2|||
25157370|NCT01764854|50274092|FG000|Overall Study|Adverse Event|0|||
25157371|NCT01764854|50274093|FG001|Overall Study|Adverse Event|0|||
25157372|NCT01764854|50274094|FG002|Overall Study|Adverse Event|2|||
25157373|NCT01764854|50274095|FG003|Overall Study|Adverse Event|0|||
25157374|NCT01764854|50274092|FG000|Overall Study|Withdrawal by Subject|0|||
25157375|NCT01764854|50274093|FG001|Overall Study|Withdrawal by Subject|0|||
25157376|NCT01764854|50274094|FG002|Overall Study|Withdrawal by Subject|1|||
25157377|NCT01764854|50274095|FG003|Overall Study|Withdrawal by Subject|0|||
25157378|NCT01764854|50274092|FG000|Overall Study|relocation|0|||
25157379|NCT01764854|50274093|FG001|Overall Study|relocation|0|||
25157380|NCT01764854|50274094|FG002|Overall Study|relocation|2|||
24937938|NCT00566501|50030981|FG000|Overall Study|Request of Investigator or Sponsor|6|||
24937939|NCT00566501|50030982|FG001|Overall Study|Request of Investigator or Sponsor|7|||
25028773|NCT02904200|50127082|FG001|Overall Study|Withdrawal by Subject|0|||
25028774|NCT03432533|50127088|FG000|Overall Study|Lost to Follow-up|1|||
25028775|NCT03432533|50127089|FG001|Overall Study|Lost to Follow-up|2|||
25028776|NCT03432533|50127088|FG000|Overall Study|Withdrawal by Subject|14|||
25028777|NCT03432533|50127089|FG001|Overall Study|Withdrawal by Subject|9|||
25028778|NCT02901548|50127095|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
25028779|NCT02903966|50127101|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
25028780|NCT02903966|50127102|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
25028781|NCT02903966|50127101|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
25028782|NCT02903966|50127102|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
25028783|NCT02903966|50127101|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
25028784|NCT02903966|50127102|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
25028785|NCT03457727|50127118|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
25028786|NCT03457727|50127119|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
24937940|NCT00566501|50030981|FG000|Overall Study|Withdrawal by Subject|33|||
24937941|NCT00566501|50030982|FG001|Overall Study|Withdrawal by Subject|30|||
25028787|NCT03457727|50127120|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
25028788|NCT03457727|50127121|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
25028789|NCT03431441|50127153|FG000|Overall Study|Withdrawal by Subject|2|||
25028790|NCT03431441|50127153|FG000|Overall Study|Adverse Event|2|||
25028791|NCT03431441|50127153|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
25157381|NCT01764854|50274095|FG003|Overall Study|relocation|0|||
24937942|NCT00566501|50030981|FG000|Overall Study|Lack of Efficacy|8|||
25157382|NCT01764854|50274092|FG000|Overall Study|Protocol Violation|0|||
25157383|NCT01764854|50274093|FG001|Overall Study|Protocol Violation|0|||
24937943|NCT00566501|50030982|FG001|Overall Study|Lack of Efficacy|3|||
25186102|NCT01474538|50335969|FG000|Treatment Period 1|Physician Decision|1|||
25028792|NCT03457103|50127159|FG000|Overall Study|illness/hospitalization|4|||
25028793|NCT03457103|50127160|FG001|Overall Study|illness/hospitalization|2|||
25028794|NCT03457103|50127159|FG000|Overall Study|Lost to Follow-up|2|||
25028795|NCT03457103|50127160|FG001|Overall Study|Lost to Follow-up|1|||
25028796|NCT03457103|50127159|FG000|Overall Study|Withdrawal by Subject|1|||
25028797|NCT03457103|50127160|FG001|Overall Study|Withdrawal by Subject|2|||
25028798|NCT03457103|50127159|FG000|Overall Study|financial/ insurance issues|1|||
25028799|NCT03457103|50127160|FG001|Overall Study|financial/ insurance issues|1|||
24937944|NCT00566501|50030981|FG000|Overall Study|Other|25|||
24937945|NCT00566501|50030982|FG001|Overall Study|Other|21|||
24937946|NCT00504894|50030991|FG000|Overall Study|fMRI technical problems|1|||
24937947|NCT00504894|50030992|FG001|Overall Study|fMRI technical problems|1|||
24937948|NCT00504894|50030993|FG002|Overall Study|fMRI technical problems|0|||
24937949|NCT00504894|50030991|FG000|Overall Study|Withdrawal by Subject|0|||
24937950|NCT00504894|50030992|FG001|Overall Study|Withdrawal by Subject|1|||
24937951|NCT00504894|50030993|FG002|Overall Study|Withdrawal by Subject|0|||
24937952|NCT00504894|50030991|FG000|Overall Study|Infusion technical problems|0|||
24937953|NCT00504894|50030992|FG001|Overall Study|Infusion technical problems|1|||
24937954|NCT00504894|50030993|FG002|Overall Study|Infusion technical problems|0|||
24937955|NCT00504894|50030991|FG000|Overall Study|poor subject data|2|||
24937956|NCT00504894|50030992|FG001|Overall Study|poor subject data|0|||
24937957|NCT00504894|50030993|FG002|Overall Study|poor subject data|0|||
24937958|NCT00513240|50031003|FG000|Overall Study|Did not have intended surgery|3|||
24937959|NCT00513240|50031004|FG001|Overall Study|Did not have intended surgery|0|||
24937960|NCT00513240|50031003|FG000|Overall Study|Death|3|||
24937961|NCT00513240|50031004|FG001|Overall Study|Death|3|||
24937962|NCT00513240|50031003|FG000|Overall Study|Withdrawal by Subject|7|||
24937963|NCT00513240|50031004|FG001|Overall Study|Withdrawal by Subject|4|||
24937964|NCT00504426|50031017|FG000|Overall Study|Adverse Event|0|||
24937965|NCT00504426|50031018|FG001|Overall Study|Adverse Event|0|||
24937966|NCT00504426|50031019|FG002|Overall Study|Adverse Event|2|||
24937967|NCT00504426|50031020|FG003|Overall Study|Adverse Event|0|||
24937968|NCT00504426|50031017|FG000|Overall Study|Protocol Violation|1|||
24937969|NCT00504426|50031018|FG001|Overall Study|Protocol Violation|1|||
24937970|NCT00504426|50031019|FG002|Overall Study|Protocol Violation|2|||
24937971|NCT00504426|50031020|FG003|Overall Study|Protocol Violation|0|||
24937972|NCT00504426|50031017|FG000|Overall Study|Withdrawal by Subject|2|||
24937973|NCT00504426|50031018|FG001|Overall Study|Withdrawal by Subject|0|||
24937974|NCT00504426|50031019|FG002|Overall Study|Withdrawal by Subject|0|||
24937975|NCT00504426|50031020|FG003|Overall Study|Withdrawal by Subject|0|||
24937976|NCT00504348|50031033|FG000|Overall Study|Adverse Event|3|||
24937977|NCT00504348|50031033|FG000|Overall Study|Lack of Efficacy|4|||
24937978|NCT00504348|50031033|FG000|Overall Study|Physician Decision|1|||
24937979|NCT00507546|50031039|FG000|Overall Study|Withdrawal by Subject|1|||
24937980|NCT00507546|50031040|FG001|Overall Study|Withdrawal by Subject|0|||
24937981|NCT00507546|50031039|FG000|Overall Study|Protocol Violation|1|||
24937982|NCT00507546|50031040|FG001|Overall Study|Protocol Violation|0|||
24937983|NCT00507546|50031039|FG000|Overall Study|Physician Decision|0|||
24937984|NCT00507546|50031040|FG001|Overall Study|Physician Decision|1|||
24937985|NCT00567593|50031048|FG000|Overall Study|Adverse Event|1|||
24937986|NCT00567593|50031048|FG000|Overall Study|Physician Decision|1|||
24937987|NCT00335764|50031057|FG000|Overall Study|wrong histology|1|||
24937988|NCT00335764|50031058|FG001|Overall Study|wrong histology|0|||
24937989|NCT00335764|50031059|FG002|Overall Study|wrong histology|0|||
24937990|NCT00335764|50031060|FG003|Overall Study|wrong histology|0|||
24937991|NCT00335764|50031061|FG004|Overall Study|wrong histology|1|||
24937992|NCT00567359|50031097|FG000|Overall Study|Withdrawal by Subject|1|||
25028800|NCT03455543|50127168|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
24937993|NCT00492726|50031103|FG000|Overall Study|Adverse Event|10|||
24937994|NCT00492726|50031104|FG001|Overall Study|Adverse Event|6|||
24937995|NCT00492726|50031103|FG000|Overall Study|Death|7|||
24937996|NCT00492726|50031104|FG001|Overall Study|Death|2|||
24937997|NCT00492726|50031103|FG000|Overall Study|Lack of Efficacy|0|||
24937998|NCT00492726|50031104|FG001|Overall Study|Lack of Efficacy|2|||
24937999|NCT00492726|50031103|FG000|Overall Study|Lost to Follow-up|27|||
24938000|NCT00492726|50031104|FG001|Overall Study|Lost to Follow-up|19|||
24938001|NCT00492726|50031103|FG000|Overall Study|Physician Decision|0|||
24938002|NCT00492726|50031104|FG001|Overall Study|Physician Decision|1|||
24938003|NCT00492726|50031103|FG000|Overall Study|Withdrawal by Subject|6|||
25028801|NCT03455543|50127169|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
25028802|NCT03455543|50127170|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
25028803|NCT03455543|50127168|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
25028804|NCT03455543|50127169|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
25028805|NCT03455543|50127170|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
25028806|NCT03455543|50127168|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
25028807|NCT03455543|50127169|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
25028808|NCT03455543|50127170|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
25028809|NCT03455543|50127168|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
25028810|NCT03455543|50127169|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
25028811|NCT03455543|50127170|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
25028812|NCT03455543|50127168|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
25028813|NCT03455543|50127169|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
25028814|NCT03455543|50127170|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
25028815|NCT03455543|50127168|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
25028816|NCT03455543|50127169|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
25028817|NCT03455543|50127170|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
25028818|NCT03455543|50127168|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
25028819|NCT03455543|50127169|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
25028820|NCT03455543|50127170|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
25028821|NCT03455543|50127168|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
25028822|NCT03455543|50127169|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
25028823|NCT03455543|50127170|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
25028824|NCT03455543|50127168|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
25028825|NCT03455543|50127169|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
25157384|NCT01764854|50274094|FG002|Overall Study|Protocol Violation|1|||
25157385|NCT01764854|50274095|FG003|Overall Study|Protocol Violation|2|||
25157386|NCT01764464|50274107|FG000|First Intervention|Withdrawal by Subject|1|||
25157387|NCT01764464|50274108|FG001|First Intervention|Withdrawal by Subject|0|||
25157388|NCT01764464|50274107|FG000|First Intervention|Lost to Follow-up|1|||
25157389|NCT01764464|50274108|FG001|First Intervention|Lost to Follow-up|0|||
25157390|NCT01764464|50274107|FG000|First Intervention|Adverse Event|0|||
25157391|NCT01764464|50274108|FG001|First Intervention|Adverse Event|2|||
25028826|NCT03455543|50127170|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
25028827|NCT03068754|50127180|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
25028828|NCT03068754|50127181|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
25028829|NCT03068754|50127182|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
25028830|NCT03068754|50127183|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
25028831|NCT03068754|50127180|FG000|Randomized Treatment Period (RTP)|Death|2|||
25028832|NCT03068754|50127181|FG001|Randomized Treatment Period (RTP)|Death|2|||
25028833|NCT03068754|50127182|FG002|Randomized Treatment Period (RTP)|Death|0|||
25028834|NCT03068754|50127183|FG003|Randomized Treatment Period (RTP)|Death|0|||
25028835|NCT03068754|50127180|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
25028836|NCT03068754|50127181|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
25028837|NCT03068754|50127182|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
25028838|NCT03068754|50127183|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
25028839|NCT03068754|50127180|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
25028840|NCT03068754|50127181|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
25028841|NCT03068754|50127182|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
25028842|NCT03068754|50127183|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
25157392|NCT01764464|50274107|FG000|First Intervention|did not receive study drug|0|||
25157393|NCT01764464|50274108|FG001|First Intervention|did not receive study drug|1|||
25157394|NCT01764464|50274107|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
25157395|NCT01764464|50274108|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
24938004|NCT00492726|50031104|FG001|Overall Study|Withdrawal by Subject|3|||
24938005|NCT00492726|50031103|FG000|Overall Study|Non compliant with study medication|0|||
25028843|NCT03068754|50127180|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
25028844|NCT03068754|50127181|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
25028845|NCT03068754|50127182|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
25028846|NCT03068754|50127183|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
25028847|NCT03068754|50127180|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
25028848|NCT03068754|50127181|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
25028849|NCT03068754|50127182|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
25028850|NCT03068754|50127183|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
24938006|NCT00492726|50031104|FG001|Overall Study|Non compliant with study medication|3|||
24938007|NCT00309946|50031110|FG000|Overall Study|Withdrawal by Subject|1|||
24938008|NCT00492648|50031116|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
24938009|NCT00492648|50031117|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
24938010|NCT00506922|50031128|FG000|Overall Study|Physician Decision|0|||
24938011|NCT00506922|50031129|FG001|Overall Study|Physician Decision|0|||
24938012|NCT00506922|50031130|FG002|Overall Study|Physician Decision|0|||
24938013|NCT00506922|50031131|FG003|Overall Study|Physician Decision|2|||
24938014|NCT00506922|50031132|FG004|Overall Study|Physician Decision|0|||
24938015|NCT00506922|50031128|FG000|Overall Study|Withdrawal by Subject|0|||
25157396|NCT01764386|50274116|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
25157397|NCT01764386|50274117|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
25157398|NCT01764386|50274116|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
25157399|NCT01764386|50274117|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
25157400|NCT01764386|50274116|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
25157401|NCT01764386|50274117|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
25157402|NCT01764386|50274116|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
25157403|NCT01764386|50274117|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
25157404|NCT01764386|50274116|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
25157405|NCT01764386|50274117|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
25157406|NCT01764386|50274116|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
25157407|NCT01764386|50274117|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
25157408|NCT01764386|50274116|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
25157409|NCT01764386|50274117|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
25157410|NCT01764386|50274116|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
25157411|NCT01764386|50274117|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
25157412|NCT01763918|50274128|FG000|Overall Study|Withdrawal by Subject|2|||
25157413|NCT01763918|50274129|FG001|Overall Study|Withdrawal by Subject|1|||
25157414|NCT01763918|50274130|FG002|Overall Study|Withdrawal by Subject|1|||
25157415|NCT01763918|50274131|FG003|Overall Study|Withdrawal by Subject|2|||
25157416|NCT01763918|50274128|FG000|Overall Study|Sponsor Decision|4|||
25157417|NCT01763918|50274129|FG001|Overall Study|Sponsor Decision|0|||
25157418|NCT01763918|50274130|FG002|Overall Study|Sponsor Decision|9|||
25157419|NCT01763918|50274131|FG003|Overall Study|Sponsor Decision|0|||
24938016|NCT00506922|50031129|FG001|Overall Study|Withdrawal by Subject|0|||
24938017|NCT00506922|50031130|FG002|Overall Study|Withdrawal by Subject|0|||
24938018|NCT00506922|50031131|FG003|Overall Study|Withdrawal by Subject|0|||
24938019|NCT00506922|50031132|FG004|Overall Study|Withdrawal by Subject|1|||
24938020|NCT00492024|50031142|FG000|Treatment|Adverse Event|3|||
24938021|NCT00492024|50031143|FG001|Treatment|Adverse Event|1|||
24938022|NCT00492024|50031142|FG000|Treatment|Lack of Efficacy|21|||
24938023|NCT00492024|50031143|FG001|Treatment|Lack of Efficacy|20|||
24938024|NCT00492024|50031142|FG000|Treatment|Lost to Follow-up|3|||
24938025|NCT00492024|50031143|FG001|Treatment|Lost to Follow-up|1|||
24938026|NCT00492024|50031142|FG000|Treatment|Withdrawal by Subject|2|||
24938027|NCT00492024|50031143|FG001|Treatment|Withdrawal by Subject|0|||
24938028|NCT00492024|50031142|FG000|Follow up|Lack of Efficacy|0|||
25028851|NCT03068754|50127180|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
25028852|NCT03068754|50127181|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
25028853|NCT03068754|50127182|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
25028854|NCT03068754|50127183|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
25028855|NCT03068754|50127180|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
25028856|NCT03068754|50127181|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
25028857|NCT03068754|50127182|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
25028858|NCT03068754|50127183|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
25157420|NCT01763684|50274143|FG000|Overall Study|Study terminated early due to low enrollment|126|||
25157421|NCT01763684|50274144|FG001|Overall Study|Study terminated early due to low enrollment|127|||
24938029|NCT00492024|50031143|FG001|Follow up|Lack of Efficacy|1|||
24938030|NCT00492024|50031142|FG000|Follow up|Lost to Follow-up|1|||
24938031|NCT00492024|50031143|FG001|Follow up|Lost to Follow-up|1|||
24938032|NCT00491556|50031151|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
25028859|NCT03068754|50127180|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
25028860|NCT03068754|50127181|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
25028861|NCT03068754|50127182|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
25028862|NCT03068754|50127183|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
25028863|NCT03068754|50127180|FG000|Open Label Extension Period (OLE)|Death|0|||
25028864|NCT03068754|50127181|FG001|Open Label Extension Period (OLE)|Death|0|||
25028865|NCT03068754|50127182|FG002|Open Label Extension Period (OLE)|Death|0|||
25028866|NCT03068754|50127183|FG003|Open Label Extension Period (OLE)|Death|1|||
24938033|NCT00491556|50031152|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
24938034|NCT00491556|50031151|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
24938035|NCT00491556|50031152|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
24938036|NCT00491556|50031151|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
24938037|NCT00491556|50031152|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
24938038|NCT00491556|50031151|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
24938039|NCT00491556|50031152|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
24938040|NCT00491556|50031151|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
24938041|NCT00491556|50031152|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
24938042|NCT00491556|50031151|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
24938043|NCT00491556|50031152|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
24938044|NCT00491556|50031151|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
24938045|NCT00491556|50031152|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
24938046|NCT00491556|50031151|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
24938047|NCT00491556|50031152|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
24938048|NCT00491556|50031151|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
25028867|NCT03068754|50127180|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
25028868|NCT03068754|50127181|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
24938049|NCT00491556|50031152|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
24938050|NCT00491556|50031151|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
24938051|NCT00491556|50031152|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
24938052|NCT00491556|50031151|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
24938053|NCT00491556|50031152|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
24938054|NCT00491556|50031151|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
25028869|NCT03068754|50127182|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
25028870|NCT03068754|50127183|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
25028871|NCT03068754|50127180|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
25157422|NCT01763684|50274143|FG000|Overall Study|Study surgery not performed|7|||
25157423|NCT01763684|50274144|FG001|Overall Study|Study surgery not performed|6|||
25157424|NCT01606748|50274152|FG000|Overall Study|Adverse Event|1|||
25157425|NCT01606748|50274153|FG001|Overall Study|Adverse Event|0|||
24938055|NCT00491556|50031152|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
24938056|NCT00491556|50031151|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
24938057|NCT00491556|50031152|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
24938058|NCT00491556|50031151|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
24938059|NCT00491556|50031152|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
24938060|NCT00491556|50031151|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
24938061|NCT00491556|50031152|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
24938062|NCT00491556|50031151|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
24938063|NCT00491556|50031152|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
24938064|NCT00491556|50031151|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
24938065|NCT00491556|50031152|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
24938066|NCT00491556|50031151|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
25028872|NCT03068754|50127181|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
25028873|NCT03068754|50127182|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
24938067|NCT00491556|50031152|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
24938068|NCT00491556|50031151|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
25028874|NCT03068754|50127183|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
25028875|NCT03068754|50127180|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
25028876|NCT03068754|50127181|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
25028877|NCT03068754|50127182|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
24938069|NCT00491556|50031152|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
24938070|NCT00491556|50031151|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
24938071|NCT00491556|50031152|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
24938072|NCT00506454|50031168|FG000|Overall Study|Withdrawal by Subject|1|||
24938073|NCT00506454|50031169|FG001|Overall Study|Withdrawal by Subject|1|||
24938074|NCT00485472|50031177|FG000|Overall Study|Adverse Event|8|||
25157426|NCT01606748|50274152|FG000|Overall Study|Progressive Disease|1|||
25157427|NCT01606748|50274153|FG001|Overall Study|Progressive Disease|0|||
25157428|NCT01606748|50274152|FG000|Overall Study|Withdrawal by Subject|1|||
25157429|NCT01606748|50274153|FG001|Overall Study|Withdrawal by Subject|0|||
25157430|NCT01597622|50274171|FG000|Overall Study|Adverse Event|7|||
25157431|NCT01597622|50274171|FG000|Overall Study|Lack of Efficacy|3|||
25157432|NCT01597622|50274171|FG000|Overall Study|Protocol Violation|1|||
25157433|NCT01597622|50274171|FG000|Overall Study|Lost to Follow-up|1|||
25157434|NCT01597622|50274171|FG000|Overall Study|Investigator Discretion|5|||
25157435|NCT01597622|50274171|FG000|Overall Study|Withdrawal by Subject|20|||
25157436|NCT01597622|50274171|FG000|Overall Study|Death|1|||
25157437|NCT01761266|50274177|FG000|Overall Study|Death|415|||
25157438|NCT01761266|50274178|FG001|Overall Study|Death|402|||
25157439|NCT01761266|50274177|FG000|Overall Study|Lost to Follow-up|8|||
25157440|NCT01761266|50274178|FG001|Overall Study|Lost to Follow-up|12|||
25157441|NCT01761266|50274177|FG000|Overall Study|Withdrawal by Subject|14|||
25157442|NCT01761266|50274178|FG001|Overall Study|Withdrawal by Subject|10|||
25157443|NCT01761266|50274177|FG000|Overall Study|Sponsor Decision|41|||
25157444|NCT01761266|50274178|FG001|Overall Study|Sponsor Decision|52|||
25157445|NCT01760954|50274191|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
25157446|NCT01760954|50274192|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
25157447|NCT01760954|50274193|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
25157448|NCT01760954|50274194|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
25157449|NCT01760954|50274191|FG000|Treatment Period (6 Months)|Adverse Event|5|||
25157450|NCT01760954|50274192|FG001|Treatment Period (6 Months)|Adverse Event|3|||
25157451|NCT01760954|50274193|FG002|Treatment Period (6 Months)|Adverse Event|4|||
25157452|NCT01760954|50274194|FG003|Treatment Period (6 Months)|Adverse Event|10|||
25157453|NCT01760954|50274191|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
25028878|NCT03068754|50127183|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
25028879|NCT03068754|50127180|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
25028880|NCT03068754|50127181|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
25028881|NCT03068754|50127182|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
25028882|NCT03068754|50127183|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
25028883|NCT02965820|50127193|FG000|Period 2, Second 30 Days|Adverse Event|1|||
25028884|NCT02965820|50127194|FG001|Period 2, Second 30 Days|Adverse Event|1|||
25028885|NCT03430895|50127200|FG000|Overall Study|Not Treated|2|||
25028886|NCT03452189|50127204|FG000|First Intervention (3 Months)|Adverse Event|1|||
25028887|NCT03452189|50127205|FG001|First Intervention (3 Months)|Adverse Event|0|||
25028888|NCT03452189|50127204|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
25028889|NCT03452189|50127205|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
25028890|NCT03451721|50127211|FG000|Overall Study|Death|1|||
25028891|NCT00603954|50127217|FG000|Overall Study|Protocol Violation|1|||
25028892|NCT00603954|50127218|FG001|Overall Study|Protocol Violation|2|||
25028893|NCT03427619|50127225|FG000|Overall Study|Physician Decision|3|||
25028894|NCT03427619|50127225|FG000|Overall Study|Withdrawal by Subject|4|||
25028895|NCT03427619|50127225|FG000|Overall Study|Lost to Follow-up|5|||
25157454|NCT01760954|50274192|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
25157455|NCT01760954|50274193|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
25157456|NCT01760954|50274194|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
25157457|NCT01760954|50274191|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
24938075|NCT00485472|50031178|FG001|Overall Study|Adverse Event|5|||
24938076|NCT00485472|50031177|FG000|Overall Study|Lack of Efficacy|5|||
24938077|NCT00485472|50031178|FG001|Overall Study|Lack of Efficacy|4|||
25028896|NCT03427619|50127225|FG000|Overall Study|Administrative|4|||
25028897|NCT03427619|50127225|FG000|Overall Study|Other|2|||
25028898|NCT03427619|50127225|FG000|Overall Study|Unknown or Missing Completion Status|48|||
25028899|NCT03407729|50127231|FG000|Overall Study|Lost to Follow-up|2|||
25028900|NCT03407729|50127232|FG001|Overall Study|Lost to Follow-up|0|||
25028901|NCT03407729|50127231|FG000|Overall Study|Unable to schedule|0|||
25028902|NCT03407729|50127232|FG001|Overall Study|Unable to schedule|3|||
25028903|NCT02435433|50127243|FG000|Overall Study|Withdrawal by Subject|2|||
25028904|NCT02435433|50127244|FG001|Overall Study|Withdrawal by Subject|3|||
25028905|NCT02435433|50127245|FG002|Overall Study|Withdrawal by Subject|1|||
25028906|NCT02435433|50127246|FG003|Overall Study|Withdrawal by Subject|0|||
25028907|NCT02435433|50127247|FG004|Overall Study|Withdrawal by Subject|0|||
25028908|NCT02435433|50127243|FG000|Overall Study|Lost to Follow-up|2|||
25028909|NCT02435433|50127244|FG001|Overall Study|Lost to Follow-up|2|||
25028910|NCT02435433|50127245|FG002|Overall Study|Lost to Follow-up|4|||
25028911|NCT02435433|50127246|FG003|Overall Study|Lost to Follow-up|1|||
25028912|NCT02435433|50127247|FG004|Overall Study|Lost to Follow-up|0|||
25028913|NCT03120351|50127260|FG000|Overall Study|Physician Decision|1|||
25028914|NCT03120351|50127261|FG001|Overall Study|Physician Decision|1|||
25028915|NCT02354703|50127271|FG000|Overall Study|Withdrawal by Subject|1|||
25028916|NCT02354703|50127272|FG001|Overall Study|Withdrawal by Subject|1|||
25028917|NCT02354703|50127273|FG002|Overall Study|Withdrawal by Subject|1|||
25028918|NCT02354703|50127274|FG003|Overall Study|Withdrawal by Subject|1|||
25028919|NCT02354703|50127271|FG000|Overall Study|Lost to Follow-up|2|||
25028920|NCT02354703|50127272|FG001|Overall Study|Lost to Follow-up|7|||
25028921|NCT02354703|50127273|FG002|Overall Study|Lost to Follow-up|9|||
25028922|NCT02354703|50127274|FG003|Overall Study|Lost to Follow-up|2|||
25028923|NCT02354703|50127271|FG000|Overall Study|Adverse Event|0|||
25028924|NCT02354703|50127272|FG001|Overall Study|Adverse Event|0|||
25028925|NCT02354703|50127273|FG002|Overall Study|Adverse Event|1|||
25028926|NCT02354703|50127274|FG003|Overall Study|Adverse Event|0|||
25028927|NCT00384111|50127290|FG000|Overall Study|Disease Progression|3|||
25028928|NCT00384111|50127290|FG000|Overall Study|Adverse Event|1|||
25028929|NCT00384111|50127290|FG000|Overall Study|Investigator Decision|3|||
25028930|NCT00384111|50127290|FG000|Overall Study|Study Terminated by the Sponsor|19|||
25028931|NCT03113409|50127294|FG000|Overall Study|Withdrawal by Subject|5|||
25028932|NCT03113409|50127295|FG001|Overall Study|Withdrawal by Subject|0|||
25028933|NCT03113409|50127296|FG002|Overall Study|Withdrawal by Subject|0|||
25028934|NCT01319877|50127302|FG000|Overall Study|Lost to Follow-up|100|||
25028935|NCT01319877|50127303|FG001|Overall Study|Lost to Follow-up|37|||
25028936|NCT01319877|50127302|FG000|Overall Study|Physician Decision|2|||
25028937|NCT01319877|50127303|FG001|Overall Study|Physician Decision|0|||
25028938|NCT01319877|50127302|FG000|Overall Study|Disease Progression|2|||
25028939|NCT01319877|50127303|FG001|Overall Study|Disease Progression|2|||
25028940|NCT01319877|50127302|FG000|Overall Study|Withdrawal by Subject|0|||
25028941|NCT01319877|50127303|FG001|Overall Study|Withdrawal by Subject|1|||
25028942|NCT01319877|50127302|FG000|Overall Study|Reason Not Specified|4|||
25028943|NCT01319877|50127303|FG001|Overall Study|Reason Not Specified|5|||
25028944|NCT03427073|50127316|FG000|Overall Study|Disease Progression|1|||
25028945|NCT03427073|50127317|FG001|Overall Study|Disease Progression|1|||
25028946|NCT03427073|50127318|FG002|Overall Study|Disease Progression|1|||
25028947|NCT03427073|50127319|FG003|Overall Study|Disease Progression|3|||
25028948|NCT03427073|50127320|FG004|Overall Study|Disease Progression|3|||
25028949|NCT03427073|50127321|FG005|Overall Study|Disease Progression|4|||
25028950|NCT03427073|50127322|FG006|Overall Study|Disease Progression|2|||
25028951|NCT03427073|50127323|FG007|Overall Study|Disease Progression|3|||
25028952|NCT03427073|50127316|FG000|Overall Study|Physician Decision|0|||
25028953|NCT03427073|50127317|FG001|Overall Study|Physician Decision|0|||
24938078|NCT00485472|50031177|FG000|Overall Study|Withdrawal by Subject|1|||
24938079|NCT00485472|50031178|FG001|Overall Study|Withdrawal by Subject|0|||
24938080|NCT00485472|50031177|FG000|Overall Study|Protocol Violation|0|||
24938081|NCT00485472|50031178|FG001|Overall Study|Protocol Violation|1|||
24938082|NCT00485472|50031177|FG000|Overall Study|Other|2|||
24938083|NCT00485472|50031178|FG001|Overall Study|Other|1|||
24938084|NCT00485472|50031177|FG000|Overall Study|Lost to Follow-up|0|||
24938085|NCT00485472|50031178|FG001|Overall Study|Lost to Follow-up|1|||
24938086|NCT00491400|50031186|FG000|Overall Study|Withdrawal by Subject|5|||
25028954|NCT03427073|50127318|FG002|Overall Study|Physician Decision|0|||
25028955|NCT03427073|50127319|FG003|Overall Study|Physician Decision|0|||
25028956|NCT03427073|50127320|FG004|Overall Study|Physician Decision|0|||
25028957|NCT03427073|50127321|FG005|Overall Study|Physician Decision|0|||
25028958|NCT03427073|50127322|FG006|Overall Study|Physician Decision|1|||
25028959|NCT03427073|50127323|FG007|Overall Study|Physician Decision|1|||
25157458|NCT01760954|50274192|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
24938087|NCT00491400|50031187|FG001|Overall Study|Withdrawal by Subject|4|||
24938088|NCT00491322|50031197|FG000|Overall Study|Protocol Violation|1|||
24938089|NCT00491322|50031198|FG001|Overall Study|Protocol Violation|0|||
25028960|NCT03066804|50127343|FG000|Overall Study|Physician Decision|0|||
25028961|NCT03066804|50127344|FG001|Overall Study|Physician Decision|4|||
24938090|NCT00491322|50031197|FG000|Overall Study|Pregnancy|0|||
25157459|NCT01760954|50274193|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
25028962|NCT03066804|50127343|FG000|Overall Study|Death|23|||
25028963|NCT03066804|50127344|FG001|Overall Study|Death|17|||
25028964|NCT03066804|50127343|FG000|Overall Study|Withdrawal by Subject|19|||
25028965|NCT03066804|50127344|FG001|Overall Study|Withdrawal by Subject|25|||
25028966|NCT03066804|50127343|FG000|Overall Study|Lost to Follow-up|2|||
25028967|NCT03066804|50127344|FG001|Overall Study|Lost to Follow-up|0|||
25028968|NCT03066804|50127343|FG000|Overall Study|Adverse Event|2|||
25028969|NCT03066804|50127344|FG001|Overall Study|Adverse Event|3|||
25028970|NCT03066804|50127343|FG000|Overall Study|Technical problems|5|||
25028971|NCT03066804|50127344|FG001|Overall Study|Technical problems|1|||
25028972|NCT02954237|50127351|FG000|Overall Study|Withdrawal by Subject|25|||
25028973|NCT02954237|50127351|FG000|Overall Study|Missed visit|16|||
25028974|NCT02954237|50127351|FG000|Overall Study|Death|2|||
25028975|NCT04250337|50127357|FG000|Overall Study|Adverse Event|0|||
25028976|NCT04250337|50127358|FG001|Overall Study|Adverse Event|3|||
25028977|NCT04250337|50127357|FG000|Overall Study|Lack of Efficacy|1|||
25028978|NCT04250337|50127358|FG001|Overall Study|Lack of Efficacy|3|||
25028979|NCT04250337|50127357|FG000|Overall Study|Physician Decision|1|||
25028980|NCT04250337|50127358|FG001|Overall Study|Physician Decision|0|||
25028981|NCT04250337|50127357|FG000|Overall Study|Protocol Deviation|2|||
25028982|NCT04250337|50127358|FG001|Overall Study|Protocol Deviation|2|||
25028983|NCT04250337|50127357|FG000|Overall Study|Withdrawal by Subject|4|||
25028984|NCT04250337|50127358|FG001|Overall Study|Withdrawal by Subject|3|||
25028985|NCT03118947|50127365|FG000|Overall Study|Adverse Event|7|||
25028986|NCT03118947|50127365|FG000|Overall Study|Death|3|||
25028987|NCT03118947|50127365|FG000|Overall Study|Lack of Efficacy|4|||
25028988|NCT03118947|50127365|FG000|Overall Study|Non-compliance with study drug|1|||
25028989|NCT03118947|50127365|FG000|Overall Study|Protocol Violation|2|||
25028990|NCT03118947|50127365|FG000|Overall Study|Withdrawal by Subject|3|||
25028991|NCT03118947|50127365|FG000|Overall Study|Withdrawal by caregiver|3|||
25028992|NCT03118947|50127365|FG000|Overall Study|Change in patient's living situation|4|||
25028993|NCT03118947|50127365|FG000|Overall Study|Lost to Follow-up|2|||
25028994|NCT03953079|50127372|FG000|Core Study|Withdrawal by Subject|1|||
25028995|NCT03953079|50127373|FG001|Core Study|Withdrawal by Subject|2|||
25275489|NCT01073865|50589365|FG001|Overall Study|Death|2|||
24938091|NCT00491322|50031198|FG001|Overall Study|Pregnancy|1|||
24938092|NCT00502320|50031206|FG000|Overall Study|Lost to Follow-up|1|||
24938093|NCT00502320|50031207|FG001|Overall Study|Lost to Follow-up|1|||
24938094|NCT00502320|50031206|FG000|Overall Study|Withdrew Consent|1|||
24938095|NCT00502320|50031207|FG001|Overall Study|Withdrew Consent|0|||
24938096|NCT00502320|50031206|FG000|Overall Study|No longer met criteria|1|||
24938097|NCT00502320|50031207|FG001|Overall Study|No longer met criteria|0|||
24938098|NCT00502320|50031206|FG000|Overall Study|Screen Failure|0|||
24938099|NCT00502320|50031207|FG001|Overall Study|Screen Failure|1|||
24938100|NCT00502320|50031206|FG000|Overall Study|Adverse Event|3|||
24938101|NCT00502320|50031207|FG001|Overall Study|Adverse Event|5|||
24938102|NCT02567825|50031215|FG000|Overall Study|No follow-up post-randomization|5|||
24938103|NCT02567825|50031216|FG001|Overall Study|No follow-up post-randomization|1|||
24938104|NCT02567825|50031215|FG000|Overall Study|Follow-up less than 23 months|16|||
24938105|NCT02567825|50031216|FG001|Overall Study|Follow-up less than 23 months|20|||
24938106|NCT00490776|50031222|FG000|Overall Study|Withdrawal by Subject|1|||
24938107|NCT00490776|50031222|FG000|Overall Study|Administrative Problems|1|||
24938108|NCT00490776|50031222|FG000|Overall Study|Death|1|||
24938109|NCT00490776|50031222|FG000|Overall Study|New Cancer Therapy|1|||
24938110|NCT00490776|50031222|FG000|Overall Study|Disease Progression|5|||
24938111|NCT00566735|50031228|FG000|Overall Study|Withdrawal by Subject|0|||
24938112|NCT00566735|50031229|FG001|Overall Study|Withdrawal by Subject|1|||
24938113|NCT00566735|50031228|FG000|Overall Study|Refused neuropsychological testing|2|||
24938114|NCT00566735|50031229|FG001|Overall Study|Refused neuropsychological testing|5|||
24938115|NCT00566735|50031228|FG000|Overall Study|Switched into a manic episode|0|||
24938116|NCT00566735|50031229|FG001|Overall Study|Switched into a manic episode|1|||
25028996|NCT03953079|50127374|FG002|Core Study|Withdrawal by Subject|1|||
25028997|NCT03953079|50127372|FG000|Core Study|COVID-19|0|||
25028998|NCT03953079|50127373|FG001|Core Study|COVID-19|1|||
25028999|NCT03953079|50127374|FG002|Core Study|COVID-19|0|||
24938117|NCT00566111|50031237|FG000|Overall Study|Adverse Event|0|||
24938118|NCT00566111|50031238|FG001|Overall Study|Adverse Event|2|||
24938119|NCT00514046|50031253|FG000|Overall Study|transferred to another protocol|2|||
24938120|NCT00514046|50031254|FG001|Overall Study|transferred to another protocol|1|||
24938121|NCT00514046|50031255|FG002|Overall Study|transferred to another protocol|3|||
24938122|NCT00514046|50031256|FG003|Overall Study|transferred to another protocol|0|||
24938123|NCT00514046|50031257|FG004|Overall Study|transferred to another protocol|1|||
25029000|NCT03953079|50127372|FG000|Core Study|Difficulties leaving the house|0|||
25029001|NCT03953079|50127373|FG001|Core Study|Difficulties leaving the house|1|||
25029002|NCT03953079|50127374|FG002|Core Study|Difficulties leaving the house|0|||
25029003|NCT03953079|50127372|FG000|Extension Study|Withdrawal by Subject|1|||
24938124|NCT00514046|50031258|FG005|Overall Study|transferred to another protocol|0|||
24938125|NCT00514046|50031259|FG006|Overall Study|transferred to another protocol|0|||
24938126|NCT00514046|50031260|FG007|Overall Study|transferred to another protocol|0|||
24938127|NCT00514046|50031261|FG008|Overall Study|transferred to another protocol|0|||
24938128|NCT00514046|50031253|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
24938129|NCT00514046|50031254|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
24938130|NCT00514046|50031255|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
24938131|NCT00514046|50031256|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
24938132|NCT00514046|50031257|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
24938133|NCT00514046|50031258|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
24938134|NCT00514046|50031259|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
24938135|NCT00514046|50031260|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
24938136|NCT00514046|50031261|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
24938137|NCT00514046|50031253|FG000|Overall Study|Disease progression on study|0|||
24938138|NCT00514046|50031254|FG001|Overall Study|Disease progression on study|0|||
24938139|NCT00514046|50031255|FG002|Overall Study|Disease progression on study|2|||
24938140|NCT00514046|50031256|FG003|Overall Study|Disease progression on study|0|||
24938141|NCT00514046|50031257|FG004|Overall Study|Disease progression on study|0|||
24938142|NCT00514046|50031258|FG005|Overall Study|Disease progression on study|1|||
24938143|NCT00514046|50031259|FG006|Overall Study|Disease progression on study|0|||
24938144|NCT00514046|50031260|FG007|Overall Study|Disease progression on study|0|||
24938145|NCT00514046|50031261|FG008|Overall Study|Disease progression on study|0|||
24938146|NCT00564629|50031285|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
24938147|NCT00564629|50031286|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
24938148|NCT00564395|50031292|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
24938149|NCT00564395|50031293|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
24938150|NCT00564395|50031292|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
24938151|NCT00564395|50031293|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
24938152|NCT00502242|50031301|FG000|Overall Study|Lack of Efficacy|1|||
24938153|NCT00502242|50031302|FG001|Overall Study|Lack of Efficacy|11|||
24938154|NCT00502242|50031301|FG000|Overall Study|Adverse Event|31|||
24938155|NCT00502242|50031302|FG001|Overall Study|Adverse Event|20|||
24938156|NCT00502242|50031301|FG000|Overall Study|Physician Decision|2|||
24938157|NCT00502242|50031302|FG001|Overall Study|Physician Decision|3|||
24938158|NCT00502242|50031301|FG000|Overall Study|Other - Unspecified|8|||
24938159|NCT00502242|50031302|FG001|Overall Study|Other - Unspecified|14|||
24938160|NCT00502242|50031301|FG000|Overall Study|Protocol Violation|3|||
24938161|NCT00502242|50031302|FG001|Overall Study|Protocol Violation|1|||
24938162|NCT00502242|50031301|FG000|Overall Study|Withdrawal by Subject|6|||
24938163|NCT00502242|50031302|FG001|Overall Study|Withdrawal by Subject|7|||
24938164|NCT03972137|50031312|FG000|Overall Study|Lost to Follow-up|2|||
24938165|NCT03972137|50031312|FG000|Overall Study|Withdrawal by Subject|4|||
24938166|NCT00490698|50031328|FG000|Overall Study|Withdrawal by Subject|1|||
24938167|NCT00490698|50031328|FG000|Overall Study|Disease Progression|7|||
24938168|NCT00490698|50031328|FG000|Overall Study|Physician Decision|2|||
24938169|NCT03855228|50031336|FG000|Overall Study|Adverse Event|2|||
24938170|NCT03855228|50031337|FG001|Overall Study|Adverse Event|4|||
24938171|NCT03855228|50031338|FG002|Overall Study|Adverse Event|4|||
24938172|NCT03855228|50031339|FG003|Overall Study|Adverse Event|8|||
24938173|NCT03855228|50031336|FG000|Overall Study|Treatment Failure|1|||
24938174|NCT03855228|50031337|FG001|Overall Study|Treatment Failure|2|||
24938175|NCT03855228|50031338|FG002|Overall Study|Treatment Failure|1|||
24938176|NCT03855228|50031339|FG003|Overall Study|Treatment Failure|8|||
24938177|NCT03855228|50031336|FG000|Overall Study|Lost to Follow-up|0|||
25029004|NCT03953079|50127373|FG001|Extension Study|Withdrawal by Subject|0|||
25029005|NCT03953079|50127374|FG002|Extension Study|Withdrawal by Subject|0|||
25029006|NCT03953079|50127372|FG000|Extension Study|Received Rescue Treatment|5|||
25029007|NCT03953079|50127373|FG001|Extension Study|Received Rescue Treatment|6|||
25029008|NCT03953079|50127374|FG002|Extension Study|Received Rescue Treatment|5|||
25029009|NCT03885999|50127387|FG000|Overall Study|Adverse Event|1|||
25029010|NCT03108027|50127401|FG000|Period 1|Subject/Guardian Decision|0|||
25029011|NCT03108027|50127402|FG001|Period 1|Subject/Guardian Decision|0|||
25029012|NCT03108027|50127403|FG002|Period 1|Subject/Guardian Decision|0|||
25029013|NCT03108027|50127404|FG003|Period 1|Subject/Guardian Decision|2|||
25029014|NCT03108027|50127405|FG004|Period 1|Subject/Guardian Decision|0|||
25029015|NCT03108027|50127406|FG005|Period 1|Subject/Guardian Decision|0|||
24938178|NCT03855228|50031337|FG001|Overall Study|Lost to Follow-up|0|||
25029016|NCT03108027|50127401|FG000|Period 3|Adverse Event|0|||
25029017|NCT03108027|50127402|FG001|Period 3|Adverse Event|1|||
25029018|NCT03108027|50127403|FG002|Period 3|Adverse Event|0|||
25029019|NCT03108027|50127404|FG003|Period 3|Adverse Event|0|||
24938179|NCT03855228|50031338|FG002|Overall Study|Lost to Follow-up|0|||
24938180|NCT03855228|50031339|FG003|Overall Study|Lost to Follow-up|1|||
25029020|NCT03108027|50127405|FG004|Period 3|Adverse Event|0|||
25029021|NCT03108027|50127406|FG005|Period 3|Adverse Event|0|||
25029022|NCT03107715|50127422|FG000|Overall Study|did not deliver at the home hospital|4|||
25029023|NCT03107715|50127423|FG001|Overall Study|did not deliver at the home hospital|6|||
25029024|NCT03107715|50127422|FG000|Overall Study|infant stillborn|0|||
25029025|NCT03107715|50127423|FG001|Overall Study|infant stillborn|1|||
25029026|NCT03567057|50127432|FG000|Overall Study|Adverse Event|56|||
25029027|NCT03567057|50127433|FG001|Overall Study|Adverse Event|53|||
25029028|NCT03567057|50127434|FG002|Overall Study|Adverse Event|28|||
24938181|NCT03855228|50031336|FG000|Overall Study|Protocol Violation|0|||
24938182|NCT03855228|50031337|FG001|Overall Study|Protocol Violation|1|||
24938183|NCT03855228|50031338|FG002|Overall Study|Protocol Violation|2|||
24938184|NCT03855228|50031339|FG003|Overall Study|Protocol Violation|1|||
24938185|NCT03855228|50031336|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
24938186|NCT03855228|50031337|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
24938187|NCT03855228|50031338|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
24938188|NCT03855228|50031339|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
24938189|NCT00511238|50031351|FG000|Overall Study|Adverse Event|13|||
24938190|NCT00511238|50031352|FG001|Overall Study|Adverse Event|33|||
25029029|NCT03567057|50127432|FG000|Overall Study|Withdrawal by Subject|22|||
25029030|NCT03567057|50127433|FG001|Overall Study|Withdrawal by Subject|24|||
25029031|NCT03567057|50127434|FG002|Overall Study|Withdrawal by Subject|13|||
25029032|NCT03567057|50127432|FG000|Overall Study|Lost to Follow-up|3|||
25029033|NCT03567057|50127433|FG001|Overall Study|Lost to Follow-up|5|||
25029034|NCT03567057|50127434|FG002|Overall Study|Lost to Follow-up|2|||
25029035|NCT03567057|50127432|FG000|Overall Study|COVID-19 pandemic|4|||
25029036|NCT03567057|50127433|FG001|Overall Study|COVID-19 pandemic|3|||
25029037|NCT03567057|50127434|FG002|Overall Study|COVID-19 pandemic|0|||
25029038|NCT03567057|50127432|FG000|Overall Study|Non-compliance with study drug|4|||
25029039|NCT03567057|50127433|FG001|Overall Study|Non-compliance with study drug|2|||
25029040|NCT03567057|50127434|FG002|Overall Study|Non-compliance with study drug|0|||
25029041|NCT03567057|50127432|FG000|Overall Study|Lack of Efficacy|3|||
25029042|NCT03567057|50127433|FG001|Overall Study|Lack of Efficacy|0|||
24938191|NCT00511238|50031351|FG000|Overall Study|Withdrawal by Subject|2|||
24938192|NCT00511238|50031352|FG001|Overall Study|Withdrawal by Subject|22|||
24938193|NCT00511238|50031351|FG000|Overall Study|Progressive Disease|23|||
24938194|NCT00511238|50031352|FG001|Overall Study|Progressive Disease|157|||
24938195|NCT00511238|50031351|FG000|Overall Study|various reasons|4|||
24938196|NCT00511238|50031352|FG001|Overall Study|various reasons|14|||
24938197|NCT00513500|50031370|FG000|Overall Study|Lost to Follow-up|35|||
24938198|NCT00513500|50031371|FG001|Overall Study|Lost to Follow-up|39|||
24938199|NCT00513500|50031370|FG000|Overall Study|Death|2|||
24938200|NCT00513500|50031371|FG001|Overall Study|Death|1|||
24938201|NCT00513500|50031370|FG000|Overall Study|Hospitalized|4|||
24938202|NCT00513500|50031371|FG001|Overall Study|Hospitalized|14|||
24938203|NCT03969719|50031380|FG000|Overall Study|Other reasons not specified|1|||
24938204|NCT03969719|50031381|FG001|Overall Study|Other reasons not specified|1|||
24938205|NCT03969719|50031382|FG002|Overall Study|Other reasons not specified|3|||
24938206|NCT03969719|50031380|FG000|Overall Study|Withdrawal by Subject|2|||
25029043|NCT03567057|50127434|FG002|Overall Study|Lack of Efficacy|1|||
25029044|NCT03567057|50127432|FG000|Overall Study|Death|1|||
24938207|NCT03969719|50031381|FG001|Overall Study|Withdrawal by Subject|3|||
24938208|NCT03969719|50031382|FG002|Overall Study|Withdrawal by Subject|2|||
24938209|NCT03969719|50031380|FG000|Overall Study|Protocol Violation|1|||
24938210|NCT03969719|50031381|FG001|Overall Study|Protocol Violation|2|||
24938211|NCT03969719|50031382|FG002|Overall Study|Protocol Violation|0|||
24938212|NCT03969719|50031380|FG000|Overall Study|Adverse Event|0|||
24938213|NCT03969719|50031381|FG001|Overall Study|Adverse Event|2|||
24938214|NCT03969719|50031382|FG002|Overall Study|Adverse Event|0|||
24938215|NCT03969719|50031380|FG000|Overall Study|Lost to Follow-up|0|||
24938216|NCT03969719|50031381|FG001|Overall Study|Lost to Follow-up|1|||
24938217|NCT03969719|50031382|FG002|Overall Study|Lost to Follow-up|0|||
24938218|NCT00511004|50031393|FG000|Overall Study|Lost to Follow-up|0|||
24938219|NCT00511004|50031394|FG001|Overall Study|Lost to Follow-up|0|||
24938220|NCT00511004|50031395|FG002|Overall Study|Lost to Follow-up|4|||
24938221|NCT02877134|50031422|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
24938222|NCT02877134|50031423|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
25029045|NCT03567057|50127433|FG001|Overall Study|Death|0|||
25029046|NCT03567057|50127434|FG002|Overall Study|Death|0|||
25029047|NCT03567057|50127432|FG000|Overall Study|Physician Decision|1|||
25029048|NCT03567057|50127433|FG001|Overall Study|Physician Decision|0|||
25029049|NCT03567057|50127434|FG002|Overall Study|Physician Decision|0|||
25029050|NCT03567057|50127432|FG000|Overall Study|Unstable medical condition|1|||
24938223|NCT02877134|50031424|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
24938224|NCT02877134|50031425|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
24938225|NCT02877134|50031426|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
24938226|NCT02877134|50031427|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
25029051|NCT03567057|50127433|FG001|Overall Study|Unstable medical condition|0|||
25029052|NCT03567057|50127434|FG002|Overall Study|Unstable medical condition|0|||
24938227|NCT02877134|50031428|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
24938228|NCT02877134|50031429|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
24938229|NCT02877134|50031430|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
24938230|NCT02877134|50031431|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
24938231|NCT02877134|50031432|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
24938232|NCT02877134|50031433|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
24938233|NCT02877134|50031422|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
24938234|NCT02877134|50031423|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
24938235|NCT02877134|50031424|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
24938236|NCT02877134|50031425|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
24938237|NCT02877134|50031426|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
24938238|NCT02877134|50031427|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
24938239|NCT02877134|50031428|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
24938240|NCT02877134|50031429|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
24938241|NCT02877134|50031430|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
24938242|NCT02877134|50031431|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
24938243|NCT02877134|50031432|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
24938244|NCT02877134|50031433|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
24938245|NCT02877134|50031422|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
24938246|NCT02877134|50031423|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
24938247|NCT02877134|50031424|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
24938248|NCT02877134|50031425|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
24938249|NCT02877134|50031426|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
25029053|NCT03567057|50127432|FG000|Overall Study|Medical history event|0|||
25029054|NCT03567057|50127433|FG001|Overall Study|Medical history event|0|||
25029055|NCT03567057|50127434|FG002|Overall Study|Medical history event|1|||
25029056|NCT03567057|50127432|FG000|Overall Study|Other|0|||
25029057|NCT03567057|50127433|FG001|Overall Study|Other|0|||
25029058|NCT03567057|50127434|FG002|Overall Study|Other|1|||
25029059|NCT04388787|50127442|FG000|Blinded Period|Patient could not follow instructions|1|||
25029060|NCT04388787|50127442|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
25029061|NCT03057600|50127454|FG000|Overall Study|Adverse Event|0|||
25186103|NCT01474538|50335970|FG001|Treatment Period 1|Physician Decision|0|||
25186104|NCT01474538|50335969|FG000|Treatment Period 1|Withdrawal by Subject|1|||
24938250|NCT02877134|50031427|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
24938251|NCT02877134|50031428|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
24938252|NCT02877134|50031429|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
24938253|NCT02877134|50031430|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
24938254|NCT02877134|50031431|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
24938255|NCT02877134|50031432|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
24938256|NCT02877134|50031433|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
24938257|NCT02877134|50031422|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
24938258|NCT02877134|50031423|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
24938259|NCT02877134|50031424|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
24938260|NCT02877134|50031425|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
24938261|NCT02877134|50031426|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
24938262|NCT02877134|50031427|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
24938263|NCT02877134|50031428|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
24938264|NCT02877134|50031429|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
24938265|NCT02877134|50031430|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
24938266|NCT02877134|50031431|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
24938267|NCT02877134|50031432|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
24938268|NCT02877134|50031433|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
24938269|NCT02877134|50031422|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
24938270|NCT02877134|50031423|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
24938271|NCT02877134|50031424|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
24938272|NCT02877134|50031425|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
24938273|NCT02877134|50031426|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
24938274|NCT02877134|50031427|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
24938275|NCT02877134|50031428|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
24938276|NCT02877134|50031429|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
24938277|NCT02877134|50031430|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
24938278|NCT02877134|50031431|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
24938279|NCT02877134|50031432|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
25029062|NCT03057600|50127455|FG001|Overall Study|Adverse Event|0|||
25029063|NCT03057600|50127456|FG002|Overall Study|Adverse Event|4|||
25029064|NCT03057600|50127457|FG003|Overall Study|Adverse Event|0|||
25029065|NCT03057600|50127454|FG000|Overall Study|Radiologic Disease Progression|8|||
24938280|NCT02877134|50031433|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
24938281|NCT02877134|50031422|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
24938282|NCT02877134|50031423|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
24938283|NCT02877134|50031424|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
24938284|NCT02877134|50031425|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
24938285|NCT02877134|50031426|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
24938286|NCT02877134|50031427|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
24938287|NCT02877134|50031428|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
24938288|NCT02877134|50031429|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
24938289|NCT02877134|50031430|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
24938290|NCT02877134|50031431|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
24938291|NCT02877134|50031432|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
24938292|NCT02877134|50031433|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
24938293|NCT02877134|50031422|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
24938294|NCT02877134|50031423|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
24938295|NCT02877134|50031424|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
25157460|NCT01760954|50274194|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
25157461|NCT01760954|50274191|FG000|Treatment Period (6 Months)|Pregnancy|5|||
25157462|NCT01760954|50274192|FG001|Treatment Period (6 Months)|Pregnancy|0|||
25157463|NCT01760954|50274193|FG002|Treatment Period (6 Months)|Pregnancy|3|||
24938296|NCT02877134|50031425|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
24938297|NCT02877134|50031426|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
24938298|NCT02877134|50031427|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
24938299|NCT02877134|50031428|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
24938300|NCT02877134|50031429|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
24938301|NCT02877134|50031430|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
24938302|NCT02877134|50031431|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
24938303|NCT02877134|50031432|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
24938304|NCT02877134|50031433|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
24938305|NCT02877134|50031422|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
24938306|NCT02877134|50031423|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
24938307|NCT02877134|50031424|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
24938308|NCT02877134|50031425|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
24938309|NCT02877134|50031426|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
24938310|NCT02877134|50031427|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
24938311|NCT02877134|50031428|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
24938312|NCT02877134|50031429|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
24938313|NCT02877134|50031430|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
24938314|NCT02877134|50031431|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
24938315|NCT02877134|50031432|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
24938316|NCT02877134|50031433|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
24938317|NCT00563381|50031459|FG000|Overall Study|Adverse Event|264|||
24938318|NCT00563381|50031460|FG001|Overall Study|Adverse Event|292|||
24938319|NCT00563381|50031459|FG000|Overall Study|Protocol Violation|66|||
24938320|NCT00563381|50031460|FG001|Overall Study|Protocol Violation|74|||
24938321|NCT00563381|50031459|FG000|Overall Study|Lost to Follow-up|7|||
24938322|NCT00563381|50031460|FG001|Overall Study|Lost to Follow-up|15|||
24938323|NCT00563381|50031459|FG000|Overall Study|Withdrawal by Subject|192|||
24938324|NCT00563381|50031460|FG001|Overall Study|Withdrawal by Subject|209|||
24938325|NCT00563381|50031459|FG000|Overall Study|Lack of Efficacy|32|||
24938326|NCT00563381|50031460|FG001|Overall Study|Lack of Efficacy|24|||
24938327|NCT00563381|50031459|FG000|Overall Study|Individual different reasons|24|||
24938328|NCT00563381|50031460|FG001|Overall Study|Individual different reasons|34|||
24938329|NCT00512798|50031468|FG000|Overall Study|Death|0|||
24938330|NCT00512798|50031469|FG001|Overall Study|Death|3|||
24938331|NCT00512798|50031468|FG000|Overall Study|Adverse Event|2|||
24938332|NCT00512798|50031469|FG001|Overall Study|Adverse Event|4|||
24938333|NCT00512798|50031468|FG000|Overall Study|Progression of disease|14|||
24938334|NCT00512798|50031469|FG001|Overall Study|Progression of disease|20|||
24938335|NCT00512798|50031468|FG000|Overall Study|Withdrawal by Subject|3|||
24938336|NCT00512798|50031469|FG001|Overall Study|Withdrawal by Subject|0|||
24938337|NCT00565721|50031476|FG000|Overall Study|Screen Failure|2|||
24938338|NCT00565721|50031476|FG000|Overall Study|Lost to Follow-up|6|||
24938339|NCT00565721|50031476|FG000|Overall Study|Technical Problems|1|||
24938340|NCT00565721|50031476|FG000|Overall Study|Physician Decision|2|||
24938341|NCT00565721|50031476|FG000|Overall Study|Other reasons|6|||
25157464|NCT01760954|50274194|FG003|Treatment Period (6 Months)|Pregnancy|2|||
24938342|NCT00561977|50031498|FG000|Overall Study|Withdrawal by Subject|0|||
24938343|NCT00561977|50031499|FG001|Overall Study|Withdrawal by Subject|2|||
24938344|NCT00561977|50031500|FG002|Overall Study|Withdrawal by Subject|1|||
24938345|NCT00561977|50031498|FG000|Overall Study|Pregnancy|0|||
25157465|NCT01760954|50274191|FG000|Treatment Period (6 Months)|Non-compliance|1|||
24938346|NCT00561977|50031499|FG001|Overall Study|Pregnancy|1|||
24938347|NCT00561977|50031500|FG002|Overall Study|Pregnancy|1|||
24938348|NCT00561821|50031512|FG000|Overall Study|Not treated|0|||
24938349|NCT00561821|50031513|FG001|Overall Study|Not treated|0|||
24938350|NCT00561821|50031514|FG002|Overall Study|Not treated|1|||
24938351|NCT00561821|50031515|FG003|Overall Study|Not treated|0|||
24938352|NCT00561821|50031512|FG000|Overall Study|Withdrawal by Subject|0|||
24938353|NCT00561821|50031513|FG001|Overall Study|Withdrawal by Subject|1|||
24938354|NCT00561821|50031514|FG002|Overall Study|Withdrawal by Subject|0|||
24938355|NCT00561821|50031515|FG003|Overall Study|Withdrawal by Subject|2|||
24938356|NCT00561821|50031512|FG000|Overall Study|Reasons not related to trial|2|||
24938357|NCT00561821|50031513|FG001|Overall Study|Reasons not related to trial|1|||
24938358|NCT00561821|50031514|FG002|Overall Study|Reasons not related to trial|0|||
24938359|NCT00561821|50031515|FG003|Overall Study|Reasons not related to trial|0|||
24938360|NCT00561821|50031512|FG000|Overall Study|Other (reason not specified)|1|||
24938361|NCT00561821|50031513|FG001|Overall Study|Other (reason not specified)|1|||
24938362|NCT00561821|50031514|FG002|Overall Study|Other (reason not specified)|0|||
24938363|NCT00561821|50031515|FG003|Overall Study|Other (reason not specified)|0|||
24938364|NCT00561821|50031512|FG000|Overall Study|Adverse Event|2|||
24938365|NCT00561821|50031513|FG001|Overall Study|Adverse Event|3|||
24938366|NCT00561821|50031514|FG002|Overall Study|Adverse Event|1|||
24938367|NCT00561821|50031515|FG003|Overall Study|Adverse Event|1|||
24938368|NCT00558701|50031527|FG000|Overall Study|Protocol Deviations|1|||
24938369|NCT00558701|50031528|FG001|Overall Study|Protocol Deviations|4|||
24938370|NCT03684044|50031536|FG000|Overall Study|Adverse Event|3|||
24938371|NCT03684044|50031537|FG001|Overall Study|Adverse Event|0|||
24938372|NCT03684044|50031536|FG000|Overall Study|Death|4|||
24938373|NCT03684044|50031537|FG001|Overall Study|Death|7|||
24938374|NCT03684044|50031536|FG000|Overall Study|Lost to Follow-up|3|||
24938375|NCT03684044|50031537|FG001|Overall Study|Lost to Follow-up|2|||
24938376|NCT03684044|50031536|FG000|Overall Study|Patient Not Available|0|||
24938377|NCT03684044|50031537|FG001|Overall Study|Patient Not Available|2|||
24938378|NCT03684044|50031536|FG000|Overall Study|Physician Decision|1|||
24938379|NCT03684044|50031537|FG001|Overall Study|Physician Decision|0|||
24938380|NCT03684044|50031536|FG000|Overall Study|Withdrawal by Subject|11|||
24938381|NCT03684044|50031537|FG001|Overall Study|Withdrawal by Subject|9|||
24938382|NCT00510692|50031545|FG000|Overall Study|Adverse Event|1|||
24938383|NCT00510692|50031546|FG001|Overall Study|Adverse Event|3|||
24938384|NCT00510692|50031545|FG000|Overall Study|Withdrawal by Subject|1|||
24938385|NCT00510692|50031546|FG001|Overall Study|Withdrawal by Subject|0|||
24938386|NCT00335452|50031558|FG000|Overall Study|Death|156|||
24938387|NCT00335452|50031559|FG001|Overall Study|Death|144|||
24938388|NCT00335452|50031560|FG002|Overall Study|Death|158|||
24938389|NCT00335452|50031561|FG003|Overall Study|Death|129|||
24938390|NCT00335452|50031558|FG000|Overall Study|Lost to Follow-up|2|||
24938391|NCT00335452|50031559|FG001|Overall Study|Lost to Follow-up|3|||
24938392|NCT00335452|50031560|FG002|Overall Study|Lost to Follow-up|1|||
24938393|NCT00335452|50031561|FG003|Overall Study|Lost to Follow-up|2|||
24938394|NCT00522548|50031578|FG000|Overall Study|Adverse Event|2|||
24938395|NCT00522548|50031579|FG001|Overall Study|Adverse Event|2|||
24938396|NCT00522548|50031578|FG000|Overall Study|Withdrawal by Subject|0|||
25157466|NCT01760954|50274192|FG001|Treatment Period (6 Months)|Non-compliance|4|||
24938397|NCT00522548|50031579|FG001|Overall Study|Withdrawal by Subject|2|||
24938398|NCT00522392|50031587|FG000|Overall Study|Disease progression|0|||
24938399|NCT00522392|50031588|FG001|Overall Study|Disease progression|3|||
24938400|NCT00522392|50031587|FG000|Overall Study|Adverse Event|7|||
24938401|NCT00522392|50031588|FG001|Overall Study|Adverse Event|7|||
24938402|NCT00522392|50031587|FG000|Overall Study|Withdrawal by Subject|1|||
24938403|NCT00522392|50031588|FG001|Overall Study|Withdrawal by Subject|1|||
24938404|NCT00522392|50031587|FG000|Overall Study|Physician Decision|0|||
24938405|NCT00522392|50031588|FG001|Overall Study|Physician Decision|1|||
24938406|NCT00522392|50031587|FG000|Overall Study|Non-compliance|0|||
24938407|NCT00522392|50031588|FG001|Overall Study|Non-compliance|1|||
24938408|NCT00335140|50031594|FG000|Overall Study|Ineligible|1|||
25157467|NCT01760954|50274193|FG002|Treatment Period (6 Months)|Non-compliance|0|||
25157468|NCT01760954|50274194|FG003|Treatment Period (6 Months)|Non-compliance|3|||
25157469|NCT01760954|50274191|FG000|Treatment Period (6 Months)|Other|0|||
24938409|NCT00309244|50031600|FG000|Overall Study|Adverse Event|29|||
24938410|NCT00309244|50031601|FG001|Overall Study|Adverse Event|12|||
24938411|NCT00309244|50031600|FG000|Overall Study|Lost to Follow-up|6|||
24938412|NCT00309244|50031601|FG001|Overall Study|Lost to Follow-up|22|||
24938413|NCT00309244|50031600|FG000|Overall Study|Physician Decision|5|||
24938414|NCT00309244|50031601|FG001|Overall Study|Physician Decision|8|||
24938415|NCT00309244|50031600|FG000|Overall Study|Protocol Violation|6|||
25157470|NCT01760954|50274192|FG001|Treatment Period (6 Months)|Other|3|||
25186105|NCT01474538|50335970|FG001|Treatment Period 1|Withdrawal by Subject|3|||
24938416|NCT00309244|50031601|FG001|Overall Study|Protocol Violation|3|||
24938417|NCT00309244|50031600|FG000|Overall Study|Withdrawal by Subject|50|||
24938418|NCT00309244|50031601|FG001|Overall Study|Withdrawal by Subject|32|||
24938419|NCT00309244|50031600|FG000|Overall Study|Various|7|||
24938420|NCT00309244|50031601|FG001|Overall Study|Various|7|||
24938421|NCT00309244|50031600|FG000|Overall Study|Randomized but not dosed|11|||
24938422|NCT00309244|50031601|FG001|Overall Study|Randomized but not dosed|12|||
24938423|NCT00309244|50031600|FG000|Overall Study|Death|4|||
24938424|NCT00309244|50031601|FG001|Overall Study|Death|1|||
24938425|NCT00483756|50031610|FG000|Overall Study|Death|2|||
24938426|NCT00483756|50031611|FG001|Overall Study|Death|0|||
24938427|NCT00483756|50031612|FG002|Overall Study|Death|1|||
24938428|NCT00483756|50031610|FG000|Overall Study|Adverse Event|19|||
24938429|NCT00483756|50031611|FG001|Overall Study|Adverse Event|38|||
24938430|NCT00483756|50031612|FG002|Overall Study|Adverse Event|40|||
24938431|NCT00483756|50031610|FG000|Overall Study|Lack of Efficacy|1|||
24938432|NCT00483756|50031611|FG001|Overall Study|Lack of Efficacy|0|||
24938433|NCT00483756|50031612|FG002|Overall Study|Lack of Efficacy|0|||
24938434|NCT00483756|50031610|FG000|Overall Study|Lost to Follow-up|3|||
24938435|NCT00483756|50031611|FG001|Overall Study|Lost to Follow-up|1|||
24938436|NCT00483756|50031612|FG002|Overall Study|Lost to Follow-up|0|||
24938437|NCT00483756|50031610|FG000|Overall Study|Withdrawal by Subject|5|||
24938438|NCT00483756|50031611|FG001|Overall Study|Withdrawal by Subject|3|||
24938439|NCT00483756|50031612|FG002|Overall Study|Withdrawal by Subject|4|||
24938440|NCT00483756|50031610|FG000|Overall Study|Other|2|||
24938441|NCT00483756|50031611|FG001|Overall Study|Other|4|||
24938442|NCT00483756|50031612|FG002|Overall Study|Other|3|||
24938443|NCT00483756|50031610|FG000|Overall Study|Randomized, Not Treated|1|||
24938444|NCT00483756|50031611|FG001|Overall Study|Randomized, Not Treated|4|||
24938445|NCT00483756|50031612|FG002|Overall Study|Randomized, Not Treated|4|||
24938446|NCT00309166|50031622|FG000|Overall Study|Adverse event, non-fatal|1|||
24938447|NCT00309166|50031623|FG001|Overall Study|Adverse event, non-fatal|0|||
24938448|NCT00309166|50031622|FG000|Overall Study|Withdrawal by Subject|4|||
24938449|NCT00309166|50031623|FG001|Overall Study|Withdrawal by Subject|3|||
24938450|NCT00501852|50031629|FG000|Overall Study|Adverse Event|3|||
24938451|NCT00501852|50031629|FG000|Overall Study|Withdrawal by Subject|2|||
24938452|NCT00482274|50031643|FG000|Overall Study|Adverse Event|1|||
24938453|NCT00490542|50031649|FG000|Overall Study|Lost to Follow-up|3|||
24938454|NCT00490542|50031650|FG001|Overall Study|Lost to Follow-up|0|||
24938455|NCT00490542|50031649|FG000|Overall Study|Adverse Event|3|||
24938456|NCT00490542|50031650|FG001|Overall Study|Adverse Event|3|||
24938457|NCT00490542|50031649|FG000|Overall Study|Lack of Efficacy|1|||
24938458|NCT00490542|50031650|FG001|Overall Study|Lack of Efficacy|1|||
24938459|NCT00501540|50031656|FG000|Overall Study|Death|5|||
24938460|NCT00322348|50031662|FG000|Overall Study|Adverse Event|0|||
24938461|NCT00322348|50031663|FG001|Overall Study|Adverse Event|1|||
24938462|NCT00322348|50031662|FG000|Overall Study|Withdrawal by Subject|1|||
24938463|NCT00322348|50031663|FG001|Overall Study|Withdrawal by Subject|4|||
24938464|NCT00322348|50031662|FG000|Overall Study|Lost to Follow-up|1|||
24938465|NCT00322348|50031663|FG001|Overall Study|Lost to Follow-up|0|||
24938466|NCT00322348|50031662|FG000|Overall Study|Death|0|||
24938467|NCT00322348|50031663|FG001|Overall Study|Death|2|||
24938468|NCT00322348|50031662|FG000|Overall Study|Disease Progression|30|||
24938469|NCT00322348|50031663|FG001|Overall Study|Disease Progression|25|||
24938470|NCT00322348|50031662|FG000|Overall Study|Reasons not specified|5|||
24938471|NCT00322348|50031663|FG001|Overall Study|Reasons not specified|1|||
24938472|NCT00501228|50031669|FG000|Overall Study|Withdrawal by Subject|1|||
25029066|NCT03057600|50127455|FG001|Overall Study|Radiologic Disease Progression|7|||
25029067|NCT03057600|50127456|FG002|Overall Study|Radiologic Disease Progression|13|||
25029068|NCT03057600|50127457|FG003|Overall Study|Radiologic Disease Progression|10|||
25029069|NCT03057600|50127454|FG000|Overall Study|Symptomatic Deterioration|0|||
25029070|NCT03057600|50127455|FG001|Overall Study|Symptomatic Deterioration|1|||
25029071|NCT03057600|50127456|FG002|Overall Study|Symptomatic Deterioration|1|||
25157471|NCT01760954|50274193|FG002|Treatment Period (6 Months)|Other|3|||
24938473|NCT00308620|50031676|FG000|Overall Study|Death|1|||
24938474|NCT00308620|50031677|FG001|Overall Study|Death|1|||
24938475|NCT00308620|50031678|FG002|Overall Study|Death|0|||
24938476|NCT00308620|50031676|FG000|Overall Study|Lost to Follow-up|0|||
25157472|NCT01760954|50274194|FG003|Treatment Period (6 Months)|Other|1|||
24938477|NCT00308620|50031677|FG001|Overall Study|Lost to Follow-up|0|||
24938478|NCT00308620|50031678|FG002|Overall Study|Lost to Follow-up|1|||
25157473|NCT01760954|50274191|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
25157474|NCT01760954|50274192|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
24938479|NCT00492752|50031688|FG000|Double Blind Treatment|Death|13|||
24938480|NCT00492752|50031689|FG001|Double Blind Treatment|Death|0|||
24938481|NCT00492752|50031690|FG002|Double Blind Treatment|Death|2|||
24938482|NCT00492752|50031691|FG003|Double Blind Treatment|Death|0|||
24938483|NCT00492752|50031688|FG000|Double Blind Treatment|Adverse Event|1|||
24938484|NCT00492752|50031689|FG001|Double Blind Treatment|Adverse Event|0|||
24938485|NCT00492752|50031690|FG002|Double Blind Treatment|Adverse Event|0|||
25029072|NCT03057600|50127457|FG003|Overall Study|Symptomatic Deterioration|0|||
25029073|NCT03057600|50127454|FG000|Overall Study|Investigator Decision|0|||
24938486|NCT00492752|50031691|FG003|Double Blind Treatment|Adverse Event|0|||
24938487|NCT00492752|50031688|FG000|Double Blind Treatment|Protocol Violation|0|||
24938488|NCT00492752|50031689|FG001|Double Blind Treatment|Protocol Violation|0|||
24938489|NCT00492752|50031690|FG002|Double Blind Treatment|Protocol Violation|1|||
24938490|NCT00492752|50031691|FG003|Double Blind Treatment|Protocol Violation|0|||
24938491|NCT00492752|50031688|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
24938492|NCT00492752|50031689|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
24938493|NCT00492752|50031690|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
24938494|NCT00492752|50031691|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
24938495|NCT00492752|50031688|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
24938496|NCT00492752|50031689|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
24938497|NCT00492752|50031690|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
24938498|NCT00492752|50031691|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
24938499|NCT00492752|50031688|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
24938500|NCT00492752|50031689|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
24938501|NCT00492752|50031690|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
24938502|NCT00492752|50031691|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
24938503|NCT00492752|50031688|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
24938504|NCT00492752|50031689|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
25029074|NCT03057600|50127455|FG001|Overall Study|Investigator Decision|0|||
25029075|NCT03057600|50127456|FG002|Overall Study|Investigator Decision|1|||
25157475|NCT01760954|50274193|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
25157476|NCT01760954|50274194|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
25157477|NCT01760954|50274191|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
25157478|NCT01760954|50274192|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
25157479|NCT01760954|50274193|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
25157480|NCT01760954|50274194|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
24938505|NCT00492752|50031690|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
25157481|NCT01760954|50274191|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
25157482|NCT01760954|50274192|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
25157483|NCT01760954|50274193|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
25157484|NCT01760954|50274194|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
25157485|NCT01760954|50274191|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
25157486|NCT01760954|50274192|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
25157487|NCT01760954|50274193|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
25157488|NCT01760954|50274194|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
25157489|NCT01760954|50274191|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
25157490|NCT01760954|50274192|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
25157491|NCT01760954|50274193|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
25157492|NCT01760954|50274194|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
25157493|NCT01760954|50274191|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
25157494|NCT01760954|50274192|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
25157495|NCT01760954|50274193|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
25157496|NCT01760954|50274194|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
25157497|NCT01760954|50274191|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
25157498|NCT01760954|50274192|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
25157499|NCT01760954|50274193|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
25157500|NCT01760954|50274194|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
25157501|NCT01760954|50274191|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
25157502|NCT01760954|50274192|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
25157503|NCT01760954|50274193|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
25157504|NCT01760954|50274194|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
25157505|NCT01760876|50274204|FG000|Overall Study|Non-cardiac death (head injury)|1|||
25157506|NCT01760876|50274204|FG000|Overall Study|Carcinoma of prostate|1|||
25157507|NCT01760876|50274204|FG000|Overall Study|Impaired renal function|1|||
25157508|NCT01760876|50274204|FG000|Overall Study|Major depression|1|||
25157509|NCT01760876|50274204|FG000|Overall Study|Very poor baseline OCT quality|2|||
24938506|NCT00492752|50031691|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
24938507|NCT00492752|50031688|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
24938508|NCT00492752|50031689|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
24938509|NCT00492752|50031690|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
24938510|NCT00492752|50031691|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
24938511|NCT00492752|50031688|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
24938512|NCT00492752|50031689|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
24938513|NCT00492752|50031690|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
24938514|NCT00492752|50031691|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
24938515|NCT00492752|50031688|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
24938516|NCT00492752|50031689|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
24938517|NCT00492752|50031690|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
24938518|NCT00492752|50031691|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
25029076|NCT03057600|50127457|FG003|Overall Study|Investigator Decision|0|||
25029077|NCT03057600|50127454|FG000|Overall Study|Study Termination by Sponsor|0|||
25029078|NCT03057600|50127455|FG001|Overall Study|Study Termination by Sponsor|0|||
25029079|NCT03057600|50127456|FG002|Overall Study|Study Termination by Sponsor|0|||
25029080|NCT03057600|50127457|FG003|Overall Study|Study Termination by Sponsor|2|||
25029081|NCT03057600|50127454|FG000|Overall Study|Withdrawal by Subject|0|||
25029082|NCT03057600|50127455|FG001|Overall Study|Withdrawal by Subject|1|||
25029083|NCT03057600|50127456|FG002|Overall Study|Withdrawal by Subject|0|||
25029084|NCT03057600|50127457|FG003|Overall Study|Withdrawal by Subject|0|||
25029085|NCT03057600|50127454|FG000|Overall Study|Other, Not Specified|1|||
25029086|NCT03057600|50127455|FG001|Overall Study|Other, Not Specified|1|||
25029087|NCT03057600|50127456|FG002|Overall Study|Other, Not Specified|1|||
25029088|NCT03057600|50127457|FG003|Overall Study|Other, Not Specified|1|||
25029089|NCT03371823|50127487|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
25029090|NCT03371823|50127488|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
25029091|NCT02966301|50127503|FG000|Overall Study|Death|2|||
25029092|NCT02966301|50127503|FG000|Overall Study|Withdrawal by Subject|1|||
25029093|NCT03107091|50127507|FG000|Overall Study|Physician Decision|1|||
25157510|NCT01759862|50274210|FG000|Overall Study|Physician Decision|3|||
25157511|NCT01759862|50274211|FG001|Overall Study|Physician Decision|1|||
25157512|NCT01759862|50274210|FG000|Overall Study|Adverse Event|0|||
25157513|NCT01759862|50274211|FG001|Overall Study|Adverse Event|1|||
25157514|NCT01606670|50274217|FG000|Overall Study|Adverse Event|6|||
25157515|NCT01606670|50274217|FG000|Overall Study|Lack of Efficacy|2|||
25157516|NCT01606670|50274217|FG000|Overall Study|Lost to Follow-up|3|||
25157517|NCT01606670|50274217|FG000|Overall Study|Withdrawal by Subject|3|||
25157518|NCT01606670|50274217|FG000|Overall Study|Other Reason|2|||
25029094|NCT03065400|50127521|FG000|Overall Study|Adverse Event|1|||
25029095|NCT03065400|50127521|FG000|Overall Study|Physician Decision|3|||
25029096|NCT03065400|50127521|FG000|Overall Study|Withdrawal by Subject|1|||
25029097|NCT03065400|50127521|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
25029098|NCT03085095|50127527|FG000|Overall Study|Adverse Event|23|||
25029099|NCT03085095|50127528|FG001|Overall Study|Adverse Event|8|||
25029100|NCT03085095|50127527|FG000|Overall Study|Protocol Violation|0|||
25029101|NCT03085095|50127528|FG001|Overall Study|Protocol Violation|1|||
25029102|NCT03085095|50127527|FG000|Overall Study|Lost to Follow-up|2|||
25029103|NCT03085095|50127528|FG001|Overall Study|Lost to Follow-up|1|||
25029104|NCT03085095|50127527|FG000|Overall Study|Withdrawal by Subject|17|||
25029105|NCT03085095|50127528|FG001|Overall Study|Withdrawal by Subject|6|||
25029106|NCT03085095|50127527|FG000|Overall Study|Physician Decision|9|||
25029107|NCT03085095|50127528|FG001|Overall Study|Physician Decision|3|||
25029108|NCT03085095|50127527|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
25029109|NCT03085095|50127528|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
25029110|NCT03085095|50127527|FG000|Overall Study|Did not Receive Study Drug|2|||
25029111|NCT03085095|50127528|FG001|Overall Study|Did not Receive Study Drug|2|||
25157519|NCT01793792|50274221|FG000|Overall Study|Death|5|||
24938519|NCT00492752|50031688|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
25029112|NCT03085095|50127527|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
25029113|NCT03085095|50127528|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
25029114|NCT04097301|50127537|FG000|Overall Study|Death|1|||
25029115|NCT04097301|50127537|FG000|Overall Study|Withdrawal by Subject|1|||
25029116|NCT04097301|50127537|FG000|Overall Study|Screening Failure|5|||
25157520|NCT01793792|50274221|FG000|Overall Study|Lost to Follow-up|5|||
25029117|NCT02276547|50127543|FG000|Overall Study|Death|2|||
25157521|NCT01793792|50274221|FG000|Overall Study|Withdrawal by Subject|1|||
25029118|NCT02276547|50127543|FG000|Overall Study|Explant|2|||
25029119|NCT02966834|50127553|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
24938520|NCT00492752|50031689|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
24938521|NCT00492752|50031690|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
24938522|NCT00492752|50031691|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
24938523|NCT00308308|50031700|FG000|Overall Study|Adverse Event|17|||
24938524|NCT00308308|50031701|FG001|Overall Study|Adverse Event|2|||
24938525|NCT00308308|50031700|FG000|Overall Study|Lost to Follow-up|5|||
24938526|NCT00308308|50031701|FG001|Overall Study|Lost to Follow-up|5|||
24938527|NCT00308308|50031700|FG000|Overall Study|Physician Decision|15|||
24938528|NCT00308308|50031701|FG001|Overall Study|Physician Decision|7|||
24938529|NCT00308308|50031700|FG000|Overall Study|Protocol Violation|3|||
24938530|NCT00308308|50031701|FG001|Overall Study|Protocol Violation|14|||
24938531|NCT00308308|50031700|FG000|Overall Study|Withdrawal by Subject|47|||
24938532|NCT00308308|50031701|FG001|Overall Study|Withdrawal by Subject|19|||
24938533|NCT00308308|50031700|FG000|Overall Study|Various|7|||
24938534|NCT00308308|50031701|FG001|Overall Study|Various|5|||
24938535|NCT00308308|50031700|FG000|Overall Study|Randomized but not dosed|8|||
24938536|NCT00308308|50031701|FG001|Overall Study|Randomized but not dosed|16|||
24938537|NCT00308308|50031700|FG000|Overall Study|Other|1|||
24938538|NCT00308308|50031701|FG001|Overall Study|Other|0|||
24938539|NCT00505934|50031707|FG000|Overall Study|Adverse Event|1|||
24938540|NCT00505934|50031707|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
25029120|NCT02966834|50127554|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
25029121|NCT02966834|50127555|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
25029122|NCT02966834|50127556|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
25029123|NCT02966834|50127557|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
25029124|NCT02966834|50127558|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
25029125|NCT02966834|50127553|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
25029126|NCT02966834|50127554|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
25029127|NCT02966834|50127555|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
25029128|NCT02966834|50127556|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
25029129|NCT02966834|50127557|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
25029130|NCT02966834|50127558|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
25029131|NCT02966834|50127553|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
25029132|NCT02966834|50127554|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
25029133|NCT02966834|50127555|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
25029134|NCT02966834|50127556|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
25029135|NCT02966834|50127557|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
25029136|NCT02966834|50127558|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
25029137|NCT02966834|50127553|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
25029138|NCT02966834|50127554|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
25157522|NCT01793792|50274221|FG000|Overall Study|Device Not Implanted|1|||
25157523|NCT01790984|50274227|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
24938541|NCT00505934|50031707|FG000|Overall Study|Other: IV dose needed to be changed|1|||
24938542|NCT00505778|50031713|FG000|Overall Study|Adverse Event|2|||
24938543|NCT00505778|50031714|FG001|Overall Study|Adverse Event|7|||
24938544|NCT00505778|50031713|FG000|Overall Study|Physician Decision|8|||
24938545|NCT00505778|50031714|FG001|Overall Study|Physician Decision|14|||
24938546|NCT00505778|50031713|FG000|Overall Study|Lost to Follow-up|17|||
24938547|NCT00505778|50031714|FG001|Overall Study|Lost to Follow-up|23|||
24938548|NCT00505778|50031713|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
24938549|NCT00505778|50031714|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
24938550|NCT00505778|50031713|FG000|Overall Study|Protocol Violation|7|||
24938551|NCT00505778|50031714|FG001|Overall Study|Protocol Violation|9|||
24938552|NCT00505778|50031713|FG000|Overall Study|Withdrawal by Subject|29|||
24938553|NCT00505778|50031714|FG001|Overall Study|Withdrawal by Subject|14|||
24938554|NCT00505778|50031713|FG000|Overall Study|Relapse|65|||
24938555|NCT00505778|50031714|FG001|Overall Study|Relapse|65|||
24938556|NCT00505778|50031713|FG000|Overall Study|Took No Study Drug|2|||
24938557|NCT00505778|50031714|FG001|Overall Study|Took No Study Drug|2|||
24938558|NCT00308074|50031720|FG000|Overall Study|Withdrawal by Subject|1|||
24938559|NCT00500760|50031726|FG000|Overall Study|Death|32|||
24938560|NCT00500760|50031727|FG001|Overall Study|Death|15|||
24938561|NCT00500760|50031726|FG000|Overall Study|Withdrawal by Subject|5|||
24938562|NCT00500760|50031727|FG001|Overall Study|Withdrawal by Subject|7|||
24938563|NCT00500760|50031726|FG000|Overall Study|Administrative decision|2|||
24938564|NCT00500760|50031727|FG001|Overall Study|Administrative decision|0|||
25157524|NCT01790984|50274228|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
24938565|NCT00500760|50031726|FG000|Overall Study|Lost to Follow-up|3|||
24938566|NCT00500760|50031727|FG001|Overall Study|Lost to Follow-up|0|||
25029139|NCT02966834|50127555|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
24938567|NCT00500760|50031726|FG000|Overall Study|Other|1|||
24938568|NCT00500760|50031727|FG001|Overall Study|Other|2|||
24938569|NCT00505622|50031736|FG000|Overall Study|Adverse Event|5|||
24938570|NCT00505622|50031737|FG001|Overall Study|Adverse Event|6|||
24938571|NCT00505622|50031738|FG002|Overall Study|Adverse Event|4|||
24938572|NCT00505622|50031736|FG000|Overall Study|Protocol Violation|1|||
24938573|NCT00505622|50031737|FG001|Overall Study|Protocol Violation|1|||
24938574|NCT00505622|50031738|FG002|Overall Study|Protocol Violation|0|||
24938575|NCT00505622|50031736|FG000|Overall Study|Withdrawal by Subject|0|||
24938576|NCT00505622|50031737|FG001|Overall Study|Withdrawal by Subject|3|||
24938577|NCT00505622|50031738|FG002|Overall Study|Withdrawal by Subject|2|||
24938578|NCT00505622|50031736|FG000|Overall Study|Study termination by sponsor|115|||
24938579|NCT00505622|50031737|FG001|Overall Study|Study termination by sponsor|98|||
24938580|NCT00505622|50031738|FG002|Overall Study|Study termination by sponsor|90|||
24938581|NCT03851094|50031748|FG000|Overall Study|Withdrawal by Subject|0|||
24938582|NCT03851094|50031749|FG001|Overall Study|Withdrawal by Subject|1|||
24938583|NCT03851094|50031748|FG000|Overall Study|Participant lost device|0|||
24938584|NCT03851094|50031749|FG001|Overall Study|Participant lost device|1|||
24938585|NCT03851094|50031748|FG000|Overall Study|Participant returned device|0|||
24938586|NCT03851094|50031749|FG001|Overall Study|Participant returned device|2|||
24938587|NCT00505076|50031760|FG000|Overall Study|Adverse Event|1|||
24938588|NCT00505076|50031761|FG001|Overall Study|Adverse Event|0|||
24938589|NCT00505076|50031762|FG002|Overall Study|Adverse Event|1|||
24938590|NCT00505076|50031760|FG000|Overall Study|Protocol Violation|2|||
24938591|NCT00505076|50031761|FG001|Overall Study|Protocol Violation|1|||
24938592|NCT00505076|50031762|FG002|Overall Study|Protocol Violation|2|||
24938593|NCT00505076|50031760|FG000|Overall Study|Withdrawal by Subject|0|||
24938594|NCT00505076|50031761|FG001|Overall Study|Withdrawal by Subject|1|||
24938595|NCT00505076|50031762|FG002|Overall Study|Withdrawal by Subject|2|||
24938596|NCT00307684|50031770|FG000|Open Label Phase|Lack of Efficacy|0|||
24938597|NCT00307684|50031771|FG001|Open Label Phase|Lack of Efficacy|0|||
24938598|NCT00307684|50031772|FG002|Open Label Phase|Lack of Efficacy|3|||
24938599|NCT00307684|50031770|FG000|Open Label Phase|Adverse Event|0|||
24938600|NCT00307684|50031771|FG001|Open Label Phase|Adverse Event|0|||
24938601|NCT00307684|50031772|FG002|Open Label Phase|Adverse Event|16|||
24938602|NCT00307684|50031770|FG000|Open Label Phase|Withdrawal by Subject|0|||
24938603|NCT00307684|50031771|FG001|Open Label Phase|Withdrawal by Subject|0|||
24938604|NCT00307684|50031772|FG002|Open Label Phase|Withdrawal by Subject|15|||
24938605|NCT00307684|50031770|FG000|Open Label Phase|Lost to Follow-up|0|||
24938606|NCT00307684|50031771|FG001|Open Label Phase|Lost to Follow-up|0|||
24938607|NCT00307684|50031772|FG002|Open Label Phase|Lost to Follow-up|11|||
24938608|NCT00307684|50031770|FG000|Open Label Phase|non compliance|0|||
24938609|NCT00307684|50031771|FG001|Open Label Phase|non compliance|0|||
24938610|NCT00307684|50031772|FG002|Open Label Phase|non compliance|5|||
24938611|NCT00307684|50031770|FG000|Open Label Phase|other|0|||
24938612|NCT00307684|50031771|FG001|Open Label Phase|other|0|||
24938613|NCT00307684|50031772|FG002|Open Label Phase|other|6|||
24938614|NCT00307684|50031770|FG000|Double Blind Phase|Lack of Efficacy|2|||
24938615|NCT00307684|50031771|FG001|Double Blind Phase|Lack of Efficacy|5|||
24938616|NCT00307684|50031772|FG002|Double Blind Phase|Lack of Efficacy|0|||
24938617|NCT00489918|50031785|FG000|Overall Study|Withdrawal by Subject|2|||
24938618|NCT00489918|50031786|FG001|Overall Study|Withdrawal by Subject|1|||
24938619|NCT00489918|50031787|FG002|Overall Study|Withdrawal by Subject|1|||
24938620|NCT00489918|50031788|FG003|Overall Study|Withdrawal by Subject|0|||
24938621|NCT00489918|50031789|FG004|Overall Study|Withdrawal by Subject|1|||
24938622|NCT00489918|50031785|FG000|Overall Study|Adverse Event|0|||
24938623|NCT00489918|50031786|FG001|Overall Study|Adverse Event|1|||
24938624|NCT00489918|50031787|FG002|Overall Study|Adverse Event|1|||
24938625|NCT00489918|50031788|FG003|Overall Study|Adverse Event|0|||
24938626|NCT00489918|50031789|FG004|Overall Study|Adverse Event|0|||
24938627|NCT00489918|50031785|FG000|Overall Study|Lost to Follow-up|0|||
24938628|NCT00489918|50031786|FG001|Overall Study|Lost to Follow-up|0|||
25029140|NCT02966834|50127556|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
25029141|NCT02966834|50127557|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
25157525|NCT01790984|50274229|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
24938629|NCT00489918|50031787|FG002|Overall Study|Lost to Follow-up|1|||
24938630|NCT00489918|50031788|FG003|Overall Study|Lost to Follow-up|1|||
24938631|NCT00489918|50031789|FG004|Overall Study|Lost to Follow-up|0|||
24938632|NCT00489918|50031785|FG000|Overall Study|Physician Decision|0|||
24938633|NCT00489918|50031786|FG001|Overall Study|Physician Decision|0|||
24938634|NCT00489918|50031787|FG002|Overall Study|Physician Decision|1|||
24938635|NCT00489918|50031788|FG003|Overall Study|Physician Decision|0|||
24938636|NCT00489918|50031789|FG004|Overall Study|Physician Decision|0|||
25157526|NCT01790984|50274230|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
24938637|NCT00307294|50031801|FG000|Overall Study|Withdrawal by Subject|1|||
24938638|NCT03963401|50031812|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
24938639|NCT03963401|50031813|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
24938640|NCT03963401|50031814|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
24938641|NCT03963401|50031815|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
24938642|NCT03963401|50031816|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
24938643|NCT03963401|50031817|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
24938644|NCT03963401|50031812|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
24938645|NCT03963401|50031813|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
24938646|NCT03963401|50031814|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
24938647|NCT03963401|50031815|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
24938648|NCT03963401|50031816|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
24938649|NCT03963401|50031817|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
24938650|NCT03963401|50031812|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
24938651|NCT03963401|50031813|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
24938652|NCT03963401|50031814|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
24938653|NCT03963401|50031815|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
24938654|NCT03963401|50031816|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
24938655|NCT03963401|50031817|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
24938656|NCT03963401|50031812|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
24938657|NCT03963401|50031813|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
24938658|NCT03963401|50031814|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
24938659|NCT03963401|50031815|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
24938660|NCT03963401|50031816|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
24938661|NCT03963401|50031817|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
24938662|NCT03963401|50031812|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
24938663|NCT03963401|50031813|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
24938664|NCT03963401|50031814|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
24938665|NCT03963401|50031815|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
24938666|NCT03963401|50031816|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
24938667|NCT03963401|50031817|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
24938668|NCT03963401|50031812|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
24938669|NCT03963401|50031813|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
24938670|NCT03963401|50031814|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
24938671|NCT03963401|50031815|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
24938672|NCT03963401|50031816|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
24938673|NCT03963401|50031817|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
24938674|NCT03963401|50031812|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
24938675|NCT03963401|50031813|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
24938676|NCT03963401|50031814|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
24938677|NCT03963401|50031815|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
24938678|NCT03963401|50031816|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
24938679|NCT03963401|50031817|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
24938680|NCT03963401|50031812|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
24938681|NCT03963401|50031813|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
24938682|NCT03963401|50031814|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
24938683|NCT03963401|50031815|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
24938684|NCT03963401|50031816|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
24938685|NCT03963401|50031817|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
24938686|NCT03963401|50031812|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
24938687|NCT03963401|50031813|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
24938688|NCT03963401|50031814|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
24938689|NCT03963401|50031815|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
24938690|NCT03963401|50031816|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
24938691|NCT03963401|50031817|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
24938692|NCT03963401|50031812|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
24938693|NCT03963401|50031813|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
24938694|NCT03963401|50031814|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
24938695|NCT03963401|50031815|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
24938696|NCT03963401|50031816|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
24938697|NCT03963401|50031817|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
24938698|NCT03963401|50031812|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
24938699|NCT03963401|50031813|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
24938700|NCT03963401|50031814|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
24938701|NCT03963401|50031815|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
25157527|NCT01735994|50274255|FG000|Overall Study|Withdrawal by Subject|6|||
25157528|NCT01735994|50274256|FG001|Overall Study|Withdrawal by Subject|4|||
25157529|NCT01735994|50274255|FG000|Overall Study|Injury|2|||
25157530|NCT01735994|50274256|FG001|Overall Study|Injury|0|||
24938702|NCT03963401|50031816|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
24938703|NCT03963401|50031817|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
24938704|NCT00334282|50031837|FG000|Overall Study|Lost to Follow-up|11|||
24938705|NCT00334282|50031838|FG001|Overall Study|Lost to Follow-up|5|||
24938706|NCT00334282|50031837|FG000|Overall Study|Withdrawal by Subject|17|||
24938707|NCT00334282|50031838|FG001|Overall Study|Withdrawal by Subject|3|||
24938708|NCT00334282|50031837|FG000|Overall Study|Death|194|||
25157531|NCT01735994|50274255|FG000|Overall Study|Kicked off team|5|||
25157532|NCT01735994|50274256|FG001|Overall Study|Kicked off team|0|||
25157533|NCT01735994|50274255|FG000|Overall Study|Lost to Follow-up|50|||
25157534|NCT01735994|50274256|FG001|Overall Study|Lost to Follow-up|62|||
25157535|NCT01790828|50274262|FG000|Overall Study|Other|34|||
25157536|NCT01790594|50274268|FG000|Overall Study|Death|1|||
25157537|NCT01790594|50274269|FG001|Overall Study|Death|0|||
25157538|NCT01790594|50274270|FG002|Overall Study|Death|0|||
25157539|NCT01790594|50274268|FG000|Overall Study|Physician Decision|2|||
25157540|NCT01790594|50274269|FG001|Overall Study|Physician Decision|1|||
25275490|NCT01073865|50589364|FG000|Overall Study|Withdrawal by Subject|5|||
25275491|NCT01073865|50589365|FG001|Overall Study|Withdrawal by Subject|5|||
25275492|NCT04862065|50589374|FG000|Screening|Protocol Violation|54|||
25275493|NCT04862065|50589375|FG001|Screening|Protocol Violation|0|||
25275494|NCT04862065|50589376|FG002|Screening|Protocol Violation|0|||
25275495|NCT04862065|50589374|FG000|Screening|Insufficient Sample|1|||
25275496|NCT04862065|50589375|FG001|Screening|Insufficient Sample|0|||
24938709|NCT00334282|50031838|FG001|Overall Study|Death|100|||
25157541|NCT01790594|50274270|FG002|Overall Study|Physician Decision|0|||
25029142|NCT02966834|50127558|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
25029143|NCT02966834|50127553|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
25029144|NCT02966834|50127554|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
25029145|NCT02966834|50127555|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
25029146|NCT02966834|50127556|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
25029147|NCT02966834|50127557|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
25029148|NCT02966834|50127558|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
25029149|NCT02966834|50127553|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
25029150|NCT02966834|50127554|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
25029151|NCT02966834|50127555|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
25029152|NCT02966834|50127556|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
25275497|NCT04862065|50589376|FG002|Screening|Insufficient Sample|0|||
24938710|NCT00306670|50031850|FG000|Overall Study|patients recruited; Genentech, the st|0|||
24938711|NCT00306670|50031851|FG001|Overall Study|patients recruited; Genentech, the st|2|||
24938712|NCT00306592|50031857|FG000|Overall Study|Adverse Event|8|||
24938713|NCT00306592|50031858|FG001|Overall Study|Adverse Event|15|||
24938714|NCT00306592|50031857|FG000|Overall Study|Lost to Follow-up|1|||
24938715|NCT00306592|50031858|FG001|Overall Study|Lost to Follow-up|0|||
24938716|NCT00306592|50031857|FG000|Overall Study|Noncompliance|0|||
24938717|NCT00306592|50031858|FG001|Overall Study|Noncompliance|2|||
24938718|NCT00306592|50031857|FG000|Overall Study|Persistent Antibodies|6|||
24938719|NCT00306592|50031858|FG001|Overall Study|Persistent Antibodies|3|||
24938720|NCT00306592|50031857|FG000|Overall Study|Voluntary|10|||
24938721|NCT00306592|50031858|FG001|Overall Study|Voluntary|6|||
24938722|NCT00306592|50031857|FG000|Overall Study|Other|5|||
24938723|NCT00306592|50031858|FG001|Overall Study|Other|10|||
24938724|NCT00306592|50031857|FG000|Overall Study|Other|1|||
24938725|NCT00306592|50031858|FG001|Overall Study|Other|2|||
24938726|NCT00306592|50031857|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
24938727|NCT00306592|50031858|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
24938728|NCT00321646|50031862|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
24938729|NCT00321646|50031862|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
24938730|NCT00321646|50031862|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
24938731|NCT00403767|50031868|FG000|Overall Study|Adverse Event|993|||
24938732|NCT00403767|50031869|FG001|Overall Study|Adverse Event|919|||
24938733|NCT00403767|50031868|FG000|Overall Study|Non-compliant with study medication|134|||
24938734|NCT00403767|50031869|FG001|Overall Study|Non-compliant with study medication|164|||
24938735|NCT00403767|50031868|FG000|Overall Study|Consent withdrawn|671|||
24938736|NCT00403767|50031869|FG001|Overall Study|Consent withdrawn|673|||
24938737|NCT00403767|50031868|FG000|Overall Study|Investigator dec./not protocol-related|191|||
24938738|NCT00403767|50031869|FG001|Overall Study|Investigator dec./not protocol-related|178|||
24938739|NCT00403767|50031868|FG000|Overall Study|Lost to Follow-up|6|||
24938740|NCT00403767|50031869|FG001|Overall Study|Lost to Follow-up|8|||
24938741|NCT00403767|50031868|FG000|Overall Study|Protocol Violation|142|||
24938742|NCT00403767|50031869|FG001|Overall Study|Protocol Violation|124|||
24938743|NCT00403767|50031868|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
24938744|NCT00403767|50031869|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
24938745|NCT00403767|50031868|FG000|Overall Study|Study terminated by sponsor|82|||
24938746|NCT00403767|50031869|FG001|Overall Study|Study terminated by sponsor|69|||
24938747|NCT00403767|50031868|FG000|Overall Study|Missing/incomplete data|1|||
24938748|NCT00403767|50031869|FG001|Overall Study|Missing/incomplete data|1|||
24938749|NCT00492284|50031879|FG000|Overall Study|Adverse Event|0|||
24938750|NCT00492284|50031880|FG001|Overall Study|Adverse Event|1|||
24938751|NCT00492284|50031881|FG002|Overall Study|Adverse Event|1|||
24938752|NCT00492284|50031882|FG003|Overall Study|Adverse Event|2|||
24938753|NCT00492284|50031879|FG000|Overall Study|Lost to Follow-up|0|||
24938754|NCT00492284|50031880|FG001|Overall Study|Lost to Follow-up|0|||
24938755|NCT00492284|50031881|FG002|Overall Study|Lost to Follow-up|3|||
24938756|NCT00492284|50031882|FG003|Overall Study|Lost to Follow-up|1|||
24938757|NCT00492284|50031879|FG000|Overall Study|Death|0|||
24938758|NCT00492284|50031880|FG001|Overall Study|Death|3|||
24938759|NCT00492284|50031881|FG002|Overall Study|Death|2|||
24938760|NCT00492284|50031882|FG003|Overall Study|Death|5|||
24938761|NCT00492284|50031879|FG000|Overall Study|Withdrawal by Subject|1|||
24938762|NCT00492284|50031880|FG001|Overall Study|Withdrawal by Subject|0|||
24938763|NCT00492284|50031881|FG002|Overall Study|Withdrawal by Subject|0|||
24938764|NCT00492284|50031882|FG003|Overall Study|Withdrawal by Subject|2|||
24938765|NCT00510458|50031892|FG000|Overall Study|5 year not evaluable/missed|21|||
24938766|NCT00510458|50031892|FG000|Overall Study|Death|1|||
24938767|NCT00510458|50031892|FG000|Overall Study|Terminated|14|||
25029153|NCT02966834|50127557|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
24938768|NCT00510458|50031892|FG000|Overall Study|Lost to Follow-up|6|||
24938769|NCT00510458|50031892|FG000|Overall Study|Withdrawal by Subject|3|||
24938770|NCT00510458|50031892|FG000|Overall Study|Revision|2|||
24938771|NCT00414765|50031899|FG000|Overall Study|Adverse Event|5|||
24938772|NCT00414765|50031900|FG001|Overall Study|Adverse Event|9|||
25029154|NCT02966834|50127558|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
24938773|NCT00414765|50031899|FG000|Overall Study|Withdrawal by Subject|1|||
24938774|NCT00414765|50031900|FG001|Overall Study|Withdrawal by Subject|1|||
24938775|NCT00414765|50031899|FG000|Overall Study|Disease Progression|0|||
24938776|NCT00414765|50031900|FG001|Overall Study|Disease Progression|1|||
24938777|NCT00500682|50031908|FG000|Overall Study|Adverse Event|37|||
24938778|NCT00500682|50031909|FG001|Overall Study|Adverse Event|29|||
24938779|NCT00500682|50031908|FG000|Overall Study|Death|25|||
24938780|NCT00500682|50031909|FG001|Overall Study|Death|16|||
24938781|NCT00500682|50031908|FG000|Overall Study|Lost to Follow-up|11|||
24938782|NCT00500682|50031909|FG001|Overall Study|Lost to Follow-up|11|||
24938783|NCT00500682|50031908|FG000|Overall Study|Physician Decision|6|||
24938784|NCT00500682|50031909|FG001|Overall Study|Physician Decision|10|||
24938785|NCT00500682|50031908|FG000|Overall Study|Pregnancy|2|||
24938786|NCT00500682|50031909|FG001|Overall Study|Pregnancy|0|||
24938787|NCT00500682|50031908|FG000|Overall Study|Protocol Violation|1|||
24938788|NCT00500682|50031909|FG001|Overall Study|Protocol Violation|3|||
24938789|NCT00500682|50031908|FG000|Overall Study|Withdrawal by Subject|80|||
24938790|NCT00500682|50031909|FG001|Overall Study|Withdrawal by Subject|74|||
24938791|NCT00500682|50031908|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
24938792|NCT00500682|50031909|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
24938793|NCT00500370|50031917|FG000|Overall Study|Adverse Event|9|||
24938794|NCT00500370|50031918|FG001|Overall Study|Adverse Event|3|||
24938795|NCT00500370|50031917|FG000|Overall Study|Lost to Follow-up|10|||
24938796|NCT00500370|50031918|FG001|Overall Study|Lost to Follow-up|10|||
24938797|NCT00500370|50031917|FG000|Overall Study|Protocol Violation|2|||
24938798|NCT00500370|50031918|FG001|Overall Study|Protocol Violation|4|||
24938799|NCT00500370|50031917|FG000|Overall Study|Sponsor Decision|2|||
24938800|NCT00500370|50031918|FG001|Overall Study|Sponsor Decision|0|||
24938801|NCT00500370|50031917|FG000|Overall Study|Subject Decision|10|||
24938802|NCT00500370|50031918|FG001|Overall Study|Subject Decision|17|||
24938803|NCT00320788|50031929|FG000|Overall Study|Adverse Event|0|||
24938804|NCT00320788|50031930|FG001|Overall Study|Adverse Event|0|||
24938805|NCT00320788|50031931|FG002|Overall Study|Adverse Event|0|||
24938806|NCT00320788|50031932|FG003|Overall Study|Adverse Event|1|||
24938807|NCT00320788|50031933|FG004|Overall Study|Adverse Event|0|||
24938808|NCT00320788|50031929|FG000|Overall Study|Death|0|||
24938809|NCT00320788|50031930|FG001|Overall Study|Death|0|||
24938810|NCT00320788|50031931|FG002|Overall Study|Death|1|||
24938811|NCT00320788|50031932|FG003|Overall Study|Death|0|||
24938812|NCT00320788|50031933|FG004|Overall Study|Death|1|||
24938813|NCT00320788|50031929|FG000|Overall Study|Lost to Follow-up|0|||
24938814|NCT00320788|50031930|FG001|Overall Study|Lost to Follow-up|2|||
24938815|NCT00320788|50031931|FG002|Overall Study|Lost to Follow-up|1|||
24938816|NCT00320788|50031932|FG003|Overall Study|Lost to Follow-up|0|||
24938817|NCT00320788|50031933|FG004|Overall Study|Lost to Follow-up|0|||
24938818|NCT00320788|50031929|FG000|Overall Study|Decision by the Sponsor|1|||
24938819|NCT00320788|50031930|FG001|Overall Study|Decision by the Sponsor|1|||
24938820|NCT00320788|50031931|FG002|Overall Study|Decision by the Sponsor|0|||
24938821|NCT00320788|50031932|FG003|Overall Study|Decision by the Sponsor|0|||
24938822|NCT00320788|50031933|FG004|Overall Study|Decision by the Sponsor|1|||
24938823|NCT00320788|50031929|FG000|Overall Study|Other|1|||
24938824|NCT00320788|50031930|FG001|Overall Study|Other|2|||
24938825|NCT00320788|50031931|FG002|Overall Study|Other|1|||
24938826|NCT00320788|50031932|FG003|Overall Study|Other|1|||
24938827|NCT00320788|50031933|FG004|Overall Study|Other|1|||
24938828|NCT00320788|50031929|FG000|Overall Study|Physician Decision|1|||
24938829|NCT00320788|50031930|FG001|Overall Study|Physician Decision|1|||
24938830|NCT00320788|50031931|FG002|Overall Study|Physician Decision|0|||
24938831|NCT00320788|50031932|FG003|Overall Study|Physician Decision|0|||
24938832|NCT00320788|50031933|FG004|Overall Study|Physician Decision|0|||
25029155|NCT03106077|50127607|FG000|Overall Study|Screen Failure|94|||
24938833|NCT00320788|50031929|FG000|Overall Study|Protocol Violation|0|||
24938834|NCT00320788|50031930|FG001|Overall Study|Protocol Violation|0|||
24938835|NCT00320788|50031931|FG002|Overall Study|Protocol Violation|0|||
24938836|NCT00320788|50031932|FG003|Overall Study|Protocol Violation|0|||
24938837|NCT00320788|50031933|FG004|Overall Study|Protocol Violation|1|||
24938838|NCT00320788|50031929|FG000|Overall Study|Withdrawal by Subject|3|||
24938839|NCT00320788|50031930|FG001|Overall Study|Withdrawal by Subject|0|||
24938840|NCT00320788|50031931|FG002|Overall Study|Withdrawal by Subject|0|||
25029156|NCT03106077|50127608|FG001|Overall Study|Screen Failure|0|||
24938841|NCT00320788|50031932|FG003|Overall Study|Withdrawal by Subject|3|||
24938842|NCT00320788|50031933|FG004|Overall Study|Withdrawal by Subject|1|||
24938843|NCT00503984|50031953|FG000|Overall Study|Protocol Violation|0|||
24938844|NCT00503984|50031954|FG001|Overall Study|Protocol Violation|1|||
24938845|NCT00503984|50031955|FG002|Overall Study|Protocol Violation|0|||
24938846|NCT00503984|50031956|FG003|Overall Study|Protocol Violation|0|||
24938847|NCT00503984|50031957|FG004|Overall Study|Protocol Violation|0|||
24938848|NCT00503984|50031958|FG005|Overall Study|Protocol Violation|0|||
24938849|NCT00503984|50031953|FG000|Overall Study|Adverse Event|0|||
24938850|NCT00503984|50031954|FG001|Overall Study|Adverse Event|1|||
25029157|NCT03105297|50127613|FG000|Baseline Phase (Day 1)|Other|21|||
24938851|NCT00503984|50031955|FG002|Overall Study|Adverse Event|0|||
24938852|NCT00503984|50031956|FG003|Overall Study|Adverse Event|0|||
24938853|NCT00503984|50031957|FG004|Overall Study|Adverse Event|0|||
24938854|NCT00503984|50031958|FG005|Overall Study|Adverse Event|0|||
24938855|NCT00503984|50031953|FG000|Overall Study|Death|0|||
24938856|NCT00503984|50031954|FG001|Overall Study|Death|0|||
24938857|NCT00503984|50031955|FG002|Overall Study|Death|0|||
24938858|NCT00503984|50031956|FG003|Overall Study|Death|0|||
24938859|NCT00503984|50031957|FG004|Overall Study|Death|1|||
24938860|NCT00503984|50031958|FG005|Overall Study|Death|0|||
24938861|NCT00565409|50031982|FG000|Period 1 Open Label|Adverse Event|17|||
24938862|NCT00565409|50031983|FG001|Period 1 Open Label|Adverse Event|0|||
24938863|NCT00565409|50031984|FG002|Period 1 Open Label|Adverse Event|0|||
24938864|NCT00565409|50031985|FG003|Period 1 Open Label|Adverse Event|0|||
24938865|NCT00565409|50031982|FG000|Period 1 Open Label|Death|2|||
24938866|NCT00565409|50031983|FG001|Period 1 Open Label|Death|0|||
24938867|NCT00565409|50031984|FG002|Period 1 Open Label|Death|0|||
24938868|NCT00565409|50031985|FG003|Period 1 Open Label|Death|0|||
24938869|NCT00565409|50031982|FG000|Period 1 Open Label|Lost to Follow-up|1|||
24938870|NCT00565409|50031983|FG001|Period 1 Open Label|Lost to Follow-up|0|||
24938871|NCT00565409|50031984|FG002|Period 1 Open Label|Lost to Follow-up|0|||
24938872|NCT00565409|50031985|FG003|Period 1 Open Label|Lost to Follow-up|0|||
24938873|NCT00565409|50031982|FG000|Period 1 Open Label|Other|21|||
24938874|NCT00565409|50031983|FG001|Period 1 Open Label|Other|0|||
24938875|NCT00565409|50031984|FG002|Period 1 Open Label|Other|0|||
24938876|NCT00565409|50031985|FG003|Period 1 Open Label|Other|0|||
24938877|NCT00565409|50031982|FG000|Period 1 Open Label|Protocol Violation|14|||
24938878|NCT00565409|50031983|FG001|Period 1 Open Label|Protocol Violation|0|||
24938879|NCT00565409|50031984|FG002|Period 1 Open Label|Protocol Violation|0|||
24938880|NCT00565409|50031985|FG003|Period 1 Open Label|Protocol Violation|0|||
24938881|NCT00565409|50031982|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
24938882|NCT00565409|50031983|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
24938883|NCT00565409|50031984|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
24938884|NCT00565409|50031985|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
24938885|NCT00565409|50031982|FG000|Period 1 Open Label|no conclusion of participation record|1|||
24938886|NCT00565409|50031983|FG001|Period 1 Open Label|no conclusion of participation record|0|||
24938887|NCT00565409|50031984|FG002|Period 1 Open Label|no conclusion of participation record|0|||
24938888|NCT00565409|50031985|FG003|Period 1 Open Label|no conclusion of participation record|0|||
24938889|NCT00565409|50031982|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
24938890|NCT00565409|50031983|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
24938891|NCT00565409|50031984|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
24938892|NCT00565409|50031985|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
24938893|NCT00565409|50031982|FG000|Period 2 Double-Blind|Adverse Event|0|||
24938894|NCT00565409|50031983|FG001|Period 2 Double-Blind|Adverse Event|7|||
24938895|NCT00565409|50031984|FG002|Period 2 Double-Blind|Adverse Event|4|||
24938896|NCT00565409|50031985|FG003|Period 2 Double-Blind|Adverse Event|5|||
24938897|NCT00565409|50031982|FG000|Period 2 Double-Blind|Death|0|||
24938898|NCT00565409|50031983|FG001|Period 2 Double-Blind|Death|2|||
24938899|NCT00565409|50031984|FG002|Period 2 Double-Blind|Death|0|||
24938900|NCT00565409|50031985|FG003|Period 2 Double-Blind|Death|0|||
24938901|NCT00565409|50031982|FG000|Period 2 Double-Blind|Protocol Violation|0|||
24938902|NCT00565409|50031983|FG001|Period 2 Double-Blind|Protocol Violation|4|||
24938903|NCT00565409|50031984|FG002|Period 2 Double-Blind|Protocol Violation|6|||
24938904|NCT00565409|50031985|FG003|Period 2 Double-Blind|Protocol Violation|2|||
24938905|NCT00565409|50031982|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
24938906|NCT00565409|50031983|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
24938907|NCT00565409|50031984|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
25029158|NCT03105297|50127613|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
25029159|NCT03105297|50127613|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
25029160|NCT03426995|50127643|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
25029161|NCT03426995|50127644|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
25029162|NCT03426995|50127645|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
24938908|NCT00565409|50031985|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
25029163|NCT03426995|50127646|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
24938909|NCT00565409|50031982|FG000|Period 2 Double-Blind|Other|0|||
24938910|NCT00565409|50031983|FG001|Period 2 Double-Blind|Other|4|||
24938911|NCT00565409|50031984|FG002|Period 2 Double-Blind|Other|5|||
24938912|NCT00565409|50031985|FG003|Period 2 Double-Blind|Other|9|||
24938913|NCT00565409|50031982|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
24938914|NCT00565409|50031983|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
24938915|NCT00565409|50031984|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
24938916|NCT00565409|50031985|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
24938917|NCT00394251|50031997|FG000|Overall Study|Adverse Event|7|||
24938918|NCT00394251|50031998|FG001|Overall Study|Adverse Event|5|||
24938919|NCT00394251|50031997|FG000|Overall Study|Unacceptable Toxicity|20|||
24938920|NCT00394251|50031998|FG001|Overall Study|Unacceptable Toxicity|18|||
24938921|NCT00394251|50031997|FG000|Overall Study|Physician Decision|1|||
24938922|NCT00394251|50031998|FG001|Overall Study|Physician Decision|1|||
24938923|NCT00394251|50031997|FG000|Overall Study|Protocol Violation|0|||
24938924|NCT00394251|50031998|FG001|Overall Study|Protocol Violation|1|||
24938925|NCT00394251|50031997|FG000|Overall Study|Withdrawal by Subject|7|||
24938926|NCT00394251|50031998|FG001|Overall Study|Withdrawal by Subject|11|||
24938927|NCT00394251|50031997|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
24938928|NCT00394251|50031998|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
24938929|NCT00394095|50032010|FG000|Overall Study|Adverse Event|1|||
24938930|NCT00394095|50032011|FG001|Overall Study|Adverse Event|0|||
24938931|NCT00503906|50032018|FG000|Overall Study|Withdrawal by Subject|1|||
24938932|NCT00305110|50032023|FG000|Overall Study|Missing data|29|||
24938933|NCT00491894|50032027|FG000|Overall Study|Adverse Event|14|||
24938934|NCT00491894|50032027|FG000|Overall Study|Withdrawal by Subject|5|||
24938935|NCT00491894|50032027|FG000|Overall Study|Death|3|||
24938936|NCT00491894|50032027|FG000|Overall Study|Lost to Follow-up|3|||
24938937|NCT00491894|50032027|FG000|Overall Study|Lack of Efficacy|2|||
24938938|NCT00491894|50032027|FG000|Overall Study|Other-Failed to meet any criteria|2|||
24938939|NCT00491894|50032027|FG000|Overall Study|Physician Decision|2|||
24938940|NCT00491894|50032027|FG000|Overall Study|Protocol Violation|2|||
24938941|NCT00491894|50032027|FG000|Overall Study|Other-Intake of prohibited medication|1|||
24938942|NCT00491504|50032035|FG000|Overall Study|Adverse Event|0|||
24938943|NCT00491504|50032036|FG001|Overall Study|Adverse Event|1|||
24938944|NCT00491504|50032037|FG002|Overall Study|Adverse Event|0|||
24938945|NCT00491504|50032038|FG003|Overall Study|Adverse Event|0|||
24938946|NCT00491504|50032035|FG000|Overall Study|Withdrawal by Subject|0|||
24938947|NCT00491504|50032036|FG001|Overall Study|Withdrawal by Subject|0|||
24938948|NCT00491504|50032037|FG002|Overall Study|Withdrawal by Subject|1|||
24938949|NCT00491504|50032038|FG003|Overall Study|Withdrawal by Subject|2|||
24938950|NCT00491504|50032035|FG000|Overall Study|Protocol Violation|0|||
24938951|NCT00491504|50032036|FG001|Overall Study|Protocol Violation|0|||
24938952|NCT00491504|50032037|FG002|Overall Study|Protocol Violation|3|||
24938953|NCT00491504|50032038|FG003|Overall Study|Protocol Violation|2|||
24938954|NCT00500292|50032049|FG000|Overall Study|Adverse Event|3|||
24938955|NCT00500292|50032050|FG001|Overall Study|Adverse Event|6|||
24938956|NCT00500292|50032051|FG002|Overall Study|Adverse Event|4|||
24938957|NCT00500292|50032049|FG000|Overall Study|Condition under investigation worsened|21|||
25029164|NCT03426995|50127647|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
25029165|NCT03426995|50127648|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
25029166|NCT03426995|50127649|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
24938958|NCT00500292|50032050|FG001|Overall Study|Condition under investigation worsened|23|||
24938959|NCT00500292|50032051|FG002|Overall Study|Condition under investigation worsened|19|||
24938960|NCT00500292|50032049|FG000|Overall Study|Withdrawal by Subject|0|||
24938961|NCT00500292|50032050|FG001|Overall Study|Withdrawal by Subject|1|||
24938962|NCT00500292|50032051|FG002|Overall Study|Withdrawal by Subject|0|||
24938963|NCT00500292|50032049|FG000|Overall Study|Other|1|||
24938964|NCT00500292|50032050|FG001|Overall Study|Other|1|||
24938965|NCT00500292|50032051|FG002|Overall Study|Other|4|||
25029167|NCT03426995|50127650|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
25029168|NCT03426995|50127651|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
25029169|NCT03426995|50127652|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
25029170|NCT03426995|50127653|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
25029171|NCT03426995|50127654|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
25029172|NCT03426995|50127655|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
24938966|NCT00499746|50032059|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
24938967|NCT00499746|50032059|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
24938968|NCT00499746|50032059|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
24938969|NCT00499746|50032059|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
24938970|NCT00489216|50032073|FG000|Overall Study|Adverse Event|1|||
25157542|NCT01790594|50274268|FG000|Overall Study|Withdrawal by Subject|2|||
24938971|NCT00499590|50032080|FG000|Overall Study|Study Terminated|112|||
24938972|NCT00499590|50032081|FG001|Overall Study|Study Terminated|112|||
24938973|NCT00499590|50032082|FG002|Overall Study|Study Terminated|112|||
24938974|NCT00499590|50032080|FG000|Overall Study|Not treated|1|||
24938975|NCT00499590|50032081|FG001|Overall Study|Not treated|0|||
24938976|NCT00499590|50032082|FG002|Overall Study|Not treated|1|||
24938977|NCT00510146|50032093|FG000|Double-Blind Treatment|Adverse Event|30|||
24938978|NCT00510146|50032094|FG001|Double-Blind Treatment|Adverse Event|13|||
24938979|NCT00510146|50032093|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
24938980|NCT00510146|50032094|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
24938981|NCT00510146|50032093|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
24938982|NCT00510146|50032094|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
24938983|NCT00510146|50032093|FG000|Double-Blind Treatment|Physician Decision|6|||
24938984|NCT00510146|50032094|FG001|Double-Blind Treatment|Physician Decision|0|||
24938985|NCT00510146|50032093|FG000|Double-Blind Treatment|Protocol Violation|1|||
24938986|NCT00510146|50032094|FG001|Double-Blind Treatment|Protocol Violation|2|||
24938987|NCT00510146|50032093|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
24938988|NCT00510146|50032094|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
24938989|NCT00510146|50032093|FG000|Double-Blind Treatment|Clinical Relapse|0|||
24938990|NCT00510146|50032094|FG001|Double-Blind Treatment|Clinical Relapse|1|||
24938991|NCT00510146|50032093|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
24938992|NCT00510146|50032094|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
24938993|NCT00510146|50032093|FG000|Open-Label Treatment|Adverse Event|22|||
24938994|NCT00510146|50032094|FG001|Open-Label Treatment|Adverse Event|8|||
24938995|NCT00510146|50032093|FG000|Open-Label Treatment|Death|1|||
24938996|NCT00510146|50032094|FG001|Open-Label Treatment|Death|1|||
24938997|NCT00510146|50032093|FG000|Open-Label Treatment|Lack of Efficacy|4|||
24938998|NCT00510146|50032094|FG001|Open-Label Treatment|Lack of Efficacy|0|||
24938999|NCT00510146|50032093|FG000|Open-Label Treatment|Lost to Follow-up|10|||
24939000|NCT00510146|50032094|FG001|Open-Label Treatment|Lost to Follow-up|1|||
24939001|NCT00510146|50032093|FG000|Open-Label Treatment|Physician Decision|3|||
24939002|NCT00510146|50032094|FG001|Open-Label Treatment|Physician Decision|1|||
24939003|NCT00510146|50032093|FG000|Open-Label Treatment|Protocol Violation|4|||
24939004|NCT00510146|50032094|FG001|Open-Label Treatment|Protocol Violation|2|||
24939005|NCT00510146|50032093|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
24939006|NCT00510146|50032094|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
24939007|NCT00510146|50032093|FG000|Open-Label Treatment|Clinical Relapse|1|||
24939008|NCT00510146|50032094|FG001|Open-Label Treatment|Clinical Relapse|1|||
24939009|NCT00510146|50032093|FG000|Open-Label Treatment|Sponsor Decision|2|||
24939010|NCT00510146|50032094|FG001|Open-Label Treatment|Sponsor Decision|0|||
24939011|NCT00480636|50032102|FG000|Overall Study|Death|12|||
24939012|NCT00480636|50032102|FG000|Overall Study|Lost to Follow-up|4|||
24939013|NCT00480636|50032102|FG000|Overall Study|Other|2|||
24939014|NCT00480636|50032102|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
24939015|NCT00499122|50032106|FG000|Overall Study|Withdrawal by Subject|2|||
24939016|NCT00393939|50032113|FG000|Overall Study|Protocol Violation|1|||
24939017|NCT00393939|50032114|FG001|Overall Study|Protocol Violation|1|||
24939018|NCT00393939|50032113|FG000|Overall Study|Lost to Follow-up|2|||
24939019|NCT00393939|50032114|FG001|Overall Study|Lost to Follow-up|4|||
24939020|NCT00393939|50032113|FG000|Overall Study|Death|10|||
24939021|NCT00393939|50032114|FG001|Overall Study|Death|4|||
25029173|NCT03426995|50127656|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
25029174|NCT03426995|50127657|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
25029175|NCT03426995|50127658|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
24939022|NCT00393939|50032113|FG000|Overall Study|Sponsor|5|||
24939023|NCT00393939|50032114|FG001|Overall Study|Sponsor|13|||
24939024|NCT00393939|50032113|FG000|Overall Study|Objective progression or relapse|239|||
24939025|NCT00393939|50032114|FG001|Overall Study|Objective progression or relapse|223|||
24939026|NCT00393939|50032113|FG000|Overall Study|Withdrawal by Subject|2|||
24939027|NCT00393939|50032114|FG001|Overall Study|Withdrawal by Subject|7|||
24939028|NCT00393939|50032113|FG000|Overall Study|Other|37|||
24939029|NCT00393939|50032114|FG001|Overall Study|Other|45|||
24939030|NCT00488982|50032120|FG000|Course 1|Physician Decision|0|||
24939031|NCT00488982|50032121|FG001|Course 1|Physician Decision|2|||
24939032|NCT00488982|50032122|FG002|Course 1|Physician Decision|4|||
24939033|NCT00488982|50032120|FG000|Course 1|Withdrawal by Subject|0|||
24939034|NCT00488982|50032121|FG001|Course 1|Withdrawal by Subject|8|||
24939035|NCT00488982|50032122|FG002|Course 1|Withdrawal by Subject|2|||
24939036|NCT00488982|50032120|FG000|Course 1|nonprotocol therapy|0|||
24939037|NCT00488982|50032121|FG001|Course 1|nonprotocol therapy|2|||
24939038|NCT00488982|50032122|FG002|Course 1|nonprotocol therapy|2|||
24939039|NCT00488982|50032120|FG000|Course 1|Adverse Event|0|||
24939040|NCT00488982|50032121|FG001|Course 1|Adverse Event|0|||
24939041|NCT00488982|50032122|FG002|Course 1|Adverse Event|6|||
24939042|NCT00488826|50032139|FG000|Overall Study|Withdrawal by Subject|40|||
24939043|NCT00488826|50032140|FG001|Overall Study|Withdrawal by Subject|35|||
25029176|NCT03426995|50127659|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
25029177|NCT03426995|50127660|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
25275498|NCT04862065|50589374|FG000|Follow-Up|Lost to Follow-up|3|||
24939044|NCT00488826|50032141|FG002|Overall Study|Withdrawal by Subject|19|||
24939045|NCT00488826|50032139|FG000|Overall Study|Protocol Violation|0|||
24939046|NCT00488826|50032140|FG001|Overall Study|Protocol Violation|0|||
24939047|NCT00488826|50032141|FG002|Overall Study|Protocol Violation|2|||
24939048|NCT00488826|50032139|FG000|Overall Study|Adverse Event|9|||
24939049|NCT00488826|50032140|FG001|Overall Study|Adverse Event|15|||
24939050|NCT00488826|50032141|FG002|Overall Study|Adverse Event|4|||
24939051|NCT00488826|50032139|FG000|Overall Study|Lost to Follow-up|5|||
24939052|NCT00488826|50032140|FG001|Overall Study|Lost to Follow-up|1|||
24939053|NCT00488826|50032141|FG002|Overall Study|Lost to Follow-up|0|||
24939054|NCT00488826|50032139|FG000|Overall Study|Protocol Deviations|2|||
24939055|NCT00488826|50032140|FG001|Overall Study|Protocol Deviations|1|||
24939056|NCT00488826|50032141|FG002|Overall Study|Protocol Deviations|1|||
24939057|NCT00393861|50032149|FG000|Overall Study|Adverse Event|2|||
24939058|NCT00393861|50032149|FG000|Overall Study|Disease Progression|24|||
24939059|NCT00480324|50032155|FG000|Overall Study|Adverse Event|1|||
24939060|NCT00480324|50032156|FG001|Overall Study|Adverse Event|1|||
24939061|NCT00480324|50032155|FG000|Overall Study|Protocol Violation|0|||
24939062|NCT00480324|50032156|FG001|Overall Study|Protocol Violation|1|||
24939063|NCT00480324|50032155|FG000|Overall Study|Withdrawal by Subject|14|||
24939064|NCT00480324|50032156|FG001|Overall Study|Withdrawal by Subject|5|||
24939065|NCT00480324|50032155|FG000|Overall Study|Lost to Follow-up|17|||
24939066|NCT00480324|50032156|FG001|Overall Study|Lost to Follow-up|8|||
24939067|NCT00480324|50032155|FG000|Overall Study|Subject's mother pregnant|0|||
24939068|NCT00480324|50032156|FG001|Overall Study|Subject's mother pregnant|1|||
24939069|NCT00488592|50032162|FG000|Overall Study|Withdrawal by Subject|1|||
24939070|NCT00488592|50032162|FG000|Overall Study|Disease progression|1|||
24939071|NCT00488592|50032162|FG000|Overall Study|Enrolled but not treated|1|||
24939072|NCT00488514|50032166|FG000|Overall Study|Adverse Event|41|||
24939073|NCT00488514|50032166|FG000|Overall Study|Lost to Follow-up|44|||
24939074|NCT00488514|50032166|FG000|Overall Study|Protocol Violation|32|||
24939075|NCT00488514|50032166|FG000|Overall Study|Withdrawal by Subject|106|||
24939076|NCT00488514|50032166|FG000|Overall Study|Lack of Efficacy|28|||
24939077|NCT00488514|50032166|FG000|Overall Study|Did not meet criteria for treatment|30|||
24939078|NCT00488514|50032166|FG000|Overall Study|Postive drug screen|1|||
24939079|NCT00488514|50032166|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
24939080|NCT00488514|50032166|FG000|Overall Study|Investigator decision|1|||
24939081|NCT00488514|50032166|FG000|Overall Study|Participant had too few migraines|5|||
24939082|NCT00488514|50032166|FG000|Overall Study|Increase in number of migraines|2|||
24939083|NCT00488514|50032166|FG000|Overall Study|Increased use of concomitant medication|1|||
24939084|NCT00320710|50032190|FG000|Overall Study|Disease progression|24|||
24939085|NCT00320710|50032191|FG001|Overall Study|Disease progression|19|||
24939086|NCT00320710|50032192|FG002|Overall Study|Disease progression|2|||
24939087|NCT00320710|50032190|FG000|Overall Study|Death|10|||
24939088|NCT00320710|50032191|FG001|Overall Study|Death|7|||
24939089|NCT00320710|50032192|FG002|Overall Study|Death|1|||
24939090|NCT00320710|50032190|FG000|Overall Study|Administrative problems|1|||
24939091|NCT00320710|50032191|FG001|Overall Study|Administrative problems|2|||
24939092|NCT00320710|50032192|FG002|Overall Study|Administrative problems|0|||
24939093|NCT00320710|50032190|FG000|Overall Study|Withdrawal by Subject|20|||
24939094|NCT00320710|50032191|FG001|Overall Study|Withdrawal by Subject|26|||
24939095|NCT00320710|50032192|FG002|Overall Study|Withdrawal by Subject|1|||
24939096|NCT00320710|50032190|FG000|Overall Study|Protocol Violation|6|||
24939097|NCT00320710|50032191|FG001|Overall Study|Protocol Violation|5|||
24939098|NCT00320710|50032192|FG002|Overall Study|Protocol Violation|0|||
24939099|NCT00320710|50032190|FG000|Overall Study|Abnormal test procedure result(s)|2|||
24939100|NCT00320710|50032191|FG001|Overall Study|Abnormal test procedure result(s)|0|||
24939101|NCT00320710|50032192|FG002|Overall Study|Abnormal test procedure result(s)|0|||
24939102|NCT00320710|50032190|FG000|Overall Study|Abnormal laboratory value(s)|12|||
24939103|NCT00320710|50032191|FG001|Overall Study|Abnormal laboratory value(s)|3|||
24939104|NCT00320710|50032192|FG002|Overall Study|Abnormal laboratory value(s)|0|||
24939105|NCT00320710|50032190|FG000|Overall Study|Adverse Event|18|||
24939106|NCT00320710|50032191|FG001|Overall Study|Adverse Event|14|||
24939107|NCT00320710|50032192|FG002|Overall Study|Adverse Event|1|||
24939108|NCT00320710|50032190|FG000|Overall Study|Lost to Follow-up|1|||
24939109|NCT00320710|50032191|FG001|Overall Study|Lost to Follow-up|0|||
24939110|NCT00320710|50032192|FG002|Overall Study|Lost to Follow-up|0|||
24939111|NCT00320398|50032201|FG000|Overall Study|Adverse Event|1|||
24939112|NCT00320398|50032202|FG001|Overall Study|Adverse Event|4|||
24939113|NCT00320398|50032201|FG000|Overall Study|Other|1|||
24939114|NCT00320398|50032202|FG001|Overall Study|Other|0|||
24939115|NCT00498186|50032209|FG000|Overall Study|Protocol Violation|10|||
24939116|NCT00498186|50032209|FG000|Overall Study|Lack of Efficacy|31|||
24939117|NCT00498186|50032209|FG000|Overall Study|Adverse Event|89|||
25029178|NCT03426995|50127661|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
25029179|NCT03426995|50127643|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
25029180|NCT03426995|50127644|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
25029181|NCT03426995|50127645|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
24939118|NCT00498186|50032209|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
24939119|NCT00498186|50032209|FG000|Overall Study|Withdrawal by Subject|18|||
24939120|NCT00498186|50032209|FG000|Overall Study|Lost to Follow-up|3|||
24939121|NCT00498186|50032209|FG000|Overall Study|Other|10|||
24939122|NCT00333970|50032215|FG000|Overall Study|Withdrawal by Subject|13|||
24939123|NCT00333970|50032216|FG001|Overall Study|Withdrawal by Subject|7|||
24939124|NCT00477594|50032224|FG000|Year 1 and Year 2|Adverse Event|4|||
24939125|NCT00477594|50032225|FG001|Year 1 and Year 2|Adverse Event|2|||
24939126|NCT00477594|50032224|FG000|Year 1 and Year 2|Physician Decision|2|||
24939127|NCT00477594|50032225|FG001|Year 1 and Year 2|Physician Decision|1|||
24939128|NCT00477594|50032224|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
24939129|NCT00477594|50032225|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
24939130|NCT00477594|50032224|FG000|Year 1 and Year 2|Other|1|||
24939131|NCT00477594|50032225|FG001|Year 1 and Year 2|Other|0|||
24939132|NCT00477594|50032224|FG000|Year 3|Adverse Event|1|||
25029182|NCT03426995|50127646|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
24939133|NCT00477594|50032225|FG001|Year 3|Adverse Event|0|||
24939134|NCT00477594|50032224|FG000|Year 3|Withdrawal by Subject|1|||
24939135|NCT00477594|50032225|FG001|Year 3|Withdrawal by Subject|0|||
24939136|NCT00477594|50032224|FG000|Follow-up Period|Withdrawal by Subject|2|||
24939137|NCT00477594|50032225|FG001|Follow-up Period|Withdrawal by Subject|1|||
25157543|NCT01790594|50274269|FG001|Overall Study|Withdrawal by Subject|0|||
24939138|NCT00477594|50032224|FG000|Follow-up Period|Other|1|||
24939139|NCT00477594|50032225|FG001|Follow-up Period|Other|0|||
24939140|NCT00475722|50032233|FG000|Overall Study|Withdrawal by Subject|12|||
24939141|NCT00475722|50032234|FG001|Overall Study|Withdrawal by Subject|12|||
24939142|NCT00475722|50032233|FG000|Overall Study|Protocol Violation|3|||
24939143|NCT00475722|50032234|FG001|Overall Study|Protocol Violation|0|||
24939144|NCT00304954|50032244|FG000|Overall Study|Withdrawal by Subject|0|||
24939145|NCT00304954|50032245|FG001|Overall Study|Withdrawal by Subject|0|||
24939146|NCT00304954|50032246|FG002|Overall Study|Withdrawal by Subject|1|||
24939147|NCT00304954|50032247|FG003|Overall Study|Withdrawal by Subject|0|||
24939148|NCT00304954|50032244|FG000|Overall Study|Adverse Event|1|||
24939149|NCT00304954|50032245|FG001|Overall Study|Adverse Event|0|||
24939150|NCT00304954|50032246|FG002|Overall Study|Adverse Event|0|||
24939151|NCT00304954|50032247|FG003|Overall Study|Adverse Event|0|||
24939152|NCT00475176|50032265|FG000|Overall Study|Adverse Event|2|||
24939153|NCT00475176|50032265|FG000|Overall Study|Withdrawal by Subject|1|||
24939154|NCT00475176|50032265|FG000|Overall Study|Protocol Violation|1|||
24939155|NCT00414609|50032271|FG000|Core Study|Adverse Event|9|||
24939156|NCT00414609|50032272|FG001|Core Study|Adverse Event|11|||
24939157|NCT00414609|50032273|FG002|Core Study|Adverse Event|0|||
24939158|NCT00414609|50032271|FG000|Core Study|Abnormal laboratory values|0|||
24939159|NCT00414609|50032272|FG001|Core Study|Abnormal laboratory values|1|||
24939160|NCT00414609|50032273|FG002|Core Study|Abnormal laboratory values|0|||
24939161|NCT00414609|50032271|FG000|Core Study|Abnormal test procedure results|1|||
24939162|NCT00414609|50032272|FG001|Core Study|Abnormal test procedure results|1|||
24939163|NCT00414609|50032273|FG002|Core Study|Abnormal test procedure results|0|||
24939164|NCT00414609|50032271|FG000|Core Study|Protocol deviation|0|||
24939165|NCT00414609|50032272|FG001|Core Study|Protocol deviation|1|||
24939166|NCT00414609|50032273|FG002|Core Study|Protocol deviation|0|||
24939167|NCT00414609|50032271|FG000|Core Study|Patient withdrew consent|10|||
24939168|NCT00414609|50032272|FG001|Core Study|Patient withdrew consent|11|||
24939169|NCT00414609|50032273|FG002|Core Study|Patient withdrew consent|0|||
24939170|NCT00414609|50032271|FG000|Core Study|Lost to Follow-up|7|||
24939171|NCT00414609|50032272|FG001|Core Study|Lost to Follow-up|4|||
24939172|NCT00414609|50032273|FG002|Core Study|Lost to Follow-up|0|||
24939173|NCT00414609|50032271|FG000|Core Study|Administrative problems|0|||
24939174|NCT00414609|50032272|FG001|Core Study|Administrative problems|2|||
25157544|NCT01790594|50274270|FG002|Overall Study|Withdrawal by Subject|0|||
24939175|NCT00414609|50032273|FG002|Core Study|Administrative problems|0|||
24939176|NCT00414609|50032271|FG000|Core Study|Death|7|||
24939177|NCT00414609|50032272|FG001|Core Study|Death|14|||
24939178|NCT00414609|50032273|FG002|Core Study|Death|0|||
24939179|NCT00414609|50032271|FG000|Extension Study|Adverse Event|0|||
24939180|NCT00414609|50032272|FG001|Extension Study|Adverse Event|0|||
24939181|NCT00414609|50032273|FG002|Extension Study|Adverse Event|14|||
24939182|NCT00414609|50032271|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
24939183|NCT00414609|50032272|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
24939184|NCT00414609|50032273|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
24939185|NCT00414609|50032271|FG000|Extension Study|Withdrawal by Subject|0|||
24939186|NCT00414609|50032272|FG001|Extension Study|Withdrawal by Subject|0|||
24939187|NCT00414609|50032273|FG002|Extension Study|Withdrawal by Subject|13|||
24939188|NCT00414609|50032271|FG000|Extension Study|Lost to Follow-up|0|||
24939189|NCT00414609|50032272|FG001|Extension Study|Lost to Follow-up|0|||
24939190|NCT00414609|50032273|FG002|Extension Study|Lost to Follow-up|10|||
24939191|NCT00414609|50032271|FG000|Extension Study|Administrative problems|0|||
24939192|NCT00414609|50032272|FG001|Extension Study|Administrative problems|0|||
24939193|NCT00414609|50032273|FG002|Extension Study|Administrative problems|1|||
24939194|NCT00414609|50032271|FG000|Extension Study|Death|0|||
24939195|NCT00414609|50032272|FG001|Extension Study|Death|0|||
24939196|NCT00414609|50032273|FG002|Extension Study|Death|17|||
24939197|NCT00393705|50032284|FG000|Overall Study|Adverse Event|0|||
24939198|NCT00393705|50032285|FG001|Overall Study|Adverse Event|2|||
24939199|NCT00393705|50032284|FG000|Overall Study|Death|0|||
24939200|NCT00393705|50032285|FG001|Overall Study|Death|1|||
24939201|NCT00393705|50032284|FG000|Overall Study|Lost to Follow-up|2|||
24939202|NCT00393705|50032285|FG001|Overall Study|Lost to Follow-up|2|||
24939203|NCT00393705|50032284|FG000|Overall Study|Entry Criteria Not Met|10|||
24939204|NCT00393705|50032285|FG001|Overall Study|Entry Criteria Not Met|10|||
24939205|NCT00393705|50032284|FG000|Overall Study|Protocol Violation|4|||
24939206|NCT00393705|50032285|FG001|Overall Study|Protocol Violation|3|||
24939207|NCT00393705|50032284|FG000|Overall Study|Withdrawal by Subject|5|||
24939208|NCT00393705|50032285|FG001|Overall Study|Withdrawal by Subject|3|||
24939209|NCT00393705|50032284|FG000|Overall Study|Physician Decision|2|||
24939210|NCT00393705|50032285|FG001|Overall Study|Physician Decision|2|||
24939211|NCT00303628|50032293|FG000|Overall Study|Disease progression|0|||
24939212|NCT00303628|50032294|FG001|Overall Study|Disease progression|1|||
24939213|NCT00303628|50032293|FG000|Overall Study|Adverse Event|26|||
24939214|NCT00303628|50032294|FG001|Overall Study|Adverse Event|36|||
24939215|NCT00303628|50032293|FG000|Overall Study|Death|0|||
24939216|NCT00303628|50032294|FG001|Overall Study|Death|1|||
24939217|NCT00303628|50032293|FG000|Overall Study|Withdrawal by Subject|11|||
24939218|NCT00303628|50032294|FG001|Overall Study|Withdrawal by Subject|20|||
24939219|NCT00303628|50032293|FG000|Overall Study|Alternative therapy|2|||
24939220|NCT00303628|50032294|FG001|Overall Study|Alternative therapy|0|||
24939221|NCT00303628|50032293|FG000|Overall Study|Other complicating disease|0|||
24939222|NCT00303628|50032294|FG001|Overall Study|Other complicating disease|1|||
24939223|NCT00303628|50032293|FG000|Overall Study|Not start protocol therapy|3|||
24939224|NCT00303628|50032294|FG001|Overall Study|Not start protocol therapy|5|||
24939225|NCT00303628|50032293|FG000|Overall Study|Other|8|||
24939226|NCT00303628|50032294|FG001|Overall Study|Other|9|||
24939227|NCT00414453|50032300|FG000|Overall Study|Abnormal lab work|16|||
24939228|NCT00332488|50032313|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
24939229|NCT00332488|50032314|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
24939230|NCT00332488|50032315|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
24939231|NCT00332488|50032313|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
24939232|NCT00332488|50032314|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
24939233|NCT00332488|50032315|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
24939234|NCT00332488|50032313|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
24939235|NCT00332488|50032314|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
24939236|NCT00332488|50032315|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
24939237|NCT00332488|50032313|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
24939238|NCT00332488|50032314|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
24939239|NCT00332488|50032315|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
24939240|NCT00332488|50032313|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
24939241|NCT00332488|50032314|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
24939242|NCT00332488|50032315|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
24939243|NCT00332488|50032313|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
24939244|NCT00332488|50032314|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
24939245|NCT00332488|50032315|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
24939246|NCT00332488|50032313|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
24939247|NCT00332488|50032314|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
24939248|NCT00332488|50032315|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
24939249|NCT00332488|50032313|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
24939250|NCT00332488|50032314|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
25157545|NCT01790594|50274268|FG000|Overall Study|Transplant was not done|0|||
25157546|NCT01790594|50274269|FG001|Overall Study|Transplant was not done|0|||
25157547|NCT01790594|50274270|FG002|Overall Study|Transplant was not done|3|||
25157548|NCT01790594|50274268|FG000|Overall Study|Terminated prior to week 76|0|||
24939251|NCT00332488|50032315|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
24939252|NCT00332488|50032313|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
24939253|NCT00332488|50032314|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
24939254|NCT00332488|50032315|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
24939255|NCT00332488|50032313|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
24939256|NCT00332488|50032314|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
24939257|NCT00332488|50032315|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
24939258|NCT00332488|50032313|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
25029183|NCT03426995|50127647|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
25157549|NCT01790594|50274269|FG001|Overall Study|Terminated prior to week 76|2|||
25157550|NCT01790594|50274270|FG002|Overall Study|Terminated prior to week 76|0|||
25157551|NCT01790516|50274279|FG000|Overall Study|Physician Decision|1|||
24939259|NCT00332488|50032314|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
24939260|NCT00332488|50032315|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
24939261|NCT00332488|50032313|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
24939262|NCT00332488|50032314|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
25157552|NCT01790516|50274280|FG001|Overall Study|Physician Decision|0|||
25157553|NCT01790438|50274288|FG000|Overall Study|Adverse Event|3|||
25157554|NCT01790438|50274289|FG001|Overall Study|Adverse Event|2|||
25157555|NCT01790438|50274288|FG000|Overall Study|Death|4|||
25157556|NCT01790438|50274289|FG001|Overall Study|Death|0|||
25157557|NCT01790438|50274288|FG000|Overall Study|Lost to Follow-up|5|||
25157558|NCT01790438|50274289|FG001|Overall Study|Lost to Follow-up|2|||
24939263|NCT00332488|50032315|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
24939264|NCT00332332|50032325|FG000|Overall Study|Adverse Event|13|||
24939265|NCT00332332|50032325|FG000|Overall Study|Death|1|||
24939266|NCT00332332|50032325|FG000|Overall Study|Withdrawal by Subject|8|||
24939267|NCT00332332|50032325|FG000|Overall Study|Physician Decision|1|||
24939268|NCT00332332|50032325|FG000|Overall Study|Lost to Follow-up|3|||
24939269|NCT00332332|50032325|FG000|Overall Study|Protocol deviation|4|||
24939270|NCT00332332|50032325|FG000|Overall Study|Noncompliance|2|||
24939271|NCT00332332|50032325|FG000|Overall Study|Disease progression|2|||
24939272|NCT00332332|50032325|FG000|Overall Study|Other|18|||
24939273|NCT00332332|50032325|FG000|Overall Study|Did not receive study treatment|16|||
24939274|NCT00392925|50032333|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
24939275|NCT00392925|50032334|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
24939276|NCT00392925|50032335|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
24939277|NCT00392925|50032336|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
24939278|NCT00392925|50032333|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
24939279|NCT00392925|50032334|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
24939280|NCT00392925|50032335|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
24939281|NCT00392925|50032336|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
24939282|NCT00392925|50032333|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
24939283|NCT00392925|50032334|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
24939284|NCT00392925|50032335|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
24939285|NCT00392925|50032336|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
24939286|NCT00392925|50032333|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
24939287|NCT00392925|50032334|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
24939288|NCT00392925|50032335|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
24939289|NCT00392925|50032336|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
24939290|NCT00392925|50032333|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
24939291|NCT00392925|50032334|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
24939292|NCT00392925|50032335|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
24939293|NCT00392925|50032336|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
24939294|NCT00392925|50032333|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
24939295|NCT00392925|50032334|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
24939296|NCT00392925|50032335|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
24939297|NCT00392925|50032336|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
24939298|NCT00392925|50032333|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
24939299|NCT00392925|50032334|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
24939300|NCT00392925|50032335|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
24939301|NCT00392925|50032336|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
24939302|NCT00392925|50032333|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
24939303|NCT00392925|50032334|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
24939304|NCT00392925|50032335|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
24939305|NCT00392925|50032336|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
24939306|NCT00392925|50032333|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
24939307|NCT00392925|50032334|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
24939308|NCT00392925|50032335|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
24939309|NCT00392925|50032336|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
24939310|NCT00474786|50032354|FG000|Overall Study|Not Meeting Study Criteria|0|||
24939311|NCT00474786|50032355|FG001|Overall Study|Not Meeting Study Criteria|1|||
24939312|NCT00474786|50032354|FG000|Overall Study|Investigator Request|2|||
24939313|NCT00474786|50032355|FG001|Overall Study|Investigator Request|1|||
24939314|NCT00474786|50032354|FG000|Overall Study|Death|189|||
24939315|NCT00474786|50032355|FG001|Overall Study|Death|170|||
24939316|NCT00474786|50032354|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
24939317|NCT00474786|50032355|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
24939318|NCT00474786|50032354|FG000|Overall Study|Lost to Follow-up|4|||
24939319|NCT00474786|50032355|FG001|Overall Study|Lost to Follow-up|7|||
24939320|NCT00474786|50032354|FG000|Overall Study|Protocol Violation|2|||
24939321|NCT00474786|50032355|FG001|Overall Study|Protocol Violation|0|||
24939322|NCT00474786|50032354|FG000|Overall Study|Withdrawal by Subject|15|||
25029184|NCT03426995|50127648|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
25157559|NCT01790438|50274288|FG000|Overall Study|Withdrawal by Subject|13|||
25157560|NCT01790438|50274289|FG001|Overall Study|Withdrawal by Subject|2|||
25157561|NCT01790438|50274288|FG000|Overall Study|Physician Decision|3|||
24939323|NCT00474786|50032355|FG001|Overall Study|Withdrawal by Subject|15|||
25157562|NCT01790438|50274289|FG001|Overall Study|Physician Decision|1|||
24939324|NCT00474786|50032354|FG000|Overall Study|Other|5|||
24939325|NCT00474786|50032355|FG001|Overall Study|Other|0|||
24939326|NCT00392769|50032361|FG000|Overall Study|Clinical Deterioration|9|||
24939327|NCT00392769|50032361|FG000|Overall Study|Adverse Event|1|||
24939328|NCT00319696|50032365|FG000|Overall Study|Adverse Event|36|||
24939329|NCT00319696|50032365|FG000|Overall Study|withdrawal of consent|14|||
24939330|NCT00319696|50032365|FG000|Overall Study|administrative|7|||
24939331|NCT00319696|50032365|FG000|Overall Study|Lost to Follow-up|3|||
24939332|NCT00474630|50032377|FG000|Overall Study|Adverse Event|98|||
24939333|NCT00474630|50032378|FG001|Overall Study|Adverse Event|26|||
24939334|NCT00474630|50032377|FG000|Overall Study|Lost to Follow-up|22|||
24939335|NCT00474630|50032378|FG001|Overall Study|Lost to Follow-up|15|||
24939336|NCT00474630|50032377|FG000|Overall Study|Withdrawal by Subject|21|||
24939337|NCT00474630|50032378|FG001|Overall Study|Withdrawal by Subject|15|||
24939338|NCT00474630|50032377|FG000|Overall Study|Protocol Violation|3|||
24939339|NCT00474630|50032378|FG001|Overall Study|Protocol Violation|4|||
24939340|NCT00474630|50032377|FG000|Overall Study|Lack of Efficacy|5|||
24939341|NCT00474630|50032378|FG001|Overall Study|Lack of Efficacy|6|||
24939342|NCT00474630|50032377|FG000|Overall Study|Drug noncompliance, other|11|||
24939343|NCT00474630|50032378|FG001|Overall Study|Drug noncompliance, other|4|||
24939344|NCT00392379|50032387|FG000|Overall Study|Withdrawal by Subject|17|||
24939345|NCT00392379|50032388|FG001|Overall Study|Withdrawal by Subject|28|||
24939346|NCT00392379|50032387|FG000|Overall Study|Lost to Follow-up|4|||
24939347|NCT00392379|50032388|FG001|Overall Study|Lost to Follow-up|9|||
24939348|NCT00392379|50032387|FG000|Overall Study|Adverse Event|1|||
24939349|NCT00392379|50032388|FG001|Overall Study|Adverse Event|1|||
24939350|NCT00497874|50032396|FG000|Overall Study|Withdrawal by Subject|48|||
24939351|NCT00497874|50032397|FG001|Overall Study|Withdrawal by Subject|17|||
24939352|NCT00497874|50032396|FG000|Overall Study|Illness|8|||
24939353|NCT00497874|50032397|FG001|Overall Study|Illness|4|||
24939354|NCT00497874|50032396|FG000|Overall Study|Death|2|||
24939355|NCT00497874|50032397|FG001|Overall Study|Death|4|||
24939356|NCT00497874|50032396|FG000|Overall Study|Unable to contact|52|||
24939357|NCT00497874|50032397|FG001|Overall Study|Unable to contact|67|||
24939358|NCT00497874|50032396|FG000|Overall Study|Unable to schedule|37|||
24939359|NCT00497874|50032397|FG001|Overall Study|Unable to schedule|24|||
24939360|NCT00403455|50032405|FG000|Overall Study|Withdrawal by Subject|1|||
24939361|NCT00318370|50032409|FG000|Period 1|Lack of Efficacy|5|||
24939362|NCT00318370|50032410|FG001|Period 1|Lack of Efficacy|0|||
24939363|NCT00318370|50032411|FG002|Period 1|Lack of Efficacy|0|||
24939364|NCT00318370|50032409|FG000|Period 1|Physician Decision|1|||
24939365|NCT00318370|50032410|FG001|Period 1|Physician Decision|0|||
24939366|NCT00318370|50032411|FG002|Period 1|Physician Decision|0|||
24939367|NCT00318370|50032409|FG000|Period 1|Withdrawal by Subject|1|||
24939368|NCT00318370|50032410|FG001|Period 1|Withdrawal by Subject|0|||
24939369|NCT00318370|50032411|FG002|Period 1|Withdrawal by Subject|0|||
24939370|NCT00318370|50032409|FG000|Period 2|Adverse Event|0|||
24939371|NCT00318370|50032410|FG001|Period 2|Adverse Event|3|||
24939372|NCT00318370|50032411|FG002|Period 2|Adverse Event|0|||
24939373|NCT00318370|50032409|FG000|Period 2|Lack of Efficacy|0|||
24939374|NCT00318370|50032410|FG001|Period 2|Lack of Efficacy|5|||
24939375|NCT00318370|50032411|FG002|Period 2|Lack of Efficacy|0|||
24939376|NCT00318370|50032409|FG000|Period 2|Physician Decision|0|||
24939377|NCT00318370|50032410|FG001|Period 2|Physician Decision|1|||
24939378|NCT00318370|50032411|FG002|Period 2|Physician Decision|0|||
25029185|NCT03426995|50127649|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
25157563|NCT01790438|50274288|FG000|Overall Study|Sponsor Decision|0|||
25157564|NCT01790438|50274289|FG001|Overall Study|Sponsor Decision|3|||
25157565|NCT01790438|50274288|FG000|Overall Study|Protocol Required Discontinuation|7|||
25157566|NCT01790438|50274289|FG001|Overall Study|Protocol Required Discontinuation|1|||
25157567|NCT01735916|50274300|FG000|Overall Study|Subject not eligible to be randomized|11|||
24939379|NCT00318370|50032409|FG000|Period 2|Withdrawal by Subject|0|||
24939380|NCT00318370|50032410|FG001|Period 2|Withdrawal by Subject|1|||
24939381|NCT00318370|50032411|FG002|Period 2|Withdrawal by Subject|0|||
24939382|NCT00318370|50032409|FG000|Period 2|Other|0|||
24939383|NCT00318370|50032410|FG001|Period 2|Other|1|||
24939384|NCT00318370|50032411|FG002|Period 2|Other|0|||
24939385|NCT00318370|50032409|FG000|Period 3|Adverse Event|0|||
24939386|NCT00318370|50032410|FG001|Period 3|Adverse Event|0|||
24939387|NCT00318370|50032411|FG002|Period 3|Adverse Event|1|||
24939388|NCT00318370|50032409|FG000|Period 3|Lack of Efficacy|0|||
24939389|NCT00318370|50032410|FG001|Period 3|Lack of Efficacy|0|||
24939390|NCT00318370|50032411|FG002|Period 3|Lack of Efficacy|24|||
25029186|NCT03426995|50127650|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
24939391|NCT00318370|50032409|FG000|Period 3|Death|0|||
24939392|NCT00318370|50032410|FG001|Period 3|Death|0|||
24939393|NCT00318370|50032411|FG002|Period 3|Death|1|||
24939394|NCT00318370|50032409|FG000|Period 3|Physician Decision|0|||
24939395|NCT00318370|50032410|FG001|Period 3|Physician Decision|0|||
24939396|NCT00318370|50032411|FG002|Period 3|Physician Decision|1|||
24939397|NCT00318370|50032409|FG000|Period 3|Withdrawal by Subject|0|||
24939398|NCT00318370|50032410|FG001|Period 3|Withdrawal by Subject|0|||
24939399|NCT00318370|50032411|FG002|Period 3|Withdrawal by Subject|3|||
24939400|NCT00318370|50032409|FG000|Period 3|Other|0|||
24939401|NCT00318370|50032410|FG001|Period 3|Other|0|||
24939402|NCT00318370|50032411|FG002|Period 3|Other|3|||
24939403|NCT00510068|50032419|FG000|Double-blind Period|Disease progression|98|||
24939404|NCT00510068|50032420|FG001|Double-blind Period|Disease progression|169|||
24939405|NCT00510068|50032419|FG000|Double-blind Period|Final primary analysis|52|||
24939406|NCT00510068|50032420|FG001|Double-blind Period|Final primary analysis|18|||
24939407|NCT00510068|50032419|FG000|Double-blind Period|Adverse Event|37|||
24939408|NCT00510068|50032420|FG001|Double-blind Period|Adverse Event|7|||
24939409|NCT00510068|50032419|FG000|Double-blind Period|Withdrawal by Subject|8|||
24939410|NCT00510068|50032420|FG001|Double-blind Period|Withdrawal by Subject|6|||
24939411|NCT00510068|50032419|FG000|Double-blind Period|Death|4|||
24939412|NCT00510068|50032420|FG001|Double-blind Period|Death|3|||
24939413|NCT00510068|50032419|FG000|Double-blind Period|Abnormal test result (s)|1|||
24939414|NCT00510068|50032420|FG001|Double-blind Period|Abnormal test result (s)|0|||
24939415|NCT00510068|50032419|FG000|Double-blind Period|Lost to Follow-up|1|||
24939416|NCT00510068|50032420|FG001|Double-blind Period|Lost to Follow-up|0|||
24939417|NCT00510068|50032419|FG000|Double-blind Period|Protocol Violation|6|||
24939418|NCT00510068|50032420|FG001|Double-blind Period|Protocol Violation|0|||
24939419|NCT00510068|50032419|FG000|Open-label Period|Disease Progression|124|||
24939420|NCT00510068|50032420|FG001|Open-label Period|Disease Progression|0|||
24939421|NCT00510068|50032419|FG000|Open-label Period|Adverse Event|46|||
24939422|NCT00510068|50032420|FG001|Open-label Period|Adverse Event|0|||
24939423|NCT00510068|50032419|FG000|Open-label Period|Withdrawal by Subject|21|||
24939424|NCT00510068|50032420|FG001|Open-label Period|Withdrawal by Subject|0|||
24939425|NCT00510068|50032419|FG000|Open-label Period|Administrative problems|17|||
24939426|NCT00510068|50032420|FG001|Open-label Period|Administrative problems|0|||
24939427|NCT00510068|50032419|FG000|Open-label Period|Death|7|||
24939428|NCT00510068|50032420|FG001|Open-label Period|Death|0|||
24939429|NCT00510068|50032419|FG000|Open-label Period|New cancer therapy|7|||
24939430|NCT00510068|50032420|FG001|Open-label Period|New cancer therapy|0|||
24939431|NCT00510068|50032419|FG000|Open-label Period|Protocol Violation|2|||
24939432|NCT00510068|50032420|FG001|Open-label Period|Protocol Violation|0|||
24939433|NCT00510068|50032419|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
24939434|NCT00510068|50032420|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
24939435|NCT00509600|50032428|FG000|Overall Study|Adverse Event|1|||
24939436|NCT00402987|50032436|FG000|Overall Study|Lack of Efficacy|0|||
24939437|NCT00402987|50032437|FG001|Overall Study|Lack of Efficacy|0|||
24939438|NCT00402987|50032438|FG002|Overall Study|Lack of Efficacy|1|||
24939439|NCT00402987|50032439|FG003|Overall Study|Lack of Efficacy|0|||
24939440|NCT00501644|50032463|FG000|Overall Study|Adverse Event|4|||
24939441|NCT00501644|50032463|FG000|Overall Study|Withdrawal by Subject|1|||
24939442|NCT00497796|50032469|FG000|Overall Study|Adverse event (not related)|9|||
24939443|NCT00497796|50032470|FG001|Overall Study|Adverse event (not related)|9|||
24939444|NCT00497796|50032469|FG000|Overall Study|Adverse event (related)|5|||
24939445|NCT00497796|50032470|FG001|Overall Study|Adverse event (related)|4|||
24939446|NCT00497796|50032469|FG000|Overall Study|CMV infection or disease treatment|30|||
24939447|NCT00497796|50032470|FG001|Overall Study|CMV infection or disease treatment|4|||
24939448|NCT00497796|50032469|FG000|Overall Study|Consent withdrawn|10|||
24939449|NCT00497796|50032470|FG001|Overall Study|Consent withdrawn|3|||
24939450|NCT00497796|50032469|FG000|Overall Study|Investigator/sponsor discretion|31|||
24939451|NCT00497796|50032470|FG001|Overall Study|Investigator/sponsor discretion|34|||
24939452|NCT00497796|50032469|FG000|Overall Study|Lost to Follow-up|0|||
25157568|NCT01735916|50274301|FG001|Overall Study|Subject not eligible to be randomized|0|||
25157569|NCT01735916|50274302|FG002|Overall Study|Subject not eligible to be randomized|0|||
25157570|NCT01735916|50274300|FG000|Overall Study|Early termination of study by sponsor|4|||
24939453|NCT00497796|50032470|FG001|Overall Study|Lost to Follow-up|1|||
24939454|NCT00497796|50032469|FG000|Overall Study|Not applicable (randomized not treated)|0|||
24939455|NCT00497796|50032470|FG001|Overall Study|Not applicable (randomized not treated)|4|||
24939456|NCT00496782|50032478|FG000|Overall Study|Protocol Violation|1|||
24939457|NCT00496782|50032479|FG001|Overall Study|Protocol Violation|2|||
25157571|NCT01735916|50274301|FG001|Overall Study|Early termination of study by sponsor|19|||
24939458|NCT00402831|50032487|FG000|Overall Study|Lost to Follow-up|1|||
24939459|NCT00402831|50032488|FG001|Overall Study|Lost to Follow-up|2|||
24939460|NCT00402831|50032487|FG000|Overall Study|Non-compliance with protocol|0|||
24939461|NCT00402831|50032488|FG001|Overall Study|Non-compliance with protocol|1|||
24939462|NCT00496626|50032498|FG000|Overall Study|Lost to Follow-up|0|||
24939463|NCT00496626|50032499|FG001|Overall Study|Lost to Follow-up|1|||
24939464|NCT00496626|50032498|FG000|Overall Study|Protocol Violation|1|||
24939465|NCT00496626|50032499|FG001|Overall Study|Protocol Violation|0|||
24939466|NCT00496626|50032498|FG000|Overall Study|Withdrawal by Subject|5|||
24939467|NCT00496626|50032499|FG001|Overall Study|Withdrawal by Subject|4|||
24939468|NCT00496626|50032498|FG000|Overall Study|Relocated|0|||
24939469|NCT00496626|50032499|FG001|Overall Study|Relocated|1|||
24939470|NCT00471822|50032509|FG000|Overall Study|Protocol Violation|2|||
24939471|NCT00471276|50032513|FG000|Overall Study|Death|2|||
24939472|NCT00471276|50032513|FG000|Overall Study|Adverse Event|16|||
24939473|NCT00471276|50032513|FG000|Overall Study|Protocol Violation|1|||
24939474|NCT00471276|50032513|FG000|Overall Study|Objective progression or relapse|54|||
24939475|NCT00471276|50032513|FG000|Overall Study|Global deterioration of health status|1|||
24939476|NCT00471276|50032513|FG000|Overall Study|Other|3|||
24939477|NCT00471276|50032513|FG000|Overall Study|Refused treatment|6|||
24939478|NCT00470262|50032519|FG000|Overall Study|Withdrawal by Subject|2|||
24939479|NCT00470262|50032520|FG001|Overall Study|Withdrawal by Subject|0|||
24939480|NCT00496470|50032529|FG000|Overall Study|Adverse Event|8|||
24939481|NCT00496470|50032530|FG001|Overall Study|Adverse Event|10|||
24939482|NCT00496470|50032529|FG000|Overall Study|Withdrawal by Subject|5|||
24939483|NCT00496470|50032530|FG001|Overall Study|Withdrawal by Subject|12|||
24939484|NCT00496470|50032529|FG000|Overall Study|Incorrectly enrolled|13|||
24939485|NCT00496470|50032530|FG001|Overall Study|Incorrectly enrolled|5|||
24939486|NCT00496470|50032529|FG000|Overall Study|Other reason|0|||
24939487|NCT00496470|50032530|FG001|Overall Study|Other reason|2|||
24939488|NCT00496080|50032536|FG000|Overall Study|Lost to Follow-up|9|||
24939489|NCT00496080|50032536|FG000|Overall Study|Surgical re-intervention|7|||
24939490|NCT00496080|50032536|FG000|Overall Study|Withdrawal by Subject|5|||
24939491|NCT00496080|50032536|FG000|Overall Study|Physician Decision|6|||
24939492|NCT00487578|50032543|FG000|Overall Study|Adverse Event|1|||
24939493|NCT00487578|50032544|FG001|Overall Study|Adverse Event|2|||
24939494|NCT00487578|50032543|FG000|Overall Study|Lack of Efficacy|0|||
24939495|NCT00487578|50032544|FG001|Overall Study|Lack of Efficacy|1|||
24939496|NCT00487578|50032543|FG000|Overall Study|Lost to Follow-up|0|||
24939497|NCT00487578|50032544|FG001|Overall Study|Lost to Follow-up|1|||
24939498|NCT00495612|50032552|FG000|Overall Study|Lost to Follow-up|1|||
24939499|NCT00495612|50032553|FG001|Overall Study|Lost to Follow-up|0|||
24939500|NCT00495612|50032552|FG000|Overall Study|Subject's Decision to Withdraw|3|||
24939501|NCT00495612|50032553|FG001|Overall Study|Subject's Decision to Withdraw|0|||
24939502|NCT00487188|50032561|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
24939503|NCT00487188|50032562|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
24939504|NCT00487188|50032563|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
24939505|NCT00487188|50032561|FG000|Induction Phase|Adverse Event|5|||
24939506|NCT00487188|50032562|FG001|Induction Phase|Adverse Event|0|||
24939507|NCT00487188|50032563|FG002|Induction Phase|Adverse Event|0|||
24939508|NCT00487188|50032561|FG000|Induction Phase|Lack of Efficacy|0|||
24939509|NCT00487188|50032562|FG001|Induction Phase|Lack of Efficacy|1|||
24939510|NCT00487188|50032563|FG002|Induction Phase|Lack of Efficacy|0|||
24939511|NCT00487188|50032561|FG000|Induction Phase|Protocol Violation|1|||
24939512|NCT00487188|50032562|FG001|Induction Phase|Protocol Violation|0|||
24939513|NCT00487188|50032563|FG002|Induction Phase|Protocol Violation|0|||
24939514|NCT00487188|50032561|FG000|Induction Phase|Refused Treatment|1|||
24939515|NCT00487188|50032562|FG001|Induction Phase|Refused Treatment|2|||
24939516|NCT00487188|50032563|FG002|Induction Phase|Refused Treatment|0|||
24939517|NCT00487188|50032561|FG000|Induction Phase|Lost to Follow-up|2|||
24939518|NCT00487188|50032562|FG001|Induction Phase|Lost to Follow-up|2|||
24939519|NCT00487188|50032563|FG002|Induction Phase|Lost to Follow-up|0|||
24939520|NCT00487188|50032561|FG000|Induction Phase|Administrative|0|||
24939521|NCT00487188|50032562|FG001|Induction Phase|Administrative|1|||
24939522|NCT00487188|50032563|FG002|Induction Phase|Administrative|0|||
24939523|NCT00487188|50032561|FG000|Maintenance Phase|Adverse Event|1|||
24939524|NCT00487188|50032562|FG001|Maintenance Phase|Adverse Event|0|||
24939525|NCT00487188|50032563|FG002|Maintenance Phase|Adverse Event|0|||
24939526|NCT00487188|50032561|FG000|Maintenance Phase|Death|1|||
24939527|NCT00487188|50032562|FG001|Maintenance Phase|Death|0|||
24939528|NCT00487188|50032563|FG002|Maintenance Phase|Death|0|||
24939529|NCT00487188|50032561|FG000|Maintenance Phase|Lost to Follow-up|1|||
24939530|NCT00487188|50032562|FG001|Maintenance Phase|Lost to Follow-up|0|||
24939531|NCT00487188|50032563|FG002|Maintenance Phase|Lost to Follow-up|0|||
24939532|NCT00487188|50032561|FG000|Maintenance Phase|Administrative|0|||
24939533|NCT00487188|50032562|FG001|Maintenance Phase|Administrative|0|||
24939534|NCT00487188|50032563|FG002|Maintenance Phase|Administrative|1|||
24939535|NCT00509366|50032584|FG000|Overall Study|Not Treated (Screen Failure)|1|||
24939536|NCT00509366|50032585|FG001|Overall Study|Not Treated (Screen Failure)|1|||
24939537|NCT00509366|50032586|FG002|Overall Study|Not Treated (Screen Failure)|1|||
24939538|NCT00509366|50032587|FG003|Overall Study|Not Treated (Screen Failure)|0|||
24939539|NCT00509366|50032588|FG004|Overall Study|Not Treated (Screen Failure)|0|||
24939540|NCT00500318|50032600|FG000|Overall Study|Adverse Event|3|||
24939541|NCT00500318|50032601|FG001|Overall Study|Adverse Event|8|||
24939542|NCT00500318|50032600|FG000|Overall Study|Protocol Violation|1|||
24939543|NCT00500318|50032601|FG001|Overall Study|Protocol Violation|3|||
24939544|NCT00500318|50032600|FG000|Overall Study|Withdrawal by Subject|1|||
24939545|NCT00500318|50032601|FG001|Overall Study|Withdrawal by Subject|2|||
24939546|NCT00500318|50032600|FG000|Overall Study|Lack of Efficacy|0|||
24939547|NCT00500318|50032601|FG001|Overall Study|Lack of Efficacy|3|||
24939548|NCT00500318|50032600|FG000|Overall Study|Other Reason|0|||
24939549|NCT00500318|50032601|FG001|Overall Study|Other Reason|1|||
24939550|NCT00508820|50032609|FG000|Overall Study|Adverse Event|6|||
24939551|NCT00508820|50032610|FG001|Overall Study|Adverse Event|10|||
25029187|NCT03426995|50127651|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
25157572|NCT01735916|50274302|FG002|Overall Study|Early termination of study by sponsor|7|||
25157573|NCT01735916|50274300|FG000|Overall Study|Withdrawal by Subject|3|||
25157574|NCT01735916|50274301|FG001|Overall Study|Withdrawal by Subject|0|||
25157575|NCT01735916|50274302|FG002|Overall Study|Withdrawal by Subject|0|||
25157576|NCT01790126|50274312|FG000|Overall Study|PSA Progression|12|||
25157577|NCT01790126|50274313|FG001|Overall Study|PSA Progression|16|||
25157578|NCT01790126|50274314|FG002|Overall Study|PSA Progression|16|||
25157579|NCT01790126|50274312|FG000|Overall Study|Other|5|||
25157580|NCT01790126|50274313|FG001|Overall Study|Other|4|||
25157581|NCT01790126|50274314|FG002|Overall Study|Other|8|||
25157582|NCT01790126|50274312|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
25157583|NCT01790126|50274313|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
25157584|NCT01790126|50274314|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
25157585|NCT01790126|50274312|FG000|Overall Study|Withdrawal by Physician|1|||
25157586|NCT01790126|50274313|FG001|Overall Study|Withdrawal by Physician|1|||
25157587|NCT01790126|50274314|FG002|Overall Study|Withdrawal by Physician|2|||
25157588|NCT01790126|50274312|FG000|Overall Study|Withdrawal by Subject|3|||
25157589|NCT01790126|50274313|FG001|Overall Study|Withdrawal by Subject|1|||
25157590|NCT01790126|50274314|FG002|Overall Study|Withdrawal by Subject|2|||
25157591|NCT01790126|50274312|FG000|Overall Study|Lost to Follow-up|1|||
25157592|NCT01790126|50274313|FG001|Overall Study|Lost to Follow-up|0|||
25157593|NCT01790126|50274314|FG002|Overall Study|Lost to Follow-up|1|||
25157594|NCT01790126|50274312|FG000|Overall Study|Adverse Event|0|||
25157595|NCT01790126|50274313|FG001|Overall Study|Adverse Event|2|||
25157596|NCT01790126|50274314|FG002|Overall Study|Adverse Event|0|||
25157597|NCT01790126|50274312|FG000|Overall Study|Death|2|||
25157598|NCT01790126|50274313|FG001|Overall Study|Death|0|||
25157599|NCT01790126|50274314|FG002|Overall Study|Death|0|||
25157600|NCT01790126|50274312|FG000|Overall Study|Radiographic Progression|3|||
25157601|NCT01790126|50274313|FG001|Overall Study|Radiographic Progression|1|||
25157602|NCT01790126|50274314|FG002|Overall Study|Radiographic Progression|0|||
25157603|NCT01734902|50274325|FG000|Overall Study|Other than listed|0|||
25157604|NCT01734902|50274326|FG001|Overall Study|Other than listed|2|||
25157605|NCT01790048|50274334|FG000|Overall Study|Incorrect Age|9|||
25157606|NCT01790048|50274335|FG001|Overall Study|Incorrect Age|14|||
25157607|NCT01790048|50274334|FG000|Overall Study|data entry error|0|||
25157608|NCT01790048|50274335|FG001|Overall Study|data entry error|1|||
25157609|NCT01790048|50274334|FG000|Overall Study|Other|0|||
25157610|NCT01790048|50274335|FG001|Overall Study|Other|2|||
25157611|NCT01790048|50274334|FG000|Overall Study|SAM at Enrollment|2|||
25157612|NCT01790048|50274335|FG001|Overall Study|SAM at Enrollment|0|||
25157613|NCT01790048|50274334|FG000|Overall Study|Measurement error|1|||
25157614|NCT01790048|50274335|FG001|Overall Study|Measurement error|0|||
25157615|NCT01789970|50274345|FG000|Open-label Titration Period|Adverse Event|68|||
25157616|NCT01789970|50274346|FG001|Open-label Titration Period|Adverse Event|0|||
25157617|NCT01789970|50274347|FG002|Open-label Titration Period|Adverse Event|0|||
25157618|NCT01789970|50274345|FG000|Open-label Titration Period|Lack of Efficacy|31|||
25157619|NCT01789970|50274346|FG001|Open-label Titration Period|Lack of Efficacy|0|||
25157620|NCT01789970|50274347|FG002|Open-label Titration Period|Lack of Efficacy|0|||
25157621|NCT01789970|50274345|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
25157622|NCT01789970|50274346|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
25157623|NCT01789970|50274347|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
25157624|NCT01789970|50274345|FG000|Open-label Titration Period|Protocol Violation|18|||
25157625|NCT01789970|50274346|FG001|Open-label Titration Period|Protocol Violation|0|||
25157626|NCT01789970|50274347|FG002|Open-label Titration Period|Protocol Violation|0|||
25157627|NCT01789970|50274345|FG000|Open-label Titration Period|Lost to Follow-up|5|||
25157628|NCT01789970|50274346|FG001|Open-label Titration Period|Lost to Follow-up|0|||
25157629|NCT01789970|50274347|FG002|Open-label Titration Period|Lost to Follow-up|0|||
25157630|NCT01789970|50274345|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
25157631|NCT01789970|50274346|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
25157632|NCT01789970|50274347|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
25029188|NCT03426995|50127652|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
25157633|NCT01789970|50274345|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
25157634|NCT01789970|50274346|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
25157635|NCT01789970|50274347|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
25157636|NCT01789970|50274345|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
25157637|NCT01789970|50274346|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
25157638|NCT01789970|50274347|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
25157639|NCT01789970|50274345|FG000|Open-label Titration Period|Pregnancy|2|||
25157640|NCT01789970|50274346|FG001|Open-label Titration Period|Pregnancy|0|||
24939552|NCT00508820|50032609|FG000|Overall Study|Death|6|||
25029189|NCT03426995|50127653|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
25029190|NCT03426995|50127654|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
25029191|NCT03426995|50127655|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
25029192|NCT03426995|50127656|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
25157641|NCT01789970|50274347|FG002|Open-label Titration Period|Pregnancy|0|||
25157642|NCT01789970|50274345|FG000|Open-label Titration Period|Other|76|||
24939553|NCT00508820|50032610|FG001|Overall Study|Death|8|||
24939554|NCT00508820|50032609|FG000|Overall Study|Lost to Follow-up|1|||
24939555|NCT00508820|50032610|FG001|Overall Study|Lost to Follow-up|1|||
24939556|NCT00508820|50032609|FG000|Overall Study|Physician Decision|8|||
24939557|NCT00508820|50032610|FG001|Overall Study|Physician Decision|2|||
24939558|NCT00508820|50032609|FG000|Overall Study|Pregnancy|0|||
24939559|NCT00508820|50032610|FG001|Overall Study|Pregnancy|2|||
24939560|NCT00508820|50032609|FG000|Overall Study|Protocol Violation|2|||
24939561|NCT00508820|50032610|FG001|Overall Study|Protocol Violation|0|||
24939562|NCT00508820|50032609|FG000|Overall Study|Withdrawal by Subject|10|||
24939563|NCT00508820|50032610|FG001|Overall Study|Withdrawal by Subject|12|||
24939564|NCT00508820|50032609|FG000|Overall Study|Other|11|||
24939565|NCT00508820|50032610|FG001|Overall Study|Other|2|||
24939566|NCT00508820|50032609|FG000|Overall Study|Noncompliance|1|||
25157643|NCT01789970|50274346|FG001|Open-label Titration Period|Other|0|||
25157644|NCT01789970|50274347|FG002|Open-label Titration Period|Other|0|||
25157645|NCT01789970|50274345|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
25157646|NCT01789970|50274346|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
25157647|NCT01789970|50274347|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
25157648|NCT01789970|50274345|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
25157649|NCT01789970|50274346|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
25157650|NCT01789970|50274347|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
25157651|NCT01789970|50274345|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
25157652|NCT01789970|50274346|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
25157653|NCT01789970|50274347|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
25157654|NCT01789970|50274345|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
25157655|NCT01789970|50274346|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
24939567|NCT00508820|50032610|FG001|Overall Study|Noncompliance|0|||
24939568|NCT00508820|50032609|FG000|Overall Study|Requirement for alternative therapy|7|||
24939569|NCT00508820|50032610|FG001|Overall Study|Requirement for alternative therapy|15|||
24939570|NCT00508820|50032609|FG000|Overall Study|Protocol-specified Criteria|3|||
24939571|NCT00508820|50032610|FG001|Overall Study|Protocol-specified Criteria|12|||
24939572|NCT00499694|50032616|FG000|Overall Study|Patient never received treatment.|1|||
24939573|NCT00486954|50032625|FG000|Pilot Part|Adverse Event|4|||
24939574|NCT00486954|50032626|FG001|Pilot Part|Adverse Event|0|||
24939575|NCT00486954|50032627|FG002|Pilot Part|Adverse Event|5|||
24939576|NCT00486954|50032628|FG003|Pilot Part|Adverse Event|0|||
24939577|NCT00486954|50032629|FG004|Pilot Part|Adverse Event|0|||
24939578|NCT00486954|50032625|FG000|Pilot Part|Disease Progression|2|||
24939579|NCT00486954|50032626|FG001|Pilot Part|Disease Progression|0|||
24939580|NCT00486954|50032627|FG002|Pilot Part|Disease Progression|1|||
24939581|NCT00486954|50032628|FG003|Pilot Part|Disease Progression|0|||
24939582|NCT00486954|50032629|FG004|Pilot Part|Disease Progression|0|||
24939583|NCT00486954|50032625|FG000|Randomized Part|Lost to Follow-up|0|||
24939584|NCT00486954|50032626|FG001|Randomized Part|Lost to Follow-up|0|||
24939585|NCT00486954|50032627|FG002|Randomized Part|Lost to Follow-up|0|||
25157656|NCT01789970|50274347|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
25157657|NCT01789970|50274345|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
25157658|NCT01789970|50274346|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
25157659|NCT01789970|50274347|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
25157660|NCT01789970|50274345|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
25157661|NCT01789970|50274346|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
25157662|NCT01789970|50274347|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
25157663|NCT01789970|50274345|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
25157664|NCT01789970|50274346|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
24939586|NCT00486954|50032628|FG003|Randomized Part|Lost to Follow-up|0|||
24939587|NCT00486954|50032629|FG004|Randomized Part|Lost to Follow-up|1|||
25029193|NCT03426995|50127657|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
24939588|NCT00486954|50032625|FG000|Randomized Part|Withdrawal by Subject|0|||
24939589|NCT00486954|50032626|FG001|Randomized Part|Withdrawal by Subject|0|||
24939590|NCT00486954|50032627|FG002|Randomized Part|Withdrawal by Subject|0|||
24939591|NCT00486954|50032628|FG003|Randomized Part|Withdrawal by Subject|1|||
24939592|NCT00486954|50032629|FG004|Randomized Part|Withdrawal by Subject|0|||
24939593|NCT00486954|50032625|FG000|Randomized Part|Sponsor Terminated Study|0|||
24939594|NCT00486954|50032626|FG001|Randomized Part|Sponsor Terminated Study|0|||
24939595|NCT00486954|50032627|FG002|Randomized Part|Sponsor Terminated Study|0|||
24939596|NCT00486954|50032628|FG003|Randomized Part|Sponsor Terminated Study|19|||
24939597|NCT00486954|50032629|FG004|Randomized Part|Sponsor Terminated Study|13|||
24939598|NCT00494676|50032639|FG000|Allocation|Withdrawal by Subject|2|||
24939599|NCT00494676|50032640|FG001|Allocation|Withdrawal by Subject|4|||
24939600|NCT00494676|50032639|FG000|First Intervention|Withdrawal by Subject|1|||
24939601|NCT00494676|50032640|FG001|First Intervention|Withdrawal by Subject|3|||
24939602|NCT00494676|50032639|FG000|Second Intervention|Withdrawal by Subject|1|||
24939603|NCT00494676|50032640|FG001|Second Intervention|Withdrawal by Subject|1|||
24939604|NCT00486720|50032648|FG000|Overall Study|Adverse Event|1|||
24939605|NCT00486720|50032649|FG001|Overall Study|Adverse Event|2|||
24939606|NCT00486720|50032648|FG000|Overall Study|Lack of Efficacy|4|||
24939607|NCT00486720|50032649|FG001|Overall Study|Lack of Efficacy|6|||
24939608|NCT00486720|50032648|FG000|Overall Study|Physician Decision|1|||
24939609|NCT00486720|50032649|FG001|Overall Study|Physician Decision|2|||
24939610|NCT00486720|50032648|FG000|Overall Study|Protocol Violation|1|||
24939611|NCT00486720|50032649|FG001|Overall Study|Protocol Violation|0|||
24939612|NCT00486720|50032648|FG000|Overall Study|Withdrawal by Subject|3|||
24939613|NCT00486720|50032649|FG001|Overall Study|Withdrawal by Subject|1|||
24939614|NCT00486720|50032648|FG000|Overall Study|Progressive Disease|0|||
24939615|NCT00486720|50032649|FG001|Overall Study|Progressive Disease|1|||
24939616|NCT00486330|50032655|FG000|Overall Study|Adverse Event|2|||
24939617|NCT00486252|50032659|FG000|Overall Study|Adverse Event|7|||
24939618|NCT00486252|50032659|FG000|Overall Study|Lack of Efficacy|9|||
24939619|NCT00486252|50032659|FG000|Overall Study|Lost to Follow-up|24|||
24939620|NCT00486252|50032659|FG000|Overall Study|Other|18|||
24939621|NCT00494442|50032667|FG000|Overall Study|Death|1|||
24939622|NCT00494442|50032668|FG001|Overall Study|Death|1|||
24939623|NCT00494442|50032667|FG000|Overall Study|Lack of Efficacy|16|||
24939624|NCT00494442|50032668|FG001|Overall Study|Lack of Efficacy|10|||
24939625|NCT00494442|50032667|FG000|Overall Study|Adverse Event|0|||
24939626|NCT00494442|50032668|FG001|Overall Study|Adverse Event|2|||
25029194|NCT03426995|50127658|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
25157665|NCT01789970|50274347|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
24939627|NCT00494442|50032667|FG000|Overall Study|Physician Decision|0|||
24939628|NCT00494442|50032668|FG001|Overall Study|Physician Decision|1|||
24939629|NCT00494442|50032667|FG000|Overall Study|Non-compliance|0|||
24939630|NCT00494442|50032668|FG001|Overall Study|Non-compliance|1|||
24939631|NCT00494442|50032667|FG000|Overall Study|Intercurrent illness|0|||
24939632|NCT00494442|50032668|FG001|Overall Study|Intercurrent illness|1|||
24939633|NCT03851016|50032676|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
24939634|NCT03851016|50032677|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
24939635|NCT00493974|50032685|FG000|Overall Study|Death|1|||
24939636|NCT00493974|50032686|FG001|Overall Study|Death|2|||
24939637|NCT00493974|50032685|FG000|Overall Study|Withdrawal by Subject|8|||
24939638|NCT00493974|50032686|FG001|Overall Study|Withdrawal by Subject|6|||
24939639|NCT00493974|50032685|FG000|Overall Study|Lost to Follow-up|4|||
24939640|NCT00493974|50032686|FG001|Overall Study|Lost to Follow-up|6|||
24939641|NCT00469092|50032694|FG000|Overall Study|Adverse Event|5|||
24939642|NCT00469092|50032695|FG001|Overall Study|Adverse Event|4|||
25157666|NCT01789970|50274345|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
25157667|NCT01789970|50274346|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
25157668|NCT01789970|50274347|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
25157669|NCT01789970|50274345|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
25157670|NCT01789970|50274346|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
25157671|NCT01789970|50274347|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
25157672|NCT01789970|50274345|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
25157673|NCT01789970|50274346|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
25157674|NCT01789970|50274347|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
25157675|NCT01789970|50274345|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
25157676|NCT01789970|50274346|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
25157677|NCT01789970|50274347|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
25157678|NCT01734434|50274365|FG000|Overall Study|Death Infant|3|||
24939643|NCT00469092|50032694|FG000|Overall Study|Lack of Efficacy|1|||
24939644|NCT00469092|50032695|FG001|Overall Study|Lack of Efficacy|0|||
24939645|NCT00469092|50032694|FG000|Overall Study|Lost to Follow-up|1|||
24939646|NCT00469092|50032695|FG001|Overall Study|Lost to Follow-up|2|||
25029195|NCT03426995|50127659|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
24939647|NCT00469092|50032694|FG000|Overall Study|Protocol Violation|3|||
24939648|NCT00469092|50032695|FG001|Overall Study|Protocol Violation|3|||
24939649|NCT00469092|50032694|FG000|Overall Study|Withdrawal by Subject|4|||
24939650|NCT00469092|50032695|FG001|Overall Study|Withdrawal by Subject|4|||
24939651|NCT00469092|50032694|FG000|Overall Study|Withdrawal Criteria|3|||
24939652|NCT00469092|50032695|FG001|Overall Study|Withdrawal Criteria|4|||
24939653|NCT00469092|50032694|FG000|Overall Study|Incorrectly Randomised|4|||
24939654|NCT00469092|50032695|FG001|Overall Study|Incorrectly Randomised|3|||
24939655|NCT00469092|50032694|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
25157679|NCT01734434|50274366|FG001|Overall Study|Death Infant|1|||
25157680|NCT01734434|50274367|FG002|Overall Study|Death Infant|17|||
25157681|NCT01734434|50274368|FG003|Overall Study|Death Infant|5|||
25157682|NCT01734434|50274365|FG000|Overall Study|Lost to Follow-up|2|||
25186106|NCT01474538|50335969|FG000|Treatment Period 1|Protocol Violation|0|||
25186107|NCT01474538|50335970|FG001|Treatment Period 1|Protocol Violation|1|||
25186108|NCT01474538|50335969|FG000|Treatment Period 2|Death|1|||
24939656|NCT00469092|50032695|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
25186109|NCT01474538|50335970|FG001|Treatment Period 2|Death|0|||
25186110|NCT01474538|50335969|FG000|Treatment Period 2|Adverse Event|1|||
25186111|NCT01474538|50335970|FG001|Treatment Period 2|Adverse Event|1|||
25186112|NCT01474538|50335969|FG000|Treatment Period 2|Withdrawal by Subject|2|||
24939657|NCT00469092|50032694|FG000|Overall Study|Use of lipid lowering drug|1|||
24939658|NCT00469092|50032695|FG001|Overall Study|Use of lipid lowering drug|0|||
24939659|NCT00469092|50032694|FG000|Overall Study|Hypoglycaemic Episodes|1|||
24939660|NCT00469092|50032695|FG001|Overall Study|Hypoglycaemic Episodes|1|||
24939661|NCT00469092|50032694|FG000|Overall Study|Abnormal lab value|1|||
24939662|NCT00469092|50032695|FG001|Overall Study|Abnormal lab value|0|||
24939663|NCT00469092|50032694|FG000|Overall Study|Use of Corticosteroid|1|||
24939664|NCT00469092|50032695|FG001|Overall Study|Use of Corticosteroid|0|||
24939665|NCT00499616|50032705|FG000|Overall Study|Death|1|||
24939666|NCT00499616|50032706|FG001|Overall Study|Death|5|||
24939667|NCT00499616|50032707|FG002|Overall Study|Death|3|||
24939668|NCT00499616|50032708|FG003|Overall Study|Death|1|||
25157683|NCT01734434|50274366|FG001|Overall Study|Lost to Follow-up|9|||
24939669|NCT00499616|50032705|FG000|Overall Study|Lack of Efficacy|5|||
24939670|NCT00499616|50032706|FG001|Overall Study|Lack of Efficacy|0|||
24939671|NCT00499616|50032707|FG002|Overall Study|Lack of Efficacy|19|||
24939672|NCT00499616|50032708|FG003|Overall Study|Lack of Efficacy|0|||
24939673|NCT00499616|50032705|FG000|Overall Study|Lost to Follow-up|0|||
24939674|NCT00499616|50032706|FG001|Overall Study|Lost to Follow-up|0|||
24939675|NCT00499616|50032707|FG002|Overall Study|Lost to Follow-up|1|||
24939676|NCT00499616|50032708|FG003|Overall Study|Lost to Follow-up|0|||
24939677|NCT00499616|50032705|FG000|Overall Study|Physician Decision|6|||
24939678|NCT00499616|50032706|FG001|Overall Study|Physician Decision|16|||
24939679|NCT00499616|50032707|FG002|Overall Study|Physician Decision|9|||
24939680|NCT00499616|50032708|FG003|Overall Study|Physician Decision|0|||
24939681|NCT00499616|50032705|FG000|Overall Study|Withdrawal by Subject|1|||
24939682|NCT00499616|50032706|FG001|Overall Study|Withdrawal by Subject|0|||
24939683|NCT00499616|50032707|FG002|Overall Study|Withdrawal by Subject|1|||
24939684|NCT00499616|50032708|FG003|Overall Study|Withdrawal by Subject|0|||
24939685|NCT00499616|50032705|FG000|Overall Study|Ineligible|1|||
24939686|NCT00499616|50032706|FG001|Overall Study|Ineligible|2|||
24939687|NCT00499616|50032707|FG002|Overall Study|Ineligible|0|||
24939688|NCT00499616|50032708|FG003|Overall Study|Ineligible|15|||
24939689|NCT00499616|50032705|FG000|Overall Study|Not evaluable|0|||
24939690|NCT00499616|50032706|FG001|Overall Study|Not evaluable|0|||
24939691|NCT00499616|50032707|FG002|Overall Study|Not evaluable|0|||
24939692|NCT00499616|50032708|FG003|Overall Study|Not evaluable|41|||
24939693|NCT00499616|50032705|FG000|Overall Study|Patient/Parent Refusal|1|||
24939694|NCT00499616|50032706|FG001|Overall Study|Patient/Parent Refusal|5|||
25029196|NCT03426995|50127660|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
25157684|NCT01734434|50274367|FG002|Overall Study|Lost to Follow-up|67|||
25157685|NCT01734434|50274368|FG003|Overall Study|Lost to Follow-up|11|||
25186113|NCT01474538|50335970|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25186114|NCT01474538|50335969|FG000|Treatment Period 2|Sponsor decision|1|||
25186115|NCT01474538|50335970|FG001|Treatment Period 2|Sponsor decision|0|||
25186116|NCT01474538|50335969|FG000|Treatment Period 2|Physician Decision|0|||
25186117|NCT01474538|50335970|FG001|Treatment Period 2|Physician Decision|1|||
24939695|NCT00499616|50032707|FG002|Overall Study|Patient/Parent Refusal|3|||
24939696|NCT00499616|50032708|FG003|Overall Study|Patient/Parent Refusal|0|||
24939697|NCT00402597|50032726|FG000|Overall Study|Death|15|||
24939698|NCT00402597|50032727|FG001|Overall Study|Death|7|||
24939699|NCT00402597|50032728|FG002|Overall Study|Death|6|||
24939700|NCT00402597|50032729|FG003|Overall Study|Death|4|||
24939701|NCT00402597|50032730|FG004|Overall Study|Death|6|||
24939702|NCT00402597|50032726|FG000|Overall Study|Adverse Event|81|||
24939703|NCT00402597|50032727|FG001|Overall Study|Adverse Event|18|||
24939704|NCT00402597|50032728|FG002|Overall Study|Adverse Event|106|||
24939705|NCT00402597|50032729|FG003|Overall Study|Adverse Event|39|||
24939706|NCT00402597|50032730|FG004|Overall Study|Adverse Event|71|||
25157686|NCT01734434|50274365|FG000|Overall Study|No Live Birth|1|||
25186118|NCT01474538|50335969|FG000|Treatment Period 2|Protocol Violation|1|||
25186119|NCT01474538|50335970|FG001|Treatment Period 2|Protocol Violation|0|||
25186120|NCT02647788|50335978|FG000|Overall Study|Lost to Follow-up|13|||
24939707|NCT00402597|50032726|FG000|Overall Study|Lost to Follow-up|8|||
24939708|NCT00402597|50032727|FG001|Overall Study|Lost to Follow-up|1|||
24939709|NCT00402597|50032728|FG002|Overall Study|Lost to Follow-up|8|||
25157687|NCT01734434|50274366|FG001|Overall Study|No Live Birth|2|||
25186121|NCT02647788|50335979|FG001|Overall Study|Lost to Follow-up|11|||
25157688|NCT01734434|50274367|FG002|Overall Study|No Live Birth|32|||
25157689|NCT01734434|50274368|FG003|Overall Study|No Live Birth|6|||
25157690|NCT01734434|50274365|FG000|Overall Study|Withdrawal by Subject|4|||
25157691|NCT01734434|50274366|FG001|Overall Study|Withdrawal by Subject|0|||
25157692|NCT01734434|50274367|FG002|Overall Study|Withdrawal by Subject|8|||
25157693|NCT01734434|50274368|FG003|Overall Study|Withdrawal by Subject|1|||
25157694|NCT01734434|50274365|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
25157695|NCT01734434|50274366|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
25157696|NCT01734434|50274367|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
25157697|NCT01734434|50274368|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
25157698|NCT01734434|50274365|FG000|Overall Study|Subject Not Reachable|0|||
25157699|NCT01734434|50274366|FG001|Overall Study|Subject Not Reachable|0|||
25157700|NCT01734434|50274367|FG002|Overall Study|Subject Not Reachable|1|||
25157701|NCT01734434|50274368|FG003|Overall Study|Subject Not Reachable|0|||
25157702|NCT01734434|50274365|FG000|Overall Study|Treatment Defaulter|0|||
25157703|NCT01734434|50274366|FG001|Overall Study|Treatment Defaulter|0|||
25157704|NCT01734434|50274367|FG002|Overall Study|Treatment Defaulter|1|||
25157705|NCT01734434|50274368|FG003|Overall Study|Treatment Defaulter|0|||
25157706|NCT01734434|50274365|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
25157707|NCT01734434|50274366|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
25157708|NCT01734434|50274367|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
25157709|NCT01734434|50274368|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
25157710|NCT01734434|50274365|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
25157711|NCT01734434|50274366|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
25157712|NCT01734434|50274367|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
25157713|NCT01734434|50274368|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
25157714|NCT01788566|50274386|FG000|Overall Study|Death|4|||
25157715|NCT01788566|50274386|FG000|Overall Study|Adverse Event|1|||
25157716|NCT01788566|50274386|FG000|Overall Study|Clinical Progressive Disease|3|||
25157717|NCT01733732|50274392|FG000|Overall Study|Adverse Event|1|||
25157718|NCT01733732|50274393|FG001|Overall Study|Adverse Event|0|||
25157719|NCT01733732|50274392|FG000|Overall Study|Did not attend all study visits|1|||
25157720|NCT01733732|50274393|FG001|Overall Study|Did not attend all study visits|0|||
25157721|NCT01732874|50274411|FG000|Overall Study|Withdrawal by Subject|5|||
25157722|NCT01732874|50274412|FG001|Overall Study|Withdrawal by Subject|1|||
25157723|NCT01732874|50274411|FG000|Overall Study|Death of Infant|3|||
25157724|NCT01732874|50274412|FG001|Overall Study|Death of Infant|2|||
25157725|NCT01732796|50274421|FG000|Overall Study|Adverse Event|16|||
25157726|NCT01732796|50274422|FG001|Overall Study|Adverse Event|16|||
25157727|NCT01732796|50274423|FG002|Overall Study|Adverse Event|4|||
24939710|NCT00402597|50032729|FG003|Overall Study|Lost to Follow-up|2|||
24939711|NCT00402597|50032730|FG004|Overall Study|Lost to Follow-up|3|||
24939712|NCT00402597|50032726|FG000|Overall Study|Withdrawal by Subject|57|||
24939713|NCT00402597|50032727|FG001|Overall Study|Withdrawal by Subject|16|||
25029197|NCT03426995|50127661|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
25029198|NCT03426995|50127643|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
25157728|NCT01732796|50274421|FG000|Overall Study|Lack of Efficacy|21|||
25157729|NCT01732796|50274422|FG001|Overall Study|Lack of Efficacy|18|||
25157730|NCT01732796|50274423|FG002|Overall Study|Lack of Efficacy|5|||
25157731|NCT01732796|50274421|FG000|Overall Study|Lost to Follow-up|2|||
25157732|NCT01732796|50274422|FG001|Overall Study|Lost to Follow-up|0|||
25157733|NCT01732796|50274423|FG002|Overall Study|Lost to Follow-up|0|||
25157734|NCT01732796|50274421|FG000|Overall Study|Withdrawal by Subject|6|||
25157735|NCT01732796|50274422|FG001|Overall Study|Withdrawal by Subject|8|||
25157736|NCT01732796|50274423|FG002|Overall Study|Withdrawal by Subject|2|||
25157737|NCT01732796|50274421|FG000|Overall Study|Other reason not defined above|1|||
25157738|NCT01732796|50274422|FG001|Overall Study|Other reason not defined above|0|||
25157739|NCT01732796|50274423|FG002|Overall Study|Other reason not defined above|2|||
25157740|NCT01732640|50274433|FG000|Overall Study|Adverse Event|0|||
24939714|NCT00402597|50032728|FG002|Overall Study|Withdrawal by Subject|65|||
24939715|NCT00402597|50032729|FG003|Overall Study|Withdrawal by Subject|15|||
25157741|NCT01732640|50274434|FG001|Overall Study|Adverse Event|1|||
25157742|NCT01732640|50274433|FG000|Overall Study|Death|0|||
25157743|NCT01732640|50274434|FG001|Overall Study|Death|1|||
25157744|NCT01732484|50274444|FG000|Overall Study|Death|7|||
25157745|NCT01732484|50274444|FG000|Overall Study|Lost to Follow-up|14|||
25157746|NCT01732484|50274444|FG000|Overall Study|chronical illness|5|||
25157747|NCT01786148|50274452|FG000|Overall Study|Lost to Follow-up|21|||
25157748|NCT01786148|50274453|FG001|Overall Study|Lost to Follow-up|13|||
25157749|NCT01786148|50274452|FG000|Overall Study|Death|0|||
25157750|NCT01786148|50274453|FG001|Overall Study|Death|1|||
25157751|NCT01786148|50274452|FG000|Overall Study|Withdrawal by Subject|0|||
24939716|NCT00402597|50032730|FG004|Overall Study|Withdrawal by Subject|24|||
25029199|NCT03426995|50127644|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
25157752|NCT01786148|50274453|FG001|Overall Study|Withdrawal by Subject|7|||
25157753|NCT01786148|50274452|FG000|Overall Study|Incarceration|1|||
25157754|NCT01786148|50274453|FG001|Overall Study|Incarceration|1|||
25157755|NCT01785602|50274465|FG000|Overall Study|Withdrawal by Subject|2|||
25275499|NCT04862065|50589375|FG001|Follow-Up|Lost to Follow-up|0|||
24939717|NCT00402597|50032726|FG000|Overall Study|reason not specified|30|||
24939718|NCT00402597|50032727|FG001|Overall Study|reason not specified|4|||
24939719|NCT00402597|50032728|FG002|Overall Study|reason not specified|27|||
24939720|NCT00402597|50032729|FG003|Overall Study|reason not specified|14|||
24939721|NCT00402597|50032730|FG004|Overall Study|reason not specified|20|||
24939722|NCT00402363|50032746|FG000|Overall Study|Adverse Event|9|||
24939723|NCT00402363|50032747|FG001|Overall Study|Adverse Event|14|||
24939724|NCT00402363|50032748|FG002|Overall Study|Adverse Event|2|||
24939725|NCT00402363|50032749|FG003|Overall Study|Adverse Event|2|||
25029200|NCT03426995|50127645|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
25029201|NCT03426995|50127646|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
25029202|NCT03426995|50127647|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
25029203|NCT03426995|50127648|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
25029204|NCT03426995|50127649|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
24939726|NCT00402363|50032746|FG000|Overall Study|Withdrew Consent|10|||
24939727|NCT00402363|50032747|FG001|Overall Study|Withdrew Consent|5|||
24939728|NCT00402363|50032748|FG002|Overall Study|Withdrew Consent|2|||
24939729|NCT00402363|50032749|FG003|Overall Study|Withdrew Consent|1|||
25029205|NCT03426995|50127650|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
24939730|NCT00402363|50032746|FG000|Overall Study|Protocol Violation|3|||
24939731|NCT00402363|50032747|FG001|Overall Study|Protocol Violation|5|||
24939732|NCT00402363|50032748|FG002|Overall Study|Protocol Violation|0|||
24939733|NCT00402363|50032749|FG003|Overall Study|Protocol Violation|3|||
24939734|NCT00402363|50032746|FG000|Overall Study|Lost to Follow-up|5|||
24939735|NCT00402363|50032747|FG001|Overall Study|Lost to Follow-up|4|||
24939736|NCT00402363|50032748|FG002|Overall Study|Lost to Follow-up|0|||
25029206|NCT03426995|50127651|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
25029207|NCT03426995|50127652|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
25029208|NCT03426995|50127653|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
25029209|NCT03426995|50127654|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
25029210|NCT03426995|50127655|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
25029211|NCT03426995|50127656|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
25029212|NCT03426995|50127657|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
25029213|NCT03426995|50127658|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
25029214|NCT03426995|50127659|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
25029215|NCT03426995|50127660|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
25029216|NCT03426995|50127661|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
25157756|NCT01785602|50274466|FG001|Overall Study|Withdrawal by Subject|0|||
24939737|NCT00402363|50032749|FG003|Overall Study|Lost to Follow-up|2|||
24939738|NCT00402363|50032746|FG000|Overall Study|"Captured as Other"|6|||
24939739|NCT00402363|50032747|FG001|Overall Study|"Captured as Other"|2|||
25029217|NCT03426995|50127643|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
25029218|NCT03426995|50127644|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
24939740|NCT00402363|50032748|FG002|Overall Study|"Captured as Other"|2|||
24939741|NCT00402363|50032749|FG003|Overall Study|"Captured as Other"|2|||
24939742|NCT00469014|50032769|FG000|Initial Phase Randomization|Disease Progression|0|||
24939743|NCT00469014|50032770|FG001|Initial Phase Randomization|Disease Progression|1|||
25029219|NCT03426995|50127645|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
25029220|NCT03426995|50127646|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
25029221|NCT03426995|50127647|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
25029222|NCT03426995|50127648|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
25029223|NCT03426995|50127649|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
25029224|NCT03426995|50127650|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
25029225|NCT03426995|50127651|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
25029226|NCT03426995|50127652|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
25029227|NCT03426995|50127653|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
25029228|NCT03426995|50127654|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
24939744|NCT00469014|50032771|FG002|Initial Phase Randomization|Disease Progression|1|||
24939745|NCT00469014|50032772|FG003|Initial Phase Randomization|Disease Progression|0|||
24939746|NCT00469014|50032769|FG000|Initial Phase Randomization|No Response|1|||
24939747|NCT00469014|50032770|FG001|Initial Phase Randomization|No Response|0|||
24939748|NCT00469014|50032771|FG002|Initial Phase Randomization|No Response|0|||
24939749|NCT00469014|50032772|FG003|Initial Phase Randomization|No Response|1|||
24939750|NCT00469014|50032769|FG000|Adaptive Randomization|Not Evaluable|1|||
24939751|NCT00469014|50032770|FG001|Adaptive Randomization|Not Evaluable|0|||
24939752|NCT00469014|50032771|FG002|Adaptive Randomization|Not Evaluable|0|||
24939753|NCT00469014|50032772|FG003|Adaptive Randomization|Not Evaluable|1|||
24939754|NCT00469014|50032769|FG000|Adaptive Randomization|No Response|0|||
24939755|NCT00469014|50032770|FG001|Adaptive Randomization|No Response|1|||
24939756|NCT00469014|50032771|FG002|Adaptive Randomization|No Response|0|||
24939757|NCT00469014|50032772|FG003|Adaptive Randomization|No Response|0|||
24939758|NCT00469014|50032769|FG000|Adaptive Randomization|Death|0|||
24939759|NCT00469014|50032770|FG001|Adaptive Randomization|Death|0|||
24939760|NCT00469014|50032771|FG002|Adaptive Randomization|Death|1|||
24939761|NCT00469014|50032772|FG003|Adaptive Randomization|Death|0|||
24939762|NCT00493038|50032784|FG000|Treatment|Adverse Event|8|||
24939763|NCT00493038|50032785|FG001|Treatment|Adverse Event|4|||
24939764|NCT00493038|50032784|FG000|Treatment|Lost to Follow-up|5|||
24939765|NCT00493038|50032785|FG001|Treatment|Lost to Follow-up|3|||
24939766|NCT00493038|50032784|FG000|Treatment|Withdrawal by Subject|11|||
24939767|NCT00493038|50032785|FG001|Treatment|Withdrawal by Subject|12|||
24939768|NCT00493038|50032784|FG000|Treatment|Other|0|||
24939769|NCT00493038|50032785|FG001|Treatment|Other|1|||
24939770|NCT00493038|50032784|FG000|Follow-up|Lost to Follow-up|1|||
24939771|NCT00493038|50032785|FG001|Follow-up|Lost to Follow-up|0|||
24939772|NCT00392223|50032793|FG000|Overall Study|Adverse Event|5|||
25029229|NCT03426995|50127655|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
25157757|NCT01785602|50274465|FG000|Overall Study|Lost to Follow-up|1|||
25157758|NCT01785602|50274466|FG001|Overall Study|Lost to Follow-up|1|||
25157759|NCT01785602|50274465|FG000|Overall Study|Adverse Event|3|||
25157760|NCT01785602|50274466|FG001|Overall Study|Adverse Event|5|||
25157761|NCT01785602|50274465|FG000|Overall Study|Administrative problems|7|||
25157762|NCT01785602|50274466|FG001|Overall Study|Administrative problems|3|||
25157763|NCT01785524|50274474|FG000|Overall Study|Withdrawal by Subject|2|||
25157764|NCT01785524|50274475|FG001|Overall Study|Withdrawal by Subject|2|||
25157765|NCT01757288|50274484|FG000|Overall Study|Consent withdrawal|0|||
25157766|NCT01757288|50274485|FG001|Overall Study|Consent withdrawal|4|||
25157767|NCT01757288|50274486|FG002|Overall Study|Consent withdrawal|4|||
25157768|NCT01757288|50274484|FG000|Overall Study|Patient off study, IRB hold.|0|||
25186122|NCT02647788|50335978|FG000|Overall Study|Did not want opiate|0|||
25157769|NCT01757288|50274485|FG001|Overall Study|Patient off study, IRB hold.|0|||
24939773|NCT00392223|50032794|FG001|Overall Study|Adverse Event|4|||
24939774|NCT00392223|50032793|FG000|Overall Study|Lost to Follow-up|1|||
24939775|NCT00392223|50032794|FG001|Overall Study|Lost to Follow-up|4|||
24939776|NCT00392223|50032793|FG000|Overall Study|Protocol Violation|0|||
24939777|NCT00392223|50032794|FG001|Overall Study|Protocol Violation|3|||
24939778|NCT00392223|50032793|FG000|Overall Study|Withdrawal by Subject|3|||
24939779|NCT00392223|50032794|FG001|Overall Study|Withdrawal by Subject|2|||
24939780|NCT00402285|50032803|FG000|Overall Study|insufficient RNA quality|7|||
25157770|NCT01757288|50274486|FG002|Overall Study|Patient off study, IRB hold.|1|||
25157771|NCT01757288|50274484|FG000|Overall Study|Patient death prior to starting treatment|0|||
25157772|NCT01757288|50274485|FG001|Overall Study|Patient death prior to starting treatment|0|||
25157773|NCT01757288|50274486|FG002|Overall Study|Patient death prior to starting treatment|1|||
25157774|NCT01757288|50274484|FG000|Overall Study|Wrong medication administered|0|||
25157775|NCT01757288|50274485|FG001|Overall Study|Wrong medication administered|1|||
25157776|NCT01757288|50274486|FG002|Overall Study|Wrong medication administered|0|||
25157777|NCT01757288|50274484|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
25157778|NCT01757288|50274485|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
25157779|NCT01757288|50274486|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
25157780|NCT01757288|50274484|FG000|Overall Study|Not meeting protocol constraints|0|||
25157781|NCT01757288|50274485|FG001|Overall Study|Not meeting protocol constraints|1|||
25157782|NCT01757288|50274486|FG002|Overall Study|Not meeting protocol constraints|1|||
25157783|NCT01757288|50274484|FG000|Overall Study|Multiple missed appointments|0|||
25157784|NCT01757288|50274485|FG001|Overall Study|Multiple missed appointments|1|||
25157785|NCT01757288|50274486|FG002|Overall Study|Multiple missed appointments|0|||
25157786|NCT01757288|50274484|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
25157787|NCT01757288|50274485|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
25157788|NCT01757288|50274486|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
25157789|NCT01757288|50274484|FG000|Overall Study|>2 weeks treatment break|0|||
25157790|NCT01757288|50274485|FG001|Overall Study|>2 weeks treatment break|0|||
25157791|NCT01757288|50274486|FG002|Overall Study|>2 weeks treatment break|1|||
25157792|NCT01756898|50274499|FG000|Overall Study|Adverse Event|7|||
25186123|NCT02647788|50335979|FG001|Overall Study|Did not want opiate|1|||
25186124|NCT02647788|50335978|FG000|Overall Study|Withdrawal by Subject|1|||
25186125|NCT02647788|50335979|FG001|Overall Study|Withdrawal by Subject|0|||
25186126|NCT02647788|50335978|FG000|Overall Study|Felt itchy with assigned medication|1|||
25186127|NCT02647788|50335979|FG001|Overall Study|Felt itchy with assigned medication|0|||
25186128|NCT02647788|50335978|FG000|Overall Study|Felt nauseous with assigned medication|1|||
25186129|NCT02647788|50335979|FG001|Overall Study|Felt nauseous with assigned medication|1|||
24939781|NCT00402285|50032804|FG001|Overall Study|insufficient RNA quality|6|||
24939782|NCT00402285|50032805|FG002|Overall Study|insufficient RNA quality|2|||
24939783|NCT00413283|50032815|FG000|Overall Study|Withdrawal by Subject|1|||
24939784|NCT00413283|50032816|FG001|Overall Study|Withdrawal by Subject|0|||
24939785|NCT00413283|50032817|FG002|Overall Study|Withdrawal by Subject|0|||
24939786|NCT00413283|50032818|FG003|Overall Study|Withdrawal by Subject|1|||
24939787|NCT00413283|50032815|FG000|Overall Study|Death|0|||
24939788|NCT00413283|50032816|FG001|Overall Study|Death|0|||
24939789|NCT00413283|50032817|FG002|Overall Study|Death|1|||
24939790|NCT00413283|50032818|FG003|Overall Study|Death|1|||
24939791|NCT00413283|50032815|FG000|Overall Study|Adverse Event|0|||
24939792|NCT00413283|50032816|FG001|Overall Study|Adverse Event|0|||
24939793|NCT00413283|50032817|FG002|Overall Study|Adverse Event|0|||
24939794|NCT00413283|50032818|FG003|Overall Study|Adverse Event|1|||
24939795|NCT00413283|50032815|FG000|Overall Study|Ineligibility determined|0|||
24939796|NCT00413283|50032816|FG001|Overall Study|Ineligibility determined|0|||
24939797|NCT00413283|50032817|FG002|Overall Study|Ineligibility determined|0|||
24939798|NCT00413283|50032818|FG003|Overall Study|Ineligibility determined|1|||
24939799|NCT00413283|50032815|FG000|Overall Study|Protocol deviation|0|||
24939800|NCT00413283|50032816|FG001|Overall Study|Protocol deviation|1|||
24939801|NCT00413283|50032817|FG002|Overall Study|Protocol deviation|0|||
24939802|NCT00413283|50032818|FG003|Overall Study|Protocol deviation|0|||
24939803|NCT00413283|50032815|FG000|Overall Study|Requirement for alternative therapy|0|||
24939804|NCT00413283|50032816|FG001|Overall Study|Requirement for alternative therapy|2|||
24939805|NCT00413283|50032817|FG002|Overall Study|Requirement for alternative therapy|0|||
25157793|NCT01756898|50274500|FG001|Overall Study|Adverse Event|1|||
24939806|NCT00413283|50032818|FG003|Overall Study|Requirement for alternative therapy|0|||
24939807|NCT00413283|50032815|FG000|Overall Study|Other|0|||
24939808|NCT00413283|50032816|FG001|Overall Study|Other|0|||
25157794|NCT01756898|50274501|FG002|Overall Study|Adverse Event|0|||
25186130|NCT01459016|50335985|FG000|Overall Study|Withdrawal by Subject|11|||
24939809|NCT00413283|50032817|FG002|Overall Study|Other|1|||
24939810|NCT00413283|50032818|FG003|Overall Study|Other|0|||
24939811|NCT00402051|50032830|FG000|Overall Study|Progressive Disease|13|||
24939812|NCT00402051|50032831|FG001|Overall Study|Progressive Disease|20|||
24939813|NCT00402051|50032830|FG000|Overall Study|Adverse Event|11|||
24939814|NCT00402051|50032831|FG001|Overall Study|Adverse Event|4|||
25029230|NCT03426995|50127656|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
25029231|NCT03426995|50127657|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
25029232|NCT03426995|50127658|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
25029233|NCT03426995|50127659|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
25029234|NCT03426995|50127660|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
25029235|NCT03426995|50127661|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
25029236|NCT03426995|50127643|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
25029237|NCT03426995|50127644|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
25029238|NCT03426995|50127645|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
25029239|NCT03426995|50127646|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
25029240|NCT03426995|50127647|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
25029241|NCT03426995|50127648|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
25029242|NCT03426995|50127649|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
25029243|NCT03426995|50127650|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
25029244|NCT03426995|50127651|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
25029245|NCT03426995|50127652|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
25029246|NCT03426995|50127653|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
25029247|NCT03426995|50127654|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
24939815|NCT00402051|50032830|FG000|Overall Study|Physician Decision|7|||
24939816|NCT00402051|50032831|FG001|Overall Study|Physician Decision|3|||
25029248|NCT03426995|50127655|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
25029249|NCT03426995|50127656|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
25029250|NCT03426995|50127657|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
25029251|NCT03426995|50127658|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
25029252|NCT03426995|50127659|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
25029253|NCT03426995|50127660|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
25029254|NCT03426995|50127661|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
25029255|NCT03426995|50127643|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
25029256|NCT03426995|50127644|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
25029257|NCT03426995|50127645|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
25029258|NCT03426995|50127646|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
25029259|NCT03426995|50127647|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
25029260|NCT03426995|50127648|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
25029261|NCT03426995|50127649|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
25029262|NCT03426995|50127650|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
25029263|NCT03426995|50127651|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
25029264|NCT03426995|50127652|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
25029265|NCT03426995|50127653|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
25029266|NCT03426995|50127654|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
25029267|NCT03426995|50127655|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
25029268|NCT03426995|50127656|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
25029269|NCT03426995|50127657|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
25029270|NCT03426995|50127658|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
25157795|NCT01756898|50274502|FG003|Overall Study|Adverse Event|0|||
25157796|NCT01756898|50274499|FG000|Overall Study|Lack of Efficacy|4|||
25157797|NCT01756898|50274500|FG001|Overall Study|Lack of Efficacy|7|||
25157798|NCT01756898|50274501|FG002|Overall Study|Lack of Efficacy|6|||
25157799|NCT01756898|50274502|FG003|Overall Study|Lack of Efficacy|6|||
25157800|NCT01756898|50274499|FG000|Overall Study|Lost to Follow-up|2|||
25157801|NCT01756898|50274500|FG001|Overall Study|Lost to Follow-up|4|||
24939817|NCT00402051|50032830|FG000|Overall Study|Withdrawal by Subject|3|||
24939818|NCT00402051|50032831|FG001|Overall Study|Withdrawal by Subject|3|||
24939819|NCT00402051|50032830|FG000|Overall Study|Death - Related to Study Drug|1|||
24939820|NCT00402051|50032831|FG001|Overall Study|Death - Related to Study Drug|2|||
24939821|NCT00402051|50032830|FG000|Overall Study|Death Due to Study Disease|2|||
24939822|NCT00402051|50032831|FG001|Overall Study|Death Due to Study Disease|1|||
25157802|NCT01756898|50274501|FG002|Overall Study|Lost to Follow-up|2|||
25157803|NCT01756898|50274502|FG003|Overall Study|Lost to Follow-up|3|||
25157804|NCT01756898|50274499|FG000|Overall Study|Protocol Violation|1|||
25186131|NCT01459016|50335985|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
25186132|NCT01458392|50336027|FG000|Overall Study|Death|2|||
25186133|NCT01458392|50336028|FG001|Overall Study|Death|11|||
25275500|NCT04862065|50589376|FG002|Follow-Up|Lost to Follow-up|0|||
24939823|NCT00402051|50032830|FG000|Overall Study|Death Due to Adverse Event|0|||
25029271|NCT03426995|50127659|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
25029272|NCT03426995|50127660|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
25157805|NCT01756898|50274500|FG001|Overall Study|Protocol Violation|2|||
25157806|NCT01756898|50274501|FG002|Overall Study|Protocol Violation|2|||
25157807|NCT01756898|50274502|FG003|Overall Study|Protocol Violation|1|||
25157808|NCT01756898|50274499|FG000|Overall Study|Withdrew Consent|5|||
25157809|NCT01756898|50274500|FG001|Overall Study|Withdrew Consent|3|||
25157810|NCT01756898|50274501|FG002|Overall Study|Withdrew Consent|5|||
25157811|NCT01756898|50274502|FG003|Overall Study|Withdrew Consent|6|||
25157812|NCT01756898|50274499|FG000|Overall Study|Other|0|||
25157813|NCT01756898|50274500|FG001|Overall Study|Other|2|||
25157814|NCT01756898|50274501|FG002|Overall Study|Other|2|||
25157815|NCT01756898|50274502|FG003|Overall Study|Other|0|||
25157816|NCT01731938|50274519|FG000|Preliminary Part I|Withdrawal by Subject|2|||
25157817|NCT01731938|50274520|FG001|Preliminary Part I|Withdrawal by Subject|2|||
25157818|NCT01731938|50274519|FG000|Preliminary Part I|Physician Decision|1|||
25157819|NCT01731938|50274520|FG001|Preliminary Part I|Physician Decision|0|||
25157820|NCT01731938|50274519|FG000|Preliminary Part I|Lost to Follow-up|0|||
25157821|NCT01731938|50274520|FG001|Preliminary Part I|Lost to Follow-up|3|||
25157822|NCT01731938|50274519|FG000|Preliminary Part I|Missed Week 6 visit|0|||
25157823|NCT01731938|50274520|FG001|Preliminary Part I|Missed Week 6 visit|3|||
25157824|NCT01731938|50274519|FG000|Primary Part II|Withdrawal by Subject|5|||
25157825|NCT01731938|50274520|FG001|Primary Part II|Withdrawal by Subject|4|||
24939824|NCT00402051|50032831|FG001|Overall Study|Death Due to Adverse Event|2|||
24939825|NCT00402051|50032830|FG000|Overall Study|Lost to Follow-up|1|||
24939826|NCT00402051|50032831|FG001|Overall Study|Lost to Follow-up|0|||
24939827|NCT00468858|50032840|FG000|Overall Study|Adverse Event|0|||
24939828|NCT00468858|50032841|FG001|Overall Study|Adverse Event|1|||
24939829|NCT00468858|50032842|FG002|Overall Study|Adverse Event|0|||
24939830|NCT00468858|50032840|FG000|Overall Study|Withdrawal by Subject|7|||
25029273|NCT03426995|50127661|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
25029274|NCT03426995|50127643|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
25029275|NCT03426995|50127644|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
25029276|NCT03426995|50127645|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
25029277|NCT03426995|50127646|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
25029278|NCT03426995|50127647|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
25029279|NCT03426995|50127648|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
25029280|NCT03426995|50127649|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
25029281|NCT03426995|50127650|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
25029282|NCT03426995|50127651|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
25029283|NCT03426995|50127652|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
25029284|NCT03426995|50127653|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
25029285|NCT03426995|50127654|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
25029286|NCT03426995|50127655|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
25157826|NCT01731938|50274519|FG000|Primary Part II|Lost to Follow-up|4|||
25157827|NCT01731938|50274520|FG001|Primary Part II|Lost to Follow-up|5|||
25157828|NCT01731938|50274519|FG000|Primary Part II|Death|2|||
25157829|NCT01731938|50274520|FG001|Primary Part II|Death|1|||
25157830|NCT01731938|50274519|FG000|Primary Part II|Missed Week 6 visit|2|||
25157831|NCT01731938|50274520|FG001|Primary Part II|Missed Week 6 visit|3|||
25157832|NCT01731470|50274527|FG000|Overall Study|Withdrawal by Subject|1|||
25157833|NCT01731470|50274527|FG000|Overall Study|Did not meet study criteria|1|||
25157834|NCT01756352|50274531|FG000|Overall Study|moved away and lost to followup|1|||
25157835|NCT01756274|50274535|FG000|Overall Study|Protocol Violation|2|||
25157836|NCT01756274|50274535|FG000|Overall Study|Laboratory error|1|||
25157837|NCT01731002|50274543|FG000|Overall Study|Adverse Event|0|||
25157838|NCT01731002|50274544|FG001|Overall Study|Adverse Event|2|||
25157839|NCT01731002|50274545|FG002|Overall Study|Adverse Event|2|||
25157840|NCT01731002|50274543|FG000|Overall Study|Non-Compliant|0|||
25157841|NCT01731002|50274544|FG001|Overall Study|Non-Compliant|1|||
25157842|NCT01731002|50274545|FG002|Overall Study|Non-Compliant|0|||
25157843|NCT01731002|50274543|FG000|Overall Study|Lost to Follow-up|1|||
25157844|NCT01731002|50274544|FG001|Overall Study|Lost to Follow-up|0|||
25157845|NCT01731002|50274545|FG002|Overall Study|Lost to Follow-up|0|||
25157846|NCT01731002|50274543|FG000|Overall Study|Test Agent Discontinuation|0|||
25157847|NCT01731002|50274544|FG001|Overall Study|Test Agent Discontinuation|1|||
25157848|NCT01731002|50274545|FG002|Overall Study|Test Agent Discontinuation|0|||
25157849|NCT01731002|50274543|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
24939831|NCT00468858|50032841|FG001|Overall Study|Withdrawal by Subject|4|||
24939832|NCT00468858|50032842|FG002|Overall Study|Withdrawal by Subject|5|||
25157850|NCT01731002|50274544|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
25157851|NCT01731002|50274545|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
25157852|NCT01731002|50274543|FG000|Overall Study|Elevated IOP|1|||
25157853|NCT01731002|50274544|FG001|Overall Study|Elevated IOP|0|||
25157854|NCT01731002|50274545|FG002|Overall Study|Elevated IOP|0|||
25157855|NCT01731002|50274543|FG000|Overall Study|Inappropriate use of study medications|0|||
25157856|NCT01731002|50274544|FG001|Overall Study|Inappropriate use of study medications|0|||
25157857|NCT01731002|50274545|FG002|Overall Study|Inappropriate use of study medications|1|||
25157858|NCT01783886|50274556|FG000|Overall Study|Lost to Follow-up|0|||
25157859|NCT01783886|50274557|FG001|Overall Study|Lost to Follow-up|3|||
25157860|NCT01783886|50274558|FG002|Overall Study|Lost to Follow-up|0|||
25157861|NCT01783886|50274556|FG000|Overall Study|Protocol deviation|0|||
25157862|NCT01783886|50274557|FG001|Overall Study|Protocol deviation|0|||
25157863|NCT01783886|50274558|FG002|Overall Study|Protocol deviation|2|||
25157864|NCT01783886|50274556|FG000|Overall Study|Withdrawal of consent by participant|1|||
25157865|NCT01783886|50274557|FG001|Overall Study|Withdrawal of consent by participant|3|||
25157866|NCT01783886|50274558|FG002|Overall Study|Withdrawal of consent by participant|4|||
25157867|NCT01783886|50274556|FG000|Overall Study|Adverse Event|4|||
25157868|NCT01783886|50274557|FG001|Overall Study|Adverse Event|5|||
25157869|NCT01783886|50274558|FG002|Overall Study|Adverse Event|4|||
25157870|NCT01609556|50274582|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
25157871|NCT01609556|50274583|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
25157872|NCT01609556|50274584|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
25157873|NCT01609556|50274585|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
25157874|NCT01609556|50274586|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
25157875|NCT01609556|50274587|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
25029287|NCT03426995|50127656|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
25029288|NCT03426995|50127657|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
25157876|NCT01609556|50274588|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
25157877|NCT01609556|50274589|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
25157878|NCT01609556|50274590|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
25029289|NCT03426995|50127658|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
25029290|NCT03426995|50127659|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
24939833|NCT00468858|50032840|FG000|Overall Study|Relocation|1|||
24939834|NCT00468858|50032841|FG001|Overall Study|Relocation|3|||
24939835|NCT00468858|50032842|FG002|Overall Study|Relocation|3|||
24939836|NCT00468858|50032840|FG000|Overall Study|Lost to Follow-up|1|||
24939837|NCT00468858|50032841|FG001|Overall Study|Lost to Follow-up|2|||
24939838|NCT00468858|50032842|FG002|Overall Study|Lost to Follow-up|5|||
24939839|NCT00468858|50032840|FG000|Overall Study|Other|0|||
24939840|NCT00468858|50032841|FG001|Overall Study|Other|0|||
24939841|NCT00468858|50032842|FG002|Overall Study|Other|1|||
24939842|NCT00401973|50032907|FG000|Overall Study|Adverse Event|2|||
25029291|NCT03426995|50127660|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
25157879|NCT01609556|50274591|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
25157880|NCT01609556|50274592|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
25157881|NCT01609556|50274593|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
25157882|NCT01609556|50274594|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
25157883|NCT01609556|50274595|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
25157884|NCT01609556|50274596|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
25157885|NCT01609556|50274597|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
25157886|NCT01609556|50274582|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
25157887|NCT01609556|50274583|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
25157888|NCT01609556|50274584|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
25157889|NCT01609556|50274585|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
25157890|NCT01609556|50274586|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
25157891|NCT01609556|50274587|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
25157892|NCT01609556|50274588|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
25157893|NCT01609556|50274589|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
25157894|NCT01609556|50274590|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
25157895|NCT01609556|50274591|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
25157896|NCT01609556|50274592|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
25157897|NCT01609556|50274593|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
25157898|NCT01609556|50274594|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
25157899|NCT01609556|50274595|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
25157900|NCT01609556|50274596|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
25157901|NCT01609556|50274597|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
25157902|NCT01609556|50274582|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
25157903|NCT01609556|50274583|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
25157904|NCT01609556|50274584|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
25157905|NCT01609556|50274585|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
25157906|NCT01609556|50274586|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
25157907|NCT01609556|50274587|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
25157908|NCT01609556|50274588|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
25157909|NCT01609556|50274589|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
24939843|NCT00401973|50032908|FG001|Overall Study|Adverse Event|8|||
24939844|NCT00401973|50032909|FG002|Overall Study|Adverse Event|4|||
24939845|NCT00401973|50032907|FG000|Overall Study|Clinical Relapse|0|||
24939846|NCT00401973|50032908|FG001|Overall Study|Clinical Relapse|1|||
24939847|NCT00401973|50032909|FG002|Overall Study|Clinical Relapse|1|||
24939848|NCT00401973|50032907|FG000|Overall Study|Lack of Efficacy|0|||
25157910|NCT01609556|50274590|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
25157911|NCT01609556|50274591|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
25157912|NCT01609556|50274592|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
25157913|NCT01609556|50274593|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
25157914|NCT01609556|50274594|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
25157915|NCT01609556|50274595|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
25157916|NCT01609556|50274596|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
25157917|NCT01609556|50274597|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
24939849|NCT00401973|50032908|FG001|Overall Study|Lack of Efficacy|0|||
24939850|NCT00401973|50032909|FG002|Overall Study|Lack of Efficacy|3|||
24939851|NCT00401973|50032907|FG000|Overall Study|Lost to Follow-up|2|||
24939852|NCT00401973|50032908|FG001|Overall Study|Lost to Follow-up|2|||
24939853|NCT00401973|50032909|FG002|Overall Study|Lost to Follow-up|2|||
24939854|NCT00401973|50032907|FG000|Overall Study|Physician Decision|2|||
24939855|NCT00401973|50032908|FG001|Overall Study|Physician Decision|0|||
24939856|NCT00401973|50032909|FG002|Overall Study|Physician Decision|1|||
24939857|NCT00401973|50032907|FG000|Overall Study|Protocol Violation|1|||
24939858|NCT00401973|50032908|FG001|Overall Study|Protocol Violation|2|||
24939859|NCT00401973|50032909|FG002|Overall Study|Protocol Violation|3|||
25157918|NCT01609556|50274582|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
25157919|NCT01609556|50274583|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
25157920|NCT01609556|50274584|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
25157921|NCT01609556|50274585|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
25157922|NCT01609556|50274586|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
25157923|NCT01609556|50274587|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
25157924|NCT01609556|50274588|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
25157925|NCT01609556|50274589|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
25157926|NCT01609556|50274590|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
25157927|NCT01609556|50274591|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
25157928|NCT01609556|50274592|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
24939860|NCT00401973|50032907|FG000|Overall Study|Sponsor Decision|0|||
24939861|NCT00401973|50032908|FG001|Overall Study|Sponsor Decision|1|||
24939862|NCT00401973|50032909|FG002|Overall Study|Sponsor Decision|0|||
24939863|NCT00401973|50032907|FG000|Overall Study|Withdrawal by Subject|4|||
24939864|NCT00401973|50032908|FG001|Overall Study|Withdrawal by Subject|12|||
24939865|NCT00401973|50032909|FG002|Overall Study|Withdrawal by Subject|9|||
24939866|NCT00401193|50032922|FG000|Overall Study|Adverse Event|1|||
24939867|NCT00401193|50032923|FG001|Overall Study|Adverse Event|3|||
24939868|NCT00401193|50032924|FG002|Overall Study|Adverse Event|1|||
24939869|NCT00401193|50032922|FG000|Overall Study|Protocol Violation|3|||
24939870|NCT00401193|50032923|FG001|Overall Study|Protocol Violation|1|||
24939871|NCT00401193|50032924|FG002|Overall Study|Protocol Violation|1|||
24939872|NCT00401193|50032922|FG000|Overall Study|Lost to Follow-up|6|||
24939873|NCT00401193|50032923|FG001|Overall Study|Lost to Follow-up|5|||
24939874|NCT00401193|50032924|FG002|Overall Study|Lost to Follow-up|1|||
24939875|NCT00401193|50032922|FG000|Overall Study|Withdrawal by Subject|2|||
24939876|NCT00401193|50032923|FG001|Overall Study|Withdrawal by Subject|0|||
24939877|NCT00401193|50032924|FG002|Overall Study|Withdrawal by Subject|1|||
24939878|NCT00401193|50032922|FG000|Overall Study|Other Event|3|||
24939879|NCT00401193|50032923|FG001|Overall Study|Other Event|2|||
24939880|NCT00401193|50032924|FG002|Overall Study|Other Event|2|||
24939881|NCT00400569|50032933|FG000|Overall Study|Death|1|||
25157929|NCT01609556|50274593|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
25157930|NCT01609556|50274594|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
25157931|NCT01609556|50274595|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
25157932|NCT01609556|50274596|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
25157933|NCT01609556|50274597|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
24939882|NCT00413049|50032942|FG000|Overall Study|Adverse Event|10|||
24939883|NCT00413049|50032943|FG001|Overall Study|Adverse Event|8|||
24939884|NCT00413049|50032942|FG000|Overall Study|Withdrawal by Subject|7|||
25157934|NCT01609556|50274582|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
25157935|NCT01609556|50274583|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
25157936|NCT01609556|50274584|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
24939885|NCT00413049|50032943|FG001|Overall Study|Withdrawal by Subject|5|||
24939886|NCT00413049|50032942|FG000|Overall Study|Lost to Follow-up|2|||
24939887|NCT00413049|50032943|FG001|Overall Study|Lost to Follow-up|3|||
25157937|NCT01609556|50274585|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
24939888|NCT00413049|50032942|FG000|Overall Study|Protocol Violation|3|||
24939889|NCT00413049|50032943|FG001|Overall Study|Protocol Violation|1|||
24939890|NCT00413049|50032942|FG000|Overall Study|Subject no longer requires study drug|0|||
24939891|NCT00413049|50032943|FG001|Overall Study|Subject no longer requires study drug|1|||
24939892|NCT00413049|50032942|FG000|Overall Study|Abnormal laboratory value(s)|1|||
24939893|NCT00413049|50032943|FG001|Overall Study|Abnormal laboratory value(s)|0|||
24939894|NCT00413049|50032942|FG000|Overall Study|Lack of Efficacy|1|||
24939895|NCT00413049|50032943|FG001|Overall Study|Lack of Efficacy|0|||
24939896|NCT00454194|50032951|FG000|Overall Study|Adverse Event|7|||
24939897|NCT00454194|50032952|FG001|Overall Study|Adverse Event|2|||
24939898|NCT00454194|50032951|FG000|Overall Study|Withdrawal by Subject|12|||
25157938|NCT01609556|50274586|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
25157939|NCT01609556|50274587|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
25157940|NCT01609556|50274588|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
25157941|NCT01609556|50274589|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
25157942|NCT01609556|50274590|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
25157943|NCT01609556|50274591|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
25157944|NCT01609556|50274592|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
25157945|NCT01609556|50274593|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
25157946|NCT01609556|50274594|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
25157947|NCT01609556|50274595|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
25157948|NCT01609556|50274596|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
25157949|NCT01609556|50274597|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
25157950|NCT01609556|50274582|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
25157951|NCT01609556|50274583|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
24939899|NCT00454194|50032952|FG001|Overall Study|Withdrawal by Subject|8|||
24939900|NCT00454194|50032951|FG000|Overall Study|Other Medical Problems|1|||
24939901|NCT00454194|50032952|FG001|Overall Study|Other Medical Problems|2|||
24939902|NCT00454194|50032951|FG000|Overall Study|Other Unspecified Reason|2|||
24939903|NCT00454194|50032952|FG001|Overall Study|Other Unspecified Reason|2|||
24939904|NCT00412971|50032960|FG000|Overall Study|Lost to Follow-up|17|||
24939905|NCT00412971|50032961|FG001|Overall Study|Lost to Follow-up|9|||
24939906|NCT00412971|50032960|FG000|Overall Study|Protocol Violation|13|||
24939907|NCT00412971|50032961|FG001|Overall Study|Protocol Violation|1|||
24939908|NCT00303472|50032974|FG000|Treatment Period|Adverse Event|0|||
24939909|NCT00303472|50032975|FG001|Treatment Period|Adverse Event|0|||
24939910|NCT00303472|50032976|FG002|Treatment Period|Adverse Event|0|||
24939911|NCT00303472|50032977|FG003|Treatment Period|Adverse Event|0|||
24939912|NCT00303472|50032978|FG004|Treatment Period|Adverse Event|1|||
24939913|NCT00303472|50032979|FG005|Treatment Period|Adverse Event|0|||
24939914|NCT00303472|50032980|FG006|Treatment Period|Adverse Event|0|||
24939915|NCT00303472|50032974|FG000|Treatment Period|Death|0|||
24939916|NCT00303472|50032975|FG001|Treatment Period|Death|0|||
24939917|NCT00303472|50032976|FG002|Treatment Period|Death|0|||
24939918|NCT00303472|50032977|FG003|Treatment Period|Death|1|||
24939919|NCT00303472|50032978|FG004|Treatment Period|Death|0|||
24939920|NCT00303472|50032979|FG005|Treatment Period|Death|0|||
24939921|NCT00303472|50032980|FG006|Treatment Period|Death|1|||
24939922|NCT00303472|50032974|FG000|Treatment Period|Withdrawal by Subject|0|||
24939923|NCT00303472|50032975|FG001|Treatment Period|Withdrawal by Subject|0|||
24939924|NCT00303472|50032976|FG002|Treatment Period|Withdrawal by Subject|0|||
24939925|NCT00303472|50032977|FG003|Treatment Period|Withdrawal by Subject|1|||
24939926|NCT00303472|50032978|FG004|Treatment Period|Withdrawal by Subject|0|||
24939927|NCT00303472|50032979|FG005|Treatment Period|Withdrawal by Subject|1|||
24939928|NCT00303472|50032980|FG006|Treatment Period|Withdrawal by Subject|0|||
25157952|NCT01609556|50274584|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
25157953|NCT01609556|50274585|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
25157954|NCT01609556|50274586|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
25157955|NCT01609556|50274587|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
25157956|NCT01609556|50274588|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
25157957|NCT01609556|50274589|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
25157958|NCT01609556|50274590|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
25157959|NCT01609556|50274591|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
25157960|NCT01609556|50274592|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
25157961|NCT01609556|50274593|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
24939929|NCT00303472|50032974|FG000|Treatment Period|Other|0|||
24939930|NCT00303472|50032975|FG001|Treatment Period|Other|0|||
24939931|NCT00303472|50032976|FG002|Treatment Period|Other|0|||
24939932|NCT00303472|50032977|FG003|Treatment Period|Other|0|||
24939933|NCT00303472|50032978|FG004|Treatment Period|Other|1|||
24939934|NCT00303472|50032979|FG005|Treatment Period|Other|0|||
24939935|NCT00303472|50032980|FG006|Treatment Period|Other|1|||
24939936|NCT00303472|50032974|FG000|Treatment Period|Disease Progression (to AML)|0|||
24939937|NCT00303472|50032975|FG001|Treatment Period|Disease Progression (to AML)|0|||
24939938|NCT00303472|50032976|FG002|Treatment Period|Disease Progression (to AML)|0|||
24939939|NCT00303472|50032977|FG003|Treatment Period|Disease Progression (to AML)|0|||
24939940|NCT00303472|50032978|FG004|Treatment Period|Disease Progression (to AML)|1|||
25157962|NCT01609556|50274594|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
25157963|NCT01609556|50274595|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
25157964|NCT01609556|50274596|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
25157965|NCT01609556|50274597|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
25157966|NCT01609556|50274582|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
25157967|NCT01609556|50274583|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
25157968|NCT01609556|50274584|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
25157969|NCT01609556|50274585|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
24939941|NCT00303472|50032979|FG005|Treatment Period|Disease Progression (to AML)|0|||
24939942|NCT00303472|50032980|FG006|Treatment Period|Disease Progression (to AML)|0|||
25157970|NCT01609556|50274586|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
25186134|NCT01458392|50336029|FG002|Overall Study|Death|22|||
25157971|NCT01609556|50274587|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
25157972|NCT01609556|50274588|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
25157973|NCT01609556|50274589|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
25157974|NCT01609556|50274590|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
25157975|NCT01609556|50274591|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
25157976|NCT01609556|50274592|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
25157977|NCT01609556|50274593|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
25157978|NCT01609556|50274594|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
25157979|NCT01609556|50274595|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
24939943|NCT00303472|50032974|FG000|Treatment Extension (Optional)|Adverse Event|1|||
24939944|NCT00303472|50032975|FG001|Treatment Extension (Optional)|Adverse Event|0|||
25157980|NCT01609556|50274596|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
25157981|NCT01609556|50274597|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
25157982|NCT01609556|50274582|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
25157983|NCT01609556|50274583|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
25157984|NCT01609556|50274584|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
25157985|NCT01609556|50274585|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
25157986|NCT01609556|50274586|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
25157987|NCT01609556|50274587|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
25157988|NCT01609556|50274588|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
25157989|NCT01609556|50274589|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
25157990|NCT01609556|50274590|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
25157991|NCT01609556|50274591|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
25157992|NCT01609556|50274592|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
25157993|NCT01609556|50274593|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
25157994|NCT01609556|50274594|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
25157995|NCT01609556|50274595|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
25157996|NCT01609556|50274596|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
25157997|NCT01609556|50274597|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
25157998|NCT01609556|50274582|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
25157999|NCT01609556|50274583|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
25158000|NCT01609556|50274584|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
25158001|NCT01609556|50274585|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
24939945|NCT00303472|50032976|FG002|Treatment Extension (Optional)|Adverse Event|1|||
24939946|NCT00303472|50032977|FG003|Treatment Extension (Optional)|Adverse Event|0|||
25158002|NCT01609556|50274586|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
25158003|NCT01609556|50274587|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
25158004|NCT01609556|50274588|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
25158005|NCT01609556|50274589|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
25158006|NCT01609556|50274590|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
25158007|NCT01609556|50274591|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
25158008|NCT01609556|50274592|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
25158009|NCT01609556|50274593|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
25158010|NCT01609556|50274594|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
25158011|NCT01609556|50274595|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
25158012|NCT01609556|50274596|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
25158013|NCT01609556|50274597|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
25158014|NCT01609556|50274582|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
25158015|NCT01609556|50274583|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
25158016|NCT01609556|50274584|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
25158017|NCT01609556|50274585|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
25158018|NCT01609556|50274586|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
25158019|NCT01609556|50274587|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
25158020|NCT01609556|50274588|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
25158021|NCT01609556|50274589|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
25158022|NCT01609556|50274590|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
25158023|NCT01609556|50274591|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
25158024|NCT01609556|50274592|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
25158025|NCT01609556|50274593|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
25158026|NCT01609556|50274594|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
25158027|NCT01609556|50274595|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
25158028|NCT01609556|50274596|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
25158029|NCT01609556|50274597|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
25158030|NCT01609556|50274582|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
24939947|NCT00303472|50032978|FG004|Treatment Extension (Optional)|Adverse Event|0|||
25029292|NCT03426995|50127661|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
25158031|NCT01609556|50274583|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
25275501|NCT01073631|50589382|FG000|Overall Study|Death|82|||
25158032|NCT01609556|50274584|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
25158033|NCT01609556|50274585|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
25158034|NCT01609556|50274586|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
25158035|NCT01609556|50274587|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
25158036|NCT01609556|50274588|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
25158037|NCT01609556|50274589|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
25158038|NCT01609556|50274590|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
25158039|NCT01609556|50274591|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
25158040|NCT01609556|50274592|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
25158041|NCT01609556|50274593|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
25158042|NCT01609556|50274594|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
25158043|NCT01609556|50274595|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
25158044|NCT01609556|50274596|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
24939948|NCT00303472|50032979|FG005|Treatment Extension (Optional)|Adverse Event|0|||
24939949|NCT00303472|50032980|FG006|Treatment Extension (Optional)|Adverse Event|0|||
24939950|NCT00303472|50032974|FG000|Treatment Extension (Optional)|Death|2|||
24939951|NCT00303472|50032975|FG001|Treatment Extension (Optional)|Death|0|||
24939952|NCT00303472|50032976|FG002|Treatment Extension (Optional)|Death|1|||
24939953|NCT00303472|50032977|FG003|Treatment Extension (Optional)|Death|0|||
24939954|NCT00303472|50032978|FG004|Treatment Extension (Optional)|Death|0|||
24939955|NCT00303472|50032979|FG005|Treatment Extension (Optional)|Death|0|||
24939956|NCT00303472|50032980|FG006|Treatment Extension (Optional)|Death|0|||
24939957|NCT00303472|50032974|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
24939958|NCT00303472|50032975|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
24939959|NCT00303472|50032976|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
24939960|NCT00303472|50032977|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
24939961|NCT00303472|50032978|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
24939962|NCT00303472|50032979|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
24939963|NCT00303472|50032980|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
24939964|NCT00303472|50032974|FG000|Treatment Extension (Optional)|Physician Decision|0|||
24939965|NCT00303472|50032975|FG001|Treatment Extension (Optional)|Physician Decision|4|||
24939966|NCT00303472|50032976|FG002|Treatment Extension (Optional)|Physician Decision|2|||
24939967|NCT00303472|50032977|FG003|Treatment Extension (Optional)|Physician Decision|3|||
24939968|NCT00303472|50032978|FG004|Treatment Extension (Optional)|Physician Decision|2|||
24939969|NCT00303472|50032979|FG005|Treatment Extension (Optional)|Physician Decision|0|||
24939970|NCT00303472|50032980|FG006|Treatment Extension (Optional)|Physician Decision|0|||
24939971|NCT00303472|50032974|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
24939972|NCT00303472|50032975|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
24939973|NCT00303472|50032976|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
24939974|NCT00303472|50032977|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
24939975|NCT00303472|50032978|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
24939976|NCT00303472|50032979|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
24939977|NCT00303472|50032980|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
24939978|NCT00303472|50032974|FG000|Treatment Extension (Optional)|Other|0|||
24939979|NCT00303472|50032975|FG001|Treatment Extension (Optional)|Other|2|||
24939980|NCT00303472|50032976|FG002|Treatment Extension (Optional)|Other|4|||
24939981|NCT00303472|50032977|FG003|Treatment Extension (Optional)|Other|2|||
24939982|NCT00303472|50032978|FG004|Treatment Extension (Optional)|Other|1|||
24939983|NCT00303472|50032979|FG005|Treatment Extension (Optional)|Other|0|||
24939984|NCT00303472|50032980|FG006|Treatment Extension (Optional)|Other|0|||
24939985|NCT00303472|50032974|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
24939986|NCT00303472|50032975|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
24939987|NCT00303472|50032976|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
24939988|NCT00303472|50032977|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
24939989|NCT00303472|50032978|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
24939990|NCT00303472|50032979|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
25158045|NCT01609556|50274597|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
25158046|NCT01609556|50274582|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
25158047|NCT01609556|50274583|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
24939991|NCT00303472|50032980|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
24939992|NCT00468546|50032998|FG000|Week 24 Analysis|Lack of Efficacy|83|||
24939993|NCT00468546|50032999|FG001|Week 24 Analysis|Lack of Efficacy|37|||
24939994|NCT00468546|50032998|FG000|Week 24 Analysis|Refused treatment|5|||
24939995|NCT00468546|50032999|FG001|Week 24 Analysis|Refused treatment|5|||
24939996|NCT00468546|50032998|FG000|Week 24 Analysis|Adverse Event|1|||
24939997|NCT00468546|50032999|FG001|Week 24 Analysis|Adverse Event|8|||
24939998|NCT00468546|50032998|FG000|Week 24 Analysis|Failure to return|3|||
25029293|NCT03424265|50127710|FG000|Overall Study|screening failure|1|||
25158048|NCT01609556|50274584|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
25158049|NCT01609556|50274585|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
25158050|NCT01609556|50274586|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
25158051|NCT01609556|50274587|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
25158052|NCT01609556|50274588|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
24939999|NCT00468546|50032999|FG001|Week 24 Analysis|Failure to return|4|||
24940000|NCT00468546|50032998|FG000|Week 24 Analysis|Rescue therapy|2|||
24940001|NCT00468546|50032999|FG001|Week 24 Analysis|Rescue therapy|0|||
24940002|NCT00468546|50032998|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
24940003|NCT00468546|50032999|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
24940004|NCT00468546|50032998|FG000|Week 24 Analysis|Due to clinical hold|1|||
24940005|NCT00468546|50032999|FG001|Week 24 Analysis|Due to clinical hold|0|||
24940006|NCT00468546|50032998|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
24940007|NCT00468546|50032999|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
24940008|NCT00468546|50032998|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
24940009|NCT00468546|50032999|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
24940010|NCT00468546|50032998|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
24940011|NCT00468546|50032999|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
24940012|NCT00468546|50032998|FG000|Week 24 to Week 104 Analysis|Death|1|||
24940013|NCT00468546|50032999|FG001|Week 24 to Week 104 Analysis|Death|0|||
24940014|NCT00468546|50032998|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
24940015|NCT00468546|50032999|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
25186135|NCT01458392|50336027|FG000|Overall Study|At the discretion of the sponsor|0|||
25186136|NCT01458392|50336028|FG001|Overall Study|At the discretion of the sponsor|2|||
25186137|NCT01458392|50336029|FG002|Overall Study|At the discretion of the sponsor|7|||
25186138|NCT01458392|50336027|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
24940016|NCT00468546|50032998|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
24940017|NCT00468546|50032999|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
24940018|NCT00468546|50032998|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
24940019|NCT00468546|50032999|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
24940020|NCT00468546|50032998|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
24940021|NCT00468546|50032999|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
25275502|NCT01073631|50589382|FG000|Overall Study|Adverse Event|24|||
24940022|NCT00468546|50032998|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
24940023|NCT00468546|50032999|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
24940024|NCT00468546|50032998|FG000|Week 24 to Week 104 Analysis|Other|17|||
25158053|NCT01609556|50274589|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
25158054|NCT01609556|50274590|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
25158055|NCT01609556|50274591|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
25158056|NCT01609556|50274592|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
25158057|NCT01609556|50274593|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
25158058|NCT01609556|50274594|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
25186139|NCT01458392|50336028|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
25186140|NCT01458392|50336029|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
25186141|NCT01421069|50336041|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
25186142|NCT01421069|50336041|FG000|Parent Study|Failed to return|3|||
25186143|NCT01421069|50336041|FG000|Parent Study|Withdrawal by Subject|1|||
25186144|NCT01421069|50336041|FG000|Parent Study|Lost to Follow-up|2|||
25186145|NCT01421069|50336041|FG000|Parent Study|Lack of Efficacy|1|||
25186146|NCT01421069|50336041|FG000|Overall Period for Extension Study|Other|2|||
25186147|NCT01421069|50336041|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
25186148|NCT01421069|50336041|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
25186149|NCT01421069|50336041|FG000|Overall Period for Extension Study|Pregnancy|1|||
25186150|NCT01421069|50336041|FG000|Overall Period for Extension Study|Adverse Event|1|||
24940025|NCT00468546|50032999|FG001|Week 24 to Week 104 Analysis|Other|14|||
24940026|NCT00303316|50033007|FG000|Overall Study|Protocol Violation|1|||
24940027|NCT00303316|50033008|FG001|Overall Study|Protocol Violation|0|||
24940028|NCT00303316|50033007|FG000|Overall Study|Lost to Follow-up|0|||
24940029|NCT00303316|50033008|FG001|Overall Study|Lost to Follow-up|1|||
24940030|NCT00303316|50033007|FG000|Overall Study|Withdrawal by Subject|1|||
24940031|NCT00303316|50033008|FG001|Overall Study|Withdrawal by Subject|2|||
24940032|NCT00468312|50033016|FG000|Overall Study|Adverse Event|2|||
24940033|NCT00468312|50033017|FG001|Overall Study|Adverse Event|1|||
24940034|NCT00468312|50033016|FG000|Overall Study|Lack of Efficacy|0|||
24940035|NCT00468312|50033017|FG001|Overall Study|Lack of Efficacy|1|||
24940036|NCT00468312|50033016|FG000|Overall Study|Withdrawal by Subject|0|||
24940037|NCT00468312|50033017|FG001|Overall Study|Withdrawal by Subject|1|||
24940038|NCT00468312|50033016|FG000|Overall Study|Protocol Violation|2|||
24940039|NCT00468312|50033017|FG001|Overall Study|Protocol Violation|1|||
24940040|NCT00468312|50033016|FG000|Overall Study|Did not meet protocol eligibility|0|||
24940041|NCT00468312|50033017|FG001|Overall Study|Did not meet protocol eligibility|1|||
24940042|NCT00331864|50033025|FG000|Overall Study|Adverse Event|30|||
24940043|NCT00331864|50033026|FG001|Overall Study|Adverse Event|1|||
24940044|NCT00331864|50033025|FG000|Overall Study|Lack of Efficacy|4|||
24940045|NCT00331864|50033026|FG001|Overall Study|Lack of Efficacy|0|||
24940046|NCT00331864|50033025|FG000|Overall Study|Protocol Violation|3|||
24940047|NCT00331864|50033026|FG001|Overall Study|Protocol Violation|0|||
24940048|NCT00331864|50033025|FG000|Overall Study|Withdrawal by Subject|10|||
24940049|NCT00331864|50033026|FG001|Overall Study|Withdrawal by Subject|0|||
24940050|NCT00331864|50033025|FG000|Overall Study|Lost to Follow-up|4|||
24940051|NCT00331864|50033026|FG001|Overall Study|Lost to Follow-up|3|||
24940052|NCT00331864|50033025|FG000|Overall Study|Administrative Problems|1|||
24940053|NCT00331864|50033026|FG001|Overall Study|Administrative Problems|0|||
24940054|NCT00331864|50033025|FG000|Overall Study|Death|6|||
25029294|NCT03424265|50127711|FG001|Overall Study|screening failure|0|||
25029295|NCT03424265|50127710|FG000|Overall Study|Withdrawal by Subject|0|||
25029296|NCT03424265|50127711|FG001|Overall Study|Withdrawal by Subject|2|||
25029297|NCT03322566|50127720|FG000|Overall Study|Death|34|||
25029298|NCT03322566|50127721|FG001|Overall Study|Death|35|||
25029299|NCT03322566|50127722|FG002|Overall Study|Death|23|||
25029300|NCT03322566|50127720|FG000|Overall Study|Physician Decision|6|||
25029301|NCT03322566|50127721|FG001|Overall Study|Physician Decision|7|||
25029302|NCT03322566|50127722|FG002|Overall Study|Physician Decision|2|||
25029303|NCT03322566|50127720|FG000|Overall Study|Withdrawal by Subject|4|||
25029304|NCT03322566|50127721|FG001|Overall Study|Withdrawal by Subject|3|||
25029305|NCT03322566|50127722|FG002|Overall Study|Withdrawal by Subject|6|||
25029306|NCT03322566|50127720|FG000|Overall Study|Lost to Follow-up|0|||
25029307|NCT03322566|50127721|FG001|Overall Study|Lost to Follow-up|0|||
25029308|NCT03322566|50127722|FG002|Overall Study|Lost to Follow-up|1|||
25029309|NCT03322566|50127720|FG000|Overall Study|Study terminated by sponsor|1|||
25029310|NCT03322566|50127721|FG001|Overall Study|Study terminated by sponsor|0|||
25029311|NCT03322566|50127722|FG002|Overall Study|Study terminated by sponsor|1|||
25029312|NCT02969018|50127738|FG000|Overall Study|Adverse Event|2|||
25029313|NCT02969018|50127739|FG001|Overall Study|Adverse Event|4|||
25029314|NCT02969018|50127740|FG002|Overall Study|Adverse Event|1|||
25158059|NCT01609556|50274595|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
25158060|NCT01609556|50274596|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
25158061|NCT01609556|50274597|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
25158062|NCT01609556|50274582|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
25158063|NCT01609556|50274583|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
25158064|NCT01609556|50274584|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
25158065|NCT01609556|50274585|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
25158066|NCT01609556|50274586|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
25158067|NCT01609556|50274587|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
25186151|NCT01421069|50336041|FG000|Overall Period for Extension Study|Protocol Violation|1|||
25186152|NCT01421069|50336041|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
24940055|NCT00331864|50033026|FG001|Overall Study|Death|0|||
24940056|NCT00331630|50033032|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
24940057|NCT00331630|50033032|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
24940058|NCT00331630|50033032|FG000|Follow up for 5 Years|Death|5|||
24940059|NCT00331630|50033032|FG000|Follow up for 5 Years|Data collection was stopped|24|||
24940060|NCT00331552|50033038|FG000|Period 3: Phase II|Neurological Symptoms|1|||
24940061|NCT00331552|50033039|FG001|Period 3: Phase II|Neurological Symptoms|0|||
24940062|NCT00331552|50033038|FG000|Period 3: Phase II|Severe Nausea|1|||
25029315|NCT02969018|50127741|FG003|Overall Study|Adverse Event|2|||
25029316|NCT02969018|50127742|FG004|Overall Study|Adverse Event|0|||
25029317|NCT02969018|50127743|FG005|Overall Study|Adverse Event|1|||
24940063|NCT00331552|50033039|FG001|Period 3: Phase II|Severe Nausea|0|||
25029318|NCT02969018|50127744|FG006|Overall Study|Adverse Event|2|||
25029319|NCT02969018|50127745|FG007|Overall Study|Adverse Event|0|||
25029320|NCT02969018|50127738|FG000|Overall Study|Lack of Efficacy|0|||
25029321|NCT02969018|50127739|FG001|Overall Study|Lack of Efficacy|1|||
25029322|NCT02969018|50127740|FG002|Overall Study|Lack of Efficacy|0|||
25029323|NCT02969018|50127741|FG003|Overall Study|Lack of Efficacy|0|||
24940064|NCT00317356|50033054|FG000|Overall Study|Adverse Event|0|||
24940065|NCT00317356|50033055|FG001|Overall Study|Adverse Event|0|||
24940066|NCT00317356|50033056|FG002|Overall Study|Adverse Event|1|||
24940067|NCT00317356|50033057|FG003|Overall Study|Adverse Event|0|||
24940068|NCT00317356|50033054|FG000|Overall Study|Lack of Efficacy|1|||
24940069|NCT00317356|50033055|FG001|Overall Study|Lack of Efficacy|1|||
24940070|NCT00317356|50033056|FG002|Overall Study|Lack of Efficacy|0|||
24940071|NCT00317356|50033057|FG003|Overall Study|Lack of Efficacy|3|||
24940072|NCT00317356|50033054|FG000|Overall Study|Physician Decision|0|||
24940073|NCT00317356|50033055|FG001|Overall Study|Physician Decision|1|||
24940074|NCT00317356|50033056|FG002|Overall Study|Physician Decision|0|||
24940075|NCT00317356|50033057|FG003|Overall Study|Physician Decision|0|||
24940076|NCT00331006|50033067|FG000|Screening Phase|Withdrawal by Subject|1|||
24940077|NCT00331006|50033067|FG000|Screening Phase|enrollment halted|1|||
25029324|NCT02969018|50127742|FG004|Overall Study|Lack of Efficacy|1|||
25029325|NCT02969018|50127743|FG005|Overall Study|Lack of Efficacy|1|||
25029326|NCT02969018|50127744|FG006|Overall Study|Lack of Efficacy|1|||
25029327|NCT02969018|50127745|FG007|Overall Study|Lack of Efficacy|1|||
25029328|NCT02969018|50127738|FG000|Overall Study|Lost to Follow-up|1|||
25029329|NCT02969018|50127739|FG001|Overall Study|Lost to Follow-up|2|||
25029330|NCT02969018|50127740|FG002|Overall Study|Lost to Follow-up|2|||
25029331|NCT02969018|50127741|FG003|Overall Study|Lost to Follow-up|0|||
25029332|NCT02969018|50127742|FG004|Overall Study|Lost to Follow-up|1|||
25029333|NCT02969018|50127743|FG005|Overall Study|Lost to Follow-up|1|||
25029334|NCT02969018|50127744|FG006|Overall Study|Lost to Follow-up|0|||
25158068|NCT01609556|50274588|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
25158069|NCT01609556|50274589|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
25158070|NCT01609556|50274590|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
25158071|NCT01609556|50274591|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
25158072|NCT01609556|50274592|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
24940078|NCT00331006|50033067|FG000|Screening Phase|Lost to Follow-up|1|||
24940079|NCT00331006|50033067|FG000|Screening Phase|Ineligible for treatment phase|4|||
24940080|NCT00331006|50033067|FG000|Treatment Phase|Withdrawal by Subject|1|||
24940081|NCT00331006|50033067|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
24940082|NCT00331006|50033067|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
24940083|NCT00302458|50033071|FG000|Overall Study|Lost to Follow-up|1|||
24940084|NCT00302458|50033071|FG000|Overall Study|Ineligible after screening|1|||
24940085|NCT00302458|50033071|FG000|Overall Study|Withdrawal by Subject|1|||
24940086|NCT00391053|50033083|FG000|Overall Study|Serious Adverse Events|1|||
24940087|NCT00391053|50033084|FG001|Overall Study|Serious Adverse Events|0|||
24940088|NCT00391053|50033085|FG002|Overall Study|Serious Adverse Events|1|||
24940089|NCT00391053|50033086|FG003|Overall Study|Serious Adverse Events|4|||
24940090|NCT00391053|50033083|FG000|Overall Study|Protocol Violation|2|||
24940091|NCT00391053|50033084|FG001|Overall Study|Protocol Violation|0|||
24940092|NCT00391053|50033085|FG002|Overall Study|Protocol Violation|0|||
24940093|NCT00391053|50033086|FG003|Overall Study|Protocol Violation|0|||
24940094|NCT00391053|50033083|FG000|Overall Study|Lost to Follow-up|1|||
25158073|NCT01609556|50274593|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
25158074|NCT01609556|50274594|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
25158075|NCT01609556|50274595|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
25158076|NCT01609556|50274596|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
25158077|NCT01609556|50274597|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
25158078|NCT01609556|50274582|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
25158079|NCT01609556|50274583|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
25158080|NCT01609556|50274584|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
25158081|NCT01609556|50274585|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
25158082|NCT01609556|50274586|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
25158083|NCT01609556|50274587|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
24940095|NCT00391053|50033084|FG001|Overall Study|Lost to Follow-up|0|||
24940096|NCT00391053|50033085|FG002|Overall Study|Lost to Follow-up|0|||
24940097|NCT00391053|50033086|FG003|Overall Study|Lost to Follow-up|5|||
24940098|NCT00391053|50033083|FG000|Overall Study|Withdrawal by Subject|5|||
24940099|NCT00391053|50033084|FG001|Overall Study|Withdrawal by Subject|1|||
24940100|NCT00391053|50033085|FG002|Overall Study|Withdrawal by Subject|1|||
24940101|NCT00391053|50033086|FG003|Overall Study|Withdrawal by Subject|1|||
24940102|NCT00317044|50033099|FG000|Overall Study|Protocol Violation|28|||
24940103|NCT00317044|50033100|FG001|Overall Study|Protocol Violation|22|||
25029335|NCT02969018|50127745|FG007|Overall Study|Lost to Follow-up|1|||
25029336|NCT02969018|50127738|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
25029337|NCT02969018|50127739|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
25029338|NCT02969018|50127740|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
24940104|NCT00317044|50033101|FG002|Overall Study|Protocol Violation|20|||
25158084|NCT01609556|50274588|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
25158085|NCT01609556|50274589|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
25158086|NCT01609556|50274590|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
25158087|NCT01609556|50274591|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
25158088|NCT01609556|50274592|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
25158089|NCT01609556|50274593|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
25158090|NCT01609556|50274594|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
25158091|NCT01609556|50274595|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
25158092|NCT01609556|50274596|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
24940105|NCT00317044|50033099|FG000|Overall Study|Adverse Event|4|||
24940106|NCT00317044|50033100|FG001|Overall Study|Adverse Event|7|||
24940107|NCT00317044|50033101|FG002|Overall Study|Adverse Event|4|||
24940108|NCT00317044|50033099|FG000|Overall Study|Withdrawal by Subject|10|||
24940109|NCT00317044|50033100|FG001|Overall Study|Withdrawal by Subject|7|||
24940110|NCT00317044|50033101|FG002|Overall Study|Withdrawal by Subject|12|||
24940111|NCT00317044|50033099|FG000|Overall Study|Lost to Follow-up|0|||
24940112|NCT00317044|50033100|FG001|Overall Study|Lost to Follow-up|2|||
25029339|NCT02969018|50127741|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
25029340|NCT02969018|50127742|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
25029341|NCT02969018|50127743|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
25029342|NCT02969018|50127744|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
25029343|NCT02969018|50127745|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
25029344|NCT02969018|50127738|FG000|Overall Study|Non-Compliance With Study Drug|1|||
25029345|NCT02969018|50127739|FG001|Overall Study|Non-Compliance With Study Drug|0|||
25158093|NCT01609556|50274597|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
25158094|NCT01609556|50274582|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
25158095|NCT01609556|50274583|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
25158096|NCT01609556|50274584|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
25158097|NCT01609556|50274585|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
25158098|NCT01609556|50274586|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
25158099|NCT01609556|50274587|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
25158100|NCT01609556|50274588|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
25158101|NCT01609556|50274589|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
25158102|NCT01609556|50274590|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
25158103|NCT01609556|50274591|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
25158104|NCT01609556|50274592|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
25158105|NCT01609556|50274593|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
25158106|NCT01609556|50274594|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
25158107|NCT01609556|50274595|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
25158108|NCT01609556|50274596|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
25158109|NCT01609556|50274597|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
25158110|NCT01763996|50274971|FG000|Treatment Period 2|Adverse Event|0|||
24940113|NCT00317044|50033101|FG002|Overall Study|Lost to Follow-up|3|||
24940114|NCT00317044|50033099|FG000|Overall Study|Multiple Reasons|6|||
24940115|NCT00317044|50033100|FG001|Overall Study|Multiple Reasons|2|||
25158111|NCT01763996|50274972|FG001|Treatment Period 2|Adverse Event|1|||
24940116|NCT00317044|50033101|FG002|Overall Study|Multiple Reasons|6|||
24940117|NCT00301834|50033109|FG000|Overall Study|Death|1|||
24940118|NCT00301366|50033116|FG000|Overall Study|Adverse Event|1|||
24940119|NCT00330928|50033120|FG000|Overall Study|Lost to Follow-up|6|||
24940120|NCT00330928|50033120|FG000|Overall Study|Physician Decision|9|||
24940121|NCT00330928|50033120|FG000|Overall Study|Death|1|||
24940122|NCT00330928|50033120|FG000|Overall Study|IVUS could not be performed.|1|||
24940123|NCT00330616|50033124|FG000|Overall Study|Adverse Event|13|||
24940124|NCT00330616|50033124|FG000|Overall Study|Lack of Efficacy|1|||
24940125|NCT00330616|50033124|FG000|Overall Study|Lost to Follow-up|2|||
24940126|NCT00330616|50033124|FG000|Overall Study|Withdrawal by Subject|4|||
25029346|NCT02969018|50127740|FG002|Overall Study|Non-Compliance With Study Drug|0|||
25029347|NCT02969018|50127741|FG003|Overall Study|Non-Compliance With Study Drug|0|||
25029348|NCT02969018|50127742|FG004|Overall Study|Non-Compliance With Study Drug|0|||
24940127|NCT00330616|50033124|FG000|Overall Study|Other|1|||
24940128|NCT00466440|50033131|FG000|Overall Study|Adverse Event|0|||
24940129|NCT00466440|50033132|FG001|Overall Study|Adverse Event|3|||
25158112|NCT01468701|50275415|FG000|Overall Study|Not eligible|91|||
25158113|NCT01468701|50275416|FG001|Overall Study|Not eligible|140|||
25158114|NCT01468701|50275417|FG002|Overall Study|Not eligible|29|||
25158115|NCT01468701|50275418|FG003|Overall Study|Not eligible|12|||
25158116|NCT01468701|50275419|FG004|Overall Study|Not eligible|22|||
25158117|NCT01468701|50275420|FG005|Overall Study|Not eligible|2|||
25158118|NCT01468701|50275421|FG006|Overall Study|Not eligible|39|||
25158119|NCT01468701|50275422|FG007|Overall Study|Not eligible|1|||
25158120|NCT01468701|50275423|FG008|Overall Study|Not eligible|40|||
25158121|NCT01468701|50275424|FG009|Overall Study|Not eligible|126|||
25158122|NCT01468701|50275425|FG010|Overall Study|Not eligible|39|||
25158123|NCT01468701|50275426|FG011|Overall Study|Not eligible|33|||
25158124|NCT01468701|50275427|FG012|Overall Study|Not eligible|1|||
25158125|NCT01468701|50275428|FG013|Overall Study|Not eligible|19|||
25158126|NCT01468701|50275429|FG014|Overall Study|Not eligible|1|||
25158127|NCT01468701|50275430|FG015|Overall Study|Not eligible|32|||
25158128|NCT01468701|50275431|FG016|Overall Study|Not eligible|0|||
25158129|NCT01468701|50275415|FG000|Overall Study|Lost to Follow-up|306|||
25158130|NCT01468701|50275416|FG001|Overall Study|Lost to Follow-up|0|||
25158131|NCT01468701|50275417|FG002|Overall Study|Lost to Follow-up|0|||
25158132|NCT01468701|50275418|FG003|Overall Study|Lost to Follow-up|0|||
25158133|NCT01468701|50275419|FG004|Overall Study|Lost to Follow-up|0|||
25158134|NCT01468701|50275420|FG005|Overall Study|Lost to Follow-up|0|||
25158135|NCT01468701|50275421|FG006|Overall Study|Lost to Follow-up|0|||
25158136|NCT01468701|50275422|FG007|Overall Study|Lost to Follow-up|0|||
25158137|NCT01468701|50275423|FG008|Overall Study|Lost to Follow-up|215|||
25158138|NCT01468701|50275424|FG009|Overall Study|Lost to Follow-up|309|||
25158139|NCT01468701|50275425|FG010|Overall Study|Lost to Follow-up|224|||
25158140|NCT01468701|50275426|FG011|Overall Study|Lost to Follow-up|212|||
25158141|NCT01468701|50275427|FG012|Overall Study|Lost to Follow-up|11|||
25158142|NCT01468701|50275428|FG013|Overall Study|Lost to Follow-up|164|||
25158143|NCT01468701|50275429|FG014|Overall Study|Lost to Follow-up|17|||
24940130|NCT00466440|50033133|FG002|Overall Study|Adverse Event|1|||
24940131|NCT00466440|50033131|FG000|Overall Study|Death|1|||
24940132|NCT00466440|50033132|FG001|Overall Study|Death|1|||
24940133|NCT00466440|50033133|FG002|Overall Study|Death|0|||
24940134|NCT00466440|50033131|FG000|Overall Study|Progressive disease|13|||
24940135|NCT00466440|50033132|FG001|Overall Study|Progressive disease|5|||
24940136|NCT00466440|50033133|FG002|Overall Study|Progressive disease|4|||
24940137|NCT00466440|50033131|FG000|Overall Study|Lost to Follow-up|0|||
24940138|NCT00466440|50033132|FG001|Overall Study|Lost to Follow-up|1|||
24940139|NCT00466440|50033133|FG002|Overall Study|Lost to Follow-up|0|||
24940140|NCT00466440|50033131|FG000|Overall Study|Physician Decision|0|||
24940141|NCT00466440|50033132|FG001|Overall Study|Physician Decision|1|||
24940142|NCT00466440|50033133|FG002|Overall Study|Physician Decision|2|||
25029349|NCT02969018|50127743|FG005|Overall Study|Non-Compliance With Study Drug|0|||
25158144|NCT01468701|50275430|FG015|Overall Study|Lost to Follow-up|127|||
25158145|NCT01468701|50275431|FG016|Overall Study|Lost to Follow-up|1|||
25158146|NCT01468701|50275415|FG000|Overall Study|Withdrawal by Subject|165|||
24940143|NCT00466440|50033131|FG000|Overall Study|Protocol entry criteria not met|0|||
24940144|NCT00466440|50033132|FG001|Overall Study|Protocol entry criteria not met|0|||
25158147|NCT01468701|50275416|FG001|Overall Study|Withdrawal by Subject|0|||
25029350|NCT02969018|50127744|FG006|Overall Study|Non-Compliance With Study Drug|0|||
24940145|NCT00466440|50033133|FG002|Overall Study|Protocol entry criteria not met|4|||
24940146|NCT00466440|50033131|FG000|Overall Study|Withdrawal by Subject|0|||
24940147|NCT00466440|50033132|FG001|Overall Study|Withdrawal by Subject|1|||
25158148|NCT01468701|50275417|FG002|Overall Study|Withdrawal by Subject|0|||
25158149|NCT01468701|50275418|FG003|Overall Study|Withdrawal by Subject|0|||
25158150|NCT01468701|50275419|FG004|Overall Study|Withdrawal by Subject|0|||
25158151|NCT01468701|50275420|FG005|Overall Study|Withdrawal by Subject|0|||
25158152|NCT01468701|50275421|FG006|Overall Study|Withdrawal by Subject|0|||
24940148|NCT00466440|50033133|FG002|Overall Study|Withdrawal by Subject|0|||
24940149|NCT00466440|50033131|FG000|Overall Study|Sponsor decision|0|||
24940150|NCT00466440|50033132|FG001|Overall Study|Sponsor decision|0|||
24940151|NCT00466440|50033133|FG002|Overall Study|Sponsor decision|1|||
24940152|NCT00465972|50033152|FG000|Overall Study|Withdrawal by Subject|2|||
24940153|NCT00465972|50033153|FG001|Overall Study|Withdrawal by Subject|1|||
24940154|NCT00465894|50033163|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
24940155|NCT00465894|50033164|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
24940156|NCT00465894|50033163|FG000|Treatment For 12 Weeks|Family Issues|1|||
24940157|NCT00465894|50033164|FG001|Treatment For 12 Weeks|Family Issues|1|||
24940158|NCT00465894|50033163|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
24940159|NCT00465894|50033164|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
24940160|NCT00330460|50033188|FG000|Overall Study|Physician Decision|1|||
24940161|NCT00330460|50033189|FG001|Overall Study|Physician Decision|0|||
24940162|NCT00330460|50033188|FG000|Overall Study|Adverse Event|10|||
24940163|NCT00330460|50033189|FG001|Overall Study|Adverse Event|8|||
24940164|NCT00330460|50033188|FG000|Overall Study|Withdrawal by Subject|18|||
25029351|NCT02969018|50127745|FG007|Overall Study|Non-Compliance With Study Drug|0|||
25029352|NCT02969018|50127738|FG000|Overall Study|Other|0|||
25029353|NCT02969018|50127739|FG001|Overall Study|Other|0|||
25029354|NCT02969018|50127740|FG002|Overall Study|Other|0|||
25029355|NCT02969018|50127741|FG003|Overall Study|Other|1|||
25029356|NCT02969018|50127742|FG004|Overall Study|Other|0|||
25029357|NCT02969018|50127743|FG005|Overall Study|Other|0|||
25029358|NCT02969018|50127744|FG006|Overall Study|Other|0|||
25029359|NCT02969018|50127745|FG007|Overall Study|Other|2|||
25029360|NCT02969018|50127738|FG000|Overall Study|Pregnancy|0|||
25029361|NCT02969018|50127739|FG001|Overall Study|Pregnancy|0|||
25029362|NCT02969018|50127740|FG002|Overall Study|Pregnancy|0|||
25029363|NCT02969018|50127741|FG003|Overall Study|Pregnancy|0|||
25029364|NCT02969018|50127742|FG004|Overall Study|Pregnancy|0|||
25029365|NCT02969018|50127743|FG005|Overall Study|Pregnancy|1|||
25158153|NCT01468701|50275422|FG007|Overall Study|Withdrawal by Subject|0|||
25158154|NCT01468701|50275423|FG008|Overall Study|Withdrawal by Subject|83|||
25158155|NCT01468701|50275424|FG009|Overall Study|Withdrawal by Subject|88|||
25158156|NCT01468701|50275425|FG010|Overall Study|Withdrawal by Subject|100|||
25158157|NCT01468701|50275426|FG011|Overall Study|Withdrawal by Subject|114|||
25158158|NCT01468701|50275427|FG012|Overall Study|Withdrawal by Subject|9|||
25158159|NCT01468701|50275428|FG013|Overall Study|Withdrawal by Subject|47|||
25158160|NCT01468701|50275429|FG014|Overall Study|Withdrawal by Subject|6|||
25158161|NCT01468701|50275430|FG015|Overall Study|Withdrawal by Subject|31|||
25158162|NCT01468701|50275431|FG016|Overall Study|Withdrawal by Subject|0|||
25158163|NCT01468701|50275415|FG000|Overall Study|Other reasons than listed|437|||
25158164|NCT01468701|50275416|FG001|Overall Study|Other reasons than listed|0|||
25158165|NCT01468701|50275417|FG002|Overall Study|Other reasons than listed|0|||
25158166|NCT01468701|50275418|FG003|Overall Study|Other reasons than listed|0|||
25158167|NCT01468701|50275419|FG004|Overall Study|Other reasons than listed|0|||
25186153|NCT01421069|50336041|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
25186154|NCT01421069|50336041|FG000|Active Treatment Period|Other|1|||
24940165|NCT00330460|50033189|FG001|Overall Study|Withdrawal by Subject|17|||
24940166|NCT00330460|50033188|FG000|Overall Study|Death|1|||
24940167|NCT00330460|50033189|FG001|Overall Study|Death|1|||
25029366|NCT02969018|50127744|FG006|Overall Study|Pregnancy|0|||
25029367|NCT02969018|50127745|FG007|Overall Study|Pregnancy|0|||
25029368|NCT02969018|50127738|FG000|Overall Study|Protocol Violation|0|||
25029369|NCT02969018|50127739|FG001|Overall Study|Protocol Violation|0|||
25158168|NCT01468701|50275420|FG005|Overall Study|Other reasons than listed|0|||
25158169|NCT01468701|50275421|FG006|Overall Study|Other reasons than listed|0|||
25158170|NCT01468701|50275422|FG007|Overall Study|Other reasons than listed|0|||
25186155|NCT01421069|50336041|FG000|Active Treatment Period|No longer willing to participate in study|8|||
24940168|NCT00330460|50033188|FG000|Overall Study|Ineligibility determined|1|||
25029370|NCT02969018|50127740|FG002|Overall Study|Protocol Violation|1|||
25029371|NCT02969018|50127741|FG003|Overall Study|Protocol Violation|1|||
25158171|NCT01468701|50275423|FG008|Overall Study|Other reasons than listed|318|||
25158172|NCT01468701|50275424|FG009|Overall Study|Other reasons than listed|658|||
25158173|NCT01468701|50275425|FG010|Overall Study|Other reasons than listed|433|||
25158174|NCT01468701|50275426|FG011|Overall Study|Other reasons than listed|504|||
25158175|NCT01468701|50275427|FG012|Overall Study|Other reasons than listed|28|||
25158176|NCT01468701|50275428|FG013|Overall Study|Other reasons than listed|239|||
25158177|NCT01468701|50275429|FG014|Overall Study|Other reasons than listed|39|||
25158178|NCT01468701|50275430|FG015|Overall Study|Other reasons than listed|172|||
25158179|NCT01468701|50275431|FG016|Overall Study|Other reasons than listed|0|||
25158180|NCT01468701|50275415|FG000|Overall Study|No end of study case report form|0|||
25158181|NCT01468701|50275416|FG001|Overall Study|No end of study case report form|0|||
25158182|NCT01468701|50275417|FG002|Overall Study|No end of study case report form|0|||
25158183|NCT01468701|50275418|FG003|Overall Study|No end of study case report form|0|||
25158184|NCT01468701|50275419|FG004|Overall Study|No end of study case report form|0|||
25158185|NCT01468701|50275420|FG005|Overall Study|No end of study case report form|0|||
25158186|NCT01468701|50275421|FG006|Overall Study|No end of study case report form|0|||
25158187|NCT01468701|50275422|FG007|Overall Study|No end of study case report form|0|||
25158188|NCT01468701|50275423|FG008|Overall Study|No end of study case report form|4|||
25158189|NCT01468701|50275424|FG009|Overall Study|No end of study case report form|1|||
25158190|NCT01468701|50275425|FG010|Overall Study|No end of study case report form|2|||
25158191|NCT01468701|50275426|FG011|Overall Study|No end of study case report form|3|||
25158192|NCT01468701|50275427|FG012|Overall Study|No end of study case report form|0|||
25158193|NCT01468701|50275428|FG013|Overall Study|No end of study case report form|1|||
25158194|NCT01468701|50275429|FG014|Overall Study|No end of study case report form|0|||
25158195|NCT01468701|50275430|FG015|Overall Study|No end of study case report form|0|||
25158196|NCT01468701|50275431|FG016|Overall Study|No end of study case report form|0|||
25158197|NCT01468701|50275415|FG000|Overall Study|Not being followed up|0|||
25158198|NCT01468701|50275416|FG001|Overall Study|Not being followed up|4963|||
25158199|NCT01468701|50275417|FG002|Overall Study|Not being followed up|1755|||
25158200|NCT01468701|50275418|FG003|Overall Study|Not being followed up|703|||
25158201|NCT01468701|50275419|FG004|Overall Study|Not being followed up|1714|||
25158202|NCT01468701|50275420|FG005|Overall Study|Not being followed up|126|||
25158203|NCT01468701|50275421|FG006|Overall Study|Not being followed up|1170|||
25158204|NCT01468701|50275422|FG007|Overall Study|Not being followed up|4|||
25158205|NCT01468701|50275423|FG008|Overall Study|Not being followed up|0|||
25158206|NCT01468701|50275424|FG009|Overall Study|Not being followed up|0|||
25158207|NCT01468701|50275425|FG010|Overall Study|Not being followed up|0|||
25158208|NCT01468701|50275426|FG011|Overall Study|Not being followed up|0|||
25158209|NCT01468701|50275427|FG012|Overall Study|Not being followed up|0|||
25158210|NCT01468701|50275428|FG013|Overall Study|Not being followed up|0|||
25158211|NCT01468701|50275429|FG014|Overall Study|Not being followed up|0|||
25158212|NCT01468701|50275430|FG015|Overall Study|Not being followed up|0|||
25158213|NCT01468701|50275431|FG016|Overall Study|Not being followed up|0|||
25158214|NCT01492101|50275446|FG000|Overall Study|Death|323|||
25158215|NCT01492101|50275447|FG001|Overall Study|Death|322|||
25158216|NCT01492101|50275446|FG000|Overall Study|Withdrawal by Subject|14|||
25158217|NCT01492101|50275447|FG001|Overall Study|Withdrawal by Subject|18|||
25158218|NCT01492101|50275446|FG000|Overall Study|Lost to Follow-up|0|||
25158219|NCT01492101|50275447|FG001|Overall Study|Lost to Follow-up|2|||
25158220|NCT01468311|50275453|FG000|Overall Study|mobilization failure|1|||
25158221|NCT01468311|50275453|FG000|Overall Study|Withdrawal by Subject|1|||
25158222|NCT01730534|50275564|FG000|Overall Study|Withdrawal by Subject|97|||
25158223|NCT01730534|50275565|FG001|Overall Study|Withdrawal by Subject|127|||
25158224|NCT01730534|50275564|FG000|Overall Study|Lost to Follow-up|12|||
25158225|NCT01730534|50275565|FG001|Overall Study|Lost to Follow-up|18|||
25158226|NCT01783730|50275585|FG000|Overall Study|Failed to meet inclusion criteria|6|||
25158227|NCT01730378|50275591|FG000|Overall Study|Lost to Follow-up|1|||
25158228|NCT01730378|50275592|FG001|Overall Study|Lost to Follow-up|0|||
25158229|NCT01783496|50275605|FG000|Overall Study|Lost to Follow-up|0|||
25158230|NCT01783496|50275606|FG001|Overall Study|Lost to Follow-up|0|||
25158231|NCT01783496|50275607|FG002|Overall Study|Lost to Follow-up|0|||
25158232|NCT01783496|50275608|FG003|Overall Study|Lost to Follow-up|2|||
25158233|NCT01783496|50275609|FG004|Overall Study|Lost to Follow-up|0|||
25158234|NCT01783496|50275610|FG005|Overall Study|Lost to Follow-up|1|||
25158235|NCT01783496|50275605|FG000|Overall Study|Withdrawal by Subject|1|||
25158236|NCT01783496|50275606|FG001|Overall Study|Withdrawal by Subject|0|||
25158237|NCT01783496|50275607|FG002|Overall Study|Withdrawal by Subject|0|||
25158238|NCT01783496|50275608|FG003|Overall Study|Withdrawal by Subject|0|||
25158239|NCT01783496|50275609|FG004|Overall Study|Withdrawal by Subject|0|||
25158240|NCT01783496|50275610|FG005|Overall Study|Withdrawal by Subject|0|||
25158241|NCT01729208|50275635|FG000|Baseline|Physician Decision|5|||
25158242|NCT01729208|50275636|FG001|Baseline|Physician Decision|4|||
25158243|NCT01729208|50275635|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
25158244|NCT01729208|50275636|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
25158245|NCT01729208|50275635|FG000|12 Months Follow-up|Lost to Follow-up|3|||
25158246|NCT01729208|50275636|FG001|12 Months Follow-up|Lost to Follow-up|3|||
25158247|NCT01729208|50275635|FG000|24 Months Follow-up|Lost to Follow-up|3|||
25158248|NCT01729208|50275636|FG001|24 Months Follow-up|Lost to Follow-up|0|||
25029372|NCT02969018|50127742|FG004|Overall Study|Protocol Violation|0|||
25029373|NCT02969018|50127743|FG005|Overall Study|Protocol Violation|0|||
25158249|NCT01729208|50275635|FG000|36 Months Follow-up|Physician Decision|1|||
25158250|NCT01729208|50275636|FG001|36 Months Follow-up|Physician Decision|0|||
25158251|NCT01729208|50275635|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
25158252|NCT01729208|50275636|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
25158253|NCT01609010|50275653|FG000|Overall Study|Stable disease (SD)|22|||
25158254|NCT01609010|50275654|FG001|Overall Study|Stable disease (SD)|16|||
25158255|NCT01609010|50275653|FG000|Overall Study|Progressive disease (PD)|8|||
25158256|NCT01609010|50275654|FG001|Overall Study|Progressive disease (PD)|10|||
25186156|NCT01421069|50336041|FG000|Active Treatment Period|Insufficient clinical response|1|||
24940169|NCT00330460|50033189|FG001|Overall Study|Ineligibility determined|3|||
24940170|NCT00330460|50033188|FG000|Overall Study|Lost to Follow-up|8|||
24940171|NCT00330460|50033189|FG001|Overall Study|Lost to Follow-up|3|||
24940172|NCT00330460|50033188|FG000|Overall Study|Noncompliance|2|||
24940173|NCT00330460|50033189|FG001|Overall Study|Noncompliance|1|||
25029374|NCT02969018|50127744|FG006|Overall Study|Protocol Violation|0|||
25029375|NCT02969018|50127745|FG007|Overall Study|Protocol Violation|0|||
25158257|NCT01609010|50275653|FG000|Overall Study|Adverse Event|3|||
25158258|NCT01609010|50275654|FG001|Overall Study|Adverse Event|6|||
24940174|NCT00330460|50033188|FG000|Overall Study|Other|1|||
24940175|NCT00330460|50033189|FG001|Overall Study|Other|0|||
25158259|NCT01609010|50275653|FG000|Overall Study|Withdrawal by Subject|2|||
25158260|NCT01609010|50275654|FG001|Overall Study|Withdrawal by Subject|2|||
25158261|NCT01609010|50275653|FG000|Overall Study|Other|2|||
25158262|NCT01609010|50275654|FG001|Overall Study|Other|0|||
25158263|NCT01609010|50275653|FG000|Overall Study|Other malignancy|1|||
25158264|NCT01609010|50275654|FG001|Overall Study|Other malignancy|0|||
25158265|NCT01609010|50275653|FG000|Overall Study|Pathology review|2|||
25158266|NCT01609010|50275654|FG001|Overall Study|Pathology review|1|||
25158267|NCT01609010|50275653|FG000|Overall Study|Protocol Violation|1|||
25158268|NCT01609010|50275654|FG001|Overall Study|Protocol Violation|1|||
25158269|NCT01609010|50275653|FG000|Overall Study|New cancer|1|||
25158270|NCT01609010|50275654|FG001|Overall Study|New cancer|0|||
25158271|NCT01609010|50275653|FG000|Overall Study|Lost to Follow-up|1|||
25158272|NCT01609010|50275654|FG001|Overall Study|Lost to Follow-up|1|||
25158273|NCT01608308|50275662|FG000|Overall Study|pretreatment medical and billing reasons|0|||
25158274|NCT01608308|50275663|FG001|Overall Study|pretreatment medical and billing reasons|2|||
25158275|NCT01755416|50275694|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
25158276|NCT01755416|50275695|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
25158277|NCT01755026|50275703|FG000|Overall Study|Adverse Event|1|||
25158278|NCT01755026|50275704|FG001|Overall Study|Adverse Event|0|||
25158279|NCT01755026|50275703|FG000|Overall Study|Withdrawal by Subject|1|||
25158280|NCT01755026|50275704|FG001|Overall Study|Withdrawal by Subject|1|||
25158281|NCT01491945|50275719|FG000|Overall Study|Death|30|||
25158282|NCT01491945|50275719|FG000|Overall Study|Withdrwan/LTF|16|||
25158283|NCT01491945|50275719|FG000|Overall Study|Conversion|4|||
25158284|NCT01491945|50275719|FG000|Overall Study|Missed Visit|1|||
25158285|NCT01728584|50275741|FG000|Overall Study|Adverse Event|1|||
25158286|NCT01728584|50275742|FG001|Overall Study|Adverse Event|0|||
25158287|NCT01728584|50275743|FG002|Overall Study|Adverse Event|0|||
25158288|NCT01728584|50275744|FG003|Overall Study|Adverse Event|0|||
25158289|NCT01728584|50275741|FG000|Overall Study|Physician Decision|4|||
25158290|NCT01728584|50275742|FG001|Overall Study|Physician Decision|0|||
25158291|NCT01728584|50275743|FG002|Overall Study|Physician Decision|1|||
25158292|NCT01728584|50275744|FG003|Overall Study|Physician Decision|0|||
25158293|NCT01728584|50275741|FG000|Overall Study|Withdrawal by Subject|1|||
25158294|NCT01728584|50275742|FG001|Overall Study|Withdrawal by Subject|0|||
25158295|NCT01728584|50275743|FG002|Overall Study|Withdrawal by Subject|0|||
25158296|NCT01728584|50275744|FG003|Overall Study|Withdrawal by Subject|0|||
25158297|NCT01728584|50275741|FG000|Overall Study|Screen failure|1|||
25158298|NCT01728584|50275742|FG001|Overall Study|Screen failure|0|||
25158299|NCT01728584|50275743|FG002|Overall Study|Screen failure|0|||
25158300|NCT01728584|50275744|FG003|Overall Study|Screen failure|0|||
25158301|NCT01728584|50275741|FG000|Overall Study|Other reason (not specified)|1|||
25158302|NCT01728584|50275742|FG001|Overall Study|Other reason (not specified)|0|||
25158303|NCT01728584|50275743|FG002|Overall Study|Other reason (not specified)|0|||
25158304|NCT01728584|50275744|FG003|Overall Study|Other reason (not specified)|1|||
25158305|NCT01522443|50275777|FG000|Overall Study|No longer receiving clinical benefit|36|||
25158306|NCT01522443|50275778|FG001|Overall Study|No longer receiving clinical benefit|28|||
25158307|NCT01522443|50275777|FG000|Overall Study|Adverse Event|10|||
25158308|NCT01522443|50275778|FG001|Overall Study|Adverse Event|15|||
25158309|NCT01522443|50275777|FG000|Overall Study|Withdrawal by Subject|5|||
25158310|NCT01522443|50275778|FG001|Overall Study|Withdrawal by Subject|8|||
25158311|NCT01522443|50275777|FG000|Overall Study|No study treatment given|1|||
25158312|NCT01522443|50275778|FG001|Overall Study|No study treatment given|1|||
25158313|NCT01522443|50275777|FG000|Overall Study|Other|1|||
25158314|NCT01522443|50275778|FG001|Overall Study|Other|3|||
25158315|NCT01468233|50275799|FG000|Treatment Period 1|Adverse Event|5|||
25158316|NCT01468233|50275800|FG001|Treatment Period 1|Adverse Event|3|||
25158317|NCT01468233|50275801|FG002|Treatment Period 1|Adverse Event|0|||
25158318|NCT01468233|50275802|FG003|Treatment Period 1|Adverse Event|0|||
25158319|NCT01468233|50275803|FG004|Treatment Period 1|Adverse Event|0|||
25158320|NCT01468233|50275804|FG005|Treatment Period 1|Adverse Event|0|||
25158321|NCT01468233|50275799|FG000|Treatment Period 1|Withdrawal by Subject|3|||
25158322|NCT01468233|50275800|FG001|Treatment Period 1|Withdrawal by Subject|4|||
25158323|NCT01468233|50275801|FG002|Treatment Period 1|Withdrawal by Subject|0|||
25158324|NCT01468233|50275802|FG003|Treatment Period 1|Withdrawal by Subject|0|||
25158325|NCT01468233|50275803|FG004|Treatment Period 1|Withdrawal by Subject|0|||
25158326|NCT01468233|50275804|FG005|Treatment Period 1|Withdrawal by Subject|0|||
25158327|NCT01468233|50275799|FG000|Treatment Period 1|Lost to Follow-up|3|||
25158328|NCT01468233|50275800|FG001|Treatment Period 1|Lost to Follow-up|0|||
25158329|NCT01468233|50275801|FG002|Treatment Period 1|Lost to Follow-up|0|||
25158330|NCT01468233|50275802|FG003|Treatment Period 1|Lost to Follow-up|0|||
25158331|NCT01468233|50275803|FG004|Treatment Period 1|Lost to Follow-up|0|||
25158332|NCT01468233|50275804|FG005|Treatment Period 1|Lost to Follow-up|0|||
25158333|NCT01468233|50275799|FG000|Treatment Period 1|Other|1|||
25158334|NCT01468233|50275800|FG001|Treatment Period 1|Other|1|||
25158335|NCT01468233|50275801|FG002|Treatment Period 1|Other|0|||
25158336|NCT01468233|50275802|FG003|Treatment Period 1|Other|0|||
25158337|NCT01468233|50275803|FG004|Treatment Period 1|Other|0|||
25158338|NCT01468233|50275804|FG005|Treatment Period 1|Other|0|||
25158339|NCT01468233|50275799|FG000|Treatment Period 2|Adverse Event|0|||
25158340|NCT01468233|50275800|FG001|Treatment Period 2|Adverse Event|0|||
25158341|NCT01468233|50275801|FG002|Treatment Period 2|Adverse Event|3|||
25158342|NCT01468233|50275802|FG003|Treatment Period 2|Adverse Event|0|||
25158343|NCT01468233|50275803|FG004|Treatment Period 2|Adverse Event|2|||
25158344|NCT01468233|50275804|FG005|Treatment Period 2|Adverse Event|1|||
25158345|NCT01468233|50275799|FG000|Treatment Period 2|Lack of Efficacy|0|||
25158346|NCT01468233|50275800|FG001|Treatment Period 2|Lack of Efficacy|0|||
25158347|NCT01468233|50275801|FG002|Treatment Period 2|Lack of Efficacy|9|||
25158348|NCT01468233|50275802|FG003|Treatment Period 2|Lack of Efficacy|2|||
25158349|NCT01468233|50275803|FG004|Treatment Period 2|Lack of Efficacy|0|||
25158350|NCT01468233|50275804|FG005|Treatment Period 2|Lack of Efficacy|1|||
25158351|NCT01468233|50275799|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25158352|NCT01468233|50275800|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25158353|NCT01468233|50275801|FG002|Treatment Period 2|Withdrawal by Subject|9|||
25158354|NCT01468233|50275802|FG003|Treatment Period 2|Withdrawal by Subject|1|||
25158355|NCT01468233|50275803|FG004|Treatment Period 2|Withdrawal by Subject|1|||
25158356|NCT01468233|50275804|FG005|Treatment Period 2|Withdrawal by Subject|1|||
25158357|NCT01468233|50275799|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
25158358|NCT01468233|50275800|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
25158359|NCT01468233|50275801|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
25158360|NCT01468233|50275802|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
24940176|NCT00454116|50033198|FG000|Overall Study|Adverse Event|5|||
24940177|NCT00454116|50033199|FG001|Overall Study|Adverse Event|11|||
24940178|NCT00454116|50033200|FG002|Overall Study|Adverse Event|9|||
24940179|NCT00454116|50033198|FG000|Overall Study|Condition under investigation worsened|17|||
24940180|NCT00454116|50033199|FG001|Overall Study|Condition under investigation worsened|13|||
24940181|NCT00454116|50033200|FG002|Overall Study|Condition under investigation worsened|18|||
24940182|NCT00454116|50033198|FG000|Overall Study|Withdrawal by Subject|3|||
25029376|NCT02969018|50127738|FG000|Overall Study|Withdrawal by Subject|0|||
25029377|NCT02969018|50127739|FG001|Overall Study|Withdrawal by Subject|1|||
25029378|NCT02969018|50127740|FG002|Overall Study|Withdrawal by Subject|2|||
25029379|NCT02969018|50127741|FG003|Overall Study|Withdrawal by Subject|1|||
25029380|NCT02969018|50127742|FG004|Overall Study|Withdrawal by Subject|0|||
25029381|NCT02969018|50127743|FG005|Overall Study|Withdrawal by Subject|4|||
25029382|NCT02969018|50127744|FG006|Overall Study|Withdrawal by Subject|4|||
25029383|NCT02969018|50127745|FG007|Overall Study|Withdrawal by Subject|3|||
25029384|NCT01319721|50127768|FG000|Overall Study|Lost to Follow-up|1|||
25158361|NCT01468233|50275803|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
24940183|NCT00454116|50033199|FG001|Overall Study|Withdrawal by Subject|3|||
24940184|NCT00454116|50033200|FG002|Overall Study|Withdrawal by Subject|1|||
24940185|NCT00454116|50033198|FG000|Overall Study|Other|2|||
24940186|NCT00454116|50033199|FG001|Overall Study|Other|2|||
25158362|NCT01468233|50275804|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
25158363|NCT01468233|50275799|FG000|Treatment Period 2|Lost to Follow-up|0|||
25158364|NCT01468233|50275800|FG001|Treatment Period 2|Lost to Follow-up|0|||
25275503|NCT01073631|50589382|FG000|Overall Study|Other|63|||
25029385|NCT01319721|50127769|FG001|Overall Study|Lost to Follow-up|6|||
25158365|NCT01468233|50275801|FG002|Treatment Period 2|Lost to Follow-up|3|||
25158366|NCT01468233|50275802|FG003|Treatment Period 2|Lost to Follow-up|0|||
25158367|NCT01468233|50275803|FG004|Treatment Period 2|Lost to Follow-up|2|||
25158368|NCT01468233|50275804|FG005|Treatment Period 2|Lost to Follow-up|0|||
24940187|NCT00454116|50033200|FG002|Overall Study|Other|0|||
24940188|NCT00465816|50033211|FG000|Overall Study|Lost to Follow-up|0|||
25158369|NCT01468233|50275799|FG000|Treatment Period 2|Other|0|||
25158370|NCT01468233|50275800|FG001|Treatment Period 2|Other|0|||
25158371|NCT01468233|50275801|FG002|Treatment Period 2|Other|3|||
25158372|NCT01468233|50275802|FG003|Treatment Period 2|Other|0|||
25158373|NCT01468233|50275803|FG004|Treatment Period 2|Other|1|||
25158374|NCT01468233|50275804|FG005|Treatment Period 2|Other|0|||
25158375|NCT01468077|50275824|FG000|Overall Study|Adverse Event|2|||
25158376|NCT01468077|50275825|FG001|Overall Study|Adverse Event|2|||
25158377|NCT01468077|50275824|FG000|Overall Study|Lack of Efficacy|1|||
25158378|NCT01468077|50275825|FG001|Overall Study|Lack of Efficacy|1|||
25158379|NCT01468077|50275824|FG000|Overall Study|Physician Decision|1|||
25158380|NCT01468077|50275825|FG001|Overall Study|Physician Decision|0|||
25158381|NCT01522365|50275833|FG000|Overall Study|Withdrawal by Subject|1|||
25158382|NCT01522365|50275834|FG001|Overall Study|Withdrawal by Subject|1|||
25158383|NCT01522365|50275833|FG000|Overall Study|Lost to Follow-up|1|||
25158384|NCT01522365|50275834|FG001|Overall Study|Lost to Follow-up|1|||
25158385|NCT01754402|50275844|FG000|Overall Study|Death|0|||
25158386|NCT01754402|50275845|FG001|Overall Study|Death|0|||
25158387|NCT01754402|50275846|FG002|Overall Study|Death|1|||
25158388|NCT01754402|50275844|FG000|Overall Study|Adverse Event|2|||
25158389|NCT01754402|50275845|FG001|Overall Study|Adverse Event|2|||
25158390|NCT01754402|50275846|FG002|Overall Study|Adverse Event|1|||
25158391|NCT01754402|50275844|FG000|Overall Study|Withdrawal by Subject|0|||
25158392|NCT01754402|50275845|FG001|Overall Study|Withdrawal by Subject|0|||
25158393|NCT01754402|50275846|FG002|Overall Study|Withdrawal by Subject|1|||
25158394|NCT01754402|50275844|FG000|Overall Study|Lack of Efficacy|0|||
25158395|NCT01754402|50275845|FG001|Overall Study|Lack of Efficacy|0|||
25158396|NCT01754402|50275846|FG002|Overall Study|Lack of Efficacy|1|||
25158397|NCT01783418|50275857|FG000|Overall Study|Withdrawal by Subject|1|||
25158398|NCT01783418|50275858|FG001|Overall Study|Withdrawal by Subject|0|||
25158399|NCT01521897|50275864|FG000|Overall Study|Protocol Violation|18|||
25158400|NCT01521897|50275864|FG000|Overall Study|Lost to Follow-up|5|||
25158401|NCT01782872|50275872|FG000|Overall Study|Protocol Violation|0|||
25158402|NCT01782872|50275873|FG001|Overall Study|Protocol Violation|0|||
25158403|NCT01782872|50275874|FG002|Overall Study|Protocol Violation|0|||
25158404|NCT01782872|50275875|FG003|Overall Study|Protocol Violation|1|||
25158405|NCT01782872|50275872|FG000|Overall Study|Withdrawal by Subject|0|||
25158406|NCT01782872|50275873|FG001|Overall Study|Withdrawal by Subject|1|||
25158407|NCT01782872|50275874|FG002|Overall Study|Withdrawal by Subject|0|||
25158408|NCT01782872|50275875|FG003|Overall Study|Withdrawal by Subject|0|||
25158409|NCT01490697|50275887|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
25158410|NCT01490697|50275888|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
25158411|NCT01728194|50275896|FG000|Overall Study|Lost to Follow-up|4|||
25158412|NCT01728194|50275897|FG001|Overall Study|Lost to Follow-up|3|||
25158413|NCT01728194|50275896|FG000|Overall Study|Physician Decision|4|||
25158414|NCT01728194|50275897|FG001|Overall Study|Physician Decision|0|||
25158415|NCT01728194|50275896|FG000|Overall Study|Withdrawal by Subject|7|||
25158416|NCT01728194|50275897|FG001|Overall Study|Withdrawal by Subject|3|||
25158417|NCT01728194|50275896|FG000|Overall Study|Perceived Medication Side Effects|4|||
25158418|NCT01728194|50275897|FG001|Overall Study|Perceived Medication Side Effects|0|||
24940189|NCT00465816|50033212|FG001|Overall Study|Lost to Follow-up|0|||
24940190|NCT00465816|50033213|FG002|Overall Study|Lost to Follow-up|2|||
25158419|NCT01728194|50275896|FG000|Overall Study|Family Member Request|1|||
25158420|NCT01728194|50275897|FG001|Overall Study|Family Member Request|0|||
25158421|NCT01782482|50275905|FG000|Overall Study|Adverse Event|2|||
25158422|NCT01782482|50275906|FG001|Overall Study|Adverse Event|1|||
24940191|NCT00465738|50033224|FG000|Overall Study|Lost to Follow-up|2|||
24940192|NCT00465738|50033225|FG001|Overall Study|Lost to Follow-up|0|||
24940193|NCT00465738|50033224|FG000|Overall Study|Adverse Event|0|||
24940194|NCT00465738|50033225|FG001|Overall Study|Adverse Event|1|||
24940195|NCT00465738|50033224|FG000|Overall Study|Withdrawal by Subject|2|||
24940196|NCT00465738|50033225|FG001|Overall Study|Withdrawal by Subject|0|||
24940197|NCT00465738|50033224|FG000|Overall Study|Other|2|||
24940198|NCT00465738|50033225|FG001|Overall Study|Other|5|||
25158423|NCT01782482|50275905|FG000|Overall Study|Lost to Follow-up|2|||
24940199|NCT00400179|50033233|FG000|Overall Study|Adverse Event|2|||
25158424|NCT01782482|50275906|FG001|Overall Study|Lost to Follow-up|3|||
25158425|NCT01782482|50275905|FG000|Overall Study|Physician Decision|1|||
25158426|NCT01782482|50275906|FG001|Overall Study|Physician Decision|0|||
25158427|NCT01782482|50275905|FG000|Overall Study|Protocol Violation|1|||
25158428|NCT01782482|50275906|FG001|Overall Study|Protocol Violation|0|||
25158429|NCT01782482|50275905|FG000|Overall Study|Withdrawal by Subject|2|||
25158430|NCT01782482|50275906|FG001|Overall Study|Withdrawal by Subject|3|||
25158431|NCT01782482|50275905|FG000|Overall Study|Randomized in Error|2|||
25158432|NCT01782482|50275906|FG001|Overall Study|Randomized in Error|2|||
25158433|NCT01782482|50275905|FG000|Overall Study|Habitually wearing toric lens OS|0|||
25158434|NCT01782482|50275906|FG001|Overall Study|Habitually wearing toric lens OS|1|||
25158435|NCT01466673|50275914|FG000|Overall Study|Non-compliance with study treatment|2|||
25158436|NCT01466673|50275915|FG001|Overall Study|Non-compliance with study treatment|0|||
25158437|NCT01466673|50275914|FG000|Overall Study|Lost to Follow-up|3|||
25158438|NCT01466673|50275915|FG001|Overall Study|Lost to Follow-up|5|||
25158439|NCT01466673|50275914|FG000|Overall Study|Adverse Event|2|||
25158440|NCT01466673|50275915|FG001|Overall Study|Adverse Event|1|||
25158441|NCT01753856|50275923|FG000|Overall Study|Adverse Event|1|||
25158442|NCT01753856|50275924|FG001|Overall Study|Adverse Event|0|||
25158443|NCT01753856|50275923|FG000|Overall Study|Withdrawal by Subject|0|||
25158444|NCT01753856|50275924|FG001|Overall Study|Withdrawal by Subject|2|||
25158445|NCT01753856|50275923|FG000|Overall Study|Sponsor Decision|2|||
25158446|NCT01753856|50275924|FG001|Overall Study|Sponsor Decision|0|||
25158447|NCT01464333|50275933|FG000|Overall Study|Adverse Event|34|||
25158448|NCT01464333|50275933|FG000|Overall Study|Lack of Efficacy|72|||
25158449|NCT01464333|50275933|FG000|Overall Study|Withdrawal by Subject|11|||
25158450|NCT01464333|50275933|FG000|Overall Study|Other|4|||
25158451|NCT01464333|50275933|FG000|Overall Study|No Hospital Visit|42|||
25158452|NCT01464255|50275939|FG000|Overall Study|unresolve corneal staining|0|||
25158453|NCT01464255|50275940|FG001|Overall Study|unresolve corneal staining|1|||
25158454|NCT01464021|50275947|FG000|Overall Study|Withdrawal by Subject|13|||
25158455|NCT01464021|50275947|FG000|Overall Study|Lost to Follow-up|1|||
25158456|NCT01464021|50275947|FG000|Overall Study|Lack of Efficacy|1|||
25158457|NCT01464021|50275947|FG000|Overall Study|various|11|||
25158458|NCT01753310|50275953|FG000|Overall Study|Entered into open label extension study|25|||
25158459|NCT01753310|50275954|FG001|Overall Study|Entered into open label extension study|22|||
25158460|NCT01753310|50275953|FG000|Overall Study|Adverse Event|1|||
25158461|NCT01753310|50275954|FG001|Overall Study|Adverse Event|0|||
25158462|NCT01753310|50275953|FG000|Overall Study|Lost to Follow-up|2|||
25158463|NCT01753310|50275954|FG001|Overall Study|Lost to Follow-up|0|||
25158464|NCT01753310|50275953|FG000|Overall Study|Subject decision|2|||
25158465|NCT01753310|50275954|FG001|Overall Study|Subject decision|2|||
25158466|NCT01753310|50275953|FG000|Overall Study|Sponsor decision|1|||
25158467|NCT01753310|50275954|FG001|Overall Study|Sponsor decision|0|||
25158468|NCT01753310|50275953|FG000|Overall Study|Withdrawal by Subject|1|||
25158469|NCT01753310|50275954|FG001|Overall Study|Withdrawal by Subject|0|||
25158470|NCT01463631|50275964|FG000|Overall Study|Withdrawal by Subject|0|||
25158471|NCT01463631|50275965|FG001|Overall Study|Withdrawal by Subject|0|||
25158472|NCT01463631|50275966|FG002|Overall Study|Withdrawal by Subject|0|||
25158473|NCT01463631|50275967|FG003|Overall Study|Withdrawal by Subject|1|||
25158474|NCT01463631|50275964|FG000|Overall Study|Death|0|||
25158475|NCT01463631|50275965|FG001|Overall Study|Death|0|||
25158476|NCT01463631|50275966|FG002|Overall Study|Death|1|||
25158477|NCT01463631|50275967|FG003|Overall Study|Death|0|||
25158478|NCT01463631|50275964|FG000|Overall Study|Progressive Disease|0|||
25158479|NCT01463631|50275965|FG001|Overall Study|Progressive Disease|0|||
25158480|NCT01463631|50275966|FG002|Overall Study|Progressive Disease|0|||
25158481|NCT01463631|50275967|FG003|Overall Study|Progressive Disease|5|||
25158482|NCT01521507|50275981|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
25158483|NCT01521507|50275982|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
25158484|NCT01521507|50275981|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
25158485|NCT01521507|50275982|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
25158486|NCT01521507|50275981|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
25158487|NCT01521507|50275982|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
25029386|NCT02905032|50127778|FG000|Overall Study|Withdrawal by Subject|2|||
25029387|NCT02905032|50127779|FG001|Overall Study|Withdrawal by Subject|0|||
25029388|NCT02905032|50127780|FG002|Overall Study|Withdrawal by Subject|0|||
25029389|NCT02905032|50127778|FG000|Overall Study|Protocol Violation|6|||
25029390|NCT02905032|50127779|FG001|Overall Study|Protocol Violation|12|||
25158488|NCT01521507|50275981|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
25158489|NCT01521507|50275982|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
25158490|NCT01521507|50275981|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
25158491|NCT01521507|50275982|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
25158492|NCT01521507|50275981|FG000|Stage 2: Observational Design|Physician Decision|1|||
25158493|NCT01521507|50275982|FG001|Stage 2: Observational Design|Physician Decision|0|||
25158494|NCT01521117|50275995|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
25158495|NCT01521117|50275996|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
25158496|NCT01521117|50275995|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
25158497|NCT01521117|50275996|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
25029391|NCT02905032|50127780|FG002|Overall Study|Protocol Violation|0|||
25029392|NCT03259425|50127787|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
25029393|NCT03101241|50127793|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
25029394|NCT03101241|50127794|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
25029395|NCT03101241|50127793|FG000|Overall Study|Participant withdrew consent|3|||
25029396|NCT03101241|50127794|FG001|Overall Study|Participant withdrew consent|1|||
25029397|NCT03101241|50127793|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
25029398|NCT03101241|50127794|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
25029399|NCT03101241|50127793|FG000|Overall Study|Lost to Follow-up|2|||
25029400|NCT03101241|50127794|FG001|Overall Study|Lost to Follow-up|0|||
25029401|NCT03101241|50127793|FG000|Overall Study|Lack of Efficacy|0|||
25029402|NCT03101241|50127794|FG001|Overall Study|Lack of Efficacy|1|||
25029403|NCT03101241|50127793|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
25029404|NCT03101241|50127794|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
25029405|NCT03061188|50127804|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
25029406|NCT03061188|50127805|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
25029407|NCT03061188|50127806|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
25029408|NCT03061188|50127807|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
25029409|NCT03061188|50127804|FG000|On Follow-up for 3 Years|Death|0|||
24940200|NCT00400179|50033234|FG001|Overall Study|Adverse Event|2|||
24940201|NCT00400179|50033233|FG000|Overall Study|Death|1|||
24940202|NCT00400179|50033234|FG001|Overall Study|Death|2|||
24940203|NCT00400179|50033233|FG000|Overall Study|Withdrew Consent|1|||
24940204|NCT00400179|50033234|FG001|Overall Study|Withdrew Consent|5|||
24940205|NCT00400179|50033233|FG000|Overall Study|Disease progression|1|||
24940206|NCT00400179|50033234|FG001|Overall Study|Disease progression|1|||
24940207|NCT00400179|50033233|FG000|Overall Study|Intercurrent illness|0|||
24940208|NCT00400179|50033234|FG001|Overall Study|Intercurrent illness|1|||
24940209|NCT00400179|50033233|FG000|Overall Study|Investigator judgment|0|||
24940210|NCT00400179|50033234|FG001|Overall Study|Investigator judgment|1|||
24940211|NCT00400179|50033233|FG000|Overall Study|Randomization error/patient ineligible|1|||
24940212|NCT00400179|50033234|FG001|Overall Study|Randomization error/patient ineligible|6|||
24940213|NCT00465270|50033242|FG000|Overall Study|Death|7|||
24940214|NCT00465270|50033243|FG001|Overall Study|Death|11|||
24940215|NCT00465270|50033242|FG000|Overall Study|Withdrawal by Subject|34|||
24940216|NCT00465270|50033243|FG001|Overall Study|Withdrawal by Subject|78|||
24940217|NCT00465270|50033242|FG000|Overall Study|Lost to Follow-up|60|||
24940218|NCT00465270|50033243|FG001|Overall Study|Lost to Follow-up|67|||
24940219|NCT00465270|50033242|FG000|Overall Study|Investigator request|3|||
24940220|NCT00465270|50033243|FG001|Overall Study|Investigator request|4|||
24940221|NCT00464568|50033249|FG000|Overall Study|Adverse Event|2|||
24940222|NCT00464490|50033268|FG000|Overall Study|Physician Decision|11|||
24940223|NCT00464490|50033269|FG001|Overall Study|Physician Decision|11|||
24940224|NCT03849300|50033279|FG000|Overall Study|move out to different area|1|||
24940225|NCT03849300|50033280|FG001|Overall Study|move out to different area|3|||
25029410|NCT03061188|50127805|FG001|On Follow-up for 3 Years|Death|3|||
25029411|NCT03061188|50127806|FG002|On Follow-up for 3 Years|Death|5|||
25029412|NCT03061188|50127807|FG003|On Follow-up for 3 Years|Death|2|||
25158498|NCT01521117|50275995|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
25158499|NCT01521117|50275996|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
25158500|NCT01466595|50276004|FG000|Overall Study|Withdrawal by Subject|0|||
25158501|NCT01466595|50276005|FG001|Overall Study|Withdrawal by Subject|1|||
25158502|NCT01728116|50276022|FG000|Overall Study|Sponsor Terminated Study|106|||
25158503|NCT01728116|50276023|FG001|Overall Study|Sponsor Terminated Study|35|||
25158504|NCT01728116|50276022|FG000|Overall Study|Withdrawal by Subject|16|||
25158505|NCT01728116|50276023|FG001|Overall Study|Withdrawal by Subject|9|||
25158506|NCT01728116|50276022|FG000|Overall Study|Adverse Event|13|||
25158507|NCT01728116|50276023|FG001|Overall Study|Adverse Event|0|||
25158508|NCT01728116|50276022|FG000|Overall Study|Procedure/device failure|7|||
25158509|NCT01728116|50276023|FG001|Overall Study|Procedure/device failure|0|||
25158510|NCT01728116|50276022|FG000|Overall Study|Lost to Follow-up|9|||
25158511|NCT01728116|50276023|FG001|Overall Study|Lost to Follow-up|2|||
24940226|NCT03849300|50033281|FG002|Overall Study|move out to different area|1|||
24940227|NCT03849300|50033282|FG003|Overall Study|move out to different area|4|||
24940228|NCT03849300|50033279|FG000|Overall Study|scheduling/transportation conflict|4|||
25158512|NCT01728116|50276022|FG000|Overall Study|Physician Decision|2|||
25158513|NCT01728116|50276023|FG001|Overall Study|Physician Decision|0|||
25158514|NCT01728116|50276022|FG000|Overall Study|Subject Non-Compliance|2|||
25158515|NCT01728116|50276023|FG001|Overall Study|Subject Non-Compliance|0|||
25158516|NCT01728116|50276022|FG000|Overall Study|Inter-current finding at procedure|1|||
25186157|NCT01421069|50336041|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
24940229|NCT03849300|50033280|FG001|Overall Study|scheduling/transportation conflict|4|||
25029413|NCT03061188|50127804|FG000|On Follow-up for 3 Years|Still in follow-up|0|||
25186158|NCT01421069|50336041|FG000|Active Treatment Period|Pregnancy|1|||
24940230|NCT03849300|50033281|FG002|Overall Study|scheduling/transportation conflict|3|||
25158517|NCT01728116|50276023|FG001|Overall Study|Inter-current finding at procedure|0|||
25158518|NCT01728116|50276022|FG000|Overall Study|Incorrectly enrolled in Study|0|||
25158519|NCT01728116|50276023|FG001|Overall Study|Incorrectly enrolled in Study|1|||
25158520|NCT01728116|50276022|FG000|Overall Study|various not noted previously|5|||
25158521|NCT01728116|50276023|FG001|Overall Study|various not noted previously|0|||
25158522|NCT01465659|50276034|FG000|Completed 1 Cycle of Treatment|Death|0|||
25158523|NCT01465659|50276035|FG001|Completed 1 Cycle of Treatment|Death|1|||
25158524|NCT01465659|50276036|FG002|Completed 1 Cycle of Treatment|Death|0|||
25158525|NCT01465659|50276037|FG003|Completed 1 Cycle of Treatment|Death|0|||
25029414|NCT03061188|50127805|FG001|On Follow-up for 3 Years|Still in follow-up|0|||
25029415|NCT03061188|50127806|FG002|On Follow-up for 3 Years|Still in follow-up|0|||
25029416|NCT03061188|50127807|FG003|On Follow-up for 3 Years|Still in follow-up|3|||
25029417|NCT03449147|50127825|FG000|52-week Treatment Period|Death|0|||
25029418|NCT03449147|50127826|FG001|52-week Treatment Period|Death|1|||
25029419|NCT03449147|50127827|FG002|52-week Treatment Period|Death|0|||
25029420|NCT03449147|50127825|FG000|52-week Treatment Period|Lost to Follow-up|6|||
25029421|NCT03449147|50127826|FG001|52-week Treatment Period|Lost to Follow-up|2|||
25029422|NCT03449147|50127827|FG002|52-week Treatment Period|Lost to Follow-up|5|||
25029423|NCT03449147|50127825|FG000|52-week Treatment Period|Other|0|||
25029424|NCT03449147|50127826|FG001|52-week Treatment Period|Other|1|||
25029425|NCT03449147|50127827|FG002|52-week Treatment Period|Other|2|||
25029426|NCT03449147|50127825|FG000|52-week Treatment Period|Physician Decision|1|||
25029427|NCT03449147|50127826|FG001|52-week Treatment Period|Physician Decision|0|||
25029428|NCT03449147|50127827|FG002|52-week Treatment Period|Physician Decision|3|||
25029429|NCT03449147|50127825|FG000|52-week Treatment Period|Screen Failure|1|||
25029430|NCT03449147|50127826|FG001|52-week Treatment Period|Screen Failure|2|||
25029431|NCT03449147|50127827|FG002|52-week Treatment Period|Screen Failure|0|||
25029432|NCT03449147|50127825|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
25029433|NCT03449147|50127826|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
25029434|NCT03449147|50127827|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
25029435|NCT03449147|50127825|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
25029436|NCT03449147|50127826|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
25029437|NCT03449147|50127827|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
25029438|NCT03449147|50127825|FG000|12-Week Off-Treatment Durability Period|Other|0|||
25029439|NCT03449147|50127826|FG001|12-Week Off-Treatment Durability Period|Other|1|||
25029440|NCT03449147|50127827|FG002|12-Week Off-Treatment Durability Period|Other|0|||
25029441|NCT03423173|50127843|FG000|Overall Study|Randomized but not vaccinated|1|||
25029442|NCT03423173|50127844|FG001|Overall Study|Randomized but not vaccinated|0|||
25029443|NCT03423173|50127845|FG002|Overall Study|Randomized but not vaccinated|2|||
25029444|NCT03423173|50127846|FG003|Overall Study|Randomized but not vaccinated|1|||
25029445|NCT03423173|50127843|FG000|Overall Study|Adverse Event|1|||
25029446|NCT03423173|50127844|FG001|Overall Study|Adverse Event|1|||
25029447|NCT03423173|50127845|FG002|Overall Study|Adverse Event|1|||
25029448|NCT03423173|50127846|FG003|Overall Study|Adverse Event|1|||
25029449|NCT03423173|50127843|FG000|Overall Study|Lost to Follow-up|10|||
24940231|NCT03849300|50033282|FG003|Overall Study|scheduling/transportation conflict|2|||
24940232|NCT00412893|50033296|FG000|Overall Study|Adverse Event|31|||
24940233|NCT00412893|50033297|FG001|Overall Study|Adverse Event|53|||
24940234|NCT00412893|50033296|FG000|Overall Study|Death|17|||
24940235|NCT00412893|50033297|FG001|Overall Study|Death|21|||
24940236|NCT00412893|50033296|FG000|Overall Study|Insufficient Therapeutic Response|39|||
24940237|NCT00412893|50033297|FG001|Overall Study|Insufficient Therapeutic Response|23|||
24940238|NCT00412893|50033296|FG000|Overall Study|Lost to Follow-up|2|||
24940239|NCT00412893|50033297|FG001|Overall Study|Lost to Follow-up|1|||
24940240|NCT00412893|50033296|FG000|Overall Study|Violation of Selection at Entry|17|||
24940241|NCT00412893|50033297|FG001|Overall Study|Violation of Selection at Entry|10|||
25029450|NCT03423173|50127844|FG001|Overall Study|Lost to Follow-up|19|||
25029451|NCT03423173|50127845|FG002|Overall Study|Lost to Follow-up|17|||
25029452|NCT03423173|50127846|FG003|Overall Study|Lost to Follow-up|22|||
25029453|NCT03423173|50127843|FG000|Overall Study|Withdrawal of consent|4|||
25029454|NCT03423173|50127844|FG001|Overall Study|Withdrawal of consent|10|||
25158526|NCT01465659|50276034|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
24940242|NCT00412893|50033296|FG000|Overall Study|Other Protocol Violation|10|||
24940243|NCT00412893|50033297|FG001|Overall Study|Other Protocol Violation|6|||
24940244|NCT00412893|50033296|FG000|Overall Study|Did Not Cooperate|12|||
24940245|NCT00412893|50033297|FG001|Overall Study|Did Not Cooperate|9|||
24940246|NCT00412893|50033296|FG000|Overall Study|Administrative Reason|12|||
24940247|NCT00412893|50033297|FG001|Overall Study|Administrative Reason|15|||
24940248|NCT00412893|50033296|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
24940249|NCT00412893|50033297|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
25158527|NCT01465659|50276035|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
25158528|NCT01465659|50276036|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
25158529|NCT01465659|50276037|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
25158530|NCT01465659|50276034|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
25158531|NCT01465659|50276035|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
25158532|NCT01465659|50276036|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
25158533|NCT01465659|50276037|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
25158534|NCT01465659|50276034|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
25158535|NCT01465659|50276035|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
25158536|NCT01465659|50276036|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
25158537|NCT01465659|50276037|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
25158538|NCT01465659|50276034|FG000|Completed Follow for 1 Year|Death|6|||
25158539|NCT01465659|50276035|FG001|Completed Follow for 1 Year|Death|3|||
25158540|NCT01465659|50276036|FG002|Completed Follow for 1 Year|Death|2|||
25158541|NCT01465659|50276037|FG003|Completed Follow for 1 Year|Death|4|||
25158542|NCT01753076|50276052|FG000|Overall Study|Adverse Event|17|||
24940250|NCT00412737|50033305|FG000|Overall Study|Death|1|||
24940251|NCT00412737|50033306|FG001|Overall Study|Death|0|||
24940252|NCT00412737|50033305|FG000|Overall Study|Adverse Event|3|||
24940253|NCT00412737|50033306|FG001|Overall Study|Adverse Event|2|||
24940254|NCT00412737|50033305|FG000|Overall Study|Refused Treatment|6|||
24940255|NCT00412737|50033306|FG001|Overall Study|Refused Treatment|2|||
24940256|NCT00412737|50033305|FG000|Overall Study|Failure to Return|6|||
24940257|NCT00412737|50033306|FG001|Overall Study|Failure to Return|2|||
24940258|NCT00508742|50033314|FG000|Period 1: Infant Series|Adverse Event|5|||
24940259|NCT00508742|50033315|FG001|Period 1: Infant Series|Adverse Event|4|||
24940260|NCT00508742|50033314|FG000|Period 1: Infant Series|Protocol Violation|1|||
24940261|NCT00508742|50033315|FG001|Period 1: Infant Series|Protocol Violation|0|||
24940262|NCT00508742|50033314|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
25029455|NCT03423173|50127845|FG002|Overall Study|Withdrawal of consent|4|||
25029456|NCT03423173|50127846|FG003|Overall Study|Withdrawal of consent|5|||
25029457|NCT03423173|50127843|FG000|Overall Study|Death|1|||
25029458|NCT03423173|50127844|FG001|Overall Study|Death|0|||
25029459|NCT03423173|50127845|FG002|Overall Study|Death|0|||
25029460|NCT03423173|50127846|FG003|Overall Study|Death|0|||
25029461|NCT03423173|50127843|FG000|Overall Study|Reason not Specified|2|||
25029462|NCT03423173|50127844|FG001|Overall Study|Reason not Specified|5|||
25029463|NCT03423173|50127845|FG002|Overall Study|Reason not Specified|3|||
25158543|NCT01753076|50276053|FG001|Overall Study|Adverse Event|18|||
25158544|NCT01753076|50276052|FG000|Overall Study|Lack of Efficacy|3|||
25158545|NCT01753076|50276053|FG001|Overall Study|Lack of Efficacy|1|||
25158546|NCT01753076|50276052|FG000|Overall Study|Lost to Follow-up|2|||
25158547|NCT01753076|50276053|FG001|Overall Study|Lost to Follow-up|1|||
25158548|NCT01753076|50276052|FG000|Overall Study|Physician Decision|4|||
25158549|NCT01753076|50276053|FG001|Overall Study|Physician Decision|2|||
25158550|NCT01753076|50276052|FG000|Overall Study|Withdrawal by Subject|14|||
25275504|NCT01073163|50589386|FG000|Overall Study|Adverse Event|1|||
25029464|NCT03423173|50127846|FG003|Overall Study|Reason not Specified|1|||
25158551|NCT01753076|50276053|FG001|Overall Study|Withdrawal by Subject|24|||
24940263|NCT00508742|50033315|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
24940264|NCT00508742|50033314|FG000|Period 1: Infant Series|Physician Decision|1|||
24940265|NCT00508742|50033315|FG001|Period 1: Infant Series|Physician Decision|0|||
24940266|NCT00508742|50033314|FG000|Period 1: Infant Series|Other|4|||
25029465|NCT03447821|50127859|FG000|Overall Study|Withdrawal by Subject|1|||
25158552|NCT01753076|50276052|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
25275505|NCT01073163|50589386|FG000|Overall Study|Disease Progression|1|||
25158553|NCT01753076|50276053|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
25158554|NCT01463007|50276061|FG000|Overall Study|Physician Decision|1|||
25158555|NCT01462929|50276069|FG000|Overall Study|Adverse Event|3|||
25158556|NCT01462929|50276070|FG001|Overall Study|Adverse Event|3|||
25029466|NCT03447821|50127860|FG001|Overall Study|Withdrawal by Subject|1|||
24940267|NCT00508742|50033315|FG001|Period 1: Infant Series|Other|1|||
24940268|NCT00508742|50033314|FG000|Period 2: After Infant Series|Adverse Event|2|||
24940269|NCT00508742|50033315|FG001|Period 2: After Infant Series|Adverse Event|6|||
24940270|NCT00508742|50033314|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
24940271|NCT00508742|50033315|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
24940272|NCT00508742|50033314|FG000|Period 2: After Infant Series|Protocol Violation|1|||
24940273|NCT00508742|50033315|FG001|Period 2: After Infant Series|Protocol Violation|0|||
24940274|NCT00508742|50033314|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
24940275|NCT00508742|50033315|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
24940276|NCT00508742|50033314|FG000|Period 2: After Infant Series|Failed to Return|1|||
24940277|NCT00508742|50033315|FG001|Period 2: After Infant Series|Failed to Return|0|||
24940278|NCT00508742|50033314|FG000|Period 2: After Infant Series|Other|2|||
24940279|NCT00508742|50033315|FG001|Period 2: After Infant Series|Other|1|||
24940280|NCT00508742|50033314|FG000|Period 3: Toddler Dose|Adverse Event|1|||
24940281|NCT00508742|50033315|FG001|Period 3: Toddler Dose|Adverse Event|0|||
25029467|NCT03447821|50127861|FG002|Overall Study|Withdrawal by Subject|0|||
25029468|NCT03447821|50127859|FG000|Overall Study|Lost to Follow-up|0|||
24940282|NCT00508742|50033314|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
24940283|NCT00508742|50033315|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
24940284|NCT00508742|50033314|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
24940285|NCT00508742|50033315|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
24940286|NCT00508742|50033314|FG000|Period 3: Toddler Dose|Other|5|||
24940287|NCT00508742|50033315|FG001|Period 3: Toddler Dose|Other|4|||
24940288|NCT00508274|50033336|FG000|Overall Study|Adverse Event|5|||
24940289|NCT00508274|50033336|FG000|Overall Study|Death|7|||
24940290|NCT00508274|50033336|FG000|Overall Study|Disease progression|32|||
24940291|NCT00508274|50033336|FG000|Overall Study|Withdrawal by Subject|1|||
24940292|NCT00508274|50033336|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
24940293|NCT00508274|50033336|FG000|Overall Study|Missing|3|||
24940294|NCT00499460|50033342|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
24940295|NCT00499460|50033343|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
24940296|NCT00499460|50033342|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
24940297|NCT00499460|50033343|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
24940298|NCT00499460|50033342|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
24940299|NCT00499460|50033343|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
24940300|NCT00412113|50033361|FG000|Overall Study|Adverse Event|11|||
24940301|NCT00412113|50033362|FG001|Overall Study|Adverse Event|15|||
24940302|NCT00412113|50033361|FG000|Overall Study|did not receive treatment|1|||
25029469|NCT03447821|50127860|FG001|Overall Study|Lost to Follow-up|0|||
25029470|NCT03447821|50127861|FG002|Overall Study|Lost to Follow-up|1|||
25029471|NCT03447353|50127875|FG000|Overall Study|Failure at Screening Visit|2|||
25029472|NCT03447353|50127875|FG000|Overall Study|Lost to Follow-up|4|||
25029473|NCT03447353|50127875|FG000|Overall Study|Scheduling Conflicts|3|||
25029474|NCT03447353|50127875|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
25029475|NCT03446885|50127885|FG000|Overall Study|Lost to Follow-up|1|||
24940303|NCT00412113|50033362|FG001|Overall Study|did not receive treatment|0|||
24940304|NCT00411645|50033370|FG000|Overall Study|Consent Withdrawn|13|||
25029476|NCT03446885|50127886|FG001|Overall Study|Lost to Follow-up|0|||
25029477|NCT03446885|50127885|FG000|Overall Study|Did not complete entire visit|1|||
25029478|NCT03446885|50127886|FG001|Overall Study|Did not complete entire visit|0|||
25029479|NCT00710970|50127894|FG000|Overall Study|Never took drug|3|||
24940305|NCT00411645|50033371|FG001|Overall Study|Consent Withdrawn|22|||
24940306|NCT00411645|50033370|FG000|Overall Study|Death|56|||
24940307|NCT00411645|50033371|FG001|Overall Study|Death|135|||
25029480|NCT03421379|50127900|FG000|Period 1|Withdrawal by Subject|0|||
25029481|NCT03421379|50127901|FG001|Period 1|Withdrawal by Subject|1|||
25029482|NCT03421379|50127900|FG000|Period 1|Physician Decision|1|||
25029483|NCT03421379|50127901|FG001|Period 1|Physician Decision|1|||
25029484|NCT03421379|50127900|FG000|Period 1|Did not receive treatment|1|||
25029485|NCT03421379|50127901|FG001|Period 1|Did not receive treatment|2|||
25029486|NCT02900378|50127909|FG000|Randomization (Visit 2)|Adverse Event|14|||
25029487|NCT02900378|50127910|FG001|Randomization (Visit 2)|Adverse Event|11|||
25029488|NCT02900378|50127909|FG000|Randomization (Visit 2)|Death|1|||
25029489|NCT02900378|50127910|FG001|Randomization (Visit 2)|Death|4|||
25029490|NCT02900378|50127909|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
25029491|NCT02900378|50127910|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
25029492|NCT02900378|50127909|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
25029493|NCT02900378|50127910|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
25029494|NCT02900378|50127909|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
24940308|NCT00411645|50033370|FG000|Overall Study|Investigator/Sponsor Decision|10|||
24940309|NCT00411645|50033371|FG001|Overall Study|Investigator/Sponsor Decision|7|||
24940310|NCT00411645|50033370|FG000|Overall Study|Lost to Follow-up|2|||
24940311|NCT00411645|50033371|FG001|Overall Study|Lost to Follow-up|0|||
24940312|NCT00490724|50033381|FG000|Period I|Physician Decision|0|||
24940313|NCT00490724|50033382|FG001|Period I|Physician Decision|0|||
24940314|NCT00490724|50033383|FG002|Period I|Physician Decision|1|||
24940315|NCT00490724|50033381|FG000|Period II|Treatment Discontinuation|3|||
24940316|NCT00490724|50033382|FG001|Period II|Treatment Discontinuation|1|||
24940317|NCT00490724|50033383|FG002|Period II|Treatment Discontinuation|3|||
24940318|NCT03835221|50033391|FG000|Methafilcon A|Withdrawal by Subject|1|||
24940319|NCT00398073|50033399|FG000|Overall Study|Withdrawal by Subject|1|||
24940320|NCT00398073|50033400|FG001|Overall Study|Withdrawal by Subject|0|||
24940321|NCT00490646|50033408|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
24940322|NCT00490646|50033409|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
24940323|NCT00490646|50033408|FG000|Overall Study|Never Treated (had an adverse event)|1|||
24940324|NCT00490646|50033409|FG001|Overall Study|Never Treated (had an adverse event)|0|||
24940325|NCT00490646|50033408|FG000|Overall Study|Never Treated (withdrew consent)|0|||
24940326|NCT00490646|50033409|FG001|Overall Study|Never Treated (withdrew consent)|1|||
24940327|NCT00388947|50033415|FG000|Overall Study|Protocol Violation|47|||
24940328|NCT00490568|50033419|FG000|Overall Study|Adverse Event|116|||
24940329|NCT00490568|50033419|FG000|Overall Study|Lost to Follow-up|13|||
24940330|NCT00490568|50033419|FG000|Overall Study|Protocol Violation|45|||
24940331|NCT00490568|50033419|FG000|Overall Study|Withdrawal by Subject|135|||
24940332|NCT00490568|50033419|FG000|Overall Study|Still in the study at termination|974|||
24940333|NCT00490568|50033419|FG000|Overall Study|Other|1|||
24940334|NCT00490568|50033419|FG000|Overall Study|Exclusion criteria met|1|||
24940335|NCT00490568|50033419|FG000|Overall Study|Caregiver related|20|||
24940336|NCT00490568|50033419|FG000|Overall Study|Abnormal ECG|25|||
24940337|NCT00490568|50033419|FG000|Overall Study|Participant refused follow-up|9|||
24940338|NCT00490568|50033419|FG000|Overall Study|Legal representative withdrew consent|1|||
24940339|NCT00490568|50033419|FG000|Overall Study|Disease progression|4|||
24940340|NCT00490568|50033419|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
24940341|NCT00490568|50033419|FG000|Overall Study|Investigator decision|3|||
24940342|NCT00490568|50033419|FG000|Overall Study|Non-Compliance|7|||
24940343|NCT00490568|50033419|FG000|Overall Study|Efficacy related|3|||
24940344|NCT00490568|50033419|FG000|Overall Study|Participant died|1|||
24940345|NCT00490568|50033419|FG000|Overall Study|Participant withdrawal due to surgery|1|||
24940346|NCT00561353|50033434|FG000|Overall Study|Subject reached a virologic endpoint|2|||
24940347|NCT00561353|50033435|FG001|Overall Study|Subject reached a virologic endpoint|1|||
24940348|NCT00561353|50033436|FG002|Overall Study|Subject reached a virologic endpoint|1|||
25029495|NCT02900378|50127910|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
25029496|NCT02900378|50127909|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
24940349|NCT00561353|50033437|FG003|Overall Study|Subject reached a virologic endpoint|4|||
24940350|NCT00561353|50033438|FG004|Overall Study|Subject reached a virologic endpoint|1|||
24940351|NCT00561353|50033439|FG005|Overall Study|Subject reached a virologic endpoint|3|||
25029497|NCT02900378|50127910|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
25029498|NCT02900378|50127909|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
24940352|NCT00561353|50033440|FG006|Overall Study|Subject reached a virologic endpoint|4|||
24940353|NCT00561353|50033441|FG007|Overall Study|Subject reached a virologic endpoint|4|||
24940354|NCT00561353|50033442|FG008|Overall Study|Subject reached a virologic endpoint|5|||
24940355|NCT00561353|50033443|FG009|Overall Study|Subject reached a virologic endpoint|0|||
24940356|NCT00561353|50033434|FG000|Overall Study|Subject ineligible to continue the trial|0|||
24940357|NCT00561353|50033435|FG001|Overall Study|Subject ineligible to continue the trial|0|||
24940358|NCT00561353|50033436|FG002|Overall Study|Subject ineligible to continue the trial|0|||
25029499|NCT02900378|50127910|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
25029500|NCT03058692|50127918|FG000|Overall Study|Lost to Follow-up|2|||
25029501|NCT03058692|50127919|FG001|Overall Study|Lost to Follow-up|1|||
25029502|NCT03058692|50127918|FG000|Overall Study|Withdrawal by Subject|1|||
24940359|NCT00561353|50033437|FG003|Overall Study|Subject ineligible to continue the trial|0|||
24940360|NCT00561353|50033438|FG004|Overall Study|Subject ineligible to continue the trial|0|||
24940361|NCT00561353|50033439|FG005|Overall Study|Subject ineligible to continue the trial|1|||
24940362|NCT00561353|50033440|FG006|Overall Study|Subject ineligible to continue the trial|1|||
24940363|NCT00561353|50033441|FG007|Overall Study|Subject ineligible to continue the trial|0|||
24940364|NCT00561353|50033442|FG008|Overall Study|Subject ineligible to continue the trial|2|||
24940365|NCT00561353|50033443|FG009|Overall Study|Subject ineligible to continue the trial|1|||
24940366|NCT00561353|50033434|FG000|Overall Study|Other|1|||
24940367|NCT00561353|50033435|FG001|Overall Study|Other|0|||
24940368|NCT00561353|50033436|FG002|Overall Study|Other|1|||
24940369|NCT00561353|50033437|FG003|Overall Study|Other|0|||
24940370|NCT00561353|50033438|FG004|Overall Study|Other|0|||
24940371|NCT00561353|50033439|FG005|Overall Study|Other|2|||
24940372|NCT00561353|50033440|FG006|Overall Study|Other|0|||
24940373|NCT00561353|50033441|FG007|Overall Study|Other|0|||
24940374|NCT00561353|50033442|FG008|Overall Study|Other|0|||
24940375|NCT00561353|50033443|FG009|Overall Study|Other|0|||
24940376|NCT00561353|50033434|FG000|Overall Study|Adverse Event|0|||
24940377|NCT00561353|50033435|FG001|Overall Study|Adverse Event|0|||
24940378|NCT00561353|50033436|FG002|Overall Study|Adverse Event|0|||
24940379|NCT00561353|50033437|FG003|Overall Study|Adverse Event|2|||
24940380|NCT00561353|50033438|FG004|Overall Study|Adverse Event|0|||
24940381|NCT00561353|50033439|FG005|Overall Study|Adverse Event|0|||
24940382|NCT00561353|50033440|FG006|Overall Study|Adverse Event|1|||
24940383|NCT00561353|50033441|FG007|Overall Study|Adverse Event|0|||
24940384|NCT00561353|50033442|FG008|Overall Study|Adverse Event|0|||
24940385|NCT00561353|50033443|FG009|Overall Study|Adverse Event|1|||
24940386|NCT00561353|50033434|FG000|Overall Study|Lost to Follow-up|2|||
24940387|NCT00561353|50033435|FG001|Overall Study|Lost to Follow-up|0|||
24940388|NCT00561353|50033436|FG002|Overall Study|Lost to Follow-up|1|||
24940389|NCT00561353|50033437|FG003|Overall Study|Lost to Follow-up|0|||
24940390|NCT00561353|50033438|FG004|Overall Study|Lost to Follow-up|0|||
24940391|NCT00561353|50033439|FG005|Overall Study|Lost to Follow-up|0|||
24940392|NCT00561353|50033440|FG006|Overall Study|Lost to Follow-up|0|||
25158557|NCT01462929|50276071|FG002|Overall Study|Adverse Event|4|||
25158558|NCT01462929|50276069|FG000|Overall Study|Withdrawal by Subject|2|||
25158559|NCT01462929|50276070|FG001|Overall Study|Withdrawal by Subject|1|||
25158560|NCT01462929|50276071|FG002|Overall Study|Withdrawal by Subject|0|||
25158561|NCT01462929|50276069|FG000|Overall Study|Lack of Efficacy|0|||
25158562|NCT01462929|50276070|FG001|Overall Study|Lack of Efficacy|0|||
25158563|NCT01462929|50276071|FG002|Overall Study|Lack of Efficacy|1|||
25158564|NCT01462695|50276081|FG000|Overall Study|Adverse Event|1|||
25158565|NCT01462695|50276082|FG001|Overall Study|Adverse Event|1|||
25158566|NCT01462695|50276081|FG000|Overall Study|Death|2|||
25029503|NCT03058692|50127919|FG001|Overall Study|Withdrawal by Subject|1|||
25029504|NCT02964338|50127929|FG000|Overall Study|Sponsor terminated study for futility|12|||
25029505|NCT02964338|50127930|FG001|Overall Study|Sponsor terminated study for futility|15|||
25029506|NCT02964338|50127931|FG002|Overall Study|Sponsor terminated study for futility|14|||
25186159|NCT01421069|50336041|FG000|Active Treatment Period|Adverse Event|1|||
25158567|NCT01462695|50276082|FG001|Overall Study|Death|0|||
24940393|NCT00561353|50033441|FG007|Overall Study|Lost to Follow-up|0|||
24940394|NCT00561353|50033442|FG008|Overall Study|Lost to Follow-up|0|||
24940395|NCT00561353|50033443|FG009|Overall Study|Lost to Follow-up|0|||
24940396|NCT00561353|50033434|FG000|Overall Study|Withdrawal by Subject|0|||
24940397|NCT00561353|50033435|FG001|Overall Study|Withdrawal by Subject|2|||
24940398|NCT00561353|50033436|FG002|Overall Study|Withdrawal by Subject|0|||
24940399|NCT00561353|50033437|FG003|Overall Study|Withdrawal by Subject|0|||
24940400|NCT00561353|50033438|FG004|Overall Study|Withdrawal by Subject|0|||
24940401|NCT00561353|50033439|FG005|Overall Study|Withdrawal by Subject|0|||
24940402|NCT00561353|50033440|FG006|Overall Study|Withdrawal by Subject|0|||
24940403|NCT00561353|50033441|FG007|Overall Study|Withdrawal by Subject|0|||
24940404|NCT00561353|50033442|FG008|Overall Study|Withdrawal by Subject|0|||
25029507|NCT02964338|50127929|FG000|Overall Study|Lack of Efficacy|0|||
25158568|NCT01462695|50276081|FG000|Overall Study|Lack of Efficacy|6|||
25029508|NCT02964338|50127930|FG001|Overall Study|Lack of Efficacy|3|||
25029509|NCT02964338|50127931|FG002|Overall Study|Lack of Efficacy|0|||
25029510|NCT02964338|50127929|FG000|Overall Study|Lost to Follow-up|1|||
25029511|NCT02964338|50127930|FG001|Overall Study|Lost to Follow-up|0|||
24940405|NCT00561353|50033443|FG009|Overall Study|Withdrawal by Subject|0|||
24940406|NCT00560885|50033510|FG000|Overall Study|Death|7|||
24940407|NCT00560885|50033510|FG000|Overall Study|Withdrawal by Subject|1|||
24940408|NCT00397215|50033518|FG000|Month 0 (Day 0)|Adverse Event|0|||
24940409|NCT00397215|50033519|FG001|Month 0 (Day 0)|Adverse Event|1|||
24940410|NCT00397215|50033520|FG002|Month 0 (Day 0)|Adverse Event|0|||
24940411|NCT00397215|50033521|FG003|Month 0 (Day 0)|Adverse Event|0|||
24940412|NCT00397215|50033518|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
24940413|NCT00397215|50033519|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
24940414|NCT00397215|50033520|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
24940415|NCT00397215|50033521|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
24940416|NCT00397215|50033518|FG000|Month 0 (Day 0)|Other|4|||
24940417|NCT00397215|50033519|FG001|Month 0 (Day 0)|Other|1|||
24940418|NCT00397215|50033520|FG002|Month 0 (Day 0)|Other|3|||
24940419|NCT00397215|50033521|FG003|Month 0 (Day 0)|Other|3|||
24940420|NCT00397215|50033518|FG000|Month 6 (Day 180)|Adverse Event|0|||
24940421|NCT00397215|50033519|FG001|Month 6 (Day 180)|Adverse Event|3|||
25029512|NCT02964338|50127931|FG002|Overall Study|Lost to Follow-up|3|||
25029513|NCT02964338|50127929|FG000|Overall Study|Protocol Violation|0|||
25029514|NCT02964338|50127930|FG001|Overall Study|Protocol Violation|1|||
25029515|NCT02964338|50127931|FG002|Overall Study|Protocol Violation|0|||
25029516|NCT02964338|50127929|FG000|Overall Study|Withdrawal by Subject|1|||
25029517|NCT02964338|50127930|FG001|Overall Study|Withdrawal by Subject|3|||
25029518|NCT02964338|50127931|FG002|Overall Study|Withdrawal by Subject|1|||
25029519|NCT02964338|50127929|FG000|Overall Study|Adverse Event|2|||
24940422|NCT00397215|50033520|FG002|Month 6 (Day 180)|Adverse Event|2|||
24940423|NCT00397215|50033521|FG003|Month 6 (Day 180)|Adverse Event|0|||
24940424|NCT00397215|50033518|FG000|Month 6 (Day 180)|Other|2|||
24940425|NCT00397215|50033519|FG001|Month 6 (Day 180)|Other|0|||
24940426|NCT00397215|50033520|FG002|Month 6 (Day 180)|Other|3|||
24940427|NCT00397215|50033521|FG003|Month 6 (Day 180)|Other|0|||
24940428|NCT00556439|50033538|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
24940429|NCT00556439|50033539|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
24940430|NCT00556439|50033540|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
24940431|NCT00556439|50033541|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
24940432|NCT00556439|50033538|FG000|Study Entry to Week 12|Physician Decision|1|||
24940433|NCT00556439|50033539|FG001|Study Entry to Week 12|Physician Decision|0|||
24940434|NCT00556439|50033540|FG002|Study Entry to Week 12|Physician Decision|0|||
24940435|NCT00556439|50033541|FG003|Study Entry to Week 12|Physician Decision|0|||
24940436|NCT00556439|50033538|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
24940437|NCT00556439|50033539|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
25029520|NCT02964338|50127930|FG001|Overall Study|Adverse Event|1|||
25029521|NCT02964338|50127931|FG002|Overall Study|Adverse Event|1|||
25029522|NCT02964338|50127929|FG000|Overall Study|Non-compliant with e-diary|0|||
25029523|NCT02964338|50127930|FG001|Overall Study|Non-compliant with e-diary|1|||
25029524|NCT02964338|50127931|FG002|Overall Study|Non-compliant with e-diary|0|||
25029525|NCT02964338|50127929|FG000|Overall Study|Did not meet criteria|1|||
25029526|NCT02964338|50127930|FG001|Overall Study|Did not meet criteria|0|||
24940438|NCT00556439|50033540|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
24940439|NCT00556439|50033541|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
24940440|NCT00556439|50033538|FG000|Study Entry to Week 12|Recurrent infection|1|||
24940441|NCT00556439|50033539|FG001|Study Entry to Week 12|Recurrent infection|0|||
24940442|NCT00556439|50033540|FG002|Study Entry to Week 12|Recurrent infection|0|||
24940443|NCT00556439|50033541|FG003|Study Entry to Week 12|Recurrent infection|0|||
24940444|NCT00556439|50033538|FG000|Study Entry to Week 12|Malignancy|0|||
24940445|NCT00556439|50033539|FG001|Study Entry to Week 12|Malignancy|0|||
24940446|NCT00556439|50033540|FG002|Study Entry to Week 12|Malignancy|1|||
24940447|NCT00556439|50033541|FG003|Study Entry to Week 12|Malignancy|0|||
24940448|NCT00556439|50033538|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
24940449|NCT00556439|50033539|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
24940450|NCT00556439|50033540|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
24940451|NCT00556439|50033541|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
24940452|NCT00556439|50033538|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
25029527|NCT02964338|50127931|FG002|Overall Study|Did not meet criteria|0|||
25029528|NCT03056352|50127939|FG000|Overall Study|Lost to Follow-up|1|||
25029529|NCT03446573|50127945|FG000|Overall Study|Withdrawal by Subject|7|||
25029530|NCT03446573|50127946|FG001|Overall Study|Withdrawal by Subject|16|||
24940453|NCT00556439|50033539|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
24940454|NCT00556439|50033540|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
24940455|NCT00556439|50033541|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
24940456|NCT00556439|50033538|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
25029531|NCT03446573|50127945|FG000|Overall Study|Physician Decision|1|||
25029532|NCT03446573|50127946|FG001|Overall Study|Physician Decision|1|||
25029533|NCT03446573|50127945|FG000|Overall Study|Lost to Follow-up|3|||
25029534|NCT03446573|50127946|FG001|Overall Study|Lost to Follow-up|5|||
24940457|NCT00556439|50033539|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
24940458|NCT00556439|50033540|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
24940459|NCT00556439|50033541|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
24940460|NCT00556439|50033538|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
24940461|NCT00556439|50033539|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
24940462|NCT00556439|50033540|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
24940463|NCT00556439|50033541|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
24940464|NCT00387465|50033554|FG000|Overall Study|Withdrawal by Subject|0|||
24940465|NCT00387465|50033555|FG001|Overall Study|Withdrawal by Subject|1|||
24940466|NCT00387465|50033556|FG002|Overall Study|Withdrawal by Subject|0|||
24940467|NCT00387153|50033573|FG000|Overall Study|Adverse Event|1|||
24940468|NCT00387153|50033573|FG000|Overall Study|Disease Progression|3|||
24940469|NCT00387153|50033573|FG000|Overall Study|Lack of Response|4|||
24940470|NCT00386607|50033577|FG000|Core|Adverse Event|40|||
24940471|NCT00386607|50033578|FG001|Core|Adverse Event|0|||
24940472|NCT00386607|50033577|FG000|Core|Abnormal laboratory value(s)|3|||
24940473|NCT00386607|50033578|FG001|Core|Abnormal laboratory value(s)|0|||
24940474|NCT00386607|50033577|FG000|Core|Unsatisfactory therapeutic effect|23|||
24940475|NCT00386607|50033578|FG001|Core|Unsatisfactory therapeutic effect|0|||
24940476|NCT00386607|50033577|FG000|Core|Condition no longer requires study drug|4|||
24940477|NCT00386607|50033578|FG001|Core|Condition no longer requires study drug|0|||
24940478|NCT00386607|50033577|FG000|Core|Patient withdrew consent|15|||
24940479|NCT00386607|50033578|FG001|Core|Patient withdrew consent|0|||
24940480|NCT00386607|50033577|FG000|Core|Lost to Follow-up|23|||
24940481|NCT00386607|50033578|FG001|Core|Lost to Follow-up|0|||
24940482|NCT00386607|50033577|FG000|Core|Administrative problems|1|||
24940483|NCT00386607|50033578|FG001|Core|Administrative problems|0|||
24940484|NCT00386607|50033577|FG000|Core|Protocol Deviation|6|||
24940485|NCT00386607|50033578|FG001|Core|Protocol Deviation|0|||
24940486|NCT00386607|50033577|FG000|Extension|Adverse Event|0|||
24940487|NCT00386607|50033578|FG001|Extension|Adverse Event|6|||
24940488|NCT00386607|50033577|FG000|Extension|Abnormal laboratory value(s)|0|||
24940489|NCT00386607|50033578|FG001|Extension|Abnormal laboratory value(s)|1|||
25029535|NCT03446573|50127945|FG000|Overall Study|Protocol Violation|3|||
25029536|NCT03446573|50127946|FG001|Overall Study|Protocol Violation|2|||
25029537|NCT03446573|50127945|FG000|Overall Study|Lack of Efficacy|0|||
25029538|NCT03446573|50127946|FG001|Overall Study|Lack of Efficacy|3|||
24940490|NCT00386607|50033577|FG000|Extension|Administrative problems|0|||
24940491|NCT00386607|50033578|FG001|Extension|Administrative problems|1|||
24940492|NCT00386607|50033577|FG000|Extension|Lost to Follow-up|0|||
24940493|NCT00386607|50033578|FG001|Extension|Lost to Follow-up|3|||
24940494|NCT00386607|50033577|FG000|Extension|Patient withdrew consent|0|||
24940495|NCT00386607|50033578|FG001|Extension|Patient withdrew consent|5|||
24940496|NCT00386607|50033577|FG000|Extension|Unsatisfactory therapeutic effect|0|||
24940497|NCT00386607|50033578|FG001|Extension|Unsatisfactory therapeutic effect|1|||
24940498|NCT00410163|50033592|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
24940499|NCT00410163|50033593|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
25029539|NCT03446573|50127945|FG000|Overall Study|Adverse Event|13|||
25029540|NCT03446573|50127946|FG001|Overall Study|Adverse Event|2|||
25029541|NCT03446573|50127945|FG000|Overall Study|Ongoing at the time of interim analysis|342|||
25158569|NCT01462695|50276082|FG001|Overall Study|Lack of Efficacy|12|||
24940500|NCT00410163|50033592|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
24940501|NCT00410163|50033593|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
24940502|NCT00410163|50033592|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
24940503|NCT00410163|50033593|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
24940504|NCT00410163|50033592|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
24940505|NCT00410163|50033593|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
25158570|NCT01462695|50276081|FG000|Overall Study|Physician Decision|5|||
24940506|NCT00410163|50033592|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
24940507|NCT00410163|50033593|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
24940508|NCT00410163|50033592|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
24940509|NCT00410163|50033593|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
24940510|NCT00410163|50033592|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
24940511|NCT00410163|50033593|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
24940512|NCT00410163|50033592|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
24940513|NCT00410163|50033593|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
24940514|NCT00410163|50033592|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
25158571|NCT01462695|50276082|FG001|Overall Study|Physician Decision|0|||
25158572|NCT01462695|50276081|FG000|Overall Study|Withdrawal by Subject|2|||
25158573|NCT01462695|50276082|FG001|Overall Study|Withdrawal by Subject|0|||
25158574|NCT01462695|50276081|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
25158575|NCT01462695|50276082|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
25158576|NCT01465347|50276088|FG000|Overall Study|Withdrawal by Subject|1|||
24940515|NCT00410163|50033593|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
24940516|NCT00410163|50033592|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
24940517|NCT00410163|50033593|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
24940518|NCT00410163|50033592|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
24940519|NCT00410163|50033593|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
24940520|NCT00410163|50033592|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
24940521|NCT00410163|50033593|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
24940522|NCT00410163|50033592|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
24940523|NCT00410163|50033593|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
24940524|NCT00410163|50033592|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
24940525|NCT00410163|50033593|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
24940526|NCT00409617|50033629|FG000|Overall Study|Adverse Event|57|||
24940527|NCT00409617|50033629|FG000|Overall Study|Lack of Efficacy|54|||
24940528|NCT00409617|50033629|FG000|Overall Study|Lost to Follow-up|2|||
24940529|NCT00409617|50033629|FG000|Overall Study|Protocol Violation|24|||
24940530|NCT00409617|50033629|FG000|Overall Study|Withdrawal by Subject|8|||
24940531|NCT00409617|50033629|FG000|Overall Study|Administrative reasons|1|||
24940532|NCT00409617|50033629|FG000|Overall Study|Not described|14|||
24940533|NCT00300274|50033636|FG000|Overall Study|Withdrawal by Subject|12|||
24940534|NCT00300274|50033637|FG001|Overall Study|Withdrawal by Subject|3|||
24940535|NCT00300274|50033638|FG002|Overall Study|Withdrawal by Subject|14|||
24940536|NCT00300274|50033636|FG000|Overall Study|Lost to Follow-up|3|||
24940537|NCT00300274|50033637|FG001|Overall Study|Lost to Follow-up|4|||
24940538|NCT00300274|50033638|FG002|Overall Study|Lost to Follow-up|5|||
24940539|NCT00300274|50033636|FG000|Overall Study|Death|31|||
24940540|NCT00300274|50033637|FG001|Overall Study|Death|20|||
24940541|NCT00300274|50033638|FG002|Overall Study|Death|25|||
24940542|NCT00300274|50033636|FG000|Overall Study|Re-transplant|0|||
24940543|NCT00300274|50033637|FG001|Overall Study|Re-transplant|0|||
24940544|NCT00300274|50033638|FG002|Overall Study|Re-transplant|1|||
24940545|NCT00299728|50033648|FG000|Overall Study|Lost to Follow-up|0|||
24940546|NCT00299728|50033649|FG001|Overall Study|Lost to Follow-up|1|||
24940547|NCT00299728|50033648|FG000|Overall Study|Withdrawal by Subject|0|||
24940548|NCT00299728|50033649|FG001|Overall Study|Withdrawal by Subject|1|||
24940549|NCT00299728|50033648|FG000|Overall Study|Progressive disease|0|||
24940550|NCT00299728|50033649|FG001|Overall Study|Progressive disease|1|||
24940551|NCT00396591|50033655|FG000|Overall Study|Disease Progression|13|||
24940552|NCT00396591|50033655|FG000|Overall Study|Adverse Event|2|||
24940553|NCT00396591|50033655|FG000|Overall Study|Participant request|1|||
24940554|NCT00316264|50033662|FG000|Overall Study|Lost to Follow-up|0|||
24940555|NCT00316264|50033663|FG001|Overall Study|Lost to Follow-up|1|||
24940556|NCT00316264|50033664|FG002|Overall Study|Lost to Follow-up|0|||
24940557|NCT00316264|50033662|FG000|Overall Study|Withdrawal of Consent|3|||
24940558|NCT00316264|50033663|FG001|Overall Study|Withdrawal of Consent|5|||
24940559|NCT00316264|50033664|FG002|Overall Study|Withdrawal of Consent|6|||
24940560|NCT00316264|50033662|FG000|Overall Study|Death|2|||
24940561|NCT00316264|50033663|FG001|Overall Study|Death|0|||
24940562|NCT00316264|50033664|FG002|Overall Study|Death|0|||
24940563|NCT00316264|50033662|FG000|Overall Study|Other|1|||
24940564|NCT00316264|50033663|FG001|Overall Study|Other|1|||
24940565|NCT00316264|50033664|FG002|Overall Study|Other|0|||
24940566|NCT00385827|50033675|FG000|Part 1|Adverse Event|1|||
25158577|NCT01465347|50276089|FG001|Overall Study|Withdrawal by Subject|1|||
25158578|NCT01465347|50276088|FG000|Overall Study|Physician Decision|0|||
25186160|NCT01421069|50336041|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
24940567|NCT00385827|50033676|FG001|Part 1|Adverse Event|0|||
24940568|NCT00385827|50033677|FG002|Part 1|Adverse Event|0|||
24940569|NCT00385827|50033675|FG000|Part 1|Death|2|||
24940570|NCT00385827|50033676|FG001|Part 1|Death|0|||
24940571|NCT00385827|50033677|FG002|Part 1|Death|0|||
24940572|NCT00385827|50033675|FG000|Part 1|Lack of Efficacy|5|||
24940573|NCT00385827|50033676|FG001|Part 1|Lack of Efficacy|0|||
24940574|NCT00385827|50033677|FG002|Part 1|Lack of Efficacy|0|||
24940575|NCT00385827|50033675|FG000|Part 1|Other|1|||
24940576|NCT00385827|50033676|FG001|Part 1|Other|0|||
24940577|NCT00385827|50033677|FG002|Part 1|Other|0|||
24940578|NCT00385827|50033675|FG000|Part 2|Adverse Event|0|||
24940579|NCT00385827|50033676|FG001|Part 2|Adverse Event|6|||
25029542|NCT03446573|50127946|FG001|Overall Study|Ongoing at the time of interim analysis|343|||
25029543|NCT02898662|50127957|FG000|Overall Study|Adverse Event|1|||
25029544|NCT02898662|50127958|FG001|Overall Study|Adverse Event|0|||
25029545|NCT02898662|50127957|FG000|Overall Study|Loss of asthma control|23|||
25029546|NCT02898662|50127958|FG001|Overall Study|Loss of asthma control|24|||
25029547|NCT02898662|50127957|FG000|Overall Study|Withdrawal by Subject|4|||
25029548|NCT02898662|50127958|FG001|Overall Study|Withdrawal by Subject|1|||
25029549|NCT02898662|50127957|FG000|Overall Study|Technical issue|0|||
24940580|NCT00385827|50033677|FG002|Part 2|Adverse Event|10|||
24940581|NCT00385827|50033675|FG000|Part 2|Death|0|||
24940582|NCT00385827|50033676|FG001|Part 2|Death|0|||
24940583|NCT00385827|50033677|FG002|Part 2|Death|2|||
24940584|NCT00385827|50033675|FG000|Part 2|Lack of Efficacy|0|||
24940585|NCT00385827|50033676|FG001|Part 2|Lack of Efficacy|14|||
24940586|NCT00385827|50033677|FG002|Part 2|Lack of Efficacy|13|||
24940587|NCT00385827|50033675|FG000|Part 2|Randomized but not treated|0|||
24940588|NCT00385827|50033676|FG001|Part 2|Randomized but not treated|2|||
24940589|NCT00385827|50033677|FG002|Part 2|Randomized but not treated|2|||
24940590|NCT00385827|50033675|FG000|Part 2|Other|0|||
24940591|NCT00385827|50033676|FG001|Part 2|Other|11|||
24940592|NCT00385827|50033677|FG002|Part 2|Other|21|||
24940593|NCT00498602|50033694|FG000|Overall Study|Death|0|||
24940594|NCT00498602|50033695|FG001|Overall Study|Death|0|||
24940595|NCT00498602|50033696|FG002|Overall Study|Death|0|||
24940596|NCT00498602|50033697|FG003|Overall Study|Death|0|||
24940597|NCT00498602|50033698|FG004|Overall Study|Death|0|||
24940598|NCT00498602|50033699|FG005|Overall Study|Death|1|||
24940599|NCT00498602|50033700|FG006|Overall Study|Death|0|||
24940600|NCT00498602|50033694|FG000|Overall Study|Lack of Efficacy|1|||
25029550|NCT02898662|50127958|FG001|Overall Study|Technical issue|1|||
25029551|NCT02898662|50127957|FG000|Overall Study|Randomized in error|0|||
24940601|NCT00498602|50033695|FG001|Overall Study|Lack of Efficacy|0|||
24940602|NCT00498602|50033696|FG002|Overall Study|Lack of Efficacy|0|||
24940603|NCT00498602|50033697|FG003|Overall Study|Lack of Efficacy|0|||
24940604|NCT00498602|50033698|FG004|Overall Study|Lack of Efficacy|0|||
24940605|NCT00498602|50033699|FG005|Overall Study|Lack of Efficacy|0|||
25029552|NCT02898662|50127958|FG001|Overall Study|Randomized in error|1|||
25029553|NCT02898662|50127957|FG000|Overall Study|Subject decision|1|||
25029554|NCT02898662|50127958|FG001|Overall Study|Subject decision|0|||
25029555|NCT02898662|50127957|FG000|Overall Study|Other|0|||
25029556|NCT02898662|50127958|FG001|Overall Study|Other|1|||
25029557|NCT03055338|50127967|FG000|Overall Study|Lost to Follow-up|9|||
25029558|NCT03055338|50127968|FG001|Overall Study|Lost to Follow-up|2|||
25029559|NCT03055338|50127969|FG002|Overall Study|Lost to Follow-up|3|||
25186161|NCT01421069|50336041|FG000|Active Treatment Period|Enrolled in observational period|29|||
24940606|NCT00498602|50033700|FG006|Overall Study|Lack of Efficacy|0|||
24940607|NCT00498602|50033694|FG000|Overall Study|Lost to Follow-up|0|||
24940608|NCT00498602|50033695|FG001|Overall Study|Lost to Follow-up|2|||
24940609|NCT00498602|50033696|FG002|Overall Study|Lost to Follow-up|0|||
24940610|NCT00498602|50033697|FG003|Overall Study|Lost to Follow-up|2|||
24940611|NCT00498602|50033698|FG004|Overall Study|Lost to Follow-up|0|||
24940612|NCT00498602|50033699|FG005|Overall Study|Lost to Follow-up|0|||
24940613|NCT00498602|50033700|FG006|Overall Study|Lost to Follow-up|0|||
24940614|NCT00498602|50033694|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
24940615|NCT00498602|50033695|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
24940616|NCT00498602|50033696|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
24940617|NCT00498602|50033697|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
24940618|NCT00498602|50033698|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
24940619|NCT00498602|50033699|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
24940620|NCT00498602|50033700|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
24940621|NCT00498602|50033694|FG000|Overall Study|AE not related to Study Drug|1|||
24940622|NCT00498602|50033695|FG001|Overall Study|AE not related to Study Drug|3|||
24940623|NCT00498602|50033696|FG002|Overall Study|AE not related to Study Drug|0|||
24940624|NCT00498602|50033697|FG003|Overall Study|AE not related to Study Drug|0|||
25029560|NCT03055338|50127967|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
25029561|NCT03055338|50127968|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
25029562|NCT03055338|50127969|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
25186162|NCT01421069|50336041|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
24940625|NCT00498602|50033698|FG004|Overall Study|AE not related to Study Drug|2|||
24940626|NCT00498602|50033699|FG005|Overall Study|AE not related to Study Drug|2|||
24940627|NCT00498602|50033700|FG006|Overall Study|AE not related to Study Drug|1|||
24940628|NCT00498602|50033694|FG000|Overall Study|Caregiver Request|2|||
24940629|NCT00498602|50033695|FG001|Overall Study|Caregiver Request|2|||
24940630|NCT00498602|50033696|FG002|Overall Study|Caregiver Request|2|||
24940631|NCT00498602|50033697|FG003|Overall Study|Caregiver Request|0|||
24940632|NCT00498602|50033698|FG004|Overall Study|Caregiver Request|1|||
24940633|NCT00498602|50033699|FG005|Overall Study|Caregiver Request|2|||
24940634|NCT00498602|50033700|FG006|Overall Study|Caregiver Request|0|||
24940635|NCT00498602|50033694|FG000|Overall Study|Investigator Request|0|||
24940636|NCT00498602|50033695|FG001|Overall Study|Investigator Request|0|||
24940637|NCT00498602|50033696|FG002|Overall Study|Investigator Request|1|||
24940638|NCT00498602|50033697|FG003|Overall Study|Investigator Request|0|||
24940639|NCT00498602|50033698|FG004|Overall Study|Investigator Request|0|||
24940640|NCT00498602|50033699|FG005|Overall Study|Investigator Request|0|||
24940641|NCT00498602|50033700|FG006|Overall Study|Investigator Request|0|||
24940642|NCT00498602|50033694|FG000|Overall Study|Subject Request|3|||
24940643|NCT00498602|50033695|FG001|Overall Study|Subject Request|0|||
24940644|NCT00498602|50033696|FG002|Overall Study|Subject Request|1|||
24940645|NCT00498602|50033697|FG003|Overall Study|Subject Request|1|||
24940646|NCT00498602|50033698|FG004|Overall Study|Subject Request|1|||
24940647|NCT00498602|50033699|FG005|Overall Study|Subject Request|4|||
24940648|NCT00498602|50033700|FG006|Overall Study|Subject Request|1|||
24940649|NCT00498602|50033694|FG000|Overall Study|Other|2|||
24940650|NCT00498602|50033695|FG001|Overall Study|Other|3|||
24940651|NCT00498602|50033696|FG002|Overall Study|Other|1|||
24940652|NCT00498602|50033697|FG003|Overall Study|Other|0|||
24940653|NCT00498602|50033698|FG004|Overall Study|Other|0|||
24940654|NCT00498602|50033699|FG005|Overall Study|Other|3|||
24940655|NCT00498602|50033700|FG006|Overall Study|Other|0|||
24940656|NCT00507728|50033719|FG000|Randomization to Month 3|Lost to Follow-up|15|||
24940657|NCT00507728|50033720|FG001|Randomization to Month 3|Lost to Follow-up|14|||
24940658|NCT00507728|50033721|FG002|Randomization to Month 3|Lost to Follow-up|20|||
24940659|NCT00507728|50033719|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
24940660|NCT00507728|50033720|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
24940661|NCT00507728|50033721|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
25158579|NCT01465347|50276089|FG001|Overall Study|Physician Decision|1|||
25158580|NCT01465347|50276088|FG000|Overall Study|Admitted to hospice|0|||
25158581|NCT01465347|50276089|FG001|Overall Study|Admitted to hospice|1|||
25158582|NCT01465191|50276101|FG000|Overall Study|Protocol Violation|6|||
24940662|NCT00498368|50033737|FG000|Overall Study|Withdrawal by Subject|3|||
24940663|NCT00498368|50033738|FG001|Overall Study|Withdrawal by Subject|2|||
24940664|NCT00385671|50033747|FG000|Overall Study|Adverse Event|14|||
24940665|NCT00385671|50033748|FG001|Overall Study|Adverse Event|27|||
24940666|NCT00385671|50033749|FG002|Overall Study|Adverse Event|18|||
24940667|NCT00385671|50033747|FG000|Overall Study|Lack of Efficacy|5|||
24940668|NCT00385671|50033748|FG001|Overall Study|Lack of Efficacy|9|||
25158583|NCT01465191|50276102|FG001|Overall Study|Protocol Violation|3|||
24940669|NCT00385671|50033749|FG002|Overall Study|Lack of Efficacy|5|||
24940670|NCT00385671|50033747|FG000|Overall Study|Lost to Follow-up|6|||
24940671|NCT00385671|50033748|FG001|Overall Study|Lost to Follow-up|6|||
24940672|NCT00385671|50033749|FG002|Overall Study|Lost to Follow-up|5|||
24940673|NCT00385671|50033747|FG000|Overall Study|Physician Decision|2|||
24940674|NCT00385671|50033748|FG001|Overall Study|Physician Decision|1|||
24940675|NCT00385671|50033749|FG002|Overall Study|Physician Decision|2|||
24940676|NCT00385671|50033747|FG000|Overall Study|Protocol Violation|5|||
24940677|NCT00385671|50033748|FG001|Overall Study|Protocol Violation|2|||
24940678|NCT00385671|50033749|FG002|Overall Study|Protocol Violation|1|||
24940679|NCT00385671|50033747|FG000|Overall Study|Sponsor Decision|2|||
24940680|NCT00385671|50033748|FG001|Overall Study|Sponsor Decision|2|||
24940681|NCT00385671|50033749|FG002|Overall Study|Sponsor Decision|1|||
24940682|NCT00385671|50033747|FG000|Overall Study|Withdrawal by Subject|4|||
24940683|NCT00385671|50033748|FG001|Overall Study|Withdrawal by Subject|4|||
25158584|NCT01465191|50276103|FG002|Overall Study|Protocol Violation|3|||
24940684|NCT00385671|50033749|FG002|Overall Study|Withdrawal by Subject|4|||
24940685|NCT00497198|50033761|FG000|Overall Study|Adverse Event|4|||
24940686|NCT00497198|50033762|FG001|Overall Study|Adverse Event|2|||
24940687|NCT00497198|50033761|FG000|Overall Study|Physician Decision|1|||
24940688|NCT00497198|50033762|FG001|Overall Study|Physician Decision|2|||
24940689|NCT00497198|50033761|FG000|Overall Study|Withdrawal by Subject|0|||
24940690|NCT00497198|50033762|FG001|Overall Study|Withdrawal by Subject|1|||
24940691|NCT00496964|50033770|FG000|Overall Study|Withdrawal by Subject|0|||
24940692|NCT00496964|50033771|FG001|Overall Study|Withdrawal by Subject|1|||
24940693|NCT00490490|50033779|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
25158585|NCT01465191|50276101|FG000|Overall Study|Lost to Follow-up|3|||
24940694|NCT00490490|50033779|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
24940695|NCT00385593|50033785|FG000|Overall Study|Adverse Event|3|||
24940696|NCT00385593|50033786|FG001|Overall Study|Adverse Event|2|||
24940697|NCT00385593|50033785|FG000|Overall Study|Withdrawal by Subject|17|||
24940698|NCT00385593|50033786|FG001|Overall Study|Withdrawal by Subject|7|||
25158586|NCT01465191|50276102|FG001|Overall Study|Lost to Follow-up|6|||
24940699|NCT00385593|50033785|FG000|Overall Study|Lost to Follow-up|12|||
24940700|NCT00385593|50033786|FG001|Overall Study|Lost to Follow-up|8|||
24940701|NCT00385593|50033785|FG000|Overall Study|Protocol Violation|7|||
24940702|NCT00385593|50033786|FG001|Overall Study|Protocol Violation|4|||
24940703|NCT00385593|50033785|FG000|Overall Study|Several reasons|17|||
24940704|NCT00385593|50033786|FG001|Overall Study|Several reasons|15|||
24940705|NCT00385593|50033785|FG000|Overall Study|Incorrect inclusion|2|||
24940706|NCT00385593|50033786|FG001|Overall Study|Incorrect inclusion|0|||
24940707|NCT00385593|50033785|FG000|Overall Study|Incorrect randomization|0|||
24940708|NCT00385593|50033786|FG001|Overall Study|Incorrect randomization|1|||
24940709|NCT00495794|50033794|FG000|Overall Study|Pharmacist did not activate patient|522|||
24940710|NCT00495794|50033795|FG001|Overall Study|Pharmacist did not activate patient|0|||
24940711|NCT00495170|50033801|FG000|Overall Study|Lost to Follow-up|9|||
24940712|NCT00495170|50033801|FG000|Overall Study|Withdrawal by Subject|3|||
24940713|NCT00495170|50033801|FG000|Overall Study|Inappropriate staging|8|||
24940714|NCT03853148|50033809|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
24940715|NCT03853148|50033810|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
24940716|NCT03853148|50033811|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
24940717|NCT03853148|50033812|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
24940718|NCT00385203|50033824|FG000|Overall Study|Adverse Event|5|||
24940719|NCT00385203|50033825|FG001|Overall Study|Adverse Event|4|||
24940720|NCT00385203|50033824|FG000|Overall Study|Death|1|||
24940721|NCT00385203|50033825|FG001|Overall Study|Death|0|||
24940722|NCT00385203|50033824|FG000|Overall Study|Condition under investigation worsened|18|||
24940723|NCT00385203|50033825|FG001|Overall Study|Condition under investigation worsened|3|||
24940724|NCT00385203|50033824|FG000|Overall Study|Incorrect enrollment|2|||
24940725|NCT00385203|50033825|FG001|Overall Study|Incorrect enrollment|0|||
24940726|NCT00408993|50033834|FG000|Overall Study|Adverse Event|15|||
24940727|NCT00408993|50033835|FG001|Overall Study|Adverse Event|4|||
24940728|NCT00408993|50033834|FG000|Overall Study|Protocol Violation|1|||
24940729|NCT00408993|50033835|FG001|Overall Study|Protocol Violation|6|||
24940730|NCT00408993|50033834|FG000|Overall Study|Lack of Efficacy|1|||
24940731|NCT00408993|50033835|FG001|Overall Study|Lack of Efficacy|4|||
24940732|NCT00408993|50033834|FG000|Overall Study|Withdrawal by Subject|2|||
24940733|NCT00408993|50033835|FG001|Overall Study|Withdrawal by Subject|3|||
24940734|NCT00395967|50033845|FG000|Treatment Period|Failed Mobilization|1|||
24940735|NCT00395967|50033845|FG000|Follow-up Period|Death|1|||
24940736|NCT00395967|50033845|FG000|Follow-up Period|Lost to Follow-up|1|||
24940737|NCT00395733|50033851|FG000|Period 2|Withdrawal by Subject|1|||
24940738|NCT00395733|50033852|FG001|Period 2|Withdrawal by Subject|2|||
24940739|NCT00395733|50033851|FG000|Period 2|Protocol Violation|0|||
24940740|NCT00395733|50033852|FG001|Period 2|Protocol Violation|1|||
24940741|NCT00395733|50033851|FG000|Period 2|Adverse Event|0|||
24940742|NCT00395733|50033852|FG001|Period 2|Adverse Event|2|||
24940743|NCT00395733|50033851|FG000|Period 2|Technical problems|1|||
24940744|NCT00395733|50033852|FG001|Period 2|Technical problems|0|||
24940745|NCT00395343|50033860|FG000|Overall Study|Adverse Event|13|||
24940746|NCT00395343|50033861|FG001|Overall Study|Adverse Event|5|||
24940747|NCT00395343|50033860|FG000|Overall Study|Lack of Efficacy|0|||
24940748|NCT00395343|50033861|FG001|Overall Study|Lack of Efficacy|1|||
24940749|NCT00395343|50033860|FG000|Overall Study|Lost to Follow-up|4|||
24940750|NCT00395343|50033861|FG001|Overall Study|Lost to Follow-up|4|||
24940751|NCT00395343|50033860|FG000|Overall Study|Physician Decision|2|||
24940752|NCT00395343|50033861|FG001|Overall Study|Physician Decision|4|||
24940753|NCT00395343|50033860|FG000|Overall Study|Protocol Violation|6|||
24940754|NCT00395343|50033861|FG001|Overall Study|Protocol Violation|8|||
24940755|NCT00395343|50033860|FG000|Overall Study|Withdrawal by Subject|11|||
25029563|NCT03055338|50127967|FG000|Overall Study|Physician Decision|0|||
25029564|NCT03055338|50127968|FG001|Overall Study|Physician Decision|0|||
25029565|NCT03055338|50127969|FG002|Overall Study|Physician Decision|2|||
25029566|NCT03055338|50127967|FG000|Overall Study|Withdrawal by Subject|9|||
25029567|NCT03055338|50127968|FG001|Overall Study|Withdrawal by Subject|8|||
25029568|NCT03055338|50127969|FG002|Overall Study|Withdrawal by Subject|7|||
25186163|NCT01421069|50336041|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
24940756|NCT00395343|50033861|FG001|Overall Study|Withdrawal by Subject|12|||
24940757|NCT00395343|50033860|FG000|Overall Study|Other|5|||
24940758|NCT00395343|50033861|FG001|Overall Study|Other|2|||
24940759|NCT00560573|50033867|FG000|Overall Study|Death|4|||
25029569|NCT03913130|50127977|FG000|Overall Study|Sponsor Decision|1|||
25029570|NCT03419741|50127983|FG000|Overall Study|Adverse Event|1|||
25029571|NCT03419741|50127984|FG001|Overall Study|Adverse Event|0|||
24940760|NCT00560573|50033868|FG001|Overall Study|Death|1|||
24940761|NCT00560573|50033869|FG002|Overall Study|Death|4|||
24940762|NCT00560573|50033870|FG003|Overall Study|Death|5|||
24940763|NCT00560573|50033871|FG004|Overall Study|Death|1|||
24940764|NCT00560573|50033872|FG005|Overall Study|Death|10|||
24940765|NCT00560573|50033867|FG000|Overall Study|Lost to Follow-up|0|||
25029572|NCT03419741|50127983|FG000|Overall Study|Withdrawal by Subject|1|||
25029573|NCT03419741|50127984|FG001|Overall Study|Withdrawal by Subject|2|||
25029574|NCT02896400|50128006|FG000|1 Month Follow-up|Lost to Follow-up|7|||
25029575|NCT02896400|50128007|FG001|1 Month Follow-up|Lost to Follow-up|7|||
25029576|NCT02896400|50128008|FG002|1 Month Follow-up|Lost to Follow-up|5|||
25029577|NCT02896400|50128009|FG003|1 Month Follow-up|Lost to Follow-up|8|||
25029578|NCT02896400|50128010|FG004|1 Month Follow-up|Lost to Follow-up|9|||
25029579|NCT02896400|50128011|FG005|1 Month Follow-up|Lost to Follow-up|6|||
25029580|NCT02896400|50128012|FG006|1 Month Follow-up|Lost to Follow-up|5|||
25029581|NCT02896400|50128013|FG007|1 Month Follow-up|Lost to Follow-up|6|||
25029582|NCT02896400|50128014|FG008|1 Month Follow-up|Lost to Follow-up|4|||
25029583|NCT02896400|50128015|FG009|1 Month Follow-up|Lost to Follow-up|7|||
25029584|NCT02896400|50128016|FG010|1 Month Follow-up|Lost to Follow-up|5|||
25029585|NCT02896400|50128017|FG011|1 Month Follow-up|Lost to Follow-up|5|||
25029586|NCT02896400|50128018|FG012|1 Month Follow-up|Lost to Follow-up|3|||
25029587|NCT02896400|50128019|FG013|1 Month Follow-up|Lost to Follow-up|4|||
25029588|NCT02896400|50128020|FG014|1 Month Follow-up|Lost to Follow-up|1|||
25029589|NCT02896400|50128021|FG015|1 Month Follow-up|Lost to Follow-up|2|||
25029590|NCT02896400|50128006|FG000|1 Month Follow-up|Death|0|||
25029591|NCT02896400|50128007|FG001|1 Month Follow-up|Death|0|||
25029592|NCT02896400|50128008|FG002|1 Month Follow-up|Death|0|||
25029593|NCT02896400|50128009|FG003|1 Month Follow-up|Death|0|||
25029594|NCT02896400|50128010|FG004|1 Month Follow-up|Death|0|||
25029595|NCT02896400|50128011|FG005|1 Month Follow-up|Death|0|||
25029596|NCT02896400|50128012|FG006|1 Month Follow-up|Death|0|||
25029597|NCT02896400|50128013|FG007|1 Month Follow-up|Death|0|||
25029598|NCT02896400|50128014|FG008|1 Month Follow-up|Death|0|||
25029599|NCT02896400|50128015|FG009|1 Month Follow-up|Death|0|||
25029600|NCT02896400|50128016|FG010|1 Month Follow-up|Death|0|||
25029601|NCT02896400|50128017|FG011|1 Month Follow-up|Death|0|||
25029602|NCT02896400|50128018|FG012|1 Month Follow-up|Death|0|||
25029603|NCT02896400|50128019|FG013|1 Month Follow-up|Death|0|||
25029604|NCT02896400|50128020|FG014|1 Month Follow-up|Death|0|||
25029605|NCT02896400|50128021|FG015|1 Month Follow-up|Death|1|||
25029606|NCT02896400|50128006|FG000|3 Month Follow-up|Lost to Follow-up|6|||
25029607|NCT02896400|50128007|FG001|3 Month Follow-up|Lost to Follow-up|3|||
25029608|NCT02896400|50128008|FG002|3 Month Follow-up|Lost to Follow-up|6|||
25029609|NCT02896400|50128009|FG003|3 Month Follow-up|Lost to Follow-up|11|||
25029610|NCT02896400|50128010|FG004|3 Month Follow-up|Lost to Follow-up|12|||
25029611|NCT02896400|50128011|FG005|3 Month Follow-up|Lost to Follow-up|6|||
25029612|NCT02896400|50128012|FG006|3 Month Follow-up|Lost to Follow-up|4|||
25029613|NCT02896400|50128013|FG007|3 Month Follow-up|Lost to Follow-up|3|||
25029614|NCT02896400|50128014|FG008|3 Month Follow-up|Lost to Follow-up|6|||
25029615|NCT02896400|50128015|FG009|3 Month Follow-up|Lost to Follow-up|5|||
25029616|NCT02896400|50128016|FG010|3 Month Follow-up|Lost to Follow-up|6|||
25029617|NCT02896400|50128017|FG011|3 Month Follow-up|Lost to Follow-up|6|||
25029618|NCT02896400|50128018|FG012|3 Month Follow-up|Lost to Follow-up|3|||
25029619|NCT02896400|50128019|FG013|3 Month Follow-up|Lost to Follow-up|5|||
25029620|NCT02896400|50128020|FG014|3 Month Follow-up|Lost to Follow-up|3|||
25029621|NCT02896400|50128021|FG015|3 Month Follow-up|Lost to Follow-up|2|||
25029622|NCT02896400|50128006|FG000|3 Month Follow-up|Death|0|||
25029623|NCT02896400|50128007|FG001|3 Month Follow-up|Death|0|||
25029624|NCT02896400|50128008|FG002|3 Month Follow-up|Death|0|||
25029625|NCT02896400|50128009|FG003|3 Month Follow-up|Death|0|||
25029626|NCT02896400|50128010|FG004|3 Month Follow-up|Death|0|||
25029627|NCT02896400|50128011|FG005|3 Month Follow-up|Death|0|||
25029628|NCT02896400|50128012|FG006|3 Month Follow-up|Death|0|||
25029629|NCT02896400|50128013|FG007|3 Month Follow-up|Death|0|||
25158587|NCT01465191|50276103|FG002|Overall Study|Lost to Follow-up|4|||
25158588|NCT01519947|50276118|FG000|Overall Study|Death|0|||
25158589|NCT01519947|50276119|FG001|Overall Study|Death|0|||
25158590|NCT01519947|50276120|FG002|Overall Study|Death|0|||
25158591|NCT01519947|50276121|FG003|Overall Study|Death|1|||
25158592|NCT01519947|50276118|FG000|Overall Study|Protocol Violation|0|||
25158593|NCT01519947|50276119|FG001|Overall Study|Protocol Violation|0|||
25029630|NCT02896400|50128014|FG008|3 Month Follow-up|Death|0|||
25029631|NCT02896400|50128015|FG009|3 Month Follow-up|Death|0|||
25029632|NCT02896400|50128016|FG010|3 Month Follow-up|Death|0|||
25029633|NCT02896400|50128017|FG011|3 Month Follow-up|Death|0|||
25029634|NCT02896400|50128018|FG012|3 Month Follow-up|Death|0|||
25029635|NCT02896400|50128019|FG013|3 Month Follow-up|Death|1|||
25029636|NCT02896400|50128020|FG014|3 Month Follow-up|Death|1|||
25029637|NCT02896400|50128021|FG015|3 Month Follow-up|Death|0|||
25029638|NCT02896400|50128006|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
25029639|NCT02896400|50128007|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
25029640|NCT02896400|50128008|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
25029641|NCT02896400|50128009|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
25029642|NCT02896400|50128010|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
25158594|NCT01519947|50276120|FG002|Overall Study|Protocol Violation|2|||
25158595|NCT01519947|50276121|FG003|Overall Study|Protocol Violation|1|||
25158596|NCT01519947|50276118|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
25158597|NCT01519947|50276119|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
25158598|NCT01519947|50276120|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
25158599|NCT01519947|50276121|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
25158600|NCT01519947|50276118|FG000|Overall Study|Development of Anemia|0|||
25158601|NCT01519947|50276119|FG001|Overall Study|Development of Anemia|1|||
25158602|NCT01519947|50276120|FG002|Overall Study|Development of Anemia|0|||
25029643|NCT02896400|50128011|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
25029644|NCT02896400|50128012|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
25029645|NCT02896400|50128013|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
25029646|NCT02896400|50128014|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
25029647|NCT02896400|50128015|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
25029648|NCT02896400|50128016|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
25029649|NCT02896400|50128017|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
25158603|NCT01519947|50276121|FG003|Overall Study|Development of Anemia|1|||
25158604|NCT01519947|50276118|FG000|Overall Study|Blood Transfusion|0|||
24940766|NCT00560573|50033868|FG001|Overall Study|Lost to Follow-up|0|||
24940767|NCT00560573|50033869|FG002|Overall Study|Lost to Follow-up|0|||
24940768|NCT00560573|50033870|FG003|Overall Study|Lost to Follow-up|1|||
24940769|NCT00560573|50033871|FG004|Overall Study|Lost to Follow-up|1|||
24940770|NCT00560573|50033872|FG005|Overall Study|Lost to Follow-up|0|||
24940771|NCT00560573|50033867|FG000|Overall Study|Withdrawal by Subject|0|||
24940772|NCT00560573|50033868|FG001|Overall Study|Withdrawal by Subject|0|||
24940773|NCT00560573|50033869|FG002|Overall Study|Withdrawal by Subject|0|||
24940774|NCT00560573|50033870|FG003|Overall Study|Withdrawal by Subject|1|||
24940775|NCT00560573|50033871|FG004|Overall Study|Withdrawal by Subject|1|||
24940776|NCT00560573|50033872|FG005|Overall Study|Withdrawal by Subject|0|||
24940777|NCT00560573|50033867|FG000|Overall Study|Other|2|||
24940778|NCT00560573|50033868|FG001|Overall Study|Other|2|||
24940779|NCT00560573|50033869|FG002|Overall Study|Other|2|||
24940780|NCT00560573|50033870|FG003|Overall Study|Other|3|||
24940781|NCT00560573|50033871|FG004|Overall Study|Other|3|||
24940782|NCT00560573|50033872|FG005|Overall Study|Other|3|||
24940783|NCT00560573|50033867|FG000|Overall Study|Enrolled, not treated|0|||
24940784|NCT00560573|50033868|FG001|Overall Study|Enrolled, not treated|0|||
24940785|NCT00560573|50033869|FG002|Overall Study|Enrolled, not treated|0|||
24940786|NCT00560573|50033870|FG003|Overall Study|Enrolled, not treated|0|||
24940787|NCT00560573|50033871|FG004|Overall Study|Enrolled, not treated|1|||
24940788|NCT00560573|50033872|FG005|Overall Study|Enrolled, not treated|0|||
24940789|NCT03961529|50033905|FG000|Overall Study|Adverse Event|13|||
24940790|NCT03961529|50033906|FG001|Overall Study|Adverse Event|5|||
24940791|NCT03961529|50033907|FG002|Overall Study|Adverse Event|2|||
24940792|NCT03961529|50033905|FG000|Overall Study|Withdrawal by Subject|17|||
24940793|NCT03961529|50033906|FG001|Overall Study|Withdrawal by Subject|2|||
24940794|NCT03961529|50033907|FG002|Overall Study|Withdrawal by Subject|1|||
24940795|NCT03961529|50033905|FG000|Overall Study|Withdrawal by parent/guardian|0|||
24940796|NCT03961529|50033906|FG001|Overall Study|Withdrawal by parent/guardian|7|||
24940797|NCT03961529|50033907|FG002|Overall Study|Withdrawal by parent/guardian|0|||
24940798|NCT03961529|50033905|FG000|Overall Study|Physician Decision|2|||
24940799|NCT03961529|50033906|FG001|Overall Study|Physician Decision|1|||
24940800|NCT03961529|50033907|FG002|Overall Study|Physician Decision|1|||
24940801|NCT03961529|50033905|FG000|Overall Study|Lost to Follow-up|2|||
24940802|NCT03961529|50033906|FG001|Overall Study|Lost to Follow-up|1|||
24940803|NCT03961529|50033907|FG002|Overall Study|Lost to Follow-up|0|||
24940804|NCT03961529|50033905|FG000|Overall Study|Lack of Efficacy|2|||
24940805|NCT03961529|50033906|FG001|Overall Study|Lack of Efficacy|0|||
24940806|NCT03961529|50033907|FG002|Overall Study|Lack of Efficacy|1|||
25158605|NCT01519947|50276119|FG001|Overall Study|Blood Transfusion|1|||
25158606|NCT01519947|50276120|FG002|Overall Study|Blood Transfusion|1|||
25158607|NCT01519947|50276121|FG003|Overall Study|Blood Transfusion|0|||
25158608|NCT01519947|50276118|FG000|Overall Study|Withdrawal by Subject|0|||
24940807|NCT03961529|50033905|FG000|Overall Study|Other|6|||
24940808|NCT03961529|50033906|FG001|Overall Study|Other|1|||
25158609|NCT01519947|50276119|FG001|Overall Study|Withdrawal by Subject|1|||
25158610|NCT01519947|50276120|FG002|Overall Study|Withdrawal by Subject|0|||
24940809|NCT03961529|50033907|FG002|Overall Study|Other|0|||
24940810|NCT00494780|50033917|FG000|Overall Study|Adverse Event|1|||
24940811|NCT00494780|50033918|FG001|Overall Study|Adverse Event|0|||
24940812|NCT00494780|50033917|FG000|Overall Study|Withdrew before Dosed|0|||
24940813|NCT00494780|50033918|FG001|Overall Study|Withdrew before Dosed|1|||
24940814|NCT00494780|50033917|FG000|Overall Study|Progression of Study Disease|7|||
24940815|NCT00494780|50033918|FG001|Overall Study|Progression of Study Disease|8|||
24940816|NCT00494780|50033917|FG000|Overall Study|New Treatment|2|||
24940817|NCT00494780|50033918|FG001|Overall Study|New Treatment|2|||
24940818|NCT00494780|50033917|FG000|Overall Study|Non-compliance|1|||
24940819|NCT00494780|50033918|FG001|Overall Study|Non-compliance|0|||
24940820|NCT00494780|50033917|FG000|Overall Study|Residual Tumour Mass|0|||
24940821|NCT00494780|50033918|FG001|Overall Study|Residual Tumour Mass|1|||
24940822|NCT00494780|50033917|FG000|Overall Study|Insurance Issues|0|||
24940823|NCT00494780|50033918|FG001|Overall Study|Insurance Issues|1|||
24940824|NCT00490022|50033928|FG000|Overall Study|Adverse Event|0|||
24940825|NCT00490022|50033929|FG001|Overall Study|Adverse Event|2|||
24940826|NCT00490022|50033928|FG000|Overall Study|Withdrawal by Subject|1|||
24940827|NCT00490022|50033929|FG001|Overall Study|Withdrawal by Subject|0|||
24940828|NCT00490022|50033928|FG000|Overall Study|Subject failed to disclose concommitant|0|||
24940829|NCT00490022|50033929|FG001|Overall Study|Subject failed to disclose concommitant|1|||
24940830|NCT00493454|50033935|FG000|Overall Study|Withdrawal by Subject|1|||
24940831|NCT00493220|50033945|FG000|Third Intervention|Withdrawal by Subject|1|||
24940832|NCT00493220|50033946|FG001|Third Intervention|Withdrawal by Subject|0|||
24940833|NCT00493220|50033947|FG002|Third Intervention|Withdrawal by Subject|0|||
24940834|NCT00493220|50033948|FG003|Third Intervention|Withdrawal by Subject|0|||
24940835|NCT00493220|50033949|FG004|Third Intervention|Withdrawal by Subject|0|||
24940836|NCT00493220|50033950|FG005|Third Intervention|Withdrawal by Subject|0|||
24940837|NCT00394953|50033962|FG000|First Treatment Period|Adverse Event|1|||
24940838|NCT00394953|50033963|FG001|First Treatment Period|Adverse Event|2|||
25275506|NCT01073163|50589386|FG000|Overall Study|Early termination|1|||
25275507|NCT01072929|50589397|FG000|Overall Study|Adverse Event|8|||
25275508|NCT01072929|50589398|FG001|Overall Study|Adverse Event|11|||
24940839|NCT00394953|50033962|FG000|First Treatment Period|Death|6|||
24940840|NCT00394953|50033963|FG001|First Treatment Period|Death|7|||
24940841|NCT00394953|50033962|FG000|First Treatment Period|Lack of Efficacy|1|||
24940842|NCT00394953|50033963|FG001|First Treatment Period|Lack of Efficacy|1|||
24940843|NCT00394953|50033962|FG000|First Treatment Period|Withdrawal by Subject|6|||
24940844|NCT00394953|50033963|FG001|First Treatment Period|Withdrawal by Subject|3|||
24940845|NCT00394953|50033962|FG000|First Treatment Period|Lost to Follow-up|0|||
24940846|NCT00394953|50033963|FG001|First Treatment Period|Lost to Follow-up|1|||
24940847|NCT00394953|50033962|FG000|First Treatment Period|Renal transplant|11|||
24940848|NCT00394953|50033963|FG001|First Treatment Period|Renal transplant|7|||
24940849|NCT00394953|50033962|FG000|First Treatment Period|Not defined|4|||
24940850|NCT00394953|50033963|FG001|First Treatment Period|Not defined|1|||
24940851|NCT00394953|50033962|FG000|Second Treatment Period|Adverse Event|2|||
24940852|NCT00394953|50033963|FG001|Second Treatment Period|Adverse Event|5|||
24940853|NCT00394953|50033962|FG000|Second Treatment Period|Death|8|||
24940854|NCT00394953|50033963|FG001|Second Treatment Period|Death|4|||
24940855|NCT00394953|50033962|FG000|Second Treatment Period|Lack of Efficacy|9|||
24940856|NCT00394953|50033963|FG001|Second Treatment Period|Lack of Efficacy|47|||
24940857|NCT00394953|50033962|FG000|Second Treatment Period|Withdrawal by Subject|3|||
24940858|NCT00394953|50033963|FG001|Second Treatment Period|Withdrawal by Subject|3|||
24940859|NCT00394953|50033962|FG000|Second Treatment Period|Lost to Follow-up|0|||
24940860|NCT00394953|50033963|FG001|Second Treatment Period|Lost to Follow-up|1|||
24940861|NCT00394953|50033962|FG000|Second Treatment Period|Renal transplant|4|||
24940862|NCT00394953|50033963|FG001|Second Treatment Period|Renal transplant|6|||
24940863|NCT00394953|50033962|FG000|Second Treatment Period|Not defined|3|||
24940864|NCT00394953|50033963|FG001|Second Treatment Period|Not defined|8|||
24940865|NCT00485732|50033971|FG000|Overall Study|Protocol Violation|1|||
24940866|NCT00485732|50033972|FG001|Overall Study|Protocol Violation|3|||
25029650|NCT02896400|50128018|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
25029651|NCT02896400|50128019|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
25029652|NCT02896400|50128020|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
24940867|NCT00485732|50033971|FG000|Overall Study|Withdrawal by Subject|5|||
24940868|NCT00485732|50033972|FG001|Overall Study|Withdrawal by Subject|4|||
24940869|NCT00485732|50033971|FG000|Overall Study|Lost to Follow-up|2|||
24940870|NCT00485732|50033972|FG001|Overall Study|Lost to Follow-up|2|||
24940871|NCT00489554|50033978|FG000|Overall Study|Adverse Event|2|||
24940872|NCT00489554|50033978|FG000|Overall Study|Withdrawal by Subject|1|||
24940873|NCT00489554|50033978|FG000|Overall Study|Lost to Follow-up|1|||
24940874|NCT00408681|50033982|FG000|Overall Study|Lack of Efficacy|2|||
25158611|NCT01519947|50276121|FG003|Overall Study|Withdrawal by Subject|1|||
25158612|NCT01519947|50276118|FG000|Overall Study|Lost to Follow-up|0|||
25158613|NCT01519947|50276119|FG001|Overall Study|Lost to Follow-up|0|||
25158614|NCT01519947|50276120|FG002|Overall Study|Lost to Follow-up|3|||
25158615|NCT01519947|50276121|FG003|Overall Study|Lost to Follow-up|2|||
24940875|NCT00408681|50033982|FG000|Overall Study|Adverse Event|7|||
24940876|NCT00560417|50033989|FG000|Overall Study|Adverse Event|3|||
25029653|NCT02896400|50128021|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
25029654|NCT02896400|50128006|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
25029655|NCT02896400|50128007|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
25029656|NCT02896400|50128008|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
25029657|NCT02896400|50128009|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
25029658|NCT02896400|50128010|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
25029659|NCT02896400|50128011|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
25029660|NCT02896400|50128012|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
25029661|NCT02896400|50128013|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
25029662|NCT02896400|50128014|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
25029663|NCT02896400|50128015|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
25029664|NCT02896400|50128016|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
25158616|NCT01519947|50276118|FG000|Overall Study|Poor Response|1|||
25158617|NCT01519947|50276119|FG001|Overall Study|Poor Response|0|||
25158618|NCT01519947|50276120|FG002|Overall Study|Poor Response|0|||
25158619|NCT01519947|50276121|FG003|Overall Study|Poor Response|1|||
25158620|NCT01519947|50276118|FG000|Overall Study|Adverse Event|1|||
25158621|NCT01519947|50276119|FG001|Overall Study|Adverse Event|0|||
25158622|NCT01519947|50276120|FG002|Overall Study|Adverse Event|1|||
25158623|NCT01519947|50276121|FG003|Overall Study|Adverse Event|1|||
25158624|NCT01462227|50276133|FG000|Second Assignment|Lost to Follow-up|1|||
25158625|NCT01462227|50276134|FG001|Second Assignment|Lost to Follow-up|0|||
25158626|NCT01462227|50276135|FG002|Second Assignment|Lost to Follow-up|0|||
25158627|NCT01462227|50276136|FG003|Second Assignment|Lost to Follow-up|0|||
25158628|NCT01462227|50276133|FG000|Second Assignment|Protocol Violation|0|||
25158629|NCT01462227|50276134|FG001|Second Assignment|Protocol Violation|1|||
25158630|NCT01462227|50276135|FG002|Second Assignment|Protocol Violation|1|||
24940877|NCT00560417|50033990|FG001|Overall Study|Adverse Event|2|||
24940878|NCT00560417|50033989|FG000|Overall Study|Entry Criteria Not Met|1|||
24940879|NCT00560417|50033990|FG001|Overall Study|Entry Criteria Not Met|0|||
24940880|NCT00560417|50033989|FG000|Overall Study|Lost to Follow-up|0|||
24940881|NCT00560417|50033990|FG001|Overall Study|Lost to Follow-up|1|||
24940882|NCT00560417|50033989|FG000|Overall Study|Physician Decision|2|||
24940883|NCT00560417|50033990|FG001|Overall Study|Physician Decision|6|||
24940884|NCT00560417|50033989|FG000|Overall Study|Protocol Violation|6|||
24940885|NCT00560417|50033990|FG001|Overall Study|Protocol Violation|5|||
24940886|NCT00560417|50033989|FG000|Overall Study|Sponsor Decision|2|||
24940887|NCT00560417|50033990|FG001|Overall Study|Sponsor Decision|0|||
24940888|NCT00560417|50033989|FG000|Overall Study|Withdrawal by Subject|3|||
24940889|NCT00560417|50033990|FG001|Overall Study|Withdrawal by Subject|3|||
24940890|NCT03968159|50034003|FG000|Overall Study|Adverse Event|4|||
24940891|NCT03968159|50034004|FG001|Overall Study|Adverse Event|4|||
24940892|NCT03968159|50034003|FG000|Overall Study|Lost to Follow-up|1|||
24940893|NCT03968159|50034004|FG001|Overall Study|Lost to Follow-up|1|||
24940894|NCT03968159|50034003|FG000|Overall Study|Use of prohibited medication|0|||
24940895|NCT03968159|50034004|FG001|Overall Study|Use of prohibited medication|1|||
24940896|NCT03968159|50034003|FG000|Overall Study|Protocol Violation|2|||
24940897|NCT03968159|50034004|FG001|Overall Study|Protocol Violation|2|||
24940898|NCT03968159|50034003|FG000|Overall Study|Withdrawal by Subject|4|||
24940899|NCT03968159|50034004|FG001|Overall Study|Withdrawal by Subject|6|||
24940900|NCT03968159|50034003|FG000|Overall Study|Lack of Efficacy|0|||
24940901|NCT03968159|50034004|FG001|Overall Study|Lack of Efficacy|1|||
24940902|NCT03968159|50034003|FG000|Overall Study|Not further specified|2|||
24940903|NCT03968159|50034004|FG001|Overall Study|Not further specified|0|||
24940904|NCT03966911|50034012|FG000|Overall Study|Adverse Event|1|||
24940905|NCT03966911|50034013|FG001|Overall Study|Adverse Event|1|||
24940906|NCT03966911|50034012|FG000|Overall Study|Withdrawal by Subject|8|||
24940907|NCT03966911|50034013|FG001|Overall Study|Withdrawal by Subject|2|||
24940908|NCT03966911|50034012|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
24940909|NCT03966911|50034013|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
24940910|NCT03966365|50034023|FG000|Overall Study|Protocol Violation|1|||
24940911|NCT03966365|50034024|FG001|Overall Study|Protocol Violation|0|||
24940912|NCT00375219|50034033|FG000|Overall Study|Failure to achieve a response|16|||
24940913|NCT00375219|50034034|FG001|Overall Study|Failure to achieve a response|2|||
25158631|NCT01462227|50276136|FG003|Second Assignment|Protocol Violation|0|||
25158632|NCT01464879|50276144|FG000|Overall Study|Physician Decision|1|||
25158633|NCT01464879|50276144|FG000|Overall Study|Non-compliance|1|||
24940914|NCT00375219|50034035|FG002|Overall Study|Failure to achieve a response|0|||
24940915|NCT00375219|50034033|FG000|Overall Study|Adverse Event|8|||
24940916|NCT00375219|50034034|FG001|Overall Study|Adverse Event|2|||
24940917|NCT00375219|50034035|FG002|Overall Study|Adverse Event|1|||
24940918|NCT00375219|50034033|FG000|Overall Study|Protocol Violation|1|||
24940919|NCT00375219|50034034|FG001|Overall Study|Protocol Violation|0|||
24940920|NCT00375219|50034035|FG002|Overall Study|Protocol Violation|1|||
24940921|NCT00375219|50034033|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
24940922|NCT00375219|50034034|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
24940923|NCT00375219|50034035|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
25158634|NCT01519869|50276154|FG000|Overall Study|Lost to Follow-up|1|||
24940924|NCT00375219|50034033|FG000|Overall Study|Lost to Follow-up|1|||
24940925|NCT00375219|50034034|FG001|Overall Study|Lost to Follow-up|1|||
25158635|NCT01519791|50276160|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
25158636|NCT01519791|50276161|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
25158637|NCT01519791|50276160|FG000|Overall Study|Protocol Violation|6|||
25158638|NCT01519791|50276161|FG001|Overall Study|Protocol Violation|19|||
24940926|NCT00375219|50034035|FG002|Overall Study|Lost to Follow-up|0|||
25158639|NCT01519791|50276160|FG000|Overall Study|Other Reason|87|||
24940927|NCT00375219|50034033|FG000|Overall Study|Disease progression|18|||
24940928|NCT00375219|50034034|FG001|Overall Study|Disease progression|9|||
24940929|NCT00375219|50034035|FG002|Overall Study|Disease progression|12|||
24940930|NCT00375219|50034033|FG000|Overall Study|Death|4|||
24940931|NCT00375219|50034034|FG001|Overall Study|Death|3|||
24940932|NCT00375219|50034035|FG002|Overall Study|Death|7|||
24940933|NCT00375219|50034033|FG000|Overall Study|Hematologic resistance|1|||
24940934|NCT00375219|50034034|FG001|Overall Study|Hematologic resistance|0|||
25158640|NCT01519791|50276161|FG001|Overall Study|Other Reason|222|||
25158641|NCT01519791|50276160|FG000|Overall Study|subjects randomized in error|2|||
25158642|NCT01519791|50276161|FG001|Overall Study|subjects randomized in error|0|||
25158643|NCT01519791|50276160|FG000|Overall Study|Lack of Efficacy|16|||
25158644|NCT01519791|50276161|FG001|Overall Study|Lack of Efficacy|20|||
25158645|NCT01519791|50276160|FG000|Overall Study|SAE, non-fatal|6|||
25158646|NCT01519791|50276161|FG001|Overall Study|SAE, non-fatal|22|||
25158647|NCT01519791|50276160|FG000|Overall Study|AE, serious fatal|0|||
25158648|NCT01519791|50276161|FG001|Overall Study|AE, serious fatal|1|||
25158649|NCT01519791|50276160|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
24940935|NCT00375219|50034035|FG002|Overall Study|Hematologic resistance|0|||
24940936|NCT00375219|50034033|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
24940937|NCT00375219|50034034|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
24940938|NCT00375219|50034035|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
24940939|NCT00375219|50034033|FG000|Overall Study|Allograft|2|||
24940940|NCT00375219|50034034|FG001|Overall Study|Allograft|0|||
24940941|NCT00375219|50034035|FG002|Overall Study|Allograft|0|||
24940942|NCT00375219|50034033|FG000|Overall Study|Cord blood transplantation|1|||
24940943|NCT00375219|50034034|FG001|Overall Study|Cord blood transplantation|0|||
24940944|NCT00375219|50034035|FG002|Overall Study|Cord blood transplantation|0|||
24940945|NCT00375219|50034033|FG000|Overall Study|Withdrawal by Subject|1|||
25029665|NCT02896400|50128017|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
25029666|NCT02896400|50128018|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
25029667|NCT02896400|50128019|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
25029668|NCT02896400|50128020|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
25029669|NCT02896400|50128021|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
25029670|NCT03405935|50128047|FG000|Overall Study|Adverse Event|3|||
25029671|NCT03405935|50128047|FG000|Overall Study|Death|2|||
25029672|NCT03405935|50128047|FG000|Overall Study|Withdrawal by Subject|1|||
25029673|NCT03405935|50128047|FG000|Overall Study|Lost to Follow-up|2|||
25029674|NCT03055260|50128053|FG000|Overall Study|Withdrawal by Subject|1|||
25029675|NCT03055260|50128054|FG001|Overall Study|Withdrawal by Subject|0|||
25029676|NCT03404843|50128062|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
25029677|NCT03404843|50128063|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
25029678|NCT03444155|50128087|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
25029679|NCT03444155|50128088|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
25029680|NCT02898116|50128094|FG000|Overall Study|Adverse Event|1|||
25029681|NCT02898116|50128094|FG000|Overall Study|Progressive disease|1|||
25158650|NCT01519791|50276161|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
25158651|NCT01519791|50276160|FG000|Overall Study|AE, non-serious non-fatal|12|||
25158652|NCT01519791|50276161|FG001|Overall Study|AE, non-serious non-fatal|31|||
25158653|NCT01519791|50276160|FG000|Overall Study|Withdrawal by Subject|15|||
25158654|NCT01519791|50276161|FG001|Overall Study|Withdrawal by Subject|37|||
25158655|NCT01519791|50276160|FG000|Overall Study|Lost to Follow-up|6|||
24940946|NCT00375219|50034034|FG001|Overall Study|Withdrawal by Subject|0|||
24940947|NCT00375219|50034035|FG002|Overall Study|Withdrawal by Subject|0|||
24940948|NCT03965351|50034044|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
25029682|NCT03658304|50128098|FG000|Overall Study|participants still on follow up|8|||
25029683|NCT03422159|50128104|FG000|Overall Study|Exclusion due to terminal disease|2|||
25029684|NCT03422159|50128105|FG001|Overall Study|Exclusion due to terminal disease|1|||
25186164|NCT01421069|50336041|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
24940949|NCT03965351|50034045|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
24940950|NCT03965351|50034044|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
25029685|NCT03403751|50128115|FG000|Overall Study|Death|5|||
25029686|NCT03403751|50128116|FG001|Overall Study|Death|6|||
25029687|NCT03403751|50128115|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
25029688|NCT03403751|50128116|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
25029689|NCT02297412|50128126|FG000|Overall Study|Canceled|1|||
25029690|NCT02297412|50128127|FG001|Overall Study|Canceled|1|||
25029691|NCT03418727|50128136|FG000|Overall Study|Adverse Event|1|||
25029692|NCT03418727|50128137|FG001|Overall Study|Adverse Event|2|||
25029693|NCT03418727|50128138|FG002|Overall Study|Adverse Event|0|||
25029694|NCT03418727|50128136|FG000|Overall Study|Withdrawal by Subject|0|||
25029695|NCT03418727|50128137|FG001|Overall Study|Withdrawal by Subject|0|||
25029696|NCT03418727|50128138|FG002|Overall Study|Withdrawal by Subject|2|||
25029697|NCT03418571|50128148|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
25029698|NCT03418571|50128149|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
25029699|NCT03402893|50128155|FG000|Overall Study|Withdrawal by Subject|1|||
25029700|NCT03442985|50128163|FG000|Overall Study|Sponsor Request|55|||
25029701|NCT03442985|50128164|FG001|Overall Study|Sponsor Request|60|||
25029702|NCT03442985|50128165|FG002|Overall Study|Sponsor Request|54|||
25029703|NCT03442985|50128163|FG000|Overall Study|Lost to Follow-up|5|||
25029704|NCT03442985|50128164|FG001|Overall Study|Lost to Follow-up|2|||
25029705|NCT03442985|50128165|FG002|Overall Study|Lost to Follow-up|7|||
25029706|NCT03442985|50128163|FG000|Overall Study|Withdrawal by Subject|2|||
25029707|NCT03442985|50128164|FG001|Overall Study|Withdrawal by Subject|3|||
25029708|NCT03442985|50128165|FG002|Overall Study|Withdrawal by Subject|4|||
25029709|NCT03442985|50128163|FG000|Overall Study|Adverse Event|0|||
25029710|NCT03442985|50128164|FG001|Overall Study|Adverse Event|1|||
25029711|NCT03442985|50128165|FG002|Overall Study|Adverse Event|0|||
25029712|NCT01318122|50128177|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
25029713|NCT01318122|50128178|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
25275509|NCT01072929|50589399|FG002|Overall Study|Adverse Event|2|||
24940951|NCT03965351|50034045|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
24940952|NCT00554801|50034053|FG000|Overall Study|left area before completion|5|||
24940953|NCT00554801|50034054|FG001|Overall Study|left area before completion|0|||
24940954|NCT00554801|50034053|FG000|Overall Study|Withdrawal by Subject|14|||
24940955|NCT00554801|50034054|FG001|Overall Study|Withdrawal by Subject|0|||
24940956|NCT00374907|50034064|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
24940957|NCT00374907|50034065|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
24940958|NCT00374907|50034064|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
24940959|NCT00374907|50034065|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
24940960|NCT00374907|50034064|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
24940961|NCT00374907|50034065|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
24940962|NCT00374907|50034064|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
24940963|NCT00374907|50034065|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
24940964|NCT00374907|50034064|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
24940965|NCT00374907|50034065|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
24940966|NCT00374127|50034073|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
24940967|NCT00374127|50034073|FG000|Overall Study|Blood could not be drawn.|2|||
24940968|NCT00374127|50034073|FG000|Overall Study|Protocol Violation|5|||
24940969|NCT00374127|50034073|FG000|Overall Study|Pregnancy|1|||
24940970|NCT00553787|50034086|FG000|Overall Study|Adverse Event|34|||
24940971|NCT00553787|50034087|FG001|Overall Study|Adverse Event|21|||
24940972|NCT00553787|50034088|FG002|Overall Study|Adverse Event|67|||
24940973|NCT00553787|50034086|FG000|Overall Study|Lost to Follow-up|132|||
24940974|NCT00553787|50034087|FG001|Overall Study|Lost to Follow-up|44|||
24940975|NCT00553787|50034088|FG002|Overall Study|Lost to Follow-up|78|||
24940976|NCT00553787|50034086|FG000|Overall Study|Withdrawal by Subject|151|||
24940977|NCT00553787|50034087|FG001|Overall Study|Withdrawal by Subject|40|||
24940978|NCT00553787|50034088|FG002|Overall Study|Withdrawal by Subject|83|||
24940979|NCT00553787|50034086|FG000|Overall Study|Lack of Efficacy|31|||
24940980|NCT00553787|50034087|FG001|Overall Study|Lack of Efficacy|1|||
24940981|NCT00553787|50034088|FG002|Overall Study|Lack of Efficacy|3|||
24940982|NCT00553787|50034086|FG000|Overall Study|Pregnancy|0|||
24940983|NCT00553787|50034087|FG001|Overall Study|Pregnancy|1|||
24940984|NCT00553787|50034088|FG002|Overall Study|Pregnancy|2|||
25029714|NCT01318122|50128179|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
25029715|NCT01318122|50128180|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
25029716|NCT01318122|50128177|FG000|Enrolled - Long-Term Extension Study|Other|1|||
25029717|NCT01318122|50128178|FG001|Enrolled - Long-Term Extension Study|Other|0|||
25029718|NCT01318122|50128179|FG002|Enrolled - Long-Term Extension Study|Other|0|||
25029719|NCT01318122|50128180|FG003|Enrolled - Long-Term Extension Study|Other|0|||
24940985|NCT00553787|50034086|FG000|Overall Study|non compliance|4|||
24940986|NCT00553787|50034087|FG001|Overall Study|non compliance|0|||
24940987|NCT00553787|50034088|FG002|Overall Study|non compliance|11|||
24940988|NCT00553787|50034086|FG000|Overall Study|Requirement for restricted medication|8|||
24940989|NCT00553787|50034087|FG001|Overall Study|Requirement for restricted medication|7|||
24940990|NCT00553787|50034088|FG002|Overall Study|Requirement for restricted medication|5|||
24940991|NCT00553787|50034086|FG000|Overall Study|Other|18|||
24940992|NCT00553787|50034087|FG001|Overall Study|Other|10|||
24940993|NCT00553787|50034088|FG002|Overall Study|Other|13|||
24940994|NCT00407745|50034098|FG000|Overall Study|Lack of Efficacy|1|||
24940995|NCT00407745|50034099|FG001|Overall Study|Lack of Efficacy|2|||
24940996|NCT00407745|50034098|FG000|Overall Study|Withdrawal by Subject|3|||
24940997|NCT00407745|50034099|FG001|Overall Study|Withdrawal by Subject|3|||
24940998|NCT00407745|50034098|FG000|Overall Study|Protocol Violation|5|||
24940999|NCT00407745|50034099|FG001|Overall Study|Protocol Violation|3|||
24941000|NCT00407745|50034098|FG000|Overall Study|Adverse Event|8|||
24941001|NCT00407745|50034099|FG001|Overall Study|Adverse Event|8|||
24941002|NCT00407745|50034098|FG000|Overall Study|Other|2|||
24941003|NCT00407745|50034099|FG001|Overall Study|Other|0|||
24941004|NCT00407745|50034098|FG000|Overall Study|Randomized, unknown if treated|0|||
24941005|NCT00407745|50034099|FG001|Overall Study|Randomized, unknown if treated|1|||
24941006|NCT03958955|50034105|FG000|Overall Study|Adverse Event|1|||
24941007|NCT00464334|50034122|FG000|Overall Study|Adverse Event|0|||
24941008|NCT00464334|50034123|FG001|Overall Study|Adverse Event|0|||
24941009|NCT00464334|50034124|FG002|Overall Study|Adverse Event|0|||
24941010|NCT00464334|50034125|FG003|Overall Study|Adverse Event|1|||
24941011|NCT00464334|50034126|FG004|Overall Study|Adverse Event|1|||
25029720|NCT01318122|50128177|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
25029721|NCT01318122|50128178|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
25029722|NCT01318122|50128179|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
25158656|NCT01519791|50276161|FG001|Overall Study|Lost to Follow-up|14|||
25158657|NCT01461993|50276172|FG000|Overall Study|Withdrawal by Subject|60|||
25158658|NCT01461993|50276173|FG001|Overall Study|Withdrawal by Subject|53|||
25158659|NCT01461993|50276174|FG002|Overall Study|Withdrawal by Subject|16|||
24941012|NCT00464334|50034127|FG005|Overall Study|Adverse Event|1|||
24941013|NCT00464334|50034128|FG006|Overall Study|Adverse Event|0|||
25158660|NCT01461993|50276172|FG000|Overall Study|Lost to Follow-up|44|||
25158661|NCT01461993|50276173|FG001|Overall Study|Lost to Follow-up|48|||
25158662|NCT01461993|50276174|FG002|Overall Study|Lost to Follow-up|22|||
25158663|NCT01461993|50276172|FG000|Overall Study|Protocol Violation|10|||
25158664|NCT01461993|50276173|FG001|Overall Study|Protocol Violation|9|||
25158665|NCT01461993|50276174|FG002|Overall Study|Protocol Violation|7|||
25158666|NCT01461993|50276172|FG000|Overall Study|Adverse Event|9|||
24941014|NCT00464334|50034129|FG007|Overall Study|Adverse Event|0|||
24941015|NCT00464334|50034130|FG008|Overall Study|Adverse Event|2|||
24941016|NCT00464334|50034131|FG009|Overall Study|Adverse Event|1|||
24941017|NCT00464334|50034132|FG010|Overall Study|Adverse Event|2|||
24941018|NCT00464334|50034122|FG000|Overall Study|Lack of Efficacy|0|||
24941019|NCT00464334|50034123|FG001|Overall Study|Lack of Efficacy|1|||
24941020|NCT00464334|50034124|FG002|Overall Study|Lack of Efficacy|0|||
24941021|NCT00464334|50034125|FG003|Overall Study|Lack of Efficacy|0|||
25158667|NCT01461993|50276173|FG001|Overall Study|Adverse Event|11|||
25158668|NCT01461993|50276174|FG002|Overall Study|Adverse Event|3|||
25158669|NCT01461993|50276172|FG000|Overall Study|No longer met eligibility criteria|13|||
25158670|NCT01461993|50276173|FG001|Overall Study|No longer met eligibility criteria|18|||
25158671|NCT01461993|50276174|FG002|Overall Study|No longer met eligibility criteria|10|||
25158672|NCT01461993|50276172|FG000|Overall Study|Did not meet entrance criteria|2|||
25158673|NCT01461993|50276173|FG001|Overall Study|Did not meet entrance criteria|3|||
25158674|NCT01461993|50276174|FG002|Overall Study|Did not meet entrance criteria|0|||
25158675|NCT01461993|50276172|FG000|Overall Study|Other|13|||
25158676|NCT01461993|50276173|FG001|Overall Study|Other|15|||
25158677|NCT01461993|50276174|FG002|Overall Study|Other|6|||
25158678|NCT01782326|50276185|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
25158679|NCT01782326|50276186|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
25158680|NCT01782326|50276185|FG000|Planned Treatment Epoch|Death|29|||
25158681|NCT01782326|50276186|FG001|Planned Treatment Epoch|Death|30|||
24941022|NCT00464334|50034126|FG004|Overall Study|Lack of Efficacy|0|||
24941023|NCT00464334|50034127|FG005|Overall Study|Lack of Efficacy|0|||
24941024|NCT00464334|50034128|FG006|Overall Study|Lack of Efficacy|0|||
24941025|NCT00464334|50034129|FG007|Overall Study|Lack of Efficacy|0|||
25158682|NCT01782326|50276185|FG000|Planned Treatment Epoch|Physician Decision|18|||
25158683|NCT01782326|50276186|FG001|Planned Treatment Epoch|Physician Decision|16|||
25158684|NCT01782326|50276185|FG000|Planned Treatment Epoch|Protocol deviation|2|||
25158685|NCT01782326|50276186|FG001|Planned Treatment Epoch|Protocol deviation|3|||
24941026|NCT00464334|50034130|FG008|Overall Study|Lack of Efficacy|0|||
24941027|NCT00464334|50034131|FG009|Overall Study|Lack of Efficacy|0|||
25029723|NCT01318122|50128180|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
24941028|NCT00464334|50034132|FG010|Overall Study|Lack of Efficacy|0|||
24941029|NCT00464334|50034122|FG000|Overall Study|Lost to Follow-up|0|||
24941030|NCT00464334|50034123|FG001|Overall Study|Lost to Follow-up|0|||
24941031|NCT00464334|50034124|FG002|Overall Study|Lost to Follow-up|1|||
24941032|NCT00464334|50034125|FG003|Overall Study|Lost to Follow-up|0|||
24941033|NCT00464334|50034126|FG004|Overall Study|Lost to Follow-up|1|||
25158686|NCT01782326|50276185|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
25158687|NCT01782326|50276186|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
25158688|NCT01782326|50276185|FG000|Planned Treatment Epoch|Technical problems|0|||
25158689|NCT01782326|50276186|FG001|Planned Treatment Epoch|Technical problems|4|||
25158690|NCT01782326|50276185|FG000|Double-blind Treatment|Adverse Event|129|||
25158691|NCT01782326|50276186|FG001|Double-blind Treatment|Adverse Event|145|||
25158692|NCT01782326|50276185|FG000|Double-blind Treatment|Subject/guardian decision|111|||
25158693|NCT01782326|50276186|FG001|Double-blind Treatment|Subject/guardian decision|125|||
25158694|NCT01782326|50276185|FG000|Double-blind Treatment|Lack of Efficacy|17|||
25158695|NCT01782326|50276186|FG001|Double-blind Treatment|Lack of Efficacy|22|||
25158696|NCT01782326|50276185|FG000|Double-blind Treatment|Physician Decision|13|||
25158697|NCT01782326|50276186|FG001|Double-blind Treatment|Physician Decision|16|||
25158698|NCT01782326|50276185|FG000|Double-blind Treatment|Protocol deviation|8|||
25158699|NCT01782326|50276186|FG001|Double-blind Treatment|Protocol deviation|7|||
25158700|NCT01782326|50276185|FG000|Double-blind Treatment|Technical problems|0|||
25158701|NCT01782326|50276186|FG001|Double-blind Treatment|Technical problems|5|||
25158702|NCT01439373|50276194|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
25158703|NCT01439373|50276195|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
25158704|NCT01439373|50276194|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
25158705|NCT01439373|50276195|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
25158706|NCT01461369|50276208|FG000|Overall Study|Lack of Efficacy|2|||
25158707|NCT01461369|50276209|FG001|Overall Study|Lack of Efficacy|0|||
25158708|NCT01461369|50276210|FG002|Overall Study|Lack of Efficacy|6|||
24941034|NCT00464334|50034127|FG005|Overall Study|Lost to Follow-up|0|||
24941035|NCT00464334|50034128|FG006|Overall Study|Lost to Follow-up|1|||
24941036|NCT00464334|50034129|FG007|Overall Study|Lost to Follow-up|0|||
24941037|NCT00464334|50034130|FG008|Overall Study|Lost to Follow-up|0|||
24941038|NCT00464334|50034131|FG009|Overall Study|Lost to Follow-up|0|||
24941039|NCT00464334|50034132|FG010|Overall Study|Lost to Follow-up|2|||
25029724|NCT01318122|50128177|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
25029725|NCT01318122|50128178|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
25029726|NCT01318122|50128179|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
25029727|NCT01318122|50128180|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
25029728|NCT01318122|50128177|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
25029729|NCT01318122|50128178|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
25029730|NCT01318122|50128179|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
25029731|NCT01318122|50128180|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
25029732|NCT01318122|50128177|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
25029733|NCT01318122|50128178|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
25029734|NCT01318122|50128179|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
25029735|NCT01318122|50128180|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
25029736|NCT02954159|50128188|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
25029737|NCT02954159|50128189|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
24941040|NCT00464334|50034122|FG000|Overall Study|Progressive Disease|0|||
24941041|NCT00464334|50034123|FG001|Overall Study|Progressive Disease|0|||
24941042|NCT00464334|50034124|FG002|Overall Study|Progressive Disease|0|||
24941043|NCT00464334|50034125|FG003|Overall Study|Progressive Disease|0|||
24941044|NCT00464334|50034126|FG004|Overall Study|Progressive Disease|0|||
24941045|NCT00464334|50034127|FG005|Overall Study|Progressive Disease|1|||
24941046|NCT00464334|50034128|FG006|Overall Study|Progressive Disease|0|||
24941047|NCT00464334|50034129|FG007|Overall Study|Progressive Disease|0|||
24941048|NCT00464334|50034130|FG008|Overall Study|Progressive Disease|1|||
24941049|NCT00464334|50034131|FG009|Overall Study|Progressive Disease|0|||
24941050|NCT00464334|50034132|FG010|Overall Study|Progressive Disease|0|||
24941051|NCT00464334|50034122|FG000|Overall Study|Study Terminated by Sponsor|0|||
24941052|NCT00464334|50034123|FG001|Overall Study|Study Terminated by Sponsor|0|||
24941053|NCT00464334|50034124|FG002|Overall Study|Study Terminated by Sponsor|0|||
24941054|NCT00464334|50034125|FG003|Overall Study|Study Terminated by Sponsor|1|||
24941055|NCT00464334|50034126|FG004|Overall Study|Study Terminated by Sponsor|0|||
24941056|NCT00464334|50034127|FG005|Overall Study|Study Terminated by Sponsor|0|||
24941057|NCT00464334|50034128|FG006|Overall Study|Study Terminated by Sponsor|0|||
24941058|NCT00464334|50034129|FG007|Overall Study|Study Terminated by Sponsor|0|||
25029738|NCT02954159|50128188|FG000|Overall Study|Withdrawal by Subject|0|||
25158709|NCT01461369|50276208|FG000|Overall Study|Lost to Follow-up|0|||
25158710|NCT01461369|50276209|FG001|Overall Study|Lost to Follow-up|0|||
25158711|NCT01461369|50276210|FG002|Overall Study|Lost to Follow-up|3|||
25158712|NCT01461369|50276208|FG000|Overall Study|Adverse Event|9|||
25158713|NCT01461369|50276209|FG001|Overall Study|Adverse Event|12|||
25158714|NCT01461369|50276210|FG002|Overall Study|Adverse Event|4|||
25158715|NCT01461369|50276208|FG000|Overall Study|Protocol Violation|1|||
25158716|NCT01461369|50276209|FG001|Overall Study|Protocol Violation|2|||
25158717|NCT01461369|50276210|FG002|Overall Study|Protocol Violation|2|||
24941059|NCT00464334|50034130|FG008|Overall Study|Study Terminated by Sponsor|0|||
24941060|NCT00464334|50034131|FG009|Overall Study|Study Terminated by Sponsor|0|||
25029739|NCT02954159|50128189|FG001|Overall Study|Withdrawal by Subject|1|||
25029740|NCT03442829|50128197|FG000|Overall Study|Scheduling clash|3|||
25029741|NCT03442829|50128198|FG001|Overall Study|Scheduling clash|1|||
25029742|NCT03442829|50128197|FG000|Overall Study|Illness unrelated to study|1|||
25029743|NCT03442829|50128198|FG001|Overall Study|Illness unrelated to study|1|||
25029744|NCT03442595|50128206|FG000|Overall Study|Lost to Follow-up|94|||
25029745|NCT03442595|50128207|FG001|Overall Study|Lost to Follow-up|0|||
25029746|NCT03440411|50128216|FG000|Overall Study|Adverse Event|0|||
25029747|NCT03440411|50128217|FG001|Overall Study|Adverse Event|0|||
25029748|NCT03440411|50128218|FG002|Overall Study|Adverse Event|1|||
25029749|NCT03440411|50128219|FG003|Overall Study|Adverse Event|0|||
25029750|NCT03440411|50128216|FG000|Overall Study|PD|2|||
25029751|NCT03440411|50128217|FG001|Overall Study|PD|1|||
25029752|NCT03440411|50128218|FG002|Overall Study|PD|1|||
25029753|NCT03440411|50128219|FG003|Overall Study|PD|1|||
25029754|NCT03440411|50128216|FG000|Overall Study|Withdrawal by Subject|1|||
25029755|NCT03440411|50128217|FG001|Overall Study|Withdrawal by Subject|0|||
25029756|NCT03440411|50128218|FG002|Overall Study|Withdrawal by Subject|0|||
25029757|NCT03440411|50128219|FG003|Overall Study|Withdrawal by Subject|0|||
25029758|NCT03440411|50128216|FG000|Overall Study|Closed study by sponsor|0|||
25158718|NCT01461369|50276208|FG000|Overall Study|Withdrawal by Subject|1|||
25158719|NCT01461369|50276209|FG001|Overall Study|Withdrawal by Subject|3|||
25158720|NCT01461369|50276210|FG002|Overall Study|Withdrawal by Subject|2|||
25158721|NCT01727258|50276221|FG000|Overall Study|Adverse Event|0|||
25158722|NCT01727258|50276222|FG001|Overall Study|Adverse Event|2|||
25158723|NCT01727258|50276223|FG002|Overall Study|Adverse Event|0|||
25158724|NCT01727258|50276221|FG000|Overall Study|Noncompliance with Study Drug|0|||
25158725|NCT01727258|50276222|FG001|Overall Study|Noncompliance with Study Drug|0|||
25158726|NCT01727258|50276223|FG002|Overall Study|Noncompliance with Study Drug|1|||
25158727|NCT01727258|50276221|FG000|Overall Study|Withdrawal by Subject|1|||
25158728|NCT01727258|50276222|FG001|Overall Study|Withdrawal by Subject|1|||
25158729|NCT01727258|50276223|FG002|Overall Study|Withdrawal by Subject|0|||
25029759|NCT03440411|50128217|FG001|Overall Study|Closed study by sponsor|0|||
25029760|NCT03440411|50128218|FG002|Overall Study|Closed study by sponsor|0|||
25158730|NCT01727258|50276221|FG000|Overall Study|Lost to Follow-up|1|||
25029761|NCT03440411|50128219|FG003|Overall Study|Closed study by sponsor|1|||
25029762|NCT03438539|50128240|FG000|Overall Study|Lost to Follow-up|8|||
25029763|NCT03438539|50128241|FG001|Overall Study|Lost to Follow-up|4|||
25029764|NCT03438539|50128242|FG002|Overall Study|Lost to Follow-up|10|||
25158731|NCT01727258|50276222|FG001|Overall Study|Lost to Follow-up|0|||
25158732|NCT01727258|50276223|FG002|Overall Study|Lost to Follow-up|0|||
25029765|NCT03438539|50128243|FG003|Overall Study|Lost to Follow-up|9|||
25029766|NCT03438539|50128244|FG004|Overall Study|Lost to Follow-up|3|||
25029767|NCT03438539|50128245|FG005|Overall Study|Lost to Follow-up|8|||
25029768|NCT03400787|50128261|FG000|Overall Study|Lost to Follow-up|1|||
25029769|NCT03400787|50128262|FG001|Overall Study|Lost to Follow-up|0|||
25029770|NCT03400787|50128261|FG000|Overall Study|Death|1|||
25029771|NCT03400787|50128262|FG001|Overall Study|Death|0|||
25029772|NCT03400787|50128261|FG000|Overall Study|Protocol Violation|0|||
25029773|NCT03400787|50128262|FG001|Overall Study|Protocol Violation|2|||
25029774|NCT03400787|50128261|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
25029775|NCT03400787|50128262|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
25029776|NCT03417245|50128270|FG000|Overall Study|Adverse Event|1|||
25029777|NCT03417245|50128271|FG001|Overall Study|Adverse Event|0|||
25029778|NCT03417245|50128270|FG000|Overall Study|Protocol Violation|1|||
25029779|NCT03417245|50128271|FG001|Overall Study|Protocol Violation|0|||
25029780|NCT03417245|50128270|FG000|Overall Study|Withdrawal by Subject|1|||
25029781|NCT03417245|50128271|FG001|Overall Study|Withdrawal by Subject|1|||
25029782|NCT03389555|50128279|FG000|Overall Study|Protocol Violation|1|||
25029783|NCT03389555|50128280|FG001|Overall Study|Protocol Violation|3|||
25029784|NCT03389555|50128279|FG000|Overall Study|Death|1|||
25029785|NCT03389555|50128280|FG001|Overall Study|Death|0|||
25029786|NCT03395639|50128288|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
25029787|NCT03395639|50128289|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
25029788|NCT03395639|50128290|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
25158733|NCT01781390|50276234|FG000|Overall Study|Withdrawal of Consent|0|||
25158734|NCT01781390|50276235|FG001|Overall Study|Withdrawal of Consent|3|||
25158735|NCT01781390|50276236|FG002|Overall Study|Withdrawal of Consent|1|||
25158736|NCT01781390|50276234|FG000|Overall Study|Lost to Follow-up|1|||
25158737|NCT01781390|50276235|FG001|Overall Study|Lost to Follow-up|1|||
25158738|NCT01781390|50276236|FG002|Overall Study|Lost to Follow-up|1|||
25158739|NCT01781390|50276234|FG000|Overall Study|Adverse Event|1|||
25158740|NCT01781390|50276235|FG001|Overall Study|Adverse Event|2|||
25158741|NCT01781390|50276236|FG002|Overall Study|Adverse Event|1|||
25029789|NCT03395639|50128288|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
25029790|NCT03395639|50128289|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
25029791|NCT03395639|50128290|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
25067416|NCT02397460|50173040|FG003|Treatment Period 4|Physician Decision|0|||
25029792|NCT03395639|50128288|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
25029793|NCT03395639|50128289|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
25029794|NCT03395639|50128290|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
25029795|NCT03395639|50128288|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
25029796|NCT03395639|50128289|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
25029797|NCT03395639|50128290|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
25029798|NCT03395639|50128288|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
25029799|NCT03395639|50128289|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
25029800|NCT03395639|50128290|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
25029801|NCT03353922|50128297|FG000|Overall Study|Withdrawal by Subject|1|||
25029802|NCT03353922|50128298|FG001|Overall Study|Withdrawal by Subject|0|||
25029803|NCT03353922|50128299|FG002|Overall Study|Withdrawal by Subject|1|||
25029804|NCT03353922|50128300|FG003|Overall Study|Withdrawal by Subject|1|||
25029805|NCT03353922|50128301|FG004|Overall Study|Withdrawal by Subject|0|||
25029806|NCT03353922|50128302|FG005|Overall Study|Withdrawal by Subject|0|||
25029807|NCT03353922|50128297|FG000|Overall Study|Adverse Event|0|||
25029808|NCT03353922|50128298|FG001|Overall Study|Adverse Event|1|||
25029809|NCT03353922|50128299|FG002|Overall Study|Adverse Event|0|||
25029810|NCT03353922|50128300|FG003|Overall Study|Adverse Event|0|||
25029811|NCT03353922|50128301|FG004|Overall Study|Adverse Event|0|||
25029812|NCT03353922|50128302|FG005|Overall Study|Adverse Event|0|||
25029813|NCT03395405|50128315|FG000|Overall Study|Death|0|||
25029814|NCT03395405|50128316|FG001|Overall Study|Death|2|||
25029815|NCT03395405|50128315|FG000|Overall Study|Lost to Follow-up|0|||
24941061|NCT00464334|50034132|FG010|Overall Study|Study Terminated by Sponsor|0|||
25029816|NCT03395405|50128316|FG001|Overall Study|Lost to Follow-up|1|||
25029817|NCT03395405|50128315|FG000|Overall Study|Protocol Violation|0|||
25029818|NCT03395405|50128316|FG001|Overall Study|Protocol Violation|1|||
25029819|NCT03395405|50128315|FG000|Overall Study|Withdrawal by Subject|3|||
25029820|NCT03395405|50128316|FG001|Overall Study|Withdrawal by Subject|1|||
25029821|NCT03395405|50128315|FG000|Overall Study|COVID-19 Pandemic|1|||
25029822|NCT03395405|50128316|FG001|Overall Study|COVID-19 Pandemic|0|||
25029823|NCT03387683|50128324|FG000|Overall Study|In receipt of disallowed medication|1|||
25029824|NCT03387683|50128325|FG001|Overall Study|In receipt of disallowed medication|0|||
25029825|NCT03387683|50128324|FG000|Overall Study|Did not receive treatment|1|||
24941062|NCT00464334|50034122|FG000|Overall Study|Withdrawal by Subject|1|||
24941063|NCT00464334|50034123|FG001|Overall Study|Withdrawal by Subject|7|||
24941064|NCT00464334|50034124|FG002|Overall Study|Withdrawal by Subject|4|||
24941065|NCT00464334|50034125|FG003|Overall Study|Withdrawal by Subject|2|||
24941066|NCT00464334|50034126|FG004|Overall Study|Withdrawal by Subject|2|||
24941067|NCT00464334|50034127|FG005|Overall Study|Withdrawal by Subject|2|||
24941068|NCT00464334|50034128|FG006|Overall Study|Withdrawal by Subject|2|||
24941069|NCT00464334|50034129|FG007|Overall Study|Withdrawal by Subject|1|||
24941070|NCT00464334|50034130|FG008|Overall Study|Withdrawal by Subject|3|||
24941071|NCT00464334|50034131|FG009|Overall Study|Withdrawal by Subject|0|||
24941072|NCT00464334|50034132|FG010|Overall Study|Withdrawal by Subject|0|||
24941073|NCT00299494|50034173|FG000|Overall Study|Withdrawal by Subject|0|||
24941074|NCT00299494|50034174|FG001|Overall Study|Withdrawal by Subject|0|||
24941075|NCT00299494|50034175|FG002|Overall Study|Withdrawal by Subject|0|||
24941076|NCT00299494|50034176|FG003|Overall Study|Withdrawal by Subject|3|||
24941077|NCT00299494|50034177|FG004|Overall Study|Withdrawal by Subject|1|||
24941078|NCT00299494|50034178|FG005|Overall Study|Withdrawal by Subject|4|||
24941079|NCT00299494|50034173|FG000|Overall Study|Physician Decision|0|||
24941080|NCT00299494|50034174|FG001|Overall Study|Physician Decision|0|||
24941081|NCT00299494|50034175|FG002|Overall Study|Physician Decision|0|||
24941082|NCT00299494|50034176|FG003|Overall Study|Physician Decision|0|||
24941083|NCT00299494|50034177|FG004|Overall Study|Physician Decision|1|||
24941084|NCT00299494|50034178|FG005|Overall Study|Physician Decision|0|||
24941085|NCT00299494|50034173|FG000|Overall Study|Death|3|||
24941086|NCT00299494|50034174|FG001|Overall Study|Death|1|||
24941087|NCT00299494|50034175|FG002|Overall Study|Death|4|||
24941088|NCT00299494|50034176|FG003|Overall Study|Death|6|||
24941089|NCT00299494|50034177|FG004|Overall Study|Death|18|||
24941090|NCT00299494|50034178|FG005|Overall Study|Death|19|||
24941091|NCT00299494|50034173|FG000|Overall Study|Lost to Follow-up|0|||
24941092|NCT00299494|50034174|FG001|Overall Study|Lost to Follow-up|0|||
24941093|NCT00299494|50034175|FG002|Overall Study|Lost to Follow-up|0|||
24941094|NCT00299494|50034176|FG003|Overall Study|Lost to Follow-up|0|||
25029826|NCT03387683|50128325|FG001|Overall Study|Did not receive treatment|0|||
25029827|NCT03387059|50128333|FG000|Overall Study|Study termination|5|||
24941095|NCT00299494|50034177|FG004|Overall Study|Lost to Follow-up|3|||
24941096|NCT00299494|50034178|FG005|Overall Study|Lost to Follow-up|1|||
24941097|NCT00299494|50034173|FG000|Overall Study|Other - Unspecified|0|||
24941098|NCT00299494|50034174|FG001|Overall Study|Other - Unspecified|0|||
24941099|NCT00299494|50034175|FG002|Overall Study|Other - Unspecified|0|||
24941100|NCT00299494|50034176|FG003|Overall Study|Other - Unspecified|0|||
24941101|NCT00299494|50034177|FG004|Overall Study|Other - Unspecified|3|||
24941102|NCT00299494|50034178|FG005|Overall Study|Other - Unspecified|1|||
24941103|NCT00299494|50034173|FG000|Overall Study|Other - site closure|0|||
24941104|NCT00299494|50034174|FG001|Overall Study|Other - site closure|0|||
25158742|NCT01781390|50276234|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
25158743|NCT01781390|50276235|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
25158744|NCT01781390|50276236|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
25158745|NCT01781234|50276246|FG000|Overall Study|Adverse Event|2|||
25158746|NCT01781234|50276247|FG001|Overall Study|Adverse Event|0|||
25158747|NCT01781234|50276246|FG000|Overall Study|Protocol Violation|3|||
25158748|NCT01781234|50276247|FG001|Overall Study|Protocol Violation|0|||
25158749|NCT01781234|50276246|FG000|Overall Study|Withdrawal by Subject|4|||
24941105|NCT00299494|50034175|FG002|Overall Study|Other - site closure|0|||
24941106|NCT00299494|50034176|FG003|Overall Study|Other - site closure|1|||
24941107|NCT00299494|50034177|FG004|Overall Study|Other - site closure|1|||
24941108|NCT00299494|50034178|FG005|Overall Study|Other - site closure|1|||
24941109|NCT00453180|50034205|FG000|Overall Study|Lost to Follow-up|2|||
25158750|NCT01781234|50276247|FG001|Overall Study|Withdrawal by Subject|3|||
25186165|NCT01421069|50336041|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
24941110|NCT00453180|50034206|FG001|Overall Study|Lost to Follow-up|1|||
24941111|NCT00453180|50034205|FG000|Overall Study|Adverse Event|1|||
24941112|NCT00453180|50034206|FG001|Overall Study|Adverse Event|2|||
24941113|NCT00464178|50034212|FG000|Overall Study|Protocol Violation|1|||
24941114|NCT00464178|50034212|FG000|Overall Study|Withdrawal by Subject|1|||
24941115|NCT00560105|50034219|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
24941116|NCT00560105|50034220|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
24941117|NCT00467610|50034226|FG000|Overall Study|Withdrawal by Subject|1|||
24941118|NCT00316186|50034230|FG000|Overall Study|Adverse Event|6|||
25029828|NCT03387059|50128334|FG001|Overall Study|Study termination|4|||
25029829|NCT02942004|50128343|FG000|Overall Study|Withdrawal by Subject|0|||
25029830|NCT02942004|50128344|FG001|Overall Study|Withdrawal by Subject|2|||
25029831|NCT02942004|50128345|FG002|Overall Study|Withdrawal by Subject|3|||
25029832|NCT02942004|50128343|FG000|Overall Study|Lost to Follow-up|1|||
25029833|NCT02942004|50128344|FG001|Overall Study|Lost to Follow-up|1|||
25029834|NCT02942004|50128345|FG002|Overall Study|Lost to Follow-up|2|||
25029835|NCT02942004|50128343|FG000|Overall Study|Randomized but not dosed|3|||
25029836|NCT02942004|50128344|FG001|Overall Study|Randomized but not dosed|9|||
25029837|NCT02942004|50128345|FG002|Overall Study|Randomized but not dosed|4|||
25029838|NCT03394391|50128355|FG000|Overall Study|Lost to Follow-up|1|||
25029839|NCT03394391|50128356|FG001|Overall Study|Lost to Follow-up|2|||
25029840|NCT03386435|50128364|FG000|Overall Study|Protocol Violation|5|||
25029841|NCT03386435|50128365|FG001|Overall Study|Protocol Violation|7|||
25029842|NCT02726880|50128373|FG000|Overall Study|Withdrawal by Subject|2|||
25029843|NCT02726880|50128374|FG001|Overall Study|Withdrawal by Subject|0|||
25029844|NCT02726880|50128373|FG000|Overall Study|Lost to Follow-up|1|||
25158751|NCT01752842|50276257|FG000|Overall Study|Adverse Event|3|||
25186166|NCT01421069|50336041|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
25186167|NCT01421069|50336041|FG000|2b. Retreatment Period|Protocol Violation|1|||
25186168|NCT01421069|50336041|FG000|Observational Period|Other|1|||
25186169|NCT01421069|50336041|FG000|Observational Period|No longer willing to participate in study|4|||
25186170|NCT01421069|50336041|FG000|Observational Period|Lost to Follow-up|3|||
24941119|NCT00316186|50034230|FG000|Overall Study|Disease Progression|4|||
25029845|NCT02726880|50128374|FG001|Overall Study|Lost to Follow-up|3|||
25158752|NCT01752842|50276258|FG001|Overall Study|Adverse Event|0|||
25158753|NCT01752842|50276257|FG000|Overall Study|Withdrawal by Subject|0|||
25158754|NCT01752842|50276258|FG001|Overall Study|Withdrawal by Subject|2|||
25158755|NCT01461057|50276266|FG000|Overall Study|Death|10|||
24941120|NCT00316186|50034230|FG000|Overall Study|Lost to Follow-up|1|||
24941121|NCT00316186|50034230|FG000|Overall Study|Other|1|||
25029846|NCT03275389|50128391|FG000|Overall Study|Lost to Follow-up|10|||
25029847|NCT03275389|50128392|FG001|Overall Study|Lost to Follow-up|10|||
25029848|NCT03275389|50128393|FG002|Overall Study|Lost to Follow-up|19|||
25029849|NCT03275389|50128394|FG003|Overall Study|Lost to Follow-up|12|||
25029850|NCT03275389|50128395|FG004|Overall Study|Lost to Follow-up|11|||
25029851|NCT03275389|50128396|FG005|Overall Study|Lost to Follow-up|12|||
25158756|NCT01461057|50276267|FG001|Overall Study|Death|9|||
25158757|NCT01461057|50276266|FG000|Overall Study|Withdrawal by Subject|2|||
25158758|NCT01461057|50276267|FG001|Overall Study|Withdrawal by Subject|3|||
25158759|NCT01461057|50276266|FG000|Overall Study|Physician Decision|0|||
25158760|NCT01461057|50276267|FG001|Overall Study|Physician Decision|2|||
25158761|NCT01461057|50276266|FG000|Overall Study|Adverse Event|0|||
25158762|NCT01461057|50276267|FG001|Overall Study|Adverse Event|1|||
25158763|NCT01461057|50276266|FG000|Overall Study|Progression of Disease|1|||
25158764|NCT01461057|50276267|FG001|Overall Study|Progression of Disease|0|||
25158765|NCT01461057|50276266|FG000|Overall Study|Study Terminated by Sponsor|2|||
25158766|NCT01461057|50276267|FG001|Overall Study|Study Terminated by Sponsor|0|||
25158767|NCT01460901|50276273|FG000|Overall Study|Withdrawal by Subject|2|||
25158768|NCT01519635|50276282|FG000|Overall Study|Withdrawal by Subject|0|||
25158769|NCT01519635|50276283|FG001|Overall Study|Withdrawal by Subject|1|||
25158770|NCT01519635|50276282|FG000|Overall Study|No possibility to put a catheter|1|||
25158771|NCT01519635|50276283|FG001|Overall Study|No possibility to put a catheter|2|||
25158772|NCT01519323|50276289|FG000|Overall Study|Death|3|||
25158773|NCT01519323|50276290|FG001|Overall Study|Death|2|||
25158774|NCT01519323|50276289|FG000|Overall Study|Study terminated by sponsor|0|||
25158775|NCT01519323|50276290|FG001|Overall Study|Study terminated by sponsor|1|||
25158776|NCT01519245|50276298|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
25158777|NCT01519245|50276299|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
25158778|NCT01519167|50276309|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
25158779|NCT01519167|50276310|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
25158780|NCT01519167|50276309|FG000|Overall Study|Adverse Event|0|||
25158781|NCT01519167|50276310|FG001|Overall Study|Adverse Event|1|||
25158782|NCT01519167|50276309|FG000|Overall Study|Lack of Efficacy|0|||
25158783|NCT01519167|50276310|FG001|Overall Study|Lack of Efficacy|1|||
25158784|NCT01519167|50276309|FG000|Overall Study|Medical condition changes&deep sedation|0|||
25158785|NCT01519167|50276310|FG001|Overall Study|Medical condition changes&deep sedation|2|||
25158786|NCT01519167|50276309|FG000|Overall Study|Physician Decision|0|||
25158787|NCT01519167|50276310|FG001|Overall Study|Physician Decision|1|||
25158788|NCT01519089|50276551|FG000|Overall Study|Adverse Event|4|||
25158789|NCT01519089|50276552|FG001|Overall Study|Adverse Event|4|||
25158790|NCT01519089|50276551|FG000|Overall Study|Lack of Efficacy|0|||
25158791|NCT01519089|50276552|FG001|Overall Study|Lack of Efficacy|2|||
25158792|NCT01519089|50276551|FG000|Overall Study|Lost to Follow-up|1|||
25158793|NCT01519089|50276552|FG001|Overall Study|Lost to Follow-up|0|||
25158794|NCT01519089|50276551|FG000|Overall Study|Withdrawal by Subject|0|||
25158795|NCT01519089|50276552|FG001|Overall Study|Withdrawal by Subject|2|||
25158796|NCT01519089|50276551|FG000|Overall Study|Other|2|||
25158797|NCT01519089|50276552|FG001|Overall Study|Other|6|||
25158798|NCT01519089|50276551|FG000|Overall Study|Not received study drug|0|||
25158799|NCT01519089|50276552|FG001|Overall Study|Not received study drug|1|||
25158800|NCT01518699|50276574|FG000|Period 2|Protocol Violation|1|||
25158801|NCT01518699|50276575|FG001|Period 2|Protocol Violation|1|||
25158802|NCT01518699|50276576|FG002|Period 2|Protocol Violation|0|||
25158803|NCT01518699|50276577|FG003|Period 2|Protocol Violation|0|||
25158804|NCT01518699|50276578|FG004|Period 2|Protocol Violation|0|||
25158805|NCT01518699|50276579|FG005|Period 2|Protocol Violation|0|||
25158806|NCT01518699|50276574|FG000|Period 2|Lost to Follow-up|0|||
25158807|NCT01518699|50276575|FG001|Period 2|Lost to Follow-up|1|||
25158808|NCT01518699|50276576|FG002|Period 2|Lost to Follow-up|0|||
25158809|NCT01518699|50276577|FG003|Period 2|Lost to Follow-up|0|||
25158810|NCT01518699|50276578|FG004|Period 2|Lost to Follow-up|0|||
25158811|NCT01518699|50276579|FG005|Period 2|Lost to Follow-up|0|||
25186171|NCT01473836|50336073|FG000|Overall Study|Adverse Event|4|||
25186172|NCT01473836|50336073|FG000|Overall Study|Lack of Efficacy|1|||
24941122|NCT00453102|50034234|FG000|Overall Study|Withdrawal by Subject|2|||
24941123|NCT00299182|50034245|FG000|Overall Study|Withdrawal by Subject|0|||
24941124|NCT00299182|50034246|FG001|Overall Study|Withdrawal by Subject|0|||
24941125|NCT00299182|50034247|FG002|Overall Study|Withdrawal by Subject|1|||
24941126|NCT00299182|50034248|FG003|Overall Study|Withdrawal by Subject|0|||
24941127|NCT00299182|50034249|FG004|Overall Study|Withdrawal by Subject|1|||
25158812|NCT01518699|50276574|FG000|Period 2|Adverse Event|1|||
24941128|NCT00299182|50034250|FG005|Overall Study|Withdrawal by Subject|2|||
24941129|NCT00299182|50034251|FG006|Overall Study|Withdrawal by Subject|0|||
25029852|NCT03275389|50128397|FG006|Overall Study|Lost to Follow-up|21|||
25158813|NCT01518699|50276575|FG001|Period 2|Adverse Event|0|||
25158814|NCT01518699|50276576|FG002|Period 2|Adverse Event|0|||
25158815|NCT01518699|50276577|FG003|Period 2|Adverse Event|0|||
25158816|NCT01518699|50276578|FG004|Period 2|Adverse Event|0|||
25158817|NCT01518699|50276579|FG005|Period 2|Adverse Event|0|||
24941130|NCT00299182|50034245|FG000|Overall Study|Chemotherapy Changed|0|||
24941131|NCT00299182|50034246|FG001|Overall Study|Chemotherapy Changed|0|||
24941132|NCT00299182|50034247|FG002|Overall Study|Chemotherapy Changed|1|||
24941133|NCT00299182|50034248|FG003|Overall Study|Chemotherapy Changed|0|||
24941134|NCT00299182|50034249|FG004|Overall Study|Chemotherapy Changed|1|||
24941135|NCT00299182|50034250|FG005|Overall Study|Chemotherapy Changed|0|||
24941136|NCT00299182|50034251|FG006|Overall Study|Chemotherapy Changed|1|||
24941137|NCT00299182|50034245|FG000|Overall Study|Adverse Event|0|||
24941138|NCT00299182|50034246|FG001|Overall Study|Adverse Event|0|||
24941139|NCT00299182|50034247|FG002|Overall Study|Adverse Event|0|||
24941140|NCT00299182|50034248|FG003|Overall Study|Adverse Event|0|||
25029853|NCT03275389|50128398|FG007|Overall Study|Lost to Follow-up|15|||
25029854|NCT03275389|50128399|FG008|Overall Study|Lost to Follow-up|12|||
25029855|NCT03275389|50128400|FG009|Overall Study|Lost to Follow-up|14|||
25158818|NCT01518309|50276587|FG000|Overall Study|Adverse Event|6|||
24941141|NCT00299182|50034249|FG004|Overall Study|Adverse Event|0|||
24941142|NCT00299182|50034250|FG005|Overall Study|Adverse Event|1|||
24941143|NCT00299182|50034251|FG006|Overall Study|Adverse Event|0|||
24941144|NCT00299182|50034245|FG000|Overall Study|Not Eligible|0|||
24941145|NCT00299182|50034246|FG001|Overall Study|Not Eligible|0|||
24941146|NCT00299182|50034247|FG002|Overall Study|Not Eligible|0|||
24941147|NCT00299182|50034248|FG003|Overall Study|Not Eligible|0|||
24941148|NCT00299182|50034249|FG004|Overall Study|Not Eligible|1|||
24941149|NCT00299182|50034250|FG005|Overall Study|Not Eligible|0|||
24941150|NCT00299182|50034251|FG006|Overall Study|Not Eligible|0|||
24941151|NCT00467142|50034269|FG000|Overall Study|Withdrawal by Subject|1|||
24941152|NCT00467142|50034269|FG000|Overall Study|Adverse Event|1|||
24941153|NCT00467142|50034269|FG000|Overall Study|Protocol Violation|1|||
24941154|NCT00553475|50034276|FG000|Overall Study|Adverse Event|7|||
24941155|NCT00553475|50034277|FG001|Overall Study|Adverse Event|17|||
24941156|NCT00553475|50034278|FG002|Overall Study|Adverse Event|13|||
24941157|NCT00553475|50034276|FG000|Overall Study|Lack of Efficacy|7|||
25158819|NCT01518309|50276587|FG000|Overall Study|Death|6|||
25158820|NCT01518309|50276587|FG000|Overall Study|Lack of Efficacy|7|||
25158821|NCT01518309|50276587|FG000|Overall Study|Withdrawal by Subject|6|||
25158822|NCT01518309|50276587|FG000|Overall Study|Physician Decision|3|||
25158823|NCT01518309|50276587|FG000|Overall Study|Sponsor Decision|2|||
25158824|NCT01518309|50276587|FG000|Overall Study|Not in Predefined Categories|9|||
25158825|NCT01419717|50276591|FG000|Overall Study|Protocol-specified Criteria|62|||
25158826|NCT01419717|50276591|FG000|Overall Study|Adverse Event|19|||
25158827|NCT01419717|50276591|FG000|Overall Study|Death|17|||
25158828|NCT01419717|50276591|FG000|Overall Study|Withdrawal by Subject|10|||
25158829|NCT01419717|50276591|FG000|Overall Study|Disease Progression|9|||
25158830|NCT01419717|50276591|FG000|Overall Study|Other|4|||
25158831|NCT01419717|50276591|FG000|Overall Study|Lost to Follow-up|2|||
25158832|NCT01419717|50276591|FG000|Overall Study|Administrative Decision|1|||
25158833|NCT01419717|50276591|FG000|Overall Study|Noncompliance|1|||
25158834|NCT01458951|50276598|FG000|Overall Study|Other|1|||
25158835|NCT01458951|50276599|FG001|Overall Study|Other|0|||
25158836|NCT01458951|50276600|FG002|Overall Study|Other|0|||
25158837|NCT01458951|50276598|FG000|Overall Study|Protocol Violation|5|||
25158838|NCT01458951|50276599|FG001|Overall Study|Protocol Violation|1|||
25158839|NCT01458951|50276600|FG002|Overall Study|Protocol Violation|0|||
25158840|NCT01458951|50276598|FG000|Overall Study|Withdrawal by Subject|2|||
25158841|NCT01458951|50276599|FG001|Overall Study|Withdrawal by Subject|0|||
25158842|NCT01458951|50276600|FG002|Overall Study|Withdrawal by Subject|2|||
25158843|NCT01458951|50276598|FG000|Overall Study|Adverse Event|7|||
25158844|NCT01458951|50276599|FG001|Overall Study|Adverse Event|0|||
25158845|NCT01458951|50276600|FG002|Overall Study|Adverse Event|2|||
25158846|NCT01458951|50276598|FG000|Overall Study|Insufficient Clinical Response|17|||
25158847|NCT01458951|50276599|FG001|Overall Study|Insufficient Clinical Response|0|||
25158848|NCT01458951|50276600|FG002|Overall Study|Insufficient Clinical Response|11|||
25158849|NCT01458639|50276607|FG000|Overall Study|Physician Decision|4|||
25158850|NCT01458639|50276607|FG000|Overall Study|Equipment issue|1|||
25158851|NCT01458639|50276607|FG000|Overall Study|Inability to obtain subject blood sample|1|||
25158852|NCT01437423|50276611|FG000|Overall Study|Lost to Follow-up|12|||
25158853|NCT01437423|50276611|FG000|Overall Study|Off label usage|3|||
25158854|NCT01458249|50276642|FG000|Overall Study|Not treated|1|||
25158855|NCT01458249|50276642|FG000|Overall Study|Adverse Event|4|||
24941158|NCT00553475|50034277|FG001|Overall Study|Lack of Efficacy|1|||
24941159|NCT00553475|50034278|FG002|Overall Study|Lack of Efficacy|0|||
25158856|NCT01458249|50276642|FG000|Overall Study|Other|2|||
25158857|NCT01458249|50276642|FG000|Overall Study|Ongoing|1|||
24941160|NCT00553475|50034276|FG000|Overall Study|Withdrawal by Subject|1|||
25158858|NCT01458171|50276658|FG000|Overall Study|Adverse Event|1|||
25029856|NCT03275389|50128391|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
25158859|NCT01457703|50276675|FG000|Overall Study|Screen Failure|5|||
25158860|NCT01457703|50276676|FG001|Overall Study|Screen Failure|7|||
25158861|NCT01457703|50276675|FG000|Overall Study|Withdrawal by Subject|1|||
25158862|NCT01457703|50276676|FG001|Overall Study|Withdrawal by Subject|4|||
25158863|NCT01419015|50276694|FG000|Overall Study|Death|2|||
25158864|NCT01418937|50276715|FG000|Overall Study|Lost to Follow-up|5|||
25158865|NCT01418937|50276715|FG000|Overall Study|Protocol Violation|1|||
25158866|NCT01418937|50276715|FG000|Overall Study|Pregnancy|1|||
24941161|NCT00553475|50034277|FG001|Overall Study|Withdrawal by Subject|1|||
24941162|NCT00553475|50034278|FG002|Overall Study|Withdrawal by Subject|0|||
24941163|NCT00553475|50034276|FG000|Overall Study|Physician Decision|1|||
24941164|NCT00553475|50034277|FG001|Overall Study|Physician Decision|0|||
25029857|NCT03275389|50128392|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
25029858|NCT03275389|50128393|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
25029859|NCT03275389|50128394|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
25029860|NCT03275389|50128395|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
25029861|NCT03275389|50128396|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
25029862|NCT03275389|50128397|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
25029863|NCT03275389|50128398|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
25029864|NCT03275389|50128399|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
25029865|NCT03275389|50128400|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
25029866|NCT03275389|50128391|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
25029867|NCT03275389|50128392|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
25029868|NCT03275389|50128393|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
24941165|NCT00553475|50034278|FG002|Overall Study|Physician Decision|0|||
25029869|NCT03275389|50128394|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
25029870|NCT03275389|50128395|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
25029871|NCT03275389|50128396|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
25029872|NCT03275389|50128397|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
24941166|NCT00553475|50034276|FG000|Overall Study|Due to moving|0|||
24941167|NCT00553475|50034277|FG001|Overall Study|Due to moving|1|||
24941168|NCT00553475|50034278|FG002|Overall Study|Due to moving|0|||
25158867|NCT01418937|50276715|FG000|Overall Study|Withdrawal by Subject|1|||
24941169|NCT00329602|50034290|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
24941170|NCT00329602|50034291|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
24941171|NCT00329602|50034292|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
24941172|NCT00329602|50034290|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
24941173|NCT00329602|50034291|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
24941174|NCT00329602|50034292|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
24941175|NCT00329602|50034290|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
24941176|NCT00329602|50034291|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
24941177|NCT00329602|50034292|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
24941178|NCT00329602|50034290|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
24941179|NCT00329602|50034291|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
24941180|NCT00329602|50034292|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
24941181|NCT00329602|50034290|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
24941182|NCT00329602|50034291|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
24941183|NCT00329602|50034292|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
24941184|NCT00329602|50034290|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
24941185|NCT00329602|50034291|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
24941186|NCT00329602|50034292|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
24941187|NCT00463866|50034310|FG000|Overall Study|Adverse Event|70|||
24941188|NCT00463866|50034311|FG001|Overall Study|Adverse Event|93|||
24941189|NCT00463866|50034310|FG000|Overall Study|Withdrawal by Subject|81|||
25158868|NCT01417377|50276728|FG000|Overall Study|Lost to Follow-up|12|||
25158869|NCT01417377|50276728|FG000|Overall Study|Enrolled, but not treated|1|||
25158870|NCT01437267|50276775|FG000|Overall Study|Withdrawal by Subject|0|||
25158871|NCT01437267|50276776|FG001|Overall Study|Withdrawal by Subject|0|||
24941190|NCT00463866|50034311|FG001|Overall Study|Withdrawal by Subject|79|||
24941191|NCT00463866|50034310|FG000|Overall Study|Lost to Follow-up|46|||
24941192|NCT00463866|50034311|FG001|Overall Study|Lost to Follow-up|55|||
24941193|NCT00463866|50034310|FG000|Overall Study|Incorrect Enrolment|64|||
24941194|NCT00463866|50034311|FG001|Overall Study|Incorrect Enrolment|66|||
24941195|NCT00463866|50034310|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
24941196|NCT00463866|50034311|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
24941197|NCT00463866|50034310|FG000|Overall Study|Safety Reason|1|||
24941198|NCT00463866|50034311|FG001|Overall Study|Safety Reason|3|||
24941199|NCT00463866|50034310|FG000|Overall Study|Mis-Randomization of subject|0|||
25158872|NCT01437267|50276777|FG002|Overall Study|Withdrawal by Subject|0|||
25158873|NCT01437267|50276778|FG003|Overall Study|Withdrawal by Subject|1|||
25275510|NCT01072929|50589397|FG000|Overall Study|Lack of Efficacy|7|||
24941200|NCT00463866|50034311|FG001|Overall Study|Mis-Randomization of subject|1|||
24941201|NCT00463866|50034310|FG000|Overall Study|Other|22|||
25029873|NCT03275389|50128398|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
25029874|NCT03275389|50128399|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
25158874|NCT01437267|50276779|FG004|Overall Study|Withdrawal by Subject|0|||
24941202|NCT00463866|50034311|FG001|Overall Study|Other|22|||
24941203|NCT00313846|50034319|FG000|Overall Study|Withdrawal by Subject|2|||
24941204|NCT00313846|50034320|FG001|Overall Study|Withdrawal by Subject|0|||
24941205|NCT00313846|50034319|FG000|Overall Study|Adverse Event|1|||
24941206|NCT00313846|50034320|FG001|Overall Study|Adverse Event|8|||
24941207|NCT00313846|50034319|FG000|Overall Study|Administrative|2|||
24941208|NCT00313846|50034320|FG001|Overall Study|Administrative|3|||
24941209|NCT00551135|50034331|FG000|Overall Study|Adverse Event|1|||
24941210|NCT00551135|50034332|FG001|Overall Study|Adverse Event|0|||
24941211|NCT00551135|50034333|FG002|Overall Study|Adverse Event|1|||
24941212|NCT00551135|50034334|FG003|Overall Study|Adverse Event|1|||
24941213|NCT00551135|50034331|FG000|Overall Study|Lost to Follow-up|0|||
24941214|NCT00551135|50034332|FG001|Overall Study|Lost to Follow-up|0|||
24941215|NCT00551135|50034333|FG002|Overall Study|Lost to Follow-up|0|||
24941216|NCT00551135|50034334|FG003|Overall Study|Lost to Follow-up|1|||
24941217|NCT00551135|50034331|FG000|Overall Study|Other|3|||
24941218|NCT00551135|50034332|FG001|Overall Study|Other|2|||
24941219|NCT00551135|50034333|FG002|Overall Study|Other|1|||
24941220|NCT00551135|50034334|FG003|Overall Study|Other|2|||
24941221|NCT00551135|50034331|FG000|Overall Study|Withdrawal by Subject|1|||
24941222|NCT00551135|50034332|FG001|Overall Study|Withdrawal by Subject|0|||
24941223|NCT00551135|50034333|FG002|Overall Study|Withdrawal by Subject|3|||
24941224|NCT00551135|50034334|FG003|Overall Study|Withdrawal by Subject|1|||
24941225|NCT00299104|50034347|FG000|Treatment Period|Adverse Event|14|||
24941226|NCT00299104|50034348|FG001|Treatment Period|Adverse Event|9|||
24941227|NCT00299104|50034349|FG002|Treatment Period|Adverse Event|7|||
24941228|NCT00299104|50034347|FG000|Treatment Period|Death|1|||
24941229|NCT00299104|50034348|FG001|Treatment Period|Death|1|||
24941230|NCT00299104|50034349|FG002|Treatment Period|Death|1|||
24941231|NCT00299104|50034347|FG000|Treatment Period|Insufficient therapeutic response|34|||
24941232|NCT00299104|50034348|FG001|Treatment Period|Insufficient therapeutic response|13|||
24941233|NCT00299104|50034349|FG002|Treatment Period|Insufficient therapeutic response|8|||
24941234|NCT00299104|50034347|FG000|Treatment Period|Failure to return|9|||
24941235|NCT00299104|50034348|FG001|Treatment Period|Failure to return|8|||
24941236|NCT00299104|50034349|FG002|Treatment Period|Failure to return|8|||
24941237|NCT00299104|50034347|FG000|Treatment Period|Violation of selection criteria|1|||
24941238|NCT00299104|50034348|FG001|Treatment Period|Violation of selection criteria|2|||
24941239|NCT00299104|50034349|FG002|Treatment Period|Violation of selection criteria|0|||
24941240|NCT00299104|50034347|FG000|Treatment Period|Protocol Violation|1|||
24941241|NCT00299104|50034348|FG001|Treatment Period|Protocol Violation|1|||
24941242|NCT00299104|50034349|FG002|Treatment Period|Protocol Violation|0|||
24941243|NCT00299104|50034347|FG000|Treatment Period|Refused treatment|9|||
24941244|NCT00299104|50034348|FG001|Treatment Period|Refused treatment|2|||
24941245|NCT00299104|50034349|FG002|Treatment Period|Refused treatment|2|||
24941246|NCT00299104|50034347|FG000|Treatment Period|Withdrew consent|14|||
24941247|NCT00299104|50034348|FG001|Treatment Period|Withdrew consent|19|||
24941248|NCT00299104|50034349|FG002|Treatment Period|Withdrew consent|9|||
24941249|NCT00299104|50034347|FG000|Treatment Period|Administrative reasons|106|||
24941250|NCT00299104|50034348|FG001|Treatment Period|Administrative reasons|120|||
24941251|NCT00299104|50034349|FG002|Treatment Period|Administrative reasons|137|||
25158875|NCT01437267|50276780|FG005|Overall Study|Withdrawal by Subject|0|||
24941252|NCT00299104|50034347|FG000|Safety Follow-Up (SFU) Period|Death|3|||
24941253|NCT00299104|50034348|FG001|Safety Follow-Up (SFU) Period|Death|2|||
24941254|NCT00299104|50034349|FG002|Safety Follow-Up (SFU) Period|Death|1|||
24941255|NCT00299104|50034347|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
24941256|NCT00299104|50034348|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
24941257|NCT00299104|50034349|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
24941258|NCT00299104|50034347|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
24941259|NCT00299104|50034348|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
24941260|NCT00299104|50034349|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
24941261|NCT00299104|50034347|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
24941262|NCT00299104|50034348|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
24941263|NCT00299104|50034349|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
24941264|NCT00299104|50034347|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
24941265|NCT00299104|50034348|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
24941266|NCT00299104|50034349|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
24941267|NCT00299104|50034347|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
24941268|NCT00299104|50034348|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
24941269|NCT00299104|50034349|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
24941270|NCT00299104|50034347|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
24941271|NCT00299104|50034348|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
24941272|NCT00299104|50034349|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
24941273|NCT00299104|50034347|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
24941274|NCT00299104|50034348|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
24941275|NCT00299104|50034349|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
24941276|NCT00313612|50034359|FG000|Overall Study|Patient never received treatment|0|||
24941277|NCT00313612|50034360|FG001|Overall Study|Patient never received treatment|1|||
24941278|NCT00507416|50034369|FG000|Overall Study|Adverse Event|58|||
24941279|NCT00507416|50034370|FG001|Overall Study|Adverse Event|67|||
24941280|NCT00507416|50034371|FG002|Overall Study|Adverse Event|65|||
24941281|NCT00507416|50034369|FG000|Overall Study|Protocol Violation|1|||
24941282|NCT00507416|50034370|FG001|Overall Study|Protocol Violation|2|||
24941283|NCT00507416|50034371|FG002|Overall Study|Protocol Violation|0|||
24941284|NCT00507416|50034369|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
24941285|NCT00507416|50034370|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
24941286|NCT00507416|50034371|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
24941287|NCT00507416|50034369|FG000|Overall Study|Progressive Disease|20|||
24941288|NCT00507416|50034370|FG001|Overall Study|Progressive Disease|10|||
24941289|NCT00507416|50034371|FG002|Overall Study|Progressive Disease|13|||
24941290|NCT00507416|50034369|FG000|Overall Study|Patient declined further treatment|18|||
24941291|NCT00507416|50034370|FG001|Overall Study|Patient declined further treatment|14|||
24941292|NCT00507416|50034371|FG002|Overall Study|Patient declined further treatment|11|||
24941293|NCT00507416|50034369|FG000|Overall Study|Other|11|||
24941294|NCT00507416|50034370|FG001|Overall Study|Other|16|||
24941295|NCT00507416|50034371|FG002|Overall Study|Other|13|||
24941296|NCT00507416|50034369|FG000|Overall Study|Did not Receive Study Treatment|3|||
24941297|NCT00507416|50034370|FG001|Overall Study|Did not Receive Study Treatment|9|||
24941298|NCT00507416|50034371|FG002|Overall Study|Did not Receive Study Treatment|4|||
24941299|NCT00489476|50034383|FG000|Overall Study|Lost to Follow-up|0|||
24941300|NCT00489476|50034384|FG001|Overall Study|Lost to Follow-up|1|||
24941301|NCT00489476|50034385|FG002|Overall Study|Lost to Follow-up|0|||
24941302|NCT00489476|50034386|FG003|Overall Study|Lost to Follow-up|0|||
24941303|NCT00550745|50034398|FG000|Overall Study|Death|20|||
24941304|NCT00550745|50034399|FG001|Overall Study|Death|16|||
24941305|NCT00550745|50034398|FG000|Overall Study|Lost to Follow-up|45|||
24941306|NCT00550745|50034399|FG001|Overall Study|Lost to Follow-up|30|||
24941307|NCT00550745|50034398|FG000|Overall Study|Physician Decision|0|||
24941308|NCT00550745|50034399|FG001|Overall Study|Physician Decision|2|||
24941309|NCT00550745|50034398|FG000|Overall Study|Protocol Violation|4|||
24941310|NCT00550745|50034399|FG001|Overall Study|Protocol Violation|2|||
24941311|NCT00550745|50034398|FG000|Overall Study|Withdrawal by Subject|17|||
24941312|NCT00550745|50034399|FG001|Overall Study|Withdrawal by Subject|10|||
24941313|NCT00550745|50034398|FG000|Overall Study|Screen failure|1|||
24941314|NCT00550745|50034399|FG001|Overall Study|Screen failure|0|||
24941315|NCT00452790|50034407|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
24941316|NCT00452790|50034408|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
24941317|NCT00452790|50034407|FG000|Infant Series|Parent/legal guardian request|8|||
24941318|NCT00452790|50034408|FG001|Infant Series|Parent/legal guardian request|6|||
24941319|NCT00452790|50034407|FG000|Infant Series|Failed to return|4|||
24941320|NCT00452790|50034408|FG001|Infant Series|Failed to return|1|||
24941321|NCT00452790|50034407|FG000|Infant Series|Protocol Violation|1|||
24941322|NCT00452790|50034408|FG001|Infant Series|Protocol Violation|3|||
24941323|NCT00452790|50034407|FG000|Infant Series|Lost to Follow-up|2|||
24941324|NCT00452790|50034408|FG001|Infant Series|Lost to Follow-up|2|||
24941325|NCT00452790|50034407|FG000|Infant Series|Adverse Event|1|||
24941326|NCT00452790|50034408|FG001|Infant Series|Adverse Event|2|||
24941327|NCT00452790|50034407|FG000|Infant Series|Other reasons|1|||
24941328|NCT00452790|50034408|FG001|Infant Series|Other reasons|2|||
24941329|NCT00452790|50034407|FG000|Infant Series|Investigator request|0|||
24941330|NCT00452790|50034408|FG001|Infant Series|Investigator request|1|||
24941331|NCT00452790|50034407|FG000|Infant Series|Death|0|||
24941332|NCT00452790|50034408|FG001|Infant Series|Death|1|||
24941333|NCT00452790|50034407|FG000|After Infant Series|Investigator request|10|||
24941334|NCT00452790|50034408|FG001|After Infant Series|Investigator request|10|||
24941335|NCT00452790|50034407|FG000|After Infant Series|Adverse Event|4|||
24941336|NCT00452790|50034408|FG001|After Infant Series|Adverse Event|1|||
24941337|NCT00452790|50034407|FG000|After Infant Series|Parent/legal guardian request|1|||
24941338|NCT00452790|50034408|FG001|After Infant Series|Parent/legal guardian request|3|||
24941339|NCT00452790|50034407|FG000|After Infant Series|Lost to Follow-up|4|||
24941340|NCT00452790|50034408|FG001|After Infant Series|Lost to Follow-up|0|||
24941341|NCT00452790|50034407|FG000|After Infant Series|Failed to return|1|||
24941342|NCT00452790|50034408|FG001|After Infant Series|Failed to return|0|||
24941343|NCT00452790|50034407|FG000|After Infant Series|Other reasons|1|||
24941344|NCT00452790|50034408|FG001|After Infant Series|Other reasons|0|||
24941345|NCT00452790|50034407|FG000|Toddler Dose|Failed to return|0|||
24941346|NCT00452790|50034408|FG001|Toddler Dose|Failed to return|1|||
24941347|NCT00452790|50034407|FG000|Toddler Dose|Parent/legal guardian request|0|||
24941348|NCT00452790|50034408|FG001|Toddler Dose|Parent/legal guardian request|1|||
24941349|NCT00463788|50034420|FG000|Overall Study|Progressive Disease|86|||
24941350|NCT00463788|50034421|FG001|Overall Study|Progressive Disease|42|||
24941351|NCT00463788|50034420|FG000|Overall Study|Adverse Event|6|||
24941352|NCT00463788|50034421|FG001|Overall Study|Adverse Event|2|||
24941353|NCT00463788|50034420|FG000|Overall Study|Withdrawal by Subject|6|||
24941354|NCT00463788|50034421|FG001|Overall Study|Withdrawal by Subject|2|||
24941355|NCT00463788|50034420|FG000|Overall Study|Death|4|||
24941356|NCT00463788|50034421|FG001|Overall Study|Death|3|||
24941357|NCT00463788|50034420|FG000|Overall Study|Symptomatic Deterioration|2|||
24941358|NCT00463788|50034421|FG001|Overall Study|Symptomatic Deterioration|3|||
24941359|NCT00463788|50034420|FG000|Overall Study|Lost to Follow-up|1|||
24941360|NCT00463788|50034421|FG001|Overall Study|Lost to Follow-up|0|||
24941361|NCT00463788|50034420|FG000|Overall Study|Protocol Violation|0|||
24941362|NCT00463788|50034421|FG001|Overall Study|Protocol Violation|1|||
24941363|NCT00463788|50034420|FG000|Overall Study|Other|3|||
24941364|NCT00463788|50034421|FG001|Overall Study|Other|0|||
24941365|NCT00463788|50034420|FG000|Overall Study|Randomized but not treated|1|||
24941366|NCT00463788|50034421|FG001|Overall Study|Randomized but not treated|1|||
25029875|NCT03275389|50128400|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
25029876|NCT03275389|50128391|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
25029877|NCT03275389|50128392|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
25029878|NCT03275389|50128393|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
25029879|NCT03275389|50128394|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
25029880|NCT03275389|50128395|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
24941367|NCT00548249|50034433|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
24941368|NCT00548249|50034434|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
25029881|NCT03275389|50128396|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
25029882|NCT03275389|50128397|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
25029883|NCT03275389|50128398|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
25029884|NCT03275389|50128399|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
25029885|NCT03275389|50128400|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
25029886|NCT03275389|50128391|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
25029887|NCT03275389|50128392|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
25029888|NCT03275389|50128393|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
25029889|NCT03275389|50128394|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
25029890|NCT03275389|50128395|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
25029891|NCT03275389|50128396|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
25029892|NCT03275389|50128397|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
25029893|NCT03275389|50128398|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
25029894|NCT03275389|50128399|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
25029895|NCT03275389|50128400|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
25029896|NCT03275389|50128391|FG000|Overall Study|Other|0|||
25029897|NCT03275389|50128392|FG001|Overall Study|Other|4|||
25029898|NCT03275389|50128393|FG002|Overall Study|Other|3|||
25029899|NCT03275389|50128394|FG003|Overall Study|Other|2|||
25029900|NCT03275389|50128395|FG004|Overall Study|Other|2|||
25029901|NCT03275389|50128396|FG005|Overall Study|Other|2|||
25029902|NCT03275389|50128397|FG006|Overall Study|Other|0|||
25029903|NCT03275389|50128398|FG007|Overall Study|Other|0|||
25029904|NCT03275389|50128399|FG008|Overall Study|Other|1|||
24941369|NCT00548249|50034435|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
24941370|NCT00548249|50034436|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
24941371|NCT00548249|50034437|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
24941372|NCT00548249|50034433|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
24941373|NCT00548249|50034434|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
24941374|NCT00548249|50034435|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
25029905|NCT03275389|50128400|FG009|Overall Study|Other|0|||
25029906|NCT03414983|50128424|FG000|Pre-Treatment|Other reasons|1|||
25029907|NCT03414983|50128425|FG001|Pre-Treatment|Other reasons|0|||
25029908|NCT03414983|50128424|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
25158876|NCT01437267|50276775|FG000|Overall Study|Protocol Violation|0|||
24941375|NCT00548249|50034436|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
24941376|NCT00548249|50034437|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
24941377|NCT00548249|50034433|FG000|Overall Study|Protocol Violation|1|||
24941378|NCT00548249|50034434|FG001|Overall Study|Protocol Violation|1|||
24941379|NCT00548249|50034435|FG002|Overall Study|Protocol Violation|4|||
24941380|NCT00548249|50034436|FG003|Overall Study|Protocol Violation|0|||
24941381|NCT00548249|50034437|FG004|Overall Study|Protocol Violation|3|||
24941382|NCT00548249|50034433|FG000|Overall Study|Miscellaneous|2|||
24941383|NCT00548249|50034434|FG001|Overall Study|Miscellaneous|3|||
25158877|NCT01437267|50276776|FG001|Overall Study|Protocol Violation|1|||
25158878|NCT01437267|50276777|FG002|Overall Study|Protocol Violation|0|||
25158879|NCT01437267|50276778|FG003|Overall Study|Protocol Violation|0|||
25158880|NCT01437267|50276779|FG004|Overall Study|Protocol Violation|0|||
25158881|NCT01437267|50276780|FG005|Overall Study|Protocol Violation|0|||
25158882|NCT01456221|50276809|FG000|Overall Study|Withdrawal by Subject|56|||
25158883|NCT01456221|50276810|FG001|Overall Study|Withdrawal by Subject|49|||
25158884|NCT01456221|50276809|FG000|Overall Study|Lost to Follow-up|1|||
25158885|NCT01456221|50276810|FG001|Overall Study|Lost to Follow-up|4|||
25158886|NCT01456221|50276809|FG000|Overall Study|Received medication|3|||
25158887|NCT01456221|50276810|FG001|Overall Study|Received medication|2|||
25158888|NCT01456221|50276809|FG000|Overall Study|Incomplete data|4|||
25158889|NCT01456221|50276810|FG001|Overall Study|Incomplete data|2|||
25158890|NCT01437111|50276816|FG000|Overall Study|Adverse Event|2|||
25158891|NCT01437111|50276816|FG000|Overall Study|Withdrawal by Subject|4|||
25158892|NCT01437111|50276816|FG000|Overall Study|Not reported|5|||
25158893|NCT01437111|50276816|FG000|Overall Study|Physician Decision|1|||
25158894|NCT01437111|50276816|FG000|Overall Study|Lost to Follow-up|5|||
25158895|NCT01437111|50276816|FG000|Overall Study|Protocol Violation|1|||
25158896|NCT01436643|50276864|FG000|2-week Pre-treatment|Abnormal test result|0|||
25158897|NCT01436643|50276865|FG001|2-week Pre-treatment|Abnormal test result|0|||
25158898|NCT01436643|50276866|FG002|2-week Pre-treatment|Abnormal test result|0|||
25158899|NCT01436643|50276867|FG003|2-week Pre-treatment|Abnormal test result|1|||
25158900|NCT01436643|50276864|FG000|2-week Pre-treatment|Adverse Event|0|||
25158901|NCT01436643|50276865|FG001|2-week Pre-treatment|Adverse Event|0|||
25158902|NCT01436643|50276866|FG002|2-week Pre-treatment|Adverse Event|0|||
24941384|NCT00548249|50034435|FG002|Overall Study|Miscellaneous|2|||
24941385|NCT00548249|50034436|FG003|Overall Study|Miscellaneous|0|||
25158903|NCT01436643|50276867|FG003|2-week Pre-treatment|Adverse Event|5|||
25158904|NCT01436643|50276864|FG000|2-week Pre-treatment|Protocol Violation|0|||
24941386|NCT00548249|50034437|FG004|Overall Study|Miscellaneous|2|||
24941387|NCT00548249|50034433|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
24941388|NCT00548249|50034434|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
24941389|NCT00548249|50034435|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
24941390|NCT00548249|50034436|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
24941391|NCT00548249|50034437|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
24941392|NCT00548249|50034433|FG000|Overall Study|Adverse Event|2|||
24941393|NCT00548249|50034434|FG001|Overall Study|Adverse Event|2|||
24941394|NCT00548249|50034435|FG002|Overall Study|Adverse Event|0|||
24941395|NCT00548249|50034436|FG003|Overall Study|Adverse Event|1|||
24941396|NCT00548249|50034437|FG004|Overall Study|Adverse Event|1|||
24941397|NCT00548249|50034433|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
25275511|NCT01072929|50589398|FG001|Overall Study|Lack of Efficacy|4|||
25275512|NCT01072929|50589399|FG002|Overall Study|Lack of Efficacy|0|||
25275513|NCT01072929|50589397|FG000|Overall Study|Withdrawal by Subject|7|||
25275514|NCT01072929|50589398|FG001|Overall Study|Withdrawal by Subject|15|||
25275515|NCT01072929|50589399|FG002|Overall Study|Withdrawal by Subject|3|||
25275516|NCT01072929|50589397|FG000|Overall Study|Protocol Violation|13|||
25275517|NCT01072929|50589398|FG001|Overall Study|Protocol Violation|11|||
25275518|NCT01072929|50589399|FG002|Overall Study|Protocol Violation|2|||
25275519|NCT01072929|50589397|FG000|Overall Study|Lost to Follow-up|8|||
25275520|NCT01072929|50589398|FG001|Overall Study|Lost to Follow-up|4|||
25275521|NCT01072929|50589399|FG002|Overall Study|Lost to Follow-up|1|||
25275522|NCT01072929|50589397|FG000|Overall Study|Noncompliance with study medication|0|||
25275523|NCT01072929|50589398|FG001|Overall Study|Noncompliance with study medication|3|||
25275524|NCT01072929|50589399|FG002|Overall Study|Noncompliance with study medication|0|||
25275525|NCT01072929|50589397|FG000|Overall Study|Noncompliance with study procedures|1|||
25275526|NCT01072929|50589398|FG001|Overall Study|Noncompliance with study procedures|0|||
25158905|NCT01436643|50276865|FG001|2-week Pre-treatment|Protocol Violation|0|||
25158906|NCT01436643|50276866|FG002|2-week Pre-treatment|Protocol Violation|0|||
25158907|NCT01436643|50276867|FG003|2-week Pre-treatment|Protocol Violation|4|||
25158908|NCT01436643|50276864|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
25275527|NCT01072929|50589399|FG002|Overall Study|Noncompliance with study procedures|1|||
25275528|NCT01072929|50589397|FG000|Overall Study|Other|0|||
25275529|NCT01072929|50589398|FG001|Overall Study|Other|3|||
25275530|NCT01072929|50589399|FG002|Overall Study|Other|0|||
25275531|NCT01231607|50589413|FG000|Overall Study|Adverse Event|0|||
25275532|NCT01231607|50589414|FG001|Overall Study|Adverse Event|8|||
25275533|NCT01231607|50589415|FG002|Overall Study|Adverse Event|4|||
25275534|NCT01231607|50589416|FG003|Overall Study|Adverse Event|4|||
25158909|NCT01436643|50276865|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
25158910|NCT01436643|50276866|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
25158911|NCT01436643|50276867|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
25275535|NCT01231607|50589417|FG004|Overall Study|Adverse Event|5|||
25275536|NCT01231607|50589413|FG000|Overall Study|Lost to Follow-up|13|||
25275537|NCT01231607|50589414|FG001|Overall Study|Lost to Follow-up|11|||
25275538|NCT01231607|50589415|FG002|Overall Study|Lost to Follow-up|10|||
25275539|NCT01231607|50589416|FG003|Overall Study|Lost to Follow-up|10|||
25275540|NCT01231607|50589417|FG004|Overall Study|Lost to Follow-up|4|||
25275541|NCT01231607|50589413|FG000|Overall Study|Physician Decision|4|||
25275542|NCT01231607|50589414|FG001|Overall Study|Physician Decision|4|||
25275543|NCT01231607|50589415|FG002|Overall Study|Physician Decision|3|||
25029909|NCT03414983|50128425|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
25029910|NCT03414983|50128424|FG000|Pre-Treatment|Participant withdrew consent|1|||
25029911|NCT03414983|50128425|FG001|Pre-Treatment|Participant withdrew consent|3|||
25029912|NCT03414983|50128424|FG000|Treatment|Participant withdrew consent|4|||
25029913|NCT03414983|50128425|FG001|Treatment|Participant withdrew consent|3|||
25029914|NCT03414983|50128424|FG000|Treatment|Participant request to discontinue study treatment|8|||
25029915|NCT03414983|50128425|FG001|Treatment|Participant request to discontinue study treatment|10|||
25029916|NCT03414983|50128424|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
25158912|NCT01436643|50276864|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
25158913|NCT01436643|50276865|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
25158914|NCT01436643|50276866|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
25158915|NCT01436643|50276867|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
25158916|NCT01436643|50276864|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
25158917|NCT01436643|50276865|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
25158918|NCT01436643|50276866|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
25158919|NCT01436643|50276867|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
25158920|NCT01454739|50276965|FG000|Overall Study|Protocol Violation|2|||
25158921|NCT01454739|50276966|FG001|Overall Study|Protocol Violation|3|||
25158922|NCT01454739|50276965|FG000|Overall Study|Withdrawal by Subject|2|||
25158923|NCT01454739|50276966|FG001|Overall Study|Withdrawal by Subject|6|||
25158924|NCT01454739|50276965|FG000|Overall Study|Other|3|||
25029917|NCT03414983|50128425|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
25275544|NCT01231607|50589416|FG003|Overall Study|Physician Decision|5|||
25275545|NCT01231607|50589417|FG004|Overall Study|Physician Decision|4|||
24941398|NCT00548249|50034434|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
24941399|NCT00548249|50034435|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
24941400|NCT00548249|50034436|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
25029918|NCT03414983|50128424|FG000|Treatment|Death|0|||
25029919|NCT03414983|50128425|FG001|Treatment|Death|2|||
25029920|NCT03414983|50128424|FG000|Treatment|Study Drug Toxicity|11|||
25029921|NCT03414983|50128425|FG001|Treatment|Study Drug Toxicity|4|||
25158925|NCT01454739|50276966|FG001|Overall Study|Other|5|||
25158926|NCT01454739|50276965|FG000|Overall Study|Physician Decision|0|||
25158927|NCT01454739|50276966|FG001|Overall Study|Physician Decision|5|||
25029922|NCT03414983|50128424|FG000|Treatment|Disease Progression|72|||
25029923|NCT03414983|50128425|FG001|Treatment|Disease Progression|27|||
25029924|NCT03414983|50128424|FG000|Treatment|Not reported|1|||
25029925|NCT03414983|50128425|FG001|Treatment|Not reported|0|||
25029926|NCT03414983|50128424|FG000|Treatment|Other reasons|3|||
25029927|NCT03414983|50128425|FG001|Treatment|Other reasons|2|||
25029928|NCT03414983|50128424|FG000|Treatment|Completed treatment as per protocol|8|||
25158928|NCT01454739|50276965|FG000|Overall Study|Lost to Follow-up|0|||
25158929|NCT01454739|50276966|FG001|Overall Study|Lost to Follow-up|1|||
25158930|NCT01454739|50276965|FG000|Overall Study|Adverse Event|0|||
25158931|NCT01454739|50276966|FG001|Overall Study|Adverse Event|1|||
25158932|NCT01416441|50277004|FG000|Overall Study|Lost to Follow-up|5|||
25158933|NCT01416441|50277004|FG000|Overall Study|Adverse Event|6|||
24941401|NCT00548249|50034437|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
24941402|NCT00548249|50034433|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
24941403|NCT00548249|50034434|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
24941404|NCT00548249|50034435|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
24941405|NCT00548249|50034436|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
24941406|NCT00548249|50034437|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
24941407|NCT00548249|50034433|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
24941408|NCT00548249|50034434|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
24941409|NCT00548249|50034435|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
24941410|NCT00548249|50034436|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
24941411|NCT00548249|50034437|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
24941412|NCT00548249|50034433|FG000|Overall Study|Prolonged hospitalization|0|||
24941413|NCT00548249|50034434|FG001|Overall Study|Prolonged hospitalization|0|||
24941414|NCT00548249|50034435|FG002|Overall Study|Prolonged hospitalization|2|||
24941415|NCT00548249|50034436|FG003|Overall Study|Prolonged hospitalization|1|||
24941416|NCT00548249|50034437|FG004|Overall Study|Prolonged hospitalization|0|||
24941417|NCT00548249|50034433|FG000|Overall Study|Withdrawal by Subject|2|||
24941418|NCT00548249|50034434|FG001|Overall Study|Withdrawal by Subject|0|||
24941419|NCT00548249|50034435|FG002|Overall Study|Withdrawal by Subject|0|||
24941420|NCT00548249|50034436|FG003|Overall Study|Withdrawal by Subject|0|||
24941421|NCT00548249|50034437|FG004|Overall Study|Withdrawal by Subject|0|||
24941422|NCT00548249|50034433|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
24941423|NCT00548249|50034434|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
24941424|NCT00548249|50034435|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
24941425|NCT00548249|50034436|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
24941426|NCT00548249|50034437|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
24941427|NCT00548249|50034433|FG000|Overall Study|Sponsor's request|0|||
24941428|NCT00548249|50034434|FG001|Overall Study|Sponsor's request|0|||
24941429|NCT00548249|50034435|FG002|Overall Study|Sponsor's request|0|||
24941430|NCT00548249|50034436|FG003|Overall Study|Sponsor's request|1|||
24941431|NCT00548249|50034437|FG004|Overall Study|Sponsor's request|0|||
24941432|NCT00463476|50034451|FG000|Overall Study|Withdrawal by Subject|1|||
24941433|NCT00463476|50034452|FG001|Overall Study|Withdrawal by Subject|2|||
24941434|NCT00463476|50034451|FG000|Overall Study|Lost to Follow-up|1|||
24941435|NCT00463476|50034452|FG001|Overall Study|Lost to Follow-up|1|||
24941436|NCT03839940|50034460|FG000|Overall Study|Withdrawal by Subject|3|||
24941437|NCT03839940|50034461|FG001|Overall Study|Withdrawal by Subject|0|||
24941438|NCT03839940|50034460|FG000|Overall Study|Protocol Violation|0|||
24941439|NCT03839940|50034461|FG001|Overall Study|Protocol Violation|1|||
24941440|NCT03839940|50034460|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
24941441|NCT03839940|50034461|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
24941442|NCT03839628|50034469|FG000|Overall Study|Withdrawal by Subject|1|||
24941443|NCT00462462|50034475|FG000|Overall Study|Physician Decision|0|||
24941444|NCT00462462|50034476|FG001|Overall Study|Physician Decision|1|||
24941445|NCT00462384|50034484|FG000|Overall Study|Adverse Event|2|||
24941446|NCT00462384|50034484|FG000|Overall Study|Death|2|||
24941447|NCT00462384|50034484|FG000|Overall Study|Withdrawal by Subject|1|||
24941448|NCT00462384|50034484|FG000|Overall Study|Other|4|||
24941449|NCT00452400|50034493|FG000|Overall Study|Adverse Event|1|||
24941450|NCT00452400|50034494|FG001|Overall Study|Adverse Event|1|||
24941451|NCT00452400|50034495|FG002|Overall Study|Adverse Event|5|||
24941452|NCT00452400|50034496|FG003|Overall Study|Adverse Event|0|||
24941453|NCT00452400|50034497|FG004|Overall Study|Adverse Event|2|||
24941454|NCT00452400|50034493|FG000|Overall Study|Protocol Violation|0|||
24941455|NCT00452400|50034494|FG001|Overall Study|Protocol Violation|0|||
24941456|NCT00452400|50034495|FG002|Overall Study|Protocol Violation|1|||
24941457|NCT00452400|50034496|FG003|Overall Study|Protocol Violation|0|||
24941458|NCT00452400|50034497|FG004|Overall Study|Protocol Violation|0|||
24941459|NCT00452400|50034493|FG000|Overall Study|Lost to Follow-up|1|||
24941460|NCT00452400|50034494|FG001|Overall Study|Lost to Follow-up|0|||
24941461|NCT00452400|50034495|FG002|Overall Study|Lost to Follow-up|0|||
24941462|NCT00452400|50034496|FG003|Overall Study|Lost to Follow-up|0|||
24941463|NCT00452400|50034497|FG004|Overall Study|Lost to Follow-up|0|||
24941464|NCT00452400|50034493|FG000|Overall Study|Withdrawal by Subject|1|||
24941465|NCT00452400|50034494|FG001|Overall Study|Withdrawal by Subject|0|||
24941466|NCT00452400|50034495|FG002|Overall Study|Withdrawal by Subject|1|||
24941467|NCT00452400|50034496|FG003|Overall Study|Withdrawal by Subject|0|||
24941468|NCT00452400|50034497|FG004|Overall Study|Withdrawal by Subject|0|||
24941469|NCT00452400|50034493|FG000|Overall Study|Lack of Efficacy|2|||
24941470|NCT00452400|50034494|FG001|Overall Study|Lack of Efficacy|0|||
24941471|NCT00452400|50034495|FG002|Overall Study|Lack of Efficacy|0|||
24941472|NCT00452400|50034496|FG003|Overall Study|Lack of Efficacy|0|||
24941473|NCT00452400|50034497|FG004|Overall Study|Lack of Efficacy|0|||
24941474|NCT00452400|50034493|FG000|Overall Study|Other reasons not listed above|0|||
24941475|NCT00452400|50034494|FG001|Overall Study|Other reasons not listed above|0|||
24941476|NCT00452400|50034495|FG002|Overall Study|Other reasons not listed above|0|||
24941477|NCT00452400|50034496|FG003|Overall Study|Other reasons not listed above|1|||
24941478|NCT00452400|50034497|FG004|Overall Study|Other reasons not listed above|1|||
24941479|NCT00462306|50034511|FG000|Overall Study|insufficient data|0|||
24941480|NCT00462306|50034512|FG001|Overall Study|insufficient data|13|||
24941481|NCT00461682|50034520|FG000|Overall Study|Protocol Violation|1|||
24941482|NCT00443430|50034528|FG000|Overall Study|Lack of Efficacy|3|||
24941483|NCT00443430|50034529|FG001|Overall Study|Lack of Efficacy|3|||
24941484|NCT00443430|50034528|FG000|Overall Study|Adverse Event|1|||
25275546|NCT01231607|50589413|FG000|Overall Study|Protocol Violation|3|||
24941485|NCT00443430|50034529|FG001|Overall Study|Adverse Event|1|||
24941486|NCT00460746|50034535|FG000|Overall Study|Adverse Event|1|||
24941487|NCT00460746|50034535|FG000|Overall Study|Lost to Follow-up|1|||
24941488|NCT00443118|50034542|FG000|Overall Study|unknown primary outcome|3|||
24941489|NCT00443118|50034543|FG001|Overall Study|unknown primary outcome|1|||
24941490|NCT00443118|50034544|FG002|Overall Study|unknown primary outcome|0|||
24941491|NCT00443118|50034542|FG000|Overall Study|Withdrawal by Subject|1|||
24941492|NCT00443118|50034543|FG001|Overall Study|Withdrawal by Subject|0|||
24941493|NCT00443118|50034544|FG002|Overall Study|Withdrawal by Subject|0|||
24941494|NCT00460434|50034572|FG000|Overall Study|Lost to Follow-up|3|||
24941495|NCT00460434|50034573|FG001|Overall Study|Lost to Follow-up|7|||
24941496|NCT00373425|50034584|FG000|Overall Study|Relapse of NSCLC|116|||
24941497|NCT00373425|50034585|FG001|Overall Study|Relapse of NSCLC|104|||
24941498|NCT00373425|50034586|FG002|Overall Study|Relapse of NSCLC|19|||
24941499|NCT00373425|50034587|FG003|Overall Study|Relapse of NSCLC|2|||
24941500|NCT00373425|50034588|FG004|Overall Study|Relapse of NSCLC|26|||
24941501|NCT00373425|50034584|FG000|Overall Study|Adverse Event|191|||
24941502|NCT00373425|50034585|FG001|Overall Study|Adverse Event|22|||
24941503|NCT00373425|50034586|FG002|Overall Study|Adverse Event|59|||
24941504|NCT00373425|50034587|FG003|Overall Study|Adverse Event|0|||
24941505|NCT00373425|50034588|FG004|Overall Study|Adverse Event|34|||
24941506|NCT00373425|50034584|FG000|Overall Study|Patient request|35|||
24941507|NCT00373425|50034585|FG001|Overall Study|Patient request|18|||
24941508|NCT00373425|50034586|FG002|Overall Study|Patient request|43|||
24941509|NCT00373425|50034587|FG003|Overall Study|Patient request|6|||
24941510|NCT00373425|50034588|FG004|Overall Study|Patient request|7|||
25158934|NCT01416441|50277004|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
25158935|NCT01416441|50277004|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
25158936|NCT01416441|50277004|FG000|Overall Study|Investigator Withdrew Subject|2|||
25158937|NCT01416441|50277004|FG000|Overall Study|Subject Withdrew Consent|12|||
25158938|NCT01416441|50277004|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
25158939|NCT01436253|50277013|FG000|Overall Study|Lost to Follow-up|182|||
25158940|NCT01436253|50277013|FG000|Overall Study|Not meeting all eligibility criteria|117|||
24941511|NCT00373425|50034584|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
24941512|NCT00373425|50034585|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
24941513|NCT00373425|50034586|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
25158941|NCT01454583|50277926|FG000|1st Year|Lost to Follow-up|1057|||
25158942|NCT01454583|50277927|FG001|1st Year|Lost to Follow-up|318|||
25158943|NCT01454583|50277928|FG002|1st Year|Lost to Follow-up|180|||
25158944|NCT01454583|50277926|FG000|2nd Year|Lost to Follow-up|3965|||
25158945|NCT01454583|50277927|FG001|2nd Year|Lost to Follow-up|1049|||
25158946|NCT01454583|50277928|FG002|2nd Year|Lost to Follow-up|737|||
25158947|NCT01454583|50277926|FG000|3rd Year|Lost to Follow-up|1959|||
25158948|NCT01454583|50277927|FG001|3rd Year|Lost to Follow-up|512|||
24941514|NCT00373425|50034587|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
24941515|NCT00373425|50034588|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
24941516|NCT00373425|50034584|FG000|Overall Study|Death|7|||
24941517|NCT00373425|50034585|FG001|Overall Study|Death|0|||
24941518|NCT00373425|50034586|FG002|Overall Study|Death|3|||
24941519|NCT00373425|50034587|FG003|Overall Study|Death|1|||
24941520|NCT00373425|50034588|FG004|Overall Study|Death|0|||
24941521|NCT00459342|50034597|FG000|Overall Study|Not eligible|1|||
24941522|NCT00443040|50034604|FG000|Overall Study|Withdrawal by Subject|1|||
24941523|NCT00443040|50034605|FG001|Overall Study|Withdrawal by Subject|0|||
24941524|NCT00443040|50034606|FG002|Overall Study|Withdrawal by Subject|0|||
24941525|NCT00443040|50034604|FG000|Overall Study|Converted to an open laparotomy|3|||
25029929|NCT03414983|50128425|FG001|Treatment|Completed treatment as per protocol|0|||
25029930|NCT03414983|50128424|FG000|Treatment|Poor/non-compliance|2|||
25029931|NCT03414983|50128425|FG001|Treatment|Poor/non-compliance|0|||
25029932|NCT03414983|50128424|FG000|Treatment|Maximum clinical benefit|5|||
25158949|NCT01454583|50277928|FG002|3rd Year|Lost to Follow-up|297|||
25158950|NCT01436175|50277951|FG000|Overall Study|Adverse Event|111|||
25158951|NCT01436175|50277951|FG000|Overall Study|Protocol Violation|49|||
24941526|NCT00443040|50034605|FG001|Overall Study|Converted to an open laparotomy|0|||
25158952|NCT01436175|50277951|FG000|Overall Study|Withdrawal by Subject|108|||
25158953|NCT01436175|50277951|FG000|Overall Study|Lost to Follow-up|89|||
25158954|NCT01436175|50277951|FG000|Overall Study|Lack of Efficacy|24|||
25275547|NCT01231607|50589414|FG001|Overall Study|Protocol Violation|2|||
25158955|NCT01436175|50277951|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
24941527|NCT00443040|50034606|FG002|Overall Study|Converted to an open laparotomy|1|||
24941528|NCT00442962|50034614|FG000|Overall Study|Pregnancy|1|||
24941529|NCT00442962|50034614|FG000|Overall Study|Lost to Follow-up|7|||
24941530|NCT00313300|50034623|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
24941531|NCT00313300|50034624|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
24941532|NCT00313300|50034625|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
24941533|NCT00313300|50034626|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
24941534|NCT00313300|50034627|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
24941535|NCT00313300|50034623|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
24941536|NCT00313300|50034624|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
24941537|NCT00313300|50034625|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
24941538|NCT00313300|50034626|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
24941539|NCT00313300|50034627|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
24941540|NCT00313300|50034623|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
24941541|NCT00313300|50034624|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
24941542|NCT00313300|50034625|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
24941543|NCT00313300|50034626|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
24941544|NCT00313300|50034627|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
25158956|NCT01436175|50277951|FG000|Overall Study|Other|826|||
25158957|NCT01453725|50277979|FG000|Overall Study|Adverse Event|3|||
24941545|NCT00313300|50034623|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
24941546|NCT00313300|50034624|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
24941547|NCT00313300|50034625|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
24941548|NCT00313300|50034626|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
24941549|NCT00313300|50034627|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
24941550|NCT00313300|50034623|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
24941551|NCT00313300|50034624|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
24941552|NCT00313300|50034625|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
24941553|NCT00313300|50034626|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
24941554|NCT00313300|50034627|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
24941555|NCT00313300|50034623|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
24941556|NCT00313300|50034624|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
24941557|NCT00313300|50034625|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
24941558|NCT00313300|50034626|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
24941559|NCT00313300|50034627|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
24941560|NCT00313300|50034623|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
24941561|NCT00313300|50034624|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
24941562|NCT00313300|50034625|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
24941563|NCT00313300|50034626|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
24941564|NCT00313300|50034627|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
24941565|NCT00313300|50034623|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
24941566|NCT00313300|50034624|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
24941567|NCT00313300|50034625|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
24941568|NCT00313300|50034626|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
24941569|NCT00313300|50034627|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
24941570|NCT00313300|50034623|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
24941571|NCT00313300|50034624|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
24941572|NCT00313300|50034625|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
24941573|NCT00313300|50034626|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
24941574|NCT00313300|50034627|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
24941575|NCT00313300|50034623|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
24941576|NCT00313300|50034624|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
24941577|NCT00313300|50034625|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
24941578|NCT00313300|50034626|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
24941579|NCT00313300|50034627|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
24941580|NCT00313300|50034623|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
24941581|NCT00313300|50034624|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
24941582|NCT00313300|50034625|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
24941583|NCT00313300|50034626|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
24941584|NCT00313300|50034627|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
24941585|NCT00313300|50034623|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
24941586|NCT00313300|50034624|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
24941587|NCT00313300|50034625|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
24941588|NCT00313300|50034626|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
24941589|NCT00313300|50034627|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
25158958|NCT01453725|50277980|FG001|Overall Study|Adverse Event|3|||
25158959|NCT01453725|50277979|FG000|Overall Study|Lost to Follow-up|4|||
25158960|NCT01453725|50277980|FG001|Overall Study|Lost to Follow-up|0|||
24941590|NCT00313300|50034623|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
24941591|NCT00313300|50034624|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
24941592|NCT00313300|50034625|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
24941593|NCT00313300|50034626|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
24941594|NCT00313300|50034627|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
25029933|NCT03414983|50128425|FG001|Treatment|Maximum clinical benefit|9|||
25029934|NCT03414983|50128424|FG000|Treatment|Lost to Follow-up|0|||
25029935|NCT03414983|50128425|FG001|Treatment|Lost to Follow-up|1|||
25029936|NCT03414359|50128433|FG000|Overall Study|Lack of Efficacy|1|||
25029937|NCT03414359|50128434|FG001|Overall Study|Lack of Efficacy|1|||
25029938|NCT03414359|50128433|FG000|Overall Study|Protocol Violation|0|||
25029939|NCT03414359|50128434|FG001|Overall Study|Protocol Violation|1|||
25029940|NCT03285295|50128445|FG000|Alinity s HBsAg|Protocol Violation|11|||
25029941|NCT03285295|50128446|FG001|Alinity s HBsAg|Protocol Violation|0|||
25275548|NCT01231607|50589415|FG002|Overall Study|Protocol Violation|0|||
24941595|NCT00313300|50034623|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
24941596|NCT00313300|50034624|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
24941597|NCT00313300|50034625|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
24941598|NCT00313300|50034626|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
24941599|NCT00313300|50034627|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
24941600|NCT00313300|50034623|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
24941601|NCT00313300|50034624|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
24941602|NCT00313300|50034625|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
24941603|NCT00313300|50034626|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
24941604|NCT00313300|50034627|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
24941605|NCT00313300|50034623|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
24941606|NCT00313300|50034624|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
24941607|NCT00313300|50034625|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
24941608|NCT00313300|50034626|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
24941609|NCT00313300|50034627|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
24941610|NCT00313300|50034623|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
24941611|NCT00313300|50034624|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
24941612|NCT00313300|50034625|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
24941613|NCT00313300|50034626|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
24941614|NCT00313300|50034627|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
24941615|NCT00313300|50034623|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
24941616|NCT00313300|50034624|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
24941617|NCT00313300|50034625|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
24941618|NCT00313300|50034626|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
24941619|NCT00313300|50034627|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
24941620|NCT00313300|50034623|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
24941621|NCT00313300|50034624|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
24941622|NCT00313300|50034625|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
24941623|NCT00313300|50034626|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
24941624|NCT00313300|50034627|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
24941625|NCT00313300|50034623|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
24941626|NCT00313300|50034624|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
24941627|NCT00313300|50034625|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
24941628|NCT00313300|50034626|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
24941629|NCT00313300|50034627|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
24941630|NCT00313300|50034623|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
24941631|NCT00313300|50034624|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
24941632|NCT00313300|50034625|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
24941633|NCT00313300|50034626|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
24941634|NCT00313300|50034627|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
24941635|NCT00459186|50034645|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
24941636|NCT00459186|50034645|FG000|PET Imaging and Assessment|Adverse Event|3|||
24941637|NCT00328510|50034651|FG000|Overall Study|Gag disorder, could not use frame|4|||
24941638|NCT00328510|50034652|FG001|Overall Study|Gag disorder, could not use frame|0|||
24941639|NCT00328510|50034651|FG000|Overall Study|Dentition problems, could not use frame|1|||
24941640|NCT00328510|50034652|FG001|Overall Study|Dentition problems, could not use frame|0|||
24941641|NCT00328510|50034651|FG000|Overall Study|Withdrawal by Subject|4|||
24941642|NCT00328510|50034652|FG001|Overall Study|Withdrawal by Subject|2|||
25029942|NCT03285295|50128447|FG002|Alinity s HBsAg|Protocol Violation|0|||
25029943|NCT03285295|50128448|FG003|Alinity s HBsAg|Protocol Violation|0|||
25029944|NCT03285295|50128449|FG004|Alinity s HBsAg|Protocol Violation|0|||
25029945|NCT03285295|50128445|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
25275549|NCT01231607|50589416|FG003|Overall Study|Protocol Violation|2|||
24941643|NCT00328510|50034651|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
24941644|NCT00328510|50034652|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
24941645|NCT00328510|50034651|FG000|Overall Study|Treatment changed to a single fraction|1|||
24941646|NCT00328510|50034652|FG001|Overall Study|Treatment changed to a single fraction|1|||
24941647|NCT00313144|50034658|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
24941648|NCT00313144|50034658|FG000|Overall Study|Death|7|||
24941649|NCT00313144|50034658|FG000|Overall Study|Lost to Follow-up|5|||
24941650|NCT00313144|50034658|FG000|Overall Study|Withdrawal by Subject|4|||
24941651|NCT00313144|50034658|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
24941652|NCT00313144|50034658|FG000|Overall Study|Physician Decision|4|||
24941653|NCT00313144|50034658|FG000|Overall Study|Adverse event - transient|5|||
24941654|NCT00313144|50034658|FG000|Overall Study|Liver transplant|1|||
24941655|NCT00313144|50034658|FG000|Overall Study|Insurance (homecare provider) change|1|||
25158961|NCT01453725|50277979|FG000|Overall Study|Non-compliance With Protocol|1|||
25158962|NCT01453725|50277980|FG001|Overall Study|Non-compliance With Protocol|2|||
25158963|NCT01453725|50277979|FG000|Overall Study|Protocol Violation|1|||
25158964|NCT01453725|50277980|FG001|Overall Study|Protocol Violation|0|||
25158965|NCT01453725|50277979|FG000|Overall Study|Withdrawal by Subject|2|||
25158966|NCT01453725|50277980|FG001|Overall Study|Withdrawal by Subject|3|||
25158967|NCT01453725|50277979|FG000|Overall Study|Pregnancy Wish|0|||
25158968|NCT01453725|50277980|FG001|Overall Study|Pregnancy Wish|2|||
25158969|NCT01453725|50277979|FG000|Overall Study|Pregnancy|1|||
25158970|NCT01453725|50277980|FG001|Overall Study|Pregnancy|0|||
25158971|NCT01453725|50277979|FG000|Overall Study|Physician Decision|1|||
25158972|NCT01453725|50277980|FG001|Overall Study|Physician Decision|1|||
25158973|NCT01415349|50278019|FG000|Treatment Period 1|Adverse Event|0|||
25158974|NCT01415349|50278020|FG001|Treatment Period 1|Adverse Event|1|||
25158975|NCT01415349|50278019|FG000|Treatment Period 1|Withdrawal by Subject|0|||
25158976|NCT01415349|50278020|FG001|Treatment Period 1|Withdrawal by Subject|1|||
25158977|NCT01453023|50278074|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
25158978|NCT01453023|50278075|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
25158979|NCT01453023|50278074|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
25158980|NCT01453023|50278075|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
25158981|NCT01453023|50278074|FG000|Treatment Period 2|Protocol Violation|0|||
25158982|NCT01453023|50278075|FG001|Treatment Period 2|Protocol Violation|1|||
24941656|NCT00313144|50034658|FG000|Overall Study|Change to different product|1|||
24941657|NCT00313144|50034658|FG000|Overall Study|Due to termination of the study|66|||
24941658|NCT00459108|50034671|FG000|Overall Study|Withdrawal by Subject|5|||
24941659|NCT00459108|50034671|FG000|Overall Study|Adverse Event|3|||
25158983|NCT01452789|50278083|FG000|Overall Study|Withdrawal by Subject|3|||
25158984|NCT01452789|50278084|FG001|Overall Study|Withdrawal by Subject|2|||
24941660|NCT00459108|50034671|FG000|Overall Study|Death|2|||
24941661|NCT00459108|50034671|FG000|Overall Study|Progression|1|||
24941662|NCT00458484|50034683|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
24941663|NCT00458484|50034684|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
24941664|NCT00458484|50034685|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
24941665|NCT00458484|50034686|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
24941666|NCT00458484|50034687|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
24941667|NCT00458484|50034688|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
24941668|NCT00458484|50034689|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
24941669|NCT00328198|50034714|FG000|Treatment|Adverse Event|21|||
24941670|NCT00328198|50034714|FG000|Treatment|Death|1|||
24941671|NCT00328198|50034714|FG000|Treatment|Physician Decision|5|||
24941672|NCT00328198|50034714|FG000|Treatment|Withdrawal by Subject|5|||
24941673|NCT00328198|50034714|FG000|Treatment|Evidence of disease progression|2|||
24941674|NCT00328198|50034714|FG000|Treatment|Non-compliance|1|||
24941675|NCT00328198|50034714|FG000|Treatment|Confirmed complete response, MRD -|3|||
24941676|NCT00328198|50034714|FG000|Follow-up|Lost to Follow-up|4|||
24941677|NCT00328198|50034714|FG000|Follow-up|Death|31|||
24941678|NCT00450450|50034720|FG000|Overall Study|Death|1|||
24941679|NCT00450450|50034721|FG001|Overall Study|Death|3|||
24941680|NCT00450450|50034720|FG000|Overall Study|Relapse|2|||
24941681|NCT00450450|50034721|FG001|Overall Study|Relapse|0|||
24941682|NCT00450450|50034720|FG000|Overall Study|Missing Data|2|||
24941683|NCT00450450|50034721|FG001|Overall Study|Missing Data|0|||
24941684|NCT00442572|50034729|FG000|Overall Study|Relapse|8|||
24941685|NCT00442572|50034730|FG001|Overall Study|Relapse|1|||
24941686|NCT00442572|50034729|FG000|Overall Study|Lost to Follow-up|0|||
24941687|NCT00442572|50034730|FG001|Overall Study|Lost to Follow-up|1|||
24941688|NCT00442572|50034729|FG000|Overall Study|Withdrawal by Subject|0|||
24941689|NCT00442572|50034730|FG001|Overall Study|Withdrawal by Subject|1|||
25158985|NCT01451931|50278093|FG000|Overall Study|Lost to Follow-up|17|||
25158986|NCT01451931|50278094|FG001|Overall Study|Lost to Follow-up|36|||
25158987|NCT01451931|50278095|FG002|Overall Study|Lost to Follow-up|21|||
25158988|NCT01451931|50278093|FG000|Overall Study|Withdrawal by Subject|16|||
25158989|NCT01451931|50278094|FG001|Overall Study|Withdrawal by Subject|22|||
24941690|NCT00442416|50034739|FG000|Overall Study|Adverse Event|4|||
24941691|NCT00442416|50034740|FG001|Overall Study|Adverse Event|1|||
24941692|NCT00442416|50034739|FG000|Overall Study|Death|1|||
24941693|NCT00442416|50034740|FG001|Overall Study|Death|0|||
24941694|NCT00442416|50034739|FG000|Overall Study|Lack of Efficacy|2|||
24941695|NCT00442416|50034740|FG001|Overall Study|Lack of Efficacy|0|||
24941696|NCT00442416|50034739|FG000|Overall Study|Protocol Violation|2|||
24941697|NCT00442416|50034740|FG001|Overall Study|Protocol Violation|3|||
24941698|NCT00442416|50034739|FG000|Overall Study|Withdrew consent|1|||
24941699|NCT00442416|50034740|FG001|Overall Study|Withdrew consent|2|||
24941700|NCT00442416|50034739|FG000|Overall Study|Administrative/Other|27|||
24941701|NCT00442416|50034740|FG001|Overall Study|Administrative/Other|33|||
24941702|NCT00441792|50034748|FG000|Overall Study|Lost to Follow-up|0|||
24941703|NCT00441792|50034749|FG001|Overall Study|Lost to Follow-up|2|||
24941704|NCT00312208|50034757|FG000|Overall Study|Adverse Event|97|||
24941705|NCT00312208|50034758|FG001|Overall Study|Adverse Event|61|||
24941706|NCT00312208|50034757|FG000|Overall Study|Protocol Violation|5|||
24941707|NCT00312208|50034758|FG001|Overall Study|Protocol Violation|3|||
24941708|NCT00312208|50034757|FG000|Overall Study|Death|2|||
24941709|NCT00312208|50034758|FG001|Overall Study|Death|1|||
24941710|NCT00312208|50034757|FG000|Overall Study|Lack of Efficacy|7|||
24941711|NCT00312208|50034758|FG001|Overall Study|Lack of Efficacy|4|||
25158990|NCT01451931|50278095|FG002|Overall Study|Withdrawal by Subject|22|||
25158991|NCT01414257|50278118|FG000|Overall Study|No Visit After First Day of Treatment|12|||
25158992|NCT01414257|50278118|FG000|Overall Study|Protocol Violation|10|||
25158993|NCT01434693|50278161|FG000|Overall Study|Adverse Event|1|||
25158994|NCT01434693|50278162|FG001|Overall Study|Adverse Event|0|||
25158995|NCT01434693|50278163|FG002|Overall Study|Adverse Event|0|||
25158996|NCT01434693|50278164|FG003|Overall Study|Adverse Event|0|||
25158997|NCT01434693|50278161|FG000|Overall Study|Withdrawal by Subject|1|||
25158998|NCT01434693|50278162|FG001|Overall Study|Withdrawal by Subject|0|||
25158999|NCT01434693|50278163|FG002|Overall Study|Withdrawal by Subject|1|||
25159000|NCT01434693|50278164|FG003|Overall Study|Withdrawal by Subject|1|||
25159001|NCT01434693|50278161|FG000|Overall Study|Lost to Follow-up|1|||
25159002|NCT01434693|50278162|FG001|Overall Study|Lost to Follow-up|0|||
25159003|NCT01434693|50278163|FG002|Overall Study|Lost to Follow-up|0|||
25159004|NCT01434693|50278164|FG003|Overall Study|Lost to Follow-up|0|||
25159005|NCT01451541|50278181|FG000|Overall Study|Adverse Event|4|||
25159006|NCT01451541|50278182|FG001|Overall Study|Adverse Event|3|||
25159007|NCT01451541|50278183|FG002|Overall Study|Adverse Event|6|||
25159008|NCT01451541|50278181|FG000|Overall Study|Lack of Efficacy|2|||
25159009|NCT01451541|50278182|FG001|Overall Study|Lack of Efficacy|0|||
25159010|NCT01451541|50278183|FG002|Overall Study|Lack of Efficacy|0|||
25159011|NCT01451541|50278181|FG000|Overall Study|Lost to Follow-up|4|||
25159012|NCT01451541|50278182|FG001|Overall Study|Lost to Follow-up|4|||
25159013|NCT01451541|50278183|FG002|Overall Study|Lost to Follow-up|7|||
25159014|NCT01451541|50278181|FG000|Overall Study|Withdrawal by Subject|15|||
25159015|NCT01451541|50278182|FG001|Overall Study|Withdrawal by Subject|8|||
25159016|NCT01451541|50278183|FG002|Overall Study|Withdrawal by Subject|6|||
25159017|NCT01451541|50278181|FG000|Overall Study|randomization error, noncompliance|11|||
25159018|NCT01451541|50278182|FG001|Overall Study|randomization error, noncompliance|10|||
25159019|NCT01451541|50278183|FG002|Overall Study|randomization error, noncompliance|8|||
25159020|NCT01450761|50278311|FG000|Randomization|Subject no longer meets study criteria|1|||
25159021|NCT01450761|50278312|FG001|Randomization|Subject no longer meets study criteria|2|||
25159022|NCT01450761|50278311|FG000|Randomization|Withdrawal by Subject|2|||
25159023|NCT01450761|50278312|FG001|Randomization|Withdrawal by Subject|0|||
25159024|NCT01450761|50278311|FG000|Randomization|Disease progression|0|||
25159025|NCT01450761|50278312|FG001|Randomization|Disease progression|2|||
25159026|NCT01450761|50278311|FG000|Randomization|Adverse Event unrelated to study drug|1|||
25159027|NCT01450761|50278312|FG001|Randomization|Adverse Event unrelated to study drug|0|||
25159028|NCT01450761|50278311|FG000|Randomization|Other|0|||
25159029|NCT01450761|50278312|FG001|Randomization|Other|1|||
25159030|NCT01450761|50278311|FG000|Lead-in Chemotherapy|Disease progression|33|||
24941712|NCT00312208|50034757|FG000|Overall Study|Lost to Follow-up|3|||
25159031|NCT01450761|50278312|FG001|Lead-in Chemotherapy|Disease progression|32|||
25159032|NCT01450761|50278311|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
24941713|NCT00312208|50034758|FG001|Overall Study|Lost to Follow-up|5|||
24941714|NCT00312208|50034757|FG000|Overall Study|Withdrawal by Subject|53|||
24941715|NCT00312208|50034758|FG001|Overall Study|Withdrawal by Subject|42|||
24941716|NCT00312208|50034757|FG000|Overall Study|Other|5|||
25159033|NCT01450761|50278312|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
25159034|NCT01450761|50278311|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
25159035|NCT01450761|50278312|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
25159036|NCT01450761|50278311|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
25159037|NCT01450761|50278312|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
24941717|NCT00312208|50034758|FG001|Overall Study|Other|7|||
24941718|NCT00297778|50034766|FG000|Overall Study|Adverse Event|16|||
24941719|NCT00297778|50034767|FG001|Overall Study|Adverse Event|10|||
24941720|NCT00297778|50034766|FG000|Overall Study|Withdrawal by Subject|1|||
24941721|NCT00297778|50034767|FG001|Overall Study|Withdrawal by Subject|5|||
24941722|NCT00297778|50034766|FG000|Overall Study|Lack of Efficacy|2|||
24941723|NCT00297778|50034767|FG001|Overall Study|Lack of Efficacy|1|||
24941724|NCT00297778|50034766|FG000|Overall Study|Non-compliant with trial protocol|0|||
24941725|NCT00297778|50034767|FG001|Overall Study|Non-compliant with trial protocol|3|||
24941726|NCT00297778|50034766|FG000|Overall Study|Other|0|||
24941727|NCT00297778|50034767|FG001|Overall Study|Other|1|||
24941728|NCT03848832|50034776|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
24941729|NCT03848832|50034777|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
24941730|NCT03848832|50034778|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
24941731|NCT03848832|50034776|FG000|Overall Study|Withdrawal by Subject|0|||
24941732|NCT03848832|50034777|FG001|Overall Study|Withdrawal by Subject|0|||
24941733|NCT03848832|50034778|FG002|Overall Study|Withdrawal by Subject|1|||
24941734|NCT03848832|50034776|FG000|Overall Study|Withdrawal (Covid-19)|0|||
24941735|NCT03848832|50034777|FG001|Overall Study|Withdrawal (Covid-19)|2|||
24941736|NCT03848832|50034778|FG002|Overall Study|Withdrawal (Covid-19)|0|||
24941737|NCT03848832|50034776|FG000|Overall Study|Physician Decision|2|||
24941738|NCT03848832|50034777|FG001|Overall Study|Physician Decision|1|||
24941739|NCT03848832|50034778|FG002|Overall Study|Physician Decision|3|||
25159038|NCT01450761|50278311|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
25159039|NCT01450761|50278312|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
25159040|NCT01450761|50278311|FG000|Lead-in Chemotherapy|Death|3|||
25159041|NCT01450761|50278312|FG001|Lead-in Chemotherapy|Death|3|||
25159042|NCT01450761|50278311|FG000|Lead-in Chemotherapy|Other|2|||
25159043|NCT01450761|50278312|FG001|Lead-in Chemotherapy|Other|2|||
25159044|NCT01450761|50278311|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
25159045|NCT01450761|50278312|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
25159046|NCT01450761|50278311|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
25159047|NCT01450761|50278312|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
25159048|NCT01450761|50278311|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
25159049|NCT01450761|50278312|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
25159050|NCT01450761|50278311|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
25159051|NCT01450761|50278312|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
25159052|NCT01450761|50278311|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
25159053|NCT01450761|50278312|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
25159054|NCT01450761|50278311|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
25159055|NCT01450761|50278312|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
25159056|NCT01450761|50278311|FG000|Treatment With Blinded Study Therapy|Death|5|||
25159057|NCT01450761|50278312|FG001|Treatment With Blinded Study Therapy|Death|6|||
25159058|NCT01450761|50278311|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
25159059|NCT01450761|50278312|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
25159060|NCT01450761|50278311|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
25159061|NCT01450761|50278312|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
25159062|NCT01450761|50278311|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
25159063|NCT01450761|50278312|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
24941740|NCT03848832|50034776|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
25159064|NCT01450761|50278311|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
25159065|NCT01450761|50278312|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
25159066|NCT01450761|50278311|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
25159067|NCT01450761|50278312|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
24941741|NCT03848832|50034777|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
24941742|NCT03848832|50034778|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
25029946|NCT03285295|50128446|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
24941743|NCT03848832|50034776|FG000|Overall Study|Adverse Event|1|||
25159068|NCT01450761|50278311|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
25159069|NCT01450761|50278312|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
25159070|NCT01450761|50278311|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
25159071|NCT01450761|50278312|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
25159072|NCT01433991|50278362|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
25159073|NCT01433991|50278363|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
25159074|NCT01433991|50278364|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
25159075|NCT01433991|50278365|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
25159076|NCT01433991|50278362|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
25159077|NCT01433991|50278363|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
25159078|NCT01433991|50278364|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
24941744|NCT03848832|50034777|FG001|Overall Study|Adverse Event|0|||
24941745|NCT03848832|50034778|FG002|Overall Study|Adverse Event|0|||
24941746|NCT00450372|50034788|FG000|Overall Study|Physician Decision|1|||
24941747|NCT00327340|50034797|FG000|Overall Study|Withdrawal by Subject|1|||
24941748|NCT00327340|50034798|FG001|Overall Study|Withdrawal by Subject|5|||
24941749|NCT00327340|50034797|FG000|Overall Study|Physician Decision|1|||
24941750|NCT00327340|50034798|FG001|Overall Study|Physician Decision|1|||
25159079|NCT01433991|50278365|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
25159080|NCT01433991|50278362|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
24941751|NCT00327340|50034797|FG000|Overall Study|Disease Progression|10|||
24941752|NCT00327340|50034798|FG001|Overall Study|Disease Progression|19|||
24941753|NCT00327340|50034797|FG000|Overall Study|Symptomatic Disease|0|||
24941754|NCT00327340|50034798|FG001|Overall Study|Symptomatic Disease|2|||
24941755|NCT00327340|50034797|FG000|Overall Study|Adverse Event|3|||
24941756|NCT00327340|50034798|FG001|Overall Study|Adverse Event|3|||
24941757|NCT00548093|50034808|FG000|Overall Study|Death|33|||
24941758|NCT00548093|50034809|FG001|Overall Study|Death|13|||
24941759|NCT00548093|50034808|FG000|Overall Study|Lost to Follow-up|3|||
24941760|NCT00548093|50034809|FG001|Overall Study|Lost to Follow-up|1|||
24941761|NCT00548093|50034808|FG000|Overall Study|Objective progression or relapse|1|||
24941762|NCT00548093|50034809|FG001|Overall Study|Objective progression or relapse|1|||
24941763|NCT00548093|50034808|FG000|Overall Study|Other|11|||
24941764|NCT00548093|50034809|FG001|Overall Study|Other|1|||
24941765|NCT00548093|50034808|FG000|Overall Study|Withdrawal by Subject|1|||
24941766|NCT00548093|50034809|FG001|Overall Study|Withdrawal by Subject|0|||
24941767|NCT00548093|50034808|FG000|Overall Study|Completed post-treatment follow-up|1|||
24941768|NCT00548093|50034809|FG001|Overall Study|Completed post-treatment follow-up|0|||
24941769|NCT00450216|50034820|FG000|Overall Study|Adverse Event|38|||
24941770|NCT00450216|50034821|FG001|Overall Study|Adverse Event|23|||
24941771|NCT00450216|50034820|FG000|Overall Study|Withdrawal by Subject|48|||
24941772|NCT00450216|50034821|FG001|Overall Study|Withdrawal by Subject|26|||
24941773|NCT00450216|50034820|FG000|Overall Study|Lost to Follow-up|16|||
24941774|NCT00450216|50034821|FG001|Overall Study|Lost to Follow-up|9|||
24941775|NCT00450216|50034820|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
25159081|NCT01433991|50278363|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
24941776|NCT00450216|50034821|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
24941777|NCT00450216|50034820|FG000|Overall Study|misc|21|||
24941778|NCT00450216|50034821|FG001|Overall Study|misc|20|||
24941779|NCT00441480|50034829|FG000|Overall Study|Protocol Violation|1|||
24941780|NCT00441480|50034830|FG001|Overall Study|Protocol Violation|1|||
25275550|NCT01231607|50589417|FG004|Overall Study|Protocol Violation|2|||
24941781|NCT00441480|50034829|FG000|Overall Study|Withdrawal by Subject|2|||
24941782|NCT00441480|50034830|FG001|Overall Study|Withdrawal by Subject|3|||
25159082|NCT01433991|50278364|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
25159083|NCT01433991|50278365|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
25159084|NCT01433991|50278362|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
25159085|NCT01433991|50278363|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
25159086|NCT01433991|50278364|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
25159087|NCT01433991|50278365|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
25159088|NCT01433991|50278362|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
25159089|NCT01433991|50278363|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
25159090|NCT01433991|50278364|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
25159091|NCT01433991|50278365|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
25159092|NCT01433991|50278362|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
25159093|NCT01433991|50278363|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
25159094|NCT01433991|50278364|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
24941783|NCT00547703|50034838|FG000|Overall Study|Lost to Follow-up|1|||
24941784|NCT00547703|50034839|FG001|Overall Study|Lost to Follow-up|0|||
24941785|NCT00297232|50034845|FG000|Overall Study|Lack of Efficacy|7|||
24941786|NCT00297232|50034845|FG000|Overall Study|Lost to Follow-up|10|||
24941787|NCT00297232|50034845|FG000|Overall Study|Adverse Event|63|||
24941788|NCT00297232|50034845|FG000|Overall Study|Voluntary Withdrawal|120|||
24941789|NCT00297232|50034845|FG000|Overall Study|Subject was Noncompliant|9|||
24941790|NCT00297232|50034845|FG000|Overall Study|Death|9|||
24941791|NCT00297232|50034845|FG000|Overall Study|Anti-natalizumab Positive|8|||
24941792|NCT00297232|50034845|FG000|Overall Study|Switched to Commercial Tysabri|22|||
24941793|NCT00297232|50034845|FG000|Overall Study|Disease Progression|8|||
24941794|NCT00297232|50034845|FG000|Overall Study|Fear of PML|10|||
25159095|NCT01433991|50278365|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
25159096|NCT01433991|50278362|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
25159097|NCT01433991|50278363|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
25159098|NCT01433991|50278364|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
25159099|NCT01433991|50278365|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
25159100|NCT01450683|50278381|FG000|Overall Study|Adverse Event|2|||
25159101|NCT01433055|50278387|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
25159102|NCT01433055|50278388|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
25159103|NCT01433055|50278387|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
25159104|NCT01433055|50278388|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
25159105|NCT01450137|50278396|FG000|Up to Week 12|Adverse Event|2|||
25159106|NCT01450137|50278397|FG001|Up to Week 12|Adverse Event|1|||
25159107|NCT01450137|50278396|FG000|Up to Week 12|Withdrawal by Subject|0|||
25159108|NCT01450137|50278397|FG001|Up to Week 12|Withdrawal by Subject|2|||
25159109|NCT01450137|50278396|FG000|Week 12 to Study End|Death|0|||
25159110|NCT01450137|50278397|FG001|Week 12 to Study End|Death|1|||
24941795|NCT00297232|50034845|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
24941796|NCT00297232|50034845|FG000|Overall Study|Miscellaneous|5|||
24941797|NCT00297232|50034845|FG000|Overall Study|Sponsor Decision|34|||
24941798|NCT00297232|50034845|FG000|Overall Study|Subject Relocated|7|||
24941799|NCT00297232|50034845|FG000|Overall Study|Subject Withdrew Consent|37|||
24941800|NCT00297232|50034845|FG000|Overall Study|Persistently Positive Antibodies|11|||
24941801|NCT00297232|50034845|FG000|Overall Study|Investigator Withdrew From Program|19|||
24941802|NCT00297232|50034845|FG000|Overall Study|Did Not Enroll to Week 264|34|||
24941803|NCT00297232|50034845|FG000|Overall Study|Did Not Enroll to Week 480|17|||
24941804|NCT00297232|50034845|FG000|Overall Study|No data available after Week 264|161|||
24941805|NCT00297232|50034845|FG000|Overall Study|Other|1|||
24941806|NCT00449670|50034861|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
24941807|NCT00449670|50034862|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
24941808|NCT00449670|50034861|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
24941809|NCT00449670|50034862|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
24941810|NCT00449670|50034861|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
24941811|NCT00449670|50034862|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
24941812|NCT00449670|50034861|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
24941813|NCT00449670|50034862|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
24941814|NCT00449670|50034861|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
24941815|NCT00449670|50034862|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
24941816|NCT00449670|50034861|FG000|Booster Phase (Study no.109873)|Other|0|||
24941817|NCT00449670|50034862|FG001|Booster Phase (Study no.109873)|Other|2|||
24941818|NCT00296374|50034878|FG000|Overall Study|Adverse Event|14|||
24941819|NCT00296374|50034879|FG001|Overall Study|Adverse Event|10|||
24941820|NCT00296374|50034880|FG002|Overall Study|Adverse Event|7|||
24941821|NCT00296374|50034878|FG000|Overall Study|Withdrawal by Subject|3|||
24941822|NCT00296374|50034879|FG001|Overall Study|Withdrawal by Subject|5|||
24941823|NCT00296374|50034880|FG002|Overall Study|Withdrawal by Subject|11|||
24941824|NCT00296374|50034878|FG000|Overall Study|Incorrect enrollment|3|||
24941825|NCT00296374|50034879|FG001|Overall Study|Incorrect enrollment|3|||
24941826|NCT00296374|50034880|FG002|Overall Study|Incorrect enrollment|4|||
24941827|NCT00296374|50034878|FG000|Overall Study|Protocol Violation|1|||
24941828|NCT00296374|50034879|FG001|Overall Study|Protocol Violation|2|||
24941829|NCT00296374|50034880|FG002|Overall Study|Protocol Violation|3|||
25159111|NCT01450137|50278396|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
25159112|NCT01450137|50278397|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
25159113|NCT01412229|50278403|FG000|Overall Study|Physician Decision|1|||
25159114|NCT01412151|50278408|FG000|Week 0 - 306 - Treatment Period|Death|1|||
25159115|NCT01412151|50278408|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
25159116|NCT01412151|50278408|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
25159117|NCT01412151|50278408|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
25159118|NCT01432275|50278414|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
25159119|NCT01432275|50278415|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
25186173|NCT01473836|50336073|FG000|Overall Study|Does not meet entrance criteria|1|||
25186174|NCT01473758|50336113|FG000|Cycle 1|Adverse Event|10|||
25186175|NCT01473758|50336114|FG001|Cycle 1|Adverse Event|2|||
25186176|NCT01473758|50336115|FG002|Cycle 1|Adverse Event|0|||
25186177|NCT01473758|50336116|FG003|Cycle 1|Adverse Event|0|||
25186178|NCT01473758|50336113|FG000|Cycle 1|Withdrawal by Subject|1|||
25275551|NCT01231607|50589413|FG000|Overall Study|Withdrawal by Subject|9|||
24941830|NCT00296374|50034878|FG000|Overall Study|Lost to Follow-up|3|||
24941831|NCT00296374|50034879|FG001|Overall Study|Lost to Follow-up|1|||
24941832|NCT00296374|50034880|FG002|Overall Study|Lost to Follow-up|1|||
24941833|NCT00296374|50034878|FG000|Overall Study|Relocated to another state|1|||
24941834|NCT00296374|50034879|FG001|Overall Study|Relocated to another state|0|||
24941835|NCT00296374|50034880|FG002|Overall Study|Relocated to another state|0|||
25029947|NCT03285295|50128447|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
25029948|NCT03285295|50128448|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
25029949|NCT03285295|50128449|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
24941836|NCT00296374|50034878|FG000|Overall Study|Stopped drug before end of study visit|0|||
24941837|NCT00296374|50034879|FG001|Overall Study|Stopped drug before end of study visit|1|||
25159120|NCT01432275|50278414|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
24941838|NCT00296374|50034880|FG002|Overall Study|Stopped drug before end of study visit|0|||
24941839|NCT00296374|50034878|FG000|Overall Study|Nephrologist introduced ACE|0|||
24941840|NCT00296374|50034879|FG001|Overall Study|Nephrologist introduced ACE|1|||
25029950|NCT03285295|50128445|FG000|Alinity s HBsAg|No Results Generated|74|||
25159121|NCT01432275|50278415|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
25275552|NCT01231607|50589414|FG001|Overall Study|Withdrawal by Subject|9|||
25186179|NCT01473758|50336114|FG001|Cycle 1|Withdrawal by Subject|1|||
24941841|NCT00296374|50034880|FG002|Overall Study|Nephrologist introduced ACE|0|||
24941842|NCT00296374|50034878|FG000|Overall Study|Pregnancy|0|||
24941843|NCT00296374|50034879|FG001|Overall Study|Pregnancy|0|||
24941844|NCT00296374|50034880|FG002|Overall Study|Pregnancy|2|||
24941845|NCT00296374|50034878|FG000|Overall Study|Other|0|||
24941846|NCT00296374|50034879|FG001|Overall Study|Other|0|||
24941847|NCT00296374|50034880|FG002|Overall Study|Other|1|||
24941848|NCT00326950|50034903|FG000|Overall Study|Progressive Disease|1|||
24941849|NCT00548717|50034909|FG000|Overall Study|Death|5|||
24941850|NCT00548717|50034910|FG001|Overall Study|Death|2|||
24941851|NCT00548717|50034909|FG000|Overall Study|Relapse|3|||
24941852|NCT00548717|50034910|FG001|Overall Study|Relapse|0|||
24941853|NCT00548717|50034909|FG000|Overall Study|Alternative treatment for GVHD|1|||
24941854|NCT00548717|50034910|FG001|Overall Study|Alternative treatment for GVHD|0|||
24941855|NCT00441168|50034921|FG000|Treatment Period|Death|3|||
24941856|NCT00441168|50034922|FG001|Treatment Period|Death|0|||
24941857|NCT00441168|50034921|FG000|Treatment Period|Adverse Event|1|||
25186180|NCT01473758|50336115|FG002|Cycle 1|Withdrawal by Subject|0|||
24941858|NCT00441168|50034922|FG001|Treatment Period|Adverse Event|2|||
24941859|NCT00441168|50034921|FG000|Treatment Period|Progressive Disease|0|||
24941860|NCT00441168|50034922|FG001|Treatment Period|Progressive Disease|2|||
24941861|NCT00441168|50034921|FG000|Treatment Period|Protocol Violation|0|||
25186181|NCT01473758|50336116|FG003|Cycle 1|Withdrawal by Subject|0|||
25186182|NCT01473758|50336113|FG000|Cycle 2|Adverse Event|0|||
25186183|NCT01473758|50336114|FG001|Cycle 2|Adverse Event|0|||
24941862|NCT00441168|50034922|FG001|Treatment Period|Protocol Violation|1|||
24941863|NCT00441168|50034921|FG000|Treatment Period|Lost to Follow-up|0|||
24941864|NCT00441168|50034922|FG001|Treatment Period|Lost to Follow-up|1|||
24941865|NCT00441168|50034921|FG000|Treatment Period|Withdrawal by Subject|3|||
24941866|NCT00441168|50034922|FG001|Treatment Period|Withdrawal by Subject|0|||
24941867|NCT00441168|50034921|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
24941868|NCT00441168|50034922|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
24941869|NCT00441168|50034921|FG000|Treatment Period|refractory disease|1|||
24941870|NCT00441168|50034922|FG001|Treatment Period|refractory disease|0|||
24941871|NCT00441168|50034921|FG000|Follow-up Period|Death|3|||
25186184|NCT01473758|50336115|FG002|Cycle 2|Adverse Event|5|||
25186185|NCT01473758|50336116|FG003|Cycle 2|Adverse Event|0|||
25186186|NCT01420679|50336126|FG000|Overall Study|Disease Progression|3|||
25186187|NCT01420679|50336127|FG001|Overall Study|Disease Progression|2|||
25159122|NCT01432275|50278414|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
25159123|NCT01432275|50278415|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
25159124|NCT01432275|50278414|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
25159125|NCT01432275|50278415|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
25159126|NCT01432275|50278414|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
25159127|NCT01432275|50278415|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
25159128|NCT01432275|50278414|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
25159129|NCT01432275|50278415|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
25159130|NCT01432275|50278414|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
25159131|NCT01432275|50278415|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
25275553|NCT01231607|50589415|FG002|Overall Study|Withdrawal by Subject|14|||
24941872|NCT00441168|50034922|FG001|Follow-up Period|Death|0|||
24941873|NCT00441168|50034921|FG000|Follow-up Period|Lost to Follow-up|5|||
24941874|NCT00441168|50034922|FG001|Follow-up Period|Lost to Follow-up|6|||
24941875|NCT00441168|50034921|FG000|Follow-up Period|Withdrawal by Subject|3|||
24941876|NCT00441168|50034922|FG001|Follow-up Period|Withdrawal by Subject|0|||
24941877|NCT00441168|50034921|FG000|Follow-up Period|Other|1|||
24941878|NCT00441168|50034922|FG001|Follow-up Period|Other|3|||
24941879|NCT00296140|50034930|FG000|Overall Study|Lost to Follow-up|1|||
24941880|NCT00296140|50034931|FG001|Overall Study|Lost to Follow-up|0|||
24941881|NCT00296140|50034930|FG000|Overall Study|Withdrawal by Subject|1|||
24941882|NCT00296140|50034931|FG001|Overall Study|Withdrawal by Subject|0|||
24941883|NCT00296140|50034930|FG000|Overall Study|Discharge to Nursing Home|1|||
24941884|NCT00296140|50034931|FG001|Overall Study|Discharge to Nursing Home|0|||
24941885|NCT03958331|50034940|FG000|Overall Study|Withdrawal by Subject|3|||
24941886|NCT03958331|50034941|FG001|Overall Study|Withdrawal by Subject|1|||
24941887|NCT03958331|50034942|FG002|Overall Study|Withdrawal by Subject|5|||
24941888|NCT03958331|50034940|FG000|Overall Study|Weaned from medicine|2|||
25029951|NCT03285295|50128446|FG001|Alinity s HBsAg|No Results Generated|6|||
25159132|NCT01432275|50278414|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
25186188|NCT01420679|50336126|FG000|Overall Study|Adverse Event|4|||
25186189|NCT01420679|50336127|FG001|Overall Study|Adverse Event|0|||
24941889|NCT03958331|50034941|FG001|Overall Study|Weaned from medicine|0|||
24941890|NCT03958331|50034942|FG002|Overall Study|Weaned from medicine|0|||
24941891|NCT03958331|50034940|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
24941892|NCT03958331|50034941|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
24941893|NCT03958331|50034942|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
24941894|NCT03956615|50034948|FG000|Overall Study|No multiple myeloma confirmed|2|||
24941895|NCT03956615|50034948|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
24941896|NCT03956615|50034948|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
24941897|NCT03956615|50034948|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
24941898|NCT03956225|50034954|FG000|Overall Study|Lack of Efficacy|1|||
24941899|NCT03956225|50034955|FG001|Overall Study|Lack of Efficacy|1|||
24941900|NCT03956225|50034954|FG000|Overall Study|Lost to Follow-up|0|||
24941901|NCT03956225|50034955|FG001|Overall Study|Lost to Follow-up|1|||
24941902|NCT03956225|50034954|FG000|Overall Study|Withdrawal by Subject|2|||
25159133|NCT01432275|50278415|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
25159134|NCT01432275|50278414|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
25159135|NCT01432275|50278415|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
25159136|NCT01411995|50278423|FG000|Overall Study|Failed IUD insertion|0|||
25159137|NCT01411995|50278424|FG001|Overall Study|Failed IUD insertion|1|||
24941903|NCT03956225|50034955|FG001|Overall Study|Withdrawal by Subject|1|||
24941904|NCT03956225|50034954|FG000|Overall Study|Other Reasons|2|||
25029952|NCT03285295|50128447|FG002|Alinity s HBsAg|No Results Generated|0|||
25159138|NCT01411917|50278432|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
24941905|NCT03956225|50034955|FG001|Overall Study|Other Reasons|1|||
24941906|NCT00457626|50034964|FG000|Overall Study|Adverse Event|3|||
24941907|NCT00457626|50034964|FG000|Overall Study|Administrative Problems|2|||
24941908|NCT00457626|50034964|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
24941909|NCT00373113|50034970|FG000|Overall Study|Death|1|||
24941910|NCT00373113|50034971|FG001|Overall Study|Death|7|||
24941911|NCT00373113|50034970|FG000|Overall Study|Adverse Event|38|||
24941912|NCT00373113|50034971|FG001|Overall Study|Adverse Event|24|||
24941913|NCT00373113|50034970|FG000|Overall Study|Study terminated by sponsor|9|||
24941914|NCT00373113|50034971|FG001|Overall Study|Study terminated by sponsor|1|||
24941915|NCT00373113|50034970|FG000|Overall Study|Global deterioration of health status|10|||
24941916|NCT00373113|50034971|FG001|Overall Study|Global deterioration of health status|7|||
24941917|NCT00373113|50034970|FG000|Overall Study|Lost to Follow-up|1|||
24941918|NCT00373113|50034971|FG001|Overall Study|Lost to Follow-up|3|||
24941919|NCT00373113|50034970|FG000|Overall Study|Objective progression or relapse|150|||
24941920|NCT00373113|50034971|FG001|Overall Study|Objective progression or relapse|169|||
24941921|NCT00373113|50034970|FG000|Overall Study|Other|14|||
24941922|NCT00373113|50034971|FG001|Overall Study|Other|17|||
24941923|NCT00373113|50034970|FG000|Overall Study|Protocol Violation|5|||
24941924|NCT00373113|50034971|FG001|Overall Study|Protocol Violation|1|||
24941925|NCT00373113|50034970|FG000|Overall Study|Withdrawal by Subject|10|||
24941926|NCT00373113|50034971|FG001|Overall Study|Withdrawal by Subject|15|||
24941927|NCT00407511|50034977|FG000|Overall Study|Adverse Event|9|||
24941928|NCT00407511|50034977|FG000|Overall Study|Lost to Follow-up|4|||
24941929|NCT00407511|50034977|FG000|Overall Study|Other|5|||
24941930|NCT00407511|50034977|FG000|Overall Study|Withdrawal by Subject|4|||
24941931|NCT00384189|50034985|FG000|Overall Study|Reason Not Specified|50|||
24941932|NCT00384189|50034986|FG001|Overall Study|Reason Not Specified|57|||
24941933|NCT00384189|50034987|FG002|Overall Study|Reason Not Specified|58|||
24941934|NCT00384189|50034988|FG003|Overall Study|Reason Not Specified|40|||
24941935|NCT00326716|50035000|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
24941936|NCT00326716|50035001|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
24941937|NCT00326716|50035002|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
24941938|NCT00326716|50035003|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
24941939|NCT00548405|50035036|FG000|Overall Study|Adverse Event|6|||
24941940|NCT00548405|50035037|FG001|Overall Study|Adverse Event|2|||
24941941|NCT00548405|50035038|FG002|Overall Study|Adverse Event|0|||
24941942|NCT00548405|50035036|FG000|Overall Study|Lack of Efficacy|6|||
24941943|NCT00548405|50035037|FG001|Overall Study|Lack of Efficacy|0|||
24941944|NCT00548405|50035038|FG002|Overall Study|Lack of Efficacy|0|||
24941945|NCT00548405|50035036|FG000|Overall Study|Physician Decision|3|||
24941946|NCT00548405|50035037|FG001|Overall Study|Physician Decision|4|||
24941947|NCT00548405|50035038|FG002|Overall Study|Physician Decision|1|||
24941948|NCT00548405|50035036|FG000|Overall Study|Pregnancy|1|||
24941949|NCT00548405|50035037|FG001|Overall Study|Pregnancy|0|||
24941950|NCT00548405|50035038|FG002|Overall Study|Pregnancy|0|||
24941951|NCT00548405|50035036|FG000|Overall Study|Protocol Violation|1|||
24941952|NCT00548405|50035037|FG001|Overall Study|Protocol Violation|0|||
24941953|NCT00548405|50035038|FG002|Overall Study|Protocol Violation|0|||
24941954|NCT00548405|50035036|FG000|Overall Study|Withdrawal by Subject|36|||
24941955|NCT00548405|50035037|FG001|Overall Study|Withdrawal by Subject|12|||
24941956|NCT00548405|50035038|FG002|Overall Study|Withdrawal by Subject|5|||
24941957|NCT00548405|50035036|FG000|Overall Study|Lost to Follow-up|1|||
24941958|NCT00548405|50035037|FG001|Overall Study|Lost to Follow-up|1|||
24941959|NCT00548405|50035038|FG002|Overall Study|Lost to Follow-up|2|||
24941960|NCT00548405|50035036|FG000|Overall Study|Death|0|||
24941961|NCT00548405|50035037|FG001|Overall Study|Death|1|||
25159139|NCT01411917|50278433|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
24941962|NCT00548405|50035038|FG002|Overall Study|Death|1|||
24941963|NCT00548405|50035036|FG000|Overall Study|Sponsor decision|1|||
24941964|NCT00548405|50035037|FG001|Overall Study|Sponsor decision|0|||
24941965|NCT00548405|50035038|FG002|Overall Study|Sponsor decision|0|||
24941966|NCT00548405|50035036|FG000|Overall Study|Randomized but not treated|1|||
24941967|NCT00548405|50035037|FG001|Overall Study|Randomized but not treated|0|||
24941968|NCT00548405|50035038|FG002|Overall Study|Randomized but not treated|0|||
24941969|NCT00295750|50035050|FG000|Overall Study|Adverse Event|19|||
24941970|NCT00295750|50035051|FG001|Overall Study|Adverse Event|15|||
25159140|NCT01411839|50278441|FG000|Overall Study|Lost to Follow-up|4|||
25159141|NCT01411839|50278442|FG001|Overall Study|Lost to Follow-up|3|||
24941971|NCT00295750|50035052|FG002|Overall Study|Adverse Event|12|||
24941972|NCT00295750|50035050|FG000|Overall Study|Lack of Efficacy|1|||
24941973|NCT00295750|50035051|FG001|Overall Study|Lack of Efficacy|1|||
24941974|NCT00295750|50035052|FG002|Overall Study|Lack of Efficacy|0|||
24941975|NCT00295750|50035050|FG000|Overall Study|Lost to Follow-up|1|||
24941976|NCT00295750|50035051|FG001|Overall Study|Lost to Follow-up|4|||
24941977|NCT00295750|50035052|FG002|Overall Study|Lost to Follow-up|1|||
24941978|NCT00295750|50035050|FG000|Overall Study|Taking prohibited therapy|2|||
24941979|NCT00295750|50035051|FG001|Overall Study|Taking prohibited therapy|3|||
24941980|NCT00295750|50035052|FG002|Overall Study|Taking prohibited therapy|2|||
24941981|NCT00295750|50035050|FG000|Overall Study|Administrative errors|2|||
24941982|NCT00295750|50035051|FG001|Overall Study|Administrative errors|4|||
24941983|NCT00295750|50035052|FG002|Overall Study|Administrative errors|5|||
24941984|NCT00295750|50035050|FG000|Overall Study|Trial drug errors|1|||
24941985|NCT00295750|50035051|FG001|Overall Study|Trial drug errors|1|||
24941986|NCT00295750|50035052|FG002|Overall Study|Trial drug errors|0|||
24941987|NCT00295750|50035050|FG000|Overall Study|Disease progression|2|||
24941988|NCT00295750|50035051|FG001|Overall Study|Disease progression|1|||
24941989|NCT00295750|50035052|FG002|Overall Study|Disease progression|0|||
24941990|NCT00295750|50035050|FG000|Overall Study|Personal reasons|0|||
24941991|NCT00295750|50035051|FG001|Overall Study|Personal reasons|1|||
24941992|NCT00295750|50035052|FG002|Overall Study|Personal reasons|0|||
24941993|NCT00295750|50035050|FG000|Overall Study|Randomized but never received trial drug|4|||
24941994|NCT00295750|50035051|FG001|Overall Study|Randomized but never received trial drug|3|||
24941995|NCT00295750|50035052|FG002|Overall Study|Randomized but never received trial drug|3|||
24941996|NCT00295750|50035050|FG000|Overall Study|Withdrawal by Subject|9|||
24941997|NCT00295750|50035051|FG001|Overall Study|Withdrawal by Subject|4|||
24941998|NCT00295750|50035052|FG002|Overall Study|Withdrawal by Subject|7|||
24941999|NCT00295750|50035050|FG000|Overall Study|Protocol Violation|2|||
24942000|NCT00295750|50035051|FG001|Overall Study|Protocol Violation|4|||
24942001|NCT00295750|50035052|FG002|Overall Study|Protocol Violation|2|||
24942002|NCT03948581|50035062|FG000|Overall Study|Lost to Follow-up|0|||
24942003|NCT03948581|50035063|FG001|Overall Study|Lost to Follow-up|1|||
24942004|NCT00548327|50035071|FG000|Overall Study|Adverse Event|0|||
24942005|NCT00548327|50035072|FG001|Overall Study|Adverse Event|1|||
24942006|NCT03953183|50035094|FG000|Overall Study|Physician Decision|0|||
24942007|NCT03953183|50035095|FG001|Overall Study|Physician Decision|1|||
24942008|NCT03953183|50035094|FG000|Overall Study|Withdrawal by Subject|0|||
24942009|NCT03953183|50035095|FG001|Overall Study|Withdrawal by Subject|1|||
25029953|NCT03285295|50128448|FG003|Alinity s HBsAg|No Results Generated|0|||
25029954|NCT03285295|50128449|FG004|Alinity s HBsAg|No Results Generated|0|||
25029955|NCT03285295|50128445|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
25029956|NCT03285295|50128446|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
25029957|NCT03285295|50128447|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
24942010|NCT00406653|50035105|FG000|Induction Period|Adverse Event|1|||
24942011|NCT00406653|50035106|FG001|Induction Period|Adverse Event|10|||
24942012|NCT00406653|50035107|FG002|Induction Period|Adverse Event|4|||
24942013|NCT00406653|50035108|FG003|Induction Period|Adverse Event|11|||
24942014|NCT00406653|50035109|FG004|Induction Period|Adverse Event|0|||
24942015|NCT00406653|50035110|FG005|Induction Period|Adverse Event|0|||
24942016|NCT00406653|50035111|FG006|Induction Period|Adverse Event|0|||
24942017|NCT00406653|50035105|FG000|Induction Period|Lack of Efficacy|11|||
24942018|NCT00406653|50035106|FG001|Induction Period|Lack of Efficacy|14|||
24942019|NCT00406653|50035107|FG002|Induction Period|Lack of Efficacy|8|||
24942020|NCT00406653|50035108|FG003|Induction Period|Lack of Efficacy|10|||
24942021|NCT00406653|50035109|FG004|Induction Period|Lack of Efficacy|0|||
24942022|NCT00406653|50035110|FG005|Induction Period|Lack of Efficacy|0|||
24942023|NCT00406653|50035111|FG006|Induction Period|Lack of Efficacy|0|||
24942024|NCT00406653|50035105|FG000|Induction Period|Lost to Follow-up|0|||
24942025|NCT00406653|50035106|FG001|Induction Period|Lost to Follow-up|2|||
25275554|NCT01231607|50589416|FG003|Overall Study|Withdrawal by Subject|17|||
24942026|NCT00406653|50035107|FG002|Induction Period|Lost to Follow-up|0|||
25029958|NCT03285295|50128448|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
24942027|NCT00406653|50035108|FG003|Induction Period|Lost to Follow-up|0|||
24942028|NCT00406653|50035109|FG004|Induction Period|Lost to Follow-up|0|||
24942029|NCT00406653|50035110|FG005|Induction Period|Lost to Follow-up|0|||
24942030|NCT00406653|50035111|FG006|Induction Period|Lost to Follow-up|0|||
24942031|NCT00406653|50035105|FG000|Induction Period|Withdrawal of Consent|2|||
24942032|NCT00406653|50035106|FG001|Induction Period|Withdrawal of Consent|5|||
24942033|NCT00406653|50035107|FG002|Induction Period|Withdrawal of Consent|1|||
24942034|NCT00406653|50035108|FG003|Induction Period|Withdrawal of Consent|2|||
24942035|NCT00406653|50035109|FG004|Induction Period|Withdrawal of Consent|0|||
24942036|NCT00406653|50035110|FG005|Induction Period|Withdrawal of Consent|0|||
24942037|NCT00406653|50035111|FG006|Induction Period|Withdrawal of Consent|0|||
25159142|NCT01411215|50278450|FG000|Overall Study|Adverse Event|1|||
25159143|NCT01411215|50278451|FG001|Overall Study|Adverse Event|2|||
25159144|NCT01411215|50278450|FG000|Overall Study|Lack of Efficacy|2|||
25159145|NCT01411215|50278451|FG001|Overall Study|Lack of Efficacy|4|||
25159146|NCT01411215|50278450|FG000|Overall Study|Lost to Follow-up|12|||
25159147|NCT01411215|50278451|FG001|Overall Study|Lost to Follow-up|18|||
25159148|NCT01411215|50278450|FG000|Overall Study|Did not meet entrance criteria|0|||
25159149|NCT01411215|50278451|FG001|Overall Study|Did not meet entrance criteria|1|||
25159150|NCT01411215|50278450|FG000|Overall Study|Study terminated by sponsor|2|||
24942038|NCT00406653|50035105|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
24942039|NCT00406653|50035106|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
24942040|NCT00406653|50035107|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
24942041|NCT00406653|50035108|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
24942042|NCT00406653|50035109|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
24942043|NCT00406653|50035110|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
24942044|NCT00406653|50035111|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
24942045|NCT00406653|50035105|FG000|Induction Period|Pregnancy|1|||
24942046|NCT00406653|50035106|FG001|Induction Period|Pregnancy|0|||
24942047|NCT00406653|50035107|FG002|Induction Period|Pregnancy|0|||
24942048|NCT00406653|50035108|FG003|Induction Period|Pregnancy|0|||
24942049|NCT00406653|50035109|FG004|Induction Period|Pregnancy|0|||
24942050|NCT00406653|50035110|FG005|Induction Period|Pregnancy|0|||
24942051|NCT00406653|50035111|FG006|Induction Period|Pregnancy|0|||
24942052|NCT00406653|50035105|FG000|Induction Period|Declined participation but followup done|0|||
24942053|NCT00406653|50035106|FG001|Induction Period|Declined participation but followup done|2|||
24942054|NCT00406653|50035107|FG002|Induction Period|Declined participation but followup done|1|||
24942055|NCT00406653|50035108|FG003|Induction Period|Declined participation but followup done|1|||
24942056|NCT00406653|50035109|FG004|Induction Period|Declined participation but followup done|0|||
24942057|NCT00406653|50035110|FG005|Induction Period|Declined participation but followup done|0|||
24942058|NCT00406653|50035111|FG006|Induction Period|Declined participation but followup done|0|||
24942059|NCT00406653|50035105|FG000|Induction Period|Given prohibited drug|0|||
24942060|NCT00406653|50035106|FG001|Induction Period|Given prohibited drug|1|||
24942061|NCT00406653|50035107|FG002|Induction Period|Given prohibited drug|2|||
24942062|NCT00406653|50035108|FG003|Induction Period|Given prohibited drug|0|||
24942063|NCT00406653|50035109|FG004|Induction Period|Given prohibited drug|0|||
24942064|NCT00406653|50035110|FG005|Induction Period|Given prohibited drug|0|||
24942065|NCT00406653|50035111|FG006|Induction Period|Given prohibited drug|0|||
24942066|NCT00406653|50035105|FG000|Induction Period|Incarcerated|0|||
24942067|NCT00406653|50035106|FG001|Induction Period|Incarcerated|0|||
24942068|NCT00406653|50035107|FG002|Induction Period|Incarcerated|1|||
24942069|NCT00406653|50035108|FG003|Induction Period|Incarcerated|0|||
24942070|NCT00406653|50035109|FG004|Induction Period|Incarcerated|0|||
24942071|NCT00406653|50035110|FG005|Induction Period|Incarcerated|0|||
24942072|NCT00406653|50035111|FG006|Induction Period|Incarcerated|0|||
24942073|NCT00406653|50035105|FG000|Induction Period|Patient relocated|0|||
24942074|NCT00406653|50035106|FG001|Induction Period|Patient relocated|0|||
24942075|NCT00406653|50035107|FG002|Induction Period|Patient relocated|1|||
24942076|NCT00406653|50035108|FG003|Induction Period|Patient relocated|0|||
24942077|NCT00406653|50035109|FG004|Induction Period|Patient relocated|0|||
24942078|NCT00406653|50035110|FG005|Induction Period|Patient relocated|0|||
24942079|NCT00406653|50035111|FG006|Induction Period|Patient relocated|0|||
24942080|NCT00406653|50035105|FG000|Maintenance Period|Adverse Event|0|||
24942081|NCT00406653|50035106|FG001|Maintenance Period|Adverse Event|0|||
25159151|NCT01411215|50278451|FG001|Overall Study|Study terminated by sponsor|15|||
25159152|NCT01411215|50278450|FG000|Overall Study|Protocol Violation|3|||
24942082|NCT00406653|50035107|FG002|Maintenance Period|Adverse Event|0|||
24942083|NCT00406653|50035108|FG003|Maintenance Period|Adverse Event|0|||
24942084|NCT00406653|50035109|FG004|Maintenance Period|Adverse Event|1|||
24942085|NCT00406653|50035110|FG005|Maintenance Period|Adverse Event|1|||
24942086|NCT00406653|50035111|FG006|Maintenance Period|Adverse Event|0|||
24942087|NCT00406653|50035105|FG000|Maintenance Period|Lack of Efficacy|0|||
24942088|NCT00406653|50035106|FG001|Maintenance Period|Lack of Efficacy|0|||
24942089|NCT00406653|50035107|FG002|Maintenance Period|Lack of Efficacy|0|||
24942090|NCT00406653|50035108|FG003|Maintenance Period|Lack of Efficacy|0|||
24942091|NCT00406653|50035109|FG004|Maintenance Period|Lack of Efficacy|20|||
24942092|NCT00406653|50035110|FG005|Maintenance Period|Lack of Efficacy|26|||
24942093|NCT00406653|50035111|FG006|Maintenance Period|Lack of Efficacy|0|||
25159153|NCT01411215|50278451|FG001|Overall Study|Protocol Violation|5|||
25159154|NCT01411215|50278450|FG000|Overall Study|Withdrawal by Subject|34|||
24942094|NCT00406653|50035105|FG000|Maintenance Period|Lost to Follow-up|0|||
24942095|NCT00406653|50035106|FG001|Maintenance Period|Lost to Follow-up|0|||
24942096|NCT00406653|50035107|FG002|Maintenance Period|Lost to Follow-up|0|||
24942097|NCT00406653|50035108|FG003|Maintenance Period|Lost to Follow-up|0|||
24942098|NCT00406653|50035109|FG004|Maintenance Period|Lost to Follow-up|2|||
24942099|NCT00406653|50035110|FG005|Maintenance Period|Lost to Follow-up|1|||
24942100|NCT00406653|50035111|FG006|Maintenance Period|Lost to Follow-up|0|||
24942101|NCT00406653|50035105|FG000|Maintenance Period|Withdrawal of Consent|0|||
24942102|NCT00406653|50035106|FG001|Maintenance Period|Withdrawal of Consent|0|||
24942103|NCT00406653|50035107|FG002|Maintenance Period|Withdrawal of Consent|0|||
24942104|NCT00406653|50035108|FG003|Maintenance Period|Withdrawal of Consent|0|||
24942105|NCT00406653|50035109|FG004|Maintenance Period|Withdrawal of Consent|2|||
24942106|NCT00406653|50035110|FG005|Maintenance Period|Withdrawal of Consent|0|||
24942107|NCT00406653|50035111|FG006|Maintenance Period|Withdrawal of Consent|0|||
24942108|NCT00406653|50035105|FG000|Maintenance Period|Pregnancy|0|||
24942109|NCT00406653|50035106|FG001|Maintenance Period|Pregnancy|0|||
24942110|NCT00406653|50035107|FG002|Maintenance Period|Pregnancy|0|||
24942111|NCT00406653|50035108|FG003|Maintenance Period|Pregnancy|0|||
24942112|NCT00406653|50035109|FG004|Maintenance Period|Pregnancy|0|||
24942113|NCT00406653|50035110|FG005|Maintenance Period|Pregnancy|1|||
24942114|NCT00406653|50035111|FG006|Maintenance Period|Pregnancy|0|||
24942115|NCT00406653|50035105|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
24942116|NCT00406653|50035106|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
24942117|NCT00406653|50035107|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
24942118|NCT00406653|50035108|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
25029959|NCT03285295|50128449|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
25029960|NCT03285295|50128445|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
25029961|NCT03285295|50128446|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
25029962|NCT03285295|50128447|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
25029963|NCT03285295|50128448|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
25029964|NCT03285295|50128449|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
25029965|NCT03285295|50128445|FG000|Alinity s HTLV I/II|No Results Generated|70|||
25029966|NCT03285295|50128446|FG001|Alinity s HTLV I/II|No Results Generated|0|||
24942119|NCT00406653|50035109|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
24942120|NCT00406653|50035110|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
24942121|NCT00406653|50035111|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
25029967|NCT03285295|50128447|FG002|Alinity s HTLV I/II|No Results Generated|0|||
25029968|NCT03285295|50128448|FG003|Alinity s HTLV I/II|No Results Generated|0|||
25029969|NCT03285295|50128449|FG004|Alinity s HTLV I/II|No Results Generated|0|||
25029970|NCT03285295|50128445|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
25029971|NCT03285295|50128446|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
25029972|NCT03285295|50128447|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
25029973|NCT03285295|50128448|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
25029974|NCT03285295|50128449|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
25029975|NCT03285295|50128445|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
25029976|NCT03285295|50128446|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
25029977|NCT03285295|50128447|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
25029978|NCT03285295|50128448|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
25029979|NCT03285295|50128449|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
25029980|NCT03285295|50128445|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
25029981|NCT03285295|50128446|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
25029982|NCT03285295|50128447|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
25029983|NCT03285295|50128448|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
25029984|NCT03285295|50128449|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
25029985|NCT03285295|50128445|FG000|Alinity s Anti-HCV|No Results Generated|71|||
25186190|NCT01420679|50336126|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
24942122|NCT00406653|50035105|FG000|Maintenance Period|Error in disease score evaluation|0|||
24942123|NCT00406653|50035106|FG001|Maintenance Period|Error in disease score evaluation|0|||
24942124|NCT00406653|50035107|FG002|Maintenance Period|Error in disease score evaluation|0|||
24942125|NCT00406653|50035108|FG003|Maintenance Period|Error in disease score evaluation|0|||
24942126|NCT00406653|50035109|FG004|Maintenance Period|Error in disease score evaluation|1|||
24942127|NCT00406653|50035110|FG005|Maintenance Period|Error in disease score evaluation|0|||
24942128|NCT00406653|50035111|FG006|Maintenance Period|Error in disease score evaluation|0|||
24942129|NCT00406653|50035105|FG000|Open-Label Period|Death|0|||
24942130|NCT00406653|50035106|FG001|Open-Label Period|Death|0|||
24942131|NCT00406653|50035107|FG002|Open-Label Period|Death|0|||
24942132|NCT00406653|50035108|FG003|Open-Label Period|Death|0|||
24942133|NCT00406653|50035109|FG004|Open-Label Period|Death|0|||
24942134|NCT00406653|50035110|FG005|Open-Label Period|Death|0|||
24942135|NCT00406653|50035111|FG006|Open-Label Period|Death|1|||
24942136|NCT00406653|50035105|FG000|Open-Label Period|Adverse Event|0|||
24942137|NCT00406653|50035106|FG001|Open-Label Period|Adverse Event|0|||
24942138|NCT00406653|50035107|FG002|Open-Label Period|Adverse Event|0|||
24942139|NCT00406653|50035108|FG003|Open-Label Period|Adverse Event|0|||
24942140|NCT00406653|50035109|FG004|Open-Label Period|Adverse Event|0|||
24942141|NCT00406653|50035110|FG005|Open-Label Period|Adverse Event|0|||
24942142|NCT00406653|50035111|FG006|Open-Label Period|Adverse Event|18|||
24942143|NCT00406653|50035105|FG000|Open-Label Period|Lack of Efficacy|0|||
24942144|NCT00406653|50035106|FG001|Open-Label Period|Lack of Efficacy|0|||
24942145|NCT00406653|50035107|FG002|Open-Label Period|Lack of Efficacy|0|||
24942146|NCT00406653|50035108|FG003|Open-Label Period|Lack of Efficacy|0|||
24942147|NCT00406653|50035109|FG004|Open-Label Period|Lack of Efficacy|0|||
24942148|NCT00406653|50035110|FG005|Open-Label Period|Lack of Efficacy|0|||
24942149|NCT00406653|50035111|FG006|Open-Label Period|Lack of Efficacy|160|||
24942150|NCT00406653|50035105|FG000|Open-Label Period|Lost to Follow-up|0|||
24942151|NCT00406653|50035106|FG001|Open-Label Period|Lost to Follow-up|0|||
24942152|NCT00406653|50035107|FG002|Open-Label Period|Lost to Follow-up|0|||
24942153|NCT00406653|50035108|FG003|Open-Label Period|Lost to Follow-up|0|||
24942154|NCT00406653|50035109|FG004|Open-Label Period|Lost to Follow-up|0|||
24942155|NCT00406653|50035110|FG005|Open-Label Period|Lost to Follow-up|0|||
24942156|NCT00406653|50035111|FG006|Open-Label Period|Lost to Follow-up|6|||
24942157|NCT00406653|50035105|FG000|Open-Label Period|Withdrawal of Consent|0|||
24942158|NCT00406653|50035106|FG001|Open-Label Period|Withdrawal of Consent|0|||
24942159|NCT00406653|50035107|FG002|Open-Label Period|Withdrawal of Consent|0|||
24942160|NCT00406653|50035108|FG003|Open-Label Period|Withdrawal of Consent|0|||
24942161|NCT00406653|50035109|FG004|Open-Label Period|Withdrawal of Consent|0|||
24942162|NCT00406653|50035110|FG005|Open-Label Period|Withdrawal of Consent|0|||
24942163|NCT00406653|50035111|FG006|Open-Label Period|Withdrawal of Consent|11|||
24942164|NCT00406653|50035105|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
24942165|NCT00406653|50035106|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
24942166|NCT00406653|50035107|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
24942167|NCT00406653|50035108|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
24942168|NCT00406653|50035109|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
24942169|NCT00406653|50035110|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
24942170|NCT00406653|50035111|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
24942171|NCT00406653|50035105|FG000|Open-Label Period|Pregnancy|0|||
24942172|NCT00406653|50035106|FG001|Open-Label Period|Pregnancy|0|||
24942173|NCT00406653|50035107|FG002|Open-Label Period|Pregnancy|0|||
24942174|NCT00406653|50035108|FG003|Open-Label Period|Pregnancy|0|||
24942175|NCT00406653|50035109|FG004|Open-Label Period|Pregnancy|0|||
24942176|NCT00406653|50035110|FG005|Open-Label Period|Pregnancy|0|||
24942177|NCT00406653|50035111|FG006|Open-Label Period|Pregnancy|2|||
24942178|NCT00406653|50035105|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
24942179|NCT00406653|50035106|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
24942180|NCT00406653|50035107|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
24942181|NCT00406653|50035108|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
24942182|NCT00406653|50035109|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
24942183|NCT00406653|50035110|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
24942184|NCT00406653|50035111|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
24942185|NCT00406653|50035105|FG000|Open-Label Period|Declined participation but followup done|0|||
24942186|NCT00406653|50035106|FG001|Open-Label Period|Declined participation but followup done|0|||
24942187|NCT00406653|50035107|FG002|Open-Label Period|Declined participation but followup done|0|||
24942188|NCT00406653|50035108|FG003|Open-Label Period|Declined participation but followup done|0|||
24942189|NCT00406653|50035109|FG004|Open-Label Period|Declined participation but followup done|0|||
24942190|NCT00406653|50035110|FG005|Open-Label Period|Declined participation but followup done|0|||
24942191|NCT00406653|50035111|FG006|Open-Label Period|Declined participation but followup done|8|||
24942192|NCT00406653|50035105|FG000|Open-Label Period|Discontinued by Sponsor|0|||
24942193|NCT00406653|50035106|FG001|Open-Label Period|Discontinued by Sponsor|0|||
24942194|NCT00406653|50035107|FG002|Open-Label Period|Discontinued by Sponsor|0|||
24942195|NCT00406653|50035108|FG003|Open-Label Period|Discontinued by Sponsor|0|||
24942196|NCT00406653|50035109|FG004|Open-Label Period|Discontinued by Sponsor|0|||
24942197|NCT00406653|50035110|FG005|Open-Label Period|Discontinued by Sponsor|0|||
24942198|NCT00406653|50035111|FG006|Open-Label Period|Discontinued by Sponsor|1|||
24942199|NCT00406653|50035105|FG000|Open-Label Period|Refused followup|0|||
24942200|NCT00406653|50035106|FG001|Open-Label Period|Refused followup|0|||
24942201|NCT00406653|50035107|FG002|Open-Label Period|Refused followup|0|||
24942202|NCT00406653|50035108|FG003|Open-Label Period|Refused followup|0|||
24942203|NCT00406653|50035109|FG004|Open-Label Period|Refused followup|0|||
24942204|NCT00406653|50035110|FG005|Open-Label Period|Refused followup|0|||
24942205|NCT00406653|50035111|FG006|Open-Label Period|Refused followup|1|||
24942206|NCT00547157|50035133|FG000|Overall Study|Other|1|||
24942207|NCT00547157|50035134|FG001|Overall Study|Other|0|||
24942208|NCT00547157|50035133|FG000|Overall Study|Death|38|||
24942209|NCT00547157|50035134|FG001|Overall Study|Death|18|||
24942210|NCT00547157|50035133|FG000|Overall Study|Withdrawal by Subject|3|||
24942211|NCT00547157|50035134|FG001|Overall Study|Withdrawal by Subject|1|||
24942212|NCT00547157|50035133|FG000|Overall Study|Administrative decision|3|||
24942213|NCT00547157|50035134|FG001|Overall Study|Administrative decision|2|||
24942214|NCT00547157|50035133|FG000|Overall Study|Lost to Follow-up|4|||
24942215|NCT00547157|50035134|FG001|Overall Study|Lost to Follow-up|2|||
24942216|NCT00384033|50035144|FG000|Overall Study|Adverse Event|10|||
24942217|NCT00384033|50035145|FG001|Overall Study|Adverse Event|8|||
24942218|NCT00384033|50035146|FG002|Overall Study|Adverse Event|11|||
25159155|NCT01411215|50278451|FG001|Overall Study|Withdrawal by Subject|21|||
25159156|NCT01411215|50278450|FG000|Overall Study|Other|12|||
25159157|NCT01411215|50278451|FG001|Overall Study|Other|17|||
24942219|NCT00384033|50035147|FG003|Overall Study|Adverse Event|20|||
24942220|NCT00384033|50035144|FG000|Overall Study|Failed to return|1|||
24942221|NCT00384033|50035145|FG001|Overall Study|Failed to return|3|||
24942222|NCT00384033|50035146|FG002|Overall Study|Failed to return|2|||
24942223|NCT00384033|50035147|FG003|Overall Study|Failed to return|2|||
25159158|NCT01411215|50278450|FG000|Overall Study|Screen failure|0|||
25159159|NCT01411215|50278451|FG001|Overall Study|Screen failure|1|||
25159160|NCT01449279|50278457|FG000|Overall Study|Lack of Efficacy|5|||
25159161|NCT01449279|50278457|FG000|Overall Study|Toxicity|2|||
25159162|NCT01447719|50278461|FG000|Overall Study|Image acquisition failure|2|||
25159163|NCT01447719|50278461|FG000|Overall Study|Invalid image or not imaged|3|||
25159164|NCT01447719|50278461|FG000|Overall Study|Subject still living at end of study|79|||
25159165|NCT01447719|50278461|FG000|Overall Study|Withdrawal by Subject|2|||
25159166|NCT01447719|50278461|FG000|Overall Study|Family withdrew autopsy consent|7|||
25159167|NCT01431963|50278470|FG000|Overall Study|Adverse Event|18|||
25159168|NCT01431963|50278470|FG000|Overall Study|Lack of Efficacy|7|||
25159169|NCT01431963|50278470|FG000|Overall Study|Protocol Violation|1|||
25159170|NCT01431963|50278470|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
25159171|NCT01431963|50278470|FG000|Overall Study|Physician Decision|4|||
25159172|NCT01431963|50278470|FG000|Overall Study|Withdrawal by Subject|3|||
25275555|NCT01231607|50589417|FG004|Overall Study|Withdrawal by Subject|9|||
25275556|NCT01231373|50589436|FG000|Overall Study|Withdrew consent prior to randomization|2|||
24942224|NCT00384033|50035144|FG000|Overall Study|Physician Decision|1|||
24942225|NCT00384033|50035145|FG001|Overall Study|Physician Decision|0|||
24942226|NCT00384033|50035146|FG002|Overall Study|Physician Decision|0|||
24942227|NCT00384033|50035147|FG003|Overall Study|Physician Decision|0|||
24942228|NCT00384033|50035144|FG000|Overall Study|Lost to Follow-up|6|||
24942229|NCT00384033|50035145|FG001|Overall Study|Lost to Follow-up|12|||
25159173|NCT01447407|50278478|FG000|Overall Study|Withdrawal by Subject|2|||
25159174|NCT01447407|50278479|FG001|Overall Study|Withdrawal by Subject|0|||
25275557|NCT01231373|50589437|FG001|Overall Study|Withdrew consent prior to randomization|1|||
24942230|NCT00384033|50035146|FG002|Overall Study|Lost to Follow-up|7|||
24942231|NCT00384033|50035147|FG003|Overall Study|Lost to Follow-up|7|||
24942232|NCT00384033|50035144|FG000|Overall Study|Other|2|||
24942233|NCT00384033|50035145|FG001|Overall Study|Other|0|||
24942234|NCT00384033|50035146|FG002|Overall Study|Other|0|||
24942235|NCT00384033|50035147|FG003|Overall Study|Other|0|||
24942236|NCT00384033|50035144|FG000|Overall Study|Protocol Violation|5|||
24942237|NCT00384033|50035145|FG001|Overall Study|Protocol Violation|0|||
24942238|NCT00384033|50035146|FG002|Overall Study|Protocol Violation|5|||
25159175|NCT01447407|50278480|FG002|Overall Study|Withdrawal by Subject|0|||
25159176|NCT01447407|50278481|FG003|Overall Study|Withdrawal by Subject|1|||
25159177|NCT01447407|50278478|FG000|Overall Study|Physician Decision|0|||
25159178|NCT01447407|50278479|FG001|Overall Study|Physician Decision|0|||
24942239|NCT00384033|50035147|FG003|Overall Study|Protocol Violation|6|||
24942240|NCT00384033|50035144|FG000|Overall Study|Withdrawal by Subject|6|||
24942241|NCT00384033|50035145|FG001|Overall Study|Withdrawal by Subject|2|||
24942242|NCT00384033|50035146|FG002|Overall Study|Withdrawal by Subject|5|||
24942243|NCT00384033|50035147|FG003|Overall Study|Withdrawal by Subject|2|||
24942244|NCT00384033|50035144|FG000|Overall Study|Lack of Efficacy|7|||
24942245|NCT00384033|50035145|FG001|Overall Study|Lack of Efficacy|3|||
24942246|NCT00384033|50035146|FG002|Overall Study|Lack of Efficacy|3|||
24942247|NCT00384033|50035147|FG003|Overall Study|Lack of Efficacy|1|||
24942248|NCT00384033|50035144|FG000|Overall Study|Randomized but not treated|3|||
24942249|NCT00384033|50035145|FG001|Overall Study|Randomized but not treated|7|||
24942250|NCT00384033|50035146|FG002|Overall Study|Randomized but not treated|10|||
24942251|NCT00384033|50035147|FG003|Overall Study|Randomized but not treated|2|||
24942252|NCT00546377|50035157|FG000|Overall Study|Deemed ineligible|1|||
24942253|NCT00546377|50035157|FG000|Overall Study|Adverse Event|6|||
24942254|NCT00545753|50035164|FG000|Overall Study|Withdrawal by Subject|0|||
25159179|NCT01447407|50278480|FG002|Overall Study|Physician Decision|1|||
24942255|NCT00545753|50035165|FG001|Overall Study|Withdrawal by Subject|1|||
24942256|NCT00545753|50035166|FG002|Overall Study|Withdrawal by Subject|10|||
24942257|NCT00545753|50035164|FG000|Overall Study|Lost to Follow-up|13|||
24942258|NCT00545753|50035165|FG001|Overall Study|Lost to Follow-up|3|||
24942259|NCT00545753|50035166|FG002|Overall Study|Lost to Follow-up|12|||
24942260|NCT00545753|50035164|FG000|Overall Study|Protocol Violation|3|||
24942261|NCT00545753|50035165|FG001|Overall Study|Protocol Violation|1|||
24942262|NCT00545753|50035166|FG002|Overall Study|Protocol Violation|4|||
24942263|NCT00406419|50035178|FG000|Overall Study|Death|3|||
24942264|NCT00406419|50035179|FG001|Overall Study|Death|1|||
24942265|NCT00406419|50035180|FG002|Overall Study|Death|4|||
24942266|NCT00406419|50035178|FG000|Overall Study|Protocol Violation|6|||
24942267|NCT00406419|50035179|FG001|Overall Study|Protocol Violation|2|||
24942268|NCT00406419|50035180|FG002|Overall Study|Protocol Violation|5|||
24942269|NCT00406419|50035178|FG000|Overall Study|Study Terminated by Sponsor|260|||
24942270|NCT00406419|50035179|FG001|Overall Study|Study Terminated by Sponsor|288|||
24942271|NCT00406419|50035180|FG002|Overall Study|Study Terminated by Sponsor|282|||
24942272|NCT00406419|50035178|FG000|Overall Study|Withdrawal by Subject|17|||
24942273|NCT00406419|50035179|FG001|Overall Study|Withdrawal by Subject|24|||
24942274|NCT00406419|50035180|FG002|Overall Study|Withdrawal by Subject|26|||
24942275|NCT00406419|50035178|FG000|Overall Study|Lack of Efficacy|12|||
24942276|NCT00406419|50035179|FG001|Overall Study|Lack of Efficacy|1|||
24942277|NCT00406419|50035180|FG002|Overall Study|Lack of Efficacy|6|||
24942278|NCT00406419|50035178|FG000|Overall Study|Non-Compliance with Study Drug|5|||
24942279|NCT00406419|50035179|FG001|Overall Study|Non-Compliance with Study Drug|6|||
24942280|NCT00406419|50035180|FG002|Overall Study|Non-Compliance with Study Drug|3|||
24942281|NCT00406419|50035178|FG000|Overall Study|Adverse Event|10|||
24942282|NCT00406419|50035179|FG001|Overall Study|Adverse Event|12|||
24942283|NCT00406419|50035180|FG002|Overall Study|Adverse Event|16|||
24942284|NCT00406419|50035178|FG000|Overall Study|Lost to Follow-up|11|||
24942285|NCT00406419|50035179|FG001|Overall Study|Lost to Follow-up|10|||
24942286|NCT00406419|50035180|FG002|Overall Study|Lost to Follow-up|5|||
24942287|NCT00325468|50035193|FG000|Overall Study|Adverse Event|1|||
24942288|NCT00325468|50035194|FG001|Overall Study|Adverse Event|1|||
24942289|NCT00325468|50035195|FG002|Overall Study|Adverse Event|0|||
24942290|NCT00325468|50035196|FG003|Overall Study|Adverse Event|5|||
24942291|NCT00325468|50035197|FG004|Overall Study|Adverse Event|1|||
24942292|NCT00325468|50035193|FG000|Overall Study|Death|2|||
24942293|NCT00325468|50035194|FG001|Overall Study|Death|0|||
24942294|NCT00325468|50035195|FG002|Overall Study|Death|2|||
24942295|NCT00325468|50035196|FG003|Overall Study|Death|4|||
24942296|NCT00325468|50035197|FG004|Overall Study|Death|0|||
24942297|NCT00325468|50035193|FG000|Overall Study|Lost to Follow-up|0|||
24942298|NCT00325468|50035194|FG001|Overall Study|Lost to Follow-up|0|||
24942299|NCT00325468|50035195|FG002|Overall Study|Lost to Follow-up|1|||
24942300|NCT00325468|50035196|FG003|Overall Study|Lost to Follow-up|2|||
24942301|NCT00325468|50035197|FG004|Overall Study|Lost to Follow-up|2|||
24942302|NCT00325468|50035193|FG000|Overall Study|Physician Decision|1|||
24942303|NCT00325468|50035194|FG001|Overall Study|Physician Decision|1|||
24942304|NCT00325468|50035195|FG002|Overall Study|Physician Decision|0|||
24942305|NCT00325468|50035196|FG003|Overall Study|Physician Decision|1|||
24942306|NCT00325468|50035197|FG004|Overall Study|Physician Decision|0|||
24942307|NCT00325468|50035193|FG000|Overall Study|Withdrawal by Subject|3|||
24942308|NCT00325468|50035194|FG001|Overall Study|Withdrawal by Subject|1|||
24942309|NCT00325468|50035195|FG002|Overall Study|Withdrawal by Subject|0|||
24942310|NCT00325468|50035196|FG003|Overall Study|Withdrawal by Subject|14|||
25029986|NCT03285295|50128446|FG001|Alinity s Anti-HCV|No Results Generated|0|||
25029987|NCT03285295|50128447|FG002|Alinity s Anti-HCV|No Results Generated|0|||
25029988|NCT03285295|50128448|FG003|Alinity s Anti-HCV|No Results Generated|0|||
25029989|NCT03285295|50128449|FG004|Alinity s Anti-HCV|No Results Generated|0|||
25029990|NCT03285295|50128445|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
25029991|NCT03285295|50128446|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
25029992|NCT03285295|50128447|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
25029993|NCT03285295|50128448|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
25029994|NCT03285295|50128449|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
25029995|NCT03285295|50128445|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
25029996|NCT03285295|50128446|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
25029997|NCT03285295|50128447|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
25029998|NCT03285295|50128448|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
25029999|NCT03285295|50128449|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
25030000|NCT03285295|50128445|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
25030001|NCT03285295|50128446|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
25030002|NCT03285295|50128447|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
24942311|NCT00325468|50035197|FG004|Overall Study|Withdrawal by Subject|4|||
24942312|NCT00325468|50035193|FG000|Overall Study|site closure etc|4|||
25030003|NCT03285295|50128448|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
25030004|NCT03285295|50128449|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
25030005|NCT03285295|50128445|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
25030006|NCT03285295|50128446|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
25030007|NCT03285295|50128447|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
25030008|NCT03285295|50128448|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
25030009|NCT03285295|50128449|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
25030010|NCT03285295|50128445|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
25030011|NCT03285295|50128446|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
25030012|NCT03285295|50128447|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
25030013|NCT03285295|50128448|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
25030014|NCT03285295|50128449|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
25030015|NCT03285295|50128445|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
25030016|NCT03285295|50128446|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
25030017|NCT03285295|50128447|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
25030018|NCT03285295|50128448|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
25030019|NCT03285295|50128449|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
25030020|NCT03285295|50128445|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
24942313|NCT00325468|50035194|FG001|Overall Study|site closure etc|2|||
25030021|NCT03285295|50128446|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
25030022|NCT03285295|50128447|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
25030023|NCT03285295|50128448|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
25030024|NCT03285295|50128449|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
24942314|NCT00325468|50035195|FG002|Overall Study|site closure etc|1|||
24942315|NCT00325468|50035196|FG003|Overall Study|site closure etc|8|||
24942316|NCT00325468|50035197|FG004|Overall Study|site closure etc|1|||
24942317|NCT03833661|50035210|FG000|Overall Study|Treatment ongoing|9|||
24942318|NCT00311584|50035216|FG000|Overall Study|Death|1|||
24942319|NCT00311584|50035217|FG001|Overall Study|Death|0|||
24942320|NCT00311584|50035216|FG000|Overall Study|Lack of Efficacy|12|||
25030025|NCT03285295|50128445|FG000|Alinity s Anti-HBc|No Results Generated|70|||
25030026|NCT03285295|50128446|FG001|Alinity s Anti-HBc|No Results Generated|0|||
25030027|NCT03285295|50128447|FG002|Alinity s Anti-HBc|No Results Generated|0|||
25030028|NCT03285295|50128448|FG003|Alinity s Anti-HBc|No Results Generated|0|||
24942321|NCT00311584|50035217|FG001|Overall Study|Lack of Efficacy|15|||
24942322|NCT00311584|50035216|FG000|Overall Study|Physician Decision|4|||
24942323|NCT00311584|50035217|FG001|Overall Study|Physician Decision|5|||
24942324|NCT00311584|50035216|FG000|Overall Study|Withdrawal by Subject|1|||
24942325|NCT00311584|50035217|FG001|Overall Study|Withdrawal by Subject|1|||
24942326|NCT00311584|50035216|FG000|Overall Study|ineligible|2|||
24942327|NCT00311584|50035217|FG001|Overall Study|ineligible|2|||
24942328|NCT00383331|50035225|FG000|Overall Study|Protocol Violation|0|||
25030029|NCT03285295|50128449|FG004|Alinity s Anti-HBc|No Results Generated|0|||
25030030|NCT03285295|50128445|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
24942329|NCT00383331|50035226|FG001|Overall Study|Protocol Violation|1|||
24942330|NCT03934541|50035236|FG000|Overall Study|Study Terminated by Sponsor|0|||
25159180|NCT01447407|50278481|FG003|Overall Study|Physician Decision|1|||
25159181|NCT01446237|50278491|FG000|Overall Study|Adverse Event|1|||
25159182|NCT01446237|50278491|FG000|Overall Study|Lost to Follow-up|2|||
25159183|NCT01446237|50278491|FG000|Overall Study|Withdrawal by Subject|7|||
25159184|NCT01446159|50278639|FG000|Overall Study|Withdrawal by Subject|1|||
25159185|NCT01446159|50278640|FG001|Overall Study|Withdrawal by Subject|0|||
25159186|NCT01446159|50278641|FG002|Overall Study|Withdrawal by Subject|14|||
25159187|NCT01446159|50278642|FG003|Overall Study|Withdrawal by Subject|11|||
25159188|NCT01446159|50278639|FG000|Overall Study|Lost to Follow-up|0|||
25159189|NCT01446159|50278640|FG001|Overall Study|Lost to Follow-up|0|||
25159190|NCT01446159|50278641|FG002|Overall Study|Lost to Follow-up|1|||
25159191|NCT01446159|50278642|FG003|Overall Study|Lost to Follow-up|2|||
25159192|NCT01446159|50278639|FG000|Overall Study|Death|2|||
25159193|NCT01446159|50278640|FG001|Overall Study|Death|3|||
25159194|NCT01446159|50278641|FG002|Overall Study|Death|43|||
25159195|NCT01446159|50278642|FG003|Overall Study|Death|36|||
25159196|NCT01446159|50278639|FG000|Overall Study|Other|0|||
25159197|NCT01446159|50278640|FG001|Overall Study|Other|0|||
25159198|NCT01446159|50278641|FG002|Overall Study|Other|13|||
25159199|NCT01446159|50278642|FG003|Overall Study|Other|13|||
25159200|NCT01446003|50278678|FG000|Period 1|Protocol Violation|2|||
25159201|NCT01446003|50278679|FG001|Period 1|Protocol Violation|0|||
25159202|NCT01446003|50278678|FG000|Period 2|Adverse Event|1|||
25159203|NCT01446003|50278679|FG001|Period 2|Adverse Event|0|||
25159204|NCT01430559|50278696|FG000|Overall Study|Adverse Event|7|||
25159205|NCT01430559|50278697|FG001|Overall Study|Adverse Event|3|||
25159206|NCT01430559|50278696|FG000|Overall Study|Entry criteria not met|1|||
25159207|NCT01430559|50278697|FG001|Overall Study|Entry criteria not met|1|||
25159208|NCT01430559|50278696|FG000|Overall Study|Lost to Follow-up|1|||
25159209|NCT01430559|50278697|FG001|Overall Study|Lost to Follow-up|0|||
25159210|NCT01430559|50278696|FG000|Overall Study|Medication error|1|||
25159211|NCT01430559|50278697|FG001|Overall Study|Medication error|0|||
25159212|NCT01430559|50278696|FG000|Overall Study|Withdrawal by Subject|3|||
25159213|NCT01430559|50278697|FG001|Overall Study|Withdrawal by Subject|2|||
24942331|NCT03934541|50035237|FG001|Overall Study|Study Terminated by Sponsor|1|||
25030031|NCT03285295|50128446|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
25159214|NCT01430559|50278696|FG000|Overall Study|Protocol Violation|1|||
25159215|NCT01430559|50278697|FG001|Overall Study|Protocol Violation|0|||
25159216|NCT01430559|50278696|FG000|Overall Study|Other|3|||
25159217|NCT01430559|50278697|FG001|Overall Study|Other|3|||
25159218|NCT01430559|50278696|FG000|Overall Study|Randomized, Not Treated|3|||
25159219|NCT01430559|50278697|FG001|Overall Study|Randomized, Not Treated|3|||
25159220|NCT01410357|50278710|FG000|Overall Study|Death|2|||
24942332|NCT03934541|50035238|FG002|Overall Study|Study Terminated by Sponsor|0|||
25159221|NCT01410357|50278711|FG001|Overall Study|Death|1|||
25159222|NCT01410357|50278710|FG000|Overall Study|Withdrawal by Subject|1|||
25159223|NCT01410357|50278711|FG001|Overall Study|Withdrawal by Subject|2|||
25159224|NCT01410357|50278710|FG000|Overall Study|Lost to Follow-up|23|||
24942333|NCT03934541|50035239|FG003|Overall Study|Study Terminated by Sponsor|0|||
25159225|NCT01410357|50278711|FG001|Overall Study|Lost to Follow-up|21|||
25159226|NCT01409811|50278736|FG000|Overall Study|Insurance denial|1|||
25159227|NCT01445847|50278742|FG000|Overall Study|Protocol Violation|13|||
25159228|NCT01445847|50278743|FG001|Overall Study|Protocol Violation|14|||
25159229|NCT01445847|50278742|FG000|Overall Study|Missed Data|1|||
25159230|NCT01445847|50278743|FG001|Overall Study|Missed Data|0|||
25159231|NCT01445769|50278762|FG000|Overall Study|Consent Withdrawn|2|||
25159232|NCT01445769|50278762|FG000|Overall Study|Disease Progression|1|||
25159233|NCT01445769|50278762|FG000|Overall Study|Lost to Follow-up|5|||
25159234|NCT01445613|50278844|FG000|30-day Follow-up|Withdrawal by Subject|6|||
25159235|NCT01445613|50278844|FG000|30-day Follow-up|Physician Decision|3|||
25159236|NCT01445613|50278844|FG000|30-day Follow-up|Missed visit|23|||
25159237|NCT01445613|50278844|FG000|30-day Follow-up|Death|3|||
25159238|NCT01445613|50278844|FG000|1-year Follow-up|Withdrawal by Subject|12|||
25159239|NCT01445613|50278844|FG000|1-year Follow-up|Missed visit|29|||
25159240|NCT01445613|50278844|FG000|1-year Follow-up|Lost to Follow-up|2|||
25159241|NCT01445613|50278844|FG000|1-year Follow-up|Death|30|||
24942334|NCT00325234|50035251|FG000|Overall Study|Adverse Event|10|||
24942335|NCT00325234|50035252|FG001|Overall Study|Adverse Event|7|||
24942336|NCT00325234|50035251|FG000|Overall Study|Death due to Study Disease|1|||
24942337|NCT00325234|50035252|FG001|Overall Study|Death due to Study Disease|0|||
24942338|NCT00325234|50035251|FG000|Overall Study|Entry Criteria Not Met|1|||
24942339|NCT00325234|50035252|FG001|Overall Study|Entry Criteria Not Met|2|||
24942340|NCT00325234|50035251|FG000|Overall Study|Subject Decision|6|||
24942341|NCT00325234|50035252|FG001|Overall Study|Subject Decision|8|||
24942342|NCT00325234|50035251|FG000|Overall Study|Physician Decision|17|||
24942343|NCT00325234|50035252|FG001|Overall Study|Physician Decision|12|||
24942344|NCT00325234|50035251|FG000|Overall Study|Progressive Disease|34|||
24942345|NCT00325234|50035252|FG001|Overall Study|Progressive Disease|37|||
24942346|NCT00366249|50035262|FG000|Overall Study|Adverse Event|53|||
24942347|NCT00366249|50035263|FG001|Overall Study|Adverse Event|28|||
24942348|NCT00366249|50035262|FG000|Overall Study|Death|0|||
24942349|NCT00366249|50035263|FG001|Overall Study|Death|1|||
24942350|NCT00366249|50035262|FG000|Overall Study|Physician Decision|5|||
24942351|NCT00366249|50035263|FG001|Overall Study|Physician Decision|2|||
24942352|NCT00366249|50035262|FG000|Overall Study|Lost to Follow-up|2|||
24942353|NCT00366249|50035263|FG001|Overall Study|Lost to Follow-up|0|||
24942354|NCT00366249|50035262|FG000|Overall Study|Protocol Violation|1|||
24942355|NCT00366249|50035263|FG001|Overall Study|Protocol Violation|2|||
24942356|NCT00366249|50035262|FG000|Overall Study|Withdrawal by Subject|18|||
24942357|NCT00366249|50035263|FG001|Overall Study|Withdrawal by Subject|4|||
24942358|NCT00366249|50035262|FG000|Overall Study|Lack of Efficacy|21|||
24942359|NCT00366249|50035263|FG001|Overall Study|Lack of Efficacy|21|||
24942360|NCT00366249|50035262|FG000|Overall Study|Most due to osteomylitis status|31|||
24942361|NCT00366249|50035263|FG001|Overall Study|Most due to osteomylitis status|20|||
24942362|NCT00325156|50035269|FG000|Overall Study|Protocol Violation|8|||
24942363|NCT00325156|50035269|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
24942364|NCT00325156|50035269|FG000|Overall Study|Migrated/moved from study area|12|||
25030032|NCT03285295|50128447|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
25030033|NCT03285295|50128448|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
25030034|NCT03285295|50128449|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
25159242|NCT01445613|50278844|FG000|1-year Follow-up|Physician Decision|2|||
25159243|NCT01445613|50278844|FG000|1-year Follow-up|Received a non-study stent|2|||
25159244|NCT01445535|50278948|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
24942365|NCT00325156|50035269|FG000|Overall Study|Adverse event, non-fatal|3|||
24942366|NCT00325156|50035269|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
24942367|NCT00325156|50035269|FG000|Overall Study|Other|1|||
24942368|NCT00325156|50035269|FG000|Overall Study|Withdrawal by Subject|31|||
24942369|NCT03927911|50035279|FG000|Overall Study|problems with eDiary|0|||
24942370|NCT03927911|50035280|FG001|Overall Study|problems with eDiary|1|||
24942371|NCT03927911|50035281|FG002|Overall Study|problems with eDiary|0|||
24942372|NCT03927911|50035282|FG003|Overall Study|problems with eDiary|1|||
24942373|NCT03927911|50035283|FG004|Overall Study|problems with eDiary|0|||
24942374|NCT03927911|50035284|FG005|Overall Study|problems with eDiary|4|||
24942375|NCT03927911|50035279|FG000|Overall Study|Adverse Event|0|||
24942376|NCT03927911|50035280|FG001|Overall Study|Adverse Event|0|||
24942377|NCT03927911|50035281|FG002|Overall Study|Adverse Event|0|||
24942378|NCT03927911|50035282|FG003|Overall Study|Adverse Event|0|||
24942379|NCT03927911|50035283|FG004|Overall Study|Adverse Event|0|||
24942380|NCT03927911|50035284|FG005|Overall Study|Adverse Event|1|||
24942381|NCT03927911|50035279|FG000|Overall Study|not treated -study terminated by sponsor|0|||
24942382|NCT03927911|50035280|FG001|Overall Study|not treated -study terminated by sponsor|1|||
24942383|NCT03927911|50035281|FG002|Overall Study|not treated -study terminated by sponsor|0|||
24942384|NCT03927911|50035282|FG003|Overall Study|not treated -study terminated by sponsor|0|||
24942385|NCT03927911|50035283|FG004|Overall Study|not treated -study terminated by sponsor|0|||
24942386|NCT03927911|50035284|FG005|Overall Study|not treated -study terminated by sponsor|0|||
24942387|NCT03927911|50035279|FG000|Overall Study|Surgery cancelled|0|||
25159245|NCT01445535|50278949|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
25159246|NCT01445535|50278950|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
25275558|NCT01231373|50589438|FG002|Overall Study|Withdrew consent prior to randomization|0|||
24942388|NCT03927911|50035280|FG001|Overall Study|Surgery cancelled|0|||
24942389|NCT03927911|50035281|FG002|Overall Study|Surgery cancelled|0|||
24942390|NCT03927911|50035282|FG003|Overall Study|Surgery cancelled|1|||
24942391|NCT03927911|50035283|FG004|Overall Study|Surgery cancelled|0|||
24942392|NCT03927911|50035284|FG005|Overall Study|Surgery cancelled|1|||
24942393|NCT03927911|50035279|FG000|Overall Study|Protocol Violation|0|||
24942394|NCT03927911|50035280|FG001|Overall Study|Protocol Violation|0|||
25159247|NCT01445535|50278951|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
25159248|NCT01445535|50278948|FG000|Overall Study|Disease progression|1|||
25159249|NCT01445535|50278949|FG001|Overall Study|Disease progression|0|||
25159250|NCT01445535|50278950|FG002|Overall Study|Disease progression|1|||
25159251|NCT01445535|50278951|FG003|Overall Study|Disease progression|0|||
25159252|NCT01445535|50278948|FG000|Overall Study|PI discretion|0|||
25159253|NCT01445535|50278949|FG001|Overall Study|PI discretion|0|||
25159254|NCT01445535|50278950|FG002|Overall Study|PI discretion|0|||
24942395|NCT03927911|50035281|FG002|Overall Study|Protocol Violation|0|||
24942396|NCT03927911|50035282|FG003|Overall Study|Protocol Violation|0|||
24942397|NCT03927911|50035283|FG004|Overall Study|Protocol Violation|0|||
24942398|NCT03927911|50035284|FG005|Overall Study|Protocol Violation|1|||
24942399|NCT00383019|50035300|FG000|Overall Study|Adverse Event|5|||
24942400|NCT00383019|50035301|FG001|Overall Study|Adverse Event|1|||
24942401|NCT00383019|50035300|FG000|Overall Study|Withdrawal by Subject|0|||
24942402|NCT00383019|50035301|FG001|Overall Study|Withdrawal by Subject|1|||
25030035|NCT03285295|50128445|FG000|Alinity s Chagas|Protocol Violation|76|||
25030036|NCT03285295|50128446|FG001|Alinity s Chagas|Protocol Violation|0|||
24942403|NCT00310804|50035309|FG000|Overall Study|Lost to Follow-up|2|||
24942404|NCT00310804|50035310|FG001|Overall Study|Lost to Follow-up|0|||
24942405|NCT00310804|50035309|FG000|Overall Study|Withdrawal by Subject|3|||
24942406|NCT00310804|50035310|FG001|Overall Study|Withdrawal by Subject|0|||
24942407|NCT03826186|50035332|FG000|Overall Study|Protocol Violation|2|||
24942408|NCT03826186|50035333|FG001|Overall Study|Protocol Violation|0|||
24942409|NCT03826186|50035332|FG000|Overall Study|Withdrawal by Subject|1|||
24942410|NCT03826186|50035333|FG001|Overall Study|Withdrawal by Subject|0|||
24942411|NCT00382863|50035341|FG000|Overall Study|Death|9|||
24942412|NCT00382863|50035342|FG001|Overall Study|Death|9|||
24942413|NCT00382863|50035341|FG000|Overall Study|Lost to Follow-up|1|||
24942414|NCT00382863|50035342|FG001|Overall Study|Lost to Follow-up|2|||
24942415|NCT00382863|50035341|FG000|Overall Study|Withdrawal by Subject|5|||
24942416|NCT00382863|50035342|FG001|Overall Study|Withdrawal by Subject|25|||
24942417|NCT03933449|50035350|FG000|Overall Study|Adverse Event|6|||
24942418|NCT03933449|50035351|FG001|Overall Study|Adverse Event|4|||
24942419|NCT03933449|50035350|FG000|Overall Study|Death|55|||
24942420|NCT03933449|50035351|FG001|Overall Study|Death|57|||
24942421|NCT03933449|50035350|FG000|Overall Study|Sponsor Decision|1|||
24942422|NCT03933449|50035351|FG001|Overall Study|Sponsor Decision|0|||
24942423|NCT00290758|50035374|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
24942424|NCT00290758|50035375|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
24942425|NCT00290758|50035374|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
24942426|NCT00290758|50035375|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
24942427|NCT00290758|50035374|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
24942428|NCT00290758|50035375|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
24942429|NCT00290758|50035374|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
24942430|NCT00290758|50035375|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
24942431|NCT00290758|50035374|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
24942432|NCT00290758|50035375|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
24942433|NCT00290758|50035374|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
24942434|NCT00290758|50035375|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
24942435|NCT00290758|50035374|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
24942436|NCT00290758|50035375|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
24942437|NCT00290758|50035374|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
24942438|NCT00290758|50035375|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
24942439|NCT00372567|50035388|FG000|Phase 3 Study|Adverse Event|5|||
24942440|NCT00372567|50035389|FG001|Phase 3 Study|Adverse Event|1|||
25030037|NCT03285295|50128447|FG002|Alinity s Chagas|Protocol Violation|0|||
25159255|NCT01445535|50278951|FG003|Overall Study|PI discretion|1|||
25159256|NCT01445301|50278965|FG000|Overall Study|Adverse Event|15|||
24942441|NCT00372567|50035390|FG002|Phase 3 Study|Adverse Event|1|||
24942442|NCT00372567|50035388|FG000|Phase 3 Study|Death|1|||
24942443|NCT00372567|50035389|FG001|Phase 3 Study|Death|1|||
24942444|NCT00372567|50035390|FG002|Phase 3 Study|Death|0|||
24942445|NCT00372567|50035388|FG000|Phase 3 Study|Protocol Violation|0|||
24942446|NCT00372567|50035389|FG001|Phase 3 Study|Protocol Violation|0|||
25030038|NCT03285295|50128448|FG003|Alinity s Chagas|Protocol Violation|0|||
25030039|NCT03285295|50128449|FG004|Alinity s Chagas|Protocol Violation|0|||
25159257|NCT01445301|50278966|FG001|Overall Study|Adverse Event|25|||
25275559|NCT01231373|50589439|FG003|Overall Study|Withdrew consent prior to randomization|0|||
24942447|NCT00372567|50035390|FG002|Phase 3 Study|Protocol Violation|1|||
24942448|NCT00372567|50035388|FG000|Phase 3 Study|Objective progression or relapse|10|||
24942449|NCT00372567|50035389|FG001|Phase 3 Study|Objective progression or relapse|13|||
24942450|NCT00372567|50035390|FG002|Phase 3 Study|Objective progression or relapse|4|||
24942451|NCT00372567|50035388|FG000|Phase 3 Study|Global deterioration of health status|0|||
24942452|NCT00372567|50035389|FG001|Phase 3 Study|Global deterioration of health status|1|||
24942453|NCT00372567|50035390|FG002|Phase 3 Study|Global deterioration of health status|0|||
24942454|NCT00372567|50035388|FG000|Phase 3 Study|Other|2|||
24942455|NCT00372567|50035389|FG001|Phase 3 Study|Other|2|||
24942456|NCT00372567|50035390|FG002|Phase 3 Study|Other|1|||
25159258|NCT01445301|50278967|FG002|Overall Study|Adverse Event|4|||
25159259|NCT01445301|50278965|FG000|Overall Study|Lack of Efficacy|0|||
25159260|NCT01445301|50278966|FG001|Overall Study|Lack of Efficacy|1|||
25159261|NCT01445301|50278967|FG002|Overall Study|Lack of Efficacy|0|||
25159262|NCT01445301|50278965|FG000|Overall Study|Protocol Violation|1|||
25159263|NCT01445301|50278966|FG001|Overall Study|Protocol Violation|0|||
24942457|NCT00372567|50035388|FG000|Phase 3 Study|study terminated by sponsor|13|||
24942458|NCT00372567|50035389|FG001|Phase 3 Study|study terminated by sponsor|8|||
24942459|NCT00372567|50035390|FG002|Phase 3 Study|study terminated by sponsor|5|||
24942460|NCT00365547|50035398|FG000|Overall Study|Insurance did not cover Avastin|1|||
24942461|NCT00365547|50035398|FG000|Overall Study|Screen failure|1|||
24942462|NCT00365547|50035398|FG000|Overall Study|Withdrawal by Subject|1|||
24942463|NCT00545441|50035407|FG000|Overall Study|Fistula draining at 6 months|2|||
24942464|NCT00545441|50035408|FG001|Overall Study|Fistula draining at 6 months|4|||
24942465|NCT00545441|50035407|FG000|Overall Study|Lost to Follow-up|9|||
24942466|NCT00545441|50035408|FG001|Overall Study|Lost to Follow-up|5|||
25159264|NCT01445301|50278967|FG002|Overall Study|Protocol Violation|0|||
25159265|NCT01445301|50278965|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
25159266|NCT01445301|50278966|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
25159267|NCT01445301|50278967|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
24942467|NCT00545441|50035407|FG000|Overall Study|Technical failure|0|||
24942468|NCT00545441|50035408|FG001|Overall Study|Technical failure|1|||
24942469|NCT00545441|50035407|FG000|Overall Study|Withdrawal by Subject|1|||
24942470|NCT00545441|50035408|FG001|Overall Study|Withdrawal by Subject|1|||
24942471|NCT00545441|50035407|FG000|Overall Study|Persistence or recurrence of fistula|5|||
24942472|NCT00545441|50035408|FG001|Overall Study|Persistence or recurrence of fistula|2|||
24942473|NCT00545441|50035407|FG000|Overall Study|Patients were not treated|1|||
24942474|NCT00545441|50035408|FG001|Overall Study|Patients were not treated|3|||
24942475|NCT00294658|50035416|FG000|Overall Study|Death|0|||
24942476|NCT00294658|50035417|FG001|Overall Study|Death|1|||
24942477|NCT00294658|50035416|FG000|Overall Study|Lost to Follow-up|4|||
24942478|NCT00294658|50035417|FG001|Overall Study|Lost to Follow-up|0|||
24942479|NCT00294658|50035416|FG000|Overall Study|Physician Decision|1|||
24942480|NCT00294658|50035417|FG001|Overall Study|Physician Decision|2|||
24942481|NCT00294658|50035416|FG000|Overall Study|Pregnancy|0|||
24942482|NCT00294658|50035417|FG001|Overall Study|Pregnancy|1|||
24942483|NCT00294658|50035416|FG000|Overall Study|Withdrawal by Subject|0|||
24942484|NCT00294658|50035417|FG001|Overall Study|Withdrawal by Subject|4|||
24942485|NCT00294658|50035416|FG000|Overall Study|Found to have invasive thymoma|1|||
24942486|NCT00294658|50035417|FG001|Overall Study|Found to have invasive thymoma|0|||
24942487|NCT00294658|50035416|FG000|Overall Study|Patient and family were not satisfied|0|||
24942488|NCT00294658|50035417|FG001|Overall Study|Patient and family were not satisfied|1|||
24942489|NCT03923933|50035425|FG000|Overall Study|Lost to Follow-up|1|||
24942490|NCT03923933|50035426|FG001|Overall Study|Lost to Follow-up|0|||
24942491|NCT03923933|50035425|FG000|Overall Study|Withdrawal by Subject|0|||
24942492|NCT03923933|50035426|FG001|Overall Study|Withdrawal by Subject|1|||
24942493|NCT00372489|50035432|FG000|Overall Study|Adverse Event|18|||
24942494|NCT00372489|50035432|FG000|Overall Study|Lack of Efficacy|1|||
24942495|NCT00372489|50035432|FG000|Overall Study|Lost to Follow-up|3|||
24942496|NCT00372489|50035432|FG000|Overall Study|Physician Decision|3|||
24942497|NCT00372489|50035432|FG000|Overall Study|Withdrawal by Subject|5|||
24942498|NCT00372489|50035432|FG000|Overall Study|Patient Relocation|2|||
24942499|NCT00372489|50035432|FG000|Overall Study|Renal transplant|6|||
24942500|NCT00372489|50035432|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
24942501|NCT00372411|50035439|FG000|Overall Study|Withdrawal by Subject|3|||
24942502|NCT00372411|50035440|FG001|Overall Study|Withdrawal by Subject|4|||
24942503|NCT00372411|50035441|FG002|Overall Study|Withdrawal by Subject|1|||
24942504|NCT00372411|50035439|FG000|Overall Study|Death|0|||
24942505|NCT00372411|50035440|FG001|Overall Study|Death|2|||
24942506|NCT00372411|50035441|FG002|Overall Study|Death|1|||
24942507|NCT00372411|50035439|FG000|Overall Study|Lost to Follow-up|1|||
24942508|NCT00372411|50035440|FG001|Overall Study|Lost to Follow-up|1|||
25030040|NCT03285295|50128445|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
24942509|NCT00372411|50035441|FG002|Overall Study|Lost to Follow-up|1|||
24942510|NCT00372411|50035439|FG000|Overall Study|Adverse Event|1|||
24942511|NCT00372411|50035440|FG001|Overall Study|Adverse Event|1|||
25159268|NCT01445301|50278965|FG000|Overall Study|Physician Decision|0|||
24942512|NCT00372411|50035441|FG002|Overall Study|Adverse Event|0|||
24942513|NCT00372255|50035451|FG000|Overall Study|Withdrawn for other reasons|2|||
25159269|NCT01445301|50278966|FG001|Overall Study|Physician Decision|2|||
24942514|NCT00372255|50035452|FG001|Overall Study|Withdrawn for other reasons|1|||
24942515|NCT00274456|50035463|FG000|Overall Study|Still on treatment|2|||
24942516|NCT00274456|50035464|FG001|Overall Study|Still on treatment|3|||
24942517|NCT00274456|50035465|FG002|Overall Study|Still on treatment|5|||
24942518|NCT00274456|50035466|FG003|Overall Study|Still on treatment|1|||
24942519|NCT00274456|50035463|FG000|Overall Study|Unacceptable toxicity|10|||
24942520|NCT00274456|50035464|FG001|Overall Study|Unacceptable toxicity|5|||
24942521|NCT00274456|50035465|FG002|Overall Study|Unacceptable toxicity|12|||
24942522|NCT00274456|50035466|FG003|Overall Study|Unacceptable toxicity|16|||
25159270|NCT01445301|50278967|FG002|Overall Study|Physician Decision|0|||
25159271|NCT01445301|50278965|FG000|Overall Study|Withdrawal by Subject|5|||
25159272|NCT01445301|50278966|FG001|Overall Study|Withdrawal by Subject|6|||
24942523|NCT00274456|50035463|FG000|Overall Study|Adverse Event|0|||
24942524|NCT00274456|50035464|FG001|Overall Study|Adverse Event|1|||
24942525|NCT00274456|50035465|FG002|Overall Study|Adverse Event|2|||
24942526|NCT00274456|50035466|FG003|Overall Study|Adverse Event|2|||
24942527|NCT00274456|50035463|FG000|Overall Study|Physician Decision|7|||
24942528|NCT00274456|50035464|FG001|Overall Study|Physician Decision|5|||
24942529|NCT00274456|50035465|FG002|Overall Study|Physician Decision|6|||
24942530|NCT00274456|50035466|FG003|Overall Study|Physician Decision|13|||
24942531|NCT00274456|50035463|FG000|Overall Study|Lost to Follow-up|0|||
24942532|NCT00274456|50035464|FG001|Overall Study|Lost to Follow-up|0|||
25030041|NCT03285295|50128446|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
25030042|NCT03285295|50128447|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
25030043|NCT03285295|50128448|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
25030044|NCT03285295|50128449|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
25030045|NCT03285295|50128445|FG000|Alinity s Chagas|No Results Generated|105|||
25030046|NCT03285295|50128446|FG001|Alinity s Chagas|No Results Generated|0|||
25030047|NCT03285295|50128447|FG002|Alinity s Chagas|No Results Generated|0|||
25030048|NCT03285295|50128448|FG003|Alinity s Chagas|No Results Generated|0|||
25030049|NCT03285295|50128449|FG004|Alinity s Chagas|No Results Generated|0|||
25030050|NCT03285295|50128445|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
25030051|NCT03285295|50128446|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
25030052|NCT03285295|50128447|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
25030053|NCT03285295|50128448|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
25030054|NCT03285295|50128449|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
25030055|NCT02583048|50128481|FG000|Overall Study|Withdrawal by Subject|0|||
25030056|NCT02583048|50128482|FG001|Overall Study|Withdrawal by Subject|1|||
25030057|NCT02583048|50128483|FG002|Overall Study|Withdrawal by Subject|0|||
25030058|NCT02583048|50128481|FG000|Overall Study|Failed to meet eligibility criterion|0|||
25030059|NCT02583048|50128482|FG001|Overall Study|Failed to meet eligibility criterion|0|||
25030060|NCT02583048|50128483|FG002|Overall Study|Failed to meet eligibility criterion|1|||
25030061|NCT02939599|50128496|FG000|Overall Study|Adverse Event|1|||
25159273|NCT01445301|50278967|FG002|Overall Study|Withdrawal by Subject|4|||
24942533|NCT00274456|50035465|FG002|Overall Study|Lost to Follow-up|1|||
24942534|NCT00274456|50035466|FG003|Overall Study|Lost to Follow-up|0|||
24942535|NCT00274456|50035463|FG000|Overall Study|Withdrawal by Subject|18|||
24942536|NCT00274456|50035464|FG001|Overall Study|Withdrawal by Subject|13|||
24942537|NCT00274456|50035465|FG002|Overall Study|Withdrawal by Subject|9|||
24942538|NCT00274456|50035466|FG003|Overall Study|Withdrawal by Subject|13|||
24942539|NCT00364923|50035476|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
24942540|NCT00364923|50035476|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
24942541|NCT00381849|50035482|FG000|Wash Out|Withdrawal by Subject|0|||
24942542|NCT00381849|50035483|FG001|Wash Out|Withdrawal by Subject|1|||
24942543|NCT00273052|50035491|FG000|Overall Study|Withdrawal by Subject|16|||
24942544|NCT00273052|50035492|FG001|Overall Study|Withdrawal by Subject|19|||
24942545|NCT00273052|50035491|FG000|Overall Study|Adverse Event|21|||
24942546|NCT00273052|50035492|FG001|Overall Study|Adverse Event|19|||
24942547|NCT00273052|50035491|FG000|Overall Study|Protocol Violation|14|||
25030062|NCT02939599|50128497|FG001|Overall Study|Adverse Event|0|||
25030063|NCT02939599|50128496|FG000|Overall Study|Study Terminated By Sponsor|2|||
25030064|NCT02939599|50128497|FG001|Overall Study|Study Terminated By Sponsor|2|||
25030065|NCT01318512|50128504|FG000|Maintenance Period (6 Months)|Death|2|||
24942548|NCT00273052|50035492|FG001|Overall Study|Protocol Violation|18|||
24942549|NCT00273052|50035491|FG000|Overall Study|Lost to Follow-up|7|||
24942550|NCT00273052|50035492|FG001|Overall Study|Lost to Follow-up|25|||
24942551|NCT00273052|50035491|FG000|Overall Study|Lack of Efficacy|6|||
24942552|NCT00273052|50035492|FG001|Overall Study|Lack of Efficacy|4|||
25030066|NCT01318512|50128504|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
25030067|NCT03274687|50128525|FG000|Overall Study|Protocol Violation|1|||
24942553|NCT00273052|50035491|FG000|Overall Study|Non-Compliance|3|||
24942554|NCT00273052|50035492|FG001|Overall Study|Non-Compliance|1|||
24942555|NCT00273052|50035491|FG000|Overall Study|Other|2|||
25030068|NCT03274687|50128526|FG001|Overall Study|Protocol Violation|1|||
25030069|NCT04651218|50128532|FG000|Overall Study|Withdrawal by Subject|0|||
25030070|NCT04651218|50128533|FG001|Overall Study|Withdrawal by Subject|2|||
25030071|NCT03274453|50128543|FG000|Overall Study|Lost to Follow-up|2|||
25159274|NCT01409031|50278977|FG000|Overall Study|transferred to other hosp|1|||
25159275|NCT01409031|50278978|FG001|Overall Study|transferred to other hosp|0|||
25159276|NCT01430403|50278987|FG000|Overall Study|Lost to Follow-up|5|||
25159277|NCT01430403|50278988|FG001|Overall Study|Lost to Follow-up|5|||
25159278|NCT01430403|50278989|FG002|Overall Study|Lost to Follow-up|3|||
25159279|NCT01430403|50278987|FG000|Overall Study|Physician Decision|1|||
25159280|NCT01430403|50278988|FG001|Overall Study|Physician Decision|0|||
25159281|NCT01430403|50278989|FG002|Overall Study|Physician Decision|0|||
25030072|NCT03274453|50128544|FG001|Overall Study|Lost to Follow-up|5|||
25030073|NCT03274453|50128545|FG002|Overall Study|Lost to Follow-up|4|||
25030074|NCT03274453|50128546|FG003|Overall Study|Lost to Follow-up|1|||
25030075|NCT03274453|50128543|FG000|Overall Study|Physician Decision|2|||
25030076|NCT03274453|50128544|FG001|Overall Study|Physician Decision|0|||
25030077|NCT03274453|50128545|FG002|Overall Study|Physician Decision|0|||
25030078|NCT03274453|50128546|FG003|Overall Study|Physician Decision|3|||
25030079|NCT03274453|50128543|FG000|Overall Study|Surgery Cancelled|0|||
25030080|NCT03274453|50128544|FG001|Overall Study|Surgery Cancelled|1|||
25030081|NCT03274453|50128545|FG002|Overall Study|Surgery Cancelled|0|||
25030082|NCT03274453|50128546|FG003|Overall Study|Surgery Cancelled|0|||
25030083|NCT03273907|50128556|FG000|Overall Study|Death|1|||
25030084|NCT03273907|50128556|FG000|Overall Study|Lost to Follow-up|4|||
25159282|NCT01430403|50278987|FG000|Overall Study|Protocol Violation|2|||
25159283|NCT01430403|50278988|FG001|Overall Study|Protocol Violation|3|||
24942556|NCT00273052|50035492|FG001|Overall Study|Other|0|||
24942557|NCT00273052|50035491|FG000|Overall Study|Worsening serum lipid levels|0|||
24942558|NCT00273052|50035492|FG001|Overall Study|Worsening serum lipid levels|2|||
24942559|NCT00290290|50035500|FG000|Overall Study|Death|3|||
24942560|NCT00290290|50035501|FG001|Overall Study|Death|4|||
24942561|NCT00290290|50035500|FG000|Overall Study|Withdrawal by Subject|2|||
24942562|NCT00290290|50035501|FG001|Overall Study|Withdrawal by Subject|2|||
24942563|NCT00290290|50035500|FG000|Overall Study|Underwent clean surgical procedure|13|||
24942564|NCT00290290|50035501|FG001|Overall Study|Underwent clean surgical procedure|12|||
24942565|NCT00272038|50035507|FG000|Overall Study|withdrew before they received 2 cycles|7|||
25030085|NCT03273907|50128556|FG000|Overall Study|Withdrawal by Subject|2|||
25030086|NCT03273907|50128556|FG000|Overall Study|COVID 19|2|||
25030087|NCT00659646|50128578|FG000|Overall Study|Protocol Violation|12|||
25030088|NCT00659646|50128579|FG001|Overall Study|Protocol Violation|8|||
25030089|NCT00659646|50128578|FG000|Overall Study|Adverse Event|1|||
25030090|NCT00659646|50128579|FG001|Overall Study|Adverse Event|0|||
25159284|NCT01430403|50278989|FG002|Overall Study|Protocol Violation|2|||
25030091|NCT00659646|50128578|FG000|Overall Study|Lost to Follow-up|1|||
25159285|NCT01430403|50278987|FG000|Overall Study|Withdrawal by Subject|9|||
24942566|NCT00271024|50035516|FG000|Overall Study|Lost Interest|3|||
24942567|NCT00271024|50035517|FG001|Overall Study|Lost Interest|4|||
24942568|NCT00271024|50035518|FG002|Overall Study|Lost Interest|2|||
25159286|NCT01430403|50278988|FG001|Overall Study|Withdrawal by Subject|1|||
25159287|NCT01430403|50278989|FG002|Overall Study|Withdrawal by Subject|3|||
25159288|NCT01429623|50279004|FG000|Overall Study|Death|1|||
25159289|NCT01429623|50279005|FG001|Overall Study|Death|0|||
25159290|NCT01429623|50279004|FG000|Overall Study|Adverse Event|7|||
25159291|NCT01429623|50279005|FG001|Overall Study|Adverse Event|14|||
25159292|NCT01429623|50279004|FG000|Overall Study|Withdrawal by Subject|19|||
25159293|NCT01429623|50279005|FG001|Overall Study|Withdrawal by Subject|13|||
24942569|NCT00271024|50035519|FG003|Overall Study|Lost Interest|3|||
24942570|NCT00271024|50035516|FG000|Overall Study|Unknown/Unspecified|11|||
24942571|NCT00271024|50035517|FG001|Overall Study|Unknown/Unspecified|11|||
24942572|NCT00271024|50035518|FG002|Overall Study|Unknown/Unspecified|8|||
24942573|NCT00271024|50035519|FG003|Overall Study|Unknown/Unspecified|4|||
24942574|NCT00271024|50035516|FG000|Overall Study|Protocol Violation|1|||
24942575|NCT00271024|50035517|FG001|Overall Study|Protocol Violation|6|||
24942576|NCT00271024|50035518|FG002|Overall Study|Protocol Violation|5|||
24942577|NCT00271024|50035519|FG003|Overall Study|Protocol Violation|11|||
24942578|NCT00271024|50035516|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
24942579|NCT00271024|50035517|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
24942580|NCT00271024|50035518|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
24942581|NCT00271024|50035519|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
24942582|NCT00271024|50035516|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
24942583|NCT00271024|50035517|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
24942584|NCT00271024|50035518|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
24942585|NCT00271024|50035519|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
25030092|NCT00659646|50128579|FG001|Overall Study|Lost to Follow-up|0|||
25030093|NCT00659646|50128578|FG000|Overall Study|protocol noncompliance after randomized|1|||
25030094|NCT00659646|50128579|FG001|Overall Study|protocol noncompliance after randomized|0|||
25030095|NCT02236572|50128587|FG000|Overall Study|Withdrawal by Subject|1|||
24942586|NCT00381693|50035529|FG000|Overall Study|Death|1|||
24942587|NCT00381693|50035529|FG000|Overall Study|Adverse Event|4|||
25030096|NCT02236572|50128587|FG000|Overall Study|Protocol Violation|1|||
25030097|NCT02236572|50128587|FG000|Overall Study|Lost to Follow-up|1|||
25030098|NCT03054870|50128591|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
25030099|NCT03054870|50128591|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
25030100|NCT03414047|50128610|FG000|Overall Study|Adverse Event|0|||
25030101|NCT03414047|50128611|FG001|Overall Study|Adverse Event|0|||
25030102|NCT03414047|50128612|FG002|Overall Study|Adverse Event|1|||
25030103|NCT03414047|50128613|FG003|Overall Study|Adverse Event|1|||
25030104|NCT03414047|50128610|FG000|Overall Study|Physician Decision|1|||
25030105|NCT03414047|50128611|FG001|Overall Study|Physician Decision|0|||
25030106|NCT03414047|50128612|FG002|Overall Study|Physician Decision|0|||
25030107|NCT03414047|50128613|FG003|Overall Study|Physician Decision|1|||
25030108|NCT03414047|50128610|FG000|Overall Study|Withdrawal by Subject|1|||
25030109|NCT03414047|50128611|FG001|Overall Study|Withdrawal by Subject|0|||
25030110|NCT03414047|50128612|FG002|Overall Study|Withdrawal by Subject|2|||
25030111|NCT03414047|50128613|FG003|Overall Study|Withdrawal by Subject|0|||
25030112|NCT03351335|50128627|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
25030113|NCT03351335|50128628|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
25030114|NCT03351335|50128629|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
25030115|NCT03055806|50128641|FG000|Overall Study|Adverse Event|0|||
25030116|NCT03055806|50128642|FG001|Overall Study|Adverse Event|0|||
25030117|NCT03055806|50128643|FG002|Overall Study|Adverse Event|1|||
25030118|NCT03055806|50128644|FG003|Overall Study|Adverse Event|1|||
25030119|NCT03055806|50128641|FG000|Overall Study|Lost to Follow-up|0|||
25159294|NCT01429623|50279004|FG000|Overall Study|Physician Decision|2|||
25159295|NCT01429623|50279005|FG001|Overall Study|Physician Decision|3|||
25159296|NCT01429623|50279004|FG000|Overall Study|Protocol Violation|3|||
24942588|NCT00381693|50035529|FG000|Overall Study|Patient Choice|1|||
24942589|NCT00381693|50035529|FG000|Overall Study|Progression|2|||
24942590|NCT00545363|50035535|FG000|Overall Study|Adverse Event|6|||
25030120|NCT03055806|50128642|FG001|Overall Study|Lost to Follow-up|3|||
25030121|NCT03055806|50128643|FG002|Overall Study|Lost to Follow-up|6|||
25030122|NCT03055806|50128644|FG003|Overall Study|Lost to Follow-up|7|||
25030123|NCT03055806|50128641|FG000|Overall Study|Physician Decision|1|||
25030124|NCT03055806|50128642|FG001|Overall Study|Physician Decision|0|||
24942591|NCT00545363|50035536|FG001|Overall Study|Adverse Event|7|||
24942592|NCT00545363|50035535|FG000|Overall Study|Withdrawal by Subject|6|||
24942593|NCT00545363|50035536|FG001|Overall Study|Withdrawal by Subject|5|||
25030125|NCT03055806|50128643|FG002|Overall Study|Physician Decision|0|||
25030126|NCT03055806|50128644|FG003|Overall Study|Physician Decision|1|||
25030127|NCT03055806|50128641|FG000|Overall Study|Protocol Violation|1|||
25030128|NCT03055806|50128642|FG001|Overall Study|Protocol Violation|0|||
24942594|NCT00545363|50035535|FG000|Overall Study|Non-compliance|3|||
24942595|NCT00545363|50035536|FG001|Overall Study|Non-compliance|1|||
24942596|NCT00545363|50035535|FG000|Overall Study|Did not meet entry criteria|1|||
24942597|NCT00545363|50035536|FG001|Overall Study|Did not meet entry criteria|1|||
24942598|NCT00545363|50035535|FG000|Overall Study|Lost to Follow-up|2|||
24942599|NCT00545363|50035536|FG001|Overall Study|Lost to Follow-up|0|||
24942600|NCT00545363|50035535|FG000|Overall Study|Other|1|||
24942601|NCT00545363|50035536|FG001|Overall Study|Other|1|||
24942602|NCT00457392|50035544|FG000|Overall Study|Objective Progression or Relapse|229|||
24942603|NCT00457392|50035545|FG001|Overall Study|Objective Progression or Relapse|296|||
24942604|NCT00457392|50035544|FG000|Overall Study|Death|106|||
24942605|NCT00457392|50035545|FG001|Overall Study|Death|106|||
24942606|NCT00457392|50035544|FG000|Overall Study|Adverse Event|84|||
24942607|NCT00457392|50035545|FG001|Overall Study|Adverse Event|41|||
24942608|NCT00457392|50035544|FG000|Overall Study|Global Deterioration of Health Status|22|||
24942609|NCT00457392|50035545|FG001|Overall Study|Global Deterioration of Health Status|8|||
24942610|NCT00457392|50035544|FG000|Overall Study|Withdrawal by Subject|14|||
24942611|NCT00457392|50035545|FG001|Overall Study|Withdrawal by Subject|8|||
24942612|NCT00457392|50035544|FG000|Overall Study|Lost to Follow-up|6|||
24942613|NCT00457392|50035545|FG001|Overall Study|Lost to Follow-up|7|||
24942614|NCT00457392|50035544|FG000|Overall Study|Protocol Violation|4|||
24942615|NCT00457392|50035545|FG001|Overall Study|Protocol Violation|3|||
24942616|NCT00457392|50035544|FG000|Overall Study|Other|7|||
24942617|NCT00457392|50035545|FG001|Overall Study|Other|4|||
24942618|NCT00457392|50035544|FG000|Overall Study|Study Terminated by Sponsor|1|||
24942619|NCT00457392|50035545|FG001|Overall Study|Study Terminated by Sponsor|4|||
24942620|NCT00457392|50035544|FG000|Overall Study|Randomized, Not Treated|7|||
24942621|NCT00457392|50035545|FG001|Overall Study|Randomized, Not Treated|3|||
24942622|NCT00545051|50035553|FG000|Overall Study|Adverse Event|7|||
24942623|NCT00545051|50035554|FG001|Overall Study|Adverse Event|3|||
24942624|NCT00545051|50035553|FG000|Overall Study|Death|1|||
24942625|NCT00545051|50035554|FG001|Overall Study|Death|0|||
24942626|NCT00545051|50035553|FG000|Overall Study|Violation of inclusion/exclusion|0|||
24942627|NCT00545051|50035554|FG001|Overall Study|Violation of inclusion/exclusion|2|||
24942628|NCT00545051|50035553|FG000|Overall Study|Protocol Violation|1|||
24942629|NCT00545051|50035554|FG001|Overall Study|Protocol Violation|0|||
24942630|NCT00545051|50035553|FG000|Overall Study|Withdrawal by Subject|0|||
24942631|NCT00545051|50035554|FG001|Overall Study|Withdrawal by Subject|1|||
24942632|NCT00545051|50035553|FG000|Overall Study|Administrative reasons|0|||
24942633|NCT00545051|50035554|FG001|Overall Study|Administrative reasons|1|||
24942634|NCT00381615|50035564|FG000|Overall Study|Withdrawal by Subject|1|||
24942635|NCT00381615|50035565|FG001|Overall Study|Withdrawal by Subject|3|||
24942636|NCT00381615|50035566|FG002|Overall Study|Withdrawal by Subject|0|||
24942637|NCT00381615|50035567|FG003|Overall Study|Withdrawal by Subject|1|||
24942638|NCT00381615|50035564|FG000|Overall Study|Lost to Follow-up|3|||
24942639|NCT00381615|50035565|FG001|Overall Study|Lost to Follow-up|2|||
24942640|NCT00381615|50035566|FG002|Overall Study|Lost to Follow-up|0|||
24942641|NCT00381615|50035567|FG003|Overall Study|Lost to Follow-up|1|||
24942642|NCT00381615|50035564|FG000|Overall Study|Protocol Violation|0|||
24942643|NCT00381615|50035565|FG001|Overall Study|Protocol Violation|0|||
24942644|NCT00381615|50035566|FG002|Overall Study|Protocol Violation|1|||
24942645|NCT00381615|50035567|FG003|Overall Study|Protocol Violation|0|||
24942646|NCT00371865|50035581|FG000|Overall Study|Lack of Efficacy|0|||
24942647|NCT00371865|50035582|FG001|Overall Study|Lack of Efficacy|2|||
24942648|NCT00371865|50035581|FG000|Overall Study|Protocol Violation|3|||
24942649|NCT00371865|50035582|FG001|Overall Study|Protocol Violation|2|||
24942650|NCT00371865|50035581|FG000|Overall Study|Withdrawal by Subject|12|||
24942651|NCT00371865|50035582|FG001|Overall Study|Withdrawal by Subject|10|||
24942652|NCT00364845|50035590|FG000|Overall Study|Adverse Event|1|||
24942653|NCT00364845|50035591|FG001|Overall Study|Adverse Event|0|||
24942654|NCT00364845|50035590|FG000|Overall Study|Withdrawal by Subject|2|||
25030129|NCT03055806|50128643|FG002|Overall Study|Protocol Violation|0|||
25030130|NCT03055806|50128644|FG003|Overall Study|Protocol Violation|0|||
25030131|NCT03055806|50128641|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
25159297|NCT01429623|50279005|FG001|Overall Study|Protocol Violation|2|||
24942655|NCT00364845|50035591|FG001|Overall Study|Withdrawal by Subject|1|||
24942656|NCT00364845|50035590|FG000|Overall Study|Physician Decision|8|||
25159298|NCT01429623|50279004|FG000|Overall Study|Assorted|1|||
24942657|NCT00364845|50035591|FG001|Overall Study|Physician Decision|8|||
24942658|NCT00364845|50035590|FG000|Overall Study|Lost to Follow-up|0|||
24942659|NCT00364845|50035591|FG001|Overall Study|Lost to Follow-up|1|||
24942660|NCT00364845|50035590|FG000|Overall Study|Death|0|||
24942661|NCT00364845|50035591|FG001|Overall Study|Death|1|||
24942662|NCT00293722|50035597|FG000|Overall Study|Other|427|||
24942663|NCT00381303|50035603|FG000|Overall Study|Lost to Follow-up|25|||
25159299|NCT01429623|50279005|FG001|Overall Study|Assorted|2|||
24942664|NCT00381303|50035604|FG001|Overall Study|Lost to Follow-up|9|||
24942665|NCT00381303|50035603|FG000|Overall Study|AE/HIV-related event|22|||
24942666|NCT00381303|50035604|FG001|Overall Study|AE/HIV-related event|6|||
24942667|NCT00381303|50035603|FG000|Overall Study|Non-Adherence|13|||
25030132|NCT03055806|50128642|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
25030133|NCT03055806|50128643|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
25030134|NCT03055806|50128644|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
25030135|NCT03055806|50128641|FG000|Overall Study|Withdrawal of consent to continue study|2|||
25030136|NCT03055806|50128642|FG001|Overall Study|Withdrawal of consent to continue study|3|||
25030137|NCT03055806|50128643|FG002|Overall Study|Withdrawal of consent to continue study|4|||
25030138|NCT03055806|50128644|FG003|Overall Study|Withdrawal of consent to continue study|6|||
25030139|NCT03055806|50128641|FG000|Overall Study|Partner not willing to try intercourse|1|||
25030140|NCT03055806|50128642|FG001|Overall Study|Partner not willing to try intercourse|0|||
25030141|NCT03055806|50128643|FG002|Overall Study|Partner not willing to try intercourse|0|||
25030142|NCT03055806|50128644|FG003|Overall Study|Partner not willing to try intercourse|0|||
25030143|NCT04620798|50128656|FG000|Overall Study|Lost to Follow-up|126|||
25030144|NCT04620798|50128657|FG001|Overall Study|Lost to Follow-up|138|||
25030145|NCT03052764|50128665|FG000|Double-Blind Treatment Period|Adverse Event|2|||
25030146|NCT03052764|50128666|FG001|Double-Blind Treatment Period|Adverse Event|0|||
25030147|NCT03052764|50128665|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
25030148|NCT03052764|50128666|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
25030149|NCT03052764|50128665|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
25030150|NCT03052764|50128666|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
25030151|NCT03052764|50128665|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
25030152|NCT03052764|50128666|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
25030153|NCT03052764|50128665|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
25030154|NCT03052764|50128666|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
25030155|NCT02951819|50128676|FG000|Overall Study|Death|9|||
25030156|NCT02951819|50128677|FG001|Overall Study|Death|7|||
25030157|NCT02951819|50128676|FG000|Overall Study|Withdrawal by Subject|3|||
25030158|NCT02951819|50128677|FG001|Overall Study|Withdrawal by Subject|0|||
25030159|NCT02951819|50128676|FG000|Overall Study|Adverse Event|1|||
25030160|NCT02951819|50128677|FG001|Overall Study|Adverse Event|0|||
25030161|NCT02951819|50128676|FG000|Overall Study|Lack of Efficacy|4|||
25030162|NCT02951819|50128677|FG001|Overall Study|Lack of Efficacy|0|||
25030163|NCT02951819|50128676|FG000|Overall Study|Lost to Follow-up|1|||
25030164|NCT02951819|50128677|FG001|Overall Study|Lost to Follow-up|0|||
25030165|NCT02951819|50128676|FG000|Overall Study|Progressive Disease|1|||
25030166|NCT02951819|50128677|FG001|Overall Study|Progressive Disease|0|||
25030167|NCT02951819|50128676|FG000|Overall Study|Other|9|||
25030168|NCT02951819|50128677|FG001|Overall Study|Other|0|||
25030169|NCT03383783|50128683|FG000|Overall Study|Withdrawal by Subject|2|||
25030170|NCT03334721|50128701|FG000|Overall Study|Withdrawal by Subject|1|||
25030171|NCT03334721|50128702|FG001|Overall Study|Withdrawal by Subject|0|||
25030172|NCT03334721|50128701|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
24942668|NCT00381303|50035604|FG001|Overall Study|Non-Adherence|6|||
24942669|NCT00381303|50035603|FG000|Overall Study|Withdrawal by Subject|13|||
24942670|NCT00381303|50035604|FG001|Overall Study|Withdrawal by Subject|6|||
24942671|NCT00381303|50035603|FG000|Overall Study|Virologic failure|6|||
24942672|NCT00381303|50035604|FG001|Overall Study|Virologic failure|4|||
24942673|NCT00381303|50035603|FG000|Overall Study|Ineligible to continue the trial|2|||
24942674|NCT00381303|50035604|FG001|Overall Study|Ineligible to continue the trial|1|||
24942675|NCT00381303|50035603|FG000|Overall Study|Pregnancy|2|||
24942676|NCT00381303|50035604|FG001|Overall Study|Pregnancy|0|||
24942677|NCT00381303|50035603|FG000|Overall Study|Physician Decision|1|||
24942678|NCT00381303|50035604|FG001|Overall Study|Physician Decision|0|||
24942679|NCT00381303|50035603|FG000|Overall Study|Physician's decision to close the site|3|||
24942680|NCT00381303|50035604|FG001|Overall Study|Physician's decision to close the site|1|||
24942681|NCT00381303|50035603|FG000|Overall Study|Subject moved out of state|2|||
24942682|NCT00381303|50035604|FG001|Overall Study|Subject moved out of state|0|||
24942683|NCT00381303|50035603|FG000|Overall Study|Subject taking too many different meds|1|||
24942684|NCT00381303|50035604|FG001|Overall Study|Subject taking too many different meds|0|||
24942685|NCT00381303|50035603|FG000|Overall Study|No virologic response by week 12|1|||
24942686|NCT00381303|50035604|FG001|Overall Study|No virologic response by week 12|0|||
24942687|NCT00381303|50035603|FG000|Overall Study|Subject was too busy for appointments|1|||
24942688|NCT00381303|50035604|FG001|Overall Study|Subject was too busy for appointments|0|||
24942689|NCT00381303|50035603|FG000|Overall Study|Subject did not continue visits|1|||
24942690|NCT00381303|50035604|FG001|Overall Study|Subject did not continue visits|0|||
24942691|NCT00381303|50035603|FG000|Overall Study|Subject primary physician's decision|1|||
24942692|NCT00381303|50035604|FG001|Overall Study|Subject primary physician's decision|0|||
25030173|NCT03334721|50128702|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
25030174|NCT03515551|50128715|FG000|Overall Study|Death|4|||
25030175|NCT03515551|50128716|FG001|Overall Study|Death|1|||
25030176|NCT03515551|50128717|FG002|Overall Study|Death|2|||
25030177|NCT03515551|50128718|FG003|Overall Study|Death|2|||
25030178|NCT03515551|50128719|FG004|Overall Study|Death|2|||
25030179|NCT03515551|50128720|FG005|Overall Study|Death|4|||
24942693|NCT00448812|50035624|FG000|Year 2|Missed visit but remained in study|4|||
24942694|NCT00448812|50035625|FG001|Year 2|Missed visit but remained in study|1|||
24942695|NCT00448812|50035624|FG000|Year 3|Withdrawal by Subject|1|||
24942696|NCT00448812|50035625|FG001|Year 3|Withdrawal by Subject|3|||
24942697|NCT00448812|50035624|FG000|Year 3|Lost to Follow-up|1|||
24942698|NCT00448812|50035625|FG001|Year 3|Lost to Follow-up|0|||
24942699|NCT00448812|50035624|FG000|Year 3|Missed visit but remained in study|2|||
24942700|NCT00448812|50035625|FG001|Year 3|Missed visit but remained in study|0|||
24942701|NCT00448812|50035624|FG000|Year 5|Missed visit but remained in study|1|||
24942702|NCT00448812|50035625|FG001|Year 5|Missed visit but remained in study|0|||
24942703|NCT00364689|50035646|FG000|Overall Study|Lost to Follow-up|1|||
24942704|NCT00545129|50035654|FG000|Overall Study|Lack of Efficacy|2|||
24942705|NCT00545129|50035655|FG001|Overall Study|Lack of Efficacy|5|||
24942706|NCT00545129|50035654|FG000|Overall Study|Death|2|||
24942707|NCT00545129|50035655|FG001|Overall Study|Death|1|||
24942708|NCT00545129|50035654|FG000|Overall Study|Adverse Event|1|||
24942709|NCT00545129|50035655|FG001|Overall Study|Adverse Event|1|||
24942710|NCT00545129|50035654|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
24942711|NCT00545129|50035655|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
24942712|NCT00545129|50035654|FG000|Overall Study|Other|3|||
24942713|NCT00545129|50035655|FG001|Overall Study|Other|3|||
24942714|NCT00364611|50035663|FG000|Overall Study|Did not receive study medication|0|||
24942715|NCT00364611|50035664|FG001|Overall Study|Did not receive study medication|1|||
24942716|NCT00364611|50035663|FG000|Overall Study|Adverse Event|7|||
24942717|NCT00364611|50035664|FG001|Overall Study|Adverse Event|4|||
24942718|NCT00364611|50035663|FG000|Overall Study|Participant's Request|3|||
24942719|NCT00364611|50035664|FG001|Overall Study|Participant's Request|4|||
24942720|NCT00364611|50035663|FG000|Overall Study|Disease Progression|38|||
24942721|NCT00364611|50035664|FG001|Overall Study|Disease Progression|8|||
24942722|NCT00364611|50035663|FG000|Overall Study|Investigator decision|2|||
24942723|NCT00364611|50035664|FG001|Overall Study|Investigator decision|2|||
24942724|NCT00364611|50035663|FG000|Overall Study|Found Ineligible|1|||
24942725|NCT00364611|50035664|FG001|Overall Study|Found Ineligible|0|||
24942726|NCT00364611|50035663|FG000|Overall Study|Presumed CR on Study|0|||
24942727|NCT00364611|50035664|FG001|Overall Study|Presumed CR on Study|1|||
24942728|NCT00364611|50035663|FG000|Overall Study|Receiving Liver Ablation|0|||
24942729|NCT00364611|50035664|FG001|Overall Study|Receiving Liver Ablation|1|||
24942730|NCT00364533|50035675|FG000|Overall Study|Adverse Event|8|||
24942731|NCT00364533|50035676|FG001|Overall Study|Adverse Event|7|||
24942732|NCT00364533|50035677|FG002|Overall Study|Adverse Event|15|||
24942733|NCT00364533|50035678|FG003|Overall Study|Adverse Event|5|||
24942734|NCT00364533|50035679|FG004|Overall Study|Adverse Event|2|||
24942735|NCT00364533|50035675|FG000|Overall Study|Withdrawal by Subject|4|||
24942736|NCT00364533|50035676|FG001|Overall Study|Withdrawal by Subject|8|||
24942737|NCT00364533|50035677|FG002|Overall Study|Withdrawal by Subject|6|||
24942738|NCT00364533|50035678|FG003|Overall Study|Withdrawal by Subject|6|||
24942739|NCT00364533|50035679|FG004|Overall Study|Withdrawal by Subject|6|||
24942740|NCT00364533|50035675|FG000|Overall Study|Lack of Efficacy|22|||
24942741|NCT00364533|50035676|FG001|Overall Study|Lack of Efficacy|22|||
24942742|NCT00364533|50035677|FG002|Overall Study|Lack of Efficacy|21|||
24942743|NCT00364533|50035678|FG003|Overall Study|Lack of Efficacy|17|||
24942744|NCT00364533|50035679|FG004|Overall Study|Lack of Efficacy|42|||
24942745|NCT00364533|50035675|FG000|Overall Study|Subject discharged from hospital|4|||
24942746|NCT00364533|50035676|FG001|Overall Study|Subject discharged from hospital|1|||
24942747|NCT00364533|50035677|FG002|Overall Study|Subject discharged from hospital|2|||
24942748|NCT00364533|50035678|FG003|Overall Study|Subject discharged from hospital|3|||
24942749|NCT00364533|50035679|FG004|Overall Study|Subject discharged from hospital|1|||
24942750|NCT00364533|50035675|FG000|Overall Study|Variations in drug compliance|2|||
24942751|NCT00364533|50035676|FG001|Overall Study|Variations in drug compliance|1|||
24942752|NCT00364533|50035677|FG002|Overall Study|Variations in drug compliance|1|||
24942753|NCT00364533|50035678|FG003|Overall Study|Variations in drug compliance|0|||
24942754|NCT00364533|50035679|FG004|Overall Study|Variations in drug compliance|0|||
24942755|NCT00364533|50035675|FG000|Overall Study|Non-compliance|1|||
24942756|NCT00364533|50035676|FG001|Overall Study|Non-compliance|0|||
24942757|NCT00364533|50035677|FG002|Overall Study|Non-compliance|0|||
24942758|NCT00364533|50035678|FG003|Overall Study|Non-compliance|0|||
24942759|NCT00364533|50035679|FG004|Overall Study|Non-compliance|0|||
24942760|NCT00364533|50035675|FG000|Overall Study|Protocol Violation|1|||
24942761|NCT00364533|50035676|FG001|Overall Study|Protocol Violation|1|||
24942762|NCT00364533|50035677|FG002|Overall Study|Protocol Violation|0|||
24942763|NCT00364533|50035678|FG003|Overall Study|Protocol Violation|0|||
24942764|NCT00364533|50035679|FG004|Overall Study|Protocol Violation|0|||
24942765|NCT04006847|50035691|FG000|Overall Study|Product issue|1|||
24942766|NCT00544817|50035695|FG000|Combined Modality|Lack of Efficacy|2|||
24942767|NCT00544817|50035695|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
24942768|NCT00544817|50035695|FG000|Combined Modality|Adverse Event|2|||
24942769|NCT00544817|50035695|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
24942770|NCT00544817|50035695|FG000|No Treatment Interval|Lack of Efficacy|8|||
24942771|NCT00544817|50035695|FG000|No Treatment Interval|Physician Decision|3|||
24942772|NCT00544817|50035695|FG000|No Treatment Interval|Adverse Event|1|||
24942773|NCT00544817|50035695|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
24942774|NCT00544817|50035695|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
24942775|NCT00544817|50035695|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
24942776|NCT00289978|50035702|FG000|Overall Study|Withdrawal by Subject|31|||
24942777|NCT00289978|50035703|FG001|Overall Study|Withdrawal by Subject|17|||
24942778|NCT00289978|50035704|FG002|Overall Study|Withdrawal by Subject|28|||
24942779|NCT00289978|50035702|FG000|Overall Study|Adverse Event|22|||
24942780|NCT00289978|50035703|FG001|Overall Study|Adverse Event|13|||
24942781|NCT00289978|50035704|FG002|Overall Study|Adverse Event|18|||
24942782|NCT00289978|50035702|FG000|Overall Study|Lack of Efficacy|13|||
24942783|NCT00289978|50035703|FG001|Overall Study|Lack of Efficacy|6|||
24942784|NCT00289978|50035704|FG002|Overall Study|Lack of Efficacy|25|||
24942785|NCT00289978|50035702|FG000|Overall Study|Abnormal laboratory value(s)|20|||
24942786|NCT00289978|50035703|FG001|Overall Study|Abnormal laboratory value(s)|9|||
24942787|NCT00289978|50035704|FG002|Overall Study|Abnormal laboratory value(s)|1|||
24942788|NCT00289978|50035702|FG000|Overall Study|Lost to Follow-up|3|||
24942789|NCT00289978|50035703|FG001|Overall Study|Lost to Follow-up|5|||
24942790|NCT00289978|50035704|FG002|Overall Study|Lost to Follow-up|7|||
24942791|NCT00289978|50035702|FG000|Overall Study|Protocol Violation|5|||
24942792|NCT00289978|50035703|FG001|Overall Study|Protocol Violation|5|||
24942793|NCT00289978|50035704|FG002|Overall Study|Protocol Violation|4|||
24942794|NCT00289978|50035702|FG000|Overall Study|Abnormal test procedure result(s)|2|||
24942795|NCT00289978|50035703|FG001|Overall Study|Abnormal test procedure result(s)|1|||
24942796|NCT00289978|50035704|FG002|Overall Study|Abnormal test procedure result(s)|1|||
24942797|NCT00289978|50035702|FG000|Overall Study|Death|1|||
24942798|NCT00289978|50035703|FG001|Overall Study|Death|0|||
24942799|NCT00289978|50035704|FG002|Overall Study|Death|2|||
24942800|NCT00543803|50035712|FG000|Overall Study|Adverse Event|14|||
24942801|NCT00543803|50035712|FG000|Overall Study|Lack of Efficacy|22|||
24942802|NCT00543803|50035712|FG000|Overall Study|Lost to Follow-up|20|||
24942803|NCT00543803|50035712|FG000|Overall Study|Other|86|||
24942804|NCT00542321|50035720|FG000|Overall Study|Death|0|||
24942805|NCT00542321|50035721|FG001|Overall Study|Death|1|||
24942806|NCT00289900|50035733|FG000|Overall Study|Adverse Event|28|||
24942807|NCT00289900|50035734|FG001|Overall Study|Adverse Event|40|||
24942808|NCT00289900|50035735|FG002|Overall Study|Adverse Event|13|||
24942809|NCT00289900|50035736|FG003|Overall Study|Adverse Event|19|||
24942810|NCT00289900|50035737|FG004|Overall Study|Adverse Event|20|||
24942811|NCT00289900|50035738|FG005|Overall Study|Adverse Event|33|||
24942812|NCT00289900|50035733|FG000|Overall Study|Lost to Follow-up|7|||
24942813|NCT00289900|50035734|FG001|Overall Study|Lost to Follow-up|7|||
24942814|NCT00289900|50035735|FG002|Overall Study|Lost to Follow-up|8|||
24942815|NCT00289900|50035736|FG003|Overall Study|Lost to Follow-up|8|||
24942816|NCT00289900|50035737|FG004|Overall Study|Lost to Follow-up|4|||
24942817|NCT00289900|50035738|FG005|Overall Study|Lost to Follow-up|8|||
24942818|NCT00289900|50035733|FG000|Overall Study|Participant had flushing|18|||
24942819|NCT00289900|50035734|FG001|Overall Study|Participant had flushing|42|||
24942820|NCT00289900|50035735|FG002|Overall Study|Participant had flushing|1|||
24942821|NCT00289900|50035736|FG003|Overall Study|Participant had flushing|2|||
24942822|NCT00289900|50035737|FG004|Overall Study|Participant had flushing|0|||
24942823|NCT00289900|50035738|FG005|Overall Study|Participant had flushing|4|||
24942824|NCT00289900|50035733|FG000|Overall Study|Other|0|||
24942825|NCT00289900|50035734|FG001|Overall Study|Other|0|||
24942826|NCT00289900|50035735|FG002|Overall Study|Other|0|||
24942827|NCT00289900|50035736|FG003|Overall Study|Other|5|||
24942828|NCT00289900|50035737|FG004|Overall Study|Other|1|||
24942829|NCT00289900|50035738|FG005|Overall Study|Other|0|||
24942830|NCT00289900|50035733|FG000|Overall Study|Participant moved|1|||
24942831|NCT00289900|50035734|FG001|Overall Study|Participant moved|0|||
24942832|NCT00289900|50035735|FG002|Overall Study|Participant moved|0|||
24942833|NCT00289900|50035736|FG003|Overall Study|Participant moved|1|||
24942834|NCT00289900|50035737|FG004|Overall Study|Participant moved|1|||
24942835|NCT00289900|50035738|FG005|Overall Study|Participant moved|1|||
24942836|NCT00289900|50035733|FG000|Overall Study|Withdrawal by Subject|10|||
24942837|NCT00289900|50035734|FG001|Overall Study|Withdrawal by Subject|21|||
24942838|NCT00289900|50035735|FG002|Overall Study|Withdrawal by Subject|8|||
24942839|NCT00289900|50035736|FG003|Overall Study|Withdrawal by Subject|18|||
24942840|NCT00289900|50035737|FG004|Overall Study|Withdrawal by Subject|12|||
24942841|NCT00289900|50035738|FG005|Overall Study|Withdrawal by Subject|11|||
24942842|NCT00289900|50035733|FG000|Overall Study|Protocol Violation|3|||
24942843|NCT00289900|50035734|FG001|Overall Study|Protocol Violation|9|||
24942844|NCT00289900|50035735|FG002|Overall Study|Protocol Violation|2|||
24942845|NCT00289900|50035736|FG003|Overall Study|Protocol Violation|6|||
24942846|NCT00289900|50035737|FG004|Overall Study|Protocol Violation|7|||
24942847|NCT00289900|50035738|FG005|Overall Study|Protocol Violation|4|||
24942848|NCT00289900|50035733|FG000|Overall Study|site terminated|1|||
24942849|NCT00289900|50035734|FG001|Overall Study|site terminated|0|||
24942850|NCT00289900|50035735|FG002|Overall Study|site terminated|1|||
24942851|NCT00289900|50035736|FG003|Overall Study|site terminated|0|||
24942852|NCT00289900|50035737|FG004|Overall Study|site terminated|0|||
24942853|NCT00289900|50035738|FG005|Overall Study|site terminated|0|||
24942854|NCT00289900|50035733|FG000|Overall Study|Not treated|0|||
24942855|NCT00289900|50035734|FG001|Overall Study|Not treated|1|||
24942856|NCT00289900|50035735|FG002|Overall Study|Not treated|0|||
24942857|NCT00289900|50035736|FG003|Overall Study|Not treated|0|||
24942858|NCT00289900|50035737|FG004|Overall Study|Not treated|0|||
24942859|NCT00289900|50035738|FG005|Overall Study|Not treated|0|||
24942860|NCT00543725|50035757|FG000|Overall Study|Adverse Event|18|||
24942861|NCT00543725|50035758|FG001|Overall Study|Adverse Event|27|||
24942862|NCT00543725|50035757|FG000|Overall Study|Sponsor's Decision|0|||
24942863|NCT00543725|50035758|FG001|Overall Study|Sponsor's Decision|1|||
24942864|NCT00543725|50035757|FG000|Overall Study|Subject Non-Compliant|4|||
24942865|NCT00543725|50035758|FG001|Overall Study|Subject Non-Compliant|4|||
24942866|NCT00543725|50035757|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
24942867|NCT00543725|50035758|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
24942868|NCT00543725|50035757|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
24942869|NCT00543725|50035758|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
24942870|NCT00543725|50035757|FG000|Overall Study|Protocol Violation|0|||
24942871|NCT00543725|50035758|FG001|Overall Study|Protocol Violation|1|||
24942872|NCT00543725|50035757|FG000|Overall Study|Withdrawal by Subject|4|||
24942873|NCT00543725|50035758|FG001|Overall Study|Withdrawal by Subject|13|||
24942874|NCT00543725|50035757|FG000|Overall Study|Lost to Follow-up|15|||
24942875|NCT00543725|50035758|FG001|Overall Study|Lost to Follow-up|11|||
24942876|NCT00543725|50035757|FG000|Overall Study|Other|3|||
24942877|NCT00543725|50035758|FG001|Overall Study|Other|3|||
24942878|NCT00269152|50035766|FG000|Overall Study|Adverse Event|9|||
24942879|NCT00269152|50035767|FG001|Overall Study|Adverse Event|3|||
24942880|NCT00269152|50035766|FG000|Overall Study|Withdrawal by Subject|7|||
24942881|NCT00269152|50035767|FG001|Overall Study|Withdrawal by Subject|3|||
25030180|NCT03515551|50128721|FG006|Overall Study|Death|1|||
25030181|NCT03515551|50128715|FG000|Overall Study|Lost to Follow-up|0|||
24942882|NCT00269152|50035766|FG000|Overall Study|Physician Decision|2|||
24942883|NCT00269152|50035767|FG001|Overall Study|Physician Decision|3|||
24942884|NCT00269152|50035766|FG000|Overall Study|Protocol Violation|0|||
24942885|NCT00269152|50035767|FG001|Overall Study|Protocol Violation|1|||
24942886|NCT00379899|50035775|FG000|Overall Study|Adverse Event|7|||
24942887|NCT00379899|50035776|FG001|Overall Study|Adverse Event|3|||
24942888|NCT00379899|50035775|FG000|Overall Study|Death|10|||
24942889|NCT00379899|50035776|FG001|Overall Study|Death|10|||
24942890|NCT00379899|50035775|FG000|Overall Study|Lost to Follow-up|2|||
24942891|NCT00379899|50035776|FG001|Overall Study|Lost to Follow-up|4|||
24942892|NCT00379899|50035775|FG000|Overall Study|Physician Decision|3|||
24942893|NCT00379899|50035776|FG001|Overall Study|Physician Decision|4|||
24942894|NCT00379899|50035775|FG000|Overall Study|Withdrawal by Subject|5|||
24942895|NCT00379899|50035776|FG001|Overall Study|Withdrawal by Subject|5|||
24942896|NCT00379899|50035775|FG000|Overall Study|Ineligibility determined|0|||
24942897|NCT00379899|50035776|FG001|Overall Study|Ineligibility determined|1|||
24942898|NCT00379899|50035775|FG000|Overall Study|Noncompliance|1|||
24942899|NCT00379899|50035776|FG001|Overall Study|Noncompliance|1|||
24942900|NCT00379899|50035775|FG000|Overall Study|Parathyroidectomy|0|||
24942901|NCT00379899|50035776|FG001|Overall Study|Parathyroidectomy|2|||
24942902|NCT00379899|50035775|FG000|Overall Study|Renal transplantation|5|||
24942903|NCT00379899|50035776|FG001|Overall Study|Renal transplantation|4|||
24942904|NCT00379899|50035775|FG000|Overall Study|Coronary artery bypass graft|1|||
24942905|NCT00379899|50035776|FG001|Overall Study|Coronary artery bypass graft|1|||
24942906|NCT00379899|50035775|FG000|Overall Study|Other protocol-specified criteria|3|||
24942907|NCT00379899|50035776|FG001|Overall Study|Other protocol-specified criteria|4|||
25030182|NCT03515551|50128716|FG001|Overall Study|Lost to Follow-up|0|||
24942908|NCT00379899|50035775|FG000|Overall Study|Other|3|||
24942909|NCT00379899|50035776|FG001|Overall Study|Other|1|||
24942910|NCT00371787|50035784|FG000|Overall Study|Withdrawal by Subject|3|||
25030183|NCT03515551|50128717|FG002|Overall Study|Lost to Follow-up|1|||
25159300|NCT01429623|50279004|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
24942911|NCT00371787|50035785|FG001|Overall Study|Withdrawal by Subject|1|||
24942912|NCT00363129|50035793|FG000|Overall Study|Withdrawal by Subject|11|||
24942913|NCT00363129|50035794|FG001|Overall Study|Withdrawal by Subject|18|||
24942914|NCT00363129|50035793|FG000|Overall Study|Adverse Event|8|||
24942915|NCT00363129|50035794|FG001|Overall Study|Adverse Event|3|||
24942916|NCT00363129|50035793|FG000|Overall Study|Alternate Treatment|2|||
24942917|NCT00363129|50035794|FG001|Overall Study|Alternate Treatment|4|||
24942918|NCT00363129|50035793|FG000|Overall Study|Other Medical Problems|2|||
24942919|NCT00363129|50035794|FG001|Overall Study|Other Medical Problems|4|||
24942920|NCT00363129|50035793|FG000|Overall Study|Death|0|||
24942921|NCT00363129|50035794|FG001|Overall Study|Death|1|||
25030184|NCT03515551|50128718|FG003|Overall Study|Lost to Follow-up|0|||
24942922|NCT00363129|50035793|FG000|Overall Study|Other Reasons|6|||
24942923|NCT00363129|50035794|FG001|Overall Study|Other Reasons|3|||
24942924|NCT00268996|50035802|FG000|Overall Study|Adverse Event|11|||
24942925|NCT00268996|50035803|FG001|Overall Study|Adverse Event|7|||
24942926|NCT00268996|50035802|FG000|Overall Study|Lost to Follow-up|3|||
24942927|NCT00268996|50035803|FG001|Overall Study|Lost to Follow-up|1|||
24942928|NCT00268996|50035802|FG000|Overall Study|Withdrawal by Subject|5|||
24942929|NCT00268996|50035803|FG001|Overall Study|Withdrawal by Subject|11|||
24942930|NCT00268996|50035802|FG000|Overall Study|Non-compliance|1|||
24942931|NCT00268996|50035803|FG001|Overall Study|Non-compliance|0|||
24942932|NCT00268996|50035802|FG000|Overall Study|Other|1|||
24942933|NCT00268996|50035803|FG001|Overall Study|Other|1|||
24942934|NCT00371397|50035811|FG000|Session 1|Withdrawal by Subject|1|||
24942935|NCT00371397|50035812|FG001|Session 1|Withdrawal by Subject|0|||
24942936|NCT00371397|50035813|FG002|Session 1|Withdrawal by Subject|0|||
24942937|NCT00371397|50035814|FG003|Session 1|Withdrawal by Subject|0|||
24942938|NCT00371397|50035815|FG004|Session 1|Withdrawal by Subject|0|||
24942939|NCT00371397|50035816|FG005|Session 1|Withdrawal by Subject|0|||
24942940|NCT00371397|50035817|FG006|Session 1|Withdrawal by Subject|0|||
24942941|NCT00371397|50035818|FG007|Session 1|Withdrawal by Subject|1|||
24942942|NCT00371397|50035819|FG008|Session 1|Withdrawal by Subject|0|||
24942943|NCT00371397|50035820|FG009|Session 1|Withdrawal by Subject|0|||
24942944|NCT00371397|50035821|FG010|Session 1|Withdrawal by Subject|0|||
24942945|NCT00371397|50035822|FG011|Session 1|Withdrawal by Subject|0|||
24942946|NCT00379587|50035828|FG000|Overall Study|Lost to Follow-up|2|||
24942947|NCT00289276|50035834|FG000|Second Part of FAST Study (Expansion)|Death|0|||
24942948|NCT00289276|50035835|FG001|Second Part of FAST Study (Expansion)|Death|2|||
24942949|NCT00289276|50035834|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
24942950|NCT00289276|50035835|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
24942951|NCT00289198|50035843|FG000|Overall Study|Adverse Event|0|||
24942952|NCT00289198|50035844|FG001|Overall Study|Adverse Event|2|||
24942953|NCT00289198|50035843|FG000|Overall Study|Protocol Violation|2|||
24942954|NCT00289198|50035844|FG001|Overall Study|Protocol Violation|1|||
24942955|NCT00289198|50035843|FG000|Overall Study|Withdrawal by Subject|4|||
24942956|NCT00289198|50035844|FG001|Overall Study|Withdrawal by Subject|1|||
24942957|NCT00289198|50035843|FG000|Overall Study|Lack of Efficacy|2|||
24942958|NCT00289198|50035844|FG001|Overall Study|Lack of Efficacy|0|||
24942959|NCT00289198|50035843|FG000|Overall Study|Other: Low compliance|0|||
24942960|NCT00289198|50035844|FG001|Overall Study|Other: Low compliance|1|||
24942961|NCT00289198|50035843|FG000|Overall Study|Other: Physician's decision|0|||
24942962|NCT00289198|50035844|FG001|Overall Study|Other: Physician's decision|1|||
24942963|NCT00289198|50035843|FG000|Overall Study|Other: Unable to attend on schedule|2|||
24942964|NCT00289198|50035844|FG001|Overall Study|Other: Unable to attend on schedule|1|||
24942965|NCT00289198|50035843|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
24942966|NCT00289198|50035844|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
24942967|NCT00289198|50035843|FG000|Overall Study|Other: Impossible to come on visit|0|||
24942968|NCT00289198|50035844|FG001|Overall Study|Other: Impossible to come on visit|1|||
24942969|NCT00363051|50035853|FG000|Overall Study|Adminstrative problems|1|||
24942970|NCT00363051|50035854|FG001|Overall Study|Adminstrative problems|1|||
24942971|NCT00363051|50035853|FG000|Overall Study|Adverse Event|21|||
24942972|NCT00363051|50035854|FG001|Overall Study|Adverse Event|12|||
24942973|NCT00363051|50035853|FG000|Overall Study|New Cancer Therapy|2|||
24942974|NCT00363051|50035854|FG001|Overall Study|New Cancer Therapy|1|||
24942975|NCT00363051|50035853|FG000|Overall Study|Withdrawal by Subject|11|||
24942976|NCT00363051|50035854|FG001|Overall Study|Withdrawal by Subject|3|||
24942977|NCT00363051|50035853|FG000|Overall Study|Lost to Follow-up|0|||
24942978|NCT00363051|50035854|FG001|Overall Study|Lost to Follow-up|1|||
24942979|NCT00363051|50035853|FG000|Overall Study|Protocol Violation|0|||
24942980|NCT00363051|50035854|FG001|Overall Study|Protocol Violation|2|||
24942981|NCT00363051|50035853|FG000|Overall Study|Death|3|||
24942982|NCT00363051|50035854|FG001|Overall Study|Death|2|||
24942983|NCT00379353|50035864|FG000|Overall Study|Hospitalization|3|||
25275560|NCT01231373|50589436|FG000|Overall Study|Lost to Follow-up|0|||
24942984|NCT00379353|50035865|FG001|Overall Study|Hospitalization|3|||
24942985|NCT00379353|50035864|FG000|Overall Study|Withdrawal by Subject|5|||
24942986|NCT00379353|50035865|FG001|Overall Study|Withdrawal by Subject|2|||
24942987|NCT00379353|50035864|FG000|Overall Study|Death|1|||
25275561|NCT01231373|50589437|FG001|Overall Study|Lost to Follow-up|0|||
25275562|NCT01231373|50589438|FG002|Overall Study|Lost to Follow-up|0|||
24942988|NCT00379353|50035865|FG001|Overall Study|Death|0|||
24942989|NCT00379353|50035864|FG000|Overall Study|Cardiac Tamponade|1|||
24942990|NCT00379353|50035865|FG001|Overall Study|Cardiac Tamponade|0|||
24942991|NCT00379353|50035864|FG000|Overall Study|Non-compliance|1|||
24942992|NCT00379353|50035865|FG001|Overall Study|Non-compliance|0|||
24942993|NCT00379353|50035864|FG000|Overall Study|Conflicting drug treatment|0|||
24942994|NCT00379353|50035865|FG001|Overall Study|Conflicting drug treatment|1|||
24942995|NCT00378573|50035881|FG000|Treatment Period|Adverse Event|9|||
24942996|NCT00378573|50035881|FG000|Treatment Period|Physician Decision|1|||
24942997|NCT00378573|50035881|FG000|Treatment Period|Withdrawal by Subject|2|||
24942998|NCT00378573|50035881|FG000|Treatment Period|Disease Progression|4|||
24942999|NCT00378573|50035881|FG000|Treatment Period|Sponsor decision to close study|1|||
24943000|NCT00378573|50035881|FG000|Follow-up|Death|12|||
24943001|NCT00378573|50035881|FG000|Follow-up|Lost to Follow-up|1|||
24943002|NCT00378573|50035881|FG000|Follow-up|Withdrawal by Subject|1|||
24943003|NCT03831945|50035887|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
24943004|NCT03831945|50035888|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
24943005|NCT03831945|50035887|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
24943006|NCT03831945|50035888|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
24943007|NCT03831945|50035887|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
24943008|NCT03831945|50035888|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
24943009|NCT00457002|50035896|FG000|Overall Study|Death|40|||
24943010|NCT00457002|50035897|FG001|Overall Study|Death|47|||
24943011|NCT00457002|50035896|FG000|Overall Study|Adverse Event|284|||
24943012|NCT00457002|50035897|FG001|Overall Study|Adverse Event|260|||
24943013|NCT00457002|50035896|FG000|Overall Study|Withdrawal by Subject|299|||
24943014|NCT00457002|50035897|FG001|Overall Study|Withdrawal by Subject|271|||
24943015|NCT00457002|50035896|FG000|Overall Study|Lost to Follow-up|72|||
24943016|NCT00457002|50035897|FG001|Overall Study|Lost to Follow-up|71|||
24943017|NCT00457002|50035896|FG000|Overall Study|Poor/Non-compliance|46|||
24943018|NCT00457002|50035897|FG001|Overall Study|Poor/Non-compliance|33|||
24943019|NCT00457002|50035896|FG000|Overall Study|No longer met criteria|41|||
24943020|NCT00457002|50035897|FG001|Overall Study|No longer met criteria|37|||
24943021|NCT00457002|50035896|FG000|Overall Study|Administrative reason by Sponsor|1|||
24943022|NCT00457002|50035897|FG001|Overall Study|Administrative reason by Sponsor|0|||
24943023|NCT00457002|50035896|FG000|Overall Study|non-specified|29|||
24943024|NCT00457002|50035897|FG001|Overall Study|non-specified|38|||
24943025|NCT00457002|50035896|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
24943026|NCT00457002|50035897|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
24943027|NCT00362115|50035910|FG000|Overall Study|Adverse Event|0|||
24943028|NCT00362115|50035911|FG001|Overall Study|Adverse Event|1|||
24943029|NCT00362115|50035912|FG002|Overall Study|Adverse Event|1|||
24943030|NCT00362115|50035913|FG003|Overall Study|Adverse Event|1|||
24943031|NCT00362115|50035914|FG004|Overall Study|Adverse Event|2|||
24943032|NCT00362115|50035915|FG005|Overall Study|Adverse Event|2|||
24943033|NCT00362115|50035916|FG006|Overall Study|Adverse Event|1|||
24943034|NCT00362115|50035910|FG000|Overall Study|Protocol Violation|0|||
24943035|NCT00362115|50035911|FG001|Overall Study|Protocol Violation|0|||
24943036|NCT00362115|50035912|FG002|Overall Study|Protocol Violation|0|||
24943037|NCT00362115|50035913|FG003|Overall Study|Protocol Violation|0|||
24943038|NCT00362115|50035914|FG004|Overall Study|Protocol Violation|0|||
24943039|NCT00362115|50035915|FG005|Overall Study|Protocol Violation|1|||
24943040|NCT00362115|50035916|FG006|Overall Study|Protocol Violation|0|||
24943041|NCT00362115|50035910|FG000|Overall Study|Lost to Follow-up|0|||
24943042|NCT00362115|50035911|FG001|Overall Study|Lost to Follow-up|1|||
24943043|NCT00362115|50035912|FG002|Overall Study|Lost to Follow-up|0|||
24943044|NCT00362115|50035913|FG003|Overall Study|Lost to Follow-up|0|||
24943045|NCT00362115|50035914|FG004|Overall Study|Lost to Follow-up|2|||
24943046|NCT00362115|50035915|FG005|Overall Study|Lost to Follow-up|0|||
24943047|NCT00362115|50035916|FG006|Overall Study|Lost to Follow-up|1|||
24943048|NCT00362115|50035910|FG000|Overall Study|Withdrawal by Subject|1|||
24943049|NCT00362115|50035911|FG001|Overall Study|Withdrawal by Subject|3|||
24943050|NCT00362115|50035912|FG002|Overall Study|Withdrawal by Subject|1|||
24943051|NCT00362115|50035913|FG003|Overall Study|Withdrawal by Subject|0|||
24943052|NCT00362115|50035914|FG004|Overall Study|Withdrawal by Subject|1|||
24943053|NCT00362115|50035915|FG005|Overall Study|Withdrawal by Subject|3|||
24943054|NCT00362115|50035916|FG006|Overall Study|Withdrawal by Subject|4|||
24943055|NCT00362115|50035910|FG000|Overall Study|Lack of Efficacy|1|||
24943056|NCT00362115|50035911|FG001|Overall Study|Lack of Efficacy|0|||
24943057|NCT00362115|50035912|FG002|Overall Study|Lack of Efficacy|5|||
25159301|NCT01429623|50279005|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
24943058|NCT00362115|50035913|FG003|Overall Study|Lack of Efficacy|2|||
24943059|NCT00362115|50035914|FG004|Overall Study|Lack of Efficacy|2|||
24943060|NCT00362115|50035915|FG005|Overall Study|Lack of Efficacy|0|||
24943061|NCT00362115|50035916|FG006|Overall Study|Lack of Efficacy|3|||
24943062|NCT00362115|50035910|FG000|Overall Study|Physician Decision|0|||
24943063|NCT00362115|50035911|FG001|Overall Study|Physician Decision|0|||
24943064|NCT00362115|50035912|FG002|Overall Study|Physician Decision|0|||
24943065|NCT00362115|50035913|FG003|Overall Study|Physician Decision|0|||
24943066|NCT00362115|50035914|FG004|Overall Study|Physician Decision|0|||
24943067|NCT00362115|50035915|FG005|Overall Study|Physician Decision|0|||
24943068|NCT00362115|50035916|FG006|Overall Study|Physician Decision|3|||
24943069|NCT00362115|50035910|FG000|Overall Study|Other|0|||
24943070|NCT00362115|50035911|FG001|Overall Study|Other|1|||
25030185|NCT03515551|50128719|FG004|Overall Study|Lost to Follow-up|0|||
25030186|NCT03515551|50128720|FG005|Overall Study|Lost to Follow-up|0|||
24943071|NCT00362115|50035912|FG002|Overall Study|Other|0|||
24943072|NCT00362115|50035913|FG003|Overall Study|Other|1|||
24943073|NCT00362115|50035914|FG004|Overall Study|Other|0|||
24943074|NCT00362115|50035915|FG005|Overall Study|Other|1|||
24943075|NCT00362115|50035916|FG006|Overall Study|Other|0|||
24943076|NCT00485264|50035938|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
24943077|NCT00485264|50035939|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
24943078|NCT00485264|50035940|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
24943079|NCT00485264|50035941|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
24943080|NCT00485264|50035942|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
24943081|NCT00485264|50035943|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
24943082|NCT00485264|50035938|FG000|Overall Study|Death|1|||
24943083|NCT00485264|50035939|FG001|Overall Study|Death|0|||
24943084|NCT00485264|50035940|FG002|Overall Study|Death|0|||
24943085|NCT00485264|50035941|FG003|Overall Study|Death|0|||
24943086|NCT00485264|50035942|FG004|Overall Study|Death|1|||
24943087|NCT00485264|50035943|FG005|Overall Study|Death|0|||
24943088|NCT00485264|50035938|FG000|Overall Study|Adverse Event|1|||
24943089|NCT00485264|50035939|FG001|Overall Study|Adverse Event|0|||
24943090|NCT00485264|50035940|FG002|Overall Study|Adverse Event|2|||
25030187|NCT03515551|50128721|FG006|Overall Study|Lost to Follow-up|0|||
25030188|NCT03515551|50128715|FG000|Overall Study|Withdrawal by Subject|0|||
25030189|NCT03515551|50128716|FG001|Overall Study|Withdrawal by Subject|1|||
25030190|NCT03515551|50128717|FG002|Overall Study|Withdrawal by Subject|0|||
25030191|NCT03515551|50128718|FG003|Overall Study|Withdrawal by Subject|0|||
25030192|NCT03515551|50128719|FG004|Overall Study|Withdrawal by Subject|0|||
25030193|NCT03515551|50128720|FG005|Overall Study|Withdrawal by Subject|0|||
25030194|NCT03515551|50128721|FG006|Overall Study|Withdrawal by Subject|1|||
25030195|NCT03515551|50128715|FG000|Overall Study|Study ended by sponsor|0|||
25030196|NCT03515551|50128716|FG001|Overall Study|Study ended by sponsor|0|||
25030197|NCT03515551|50128717|FG002|Overall Study|Study ended by sponsor|2|||
25030198|NCT03515551|50128718|FG003|Overall Study|Study ended by sponsor|1|||
25030199|NCT03515551|50128719|FG004|Overall Study|Study ended by sponsor|3|||
25030200|NCT03515551|50128720|FG005|Overall Study|Study ended by sponsor|0|||
25030201|NCT03515551|50128721|FG006|Overall Study|Study ended by sponsor|3|||
25030202|NCT03515551|50128715|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
25030203|NCT03515551|50128716|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
25030204|NCT03515551|50128717|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
25030205|NCT03515551|50128718|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
25030206|NCT03515551|50128719|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
25030207|NCT03515551|50128720|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
25030208|NCT03515551|50128721|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
25030209|NCT03380429|50128747|FG000|Overall Study|Physician Decision|0|||
25030210|NCT03380429|50128748|FG001|Overall Study|Physician Decision|1|||
25030211|NCT03380429|50128749|FG002|Overall Study|Physician Decision|0|||
25030212|NCT03380429|50128750|FG003|Overall Study|Physician Decision|1|||
25030213|NCT03380429|50128751|FG004|Overall Study|Physician Decision|1|||
25030214|NCT03380429|50128747|FG000|Overall Study|Withdrawal by Subject|3|||
25030215|NCT03380429|50128748|FG001|Overall Study|Withdrawal by Subject|3|||
25030216|NCT03380429|50128749|FG002|Overall Study|Withdrawal by Subject|5|||
25030217|NCT03380429|50128750|FG003|Overall Study|Withdrawal by Subject|2|||
24943091|NCT00485264|50035941|FG003|Overall Study|Adverse Event|3|||
24943092|NCT00485264|50035942|FG004|Overall Study|Adverse Event|1|||
24943093|NCT00485264|50035943|FG005|Overall Study|Adverse Event|3|||
25030218|NCT03380429|50128751|FG004|Overall Study|Withdrawal by Subject|1|||
25030219|NCT03380429|50128747|FG000|Overall Study|Lost to Follow-up|0|||
25030220|NCT03380429|50128748|FG001|Overall Study|Lost to Follow-up|2|||
25030221|NCT03380429|50128749|FG002|Overall Study|Lost to Follow-up|4|||
25030222|NCT03380429|50128750|FG003|Overall Study|Lost to Follow-up|3|||
25030223|NCT03380429|50128751|FG004|Overall Study|Lost to Follow-up|1|||
25030224|NCT03380429|50128747|FG000|Overall Study|Protocol Violation|1|||
25030225|NCT03380429|50128748|FG001|Overall Study|Protocol Violation|0|||
25030226|NCT03380429|50128749|FG002|Overall Study|Protocol Violation|1|||
25030227|NCT03380429|50128750|FG003|Overall Study|Protocol Violation|0|||
25030228|NCT03380429|50128751|FG004|Overall Study|Protocol Violation|1|||
25030229|NCT03380429|50128747|FG000|Overall Study|Lack of Efficacy|0|||
25030230|NCT03380429|50128748|FG001|Overall Study|Lack of Efficacy|0|||
25030231|NCT03380429|50128749|FG002|Overall Study|Lack of Efficacy|0|||
25030232|NCT03380429|50128750|FG003|Overall Study|Lack of Efficacy|2|||
25030233|NCT03380429|50128751|FG004|Overall Study|Lack of Efficacy|1|||
25030234|NCT03380429|50128747|FG000|Overall Study|Adverse Event|1|||
25030235|NCT03380429|50128748|FG001|Overall Study|Adverse Event|1|||
25030236|NCT03380429|50128749|FG002|Overall Study|Adverse Event|1|||
25030237|NCT03380429|50128750|FG003|Overall Study|Adverse Event|2|||
25030238|NCT03380429|50128751|FG004|Overall Study|Adverse Event|0|||
25030239|NCT03280615|50128770|FG000|Overall Study|Lost to Follow-up|1|||
24943094|NCT00485264|50035938|FG000|Overall Study|Pregnancy|4|||
24943095|NCT00485264|50035939|FG001|Overall Study|Pregnancy|0|||
24943096|NCT00485264|50035940|FG002|Overall Study|Pregnancy|0|||
24943097|NCT00485264|50035941|FG003|Overall Study|Pregnancy|0|||
24943098|NCT00485264|50035942|FG004|Overall Study|Pregnancy|0|||
24943099|NCT00485264|50035943|FG005|Overall Study|Pregnancy|0|||
24943100|NCT00485264|50035938|FG000|Overall Study|Disallowed Medication|0|||
24943101|NCT00485264|50035939|FG001|Overall Study|Disallowed Medication|0|||
24943102|NCT00485264|50035940|FG002|Overall Study|Disallowed Medication|0|||
24943103|NCT00485264|50035941|FG003|Overall Study|Disallowed Medication|0|||
24943104|NCT00485264|50035942|FG004|Overall Study|Disallowed Medication|0|||
24943105|NCT00485264|50035943|FG005|Overall Study|Disallowed Medication|1|||
24943106|NCT00485264|50035938|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
24943107|NCT00485264|50035939|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
24943108|NCT00485264|50035940|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
24943109|NCT00485264|50035941|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
24943110|NCT00485264|50035942|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
24943111|NCT00485264|50035943|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
24943112|NCT00485264|50035938|FG000|Overall Study|Lack of Efficacy|0|||
24943113|NCT00485264|50035939|FG001|Overall Study|Lack of Efficacy|1|||
24943114|NCT00485264|50035940|FG002|Overall Study|Lack of Efficacy|0|||
24943115|NCT00485264|50035941|FG003|Overall Study|Lack of Efficacy|0|||
24943116|NCT00485264|50035942|FG004|Overall Study|Lack of Efficacy|0|||
24943117|NCT00485264|50035943|FG005|Overall Study|Lack of Efficacy|0|||
24943118|NCT00485264|50035938|FG000|Overall Study|Guardian Consent Withdrawn|1|||
24943119|NCT00485264|50035939|FG001|Overall Study|Guardian Consent Withdrawn|0|||
24943120|NCT00485264|50035940|FG002|Overall Study|Guardian Consent Withdrawn|0|||
24943121|NCT00485264|50035941|FG003|Overall Study|Guardian Consent Withdrawn|0|||
25030240|NCT03280615|50128771|FG001|Overall Study|Lost to Follow-up|2|||
25030241|NCT03280615|50128770|FG000|Overall Study|Adverse Event|1|||
25159302|NCT01429623|50279004|FG000|Overall Study|No post baseline data|4|||
24943122|NCT00485264|50035942|FG004|Overall Study|Guardian Consent Withdrawn|1|||
24943123|NCT00485264|50035943|FG005|Overall Study|Guardian Consent Withdrawn|0|||
24943124|NCT00485264|50035938|FG000|Overall Study|Physician Decision|0|||
24943125|NCT00485264|50035939|FG001|Overall Study|Physician Decision|2|||
24943126|NCT00485264|50035940|FG002|Overall Study|Physician Decision|0|||
25030242|NCT03280615|50128771|FG001|Overall Study|Adverse Event|1|||
25030243|NCT03280615|50128770|FG000|Overall Study|Withdrawal by Subject|2|||
25030244|NCT03280615|50128771|FG001|Overall Study|Withdrawal by Subject|2|||
25030245|NCT03280537|50128779|FG000|Overall Study|Withdrawal by Subject|2|||
25030246|NCT03280537|50128780|FG001|Overall Study|Withdrawal by Subject|4|||
25030247|NCT03280381|50128788|FG000|Overall Study|Physician Decision|0|||
25030248|NCT03280381|50128789|FG001|Overall Study|Physician Decision|2|||
25030249|NCT03270085|50128798|FG000|Overall Study|Withdrawal by Subject|1|||
25030250|NCT03270085|50128799|FG001|Overall Study|Withdrawal by Subject|0|||
25030251|NCT03267511|50128809|FG000|Overall Study|Lost to Follow-up|0|||
25030252|NCT03267511|50128810|FG001|Overall Study|Lost to Follow-up|0|||
25030253|NCT03267511|50128811|FG002|Overall Study|Lost to Follow-up|0|||
25030254|NCT03267511|50128812|FG003|Overall Study|Lost to Follow-up|1|||
25030255|NCT03379259|50128839|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
25030256|NCT03379259|50128840|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
25030257|NCT03379259|50128841|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
25030258|NCT03379259|50128842|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
25030259|NCT03379259|50128843|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
25030260|NCT03379259|50128844|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
25030261|NCT03379259|50128839|FG000|Overall Study|Death|0|||
25030262|NCT03379259|50128840|FG001|Overall Study|Death|1|||
25030263|NCT03379259|50128841|FG002|Overall Study|Death|2|||
25030264|NCT03379259|50128842|FG003|Overall Study|Death|1|||
25030265|NCT03379259|50128843|FG004|Overall Study|Death|4|||
25030266|NCT03379259|50128844|FG005|Overall Study|Death|2|||
25030267|NCT03379259|50128839|FG000|Overall Study|Withdrawal by Subject|0|||
25030268|NCT03379259|50128840|FG001|Overall Study|Withdrawal by Subject|0|||
25030269|NCT03379259|50128841|FG002|Overall Study|Withdrawal by Subject|1|||
25030270|NCT03379259|50128842|FG003|Overall Study|Withdrawal by Subject|0|||
25030271|NCT03379259|50128843|FG004|Overall Study|Withdrawal by Subject|2|||
25030272|NCT03379259|50128844|FG005|Overall Study|Withdrawal by Subject|0|||
25030273|NCT03379259|50128839|FG000|Overall Study|Study terminated by sponsor|0|||
25030274|NCT03379259|50128840|FG001|Overall Study|Study terminated by sponsor|0|||
24943127|NCT00485264|50035941|FG003|Overall Study|Physician Decision|0|||
24943128|NCT00485264|50035942|FG004|Overall Study|Physician Decision|0|||
24943129|NCT00485264|50035943|FG005|Overall Study|Physician Decision|0|||
24943130|NCT00485264|50035938|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
25030275|NCT03379259|50128841|FG002|Overall Study|Study terminated by sponsor|0|||
25030276|NCT03379259|50128842|FG003|Overall Study|Study terminated by sponsor|1|||
25030277|NCT03379259|50128843|FG004|Overall Study|Study terminated by sponsor|1|||
25030278|NCT03379259|50128844|FG005|Overall Study|Study terminated by sponsor|4|||
25030279|NCT03379259|50128839|FG000|Overall Study|Disease progression|0|||
25030280|NCT03379259|50128840|FG001|Overall Study|Disease progression|0|||
25030281|NCT03379259|50128841|FG002|Overall Study|Disease progression|0|||
25030282|NCT03379259|50128842|FG003|Overall Study|Disease progression|1|||
25030283|NCT03379259|50128843|FG004|Overall Study|Disease progression|0|||
25030284|NCT03379259|50128844|FG005|Overall Study|Disease progression|1|||
25030285|NCT03379259|50128839|FG000|Overall Study|Lost to Follow-up|0|||
25030286|NCT03379259|50128840|FG001|Overall Study|Lost to Follow-up|0|||
25030287|NCT03379259|50128841|FG002|Overall Study|Lost to Follow-up|0|||
25030288|NCT03379259|50128842|FG003|Overall Study|Lost to Follow-up|0|||
25030289|NCT03379259|50128843|FG004|Overall Study|Lost to Follow-up|1|||
25030290|NCT03379259|50128844|FG005|Overall Study|Lost to Follow-up|0|||
25030291|NCT03379259|50128839|FG000|Overall Study|Deteriorating condition|0|||
25030292|NCT03379259|50128840|FG001|Overall Study|Deteriorating condition|0|||
25030293|NCT03379259|50128841|FG002|Overall Study|Deteriorating condition|0|||
25030294|NCT03379259|50128842|FG003|Overall Study|Deteriorating condition|0|||
25030295|NCT03379259|50128843|FG004|Overall Study|Deteriorating condition|1|||
25030296|NCT03379259|50128844|FG005|Overall Study|Deteriorating condition|0|||
25030297|NCT03328897|50128864|FG000|Randomized-treatment Epoch|Adverse Event|4|||
24943131|NCT00485264|50035939|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
24943132|NCT00485264|50035940|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
24943133|NCT00485264|50035941|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
24943134|NCT00485264|50035942|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
24943135|NCT00485264|50035943|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
25030298|NCT03328897|50128865|FG001|Randomized-treatment Epoch|Adverse Event|1|||
25030299|NCT03328897|50128866|FG002|Randomized-treatment Epoch|Adverse Event|1|||
25030300|NCT03328897|50128864|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
25030301|NCT03328897|50128865|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
24943136|NCT00485264|50035938|FG000|Overall Study|Not Able to Attend Clinic|5|||
25030302|NCT03328897|50128866|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
25030303|NCT03328897|50128864|FG000|Randomized-treatment Epoch|Pregnancy|3|||
25030304|NCT03328897|50128865|FG001|Randomized-treatment Epoch|Pregnancy|0|||
24943137|NCT00485264|50035939|FG001|Overall Study|Not Able to Attend Clinic|0|||
25030305|NCT03328897|50128866|FG002|Randomized-treatment Epoch|Pregnancy|0|||
25030306|NCT03328897|50128864|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
25030307|NCT03328897|50128865|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
25030308|NCT03328897|50128866|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
25030309|NCT03328897|50128864|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
25030310|NCT03328897|50128865|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
24943138|NCT00485264|50035940|FG002|Overall Study|Not Able to Attend Clinic|0|||
24943139|NCT00485264|50035941|FG003|Overall Study|Not Able to Attend Clinic|1|||
24943140|NCT00485264|50035942|FG004|Overall Study|Not Able to Attend Clinic|1|||
24943141|NCT00485264|50035943|FG005|Overall Study|Not Able to Attend Clinic|2|||
24943142|NCT00485264|50035938|FG000|Overall Study|Non-Compliant|17|||
24943143|NCT00485264|50035939|FG001|Overall Study|Non-Compliant|2|||
24943144|NCT00485264|50035940|FG002|Overall Study|Non-Compliant|1|||
24943145|NCT00485264|50035941|FG003|Overall Study|Non-Compliant|0|||
24943146|NCT00485264|50035942|FG004|Overall Study|Non-Compliant|1|||
24943147|NCT00485264|50035943|FG005|Overall Study|Non-Compliant|0|||
24943148|NCT00485264|50035938|FG000|Overall Study|Lost to Follow-up|2|||
24943149|NCT00485264|50035939|FG001|Overall Study|Lost to Follow-up|1|||
24943150|NCT00485264|50035940|FG002|Overall Study|Lost to Follow-up|1|||
24943151|NCT00485264|50035941|FG003|Overall Study|Lost to Follow-up|0|||
24943152|NCT00485264|50035942|FG004|Overall Study|Lost to Follow-up|0|||
24943153|NCT00485264|50035943|FG005|Overall Study|Lost to Follow-up|1|||
24943154|NCT00485264|50035938|FG000|Overall Study|Other Reason|3|||
24943155|NCT00485264|50035939|FG001|Overall Study|Other Reason|0|||
24943156|NCT00485264|50035940|FG002|Overall Study|Other Reason|0|||
24943157|NCT00485264|50035941|FG003|Overall Study|Other Reason|0|||
24943158|NCT00485264|50035942|FG004|Overall Study|Other Reason|0|||
24943159|NCT00485264|50035943|FG005|Overall Study|Other Reason|0|||
24943160|NCT00293254|50035964|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
24943161|NCT00293254|50035965|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
24943162|NCT00293254|50035964|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
24943163|NCT00293254|50035965|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
24943164|NCT00293254|50035964|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
24943165|NCT00293254|50035965|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
25030311|NCT03328897|50128866|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
25030312|NCT03328897|50128864|FG000|Follow-up Epoch|Adverse Event|4|||
25030313|NCT03328897|50128865|FG001|Follow-up Epoch|Adverse Event|0|||
25030314|NCT03328897|50128866|FG002|Follow-up Epoch|Adverse Event|1|||
25030315|NCT03328897|50128864|FG000|Follow-up Epoch|Lack of Efficacy|1|||
25030316|NCT03328897|50128865|FG001|Follow-up Epoch|Lack of Efficacy|1|||
24943166|NCT00293254|50035964|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
24943167|NCT00293254|50035965|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
25030317|NCT03328897|50128866|FG002|Follow-up Epoch|Lack of Efficacy|1|||
25030318|NCT03328897|50128864|FG000|Follow-up Epoch|Lost to Follow-up|0|||
25030319|NCT03328897|50128865|FG001|Follow-up Epoch|Lost to Follow-up|1|||
25030320|NCT03328897|50128866|FG002|Follow-up Epoch|Lost to Follow-up|0|||
25030321|NCT03328897|50128864|FG000|Follow-up Epoch|Pregnancy|1|||
25030322|NCT03328897|50128865|FG001|Follow-up Epoch|Pregnancy|0|||
25030323|NCT03328897|50128866|FG002|Follow-up Epoch|Pregnancy|0|||
24943168|NCT00293254|50035964|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
24943169|NCT00293254|50035965|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
24943170|NCT00293254|50035964|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
24943171|NCT00293254|50035965|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
24943172|NCT00293254|50035964|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
24943173|NCT00293254|50035965|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
24943174|NCT00293254|50035964|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
24943175|NCT00293254|50035965|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
24943176|NCT00293254|50035964|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
24943177|NCT00293254|50035965|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
24943178|NCT00293254|50035964|FG000|Extension - Double-Blind Week 49-156|Death|4|||
24943179|NCT00293254|50035965|FG001|Extension - Double-Blind Week 49-156|Death|1|||
24943180|NCT00293254|50035964|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
24943181|NCT00293254|50035965|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
24943182|NCT00293254|50035964|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
24943183|NCT00293254|50035965|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
25030324|NCT03328897|50128864|FG000|Follow-up Epoch|Patient/guardian decision|2|||
25030325|NCT03328897|50128865|FG001|Follow-up Epoch|Patient/guardian decision|1|||
25030326|NCT03328897|50128866|FG002|Follow-up Epoch|Patient/guardian decision|0|||
25030327|NCT03266107|50128874|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
25030328|NCT03266107|50128874|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
25030329|NCT03266107|50128874|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
25030330|NCT03266107|50128874|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
25030331|NCT03378635|50128883|FG000|Overall Study|Adverse Event|1|||
24943184|NCT00293254|50035964|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
24943185|NCT00293254|50035965|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
24943186|NCT00293254|50035964|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
24943187|NCT00293254|50035965|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
24943188|NCT00293254|50035964|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
24943189|NCT00293254|50035965|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
24943190|NCT00293254|50035964|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
24943191|NCT00293254|50035965|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
24943192|NCT00293254|50035964|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
24943193|NCT00293254|50035965|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
24943194|NCT00293254|50035964|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
24943195|NCT00293254|50035965|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
24943196|NCT00293254|50035964|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
24943197|NCT00293254|50035965|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
24943198|NCT00293254|50035964|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
24943199|NCT00293254|50035965|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
24943200|NCT00293254|50035964|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
24943201|NCT00293254|50035965|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
24943202|NCT00293254|50035964|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
24943203|NCT00293254|50035965|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
24943204|NCT00293254|50035964|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
24943205|NCT00293254|50035965|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
24943206|NCT00293254|50035964|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
24943207|NCT00293254|50035965|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
24943208|NCT00293254|50035964|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
24943209|NCT00293254|50035965|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
24943210|NCT00293254|50035964|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
24943211|NCT00293254|50035965|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
24943212|NCT00293254|50035964|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
24943213|NCT00293254|50035965|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
24943214|NCT00456846|50035979|FG000|Overall Study|Adverse Event|2|||
24943215|NCT00456846|50035980|FG001|Overall Study|Adverse Event|15|||
24943216|NCT00456846|50035979|FG000|Overall Study|Physician Decision|11|||
24943217|NCT00456846|50035980|FG001|Overall Study|Physician Decision|6|||
24943218|NCT00456846|50035979|FG000|Overall Study|Protocol Deviation|2|||
24943219|NCT00456846|50035980|FG001|Overall Study|Protocol Deviation|0|||
24943220|NCT00456846|50035979|FG000|Overall Study|Participant Discretion|1|||
24943221|NCT00456846|50035980|FG001|Overall Study|Participant Discretion|5|||
24943222|NCT00456846|50035979|FG000|Overall Study|Other|0|||
24943223|NCT00456846|50035980|FG001|Overall Study|Other|2|||
24943224|NCT00448344|50035988|FG000|Overall Study|Lost to Follow-up|20|||
24943225|NCT00448344|50035989|FG001|Overall Study|Lost to Follow-up|22|||
24943226|NCT00448344|50035988|FG000|Overall Study|Withdrawal by Subject|6|||
24943227|NCT00448344|50035989|FG001|Overall Study|Withdrawal by Subject|8|||
24943228|NCT00448344|50035988|FG000|Overall Study|Death|3|||
24943229|NCT00448344|50035989|FG001|Overall Study|Death|4|||
24943230|NCT00448344|50035988|FG000|Overall Study|Physician Decision|1|||
24943231|NCT00448344|50035989|FG001|Overall Study|Physician Decision|2|||
24943232|NCT00484094|50035995|FG000|Overall Study|Discontinued|39|||
24943233|NCT00484094|50035995|FG000|Overall Study|Other|3|||
24943234|NCT00447876|50036001|FG000|Overall Study|Withdrawal by Subject|1|||
24943235|NCT00447876|50036002|FG001|Overall Study|Withdrawal by Subject|4|||
24943236|NCT00447876|50036001|FG000|Overall Study|Lost to Follow-up|1|||
24943237|NCT00447876|50036002|FG001|Overall Study|Lost to Follow-up|0|||
24943238|NCT00447876|50036001|FG000|Overall Study|Deterioration of symptomology|1|||
24943239|NCT00447876|50036002|FG001|Overall Study|Deterioration of symptomology|0|||
24943240|NCT00456612|50036008|FG000|Overall Study|Withdrawal by Subject|3|||
24943241|NCT00456300|50036013|FG000|Overall Study|Adverse Event|1|||
24943242|NCT00456300|50036014|FG001|Overall Study|Adverse Event|0|||
24943243|NCT00267748|50036025|FG000|Non-randomized Period|Progressive disease|10|||
24943244|NCT00267748|50036026|FG001|Non-randomized Period|Progressive disease|0|||
24943245|NCT00267748|50036027|FG002|Non-randomized Period|Progressive disease|0|||
24943246|NCT00267748|50036025|FG000|Non-randomized Period|Adverse Event|8|||
24943247|NCT00267748|50036026|FG001|Non-randomized Period|Adverse Event|0|||
24943248|NCT00267748|50036027|FG002|Non-randomized Period|Adverse Event|0|||
24943249|NCT00267748|50036025|FG000|Non-randomized Period|Death|1|||
24943250|NCT00267748|50036026|FG001|Non-randomized Period|Death|0|||
24943251|NCT00267748|50036027|FG002|Non-randomized Period|Death|0|||
24943252|NCT00267748|50036025|FG000|Non-randomized Period|Participant not willing to participate|1|||
25186191|NCT01420679|50336127|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
25275563|NCT01231373|50589439|FG003|Overall Study|Lost to Follow-up|1|||
24943253|NCT00267748|50036026|FG001|Non-randomized Period|Participant not willing to participate|0|||
24943254|NCT00267748|50036027|FG002|Non-randomized Period|Participant not willing to participate|0|||
24943255|NCT00267748|50036025|FG000|Non-randomized Period|Other|3|||
24943256|NCT00267748|50036026|FG001|Non-randomized Period|Other|0|||
24943257|NCT00267748|50036027|FG002|Non-randomized Period|Other|0|||
24943258|NCT00267748|50036025|FG000|Randomized Period|Death|0|||
24943259|NCT00267748|50036026|FG001|Randomized Period|Death|2|||
24943260|NCT00267748|50036027|FG002|Randomized Period|Death|3|||
24943261|NCT00267748|50036025|FG000|Randomized Period|Adverse Event|0|||
24943262|NCT00267748|50036026|FG001|Randomized Period|Adverse Event|23|||
24943263|NCT00267748|50036027|FG002|Randomized Period|Adverse Event|25|||
24943264|NCT00267748|50036025|FG000|Randomized Period|Global deterioration of health status|0|||
24943265|NCT00267748|50036026|FG001|Randomized Period|Global deterioration of health status|6|||
24943266|NCT00267748|50036027|FG002|Randomized Period|Global deterioration of health status|7|||
24943267|NCT00267748|50036025|FG000|Randomized Period|Lost to Follow-up|0|||
24943268|NCT00267748|50036026|FG001|Randomized Period|Lost to Follow-up|1|||
24943269|NCT00267748|50036027|FG002|Randomized Period|Lost to Follow-up|0|||
24943270|NCT00267748|50036025|FG000|Randomized Period|Objective progression or relapse|0|||
24943271|NCT00267748|50036026|FG001|Randomized Period|Objective progression or relapse|77|||
24943272|NCT00267748|50036027|FG002|Randomized Period|Objective progression or relapse|86|||
24943273|NCT00267748|50036025|FG000|Randomized Period|Withdrawal by Subject|0|||
24943274|NCT00267748|50036026|FG001|Randomized Period|Withdrawal by Subject|9|||
24943275|NCT00267748|50036027|FG002|Randomized Period|Withdrawal by Subject|2|||
24943276|NCT00267748|50036025|FG000|Randomized Period|Other|0|||
24943277|NCT00267748|50036026|FG001|Randomized Period|Other|9|||
24943278|NCT00267748|50036027|FG002|Randomized Period|Other|6|||
25030332|NCT03378635|50128884|FG001|Overall Study|Adverse Event|0|||
25030333|NCT03378635|50128885|FG002|Overall Study|Adverse Event|0|||
25030334|NCT03378635|50128883|FG000|Overall Study|Withdrawal by Subject|1|||
25030335|NCT03378635|50128884|FG001|Overall Study|Withdrawal by Subject|0|||
24943279|NCT00267748|50036025|FG000|Randomized Period|randomized but not treated|0|||
24943280|NCT00267748|50036026|FG001|Randomized Period|randomized but not treated|0|||
24943281|NCT00267748|50036027|FG002|Randomized Period|randomized but not treated|3|||
24943282|NCT00267202|50036036|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
24943283|NCT00267202|50036037|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
24943284|NCT00267202|50036036|FG000|Overall Study|Withdrawal by Subject|12|||
24943285|NCT00267202|50036037|FG001|Overall Study|Withdrawal by Subject|15|||
24943286|NCT00267202|50036036|FG000|Overall Study|Adverse Event|13|||
25030336|NCT03378635|50128885|FG002|Overall Study|Withdrawal by Subject|0|||
25030337|NCT03326869|50128896|FG000|Overall Study|Study data has been lost to natural disa|1|||
25030338|NCT03326869|50128897|FG001|Overall Study|Study data has been lost to natural disa|1|||
25030339|NCT03334409|50128909|FG000|Overall Study|Did not meet inclusion criteria|1|||
25030340|NCT03334409|50128910|FG001|Overall Study|Did not meet inclusion criteria|0|||
25030341|NCT02891915|50128918|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
25030342|NCT02891915|50128919|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
25030343|NCT02891915|50128918|FG000|Overall Study|Withdrawal by Subject|3|||
25030344|NCT02891915|50128919|FG001|Overall Study|Withdrawal by Subject|3|||
25030345|NCT02891915|50128918|FG000|Overall Study|Became Ineligible After Enrollment|2|||
25030346|NCT02891915|50128919|FG001|Overall Study|Became Ineligible After Enrollment|1|||
25030347|NCT02891915|50128918|FG000|Overall Study|Lost to Follow-up|1|||
25030348|NCT02891915|50128919|FG001|Overall Study|Lost to Follow-up|4|||
25030349|NCT02891915|50128918|FG000|Overall Study|Physician Decision|1|||
25030350|NCT02891915|50128919|FG001|Overall Study|Physician Decision|0|||
25030351|NCT02891681|50128928|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
25030352|NCT02891681|50128929|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
25030353|NCT02891681|50128930|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
25030354|NCT02891681|50128928|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
25030355|NCT02891681|50128929|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
25030356|NCT02891681|50128930|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
25030357|NCT02891681|50128928|FG000|Overall Study|Taken off study after first imaging appointment|1|||
25030358|NCT02891681|50128929|FG001|Overall Study|Taken off study after first imaging appointment|0|||
25030359|NCT02891681|50128930|FG002|Overall Study|Taken off study after first imaging appointment|0|||
25030360|NCT04671342|50128938|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
25030361|NCT04671342|50128938|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
25030362|NCT04671342|50128938|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
25030363|NCT04671342|50128938|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
25030364|NCT04671342|50128938|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
25030365|NCT04671342|50128938|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
25030366|NCT03046446|50128942|FG000|Overall Study|Lack of Efficacy|7|||
25275564|NCT01231373|50589436|FG000|Overall Study|Withdrew Consent|1|||
25030367|NCT03046446|50128942|FG000|Overall Study|Adverse Event|6|||
25030368|NCT03046446|50128942|FG000|Overall Study|Lost to Follow-up|3|||
25030369|NCT03046446|50128942|FG000|Overall Study|Withdrawal by Subject|14|||
24943287|NCT00267202|50036037|FG001|Overall Study|Adverse Event|7|||
24943288|NCT00267202|50036036|FG000|Overall Study|Protocol Violation|2|||
24943289|NCT00267202|50036037|FG001|Overall Study|Protocol Violation|3|||
24943290|NCT00267202|50036036|FG000|Overall Study|Administrative problems|2|||
24943291|NCT00267202|50036037|FG001|Overall Study|Administrative problems|1|||
25030370|NCT03046446|50128942|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
25030371|NCT03046446|50128942|FG000|Overall Study|Disease Progression (see caveats)|25|||
25030372|NCT03046446|50128942|FG000|Overall Study|Non OA related knee surgery|1|||
25030373|NCT03051217|50128949|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
25030374|NCT03051217|50128950|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25030375|NCT03051217|50128951|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
25030376|NCT03051217|50128952|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25030377|NCT03051217|50128953|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25030378|NCT03051217|50128954|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25030379|NCT03051217|50128955|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25030380|NCT03051217|50128949|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
25030381|NCT03051217|50128950|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
25030382|NCT03051217|50128951|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
25030383|NCT03051217|50128952|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
25030384|NCT03051217|50128953|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
25030385|NCT03051217|50128954|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
25030386|NCT03051217|50128955|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
25030387|NCT03051217|50128949|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
25030388|NCT03051217|50128950|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
25030389|NCT03051217|50128951|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
25030390|NCT03051217|50128952|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25030391|NCT03051217|50128953|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25030392|NCT03051217|50128954|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25030393|NCT03051217|50128955|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25030394|NCT03051217|50128949|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
25030395|NCT03051217|50128950|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
25030396|NCT03051217|50128951|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
25159303|NCT01429623|50279005|FG001|Overall Study|No post baseline data|4|||
24943292|NCT00267202|50036036|FG000|Overall Study|Lost to Follow-up|3|||
24943293|NCT00267202|50036037|FG001|Overall Study|Lost to Follow-up|0|||
24943294|NCT00267046|50036046|FG000|Overall Study|Disease progression|4|||
24943295|NCT00267046|50036047|FG001|Overall Study|Disease progression|2|||
24943296|NCT00267046|50036046|FG000|Overall Study|Chemotoxicity|2|||
24943297|NCT00267046|50036047|FG001|Overall Study|Chemotoxicity|0|||
24943298|NCT00267046|50036046|FG000|Overall Study|Open-label palifermin|2|||
24943299|NCT00267046|50036047|FG001|Overall Study|Open-label palifermin|7|||
24943300|NCT00267046|50036046|FG000|Overall Study|Surgery|3|||
24943301|NCT00267046|50036047|FG001|Overall Study|Surgery|1|||
24943302|NCT00267046|50036046|FG000|Overall Study|Withdrawal by Subject|1|||
24943303|NCT00267046|50036047|FG001|Overall Study|Withdrawal by Subject|0|||
24943304|NCT00267046|50036046|FG000|Overall Study|Radiation|0|||
24943305|NCT00267046|50036047|FG001|Overall Study|Radiation|1|||
24943306|NCT00441090|50036058|FG000|Overall Study|Adverse Event|0|||
24943307|NCT00441090|50036059|FG001|Overall Study|Adverse Event|1|||
24943308|NCT00441090|50036060|FG002|Overall Study|Adverse Event|1|||
24943309|NCT00441090|50036061|FG003|Overall Study|Adverse Event|0|||
24943310|NCT00441090|50036062|FG004|Overall Study|Adverse Event|0|||
24943311|NCT00441090|50036058|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
24943312|NCT00441090|50036059|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
24943313|NCT00441090|50036060|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
24943314|NCT00441090|50036061|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
24943315|NCT00441090|50036062|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
24943316|NCT00441090|50036058|FG000|Overall Study|Withdrawal by Subject|1|||
24943317|NCT00441090|50036059|FG001|Overall Study|Withdrawal by Subject|0|||
24943318|NCT00441090|50036060|FG002|Overall Study|Withdrawal by Subject|1|||
24943319|NCT00441090|50036061|FG003|Overall Study|Withdrawal by Subject|0|||
24943320|NCT00441090|50036062|FG004|Overall Study|Withdrawal by Subject|0|||
24943321|NCT00441090|50036058|FG000|Overall Study|Lack of Efficacy|1|||
24943322|NCT00441090|50036059|FG001|Overall Study|Lack of Efficacy|0|||
24943323|NCT00441090|50036060|FG002|Overall Study|Lack of Efficacy|0|||
24943324|NCT00441090|50036061|FG003|Overall Study|Lack of Efficacy|0|||
25030397|NCT03051217|50128952|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
25030398|NCT03051217|50128953|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
25159304|NCT01408641|50279013|FG000|Overall Study|Physician Decision|1|||
25159305|NCT01408641|50279014|FG001|Overall Study|Physician Decision|0|||
24943325|NCT00441090|50036062|FG004|Overall Study|Lack of Efficacy|0|||
24943326|NCT00441012|50036076|FG000|Overall Study|Adverse Event|0|||
24943327|NCT00441012|50036077|FG001|Overall Study|Adverse Event|1|||
24943328|NCT00441012|50036076|FG000|Overall Study|Lost to Follow-up|3|||
24943329|NCT00441012|50036077|FG001|Overall Study|Lost to Follow-up|3|||
24943330|NCT00441012|50036076|FG000|Overall Study|Protocol Violation|10|||
24943331|NCT00441012|50036077|FG001|Overall Study|Protocol Violation|9|||
24943332|NCT00441012|50036076|FG000|Overall Study|Withdrawal by Subject|4|||
24943333|NCT00441012|50036077|FG001|Overall Study|Withdrawal by Subject|0|||
24943334|NCT00441012|50036076|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
24943335|NCT00441012|50036077|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
24943336|NCT00286468|50036086|FG000|Overall Study|Hyperglycemic Rescue|28|||
24943337|NCT00286468|50036087|FG001|Overall Study|Hyperglycemic Rescue|30|||
24943338|NCT00286468|50036088|FG002|Overall Study|Hyperglycemic Rescue|31|||
24943339|NCT00286468|50036086|FG000|Overall Study|Adverse Event|2|||
24943340|NCT00286468|50036087|FG001|Overall Study|Adverse Event|6|||
24943341|NCT00286468|50036088|FG002|Overall Study|Adverse Event|4|||
24943342|NCT00286468|50036086|FG000|Overall Study|Protocol Violation|0|||
24943343|NCT00286468|50036087|FG001|Overall Study|Protocol Violation|3|||
24943344|NCT00286468|50036088|FG002|Overall Study|Protocol Violation|1|||
24943345|NCT00286468|50036086|FG000|Overall Study|Lost to Follow-up|1|||
24943346|NCT00286468|50036087|FG001|Overall Study|Lost to Follow-up|1|||
24943347|NCT00286468|50036088|FG002|Overall Study|Lost to Follow-up|2|||
24943348|NCT00286468|50036086|FG000|Overall Study|Withdrawal by Subject|3|||
24943349|NCT00286468|50036087|FG001|Overall Study|Withdrawal by Subject|8|||
24943350|NCT00286468|50036088|FG002|Overall Study|Withdrawal by Subject|11|||
24943351|NCT00286468|50036086|FG000|Overall Study|Physician Decision|3|||
24943352|NCT00286468|50036087|FG001|Overall Study|Physician Decision|2|||
24943353|NCT00286468|50036088|FG002|Overall Study|Physician Decision|1|||
24943354|NCT00507026|50036099|FG000|Overall Study|Lack of Efficacy|6|||
24943355|NCT00507026|50036100|FG001|Overall Study|Lack of Efficacy|4|||
24943356|NCT00507026|50036101|FG002|Overall Study|Lack of Efficacy|21|||
24943357|NCT00507026|50036099|FG000|Overall Study|Withdrawal by Subject|2|||
24943358|NCT00507026|50036100|FG001|Overall Study|Withdrawal by Subject|0|||
24943359|NCT00507026|50036101|FG002|Overall Study|Withdrawal by Subject|0|||
24943360|NCT00507026|50036099|FG000|Overall Study|Investigator Decision|1|||
24943361|NCT00507026|50036100|FG001|Overall Study|Investigator Decision|0|||
24943362|NCT00507026|50036101|FG002|Overall Study|Investigator Decision|0|||
24943363|NCT00507026|50036099|FG000|Overall Study|Adverse Event|2|||
24943364|NCT00507026|50036100|FG001|Overall Study|Adverse Event|0|||
24943365|NCT00507026|50036101|FG002|Overall Study|Adverse Event|0|||
24943366|NCT00507026|50036099|FG000|Overall Study|Protocol Violation|1|||
24943367|NCT00507026|50036100|FG001|Overall Study|Protocol Violation|0|||
24943368|NCT00507026|50036101|FG002|Overall Study|Protocol Violation|0|||
24943369|NCT00507026|50036099|FG000|Overall Study|Other|1|||
24943370|NCT00507026|50036100|FG001|Overall Study|Other|0|||
24943371|NCT00507026|50036101|FG002|Overall Study|Other|0|||
24943372|NCT00446550|50036111|FG000|Overall Study|Adverse Event|1|||
24943373|NCT00446550|50036112|FG001|Overall Study|Adverse Event|0|||
24943374|NCT03847974|50036119|FG000|Overall Study|relocated out of region|3|||
24943375|NCT03847974|50036119|FG000|Overall Study|Withdrawal by Subject|2|||
24943376|NCT03847974|50036119|FG000|Overall Study|Adverse Event|1|||
24943377|NCT00506948|50036123|FG000|Overall Study|Death|4|||
24943378|NCT00506948|50036123|FG000|Overall Study|Adverse Event|5|||
24943379|NCT00506948|50036123|FG000|Overall Study|Physician Decision|1|||
24943380|NCT00286234|50036131|FG000|Overall Study|Protocol Violation|1|||
24943381|NCT00286234|50036132|FG001|Overall Study|Protocol Violation|2|||
24943382|NCT00286234|50036133|FG002|Overall Study|Protocol Violation|0|||
24943383|NCT00286234|50036134|FG003|Overall Study|Protocol Violation|1|||
24943384|NCT00286234|50036131|FG000|Overall Study|Physician Decision|1|||
24943385|NCT00286234|50036132|FG001|Overall Study|Physician Decision|0|||
24943386|NCT00286234|50036133|FG002|Overall Study|Physician Decision|0|||
24943387|NCT00286234|50036134|FG003|Overall Study|Physician Decision|1|||
24943388|NCT00286234|50036131|FG000|Overall Study|Adverse Event|0|||
24943389|NCT00286234|50036132|FG001|Overall Study|Adverse Event|0|||
24943390|NCT00286234|50036133|FG002|Overall Study|Adverse Event|0|||
24943391|NCT00286234|50036134|FG003|Overall Study|Adverse Event|1|||
24943392|NCT00286234|50036131|FG000|Overall Study|Adverse Event|0|||
24943393|NCT00286234|50036132|FG001|Overall Study|Adverse Event|0|||
24943394|NCT00286234|50036133|FG002|Overall Study|Adverse Event|0|||
24943395|NCT00286234|50036134|FG003|Overall Study|Adverse Event|1|||
24943396|NCT00445848|50036144|FG000|Overall Study|Adverse Event|14|||
24943397|NCT00445848|50036144|FG000|Overall Study|Withdrawal by Subject|4|||
24943398|NCT00445848|50036144|FG000|Overall Study|Progression|62|||
24943399|NCT00445848|50036144|FG000|Overall Study|Other-Not protocol specified|5|||
24943400|NCT00286156|50036151|FG000|Overall Study|Missed 12 month visit|0|||
24943401|NCT00286156|50036152|FG001|Overall Study|Missed 12 month visit|0|||
24943402|NCT00286156|50036153|FG002|Overall Study|Missed 12 month visit|1|||
24943403|NCT00286156|50036151|FG000|Overall Study|AE: pulmonary embolus|0|||
24943404|NCT00286156|50036152|FG001|Overall Study|AE: pulmonary embolus|1|||
24943405|NCT00286156|50036153|FG002|Overall Study|AE: pulmonary embolus|0|||
24943406|NCT00286156|50036151|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
24943407|NCT00286156|50036152|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
24943408|NCT00286156|50036153|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
24943409|NCT00286156|50036151|FG000|Overall Study|AE: pneumonia|1|||
24943410|NCT00286156|50036152|FG001|Overall Study|AE: pneumonia|0|||
24943411|NCT00286156|50036153|FG002|Overall Study|AE: pneumonia|0|||
24943412|NCT00455520|50036163|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
24943413|NCT00455520|50036164|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
24943414|NCT00455520|50036163|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
24943415|NCT00455520|50036164|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
24943416|NCT00455520|50036163|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
24943417|NCT00455520|50036164|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
24943418|NCT00455520|50036163|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
24943419|NCT00455520|50036164|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
24943420|NCT00455520|50036163|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
25030399|NCT03051217|50128954|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
25030400|NCT03051217|50128955|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
25030401|NCT03051217|50128949|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
24943421|NCT00455520|50036164|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
24943422|NCT00455520|50036163|FG000|Open Label Tapentadol Extended Release|All other|33|||
24943423|NCT00455520|50036164|FG001|Open Label Tapentadol Extended Release|All other|0|||
24943424|NCT00455520|50036163|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
24943425|NCT00455520|50036164|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
24943426|NCT00455520|50036163|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
24943427|NCT00455520|50036164|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
24943428|NCT00455520|50036163|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
24943429|NCT00455520|50036164|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
24943430|NCT00455520|50036163|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
24943431|NCT00455520|50036164|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
24943432|NCT00455520|50036163|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
24943433|NCT00455520|50036164|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
24943434|NCT00455520|50036163|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
24943435|NCT00455520|50036164|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
24943436|NCT00440700|50036173|FG000|Overall Study|Withdrawal by Subject|8|||
24943437|NCT00440700|50036174|FG001|Overall Study|Withdrawal by Subject|8|||
24943438|NCT00440700|50036175|FG002|Overall Study|Withdrawal by Subject|4|||
24943439|NCT00284050|50036186|FG000|Overall Study|Adverse Event|1|||
24943440|NCT00284050|50036187|FG001|Overall Study|Adverse Event|1|||
24943441|NCT00284050|50036188|FG002|Overall Study|Adverse Event|1|||
24943442|NCT00284050|50036186|FG000|Overall Study|Lack of Efficacy|0|||
24943443|NCT00284050|50036187|FG001|Overall Study|Lack of Efficacy|1|||
24943444|NCT00284050|50036188|FG002|Overall Study|Lack of Efficacy|3|||
25030402|NCT03051217|50128950|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
25030403|NCT03051217|50128951|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
24943445|NCT00284050|50036186|FG000|Overall Study|Protocol Violation|0|||
24943446|NCT00284050|50036187|FG001|Overall Study|Protocol Violation|1|||
24943447|NCT00284050|50036188|FG002|Overall Study|Protocol Violation|2|||
24943448|NCT00284050|50036186|FG000|Overall Study|Withdrawal by Subject|2|||
24943449|NCT00284050|50036187|FG001|Overall Study|Withdrawal by Subject|2|||
24943450|NCT00284050|50036188|FG002|Overall Study|Withdrawal by Subject|2|||
25030404|NCT03051217|50128952|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
25030405|NCT03051217|50128953|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
25030406|NCT03051217|50128954|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
25030407|NCT03051217|50128955|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
25030408|NCT03051217|50128949|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
25030409|NCT03051217|50128950|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
25030410|NCT03051217|50128951|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
25030411|NCT03051217|50128952|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
25030412|NCT03051217|50128953|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
25030413|NCT03051217|50128954|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
25030414|NCT03051217|50128955|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
25030415|NCT03051217|50128949|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
25030416|NCT03051217|50128950|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
25030417|NCT03051217|50128951|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
25030418|NCT03051217|50128952|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
25030419|NCT03051217|50128953|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
25030420|NCT03051217|50128954|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
25159306|NCT01429077|50279022|FG000|Overall Study|Lost to Follow-up|0|||
24943451|NCT00284050|50036186|FG000|Overall Study|Lost to Follow-up|1|||
24943452|NCT00284050|50036187|FG001|Overall Study|Lost to Follow-up|0|||
24943453|NCT00284050|50036188|FG002|Overall Study|Lost to Follow-up|1|||
24943454|NCT00284050|50036186|FG000|Overall Study|Death|1|||
24943455|NCT00284050|50036187|FG001|Overall Study|Death|0|||
24943456|NCT00284050|50036188|FG002|Overall Study|Death|0|||
25030421|NCT03051217|50128955|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
25030422|NCT03051217|50128949|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
25030423|NCT03051217|50128950|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
25030424|NCT03051217|50128951|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
25030425|NCT03051217|50128952|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
25030426|NCT03051217|50128953|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
25030427|NCT03051217|50128954|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
25030428|NCT03051217|50128955|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
25030429|NCT03046056|50128981|FG000|Overall Study|Non-responder at Week 10|6|||
25030430|NCT03046056|50128982|FG001|Overall Study|Non-responder at Week 10|6|||
25030431|NCT03046056|50128983|FG002|Overall Study|Non-responder at Week 10|4|||
25030432|NCT03046056|50128981|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
25030433|NCT03046056|50128982|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
25030434|NCT03046056|50128983|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
25030435|NCT03046056|50128981|FG000|Overall Study|Adverse Event|1|||
25030436|NCT03046056|50128982|FG001|Overall Study|Adverse Event|5|||
24943457|NCT00293020|50036196|FG000|Overall Study|Withdrawal by Subject|34|||
24943458|NCT00293020|50036196|FG000|Overall Study|Adverse Event|30|||
24943459|NCT00293020|50036196|FG000|Overall Study|Death|32|||
24943460|NCT00293020|50036196|FG000|Overall Study|Lack of Efficacy|12|||
24943461|NCT00293020|50036196|FG000|Overall Study|Lost to Follow-up|4|||
24943462|NCT00293020|50036196|FG000|Overall Study|Protocol Violation|6|||
24943463|NCT00293020|50036196|FG000|Overall Study|Physician Decision|21|||
24943464|NCT00293020|50036196|FG000|Overall Study|Other Reason|22|||
24943465|NCT00293020|50036196|FG000|Overall Study|No dose taken|1|||
24943466|NCT00377637|50036204|FG000|Induction Phase|Adverse Event|12|||
24943467|NCT00377637|50036205|FG001|Induction Phase|Adverse Event|21|||
24943468|NCT00377637|50036206|FG002|Induction Phase|Adverse Event|0|||
24943469|NCT00377637|50036207|FG003|Induction Phase|Adverse Event|0|||
24943470|NCT00377637|50036204|FG000|Induction Phase|Deterioration/serum creatinine|2|||
24943471|NCT00377637|50036205|FG001|Induction Phase|Deterioration/serum creatinine|0|||
24943472|NCT00377637|50036206|FG002|Induction Phase|Deterioration/serum creatinine|0|||
25030437|NCT03046056|50128983|FG002|Overall Study|Adverse Event|0|||
25030438|NCT03046056|50128981|FG000|Overall Study|Non-compliance With Study Drug|0|||
25030439|NCT03046056|50128982|FG001|Overall Study|Non-compliance With Study Drug|0|||
25030440|NCT03046056|50128983|FG002|Overall Study|Non-compliance With Study Drug|2|||
25030441|NCT03046056|50128981|FG000|Overall Study|Protocol Violation|1|||
24943473|NCT00377637|50036207|FG003|Induction Phase|Deterioration/serum creatinine|0|||
24943474|NCT00377637|50036204|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
24943475|NCT00377637|50036205|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
24943476|NCT00377637|50036206|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
25030442|NCT03046056|50128982|FG001|Overall Study|Protocol Violation|1|||
25030443|NCT03046056|50128983|FG002|Overall Study|Protocol Violation|0|||
25030444|NCT03046056|50128981|FG000|Overall Study|Investigator's Discretion|0|||
24943477|NCT00377637|50036207|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
24943478|NCT00377637|50036204|FG000|Induction Phase|Lost to Follow-up|2|||
24943479|NCT00377637|50036205|FG001|Induction Phase|Lost to Follow-up|1|||
25030445|NCT03046056|50128982|FG001|Overall Study|Investigator's Discretion|1|||
25030446|NCT03046056|50128983|FG002|Overall Study|Investigator's Discretion|0|||
24943480|NCT00377637|50036206|FG002|Induction Phase|Lost to Follow-up|0|||
24943481|NCT00377637|50036207|FG003|Induction Phase|Lost to Follow-up|0|||
24943482|NCT00377637|50036204|FG000|Induction Phase|Death|1|||
24943483|NCT00377637|50036205|FG001|Induction Phase|Death|3|||
24943484|NCT00377637|50036206|FG002|Induction Phase|Death|0|||
24943485|NCT00377637|50036207|FG003|Induction Phase|Death|0|||
25030447|NCT03046056|50128981|FG000|Overall Study|Withdrew Consent|1|||
25030448|NCT03046056|50128982|FG001|Overall Study|Withdrew Consent|0|||
25030449|NCT03046056|50128983|FG002|Overall Study|Withdrew Consent|0|||
25030450|NCT02849587|50128994|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
25030451|NCT02849587|50128995|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
25030452|NCT02849587|50128996|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
25030453|NCT02849587|50128994|FG000|Overall Study|Withdrawal by Subject|0|||
25030454|NCT02849587|50128995|FG001|Overall Study|Withdrawal by Subject|1|||
24943486|NCT00377637|50036204|FG000|Induction Phase|Withdrawal by Subject|5|||
24943487|NCT00377637|50036205|FG001|Induction Phase|Withdrawal by Subject|6|||
24943488|NCT00377637|50036206|FG002|Induction Phase|Withdrawal by Subject|0|||
24943489|NCT00377637|50036207|FG003|Induction Phase|Withdrawal by Subject|0|||
24943490|NCT00377637|50036204|FG000|Induction Phase|Physician Decision|3|||
24943491|NCT00377637|50036205|FG001|Induction Phase|Physician Decision|1|||
24943492|NCT00377637|50036206|FG002|Induction Phase|Physician Decision|0|||
24943493|NCT00377637|50036207|FG003|Induction Phase|Physician Decision|0|||
24943494|NCT00377637|50036204|FG000|Induction Phase|Sponsor decision|1|||
24943495|NCT00377637|50036205|FG001|Induction Phase|Sponsor decision|2|||
24943496|NCT00377637|50036206|FG002|Induction Phase|Sponsor decision|0|||
24943497|NCT00377637|50036207|FG003|Induction Phase|Sponsor decision|0|||
24943498|NCT00377637|50036204|FG000|Induction Phase|Non-Compliance|1|||
24943499|NCT00377637|50036205|FG001|Induction Phase|Non-Compliance|0|||
24943500|NCT00377637|50036206|FG002|Induction Phase|Non-Compliance|0|||
24943501|NCT00377637|50036207|FG003|Induction Phase|Non-Compliance|0|||
24943502|NCT00377637|50036204|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
24943503|NCT00377637|50036205|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
24943504|NCT00377637|50036206|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
24943505|NCT00377637|50036207|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
24943506|NCT00377637|50036204|FG000|Maintenance Phase|Adverse Event|0|||
24943507|NCT00377637|50036205|FG001|Maintenance Phase|Adverse Event|0|||
24943508|NCT00377637|50036206|FG002|Maintenance Phase|Adverse Event|29|||
24943509|NCT00377637|50036207|FG003|Maintenance Phase|Adverse Event|43|||
24943510|NCT00377637|50036204|FG000|Maintenance Phase|Physician Decision|0|||
24943511|NCT00377637|50036205|FG001|Maintenance Phase|Physician Decision|0|||
24943512|NCT00377637|50036206|FG002|Maintenance Phase|Physician Decision|5|||
24943513|NCT00377637|50036207|FG003|Maintenance Phase|Physician Decision|4|||
25030455|NCT02849587|50128996|FG002|Overall Study|Withdrawal by Subject|0|||
25030456|NCT03347279|50129010|FG000|Overall Study|Withdrawal by Subject|8|||
25030457|NCT03347279|50129011|FG001|Overall Study|Withdrawal by Subject|15|||
24943514|NCT00377637|50036204|FG000|Maintenance Phase|Lost to Follow-up|0|||
24943515|NCT00377637|50036205|FG001|Maintenance Phase|Lost to Follow-up|0|||
24943516|NCT00377637|50036206|FG002|Maintenance Phase|Lost to Follow-up|3|||
24943517|NCT00377637|50036207|FG003|Maintenance Phase|Lost to Follow-up|1|||
25030458|NCT03347279|50129010|FG000|Overall Study|Death|0|||
25159307|NCT01429077|50279023|FG001|Overall Study|Lost to Follow-up|3|||
24943518|NCT00377637|50036204|FG000|Maintenance Phase|Withdrawal by Subject|0|||
24943519|NCT00377637|50036205|FG001|Maintenance Phase|Withdrawal by Subject|0|||
24943520|NCT00377637|50036206|FG002|Maintenance Phase|Withdrawal by Subject|3|||
24943521|NCT00377637|50036207|FG003|Maintenance Phase|Withdrawal by Subject|3|||
24943522|NCT00377637|50036204|FG000|Maintenance Phase|Sponsor decision|0|||
24943523|NCT00377637|50036205|FG001|Maintenance Phase|Sponsor decision|0|||
24943524|NCT00377637|50036206|FG002|Maintenance Phase|Sponsor decision|2|||
24943525|NCT00377637|50036207|FG003|Maintenance Phase|Sponsor decision|3|||
24943526|NCT00377637|50036204|FG000|Maintenance Phase|Non-compliance|0|||
24943527|NCT00377637|50036205|FG001|Maintenance Phase|Non-compliance|0|||
24943528|NCT00377637|50036206|FG002|Maintenance Phase|Non-compliance|1|||
24943529|NCT00377637|50036207|FG003|Maintenance Phase|Non-compliance|1|||
24943530|NCT00377637|50036204|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
24943531|NCT00377637|50036205|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
24943532|NCT00377637|50036206|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
24943533|NCT00377637|50036207|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
24943534|NCT00377637|50036204|FG000|Maintenance Phase|Death|0|||
24943535|NCT00377637|50036205|FG001|Maintenance Phase|Death|0|||
24943536|NCT00377637|50036206|FG002|Maintenance Phase|Death|0|||
24943537|NCT00377637|50036207|FG003|Maintenance Phase|Death|1|||
24943538|NCT00377403|50036223|FG000|Overall Study|Unable to contact for telephone intervie|4|||
24943539|NCT00377403|50036224|FG001|Overall Study|Unable to contact for telephone intervie|7|||
24943540|NCT00370149|50036232|FG000|Overall Study|Physician Decision|16|||
24943541|NCT00370149|50036233|FG001|Overall Study|Physician Decision|16|||
24943542|NCT00370149|50036232|FG000|Overall Study|Protocol Violation|1|||
24943543|NCT00370149|50036233|FG001|Overall Study|Protocol Violation|0|||
24943544|NCT00370149|50036232|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
24943545|NCT00370149|50036233|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
24943546|NCT00370149|50036232|FG000|Overall Study|Pre-existing infection|0|||
24943547|NCT00370149|50036233|FG001|Overall Study|Pre-existing infection|1|||
24943548|NCT00370149|50036232|FG000|Overall Study|Antibiotic coated dressing placed|0|||
24943549|NCT00370149|50036233|FG001|Overall Study|Antibiotic coated dressing placed|1|||
24943550|NCT00292942|50036246|FG000|Overall Study|Withdrawal by Subject|0|||
24943551|NCT00292942|50036247|FG001|Overall Study|Withdrawal by Subject|0|||
24943552|NCT00292942|50036248|FG002|Overall Study|Withdrawal by Subject|1|||
24943553|NCT00292942|50036249|FG003|Overall Study|Withdrawal by Subject|0|||
24943554|NCT00292942|50036246|FG000|Overall Study|Adverse Event|0|||
24943555|NCT00292942|50036247|FG001|Overall Study|Adverse Event|0|||
24943556|NCT00292942|50036248|FG002|Overall Study|Adverse Event|0|||
24943557|NCT00292942|50036249|FG003|Overall Study|Adverse Event|1|||
24943558|NCT00483938|50036269|FG000|Overall Study|Protocol Violation|0|||
24943559|NCT00483938|50036270|FG001|Overall Study|Protocol Violation|0|||
24943560|NCT00483938|50036271|FG002|Overall Study|Protocol Violation|0|||
24943561|NCT00483938|50036272|FG003|Overall Study|Protocol Violation|0|||
24943562|NCT00483938|50036273|FG004|Overall Study|Protocol Violation|0|||
24943563|NCT00483938|50036274|FG005|Overall Study|Protocol Violation|0|||
24943564|NCT00483938|50036275|FG006|Overall Study|Protocol Violation|3|||
24943565|NCT00483938|50036269|FG000|Overall Study|Withdrawal by Subject|1|||
24943566|NCT00483938|50036270|FG001|Overall Study|Withdrawal by Subject|6|||
24943567|NCT00483938|50036271|FG002|Overall Study|Withdrawal by Subject|0|||
24943568|NCT00483938|50036272|FG003|Overall Study|Withdrawal by Subject|0|||
24943569|NCT00483938|50036273|FG004|Overall Study|Withdrawal by Subject|1|||
24943570|NCT00483938|50036274|FG005|Overall Study|Withdrawal by Subject|3|||
24943571|NCT00483938|50036275|FG006|Overall Study|Withdrawal by Subject|2|||
24943572|NCT00483938|50036269|FG000|Overall Study|Lost to Follow-up|1|||
24943573|NCT00483938|50036270|FG001|Overall Study|Lost to Follow-up|2|||
24943574|NCT00483938|50036271|FG002|Overall Study|Lost to Follow-up|0|||
24943575|NCT00483938|50036272|FG003|Overall Study|Lost to Follow-up|2|||
24943576|NCT00483938|50036273|FG004|Overall Study|Lost to Follow-up|1|||
24943577|NCT00483938|50036274|FG005|Overall Study|Lost to Follow-up|1|||
24943578|NCT00483938|50036275|FG006|Overall Study|Lost to Follow-up|3|||
24943579|NCT00483938|50036269|FG000|Overall Study|Death|0|||
24943580|NCT00483938|50036270|FG001|Overall Study|Death|2|||
25159308|NCT01428453|50279031|FG000|Overall Study|Adverse Event|2|||
24943581|NCT00483938|50036271|FG002|Overall Study|Death|0|||
24943582|NCT00483938|50036272|FG003|Overall Study|Death|0|||
24943583|NCT00483938|50036273|FG004|Overall Study|Death|0|||
24943584|NCT00483938|50036274|FG005|Overall Study|Death|0|||
24943585|NCT00483938|50036275|FG006|Overall Study|Death|0|||
25159309|NCT01428453|50279032|FG001|Overall Study|Adverse Event|7|||
24943586|NCT00483938|50036269|FG000|Overall Study|Other|3|||
24943587|NCT00483938|50036270|FG001|Overall Study|Other|9|||
24943588|NCT00483938|50036271|FG002|Overall Study|Other|0|||
24943589|NCT00483938|50036272|FG003|Overall Study|Other|4|||
24943590|NCT00483938|50036273|FG004|Overall Study|Other|0|||
24943591|NCT00483938|50036274|FG005|Overall Study|Other|4|||
24943592|NCT00483938|50036275|FG006|Overall Study|Other|32|||
24943593|NCT00370071|50036294|FG000|Overall Study|Withdrawal by Subject|2|||
24943594|NCT00369915|50036300|FG000|Overall Study|expected side effects|2|||
24943595|NCT00369915|50036301|FG001|Overall Study|expected side effects|1|||
24943596|NCT00369915|50036300|FG000|Overall Study|Withdrawal by Subject|4|||
24943597|NCT00369915|50036301|FG001|Overall Study|Withdrawal by Subject|1|||
24943598|NCT00369915|50036300|FG000|Overall Study|W/drawl by investigators|0|||
24943599|NCT00369915|50036301|FG001|Overall Study|W/drawl by investigators|1|||
24943600|NCT00369681|50036307|FG000|Overall Study|Death|1|||
24943601|NCT00266812|50036313|FG000|Overall Study|Disease Progression|9|||
24943602|NCT00266812|50036314|FG001|Overall Study|Disease Progression|3|||
25030459|NCT03347279|50129011|FG001|Overall Study|Death|2|||
25030460|NCT03347279|50129010|FG000|Overall Study|Lost to Follow-up|5|||
25030461|NCT03347279|50129011|FG001|Overall Study|Lost to Follow-up|2|||
25030462|NCT03347279|50129010|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
25030463|NCT03347279|50129011|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
25030464|NCT03262441|50129017|FG000|Overall Study|Withdrawal by Subject|1|||
25030465|NCT04580394|50129021|FG000|First Intervention|Incorrectly Randomized|1|||
25030466|NCT04580394|50129021|FG000|First Intervention|Physician Decision|1|||
25030467|NCT04580394|50129021|FG000|First Intervention|Lost to Follow-up|1|||
25030468|NCT04580394|50129021|FG000|Washout (One Week)|Withdrawal by Subject|1|||
25030469|NCT04580394|50129021|FG000|Washout (One Week)|Adverse Event|1|||
25030470|NCT04580394|50129021|FG000|Washout (One Week)|Withdrawal by Subject|2|||
25030471|NCT04580394|50129021|FG000|Third Intervention|Adverse Event|1|||
25030472|NCT04580394|50129021|FG000|Third Intervention|Withdrawal by Subject|1|||
25030473|NCT04580394|50129021|FG000|Washout (One Week)|Withdrawal by Subject|2|||
25030474|NCT02781727|50129033|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
25030475|NCT02781727|50129034|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
25030476|NCT02781727|50129033|FG000|Treatment Period|Withdrawal by Subject|1|||
25030477|NCT02781727|50129034|FG001|Treatment Period|Withdrawal by Subject|0|||
25030478|NCT02781727|50129033|FG000|Treatment Period|Lost to Follow-up|0|||
25030479|NCT02781727|50129034|FG001|Treatment Period|Lost to Follow-up|1|||
25030480|NCT01343082|50129040|FG000|The run-in Period|Not meeting criteria|3|||
25030481|NCT01343082|50129041|FG001|The run-in Period|Not meeting criteria|4|||
25030482|NCT01343082|50129042|FG002|The run-in Period|Not meeting criteria|5|||
25030483|NCT01343082|50129040|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
25030484|NCT01343082|50129041|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
25030485|NCT01343082|50129042|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
24943603|NCT00266812|50036313|FG000|Overall Study|Death|5|||
24943604|NCT00266812|50036314|FG001|Overall Study|Death|4|||
24943605|NCT00266812|50036313|FG000|Overall Study|Adverse Event|3|||
24943606|NCT00266812|50036314|FG001|Overall Study|Adverse Event|1|||
24943607|NCT00266812|50036313|FG000|Overall Study|Protocol Violation|0|||
24943608|NCT00266812|50036314|FG001|Overall Study|Protocol Violation|1|||
24943609|NCT00266812|50036313|FG000|Overall Study|Withdrawal by Subject|0|||
24943610|NCT00266812|50036314|FG001|Overall Study|Withdrawal by Subject|2|||
24943611|NCT00266812|50036313|FG000|Overall Study|Discontinued before starting study drug|4|||
24943612|NCT00266812|50036314|FG001|Overall Study|Discontinued before starting study drug|0|||
24943613|NCT00488774|50036324|FG000|Overall Study|Withdrawal of consent|2|||
24943614|NCT00488774|50036325|FG001|Overall Study|Withdrawal of consent|2|||
24943615|NCT00488774|50036326|FG002|Overall Study|Withdrawal of consent|2|||
24943616|NCT00488774|50036327|FG003|Overall Study|Withdrawal of consent|0|||
24943617|NCT00488774|50036324|FG000|Overall Study|Other|6|||
24943618|NCT00488774|50036325|FG001|Overall Study|Other|3|||
24943619|NCT00488774|50036326|FG002|Overall Study|Other|2|||
24943620|NCT00488774|50036327|FG003|Overall Study|Other|2|||
25030486|NCT01343082|50129040|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
25030487|NCT01343082|50129041|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
25030488|NCT01343082|50129042|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
25030489|NCT01343082|50129040|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
25030490|NCT01343082|50129041|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
25030491|NCT01343082|50129042|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
25030492|NCT01343082|50129040|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
25030493|NCT01343082|50129041|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
25030494|NCT01343082|50129042|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
25030495|NCT03374189|50129048|FG000|Overall Study|Lost to Follow-up|1|||
25030496|NCT03374189|50129049|FG001|Overall Study|Lost to Follow-up|0|||
25030497|NCT03261037|50129059|FG000|Overall Study|Withdrawal by Subject|2|||
25030498|NCT03261037|50129060|FG001|Overall Study|Withdrawal by Subject|13|||
25030499|NCT03261037|50129061|FG002|Overall Study|Withdrawal by Subject|0|||
25030500|NCT03261037|50129062|FG003|Overall Study|Withdrawal by Subject|18|||
24943621|NCT00488774|50036324|FG000|Overall Study|Lost to Follow-up|0|||
24943622|NCT00488774|50036325|FG001|Overall Study|Lost to Follow-up|0|||
24943623|NCT00488774|50036326|FG002|Overall Study|Lost to Follow-up|1|||
24943624|NCT00488774|50036327|FG003|Overall Study|Lost to Follow-up|1|||
24943625|NCT00361569|50036342|FG000|Overall Study|Protocol Violation|3|||
24943626|NCT00361569|50036343|FG001|Overall Study|Protocol Violation|2|||
25030501|NCT03261037|50129059|FG000|Overall Study|Non-compliance with study procedures|0|||
25030502|NCT03261037|50129060|FG001|Overall Study|Non-compliance with study procedures|2|||
25030503|NCT03261037|50129061|FG002|Overall Study|Non-compliance with study procedures|0|||
25030504|NCT03261037|50129062|FG003|Overall Study|Non-compliance with study procedures|6|||
25030505|NCT03261037|50129059|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
25030506|NCT03261037|50129060|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
25030507|NCT03261037|50129061|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
25030508|NCT03261037|50129062|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
25030509|NCT03261037|50129059|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
25030510|NCT03261037|50129060|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
25159310|NCT01428453|50279031|FG000|Overall Study|Protocol Violation|1|||
25159311|NCT01428453|50279032|FG001|Overall Study|Protocol Violation|0|||
25275565|NCT01231373|50589437|FG001|Overall Study|Withdrew Consent|0|||
24943627|NCT00361569|50036344|FG002|Overall Study|Protocol Violation|4|||
24943628|NCT00361569|50036345|FG003|Overall Study|Protocol Violation|2|||
24943629|NCT00361569|50036342|FG000|Overall Study|Withdrawal by Subject|2|||
24943630|NCT00361569|50036343|FG001|Overall Study|Withdrawal by Subject|1|||
24943631|NCT00361569|50036344|FG002|Overall Study|Withdrawal by Subject|9|||
24943632|NCT00361569|50036345|FG003|Overall Study|Withdrawal by Subject|14|||
24943633|NCT00361569|50036342|FG000|Overall Study|Adverse Event|3|||
24943634|NCT00361569|50036343|FG001|Overall Study|Adverse Event|5|||
24943635|NCT00361569|50036344|FG002|Overall Study|Adverse Event|2|||
24943636|NCT00361569|50036345|FG003|Overall Study|Adverse Event|2|||
24943637|NCT00361569|50036342|FG000|Overall Study|Lost to Follow-up|2|||
24943638|NCT00361569|50036343|FG001|Overall Study|Lost to Follow-up|3|||
24943639|NCT00361569|50036344|FG002|Overall Study|Lost to Follow-up|3|||
24943640|NCT00361569|50036345|FG003|Overall Study|Lost to Follow-up|2|||
24943641|NCT00361569|50036342|FG000|Overall Study|Not specified by investigator|2|||
24943642|NCT00361569|50036343|FG001|Overall Study|Not specified by investigator|0|||
24943643|NCT00361569|50036344|FG002|Overall Study|Not specified by investigator|0|||
24943644|NCT00361569|50036345|FG003|Overall Study|Not specified by investigator|1|||
24943645|NCT00488618|50036357|FG000|Overall Study|Adverse Event|13|||
24943646|NCT00488618|50036358|FG001|Overall Study|Adverse Event|17|||
24943647|NCT00488618|50036357|FG000|Overall Study|Insufficient Therapeutic Response|18|||
24943648|NCT00488618|50036358|FG001|Overall Study|Insufficient Therapeutic Response|11|||
24943649|NCT00488618|50036357|FG000|Overall Study|Protocol Violation|0|||
24943650|NCT00488618|50036358|FG001|Overall Study|Protocol Violation|2|||
24943651|NCT00488618|50036357|FG000|Overall Study|Withdrawal of Consent|15|||
24943652|NCT00488618|50036358|FG001|Overall Study|Withdrawal of Consent|13|||
24943653|NCT00488618|50036357|FG000|Overall Study|Lost to Follow-up|1|||
24943654|NCT00488618|50036358|FG001|Overall Study|Lost to Follow-up|0|||
24943655|NCT00266656|50036366|FG000|Overall Study|Death|1|||
24943656|NCT00266656|50036367|FG001|Overall Study|Death|0|||
24943657|NCT00266656|50036366|FG000|Overall Study|Lost to Follow-up|4|||
24943658|NCT00266656|50036367|FG001|Overall Study|Lost to Follow-up|1|||
24943659|NCT00266656|50036366|FG000|Overall Study|Withdrawal by Subject|4|||
24943660|NCT00266656|50036367|FG001|Overall Study|Withdrawal by Subject|2|||
24943661|NCT00266656|50036366|FG000|Overall Study|Did Not Reach Final Height|4|||
24943662|NCT00266656|50036367|FG001|Overall Study|Did Not Reach Final Height|8|||
24943663|NCT00266656|50036366|FG000|Overall Study|Parent/Caregiver Decision|1|||
24943664|NCT00266656|50036367|FG001|Overall Study|Parent/Caregiver Decision|2|||
24943665|NCT00483704|50036376|FG000|Randomization|Withdrawal by Subject|19|||
24943666|NCT00483704|50036377|FG001|Randomization|Withdrawal by Subject|28|||
24943667|NCT00483704|50036378|FG002|Randomization|Withdrawal by Subject|18|||
24943668|NCT00483704|50036376|FG000|Randomization|Protocol Violation|14|||
24943669|NCT00483704|50036377|FG001|Randomization|Protocol Violation|25|||
24943670|NCT00483704|50036378|FG002|Randomization|Protocol Violation|22|||
24943671|NCT00483704|50036376|FG000|Randomization|Lost to Follow-up|14|||
24943672|NCT00483704|50036377|FG001|Randomization|Lost to Follow-up|14|||
24943673|NCT00483704|50036378|FG002|Randomization|Lost to Follow-up|19|||
24943674|NCT00483704|50036376|FG000|Randomization|Pregnancy|1|||
24943675|NCT00483704|50036377|FG001|Randomization|Pregnancy|0|||
24943676|NCT00483704|50036378|FG002|Randomization|Pregnancy|0|||
24943677|NCT00483704|50036376|FG000|Randomization|Physician Decision|2|||
24943678|NCT00483704|50036377|FG001|Randomization|Physician Decision|4|||
24943679|NCT00483704|50036378|FG002|Randomization|Physician Decision|0|||
24943680|NCT00483704|50036376|FG000|Randomization|Progressive disease|0|||
24943681|NCT00483704|50036377|FG001|Randomization|Progressive disease|0|||
24943682|NCT00483704|50036378|FG002|Randomization|Progressive disease|1|||
24943683|NCT00483704|50036376|FG000|Randomization|Lack of qualifying migraines|21|||
24943684|NCT00483704|50036377|FG001|Randomization|Lack of qualifying migraines|25|||
24943685|NCT00483704|50036378|FG002|Randomization|Lack of qualifying migraines|31|||
24943686|NCT00483704|50036376|FG000|Treatment|Lack of qualifying migraines|101|||
24943687|NCT00483704|50036377|FG001|Treatment|Lack of qualifying migraines|99|||
24943688|NCT00483704|50036378|FG002|Treatment|Lack of qualifying migraines|116|||
24943689|NCT00483704|50036376|FG000|Treatment|Adverse Event|3|||
24943690|NCT00483704|50036377|FG001|Treatment|Adverse Event|5|||
24943691|NCT00483704|50036378|FG002|Treatment|Adverse Event|4|||
24943692|NCT00483704|50036376|FG000|Treatment|Withdrawal by Subject|16|||
24943693|NCT00483704|50036377|FG001|Treatment|Withdrawal by Subject|12|||
24943694|NCT00483704|50036378|FG002|Treatment|Withdrawal by Subject|21|||
24943695|NCT00483704|50036376|FG000|Treatment|Protocol Violation|6|||
24943696|NCT00483704|50036377|FG001|Treatment|Protocol Violation|3|||
24943697|NCT00483704|50036378|FG002|Treatment|Protocol Violation|5|||
24943698|NCT00483704|50036376|FG000|Treatment|Lost to Follow-up|2|||
24943699|NCT00483704|50036377|FG001|Treatment|Lost to Follow-up|7|||
24943700|NCT00483704|50036378|FG002|Treatment|Lost to Follow-up|5|||
24943701|NCT00483704|50036376|FG000|Treatment|Lack of Efficacy|1|||
24943702|NCT00483704|50036377|FG001|Treatment|Lack of Efficacy|1|||
24943703|NCT00483704|50036378|FG002|Treatment|Lack of Efficacy|1|||
24943704|NCT00483704|50036376|FG000|Treatment|Pregnancy|0|||
24943705|NCT00483704|50036377|FG001|Treatment|Pregnancy|1|||
24943706|NCT00483704|50036378|FG002|Treatment|Pregnancy|0|||
24943707|NCT00483704|50036376|FG000|Treatment|Physician Decision|0|||
24943708|NCT00483704|50036377|FG001|Treatment|Physician Decision|1|||
24943709|NCT00483704|50036378|FG002|Treatment|Physician Decision|4|||
24943710|NCT00483548|50036391|FG000|Overall Study|Randomized; not treated with study drug|1|||
24943711|NCT00483548|50036392|FG001|Overall Study|Randomized; not treated with study drug|3|||
24943712|NCT00483548|50036391|FG000|Overall Study|Adverse Event|25|||
24943713|NCT00483548|50036392|FG001|Overall Study|Adverse Event|14|||
24943714|NCT00483548|50036391|FG000|Overall Study|Laboratory abnormality|1|||
24943715|NCT00483548|50036392|FG001|Overall Study|Laboratory abnormality|2|||
24943716|NCT00483548|50036391|FG000|Overall Study|Lack of Efficacy|4|||
24943717|NCT00483548|50036392|FG001|Overall Study|Lack of Efficacy|8|||
24943718|NCT00483548|50036391|FG000|Overall Study|Protocol Violation|11|||
24943719|NCT00483548|50036392|FG001|Overall Study|Protocol Violation|7|||
24943720|NCT00483548|50036391|FG000|Overall Study|Pregnancy|1|||
24943721|NCT00483548|50036392|FG001|Overall Study|Pregnancy|0|||
24943722|NCT00483548|50036391|FG000|Overall Study|Protocol required discontinuation|6|||
24943723|NCT00483548|50036392|FG001|Overall Study|Protocol required discontinuation|6|||
24943724|NCT00483548|50036391|FG000|Overall Study|Unable to comply with protocol schedule|1|||
24943725|NCT00483548|50036392|FG001|Overall Study|Unable to comply with protocol schedule|0|||
24943726|NCT00483548|50036391|FG000|Overall Study|Non-compliance with medication|2|||
24943727|NCT00483548|50036392|FG001|Overall Study|Non-compliance with medication|0|||
24943728|NCT00483548|50036391|FG000|Overall Study|Lost to Follow-up|3|||
24943729|NCT00483548|50036392|FG001|Overall Study|Lost to Follow-up|4|||
24943730|NCT00483548|50036391|FG000|Overall Study|Withdrawal by Subject|5|||
24943731|NCT00483548|50036392|FG001|Overall Study|Withdrawal by Subject|2|||
24943732|NCT00445770|50036401|FG000|Overall Study|Adverse Event|9|||
24943733|NCT00445770|50036402|FG001|Overall Study|Adverse Event|15|||
24943734|NCT00445770|50036403|FG002|Overall Study|Adverse Event|19|||
24943735|NCT00445770|50036401|FG000|Overall Study|Lack of Efficacy|38|||
24943736|NCT00445770|50036402|FG001|Overall Study|Lack of Efficacy|13|||
24943737|NCT00445770|50036403|FG002|Overall Study|Lack of Efficacy|6|||
24943738|NCT00445770|50036401|FG000|Overall Study|Lost to Follow-up|0|||
24943739|NCT00445770|50036402|FG001|Overall Study|Lost to Follow-up|2|||
24943740|NCT00445770|50036403|FG002|Overall Study|Lost to Follow-up|0|||
24943741|NCT00445770|50036401|FG000|Overall Study|Other|6|||
24943742|NCT00445770|50036402|FG001|Overall Study|Other|5|||
24943743|NCT00445770|50036403|FG002|Overall Study|Other|6|||
24943744|NCT00266032|50036416|FG000|Treatment|Adverse Event|42|||
24943745|NCT00266032|50036417|FG001|Treatment|Adverse Event|26|||
24943746|NCT00266032|50036418|FG002|Treatment|Adverse Event|10|||
24943747|NCT00266032|50036416|FG000|Treatment|Lost to Follow-up|19|||
24943748|NCT00266032|50036417|FG001|Treatment|Lost to Follow-up|4|||
24943749|NCT00266032|50036418|FG002|Treatment|Lost to Follow-up|2|||
24943750|NCT00266032|50036416|FG000|Treatment|Pregnancy|3|||
24943751|NCT00266032|50036417|FG001|Treatment|Pregnancy|2|||
24943752|NCT00266032|50036418|FG002|Treatment|Pregnancy|2|||
24943753|NCT00266032|50036416|FG000|Treatment|Protocol Violation|6|||
24943754|NCT00266032|50036417|FG001|Treatment|Protocol Violation|14|||
24943755|NCT00266032|50036418|FG002|Treatment|Protocol Violation|13|||
24943756|NCT00266032|50036416|FG000|Treatment|Withdrawal by Subject|28|||
24943757|NCT00266032|50036417|FG001|Treatment|Withdrawal by Subject|13|||
24943758|NCT00266032|50036418|FG002|Treatment|Withdrawal by Subject|12|||
24943759|NCT00266032|50036416|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
24943760|NCT00266032|50036417|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
24943761|NCT00266032|50036418|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
24943762|NCT00266032|50036416|FG000|Open-label Safety Extension|Adverse Event|5|||
24943763|NCT00266032|50036417|FG001|Open-label Safety Extension|Adverse Event|0|||
25159312|NCT01428453|50279031|FG000|Overall Study|Lost to Follow-up|0|||
24943764|NCT00266032|50036418|FG002|Open-label Safety Extension|Adverse Event|4|||
24943765|NCT00266032|50036416|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
24943766|NCT00266032|50036417|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
24943767|NCT00266032|50036418|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
24943768|NCT00266032|50036416|FG000|Open-label Safety Extension|Pregnancy|4|||
24943769|NCT00266032|50036417|FG001|Open-label Safety Extension|Pregnancy|1|||
24943770|NCT00266032|50036418|FG002|Open-label Safety Extension|Pregnancy|2|||
24943771|NCT00266032|50036416|FG000|Open-label Safety Extension|Protocol Violation|1|||
24943772|NCT00266032|50036417|FG001|Open-label Safety Extension|Protocol Violation|3|||
24943773|NCT00266032|50036418|FG002|Open-label Safety Extension|Protocol Violation|2|||
24943774|NCT00266032|50036416|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
24943775|NCT00266032|50036417|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
24943776|NCT00266032|50036418|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
24943777|NCT00266032|50036416|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
24943778|NCT00266032|50036417|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
24943779|NCT00266032|50036418|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
24943780|NCT00483002|50036426|FG000|Overall Study|Adverse Event|68|||
24943781|NCT00483002|50036426|FG000|Overall Study|Lack of Efficacy|555|||
24943782|NCT00483002|50036426|FG000|Overall Study|Lost to Follow-up|962|||
24943783|NCT00483002|50036426|FG000|Overall Study|Other|2|||
24943784|NCT00483002|50036426|FG000|Overall Study|Other|967|||
24943785|NCT00482612|50036434|FG000|In-treatment Period|No study medication administered|0|||
24943786|NCT00482612|50036435|FG001|In-treatment Period|No study medication administered|0|||
24943787|NCT00482612|50036436|FG002|In-treatment Period|No study medication administered|1|||
24943788|NCT00482612|50036437|FG003|In-treatment Period|No study medication administered|0|||
24943789|NCT00482612|50036434|FG000|Follow-up Period|Other|4|||
24943790|NCT00482612|50036435|FG001|Follow-up Period|Other|2|||
24943791|NCT00482612|50036436|FG002|Follow-up Period|Other|1|||
24943792|NCT00482612|50036437|FG003|Follow-up Period|Other|2|||
24943793|NCT00482612|50036434|FG000|Follow-up Period|Lack of compliance|0|||
24943794|NCT00482612|50036435|FG001|Follow-up Period|Lack of compliance|0|||
24943795|NCT00482612|50036436|FG002|Follow-up Period|Lack of compliance|1|||
24943796|NCT00482612|50036437|FG003|Follow-up Period|Lack of compliance|0|||
24943797|NCT00482612|50036434|FG000|Follow-up Period|Lost to Follow-up|0|||
24943798|NCT00482612|50036435|FG001|Follow-up Period|Lost to Follow-up|4|||
24943799|NCT00482612|50036436|FG002|Follow-up Period|Lost to Follow-up|2|||
24943800|NCT00482612|50036437|FG003|Follow-up Period|Lost to Follow-up|1|||
24943801|NCT00482612|50036434|FG000|Follow-up Period|Adverse Event|4|||
24943802|NCT00482612|50036435|FG001|Follow-up Period|Adverse Event|7|||
24943803|NCT00482612|50036436|FG002|Follow-up Period|Adverse Event|9|||
24943804|NCT00482612|50036437|FG003|Follow-up Period|Adverse Event|0|||
24943805|NCT00482612|50036434|FG000|Follow-up Period|Lack of Efficacy|2|||
24943806|NCT00482612|50036435|FG001|Follow-up Period|Lack of Efficacy|0|||
24943807|NCT00482612|50036436|FG002|Follow-up Period|Lack of Efficacy|1|||
24943808|NCT00482612|50036437|FG003|Follow-up Period|Lack of Efficacy|0|||
24943809|NCT00482612|50036434|FG000|Follow-up Period|Withdrawal by Subject|3|||
24943810|NCT00482612|50036435|FG001|Follow-up Period|Withdrawal by Subject|5|||
24943811|NCT00482612|50036436|FG002|Follow-up Period|Withdrawal by Subject|7|||
24943812|NCT00482612|50036437|FG003|Follow-up Period|Withdrawal by Subject|2|||
24943813|NCT00482612|50036434|FG000|Follow-up Period|Reasons not related to trial|1|||
24943814|NCT00482612|50036435|FG001|Follow-up Period|Reasons not related to trial|0|||
24943815|NCT00482612|50036436|FG002|Follow-up Period|Reasons not related to trial|1|||
24943816|NCT00482612|50036437|FG003|Follow-up Period|Reasons not related to trial|3|||
24943817|NCT00282568|50036451|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
24943818|NCT00282568|50036451|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
24943819|NCT00282568|50036451|FG000|Extended Treatment Period|Adverse Event|17|||
24943820|NCT00282568|50036451|FG000|Extended Treatment Period|Non-compliance|4|||
24943821|NCT00282568|50036451|FG000|Extended Treatment Period|Physician Decision|1|||
24943822|NCT00282568|50036451|FG000|Extended Treatment Period|Lost to Follow-up|2|||
24943823|NCT00265564|50036457|FG000|Overall Study|Lost to Follow-up|5|||
24943824|NCT00265564|50036458|FG001|Overall Study|Lost to Follow-up|7|||
24943825|NCT00265564|50036457|FG000|Overall Study|met exclusion criteria|5|||
24943826|NCT00265564|50036458|FG001|Overall Study|met exclusion criteria|2|||
24943827|NCT00376623|50036467|FG000|Overall Study|Progressive disease|35|||
24943828|NCT00376623|50036468|FG001|Overall Study|Progressive disease|22|||
24943829|NCT00376623|50036469|FG002|Overall Study|Progressive disease|17|||
24943830|NCT00376623|50036467|FG000|Overall Study|Lost to Follow-up|0|||
24943831|NCT00376623|50036468|FG001|Overall Study|Lost to Follow-up|1|||
24943832|NCT00376623|50036469|FG002|Overall Study|Lost to Follow-up|0|||
24943833|NCT00376623|50036467|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
24943834|NCT00376623|50036468|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
24943835|NCT00376623|50036469|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
24943836|NCT00376623|50036467|FG000|Overall Study|Not treated with BI 2536|1|||
24943837|NCT00376623|50036468|FG001|Overall Study|Not treated with BI 2536|0|||
24943838|NCT00376623|50036469|FG002|Overall Study|Not treated with BI 2536|0|||
24943839|NCT00376623|50036467|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
24943840|NCT00376623|50036468|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
24943841|NCT00376623|50036469|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
24943842|NCT00376623|50036467|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
24943843|NCT00376623|50036468|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
24943844|NCT00376623|50036469|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
24943845|NCT00376623|50036467|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
24943846|NCT00376623|50036468|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
24943847|NCT00376623|50036469|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
24943848|NCT00376623|50036467|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
24943849|NCT00376623|50036468|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
24943850|NCT00376623|50036469|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
24943851|NCT00376623|50036467|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
24943852|NCT00376623|50036468|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
24943853|NCT00376623|50036469|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
24943854|NCT00376623|50036467|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
24943855|NCT00376623|50036468|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
24943856|NCT00376623|50036469|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
24943857|NCT00376623|50036467|FG000|Overall Study|Increase of tumour markers|0|||
24943858|NCT00376623|50036468|FG001|Overall Study|Increase of tumour markers|1|||
24943859|NCT00376623|50036469|FG002|Overall Study|Increase of tumour markers|0|||
24943860|NCT00376623|50036467|FG000|Overall Study|Bone metastasis|1|||
24943861|NCT00376623|50036468|FG001|Overall Study|Bone metastasis|0|||
24943862|NCT00376623|50036469|FG002|Overall Study|Bone metastasis|0|||
24943863|NCT00445692|50036483|FG000|Overall Study|Adverse Event|11|||
24943864|NCT00445692|50036483|FG000|Overall Study|Lack of Efficacy|5|||
24943865|NCT03824236|50036492|FG000|Overall Study|Lost to Follow-up|0|||
24943866|NCT03824236|50036493|FG001|Overall Study|Lost to Follow-up|0|||
24943867|NCT03824236|50036494|FG002|Overall Study|Lost to Follow-up|1|||
24943868|NCT00282412|50036502|FG000|Overall Study|Death|2|||
24943869|NCT00282334|50036508|FG000|Overall Study|Withdrawal by Subject|8|||
24943870|NCT00282334|50036509|FG001|Overall Study|Withdrawal by Subject|5|||
24943871|NCT00282256|50036515|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
24943872|NCT00282256|50036515|FG000|Extension Treatment Period|Adverse Event|2|||
24943873|NCT00265330|50036519|FG000|Overall Study|Adverse Event|41|||
24943874|NCT00265330|50036519|FG000|Overall Study|Lost to Follow-up|8|||
24943875|NCT00265330|50036519|FG000|Overall Study|Withdrawal by Subject|34|||
24943876|NCT00265330|50036519|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
25275566|NCT01231373|50589438|FG002|Overall Study|Withdrew Consent|0|||
25275567|NCT01231373|50589439|FG003|Overall Study|Withdrew Consent|0|||
25275568|NCT00975130|50589451|FG000|Study Part 1|Adverse Event|150|||
24943877|NCT00265330|50036519|FG000|Overall Study|Lack of Efficacy|4|||
24943878|NCT00265330|50036519|FG000|Overall Study|Family Scheduling Conflicts|1|||
24943879|NCT00265330|50036519|FG000|Overall Study|Began Taking Formulary Geodon|1|||
24943880|NCT00265330|50036519|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
24943881|NCT00265330|50036519|FG000|Overall Study|Site Closed by Sponsor|1|||
24943882|NCT00265330|50036519|FG000|Overall Study|Principal Investigators Request|1|||
24943883|NCT00265330|50036519|FG000|Overall Study|Withdrew Consent|1|||
24943884|NCT00265330|50036519|FG000|Overall Study|Protocol Violation|1|||
24943885|NCT00292318|50036525|FG000|Overall Study|Study terminated by officials|2|||
24943886|NCT00292318|50036526|FG001|Overall Study|Study terminated by officials|1|||
24943887|NCT00281632|50036532|FG000|Overall Study|Adverse Event|7|||
24943888|NCT00281632|50036532|FG000|Overall Study|Withdrawal by Subject|2|||
24943889|NCT00281632|50036532|FG000|Overall Study|Disease Progression|22|||
24943890|NCT00281632|50036532|FG000|Overall Study|Death|1|||
24943891|NCT00281632|50036532|FG000|Overall Study|Physician Decision|1|||
24943892|NCT00281632|50036532|FG000|Overall Study|Ongoing|3|||
24943893|NCT00543569|50036548|FG000|Overall Study|Death|2|||
24943894|NCT00543569|50036549|FG001|Overall Study|Death|2|||
24943895|NCT00543569|50036550|FG002|Overall Study|Death|3|||
24943896|NCT00543569|50036551|FG003|Overall Study|Death|1|||
24943897|NCT00543569|50036548|FG000|Overall Study|Lost to Follow-up|0|||
24943898|NCT00543569|50036549|FG001|Overall Study|Lost to Follow-up|0|||
24943899|NCT00543569|50036550|FG002|Overall Study|Lost to Follow-up|1|||
24943900|NCT00543569|50036551|FG003|Overall Study|Lost to Follow-up|1|||
24943901|NCT00543569|50036548|FG000|Overall Study|Miscellaneous Reasons|7|||
24943902|NCT00543569|50036549|FG001|Overall Study|Miscellaneous Reasons|3|||
24943903|NCT00543569|50036550|FG002|Overall Study|Miscellaneous Reasons|11|||
24943904|NCT00543569|50036551|FG003|Overall Study|Miscellaneous Reasons|4|||
24943905|NCT00543569|50036548|FG000|Overall Study|Randomized but never received study drug|3|||
24943906|NCT00543569|50036549|FG001|Overall Study|Randomized but never received study drug|3|||
24943907|NCT00543569|50036550|FG002|Overall Study|Randomized but never received study drug|5|||
24943908|NCT00543569|50036551|FG003|Overall Study|Randomized but never received study drug|3|||
24943909|NCT00445458|50036565|FG000|Overall Study|Disease Progression|3|||
24943910|NCT00445458|50036566|FG001|Overall Study|Disease Progression|4|||
24943911|NCT00445458|50036567|FG002|Overall Study|Disease Progression|54|||
24943912|NCT00445458|50036568|FG003|Overall Study|Disease Progression|27|||
24943913|NCT00445458|50036565|FG000|Overall Study|Withdrawal by Subject|0|||
24943914|NCT00445458|50036566|FG001|Overall Study|Withdrawal by Subject|0|||
24943915|NCT00445458|50036567|FG002|Overall Study|Withdrawal by Subject|7|||
24943916|NCT00445458|50036568|FG003|Overall Study|Withdrawal by Subject|0|||
24943917|NCT00445458|50036565|FG000|Overall Study|Adverse Event|0|||
24943918|NCT00445458|50036566|FG001|Overall Study|Adverse Event|0|||
24943919|NCT00445458|50036567|FG002|Overall Study|Adverse Event|3|||
24943920|NCT00445458|50036568|FG003|Overall Study|Adverse Event|0|||
24943921|NCT00445458|50036565|FG000|Overall Study|Death|0|||
24943922|NCT00445458|50036566|FG001|Overall Study|Death|1|||
24943923|NCT00445458|50036567|FG002|Overall Study|Death|2|||
24943924|NCT00445458|50036568|FG003|Overall Study|Death|0|||
24943925|NCT00445458|50036565|FG000|Overall Study|Physician Decision|0|||
24943926|NCT00445458|50036566|FG001|Overall Study|Physician Decision|0|||
24943927|NCT00445458|50036567|FG002|Overall Study|Physician Decision|1|||
24943928|NCT00445458|50036568|FG003|Overall Study|Physician Decision|1|||
24943929|NCT00445458|50036565|FG000|Overall Study|Surgery|0|||
24943930|NCT00445458|50036566|FG001|Overall Study|Surgery|0|||
24943931|NCT00445458|50036567|FG002|Overall Study|Surgery|1|||
24943932|NCT00445458|50036568|FG003|Overall Study|Surgery|0|||
24943933|NCT03914417|50036581|FG000|Overall Study|Withdrawal by Subject|2|||
24943934|NCT00541385|50036587|FG000|Overall Study|Adverse Event|6|||
24943935|NCT00541385|50036588|FG001|Overall Study|Adverse Event|3|||
24943936|NCT00541385|50036587|FG000|Overall Study|Withdrawal by Subject|2|||
24943937|NCT00541385|50036588|FG001|Overall Study|Withdrawal by Subject|2|||
24943938|NCT00541385|50036587|FG000|Overall Study|Lost to Follow-up|6|||
24943939|NCT00541385|50036588|FG001|Overall Study|Lost to Follow-up|1|||
24943940|NCT00541385|50036587|FG000|Overall Study|Parasite reappearance/malaria|67|||
25275569|NCT00975130|50589452|FG001|Study Part 1|Adverse Event|0|||
25275570|NCT00975130|50589453|FG002|Study Part 1|Adverse Event|0|||
24943941|NCT00541385|50036588|FG001|Overall Study|Parasite reappearance/malaria|32|||
24943942|NCT00265096|50036597|FG000|Overall Study|Adverse Event|14|||
24943943|NCT00265096|50036598|FG001|Overall Study|Adverse Event|18|||
24943944|NCT00265096|50036599|FG002|Overall Study|Adverse Event|18|||
24943945|NCT00265096|50036597|FG000|Overall Study|Lost to Follow-up|2|||
24943946|NCT00265096|50036598|FG001|Overall Study|Lost to Follow-up|5|||
24943947|NCT00265096|50036599|FG002|Overall Study|Lost to Follow-up|3|||
24943948|NCT00265096|50036597|FG000|Overall Study|Death|0|||
24943949|NCT00265096|50036598|FG001|Overall Study|Death|1|||
24943950|NCT00265096|50036599|FG002|Overall Study|Death|2|||
24943951|NCT00265096|50036597|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
24943952|NCT00265096|50036598|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
24943953|NCT00265096|50036599|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
24943954|NCT00265096|50036597|FG000|Overall Study|Other|11|||
24943955|NCT00265096|50036598|FG001|Overall Study|Other|19|||
24943956|NCT00265096|50036599|FG002|Overall Study|Other|10|||
24943957|NCT02201108|50036611|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
24943958|NCT02201108|50036612|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
24943959|NCT02201108|50036611|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
24943960|NCT02201108|50036612|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
24943961|NCT02201108|50036611|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
25030511|NCT03261037|50129061|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
25030512|NCT03261037|50129062|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
25030513|NCT03261037|50129059|FG000|Overall Study|Diagnosed but protocol deviation|1|||
25030514|NCT03261037|50129060|FG001|Overall Study|Diagnosed but protocol deviation|0|||
25030515|NCT03261037|50129061|FG002|Overall Study|Diagnosed but protocol deviation|0|||
25030516|NCT03261037|50129062|FG003|Overall Study|Diagnosed but protocol deviation|0|||
25030517|NCT03261037|50129059|FG000|Overall Study|Participant did not want to continue the study|0|||
25030518|NCT03261037|50129060|FG001|Overall Study|Participant did not want to continue the study|1|||
25030519|NCT03261037|50129061|FG002|Overall Study|Participant did not want to continue the study|0|||
25030520|NCT03261037|50129062|FG003|Overall Study|Participant did not want to continue the study|0|||
25030521|NCT03261037|50129059|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
25030522|NCT03261037|50129060|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
25030523|NCT03261037|50129061|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
25030524|NCT03261037|50129062|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
25030525|NCT03261037|50129059|FG000|Overall Study|Participant presented clinical improvement|0|||
25030526|NCT03261037|50129060|FG001|Overall Study|Participant presented clinical improvement|2|||
25030527|NCT03261037|50129061|FG002|Overall Study|Participant presented clinical improvement|0|||
25030528|NCT03261037|50129062|FG003|Overall Study|Participant presented clinical improvement|0|||
25030529|NCT03261037|50129059|FG000|Overall Study|Technical difficulties|0|||
25030530|NCT03261037|50129060|FG001|Overall Study|Technical difficulties|0|||
25030531|NCT03261037|50129061|FG002|Overall Study|Technical difficulties|0|||
25030532|NCT03261037|50129062|FG003|Overall Study|Technical difficulties|1|||
25030533|NCT03261037|50129059|FG000|Overall Study|Equipment failed to work|0|||
25030534|NCT03261037|50129060|FG001|Overall Study|Equipment failed to work|0|||
25030535|NCT03261037|50129061|FG002|Overall Study|Equipment failed to work|0|||
25030536|NCT03261037|50129062|FG003|Overall Study|Equipment failed to work|1|||
25030537|NCT03261037|50129059|FG000|Overall Study|End of study for participant and no follow up|0|||
25030538|NCT03261037|50129060|FG001|Overall Study|End of study for participant and no follow up|0|||
25030539|NCT03261037|50129061|FG002|Overall Study|End of study for participant and no follow up|0|||
25030540|NCT03261037|50129062|FG003|Overall Study|End of study for participant and no follow up|1|||
25030541|NCT03261037|50129059|FG000|Overall Study|Participant was too weak to continue in study|1|||
24943962|NCT02201108|50036612|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
24943963|NCT02201108|50036611|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
24943964|NCT02201108|50036612|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
24943965|NCT02201108|50036611|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
24943966|NCT02201108|50036612|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
24943967|NCT02201108|50036611|FG000|Open Label Period (up to Week 192)|Other reason|4|||
24943968|NCT02201108|50036612|FG001|Open Label Period (up to Week 192)|Other reason|7|||
24943969|NCT02201108|50036611|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
24943970|NCT02201108|50036612|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
24943971|NCT00281320|50036633|FG000|Overall Study|Adverse Event|12|||
24943972|NCT00281320|50036634|FG001|Overall Study|Adverse Event|9|||
24943973|NCT00281320|50036633|FG000|Overall Study|Lack of Efficacy|4|||
24943974|NCT00281320|50036634|FG001|Overall Study|Lack of Efficacy|3|||
24943975|NCT00281320|50036633|FG000|Overall Study|Withdrawal by Subject|5|||
24943976|NCT00281320|50036634|FG001|Overall Study|Withdrawal by Subject|6|||
25030542|NCT03261037|50129060|FG001|Overall Study|Participant was too weak to continue in study|0|||
25030543|NCT03261037|50129061|FG002|Overall Study|Participant was too weak to continue in study|0|||
25030544|NCT03261037|50129062|FG003|Overall Study|Participant was too weak to continue in study|0|||
25030545|NCT03372551|50129073|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
25030546|NCT03372551|50129074|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
25030547|NCT03326323|50129087|FG000|Overall Study|Unable to receive ANH protocol|3|||
25030548|NCT03259789|50129098|FG000|Overall Study|Adverse Event|3|||
25030549|NCT03259789|50129099|FG001|Overall Study|Adverse Event|2|||
25030550|NCT03259789|50129100|FG002|Overall Study|Adverse Event|1|||
25030551|NCT03259789|50129098|FG000|Overall Study|Withdrawal by Subject|9|||
25030552|NCT03259789|50129099|FG001|Overall Study|Withdrawal by Subject|5|||
25159313|NCT01428453|50279032|FG001|Overall Study|Lost to Follow-up|1|||
25275571|NCT00975130|50589451|FG000|Study Part 1|Lost to Follow-up|19|||
24943977|NCT00281320|50036633|FG000|Overall Study|Lost to Follow-up|1|||
24943978|NCT00281320|50036634|FG001|Overall Study|Lost to Follow-up|2|||
24943979|NCT00281320|50036633|FG000|Overall Study|Other|3|||
24943980|NCT00281320|50036634|FG001|Overall Study|Other|1|||
24943981|NCT00541307|50036646|FG000|Overall Study|Death|5|||
24943982|NCT00541307|50036646|FG000|Overall Study|Physician Decision|3|||
24943983|NCT00541307|50036646|FG000|Overall Study|Withdrawal by Subject|6|||
24943984|NCT00541307|50036646|FG000|Overall Study|Lost to Follow-up|4|||
24943985|NCT00541307|50036646|FG000|Overall Study|Subject returned early (outside window)|1|||
24943986|NCT00541307|50036646|FG000|Overall Study|Surgical Bypass|5|||
24943987|NCT00541229|50036656|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
24943988|NCT00541229|50036657|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
24943989|NCT00541229|50036658|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
24943990|NCT00541229|50036659|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
24943991|NCT00541229|50036660|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
25030553|NCT03259789|50129100|FG002|Overall Study|Withdrawal by Subject|1|||
25030554|NCT03259789|50129098|FG000|Overall Study|Lost to Follow-up|5|||
25030555|NCT03259789|50129099|FG001|Overall Study|Lost to Follow-up|9|||
25030556|NCT03259789|50129100|FG002|Overall Study|Lost to Follow-up|4|||
25030557|NCT03259789|50129098|FG000|Overall Study|Physician Decision|0|||
25030558|NCT03259789|50129099|FG001|Overall Study|Physician Decision|1|||
25030559|NCT03259789|50129100|FG002|Overall Study|Physician Decision|0|||
25030560|NCT03259555|50129111|FG000|Overall Study|Adverse Event|6|||
25030561|NCT03259555|50129112|FG001|Overall Study|Adverse Event|4|||
25030562|NCT03259555|50129111|FG000|Overall Study|Lack of Efficacy|6|||
25030563|NCT03259555|50129112|FG001|Overall Study|Lack of Efficacy|4|||
25030564|NCT03259555|50129111|FG000|Overall Study|Lost to Follow-up|0|||
25030565|NCT03259555|50129112|FG001|Overall Study|Lost to Follow-up|2|||
25030566|NCT03259555|50129111|FG000|Overall Study|Non-Compliance With Study Drug|1|||
25030567|NCT03259555|50129112|FG001|Overall Study|Non-Compliance With Study Drug|0|||
25030568|NCT03259555|50129111|FG000|Overall Study|Progressive Disease|0|||
25030569|NCT03259555|50129112|FG001|Overall Study|Progressive Disease|2|||
25030570|NCT03259555|50129111|FG000|Overall Study|Withdrawal by Subject|19|||
25030571|NCT03259555|50129112|FG001|Overall Study|Withdrawal by Subject|16|||
25030572|NCT03259555|50129111|FG000|Overall Study|Physician Decision|1|||
25030573|NCT03259555|50129112|FG001|Overall Study|Physician Decision|2|||
25030574|NCT03259555|50129111|FG000|Overall Study|Other|1|||
24943992|NCT00541229|50036661|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
24943993|NCT00541229|50036656|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
24943994|NCT00541229|50036657|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
24943995|NCT00541229|50036658|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
24943996|NCT00541229|50036659|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
24943997|NCT00541229|50036660|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
24943998|NCT00541229|50036661|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
24943999|NCT00541229|50036656|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
24944000|NCT00541229|50036657|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
24944001|NCT00541229|50036658|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
24944002|NCT00541229|50036659|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
24944003|NCT00541229|50036660|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
24944004|NCT00541229|50036661|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
24944005|NCT00541229|50036656|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
24944006|NCT00541229|50036657|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
24944007|NCT00541229|50036658|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
24944008|NCT00541229|50036659|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
24944009|NCT00541229|50036660|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
25030575|NCT03259555|50129112|FG001|Overall Study|Other|0|||
25030576|NCT03259087|50129123|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
25030577|NCT03259087|50129124|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
25030578|NCT03259087|50129125|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
25030579|NCT03259087|50129126|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
25030580|NCT03259087|50129127|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
25186192|NCT01420679|50336126|FG000|Overall Study|Patient Decision|1|||
25186193|NCT01420679|50336127|FG001|Overall Study|Patient Decision|0|||
25030581|NCT03259087|50129123|FG000|Period 2 of Part 2|Adverse Event|0|||
25030582|NCT03259087|50129124|FG001|Period 2 of Part 2|Adverse Event|0|||
25030583|NCT03259087|50129125|FG002|Period 2 of Part 2|Adverse Event|0|||
25030584|NCT03259087|50129126|FG003|Period 2 of Part 2|Adverse Event|0|||
25030585|NCT03259087|50129127|FG004|Period 2 of Part 2|Adverse Event|1|||
25030586|NCT03257995|50129149|FG000|Overall Study|Adverse Event|0|||
25030587|NCT03257995|50129150|FG001|Overall Study|Adverse Event|1|||
25159314|NCT01428453|50279031|FG000|Overall Study|Withdrawal by Subject|3|||
24944010|NCT00541229|50036661|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
24944011|NCT00541229|50036656|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
24944012|NCT00541229|50036657|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
25030588|NCT03257995|50129151|FG002|Overall Study|Adverse Event|0|||
25159315|NCT01428453|50279032|FG001|Overall Study|Withdrawal by Subject|1|||
25030589|NCT03257995|50129152|FG003|Overall Study|Adverse Event|0|||
25030590|NCT03257995|50129153|FG004|Overall Study|Adverse Event|0|||
25030591|NCT03257995|50129154|FG005|Overall Study|Adverse Event|0|||
25030592|NCT03257995|50129149|FG000|Overall Study|Protocol deviation|0|||
25030593|NCT03257995|50129150|FG001|Overall Study|Protocol deviation|0|||
25030594|NCT03257995|50129151|FG002|Overall Study|Protocol deviation|0|||
25030595|NCT03257995|50129152|FG003|Overall Study|Protocol deviation|0|||
25030596|NCT03257995|50129153|FG004|Overall Study|Protocol deviation|0|||
24944013|NCT00541229|50036658|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
24944014|NCT00541229|50036659|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
24944015|NCT00541229|50036660|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
24944016|NCT00541229|50036661|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
25030597|NCT03257995|50129154|FG005|Overall Study|Protocol deviation|2|||
25030598|NCT03049488|50129172|FG000|Overall Study|Lost to Follow-up|1|||
25030599|NCT03049488|50129173|FG001|Overall Study|Lost to Follow-up|1|||
25030600|NCT03049488|50129174|FG002|Overall Study|Lost to Follow-up|0|||
25030601|NCT03049488|50129175|FG003|Overall Study|Lost to Follow-up|0|||
25030602|NCT03049488|50129176|FG004|Overall Study|Lost to Follow-up|0|||
25030603|NCT03049488|50129177|FG005|Overall Study|Lost to Follow-up|0|||
25030604|NCT03049488|50129172|FG000|Overall Study|Moved from Area|1|||
25030605|NCT03049488|50129173|FG001|Overall Study|Moved from Area|0|||
25030606|NCT03049488|50129174|FG002|Overall Study|Moved from Area|0|||
25030607|NCT03049488|50129175|FG003|Overall Study|Moved from Area|1|||
25030608|NCT03049488|50129176|FG004|Overall Study|Moved from Area|1|||
25030609|NCT03049488|50129177|FG005|Overall Study|Moved from Area|0|||
25030610|NCT03049488|50129172|FG000|Overall Study|Physician Decision|0|||
25030611|NCT03049488|50129173|FG001|Overall Study|Physician Decision|1|||
25030612|NCT03049488|50129174|FG002|Overall Study|Physician Decision|0|||
25030613|NCT03049488|50129175|FG003|Overall Study|Physician Decision|0|||
25030614|NCT03049488|50129176|FG004|Overall Study|Physician Decision|0|||
25030615|NCT03049488|50129177|FG005|Overall Study|Physician Decision|0|||
25030616|NCT03049488|50129172|FG000|Overall Study|Withdrawal by Subject|0|||
25030617|NCT03049488|50129173|FG001|Overall Study|Withdrawal by Subject|0|||
24944017|NCT00541229|50036656|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
24944018|NCT00541229|50036657|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
24944019|NCT00541229|50036658|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
24944020|NCT00541229|50036659|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
24944021|NCT00541229|50036660|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
24944022|NCT00541229|50036661|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
24944023|NCT00541229|50036656|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
24944024|NCT00541229|50036657|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
24944025|NCT00541229|50036658|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
24944026|NCT00541229|50036659|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
24944027|NCT00541229|50036660|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
24944028|NCT00541229|50036661|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
24944029|NCT00541229|50036656|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
24944030|NCT00541229|50036657|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
24944031|NCT00541229|50036658|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
24944032|NCT00541229|50036659|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
24944033|NCT00541229|50036660|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
24944034|NCT00541229|50036661|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
24944035|NCT00541229|50036656|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
24944036|NCT00541229|50036657|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
24944037|NCT00541229|50036658|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
24944038|NCT00541229|50036659|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
24944039|NCT00541229|50036660|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
24944040|NCT00541229|50036661|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
24944041|NCT00541229|50036656|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
24944042|NCT00541229|50036657|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
24944043|NCT00541229|50036658|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
24944044|NCT00541229|50036659|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
24944045|NCT00541229|50036660|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
24944046|NCT00541229|50036661|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
24944047|NCT00541229|50036656|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
24944048|NCT00541229|50036657|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
24944049|NCT00541229|50036658|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
25030618|NCT03049488|50129174|FG002|Overall Study|Withdrawal by Subject|0|||
25030619|NCT03049488|50129175|FG003|Overall Study|Withdrawal by Subject|1|||
25030620|NCT03049488|50129176|FG004|Overall Study|Withdrawal by Subject|1|||
25030621|NCT03049488|50129177|FG005|Overall Study|Withdrawal by Subject|0|||
25030622|NCT03257371|50129192|FG000|Overall Study|Lost to Follow-up|1|||
25030623|NCT03242863|50129196|FG000|Study Week 1|Withdrawal by Subject|0|||
25030624|NCT03242863|50129197|FG001|Study Week 1|Withdrawal by Subject|1|||
25030625|NCT03242863|50129198|FG002|Study Week 1|Withdrawal by Subject|0|||
25030626|NCT03242863|50129199|FG003|Study Week 1|Withdrawal by Subject|0|||
25030627|NCT03242863|50129200|FG004|Study Week 1|Withdrawal by Subject|3|||
25030628|NCT03242863|50129201|FG005|Study Week 1|Withdrawal by Subject|0|||
25030629|NCT03044106|50129209|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
25030630|NCT03044106|50129210|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
25030631|NCT03043560|50129236|FG000|Overall Study|Discontinued Intervention|1|||
25030632|NCT03043560|50129237|FG001|Overall Study|Discontinued Intervention|2|||
25030633|NCT03043560|50129236|FG000|Overall Study|Lost to Follow-up|0|||
24944050|NCT00541229|50036659|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
25030634|NCT03043560|50129237|FG001|Overall Study|Lost to Follow-up|1|||
25030635|NCT03255733|50129263|FG000|Overall Study|Lost to Follow-up|4|||
25030636|NCT03255655|50129269|FG000|Overall Study|Lost to Follow-up|7|||
24944051|NCT00541229|50036660|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
24944052|NCT00541229|50036661|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
24944053|NCT00541229|50036656|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
24944054|NCT00541229|50036657|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
24944055|NCT00541229|50036658|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
24944056|NCT00541229|50036659|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
24944057|NCT00541229|50036660|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
24944058|NCT00541229|50036661|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
24944059|NCT00541229|50036656|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
24944060|NCT00541229|50036657|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
24944061|NCT00541229|50036658|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
24944062|NCT00541229|50036659|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
24944063|NCT00541229|50036660|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
24944064|NCT00541229|50036661|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
24944065|NCT00541229|50036656|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
24944066|NCT00541229|50036657|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
24944067|NCT00541229|50036658|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
24944068|NCT00541229|50036659|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
24944069|NCT00541229|50036660|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
24944070|NCT00541229|50036661|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
24944071|NCT00541229|50036656|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
24944072|NCT00541229|50036657|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
24944073|NCT00541229|50036658|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
24944074|NCT00541229|50036659|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
24944075|NCT00541229|50036660|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
24944076|NCT00541229|50036661|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
24944077|NCT00541229|50036656|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
24944078|NCT00541229|50036657|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
24944079|NCT00541229|50036658|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
24944080|NCT00541229|50036659|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
24944081|NCT00541229|50036660|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
24944082|NCT00541229|50036661|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
24944083|NCT00481988|50036671|FG000|Overall Study|Withdrawal by Subject|1|||
24944084|NCT00481988|50036672|FG001|Overall Study|Withdrawal by Subject|1|||
24944085|NCT00481832|50036689|FG000|Enrollment|Physician Decision|8|||
24944086|NCT00481832|50036689|FG000|Enrollment|Unable to collect enough stem cells|2|||
24944087|NCT00481832|50036689|FG000|Inter-transplant Period|Adverse Event|4|||
24944088|NCT00481832|50036689|FG000|Inter-transplant Period|Death|3|||
24944089|NCT00481832|50036689|FG000|Inter-transplant Period|Physician Decision|4|||
24944090|NCT00481832|50036689|FG000|Inter-transplant Period|Disease relapse|11|||
24944091|NCT00481832|50036689|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
24944092|NCT00481676|50036695|FG000|Overall Study|Adverse Event|0|||
24944093|NCT00481676|50036696|FG001|Overall Study|Adverse Event|1|||
24944094|NCT00481676|50036695|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
24944095|NCT00481676|50036696|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
24944096|NCT00481676|50036695|FG000|Overall Study|Administrative problem|1|||
24944097|NCT00481676|50036696|FG001|Overall Study|Administrative problem|0|||
25030637|NCT03255655|50129270|FG001|Overall Study|Lost to Follow-up|4|||
25030638|NCT02899988|50129280|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
25030639|NCT02899988|50129281|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
25030640|NCT02899988|50129282|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
25030641|NCT02899988|50129283|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
24944098|NCT00542789|50036704|FG000|Overall Study|Adverse Event|18|||
24944099|NCT00542789|50036705|FG001|Overall Study|Adverse Event|17|||
25030642|NCT02899988|50129284|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
25030643|NCT02899988|50129285|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
25030644|NCT02899988|50129286|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
25030645|NCT02899988|50129287|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
24944100|NCT00542789|50036704|FG000|Overall Study|Withdrawal by Subject|7|||
24944101|NCT00542789|50036705|FG001|Overall Study|Withdrawal by Subject|3|||
24944102|NCT00542789|50036704|FG000|Overall Study|Protocol Violation|8|||
24944103|NCT00542789|50036705|FG001|Overall Study|Protocol Violation|1|||
24944104|NCT00542789|50036704|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
24944105|NCT00542789|50036705|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
24944106|NCT00464672|50036713|FG000|Overall Study|withdrawal of consent|0|||
24944107|NCT00464672|50036714|FG001|Overall Study|withdrawal of consent|0|||
24944108|NCT00464672|50036715|FG002|Overall Study|withdrawal of consent|0|||
24944109|NCT00464672|50036716|FG003|Overall Study|withdrawal of consent|1|||
24944110|NCT00464672|50036717|FG004|Overall Study|withdrawal of consent|9|||
24944111|NCT00464672|50036718|FG005|Overall Study|withdrawal of consent|4|||
24944112|NCT00464672|50036713|FG000|Overall Study|Lost to Follow-up|25|||
24944113|NCT00464672|50036714|FG001|Overall Study|Lost to Follow-up|10|||
24944114|NCT00464672|50036715|FG002|Overall Study|Lost to Follow-up|0|||
24944115|NCT00464672|50036716|FG003|Overall Study|Lost to Follow-up|0|||
24944116|NCT00464672|50036717|FG004|Overall Study|Lost to Follow-up|1|||
24944117|NCT00464672|50036718|FG005|Overall Study|Lost to Follow-up|0|||
24944118|NCT00473876|50036748|FG000|Overall Study|Lost to Follow-up|3|||
24944119|NCT00473876|50036749|FG001|Overall Study|Lost to Follow-up|1|||
24944120|NCT00463580|50036759|FG000|Overall Study|Lost to Follow-up|1|||
24944121|NCT00463580|50036760|FG001|Overall Study|Lost to Follow-up|0|||
24944122|NCT00463580|50036759|FG000|Overall Study|Schedule conflict|2|||
24944123|NCT00463580|50036760|FG001|Overall Study|Schedule conflict|0|||
24944124|NCT00463580|50036759|FG000|Overall Study|Medical/psychiatric complications|0|||
24944125|NCT00463580|50036760|FG001|Overall Study|Medical/psychiatric complications|2|||
24944126|NCT00540449|50036774|FG000|Overall Study|Adverse Event|12|||
24944127|NCT00540449|50036775|FG001|Overall Study|Adverse Event|32|||
24944128|NCT00540449|50036774|FG000|Overall Study|Sponsor's Decision|1|||
24944129|NCT00540449|50036775|FG001|Overall Study|Sponsor's Decision|1|||
24944130|NCT00540449|50036774|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
24944131|NCT00540449|50036775|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
24944132|NCT00540449|50036774|FG000|Overall Study|Lost to Follow-up|19|||
24944133|NCT00540449|50036775|FG001|Overall Study|Lost to Follow-up|17|||
24944134|NCT00540449|50036774|FG000|Overall Study|Subject Non-Compliant|7|||
24944135|NCT00540449|50036775|FG001|Overall Study|Subject Non-Compliant|5|||
24944136|NCT00540449|50036774|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
24944137|NCT00540449|50036775|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
24944138|NCT00540449|50036774|FG000|Overall Study|Withdrawal by Subject|10|||
24944139|NCT00540449|50036775|FG001|Overall Study|Withdrawal by Subject|10|||
24944140|NCT00540449|50036774|FG000|Overall Study|Other|1|||
24944141|NCT00540449|50036775|FG001|Overall Study|Other|4|||
24944142|NCT03911843|50036783|FG000|Overall Study|Adverse Event|2|||
24944143|NCT03911843|50036784|FG001|Overall Study|Adverse Event|0|||
24944144|NCT03911843|50036783|FG000|Overall Study|Protocol Violation|2|||
24944145|NCT03911843|50036784|FG001|Overall Study|Protocol Violation|0|||
24944146|NCT03911843|50036783|FG000|Overall Study|Lost to Follow-up|0|||
24944147|NCT03911843|50036784|FG001|Overall Study|Lost to Follow-up|1|||
24944148|NCT00361335|50036795|FG000|IV Period: Baseline to E0|Adverse Event|9|||
24944149|NCT00361335|50036796|FG001|IV Period: Baseline to E0|Adverse Event|4|||
24944150|NCT00361335|50036797|FG002|IV Period: Baseline to E0|Adverse Event|5|||
24944151|NCT00361335|50036798|FG003|IV Period: Baseline to E0|Adverse Event|9|||
24944152|NCT00361335|50036799|FG004|IV Period: Baseline to E0|Adverse Event|8|||
24944153|NCT00361335|50036800|FG005|IV Period: Baseline to E0|Adverse Event|0|||
24944154|NCT00361335|50036801|FG006|IV Period: Baseline to E0|Adverse Event|0|||
24944155|NCT00361335|50036795|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
24944156|NCT00361335|50036796|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
24944157|NCT00361335|50036797|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
24944158|NCT00361335|50036798|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
24944159|NCT00361335|50036799|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
24944160|NCT00361335|50036800|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
24944161|NCT00361335|50036801|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
24944162|NCT00361335|50036795|FG000|IV Period: Baseline to E0|Death|1|||
24944163|NCT00361335|50036796|FG001|IV Period: Baseline to E0|Death|1|||
24944164|NCT00361335|50036797|FG002|IV Period: Baseline to E0|Death|1|||
24944165|NCT00361335|50036798|FG003|IV Period: Baseline to E0|Death|1|||
24944166|NCT00361335|50036799|FG004|IV Period: Baseline to E0|Death|0|||
24944167|NCT00361335|50036800|FG005|IV Period: Baseline to E0|Death|0|||
24944168|NCT00361335|50036801|FG006|IV Period: Baseline to E0|Death|0|||
25030646|NCT02899988|50129288|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
25030647|NCT02899988|50129289|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
25030648|NCT02899988|50129290|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
24944169|NCT00361335|50036795|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
24944170|NCT00361335|50036796|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
24944171|NCT00361335|50036797|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
24944172|NCT00361335|50036798|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
24944173|NCT00361335|50036799|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
24944174|NCT00361335|50036800|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
24944175|NCT00361335|50036801|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
24944176|NCT00361335|50036795|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
24944177|NCT00361335|50036796|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
24944178|NCT00361335|50036797|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
24944179|NCT00361335|50036798|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
24944180|NCT00361335|50036799|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
24944181|NCT00361335|50036800|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
24944182|NCT00361335|50036801|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
24944183|NCT00361335|50036795|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
24944184|NCT00361335|50036796|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
24944185|NCT00361335|50036797|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
24944186|NCT00361335|50036798|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
24944187|NCT00361335|50036799|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
24944188|NCT00361335|50036800|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
24944189|NCT00361335|50036801|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
24944190|NCT00361335|50036795|FG000|IV Period: Baseline to E0|Other|2|||
24944191|NCT00361335|50036796|FG001|IV Period: Baseline to E0|Other|9|||
24944192|NCT00361335|50036797|FG002|IV Period: Baseline to E0|Other|9|||
24944193|NCT00361335|50036798|FG003|IV Period: Baseline to E0|Other|3|||
24944194|NCT00361335|50036799|FG004|IV Period: Baseline to E0|Other|2|||
24944195|NCT00361335|50036800|FG005|IV Period: Baseline to E0|Other|0|||
24944196|NCT00361335|50036801|FG006|IV Period: Baseline to E0|Other|0|||
24944197|NCT00361335|50036795|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
24944198|NCT00361335|50036796|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
24944199|NCT00361335|50036797|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
24944200|NCT00361335|50036798|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
24944201|NCT00361335|50036799|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
24944202|NCT00361335|50036800|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
24944203|NCT00361335|50036801|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
24944204|NCT00361335|50036795|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
24944205|NCT00361335|50036796|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
24944206|NCT00361335|50036797|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
24944207|NCT00361335|50036798|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
24944208|NCT00361335|50036799|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
24944209|NCT00361335|50036800|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
24944210|NCT00361335|50036801|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
24944211|NCT00361335|50036795|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
24944212|NCT00361335|50036796|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
24944213|NCT00361335|50036797|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
24944214|NCT00361335|50036798|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
24944215|NCT00361335|50036799|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
24944216|NCT00361335|50036800|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
24944217|NCT00361335|50036801|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
24944218|NCT00361335|50036795|FG000|SC Period: Week E0 to Week E24|Death|0|||
24944219|NCT00361335|50036796|FG001|SC Period: Week E0 to Week E24|Death|0|||
24944220|NCT00361335|50036797|FG002|SC Period: Week E0 to Week E24|Death|0|||
24944221|NCT00361335|50036798|FG003|SC Period: Week E0 to Week E24|Death|0|||
24944222|NCT00361335|50036799|FG004|SC Period: Week E0 to Week E24|Death|0|||
24944223|NCT00361335|50036800|FG005|SC Period: Week E0 to Week E24|Death|0|||
24944224|NCT00361335|50036801|FG006|SC Period: Week E0 to Week E24|Death|1|||
24944225|NCT00361335|50036795|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
24944226|NCT00361335|50036796|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
24944227|NCT00361335|50036797|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
24944228|NCT00361335|50036798|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
24944229|NCT00361335|50036799|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
24944230|NCT00361335|50036800|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
24944231|NCT00361335|50036801|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
24944232|NCT00361335|50036795|FG000|SC Period: Week E0 to Week E24|Other|1|||
24944233|NCT00361335|50036796|FG001|SC Period: Week E0 to Week E24|Other|0|||
24944234|NCT00361335|50036797|FG002|SC Period: Week E0 to Week E24|Other|0|||
24944235|NCT00361335|50036798|FG003|SC Period: Week E0 to Week E24|Other|1|||
24944236|NCT00361335|50036799|FG004|SC Period: Week E0 to Week E24|Other|0|||
24944237|NCT00361335|50036800|FG005|SC Period: Week E0 to Week E24|Other|1|||
24944238|NCT00361335|50036801|FG006|SC Period: Week E0 to Week E24|Other|2|||
24944239|NCT00361335|50036795|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
24944240|NCT00361335|50036796|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
24944241|NCT00361335|50036797|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
24944242|NCT00361335|50036798|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
24944243|NCT00361335|50036799|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
25186194|NCT01420679|50336126|FG000|Overall Study|Investigator Decision|1|||
24944244|NCT00361335|50036800|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
24944245|NCT00361335|50036801|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
24944246|NCT00264550|50036821|FG000|Overall Study|Death|0|||
24944247|NCT00264550|50036822|FG001|Overall Study|Death|3|||
24944248|NCT00264550|50036823|FG002|Overall Study|Death|0|||
24944249|NCT00264550|50036824|FG003|Overall Study|Death|0|||
24944250|NCT00264550|50036821|FG000|Overall Study|Lost to Follow-up|3|||
24944251|NCT00264550|50036822|FG001|Overall Study|Lost to Follow-up|1|||
24944252|NCT00264550|50036823|FG002|Overall Study|Lost to Follow-up|1|||
24944253|NCT00264550|50036824|FG003|Overall Study|Lost to Follow-up|1|||
24944254|NCT00264550|50036821|FG000|Overall Study|Adverse Event|23|||
24944255|NCT00264550|50036822|FG001|Overall Study|Adverse Event|18|||
24944256|NCT00264550|50036823|FG002|Overall Study|Adverse Event|9|||
24944257|NCT00264550|50036824|FG003|Overall Study|Adverse Event|14|||
24944258|NCT00264550|50036821|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
24944259|NCT00264550|50036822|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
24944260|NCT00264550|50036823|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
24944261|NCT00264550|50036824|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
24944262|NCT00264550|50036821|FG000|Overall Study|Discontinued oral study agent|0|||
24944263|NCT00264550|50036822|FG001|Overall Study|Discontinued oral study agent|1|||
24944264|NCT00264550|50036823|FG002|Overall Study|Discontinued oral study agent|0|||
24944265|NCT00264550|50036824|FG003|Overall Study|Discontinued oral study agent|0|||
24944266|NCT00264550|50036821|FG000|Overall Study|Other|13|||
24944267|NCT00264550|50036822|FG001|Overall Study|Other|7|||
24944268|NCT00264550|50036823|FG002|Overall Study|Other|3|||
24944269|NCT00264550|50036824|FG003|Overall Study|Other|9|||
24944270|NCT00541931|50036836|FG000|Overall Study|Adverse Event|1|||
24944271|NCT00541931|50036837|FG001|Overall Study|Adverse Event|0|||
24944272|NCT00541931|50036836|FG000|Overall Study|Lost to Follow-up|3|||
24944273|NCT00541931|50036837|FG001|Overall Study|Lost to Follow-up|3|||
24944274|NCT00541931|50036836|FG000|Overall Study|Withdrawal by Subject|1|||
24944275|NCT00541931|50036837|FG001|Overall Study|Withdrawal by Subject|0|||
24944276|NCT00541931|50036836|FG000|Overall Study|Transportation Issue|0|||
24944277|NCT00541931|50036837|FG001|Overall Study|Transportation Issue|1|||
24944278|NCT00368979|50036847|FG000|Overall Study|Adverse Event|9|||
24944279|NCT00368979|50036848|FG001|Overall Study|Adverse Event|16|||
24944280|NCT00368979|50036847|FG000|Overall Study|Lack of Efficacy|5|||
24944281|NCT00368979|50036848|FG001|Overall Study|Lack of Efficacy|3|||
24944282|NCT00368979|50036847|FG000|Overall Study|Other|3|||
24944283|NCT00368979|50036848|FG001|Overall Study|Other|1|||
24944284|NCT00368979|50036847|FG000|Overall Study|Lost to Follow-up|1|||
24944285|NCT00368979|50036848|FG001|Overall Study|Lost to Follow-up|0|||
24944286|NCT00368979|50036847|FG000|Overall Study|Protocol Violation|2|||
24944287|NCT00368979|50036848|FG001|Overall Study|Protocol Violation|1|||
25030649|NCT02899988|50129280|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
25030650|NCT02899988|50129281|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
24944288|NCT00368979|50036847|FG000|Overall Study|Withdrawal by Subject|5|||
24944289|NCT00368979|50036848|FG001|Overall Study|Withdrawal by Subject|9|||
24944290|NCT00264238|50036854|FG000|Overall Study|Protocol Violation|1|||
24944291|NCT00540293|50036860|FG000|Overall Study|Adverse event related to study drug|10|||
24944292|NCT00540293|50036860|FG000|Overall Study|Adverse event not related to study drug|7|||
24944293|NCT00540293|50036860|FG000|Overall Study|Withdrawal by Subject|6|||
25030651|NCT02899988|50129282|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
25030652|NCT02899988|50129283|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
25030653|NCT02899988|50129284|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
25030654|NCT02899988|50129285|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
25030655|NCT02899988|50129286|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
25030656|NCT02899988|50129287|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
25030657|NCT02899988|50129288|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
25030658|NCT02899988|50129289|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
25030659|NCT02899988|50129290|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
25030660|NCT02899988|50129280|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
25030661|NCT02899988|50129281|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
25030662|NCT02899988|50129282|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
25030663|NCT02899988|50129283|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
25030664|NCT02899988|50129284|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
25159316|NCT01408563|50279040|FG000|Overall Study|Ineligible after consent/ registration|2|||
24944294|NCT00540293|50036860|FG000|Overall Study|Protocol violation, & subject schedule|12|||
24944295|NCT00375609|50036873|FG000|Overall Study|Did not receive treatment|1|||
24944296|NCT00375609|50036874|FG001|Overall Study|Did not receive treatment|0|||
24944297|NCT00375609|50036875|FG002|Overall Study|Did not receive treatment|0|||
24944298|NCT00375609|50036873|FG000|Overall Study|Adverse Event|0|||
25159317|NCT01442493|50279046|FG000|Overall Study|withdrawn from study|3|||
24944299|NCT00375609|50036874|FG001|Overall Study|Adverse Event|3|||
24944300|NCT00375609|50036875|FG002|Overall Study|Adverse Event|0|||
24944301|NCT00375609|50036873|FG000|Overall Study|Lost to Follow-up|1|||
24944302|NCT00375609|50036874|FG001|Overall Study|Lost to Follow-up|0|||
25030665|NCT02899988|50129285|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
25030666|NCT02899988|50129286|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
25030667|NCT02899988|50129287|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
25030668|NCT02899988|50129288|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
25030669|NCT02899988|50129289|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
25030670|NCT02899988|50129290|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
25030671|NCT02899988|50129280|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
25030672|NCT02899988|50129281|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
25030673|NCT02899988|50129282|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
25030674|NCT02899988|50129283|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
25030675|NCT02899988|50129284|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
25030676|NCT02899988|50129285|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
25030677|NCT02899988|50129286|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
25030678|NCT02899988|50129287|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
25030679|NCT02899988|50129288|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
25030680|NCT02899988|50129289|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
25030681|NCT02899988|50129290|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
25030682|NCT02899988|50129280|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
25030683|NCT02899988|50129281|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
25030684|NCT02899988|50129282|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
25030685|NCT02899988|50129283|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
25030686|NCT02899988|50129284|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
25030687|NCT02899988|50129285|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
25030688|NCT02899988|50129286|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
25030689|NCT02899988|50129287|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
25030690|NCT02899988|50129288|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
25030691|NCT02899988|50129289|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
25030692|NCT02899988|50129290|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
25030693|NCT02899988|50129280|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
25030694|NCT02899988|50129281|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
25030695|NCT02899988|50129282|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
25030696|NCT02899988|50129283|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
25030697|NCT02899988|50129284|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
25030698|NCT02899988|50129285|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
25030699|NCT02899988|50129286|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
25030700|NCT02899988|50129287|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
25030701|NCT02899988|50129288|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
25030702|NCT02899988|50129289|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
25030703|NCT02899988|50129290|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
25030704|NCT02939131|50129324|FG000|Overall Study|Unable to get to clinic|6|||
25030705|NCT02939131|50129325|FG001|Overall Study|Unable to get to clinic|4|||
25030706|NCT02939131|50129324|FG000|Overall Study|Lost to Follow-up|2|||
25030707|NCT02939131|50129325|FG001|Overall Study|Lost to Follow-up|4|||
25030708|NCT02939131|50129324|FG000|Overall Study|severe debilitation|1|||
25030709|NCT02939131|50129325|FG001|Overall Study|severe debilitation|0|||
25030710|NCT02939131|50129324|FG000|Overall Study|Other|0|||
25030711|NCT02939131|50129325|FG001|Overall Study|Other|1|||
25030712|NCT02939131|50129324|FG000|Overall Study|not willing to adhere to protocol|2|||
25030713|NCT02939131|50129325|FG001|Overall Study|not willing to adhere to protocol|0|||
25030714|NCT03345407|50129339|FG000|Overall Study|Withdrawal by Subject|11|||
25030715|NCT03345407|50129340|FG001|Overall Study|Withdrawal by Subject|1|||
25030716|NCT03345407|50129341|FG002|Overall Study|Withdrawal by Subject|5|||
25030717|NCT03345407|50129342|FG003|Overall Study|Withdrawal by Subject|6|||
25030718|NCT03345407|50129343|FG004|Overall Study|Withdrawal by Subject|3|||
25030719|NCT03345407|50129344|FG005|Overall Study|Withdrawal by Subject|6|||
25030720|NCT03345407|50129345|FG006|Overall Study|Withdrawal by Subject|16|||
25030721|NCT03345407|50129339|FG000|Overall Study|Physician Decision|3|||
25030722|NCT03345407|50129340|FG001|Overall Study|Physician Decision|1|||
25030723|NCT03345407|50129341|FG002|Overall Study|Physician Decision|0|||
25030724|NCT03345407|50129342|FG003|Overall Study|Physician Decision|0|||
25030725|NCT03345407|50129343|FG004|Overall Study|Physician Decision|1|||
25030726|NCT03345407|50129344|FG005|Overall Study|Physician Decision|2|||
25030727|NCT03345407|50129345|FG006|Overall Study|Physician Decision|3|||
25030728|NCT03345407|50129339|FG000|Overall Study|Lost to Follow-up|2|||
25030729|NCT03345407|50129340|FG001|Overall Study|Lost to Follow-up|0|||
25030730|NCT03345407|50129341|FG002|Overall Study|Lost to Follow-up|1|||
25275572|NCT00975130|50589452|FG001|Study Part 1|Lost to Follow-up|0|||
25275573|NCT00975130|50589453|FG002|Study Part 1|Lost to Follow-up|0|||
25030731|NCT03345407|50129342|FG003|Overall Study|Lost to Follow-up|0|||
25030732|NCT03345407|50129343|FG004|Overall Study|Lost to Follow-up|1|||
25030733|NCT03345407|50129344|FG005|Overall Study|Lost to Follow-up|2|||
25030734|NCT03345407|50129345|FG006|Overall Study|Lost to Follow-up|3|||
25030735|NCT03345407|50129339|FG000|Overall Study|Protocol-defined stopping criteria|9|||
25030736|NCT03345407|50129340|FG001|Overall Study|Protocol-defined stopping criteria|0|||
25030737|NCT03345407|50129341|FG002|Overall Study|Protocol-defined stopping criteria|0|||
25030738|NCT03345407|50129342|FG003|Overall Study|Protocol-defined stopping criteria|0|||
25030739|NCT03345407|50129343|FG004|Overall Study|Protocol-defined stopping criteria|2|||
25030740|NCT03345407|50129344|FG005|Overall Study|Protocol-defined stopping criteria|1|||
25030741|NCT03345407|50129345|FG006|Overall Study|Protocol-defined stopping criteria|1|||
25030742|NCT03345407|50129339|FG000|Overall Study|Protocol Violation|2|||
25030743|NCT03345407|50129340|FG001|Overall Study|Protocol Violation|0|||
25030744|NCT03345407|50129341|FG002|Overall Study|Protocol Violation|0|||
25030745|NCT03345407|50129342|FG003|Overall Study|Protocol Violation|0|||
25030746|NCT03345407|50129343|FG004|Overall Study|Protocol Violation|1|||
25030747|NCT03345407|50129344|FG005|Overall Study|Protocol Violation|0|||
25030748|NCT03345407|50129345|FG006|Overall Study|Protocol Violation|3|||
25030749|NCT03345407|50129339|FG000|Overall Study|Lack of Efficacy|1|||
25030750|NCT03345407|50129340|FG001|Overall Study|Lack of Efficacy|1|||
25030751|NCT03345407|50129341|FG002|Overall Study|Lack of Efficacy|1|||
25030752|NCT03345407|50129342|FG003|Overall Study|Lack of Efficacy|1|||
25030753|NCT03345407|50129343|FG004|Overall Study|Lack of Efficacy|1|||
25030754|NCT03345407|50129344|FG005|Overall Study|Lack of Efficacy|0|||
25030755|NCT03345407|50129345|FG006|Overall Study|Lack of Efficacy|3|||
25030756|NCT03345407|50129339|FG000|Overall Study|Adverse Event|4|||
25030757|NCT03345407|50129340|FG001|Overall Study|Adverse Event|0|||
25030758|NCT03345407|50129341|FG002|Overall Study|Adverse Event|5|||
25030759|NCT03345407|50129342|FG003|Overall Study|Adverse Event|4|||
25030760|NCT03345407|50129343|FG004|Overall Study|Adverse Event|6|||
25030761|NCT03345407|50129344|FG005|Overall Study|Adverse Event|5|||
25030762|NCT03345407|50129345|FG006|Overall Study|Adverse Event|16|||
25030763|NCT03255187|50129369|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
25030764|NCT03255187|50129370|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
25030765|NCT03255187|50129369|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
25030766|NCT03255187|50129370|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
25030767|NCT02929329|50129378|FG000|Overall Study|Withdrawal by Subject|24|||
25030768|NCT02929329|50129379|FG001|Overall Study|Withdrawal by Subject|21|||
25030769|NCT02929329|50129378|FG000|Overall Study|Lost to Follow-up|26|||
25030770|NCT02929329|50129379|FG001|Overall Study|Lost to Follow-up|20|||
25030771|NCT02929329|50129378|FG000|Overall Study|Death|1054|||
25030772|NCT02929329|50129379|FG001|Overall Study|Death|1051|||
25030773|NCT03240133|50129392|FG000|Overall Study|Withdrawal by Subject|0|||
25030774|NCT03240133|50129393|FG001|Overall Study|Withdrawal by Subject|1|||
25030775|NCT03240133|50129394|FG002|Overall Study|Withdrawal by Subject|0|||
25030776|NCT03240133|50129392|FG000|Overall Study|Adverse Event|1|||
25030777|NCT03240133|50129393|FG001|Overall Study|Adverse Event|1|||
25030778|NCT03240133|50129394|FG002|Overall Study|Adverse Event|0|||
25030779|NCT03240133|50129392|FG000|Overall Study|Rash|1|||
25030780|NCT03240133|50129393|FG001|Overall Study|Rash|0|||
25030781|NCT03240133|50129394|FG002|Overall Study|Rash|0|||
25030782|NCT03240133|50129392|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
25030783|NCT03240133|50129393|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
25030784|NCT03240133|50129394|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
25030785|NCT03240133|50129392|FG000|Overall Study|Intercurrent illness.|0|||
25030786|NCT03240133|50129393|FG001|Overall Study|Intercurrent illness.|1|||
25030787|NCT03240133|50129394|FG002|Overall Study|Intercurrent illness.|0|||
25030788|NCT03240133|50129392|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
25030789|NCT03240133|50129393|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
25030790|NCT03240133|50129394|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
25030791|NCT03372083|50129418|FG000|Overall Study|Adverse Event|3|||
25030792|NCT03372083|50129418|FG000|Overall Study|Physician Decision|1|||
25030793|NCT03372083|50129418|FG000|Overall Study|Withdrawal by Subject|1|||
25030794|NCT03044886|50129425|FG000|Overall Study|Lost to Follow-up|15|||
25030795|NCT03044886|50129426|FG001|Overall Study|Lost to Follow-up|10|||
25030796|NCT03044886|50129427|FG002|Overall Study|Lost to Follow-up|12|||
25030797|NCT02961764|50129437|FG000|Overall Study|Protocol Violation|0|||
25030798|NCT02961764|50129438|FG001|Overall Study|Protocol Violation|1|||
25030799|NCT02961764|50129437|FG000|Overall Study|Death|2|||
25030800|NCT02961764|50129438|FG001|Overall Study|Death|0|||
25030801|NCT02961764|50129437|FG000|Overall Study|Lost to Follow-up|35|||
25159318|NCT01442493|50279047|FG001|Overall Study|withdrawn from study|2|||
25030802|NCT02961764|50129438|FG001|Overall Study|Lost to Follow-up|24|||
25030803|NCT02961764|50129437|FG000|Overall Study|Withdrawal by Subject|2|||
25030804|NCT02961764|50129438|FG001|Overall Study|Withdrawal by Subject|0|||
25030805|NCT03371459|50129444|FG000|Washout|Lost to Follow-up|0|||
25030806|NCT03371459|50129445|FG001|Washout|Lost to Follow-up|1|||
25030807|NCT02961920|50129453|FG000|Overall Study|did not achive stydy protocol schedule|1|||
25030808|NCT02961920|50129454|FG001|Overall Study|did not achive stydy protocol schedule|1|||
25030809|NCT03371381|50129460|FG000|Overall Study|Death|5|||
25030810|NCT03371381|50129460|FG000|Overall Study|Study terminated by sponsor|3|||
25030811|NCT03371381|50129460|FG000|Overall Study|Other|4|||
25030812|NCT03044730|50129464|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
25030813|NCT03044730|50129464|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
25030814|NCT03044730|50129464|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
25030815|NCT03044730|50129464|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
25030816|NCT03044730|50129464|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
25030817|NCT03044730|50129464|FG000|Cycles 4 and Beyond|Adverse Event|1|||
25030818|NCT03044730|50129464|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
25030819|NCT03044730|50129464|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
25030820|NCT03044730|50129464|FG000|On Follow-up for 2 Years|Death|17|||
25030821|NCT02961374|50129469|FG000|Overall Study|Adverse Event|4|||
25030822|NCT02951429|50129475|FG000|Overall Study|Adverse Event|3|||
25030823|NCT02951429|50129476|FG001|Overall Study|Adverse Event|7|||
25030824|NCT02951429|50129475|FG000|Overall Study|Death|28|||
25030825|NCT02951429|50129476|FG001|Overall Study|Death|36|||
25030826|NCT02951429|50129475|FG000|Overall Study|Lack of Efficacy|0|||
25030827|NCT02951429|50129476|FG001|Overall Study|Lack of Efficacy|1|||
25030828|NCT02951429|50129475|FG000|Overall Study|Lost to Follow-up|0|||
25030829|NCT02951429|50129476|FG001|Overall Study|Lost to Follow-up|1|||
25030830|NCT02951429|50129475|FG000|Overall Study|Lung Transplantation|9|||
25030831|NCT02951429|50129476|FG001|Overall Study|Lung Transplantation|6|||
25030832|NCT02951429|50129475|FG000|Overall Study|Other|1|||
24944303|NCT00375609|50036875|FG002|Overall Study|Lost to Follow-up|0|||
24944304|NCT00375609|50036873|FG000|Overall Study|Physician Decision|0|||
24944305|NCT00375609|50036874|FG001|Overall Study|Physician Decision|0|||
24944306|NCT00375609|50036875|FG002|Overall Study|Physician Decision|1|||
24944307|NCT00375609|50036873|FG000|Overall Study|Withdrawal by Subject|1|||
24944308|NCT00375609|50036874|FG001|Overall Study|Withdrawal by Subject|4|||
24944309|NCT00375609|50036875|FG002|Overall Study|Withdrawal by Subject|0|||
24944310|NCT00375609|50036873|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
24944311|NCT00375609|50036874|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
24944312|NCT00375609|50036875|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
24944313|NCT00359073|50036914|FG000|Overall Study|Withdrawal by Subject|1|||
24944314|NCT00359073|50036915|FG001|Overall Study|Withdrawal by Subject|1|||
24944315|NCT00359073|50036914|FG000|Overall Study|Eligibility criteria no longer met|3|||
24944316|NCT00359073|50036915|FG001|Overall Study|Eligibility criteria no longer met|0|||
24944317|NCT00359073|50036914|FG000|Overall Study|developed RV16 antibody|0|||
24944318|NCT00359073|50036915|FG001|Overall Study|developed RV16 antibody|1|||
24944319|NCT03918239|50036925|FG000|Overall Study|Lost to Follow-up|3|||
24944320|NCT03918239|50036926|FG001|Overall Study|Lost to Follow-up|1|||
24944321|NCT03918239|50036925|FG000|Overall Study|Pregnancy|0|||
24944322|NCT03918239|50036926|FG001|Overall Study|Pregnancy|2|||
24944323|NCT03918239|50036925|FG000|Overall Study|Withdrawal by Subject|3|||
25030833|NCT02951429|50129476|FG001|Overall Study|Other|3|||
25030834|NCT02951429|50129475|FG000|Overall Study|Progressive Disease|1|||
25030835|NCT02951429|50129476|FG001|Overall Study|Progressive Disease|1|||
25030836|NCT02951429|50129475|FG000|Overall Study|Withdrawal by Subject|7|||
24944324|NCT03918239|50036926|FG001|Overall Study|Withdrawal by Subject|3|||
24944325|NCT03918239|50036925|FG000|Overall Study|positive urine drug screening results|4|||
24944326|NCT03918239|50036926|FG001|Overall Study|positive urine drug screening results|1|||
24944327|NCT00368745|50036934|FG000|Double-blind Treatment Period|Adverse Event|6|||
24944328|NCT00368745|50036935|FG001|Double-blind Treatment Period|Adverse Event|6|||
24944329|NCT00368745|50036934|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
24944330|NCT00368745|50036935|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
24944331|NCT00368745|50036934|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
24944332|NCT00368745|50036935|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
25030837|NCT02951429|50129476|FG001|Overall Study|Withdrawal by Subject|11|||
25030838|NCT02951429|50129475|FG000|Overall Study|Participant ongoing in the study|23|||
25030839|NCT02951429|50129476|FG001|Overall Study|Participant ongoing in the study|17|||
24944333|NCT00368745|50036934|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
24944334|NCT00368745|50036935|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
24944335|NCT00368745|50036934|FG000|Double-blind Treatment Period|Other|7|||
24944336|NCT00368745|50036935|FG001|Double-blind Treatment Period|Other|6|||
24944337|NCT00454818|50036949|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
24944338|NCT00454818|50036950|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
24944339|NCT00454818|50036951|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
24944340|NCT00454818|50036952|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
25030840|NCT03343067|50129489|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
25030841|NCT03343067|50129490|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
25030842|NCT03343067|50129491|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
25030843|NCT03103503|50129499|FG000|Overall Study|Death|64|||
25159319|NCT01442181|50279055|FG000|Overall Study|patient refused surgery|1|||
25030844|NCT03103503|50129499|FG000|Overall Study|Physician Decision|57|||
24944341|NCT00454818|50036953|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
25275574|NCT00975130|50589451|FG000|Study Part 1|Withdrawal by Subject|61|||
25275575|NCT00975130|50589452|FG001|Study Part 1|Withdrawal by Subject|0|||
25275576|NCT00975130|50589453|FG002|Study Part 1|Withdrawal by Subject|0|||
25275577|NCT00975130|50589451|FG000|Study Part 1|Protocol Violation|13|||
25275578|NCT00975130|50589452|FG001|Study Part 1|Protocol Violation|0|||
25275579|NCT00975130|50589453|FG002|Study Part 1|Protocol Violation|0|||
25275580|NCT00975130|50589451|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
25275581|NCT00975130|50589452|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
24944342|NCT00454818|50036949|FG000|Phase I: Open-label Dose-escalation|Death|0|||
24944343|NCT00454818|50036950|FG001|Phase I: Open-label Dose-escalation|Death|1|||
24944344|NCT00454818|50036951|FG002|Phase I: Open-label Dose-escalation|Death|0|||
24944345|NCT00454818|50036952|FG003|Phase I: Open-label Dose-escalation|Death|0|||
24944346|NCT00454818|50036953|FG004|Phase I: Open-label Dose-escalation|Death|0|||
24944347|NCT00454818|50036949|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
24944348|NCT00454818|50036950|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
24944349|NCT00454818|50036951|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
24944350|NCT00454818|50036952|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
24944351|NCT00454818|50036953|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
24944352|NCT00454818|50036949|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
24944353|NCT00454818|50036950|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
24944354|NCT00454818|50036951|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
24944355|NCT00454818|50036952|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
24944356|NCT00454818|50036953|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
24944357|NCT00454818|50036949|FG000|Phase 2: Randomized Double-blind|Death|0|||
24944358|NCT00454818|50036950|FG001|Phase 2: Randomized Double-blind|Death|1|||
24944359|NCT00454818|50036951|FG002|Phase 2: Randomized Double-blind|Death|0|||
24944360|NCT00454818|50036952|FG003|Phase 2: Randomized Double-blind|Death|0|||
24944361|NCT00454818|50036953|FG004|Phase 2: Randomized Double-blind|Death|1|||
24944362|NCT00454818|50036949|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
24944363|NCT00454818|50036950|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
24944364|NCT00454818|50036951|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
24944365|NCT00454818|50036952|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
24944366|NCT00454818|50036953|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
24944367|NCT00454818|50036949|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
24944368|NCT00454818|50036950|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
24944369|NCT00454818|50036951|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
24944370|NCT00454818|50036952|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
24944371|NCT00454818|50036953|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
24944372|NCT00445224|50036972|FG000|Specific Exercises|Withdrawal by Subject|3|||
24944373|NCT00445224|50036973|FG001|Specific Exercises|Withdrawal by Subject|3|||
24944374|NCT00445224|50036972|FG000|Specific Exercises|Withdrawal by Subject|1|||
24944375|NCT00445224|50036973|FG001|Specific Exercises|Withdrawal by Subject|0|||
24944376|NCT00358917|50036990|FG000|Overall Study|Adverse Event|14|||
25159320|NCT01442181|50279056|FG001|Overall Study|patient refused surgery|0|||
25159321|NCT01442181|50279055|FG000|Overall Study|no insurance for surgery|1|||
25159322|NCT01442181|50279056|FG001|Overall Study|no insurance for surgery|0|||
25159323|NCT01442181|50279055|FG000|Overall Study|low ejection factor|0|||
24944377|NCT00358917|50036991|FG001|Overall Study|Adverse Event|21|||
24944378|NCT00358917|50036990|FG000|Overall Study|Withdrawal by Subject|5|||
24944379|NCT00358917|50036991|FG001|Overall Study|Withdrawal by Subject|7|||
24944380|NCT00358917|50036990|FG000|Overall Study|Lost to Follow-up|20|||
25030845|NCT03103503|50129499|FG000|Overall Study|Withdrawal by Subject|10|||
25030846|NCT03103503|50129499|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
25159324|NCT01442181|50279056|FG001|Overall Study|low ejection factor|1|||
25159325|NCT01442181|50279055|FG000|Overall Study|Lost to Follow-up|1|||
25275582|NCT00975130|50589453|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
25275583|NCT00975130|50589451|FG000|Study Part 1|Administrative|4|||
24944381|NCT00358917|50036991|FG001|Overall Study|Lost to Follow-up|17|||
24944382|NCT00358917|50036990|FG000|Overall Study|Noncompliance|12|||
25159326|NCT01442181|50279056|FG001|Overall Study|Lost to Follow-up|1|||
24944383|NCT00358917|50036991|FG001|Overall Study|Noncompliance|11|||
24944384|NCT00358917|50036990|FG000|Overall Study|Death|2|||
24944385|NCT00358917|50036991|FG001|Overall Study|Death|3|||
24944386|NCT00358917|50036990|FG000|Overall Study|Virologic failure|11|||
24944387|NCT00358917|50036991|FG001|Overall Study|Virologic failure|8|||
24944388|NCT00358917|50036990|FG000|Overall Study|Unable to Continue Participation|2|||
24944389|NCT00358917|50036991|FG001|Overall Study|Unable to Continue Participation|2|||
24944390|NCT00264004|50037003|FG000|Overall Study|Adverse Event|2|||
24944391|NCT00264004|50037004|FG001|Overall Study|Adverse Event|3|||
24944392|NCT00264004|50037005|FG002|Overall Study|Adverse Event|6|||
24944393|NCT00264004|50037006|FG003|Overall Study|Adverse Event|4|||
24944394|NCT00264004|50037003|FG000|Overall Study|Withdrawal by Subject|0|||
24944395|NCT00264004|50037004|FG001|Overall Study|Withdrawal by Subject|1|||
24944396|NCT00264004|50037005|FG002|Overall Study|Withdrawal by Subject|2|||
24944397|NCT00264004|50037006|FG003|Overall Study|Withdrawal by Subject|2|||
24944398|NCT00264004|50037003|FG000|Overall Study|Other|2|||
24944399|NCT00264004|50037004|FG001|Overall Study|Other|2|||
24944400|NCT00264004|50037005|FG002|Overall Study|Other|0|||
24944401|NCT00264004|50037006|FG003|Overall Study|Other|3|||
24944402|NCT00264004|50037003|FG000|Overall Study|Development study specific disc. crit.|1|||
24944403|NCT00264004|50037004|FG001|Overall Study|Development study specific disc. crit.|0|||
24944404|NCT00264004|50037005|FG002|Overall Study|Development study specific disc. crit.|1|||
24944405|NCT00264004|50037006|FG003|Overall Study|Development study specific disc. crit.|0|||
24944406|NCT00264004|50037003|FG000|Overall Study|Cond. under inv. worsened|9|||
24944407|NCT00264004|50037004|FG001|Overall Study|Cond. under inv. worsened|5|||
24944408|NCT00264004|50037005|FG002|Overall Study|Cond. under inv. worsened|3|||
24944409|NCT00264004|50037006|FG003|Overall Study|Cond. under inv. worsened|4|||
24944410|NCT00264004|50037003|FG000|Overall Study|Not treated|3|||
24944411|NCT00264004|50037004|FG001|Overall Study|Not treated|0|||
24944412|NCT00264004|50037005|FG002|Overall Study|Not treated|2|||
24944413|NCT00264004|50037006|FG003|Overall Study|Not treated|2|||
25159327|NCT01442181|50279055|FG000|Overall Study|patient in an additional study|1|||
24944414|NCT00368355|50037018|FG000|Overall Study|Adverse Event|1|||
24944415|NCT00368355|50037019|FG001|Overall Study|Adverse Event|0|||
24944416|NCT00368355|50037018|FG000|Overall Study|Death|2|||
24944417|NCT00368355|50037019|FG001|Overall Study|Death|4|||
24944418|NCT00368355|50037018|FG000|Overall Study|Relapse|6|||
24944419|NCT00368355|50037019|FG001|Overall Study|Relapse|10|||
24944420|NCT00368355|50037018|FG000|Overall Study|Subsequent transplant|0|||
24944421|NCT00368355|50037019|FG001|Overall Study|Subsequent transplant|3|||
24944422|NCT00368355|50037018|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
24944423|NCT00368355|50037019|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
24944424|NCT00445146|50037025|FG000|Overall Study|Withdrew Consent|29|||
24944425|NCT00445146|50037025|FG000|Overall Study|Lack of Efficacy|28|||
24944426|NCT00445146|50037025|FG000|Overall Study|Investigator's Discretion|22|||
24944427|NCT00445146|50037025|FG000|Overall Study|Adverse Event|13|||
24944428|NCT00445146|50037025|FG000|Overall Study|Lost to Follow-up|13|||
24944429|NCT00445146|50037025|FG000|Overall Study|Death|9|||
24944430|NCT00445146|50037025|FG000|Overall Study|Protocol Violation|4|||
24944431|NCT00445146|50037025|FG000|Overall Study|Pregnancy|1|||
24944432|NCT00368277|50037031|FG000|Overall Study|Adverse Event|33|||
24944433|NCT00368277|50037032|FG001|Overall Study|Adverse Event|49|||
24944434|NCT00368277|50037031|FG000|Overall Study|Death|2|||
24944435|NCT00368277|50037032|FG001|Overall Study|Death|1|||
24944436|NCT00368277|50037031|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
24944437|NCT00368277|50037032|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
24944438|NCT00368277|50037031|FG000|Overall Study|Protocol deviation|7|||
24944439|NCT00368277|50037032|FG001|Overall Study|Protocol deviation|0|||
24944440|NCT00368277|50037031|FG000|Overall Study|Patient withdrew consent|32|||
24944441|NCT00368277|50037032|FG001|Overall Study|Patient withdrew consent|28|||
24944442|NCT00368277|50037031|FG000|Overall Study|Lost to Follow-up|8|||
24944443|NCT00368277|50037032|FG001|Overall Study|Lost to Follow-up|6|||
24944444|NCT00280150|50037042|FG000|Overall Study|Adverse Event|0|||
24944445|NCT00280150|50037043|FG001|Overall Study|Adverse Event|1|||
24944446|NCT00280150|50037044|FG002|Overall Study|Adverse Event|2|||
24944447|NCT00280150|50037045|FG003|Overall Study|Adverse Event|3|||
24944448|NCT00280150|50037042|FG000|Overall Study|Lack of Efficacy|0|||
24944449|NCT00280150|50037043|FG001|Overall Study|Lack of Efficacy|0|||
24944450|NCT00280150|50037044|FG002|Overall Study|Lack of Efficacy|0|||
24944451|NCT00280150|50037045|FG003|Overall Study|Lack of Efficacy|3|||
24944452|NCT00280150|50037042|FG000|Overall Study|Physician Decision|0|||
24944453|NCT00280150|50037043|FG001|Overall Study|Physician Decision|0|||
24944454|NCT00280150|50037044|FG002|Overall Study|Physician Decision|0|||
24944455|NCT00280150|50037045|FG003|Overall Study|Physician Decision|1|||
24944456|NCT00280150|50037042|FG000|Overall Study|Protocol Violation|0|||
24944457|NCT00280150|50037043|FG001|Overall Study|Protocol Violation|0|||
24944458|NCT00280150|50037044|FG002|Overall Study|Protocol Violation|0|||
24944459|NCT00280150|50037045|FG003|Overall Study|Protocol Violation|1|||
24944460|NCT00280150|50037042|FG000|Overall Study|Withdrawal by Subject|0|||
24944461|NCT00280150|50037043|FG001|Overall Study|Withdrawal by Subject|0|||
24944462|NCT00280150|50037044|FG002|Overall Study|Withdrawal by Subject|0|||
24944463|NCT00280150|50037045|FG003|Overall Study|Withdrawal by Subject|1|||
24944464|NCT00280150|50037042|FG000|Overall Study|Did not get consolidation therapy|3|||
24944465|NCT00280150|50037043|FG001|Overall Study|Did not get consolidation therapy|0|||
24944466|NCT00280150|50037044|FG002|Overall Study|Did not get consolidation therapy|3|||
24944467|NCT00280150|50037045|FG003|Overall Study|Did not get consolidation therapy|0|||
24944468|NCT00280150|50037042|FG000|Overall Study|Declining Performance Status|0|||
24944469|NCT00280150|50037043|FG001|Overall Study|Declining Performance Status|0|||
24944470|NCT00280150|50037044|FG002|Overall Study|Declining Performance Status|0|||
24944471|NCT00280150|50037045|FG003|Overall Study|Declining Performance Status|1|||
24944472|NCT00279916|50037058|FG000|Overall Study|Withdrawal by Subject|4|||
24944473|NCT00279916|50037059|FG001|Overall Study|Withdrawal by Subject|3|||
24944474|NCT00279916|50037058|FG000|Overall Study|Lost to Follow-up|3|||
24944475|NCT00279916|50037059|FG001|Overall Study|Lost to Follow-up|2|||
24944476|NCT00358527|50037067|FG000|Overall Study|Adverse Event|4|||
24944477|NCT00358527|50037068|FG001|Overall Study|Adverse Event|0|||
24944478|NCT00358527|50037067|FG000|Overall Study|Withdrawal by Subject|1|||
24944479|NCT00358527|50037068|FG001|Overall Study|Withdrawal by Subject|1|||
24944480|NCT00358527|50037067|FG000|Overall Study|Non-compliance with protocol|6|||
24944481|NCT00358527|50037068|FG001|Overall Study|Non-compliance with protocol|1|||
24944482|NCT00358527|50037067|FG000|Overall Study|Administrative|2|||
24944483|NCT00358527|50037068|FG001|Overall Study|Administrative|1|||
24944484|NCT00251758|50037077|FG000|Overall Study|Adverse Event|7|||
24944485|NCT00251758|50037078|FG001|Overall Study|Adverse Event|9|||
24944486|NCT00251758|50037079|FG002|Overall Study|Adverse Event|11|||
24944487|NCT00251758|50037077|FG000|Overall Study|Lost to Follow-up|4|||
24944488|NCT00251758|50037078|FG001|Overall Study|Lost to Follow-up|2|||
24944489|NCT00251758|50037079|FG002|Overall Study|Lost to Follow-up|5|||
24944490|NCT00251758|50037077|FG000|Overall Study|Withdrawal by Subject|13|||
24944491|NCT00251758|50037078|FG001|Overall Study|Withdrawal by Subject|7|||
24944492|NCT00251758|50037079|FG002|Overall Study|Withdrawal by Subject|3|||
24944493|NCT00251758|50037077|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
24944494|NCT00251758|50037078|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
24944495|NCT00251758|50037079|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
24944496|NCT00251758|50037077|FG000|Overall Study|Lack of Efficacy|3|||
24944497|NCT00251758|50037078|FG001|Overall Study|Lack of Efficacy|0|||
24944498|NCT00251758|50037079|FG002|Overall Study|Lack of Efficacy|0|||
24944499|NCT00251758|50037077|FG000|Overall Study|Noncompliant|0|||
24944500|NCT00251758|50037078|FG001|Overall Study|Noncompliant|2|||
24944501|NCT00251758|50037079|FG002|Overall Study|Noncompliant|2|||
24944502|NCT00251758|50037077|FG000|Overall Study|Pregnancy|0|||
24944503|NCT00251758|50037078|FG001|Overall Study|Pregnancy|1|||
24944504|NCT00251758|50037079|FG002|Overall Study|Pregnancy|0|||
24944505|NCT00251758|50037077|FG000|Overall Study|Per Subject Request|0|||
24944506|NCT00251758|50037078|FG001|Overall Study|Per Subject Request|0|||
24944507|NCT00251758|50037079|FG002|Overall Study|Per Subject Request|1|||
24944508|NCT00251758|50037077|FG000|Overall Study|Per Investigator Request|1|||
24944509|NCT00251758|50037078|FG001|Overall Study|Per Investigator Request|0|||
24944510|NCT00251758|50037079|FG002|Overall Study|Per Investigator Request|0|||
24944511|NCT00279214|50037089|FG000|Overall Study|Physician Decision|3|||
24944512|NCT00279214|50037090|FG001|Overall Study|Physician Decision|2|||
24944513|NCT00262834|50037098|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
24944514|NCT00262834|50037099|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
24944515|NCT00541775|50037112|FG000|Overall Study|Adverse Event|3|||
24944516|NCT00541775|50037113|FG001|Overall Study|Adverse Event|2|||
24944517|NCT00541775|50037114|FG002|Overall Study|Adverse Event|1|||
24944518|NCT00541775|50037112|FG000|Overall Study|Lack of Efficacy|0|||
24944519|NCT00541775|50037113|FG001|Overall Study|Lack of Efficacy|0|||
24944520|NCT00541775|50037114|FG002|Overall Study|Lack of Efficacy|3|||
24944521|NCT00541775|50037112|FG000|Overall Study|Lost to Follow-up|0|||
24944522|NCT00541775|50037113|FG001|Overall Study|Lost to Follow-up|0|||
24944523|NCT00541775|50037114|FG002|Overall Study|Lost to Follow-up|2|||
24944524|NCT00541775|50037112|FG000|Overall Study|Protocol Violation|1|||
24944525|NCT00541775|50037113|FG001|Overall Study|Protocol Violation|0|||
24944526|NCT00541775|50037114|FG002|Overall Study|Protocol Violation|0|||
24944527|NCT00541775|50037112|FG000|Overall Study|Withdrawal by Subject and Other|5|||
24944528|NCT00541775|50037113|FG001|Overall Study|Withdrawal by Subject and Other|0|||
24944529|NCT00541775|50037114|FG002|Overall Study|Withdrawal by Subject and Other|2|||
24944530|NCT00539513|50037124|FG000|Overall Study|Withdrawal by Subject|2|||
24944531|NCT00539513|50037125|FG001|Overall Study|Withdrawal by Subject|1|||
24944532|NCT00539513|50037124|FG000|Overall Study|Lost to Follow-up|0|||
24944533|NCT00539513|50037125|FG001|Overall Study|Lost to Follow-up|1|||
24944534|NCT02969915|50037135|FG000|Overall Study|Death|104|||
24944535|NCT02969915|50037136|FG001|Overall Study|Death|125|||
24944536|NCT02969915|50037135|FG000|Overall Study|Lost to Follow-up|108|||
24944537|NCT02969915|50037136|FG001|Overall Study|Lost to Follow-up|112|||
24944538|NCT02969915|50037135|FG000|Overall Study|Censored due to COVID-19|481|||
24944539|NCT02969915|50037136|FG001|Overall Study|Censored due to COVID-19|471|||
24944540|NCT00454584|50037145|FG000|Controlled Period|Adverse Event|5|||
24944541|NCT00454584|50037146|FG001|Controlled Period|Adverse Event|2|||
24944542|NCT00454584|50037147|FG002|Controlled Period|Adverse Event|1|||
24944543|NCT00454584|50037148|FG003|Controlled Period|Adverse Event|0|||
24944544|NCT00454584|50037149|FG004|Controlled Period|Adverse Event|0|||
24944545|NCT00454584|50037150|FG005|Controlled Period|Adverse Event|0|||
24944546|NCT00454584|50037145|FG000|Controlled Period|Lost to Follow-up|1|||
24944547|NCT00454584|50037146|FG001|Controlled Period|Lost to Follow-up|2|||
24944548|NCT00454584|50037147|FG002|Controlled Period|Lost to Follow-up|2|||
24944549|NCT00454584|50037148|FG003|Controlled Period|Lost to Follow-up|0|||
24944550|NCT00454584|50037149|FG004|Controlled Period|Lost to Follow-up|0|||
24944551|NCT00454584|50037150|FG005|Controlled Period|Lost to Follow-up|0|||
24944552|NCT00454584|50037145|FG000|Controlled Period|Other|5|||
24944553|NCT00454584|50037146|FG001|Controlled Period|Other|4|||
24944554|NCT00454584|50037147|FG002|Controlled Period|Other|2|||
24944555|NCT00454584|50037148|FG003|Controlled Period|Other|0|||
24944556|NCT00454584|50037149|FG004|Controlled Period|Other|0|||
24944557|NCT00454584|50037150|FG005|Controlled Period|Other|0|||
24944558|NCT00454584|50037145|FG000|After Controlled Period|Adverse Event|0|||
24944559|NCT00454584|50037146|FG001|After Controlled Period|Adverse Event|0|||
24944560|NCT00454584|50037147|FG002|After Controlled Period|Adverse Event|0|||
24944561|NCT00454584|50037148|FG003|After Controlled Period|Adverse Event|9|||
24944562|NCT00454584|50037149|FG004|After Controlled Period|Adverse Event|3|||
24944563|NCT00454584|50037150|FG005|After Controlled Period|Adverse Event|9|||
24944564|NCT00454584|50037145|FG000|After Controlled Period|Lack of Efficacy|0|||
24944565|NCT00454584|50037146|FG001|After Controlled Period|Lack of Efficacy|0|||
24944566|NCT00454584|50037147|FG002|After Controlled Period|Lack of Efficacy|0|||
24944567|NCT00454584|50037148|FG003|After Controlled Period|Lack of Efficacy|1|||
24944568|NCT00454584|50037149|FG004|After Controlled Period|Lack of Efficacy|0|||
24944569|NCT00454584|50037150|FG005|After Controlled Period|Lack of Efficacy|0|||
24944570|NCT00454584|50037145|FG000|After Controlled Period|Lost to Follow-up|0|||
24944571|NCT00454584|50037146|FG001|After Controlled Period|Lost to Follow-up|0|||
24944572|NCT00454584|50037147|FG002|After Controlled Period|Lost to Follow-up|0|||
24944573|NCT00454584|50037148|FG003|After Controlled Period|Lost to Follow-up|2|||
24944574|NCT00454584|50037149|FG004|After Controlled Period|Lost to Follow-up|4|||
24944575|NCT00454584|50037150|FG005|After Controlled Period|Lost to Follow-up|6|||
24944576|NCT00454584|50037145|FG000|After Controlled Period|Other|0|||
24944577|NCT00454584|50037146|FG001|After Controlled Period|Other|0|||
24944578|NCT00454584|50037147|FG002|After Controlled Period|Other|0|||
24944579|NCT00454584|50037148|FG003|After Controlled Period|Other|1|||
24944580|NCT00454584|50037149|FG004|After Controlled Period|Other|0|||
24944581|NCT00454584|50037150|FG005|After Controlled Period|Other|0|||
24944582|NCT00454584|50037145|FG000|After Controlled Period|Other|0|||
24944583|NCT00454584|50037146|FG001|After Controlled Period|Other|0|||
24944584|NCT00454584|50037147|FG002|After Controlled Period|Other|0|||
24944585|NCT00454584|50037148|FG003|After Controlled Period|Other|13|||
24944586|NCT00454584|50037149|FG004|After Controlled Period|Other|5|||
24944587|NCT00454584|50037150|FG005|After Controlled Period|Other|17|||
24944588|NCT00445068|50037164|FG000|Overall Study|Disease progression|26|||
24944589|NCT00445068|50037164|FG000|Overall Study|Adverse Event|5|||
24944590|NCT00445068|50037164|FG000|Overall Study|Abnormal laboratory value|2|||
24944591|NCT00445068|50037164|FG000|Overall Study|Withdrawal by Subject|2|||
24944592|NCT00445068|50037164|FG000|Overall Study|Death|1|||
24944593|NCT00539279|50037170|FG000|Treatment|Withdrawal by Subject|10|||
24944594|NCT00539279|50037171|FG001|Treatment|Withdrawal by Subject|8|||
24944595|NCT00539279|50037170|FG000|Treatment|Death|1|||
24944596|NCT00539279|50037171|FG001|Treatment|Death|0|||
24944597|NCT00539279|50037170|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
24944598|NCT00539279|50037171|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
24944599|NCT00539279|50037170|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
24944600|NCT00539279|50037171|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
24944601|NCT00444912|50037179|FG000|Overall Study|Death|1|||
24944602|NCT00444912|50037180|FG001|Overall Study|Death|2|||
24944603|NCT00444912|50037179|FG000|Overall Study|Lost to Follow-up|1|||
24944604|NCT00444912|50037180|FG001|Overall Study|Lost to Follow-up|0|||
25030847|NCT03103503|50129499|FG000|Overall Study|Lost to Follow-up|3|||
25030848|NCT03103503|50129499|FG000|Overall Study|Study Closure|757|||
25030849|NCT02961218|50129505|FG000|Overall Study|Lost to Follow-up|0|||
25030850|NCT02961218|50129506|FG001|Overall Study|Lost to Follow-up|2|||
25030851|NCT02961218|50129505|FG000|Overall Study|Physician Decision|0|||
25030852|NCT02961218|50129506|FG001|Overall Study|Physician Decision|2|||
25030853|NCT02961218|50129505|FG000|Overall Study|Subject/Guardian Decision|3|||
25030854|NCT02961218|50129506|FG001|Overall Study|Subject/Guardian Decision|1|||
25030855|NCT02949947|50129516|FG000|Overall Study|Non Compliance|0|||
25030856|NCT02949947|50129517|FG001|Overall Study|Non Compliance|1|||
25030857|NCT02949947|50129516|FG000|Overall Study|Insurance change|1|||
25030858|NCT02949947|50129517|FG001|Overall Study|Insurance change|0|||
25030859|NCT03341507|50129523|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
25275584|NCT00975130|50589452|FG001|Study Part 1|Administrative|0|||
25275585|NCT00975130|50589453|FG002|Study Part 1|Administrative|0|||
25275586|NCT00975130|50589451|FG000|Study Part 1|Withdrew Consent|24|||
25275587|NCT00975130|50589452|FG001|Study Part 1|Withdrew Consent|0|||
25275588|NCT00975130|50589453|FG002|Study Part 1|Withdrew Consent|0|||
25275589|NCT00975130|50589451|FG000|Study Part 2|Adverse Event|0|||
25275590|NCT00975130|50589452|FG001|Study Part 2|Adverse Event|14|||
25275591|NCT00975130|50589453|FG002|Study Part 2|Adverse Event|7|||
25275592|NCT00975130|50589451|FG000|Study Part 2|Lost to Follow-up|0|||
25275593|NCT00975130|50589452|FG001|Study Part 2|Lost to Follow-up|0|||
25275594|NCT00975130|50589453|FG002|Study Part 2|Lost to Follow-up|1|||
25275595|NCT00975130|50589451|FG000|Study Part 2|Withdrawal by Subject|0|||
25275596|NCT00975130|50589452|FG001|Study Part 2|Withdrawal by Subject|13|||
25275597|NCT00975130|50589453|FG002|Study Part 2|Withdrawal by Subject|5|||
25275598|NCT00975130|50589451|FG000|Study Part 2|Withdrew Consent|0|||
25275599|NCT00975130|50589452|FG001|Study Part 2|Withdrew Consent|6|||
25030876|NCT01345058|50129538|FG000|Overall Study|Withdrawal by Subject|1|||
25030877|NCT01345058|50129539|FG001|Overall Study|Withdrawal by Subject|0|||
25030878|NCT01345058|50129538|FG000|Overall Study|Participant Reported Increase in Events|1|||
25030879|NCT01345058|50129539|FG001|Overall Study|Participant Reported Increase in Events|0|||
25030880|NCT01345058|50129538|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
25030881|NCT01345058|50129539|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
25030882|NCT01345058|50129538|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
25030883|NCT01345058|50129539|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
25030884|NCT01345058|50129538|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
25030885|NCT01345058|50129539|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
24944605|NCT00444912|50037179|FG000|Overall Study|Participant Failed Mobilization|1|||
24944606|NCT00444912|50037180|FG001|Overall Study|Participant Failed Mobilization|0|||
24944607|NCT00538733|50037186|FG000|Overall Study|Adverse Event|8|||
24944608|NCT00538733|50037186|FG000|Overall Study|Death|1|||
24944609|NCT00538733|50037186|FG000|Overall Study|declined to participate|2|||
24944610|NCT00538733|50037186|FG000|Overall Study|still on therapy|1|||
24944611|NCT00444678|50037193|FG000|Overall Study|Toxicity|11|||
24944612|NCT00444678|50037193|FG000|Overall Study|Disease Progression|12|||
25030886|NCT01345292|50129548|FG000|Overall Study|Withdrawal by Subject|2|||
25030887|NCT01345292|50129549|FG001|Overall Study|Withdrawal by Subject|0|||
25030888|NCT01345292|50129550|FG002|Overall Study|Withdrawal by Subject|1|||
25159328|NCT01442181|50279056|FG001|Overall Study|patient in an additional study|0|||
24944613|NCT00444678|50037193|FG000|Overall Study|Death|3|||
24944614|NCT00444678|50037193|FG000|Overall Study|Physician Decision|3|||
24944615|NCT00444678|50037193|FG000|Overall Study|Withdrawal by Subject|2|||
24944616|NCT00358449|50037200|FG000|Overall Study|Adverse Event|1|||
24944617|NCT00358449|50037201|FG001|Overall Study|Adverse Event|0|||
24944618|NCT00358449|50037202|FG002|Overall Study|Adverse Event|1|||
24944619|NCT00358449|50037200|FG000|Overall Study|Lost to Follow-up|1|||
24944620|NCT00358449|50037201|FG001|Overall Study|Lost to Follow-up|0|||
24944621|NCT00358449|50037202|FG002|Overall Study|Lost to Follow-up|0|||
25030889|NCT03340961|50129562|FG000|Overall Study|Adverse Event|1|||
25030890|NCT03340961|50129563|FG001|Overall Study|Adverse Event|3|||
25030891|NCT03340961|50129564|FG002|Overall Study|Adverse Event|2|||
25030892|NCT03340961|50129565|FG003|Overall Study|Adverse Event|4|||
25030893|NCT03340961|50129562|FG000|Overall Study|Lost to Follow-up|0|||
25030894|NCT03340961|50129563|FG001|Overall Study|Lost to Follow-up|1|||
24944622|NCT00358449|50037200|FG000|Overall Study|Withdrawal by Subject|2|||
24944623|NCT00358449|50037201|FG001|Overall Study|Withdrawal by Subject|0|||
25030895|NCT03340961|50129564|FG002|Overall Study|Lost to Follow-up|0|||
25275600|NCT00975130|50589453|FG002|Study Part 2|Withdrew Consent|2|||
24944624|NCT00358449|50037202|FG002|Overall Study|Withdrawal by Subject|0|||
24944625|NCT00358449|50037200|FG000|Overall Study|Lack of Efficacy|0|||
24944626|NCT00358449|50037201|FG001|Overall Study|Lack of Efficacy|1|||
24944627|NCT00358449|50037202|FG002|Overall Study|Lack of Efficacy|0|||
24944628|NCT00358449|50037200|FG000|Overall Study|Steriod Inhaler was Increased|0|||
24944629|NCT00358449|50037201|FG001|Overall Study|Steriod Inhaler was Increased|0|||
24944630|NCT00358449|50037202|FG002|Overall Study|Steriod Inhaler was Increased|1|||
24944631|NCT00539981|50037214|FG000|Overall Study|Adverse events (AE)|3|||
24944632|NCT00539981|50037215|FG001|Overall Study|Adverse events (AE)|3|||
24944633|NCT00539981|50037214|FG000|Overall Study|Lost to Follow-up|260|||
24944634|NCT00539981|50037215|FG001|Overall Study|Lost to Follow-up|251|||
24944635|NCT00539981|50037214|FG000|Overall Study|Withdrew consent|22|||
24944636|NCT00539981|50037215|FG001|Overall Study|Withdrew consent|14|||
24944637|NCT00539981|50037214|FG000|Overall Study|Death|1|||
24944638|NCT00539981|50037215|FG001|Overall Study|Death|1|||
24944639|NCT00539981|50037214|FG000|Overall Study|Other reason-unspecified|9|||
24944640|NCT00539981|50037215|FG001|Overall Study|Other reason-unspecified|13|||
24944641|NCT00367341|50037226|FG000|Overall Study|Physician Decision|1|||
24944642|NCT00367341|50037227|FG001|Overall Study|Physician Decision|0|||
24944643|NCT00367341|50037226|FG000|Overall Study|Protocol Violation|1|||
24944644|NCT00367341|50037227|FG001|Overall Study|Protocol Violation|0|||
24944645|NCT00440466|50037236|FG000|Overall Study|Death|3|||
24944646|NCT00440466|50037237|FG001|Overall Study|Death|2|||
24944647|NCT00440466|50037238|FG002|Overall Study|Death|9|||
24944648|NCT00440466|50037236|FG000|Overall Study|Adverse Event|3|||
24944649|NCT00440466|50037237|FG001|Overall Study|Adverse Event|4|||
24944650|NCT00440466|50037238|FG002|Overall Study|Adverse Event|11|||
24944651|NCT00440466|50037236|FG000|Overall Study|Lost to Follow-up|1|||
24944652|NCT00440466|50037237|FG001|Overall Study|Lost to Follow-up|0|||
24944653|NCT00440466|50037238|FG002|Overall Study|Lost to Follow-up|2|||
24944654|NCT00440466|50037236|FG000|Overall Study|Physician Decision|2|||
24944655|NCT00440466|50037237|FG001|Overall Study|Physician Decision|0|||
24944656|NCT00440466|50037238|FG002|Overall Study|Physician Decision|1|||
24944657|NCT00440466|50037236|FG000|Overall Study|Protocol Violation|2|||
24944658|NCT00440466|50037237|FG001|Overall Study|Protocol Violation|0|||
25030896|NCT03340961|50129565|FG003|Overall Study|Lost to Follow-up|1|||
25030897|NCT03340961|50129562|FG000|Overall Study|Withdrawal by Subject|3|||
25030898|NCT03340961|50129563|FG001|Overall Study|Withdrawal by Subject|2|||
25030899|NCT03340961|50129564|FG002|Overall Study|Withdrawal by Subject|4|||
25030900|NCT03340961|50129565|FG003|Overall Study|Withdrawal by Subject|7|||
25030901|NCT03340961|50129562|FG000|Overall Study|Use of prohibited treatment|0|||
25030902|NCT03340961|50129563|FG001|Overall Study|Use of prohibited treatment|3|||
25030903|NCT03340961|50129564|FG002|Overall Study|Use of prohibited treatment|2|||
25030904|NCT03340961|50129565|FG003|Overall Study|Use of prohibited treatment|4|||
25030905|NCT03340961|50129562|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
25030906|NCT03340961|50129563|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
25030907|NCT03340961|50129564|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
25030908|NCT03340961|50129565|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
25030909|NCT03340961|50129562|FG000|Overall Study|Subject developed an exclusion criterion|0|||
25030910|NCT03340961|50129563|FG001|Overall Study|Subject developed an exclusion criterion|1|||
25030911|NCT03340961|50129564|FG002|Overall Study|Subject developed an exclusion criterion|0|||
25030912|NCT03340961|50129565|FG003|Overall Study|Subject developed an exclusion criterion|0|||
25030913|NCT03340961|50129562|FG000|Overall Study|Protocol Violation|1|||
25030914|NCT03340961|50129563|FG001|Overall Study|Protocol Violation|0|||
25030915|NCT03340961|50129564|FG002|Overall Study|Protocol Violation|1|||
25030916|NCT03340961|50129565|FG003|Overall Study|Protocol Violation|0|||
25030917|NCT03340961|50129562|FG000|Overall Study|Adverse Event|1|||
25030918|NCT03340961|50129563|FG001|Overall Study|Adverse Event|1|||
25030919|NCT03340961|50129564|FG002|Overall Study|Adverse Event|0|||
25030920|NCT03340961|50129565|FG003|Overall Study|Adverse Event|0|||
25030921|NCT03340961|50129562|FG000|Overall Study|Lack of Efficacy|0|||
25030922|NCT03340961|50129563|FG001|Overall Study|Lack of Efficacy|0|||
25030923|NCT03340961|50129564|FG002|Overall Study|Lack of Efficacy|0|||
25030924|NCT03340961|50129565|FG003|Overall Study|Lack of Efficacy|1|||
25030925|NCT03340025|50129577|FG000|Overall Study|Lost to Follow-up|2|||
25030926|NCT03340025|50129578|FG001|Overall Study|Lost to Follow-up|2|||
25030927|NCT03339713|50129586|FG000|Overall Study|Lost to Follow-up|2|||
25030928|NCT03339713|50129587|FG001|Overall Study|Lost to Follow-up|1|||
25030929|NCT03339713|50129586|FG000|Overall Study|Protocol Violation|1|||
25030930|NCT03339713|50129587|FG001|Overall Study|Protocol Violation|0|||
24944659|NCT00440466|50037238|FG002|Overall Study|Protocol Violation|4|||
25030931|NCT03339713|50129586|FG000|Overall Study|Withdrawal by Subject|1|||
25030932|NCT03339713|50129587|FG001|Overall Study|Withdrawal by Subject|1|||
25030933|NCT03254485|50129599|FG000|Overall Study|Adverse Event|3|||
25030934|NCT03254485|50129600|FG001|Overall Study|Adverse Event|0|||
25030935|NCT03254485|50129601|FG002|Overall Study|Adverse Event|0|||
24944660|NCT00440466|50037236|FG000|Overall Study|Withdrawal by Subject|2|||
25030936|NCT03254485|50129602|FG003|Overall Study|Adverse Event|6|||
25030937|NCT03254485|50129599|FG000|Overall Study|Protocol Violation|6|||
25030938|NCT03254485|50129600|FG001|Overall Study|Protocol Violation|0|||
24944661|NCT00440466|50037237|FG001|Overall Study|Withdrawal by Subject|5|||
24944662|NCT00440466|50037238|FG002|Overall Study|Withdrawal by Subject|9|||
24944663|NCT00440466|50037236|FG000|Overall Study|Began Dialysis|0|||
24944664|NCT00440466|50037237|FG001|Overall Study|Began Dialysis|0|||
24944665|NCT00440466|50037238|FG002|Overall Study|Began Dialysis|1|||
24944666|NCT00440466|50037236|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
24944667|NCT00440466|50037237|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
24944668|NCT00440466|50037238|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
24944669|NCT00537485|50037270|FG000|Overall Study|Adverse Event|10|||
24944670|NCT00537485|50037271|FG001|Overall Study|Adverse Event|5|||
24944671|NCT00537485|50037270|FG000|Overall Study|Withdrawal by Subject|3|||
24944672|NCT00537485|50037271|FG001|Overall Study|Withdrawal by Subject|2|||
24944673|NCT00537485|50037270|FG000|Overall Study|Withdrawal by Subject|1|||
24944674|NCT00537485|50037271|FG001|Overall Study|Withdrawal by Subject|3|||
24944675|NCT00537485|50037270|FG000|Overall Study|Physician Decision|1|||
24944676|NCT00537485|50037271|FG001|Overall Study|Physician Decision|0|||
24944677|NCT00616967|50037279|FG000|Overall Study|Withdrawal by Subject|0|||
24944678|NCT00616967|50037280|FG001|Overall Study|Withdrawal by Subject|0|||
24944679|NCT00616967|50037281|FG002|Overall Study|Withdrawal by Subject|1|||
24944680|NCT00537329|50037299|FG000|Overall Study|Death|10|||
24944681|NCT00537329|50037299|FG000|Overall Study|Adverse Event|3|||
25030939|NCT03254485|50129601|FG002|Overall Study|Protocol Violation|0|||
25030940|NCT03254485|50129602|FG003|Overall Study|Protocol Violation|2|||
25030941|NCT03254485|50129599|FG000|Overall Study|Withdrawal by Subject|1|||
25030942|NCT03254485|50129600|FG001|Overall Study|Withdrawal by Subject|0|||
25030943|NCT03254485|50129601|FG002|Overall Study|Withdrawal by Subject|0|||
25030944|NCT03254485|50129602|FG003|Overall Study|Withdrawal by Subject|4|||
25030945|NCT03254485|50129599|FG000|Overall Study|Death|0|||
25030946|NCT03254485|50129600|FG001|Overall Study|Death|0|||
25030947|NCT03254485|50129601|FG002|Overall Study|Death|0|||
25030948|NCT03254485|50129602|FG003|Overall Study|Death|1|||
25030949|NCT03254485|50129599|FG000|Overall Study|Lost to Follow-up|1|||
25030950|NCT03254485|50129600|FG001|Overall Study|Lost to Follow-up|0|||
25030951|NCT03254485|50129601|FG002|Overall Study|Lost to Follow-up|0|||
25030952|NCT03254485|50129602|FG003|Overall Study|Lost to Follow-up|0|||
25030953|NCT03254485|50129599|FG000|Overall Study|Other|1|||
25030954|NCT03254485|50129600|FG001|Overall Study|Other|0|||
25030955|NCT03254485|50129601|FG002|Overall Study|Other|0|||
25030956|NCT03254485|50129602|FG003|Overall Study|Other|2|||
25030957|NCT03339401|50129625|FG000|Overall Study|Death|2|||
25030958|NCT03339401|50129626|FG001|Overall Study|Death|1|||
25030959|NCT03339401|50129625|FG000|Overall Study|Withdrawal by Subject|2|||
25030960|NCT03339401|50129626|FG001|Overall Study|Withdrawal by Subject|0|||
25030961|NCT03339401|50129625|FG000|Overall Study|Study terminated|4|||
25030962|NCT03339401|50129626|FG001|Overall Study|Study terminated|3|||
24944682|NCT00537329|50037299|FG000|Overall Study|Lack of Efficacy|2|||
24944683|NCT00537329|50037299|FG000|Overall Study|Lost to Follow-up|6|||
24944684|NCT00537329|50037299|FG000|Overall Study|Withdrawal by Subject|4|||
24944685|NCT00537329|50037299|FG000|Overall Study|Other|1|||
24944686|NCT03897179|50037303|FG000|Overall Study|Withdrawal by Subject|1|||
24944687|NCT03905135|50037309|FG000|Dose Escalation|Adverse Event|1|||
25030963|NCT03339401|50129625|FG000|Overall Study|Investigator Decision|1|||
25030964|NCT03339401|50129626|FG001|Overall Study|Investigator Decision|0|||
24944688|NCT03905135|50037310|FG001|Dose Escalation|Adverse Event|1|||
24944689|NCT03905135|50037309|FG000|Dose Escalation|Progressive disease|3|||
24944690|NCT03905135|50037310|FG001|Dose Escalation|Progressive disease|1|||
25030965|NCT03370289|50129632|FG000|Overall Study|Screen Failure|1|||
25030966|NCT03370289|50129632|FG000|Overall Study|Sample Size Sufficient|4|||
25030967|NCT01344824|50129636|FG000|Overall Study|Adverse Event|15|||
25030968|NCT01344824|50129636|FG000|Overall Study|Withdrawal by Subject|6|||
25030969|NCT01344824|50129636|FG000|Overall Study|Other complicating disease|1|||
24944691|NCT03905135|50037309|FG000|Dose Escalation|Intercurrent illness|1|||
24944692|NCT03905135|50037310|FG001|Dose Escalation|Intercurrent illness|0|||
24944693|NCT00357903|50037320|FG000|Overall Study|Adverse Event|87|||
24944694|NCT00357903|50037321|FG001|Overall Study|Adverse Event|4|||
24944695|NCT00357903|50037320|FG000|Overall Study|Death|33|||
25030970|NCT01344824|50129636|FG000|Overall Study|Progression|15|||
25030971|NCT03339245|50129643|FG000|Overall Study|Adverse Event|1|||
25030972|NCT03339245|50129644|FG001|Overall Study|Adverse Event|1|||
25030973|NCT03339245|50129643|FG000|Overall Study|Withdrawal by Subject|1|||
25030974|NCT03339245|50129644|FG001|Overall Study|Withdrawal by Subject|0|||
25030975|NCT03044574|50129652|FG000|Overall Study|Lost to Follow-up|37|||
25030976|NCT03044574|50129653|FG001|Overall Study|Lost to Follow-up|45|||
24944696|NCT00357903|50037321|FG001|Overall Study|Death|0|||
24944697|NCT00357903|50037320|FG000|Overall Study|Lost to Follow-up|23|||
24944698|NCT00357903|50037321|FG001|Overall Study|Lost to Follow-up|4|||
24944699|NCT00357903|50037320|FG000|Overall Study|Physician Decision|39|||
24944700|NCT00357903|50037321|FG001|Overall Study|Physician Decision|5|||
24944701|NCT00357903|50037320|FG000|Overall Study|Withdrawal by Subject|57|||
24944702|NCT00357903|50037321|FG001|Overall Study|Withdrawal by Subject|7|||
24944703|NCT00357903|50037320|FG000|Overall Study|Completed month 12 only|0|||
24944704|NCT00357903|50037321|FG001|Overall Study|Completed month 12 only|1|||
24944705|NCT00357903|50037320|FG000|Overall Study|Protocol issues|14|||
24944706|NCT00357903|50037321|FG001|Overall Study|Protocol issues|3|||
24944707|NCT00357903|50037320|FG000|Overall Study|Response status|61|||
24944708|NCT00357903|50037321|FG001|Overall Study|Response status|9|||
24944709|NCT00357903|50037320|FG000|Overall Study|Other|49|||
24944710|NCT00357903|50037321|FG001|Overall Study|Other|10|||
24944711|NCT00348933|50037328|FG000|Overall Study|Withdrawal by Subject|10|||
24944712|NCT00348933|50037328|FG000|Overall Study|Lost to Follow-up|6|||
24944713|NCT00348933|50037328|FG000|Overall Study|Protocol Violation|2|||
24944714|NCT00348933|50037328|FG000|Overall Study|Adverse Event|7|||
24944715|NCT03896477|50037336|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
24944716|NCT03896477|50037337|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
24944717|NCT03896477|50037338|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
24944718|NCT03896477|50037336|FG000|Overall Study|Parent Requested Withdrawal|8|||
24944719|NCT03896477|50037337|FG001|Overall Study|Parent Requested Withdrawal|12|||
24944720|NCT03896477|50037338|FG002|Overall Study|Parent Requested Withdrawal|9|||
24944721|NCT03896477|50037336|FG000|Overall Study|Adverse Event|0|||
24944722|NCT03896477|50037337|FG001|Overall Study|Adverse Event|0|||
24944723|NCT03896477|50037338|FG002|Overall Study|Adverse Event|1|||
24944724|NCT03896477|50037336|FG000|Overall Study|Death|1|||
24944725|NCT03896477|50037337|FG001|Overall Study|Death|0|||
24944726|NCT03896477|50037338|FG002|Overall Study|Death|0|||
24944727|NCT03896477|50037336|FG000|Overall Study|Other|5|||
24944728|NCT03896477|50037337|FG001|Overall Study|Other|6|||
24944729|NCT03896477|50037338|FG002|Overall Study|Other|7|||
24944730|NCT03896477|50037336|FG000|Overall Study|Lost to Follow-up|2|||
24944731|NCT03896477|50037337|FG001|Overall Study|Lost to Follow-up|1|||
24944732|NCT03896477|50037338|FG002|Overall Study|Lost to Follow-up|1|||
24944733|NCT00444600|50037353|FG000|Overall Study|Death|7|||
24944734|NCT00444600|50037354|FG001|Overall Study|Death|5|||
24944735|NCT00444600|50037355|FG002|Overall Study|Death|3|||
24944736|NCT00444600|50037356|FG003|Overall Study|Death|2|||
24944737|NCT00444600|50037353|FG000|Overall Study|Dropped|11|||
24944738|NCT00444600|50037354|FG001|Overall Study|Dropped|11|||
24944739|NCT00444600|50037355|FG002|Overall Study|Dropped|7|||
24944740|NCT00444600|50037356|FG003|Overall Study|Dropped|7|||
24944741|NCT00444600|50037353|FG000|Overall Study|Missed visit|1|||
25030977|NCT02959892|50129661|FG000|Overall Study|PET tracer synthesis failure|1|||
24944742|NCT00444600|50037354|FG001|Overall Study|Missed visit|0|||
24944743|NCT00444600|50037355|FG002|Overall Study|Missed visit|0|||
24944744|NCT00444600|50037356|FG003|Overall Study|Missed visit|1|||
24944745|NCT00537095|50037374|FG000|Overall Study|surgery|1|||
25030978|NCT02959892|50129662|FG001|Overall Study|PET tracer synthesis failure|0|||
25030979|NCT02959892|50129661|FG000|Overall Study|Study termination|0|||
24944746|NCT00537095|50037375|FG001|Overall Study|surgery|0|||
24944747|NCT00537095|50037374|FG000|Overall Study|Adverse Event|24|||
25030980|NCT02959892|50129662|FG001|Overall Study|Study termination|1|||
24944748|NCT00537095|50037375|FG001|Overall Study|Adverse Event|4|||
24944749|NCT00537095|50037374|FG000|Overall Study|disease progression|21|||
24944750|NCT00537095|50037375|FG001|Overall Study|disease progression|48|||
24944751|NCT00537095|50037374|FG000|Overall Study|Death|3|||
24944752|NCT00537095|50037375|FG001|Overall Study|Death|1|||
24944753|NCT00537095|50037374|FG000|Overall Study|Withdrawal by Subject|2|||
24944754|NCT00537095|50037375|FG001|Overall Study|Withdrawal by Subject|2|||
24944755|NCT00537095|50037374|FG000|Overall Study|subjective disease progression|0|||
24944756|NCT00537095|50037375|FG001|Overall Study|subjective disease progression|1|||
24944757|NCT00537095|50037374|FG000|Overall Study|Incorrect enrolment|0|||
24944758|NCT00537095|50037375|FG001|Overall Study|Incorrect enrolment|1|||
24944759|NCT00443898|50037385|FG000|Overall Study|Adverse Event|0|||
24944760|NCT00443898|50037386|FG001|Overall Study|Adverse Event|0|||
24944761|NCT00443898|50037387|FG002|Overall Study|Adverse Event|1|||
24944762|NCT00443898|50037388|FG003|Overall Study|Adverse Event|1|||
24944763|NCT00443898|50037385|FG000|Overall Study|Lack of Efficacy|2|||
24944764|NCT00443898|50037386|FG001|Overall Study|Lack of Efficacy|3|||
24944765|NCT00443898|50037387|FG002|Overall Study|Lack of Efficacy|3|||
24944766|NCT00443898|50037388|FG003|Overall Study|Lack of Efficacy|1|||
24944767|NCT00443898|50037385|FG000|Overall Study|Protocol Violation|1|||
25159329|NCT01442181|50279055|FG000|Overall Study|atrial fibrillation not noted|0|||
25159330|NCT01442181|50279056|FG001|Overall Study|atrial fibrillation not noted|1|||
25159331|NCT01442103|50279063|FG000|Overall Study|Lost to Follow-up|2|||
25159332|NCT01428219|50279067|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
25159333|NCT01428063|50279074|FG000|Overall Study|Lack of Efficacy|8|||
25159334|NCT01428063|50279075|FG001|Overall Study|Lack of Efficacy|4|||
25159335|NCT01428063|50279076|FG002|Overall Study|Lack of Efficacy|1|||
25159336|NCT01428063|50279074|FG000|Overall Study|Adverse Event|2|||
25159337|NCT01428063|50279075|FG001|Overall Study|Adverse Event|3|||
25159338|NCT01428063|50279076|FG002|Overall Study|Adverse Event|0|||
25159339|NCT01428063|50279074|FG000|Overall Study|Lost to Follow-up|0|||
25159340|NCT01428063|50279075|FG001|Overall Study|Lost to Follow-up|2|||
25159341|NCT01428063|50279076|FG002|Overall Study|Lost to Follow-up|0|||
25159342|NCT01428063|50279074|FG000|Overall Study|No longer meets study criteria|0|||
25159343|NCT01428063|50279075|FG001|Overall Study|No longer meets study criteria|1|||
25159344|NCT01428063|50279076|FG002|Overall Study|No longer meets study criteria|0|||
25159345|NCT01441635|50279240|FG000|Overall Study|Adverse Event|4|||
25159346|NCT01441635|50279241|FG001|Overall Study|Adverse Event|3|||
25159347|NCT01441635|50279242|FG002|Overall Study|Adverse Event|1|||
25159348|NCT01441635|50279243|FG003|Overall Study|Adverse Event|5|||
25159349|NCT01441635|50279244|FG004|Overall Study|Adverse Event|1|||
25159350|NCT01441635|50279245|FG005|Overall Study|Adverse Event|2|||
25159351|NCT01441635|50279246|FG006|Overall Study|Adverse Event|2|||
25159352|NCT01441635|50279247|FG007|Overall Study|Adverse Event|2|||
25159353|NCT01441635|50279248|FG008|Overall Study|Adverse Event|1|||
25159354|NCT01441635|50279249|FG009|Overall Study|Adverse Event|0|||
25159355|NCT01441635|50279240|FG000|Overall Study|Withdrawal by Subject|1|||
25159356|NCT01441635|50279241|FG001|Overall Study|Withdrawal by Subject|1|||
24944768|NCT00443898|50037386|FG001|Overall Study|Protocol Violation|1|||
24944769|NCT00443898|50037387|FG002|Overall Study|Protocol Violation|1|||
24944770|NCT00443898|50037388|FG003|Overall Study|Protocol Violation|0|||
24944771|NCT00443898|50037385|FG000|Overall Study|Withdrawal by Subject|11|||
24944772|NCT00443898|50037386|FG001|Overall Study|Withdrawal by Subject|10|||
24944773|NCT00443898|50037387|FG002|Overall Study|Withdrawal by Subject|10|||
24944774|NCT00443898|50037388|FG003|Overall Study|Withdrawal by Subject|6|||
24944775|NCT00443898|50037385|FG000|Overall Study|Lost to Follow-up|10|||
24944776|NCT00443898|50037386|FG001|Overall Study|Lost to Follow-up|10|||
24944777|NCT00443898|50037387|FG002|Overall Study|Lost to Follow-up|14|||
24944778|NCT00443898|50037388|FG003|Overall Study|Lost to Follow-up|10|||
24944779|NCT00443898|50037385|FG000|Overall Study|Death|0|||
24944780|NCT00443898|50037386|FG001|Overall Study|Death|1|||
24944781|NCT00443898|50037387|FG002|Overall Study|Death|0|||
24944782|NCT00443898|50037388|FG003|Overall Study|Death|0|||
24944783|NCT00537017|50037398|FG000|Treatment Phase|Adverse Event|19|||
24944784|NCT00537017|50037398|FG000|Treatment Phase|Withdrawal by Subject|13|||
24944785|NCT00537017|50037398|FG000|Treatment Phase|Protocol Violation|2|||
25030981|NCT03252145|50129670|FG000|Overall Study|Withdrawal by Subject|1|||
25030982|NCT03252145|50129671|FG001|Overall Study|Withdrawal by Subject|0|||
25159357|NCT01441635|50279242|FG002|Overall Study|Withdrawal by Subject|0|||
25186195|NCT01420679|50336127|FG001|Overall Study|Investigator Decision|2|||
25186196|NCT01420679|50336126|FG000|Overall Study|Sponsor Decision|3|||
25186197|NCT01420679|50336127|FG001|Overall Study|Sponsor Decision|3|||
24944786|NCT00537017|50037398|FG000|Follow-up Phase|Withdrawal by Subject|9|||
24944787|NCT00348309|50037405|FG000|Overall Study|Adverse Event|56|||
24944788|NCT00348309|50037406|FG001|Overall Study|Adverse Event|28|||
24944789|NCT00348309|50037407|FG002|Overall Study|Adverse Event|63|||
24944790|NCT00348309|50037405|FG000|Overall Study|Lost to Follow-up|6|||
24944791|NCT00348309|50037406|FG001|Overall Study|Lost to Follow-up|7|||
24944792|NCT00348309|50037407|FG002|Overall Study|Lost to Follow-up|4|||
24944793|NCT00348309|50037405|FG000|Overall Study|Protocol Violation|7|||
24944794|NCT00348309|50037406|FG001|Overall Study|Protocol Violation|12|||
25159358|NCT01441635|50279243|FG003|Overall Study|Withdrawal by Subject|1|||
25030983|NCT03252145|50129670|FG000|Overall Study|Complicating Disease|1|||
25030984|NCT03252145|50129671|FG001|Overall Study|Complicating Disease|2|||
25030985|NCT02959814|50129677|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
25030986|NCT02959814|50129677|FG000|Overall Study|Excluded based on anatomical criteria|2|||
25030987|NCT02959814|50129677|FG000|Overall Study|Protocol Violation|7|||
25030988|NCT02959814|50129677|FG000|Overall Study|FFR not measured|2|||
24944795|NCT00348309|50037407|FG002|Overall Study|Protocol Violation|7|||
24944796|NCT00348309|50037405|FG000|Overall Study|Withdrawal by Subject|33|||
24944797|NCT00348309|50037406|FG001|Overall Study|Withdrawal by Subject|37|||
24944798|NCT00348309|50037407|FG002|Overall Study|Withdrawal by Subject|40|||
24944799|NCT00348309|50037405|FG000|Overall Study|Non-compliance|8|||
24944800|NCT00348309|50037406|FG001|Overall Study|Non-compliance|6|||
24944801|NCT00348309|50037407|FG002|Overall Study|Non-compliance|8|||
24944802|NCT00348309|50037405|FG000|Overall Study|Death of caregiver|1|||
24944803|NCT00348309|50037406|FG001|Overall Study|Death of caregiver|0|||
24944804|NCT00348309|50037407|FG002|Overall Study|Death of caregiver|1|||
24944805|NCT00348309|50037405|FG000|Overall Study|Lack of insight, dementia|1|||
24944806|NCT00348309|50037406|FG001|Overall Study|Lack of insight, dementia|0|||
24944807|NCT00348309|50037407|FG002|Overall Study|Lack of insight, dementia|0|||
24944808|NCT00348309|50037405|FG000|Overall Study|Wrong bottle allocated|1|||
24944809|NCT00348309|50037406|FG001|Overall Study|Wrong bottle allocated|0|||
24944810|NCT00348309|50037407|FG002|Overall Study|Wrong bottle allocated|0|||
24944811|NCT00348309|50037405|FG000|Overall Study|Caregiver sick|1|||
24944812|NCT00348309|50037406|FG001|Overall Study|Caregiver sick|0|||
24944813|NCT00348309|50037407|FG002|Overall Study|Caregiver sick|0|||
24944814|NCT00348309|50037405|FG000|Overall Study|Use of prohibited medication|5|||
24944815|NCT00348309|50037406|FG001|Overall Study|Use of prohibited medication|2|||
24944816|NCT00348309|50037407|FG002|Overall Study|Use of prohibited medication|2|||
24944817|NCT00348309|50037405|FG000|Overall Study|Caregiver withdrawal|3|||
24944818|NCT00348309|50037406|FG001|Overall Study|Caregiver withdrawal|0|||
24944819|NCT00348309|50037407|FG002|Overall Study|Caregiver withdrawal|7|||
24944820|NCT00348309|50037405|FG000|Overall Study|Unable to complete ET visit|1|||
24944821|NCT00348309|50037406|FG001|Overall Study|Unable to complete ET visit|0|||
24944822|NCT00348309|50037407|FG002|Overall Study|Unable to complete ET visit|0|||
24944823|NCT00348309|50037405|FG000|Overall Study|PI closing medical practice|1|||
24944824|NCT00348309|50037406|FG001|Overall Study|PI closing medical practice|0|||
24944825|NCT00348309|50037407|FG002|Overall Study|PI closing medical practice|0|||
24944826|NCT00348309|50037405|FG000|Overall Study|Principal investigator's decision|1|||
24944827|NCT00348309|50037406|FG001|Overall Study|Principal investigator's decision|0|||
24944828|NCT00348309|50037407|FG002|Overall Study|Principal investigator's decision|0|||
24944829|NCT00348309|50037405|FG000|Overall Study|No disponibility of medication|1|||
24944830|NCT00348309|50037406|FG001|Overall Study|No disponibility of medication|0|||
24944831|NCT00348309|50037407|FG002|Overall Study|No disponibility of medication|0|||
24944832|NCT00348309|50037405|FG000|Overall Study|Worsened neurodegenerative disease|1|||
24944833|NCT00348309|50037406|FG001|Overall Study|Worsened neurodegenerative disease|0|||
24944834|NCT00348309|50037407|FG002|Overall Study|Worsened neurodegenerative disease|0|||
24944835|NCT00348309|50037405|FG000|Overall Study|Cognitive and behaviour worsening|2|||
24944836|NCT00348309|50037406|FG001|Overall Study|Cognitive and behaviour worsening|0|||
24944837|NCT00348309|50037407|FG002|Overall Study|Cognitive and behaviour worsening|0|||
24944838|NCT00348309|50037405|FG000|Overall Study|Worsening of alzheimer|1|||
24944839|NCT00348309|50037406|FG001|Overall Study|Worsening of alzheimer|0|||
24944840|NCT00348309|50037407|FG002|Overall Study|Worsening of alzheimer|1|||
24944841|NCT00348309|50037405|FG000|Overall Study|Did not appear in time for Visit 3|1|||
24944842|NCT00348309|50037406|FG001|Overall Study|Did not appear in time for Visit 3|0|||
24944843|NCT00348309|50037407|FG002|Overall Study|Did not appear in time for Visit 3|0|||
24944844|NCT00348309|50037405|FG000|Overall Study|Participant died|2|||
24944845|NCT00348309|50037406|FG001|Overall Study|Participant died|1|||
24944846|NCT00348309|50037407|FG002|Overall Study|Participant died|1|||
24944847|NCT00348309|50037405|FG000|Overall Study|Decision of sponsor|1|||
24944848|NCT00348309|50037406|FG001|Overall Study|Decision of sponsor|0|||
24944849|NCT00348309|50037407|FG002|Overall Study|Decision of sponsor|0|||
24944850|NCT00348309|50037405|FG000|Overall Study|Ineffectiveness of treatment|0|||
24944851|NCT00348309|50037406|FG001|Overall Study|Ineffectiveness of treatment|1|||
25030989|NCT02959814|50129677|FG000|Overall Study|In-procedure QFR not computed|6|||
25030990|NCT02959814|50129677|FG000|Overall Study|Excluded by FFR core-lab|24|||
25030991|NCT03666624|50129684|FG000|Overall Study|participant grieving over recent death of parent|1|||
25275601|NCT00975130|50589451|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
24944852|NCT00348309|50037407|FG002|Overall Study|Ineffectiveness of treatment|0|||
24944853|NCT00348309|50037405|FG000|Overall Study|A foul of exclusion criteria|0|||
24944854|NCT00348309|50037406|FG001|Overall Study|A foul of exclusion criteria|1|||
24944855|NCT00348309|50037407|FG002|Overall Study|A foul of exclusion criteria|0|||
24944856|NCT00348309|50037405|FG000|Overall Study|Participant was hospitalized|0|||
24944857|NCT00348309|50037406|FG001|Overall Study|Participant was hospitalized|1|||
25275602|NCT00975130|50589452|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
25030992|NCT03666624|50129685|FG001|Overall Study|participant grieving over recent death of parent|0|||
25030993|NCT03368807|50129691|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
25030994|NCT03368807|50129691|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
25030995|NCT03368807|50129691|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
25030996|NCT03368807|50129691|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
25030997|NCT03338855|50129699|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
25030998|NCT03338855|50129700|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
25030999|NCT03367793|50129712|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
25031000|NCT03367793|50129713|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
25031001|NCT03367793|50129714|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
25031002|NCT03367793|50129715|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
25031003|NCT03367793|50129716|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
25031004|NCT03367793|50129717|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
25031005|NCT01347307|50129739|FG000|Overall Study|Death|0|||
25031006|NCT01347307|50129740|FG001|Overall Study|Death|4|||
25031007|NCT01347307|50129739|FG000|Overall Study|Physician Decision|0|||
24944858|NCT00348309|50037407|FG002|Overall Study|Participant was hospitalized|0|||
24944859|NCT00348309|50037405|FG000|Overall Study|Sponsor refuseal|0|||
24944860|NCT00348309|50037406|FG001|Overall Study|Sponsor refuseal|1|||
24944861|NCT00348309|50037407|FG002|Overall Study|Sponsor refuseal|1|||
24944862|NCT00348309|50037405|FG000|Overall Study|Forgot often medication|0|||
24944863|NCT00348309|50037406|FG001|Overall Study|Forgot often medication|1|||
24944864|NCT00348309|50037407|FG002|Overall Study|Forgot often medication|0|||
24944865|NCT00348309|50037405|FG000|Overall Study|Medical Monitor decision|0|||
24944866|NCT00348309|50037406|FG001|Overall Study|Medical Monitor decision|0|||
24944867|NCT00348309|50037407|FG002|Overall Study|Medical Monitor decision|1|||
24944868|NCT00348309|50037405|FG000|Overall Study|Increased dose of Aricept|0|||
24944869|NCT00348309|50037406|FG001|Overall Study|Increased dose of Aricept|0|||
24944870|NCT00348309|50037407|FG002|Overall Study|Increased dose of Aricept|1|||
24944871|NCT00348309|50037405|FG000|Overall Study|Site closure|0|||
24944872|NCT00348309|50037406|FG001|Overall Study|Site closure|0|||
24944873|NCT00348309|50037407|FG002|Overall Study|Site closure|1|||
24944874|NCT00348309|50037405|FG000|Overall Study|Adverse event not attended|0|||
24944875|NCT00348309|50037406|FG001|Overall Study|Adverse event not attended|0|||
24944876|NCT00348309|50037407|FG002|Overall Study|Adverse event not attended|1|||
24944877|NCT00348309|50037405|FG000|Overall Study|ECG abnormal|0|||
24944878|NCT00348309|50037406|FG001|Overall Study|ECG abnormal|0|||
24944879|NCT00348309|50037407|FG002|Overall Study|ECG abnormal|2|||
24944880|NCT00348309|50037405|FG000|Overall Study|Cardiologist recommendations|0|||
24944881|NCT00348309|50037406|FG001|Overall Study|Cardiologist recommendations|0|||
24944882|NCT00348309|50037407|FG002|Overall Study|Cardiologist recommendations|1|||
24944883|NCT00348309|50037405|FG000|Overall Study|HCV career|0|||
25031008|NCT01347307|50129740|FG001|Overall Study|Physician Decision|1|||
25031009|NCT03247543|50129797|FG000|Overall Study|Adverse Event|3|||
25031010|NCT03247543|50129798|FG001|Overall Study|Adverse Event|6|||
25031011|NCT03247543|50129799|FG002|Overall Study|Adverse Event|4|||
25031012|NCT03247543|50129797|FG000|Overall Study|Lost to Follow-up|10|||
25031013|NCT03247543|50129798|FG001|Overall Study|Lost to Follow-up|7|||
25031014|NCT03247543|50129799|FG002|Overall Study|Lost to Follow-up|8|||
25031015|NCT03247543|50129797|FG000|Overall Study|Consent withdrawn by caregiver|2|||
25031016|NCT03247543|50129798|FG001|Overall Study|Consent withdrawn by caregiver|2|||
25031017|NCT03247543|50129799|FG002|Overall Study|Consent withdrawn by caregiver|9|||
25031018|NCT03247543|50129797|FG000|Overall Study|Withdrawal by Subject|0|||
25031019|NCT03247543|50129798|FG001|Overall Study|Withdrawal by Subject|0|||
25031020|NCT03247543|50129799|FG002|Overall Study|Withdrawal by Subject|1|||
25031021|NCT03247543|50129797|FG000|Overall Study|Failure to Follow study procedures|1|||
25031022|NCT03247543|50129798|FG001|Overall Study|Failure to Follow study procedures|3|||
25031023|NCT03247543|50129799|FG002|Overall Study|Failure to Follow study procedures|1|||
25031024|NCT03247543|50129797|FG000|Overall Study|Lack of Efficacy|1|||
25031025|NCT03247543|50129798|FG001|Overall Study|Lack of Efficacy|0|||
25031026|NCT03247543|50129799|FG002|Overall Study|Lack of Efficacy|0|||
25031027|NCT03247543|50129797|FG000|Overall Study|Non-compliance with study visits|0|||
24944884|NCT00348309|50037406|FG001|Overall Study|HCV career|0|||
24944885|NCT00348309|50037407|FG002|Overall Study|HCV career|1|||
25031028|NCT03247543|50129798|FG001|Overall Study|Non-compliance with study visits|1|||
25031029|NCT03247543|50129799|FG002|Overall Study|Non-compliance with study visits|0|||
25031030|NCT01347073|50129809|FG000|Overall Study|Adverse Event|1|||
24944886|NCT00440310|50037418|FG000|Overall Study|Lost to Follow-up|4|||
24944887|NCT00440310|50037419|FG001|Overall Study|Lost to Follow-up|5|||
24944888|NCT00440310|50037418|FG000|Overall Study|Protocol Violation|0|||
25031031|NCT01347073|50129809|FG000|Overall Study|Liver Transplant|1|||
25031032|NCT01315236|50129821|FG000|Double-blind Phase|Death|1|||
25031033|NCT01315236|50129822|FG001|Double-blind Phase|Death|0|||
25031034|NCT01315236|50129821|FG000|Double-blind Phase|Adverse Event|1|||
25186198|NCT01420679|50336126|FG000|Overall Study|Other|1|||
24944889|NCT00440310|50037419|FG001|Overall Study|Protocol Violation|1|||
24944890|NCT00440310|50037418|FG000|Overall Study|Withdrawal by Subject|15|||
24944891|NCT00440310|50037419|FG001|Overall Study|Withdrawal by Subject|14|||
24944892|NCT00440310|50037418|FG000|Overall Study|No Reply at EOS|7|||
24944893|NCT00440310|50037419|FG001|Overall Study|No Reply at EOS|7|||
24944894|NCT00440310|50037418|FG000|Overall Study|Other|1|||
25031035|NCT01315236|50129822|FG001|Double-blind Phase|Adverse Event|0|||
25031036|NCT01315236|50129821|FG000|Double-blind Phase|Withdrawal of Consent|1|||
25031037|NCT01315236|50129822|FG001|Double-blind Phase|Withdrawal of Consent|0|||
25031038|NCT01315236|50129821|FG000|Double-blind Phase|Lost to Follow-up|1|||
24944895|NCT00440310|50037419|FG001|Overall Study|Other|0|||
24944896|NCT00440310|50037418|FG000|Overall Study|Status Unknown|1|||
24944897|NCT00440310|50037419|FG001|Overall Study|Status Unknown|3|||
24944898|NCT00440232|50037427|FG000|Overall Study|Lost to Follow-up|1|||
24944899|NCT00440232|50037428|FG001|Overall Study|Lost to Follow-up|1|||
24944900|NCT00440232|50037427|FG000|Overall Study|Unable to treat within allowed time|0|||
24944901|NCT00440232|50037428|FG001|Overall Study|Unable to treat within allowed time|1|||
24944902|NCT00440232|50037427|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
24944903|NCT00440232|50037428|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
24944904|NCT00356889|50037434|FG000|Overall Study|Protocol Violation|2|||
24944905|NCT00356889|50037434|FG000|Overall Study|Adverse Event|1|||
24944906|NCT00356811|50037439|FG000|Overall Study|Death|35|||
24944907|NCT00356811|50037439|FG000|Overall Study|Lost to Follow-up|2|||
24944908|NCT00356811|50037439|FG000|Overall Study|Withdrawal by Subject|6|||
24944909|NCT00356811|50037439|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
24944910|NCT00356811|50037439|FG000|Overall Study|Study Is Terminating|3|||
24944911|NCT00356811|50037439|FG000|Overall Study|Site Closed during Follow-up|2|||
24944912|NCT00439218|50037444|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
25031039|NCT01315236|50129822|FG001|Double-blind Phase|Lost to Follow-up|0|||
25031040|NCT01315236|50129821|FG000|Open-label Phase|Death|1|||
25031041|NCT01315236|50129822|FG001|Open-label Phase|Death|0|||
25031042|NCT01315236|50129821|FG000|Open-label Phase|Adverse Event|0|||
25031043|NCT01315236|50129822|FG001|Open-label Phase|Adverse Event|1|||
25031044|NCT01315236|50129821|FG000|Open-label Phase|Other|0|||
25031045|NCT01315236|50129822|FG001|Open-label Phase|Other|1|||
25031046|NCT01315236|50129821|FG000|12-Month Follow-up Period|Death|0|||
25031047|NCT01315236|50129822|FG001|12-Month Follow-up Period|Death|1|||
25031048|NCT01315236|50129821|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
25031049|NCT01315236|50129822|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
25031050|NCT03232567|50129834|FG000|Overall Study|Withdrawal by Subject|0|||
25031051|NCT03232567|50129835|FG001|Overall Study|Withdrawal by Subject|1|||
25031052|NCT03232567|50129836|FG002|Overall Study|Withdrawal by Subject|0|||
25031053|NCT03232567|50129837|FG003|Overall Study|Withdrawal by Subject|0|||
25031054|NCT01348490|50129858|FG000|Overall Study|Death|1|||
25031055|NCT01348490|50129858|FG000|Overall Study|Adverse Event|3|||
25031056|NCT01348490|50129858|FG000|Overall Study|Consent withdrawn|7|||
25031057|NCT01348490|50129858|FG000|Overall Study|Disease progression|3|||
25031058|NCT01348490|50129858|FG000|Overall Study|Lost to Follow-up|1|||
25031059|NCT01348490|50129858|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
25031060|NCT01348490|50129858|FG000|Overall Study|Other Unspecified|8|||
25031061|NCT03040674|50129879|FG000|Overall Study|Lost to Follow-up|225|||
25031062|NCT03040674|50129879|FG000|Overall Study|Death|23|||
25031063|NCT03232333|50129884|FG000|Overall Study|Infection or Osteomyelitis|9|||
25031064|NCT03232333|50129884|FG000|Overall Study|Lost to Follow-up|4|||
25031065|NCT03232333|50129884|FG000|Overall Study|Withdrawal by Subject|2|||
25031066|NCT03364049|50129892|FG000|Overall Study|Death|6|||
25031067|NCT03364049|50129893|FG001|Overall Study|Death|4|||
25031068|NCT03364049|50129894|FG002|Overall Study|Death|5|||
25031069|NCT03364049|50129895|FG003|Overall Study|Death|14|||
25031070|NCT03364049|50129892|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
25159359|NCT01441635|50279244|FG004|Overall Study|Withdrawal by Subject|0|||
25159360|NCT01441635|50279245|FG005|Overall Study|Withdrawal by Subject|0|||
25186199|NCT01420679|50336127|FG001|Overall Study|Other|0|||
24944913|NCT00535223|50037463|FG000|Overall Study|Withdrawal by Subject|4|||
24944914|NCT00535223|50037464|FG001|Overall Study|Withdrawal by Subject|1|||
24944915|NCT00536939|50037470|FG000|Overall Study|Withdrawal by Subject|1|||
24944916|NCT00536939|50037471|FG001|Overall Study|Withdrawal by Subject|0|||
24944917|NCT00536939|50037470|FG000|Overall Study|Other Complicating Disease|1|||
25031071|NCT03364049|50129893|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
25031072|NCT03364049|50129894|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
25031073|NCT03364049|50129895|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
25031074|NCT03364049|50129892|FG000|Overall Study|Withdrawal by Subject|0|||
25031075|NCT03364049|50129893|FG001|Overall Study|Withdrawal by Subject|1|||
25031076|NCT03364049|50129894|FG002|Overall Study|Withdrawal by Subject|1|||
24944918|NCT00536939|50037471|FG001|Overall Study|Other Complicating Disease|0|||
24944919|NCT00347919|50037479|FG000|Overall Study|Lost to Follow-up|11|||
25031077|NCT03364049|50129895|FG003|Overall Study|Withdrawal by Subject|1|||
25031078|NCT03238963|50129907|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
25031079|NCT03238963|50129908|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
25031080|NCT03238963|50129907|FG000|Overall Study|Withdrawal by Subject|1|||
25031081|NCT03238963|50129908|FG001|Overall Study|Withdrawal by Subject|1|||
25031082|NCT03238963|50129907|FG000|Overall Study|Lost to Follow-up|1|||
25031083|NCT03238963|50129908|FG001|Overall Study|Lost to Follow-up|0|||
25031084|NCT03238963|50129907|FG000|Overall Study|Protocol Violation|1|||
24944920|NCT00347919|50037480|FG001|Overall Study|Lost to Follow-up|13|||
24944921|NCT00347919|50037481|FG002|Overall Study|Lost to Follow-up|0|||
24944922|NCT00347919|50037479|FG000|Overall Study|Withdrawal by Subject|6|||
24944923|NCT00347919|50037480|FG001|Overall Study|Withdrawal by Subject|8|||
24944924|NCT00347919|50037481|FG002|Overall Study|Withdrawal by Subject|0|||
24944925|NCT00347919|50037479|FG000|Overall Study|Physician Decision|1|||
24944926|NCT00347919|50037480|FG001|Overall Study|Physician Decision|1|||
24944927|NCT00347919|50037481|FG002|Overall Study|Physician Decision|0|||
24944928|NCT00347919|50037479|FG000|Overall Study|Sponsor terminated study|15|||
24944929|NCT00347919|50037480|FG001|Overall Study|Sponsor terminated study|10|||
24944930|NCT00347919|50037481|FG002|Overall Study|Sponsor terminated study|16|||
24944931|NCT00347919|50037479|FG000|Overall Study|Death|35|||
24944932|NCT00347919|50037480|FG001|Overall Study|Death|42|||
24944933|NCT00347919|50037481|FG002|Overall Study|Death|19|||
24944934|NCT00347919|50037479|FG000|Overall Study|Par. Started Other Treatment|1|||
24944935|NCT00347919|50037480|FG001|Overall Study|Par. Started Other Treatment|1|||
24944936|NCT00347919|50037481|FG002|Overall Study|Par. Started Other Treatment|1|||
24944937|NCT00347919|50037479|FG000|Overall Study|Missing|2|||
24944938|NCT00347919|50037480|FG001|Overall Study|Missing|1|||
24944939|NCT00347919|50037481|FG002|Overall Study|Missing|2|||
24944940|NCT00439140|50037494|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
24944941|NCT00439140|50037495|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
24944942|NCT00439140|50037496|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
25031085|NCT03238963|50129908|FG001|Overall Study|Protocol Violation|1|||
25031086|NCT03238963|50129907|FG000|Overall Study|Adverse Event|1|||
25031087|NCT03238963|50129908|FG001|Overall Study|Adverse Event|0|||
25031088|NCT03337139|50129916|FG000|Phase I|Withdrawal by Subject|10|||
25031089|NCT03337139|50129917|FG001|Phase I|Withdrawal by Subject|0|||
25031090|NCT03042312|50129925|FG000|Overall Study|Administrative Reason|1|||
25031091|NCT03042312|50129926|FG001|Overall Study|Administrative Reason|1|||
25031092|NCT03042312|50129925|FG000|Overall Study|Adverse Event|0|||
25031093|NCT03042312|50129926|FG001|Overall Study|Adverse Event|1|||
25031094|NCT03042312|50129925|FG000|Overall Study|Lost to Follow-up|1|||
25031095|NCT03042312|50129926|FG001|Overall Study|Lost to Follow-up|3|||
25031096|NCT03042312|50129925|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
25031097|NCT03042312|50129926|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
25031098|NCT03042312|50129925|FG000|Overall Study|Withdrawal by Subject|4|||
25031099|NCT03042312|50129926|FG001|Overall Study|Withdrawal by Subject|5|||
25031100|NCT03360071|50129934|FG000|Overall Study|Lost to Follow-up|1|||
25031101|NCT03360071|50129935|FG001|Overall Study|Lost to Follow-up|0|||
25031102|NCT02949011|50129944|FG000|Overall Study|Adverse Event|6|||
25031103|NCT02949011|50129945|FG001|Overall Study|Adverse Event|7|||
25031104|NCT02949011|50129946|FG002|Overall Study|Adverse Event|3|||
25031105|NCT02949011|50129944|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
25031106|NCT02949011|50129945|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
25031107|NCT02949011|50129946|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
25031108|NCT02949011|50129944|FG000|Overall Study|Protocol Deviation|5|||
25031109|NCT02949011|50129945|FG001|Overall Study|Protocol Deviation|3|||
25031110|NCT02949011|50129946|FG002|Overall Study|Protocol Deviation|3|||
25031111|NCT02949011|50129944|FG000|Overall Study|Lack of Efficacy|0|||
25031112|NCT02949011|50129945|FG001|Overall Study|Lack of Efficacy|2|||
25031113|NCT02949011|50129946|FG002|Overall Study|Lack of Efficacy|0|||
25031114|NCT02949011|50129944|FG000|Overall Study|Withdrawal by Subject|13|||
25031115|NCT02949011|50129945|FG001|Overall Study|Withdrawal by Subject|13|||
25031116|NCT02949011|50129946|FG002|Overall Study|Withdrawal by Subject|21|||
25031117|NCT02949011|50129944|FG000|Overall Study|Lost to Follow-up|7|||
25031118|NCT02949011|50129945|FG001|Overall Study|Lost to Follow-up|5|||
25031119|NCT02949011|50129946|FG002|Overall Study|Lost to Follow-up|5|||
25031120|NCT02949011|50129944|FG000|Overall Study|Death|0|||
25031121|NCT02949011|50129945|FG001|Overall Study|Death|0|||
25031122|NCT02949011|50129946|FG002|Overall Study|Death|1|||
25031123|NCT02949011|50129944|FG000|Overall Study|Miscellaneous|2|||
25031124|NCT02949011|50129945|FG001|Overall Study|Miscellaneous|4|||
25031125|NCT02949011|50129946|FG002|Overall Study|Miscellaneous|6|||
25031126|NCT03357731|50129958|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
24944943|NCT00439140|50037494|FG000|Treatment Cycle 1|Personal reasons|0|||
24944944|NCT00439140|50037495|FG001|Treatment Cycle 1|Personal reasons|2|||
24944945|NCT00439140|50037496|FG002|Treatment Cycle 1|Personal reasons|0|||
24944946|NCT00439140|50037494|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
25031127|NCT03357731|50129959|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
25031128|NCT03357731|50129960|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
25031129|NCT03357731|50129961|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
25031130|NCT03357731|50129962|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
25031131|NCT03357731|50129963|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
25031132|NCT03357731|50129958|FG000|Overall Study|Acute bradycardia and hypotension|0|||
24944947|NCT00439140|50037495|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
24944948|NCT00439140|50037496|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
24944949|NCT00439140|50037494|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
25031133|NCT03357731|50129959|FG001|Overall Study|Acute bradycardia and hypotension|0|||
25031134|NCT03357731|50129960|FG002|Overall Study|Acute bradycardia and hypotension|0|||
25031135|NCT03357731|50129961|FG003|Overall Study|Acute bradycardia and hypotension|1|||
25031136|NCT03357731|50129962|FG004|Overall Study|Acute bradycardia and hypotension|0|||
25031137|NCT03357731|50129963|FG005|Overall Study|Acute bradycardia and hypotension|0|||
25031138|NCT03357731|50129958|FG000|Overall Study|Adverse Event|0|||
25031139|NCT03357731|50129959|FG001|Overall Study|Adverse Event|0|||
25031140|NCT03357731|50129960|FG002|Overall Study|Adverse Event|0|||
25031141|NCT03357731|50129961|FG003|Overall Study|Adverse Event|0|||
25031142|NCT03357731|50129962|FG004|Overall Study|Adverse Event|0|||
25031143|NCT03357731|50129963|FG005|Overall Study|Adverse Event|1|||
25031144|NCT03357731|50129958|FG000|Overall Study|Hypotension|0|||
25031145|NCT03357731|50129959|FG001|Overall Study|Hypotension|0|||
25031146|NCT03357731|50129960|FG002|Overall Study|Hypotension|1|||
25031147|NCT03357731|50129961|FG003|Overall Study|Hypotension|1|||
25031148|NCT03357731|50129962|FG004|Overall Study|Hypotension|0|||
25031149|NCT03357731|50129963|FG005|Overall Study|Hypotension|0|||
25031150|NCT03357731|50129958|FG000|Overall Study|Lost to Follow-up|0|||
25031151|NCT03357731|50129959|FG001|Overall Study|Lost to Follow-up|0|||
25031152|NCT03357731|50129960|FG002|Overall Study|Lost to Follow-up|0|||
25031153|NCT03357731|50129961|FG003|Overall Study|Lost to Follow-up|1|||
25031154|NCT03357731|50129962|FG004|Overall Study|Lost to Follow-up|0|||
25031155|NCT03357731|50129963|FG005|Overall Study|Lost to Follow-up|0|||
25031156|NCT03357341|50129973|FG000|Overall Study|Withdrawal by Subject|3|||
25031157|NCT03357341|50129974|FG001|Overall Study|Withdrawal by Subject|6|||
25031158|NCT03357341|50129973|FG000|Overall Study|Lost to Follow-up|4|||
25031159|NCT03357341|50129974|FG001|Overall Study|Lost to Follow-up|5|||
25031160|NCT03357341|50129973|FG000|Overall Study|Death|0|||
25031161|NCT03357341|50129974|FG001|Overall Study|Death|1|||
25031162|NCT03039738|50129983|FG000|Overall Study|Incomplete data sets|54|||
25031163|NCT03039738|50129984|FG001|Overall Study|Incomplete data sets|0|||
25031164|NCT02946515|50130001|FG000|Overall Study|Lost to Follow-up|2|||
25031165|NCT02946515|50130002|FG001|Overall Study|Lost to Follow-up|1|||
25031166|NCT03036852|50130014|FG000|Overall Study|Death|2|||
25031167|NCT03036852|50130014|FG000|Overall Study|Lack of Efficacy|2|||
25031168|NCT03036852|50130014|FG000|Overall Study|Adverse Event|1|||
25031169|NCT03036852|50130014|FG000|Overall Study|Lost to Follow-up|1|||
25031170|NCT02945657|50130025|FG000|Overall Study|Adverse Event|1|||
25031171|NCT02945657|50130025|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
25031172|NCT02948777|50130030|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
25031173|NCT03324581|50130038|FG000|Overall Study|Adverse Event|18|||
25031174|NCT03324581|50130039|FG001|Overall Study|Adverse Event|11|||
25031175|NCT03324581|50130040|FG002|Overall Study|Adverse Event|7|||
25031176|NCT03324581|50130038|FG000|Overall Study|Lack of Efficacy|0|||
25031177|NCT03324581|50130039|FG001|Overall Study|Lack of Efficacy|1|||
25031178|NCT03324581|50130040|FG002|Overall Study|Lack of Efficacy|0|||
25031179|NCT03324581|50130038|FG000|Overall Study|Lost to Follow-up|5|||
25031180|NCT03324581|50130039|FG001|Overall Study|Lost to Follow-up|3|||
25031181|NCT03324581|50130040|FG002|Overall Study|Lost to Follow-up|6|||
24944950|NCT00439140|50037495|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
24944951|NCT00439140|50037496|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
24944952|NCT00439140|50037494|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
24944953|NCT00439140|50037495|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
24944954|NCT00439140|50037496|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
24944955|NCT00356421|50037506|FG000|Overall Study|Lack of Efficacy|3|||
24944956|NCT00356421|50037507|FG001|Overall Study|Lack of Efficacy|0|||
24944957|NCT00356421|50037506|FG000|Overall Study|Withdrawal by Subject|9|||
24944958|NCT00356421|50037507|FG001|Overall Study|Withdrawal by Subject|2|||
24944959|NCT00356421|50037506|FG000|Overall Study|Related to study drug|15|||
24944960|NCT00356421|50037507|FG001|Overall Study|Related to study drug|12|||
24944961|NCT00356421|50037506|FG000|Overall Study|Not related to study drug|5|||
24944962|NCT00356421|50037507|FG001|Overall Study|Not related to study drug|3|||
24944963|NCT00443820|50037517|FG000|Overall Study|Adverse Event|1|||
24944964|NCT00443820|50037518|FG001|Overall Study|Adverse Event|1|||
25031182|NCT03324581|50130038|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
25031183|NCT03324581|50130039|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
25031184|NCT03324581|50130040|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
25031185|NCT03324581|50130038|FG000|Overall Study|Physician Decision|0|||
25031186|NCT03324581|50130039|FG001|Overall Study|Physician Decision|1|||
25031187|NCT03324581|50130040|FG002|Overall Study|Physician Decision|2|||
25031188|NCT03324581|50130038|FG000|Overall Study|Protocol Deviation|8|||
25031189|NCT03324581|50130039|FG001|Overall Study|Protocol Deviation|9|||
25031190|NCT03324581|50130040|FG002|Overall Study|Protocol Deviation|4|||
25031191|NCT03324581|50130038|FG000|Overall Study|Withdrawal by Subject|6|||
25031192|NCT03324581|50130039|FG001|Overall Study|Withdrawal by Subject|8|||
24944965|NCT00443820|50037519|FG002|Overall Study|Adverse Event|0|||
24944966|NCT00443820|50037520|FG003|Overall Study|Adverse Event|0|||
24944967|NCT00443820|50037517|FG000|Overall Study|Lack of Efficacy|3|||
24944968|NCT00443820|50037518|FG001|Overall Study|Lack of Efficacy|2|||
24944969|NCT00443820|50037519|FG002|Overall Study|Lack of Efficacy|1|||
24944970|NCT00443820|50037520|FG003|Overall Study|Lack of Efficacy|1|||
25031193|NCT03324581|50130040|FG002|Overall Study|Withdrawal by Subject|6|||
25031194|NCT03324581|50130038|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
25031195|NCT03324581|50130039|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
25031196|NCT03324581|50130040|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
25031197|NCT02943473|50130048|FG000|Overall Study|enrolled but not dosed|1|||
25031198|NCT02943473|50130048|FG000|Overall Study|screen failure|1|||
25031199|NCT02943473|50130048|FG000|Overall Study|Physician Decision|4|||
25031200|NCT03073733|50130055|FG000|Overall Study|Lost to Follow-up|1|||
25031201|NCT03073733|50130056|FG001|Overall Study|Lost to Follow-up|0|||
25031202|NCT03073733|50130057|FG002|Overall Study|Lost to Follow-up|0|||
25031203|NCT03073733|50130055|FG000|Overall Study|Physician Decision|0|||
25031204|NCT03073733|50130056|FG001|Overall Study|Physician Decision|1|||
25031205|NCT03073733|50130057|FG002|Overall Study|Physician Decision|0|||
25031206|NCT03073733|50130055|FG000|Overall Study|Withdrawal by Subject|0|||
25031207|NCT03073733|50130056|FG001|Overall Study|Withdrawal by Subject|0|||
25031208|NCT03073733|50130057|FG002|Overall Study|Withdrawal by Subject|1|||
25031209|NCT03320369|50130067|FG000|Overall Study|Adverse Event|1|||
25031210|NCT03320369|50130067|FG000|Overall Study|Withdrawal by Subject|2|||
25031211|NCT02650895|50130077|FG000|Overall Study|Withdrawal by Subject|0|||
25031212|NCT02650895|50130078|FG001|Overall Study|Withdrawal by Subject|1|||
25031213|NCT02650895|50130079|FG002|Overall Study|Withdrawal by Subject|0|||
25031214|NCT02650895|50130080|FG003|Overall Study|Withdrawal by Subject|0|||
25031215|NCT02650895|50130081|FG004|Overall Study|Withdrawal by Subject|0|||
25031216|NCT02650895|50130082|FG005|Overall Study|Withdrawal by Subject|0|||
25031217|NCT03320057|50130101|FG000|Overall Study|Lost to Follow-up|4|||
25031218|NCT03320057|50130102|FG001|Overall Study|Lost to Follow-up|17|||
25031219|NCT03320057|50130101|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
25031220|NCT03320057|50130102|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
25275603|NCT00975130|50589453|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
25275604|NCT00975130|50589451|FG000|Study Part 2|Administrative|0|||
25275605|NCT00975130|50589452|FG001|Study Part 2|Administrative|1|||
25275606|NCT00975130|50589453|FG002|Study Part 2|Administrative|0|||
25275607|NCT00975130|50589451|FG000|Study Part 2|Protocol Violation|0|||
25275608|NCT00975130|50589452|FG001|Study Part 2|Protocol Violation|0|||
25275609|NCT00975130|50589453|FG002|Study Part 2|Protocol Violation|1|||
25275610|NCT01230827|50589470|FG000|Overall Study|Lost to Follow-up|0|||
25275611|NCT01230827|50589471|FG001|Overall Study|Lost to Follow-up|0|||
25275612|NCT01230827|50589472|FG002|Overall Study|Lost to Follow-up|1|||
25275613|NCT01230827|50589473|FG003|Overall Study|Lost to Follow-up|3|||
25275614|NCT01230827|50589470|FG000|Overall Study|Withdrawal by Subject|1|||
25275615|NCT01230827|50589471|FG001|Overall Study|Withdrawal by Subject|0|||
25275616|NCT01230827|50589472|FG002|Overall Study|Withdrawal by Subject|3|||
25275617|NCT01230827|50589473|FG003|Overall Study|Withdrawal by Subject|2|||
25275618|NCT01230827|50589470|FG000|Overall Study|Lack of Efficacy|14|||
25275619|NCT01230827|50589471|FG001|Overall Study|Lack of Efficacy|1|||
25275620|NCT01230827|50589472|FG002|Overall Study|Lack of Efficacy|2|||
24944971|NCT00443820|50037517|FG000|Overall Study|Protocol Violation|2|||
24944972|NCT00443820|50037518|FG001|Overall Study|Protocol Violation|1|||
24944973|NCT00443820|50037519|FG002|Overall Study|Protocol Violation|2|||
24944974|NCT00443820|50037520|FG003|Overall Study|Protocol Violation|1|||
25031221|NCT03316547|50130110|FG000|Overall Study|Death|3|||
25031222|NCT03316547|50130111|FG001|Overall Study|Death|1|||
24944975|NCT00443820|50037517|FG000|Overall Study|Withdrawal by Subject|6|||
25031223|NCT03316547|50130110|FG000|Overall Study|Lost to Follow-up|6|||
25031224|NCT03316547|50130111|FG001|Overall Study|Lost to Follow-up|6|||
25031225|NCT03316547|50130110|FG000|Overall Study|Withdrawal by Subject|3|||
25031226|NCT03316547|50130111|FG001|Overall Study|Withdrawal by Subject|2|||
25031227|NCT03316547|50130110|FG000|Overall Study|Transfer to another hospital|6|||
25275621|NCT01230827|50589473|FG003|Overall Study|Lack of Efficacy|3|||
25275622|NCT01230827|50589470|FG000|Overall Study|Adverse Event|4|||
25275623|NCT01230827|50589471|FG001|Overall Study|Adverse Event|2|||
25275624|NCT01230827|50589472|FG002|Overall Study|Adverse Event|3|||
25275625|NCT01230827|50589473|FG003|Overall Study|Adverse Event|7|||
24944976|NCT00443820|50037518|FG001|Overall Study|Withdrawal by Subject|7|||
24944977|NCT00443820|50037519|FG002|Overall Study|Withdrawal by Subject|8|||
24944978|NCT00443820|50037520|FG003|Overall Study|Withdrawal by Subject|9|||
24944979|NCT00443820|50037517|FG000|Overall Study|Lost to Follow-up|9|||
24944980|NCT00443820|50037518|FG001|Overall Study|Lost to Follow-up|8|||
24944981|NCT00443820|50037519|FG002|Overall Study|Lost to Follow-up|6|||
25275626|NCT01230827|50589470|FG000|Overall Study|Recovery|0|||
25275627|NCT01230827|50589471|FG001|Overall Study|Recovery|6|||
25275628|NCT01230827|50589472|FG002|Overall Study|Recovery|0|||
25275629|NCT01230827|50589473|FG003|Overall Study|Recovery|0|||
25275630|NCT01230827|50589470|FG000|Overall Study|Study terminated by Sponsor|0|||
25275631|NCT01230827|50589471|FG001|Overall Study|Study terminated by Sponsor|2|||
25275632|NCT01230827|50589472|FG002|Overall Study|Study terminated by Sponsor|56|||
25275633|NCT01230827|50589473|FG003|Overall Study|Study terminated by Sponsor|63|||
25275634|NCT01230749|50589485|FG000|Overall Study|Adverse Event|0|||
25275635|NCT01230749|50589486|FG001|Overall Study|Adverse Event|0|||
25275636|NCT01230749|50589487|FG002|Overall Study|Adverse Event|0|||
25275637|NCT01230749|50589488|FG003|Overall Study|Adverse Event|1|||
25275638|NCT01230749|50589485|FG000|Overall Study|Physician Decision|0|||
24944982|NCT00443820|50037520|FG003|Overall Study|Lost to Follow-up|5|||
24944983|NCT00443820|50037517|FG000|Overall Study|Administrative problems|0|||
25275639|NCT01230749|50589486|FG001|Overall Study|Physician Decision|0|||
24944984|NCT00443820|50037518|FG001|Overall Study|Administrative problems|0|||
24944985|NCT00443820|50037519|FG002|Overall Study|Administrative problems|0|||
24944986|NCT00443820|50037520|FG003|Overall Study|Administrative problems|1|||
25031228|NCT03316547|50130111|FG001|Overall Study|Transfer to another hospital|4|||
25275640|NCT01230749|50589487|FG002|Overall Study|Physician Decision|1|||
25275641|NCT01230749|50589488|FG003|Overall Study|Physician Decision|0|||
25275642|NCT01230749|50589485|FG000|Overall Study|Withdrawal by Subject|0|||
25031229|NCT02227199|50130135|FG000|Overall Study|Physician Decision|0|||
25031230|NCT02227199|50130136|FG001|Overall Study|Physician Decision|0|||
25031231|NCT02227199|50130137|FG002|Overall Study|Physician Decision|1|||
25031232|NCT02227199|50130135|FG000|Overall Study|Adverse Event|0|||
25031233|NCT02227199|50130136|FG001|Overall Study|Adverse Event|0|||
25031234|NCT02227199|50130137|FG002|Overall Study|Adverse Event|3|||
25031235|NCT03315689|50130151|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
25031236|NCT03315689|50130152|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
25031237|NCT03315689|50130151|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
25031238|NCT03315689|50130152|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
25031239|NCT03315689|50130151|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
25031240|NCT03315689|50130152|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
25031241|NCT03314519|50130162|FG000|Overall Study|Protocol Violation|3|||
25031242|NCT03314519|50130163|FG001|Overall Study|Protocol Violation|2|||
25031243|NCT03313037|50130175|FG000|Overall Study|Protocol Violation|4|||
25031244|NCT03313037|50130176|FG001|Overall Study|Protocol Violation|1|||
25031245|NCT03313037|50130175|FG000|Overall Study|Other|1|||
25031246|NCT03313037|50130176|FG001|Overall Study|Other|1|||
25031247|NCT03313037|50130175|FG000|Overall Study|Withdrawal by Subject|4|||
25031248|NCT03313037|50130176|FG001|Overall Study|Withdrawal by Subject|3|||
25031249|NCT03313037|50130175|FG000|Overall Study|No longer meets eligibility criteria|1|||
25031250|NCT03313037|50130176|FG001|Overall Study|No longer meets eligibility criteria|7|||
25031251|NCT03313037|50130175|FG000|Overall Study|Lost to Follow-up|9|||
25031252|NCT03313037|50130176|FG001|Overall Study|Lost to Follow-up|8|||
25159361|NCT01441635|50279246|FG006|Overall Study|Withdrawal by Subject|2|||
25159362|NCT01441635|50279247|FG007|Overall Study|Withdrawal by Subject|0|||
25159363|NCT01441635|50279248|FG008|Overall Study|Withdrawal by Subject|1|||
24944987|NCT00443820|50037517|FG000|Overall Study|Death|0|||
24944988|NCT00443820|50037518|FG001|Overall Study|Death|0|||
25031253|NCT03313037|50130175|FG000|Overall Study|Randomized but not treated|1|||
25159364|NCT01441635|50279249|FG009|Overall Study|Withdrawal by Subject|1|||
25275643|NCT01230749|50589486|FG001|Overall Study|Withdrawal by Subject|1|||
25275644|NCT01230749|50589487|FG002|Overall Study|Withdrawal by Subject|0|||
25275645|NCT01230749|50589488|FG003|Overall Study|Withdrawal by Subject|0|||
25159365|NCT01441635|50279240|FG000|Overall Study|Lost to Follow-up|0|||
25159366|NCT01441635|50279241|FG001|Overall Study|Lost to Follow-up|1|||
25159367|NCT01441635|50279242|FG002|Overall Study|Lost to Follow-up|1|||
25159368|NCT01441635|50279243|FG003|Overall Study|Lost to Follow-up|1|||
25159369|NCT01441635|50279244|FG004|Overall Study|Lost to Follow-up|1|||
25031254|NCT03313037|50130176|FG001|Overall Study|Randomized but not treated|0|||
25031255|NCT02420795|50130185|FG000|Overall Study|Withdrawal by Subject|1|||
25031256|NCT02420795|50130186|FG001|Overall Study|Withdrawal by Subject|0|||
25031257|NCT02420795|50130187|FG002|Overall Study|Withdrawal by Subject|0|||
25031258|NCT02420795|50130185|FG000|Overall Study|Adverse Event|1|||
25031259|NCT02420795|50130186|FG001|Overall Study|Adverse Event|0|||
25031260|NCT02420795|50130187|FG002|Overall Study|Adverse Event|0|||
25031261|NCT02420795|50130185|FG000|Overall Study|Progressive disease|2|||
25031262|NCT02420795|50130186|FG001|Overall Study|Progressive disease|2|||
25031263|NCT02420795|50130187|FG002|Overall Study|Progressive disease|4|||
25031264|NCT02420795|50130185|FG000|Overall Study|Death|0|||
25031265|NCT02420795|50130186|FG001|Overall Study|Death|0|||
25031266|NCT02420795|50130187|FG002|Overall Study|Death|1|||
25031267|NCT03334175|50130199|FG000|Overall Study|Lost to Follow-up|0|||
25031268|NCT03334175|50130200|FG001|Overall Study|Lost to Follow-up|1|||
25031269|NCT03333941|50130206|FG000|Overall Study|Lost to Follow-up|10|||
25031270|NCT03333941|50130206|FG000|Overall Study|Death|2|||
25031271|NCT03333941|50130206|FG000|Overall Study|Adverse Event|1|||
25031272|NCT02942771|50130215|FG000|Overall Study|Adverse Event|1|||
25031273|NCT02942771|50130216|FG001|Overall Study|Adverse Event|0|||
25031274|NCT02942771|50130217|FG002|Overall Study|Adverse Event|0|||
25031275|NCT02942771|50130218|FG003|Overall Study|Adverse Event|0|||
25031276|NCT02942771|50130219|FG004|Overall Study|Adverse Event|2|||
25031277|NCT02942771|50130215|FG000|Overall Study|Lost to Follow-up|1|||
25031278|NCT02942771|50130216|FG001|Overall Study|Lost to Follow-up|0|||
24944989|NCT00443820|50037519|FG002|Overall Study|Death|1|||
24944990|NCT00443820|50037520|FG003|Overall Study|Death|0|||
24944991|NCT00438672|50037532|FG000|Overall Study|Lost to Follow-up|7|||
24944992|NCT00438672|50037533|FG001|Overall Study|Lost to Follow-up|9|||
24944993|NCT00438360|50037541|FG000|Overall Study|Adverse Event|6|||
24944994|NCT00438360|50037542|FG001|Overall Study|Adverse Event|1|||
24944995|NCT00438360|50037541|FG000|Overall Study|Lack of Efficacy|42|||
24944996|NCT00438360|50037542|FG001|Overall Study|Lack of Efficacy|27|||
24944997|NCT00438360|50037541|FG000|Overall Study|Other|24|||
24944998|NCT00438360|50037542|FG001|Overall Study|Other|15|||
24944999|NCT00536471|50037552|FG000|Overall Study|Lost to Follow-up|48|||
24945000|NCT00536471|50037553|FG001|Overall Study|Lost to Follow-up|23|||
24945001|NCT00536471|50037554|FG002|Overall Study|Lost to Follow-up|48|||
24945002|NCT00536471|50037555|FG003|Overall Study|Lost to Follow-up|22|||
24945003|NCT00536471|50037552|FG000|Overall Study|Adverse Event|32|||
24945004|NCT00536471|50037553|FG001|Overall Study|Adverse Event|16|||
24945005|NCT00536471|50037554|FG002|Overall Study|Adverse Event|28|||
24945006|NCT00536471|50037555|FG003|Overall Study|Adverse Event|13|||
24945007|NCT00536471|50037552|FG000|Overall Study|Withdrawal by Subject|40|||
24945008|NCT00536471|50037553|FG001|Overall Study|Withdrawal by Subject|24|||
24945009|NCT00536471|50037554|FG002|Overall Study|Withdrawal by Subject|43|||
24945010|NCT00536471|50037555|FG003|Overall Study|Withdrawal by Subject|21|||
24945011|NCT00536471|50037552|FG000|Overall Study|Lack of Efficacy|17|||
24945012|NCT00536471|50037553|FG001|Overall Study|Lack of Efficacy|18|||
24945013|NCT00536471|50037554|FG002|Overall Study|Lack of Efficacy|11|||
24945014|NCT00536471|50037555|FG003|Overall Study|Lack of Efficacy|9|||
24945015|NCT00536471|50037552|FG000|Overall Study|Protocol Violation|8|||
24945016|NCT00536471|50037553|FG001|Overall Study|Protocol Violation|1|||
24945017|NCT00536471|50037554|FG002|Overall Study|Protocol Violation|2|||
24945018|NCT00536471|50037555|FG003|Overall Study|Protocol Violation|3|||
24945019|NCT00536471|50037552|FG000|Overall Study|Physician Decision|11|||
24945020|NCT00536471|50037553|FG001|Overall Study|Physician Decision|1|||
24945021|NCT00536471|50037554|FG002|Overall Study|Physician Decision|3|||
25031279|NCT02942771|50130217|FG002|Overall Study|Lost to Follow-up|0|||
25031280|NCT02942771|50130218|FG003|Overall Study|Lost to Follow-up|0|||
25031281|NCT02942771|50130219|FG004|Overall Study|Lost to Follow-up|0|||
24945022|NCT00536471|50037555|FG003|Overall Study|Physician Decision|2|||
24945023|NCT00536471|50037552|FG000|Overall Study|Death|0|||
25031282|NCT02942771|50130215|FG000|Overall Study|Withdrawal by Subject|1|||
25031283|NCT02942771|50130216|FG001|Overall Study|Withdrawal by Subject|0|||
25031284|NCT02942771|50130217|FG002|Overall Study|Withdrawal by Subject|0|||
25031285|NCT02942771|50130218|FG003|Overall Study|Withdrawal by Subject|0|||
24945024|NCT00536471|50037553|FG001|Overall Study|Death|0|||
24945025|NCT00536471|50037554|FG002|Overall Study|Death|1|||
24945026|NCT00536471|50037555|FG003|Overall Study|Death|2|||
24945027|NCT00536471|50037552|FG000|Overall Study|Sponsor Decision|0|||
24945028|NCT00536471|50037553|FG001|Overall Study|Sponsor Decision|1|||
24945029|NCT00536471|50037554|FG002|Overall Study|Sponsor Decision|3|||
24945030|NCT00536471|50037555|FG003|Overall Study|Sponsor Decision|2|||
25031286|NCT02942771|50130219|FG004|Overall Study|Withdrawal by Subject|2|||
25031287|NCT03036150|50130233|FG000|Overall Study|Withdrawal by Subject|8|||
24945031|NCT00359619|50037579|FG000|Overall Study|Adverse Event|0|||
24945032|NCT00359619|50037580|FG001|Overall Study|Adverse Event|0|||
24945033|NCT00359619|50037581|FG002|Overall Study|Adverse Event|1|||
24945034|NCT00359619|50037582|FG003|Overall Study|Adverse Event|0|||
24945035|NCT00359619|50037583|FG004|Overall Study|Adverse Event|0|||
24945036|NCT00359619|50037584|FG005|Overall Study|Adverse Event|0|||
24945037|NCT00359619|50037585|FG006|Overall Study|Adverse Event|1|||
24945038|NCT00359619|50037579|FG000|Overall Study|Withdrawal by Subject|3|||
24945039|NCT00359619|50037580|FG001|Overall Study|Withdrawal by Subject|1|||
24945040|NCT00359619|50037581|FG002|Overall Study|Withdrawal by Subject|4|||
24945041|NCT00359619|50037582|FG003|Overall Study|Withdrawal by Subject|2|||
24945042|NCT00359619|50037583|FG004|Overall Study|Withdrawal by Subject|2|||
24945043|NCT00359619|50037584|FG005|Overall Study|Withdrawal by Subject|0|||
24945044|NCT00359619|50037585|FG006|Overall Study|Withdrawal by Subject|3|||
24945045|NCT00359619|50037579|FG000|Overall Study|Other|1|||
24945046|NCT00359619|50037580|FG001|Overall Study|Other|0|||
24945047|NCT00359619|50037581|FG002|Overall Study|Other|0|||
24945048|NCT00359619|50037582|FG003|Overall Study|Other|0|||
24945049|NCT00359619|50037583|FG004|Overall Study|Other|0|||
24945050|NCT00359619|50037584|FG005|Overall Study|Other|0|||
24945051|NCT00359619|50037585|FG006|Overall Study|Other|0|||
24945052|NCT00359619|50037579|FG000|Overall Study|Lost to Follow-up|4|||
24945053|NCT00359619|50037580|FG001|Overall Study|Lost to Follow-up|4|||
24945054|NCT00359619|50037581|FG002|Overall Study|Lost to Follow-up|2|||
24945055|NCT00359619|50037582|FG003|Overall Study|Lost to Follow-up|1|||
24945056|NCT00359619|50037583|FG004|Overall Study|Lost to Follow-up|1|||
24945057|NCT00359619|50037584|FG005|Overall Study|Lost to Follow-up|5|||
24945058|NCT00359619|50037585|FG006|Overall Study|Lost to Follow-up|0|||
24945059|NCT00437658|50037604|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
24945060|NCT00437658|50037605|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
24945061|NCT00437658|50037606|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
24945062|NCT00437658|50037604|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
24945063|NCT00437658|50037605|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
24945064|NCT00437658|50037606|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
24945065|NCT00437658|50037604|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
24945066|NCT00437658|50037605|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
24945067|NCT00437658|50037606|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
24945068|NCT00437658|50037604|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
24945069|NCT00437658|50037605|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
24945070|NCT00437658|50037606|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
25031288|NCT03036150|50130234|FG001|Overall Study|Withdrawal by Subject|3|||
24945071|NCT00437658|50037604|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
24945072|NCT00437658|50037605|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
25031289|NCT03036150|50130233|FG000|Overall Study|Lost to Follow-up|2|||
25031290|NCT03036150|50130234|FG001|Overall Study|Lost to Follow-up|2|||
25031291|NCT03332771|50130244|FG000|Overall Study|Adverse Event|6|||
25031292|NCT03332771|50130245|FG001|Overall Study|Adverse Event|4|||
25031293|NCT03332771|50130246|FG002|Overall Study|Adverse Event|1|||
25031294|NCT03332771|50130247|FG003|Overall Study|Adverse Event|3|||
25031295|NCT03332771|50130244|FG000|Overall Study|Poor Compliance to Protocol|0|||
25031296|NCT03332771|50130245|FG001|Overall Study|Poor Compliance to Protocol|1|||
25031297|NCT03332771|50130246|FG002|Overall Study|Poor Compliance to Protocol|0|||
25031298|NCT03332771|50130247|FG003|Overall Study|Poor Compliance to Protocol|1|||
25031299|NCT03332771|50130244|FG000|Overall Study|Lost to Follow-up|2|||
25031300|NCT03332771|50130245|FG001|Overall Study|Lost to Follow-up|2|||
25031301|NCT03332771|50130246|FG002|Overall Study|Lost to Follow-up|1|||
25031302|NCT03332771|50130247|FG003|Overall Study|Lost to Follow-up|2|||
25031303|NCT03332771|50130244|FG000|Overall Study|At the Participant's own request|20|||
25031304|NCT03332771|50130245|FG001|Overall Study|At the Participant's own request|26|||
25031305|NCT03332771|50130246|FG002|Overall Study|At the Participant's own request|14|||
25031306|NCT03332771|50130247|FG003|Overall Study|At the Participant's own request|23|||
25031307|NCT03332771|50130244|FG000|Overall Study|Reason Not Specified|6|||
25031308|NCT03332771|50130245|FG001|Overall Study|Reason Not Specified|18|||
25031309|NCT03332771|50130246|FG002|Overall Study|Reason Not Specified|16|||
25031310|NCT03332771|50130247|FG003|Overall Study|Reason Not Specified|19|||
25031311|NCT03310775|50130259|FG000|Overall Study|Lost to Follow-up|2|||
24945073|NCT00437658|50037606|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
24945074|NCT00437658|50037604|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
24945075|NCT00437658|50037605|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
24945076|NCT00437658|50037606|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
24945077|NCT00437658|50037604|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
24945078|NCT00437658|50037605|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
24945079|NCT00437658|50037606|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
24945080|NCT00437658|50037604|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
24945081|NCT00437658|50037605|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
25031312|NCT03310775|50130260|FG001|Overall Study|Lost to Follow-up|3|||
25031313|NCT03310775|50130259|FG000|Overall Study|aggravation of depression|0|||
25031314|NCT03310775|50130260|FG001|Overall Study|aggravation of depression|1|||
25031315|NCT03330119|50130272|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
25031316|NCT03330119|50130273|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
25031317|NCT03040986|50130281|FG000|Overall Study|Hospice|1|||
25031318|NCT03040986|50130282|FG001|Overall Study|Hospice|0|||
25031319|NCT03040986|50130281|FG000|Overall Study|Adverse Event|2|||
25031320|NCT03040986|50130282|FG001|Overall Study|Adverse Event|1|||
25031321|NCT03040986|50130281|FG000|Overall Study|Disease progression on study|3|||
25031322|NCT03040986|50130282|FG001|Overall Study|Disease progression on study|1|||
25031323|NCT03039192|50130292|FG000|Overall Study|Lost to Follow-up|4|||
25031324|NCT03039192|50130293|FG001|Overall Study|Lost to Follow-up|4|||
25031325|NCT03039192|50130292|FG000|Overall Study|Adverse event, serious fatal|0|||
25031326|NCT03039192|50130293|FG001|Overall Study|Adverse event, serious fatal|1|||
25031327|NCT03039192|50130292|FG000|Overall Study|Adverse event, non-fatal|0|||
25031328|NCT03039192|50130293|FG001|Overall Study|Adverse event, non-fatal|2|||
25031329|NCT03039192|50130292|FG000|Overall Study|Withdrawal by Subject|6|||
25031330|NCT03039192|50130293|FG001|Overall Study|Withdrawal by Subject|9|||
25031331|NCT03039192|50130292|FG000|Overall Study|Discontinued from treatment phase|19|||
25031332|NCT03039192|50130293|FG001|Overall Study|Discontinued from treatment phase|12|||
25031333|NCT03039192|50130292|FG000|Overall Study|Other|3|||
25031334|NCT03039192|50130293|FG001|Overall Study|Other|2|||
25031335|NCT03698279|50130305|FG000|Overall Study|Withdrawal by parent/guardian|1|||
25031336|NCT03698279|50130306|FG001|Overall Study|Withdrawal by parent/guardian|1|||
25031337|NCT03698279|50130307|FG002|Overall Study|Withdrawal by parent/guardian|1|||
25031338|NCT03698279|50130308|FG003|Overall Study|Withdrawal by parent/guardian|1|||
25031339|NCT03698279|50130309|FG004|Overall Study|Withdrawal by parent/guardian|0|||
25031340|NCT03698279|50130310|FG005|Overall Study|Withdrawal by parent/guardian|0|||
25031341|NCT03698279|50130305|FG000|Overall Study|Protocol deviation|1|||
25031342|NCT03698279|50130306|FG001|Overall Study|Protocol deviation|0|||
25031343|NCT03698279|50130307|FG002|Overall Study|Protocol deviation|1|||
24945082|NCT00437658|50037606|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
24945083|NCT00437658|50037604|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
24945084|NCT00437658|50037605|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
24945085|NCT00437658|50037606|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
24945086|NCT00437658|50037604|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
24945087|NCT00437658|50037605|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
24945088|NCT00437658|50037606|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
24945089|NCT00437658|50037604|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
24945090|NCT00437658|50037605|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
25031344|NCT03698279|50130308|FG003|Overall Study|Protocol deviation|0|||
25031345|NCT03698279|50130309|FG004|Overall Study|Protocol deviation|0|||
25031346|NCT03698279|50130310|FG005|Overall Study|Protocol deviation|0|||
25031347|NCT03698279|50130305|FG000|Overall Study|Withdrawal by Subject|0|||
25031348|NCT03698279|50130306|FG001|Overall Study|Withdrawal by Subject|0|||
25031349|NCT03698279|50130307|FG002|Overall Study|Withdrawal by Subject|1|||
25031350|NCT03698279|50130308|FG003|Overall Study|Withdrawal by Subject|0|||
25031351|NCT03698279|50130309|FG004|Overall Study|Withdrawal by Subject|0|||
25031352|NCT03698279|50130310|FG005|Overall Study|Withdrawal by Subject|0|||
25031353|NCT03698279|50130305|FG000|Overall Study|Lost to Follow-up|3|||
25031354|NCT03698279|50130306|FG001|Overall Study|Lost to Follow-up|1|||
25031355|NCT03698279|50130307|FG002|Overall Study|Lost to Follow-up|4|||
25031356|NCT03698279|50130308|FG003|Overall Study|Lost to Follow-up|5|||
25031357|NCT03698279|50130309|FG004|Overall Study|Lost to Follow-up|0|||
25031358|NCT03698279|50130310|FG005|Overall Study|Lost to Follow-up|0|||
25031359|NCT01529034|50130329|FG000|Overall Study|Discontinued prior to study treatment|14|||
25031360|NCT01529034|50130329|FG000|Overall Study|Site closure|62|||
25031361|NCT01529034|50130329|FG000|Overall Study|Study termination|29|||
25031362|NCT01529034|50130329|FG000|Overall Study|Withdrawal by Subject|25|||
25031363|NCT01529034|50130329|FG000|Overall Study|No treated SCs within protocol window|13|||
25031364|NCT01529034|50130329|FG000|Overall Study|Noncompliance|8|||
25031365|NCT01529034|50130329|FG000|Overall Study|Caregiver no longer available|7|||
25031366|NCT01529034|50130329|FG000|Overall Study|Adverse Event|4|||
25159370|NCT01441635|50279245|FG005|Overall Study|Lost to Follow-up|3|||
25159371|NCT01441635|50279246|FG006|Overall Study|Lost to Follow-up|1|||
24945091|NCT00437658|50037606|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
25031367|NCT01529034|50130329|FG000|Overall Study|Protocol Violation|4|||
25031368|NCT01529034|50130329|FG000|Overall Study|Lack of Efficacy|4|||
25031369|NCT01529034|50130329|FG000|Overall Study|Investigator no longer available|2|||
25031370|NCT01529034|50130329|FG000|Overall Study|Study drug not available|2|||
25031371|NCT03036072|50130336|FG000|Overall Study|Death|0|||
25031372|NCT03036072|50130337|FG001|Overall Study|Death|1|||
25031373|NCT03036072|50130336|FG000|Overall Study|Withdrawal by Subject|0|||
25031374|NCT03036072|50130337|FG001|Overall Study|Withdrawal by Subject|1|||
25031375|NCT03036072|50130336|FG000|Overall Study|Physician Decision|0|||
25031376|NCT03036072|50130337|FG001|Overall Study|Physician Decision|1|||
25031377|NCT03038880|50130346|FG000|Overall Study|Death|1|||
25031378|NCT03038880|50130347|FG001|Overall Study|Death|2|||
25031379|NCT03038880|50130348|FG002|Overall Study|Death|0|||
25031380|NCT03038880|50130346|FG000|Overall Study|Physician Decision|2|||
25031381|NCT03038880|50130347|FG001|Overall Study|Physician Decision|1|||
25031382|NCT03038880|50130348|FG002|Overall Study|Physician Decision|0|||
25031383|NCT03035916|50130359|FG000|Overall Study|Puncture failed|0|||
25031384|NCT03035916|50130360|FG001|Overall Study|Puncture failed|2|||
25031385|NCT03035916|50130361|FG002|Overall Study|Puncture failed|0|||
25031386|NCT01702571|50130371|FG000|Overall Study|Death|1067|||
25031387|NCT01702571|50130372|FG001|Overall Study|Death|76|||
25031388|NCT01702571|50130371|FG000|Overall Study|Lost to Follow-up|144|||
25031389|NCT01702571|50130372|FG001|Overall Study|Lost to Follow-up|10|||
25031390|NCT01702571|50130371|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
25031391|NCT01702571|50130372|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
25031392|NCT01702571|50130371|FG000|Overall Study|Investigator Decision|5|||
25031393|NCT01702571|50130372|FG001|Overall Study|Investigator Decision|0|||
25031394|NCT01702571|50130371|FG000|Overall Study|Not Classifiable|1|||
25031395|NCT01702571|50130372|FG001|Overall Study|Not Classifiable|0|||
25031396|NCT01702571|50130371|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
25031397|NCT01702571|50130372|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
25031398|NCT01702571|50130371|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
25031399|NCT01702571|50130372|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
25031400|NCT01702571|50130371|FG000|Overall Study|Progressive Disease|3|||
25031401|NCT01702571|50130372|FG001|Overall Study|Progressive Disease|0|||
25031402|NCT01702571|50130371|FG000|Overall Study|Protocol Violation|2|||
25031403|NCT01702571|50130372|FG001|Overall Study|Protocol Violation|0|||
25031404|NCT01702571|50130371|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
25031405|NCT01702571|50130372|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
25031406|NCT01702571|50130371|FG000|Overall Study|Termination By Sponsor|4|||
25031407|NCT01702571|50130372|FG001|Overall Study|Termination By Sponsor|0|||
25031408|NCT01702571|50130371|FG000|Overall Study|Withdrawal by Subject|177|||
25031409|NCT01702571|50130372|FG001|Overall Study|Withdrawal by Subject|29|||
25031410|NCT03231943|50130395|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
25031411|NCT03231943|50130396|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
25031412|NCT03231943|50130397|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
25031413|NCT03231943|50130398|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
25031414|NCT03231943|50130399|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
25031415|NCT03231943|50130400|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
24945092|NCT00437658|50037604|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
24945093|NCT00437658|50037605|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
24945094|NCT00437658|50037606|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
24945095|NCT03828747|50037616|FG000|Double-Blind Treatment Period|Adverse Event|6|||
24945096|NCT03828747|50037617|FG001|Double-Blind Treatment Period|Adverse Event|6|||
24945097|NCT03828747|50037616|FG000|Double-Blind Treatment Period|Death|1|||
25031416|NCT03231943|50130401|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
25031417|NCT03231943|50130402|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
25031418|NCT03231943|50130403|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
25031419|NCT03231943|50130404|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
25031420|NCT03231943|50130405|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
25031421|NCT03231943|50130406|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
25031422|NCT03231943|50130407|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
25031423|NCT03231943|50130395|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
25031424|NCT03231943|50130396|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
25031425|NCT03231943|50130397|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
25186200|NCT01496846|50336144|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
24945098|NCT03828747|50037617|FG001|Double-Blind Treatment Period|Death|2|||
24945099|NCT03828747|50037616|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
24945100|NCT03828747|50037617|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
24945101|NCT03828747|50037616|FG000|Double-Blind Treatment Period|Withdrawal by Subject|19|||
24945102|NCT03828747|50037617|FG001|Double-Blind Treatment Period|Withdrawal by Subject|21|||
25031426|NCT03231943|50130398|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
25031427|NCT03231943|50130399|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
25031428|NCT03231943|50130400|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
25031429|NCT03231943|50130401|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
25031430|NCT03231943|50130402|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
25031431|NCT03231943|50130403|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
25031432|NCT03231943|50130404|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
25031433|NCT03231943|50130405|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
25031434|NCT03231943|50130406|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
25031435|NCT03231943|50130407|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
25031436|NCT03231943|50130395|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
25031437|NCT03231943|50130396|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
25031438|NCT03231943|50130397|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
25031439|NCT03231943|50130398|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
25031440|NCT03231943|50130399|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
25031441|NCT03231943|50130400|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
25031442|NCT03231943|50130401|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
25031443|NCT03231943|50130402|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
25031444|NCT03231943|50130403|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
25031445|NCT03231943|50130404|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
25031446|NCT03231943|50130405|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
25031447|NCT03231943|50130406|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
25031448|NCT03231943|50130407|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
25031449|NCT03231943|50130395|FG000|Part 2|Adverse Event|0|||
25031450|NCT03231943|50130396|FG001|Part 2|Adverse Event|0|||
25031451|NCT03231943|50130397|FG002|Part 2|Adverse Event|0|||
25031452|NCT03231943|50130398|FG003|Part 2|Adverse Event|0|||
25031453|NCT03231943|50130399|FG004|Part 2|Adverse Event|0|||
24945103|NCT03828747|50037616|FG000|Double-Blind Treatment Period|Physician Decision|0|||
24945104|NCT03828747|50037617|FG001|Double-Blind Treatment Period|Physician Decision|3|||
24945105|NCT03828747|50037616|FG000|Double-Blind Treatment Period|Various reasons|5|||
24945106|NCT03828747|50037617|FG001|Double-Blind Treatment Period|Various reasons|3|||
24945107|NCT03828747|50037616|FG000|Open-Label Extension|Continuing on Study|77|||
24945108|NCT03828747|50037617|FG001|Open-Label Extension|Continuing on Study|72|||
24945109|NCT03828747|50037616|FG000|Open-Label Extension|Adverse Event|3|||
24945110|NCT03828747|50037617|FG001|Open-Label Extension|Adverse Event|4|||
25031454|NCT03231943|50130400|FG005|Part 2|Adverse Event|0|||
25031455|NCT03231943|50130401|FG006|Part 2|Adverse Event|0|||
25031456|NCT03231943|50130402|FG007|Part 2|Adverse Event|0|||
25031457|NCT03231943|50130403|FG008|Part 2|Adverse Event|0|||
25031458|NCT03231943|50130404|FG009|Part 2|Adverse Event|0|||
25031459|NCT03231943|50130405|FG010|Part 2|Adverse Event|1|||
25031460|NCT03231943|50130406|FG011|Part 2|Adverse Event|0|||
25031461|NCT03231943|50130407|FG012|Part 2|Adverse Event|0|||
25031462|NCT03231943|50130395|FG000|Part 2|Withdrawal by Subject|0|||
25031463|NCT03231943|50130396|FG001|Part 2|Withdrawal by Subject|0|||
25031464|NCT03231943|50130397|FG002|Part 2|Withdrawal by Subject|0|||
25031465|NCT03231943|50130398|FG003|Part 2|Withdrawal by Subject|0|||
25031466|NCT03231943|50130399|FG004|Part 2|Withdrawal by Subject|0|||
25031467|NCT03231943|50130400|FG005|Part 2|Withdrawal by Subject|0|||
25031468|NCT03231943|50130401|FG006|Part 2|Withdrawal by Subject|0|||
25031469|NCT03231943|50130402|FG007|Part 2|Withdrawal by Subject|0|||
25031470|NCT03231943|50130403|FG008|Part 2|Withdrawal by Subject|0|||
25031471|NCT03231943|50130404|FG009|Part 2|Withdrawal by Subject|0|||
25031472|NCT03231943|50130405|FG010|Part 2|Withdrawal by Subject|0|||
25031473|NCT03231943|50130406|FG011|Part 2|Withdrawal by Subject|1|||
25031474|NCT03231943|50130407|FG012|Part 2|Withdrawal by Subject|0|||
25031475|NCT01578239|50130439|FG000|Treatment Period|Progressive Disease|19|||
25031476|NCT01578239|50130440|FG001|Treatment Period|Progressive Disease|64|||
25031477|NCT01578239|50130439|FG000|Treatment Period|Physician Decision|17|||
25031478|NCT01578239|50130440|FG001|Treatment Period|Physician Decision|17|||
25031479|NCT01578239|50130439|FG000|Treatment Period|Adverse Event|13|||
25031480|NCT01578239|50130440|FG001|Treatment Period|Adverse Event|10|||
25031481|NCT01578239|50130439|FG000|Treatment Period|Non-compliance|2|||
25031482|NCT01578239|50130440|FG001|Treatment Period|Non-compliance|0|||
25031483|NCT01578239|50130439|FG000|Treatment Period|Withdrawal by Subject|10|||
25031484|NCT01578239|50130440|FG001|Treatment Period|Withdrawal by Subject|9|||
25031485|NCT01578239|50130439|FG000|Treatment Period|Other|6|||
25031486|NCT01578239|50130440|FG001|Treatment Period|Other|1|||
25186201|NCT01496846|50336145|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
25031487|NCT01578239|50130439|FG000|Long-term Follow-Up Period|Death|69|||
25031488|NCT01578239|50130440|FG001|Long-term Follow-Up Period|Death|64|||
25031489|NCT01578239|50130439|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
25031490|NCT01578239|50130440|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
25031491|NCT01578239|50130439|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
25031492|NCT01578239|50130440|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
25031493|NCT01578239|50130439|FG000|Long-term Follow-Up Period|Other|2|||
25031494|NCT01578239|50130440|FG001|Long-term Follow-Up Period|Other|2|||
25031495|NCT03231709|50130448|FG000|Treatment Period 1|Reason not Specified|0|||
25031496|NCT03231709|50130449|FG001|Treatment Period 1|Reason not Specified|1|||
25186202|NCT01496846|50336146|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
24945111|NCT03828747|50037616|FG000|Open-Label Extension|Death|0|||
24945112|NCT03828747|50037617|FG001|Open-Label Extension|Death|2|||
25031497|NCT03231709|50130448|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
25031498|NCT03231709|50130449|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
25031499|NCT03241927|50130459|FG000|Overall Study|study terminated|1|||
25031500|NCT03241927|50130460|FG001|Overall Study|study terminated|0|||
25031501|NCT03329885|50130472|FG000|Overall Study|Sponsor discontinued the study early|0|||
25031502|NCT03329885|50130473|FG001|Overall Study|Sponsor discontinued the study early|0|||
25031503|NCT03329885|50130474|FG002|Overall Study|Sponsor discontinued the study early|0|||
25031504|NCT03329885|50130475|FG003|Overall Study|Sponsor discontinued the study early|0|||
25031505|NCT03329885|50130476|FG004|Overall Study|Sponsor discontinued the study early|0|||
25031506|NCT03329885|50130477|FG005|Overall Study|Sponsor discontinued the study early|0|||
25031507|NCT03329885|50130478|FG006|Overall Study|Sponsor discontinued the study early|1|||
25031508|NCT03329885|50130479|FG007|Overall Study|Sponsor discontinued the study early|1|||
25031509|NCT03329885|50130480|FG008|Overall Study|Sponsor discontinued the study early|0|||
25031510|NCT02941523|50130502|FG000|Monotherapy|Withdrawal by Subject|0|||
25031511|NCT02941523|50130503|FG001|Monotherapy|Withdrawal by Subject|1|||
25031512|NCT02941523|50130502|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
25031513|NCT02941523|50130503|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
25031514|NCT02941523|50130502|FG000|Carboplatin Combination Therapy|Death|1|||
25031515|NCT02941523|50130503|FG001|Carboplatin Combination Therapy|Death|2|||
25031516|NCT02941523|50130502|FG000|Carboplatin Combination Therapy|Disease progression|2|||
25031517|NCT02941523|50130503|FG001|Carboplatin Combination Therapy|Disease progression|0|||
25031518|NCT02941523|50130502|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
25031519|NCT02941523|50130503|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
25031520|NCT02938585|50130521|FG000|Overall Study|Withdrawal by parent or guardian|0|||
25031521|NCT02938585|50130522|FG001|Overall Study|Withdrawal by parent or guardian|1|||
25031522|NCT02938585|50130523|FG002|Overall Study|Withdrawal by parent or guardian|0|||
25031523|NCT02938585|50130524|FG003|Overall Study|Withdrawal by parent or guardian|0|||
25031524|NCT02938585|50130521|FG000|Overall Study|Withdrawal by Subject|0|||
25031525|NCT02938585|50130522|FG001|Overall Study|Withdrawal by Subject|0|||
25031526|NCT02938585|50130523|FG002|Overall Study|Withdrawal by Subject|0|||
25031527|NCT02938585|50130524|FG003|Overall Study|Withdrawal by Subject|5|||
25031528|NCT03229759|50130548|FG000|Overall Study|Screen Failure|30|||
25031529|NCT03228433|50130560|FG000|Overall Study|Lost to Follow-up|1|||
25031530|NCT03228433|50130561|FG001|Overall Study|Lost to Follow-up|0|||
25031531|NCT03228433|50130562|FG002|Overall Study|Lost to Follow-up|0|||
25031532|NCT03228433|50130563|FG003|Overall Study|Lost to Follow-up|0|||
25031533|NCT03228433|50130564|FG004|Overall Study|Lost to Follow-up|0|||
25031534|NCT03228433|50130565|FG005|Overall Study|Lost to Follow-up|0|||
25031535|NCT03228433|50130560|FG000|Overall Study|Positive alcohol test|0|||
25031536|NCT03228433|50130561|FG001|Overall Study|Positive alcohol test|0|||
25031537|NCT03228433|50130562|FG002|Overall Study|Positive alcohol test|0|||
25031538|NCT03228433|50130563|FG003|Overall Study|Positive alcohol test|1|||
25031539|NCT03228433|50130564|FG004|Overall Study|Positive alcohol test|0|||
25031540|NCT03228433|50130565|FG005|Overall Study|Positive alcohol test|0|||
25031541|NCT01496118|50130595|FG000|Overall Study|Disease progression|3|||
25031542|NCT01496118|50130596|FG001|Overall Study|Disease progression|2|||
25031543|NCT01496118|50130597|FG002|Overall Study|Disease progression|3|||
25031544|NCT01496118|50130598|FG003|Overall Study|Disease progression|1|||
25031545|NCT01496118|50130599|FG004|Overall Study|Disease progression|2|||
25031546|NCT01496118|50130600|FG005|Overall Study|Disease progression|2|||
25031547|NCT01496118|50130601|FG006|Overall Study|Disease progression|14|||
25031548|NCT01496118|50130602|FG007|Overall Study|Disease progression|10|||
25031549|NCT01496118|50130595|FG000|Overall Study|Physician Decision|0|||
25031550|NCT01496118|50130596|FG001|Overall Study|Physician Decision|0|||
25031551|NCT01496118|50130597|FG002|Overall Study|Physician Decision|0|||
25031552|NCT01496118|50130598|FG003|Overall Study|Physician Decision|0|||
25031553|NCT01496118|50130599|FG004|Overall Study|Physician Decision|1|||
25031554|NCT01496118|50130600|FG005|Overall Study|Physician Decision|0|||
25031555|NCT01496118|50130601|FG006|Overall Study|Physician Decision|3|||
25031556|NCT01496118|50130602|FG007|Overall Study|Physician Decision|6|||
25031557|NCT01496118|50130595|FG000|Overall Study|Adverse Event|1|||
25031558|NCT01496118|50130596|FG001|Overall Study|Adverse Event|1|||
25031559|NCT01496118|50130597|FG002|Overall Study|Adverse Event|0|||
25031560|NCT01496118|50130598|FG003|Overall Study|Adverse Event|0|||
25031561|NCT01496118|50130599|FG004|Overall Study|Adverse Event|0|||
25031562|NCT01496118|50130600|FG005|Overall Study|Adverse Event|0|||
25031563|NCT01496118|50130601|FG006|Overall Study|Adverse Event|6|||
25031564|NCT01496118|50130602|FG007|Overall Study|Adverse Event|10|||
25031565|NCT01496118|50130595|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
25031566|NCT01496118|50130596|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
25031567|NCT01496118|50130597|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
25031568|NCT01496118|50130598|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
25031569|NCT01496118|50130599|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
25031570|NCT01496118|50130600|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
25031571|NCT01496118|50130601|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
25159372|NCT01441635|50279247|FG007|Overall Study|Lost to Follow-up|1|||
25031572|NCT01496118|50130602|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
25031573|NCT01496118|50130595|FG000|Overall Study|Death|0|||
25031574|NCT01496118|50130596|FG001|Overall Study|Death|0|||
25031575|NCT01496118|50130597|FG002|Overall Study|Death|0|||
25031576|NCT01496118|50130598|FG003|Overall Study|Death|0|||
25031577|NCT01496118|50130599|FG004|Overall Study|Death|0|||
25031578|NCT01496118|50130600|FG005|Overall Study|Death|0|||
25031579|NCT01496118|50130601|FG006|Overall Study|Death|1|||
25031580|NCT01496118|50130602|FG007|Overall Study|Death|1|||
25031581|NCT01496118|50130595|FG000|Overall Study|Withdrawal by Subject|0|||
25031582|NCT01496118|50130596|FG001|Overall Study|Withdrawal by Subject|0|||
25031583|NCT01496118|50130597|FG002|Overall Study|Withdrawal by Subject|0|||
25031584|NCT01496118|50130598|FG003|Overall Study|Withdrawal by Subject|2|||
25031585|NCT01496118|50130599|FG004|Overall Study|Withdrawal by Subject|0|||
25031586|NCT01496118|50130600|FG005|Overall Study|Withdrawal by Subject|1|||
25031587|NCT01496118|50130601|FG006|Overall Study|Withdrawal by Subject|6|||
25031588|NCT01496118|50130602|FG007|Overall Study|Withdrawal by Subject|3|||
25031589|NCT02936869|50130622|FG000|Overall Study|Lost to Follow-up|1|||
25031590|NCT02936869|50130623|FG001|Overall Study|Lost to Follow-up|3|||
25031591|NCT02936869|50130622|FG000|Overall Study|Death|0|||
25031592|NCT02936869|50130623|FG001|Overall Study|Death|1|||
25031593|NCT02936869|50130622|FG000|Overall Study|Legal Case|0|||
25031594|NCT02936869|50130623|FG001|Overall Study|Legal Case|1|||
25031595|NCT02936869|50130622|FG000|Overall Study|Protocol Violation|1|||
24945113|NCT03828747|50037616|FG000|Open-Label Extension|Lost to Follow-up|4|||
24945114|NCT03828747|50037617|FG001|Open-Label Extension|Lost to Follow-up|0|||
24945115|NCT03828747|50037616|FG000|Open-Label Extension|Withdrawal by Subject|19|||
24945116|NCT03828747|50037617|FG001|Open-Label Extension|Withdrawal by Subject|16|||
24945117|NCT03828747|50037616|FG000|Open-Label Extension|Various reasons|1|||
24945118|NCT03828747|50037617|FG001|Open-Label Extension|Various reasons|1|||
24945119|NCT00356265|50037627|FG000|Overall Study|Withdrawal by Subject|0|||
24945120|NCT00356265|50037628|FG001|Overall Study|Withdrawal by Subject|0|||
24945121|NCT00356265|50037629|FG002|Overall Study|Withdrawal by Subject|1|||
24945122|NCT00535145|50037638|FG000|Phase I|Adverse Event|3|||
24945123|NCT00535145|50037638|FG000|Phase I|Lost to Follow-up|7|||
24945124|NCT00535145|50037638|FG000|Phase I|Withdrawal by Subject|6|||
24945125|NCT00535145|50037638|FG000|Phase I|(eligibility)|8|||
24945126|NCT00535145|50037638|FG000|Phase I|(protocol violation)|1|||
24945127|NCT00535145|50037638|FG000|Phase I|(PI decision)|1|||
24945128|NCT00535145|50037638|FG000|Phase I|(diagnosis)|3|||
24945129|NCT00535145|50037638|FG000|Phase II|Adverse Event|2|||
24945130|NCT00535145|50037638|FG000|Phase II|Lack of Efficacy|1|||
24945131|NCT00535145|50037638|FG000|Phase II|Lost to Follow-up|5|||
24945132|NCT00535145|50037638|FG000|Phase II|Withdrawal by Subject|5|||
24945133|NCT00535145|50037638|FG000|Phase II|Subject non-compliance|2|||
24945134|NCT00437268|50037648|FG000|Overall Study|Adverse Event|1|||
24945135|NCT00437268|50037649|FG001|Overall Study|Adverse Event|1|||
24945136|NCT00437268|50037648|FG000|Overall Study|Withdrawal by Subject|2|||
24945137|NCT00437268|50037649|FG001|Overall Study|Withdrawal by Subject|2|||
24945138|NCT00437268|50037648|FG000|Overall Study|Progressive disease|9|||
24945139|NCT00437268|50037649|FG001|Overall Study|Progressive disease|9|||
24945140|NCT00437268|50037648|FG000|Overall Study|Physician Decision|1|||
24945141|NCT00437268|50037649|FG001|Overall Study|Physician Decision|0|||
24945142|NCT00437268|50037648|FG000|Overall Study|Death|0|||
24945143|NCT00437268|50037649|FG001|Overall Study|Death|1|||
24945144|NCT00437034|50037657|FG000|Overall Study|Adverse Event|1|||
24945145|NCT00437034|50037657|FG000|Overall Study|Disease progression during treatment|5|||
24945146|NCT00337467|50037661|FG000|Overall Study|Adverse Event|3|||
24945147|NCT00337467|50037661|FG000|Overall Study|Subject Withdrew Consent|2|||
24945148|NCT00337467|50037661|FG000|Overall Study|Pregnancy|1|||
24945149|NCT00337467|50037661|FG000|Overall Study|Lost to Follow-up|2|||
24945150|NCT00337467|50037661|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
25159373|NCT01441635|50279248|FG008|Overall Study|Lost to Follow-up|0|||
25159374|NCT01441635|50279249|FG009|Overall Study|Lost to Follow-up|1|||
25159375|NCT01441635|50279240|FG000|Overall Study|Noncompliance|0|||
24945151|NCT00337077|50037671|FG000|Overall Study|Progressive disease|25|||
24945152|NCT00337077|50037672|FG001|Overall Study|Progressive disease|37|||
24945153|NCT00337077|50037673|FG002|Overall Study|Progressive disease|19|||
24945154|NCT00337077|50037671|FG000|Overall Study|Adverse Event|7|||
24945155|NCT00337077|50037672|FG001|Overall Study|Adverse Event|7|||
24945156|NCT00337077|50037673|FG002|Overall Study|Adverse Event|1|||
24945157|NCT00337077|50037671|FG000|Overall Study|Death|0|||
25031596|NCT02936869|50130623|FG001|Overall Study|Protocol Violation|0|||
24945158|NCT00337077|50037672|FG001|Overall Study|Death|1|||
24945159|NCT00337077|50037673|FG002|Overall Study|Death|0|||
24945160|NCT00337077|50037671|FG000|Overall Study|Withdrawal by Subject|7|||
25031597|NCT03309605|50130638|FG000|Overall Study|Adverse Event|0|||
25031598|NCT03309605|50130639|FG001|Overall Study|Adverse Event|0|||
25031599|NCT03309605|50130640|FG002|Overall Study|Adverse Event|0|||
25031600|NCT03309605|50130641|FG003|Overall Study|Adverse Event|1|||
24945161|NCT00337077|50037672|FG001|Overall Study|Withdrawal by Subject|2|||
24945162|NCT00337077|50037673|FG002|Overall Study|Withdrawal by Subject|2|||
24945163|NCT00337077|50037671|FG000|Overall Study|Alternative therapy|1|||
24945164|NCT00337077|50037672|FG001|Overall Study|Alternative therapy|0|||
24945165|NCT00337077|50037673|FG002|Overall Study|Alternative therapy|0|||
24945166|NCT00337077|50037671|FG000|Overall Study|Physician Decision|1|||
24945167|NCT00337077|50037672|FG001|Overall Study|Physician Decision|4|||
24945168|NCT00337077|50037673|FG002|Overall Study|Physician Decision|2|||
24945169|NCT00337077|50037671|FG000|Overall Study|Never started treatment|1|||
24945170|NCT00337077|50037672|FG001|Overall Study|Never started treatment|1|||
24945171|NCT00337077|50037673|FG002|Overall Study|Never started treatment|0|||
24945172|NCT00337077|50037671|FG000|Overall Study|Ineligible|1|||
24945173|NCT00337077|50037672|FG001|Overall Study|Ineligible|1|||
24945174|NCT00337077|50037673|FG002|Overall Study|Ineligible|1|||
24945175|NCT00428220|50037679|FG000|Overall Study|Participant died|8|||
24945176|NCT00428220|50037679|FG000|Overall Study|Global deterioration of health status|7|||
24945177|NCT00428220|50037679|FG000|Overall Study|Lost to Follow-up|4|||
24945178|NCT00428220|50037679|FG000|Overall Study|Objective progression or relapse|123|||
24945179|NCT00428220|50037679|FG000|Overall Study|Participant refused continued treatment|7|||
24945180|NCT00428220|50037679|FG000|Overall Study|Adverse Event|51|||
24945181|NCT00428220|50037679|FG000|Overall Study|Other|23|||
24945182|NCT00345579|50037709|FG000|Overall Study|Adverse Event|9|||
24945183|NCT00345579|50037710|FG001|Overall Study|Adverse Event|6|||
25031601|NCT03309605|50130642|FG004|Overall Study|Adverse Event|0|||
25031602|NCT03309605|50130643|FG005|Overall Study|Adverse Event|0|||
25031603|NCT03309605|50130644|FG006|Overall Study|Adverse Event|2|||
25031604|NCT03309605|50130645|FG007|Overall Study|Adverse Event|1|||
25031605|NCT03309605|50130638|FG000|Overall Study|Withdrawal by Subject|0|||
25031606|NCT03309605|50130639|FG001|Overall Study|Withdrawal by Subject|0|||
25031607|NCT03309605|50130640|FG002|Overall Study|Withdrawal by Subject|0|||
25031608|NCT03309605|50130641|FG003|Overall Study|Withdrawal by Subject|0|||
25031609|NCT03309605|50130642|FG004|Overall Study|Withdrawal by Subject|1|||
25031610|NCT03309605|50130643|FG005|Overall Study|Withdrawal by Subject|0|||
25031611|NCT03309605|50130644|FG006|Overall Study|Withdrawal by Subject|1|||
25031612|NCT03309605|50130645|FG007|Overall Study|Withdrawal by Subject|1|||
25031613|NCT02936635|50130661|FG000|Overall Study|Adverse Event|43|||
25031614|NCT02936635|50130662|FG001|Overall Study|Adverse Event|25|||
25031615|NCT02936635|50130661|FG000|Overall Study|Progressive Disease|10|||
25031616|NCT02936635|50130662|FG001|Overall Study|Progressive Disease|18|||
25031617|NCT02936635|50130661|FG000|Overall Study|Sponsor Discretion|10|||
25031618|NCT02936635|50130662|FG001|Overall Study|Sponsor Discretion|16|||
25031619|NCT02936635|50130661|FG000|Overall Study|Death|9|||
25031620|NCT02936635|50130662|FG001|Overall Study|Death|15|||
25031621|NCT02936635|50130661|FG000|Overall Study|Withdrawal by Subject|8|||
25031622|NCT02936635|50130662|FG001|Overall Study|Withdrawal by Subject|15|||
25031623|NCT02936635|50130661|FG000|Overall Study|Physician Decision|2|||
25031624|NCT02936635|50130662|FG001|Overall Study|Physician Decision|9|||
25031625|NCT02936635|50130661|FG000|Overall Study|Lost to Follow-up|1|||
25031626|NCT02936635|50130662|FG001|Overall Study|Lost to Follow-up|2|||
25031627|NCT02936635|50130661|FG000|Overall Study|Protocol Violation|1|||
25031628|NCT02936635|50130662|FG001|Overall Study|Protocol Violation|0|||
25031629|NCT02936635|50130661|FG000|Overall Study|Lack of effect/Entry into other study|31|||
25031630|NCT02936635|50130662|FG001|Overall Study|Lack of effect/Entry into other study|65|||
25031631|NCT03227029|50130671|FG000|Overall Study|Child Wheezed (no treatment)|0|||
25031632|NCT03227029|50130672|FG001|Overall Study|Child Wheezed (no treatment)|1|||
25031633|NCT03227029|50130673|FG002|Overall Study|Child Wheezed (no treatment)|0|||
25031634|NCT03227029|50130671|FG000|Overall Study|No post RSV season visit due to COVID|3|||
25031635|NCT03227029|50130672|FG001|Overall Study|No post RSV season visit due to COVID|3|||
25031636|NCT03227029|50130673|FG002|Overall Study|No post RSV season visit due to COVID|2|||
25031637|NCT03227029|50130671|FG000|Overall Study|Not able to get to clinic|0|||
25031638|NCT03227029|50130672|FG001|Overall Study|Not able to get to clinic|0|||
25031639|NCT03227029|50130673|FG002|Overall Study|Not able to get to clinic|1|||
25159376|NCT01441635|50279241|FG001|Overall Study|Noncompliance|1|||
25159377|NCT01441635|50279242|FG002|Overall Study|Noncompliance|0|||
24945184|NCT00345579|50037709|FG000|Overall Study|Protocol Violation|14|||
24945185|NCT00345579|50037710|FG001|Overall Study|Protocol Violation|5|||
24945186|NCT00345579|50037709|FG000|Overall Study|Withdrawal by Subject|50|||
24945187|NCT00345579|50037710|FG001|Overall Study|Withdrawal by Subject|17|||
24945188|NCT00345579|50037709|FG000|Overall Study|Lost to Follow-up|82|||
24945189|NCT00345579|50037710|FG001|Overall Study|Lost to Follow-up|36|||
24945190|NCT00345579|50037709|FG000|Overall Study|Other|9|||
25031640|NCT03227029|50130671|FG000|Overall Study|Withdrawal by Subject|1|||
25031641|NCT03227029|50130672|FG001|Overall Study|Withdrawal by Subject|0|||
25031642|NCT03227029|50130673|FG002|Overall Study|Withdrawal by Subject|0|||
25031643|NCT03227029|50130671|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
25031644|NCT03227029|50130672|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
25159378|NCT01441635|50279243|FG003|Overall Study|Noncompliance|0|||
25159379|NCT01441635|50279244|FG004|Overall Study|Noncompliance|0|||
25159380|NCT01441635|50279245|FG005|Overall Study|Noncompliance|0|||
25159381|NCT01441635|50279246|FG006|Overall Study|Noncompliance|1|||
25159382|NCT01441635|50279247|FG007|Overall Study|Noncompliance|0|||
25159383|NCT01441635|50279248|FG008|Overall Study|Noncompliance|0|||
25159384|NCT01441635|50279249|FG009|Overall Study|Noncompliance|0|||
25159385|NCT01441635|50279240|FG000|Overall Study|Surgery or Invasive Intervention|0|||
25159386|NCT01441635|50279241|FG001|Overall Study|Surgery or Invasive Intervention|0|||
25159387|NCT01441635|50279242|FG002|Overall Study|Surgery or Invasive Intervention|1|||
25159388|NCT01441635|50279243|FG003|Overall Study|Surgery or Invasive Intervention|0|||
25159389|NCT01441635|50279244|FG004|Overall Study|Surgery or Invasive Intervention|0|||
25159390|NCT01441635|50279245|FG005|Overall Study|Surgery or Invasive Intervention|0|||
25159391|NCT01441635|50279246|FG006|Overall Study|Surgery or Invasive Intervention|0|||
25159392|NCT01441635|50279247|FG007|Overall Study|Surgery or Invasive Intervention|0|||
25159393|NCT01441635|50279248|FG008|Overall Study|Surgery or Invasive Intervention|0|||
25159394|NCT01441635|50279249|FG009|Overall Study|Surgery or Invasive Intervention|0|||
25159395|NCT01441635|50279240|FG000|Overall Study|Received Exclusionary Medication|1|||
25159396|NCT01441635|50279241|FG001|Overall Study|Received Exclusionary Medication|0|||
25159397|NCT01441635|50279242|FG002|Overall Study|Received Exclusionary Medication|0|||
25159398|NCT01441635|50279243|FG003|Overall Study|Received Exclusionary Medication|0|||
25159399|NCT01441635|50279244|FG004|Overall Study|Received Exclusionary Medication|0|||
25159400|NCT01441635|50279245|FG005|Overall Study|Received Exclusionary Medication|0|||
25159401|NCT01441635|50279246|FG006|Overall Study|Received Exclusionary Medication|0|||
25159402|NCT01441635|50279247|FG007|Overall Study|Received Exclusionary Medication|0|||
25159403|NCT01441635|50279248|FG008|Overall Study|Received Exclusionary Medication|0|||
25159404|NCT01441635|50279249|FG009|Overall Study|Received Exclusionary Medication|0|||
25159405|NCT01441635|50279240|FG000|Overall Study|Other|0|||
25159406|NCT01441635|50279241|FG001|Overall Study|Other|0|||
25159407|NCT01441635|50279242|FG002|Overall Study|Other|0|||
25159408|NCT01441635|50279243|FG003|Overall Study|Other|0|||
25159409|NCT01441635|50279244|FG004|Overall Study|Other|0|||
25159410|NCT01441635|50279245|FG005|Overall Study|Other|0|||
25159411|NCT01441635|50279246|FG006|Overall Study|Other|0|||
25159412|NCT01441635|50279247|FG007|Overall Study|Other|1|||
25159413|NCT01441635|50279248|FG008|Overall Study|Other|0|||
25159414|NCT01441635|50279249|FG009|Overall Study|Other|0|||
25159415|NCT01408485|50279271|FG000|Overall Study|Withdrawal by Subject|21|||
25159416|NCT01427907|50279277|FG000|Overall Study|Withdrawal by Subject|3|||
25159417|NCT01427907|50279278|FG001|Overall Study|Withdrawal by Subject|4|||
25159418|NCT01427751|50279286|FG000|Overall Study|Adverse Event|18|||
25159419|NCT01427751|50279287|FG001|Overall Study|Adverse Event|2|||
25159420|NCT01427751|50279286|FG000|Overall Study|No further treatment benefit expected|5|||
25159421|NCT01427751|50279287|FG001|Overall Study|No further treatment benefit expected|1|||
24945191|NCT00345579|50037710|FG001|Overall Study|Other|1|||
24945192|NCT00335829|50037717|FG000|Overall Study|Withdrawal by Subject|1|||
24945193|NCT00335829|50037717|FG000|Overall Study|Lost to Follow-up|1|||
24945194|NCT00335829|50037717|FG000|Overall Study|Adverse Event|1|||
24945195|NCT00344019|50037724|FG000|Overall Study|did not meet final inclusion criteria|0|||
24945196|NCT00344019|50037725|FG001|Overall Study|did not meet final inclusion criteria|0|||
24945197|NCT00344019|50037726|FG002|Overall Study|did not meet final inclusion criteria|74|||
24945198|NCT00535847|50037740|FG000|Overall Study|Adverse Event|5|||
24945199|NCT00535847|50037741|FG001|Overall Study|Adverse Event|3|||
24945200|NCT00535847|50037742|FG002|Overall Study|Adverse Event|2|||
24945201|NCT00535847|50037740|FG000|Overall Study|Non compliance|1|||
24945202|NCT00535847|50037741|FG001|Overall Study|Non compliance|1|||
24945203|NCT00535847|50037742|FG002|Overall Study|Non compliance|0|||
24945204|NCT00535847|50037740|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
24945205|NCT00535847|50037741|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
25159422|NCT01427751|50279286|FG000|Overall Study|Lost to Follow-up|3|||
25159423|NCT01427751|50279287|FG001|Overall Study|Lost to Follow-up|1|||
25159424|NCT01427751|50279286|FG000|Overall Study|Withdrawal of consent|2|||
25159425|NCT01427751|50279287|FG001|Overall Study|Withdrawal of consent|2|||
25159426|NCT01427751|50279286|FG000|Overall Study|Protocol Violation|6|||
25159427|NCT01427751|50279287|FG001|Overall Study|Protocol Violation|4|||
25159428|NCT01427751|50279286|FG000|Overall Study|Death|2|||
25159429|NCT01427751|50279287|FG001|Overall Study|Death|0|||
25275646|NCT01230749|50589485|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
25031645|NCT03227029|50130673|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
25031646|NCT03329573|50130685|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
25031647|NCT03329573|50130686|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
25031648|NCT03329573|50130687|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
25031649|NCT03329573|50130688|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
25031650|NCT03329573|50130685|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
25031651|NCT03329573|50130686|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
25031652|NCT03329573|50130687|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
25031653|NCT03329573|50130688|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
25031654|NCT03329573|50130685|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
25031655|NCT03329573|50130686|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
25031656|NCT03329573|50130687|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
25031657|NCT03329573|50130688|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
25031658|NCT03329573|50130685|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
25031659|NCT03329573|50130686|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
25031660|NCT03329573|50130687|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
25031661|NCT03329573|50130688|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
25031662|NCT03308825|50130719|FG000|Overall Study|Lost to Follow-up|2|||
25031663|NCT03308825|50130720|FG001|Overall Study|Lost to Follow-up|2|||
25031664|NCT03308825|50130721|FG002|Overall Study|Lost to Follow-up|1|||
25031665|NCT03308825|50130722|FG003|Overall Study|Lost to Follow-up|0|||
25031666|NCT03308825|50130719|FG000|Overall Study|Protocol Violation|0|||
25031667|NCT03308825|50130720|FG001|Overall Study|Protocol Violation|2|||
25031668|NCT03308825|50130721|FG002|Overall Study|Protocol Violation|0|||
25031669|NCT03308825|50130722|FG003|Overall Study|Protocol Violation|0|||
25031670|NCT03238417|50130738|FG000|Overall|non-response|955|||
25031671|NCT03238417|50130739|FG001|Overall|non-response|1920|||
25031672|NCT03238417|50130738|FG000|Overall|partial completion|48|||
25031673|NCT03238417|50130739|FG001|Overall|partial completion|68|||
25031674|NCT03238417|50130738|FG000|Baseline|Partial completion|17|||
25031675|NCT03238417|50130739|FG001|Baseline|Partial completion|48|||
25031676|NCT03238417|50130738|FG000|Baseline|non-response|372|||
25031677|NCT03238417|50130739|FG001|Baseline|non-response|669|||
25031678|NCT03238417|50130738|FG000|12-month|non-response|296|||
25031679|NCT03238417|50130739|FG001|12-month|non-response|669|||
25031680|NCT03238417|50130738|FG000|12-month|partial completion|23|||
25031681|NCT03238417|50130739|FG001|12-month|partial completion|37|||
25031682|NCT03238417|50130738|FG000|24-month|non-response|287|||
25031683|NCT03238417|50130739|FG001|24-month|non-response|594|||
25031684|NCT03238417|50130738|FG000|24-month|partial completion|8|||
25031685|NCT03238417|50130739|FG001|24-month|partial completion|31|||
25031686|NCT03328325|50130745|FG000|Overall Study|Lost to Follow-up|4|||
25031687|NCT03328325|50130745|FG000|Overall Study|Physician Decision|1|||
25031688|NCT03328325|50130745|FG000|Overall Study|Withdrawal by Subject|3|||
25031689|NCT03328325|50130745|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
25031690|NCT03305081|50130755|FG000|Overall Study|Lost to Follow-up|10|||
25031691|NCT03305081|50130756|FG001|Overall Study|Lost to Follow-up|15|||
25031692|NCT03325673|50130774|FG000|Overall Study|Adverse Event|4|||
25031693|NCT03325673|50130775|FG001|Overall Study|Adverse Event|0|||
25031694|NCT03223909|50130784|FG000|Overall Study|Protocol Violation|48|||
25031695|NCT03223909|50130785|FG001|Overall Study|Protocol Violation|45|||
25031696|NCT03223909|50130786|FG002|Overall Study|Protocol Violation|16|||
25031697|NCT03733925|50130794|FG000|Overall Study|Lost to Follow-up|1|||
25031698|NCT03733925|50130794|FG000|Overall Study|Withdrawal by Subject|2|||
25031699|NCT03733925|50130794|FG000|Overall Study|Adverse Event|2|||
25031700|NCT03733925|50130794|FG000|Overall Study|Non-Compliance with Study Drug|1|||
25031701|NCT03649711|50130801|FG000|Overall Study|Adverse Event|0|||
25031702|NCT03649711|50130802|FG001|Overall Study|Adverse Event|1|||
25031703|NCT03649711|50130803|FG002|Overall Study|Adverse Event|0|||
25031704|NCT03649711|50130801|FG000|Overall Study|Kidney Transplant|1|||
25031705|NCT03649711|50130802|FG001|Overall Study|Kidney Transplant|0|||
25031706|NCT03649711|50130803|FG002|Overall Study|Kidney Transplant|0|||
25031707|NCT03303521|50130813|FG000|Overall Study|Withdrawal by Subject|2|||
25031708|NCT03303521|50130814|FG001|Overall Study|Withdrawal by Subject|0|||
25031709|NCT03303521|50130813|FG000|Overall Study|Death|1|||
25031710|NCT03303521|50130814|FG001|Overall Study|Death|0|||
25031711|NCT03303521|50130813|FG000|Overall Study|Kidney transplantation|0|||
25031712|NCT03303521|50130814|FG001|Overall Study|Kidney transplantation|1|||
25031713|NCT03303521|50130813|FG000|Overall Study|Investigational product discontinuation|0|||
25031714|NCT03303521|50130814|FG001|Overall Study|Investigational product discontinuation|1|||
25031715|NCT03303521|50130813|FG000|Overall Study|Transferred to non-study dialysis center|1|||
25031716|NCT03303521|50130814|FG001|Overall Study|Transferred to non-study dialysis center|0|||
24945206|NCT00535847|50037742|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
24945207|NCT00334893|50037756|FG000|Overall Study|Not Treated|1|||
24945208|NCT00334893|50037757|FG001|Overall Study|Not Treated|0|||
24945209|NCT00334737|50037768|FG000|Hospital Phase|Death|1|||
24945210|NCT00334737|50037769|FG001|Hospital Phase|Death|2|||
24945211|NCT00334737|50037770|FG002|Hospital Phase|Death|3|||
24945212|NCT00334737|50037768|FG000|Hospital Phase|Withdrawal by Subject|0|||
24945213|NCT00334737|50037769|FG001|Hospital Phase|Withdrawal by Subject|0|||
24945214|NCT00334737|50037770|FG002|Hospital Phase|Withdrawal by Subject|1|||
24945215|NCT00334737|50037768|FG000|Hospital Phase|Did not receive study drug|1|||
24945216|NCT00334737|50037769|FG001|Hospital Phase|Did not receive study drug|0|||
24945217|NCT00334737|50037770|FG002|Hospital Phase|Did not receive study drug|0|||
24945218|NCT00334737|50037768|FG000|Follow up Phase|Lost to Follow-up|5|||
24945219|NCT00334737|50037769|FG001|Follow up Phase|Lost to Follow-up|3|||
24945220|NCT00334737|50037770|FG002|Follow up Phase|Lost to Follow-up|6|||
24945221|NCT00427908|50037782|FG000|Primary Phase|Lost to Follow-up|4|||
24945222|NCT00427908|50037783|FG001|Primary Phase|Lost to Follow-up|0|||
24945223|NCT00427908|50037784|FG002|Primary Phase|Lost to Follow-up|2|||
24945224|NCT00427908|50037785|FG003|Primary Phase|Lost to Follow-up|0|||
24945225|NCT00427908|50037782|FG000|Primary Phase|Withdrawal by Subject|1|||
24945226|NCT00427908|50037783|FG001|Primary Phase|Withdrawal by Subject|2|||
25031717|NCT03303521|50130813|FG000|Overall Study|Non-comliance to study protocol|0|||
25031718|NCT03303521|50130814|FG001|Overall Study|Non-comliance to study protocol|1|||
25031719|NCT03303521|50130813|FG000|Overall Study|Adverse Event|1|||
25031720|NCT03303521|50130814|FG001|Overall Study|Adverse Event|0|||
25031721|NCT03214081|50130820|FG000|Overall Study|Case Report Forms Uncollected|9|||
25031722|NCT03214081|50130820|FG000|Overall Study|Protocol Deviation|54|||
25031723|NCT02888171|50130826|FG000|Overall Study|Lost to Follow-up|2|||
25031724|NCT02888171|50130827|FG001|Overall Study|Lost to Follow-up|1|||
25031725|NCT02888171|50130826|FG000|Overall Study|Withdrawal by Subject|3|||
25031726|NCT02888171|50130827|FG001|Overall Study|Withdrawal by Subject|2|||
25031727|NCT02888171|50130826|FG000|Overall Study|Adverse Event|0|||
25031728|NCT02888171|50130827|FG001|Overall Study|Adverse Event|1|||
25159430|NCT01427751|50279286|FG000|Overall Study|Other miscellaneous reasons|6|||
25159431|NCT01427751|50279287|FG001|Overall Study|Other miscellaneous reasons|4|||
25159432|NCT01920061|50279313|FG000|Overall Study|Death|1|||
25159433|NCT01920061|50279314|FG001|Overall Study|Death|1|||
25159434|NCT01920061|50279315|FG002|Overall Study|Death|0|||
25159435|NCT01920061|50279316|FG003|Overall Study|Death|1|||
25159436|NCT01920061|50279317|FG004|Overall Study|Death|1|||
25159437|NCT01920061|50279318|FG005|Overall Study|Death|0|||
25159438|NCT01920061|50279319|FG006|Overall Study|Death|0|||
25159439|NCT01920061|50279320|FG007|Overall Study|Death|1|||
25159440|NCT01920061|50279321|FG008|Overall Study|Death|0|||
25159441|NCT01920061|50279322|FG009|Overall Study|Death|1|||
25159442|NCT01920061|50279323|FG010|Overall Study|Death|0|||
25159443|NCT01920061|50279324|FG011|Overall Study|Death|1|||
25159444|NCT01920061|50279325|FG012|Overall Study|Death|0|||
25159445|NCT01920061|50279326|FG013|Overall Study|Death|2|||
25159446|NCT01920061|50279327|FG014|Overall Study|Death|0|||
25186203|NCT01496846|50336147|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
24945227|NCT00427908|50037784|FG002|Primary Phase|Withdrawal by Subject|1|||
24945228|NCT00427908|50037785|FG003|Primary Phase|Withdrawal by Subject|0|||
24945229|NCT00427908|50037782|FG000|Primary Phase|Adverse Event|0|||
24945230|NCT00427908|50037783|FG001|Primary Phase|Adverse Event|1|||
25159447|NCT01920061|50279328|FG015|Overall Study|Death|0|||
25159448|NCT01920061|50279329|FG016|Overall Study|Death|0|||
25159449|NCT01920061|50279330|FG017|Overall Study|Death|0|||
25159450|NCT01920061|50279331|FG018|Overall Study|Death|1|||
24945231|NCT00427908|50037784|FG002|Primary Phase|Adverse Event|0|||
25159451|NCT01920061|50279332|FG019|Overall Study|Death|0|||
24945232|NCT00427908|50037785|FG003|Primary Phase|Adverse Event|0|||
24945233|NCT00334113|50037822|FG000|Overall Study|Lost to Follow-up|2|||
24945234|NCT00334113|50037823|FG001|Overall Study|Lost to Follow-up|2|||
24945235|NCT00334113|50037822|FG000|Overall Study|Withdrawal by Subject|0|||
24945236|NCT00334113|50037823|FG001|Overall Study|Withdrawal by Subject|1|||
24945237|NCT00416598|50037829|FG000|Induction & Intensification|Adverse Event|38|||
24945238|NCT00416598|50037829|FG000|Induction & Intensification|Death|32|||
24945239|NCT00416598|50037829|FG000|Induction & Intensification|Withdrawal by Subject|46|||
25031729|NCT02932891|50130833|FG000|Overall Study|Lost to Follow-up|2|||
25031730|NCT02932891|50130833|FG000|Overall Study|HPA Suppress|2|||
25031731|NCT03302975|50130837|FG000|Overall Study|Lost to Follow-up|4|||
24945240|NCT00416598|50037829|FG000|Induction & Intensification|Alternative Treatment|135|||
24945241|NCT00416598|50037829|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
25031732|NCT03212521|50130841|FG000|Overall Study|Adverse Event|1|||
25031733|NCT03212521|50130841|FG000|Overall Study|Lost to Follow-up|4|||
25031734|NCT03212521|50130841|FG000|Overall Study|Withdrawal by Subject|1|||
25031735|NCT03212521|50130841|FG000|Overall Study|Other|1|||
25031736|NCT03212365|50130847|FG000|Overall Study|Discharged prior to Xa level|12|||
25031737|NCT03212365|50130848|FG001|Overall Study|Discharged prior to Xa level|8|||
25159452|NCT01920061|50279313|FG000|Overall Study|Lost to Follow-up|0|||
24945242|NCT00416598|50037829|FG000|Induction & Intensification|Relapse/progression|29|||
24945243|NCT00416598|50037829|FG000|Induction & Intensification|Failed induction|87|||
24945244|NCT00416598|50037829|FG000|Decitabine Maintenance|Adverse Event|5|||
24945245|NCT00416598|50037829|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
24945246|NCT00416598|50037829|FG000|Decitabine Maintenance|Progression/relapse|38|||
24945247|NCT00416598|50037829|FG000|Decitabine Maintenance|Alternative treatment|2|||
24945248|NCT00416598|50037829|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
24945249|NCT00534599|50037835|FG000|Overall Study|Adverse Event|25|||
24945250|NCT00534599|50037836|FG001|Overall Study|Adverse Event|4|||
24945251|NCT00534599|50037835|FG000|Overall Study|Incorrect enrollment|2|||
24945252|NCT00534599|50037836|FG001|Overall Study|Incorrect enrollment|1|||
24945253|NCT00534599|50037835|FG000|Overall Study|Mis-randomization|2|||
24945254|NCT00534599|50037836|FG001|Overall Study|Mis-randomization|2|||
24945255|NCT00534599|50037835|FG000|Overall Study|Developed study-specific d/c criteria|5|||
24945256|NCT00534599|50037836|FG001|Overall Study|Developed study-specific d/c criteria|0|||
24945257|NCT00534599|50037835|FG000|Overall Study|Lack of Efficacy|0|||
24945258|NCT00534599|50037836|FG001|Overall Study|Lack of Efficacy|1|||
24945259|NCT00534599|50037835|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
24945260|NCT00534599|50037836|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
24945261|NCT00534599|50037835|FG000|Overall Study|Protocol Violation|1|||
24945262|NCT00534599|50037836|FG001|Overall Study|Protocol Violation|3|||
24945263|NCT00534599|50037835|FG000|Overall Study|Lost to Follow-up|11|||
24945264|NCT00534599|50037836|FG001|Overall Study|Lost to Follow-up|14|||
24945265|NCT00534599|50037835|FG000|Overall Study|Withdrawal by Subject|4|||
24945266|NCT00534599|50037836|FG001|Overall Study|Withdrawal by Subject|6|||
24945267|NCT00534599|50037835|FG000|Overall Study|Other|7|||
24945268|NCT00534599|50037836|FG001|Overall Study|Other|0|||
24945269|NCT03892889|50037859|FG000|Overall Study|Adverse Event|17|||
24945270|NCT03892889|50037859|FG000|Overall Study|Lack of Efficacy|1|||
24945271|NCT03892889|50037859|FG000|Overall Study|Lost to Follow-up|46|||
24945272|NCT03892889|50037859|FG000|Overall Study|Non-compliance with study drug|22|||
24945273|NCT03892889|50037859|FG000|Overall Study|Pregnancy|1|||
24945274|NCT03892889|50037859|FG000|Overall Study|Protocol Deviation|3|||
24945275|NCT03892889|50037859|FG000|Overall Study|Withdrawal by Subject|50|||
24945276|NCT03892889|50037859|FG000|Overall Study|Withdrawal by Caregiver|1|||
24945277|NCT03892889|50037859|FG000|Overall Study|Study Terminated by Sponsor|50|||
24945278|NCT03892889|50037859|FG000|Overall Study|Physician Decision|8|||
24945279|NCT03892889|50037859|FG000|Overall Study|Reason not Specified|5|||
24945280|NCT00473330|50037866|FG000|Core Study|Adverse Event|4|||
24945281|NCT00473330|50037867|FG001|Core Study|Adverse Event|4|||
24945282|NCT00473330|50037868|FG002|Core Study|Adverse Event|1|||
24945283|NCT00473330|50037866|FG000|Core Study|Death|6|||
24945284|NCT00473330|50037867|FG001|Core Study|Death|4|||
24945285|NCT00473330|50037868|FG002|Core Study|Death|4|||
24945286|NCT00473330|50037866|FG000|Core Study|Lost to Follow-up|5|||
24945287|NCT00473330|50037867|FG001|Core Study|Lost to Follow-up|5|||
24945288|NCT00473330|50037868|FG002|Core Study|Lost to Follow-up|10|||
24945289|NCT00473330|50037866|FG000|Core Study|Physician Decision|2|||
25159453|NCT01920061|50279314|FG001|Overall Study|Lost to Follow-up|2|||
24945290|NCT00473330|50037867|FG001|Core Study|Physician Decision|1|||
24945291|NCT00473330|50037868|FG002|Core Study|Physician Decision|3|||
24945292|NCT00473330|50037866|FG000|Core Study|Subject Non-compliance|1|||
24945293|NCT00473330|50037867|FG001|Core Study|Subject Non-compliance|2|||
24945294|NCT00473330|50037868|FG002|Core Study|Subject Non-compliance|1|||
24945295|NCT00473330|50037866|FG000|Core Study|Subject Required Other Therapy|0|||
24945296|NCT00473330|50037867|FG001|Core Study|Subject Required Other Therapy|1|||
24945297|NCT00473330|50037868|FG002|Core Study|Subject Required Other Therapy|3|||
24945298|NCT00473330|50037866|FG000|Core Study|Subject's Decision|9|||
24945299|NCT00473330|50037867|FG001|Core Study|Subject's Decision|8|||
24945300|NCT00473330|50037868|FG002|Core Study|Subject's Decision|19|||
24945301|NCT00473330|50037866|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
24945302|NCT00473330|50037867|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
24945303|NCT00473330|50037868|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
24945304|NCT00473330|50037866|FG000|Open-label Extension Through Month 48|Death|2|||
24945305|NCT00473330|50037867|FG001|Open-label Extension Through Month 48|Death|0|||
24945306|NCT00473330|50037868|FG002|Open-label Extension Through Month 48|Death|0|||
24945307|NCT00473330|50037866|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
24945308|NCT00473330|50037867|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
24945309|NCT00473330|50037868|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
24945310|NCT00473330|50037866|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
24945311|NCT00473330|50037867|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
24945312|NCT00473330|50037868|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
24945313|NCT00473330|50037866|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
24945314|NCT00473330|50037867|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
24945315|NCT00473330|50037868|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
24945316|NCT00473330|50037866|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
24945317|NCT00473330|50037867|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
24945318|NCT00473330|50037868|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
24945319|NCT00473330|50037866|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
24945320|NCT00473330|50037867|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
24945321|NCT00473330|50037868|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
24945322|NCT00473330|50037866|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
24945323|NCT00473330|50037867|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
24945324|NCT00473330|50037868|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
24945325|NCT00473330|50037866|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
24945326|NCT00473330|50037867|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
24945327|NCT00473330|50037868|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
24945328|NCT00473330|50037866|FG000|Open-label Extension Through Month 60|Death|2|||
24945329|NCT00473330|50037867|FG001|Open-label Extension Through Month 60|Death|2|||
24945330|NCT00473330|50037868|FG002|Open-label Extension Through Month 60|Death|1|||
25031738|NCT03212365|50130847|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
25031739|NCT03212365|50130848|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
25031740|NCT03212365|50130847|FG000|Overall Study|Refused study medication|3|||
25031741|NCT03212365|50130848|FG001|Overall Study|Refused study medication|0|||
25031742|NCT03212365|50130847|FG000|Overall Study|Initiated heparin infusion on floor|1|||
25031743|NCT03212365|50130848|FG001|Overall Study|Initiated heparin infusion on floor|1|||
25031744|NCT03212365|50130847|FG000|Overall Study|Unexpected return to OR|1|||
25031745|NCT03212365|50130848|FG001|Overall Study|Unexpected return to OR|1|||
25031746|NCT03212365|50130847|FG000|Overall Study|Medication distribution error|1|||
25031747|NCT03212365|50130848|FG001|Overall Study|Medication distribution error|0|||
25031748|NCT03212365|50130847|FG000|Overall Study|Required epidural placement|1|||
25031749|NCT03212365|50130848|FG001|Overall Study|Required epidural placement|0|||
25031750|NCT03212365|50130847|FG000|Overall Study|Withdrawal by Subject|0|||
25031751|NCT03212365|50130848|FG001|Overall Study|Withdrawal by Subject|1|||
25031752|NCT03212365|50130847|FG000|Overall Study|developed acute renal failure|0|||
25031753|NCT03212365|50130848|FG001|Overall Study|developed acute renal failure|1|||
25031754|NCT03273257|50130856|FG000|Overall Study|Death|0|||
25031755|NCT03273257|50130857|FG001|Overall Study|Death|1|||
25031756|NCT03273257|50130856|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
25031757|NCT03273257|50130857|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
25031758|NCT03273257|50130856|FG000|Overall Study|Study terminated|3|||
25031759|NCT03273257|50130857|FG001|Overall Study|Study terminated|2|||
25031760|NCT04316741|50130865|FG000|Baseline Enrollment|Lost to Follow-up|1|||
25031761|NCT04316741|50130866|FG001|Baseline Enrollment|Lost to Follow-up|1|||
25031762|NCT04316741|50130865|FG000|Immediate Post-Test|Lost to Follow-up|5|||
25031763|NCT04316741|50130866|FG001|Immediate Post-Test|Lost to Follow-up|1|||
25031764|NCT04316741|50130865|FG000|1-month Post-test|Lost to Follow-up|7|||
25031765|NCT04316741|50130866|FG001|1-month Post-test|Lost to Follow-up|2|||
25031766|NCT04316741|50130865|FG000|3-month Follow-up|Lost to Follow-up|10|||
25031767|NCT04316741|50130866|FG001|3-month Follow-up|Lost to Follow-up|2|||
25031768|NCT03271307|50130876|FG000|Overall Study|Lost to Follow-up|0|||
25031769|NCT03271307|50130877|FG001|Overall Study|Lost to Follow-up|0|||
25031770|NCT03271307|50130878|FG002|Overall Study|Lost to Follow-up|0|||
25275647|NCT01230749|50589486|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
25031771|NCT03271307|50130879|FG003|Overall Study|Lost to Follow-up|28|||
25031772|NCT03271307|50130880|FG004|Overall Study|Lost to Follow-up|91|||
25031773|NCT03271151|50130897|FG000|Overall Study|Lost to Follow-up|1|||
25031774|NCT03271151|50130898|FG001|Overall Study|Lost to Follow-up|3|||
25031775|NCT03271151|50130897|FG000|Overall Study|Withdrawal by Subject|1|||
25031776|NCT03271151|50130898|FG001|Overall Study|Withdrawal by Subject|0|||
25031777|NCT03245723|50130906|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
25031778|NCT03245723|50130907|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
25031779|NCT03245723|50130906|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
25031780|NCT03245723|50130907|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
25031781|NCT03245723|50130906|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
25031782|NCT03245723|50130907|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
25031783|NCT03245723|50130906|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
25031784|NCT03245723|50130907|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
25031785|NCT03301649|50130916|FG000|Overall Study|Need alternate therapy due to live lice|17|||
25031786|NCT03301649|50130917|FG001|Overall Study|Need alternate therapy due to live lice|25|||
25031787|NCT03301649|50130918|FG002|Overall Study|Need alternate therapy due to live lice|81|||
25031788|NCT03301649|50130916|FG000|Overall Study|Lost to Follow-up|11|||
25031789|NCT03301649|50130917|FG001|Overall Study|Lost to Follow-up|11|||
25031790|NCT03301649|50130918|FG002|Overall Study|Lost to Follow-up|3|||
25031791|NCT03301649|50130916|FG000|Overall Study|Protocol Violation|0|||
25031792|NCT03301649|50130917|FG001|Overall Study|Protocol Violation|1|||
25031793|NCT03301649|50130918|FG002|Overall Study|Protocol Violation|1|||
25031794|NCT03301649|50130916|FG000|Overall Study|Withdrawal by Subject|10|||
25031795|NCT03301649|50130917|FG001|Overall Study|Withdrawal by Subject|4|||
25031796|NCT03301649|50130918|FG002|Overall Study|Withdrawal by Subject|0|||
25031797|NCT03301649|50130916|FG000|Overall Study|Other than specified|5|||
25031798|NCT03301649|50130917|FG001|Overall Study|Other than specified|3|||
25031799|NCT03301649|50130918|FG002|Overall Study|Other than specified|0|||
25031800|NCT03222973|50130928|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
25031801|NCT03222973|50130929|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
25031802|NCT03222973|50130930|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
25031803|NCT03222973|50130931|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
25031804|NCT03222973|50130928|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
25031805|NCT03222973|50130929|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
25031806|NCT03222973|50130930|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
25031807|NCT03222973|50130931|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
25031808|NCT03222973|50130928|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
25031809|NCT03222973|50130929|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
25031810|NCT03222973|50130930|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
25031811|NCT03222973|50130931|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
25031812|NCT03222973|50130928|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
25031813|NCT03222973|50130929|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
25031814|NCT03222973|50130930|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
25031815|NCT03222973|50130931|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
25031816|NCT03222973|50130928|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
25031817|NCT03222973|50130929|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
25031818|NCT03222973|50130930|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
25031819|NCT03222973|50130931|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
25031820|NCT03222973|50130928|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
25031821|NCT03222973|50130929|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
25031822|NCT03222973|50130930|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
25031823|NCT03222973|50130931|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
25031824|NCT03222973|50130928|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
25031825|NCT03222973|50130929|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
24945331|NCT00473330|50037866|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
24945332|NCT00473330|50037867|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
24945333|NCT00473330|50037868|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
24945334|NCT00473330|50037866|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
24945335|NCT00473330|50037867|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
24945336|NCT00473330|50037868|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
24945337|NCT00473330|50037866|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
24945338|NCT00473330|50037867|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
24945339|NCT00473330|50037868|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
24945340|NCT00473330|50037866|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
25031826|NCT03222973|50130930|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
25031827|NCT03222973|50130931|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
25031828|NCT03222973|50130928|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
25031829|NCT03222973|50130929|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
25031830|NCT03222973|50130930|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
25031831|NCT03222973|50130931|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
25031832|NCT03222973|50130928|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
25275648|NCT01230749|50589487|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
25275649|NCT01230749|50589488|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
24945341|NCT00473330|50037867|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
25031833|NCT03222973|50130929|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
25031834|NCT03222973|50130930|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
25031835|NCT03222973|50130931|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
25031836|NCT03222973|50130928|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
25031837|NCT03222973|50130929|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
25031838|NCT03222973|50130930|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
25031839|NCT03222973|50130931|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
25031840|NCT03222973|50130928|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
25031841|NCT03222973|50130929|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
25031842|NCT03222973|50130930|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
25031843|NCT03222973|50130931|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
25031844|NCT03222973|50130928|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
25031845|NCT03222973|50130929|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
25031846|NCT03222973|50130930|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
25031847|NCT03222973|50130931|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
25031848|NCT01144416|50130943|FG000|Intervention Period|Adverse Event|5|||
25031849|NCT01144416|50130944|FG001|Intervention Period|Adverse Event|6|||
25031850|NCT01144416|50130943|FG000|Intervention Period|Insufficient ovarian response|11|||
25031851|NCT01144416|50130944|FG001|Intervention Period|Insufficient ovarian response|17|||
25031852|NCT01144416|50130943|FG000|Intervention Period|Risk of OHSS|0|||
25031853|NCT01144416|50130944|FG001|Intervention Period|Risk of OHSS|1|||
25031854|NCT01144416|50130943|FG000|Intervention Period|Too high ovarian response|4|||
25031855|NCT01144416|50130944|FG001|Intervention Period|Too high ovarian response|2|||
25031856|NCT01144416|50130943|FG000|Intervention Period|No/too few/bad oocytes|7|||
25031857|NCT01144416|50130944|FG001|Intervention Period|No/too few/bad oocytes|5|||
25031858|NCT01144416|50130943|FG000|Intervention Period|No or abnormal fertilization|25|||
25031859|NCT01144416|50130944|FG001|Intervention Period|No or abnormal fertilization|10|||
25031860|NCT01144416|50130943|FG000|Intervention Period|No/too few/bad quality embryos|3|||
25031861|NCT01144416|50130944|FG001|Intervention Period|No/too few/bad quality embryos|3|||
25031862|NCT01144416|50130943|FG000|Intervention Period|Other|7|||
25031863|NCT01144416|50130944|FG001|Intervention Period|Other|5|||
25031864|NCT00335777|50130954|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
25031865|NCT00335777|50130954|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
25031866|NCT00335777|50130954|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
25031867|NCT00335777|50130954|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
25031868|NCT00335777|50130954|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
25031869|NCT01140048|50130959|FG000|Overall Study|Physician Decision|1|||
25031870|NCT01140048|50130959|FG000|Overall Study|Withdrawal by Subject|13|||
25031871|NCT01140048|50130959|FG000|Overall Study|Lost to Follow-up|31|||
25031872|NCT02889809|50130965|FG000|Overall Study|Withdrawal by Subject|30|||
25031873|NCT02889809|50130966|FG001|Overall Study|Withdrawal by Subject|21|||
25031874|NCT02889809|50130965|FG000|Overall Study|Lost to Follow-up|1|||
25031875|NCT02889809|50130966|FG001|Overall Study|Lost to Follow-up|1|||
25031876|NCT02889809|50130965|FG000|Overall Study|Site Closed|12|||
25031877|NCT02889809|50130966|FG001|Overall Study|Site Closed|11|||
25031878|NCT00972738|50130979|FG000|Overall Study|Adverse Event|7|||
25031879|NCT00972738|50130980|FG001|Overall Study|Adverse Event|1|||
25159454|NCT01920061|50279315|FG002|Overall Study|Lost to Follow-up|0|||
24945342|NCT00473330|50037868|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
24945343|NCT00473330|50037866|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
24945344|NCT00473330|50037867|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
24945345|NCT00473330|50037868|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
24945346|NCT00473330|50037866|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
24945347|NCT00473330|50037867|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
24945348|NCT00473330|50037868|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
24945349|NCT00416520|50037898|FG000|Open-label Period|Adverse Event|28|||
24945350|NCT00416520|50037899|FG001|Open-label Period|Adverse Event|10|||
24945351|NCT00416520|50037900|FG002|Open-label Period|Adverse Event|0|||
24945352|NCT00416520|50037901|FG003|Open-label Period|Adverse Event|0|||
24945353|NCT00416520|50037898|FG000|Open-label Period|Death|2|||
24945354|NCT00416520|50037899|FG001|Open-label Period|Death|1|||
24945355|NCT00416520|50037900|FG002|Open-label Period|Death|0|||
24945356|NCT00416520|50037901|FG003|Open-label Period|Death|0|||
25031880|NCT00972738|50130981|FG002|Overall Study|Adverse Event|8|||
25031881|NCT00972738|50130979|FG000|Overall Study|Protocol Violation|2|||
25031882|NCT00972738|50130980|FG001|Overall Study|Protocol Violation|1|||
25031883|NCT00972738|50130981|FG002|Overall Study|Protocol Violation|3|||
25031884|NCT00972738|50130979|FG000|Overall Study|Lost to Follow-up|1|||
25031885|NCT00972738|50130980|FG001|Overall Study|Lost to Follow-up|0|||
25031886|NCT00972738|50130981|FG002|Overall Study|Lost to Follow-up|1|||
25031887|NCT00972738|50130979|FG000|Overall Study|Lack of Efficacy|5|||
25159455|NCT01920061|50279316|FG003|Overall Study|Lost to Follow-up|0|||
24945357|NCT00416520|50037898|FG000|Open-label Period|Lack of Efficacy|8|||
24945358|NCT00416520|50037899|FG001|Open-label Period|Lack of Efficacy|1|||
24945359|NCT00416520|50037900|FG002|Open-label Period|Lack of Efficacy|0|||
24945360|NCT00416520|50037901|FG003|Open-label Period|Lack of Efficacy|0|||
24945361|NCT00416520|50037898|FG000|Open-label Period|Protocol Violation|3|||
24945362|NCT00416520|50037899|FG001|Open-label Period|Protocol Violation|3|||
25031888|NCT00972738|50130980|FG001|Overall Study|Lack of Efficacy|1|||
25031889|NCT00972738|50130981|FG002|Overall Study|Lack of Efficacy|11|||
25031890|NCT00972738|50130979|FG000|Overall Study|Withdrawal by Subject|5|||
25031891|NCT00972738|50130980|FG001|Overall Study|Withdrawal by Subject|1|||
25031892|NCT00972738|50130981|FG002|Overall Study|Withdrawal by Subject|4|||
25031893|NCT00972738|50130979|FG000|Overall Study|Moved|0|||
25031894|NCT00972738|50130980|FG001|Overall Study|Moved|0|||
25031895|NCT00972738|50130981|FG002|Overall Study|Moved|1|||
25031896|NCT00972738|50130979|FG000|Overall Study|Other|1|||
25031897|NCT00972738|50130980|FG001|Overall Study|Other|2|||
25031898|NCT00972738|50130981|FG002|Overall Study|Other|1|||
25031899|NCT03243305|50130989|FG000|Overall Study|Lost to Follow-up|250|||
25031900|NCT03243305|50130989|FG000|Overall Study|Withdrawal by Subject|170|||
25031901|NCT03243305|50130989|FG000|Overall Study|Pregnancy|104|||
25031902|NCT03243305|50130989|FG000|Overall Study|Non-Compliance with Study Drug|38|||
25031903|NCT03243305|50130989|FG000|Overall Study|Adverse Event|23|||
25031904|NCT03243305|50130989|FG000|Overall Study|No sexually active|26|||
25031905|NCT03243305|50130989|FG000|Overall Study|Physician Decision|22|||
25031906|NCT03243305|50130989|FG000|Overall Study|Protocol Violation|22|||
25031907|NCT03243305|50130989|FG000|Overall Study|Study method no longer primary method|12|||
25031908|NCT03243305|50130989|FG000|Overall Study|Study Terminated by Sponsor|1|||
25031909|NCT03243305|50130989|FG000|Overall Study|Early terminations|267|||
25031910|NCT03222583|50130995|FG000|Overall Study|Withdrawal by Subject|3|||
25031911|NCT03222583|50130996|FG001|Overall Study|Withdrawal by Subject|3|||
25031912|NCT03222583|50130995|FG000|Overall Study|Lost to Follow-up|1|||
25031913|NCT03222583|50130996|FG001|Overall Study|Lost to Follow-up|0|||
25031914|NCT03222583|50130995|FG000|Overall Study|Other|1|||
25031915|NCT03222583|50130996|FG001|Overall Study|Other|3|||
25031916|NCT03295721|50131005|FG000|Overall Study|Adverse Event|1|||
25031917|NCT03295721|50131006|FG001|Overall Study|Adverse Event|0|||
25031918|NCT03295721|50131007|FG002|Overall Study|Adverse Event|0|||
25031919|NCT03295721|50131005|FG000|Overall Study|Lost to Follow-up|1|||
25031920|NCT03295721|50131006|FG001|Overall Study|Lost to Follow-up|1|||
25031921|NCT03295721|50131007|FG002|Overall Study|Lost to Follow-up|1|||
25031922|NCT03295721|50131005|FG000|Overall Study|Withdrawal by Subject|1|||
25031923|NCT03295721|50131006|FG001|Overall Study|Withdrawal by Subject|0|||
25031924|NCT03295721|50131007|FG002|Overall Study|Withdrawal by Subject|1|||
25031925|NCT03295721|50131005|FG000|Overall Study|Death|0|||
25031926|NCT03295721|50131006|FG001|Overall Study|Death|0|||
25031927|NCT03295721|50131007|FG002|Overall Study|Death|1|||
25159456|NCT01920061|50279317|FG004|Overall Study|Lost to Follow-up|0|||
25159457|NCT01920061|50279318|FG005|Overall Study|Lost to Follow-up|0|||
24945363|NCT00416520|50037900|FG002|Open-label Period|Protocol Violation|0|||
24945364|NCT00416520|50037901|FG003|Open-label Period|Protocol Violation|0|||
24945365|NCT00416520|50037898|FG000|Open-label Period|Withdrawal by Subject|16|||
24945366|NCT00416520|50037899|FG001|Open-label Period|Withdrawal by Subject|5|||
24945367|NCT00416520|50037900|FG002|Open-label Period|Withdrawal by Subject|0|||
24945368|NCT00416520|50037901|FG003|Open-label Period|Withdrawal by Subject|0|||
24945369|NCT00416520|50037898|FG000|Open-label Period|Other Reasons|3|||
24945370|NCT00416520|50037899|FG001|Open-label Period|Other Reasons|12|||
24945371|NCT00416520|50037900|FG002|Open-label Period|Other Reasons|0|||
24945372|NCT00416520|50037901|FG003|Open-label Period|Other Reasons|0|||
24945373|NCT00416520|50037898|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
24945374|NCT00416520|50037899|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
24945375|NCT00416520|50037900|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
24945376|NCT00416520|50037901|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
24945377|NCT00416520|50037898|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
24945378|NCT00416520|50037899|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
24945379|NCT00416520|50037900|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
25031928|NCT00803790|50131018|FG000|Period 1|Adverse Event|0|||
25159458|NCT01920061|50279319|FG006|Overall Study|Lost to Follow-up|1|||
25031929|NCT00803790|50131019|FG001|Period 1|Adverse Event|1|||
25031930|NCT00803790|50131020|FG002|Period 1|Adverse Event|0|||
25031931|NCT00803790|50131021|FG003|Period 1|Adverse Event|0|||
25031932|NCT00803790|50131018|FG000|Period 1|Lost to Follow-up|1|||
25031933|NCT00803790|50131019|FG001|Period 1|Lost to Follow-up|2|||
25031934|NCT00803790|50131020|FG002|Period 1|Lost to Follow-up|0|||
25031935|NCT00803790|50131021|FG003|Period 1|Lost to Follow-up|0|||
25031936|NCT00803790|50131018|FG000|Period 1|Withdrawal by Subject|8|||
25031937|NCT00803790|50131019|FG001|Period 1|Withdrawal by Subject|6|||
25031938|NCT00803790|50131020|FG002|Period 1|Withdrawal by Subject|0|||
25159459|NCT01920061|50279320|FG007|Overall Study|Lost to Follow-up|0|||
25159460|NCT01920061|50279321|FG008|Overall Study|Lost to Follow-up|0|||
25031939|NCT00803790|50131021|FG003|Period 1|Withdrawal by Subject|0|||
25031940|NCT00803790|50131018|FG000|Period 1|positive drug screen or personal reasons|0|||
25031941|NCT00803790|50131019|FG001|Period 1|positive drug screen or personal reasons|3|||
25031942|NCT00803790|50131020|FG002|Period 1|positive drug screen or personal reasons|0|||
25031943|NCT00803790|50131021|FG003|Period 1|positive drug screen or personal reasons|4|||
25031944|NCT00803790|50131018|FG000|Period 1|Protocol Violation|0|||
25031945|NCT00803790|50131019|FG001|Period 1|Protocol Violation|0|||
25031946|NCT00803790|50131020|FG002|Period 1|Protocol Violation|1|||
25031947|NCT00803790|50131021|FG003|Period 1|Protocol Violation|0|||
25031948|NCT00803790|50131018|FG000|Period 2|Adverse Event|0|||
25031949|NCT00803790|50131019|FG001|Period 2|Adverse Event|0|||
25031950|NCT00803790|50131020|FG002|Period 2|Adverse Event|1|||
25031951|NCT00803790|50131021|FG003|Period 2|Adverse Event|1|||
25031952|NCT00803790|50131018|FG000|Period 2|Withdrawal by Subject|1|||
25031953|NCT00803790|50131019|FG001|Period 2|Withdrawal by Subject|0|||
25031954|NCT00803790|50131020|FG002|Period 2|Withdrawal by Subject|0|||
25031955|NCT00803790|50131021|FG003|Period 2|Withdrawal by Subject|0|||
25031956|NCT00803790|50131018|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
25031957|NCT00803790|50131019|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
25031958|NCT00803790|50131020|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
25031959|NCT00803790|50131021|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
25031960|NCT00250458|50131069|FG000|Overall Study|Lost to Follow-up|4|||
25031961|NCT00250458|50131070|FG001|Overall Study|Lost to Follow-up|2|||
25031962|NCT00250458|50131069|FG000|Overall Study|Protocol Violation|0|||
25031963|NCT00250458|50131070|FG001|Overall Study|Protocol Violation|1|||
25031964|NCT00250458|50131069|FG000|Overall Study|Withdrawal by Subject|4|||
25031965|NCT00250458|50131070|FG001|Overall Study|Withdrawal by Subject|2|||
25031966|NCT00250458|50131069|FG000|Overall Study|Lack of Migraine Attack|20|||
25031967|NCT00250458|50131070|FG001|Overall Study|Lack of Migraine Attack|9|||
25031968|NCT00250458|50131069|FG000|Overall Study|Qualifying migraine but did not treat|3|||
25031969|NCT00250458|50131070|FG001|Overall Study|Qualifying migraine but did not treat|3|||
25031970|NCT00250458|50131069|FG000|Overall Study|Other|1|||
25031971|NCT00250458|50131070|FG001|Overall Study|Other|0|||
25031972|NCT01667133|50131088|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
25031973|NCT01667133|50131089|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
25031974|NCT01667133|50131090|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
25031975|NCT01667133|50131091|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
25031976|NCT01667133|50131092|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
25031977|NCT01667133|50131093|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
25031978|NCT01667133|50131094|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
25031979|NCT01667133|50131095|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
25031980|NCT01667133|50131096|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
25031981|NCT01667133|50131097|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
25031982|NCT01667133|50131098|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
25031983|NCT01667133|50131099|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
25031984|NCT01667133|50131088|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
25031985|NCT01667133|50131089|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
24945380|NCT00416520|50037901|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
24945381|NCT00416520|50037898|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
24945382|NCT00416520|50037899|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
24945383|NCT00416520|50037900|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
24945384|NCT00416520|50037901|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
24945385|NCT00533429|50037913|FG000|Overall Study|Adverse Event|3|||
25031986|NCT01667133|50131090|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
25031987|NCT01667133|50131091|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
25031988|NCT01667133|50131092|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
25031989|NCT01667133|50131093|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
25031990|NCT01667133|50131094|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
25031991|NCT01667133|50131095|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
25031992|NCT01667133|50131096|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
25031993|NCT01667133|50131097|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
25031994|NCT01667133|50131098|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
24945386|NCT00533429|50037914|FG001|Overall Study|Adverse Event|1|||
24945387|NCT00533429|50037913|FG000|Overall Study|Death|1|||
24945388|NCT00533429|50037914|FG001|Overall Study|Death|0|||
24945389|NCT00533429|50037913|FG000|Overall Study|Withdrawal by Subject|2|||
24945390|NCT00533429|50037914|FG001|Overall Study|Withdrawal by Subject|0|||
24945391|NCT00533429|50037913|FG000|Overall Study|Progressive Disease|12|||
24945392|NCT00533429|50037914|FG001|Overall Study|Progressive Disease|13|||
24945393|NCT00533429|50037913|FG000|Overall Study|Symptomatic deterioration|1|||
24945394|NCT00533429|50037914|FG001|Overall Study|Symptomatic deterioration|2|||
24945395|NCT00533273|50037924|FG000|Double-blind|Withdrew consent|0|||
24945396|NCT00533273|50037925|FG001|Double-blind|Withdrew consent|2|||
25031995|NCT01667133|50131099|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
25031996|NCT01667133|50131088|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
25275650|NCT00903175|50589503|FG000|Period 1 - First Line|Adverse Event|36|||
25031997|NCT01667133|50131089|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
25031998|NCT01667133|50131090|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
25031999|NCT01667133|50131091|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
25032000|NCT01667133|50131092|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
25032001|NCT01667133|50131093|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
25032002|NCT01667133|50131094|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
25032003|NCT01667133|50131095|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
25032004|NCT01667133|50131096|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
25032005|NCT01667133|50131097|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
25032006|NCT01667133|50131098|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
25032007|NCT01667133|50131099|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
25032008|NCT01667133|50131088|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
25032009|NCT01667133|50131089|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
25032010|NCT01667133|50131090|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
25032011|NCT01667133|50131091|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
25159461|NCT01920061|50279322|FG009|Overall Study|Lost to Follow-up|0|||
25159462|NCT01920061|50279323|FG010|Overall Study|Lost to Follow-up|3|||
24945397|NCT00533273|50037924|FG000|Open-label|Withdrawal by Subject|6|||
24945398|NCT00533273|50037925|FG001|Open-label|Withdrawal by Subject|0|||
24945399|NCT03891641|50037933|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
24945400|NCT03891641|50037934|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
24945401|NCT00339183|50037942|FG000|Overall Study|Adverse Event|5|||
24945402|NCT00339183|50037943|FG001|Overall Study|Adverse Event|3|||
24945403|NCT00339183|50037942|FG000|Overall Study|Withdrawal by Subject|16|||
24945404|NCT00339183|50037943|FG001|Overall Study|Withdrawal by Subject|19|||
24945405|NCT00339183|50037942|FG000|Overall Study|Physician Decision|2|||
24945406|NCT00339183|50037943|FG001|Overall Study|Physician Decision|4|||
24945407|NCT00339183|50037942|FG000|Overall Study|Lost to Follow-up|17|||
24945408|NCT00339183|50037943|FG001|Overall Study|Lost to Follow-up|17|||
24945409|NCT00339183|50037942|FG000|Overall Study|Protocol-specified criteria|12|||
24945410|NCT00339183|50037943|FG001|Overall Study|Protocol-specified criteria|8|||
24945411|NCT00339183|50037942|FG000|Overall Study|Missing reason|3|||
24945412|NCT00339183|50037943|FG001|Overall Study|Missing reason|1|||
24945413|NCT00339183|50037942|FG000|Overall Study|Other|46|||
24945414|NCT00339183|50037943|FG001|Overall Study|Other|40|||
24945415|NCT00339183|50037942|FG000|Overall Study|Ongoing|20|||
24945416|NCT00339183|50037943|FG001|Overall Study|Ongoing|13|||
24945417|NCT00333801|50037955|FG000|Overall Study|Moved to another state|5|||
24945418|NCT00333801|50037956|FG001|Overall Study|Moved to another state|3|||
24945419|NCT00333801|50037955|FG000|Overall Study|Lost to Follow-up|2|||
24945420|NCT00333801|50037956|FG001|Overall Study|Lost to Follow-up|0|||
24945421|NCT00333801|50037955|FG000|Overall Study|Incarcerated|1|||
24945422|NCT00333801|50037956|FG001|Overall Study|Incarcerated|2|||
24945423|NCT00333801|50037955|FG000|Overall Study|Withdrawal by Subject|0|||
24945424|NCT00333801|50037956|FG001|Overall Study|Withdrawal by Subject|1|||
24945425|NCT00532883|50037966|FG000|Overall Study|Adverse Event|1|||
24945426|NCT00532883|50037967|FG001|Overall Study|Adverse Event|0|||
24945427|NCT00532883|50037968|FG002|Overall Study|Adverse Event|0|||
24945428|NCT00532883|50037969|FG003|Overall Study|Adverse Event|1|||
24945429|NCT00532883|50037966|FG000|Overall Study|Lost to Follow-up|1|||
24945430|NCT00532883|50037967|FG001|Overall Study|Lost to Follow-up|1|||
24945431|NCT00532883|50037968|FG002|Overall Study|Lost to Follow-up|1|||
24945432|NCT00532883|50037969|FG003|Overall Study|Lost to Follow-up|0|||
24945433|NCT00532883|50037966|FG000|Overall Study|Withdrawal by Subject|0|||
24945434|NCT00532883|50037967|FG001|Overall Study|Withdrawal by Subject|1|||
24945435|NCT00532883|50037968|FG002|Overall Study|Withdrawal by Subject|1|||
24945436|NCT00532883|50037969|FG003|Overall Study|Withdrawal by Subject|0|||
24945437|NCT00532883|50037966|FG000|Overall Study|Subject was Nonadherent|0|||
24945438|NCT00532883|50037967|FG001|Overall Study|Subject was Nonadherent|1|||
24945439|NCT00532883|50037968|FG002|Overall Study|Subject was Nonadherent|1|||
25159463|NCT01920061|50279324|FG011|Overall Study|Lost to Follow-up|0|||
25159464|NCT01920061|50279325|FG012|Overall Study|Lost to Follow-up|0|||
24945440|NCT00532883|50037969|FG003|Overall Study|Subject was Nonadherent|0|||
24945441|NCT00532883|50037966|FG000|Overall Study|Early Study Termination|4|||
24945442|NCT00532883|50037967|FG001|Overall Study|Early Study Termination|4|||
24945443|NCT00532883|50037968|FG002|Overall Study|Early Study Termination|1|||
25032012|NCT01667133|50131092|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
25159465|NCT01920061|50279326|FG013|Overall Study|Lost to Follow-up|0|||
25159466|NCT01920061|50279327|FG014|Overall Study|Lost to Follow-up|0|||
24945444|NCT00532883|50037969|FG003|Overall Study|Early Study Termination|4|||
24945445|NCT00354159|50037981|FG000|Randomized Study Period|Withdrawal by Subject|5|||
24945446|NCT00354159|50037982|FG001|Randomized Study Period|Withdrawal by Subject|3|||
24945447|NCT00354159|50037981|FG000|Randomized Study Period|Physician Decision|6|||
24945448|NCT00354159|50037982|FG001|Randomized Study Period|Physician Decision|10|||
24945449|NCT00354159|50037981|FG000|Randomized Study Period|Lost to Follow-up|4|||
25032013|NCT01667133|50131093|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
25032014|NCT01667133|50131094|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
25032015|NCT01667133|50131095|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
25032016|NCT01667133|50131096|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
25032017|NCT01667133|50131097|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
25032018|NCT01667133|50131098|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
25032019|NCT01667133|50131099|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
25032020|NCT01667133|50131088|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
25032021|NCT01667133|50131089|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
25032022|NCT01667133|50131090|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
25032023|NCT01667133|50131091|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
25032024|NCT01667133|50131092|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
25032025|NCT01667133|50131093|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
25032026|NCT01667133|50131094|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
25032027|NCT01667133|50131095|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
25032028|NCT01667133|50131096|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
25032029|NCT01667133|50131097|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
25032030|NCT01667133|50131098|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
25032031|NCT01667133|50131099|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
25032032|NCT01667133|50131088|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
25032033|NCT01667133|50131089|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
25032034|NCT01667133|50131090|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
25032035|NCT01667133|50131091|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
25032036|NCT01667133|50131092|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
25032037|NCT01667133|50131093|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
25032038|NCT01667133|50131094|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
25032039|NCT01667133|50131095|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
25032040|NCT01667133|50131096|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
25159467|NCT01920061|50279328|FG015|Overall Study|Lost to Follow-up|0|||
25159468|NCT01920061|50279329|FG016|Overall Study|Lost to Follow-up|0|||
25159469|NCT01920061|50279330|FG017|Overall Study|Lost to Follow-up|1|||
25159470|NCT01920061|50279331|FG018|Overall Study|Lost to Follow-up|4|||
25159471|NCT01920061|50279332|FG019|Overall Study|Lost to Follow-up|3|||
25159472|NCT01920061|50279313|FG000|Overall Study|Other|1|||
25159473|NCT01920061|50279314|FG001|Overall Study|Other|1|||
25032041|NCT01667133|50131097|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
25032042|NCT01667133|50131098|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
25032043|NCT01667133|50131099|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
25032044|NCT01667133|50131088|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
25032045|NCT01667133|50131089|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
25032046|NCT01667133|50131090|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
25032047|NCT01667133|50131091|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
25032048|NCT01667133|50131092|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
25032049|NCT01667133|50131093|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
25032050|NCT01667133|50131094|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
25032051|NCT01667133|50131095|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
25032052|NCT01667133|50131096|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
25032053|NCT01667133|50131097|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
25032054|NCT01667133|50131098|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
25032055|NCT01667133|50131099|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
25032056|NCT01667133|50131088|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
25032057|NCT01667133|50131089|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
25032058|NCT01667133|50131090|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
25032059|NCT01667133|50131091|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
25159474|NCT01920061|50279315|FG002|Overall Study|Other|2|||
25159475|NCT01920061|50279316|FG003|Overall Study|Other|1|||
25032060|NCT01667133|50131092|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
25032061|NCT01667133|50131093|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
25032062|NCT01667133|50131094|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
25032063|NCT01667133|50131095|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
25032064|NCT01667133|50131096|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
25032065|NCT01667133|50131097|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
25032066|NCT01667133|50131098|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
25159476|NCT01920061|50279317|FG004|Overall Study|Other|0|||
25159477|NCT01920061|50279318|FG005|Overall Study|Other|1|||
25159478|NCT01920061|50279319|FG006|Overall Study|Other|0|||
25159479|NCT01920061|50279320|FG007|Overall Study|Other|0|||
25032067|NCT01667133|50131099|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
25032068|NCT01667133|50131088|FG000|Phase 2: Dose-expansion|Death|0|||
25032069|NCT01667133|50131089|FG001|Phase 2: Dose-expansion|Death|0|||
25032070|NCT01667133|50131090|FG002|Phase 2: Dose-expansion|Death|0|||
25159480|NCT01920061|50279321|FG008|Overall Study|Other|0|||
25159481|NCT01920061|50279322|FG009|Overall Study|Other|1|||
25032071|NCT01667133|50131091|FG003|Phase 2: Dose-expansion|Death|0|||
25159482|NCT01920061|50279323|FG010|Overall Study|Other|1|||
25159483|NCT01920061|50279324|FG011|Overall Study|Other|2|||
25159484|NCT01920061|50279325|FG012|Overall Study|Other|1|||
25032072|NCT01667133|50131092|FG004|Phase 2: Dose-expansion|Death|0|||
25032073|NCT01667133|50131093|FG005|Phase 2: Dose-expansion|Death|0|||
25032074|NCT01667133|50131094|FG006|Phase 2: Dose-expansion|Death|0|||
25032075|NCT01667133|50131095|FG007|Phase 2: Dose-expansion|Death|0|||
25032076|NCT01667133|50131096|FG008|Phase 2: Dose-expansion|Death|0|||
25032077|NCT01667133|50131097|FG009|Phase 2: Dose-expansion|Death|1|||
25032078|NCT01667133|50131098|FG010|Phase 2: Dose-expansion|Death|0|||
25032079|NCT01667133|50131099|FG011|Phase 2: Dose-expansion|Death|0|||
25032080|NCT01667133|50131088|FG000|Phase 2: Dose-expansion|Other|0|||
25032081|NCT01667133|50131089|FG001|Phase 2: Dose-expansion|Other|0|||
25032082|NCT01667133|50131090|FG002|Phase 2: Dose-expansion|Other|0|||
25032083|NCT01667133|50131091|FG003|Phase 2: Dose-expansion|Other|0|||
25032084|NCT01667133|50131092|FG004|Phase 2: Dose-expansion|Other|0|||
25032085|NCT01667133|50131093|FG005|Phase 2: Dose-expansion|Other|0|||
25032086|NCT01667133|50131094|FG006|Phase 2: Dose-expansion|Other|0|||
25032087|NCT01667133|50131095|FG007|Phase 2: Dose-expansion|Other|0|||
25032088|NCT01667133|50131096|FG008|Phase 2: Dose-expansion|Other|0|||
25032089|NCT01667133|50131097|FG009|Phase 2: Dose-expansion|Other|0|||
25032090|NCT01667133|50131098|FG010|Phase 2: Dose-expansion|Other|0|||
25032091|NCT01667133|50131099|FG011|Phase 2: Dose-expansion|Other|1|||
25032092|NCT01181778|50131164|FG000|Overall Study|Physician Decision|48|||
25032093|NCT00092118|50131172|FG000|Overall Study|Adverse Event|35|||
25032094|NCT00092118|50131173|FG001|Overall Study|Adverse Event|32|||
25032095|NCT00092118|50131172|FG000|Overall Study|Lack of Efficacy|12|||
25032096|NCT00092118|50131173|FG001|Overall Study|Lack of Efficacy|14|||
25032097|NCT00092118|50131172|FG000|Overall Study|Lost to Follow-up|4|||
25032098|NCT00092118|50131173|FG001|Overall Study|Lost to Follow-up|3|||
25032099|NCT00092118|50131172|FG000|Overall Study|Protocol Violation|23|||
25032100|NCT00092118|50131173|FG001|Overall Study|Protocol Violation|25|||
25032101|NCT00092118|50131172|FG000|Overall Study|Withdrawal by Subject|4|||
25032102|NCT00092118|50131173|FG001|Overall Study|Withdrawal by Subject|10|||
25032103|NCT00092118|50131172|FG000|Overall Study|Other|6|||
25032104|NCT00092118|50131173|FG001|Overall Study|Other|5|||
25032105|NCT03261947|50131184|FG000|Overall Study|Death|10|||
25032106|NCT03261947|50131185|FG001|Overall Study|Death|13|||
25032107|NCT03261947|50131186|FG002|Overall Study|Death|17|||
25032108|NCT03261947|50131187|FG003|Overall Study|Death|12|||
25032109|NCT03261947|50131188|FG004|Overall Study|Death|8|||
25032110|NCT03261947|50131184|FG000|Overall Study|Lost to Follow-up|0|||
25032111|NCT03261947|50131185|FG001|Overall Study|Lost to Follow-up|0|||
25032112|NCT03261947|50131186|FG002|Overall Study|Lost to Follow-up|2|||
25032113|NCT03261947|50131187|FG003|Overall Study|Lost to Follow-up|1|||
25032114|NCT03261947|50131188|FG004|Overall Study|Lost to Follow-up|0|||
25032115|NCT03261947|50131184|FG000|Overall Study|Withdrawal by Subject|0|||
25032116|NCT03261947|50131185|FG001|Overall Study|Withdrawal by Subject|0|||
25032117|NCT03261947|50131186|FG002|Overall Study|Withdrawal by Subject|3|||
25032118|NCT03261947|50131187|FG003|Overall Study|Withdrawal by Subject|0|||
25032119|NCT03261947|50131188|FG004|Overall Study|Withdrawal by Subject|1|||
25032120|NCT03261947|50131184|FG000|Overall Study|Site Terminated by Sponsor|0|||
25032121|NCT03261947|50131185|FG001|Overall Study|Site Terminated by Sponsor|0|||
25032122|NCT03261947|50131186|FG002|Overall Study|Site Terminated by Sponsor|4|||
25032123|NCT03261947|50131187|FG003|Overall Study|Site Terminated by Sponsor|7|||
25032124|NCT03261947|50131188|FG004|Overall Study|Site Terminated by Sponsor|5|||
25032125|NCT03261947|50131184|FG000|Overall Study|Reason not Specified|2|||
25032126|NCT03261947|50131185|FG001|Overall Study|Reason not Specified|0|||
25032127|NCT03261947|50131186|FG002|Overall Study|Reason not Specified|4|||
25032128|NCT03261947|50131187|FG003|Overall Study|Reason not Specified|1|||
25032129|NCT03261947|50131188|FG004|Overall Study|Reason not Specified|3|||
25032130|NCT03034044|50131204|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
25032131|NCT03098979|50131223|FG000|Overall Study|Adverse Event|1|||
25032132|NCT03098979|50131224|FG001|Overall Study|Adverse Event|0|||
25032133|NCT03098979|50131225|FG002|Overall Study|Adverse Event|1|||
25032134|NCT03098979|50131226|FG003|Overall Study|Adverse Event|4|||
25032135|NCT03098979|50131227|FG004|Overall Study|Adverse Event|6|||
25032136|NCT03098979|50131228|FG005|Overall Study|Adverse Event|1|||
25032137|NCT03098979|50131223|FG000|Overall Study|Withdrawal by Subject|2|||
25032138|NCT03098979|50131224|FG001|Overall Study|Withdrawal by Subject|1|||
25032139|NCT03098979|50131225|FG002|Overall Study|Withdrawal by Subject|1|||
25032140|NCT03098979|50131226|FG003|Overall Study|Withdrawal by Subject|1|||
25032141|NCT03098979|50131227|FG004|Overall Study|Withdrawal by Subject|2|||
25032142|NCT03098979|50131228|FG005|Overall Study|Withdrawal by Subject|1|||
25032143|NCT03098979|50131223|FG000|Overall Study|Death|1|||
25275651|NCT00903175|50589504|FG001|Period 1 - First Line|Adverse Event|50|||
25032144|NCT03098979|50131224|FG001|Overall Study|Death|0|||
25032145|NCT03098979|50131225|FG002|Overall Study|Death|2|||
25032146|NCT03098979|50131226|FG003|Overall Study|Death|0|||
25032147|NCT03098979|50131227|FG004|Overall Study|Death|1|||
25032148|NCT03098979|50131228|FG005|Overall Study|Death|0|||
25032149|NCT03098979|50131223|FG000|Overall Study|Physician Decision|2|||
25032150|NCT03098979|50131224|FG001|Overall Study|Physician Decision|1|||
25032151|NCT03098979|50131225|FG002|Overall Study|Physician Decision|0|||
25032152|NCT03098979|50131226|FG003|Overall Study|Physician Decision|0|||
25032153|NCT03098979|50131227|FG004|Overall Study|Physician Decision|0|||
25032154|NCT03098979|50131228|FG005|Overall Study|Physician Decision|0|||
25032155|NCT03098979|50131223|FG000|Overall Study|Non-compliance|0|||
25032156|NCT03098979|50131224|FG001|Overall Study|Non-compliance|0|||
25032157|NCT03098979|50131225|FG002|Overall Study|Non-compliance|0|||
25032158|NCT03098979|50131226|FG003|Overall Study|Non-compliance|0|||
25032159|NCT03098979|50131227|FG004|Overall Study|Non-compliance|0|||
25032160|NCT03098979|50131228|FG005|Overall Study|Non-compliance|1|||
25032161|NCT03098979|50131223|FG000|Overall Study|Protocol Violation|0|||
25032162|NCT03098979|50131224|FG001|Overall Study|Protocol Violation|0|||
25032163|NCT03098979|50131225|FG002|Overall Study|Protocol Violation|0|||
25032164|NCT03098979|50131226|FG003|Overall Study|Protocol Violation|0|||
25032165|NCT03098979|50131227|FG004|Overall Study|Protocol Violation|0|||
25032166|NCT03098979|50131228|FG005|Overall Study|Protocol Violation|1|||
25032167|NCT03261167|50131244|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
25032168|NCT03261167|50131245|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
25032169|NCT03261167|50131244|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
25032170|NCT03261167|50131245|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
25032171|NCT03261167|50131244|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
25032172|NCT03261167|50131245|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
25032173|NCT03261167|50131244|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
25032174|NCT03261167|50131245|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
25032175|NCT03261167|50131244|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
25032176|NCT03261167|50131245|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
25032177|NCT03294941|50131259|FG000|Overall Study|Withdrawal by Subject|0|||
25032178|NCT03294941|50131260|FG001|Overall Study|Withdrawal by Subject|2|||
25032179|NCT03098433|50131267|FG000|Overall Study|Withdrawal by Subject|10|||
25032180|NCT03294317|50131272|FG000|Overall Study|Physician Decision|1|||
25032181|NCT03294317|50131272|FG000|Overall Study|Withdrawal by Subject|6|||
25032182|NCT03294317|50131272|FG000|Overall Study|Lost to Follow-up|1|||
25032183|NCT03294317|50131272|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
25032184|NCT03294317|50131272|FG000|Overall Study|Failed HB lead implant|8|||
25032185|NCT03294317|50131272|FG000|Overall Study|Received CRT instead|1|||
25032186|NCT03294317|50131272|FG000|Overall Study|Exited after lead revision|2|||
25032187|NCT03292913|50131278|FG000|Overall Study|Death|9|||
25032188|NCT03292913|50131279|FG001|Overall Study|Death|3|||
25032189|NCT03292913|50131278|FG000|Overall Study|Lost to Follow-up|49|||
25032190|NCT03292913|50131279|FG001|Overall Study|Lost to Follow-up|49|||
25032191|NCT03292913|50131278|FG000|Overall Study|Withdrawal by Subject|2|||
25032192|NCT03292913|50131279|FG001|Overall Study|Withdrawal by Subject|0|||
25032193|NCT03292913|50131278|FG000|Overall Study|Clinic closed due to COVID|22|||
25032194|NCT03292913|50131279|FG001|Overall Study|Clinic closed due to COVID|36|||
25032195|NCT03291587|50131291|FG000|Overall Study|Lost to Follow-up|62|||
25032196|NCT03291587|50131292|FG001|Overall Study|Lost to Follow-up|43|||
25032197|NCT03291587|50131291|FG000|Overall Study|Refused to Answer|5|||
25032198|NCT03291587|50131292|FG001|Overall Study|Refused to Answer|2|||
25032199|NCT03291587|50131291|FG000|Overall Study|Death|2|||
25032200|NCT03291587|50131292|FG001|Overall Study|Death|4|||
25032201|NCT03291587|50131291|FG000|Overall Study|Not interested in participating|8|||
25032202|NCT03291587|50131292|FG001|Overall Study|Not interested in participating|6|||
25032203|NCT03291587|50131291|FG000|Overall Study|Too busy to participate|4|||
25032204|NCT03291587|50131292|FG001|Overall Study|Too busy to participate|2|||
24945450|NCT00354159|50037982|FG001|Randomized Study Period|Lost to Follow-up|0|||
24945451|NCT00354159|50037981|FG000|Randomized Study Period|Death|7|||
24945452|NCT00354159|50037982|FG001|Randomized Study Period|Death|9|||
24945453|NCT00354159|50037981|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
24945454|NCT00354159|50037982|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
24945455|NCT00354159|50037981|FG000|Long-term Follow-up|Physician Decision|127|||
24945456|NCT00354159|50037982|FG001|Long-term Follow-up|Physician Decision|122|||
24945457|NCT00354159|50037981|FG000|Long-term Follow-up|Lost to Follow-up|1|||
24945458|NCT00354159|50037982|FG001|Long-term Follow-up|Lost to Follow-up|0|||
24945459|NCT00354159|50037981|FG000|Long-term Follow-up|Death|14|||
24945460|NCT00354159|50037982|FG001|Long-term Follow-up|Death|11|||
24945461|NCT00354159|50037981|FG000|Long-term Follow-up|Study Closed|29|||
24945462|NCT00354159|50037982|FG001|Long-term Follow-up|Study Closed|34|||
24945463|NCT00338949|50037997|FG000|Subject Screening|Screen failures|11|||
24945464|NCT00338949|50037998|FG001|Subject Screening|Screen failures|11|||
24945465|NCT00338949|50037997|FG000|Randomization|Withdrawal by Subject|1|||
24945466|NCT00338949|50037998|FG001|Randomization|Withdrawal by Subject|0|||
24945467|NCT00338949|50037997|FG000|Randomization|Adverse Event|0|||
24945468|NCT00338949|50037998|FG001|Randomization|Adverse Event|5|||
25275652|NCT00903175|50589503|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
25275653|NCT00903175|50589504|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
24945469|NCT00332709|50038006|FG000|Overall Study|Adverse Event|11|||
25032205|NCT03210961|50131323|FG000|Overall Study|Adverse Event|0|||
25032206|NCT03210961|50131324|FG001|Overall Study|Adverse Event|0|||
24945470|NCT00332709|50038007|FG001|Overall Study|Adverse Event|14|||
24945471|NCT00332709|50038006|FG000|Overall Study|Withdrawal by Subject|2|||
24945472|NCT00332709|50038007|FG001|Overall Study|Withdrawal by Subject|3|||
24945473|NCT00332709|50038006|FG000|Overall Study|Lost to Follow-up|2|||
24945474|NCT00332709|50038007|FG001|Overall Study|Lost to Follow-up|0|||
25032207|NCT03210961|50131325|FG002|Overall Study|Adverse Event|0|||
25032208|NCT03210961|50131326|FG003|Overall Study|Adverse Event|0|||
25032209|NCT03210961|50131327|FG004|Overall Study|Adverse Event|0|||
25159485|NCT01920061|50279326|FG013|Overall Study|Other|4|||
25159486|NCT01920061|50279327|FG014|Overall Study|Other|0|||
25159487|NCT01920061|50279328|FG015|Overall Study|Other|1|||
25159488|NCT01920061|50279329|FG016|Overall Study|Other|1|||
25032210|NCT03210961|50131328|FG005|Overall Study|Adverse Event|0|||
25032211|NCT03210961|50131329|FG006|Overall Study|Adverse Event|0|||
25032212|NCT03210961|50131330|FG007|Overall Study|Adverse Event|0|||
25032213|NCT03210961|50131331|FG008|Overall Study|Adverse Event|0|||
25032214|NCT03210961|50131332|FG009|Overall Study|Adverse Event|0|||
25032215|NCT03210961|50131333|FG010|Overall Study|Adverse Event|0|||
25032216|NCT03210961|50131334|FG011|Overall Study|Adverse Event|0|||
25159489|NCT01920061|50279330|FG017|Overall Study|Other|0|||
25159490|NCT01920061|50279331|FG018|Overall Study|Other|1|||
25159491|NCT01920061|50279332|FG019|Overall Study|Other|1|||
25159492|NCT01920061|50279313|FG000|Overall Study|Participant refused further follow-up|0|||
25159493|NCT01920061|50279314|FG001|Overall Study|Participant refused further follow-up|0|||
25032217|NCT03210961|50131335|FG012|Overall Study|Adverse Event|0|||
25032218|NCT03210961|50131336|FG013|Overall Study|Adverse Event|1|||
25032219|NCT03210961|50131337|FG014|Overall Study|Adverse Event|0|||
25032220|NCT03210961|50131323|FG000|Overall Study|Lost to Follow-up|0|||
25032221|NCT03210961|50131324|FG001|Overall Study|Lost to Follow-up|0|||
25032222|NCT03210961|50131325|FG002|Overall Study|Lost to Follow-up|0|||
25032223|NCT03210961|50131326|FG003|Overall Study|Lost to Follow-up|0|||
25032224|NCT03210961|50131327|FG004|Overall Study|Lost to Follow-up|0|||
25032225|NCT03210961|50131328|FG005|Overall Study|Lost to Follow-up|0|||
25032226|NCT03210961|50131329|FG006|Overall Study|Lost to Follow-up|0|||
25032227|NCT03210961|50131330|FG007|Overall Study|Lost to Follow-up|0|||
25032228|NCT03210961|50131331|FG008|Overall Study|Lost to Follow-up|0|||
25032229|NCT03210961|50131332|FG009|Overall Study|Lost to Follow-up|0|||
25032230|NCT03210961|50131333|FG010|Overall Study|Lost to Follow-up|0|||
25032231|NCT03210961|50131334|FG011|Overall Study|Lost to Follow-up|0|||
25032232|NCT03210961|50131335|FG012|Overall Study|Lost to Follow-up|0|||
25032233|NCT03210961|50131336|FG013|Overall Study|Lost to Follow-up|0|||
25032234|NCT03210961|50131337|FG014|Overall Study|Lost to Follow-up|1|||
25032235|NCT03210961|50131323|FG000|Overall Study|Withdrawal by Subject|0|||
25032236|NCT03210961|50131324|FG001|Overall Study|Withdrawal by Subject|0|||
25032237|NCT03210961|50131325|FG002|Overall Study|Withdrawal by Subject|0|||
25032238|NCT03210961|50131326|FG003|Overall Study|Withdrawal by Subject|0|||
25159494|NCT01920061|50279315|FG002|Overall Study|Participant refused further follow-up|0|||
25186204|NCT01496846|50336148|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
25275654|NCT00903175|50589503|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
24945475|NCT00332709|50038006|FG000|Overall Study|Administrative Problems|0|||
24945476|NCT00332709|50038007|FG001|Overall Study|Administrative Problems|3|||
24945477|NCT00332709|50038006|FG000|Overall Study|Abnormal test procedure result|1|||
24945478|NCT00332709|50038007|FG001|Overall Study|Abnormal test procedure result|0|||
24945479|NCT00332241|50038015|FG000|Overall Study|Lack of Efficacy|6|||
24945480|NCT00332241|50038016|FG001|Overall Study|Lack of Efficacy|1|||
24945481|NCT00332241|50038015|FG000|Overall Study|Adverse Event|3|||
24945482|NCT00332241|50038016|FG001|Overall Study|Adverse Event|5|||
24945483|NCT00332241|50038015|FG000|Overall Study|Withdrawal by Subject|2|||
24945484|NCT00332241|50038016|FG001|Overall Study|Withdrawal by Subject|1|||
24945485|NCT00332241|50038015|FG000|Overall Study|Lost to Follow-up|4|||
24945486|NCT00332241|50038016|FG001|Overall Study|Lost to Follow-up|1|||
24945487|NCT00337935|50038024|FG000|Overall Study|Adverse Event|2|||
24945488|NCT00337935|50038025|FG001|Overall Study|Adverse Event|5|||
24945489|NCT00337935|50038024|FG000|Overall Study|Death|2|||
24945490|NCT00337935|50038025|FG001|Overall Study|Death|8|||
24945491|NCT00337935|50038024|FG000|Overall Study|Physician Decision|1|||
25032239|NCT03210961|50131327|FG004|Overall Study|Withdrawal by Subject|0|||
25159495|NCT01920061|50279316|FG003|Overall Study|Participant refused further follow-up|0|||
24945492|NCT00337935|50038025|FG001|Overall Study|Physician Decision|1|||
25032240|NCT03210961|50131328|FG005|Overall Study|Withdrawal by Subject|0|||
24945493|NCT00337935|50038024|FG000|Overall Study|Lost to Follow-up|0|||
25032241|NCT03210961|50131329|FG006|Overall Study|Withdrawal by Subject|0|||
25032242|NCT03210961|50131330|FG007|Overall Study|Withdrawal by Subject|0|||
25032243|NCT03210961|50131331|FG008|Overall Study|Withdrawal by Subject|0|||
25032244|NCT03210961|50131332|FG009|Overall Study|Withdrawal by Subject|0|||
25159496|NCT01920061|50279317|FG004|Overall Study|Participant refused further follow-up|1|||
25032245|NCT03210961|50131333|FG010|Overall Study|Withdrawal by Subject|0|||
25032246|NCT03210961|50131334|FG011|Overall Study|Withdrawal by Subject|0|||
25032247|NCT03210961|50131335|FG012|Overall Study|Withdrawal by Subject|0|||
25032248|NCT03210961|50131336|FG013|Overall Study|Withdrawal by Subject|0|||
25032249|NCT03210961|50131337|FG014|Overall Study|Withdrawal by Subject|1|||
25032250|NCT03210961|50131323|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
25032251|NCT03210961|50131324|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
25032252|NCT03210961|50131325|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
25032253|NCT03210961|50131326|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
25032254|NCT03210961|50131327|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
25032255|NCT03210961|50131328|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
25032256|NCT03210961|50131329|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
25032257|NCT03210961|50131330|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
25032258|NCT03210961|50131331|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
25032259|NCT03210961|50131332|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
25032260|NCT03210961|50131333|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
25032261|NCT03210961|50131334|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
25032262|NCT03210961|50131335|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
25032263|NCT03210961|50131336|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
25032264|NCT03210961|50131337|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
25032265|NCT03210961|50131323|FG000|Overall Study|Other|0|||
25032266|NCT03210961|50131324|FG001|Overall Study|Other|0|||
25032267|NCT03210961|50131325|FG002|Overall Study|Other|0|||
25032268|NCT03210961|50131326|FG003|Overall Study|Other|1|||
25032269|NCT03210961|50131327|FG004|Overall Study|Other|0|||
25032270|NCT03210961|50131328|FG005|Overall Study|Other|0|||
25032271|NCT03210961|50131329|FG006|Overall Study|Other|1|||
25032272|NCT03210961|50131330|FG007|Overall Study|Other|0|||
25032273|NCT03210961|50131331|FG008|Overall Study|Other|0|||
25032274|NCT03210961|50131332|FG009|Overall Study|Other|0|||
25032275|NCT03210961|50131333|FG010|Overall Study|Other|1|||
25032276|NCT03210961|50131334|FG011|Overall Study|Other|0|||
25032277|NCT03210961|50131335|FG012|Overall Study|Other|2|||
25032278|NCT03210961|50131336|FG013|Overall Study|Other|2|||
25032279|NCT03210961|50131337|FG014|Overall Study|Other|0|||
25032280|NCT03242759|50131390|FG000|Overall Study|Adverse Event|5|||
25032281|NCT03242759|50131391|FG001|Overall Study|Adverse Event|1|||
25032282|NCT03242759|50131390|FG000|Overall Study|Withdrawal by Subject|4|||
25032283|NCT03242759|50131391|FG001|Overall Study|Withdrawal by Subject|3|||
25032284|NCT03242759|50131390|FG000|Overall Study|Lost to Follow-up|3|||
25032285|NCT03242759|50131391|FG001|Overall Study|Lost to Follow-up|1|||
25032286|NCT03242759|50131390|FG000|Overall Study|Administrative problems|1|||
25032287|NCT03242759|50131391|FG001|Overall Study|Administrative problems|1|||
25032288|NCT03242759|50131390|FG000|Overall Study|Death|22|||
25032289|NCT03242759|50131391|FG001|Overall Study|Death|0|||
25032290|NCT03242759|50131390|FG000|Overall Study|Change visit schedule|0|||
25032291|NCT03242759|50131391|FG001|Overall Study|Change visit schedule|1|||
25032292|NCT03097029|50131397|FG000|Overall Study|Withdrawal by Subject|1|||
25032293|NCT03257813|50131403|FG000|Overall Study|Protocol Violation|6|||
25032294|NCT03257813|50131404|FG001|Overall Study|Protocol Violation|3|||
25032295|NCT03210259|50131415|FG000|12-Week Run-in Period|Adverse Event|1|||
25032296|NCT03210259|50131416|FG001|12-Week Run-in Period|Adverse Event|0|||
25032297|NCT03210259|50131417|FG002|12-Week Run-in Period|Adverse Event|0|||
25032298|NCT03210259|50131415|FG000|12-Week Run-in Period|Death|1|||
25032299|NCT03210259|50131416|FG001|12-Week Run-in Period|Death|0|||
25032300|NCT03210259|50131417|FG002|12-Week Run-in Period|Death|0|||
25032301|NCT03210259|50131415|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
25032302|NCT03210259|50131416|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
25032303|NCT03210259|50131417|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
25032304|NCT03210259|50131415|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
25032305|NCT03210259|50131416|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
25032306|NCT03210259|50131417|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
25032307|NCT03210259|50131415|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
25032308|NCT03210259|50131416|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
25032309|NCT03210259|50131417|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
25032310|NCT03210259|50131415|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
25032311|NCT03210259|50131416|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
25032312|NCT03210259|50131417|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
25032313|NCT03210259|50131415|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
25032314|NCT03210259|50131416|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
25032315|NCT03210259|50131417|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
25032316|NCT03210259|50131415|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
25032317|NCT03210259|50131416|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
25032318|NCT03210259|50131417|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
25275655|NCT00903175|50589504|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
25032319|NCT03210259|50131415|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
25032320|NCT03210259|50131416|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
25032321|NCT03210259|50131417|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
25032322|NCT03210259|50131415|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
25032323|NCT03210259|50131416|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
25032324|NCT03210259|50131417|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
25032325|NCT03210259|50131415|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
25032326|NCT03210259|50131416|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
24945494|NCT00337935|50038025|FG001|Overall Study|Lost to Follow-up|1|||
24945495|NCT00337935|50038024|FG000|Overall Study|Protocol Violation|4|||
24945496|NCT00337935|50038025|FG001|Overall Study|Protocol Violation|3|||
25032327|NCT03210259|50131417|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
25032328|NCT03257657|50131426|FG000|Overall Study|Lost to Follow-up|0|||
25032329|NCT03257657|50131427|FG001|Overall Study|Lost to Follow-up|3|||
25032330|NCT03257657|50131426|FG000|Overall Study|Withdrawn|0|||
25032331|NCT03257657|50131427|FG001|Overall Study|Withdrawn|1|||
25032332|NCT03257657|50131426|FG000|Overall Study|Noted not eligible right after enrolled|0|||
25032333|NCT03257657|50131427|FG001|Overall Study|Noted not eligible right after enrolled|1|||
25032334|NCT02496611|50131436|FG000|Overall Study|Lost to Follow-up|2|||
25032335|NCT02496611|50131437|FG001|Overall Study|Lost to Follow-up|1|||
25032336|NCT02496611|50131436|FG000|Overall Study|Withdrawal by Subject|5|||
25032337|NCT02496611|50131437|FG001|Overall Study|Withdrawal by Subject|2|||
25032338|NCT03237481|50131447|FG000|Overall Study|Lost to Follow-up|1|||
25032339|NCT03237481|50131448|FG001|Overall Study|Lost to Follow-up|0|||
25032340|NCT03237481|50131449|FG002|Overall Study|Lost to Follow-up|0|||
25032341|NCT03237481|50131447|FG000|Overall Study|Protocol Violation|1|||
25032342|NCT03237481|50131448|FG001|Overall Study|Protocol Violation|0|||
25032343|NCT03237481|50131449|FG002|Overall Study|Protocol Violation|0|||
25032344|NCT03237481|50131447|FG000|Overall Study|Withdrawal by Subject|3|||
25032345|NCT03237481|50131448|FG001|Overall Study|Withdrawal by Subject|2|||
25032346|NCT03237481|50131449|FG002|Overall Study|Withdrawal by Subject|1|||
25032347|NCT03222349|50131457|FG000|Overall Study|Treatment B not done|5|||
25032348|NCT03222349|50131458|FG001|Overall Study|Treatment B not done|0|||
25032349|NCT03222349|50131457|FG000|Overall Study|Lost to Follow-up|1|||
25032350|NCT03222349|50131458|FG001|Overall Study|Lost to Follow-up|2|||
25032351|NCT03222349|50131457|FG000|Overall Study|Withdrawal by Subject|1|||
25032352|NCT03222349|50131458|FG001|Overall Study|Withdrawal by Subject|0|||
25032353|NCT03222349|50131457|FG000|Overall Study|Treatment A not done|0|||
25032354|NCT03222349|50131458|FG001|Overall Study|Treatment A not done|5|||
25032355|NCT03222349|50131457|FG000|Overall Study|Study terminated by sponsor|1|||
25032356|NCT03222349|50131458|FG001|Overall Study|Study terminated by sponsor|0|||
24945497|NCT00337935|50038024|FG000|Overall Study|Withdrawal by Subject|1|||
24945498|NCT00337935|50038025|FG001|Overall Study|Withdrawal by Subject|7|||
25032357|NCT02927925|50131471|FG000|Overall Study|Death|16|||
25032358|NCT02927925|50131471|FG000|Overall Study|Physician Decision|1|||
25032359|NCT02927925|50131471|FG000|Overall Study|Withdrawal by Subject|11|||
25032360|NCT02927925|50131471|FG000|Overall Study|Other|3|||
25032361|NCT02927925|50131471|FG000|Overall Study|Disease progression at clinical cutoff|1|||
25032362|NCT03208933|50131475|FG000|Overall Study|Death|3|||
25032363|NCT03208933|50131475|FG000|Overall Study|Withdrawal by Subject|3|||
25032364|NCT03208933|50131475|FG000|Overall Study|Adverse Event|1|||
25032365|NCT03208933|50131475|FG000|Overall Study|Lost to Follow-up|2|||
25032366|NCT03208933|50131475|FG000|Overall Study|Physician Decision|3|||
25032367|NCT03208933|50131475|FG000|Overall Study|Protocol Violation|1|||
24945499|NCT00337935|50038024|FG000|Overall Study|Other|0|||
24945500|NCT00337935|50038025|FG001|Overall Study|Other|1|||
24945501|NCT00337935|50038024|FG000|Overall Study|Lack of Efficacy|0|||
24945502|NCT00337935|50038025|FG001|Overall Study|Lack of Efficacy|1|||
24945503|NCT00337779|50038034|FG000|Overall Study|Withdrawal by Subject|10|||
24945504|NCT00337779|50038035|FG001|Overall Study|Withdrawal by Subject|12|||
24945505|NCT00337779|50038034|FG000|Overall Study|Sponsor decision|1|||
24945506|NCT00337779|50038035|FG001|Overall Study|Sponsor decision|1|||
24945507|NCT00337779|50038034|FG000|Overall Study|Physician Decision|3|||
24945508|NCT00337779|50038035|FG001|Overall Study|Physician Decision|6|||
25032368|NCT02499120|50131481|FG000|Overall Study|Death|45|||
25032369|NCT02499120|50131482|FG001|Overall Study|Death|42|||
25032370|NCT02499120|50131481|FG000|Overall Study|Lost to Follow-up|1|||
25032371|NCT02499120|50131482|FG001|Overall Study|Lost to Follow-up|2|||
25032372|NCT02499120|50131481|FG000|Overall Study|Participant refused further follow-up|1|||
25032373|NCT02499120|50131482|FG001|Overall Study|Participant refused further follow-up|0|||
25032374|NCT02499120|50131481|FG000|Overall Study|Withdrawal by Subject|2|||
25032375|NCT02499120|50131482|FG001|Overall Study|Withdrawal by Subject|5|||
24945509|NCT00337779|50038034|FG000|Overall Study|Protocol Violation|1|||
25032376|NCT02499120|50131481|FG000|Overall Study|Other|1|||
25032377|NCT02499120|50131482|FG001|Overall Study|Other|0|||
24945510|NCT00337779|50038035|FG001|Overall Study|Protocol Violation|1|||
24945511|NCT00337779|50038034|FG000|Overall Study|Lost to Follow-up|6|||
24945512|NCT00337779|50038035|FG001|Overall Study|Lost to Follow-up|5|||
24945513|NCT00337779|50038034|FG000|Overall Study|Adverse Event|28|||
24945514|NCT00337779|50038035|FG001|Overall Study|Adverse Event|51|||
24945515|NCT00337779|50038034|FG000|Overall Study|Pregnancy|3|||
24945516|NCT00337779|50038035|FG001|Overall Study|Pregnancy|2|||
24945517|NCT00337779|50038034|FG000|Overall Study|Death|0|||
24945518|NCT00337779|50038035|FG001|Overall Study|Death|1|||
24945519|NCT00352755|50038041|FG000|Overall Study|Physician Decision|1|||
25032378|NCT02499120|50131481|FG000|Overall Study|Ongoing on study|15|||
25032379|NCT02499120|50131482|FG001|Overall Study|Ongoing on study|11|||
25032380|NCT03207763|50131490|FG000|Overall Study|Lost to Follow-up|1|||
25032381|NCT03207763|50131491|FG001|Overall Study|Lost to Follow-up|0|||
24945520|NCT00352755|50038041|FG000|Overall Study|Adverse Event|1|||
25032382|NCT04766034|50131510|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
25032383|NCT04766034|50131511|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
25032384|NCT04766034|50131512|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
25032385|NCT04766034|50131513|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
25032386|NCT04766034|50131514|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
25032387|NCT04766034|50131510|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
25032388|NCT04766034|50131511|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
25032389|NCT04766034|50131512|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
25032390|NCT04766034|50131513|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
25032391|NCT04766034|50131514|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
25032392|NCT04766034|50131510|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
25032393|NCT04766034|50131511|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
25032394|NCT04766034|50131512|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
25032395|NCT04766034|50131513|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
25032396|NCT04766034|50131514|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
25032397|NCT04766034|50131510|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
25032398|NCT04766034|50131511|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
25032399|NCT04766034|50131512|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
25032400|NCT04766034|50131513|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
25032401|NCT04766034|50131514|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
25032402|NCT03237013|50131529|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
25032403|NCT03237013|50131530|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
25032404|NCT03237013|50131531|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
25032405|NCT03236779|50131541|FG000|Overall Study|Lost to Follow-up|13|||
25032406|NCT03236779|50131542|FG001|Overall Study|Lost to Follow-up|21|||
25032407|NCT03096483|50131550|FG000|Overall Study|Withdrawal by site|1|||
25032408|NCT03257267|50131556|FG000|Overall Study|Adverse Event|9|||
25032409|NCT03257267|50131557|FG001|Overall Study|Adverse Event|7|||
25032410|NCT03257267|50131556|FG000|Overall Study|Death|92|||
25032411|NCT03257267|50131557|FG001|Overall Study|Death|95|||
25032412|NCT03257267|50131556|FG000|Overall Study|Lost to Follow-up|2|||
25186205|NCT01496846|50336149|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
24945521|NCT00533897|50038048|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
24945522|NCT00533897|50038049|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
24945523|NCT00533897|50038050|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
24945524|NCT00533897|50038051|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
24945525|NCT00533897|50038052|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
24945526|NCT00533897|50038053|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
24945527|NCT00533897|50038054|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
24945528|NCT00533897|50038055|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
24945529|NCT00533897|50038048|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
24945530|NCT00533897|50038049|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
24945531|NCT00533897|50038050|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
24945532|NCT00533897|50038051|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
24945533|NCT00533897|50038052|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
24945534|NCT00533897|50038053|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
24945535|NCT00533897|50038054|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
24945536|NCT00533897|50038055|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
24945537|NCT00533897|50038048|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
24945538|NCT00533897|50038049|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
24945539|NCT00533897|50038050|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
24945540|NCT00533897|50038051|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
24945541|NCT00533897|50038052|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
24945542|NCT00533897|50038053|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
24945543|NCT00533897|50038054|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
24945544|NCT00533897|50038055|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
24945545|NCT00533897|50038048|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
25032413|NCT03257267|50131557|FG001|Overall Study|Lost to Follow-up|2|||
25032414|NCT03257267|50131556|FG000|Overall Study|Non-compliance with Study Drug|0|||
25032415|NCT03257267|50131557|FG001|Overall Study|Non-compliance with Study Drug|1|||
25032416|NCT03257267|50131556|FG000|Overall Study|Participant Decision|34|||
25032417|NCT03257267|50131557|FG001|Overall Study|Participant Decision|42|||
25032418|NCT03257267|50131556|FG000|Overall Study|Physician Decision|1|||
25032419|NCT03257267|50131557|FG001|Overall Study|Physician Decision|3|||
25032420|NCT03257267|50131556|FG000|Overall Study|Disease Progression|98|||
25032421|NCT03257267|50131557|FG001|Overall Study|Disease Progression|117|||
25032422|NCT03257267|50131556|FG000|Overall Study|Withdrawal of Consent|8|||
25032423|NCT03257267|50131557|FG001|Overall Study|Withdrawal of Consent|26|||
25032424|NCT03257267|50131556|FG000|Overall Study|Study Ongoing|53|||
25032425|NCT03257267|50131557|FG001|Overall Study|Study Ongoing|11|||
25032426|NCT02932579|50131565|FG000|Overall Study|Withdrawal by Subject|4|||
25032427|NCT02932579|50131566|FG001|Overall Study|Withdrawal by Subject|1|||
25032428|NCT03207451|50131576|FG000|Overall Study|scheduling conflict|1|||
25032429|NCT03207451|50131577|FG001|Overall Study|scheduling conflict|0|||
25032430|NCT03207451|50131578|FG002|Overall Study|scheduling conflict|2|||
25032431|NCT03207451|50131579|FG003|Overall Study|scheduling conflict|2|||
25032432|NCT03207451|50131576|FG000|Overall Study|Adverse Event|0|||
25032433|NCT03207451|50131577|FG001|Overall Study|Adverse Event|0|||
25032434|NCT03207451|50131578|FG002|Overall Study|Adverse Event|0|||
25032435|NCT03207451|50131579|FG003|Overall Study|Adverse Event|1|||
25032436|NCT03350503|50131606|FG000|Overall Study|Adverse Event|5|||
25032437|NCT03350503|50131606|FG000|Overall Study|Withdrawal by Subject|5|||
25032438|NCT03350503|50131606|FG000|Overall Study|Continuation impossible due to move|4|||
25032439|NCT03350503|50131606|FG000|Overall Study|Physician Decision|3|||
25032440|NCT03288779|50131629|FG000|Overall Study|Withdrawal by Subject|3|||
25032441|NCT03206749|50131636|FG000|Overall Study|Withdrawal of consent|5|||
25032442|NCT03206749|50131637|FG001|Overall Study|Withdrawal of consent|3|||
25032443|NCT03206749|50131638|FG002|Overall Study|Withdrawal of consent|6|||
25032444|NCT03206749|50131636|FG000|Overall Study|Lost to Follow-up|0|||
25032445|NCT03206749|50131637|FG001|Overall Study|Lost to Follow-up|0|||
25032446|NCT03206749|50131638|FG002|Overall Study|Lost to Follow-up|1|||
25032447|NCT03255941|50131658|FG000|Overall Study|Not eligible or refused injection|37|||
25032448|NCT03255941|50131659|FG001|Overall Study|Not eligible or refused injection|44|||
25032449|NCT03255941|50131660|FG002|Overall Study|Not eligible or refused injection|5|||
25032450|NCT03255941|50131661|FG003|Overall Study|Not eligible or refused injection|6|||
25032451|NCT03255941|50131658|FG000|Overall Study|Did not complete exit interview|1|||
25032452|NCT03255941|50131659|FG001|Overall Study|Did not complete exit interview|2|||
25032453|NCT03255941|50131660|FG002|Overall Study|Did not complete exit interview|0|||
25032454|NCT03255941|50131661|FG003|Overall Study|Did not complete exit interview|0|||
25032455|NCT03255629|50131683|FG000|Overall Study|Adverse Event|1|||
24945546|NCT00533897|50038049|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
24945547|NCT00533897|50038050|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
24945548|NCT00533897|50038051|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
24945549|NCT00533897|50038052|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
24945550|NCT00533897|50038053|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
24945551|NCT00533897|50038054|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
24945552|NCT00533897|50038055|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
24945553|NCT00533897|50038048|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
24945554|NCT00533897|50038049|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
24945555|NCT00533897|50038050|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
24945556|NCT00533897|50038051|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
24945557|NCT00533897|50038052|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
24945558|NCT00533897|50038053|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
24945559|NCT00533897|50038054|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
24945560|NCT00533897|50038055|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
24945561|NCT00533897|50038048|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
25032456|NCT03255629|50131684|FG001|Overall Study|Adverse Event|0|||
25032457|NCT03255629|50131683|FG000|Overall Study|did not experience hypoglycemia|2|||
25032458|NCT03255629|50131684|FG001|Overall Study|did not experience hypoglycemia|1|||
25275656|NCT00903175|50589503|FG000|Period 1 - First Line|Protocol Violation|3|||
25032459|NCT03031938|50131693|FG000|Overall Study|Death|1|||
25032460|NCT03031938|50131694|FG001|Overall Study|Death|0|||
25032461|NCT01137773|50131702|FG000|Overall Study|Death|3|||
25032462|NCT01137773|50131703|FG001|Overall Study|Death|3|||
25032463|NCT01137773|50131702|FG000|Overall Study|Lost to Follow-up|6|||
25032464|NCT01137773|50131703|FG001|Overall Study|Lost to Follow-up|0|||
25032465|NCT03094611|50131711|FG000|Overall Study|Lack of Efficacy|1|||
25032466|NCT03094611|50131711|FG000|Overall Study|Stem Cell Transplant|1|||
25032467|NCT04105725|50131735|FG000|Primary Intervention|Lost to Follow-up|0|||
25032468|NCT04105725|50131736|FG001|Primary Intervention|Lost to Follow-up|2|||
25032469|NCT04105725|50131735|FG000|Primary Intervention|Withdrawal by Subject|0|||
25032470|NCT04105725|50131736|FG001|Primary Intervention|Withdrawal by Subject|1|||
25032471|NCT04066023|50131745|FG000|Overall Study|Adverse Event|0|||
25032472|NCT04066023|50131746|FG001|Overall Study|Adverse Event|0|||
25032473|NCT04066023|50131747|FG002|Overall Study|Adverse Event|1|||
25032474|NCT04066023|50131745|FG000|Overall Study|Sponsor decision|3|||
25032475|NCT04066023|50131746|FG001|Overall Study|Sponsor decision|6|||
25032476|NCT04066023|50131747|FG002|Overall Study|Sponsor decision|2|||
25032477|NCT04066023|50131745|FG000|Overall Study|Physician Decision|0|||
25032478|NCT04066023|50131746|FG001|Overall Study|Physician Decision|0|||
25032479|NCT04066023|50131747|FG002|Overall Study|Physician Decision|1|||
25032480|NCT04066023|50131745|FG000|Overall Study|Lost to Follow-up|0|||
25032481|NCT04066023|50131746|FG001|Overall Study|Lost to Follow-up|1|||
25032482|NCT04066023|50131747|FG002|Overall Study|Lost to Follow-up|1|||
25032483|NCT04066023|50131745|FG000|Overall Study|Noncompliance|0|||
25032484|NCT04066023|50131746|FG001|Overall Study|Noncompliance|1|||
25032485|NCT04066023|50131747|FG002|Overall Study|Noncompliance|1|||
25032486|NCT03106987|50131759|FG000|Overall Study|Death|37|||
25032487|NCT03106987|50131760|FG001|Overall Study|Death|22|||
25032488|NCT03106987|50131761|FG002|Overall Study|Death|12|||
25032489|NCT03106987|50131762|FG003|Overall Study|Death|8|||
25032490|NCT03106987|50131759|FG000|Overall Study|Lost to Follow-up|2|||
25032491|NCT03106987|50131760|FG001|Overall Study|Lost to Follow-up|0|||
25032492|NCT03106987|50131761|FG002|Overall Study|Lost to Follow-up|2|||
25032493|NCT03106987|50131762|FG003|Overall Study|Lost to Follow-up|2|||
25032494|NCT03106987|50131759|FG000|Overall Study|Withdrawal by Subject|5|||
25032495|NCT03106987|50131760|FG001|Overall Study|Withdrawal by Subject|1|||
25032496|NCT03106987|50131761|FG002|Overall Study|Withdrawal by Subject|4|||
25032497|NCT03106987|50131762|FG003|Overall Study|Withdrawal by Subject|1|||
25032498|NCT02932267|50131772|FG000|Overall Study|Withdrawal by Subject|3|||
25032499|NCT02932267|50131772|FG000|Overall Study|Lost to Follow-up|4|||
25032500|NCT02932267|50131772|FG000|Overall Study|Pregnancy|1|||
25032501|NCT03217591|50131779|FG000|Overall Study|Adverse Event|1|||
25032502|NCT03217591|50131780|FG001|Overall Study|Adverse Event|2|||
25032503|NCT03217591|50131781|FG002|Overall Study|Adverse Event|6|||
25032504|NCT03217591|50131779|FG000|Overall Study|Withdrawal by Subject|0|||
25032505|NCT03217591|50131780|FG001|Overall Study|Withdrawal by Subject|1|||
25032506|NCT03217591|50131781|FG002|Overall Study|Withdrawal by Subject|3|||
25032507|NCT03217591|50131779|FG000|Overall Study|Lost to Follow-up|1|||
25032508|NCT03217591|50131780|FG001|Overall Study|Lost to Follow-up|0|||
25032509|NCT03217591|50131781|FG002|Overall Study|Lost to Follow-up|0|||
25032510|NCT03217591|50131779|FG000|Overall Study|Protocol Violation|1|||
25032511|NCT03217591|50131780|FG001|Overall Study|Protocol Violation|0|||
25032512|NCT03217591|50131781|FG002|Overall Study|Protocol Violation|1|||
25032513|NCT03031782|50131790|FG000|Treatment Period 1|Lack of Efficacy|3|||
25032514|NCT03031782|50131791|FG001|Treatment Period 1|Lack of Efficacy|0|||
25159497|NCT01920061|50279318|FG005|Overall Study|Participant refused further follow-up|1|||
25159498|NCT01920061|50279319|FG006|Overall Study|Participant refused further follow-up|0|||
25186206|NCT00964002|50336160|FG000|Overall Study|Protocol Violation|8|||
25275657|NCT00903175|50589504|FG001|Period 1 - First Line|Protocol Violation|3|||
24945562|NCT00533897|50038049|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
24945563|NCT00533897|50038050|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
24945564|NCT00533897|50038051|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
24945565|NCT00533897|50038052|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
24945566|NCT00533897|50038053|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
24945567|NCT00533897|50038054|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
24945568|NCT00533897|50038055|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
24945569|NCT00533897|50038048|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
24945570|NCT00533897|50038049|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
24945571|NCT00533897|50038050|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
24945572|NCT00533897|50038051|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
24945573|NCT00533897|50038052|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
24945574|NCT00533897|50038053|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
24945575|NCT00533897|50038054|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
24945576|NCT00533897|50038055|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
25032515|NCT03031782|50131792|FG002|Treatment Period 1|Lack of Efficacy|0|||
25032516|NCT03031782|50131793|FG003|Treatment Period 1|Lack of Efficacy|0|||
25032517|NCT03031782|50131794|FG004|Treatment Period 1|Lack of Efficacy|0|||
25032518|NCT03031782|50131790|FG000|Treatment Period 2|Physician Decision|0|||
25032519|NCT03031782|50131791|FG001|Treatment Period 2|Physician Decision|1|||
25032520|NCT03031782|50131792|FG002|Treatment Period 2|Physician Decision|0|||
25032521|NCT03031782|50131793|FG003|Treatment Period 2|Physician Decision|0|||
24945577|NCT00533897|50038048|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
24945578|NCT00533897|50038049|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
24945579|NCT00533897|50038050|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
24945580|NCT00533897|50038051|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
24945581|NCT00533897|50038052|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
24945582|NCT00533897|50038053|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
24945583|NCT00533897|50038054|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
24945584|NCT00533897|50038055|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
24945585|NCT00533897|50038048|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
24945586|NCT00533897|50038049|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
24945587|NCT00533897|50038050|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
24945588|NCT00533897|50038051|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
24945589|NCT00533897|50038052|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
24945590|NCT00533897|50038053|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
24945591|NCT00533897|50038054|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
24945592|NCT00533897|50038055|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
24945593|NCT00533897|50038048|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
24945594|NCT00533897|50038049|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
24945595|NCT00533897|50038050|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
24945596|NCT00533897|50038051|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
24945597|NCT00533897|50038052|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
24945598|NCT00533897|50038053|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
24945599|NCT00533897|50038054|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
24945600|NCT00533897|50038055|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
24945601|NCT00533897|50038048|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
24945602|NCT00533897|50038049|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
24945603|NCT00533897|50038050|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
24945604|NCT00533897|50038051|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
24945605|NCT00533897|50038052|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
24945606|NCT00533897|50038053|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
24945607|NCT00533897|50038054|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
24945608|NCT00533897|50038055|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
24945609|NCT00533897|50038048|FG000|Long Term Extension (LTE)|Death|0|||
24945610|NCT00533897|50038049|FG001|Long Term Extension (LTE)|Death|0|||
24945611|NCT00533897|50038050|FG002|Long Term Extension (LTE)|Death|0|||
24945612|NCT00533897|50038051|FG003|Long Term Extension (LTE)|Death|0|||
24945613|NCT00533897|50038052|FG004|Long Term Extension (LTE)|Death|0|||
24945614|NCT00533897|50038053|FG005|Long Term Extension (LTE)|Death|0|||
24945615|NCT00533897|50038054|FG006|Long Term Extension (LTE)|Death|1|||
24945616|NCT00533897|50038055|FG007|Long Term Extension (LTE)|Death|3|||
24945617|NCT00533897|50038048|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
24945618|NCT00533897|50038049|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
24945619|NCT00533897|50038050|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
24945620|NCT00533897|50038051|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
24945621|NCT00533897|50038052|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
24945622|NCT00533897|50038053|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
24945623|NCT00533897|50038054|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
24945624|NCT00533897|50038055|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
24945625|NCT00533897|50038048|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
24945626|NCT00533897|50038049|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
24945627|NCT00533897|50038050|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
24945628|NCT00533897|50038051|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
24945629|NCT00533897|50038052|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
24945630|NCT00533897|50038053|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
24945631|NCT00533897|50038054|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
24945632|NCT00533897|50038055|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
24945633|NCT00533897|50038048|FG000|Long Term Extension (LTE)|Adverse Event|0|||
24945634|NCT00533897|50038049|FG001|Long Term Extension (LTE)|Adverse Event|0|||
24945635|NCT00533897|50038050|FG002|Long Term Extension (LTE)|Adverse Event|0|||
24945636|NCT00533897|50038051|FG003|Long Term Extension (LTE)|Adverse Event|0|||
24945637|NCT00533897|50038052|FG004|Long Term Extension (LTE)|Adverse Event|0|||
24945638|NCT00533897|50038053|FG005|Long Term Extension (LTE)|Adverse Event|0|||
25032522|NCT03031782|50131794|FG004|Treatment Period 2|Physician Decision|3|||
25032523|NCT03031782|50131790|FG000|Treatment Period 2|Lack of Efficacy|0|||
25032524|NCT03031782|50131791|FG001|Treatment Period 2|Lack of Efficacy|1|||
25032525|NCT03031782|50131792|FG002|Treatment Period 2|Lack of Efficacy|0|||
25032526|NCT03031782|50131793|FG003|Treatment Period 2|Lack of Efficacy|0|||
25032527|NCT03031782|50131794|FG004|Treatment Period 2|Lack of Efficacy|1|||
25032528|NCT03031782|50131790|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25032529|NCT03031782|50131791|FG001|Treatment Period 2|Withdrawal by Subject|3|||
25032530|NCT03031782|50131792|FG002|Treatment Period 2|Withdrawal by Subject|0|||
25032531|NCT03031782|50131793|FG003|Treatment Period 2|Withdrawal by Subject|0|||
25032532|NCT03031782|50131794|FG004|Treatment Period 2|Withdrawal by Subject|1|||
25032533|NCT03031782|50131790|FG000|Treatment Period 2|Adverse Event|0|||
25032534|NCT03031782|50131791|FG001|Treatment Period 2|Adverse Event|1|||
25032535|NCT03031782|50131792|FG002|Treatment Period 2|Adverse Event|2|||
25032536|NCT03031782|50131793|FG003|Treatment Period 2|Adverse Event|0|||
25032537|NCT03031782|50131794|FG004|Treatment Period 2|Adverse Event|0|||
25032538|NCT03031782|50131790|FG000|Treatment Period 3|Withdrawal by Subject|0|||
25032539|NCT03031782|50131791|FG001|Treatment Period 3|Withdrawal by Subject|0|||
25032540|NCT03031782|50131792|FG002|Treatment Period 3|Withdrawal by Subject|0|||
25032541|NCT03031782|50131793|FG003|Treatment Period 3|Withdrawal by Subject|1|||
25032542|NCT03031782|50131794|FG004|Treatment Period 3|Withdrawal by Subject|0|||
25032543|NCT03216265|50131811|FG000|Overall Study|Adverse Event|2|||
25032544|NCT03216265|50131812|FG001|Overall Study|Adverse Event|0|||
25159499|NCT01920061|50279320|FG007|Overall Study|Participant refused further follow-up|0|||
25159500|NCT01920061|50279321|FG008|Overall Study|Participant refused further follow-up|1|||
24945639|NCT00533897|50038054|FG006|Long Term Extension (LTE)|Adverse Event|2|||
24945640|NCT00533897|50038055|FG007|Long Term Extension (LTE)|Adverse Event|5|||
24945641|NCT00533897|50038048|FG000|Long Term Extension (LTE)|Pregnancy|0|||
24945642|NCT00533897|50038049|FG001|Long Term Extension (LTE)|Pregnancy|0|||
24945643|NCT00533897|50038050|FG002|Long Term Extension (LTE)|Pregnancy|0|||
24945644|NCT00533897|50038051|FG003|Long Term Extension (LTE)|Pregnancy|0|||
24945645|NCT00533897|50038052|FG004|Long Term Extension (LTE)|Pregnancy|0|||
24945646|NCT00533897|50038053|FG005|Long Term Extension (LTE)|Pregnancy|0|||
24945647|NCT00533897|50038054|FG006|Long Term Extension (LTE)|Pregnancy|0|||
24945648|NCT00533897|50038055|FG007|Long Term Extension (LTE)|Pregnancy|2|||
24945649|NCT00533897|50038048|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
24945650|NCT00533897|50038049|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
24945651|NCT00533897|50038050|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
24945652|NCT00533897|50038051|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
24945653|NCT00533897|50038052|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
24945654|NCT00533897|50038053|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
24945655|NCT00533897|50038054|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
24945656|NCT00533897|50038055|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
24945657|NCT00533897|50038048|FG000|Long Term Extension (LTE)|Other|0|||
24945658|NCT00533897|50038049|FG001|Long Term Extension (LTE)|Other|0|||
24945659|NCT00533897|50038050|FG002|Long Term Extension (LTE)|Other|0|||
24945660|NCT00533897|50038051|FG003|Long Term Extension (LTE)|Other|0|||
24945661|NCT00533897|50038052|FG004|Long Term Extension (LTE)|Other|0|||
24945662|NCT00533897|50038053|FG005|Long Term Extension (LTE)|Other|0|||
24945663|NCT00533897|50038054|FG006|Long Term Extension (LTE)|Other|1|||
24945664|NCT00533897|50038055|FG007|Long Term Extension (LTE)|Other|6|||
24945665|NCT00426660|50038086|FG000|Overall Study|Death|14|||
24945666|NCT00426660|50038086|FG000|Overall Study|Adverse Event|23|||
24945667|NCT00426660|50038086|FG000|Overall Study|Insufficient Clinical Response|22|||
24945668|NCT00426660|50038086|FG000|Overall Study|Lost to Follow-up|15|||
24945669|NCT00426660|50038086|FG000|Overall Study|Other|23|||
24945670|NCT00426660|50038086|FG000|Overall Study|Withdrawal by Subject|18|||
24945671|NCT00426660|50038086|FG000|Overall Study|Protocol Violation|1|||
24945672|NCT00426660|50038086|FG000|Overall Study|Enrolled Not Treated|15|||
24945673|NCT00426270|50038090|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
24945674|NCT00426270|50038090|FG000|Overall Study|Adverse Event|5|||
24945675|NCT00330681|50038096|FG000|Overall Study|Adverse Event|3|||
24945676|NCT00330681|50038097|FG001|Overall Study|Adverse Event|6|||
24945677|NCT00330681|50038096|FG000|Overall Study|Protocol Violation|0|||
24945678|NCT00330681|50038097|FG001|Overall Study|Protocol Violation|1|||
25032545|NCT03216265|50131813|FG002|Overall Study|Adverse Event|2|||
25275658|NCT00903175|50589503|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
25275659|NCT00903175|50589504|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
25032546|NCT03216265|50131811|FG000|Overall Study|Lost to Follow-up|0|||
24945679|NCT00330681|50038096|FG000|Overall Study|Withdrawal by Subject|5|||
24945680|NCT00330681|50038097|FG001|Overall Study|Withdrawal by Subject|5|||
24945681|NCT00330681|50038096|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
25032547|NCT03216265|50131812|FG001|Overall Study|Lost to Follow-up|1|||
25032548|NCT03216265|50131813|FG002|Overall Study|Lost to Follow-up|0|||
25032549|NCT03216265|50131811|FG000|Overall Study|Withdrawal by Subject|0|||
25032550|NCT03216265|50131812|FG001|Overall Study|Withdrawal by Subject|0|||
25032551|NCT03216265|50131813|FG002|Overall Study|Withdrawal by Subject|1|||
25032552|NCT04486950|50131835|FG000|Overall Study|Lost to Follow-up|0|||
25032553|NCT04486950|50131836|FG001|Overall Study|Lost to Follow-up|0|||
25032554|NCT04486950|50131837|FG002|Overall Study|Lost to Follow-up|0|||
25032555|NCT04486950|50131838|FG003|Overall Study|Lost to Follow-up|0|||
25032556|NCT04486950|50131839|FG004|Overall Study|Lost to Follow-up|0|||
25032557|NCT04486950|50131840|FG005|Overall Study|Lost to Follow-up|1|||
25032558|NCT04486950|50131841|FG006|Overall Study|Lost to Follow-up|0|||
25032559|NCT04693416|50131863|FG000|Overall Study|Lost to Follow-up|13|||
25032560|NCT04693416|50131864|FG001|Overall Study|Lost to Follow-up|0|||
25032561|NCT00265941|50131872|FG000|Overall Study|Protocol Violation|22|||
25032562|NCT00265941|50131873|FG001|Overall Study|Protocol Violation|25|||
25032563|NCT00265941|50131872|FG000|Overall Study|Lost to Follow-up|1|||
25032564|NCT00265941|50131873|FG001|Overall Study|Lost to Follow-up|1|||
25032565|NCT03882957|50131887|FG000|Overall Study|Did not complete all three arms|1|||
25032566|NCT03201211|50131899|FG000|Overall Study|Adverse Event|1|||
25032567|NCT03201211|50131900|FG001|Overall Study|Adverse Event|0|||
25032568|NCT03201211|50131901|FG002|Overall Study|Adverse Event|0|||
25032569|NCT03201211|50131899|FG000|Overall Study|Protocol Violation|1|||
25032570|NCT03201211|50131900|FG001|Overall Study|Protocol Violation|0|||
25032571|NCT03201211|50131901|FG002|Overall Study|Protocol Violation|0|||
25032572|NCT03201211|50131899|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
25032573|NCT03201211|50131900|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
25032574|NCT03201211|50131901|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
25032575|NCT03201211|50131899|FG000|Overall Study|OTHER unknown reasons|0|||
25032576|NCT03201211|50131900|FG001|Overall Study|OTHER unknown reasons|1|||
25032577|NCT03201211|50131901|FG002|Overall Study|OTHER unknown reasons|0|||
25032578|NCT04633837|50131911|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
25032579|NCT04633837|50131912|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
25032580|NCT03929913|50131918|FG000|Overall Study|Death|4|||
25032581|NCT03929913|50131918|FG000|Overall Study|Lost to Follow-up|1|||
25032582|NCT03929913|50131918|FG000|Overall Study|Failed Procedure|2|||
25032583|NCT03029832|50131924|FG000|Overall Study|Safety Follow-Up Completed|2|||
25032584|NCT03029832|50131925|FG001|Overall Study|Safety Follow-Up Completed|0|||
25032585|NCT03029832|50131924|FG000|Overall Study|Death due to Disease Progression|1|||
25032586|NCT03029832|50131925|FG001|Overall Study|Death due to Disease Progression|0|||
25032587|NCT03029832|50131924|FG000|Overall Study|Study Terminated By Sponsor|1|||
25032588|NCT03029832|50131925|FG001|Overall Study|Study Terminated By Sponsor|1|||
25032589|NCT03089697|50131933|FG000|Overall Study|Adverse Event|1|||
25032590|NCT03089697|50131934|FG001|Overall Study|Adverse Event|2|||
25032591|NCT03089697|50131933|FG000|Overall Study|Withdrawal by Subject|1|||
25032592|NCT03089697|50131934|FG001|Overall Study|Withdrawal by Subject|0|||
25032593|NCT03199963|50131942|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
25032594|NCT03199963|50131943|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
25032595|NCT03199963|50131942|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
25032596|NCT03199963|50131943|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
25032597|NCT03199963|50131942|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
25032598|NCT03199963|50131943|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
25032599|NCT03199963|50131942|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
25032600|NCT03199963|50131943|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
25032601|NCT03199963|50131942|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
24945682|NCT00330681|50038097|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
24945683|NCT00329901|50038106|FG000|Overall Study|Withdrawal by Subject|4|||
24945684|NCT00329901|50038107|FG001|Overall Study|Withdrawal by Subject|3|||
24945685|NCT00329901|50038108|FG002|Overall Study|Withdrawal by Subject|2|||
24945686|NCT00329901|50038106|FG000|Overall Study|Lost to Follow-up|2|||
24945687|NCT00329901|50038107|FG001|Overall Study|Lost to Follow-up|0|||
24945688|NCT00329901|50038108|FG002|Overall Study|Lost to Follow-up|1|||
24945689|NCT00329901|50038106|FG000|Overall Study|Protocol Violation|1|||
24945690|NCT00329901|50038107|FG001|Overall Study|Protocol Violation|0|||
24945691|NCT00329901|50038108|FG002|Overall Study|Protocol Violation|1|||
24945692|NCT00329901|50038106|FG000|Overall Study|Unable to classify|2|||
24945693|NCT00329901|50038107|FG001|Overall Study|Unable to classify|2|||
24945694|NCT00329901|50038108|FG002|Overall Study|Unable to classify|0|||
24945695|NCT00436956|50038120|FG000|Overall Study|Not evaluable|1|||
24945696|NCT00436956|50038121|FG001|Overall Study|Not evaluable|0|||
24945697|NCT00329745|50038130|FG000|Overall Study|Protocol Violation|1|||
24945698|NCT00329745|50038131|FG001|Overall Study|Protocol Violation|0|||
24945699|NCT00329745|50038130|FG000|Overall Study|Withdrawal by Subject|0|||
24945700|NCT00329745|50038131|FG001|Overall Study|Withdrawal by Subject|1|||
24945701|NCT00329745|50038130|FG000|Overall Study|Lost to Follow-up|86|||
25032602|NCT03199963|50131943|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
25032603|NCT03199963|50131942|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
25032604|NCT03199963|50131943|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
25032605|NCT03257631|50131959|FG000|Overall Study|Death|8|||
25032606|NCT03257631|50131960|FG001|Overall Study|Death|5|||
25032607|NCT03257631|50131961|FG002|Overall Study|Death|13|||
25032608|NCT03257631|50131962|FG003|Overall Study|Death|5|||
25032609|NCT03257631|50131959|FG000|Overall Study|Progressive Disease|0|||
25032610|NCT03257631|50131960|FG001|Overall Study|Progressive Disease|0|||
25032611|NCT03257631|50131961|FG002|Overall Study|Progressive Disease|1|||
25032612|NCT03257631|50131962|FG003|Overall Study|Progressive Disease|0|||
25032613|NCT03257631|50131959|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
25032614|NCT03257631|50131960|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
25032615|NCT03257631|50131961|FG002|Overall Study|Withdrawal by Parent/Guardian|4|||
25032616|NCT03257631|50131962|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
25032617|NCT03257631|50131959|FG000|Overall Study|Lost to Follow-up|0|||
25032618|NCT03257631|50131960|FG001|Overall Study|Lost to Follow-up|0|||
25032619|NCT03257631|50131961|FG002|Overall Study|Lost to Follow-up|1|||
25032620|NCT03257631|50131962|FG003|Overall Study|Lost to Follow-up|0|||
25032621|NCT03257631|50131959|FG000|Overall Study|Still on Study|3|||
25032622|NCT03257631|50131960|FG001|Overall Study|Still on Study|2|||
25032623|NCT03257631|50131961|FG002|Overall Study|Still on Study|4|||
25032624|NCT03257631|50131962|FG003|Overall Study|Still on Study|4|||
25032625|NCT03883581|50131972|FG000|Overall Study|Withdrawal by Subject|4|||
25032626|NCT03029208|50131978|FG000|Overall Study|Withdrawal by Subject|2|||
25032627|NCT03029208|50131979|FG001|Overall Study|Withdrawal by Subject|3|||
25032628|NCT03029208|50131978|FG000|Overall Study|Lost to Follow-up|0|||
25032629|NCT03029208|50131979|FG001|Overall Study|Lost to Follow-up|1|||
25032630|NCT03198715|50131999|FG000|Overall Study|Death|0|||
25032631|NCT03198715|50132000|FG001|Overall Study|Death|0|||
25032632|NCT03198715|50132001|FG002|Overall Study|Death|1|||
25032633|NCT03198715|50132002|FG003|Overall Study|Death|0|||
25032634|NCT03198715|50132003|FG004|Overall Study|Death|2|||
25032635|NCT03198715|50131999|FG000|Overall Study|Other|0|||
25032636|NCT03198715|50132000|FG001|Overall Study|Other|1|||
25032637|NCT03198715|50132001|FG002|Overall Study|Other|1|||
25032638|NCT03198715|50132002|FG003|Overall Study|Other|0|||
25032639|NCT03198715|50132003|FG004|Overall Study|Other|0|||
25032640|NCT03197935|50132026|FG000|Overall Study|Death due to any cause|9|||
25032641|NCT03197935|50132027|FG001|Overall Study|Death due to any cause|7|||
25032642|NCT03197935|50132026|FG000|Overall Study|Lost to Follow-up|0|||
25032643|NCT03197935|50132027|FG001|Overall Study|Lost to Follow-up|3|||
25032644|NCT03197935|50132026|FG000|Overall Study|Physician Decision|0|||
25032645|NCT03197935|50132027|FG001|Overall Study|Physician Decision|1|||
25032646|NCT03197935|50132026|FG000|Overall Study|Withdrawal by Subject|11|||
25032647|NCT03197935|50132027|FG001|Overall Study|Withdrawal by Subject|7|||
25032648|NCT03197935|50132026|FG000|Overall Study|On-Going in Study|147|||
25032649|NCT03197935|50132027|FG001|Overall Study|On-Going in Study|146|||
25032650|NCT03197935|50132026|FG000|Overall Study|Did not receive any study treatment|1|||
25032651|NCT03197935|50132027|FG001|Overall Study|Did not receive any study treatment|1|||
25032652|NCT03088917|50132034|FG000|Overall Study|In care/cured elsewhere|15|||
25032653|NCT03088917|50132034|FG000|Overall Study|Refuse re-evaluation|13|||
25032654|NCT03088917|50132034|FG000|Overall Study|Contact not established|13|||
25032655|NCT03088917|50132034|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
25032656|NCT03088917|50132034|FG000|Overall Study|Moved outside study region|50|||
25032657|NCT03087513|50132040|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
25032658|NCT02917629|50132055|FG000|Overall Study|Withdrawal by Subject|0|||
25032659|NCT02917629|50132056|FG001|Overall Study|Withdrawal by Subject|1|||
25032660|NCT02927847|50132065|FG000|Overall Study|Lost to Follow-up|1|||
25032661|NCT02927847|50132066|FG001|Overall Study|Lost to Follow-up|0|||
25032662|NCT02927847|50132065|FG000|Overall Study|Withdrawal by Subject|4|||
25032663|NCT02927847|50132066|FG001|Overall Study|Withdrawal by Subject|2|||
25032664|NCT02927847|50132065|FG000|Overall Study|PI withdrawn due to missed visits|1|||
25032665|NCT02927847|50132066|FG001|Overall Study|PI withdrawn due to missed visits|1|||
25032666|NCT02960438|50132076|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
25159501|NCT01920061|50279322|FG009|Overall Study|Participant refused further follow-up|0|||
25159502|NCT01920061|50279323|FG010|Overall Study|Participant refused further follow-up|1|||
25032667|NCT02960438|50132077|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
25032668|NCT02960438|50132078|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
25032669|NCT02960438|50132079|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
25032670|NCT02960438|50132076|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
25032671|NCT02960438|50132077|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
25032672|NCT02960438|50132078|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
25032673|NCT02960438|50132079|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
25032674|NCT02960438|50132076|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
25032675|NCT02960438|50132077|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
25032676|NCT02960438|50132078|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
25032677|NCT02960438|50132079|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
25032678|NCT02960438|50132076|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
25032679|NCT02960438|50132077|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
25032680|NCT02960438|50132078|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
25032681|NCT02960438|50132079|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
25032682|NCT02960438|50132076|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
25032683|NCT02960438|50132077|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
25032684|NCT02960438|50132078|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
25032685|NCT02960438|50132079|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
25032686|NCT02960438|50132076|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
25032687|NCT02960438|50132077|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
25032688|NCT02960438|50132078|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
25032689|NCT02960438|50132079|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
25032690|NCT02960438|50132076|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
25032691|NCT02960438|50132077|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
25032692|NCT02960438|50132078|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
25032693|NCT02960438|50132079|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
25032694|NCT02960438|50132076|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
25032695|NCT02960438|50132077|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
25032696|NCT02960438|50132078|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
25032697|NCT02960438|50132079|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
25032698|NCT02960438|50132076|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
25032699|NCT02960438|50132077|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
25032700|NCT02960438|50132078|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
25032701|NCT02960438|50132079|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
25032702|NCT02960438|50132076|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
25032703|NCT02960438|50132077|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
25032704|NCT02960438|50132078|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
25032705|NCT02960438|50132079|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
25032706|NCT02960438|50132076|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
25032707|NCT02960438|50132077|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
25032708|NCT02960438|50132078|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
25032709|NCT02960438|50132079|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
25032710|NCT02960438|50132076|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
25032711|NCT02960438|50132077|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
25032712|NCT02960438|50132078|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
25032713|NCT02960438|50132079|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
25032714|NCT02957942|50132099|FG000|Overall Study|Withdrawal by Subject|0|||
25032715|NCT02957942|50132100|FG001|Overall Study|Withdrawal by Subject|1|||
25032716|NCT02957942|50132099|FG000|Overall Study|Practicing experiment protocol|0|||
25032717|NCT02957942|50132100|FG001|Overall Study|Practicing experiment protocol|6|||
25032718|NCT02959970|50132108|FG000|Overall Study|Adverse Event|1|||
25032719|NCT02959970|50132109|FG001|Overall Study|Adverse Event|0|||
25032720|NCT02959970|50132108|FG000|Overall Study|Withdrawal by Subject|0|||
25032721|NCT02959970|50132109|FG001|Overall Study|Withdrawal by Subject|2|||
25032722|NCT02959970|50132108|FG000|Overall Study|Lost to Follow-up|1|||
25032723|NCT02959970|50132109|FG001|Overall Study|Lost to Follow-up|5|||
25032724|NCT03580369|50132144|FG000|Overall Study|No treatment due to mis-randomization|1|||
25032725|NCT03580369|50132145|FG001|Overall Study|No treatment due to mis-randomization|0|||
25032726|NCT03580369|50132146|FG002|Overall Study|No treatment due to mis-randomization|0|||
25032727|NCT03580369|50132147|FG003|Overall Study|No treatment due to mis-randomization|0|||
25032728|NCT03580369|50132148|FG004|Overall Study|No treatment due to mis-randomization|3|||
25032729|NCT03580369|50132149|FG005|Overall Study|No treatment due to mis-randomization|0|||
25032730|NCT03580369|50132150|FG006|Overall Study|No treatment due to mis-randomization|0|||
25032731|NCT03580369|50132151|FG007|Overall Study|No treatment due to mis-randomization|0|||
25032732|NCT03580369|50132144|FG000|Overall Study|Reason unknown|0|||
25032733|NCT03580369|50132145|FG001|Overall Study|Reason unknown|0|||
25032734|NCT03580369|50132146|FG002|Overall Study|Reason unknown|1|||
25032735|NCT03580369|50132147|FG003|Overall Study|Reason unknown|0|||
25032736|NCT03580369|50132148|FG004|Overall Study|Reason unknown|0|||
25032737|NCT03580369|50132149|FG005|Overall Study|Reason unknown|0|||
25032738|NCT03580369|50132150|FG006|Overall Study|Reason unknown|0|||
25159503|NCT01920061|50279324|FG011|Overall Study|Participant refused further follow-up|0|||
25032739|NCT03580369|50132151|FG007|Overall Study|Reason unknown|0|||
25032740|NCT03580369|50132144|FG000|Overall Study|Technical problems|0|||
25032741|NCT03580369|50132145|FG001|Overall Study|Technical problems|0|||
25032742|NCT03580369|50132146|FG002|Overall Study|Technical problems|0|||
25032743|NCT03580369|50132147|FG003|Overall Study|Technical problems|0|||
25032744|NCT03580369|50132148|FG004|Overall Study|Technical problems|1|||
25032745|NCT03580369|50132149|FG005|Overall Study|Technical problems|0|||
25032746|NCT03580369|50132150|FG006|Overall Study|Technical problems|2|||
25032747|NCT03580369|50132151|FG007|Overall Study|Technical problems|0|||
25032748|NCT03580369|50132144|FG000|Overall Study|Pregnancy|2|||
25032749|NCT03580369|50132145|FG001|Overall Study|Pregnancy|0|||
25032750|NCT03580369|50132146|FG002|Overall Study|Pregnancy|3|||
25032751|NCT03580369|50132147|FG003|Overall Study|Pregnancy|0|||
25032752|NCT03580369|50132148|FG004|Overall Study|Pregnancy|2|||
25032753|NCT03580369|50132149|FG005|Overall Study|Pregnancy|0|||
25032754|NCT03580369|50132150|FG006|Overall Study|Pregnancy|0|||
24945702|NCT00329745|50038131|FG001|Overall Study|Lost to Follow-up|101|||
24945703|NCT00436644|50038137|FG000|Overall Study|Adverse Event|2|||
24945704|NCT00436644|50038137|FG000|Overall Study|Death|1|||
25032755|NCT03580369|50132151|FG007|Overall Study|Pregnancy|0|||
25032756|NCT03580369|50132144|FG000|Overall Study|Lost to Follow-up|2|||
25032757|NCT03580369|50132145|FG001|Overall Study|Lost to Follow-up|0|||
25032758|NCT03580369|50132146|FG002|Overall Study|Lost to Follow-up|2|||
25032759|NCT03580369|50132147|FG003|Overall Study|Lost to Follow-up|0|||
25032760|NCT03580369|50132148|FG004|Overall Study|Lost to Follow-up|3|||
25032761|NCT03580369|50132149|FG005|Overall Study|Lost to Follow-up|0|||
25032762|NCT03580369|50132150|FG006|Overall Study|Lost to Follow-up|1|||
25032763|NCT03580369|50132151|FG007|Overall Study|Lost to Follow-up|0|||
25032764|NCT03580369|50132144|FG000|Overall Study|Physician Decision|4|||
25032765|NCT03580369|50132145|FG001|Overall Study|Physician Decision|0|||
25032766|NCT03580369|50132146|FG002|Overall Study|Physician Decision|4|||
25032767|NCT03580369|50132147|FG003|Overall Study|Physician Decision|1|||
25032768|NCT03580369|50132148|FG004|Overall Study|Physician Decision|1|||
25032769|NCT03580369|50132149|FG005|Overall Study|Physician Decision|0|||
25032770|NCT03580369|50132150|FG006|Overall Study|Physician Decision|0|||
25032771|NCT03580369|50132151|FG007|Overall Study|Physician Decision|0|||
25032772|NCT03580369|50132144|FG000|Overall Study|Lack of Efficacy|3|||
25032773|NCT03580369|50132145|FG001|Overall Study|Lack of Efficacy|0|||
25032774|NCT03580369|50132146|FG002|Overall Study|Lack of Efficacy|7|||
25032775|NCT03580369|50132147|FG003|Overall Study|Lack of Efficacy|0|||
25032776|NCT03580369|50132148|FG004|Overall Study|Lack of Efficacy|2|||
25032777|NCT03580369|50132149|FG005|Overall Study|Lack of Efficacy|0|||
25032778|NCT03580369|50132150|FG006|Overall Study|Lack of Efficacy|3|||
25032779|NCT03580369|50132151|FG007|Overall Study|Lack of Efficacy|0|||
25032780|NCT03580369|50132144|FG000|Overall Study|Protocol Violation|6|||
25032781|NCT03580369|50132145|FG001|Overall Study|Protocol Violation|0|||
25159504|NCT01920061|50279325|FG012|Overall Study|Participant refused further follow-up|1|||
24945705|NCT00324987|50038143|FG000|Overall Study|Adverse Event|2|||
24945706|NCT00324987|50038144|FG001|Overall Study|Adverse Event|1|||
24945707|NCT00324987|50038143|FG000|Overall Study|Withdrawal by Subject|1|||
24945708|NCT00324987|50038144|FG001|Overall Study|Withdrawal by Subject|1|||
24945709|NCT00324987|50038143|FG000|Overall Study|Progression|1|||
24945710|NCT00324987|50038144|FG001|Overall Study|Progression|1|||
24945711|NCT00324987|50038143|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
24945712|NCT00324987|50038144|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
24945713|NCT00324675|50038152|FG000|Overall Study|Adverse Event|1|||
24945714|NCT00324675|50038153|FG001|Overall Study|Adverse Event|0|||
24945715|NCT00436566|50038159|FG000|Overall Study|Withdrawal by Subject|2|||
24945716|NCT00436566|50038159|FG000|Overall Study|Protocol Violation|1|||
24945717|NCT00352365|50038163|FG000|Induction Therapy|Adverse Event|7|||
24945718|NCT00352365|50038163|FG000|Induction Therapy|Progression/Relapse|8|||
24945719|NCT00352365|50038163|FG000|Induction Therapy|Death|7|||
24945720|NCT00352365|50038163|FG000|Induction Therapy|Not protocol specified|1|||
24945721|NCT00352365|50038163|FG000|Induction Therapy|Not eligible|3|||
24945722|NCT00352365|50038163|FG000|Induction Therapy|Death before starting protocol therapy|1|||
25032782|NCT03580369|50132146|FG002|Overall Study|Protocol Violation|6|||
25032783|NCT03580369|50132147|FG003|Overall Study|Protocol Violation|1|||
25032784|NCT03580369|50132148|FG004|Overall Study|Protocol Violation|8|||
24945723|NCT00352365|50038163|FG000|Maintenance Therapy|Progression/Relapse|3|||
24945724|NCT00352365|50038163|FG000|Maintenance Therapy|Death|2|||
24945725|NCT00352365|50038163|FG000|Maintenance Therapy|Not protocol specified|3|||
25032785|NCT03580369|50132149|FG005|Overall Study|Protocol Violation|2|||
25032786|NCT03580369|50132150|FG006|Overall Study|Protocol Violation|1|||
25032787|NCT03580369|50132151|FG007|Overall Study|Protocol Violation|0|||
25032788|NCT03580369|50132144|FG000|Overall Study|Adverse Event|7|||
24945726|NCT00352365|50038163|FG000|Maintenance Therapy|Not eligible|4|||
25032789|NCT03580369|50132145|FG001|Overall Study|Adverse Event|0|||
25032790|NCT03580369|50132146|FG002|Overall Study|Adverse Event|14|||
25032791|NCT03580369|50132147|FG003|Overall Study|Adverse Event|1|||
25032792|NCT03580369|50132148|FG004|Overall Study|Adverse Event|6|||
25032793|NCT03580369|50132149|FG005|Overall Study|Adverse Event|0|||
25032794|NCT03580369|50132150|FG006|Overall Study|Adverse Event|1|||
25032795|NCT03580369|50132151|FG007|Overall Study|Adverse Event|0|||
25032796|NCT03580369|50132144|FG000|Overall Study|Withdrawal by Subject|19|||
25032797|NCT03580369|50132145|FG001|Overall Study|Withdrawal by Subject|0|||
25032798|NCT03580369|50132146|FG002|Overall Study|Withdrawal by Subject|17|||
25032799|NCT03580369|50132147|FG003|Overall Study|Withdrawal by Subject|0|||
25032800|NCT03580369|50132148|FG004|Overall Study|Withdrawal by Subject|16|||
25032801|NCT03580369|50132149|FG005|Overall Study|Withdrawal by Subject|1|||
25032802|NCT03580369|50132150|FG006|Overall Study|Withdrawal by Subject|7|||
25032803|NCT03580369|50132151|FG007|Overall Study|Withdrawal by Subject|0|||
25032804|NCT05300763|50132164|FG000|Overall Study|Adverse Event|0|||
25032805|NCT05300763|50132165|FG001|Overall Study|Adverse Event|1|||
25032806|NCT05300763|50132164|FG000|Overall Study|Major Protocol Deviation|1|||
25032807|NCT05300763|50132165|FG001|Overall Study|Major Protocol Deviation|0|||
25032808|NCT05300763|50132164|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
25032809|NCT05300763|50132165|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
25032810|NCT02925312|50132173|FG000|Overall Study|Lost to Follow-up|25|||
25032811|NCT02925312|50132174|FG001|Overall Study|Lost to Follow-up|0|||
25032812|NCT02925312|50132173|FG000|Overall Study|Adverse Event|2|||
25032813|NCT02925312|50132174|FG001|Overall Study|Adverse Event|0|||
25032814|NCT03196297|50132189|FG000|Main Period|Withdrawal by Subject|4|||
25032815|NCT03196297|50132189|FG000|Extension Period|Withdrawal by Subject|1|||
25032816|NCT03196297|50132189|FG000|Extension Period|Lack of Efficacy|2|||
25032817|NCT03192475|50132214|FG000|Overall Study|Death|0|||
24945727|NCT00532493|50038173|FG000|Overall Study|Death|1|||
24945728|NCT00532493|50038174|FG001|Overall Study|Death|1|||
25032818|NCT03192475|50132215|FG001|Overall Study|Death|1|||
25032819|NCT03192475|50132214|FG000|Overall Study|Lost to Follow-up|13|||
25032820|NCT03192475|50132215|FG001|Overall Study|Lost to Follow-up|8|||
25032821|NCT03189745|50132224|FG000|Overall Study|Conflict in work schedule of participant|1|||
25032822|NCT03189745|50132225|FG001|Overall Study|Conflict in work schedule of participant|1|||
25032823|NCT03188263|50132233|FG000|Overall Study|Withdrawal by Subject|3|||
25032824|NCT03188263|50132234|FG001|Overall Study|Withdrawal by Subject|0|||
24945729|NCT00532493|50038173|FG000|Overall Study|Lost to Follow-up|10|||
24945730|NCT00532493|50038174|FG001|Overall Study|Lost to Follow-up|7|||
24945731|NCT00532493|50038173|FG000|Overall Study|Withdrawal by Subject|7|||
24945732|NCT00532493|50038174|FG001|Overall Study|Withdrawal by Subject|9|||
25032825|NCT03188263|50132233|FG000|Overall Study|Physician Decision|1|||
25032826|NCT03188263|50132234|FG001|Overall Study|Physician Decision|0|||
25032827|NCT03188185|50132242|FG000|Stage 1|Adverse Event|4|||
25032828|NCT03188185|50132243|FG001|Stage 1|Adverse Event|12|||
25032829|NCT03188185|50132244|FG002|Stage 1|Adverse Event|0|||
25032830|NCT03188185|50132245|FG003|Stage 1|Adverse Event|0|||
25032831|NCT03188185|50132242|FG000|Stage 1|Lack of Efficacy|0|||
24945733|NCT00532493|50038173|FG000|Overall Study|Physician Decision|1|||
24945734|NCT00532493|50038174|FG001|Overall Study|Physician Decision|6|||
24945735|NCT00532493|50038173|FG000|Overall Study|Adverse Event|6|||
24945736|NCT00532493|50038174|FG001|Overall Study|Adverse Event|5|||
24945737|NCT00532493|50038173|FG000|Overall Study|Protocol Deviation|1|||
24945738|NCT00532493|50038174|FG001|Overall Study|Protocol Deviation|0|||
24945739|NCT00532493|50038173|FG000|Overall Study|Subject Moved Away|3|||
24945740|NCT00532493|50038174|FG001|Overall Study|Subject Moved Away|1|||
24945741|NCT00532493|50038173|FG000|Overall Study|Contraindicative Medication|1|||
24945742|NCT00532493|50038174|FG001|Overall Study|Contraindicative Medication|0|||
24945743|NCT00533507|50038182|FG000|Overall Study|Withdrawal by Subject|1|||
24945744|NCT03886493|50038186|FG000|Overall Study|Adverse Event|1|||
24945745|NCT00352053|50038192|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
24945746|NCT00352053|50038193|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
25032832|NCT03188185|50132243|FG001|Stage 1|Lack of Efficacy|2|||
25032833|NCT03188185|50132244|FG002|Stage 1|Lack of Efficacy|0|||
25032834|NCT03188185|50132245|FG003|Stage 1|Lack of Efficacy|0|||
25032835|NCT03188185|50132242|FG000|Stage 1|Lost to Follow-up|6|||
25032836|NCT03188185|50132243|FG001|Stage 1|Lost to Follow-up|1|||
25032837|NCT03188185|50132244|FG002|Stage 1|Lost to Follow-up|0|||
25032838|NCT03188185|50132245|FG003|Stage 1|Lost to Follow-up|0|||
25032839|NCT03188185|50132242|FG000|Stage 1|Withdrawal by Subject|9|||
25032840|NCT03188185|50132243|FG001|Stage 1|Withdrawal by Subject|0|||
25032841|NCT03188185|50132244|FG002|Stage 1|Withdrawal by Subject|0|||
25032842|NCT03188185|50132245|FG003|Stage 1|Withdrawal by Subject|0|||
25032843|NCT03188185|50132242|FG000|Stage 1|Identified as a professional patient|0|||
25032844|NCT03188185|50132243|FG001|Stage 1|Identified as a professional patient|1|||
25032845|NCT03188185|50132244|FG002|Stage 1|Identified as a professional patient|0|||
25032846|NCT03188185|50132245|FG003|Stage 1|Identified as a professional patient|0|||
25032847|NCT03188185|50132242|FG000|Stage 2|Adverse Event|0|||
25032848|NCT03188185|50132243|FG001|Stage 2|Adverse Event|0|||
24945747|NCT00352053|50038192|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
24945748|NCT00352053|50038193|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
24945749|NCT00352053|50038192|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
24945750|NCT00352053|50038193|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
24945751|NCT00352053|50038192|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
24945752|NCT00352053|50038193|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
24945753|NCT00352053|50038192|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
24945754|NCT00352053|50038193|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
24945755|NCT00352053|50038192|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
24945756|NCT00352053|50038193|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
24945757|NCT00352053|50038192|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
25032849|NCT03188185|50132244|FG002|Stage 2|Adverse Event|2|||
25032850|NCT03188185|50132245|FG003|Stage 2|Adverse Event|4|||
25032851|NCT03188185|50132242|FG000|Stage 2|Lack of Efficacy|0|||
25032852|NCT03188185|50132243|FG001|Stage 2|Lack of Efficacy|0|||
25032853|NCT03188185|50132244|FG002|Stage 2|Lack of Efficacy|3|||
25032854|NCT03188185|50132245|FG003|Stage 2|Lack of Efficacy|0|||
25032855|NCT03188185|50132242|FG000|Stage 2|Lost to Follow-up|0|||
25032856|NCT03188185|50132243|FG001|Stage 2|Lost to Follow-up|0|||
25032857|NCT03188185|50132244|FG002|Stage 2|Lost to Follow-up|1|||
25032858|NCT03188185|50132245|FG003|Stage 2|Lost to Follow-up|0|||
25032859|NCT03188185|50132242|FG000|Stage 2|Physician Decision|0|||
25032860|NCT03188185|50132243|FG001|Stage 2|Physician Decision|0|||
25032861|NCT03188185|50132244|FG002|Stage 2|Physician Decision|0|||
25032862|NCT03188185|50132245|FG003|Stage 2|Physician Decision|1|||
25032863|NCT03188185|50132242|FG000|Stage 2|Withdrawal by Subject|0|||
25032864|NCT03188185|50132243|FG001|Stage 2|Withdrawal by Subject|0|||
25032865|NCT03188185|50132244|FG002|Stage 2|Withdrawal by Subject|3|||
25032866|NCT03188185|50132245|FG003|Stage 2|Withdrawal by Subject|1|||
25032867|NCT03186781|50132261|FG000|Overall Study|Lost to Follow-up|0|||
25032868|NCT03186781|50132262|FG001|Overall Study|Lost to Follow-up|0|||
25032869|NCT03186781|50132263|FG002|Overall Study|Lost to Follow-up|1|||
25032870|NCT03186781|50132264|FG003|Overall Study|Lost to Follow-up|0|||
25032871|NCT03186781|50132265|FG004|Overall Study|Lost to Follow-up|1|||
25032872|NCT03186781|50132266|FG005|Overall Study|Lost to Follow-up|0|||
25032873|NCT03186781|50132261|FG000|Overall Study|Moved from Area|0|||
25032874|NCT03186781|50132262|FG001|Overall Study|Moved from Area|0|||
25032875|NCT03186781|50132263|FG002|Overall Study|Moved from Area|0|||
25032876|NCT03186781|50132264|FG003|Overall Study|Moved from Area|0|||
25032877|NCT03186781|50132265|FG004|Overall Study|Moved from Area|1|||
25032878|NCT03186781|50132266|FG005|Overall Study|Moved from Area|0|||
25032879|NCT03186781|50132261|FG000|Overall Study|Withdrawal by Subject|0|||
25032880|NCT03186781|50132262|FG001|Overall Study|Withdrawal by Subject|0|||
25032881|NCT03186781|50132263|FG002|Overall Study|Withdrawal by Subject|0|||
25032882|NCT03186781|50132264|FG003|Overall Study|Withdrawal by Subject|0|||
25032883|NCT03186781|50132265|FG004|Overall Study|Withdrawal by Subject|1|||
25032884|NCT03186781|50132266|FG005|Overall Study|Withdrawal by Subject|0|||
25032885|NCT03184987|50132293|FG000|Overall Study|Withdrawal by Subject|0|||
25032886|NCT03184987|50132294|FG001|Overall Study|Withdrawal by Subject|1|||
25032887|NCT03184987|50132295|FG002|Overall Study|Withdrawal by Subject|2|||
25159505|NCT01920061|50279326|FG013|Overall Study|Participant refused further follow-up|0|||
25032888|NCT03184987|50132293|FG000|Overall Study|Physician Decision|0|||
25032889|NCT03184987|50132294|FG001|Overall Study|Physician Decision|0|||
25159506|NCT01920061|50279327|FG014|Overall Study|Participant refused further follow-up|1|||
25159507|NCT01920061|50279328|FG015|Overall Study|Participant refused further follow-up|2|||
25186207|NCT01399697|50336172|FG000|Overall Study|Adverse Event|13|||
25032890|NCT03184987|50132295|FG002|Overall Study|Physician Decision|1|||
25032891|NCT03184987|50132293|FG000|Overall Study|Adverse Event|1|||
25032892|NCT03184987|50132294|FG001|Overall Study|Adverse Event|0|||
25032893|NCT03184987|50132295|FG002|Overall Study|Adverse Event|1|||
25032894|NCT03184519|50132303|FG000|Overall Study|Lost to Follow-up|6|||
25032895|NCT03184519|50132303|FG000|Overall Study|Physician Decision|21|||
25032896|NCT03184441|50132307|FG000|Overall Study|Withdrawal by Subject|1|||
25032897|NCT03026166|50132316|FG000|Overall Study|Death|22|||
25032898|NCT03026166|50132317|FG001|Overall Study|Death|7|||
25032899|NCT03026166|50132316|FG000|Overall Study|Physician Decision|2|||
25032900|NCT03026166|50132317|FG001|Overall Study|Physician Decision|0|||
25032901|NCT03026166|50132316|FG000|Overall Study|Withdrawal by Subject|1|||
25032902|NCT03026166|50132317|FG001|Overall Study|Withdrawal by Subject|2|||
25032903|NCT03026166|50132316|FG000|Overall Study|Lost to Follow-up|1|||
25032904|NCT03026166|50132317|FG001|Overall Study|Lost to Follow-up|0|||
25032905|NCT03026166|50132316|FG000|Overall Study|Study Terminated by Sponsor|3|||
25032906|NCT03026166|50132317|FG001|Overall Study|Study Terminated by Sponsor|3|||
25032907|NCT03026166|50132316|FG000|Overall Study|Other|1|||
25032908|NCT03026166|50132317|FG001|Overall Study|Other|0|||
25032909|NCT03026088|50132323|FG000|Overall Study|Study termination|20|||
25032910|NCT03181789|50132331|FG000|Overall Study|Withdrawal by Subject|0|||
25032911|NCT03181789|50132332|FG001|Overall Study|Withdrawal by Subject|1|||
25032912|NCT03181789|50132333|FG002|Overall Study|Withdrawal by Subject|1|||
25032913|NCT03181789|50132334|FG003|Overall Study|Withdrawal by Subject|0|||
25032914|NCT03181789|50132331|FG000|Overall Study|Lost to Follow-up|7|||
25032915|NCT03181789|50132332|FG001|Overall Study|Lost to Follow-up|1|||
25032916|NCT03181789|50132333|FG002|Overall Study|Lost to Follow-up|0|||
25032917|NCT03181789|50132334|FG003|Overall Study|Lost to Follow-up|0|||
25032918|NCT03181789|50132331|FG000|Overall Study|Participant unable to adhere to visit|0|||
25032919|NCT03181789|50132332|FG001|Overall Study|Participant unable to adhere to visit|1|||
25032920|NCT03181789|50132333|FG002|Overall Study|Participant unable to adhere to visit|0|||
25032921|NCT03181789|50132334|FG003|Overall Study|Participant unable to adhere to visit|0|||
25032922|NCT03259074|50132347|FG000|Overall Study|Adverse Event|9|||
25032923|NCT03259074|50132348|FG001|Overall Study|Adverse Event|12|||
25032924|NCT03259074|50132349|FG002|Overall Study|Adverse Event|8|||
25032925|NCT03259074|50132347|FG000|Overall Study|Death|1|||
25032926|NCT03259074|50132348|FG001|Overall Study|Death|1|||
25032927|NCT03259074|50132349|FG002|Overall Study|Death|3|||
25032928|NCT03259074|50132347|FG000|Overall Study|Lost to Follow-up|2|||
25032929|NCT03259074|50132348|FG001|Overall Study|Lost to Follow-up|4|||
25032930|NCT03259074|50132349|FG002|Overall Study|Lost to Follow-up|3|||
25032931|NCT03259074|50132347|FG000|Overall Study|New Therapy For Study Indication|1|||
25032932|NCT03259074|50132348|FG001|Overall Study|New Therapy For Study Indication|2|||
25032933|NCT03259074|50132349|FG002|Overall Study|New Therapy For Study Indication|2|||
25032934|NCT03259074|50132347|FG000|Overall Study|Physician Decision|4|||
25032935|NCT03259074|50132348|FG001|Overall Study|Physician Decision|12|||
25032936|NCT03259074|50132349|FG002|Overall Study|Physician Decision|10|||
24945758|NCT00352053|50038193|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
24945759|NCT00352053|50038192|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
24945760|NCT00352053|50038193|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
24945761|NCT00352053|50038192|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
24945762|NCT00352053|50038193|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
24945763|NCT00352053|50038192|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
24945764|NCT00352053|50038193|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
24945765|NCT00352053|50038192|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
24945766|NCT00352053|50038193|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
24945767|NCT00352053|50038192|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
24945768|NCT00352053|50038193|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
24945769|NCT00352053|50038192|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
24945770|NCT00352053|50038193|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
24945771|NCT00351819|50038209|FG000|Overall Study|Lost to Follow-up|4|||
24945772|NCT00351819|50038210|FG001|Overall Study|Lost to Follow-up|4|||
24945773|NCT00351819|50038209|FG000|Overall Study|Withdrawal by Subject|0|||
24945774|NCT00351819|50038210|FG001|Overall Study|Withdrawal by Subject|4|||
24945775|NCT00351819|50038209|FG000|Overall Study|Elevated PSA|1|||
24945776|NCT00351819|50038210|FG001|Overall Study|Elevated PSA|1|||
24945777|NCT00351819|50038209|FG000|Overall Study|Traumatic ankle fracture|1|||
24945778|NCT00351819|50038210|FG001|Overall Study|Traumatic ankle fracture|0|||
24945779|NCT00351819|50038209|FG000|Overall Study|Unprofessional behavior|1|||
24945780|NCT00351819|50038210|FG001|Overall Study|Unprofessional behavior|0|||
24945781|NCT00351819|50038209|FG000|Overall Study|Non-compliance|0|||
24945782|NCT00351819|50038210|FG001|Overall Study|Non-compliance|1|||
24945783|NCT00351819|50038209|FG000|Overall Study|Incarcerated|0|||
24945784|NCT00351819|50038210|FG001|Overall Study|Incarcerated|1|||
24945785|NCT00351819|50038209|FG000|Overall Study|Enrolled in another trial|0|||
24945786|NCT00351819|50038210|FG001|Overall Study|Enrolled in another trial|1|||
25032937|NCT03259074|50132347|FG000|Overall Study|Pregnancy|1|||
25032938|NCT03259074|50132348|FG001|Overall Study|Pregnancy|1|||
25032939|NCT03259074|50132349|FG002|Overall Study|Pregnancy|0|||
25032940|NCT03259074|50132347|FG000|Overall Study|Progressive Disease|1|||
25032941|NCT03259074|50132348|FG001|Overall Study|Progressive Disease|0|||
25032942|NCT03259074|50132349|FG002|Overall Study|Progressive Disease|0|||
25032943|NCT03259074|50132347|FG000|Overall Study|Protocol Deviation|1|||
25032944|NCT03259074|50132348|FG001|Overall Study|Protocol Deviation|1|||
25032945|NCT03259074|50132349|FG002|Overall Study|Protocol Deviation|3|||
25032946|NCT03259074|50132347|FG000|Overall Study|Subject/Guardian Decision|13|||
25032947|NCT03259074|50132348|FG001|Overall Study|Subject/Guardian Decision|16|||
25032948|NCT03259074|50132349|FG002|Overall Study|Subject/Guardian Decision|14|||
25032949|NCT03024606|50132359|FG000|Overall Study|Withdrawal by Subject|9|||
25032950|NCT03024606|50132360|FG001|Overall Study|Withdrawal by Subject|10|||
25032951|NCT03180619|50132369|FG000|Overall Study|Withdrew Consent|5|||
25032952|NCT03180619|50132370|FG001|Overall Study|Withdrew Consent|0|||
25032953|NCT03180619|50132371|FG002|Overall Study|Withdrew Consent|2|||
25032954|NCT03180619|50132369|FG000|Overall Study|Death|2|||
25032955|NCT03180619|50132370|FG001|Overall Study|Death|1|||
25032956|NCT03180619|50132371|FG002|Overall Study|Death|2|||
25032957|NCT03180619|50132369|FG000|Overall Study|Adverse Event|2|||
25032958|NCT03180619|50132370|FG001|Overall Study|Adverse Event|0|||
25032959|NCT03180619|50132371|FG002|Overall Study|Adverse Event|1|||
25032960|NCT03180619|50132369|FG000|Overall Study|Investigator's discretion|2|||
25032961|NCT03180619|50132370|FG001|Overall Study|Investigator's discretion|0|||
25032962|NCT03180619|50132371|FG002|Overall Study|Investigator's discretion|1|||
25032963|NCT02915874|50132388|FG000|Overall Study|Lost to Follow-up|5|||
25032964|NCT02915874|50132389|FG001|Overall Study|Lost to Follow-up|4|||
24945787|NCT00351351|50038218|FG000|Overall Study|surgical access pbs; device issues|9|||
24945788|NCT00351351|50038219|FG001|Overall Study|surgical access pbs; device issues|4|||
24945789|NCT00323115|50038225|FG000|Vaccine Administration|Adverse Event|1|||
24945790|NCT00323115|50038225|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
24945791|NCT00322881|50038234|FG000|Overall Study|Death|2|||
24945792|NCT00322881|50038234|FG000|Overall Study|Adverse Event|1|||
24945793|NCT00322881|50038234|FG000|Overall Study|Disease Progression|2|||
24945794|NCT00415194|50038240|FG000|Overall Study|Adverse Event|37|||
24945795|NCT00415194|50038241|FG001|Overall Study|Adverse Event|32|||
24945796|NCT00415194|50038240|FG000|Overall Study|Entry Criteria Not Met|4|||
24945797|NCT00415194|50038241|FG001|Overall Study|Entry Criteria Not Met|8|||
24945798|NCT00415194|50038240|FG000|Overall Study|Lost to Follow-up|1|||
24945799|NCT00415194|50038241|FG001|Overall Study|Lost to Follow-up|0|||
24945800|NCT00415194|50038240|FG000|Overall Study|Physician Decision|10|||
24945801|NCT00415194|50038241|FG001|Overall Study|Physician Decision|16|||
24945802|NCT00415194|50038240|FG000|Overall Study|Progressive Disease|180|||
24945803|NCT00415194|50038241|FG001|Overall Study|Progressive Disease|217|||
24945804|NCT00415194|50038240|FG000|Overall Study|Protocol Violation|4|||
24945805|NCT00415194|50038241|FG001|Overall Study|Protocol Violation|2|||
24945806|NCT00415194|50038240|FG000|Overall Study|Withdrawal by Subject|28|||
24945807|NCT00415194|50038241|FG001|Overall Study|Withdrawal by Subject|21|||
24945808|NCT00415194|50038240|FG000|Overall Study|Death Due to Study Disease|26|||
24945809|NCT00415194|50038241|FG001|Overall Study|Death Due to Study Disease|29|||
24945810|NCT00415194|50038240|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
24945811|NCT00415194|50038241|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
24945812|NCT00415194|50038240|FG000|Overall Study|Death Due to Procedural Related AE|0|||
24945813|NCT00415194|50038241|FG001|Overall Study|Death Due to Procedural Related AE|1|||
24945814|NCT00415194|50038240|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
24945815|NCT00415194|50038241|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
24945816|NCT00436332|50038247|FG000|Overall Study|Adverse Event|9|||
25032965|NCT02915874|50132388|FG000|Overall Study|Withdrawal by Subject|1|||
25032966|NCT02915874|50132389|FG001|Overall Study|Withdrawal by Subject|1|||
25032967|NCT02915874|50132388|FG000|Overall Study|Started New Anxiety Medication|0|||
25032968|NCT02915874|50132389|FG001|Overall Study|Started New Anxiety Medication|1|||
25032969|NCT03022578|50132395|FG000|Overall Study|Adverse Event|1|||
24945817|NCT00436332|50038247|FG000|Overall Study|Withdrawal by Subject|2|||
24945818|NCT00436332|50038247|FG000|Overall Study|Progression|59|||
24945819|NCT00436332|50038247|FG000|Overall Study|Death|2|||
24945820|NCT00436332|50038247|FG000|Overall Study|Not Protocol Specified|6|||
24945821|NCT00436332|50038247|FG000|Overall Study|Ineligible|2|||
24945822|NCT00436332|50038247|FG000|Overall Study|Never Received Treatment|3|||
24945823|NCT00532259|50038251|FG000|Overall Study|Withdrawal by Subject|2|||
25032970|NCT03022578|50132395|FG000|Overall Study|Lack of Efficacy|2|||
25032971|NCT03022578|50132395|FG000|Overall Study|Withdrawal by Subject|1|||
25032972|NCT03022422|50132405|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
25032973|NCT03022422|50132406|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
25032974|NCT03022422|50132407|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
25032975|NCT03022422|50132408|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
25032976|NCT03022422|50132409|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
25032977|NCT03022422|50132410|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
25032978|NCT03023826|50132426|FG000|Period 1|Withdrawal by Subject|0|||
25032979|NCT03023826|50132427|FG001|Period 1|Withdrawal by Subject|0|||
25032980|NCT03023826|50132428|FG002|Period 1|Withdrawal by Subject|0|||
25032981|NCT03023826|50132429|FG003|Period 1|Withdrawal by Subject|0|||
25032982|NCT03023826|50132430|FG004|Period 1|Withdrawal by Subject|1|||
25032983|NCT03023826|50132431|FG005|Period 1|Withdrawal by Subject|0|||
25032984|NCT03166735|50132444|FG000|Overall Study|Not Treated|1|||
25032985|NCT03166735|50132445|FG001|Overall Study|Not Treated|0|||
25032986|NCT03166735|50132446|FG002|Overall Study|Not Treated|0|||
25032987|NCT03166735|50132447|FG003|Overall Study|Not Treated|0|||
25032988|NCT03166735|50132448|FG004|Overall Study|Not Treated|0|||
25032989|NCT03166735|50132444|FG000|Overall Study|follow-up not completed as planned|0|||
25032990|NCT03166735|50132445|FG001|Overall Study|follow-up not completed as planned|1|||
25032991|NCT03166735|50132446|FG002|Overall Study|follow-up not completed as planned|1|||
25032992|NCT03166735|50132447|FG003|Overall Study|follow-up not completed as planned|0|||
25032993|NCT03166735|50132448|FG004|Overall Study|follow-up not completed as planned|1|||
25032994|NCT03166735|50132444|FG000|Overall Study|Withdrawal by Subject|0|||
25032995|NCT03166735|50132445|FG001|Overall Study|Withdrawal by Subject|0|||
25032996|NCT03166735|50132446|FG002|Overall Study|Withdrawal by Subject|1|||
25032997|NCT03166735|50132447|FG003|Overall Study|Withdrawal by Subject|1|||
25032998|NCT03166735|50132448|FG004|Overall Study|Withdrawal by Subject|2|||
25032999|NCT03166735|50132444|FG000|Overall Study|Lost to Follow-up|0|||
25033000|NCT03166735|50132445|FG001|Overall Study|Lost to Follow-up|2|||
25033001|NCT03166735|50132446|FG002|Overall Study|Lost to Follow-up|1|||
25033002|NCT03166735|50132447|FG003|Overall Study|Lost to Follow-up|0|||
25033003|NCT03166735|50132448|FG004|Overall Study|Lost to Follow-up|1|||
25033004|NCT03165955|50132461|FG000|Treatment|Withdrawal by Subject|3|||
25033005|NCT03165955|50132461|FG000|Treatment|Death|1|||
25033006|NCT03165955|50132461|FG000|Treatment|Adverse Event|1|||
25033007|NCT03165955|50132461|FG000|Treatment|Progressive disease|3|||
25033008|NCT03055494|50132467|FG000|Overall Study|Lost to Follow-up|6|||
25033009|NCT03055494|50132468|FG001|Overall Study|Lost to Follow-up|0|||
25033010|NCT03055494|50132467|FG000|Overall Study|Physician Decision|2|||
25033011|NCT03055494|50132468|FG001|Overall Study|Physician Decision|0|||
25033012|NCT03055494|50132467|FG000|Overall Study|Withdrawal by Subject|1|||
25033013|NCT03055494|50132468|FG001|Overall Study|Withdrawal by Subject|0|||
25033014|NCT03055494|50132467|FG000|Overall Study|Adverse Event|0|||
25033015|NCT03055494|50132468|FG001|Overall Study|Adverse Event|1|||
25033016|NCT03055494|50132467|FG000|Overall Study|Non-compliance with study treatment|1|||
24945824|NCT00532259|50038251|FG000|Overall Study|Adverse Event|1|||
24945825|NCT00532259|50038251|FG000|Overall Study|Death|1|||
25033017|NCT03055494|50132468|FG001|Overall Study|Non-compliance with study treatment|0|||
25033018|NCT02914548|50132478|FG000|Overall Study|Adverse Event|15|||
25033019|NCT02914548|50132479|FG001|Overall Study|Adverse Event|7|||
25033020|NCT02914548|50132480|FG002|Overall Study|Adverse Event|15|||
25033021|NCT02914548|50132478|FG000|Overall Study|Physician Decision|2|||
25033022|NCT02914548|50132479|FG001|Overall Study|Physician Decision|2|||
25033023|NCT02914548|50132480|FG002|Overall Study|Physician Decision|0|||
25033024|NCT02914548|50132478|FG000|Overall Study|Protocol Violation|1|||
25033025|NCT02914548|50132479|FG001|Overall Study|Protocol Violation|0|||
25033026|NCT02914548|50132480|FG002|Overall Study|Protocol Violation|0|||
25033027|NCT02914548|50132478|FG000|Overall Study|Withdrawal by Subject|3|||
25033028|NCT02914548|50132479|FG001|Overall Study|Withdrawal by Subject|4|||
25033029|NCT02914548|50132480|FG002|Overall Study|Withdrawal by Subject|4|||
24945826|NCT00532259|50038251|FG000|Overall Study|Lack of Efficacy|21|||
24945827|NCT00532259|50038251|FG000|Overall Study|Lost to Follow-up|3|||
24945828|NCT00532259|50038251|FG000|Overall Study|Physician Decision|3|||
24945829|NCT00532259|50038251|FG000|Overall Study|Protocol Violation|1|||
24945830|NCT00322491|50038258|FG000|Overall Study|Adverse Event|1|||
24945831|NCT00322491|50038259|FG001|Overall Study|Adverse Event|0|||
25033030|NCT02914548|50132478|FG000|Overall Study|>40% of body surface area|0|||
25033031|NCT02914548|50132479|FG001|Overall Study|>40% of body surface area|1|||
25186208|NCT01399697|50336173|FG001|Overall Study|Adverse Event|3|||
24945832|NCT00322491|50038258|FG000|Overall Study|Death|1|||
24945833|NCT00322491|50038259|FG001|Overall Study|Death|2|||
25033032|NCT02914548|50132480|FG002|Overall Study|>40% of body surface area|1|||
25033033|NCT03165721|50132496|FG000|Overall Study|Refused further treatment|3|||
25033034|NCT03165721|50132497|FG001|Overall Study|Refused further treatment|0|||
25033035|NCT03165721|50132498|FG002|Overall Study|Refused further treatment|0|||
25033036|NCT03165721|50132496|FG000|Overall Study|Physician Decision|1|||
25033037|NCT03165721|50132497|FG001|Overall Study|Physician Decision|0|||
25033038|NCT03165721|50132498|FG002|Overall Study|Physician Decision|0|||
25033039|NCT02187198|50132514|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
25033040|NCT02187198|50132515|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
24945834|NCT00322023|50038269|FG000|Overall Study|various|0|||
24945835|NCT00322023|50038270|FG001|Overall Study|various|2|||
24945836|NCT00322023|50038271|FG002|Overall Study|various|6|||
24945837|NCT00414960|50038281|FG000|Overall Study|Adverse Event|4|||
25033041|NCT02187198|50132514|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
25033042|NCT02187198|50132515|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
25033043|NCT02642029|50132521|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
25033044|NCT02642029|50132522|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
25033045|NCT02642029|50132523|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
25033046|NCT02642029|50132524|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
25033047|NCT02642029|50132525|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
25033048|NCT02642029|50132526|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
25033049|NCT02642029|50132521|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
25033050|NCT02642029|50132522|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
24945838|NCT00414960|50038282|FG001|Overall Study|Adverse Event|0|||
24945839|NCT00414960|50038281|FG000|Overall Study|Withdrawal by Subject|3|||
24945840|NCT00414960|50038282|FG001|Overall Study|Withdrawal by Subject|0|||
24945841|NCT00414960|50038281|FG000|Overall Study|Physician Decision|0|||
24945842|NCT00414960|50038282|FG001|Overall Study|Physician Decision|1|||
24945843|NCT00321789|50038290|FG000|Overall Study|Lost to Follow-up|4|||
24945844|NCT00321789|50038291|FG001|Overall Study|Lost to Follow-up|7|||
24945845|NCT00321789|50038290|FG000|Overall Study|Withdrawal by Subject|6|||
24945846|NCT00321789|50038291|FG001|Overall Study|Withdrawal by Subject|6|||
24945847|NCT00321789|50038290|FG000|Overall Study|Protocol Violation|5|||
24945848|NCT00321789|50038291|FG001|Overall Study|Protocol Violation|3|||
24945849|NCT00414726|50038299|FG000|Overall Study|Withdrawal by Subject|0|||
24945850|NCT00414726|50038300|FG001|Overall Study|Withdrawal by Subject|1|||
24945851|NCT00531947|50038308|FG000|Overall Study|Adverse Event|5|||
24945852|NCT00531947|50038309|FG001|Overall Study|Adverse Event|10|||
24945853|NCT00531947|50038308|FG000|Overall Study|Lost to Follow-up|12|||
24945854|NCT00531947|50038309|FG001|Overall Study|Lost to Follow-up|9|||
24945855|NCT00531947|50038308|FG000|Overall Study|Withdrawal by Subject|14|||
24945856|NCT00531947|50038309|FG001|Overall Study|Withdrawal by Subject|19|||
24945857|NCT00531947|50038308|FG000|Overall Study|Protocol Violation|2|||
24945858|NCT00531947|50038309|FG001|Overall Study|Protocol Violation|1|||
24945859|NCT00531947|50038308|FG000|Overall Study|Non-Compliance|4|||
24945860|NCT00531947|50038309|FG001|Overall Study|Non-Compliance|7|||
24945861|NCT00531947|50038308|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
24945862|NCT00531947|50038309|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
24945863|NCT00530855|50038315|FG000|Overall Study|Lack of Efficacy|20|||
24945864|NCT00530855|50038315|FG000|Overall Study|Withdrawal by Subject|30|||
24945865|NCT00530855|50038315|FG000|Overall Study|Fatal Serious AE|3|||
24945866|NCT00530855|50038315|FG000|Overall Study|Non Fatal Serious AE|7|||
24945867|NCT00530855|50038315|FG000|Overall Study|Non Fatal Non Serious AE|12|||
24945868|NCT00530855|50038315|FG000|Overall Study|Protocol Violation|3|||
24945869|NCT00530855|50038315|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
24945870|NCT00530855|50038315|FG000|Overall Study|Lost to Follow-up|9|||
24945871|NCT00530855|50038315|FG000|Overall Study|Other reason for premature termination|17|||
24945872|NCT00530777|50038321|FG000|Overall Study|Lost to Follow-up|0|||
24945873|NCT00530777|50038322|FG001|Overall Study|Lost to Follow-up|1|||
24945874|NCT00530777|50038321|FG000|Overall Study|Death|1|||
24945875|NCT00530777|50038322|FG001|Overall Study|Death|2|||
24945876|NCT00530777|50038321|FG000|Overall Study|Physician Decision|1|||
25033051|NCT02642029|50132523|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
25033052|NCT02642029|50132524|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
25033053|NCT02642029|50132525|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
25033054|NCT02642029|50132526|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
25033055|NCT02642029|50132521|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
25033056|NCT02642029|50132522|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
25033057|NCT02642029|50132523|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
25033058|NCT02642029|50132524|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
25033059|NCT02642029|50132525|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
25033060|NCT02642029|50132526|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
25033061|NCT02642029|50132521|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
25033062|NCT02642029|50132522|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
25159508|NCT01920061|50279329|FG016|Overall Study|Participant refused further follow-up|1|||
25159509|NCT01920061|50279330|FG017|Overall Study|Participant refused further follow-up|1|||
24945877|NCT00530777|50038322|FG001|Overall Study|Physician Decision|0|||
24945878|NCT00530777|50038321|FG000|Overall Study|Withdrawal by Subject|0|||
24945879|NCT00530777|50038322|FG001|Overall Study|Withdrawal by Subject|1|||
24945880|NCT00530777|50038321|FG000|Overall Study|Unable to adhere to visit schedule|5|||
24945881|NCT00530777|50038322|FG001|Overall Study|Unable to adhere to visit schedule|1|||
24945882|NCT03882047|50038331|FG000|Overall Study|Adverse Event|0|||
25033063|NCT02642029|50132523|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
25033064|NCT02642029|50132524|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
25033065|NCT02642029|50132525|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
25033066|NCT02642029|50132526|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
25033067|NCT02642029|50132521|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
25033068|NCT02642029|50132522|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
25033069|NCT02642029|50132523|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
25033070|NCT02642029|50132524|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
25033071|NCT02642029|50132525|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
25033072|NCT02642029|50132526|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
25033073|NCT02642029|50132521|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
25033074|NCT02642029|50132522|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
25033075|NCT02642029|50132523|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
25033076|NCT02642029|50132524|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
25033077|NCT02642029|50132525|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
25033078|NCT02642029|50132526|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
25033079|NCT03178669|50132539|FG000|Overall Study|Adverse Event|4|||
25033080|NCT03178669|50132540|FG001|Overall Study|Adverse Event|1|||
25033081|NCT03178669|50132541|FG002|Overall Study|Adverse Event|4|||
25033082|NCT03178669|50132542|FG003|Overall Study|Adverse Event|2|||
25033083|NCT03178669|50132543|FG004|Overall Study|Adverse Event|2|||
25033084|NCT03178669|50132539|FG000|Overall Study|Lack of Efficacy|0|||
25033085|NCT03178669|50132540|FG001|Overall Study|Lack of Efficacy|0|||
25033086|NCT03178669|50132541|FG002|Overall Study|Lack of Efficacy|2|||
25033087|NCT03178669|50132542|FG003|Overall Study|Lack of Efficacy|0|||
25033088|NCT03178669|50132543|FG004|Overall Study|Lack of Efficacy|1|||
25033089|NCT03178669|50132539|FG000|Overall Study|Physician Decision|0|||
25033090|NCT03178669|50132540|FG001|Overall Study|Physician Decision|0|||
25033091|NCT03178669|50132541|FG002|Overall Study|Physician Decision|0|||
25033092|NCT03178669|50132542|FG003|Overall Study|Physician Decision|0|||
25033093|NCT03178669|50132543|FG004|Overall Study|Physician Decision|1|||
25033094|NCT03178669|50132539|FG000|Overall Study|Withdrawal by Subject|1|||
25033095|NCT03178669|50132540|FG001|Overall Study|Withdrawal by Subject|0|||
25033096|NCT03178669|50132541|FG002|Overall Study|Withdrawal by Subject|1|||
25033097|NCT03178669|50132542|FG003|Overall Study|Withdrawal by Subject|1|||
25033098|NCT03178669|50132543|FG004|Overall Study|Withdrawal by Subject|0|||
25033099|NCT03178669|50132539|FG000|Overall Study|Lost to Follow-up|0|||
25033100|NCT03178669|50132540|FG001|Overall Study|Lost to Follow-up|0|||
25033101|NCT03178669|50132541|FG002|Overall Study|Lost to Follow-up|0|||
25033102|NCT03178669|50132542|FG003|Overall Study|Lost to Follow-up|1|||
25033103|NCT03178669|50132543|FG004|Overall Study|Lost to Follow-up|0|||
25033104|NCT03178201|50132555|FG000|Overall Study|Off study|5|||
25033105|NCT02085408|50132561|FG000|Step 1: Induction|Disease Progression|19|||
25033106|NCT02085408|50132562|FG001|Step 1: Induction|Disease Progression|19|||
25033107|NCT02085408|50132561|FG000|Step 1: Induction|Adverse Event|18|||
25033108|NCT02085408|50132562|FG001|Step 1: Induction|Adverse Event|17|||
25033109|NCT02085408|50132561|FG000|Step 1: Induction|Death|33|||
25033110|NCT02085408|50132562|FG001|Step 1: Induction|Death|30|||
25033111|NCT02085408|50132561|FG000|Step 1: Induction|Withdrawal by Subject|16|||
25033112|NCT02085408|50132562|FG001|Step 1: Induction|Withdrawal by Subject|8|||
25033113|NCT02085408|50132561|FG000|Step 1: Induction|Alternative Therapy|15|||
25033114|NCT02085408|50132562|FG001|Step 1: Induction|Alternative Therapy|19|||
25033115|NCT02085408|50132561|FG000|Step 1: Induction|Complicating Disease|2|||
25033116|NCT02085408|50132562|FG001|Step 1: Induction|Complicating Disease|3|||
25033117|NCT02085408|50132561|FG000|Step 1: Induction|Other|27|||
25033118|NCT02085408|50132562|FG001|Step 1: Induction|Other|39|||
25033119|NCT02085408|50132561|FG000|Step 1: Induction|Never started treatment|6|||
25033120|NCT02085408|50132562|FG001|Step 1: Induction|Never started treatment|4|||
25033121|NCT02085408|50132561|FG000|Step 2: Consolidation|Disease Progression|5|||
25033122|NCT02085408|50132562|FG001|Step 2: Consolidation|Disease Progression|20|||
25033123|NCT02085408|50132561|FG000|Step 2: Consolidation|Adverse Event|9|||
25033124|NCT02085408|50132562|FG001|Step 2: Consolidation|Adverse Event|8|||
25033125|NCT02085408|50132561|FG000|Step 2: Consolidation|Death|4|||
25033126|NCT02085408|50132562|FG001|Step 2: Consolidation|Death|3|||
25033127|NCT02085408|50132561|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
25186209|NCT01399697|50336174|FG002|Overall Study|Adverse Event|1|||
25033128|NCT02085408|50132562|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
25033129|NCT02085408|50132561|FG000|Step 2: Consolidation|Alternative Therapy|9|||
25033130|NCT02085408|50132562|FG001|Step 2: Consolidation|Alternative Therapy|3|||
25033131|NCT02085408|50132561|FG000|Step 2: Consolidation|Complicating Disease|0|||
25033132|NCT02085408|50132562|FG001|Step 2: Consolidation|Complicating Disease|2|||
25033133|NCT02085408|50132561|FG000|Step 2: Consolidation|Other|6|||
25033134|NCT02085408|50132562|FG001|Step 2: Consolidation|Other|6|||
25033135|NCT02085408|50132561|FG000|Step 2: Consolidation|Never started treatment|4|||
25033136|NCT02085408|50132562|FG001|Step 2: Consolidation|Never started treatment|3|||
25033137|NCT02085408|50132561|FG000|Step 3: Maintenance|Disease Progression|13|||
25033138|NCT02085408|50132562|FG001|Step 3: Maintenance|Disease Progression|11|||
25033139|NCT02085408|50132561|FG000|Step 3: Maintenance|Adverse Event|2|||
25033140|NCT02085408|50132562|FG001|Step 3: Maintenance|Adverse Event|4|||
25033141|NCT02085408|50132561|FG000|Step 3: Maintenance|Death|1|||
25033142|NCT02085408|50132562|FG001|Step 3: Maintenance|Death|2|||
25033143|NCT02085408|50132561|FG000|Step 3: Maintenance|Alternative Therapy|1|||
25033144|NCT02085408|50132562|FG001|Step 3: Maintenance|Alternative Therapy|1|||
25033145|NCT02085408|50132561|FG000|Step 3: Maintenance|Complicating Disease|0|||
25033146|NCT02085408|50132562|FG001|Step 3: Maintenance|Complicating Disease|1|||
25033147|NCT02085408|50132561|FG000|Step 3: Maintenance|Other|3|||
25033148|NCT02085408|50132562|FG001|Step 3: Maintenance|Other|2|||
25033149|NCT02085408|50132561|FG000|Step 3: Maintenance|Never started treatment|5|||
25033150|NCT02085408|50132562|FG001|Step 3: Maintenance|Never started treatment|1|||
25033151|NCT03021642|50132577|FG000|Washout Period (21 Days)|Adverse Event|1|||
25033152|NCT03021642|50132578|FG001|Washout Period (21 Days)|Adverse Event|1|||
25033153|NCT03021564|50132586|FG000|Overall Study|Death|84|||
25033154|NCT03021564|50132587|FG001|Overall Study|Death|466|||
25033155|NCT03021564|50132586|FG000|Overall Study|Lost to Follow-up|0|||
25033156|NCT03021564|50132587|FG001|Overall Study|Lost to Follow-up|2|||
25033157|NCT03023046|50132597|FG000|Overall Study|Withdrawal by Subject|1|||
25033158|NCT03019458|50132605|FG000|Overall Study|Death|0|||
25033159|NCT03019458|50132606|FG001|Overall Study|Death|1|||
25033160|NCT02923830|50132616|FG000|Overall Study|Physician Decision|13|||
25033161|NCT02923830|50132617|FG001|Overall Study|Physician Decision|15|||
25033162|NCT03021018|50132626|FG000|Overall Study|Adverse Event|1|||
25033163|NCT03021018|50132627|FG001|Overall Study|Adverse Event|0|||
25033164|NCT03021018|50132628|FG002|Overall Study|Adverse Event|0|||
25033165|NCT03021018|50132626|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
25033166|NCT03021018|50132627|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
25033167|NCT03021018|50132628|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
25033168|NCT02509507|50132645|FG000|Overall Study|Death|21|||
25033169|NCT02509507|50132646|FG001|Overall Study|Death|3|||
25033170|NCT02509507|50132647|FG002|Overall Study|Death|22|||
25033171|NCT02509507|50132648|FG003|Overall Study|Death|13|||
25033172|NCT02509507|50132649|FG004|Overall Study|Death|6|||
25033173|NCT02509507|50132650|FG005|Overall Study|Death|9|||
25033174|NCT02509507|50132651|FG006|Overall Study|Death|4|||
25033175|NCT02509507|50132652|FG007|Overall Study|Death|3|||
25033176|NCT02509507|50132653|FG008|Overall Study|Death|7|||
25033177|NCT02509507|50132645|FG000|Overall Study|Lost to Follow-up|0|||
25033178|NCT02509507|50132646|FG001|Overall Study|Lost to Follow-up|1|||
25033179|NCT02509507|50132647|FG002|Overall Study|Lost to Follow-up|0|||
25033180|NCT02509507|50132648|FG003|Overall Study|Lost to Follow-up|0|||
25033181|NCT02509507|50132649|FG004|Overall Study|Lost to Follow-up|0|||
25033182|NCT02509507|50132650|FG005|Overall Study|Lost to Follow-up|1|||
25033183|NCT02509507|50132651|FG006|Overall Study|Lost to Follow-up|0|||
25033184|NCT02509507|50132652|FG007|Overall Study|Lost to Follow-up|0|||
25033185|NCT02509507|50132653|FG008|Overall Study|Lost to Follow-up|0|||
25033186|NCT02509507|50132645|FG000|Overall Study|Withdrawal by Subject|2|||
25159510|NCT01920061|50279331|FG018|Overall Study|Participant refused further follow-up|0|||
25159511|NCT01920061|50279332|FG019|Overall Study|Participant refused further follow-up|0|||
25033187|NCT02509507|50132646|FG001|Overall Study|Withdrawal by Subject|0|||
25033188|NCT02509507|50132647|FG002|Overall Study|Withdrawal by Subject|1|||
25033189|NCT02509507|50132648|FG003|Overall Study|Withdrawal by Subject|4|||
25033190|NCT02509507|50132649|FG004|Overall Study|Withdrawal by Subject|0|||
25033191|NCT02509507|50132650|FG005|Overall Study|Withdrawal by Subject|3|||
25033192|NCT02509507|50132651|FG006|Overall Study|Withdrawal by Subject|3|||
25033193|NCT02509507|50132652|FG007|Overall Study|Withdrawal by Subject|0|||
25033194|NCT02509507|50132653|FG008|Overall Study|Withdrawal by Subject|0|||
25033195|NCT02509507|50132645|FG000|Overall Study|Continuing Study|0|||
25159512|NCT01426425|50279395|FG000|Overall Study|Exited prior to EP study|22|||
25186210|NCT01399697|50336172|FG000|Overall Study|Lost to Follow-up|2|||
25275660|NCT00903175|50589503|FG000|Period 1 - First Line|Administrative problems|12|||
25033196|NCT02509507|50132646|FG001|Overall Study|Continuing Study|1|||
25033197|NCT02509507|50132647|FG002|Overall Study|Continuing Study|1|||
25033198|NCT02509507|50132648|FG003|Overall Study|Continuing Study|5|||
25033199|NCT02509507|50132649|FG004|Overall Study|Continuing Study|4|||
25033200|NCT02509507|50132650|FG005|Overall Study|Continuing Study|5|||
25033201|NCT02509507|50132651|FG006|Overall Study|Continuing Study|3|||
25033202|NCT02509507|50132652|FG007|Overall Study|Continuing Study|2|||
25033203|NCT02509507|50132653|FG008|Overall Study|Continuing Study|3|||
25033204|NCT03176407|50132678|FG000|Overall Study|Protocol Violation|1|||
25033205|NCT03176407|50132678|FG000|Overall Study|human failure|1|||
25033206|NCT03176407|50132678|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
25033207|NCT03175549|50132686|FG000|Overall Study|Lost to Follow-up|2|||
25033208|NCT03175549|50132687|FG001|Overall Study|Lost to Follow-up|2|||
25033209|NCT03175549|50132686|FG000|Overall Study|Medication non-compliance|2|||
25033210|NCT03175549|50132687|FG001|Overall Study|Medication non-compliance|2|||
25033211|NCT03174925|50132695|FG000|Overall Study|Elastographic images not retrievable|2|||
25033212|NCT03174925|50132695|FG000|Overall Study|Elastography image not interpretable|1|||
25033213|NCT02924688|50132705|FG000|Overall Study|Adverse Event|9|||
25033214|NCT02924688|50132706|FG001|Overall Study|Adverse Event|3|||
25033215|NCT02924688|50132707|FG002|Overall Study|Adverse Event|2|||
25033216|NCT02924688|50132708|FG003|Overall Study|Adverse Event|2|||
25033217|NCT02924688|50132709|FG004|Overall Study|Adverse Event|3|||
25033218|NCT02924688|50132710|FG005|Overall Study|Adverse Event|2|||
25033219|NCT02924688|50132705|FG000|Overall Study|Lack of Efficacy|2|||
25033220|NCT02924688|50132706|FG001|Overall Study|Lack of Efficacy|3|||
25033221|NCT02924688|50132707|FG002|Overall Study|Lack of Efficacy|4|||
25033222|NCT02924688|50132708|FG003|Overall Study|Lack of Efficacy|2|||
25033223|NCT02924688|50132709|FG004|Overall Study|Lack of Efficacy|1|||
25033224|NCT02924688|50132710|FG005|Overall Study|Lack of Efficacy|1|||
25033225|NCT02924688|50132705|FG000|Overall Study|Protocol Violation|3|||
25033226|NCT02924688|50132706|FG001|Overall Study|Protocol Violation|7|||
25033227|NCT02924688|50132707|FG002|Overall Study|Protocol Violation|5|||
25033228|NCT02924688|50132708|FG003|Overall Study|Protocol Violation|6|||
25033229|NCT02924688|50132709|FG004|Overall Study|Protocol Violation|2|||
25033230|NCT02924688|50132710|FG005|Overall Study|Protocol Violation|2|||
25033231|NCT02924688|50132705|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
25033232|NCT02924688|50132706|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
25033233|NCT02924688|50132707|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
25033234|NCT02924688|50132708|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
25033235|NCT02924688|50132709|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
25033236|NCT02924688|50132710|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
25033237|NCT02924688|50132705|FG000|Overall Study|Lost to Follow-up|2|||
25033238|NCT02924688|50132706|FG001|Overall Study|Lost to Follow-up|4|||
25033239|NCT02924688|50132707|FG002|Overall Study|Lost to Follow-up|2|||
25033240|NCT02924688|50132708|FG003|Overall Study|Lost to Follow-up|4|||
25033241|NCT02924688|50132709|FG004|Overall Study|Lost to Follow-up|2|||
25033242|NCT02924688|50132710|FG005|Overall Study|Lost to Follow-up|4|||
25033243|NCT02924688|50132705|FG000|Overall Study|Physician Decision|2|||
25033244|NCT02924688|50132706|FG001|Overall Study|Physician Decision|1|||
25033245|NCT02924688|50132707|FG002|Overall Study|Physician Decision|0|||
25033246|NCT02924688|50132708|FG003|Overall Study|Physician Decision|1|||
25033247|NCT02924688|50132709|FG004|Overall Study|Physician Decision|1|||
25033248|NCT02924688|50132710|FG005|Overall Study|Physician Decision|1|||
25033249|NCT02924688|50132705|FG000|Overall Study|Withdrawal by Subject|14|||
25033250|NCT02924688|50132706|FG001|Overall Study|Withdrawal by Subject|13|||
25033251|NCT02924688|50132707|FG002|Overall Study|Withdrawal by Subject|9|||
25033252|NCT02924688|50132708|FG003|Overall Study|Withdrawal by Subject|12|||
25033253|NCT02924688|50132709|FG004|Overall Study|Withdrawal by Subject|13|||
25159513|NCT01426425|50279395|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
25159514|NCT01426425|50279395|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
25159515|NCT01426347|50279408|FG000|Overall Study|Lost to Follow-up|0|||
25159516|NCT01426347|50279409|FG001|Overall Study|Lost to Follow-up|3|||
25275661|NCT00903175|50589504|FG001|Period 1 - First Line|Administrative problems|13|||
25275662|NCT00903175|50589503|FG000|Period 1 - First Line|Death|17|||
24945883|NCT03882047|50038332|FG001|Overall Study|Adverse Event|2|||
24945884|NCT03882047|50038333|FG002|Overall Study|Adverse Event|2|||
24945885|NCT03882047|50038331|FG000|Overall Study|Treatment Failure|3|||
24945886|NCT03882047|50038332|FG001|Overall Study|Treatment Failure|3|||
24945887|NCT03882047|50038333|FG002|Overall Study|Treatment Failure|12|||
24945888|NCT03882047|50038331|FG000|Overall Study|Lost to Follow-up|0|||
24945889|NCT03882047|50038332|FG001|Overall Study|Lost to Follow-up|1|||
24945890|NCT03882047|50038333|FG002|Overall Study|Lost to Follow-up|0|||
24945891|NCT03882047|50038331|FG000|Overall Study|Did Not Wish to Continue|1|||
24945892|NCT03882047|50038332|FG001|Overall Study|Did Not Wish to Continue|4|||
24945893|NCT03882047|50038333|FG002|Overall Study|Did Not Wish to Continue|1|||
24945894|NCT03882047|50038331|FG000|Overall Study|Noncompliance With Protocol|2|||
24945895|NCT03882047|50038332|FG001|Overall Study|Noncompliance With Protocol|0|||
24945896|NCT03882047|50038333|FG002|Overall Study|Noncompliance With Protocol|0|||
24945897|NCT03882047|50038331|FG000|Overall Study|Did Not Meet Eligibility|0|||
24945898|NCT03882047|50038332|FG001|Overall Study|Did Not Meet Eligibility|0|||
24945899|NCT03882047|50038333|FG002|Overall Study|Did Not Meet Eligibility|1|||
24945900|NCT00530621|50038343|FG000|Overall Study|Adverse Event|11|||
24945901|NCT00530621|50038344|FG001|Overall Study|Adverse Event|8|||
24945902|NCT00530621|50038343|FG000|Overall Study|Physician Decision|2|||
24945903|NCT00530621|50038344|FG001|Overall Study|Physician Decision|4|||
25033254|NCT02924688|50132710|FG005|Overall Study|Withdrawal by Subject|14|||
25033255|NCT03011892|50132733|FG000|Double Blind (DB) Period|Adverse Event|0|||
25033256|NCT03011892|50132734|FG001|Double Blind (DB) Period|Adverse Event|1|||
25033257|NCT03011892|50132735|FG002|Double Blind (DB) Period|Adverse Event|1|||
25033258|NCT03011892|50132736|FG003|Double Blind (DB) Period|Adverse Event|0|||
25033259|NCT03011892|50132737|FG004|Double Blind (DB) Period|Adverse Event|0|||
25033260|NCT03011892|50132738|FG005|Double Blind (DB) Period|Adverse Event|0|||
25033261|NCT03011892|50132739|FG006|Double Blind (DB) Period|Adverse Event|0|||
25033262|NCT03011892|50132740|FG007|Double Blind (DB) Period|Adverse Event|0|||
25033263|NCT03011892|50132741|FG008|Double Blind (DB) Period|Adverse Event|0|||
25033264|NCT03011892|50132742|FG009|Double Blind (DB) Period|Adverse Event|0|||
25033265|NCT03011892|50132743|FG010|Double Blind (DB) Period|Adverse Event|0|||
25033266|NCT03011892|50132744|FG011|Double Blind (DB) Period|Adverse Event|0|||
25033267|NCT03011892|50132733|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
25033268|NCT03011892|50132734|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
25033269|NCT03011892|50132735|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
25033270|NCT03011892|50132736|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
25033271|NCT03011892|50132737|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
25033272|NCT03011892|50132738|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
25033273|NCT03011892|50132739|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
25033274|NCT03011892|50132740|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
25033275|NCT03011892|50132741|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
25033276|NCT03011892|50132742|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
25033277|NCT03011892|50132743|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
25033278|NCT03011892|50132744|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
25033279|NCT03011892|50132733|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
25033280|NCT03011892|50132734|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
25033281|NCT03011892|50132735|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
25033282|NCT03011892|50132736|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
25033283|NCT03011892|50132737|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
25033284|NCT03011892|50132738|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
25033285|NCT03011892|50132739|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
25033286|NCT03011892|50132740|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
25033287|NCT03011892|50132741|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
25033288|NCT03011892|50132742|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
25033289|NCT03011892|50132743|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
25033290|NCT03011892|50132744|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
25033291|NCT03011892|50132733|FG000|Double Blind (DB) Period|Other|1|||
25033292|NCT03011892|50132734|FG001|Double Blind (DB) Period|Other|1|||
25033293|NCT03011892|50132735|FG002|Double Blind (DB) Period|Other|1|||
25033294|NCT03011892|50132736|FG003|Double Blind (DB) Period|Other|0|||
25033295|NCT03011892|50132737|FG004|Double Blind (DB) Period|Other|1|||
25033296|NCT03011892|50132738|FG005|Double Blind (DB) Period|Other|0|||
25033297|NCT03011892|50132739|FG006|Double Blind (DB) Period|Other|0|||
25033298|NCT03011892|50132740|FG007|Double Blind (DB) Period|Other|0|||
25033299|NCT03011892|50132741|FG008|Double Blind (DB) Period|Other|0|||
25033300|NCT03011892|50132742|FG009|Double Blind (DB) Period|Other|0|||
25033301|NCT03011892|50132743|FG010|Double Blind (DB) Period|Other|0|||
25033302|NCT03011892|50132744|FG011|Double Blind (DB) Period|Other|0|||
25033303|NCT03011892|50132733|FG000|Double Blind (DB) Period|Physician Decision|1|||
25033304|NCT03011892|50132734|FG001|Double Blind (DB) Period|Physician Decision|0|||
25033305|NCT03011892|50132735|FG002|Double Blind (DB) Period|Physician Decision|1|||
25033306|NCT03011892|50132736|FG003|Double Blind (DB) Period|Physician Decision|0|||
25033307|NCT03011892|50132737|FG004|Double Blind (DB) Period|Physician Decision|0|||
25033308|NCT03011892|50132738|FG005|Double Blind (DB) Period|Physician Decision|0|||
25033309|NCT03011892|50132739|FG006|Double Blind (DB) Period|Physician Decision|0|||
25033310|NCT03011892|50132740|FG007|Double Blind (DB) Period|Physician Decision|0|||
25033311|NCT03011892|50132741|FG008|Double Blind (DB) Period|Physician Decision|0|||
25033312|NCT03011892|50132742|FG009|Double Blind (DB) Period|Physician Decision|0|||
25033313|NCT03011892|50132743|FG010|Double Blind (DB) Period|Physician Decision|0|||
25033314|NCT03011892|50132744|FG011|Double Blind (DB) Period|Physician Decision|0|||
25033315|NCT03011892|50132733|FG000|Double Blind (DB) Period|Pregnancy|0|||
25033316|NCT03011892|50132734|FG001|Double Blind (DB) Period|Pregnancy|0|||
25033317|NCT03011892|50132735|FG002|Double Blind (DB) Period|Pregnancy|0|||
24945904|NCT00530621|50038343|FG000|Overall Study|Progressive Disease (PD)|47|||
24945905|NCT00530621|50038344|FG001|Overall Study|Progressive Disease (PD)|40|||
24945906|NCT00530621|50038343|FG000|Overall Study|Sponsor Decision|12|||
25033318|NCT03011892|50132736|FG003|Double Blind (DB) Period|Pregnancy|0|||
25033319|NCT03011892|50132737|FG004|Double Blind (DB) Period|Pregnancy|1|||
25033320|NCT03011892|50132738|FG005|Double Blind (DB) Period|Pregnancy|0|||
25033321|NCT03011892|50132739|FG006|Double Blind (DB) Period|Pregnancy|0|||
25033322|NCT03011892|50132740|FG007|Double Blind (DB) Period|Pregnancy|0|||
25033323|NCT03011892|50132741|FG008|Double Blind (DB) Period|Pregnancy|0|||
25033324|NCT03011892|50132742|FG009|Double Blind (DB) Period|Pregnancy|0|||
25033325|NCT03011892|50132743|FG010|Double Blind (DB) Period|Pregnancy|0|||
25033326|NCT03011892|50132744|FG011|Double Blind (DB) Period|Pregnancy|0|||
25033327|NCT03011892|50132733|FG000|Double Blind (DB) Period|Protocol Violation|1|||
25033328|NCT03011892|50132734|FG001|Double Blind (DB) Period|Protocol Violation|0|||
25033329|NCT03011892|50132735|FG002|Double Blind (DB) Period|Protocol Violation|0|||
25033330|NCT03011892|50132736|FG003|Double Blind (DB) Period|Protocol Violation|0|||
25033331|NCT03011892|50132737|FG004|Double Blind (DB) Period|Protocol Violation|0|||
25033332|NCT03011892|50132738|FG005|Double Blind (DB) Period|Protocol Violation|0|||
25033333|NCT03011892|50132739|FG006|Double Blind (DB) Period|Protocol Violation|0|||
25033334|NCT03011892|50132740|FG007|Double Blind (DB) Period|Protocol Violation|0|||
25033335|NCT03011892|50132741|FG008|Double Blind (DB) Period|Protocol Violation|0|||
25033336|NCT03011892|50132742|FG009|Double Blind (DB) Period|Protocol Violation|0|||
25033337|NCT03011892|50132743|FG010|Double Blind (DB) Period|Protocol Violation|0|||
25033338|NCT03011892|50132744|FG011|Double Blind (DB) Period|Protocol Violation|0|||
25033339|NCT03011892|50132733|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
25033340|NCT03011892|50132734|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
25033341|NCT03011892|50132735|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
25033342|NCT03011892|50132736|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
25033343|NCT03011892|50132737|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
25033344|NCT03011892|50132738|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
25033345|NCT03011892|50132739|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
25033346|NCT03011892|50132740|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
25033347|NCT03011892|50132741|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
25033348|NCT03011892|50132742|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
25033349|NCT03011892|50132743|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
25033350|NCT03011892|50132744|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
25033351|NCT03011892|50132733|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
25033352|NCT03011892|50132734|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
25033353|NCT03011892|50132735|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
24945907|NCT00530621|50038344|FG001|Overall Study|Sponsor Decision|15|||
24945908|NCT00530621|50038343|FG000|Overall Study|Subject Decision|4|||
24945909|NCT00530621|50038344|FG001|Overall Study|Subject Decision|7|||
24945910|NCT00530621|50038343|FG000|Overall Study|Death|3|||
24945911|NCT00530621|50038344|FG001|Overall Study|Death|6|||
24945912|NCT00530621|50038343|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
24945913|NCT00530621|50038344|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
24945914|NCT00531479|50038356|FG000|Overall Study|Death|68|||
24945915|NCT00531479|50038357|FG001|Overall Study|Death|71|||
24945916|NCT00531479|50038356|FG000|Overall Study|Lost to Follow-up|0|||
24945917|NCT00531479|50038357|FG001|Overall Study|Lost to Follow-up|2|||
24945918|NCT00531479|50038356|FG000|Overall Study|Other|0|||
24945919|NCT00531479|50038357|FG001|Overall Study|Other|1|||
24945920|NCT00531479|50038356|FG000|Overall Study|Withdrawal by Subject|6|||
24945921|NCT00531479|50038357|FG001|Overall Study|Withdrawal by Subject|6|||
24945922|NCT00531479|50038356|FG000|Overall Study|Did not receive treatment|2|||
24945923|NCT00531479|50038357|FG001|Overall Study|Did not receive treatment|3|||
25033354|NCT03011892|50132736|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
25033355|NCT03011892|50132737|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
25033356|NCT03011892|50132738|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
25033357|NCT03011892|50132739|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
24945924|NCT00530075|50038363|FG000|Overall Study|Adverse Event|1|||
24945925|NCT00530075|50038363|FG000|Overall Study|Death|1|||
24945926|NCT00530075|50038363|FG000|Overall Study|Lack of Efficacy|3|||
24945927|NCT00530075|50038363|FG000|Overall Study|Protocol Violation|1|||
24945928|NCT00530075|50038363|FG000|Overall Study|Withdrawal by Subject|1|||
24945929|NCT00531011|50038369|FG000|Overall Study|Withdrawal by Subject|2|||
24945930|NCT00531011|50038370|FG001|Overall Study|Withdrawal by Subject|4|||
24945931|NCT00531011|50038369|FG000|Overall Study|Death|1|||
24945932|NCT00531011|50038370|FG001|Overall Study|Death|0|||
24945933|NCT00531011|50038369|FG000|Overall Study|Lost to Follow-up|1|||
24945934|NCT00531011|50038370|FG001|Overall Study|Lost to Follow-up|0|||
24945935|NCT00531011|50038369|FG000|Overall Study|Physician Decision|0|||
24945936|NCT00531011|50038370|FG001|Overall Study|Physician Decision|3|||
24945937|NCT00529217|50038376|FG000|Overall Study|Lack of Efficacy|2|||
24945938|NCT00529217|50038376|FG000|Overall Study|Unable to adhere to study schedule|2|||
24945939|NCT00471146|50038383|FG000|Overall Study|Adverse Event|32|||
24945940|NCT00471146|50038384|FG001|Overall Study|Adverse Event|33|||
24945941|NCT00471146|50038383|FG000|Overall Study|Withdrawal by Subject|14|||
24945942|NCT00471146|50038384|FG001|Overall Study|Withdrawal by Subject|11|||
24945943|NCT00471146|50038383|FG000|Overall Study|Death|11|||
24945944|NCT00471146|50038384|FG001|Overall Study|Death|12|||
24945945|NCT00471146|50038383|FG000|Overall Study|Lost to Follow-up|4|||
24945946|NCT00471146|50038384|FG001|Overall Study|Lost to Follow-up|2|||
24945947|NCT00471146|50038383|FG000|Overall Study|Protocol Violation|2|||
24945948|NCT00471146|50038384|FG001|Overall Study|Protocol Violation|2|||
24945949|NCT00471146|50038383|FG000|Overall Study|Objective progression or relapse|84|||
24945950|NCT00471146|50038384|FG001|Overall Study|Objective progression or relapse|87|||
24945951|NCT00471146|50038383|FG000|Overall Study|Global deterioration of health status|12|||
24945952|NCT00471146|50038384|FG001|Overall Study|Global deterioration of health status|14|||
24945953|NCT00471146|50038383|FG000|Overall Study|Randomized but not treated|9|||
24945954|NCT00471146|50038384|FG001|Overall Study|Randomized but not treated|8|||
24945955|NCT00471146|50038383|FG000|Overall Study|Other|4|||
24945956|NCT00471146|50038384|FG001|Overall Study|Other|5|||
24945957|NCT00469898|50038390|FG000|Overall Study|Adverse Event|7|||
24945958|NCT00469898|50038390|FG000|Overall Study|Withdrawal by Subject|4|||
25159517|NCT01426347|50279408|FG000|Overall Study|Protocol Violation|2|||
25159518|NCT01426347|50279409|FG001|Overall Study|Protocol Violation|0|||
25159519|NCT01426347|50279408|FG000|Overall Study|Withdrawal by Subject|5|||
25159520|NCT01426347|50279409|FG001|Overall Study|Withdrawal by Subject|0|||
25159521|NCT01882465|50279415|FG000|Period 1|Lens Discomfort|0|||
25159522|NCT01882465|50279416|FG001|Period 1|Lens Discomfort|0|||
25159523|NCT01882465|50279417|FG002|Period 1|Lens Discomfort|0|||
24945959|NCT00469898|50038390|FG000|Overall Study|Death|4|||
24945960|NCT00469898|50038390|FG000|Overall Study|Disease progression|9|||
25033358|NCT03011892|50132740|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
25033359|NCT03011892|50132741|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
25033360|NCT03011892|50132742|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
25033361|NCT03011892|50132743|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
25033362|NCT03011892|50132744|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
25033363|NCT03011892|50132733|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
25033364|NCT03011892|50132734|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
25033365|NCT03011892|50132735|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
25033366|NCT03011892|50132736|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
25033367|NCT03011892|50132737|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
25033368|NCT03011892|50132738|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
25033369|NCT03011892|50132739|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
25033370|NCT03011892|50132740|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
25033371|NCT03011892|50132741|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
25033372|NCT03011892|50132742|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
25033373|NCT03011892|50132743|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
25033374|NCT03011892|50132744|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
25033375|NCT03011892|50132733|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
25033376|NCT03011892|50132734|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
25033377|NCT03011892|50132735|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
25033378|NCT03011892|50132736|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
25033379|NCT03011892|50132737|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
25033380|NCT03011892|50132738|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
25033381|NCT03011892|50132739|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
25033382|NCT03011892|50132740|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
25033383|NCT03011892|50132741|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
25033384|NCT03011892|50132742|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
25033385|NCT03011892|50132743|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
25033386|NCT03011892|50132744|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
25159524|NCT01882465|50279418|FG003|Period 1|Lens Discomfort|1|||
25159525|NCT01882465|50279419|FG004|Period 1|Lens Discomfort|0|||
24945961|NCT00469898|50038390|FG000|Overall Study|Decreased performance status|1|||
24945962|NCT00529763|50038397|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
24945963|NCT00529763|50038398|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
25033387|NCT03011892|50132733|FG000|Open Label (OL) Period|Reason not specified|0|||
25033388|NCT03011892|50132734|FG001|Open Label (OL) Period|Reason not specified|0|||
25033389|NCT03011892|50132735|FG002|Open Label (OL) Period|Reason not specified|0|||
25033390|NCT03011892|50132736|FG003|Open Label (OL) Period|Reason not specified|0|||
25033391|NCT03011892|50132737|FG004|Open Label (OL) Period|Reason not specified|0|||
25033392|NCT03011892|50132738|FG005|Open Label (OL) Period|Reason not specified|0|||
25033393|NCT03011892|50132739|FG006|Open Label (OL) Period|Reason not specified|0|||
25033394|NCT03011892|50132740|FG007|Open Label (OL) Period|Reason not specified|1|||
25033395|NCT03011892|50132741|FG008|Open Label (OL) Period|Reason not specified|0|||
25033396|NCT03011892|50132742|FG009|Open Label (OL) Period|Reason not specified|0|||
25033397|NCT03011892|50132743|FG010|Open Label (OL) Period|Reason not specified|0|||
25033398|NCT03011892|50132744|FG011|Open Label (OL) Period|Reason not specified|0|||
25033399|NCT03017742|50132771|FG000|Overall Study|Protocol Violation|36|||
25033400|NCT03017742|50132771|FG000|Overall Study|Withdrawal by Subject|37|||
25033401|NCT03012828|50132781|FG000|Overall Study|Lost to Follow-up|1|||
25033402|NCT03012828|50132782|FG001|Overall Study|Lost to Follow-up|0|||
25033403|NCT03012828|50132783|FG002|Overall Study|Lost to Follow-up|1|||
25033404|NCT03012828|50132784|FG003|Overall Study|Lost to Follow-up|0|||
25033405|NCT03012828|50132785|FG004|Overall Study|Lost to Follow-up|1|||
25033406|NCT03012828|50132786|FG005|Overall Study|Lost to Follow-up|0|||
25033407|NCT03012828|50132781|FG000|Overall Study|Withdrawal by Subject|0|||
25033408|NCT03012828|50132782|FG001|Overall Study|Withdrawal by Subject|0|||
25033409|NCT03012828|50132783|FG002|Overall Study|Withdrawal by Subject|1|||
25033410|NCT03012828|50132784|FG003|Overall Study|Withdrawal by Subject|0|||
25033411|NCT03012828|50132785|FG004|Overall Study|Withdrawal by Subject|0|||
25033412|NCT03012828|50132786|FG005|Overall Study|Withdrawal by Subject|1|||
25033413|NCT03012828|50132781|FG000|Overall Study|Non-compliance with protocol|0|||
25033414|NCT03012828|50132782|FG001|Overall Study|Non-compliance with protocol|0|||
25033415|NCT03012828|50132783|FG002|Overall Study|Non-compliance with protocol|0|||
25033416|NCT03012828|50132784|FG003|Overall Study|Non-compliance with protocol|0|||
25033417|NCT03012828|50132785|FG004|Overall Study|Non-compliance with protocol|1|||
25033418|NCT03012828|50132786|FG005|Overall Study|Non-compliance with protocol|0|||
25033419|NCT03012828|50132781|FG000|Overall Study|Delay to last visit would delay DBL|0|||
25159526|NCT01882465|50279420|FG005|Period 1|Lens Discomfort|0|||
25159527|NCT01882465|50279421|FG006|Period 1|Lens Discomfort|0|||
25159528|NCT01882465|50279415|FG000|Period 1|Withdrawal by Subject|0|||
25159529|NCT01882465|50279416|FG001|Period 1|Withdrawal by Subject|0|||
25159530|NCT01882465|50279417|FG002|Period 1|Withdrawal by Subject|0|||
25159531|NCT01882465|50279418|FG003|Period 1|Withdrawal by Subject|0|||
25159532|NCT01882465|50279419|FG004|Period 1|Withdrawal by Subject|0|||
25159533|NCT01882465|50279420|FG005|Period 1|Withdrawal by Subject|0|||
25159534|NCT01882465|50279421|FG006|Period 1|Withdrawal by Subject|1|||
25159535|NCT01882465|50279415|FG000|Period 2|Protocol Violation|0|||
25159536|NCT01882465|50279416|FG001|Period 2|Protocol Violation|0|||
25159537|NCT01882465|50279417|FG002|Period 2|Protocol Violation|0|||
24945964|NCT00529763|50038399|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
24945965|NCT00529763|50038397|FG000|Overall Study|Death|1|||
24945966|NCT00529763|50038398|FG001|Overall Study|Death|1|||
24945967|NCT00529763|50038399|FG002|Overall Study|Death|1|||
24945968|NCT00529763|50038397|FG000|Overall Study|Disease Progression|10|||
24945969|NCT00529763|50038398|FG001|Overall Study|Disease Progression|16|||
24945970|NCT00529763|50038399|FG002|Overall Study|Disease Progression|11|||
24945971|NCT00529763|50038397|FG000|Overall Study|Lost to Follow-up|1|||
24945972|NCT00529763|50038398|FG001|Overall Study|Lost to Follow-up|2|||
24945973|NCT00529763|50038399|FG002|Overall Study|Lost to Follow-up|3|||
24945974|NCT00529763|50038397|FG000|Overall Study|Stem Cell Transplant|0|||
24945975|NCT00529763|50038398|FG001|Overall Study|Stem Cell Transplant|3|||
24945976|NCT00529763|50038399|FG002|Overall Study|Stem Cell Transplant|1|||
24945977|NCT00529763|50038397|FG000|Overall Study|Study Drug Toxicity|3|||
24945978|NCT00529763|50038398|FG001|Overall Study|Study Drug Toxicity|6|||
24945979|NCT00529763|50038399|FG002|Overall Study|Study Drug Toxicity|4|||
24945980|NCT00529763|50038397|FG000|Overall Study|Participant Withdrew Consent|2|||
24945981|NCT00529763|50038398|FG001|Overall Study|Participant Withdrew Consent|3|||
24945982|NCT00529763|50038399|FG002|Overall Study|Participant Withdrew Consent|4|||
24945983|NCT00529763|50038397|FG000|Overall Study|Other reasons|2|||
24945984|NCT00529763|50038398|FG001|Overall Study|Other reasons|0|||
24945985|NCT00529763|50038399|FG002|Overall Study|Other reasons|2|||
24945986|NCT00529763|50038397|FG000|Overall Study|Participant request to discontinue treatment|1|||
24945987|NCT00529763|50038398|FG001|Overall Study|Participant request to discontinue treatment|1|||
24945988|NCT00529763|50038399|FG002|Overall Study|Participant request to discontinue treatment|3|||
24945989|NCT00486902|50038414|FG000|Overall Study|Withdrawal by Subject|1|||
24945990|NCT00486902|50038415|FG001|Overall Study|Withdrawal by Subject|2|||
24945991|NCT00486902|50038414|FG000|Overall Study|decision for postpartum tubal ligation|3|||
25033420|NCT03012828|50132782|FG001|Overall Study|Delay to last visit would delay DBL|0|||
25159538|NCT01882465|50279418|FG003|Period 2|Protocol Violation|0|||
25159539|NCT01882465|50279419|FG004|Period 2|Protocol Violation|1|||
25033421|NCT03012828|50132783|FG002|Overall Study|Delay to last visit would delay DBL|0|||
25033422|NCT03012828|50132784|FG003|Overall Study|Delay to last visit would delay DBL|0|||
25033423|NCT03012828|50132785|FG004|Overall Study|Delay to last visit would delay DBL|0|||
25033424|NCT03012828|50132786|FG005|Overall Study|Delay to last visit would delay DBL|1|||
25033425|NCT03010254|50132804|FG000|Overall Study|Adverse Event|0|||
25033426|NCT03010254|50132805|FG001|Overall Study|Adverse Event|1|||
25033427|NCT03010254|50132804|FG000|Overall Study|Lost to Follow-up|4|||
25033428|NCT03010254|50132805|FG001|Overall Study|Lost to Follow-up|0|||
25033429|NCT03010254|50132804|FG000|Overall Study|Withdrawal by Subject|1|||
25033430|NCT03010254|50132805|FG001|Overall Study|Withdrawal by Subject|1|||
25033431|NCT03010254|50132804|FG000|Overall Study|Other|2|||
25033432|NCT03010254|50132805|FG001|Overall Study|Other|3|||
25033433|NCT03008460|50132820|FG000|Overall Study|Protocol deviation|0|||
25033434|NCT03008460|50132821|FG001|Overall Study|Protocol deviation|2|||
25033435|NCT03008460|50132820|FG000|Overall Study|Study drug not dispensed|0|||
25159540|NCT01882465|50279420|FG005|Period 2|Protocol Violation|0|||
25159541|NCT01882465|50279421|FG006|Period 2|Protocol Violation|0|||
25159542|NCT01426269|50279429|FG000|Period 1: 12 Weeks|Adverse Event|5|||
25159543|NCT01426269|50279430|FG001|Period 1: 12 Weeks|Adverse Event|0|||
25159544|NCT01426269|50279431|FG002|Period 1: 12 Weeks|Adverse Event|0|||
25159545|NCT01426269|50279429|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
25159546|NCT01426269|50279430|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
25159547|NCT01426269|50279431|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
25159548|NCT01426269|50279429|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
25159549|NCT01426269|50279430|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
25159550|NCT01426269|50279431|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
25159551|NCT01426269|50279429|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
25159552|NCT01426269|50279430|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
25159553|NCT01426269|50279431|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
25159554|NCT01426269|50279429|FG000|Period 1: 12 Weeks|Pregnancy|1|||
25159555|NCT01426269|50279430|FG001|Period 1: 12 Weeks|Pregnancy|0|||
25159556|NCT01426269|50279431|FG002|Period 1: 12 Weeks|Pregnancy|0|||
25159557|NCT01426269|50279429|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
25159558|NCT01426269|50279430|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
25159559|NCT01426269|50279431|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
25159560|NCT01426269|50279429|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
25159561|NCT01426269|50279430|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
25159562|NCT01426269|50279431|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
25159563|NCT01426269|50279429|FG000|Period 2: 40 Weeks|Adverse Event|0|||
25159564|NCT01426269|50279430|FG001|Period 2: 40 Weeks|Adverse Event|1|||
25159565|NCT01426269|50279431|FG002|Period 2: 40 Weeks|Adverse Event|2|||
25159566|NCT01426269|50279429|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
25159567|NCT01426269|50279430|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
25159568|NCT01426269|50279431|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
25159569|NCT01426269|50279429|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
25159570|NCT01426269|50279430|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
25159571|NCT01426269|50279431|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
25159572|NCT01426269|50279429|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
25159573|NCT01426269|50279430|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
25159574|NCT01426269|50279431|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
25159575|NCT01426269|50279429|FG000|Period 2: 40 Weeks|Site closed|0|||
25159576|NCT01426269|50279430|FG001|Period 2: 40 Weeks|Site closed|6|||
25159577|NCT01426269|50279431|FG002|Period 2: 40 Weeks|Site closed|5|||
25159578|NCT01426269|50279429|FG000|Period 2: 40 Weeks|Relapsed|0|||
25159579|NCT01426269|50279430|FG001|Period 2: 40 Weeks|Relapsed|9|||
25159580|NCT01426269|50279431|FG002|Period 2: 40 Weeks|Relapsed|18|||
25159581|NCT01426113|50279444|FG000|Overall Study|Study Discontinued|1|||
25159582|NCT01426113|50279445|FG001|Overall Study|Study Discontinued|1|||
25159583|NCT01426113|50279444|FG000|Overall Study|Adverse Event|0|||
25159584|NCT01426113|50279445|FG001|Overall Study|Adverse Event|1|||
25159585|NCT01864603|50279453|FG000|Stage 2|DSMB design modification|86056|||
25159586|NCT01864603|50279454|FG001|Stage 2|DSMB design modification|92558|||
25159587|NCT01892293|50279465|FG000|Overall Study|Apheresed but not treated|4|||
25159588|NCT01393899|50279472|FG000|Overall Study|Study terminated by sponsor|1|||
25159589|NCT01393899|50279473|FG001|Overall Study|Study terminated by sponsor|0|||
25159590|NCT01393899|50279474|FG002|Overall Study|Study terminated by sponsor|1|||
25159591|NCT01393899|50279472|FG000|Overall Study|Other|1|||
25033436|NCT03008460|50132821|FG001|Overall Study|Study drug not dispensed|1|||
25033437|NCT03008460|50132820|FG000|Overall Study|Adverse Event|0|||
25033438|NCT03008460|50132821|FG001|Overall Study|Adverse Event|1|||
25159592|NCT01393899|50279473|FG001|Overall Study|Other|0|||
25159593|NCT01393899|50279474|FG002|Overall Study|Other|0|||
25159594|NCT01393899|50279472|FG000|Overall Study|Withdrawal by Subject|2|||
25159595|NCT01393899|50279473|FG001|Overall Study|Withdrawal by Subject|2|||
25159596|NCT01393899|50279474|FG002|Overall Study|Withdrawal by Subject|1|||
25159597|NCT01393899|50279472|FG000|Overall Study|Lost to Follow-up|0|||
25159598|NCT01393899|50279473|FG001|Overall Study|Lost to Follow-up|0|||
25033439|NCT03008460|50132820|FG000|Overall Study|Withdrawal by Subject|5|||
25033440|NCT03008460|50132821|FG001|Overall Study|Withdrawal by Subject|6|||
25033441|NCT03008460|50132820|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
25033442|NCT03008460|50132821|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
25033443|NCT03008460|50132820|FG000|Overall Study|End of study visit outside permitted time window|0|||
25033444|NCT03008460|50132821|FG001|Overall Study|End of study visit outside permitted time window|1|||
25033445|NCT03008460|50132820|FG000|Overall Study|Lost to Follow-up|1|||
25033446|NCT03008460|50132821|FG001|Overall Study|Lost to Follow-up|3|||
25033447|NCT03008070|50132830|FG000|Overall Study|Adverse Event|3|||
25033448|NCT03008070|50132831|FG001|Overall Study|Adverse Event|3|||
25033449|NCT03008070|50132832|FG002|Overall Study|Adverse Event|3|||
25033450|NCT03008070|50132830|FG000|Overall Study|Lost to Follow-up|1|||
25033451|NCT03008070|50132831|FG001|Overall Study|Lost to Follow-up|1|||
25033452|NCT03008070|50132832|FG002|Overall Study|Lost to Follow-up|0|||
25033453|NCT03008070|50132830|FG000|Overall Study|Non compliance|0|||
25033454|NCT03008070|50132831|FG001|Overall Study|Non compliance|1|||
25033455|NCT03008070|50132832|FG002|Overall Study|Non compliance|1|||
25033456|NCT03008070|50132830|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
25033457|NCT03008070|50132831|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
25033458|NCT03008070|50132832|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
25033459|NCT03008070|50132830|FG000|Overall Study|Withdrawal by Subject|2|||
25033460|NCT03008070|50132831|FG001|Overall Study|Withdrawal by Subject|0|||
25033461|NCT03008070|50132832|FG002|Overall Study|Withdrawal by Subject|1|||
25033462|NCT03008070|50132830|FG000|Overall Study|Use of prohibited drug|0|||
25033463|NCT03008070|50132831|FG001|Overall Study|Use of prohibited drug|0|||
25033464|NCT03008070|50132832|FG002|Overall Study|Use of prohibited drug|2|||
25033465|NCT02914236|50132842|FG000|Overall Study|Lost to Follow-up|1|||
25033466|NCT03003390|50132848|FG000|Overall Study|Physician Decision|2|||
25033467|NCT03003390|50132849|FG001|Overall Study|Physician Decision|0|||
25033468|NCT03003390|50132848|FG000|Overall Study|Parent refused intervention|2|||
25033469|NCT03003390|50132849|FG001|Overall Study|Parent refused intervention|0|||
25033470|NCT03003000|50132863|FG000|Overall Study|Adverse Event|1|||
25033471|NCT03003000|50132864|FG001|Overall Study|Adverse Event|2|||
25033472|NCT03003000|50132865|FG002|Overall Study|Adverse Event|3|||
25033473|NCT03003000|50132863|FG000|Overall Study|Lack of Efficacy|1|||
25033474|NCT03003000|50132864|FG001|Overall Study|Lack of Efficacy|0|||
25033475|NCT03003000|50132865|FG002|Overall Study|Lack of Efficacy|0|||
25033476|NCT03003000|50132863|FG000|Overall Study|Non-compliant with protocol|0|||
25033477|NCT03003000|50132864|FG001|Overall Study|Non-compliant with protocol|1|||
25033478|NCT03003000|50132865|FG002|Overall Study|Non-compliant with protocol|1|||
25033479|NCT03003000|50132863|FG000|Overall Study|Refused to continue medication|2|||
25033480|NCT03003000|50132864|FG001|Overall Study|Refused to continue medication|0|||
25033481|NCT03003000|50132865|FG002|Overall Study|Refused to continue medication|0|||
25033482|NCT03003000|50132863|FG000|Overall Study|Other than listed|1|||
25033483|NCT03003000|50132864|FG001|Overall Study|Other than listed|1|||
25033484|NCT03003000|50132865|FG002|Overall Study|Other than listed|1|||
25033485|NCT03002610|50132876|FG000|Overall Study|Withdrawal by Subject|6|||
25033486|NCT03002610|50132877|FG001|Overall Study|Withdrawal by Subject|25|||
25033487|NCT03002610|50132878|FG002|Overall Study|Withdrawal by Subject|13|||
25033488|NCT03005106|50132886|FG000|Overall Study|Lost to Follow-up|16|||
25033489|NCT03005106|50132886|FG000|Overall Study|Adverse Event|1|||
25033490|NCT03005106|50132886|FG000|Overall Study|Physician Decision|1|||
25033491|NCT03005106|50132886|FG000|Overall Study|Death|2|||
25033492|NCT01004861|50132903|FG000|Overall Study|Disease progression|3|||
25033493|NCT01004861|50132904|FG001|Overall Study|Disease progression|4|||
25033494|NCT01004861|50132905|FG002|Overall Study|Disease progression|5|||
25033495|NCT01004861|50132906|FG003|Overall Study|Disease progression|4|||
25033496|NCT01004861|50132907|FG004|Overall Study|Disease progression|4|||
25033497|NCT01004861|50132908|FG005|Overall Study|Disease progression|4|||
25159599|NCT01393899|50279474|FG002|Overall Study|Lost to Follow-up|1|||
25159600|NCT01393899|50279472|FG000|Overall Study|Does not meet entrance criteria|1|||
25159601|NCT01393899|50279473|FG001|Overall Study|Does not meet entrance criteria|0|||
25033498|NCT01004861|50132909|FG006|Overall Study|Disease progression|5|||
25033499|NCT01004861|50132910|FG007|Overall Study|Disease progression|1|||
25033500|NCT01004861|50132911|FG008|Overall Study|Disease progression|4|||
25033501|NCT01004861|50132912|FG009|Overall Study|Disease progression|7|||
25033502|NCT01004861|50132913|FG010|Overall Study|Disease progression|6|||
25033503|NCT01004861|50132914|FG011|Overall Study|Disease progression|3|||
25033504|NCT01004861|50132915|FG012|Overall Study|Disease progression|8|||
25033505|NCT01004861|50132903|FG000|Overall Study|Physician Decision|0|||
25033506|NCT01004861|50132904|FG001|Overall Study|Physician Decision|2|||
25033507|NCT01004861|50132905|FG002|Overall Study|Physician Decision|1|||
25033508|NCT01004861|50132906|FG003|Overall Study|Physician Decision|1|||
25159602|NCT01393899|50279474|FG002|Overall Study|Does not meet entrance criteria|1|||
25033509|NCT01004861|50132907|FG004|Overall Study|Physician Decision|1|||
25159603|NCT01393899|50279472|FG000|Overall Study|Lack of Efficacy|26|||
25033510|NCT01004861|50132908|FG005|Overall Study|Physician Decision|0|||
25033511|NCT01004861|50132909|FG006|Overall Study|Physician Decision|0|||
25033512|NCT01004861|50132910|FG007|Overall Study|Physician Decision|1|||
25033513|NCT01004861|50132911|FG008|Overall Study|Physician Decision|0|||
24945992|NCT00486902|50038415|FG001|Overall Study|decision for postpartum tubal ligation|1|||
24945993|NCT00486902|50038414|FG000|Overall Study|spinal anesthetic protocal violation|1|||
24945994|NCT00486902|50038415|FG001|Overall Study|spinal anesthetic protocal violation|1|||
24945995|NCT00486902|50038414|FG000|Overall Study|Did not meet inclusion criteria|1|||
24945996|NCT00486902|50038415|FG001|Overall Study|Did not meet inclusion criteria|0|||
24945997|NCT00486902|50038414|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
25033514|NCT01004861|50132912|FG009|Overall Study|Physician Decision|0|||
25033515|NCT01004861|50132913|FG010|Overall Study|Physician Decision|0|||
25033516|NCT01004861|50132914|FG011|Overall Study|Physician Decision|0|||
25033517|NCT01004861|50132915|FG012|Overall Study|Physician Decision|3|||
25033518|NCT01004861|50132903|FG000|Overall Study|Adverse Event|0|||
25033519|NCT01004861|50132904|FG001|Overall Study|Adverse Event|0|||
25033520|NCT01004861|50132905|FG002|Overall Study|Adverse Event|0|||
25033521|NCT01004861|50132906|FG003|Overall Study|Adverse Event|1|||
25033522|NCT01004861|50132907|FG004|Overall Study|Adverse Event|0|||
25033523|NCT01004861|50132908|FG005|Overall Study|Adverse Event|2|||
25033524|NCT01004861|50132909|FG006|Overall Study|Adverse Event|1|||
25033525|NCT01004861|50132910|FG007|Overall Study|Adverse Event|1|||
25033526|NCT01004861|50132911|FG008|Overall Study|Adverse Event|13|||
25033527|NCT01004861|50132912|FG009|Overall Study|Adverse Event|1|||
25033528|NCT01004861|50132913|FG010|Overall Study|Adverse Event|1|||
25033529|NCT01004861|50132914|FG011|Overall Study|Adverse Event|0|||
25033530|NCT01004861|50132915|FG012|Overall Study|Adverse Event|2|||
25033531|NCT01004861|50132903|FG000|Overall Study|Protocol Violation|0|||
25033532|NCT01004861|50132904|FG001|Overall Study|Protocol Violation|0|||
25033533|NCT01004861|50132905|FG002|Overall Study|Protocol Violation|0|||
25033534|NCT01004861|50132906|FG003|Overall Study|Protocol Violation|0|||
25033535|NCT01004861|50132907|FG004|Overall Study|Protocol Violation|1|||
25033536|NCT01004861|50132908|FG005|Overall Study|Protocol Violation|0|||
25033537|NCT01004861|50132909|FG006|Overall Study|Protocol Violation|0|||
25033538|NCT01004861|50132910|FG007|Overall Study|Protocol Violation|0|||
25033539|NCT01004861|50132911|FG008|Overall Study|Protocol Violation|0|||
25033540|NCT01004861|50132912|FG009|Overall Study|Protocol Violation|0|||
25033541|NCT01004861|50132913|FG010|Overall Study|Protocol Violation|0|||
25033542|NCT01004861|50132914|FG011|Overall Study|Protocol Violation|0|||
25033543|NCT01004861|50132915|FG012|Overall Study|Protocol Violation|0|||
25033544|NCT01004861|50132903|FG000|Overall Study|Lost to Follow-up|0|||
25033545|NCT01004861|50132904|FG001|Overall Study|Lost to Follow-up|0|||
25033546|NCT01004861|50132905|FG002|Overall Study|Lost to Follow-up|0|||
25033547|NCT01004861|50132906|FG003|Overall Study|Lost to Follow-up|0|||
25033548|NCT01004861|50132907|FG004|Overall Study|Lost to Follow-up|0|||
25033549|NCT01004861|50132908|FG005|Overall Study|Lost to Follow-up|0|||
25033550|NCT01004861|50132909|FG006|Overall Study|Lost to Follow-up|0|||
25033551|NCT01004861|50132910|FG007|Overall Study|Lost to Follow-up|1|||
25033552|NCT01004861|50132911|FG008|Overall Study|Lost to Follow-up|3|||
25033553|NCT01004861|50132912|FG009|Overall Study|Lost to Follow-up|0|||
25033554|NCT01004861|50132913|FG010|Overall Study|Lost to Follow-up|0|||
25033555|NCT01004861|50132914|FG011|Overall Study|Lost to Follow-up|1|||
25033556|NCT01004861|50132915|FG012|Overall Study|Lost to Follow-up|0|||
25033557|NCT01004861|50132903|FG000|Overall Study|Non-compliance|0|||
25033558|NCT01004861|50132904|FG001|Overall Study|Non-compliance|0|||
24945998|NCT00486902|50038415|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
24945999|NCT03687827|50038421|FG000|Treatment Period 1|Death|0|||
24946000|NCT03687827|50038422|FG001|Treatment Period 1|Death|1|||
24946001|NCT03687827|50038421|FG000|Treatment Period 1|Lost to Follow-up|2|||
24946002|NCT03687827|50038422|FG001|Treatment Period 1|Lost to Follow-up|2|||
24946003|NCT03687827|50038421|FG000|Treatment Period 1|Physician Decision|5|||
24946004|NCT03687827|50038422|FG001|Treatment Period 1|Physician Decision|2|||
24946005|NCT03687827|50038421|FG000|Treatment Period 1|Withdrawal by Subject|7|||
24946006|NCT03687827|50038422|FG001|Treatment Period 1|Withdrawal by Subject|3|||
25033559|NCT01004861|50132905|FG002|Overall Study|Non-compliance|0|||
24946007|NCT03687827|50038421|FG000|Treatment Period 2|Physician Decision|4|||
25033560|NCT01004861|50132906|FG003|Overall Study|Non-compliance|0|||
25033561|NCT01004861|50132907|FG004|Overall Study|Non-compliance|0|||
25033562|NCT01004861|50132908|FG005|Overall Study|Non-compliance|0|||
25033563|NCT01004861|50132909|FG006|Overall Study|Non-compliance|0|||
25033564|NCT01004861|50132910|FG007|Overall Study|Non-compliance|0|||
25033565|NCT01004861|50132911|FG008|Overall Study|Non-compliance|5|||
25033566|NCT01004861|50132912|FG009|Overall Study|Non-compliance|0|||
25033567|NCT01004861|50132913|FG010|Overall Study|Non-compliance|0|||
25033568|NCT01004861|50132914|FG011|Overall Study|Non-compliance|0|||
25033569|NCT01004861|50132915|FG012|Overall Study|Non-compliance|1|||
25033570|NCT01004861|50132903|FG000|Overall Study|Other|0|||
25033571|NCT01004861|50132904|FG001|Overall Study|Other|0|||
25033572|NCT01004861|50132905|FG002|Overall Study|Other|0|||
25033573|NCT01004861|50132906|FG003|Overall Study|Other|0|||
25033574|NCT01004861|50132907|FG004|Overall Study|Other|0|||
25033575|NCT01004861|50132908|FG005|Overall Study|Other|0|||
25033576|NCT01004861|50132909|FG006|Overall Study|Other|0|||
25033577|NCT01004861|50132910|FG007|Overall Study|Other|0|||
25033578|NCT01004861|50132911|FG008|Overall Study|Other|0|||
25033579|NCT01004861|50132912|FG009|Overall Study|Other|2|||
25033580|NCT01004861|50132913|FG010|Overall Study|Other|1|||
25033581|NCT01004861|50132914|FG011|Overall Study|Other|2|||
25033582|NCT01004861|50132915|FG012|Overall Study|Other|3|||
25033583|NCT01004861|50132903|FG000|Overall Study|Patient decision|0|||
25033584|NCT01004861|50132904|FG001|Overall Study|Patient decision|0|||
25033585|NCT01004861|50132905|FG002|Overall Study|Patient decision|0|||
25033586|NCT01004861|50132906|FG003|Overall Study|Patient decision|0|||
25033587|NCT01004861|50132907|FG004|Overall Study|Patient decision|1|||
25033588|NCT01004861|50132908|FG005|Overall Study|Patient decision|0|||
25033589|NCT01004861|50132909|FG006|Overall Study|Patient decision|1|||
25033590|NCT01004861|50132910|FG007|Overall Study|Patient decision|0|||
25033591|NCT01004861|50132911|FG008|Overall Study|Patient decision|7|||
25033592|NCT01004861|50132912|FG009|Overall Study|Patient decision|1|||
25033593|NCT01004861|50132913|FG010|Overall Study|Patient decision|1|||
25033594|NCT01004861|50132914|FG011|Overall Study|Patient decision|2|||
25033595|NCT01004861|50132915|FG012|Overall Study|Patient decision|3|||
25033596|NCT01004861|50132903|FG000|Overall Study|Transitioned to Phase 4 study|0|||
25033597|NCT01004861|50132904|FG001|Overall Study|Transitioned to Phase 4 study|0|||
25033598|NCT01004861|50132905|FG002|Overall Study|Transitioned to Phase 4 study|0|||
25033599|NCT01004861|50132906|FG003|Overall Study|Transitioned to Phase 4 study|0|||
25033600|NCT01004861|50132907|FG004|Overall Study|Transitioned to Phase 4 study|0|||
25033601|NCT01004861|50132908|FG005|Overall Study|Transitioned to Phase 4 study|0|||
25033602|NCT01004861|50132909|FG006|Overall Study|Transitioned to Phase 4 study|0|||
25033603|NCT01004861|50132910|FG007|Overall Study|Transitioned to Phase 4 study|0|||
25033604|NCT01004861|50132911|FG008|Overall Study|Transitioned to Phase 4 study|2|||
25033605|NCT01004861|50132912|FG009|Overall Study|Transitioned to Phase 4 study|0|||
25033606|NCT01004861|50132913|FG010|Overall Study|Transitioned to Phase 4 study|0|||
25033607|NCT01004861|50132914|FG011|Overall Study|Transitioned to Phase 4 study|0|||
25033608|NCT01004861|50132915|FG012|Overall Study|Transitioned to Phase 4 study|0|||
25033609|NCT01004861|50132903|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
25033610|NCT01004861|50132904|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
25033611|NCT01004861|50132905|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
25033612|NCT01004861|50132906|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
25033613|NCT01004861|50132907|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
25033614|NCT01004861|50132908|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
25033615|NCT01004861|50132909|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
25033616|NCT01004861|50132910|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
25033617|NCT01004861|50132911|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
25033618|NCT01004861|50132912|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
25033619|NCT01004861|50132913|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
25033620|NCT01004861|50132914|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
25033621|NCT01004861|50132915|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
25033622|NCT01004861|50132903|FG000|Overall Study|Patient withdrew|0|||
25033623|NCT01004861|50132904|FG001|Overall Study|Patient withdrew|0|||
25033624|NCT01004861|50132905|FG002|Overall Study|Patient withdrew|0|||
25033625|NCT01004861|50132906|FG003|Overall Study|Patient withdrew|0|||
25033626|NCT01004861|50132907|FG004|Overall Study|Patient withdrew|0|||
25033627|NCT01004861|50132908|FG005|Overall Study|Patient withdrew|0|||
25033628|NCT01004861|50132909|FG006|Overall Study|Patient withdrew|0|||
25033629|NCT01004861|50132910|FG007|Overall Study|Patient withdrew|0|||
25033630|NCT01004861|50132911|FG008|Overall Study|Patient withdrew|1|||
25033631|NCT01004861|50132912|FG009|Overall Study|Patient withdrew|0|||
25033632|NCT01004861|50132913|FG010|Overall Study|Patient withdrew|0|||
25033633|NCT01004861|50132914|FG011|Overall Study|Patient withdrew|0|||
25033634|NCT01004861|50132915|FG012|Overall Study|Patient withdrew|0|||
25033635|NCT01004861|50132903|FG000|Overall Study|Surgical resection|0|||
25033636|NCT01004861|50132904|FG001|Overall Study|Surgical resection|0|||
25033637|NCT01004861|50132905|FG002|Overall Study|Surgical resection|0|||
25033638|NCT01004861|50132906|FG003|Overall Study|Surgical resection|0|||
25159604|NCT01393899|50279473|FG001|Overall Study|Lack of Efficacy|21|||
25033639|NCT01004861|50132907|FG004|Overall Study|Surgical resection|0|||
25033640|NCT01004861|50132908|FG005|Overall Study|Surgical resection|0|||
25033641|NCT01004861|50132909|FG006|Overall Study|Surgical resection|0|||
25033642|NCT01004861|50132910|FG007|Overall Study|Surgical resection|0|||
25033643|NCT01004861|50132911|FG008|Overall Study|Surgical resection|1|||
25159605|NCT01393899|50279474|FG002|Overall Study|Lack of Efficacy|16|||
25033644|NCT01004861|50132912|FG009|Overall Study|Surgical resection|0|||
25033645|NCT01004861|50132913|FG010|Overall Study|Surgical resection|0|||
25033646|NCT01004861|50132914|FG011|Overall Study|Surgical resection|0|||
25033647|NCT01004861|50132915|FG012|Overall Study|Surgical resection|0|||
25033648|NCT01004861|50132903|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
25033649|NCT01004861|50132904|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
25033650|NCT01004861|50132905|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
25033651|NCT01004861|50132906|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
25033652|NCT01004861|50132907|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
25033653|NCT01004861|50132908|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
25033654|NCT01004861|50132909|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
25033655|NCT01004861|50132910|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
25033656|NCT01004861|50132911|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
25033657|NCT01004861|50132912|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
25033658|NCT01004861|50132913|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
25033659|NCT01004861|50132914|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
25033660|NCT01004861|50132915|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
25033661|NCT01004861|50132903|FG000|Overall Study|Study termination by Sponsor|0|||
25033662|NCT01004861|50132904|FG001|Overall Study|Study termination by Sponsor|0|||
25033663|NCT01004861|50132905|FG002|Overall Study|Study termination by Sponsor|0|||
25033664|NCT01004861|50132906|FG003|Overall Study|Study termination by Sponsor|0|||
24946008|NCT03687827|50038422|FG001|Treatment Period 2|Physician Decision|1|||
24946009|NCT03687827|50038421|FG000|Treatment Period 2|Withdrawal by Subject|1|||
24946010|NCT03687827|50038422|FG001|Treatment Period 2|Withdrawal by Subject|2|||
24946011|NCT00529529|50038431|FG000|Overall Study|Adverse Event|12|||
24946012|NCT00529529|50038432|FG001|Overall Study|Adverse Event|17|||
24946013|NCT00529529|50038433|FG002|Overall Study|Adverse Event|8|||
24946014|NCT00529529|50038431|FG000|Overall Study|Subject withdrew consent|12|||
24946015|NCT00529529|50038432|FG001|Overall Study|Subject withdrew consent|9|||
24946016|NCT00529529|50038433|FG002|Overall Study|Subject withdrew consent|12|||
24946017|NCT00529529|50038431|FG000|Overall Study|Protocol deviation|8|||
24946018|NCT00529529|50038432|FG001|Overall Study|Protocol deviation|12|||
24946019|NCT00529529|50038433|FG002|Overall Study|Protocol deviation|5|||
24946020|NCT00529529|50038431|FG000|Overall Study|Lost to Follow-up|5|||
24946021|NCT00529529|50038432|FG001|Overall Study|Lost to Follow-up|3|||
24946022|NCT00529529|50038433|FG002|Overall Study|Lost to Follow-up|1|||
24946023|NCT00529529|50038431|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
24946024|NCT00529529|50038432|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
24946025|NCT00529529|50038433|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
24946026|NCT00529529|50038431|FG000|Overall Study|Death|2|||
24946027|NCT00529529|50038432|FG001|Overall Study|Death|0|||
25033665|NCT01004861|50132907|FG004|Overall Study|Study termination by Sponsor|0|||
25033666|NCT01004861|50132908|FG005|Overall Study|Study termination by Sponsor|0|||
25033667|NCT01004861|50132909|FG006|Overall Study|Study termination by Sponsor|0|||
25033668|NCT01004861|50132910|FG007|Overall Study|Study termination by Sponsor|0|||
25033669|NCT01004861|50132911|FG008|Overall Study|Study termination by Sponsor|1|||
25033670|NCT01004861|50132912|FG009|Overall Study|Study termination by Sponsor|0|||
25033671|NCT01004861|50132913|FG010|Overall Study|Study termination by Sponsor|0|||
25033672|NCT01004861|50132914|FG011|Overall Study|Study termination by Sponsor|0|||
25033673|NCT01004861|50132915|FG012|Overall Study|Study termination by Sponsor|0|||
25033674|NCT03254459|50132962|FG000|Overall Study|Adverse Event|7|||
25033675|NCT03254459|50132963|FG001|Overall Study|Adverse Event|20|||
25033676|NCT03254459|50132962|FG000|Overall Study|Withdrawal by Subject Consent|3|||
25033677|NCT03254459|50132963|FG001|Overall Study|Withdrawal by Subject Consent|1|||
25033678|NCT03254459|50132962|FG000|Overall Study|Lost to Follow-up|0|||
25033679|NCT03254459|50132963|FG001|Overall Study|Lost to Follow-up|1|||
25033680|NCT03254459|50132962|FG000|Overall Study|Miscellaneous|0|||
25033681|NCT03254459|50132963|FG001|Overall Study|Miscellaneous|1|||
25033682|NCT02736617|50132969|FG000|Treatment|Adverse Event|1|||
25033683|NCT02736617|50132969|FG000|Treatment|Lack of Efficacy|1|||
25033684|NCT02736617|50132969|FG000|Treatment|Withdrawal by Subject|1|||
25033685|NCT02736617|50132969|FG000|Maintenance|Lack of Efficacy|4|||
25033686|NCT02736617|50132969|FG000|Maintenance|Physician Decision|1|||
25033687|NCT03251963|50132976|FG000|Overall Study|inappropriate Xa level timing|6|||
25033688|NCT03251963|50132977|FG001|Overall Study|inappropriate Xa level timing|3|||
25033689|NCT03251963|50132976|FG000|Overall Study|no peak Xa level drawn|2|||
25033690|NCT03251963|50132977|FG001|Overall Study|no peak Xa level drawn|0|||
25033691|NCT03251963|50132976|FG000|Overall Study|bled prior to Xa level|1|||
24946028|NCT00529529|50038433|FG002|Overall Study|Death|0|||
24946029|NCT00529529|50038431|FG000|Overall Study|Abnormal test procedure result(s)|1|||
24946030|NCT00529529|50038432|FG001|Overall Study|Abnormal test procedure result(s)|0|||
25033692|NCT03251963|50132977|FG001|Overall Study|bled prior to Xa level|2|||
25033693|NCT03287219|50132985|FG000|Overall Study|Protocol Violation|0|||
25033694|NCT03287219|50132986|FG001|Overall Study|Protocol Violation|2|||
25033695|NCT03286751|50133025|FG000|Washout Period 1|Withdrawal by Subject|0|||
25033696|NCT03286751|50133026|FG001|Washout Period 1|Withdrawal by Subject|0|||
25033697|NCT03286751|50133027|FG002|Washout Period 1|Withdrawal by Subject|0|||
25033698|NCT03286751|50133028|FG003|Washout Period 1|Withdrawal by Subject|0|||
25033699|NCT03286751|50133029|FG004|Washout Period 1|Withdrawal by Subject|1|||
25033700|NCT03286751|50133030|FG005|Washout Period 1|Withdrawal by Subject|0|||
25033701|NCT03286751|50133025|FG000|Washout Period 2|Personal Reasons|0|||
25033702|NCT03286751|50133026|FG001|Washout Period 2|Personal Reasons|1|||
25033703|NCT03286751|50133027|FG002|Washout Period 2|Personal Reasons|0|||
25033704|NCT03286751|50133028|FG003|Washout Period 2|Personal Reasons|0|||
25033705|NCT03286751|50133029|FG004|Washout Period 2|Personal Reasons|0|||
25033706|NCT03286751|50133030|FG005|Washout Period 2|Personal Reasons|0|||
25033707|NCT03286751|50133025|FG000|Washout Period 5|Adverse Event|0|||
25033708|NCT03286751|50133026|FG001|Washout Period 5|Adverse Event|0|||
25033709|NCT03286751|50133027|FG002|Washout Period 5|Adverse Event|0|||
25033710|NCT03286751|50133028|FG003|Washout Period 5|Adverse Event|0|||
25033711|NCT03286751|50133029|FG004|Washout Period 5|Adverse Event|1|||
25033712|NCT03286751|50133030|FG005|Washout Period 5|Adverse Event|0|||
25033713|NCT03249935|50133044|FG000|Overall Study|Discharged from facility early|36|||
25033714|NCT03249935|50133044|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
25033715|NCT03249935|50133044|FG000|Overall Study|Protocol Violation|5|||
25033716|NCT03285113|50133050|FG000|Overall Study|Unable to implant leads|2|||
25033717|NCT03000348|50133060|FG000|Overall Study|Adverse Event|1|||
25033718|NCT03000348|50133061|FG001|Overall Study|Adverse Event|1|||
25033719|NCT03000348|50133062|FG002|Overall Study|Adverse Event|1|||
25033720|NCT03000348|50133063|FG003|Overall Study|Adverse Event|1|||
25033721|NCT03000348|50133064|FG004|Overall Study|Adverse Event|1|||
25033722|NCT03000348|50133065|FG005|Overall Study|Adverse Event|1|||
25033723|NCT03000348|50133060|FG000|Overall Study|Lost to Follow-up|0|||
25033724|NCT03000348|50133061|FG001|Overall Study|Lost to Follow-up|0|||
25033725|NCT03000348|50133062|FG002|Overall Study|Lost to Follow-up|1|||
25033726|NCT03000348|50133063|FG003|Overall Study|Lost to Follow-up|0|||
25033727|NCT03000348|50133064|FG004|Overall Study|Lost to Follow-up|0|||
25033728|NCT03000348|50133065|FG005|Overall Study|Lost to Follow-up|0|||
25033729|NCT03000348|50133060|FG000|Overall Study|Withdrawal by Subject|0|||
25033730|NCT03000348|50133061|FG001|Overall Study|Withdrawal by Subject|1|||
25033731|NCT03000348|50133062|FG002|Overall Study|Withdrawal by Subject|0|||
25033732|NCT03000348|50133063|FG003|Overall Study|Withdrawal by Subject|0|||
25033733|NCT03000348|50133064|FG004|Overall Study|Withdrawal by Subject|0|||
25033734|NCT03000348|50133065|FG005|Overall Study|Withdrawal by Subject|0|||
25033735|NCT03000348|50133060|FG000|Overall Study|Consent|0|||
25033736|NCT03000348|50133061|FG001|Overall Study|Consent|0|||
25033737|NCT03000348|50133062|FG002|Overall Study|Consent|0|||
25033738|NCT03000348|50133063|FG003|Overall Study|Consent|0|||
25033739|NCT03000348|50133064|FG004|Overall Study|Consent|1|||
25033740|NCT03000348|50133065|FG005|Overall Study|Consent|0|||
25033741|NCT03000348|50133060|FG000|Overall Study|Failure to expectorate sputum|1|||
25033742|NCT03000348|50133061|FG001|Overall Study|Failure to expectorate sputum|0|||
25033743|NCT03000348|50133062|FG002|Overall Study|Failure to expectorate sputum|1|||
25033744|NCT03000348|50133063|FG003|Overall Study|Failure to expectorate sputum|0|||
25033745|NCT03000348|50133064|FG004|Overall Study|Failure to expectorate sputum|1|||
25033746|NCT03000348|50133065|FG005|Overall Study|Failure to expectorate sputum|0|||
25033747|NCT03000348|50133060|FG000|Overall Study|No gram negative|1|||
25033748|NCT03000348|50133061|FG001|Overall Study|No gram negative|2|||
25033749|NCT03000348|50133062|FG002|Overall Study|No gram negative|1|||
25033750|NCT03000348|50133063|FG003|Overall Study|No gram negative|1|||
25033751|NCT03000348|50133064|FG004|Overall Study|No gram negative|1|||
25033752|NCT03000348|50133065|FG005|Overall Study|No gram negative|1|||
25033753|NCT03000348|50133060|FG000|Overall Study|Patient had no transport|0|||
25033754|NCT03000348|50133061|FG001|Overall Study|Patient had no transport|0|||
25033755|NCT03000348|50133062|FG002|Overall Study|Patient had no transport|0|||
25033756|NCT03000348|50133063|FG003|Overall Study|Patient had no transport|1|||
25033757|NCT03000348|50133064|FG004|Overall Study|Patient had no transport|0|||
25033758|NCT03000348|50133065|FG005|Overall Study|Patient had no transport|0|||
25033759|NCT03000348|50133060|FG000|Overall Study|Dosing|0|||
25033760|NCT03000348|50133061|FG001|Overall Study|Dosing|0|||
25033761|NCT03000348|50133062|FG002|Overall Study|Dosing|0|||
25186211|NCT01399697|50336173|FG001|Overall Study|Lost to Follow-up|0|||
25033762|NCT03000348|50133063|FG003|Overall Study|Dosing|0|||
25033763|NCT03000348|50133064|FG004|Overall Study|Dosing|1|||
25033764|NCT03000348|50133065|FG005|Overall Study|Dosing|0|||
25033765|NCT03283709|50133084|FG000|Overall Study|trial terminated|0|||
25033766|NCT03283709|50133085|FG001|Overall Study|trial terminated|1|||
25033767|NCT03247673|50133094|FG000|Overall Study|Withdrawal by Subject|1|||
25033768|NCT03247673|50133095|FG001|Overall Study|Withdrawal by Subject|0|||
25033769|NCT03247673|50133096|FG002|Overall Study|Withdrawal by Subject|3|||
25033770|NCT03247673|50133094|FG000|Overall Study|Lost to Follow-up|0|||
25033771|NCT03247673|50133095|FG001|Overall Study|Lost to Follow-up|0|||
25033772|NCT03247673|50133096|FG002|Overall Study|Lost to Follow-up|1|||
25033773|NCT03247517|50133107|FG000|Overall Study|Adverse Event|0|||
25033774|NCT03247517|50133108|FG001|Overall Study|Adverse Event|4|||
25033775|NCT03247517|50133109|FG002|Overall Study|Adverse Event|2|||
25033776|NCT03247517|50133107|FG000|Overall Study|Lost to Follow-up|2|||
25033777|NCT03247517|50133108|FG001|Overall Study|Lost to Follow-up|6|||
25033778|NCT03247517|50133109|FG002|Overall Study|Lost to Follow-up|4|||
25033779|NCT03247517|50133107|FG000|Overall Study|Consent withdrawn by caregiver|1|||
25033780|NCT03247517|50133108|FG001|Overall Study|Consent withdrawn by caregiver|4|||
25033781|NCT03247517|50133109|FG002|Overall Study|Consent withdrawn by caregiver|7|||
25033782|NCT03247517|50133107|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
25033783|NCT03247517|50133108|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
25033784|NCT03247517|50133109|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
25033785|NCT03247517|50133107|FG000|Overall Study|Protocol Violation|0|||
25033786|NCT03247517|50133108|FG001|Overall Study|Protocol Violation|2|||
25033787|NCT03247517|50133109|FG002|Overall Study|Protocol Violation|0|||
25033788|NCT03247517|50133107|FG000|Overall Study|Multiple reasons|3|||
25033789|NCT03247517|50133108|FG001|Overall Study|Multiple reasons|1|||
24946031|NCT00529529|50038433|FG002|Overall Study|Abnormal test procedure result(s)|0|||
24946032|NCT00529529|50038431|FG000|Overall Study|Administrative problems|1|||
24946033|NCT00529529|50038432|FG001|Overall Study|Administrative problems|0|||
24946034|NCT00529529|50038433|FG002|Overall Study|Administrative problems|3|||
24946035|NCT05655377|50038441|FG000|Overall Study|Withdrawal by Subject|2|||
24946036|NCT00486434|50038447|FG000|Overall Study|Withdrawal by Subject|34|||
24946037|NCT00486434|50038448|FG001|Overall Study|Withdrawal by Subject|39|||
24946038|NCT00486434|50038447|FG000|Overall Study|Adverse Event|118|||
24946039|NCT00486434|50038448|FG001|Overall Study|Adverse Event|44|||
24946040|NCT00486434|50038447|FG000|Overall Study|Protocol Violation|22|||
25033790|NCT03247517|50133109|FG002|Overall Study|Multiple reasons|0|||
25033791|NCT03283553|50133119|FG000|Patient Participant Flow|Death|5|||
25033792|NCT03283553|50133120|FG001|Patient Participant Flow|Death|10|||
25033793|NCT03283553|50133119|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
25033794|NCT03283553|50133120|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
25033795|NCT03283553|50133119|FG000|Patient Participant Flow|Lost to Follow-up|1|||
25033796|NCT03283553|50133120|FG001|Patient Participant Flow|Lost to Follow-up|1|||
25033797|NCT03283553|50133119|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
25033798|NCT03283553|50133120|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
25033799|NCT03283553|50133119|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
25033800|NCT03283553|50133120|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
25033801|NCT03283553|50133119|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
25033802|NCT03283553|50133120|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
25033803|NCT03283319|50133134|FG000|Overall Study|Lost to Follow-up|5|||
25033804|NCT03283319|50133135|FG001|Overall Study|Lost to Follow-up|4|||
25033805|NCT03283319|50133136|FG002|Overall Study|Lost to Follow-up|5|||
24946041|NCT00486434|50038448|FG001|Overall Study|Protocol Violation|21|||
25033806|NCT03283319|50133137|FG003|Overall Study|Lost to Follow-up|5|||
25033807|NCT03283319|50133138|FG004|Overall Study|Lost to Follow-up|4|||
25033808|NCT03283319|50133139|FG005|Overall Study|Lost to Follow-up|3|||
25033809|NCT03283319|50133134|FG000|Overall Study|Withdrawal by Subject|2|||
25033810|NCT03283319|50133135|FG001|Overall Study|Withdrawal by Subject|2|||
25033811|NCT03283319|50133136|FG002|Overall Study|Withdrawal by Subject|2|||
25033812|NCT03283319|50133137|FG003|Overall Study|Withdrawal by Subject|1|||
25033813|NCT03283319|50133138|FG004|Overall Study|Withdrawal by Subject|0|||
25033814|NCT03283319|50133139|FG005|Overall Study|Withdrawal by Subject|1|||
25033815|NCT03283319|50133134|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
25033816|NCT03283319|50133135|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
25033817|NCT03283319|50133136|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
25033818|NCT03283319|50133137|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
25033819|NCT03283319|50133138|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
25033820|NCT03283319|50133139|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
25033821|NCT03282227|50133153|FG000|Overall Study|Exposure Goals Achieved|60|||
25033822|NCT03282227|50133153|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
25033823|NCT03282227|50133153|FG000|Overall Study|Adverse Event|15|||
25033824|NCT03282227|50133153|FG000|Overall Study|Lost to Follow-up|21|||
25033825|NCT03282227|50133153|FG000|Overall Study|Withdrawal by Subject|20|||
24946042|NCT00486434|50038447|FG000|Overall Study|Lack of Efficacy|12|||
24946043|NCT00486434|50038448|FG001|Overall Study|Lack of Efficacy|19|||
25033826|NCT03282227|50133153|FG000|Overall Study|Lack of Efficacy|12|||
24946044|NCT00486434|50038447|FG000|Overall Study|Lost to Follow-up|2|||
24946045|NCT00486434|50038448|FG001|Overall Study|Lost to Follow-up|3|||
24946046|NCT00486434|50038447|FG000|Overall Study|Death|1|||
25033827|NCT03282227|50133153|FG000|Overall Study|Sponsor decision|3|||
24946047|NCT00486434|50038448|FG001|Overall Study|Death|2|||
25033828|NCT03282227|50133153|FG000|Overall Study|Physician Decision|2|||
25033829|NCT03282227|50133153|FG000|Overall Study|Pregnancy|2|||
25033830|NCT03282227|50133153|FG000|Overall Study|Other|1|||
25033831|NCT03240575|50133161|FG000|Overall Study|Adverse Event|0|||
25033832|NCT03240575|50133162|FG001|Overall Study|Adverse Event|2|||
25033833|NCT03240575|50133163|FG002|Overall Study|Adverse Event|0|||
25033834|NCT03240575|50133164|FG003|Overall Study|Adverse Event|1|||
25033835|NCT03240575|50133161|FG000|Overall Study|Withdrawal by Subject|2|||
25033836|NCT03240575|50133162|FG001|Overall Study|Withdrawal by Subject|11|||
25033837|NCT03240575|50133163|FG002|Overall Study|Withdrawal by Subject|0|||
25033838|NCT03240575|50133164|FG003|Overall Study|Withdrawal by Subject|1|||
25033839|NCT03240575|50133161|FG000|Overall Study|Other|0|||
25033840|NCT03240575|50133162|FG001|Overall Study|Other|1|||
25033841|NCT03240575|50133163|FG002|Overall Study|Other|0|||
25033842|NCT03240575|50133164|FG003|Overall Study|Other|0|||
25033843|NCT03385265|50133176|FG000|Overall Study|Withdrawal by Subject|5|||
25033844|NCT03385265|50133177|FG001|Overall Study|Withdrawal by Subject|2|||
25033845|NCT03385265|50133178|FG002|Overall Study|Withdrawal by Subject|5|||
25033846|NCT03385265|50133179|FG003|Overall Study|Withdrawal by Subject|2|||
25033847|NCT03280121|50133191|FG000|Overall Study|Physician Decision|1|||
25033848|NCT03280121|50133191|FG000|Overall Study|Lost to Follow-up|1|||
25033849|NCT03280121|50133191|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
25033850|NCT03233009|50133195|FG000|Overall Study|Lost to Follow-up|1|||
25033851|NCT04034225|50133210|FG000|Overall Study|Death|3|||
25033852|NCT04034225|50133210|FG000|Overall Study|Withdrawal by Subject|2|||
25033853|NCT04034225|50133210|FG000|Overall Study|Study termination by Sponsor|18|||
25033854|NCT04034225|50133210|FG000|Overall Study|Physician Decision|1|||
25033855|NCT04034225|50133210|FG000|Overall Study|Lack of Efficacy|1|||
25033856|NCT02999178|50133218|FG000|Overall Study|Adverse Event|85|||
25033857|NCT02999178|50133219|FG001|Overall Study|Adverse Event|62|||
25033858|NCT02999178|50133218|FG000|Overall Study|Protocol Violation|1|||
25033859|NCT02999178|50133219|FG001|Overall Study|Protocol Violation|2|||
25033860|NCT02999178|50133218|FG000|Overall Study|Lost to Follow-up|0|||
25033861|NCT02999178|50133219|FG001|Overall Study|Lost to Follow-up|2|||
25033862|NCT02999178|50133218|FG000|Overall Study|Withdrawal by Subject|21|||
25033863|NCT02999178|50133219|FG001|Overall Study|Withdrawal by Subject|21|||
25033864|NCT02999178|50133218|FG000|Overall Study|Other reason not defined above|7|||
25033865|NCT02999178|50133219|FG001|Overall Study|Other reason not defined above|13|||
25033866|NCT02959190|50133231|FG000|Open Label|Adverse Event|5|||
25033867|NCT02959190|50133232|FG001|Open Label|Adverse Event|7|||
25033868|NCT02959190|50133233|FG002|Open Label|Adverse Event|3|||
25033869|NCT02959190|50133234|FG003|Open Label|Adverse Event|4|||
25033870|NCT02959190|50133231|FG000|Open Label|Pregnancy|0|||
25033871|NCT02959190|50133232|FG001|Open Label|Pregnancy|1|||
25033872|NCT02959190|50133233|FG002|Open Label|Pregnancy|0|||
25033873|NCT02959190|50133234|FG003|Open Label|Pregnancy|0|||
25033874|NCT02959190|50133231|FG000|Open Label|Withdrawal by Subject|2|||
25159606|NCT01393899|50279472|FG000|Overall Study|Adverse Event|1|||
25159607|NCT01393899|50279473|FG001|Overall Study|Adverse Event|5|||
25159608|NCT01393899|50279474|FG002|Overall Study|Adverse Event|3|||
24946048|NCT00486434|50038447|FG000|Overall Study|Personal reasons|5|||
24946049|NCT00486434|50038448|FG001|Overall Study|Personal reasons|6|||
24946050|NCT00424632|50038457|FG000|Overall Study|Death|0|||
24946051|NCT00424632|50038458|FG001|Overall Study|Death|0|||
24946052|NCT00424632|50038459|FG002|Overall Study|Death|0|||
24946053|NCT00424632|50038460|FG003|Overall Study|Death|0|||
24946054|NCT00424632|50038461|FG004|Overall Study|Death|0|||
24946055|NCT00424632|50038462|FG005|Overall Study|Death|2|||
24946056|NCT00424632|50038463|FG006|Overall Study|Death|0|||
24946057|NCT00424632|50038464|FG007|Overall Study|Death|0|||
24946058|NCT00424632|50038465|FG008|Overall Study|Death|0|||
24946059|NCT00424632|50038466|FG009|Overall Study|Death|0|||
24946060|NCT00424632|50038457|FG000|Overall Study|Adverse Event|0|||
24946061|NCT00424632|50038458|FG001|Overall Study|Adverse Event|0|||
24946062|NCT00424632|50038459|FG002|Overall Study|Adverse Event|0|||
24946063|NCT00424632|50038460|FG003|Overall Study|Adverse Event|0|||
24946064|NCT00424632|50038461|FG004|Overall Study|Adverse Event|0|||
24946065|NCT00424632|50038462|FG005|Overall Study|Adverse Event|0|||
25186212|NCT01399697|50336174|FG002|Overall Study|Lost to Follow-up|0|||
24946066|NCT00424632|50038463|FG006|Overall Study|Adverse Event|0|||
24946067|NCT00424632|50038464|FG007|Overall Study|Adverse Event|0|||
24946068|NCT00424632|50038465|FG008|Overall Study|Adverse Event|3|||
24946069|NCT00424632|50038466|FG009|Overall Study|Adverse Event|2|||
24946070|NCT00424632|50038457|FG000|Overall Study|Global deterioration of health status|0|||
25033875|NCT02959190|50133232|FG001|Open Label|Withdrawal by Subject|8|||
25033876|NCT02959190|50133233|FG002|Open Label|Withdrawal by Subject|0|||
25033877|NCT02959190|50133234|FG003|Open Label|Withdrawal by Subject|0|||
25033878|NCT02959190|50133231|FG000|Open Label|Physician Decision|0|||
25033879|NCT02959190|50133232|FG001|Open Label|Physician Decision|0|||
25033880|NCT02959190|50133233|FG002|Open Label|Physician Decision|1|||
25159609|NCT01393743|50279486|FG000|Core Study|Adverse Event|5|||
24946071|NCT00424632|50038458|FG001|Overall Study|Global deterioration of health status|0|||
24946072|NCT00424632|50038459|FG002|Overall Study|Global deterioration of health status|0|||
24946073|NCT00424632|50038460|FG003|Overall Study|Global deterioration of health status|1|||
24946074|NCT00424632|50038461|FG004|Overall Study|Global deterioration of health status|1|||
24946075|NCT00424632|50038462|FG005|Overall Study|Global deterioration of health status|0|||
25033881|NCT02959190|50133234|FG003|Open Label|Physician Decision|0|||
25033882|NCT02959190|50133231|FG000|Open Label|Protocol Violation|0|||
25033883|NCT02959190|50133232|FG001|Open Label|Protocol Violation|0|||
25033884|NCT02959190|50133233|FG002|Open Label|Protocol Violation|0|||
25033885|NCT02959190|50133234|FG003|Open Label|Protocol Violation|2|||
25033886|NCT02959190|50133231|FG000|Post Treatment Follow Up|Adverse Event|1|||
25033887|NCT02959190|50133232|FG001|Post Treatment Follow Up|Adverse Event|1|||
25033888|NCT02959190|50133233|FG002|Post Treatment Follow Up|Adverse Event|0|||
25033889|NCT02959190|50133234|FG003|Post Treatment Follow Up|Adverse Event|0|||
25033890|NCT02959190|50133231|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
25033891|NCT02959190|50133232|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
25033892|NCT02959190|50133233|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
25033893|NCT02959190|50133234|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
25033894|NCT01344356|50133255|FG000|Overall Study|Physician Decision|0|||
25033895|NCT01344356|50133256|FG001|Overall Study|Physician Decision|3|||
25033896|NCT01344356|50133255|FG000|Overall Study|Lost to Follow-up|0|||
25033897|NCT01344356|50133256|FG001|Overall Study|Lost to Follow-up|6|||
25033898|NCT02956460|50133282|FG000|Lens 1|Lost to Follow-up|1|||
25033899|NCT02956460|50133283|FG001|Lens 1|Lost to Follow-up|0|||
25033900|NCT02999100|50133295|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
25033901|NCT02999100|50133296|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
25033902|NCT02999100|50133297|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
25033903|NCT02999100|50133298|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
25033904|NCT02999100|50133299|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
25033905|NCT02999100|50133300|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
25033906|NCT02999100|50133295|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
25033907|NCT02999100|50133296|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
25033908|NCT02999100|50133297|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
25033909|NCT02999100|50133298|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
24946076|NCT00424632|50038463|FG006|Overall Study|Global deterioration of health status|0|||
24946077|NCT00424632|50038464|FG007|Overall Study|Global deterioration of health status|0|||
25033910|NCT02999100|50133299|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
25033911|NCT02999100|50133300|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
25033912|NCT02999100|50133295|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
25033913|NCT02999100|50133296|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
25033914|NCT02999100|50133297|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
25033915|NCT02999100|50133298|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
25033916|NCT02999100|50133299|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
25033917|NCT02999100|50133300|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
25033918|NCT02749370|50133322|FG000|Overall Study|Withdrawal by Subject|11|||
25033919|NCT02749370|50133322|FG000|Overall Study|Lost to Follow-up|3|||
25033920|NCT03607994|50133328|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
25033921|NCT03607994|50133329|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
25033922|NCT02996682|50133337|FG000|Overall Study|Death|0|||
25033923|NCT02996682|50133338|FG001|Overall Study|Death|3|||
25033924|NCT02873702|50133346|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
25033925|NCT02873702|50133347|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
25033926|NCT02873702|50133348|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
25033927|NCT02873702|50133349|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
25033928|NCT02873702|50133346|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
25033929|NCT02873702|50133347|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
25033930|NCT02873702|50133348|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
25033931|NCT02873702|50133349|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
25033932|NCT02873702|50133346|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
25033933|NCT02873702|50133347|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
25033934|NCT02873702|50133348|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
25033935|NCT02873702|50133349|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
25033936|NCT02873702|50133346|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
25033937|NCT02873702|50133347|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
25033938|NCT02873702|50133348|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
25033939|NCT02873702|50133349|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
24946078|NCT00424632|50038465|FG008|Overall Study|Global deterioration of health status|0|||
24946079|NCT00424632|50038466|FG009|Overall Study|Global deterioration of health status|0|||
25033940|NCT02873702|50133346|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
25033941|NCT02873702|50133347|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
25033942|NCT02873702|50133348|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
25033943|NCT02873702|50133349|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
25033944|NCT02911116|50133361|FG000|Overall Study|Insufficient Therapeutic Response|1|||
25033945|NCT02911116|50133362|FG001|Overall Study|Insufficient Therapeutic Response|0|||
25033946|NCT02911116|50133361|FG000|Overall Study|Lost to Follow-up|0|||
25033947|NCT02911116|50133362|FG001|Overall Study|Lost to Follow-up|1|||
25033948|NCT02998554|50133370|FG000|Overall Study|Adverse Event|8|||
25033949|NCT02998554|50133371|FG001|Overall Study|Adverse Event|3|||
25033950|NCT02998554|50133370|FG000|Overall Study|Protocol deviation|1|||
25033951|NCT02998554|50133371|FG001|Overall Study|Protocol deviation|0|||
25033952|NCT02998554|50133370|FG000|Overall Study|Withdrawal by Subject|2|||
25033953|NCT02998554|50133371|FG001|Overall Study|Withdrawal by Subject|6|||
25033954|NCT02998554|50133370|FG000|Overall Study|Lost to Follow-up|0|||
25033955|NCT02998554|50133371|FG001|Overall Study|Lost to Follow-up|1|||
25033956|NCT02998554|50133370|FG000|Overall Study|Lack of Efficacy|0|||
25033957|NCT02998554|50133371|FG001|Overall Study|Lack of Efficacy|1|||
25033958|NCT02996448|50133379|FG000|Overall Study|Study terminated due to adverse effects|3|||
25033959|NCT02995980|50133384|FG000|Overall Study|Lost to Follow-up|14|||
25033960|NCT02872142|50133389|FG000|Overall Study|Adverse Event|2|||
25033961|NCT02872142|50133389|FG000|Overall Study|Death|1|||
25033962|NCT02872142|50133389|FG000|Overall Study|Participant Decision|3|||
25033963|NCT02994654|50133393|FG000|Overall Study|Lost to Follow-up|1|||
25033964|NCT02870972|50133403|FG000|Overall Study|Adverse Event|1|||
25033965|NCT02870972|50133404|FG001|Overall Study|Adverse Event|0|||
25033966|NCT02870972|50133405|FG002|Overall Study|Adverse Event|0|||
25033967|NCT02870972|50133406|FG003|Overall Study|Adverse Event|0|||
25033968|NCT02870972|50133407|FG004|Overall Study|Adverse Event|0|||
24946080|NCT00424632|50038457|FG000|Overall Study|Objective progression or relapse|1|||
24946081|NCT00424632|50038458|FG001|Overall Study|Objective progression or relapse|1|||
24946082|NCT00424632|50038459|FG002|Overall Study|Objective progression or relapse|1|||
24946083|NCT00424632|50038460|FG003|Overall Study|Objective progression or relapse|2|||
24946084|NCT00424632|50038461|FG004|Overall Study|Objective progression or relapse|2|||
24946085|NCT00424632|50038462|FG005|Overall Study|Objective progression or relapse|13|||
24946086|NCT00424632|50038463|FG006|Overall Study|Objective progression or relapse|7|||
24946087|NCT00424632|50038464|FG007|Overall Study|Objective progression or relapse|3|||
24946088|NCT00424632|50038465|FG008|Overall Study|Objective progression or relapse|12|||
24946089|NCT00424632|50038466|FG009|Overall Study|Objective progression or relapse|4|||
24946090|NCT00424632|50038457|FG000|Overall Study|Other|0|||
24946091|NCT00424632|50038458|FG001|Overall Study|Other|0|||
24946092|NCT00424632|50038459|FG002|Overall Study|Other|0|||
24946093|NCT00424632|50038460|FG003|Overall Study|Other|1|||
24946094|NCT00424632|50038461|FG004|Overall Study|Other|0|||
24946095|NCT00424632|50038462|FG005|Overall Study|Other|0|||
24946096|NCT00424632|50038463|FG006|Overall Study|Other|0|||
24946097|NCT00424632|50038464|FG007|Overall Study|Other|0|||
25033969|NCT03214367|50133427|FG000|Lead-in Period|Withdrawal by Subject|50|||
25033970|NCT03214367|50133428|FG001|Lead-in Period|Withdrawal by Subject|0|||
25033971|NCT03214367|50133429|FG002|Lead-in Period|Withdrawal by Subject|0|||
25033972|NCT03214367|50133430|FG003|Lead-in Period|Withdrawal by Subject|0|||
25033973|NCT03214367|50133431|FG004|Lead-in Period|Withdrawal by Subject|2|||
25033974|NCT03214367|50133432|FG005|Lead-in Period|Withdrawal by Subject|0|||
25033975|NCT03214367|50133433|FG006|Lead-in Period|Withdrawal by Subject|0|||
25033976|NCT03214367|50133434|FG007|Lead-in Period|Withdrawal by Subject|0|||
25033977|NCT03214367|50133427|FG000|Lead-in Period|Adverse Event|3|||
25033978|NCT03214367|50133428|FG001|Lead-in Period|Adverse Event|0|||
25033979|NCT03214367|50133429|FG002|Lead-in Period|Adverse Event|0|||
25033980|NCT03214367|50133430|FG003|Lead-in Period|Adverse Event|0|||
25033981|NCT03214367|50133431|FG004|Lead-in Period|Adverse Event|0|||
25033982|NCT03214367|50133432|FG005|Lead-in Period|Adverse Event|0|||
25033983|NCT03214367|50133433|FG006|Lead-in Period|Adverse Event|0|||
25033984|NCT03214367|50133434|FG007|Lead-in Period|Adverse Event|0|||
25033985|NCT03214367|50133427|FG000|Lead-in Period|Lost to Follow-up|12|||
25033986|NCT03214367|50133428|FG001|Lead-in Period|Lost to Follow-up|0|||
25033987|NCT03214367|50133429|FG002|Lead-in Period|Lost to Follow-up|0|||
24946098|NCT00424632|50038465|FG008|Overall Study|Other|1|||
24946099|NCT00424632|50038466|FG009|Overall Study|Other|0|||
25033988|NCT03214367|50133430|FG003|Lead-in Period|Lost to Follow-up|0|||
25159610|NCT01393743|50279487|FG001|Core Study|Adverse Event|9|||
24946100|NCT00529451|50038501|FG000|Overall Study|Subject withdrew consent|16|||
24946101|NCT00529451|50038502|FG001|Overall Study|Subject withdrew consent|21|||
24946102|NCT00529451|50038503|FG002|Overall Study|Subject withdrew consent|13|||
24946103|NCT00529451|50038504|FG003|Overall Study|Subject withdrew consent|12|||
25033989|NCT03214367|50133431|FG004|Lead-in Period|Lost to Follow-up|0|||
25033990|NCT03214367|50133432|FG005|Lead-in Period|Lost to Follow-up|0|||
25033991|NCT03214367|50133433|FG006|Lead-in Period|Lost to Follow-up|0|||
25033992|NCT03214367|50133434|FG007|Lead-in Period|Lost to Follow-up|0|||
25033993|NCT03214367|50133427|FG000|Lead-in Period|Sponsor Decision|11|||
25033994|NCT03214367|50133428|FG001|Lead-in Period|Sponsor Decision|0|||
25033995|NCT03214367|50133429|FG002|Lead-in Period|Sponsor Decision|0|||
25033996|NCT03214367|50133430|FG003|Lead-in Period|Sponsor Decision|0|||
25033997|NCT03214367|50133431|FG004|Lead-in Period|Sponsor Decision|0|||
25033998|NCT03214367|50133432|FG005|Lead-in Period|Sponsor Decision|0|||
25033999|NCT03214367|50133433|FG006|Lead-in Period|Sponsor Decision|0|||
25034000|NCT03214367|50133434|FG007|Lead-in Period|Sponsor Decision|0|||
25034001|NCT03214367|50133427|FG000|Lead-in Period|Physician Decision|12|||
24946104|NCT00529451|50038501|FG000|Overall Study|Adverse Event|9|||
24946105|NCT00529451|50038502|FG001|Overall Study|Adverse Event|16|||
24946106|NCT00529451|50038503|FG002|Overall Study|Adverse Event|14|||
25034002|NCT03214367|50133428|FG001|Lead-in Period|Physician Decision|0|||
25034003|NCT03214367|50133429|FG002|Lead-in Period|Physician Decision|0|||
25034004|NCT03214367|50133430|FG003|Lead-in Period|Physician Decision|0|||
25034005|NCT03214367|50133431|FG004|Lead-in Period|Physician Decision|0|||
25034006|NCT03214367|50133432|FG005|Lead-in Period|Physician Decision|0|||
25034007|NCT03214367|50133433|FG006|Lead-in Period|Physician Decision|0|||
25034008|NCT03214367|50133434|FG007|Lead-in Period|Physician Decision|0|||
25034009|NCT03214367|50133427|FG000|Lead-in Period|Protocol Violation|5|||
25034010|NCT03214367|50133428|FG001|Lead-in Period|Protocol Violation|0|||
25034011|NCT03214367|50133429|FG002|Lead-in Period|Protocol Violation|0|||
25034012|NCT03214367|50133430|FG003|Lead-in Period|Protocol Violation|0|||
25034013|NCT03214367|50133431|FG004|Lead-in Period|Protocol Violation|0|||
25034014|NCT03214367|50133432|FG005|Lead-in Period|Protocol Violation|0|||
25034015|NCT03214367|50133433|FG006|Lead-in Period|Protocol Violation|0|||
25034016|NCT03214367|50133434|FG007|Lead-in Period|Protocol Violation|0|||
25034017|NCT03214367|50133427|FG000|Lead-in Period|Treatment Interruption|1|||
25034018|NCT03214367|50133428|FG001|Lead-in Period|Treatment Interruption|0|||
25034019|NCT03214367|50133429|FG002|Lead-in Period|Treatment Interruption|0|||
25034020|NCT03214367|50133430|FG003|Lead-in Period|Treatment Interruption|0|||
25034021|NCT03214367|50133431|FG004|Lead-in Period|Treatment Interruption|0|||
25034022|NCT03214367|50133432|FG005|Lead-in Period|Treatment Interruption|0|||
25034023|NCT03214367|50133433|FG006|Lead-in Period|Treatment Interruption|0|||
25034024|NCT03214367|50133434|FG007|Lead-in Period|Treatment Interruption|0|||
25034025|NCT03214367|50133427|FG000|Treatment Period|Adverse Event|0|||
25034026|NCT03214367|50133428|FG001|Treatment Period|Adverse Event|1|||
25034027|NCT03214367|50133429|FG002|Treatment Period|Adverse Event|4|||
25034028|NCT03214367|50133430|FG003|Treatment Period|Adverse Event|2|||
25034029|NCT03214367|50133431|FG004|Treatment Period|Adverse Event|0|||
25034030|NCT03214367|50133432|FG005|Treatment Period|Adverse Event|0|||
25034031|NCT03214367|50133433|FG006|Treatment Period|Adverse Event|0|||
25034032|NCT03214367|50133434|FG007|Treatment Period|Adverse Event|0|||
25034033|NCT03214367|50133427|FG000|Treatment Period|Death|0|||
25034034|NCT03214367|50133428|FG001|Treatment Period|Death|1|||
25034035|NCT03214367|50133429|FG002|Treatment Period|Death|1|||
25034036|NCT03214367|50133430|FG003|Treatment Period|Death|1|||
24946107|NCT00529451|50038504|FG003|Overall Study|Adverse Event|8|||
24946108|NCT00529451|50038501|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
24946109|NCT00529451|50038502|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
24946110|NCT00529451|50038503|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
24946111|NCT00529451|50038504|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
24946112|NCT00529451|50038501|FG000|Overall Study|Lost to Follow-up|4|||
24946113|NCT00529451|50038502|FG001|Overall Study|Lost to Follow-up|7|||
24946114|NCT00529451|50038503|FG002|Overall Study|Lost to Follow-up|4|||
24946115|NCT00529451|50038504|FG003|Overall Study|Lost to Follow-up|4|||
24946116|NCT00529451|50038501|FG000|Overall Study|Protocol deviation|1|||
24946117|NCT00529451|50038502|FG001|Overall Study|Protocol deviation|1|||
24946118|NCT00529451|50038503|FG002|Overall Study|Protocol deviation|4|||
24946119|NCT00529451|50038504|FG003|Overall Study|Protocol deviation|1|||
24946120|NCT00529451|50038501|FG000|Overall Study|Administrative problems|1|||
24946121|NCT00529451|50038502|FG001|Overall Study|Administrative problems|1|||
24946122|NCT00529451|50038503|FG002|Overall Study|Administrative problems|0|||
25034037|NCT03214367|50133431|FG004|Treatment Period|Death|0|||
24946123|NCT00529451|50038504|FG003|Overall Study|Administrative problems|2|||
24946124|NCT03876743|50038521|FG000|Overall Study|Lost to Follow-up|6|||
25034038|NCT03214367|50133432|FG005|Treatment Period|Death|0|||
25034039|NCT03214367|50133433|FG006|Treatment Period|Death|0|||
25034040|NCT03214367|50133434|FG007|Treatment Period|Death|0|||
25034041|NCT03214367|50133427|FG000|Treatment Period|Lost to Follow-up|0|||
25034042|NCT03214367|50133428|FG001|Treatment Period|Lost to Follow-up|5|||
25034043|NCT03214367|50133429|FG002|Treatment Period|Lost to Follow-up|3|||
25034044|NCT03214367|50133430|FG003|Treatment Period|Lost to Follow-up|2|||
25034045|NCT03214367|50133431|FG004|Treatment Period|Lost to Follow-up|0|||
25034046|NCT03214367|50133432|FG005|Treatment Period|Lost to Follow-up|2|||
25034047|NCT03214367|50133433|FG006|Treatment Period|Lost to Follow-up|1|||
25034048|NCT03214367|50133434|FG007|Treatment Period|Lost to Follow-up|0|||
25034049|NCT03214367|50133427|FG000|Treatment Period|Sponsor Decision|0|||
25034050|NCT03214367|50133428|FG001|Treatment Period|Sponsor Decision|3|||
25034051|NCT03214367|50133429|FG002|Treatment Period|Sponsor Decision|0|||
25034052|NCT03214367|50133430|FG003|Treatment Period|Sponsor Decision|0|||
25034053|NCT03214367|50133431|FG004|Treatment Period|Sponsor Decision|0|||
25034054|NCT03214367|50133432|FG005|Treatment Period|Sponsor Decision|0|||
25034055|NCT03214367|50133433|FG006|Treatment Period|Sponsor Decision|0|||
25034056|NCT03214367|50133434|FG007|Treatment Period|Sponsor Decision|0|||
25034057|NCT03214367|50133427|FG000|Treatment Period|Physician Decision|0|||
25034058|NCT03214367|50133428|FG001|Treatment Period|Physician Decision|1|||
25034059|NCT03214367|50133429|FG002|Treatment Period|Physician Decision|2|||
25034060|NCT03214367|50133430|FG003|Treatment Period|Physician Decision|0|||
25034061|NCT03214367|50133431|FG004|Treatment Period|Physician Decision|0|||
25034062|NCT03214367|50133432|FG005|Treatment Period|Physician Decision|0|||
25034063|NCT03214367|50133433|FG006|Treatment Period|Physician Decision|0|||
25034064|NCT03214367|50133434|FG007|Treatment Period|Physician Decision|0|||
25034065|NCT03214367|50133427|FG000|Treatment Period|Protocol Violation|0|||
25034066|NCT03214367|50133428|FG001|Treatment Period|Protocol Violation|3|||
25034067|NCT03214367|50133429|FG002|Treatment Period|Protocol Violation|0|||
25034068|NCT03214367|50133430|FG003|Treatment Period|Protocol Violation|0|||
24946125|NCT03876743|50038522|FG001|Overall Study|Lost to Follow-up|4|||
24946126|NCT03876743|50038523|FG002|Overall Study|Lost to Follow-up|4|||
24946127|NCT03876743|50038524|FG003|Overall Study|Lost to Follow-up|7|||
24946128|NCT00486278|50038538|FG000|Overall Study|Adverse Event|5|||
24946129|NCT00486278|50038538|FG000|Overall Study|Withdrawal by Subject|2|||
24946130|NCT00486278|50038538|FG000|Overall Study|Physician Decision|2|||
24946131|NCT00321711|50038557|FG000|Part A|Adverse Event|3|||
24946132|NCT00321711|50038558|FG001|Part A|Adverse Event|3|||
24946133|NCT00321711|50038559|FG002|Part A|Adverse Event|2|||
24946134|NCT00321711|50038560|FG003|Part A|Adverse Event|0|||
24946135|NCT00321711|50038561|FG004|Part A|Adverse Event|0|||
24946136|NCT00321711|50038557|FG000|Part A|Withdrawal by Subject|1|||
24946137|NCT00321711|50038558|FG001|Part A|Withdrawal by Subject|1|||
24946138|NCT00321711|50038559|FG002|Part A|Withdrawal by Subject|1|||
24946139|NCT00321711|50038560|FG003|Part A|Withdrawal by Subject|0|||
24946140|NCT00321711|50038561|FG004|Part A|Withdrawal by Subject|0|||
24946141|NCT00321711|50038557|FG000|Part A|Disease progression|0|||
24946142|NCT00321711|50038558|FG001|Part A|Disease progression|1|||
24946143|NCT00321711|50038559|FG002|Part A|Disease progression|0|||
24946144|NCT00321711|50038560|FG003|Part A|Disease progression|0|||
24946145|NCT00321711|50038561|FG004|Part A|Disease progression|0|||
24946146|NCT00321711|50038557|FG000|Part A|Requirement for alternative therapy|0|||
24946147|NCT00321711|50038558|FG001|Part A|Requirement for alternative therapy|2|||
24946148|NCT00321711|50038559|FG002|Part A|Requirement for alternative therapy|1|||
24946149|NCT00321711|50038560|FG003|Part A|Requirement for alternative therapy|0|||
24946150|NCT00321711|50038561|FG004|Part A|Requirement for alternative therapy|0|||
24946151|NCT00321711|50038557|FG000|Part A|Physician Decision|0|||
24946152|NCT00321711|50038558|FG001|Part A|Physician Decision|1|||
24946153|NCT00321711|50038559|FG002|Part A|Physician Decision|3|||
24946154|NCT00321711|50038560|FG003|Part A|Physician Decision|0|||
24946155|NCT00321711|50038561|FG004|Part A|Physician Decision|0|||
24946156|NCT00321711|50038557|FG000|Part A|Other|1|||
24946157|NCT00321711|50038558|FG001|Part A|Other|2|||
24946158|NCT00321711|50038559|FG002|Part A|Other|3|||
24946159|NCT00321711|50038560|FG003|Part A|Other|0|||
24946160|NCT00321711|50038561|FG004|Part A|Other|0|||
24946161|NCT00321711|50038557|FG000|Part A|Protocol deviation|0|||
24946162|NCT00321711|50038558|FG001|Part A|Protocol deviation|0|||
24946163|NCT00321711|50038559|FG002|Part A|Protocol deviation|1|||
24946164|NCT00321711|50038560|FG003|Part A|Protocol deviation|0|||
24946165|NCT00321711|50038561|FG004|Part A|Protocol deviation|0|||
25034069|NCT03214367|50133431|FG004|Treatment Period|Protocol Violation|0|||
25034070|NCT03214367|50133432|FG005|Treatment Period|Protocol Violation|0|||
25034071|NCT03214367|50133433|FG006|Treatment Period|Protocol Violation|0|||
25034072|NCT03214367|50133434|FG007|Treatment Period|Protocol Violation|0|||
25034073|NCT03214367|50133427|FG000|Treatment Period|Withdrawal by Subject|0|||
25034074|NCT03214367|50133428|FG001|Treatment Period|Withdrawal by Subject|20|||
24946166|NCT00321711|50038557|FG000|Part B|Noncompliance|0|||
24946167|NCT00321711|50038558|FG001|Part B|Noncompliance|0|||
24946168|NCT00321711|50038559|FG002|Part B|Noncompliance|0|||
24946169|NCT00321711|50038560|FG003|Part B|Noncompliance|0|||
24946170|NCT00321711|50038561|FG004|Part B|Noncompliance|1|||
24946171|NCT00321711|50038557|FG000|Part B|Adverse Event|0|||
25034075|NCT03214367|50133429|FG002|Treatment Period|Withdrawal by Subject|23|||
25034076|NCT03214367|50133430|FG003|Treatment Period|Withdrawal by Subject|14|||
25034077|NCT03214367|50133431|FG004|Treatment Period|Withdrawal by Subject|0|||
25034078|NCT03214367|50133432|FG005|Treatment Period|Withdrawal by Subject|1|||
25034079|NCT03214367|50133433|FG006|Treatment Period|Withdrawal by Subject|1|||
25034080|NCT03214367|50133434|FG007|Treatment Period|Withdrawal by Subject|1|||
25034081|NCT02994108|50133450|FG000|Intervention Messages|Withdrawal by Subject|2|||
25034082|NCT02994108|50133451|FG001|Intervention Messages|Withdrawal by Subject|0|||
25034083|NCT02994108|50133450|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
25034084|NCT02994108|50133451|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
25034085|NCT02994108|50133450|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
25034086|NCT02994108|50133451|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
25034087|NCT02994108|50133450|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
25034088|NCT02994108|50133451|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
25034089|NCT03231371|50133458|FG000|Overall Study|Withdrawal by Subject|1|||
25034090|NCT03231371|50133458|FG000|Overall Study|chose or were ineligible to have MRI|12|||
25034091|NCT02870348|50133462|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
25034092|NCT03239873|50133468|FG000|Overall Study|Lost to Follow-up|15|||
25034093|NCT03239873|50133469|FG001|Overall Study|Lost to Follow-up|16|||
25034094|NCT03239873|50133468|FG000|Overall Study|Physician Decision|1|||
25034095|NCT03239873|50133469|FG001|Overall Study|Physician Decision|0|||
25034096|NCT03239873|50133468|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
25034097|NCT03239873|50133469|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
25034098|NCT03239873|50133468|FG000|Overall Study|Withdrawal by Subject|2|||
25034099|NCT03239873|50133469|FG001|Overall Study|Withdrawal by Subject|0|||
25034100|NCT03239873|50133468|FG000|Overall Study|Contraindication to study medication|1|||
25034101|NCT03239873|50133469|FG001|Overall Study|Contraindication to study medication|0|||
25034102|NCT03239873|50133468|FG000|Overall Study|Protocol Violation|1|||
25034103|NCT03239873|50133469|FG001|Overall Study|Protocol Violation|0|||
25034104|NCT03213509|50133477|FG000|Overall Study|Did not consent for verbal autopsy|4|||
25034105|NCT03213509|50133478|FG001|Overall Study|Did not consent for verbal autopsy|5|||
25034106|NCT03239483|50133487|FG000|Overall Study|Lost to Follow-up|1|||
25034107|NCT03239483|50133488|FG001|Overall Study|Lost to Follow-up|0|||
25034108|NCT03239483|50133487|FG000|Overall Study|Withdrawal by Subject|1|||
25034109|NCT03239483|50133488|FG001|Overall Study|Withdrawal by Subject|0|||
25034110|NCT02868554|50133497|FG000|Overall Study|Lost to Follow-up|3|||
25034111|NCT02868554|50133498|FG001|Overall Study|Lost to Follow-up|0|||
25034112|NCT02868554|50133499|FG002|Overall Study|Lost to Follow-up|1|||
25034113|NCT01068912|50133510|FG000|Overall Study|Adverse Event|2|||
25034114|NCT01068912|50133511|FG001|Overall Study|Adverse Event|3|||
25034115|NCT01068912|50133512|FG002|Overall Study|Adverse Event|2|||
25034116|NCT01068912|50133510|FG000|Overall Study|Withdrawal by Subject|5|||
25034117|NCT01068912|50133511|FG001|Overall Study|Withdrawal by Subject|6|||
25034118|NCT01068912|50133512|FG002|Overall Study|Withdrawal by Subject|6|||
25034119|NCT01068912|50133510|FG000|Overall Study|Lost to Follow-up|3|||
25034120|NCT01068912|50133511|FG001|Overall Study|Lost to Follow-up|7|||
25034121|NCT01068912|50133512|FG002|Overall Study|Lost to Follow-up|3|||
25034122|NCT01068912|50133510|FG000|Overall Study|Protocol Violation|0|||
24946172|NCT00321711|50038558|FG001|Part B|Adverse Event|0|||
24946173|NCT00321711|50038559|FG002|Part B|Adverse Event|0|||
24946174|NCT00321711|50038560|FG003|Part B|Adverse Event|2|||
24946175|NCT00321711|50038561|FG004|Part B|Adverse Event|1|||
24946176|NCT00321711|50038557|FG000|Part B|Disease progression|0|||
24946177|NCT00321711|50038558|FG001|Part B|Disease progression|0|||
24946178|NCT00321711|50038559|FG002|Part B|Disease progression|0|||
24946179|NCT00321711|50038560|FG003|Part B|Disease progression|1|||
25034123|NCT01068912|50133511|FG001|Overall Study|Protocol Violation|2|||
25034124|NCT01068912|50133512|FG002|Overall Study|Protocol Violation|0|||
25034125|NCT01068912|50133510|FG000|Overall Study|aggravation influenza|1|||
25034126|NCT01068912|50133511|FG001|Overall Study|aggravation influenza|1|||
25034127|NCT01068912|50133512|FG002|Overall Study|aggravation influenza|1|||
24946180|NCT00321711|50038561|FG004|Part B|Disease progression|0|||
24946181|NCT00321711|50038557|FG000|Part B|Physician Decision|0|||
25034128|NCT01068912|50133510|FG000|Overall Study|other underlying illness|0|||
25034129|NCT01068912|50133511|FG001|Overall Study|other underlying illness|3|||
25034130|NCT01068912|50133512|FG002|Overall Study|other underlying illness|3|||
24946182|NCT00321711|50038558|FG001|Part B|Physician Decision|0|||
24946183|NCT00321711|50038559|FG002|Part B|Physician Decision|0|||
24946184|NCT00321711|50038560|FG003|Part B|Physician Decision|1|||
24946185|NCT00321711|50038561|FG004|Part B|Physician Decision|2|||
24946186|NCT00321711|50038557|FG000|Part B|Death|0|||
24946187|NCT00321711|50038558|FG001|Part B|Death|0|||
24946188|NCT00321711|50038559|FG002|Part B|Death|0|||
24946189|NCT00321711|50038560|FG003|Part B|Death|2|||
24946190|NCT00321711|50038561|FG004|Part B|Death|1|||
24946191|NCT00486044|50038575|FG000|Overall Study|Withdrawal by Subject|2|||
24946192|NCT00486044|50038576|FG001|Overall Study|Withdrawal by Subject|1|||
24946193|NCT00486044|50038575|FG000|Overall Study|Adverse Event|0|||
24946194|NCT00486044|50038576|FG001|Overall Study|Adverse Event|1|||
24946195|NCT00486044|50038575|FG000|Overall Study|Lost to Follow-up|0|||
24946196|NCT00486044|50038576|FG001|Overall Study|Lost to Follow-up|1|||
24946197|NCT00351273|50038585|FG000|Overall Study|Lost to Follow-up|1|||
24946198|NCT00351273|50038586|FG001|Overall Study|Lost to Follow-up|2|||
24946199|NCT00351273|50038587|FG002|Overall Study|Lost to Follow-up|5|||
24946200|NCT00327717|50038602|FG000|Overall Study|Adverse Event|6|||
24946201|NCT00327717|50038603|FG001|Overall Study|Adverse Event|6|||
24946202|NCT00327717|50038602|FG000|Overall Study|Lack of Efficacy|0|||
24946203|NCT00327717|50038603|FG001|Overall Study|Lack of Efficacy|1|||
24946204|NCT00327717|50038602|FG000|Overall Study|Withdrawal by Subject|3|||
24946205|NCT00327717|50038603|FG001|Overall Study|Withdrawal by Subject|7|||
24946206|NCT00463346|50038611|FG000|Overall Study|Withdrawal by Subject|3|||
24946207|NCT00463346|50038612|FG001|Overall Study|Withdrawal by Subject|3|||
24946208|NCT00462488|50038622|FG000|Overall Study|Protocol Violation|1|||
24946209|NCT00462488|50038623|FG001|Overall Study|Protocol Violation|0|||
24946210|NCT00462488|50038622|FG000|Overall Study|Lack of Efficacy|19|||
24946211|NCT00462488|50038623|FG001|Overall Study|Lack of Efficacy|17|||
24946212|NCT00454142|50038629|FG000|Overall Study|Withdrawal by Subject|1|||
24946213|NCT00424476|50038638|FG000|Overall Study|Withdrawal by Subject|7|||
24946214|NCT00424476|50038639|FG001|Overall Study|Withdrawal by Subject|6|||
24946215|NCT00424476|50038640|FG002|Overall Study|Withdrawal by Subject|3|||
24946216|NCT00424476|50038638|FG000|Overall Study|Adverse Event|19|||
24946217|NCT00424476|50038639|FG001|Overall Study|Adverse Event|16|||
25034131|NCT03229109|50133524|FG000|Overall Study|Withdrawal by Subject|0|||
25034132|NCT03229109|50133525|FG001|Overall Study|Withdrawal by Subject|0|||
25034133|NCT03229109|50133526|FG002|Overall Study|Withdrawal by Subject|0|||
25034134|NCT03229109|50133527|FG003|Overall Study|Withdrawal by Subject|1|||
25034135|NCT03212261|50133537|FG000|Overall Study|Became ineligible d/t tech|2|||
25034136|NCT03212261|50133537|FG000|Overall Study|Tech Trouble- No first study visit|1|||
25034137|NCT03212261|50133537|FG000|Overall Study|Lost to Follow-up|7|||
25034138|NCT03212261|50133537|FG000|Overall Study|Family Emergency|1|||
25034139|NCT03212261|50133537|FG000|Overall Study|Too busy/ No time|5|||
25034140|NCT02993250|50133544|FG000|Overall Study|Lost to Follow-up|0|||
25034141|NCT02993250|50133545|FG001|Overall Study|Lost to Follow-up|1|||
25034142|NCT02989194|50133554|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
25034143|NCT02989194|50133555|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
25034144|NCT02989194|50133556|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
25034145|NCT02989194|50133554|FG000|Overall Study|Lost to Follow-up|0|||
25034146|NCT02989194|50133555|FG001|Overall Study|Lost to Follow-up|1|||
24946218|NCT00424476|50038640|FG002|Overall Study|Adverse Event|15|||
24946219|NCT00424476|50038638|FG000|Overall Study|Lack of Efficacy|16|||
24946220|NCT00424476|50038639|FG001|Overall Study|Lack of Efficacy|12|||
24946221|NCT00424476|50038640|FG002|Overall Study|Lack of Efficacy|12|||
24946222|NCT00424476|50038638|FG000|Overall Study|Lack of Compliance|1|||
24946223|NCT00424476|50038639|FG001|Overall Study|Lack of Compliance|1|||
24946224|NCT00424476|50038640|FG002|Overall Study|Lack of Compliance|1|||
24946225|NCT00424476|50038638|FG000|Overall Study|Lost to Follow-up|4|||
24946226|NCT00424476|50038639|FG001|Overall Study|Lost to Follow-up|6|||
24946227|NCT00424476|50038640|FG002|Overall Study|Lost to Follow-up|3|||
25034147|NCT02989194|50133556|FG002|Overall Study|Lost to Follow-up|0|||
25034148|NCT02989194|50133554|FG000|Overall Study|Withdrawal by Subject|0|||
25034149|NCT02989194|50133555|FG001|Overall Study|Withdrawal by Subject|1|||
25034150|NCT02989194|50133556|FG002|Overall Study|Withdrawal by Subject|0|||
25034151|NCT02990910|50133577|FG000|Overall Study|Lack of Efficacy|6|||
25034152|NCT02990910|50133578|FG001|Overall Study|Lack of Efficacy|10|||
25034153|NCT03227861|50133584|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
25034154|NCT03227861|50133584|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
25034155|NCT03227861|50133584|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
25034156|NCT03227861|50133584|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
25034157|NCT03227861|50133584|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
25034158|NCT03227861|50133584|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
25034159|NCT03227861|50133584|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
25034160|NCT03227861|50133584|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
25034161|NCT03227861|50133584|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
25034162|NCT03227861|50133584|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
25034163|NCT01336712|50133590|FG000|Overall Study|Death|2|||
25034164|NCT01336712|50133590|FG000|Overall Study|Lack of Efficacy|1|||
25034165|NCT03208127|50133594|FG000|Overall Study|Death|1|||
25034166|NCT02865122|50133601|FG000|Overall Study|Adverse Event|1|||
25034167|NCT02865122|50133602|FG001|Overall Study|Adverse Event|0|||
24946228|NCT00424476|50038638|FG000|Overall Study|Protocol Violation|7|||
24946229|NCT00424476|50038639|FG001|Overall Study|Protocol Violation|2|||
24946230|NCT00424476|50038640|FG002|Overall Study|Protocol Violation|3|||
24946231|NCT00424476|50038638|FG000|Overall Study|Physician Decision|3|||
24946232|NCT00424476|50038639|FG001|Overall Study|Physician Decision|2|||
24946233|NCT00424476|50038640|FG002|Overall Study|Physician Decision|3|||
25034168|NCT02865122|50133603|FG002|Overall Study|Adverse Event|0|||
25034169|NCT02864498|50133614|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
25034170|NCT02864498|50133615|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
25034171|NCT02864498|50133616|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
25034172|NCT02864498|50133614|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
25034173|NCT02864498|50133615|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
25034174|NCT02864498|50133616|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
25034175|NCT02864498|50133614|FG000|Overall Study|Investigator Discretion|0|||
25034176|NCT02864498|50133615|FG001|Overall Study|Investigator Discretion|2|||
25034177|NCT02864498|50133616|FG002|Overall Study|Investigator Discretion|1|||
25034178|NCT02864498|50133614|FG000|Overall Study|Lost to Follow-up|8|||
25034179|NCT02864498|50133615|FG001|Overall Study|Lost to Follow-up|6|||
25034180|NCT02864498|50133616|FG002|Overall Study|Lost to Follow-up|3|||
25034181|NCT02864498|50133614|FG000|Overall Study|Lack of Efficacy|5|||
25034182|NCT02864498|50133615|FG001|Overall Study|Lack of Efficacy|3|||
25034183|NCT02864498|50133616|FG002|Overall Study|Lack of Efficacy|3|||
25034184|NCT02864498|50133614|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
25034185|NCT02864498|50133615|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
25034186|NCT02864498|50133616|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
25034187|NCT02864498|50133614|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
25034188|NCT02864498|50133615|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
25034189|NCT02864498|50133616|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
24946234|NCT00424476|50038638|FG000|Overall Study|Other|4|||
24946235|NCT00424476|50038639|FG001|Overall Study|Other|3|||
24946236|NCT00424476|50038640|FG002|Overall Study|Other|9|||
24946237|NCT00453986|50038653|FG000|Overall Study|Lost to Follow-up|6|||
24946238|NCT00453986|50038654|FG001|Overall Study|Lost to Follow-up|5|||
24946239|NCT00453986|50038655|FG002|Overall Study|Lost to Follow-up|6|||
24946240|NCT00453986|50038656|FG003|Overall Study|Lost to Follow-up|2|||
24946241|NCT00453986|50038657|FG004|Overall Study|Lost to Follow-up|0|||
24946242|NCT00435942|50038675|FG000|Overall Study|Death|17|||
24946243|NCT00435942|50038676|FG001|Overall Study|Death|10|||
24946244|NCT00435942|50038675|FG000|Overall Study|Withdrawal by Subject|2|||
25034190|NCT02864498|50133614|FG000|Overall Study|Subject moved out of the country.|0|||
24946245|NCT00435942|50038676|FG001|Overall Study|Withdrawal by Subject|0|||
24946246|NCT00435942|50038675|FG000|Overall Study|Lost to Follow-up|0|||
24946247|NCT00435942|50038676|FG001|Overall Study|Lost to Follow-up|16|||
24946248|NCT00435942|50038675|FG000|Overall Study|Conversion to Open Repair|1|||
25034191|NCT02864498|50133615|FG001|Overall Study|Subject moved out of the country.|0|||
25034192|NCT02864498|50133616|FG002|Overall Study|Subject moved out of the country.|1|||
25034193|NCT03238781|50133627|FG000|Overall Study|Adverse Event|1|||
25034194|NCT03238781|50133628|FG001|Overall Study|Adverse Event|1|||
25034195|NCT03238781|50133629|FG002|Overall Study|Adverse Event|2|||
25034196|NCT03238781|50133627|FG000|Overall Study|Lost to Follow-up|2|||
25034197|NCT03238781|50133628|FG001|Overall Study|Lost to Follow-up|1|||
25034198|NCT03238781|50133629|FG002|Overall Study|Lost to Follow-up|2|||
25034199|NCT03238781|50133627|FG000|Overall Study|Withdrawal by Subject|23|||
25034200|NCT03238781|50133628|FG001|Overall Study|Withdrawal by Subject|14|||
25034201|NCT03238781|50133629|FG002|Overall Study|Withdrawal by Subject|16|||
25034202|NCT03238781|50133627|FG000|Overall Study|Decision by sponsor|0|||
25034203|NCT03238781|50133628|FG001|Overall Study|Decision by sponsor|1|||
25034204|NCT03238781|50133629|FG002|Overall Study|Decision by sponsor|0|||
25034205|NCT02097121|50133640|FG000|Overall Study|Other, not specified|4|||
25034206|NCT02097121|50133641|FG001|Overall Study|Other, not specified|2|||
25034207|NCT02097121|50133642|FG002|Overall Study|Other, not specified|3|||
25034208|NCT02097121|50133640|FG000|Overall Study|Lack of Efficacy|2|||
25034209|NCT02097121|50133641|FG001|Overall Study|Lack of Efficacy|1|||
25034210|NCT02097121|50133642|FG002|Overall Study|Lack of Efficacy|3|||
25034211|NCT02097121|50133640|FG000|Overall Study|Withdrawal by Subject|0|||
25034212|NCT02097121|50133641|FG001|Overall Study|Withdrawal by Subject|1|||
25034213|NCT02097121|50133642|FG002|Overall Study|Withdrawal by Subject|2|||
25034214|NCT02097121|50133640|FG000|Overall Study|Adverse Event|0|||
25034215|NCT02097121|50133641|FG001|Overall Study|Adverse Event|1|||
25034216|NCT02097121|50133642|FG002|Overall Study|Adverse Event|0|||
25034217|NCT02097121|50133640|FG000|Overall Study|Lost to Follow-up|1|||
25034218|NCT02097121|50133641|FG001|Overall Study|Lost to Follow-up|1|||
25034219|NCT02097121|50133642|FG002|Overall Study|Lost to Follow-up|2|||
25034220|NCT02747420|50133671|FG000|Overall Study|Lost to Follow-up|4|||
25034221|NCT02747420|50133672|FG001|Overall Study|Lost to Follow-up|2|||
25034222|NCT02747420|50133671|FG000|Overall Study|Withdrawal by Subject|3|||
25034223|NCT02747420|50133672|FG001|Overall Study|Withdrawal by Subject|2|||
25034224|NCT03238001|50133678|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
25034225|NCT03238001|50133678|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
25034226|NCT03238001|50133678|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
25034227|NCT03238001|50133678|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
25034228|NCT03238001|50133678|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
25034229|NCT03238001|50133678|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
25034230|NCT03238001|50133678|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
25034231|NCT03238001|50133678|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
25034232|NCT02747108|50133692|FG000|Overall Study|Death|2|||
25034233|NCT02747108|50133693|FG001|Overall Study|Death|2|||
25034234|NCT02747108|50133692|FG000|Overall Study|Withdrawal by Subject|1|||
25034235|NCT02747108|50133693|FG001|Overall Study|Withdrawal by Subject|0|||
25034236|NCT02747108|50133692|FG000|Overall Study|Protocol Violation|2|||
25034237|NCT02747108|50133693|FG001|Overall Study|Protocol Violation|0|||
25034238|NCT03226769|50133721|FG000|Overall Study|Withdrawal by Subject|0|||
25034239|NCT03226769|50133722|FG001|Overall Study|Withdrawal by Subject|1|||
25034240|NCT02864342|50133730|FG000|Overall Study|Eligibility Criteria Deviation|2|||
25034241|NCT02864342|50133731|FG001|Overall Study|Eligibility Criteria Deviation|3|||
25034242|NCT02864342|50133730|FG000|Overall Study|Withdrawal by Subject|4|||
25034243|NCT02864342|50133731|FG001|Overall Study|Withdrawal by Subject|2|||
25034244|NCT02864342|50133730|FG000|Overall Study|Device Technology Issue|6|||
25034245|NCT02864342|50133731|FG001|Overall Study|Device Technology Issue|7|||
25034246|NCT02864342|50133730|FG000|Overall Study|Death|0|||
25034247|NCT02864342|50133731|FG001|Overall Study|Death|1|||
25034248|NCT02864342|50133730|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
25034249|NCT02864342|50133731|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
25034250|NCT02864342|50133730|FG000|Overall Study|Lost to Follow-up|1|||
25034251|NCT02864342|50133731|FG001|Overall Study|Lost to Follow-up|5|||
25034252|NCT02864342|50133730|FG000|Overall Study|Lost Device|1|||
25034253|NCT02864342|50133731|FG001|Overall Study|Lost Device|0|||
25034254|NCT02864342|50133730|FG000|Overall Study|Adverse Event|1|||
25034255|NCT02864342|50133731|FG001|Overall Study|Adverse Event|0|||
25034256|NCT03237065|50133740|FG000|Overall Study|Adverse Event|0|||
25034257|NCT03237065|50133741|FG001|Overall Study|Adverse Event|2|||
25186213|NCT01399697|50336172|FG000|Overall Study|Withdrawal by Subject|8|||
25034258|NCT03237065|50133740|FG000|Overall Study|Protocol Violation|0|||
25034259|NCT03237065|50133741|FG001|Overall Study|Protocol Violation|1|||
25034260|NCT03237065|50133740|FG000|Overall Study|Withdrawal by Subject|3|||
25034261|NCT03237065|50133741|FG001|Overall Study|Withdrawal by Subject|0|||
25034262|NCT03237065|50133740|FG000|Overall Study|Lost to Follow-up|1|||
25034263|NCT03237065|50133741|FG001|Overall Study|Lost to Follow-up|0|||
25275663|NCT00903175|50589504|FG001|Period 1 - First Line|Death|10|||
25034264|NCT03237065|50133740|FG000|Overall Study|Unable to obtain venous access|0|||
25034265|NCT03237065|50133741|FG001|Overall Study|Unable to obtain venous access|1|||
25034266|NCT03171415|50133752|FG000|Overall Study|Lost to Follow-up|0|||
24946249|NCT00435942|50038676|FG001|Overall Study|Conversion to Open Repair|0|||
24946250|NCT00435942|50038675|FG000|Overall Study|Technical Failure|3|||
24946251|NCT00435942|50038676|FG001|Overall Study|Technical Failure|0|||
24946252|NCT00435942|50038675|FG000|Overall Study|Other|0|||
24946253|NCT00435942|50038676|FG001|Overall Study|Other|1|||
24946254|NCT00453362|50038682|FG000|Overall Study|Adverse Event|5|||
24946255|NCT00453362|50038682|FG000|Overall Study|Death|7|||
24946256|NCT00453362|50038682|FG000|Overall Study|Physician Decision|2|||
24946257|NCT00453362|50038682|FG000|Overall Study|Withdrawal by Subject|3|||
24946258|NCT00453362|50038682|FG000|Overall Study|Progression of disease|56|||
24946259|NCT00453362|50038682|FG000|Overall Study|Screening Failure|14|||
24946260|NCT00424398|50038701|FG000|Overall Study|Withdrawal by Subject|2|||
24946261|NCT00424398|50038702|FG001|Overall Study|Withdrawal by Subject|1|||
24946262|NCT00424398|50038703|FG002|Overall Study|Withdrawal by Subject|0|||
24946263|NCT00424398|50038701|FG000|Overall Study|Subject met exclusion criteria|1|||
24946264|NCT00424398|50038702|FG001|Overall Study|Subject met exclusion criteria|0|||
24946265|NCT00424398|50038703|FG002|Overall Study|Subject met exclusion criteria|0|||
24946266|NCT00461786|50038711|FG000|Overall Study|Entry Criteria Not Met|2|||
24946267|NCT00461786|50038711|FG000|Overall Study|Inevaluable (Never Treated)|1|||
25034267|NCT03171415|50133753|FG001|Overall Study|Lost to Follow-up|0|||
25034268|NCT03171415|50133754|FG002|Overall Study|Lost to Follow-up|0|||
25034269|NCT03171415|50133755|FG003|Overall Study|Lost to Follow-up|0|||
25034270|NCT03171415|50133756|FG004|Overall Study|Lost to Follow-up|2|||
25034271|NCT03829241|50133781|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
25034272|NCT03829241|50133782|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
25034273|NCT03829241|50133781|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
25034274|NCT03829241|50133782|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
25034275|NCT03829241|50133781|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
25034276|NCT03829241|50133782|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
25034277|NCT03829241|50133781|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
25034278|NCT03829241|50133782|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
25034279|NCT03829241|50133781|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
25034280|NCT03829241|50133782|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
25034281|NCT03829241|50133781|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
25034282|NCT03829241|50133782|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
25034283|NCT03829241|50133781|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
25034284|NCT03829241|50133782|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
25034285|NCT03829241|50133781|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
25034286|NCT03829241|50133782|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
25034287|NCT03829241|50133781|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
25034288|NCT03829241|50133782|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
25034289|NCT03829241|50133781|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
25034290|NCT03829241|50133782|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
25034291|NCT03829241|50133781|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
25034292|NCT03829241|50133782|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
25034293|NCT03829241|50133781|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
25034294|NCT03829241|50133782|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
25034295|NCT03829241|50133781|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
25034296|NCT03829241|50133782|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
25034297|NCT03829241|50133781|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
25034298|NCT03829241|50133782|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
25034299|NCT03164551|50133794|FG000|Overall Study|Imaging discontinued prior completion|8|||
25034300|NCT03164551|50133795|FG001|Overall Study|Imaging discontinued prior completion|0|||
25034301|NCT03164551|50133794|FG000|Overall Study|Participant was non-compliant|1|||
25034302|NCT03164551|50133795|FG001|Overall Study|Participant was non-compliant|0|||
25034303|NCT03164551|50133794|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
25034304|NCT03164551|50133795|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
25275664|NCT00903175|50589503|FG000|Period 2 - Second Line|Missing|1|||
25275665|NCT00903175|50589504|FG001|Period 2 - Second Line|Missing|0|||
24946268|NCT00435162|50038718|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
24946269|NCT00435162|50038719|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
24946270|NCT00435162|50038720|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
24946271|NCT00435162|50038721|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
24946272|NCT00435162|50038722|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
24946273|NCT00435162|50038723|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
24946274|NCT03836664|50038738|FG000|Overall Study|Didn't complete forms and lost drug|3|||
24946275|NCT03836664|50038739|FG001|Overall Study|Didn't complete forms and lost drug|3|||
24946276|NCT00350727|50038752|FG000|Phase I: Dose Escalation|Adverse Event|4|||
24946277|NCT00350727|50038753|FG001|Phase I: Dose Escalation|Adverse Event|0|||
24946278|NCT00350727|50038754|FG002|Phase I: Dose Escalation|Adverse Event|0|||
24946279|NCT00350727|50038752|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
24946280|NCT00350727|50038753|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
24946281|NCT00350727|50038754|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
24946282|NCT00350727|50038752|FG000|Phase I: Dose Escalation|Death|1|||
24946283|NCT00350727|50038753|FG001|Phase I: Dose Escalation|Death|0|||
24946284|NCT00350727|50038754|FG002|Phase I: Dose Escalation|Death|0|||
24946285|NCT00350727|50038752|FG000|Phase I: Dose Escalation|Physician Decision|1|||
24946286|NCT00350727|50038753|FG001|Phase I: Dose Escalation|Physician Decision|0|||
24946287|NCT00350727|50038754|FG002|Phase I: Dose Escalation|Physician Decision|0|||
24946288|NCT00350727|50038752|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
24946289|NCT00350727|50038753|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
24946290|NCT00350727|50038754|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
24946291|NCT00350727|50038752|FG000|Phase II|Disease Progression|0|||
24946292|NCT00350727|50038753|FG001|Phase II|Disease Progression|15|||
25159611|NCT01393743|50279488|FG002|Core Study|Adverse Event|0|||
25159612|NCT01393743|50279486|FG000|Core Study|Lost to Follow-up|1|||
25159613|NCT01393743|50279487|FG001|Core Study|Lost to Follow-up|1|||
25159614|NCT01393743|50279488|FG002|Core Study|Lost to Follow-up|0|||
25159615|NCT01393743|50279486|FG000|Core Study|Participant's Choice|2|||
25275666|NCT00903175|50589503|FG000|Period 2 - Second Line|Adverse Event|16|||
25275667|NCT00903175|50589504|FG001|Period 2 - Second Line|Adverse Event|20|||
24946293|NCT00350727|50038754|FG002|Phase II|Disease Progression|16|||
24946294|NCT00350727|50038752|FG000|Phase II|Clinical Deterioration|0|||
24946295|NCT00350727|50038753|FG001|Phase II|Clinical Deterioration|1|||
24946296|NCT00350727|50038754|FG002|Phase II|Clinical Deterioration|0|||
24946297|NCT00350727|50038752|FG000|Phase II|Withdrawal by Subject|0|||
24946298|NCT00350727|50038753|FG001|Phase II|Withdrawal by Subject|2|||
24946299|NCT00350727|50038754|FG002|Phase II|Withdrawal by Subject|1|||
24946300|NCT00350727|50038752|FG000|Phase II|Adverse Event|0|||
25159616|NCT01393743|50279487|FG001|Core Study|Participant's Choice|3|||
25159617|NCT01393743|50279488|FG002|Core Study|Participant's Choice|0|||
24946301|NCT00350727|50038753|FG001|Phase II|Adverse Event|1|||
24946302|NCT00350727|50038754|FG002|Phase II|Adverse Event|1|||
24946303|NCT00350727|50038752|FG000|Phase II|Death|0|||
24946304|NCT00350727|50038753|FG001|Phase II|Death|0|||
24946305|NCT00350727|50038754|FG002|Phase II|Death|2|||
24946306|NCT00350727|50038752|FG000|Phase II|Sponsor Terminated Study|0|||
24946307|NCT00350727|50038753|FG001|Phase II|Sponsor Terminated Study|0|||
24946308|NCT00350727|50038754|FG002|Phase II|Sponsor Terminated Study|1|||
24946309|NCT00350727|50038752|FG000|Phase II|Enrolled in Rollover Study|0|||
25159618|NCT01393743|50279486|FG000|Core Study|Inadequate therapeutic effect|2|||
25159619|NCT01393743|50279487|FG001|Core Study|Inadequate therapeutic effect|0|||
24946310|NCT00350727|50038753|FG001|Phase II|Enrolled in Rollover Study|0|||
24946311|NCT00350727|50038754|FG002|Phase II|Enrolled in Rollover Study|1|||
24946312|NCT00434304|50038773|FG000|Overall Study|Adverse Event|14|||
24946313|NCT00434304|50038773|FG000|Overall Study|Lack of Efficacy|2|||
24946314|NCT00434304|50038773|FG000|Overall Study|Withdrawal by Subject|4|||
24946315|NCT00424008|50038780|FG000|Overall Study|Adverse Event|8|||
24946316|NCT00424008|50038781|FG001|Overall Study|Adverse Event|6|||
24946317|NCT00424008|50038780|FG000|Overall Study|Lack of Efficacy|40|||
24946318|NCT00424008|50038781|FG001|Overall Study|Lack of Efficacy|34|||
24946319|NCT00424008|50038780|FG000|Overall Study|Lost to Follow-up|1|||
24946320|NCT00424008|50038781|FG001|Overall Study|Lost to Follow-up|2|||
24946321|NCT00424008|50038780|FG000|Overall Study|Withdrawal by Subject|5|||
24946322|NCT00424008|50038781|FG001|Overall Study|Withdrawal by Subject|8|||
24946323|NCT00424008|50038780|FG000|Overall Study|Noncompliance with protocol|13|||
24946324|NCT00424008|50038781|FG001|Overall Study|Noncompliance with protocol|7|||
24946325|NCT00424008|50038780|FG000|Overall Study|Did not meet protocol eligibility|16|||
24946326|NCT00424008|50038781|FG001|Overall Study|Did not meet protocol eligibility|21|||
24946327|NCT00424008|50038780|FG000|Overall Study|Administrative|266|||
24946328|NCT00424008|50038781|FG001|Overall Study|Administrative|257|||
24946329|NCT00423930|50038788|FG000|Overall Study|Withdrawal by Subject|2|||
24946330|NCT00423852|50038792|FG000|Overall Study|Removed pior to the high-dose portion|3|||
24946331|NCT00461708|50038798|FG000|Overall Study|Adverse Event|17|||
24946332|NCT00461708|50038799|FG001|Overall Study|Adverse Event|7|||
24946333|NCT00461708|50038798|FG000|Overall Study|Lack of Efficacy|68|||
24946334|NCT00461708|50038799|FG001|Overall Study|Lack of Efficacy|20|||
24946335|NCT00461708|50038798|FG000|Overall Study|Physician Decision|10|||
24946336|NCT00461708|50038799|FG001|Overall Study|Physician Decision|4|||
25034305|NCT03164551|50133794|FG000|Overall Study|Other|8|||
25034306|NCT03164551|50133795|FG001|Overall Study|Other|2|||
25034307|NCT02863328|50133803|FG000|Overall Study|Lost to Follow-up|4|||
25034308|NCT02863328|50133804|FG001|Overall Study|Lost to Follow-up|10|||
25034309|NCT02863328|50133803|FG000|Overall Study|Withdrawal by Subject|7|||
25034310|NCT02863328|50133804|FG001|Overall Study|Withdrawal by Subject|12|||
25034311|NCT02863328|50133803|FG000|Overall Study|Died|0|||
25034312|NCT02863328|50133804|FG001|Overall Study|Died|1|||
25034313|NCT03040141|50133813|FG000|Overall Study|Death|1|||
25034314|NCT03040141|50133814|FG001|Overall Study|Death|2|||
25034315|NCT03040141|50133815|FG002|Overall Study|Death|3|||
25034316|NCT03040141|50133813|FG000|Overall Study|Withdrawal by Subject|3|||
25034317|NCT03040141|50133814|FG001|Overall Study|Withdrawal by Subject|1|||
25034318|NCT03040141|50133815|FG002|Overall Study|Withdrawal by Subject|1|||
25034319|NCT03040141|50133813|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
25034320|NCT03040141|50133814|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
25034321|NCT03040141|50133815|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
25034322|NCT03040141|50133813|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
25034323|NCT03040141|50133814|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
25034324|NCT03040141|50133815|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
25034325|NCT02937701|50133829|FG000|Day 1 to Week 22|Adverse Event|11|||
25034326|NCT02937701|50133830|FG001|Day 1 to Week 22|Adverse Event|14|||
25034327|NCT02937701|50133831|FG002|Day 1 to Week 22|Adverse Event|0|||
25034328|NCT02937701|50133832|FG003|Day 1 to Week 22|Adverse Event|0|||
25034329|NCT02937701|50133833|FG004|Day 1 to Week 22|Adverse Event|0|||
25034330|NCT02937701|50133829|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
25034331|NCT02937701|50133830|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
25034332|NCT02937701|50133831|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
25034333|NCT02937701|50133832|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
25034334|NCT02937701|50133833|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
25034335|NCT02937701|50133829|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
25034336|NCT02937701|50133830|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
25034337|NCT02937701|50133831|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
24946337|NCT00461708|50038798|FG000|Overall Study|Withdrawal by Subject|8|||
24946338|NCT00461708|50038799|FG001|Overall Study|Withdrawal by Subject|2|||
24946339|NCT00461708|50038798|FG000|Overall Study|Other|4|||
24946340|NCT00461708|50038799|FG001|Overall Study|Other|4|||
24946341|NCT00461708|50038798|FG000|Overall Study|Death|8|||
25034338|NCT02937701|50133832|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
25034339|NCT02937701|50133833|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
25034340|NCT02937701|50133829|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
25034341|NCT02937701|50133830|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
25034342|NCT02937701|50133831|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
25034343|NCT02937701|50133832|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
25034344|NCT02937701|50133833|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
24946342|NCT00461708|50038799|FG001|Overall Study|Death|1|||
25034345|NCT02937701|50133829|FG000|Day 1 to Week 22|Death|1|||
25034346|NCT02937701|50133830|FG001|Day 1 to Week 22|Death|1|||
25034347|NCT02937701|50133831|FG002|Day 1 to Week 22|Death|0|||
25034348|NCT02937701|50133832|FG003|Day 1 to Week 22|Death|0|||
25034349|NCT02937701|50133833|FG004|Day 1 to Week 22|Death|0|||
25159620|NCT01393743|50279488|FG002|Core Study|Inadequate therapeutic effect|0|||
25159621|NCT01393743|50279486|FG000|Extension Phase|Adverse Event|0|||
25159622|NCT01393743|50279487|FG001|Extension Phase|Adverse Event|0|||
25159623|NCT01393743|50279488|FG002|Extension Phase|Adverse Event|12|||
25159624|NCT01393743|50279486|FG000|Extension Phase|Lost to Follow-up|0|||
25159625|NCT01393743|50279487|FG001|Extension Phase|Lost to Follow-up|0|||
25159626|NCT01393743|50279488|FG002|Extension Phase|Lost to Follow-up|2|||
25159627|NCT01393743|50279486|FG000|Extension Phase|Participant choice|0|||
25159628|NCT01393743|50279487|FG001|Extension Phase|Participant choice|0|||
25159629|NCT01393743|50279488|FG002|Extension Phase|Participant choice|16|||
25159630|NCT01393743|50279486|FG000|Extension Phase|Inadequate therapeutic effect|0|||
25159631|NCT01393743|50279487|FG001|Extension Phase|Inadequate therapeutic effect|0|||
25159632|NCT01393743|50279488|FG002|Extension Phase|Inadequate therapeutic effect|7|||
25159633|NCT01393743|50279486|FG000|Extension Phase|Withdrawal by Subject|0|||
25159634|NCT01393743|50279487|FG001|Extension Phase|Withdrawal by Subject|0|||
25159635|NCT01393743|50279488|FG002|Extension Phase|Withdrawal by Subject|8|||
25159636|NCT01393743|50279486|FG000|Extension Phase|Pregnancy|0|||
25159637|NCT01393743|50279487|FG001|Extension Phase|Pregnancy|0|||
25159638|NCT01393743|50279488|FG002|Extension Phase|Pregnancy|1|||
25159639|NCT01393743|50279486|FG000|Extension Phase|Other|0|||
25159640|NCT01393743|50279487|FG001|Extension Phase|Other|0|||
25159641|NCT01393743|50279488|FG002|Extension Phase|Other|14|||
25159642|NCT01405911|50279507|FG000|Overall Study|Pre-treatment lab AE|0|||
25159643|NCT01405911|50279508|FG001|Overall Study|Pre-treatment lab AE|1|||
25159644|NCT01405911|50279509|FG002|Overall Study|Pre-treatment lab AE|0|||
25159645|NCT01405911|50279507|FG000|Overall Study|Lost to Follow-up|0|||
25159646|NCT01405911|50279508|FG001|Overall Study|Lost to Follow-up|1|||
25159647|NCT01405911|50279509|FG002|Overall Study|Lost to Follow-up|0|||
25159648|NCT01405911|50279507|FG000|Overall Study|Protocol Violation|1|||
25159649|NCT01405911|50279508|FG001|Overall Study|Protocol Violation|0|||
25159650|NCT01405911|50279509|FG002|Overall Study|Protocol Violation|0|||
25159651|NCT01405911|50279507|FG000|Overall Study|Withdrawal by Subject|3|||
25159652|NCT01405911|50279508|FG001|Overall Study|Withdrawal by Subject|1|||
25159653|NCT01405911|50279509|FG002|Overall Study|Withdrawal by Subject|1|||
25159654|NCT01425801|50279517|FG000|Period 1|Withdrawal by Subject|0|||
25159655|NCT01425801|50279518|FG001|Period 1|Withdrawal by Subject|0|||
25159656|NCT01425801|50279519|FG002|Period 1|Withdrawal by Subject|0|||
25159657|NCT01425801|50279520|FG003|Period 1|Withdrawal by Subject|0|||
25159658|NCT01425801|50279521|FG004|Period 1|Withdrawal by Subject|1|||
25159659|NCT01425801|50279522|FG005|Period 1|Withdrawal by Subject|0|||
25159660|NCT01425801|50279517|FG000|Period 2|Withdrawal by Subject|0|||
25159661|NCT01425801|50279518|FG001|Period 2|Withdrawal by Subject|0|||
25159662|NCT01425801|50279519|FG002|Period 2|Withdrawal by Subject|0|||
25159663|NCT01425801|50279520|FG003|Period 2|Withdrawal by Subject|0|||
25159664|NCT01425801|50279521|FG004|Period 2|Withdrawal by Subject|1|||
25159665|NCT01425801|50279522|FG005|Period 2|Withdrawal by Subject|0|||
25159666|NCT01425801|50279517|FG000|Period 3|Stability criteria not fullfilled|0|||
25159667|NCT01425801|50279518|FG001|Period 3|Stability criteria not fullfilled|0|||
25159668|NCT01425801|50279519|FG002|Period 3|Stability criteria not fullfilled|1|||
25159669|NCT01425801|50279520|FG003|Period 3|Stability criteria not fullfilled|0|||
25159670|NCT01425801|50279521|FG004|Period 3|Stability criteria not fullfilled|0|||
25159671|NCT01425801|50279522|FG005|Period 3|Stability criteria not fullfilled|0|||
25159672|NCT01425801|50279517|FG000|Period 4|Not able to maintain visit schedule|0|||
25159673|NCT01425801|50279518|FG001|Period 4|Not able to maintain visit schedule|0|||
25159674|NCT01425801|50279519|FG002|Period 4|Not able to maintain visit schedule|1|||
25159675|NCT01425801|50279520|FG003|Period 4|Not able to maintain visit schedule|0|||
25159676|NCT01425801|50279521|FG004|Period 4|Not able to maintain visit schedule|0|||
25186214|NCT01399697|50336173|FG001|Overall Study|Withdrawal by Subject|0|||
25186215|NCT01399697|50336174|FG002|Overall Study|Withdrawal by Subject|0|||
25159677|NCT01425801|50279522|FG005|Period 4|Not able to maintain visit schedule|0|||
25159678|NCT01425723|50279547|FG000|Overall Study|Lack of Efficacy|0|||
25159679|NCT01425723|50279548|FG001|Overall Study|Lack of Efficacy|1|||
25159680|NCT01425723|50279547|FG000|Overall Study|Withdrawal by Subject|1|||
25159681|NCT01425723|50279548|FG001|Overall Study|Withdrawal by Subject|4|||
25159682|NCT01425723|50279547|FG000|Overall Study|Lost to Follow-up|0|||
25186216|NCT01399697|50336172|FG000|Overall Study|Investigator Decisión|1|||
25186217|NCT01399697|50336173|FG001|Overall Study|Investigator Decisión|0|||
25159683|NCT01425723|50279548|FG001|Overall Study|Lost to Follow-up|3|||
25159684|NCT01425723|50279547|FG000|Overall Study|Physician Decision|2|||
25159685|NCT01425723|50279548|FG001|Overall Study|Physician Decision|0|||
25159686|NCT01425723|50279547|FG000|Overall Study|Other|1|||
25159687|NCT01425723|50279548|FG001|Overall Study|Other|10|||
25159688|NCT01424397|50279579|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
25159689|NCT01424397|50279580|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
25159690|NCT01424397|50279581|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
24946343|NCT00327171|50038810|FG000|Overall Study|Did not receive study medication|3|||
24946344|NCT00327171|50038811|FG001|Overall Study|Did not receive study medication|0|||
24946345|NCT00327171|50038810|FG000|Overall Study|Adverse Event|23|||
24946346|NCT00327171|50038811|FG001|Overall Study|Adverse Event|23|||
24946347|NCT00327171|50038810|FG000|Overall Study|Disease progression/lack of efficacy|68|||
24946348|NCT00327171|50038811|FG001|Overall Study|Disease progression/lack of efficacy|69|||
24946349|NCT00327171|50038810|FG000|Overall Study|Investigator/participant request|1|||
24946350|NCT00327171|50038811|FG001|Overall Study|Investigator/participant request|8|||
25034350|NCT02937701|50133829|FG000|Day 1 to Week 22|Protocol Violation|1|||
25034351|NCT02937701|50133830|FG001|Day 1 to Week 22|Protocol Violation|1|||
25034352|NCT02937701|50133831|FG002|Day 1 to Week 22|Protocol Violation|0|||
24946351|NCT00327171|50038810|FG000|Overall Study|Clinical progression|12|||
24946352|NCT00327171|50038811|FG001|Overall Study|Clinical progression|8|||
24946353|NCT00327171|50038810|FG000|Overall Study|Undisclosed history of ischemia|0|||
24946354|NCT00327171|50038811|FG001|Overall Study|Undisclosed history of ischemia|1|||
24946355|NCT00327171|50038810|FG000|Overall Study|Other|1|||
24946356|NCT00327171|50038811|FG001|Overall Study|Other|0|||
24946357|NCT00461630|50038819|FG000|Overall Study|Death|798|||
24946358|NCT00461630|50038820|FG001|Overall Study|Death|732|||
24946359|NCT00461630|50038819|FG000|Overall Study|Lost to Follow-up|108|||
24946360|NCT00461630|50038820|FG001|Overall Study|Lost to Follow-up|95|||
24946361|NCT00461552|50038828|FG000|Overall Study|Drug Dispensing error|0|||
24946362|NCT00461552|50038829|FG001|Overall Study|Drug Dispensing error|2|||
24946363|NCT00453206|50038835|FG000|Overall Study|Death|1|||
24946364|NCT03850496|50038842|FG000|Overall Study|Withdrawal by Subject|1|||
24946365|NCT03850496|50038843|FG001|Overall Study|Withdrawal by Subject|0|||
24946366|NCT03850496|50038844|FG002|Overall Study|Withdrawal by Subject|0|||
24946367|NCT03850496|50038842|FG000|Overall Study|Lost to Follow-up|0|||
24946368|NCT03850496|50038843|FG001|Overall Study|Lost to Follow-up|1|||
24946369|NCT03850496|50038844|FG002|Overall Study|Lost to Follow-up|4|||
24946370|NCT00327015|50038856|FG000|Overall Study|Lack of Efficacy|18|||
24946371|NCT00327015|50038857|FG001|Overall Study|Lack of Efficacy|18|||
24946372|NCT00327015|50038858|FG002|Overall Study|Lack of Efficacy|35|||
24946373|NCT00327015|50038859|FG003|Overall Study|Lack of Efficacy|29|||
24946374|NCT00327015|50038856|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
24946375|NCT00327015|50038857|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
24946376|NCT00327015|50038858|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
24946377|NCT00327015|50038859|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
24946378|NCT00327015|50038856|FG000|Overall Study|Lost to Follow-up|22|||
24946379|NCT00327015|50038857|FG001|Overall Study|Lost to Follow-up|23|||
24946380|NCT00327015|50038858|FG002|Overall Study|Lost to Follow-up|29|||
24946381|NCT00327015|50038859|FG003|Overall Study|Lost to Follow-up|22|||
24946382|NCT00327015|50038856|FG000|Overall Study|Adverse Event|14|||
24946383|NCT00327015|50038857|FG001|Overall Study|Adverse Event|10|||
24946384|NCT00327015|50038858|FG002|Overall Study|Adverse Event|14|||
24946385|NCT00327015|50038859|FG003|Overall Study|Adverse Event|14|||
24946386|NCT00327015|50038856|FG000|Overall Study|Subject no longer meets study criteria|4|||
24946387|NCT00327015|50038857|FG001|Overall Study|Subject no longer meets study criteria|2|||
24946388|NCT00327015|50038858|FG002|Overall Study|Subject no longer meets study criteria|8|||
24946389|NCT00327015|50038859|FG003|Overall Study|Subject no longer meets study criteria|7|||
24946390|NCT00327015|50038856|FG000|Overall Study|Poor/Noncompliance|11|||
24946391|NCT00327015|50038857|FG001|Overall Study|Poor/Noncompliance|8|||
24946392|NCT00327015|50038858|FG002|Overall Study|Poor/Noncompliance|4|||
24946393|NCT00327015|50038859|FG003|Overall Study|Poor/Noncompliance|5|||
24946394|NCT00327015|50038856|FG000|Overall Study|Physician Decision|0|||
24946395|NCT00327015|50038857|FG001|Overall Study|Physician Decision|1|||
24946396|NCT00327015|50038858|FG002|Overall Study|Physician Decision|3|||
24946397|NCT00327015|50038859|FG003|Overall Study|Physician Decision|2|||
24946398|NCT00327015|50038856|FG000|Overall Study|Death|1|||
24946399|NCT00327015|50038857|FG001|Overall Study|Death|2|||
24946400|NCT00327015|50038858|FG002|Overall Study|Death|2|||
24946401|NCT00327015|50038859|FG003|Overall Study|Death|3|||
24946402|NCT00327015|50038856|FG000|Overall Study|Pregnancy|0|||
24946403|NCT00327015|50038857|FG001|Overall Study|Pregnancy|2|||
24946404|NCT00327015|50038858|FG002|Overall Study|Pregnancy|1|||
24946405|NCT00327015|50038859|FG003|Overall Study|Pregnancy|1|||
24946406|NCT00327015|50038856|FG000|Overall Study|Administrative Reason by Sponsor|1|||
24946407|NCT00327015|50038857|FG001|Overall Study|Administrative Reason by Sponsor|2|||
24946408|NCT00327015|50038858|FG002|Overall Study|Administrative Reason by Sponsor|2|||
24946409|NCT00327015|50038859|FG003|Overall Study|Administrative Reason by Sponsor|1|||
24946410|NCT00434148|50038871|FG000|Overall Study|Adverse Event|18|||
24946411|NCT00434148|50038872|FG001|Overall Study|Adverse Event|18|||
25034353|NCT02937701|50133832|FG003|Day 1 to Week 22|Protocol Violation|0|||
24946412|NCT00434148|50038871|FG000|Overall Study|Lack of Efficacy|25|||
24946413|NCT00434148|50038872|FG001|Overall Study|Lack of Efficacy|28|||
24946414|NCT00434148|50038871|FG000|Overall Study|Withdrawal by Subject|15|||
24946415|NCT00434148|50038872|FG001|Overall Study|Withdrawal by Subject|15|||
25034354|NCT02937701|50133833|FG004|Day 1 to Week 22|Protocol Violation|0|||
25034355|NCT02937701|50133829|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
25034356|NCT02937701|50133830|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
25034357|NCT02937701|50133831|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
25034358|NCT02937701|50133832|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
25034359|NCT02937701|50133833|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
25034360|NCT02937701|50133829|FG000|Day 1 to Week 22|Physician Decision|2|||
25034361|NCT02937701|50133830|FG001|Day 1 to Week 22|Physician Decision|0|||
25034362|NCT02937701|50133831|FG002|Day 1 to Week 22|Physician Decision|0|||
25034363|NCT02937701|50133832|FG003|Day 1 to Week 22|Physician Decision|0|||
25034364|NCT02937701|50133833|FG004|Day 1 to Week 22|Physician Decision|0|||
25034365|NCT02937701|50133829|FG000|Day 1 to Week 22|Other|1|||
25034366|NCT02937701|50133830|FG001|Day 1 to Week 22|Other|0|||
25034367|NCT02937701|50133831|FG002|Day 1 to Week 22|Other|0|||
25034368|NCT02937701|50133832|FG003|Day 1 to Week 22|Other|0|||
25034369|NCT02937701|50133833|FG004|Day 1 to Week 22|Other|0|||
25034370|NCT02937701|50133829|FG000|Week 22 to Week 50|Adverse Event|0|||
25034371|NCT02937701|50133830|FG001|Week 22 to Week 50|Adverse Event|0|||
25034372|NCT02937701|50133831|FG002|Week 22 to Week 50|Adverse Event|10|||
25034373|NCT02937701|50133832|FG003|Week 22 to Week 50|Adverse Event|3|||
25034374|NCT02937701|50133833|FG004|Week 22 to Week 50|Adverse Event|3|||
25034375|NCT02937701|50133829|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
25034376|NCT02937701|50133830|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
24946416|NCT00434148|50038871|FG000|Overall Study|Protocol Violation|4|||
24946417|NCT00434148|50038872|FG001|Overall Study|Protocol Violation|0|||
24946418|NCT00434148|50038871|FG000|Overall Study|Administrative problems|6|||
24946419|NCT00434148|50038872|FG001|Overall Study|Administrative problems|10|||
24946420|NCT00434148|50038871|FG000|Overall Study|Lost to Follow-up|0|||
24946421|NCT00434148|50038872|FG001|Overall Study|Lost to Follow-up|1|||
24946422|NCT00434148|50038871|FG000|Overall Study|Condition no longer requires study drug|1|||
24946423|NCT00434148|50038872|FG001|Overall Study|Condition no longer requires study drug|0|||
24946424|NCT00434148|50038871|FG000|Overall Study|Abnormal test procedure result|0|||
24946425|NCT00434148|50038872|FG001|Overall Study|Abnormal test procedure result|1|||
24946426|NCT00468728|50038880|FG000|Treatment|criteria for mITT population|4|||
24946427|NCT00468728|50038881|FG001|Treatment|criteria for mITT population|11|||
24946428|NCT00468728|50038880|FG000|Follow-up|mITT failure|34|||
24946429|NCT00468728|50038881|FG001|Follow-up|mITT failure|31|||
24946430|NCT00433914|50038891|FG000|Overall Study|Withdrawal by Subject|0|||
24946431|NCT00433914|50038892|FG001|Overall Study|Withdrawal by Subject|2|||
24946432|NCT00433914|50038891|FG000|Overall Study|Lost to Follow-up|0|||
24946433|NCT00433914|50038892|FG001|Overall Study|Lost to Follow-up|1|||
24946434|NCT00468650|50038898|FG000|Overall Study|Lost to Follow-up|4|||
24946435|NCT00468650|50038898|FG000|Overall Study|Withdrawal by Subject|2|||
24946436|NCT00468650|50038898|FG000|Overall Study|Protocol Violation|1|||
24946437|NCT00423150|50038903|FG000|Overall Study|Adverse Event|11|||
24946438|NCT00423150|50038903|FG000|Overall Study|Progression of disease being studied|69|||
24946439|NCT00423150|50038903|FG000|Overall Study|Withdrawal by Subject|1|||
24946440|NCT00423150|50038903|FG000|Overall Study|Non-compliance with protocol|1|||
24946441|NCT00423150|50038903|FG000|Overall Study|Administrative|4|||
24946442|NCT00433836|50038909|FG000|Overall Study|Adverse Event|7|||
24946443|NCT00433836|50038910|FG001|Overall Study|Adverse Event|0|||
24946444|NCT00433836|50038909|FG000|Overall Study|Lost to Follow-up|3|||
24946445|NCT00433836|50038910|FG001|Overall Study|Lost to Follow-up|0|||
25034377|NCT02937701|50133831|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
25034378|NCT02937701|50133832|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
25034379|NCT02937701|50133833|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
25034380|NCT02937701|50133829|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
25034381|NCT02937701|50133830|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
25034382|NCT02937701|50133831|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
25034383|NCT02937701|50133832|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
25034384|NCT02937701|50133833|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
25034385|NCT02937701|50133829|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
25034386|NCT02937701|50133830|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
25034387|NCT02937701|50133831|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
25034388|NCT02937701|50133832|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
25034389|NCT02937701|50133833|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
25034390|NCT02937701|50133829|FG000|Week 22 to Week 50|Physician Decision|0|||
25034391|NCT02937701|50133830|FG001|Week 22 to Week 50|Physician Decision|0|||
25034392|NCT02937701|50133831|FG002|Week 22 to Week 50|Physician Decision|2|||
25159691|NCT01424397|50279582|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
25159692|NCT01424397|50279583|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
24946446|NCT00433836|50038909|FG000|Overall Study|Withdrawal by Subject|2|||
24946447|NCT00433836|50038910|FG001|Overall Study|Withdrawal by Subject|1|||
24946448|NCT00433836|50038909|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
24946449|NCT00433836|50038910|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
24946450|NCT00433836|50038909|FG000|Overall Study|Protocol Violation|0|||
25034393|NCT02937701|50133832|FG003|Week 22 to Week 50|Physician Decision|0|||
25034394|NCT02937701|50133833|FG004|Week 22 to Week 50|Physician Decision|1|||
25034395|NCT02937701|50133829|FG000|Week 22 to Week 50|Other|0|||
25034396|NCT02937701|50133830|FG001|Week 22 to Week 50|Other|0|||
25034397|NCT02937701|50133831|FG002|Week 22 to Week 50|Other|0|||
25034398|NCT02937701|50133832|FG003|Week 22 to Week 50|Other|0|||
25034399|NCT02937701|50133833|FG004|Week 22 to Week 50|Other|1|||
25034400|NCT03169153|50133845|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
25034401|NCT03169153|50133846|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
25034402|NCT03169153|50133845|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
25034403|NCT03169153|50133846|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
25034404|NCT03169153|50133845|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
25034405|NCT03169153|50133846|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
25034406|NCT03169153|50133845|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
25034407|NCT03169153|50133846|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
25034408|NCT03168919|50133852|FG000|Overall Study|Withdrawal by Subject|2|||
25034409|NCT03205163|50133862|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
25034410|NCT03205163|50133863|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
24946451|NCT00433836|50038910|FG001|Overall Study|Protocol Violation|2|||
24946452|NCT00433836|50038909|FG000|Overall Study|Condition no longer requires study drug|0|||
24946453|NCT00433836|50038910|FG001|Overall Study|Condition no longer requires study drug|1|||
24946454|NCT00433836|50038909|FG000|Overall Study|Abnormal laboratory values|0|||
24946455|NCT00433836|50038910|FG001|Overall Study|Abnormal laboratory values|1|||
24946456|NCT00433446|50038916|FG000|Overall Study|Adverse Event|4|||
24946457|NCT00433446|50038916|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
24946458|NCT00433446|50038916|FG000|Overall Study|Progression|44|||
24946459|NCT00433446|50038916|FG000|Overall Study|Other - Not Protocol specified|3|||
24946460|NCT00433446|50038916|FG000|Overall Study|Ineligible|9|||
24946461|NCT00468104|50038920|FG000|First Intervention|Protocol Violation|2|||
24946462|NCT00468104|50038921|FG001|First Intervention|Protocol Violation|1|||
24946463|NCT00468104|50038920|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
24946464|NCT00468104|50038921|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
24946465|NCT00468104|50038920|FG000|First Intervention|died within 3 weeks|1|||
24946466|NCT00468104|50038921|FG001|First Intervention|died within 3 weeks|0|||
24946467|NCT00468104|50038920|FG000|First Intervention|malposition/blocked chest tube tube|2|||
24946468|NCT00468104|50038921|FG001|First Intervention|malposition/blocked chest tube tube|0|||
24946469|NCT00468104|50038920|FG000|First Intervention|large lung mass with minimal effusion|1|||
24946470|NCT00468104|50038921|FG001|First Intervention|large lung mass with minimal effusion|0|||
24946471|NCT00468104|50038920|FG000|First Intervention|associated prolonged pneumothorax|1|||
24946472|NCT00468104|50038921|FG001|First Intervention|associated prolonged pneumothorax|0|||
25159693|NCT01424397|50279584|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
25159694|NCT01424397|50279585|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
25159695|NCT01424397|50279586|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
24946473|NCT00468104|50038920|FG000|First Intervention|trapped lung|1|||
25034411|NCT01759537|50133878|FG000|Overall Study|Death|1|||
25034412|NCT01759537|50133879|FG001|Overall Study|Death|1|||
25034413|NCT01759537|50133878|FG000|Overall Study|Pregnancy|1|||
25034414|NCT01759537|50133879|FG001|Overall Study|Pregnancy|1|||
25034415|NCT01759537|50133878|FG000|Overall Study|Lost to Follow-up|9|||
25034416|NCT01759537|50133879|FG001|Overall Study|Lost to Follow-up|9|||
25034417|NCT01759537|50133878|FG000|Overall Study|Accident involving jaw fracture|1|||
25034418|NCT01759537|50133879|FG001|Overall Study|Accident involving jaw fracture|1|||
25034419|NCT01759537|50133878|FG000|Overall Study|Subcrestal implant too coronal|1|||
25034420|NCT01759537|50133879|FG001|Overall Study|Subcrestal implant too coronal|1|||
25034421|NCT03204539|50133887|FG000|Overall Study|Loss of funding|0|||
25034422|NCT03204539|50133888|FG001|Overall Study|Loss of funding|1|||
25034423|NCT03502681|50133905|FG000|Overall Study|Adverse Event|1|||
25034424|NCT03502681|50133906|FG001|Overall Study|Adverse Event|1|||
25034425|NCT03502681|50133905|FG000|Overall Study|Disease Progression|2|||
25034426|NCT03502681|50133906|FG001|Overall Study|Disease Progression|1|||
25034427|NCT02860130|50133913|FG000|Overall Study|Adverse Event|2|||
25034428|NCT02860130|50133914|FG001|Overall Study|Adverse Event|3|||
25034429|NCT02860130|50133913|FG000|Overall Study|Protocol Violation|1|||
25034430|NCT02860130|50133914|FG001|Overall Study|Protocol Violation|1|||
25034431|NCT02860130|50133913|FG000|Overall Study|Withdrawal by Subject|0|||
25034432|NCT02860130|50133914|FG001|Overall Study|Withdrawal by Subject|2|||
25034433|NCT02860130|50133913|FG000|Overall Study|Physician Decision|2|||
25034434|NCT02860130|50133914|FG001|Overall Study|Physician Decision|2|||
25034435|NCT02860130|50133913|FG000|Overall Study|Other|2|||
25034436|NCT02860130|50133914|FG001|Overall Study|Other|1|||
25034437|NCT00788671|50133920|FG000|Overall Study|Death|2|||
25034438|NCT00788671|50133920|FG000|Overall Study|Unable to biopsy|1|||
25034439|NCT00788671|50133920|FG000|Overall Study|Withdrawal by Subject|4|||
25034440|NCT00788671|50133920|FG000|Overall Study|IUD expulsed|1|||
25034441|NCT00788671|50133920|FG000|Overall Study|Lost to follow up|2|||
25034442|NCT02986854|50133927|FG000|Overall Study|Withdrawal by Subject|0|||
25034443|NCT02986854|50133928|FG001|Overall Study|Withdrawal by Subject|1|||
25034444|NCT02986854|50133929|FG002|Overall Study|Withdrawal by Subject|1|||
25034445|NCT02986854|50133927|FG000|Overall Study|Lost to Follow-up|3|||
25034446|NCT02986854|50133928|FG001|Overall Study|Lost to Follow-up|11|||
25034447|NCT02986854|50133929|FG002|Overall Study|Lost to Follow-up|2|||
25034448|NCT02887183|50133939|FG000|Overall Study|Adverse Event|44|||
25034449|NCT02887183|50133939|FG000|Overall Study|Death|30|||
25034450|NCT02887183|50133939|FG000|Overall Study|Pregnancy|1|||
25034451|NCT02887183|50133939|FG000|Overall Study|Protocol Violation|6|||
25034452|NCT02887183|50133939|FG000|Overall Study|Technical Problems|2|||
25034453|NCT02887183|50133939|FG000|Overall Study|Lost to Follow-up|13|||
25034454|NCT02887183|50133939|FG000|Overall Study|Physician Decision|10|||
25034455|NCT02887183|50133939|FG000|Overall Study|Withdrawal by Subject|35|||
25034456|NCT03167359|50133947|FG000|Overall Study|Physician Decision|1|||
25034457|NCT03167359|50133947|FG000|Overall Study|Lost to Follow-up|1|||
25034458|NCT01068600|50133953|FG000|Overall Study|Withdrawal by Subject|5|||
25034459|NCT01068600|50133954|FG001|Overall Study|Withdrawal by Subject|6|||
25034460|NCT01068600|50133953|FG000|Overall Study|Adverse Event|3|||
25034461|NCT01068600|50133954|FG001|Overall Study|Adverse Event|3|||
25034462|NCT01068600|50133953|FG000|Overall Study|Abnormal laboratory value(s)|1|||
25034463|NCT01068600|50133954|FG001|Overall Study|Abnormal laboratory value(s)|0|||
25034464|NCT01068600|50133953|FG000|Overall Study|Lost to Follow-up|1|||
25034465|NCT01068600|50133954|FG001|Overall Study|Lost to Follow-up|2|||
25034466|NCT01068600|50133953|FG000|Overall Study|Protocol deviation|1|||
25034467|NCT01068600|50133954|FG001|Overall Study|Protocol deviation|1|||
25034468|NCT01068600|50133953|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25034469|NCT01068600|50133954|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
25034470|NCT01068600|50133953|FG000|Overall Study|Administrative problems|0|||
25034471|NCT01068600|50133954|FG001|Overall Study|Administrative problems|1|||
25034472|NCT01067976|50133960|FG000|Overall Study|Study drug never administered|20|||
25034473|NCT01067976|50133960|FG000|Overall Study|Study prematurely discontinued|2|||
25034474|NCT02858492|50133982|FG000|Overall Study|Withdrawal by Subject|0|||
25034475|NCT02858492|50133983|FG001|Overall Study|Withdrawal by Subject|1|||
25034476|NCT02858492|50133984|FG002|Overall Study|Withdrawal by Subject|0|||
25034477|NCT02858492|50133985|FG003|Overall Study|Withdrawal by Subject|1|||
25034478|NCT02858492|50133982|FG000|Overall Study|Adverse Event|0|||
25034479|NCT02858492|50133983|FG001|Overall Study|Adverse Event|0|||
25034480|NCT02858492|50133984|FG002|Overall Study|Adverse Event|0|||
25034481|NCT02858492|50133985|FG003|Overall Study|Adverse Event|3|||
25034482|NCT02858492|50133982|FG000|Overall Study|Lack of Efficacy|0|||
25034483|NCT02858492|50133983|FG001|Overall Study|Lack of Efficacy|0|||
25034484|NCT02858492|50133984|FG002|Overall Study|Lack of Efficacy|0|||
25034485|NCT02858492|50133985|FG003|Overall Study|Lack of Efficacy|1|||
25034486|NCT02858492|50133982|FG000|Overall Study|Protocol defined stopping criteria|0|||
25034487|NCT02858492|50133983|FG001|Overall Study|Protocol defined stopping criteria|0|||
25034488|NCT02858492|50133984|FG002|Overall Study|Protocol defined stopping criteria|0|||
25034489|NCT02858492|50133985|FG003|Overall Study|Protocol defined stopping criteria|1|||
25034490|NCT01067508|50133999|FG000|Overall Study|Physician Decision|0|||
25034491|NCT01067508|50134000|FG001|Overall Study|Physician Decision|1|||
25034492|NCT01067508|50133999|FG000|Overall Study|Withdrawal by Subject|0|||
25034493|NCT01067508|50134000|FG001|Overall Study|Withdrawal by Subject|1|||
25034494|NCT01067352|50134009|FG000|Overall Study|Withdrawal by Subject|1|||
25034495|NCT01067352|50134010|FG001|Overall Study|Withdrawal by Subject|2|||
25034496|NCT01067352|50134011|FG002|Overall Study|Withdrawal by Subject|1|||
25034497|NCT01067352|50134009|FG000|Overall Study|Physician Decision|0|||
25034498|NCT01067352|50134010|FG001|Overall Study|Physician Decision|1|||
25034499|NCT01067352|50134011|FG002|Overall Study|Physician Decision|0|||
25034500|NCT02986074|50134019|FG000|First Trial Period|Adverse Event|1|||
25034501|NCT02986074|50134020|FG001|First Trial Period|Adverse Event|0|||
25159696|NCT01424397|50279587|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
25034502|NCT02986074|50134021|FG002|First Trial Period|Adverse Event|0|||
25034503|NCT02986074|50134022|FG003|First Trial Period|Adverse Event|0|||
25034504|NCT02986074|50134019|FG000|Follow up Period|system explant|0|||
25034505|NCT02986074|50134020|FG001|Follow up Period|system explant|0|||
25034506|NCT02986074|50134021|FG002|Follow up Period|system explant|1|||
25034507|NCT02986074|50134022|FG003|Follow up Period|system explant|2|||
25034508|NCT02986074|50134019|FG000|Follow up Period|Physician Decision|0|||
25034509|NCT02986074|50134020|FG001|Follow up Period|Physician Decision|0|||
25034510|NCT02986074|50134021|FG002|Follow up Period|Physician Decision|0|||
25034511|NCT02986074|50134022|FG003|Follow up Period|Physician Decision|1|||
25034512|NCT02920242|50134030|FG000|Overall Study|Withdrawal by Subject|1|||
25034513|NCT02920242|50134031|FG001|Overall Study|Withdrawal by Subject|0|||
25034514|NCT02920242|50134032|FG002|Overall Study|Withdrawal by Subject|1|||
25034515|NCT02920242|50134030|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
25034516|NCT02920242|50134031|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
25034517|NCT02920242|50134032|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
25034518|NCT02985996|50134045|FG000|Overall Study|Withdrawal by Subject|0|||
25034519|NCT02985996|50134046|FG001|Overall Study|Withdrawal by Subject|0|||
25034520|NCT02985996|50134047|FG002|Overall Study|Withdrawal by Subject|1|||
25034521|NCT02985996|50134048|FG003|Overall Study|Withdrawal by Subject|0|||
25034522|NCT02985996|50134049|FG004|Overall Study|Withdrawal by Subject|0|||
25034523|NCT02985996|50134045|FG000|Overall Study|Protocol Violation|0|||
25034524|NCT02985996|50134046|FG001|Overall Study|Protocol Violation|1|||
25034525|NCT02985996|50134047|FG002|Overall Study|Protocol Violation|0|||
25034526|NCT02985996|50134048|FG003|Overall Study|Protocol Violation|0|||
25034527|NCT02985996|50134049|FG004|Overall Study|Protocol Violation|0|||
25034528|NCT03225833|50134071|FG000|Overall Study|Adverse Event|0|||
25034529|NCT03225833|50134072|FG001|Overall Study|Adverse Event|1|||
25034530|NCT03225833|50134073|FG002|Overall Study|Adverse Event|2|||
25034531|NCT03225833|50134074|FG003|Overall Study|Adverse Event|0|||
25034532|NCT03225833|50134075|FG004|Overall Study|Adverse Event|0|||
25034533|NCT03225833|50134076|FG005|Overall Study|Adverse Event|2|||
25034534|NCT03225833|50134071|FG000|Overall Study|Withdrawal by Subject|1|||
25034535|NCT03225833|50134072|FG001|Overall Study|Withdrawal by Subject|0|||
25034536|NCT03225833|50134073|FG002|Overall Study|Withdrawal by Subject|0|||
25034537|NCT03225833|50134074|FG003|Overall Study|Withdrawal by Subject|0|||
25034538|NCT03225833|50134075|FG004|Overall Study|Withdrawal by Subject|1|||
25034539|NCT03225833|50134076|FG005|Overall Study|Withdrawal by Subject|0|||
25034540|NCT03225833|50134071|FG000|Overall Study|Termination of Study by Sponsor|4|||
25034541|NCT03225833|50134072|FG001|Overall Study|Termination of Study by Sponsor|0|||
25034542|NCT03225833|50134073|FG002|Overall Study|Termination of Study by Sponsor|0|||
25034543|NCT03225833|50134074|FG003|Overall Study|Termination of Study by Sponsor|0|||
25034544|NCT03225833|50134075|FG004|Overall Study|Termination of Study by Sponsor|0|||
25034545|NCT03225833|50134076|FG005|Overall Study|Termination of Study by Sponsor|7|||
25034546|NCT03225833|50134071|FG000|Overall Study|Sponsor Decision|0|||
25034547|NCT03225833|50134072|FG001|Overall Study|Sponsor Decision|0|||
25034548|NCT03225833|50134073|FG002|Overall Study|Sponsor Decision|0|||
25034549|NCT03225833|50134074|FG003|Overall Study|Sponsor Decision|0|||
25034550|NCT03225833|50134075|FG004|Overall Study|Sponsor Decision|0|||
25034551|NCT03225833|50134076|FG005|Overall Study|Sponsor Decision|1|||
25034552|NCT03203447|50134097|FG000|Overall Study|Withdrawal by Subject|2|||
25034553|NCT03203447|50134098|FG001|Overall Study|Withdrawal by Subject|1|||
25034554|NCT03203447|50134097|FG000|Overall Study|Lost to Follow-up|1|||
25034555|NCT03203447|50134098|FG001|Overall Study|Lost to Follow-up|10|||
25034556|NCT03203447|50134097|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
25034557|NCT03203447|50134098|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
25034558|NCT02858726|50134108|FG000|Overall Study|Adverse Event|4|||
25034559|NCT02858726|50134109|FG001|Overall Study|Adverse Event|4|||
25034560|NCT02858726|50134110|FG002|Overall Study|Adverse Event|9|||
25034561|NCT02858726|50134111|FG003|Overall Study|Adverse Event|1|||
25034562|NCT02858726|50134108|FG000|Overall Study|Physician Decision|0|||
25034563|NCT02858726|50134109|FG001|Overall Study|Physician Decision|0|||
25034564|NCT02858726|50134110|FG002|Overall Study|Physician Decision|1|||
25034565|NCT02858726|50134111|FG003|Overall Study|Physician Decision|0|||
25034566|NCT02858726|50134108|FG000|Overall Study|Protocol Violation|0|||
25034567|NCT02858726|50134109|FG001|Overall Study|Protocol Violation|0|||
25034568|NCT02858726|50134110|FG002|Overall Study|Protocol Violation|0|||
25034569|NCT02858726|50134111|FG003|Overall Study|Protocol Violation|1|||
25034570|NCT02858726|50134108|FG000|Overall Study|Study Terminated by Sponsor|0|||
25034571|NCT02858726|50134109|FG001|Overall Study|Study Terminated by Sponsor|0|||
25034572|NCT02858726|50134110|FG002|Overall Study|Study Terminated by Sponsor|0|||
25034573|NCT02858726|50134111|FG003|Overall Study|Study Terminated by Sponsor|1|||
25034574|NCT02858726|50134108|FG000|Overall Study|Withdrawal by Subject|1|||
25034575|NCT02858726|50134109|FG001|Overall Study|Withdrawal by Subject|2|||
25034576|NCT02858726|50134110|FG002|Overall Study|Withdrawal by Subject|1|||
25034577|NCT02858726|50134111|FG003|Overall Study|Withdrawal by Subject|0|||
25034578|NCT02858726|50134108|FG000|Overall Study|Noncompliance|0|||
25034579|NCT02858726|50134109|FG001|Overall Study|Noncompliance|1|||
25034580|NCT02858726|50134110|FG002|Overall Study|Noncompliance|0|||
25034581|NCT02858726|50134111|FG003|Overall Study|Noncompliance|0|||
25034582|NCT03203291|50134125|FG000|Overall Study|Withdrawal by Subject|1|||
25034583|NCT01068678|50134131|FG000|Overall Study|Lack of Efficacy|3|||
25034584|NCT01068678|50134132|FG001|Overall Study|Lack of Efficacy|2|||
25034585|NCT01068678|50134131|FG000|Overall Study|Protocol Violation|5|||
25034586|NCT01068678|50134132|FG001|Overall Study|Protocol Violation|1|||
25034587|NCT01068678|50134131|FG000|Overall Study|Withdrawal criteria|12|||
25034588|NCT01068678|50134132|FG001|Overall Study|Withdrawal criteria|6|||
25034589|NCT01068678|50134131|FG000|Overall Study|Unclassified|18|||
25034590|NCT01068678|50134132|FG001|Overall Study|Unclassified|15|||
25034591|NCT03202511|50134138|FG000|Overall Study|Withdrawal by Subject|1|||
25034592|NCT03202511|50134139|FG001|Overall Study|Withdrawal by Subject|0|||
25034593|NCT02919696|50134160|FG000|Overall Study|Adverse Event|1|||
25034594|NCT02919696|50134161|FG001|Overall Study|Adverse Event|2|||
25034595|NCT02919696|50134160|FG000|Overall Study|Withdrawal by Subject|2|||
25034596|NCT02919696|50134161|FG001|Overall Study|Withdrawal by Subject|1|||
25034597|NCT02919696|50134160|FG000|Overall Study|Sponsor Decision|1|||
25034598|NCT02919696|50134161|FG001|Overall Study|Sponsor Decision|1|||
25034599|NCT02919696|50134160|FG000|Overall Study|Never Treated|0|||
25034600|NCT02919696|50134161|FG001|Overall Study|Never Treated|1|||
25034601|NCT02935673|50134176|FG000|Overall Study|Adverse Event|0|||
25034602|NCT02935673|50134177|FG001|Overall Study|Adverse Event|1|||
25034603|NCT02935673|50134178|FG002|Overall Study|Adverse Event|0|||
25034604|NCT02935673|50134176|FG000|Overall Study|Withdrawal by Subject|1|||
25034605|NCT02935673|50134177|FG001|Overall Study|Withdrawal by Subject|2|||
25034606|NCT02935673|50134178|FG002|Overall Study|Withdrawal by Subject|0|||
25034607|NCT03201809|50134190|FG000|Overall Study|Lost to Follow-up|2|||
25034608|NCT03201809|50134191|FG001|Overall Study|Lost to Follow-up|0|||
25034609|NCT02919618|50134197|FG000|Overall Study|Death|1|||
25034610|NCT02985450|50134217|FG000|Overall Study|Lost to Follow-up|7|||
25034611|NCT02908464|50134226|FG000|Overall Study|Withdrawal by Subject|2|||
25034612|NCT02908464|50134227|FG001|Overall Study|Withdrawal by Subject|1|||
25034613|NCT02908464|50134226|FG000|Overall Study|Found ineligible after randomization|0|||
25034614|NCT02908464|50134227|FG001|Overall Study|Found ineligible after randomization|2|||
25034615|NCT02907216|50134236|FG000|Overall Study|No benefit to be obtained by continuing|0|||
25034616|NCT02907216|50134237|FG001|Overall Study|No benefit to be obtained by continuing|1|||
25034617|NCT02907216|50134236|FG000|Overall Study|Withdrawal by Subject|1|||
25034618|NCT02907216|50134237|FG001|Overall Study|Withdrawal by Subject|0|||
25034619|NCT02984982|50134245|FG000|Overall Study|Adverse Event|2|||
25034620|NCT02984982|50134246|FG001|Overall Study|Adverse Event|5|||
25034621|NCT02984982|50134245|FG000|Overall Study|Poor Compliance to Protocol|4|||
25034622|NCT02984982|50134246|FG001|Overall Study|Poor Compliance to Protocol|4|||
25034623|NCT02984982|50134245|FG000|Overall Study|Withdrawal by Subject|2|||
25034624|NCT02984982|50134246|FG001|Overall Study|Withdrawal by Subject|0|||
25034625|NCT02984982|50134245|FG000|Overall Study|Randomized but not treated|0|||
25034626|NCT02984982|50134246|FG001|Overall Study|Randomized but not treated|1|||
24946474|NCT00468104|50038921|FG001|First Intervention|trapped lung|0|||
24946475|NCT00468104|50038920|FG000|Second Intervention|Withdrawal by Subject|5|||
24946476|NCT00468104|50038921|FG001|Second Intervention|Withdrawal by Subject|2|||
24946477|NCT00468104|50038920|FG000|Second Intervention|discarded for malposition of chest tube|0|||
24946478|NCT00468104|50038921|FG001|Second Intervention|discarded for malposition of chest tube|2|||
24946479|NCT00326625|50038932|FG000|Overall Study|Adverse Event|20|||
24946480|NCT00326625|50038933|FG001|Overall Study|Adverse Event|9|||
24946481|NCT00326625|50038932|FG000|Overall Study|Withdrawal by Subject|15|||
24946482|NCT00326625|50038933|FG001|Overall Study|Withdrawal by Subject|12|||
24946483|NCT00326625|50038932|FG000|Overall Study|Death|18|||
24946484|NCT00326625|50038933|FG001|Overall Study|Death|16|||
24946485|NCT00326625|50038932|FG000|Overall Study|Lost to Follow-up|1|||
24946486|NCT00326625|50038933|FG001|Overall Study|Lost to Follow-up|0|||
24946487|NCT00326625|50038932|FG000|Overall Study|prescheduled medical intervention|0|||
24946488|NCT00326625|50038933|FG001|Overall Study|prescheduled medical intervention|1|||
24946489|NCT00433290|50038941|FG000|Overall Study|Adverse Event|24|||
24946490|NCT00433290|50038942|FG001|Overall Study|Adverse Event|7|||
24946491|NCT00433290|50038941|FG000|Overall Study|Lack of Efficacy|1|||
24946492|NCT00433290|50038942|FG001|Overall Study|Lack of Efficacy|5|||
24946493|NCT00433290|50038941|FG000|Overall Study|Withdrawal by Subject|4|||
24946494|NCT00433290|50038942|FG001|Overall Study|Withdrawal by Subject|2|||
24946495|NCT00433290|50038941|FG000|Overall Study|Protocol Violation|3|||
24946496|NCT00433290|50038942|FG001|Overall Study|Protocol Violation|2|||
24946497|NCT00433290|50038941|FG000|Overall Study|Physician Decision|2|||
24946498|NCT00433290|50038942|FG001|Overall Study|Physician Decision|0|||
24946499|NCT00433290|50038941|FG000|Overall Study|Entry Criteria Not Met|0|||
24946500|NCT00433290|50038942|FG001|Overall Study|Entry Criteria Not Met|1|||
24946501|NCT00433290|50038941|FG000|Overall Study|Lost to Follow-up|1|||
24946502|NCT00433290|50038942|FG001|Overall Study|Lost to Follow-up|0|||
24946503|NCT00467870|50038954|FG000|Overall Study|Adverse Event|13|||
24946504|NCT00467870|50038955|FG001|Overall Study|Adverse Event|9|||
24946505|NCT00467870|50038956|FG002|Overall Study|Adverse Event|1|||
24946506|NCT00467870|50038957|FG003|Overall Study|Adverse Event|15|||
24946507|NCT00467870|50038958|FG004|Overall Study|Adverse Event|15|||
25034627|NCT02981472|50134255|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
25034628|NCT02981472|50134256|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
25034629|NCT02981472|50134255|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
25034630|NCT02981472|50134256|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
24946508|NCT00467870|50038959|FG005|Overall Study|Adverse Event|1|||
24946509|NCT00467870|50038954|FG000|Overall Study|Protocol Violation|2|||
24946510|NCT00467870|50038955|FG001|Overall Study|Protocol Violation|1|||
24946511|NCT00467870|50038956|FG002|Overall Study|Protocol Violation|1|||
24946512|NCT00467870|50038957|FG003|Overall Study|Protocol Violation|2|||
25034631|NCT02981472|50134255|FG000|Treatment Period|Adverse Event|6|||
25034632|NCT02981472|50134256|FG001|Treatment Period|Adverse Event|1|||
24946513|NCT00467870|50038958|FG004|Overall Study|Protocol Violation|0|||
25034633|NCT02981472|50134255|FG000|Treatment Period|Participant withdrew consent|1|||
25034634|NCT02981472|50134256|FG001|Treatment Period|Participant withdrew consent|0|||
25034635|NCT02981472|50134255|FG000|Treatment Period|Lost to Follow-up|0|||
25034636|NCT02981472|50134256|FG001|Treatment Period|Lost to Follow-up|1|||
25034637|NCT02982720|50134268|FG000|Overall Study|Adverse Event|3|||
25034638|NCT02982720|50134268|FG000|Overall Study|Death|1|||
25034639|NCT00849667|50134275|FG000|Overall Study|Withdrawal by Subject|16|||
25034640|NCT00849667|50134276|FG001|Overall Study|Withdrawal by Subject|33|||
25034641|NCT00849667|50134277|FG002|Overall Study|Withdrawal by Subject|35|||
25034642|NCT00849667|50134275|FG000|Overall Study|Lost to Follow-up|8|||
25034643|NCT00849667|50134276|FG001|Overall Study|Lost to Follow-up|8|||
25034644|NCT00849667|50134277|FG002|Overall Study|Lost to Follow-up|8|||
25034645|NCT00849667|50134275|FG000|Overall Study|Adverse Event|1|||
25034646|NCT00849667|50134276|FG001|Overall Study|Adverse Event|2|||
25034647|NCT00849667|50134277|FG002|Overall Study|Adverse Event|0|||
25034648|NCT00849667|50134275|FG000|Overall Study|Other|18|||
25034649|NCT00849667|50134276|FG001|Overall Study|Other|19|||
25034650|NCT00849667|50134277|FG002|Overall Study|Other|18|||
25034651|NCT00849667|50134275|FG000|Overall Study|Progressive disease|119|||
25034652|NCT00849667|50134276|FG001|Overall Study|Progressive disease|100|||
25034653|NCT00849667|50134277|FG002|Overall Study|Progressive disease|112|||
25034654|NCT00849667|50134275|FG000|Overall Study|Sponsor decision|208|||
25034655|NCT00849667|50134276|FG001|Overall Study|Sponsor decision|204|||
25034656|NCT00849667|50134277|FG002|Overall Study|Sponsor decision|190|||
25034657|NCT00849667|50134275|FG000|Overall Study|Investigator discretion|0|||
25034658|NCT00849667|50134276|FG001|Overall Study|Investigator discretion|0|||
25034659|NCT00849667|50134277|FG002|Overall Study|Investigator discretion|1|||
25034660|NCT03201419|50134296|FG000|Overall Study|Adverse Event|3|||
25034661|NCT03201419|50134297|FG001|Overall Study|Adverse Event|1|||
24946514|NCT00467870|50038959|FG005|Overall Study|Protocol Violation|0|||
24946515|NCT00467870|50038954|FG000|Overall Study|Withdrawal by Subject|14|||
24946516|NCT00467870|50038955|FG001|Overall Study|Withdrawal by Subject|21|||
24946517|NCT00467870|50038956|FG002|Overall Study|Withdrawal by Subject|0|||
24946518|NCT00467870|50038957|FG003|Overall Study|Withdrawal by Subject|9|||
24946519|NCT00467870|50038958|FG004|Overall Study|Withdrawal by Subject|10|||
24946520|NCT00467870|50038959|FG005|Overall Study|Withdrawal by Subject|1|||
24946521|NCT00467870|50038954|FG000|Overall Study|Lost to Follow-up|5|||
24946522|NCT00467870|50038955|FG001|Overall Study|Lost to Follow-up|3|||
24946523|NCT00467870|50038956|FG002|Overall Study|Lost to Follow-up|1|||
24946524|NCT00467870|50038957|FG003|Overall Study|Lost to Follow-up|1|||
24946525|NCT00467870|50038958|FG004|Overall Study|Lost to Follow-up|3|||
24946526|NCT00467870|50038959|FG005|Overall Study|Lost to Follow-up|0|||
24946527|NCT00467870|50038954|FG000|Overall Study|Subject Non-compliance|3|||
24946528|NCT00467870|50038955|FG001|Overall Study|Subject Non-compliance|4|||
24946529|NCT00467870|50038956|FG002|Overall Study|Subject Non-compliance|0|||
24946530|NCT00467870|50038957|FG003|Overall Study|Subject Non-compliance|1|||
24946531|NCT00467870|50038958|FG004|Overall Study|Subject Non-compliance|5|||
24946532|NCT00467870|50038959|FG005|Overall Study|Subject Non-compliance|0|||
24946533|NCT00467870|50038954|FG000|Overall Study|Other/Unknown|8|||
24946534|NCT00467870|50038955|FG001|Overall Study|Other/Unknown|5|||
24946535|NCT00467870|50038956|FG002|Overall Study|Other/Unknown|1|||
24946536|NCT00467870|50038957|FG003|Overall Study|Other/Unknown|5|||
24946537|NCT00467870|50038958|FG004|Overall Study|Other/Unknown|4|||
24946538|NCT00467870|50038959|FG005|Overall Study|Other/Unknown|0|||
24946539|NCT00467558|50038971|FG000|Overall Study|Lost to Follow-up|2|||
24946540|NCT00467558|50038972|FG001|Overall Study|Lost to Follow-up|0|||
24946541|NCT00422292|50038982|FG000|Overall Study|Serious adverse events|1|||
24946542|NCT00422292|50038983|FG001|Overall Study|Serious adverse events|4|||
24946543|NCT00422292|50038984|FG002|Overall Study|Serious adverse events|0|||
24946544|NCT00422292|50038985|FG003|Overall Study|Serious adverse events|0|||
24946545|NCT00422292|50038982|FG000|Overall Study|Adverse Event|1|||
25034662|NCT03201419|50134298|FG002|Overall Study|Adverse Event|0|||
25034663|NCT03201419|50134299|FG003|Overall Study|Adverse Event|0|||
25034664|NCT03201419|50134300|FG004|Overall Study|Adverse Event|1|||
25034665|NCT03201419|50134301|FG005|Overall Study|Adverse Event|1|||
25034666|NCT03201419|50134302|FG006|Overall Study|Adverse Event|5|||
24946546|NCT00422292|50038983|FG001|Overall Study|Adverse Event|0|||
24946547|NCT00422292|50038984|FG002|Overall Study|Adverse Event|1|||
24946548|NCT00422292|50038985|FG003|Overall Study|Adverse Event|0|||
24946549|NCT00422292|50038982|FG000|Overall Study|Protocol Violation|4|||
24946550|NCT00422292|50038983|FG001|Overall Study|Protocol Violation|25|||
24946551|NCT00422292|50038984|FG002|Overall Study|Protocol Violation|8|||
24946552|NCT00422292|50038985|FG003|Overall Study|Protocol Violation|5|||
24946553|NCT00422292|50038982|FG000|Overall Study|Lost to Follow-up|6|||
25034667|NCT03201419|50134303|FG007|Overall Study|Adverse Event|0|||
25034668|NCT03201419|50134304|FG008|Overall Study|Adverse Event|0|||
24946554|NCT00422292|50038983|FG001|Overall Study|Lost to Follow-up|12|||
25034669|NCT03201419|50134296|FG000|Overall Study|Lost to Follow-up|1|||
25034670|NCT03201419|50134297|FG001|Overall Study|Lost to Follow-up|0|||
25034671|NCT03201419|50134298|FG002|Overall Study|Lost to Follow-up|0|||
25034672|NCT03201419|50134299|FG003|Overall Study|Lost to Follow-up|0|||
25034673|NCT03201419|50134300|FG004|Overall Study|Lost to Follow-up|0|||
25034674|NCT03201419|50134301|FG005|Overall Study|Lost to Follow-up|0|||
25034675|NCT03201419|50134302|FG006|Overall Study|Lost to Follow-up|0|||
25034676|NCT03201419|50134303|FG007|Overall Study|Lost to Follow-up|0|||
25034677|NCT03201419|50134304|FG008|Overall Study|Lost to Follow-up|0|||
25034678|NCT03201419|50134296|FG000|Overall Study|Protocol Deviation|0|||
25034679|NCT03201419|50134297|FG001|Overall Study|Protocol Deviation|0|||
25034680|NCT03201419|50134298|FG002|Overall Study|Protocol Deviation|0|||
25034681|NCT03201419|50134299|FG003|Overall Study|Protocol Deviation|0|||
25034682|NCT03201419|50134300|FG004|Overall Study|Protocol Deviation|0|||
25034683|NCT03201419|50134301|FG005|Overall Study|Protocol Deviation|0|||
25034684|NCT03201419|50134302|FG006|Overall Study|Protocol Deviation|1|||
25034685|NCT03201419|50134303|FG007|Overall Study|Protocol Deviation|0|||
25034686|NCT03201419|50134304|FG008|Overall Study|Protocol Deviation|0|||
25034687|NCT03201419|50134296|FG000|Overall Study|Withdrawal by Subject|4|||
25034688|NCT03201419|50134297|FG001|Overall Study|Withdrawal by Subject|2|||
25034689|NCT03201419|50134298|FG002|Overall Study|Withdrawal by Subject|1|||
25034690|NCT03201419|50134299|FG003|Overall Study|Withdrawal by Subject|0|||
25034691|NCT03201419|50134300|FG004|Overall Study|Withdrawal by Subject|0|||
25034692|NCT03201419|50134301|FG005|Overall Study|Withdrawal by Subject|0|||
25034693|NCT03201419|50134302|FG006|Overall Study|Withdrawal by Subject|0|||
25034694|NCT03201419|50134303|FG007|Overall Study|Withdrawal by Subject|1|||
25034695|NCT03201419|50134304|FG008|Overall Study|Withdrawal by Subject|2|||
25034696|NCT03201419|50134296|FG000|Overall Study|Other|0|||
25034697|NCT03201419|50134297|FG001|Overall Study|Other|0|||
25034698|NCT03201419|50134298|FG002|Overall Study|Other|1|||
25034699|NCT03201419|50134299|FG003|Overall Study|Other|0|||
25034700|NCT03201419|50134300|FG004|Overall Study|Other|0|||
25034701|NCT03201419|50134301|FG005|Overall Study|Other|0|||
25034702|NCT03201419|50134302|FG006|Overall Study|Other|0|||
25034703|NCT03201419|50134303|FG007|Overall Study|Other|0|||
25034704|NCT03201419|50134304|FG008|Overall Study|Other|0|||
25034705|NCT01764633|50134340|FG000|Overall Study|Withdrawal by Subject|105|||
25034706|NCT01764633|50134341|FG001|Overall Study|Withdrawal by Subject|88|||
25034707|NCT01764633|50134340|FG000|Overall Study|Lost to Follow-up|13|||
25034708|NCT01764633|50134341|FG001|Overall Study|Lost to Follow-up|5|||
25034709|NCT02924389|50134349|FG000|Overall Study|Lost to Follow-up|1|||
25034710|NCT02924389|50134350|FG001|Overall Study|Lost to Follow-up|0|||
25034711|NCT02924389|50134349|FG000|Overall Study|Physician Decision|2|||
25034712|NCT02924389|50134350|FG001|Overall Study|Physician Decision|0|||
25034713|NCT02924389|50134349|FG000|Overall Study|Withdrawal by Subject|3|||
25034714|NCT02924389|50134350|FG001|Overall Study|Withdrawal by Subject|0|||
25034715|NCT02924389|50134349|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
25034716|NCT02924389|50134350|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
25034717|NCT03235349|50134357|FG000|Overall Study|Adverse Event|1|||
25034718|NCT03235349|50134357|FG000|Overall Study|Other|1|||
25034719|NCT03235115|50134361|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
25034720|NCT03235115|50134362|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
25034721|NCT03235115|50134363|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
25034722|NCT03235115|50134364|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
25034723|NCT03235115|50134365|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
25034724|NCT03235115|50134366|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
25034725|NCT02923531|50134374|FG000|Overall Study|Adverse Event|4|||
25034726|NCT02923531|50134374|FG000|Overall Study|Clinical Deterioration|1|||
25034727|NCT02923531|50134374|FG000|Overall Study|Disease Progression|3|||
25034728|NCT02923531|50134374|FG000|Overall Study|Study Termination|1|||
25034729|NCT02934503|50134379|FG000|Overall Study|progression of disease|3|||
24946555|NCT00422292|50038984|FG002|Overall Study|Lost to Follow-up|6|||
24946556|NCT00422292|50038985|FG003|Overall Study|Lost to Follow-up|6|||
24946557|NCT00422292|50038982|FG000|Overall Study|Withdrawal by Subject|6|||
24946558|NCT00422292|50038983|FG001|Overall Study|Withdrawal by Subject|25|||
24946559|NCT00422292|50038984|FG002|Overall Study|Withdrawal by Subject|7|||
24946560|NCT00422292|50038985|FG003|Overall Study|Withdrawal by Subject|13|||
24946561|NCT00452348|50038997|FG000|Overall Study|Adverse Event|6|||
24946562|NCT00452348|50038998|FG001|Overall Study|Adverse Event|9|||
24946563|NCT00452348|50038997|FG000|Overall Study|Lack of Efficacy|10|||
24946564|NCT00452348|50038998|FG001|Overall Study|Lack of Efficacy|9|||
25034730|NCT02934503|50134379|FG000|Overall Study|Withdrawal by Subject|1|||
24946565|NCT00452348|50038997|FG000|Overall Study|Lost to Follow-up|14|||
25034731|NCT02937545|50134385|FG000|Overall Study|Withdrawal by Subject|1|||
24946566|NCT00452348|50038998|FG001|Overall Study|Lost to Follow-up|8|||
25034732|NCT02937545|50134386|FG001|Overall Study|Withdrawal by Subject|2|||
25034733|NCT02937545|50134387|FG002|Overall Study|Withdrawal by Subject|6|||
25034734|NCT02937545|50134388|FG003|Overall Study|Withdrawal by Subject|7|||
25034735|NCT02937545|50134385|FG000|Overall Study|Lost to Follow-up|1|||
24946567|NCT00452348|50038997|FG000|Overall Study|Protocol Violation|22|||
25034736|NCT02937545|50134386|FG001|Overall Study|Lost to Follow-up|0|||
25034737|NCT02937545|50134387|FG002|Overall Study|Lost to Follow-up|0|||
25034738|NCT02937545|50134388|FG003|Overall Study|Lost to Follow-up|0|||
25034739|NCT03199391|50134399|FG000|Overall Study|Death|1|||
25034740|NCT03199391|50134399|FG000|Overall Study|Lost to Follow-up|3|||
25034741|NCT03199391|50134399|FG000|Overall Study|Adverse Event|2|||
25034742|NCT03199391|50134399|FG000|Overall Study|Withdrawal by Subject|10|||
25034743|NCT03198767|50134410|FG000|Overall Study|Protocol Violation|0|||
25034744|NCT03198767|50134411|FG001|Overall Study|Protocol Violation|0|||
25034745|NCT03198767|50134412|FG002|Overall Study|Protocol Violation|0|||
25034746|NCT03198767|50134413|FG003|Overall Study|Protocol Violation|6|||
25034747|NCT03198767|50134414|FG004|Overall Study|Protocol Violation|0|||
25034748|NCT03198767|50134415|FG005|Overall Study|Protocol Violation|0|||
25034749|NCT03198767|50134416|FG006|Overall Study|Protocol Violation|0|||
25034750|NCT03162055|50134433|FG000|Overall Study|Adverse Event|6|||
25034751|NCT03162055|50134434|FG001|Overall Study|Adverse Event|5|||
25034752|NCT03162055|50134433|FG000|Overall Study|Death|3|||
25034753|NCT03162055|50134434|FG001|Overall Study|Death|3|||
25034754|NCT03162055|50134433|FG000|Overall Study|Lost to Follow-up|0|||
25034755|NCT03162055|50134434|FG001|Overall Study|Lost to Follow-up|1|||
25034756|NCT03162055|50134433|FG000|Overall Study|Study-specific withdrawal criteria|22|||
25034757|NCT03162055|50134434|FG001|Overall Study|Study-specific withdrawal criteria|14|||
25034758|NCT03162055|50134433|FG000|Overall Study|Withdrawal by Subject|17|||
25034759|NCT03162055|50134434|FG001|Overall Study|Withdrawal by Subject|2|||
25034760|NCT03162055|50134433|FG000|Overall Study|Did not receive treatment|2|||
25034761|NCT03162055|50134434|FG001|Overall Study|Did not receive treatment|0|||
25034762|NCT03162055|50134433|FG000|Overall Study|Incorrect randomization|4|||
25034763|NCT03162055|50134434|FG001|Overall Study|Incorrect randomization|3|||
25034764|NCT03162055|50134433|FG000|Overall Study|Other|8|||
25034765|NCT03162055|50134434|FG001|Overall Study|Other|15|||
25034766|NCT02927145|50134447|FG000|Initial Recruitment|Withdrawal by Subject|0|||
25034767|NCT02927145|50134448|FG001|Initial Recruitment|Withdrawal by Subject|1|||
25034768|NCT02927145|50134449|FG002|Initial Recruitment|Withdrawal by Subject|1|||
25034769|NCT02927145|50134450|FG003|Initial Recruitment|Withdrawal by Subject|4|||
25034770|NCT02927145|50134451|FG004|Initial Recruitment|Withdrawal by Subject|1|||
25034771|NCT02927145|50134452|FG005|Initial Recruitment|Withdrawal by Subject|1|||
25034772|NCT02927145|50134453|FG006|Initial Recruitment|Withdrawal by Subject|0|||
25034773|NCT02927145|50134454|FG007|Initial Recruitment|Withdrawal by Subject|0|||
25034774|NCT02927145|50134455|FG008|Initial Recruitment|Withdrawal by Subject|2|||
25034775|NCT02927145|50134447|FG000|Initial Recruitment|Adverse Event|0|||
25034776|NCT02927145|50134448|FG001|Initial Recruitment|Adverse Event|0|||
25034777|NCT02927145|50134449|FG002|Initial Recruitment|Adverse Event|0|||
25034778|NCT02927145|50134450|FG003|Initial Recruitment|Adverse Event|0|||
25034779|NCT02927145|50134451|FG004|Initial Recruitment|Adverse Event|2|||
25034780|NCT02927145|50134452|FG005|Initial Recruitment|Adverse Event|0|||
25034781|NCT02927145|50134453|FG006|Initial Recruitment|Adverse Event|0|||
25034782|NCT02927145|50134454|FG007|Initial Recruitment|Adverse Event|0|||
25034783|NCT02927145|50134455|FG008|Initial Recruitment|Adverse Event|0|||
25034784|NCT02927145|50134447|FG000|Invitation for Additional Challenge|Pregnancy|0|||
24946568|NCT00452348|50038998|FG001|Overall Study|Protocol Violation|28|||
24946569|NCT00452348|50038997|FG000|Overall Study|Withdrawal by Subject|18|||
24946570|NCT00452348|50038998|FG001|Overall Study|Withdrawal by Subject|21|||
24946571|NCT00452348|50038997|FG000|Overall Study|Other|9|||
24946572|NCT00452348|50038998|FG001|Overall Study|Other|9|||
24946573|NCT00452114|50039006|FG000|Overall Study|Physician Decision|3|||
24946574|NCT00452114|50039007|FG001|Overall Study|Physician Decision|3|||
24946575|NCT00320541|50039015|FG000|Overall Study|Adverse Event|21|||
24946576|NCT00320541|50039016|FG001|Overall Study|Adverse Event|19|||
24946577|NCT00320541|50039015|FG000|Overall Study|Protocol Violation|0|||
24946578|NCT00320541|50039016|FG001|Overall Study|Protocol Violation|1|||
24946579|NCT00320541|50039015|FG000|Overall Study|Withdrawal by Subject|12|||
24946580|NCT00320541|50039016|FG001|Overall Study|Withdrawal by Subject|16|||
24946581|NCT00320541|50039015|FG000|Overall Study|Physician Decision|9|||
24946582|NCT00320541|50039016|FG001|Overall Study|Physician Decision|13|||
24946583|NCT00320541|50039015|FG000|Overall Study|Other|3|||
24946584|NCT00320541|50039016|FG001|Overall Study|Other|4|||
25034785|NCT02927145|50134448|FG001|Invitation for Additional Challenge|Pregnancy|0|||
25275668|NCT00903175|50589503|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
25034786|NCT02927145|50134449|FG002|Invitation for Additional Challenge|Pregnancy|0|||
25034787|NCT02927145|50134450|FG003|Invitation for Additional Challenge|Pregnancy|0|||
25034788|NCT02927145|50134451|FG004|Invitation for Additional Challenge|Pregnancy|0|||
25034789|NCT02927145|50134452|FG005|Invitation for Additional Challenge|Pregnancy|0|||
25034790|NCT02927145|50134453|FG006|Invitation for Additional Challenge|Pregnancy|1|||
25034791|NCT02927145|50134454|FG007|Invitation for Additional Challenge|Pregnancy|0|||
25034792|NCT02927145|50134455|FG008|Invitation for Additional Challenge|Pregnancy|0|||
24946585|NCT00320541|50039015|FG000|Overall Study|Sponsor Decision|2|||
24946586|NCT00320541|50039016|FG001|Overall Study|Sponsor Decision|1|||
24946587|NCT00320541|50039015|FG000|Overall Study|Death due to Study Disease|1|||
24946588|NCT00320541|50039016|FG001|Overall Study|Death due to Study Disease|3|||
24946589|NCT00320541|50039015|FG000|Overall Study|Death due to Adverse Event(s)|1|||
24946590|NCT00320541|50039016|FG001|Overall Study|Death due to Adverse Event(s)|0|||
24946591|NCT00320541|50039015|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
24946592|NCT00320541|50039016|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
24946593|NCT00320385|50039024|FG000|Overall Study|Lost to Follow-up|7|||
24946594|NCT00320385|50039025|FG001|Overall Study|Lost to Follow-up|10|||
24946595|NCT00320385|50039024|FG000|Overall Study|Withdrawal by Subject|6|||
24946596|NCT00320385|50039025|FG001|Overall Study|Withdrawal by Subject|7|||
24946597|NCT00320385|50039024|FG000|Overall Study|Sponsor Terminated Study|2|||
24946598|NCT00320385|50039025|FG001|Overall Study|Sponsor Terminated Study|1|||
24946599|NCT00320385|50039024|FG000|Overall Study|Investigator Decision|0|||
24946600|NCT00320385|50039025|FG001|Overall Study|Investigator Decision|1|||
24946601|NCT00320385|50039024|FG000|Overall Study|Death|1|||
24946602|NCT00320385|50039025|FG001|Overall Study|Death|2|||
24946603|NCT00320385|50039024|FG000|Overall Study|Serious Adverse Event|1|||
24946604|NCT00320385|50039025|FG001|Overall Study|Serious Adverse Event|0|||
24946605|NCT00320385|50039024|FG000|Overall Study|Withdrew Consent|1|||
24946606|NCT00320385|50039025|FG001|Overall Study|Withdrew Consent|0|||
24946607|NCT00320385|50039024|FG000|Overall Study|Adverse Event|0|||
24946608|NCT00320385|50039025|FG001|Overall Study|Adverse Event|1|||
24946609|NCT00326001|50039033|FG000|Overall Study|Adverse Event|4|||
24946610|NCT00326001|50039034|FG001|Overall Study|Adverse Event|5|||
25034793|NCT03688919|50134478|FG000|Overall Study|Lost to Follow-up|2|||
25034794|NCT03688919|50134479|FG001|Overall Study|Lost to Follow-up|1|||
25034795|NCT03688919|50134478|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
25034796|NCT03688919|50134479|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
25034797|NCT02888119|50134502|FG000|Overall Study|Lost to Follow-up|5|||
25034798|NCT02888119|50134503|FG001|Overall Study|Lost to Follow-up|4|||
25034799|NCT02888119|50134504|FG002|Overall Study|Lost to Follow-up|0|||
25034800|NCT03197129|50134513|FG000|Overall Study|did not answer the VPT: shyness|4|||
25034801|NCT03197129|50134514|FG001|Overall Study|did not answer the VPT: shyness|5|||
25034802|NCT03196973|50134523|FG000|Overall Study|Adverse Event|1|||
25034803|NCT03196973|50134524|FG001|Overall Study|Adverse Event|1|||
25034804|NCT03196973|50134525|FG002|Overall Study|Adverse Event|2|||
25034805|NCT03196973|50134523|FG000|Overall Study|Lack of Efficacy|2|||
25034806|NCT03196973|50134524|FG001|Overall Study|Lack of Efficacy|6|||
25034807|NCT03196973|50134525|FG002|Overall Study|Lack of Efficacy|1|||
25034808|NCT03196973|50134523|FG000|Overall Study|Lost to Follow-up|4|||
25034809|NCT03196973|50134524|FG001|Overall Study|Lost to Follow-up|3|||
25034810|NCT03196973|50134525|FG002|Overall Study|Lost to Follow-up|2|||
25034811|NCT03196973|50134523|FG000|Overall Study|Consent withdrawn|2|||
25034812|NCT03196973|50134524|FG001|Overall Study|Consent withdrawn|1|||
25034813|NCT03196973|50134525|FG002|Overall Study|Consent withdrawn|0|||
25034814|NCT03196973|50134523|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
25034815|NCT03196973|50134524|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
25034816|NCT03196973|50134525|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
25034817|NCT03196505|50134535|FG000|Overall Study|Physician Decision|26|||
25034818|NCT03196505|50134536|FG001|Overall Study|Physician Decision|26|||
25034819|NCT03196349|50134545|FG000|Overall Study|Did not receive study drug|0|||
25034820|NCT03196349|50134546|FG001|Overall Study|Did not receive study drug|1|||
25034821|NCT03196349|50134547|FG002|Overall Study|Did not receive study drug|2|||
25034822|NCT03196349|50134545|FG000|Overall Study|No data entered|2|||
25034823|NCT03196349|50134546|FG001|Overall Study|No data entered|4|||
25034824|NCT03196349|50134547|FG002|Overall Study|No data entered|0|||
25034825|NCT03196349|50134545|FG000|Overall Study|Study Terminated early|15|||
25034826|NCT03196349|50134546|FG001|Overall Study|Study Terminated early|9|||
25034827|NCT03196349|50134547|FG002|Overall Study|Study Terminated early|11|||
25034828|NCT02886715|50134558|FG000|Overall Study|Non-Compliance With Study Drug|0|||
25034829|NCT02886715|50134559|FG001|Overall Study|Non-Compliance With Study Drug|2|||
25159697|NCT01424397|50279588|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
25159698|NCT01424397|50279589|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
25159699|NCT01424397|50279590|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
25159700|NCT01392963|50279606|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
25034830|NCT02886715|50134560|FG002|Overall Study|Non-Compliance With Study Drug|0|||
25034831|NCT02886715|50134558|FG000|Overall Study|Adverse Event|4|||
25034832|NCT02886715|50134559|FG001|Overall Study|Adverse Event|2|||
25034833|NCT02886715|50134560|FG002|Overall Study|Adverse Event|0|||
25034834|NCT02886715|50134558|FG000|Overall Study|Lack of Efficacy|0|||
25034835|NCT02886715|50134559|FG001|Overall Study|Lack of Efficacy|2|||
25034836|NCT02886715|50134560|FG002|Overall Study|Lack of Efficacy|1|||
25034837|NCT02886715|50134558|FG000|Overall Study|Lost to Follow-up|29|||
25159701|NCT01392963|50279607|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
24946611|NCT00326001|50039033|FG000|Overall Study|Physician Decision|3|||
24946612|NCT00326001|50039034|FG001|Overall Study|Physician Decision|3|||
24946613|NCT00309777|50039044|FG000|Overall Study|Adverse Event|13|||
25159702|NCT01392963|50279606|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
25159703|NCT01392963|50279607|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
25159704|NCT01392963|50279606|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
25159705|NCT01392963|50279607|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
25159706|NCT01392573|50279617|FG000|Overall Study|Adverse Event|1|||
25034838|NCT02886715|50134559|FG001|Overall Study|Lost to Follow-up|26|||
25034839|NCT02886715|50134560|FG002|Overall Study|Lost to Follow-up|10|||
25034840|NCT02886715|50134558|FG000|Overall Study|Pregnancy|1|||
25034841|NCT02886715|50134559|FG001|Overall Study|Pregnancy|1|||
25034842|NCT02886715|50134560|FG002|Overall Study|Pregnancy|1|||
25034843|NCT02886715|50134558|FG000|Overall Study|Protocol Violation|3|||
25034844|NCT02886715|50134559|FG001|Overall Study|Protocol Violation|2|||
25034845|NCT02886715|50134560|FG002|Overall Study|Protocol Violation|1|||
25034846|NCT02886715|50134558|FG000|Overall Study|Withdrawal by Subject|20|||
25034847|NCT02886715|50134559|FG001|Overall Study|Withdrawal by Subject|18|||
25034848|NCT02886715|50134560|FG002|Overall Study|Withdrawal by Subject|5|||
25034849|NCT02886715|50134558|FG000|Overall Study|missing|7|||
25034850|NCT02886715|50134559|FG001|Overall Study|missing|2|||
25034851|NCT02886715|50134560|FG002|Overall Study|missing|2|||
25034852|NCT03085797|50134570|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
25034853|NCT03085797|50134571|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
25034854|NCT03085797|50134570|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
25034855|NCT03085797|50134571|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
25034856|NCT03085797|50134570|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
25034857|NCT03085797|50134571|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
25034858|NCT03157531|50134579|FG000|Overall Study|Death|2|||
25034859|NCT03157531|50134579|FG000|Overall Study|Lost to Follow-up|4|||
25275669|NCT00903175|50589504|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
25275670|NCT00903175|50589503|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
25275671|NCT00903175|50589504|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
25275672|NCT00903175|50589503|FG000|Period 2 - Second Line|Administrative problems|19|||
25159707|NCT01392573|50279618|FG001|Overall Study|Adverse Event|3|||
25275673|NCT00903175|50589504|FG001|Period 2 - Second Line|Administrative problems|9|||
25275674|NCT00903175|50589503|FG000|Period 2 - Second Line|Death|5|||
25275675|NCT00903175|50589504|FG001|Period 2 - Second Line|Death|2|||
25275676|NCT01229735|50589512|FG000|Overall Study|Lack of Efficacy|8|||
25275677|NCT01229735|50589513|FG001|Overall Study|Lack of Efficacy|8|||
25275678|NCT01229735|50589512|FG000|Overall Study|Protocol Violation|13|||
25275679|NCT01229735|50589513|FG001|Overall Study|Protocol Violation|8|||
25275680|NCT01229735|50589512|FG000|Overall Study|Lost to Follow-up|0|||
25275681|NCT01229735|50589513|FG001|Overall Study|Lost to Follow-up|2|||
25275682|NCT01229735|50589512|FG000|Overall Study|Withdrawal by Subject|18|||
25275683|NCT01229735|50589513|FG001|Overall Study|Withdrawal by Subject|17|||
25275684|NCT01229735|50589512|FG000|Overall Study|Other Reason|13|||
25275685|NCT01229735|50589513|FG001|Overall Study|Other Reason|10|||
25275686|NCT01229735|50589512|FG000|Overall Study|SAE, non-fatal|0|||
25275687|NCT01229735|50589513|FG001|Overall Study|SAE, non-fatal|4|||
25275688|NCT01229735|50589512|FG000|Overall Study|AE, non-serious non-fatal|13|||
25275689|NCT01229735|50589513|FG001|Overall Study|AE, non-serious non-fatal|17|||
25275690|NCT01229735|50589512|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
25275691|NCT01229735|50589513|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
25275692|NCT00974974|50589532|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
25275693|NCT00974974|50589533|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
25275694|NCT00974974|50589532|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
24946614|NCT00309777|50039045|FG001|Overall Study|Adverse Event|2|||
24946615|NCT00309777|50039046|FG002|Overall Study|Adverse Event|8|||
24946616|NCT00309777|50039047|FG003|Overall Study|Adverse Event|1|||
24946617|NCT00309777|50039044|FG000|Overall Study|Protocol Violation|4|||
24946618|NCT00309777|50039045|FG001|Overall Study|Protocol Violation|1|||
24946619|NCT00309777|50039046|FG002|Overall Study|Protocol Violation|3|||
24946620|NCT00309777|50039047|FG003|Overall Study|Protocol Violation|1|||
24946621|NCT00309777|50039044|FG000|Overall Study|Withdrawal by Subject|6|||
24946622|NCT00309777|50039045|FG001|Overall Study|Withdrawal by Subject|5|||
24946623|NCT00309777|50039046|FG002|Overall Study|Withdrawal by Subject|7|||
24946624|NCT00309777|50039047|FG003|Overall Study|Withdrawal by Subject|2|||
25275695|NCT00974974|50589533|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
25275696|NCT00974974|50589532|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
25275697|NCT00974974|50589533|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
25275698|NCT00974974|50589532|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
25275699|NCT00974974|50589533|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
24946625|NCT00309777|50039044|FG000|Overall Study|Lost to Follow-up|0|||
25275700|NCT00974974|50589532|FG000|IR CD-LD Dose Adjustment|Various|0|||
25275701|NCT00974974|50589533|FG001|IR CD-LD Dose Adjustment|Various|9|||
25275702|NCT00974974|50589532|FG000|IPX066 Dose Conversion|Adverse Event|23|||
25159708|NCT01392573|50279617|FG000|Overall Study|Lack of Efficacy|1|||
25159709|NCT01392573|50279618|FG001|Overall Study|Lack of Efficacy|2|||
24946626|NCT00309777|50039045|FG001|Overall Study|Lost to Follow-up|0|||
24946627|NCT00309777|50039046|FG002|Overall Study|Lost to Follow-up|1|||
24946628|NCT00309777|50039047|FG003|Overall Study|Lost to Follow-up|0|||
24946629|NCT00309777|50039044|FG000|Overall Study|Death|0|||
25275703|NCT00974974|50589533|FG001|IPX066 Dose Conversion|Adverse Event|0|||
25275704|NCT00974974|50589532|FG000|IPX066 Dose Conversion|Death|2|||
25275705|NCT00974974|50589533|FG001|IPX066 Dose Conversion|Death|0|||
25275706|NCT00974974|50589532|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
25275707|NCT00974974|50589533|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
25275708|NCT00974974|50589532|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
25275709|NCT00974974|50589533|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
25275710|NCT00974974|50589532|FG000|IPX066 Dose Conversion|Various|3|||
25275711|NCT00974974|50589533|FG001|IPX066 Dose Conversion|Various|0|||
25275712|NCT00974974|50589532|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
25275713|NCT00974974|50589533|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
25275714|NCT00974974|50589532|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
24946630|NCT00309777|50039045|FG001|Overall Study|Death|1|||
24946631|NCT00309777|50039046|FG002|Overall Study|Death|0|||
24946632|NCT00309777|50039047|FG003|Overall Study|Death|0|||
24946633|NCT00309387|50039059|FG000|Overall Study|Death|72|||
24946634|NCT00309387|50039060|FG001|Overall Study|Death|73|||
24946635|NCT00309387|50039059|FG000|Overall Study|Lost to Follow-up|70|||
24946636|NCT00309387|50039060|FG001|Overall Study|Lost to Follow-up|86|||
24946637|NCT00325143|50039067|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
24946638|NCT00325143|50039067|FG000|Overall Study|Migrated/moved from study area|1|||
24946639|NCT00325143|50039067|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
24946640|NCT00325143|50039067|FG000|Overall Study|Withdrawal by Subject|8|||
25275715|NCT00974974|50589533|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
25275716|NCT00974974|50589532|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
25275717|NCT00974974|50589533|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
25275718|NCT00974974|50589532|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
25275719|NCT00974974|50589533|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
25275720|NCT00974974|50589532|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
25275721|NCT00974974|50589533|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
25034915|NCT03159091|50134606|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
25034916|NCT03159091|50134607|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
25034917|NCT03159091|50134606|FG000|Overall Study|Patient has taken no dose of study drug|0|||
25034918|NCT03159091|50134607|FG001|Overall Study|Patient has taken no dose of study drug|1|||
25034919|NCT03196193|50134615|FG000|Overall Study|Adverse Event|1|||
25034920|NCT03196193|50134616|FG001|Overall Study|Adverse Event|0|||
25034921|NCT03196193|50134615|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
25034922|NCT03196193|50134616|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
25034923|NCT03621761|50134625|FG000|Overall Study|Lost to Follow-up|1|||
25034924|NCT03621761|50134626|FG001|Overall Study|Lost to Follow-up|1|||
25034925|NCT03621761|50134627|FG002|Overall Study|Lost to Follow-up|2|||
25034926|NCT03621761|50134625|FG000|Overall Study|Withdrawal by Subject|2|||
25034927|NCT03621761|50134626|FG001|Overall Study|Withdrawal by Subject|1|||
25034928|NCT03621761|50134627|FG002|Overall Study|Withdrawal by Subject|1|||
25034929|NCT03621761|50134625|FG000|Overall Study|Became Ineligible|0|||
25034930|NCT03621761|50134626|FG001|Overall Study|Became Ineligible|2|||
25034931|NCT03621761|50134627|FG002|Overall Study|Became Ineligible|0|||
25034932|NCT03221387|50134635|FG000|Overall Study|Lost to Follow-up|1|||
25034933|NCT03221387|50134635|FG000|Overall Study|Lung transplant|1|||
25034934|NCT03318861|50134644|FG000|Overall Study|Death|1|||
25034935|NCT03318861|50134645|FG001|Overall Study|Death|2|||
25034936|NCT03318861|50134646|FG002|Overall Study|Death|2|||
25034937|NCT03318861|50134647|FG003|Overall Study|Death|1|||
25034938|NCT03318861|50134648|FG004|Overall Study|Death|1|||
25034939|NCT03318861|50134644|FG000|Overall Study|Still on Study|2|||
25034940|NCT03318861|50134645|FG001|Overall Study|Still on Study|1|||
25034941|NCT03318861|50134646|FG002|Overall Study|Still on Study|1|||
25034942|NCT03318861|50134647|FG003|Overall Study|Still on Study|2|||
25034943|NCT03318861|50134648|FG004|Overall Study|Still on Study|1|||
25159710|NCT01392573|50279617|FG000|Overall Study|Protocol Violation|0|||
25159711|NCT01392573|50279618|FG001|Overall Study|Protocol Violation|2|||
24946641|NCT00319839|50039071|FG000|Overall Study|Adverse Event|5|||
24946642|NCT00319839|50039071|FG000|Overall Study|Withdrawal by Subject|1|||
25034944|NCT03318861|50134644|FG000|Overall Study|Enrolled But Did Not Initiate KITE-585|0|||
25034945|NCT03318861|50134645|FG001|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
25034946|NCT03318861|50134646|FG002|Overall Study|Enrolled But Did Not Initiate KITE-585|0|||
25034947|NCT03318861|50134647|FG003|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
25034948|NCT03318861|50134648|FG004|Overall Study|Enrolled But Did Not Initiate KITE-585|1|||
25034949|NCT03084315|50134662|FG000|Overall Study|Lost to Follow-up|8|||
25034950|NCT03084315|50134663|FG001|Overall Study|Lost to Follow-up|7|||
25034951|NCT03084315|50134662|FG000|Overall Study|Withdrawal by Subject|2|||
25034952|NCT03084315|50134663|FG001|Overall Study|Withdrawal by Subject|2|||
25034953|NCT03187301|50134669|FG000|Titration Period|Adverse Event|0|||
25034954|NCT03187301|50134670|FG001|Titration Period|Adverse Event|0|||
25034955|NCT03187301|50134671|FG002|Titration Period|Adverse Event|0|||
25034956|NCT03187301|50134672|FG003|Titration Period|Adverse Event|0|||
25034957|NCT03187301|50134673|FG004|Titration Period|Adverse Event|0|||
25034958|NCT03187301|50134674|FG005|Titration Period|Adverse Event|0|||
25034959|NCT03187301|50134675|FG006|Titration Period|Adverse Event|5|||
25034960|NCT03187301|50134669|FG000|Titration Period|Withdrawal by Subject|0|||
25034961|NCT03187301|50134670|FG001|Titration Period|Withdrawal by Subject|0|||
25034962|NCT03187301|50134671|FG002|Titration Period|Withdrawal by Subject|0|||
25034963|NCT03187301|50134672|FG003|Titration Period|Withdrawal by Subject|0|||
25034964|NCT03187301|50134673|FG004|Titration Period|Withdrawal by Subject|0|||
25034965|NCT03187301|50134674|FG005|Titration Period|Withdrawal by Subject|0|||
25034966|NCT03187301|50134675|FG006|Titration Period|Withdrawal by Subject|1|||
25034967|NCT03187301|50134669|FG000|Titration Period|Exclusion Criteria Met|0|||
25034968|NCT03187301|50134670|FG001|Titration Period|Exclusion Criteria Met|0|||
25034969|NCT03187301|50134671|FG002|Titration Period|Exclusion Criteria Met|0|||
25034970|NCT03187301|50134672|FG003|Titration Period|Exclusion Criteria Met|0|||
25034971|NCT03187301|50134673|FG004|Titration Period|Exclusion Criteria Met|0|||
25034972|NCT03187301|50134674|FG005|Titration Period|Exclusion Criteria Met|0|||
25034973|NCT03187301|50134675|FG006|Titration Period|Exclusion Criteria Met|1|||
25034974|NCT03187301|50134669|FG000|Pre-Intervention|Withdrawal by Subject|1|||
25034975|NCT03187301|50134670|FG001|Pre-Intervention|Withdrawal by Subject|0|||
25034976|NCT03187301|50134671|FG002|Pre-Intervention|Withdrawal by Subject|0|||
25034977|NCT03187301|50134672|FG003|Pre-Intervention|Withdrawal by Subject|0|||
25034978|NCT03187301|50134673|FG004|Pre-Intervention|Withdrawal by Subject|0|||
25034979|NCT03187301|50134674|FG005|Pre-Intervention|Withdrawal by Subject|0|||
25034980|NCT03187301|50134675|FG006|Pre-Intervention|Withdrawal by Subject|0|||
25034981|NCT02946047|50134700|FG000|Overall Study|Adverse Event|1|||
25034982|NCT02946047|50134701|FG001|Overall Study|Adverse Event|0|||
25034983|NCT02946047|50134702|FG002|Overall Study|Adverse Event|0|||
25034984|NCT02946047|50134703|FG003|Overall Study|Adverse Event|0|||
25034985|NCT03077919|50134715|FG000|Overall Study|Lost to Follow-up|4|||
25034986|NCT03077919|50134716|FG001|Overall Study|Lost to Follow-up|1|||
25034987|NCT03220217|50134725|FG000|Overall Study|Withdrawal by Subject|0|||
25034988|NCT03220217|50134726|FG001|Overall Study|Withdrawal by Subject|1|||
25159712|NCT01392573|50279617|FG000|Overall Study|Withdrawal Criteria|13|||
25159713|NCT01392573|50279618|FG001|Overall Study|Withdrawal Criteria|15|||
24946643|NCT00319449|50039077|FG000|Overall Study|Subject did not wish to continue|1|||
24946644|NCT00319449|50039078|FG001|Overall Study|Subject did not wish to continue|0|||
24946645|NCT00319449|50039077|FG000|Overall Study|Noncompliance with the protocol|1|||
25034989|NCT03220217|50134727|FG002|Overall Study|Withdrawal by Subject|0|||
25034990|NCT03220217|50134725|FG000|Overall Study|Subject Missed Procedure|0|||
25034991|NCT03220217|50134726|FG001|Overall Study|Subject Missed Procedure|0|||
25034992|NCT03220217|50134727|FG002|Overall Study|Subject Missed Procedure|1|||
25034993|NCT03192137|50134758|FG000|Overall Study|Adverse Event|10|||
25034994|NCT03192137|50134759|FG001|Overall Study|Adverse Event|11|||
25034995|NCT03192137|50134758|FG000|Overall Study|Physician Decision|1|||
25034996|NCT03192137|50134759|FG001|Overall Study|Physician Decision|0|||
25034997|NCT03192137|50134758|FG000|Overall Study|Lack of Efficacy|20|||
25034998|NCT03192137|50134759|FG001|Overall Study|Lack of Efficacy|37|||
25034999|NCT03192137|50134758|FG000|Overall Study|Withdrawal by Subject|3|||
25035000|NCT03192137|50134759|FG001|Overall Study|Withdrawal by Subject|3|||
25035001|NCT03192137|50134758|FG000|Overall Study|Protocol Violation|4|||
25035002|NCT03192137|50134759|FG001|Overall Study|Protocol Violation|3|||
25035003|NCT03192137|50134758|FG000|Overall Study|Surgery Cancelled|4|||
25035004|NCT03192137|50134759|FG001|Overall Study|Surgery Cancelled|1|||
24946646|NCT00319449|50039078|FG001|Overall Study|Noncompliance with the protocol|0|||
24946647|NCT00308997|50039086|FG000|Overall Study|Subject feigned clinical data|0|||
24946648|NCT00308997|50039087|FG001|Overall Study|Subject feigned clinical data|1|||
24946649|NCT00308997|50039086|FG000|Overall Study|Unable to tolerate intervention|1|||
24946650|NCT00308997|50039087|FG001|Overall Study|Unable to tolerate intervention|0|||
24946651|NCT00308685|50039095|FG000|Overall Study|Lost to Follow-up|1|||
25035005|NCT03192137|50134758|FG000|Overall Study|Other - Various Administrative Reasons|8|||
25035006|NCT03192137|50134759|FG001|Overall Study|Other - Various Administrative Reasons|3|||
24946652|NCT00308685|50039096|FG001|Overall Study|Lost to Follow-up|0|||
25035007|NCT03881059|50134779|FG000|Treatment Period - Part A|Adverse Event|1|||
25035008|NCT03881059|50134780|FG001|Treatment Period - Part A|Adverse Event|3|||
25035009|NCT03881059|50134781|FG002|Treatment Period - Part A|Adverse Event|4|||
25035010|NCT03881059|50134779|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
25035011|NCT03881059|50134780|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
25035012|NCT03881059|50134781|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
25035013|NCT03881059|50134779|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
25035014|NCT03881059|50134780|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
25035015|NCT03881059|50134781|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
25035016|NCT03881059|50134779|FG000|Treatment Period - Part A|Other reasons|2|||
25035017|NCT03881059|50134780|FG001|Treatment Period - Part A|Other reasons|1|||
25035018|NCT03881059|50134781|FG002|Treatment Period - Part A|Other reasons|0|||
25035019|NCT03881059|50134779|FG000|Treatment Period - Part B|Adverse Event|0|||
25035020|NCT03881059|50134780|FG001|Treatment Period - Part B|Adverse Event|0|||
25035021|NCT03881059|50134781|FG002|Treatment Period - Part B|Adverse Event|3|||
25035022|NCT03881059|50134779|FG000|Treatment Period - Part B|Death|0|||
25035023|NCT03881059|50134780|FG001|Treatment Period - Part B|Death|1|||
25035024|NCT03881059|50134781|FG002|Treatment Period - Part B|Death|1|||
24946653|NCT00308685|50039095|FG000|Overall Study|Need to administer prohibited medication|1|||
24946654|NCT00308685|50039096|FG001|Overall Study|Need to administer prohibited medication|2|||
24946655|NCT00308685|50039095|FG000|Overall Study|Other than specified|1|||
24946656|NCT00308685|50039096|FG001|Overall Study|Other than specified|3|||
24946657|NCT00317109|50039104|FG000|Overall Study|Withdrawal by Subject|2|||
24946658|NCT00317109|50039105|FG001|Overall Study|Withdrawal by Subject|0|||
24946659|NCT00317109|50039104|FG000|Overall Study|Migated/moved from study area|1|||
24946660|NCT00317109|50039105|FG001|Overall Study|Migated/moved from study area|0|||
25035025|NCT03881059|50134779|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
25035026|NCT03881059|50134780|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
25035027|NCT03881059|50134781|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
25035028|NCT03881059|50134779|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
25035029|NCT03881059|50134780|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
25035030|NCT03881059|50134781|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
25035031|NCT03881059|50134779|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
25035032|NCT03881059|50134780|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
25035033|NCT03881059|50134781|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
25035034|NCT03881059|50134779|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
25035035|NCT03881059|50134780|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
25035036|NCT03881059|50134781|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
25035037|NCT03881059|50134779|FG000|Treatment Period - Part B|Other reasons|4|||
25035038|NCT03881059|50134780|FG001|Treatment Period - Part B|Other reasons|3|||
25035039|NCT03881059|50134781|FG002|Treatment Period - Part B|Other reasons|3|||
25035040|NCT02861534|50134796|FG000|Overall Study|Death|541|||
25035041|NCT02861534|50134797|FG001|Overall Study|Death|552|||
25035042|NCT02861534|50134796|FG000|Overall Study|Lost to Follow-up|14|||
25035043|NCT02861534|50134797|FG001|Overall Study|Lost to Follow-up|14|||
25035044|NCT02861534|50134796|FG000|Overall Study|Site Terminated by Sponsor|4|||
25035045|NCT02861534|50134797|FG001|Overall Study|Site Terminated by Sponsor|3|||
25035046|NCT02861534|50134796|FG000|Overall Study|Withdrawal by Subject|15|||
25035047|NCT02861534|50134797|FG001|Overall Study|Withdrawal by Subject|18|||
25035048|NCT03083847|50134838|FG000|Main|Physician Decision|0|||
25035049|NCT03083847|50134839|FG001|Main|Physician Decision|0|||
25035050|NCT03083847|50134840|FG002|Main|Physician Decision|0|||
25035051|NCT03083847|50134841|FG003|Main|Physician Decision|0|||
25035052|NCT03083847|50134842|FG004|Main|Physician Decision|0|||
25035053|NCT03083847|50134843|FG005|Main|Physician Decision|1|||
25035054|NCT03083847|50134844|FG006|Main|Physician Decision|0|||
25035055|NCT03083847|50134845|FG007|Main|Physician Decision|0|||
25035056|NCT03083847|50134846|FG008|Main|Physician Decision|0|||
25035057|NCT03083847|50134847|FG009|Main|Physician Decision|0|||
25035058|NCT03083847|50134838|FG000|Main|Pregnancy|0|||
25035059|NCT03083847|50134839|FG001|Main|Pregnancy|0|||
25035060|NCT03083847|50134840|FG002|Main|Pregnancy|0|||
25035061|NCT03083847|50134841|FG003|Main|Pregnancy|0|||
25035062|NCT03083847|50134842|FG004|Main|Pregnancy|0|||
25035063|NCT03083847|50134843|FG005|Main|Pregnancy|0|||
25035064|NCT03083847|50134844|FG006|Main|Pregnancy|0|||
25035065|NCT03083847|50134845|FG007|Main|Pregnancy|1|||
25035066|NCT03083847|50134846|FG008|Main|Pregnancy|0|||
25159714|NCT01392573|50279617|FG000|Overall Study|Site closure|8|||
24946661|NCT00316719|50039113|FG000|Overall Study|Adverse Event|0|||
24946662|NCT00316719|50039114|FG001|Overall Study|Adverse Event|6|||
24946663|NCT00316719|50039113|FG000|Overall Study|Consent withdrawn|2|||
25035067|NCT03083847|50134847|FG009|Main|Pregnancy|0|||
25035068|NCT03083847|50134838|FG000|Main|Adverse Event|0|||
25035069|NCT03083847|50134839|FG001|Main|Adverse Event|0|||
25035070|NCT03083847|50134840|FG002|Main|Adverse Event|0|||
25035071|NCT03083847|50134841|FG003|Main|Adverse Event|0|||
25035072|NCT03083847|50134842|FG004|Main|Adverse Event|0|||
25035073|NCT03083847|50134843|FG005|Main|Adverse Event|0|||
25035074|NCT03083847|50134844|FG006|Main|Adverse Event|0|||
25035075|NCT03083847|50134845|FG007|Main|Adverse Event|2|||
25035076|NCT03083847|50134846|FG008|Main|Adverse Event|0|||
24946664|NCT00316719|50039114|FG001|Overall Study|Consent withdrawn|0|||
25035077|NCT03083847|50134847|FG009|Main|Adverse Event|0|||
25035078|NCT03083847|50134838|FG000|Main|Withdrawal by Subject|0|||
25035079|NCT03083847|50134839|FG001|Main|Withdrawal by Subject|0|||
25035080|NCT03083847|50134840|FG002|Main|Withdrawal by Subject|0|||
25035081|NCT03083847|50134841|FG003|Main|Withdrawal by Subject|0|||
25035082|NCT03083847|50134842|FG004|Main|Withdrawal by Subject|0|||
25035083|NCT03083847|50134843|FG005|Main|Withdrawal by Subject|0|||
25035084|NCT03083847|50134844|FG006|Main|Withdrawal by Subject|1|||
25035085|NCT03083847|50134845|FG007|Main|Withdrawal by Subject|1|||
25035086|NCT03083847|50134846|FG008|Main|Withdrawal by Subject|0|||
25035087|NCT03083847|50134847|FG009|Main|Withdrawal by Subject|0|||
25035088|NCT03082677|50134875|FG000|Overall Study|Not Treated|2|||
25035089|NCT02858180|50134890|FG000|Overall Study|Lost to Follow-up|0|||
25035090|NCT02858180|50134891|FG001|Overall Study|Lost to Follow-up|2|||
25035091|NCT03082599|50134899|FG000|Overall Study|Lost to Follow-up|1|||
25035092|NCT03082599|50134900|FG001|Overall Study|Lost to Follow-up|0|||
25035093|NCT01346501|50134908|FG000|Overall Study|Initiated Other Biological Agents|3|||
25035094|NCT01346501|50134909|FG001|Overall Study|Initiated Other Biological Agents|1|||
25035095|NCT01346501|50134908|FG000|Overall Study|Other|8|||
25035096|NCT01346501|50134909|FG001|Overall Study|Other|12|||
25035097|NCT03160885|50134919|FG000|Initial Treatment Period|Not dosed|2|||
25035098|NCT03160885|50134920|FG001|Initial Treatment Period|Not dosed|0|||
25035099|NCT03160885|50134921|FG002|Initial Treatment Period|Not dosed|0|||
24946665|NCT00422058|50039126|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
24946666|NCT00422058|50039127|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
24946667|NCT00422058|50039128|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
24946668|NCT00422058|50039129|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
24946669|NCT00422058|50039130|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
24946670|NCT00422058|50039131|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
24946671|NCT00422058|50039126|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
24946672|NCT00422058|50039127|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
24946673|NCT00422058|50039128|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
24946674|NCT00422058|50039129|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
24946675|NCT00422058|50039130|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
24946676|NCT00422058|50039131|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
24946677|NCT00422058|50039126|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
24946678|NCT00422058|50039127|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
24946679|NCT00422058|50039128|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
24946680|NCT00422058|50039129|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
24946681|NCT00422058|50039130|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
24946682|NCT00422058|50039131|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
25035100|NCT03160885|50134922|FG003|Initial Treatment Period|Not dosed|0|||
25035101|NCT03160885|50134923|FG004|Initial Treatment Period|Not dosed|0|||
25035102|NCT03160885|50134924|FG005|Initial Treatment Period|Not dosed|0|||
25035103|NCT03160885|50134925|FG006|Initial Treatment Period|Not dosed|0|||
25035104|NCT03160885|50134919|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
25035105|NCT03160885|50134920|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
25035106|NCT03160885|50134921|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
24946683|NCT00422058|50039126|FG000|Double-Blind, Week 0-20|Other|11|||
24946684|NCT00422058|50039127|FG001|Double-Blind, Week 0-20|Other|3|||
24946685|NCT00422058|50039128|FG002|Double-Blind, Week 0-20|Other|8|||
24946686|NCT00422058|50039129|FG003|Double-Blind, Week 0-20|Other|8|||
24946687|NCT00422058|50039130|FG004|Double-Blind, Week 0-20|Other|4|||
24946688|NCT00422058|50039131|FG005|Double-Blind, Week 0-20|Other|10|||
24946689|NCT00422058|50039126|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
24946690|NCT00422058|50039127|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
24946691|NCT00422058|50039128|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
24946692|NCT00422058|50039129|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
24946693|NCT00422058|50039130|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
24946694|NCT00422058|50039131|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
24946695|NCT00422058|50039126|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
24946696|NCT00422058|50039127|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
24946697|NCT00422058|50039128|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
24946698|NCT00422058|50039129|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
24946699|NCT00422058|50039130|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
24946700|NCT00422058|50039131|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
24946701|NCT00422058|50039126|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
24946702|NCT00422058|50039127|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
24946703|NCT00422058|50039128|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
24946704|NCT00422058|50039129|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
25035107|NCT03160885|50134922|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
25035108|NCT03160885|50134923|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
25035109|NCT03160885|50134924|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
25035110|NCT03160885|50134925|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
25035111|NCT03160885|50134919|FG000|Open-label Treatment|Not dosed|0|||
25035112|NCT03160885|50134920|FG001|Open-label Treatment|Not dosed|0|||
25035113|NCT03160885|50134921|FG002|Open-label Treatment|Not dosed|0|||
25035114|NCT03160885|50134922|FG003|Open-label Treatment|Not dosed|0|||
24946705|NCT00422058|50039130|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
24946706|NCT00422058|50039131|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
24946707|NCT00422058|50039126|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
24946708|NCT00422058|50039127|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
24946709|NCT00422058|50039128|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
24946710|NCT00422058|50039129|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
24946711|NCT00422058|50039130|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
25035115|NCT03160885|50134923|FG004|Open-label Treatment|Not dosed|0|||
25035116|NCT03160885|50134924|FG005|Open-label Treatment|Not dosed|0|||
25035117|NCT03160885|50134925|FG006|Open-label Treatment|Not dosed|2|||
25035118|NCT03160885|50134919|FG000|Open-label Treatment|Discontinued IMP|0|||
25035119|NCT03160885|50134920|FG001|Open-label Treatment|Discontinued IMP|0|||
25035120|NCT03160885|50134921|FG002|Open-label Treatment|Discontinued IMP|0|||
25035121|NCT03160885|50134922|FG003|Open-label Treatment|Discontinued IMP|0|||
25035122|NCT03160885|50134923|FG004|Open-label Treatment|Discontinued IMP|0|||
25035123|NCT03160885|50134924|FG005|Open-label Treatment|Discontinued IMP|0|||
25035124|NCT03160885|50134925|FG006|Open-label Treatment|Discontinued IMP|131|||
25035125|NCT03160885|50134919|FG000|Open-label Treatment|Completed Week 50|0|||
25035126|NCT03160885|50134920|FG001|Open-label Treatment|Completed Week 50|0|||
25035127|NCT03160885|50134921|FG002|Open-label Treatment|Completed Week 50|0|||
25035128|NCT03160885|50134922|FG003|Open-label Treatment|Completed Week 50|0|||
25035129|NCT03160885|50134923|FG004|Open-label Treatment|Completed Week 50|0|||
25035130|NCT03160885|50134924|FG005|Open-label Treatment|Completed Week 50|0|||
25035131|NCT03160885|50134925|FG006|Open-label Treatment|Completed Week 50|4|||
25035132|NCT03160885|50134919|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
25035133|NCT03160885|50134920|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
25035134|NCT03160885|50134921|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
25035135|NCT03160885|50134922|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
25035136|NCT03160885|50134923|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
25035137|NCT03160885|50134924|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
25035138|NCT03160885|50134925|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
25035139|NCT03160885|50134919|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
25035140|NCT03160885|50134920|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
25035141|NCT03160885|50134921|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
25035142|NCT03160885|50134922|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
25035143|NCT03160885|50134923|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
25035144|NCT03160885|50134924|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
25035145|NCT03160885|50134925|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
25035146|NCT03160885|50134919|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
24946712|NCT00422058|50039131|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
24946713|NCT00422058|50039126|FG000|Open-Label Extension, Week 20-104|Other|13|||
24946714|NCT00422058|50039127|FG001|Open-Label Extension, Week 20-104|Other|14|||
24946715|NCT00422058|50039128|FG002|Open-Label Extension, Week 20-104|Other|6|||
24946716|NCT00422058|50039129|FG003|Open-Label Extension, Week 20-104|Other|13|||
24946717|NCT00422058|50039130|FG004|Open-Label Extension, Week 20-104|Other|16|||
24946718|NCT00422058|50039131|FG005|Open-Label Extension, Week 20-104|Other|18|||
24946719|NCT00413244|50039155|FG000|Overall Study|Withdrawal by Subject|10|||
24946720|NCT00413244|50039156|FG001|Overall Study|Withdrawal by Subject|1|||
24946721|NCT00420420|50039184|FG000|Overall Study|Adverse Event|5|||
24946722|NCT00420420|50039185|FG001|Overall Study|Adverse Event|3|||
24946723|NCT00420420|50039184|FG000|Overall Study|Protocol Violation|1|||
24946724|NCT00420420|50039185|FG001|Overall Study|Protocol Violation|1|||
24946725|NCT00420420|50039184|FG000|Overall Study|Withdrawal by Subject|1|||
24946726|NCT00420420|50039185|FG001|Overall Study|Withdrawal by Subject|0|||
24946727|NCT00420420|50039184|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
25035147|NCT03160885|50134920|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
25035148|NCT03160885|50134921|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
25035149|NCT03160885|50134922|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
25035150|NCT03160885|50134923|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
25035151|NCT03160885|50134924|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
25035152|NCT03160885|50134925|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
25035153|NCT03160885|50134919|FG000|Maintenance Treatment Period|Completed Week 50|0|||
25035154|NCT03160885|50134920|FG001|Maintenance Treatment Period|Completed Week 50|0|||
25035155|NCT03160885|50134921|FG002|Maintenance Treatment Period|Completed Week 50|1|||
25035156|NCT03160885|50134922|FG003|Maintenance Treatment Period|Completed Week 50|0|||
25035157|NCT03160885|50134923|FG004|Maintenance Treatment Period|Completed Week 50|0|||
25035158|NCT03160885|50134924|FG005|Maintenance Treatment Period|Completed Week 50|0|||
25035159|NCT03160885|50134925|FG006|Maintenance Treatment Period|Completed Week 50|0|||
25035160|NCT03181451|50134945|FG000|Overall Study|Adverse Event|0|||
25035161|NCT03181451|50134946|FG001|Overall Study|Adverse Event|1|||
25035162|NCT03181451|50134947|FG002|Overall Study|Adverse Event|0|||
25035163|NCT03181451|50134945|FG000|Overall Study|Withdrawal by Subject|0|||
25035164|NCT03181451|50134946|FG001|Overall Study|Withdrawal by Subject|1|||
25035165|NCT03181451|50134947|FG002|Overall Study|Withdrawal by Subject|0|||
25035166|NCT00406783|50134959|FG000|Overall Study|Adverse Event|4|||
25035167|NCT00406783|50134960|FG001|Overall Study|Adverse Event|4|||
25035168|NCT00406783|50134959|FG000|Overall Study|Treatment Failure|2|||
25035169|NCT00406783|50134960|FG001|Overall Study|Treatment Failure|3|||
25035170|NCT00406783|50134959|FG000|Overall Study|Lost to Follow-up|3|||
25035171|NCT00406783|50134960|FG001|Overall Study|Lost to Follow-up|0|||
25035172|NCT00406783|50134959|FG000|Overall Study|Withdrawal by Subject|1|||
25035173|NCT00406783|50134960|FG001|Overall Study|Withdrawal by Subject|4|||
25035174|NCT00406783|50134959|FG000|Overall Study|Protocol Violation|4|||
25035175|NCT00406783|50134960|FG001|Overall Study|Protocol Violation|4|||
25035176|NCT03179891|50134966|FG000|First Intervention|Withdrawal by Subject|1|||
24946728|NCT00420420|50039185|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
24946729|NCT00420342|50039194|FG000|Overall Study|Lost to Follow-up|1|||
24946730|NCT00420342|50039195|FG001|Overall Study|Lost to Follow-up|0|||
24946731|NCT00420342|50039196|FG002|Overall Study|Lost to Follow-up|1|||
24946732|NCT00420342|50039194|FG000|Overall Study|Withdrawal by Subject|0|||
24946733|NCT00420342|50039195|FG001|Overall Study|Withdrawal by Subject|2|||
24946734|NCT00420342|50039196|FG002|Overall Study|Withdrawal by Subject|0|||
24946735|NCT00432744|50039206|FG000|Months 0-6|Withdrawal by Subject|4|||
25035177|NCT03179891|50134967|FG001|First Intervention|Withdrawal by Subject|1|||
25035178|NCT03179891|50134966|FG000|First Intervention|Unspecified reason|1|||
25035179|NCT03179891|50134967|FG001|First Intervention|Unspecified reason|0|||
25035180|NCT03179891|50134966|FG000|First Intervention|Protocol Violation|0|||
25035181|NCT03179891|50134967|FG001|First Intervention|Protocol Violation|1|||
25035182|NCT02973815|50134978|FG000|Post Intervention|Death|1|||
25035183|NCT02973815|50134979|FG001|Post Intervention|Death|0|||
25035184|NCT02973815|50134978|FG000|Post Intervention|Lost to Follow-up|7|||
25035185|NCT02973815|50134979|FG001|Post Intervention|Lost to Follow-up|24|||
25035186|NCT02973815|50134978|FG000|Follow-up|Lost to Follow-up|2|||
25035187|NCT02973815|50134979|FG001|Follow-up|Lost to Follow-up|0|||
25035188|NCT03160573|50134989|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
25035189|NCT03160573|50134990|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
25035190|NCT03160573|50134991|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
25035191|NCT03160573|50134992|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
25035192|NCT02736227|50135005|FG000|Overall Study|Withdrawal by Subject|0|||
25035193|NCT02736227|50135006|FG001|Overall Study|Withdrawal by Subject|0|||
25035194|NCT02736227|50135007|FG002|Overall Study|Withdrawal by Subject|1|||
25035195|NCT02736227|50135005|FG000|Overall Study|Physician Decision|0|||
25035196|NCT02736227|50135006|FG001|Overall Study|Physician Decision|0|||
25035197|NCT02736227|50135007|FG002|Overall Study|Physician Decision|5|||
25035198|NCT02736227|50135005|FG000|Overall Study|Non Compliant|0|||
25035199|NCT02736227|50135006|FG001|Overall Study|Non Compliant|0|||
25035200|NCT02736227|50135007|FG002|Overall Study|Non Compliant|2|||
25035201|NCT03176459|50135016|FG000|Overall Study|Lost to Follow-up|5|||
25035202|NCT03176459|50135017|FG001|Overall Study|Lost to Follow-up|7|||
25035203|NCT03155269|50135025|FG000|Overall Study|Withdrawal by Subject|4|||
25035204|NCT03155269|50135026|FG001|Overall Study|Withdrawal by Subject|5|||
25035205|NCT03155269|50135025|FG000|Overall Study|Lost to Follow-up|1|||
25035206|NCT03155269|50135026|FG001|Overall Study|Lost to Follow-up|2|||
25035207|NCT02906670|50135042|FG000|Cohort 1, QW|Radiological Progression|1|||
25035208|NCT02906670|50135043|FG001|Cohort 1, QW|Radiological Progression|0|||
25035209|NCT02906670|50135044|FG002|Cohort 1, QW|Radiological Progression|0|||
25035210|NCT02906670|50135045|FG003|Cohort 1, QW|Radiological Progression|0|||
25035211|NCT02906670|50135046|FG004|Cohort 1, QW|Radiological Progression|0|||
24946736|NCT00432744|50039207|FG001|Months 0-6|Withdrawal by Subject|4|||
24946737|NCT00432744|50039206|FG000|Months 0-6|Too disabled to score|1|||
25035212|NCT02906670|50135047|FG005|Cohort 1, QW|Radiological Progression|0|||
25035213|NCT02906670|50135048|FG006|Cohort 1, QW|Radiological Progression|0|||
25035214|NCT02906670|50135049|FG007|Cohort 1, QW|Radiological Progression|0|||
25035215|NCT02906670|50135050|FG008|Cohort 1, QW|Radiological Progression|0|||
25035216|NCT02906670|50135051|FG009|Cohort 1, QW|Radiological Progression|0|||
25035217|NCT02906670|50135042|FG000|Cohort 2, QW|Radiological Progression|0|||
25035218|NCT02906670|50135043|FG001|Cohort 2, QW|Radiological Progression|1|||
25035219|NCT02906670|50135044|FG002|Cohort 2, QW|Radiological Progression|0|||
25035220|NCT02906670|50135045|FG003|Cohort 2, QW|Radiological Progression|0|||
25035221|NCT02906670|50135046|FG004|Cohort 2, QW|Radiological Progression|0|||
25035222|NCT02906670|50135047|FG005|Cohort 2, QW|Radiological Progression|0|||
25035223|NCT02906670|50135048|FG006|Cohort 2, QW|Radiological Progression|0|||
25035224|NCT02906670|50135049|FG007|Cohort 2, QW|Radiological Progression|0|||
25035225|NCT02906670|50135050|FG008|Cohort 2, QW|Radiological Progression|0|||
25035226|NCT02906670|50135051|FG009|Cohort 2, QW|Radiological Progression|0|||
25035227|NCT02906670|50135042|FG000|Cohort 3, QW|Radiological Progression|0|||
25035228|NCT02906670|50135043|FG001|Cohort 3, QW|Radiological Progression|0|||
25035229|NCT02906670|50135044|FG002|Cohort 3, QW|Radiological Progression|2|||
25035230|NCT02906670|50135045|FG003|Cohort 3, QW|Radiological Progression|0|||
25035231|NCT02906670|50135046|FG004|Cohort 3, QW|Radiological Progression|0|||
25035232|NCT02906670|50135047|FG005|Cohort 3, QW|Radiological Progression|0|||
25035233|NCT02906670|50135048|FG006|Cohort 3, QW|Radiological Progression|0|||
25035234|NCT02906670|50135049|FG007|Cohort 3, QW|Radiological Progression|0|||
25035235|NCT02906670|50135050|FG008|Cohort 3, QW|Radiological Progression|0|||
25035236|NCT02906670|50135051|FG009|Cohort 3, QW|Radiological Progression|0|||
25035237|NCT02906670|50135042|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
25035238|NCT02906670|50135043|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
25035239|NCT02906670|50135044|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
25035240|NCT02906670|50135045|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
25035241|NCT02906670|50135046|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
25035242|NCT02906670|50135047|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
25035243|NCT02906670|50135048|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
25035244|NCT02906670|50135049|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
25035245|NCT02906670|50135050|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
25035246|NCT02906670|50135051|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
25035247|NCT02906670|50135042|FG000|Cohort 4, Q2W|Radiological Progression|0|||
25035248|NCT02906670|50135043|FG001|Cohort 4, Q2W|Radiological Progression|0|||
25035249|NCT02906670|50135044|FG002|Cohort 4, Q2W|Radiological Progression|0|||
25035250|NCT02906670|50135045|FG003|Cohort 4, Q2W|Radiological Progression|0|||
25035251|NCT02906670|50135046|FG004|Cohort 4, Q2W|Radiological Progression|0|||
25035252|NCT02906670|50135047|FG005|Cohort 4, Q2W|Radiological Progression|1|||
25035253|NCT02906670|50135048|FG006|Cohort 4, Q2W|Radiological Progression|0|||
25035254|NCT02906670|50135049|FG007|Cohort 4, Q2W|Radiological Progression|0|||
25035255|NCT02906670|50135050|FG008|Cohort 4, Q2W|Radiological Progression|0|||
25035256|NCT02906670|50135051|FG009|Cohort 4, Q2W|Radiological Progression|0|||
25035257|NCT02906670|50135042|FG000|Cohort 4, Q2W|Clinical Progression|0|||
25035258|NCT02906670|50135043|FG001|Cohort 4, Q2W|Clinical Progression|0|||
25035259|NCT02906670|50135044|FG002|Cohort 4, Q2W|Clinical Progression|0|||
25035260|NCT02906670|50135045|FG003|Cohort 4, Q2W|Clinical Progression|0|||
25035261|NCT02906670|50135046|FG004|Cohort 4, Q2W|Clinical Progression|0|||
25035262|NCT02906670|50135047|FG005|Cohort 4, Q2W|Clinical Progression|2|||
25035263|NCT02906670|50135048|FG006|Cohort 4, Q2W|Clinical Progression|0|||
25035264|NCT02906670|50135049|FG007|Cohort 4, Q2W|Clinical Progression|0|||
25035265|NCT02906670|50135050|FG008|Cohort 4, Q2W|Clinical Progression|0|||
25035266|NCT02906670|50135051|FG009|Cohort 4, Q2W|Clinical Progression|0|||
25035267|NCT02906670|50135042|FG000|Cohort 5, Q2W|Radiological Progression|0|||
25035268|NCT02906670|50135043|FG001|Cohort 5, Q2W|Radiological Progression|0|||
25035269|NCT02906670|50135044|FG002|Cohort 5, Q2W|Radiological Progression|0|||
25035270|NCT02906670|50135045|FG003|Cohort 5, Q2W|Radiological Progression|0|||
25035271|NCT02906670|50135046|FG004|Cohort 5, Q2W|Radiological Progression|0|||
25035272|NCT02906670|50135047|FG005|Cohort 5, Q2W|Radiological Progression|0|||
25035273|NCT02906670|50135048|FG006|Cohort 5, Q2W|Radiological Progression|4|||
25035274|NCT02906670|50135049|FG007|Cohort 5, Q2W|Radiological Progression|0|||
25035275|NCT02906670|50135050|FG008|Cohort 5, Q2W|Radiological Progression|0|||
25035276|NCT02906670|50135051|FG009|Cohort 5, Q2W|Radiological Progression|0|||
25035277|NCT02906670|50135042|FG000|Cohort 5, Q2W|Clinical Progression|0|||
25035278|NCT02906670|50135043|FG001|Cohort 5, Q2W|Clinical Progression|0|||
25035279|NCT02906670|50135044|FG002|Cohort 5, Q2W|Clinical Progression|0|||
25035280|NCT02906670|50135045|FG003|Cohort 5, Q2W|Clinical Progression|0|||
25035281|NCT02906670|50135046|FG004|Cohort 5, Q2W|Clinical Progression|0|||
25035282|NCT02906670|50135047|FG005|Cohort 5, Q2W|Clinical Progression|0|||
25035283|NCT02906670|50135048|FG006|Cohort 5, Q2W|Clinical Progression|1|||
25035284|NCT02906670|50135049|FG007|Cohort 5, Q2W|Clinical Progression|0|||
25035285|NCT02906670|50135050|FG008|Cohort 5, Q2W|Clinical Progression|0|||
25035286|NCT02906670|50135051|FG009|Cohort 5, Q2W|Clinical Progression|0|||
25035287|NCT02906670|50135042|FG000|Cohort 5, Q2W|Adverse Event|0|||
25035288|NCT02906670|50135043|FG001|Cohort 5, Q2W|Adverse Event|0|||
25035289|NCT02906670|50135044|FG002|Cohort 5, Q2W|Adverse Event|0|||
25035290|NCT02906670|50135045|FG003|Cohort 5, Q2W|Adverse Event|0|||
25035291|NCT02906670|50135046|FG004|Cohort 5, Q2W|Adverse Event|0|||
25035292|NCT02906670|50135047|FG005|Cohort 5, Q2W|Adverse Event|0|||
25035293|NCT02906670|50135048|FG006|Cohort 5, Q2W|Adverse Event|1|||
25035294|NCT02906670|50135049|FG007|Cohort 5, Q2W|Adverse Event|0|||
25035295|NCT02906670|50135050|FG008|Cohort 5, Q2W|Adverse Event|0|||
25035296|NCT02906670|50135051|FG009|Cohort 5, Q2W|Adverse Event|0|||
25035297|NCT02906670|50135042|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
25035298|NCT02906670|50135043|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
25035299|NCT02906670|50135044|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
25035300|NCT02906670|50135045|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
25035301|NCT02906670|50135046|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
25035302|NCT02906670|50135047|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
25035303|NCT02906670|50135048|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
25035304|NCT02906670|50135049|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
25035305|NCT02906670|50135050|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
25035306|NCT02906670|50135051|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
25035307|NCT02906670|50135042|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
25035308|NCT02906670|50135043|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
25035309|NCT02906670|50135044|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
25035310|NCT02906670|50135045|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
25035311|NCT02906670|50135046|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
25035312|NCT02906670|50135047|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
25035313|NCT02906670|50135048|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
25035314|NCT02906670|50135049|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
25035315|NCT02906670|50135050|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
25035316|NCT02906670|50135051|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
25035317|NCT02906670|50135042|FG000|Cohort 5P, Q2W|Adverse Event|0|||
25186218|NCT01399697|50336174|FG002|Overall Study|Investigator Decisión|2|||
25186219|NCT01399697|50336172|FG000|Overall Study|Lack of Efficacy|9|||
25186220|NCT01399697|50336173|FG001|Overall Study|Lack of Efficacy|0|||
25186221|NCT01399697|50336174|FG002|Overall Study|Lack of Efficacy|1|||
25186222|NCT01399697|50336172|FG000|Overall Study|Protocol Violation|2|||
25186223|NCT01399697|50336173|FG001|Overall Study|Protocol Violation|0|||
25186224|NCT01399697|50336174|FG002|Overall Study|Protocol Violation|0|||
25186225|NCT01399697|50336172|FG000|Overall Study|Non-Compliant|1|||
25186226|NCT01399697|50336173|FG001|Overall Study|Non-Compliant|0|||
25186227|NCT01399697|50336174|FG002|Overall Study|Non-Compliant|0|||
25186228|NCT01399697|50336172|FG000|Overall Study|Inclusion Error|2|||
25186229|NCT01399697|50336173|FG001|Overall Study|Inclusion Error|0|||
25186230|NCT01399697|50336174|FG002|Overall Study|Inclusion Error|0|||
25186231|NCT01399697|50336172|FG000|Overall Study|Positive result for hepatitis B|1|||
24946738|NCT00432744|50039207|FG001|Months 0-6|Too disabled to score|0|||
24946739|NCT00432744|50039206|FG000|Months 7 - 12|Withdrawal by Subject|1|||
24946740|NCT00432744|50039207|FG001|Months 7 - 12|Withdrawal by Subject|0|||
24946741|NCT00432744|50039206|FG000|Months 7 - 12|Too disabled to score|0|||
24946742|NCT00432744|50039207|FG001|Months 7 - 12|Too disabled to score|1|||
24946743|NCT00432666|50039215|FG000|Main Period|Adverse Event|1|||
24946744|NCT00432666|50039216|FG001|Main Period|Adverse Event|1|||
24946745|NCT00432666|50039215|FG000|Main Period|Consent Withdrawn|1|||
24946746|NCT00432666|50039216|FG001|Main Period|Consent Withdrawn|0|||
24946747|NCT00432666|50039215|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
24946748|NCT00432666|50039216|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
24946749|NCT00432666|50039215|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
24946750|NCT00432666|50039216|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
24946751|NCT00432666|50039215|FG000|Open-Label Extension Period|Adverse Event|5|||
24946752|NCT00432666|50039216|FG001|Open-Label Extension Period|Adverse Event|0|||
24946753|NCT00432666|50039215|FG000|Open-Label Extension Period|Consent withdrawn|10|||
24946754|NCT00432666|50039216|FG001|Open-Label Extension Period|Consent withdrawn|0|||
24946755|NCT00432666|50039215|FG000|Open-Label Extension Period|Physician Decision|3|||
24946756|NCT00432666|50039216|FG001|Open-Label Extension Period|Physician Decision|0|||
24946757|NCT00451958|50039226|FG000|CS21A (NCT00451958)|Adverse Event|21|||
24946758|NCT00451958|50039227|FG001|CS21A (NCT00451958)|Adverse Event|34|||
24946759|NCT00451958|50039228|FG002|CS21A (NCT00451958)|Adverse Event|14|||
24946760|NCT00451958|50039229|FG003|CS21A (NCT00451958)|Adverse Event|17|||
24946761|NCT00451958|50039230|FG004|CS21A (NCT00451958)|Adverse Event|0|||
24946762|NCT00451958|50039226|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
24946763|NCT00451958|50039227|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
24946764|NCT00451958|50039228|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
24946765|NCT00451958|50039229|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
24946766|NCT00451958|50039230|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
24946767|NCT00451958|50039226|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
25035318|NCT02906670|50135043|FG001|Cohort 5P, Q2W|Adverse Event|0|||
25035319|NCT02906670|50135044|FG002|Cohort 5P, Q2W|Adverse Event|0|||
25035320|NCT02906670|50135045|FG003|Cohort 5P, Q2W|Adverse Event|0|||
25186232|NCT01399697|50336173|FG001|Overall Study|Positive result for hepatitis B|0|||
25186233|NCT01399697|50336174|FG002|Overall Study|Positive result for hepatitis B|0|||
25186234|NCT01399697|50336172|FG000|Overall Study|Clinical RA remission|1|||
25186235|NCT01399697|50336173|FG001|Overall Study|Clinical RA remission|0|||
25186236|NCT01399697|50336174|FG002|Overall Study|Clinical RA remission|0|||
25035321|NCT02906670|50135046|FG004|Cohort 5P, Q2W|Adverse Event|0|||
25035322|NCT02906670|50135047|FG005|Cohort 5P, Q2W|Adverse Event|0|||
25035323|NCT02906670|50135048|FG006|Cohort 5P, Q2W|Adverse Event|0|||
25035324|NCT02906670|50135049|FG007|Cohort 5P, Q2W|Adverse Event|1|||
25035325|NCT02906670|50135050|FG008|Cohort 5P, Q2W|Adverse Event|0|||
25035326|NCT02906670|50135051|FG009|Cohort 5P, Q2W|Adverse Event|0|||
25035327|NCT02906670|50135042|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
24946768|NCT00451958|50039227|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
25035328|NCT02906670|50135043|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
25035329|NCT02906670|50135044|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
25035330|NCT02906670|50135045|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
25035331|NCT02906670|50135046|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
25035332|NCT02906670|50135047|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
25035333|NCT02906670|50135048|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
25035334|NCT02906670|50135049|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
25035335|NCT02906670|50135050|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
25035336|NCT02906670|50135051|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
25035337|NCT02906670|50135042|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
25035338|NCT02906670|50135043|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
25035339|NCT02906670|50135044|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
25035340|NCT02906670|50135045|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
25159715|NCT01392573|50279618|FG001|Overall Study|Site closure|7|||
25159716|NCT01392573|50279617|FG000|Overall Study|Unclassified|9|||
24946769|NCT00451958|50039228|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
24946770|NCT00451958|50039229|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
24946771|NCT00451958|50039230|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
24946772|NCT00451958|50039226|FG000|CS21A (NCT00451958)|Physician Decision|2|||
24946773|NCT00451958|50039227|FG001|CS21A (NCT00451958)|Physician Decision|4|||
24946774|NCT00451958|50039228|FG002|CS21A (NCT00451958)|Physician Decision|4|||
24946775|NCT00451958|50039229|FG003|CS21A (NCT00451958)|Physician Decision|4|||
24946776|NCT00451958|50039230|FG004|CS21A (NCT00451958)|Physician Decision|0|||
24946777|NCT00451958|50039226|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
24946778|NCT00451958|50039227|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
24946779|NCT00451958|50039228|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
24946780|NCT00451958|50039229|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
24946781|NCT00451958|50039230|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
24946782|NCT00451958|50039226|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
25159717|NCT01392573|50279618|FG001|Overall Study|Unclassified|6|||
25159718|NCT01392495|50279624|FG000|Overall Study|Death|3|||
25159719|NCT01392495|50279624|FG000|Overall Study|Administrative problems|8|||
25159720|NCT01392495|50279624|FG000|Overall Study|Withdrawal by Subject|2|||
25159721|NCT01392495|50279624|FG000|Overall Study|Adverse Event|3|||
25159722|NCT01405053|50279632|FG000|Overall Study|Adverse Event|3|||
25159723|NCT01405053|50279633|FG001|Overall Study|Adverse Event|0|||
25159724|NCT01405053|50279632|FG000|Overall Study|Lost to Follow-up|0|||
25159725|NCT01405053|50279633|FG001|Overall Study|Lost to Follow-up|1|||
25159726|NCT01405053|50279632|FG000|Overall Study|Participant choice|2|||
25159727|NCT01405053|50279633|FG001|Overall Study|Participant choice|1|||
25159728|NCT01405053|50279632|FG000|Overall Study|Inadequate therapeutic effect|2|||
25159729|NCT01405053|50279633|FG001|Overall Study|Inadequate therapeutic effect|1|||
25159730|NCT01405053|50279632|FG000|Overall Study|Withdrawal by Subject|3|||
25159731|NCT01405053|50279633|FG001|Overall Study|Withdrawal by Subject|4|||
25159732|NCT01405053|50279632|FG000|Overall Study|Other|0|||
25159733|NCT01405053|50279633|FG001|Overall Study|Other|1|||
25159734|NCT01403805|50279641|FG000|Overall Study|Withdrawal by Subject|0|||
24946783|NCT00451958|50039227|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
24946784|NCT00451958|50039228|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
24946785|NCT00451958|50039229|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
24946786|NCT00451958|50039230|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
24946787|NCT00432276|50039246|FG000|Overall Study|Hyperglycemic Rescue|44|||
24946788|NCT00432276|50039247|FG001|Overall Study|Hyperglycemic Rescue|87|||
24946789|NCT00432276|50039246|FG000|Overall Study|Adverse Event|13|||
24946790|NCT00432276|50039247|FG001|Overall Study|Adverse Event|16|||
24946791|NCT00432276|50039246|FG000|Overall Study|Protocol Violation|25|||
24946792|NCT00432276|50039247|FG001|Overall Study|Protocol Violation|20|||
24946793|NCT00432276|50039246|FG000|Overall Study|Lost to Follow-up|6|||
24946794|NCT00432276|50039247|FG001|Overall Study|Lost to Follow-up|2|||
25035341|NCT02906670|50135046|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
25035342|NCT02906670|50135047|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
25035343|NCT02906670|50135048|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
25159735|NCT01403805|50279642|FG001|Overall Study|Withdrawal by Subject|4|||
25159736|NCT01403805|50279641|FG000|Overall Study|Lost to Follow-up|0|||
25159737|NCT01403805|50279642|FG001|Overall Study|Lost to Follow-up|2|||
25159738|NCT01403805|50279641|FG000|Overall Study|Death|0|||
25159739|NCT01403805|50279642|FG001|Overall Study|Death|1|||
25035344|NCT02906670|50135049|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
25035345|NCT02906670|50135050|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
25159740|NCT01423617|50279654|FG000|Overall Study|Lost to Follow-up|0|||
24946795|NCT00432276|50039246|FG000|Overall Study|Withdrawal by Subject|25|||
24946796|NCT00432276|50039247|FG001|Overall Study|Withdrawal by Subject|20|||
24946797|NCT00432276|50039246|FG000|Overall Study|Physician Decision|6|||
24946798|NCT00432276|50039247|FG001|Overall Study|Physician Decision|8|||
24946799|NCT00432276|50039246|FG000|Overall Study|Other|2|||
24946800|NCT00432276|50039247|FG001|Overall Study|Other|3|||
24946801|NCT00413010|50039255|FG000|Overall Study|Adverse Event|8|||
24946802|NCT00413010|50039256|FG001|Overall Study|Adverse Event|4|||
24946803|NCT00413010|50039255|FG000|Overall Study|Laboratory abnormality|0|||
24946804|NCT00413010|50039256|FG001|Overall Study|Laboratory abnormality|2|||
25159741|NCT01423617|50279655|FG001|Overall Study|Lost to Follow-up|1|||
25159742|NCT01392183|50279663|FG000|First Drug Administration|Adverse Event|3|||
25159743|NCT01392183|50279664|FG001|First Drug Administration|Adverse Event|2|||
25159744|NCT01392183|50279663|FG000|First Drug Administration|Death|1|||
25159745|NCT01392183|50279664|FG001|First Drug Administration|Death|0|||
25159746|NCT01392183|50279663|FG000|First Drug Administration|Withdrawal by Subject|10|||
25159747|NCT01392183|50279664|FG001|First Drug Administration|Withdrawal by Subject|17|||
25159748|NCT01751906|50279674|FG000|Overall Study|Lost to Follow-up|151|||
25159749|NCT01751906|50279675|FG001|Overall Study|Lost to Follow-up|68|||
25159750|NCT01751906|50279674|FG000|Overall Study|Withdrawal by Subject|22|||
25159751|NCT01751906|50279675|FG001|Overall Study|Withdrawal by Subject|18|||
25159752|NCT01751906|50279674|FG000|Overall Study|Physician Decision|5|||
25159753|NCT01751906|50279675|FG001|Overall Study|Physician Decision|2|||
25159754|NCT01751906|50279674|FG000|Overall Study|Death|84|||
25159755|NCT01751906|50279675|FG001|Overall Study|Death|43|||
25159756|NCT01751906|50279674|FG000|Overall Study|Denied on premises for follow-up by law|1|||
25159757|NCT01751906|50279675|FG001|Overall Study|Denied on premises for follow-up by law|0|||
25159758|NCT01402947|50279683|FG000|First Intervention|Adverse Event|0|||
25159759|NCT01402947|50279684|FG001|First Intervention|Adverse Event|1|||
25159760|NCT01402869|50279693|FG000|Overall Study|Required Tooth Extraction|0|||
25159761|NCT01402869|50279694|FG001|Overall Study|Required Tooth Extraction|0|||
25159762|NCT01402869|50279695|FG002|Overall Study|Required Tooth Extraction|1|||
25159763|NCT01391793|50279705|FG000|Overall Study|Ineligible|3|||
25159764|NCT01391793|50279706|FG001|Overall Study|Ineligible|0|||
25159765|NCT01391793|50279705|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
25159766|NCT01391793|50279706|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
25159767|NCT01391793|50279705|FG000|Overall Study|No DMSA|73|||
25159768|NCT01391793|50279706|FG001|Overall Study|No DMSA|57|||
25159769|NCT01422915|50279712|FG000|Overall Study|Adverse Event|1|||
25159770|NCT01727024|50279717|FG000|Period 1|Lost to Follow-up|1|||
25159771|NCT01727024|50279718|FG001|Period 1|Lost to Follow-up|1|||
25159772|NCT01727024|50279717|FG000|Period 1|Withdrawal by Subject|2|||
25159773|NCT01727024|50279718|FG001|Period 1|Withdrawal by Subject|3|||
25159774|NCT01422213|50279727|FG000|Overall Study|Adverse Event|8|||
25159775|NCT01422213|50279728|FG001|Overall Study|Adverse Event|7|||
25159776|NCT01422213|50279729|FG002|Overall Study|Adverse Event|11|||
25159777|NCT01422213|50279727|FG000|Overall Study|Lack of Efficacy|10|||
25159778|NCT01422213|50279728|FG001|Overall Study|Lack of Efficacy|2|||
25159779|NCT01422213|50279729|FG002|Overall Study|Lack of Efficacy|2|||
25159780|NCT01422213|50279727|FG000|Overall Study|Non-compliance with study drug|0|||
25159781|NCT01422213|50279728|FG001|Overall Study|Non-compliance with study drug|1|||
25159782|NCT01422213|50279729|FG002|Overall Study|Non-compliance with study drug|0|||
25159783|NCT01422213|50279727|FG000|Overall Study|Protocol Violation|0|||
25159784|NCT01422213|50279728|FG001|Overall Study|Protocol Violation|2|||
25159785|NCT01422213|50279729|FG002|Overall Study|Protocol Violation|4|||
25159786|NCT01422213|50279727|FG000|Overall Study|Withdrawal of Consent|7|||
25159787|NCT01422213|50279728|FG001|Overall Study|Withdrawal of Consent|3|||
25159788|NCT01422213|50279729|FG002|Overall Study|Withdrawal of Consent|5|||
25159789|NCT01422213|50279727|FG000|Overall Study|Lost to Follow-up|3|||
25159790|NCT01422213|50279728|FG001|Overall Study|Lost to Follow-up|3|||
25159791|NCT01422213|50279729|FG002|Overall Study|Lost to Follow-up|5|||
25159792|NCT01422213|50279727|FG000|Overall Study|Administrative or Other Reason(s)|5|||
25275722|NCT00974974|50589532|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
24946805|NCT00413010|50039255|FG000|Overall Study|Lack of Efficacy|0|||
24946806|NCT00413010|50039256|FG001|Overall Study|Lack of Efficacy|3|||
25159793|NCT01422213|50279728|FG001|Overall Study|Administrative or Other Reason(s)|4|||
25159794|NCT01422213|50279729|FG002|Overall Study|Administrative or Other Reason(s)|2|||
25159795|NCT01390857|50279737|FG000|Overall Study|Protocol Violation|2|||
25159796|NCT01390857|50279737|FG000|Overall Study|Lost to Follow-up|1|||
25159797|NCT01390857|50279737|FG000|Overall Study|No Visit after the First Visit|7|||
25159798|NCT01725386|50279743|FG000|Overall Study|Death|84|||
25159799|NCT01725386|50279744|FG001|Overall Study|Death|40|||
25159800|NCT01725386|50279743|FG000|Overall Study|Lost to Follow-up|81|||
25159801|NCT01725386|50279744|FG001|Overall Study|Lost to Follow-up|6|||
25275723|NCT00974974|50589533|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
24946807|NCT00413010|50039255|FG000|Overall Study|Lost to Follow-up|3|||
25159802|NCT01725386|50279743|FG000|Overall Study|Withdrawal by Subject|10|||
25159803|NCT01725386|50279744|FG001|Overall Study|Withdrawal by Subject|0|||
25035346|NCT02906670|50135051|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
25035347|NCT02906670|50135042|FG000|Cohort 4P, QW|Radiological Progression|0|||
25035348|NCT02906670|50135043|FG001|Cohort 4P, QW|Radiological Progression|0|||
25035349|NCT02906670|50135044|FG002|Cohort 4P, QW|Radiological Progression|0|||
25035350|NCT02906670|50135045|FG003|Cohort 4P, QW|Radiological Progression|3|||
25035351|NCT02906670|50135046|FG004|Cohort 4P, QW|Radiological Progression|0|||
25035352|NCT02906670|50135047|FG005|Cohort 4P, QW|Radiological Progression|0|||
25035353|NCT02906670|50135048|FG006|Cohort 4P, QW|Radiological Progression|0|||
25035354|NCT02906670|50135049|FG007|Cohort 4P, QW|Radiological Progression|0|||
25035355|NCT02906670|50135050|FG008|Cohort 4P, QW|Radiological Progression|0|||
25035356|NCT02906670|50135051|FG009|Cohort 4P, QW|Radiological Progression|0|||
25035357|NCT02906670|50135042|FG000|Cohort 7P, Q2W|Adverse Event|0|||
25035358|NCT02906670|50135043|FG001|Cohort 7P, Q2W|Adverse Event|0|||
25035359|NCT02906670|50135044|FG002|Cohort 7P, Q2W|Adverse Event|0|||
25035360|NCT02906670|50135045|FG003|Cohort 7P, Q2W|Adverse Event|0|||
25035361|NCT02906670|50135046|FG004|Cohort 7P, Q2W|Adverse Event|0|||
25035362|NCT02906670|50135047|FG005|Cohort 7P, Q2W|Adverse Event|0|||
25035363|NCT02906670|50135048|FG006|Cohort 7P, Q2W|Adverse Event|0|||
25035364|NCT02906670|50135049|FG007|Cohort 7P, Q2W|Adverse Event|0|||
25035365|NCT02906670|50135050|FG008|Cohort 7P, Q2W|Adverse Event|0|||
25035366|NCT02906670|50135051|FG009|Cohort 7P, Q2W|Adverse Event|1|||
25035367|NCT02906670|50135042|FG000|Cohort 7P, Q2W|Physician Decision|0|||
25035368|NCT02906670|50135043|FG001|Cohort 7P, Q2W|Physician Decision|0|||
25035369|NCT02906670|50135044|FG002|Cohort 7P, Q2W|Physician Decision|0|||
25035370|NCT02906670|50135045|FG003|Cohort 7P, Q2W|Physician Decision|0|||
25035371|NCT02906670|50135046|FG004|Cohort 7P, Q2W|Physician Decision|0|||
25035372|NCT02906670|50135047|FG005|Cohort 7P, Q2W|Physician Decision|0|||
25035373|NCT02906670|50135048|FG006|Cohort 7P, Q2W|Physician Decision|0|||
25035374|NCT02906670|50135049|FG007|Cohort 7P, Q2W|Physician Decision|0|||
25035375|NCT02906670|50135050|FG008|Cohort 7P, Q2W|Physician Decision|0|||
25035376|NCT02906670|50135051|FG009|Cohort 7P, Q2W|Physician Decision|1|||
25035377|NCT02906670|50135042|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
25035378|NCT02906670|50135043|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
25035379|NCT02906670|50135044|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
25035380|NCT02906670|50135045|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
25035381|NCT02906670|50135046|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
25035382|NCT02906670|50135047|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
25035383|NCT02906670|50135048|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
25035384|NCT02906670|50135049|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
25035385|NCT02906670|50135050|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
25035386|NCT02906670|50135051|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
25035387|NCT02906670|50135042|FG000|Cohort 5P, QW|Radiological Progression|0|||
25035388|NCT02906670|50135043|FG001|Cohort 5P, QW|Radiological Progression|0|||
25035389|NCT02906670|50135044|FG002|Cohort 5P, QW|Radiological Progression|0|||
25035390|NCT02906670|50135045|FG003|Cohort 5P, QW|Radiological Progression|0|||
25035391|NCT02906670|50135046|FG004|Cohort 5P, QW|Radiological Progression|3|||
25035392|NCT02906670|50135047|FG005|Cohort 5P, QW|Radiological Progression|0|||
24946808|NCT00413010|50039256|FG001|Overall Study|Lost to Follow-up|0|||
24946809|NCT00413010|50039255|FG000|Overall Study|Withdrawal by Subject|7|||
24946810|NCT00413010|50039256|FG001|Overall Study|Withdrawal by Subject|2|||
24946811|NCT00413010|50039255|FG000|Overall Study|Due to termination of the study|54|||
24946812|NCT00413010|50039256|FG001|Overall Study|Due to termination of the study|52|||
24946813|NCT00459290|50039262|FG000|Overall Study|Adverse Event|3|||
24946814|NCT00459290|50039262|FG000|Overall Study|Ineligible|2|||
24946815|NCT00443534|50039273|FG000|Overall Study|Lack of Efficacy|67|||
24946816|NCT00443534|50039273|FG000|Overall Study|Adverse Event|16|||
24946817|NCT00443534|50039273|FG000|Overall Study|Death|9|||
24946818|NCT00443534|50039273|FG000|Overall Study|Withdrawal by Subject|8|||
24946819|NCT00443534|50039273|FG000|Overall Study|Study Terminated by Sponsor|12|||
24946820|NCT00443534|50039273|FG000|Overall Study|Other|10|||
24946821|NCT00443534|50039273|FG000|Overall Study|Enrolled, Not Treated|1|||
24946822|NCT00419952|50039279|FG000|Overall Study|Adverse Event|8|||
24946823|NCT00419952|50039280|FG001|Overall Study|Adverse Event|10|||
24946824|NCT00419952|50039279|FG000|Overall Study|Withdrawal by Subject|44|||
24946825|NCT00419952|50039280|FG001|Overall Study|Withdrawal by Subject|43|||
24946826|NCT00419952|50039279|FG000|Overall Study|Lost to Follow-up|43|||
24946827|NCT00419952|50039280|FG001|Overall Study|Lost to Follow-up|34|||
24946828|NCT00419952|50039279|FG000|Overall Study|Protocol Violation|32|||
24946829|NCT00419952|50039280|FG001|Overall Study|Protocol Violation|24|||
24946830|NCT00419952|50039279|FG000|Overall Study|Pregnancy|4|||
24946831|NCT00419952|50039280|FG001|Overall Study|Pregnancy|2|||
25035393|NCT02906670|50135048|FG006|Cohort 5P, QW|Radiological Progression|0|||
25159804|NCT01402011|50279753|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
25159805|NCT01402011|50279754|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
25186237|NCT01399697|50336172|FG000|Overall Study|Sponsor Decision|1|||
24946832|NCT00419952|50039279|FG000|Overall Study|Physician Decision|1|||
24946833|NCT00419952|50039280|FG001|Overall Study|Physician Decision|3|||
25035394|NCT02906670|50135049|FG007|Cohort 5P, QW|Radiological Progression|0|||
25035395|NCT02906670|50135050|FG008|Cohort 5P, QW|Radiological Progression|0|||
25035396|NCT02906670|50135051|FG009|Cohort 5P, QW|Radiological Progression|0|||
25035397|NCT02906358|50135103|FG000|Overall Study|Withdrawal by Subject|10|||
25035398|NCT02906358|50135104|FG001|Overall Study|Withdrawal by Subject|7|||
25035399|NCT02906358|50135103|FG000|Overall Study|Lost to Follow-up|12|||
25035400|NCT02906358|50135104|FG001|Overall Study|Lost to Follow-up|15|||
25035401|NCT02186834|50135110|FG000|Dose Escalation|Death|0|||
25035402|NCT02186834|50135111|FG001|Dose Escalation|Death|0|||
25035403|NCT02186834|50135112|FG002|Dose Escalation|Death|0|||
25035404|NCT02186834|50135113|FG003|Dose Escalation|Death|1|||
25035405|NCT02186834|50135114|FG004|Dose Escalation|Death|0|||
25035406|NCT02186834|50135115|FG005|Dose Escalation|Death|0|||
25035407|NCT02186834|50135110|FG000|Treatment at RP2D|Died prior to treatment|0|||
25035408|NCT02186834|50135111|FG001|Treatment at RP2D|Died prior to treatment|0|||
25035409|NCT02186834|50135112|FG002|Treatment at RP2D|Died prior to treatment|0|||
25035410|NCT02186834|50135113|FG003|Treatment at RP2D|Died prior to treatment|0|||
25035411|NCT02186834|50135114|FG004|Treatment at RP2D|Died prior to treatment|0|||
25035412|NCT02186834|50135115|FG005|Treatment at RP2D|Died prior to treatment|1|||
25035413|NCT03144687|50135126|FG000|Overall Study|Death|0|||
25035414|NCT03144687|50135127|FG001|Overall Study|Death|2|||
25035415|NCT03144687|50135126|FG000|Overall Study|Lost to Follow-up|0|||
25035416|NCT03144687|50135127|FG001|Overall Study|Lost to Follow-up|1|||
25035417|NCT03144687|50135126|FG000|Overall Study|Physician Decision|0|||
25035418|NCT03144687|50135127|FG001|Overall Study|Physician Decision|1|||
25035419|NCT03144687|50135126|FG000|Overall Study|Withdrawal by Subject|1|||
25035420|NCT03144687|50135127|FG001|Overall Study|Withdrawal by Subject|3|||
25035421|NCT03144687|50135126|FG000|Overall Study|Not Reported|2|||
25035422|NCT03144687|50135127|FG001|Overall Study|Not Reported|0|||
25035423|NCT03080961|50135137|FG000|Overall Study|Withdrawal by Subject|3|||
25035424|NCT02905266|50135161|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
25035425|NCT02905266|50135162|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
25035426|NCT02905266|50135161|FG000|Treatment Phase Part 1|Disease Progression|6|||
25035427|NCT02905266|50135162|FG001|Treatment Phase Part 1|Disease Progression|7|||
25035428|NCT02905266|50135161|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
25035429|NCT02905266|50135162|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
25035430|NCT02905266|50135161|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
25035431|NCT02905266|50135162|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
25035432|NCT02905266|50135161|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
25035433|NCT02905266|50135162|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
25035434|NCT02905266|50135161|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
25035435|NCT02905266|50135162|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
25035436|NCT02905266|50135161|FG000|Transition From Part 1 to Part 2|Death|0|||
25035437|NCT02905266|50135162|FG001|Transition From Part 1 to Part 2|Death|1|||
25035438|NCT02905266|50135161|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
25035439|NCT02905266|50135162|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
25035440|NCT02905266|50135161|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
25035441|NCT02905266|50135162|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
25035442|NCT02905266|50135161|FG000|Maintenance Phase Part 2|Disease Progression|9|||
25035443|NCT02905266|50135162|FG001|Maintenance Phase Part 2|Disease Progression|2|||
25035444|NCT02905266|50135161|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
25035445|NCT02905266|50135162|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
25035446|NCT02905266|50135161|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
25035447|NCT02905266|50135162|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
25035448|NCT02982018|50135170|FG000|Overall Study|Incorrect Lens Dispensed|1|||
25035449|NCT02982018|50135171|FG001|Overall Study|Incorrect Lens Dispensed|0|||
25035450|NCT02982018|50135170|FG000|Overall Study|Protocol Violation|1|||
25035451|NCT02982018|50135171|FG001|Overall Study|Protocol Violation|1|||
25035452|NCT02982018|50135170|FG000|Overall Study|Adverse Event|1|||
25035453|NCT02982018|50135171|FG001|Overall Study|Adverse Event|1|||
25035454|NCT02982018|50135170|FG000|Overall Study|Lens Discomfort|2|||
25035455|NCT02982018|50135171|FG001|Overall Study|Lens Discomfort|0|||
25035456|NCT02982018|50135170|FG000|Overall Study|Withdrawal by Subject|0|||
25035457|NCT02982018|50135171|FG001|Overall Study|Withdrawal by Subject|1|||
25035458|NCT03080493|50135179|FG000|Overall Study|Did not provide NRS pain results|1|||
25035459|NCT03080493|50135180|FG001|Overall Study|Did not provide NRS pain results|0|||
25035460|NCT03080493|50135179|FG000|Overall Study|Adverse Event|0|||
25035461|NCT03080493|50135180|FG001|Overall Study|Adverse Event|1|||
25035462|NCT03080493|50135179|FG000|Overall Study|Randomization error (parity group)|0|||
25035463|NCT03080493|50135180|FG001|Overall Study|Randomization error (parity group)|1|||
25035464|NCT01339910|50135188|FG000|Overall Study|Withdrawal by Subject|1|||
25035465|NCT01339910|50135189|FG001|Overall Study|Withdrawal by Subject|0|||
25035466|NCT01339910|50135188|FG000|Overall Study|Physician Decision|1|||
25035467|NCT01339910|50135189|FG001|Overall Study|Physician Decision|0|||
25035468|NCT01339910|50135188|FG000|Overall Study|Disease relapse|1|||
25035469|NCT01339910|50135189|FG001|Overall Study|Disease relapse|4|||
25035470|NCT02981082|50135197|FG000|Overall Study|Withdrawal by Subject|2|||
25035471|NCT02981082|50135198|FG001|Overall Study|Withdrawal by Subject|0|||
25035472|NCT02981082|50135197|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
25035473|NCT02981082|50135198|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
25035474|NCT02981082|50135197|FG000|Overall Study|Adverse Event|0|||
25035475|NCT02981082|50135198|FG001|Overall Study|Adverse Event|1|||
25035476|NCT01066104|50135206|FG000|Overall Study|Adverse Event|1|||
25035477|NCT01066104|50135207|FG001|Overall Study|Adverse Event|1|||
25035478|NCT01066104|50135206|FG000|Overall Study|Protocol Violation|1|||
25035479|NCT01066104|50135207|FG001|Overall Study|Protocol Violation|0|||
25035480|NCT02736968|50135218|FG000|Overall Study|Lost to Follow-up|0|||
25035481|NCT02736968|50135219|FG001|Overall Study|Lost to Follow-up|0|||
25035482|NCT02736968|50135220|FG002|Overall Study|Lost to Follow-up|0|||
25035483|NCT02736968|50135221|FG003|Overall Study|Lost to Follow-up|0|||
25035484|NCT02736968|50135222|FG004|Overall Study|Lost to Follow-up|0|||
25035485|NCT02736968|50135223|FG005|Overall Study|Lost to Follow-up|0|||
25035486|NCT02736968|50135224|FG006|Overall Study|Lost to Follow-up|5|||
25035487|NCT02736968|50135225|FG007|Overall Study|Lost to Follow-up|2|||
25035488|NCT02736968|50135218|FG000|Overall Study|COVID-19 Pandemic|0|||
25035489|NCT02736968|50135219|FG001|Overall Study|COVID-19 Pandemic|0|||
25035490|NCT02736968|50135220|FG002|Overall Study|COVID-19 Pandemic|0|||
25035491|NCT02736968|50135221|FG003|Overall Study|COVID-19 Pandemic|0|||
25035492|NCT02736968|50135222|FG004|Overall Study|COVID-19 Pandemic|0|||
25035493|NCT02736968|50135223|FG005|Overall Study|COVID-19 Pandemic|0|||
25035494|NCT02736968|50135224|FG006|Overall Study|COVID-19 Pandemic|2|||
25035495|NCT02736968|50135225|FG007|Overall Study|COVID-19 Pandemic|0|||
25035496|NCT02736968|50135218|FG000|Overall Study|Withdrawal by Subject|0|||
25035497|NCT02736968|50135219|FG001|Overall Study|Withdrawal by Subject|0|||
25035498|NCT02736968|50135220|FG002|Overall Study|Withdrawal by Subject|0|||
25035499|NCT02736968|50135221|FG003|Overall Study|Withdrawal by Subject|0|||
25035500|NCT02736968|50135222|FG004|Overall Study|Withdrawal by Subject|0|||
25035501|NCT02736968|50135223|FG005|Overall Study|Withdrawal by Subject|0|||
25035502|NCT02736968|50135224|FG006|Overall Study|Withdrawal by Subject|1|||
25035503|NCT02736968|50135225|FG007|Overall Study|Withdrawal by Subject|0|||
25035504|NCT02980224|50135238|FG000|Overall Study|Adverse Event|4|||
25035505|NCT02980224|50135239|FG001|Overall Study|Adverse Event|1|||
25035506|NCT02980224|50135238|FG000|Overall Study|Withdrawal by Subject|0|||
25035507|NCT02980224|50135239|FG001|Overall Study|Withdrawal by Subject|2|||
25035508|NCT02591615|50135249|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
25035509|NCT02591615|50135250|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
25035510|NCT02591615|50135251|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
25035511|NCT02591615|50135252|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
25035512|NCT02591615|50135249|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
25035513|NCT02591615|50135250|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
25035514|NCT02591615|50135251|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
25035515|NCT02591615|50135252|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
25035516|NCT02591615|50135249|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
25035517|NCT02591615|50135250|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
25035518|NCT02591615|50135251|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
25035519|NCT02591615|50135252|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
25035520|NCT02591615|50135249|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
25035521|NCT02591615|50135250|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
25035522|NCT02591615|50135251|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
25035523|NCT02591615|50135252|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
25035524|NCT02591615|50135249|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
25035525|NCT02591615|50135250|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
25035526|NCT02591615|50135251|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
25035527|NCT02591615|50135252|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
25035528|NCT02591615|50135249|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
25035529|NCT02591615|50135250|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
25035530|NCT02591615|50135251|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
25035531|NCT02591615|50135252|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
25035532|NCT02591615|50135249|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
25035533|NCT02591615|50135250|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
25035534|NCT02591615|50135251|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
25035535|NCT02591615|50135252|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
25035536|NCT02591615|50135249|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
25035537|NCT02591615|50135250|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
25035538|NCT02591615|50135251|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
25159806|NCT01402011|50279755|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
25035539|NCT02591615|50135252|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
25035540|NCT02591615|50135249|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
25035541|NCT02591615|50135250|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
25035542|NCT02591615|50135251|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
25035543|NCT02591615|50135252|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
25035544|NCT02591615|50135249|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
25035545|NCT02591615|50135250|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
25035546|NCT02591615|50135251|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
25035547|NCT02591615|50135252|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
25035548|NCT02591615|50135249|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
24946834|NCT00419952|50039279|FG000|Overall Study|Incorrectly enrolled|10|||
24946835|NCT00419952|50039280|FG001|Overall Study|Incorrectly enrolled|3|||
24946836|NCT00419952|50039279|FG000|Overall Study|Intake of prohibited medication|2|||
24946837|NCT00419952|50039280|FG001|Overall Study|Intake of prohibited medication|2|||
24946838|NCT00419952|50039279|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
24946839|NCT00419952|50039280|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
24946840|NCT00419952|50039279|FG000|Overall Study|Diary or medication non-compliance|2|||
24946841|NCT00419952|50039280|FG001|Overall Study|Diary or medication non-compliance|4|||
24946842|NCT00419952|50039279|FG000|Overall Study|Abnormal ECG|1|||
24946843|NCT00419952|50039280|FG001|Overall Study|Abnormal ECG|0|||
24946844|NCT00443456|50039286|FG000|Overall Study|Adverse Event|16|||
24946845|NCT00443456|50039286|FG000|Overall Study|Move|1|||
24946846|NCT00443456|50039286|FG000|Overall Study|Withdrawal by Subject|1|||
24946847|NCT00419562|50039296|FG000|Overall Study|Lost to Follow-up|12|||
24946848|NCT00419562|50039297|FG001|Overall Study|Lost to Follow-up|13|||
24946849|NCT00419562|50039296|FG000|Overall Study|Withdrawal by Subject|20|||
25035549|NCT02591615|50135250|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
25035550|NCT02591615|50135251|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
25035551|NCT02591615|50135252|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
25035552|NCT02591615|50135249|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
25035553|NCT02591615|50135250|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
25035554|NCT02591615|50135251|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
25035555|NCT02591615|50135252|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
25035556|NCT02591615|50135249|FG000|Maintenance MK-3475|Adverse Event|0|||
25035557|NCT02591615|50135250|FG001|Maintenance MK-3475|Adverse Event|3|||
25035558|NCT02591615|50135251|FG002|Maintenance MK-3475|Adverse Event|1|||
25035559|NCT02591615|50135252|FG003|Maintenance MK-3475|Adverse Event|2|||
25035560|NCT02591615|50135249|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
25035561|NCT02591615|50135250|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
25035562|NCT02591615|50135251|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
25035563|NCT02591615|50135252|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
25035564|NCT02591615|50135249|FG000|Maintenance MK-3475|Death|0|||
25035565|NCT02591615|50135250|FG001|Maintenance MK-3475|Death|1|||
25035566|NCT02591615|50135251|FG002|Maintenance MK-3475|Death|1|||
25035567|NCT02591615|50135252|FG003|Maintenance MK-3475|Death|0|||
25035568|NCT02591615|50135249|FG000|Maintenance MK-3475|Physician discretion|0|||
25035569|NCT02591615|50135250|FG001|Maintenance MK-3475|Physician discretion|0|||
25035570|NCT02591615|50135251|FG002|Maintenance MK-3475|Physician discretion|1|||
25035571|NCT02591615|50135252|FG003|Maintenance MK-3475|Physician discretion|0|||
25035572|NCT02591615|50135249|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
25035573|NCT02591615|50135250|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
25035574|NCT02591615|50135251|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
25035575|NCT02591615|50135252|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
25035576|NCT02591615|50135249|FG000|Maintenance MK-3475|In active treatment|2|||
25035577|NCT02591615|50135250|FG001|Maintenance MK-3475|In active treatment|0|||
25035578|NCT02591615|50135251|FG002|Maintenance MK-3475|In active treatment|0|||
25035579|NCT02591615|50135252|FG003|Maintenance MK-3475|In active treatment|1|||
25035580|NCT03077607|50135267|FG000|Period 1 (15 Days)|Adverse Event|1|||
25035581|NCT03077607|50135268|FG001|Period 1 (15 Days)|Adverse Event|0|||
25035582|NCT03077607|50135267|FG000|Period 1 (15 Days)|Death|1|||
25035583|NCT03077607|50135268|FG001|Period 1 (15 Days)|Death|0|||
25035584|NCT03077607|50135267|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
25035585|NCT03077607|50135268|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
25035586|NCT03077607|50135267|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
25035587|NCT03077607|50135268|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
25035588|NCT02977572|50135287|FG000|Overall Study|Exclusion criterion|2|||
25035589|NCT02977572|50135288|FG001|Overall Study|Exclusion criterion|2|||
25159807|NCT01402011|50279753|FG000|Active Treatment Period|Withdrawal by Subject|1|||
24946850|NCT00419562|50039297|FG001|Overall Study|Withdrawal by Subject|18|||
24946851|NCT00419562|50039296|FG000|Overall Study|Participant Institutionalized|1|||
25035590|NCT02746874|50135300|FG000|Overall Study|Withdrawal by Subject|0|||
25035591|NCT02746874|50135301|FG001|Overall Study|Withdrawal by Subject|1|||
25035592|NCT02746874|50135300|FG000|Overall Study|Surgery Date Changed|0|||
25035593|NCT02746874|50135301|FG001|Overall Study|Surgery Date Changed|2|||
25035594|NCT03217175|50135307|FG000|Overall Study|Physician Decision|4|||
25035595|NCT03217175|50135308|FG001|Overall Study|Physician Decision|1|||
25035596|NCT01062126|50135314|FG000|Overall Study|Death|209|||
25035597|NCT01062126|50135314|FG000|Overall Study|All Withdrawals|324|||
25035598|NCT02522429|50135318|FG000|Overall Study|Lost to Follow-up|8|||
25035599|NCT02522429|50135318|FG000|Overall Study|Adverse Event|2|||
25035600|NCT02522429|50135318|FG000|Overall Study|Death|1|||
25035601|NCT02522429|50135318|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
25035602|NCT02974140|50135322|FG000|Overall Study|Adverse Event|2|||
25035603|NCT02974140|50135322|FG000|Overall Study|Lost to Follow-up|1|||
25035604|NCT02974140|50135322|FG000|Overall Study|Study Terminated by Sponsor|36|||
25035605|NCT02974842|50135329|FG000|Overall Study|Withdrawal by Subject|4|||
25035606|NCT02974842|50135329|FG000|Overall Study|Screen failures|4|||
25035607|NCT03172481|50135335|FG000|Double-blind|Withdrawal by Subject|1|||
25035608|NCT03172481|50135336|FG001|Double-blind|Withdrawal by Subject|0|||
25035609|NCT02855450|50135344|FG000|Overall Study|Adverse Event|1|||
25035610|NCT02855450|50135345|FG001|Overall Study|Adverse Event|0|||
25035611|NCT02855450|50135344|FG000|Overall Study|Lost to Follow-up|4|||
25035612|NCT02855450|50135345|FG001|Overall Study|Lost to Follow-up|0|||
25035613|NCT03172325|50135353|FG000|Overall Study|Adverse Event|2|||
24946852|NCT00419562|50039297|FG001|Overall Study|Participant Institutionalized|0|||
24946853|NCT00432042|50039306|FG000|Overall Study|Protocol Violation|2|||
24946854|NCT00432042|50039307|FG001|Overall Study|Protocol Violation|0|||
24946855|NCT00432042|50039308|FG002|Overall Study|Protocol Violation|0|||
24946856|NCT00432042|50039306|FG000|Overall Study|Withdrawal by Subject|0|||
24946857|NCT00432042|50039307|FG001|Overall Study|Withdrawal by Subject|0|||
24946858|NCT00432042|50039308|FG002|Overall Study|Withdrawal by Subject|2|||
24946859|NCT00432042|50039306|FG000|Overall Study|Lost to Follow-up|5|||
24946860|NCT00432042|50039307|FG001|Overall Study|Lost to Follow-up|1|||
25035614|NCT03172325|50135354|FG001|Overall Study|Adverse Event|3|||
25035615|NCT03172325|50135353|FG000|Overall Study|Positive PPD|1|||
25035616|NCT03172325|50135354|FG001|Overall Study|Positive PPD|0|||
25035617|NCT03172325|50135353|FG000|Overall Study|Poor Compliance|1|||
25035618|NCT03172325|50135354|FG001|Overall Study|Poor Compliance|1|||
25035619|NCT03085017|50135362|FG000|Overall Study|Death|0|||
25035620|NCT03085017|50135363|FG001|Overall Study|Death|3|||
25035621|NCT03215771|50135369|FG000|Overall Study|Withdrawal by Subject|2|||
25035622|NCT03215771|50135369|FG000|Overall Study|Physician Decision|1|||
25035623|NCT02745392|50135378|FG000|Overall Study|Lost to Follow-up|0|||
25035624|NCT02745392|50135379|FG001|Overall Study|Lost to Follow-up|1|||
25035625|NCT02745392|50135380|FG002|Overall Study|Lost to Follow-up|0|||
25035626|NCT02745392|50135381|FG003|Overall Study|Lost to Follow-up|0|||
25035627|NCT03076515|50135393|FG000|Overall Study|DMC decision based on interim analysis|25|||
25035628|NCT03076515|50135394|FG001|Overall Study|DMC decision based on interim analysis|29|||
25035629|NCT03170609|50135407|FG000|Overall Study|Death|0|||
25035630|NCT03170609|50135408|FG001|Overall Study|Death|0|||
25035631|NCT03170609|50135409|FG002|Overall Study|Death|1|||
25035632|NCT03170609|50135410|FG003|Overall Study|Death|0|||
25035633|NCT03170609|50135411|FG004|Overall Study|Death|0|||
25035634|NCT03170609|50135412|FG005|Overall Study|Death|0|||
25035635|NCT03170609|50135413|FG006|Overall Study|Death|0|||
25035636|NCT03170609|50135407|FG000|Overall Study|Withdrawal by Subject|1|||
25035637|NCT03170609|50135408|FG001|Overall Study|Withdrawal by Subject|2|||
25035638|NCT03170609|50135409|FG002|Overall Study|Withdrawal by Subject|0|||
25035639|NCT03170609|50135410|FG003|Overall Study|Withdrawal by Subject|0|||
25035640|NCT03170609|50135411|FG004|Overall Study|Withdrawal by Subject|0|||
25035641|NCT03170609|50135412|FG005|Overall Study|Withdrawal by Subject|0|||
25035642|NCT03170609|50135413|FG006|Overall Study|Withdrawal by Subject|1|||
25035643|NCT03170609|50135407|FG000|Overall Study|Lost to Follow-up|1|||
25035644|NCT03170609|50135408|FG001|Overall Study|Lost to Follow-up|0|||
25035645|NCT03170609|50135409|FG002|Overall Study|Lost to Follow-up|5|||
25035646|NCT03170609|50135410|FG003|Overall Study|Lost to Follow-up|2|||
25035647|NCT03170609|50135411|FG004|Overall Study|Lost to Follow-up|1|||
25159808|NCT01402011|50279754|FG001|Active Treatment Period|Withdrawal by Subject|3|||
25186238|NCT01399697|50336173|FG001|Overall Study|Sponsor Decision|0|||
25035648|NCT03170609|50135412|FG005|Overall Study|Lost to Follow-up|1|||
25035649|NCT03170609|50135413|FG006|Overall Study|Lost to Follow-up|0|||
25035650|NCT03170609|50135407|FG000|Overall Study|Other|1|||
24946861|NCT00432042|50039308|FG002|Overall Study|Lost to Follow-up|0|||
25035651|NCT03170609|50135408|FG001|Overall Study|Other|0|||
25035652|NCT03170609|50135409|FG002|Overall Study|Other|0|||
25035653|NCT03170609|50135410|FG003|Overall Study|Other|0|||
24946862|NCT00308139|50039318|FG000|Overall Study|Adverse Event|20|||
25035654|NCT03170609|50135411|FG004|Overall Study|Other|0|||
25035655|NCT03170609|50135412|FG005|Overall Study|Other|1|||
25035656|NCT03170609|50135413|FG006|Overall Study|Other|0|||
25035657|NCT01141712|50135429|FG000|Overall Study|Disease progression|3|||
25035658|NCT03219333|50135439|FG000|Overall Study|Withdrawal by Subject|8|||
25035659|NCT03219333|50135440|FG001|Overall Study|Withdrawal by Subject|3|||
25035660|NCT03219333|50135439|FG000|Overall Study|Lost to Follow-up|1|||
25035661|NCT03219333|50135440|FG001|Overall Study|Lost to Follow-up|0|||
25035662|NCT03219333|50135439|FG000|Overall Study|Death|94|||
25035663|NCT03219333|50135440|FG001|Overall Study|Death|44|||
25035664|NCT03219333|50135439|FG000|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
25035665|NCT03219333|50135440|FG001|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
25035666|NCT03168867|50135448|FG000|Overall Study|Withdrawal by Subject|1|||
25035667|NCT03168867|50135449|FG001|Overall Study|Withdrawal by Subject|5|||
25035668|NCT01064622|50135458|FG000|Randomized Phase II|Withdrawal by Subject|2|||
25035669|NCT01064622|50135459|FG001|Randomized Phase II|Withdrawal by Subject|2|||
25035670|NCT01064622|50135458|FG000|Randomized Phase II|Protocol Violation|0|||
25035671|NCT01064622|50135459|FG001|Randomized Phase II|Protocol Violation|1|||
25035672|NCT04163718|50135468|FG000|Overall Study|Study terminated|12|||
25035673|NCT01063764|50135472|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
25035674|NCT01063764|50135472|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
25035675|NCT01063764|50135472|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
25035676|NCT01063764|50135472|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
25035677|NCT01063764|50135472|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
25035678|NCT01063764|50135472|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
25035679|NCT01063764|50135472|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
25035680|NCT03075891|50135482|FG000|Overall Study|Withdrawal by Subject|3|||
25035681|NCT03075891|50135483|FG001|Overall Study|Withdrawal by Subject|6|||
25035682|NCT03075891|50135482|FG000|Overall Study|Lost to Follow-up|1|||
25035683|NCT03075891|50135483|FG001|Overall Study|Lost to Follow-up|0|||
25035684|NCT03075891|50135482|FG000|Overall Study|Pregnancy|3|||
25035685|NCT03075891|50135483|FG001|Overall Study|Pregnancy|1|||
25035686|NCT03075891|50135482|FG000|Overall Study|visits not performed (no time)|1|||
25035687|NCT03075891|50135483|FG001|Overall Study|visits not performed (no time)|0|||
25035688|NCT03075891|50135482|FG000|Overall Study|Drug abuse relapse issue|0|||
25035689|NCT03075891|50135483|FG001|Overall Study|Drug abuse relapse issue|1|||
25035690|NCT03075891|50135482|FG000|Overall Study|Participant requiring study withdrawal|0|||
25035691|NCT03075891|50135483|FG001|Overall Study|Participant requiring study withdrawal|1|||
25035692|NCT03075891|50135482|FG000|Overall Study|Adverse event, non-fatal|1|||
25035693|NCT03075891|50135483|FG001|Overall Study|Adverse event, non-fatal|4|||
25035694|NCT02013167|50135493|FG000|Overall Study|Withdrawal by Subject|15|||
25035695|NCT02013167|50135494|FG001|Overall Study|Withdrawal by Subject|14|||
25035696|NCT02013167|50135493|FG000|Overall Study|Sponsor Decision|1|||
25035697|NCT02013167|50135494|FG001|Overall Study|Sponsor Decision|3|||
25035698|NCT02013167|50135493|FG000|Overall Study|Lost to Follow-up|0|||
25035699|NCT02013167|50135494|FG001|Overall Study|Lost to Follow-up|1|||
25035700|NCT02013167|50135493|FG000|Overall Study|Death|85|||
24946863|NCT00308139|50039319|FG001|Overall Study|Adverse Event|14|||
24946864|NCT00308139|50039318|FG000|Overall Study|Lost to Follow-up|13|||
24946865|NCT00308139|50039319|FG001|Overall Study|Lost to Follow-up|8|||
24946866|NCT00308139|50039318|FG000|Overall Study|Protocol Violation|3|||
24946867|NCT00308139|50039319|FG001|Overall Study|Protocol Violation|2|||
24946868|NCT00308139|50039318|FG000|Overall Study|Withdrawal of Consent|40|||
24946869|NCT00308139|50039319|FG001|Overall Study|Withdrawal of Consent|42|||
24946870|NCT00308139|50039318|FG000|Overall Study|Investigator Decision|11|||
24946871|NCT00308139|50039319|FG001|Overall Study|Investigator Decision|10|||
24946872|NCT00308139|50039318|FG000|Overall Study|Loss of Glucose Control|5|||
24946873|NCT00308139|50039319|FG001|Overall Study|Loss of Glucose Control|7|||
24946874|NCT00308139|50039318|FG000|Overall Study|Administrative|1|||
24946875|NCT00308139|50039319|FG001|Overall Study|Administrative|4|||
24946876|NCT00308139|50039318|FG000|Overall Study|Other|1|||
24946877|NCT00308139|50039319|FG001|Overall Study|Other|0|||
24946878|NCT00459134|50039347|FG000|Overall Study|Physician Decision|1|||
24946879|NCT00459134|50039348|FG001|Overall Study|Physician Decision|1|||
24946880|NCT00459134|50039347|FG000|Overall Study|Withdrawal by Subject|8|||
24946881|NCT00459134|50039348|FG001|Overall Study|Withdrawal by Subject|7|||
24946882|NCT00459134|50039347|FG000|Overall Study|Lost to Follow-up|6|||
24946883|NCT00459134|50039348|FG001|Overall Study|Lost to Follow-up|7|||
24946884|NCT00459134|50039347|FG000|Overall Study|Surgery|1|||
24946885|NCT00459134|50039348|FG001|Overall Study|Surgery|2|||
24946886|NCT00459134|50039347|FG000|Overall Study|Toxicity|4|||
24946887|NCT00459134|50039348|FG001|Overall Study|Toxicity|5|||
24946888|NCT00459134|50039347|FG000|Overall Study|Progression|1|||
25035701|NCT02013167|50135494|FG001|Overall Study|Death|160|||
24946889|NCT00459134|50039348|FG001|Overall Study|Progression|0|||
24946890|NCT00459134|50039347|FG000|Overall Study|Multiple Reasons|2|||
25035702|NCT01063062|50135503|FG000|Overall Study|Patient withdrew consent|0|||
25035703|NCT01063062|50135504|FG001|Overall Study|Patient withdrew consent|1|||
25035704|NCT01063062|50135503|FG000|Overall Study|Adverse Event|2|||
25035705|NCT01063062|50135504|FG001|Overall Study|Adverse Event|4|||
25035706|NCT01063062|50135503|FG000|Overall Study|Protocol Violation|5|||
24946891|NCT00459134|50039348|FG001|Overall Study|Multiple Reasons|3|||
25035707|NCT01063062|50135504|FG001|Overall Study|Protocol Violation|4|||
25186239|NCT01399697|50336174|FG002|Overall Study|Sponsor Decision|0|||
25035708|NCT01063062|50135503|FG000|Overall Study|Investigator's request|1|||
25035709|NCT01063062|50135504|FG001|Overall Study|Investigator's request|0|||
25035710|NCT01063062|50135503|FG000|Overall Study|Lost to Follow-up|0|||
25035711|NCT01063062|50135504|FG001|Overall Study|Lost to Follow-up|2|||
25035712|NCT01063062|50135503|FG000|Overall Study|Miscellaneous reason|0|||
25035713|NCT01063062|50135504|FG001|Overall Study|Miscellaneous reason|1|||
25035714|NCT02973048|50135513|FG000|Overall Study|Epidural catheter insertion failure|1|||
25035715|NCT02973048|50135514|FG001|Overall Study|Epidural catheter insertion failure|0|||
25035716|NCT02973048|50135513|FG000|Overall Study|Withdrawal by Subject|0|||
25035717|NCT02973048|50135514|FG001|Overall Study|Withdrawal by Subject|3|||
25035718|NCT02932943|50135522|FG000|Overall Study|Lost to Follow-up|0|||
25035719|NCT02932943|50135523|FG001|Overall Study|Lost to Follow-up|2|||
25035720|NCT02932943|50135522|FG000|Overall Study|Adverse Event|2|||
25035721|NCT02932943|50135523|FG001|Overall Study|Adverse Event|2|||
25035722|NCT02932943|50135522|FG000|Overall Study|Withdrawal by Subject|3|||
25035723|NCT02932943|50135523|FG001|Overall Study|Withdrawal by Subject|3|||
25035724|NCT02972658|50135548|FG000|Overall Study|Adverse Event|0|||
25035725|NCT02972658|50135549|FG001|Overall Study|Adverse Event|3|||
25035726|NCT02972658|50135550|FG002|Overall Study|Adverse Event|0|||
25035727|NCT02972658|50135551|FG003|Overall Study|Adverse Event|2|||
25035728|NCT02972658|50135548|FG000|Overall Study|Other-determined by Investigator|1|||
25035729|NCT02972658|50135549|FG001|Overall Study|Other-determined by Investigator|1|||
25035730|NCT02972658|50135550|FG002|Overall Study|Other-determined by Investigator|0|||
25035731|NCT02972658|50135551|FG003|Overall Study|Other-determined by Investigator|0|||
25035732|NCT02972658|50135548|FG000|Overall Study|Death|0|||
25035733|NCT02972658|50135549|FG001|Overall Study|Death|0|||
25035734|NCT02972658|50135550|FG002|Overall Study|Death|0|||
25035735|NCT02972658|50135551|FG003|Overall Study|Death|1|||
25035736|NCT02972658|50135548|FG000|Overall Study|Lost to Follow-up|0|||
25035737|NCT02972658|50135549|FG001|Overall Study|Lost to Follow-up|1|||
25035738|NCT02972658|50135550|FG002|Overall Study|Lost to Follow-up|1|||
25035739|NCT02972658|50135551|FG003|Overall Study|Lost to Follow-up|2|||
25035740|NCT02972658|50135548|FG000|Overall Study|Progressive Disease|0|||
25035741|NCT02972658|50135549|FG001|Overall Study|Progressive Disease|1|||
25035742|NCT02972658|50135550|FG002|Overall Study|Progressive Disease|0|||
25035743|NCT02972658|50135551|FG003|Overall Study|Progressive Disease|1|||
25035744|NCT02972658|50135548|FG000|Overall Study|Withdrawal by Subject|4|||
25035745|NCT02972658|50135549|FG001|Overall Study|Withdrawal by Subject|4|||
25035746|NCT02972658|50135550|FG002|Overall Study|Withdrawal by Subject|1|||
25035747|NCT02972658|50135551|FG003|Overall Study|Withdrawal by Subject|6|||
25035748|NCT02972658|50135548|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
25035749|NCT02972658|50135549|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
25035750|NCT02972658|50135550|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
25035751|NCT02972658|50135551|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
25035752|NCT02972658|50135548|FG000|Overall Study|Sponsor Decision|70|||
25035753|NCT02972658|50135549|FG001|Overall Study|Sponsor Decision|127|||
25035754|NCT02972658|50135550|FG002|Overall Study|Sponsor Decision|72|||
25035755|NCT02972658|50135551|FG003|Overall Study|Sponsor Decision|119|||
25035756|NCT02853032|50135563|FG000|Overall Study|Adverse Event|4|||
25035757|NCT02853032|50135564|FG001|Overall Study|Adverse Event|0|||
24946892|NCT00459056|50039356|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
24946893|NCT00459056|50039357|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
24946894|NCT00431964|50039365|FG000|Overall Study|Adverse Event|1|||
24946895|NCT00431964|50039366|FG001|Overall Study|Adverse Event|0|||
24946896|NCT00431964|50039365|FG000|Overall Study|Lost to Follow-up|1|||
24946897|NCT00431964|50039366|FG001|Overall Study|Lost to Follow-up|2|||
24946898|NCT00431964|50039365|FG000|Overall Study|Physician Decision|2|||
24946899|NCT00431964|50039366|FG001|Overall Study|Physician Decision|2|||
24946900|NCT00431964|50039365|FG000|Overall Study|Withdrawal by Subject|2|||
24946901|NCT00431964|50039366|FG001|Overall Study|Withdrawal by Subject|1|||
24946902|NCT00431964|50039365|FG000|Overall Study|Parental Consent Withdrawn|0|||
24946903|NCT00431964|50039366|FG001|Overall Study|Parental Consent Withdrawn|2|||
24946904|NCT00431964|50039365|FG000|Overall Study|Due to Unstable Health|0|||
24946905|NCT00431964|50039366|FG001|Overall Study|Due to Unstable Health|1|||
24946906|NCT00412854|50039374|FG000|Overall Study|Withdrawn due to adverse events|1|||
25035758|NCT02853032|50135563|FG000|Overall Study|Withdrawal by Subject|3|||
25035759|NCT02853032|50135564|FG001|Overall Study|Withdrawal by Subject|1|||
25035760|NCT02853032|50135563|FG000|Overall Study|Requested to withdraw from all treatment|2|||
25035761|NCT02853032|50135564|FG001|Overall Study|Requested to withdraw from all treatment|2|||
25035762|NCT02232087|50135572|FG000|Overall Study|Withdrawal by Subject|2|||
25035763|NCT02232087|50135573|FG001|Overall Study|Withdrawal by Subject|0|||
25035764|NCT02232087|50135574|FG002|Overall Study|Withdrawal by Subject|0|||
25035765|NCT02232087|50135575|FG003|Overall Study|Withdrawal by Subject|0|||
25035766|NCT02232087|50135576|FG004|Overall Study|Withdrawal by Subject|0|||
25035767|NCT02232087|50135577|FG005|Overall Study|Withdrawal by Subject|1|||
25035768|NCT02232087|50135572|FG000|Overall Study|poor inhalation technique|0|||
25035769|NCT02232087|50135573|FG001|Overall Study|poor inhalation technique|1|||
25035770|NCT02232087|50135574|FG002|Overall Study|poor inhalation technique|0|||
25035771|NCT02232087|50135575|FG003|Overall Study|poor inhalation technique|0|||
25035772|NCT02232087|50135576|FG004|Overall Study|poor inhalation technique|0|||
25035773|NCT02232087|50135577|FG005|Overall Study|poor inhalation technique|2|||
25035774|NCT02232087|50135572|FG000|Overall Study|protocol stop criteria|0|||
25035775|NCT02232087|50135573|FG001|Overall Study|protocol stop criteria|1|||
25035776|NCT02232087|50135574|FG002|Overall Study|protocol stop criteria|0|||
25035777|NCT02232087|50135575|FG003|Overall Study|protocol stop criteria|1|||
25035778|NCT02232087|50135576|FG004|Overall Study|protocol stop criteria|0|||
25035779|NCT02232087|50135577|FG005|Overall Study|protocol stop criteria|0|||
25035780|NCT02232087|50135572|FG000|Overall Study|Adverse Event|0|||
25035781|NCT02232087|50135573|FG001|Overall Study|Adverse Event|0|||
25035782|NCT02232087|50135574|FG002|Overall Study|Adverse Event|0|||
25035783|NCT02232087|50135575|FG003|Overall Study|Adverse Event|0|||
25035784|NCT02232087|50135576|FG004|Overall Study|Adverse Event|1|||
25035785|NCT02232087|50135577|FG005|Overall Study|Adverse Event|0|||
25035786|NCT03168425|50135598|FG000|Overall Study|Lost to Follow-up|5|||
25035787|NCT03168425|50135599|FG001|Overall Study|Lost to Follow-up|8|||
25035788|NCT03168425|50135598|FG000|Overall Study|unable to confirm post op opioids|2|||
25035789|NCT03168425|50135599|FG001|Overall Study|unable to confirm post op opioids|3|||
25035790|NCT00004445|50135606|FG000|Overall Study|Physician Decision|2|||
25035791|NCT00004445|50135606|FG000|Overall Study|Withdrawal by Subject|1|||
25035792|NCT02972502|50135616|FG000|Overall Study|Lost to Follow-up|3|||
25035793|NCT02972502|50135617|FG001|Overall Study|Lost to Follow-up|1|||
25035794|NCT02972502|50135616|FG000|Overall Study|Withdrawal by Subject|1|||
25035795|NCT02972502|50135617|FG001|Overall Study|Withdrawal by Subject|1|||
25035796|NCT02971800|50135623|FG000|Overall Study|Protocol Violation|1|||
25035797|NCT02971800|50135623|FG000|Overall Study|Withdrawal by Subject|1|||
25035798|NCT02971800|50135623|FG000|Overall Study|Exclusion criteria prior intervention|1|||
25035799|NCT02971800|50135623|FG000|Overall Study|Number evaluable participant already reached|4|||
25035800|NCT03163667|50135629|FG000|Overall Study|Death|15|||
25035801|NCT03163667|50135630|FG001|Overall Study|Death|27|||
25035802|NCT03163667|50135629|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
25035803|NCT03163667|50135630|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
25035804|NCT03167411|50135638|FG000|Overall Study|Adverse Event|0|||
25035805|NCT03167411|50135639|FG001|Overall Study|Adverse Event|1|||
25035806|NCT01952847|50135649|FG000|Overall Study|Ineligible|1|||
25035807|NCT01952847|50135650|FG001|Overall Study|Ineligible|0|||
25035808|NCT01952847|50135651|FG002|Overall Study|Ineligible|0|||
25035809|NCT01952847|50135652|FG003|Overall Study|Ineligible|0|||
25035810|NCT01952847|50135649|FG000|Overall Study|Lack of Insurance Coverage|0|||
25035811|NCT01952847|50135650|FG001|Overall Study|Lack of Insurance Coverage|1|||
25035812|NCT01952847|50135651|FG002|Overall Study|Lack of Insurance Coverage|0|||
25035813|NCT01952847|50135652|FG003|Overall Study|Lack of Insurance Coverage|0|||
25035814|NCT01952847|50135649|FG000|Overall Study|Withdrawal by Subject|1|||
25035815|NCT01952847|50135650|FG001|Overall Study|Withdrawal by Subject|1|||
24946907|NCT00412854|50039375|FG001|Overall Study|Withdrawn due to adverse events|5|||
24946908|NCT00412854|50039374|FG000|Overall Study|Withdrawn for other reasons|13|||
24946909|NCT00412854|50039375|FG001|Overall Study|Withdrawn for other reasons|11|||
24946910|NCT00431496|50039381|FG000|Overall Study|Adverse Event|3|||
24946911|NCT00431496|50039381|FG000|Overall Study|Lost to Follow-up|1|||
24946912|NCT00431496|50039381|FG000|Overall Study|Withdrawal by Subject|2|||
24946913|NCT00431496|50039381|FG000|Overall Study|Protocol-specified criteria|5|||
24946914|NCT00316173|50039387|FG000|Run-in Phase|Adverse Event|1|||
24946915|NCT00316173|50039388|FG001|Run-in Phase|Adverse Event|0|||
24946916|NCT00316173|50039387|FG000|Run-in Phase|Protocol Violation|1|||
24946917|NCT00316173|50039388|FG001|Run-in Phase|Protocol Violation|0|||
24946918|NCT00316173|50039387|FG000|Run-in Phase|Study Follow-up Stopped|5|||
24946919|NCT00316173|50039388|FG001|Run-in Phase|Study Follow-up Stopped|0|||
24946920|NCT00316173|50039387|FG000|Treatment Phase|Adverse Event|0|||
24946921|NCT00316173|50039388|FG001|Treatment Phase|Adverse Event|1|||
25035816|NCT01952847|50135651|FG002|Overall Study|Withdrawal by Subject|0|||
25035817|NCT01952847|50135652|FG003|Overall Study|Withdrawal by Subject|1|||
25035818|NCT01560585|50135664|FG000|Overall Study|Physician Decision|3|||
25035819|NCT03075501|50135671|FG000|Overall Study|Scheduling difficulties|15|||
25035820|NCT03075501|50135672|FG001|Overall Study|Scheduling difficulties|9|||
25035821|NCT02317991|50135679|FG000|Overall Study|Adverse Event|12|||
25035822|NCT02317991|50135679|FG000|Overall Study|Death|4|||
25035823|NCT02317991|50135679|FG000|Overall Study|Withdrawal by Subject|8|||
25035824|NCT02317991|50135679|FG000|Overall Study|Progressive Disease|41|||
25035825|NCT03075267|50135686|FG000|Overall Study|Protocol Violation|1|||
25035826|NCT03075267|50135687|FG001|Overall Study|Protocol Violation|0|||
25035827|NCT03075267|50135688|FG002|Overall Study|Protocol Violation|0|||
24946922|NCT00316173|50039387|FG000|Treatment Phase|Lack of Efficacy|0|||
24946923|NCT00316173|50039388|FG001|Treatment Phase|Lack of Efficacy|3|||
25035828|NCT03074331|50135696|FG000|Overall Study|Enrolled but Not Treated|1|||
25035829|NCT03074331|50135696|FG000|Overall Study|Lost to Follow-up|5|||
25035830|NCT03074331|50135696|FG000|Overall Study|Withdrew Consent|1|||
25035831|NCT02260193|50135703|FG000|Overall Study|Lack of Efficacy|0|||
25035832|NCT02260193|50135704|FG001|Overall Study|Lack of Efficacy|1|||
25035833|NCT02260193|50135705|FG002|Overall Study|Lack of Efficacy|6|||
25035834|NCT02260193|50135703|FG000|Overall Study|Adverse Event|3|||
25035835|NCT02260193|50135704|FG001|Overall Study|Adverse Event|4|||
25035836|NCT02260193|50135705|FG002|Overall Study|Adverse Event|1|||
25035837|NCT02260193|50135703|FG000|Overall Study|Protocol Violation|0|||
25035838|NCT02260193|50135704|FG001|Overall Study|Protocol Violation|4|||
25035839|NCT02260193|50135705|FG002|Overall Study|Protocol Violation|0|||
25035840|NCT02260193|50135703|FG000|Overall Study|Withdrawal by Subject|3|||
25035841|NCT02260193|50135704|FG001|Overall Study|Withdrawal by Subject|0|||
24946924|NCT00316173|50039387|FG000|Treatment Phase|Lost to Follow-up|0|||
24946925|NCT00316173|50039388|FG001|Treatment Phase|Lost to Follow-up|3|||
24946926|NCT00316173|50039387|FG000|Treatment Phase|Withdrawal by Subject|0|||
24946927|NCT00316173|50039388|FG001|Treatment Phase|Withdrawal by Subject|1|||
24946928|NCT00316173|50039387|FG000|Treatment Phase|Study Follow-up Stopped|0|||
24946929|NCT00316173|50039388|FG001|Treatment Phase|Study Follow-up Stopped|34|||
24946930|NCT00412542|50039395|FG000|Overall Study|Withdrawal by Subject|0|||
24946931|NCT00412542|50039396|FG001|Overall Study|Withdrawal by Subject|2|||
24946932|NCT00412542|50039395|FG000|Overall Study|Not Eligible|0|||
24946933|NCT00412542|50039396|FG001|Overall Study|Not Eligible|1|||
24946934|NCT00316017|50039403|FG000|Overall Study|Protocol Violation|11|||
24946935|NCT00316017|50039404|FG001|Overall Study|Protocol Violation|13|||
24946936|NCT00316017|50039405|FG002|Overall Study|Protocol Violation|19|||
24946937|NCT00451178|50039415|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
24946938|NCT00451178|50039416|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
24946939|NCT00451178|50039415|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
24946940|NCT00451178|50039416|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
24946941|NCT00451178|50039415|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
24946942|NCT00451178|50039416|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
24946943|NCT00451178|50039415|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
24946944|NCT00451178|50039416|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
24946945|NCT00451178|50039415|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
24946946|NCT00451178|50039416|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
24946947|NCT00451178|50039415|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
24946948|NCT00451178|50039416|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
24946949|NCT00451178|50039415|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
24946950|NCT00451178|50039416|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
24946951|NCT00451178|50039415|FG000|Prior to Maintenance Therapy|PD|2|||
24946952|NCT00451178|50039416|FG001|Prior to Maintenance Therapy|PD|0|||
24946953|NCT00451178|50039415|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
24946954|NCT00451178|50039416|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
24946955|NCT00451178|50039415|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
24946956|NCT00451178|50039416|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
24946957|NCT00451178|50039415|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
24946958|NCT00451178|50039416|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
24946959|NCT00451178|50039415|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
24946960|NCT00451178|50039416|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
24946961|NCT00451178|50039415|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
24946962|NCT00451178|50039416|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
24946963|NCT00451178|50039415|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
24946964|NCT00451178|50039416|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
24946965|NCT00451178|50039415|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
25035842|NCT02260193|50135705|FG002|Overall Study|Withdrawal by Subject|2|||
25035843|NCT02260193|50135703|FG000|Overall Study|Kidney Transplantation|0|||
25035844|NCT02260193|50135704|FG001|Overall Study|Kidney Transplantation|0|||
25035845|NCT02260193|50135705|FG002|Overall Study|Kidney Transplantation|1|||
25035846|NCT02849678|50135715|FG000|Overall Study|Protocol Violation|3|||
25035847|NCT02849678|50135716|FG001|Overall Study|Protocol Violation|6|||
25035848|NCT01596257|50135724|FG000|Overall Study|Inadequate Collection|23|||
25035849|NCT01596257|50135725|FG001|Overall Study|Inadequate Collection|19|||
25035850|NCT04577781|50135735|FG000|Overall Study|Adverse Event|2|||
25035851|NCT04577781|50135736|FG001|Overall Study|Adverse Event|2|||
25035852|NCT04577781|50135735|FG000|Overall Study|Physician Decision|1|||
25035853|NCT04577781|50135736|FG001|Overall Study|Physician Decision|0|||
25035854|NCT02737826|50135743|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
25035855|NCT02737826|50135744|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
25035856|NCT02737826|50135745|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
25035857|NCT03070431|50135772|FG000|Overall Study|Withdrawal by Subject|2|||
25035858|NCT03070431|50135772|FG000|Overall Study|Lost to Follow-up|2|||
25035859|NCT01071395|50135783|FG000|Overall Study|Withdrawal by Subject|2|||
25035860|NCT01071395|50135784|FG001|Overall Study|Withdrawal by Subject|1|||
25035861|NCT01071395|50135783|FG000|Overall Study|Adverse Event|3|||
25035862|NCT01071395|50135784|FG001|Overall Study|Adverse Event|1|||
25035863|NCT02970942|50135794|FG000|Overall Study|Death|0|||
25035864|NCT02970942|50135795|FG001|Overall Study|Death|1|||
25035865|NCT02970942|50135796|FG002|Overall Study|Death|0|||
25035866|NCT02970942|50135797|FG003|Overall Study|Death|0|||
25035867|NCT02970942|50135794|FG000|Overall Study|Lost to Follow-up|1|||
24946966|NCT00451178|50039416|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
24946967|NCT00450866|50039426|FG000|Overall Study|Adverse Event|0|||
24946968|NCT00450866|50039427|FG001|Overall Study|Adverse Event|1|||
25035868|NCT02970942|50135795|FG001|Overall Study|Lost to Follow-up|0|||
25035869|NCT02970942|50135796|FG002|Overall Study|Lost to Follow-up|2|||
25035870|NCT02970942|50135797|FG003|Overall Study|Lost to Follow-up|1|||
25035871|NCT02970942|50135794|FG000|Overall Study|Withdrawal by Subject|3|||
25035872|NCT02970942|50135795|FG001|Overall Study|Withdrawal by Subject|5|||
25035873|NCT02970942|50135796|FG002|Overall Study|Withdrawal by Subject|3|||
25035874|NCT02970942|50135797|FG003|Overall Study|Withdrawal by Subject|2|||
25035875|NCT03073005|50135811|FG000|Overall Study|Death|6|||
25035876|NCT03073005|50135812|FG001|Overall Study|Death|0|||
25035877|NCT03073005|50135813|FG002|Overall Study|Death|7|||
25035878|NCT03073005|50135814|FG003|Overall Study|Death|0|||
25035879|NCT03073005|50135811|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
25035880|NCT03073005|50135812|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
25035881|NCT03073005|50135813|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
25035882|NCT03073005|50135814|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
25035883|NCT03073005|50135811|FG000|Overall Study|Lost to Follow-up|2|||
25035884|NCT03073005|50135812|FG001|Overall Study|Lost to Follow-up|2|||
25035885|NCT03073005|50135813|FG002|Overall Study|Lost to Follow-up|1|||
25035886|NCT03073005|50135814|FG003|Overall Study|Lost to Follow-up|2|||
25035887|NCT03073005|50135811|FG000|Overall Study|Withdrawal by Subject|0|||
25035888|NCT03073005|50135812|FG001|Overall Study|Withdrawal by Subject|4|||
25035889|NCT03073005|50135813|FG002|Overall Study|Withdrawal by Subject|4|||
25035890|NCT03073005|50135814|FG003|Overall Study|Withdrawal by Subject|4|||
25035891|NCT02849171|50135827|FG000|Overall Study|Withdrawal by Subject|1|||
25035892|NCT02849171|50135827|FG000|Overall Study|Not treated|1|||
25035893|NCT02848664|50135840|FG000|Overall Study|Withdrawal by Subject|2|||
25035894|NCT02848664|50135840|FG000|Overall Study|Adverse Event|1|||
25035895|NCT02848664|50135840|FG000|Overall Study|no assistance for device training|1|||
24946969|NCT00450866|50039426|FG000|Overall Study|Withdrawal by Subject|5|||
24946970|NCT00450866|50039427|FG001|Overall Study|Withdrawal by Subject|2|||
24946971|NCT00450866|50039426|FG000|Overall Study|Death|1|||
24946972|NCT00450866|50039427|FG001|Overall Study|Death|0|||
24946973|NCT00450866|50039426|FG000|Overall Study|Physician Decision|1|||
24946974|NCT00450866|50039427|FG001|Overall Study|Physician Decision|0|||
24946975|NCT00442598|50039436|FG000|Overall Study|Adverse Event|1|||
24946976|NCT00442598|50039437|FG001|Overall Study|Adverse Event|0|||
24946977|NCT00442598|50039438|FG002|Overall Study|Adverse Event|0|||
24946978|NCT00442598|50039436|FG000|Overall Study|Tumor progression|3|||
24946979|NCT00442598|50039437|FG001|Overall Study|Tumor progression|4|||
25035896|NCT02969382|50135850|FG000|Overall Study|Adverse Event|8|||
25035897|NCT02969382|50135851|FG001|Overall Study|Adverse Event|10|||
25035898|NCT02969382|50135850|FG000|Overall Study|Lack of Efficacy|4|||
25035899|NCT02969382|50135851|FG001|Overall Study|Lack of Efficacy|5|||
25035900|NCT02969382|50135850|FG000|Overall Study|Death|0|||
25035901|NCT02969382|50135851|FG001|Overall Study|Death|1|||
24946980|NCT00442598|50039438|FG002|Overall Study|Tumor progression|0|||
25035902|NCT02969382|50135850|FG000|Overall Study|PROTOCOL DEVIATION|0|||
25035903|NCT02969382|50135851|FG001|Overall Study|PROTOCOL DEVIATION|1|||
24946981|NCT00442598|50039436|FG000|Overall Study|Clinical deterioration|1|||
25035904|NCT02969382|50135850|FG000|Overall Study|Withdrawal by Subject|14|||
25035905|NCT02969382|50135851|FG001|Overall Study|Withdrawal by Subject|9|||
25035906|NCT01989104|50135862|FG000|Overall Study|Withdrawal by Subject|3|||
24946982|NCT00442598|50039437|FG001|Overall Study|Clinical deterioration|2|||
24946983|NCT00442598|50039438|FG002|Overall Study|Clinical deterioration|0|||
24946984|NCT00442598|50039436|FG000|Overall Study|CA125 progression|0|||
24946985|NCT00442598|50039437|FG001|Overall Study|CA125 progression|1|||
24946986|NCT00442598|50039438|FG002|Overall Study|CA125 progression|0|||
24946987|NCT00442598|50039436|FG000|Overall Study|Reduced creatinine clearance|1|||
24946988|NCT00442598|50039437|FG001|Overall Study|Reduced creatinine clearance|0|||
24946989|NCT00442598|50039438|FG002|Overall Study|Reduced creatinine clearance|0|||
24946990|NCT00442598|50039436|FG000|Overall Study|Death|0|||
24946991|NCT00442598|50039437|FG001|Overall Study|Death|1|||
24946992|NCT00442598|50039438|FG002|Overall Study|Death|0|||
24946993|NCT00442286|50039448|FG000|Overall Study|Death|2|||
24946994|NCT00442286|50039449|FG001|Overall Study|Death|2|||
24946995|NCT00442286|50039448|FG000|Overall Study|Lost to Follow-up|1|||
24946996|NCT00442286|50039449|FG001|Overall Study|Lost to Follow-up|0|||
24946997|NCT00442286|50039448|FG000|Overall Study|Withdrawal by Subject|2|||
24946998|NCT00442286|50039449|FG001|Overall Study|Withdrawal by Subject|0|||
24946999|NCT00442286|50039448|FG000|Overall Study|System explanted|1|||
24947000|NCT00442286|50039449|FG001|Overall Study|System explanted|0|||
24947001|NCT00442286|50039448|FG000|Overall Study|Patient Injury|1|||
24947002|NCT00442286|50039449|FG001|Overall Study|Patient Injury|0|||
24947003|NCT00441974|50039457|FG000|Overall Study|Adverse Event|6|||
24947004|NCT00441974|50039457|FG000|Overall Study|Consent Withdrawn|35|||
24947005|NCT00441974|50039457|FG000|Overall Study|Lost to Follow-up|80|||
24947006|NCT00441974|50039457|FG000|Overall Study|Protocol Violation|7|||
24947007|NCT00441584|50039464|FG000|Overall Study|Lack of Efficacy|79|||
24947008|NCT00441584|50039464|FG000|Overall Study|Withdrawal by Subject|8|||
24947009|NCT00441584|50039464|FG000|Overall Study|Adverse Event|6|||
24947010|NCT00441584|50039464|FG000|Overall Study|Protocol Violation|5|||
24947011|NCT00441584|50039464|FG000|Overall Study|Lost to Follow-up|4|||
24947012|NCT00441584|50039464|FG000|Overall Study|Failure to meet eligibility criteria|3|||
24947013|NCT00430716|50039471|FG000|Double Blind Phase|Death|1|||
24947014|NCT00430716|50039472|FG001|Double Blind Phase|Death|0|||
24947015|NCT00430716|50039473|FG002|Double Blind Phase|Death|0|||
24947016|NCT00430716|50039471|FG000|Double Blind Phase|No longer willing to participate|2|||
24947017|NCT00430716|50039472|FG001|Double Blind Phase|No longer willing to participate|1|||
24947018|NCT00430716|50039473|FG002|Double Blind Phase|No longer willing to participate|1|||
24947019|NCT00430716|50039471|FG000|Double Blind Phase|Other|0|||
24947020|NCT00430716|50039472|FG001|Double Blind Phase|Other|2|||
24947021|NCT00430716|50039473|FG002|Double Blind Phase|Other|0|||
24947022|NCT00430716|50039471|FG000|Double Blind Phase|Study terminated by sponsor|1|||
24947023|NCT00430716|50039472|FG001|Double Blind Phase|Study terminated by sponsor|1|||
24947024|NCT00430716|50039473|FG002|Double Blind Phase|Study terminated by sponsor|2|||
24947025|NCT00430716|50039471|FG000|Double Blind Phase|Adverse Event|1|||
24947026|NCT00430716|50039472|FG001|Double Blind Phase|Adverse Event|1|||
24947027|NCT00430716|50039473|FG002|Double Blind Phase|Adverse Event|3|||
24947028|NCT00430716|50039471|FG000|Double Blind Phase|Not treated|1|||
24947029|NCT00430716|50039472|FG001|Double Blind Phase|Not treated|0|||
24947030|NCT00430716|50039473|FG002|Double Blind Phase|Not treated|0|||
24947031|NCT00430716|50039471|FG000|Open Label Phase|Lost to Follow-up|1|||
24947032|NCT00430716|50039472|FG001|Open Label Phase|Lost to Follow-up|0|||
24947033|NCT00430716|50039473|FG002|Open Label Phase|Lost to Follow-up|1|||
24947034|NCT00430716|50039471|FG000|Open Label Phase|No longer willing to participate|0|||
24947035|NCT00430716|50039472|FG001|Open Label Phase|No longer willing to participate|1|||
24947036|NCT00430716|50039473|FG002|Open Label Phase|No longer willing to participate|1|||
25035907|NCT01989104|50135863|FG001|Overall Study|Withdrawal by Subject|0|||
25035908|NCT01989104|50135864|FG002|Overall Study|Withdrawal by Subject|0|||
25035909|NCT01989104|50135865|FG003|Overall Study|Withdrawal by Subject|0|||
25035910|NCT01989104|50135866|FG004|Overall Study|Withdrawal by Subject|0|||
25035911|NCT02903238|50135878|FG000|Overall Study|Lost to Follow-up|4|||
25035912|NCT02847260|50135883|FG000|Overall Study|Adverse Event|3|||
25035913|NCT02847260|50135883|FG000|Overall Study|Withdrawal by Subject|2|||
25035914|NCT02847260|50135883|FG000|Overall Study|Clinical Deterioration|1|||
25035915|NCT02847260|50135883|FG000|Overall Study|Physician Decision|1|||
25035916|NCT02968563|50135889|FG000|Overall Study|Adverse Event|0|||
25035917|NCT02968563|50135890|FG001|Overall Study|Adverse Event|6|||
25035918|NCT02968563|50135889|FG000|Overall Study|Death|1|||
25035919|NCT02968563|50135890|FG001|Overall Study|Death|1|||
25035920|NCT02968563|50135889|FG000|Overall Study|Lost to Follow-up|0|||
25035921|NCT02968563|50135890|FG001|Overall Study|Lost to Follow-up|1|||
25035922|NCT02904096|50135898|FG000|Overall Study|Adverse Event|1|||
25035923|NCT02904096|50135899|FG001|Overall Study|Adverse Event|0|||
25035924|NCT02904096|50135898|FG000|Overall Study|Withdrawal by Subject|4|||
25035925|NCT02904096|50135899|FG001|Overall Study|Withdrawal by Subject|3|||
25035926|NCT02904096|50135898|FG000|Overall Study|Lost to Follow-up|10|||
25035927|NCT02904096|50135899|FG001|Overall Study|Lost to Follow-up|17|||
25035928|NCT02904096|50135898|FG000|Overall Study|Non-compliant|3|||
25035929|NCT02904096|50135899|FG001|Overall Study|Non-compliant|1|||
25035930|NCT02904096|50135898|FG000|Overall Study|Sponsor instructed|1|||
25035931|NCT02904096|50135899|FG001|Overall Study|Sponsor instructed|0|||
25035932|NCT03161405|50135909|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
25035933|NCT01813929|50135918|FG000|Overall Study|Withdrawal by Subject|0|||
25035934|NCT01813929|50135919|FG001|Overall Study|Withdrawal by Subject|1|||
25035935|NCT02901054|50135929|FG000|Overall Study|Physician Decision|1|||
25035936|NCT02901054|50135929|FG000|Overall Study|Withdrawal by Subject|3|||
25035937|NCT03068715|50135935|FG000|Overall Study|No longer met inclusion criteria|1|||
25035938|NCT03068715|50135936|FG001|Overall Study|No longer met inclusion criteria|0|||
25035939|NCT02966340|50135944|FG000|Overall Study|Adverse Event|0|||
25035940|NCT02966340|50135945|FG001|Overall Study|Adverse Event|1|||
25035941|NCT02966340|50135944|FG000|Overall Study|Lost to Follow-up|0|||
25035942|NCT02966340|50135945|FG001|Overall Study|Lost to Follow-up|1|||
25035943|NCT02966340|50135944|FG000|Overall Study|Withdrawal by Subject|1|||
25035944|NCT02966340|50135945|FG001|Overall Study|Withdrawal by Subject|0|||
25035945|NCT02966340|50135944|FG000|Overall Study|data acquisition error|1|||
25035946|NCT02966340|50135945|FG001|Overall Study|data acquisition error|0|||
25035947|NCT02966340|50135944|FG000|Overall Study|startle non-responder|1|||
25035948|NCT02966340|50135945|FG001|Overall Study|startle non-responder|1|||
25035949|NCT03067311|50135953|FG000|Overall Study|Lost to Follow-up|1|||
25035950|NCT03067311|50135954|FG001|Overall Study|Lost to Follow-up|1|||
25035951|NCT03067311|50135953|FG000|Overall Study|Moved away|1|||
25035952|NCT03067311|50135954|FG001|Overall Study|Moved away|1|||
25035953|NCT04380519|50135963|FG000|Overall Study|Withdrawal by Subject|4|||
25035954|NCT04380519|50135964|FG001|Overall Study|Withdrawal by Subject|0|||
25275724|NCT00974974|50589532|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
25275725|NCT00974974|50589533|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
25275726|NCT00974974|50589532|FG000|Maintenance - Double Blind Treatment|Various|4|||
25275727|NCT00974974|50589533|FG001|Maintenance - Double Blind Treatment|Various|0|||
25275728|NCT01233869|50589543|FG000|Initial Treatment Period (24 Months)|Death|1|||
25275729|NCT01233869|50589544|FG001|Initial Treatment Period (24 Months)|Death|0|||
25275730|NCT01233869|50589545|FG002|Initial Treatment Period (24 Months)|Death|0|||
24947037|NCT00430716|50039471|FG000|Open Label Phase|Other|3|||
24947038|NCT00430716|50039472|FG001|Open Label Phase|Other|1|||
24947039|NCT00430716|50039473|FG002|Open Label Phase|Other|1|||
25035955|NCT04380519|50135965|FG002|Overall Study|Withdrawal by Subject|1|||
25035956|NCT04380519|50135963|FG000|Overall Study|Death|14|||
25035957|NCT04380519|50135964|FG001|Overall Study|Death|9|||
25035958|NCT04380519|50135965|FG002|Overall Study|Death|6|||
25035959|NCT04380519|50135963|FG000|Overall Study|Adverse Event|0|||
25035960|NCT04380519|50135964|FG001|Overall Study|Adverse Event|1|||
25035961|NCT04380519|50135965|FG002|Overall Study|Adverse Event|0|||
25035962|NCT04380519|50135963|FG000|Overall Study|relatives' decision|0|||
25035963|NCT04380519|50135964|FG001|Overall Study|relatives' decision|1|||
25035964|NCT04380519|50135965|FG002|Overall Study|relatives' decision|0|||
25035965|NCT02847182|50135975|FG000|Overall Study|Withdrawal by Subject|0|||
25035966|NCT02847182|50135976|FG001|Overall Study|Withdrawal by Subject|1|||
25035967|NCT02846558|50135992|FG000|Overall Study|Adverse Event|1|||
25035968|NCT02846558|50135993|FG001|Overall Study|Adverse Event|0|||
25035969|NCT02846558|50135994|FG002|Overall Study|Adverse Event|0|||
25035970|NCT02846558|50135995|FG003|Overall Study|Adverse Event|0|||
25035971|NCT02846558|50135992|FG000|Overall Study|Withdrawal by Subject|5|||
25035972|NCT02846558|50135993|FG001|Overall Study|Withdrawal by Subject|4|||
25035973|NCT02846558|50135994|FG002|Overall Study|Withdrawal by Subject|2|||
25035974|NCT02846558|50135995|FG003|Overall Study|Withdrawal by Subject|2|||
25035975|NCT02846558|50135992|FG000|Overall Study|Lost to Follow-up|2|||
25035976|NCT02846558|50135993|FG001|Overall Study|Lost to Follow-up|0|||
25035977|NCT02846558|50135994|FG002|Overall Study|Lost to Follow-up|0|||
25035978|NCT02846558|50135995|FG003|Overall Study|Lost to Follow-up|0|||
25035979|NCT04362813|50136014|FG000|Overall Study|Death|12|||
25035980|NCT04362813|50136015|FG001|Overall Study|Death|16|||
25035981|NCT04362813|50136014|FG000|Overall Study|Withdrawal by Subject|3|||
25035982|NCT04362813|50136015|FG001|Overall Study|Withdrawal by Subject|1|||
25035983|NCT04362813|50136014|FG000|Overall Study|Protocol Violation|0|||
25035984|NCT04362813|50136015|FG001|Overall Study|Protocol Violation|3|||
25035985|NCT04362813|50136014|FG000|Overall Study|Lost to Follow-up|1|||
25035986|NCT04362813|50136015|FG001|Overall Study|Lost to Follow-up|1|||
25035987|NCT04362813|50136014|FG000|Overall Study|Enrolled but did not receive treatment|2|||
25035988|NCT04362813|50136015|FG001|Overall Study|Enrolled but did not receive treatment|4|||
25035989|NCT02966028|50136024|FG000|Overall Study|Adverse Event|7|||
25035990|NCT02966028|50136025|FG001|Overall Study|Adverse Event|13|||
25035991|NCT02966028|50136026|FG002|Overall Study|Adverse Event|10|||
25035992|NCT02966028|50136024|FG000|Overall Study|Physician Decision|1|||
24947040|NCT00430716|50039471|FG000|Open Label Phase|Protocol Violation|1|||
24947041|NCT00430716|50039472|FG001|Open Label Phase|Protocol Violation|0|||
25035993|NCT02966028|50136025|FG001|Overall Study|Physician Decision|0|||
25035994|NCT02966028|50136026|FG002|Overall Study|Physician Decision|2|||
25035995|NCT02966028|50136024|FG000|Overall Study|Withdrawal by Subject|7|||
24947042|NCT00430716|50039473|FG002|Open Label Phase|Protocol Violation|0|||
24947043|NCT00430716|50039471|FG000|Open Label Phase|Study terminated by sponsor|4|||
24947044|NCT00430716|50039472|FG001|Open Label Phase|Study terminated by sponsor|5|||
24947045|NCT00430716|50039473|FG002|Open Label Phase|Study terminated by sponsor|4|||
25035996|NCT02966028|50136025|FG001|Overall Study|Withdrawal by Subject|5|||
25035997|NCT02966028|50136026|FG002|Overall Study|Withdrawal by Subject|5|||
24947046|NCT00441272|50039483|FG000|Overall Study|Study terminated prior to enrollment|25|||
24947047|NCT00441272|50039484|FG001|Overall Study|Study terminated prior to enrollment|25|||
24947048|NCT00430638|50039492|FG000|Overall Study|Adverse Event|15|||
24947049|NCT00430638|50039493|FG001|Overall Study|Adverse Event|15|||
24947050|NCT00430638|50039492|FG000|Overall Study|Uncontrolled blood pressure|48|||
24947051|NCT00430638|50039493|FG001|Overall Study|Uncontrolled blood pressure|13|||
24947052|NCT00430638|50039492|FG000|Overall Study|Lost to Follow-up|1|||
24947053|NCT00430638|50039493|FG001|Overall Study|Lost to Follow-up|7|||
24947054|NCT00430638|50039492|FG000|Overall Study|Protocol Violation|6|||
24947055|NCT00430638|50039493|FG001|Overall Study|Protocol Violation|4|||
24947056|NCT00430638|50039492|FG000|Overall Study|Withdrawal by Subject|4|||
24947057|NCT00430638|50039493|FG001|Overall Study|Withdrawal by Subject|6|||
24947058|NCT00430638|50039492|FG000|Overall Study|Non-compliant|2|||
24947059|NCT00430638|50039493|FG001|Overall Study|Non-compliant|1|||
24947060|NCT00430638|50039492|FG000|Overall Study|Other|2|||
24947061|NCT00430638|50039493|FG001|Overall Study|Other|2|||
24947062|NCT00430482|50039505|FG000|Completed Treatment|Insufficient Treatment|7|||
24947063|NCT00430482|50039506|FG001|Completed Treatment|Insufficient Treatment|11|||
24947064|NCT00449930|50039514|FG000|Overall Study|Adverse Event|9|||
24947065|NCT00449930|50039515|FG001|Overall Study|Adverse Event|19|||
24947066|NCT00449930|50039514|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
24947067|NCT00449930|50039515|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
24947068|NCT00449930|50039514|FG000|Overall Study|Lack of Efficacy|10|||
24947069|NCT00449930|50039515|FG001|Overall Study|Lack of Efficacy|1|||
24947070|NCT00449930|50039514|FG000|Overall Study|Lost to Follow-up|9|||
24947071|NCT00449930|50039515|FG001|Overall Study|Lost to Follow-up|14|||
24947072|NCT00449930|50039514|FG000|Overall Study|Physician Decision|1|||
24947073|NCT00449930|50039515|FG001|Overall Study|Physician Decision|2|||
24947074|NCT00449930|50039514|FG000|Overall Study|Protocol Violation|14|||
24947075|NCT00449930|50039515|FG001|Overall Study|Protocol Violation|15|||
24947076|NCT00449930|50039514|FG000|Overall Study|Withdrawal by Subject|16|||
24947077|NCT00449930|50039515|FG001|Overall Study|Withdrawal by Subject|23|||
25035998|NCT02966028|50136024|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
25035999|NCT02966028|50136025|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
25036000|NCT02966028|50136026|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
25036001|NCT02925741|50136040|FG000|Overall Study|Withdrawal by Subject|11|||
25036002|NCT02925741|50136041|FG001|Overall Study|Withdrawal by Subject|0|||
25036003|NCT02964312|50136050|FG000|Overall Study|Lost to Follow-up|28|||
25036004|NCT02964312|50136050|FG000|Overall Study|Withdrawal by Subject|11|||
25036005|NCT02964312|50136050|FG000|Overall Study|Lack of Efficacy|10|||
25036006|NCT02964312|50136050|FG000|Overall Study|Did not consent to long-term FU|14|||
25036007|NCT02964312|50136050|FG000|Overall Study|Death|1|||
25036008|NCT02899962|50136074|FG000|Open-label Phase|Adverse Event|2|||
25036009|NCT02899962|50136075|FG001|Open-label Phase|Adverse Event|0|||
25036010|NCT02899962|50136076|FG002|Open-label Phase|Adverse Event|0|||
25036011|NCT02899962|50136074|FG000|Open-label Phase|Lost to Follow-up|9|||
25036012|NCT02899962|50136075|FG001|Open-label Phase|Lost to Follow-up|0|||
25036013|NCT02899962|50136076|FG002|Open-label Phase|Lost to Follow-up|0|||
25036014|NCT02899962|50136074|FG000|Open-label Phase|Other reasons|9|||
25036015|NCT02899962|50136075|FG001|Open-label Phase|Other reasons|0|||
25036016|NCT02899962|50136076|FG002|Open-label Phase|Other reasons|0|||
25036017|NCT02899962|50136074|FG000|Open-label Phase|Withdrawal by Subject|7|||
25036018|NCT02899962|50136075|FG001|Open-label Phase|Withdrawal by Subject|0|||
25036019|NCT02899962|50136076|FG002|Open-label Phase|Withdrawal by Subject|0|||
25036020|NCT02899962|50136074|FG000|Maintenance Phase|Adverse Event|0|||
25036021|NCT02899962|50136075|FG001|Maintenance Phase|Adverse Event|2|||
25036022|NCT02899962|50136076|FG002|Maintenance Phase|Adverse Event|1|||
25036023|NCT02899962|50136074|FG000|Maintenance Phase|Death|0|||
25036024|NCT02899962|50136075|FG001|Maintenance Phase|Death|0|||
25036025|NCT02899962|50136076|FG002|Maintenance Phase|Death|1|||
25036026|NCT02899962|50136074|FG000|Maintenance Phase|Lack of Efficacy|0|||
25036027|NCT02899962|50136075|FG001|Maintenance Phase|Lack of Efficacy|20|||
25036028|NCT02899962|50136076|FG002|Maintenance Phase|Lack of Efficacy|16|||
25036029|NCT02899962|50136074|FG000|Maintenance Phase|Lost to Follow-up|0|||
25036030|NCT02899962|50136075|FG001|Maintenance Phase|Lost to Follow-up|12|||
25036031|NCT02899962|50136076|FG002|Maintenance Phase|Lost to Follow-up|14|||
25036032|NCT02899962|50136074|FG000|Maintenance Phase|Other reasons|0|||
25036033|NCT02899962|50136075|FG001|Maintenance Phase|Other reasons|9|||
25036034|NCT02899962|50136076|FG002|Maintenance Phase|Other reasons|13|||
25036035|NCT02899962|50136074|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
25036036|NCT02899962|50136075|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
25036037|NCT02899962|50136076|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
25036038|NCT02899962|50136074|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
25036039|NCT02899962|50136075|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
25036040|NCT02899962|50136076|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
25036041|NCT02899962|50136074|FG000|Maintenance Phase|Withdrawal by Subject|0|||
25036042|NCT02899962|50136075|FG001|Maintenance Phase|Withdrawal by Subject|30|||
25036043|NCT02899962|50136076|FG002|Maintenance Phase|Withdrawal by Subject|36|||
25036044|NCT02899728|50136085|FG000|Overall Study|Withdrawal by Subject|1|||
25036045|NCT02899728|50136086|FG001|Overall Study|Withdrawal by Subject|1|||
25036046|NCT02899338|50136094|FG000|Overall Study|Adverse Event|1|||
25036047|NCT02899338|50136095|FG001|Overall Study|Adverse Event|2|||
25036048|NCT02899338|50136094|FG000|Overall Study|Withdrawal by Subject|2|||
25036049|NCT02899338|50136095|FG001|Overall Study|Withdrawal by Subject|0|||
25036050|NCT03066609|50136104|FG000|INDUCTION|Pregnancy|0|||
25036051|NCT03066609|50136105|FG001|INDUCTION|Pregnancy|0|||
25036052|NCT03066609|50136106|FG002|INDUCTION|Pregnancy|1|||
25036053|NCT03066609|50136107|FG003|INDUCTION|Pregnancy|0|||
25036054|NCT03066609|50136104|FG000|INDUCTION|Lack of Efficacy|0|||
25036055|NCT03066609|50136105|FG001|INDUCTION|Lack of Efficacy|0|||
25036056|NCT03066609|50136106|FG002|INDUCTION|Lack of Efficacy|1|||
25036057|NCT03066609|50136107|FG003|INDUCTION|Lack of Efficacy|0|||
25036058|NCT03066609|50136104|FG000|INDUCTION|Adverse Event|2|||
25036059|NCT03066609|50136105|FG001|INDUCTION|Adverse Event|2|||
25036060|NCT03066609|50136106|FG002|INDUCTION|Adverse Event|0|||
25036061|NCT03066609|50136107|FG003|INDUCTION|Adverse Event|0|||
25036062|NCT03066609|50136104|FG000|MAINTENANCE|Adverse Event|0|||
25036063|NCT03066609|50136105|FG001|MAINTENANCE|Adverse Event|0|||
25036064|NCT03066609|50136106|FG002|MAINTENANCE|Adverse Event|0|||
25036065|NCT03066609|50136107|FG003|MAINTENANCE|Adverse Event|1|||
25036066|NCT03066609|50136104|FG000|MAINTENANCE|Withdrawal by Subject|4|||
25036067|NCT03066609|50136105|FG001|MAINTENANCE|Withdrawal by Subject|2|||
25036068|NCT03066609|50136106|FG002|MAINTENANCE|Withdrawal by Subject|1|||
25036069|NCT03066609|50136107|FG003|MAINTENANCE|Withdrawal by Subject|1|||
25036070|NCT03066609|50136104|FG000|MAINTENANCE|Lost to Follow-up|0|||
25036071|NCT03066609|50136105|FG001|MAINTENANCE|Lost to Follow-up|1|||
25036072|NCT03066609|50136106|FG002|MAINTENANCE|Lost to Follow-up|1|||
25036073|NCT03066609|50136107|FG003|MAINTENANCE|Lost to Follow-up|0|||
25036074|NCT03066609|50136104|FG000|MAINTENANCE|Pregnancy|1|||
25036075|NCT03066609|50136105|FG001|MAINTENANCE|Pregnancy|0|||
25036076|NCT03066609|50136106|FG002|MAINTENANCE|Pregnancy|0|||
25036077|NCT03066609|50136107|FG003|MAINTENANCE|Pregnancy|0|||
25036078|NCT03066609|50136104|FG000|MAINTENANCE|Lack of Efficacy|2|||
25036079|NCT03066609|50136105|FG001|MAINTENANCE|Lack of Efficacy|1|||
25036080|NCT03066609|50136106|FG002|MAINTENANCE|Lack of Efficacy|0|||
25036081|NCT03066609|50136107|FG003|MAINTENANCE|Lack of Efficacy|1|||
25036082|NCT03066609|50136104|FG000|OVERALL STUDY|Adverse Event|2|||
25036083|NCT03066609|50136105|FG001|OVERALL STUDY|Adverse Event|2|||
25036084|NCT03066609|50136106|FG002|OVERALL STUDY|Adverse Event|0|||
25036085|NCT03066609|50136107|FG003|OVERALL STUDY|Adverse Event|1|||
25036086|NCT03066609|50136104|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
25036087|NCT03066609|50136105|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
25036088|NCT03066609|50136106|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
25036089|NCT03066609|50136107|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
25036090|NCT03066609|50136104|FG000|OVERALL STUDY|Lost to Follow-up|1|||
25036091|NCT03066609|50136105|FG001|OVERALL STUDY|Lost to Follow-up|1|||
25036092|NCT03066609|50136106|FG002|OVERALL STUDY|Lost to Follow-up|1|||
25036093|NCT03066609|50136107|FG003|OVERALL STUDY|Lost to Follow-up|1|||
25036094|NCT03066609|50136104|FG000|OVERALL STUDY|Pregnancy|1|||
25036095|NCT03066609|50136105|FG001|OVERALL STUDY|Pregnancy|0|||
25036096|NCT03066609|50136106|FG002|OVERALL STUDY|Pregnancy|1|||
25036097|NCT03066609|50136107|FG003|OVERALL STUDY|Pregnancy|0|||
25036098|NCT03066609|50136104|FG000|OVERALL STUDY|Lack of Efficacy|2|||
25036099|NCT03066609|50136105|FG001|OVERALL STUDY|Lack of Efficacy|1|||
25036100|NCT03066609|50136106|FG002|OVERALL STUDY|Lack of Efficacy|1|||
25036101|NCT03066609|50136107|FG003|OVERALL STUDY|Lack of Efficacy|1|||
25036102|NCT03066609|50136104|FG000|OVERALL STUDY|discontinued follow up|0|||
25036103|NCT03066609|50136105|FG001|OVERALL STUDY|discontinued follow up|2|||
25036104|NCT03066609|50136106|FG002|OVERALL STUDY|discontinued follow up|0|||
25036105|NCT03066609|50136107|FG003|OVERALL STUDY|discontinued follow up|0|||
25036106|NCT02964234|50136124|FG000|Overall Study|Lost to Follow-up|22|||
25036107|NCT02964234|50136125|FG001|Overall Study|Lost to Follow-up|13|||
25036108|NCT01345188|50136131|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
25036109|NCT01345188|50136131|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
25036110|NCT03852459|50136140|FG000|Overall Study|Adverse Event|2|||
25036111|NCT03852459|50136141|FG001|Overall Study|Adverse Event|2|||
25036112|NCT03852459|50136140|FG000|Overall Study|Withdrawal by Subject|1|||
25036113|NCT03852459|50136141|FG001|Overall Study|Withdrawal by Subject|1|||
25036114|NCT02896296|50136147|FG000|Overall Study|Adverse Event|1|||
25036115|NCT02896296|50136147|FG000|Overall Study|Lost to Follow-up|19|||
25036116|NCT02896296|50136147|FG000|Overall Study|Pregnancy|1|||
25036117|NCT02896296|50136147|FG000|Overall Study|Physician Decision|2|||
25036118|NCT02896296|50136147|FG000|Overall Study|Withdrawal by Subject|10|||
25036119|NCT02896296|50136147|FG000|Overall Study|Site closing|7|||
25036120|NCT02896296|50136147|FG000|Overall Study|Incarceration|1|||
25036121|NCT02896296|50136147|FG000|Overall Study|Relocation|1|||
25036122|NCT03740919|50136154|FG000|Lead-in Period|Lost to Follow-up|1|||
25036123|NCT03740919|50136155|FG001|Lead-in Period|Lost to Follow-up|0|||
25036124|NCT03740919|50136156|FG002|Lead-in Period|Lost to Follow-up|0|||
25036125|NCT03740919|50136157|FG003|Lead-in Period|Lost to Follow-up|0|||
25036126|NCT03740919|50136154|FG000|Lead-in Period|Physician Decision|2|||
25036127|NCT03740919|50136155|FG001|Lead-in Period|Physician Decision|0|||
25036128|NCT03740919|50136156|FG002|Lead-in Period|Physician Decision|0|||
25036129|NCT03740919|50136157|FG003|Lead-in Period|Physician Decision|0|||
25036130|NCT03740919|50136154|FG000|Lead-in Period|Protocol Violation|1|||
25036131|NCT03740919|50136155|FG001|Lead-in Period|Protocol Violation|0|||
25036132|NCT03740919|50136156|FG002|Lead-in Period|Protocol Violation|0|||
25036133|NCT03740919|50136157|FG003|Lead-in Period|Protocol Violation|0|||
25036134|NCT03740919|50136154|FG000|Lead-in Period|Withdrawal by Subject|10|||
25036135|NCT03740919|50136155|FG001|Lead-in Period|Withdrawal by Subject|0|||
25036136|NCT03740919|50136156|FG002|Lead-in Period|Withdrawal by Subject|0|||
25036137|NCT03740919|50136157|FG003|Lead-in Period|Withdrawal by Subject|0|||
25036138|NCT03740919|50136154|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
25036139|NCT03740919|50136155|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
25036140|NCT03740919|50136156|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
25036141|NCT03740919|50136157|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
25036142|NCT03740919|50136154|FG000|Lead-in Period|Study Task Too Burdensome|1|||
25036143|NCT03740919|50136155|FG001|Lead-in Period|Study Task Too Burdensome|0|||
25036144|NCT03740919|50136156|FG002|Lead-in Period|Study Task Too Burdensome|0|||
25036145|NCT03740919|50136157|FG003|Lead-in Period|Study Task Too Burdensome|0|||
25036146|NCT03740919|50136154|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
25036147|NCT03740919|50136155|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
25036148|NCT03740919|50136156|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
25036149|NCT03740919|50136157|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
25036150|NCT03740919|50136154|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
25036151|NCT03740919|50136155|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
25036152|NCT03740919|50136156|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
25036153|NCT03740919|50136157|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
25036154|NCT03740919|50136154|FG000|Treatment Period|Adverse Event|0|||
25036155|NCT03740919|50136155|FG001|Treatment Period|Adverse Event|0|||
25036156|NCT03740919|50136156|FG002|Treatment Period|Adverse Event|2|||
25036157|NCT03740919|50136157|FG003|Treatment Period|Adverse Event|0|||
25036158|NCT03740919|50136154|FG000|Treatment Period|Protocol Violation|0|||
25036159|NCT03740919|50136155|FG001|Treatment Period|Protocol Violation|1|||
25036160|NCT03740919|50136156|FG002|Treatment Period|Protocol Violation|0|||
25036161|NCT03740919|50136157|FG003|Treatment Period|Protocol Violation|0|||
25036162|NCT03740919|50136154|FG000|Treatment Period|Withdrawal by Subject|0|||
25036163|NCT03740919|50136155|FG001|Treatment Period|Withdrawal by Subject|7|||
25036164|NCT03740919|50136156|FG002|Treatment Period|Withdrawal by Subject|6|||
25036165|NCT03740919|50136157|FG003|Treatment Period|Withdrawal by Subject|2|||
25036166|NCT03740919|50136154|FG000|Treatment Period|Terminated by Sponsor|0|||
25036167|NCT03740919|50136155|FG001|Treatment Period|Terminated by Sponsor|1|||
25036168|NCT03740919|50136156|FG002|Treatment Period|Terminated by Sponsor|0|||
25036169|NCT03740919|50136157|FG003|Treatment Period|Terminated by Sponsor|0|||
25036170|NCT03740919|50136154|FG000|Treatment Period|Issue with Insulin Pump|0|||
25036171|NCT03740919|50136155|FG001|Treatment Period|Issue with Insulin Pump|1|||
25036172|NCT03740919|50136156|FG002|Treatment Period|Issue with Insulin Pump|0|||
25036173|NCT03740919|50136157|FG003|Treatment Period|Issue with Insulin Pump|0|||
25036174|NCT03740919|50136154|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
25036175|NCT03740919|50136155|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
25036176|NCT03740919|50136156|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
25036177|NCT03740919|50136157|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
25036178|NCT03740919|50136154|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
25036179|NCT03740919|50136155|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
25036180|NCT03740919|50136156|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
25036181|NCT03740919|50136157|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
25036182|NCT03740919|50136154|FG000|Treatment Period|Not Completing Diary|0|||
25036183|NCT03740919|50136155|FG001|Treatment Period|Not Completing Diary|0|||
25036184|NCT03740919|50136156|FG002|Treatment Period|Not Completing Diary|1|||
25036185|NCT03740919|50136157|FG003|Treatment Period|Not Completing Diary|0|||
25036186|NCT03740919|50136154|FG000|Treatment Period|Insulin Painful to Participant|0|||
25036187|NCT03740919|50136155|FG001|Treatment Period|Insulin Painful to Participant|0|||
25036188|NCT03740919|50136156|FG002|Treatment Period|Insulin Painful to Participant|1|||
25036189|NCT03740919|50136157|FG003|Treatment Period|Insulin Painful to Participant|0|||
25036190|NCT01335685|50136172|FG000|Overall Study|Study Terminated by Sponsor|2|||
25036191|NCT01335685|50136173|FG001|Overall Study|Study Terminated by Sponsor|1|||
25036192|NCT01335685|50136174|FG002|Overall Study|Study Terminated by Sponsor|1|||
25036193|NCT01335685|50136175|FG003|Overall Study|Study Terminated by Sponsor|10|||
25036194|NCT01335685|50136176|FG004|Overall Study|Study Terminated by Sponsor|0|||
25036195|NCT01335685|50136177|FG005|Overall Study|Study Terminated by Sponsor|4|||
25036196|NCT01335685|50136178|FG006|Overall Study|Study Terminated by Sponsor|2|||
25036197|NCT01335685|50136179|FG007|Overall Study|Study Terminated by Sponsor|3|||
25036198|NCT01335685|50136172|FG000|Overall Study|Withdrawal by Subject|1|||
25036199|NCT01335685|50136173|FG001|Overall Study|Withdrawal by Subject|0|||
25036200|NCT01335685|50136174|FG002|Overall Study|Withdrawal by Subject|0|||
25036201|NCT01335685|50136175|FG003|Overall Study|Withdrawal by Subject|1|||
25036202|NCT01335685|50136176|FG004|Overall Study|Withdrawal by Subject|0|||
25036203|NCT01335685|50136177|FG005|Overall Study|Withdrawal by Subject|0|||
25036204|NCT01335685|50136178|FG006|Overall Study|Withdrawal by Subject|0|||
25036205|NCT01335685|50136179|FG007|Overall Study|Withdrawal by Subject|0|||
25036206|NCT01335685|50136172|FG000|Overall Study|Reason not Specified|0|||
25036207|NCT01335685|50136173|FG001|Overall Study|Reason not Specified|0|||
25159809|NCT01402011|50279755|FG002|Active Treatment Period|Withdrawal by Subject|0|||
25159810|NCT01402011|50279753|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
25159811|NCT01402011|50279754|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
25159812|NCT01402011|50279755|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
25159813|NCT01421667|50279770|FG000|Overall Study|Withdrawal by Subject|0|||
25159814|NCT01421667|50279771|FG001|Overall Study|Withdrawal by Subject|1|||
25159815|NCT01421667|50279772|FG002|Overall Study|Withdrawal by Subject|2|||
25159816|NCT01421667|50279773|FG003|Overall Study|Withdrawal by Subject|1|||
25159817|NCT01421667|50279770|FG000|Overall Study|Lost to Follow-up|0|||
25159818|NCT01421667|50279771|FG001|Overall Study|Lost to Follow-up|1|||
25159819|NCT01421667|50279772|FG002|Overall Study|Lost to Follow-up|0|||
25159820|NCT01421667|50279773|FG003|Overall Study|Lost to Follow-up|0|||
25159821|NCT01390779|50279791|FG000|Overall Study|Physician Decision|1|||
25036208|NCT01335685|50136174|FG002|Overall Study|Reason not Specified|1|||
25036209|NCT01335685|50136175|FG003|Overall Study|Reason not Specified|0|||
25036210|NCT01335685|50136176|FG004|Overall Study|Reason not Specified|0|||
25036211|NCT01335685|50136177|FG005|Overall Study|Reason not Specified|1|||
25036212|NCT01335685|50136178|FG006|Overall Study|Reason not Specified|0|||
25036213|NCT01335685|50136179|FG007|Overall Study|Reason not Specified|0|||
25159822|NCT01891669|50279805|FG000|Overall Study|Death|0|||
25159823|NCT01891669|50279806|FG001|Overall Study|Death|0|||
25159824|NCT01891669|50279807|FG002|Overall Study|Death|0|||
25036214|NCT02926209|50136202|FG000|Study Cohort|Poor Bowel Preparation|1|||
25036215|NCT02926209|50136203|FG001|Study Cohort|Poor Bowel Preparation|0|||
25036216|NCT03066999|50136212|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
25036217|NCT03066999|50136213|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
25036218|NCT02963922|50136227|FG000|Overall Study|Adverse Event|15|||
25036219|NCT02963922|50136228|FG001|Overall Study|Adverse Event|6|||
25036220|NCT02963922|50136227|FG000|Overall Study|Protocol deviation|6|||
25036221|NCT02963922|50136228|FG001|Overall Study|Protocol deviation|6|||
25036222|NCT02963922|50136227|FG000|Overall Study|Lack of Efficacy|1|||
25036223|NCT02963922|50136228|FG001|Overall Study|Lack of Efficacy|1|||
25036224|NCT02963922|50136227|FG000|Overall Study|Lost to Follow-up|2|||
25036225|NCT02963922|50136228|FG001|Overall Study|Lost to Follow-up|3|||
25036226|NCT02963922|50136227|FG000|Overall Study|Other|8|||
25036227|NCT02963922|50136228|FG001|Overall Study|Other|14|||
25036228|NCT02881567|50136234|FG000|Overall Study|Adverse Event|1|||
25036229|NCT02881567|50136234|FG000|Overall Study|Lost to Follow-up|3|||
25036230|NCT02881567|50136234|FG000|Overall Study|Consent withdrawn|1|||
25036231|NCT02881567|50136234|FG000|Overall Study|Investigator decision|1|||
25036232|NCT02881567|50136234|FG000|Overall Study|Study terminated by sponsor|9|||
25036233|NCT02881567|50136234|FG000|Overall Study|Reason not Specified|3|||
25036234|NCT02962674|50136238|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
25036235|NCT02962908|50136248|FG000|Overall Study|Lost to Follow-up|0|||
25036236|NCT02962908|50136249|FG001|Overall Study|Lost to Follow-up|3|||
25036237|NCT02962908|50136250|FG002|Overall Study|Lost to Follow-up|0|||
25036238|NCT02962908|50136251|FG003|Overall Study|Lost to Follow-up|1|||
25036239|NCT02962908|50136248|FG000|Overall Study|Withdrawal by Subject|0|||
25036240|NCT02962908|50136249|FG001|Overall Study|Withdrawal by Subject|3|||
25036241|NCT02962908|50136250|FG002|Overall Study|Withdrawal by Subject|0|||
25036242|NCT02962908|50136251|FG003|Overall Study|Withdrawal by Subject|2|||
25036243|NCT02962908|50136248|FG000|Overall Study|Protocol Violation|0|||
25036244|NCT02962908|50136249|FG001|Overall Study|Protocol Violation|1|||
25036245|NCT02962908|50136250|FG002|Overall Study|Protocol Violation|0|||
25036246|NCT02962908|50136251|FG003|Overall Study|Protocol Violation|0|||
25036247|NCT02962908|50136248|FG000|Overall Study|Physician Decision|0|||
25036248|NCT02962908|50136249|FG001|Overall Study|Physician Decision|1|||
25036249|NCT02962908|50136250|FG002|Overall Study|Physician Decision|0|||
25036250|NCT02962908|50136251|FG003|Overall Study|Physician Decision|0|||
25036251|NCT02962284|50136269|FG000|Overall Study|Death|2|||
25036252|NCT02962284|50136270|FG001|Overall Study|Death|0|||
25036253|NCT02962284|50136269|FG000|Overall Study|Progressive disease|2|||
25036254|NCT02962284|50136270|FG001|Overall Study|Progressive disease|3|||
25036255|NCT02962284|50136269|FG000|Overall Study|Withdrawal by Subject|1|||
25036256|NCT02962284|50136270|FG001|Overall Study|Withdrawal by Subject|0|||
25036257|NCT01344876|50136278|FG000|Overall Study|Adverse Event|0|||
25036258|NCT01344876|50136279|FG001|Overall Study|Adverse Event|0|||
25036259|NCT01344876|50136280|FG002|Overall Study|Adverse Event|0|||
25036260|NCT01344876|50136281|FG003|Overall Study|Adverse Event|0|||
25036261|NCT01344876|50136282|FG004|Overall Study|Adverse Event|1|||
25036262|NCT01344876|50136278|FG000|Overall Study|Withdrawal by Subject|0|||
25036263|NCT01344876|50136279|FG001|Overall Study|Withdrawal by Subject|0|||
25036264|NCT01344876|50136280|FG002|Overall Study|Withdrawal by Subject|1|||
25036265|NCT01344876|50136281|FG003|Overall Study|Withdrawal by Subject|0|||
25036266|NCT01344876|50136282|FG004|Overall Study|Withdrawal by Subject|0|||
25036267|NCT01344876|50136278|FG000|Overall Study|Definite progression of primary disease|1|||
25036268|NCT01344876|50136279|FG001|Overall Study|Definite progression of primary disease|0|||
25036269|NCT01344876|50136280|FG002|Overall Study|Definite progression of primary disease|0|||
25036270|NCT01344876|50136281|FG003|Overall Study|Definite progression of primary disease|3|||
25036271|NCT01344876|50136282|FG004|Overall Study|Definite progression of primary disease|0|||
25036272|NCT02846324|50136299|FG000|Overall Study|Other|1|||
25036273|NCT02846324|50136300|FG001|Overall Study|Other|0|||
25036274|NCT02846324|50136301|FG002|Overall Study|Other|0|||
25036275|NCT02846324|50136302|FG003|Overall Study|Other|0|||
25036276|NCT02846324|50136299|FG000|Overall Study|Withdrawal by Subject|1|||
25036277|NCT02846324|50136300|FG001|Overall Study|Withdrawal by Subject|0|||
25036278|NCT02846324|50136301|FG002|Overall Study|Withdrawal by Subject|4|||
25036279|NCT02846324|50136302|FG003|Overall Study|Withdrawal by Subject|0|||
25036280|NCT03161093|50136327|FG000|Overall Study|Protocol Violation|11|||
25036281|NCT03161093|50136328|FG001|Overall Study|Protocol Violation|14|||
25036282|NCT03161093|50136329|FG002|Overall Study|Protocol Violation|6|||
25036283|NCT03161093|50136330|FG003|Overall Study|Protocol Violation|13|||
25036284|NCT03161093|50136331|FG004|Overall Study|Protocol Violation|1|||
25036285|NCT03161093|50136332|FG005|Overall Study|Protocol Violation|0|||
25036286|NCT03161093|50136327|FG000|Overall Study|Adverse Event|5|||
25036287|NCT03161093|50136328|FG001|Overall Study|Adverse Event|21|||
25159825|NCT01891669|50279808|FG003|Overall Study|Death|0|||
25036288|NCT03161093|50136329|FG002|Overall Study|Adverse Event|16|||
25036289|NCT03161093|50136330|FG003|Overall Study|Adverse Event|35|||
25036290|NCT03161093|50136331|FG004|Overall Study|Adverse Event|2|||
25159826|NCT01891669|50279809|FG004|Overall Study|Death|0|||
25036291|NCT03161093|50136332|FG005|Overall Study|Adverse Event|1|||
25036292|NCT03161093|50136327|FG000|Overall Study|Lack of Efficacy|9|||
25036293|NCT03161093|50136328|FG001|Overall Study|Lack of Efficacy|13|||
25036294|NCT03161093|50136329|FG002|Overall Study|Lack of Efficacy|9|||
24947078|NCT00449930|50039514|FG000|Overall Study|Glycemic discontinuation criteria|1|||
24947079|NCT00449930|50039515|FG001|Overall Study|Glycemic discontinuation criteria|1|||
24947080|NCT00449696|50039523|FG000|Overall Study|Other Treatment Required|6|||
24947081|NCT00449696|50039524|FG001|Overall Study|Other Treatment Required|1|||
24947082|NCT00449696|50039523|FG000|Overall Study|Withdrawal by Subject|5|||
24947083|NCT00449696|50039524|FG001|Overall Study|Withdrawal by Subject|5|||
25036295|NCT03161093|50136330|FG003|Overall Study|Lack of Efficacy|24|||
25036296|NCT03161093|50136331|FG004|Overall Study|Lack of Efficacy|4|||
25036297|NCT03161093|50136332|FG005|Overall Study|Lack of Efficacy|1|||
25036298|NCT03161093|50136327|FG000|Overall Study|Physician Decision|0|||
25036299|NCT03161093|50136328|FG001|Overall Study|Physician Decision|1|||
25036300|NCT03161093|50136329|FG002|Overall Study|Physician Decision|0|||
25036301|NCT03161093|50136330|FG003|Overall Study|Physician Decision|2|||
25036302|NCT03161093|50136331|FG004|Overall Study|Physician Decision|17|||
25036303|NCT03161093|50136332|FG005|Overall Study|Physician Decision|15|||
25036304|NCT03161093|50136327|FG000|Overall Study|Withdrawal by Subject|24|||
25036305|NCT03161093|50136328|FG001|Overall Study|Withdrawal by Subject|73|||
25036306|NCT03161093|50136329|FG002|Overall Study|Withdrawal by Subject|44|||
25036307|NCT03161093|50136330|FG003|Overall Study|Withdrawal by Subject|97|||
25036308|NCT03161093|50136331|FG004|Overall Study|Withdrawal by Subject|11|||
25036309|NCT03161093|50136332|FG005|Overall Study|Withdrawal by Subject|10|||
25036310|NCT03161093|50136327|FG000|Overall Study|Lost to Follow-up|3|||
25036311|NCT03161093|50136328|FG001|Overall Study|Lost to Follow-up|12|||
25036312|NCT03161093|50136329|FG002|Overall Study|Lost to Follow-up|4|||
25036313|NCT03161093|50136330|FG003|Overall Study|Lost to Follow-up|7|||
25036314|NCT03161093|50136331|FG004|Overall Study|Lost to Follow-up|8|||
25036315|NCT03161093|50136332|FG005|Overall Study|Lost to Follow-up|13|||
25036316|NCT03161093|50136327|FG000|Overall Study|Death|3|||
25036317|NCT03161093|50136328|FG001|Overall Study|Death|9|||
25036318|NCT03161093|50136329|FG002|Overall Study|Death|7|||
25036319|NCT03161093|50136330|FG003|Overall Study|Death|9|||
25036320|NCT03161093|50136331|FG004|Overall Study|Death|0|||
25036321|NCT03161093|50136332|FG005|Overall Study|Death|0|||
25036322|NCT03161093|50136327|FG000|Overall Study|Unknown - Not reported|0|||
25036323|NCT03161093|50136328|FG001|Overall Study|Unknown - Not reported|1|||
25036324|NCT03161093|50136329|FG002|Overall Study|Unknown - Not reported|0|||
25036325|NCT03161093|50136330|FG003|Overall Study|Unknown - Not reported|0|||
25036326|NCT03161093|50136331|FG004|Overall Study|Unknown - Not reported|0|||
25036327|NCT03161093|50136332|FG005|Overall Study|Unknown - Not reported|1|||
25036328|NCT02847650|50136353|FG000|Overall Study|Adverse Event|2|||
25036329|NCT02847650|50136354|FG001|Overall Study|Adverse Event|4|||
25036330|NCT02847650|50136353|FG000|Overall Study|Lost to Follow-up|1|||
25036331|NCT02847650|50136354|FG001|Overall Study|Lost to Follow-up|0|||
25036332|NCT02847650|50136353|FG000|Overall Study|Protocol Violation|0|||
25036333|NCT02847650|50136354|FG001|Overall Study|Protocol Violation|1|||
25036334|NCT02847650|50136353|FG000|Overall Study|Withdrawal by Subject|1|||
24947084|NCT00449696|50039523|FG000|Overall Study|Lost to Follow-up|2|||
25036335|NCT02847650|50136354|FG001|Overall Study|Withdrawal by Subject|1|||
25036336|NCT02847494|50136362|FG000|Overall Study|Lost to Follow-up|8|||
25036337|NCT02847494|50136363|FG001|Overall Study|Lost to Follow-up|5|||
25036338|NCT02554253|50136371|FG000|Overall Study|ineligible after enrollment|1|||
25036339|NCT02554253|50136372|FG001|Overall Study|ineligible after enrollment|0|||
25036340|NCT02554253|50136371|FG000|Overall Study|converted to transcatheter procedure|0|||
25036341|NCT02554253|50136372|FG001|Overall Study|converted to transcatheter procedure|1|||
25036342|NCT02554253|50136371|FG000|Overall Study|received both drugs|0|||
25036343|NCT02554253|50136372|FG001|Overall Study|received both drugs|1|||
24947085|NCT00449696|50039524|FG001|Overall Study|Lost to Follow-up|3|||
24947086|NCT00449696|50039523|FG000|Overall Study|Others|7|||
24947087|NCT00449696|50039524|FG001|Overall Study|Others|0|||
24947088|NCT00441116|50039532|FG000|Overall Study|Adverse Event|1|||
24947089|NCT00441116|50039533|FG001|Overall Study|Adverse Event|1|||
25036344|NCT03157583|50136379|FG000|Overall Study|Other (did not meet study criteria)|1|||
25036345|NCT02842736|50136397|FG000|Overall Study|Lost to Follow-up|13|||
25036346|NCT02842736|50136397|FG000|Overall Study|Intervention for menstrual bleeding|17|||
25036347|NCT02842736|50136397|FG000|Overall Study|Withdrawal by Subject|4|||
25036348|NCT02842736|50136397|FG000|Overall Study|Pregnancy|3|||
25036349|NCT02842736|50136397|FG000|Overall Study|Hysterectomy for fibroids|2|||
25036350|NCT02842736|50136397|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
25036351|NCT02842736|50136397|FG000|Overall Study|IUD: Mirena|1|||
25036352|NCT01307033|50136403|FG000|8-week Double-blind Period|Adverse Event|2|||
25036353|NCT01307033|50136404|FG001|8-week Double-blind Period|Adverse Event|0|||
25036354|NCT01307033|50136405|FG002|8-week Double-blind Period|Adverse Event|0|||
25036355|NCT01307033|50136406|FG003|8-week Double-blind Period|Adverse Event|0|||
25036356|NCT01307033|50136403|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
25036357|NCT01307033|50136404|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
25036358|NCT01307033|50136405|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
25036359|NCT01307033|50136406|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
25036360|NCT01307033|50136403|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
25036361|NCT01307033|50136404|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
25036362|NCT01307033|50136405|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
25036363|NCT01307033|50136406|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
25036364|NCT01307033|50136403|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
25036365|NCT01307033|50136404|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
25036366|NCT01307033|50136405|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
25036367|NCT01307033|50136406|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
25036368|NCT01307033|50136403|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
25036369|NCT01307033|50136404|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
25036370|NCT01307033|50136405|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
25036371|NCT01307033|50136406|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
25036372|NCT01307033|50136403|FG000|44-week Open-label Extension|Adverse Event|0|||
25036373|NCT01307033|50136404|FG001|44-week Open-label Extension|Adverse Event|0|||
25036374|NCT01307033|50136405|FG002|44-week Open-label Extension|Adverse Event|2|||
25036375|NCT01307033|50136406|FG003|44-week Open-label Extension|Adverse Event|1|||
25036376|NCT01307033|50136403|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
25036377|NCT01307033|50136404|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
25036378|NCT01307033|50136405|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
25036379|NCT01307033|50136406|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
25036380|NCT01307033|50136403|FG000|44-week Open-label Extension|Physician Decision|0|||
25036381|NCT01307033|50136404|FG001|44-week Open-label Extension|Physician Decision|0|||
25036382|NCT01307033|50136405|FG002|44-week Open-label Extension|Physician Decision|1|||
25036383|NCT01307033|50136406|FG003|44-week Open-label Extension|Physician Decision|0|||
25036384|NCT01307033|50136403|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
25036385|NCT01307033|50136404|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
25036386|NCT01307033|50136405|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
25036387|NCT01307033|50136406|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
25036388|NCT01307033|50136403|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
25036389|NCT01307033|50136404|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
25036390|NCT01307033|50136405|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
25036391|NCT01307033|50136406|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
25036392|NCT01307033|50136403|FG000|44-week Open-label Extension|Death|0|||
25036393|NCT01307033|50136404|FG001|44-week Open-label Extension|Death|0|||
25036394|NCT01307033|50136405|FG002|44-week Open-label Extension|Death|0|||
25036395|NCT01307033|50136406|FG003|44-week Open-label Extension|Death|1|||
25036396|NCT02844920|50136418|FG000|Overall Study|Lost to Follow-up|2|||
25036397|NCT03158311|50136425|FG000|Overall Study|Subject/Guardian Decision|10|||
25036398|NCT03158311|50136426|FG001|Overall Study|Subject/Guardian Decision|6|||
25036399|NCT03158311|50136427|FG002|Overall Study|Subject/Guardian Decision|11|||
25036400|NCT03158311|50136425|FG000|Overall Study|Adverse Event|5|||
25036401|NCT03158311|50136426|FG001|Overall Study|Adverse Event|3|||
25036402|NCT03158311|50136427|FG002|Overall Study|Adverse Event|3|||
25036403|NCT03158311|50136425|FG000|Overall Study|Techinical Problems|3|||
25036404|NCT03158311|50136426|FG001|Overall Study|Techinical Problems|1|||
25036405|NCT03158311|50136427|FG002|Overall Study|Techinical Problems|5|||
25036406|NCT03158311|50136425|FG000|Overall Study|Physician Decision|2|||
25036407|NCT03158311|50136426|FG001|Overall Study|Physician Decision|3|||
25036408|NCT03158311|50136427|FG002|Overall Study|Physician Decision|7|||
25036409|NCT03158311|50136425|FG000|Overall Study|Lost to Follow-up|1|||
25036410|NCT03158311|50136426|FG001|Overall Study|Lost to Follow-up|1|||
25036411|NCT03158311|50136427|FG002|Overall Study|Lost to Follow-up|1|||
25036412|NCT03158311|50136425|FG000|Overall Study|Sponsor decision|1|||
25036413|NCT03158311|50136426|FG001|Overall Study|Sponsor decision|0|||
25036414|NCT03158311|50136427|FG002|Overall Study|Sponsor decision|0|||
25036415|NCT03158311|50136425|FG000|Overall Study|Pregnancy|0|||
25036416|NCT03158311|50136426|FG001|Overall Study|Pregnancy|2|||
25036417|NCT03158311|50136427|FG002|Overall Study|Pregnancy|0|||
25036418|NCT03158311|50136425|FG000|Overall Study|Randomized in error|0|||
25036419|NCT03158311|50136426|FG001|Overall Study|Randomized in error|0|||
25036420|NCT03158311|50136427|FG002|Overall Study|Randomized in error|1|||
25067417|NCT02397460|50173041|FG004|Treatment Period 4|Physician Decision|1|||
25159827|NCT01891669|50279810|FG005|Overall Study|Death|0|||
25159828|NCT01891669|50279811|FG006|Overall Study|Death|0|||
25036421|NCT01336621|50136439|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
25036422|NCT01336621|50136439|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
25036423|NCT01336621|50136439|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
25036424|NCT01336621|50136439|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
25036425|NCT01336621|50136439|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
25036426|NCT01336621|50136439|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
25036427|NCT01336621|50136439|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
25036428|NCT01336621|50136439|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
25036429|NCT01336621|50136439|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
25036430|NCT01336621|50136439|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
25036431|NCT01336621|50136439|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
25036432|NCT01336621|50136439|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
25036433|NCT01336621|50136439|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
25036434|NCT01336621|50136439|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
25036435|NCT00383435|50136451|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
25036436|NCT00383435|50136452|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
25036437|NCT00383435|50136453|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
25036438|NCT00383435|50136454|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
25036439|NCT00383435|50136455|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
24947090|NCT00441116|50039532|FG000|Overall Study|Withdrawal by Subject|1|||
24947091|NCT00441116|50039533|FG001|Overall Study|Withdrawal by Subject|0|||
24947092|NCT00441116|50039532|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
24947093|NCT00441116|50039533|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
24947094|NCT00430248|50039542|FG000|Overall Study|Adverse Event|49|||
24947095|NCT00430248|50039543|FG001|Overall Study|Adverse Event|61|||
25036440|NCT00383435|50136451|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
25036441|NCT00383435|50136452|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
25036442|NCT00383435|50136453|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
25036443|NCT00383435|50136454|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
25036444|NCT00383435|50136455|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
25036445|NCT00383435|50136451|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
25036446|NCT00383435|50136452|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
25036447|NCT00383435|50136453|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
25036448|NCT00383435|50136454|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
25036449|NCT00383435|50136455|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
25036450|NCT00383435|50136451|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
25036451|NCT00383435|50136452|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
25036452|NCT00383435|50136453|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
25036453|NCT00383435|50136454|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
25036454|NCT00383435|50136455|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
25036455|NCT00383435|50136451|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
25036456|NCT00383435|50136452|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
25036457|NCT00383435|50136453|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
25036458|NCT00383435|50136454|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
25036459|NCT00383435|50136455|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
25036460|NCT00383435|50136451|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
25036461|NCT00383435|50136452|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
25036462|NCT00383435|50136453|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
25036463|NCT00383435|50136454|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
25036464|NCT00383435|50136455|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
25036465|NCT00383435|50136451|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
25159829|NCT01891669|50279812|FG007|Overall Study|Death|1|||
24947096|NCT00430248|50039544|FG002|Overall Study|Adverse Event|64|||
24947097|NCT00430248|50039542|FG000|Overall Study|Protocol Violation|10|||
24947098|NCT00430248|50039543|FG001|Overall Study|Protocol Violation|2|||
24947099|NCT00430248|50039544|FG002|Overall Study|Protocol Violation|4|||
24947100|NCT00430248|50039542|FG000|Overall Study|Personal Reasons|12|||
24947101|NCT00430248|50039543|FG001|Overall Study|Personal Reasons|24|||
25036466|NCT00383435|50136452|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
25036467|NCT00383435|50136453|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
25036468|NCT00383435|50136454|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
25036469|NCT00383435|50136455|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
25036470|NCT00383435|50136451|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
25036471|NCT00383435|50136452|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
25036472|NCT00383435|50136453|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
25036473|NCT00383435|50136454|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
25036474|NCT00383435|50136455|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
25036475|NCT00383435|50136451|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
25036476|NCT00383435|50136452|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
25036477|NCT00383435|50136453|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
25036478|NCT00383435|50136454|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
25036479|NCT00383435|50136455|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
25036480|NCT00383435|50136451|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
25036481|NCT00383435|50136452|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
25036482|NCT00383435|50136453|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
25036483|NCT00383435|50136454|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
25036484|NCT00383435|50136455|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
25036485|NCT00383435|50136451|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
25036486|NCT00383435|50136452|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
25036487|NCT00383435|50136453|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
25036488|NCT00383435|50136454|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
25036489|NCT00383435|50136455|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
25036490|NCT00383435|50136451|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
25036491|NCT00383435|50136452|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
25036492|NCT00383435|50136453|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
25036493|NCT00383435|50136454|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
25036494|NCT00383435|50136455|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
25036495|NCT00383435|50136451|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
25036496|NCT00383435|50136452|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
25036497|NCT00383435|50136453|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
25036498|NCT00383435|50136454|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
25036499|NCT00383435|50136455|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
25036500|NCT00383435|50136451|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
25036501|NCT00383435|50136452|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
25036502|NCT00383435|50136453|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
25036503|NCT00383435|50136454|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
25036504|NCT00383435|50136455|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
25036505|NCT00383435|50136451|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
25036506|NCT00383435|50136452|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
25036507|NCT00383435|50136453|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
25036508|NCT00383435|50136454|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
25036509|NCT00383435|50136455|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
25036510|NCT00383435|50136451|FG000|26-Week Treatment Safety Extension|Administrative|1|||
25036511|NCT00383435|50136452|FG001|26-Week Treatment Safety Extension|Administrative|1|||
25036512|NCT00383435|50136453|FG002|26-Week Treatment Safety Extension|Administrative|0|||
25036513|NCT00383435|50136454|FG003|26-Week Treatment Safety Extension|Administrative|1|||
25036514|NCT00383435|50136455|FG004|26-Week Treatment Safety Extension|Administrative|0|||
25036515|NCT03157037|50136467|FG000|Overall Study|Death|1|||
25036516|NCT00381485|50136489|FG000|Open-Label Run-In Period|Adverse Event|9|||
25036517|NCT00381485|50136490|FG001|Open-Label Run-In Period|Adverse Event|0|||
25036518|NCT00381485|50136491|FG002|Open-Label Run-In Period|Adverse Event|0|||
25036519|NCT00381485|50136492|FG003|Open-Label Run-In Period|Adverse Event|0|||
25036520|NCT00381485|50136489|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
25036521|NCT00381485|50136490|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
25036522|NCT00381485|50136491|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
25036523|NCT00381485|50136492|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
25036524|NCT00381485|50136489|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
25036525|NCT00381485|50136490|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
25036526|NCT00381485|50136491|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
25036527|NCT00381485|50136492|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
25159830|NCT01891669|50279813|FG008|Overall Study|Death|0|||
25159831|NCT01891669|50279814|FG009|Overall Study|Death|1|||
25186240|NCT01473602|50336208|FG000|Overall Study|Adverse Event|1|||
25036528|NCT00381485|50136489|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
25036529|NCT00381485|50136490|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
25036530|NCT00381485|50136491|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
25036531|NCT00381485|50136492|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
25036532|NCT00381485|50136489|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
25036533|NCT00381485|50136490|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
25036534|NCT00381485|50136491|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
25036535|NCT00381485|50136492|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
25036536|NCT00381485|50136489|FG000|Open-Label Run-In Period|Treatment failure|1|||
25036537|NCT00381485|50136490|FG001|Open-Label Run-In Period|Treatment failure|0|||
25036538|NCT00381485|50136491|FG002|Open-Label Run-In Period|Treatment failure|0|||
25036539|NCT00381485|50136492|FG003|Open-Label Run-In Period|Treatment failure|0|||
25036540|NCT00381485|50136489|FG000|Double-Blind Treatment Period|Adverse Event|0|||
25036541|NCT00381485|50136490|FG001|Double-Blind Treatment Period|Adverse Event|2|||
25036542|NCT00381485|50136491|FG002|Double-Blind Treatment Period|Adverse Event|2|||
25036543|NCT00381485|50136492|FG003|Double-Blind Treatment Period|Adverse Event|5|||
25036544|NCT00381485|50136489|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
25036545|NCT00381485|50136490|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
25036546|NCT00381485|50136491|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
25036547|NCT00381485|50136492|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
25036548|NCT00381485|50136489|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
25036549|NCT00381485|50136490|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
25036550|NCT00381485|50136491|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
25036551|NCT00381485|50136492|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
25036552|NCT00381485|50136489|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
25036553|NCT00381485|50136490|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
25036554|NCT00381485|50136491|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
25036555|NCT00381485|50136492|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
25036556|NCT00381485|50136489|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
25036557|NCT00381485|50136490|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
25036558|NCT00381485|50136491|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
25036559|NCT00381485|50136492|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
25036560|NCT00381485|50136489|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
25036561|NCT00381485|50136490|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
25036562|NCT00381485|50136491|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
25036563|NCT00381485|50136492|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
25036564|NCT00381485|50136489|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
25036565|NCT00381485|50136490|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
25036566|NCT00381485|50136491|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
25036567|NCT00381485|50136492|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
25036568|NCT00381485|50136489|FG000|Double-Blind Treatment Period|Administrative|0|||
25036569|NCT00381485|50136490|FG001|Double-Blind Treatment Period|Administrative|1|||
25036570|NCT00381485|50136491|FG002|Double-Blind Treatment Period|Administrative|0|||
25036571|NCT00381485|50136492|FG003|Double-Blind Treatment Period|Administrative|1|||
25036572|NCT02840474|50136503|FG000|Overall Study|Lost to Follow-up|1|||
25036573|NCT02840474|50136504|FG001|Overall Study|Lost to Follow-up|0|||
25036574|NCT03155945|50136512|FG000|Overall Study|Lost to Follow-up|0|||
25036575|NCT03155945|50136513|FG001|Overall Study|Lost to Follow-up|1|||
25036576|NCT03155945|50136512|FG000|Overall Study|Withdrawal by Subject|0|||
25036577|NCT03155945|50136513|FG001|Overall Study|Withdrawal by Subject|1|||
25036578|NCT03155945|50136512|FG000|Overall Study|Other Reason|0|||
25036579|NCT03155945|50136513|FG001|Overall Study|Other Reason|1|||
25036580|NCT03160703|50136523|FG000|Overall Study|Withdrawal by Subject|0|||
25036581|NCT03160703|50136524|FG001|Overall Study|Withdrawal by Subject|0|||
25036582|NCT03160703|50136525|FG002|Overall Study|Withdrawal by Subject|0|||
25036583|NCT03160703|50136526|FG003|Overall Study|Withdrawal by Subject|1|||
25036584|NCT03159611|50136538|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
25036585|NCT03159611|50136539|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
25036586|NCT03159611|50136538|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
25036587|NCT03159611|50136539|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
25036588|NCT03159611|50136538|FG000|Overall Study|Protocol Violation|7|||
25036589|NCT03159611|50136539|FG001|Overall Study|Protocol Violation|4|||
25036590|NCT03159611|50136538|FG000|Overall Study|Adverse Event|1|||
25036591|NCT03159611|50136539|FG001|Overall Study|Adverse Event|0|||
25159832|NCT01891669|50279805|FG000|Overall Study|Withdrawal by Subject|1|||
25036592|NCT03159611|50136538|FG000|Overall Study|Withdrawal by Subject|1|||
25159833|NCT01891669|50279806|FG001|Overall Study|Withdrawal by Subject|1|||
25159834|NCT01891669|50279807|FG002|Overall Study|Withdrawal by Subject|0|||
24947102|NCT00430248|50039544|FG002|Overall Study|Personal Reasons|9|||
25036593|NCT03159611|50136539|FG001|Overall Study|Withdrawal by Subject|1|||
25036594|NCT03159611|50136538|FG000|Overall Study|Non-compliance with protocol requirement|3|||
25036595|NCT03159611|50136539|FG001|Overall Study|Non-compliance with protocol requirement|2|||
25036596|NCT03159611|50136538|FG000|Overall Study|Inability to perform procedures|1|||
25036597|NCT03159611|50136539|FG001|Overall Study|Inability to perform procedures|0|||
25036598|NCT03159455|50136551|FG000|Overall Study|Adverse Event|0|||
25036599|NCT03159455|50136552|FG001|Overall Study|Adverse Event|0|||
25036600|NCT03159455|50136553|FG002|Overall Study|Adverse Event|0|||
25036601|NCT03159455|50136554|FG003|Overall Study|Adverse Event|0|||
25036602|NCT03159455|50136555|FG004|Overall Study|Adverse Event|0|||
25036603|NCT03159455|50136556|FG005|Overall Study|Adverse Event|1|||
25036604|NCT02838134|50136576|FG000|Overall Study|Lost to Follow-up|1|||
25036605|NCT02838134|50136577|FG001|Overall Study|Lost to Follow-up|2|||
25036606|NCT02838134|50136576|FG000|Overall Study|logistic problems|1|||
25036607|NCT02838134|50136577|FG001|Overall Study|logistic problems|1|||
25036608|NCT03150589|50136585|FG000|Overall Study|Withdrawal by Subject|16|||
25036609|NCT03150589|50136586|FG001|Overall Study|Withdrawal by Subject|9|||
25036610|NCT03150589|50136585|FG000|Overall Study|Adverse Event|7|||
25036611|NCT03150589|50136586|FG001|Overall Study|Adverse Event|6|||
25036612|NCT03150589|50136585|FG000|Overall Study|Protocol Violation|4|||
25036613|NCT03150589|50136586|FG001|Overall Study|Protocol Violation|3|||
25036614|NCT03150589|50136585|FG000|Overall Study|Lost to Follow-up|3|||
25036615|NCT03150589|50136586|FG001|Overall Study|Lost to Follow-up|3|||
25036616|NCT03150589|50136585|FG000|Overall Study|Death|2|||
25036617|NCT03150589|50136586|FG001|Overall Study|Death|3|||
25036618|NCT03150589|50136585|FG000|Overall Study|IP non-compliance and other reasons|12|||
25036619|NCT03150589|50136586|FG001|Overall Study|IP non-compliance and other reasons|3|||
25036620|NCT02835092|50136595|FG000|Overall Study|Withdrawal by Subject|3|||
25036621|NCT02835092|50136596|FG001|Overall Study|Withdrawal by Subject|6|||
25036622|NCT02835092|50136597|FG002|Overall Study|Withdrawal by Subject|3|||
25036623|NCT02835092|50136595|FG000|Overall Study|Lost to Follow-up|0|||
25036624|NCT02835092|50136596|FG001|Overall Study|Lost to Follow-up|2|||
25036625|NCT02835092|50136597|FG002|Overall Study|Lost to Follow-up|0|||
25036626|NCT03145207|50136605|FG000|Overall Study|volunteer started taking allergy shots|1|||
25036627|NCT03145207|50136605|FG000|Overall Study|baseline blood pressure high|1|||
25036628|NCT02836652|50136622|FG000|Overall Study|Death|3|||
25036629|NCT02836652|50136623|FG001|Overall Study|Death|3|||
25036630|NCT02836652|50136622|FG000|Overall Study|Transplant/Explant|3|||
25036631|NCT02836652|50136623|FG001|Overall Study|Transplant/Explant|4|||
25036632|NCT02836652|50136622|FG000|Overall Study|Withdrawn|9|||
25036633|NCT02836652|50136623|FG001|Overall Study|Withdrawn|9|||
25036634|NCT02836652|50136622|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
25036635|NCT02836652|50136623|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
25036636|NCT02836496|50136631|FG000|Overall Study|Adverse Event|2|||
25036637|NCT02836496|50136632|FG001|Overall Study|Adverse Event|1|||
25036638|NCT02836496|50136631|FG000|Overall Study|Withdrawal by Subject|0|||
25036639|NCT02836496|50136632|FG001|Overall Study|Withdrawal by Subject|1|||
25036640|NCT04213807|50136641|FG000|Overall Study|Physician Decision|0|||
25036641|NCT04213807|50136642|FG001|Overall Study|Physician Decision|0|||
25036642|NCT04213807|50136643|FG002|Overall Study|Physician Decision|1|||
25036643|NCT00577577|50136662|FG000|Overall Study|Adverse Event|3|||
25036644|NCT00577577|50136663|FG001|Overall Study|Adverse Event|2|||
25036645|NCT00577577|50136662|FG000|Overall Study|Lost to Follow-up|1|||
25036646|NCT00577577|50136663|FG001|Overall Study|Lost to Follow-up|0|||
25036647|NCT00577577|50136662|FG000|Overall Study|Protocol Violation|0|||
25036648|NCT00577577|50136663|FG001|Overall Study|Protocol Violation|3|||
25036649|NCT00577577|50136662|FG000|Overall Study|Transportation|1|||
25036650|NCT00577577|50136663|FG001|Overall Study|Transportation|0|||
25036651|NCT02833844|50136671|FG000|Double-Blind Period|Withdrawal by Subject|2|||
25036652|NCT02833844|50136672|FG001|Double-Blind Period|Withdrawal by Subject|3|||
25036653|NCT02833844|50136671|FG000|Double-Blind Period|Protocol Violation|0|||
25036654|NCT02833844|50136672|FG001|Double-Blind Period|Protocol Violation|4|||
25036655|NCT02833844|50136671|FG000|Open-Label Period|Death|0|||
25186241|NCT01473602|50336209|FG001|Overall Study|Adverse Event|2|||
25186242|NCT01473602|50336208|FG000|Overall Study|Death|0|||
25036656|NCT02833844|50136672|FG001|Open-Label Period|Death|2|||
25036657|NCT02833844|50136671|FG000|Open-Label Period|Lost to Follow-up|1|||
25036658|NCT02833844|50136672|FG001|Open-Label Period|Lost to Follow-up|0|||
25036659|NCT02833844|50136671|FG000|Open-Label Period|Withdrawal by Subject|1|||
25036660|NCT02833844|50136672|FG001|Open-Label Period|Withdrawal by Subject|0|||
25036661|NCT01341782|50136682|FG000|Overall Study|Adverse Event|1|||
25036662|NCT01341782|50136683|FG001|Overall Study|Adverse Event|1|||
25036663|NCT01341782|50136682|FG000|Overall Study|Withdrawal by Subject|6|||
25036664|NCT01341782|50136683|FG001|Overall Study|Withdrawal by Subject|5|||
25036665|NCT01341782|50136682|FG000|Overall Study|Missed 3 consecutive doses|0|||
25036666|NCT01341782|50136683|FG001|Overall Study|Missed 3 consecutive doses|4|||
25036667|NCT01341782|50136682|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
25036668|NCT01341782|50136683|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
25036669|NCT01341782|50136682|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
25036670|NCT01341782|50136683|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
25036671|NCT01341782|50136682|FG000|Overall Study|Other|5|||
25036672|NCT01341782|50136683|FG001|Overall Study|Other|0|||
25036673|NCT01341470|50136695|FG000|Overall Study|Sponsor decision|0|||
25036674|NCT01341470|50136696|FG001|Overall Study|Sponsor decision|0|||
25036675|NCT01341470|50136697|FG002|Overall Study|Sponsor decision|1|||
25036676|NCT01341470|50136698|FG003|Overall Study|Sponsor decision|1|||
25036677|NCT01341470|50136699|FG004|Overall Study|Sponsor decision|0|||
25036678|NCT01341470|50136700|FG005|Overall Study|Sponsor decision|1|||
25036679|NCT03143101|50136719|FG000|Overall Study|Withdrawal by Subject|0|||
25036680|NCT03143101|50136720|FG001|Overall Study|Withdrawal by Subject|1|||
25036681|NCT03143101|50136721|FG002|Overall Study|Withdrawal by Subject|0|||
25036682|NCT03143101|50136719|FG000|Overall Study|Lost to Follow-up|2|||
25036683|NCT03143101|50136720|FG001|Overall Study|Lost to Follow-up|2|||
25036684|NCT03143101|50136721|FG002|Overall Study|Lost to Follow-up|0|||
25036685|NCT00871351|50136732|FG000|Overall Study|Withdrawal by Subject|1|||
25036686|NCT00871351|50136733|FG001|Overall Study|Withdrawal by Subject|0|||
25036687|NCT00871351|50136734|FG002|Overall Study|Withdrawal by Subject|0|||
25036688|NCT00871351|50136732|FG000|Overall Study|Adverse Event|3|||
25036689|NCT00871351|50136733|FG001|Overall Study|Adverse Event|1|||
25036690|NCT00871351|50136734|FG002|Overall Study|Adverse Event|0|||
25036691|NCT02745080|50136744|FG000|Overall Study|Adverse Event|13|||
25036692|NCT02745080|50136745|FG001|Overall Study|Adverse Event|21|||
25036693|NCT02745080|50136744|FG000|Overall Study|Lack of Efficacy|11|||
25036694|NCT02745080|50136745|FG001|Overall Study|Lack of Efficacy|23|||
25036695|NCT02745080|50136744|FG000|Overall Study|Lost to Follow-up|3|||
25036696|NCT02745080|50136745|FG001|Overall Study|Lost to Follow-up|3|||
24947103|NCT00430248|50039542|FG000|Overall Study|Lost to Follow-up|28|||
24947104|NCT00430248|50039543|FG001|Overall Study|Lost to Follow-up|33|||
24947105|NCT00430248|50039544|FG002|Overall Study|Lost to Follow-up|28|||
24947106|NCT00430248|50039542|FG000|Overall Study|Therapeutic Failure|1|||
24947107|NCT00430248|50039543|FG001|Overall Study|Therapeutic Failure|1|||
24947108|NCT00430248|50039544|FG002|Overall Study|Therapeutic Failure|1|||
24947109|NCT00430248|50039542|FG000|Overall Study|Withdrawal by Subject|14|||
24947110|NCT00430248|50039543|FG001|Overall Study|Withdrawal by Subject|20|||
24947111|NCT00430248|50039544|FG002|Overall Study|Withdrawal by Subject|16|||
24947112|NCT00430248|50039542|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
24947113|NCT00430248|50039543|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
24947114|NCT00430248|50039544|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
24947115|NCT00430248|50039542|FG000|Overall Study|Gout Flare|3|||
24947116|NCT00430248|50039543|FG001|Overall Study|Gout Flare|7|||
24947117|NCT00430248|50039544|FG002|Overall Study|Gout Flare|2|||
24947118|NCT00430248|50039542|FG000|Overall Study|Reason Not Specified|8|||
24947119|NCT00430248|50039543|FG001|Overall Study|Reason Not Specified|8|||
24947120|NCT00430248|50039544|FG002|Overall Study|Reason Not Specified|11|||
24947121|NCT00449540|50039554|FG000|Pretreatment Phase|No migraine experienced|66|||
24947122|NCT00449540|50039555|FG001|Pretreatment Phase|No migraine experienced|0|||
24947123|NCT00449540|50039556|FG002|Pretreatment Phase|No migraine experienced|0|||
24947124|NCT00449540|50039554|FG000|Treatment Phase|did not experience or treat migraine|0|||
24947125|NCT00449540|50039555|FG001|Treatment Phase|did not experience or treat migraine|20|||
24947126|NCT00449540|50039556|FG002|Treatment Phase|did not experience or treat migraine|17|||
24947127|NCT00411762|50039564|FG000|Overall Study|Withdrawal by Subject|5|||
24947128|NCT00429858|50039568|FG000|Overall Study|Withdrawal by Subject|1|||
24947129|NCT00429858|50039568|FG000|Overall Study|Study Termination|1|||
24947130|NCT00449150|50039576|FG000|Overall Study|Adverse Event|11|||
24947131|NCT00449150|50039577|FG001|Overall Study|Adverse Event|18|||
24947132|NCT00449150|50039578|FG002|Overall Study|Adverse Event|9|||
24947133|NCT00449150|50039576|FG000|Overall Study|Lack of Efficacy|1|||
24947134|NCT00449150|50039577|FG001|Overall Study|Lack of Efficacy|2|||
24947135|NCT00449150|50039578|FG002|Overall Study|Lack of Efficacy|2|||
24947136|NCT00449150|50039576|FG000|Overall Study|Other|16|||
24947137|NCT00449150|50039577|FG001|Overall Study|Other|13|||
24947138|NCT00449150|50039578|FG002|Overall Study|Other|14|||
24947139|NCT00449150|50039576|FG000|Overall Study|Withdrawal by Subject|17|||
24947140|NCT00449150|50039577|FG001|Overall Study|Withdrawal by Subject|18|||
25036697|NCT02745080|50136744|FG000|Overall Study|Physician Decision|3|||
25036698|NCT02745080|50136745|FG001|Overall Study|Physician Decision|0|||
25036699|NCT02745080|50136744|FG000|Overall Study|Protocol Violation|3|||
25036700|NCT02745080|50136745|FG001|Overall Study|Protocol Violation|1|||
25036701|NCT02745080|50136744|FG000|Overall Study|Withdrawal by Subject|22|||
25036702|NCT02745080|50136745|FG001|Overall Study|Withdrawal by Subject|41|||
25036703|NCT00521599|50136755|FG000|Overall Study|Adverse Event|5|||
24947141|NCT00449150|50039578|FG002|Overall Study|Withdrawal by Subject|21|||
24947142|NCT00449150|50039576|FG000|Overall Study|Protocol Violation|1|||
25036704|NCT00521599|50136756|FG001|Overall Study|Adverse Event|7|||
25036705|NCT00521599|50136757|FG002|Overall Study|Adverse Event|6|||
25036706|NCT00521599|50136755|FG000|Overall Study|Treatment Failure|8|||
25036707|NCT00521599|50136756|FG001|Overall Study|Treatment Failure|9|||
25036708|NCT00521599|50136757|FG002|Overall Study|Treatment Failure|22|||
25036709|NCT00521599|50136755|FG000|Overall Study|Lost to Follow-up|2|||
25036710|NCT00521599|50136756|FG001|Overall Study|Lost to Follow-up|1|||
25036711|NCT00521599|50136757|FG002|Overall Study|Lost to Follow-up|2|||
25036712|NCT00521599|50136755|FG000|Overall Study|Withdrawal by Subject|3|||
25036713|NCT00521599|50136756|FG001|Overall Study|Withdrawal by Subject|5|||
25036714|NCT00521599|50136757|FG002|Overall Study|Withdrawal by Subject|1|||
25036715|NCT00521599|50136755|FG000|Overall Study|Withdrawal by subject treatment related|3|||
25036716|NCT00521599|50136756|FG001|Overall Study|Withdrawal by subject treatment related|1|||
25036717|NCT00521599|50136757|FG002|Overall Study|Withdrawal by subject treatment related|2|||
25036718|NCT00521599|50136755|FG000|Overall Study|Protocol Violation|2|||
25036719|NCT00521599|50136756|FG001|Overall Study|Protocol Violation|4|||
25036720|NCT00521599|50136757|FG002|Overall Study|Protocol Violation|2|||
25036721|NCT00521599|50136755|FG000|Overall Study|Did not meet protocol eligibility|2|||
25036722|NCT00521599|50136756|FG001|Overall Study|Did not meet protocol eligibility|2|||
25036723|NCT00521599|50136757|FG002|Overall Study|Did not meet protocol eligibility|1|||
25036724|NCT00442897|50136768|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
25036725|NCT00442897|50136769|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
25036726|NCT00442897|50136768|FG000|Base Study (12 Week Follow-up)|Death|0|||
25036727|NCT00442897|50136769|FG001|Base Study (12 Week Follow-up)|Death|1|||
25036728|NCT00442897|50136768|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
25036729|NCT00442897|50136769|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
25036730|NCT00442897|50136768|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
25036731|NCT00442897|50136769|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
25036732|NCT00442897|50136768|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
25036733|NCT00442897|50136769|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
25036734|NCT00442897|50136768|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
25036735|NCT00442897|50136769|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
25036736|NCT00442897|50136768|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
25036737|NCT00442897|50136769|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
25036738|NCT00442897|50136768|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
25036739|NCT00442897|50136769|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
25036740|NCT02834390|50136777|FG000|Induction Phase|Progressive disease|0|||
25036741|NCT02834390|50136778|FG001|Induction Phase|Progressive disease|1|||
25036742|NCT02834390|50136777|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
25036743|NCT02834390|50136778|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
25036744|NCT02834390|50136777|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
25036745|NCT02834390|50136778|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
25036746|NCT02834390|50136777|FG000|Consolidation Phase|Physician Decision|1|||
25036747|NCT02834390|50136778|FG001|Consolidation Phase|Physician Decision|1|||
25036748|NCT03141151|50136786|FG000|Overall Study|Lost to Follow-up|3|||
25036749|NCT03141151|50136787|FG001|Overall Study|Lost to Follow-up|2|||
25036750|NCT03141151|50136786|FG000|Overall Study|Withdrawal by Subject|3|||
25036751|NCT03141151|50136787|FG001|Overall Study|Withdrawal by Subject|2|||
25036752|NCT01358708|50136795|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
25036753|NCT01358708|50136796|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
25036754|NCT01358708|50136795|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
25036755|NCT01358708|50136796|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
25036756|NCT01356602|50136809|FG000|Overall Study|Protocol Deviation|0|||
25036757|NCT01356602|50136810|FG001|Overall Study|Protocol Deviation|1|||
25036758|NCT01356602|50136811|FG002|Overall Study|Protocol Deviation|1|||
25036759|NCT01356602|50136809|FG000|Overall Study|Administrative Problems|1|||
25036760|NCT01356602|50136810|FG001|Overall Study|Administrative Problems|4|||
25036761|NCT01356602|50136811|FG002|Overall Study|Administrative Problems|5|||
25036762|NCT01356602|50136809|FG000|Overall Study|Lost to Follow-up|4|||
25036763|NCT01356602|50136810|FG001|Overall Study|Lost to Follow-up|5|||
25036764|NCT01356602|50136811|FG002|Overall Study|Lost to Follow-up|6|||
25036765|NCT01356602|50136809|FG000|Overall Study|Withdrawal by Subject|4|||
25036766|NCT01356602|50136810|FG001|Overall Study|Withdrawal by Subject|3|||
25036767|NCT01356602|50136811|FG002|Overall Study|Withdrawal by Subject|7|||
25036768|NCT01356602|50136809|FG000|Overall Study|Lack of Efficacy|0|||
25036769|NCT01356602|50136810|FG001|Overall Study|Lack of Efficacy|1|||
25036770|NCT01356602|50136811|FG002|Overall Study|Lack of Efficacy|4|||
25036771|NCT01356602|50136809|FG000|Overall Study|Adverse Event|0|||
25036772|NCT01356602|50136810|FG001|Overall Study|Adverse Event|1|||
25036773|NCT01356602|50136811|FG002|Overall Study|Adverse Event|1|||
25036774|NCT02830880|50136819|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
25036775|NCT02830880|50136819|FG000|Overall Study|Death|1|||
25036776|NCT02830880|50136819|FG000|Overall Study|Physician Decision|1|||
25036777|NCT03141307|50136825|FG000|In-Hospital|Withdrawal by Subject|0|||
25036778|NCT03141307|50136826|FG001|In-Hospital|Withdrawal by Subject|2|||
25036779|NCT03141307|50136825|FG000|In-Hospital|Protocol Violation|4|||
25036780|NCT03141307|50136826|FG001|In-Hospital|Protocol Violation|0|||
25036781|NCT03141307|50136825|FG000|Follow-Up|Lost to Follow-up|97|||
25036782|NCT03141307|50136826|FG001|Follow-Up|Lost to Follow-up|54|||
25036783|NCT02825420|50136834|FG000|Overall Study|Death|30|||
25036784|NCT02825420|50136835|FG001|Overall Study|Death|12|||
25036785|NCT02825420|50136834|FG000|Overall Study|Progressive disease|6|||
25036786|NCT02825420|50136835|FG001|Overall Study|Progressive disease|1|||
25036787|NCT02825420|50136834|FG000|Overall Study|Lost to Follow-up|2|||
25036788|NCT02825420|50136835|FG001|Overall Study|Lost to Follow-up|2|||
25036789|NCT02825420|50136834|FG000|Overall Study|Withdrawal by Subject|1|||
25036790|NCT02825420|50136835|FG001|Overall Study|Withdrawal by Subject|1|||
25036791|NCT02825420|50136834|FG000|Overall Study|Protocol amendment not signed|1|||
25036792|NCT02825420|50136835|FG001|Overall Study|Protocol amendment not signed|1|||
25036793|NCT02825420|50136834|FG000|Overall Study|Physician Decision|1|||
25036794|NCT02825420|50136835|FG001|Overall Study|Physician Decision|0|||
25036795|NCT02825420|50136834|FG000|Overall Study|Did not receive PLD|2|||
25036796|NCT02825420|50136835|FG001|Overall Study|Did not receive PLD|0|||
25036797|NCT02829944|50136848|FG000|Overall Study|Physician Decision|0|||
25036798|NCT02829944|50136849|FG001|Overall Study|Physician Decision|1|||
25036799|NCT02829944|50136848|FG000|Overall Study|Screen Failure|2|||
25036800|NCT02829944|50136849|FG001|Overall Study|Screen Failure|2|||
25036801|NCT02829944|50136848|FG000|Overall Study|Inadequate Neuraxial Block|1|||
25036802|NCT02829944|50136849|FG001|Overall Study|Inadequate Neuraxial Block|1|||
25036803|NCT02829944|50136848|FG000|Overall Study|Withdrawal by Subject|2|||
25036804|NCT02829944|50136849|FG001|Overall Study|Withdrawal by Subject|1|||
25036805|NCT02829944|50136848|FG000|Overall Study|Catheter Displacement|1|||
25036806|NCT02829944|50136849|FG001|Overall Study|Catheter Displacement|0|||
25036807|NCT02829944|50136848|FG000|Overall Study|Catheter broke|0|||
25036808|NCT02829944|50136849|FG001|Overall Study|Catheter broke|1|||
25036809|NCT02829944|50136848|FG000|Overall Study|Staff unavailable|0|||
25036810|NCT02829944|50136849|FG001|Overall Study|Staff unavailable|1|||
25036811|NCT02824562|50136857|FG000|Overall Study|Lost to Follow-up|3|||
25036812|NCT02824562|50136858|FG001|Overall Study|Lost to Follow-up|4|||
25036813|NCT02824562|50136857|FG000|Overall Study|Death|0|||
25036814|NCT02824562|50136858|FG001|Overall Study|Death|1|||
25036815|NCT02744066|50136866|FG000|Overall Study|Withdrawal by parent|0|||
25036816|NCT02744066|50136867|FG001|Overall Study|Withdrawal by parent|1|||
25036817|NCT02744066|50136866|FG000|Overall Study|Discharged from NICU prior to completion|0|||
25036818|NCT02744066|50136867|FG001|Overall Study|Discharged from NICU prior to completion|4|||
25036819|NCT01338818|50136875|FG000|Overall Study|Adverse Event|8|||
25036820|NCT01338818|50136875|FG000|Overall Study|Lack of Efficacy|5|||
25036821|NCT01338818|50136875|FG000|Overall Study|no longer require study drug|1|||
25036822|NCT01338818|50136875|FG000|Overall Study|Withdrawal by Subject|11|||
25036823|NCT01338818|50136875|FG000|Overall Study|Lost to Follow-up|4|||
25036824|NCT01338818|50136875|FG000|Overall Study|Administrative problems|3|||
25036825|NCT01338818|50136875|FG000|Overall Study|Protocol Deviation|4|||
25036826|NCT02823470|50136881|FG000|Overall Study|Adverse Event|1|||
25036827|NCT02823470|50136882|FG001|Overall Study|Adverse Event|0|||
25036828|NCT02823470|50136881|FG000|Overall Study|Study terminated by sponsor|8|||
25036829|NCT02823470|50136882|FG001|Overall Study|Study terminated by sponsor|15|||
25036830|NCT01371656|50136893|FG000|Overall Study|Death|7|||
25036831|NCT01371656|50136894|FG001|Overall Study|Death|4|||
25036832|NCT01371656|50136893|FG000|Overall Study|Physician Decision|46|||
25036833|NCT01371656|50136894|FG001|Overall Study|Physician Decision|7|||
25036834|NCT01371656|50136893|FG000|Overall Study|Withdrawal by Subject|7|||
25036835|NCT01371656|50136894|FG001|Overall Study|Withdrawal by Subject|0|||
25036836|NCT01371656|50136893|FG000|Overall Study|Ineligible|4|||
25036837|NCT01371656|50136894|FG001|Overall Study|Ineligible|3|||
25036838|NCT01354106|50136900|FG000|Overall Study|Withdrawal by Subject|2|||
25036839|NCT01354028|50136906|FG000|Overall Study|Physician Decision|0|||
25036840|NCT01354028|50136907|FG001|Overall Study|Physician Decision|2|||
25036841|NCT01354028|50136906|FG000|Overall Study|Discharged before study start|2|||
25036842|NCT01354028|50136907|FG001|Overall Study|Discharged before study start|2|||
25036843|NCT01354028|50136906|FG000|Overall Study|No quiet alert state|0|||
25036844|NCT01354028|50136907|FG001|Overall Study|No quiet alert state|1|||
25036845|NCT01354964|50136921|FG000|Overall Study|Lost to Follow-up|2|||
25036846|NCT01354964|50136922|FG001|Overall Study|Lost to Follow-up|0|||
25036847|NCT01354964|50136921|FG000|Overall Study|IV access issues|1|||
25036848|NCT01354964|50136922|FG001|Overall Study|IV access issues|1|||
25036849|NCT01354964|50136921|FG000|Overall Study|Physician Decision|1|||
25036850|NCT01354964|50136922|FG001|Overall Study|Physician Decision|0|||
25036851|NCT01354496|50136932|FG000|Period 1|Adverse Event|0|||
25036852|NCT01354496|50136933|FG001|Period 1|Adverse Event|0|||
25036853|NCT01354496|50136934|FG002|Period 1|Adverse Event|1|||
25036854|NCT01354496|50136935|FG003|Period 1|Adverse Event|0|||
25036855|NCT01354496|50136936|FG004|Period 1|Adverse Event|0|||
25036856|NCT01354496|50136937|FG005|Period 1|Adverse Event|0|||
25036857|NCT01354496|50136932|FG000|Period 1|Physician Decision|0|||
25036858|NCT01354496|50136933|FG001|Period 1|Physician Decision|0|||
25036859|NCT01354496|50136934|FG002|Period 1|Physician Decision|1|||
25036860|NCT01354496|50136935|FG003|Period 1|Physician Decision|0|||
25036861|NCT01354496|50136936|FG004|Period 1|Physician Decision|0|||
25036862|NCT01354496|50136937|FG005|Period 1|Physician Decision|0|||
25036863|NCT01354496|50136932|FG000|Period 2|Adverse Event|0|||
25036864|NCT01354496|50136933|FG001|Period 2|Adverse Event|0|||
25036865|NCT01354496|50136934|FG002|Period 2|Adverse Event|0|||
25036866|NCT01354496|50136935|FG003|Period 2|Adverse Event|1|||
25036867|NCT01354496|50136936|FG004|Period 2|Adverse Event|0|||
25036868|NCT01354496|50136937|FG005|Period 2|Adverse Event|0|||
25036869|NCT01354496|50136932|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
25036870|NCT01354496|50136933|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
25036871|NCT01354496|50136934|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
25036872|NCT01354496|50136935|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
25036873|NCT01354496|50136936|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
25036874|NCT01354496|50136937|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
25036875|NCT02822222|50136960|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
25036876|NCT02822222|50136961|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
25036877|NCT02821910|50136973|FG000|Overall Study|Withdrawal by Subject|0|||
25036878|NCT02821910|50136974|FG001|Overall Study|Withdrawal by Subject|0|||
25036879|NCT02821910|50136975|FG002|Overall Study|Withdrawal by Subject|1|||
25036880|NCT02821910|50136976|FG003|Overall Study|Withdrawal by Subject|0|||
25036881|NCT02821910|50136977|FG004|Overall Study|Withdrawal by Subject|0|||
25036882|NCT02821910|50136978|FG005|Overall Study|Withdrawal by Subject|1|||
25036883|NCT02821910|50136973|FG000|Overall Study|Other than specified|1|||
25036884|NCT02821910|50136974|FG001|Overall Study|Other than specified|0|||
25036885|NCT02821910|50136975|FG002|Overall Study|Other than specified|1|||
25036886|NCT02821910|50136976|FG003|Overall Study|Other than specified|0|||
25036887|NCT02821910|50136977|FG004|Overall Study|Other than specified|0|||
25036888|NCT02821910|50136978|FG005|Overall Study|Other than specified|0|||
25036889|NCT02817776|50136992|FG000|Overall Study|Excluded|33|||
25036890|NCT02817776|50136992|FG000|Overall Study|Lost to Follow-up|20|||
25036891|NCT02817776|50136992|FG000|Overall Study|Withdrawal by Subject|33|||
25036892|NCT02817776|50136992|FG000|Overall Study|Death|2|||
25036893|NCT03138655|50137004|FG000|Overall Study|Adverse Event|2|||
25036894|NCT03138655|50137005|FG001|Overall Study|Adverse Event|1|||
25036895|NCT03138655|50137006|FG002|Overall Study|Adverse Event|2|||
25036896|NCT03138655|50137007|FG003|Overall Study|Adverse Event|1|||
25036897|NCT03138655|50137008|FG004|Overall Study|Adverse Event|1|||
25036898|NCT03138655|50137009|FG005|Overall Study|Adverse Event|4|||
25036899|NCT03138655|50137010|FG006|Overall Study|Adverse Event|2|||
25036900|NCT03138655|50137011|FG007|Overall Study|Adverse Event|2|||
25036901|NCT03138655|50137004|FG000|Overall Study|Withdrawal by Subject|0|||
25036902|NCT03138655|50137005|FG001|Overall Study|Withdrawal by Subject|1|||
25036903|NCT03138655|50137006|FG002|Overall Study|Withdrawal by Subject|0|||
25036904|NCT03138655|50137007|FG003|Overall Study|Withdrawal by Subject|0|||
25036905|NCT03138655|50137008|FG004|Overall Study|Withdrawal by Subject|0|||
25036906|NCT03138655|50137009|FG005|Overall Study|Withdrawal by Subject|0|||
25036907|NCT03138655|50137010|FG006|Overall Study|Withdrawal by Subject|1|||
25036908|NCT03138655|50137011|FG007|Overall Study|Withdrawal by Subject|0|||
25036909|NCT03138655|50137004|FG000|Overall Study|Reason not Specified|1|||
25036910|NCT03138655|50137005|FG001|Overall Study|Reason not Specified|0|||
25036911|NCT03138655|50137006|FG002|Overall Study|Reason not Specified|0|||
25036912|NCT03138655|50137007|FG003|Overall Study|Reason not Specified|2|||
25036913|NCT03138655|50137008|FG004|Overall Study|Reason not Specified|1|||
25036914|NCT03138655|50137009|FG005|Overall Study|Reason not Specified|1|||
25036915|NCT03138655|50137010|FG006|Overall Study|Reason not Specified|0|||
25036916|NCT03138655|50137011|FG007|Overall Study|Reason not Specified|0|||
25036917|NCT02820038|50137037|FG000|Overall Study|Lost to Follow-up|7|||
25036918|NCT02820038|50137038|FG001|Overall Study|Lost to Follow-up|11|||
25036919|NCT02820038|50137039|FG002|Overall Study|Lost to Follow-up|2|||
25036920|NCT02820038|50137040|FG003|Overall Study|Lost to Follow-up|9|||
25036921|NCT02820038|50137037|FG000|Overall Study|Withdrawal by Subject|3|||
25036922|NCT02820038|50137038|FG001|Overall Study|Withdrawal by Subject|14|||
25036923|NCT02820038|50137039|FG002|Overall Study|Withdrawal by Subject|3|||
25275731|NCT01233869|50589546|FG003|Initial Treatment Period (24 Months)|Death|0|||
24947143|NCT00449150|50039577|FG001|Overall Study|Protocol Violation|2|||
25036924|NCT02820038|50137040|FG003|Overall Study|Withdrawal by Subject|13|||
25036925|NCT02819804|50137051|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
25036926|NCT02819726|50137058|FG000|Part A (All Participants)|Lost to Follow-up|0|||
25036927|NCT02819726|50137059|FG001|Part A (All Participants)|Lost to Follow-up|1|||
25036928|NCT02819726|50137060|FG002|Part A (All Participants)|Lost to Follow-up|0|||
25036929|NCT02819726|50137061|FG003|Part A (All Participants)|Lost to Follow-up|0|||
25036930|NCT02819726|50137058|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
25036931|NCT02819726|50137059|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
25036932|NCT02819726|50137060|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
25036933|NCT02819726|50137061|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
25036934|NCT02819726|50137058|FG000|Part A (All Participants)|Protocol non-compliance|3|||
25036935|NCT02819726|50137059|FG001|Part A (All Participants)|Protocol non-compliance|4|||
25036936|NCT02819726|50137060|FG002|Part A (All Participants)|Protocol non-compliance|5|||
25036937|NCT02819726|50137061|FG003|Part A (All Participants)|Protocol non-compliance|0|||
25036938|NCT02819726|50137058|FG000|Part B (All Participants)|Lost to Follow-up|1|||
25036939|NCT02819726|50137059|FG001|Part B (All Participants)|Lost to Follow-up|1|||
25036940|NCT02819726|50137060|FG002|Part B (All Participants)|Lost to Follow-up|2|||
25036941|NCT02819726|50137061|FG003|Part B (All Participants)|Lost to Follow-up|2|||
25036942|NCT02819726|50137058|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
25036943|NCT02819726|50137059|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
25036944|NCT02819726|50137060|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
25036945|NCT02819726|50137061|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
25036946|NCT02819726|50137058|FG000|Part B (All Participants)|Protocol non-compliance|0|||
25036947|NCT02819726|50137059|FG001|Part B (All Participants)|Protocol non-compliance|0|||
25036948|NCT02819726|50137060|FG002|Part B (All Participants)|Protocol non-compliance|1|||
25036949|NCT02819726|50137061|FG003|Part B (All Participants)|Protocol non-compliance|0|||
25036950|NCT02816138|50137069|FG000|Overall Study|Adverse Event|1|||
25036951|NCT02815670|50137073|FG000|Overall Study|Prematurely discontinued of the trial|1|||
25036952|NCT02809976|50137077|FG000|Overall Study|Lost to Follow-up|1|||
25036953|NCT02809976|50137077|FG000|Overall Study|Withdrawal by Subject|1|||
25036954|NCT02880865|50137083|FG000|Overall Study|Adverse Event|1|||
25036955|NCT02880865|50137084|FG001|Overall Study|Adverse Event|0|||
25036956|NCT02880865|50137083|FG000|Overall Study|Withdrawal by Subject|0|||
25036957|NCT02880865|50137084|FG001|Overall Study|Withdrawal by Subject|2|||
25036958|NCT02880865|50137083|FG000|Overall Study|Physician Decision|0|||
25036959|NCT02880865|50137084|FG001|Overall Study|Physician Decision|1|||
25036960|NCT01854385|50137111|FG000|Pre-Treatment|Withdrawal by Subject|4|||
25036961|NCT01854385|50137111|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
25036962|NCT01854385|50137111|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
25036963|NCT01854385|50137111|FG000|Pre-Treatment|Unable to come for study visits|1|||
25036964|NCT01854385|50137111|FG000|Treatment|Lost to Follow-up|1|||
25036965|NCT02809118|50137118|FG000|Overall Study|Withdrawal by Subject|0|||
25036966|NCT02809118|50137119|FG001|Overall Study|Withdrawal by Subject|1|||
25036967|NCT02809118|50137120|FG002|Overall Study|Withdrawal by Subject|1|||
25036968|NCT03604159|50137130|FG000|Overall Study|Lost to Follow-up|6|||
25036969|NCT03604159|50137131|FG001|Overall Study|Lost to Follow-up|7|||
25036970|NCT02808338|50137137|FG000|Screening|Screen Failure|10|||
25036971|NCT02808338|50137137|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
25036972|NCT02808338|50137137|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
25036973|NCT02807948|50137148|FG000|Overall Study|Physician Decision|1|||
25036974|NCT02807948|50137149|FG001|Overall Study|Physician Decision|0|||
25036975|NCT02879383|50137158|FG000|First 24 Weeks|Physician Decision|0|||
25036976|NCT02879383|50137159|FG001|First 24 Weeks|Physician Decision|1|||
25036977|NCT02879383|50137160|FG002|First 24 Weeks|Physician Decision|0|||
25036978|NCT02879383|50137161|FG003|First 24 Weeks|Physician Decision|0|||
25036979|NCT02049710|50137175|FG000|Overall Study|Lost to Follow-up|319|||
25036980|NCT02049710|50137176|FG001|Overall Study|Lost to Follow-up|324|||
25036981|NCT02806232|50137204|FG000|Overall Study|Lost to Follow-up|1|||
25036982|NCT02806232|50137205|FG001|Overall Study|Lost to Follow-up|2|||
25159835|NCT01891669|50279808|FG003|Overall Study|Withdrawal by Subject|0|||
25159836|NCT01891669|50279809|FG004|Overall Study|Withdrawal by Subject|0|||
25159837|NCT01891669|50279810|FG005|Overall Study|Withdrawal by Subject|0|||
25159838|NCT01891669|50279811|FG006|Overall Study|Withdrawal by Subject|1|||
25036983|NCT02806232|50137206|FG002|Overall Study|Lost to Follow-up|1|||
25036984|NCT02806232|50137207|FG003|Overall Study|Lost to Follow-up|0|||
25036985|NCT02806232|50137208|FG004|Overall Study|Lost to Follow-up|0|||
25036986|NCT02806232|50137209|FG005|Overall Study|Lost to Follow-up|1|||
25036987|NCT02806232|50137210|FG006|Overall Study|Lost to Follow-up|0|||
25036988|NCT02806232|50137211|FG007|Overall Study|Lost to Follow-up|0|||
25036989|NCT02806232|50137212|FG008|Overall Study|Lost to Follow-up|0|||
25036990|NCT02806232|50137204|FG000|Overall Study|Withdrawal by Subject|0|||
25036991|NCT02806232|50137205|FG001|Overall Study|Withdrawal by Subject|2|||
25036992|NCT02806232|50137206|FG002|Overall Study|Withdrawal by Subject|0|||
25036993|NCT02806232|50137207|FG003|Overall Study|Withdrawal by Subject|0|||
25036994|NCT02806232|50137208|FG004|Overall Study|Withdrawal by Subject|2|||
25036995|NCT02806232|50137209|FG005|Overall Study|Withdrawal by Subject|1|||
25036996|NCT02806232|50137210|FG006|Overall Study|Withdrawal by Subject|0|||
25159839|NCT01891669|50279812|FG007|Overall Study|Withdrawal by Subject|2|||
25159840|NCT01891669|50279813|FG008|Overall Study|Withdrawal by Subject|1|||
25036997|NCT02806232|50137211|FG007|Overall Study|Withdrawal by Subject|0|||
25036998|NCT02806232|50137212|FG008|Overall Study|Withdrawal by Subject|0|||
25036999|NCT02807402|50137232|FG000|Overall Study|Failure to Return|1|||
25037000|NCT02807402|50137232|FG000|Overall Study|Death|3|||
25037001|NCT02807402|50137232|FG000|Overall Study|Other|2|||
25037002|NCT00392327|50137252|FG000|Overall Study|Death|1|||
25159841|NCT01891669|50279814|FG009|Overall Study|Withdrawal by Subject|1|||
25037003|NCT00392327|50137253|FG001|Overall Study|Death|0|||
25037004|NCT00392327|50137254|FG002|Overall Study|Death|1|||
25037005|NCT00392327|50137255|FG003|Overall Study|Death|0|||
25037006|NCT00392327|50137256|FG004|Overall Study|Death|0|||
25037007|NCT00392327|50137257|FG005|Overall Study|Death|0|||
25037008|NCT00392327|50137258|FG006|Overall Study|Death|0|||
25037009|NCT00392327|50137259|FG007|Overall Study|Death|0|||
25037010|NCT00392327|50137252|FG000|Overall Study|Lack of Efficacy|8|||
25037011|NCT00392327|50137253|FG001|Overall Study|Lack of Efficacy|8|||
25037012|NCT00392327|50137254|FG002|Overall Study|Lack of Efficacy|9|||
25037013|NCT00392327|50137255|FG003|Overall Study|Lack of Efficacy|6|||
25037014|NCT00392327|50137256|FG004|Overall Study|Lack of Efficacy|3|||
25037015|NCT00392327|50137257|FG005|Overall Study|Lack of Efficacy|3|||
25037016|NCT00392327|50137258|FG006|Overall Study|Lack of Efficacy|3|||
25037017|NCT00392327|50137259|FG007|Overall Study|Lack of Efficacy|3|||
25037018|NCT00392327|50137252|FG000|Overall Study|Physician Decision|3|||
25037019|NCT00392327|50137253|FG001|Overall Study|Physician Decision|5|||
25037020|NCT00392327|50137254|FG002|Overall Study|Physician Decision|2|||
25037021|NCT00392327|50137255|FG003|Overall Study|Physician Decision|2|||
25037022|NCT00392327|50137256|FG004|Overall Study|Physician Decision|0|||
25037023|NCT00392327|50137257|FG005|Overall Study|Physician Decision|1|||
25037024|NCT00392327|50137258|FG006|Overall Study|Physician Decision|5|||
25037025|NCT00392327|50137259|FG007|Overall Study|Physician Decision|3|||
25037026|NCT00392327|50137252|FG000|Overall Study|Protocol Violation|0|||
25037027|NCT00392327|50137253|FG001|Overall Study|Protocol Violation|0|||
25037028|NCT00392327|50137254|FG002|Overall Study|Protocol Violation|1|||
25037029|NCT00392327|50137255|FG003|Overall Study|Protocol Violation|0|||
25037030|NCT00392327|50137256|FG004|Overall Study|Protocol Violation|0|||
25037031|NCT00392327|50137257|FG005|Overall Study|Protocol Violation|0|||
25037032|NCT00392327|50137258|FG006|Overall Study|Protocol Violation|0|||
25037033|NCT00392327|50137259|FG007|Overall Study|Protocol Violation|0|||
25037034|NCT00392327|50137252|FG000|Overall Study|Withdrawal by Subject|3|||
25037035|NCT00392327|50137253|FG001|Overall Study|Withdrawal by Subject|2|||
25037036|NCT00392327|50137254|FG002|Overall Study|Withdrawal by Subject|4|||
25037037|NCT00392327|50137255|FG003|Overall Study|Withdrawal by Subject|6|||
25037038|NCT00392327|50137256|FG004|Overall Study|Withdrawal by Subject|0|||
25037039|NCT00392327|50137257|FG005|Overall Study|Withdrawal by Subject|1|||
25037040|NCT00392327|50137258|FG006|Overall Study|Withdrawal by Subject|1|||
25037041|NCT00392327|50137259|FG007|Overall Study|Withdrawal by Subject|5|||
25037042|NCT00392327|50137252|FG000|Overall Study|Ineligible|0|||
25037043|NCT00392327|50137253|FG001|Overall Study|Ineligible|4|||
25037044|NCT00392327|50137254|FG002|Overall Study|Ineligible|3|||
25037045|NCT00392327|50137255|FG003|Overall Study|Ineligible|2|||
25037046|NCT00392327|50137256|FG004|Overall Study|Ineligible|0|||
25037047|NCT00392327|50137257|FG005|Overall Study|Ineligible|0|||
25037048|NCT00392327|50137258|FG006|Overall Study|Ineligible|0|||
25037049|NCT00392327|50137259|FG007|Overall Study|Ineligible|0|||
25037050|NCT02960490|50137279|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
25037051|NCT02960490|50137280|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
25037052|NCT02960490|50137281|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
25037053|NCT02960490|50137282|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
25037054|NCT02960490|50137283|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
25037055|NCT02960490|50137284|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
25037056|NCT02960490|50137285|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
25037057|NCT02960490|50137286|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
25037058|NCT02960490|50137287|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
25037059|NCT02960490|50137288|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
25037060|NCT02960490|50137279|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
25037061|NCT02960490|50137280|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
25037062|NCT02960490|50137281|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
25037063|NCT02960490|50137282|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
25037064|NCT02960490|50137283|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
25037065|NCT02960490|50137284|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
25037066|NCT02960490|50137285|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
25275732|NCT01233869|50589543|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
25037067|NCT02960490|50137286|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
25037068|NCT02960490|50137287|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
25037069|NCT02960490|50137288|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
25037070|NCT02960490|50137279|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
25037071|NCT02960490|50137280|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
25037072|NCT02960490|50137281|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
25037073|NCT02960490|50137282|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
25037074|NCT02960490|50137283|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
25037075|NCT02960490|50137284|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
25159842|NCT01891669|50279805|FG000|Overall Study|Other|1|||
25037076|NCT02960490|50137285|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
25037077|NCT02960490|50137286|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
25037078|NCT02960490|50137287|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
25037079|NCT02960490|50137288|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
25037080|NCT02960490|50137279|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
25037081|NCT02960490|50137280|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
25037082|NCT02960490|50137281|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
25037083|NCT02960490|50137282|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
25037084|NCT02960490|50137283|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
25037085|NCT02960490|50137284|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
25037086|NCT02960490|50137285|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
25037087|NCT02960490|50137286|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
25037088|NCT02960490|50137287|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
25037089|NCT02960490|50137288|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
25037090|NCT02960490|50137279|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
25037091|NCT02960490|50137280|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
25037092|NCT02960490|50137281|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
25037093|NCT02960490|50137282|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
25037094|NCT02960490|50137283|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
25037095|NCT02960490|50137284|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
25037096|NCT02960490|50137285|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
25037097|NCT02960490|50137286|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
25037098|NCT02960490|50137287|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
25037099|NCT02960490|50137288|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
25037100|NCT02960490|50137279|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
25037101|NCT02960490|50137280|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
25037102|NCT02960490|50137281|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
25037103|NCT02960490|50137282|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
25037104|NCT02960490|50137283|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
25037105|NCT02960490|50137284|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
25037106|NCT02960490|50137285|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
25037107|NCT02960490|50137286|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
25037108|NCT02960490|50137287|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
25037109|NCT02960490|50137288|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
25037110|NCT02960490|50137279|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
25037111|NCT02960490|50137280|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
25037112|NCT02960490|50137281|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
25037113|NCT02960490|50137282|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
25037114|NCT02960490|50137283|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
25037115|NCT02960490|50137284|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
25037116|NCT02960490|50137285|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
25037117|NCT02960490|50137286|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
25037118|NCT02960490|50137287|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
25037119|NCT02960490|50137288|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
25037120|NCT02960490|50137279|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
25037121|NCT02960490|50137280|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
25037122|NCT02960490|50137281|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
25037123|NCT02960490|50137282|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
25037124|NCT02960490|50137283|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
25037125|NCT02960490|50137284|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
25037126|NCT02960490|50137285|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
25037127|NCT02960490|50137286|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
25037128|NCT02960490|50137287|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
25037129|NCT02960490|50137288|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
25037130|NCT02960490|50137279|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
25037131|NCT02960490|50137280|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
24947144|NCT00449150|50039578|FG002|Overall Study|Protocol Violation|1|||
24947145|NCT00428844|50039592|FG000|Completed Study Drug Treatment|Adverse Event|2|||
24947146|NCT00428844|50039593|FG001|Completed Study Drug Treatment|Adverse Event|4|||
24947147|NCT00428844|50039594|FG002|Completed Study Drug Treatment|Adverse Event|4|||
24947148|NCT00428844|50039592|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
24947149|NCT00428844|50039593|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
24947150|NCT00428844|50039594|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
24947151|NCT00428844|50039592|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
24947152|NCT00428844|50039593|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
24947153|NCT00428844|50039594|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
25037132|NCT02960490|50137281|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
25037133|NCT02960490|50137282|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
25037134|NCT02960490|50137283|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
25037135|NCT02960490|50137284|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
25037136|NCT02960490|50137285|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
25037137|NCT02960490|50137286|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
25037138|NCT02960490|50137287|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
25037139|NCT02960490|50137288|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
25037140|NCT02960490|50137279|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
25037141|NCT02960490|50137280|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
25037142|NCT02960490|50137281|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
25037143|NCT02960490|50137282|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
25037144|NCT02960490|50137283|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
25037145|NCT02960490|50137284|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
25037146|NCT02960490|50137285|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
25037147|NCT02960490|50137286|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
25037148|NCT02960490|50137287|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
25037149|NCT02960490|50137288|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
25037150|NCT02960490|50137279|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
25037151|NCT02960490|50137280|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
25037152|NCT02960490|50137281|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
25037153|NCT02960490|50137282|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
25037154|NCT02960490|50137283|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
25037155|NCT02960490|50137284|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
25037156|NCT02960490|50137285|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
25037157|NCT02960490|50137286|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
25037158|NCT02960490|50137287|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
25037159|NCT02960490|50137288|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
25037160|NCT02960490|50137279|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
25037161|NCT02960490|50137280|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
25037162|NCT02960490|50137281|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
25037163|NCT02960490|50137282|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
25037164|NCT02960490|50137283|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
25037165|NCT02960490|50137284|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
25037166|NCT02960490|50137285|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
25037167|NCT02960490|50137286|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
25037168|NCT02960490|50137287|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
25037169|NCT02960490|50137288|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
25037170|NCT02804750|50137312|FG000|Period 1|Adverse Event|0|||
25037171|NCT02804750|50137313|FG001|Period 1|Adverse Event|2|||
25037172|NCT02804750|50137312|FG000|Period 1|Withdrawal by Subject|0|||
25037173|NCT02804750|50137313|FG001|Period 1|Withdrawal by Subject|1|||
25037174|NCT02804750|50137312|FG000|Period 2|Adverse Event|1|||
25037175|NCT02804750|50137313|FG001|Period 2|Adverse Event|0|||
25037176|NCT02804750|50137312|FG000|Period 3|Adverse Event|0|||
25037177|NCT02804750|50137313|FG001|Period 3|Adverse Event|2|||
25037178|NCT02804750|50137312|FG000|Period 4|Adverse Event|0|||
25037179|NCT02804750|50137313|FG001|Period 4|Adverse Event|5|||
24947154|NCT00428844|50039592|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
24947155|NCT00428844|50039593|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
24947156|NCT00428844|50039594|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
24947157|NCT00428844|50039592|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
24947158|NCT00428844|50039593|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
24947159|NCT00428844|50039594|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
24947160|NCT00428844|50039592|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
24947161|NCT00428844|50039593|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
24947162|NCT00428844|50039594|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
24947163|NCT00428844|50039592|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
24947164|NCT00428844|50039593|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
24947165|NCT00428844|50039594|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
24947166|NCT00428844|50039592|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
24947167|NCT00428844|50039593|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
24947168|NCT00428844|50039594|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
24947169|NCT00428844|50039592|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
24947170|NCT00428844|50039593|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
25037180|NCT02959866|50137321|FG000|Overall Study|Withdrawal by Subject|1|||
25037181|NCT02748512|50137328|FG000|Overall Study|Lost to Follow-up|1|||
25037182|NCT02748512|50137329|FG001|Overall Study|Lost to Follow-up|1|||
25037183|NCT02748356|50137335|FG000|Overall Study|Withdrawal by Subject|1|||
25037184|NCT03439657|50137341|FG000|Overall Study|Adverse Event|2|||
25037185|NCT03439657|50137342|FG001|Overall Study|Adverse Event|3|||
25037186|NCT03439657|50137341|FG000|Overall Study|Lost to Follow-up|1|||
25037187|NCT03439657|50137342|FG001|Overall Study|Lost to Follow-up|0|||
25037188|NCT03439657|50137341|FG000|Overall Study|Protocol Violation|1|||
25037189|NCT03439657|50137342|FG001|Overall Study|Protocol Violation|1|||
25037190|NCT03439657|50137341|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
25037191|NCT03439657|50137342|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
25037192|NCT02803580|50137350|FG000|Overall Study|Death|13|||
25037193|NCT02803580|50137350|FG000|Overall Study|Lost to Follow-up|19|||
25037194|NCT02803580|50137350|FG000|Overall Study|Withdrawal by Subject|3|||
25037195|NCT02803580|50137350|FG000|Overall Study|Inclusion in clinical trial|1|||
25037196|NCT02878213|50137354|FG000|Overall Study|Withdrawal by Subject|2|||
25037197|NCT02878213|50137354|FG000|Overall Study|Adverse Event|1|||
25037198|NCT02802878|50137361|FG000|Overall Study|Withdrawal by Subject|3|||
25037199|NCT02802878|50137362|FG001|Overall Study|Withdrawal by Subject|3|||
25037200|NCT02802878|50137361|FG000|Overall Study|Protocol Violation|1|||
25037201|NCT02802878|50137362|FG001|Overall Study|Protocol Violation|0|||
25037202|NCT02801396|50137368|FG000|Period 1|Withdrawal by Subject|0|||
25037203|NCT02801396|50137369|FG001|Period 1|Withdrawal by Subject|0|||
25037204|NCT02801396|50137370|FG002|Period 1|Withdrawal by Subject|0|||
25037205|NCT02801396|50137371|FG003|Period 1|Withdrawal by Subject|0|||
25037206|NCT02801396|50137372|FG004|Period 1|Withdrawal by Subject|1|||
25037207|NCT02801396|50137373|FG005|Period 1|Withdrawal by Subject|0|||
25037208|NCT02800928|50137381|FG000|Overall Study|Withdrawal by Subject|1|||
25037209|NCT02800928|50137382|FG001|Overall Study|Withdrawal by Subject|1|||
25037210|NCT02800928|50137381|FG000|Overall Study|Protocol Violation|1|||
25037211|NCT02800928|50137382|FG001|Overall Study|Protocol Violation|1|||
25037212|NCT03148691|50137391|FG000|Overall Study|Protocol Violation|1|||
25037213|NCT03148691|50137392|FG001|Overall Study|Protocol Violation|2|||
25037214|NCT03148691|50137393|FG002|Overall Study|Protocol Violation|7|||
25037215|NCT03148691|50137391|FG000|Overall Study|Lost to Follow-up|0|||
25037216|NCT03148691|50137392|FG001|Overall Study|Lost to Follow-up|0|||
25037217|NCT03148691|50137393|FG002|Overall Study|Lost to Follow-up|1|||
25037218|NCT03148691|50137391|FG000|Overall Study|Other|1|||
25037219|NCT03148691|50137392|FG001|Overall Study|Other|0|||
25037220|NCT03148691|50137393|FG002|Overall Study|Other|0|||
25037221|NCT03148691|50137391|FG000|Overall Study|Withdrawal by Subject|1|||
25037222|NCT03148691|50137392|FG001|Overall Study|Withdrawal by Subject|0|||
25037223|NCT03148691|50137393|FG002|Overall Study|Withdrawal by Subject|0|||
25037224|NCT03148067|50137401|FG000|Overall Study|Lost to Follow-up|3|||
25037225|NCT03148067|50137401|FG000|Overall Study|Death|1|||
25037226|NCT03146741|50137415|FG000|Overall Study|Txp with non-HCV+ heart|4|||
25037227|NCT03146741|50137415|FG000|Overall Study|Listeted for MOT|2|||
25037228|NCT03146741|50137415|FG000|Overall Study|Physician Decision|2|||
25037229|NCT03146741|50137415|FG000|Overall Study|Awaiting txp|2|||
25037230|NCT03150719|50137421|FG000|Overall Study|Adverse Event|0|||
25037231|NCT03150719|50137422|FG001|Overall Study|Adverse Event|1|||
25037232|NCT03150719|50137421|FG000|Overall Study|Death|0|||
25037233|NCT03150719|50137422|FG001|Overall Study|Death|1|||
25037234|NCT03150719|50137421|FG000|Overall Study|Other|1|||
25037235|NCT03150719|50137422|FG001|Overall Study|Other|0|||
25037236|NCT04039217|50137428|FG000|Overall Study|Lost to Follow-up|1|||
25037237|NCT00982111|50137438|FG000|Overall Study|Adverse Event|1|||
25037238|NCT00982111|50137439|FG001|Overall Study|Adverse Event|1|||
25037239|NCT00982111|50137438|FG000|Overall Study|Progressive Disease|46|||
25037240|NCT00982111|50137439|FG001|Overall Study|Progressive Disease|39|||
25037241|NCT00982111|50137438|FG000|Overall Study|Lost to Follow-up|9|||
25037242|NCT00982111|50137439|FG001|Overall Study|Lost to Follow-up|6|||
25037243|NCT00982111|50137438|FG000|Overall Study|New Anti-Cancer Therapy|5|||
25037244|NCT00982111|50137439|FG001|Overall Study|New Anti-Cancer Therapy|5|||
24947171|NCT00428844|50039594|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
24947172|NCT00457418|50039602|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
24947173|NCT00457418|50039602|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
24947174|NCT00457418|50039602|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
24947175|NCT00457418|50039602|FG000|Post PK Maintenance|Adverse Event|10|||
24947176|NCT00457418|50039602|FG000|Post PK Maintenance|Progression of Disease|6|||
24947177|NCT00457418|50039602|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
25037245|NCT00982111|50137438|FG000|Overall Study|Medical Decision|1|||
25037246|NCT00982111|50137439|FG001|Overall Study|Medical Decision|0|||
24947178|NCT00457418|50039602|FG000|Post PK Maintenance|Lost to Follow-up|1|||
25037247|NCT00982111|50137438|FG000|Overall Study|Withdrawal by Subject|17|||
25037248|NCT00982111|50137439|FG001|Overall Study|Withdrawal by Subject|19|||
25037249|NCT00982111|50137438|FG000|Overall Study|Global Study End|0|||
25037250|NCT00982111|50137439|FG001|Overall Study|Global Study End|1|||
25037251|NCT00982111|50137438|FG000|Overall Study|Sponsor's Decision|0|||
25037252|NCT00982111|50137439|FG001|Overall Study|Sponsor's Decision|1|||
25037253|NCT02957682|50137448|FG000|Overall Study|Adverse Event|64|||
25037254|NCT02957682|50137449|FG001|Overall Study|Adverse Event|67|||
24947179|NCT00449072|50039608|FG000|Overall Study|Adverse Event|3|||
24947180|NCT00449072|50039609|FG001|Overall Study|Adverse Event|1|||
24947181|NCT00449072|50039608|FG000|Overall Study|Protocol Violation|14|||
24947182|NCT00449072|50039609|FG001|Overall Study|Protocol Violation|12|||
24947183|NCT00449072|50039608|FG000|Overall Study|Lost to Follow-up|5|||
24947184|NCT00449072|50039609|FG001|Overall Study|Lost to Follow-up|7|||
24947185|NCT00449072|50039608|FG000|Overall Study|Withdrawal by Subject|11|||
24947186|NCT00449072|50039609|FG001|Overall Study|Withdrawal by Subject|8|||
24947187|NCT00449072|50039608|FG000|Overall Study|Lack of Efficacy|1|||
24947188|NCT00449072|50039609|FG001|Overall Study|Lack of Efficacy|1|||
24947189|NCT00449072|50039608|FG000|Overall Study|Physician Decision|1|||
25037255|NCT02957682|50137448|FG000|Overall Study|Poor Compliance to Protocol|30|||
25037256|NCT02957682|50137449|FG001|Overall Study|Poor Compliance to Protocol|26|||
25037257|NCT02957682|50137448|FG000|Overall Study|Physician Decision|4|||
25037258|NCT02957682|50137449|FG001|Overall Study|Physician Decision|4|||
25037259|NCT02957682|50137448|FG000|Overall Study|Study Terminated by Sponsor|4|||
25037260|NCT02957682|50137449|FG001|Overall Study|Study Terminated by Sponsor|3|||
25037261|NCT02957682|50137448|FG000|Overall Study|Subject Moved|10|||
25037262|NCT02957682|50137449|FG001|Overall Study|Subject Moved|16|||
25037263|NCT02957682|50137448|FG000|Overall Study|Withdrawal by Subject|64|||
25037264|NCT02957682|50137449|FG001|Overall Study|Withdrawal by Subject|33|||
25037265|NCT02957682|50137448|FG000|Overall Study|Related to IMP Administration|3|||
25037266|NCT02957682|50137449|FG001|Overall Study|Related to IMP Administration|6|||
25037267|NCT02957682|50137448|FG000|Overall Study|Non-disclosed|16|||
25037268|NCT02957682|50137449|FG001|Overall Study|Non-disclosed|12|||
25037269|NCT02957682|50137448|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
25037270|NCT02957682|50137449|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
25037271|NCT03057951|50137457|FG000|Overall Study|Adverse Event|553|||
25037272|NCT03057951|50137458|FG001|Overall Study|Adverse Event|575|||
25037273|NCT03057951|50137457|FG000|Overall Study|Protocol Violation|30|||
25037274|NCT03057951|50137458|FG001|Overall Study|Protocol Violation|24|||
25037275|NCT03057951|50137457|FG000|Overall Study|Lost to Follow-up|6|||
25037276|NCT03057951|50137458|FG001|Overall Study|Lost to Follow-up|16|||
25037277|NCT03057951|50137457|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
25037278|NCT03057951|50137458|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
25037279|NCT03057951|50137457|FG000|Overall Study|Study drug stopped, reason missing|6|||
25037280|NCT03057951|50137458|FG001|Overall Study|Study drug stopped, reason missing|1|||
25037281|NCT03057951|50137457|FG000|Overall Study|Medical advice|6|||
25037282|NCT03057951|50137458|FG001|Overall Study|Medical advice|2|||
25037283|NCT03057951|50137457|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
25037284|NCT03057951|50137458|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
25037285|NCT03057951|50137457|FG000|Overall Study|Investigator decision|2|||
25037286|NCT03057951|50137458|FG001|Overall Study|Investigator decision|0|||
24947190|NCT00449072|50039609|FG001|Overall Study|Physician Decision|0|||
24947191|NCT00449072|50039608|FG000|Overall Study|Not treated|0|||
24947192|NCT00449072|50039609|FG001|Overall Study|Not treated|1|||
24947193|NCT00449072|50039608|FG000|Overall Study|Excluded medication|0|||
24947194|NCT00449072|50039609|FG001|Overall Study|Excluded medication|2|||
24947195|NCT00449072|50039608|FG000|Overall Study|Non-compliance|2|||
24947196|NCT00449072|50039609|FG001|Overall Study|Non-compliance|5|||
24947197|NCT00449072|50039608|FG000|Overall Study|Sponsor decision|1|||
24947198|NCT00449072|50039609|FG001|Overall Study|Sponsor decision|3|||
24947199|NCT00449072|50039608|FG000|Overall Study|Relocation|3|||
24947200|NCT00449072|50039609|FG001|Overall Study|Relocation|2|||
24947201|NCT00428610|50039618|FG000|Overall Study|Death Due to Adverse Event|3|||
24947202|NCT00428610|50039619|FG001|Overall Study|Death Due to Adverse Event|0|||
24947203|NCT00428610|50039620|FG002|Overall Study|Death Due to Adverse Event|5|||
24947204|NCT00428610|50039618|FG000|Overall Study|Death Due to Progressive Disease|0|||
24947205|NCT00428610|50039619|FG001|Overall Study|Death Due to Progressive Disease|0|||
24947206|NCT00428610|50039620|FG002|Overall Study|Death Due to Progressive Disease|2|||
24947207|NCT00428610|50039618|FG000|Overall Study|Adverse Event|2|||
24947208|NCT00428610|50039619|FG001|Overall Study|Adverse Event|3|||
24947209|NCT00428610|50039620|FG002|Overall Study|Adverse Event|2|||
24947210|NCT00428610|50039618|FG000|Overall Study|Investigator Decision|2|||
24947211|NCT00428610|50039619|FG001|Overall Study|Investigator Decision|1|||
24947212|NCT00428610|50039620|FG002|Overall Study|Investigator Decision|1|||
25037287|NCT03057951|50137457|FG000|Overall Study|Patient decision|5|||
25037288|NCT03057951|50137458|FG001|Overall Study|Patient decision|2|||
24947213|NCT00428610|50039618|FG000|Overall Study|Progressive Disease|42|||
24947214|NCT00428610|50039619|FG001|Overall Study|Progressive Disease|14|||
24947215|NCT00428610|50039620|FG002|Overall Study|Progressive Disease|22|||
24947216|NCT00428610|50039618|FG000|Overall Study|Withdrawal by Subject|4|||
25037289|NCT03057951|50137457|FG000|Overall Study|Not attending study visits|3|||
25037290|NCT03057951|50137458|FG001|Overall Study|Not attending study visits|0|||
25037291|NCT03057951|50137457|FG000|Overall Study|Patient moved away|3|||
25037292|NCT03057951|50137458|FG001|Overall Study|Patient moved away|4|||
24947217|NCT00428610|50039619|FG001|Overall Study|Withdrawal by Subject|0|||
25037293|NCT03057951|50137457|FG000|Overall Study|Other reason than stated above|23|||
25037294|NCT03057951|50137458|FG001|Overall Study|Other reason than stated above|29|||
25037295|NCT03057951|50137457|FG000|Overall Study|Not treated|2|||
25037296|NCT03057951|50137458|FG001|Overall Study|Not treated|1|||
25037297|NCT03146663|50137466|FG000|Overall Study|Did not receive study treatment|1|||
25037298|NCT03146663|50137467|FG001|Overall Study|Did not receive study treatment|1|||
24947218|NCT00428610|50039620|FG002|Overall Study|Withdrawal by Subject|0|||
24947219|NCT00419094|50039630|FG000|Overall Study|Adverse Event|3|||
24947220|NCT00419094|50039631|FG001|Overall Study|Adverse Event|7|||
24947221|NCT00419094|50039630|FG000|Overall Study|Lack of Efficacy|1|||
25037299|NCT02956278|50137477|FG000|Overall Study|Withdrawal by Subject|6|||
25037300|NCT02956278|50137478|FG001|Overall Study|Withdrawal by Subject|2|||
25037301|NCT02956278|50137479|FG002|Overall Study|Withdrawal by Subject|0|||
25037302|NCT02957136|50137489|FG000|Overall Study|Withdrawal by Subject|2|||
25037303|NCT02957136|50137490|FG001|Overall Study|Withdrawal by Subject|1|||
25037304|NCT03150485|50137496|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
25037305|NCT03150485|50137497|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
25037306|NCT03150485|50137498|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
25037307|NCT03150485|50137499|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
25037308|NCT03150485|50137500|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
24947222|NCT00419094|50039631|FG001|Overall Study|Lack of Efficacy|0|||
24947223|NCT00419094|50039630|FG000|Overall Study|Lost to Follow-up|0|||
24947224|NCT00419094|50039631|FG001|Overall Study|Lost to Follow-up|2|||
24947225|NCT00419094|50039630|FG000|Overall Study|Protocol Violation|1|||
24947226|NCT00419094|50039631|FG001|Overall Study|Protocol Violation|14|||
24947227|NCT00419094|50039630|FG000|Overall Study|Withdrawal of consent|1|||
24947228|NCT00419094|50039631|FG001|Overall Study|Withdrawal of consent|5|||
24947229|NCT00419094|50039630|FG000|Overall Study|Other: Error determining exit criteria|1|||
24947230|NCT00419094|50039631|FG001|Overall Study|Other: Error determining exit criteria|0|||
24947231|NCT00419094|50039630|FG000|Overall Study|Other: Patient non-compliant|0|||
24947232|NCT00419094|50039631|FG001|Overall Study|Other: Patient non-compliant|1|||
24947233|NCT00419094|50039630|FG000|Overall Study|Other: No contact for extended period|0|||
24947234|NCT00419094|50039631|FG001|Overall Study|Other: No contact for extended period|1|||
24947235|NCT00448916|50039641|FG000|Overall Study|Adverse Event|2|||
25037309|NCT03150485|50137501|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
25037310|NCT03134911|50137508|FG000|Overall Study|Screen failure|31|||
25037311|NCT03134911|50137508|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
25037312|NCT03134599|50137527|FG000|Week 1|Lost to Follow-up|0|||
25037313|NCT03134599|50137528|FG001|Week 1|Lost to Follow-up|0|||
25037314|NCT03134599|50137529|FG002|Week 1|Lost to Follow-up|0|||
25037315|NCT03134599|50137530|FG003|Week 1|Lost to Follow-up|0|||
25037316|NCT03134599|50137531|FG004|Week 1|Lost to Follow-up|1|||
25037317|NCT03134599|50137532|FG005|Week 1|Lost to Follow-up|0|||
25037318|NCT03134599|50137527|FG000|Week 2|Lost to Follow-up|1|||
25037319|NCT03134599|50137528|FG001|Week 2|Lost to Follow-up|0|||
25037320|NCT03134599|50137529|FG002|Week 2|Lost to Follow-up|0|||
25037321|NCT03134599|50137530|FG003|Week 2|Lost to Follow-up|1|||
25037322|NCT03134599|50137531|FG004|Week 2|Lost to Follow-up|1|||
24947236|NCT00448916|50039642|FG001|Overall Study|Adverse Event|2|||
24947237|NCT00448916|50039643|FG002|Overall Study|Adverse Event|3|||
24947238|NCT00448916|50039644|FG003|Overall Study|Adverse Event|2|||
24947239|NCT00448916|50039641|FG000|Overall Study|Lack of Efficacy|1|||
24947240|NCT00448916|50039642|FG001|Overall Study|Lack of Efficacy|0|||
24947241|NCT00448916|50039643|FG002|Overall Study|Lack of Efficacy|2|||
24947242|NCT00448916|50039644|FG003|Overall Study|Lack of Efficacy|1|||
24947243|NCT00448916|50039641|FG000|Overall Study|Withdrawal by Subject|3|||
24947244|NCT00448916|50039642|FG001|Overall Study|Withdrawal by Subject|3|||
24947245|NCT00448916|50039643|FG002|Overall Study|Withdrawal by Subject|1|||
24947246|NCT00448916|50039644|FG003|Overall Study|Withdrawal by Subject|1|||
24947247|NCT00448916|50039641|FG000|Overall Study|Other|1|||
24947248|NCT00448916|50039642|FG001|Overall Study|Other|0|||
25037323|NCT03134599|50137532|FG005|Week 2|Lost to Follow-up|0|||
25037324|NCT03134599|50137527|FG000|Week 3|Lost to Follow-up|0|||
25037325|NCT03134599|50137528|FG001|Week 3|Lost to Follow-up|0|||
25037326|NCT03134599|50137529|FG002|Week 3|Lost to Follow-up|0|||
24947249|NCT00448916|50039643|FG002|Overall Study|Other|0|||
24947250|NCT00448916|50039644|FG003|Overall Study|Other|0|||
24947251|NCT00448916|50039641|FG000|Overall Study|Lost to Follow-up|0|||
24947252|NCT00448916|50039642|FG001|Overall Study|Lost to Follow-up|1|||
24947253|NCT00448916|50039643|FG002|Overall Study|Lost to Follow-up|0|||
24947254|NCT00448916|50039644|FG003|Overall Study|Lost to Follow-up|1|||
24947255|NCT00448916|50039641|FG000|Overall Study|Protocol Violation|0|||
24947256|NCT00448916|50039642|FG001|Overall Study|Protocol Violation|0|||
24947257|NCT00448916|50039643|FG002|Overall Study|Protocol Violation|0|||
24947258|NCT00448916|50039644|FG003|Overall Study|Protocol Violation|1|||
24947259|NCT00418938|50039658|FG000|Overall Study|Reimbursement|1|||
25037327|NCT03134599|50137530|FG003|Week 3|Lost to Follow-up|1|||
25037328|NCT03134599|50137531|FG004|Week 3|Lost to Follow-up|0|||
25037329|NCT03134599|50137532|FG005|Week 3|Lost to Follow-up|1|||
25037330|NCT03153137|50137542|FG000|Overall Study|Lost to Follow-up|1|||
25037331|NCT03153137|50137543|FG001|Overall Study|Lost to Follow-up|0|||
25037332|NCT03153137|50137542|FG000|Overall Study|Withdrawal by Subject|2|||
25037333|NCT03153137|50137543|FG001|Overall Study|Withdrawal by Subject|1|||
25037334|NCT03153137|50137542|FG000|Overall Study|Physician Decision|0|||
25037335|NCT03153137|50137543|FG001|Overall Study|Physician Decision|3|||
25037336|NCT03136861|50137556|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
25037337|NCT03136861|50137557|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
25037338|NCT03136861|50137558|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
25037339|NCT03136861|50137559|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
25037340|NCT03136861|50137560|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
25037341|NCT03136861|50137561|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
25037342|NCT03136861|50137562|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
25037343|NCT03136861|50137556|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
25037344|NCT03136861|50137557|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
25037345|NCT03136861|50137558|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
25037346|NCT03136861|50137559|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
25037347|NCT03136861|50137560|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
25037348|NCT03136861|50137561|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
25037349|NCT03136861|50137562|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
25037350|NCT03136861|50137556|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
25037351|NCT03136861|50137557|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
25037352|NCT03136861|50137558|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
25037353|NCT03136861|50137559|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
25037354|NCT03136861|50137560|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
25037355|NCT03136861|50137561|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
25037356|NCT03136861|50137562|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
25037357|NCT03136861|50137556|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
25037358|NCT03136861|50137557|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
25037359|NCT03136861|50137558|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
25037360|NCT03136861|50137559|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
25037361|NCT03136861|50137560|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
25037362|NCT03136861|50137561|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
25037363|NCT03136861|50137562|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
25037364|NCT03136861|50137556|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
25037365|NCT03136861|50137557|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
25037366|NCT03136861|50137558|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
25037367|NCT03136861|50137559|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
25037368|NCT03136861|50137560|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
25037369|NCT03136861|50137561|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
25037370|NCT03136861|50137562|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
25037371|NCT03136861|50137556|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
25037372|NCT03136861|50137557|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
25037373|NCT03136861|50137558|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
25037374|NCT03136861|50137559|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
25037375|NCT03136861|50137560|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
25037376|NCT03136861|50137561|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
25037377|NCT03136861|50137562|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
25037378|NCT03136861|50137556|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
25037379|NCT03136861|50137557|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
25037380|NCT03136861|50137558|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
25037381|NCT03136861|50137559|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
25037382|NCT03136861|50137560|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
25037383|NCT03136861|50137561|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
25037384|NCT03136861|50137562|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
25037385|NCT03136861|50137556|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
25037386|NCT03136861|50137557|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
25037387|NCT03136861|50137558|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
25037388|NCT03136861|50137559|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
25037389|NCT03136861|50137560|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
25159843|NCT01891669|50279806|FG001|Overall Study|Other|0|||
25159844|NCT01891669|50279807|FG002|Overall Study|Other|0|||
25159845|NCT01891669|50279808|FG003|Overall Study|Other|0|||
25159846|NCT01891669|50279809|FG004|Overall Study|Other|0|||
25275733|NCT01233869|50589544|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
25275734|NCT01233869|50589545|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
25037390|NCT03136861|50137561|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
25037391|NCT03136861|50137562|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
25037392|NCT03316950|50137590|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
25037393|NCT03316950|50137591|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
25037394|NCT03316950|50137592|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
25037395|NCT03316950|50137593|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
25037396|NCT03316950|50137590|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
25037397|NCT03316950|50137591|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
25037398|NCT03316950|50137592|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
25037399|NCT03316950|50137593|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
25037400|NCT03316950|50137590|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
25037401|NCT03316950|50137591|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
25037402|NCT03316950|50137592|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
25037403|NCT03316950|50137593|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
25037404|NCT03139279|50137607|FG000|Overall Study|Physician Decision|2|||
25037405|NCT03139279|50137608|FG001|Overall Study|Physician Decision|0|||
25037406|NCT03139279|50137607|FG000|Overall Study|Protocol Violation|5|||
25037407|NCT03139279|50137608|FG001|Overall Study|Protocol Violation|4|||
25037408|NCT03139279|50137607|FG000|Overall Study|Withdrawal by Subject|0|||
25037409|NCT03139279|50137608|FG001|Overall Study|Withdrawal by Subject|2|||
25037410|NCT01370642|50137617|FG000|Overall Study|Adverse Event|2|||
25037411|NCT01370642|50137618|FG001|Overall Study|Adverse Event|1|||
25037412|NCT01370642|50137619|FG002|Overall Study|Adverse Event|1|||
25037413|NCT01370642|50137617|FG000|Overall Study|Detectable HCV RNA|0|||
25037414|NCT01370642|50137618|FG001|Overall Study|Detectable HCV RNA|0|||
25037415|NCT01370642|50137619|FG002|Overall Study|Detectable HCV RNA|22|||
25037416|NCT01370642|50137617|FG000|Overall Study|Lost to Follow-up|0|||
25037417|NCT01370642|50137618|FG001|Overall Study|Lost to Follow-up|0|||
25037418|NCT01370642|50137619|FG002|Overall Study|Lost to Follow-up|1|||
25037419|NCT01370642|50137617|FG000|Overall Study|Physician Decision|4|||
25037420|NCT01370642|50137618|FG001|Overall Study|Physician Decision|1|||
25037421|NCT01370642|50137619|FG002|Overall Study|Physician Decision|2|||
25037422|NCT01370642|50137617|FG000|Overall Study|Withdrawal by Subject|2|||
24947260|NCT00418938|50039659|FG001|Overall Study|Reimbursement|0|||
24947261|NCT00418938|50039658|FG000|Overall Study|Administrative decision|3|||
24947262|NCT00418938|50039659|FG001|Overall Study|Administrative decision|3|||
24947263|NCT00418938|50039658|FG000|Overall Study|Withdrawal by Subject|16|||
24947264|NCT00418938|50039659|FG001|Overall Study|Withdrawal by Subject|15|||
24947265|NCT00418938|50039658|FG000|Overall Study|Lost to Follow-up|1|||
24947266|NCT00418938|50039659|FG001|Overall Study|Lost to Follow-up|3|||
24947267|NCT00418938|50039658|FG000|Overall Study|Adverse Event|1|||
25037423|NCT01370642|50137618|FG001|Overall Study|Withdrawal by Subject|4|||
25037424|NCT01370642|50137619|FG002|Overall Study|Withdrawal by Subject|3|||
25037425|NCT02873208|50137627|FG000|Overall Study|Withdrawal by Subject|36|||
25037426|NCT02873208|50137627|FG000|Overall Study|Lost to Follow-up|22|||
25037427|NCT02873208|50137627|FG000|Overall Study|Adverse Event|15|||
25037428|NCT02873208|50137627|FG000|Overall Study|Non-compliance with study drug|12|||
25037429|NCT02873208|50137627|FG000|Overall Study|Protocol Violation|8|||
24947268|NCT00418938|50039659|FG001|Overall Study|Adverse Event|1|||
24947269|NCT00418938|50039658|FG000|Overall Study|On-going|1|||
24947270|NCT00418938|50039659|FG001|Overall Study|On-going|1|||
24947271|NCT00418938|50039658|FG000|Overall Study|Ineligibility Determined|1|||
24947272|NCT00418938|50039659|FG001|Overall Study|Ineligibility Determined|0|||
24947273|NCT00448760|50039665|FG000|Overall Study|Death|3|||
24947274|NCT00418314|50039671|FG000|Overall Study|Withdrawal by Subject|1|||
24947275|NCT00418314|50039672|FG001|Overall Study|Withdrawal by Subject|2|||
24947276|NCT00448448|50039680|FG000|Overall Study|Withdrawal by Subject|13|||
24947277|NCT00448448|50039681|FG001|Overall Study|Withdrawal by Subject|2|||
24947278|NCT00448448|50039680|FG000|Overall Study|On protocol when study ended|83|||
24947279|NCT00448448|50039681|FG001|Overall Study|On protocol when study ended|36|||
24947280|NCT00448448|50039680|FG000|Overall Study|Lost to Follow-up|2|||
24947281|NCT00448448|50039681|FG001|Overall Study|Lost to Follow-up|1|||
24947282|NCT00448448|50039680|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
24947283|NCT00448448|50039681|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
24947284|NCT00448448|50039680|FG000|Overall Study|Signed consent lost|0|||
24947285|NCT00448448|50039681|FG001|Overall Study|Signed consent lost|1|||
24947286|NCT00405912|50039690|FG000|Overall Study|Withdrawal by Subject|12|||
24947287|NCT00405912|50039691|FG001|Overall Study|Withdrawal by Subject|11|||
25037430|NCT02873208|50137627|FG000|Overall Study|Pregnancy|2|||
25037431|NCT02873208|50137627|FG000|Overall Study|Incarceration|1|||
25037432|NCT02873208|50137627|FG000|Overall Study|Lack of Efficacy|1|||
24947288|NCT00405912|50039692|FG002|Overall Study|Withdrawal by Subject|12|||
24947289|NCT00405912|50039690|FG000|Overall Study|Lost to Follow-up|4|||
24947290|NCT00405912|50039691|FG001|Overall Study|Lost to Follow-up|8|||
24947291|NCT00405912|50039692|FG002|Overall Study|Lost to Follow-up|4|||
25037433|NCT02873208|50137627|FG000|Overall Study|Physician Decision|1|||
25037434|NCT03138967|50137633|FG000|Overall Study|Death|0|||
25037435|NCT03138967|50137634|FG001|Overall Study|Death|1|||
25037436|NCT03138967|50137633|FG000|Overall Study|Physician Decision|1|||
25037437|NCT03138967|50137634|FG001|Overall Study|Physician Decision|3|||
25037438|NCT01547117|50137644|FG000|Overall Study|Physician Decision|0|||
25037439|NCT01547117|50137645|FG001|Overall Study|Physician Decision|1|||
25037440|NCT01547117|50137646|FG002|Overall Study|Physician Decision|1|||
25037441|NCT01547117|50137647|FG003|Overall Study|Physician Decision|3|||
25037442|NCT01547117|50137644|FG000|Overall Study|Withdrawal by Subject|1|||
25037443|NCT01547117|50137645|FG001|Overall Study|Withdrawal by Subject|2|||
25037444|NCT01547117|50137646|FG002|Overall Study|Withdrawal by Subject|1|||
25037445|NCT01547117|50137647|FG003|Overall Study|Withdrawal by Subject|2|||
25037446|NCT03136159|50137675|FG000|Overall Study|chorioamnionitis|2|||
25037447|NCT03136159|50137676|FG001|Overall Study|chorioamnionitis|0|||
25037448|NCT03136159|50137675|FG000|Overall Study|vertical skin incision|1|||
25037449|NCT03136159|50137676|FG001|Overall Study|vertical skin incision|0|||
25037450|NCT03136159|50137675|FG000|Overall Study|additional dressing|1|||
25037451|NCT03136159|50137676|FG001|Overall Study|additional dressing|0|||
25037452|NCT03136159|50137675|FG000|Overall Study|never got dressing placed|1|||
25037453|NCT03136159|50137676|FG001|Overall Study|never got dressing placed|0|||
25037454|NCT01986933|50137687|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
25037455|NCT01986933|50137688|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
25037456|NCT01986933|50137689|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
25037457|NCT01986933|50137690|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
25037458|NCT01986933|50137691|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
25037459|NCT01986933|50137687|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
25037460|NCT01986933|50137688|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
25037461|NCT01986933|50137689|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
25037462|NCT01986933|50137690|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
25037463|NCT01986933|50137691|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
25037464|NCT01986933|50137687|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
25037465|NCT01986933|50137688|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
25037466|NCT01986933|50137689|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
25037467|NCT01986933|50137690|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
25037468|NCT01986933|50137691|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
25037469|NCT01986933|50137687|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
24947292|NCT00448136|50039702|FG000|Overall Study|Death|3|||
24947293|NCT00448136|50039703|FG001|Overall Study|Death|8|||
24947294|NCT00448136|50039702|FG000|Overall Study|Investigator's decision (progression)|1|||
24947295|NCT00448136|50039703|FG001|Overall Study|Investigator's decision (progression)|0|||
24947296|NCT00447902|50039711|FG000|Overall Study|Adverse Event|0|||
24947297|NCT00447902|50039712|FG001|Overall Study|Adverse Event|3|||
24947298|NCT00447902|50039711|FG000|Overall Study|Protocol Violation|1|||
24947299|NCT00447902|50039712|FG001|Overall Study|Protocol Violation|0|||
24947300|NCT00447902|50039711|FG000|Overall Study|Withdrawal by Subject|0|||
24947301|NCT00447902|50039712|FG001|Overall Study|Withdrawal by Subject|1|||
24947302|NCT00447902|50039711|FG000|Overall Study|included patients who discontinued|1|||
24947303|NCT00447902|50039712|FG001|Overall Study|included patients who discontinued|1|||
24947304|NCT00447902|50039711|FG000|Overall Study|Lack of Efficacy|2|||
24947305|NCT00447902|50039712|FG001|Overall Study|Lack of Efficacy|1|||
24947306|NCT00307437|50039721|FG000|Controlled Period|Adverse Event|7|||
24947307|NCT00307437|50039722|FG001|Controlled Period|Adverse Event|2|||
25037470|NCT01986933|50137688|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
25037471|NCT01986933|50137689|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
25037472|NCT01986933|50137690|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
25037473|NCT01986933|50137691|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
25037474|NCT01986933|50137687|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
25037475|NCT01986933|50137688|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
25037476|NCT01986933|50137689|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
25037477|NCT01986933|50137690|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
25037478|NCT01986933|50137691|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
25037479|NCT01986933|50137687|FG000|Active-to-active (Part B)|Adverse Event|0|||
25037480|NCT01986933|50137688|FG001|Active-to-active (Part B)|Adverse Event|2|||
24947308|NCT00307437|50039723|FG002|Controlled Period|Adverse Event|5|||
25037481|NCT01986933|50137689|FG002|Active-to-active (Part B)|Adverse Event|0|||
25037482|NCT01986933|50137690|FG003|Active-to-active (Part B)|Adverse Event|1|||
25037483|NCT01986933|50137691|FG004|Active-to-active (Part B)|Adverse Event|3|||
25037484|NCT01986933|50137687|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
25037485|NCT01986933|50137688|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
25037486|NCT01986933|50137689|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
25159847|NCT01891669|50279810|FG005|Overall Study|Other|0|||
24947309|NCT00307437|50039724|FG003|Controlled Period|Adverse Event|0|||
24947310|NCT00307437|50039725|FG004|Controlled Period|Adverse Event|0|||
24947311|NCT00307437|50039726|FG005|Controlled Period|Adverse Event|0|||
25037487|NCT01986933|50137690|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
25037488|NCT01986933|50137691|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
25037489|NCT01986933|50137687|FG000|Active-to-active (Part B)|Pregnancy|0|||
25037490|NCT01986933|50137688|FG001|Active-to-active (Part B)|Pregnancy|0|||
25037491|NCT01986933|50137689|FG002|Active-to-active (Part B)|Pregnancy|0|||
25037492|NCT01986933|50137690|FG003|Active-to-active (Part B)|Pregnancy|0|||
25037493|NCT01986933|50137691|FG004|Active-to-active (Part B)|Pregnancy|1|||
25037494|NCT01986933|50137687|FG000|Active-to-active (Part B)|Physician Decision|0|||
25037495|NCT01986933|50137688|FG001|Active-to-active (Part B)|Physician Decision|0|||
25037496|NCT01986933|50137689|FG002|Active-to-active (Part B)|Physician Decision|1|||
25037497|NCT01986933|50137690|FG003|Active-to-active (Part B)|Physician Decision|1|||
25037498|NCT01986933|50137691|FG004|Active-to-active (Part B)|Physician Decision|0|||
25037499|NCT01986933|50137687|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
25037500|NCT01986933|50137688|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
24947312|NCT00307437|50039727|FG006|Controlled Period|Adverse Event|0|||
24947313|NCT00307437|50039721|FG000|Controlled Period|Death|0|||
24947314|NCT00307437|50039722|FG001|Controlled Period|Death|0|||
24947315|NCT00307437|50039723|FG002|Controlled Period|Death|1|||
25037501|NCT01986933|50137689|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
25037502|NCT01986933|50137690|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
25037503|NCT01986933|50137691|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
25037504|NCT01986933|50137687|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
25037505|NCT01986933|50137688|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
25037506|NCT01986933|50137689|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
25037507|NCT01986933|50137690|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
25037508|NCT01986933|50137691|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
25037509|NCT01986933|50137687|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
25037510|NCT01986933|50137688|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
25037511|NCT01986933|50137689|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
25037512|NCT01986933|50137690|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
25037513|NCT01986933|50137691|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
25037514|NCT01986933|50137687|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
25037515|NCT01986933|50137688|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
25037516|NCT01986933|50137689|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
25037517|NCT01986933|50137690|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
25037518|NCT01986933|50137691|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
25037519|NCT01986933|50137687|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
25037520|NCT01986933|50137688|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
25037521|NCT01986933|50137689|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
25037522|NCT01986933|50137690|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
24947316|NCT00307437|50039724|FG003|Controlled Period|Death|0|||
24947317|NCT00307437|50039725|FG004|Controlled Period|Death|0|||
24947318|NCT00307437|50039726|FG005|Controlled Period|Death|0|||
24947319|NCT00307437|50039727|FG006|Controlled Period|Death|0|||
24947320|NCT00307437|50039721|FG000|Controlled Period|Lack of Efficacy|2|||
24947321|NCT00307437|50039722|FG001|Controlled Period|Lack of Efficacy|0|||
24947322|NCT00307437|50039723|FG002|Controlled Period|Lack of Efficacy|0|||
24947323|NCT00307437|50039724|FG003|Controlled Period|Lack of Efficacy|0|||
24947324|NCT00307437|50039725|FG004|Controlled Period|Lack of Efficacy|0|||
24947325|NCT00307437|50039726|FG005|Controlled Period|Lack of Efficacy|0|||
24947326|NCT00307437|50039727|FG006|Controlled Period|Lack of Efficacy|0|||
24947327|NCT00307437|50039721|FG000|Controlled Period|Lost to Follow-up|2|||
24947328|NCT00307437|50039722|FG001|Controlled Period|Lost to Follow-up|3|||
24947329|NCT00307437|50039723|FG002|Controlled Period|Lost to Follow-up|0|||
24947330|NCT00307437|50039724|FG003|Controlled Period|Lost to Follow-up|0|||
24947331|NCT00307437|50039725|FG004|Controlled Period|Lost to Follow-up|0|||
24947332|NCT00307437|50039726|FG005|Controlled Period|Lost to Follow-up|0|||
24947333|NCT00307437|50039727|FG006|Controlled Period|Lost to Follow-up|0|||
24947334|NCT00307437|50039721|FG000|Controlled Period|Other|5|||
24947335|NCT00307437|50039722|FG001|Controlled Period|Other|1|||
24947336|NCT00307437|50039723|FG002|Controlled Period|Other|3|||
24947337|NCT00307437|50039724|FG003|Controlled Period|Other|0|||
24947338|NCT00307437|50039725|FG004|Controlled Period|Other|0|||
24947339|NCT00307437|50039726|FG005|Controlled Period|Other|0|||
24947340|NCT00307437|50039727|FG006|Controlled Period|Other|0|||
25037523|NCT01986933|50137691|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
24947341|NCT00307437|50039721|FG000|After Controlled Period|Adverse Event|0|||
24947342|NCT00307437|50039722|FG001|After Controlled Period|Adverse Event|0|||
24947343|NCT00307437|50039723|FG002|After Controlled Period|Adverse Event|0|||
24947344|NCT00307437|50039724|FG003|After Controlled Period|Adverse Event|18|||
24947345|NCT00307437|50039725|FG004|After Controlled Period|Adverse Event|16|||
24947346|NCT00307437|50039726|FG005|After Controlled Period|Adverse Event|31|||
25037524|NCT01986933|50137687|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
25037525|NCT01986933|50137688|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
25037526|NCT01986933|50137689|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
25037527|NCT01986933|50137690|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
25037528|NCT01986933|50137691|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
25037529|NCT01986933|50137687|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
25037530|NCT01986933|50137688|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
25037531|NCT01986933|50137689|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
25037532|NCT01986933|50137690|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
25037533|NCT01986933|50137691|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
25037534|NCT01986933|50137687|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
25037535|NCT01986933|50137688|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
25037536|NCT01986933|50137689|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
25037537|NCT01986933|50137690|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
25037538|NCT01986933|50137691|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
25037539|NCT00394355|50137735|FG000|Overall Study|Adverse Event|10|||
25159848|NCT01891669|50279811|FG006|Overall Study|Other|0|||
25159849|NCT01891669|50279812|FG007|Overall Study|Other|1|||
25159850|NCT01891669|50279813|FG008|Overall Study|Other|0|||
25159851|NCT01891669|50279814|FG009|Overall Study|Other|0|||
25159852|NCT01421511|50279847|FG000|Overall Study|Lost to Follow-up|11|||
25159853|NCT01421511|50279848|FG001|Overall Study|Lost to Follow-up|14|||
25159854|NCT01421511|50279847|FG000|Overall Study|Randomized but didn't receive study drug|1|||
25159855|NCT01421511|50279848|FG001|Overall Study|Randomized but didn't receive study drug|7|||
25159856|NCT01421511|50279847|FG000|Overall Study|Physician Decision|0|||
25159857|NCT01421511|50279848|FG001|Overall Study|Physician Decision|1|||
25159858|NCT01421511|50279847|FG000|Overall Study|Withdrawal by Subject|6|||
25159859|NCT01421511|50279848|FG001|Overall Study|Withdrawal by Subject|5|||
25159860|NCT01421511|50279847|FG000|Overall Study|Death|1|||
25159861|NCT01421511|50279848|FG001|Overall Study|Death|1|||
25159862|NCT01864525|50279857|FG000|Overall Study|Adverse Event|1|||
25159863|NCT01864525|50279858|FG001|Overall Study|Adverse Event|0|||
25159864|NCT01421277|50279866|FG000|Overall Study|Lack of qualifying event|0|||
25159865|NCT01421277|50279867|FG001|Overall Study|Lack of qualifying event|61|||
25159866|NCT01421277|50279866|FG000|Overall Study|Incomplete baseline data|0|||
25159867|NCT01421277|50279867|FG001|Overall Study|Incomplete baseline data|31|||
25159868|NCT01891357|50279873|FG000|Overall Study|Protocol Violation|3|||
25159869|NCT01420965|50279880|FG000|Overall Study|Withdrawal by Subject|1|||
25159870|NCT01420965|50279881|FG001|Overall Study|Withdrawal by Subject|0|||
25159871|NCT01420965|50279882|FG002|Overall Study|Withdrawal by Subject|0|||
25159872|NCT01420965|50279880|FG000|Overall Study|Adverse Event|0|||
24947347|NCT00307437|50039727|FG006|After Controlled Period|Adverse Event|40|||
24947348|NCT00307437|50039721|FG000|After Controlled Period|Death|0|||
24947349|NCT00307437|50039722|FG001|After Controlled Period|Death|0|||
24947350|NCT00307437|50039723|FG002|After Controlled Period|Death|0|||
24947351|NCT00307437|50039724|FG003|After Controlled Period|Death|3|||
24947352|NCT00307437|50039725|FG004|After Controlled Period|Death|1|||
24947353|NCT00307437|50039726|FG005|After Controlled Period|Death|1|||
24947354|NCT00307437|50039727|FG006|After Controlled Period|Death|3|||
24947355|NCT00307437|50039721|FG000|After Controlled Period|Lack of Efficacy|0|||
24947356|NCT00307437|50039722|FG001|After Controlled Period|Lack of Efficacy|0|||
25159873|NCT01420965|50279881|FG001|Overall Study|Adverse Event|1|||
25159874|NCT01420965|50279882|FG002|Overall Study|Adverse Event|0|||
25159875|NCT01390389|50279892|FG000|Overall Study|Withdrawal by Subject|2|||
24947357|NCT00307437|50039723|FG002|After Controlled Period|Lack of Efficacy|0|||
24947358|NCT00307437|50039724|FG003|After Controlled Period|Lack of Efficacy|15|||
24947359|NCT00307437|50039725|FG004|After Controlled Period|Lack of Efficacy|17|||
24947360|NCT00307437|50039726|FG005|After Controlled Period|Lack of Efficacy|37|||
24947361|NCT00307437|50039727|FG006|After Controlled Period|Lack of Efficacy|24|||
24947362|NCT00307437|50039721|FG000|After Controlled Period|Lost to Follow-up|0|||
25037540|NCT00394355|50137736|FG001|Overall Study|Adverse Event|6|||
25037541|NCT00394355|50137737|FG002|Overall Study|Adverse Event|7|||
25159876|NCT01390389|50279893|FG001|Overall Study|Withdrawal by Subject|0|||
25159877|NCT01390389|50279892|FG000|Overall Study|Screen Fail|2|||
25159878|NCT01390389|50279893|FG001|Overall Study|Screen Fail|1|||
25159879|NCT01401465|50279905|FG000|Treatment Period 1|Adverse Event|4|||
24947363|NCT00307437|50039722|FG001|After Controlled Period|Lost to Follow-up|0|||
25159880|NCT01401465|50279906|FG001|Treatment Period 1|Adverse Event|1|||
25037542|NCT00394355|50137738|FG003|Overall Study|Adverse Event|8|||
25037543|NCT00394355|50137735|FG000|Overall Study|Did not meet protocol eligibility|1|||
25037544|NCT00394355|50137736|FG001|Overall Study|Did not meet protocol eligibility|5|||
25037545|NCT00394355|50137737|FG002|Overall Study|Did not meet protocol eligibility|4|||
25037546|NCT00394355|50137738|FG003|Overall Study|Did not meet protocol eligibility|2|||
25037547|NCT00394355|50137735|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
25037548|NCT00394355|50137736|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
25037549|NCT00394355|50137737|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
25037550|NCT00394355|50137738|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
25037551|NCT00394355|50137735|FG000|Overall Study|Subject withdrawal - related to drug|1|||
25037552|NCT00394355|50137736|FG001|Overall Study|Subject withdrawal - related to drug|0|||
25037553|NCT00394355|50137737|FG002|Overall Study|Subject withdrawal - related to drug|0|||
25037554|NCT00394355|50137738|FG003|Overall Study|Subject withdrawal - related to drug|0|||
25037555|NCT00394355|50137735|FG000|Overall Study|Lost to Follow-up|7|||
25037556|NCT00394355|50137736|FG001|Overall Study|Lost to Follow-up|5|||
25037557|NCT00394355|50137737|FG002|Overall Study|Lost to Follow-up|4|||
25037558|NCT00394355|50137738|FG003|Overall Study|Lost to Follow-up|3|||
25037559|NCT00394355|50137735|FG000|Overall Study|Noncompliance with protocol|4|||
25037560|NCT00394355|50137736|FG001|Overall Study|Noncompliance with protocol|3|||
25037561|NCT00394355|50137737|FG002|Overall Study|Noncompliance with protocol|10|||
25037562|NCT00394355|50137738|FG003|Overall Study|Noncompliance with protocol|8|||
25037563|NCT00394355|50137735|FG000|Overall Study|Administrative|0|||
25037564|NCT00394355|50137736|FG001|Overall Study|Administrative|1|||
25037565|NCT00394355|50137737|FG002|Overall Study|Administrative|1|||
25037566|NCT00394355|50137738|FG003|Overall Study|Administrative|1|||
25037567|NCT00394355|50137735|FG000|Overall Study|Lack of Efficacy|0|||
25037568|NCT00394355|50137736|FG001|Overall Study|Lack of Efficacy|0|||
25037569|NCT00394355|50137737|FG002|Overall Study|Lack of Efficacy|2|||
25037570|NCT00394355|50137738|FG003|Overall Study|Lack of Efficacy|3|||
25037571|NCT02797808|50137750|FG000|Overall Study|Withdrawal by Subject|1|||
25037572|NCT02797808|50137751|FG001|Overall Study|Withdrawal by Subject|1|||
25037573|NCT02797808|50137750|FG000|Overall Study|Physician Decision|6|||
25037574|NCT02797808|50137751|FG001|Overall Study|Physician Decision|2|||
25037575|NCT02796560|50137759|FG000|Overall Study|Adverse Event|2|||
25037576|NCT02796560|50137760|FG001|Overall Study|Adverse Event|0|||
25037577|NCT02796560|50137759|FG000|Overall Study|Withdrawal by Subject|2|||
25037578|NCT02796560|50137760|FG001|Overall Study|Withdrawal by Subject|2|||
25037579|NCT00344487|50137766|FG000|Overall Study|immunologic failure|1|||
25037580|NCT02871492|50137775|FG000|Overall Study|Lost to Follow-up|6|||
25037581|NCT02871492|50137776|FG001|Overall Study|Lost to Follow-up|3|||
25037582|NCT02871492|50137777|FG002|Overall Study|Lost to Follow-up|5|||
25037583|NCT02871492|50137775|FG000|Overall Study|Withdrawal by Subject|0|||
25037584|NCT02871492|50137776|FG001|Overall Study|Withdrawal by Subject|0|||
25037585|NCT02871492|50137777|FG002|Overall Study|Withdrawal by Subject|1|||
25037586|NCT03143855|50137787|FG000|Overall Study|Withdrawal by Subject|4|||
25037587|NCT03143855|50137788|FG001|Overall Study|Withdrawal by Subject|3|||
25037588|NCT03143855|50137787|FG000|Overall Study|Protocol Violation|1|||
25159881|NCT01401465|50279905|FG000|Treatment Period 1|Pregnancy|0|||
25159882|NCT01401465|50279906|FG001|Treatment Period 1|Pregnancy|1|||
25159883|NCT01401465|50279905|FG000|Treatment Period 1|Protocol Violation|5|||
24947364|NCT00307437|50039723|FG002|After Controlled Period|Lost to Follow-up|0|||
24947365|NCT00307437|50039724|FG003|After Controlled Period|Lost to Follow-up|7|||
24947366|NCT00307437|50039725|FG004|After Controlled Period|Lost to Follow-up|12|||
24947367|NCT00307437|50039726|FG005|After Controlled Period|Lost to Follow-up|13|||
24947368|NCT00307437|50039727|FG006|After Controlled Period|Lost to Follow-up|18|||
24947369|NCT00307437|50039721|FG000|After Controlled Period|Other|0|||
24947370|NCT00307437|50039722|FG001|After Controlled Period|Other|0|||
24947371|NCT00307437|50039723|FG002|After Controlled Period|Other|0|||
24947372|NCT00307437|50039724|FG003|After Controlled Period|Other|15|||
24947373|NCT00307437|50039725|FG004|After Controlled Period|Other|9|||
24947374|NCT00307437|50039726|FG005|After Controlled Period|Other|40|||
25037589|NCT03143855|50137788|FG001|Overall Study|Protocol Violation|0|||
25037590|NCT03143855|50137787|FG000|Overall Study|Participant experienced withdrawal|0|||
25037591|NCT03143855|50137788|FG001|Overall Study|Participant experienced withdrawal|1|||
25037592|NCT02878603|50137796|FG000|Overall Study|Lost to Follow-up|4|||
25037593|NCT02878603|50137797|FG001|Overall Study|Lost to Follow-up|1|||
25037594|NCT02878603|50137796|FG000|Overall Study|Withdrawal by Subject|1|||
25037595|NCT02878603|50137797|FG001|Overall Study|Withdrawal by Subject|1|||
25159884|NCT01401465|50279906|FG001|Treatment Period 1|Protocol Violation|0|||
24947375|NCT00307437|50039727|FG006|After Controlled Period|Other|28|||
24947376|NCT00440726|50039752|FG000|Phase 1|Dose-Limiting Toxicity|0|||
25037596|NCT02878603|50137796|FG000|Overall Study|Death|1|||
25037597|NCT02878603|50137797|FG001|Overall Study|Death|0|||
25037598|NCT02878603|50137796|FG000|Overall Study|Physician Decision|0|||
25037599|NCT02878603|50137797|FG001|Overall Study|Physician Decision|3|||
25037600|NCT01370408|50137803|FG000|Overall Study|treatment failure|9|||
25159885|NCT01401465|50279905|FG000|Treatment Period 1|Withdrawal by Subject|1|||
25037601|NCT03294109|50137809|FG000|Overall Study|Withdrawal by Subject|6|||
25037602|NCT03294109|50137810|FG001|Overall Study|Withdrawal by Subject|5|||
25275735|NCT01233869|50589546|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
25275736|NCT01233869|50589543|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
25275737|NCT01233869|50589544|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
25275738|NCT01233869|50589545|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
25159886|NCT01401465|50279906|FG001|Treatment Period 1|Withdrawal by Subject|4|||
25159887|NCT01401465|50279905|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
25159888|NCT01401465|50279906|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
25159889|NCT01401465|50279905|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
25159890|NCT01401465|50279906|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
25159891|NCT01401465|50279905|FG000|Treatment Period 1|Scheduling Difficulties|1|||
25159892|NCT01401465|50279906|FG001|Treatment Period 1|Scheduling Difficulties|1|||
25186243|NCT01473602|50336209|FG001|Overall Study|Death|1|||
25186244|NCT01473602|50336208|FG000|Overall Study|Lost to Follow-up|1|||
25186245|NCT01473602|50336209|FG001|Overall Study|Lost to Follow-up|1|||
24947377|NCT00440726|50039753|FG001|Phase 1|Dose-Limiting Toxicity|1|||
24947378|NCT00440726|50039754|FG002|Phase 1|Dose-Limiting Toxicity|0|||
24947379|NCT00440726|50039752|FG000|Phase 1|Physician Decision|1|||
24947380|NCT00440726|50039753|FG001|Phase 1|Physician Decision|0|||
24947381|NCT00440726|50039754|FG002|Phase 1|Physician Decision|0|||
24947382|NCT00440726|50039752|FG000|Phase 2|Death|0|||
24947383|NCT00440726|50039753|FG001|Phase 2|Death|0|||
24947384|NCT00440726|50039754|FG002|Phase 2|Death|1|||
24947385|NCT00440726|50039752|FG000|Phase 2|Adverse Event|0|||
24947386|NCT00440726|50039753|FG001|Phase 2|Adverse Event|0|||
25275739|NCT01233869|50589546|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
24947387|NCT00440726|50039754|FG002|Phase 2|Adverse Event|1|||
24947388|NCT00447590|50039765|FG000|Overall Study|Withdrawal by Subject|26|||
24947389|NCT00447590|50039765|FG000|Overall Study|Lost to Follow-up|24|||
24947390|NCT00447590|50039765|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
25159893|NCT01401465|50279905|FG000|Treatment Period 2|Lost to Follow-up|0|||
25159894|NCT01401465|50279906|FG001|Treatment Period 2|Lost to Follow-up|1|||
25159895|NCT01401465|50279905|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25159896|NCT01401465|50279906|FG001|Treatment Period 2|Withdrawal by Subject|1|||
25159897|NCT01401153|50279917|FG000|First Test Day|Learning disabilities; illness|1|||
25159898|NCT01401153|50279918|FG001|First Test Day|Learning disabilities; illness|10|||
25037609|NCT03132805|50137838|FG000|Overall Study|Lost to Follow-up|142|||
25037610|NCT03132805|50137839|FG001|Overall Study|Lost to Follow-up|141|||
25037611|NCT03132805|50137840|FG002|Overall Study|Lost to Follow-up|113|||
25037612|NCT02793128|50137848|FG000|Overall Study|Death|4|||
25037613|NCT02793128|50137848|FG000|Overall Study|Withdrawal by Subject|2|||
25037614|NCT02793128|50137848|FG000|Overall Study|Physician Decision|1|||
25037615|NCT02793128|50137848|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
25159899|NCT01401153|50279917|FG000|Second Test Day|illness|0|||
25159900|NCT01401153|50279918|FG001|Second Test Day|illness|5|||
25159901|NCT01890967|50279931|FG000|Overall Study|Adverse Event|3|||
25037616|NCT02793128|50137848|FG000|Overall Study|Patient elected nephroureterectomy|1|||
25037617|NCT02524171|50137862|FG000|6-month Follow-up|Lost to Follow-up|53|||
25037618|NCT02524171|50137863|FG001|6-month Follow-up|Lost to Follow-up|45|||
25037619|NCT02524171|50137862|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
25037620|NCT02524171|50137863|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
25037621|NCT03142451|50137871|FG000|Overall Study|Adverse Event|5|||
25037622|NCT03142451|50137872|FG001|Overall Study|Adverse Event|2|||
25037623|NCT03142451|50137871|FG000|Overall Study|Lost to Follow-up|25|||
25037624|NCT03142451|50137872|FG001|Overall Study|Lost to Follow-up|8|||
25037625|NCT03142451|50137871|FG000|Overall Study|Participant request|24|||
25037626|NCT03142451|50137872|FG001|Overall Study|Participant request|12|||
25037627|NCT03142451|50137871|FG000|Overall Study|Protocol Violation|3|||
25037628|NCT03142451|50137872|FG001|Overall Study|Protocol Violation|1|||
25037629|NCT03142451|50137871|FG000|Overall Study|Other|1|||
25037630|NCT03142451|50137872|FG001|Overall Study|Other|1|||
25037631|NCT03141905|50137880|FG000|Overall Study|Death|3|||
25037632|NCT03141905|50137881|FG001|Overall Study|Death|2|||
25037633|NCT03141905|50137880|FG000|Overall Study|Withdrawal by Subject|1|||
25037634|NCT03141905|50137881|FG001|Overall Study|Withdrawal by Subject|0|||
25037635|NCT03141905|50137880|FG000|Overall Study|Lost to Follow-up|3|||
25037636|NCT03141905|50137881|FG001|Overall Study|Lost to Follow-up|7|||
25037637|NCT03141905|50137880|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
25037638|NCT03141905|50137881|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
25037639|NCT01370018|50137888|FG000|Overall Study|Did not meet criteria for analysis|1|||
25037640|NCT04034355|50137894|FG000|Overall Study|Study terminated by Sponsor|10|||
25037641|NCT04034355|50137895|FG001|Overall Study|Study terminated by Sponsor|17|||
25037642|NCT04034355|50137894|FG000|Overall Study|Withdrawal by Subject|12|||
25037643|NCT04034355|50137895|FG001|Overall Study|Withdrawal by Subject|11|||
25037644|NCT04034355|50137894|FG000|Overall Study|Site terminated by Sponsor|4|||
24947391|NCT00447278|50039771|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
24947392|NCT00447278|50039772|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
24947393|NCT00447278|50039771|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
24947394|NCT00447278|50039772|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
24947395|NCT00447278|50039771|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
24947396|NCT00447278|50039772|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
25037645|NCT04034355|50137895|FG001|Overall Study|Site terminated by Sponsor|5|||
25037646|NCT04034355|50137894|FG000|Overall Study|Adverse Event|2|||
25037647|NCT04034355|50137895|FG001|Overall Study|Adverse Event|0|||
25037648|NCT04034355|50137894|FG000|Overall Study|Death|1|||
25037649|NCT04034355|50137895|FG001|Overall Study|Death|1|||
25037650|NCT04034355|50137894|FG000|Overall Study|Not reported|2|||
25037651|NCT04034355|50137895|FG001|Overall Study|Not reported|0|||
25037652|NCT04034355|50137894|FG000|Overall Study|Lost to Follow-up|1|||
25037653|NCT04034355|50137895|FG001|Overall Study|Lost to Follow-up|0|||
25037654|NCT04034355|50137894|FG000|Overall Study|Physician Decision|1|||
25037655|NCT04034355|50137895|FG001|Overall Study|Physician Decision|0|||
25159902|NCT01890967|50279932|FG001|Overall Study|Adverse Event|3|||
24947397|NCT00447278|50039771|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
25037656|NCT04034355|50137894|FG000|Overall Study|Protocol Violation|0|||
25037657|NCT04034355|50137895|FG001|Overall Study|Protocol Violation|1|||
25037658|NCT04034355|50137894|FG000|Overall Study|Progressive disease|1|||
25037659|NCT04034355|50137895|FG001|Overall Study|Progressive disease|0|||
25037660|NCT01336764|50137912|FG000|Overall Study|Withdrawal by Subject|5|||
25037661|NCT01336764|50137913|FG001|Overall Study|Withdrawal by Subject|5|||
25037662|NCT01336608|50137922|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
25037663|NCT01336608|50137923|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
25037664|NCT01336608|50137924|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
25159903|NCT01890967|50279933|FG002|Overall Study|Adverse Event|3|||
25159904|NCT01890967|50279934|FG003|Overall Study|Adverse Event|2|||
25159905|NCT01890967|50279935|FG004|Overall Study|Adverse Event|1|||
25037665|NCT01336608|50137925|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
25037666|NCT01336608|50137922|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
25037667|NCT01336608|50137923|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
25037668|NCT01336608|50137924|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
25037669|NCT01336608|50137925|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
25037670|NCT01336608|50137922|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
25037671|NCT01336608|50137923|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
25037672|NCT01336608|50137924|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
25037673|NCT01336608|50137925|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
25037674|NCT01336608|50137922|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
25037675|NCT01336608|50137923|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
25037676|NCT01336608|50137924|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
25159906|NCT01890967|50279936|FG005|Overall Study|Adverse Event|7|||
25159907|NCT01890967|50279931|FG000|Overall Study|Death|1|||
25159908|NCT01890967|50279932|FG001|Overall Study|Death|0|||
25037677|NCT01336608|50137925|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
25037678|NCT01336608|50137922|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
25037679|NCT01336608|50137923|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
25037680|NCT01336608|50137924|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
25037681|NCT01336608|50137925|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
25037682|NCT01336608|50137922|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
25037683|NCT01336608|50137923|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
25037684|NCT01336608|50137924|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
25037685|NCT01336608|50137925|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
25037686|NCT01336608|50137922|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
25037687|NCT01336608|50137923|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
25037688|NCT01336608|50137924|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
25037689|NCT01336608|50137925|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
25037690|NCT01336608|50137922|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
25037691|NCT01336608|50137923|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
25037692|NCT01336608|50137924|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
25037693|NCT01336608|50137925|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
25037694|NCT01336608|50137922|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
25037695|NCT01336608|50137923|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
25037696|NCT01336608|50137924|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
25037697|NCT01336608|50137925|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
25037698|NCT01336608|50137922|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
25037699|NCT01336608|50137923|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
25037700|NCT01336608|50137924|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
25037701|NCT01336608|50137925|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
25037702|NCT01336608|50137922|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
25037703|NCT01336608|50137923|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
25037704|NCT01336608|50137924|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
25037705|NCT01336608|50137925|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
25037706|NCT01336608|50137922|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
25037707|NCT01336608|50137923|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
25037708|NCT01336608|50137924|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
25037709|NCT01336608|50137925|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
25037710|NCT01336608|50137922|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
25037711|NCT01336608|50137923|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
25037712|NCT01336608|50137924|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
25037713|NCT01336608|50137925|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
25037714|NCT01346371|50137944|FG000|Overall Study|Lost to Follow-up|2|||
25037715|NCT01346371|50137945|FG001|Overall Study|Lost to Follow-up|0|||
25037716|NCT03644849|50137963|FG000|Overall Study|Lost to Follow-up|1|||
25037717|NCT03644849|50137964|FG001|Overall Study|Lost to Follow-up|3|||
25037718|NCT03131479|50137975|FG000|Overall Study|Adverse Event|0|||
25037719|NCT03131479|50137976|FG001|Overall Study|Adverse Event|0|||
25037720|NCT03131479|50137977|FG002|Overall Study|Adverse Event|1|||
25037721|NCT03131479|50137978|FG003|Overall Study|Adverse Event|1|||
25037722|NCT03131479|50137979|FG004|Overall Study|Adverse Event|0|||
25037723|NCT03131479|50137975|FG000|Overall Study|Subject/Guardian Decision|0|||
25037724|NCT03131479|50137976|FG001|Overall Study|Subject/Guardian Decision|0|||
25159909|NCT01890967|50279933|FG002|Overall Study|Death|0|||
25159910|NCT01890967|50279934|FG003|Overall Study|Death|0|||
25037725|NCT03131479|50137977|FG002|Overall Study|Subject/Guardian Decision|0|||
25159911|NCT01890967|50279935|FG004|Overall Study|Death|0|||
25037726|NCT03131479|50137978|FG003|Overall Study|Subject/Guardian Decision|1|||
25037727|NCT03131479|50137979|FG004|Overall Study|Subject/Guardian Decision|0|||
25037728|NCT03602885|50137993|FG000|Overall Study|Lost to Follow-up|3|||
25037729|NCT03602885|50137994|FG001|Overall Study|Lost to Follow-up|0|||
25037730|NCT02880761|50138002|FG000|Overall Study|Death|6|||
25037731|NCT02880761|50138003|FG001|Overall Study|Death|8|||
25037732|NCT02880761|50138002|FG000|Overall Study|Withdrawal by Subject|3|||
25037733|NCT02880761|50138003|FG001|Overall Study|Withdrawal by Subject|6|||
25037734|NCT02880761|50138002|FG000|Overall Study|Protocol Violation|4|||
25037735|NCT02880761|50138003|FG001|Overall Study|Protocol Violation|3|||
25037736|NCT02880761|50138002|FG000|Overall Study|Lost to Follow-up|3|||
25037737|NCT02880761|50138003|FG001|Overall Study|Lost to Follow-up|4|||
25037738|NCT02930941|50138011|FG000|Overall Study|Lost to Follow-up|1|||
25037739|NCT02930941|50138012|FG001|Overall Study|Lost to Follow-up|2|||
25037740|NCT03137537|50138024|FG000|Overall Study|Adverse Event|0|||
25037741|NCT03137537|50138025|FG001|Overall Study|Adverse Event|1|||
25037742|NCT03137459|50138033|FG000|2-month Assessment|Withdrawal by Subject|13|||
25037743|NCT03137459|50138034|FG001|2-month Assessment|Withdrawal by Subject|3|||
25037744|NCT03137459|50138033|FG000|2-month Assessment|Unable to reach|42|||
25037745|NCT03137459|50138034|FG001|2-month Assessment|Unable to reach|32|||
25037746|NCT03137459|50138033|FG000|2-month Assessment|Refused assessment|7|||
25037747|NCT03137459|50138034|FG001|2-month Assessment|Refused assessment|5|||
25037748|NCT03137459|50138033|FG000|2-month Assessment|Acutely ill|6|||
25037749|NCT03137459|50138034|FG001|2-month Assessment|Acutely ill|2|||
25037750|NCT03137459|50138033|FG000|4-month Assessment|Death|4|||
25037751|NCT03137459|50138034|FG001|4-month Assessment|Death|2|||
25037752|NCT03137459|50138033|FG000|4-month Assessment|Withdrawal by Subject|4|||
25037753|NCT03137459|50138034|FG001|4-month Assessment|Withdrawal by Subject|2|||
25037754|NCT03137459|50138033|FG000|4-month Assessment|Unable to reach|44|||
25037755|NCT03137459|50138034|FG001|4-month Assessment|Unable to reach|29|||
25037756|NCT03137459|50138033|FG000|4-month Assessment|Refused assessment|24|||
25037757|NCT03137459|50138034|FG001|4-month Assessment|Refused assessment|10|||
25037758|NCT03137459|50138033|FG000|4-month Assessment|Acutely ill|2|||
24947398|NCT00447278|50039772|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
24947399|NCT00447278|50039771|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
24947400|NCT00447278|50039772|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
24947401|NCT00447278|50039771|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
24947402|NCT00447278|50039772|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
24947403|NCT00447278|50039771|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
24947404|NCT00447278|50039772|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
24947405|NCT00447278|50039771|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
24947406|NCT00447278|50039772|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
24947407|NCT00447278|50039771|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
24947408|NCT00447278|50039772|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
24947409|NCT00447278|50039771|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
24947410|NCT00447278|50039772|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
24947411|NCT00447278|50039771|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
24947412|NCT00447278|50039772|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
24947413|NCT00447278|50039771|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
24947414|NCT00447278|50039772|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
24947415|NCT00447278|50039771|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
24947416|NCT00447278|50039772|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
24947417|NCT00447278|50039771|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
24947418|NCT00447278|50039772|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
24947419|NCT00446966|50039781|FG000|Overall Study|Lost to Follow-up|10|||
24947420|NCT00446966|50039782|FG001|Overall Study|Lost to Follow-up|7|||
24947421|NCT00446654|50039790|FG000|Overall Study|Withdrawal by Subject|1|||
24947422|NCT00446654|50039791|FG001|Overall Study|Withdrawal by Subject|0|||
24947423|NCT00446654|50039790|FG000|Overall Study|Adverse Event|1|||
24947424|NCT00446654|50039791|FG001|Overall Study|Adverse Event|0|||
24947425|NCT00405756|50039800|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
24947426|NCT00405756|50039801|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
24947427|NCT00405756|50039802|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
24947428|NCT00405756|50039800|FG000|Double-blind Treatment|Adverse Event|31|||
24947429|NCT00405756|50039801|FG001|Double-blind Treatment|Adverse Event|27|||
24947430|NCT00405756|50039802|FG002|Double-blind Treatment|Adverse Event|12|||
25037759|NCT03137459|50138034|FG001|4-month Assessment|Acutely ill|3|||
25037760|NCT03137459|50138033|FG000|6-months|Lost to Follow-up|14|||
25037761|NCT03137459|50138034|FG001|6-months|Lost to Follow-up|11|||
25037762|NCT03137459|50138033|FG000|6-months|Death|0|||
25037763|NCT03137459|50138034|FG001|6-months|Death|2|||
25037764|NCT03137459|50138033|FG000|6-months|Refused assessment|6|||
25037765|NCT03137459|50138034|FG001|6-months|Refused assessment|3|||
25037766|NCT03137459|50138033|FG000|6-months|Acutely ill|1|||
25037767|NCT03137459|50138034|FG001|6-months|Acutely ill|1|||
25037768|NCT03131713|50138043|FG000|Overall Study|Lost to Follow-up|5|||
25037769|NCT03131713|50138044|FG001|Overall Study|Lost to Follow-up|0|||
25037770|NCT02930005|50138052|FG000|Overall Study|Lost to Follow-up|1|||
25037771|NCT02930005|50138053|FG001|Overall Study|Lost to Follow-up|5|||
25037772|NCT03637491|50138063|FG000|Overall Study|Death|9|||
25037773|NCT03637491|50138064|FG001|Overall Study|Death|9|||
25037774|NCT03637491|50138065|FG002|Overall Study|Death|5|||
25037775|NCT03637491|50138066|FG003|Overall Study|Death|3|||
25037776|NCT03637491|50138063|FG000|Overall Study|Lost to Follow-up|0|||
25037777|NCT03637491|50138064|FG001|Overall Study|Lost to Follow-up|1|||
25037778|NCT03637491|50138065|FG002|Overall Study|Lost to Follow-up|0|||
25037779|NCT03637491|50138066|FG003|Overall Study|Lost to Follow-up|1|||
25037780|NCT03637491|50138063|FG000|Overall Study|Study Terminated By Sponsor|0|||
25037781|NCT03637491|50138064|FG001|Overall Study|Study Terminated By Sponsor|2|||
25037782|NCT03637491|50138065|FG002|Overall Study|Study Terminated By Sponsor|1|||
25037783|NCT03637491|50138066|FG003|Overall Study|Study Terminated By Sponsor|0|||
25037784|NCT03637491|50138063|FG000|Overall Study|Withdrawal by Subject|1|||
25037785|NCT03637491|50138064|FG001|Overall Study|Withdrawal by Subject|0|||
25037786|NCT03637491|50138065|FG002|Overall Study|Withdrawal by Subject|1|||
25037787|NCT03637491|50138066|FG003|Overall Study|Withdrawal by Subject|2|||
25037788|NCT03334539|50138100|FG000|Overall Study|Adverse Event|3|||
25037789|NCT03334539|50138101|FG001|Overall Study|Adverse Event|5|||
25037790|NCT03334539|50138102|FG002|Overall Study|Adverse Event|0|||
25037791|NCT03334539|50138100|FG000|Overall Study|Withdrawal by Subject|0|||
25037792|NCT03334539|50138101|FG001|Overall Study|Withdrawal by Subject|1|||
25037793|NCT03334539|50138102|FG002|Overall Study|Withdrawal by Subject|1|||
25037794|NCT03334539|50138100|FG000|Overall Study|Administrative Reasons|1|||
25037795|NCT03334539|50138101|FG001|Overall Study|Administrative Reasons|0|||
25037796|NCT03334539|50138102|FG002|Overall Study|Administrative Reasons|0|||
25037797|NCT03334539|50138100|FG000|Overall Study|Hypertension Not Controlled|0|||
25037798|NCT03334539|50138101|FG001|Overall Study|Hypertension Not Controlled|1|||
25037799|NCT03334539|50138102|FG002|Overall Study|Hypertension Not Controlled|0|||
25037800|NCT03137303|50138117|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
25037801|NCT03137303|50138118|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
25037802|NCT03137303|50138117|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
25037803|NCT03137303|50138118|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
25037804|NCT03137303|50138117|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
25037805|NCT03137303|50138118|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
25037806|NCT03137303|50138117|FG000|T3: 9-month Follow-up|Death|1|||
25037807|NCT03137303|50138118|FG001|T3: 9-month Follow-up|Death|0|||
25037808|NCT03137303|50138117|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
25037809|NCT03137303|50138118|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
25037810|NCT03137303|50138117|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
25037811|NCT03137303|50138118|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
25037812|NCT03137303|50138117|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
25037813|NCT03137303|50138118|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
25037814|NCT03296553|50138126|FG000|Overall Study|Withdrawal by Subject|1|||
25037815|NCT03296553|50138127|FG001|Overall Study|Withdrawal by Subject|1|||
25037816|NCT03296553|50138126|FG000|Overall Study|Death|1|||
25037817|NCT03296553|50138127|FG001|Overall Study|Death|0|||
25037818|NCT03131167|50138146|FG000|Overall Study|Other (Unspecified)|0|||
25037819|NCT03131167|50138147|FG001|Overall Study|Other (Unspecified)|0|||
25037820|NCT03131167|50138148|FG002|Overall Study|Other (Unspecified)|0|||
25037821|NCT03131167|50138149|FG003|Overall Study|Other (Unspecified)|0|||
25037822|NCT03131167|50138150|FG004|Overall Study|Other (Unspecified)|0|||
25037823|NCT03131167|50138151|FG005|Overall Study|Other (Unspecified)|1|||
25037824|NCT03131167|50138152|FG006|Overall Study|Other (Unspecified)|0|||
25037825|NCT03131167|50138153|FG007|Overall Study|Other (Unspecified)|0|||
25037826|NCT03131167|50138154|FG008|Overall Study|Other (Unspecified)|0|||
25037827|NCT03131167|50138155|FG009|Overall Study|Other (Unspecified)|0|||
25037828|NCT03131167|50138156|FG010|Overall Study|Other (Unspecified)|0|||
25037829|NCT03131167|50138157|FG011|Overall Study|Other (Unspecified)|0|||
25037830|NCT03131167|50138158|FG012|Overall Study|Other (Unspecified)|0|||
25037831|NCT03060447|50138189|FG000|Overall Study|Withdrawal by Subject|2|||
25037832|NCT03060447|50138190|FG001|Overall Study|Withdrawal by Subject|0|||
25037833|NCT01712789|50138202|FG000|Overall Study|Lack of Efficacy|2|||
25037834|NCT01712789|50138202|FG000|Overall Study|Lost to Follow-up|1|||
25037835|NCT01712789|50138202|FG000|Overall Study|Progressive Disease|504|||
25037836|NCT01712789|50138202|FG000|Overall Study|Death|57|||
25037837|NCT01712789|50138202|FG000|Overall Study|Adverse Event|52|||
25037838|NCT01712789|50138202|FG000|Overall Study|Miscellaneous|31|||
25037839|NCT01712789|50138202|FG000|Overall Study|Withdrawal by Subject|21|||
25037840|NCT01712789|50138202|FG000|Overall Study|Transition to Commercial Treatment|8|||
25037841|NCT01712789|50138202|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
25037842|NCT02978781|50138209|FG000|Part A|Adverse Event|1|||
25037843|NCT02978781|50138210|FG001|Part A|Adverse Event|1|||
25037844|NCT02978781|50138211|FG002|Part A|Adverse Event|0|||
25037845|NCT02978781|50138212|FG003|Part A|Adverse Event|0|||
25037846|NCT02978781|50138213|FG004|Part A|Adverse Event|0|||
25037847|NCT02978781|50138209|FG000|Part A|Withdrawal by Subject|0|||
25037848|NCT02978781|50138210|FG001|Part A|Withdrawal by Subject|1|||
25037849|NCT02978781|50138211|FG002|Part A|Withdrawal by Subject|0|||
25037850|NCT02978781|50138212|FG003|Part A|Withdrawal by Subject|0|||
25037851|NCT02978781|50138213|FG004|Part A|Withdrawal by Subject|0|||
25037852|NCT02978781|50138209|FG000|Part B|Withdrawal by Subject|0|||
25037853|NCT02978781|50138210|FG001|Part B|Withdrawal by Subject|0|||
25037854|NCT02978781|50138211|FG002|Part B|Withdrawal by Subject|0|||
25037855|NCT02978781|50138212|FG003|Part B|Withdrawal by Subject|1|||
25037856|NCT02978781|50138213|FG004|Part B|Withdrawal by Subject|0|||
25037857|NCT02978781|50138209|FG000|Part C|Adverse Event|0|||
25037858|NCT02978781|50138210|FG001|Part C|Adverse Event|0|||
25037859|NCT02978781|50138211|FG002|Part C|Adverse Event|0|||
25037860|NCT02978781|50138212|FG003|Part C|Adverse Event|0|||
25037861|NCT02978781|50138213|FG004|Part C|Adverse Event|2|||
25037862|NCT02978781|50138209|FG000|Part C|Withdrawal by Subject|0|||
25037863|NCT02978781|50138210|FG001|Part C|Withdrawal by Subject|0|||
25037864|NCT02978781|50138211|FG002|Part C|Withdrawal by Subject|0|||
24947431|NCT00405756|50039800|FG000|Double-blind Treatment|Disease Progression|47|||
24947432|NCT00405756|50039801|FG001|Double-blind Treatment|Disease Progression|81|||
24947433|NCT00405756|50039802|FG002|Double-blind Treatment|Disease Progression|102|||
24947434|NCT00405756|50039800|FG000|Double-blind Treatment|Lack of Efficacy|1|||
24947435|NCT00405756|50039801|FG001|Double-blind Treatment|Lack of Efficacy|4|||
24947436|NCT00405756|50039802|FG002|Double-blind Treatment|Lack of Efficacy|2|||
24947437|NCT00405756|50039800|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
24947438|NCT00405756|50039801|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
24947439|NCT00405756|50039802|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
24947440|NCT00405756|50039800|FG000|Double-blind Treatment|Lost to Follow-up|1|||
24947441|NCT00405756|50039801|FG001|Double-blind Treatment|Lost to Follow-up|0|||
24947442|NCT00405756|50039802|FG002|Double-blind Treatment|Lost to Follow-up|0|||
24947443|NCT00405756|50039800|FG000|Double-blind Treatment|Death|4|||
24947444|NCT00405756|50039801|FG001|Double-blind Treatment|Death|4|||
24947445|NCT00405756|50039802|FG002|Double-blind Treatment|Death|4|||
24947446|NCT00405756|50039800|FG000|Double-blind Treatment|Protocol Violation|1|||
24947447|NCT00405756|50039801|FG001|Double-blind Treatment|Protocol Violation|0|||
24947448|NCT00405756|50039802|FG002|Double-blind Treatment|Protocol Violation|2|||
24947449|NCT00405756|50039800|FG000|Double-blind Treatment|Other|7|||
24947450|NCT00405756|50039801|FG001|Double-blind Treatment|Other|4|||
24947451|NCT00405756|50039802|FG002|Double-blind Treatment|Other|4|||
25037865|NCT02978781|50138212|FG003|Part C|Withdrawal by Subject|0|||
25037866|NCT02978781|50138213|FG004|Part C|Withdrawal by Subject|1|||
25037867|NCT02978781|50138209|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
25037868|NCT02978781|50138210|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
25037869|NCT02978781|50138211|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
24947452|NCT00405756|50039800|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
24947453|NCT00405756|50039801|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
24947454|NCT00405756|50039802|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
24947455|NCT00405756|50039800|FG000|Open-label Extension|Adverse Event|1|||
24947456|NCT00405756|50039801|FG001|Open-label Extension|Adverse Event|3|||
24947457|NCT00405756|50039802|FG002|Open-label Extension|Adverse Event|7|||
24947458|NCT00405756|50039800|FG000|Open-label Extension|Disease Progression|8|||
24947459|NCT00405756|50039801|FG001|Open-label Extension|Disease Progression|23|||
24947460|NCT00405756|50039802|FG002|Open-label Extension|Disease Progression|26|||
24947461|NCT00405756|50039800|FG000|Open-label Extension|Withdrawal by Subject|2|||
24947462|NCT00405756|50039801|FG001|Open-label Extension|Withdrawal by Subject|3|||
24947463|NCT00405756|50039802|FG002|Open-label Extension|Withdrawal by Subject|3|||
24947464|NCT00405756|50039800|FG000|Open-label Extension|Death|1|||
24947465|NCT00405756|50039801|FG001|Open-label Extension|Death|2|||
24947466|NCT00405756|50039802|FG002|Open-label Extension|Death|4|||
24947467|NCT00405756|50039800|FG000|Open-label Extension|Other|0|||
24947468|NCT00405756|50039801|FG001|Open-label Extension|Other|1|||
24947469|NCT00405756|50039802|FG002|Open-label Extension|Other|7|||
24947470|NCT00405756|50039800|FG000|Follow-up|Ongoing in Follow-up Period|52|||
24947471|NCT00405756|50039801|FG001|Follow-up|Ongoing in Follow-up Period|51|||
25037870|NCT02978781|50138212|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
25037871|NCT02978781|50138213|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
24947472|NCT00405756|50039802|FG002|Follow-up|Ongoing in Follow-up Period|60|||
24947473|NCT00405756|50039800|FG000|Follow-up|Death|21|||
24947474|NCT00405756|50039801|FG001|Follow-up|Death|31|||
24947475|NCT00405756|50039802|FG002|Follow-up|Death|24|||
24947476|NCT00405756|50039800|FG000|Follow-up|Lost to Follow-up|2|||
25037872|NCT03074318|50138243|FG000|Overall Study|Adverse Event|0|||
25037873|NCT03074318|50138244|FG001|Overall Study|Adverse Event|1|||
25037874|NCT03074318|50138245|FG002|Overall Study|Adverse Event|1|||
24947477|NCT00405756|50039801|FG001|Follow-up|Lost to Follow-up|8|||
24947478|NCT00405756|50039802|FG002|Follow-up|Lost to Follow-up|4|||
25037875|NCT03074318|50138246|FG003|Overall Study|Adverse Event|1|||
24947479|NCT00456092|50039813|FG000|Extension Phase|Grade 2 or Greater AE|2|||
24947480|NCT00456092|50039814|FG001|Extension Phase|Grade 2 or Greater AE|2|||
25159912|NCT01890967|50279936|FG005|Overall Study|Death|0|||
25159913|NCT01890967|50279931|FG000|Overall Study|Lost to Follow-up|1|||
25159914|NCT01890967|50279932|FG001|Overall Study|Lost to Follow-up|1|||
25159915|NCT01890967|50279933|FG002|Overall Study|Lost to Follow-up|1|||
25159916|NCT01890967|50279934|FG003|Overall Study|Lost to Follow-up|1|||
25159917|NCT01890967|50279935|FG004|Overall Study|Lost to Follow-up|0|||
25159918|NCT01890967|50279936|FG005|Overall Study|Lost to Follow-up|1|||
25159919|NCT01890967|50279931|FG000|Overall Study|Protocol Violation|0|||
25159920|NCT01890967|50279932|FG001|Overall Study|Protocol Violation|3|||
25186246|NCT01473602|50336208|FG000|Overall Study|Withdrawal by Subject|5|||
25186247|NCT01473602|50336209|FG001|Overall Study|Withdrawal by Subject|4|||
25186248|NCT01473602|50336208|FG000|Overall Study|Physician Decision|1|||
25037876|NCT03074318|50138243|FG000|Overall Study|Death|1|||
25037877|NCT03074318|50138244|FG001|Overall Study|Death|0|||
25037878|NCT03074318|50138245|FG002|Overall Study|Death|0|||
25186249|NCT01473602|50336209|FG001|Overall Study|Physician Decision|0|||
25186250|NCT01496612|50336217|FG000|1st Intervention|Adverse Event|1|||
25186251|NCT01496612|50336218|FG001|1st Intervention|Adverse Event|0|||
25186252|NCT01496612|50336217|FG000|1st Intervention|Withdrawal by Subject|1|||
25186253|NCT01496612|50336218|FG001|1st Intervention|Withdrawal by Subject|0|||
25037879|NCT03074318|50138246|FG003|Overall Study|Death|0|||
25037880|NCT03074318|50138243|FG000|Overall Study|Withdrawal by Subject|1|||
25037881|NCT03074318|50138244|FG001|Overall Study|Withdrawal by Subject|2|||
24947481|NCT00456092|50039815|FG002|Extension Phase|Grade 2 or Greater AE|0|||
24947482|NCT00456092|50039816|FG003|Extension Phase|Grade 2 or Greater AE|0|||
24947483|NCT00456092|50039817|FG004|Extension Phase|Grade 2 or Greater AE|2|||
24947484|NCT00456092|50039813|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
24947485|NCT00456092|50039814|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
24947486|NCT00456092|50039815|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
24947487|NCT00456092|50039816|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
24947488|NCT00456092|50039817|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
24947489|NCT00456092|50039813|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
24947490|NCT00456092|50039814|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
24947491|NCT00456092|50039815|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
24947492|NCT00456092|50039816|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
24947493|NCT00456092|50039817|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
24947494|NCT00456092|50039813|FG000|Extension Phase|Withdrew Consent|2|||
24947495|NCT00456092|50039814|FG001|Extension Phase|Withdrew Consent|0|||
24947496|NCT00456092|50039815|FG002|Extension Phase|Withdrew Consent|0|||
24947497|NCT00456092|50039816|FG003|Extension Phase|Withdrew Consent|0|||
24947498|NCT00456092|50039817|FG004|Extension Phase|Withdrew Consent|0|||
24947499|NCT00456092|50039813|FG000|Extension Phase|Lost to Follow-up|1|||
24947500|NCT00456092|50039814|FG001|Extension Phase|Lost to Follow-up|1|||
24947501|NCT00456092|50039815|FG002|Extension Phase|Lost to Follow-up|0|||
24947502|NCT00456092|50039816|FG003|Extension Phase|Lost to Follow-up|0|||
24947503|NCT00456092|50039817|FG004|Extension Phase|Lost to Follow-up|1|||
24947504|NCT00456092|50039813|FG000|Extension Phase|Other|2|||
24947505|NCT00456092|50039814|FG001|Extension Phase|Other|0|||
24947506|NCT00456092|50039815|FG002|Extension Phase|Other|0|||
24947507|NCT00456092|50039816|FG003|Extension Phase|Other|1|||
24947508|NCT00456092|50039817|FG004|Extension Phase|Other|1|||
24947509|NCT00456092|50039813|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
24947510|NCT00456092|50039814|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
24947511|NCT00456092|50039815|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
24947512|NCT00456092|50039816|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
24947513|NCT00456092|50039817|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
24947514|NCT00456092|50039813|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
24947515|NCT00456092|50039814|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
25037882|NCT03074318|50138245|FG002|Overall Study|Withdrawal by Subject|2|||
25037883|NCT03074318|50138246|FG003|Overall Study|Withdrawal by Subject|4|||
24947516|NCT00456092|50039815|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
25037884|NCT03074318|50138243|FG000|Overall Study|Trial Closure|2|||
25159921|NCT01890967|50279933|FG002|Overall Study|Protocol Violation|3|||
25159922|NCT01890967|50279934|FG003|Overall Study|Protocol Violation|2|||
25037885|NCT03074318|50138244|FG001|Overall Study|Trial Closure|2|||
25037886|NCT03074318|50138245|FG002|Overall Study|Trial Closure|3|||
25037887|NCT03074318|50138246|FG003|Overall Study|Trial Closure|11|||
25037888|NCT03135119|50138267|FG000|Overall Study|Lost to Follow-up|2|||
25159923|NCT01890967|50279935|FG004|Overall Study|Protocol Violation|4|||
25037889|NCT03135119|50138268|FG001|Overall Study|Lost to Follow-up|0|||
25037890|NCT03135119|50138267|FG000|Overall Study|Physician Decision|1|||
25037891|NCT03135119|50138268|FG001|Overall Study|Physician Decision|1|||
25037892|NCT03135119|50138267|FG000|Overall Study|COVID-19 Shutdown|2|||
25037893|NCT03135119|50138268|FG001|Overall Study|COVID-19 Shutdown|2|||
25037894|NCT01369784|50138274|FG000|Overall Study|Protocol Violation|12|||
25037895|NCT03353675|50138278|FG000|Overall Study|Adverse Event|4|||
25037896|NCT03137069|50138288|FG000|Overall Study|Withdrawal by Subject|1|||
25037897|NCT03137069|50138289|FG001|Overall Study|Withdrawal by Subject|2|||
25037898|NCT03137069|50138290|FG002|Overall Study|Withdrawal by Subject|2|||
25037899|NCT03137069|50138291|FG003|Overall Study|Withdrawal by Subject|2|||
25037900|NCT03137069|50138292|FG004|Overall Study|Withdrawal by Subject|0|||
25037901|NCT03137069|50138293|FG005|Overall Study|Withdrawal by Subject|0|||
25037902|NCT03137069|50138288|FG000|Overall Study|Adverse Event|0|||
25037903|NCT03137069|50138289|FG001|Overall Study|Adverse Event|3|||
25037904|NCT03137069|50138290|FG002|Overall Study|Adverse Event|1|||
25037905|NCT03137069|50138291|FG003|Overall Study|Adverse Event|1|||
25037906|NCT03137069|50138292|FG004|Overall Study|Adverse Event|0|||
25037907|NCT03137069|50138293|FG005|Overall Study|Adverse Event|1|||
25037908|NCT03137069|50138288|FG000|Overall Study|Protocol Violation|0|||
25037909|NCT03137069|50138289|FG001|Overall Study|Protocol Violation|1|||
25037910|NCT03137069|50138290|FG002|Overall Study|Protocol Violation|0|||
25037911|NCT03137069|50138291|FG003|Overall Study|Protocol Violation|1|||
25037912|NCT03137069|50138292|FG004|Overall Study|Protocol Violation|1|||
25037913|NCT03137069|50138293|FG005|Overall Study|Protocol Violation|1|||
25037914|NCT03137069|50138288|FG000|Overall Study|Physician Decision|0|||
25037915|NCT03137069|50138289|FG001|Overall Study|Physician Decision|0|||
25037916|NCT03137069|50138290|FG002|Overall Study|Physician Decision|0|||
25037917|NCT03137069|50138291|FG003|Overall Study|Physician Decision|1|||
25037918|NCT03137069|50138292|FG004|Overall Study|Physician Decision|0|||
25037919|NCT03137069|50138293|FG005|Overall Study|Physician Decision|0|||
25037920|NCT03137069|50138288|FG000|Overall Study|Study Terminated by Sponsor|0|||
25037921|NCT03137069|50138289|FG001|Overall Study|Study Terminated by Sponsor|0|||
25037922|NCT03137069|50138290|FG002|Overall Study|Study Terminated by Sponsor|0|||
25037923|NCT03137069|50138291|FG003|Overall Study|Study Terminated by Sponsor|0|||
25037924|NCT03137069|50138292|FG004|Overall Study|Study Terminated by Sponsor|1|||
25037925|NCT03137069|50138293|FG005|Overall Study|Study Terminated by Sponsor|0|||
25037926|NCT03137069|50138288|FG000|Overall Study|Data Entry Error|0|||
25037927|NCT03137069|50138289|FG001|Overall Study|Data Entry Error|0|||
25037928|NCT03137069|50138290|FG002|Overall Study|Data Entry Error|0|||
25037929|NCT03137069|50138291|FG003|Overall Study|Data Entry Error|1|||
25037930|NCT03137069|50138292|FG004|Overall Study|Data Entry Error|0|||
25037931|NCT03137069|50138293|FG005|Overall Study|Data Entry Error|0|||
25037932|NCT02792504|50138311|FG000|Overall Study|Lost to Follow-up|24|||
25037933|NCT02792504|50138311|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
25037934|NCT03124459|50138321|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
25037935|NCT03124459|50138322|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
25037936|NCT03124459|50138323|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
25037937|NCT03124459|50138324|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
25037938|NCT03124459|50138325|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
25159924|NCT01890967|50279936|FG005|Overall Study|Protocol Violation|1|||
25186254|NCT00790218|50336235|FG000|Overall Study|Death|1|||
25037939|NCT03124459|50138326|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
25037940|NCT03124459|50138321|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
25037941|NCT03124459|50138322|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
25037942|NCT03124459|50138323|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
25037943|NCT03124459|50138324|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
25159925|NCT01890967|50279931|FG000|Overall Study|Sponsor Decision|2|||
25037944|NCT03124459|50138325|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
25037945|NCT03124459|50138326|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
25037946|NCT03124459|50138321|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
25037947|NCT03124459|50138322|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
25159926|NCT01890967|50279932|FG001|Overall Study|Sponsor Decision|0|||
25159927|NCT01890967|50279933|FG002|Overall Study|Sponsor Decision|1|||
25037948|NCT03124459|50138323|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
25159928|NCT01890967|50279934|FG003|Overall Study|Sponsor Decision|3|||
25159929|NCT01890967|50279935|FG004|Overall Study|Sponsor Decision|2|||
25159930|NCT01890967|50279936|FG005|Overall Study|Sponsor Decision|3|||
25159931|NCT01890967|50279931|FG000|Overall Study|Withdrawal by Subject|3|||
25159932|NCT01890967|50279932|FG001|Overall Study|Withdrawal by Subject|4|||
25037949|NCT03124459|50138324|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
25037950|NCT03124459|50138325|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
25037951|NCT03124459|50138326|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
25037952|NCT03124459|50138321|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
25037953|NCT03124459|50138322|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
25037954|NCT03124459|50138323|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
25037955|NCT03124459|50138324|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
25037956|NCT03124459|50138325|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
25037957|NCT03124459|50138326|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
25037958|NCT03124459|50138321|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
25037959|NCT03124459|50138322|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
25037960|NCT03124459|50138323|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
25037961|NCT03124459|50138324|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
25037962|NCT03124459|50138325|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
25037963|NCT03124459|50138326|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
25037964|NCT03124459|50138321|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
25037965|NCT03124459|50138322|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
25037966|NCT03124459|50138323|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
24947517|NCT00456092|50039816|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
24947518|NCT00456092|50039817|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
24947519|NCT00456092|50039813|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
24947520|NCT00456092|50039814|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
24947521|NCT00456092|50039815|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
24947522|NCT00456092|50039816|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
24947523|NCT00456092|50039817|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
24947524|NCT00456092|50039813|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
24947525|NCT00456092|50039814|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
24947526|NCT00456092|50039815|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
25186255|NCT00790218|50336236|FG001|Overall Study|Death|0|||
25186256|NCT00790218|50336237|FG002|Overall Study|Death|0|||
25037967|NCT03124459|50138324|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
25159933|NCT01890967|50279933|FG002|Overall Study|Withdrawal by Subject|2|||
25037968|NCT03124459|50138325|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
25037969|NCT03124459|50138326|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
25037970|NCT03134183|50138341|FG000|Overall Study|Withdrawal by Subject|1|||
25037971|NCT03134183|50138342|FG001|Overall Study|Withdrawal by Subject|1|||
25037972|NCT03136367|50138351|FG000|T1 Consultation|discontinued mistakenly included|2|||
25037973|NCT03136367|50138352|FG001|T1 Consultation|discontinued mistakenly included|6|||
25037974|NCT03136367|50138353|FG002|T1 Consultation|discontinued mistakenly included|1|||
25037975|NCT03136367|50138351|FG000|T1 Consultation|Discontinued other|0|||
25037976|NCT03136367|50138352|FG001|T1 Consultation|Discontinued other|1|||
25037977|NCT03136367|50138353|FG002|T1 Consultation|Discontinued other|0|||
25159934|NCT01890967|50279934|FG003|Overall Study|Withdrawal by Subject|3|||
25159935|NCT01890967|50279935|FG004|Overall Study|Withdrawal by Subject|3|||
25037978|NCT03136367|50138351|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
25037979|NCT03136367|50138352|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
25037980|NCT03136367|50138353|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
25037981|NCT03136367|50138351|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
25037982|NCT03136367|50138352|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
25037983|NCT03136367|50138353|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
25037984|NCT03136367|50138351|FG000|T2 Post-consultation|Discontinued other|0|||
25037985|NCT03136367|50138352|FG001|T2 Post-consultation|Discontinued other|2|||
25037986|NCT03136367|50138353|FG002|T2 Post-consultation|Discontinued other|6|||
25037987|NCT03136367|50138351|FG000|T2 Post-consultation|Discontinued transferred care|0|||
25037988|NCT03136367|50138352|FG001|T2 Post-consultation|Discontinued transferred care|0|||
25037989|NCT03136367|50138353|FG002|T2 Post-consultation|Discontinued transferred care|3|||
25037990|NCT03136367|50138351|FG000|T2 Post-consultation|Discontinued lost contact|0|||
25037991|NCT03136367|50138352|FG001|T2 Post-consultation|Discontinued lost contact|1|||
25037992|NCT03136367|50138353|FG002|T2 Post-consultation|Discontinued lost contact|0|||
25037993|NCT03136367|50138351|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
25037994|NCT03136367|50138352|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
25037995|NCT03136367|50138353|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
25037996|NCT03136367|50138351|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
25037997|NCT03136367|50138352|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
25037998|NCT03136367|50138353|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
25037999|NCT03136367|50138351|FG000|T3 1 Week After Surgery|other discontinued|2|||
25038000|NCT03136367|50138352|FG001|T3 1 Week After Surgery|other discontinued|4|||
25038001|NCT03136367|50138353|FG002|T3 1 Week After Surgery|other discontinued|3|||
25038002|NCT03136367|50138351|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
25038003|NCT03136367|50138352|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
25038004|NCT03136367|50138353|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
25038005|NCT03136367|50138351|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
25038006|NCT03136367|50138352|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
25038007|NCT03136367|50138353|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
25038008|NCT03136367|50138351|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
25038009|NCT03136367|50138352|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
25038010|NCT03136367|50138353|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
25038011|NCT03136367|50138351|FG000|T4 12 Weeks After Surgery|Death|0|||
25038012|NCT03136367|50138352|FG001|T4 12 Weeks After Surgery|Death|1|||
25038013|NCT03136367|50138353|FG002|T4 12 Weeks After Surgery|Death|3|||
25038014|NCT03136367|50138351|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
25038015|NCT03136367|50138352|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
25038016|NCT03136367|50138353|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
25038017|NCT03136367|50138351|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
25038018|NCT03136367|50138352|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
25038019|NCT03136367|50138353|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
25038020|NCT03136367|50138351|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
25038021|NCT03136367|50138352|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
25038022|NCT03136367|50138353|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
25038023|NCT03136367|50138351|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
25038024|NCT03136367|50138352|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
25038025|NCT03136367|50138353|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
25038026|NCT03136367|50138351|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
25038027|NCT03136367|50138352|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
25038028|NCT03136367|50138353|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
25038029|NCT03136367|50138351|FG000|T5 1 Year After Surgery|Death|0|||
25038030|NCT03136367|50138352|FG001|T5 1 Year After Surgery|Death|0|||
25038031|NCT03136367|50138353|FG002|T5 1 Year After Surgery|Death|1|||
25038032|NCT03136367|50138351|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
25038033|NCT03136367|50138352|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
25038034|NCT03136367|50138353|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
25159936|NCT01890967|50279936|FG005|Overall Study|Withdrawal by Subject|1|||
25038035|NCT03136367|50138351|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
25038036|NCT03136367|50138352|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
25038037|NCT03136367|50138353|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
25038038|NCT03136367|50138351|FG000|T5 1 Year After Surgery|study ended before due|31|||
25038039|NCT03136367|50138352|FG001|T5 1 Year After Surgery|study ended before due|103|||
25038040|NCT03136367|50138353|FG002|T5 1 Year After Surgery|study ended before due|110|||
25038041|NCT03136367|50138351|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
25038042|NCT03136367|50138352|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
25038043|NCT03136367|50138353|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
25038044|NCT03124381|50138366|FG000|Overall Study|Lost to Follow-up|1|||
25038045|NCT03124381|50138367|FG001|Overall Study|Lost to Follow-up|1|||
25038046|NCT03124381|50138366|FG000|Overall Study|Withdrawal by Subject|6|||
25038047|NCT03124381|50138367|FG001|Overall Study|Withdrawal by Subject|3|||
25038048|NCT03124381|50138366|FG000|Overall Study|Protocol Violation|0|||
25038049|NCT03124381|50138367|FG001|Overall Study|Protocol Violation|1|||
25038050|NCT03124381|50138366|FG000|Overall Study|Adverse Event|1|||
25038051|NCT03124381|50138367|FG001|Overall Study|Adverse Event|1|||
25038052|NCT03124381|50138366|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
25038053|NCT03124381|50138367|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
25038054|NCT03133793|50138377|FG000|Overall Study|Withdrawal by Subject|0|||
25038055|NCT03133793|50138378|FG001|Overall Study|Withdrawal by Subject|4|||
25038056|NCT03133793|50138379|FG002|Overall Study|Withdrawal by Subject|2|||
25038057|NCT03133793|50138380|FG003|Overall Study|Withdrawal by Subject|4|||
25038058|NCT03133793|50138377|FG000|Overall Study|Lost to Follow-up|1|||
25038059|NCT03133793|50138378|FG001|Overall Study|Lost to Follow-up|0|||
25038060|NCT03133793|50138379|FG002|Overall Study|Lost to Follow-up|2|||
25038061|NCT03133793|50138380|FG003|Overall Study|Lost to Follow-up|0|||
25038062|NCT03133793|50138377|FG000|Overall Study|Death|0|||
24947527|NCT00456092|50039816|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
24947528|NCT00456092|50039817|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
24947529|NCT00456092|50039813|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
24947530|NCT00456092|50039814|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
24947531|NCT00456092|50039815|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
24947532|NCT00456092|50039816|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
24947533|NCT00456092|50039817|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
24947534|NCT00456092|50039813|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
24947535|NCT00456092|50039814|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
24947536|NCT00456092|50039815|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
24947537|NCT00456092|50039816|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
24947538|NCT00456092|50039817|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
24947539|NCT00456092|50039813|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
24947540|NCT00456092|50039814|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
24947541|NCT00456092|50039815|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
24947542|NCT00456092|50039816|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
24947543|NCT00456092|50039817|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
24947544|NCT00456092|50039813|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
24947545|NCT00456092|50039814|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
24947546|NCT00456092|50039815|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
24947547|NCT00456092|50039816|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
24947548|NCT00456092|50039817|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
24947549|NCT00456092|50039813|FG000|Treatment Phase (12 Weeks)|Other|1|||
24947550|NCT00456092|50039814|FG001|Treatment Phase (12 Weeks)|Other|0|||
24947551|NCT00456092|50039815|FG002|Treatment Phase (12 Weeks)|Other|1|||
24947552|NCT00456092|50039816|FG003|Treatment Phase (12 Weeks)|Other|0|||
24947553|NCT00456092|50039817|FG004|Treatment Phase (12 Weeks)|Other|0|||
24947554|NCT00411450|50039831|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
24947555|NCT00404820|50039839|FG000|Overall Study|Adverse Event|4|||
24947556|NCT00404820|50039840|FG001|Overall Study|Adverse Event|16|||
24947557|NCT00404820|50039839|FG000|Overall Study|Withdrawal by Subject|5|||
24947558|NCT00404820|50039840|FG001|Overall Study|Withdrawal by Subject|3|||
24947559|NCT00404820|50039839|FG000|Overall Study|Lost to Follow-up|7|||
24947560|NCT00404820|50039840|FG001|Overall Study|Lost to Follow-up|3|||
24947561|NCT00404820|50039839|FG000|Overall Study|Administrative problems|2|||
24947562|NCT00404820|50039840|FG001|Overall Study|Administrative problems|0|||
24947563|NCT00404820|50039839|FG000|Overall Study|Death|1|||
24947564|NCT00404820|50039840|FG001|Overall Study|Death|0|||
24947565|NCT00404820|50039839|FG000|Overall Study|Other|0|||
25038063|NCT03133793|50138378|FG001|Overall Study|Death|0|||
25038064|NCT03133793|50138379|FG002|Overall Study|Death|0|||
25038065|NCT03133793|50138380|FG003|Overall Study|Death|1|||
24947566|NCT00404820|50039840|FG001|Overall Study|Other|2|||
24947567|NCT00417612|50039848|FG000|Overall Study|Errant diagnosis|0|||
24947568|NCT00417612|50039849|FG001|Overall Study|Errant diagnosis|1|||
24947569|NCT00417612|50039848|FG000|Overall Study|Adverse Event|2|||
25038066|NCT02747238|50138396|FG000|Overall Study|Lack of Efficacy|0|||
25038067|NCT02747238|50138397|FG001|Overall Study|Lack of Efficacy|1|||
25038068|NCT02747238|50138396|FG000|Overall Study|Data lost|3|||
25038069|NCT02747238|50138397|FG001|Overall Study|Data lost|5|||
25038070|NCT03133481|50138405|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
25038071|NCT03133481|50138406|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
25038072|NCT02864316|50138414|FG000|Overall Study|Progressive Disease|2|||
25038073|NCT02864316|50138415|FG001|Overall Study|Progressive Disease|1|||
24947570|NCT00417612|50039849|FG001|Overall Study|Adverse Event|0|||
24947571|NCT00417612|50039848|FG000|Overall Study|Protocol Violation|0|||
24947572|NCT00417612|50039849|FG001|Overall Study|Protocol Violation|2|||
24947573|NCT00417612|50039848|FG000|Overall Study|Lost to Follow-up|1|||
24947574|NCT00417612|50039849|FG001|Overall Study|Lost to Follow-up|0|||
24947575|NCT00446030|50039859|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
25038074|NCT02864316|50138414|FG000|Overall Study|Adverse Event|0|||
25038075|NCT02864316|50138415|FG001|Overall Study|Adverse Event|1|||
25038076|NCT02862600|50138421|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
25038077|NCT02862600|50138421|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
25038078|NCT02862600|50138421|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
25038079|NCT02862600|50138421|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
25038080|NCT02864082|50138429|FG000|Overall Study|Adverse Event|1|||
25038081|NCT02864082|50138430|FG001|Overall Study|Adverse Event|1|||
25038082|NCT02864082|50138429|FG000|Overall Study|Lost to Follow-up|0|||
25038083|NCT02864082|50138430|FG001|Overall Study|Lost to Follow-up|1|||
25038084|NCT02864082|50138429|FG000|Overall Study|Withdrawal by Subject|2|||
25038085|NCT02864082|50138430|FG001|Overall Study|Withdrawal by Subject|2|||
25038086|NCT02792192|50138454|FG000|Overall Study|Death|1|||
25038087|NCT02792192|50138455|FG001|Overall Study|Death|0|||
25038088|NCT02792192|50138456|FG002|Overall Study|Death|0|||
25038089|NCT02792192|50138457|FG003|Overall Study|Death|0|||
25038090|NCT02792192|50138454|FG000|Overall Study|Informed Consent Withdrawn|4|||
25038091|NCT02792192|50138455|FG001|Overall Study|Informed Consent Withdrawn|0|||
25038092|NCT02792192|50138456|FG002|Overall Study|Informed Consent Withdrawn|0|||
25038093|NCT02792192|50138457|FG003|Overall Study|Informed Consent Withdrawn|0|||
25038094|NCT02792192|50138454|FG000|Overall Study|Physician Decision|1|||
25038095|NCT02792192|50138455|FG001|Overall Study|Physician Decision|0|||
25038096|NCT02792192|50138456|FG002|Overall Study|Physician Decision|0|||
25038097|NCT02792192|50138457|FG003|Overall Study|Physician Decision|0|||
25038098|NCT02792192|50138454|FG000|Overall Study|Progressive Disease|0|||
25038099|NCT02792192|50138455|FG001|Overall Study|Progressive Disease|1|||
24947576|NCT00446030|50039860|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
24947577|NCT00446030|50039859|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
25038100|NCT02792192|50138456|FG002|Overall Study|Progressive Disease|0|||
24947578|NCT00446030|50039860|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
24947579|NCT00446030|50039859|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
24947580|NCT00446030|50039860|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
24947581|NCT00446030|50039859|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
24947582|NCT00446030|50039860|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
25038101|NCT02792192|50138457|FG003|Overall Study|Progressive Disease|0|||
25038102|NCT02792192|50138454|FG000|Overall Study|Study Terminated By Sponsor|6|||
25038103|NCT02792192|50138455|FG001|Overall Study|Study Terminated By Sponsor|10|||
25038104|NCT02792192|50138456|FG002|Overall Study|Study Terminated By Sponsor|0|||
25038105|NCT02792192|50138457|FG003|Overall Study|Study Terminated By Sponsor|0|||
25038106|NCT02964507|50138476|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
25038107|NCT02964507|50138477|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
25038108|NCT02964507|50138478|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
25038109|NCT02964507|50138479|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
25038110|NCT02964507|50138480|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
25038111|NCT02964507|50138481|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
25038112|NCT02964507|50138482|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
25038113|NCT02964507|50138483|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
25038114|NCT02964507|50138476|FG000|Overall Study|Ongoing at the time of analysis|1|||
25038115|NCT02964507|50138477|FG001|Overall Study|Ongoing at the time of analysis|0|||
25038116|NCT02964507|50138478|FG002|Overall Study|Ongoing at the time of analysis|2|||
25038117|NCT02964507|50138479|FG003|Overall Study|Ongoing at the time of analysis|0|||
25038118|NCT02964507|50138480|FG004|Overall Study|Ongoing at the time of analysis|0|||
25038119|NCT02964507|50138481|FG005|Overall Study|Ongoing at the time of analysis|0|||
25038120|NCT02964507|50138482|FG006|Overall Study|Ongoing at the time of analysis|0|||
25038121|NCT02964507|50138483|FG007|Overall Study|Ongoing at the time of analysis|0|||
25038122|NCT02964507|50138476|FG000|Overall Study|Study terminated by Sponsor|9|||
25038123|NCT02964507|50138477|FG001|Overall Study|Study terminated by Sponsor|1|||
25038124|NCT02964507|50138478|FG002|Overall Study|Study terminated by Sponsor|9|||
24947583|NCT00446030|50039859|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
24947584|NCT00446030|50039860|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
25038125|NCT02964507|50138479|FG003|Overall Study|Study terminated by Sponsor|3|||
25038126|NCT02964507|50138480|FG004|Overall Study|Study terminated by Sponsor|3|||
25038127|NCT02964507|50138481|FG005|Overall Study|Study terminated by Sponsor|2|||
25038128|NCT02964507|50138482|FG006|Overall Study|Study terminated by Sponsor|0|||
25038129|NCT02964507|50138483|FG007|Overall Study|Study terminated by Sponsor|0|||
25038130|NCT02964507|50138476|FG000|Overall Study|Other|3|||
25038131|NCT02964507|50138477|FG001|Overall Study|Other|0|||
25038132|NCT02964507|50138478|FG002|Overall Study|Other|0|||
24947585|NCT00446030|50039859|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
24947586|NCT00446030|50039860|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
24947587|NCT00446030|50039859|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
24947588|NCT00446030|50039860|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
24947589|NCT00446030|50039859|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
24947590|NCT00446030|50039860|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
24947591|NCT00446030|50039859|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
24947592|NCT00446030|50039860|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
24947593|NCT00446030|50039859|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
24947594|NCT00446030|50039860|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
24947595|NCT00446030|50039859|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
24947596|NCT00446030|50039860|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
24947597|NCT00446030|50039859|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
24947598|NCT00446030|50039860|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
24947599|NCT00446030|50039859|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
24947600|NCT00446030|50039860|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
24947601|NCT00446030|50039859|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
24947602|NCT00446030|50039860|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
24947603|NCT00446030|50039859|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
24947604|NCT00446030|50039860|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
24947605|NCT00446030|50039859|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
24947606|NCT00446030|50039860|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
24947607|NCT00446030|50039859|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
24947608|NCT00446030|50039860|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
24947609|NCT00446030|50039859|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
24947610|NCT00446030|50039860|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
24947611|NCT00446030|50039859|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
24947612|NCT00446030|50039860|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
24947613|NCT00411216|50039868|FG000|Overall Study|Ten participants were entered into the c|0|||
24947614|NCT00411216|50039869|FG001|Overall Study|Ten participants were entered into the c|2|||
24947615|NCT00410514|50039878|FG000|Overall Study|Adverse Event|2|||
24947616|NCT00410514|50039879|FG001|Overall Study|Adverse Event|2|||
25038133|NCT02964507|50138479|FG003|Overall Study|Other|0|||
25038134|NCT02964507|50138480|FG004|Overall Study|Other|1|||
25038135|NCT02964507|50138481|FG005|Overall Study|Other|0|||
25038136|NCT02964507|50138482|FG006|Overall Study|Other|0|||
25038137|NCT02964507|50138483|FG007|Overall Study|Other|0|||
25038138|NCT02964507|50138476|FG000|Overall Study|Death|11|||
25038139|NCT02964507|50138477|FG001|Overall Study|Death|9|||
25159937|NCT01400919|50279955|FG000|Overall Study|Withdrawal by Subject|4|||
25159938|NCT01400919|50279955|FG000|Overall Study|Lost to Follow-up|2|||
25186257|NCT01457924|50336263|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
24947617|NCT00410514|50039880|FG002|Overall Study|Adverse Event|2|||
24947618|NCT00410514|50039878|FG000|Overall Study|Protocol Violation|0|||
24947619|NCT00410514|50039879|FG001|Overall Study|Protocol Violation|1|||
24947620|NCT00410514|50039880|FG002|Overall Study|Protocol Violation|1|||
24947621|NCT00410514|50039878|FG000|Overall Study|Lost to Follow-up|0|||
24947622|NCT00410514|50039879|FG001|Overall Study|Lost to Follow-up|0|||
24947623|NCT00410514|50039880|FG002|Overall Study|Lost to Follow-up|2|||
24947624|NCT00410514|50039878|FG000|Overall Study|Non-compliant with study procedures|0|||
24947625|NCT00410514|50039879|FG001|Overall Study|Non-compliant with study procedures|0|||
24947626|NCT00410514|50039880|FG002|Overall Study|Non-compliant with study procedures|2|||
24947627|NCT03847610|50039888|FG000|Overall Study|Withdrawal by Subject|1|||
24947628|NCT03843632|50039896|FG000|Overall Study|Withdrawal by Subject|1|||
24947629|NCT03843632|50039897|FG001|Overall Study|Withdrawal by Subject|0|||
24947630|NCT03843632|50039898|FG002|Overall Study|Withdrawal by Subject|0|||
24947631|NCT03843632|50039899|FG003|Overall Study|Withdrawal by Subject|0|||
24947632|NCT00455858|50039909|FG000|Overall Study|Lost to Follow-up|2|||
24947633|NCT00455858|50039909|FG000|Overall Study|Protocol Violation|1|||
24947634|NCT00455858|50039909|FG000|Overall Study|Lack of Efficacy|1|||
24947635|NCT00455858|50039909|FG000|Overall Study|Well controlled FPG without insulin|1|||
24947636|NCT00455858|50039909|FG000|Overall Study|Withdrawal|1|||
25038140|NCT02964507|50138478|FG002|Overall Study|Death|12|||
25038141|NCT02964507|50138479|FG003|Overall Study|Death|2|||
25038142|NCT02964507|50138480|FG004|Overall Study|Death|10|||
25038143|NCT02964507|50138481|FG005|Overall Study|Death|5|||
24947637|NCT00439556|50039916|FG000|Overall Study|Patient was taken off study for non-comp|0|||
24947638|NCT00439556|50039917|FG001|Overall Study|Patient was taken off study for non-comp|1|||
24947639|NCT00439556|50039918|FG002|Overall Study|Patient was taken off study for non-comp|0|||
24947640|NCT00410202|50039930|FG000|On-Treatment|Continuing treatment|69|||
24947641|NCT00410202|50039931|FG001|On-Treatment|Continuing treatment|71|||
24947642|NCT00410202|50039932|FG002|On-Treatment|Continuing treatment|66|||
24947643|NCT00410202|50039930|FG000|On-Treatment|Adverse Event|1|||
24947644|NCT00410202|50039931|FG001|On-Treatment|Adverse Event|3|||
24947645|NCT00410202|50039932|FG002|On-Treatment|Adverse Event|2|||
24947646|NCT00410202|50039930|FG000|On-Treatment|Death|1|||
24947647|NCT00410202|50039931|FG001|On-Treatment|Death|0|||
24947648|NCT00410202|50039932|FG002|On-Treatment|Death|0|||
24947649|NCT00410202|50039930|FG000|On-Treatment|Lost to Follow-up|1|||
24947650|NCT00410202|50039931|FG001|On-Treatment|Lost to Follow-up|0|||
24947651|NCT00410202|50039932|FG002|On-Treatment|Lost to Follow-up|1|||
24947652|NCT00410202|50039930|FG000|On-Treatment|Lack of Efficacy|1|||
24947653|NCT00410202|50039931|FG001|On-Treatment|Lack of Efficacy|4|||
24947654|NCT00410202|50039932|FG002|On-Treatment|Lack of Efficacy|0|||
24947655|NCT00410202|50039930|FG000|On-Treatment|Withdrawal by Subject|2|||
24947656|NCT00410202|50039931|FG001|On-Treatment|Withdrawal by Subject|1|||
24947657|NCT00410202|50039932|FG002|On-Treatment|Withdrawal by Subject|1|||
24947658|NCT00410202|50039930|FG000|On-Treatment|Other Reason|0|||
24947659|NCT00410202|50039931|FG001|On-Treatment|Other Reason|0|||
24947660|NCT00410202|50039932|FG002|On-Treatment|Other Reason|1|||
24947661|NCT00410202|50039930|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
24947662|NCT00410202|50039931|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
24947663|NCT00410202|50039932|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
24947664|NCT00410202|50039930|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
24947665|NCT00410202|50039931|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
24947666|NCT00410202|50039932|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
24947667|NCT00410202|50039930|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
24947668|NCT00410202|50039931|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
24947669|NCT00410202|50039932|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
24947670|NCT00445328|50039943|FG000|Overall Study|Death|0|||
24947671|NCT00445328|50039944|FG001|Overall Study|Death|1|||
24947672|NCT00445328|50039943|FG000|Overall Study|Adverse Event|0|||
24947673|NCT00445328|50039944|FG001|Overall Study|Adverse Event|3|||
24947674|NCT00445328|50039943|FG000|Overall Study|Other|0|||
24947675|NCT00445328|50039944|FG001|Overall Study|Other|2|||
24947676|NCT00445328|50039943|FG000|Overall Study|Withdrawal by Subject|2|||
24947677|NCT00445328|50039944|FG001|Overall Study|Withdrawal by Subject|0|||
24947678|NCT00445328|50039943|FG000|Overall Study|Protocol Violation|1|||
24947679|NCT00445328|50039944|FG001|Overall Study|Protocol Violation|0|||
24947680|NCT00455312|50039952|FG000|Overall Study|Death|0|||
24947681|NCT00455312|50039953|FG001|Overall Study|Death|1|||
24947682|NCT00444626|50039959|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
24947683|NCT00444626|50039959|FG000|Initial Treatment Period|Adverse Event|1|||
24947684|NCT00444626|50039959|FG000|Initial Treatment Period|Lost to Follow-up|9|||
24947685|NCT00404352|50039986|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
24947686|NCT00404352|50039987|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
24947687|NCT00404352|50039988|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
24947688|NCT00404352|50039989|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
24947689|NCT00404352|50039990|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
24947690|NCT00404352|50039991|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
24947691|NCT00404352|50039992|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
24947692|NCT00404352|50039993|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
24947693|NCT00404352|50039994|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
24947694|NCT00404352|50039986|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
24947695|NCT00404352|50039987|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
24947696|NCT00404352|50039988|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
24947697|NCT00404352|50039989|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
24947698|NCT00404352|50039990|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
24947699|NCT00404352|50039991|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
24947700|NCT00404352|50039992|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
24947701|NCT00404352|50039993|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
24947702|NCT00404352|50039994|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
24947703|NCT00404352|50039986|FG000|Double Blind (up to 24 Month)|Death|0|||
24947704|NCT00404352|50039987|FG001|Double Blind (up to 24 Month)|Death|0|||
24947705|NCT00404352|50039988|FG002|Double Blind (up to 24 Month)|Death|1|||
24947706|NCT00404352|50039989|FG003|Double Blind (up to 24 Month)|Death|0|||
24947707|NCT00404352|50039990|FG004|Double Blind (up to 24 Month)|Death|0|||
24947708|NCT00404352|50039991|FG005|Double Blind (up to 24 Month)|Death|0|||
25038144|NCT02964507|50138482|FG006|Overall Study|Death|0|||
25038145|NCT02964507|50138483|FG007|Overall Study|Death|0|||
25038146|NCT02964507|50138476|FG000|Overall Study|Withdrawal by Subject|1|||
25038147|NCT02964507|50138477|FG001|Overall Study|Withdrawal by Subject|0|||
25038148|NCT02964507|50138478|FG002|Overall Study|Withdrawal by Subject|1|||
25038149|NCT02964507|50138479|FG003|Overall Study|Withdrawal by Subject|1|||
25159939|NCT01400919|50279955|FG000|Overall Study|Missed visit|2|||
25159940|NCT01864291|50279959|FG000|Overall Study|need for revision surgery|2|||
25159941|NCT01400841|50279963|FG000|Initial Study Phase (6 Months)|Death|1|||
25159942|NCT01400841|50279963|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
25159943|NCT01863667|50279969|FG000|Overall Study|Adverse Event|1|||
25159944|NCT01863667|50279970|FG001|Overall Study|Adverse Event|0|||
25159945|NCT01863667|50279969|FG000|Overall Study|Study terminated by Sponsor|30|||
25159946|NCT01863667|50279970|FG001|Overall Study|Study terminated by Sponsor|30|||
25159947|NCT01863667|50279969|FG000|Overall Study|Withdrawal by Subject|2|||
25159948|NCT01863667|50279970|FG001|Overall Study|Withdrawal by Subject|2|||
25159949|NCT01614769|50279976|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
25159950|NCT01614769|50279977|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
25159951|NCT01614769|50279978|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
25159952|NCT01614769|50279979|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
25159953|NCT01614769|50279980|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
25159954|NCT01614769|50279981|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
25159955|NCT01614769|50279976|FG000|Period 1|Protocol Violation|0|||
25159956|NCT01614769|50279977|FG001|Period 1|Protocol Violation|0|||
24947709|NCT00404352|50039992|FG006|Double Blind (up to 24 Month)|Death|0|||
24947710|NCT00404352|50039993|FG007|Double Blind (up to 24 Month)|Death|0|||
24947711|NCT00404352|50039994|FG008|Double Blind (up to 24 Month)|Death|0|||
24947712|NCT00404352|50039986|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
24947713|NCT00404352|50039987|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
24947714|NCT00404352|50039988|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
25038150|NCT02964507|50138480|FG004|Overall Study|Withdrawal by Subject|0|||
25159957|NCT01614769|50279978|FG002|Period 1|Protocol Violation|0|||
25159958|NCT01614769|50279979|FG003|Period 1|Protocol Violation|1|||
25186258|NCT01457924|50336264|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
25038151|NCT02964507|50138481|FG005|Overall Study|Withdrawal by Subject|1|||
24947715|NCT00404352|50039989|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
24947716|NCT00404352|50039990|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
24947717|NCT00404352|50039991|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
24947718|NCT00404352|50039992|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
24947719|NCT00404352|50039993|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
24947720|NCT00404352|50039994|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
24947721|NCT00404352|50039986|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
24947722|NCT00404352|50039987|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
24947723|NCT00404352|50039988|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
24947724|NCT00404352|50039989|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
24947725|NCT00404352|50039990|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
24947726|NCT00404352|50039991|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
24947727|NCT00404352|50039992|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
24947728|NCT00404352|50039993|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
24947729|NCT00404352|50039994|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
24947730|NCT00404352|50039986|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
24947731|NCT00404352|50039987|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
24947732|NCT00404352|50039988|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
24947733|NCT00404352|50039989|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
24947734|NCT00404352|50039990|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
24947735|NCT00404352|50039991|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
24947736|NCT00404352|50039992|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
25038152|NCT02964507|50138482|FG006|Overall Study|Withdrawal by Subject|0|||
25038153|NCT02964507|50138483|FG007|Overall Study|Withdrawal by Subject|0|||
25038154|NCT02964507|50138476|FG000|Overall Study|Physician Decision|1|||
25038155|NCT02964507|50138477|FG001|Overall Study|Physician Decision|0|||
25038156|NCT02964507|50138478|FG002|Overall Study|Physician Decision|1|||
25038157|NCT02964507|50138479|FG003|Overall Study|Physician Decision|0|||
25038158|NCT02964507|50138480|FG004|Overall Study|Physician Decision|1|||
25038159|NCT02964507|50138481|FG005|Overall Study|Physician Decision|0|||
25038160|NCT02964507|50138482|FG006|Overall Study|Physician Decision|0|||
24947737|NCT00404352|50039993|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
25038161|NCT02964507|50138483|FG007|Overall Study|Physician Decision|0|||
25038162|NCT03170869|50138502|FG000|Overall Study|Protocol Violation|5|||
25038163|NCT03170869|50138502|FG000|Overall Study|Early study termination|3|||
25038164|NCT02440464|50138509|FG000|Overall Study|Withdrawal by Subject|3|||
25038165|NCT02440464|50138510|FG001|Overall Study|Withdrawal by Subject|2|||
25038166|NCT03103321|50138521|FG000|Overall Study|Protocol Violation|1|||
25038167|NCT03103321|50138522|FG001|Overall Study|Protocol Violation|1|||
25038168|NCT03103321|50138523|FG002|Overall Study|Protocol Violation|1|||
25038169|NCT03103321|50138524|FG003|Overall Study|Protocol Violation|0|||
25038170|NCT03131453|50138537|FG000|Overall Study|Study terminated by Sponsor|424|||
25038171|NCT03131453|50138538|FG001|Overall Study|Study terminated by Sponsor|222|||
25038172|NCT03131453|50138539|FG002|Overall Study|Study terminated by Sponsor|438|||
25038173|NCT03131453|50138537|FG000|Overall Study|Withdrawal by Subject|18|||
25038174|NCT03131453|50138538|FG001|Overall Study|Withdrawal by Subject|7|||
25038175|NCT03131453|50138539|FG002|Overall Study|Withdrawal by Subject|13|||
25038176|NCT03131453|50138537|FG000|Overall Study|Adverse Event|10|||
25038177|NCT03131453|50138538|FG001|Overall Study|Adverse Event|3|||
24947738|NCT00404352|50039994|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
24947739|NCT00404352|50039986|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
24947740|NCT00404352|50039987|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
24947741|NCT00404352|50039988|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
24947742|NCT00404352|50039989|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
24947743|NCT00404352|50039990|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
24947744|NCT00404352|50039991|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
24947745|NCT00404352|50039992|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
24947746|NCT00404352|50039993|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
24947747|NCT00404352|50039994|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
24947748|NCT00404352|50039986|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
24947749|NCT00404352|50039987|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
24947750|NCT00404352|50039988|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
24947751|NCT00404352|50039989|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
24947752|NCT00404352|50039990|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
24947753|NCT00404352|50039991|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
24947754|NCT00404352|50039992|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
24947755|NCT00404352|50039993|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
24947756|NCT00404352|50039994|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
24947757|NCT00404352|50039986|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
24947758|NCT00404352|50039987|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
25038178|NCT03131453|50138539|FG002|Overall Study|Adverse Event|3|||
25038179|NCT03131453|50138537|FG000|Overall Study|Lost to Follow-up|1|||
25038180|NCT03131453|50138538|FG001|Overall Study|Lost to Follow-up|0|||
24947759|NCT00404352|50039988|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
24947760|NCT00404352|50039989|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
24947761|NCT00404352|50039990|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
24947762|NCT00404352|50039991|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
24947763|NCT00404352|50039992|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
24947764|NCT00404352|50039993|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
24947765|NCT00404352|50039994|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
24947766|NCT00404352|50039986|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
24947767|NCT00404352|50039987|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
24947768|NCT00404352|50039988|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
24947769|NCT00404352|50039989|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
24947770|NCT00404352|50039990|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
24947771|NCT00404352|50039991|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
24947772|NCT00404352|50039992|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
24947773|NCT00404352|50039993|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
24947774|NCT00404352|50039994|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
24947775|NCT00404352|50039986|FG000|Double Blind (up to 24 Month)|Other|0|||
24947776|NCT00404352|50039987|FG001|Double Blind (up to 24 Month)|Other|1|||
24947777|NCT00404352|50039988|FG002|Double Blind (up to 24 Month)|Other|0|||
24947778|NCT00404352|50039989|FG003|Double Blind (up to 24 Month)|Other|0|||
24947779|NCT00404352|50039990|FG004|Double Blind (up to 24 Month)|Other|0|||
24947780|NCT00404352|50039991|FG005|Double Blind (up to 24 Month)|Other|0|||
24947781|NCT00404352|50039992|FG006|Double Blind (up to 24 Month)|Other|0|||
24947782|NCT00404352|50039993|FG007|Double Blind (up to 24 Month)|Other|0|||
24947783|NCT00404352|50039994|FG008|Double Blind (up to 24 Month)|Other|0|||
24947784|NCT00404352|50039986|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
24947785|NCT00404352|50039987|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
24947786|NCT00404352|50039988|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
24947787|NCT00404352|50039989|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
24947788|NCT00404352|50039990|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
24947789|NCT00404352|50039991|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
24947790|NCT00404352|50039992|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
24947791|NCT00404352|50039993|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
24947792|NCT00404352|50039994|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
24947793|NCT00404352|50039986|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
24947794|NCT00404352|50039987|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
24947795|NCT00404352|50039988|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
24947796|NCT00404352|50039989|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
24947797|NCT00404352|50039990|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
24947798|NCT00404352|50039991|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
24947799|NCT00404352|50039992|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
24947800|NCT00404352|50039993|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
24947801|NCT00404352|50039994|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
24947802|NCT00404352|50039986|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
24947803|NCT00404352|50039987|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
24947804|NCT00404352|50039988|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
24947805|NCT00404352|50039989|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
24947806|NCT00404352|50039990|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
24947807|NCT00404352|50039991|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
24947808|NCT00404352|50039992|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
24947809|NCT00404352|50039993|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
24947810|NCT00404352|50039994|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
24947811|NCT00404352|50039986|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
24947812|NCT00404352|50039987|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
24947813|NCT00404352|50039988|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
24947814|NCT00404352|50039989|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
24947815|NCT00404352|50039990|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
24947816|NCT00404352|50039991|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
24947817|NCT00404352|50039992|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
24947818|NCT00404352|50039993|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
24947819|NCT00404352|50039994|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
24947820|NCT00404352|50039986|FG000|Open Label (up to 24 Month)|Disease progression|0|||
24947821|NCT00404352|50039987|FG001|Open Label (up to 24 Month)|Disease progression|0|||
24947822|NCT00404352|50039988|FG002|Open Label (up to 24 Month)|Disease progression|0|||
24947823|NCT00404352|50039989|FG003|Open Label (up to 24 Month)|Disease progression|1|||
24947824|NCT00404352|50039990|FG004|Open Label (up to 24 Month)|Disease progression|0|||
24947825|NCT00404352|50039991|FG005|Open Label (up to 24 Month)|Disease progression|0|||
24947826|NCT00404352|50039992|FG006|Open Label (up to 24 Month)|Disease progression|0|||
25159959|NCT01614769|50279980|FG004|Period 1|Protocol Violation|0|||
25159960|NCT01614769|50279981|FG005|Period 1|Protocol Violation|0|||
25159961|NCT01614769|50279976|FG000|Period 1|Withdrawal by Subject|1|||
25159962|NCT01614769|50279977|FG001|Period 1|Withdrawal by Subject|0|||
24947827|NCT00404352|50039993|FG007|Open Label (up to 24 Month)|Disease progression|0|||
24947828|NCT00404352|50039994|FG008|Open Label (up to 24 Month)|Disease progression|0|||
24947829|NCT00404352|50039986|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
24947830|NCT00404352|50039987|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
24947831|NCT00404352|50039988|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
24947832|NCT00404352|50039989|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
24947833|NCT00404352|50039990|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
24947834|NCT00404352|50039991|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
24947835|NCT00404352|50039992|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
24947836|NCT00404352|50039993|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
25038181|NCT03131453|50138539|FG002|Overall Study|Lost to Follow-up|1|||
25038182|NCT03131453|50138537|FG000|Overall Study|Physician Decision|1|||
25038183|NCT03131453|50138538|FG001|Overall Study|Physician Decision|0|||
25038184|NCT03131453|50138539|FG002|Overall Study|Physician Decision|1|||
25038185|NCT03131453|50138537|FG000|Overall Study|Non-compliance with study treatment|1|||
25038186|NCT03131453|50138538|FG001|Overall Study|Non-compliance with study treatment|0|||
25038187|NCT03131453|50138539|FG002|Overall Study|Non-compliance with study treatment|0|||
25038188|NCT03131453|50138537|FG000|Overall Study|Technical problems|1|||
25038189|NCT03131453|50138538|FG001|Overall Study|Technical problems|0|||
25038190|NCT03131453|50138539|FG002|Overall Study|Technical problems|0|||
25038191|NCT03131453|50138537|FG000|Overall Study|Protocol deviation|0|||
25038192|NCT03131453|50138538|FG001|Overall Study|Protocol deviation|1|||
25038193|NCT03131453|50138539|FG002|Overall Study|Protocol deviation|0|||
25038194|NCT02942277|50138567|FG000|Year 1|Withdrawal by Subject|0|||
25038195|NCT02942277|50138568|FG001|Year 1|Withdrawal by Subject|0|||
25038196|NCT02942277|50138569|FG002|Year 1|Withdrawal by Subject|0|||
25038197|NCT02942277|50138570|FG003|Year 1|Withdrawal by Subject|0|||
25038198|NCT02942277|50138571|FG004|Year 1|Withdrawal by Subject|1|||
25038199|NCT02942277|50138572|FG005|Year 1|Withdrawal by Subject|3|||
24947837|NCT00404352|50039994|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
24947838|NCT00404352|50039986|FG000|Open Label Extension (up to 36 Months)|Other|0|||
24947839|NCT00404352|50039987|FG001|Open Label Extension (up to 36 Months)|Other|0|||
24947840|NCT00404352|50039988|FG002|Open Label Extension (up to 36 Months)|Other|0|||
24947841|NCT00404352|50039989|FG003|Open Label Extension (up to 36 Months)|Other|0|||
24947842|NCT00404352|50039990|FG004|Open Label Extension (up to 36 Months)|Other|0|||
24947843|NCT00404352|50039991|FG005|Open Label Extension (up to 36 Months)|Other|0|||
24947844|NCT00404352|50039992|FG006|Open Label Extension (up to 36 Months)|Other|0|||
24947845|NCT00404352|50039993|FG007|Open Label Extension (up to 36 Months)|Other|0|||
24947846|NCT00404352|50039994|FG008|Open Label Extension (up to 36 Months)|Other|2|||
24947847|NCT00439244|50040014|FG000|Overall Study|Adverse Event|5|||
24947848|NCT00439244|50040015|FG001|Overall Study|Adverse Event|2|||
25038200|NCT02942277|50138573|FG006|Year 1|Withdrawal by Subject|0|||
25038201|NCT02942277|50138574|FG007|Year 1|Withdrawal by Subject|1|||
25038202|NCT02942277|50138575|FG008|Year 1|Withdrawal by Subject|0|||
25038203|NCT02942277|50138576|FG009|Year 1|Withdrawal by Subject|0|||
25038204|NCT02942277|50138577|FG010|Year 1|Withdrawal by Subject|3|||
25038205|NCT02942277|50138567|FG000|Year 1|Travel|0|||
25038206|NCT02942277|50138568|FG001|Year 1|Travel|1|||
25038207|NCT02942277|50138569|FG002|Year 1|Travel|0|||
25038208|NCT02942277|50138570|FG003|Year 1|Travel|0|||
24947849|NCT00439244|50040016|FG002|Overall Study|Adverse Event|3|||
24947850|NCT00439244|50040014|FG000|Overall Study|Withdrawal by Subject|3|||
24947851|NCT00439244|50040015|FG001|Overall Study|Withdrawal by Subject|1|||
24947852|NCT00439244|50040016|FG002|Overall Study|Withdrawal by Subject|2|||
24947853|NCT00439244|50040014|FG000|Overall Study|Lost to Follow-up|2|||
24947854|NCT00439244|50040015|FG001|Overall Study|Lost to Follow-up|1|||
24947855|NCT00439244|50040016|FG002|Overall Study|Lost to Follow-up|2|||
24947856|NCT00439244|50040014|FG000|Overall Study|Death|0|||
24947857|NCT00439244|50040015|FG001|Overall Study|Death|1|||
24947858|NCT00439244|50040016|FG002|Overall Study|Death|0|||
24947859|NCT00439244|50040014|FG000|Overall Study|Protocol Violation|0|||
24947860|NCT00439244|50040015|FG001|Overall Study|Protocol Violation|1|||
24947861|NCT00439244|50040016|FG002|Overall Study|Protocol Violation|0|||
24947862|NCT00439244|50040014|FG000|Overall Study|Administrative problems|1|||
24947863|NCT00439244|50040015|FG001|Overall Study|Administrative problems|0|||
24947864|NCT00439244|50040016|FG002|Overall Study|Administrative problems|0|||
24947865|NCT00438464|50040035|FG000|Overall Study|Terminated Early|14|||
24947866|NCT00438464|50040036|FG001|Overall Study|Terminated Early|5|||
24947867|NCT00438464|50040035|FG000|Overall Study|Incomplete data submission|0|||
24947868|NCT00438464|50040036|FG001|Overall Study|Incomplete data submission|2|||
24947869|NCT00437294|50040056|FG000|Overall Study|Adverse Event|5|||
25038209|NCT02942277|50138571|FG004|Year 1|Travel|4|||
25159963|NCT01614769|50279978|FG002|Period 1|Withdrawal by Subject|0|||
25159964|NCT01614769|50279979|FG003|Period 1|Withdrawal by Subject|0|||
24947870|NCT00437294|50040057|FG001|Overall Study|Adverse Event|4|||
24947871|NCT00437294|50040056|FG000|Overall Study|Death|5|||
24947872|NCT00437294|50040057|FG001|Overall Study|Death|2|||
24947873|NCT00437294|50040056|FG000|Overall Study|Physician Decision|0|||
24947874|NCT00437294|50040057|FG001|Overall Study|Physician Decision|3|||
24947875|NCT00437294|50040056|FG000|Overall Study|Withdrawal by Subject|5|||
24947876|NCT00437294|50040057|FG001|Overall Study|Withdrawal by Subject|0|||
24947877|NCT00437294|50040056|FG000|Overall Study|Progressive Disease|19|||
25159965|NCT01614769|50279980|FG004|Period 1|Withdrawal by Subject|0|||
25159966|NCT01614769|50279981|FG005|Period 1|Withdrawal by Subject|0|||
25159967|NCT01614769|50279976|FG000|Period 3|Withdrawal by Subject|0|||
25159968|NCT01614769|50279977|FG001|Period 3|Withdrawal by Subject|0|||
25159969|NCT01614769|50279978|FG002|Period 3|Withdrawal by Subject|1|||
25159970|NCT01614769|50279979|FG003|Period 3|Withdrawal by Subject|0|||
25159971|NCT01614769|50279980|FG004|Period 3|Withdrawal by Subject|0|||
25159972|NCT01614769|50279981|FG005|Period 3|Withdrawal by Subject|0|||
25159973|NCT01614457|50279991|FG000|Overall Study|Non-Compliance|1|||
25159974|NCT01614457|50279992|FG001|Overall Study|Non-Compliance|0|||
25159975|NCT01614457|50279991|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
24947878|NCT00437294|50040057|FG001|Overall Study|Progressive Disease|23|||
24947879|NCT00437294|50040056|FG000|Overall Study|Sponsor Decision|8|||
24947880|NCT00437294|50040057|FG001|Overall Study|Sponsor Decision|9|||
24947881|NCT00437294|50040056|FG000|Overall Study|Protocol Violation|0|||
24947882|NCT00437294|50040057|FG001|Overall Study|Protocol Violation|1|||
24947883|NCT00437294|50040056|FG000|Overall Study|Entry criteria not met|1|||
24947884|NCT00437294|50040057|FG001|Overall Study|Entry criteria not met|1|||
24947885|NCT00436982|50040071|FG000|Overall Study|Withdrawal by Subject|3|||
24947886|NCT00436982|50040072|FG001|Overall Study|Withdrawal by Subject|1|||
24947887|NCT00436982|50040071|FG000|Overall Study|Did not receive allocated intervention|0|||
24947888|NCT00436982|50040072|FG001|Overall Study|Did not receive allocated intervention|1|||
24947889|NCT00436982|50040071|FG000|Overall Study|no RSA data|1|||
24947890|NCT00436982|50040072|FG001|Overall Study|no RSA data|2|||
24947891|NCT00443846|50040084|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
24947892|NCT00443846|50040085|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
24947893|NCT00443846|50040084|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
24947894|NCT00443846|50040085|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
24947895|NCT00443846|50040084|FG000|Overall Study|Adverse Event|0|||
24947896|NCT00443846|50040085|FG001|Overall Study|Adverse Event|1|||
25159976|NCT01614457|50279992|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
25159977|NCT01863433|50279998|FG000|Overall Study|Protocol Violation|1|||
24947897|NCT00443846|50040084|FG000|Overall Study|Personal reason|8|||
25038210|NCT02942277|50138572|FG005|Year 1|Travel|5|||
24947898|NCT00443846|50040085|FG001|Overall Study|Personal reason|3|||
24947899|NCT00443846|50040084|FG000|Overall Study|Lost to Follow-up|1|||
24947900|NCT00443846|50040085|FG001|Overall Study|Lost to Follow-up|2|||
24947901|NCT00436826|50040093|FG000|Double Blind Period (DBP)|Adverse Event|2|||
24947902|NCT00436826|50040094|FG001|Double Blind Period (DBP)|Adverse Event|0|||
24947903|NCT00436826|50040095|FG002|Double Blind Period (DBP)|Adverse Event|0|||
24947904|NCT00436826|50040096|FG003|Double Blind Period (DBP)|Adverse Event|0|||
24947905|NCT00436826|50040097|FG004|Double Blind Period (DBP)|Adverse Event|0|||
24947906|NCT00436826|50040098|FG005|Double Blind Period (DBP)|Adverse Event|0|||
24947907|NCT00436826|50040093|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
24947908|NCT00436826|50040094|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
24947909|NCT00436826|50040095|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
24947910|NCT00436826|50040096|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
24947911|NCT00436826|50040097|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
24947912|NCT00436826|50040098|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
24947913|NCT00436826|50040093|FG000|Double Blind Period (DBP)|Other|10|||
24947914|NCT00436826|50040094|FG001|Double Blind Period (DBP)|Other|11|||
24947915|NCT00436826|50040095|FG002|Double Blind Period (DBP)|Other|0|||
24947916|NCT00436826|50040096|FG003|Double Blind Period (DBP)|Other|0|||
24947917|NCT00436826|50040097|FG004|Double Blind Period (DBP)|Other|0|||
24947918|NCT00436826|50040098|FG005|Double Blind Period (DBP)|Other|0|||
25038211|NCT02942277|50138573|FG006|Year 1|Travel|0|||
25038212|NCT02942277|50138574|FG007|Year 1|Travel|0|||
25038213|NCT02942277|50138575|FG008|Year 1|Travel|0|||
25038214|NCT02942277|50138576|FG009|Year 1|Travel|0|||
25038215|NCT02942277|50138577|FG010|Year 1|Travel|8|||
25038216|NCT02942277|50138567|FG000|Year 1|Joined Army|0|||
25038217|NCT02942277|50138568|FG001|Year 1|Joined Army|1|||
25038218|NCT02942277|50138569|FG002|Year 1|Joined Army|0|||
25159978|NCT01862029|50280002|FG000|Overall Study|Physician Decision|1|||
25186259|NCT01457924|50336265|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
24947919|NCT00436826|50040093|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
24947920|NCT00436826|50040094|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
24947921|NCT00436826|50040095|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
25038219|NCT02942277|50138570|FG003|Year 1|Joined Army|0|||
25038220|NCT02942277|50138571|FG004|Year 1|Joined Army|0|||
25038221|NCT02942277|50138572|FG005|Year 1|Joined Army|0|||
25038222|NCT02942277|50138573|FG006|Year 1|Joined Army|0|||
25038223|NCT02942277|50138574|FG007|Year 1|Joined Army|0|||
24947922|NCT00436826|50040096|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
24947923|NCT00436826|50040097|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
24947924|NCT00436826|50040098|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
24947925|NCT00436826|50040093|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
24947926|NCT00436826|50040094|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
24947927|NCT00436826|50040095|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
24947928|NCT00436826|50040096|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
24947929|NCT00436826|50040097|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
24947930|NCT00436826|50040098|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
24947931|NCT00436826|50040093|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
24947932|NCT00436826|50040094|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
24947933|NCT00436826|50040095|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
24947934|NCT00436826|50040096|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
24947935|NCT00436826|50040097|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
24947936|NCT00436826|50040098|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
24947937|NCT00410124|50040116|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
24947938|NCT00410124|50040117|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
24947939|NCT00410124|50040116|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
24947940|NCT00410124|50040117|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
24947941|NCT00410124|50040116|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
24947942|NCT00410124|50040117|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
24947943|NCT00410124|50040116|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
24947944|NCT00410124|50040117|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
24947945|NCT00410124|50040116|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
24947946|NCT00410124|50040117|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
24947947|NCT00410124|50040116|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
24947948|NCT00410124|50040117|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
24947949|NCT00410124|50040116|FG000|Core Phase Double Blind (15 Months)|Death|7|||
24947950|NCT00410124|50040117|FG001|Core Phase Double Blind (15 Months)|Death|4|||
24947951|NCT00410124|50040116|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
24947952|NCT00410124|50040117|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
24947953|NCT00410124|50040116|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
24947954|NCT00410124|50040117|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
24947955|NCT00410124|50040116|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
25159979|NCT01835431|50280009|FG000|Overall Study|Adverse Event|1|||
25186260|NCT01457924|50336266|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
24947956|NCT00410124|50040117|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
25038224|NCT02942277|50138575|FG008|Year 1|Joined Army|0|||
24947957|NCT00410124|50040116|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
24947958|NCT00410124|50040117|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
24947959|NCT00410124|50040116|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
24947960|NCT00410124|50040117|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
25038225|NCT02942277|50138576|FG009|Year 1|Joined Army|0|||
25038226|NCT02942277|50138577|FG010|Year 1|Joined Army|0|||
25038227|NCT02942277|50138567|FG000|Year 1|Subject met withdrawal criteria|0|||
25038228|NCT02942277|50138568|FG001|Year 1|Subject met withdrawal criteria|0|||
25038229|NCT02942277|50138569|FG002|Year 1|Subject met withdrawal criteria|0|||
25038230|NCT02942277|50138570|FG003|Year 1|Subject met withdrawal criteria|1|||
25038231|NCT02942277|50138571|FG004|Year 1|Subject met withdrawal criteria|0|||
25038232|NCT02942277|50138572|FG005|Year 1|Subject met withdrawal criteria|0|||
25038233|NCT02942277|50138573|FG006|Year 1|Subject met withdrawal criteria|0|||
25038234|NCT02942277|50138574|FG007|Year 1|Subject met withdrawal criteria|0|||
25038235|NCT02942277|50138575|FG008|Year 1|Subject met withdrawal criteria|0|||
25038236|NCT02942277|50138576|FG009|Year 1|Subject met withdrawal criteria|0|||
25038237|NCT02942277|50138577|FG010|Year 1|Subject met withdrawal criteria|0|||
25038238|NCT02942277|50138567|FG000|Year 1|Lost to Follow-up|0|||
25038239|NCT02942277|50138568|FG001|Year 1|Lost to Follow-up|0|||
24947961|NCT00410124|50040116|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
24947962|NCT00410124|50040117|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
24947963|NCT00410124|50040116|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
24947964|NCT00410124|50040117|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
24947965|NCT00410124|50040116|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
24947966|NCT00410124|50040117|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
24947967|NCT00410124|50040116|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
24947968|NCT00410124|50040117|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
25038240|NCT02942277|50138569|FG002|Year 1|Lost to Follow-up|0|||
25038241|NCT02942277|50138570|FG003|Year 1|Lost to Follow-up|0|||
24964610|NCT00432809|50054435|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
24964611|NCT00432809|50054436|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
24964612|NCT00432809|50054437|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
24964613|NCT00431951|50054449|FG000|Overall Study|Inability to follow study procedures|1|||
24964614|NCT00431951|50054450|FG001|Overall Study|Inability to follow study procedures|0|||
24964615|NCT00431951|50054451|FG002|Overall Study|Inability to follow study procedures|1|||
24964616|NCT00431951|50054452|FG003|Overall Study|Inability to follow study procedures|2|||
24964617|NCT00431951|50054449|FG000|Overall Study|Lost to Follow-up|0|||
24947969|NCT00410046|50040127|FG000|Overall Study|Adverse Event|3|||
24947970|NCT00410046|50040127|FG000|Overall Study|Withdrawal by Subject|1|||
24947971|NCT00410046|50040127|FG000|Overall Study|Lost to Follow-up|1|||
24947972|NCT00416624|50040136|FG000|Overall Study|Withdrawal by Subject|1|||
24947973|NCT00416624|50040137|FG001|Overall Study|Withdrawal by Subject|6|||
24947974|NCT00416624|50040138|FG002|Overall Study|Withdrawal by Subject|4|||
25038242|NCT02942277|50138571|FG004|Year 1|Lost to Follow-up|1|||
25038243|NCT02942277|50138572|FG005|Year 1|Lost to Follow-up|0|||
25038244|NCT02942277|50138573|FG006|Year 1|Lost to Follow-up|0|||
25038245|NCT02942277|50138574|FG007|Year 1|Lost to Follow-up|0|||
25038246|NCT02942277|50138575|FG008|Year 1|Lost to Follow-up|0|||
25038247|NCT02942277|50138576|FG009|Year 1|Lost to Follow-up|0|||
25038248|NCT02942277|50138577|FG010|Year 1|Lost to Follow-up|2|||
25038249|NCT02942277|50138567|FG000|Year 1|Protocol Violation|0|||
25038250|NCT02942277|50138568|FG001|Year 1|Protocol Violation|0|||
25038251|NCT02942277|50138569|FG002|Year 1|Protocol Violation|0|||
25038252|NCT02942277|50138570|FG003|Year 1|Protocol Violation|0|||
25038253|NCT02942277|50138571|FG004|Year 1|Protocol Violation|1|||
25038254|NCT02942277|50138572|FG005|Year 1|Protocol Violation|1|||
25038255|NCT02942277|50138573|FG006|Year 1|Protocol Violation|0|||
25038256|NCT02942277|50138574|FG007|Year 1|Protocol Violation|0|||
25038257|NCT02942277|50138575|FG008|Year 1|Protocol Violation|0|||
25038258|NCT02942277|50138576|FG009|Year 1|Protocol Violation|0|||
25038259|NCT02942277|50138577|FG010|Year 1|Protocol Violation|2|||
25038260|NCT02942277|50138567|FG000|Year 1|Pregnancy|0|||
25038261|NCT02942277|50138568|FG001|Year 1|Pregnancy|0|||
25038262|NCT02942277|50138569|FG002|Year 1|Pregnancy|0|||
25038263|NCT02942277|50138570|FG003|Year 1|Pregnancy|0|||
24947975|NCT00416624|50040139|FG003|Overall Study|Withdrawal by Subject|9|||
24947976|NCT00416624|50040136|FG000|Overall Study|Death|4|||
24947977|NCT00416624|50040137|FG001|Overall Study|Death|7|||
24947978|NCT00416624|50040138|FG002|Overall Study|Death|7|||
24947979|NCT00416624|50040139|FG003|Overall Study|Death|1|||
24947980|NCT00416624|50040136|FG000|Overall Study|Adverse Event|8|||
24947981|NCT00416624|50040137|FG001|Overall Study|Adverse Event|3|||
24947982|NCT00416624|50040138|FG002|Overall Study|Adverse Event|2|||
24947983|NCT00416624|50040139|FG003|Overall Study|Adverse Event|2|||
24947984|NCT00416624|50040136|FG000|Overall Study|Other|8|||
24947985|NCT00416624|50040137|FG001|Overall Study|Other|11|||
24947986|NCT00416624|50040138|FG002|Overall Study|Other|5|||
24947987|NCT00416624|50040139|FG003|Overall Study|Other|5|||
24947988|NCT00416624|50040136|FG000|Overall Study|Cancel|1|||
24947989|NCT00416624|50040137|FG001|Overall Study|Cancel|0|||
24947990|NCT00416624|50040138|FG002|Overall Study|Cancel|0|||
24947991|NCT00416624|50040139|FG003|Overall Study|Cancel|0|||
24947992|NCT00262600|50040152|FG000|Overall Study|Lost to Follow-up|17|||
24947993|NCT00262600|50040153|FG001|Overall Study|Lost to Follow-up|31|||
24947994|NCT00262600|50040154|FG002|Overall Study|Lost to Follow-up|41|||
24947995|NCT00262600|50040152|FG000|Overall Study|Withdrawal by Subject|128|||
24947996|NCT00262600|50040153|FG001|Overall Study|Withdrawal by Subject|145|||
24947997|NCT00262600|50040154|FG002|Overall Study|Withdrawal by Subject|139|||
24947998|NCT00262600|50040152|FG000|Overall Study|Not Treated|32|||
24947999|NCT00262600|50040153|FG001|Overall Study|Not Treated|17|||
24948000|NCT00262600|50040154|FG002|Overall Study|Not Treated|24|||
24948001|NCT00262600|50040152|FG000|Overall Study|Other|58|||
24948002|NCT00262600|50040153|FG001|Overall Study|Other|59|||
24948003|NCT00262600|50040154|FG002|Overall Study|Other|62|||
24948004|NCT00409578|50040166|FG000|Overall Study|Adverse Event|27|||
24948005|NCT00409578|50040167|FG001|Overall Study|Adverse Event|37|||
24948006|NCT00409578|50040168|FG002|Overall Study|Adverse Event|25|||
24948007|NCT00409578|50040169|FG003|Overall Study|Adverse Event|33|||
24948008|NCT00409578|50040166|FG000|Overall Study|Abnormal laboratory value(s)|2|||
24948009|NCT00409578|50040167|FG001|Overall Study|Abnormal laboratory value(s)|2|||
24948010|NCT00409578|50040168|FG002|Overall Study|Abnormal laboratory value(s)|2|||
24948011|NCT00409578|50040169|FG003|Overall Study|Abnormal laboratory value(s)|4|||
24948012|NCT00409578|50040166|FG000|Overall Study|Lack of Efficacy|0|||
24948013|NCT00409578|50040167|FG001|Overall Study|Lack of Efficacy|0|||
24948014|NCT00409578|50040168|FG002|Overall Study|Lack of Efficacy|0|||
24948015|NCT00409578|50040169|FG003|Overall Study|Lack of Efficacy|2|||
24948016|NCT00409578|50040166|FG000|Overall Study|Subject no longer requires study drug|0|||
24948017|NCT00409578|50040167|FG001|Overall Study|Subject no longer requires study drug|0|||
24948018|NCT00409578|50040168|FG002|Overall Study|Subject no longer requires study drug|0|||
24948019|NCT00409578|50040169|FG003|Overall Study|Subject no longer requires study drug|1|||
25038264|NCT02942277|50138571|FG004|Year 1|Pregnancy|0|||
24948020|NCT00409578|50040166|FG000|Overall Study|Withdrawal by Subject|8|||
25038265|NCT02942277|50138572|FG005|Year 1|Pregnancy|1|||
24948021|NCT00409578|50040167|FG001|Overall Study|Withdrawal by Subject|15|||
24948022|NCT00409578|50040168|FG002|Overall Study|Withdrawal by Subject|16|||
24948023|NCT00409578|50040169|FG003|Overall Study|Withdrawal by Subject|17|||
25038266|NCT02942277|50138573|FG006|Year 1|Pregnancy|0|||
25038267|NCT02942277|50138574|FG007|Year 1|Pregnancy|0|||
25038268|NCT02942277|50138575|FG008|Year 1|Pregnancy|0|||
25038269|NCT02942277|50138576|FG009|Year 1|Pregnancy|0|||
24948024|NCT00409578|50040166|FG000|Overall Study|Lost to Follow-up|2|||
24948025|NCT00409578|50040167|FG001|Overall Study|Lost to Follow-up|0|||
24948026|NCT00409578|50040168|FG002|Overall Study|Lost to Follow-up|2|||
24948027|NCT00409578|50040169|FG003|Overall Study|Lost to Follow-up|2|||
24948028|NCT00409578|50040166|FG000|Overall Study|Administrative problems|8|||
24948029|NCT00409578|50040167|FG001|Overall Study|Administrative problems|9|||
25038270|NCT02942277|50138577|FG010|Year 1|Pregnancy|0|||
25038271|NCT02942277|50138567|FG000|Year 2|Lost to Follow-up|0|||
25038272|NCT02942277|50138568|FG001|Year 2|Lost to Follow-up|0|||
25038273|NCT02942277|50138569|FG002|Year 2|Lost to Follow-up|0|||
25038274|NCT02942277|50138570|FG003|Year 2|Lost to Follow-up|0|||
25038275|NCT02942277|50138571|FG004|Year 2|Lost to Follow-up|2|||
25038276|NCT02942277|50138572|FG005|Year 2|Lost to Follow-up|1|||
25038277|NCT02942277|50138573|FG006|Year 2|Lost to Follow-up|0|||
25038278|NCT02942277|50138574|FG007|Year 2|Lost to Follow-up|0|||
25038279|NCT02942277|50138575|FG008|Year 2|Lost to Follow-up|0|||
25038280|NCT02942277|50138576|FG009|Year 2|Lost to Follow-up|0|||
25038281|NCT02942277|50138577|FG010|Year 2|Lost to Follow-up|0|||
25038282|NCT02942277|50138567|FG000|Year 2|Did not rescreen|0|||
25038283|NCT02942277|50138568|FG001|Year 2|Did not rescreen|0|||
25038284|NCT02942277|50138569|FG002|Year 2|Did not rescreen|1|||
25038285|NCT02942277|50138570|FG003|Year 2|Did not rescreen|1|||
25038286|NCT02942277|50138571|FG004|Year 2|Did not rescreen|9|||
25038287|NCT02942277|50138572|FG005|Year 2|Did not rescreen|6|||
25038288|NCT02942277|50138573|FG006|Year 2|Did not rescreen|0|||
25038289|NCT02942277|50138574|FG007|Year 2|Did not rescreen|1|||
25038290|NCT02942277|50138575|FG008|Year 2|Did not rescreen|0|||
25038291|NCT02942277|50138576|FG009|Year 2|Did not rescreen|0|||
25038292|NCT02942277|50138577|FG010|Year 2|Did not rescreen|21|||
25038293|NCT02942277|50138567|FG000|Year 2|Met withdrawal criteria|0|||
25038294|NCT02942277|50138568|FG001|Year 2|Met withdrawal criteria|0|||
25038295|NCT02942277|50138569|FG002|Year 2|Met withdrawal criteria|0|||
25038296|NCT02942277|50138570|FG003|Year 2|Met withdrawal criteria|0|||
25038297|NCT02942277|50138571|FG004|Year 2|Met withdrawal criteria|1|||
25038298|NCT02942277|50138572|FG005|Year 2|Met withdrawal criteria|2|||
25038299|NCT02942277|50138573|FG006|Year 2|Met withdrawal criteria|0|||
25038300|NCT02942277|50138574|FG007|Year 2|Met withdrawal criteria|0|||
25038301|NCT02942277|50138575|FG008|Year 2|Met withdrawal criteria|0|||
25038302|NCT02942277|50138576|FG009|Year 2|Met withdrawal criteria|0|||
25038303|NCT02942277|50138577|FG010|Year 2|Met withdrawal criteria|1|||
25038304|NCT02942277|50138567|FG000|Year 2|Travel|0|||
25038305|NCT02942277|50138568|FG001|Year 2|Travel|1|||
25038306|NCT02942277|50138569|FG002|Year 2|Travel|0|||
25038307|NCT02942277|50138570|FG003|Year 2|Travel|0|||
25038308|NCT02942277|50138571|FG004|Year 2|Travel|0|||
25038309|NCT02942277|50138572|FG005|Year 2|Travel|1|||
25038310|NCT02942277|50138573|FG006|Year 2|Travel|0|||
25038311|NCT02942277|50138574|FG007|Year 2|Travel|0|||
24948030|NCT00409578|50040168|FG002|Overall Study|Administrative problems|2|||
24948031|NCT00409578|50040169|FG003|Overall Study|Administrative problems|4|||
24948032|NCT00409578|50040166|FG000|Overall Study|Death|2|||
25038312|NCT02942277|50138575|FG008|Year 2|Travel|0|||
25038313|NCT02942277|50138576|FG009|Year 2|Travel|1|||
25038314|NCT02942277|50138577|FG010|Year 2|Travel|3|||
24948033|NCT00409578|50040167|FG001|Overall Study|Death|4|||
25038315|NCT02942277|50138567|FG000|Year 2|Non-compliant|0|||
25038316|NCT02942277|50138568|FG001|Year 2|Non-compliant|0|||
25038317|NCT02942277|50138569|FG002|Year 2|Non-compliant|0|||
24948034|NCT00409578|50040168|FG002|Overall Study|Death|4|||
24948035|NCT00409578|50040169|FG003|Overall Study|Death|2|||
25038318|NCT02942277|50138570|FG003|Year 2|Non-compliant|0|||
25038319|NCT02942277|50138571|FG004|Year 2|Non-compliant|1|||
25038320|NCT02942277|50138572|FG005|Year 2|Non-compliant|1|||
25038321|NCT02942277|50138573|FG006|Year 2|Non-compliant|0|||
25038322|NCT02942277|50138574|FG007|Year 2|Non-compliant|0|||
25038323|NCT02942277|50138575|FG008|Year 2|Non-compliant|0|||
24948036|NCT00409578|50040166|FG000|Overall Study|Protocol Violation|3|||
24948037|NCT00409578|50040167|FG001|Overall Study|Protocol Violation|2|||
24948038|NCT00409578|50040168|FG002|Overall Study|Protocol Violation|3|||
24948039|NCT00409578|50040169|FG003|Overall Study|Protocol Violation|1|||
25038324|NCT02942277|50138576|FG009|Year 2|Non-compliant|0|||
25038325|NCT02942277|50138577|FG010|Year 2|Non-compliant|0|||
25038326|NCT02942277|50138567|FG000|Year 2|Withdrawal by Subject|0|||
25038327|NCT02942277|50138568|FG001|Year 2|Withdrawal by Subject|0|||
24948040|NCT00409578|50040166|FG000|Overall Study|Missing|0|||
24948041|NCT00409578|50040167|FG001|Overall Study|Missing|1|||
24948042|NCT00409578|50040168|FG002|Overall Study|Missing|0|||
25038328|NCT02942277|50138569|FG002|Year 2|Withdrawal by Subject|0|||
25038329|NCT02942277|50138570|FG003|Year 2|Withdrawal by Subject|0|||
25038330|NCT02942277|50138571|FG004|Year 2|Withdrawal by Subject|0|||
25038331|NCT02942277|50138572|FG005|Year 2|Withdrawal by Subject|0|||
25038332|NCT02942277|50138573|FG006|Year 2|Withdrawal by Subject|1|||
24948043|NCT00409578|50040169|FG003|Overall Study|Missing|1|||
24948044|NCT00428090|50040183|FG000|Overall Study|Adverse Event|10|||
24948045|NCT00428090|50040184|FG001|Overall Study|Adverse Event|8|||
24948046|NCT00428090|50040185|FG002|Overall Study|Adverse Event|10|||
24948047|NCT00428090|50040186|FG003|Overall Study|Adverse Event|11|||
24948048|NCT00428090|50040183|FG000|Overall Study|Lost to Follow-up|3|||
24948049|NCT00428090|50040184|FG001|Overall Study|Lost to Follow-up|6|||
24948050|NCT00428090|50040185|FG002|Overall Study|Lost to Follow-up|1|||
24948051|NCT00428090|50040186|FG003|Overall Study|Lost to Follow-up|4|||
24948052|NCT00428090|50040183|FG000|Overall Study|Protocol Violation|3|||
24948053|NCT00428090|50040184|FG001|Overall Study|Protocol Violation|1|||
24948054|NCT00428090|50040185|FG002|Overall Study|Protocol Violation|3|||
24948055|NCT00428090|50040186|FG003|Overall Study|Protocol Violation|3|||
24948056|NCT00428090|50040183|FG000|Overall Study|Withdrawal by Subject|10|||
24948057|NCT00428090|50040184|FG001|Overall Study|Withdrawal by Subject|12|||
24948058|NCT00428090|50040185|FG002|Overall Study|Withdrawal by Subject|15|||
24948059|NCT00428090|50040186|FG003|Overall Study|Withdrawal by Subject|5|||
24948060|NCT00428090|50040183|FG000|Overall Study|Sponsor terminated study|0|||
24948061|NCT00428090|50040184|FG001|Overall Study|Sponsor terminated study|1|||
24948062|NCT00428090|50040185|FG002|Overall Study|Sponsor terminated study|0|||
24948063|NCT00428090|50040186|FG003|Overall Study|Sponsor terminated study|0|||
24948064|NCT00428090|50040183|FG000|Overall Study|Non-compliance|4|||
24948065|NCT00428090|50040184|FG001|Overall Study|Non-compliance|0|||
24948066|NCT00428090|50040185|FG002|Overall Study|Non-compliance|1|||
24948067|NCT00428090|50040186|FG003|Overall Study|Non-compliance|3|||
24948068|NCT00428090|50040183|FG000|Overall Study|Par. did not returned to visit|1|||
24948069|NCT00428090|50040184|FG001|Overall Study|Par. did not returned to visit|0|||
24948070|NCT00428090|50040185|FG002|Overall Study|Par. did not returned to visit|0|||
24948071|NCT00428090|50040186|FG003|Overall Study|Par. did not returned to visit|1|||
24948072|NCT00428090|50040183|FG000|Overall Study|Follow-Up visit not possible|1|||
24948073|NCT00428090|50040184|FG001|Overall Study|Follow-Up visit not possible|0|||
24948074|NCT00428090|50040185|FG002|Overall Study|Follow-Up visit not possible|0|||
24948075|NCT00428090|50040186|FG003|Overall Study|Follow-Up visit not possible|0|||
24948076|NCT00428090|50040183|FG000|Overall Study|Prohibited medication used for SAE|1|||
24948077|NCT00428090|50040184|FG001|Overall Study|Prohibited medication used for SAE|0|||
24948078|NCT00428090|50040185|FG002|Overall Study|Prohibited medication used for SAE|0|||
24948079|NCT00428090|50040186|FG003|Overall Study|Prohibited medication used for SAE|0|||
24948080|NCT00428090|50040183|FG000|Overall Study|Death of par.|1|||
24948081|NCT00428090|50040184|FG001|Overall Study|Death of par.|0|||
24948082|NCT00428090|50040185|FG002|Overall Study|Death of par.|1|||
25159980|NCT01835431|50280010|FG001|Overall Study|Adverse Event|0|||
25159981|NCT01835431|50280009|FG000|Overall Study|other|0|||
24948083|NCT00428090|50040186|FG003|Overall Study|Death of par.|0|||
24948084|NCT00428090|50040183|FG000|Overall Study|Visit 7 exceed the visit window|0|||
24964618|NCT00431951|50054450|FG001|Overall Study|Lost to Follow-up|1|||
25159982|NCT01835431|50280010|FG001|Overall Study|other|2|||
24948085|NCT00428090|50040184|FG001|Overall Study|Visit 7 exceed the visit window|1|||
24948086|NCT00428090|50040185|FG002|Overall Study|Visit 7 exceed the visit window|0|||
24948087|NCT00428090|50040186|FG003|Overall Study|Visit 7 exceed the visit window|0|||
24948088|NCT00428090|50040183|FG000|Overall Study|Medical monitor terminated par.|0|||
24948089|NCT00428090|50040184|FG001|Overall Study|Medical monitor terminated par.|1|||
24948090|NCT00428090|50040185|FG002|Overall Study|Medical monitor terminated par.|0|||
24948091|NCT00428090|50040186|FG003|Overall Study|Medical monitor terminated par.|0|||
24948092|NCT00428090|50040183|FG000|Overall Study|Mental status of par. was|0|||
24948093|NCT00428090|50040184|FG001|Overall Study|Mental status of par. was|1|||
24948094|NCT00428090|50040185|FG002|Overall Study|Mental status of par. was|0|||
24948095|NCT00428090|50040186|FG003|Overall Study|Mental status of par. was|0|||
24948096|NCT00428090|50040183|FG000|Overall Study|Worsening of AD|0|||
24948097|NCT00428090|50040184|FG001|Overall Study|Worsening of AD|0|||
24948098|NCT00428090|50040185|FG002|Overall Study|Worsening of AD|1|||
24948099|NCT00428090|50040186|FG003|Overall Study|Worsening of AD|0|||
24948100|NCT00428090|50040183|FG000|Overall Study|Excluded for concerning QTc value|0|||
24948101|NCT00428090|50040184|FG001|Overall Study|Excluded for concerning QTc value|0|||
24948102|NCT00428090|50040185|FG002|Overall Study|Excluded for concerning QTc value|1|||
24948103|NCT00428090|50040186|FG003|Overall Study|Excluded for concerning QTc value|0|||
24948104|NCT00428090|50040183|FG000|Overall Study|Insufficient AD documentation|0|||
24948105|NCT00428090|50040184|FG001|Overall Study|Insufficient AD documentation|0|||
24948106|NCT00428090|50040185|FG002|Overall Study|Insufficient AD documentation|1|||
24948107|NCT00428090|50040186|FG003|Overall Study|Insufficient AD documentation|0|||
24948108|NCT00428090|50040183|FG000|Overall Study|High MMSE scores|0|||
24948109|NCT00428090|50040184|FG001|Overall Study|High MMSE scores|0|||
24948110|NCT00428090|50040185|FG002|Overall Study|High MMSE scores|1|||
24948111|NCT00428090|50040186|FG003|Overall Study|High MMSE scores|0|||
24948112|NCT00428090|50040183|FG000|Overall Study|Deterioration of cognitive status|0|||
24948113|NCT00428090|50040184|FG001|Overall Study|Deterioration of cognitive status|0|||
24948114|NCT00428090|50040185|FG002|Overall Study|Deterioration of cognitive status|1|||
24948115|NCT00428090|50040186|FG003|Overall Study|Deterioration of cognitive status|0|||
24948116|NCT00428090|50040183|FG000|Overall Study|Serious adverse event|0|||
24948117|NCT00428090|50040184|FG001|Overall Study|Serious adverse event|0|||
24948118|NCT00428090|50040185|FG002|Overall Study|Serious adverse event|1|||
24948119|NCT00428090|50040186|FG003|Overall Study|Serious adverse event|0|||
24948120|NCT00428090|50040183|FG000|Overall Study|Excluded for heart insufficiency|0|||
24948121|NCT00428090|50040184|FG001|Overall Study|Excluded for heart insufficiency|0|||
24948122|NCT00428090|50040185|FG002|Overall Study|Excluded for heart insufficiency|1|||
24948123|NCT00428090|50040186|FG003|Overall Study|Excluded for heart insufficiency|0|||
24948124|NCT00428090|50040183|FG000|Overall Study|Raised Creatinine Value|0|||
24948125|NCT00428090|50040184|FG001|Overall Study|Raised Creatinine Value|0|||
24948126|NCT00428090|50040185|FG002|Overall Study|Raised Creatinine Value|0|||
24948127|NCT00428090|50040186|FG003|Overall Study|Raised Creatinine Value|1|||
24948128|NCT00416312|50040204|FG000|Overall Study|tumors not visible on imaging|2|||
24948129|NCT00436436|50040208|FG000|Overall Study|Progression|4|||
24948130|NCT00436436|50040208|FG000|Overall Study|Adverse Event|2|||
24948131|NCT00436436|50040208|FG000|Overall Study|Death|6|||
24948132|NCT00262522|50040216|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
24948133|NCT00262522|50040217|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
24948134|NCT00262522|50040218|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
24948135|NCT00262522|50040219|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
24948136|NCT00262522|50040216|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
24948137|NCT00262522|50040217|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
24948138|NCT00262522|50040218|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
24948139|NCT00262522|50040219|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
24948140|NCT00262522|50040216|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
24948141|NCT00262522|50040217|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
24948142|NCT00262522|50040218|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
25038333|NCT02942277|50138574|FG007|Year 2|Withdrawal by Subject|0|||
25038334|NCT02942277|50138575|FG008|Year 2|Withdrawal by Subject|0|||
25038335|NCT02942277|50138576|FG009|Year 2|Withdrawal by Subject|0|||
25038336|NCT02942277|50138577|FG010|Year 2|Withdrawal by Subject|0|||
24948143|NCT00262522|50040219|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
24948144|NCT00262522|50040216|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
24948145|NCT00262522|50040217|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
24948146|NCT00262522|50040218|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
24948147|NCT00262522|50040219|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
24948148|NCT00262522|50040216|FG000|Study Start Through 8 Weeks|Death|1|||
24948149|NCT00262522|50040217|FG001|Study Start Through 8 Weeks|Death|0|||
24948150|NCT00262522|50040218|FG002|Study Start Through 8 Weeks|Death|0|||
24948151|NCT00262522|50040219|FG003|Study Start Through 8 Weeks|Death|0|||
25038337|NCT02859324|50138628|FG000|Overall Study|Death|4|||
24948152|NCT00262522|50040216|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
25038338|NCT02859324|50138629|FG001|Overall Study|Death|6|||
25038339|NCT02859324|50138630|FG002|Overall Study|Death|5|||
24948153|NCT00262522|50040217|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
24948154|NCT00262522|50040218|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
24948155|NCT00262522|50040219|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
24948156|NCT00262522|50040216|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
24948157|NCT00262522|50040217|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
24948158|NCT00262522|50040218|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
24948159|NCT00262522|50040219|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
24948160|NCT00262522|50040216|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
24948161|NCT00262522|50040217|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
24948162|NCT00262522|50040218|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
24948163|NCT00262522|50040219|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
24948164|NCT00262522|50040216|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
24948165|NCT00262522|50040217|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
24948166|NCT00262522|50040218|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
24948167|NCT00262522|50040219|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
24948168|NCT00262522|50040216|FG000|Study Start Through 48 Weeks|Death|2|||
24948169|NCT00262522|50040217|FG001|Study Start Through 48 Weeks|Death|0|||
24948170|NCT00262522|50040218|FG002|Study Start Through 48 Weeks|Death|1|||
24948171|NCT00262522|50040219|FG003|Study Start Through 48 Weeks|Death|0|||
24948172|NCT00262522|50040216|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
24948173|NCT00262522|50040217|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
24948174|NCT00262522|50040218|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
24948175|NCT00262522|50040219|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
24948176|NCT00262522|50040216|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
24948177|NCT00262522|50040217|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
24948178|NCT00262522|50040218|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
25159983|NCT01835431|50280009|FG000|Overall Study|Withdrawal by Subject|6|||
25159984|NCT01835431|50280010|FG001|Overall Study|Withdrawal by Subject|10|||
25159985|NCT01835431|50280009|FG000|Overall Study|Protocol Violation|1|||
24948179|NCT00262522|50040219|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
24948180|NCT00262522|50040216|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
24948181|NCT00262522|50040217|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
25159986|NCT01835431|50280010|FG001|Overall Study|Protocol Violation|0|||
25159987|NCT01880593|50280018|FG000|Overall Study|Adverse Event|1|||
25159988|NCT01880593|50280019|FG001|Overall Study|Adverse Event|0|||
25159989|NCT01880593|50280018|FG000|Overall Study|Lack of Efficacy|1|||
25159990|NCT01880593|50280019|FG001|Overall Study|Lack of Efficacy|5|||
25159991|NCT01880593|50280018|FG000|Overall Study|Withdrawal by Subject|6|||
25159992|NCT01880593|50280019|FG001|Overall Study|Withdrawal by Subject|1|||
25159993|NCT01400451|50280028|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
25159994|NCT01400451|50280029|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
25159995|NCT01400451|50280030|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
25159996|NCT01400451|50280028|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
25159997|NCT01400451|50280029|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
25159998|NCT01400451|50280030|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
25159999|NCT01400451|50280028|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
25160000|NCT01400451|50280029|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
25160001|NCT01400451|50280030|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
25160002|NCT01400451|50280028|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
25160003|NCT01400451|50280029|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
24948182|NCT00262522|50040218|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
24948183|NCT00262522|50040219|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
24964619|NCT00431951|50054451|FG002|Overall Study|Lost to Follow-up|0|||
25160004|NCT01400451|50280030|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
25160005|NCT01400451|50280028|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
24948184|NCT00262522|50040216|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
24948185|NCT00262522|50040217|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
25038340|NCT02859324|50138628|FG000|Overall Study|Other reasons|3|||
25038341|NCT02859324|50138629|FG001|Overall Study|Other reasons|3|||
25038342|NCT02859324|50138630|FG002|Overall Study|Other reasons|0|||
24948186|NCT00262522|50040218|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
24948187|NCT00262522|50040219|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
24948188|NCT00262522|50040216|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
24948189|NCT00262522|50040217|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
24948190|NCT00262522|50040218|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
24948191|NCT00262522|50040219|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
24948192|NCT00262522|50040216|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
24948193|NCT00262522|50040217|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
24948194|NCT00262522|50040218|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
24948195|NCT00262522|50040219|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
24948196|NCT00262522|50040216|FG000|Study Start Through 96 Weeks|Death|2|||
24948197|NCT00262522|50040217|FG001|Study Start Through 96 Weeks|Death|0|||
24948198|NCT00262522|50040218|FG002|Study Start Through 96 Weeks|Death|2|||
24948199|NCT00262522|50040219|FG003|Study Start Through 96 Weeks|Death|0|||
24948200|NCT00262522|50040216|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
24948201|NCT00262522|50040217|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
24948202|NCT00262522|50040218|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
24948203|NCT00262522|50040219|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
24948204|NCT00262522|50040216|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
24948205|NCT00262522|50040217|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
24948206|NCT00262522|50040218|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
24948207|NCT00262522|50040219|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
24948208|NCT00436280|50040227|FG000|Period 1: Induction|Adverse Event|8|||
24948209|NCT00436280|50040227|FG000|Period 1: Induction|Progressive Disease|12|||
24948210|NCT00436280|50040227|FG000|Period 1: Induction|Stable Disease|6|||
24948211|NCT00436280|50040227|FG000|Period 1: Induction|Withdrawal by Subject|1|||
24948212|NCT00436280|50040227|FG000|Period 1: Induction|Death|1|||
24948213|NCT00436280|50040227|FG000|Period 2: Consolidation|Adverse Event|1|||
24948214|NCT00436280|50040227|FG000|Period 2: Consolidation|Progressive Disease|10|||
24948215|NCT00436280|50040227|FG000|Period 2: Consolidation|Stable Disease|1|||
24948216|NCT00436280|50040227|FG000|Period 2: Consolidation|Physician Decision|2|||
24948217|NCT00436280|50040227|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
24948218|NCT00436280|50040227|FG000|Period 2: Consolidation|Death|1|||
24948219|NCT00436280|50040227|FG000|Period 3: Maintenance|Adverse Event|6|||
24948220|NCT00436280|50040227|FG000|Period 3: Maintenance|Progressive Disease|12|||
24948221|NCT00394836|50040233|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
24948222|NCT00394836|50040234|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
24948223|NCT00394836|50040233|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
24948224|NCT00394836|50040234|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
24948225|NCT00394836|50040233|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
24948226|NCT00394836|50040234|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
24948227|NCT00394836|50040233|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
24948228|NCT00394836|50040234|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
24948229|NCT00394836|50040233|FG000|Teatment or Follow-up Phase|Death|0|||
24948230|NCT00394836|50040234|FG001|Teatment or Follow-up Phase|Death|1|||
24948231|NCT00394836|50040233|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
24948232|NCT00394836|50040234|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
24948233|NCT00394836|50040233|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
24948234|NCT00394836|50040234|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
24948235|NCT00394836|50040233|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
24948236|NCT00394836|50040234|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
24948237|NCT00394836|50040233|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
24948238|NCT00394836|50040234|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
24948239|NCT00394836|50040233|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
24948240|NCT00394836|50040234|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
24948241|NCT00394836|50040233|FG000|Teatment or Follow-up Phase|Non compliance|0|||
24948242|NCT00394836|50040234|FG001|Teatment or Follow-up Phase|Non compliance|1|||
24948243|NCT00394836|50040233|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
24948244|NCT00394836|50040234|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
24948245|NCT00394836|50040233|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
24948246|NCT00394836|50040234|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
24948247|NCT00394836|50040233|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
24948248|NCT00394836|50040234|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
24948249|NCT00394836|50040233|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
24948250|NCT00394836|50040234|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
24948251|NCT00250588|50040245|FG000|Overall Study|Withdrawal by Subject|3|||
24948252|NCT00250588|50040246|FG001|Overall Study|Withdrawal by Subject|6|||
24948253|NCT00250588|50040247|FG002|Overall Study|Withdrawal by Subject|0|||
24948254|NCT00250588|50040245|FG000|Overall Study|Lost to Follow-up|6|||
24948255|NCT00250588|50040246|FG001|Overall Study|Lost to Follow-up|13|||
24948256|NCT00250588|50040247|FG002|Overall Study|Lost to Follow-up|13|||
24948257|NCT00416078|50040257|FG000|Overall Study|Death|3|||
24948258|NCT00416078|50040258|FG001|Overall Study|Death|4|||
24948259|NCT00416078|50040257|FG000|Overall Study|Withdrawal by Subject|3|||
24948260|NCT00416078|50040258|FG001|Overall Study|Withdrawal by Subject|2|||
24948261|NCT00416078|50040257|FG000|Overall Study|Physician Decision|1|||
24948262|NCT00416078|50040258|FG001|Overall Study|Physician Decision|0|||
24948263|NCT00416078|50040257|FG000|Overall Study|Lost to Follow-up|4|||
24948264|NCT00416078|50040258|FG001|Overall Study|Lost to Follow-up|2|||
24948265|NCT00394524|50040266|FG000|Overall Study|Protocol Violation|2|||
24948266|NCT00394524|50040267|FG001|Overall Study|Protocol Violation|3|||
24948267|NCT00394524|50040266|FG000|Overall Study|Death|1|||
24948268|NCT00394524|50040267|FG001|Overall Study|Death|0|||
24948269|NCT00394524|50040266|FG000|Overall Study|Withdrawal by Subject|0|||
24948270|NCT00394524|50040267|FG001|Overall Study|Withdrawal by Subject|1|||
24948271|NCT00409344|50040277|FG000|Overall Study|no enrollment|0|||
24948272|NCT00409344|50040278|FG001|Overall Study|no enrollment|0|||
24948273|NCT00415610|50040287|FG000|Overall Study|Death|3|||
24948274|NCT00415610|50040288|FG001|Overall Study|Death|2|||
24948275|NCT00415610|50040289|FG002|Overall Study|Death|5|||
24948276|NCT00394212|50040299|FG000|Overall Study|Lost to Follow-up|3|||
24948277|NCT00394212|50040300|FG001|Overall Study|Lost to Follow-up|0|||
24948278|NCT00394212|50040299|FG000|Overall Study|Withdrawal by Subject|4|||
24948279|NCT00394212|50040300|FG001|Overall Study|Withdrawal by Subject|1|||
24948280|NCT00250432|50040308|FG000|Overall Study|Adverse Event|25|||
24948281|NCT00250432|50040309|FG001|Overall Study|Adverse Event|29|||
24948282|NCT00250432|50040308|FG000|Overall Study|Lack of Efficacy|2|||
24948283|NCT00250432|50040309|FG001|Overall Study|Lack of Efficacy|1|||
24948284|NCT00250432|50040308|FG000|Overall Study|Lost to Follow-up|6|||
24948285|NCT00250432|50040309|FG001|Overall Study|Lost to Follow-up|5|||
24948286|NCT00250432|50040308|FG000|Overall Study|Patient Moved|0|||
24948287|NCT00250432|50040309|FG001|Overall Study|Patient Moved|1|||
24948288|NCT00250432|50040308|FG000|Overall Study|Protocol Violation|0|||
24948289|NCT00250432|50040309|FG001|Overall Study|Protocol Violation|3|||
24948290|NCT00250432|50040308|FG000|Overall Study|Withdrawal by Subject|6|||
24948291|NCT00250432|50040309|FG001|Overall Study|Withdrawal by Subject|2|||
24948292|NCT00250432|50040308|FG000|Overall Study|Pt died out of posttherapy report period|6|||
24948293|NCT00250432|50040309|FG001|Overall Study|Pt died out of posttherapy report period|5|||
24948294|NCT00250432|50040308|FG000|Overall Study|Pt was considered untreatable|0|||
24948295|NCT00250432|50040309|FG001|Overall Study|Pt was considered untreatable|1|||
24948296|NCT00250276|50040319|FG000|Overall Study|Serious Adverse Event|0|||
24948297|NCT00250276|50040320|FG001|Overall Study|Serious Adverse Event|0|||
24948298|NCT00250276|50040321|FG002|Overall Study|Serious Adverse Event|1|||
24948299|NCT00250276|50040322|FG003|Overall Study|Serious Adverse Event|0|||
24948300|NCT00250276|50040319|FG000|Overall Study|Non-serious Adverse Event|2|||
24948301|NCT00250276|50040320|FG001|Overall Study|Non-serious Adverse Event|0|||
24948302|NCT00250276|50040321|FG002|Overall Study|Non-serious Adverse Event|0|||
24948303|NCT00250276|50040322|FG003|Overall Study|Non-serious Adverse Event|2|||
24948304|NCT00250276|50040319|FG000|Overall Study|Protocol Violation|0|||
24948305|NCT00250276|50040320|FG001|Overall Study|Protocol Violation|1|||
24948306|NCT00250276|50040321|FG002|Overall Study|Protocol Violation|0|||
24948307|NCT00250276|50040322|FG003|Overall Study|Protocol Violation|0|||
24948308|NCT00250276|50040319|FG000|Overall Study|Withdrawal by Subject|1|||
24948309|NCT00250276|50040320|FG001|Overall Study|Withdrawal by Subject|2|||
25160006|NCT01400451|50280029|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
25160007|NCT01400451|50280030|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
25160008|NCT01400139|50280043|FG000|HYD Core Study|Adverse Event|210|||
25160009|NCT01400139|50280043|FG000|HYD Core Study|Lack of Efficacy|59|||
25160010|NCT01400139|50280043|FG000|HYD Core Study|Withdrawal by Subject|114|||
25160011|NCT01400139|50280043|FG000|HYD Core Study|Lost to Follow-up|39|||
24948310|NCT00250276|50040321|FG002|Overall Study|Withdrawal by Subject|3|||
25038343|NCT02143063|50138641|FG000|Overall Study|Lost to Follow-up|16|||
25038344|NCT02143063|50138642|FG001|Overall Study|Lost to Follow-up|28|||
24948311|NCT00250276|50040322|FG003|Overall Study|Withdrawal by Subject|2|||
24948312|NCT00250276|50040319|FG000|Overall Study|Migrated/moved from study area|3|||
24948313|NCT00250276|50040320|FG001|Overall Study|Migrated/moved from study area|0|||
24948314|NCT00250276|50040321|FG002|Overall Study|Migrated/moved from study area|2|||
24948315|NCT00250276|50040322|FG003|Overall Study|Migrated/moved from study area|7|||
24948316|NCT00250276|50040319|FG000|Overall Study|Lost to Follow-up|11|||
24948317|NCT00250276|50040320|FG001|Overall Study|Lost to Follow-up|18|||
24948318|NCT00250276|50040321|FG002|Overall Study|Lost to Follow-up|13|||
24948319|NCT00250276|50040322|FG003|Overall Study|Lost to Follow-up|8|||
24948320|NCT00249808|50040337|FG000|Overall Study|Other|27|||
24948321|NCT00249808|50040337|FG000|Overall Study|Protocol Violation|3|||
24948322|NCT00249808|50040337|FG000|Overall Study|Lost to Follow-up|8|||
24948323|NCT00249808|50040337|FG000|Overall Study|Adverse Event|81|||
24948324|NCT00249808|50040337|FG000|Overall Study|Lack of Efficacy|52|||
24948325|NCT00249808|50040337|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
24948326|NCT00278512|50040343|FG000|Overall Study|Death|1|||
24948327|NCT00278512|50040344|FG001|Overall Study|Death|0|||
24948328|NCT00427934|50040354|FG000|Overall Study|Adverse Event|1|||
24948329|NCT00427934|50040355|FG001|Overall Study|Adverse Event|0|||
24948330|NCT00427934|50040356|FG002|Overall Study|Adverse Event|5|||
24948331|NCT00427934|50040357|FG003|Overall Study|Adverse Event|4|||
24948332|NCT00427934|50040354|FG000|Overall Study|Lack of Efficacy|0|||
24948333|NCT00427934|50040355|FG001|Overall Study|Lack of Efficacy|0|||
25038345|NCT02143063|50138643|FG002|Overall Study|Lost to Follow-up|29|||
24948334|NCT00427934|50040356|FG002|Overall Study|Lack of Efficacy|5|||
24948335|NCT00427934|50040357|FG003|Overall Study|Lack of Efficacy|2|||
24948336|NCT00427934|50040354|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
24948337|NCT00427934|50040355|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
25038346|NCT02143063|50138641|FG000|Overall Study|Withdrawal by Subject|0|||
25160012|NCT01400139|50280043|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
25160013|NCT01400139|50280043|FG000|HYD Core Study|Administrative|56|||
25160014|NCT01400139|50280043|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
25160015|NCT01400139|50280043|FG000|HYD Extension Period|Adverse Event|8|||
25160016|NCT01400139|50280043|FG000|HYD Extension Period|Withdrawal by Subject|5|||
25160017|NCT01400139|50280043|FG000|HYD Extension Period|Administrative|10|||
25160018|NCT01399905|50280051|FG000|Overall Study|Withdrawal by Subject|1|||
25160019|NCT01399905|50280052|FG001|Overall Study|Withdrawal by Subject|1|||
25160020|NCT01725308|50280066|FG000|Treatment Period I|Did Not Receive Drug|1|||
24948338|NCT00427934|50040356|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
24948339|NCT00427934|50040357|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
24948340|NCT00427934|50040354|FG000|Overall Study|Other|0|||
24948341|NCT00427934|50040355|FG001|Overall Study|Other|0|||
24948342|NCT00427934|50040356|FG002|Overall Study|Other|11|||
24948343|NCT00427934|50040357|FG003|Overall Study|Other|5|||
24948344|NCT00427934|50040354|FG000|Overall Study|Withdrawal by Subject|0|||
24948345|NCT00427934|50040355|FG001|Overall Study|Withdrawal by Subject|0|||
24948346|NCT00427934|50040356|FG002|Overall Study|Withdrawal by Subject|1|||
24948347|NCT00427934|50040357|FG003|Overall Study|Withdrawal by Subject|3|||
24948348|NCT00435188|50040371|FG000|Overall Study|Death|1|||
24948349|NCT00435188|50040372|FG001|Overall Study|Death|6|||
24948350|NCT00435188|50040371|FG000|Overall Study|Withdrawal by Subject|16|||
24948351|NCT00435188|50040372|FG001|Overall Study|Withdrawal by Subject|11|||
24948352|NCT00435188|50040371|FG000|Overall Study|Lost to Follow-up|5|||
24948353|NCT00435188|50040372|FG001|Overall Study|Lost to Follow-up|6|||
24948354|NCT00427778|50040380|FG000|First Intervention (4 Weeks)|no longer interested|1|||
24948355|NCT00427778|50040381|FG001|First Intervention (4 Weeks)|no longer interested|0|||
24948356|NCT00427778|50040380|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
24948357|NCT00427778|50040381|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
24948358|NCT00427778|50040380|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
24948359|NCT00427778|50040381|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
24948360|NCT00427778|50040380|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
24948361|NCT00427778|50040381|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
24948362|NCT00427700|50040402|FG000|Overall Study|Lost to Follow-up|2|||
24948363|NCT00427700|50040403|FG001|Overall Study|Lost to Follow-up|5|||
24948364|NCT00427700|50040402|FG000|Overall Study|no induction of menses|1|||
24948365|NCT00427700|50040403|FG001|Overall Study|no induction of menses|4|||
25160021|NCT01725308|50280067|FG001|Treatment Period I|Did Not Receive Drug|0|||
24948366|NCT00427700|50040402|FG000|Overall Study|Pregnancy|0|||
24948367|NCT00427700|50040403|FG001|Overall Study|Pregnancy|2|||
24948368|NCT00409188|50040412|FG000|Overall Study|Ongoing at data cut-off|383|||
24948369|NCT00409188|50040413|FG001|Overall Study|Ongoing at data cut-off|175|||
24948370|NCT00434954|50040421|FG000|Overall Study|Adverse Event|17|||
24948371|NCT00434954|50040422|FG001|Overall Study|Adverse Event|2|||
25038347|NCT02143063|50138642|FG001|Overall Study|Withdrawal by Subject|1|||
25038348|NCT02143063|50138643|FG002|Overall Study|Withdrawal by Subject|0|||
25038349|NCT02143063|50138641|FG000|Overall Study|Death|0|||
25160022|NCT01725308|50280068|FG002|Treatment Period I|Did Not Receive Drug|0|||
25160023|NCT01725308|50280066|FG000|Treatment Period I|Adverse Event|5|||
25160024|NCT01725308|50280067|FG001|Treatment Period I|Adverse Event|4|||
25160025|NCT01725308|50280068|FG002|Treatment Period I|Adverse Event|21|||
24948372|NCT00434954|50040421|FG000|Overall Study|Entry criteria not met|14|||
24948373|NCT00434954|50040422|FG001|Overall Study|Entry criteria not met|16|||
24948374|NCT00434954|50040421|FG000|Overall Study|Lost to Follow-up|0|||
24948375|NCT00434954|50040422|FG001|Overall Study|Lost to Follow-up|1|||
24948376|NCT00434954|50040421|FG000|Overall Study|Physician Decision|6|||
24948377|NCT00434954|50040422|FG001|Overall Study|Physician Decision|3|||
24948378|NCT00434954|50040421|FG000|Overall Study|Protocol Violation|36|||
24948379|NCT00434954|50040422|FG001|Overall Study|Protocol Violation|27|||
24948380|NCT00434954|50040421|FG000|Overall Study|Sponsor decision|1|||
24948381|NCT00434954|50040422|FG001|Overall Study|Sponsor decision|0|||
24948382|NCT00434954|50040421|FG000|Overall Study|Subject decision|8|||
24948383|NCT00434954|50040422|FG001|Overall Study|Subject decision|22|||
24948384|NCT00276484|50040430|FG000|Overall Study|Adverse Event|4|||
24948385|NCT00276484|50040431|FG001|Overall Study|Adverse Event|7|||
24948386|NCT00276484|50040430|FG000|Overall Study|Lost to Follow-up|1|||
24948387|NCT00276484|50040431|FG001|Overall Study|Lost to Follow-up|1|||
24948388|NCT00276484|50040430|FG000|Overall Study|Protocol Violation|0|||
24948389|NCT00276484|50040431|FG001|Overall Study|Protocol Violation|1|||
24948390|NCT00276484|50040430|FG000|Overall Study|Withdrawal by Subject|4|||
24948391|NCT00276484|50040431|FG001|Overall Study|Withdrawal by Subject|3|||
24948392|NCT00276484|50040430|FG000|Overall Study|Could not take time off work|0|||
24948393|NCT00276484|50040431|FG001|Overall Study|Could not take time off work|1|||
24948394|NCT00426842|50040437|FG000|Overall Study|Lost to Follow-up|1|||
24948395|NCT00434876|50040445|FG000|Overall Study|Lost to Follow-up|1|||
24948396|NCT00434876|50040446|FG001|Overall Study|Lost to Follow-up|1|||
24948397|NCT00276094|50040455|FG000|Overall Study|Adverse Event|15|||
24948398|NCT00276094|50040456|FG001|Overall Study|Adverse Event|13|||
24948399|NCT00276094|50040457|FG002|Overall Study|Adverse Event|11|||
24948400|NCT00276094|50040455|FG000|Overall Study|Withdrawal by Subject|14|||
24948401|NCT00276094|50040456|FG001|Overall Study|Withdrawal by Subject|14|||
24948402|NCT00276094|50040457|FG002|Overall Study|Withdrawal by Subject|12|||
24948403|NCT00276094|50040455|FG000|Overall Study|Protocol Violation|16|||
24948404|NCT00276094|50040456|FG001|Overall Study|Protocol Violation|7|||
24948405|NCT00276094|50040457|FG002|Overall Study|Protocol Violation|10|||
24948406|NCT00276094|50040455|FG000|Overall Study|Lost to Follow-up|8|||
24948407|NCT00276094|50040456|FG001|Overall Study|Lost to Follow-up|6|||
24948408|NCT00276094|50040457|FG002|Overall Study|Lost to Follow-up|4|||
24948409|NCT00276094|50040455|FG000|Overall Study|Other-Subject moved out of country|1|||
24948410|NCT00276094|50040456|FG001|Overall Study|Other-Subject moved out of country|0|||
24948411|NCT00276094|50040457|FG002|Overall Study|Other-Subject moved out of country|0|||
24948412|NCT00276094|50040455|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
24948413|NCT00276094|50040456|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
24948414|NCT00276094|50040457|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
24948415|NCT00276094|50040455|FG000|Overall Study|Other-Lack of efficacy|1|||
24948416|NCT00276094|50040456|FG001|Overall Study|Other-Lack of efficacy|0|||
24948417|NCT00276094|50040457|FG002|Overall Study|Other-Lack of efficacy|0|||
24948418|NCT00276094|50040455|FG000|Overall Study|Other-Refused follow-up visit|1|||
24948419|NCT00276094|50040456|FG001|Overall Study|Other-Refused follow-up visit|0|||
24948420|NCT00276094|50040457|FG002|Overall Study|Other-Refused follow-up visit|0|||
24948421|NCT00276094|50040455|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
24948422|NCT00276094|50040456|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
24948423|NCT00276094|50040457|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
24948424|NCT00276094|50040455|FG000|Overall Study|Other-Relocation|0|||
24948425|NCT00276094|50040456|FG001|Overall Study|Other-Relocation|1|||
24948426|NCT00276094|50040457|FG002|Overall Study|Other-Relocation|0|||
24948427|NCT00276094|50040455|FG000|Overall Study|Other-Study medication lost|0|||
24948428|NCT00276094|50040456|FG001|Overall Study|Other-Study medication lost|0|||
24948429|NCT00276094|50040457|FG002|Overall Study|Other-Study medication lost|1|||
24948430|NCT00276016|50040471|FG000|Intervention 1|Withdrawal by Subject|0|||
24948431|NCT00276016|50040472|FG001|Intervention 1|Withdrawal by Subject|1|||
24948432|NCT00276016|50040473|FG002|Intervention 1|Withdrawal by Subject|0|||
25038350|NCT02143063|50138642|FG001|Overall Study|Death|1|||
25038351|NCT02143063|50138643|FG002|Overall Study|Death|1|||
25038352|NCT02859246|50138651|FG000|Overall Study|Screen fails|3|||
25038353|NCT02859246|50138651|FG000|Overall Study|Adverse Event|1|||
24948433|NCT00276016|50040474|FG003|Intervention 1|Withdrawal by Subject|0|||
24948434|NCT00276016|50040475|FG004|Intervention 1|Withdrawal by Subject|0|||
24948435|NCT00276016|50040476|FG005|Intervention 1|Withdrawal by Subject|0|||
25038354|NCT02859246|50138651|FG000|Overall Study|Withdrawal by Subject|1|||
25038355|NCT01083433|50138674|FG000|Overall Study|Lost to Follow-up|2|||
25038356|NCT01083433|50138675|FG001|Overall Study|Lost to Follow-up|1|||
25038357|NCT01083433|50138676|FG002|Overall Study|Lost to Follow-up|1|||
25038358|NCT01083433|50138674|FG000|Overall Study|Withdrawal by Subject|0|||
25038359|NCT01083433|50138675|FG001|Overall Study|Withdrawal by Subject|5|||
25038360|NCT01083433|50138676|FG002|Overall Study|Withdrawal by Subject|3|||
24948436|NCT00434642|50040487|FG000|Blinded Treatment Phase|Adverse Event|12|||
24948437|NCT00434642|50040488|FG001|Blinded Treatment Phase|Adverse Event|58|||
24948438|NCT00434642|50040487|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
24948439|NCT00434642|50040488|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
24948440|NCT00434642|50040487|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
24948441|NCT00434642|50040488|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
24948442|NCT00434642|50040487|FG000|Blinded Treatment Phase|Physician Decision|19|||
24948443|NCT00434642|50040488|FG001|Blinded Treatment Phase|Physician Decision|27|||
24948444|NCT00434642|50040487|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
24948445|NCT00434642|50040488|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
24948446|NCT00434642|50040487|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
24948447|NCT00434642|50040488|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
24948448|NCT00434642|50040487|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
24948449|NCT00434642|50040488|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
24948450|NCT00434642|50040487|FG000|Open-label Treatment Phase|Adverse Event|0|||
24948451|NCT00434642|50040488|FG001|Open-label Treatment Phase|Adverse Event|5|||
24948452|NCT00434642|50040487|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
24948453|NCT00434642|50040488|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
24948454|NCT00434330|50040500|FG000|Overall Study|Adverse Event|0|||
24948455|NCT00434330|50040501|FG001|Overall Study|Adverse Event|0|||
24948456|NCT00434330|50040502|FG002|Overall Study|Adverse Event|1|||
24948457|NCT00434330|50040503|FG003|Overall Study|Adverse Event|0|||
24948458|NCT00434330|50040504|FG004|Overall Study|Adverse Event|0|||
24948459|NCT00434330|50040505|FG005|Overall Study|Adverse Event|0|||
24948460|NCT00434330|50040500|FG000|Overall Study|Death|1|||
24948461|NCT00434330|50040501|FG001|Overall Study|Death|0|||
24948462|NCT00434330|50040502|FG002|Overall Study|Death|0|||
24948463|NCT00434330|50040503|FG003|Overall Study|Death|0|||
24948464|NCT00434330|50040504|FG004|Overall Study|Death|1|||
24948465|NCT00434330|50040505|FG005|Overall Study|Death|1|||
24948466|NCT00434330|50040500|FG000|Overall Study|Withdrawal by Subject|0|||
24948467|NCT00434330|50040501|FG001|Overall Study|Withdrawal by Subject|0|||
24948468|NCT00434330|50040502|FG002|Overall Study|Withdrawal by Subject|1|||
24948469|NCT00434330|50040503|FG003|Overall Study|Withdrawal by Subject|1|||
24948470|NCT00434330|50040504|FG004|Overall Study|Withdrawal by Subject|0|||
24948471|NCT00434330|50040505|FG005|Overall Study|Withdrawal by Subject|0|||
24948472|NCT00434330|50040500|FG000|Overall Study|Renal transplant|0|||
24948473|NCT00434330|50040501|FG001|Overall Study|Renal transplant|0|||
24948474|NCT00434330|50040502|FG002|Overall Study|Renal transplant|0|||
24948475|NCT00434330|50040503|FG003|Overall Study|Renal transplant|1|||
24948476|NCT00434330|50040504|FG004|Overall Study|Renal transplant|0|||
24948477|NCT00434330|50040505|FG005|Overall Study|Renal transplant|0|||
24948478|NCT00434330|50040500|FG000|Overall Study|Subject Not Compliant With Study|0|||
24948479|NCT00434330|50040501|FG001|Overall Study|Subject Not Compliant With Study|0|||
24948480|NCT00434330|50040502|FG002|Overall Study|Subject Not Compliant With Study|1|||
24948481|NCT00434330|50040503|FG003|Overall Study|Subject Not Compliant With Study|0|||
24948482|NCT00434330|50040504|FG004|Overall Study|Subject Not Compliant With Study|0|||
24948483|NCT00434330|50040505|FG005|Overall Study|Subject Not Compliant With Study|0|||
24948484|NCT00426764|50040519|FG000|Overall Study|Protocol Violation|1|||
24948485|NCT00426764|50040519|FG000|Overall Study|Withdrawal by Subject|4|||
24948486|NCT00426764|50040519|FG000|Overall Study|Physician Decision|6|||
24948487|NCT00426764|50040519|FG000|Overall Study|Compassionate Use|1|||
24948488|NCT00426764|50040519|FG000|Overall Study|Progressive Disease|83|||
24948489|NCT00426764|50040519|FG000|Overall Study|Adverse Event|24|||
24948490|NCT00426764|50040519|FG000|Overall Study|Other|1|||
24948491|NCT00426764|50040519|FG000|Overall Study|Death|1|||
24948492|NCT00426764|50040519|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
24948493|NCT00434252|50040531|FG000|Overall Study|Lack of Efficacy|50|||
24948494|NCT00434252|50040532|FG001|Overall Study|Lack of Efficacy|100|||
24948495|NCT00434252|50040531|FG000|Overall Study|Adverse Event|6|||
25038361|NCT01083433|50138674|FG000|Overall Study|Pregnancy|0|||
25038362|NCT01083433|50138675|FG001|Overall Study|Pregnancy|0|||
24948496|NCT00434252|50040532|FG001|Overall Study|Adverse Event|13|||
24948497|NCT00434252|50040531|FG000|Overall Study|Death|1|||
24948498|NCT00434252|50040532|FG001|Overall Study|Death|2|||
24948499|NCT00434252|50040531|FG000|Overall Study|Lost to Follow-up|0|||
24948500|NCT00434252|50040532|FG001|Overall Study|Lost to Follow-up|1|||
24948501|NCT00434252|50040531|FG000|Overall Study|Physician Decision|4|||
24948502|NCT00434252|50040532|FG001|Overall Study|Physician Decision|8|||
24948503|NCT00434252|50040531|FG000|Overall Study|Withdrawal by Subject|3|||
24948504|NCT00434252|50040532|FG001|Overall Study|Withdrawal by Subject|7|||
24948505|NCT00425750|50040538|FG000|Overall Study|Death|1|||
24948506|NCT00425750|50040538|FG000|Overall Study|Withdrawal by Subject|3|||
24948507|NCT00425750|50040538|FG000|Overall Study|Adverse Event|3|||
24948508|NCT00425750|50040538|FG000|Overall Study|Progression of disease|18|||
24948509|NCT00414908|50040544|FG000|Overall Study|Protocol Violation|1|||
24948510|NCT00414908|50040545|FG001|Overall Study|Protocol Violation|1|||
24948511|NCT00242710|50040557|FG000|Core Study (up to Year 1)|Adverse Event|30|||
24948512|NCT00242710|50040558|FG001|Core Study (up to Year 1)|Adverse Event|25|||
25038363|NCT01083433|50138676|FG002|Overall Study|Pregnancy|1|||
25038364|NCT02791490|50138690|FG000|Overall Study|Lost to Follow-up|1|||
25038365|NCT02791490|50138691|FG001|Overall Study|Lost to Follow-up|2|||
25038366|NCT02791490|50138690|FG000|Overall Study|Withdrawal by Subject|2|||
25038367|NCT02791490|50138691|FG001|Overall Study|Withdrawal by Subject|6|||
25038368|NCT02507973|50138706|FG000|Overall Study|Adverse Event|1|||
25038369|NCT02425644|50138714|FG000|Overall Study|Lost to Follow-up|2|||
25038370|NCT02425644|50138715|FG001|Overall Study|Lost to Follow-up|3|||
25038371|NCT02425644|50138714|FG000|Overall Study|Withdrawal by Subject|41|||
25038372|NCT02425644|50138715|FG001|Overall Study|Withdrawal by Subject|36|||
25038373|NCT02425644|50138714|FG000|Overall Study|Lack of Efficacy|3|||
25038374|NCT02425644|50138715|FG001|Overall Study|Lack of Efficacy|10|||
25038375|NCT02425644|50138714|FG000|Overall Study|Adverse Event|13|||
25038376|NCT02425644|50138715|FG001|Overall Study|Adverse Event|3|||
25038377|NCT02425644|50138714|FG000|Overall Study|Death|0|||
25038378|NCT02425644|50138715|FG001|Overall Study|Death|2|||
25038379|NCT02425644|50138714|FG000|Overall Study|Other|18|||
25038380|NCT02425644|50138715|FG001|Overall Study|Other|17|||
25038381|NCT02861664|50138727|FG000|Overall Study|Withdrawal of Consent|0|||
25038382|NCT02861664|50138728|FG001|Overall Study|Withdrawal of Consent|1|||
25038383|NCT01307787|50138736|FG000|Overall Study|Withdrawal by Subject|2|||
25038384|NCT01307787|50138737|FG001|Overall Study|Withdrawal by Subject|0|||
25038385|NCT03284853|50138750|FG000|Overall Study|Adverse Event|40|||
25038386|NCT03284853|50138751|FG001|Overall Study|Adverse Event|4|||
24948513|NCT00242710|50040559|FG002|Core Study (up to Year 1)|Adverse Event|23|||
24948514|NCT00242710|50040560|FG003|Core Study (up to Year 1)|Adverse Event|14|||
24948515|NCT00242710|50040557|FG000|Core Study (up to Year 1)|Death|0|||
24948516|NCT00242710|50040558|FG001|Core Study (up to Year 1)|Death|0|||
24948517|NCT00242710|50040559|FG002|Core Study (up to Year 1)|Death|1|||
25038387|NCT03284853|50138750|FG000|Overall Study|Withdrawal by Subject|5|||
25038388|NCT03284853|50138751|FG001|Overall Study|Withdrawal by Subject|1|||
24948518|NCT00242710|50040560|FG003|Core Study (up to Year 1)|Death|0|||
25038389|NCT03284853|50138750|FG000|Overall Study|Lost to Follow-up|1|||
25038390|NCT03284853|50138751|FG001|Overall Study|Lost to Follow-up|0|||
25038391|NCT03284853|50138750|FG000|Overall Study|Lack of Efficacy|1|||
25038392|NCT03284853|50138751|FG001|Overall Study|Lack of Efficacy|0|||
25038393|NCT03284853|50138750|FG000|Overall Study|Disallowed Concurrent Medication|1|||
25038394|NCT03284853|50138751|FG001|Overall Study|Disallowed Concurrent Medication|1|||
25038395|NCT03284853|50138750|FG000|Overall Study|Protocol Violation|3|||
25038396|NCT03284853|50138751|FG001|Overall Study|Protocol Violation|3|||
25038397|NCT03284853|50138750|FG000|Overall Study|Death|0|||
25038398|NCT03284853|50138751|FG001|Overall Study|Death|1|||
25038399|NCT03284853|50138750|FG000|Overall Study|Other - Reason not reported in CSR|4|||
25038400|NCT03284853|50138751|FG001|Overall Study|Other - Reason not reported in CSR|3|||
25038401|NCT03126019|50138759|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
25038402|NCT03126019|50138760|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
24948519|NCT00242710|50040557|FG000|Core Study (up to Year 1)|Physician Decision|0|||
25038403|NCT03126019|50138759|FG000|Overall Study|Death|2|||
25038404|NCT03126019|50138760|FG001|Overall Study|Death|7|||
25038405|NCT03126019|50138759|FG000|Overall Study|Lost to Follow-up|2|||
25038406|NCT03126019|50138760|FG001|Overall Study|Lost to Follow-up|3|||
25038407|NCT03126019|50138759|FG000|Overall Study|Withdrawal by Participant|1|||
25038408|NCT03126019|50138760|FG001|Overall Study|Withdrawal by Participant|3|||
25038409|NCT03126019|50138759|FG000|Overall Study|Reason not Specified|1|||
25038410|NCT03126019|50138760|FG001|Overall Study|Reason not Specified|3|||
24948520|NCT00242710|50040558|FG001|Core Study (up to Year 1)|Physician Decision|1|||
24948521|NCT00242710|50040559|FG002|Core Study (up to Year 1)|Physician Decision|0|||
25038411|NCT03055221|50138767|FG000|Overall Study|Adverse Event|2|||
25038412|NCT03055221|50138767|FG000|Overall Study|Withdrawal by Subject|4|||
25038413|NCT03055221|50138767|FG000|Overall Study|Death|6|||
25038414|NCT03055221|50138767|FG000|Overall Study|Physician Decision|1|||
25038415|NCT03055221|50138767|FG000|Overall Study|Study terminated by Sponsor|3|||
24948522|NCT00242710|50040560|FG003|Core Study (up to Year 1)|Physician Decision|1|||
24948523|NCT00242710|50040557|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
24948524|NCT00242710|50040558|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
24948525|NCT00242710|50040559|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
24948526|NCT00242710|50040560|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
24948527|NCT00242710|50040557|FG000|Core Study (up to Year 1)|Other|6|||
24948528|NCT00242710|50040558|FG001|Core Study (up to Year 1)|Other|1|||
24948529|NCT00242710|50040559|FG002|Core Study (up to Year 1)|Other|0|||
24948530|NCT00242710|50040560|FG003|Core Study (up to Year 1)|Other|2|||
24948531|NCT00242710|50040557|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
24948532|NCT00242710|50040558|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
24948533|NCT00242710|50040559|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
24948534|NCT00242710|50040560|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
24948535|NCT00242710|50040557|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
24948536|NCT00242710|50040558|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
24948537|NCT00242710|50040559|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
24948538|NCT00242710|50040560|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
24948539|NCT00242710|50040557|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
24948540|NCT00242710|50040558|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
24948541|NCT00242710|50040559|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
24948542|NCT00242710|50040560|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
24948543|NCT00242710|50040557|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
24948544|NCT00242710|50040558|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
24948545|NCT00242710|50040559|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
24948546|NCT00242710|50040560|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
24948547|NCT00242710|50040557|FG000|Period Between Core Study and Extension|Adverse Event|2|||
24948548|NCT00242710|50040558|FG001|Period Between Core Study and Extension|Adverse Event|3|||
24948549|NCT00242710|50040559|FG002|Period Between Core Study and Extension|Adverse Event|5|||
24948550|NCT00242710|50040560|FG003|Period Between Core Study and Extension|Adverse Event|2|||
24948551|NCT00242710|50040557|FG000|Period Between Core Study and Extension|Physician Decision|1|||
24948552|NCT00242710|50040558|FG001|Period Between Core Study and Extension|Physician Decision|1|||
24948553|NCT00242710|50040559|FG002|Period Between Core Study and Extension|Physician Decision|0|||
24948554|NCT00242710|50040560|FG003|Period Between Core Study and Extension|Physician Decision|0|||
24948555|NCT00242710|50040557|FG000|Period Between Core Study and Extension|Other|24|||
24948556|NCT00242710|50040558|FG001|Period Between Core Study and Extension|Other|24|||
24948557|NCT00242710|50040559|FG002|Period Between Core Study and Extension|Other|9|||
24948558|NCT00242710|50040560|FG003|Period Between Core Study and Extension|Other|11|||
24948559|NCT00242710|50040557|FG000|Period Between Core Study and Extension|Extension not Available|17|||
24948560|NCT00242710|50040558|FG001|Period Between Core Study and Extension|Extension not Available|21|||
24948561|NCT00242710|50040559|FG002|Period Between Core Study and Extension|Extension not Available|8|||
24948562|NCT00242710|50040560|FG003|Period Between Core Study and Extension|Extension not Available|7|||
24948563|NCT00242710|50040557|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
24948564|NCT00242710|50040558|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
24948565|NCT00242710|50040559|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
24948566|NCT00242710|50040560|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
24948567|NCT00242710|50040557|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
24948568|NCT00242710|50040558|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
24948569|NCT00242710|50040559|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
24948570|NCT00242710|50040560|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
24948571|NCT00242710|50040557|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
25038416|NCT04497415|50138793|FG000|Overall Study|Lost to Follow-up|43|||
25038417|NCT04497415|50138794|FG001|Overall Study|Lost to Follow-up|27|||
25038418|NCT03125941|50138802|FG000|Overall Study|did not receive intervention|1|||
24948572|NCT00242710|50040558|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
24948573|NCT00242710|50040559|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
24948574|NCT00242710|50040560|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
24948575|NCT00242710|50040557|FG000|Study Extension (up to Year 2)|Death|0|||
24948576|NCT00242710|50040558|FG001|Study Extension (up to Year 2)|Death|0|||
24948577|NCT00242710|50040559|FG002|Study Extension (up to Year 2)|Death|0|||
24948578|NCT00242710|50040560|FG003|Study Extension (up to Year 2)|Death|1|||
24948579|NCT00242710|50040557|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
25038419|NCT03125941|50138803|FG001|Overall Study|did not receive intervention|2|||
25038420|NCT02774889|50138811|FG000|Overall Study|Lost to Follow-up|2|||
25038421|NCT02774889|50138812|FG001|Overall Study|Lost to Follow-up|1|||
25038422|NCT03125629|50138820|FG000|Overall Study|Withdrawal by Subject|2|||
25038423|NCT03125629|50138820|FG000|Overall Study|Equipment malfunction|1|||
25038424|NCT03125395|50138832|FG000|Overall Study|Adverse Event|2|||
24948580|NCT00242710|50040558|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
24948581|NCT00242710|50040559|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
24948582|NCT00242710|50040560|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
24948583|NCT00242710|50040557|FG000|Study Extension (up to Year 2)|Other|3|||
24948584|NCT00242710|50040558|FG001|Study Extension (up to Year 2)|Other|5|||
24948585|NCT00242710|50040559|FG002|Study Extension (up to Year 2)|Other|4|||
24948586|NCT00242710|50040560|FG003|Study Extension (up to Year 2)|Other|3|||
24948587|NCT00242710|50040557|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
24948588|NCT00242710|50040558|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
24948589|NCT00242710|50040559|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
24948590|NCT00242710|50040560|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
24948591|NCT00242710|50040557|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
24948592|NCT00242710|50040558|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
24948593|NCT00242710|50040559|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
24948594|NCT00242710|50040560|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
24948595|NCT00408876|50040574|FG000|Overall Study|Adverse Event|9|||
25038425|NCT03125395|50138832|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
24948596|NCT00408876|50040575|FG001|Overall Study|Adverse Event|17|||
24948597|NCT00408876|50040576|FG002|Overall Study|Adverse Event|27|||
24948598|NCT00408876|50040577|FG003|Overall Study|Adverse Event|10|||
24948599|NCT00408876|50040574|FG000|Overall Study|Withdrawal by Subject|3|||
24948600|NCT00408876|50040575|FG001|Overall Study|Withdrawal by Subject|6|||
24948601|NCT00408876|50040576|FG002|Overall Study|Withdrawal by Subject|6|||
24948602|NCT00408876|50040577|FG003|Overall Study|Withdrawal by Subject|14|||
24948603|NCT00408876|50040574|FG000|Overall Study|Lack of Efficacy|2|||
25038426|NCT03125395|50138832|FG000|Overall Study|Physician Decision|2|||
25038427|NCT03125395|50138832|FG000|Overall Study|Commercial drug is available|5|||
25038428|NCT00261807|50138846|FG000|Overall Study|Lost to Follow-up|2|||
25038429|NCT00261807|50138846|FG000|Overall Study|Adverse Event|2|||
25038430|NCT00261807|50138846|FG000|Overall Study|Death|1|||
25038431|NCT00261807|50138846|FG000|Overall Study|Protocol Violation|2|||
25038432|NCT02820753|50138853|FG000|2 Month|Withdrawal by Subject|3|||
25038433|NCT02820753|50138854|FG001|2 Month|Withdrawal by Subject|3|||
25038434|NCT02820753|50138853|FG000|2 Month|Lost to Follow-up|24|||
25038435|NCT02820753|50138854|FG001|2 Month|Lost to Follow-up|26|||
24948604|NCT00408876|50040575|FG001|Overall Study|Lack of Efficacy|4|||
24948605|NCT00408876|50040576|FG002|Overall Study|Lack of Efficacy|5|||
24948606|NCT00408876|50040577|FG003|Overall Study|Lack of Efficacy|6|||
24948607|NCT00408876|50040574|FG000|Overall Study|Lost to Follow-up|1|||
24948608|NCT00408876|50040575|FG001|Overall Study|Lost to Follow-up|6|||
24948609|NCT00408876|50040576|FG002|Overall Study|Lost to Follow-up|5|||
24948610|NCT00408876|50040577|FG003|Overall Study|Lost to Follow-up|2|||
24948611|NCT00408876|50040574|FG000|Overall Study|Protocol Violation|0|||
24948612|NCT00408876|50040575|FG001|Overall Study|Protocol Violation|3|||
24948613|NCT00408876|50040576|FG002|Overall Study|Protocol Violation|4|||
24948614|NCT00408876|50040577|FG003|Overall Study|Protocol Violation|3|||
24948615|NCT00408876|50040574|FG000|Overall Study|Physician Decision|1|||
24948616|NCT00408876|50040575|FG001|Overall Study|Physician Decision|0|||
25038436|NCT02820753|50138853|FG000|2 Month|Stopped per NIH Hold|51|||
24948617|NCT00408876|50040576|FG002|Overall Study|Physician Decision|3|||
24948618|NCT00408876|50040577|FG003|Overall Study|Physician Decision|0|||
24948619|NCT00240994|50040587|FG000|Overall Study|Lost to Follow-up|1|||
24948620|NCT00240994|50040587|FG000|Overall Study|Protocol Violation|1|||
24948621|NCT00240994|50040587|FG000|Overall Study|Graft failure|1|||
24948622|NCT00239590|50040591|FG000|Randomized|Lost to Follow-up|0|||
24948623|NCT00239590|50040592|FG001|Randomized|Lost to Follow-up|1|||
24948624|NCT00239590|50040591|FG000|Randomized|Withdrawal by Subject|0|||
24948625|NCT00239590|50040592|FG001|Randomized|Withdrawal by Subject|1|||
24948626|NCT00239590|50040591|FG000|Completed Study Protocol|Adverse Event|1|||
24948627|NCT00239590|50040592|FG001|Completed Study Protocol|Adverse Event|1|||
24948628|NCT00239590|50040591|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
24948629|NCT00239590|50040592|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
24948630|NCT00433160|50040602|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
24948631|NCT00433160|50040603|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
24948632|NCT00433160|50040602|FG000|52-Week Double-Blind (DB) Period|Death|0|||
24948633|NCT00433160|50040603|FG001|52-Week Double-Blind (DB) Period|Death|0|||
24948634|NCT00433160|50040602|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
24948635|NCT00433160|50040603|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
24948636|NCT00433160|50040602|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
24948637|NCT00433160|50040603|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
25038437|NCT02820753|50138854|FG001|2 Month|Stopped per NIH Hold|13|||
25038438|NCT02820753|50138853|FG000|6 Month|Withdrawal by Subject|2|||
25038439|NCT02820753|50138854|FG001|6 Month|Withdrawal by Subject|2|||
25038440|NCT02820753|50138853|FG000|6 Month|Lost to Follow-up|20|||
25038441|NCT02820753|50138854|FG001|6 Month|Lost to Follow-up|27|||
24948638|NCT00433160|50040602|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
24948639|NCT00433160|50040603|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
24948640|NCT00433160|50040602|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
24948641|NCT00433160|50040603|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
24948642|NCT00433160|50040602|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
24948643|NCT00433160|50040603|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
24948644|NCT00433160|50040602|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
24948645|NCT00433160|50040603|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
24948646|NCT00433160|50040602|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
24948647|NCT00433160|50040603|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
24948648|NCT00433160|50040602|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
24948649|NCT00433160|50040603|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
24948650|NCT00433160|50040602|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
24948651|NCT00433160|50040603|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
24948652|NCT00433160|50040602|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
24948653|NCT00433160|50040603|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
24948654|NCT00433160|50040602|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
24948655|NCT00433160|50040603|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
24948656|NCT00433160|50040602|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
24948657|NCT00433160|50040603|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
24948658|NCT00433160|50040602|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
24948659|NCT00433160|50040603|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
24948660|NCT00433160|50040602|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
24948661|NCT00433160|50040603|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
25038442|NCT02820753|50138853|FG000|6 Month|Stopped per NIH Hold|81|||
25038443|NCT02820753|50138854|FG001|6 Month|Stopped per NIH Hold|81|||
25038444|NCT02820753|50138853|FG000|6 Month|Death|0|||
25038445|NCT02820753|50138854|FG001|6 Month|Death|1|||
25038446|NCT02861586|50138868|FG000|Overall Study|Withdrawal by Subject|1|||
25038447|NCT02861586|50138869|FG001|Overall Study|Withdrawal by Subject|2|||
25038448|NCT02861586|50138870|FG002|Overall Study|Withdrawal by Subject|0|||
25038449|NCT02861586|50138871|FG003|Overall Study|Withdrawal by Subject|0|||
25038450|NCT02861586|50138872|FG004|Overall Study|Withdrawal by Subject|0|||
25038451|NCT02861586|50138873|FG005|Overall Study|Withdrawal by Subject|1|||
25038452|NCT02861586|50138874|FG006|Overall Study|Withdrawal by Subject|1|||
25038453|NCT02861586|50138875|FG007|Overall Study|Withdrawal by Subject|0|||
25038454|NCT02861586|50138868|FG000|Overall Study|Lost to Follow-up|3|||
25038455|NCT02861586|50138869|FG001|Overall Study|Lost to Follow-up|1|||
25038456|NCT02861586|50138870|FG002|Overall Study|Lost to Follow-up|1|||
25038457|NCT02861586|50138871|FG003|Overall Study|Lost to Follow-up|0|||
25038458|NCT02861586|50138872|FG004|Overall Study|Lost to Follow-up|0|||
25038459|NCT02861586|50138873|FG005|Overall Study|Lost to Follow-up|3|||
25038460|NCT02861586|50138874|FG006|Overall Study|Lost to Follow-up|0|||
25038461|NCT02861586|50138875|FG007|Overall Study|Lost to Follow-up|0|||
25038462|NCT02861586|50138868|FG000|Overall Study|Adverse Event|0|||
25038463|NCT02861586|50138869|FG001|Overall Study|Adverse Event|0|||
25038464|NCT02861586|50138870|FG002|Overall Study|Adverse Event|0|||
25038465|NCT02861586|50138871|FG003|Overall Study|Adverse Event|0|||
25038466|NCT02861586|50138872|FG004|Overall Study|Adverse Event|0|||
25038467|NCT02861586|50138873|FG005|Overall Study|Adverse Event|1|||
25038468|NCT02861586|50138874|FG006|Overall Study|Adverse Event|0|||
25038469|NCT02861586|50138875|FG007|Overall Study|Adverse Event|0|||
25038470|NCT03120949|50138911|FG000|Overall Study|randomized in error|1|||
25038471|NCT03120949|50138912|FG001|Overall Study|randomized in error|0|||
25038472|NCT03120949|50138911|FG000|Overall Study|Death|13|||
25038473|NCT03120949|50138912|FG001|Overall Study|Death|13|||
25038474|NCT03120949|50138911|FG000|Overall Study|Lost to Follow-up|23|||
25038475|NCT03120949|50138912|FG001|Overall Study|Lost to Follow-up|13|||
25038476|NCT03120949|50138911|FG000|Overall Study|Withdrawal by Subject|139|||
25038477|NCT03120949|50138912|FG001|Overall Study|Withdrawal by Subject|124|||
25038478|NCT03120949|50138911|FG000|Overall Study|Covid-19|43|||
25038479|NCT03120949|50138912|FG001|Overall Study|Covid-19|34|||
25038480|NCT03120949|50138911|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
25038481|NCT03120949|50138912|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
25038482|NCT03120949|50138911|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
25038483|NCT03120949|50138912|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
25038484|NCT03120949|50138911|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
25038485|NCT03120949|50138912|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
25038486|NCT03120949|50138911|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
25038487|NCT03120949|50138912|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
25038488|NCT03120949|50138911|FG000|Overall Study|Site was closed|2|||
25038489|NCT03120949|50138912|FG001|Overall Study|Site was closed|3|||
25038490|NCT03120949|50138911|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
25038491|NCT03120949|50138912|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
25038492|NCT03120949|50138911|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
25038493|NCT03120949|50138912|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
24948662|NCT00239356|50040615|FG000|Overall Study|Lack of Efficacy|1|||
24948663|NCT00239356|50040616|FG001|Overall Study|Lack of Efficacy|0|||
24948664|NCT00239356|50040615|FG000|Overall Study|Adverse Event|6|||
24948665|NCT00239356|50040616|FG001|Overall Study|Adverse Event|0|||
24948666|NCT00239356|50040615|FG000|Overall Study|Withdrawal by Subject|15|||
24948667|NCT00239356|50040616|FG001|Overall Study|Withdrawal by Subject|6|||
24948668|NCT00239356|50040615|FG000|Overall Study|Lost to Follow-up|3|||
24948669|NCT00239356|50040616|FG001|Overall Study|Lost to Follow-up|0|||
24948670|NCT00239356|50040615|FG000|Overall Study|poor/non-compliance|2|||
24948671|NCT00239356|50040616|FG001|Overall Study|poor/non-compliance|0|||
24948672|NCT00239356|50040615|FG000|Overall Study|Pregnancy|1|||
24948673|NCT00239356|50040616|FG001|Overall Study|Pregnancy|0|||
24948674|NCT00239356|50040615|FG000|Overall Study|Administrative reason|0|||
25038494|NCT03120949|50138911|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
24948675|NCT00239356|50040616|FG001|Overall Study|Administrative reason|1|||
24948676|NCT00239356|50040615|FG000|Overall Study|Drug available on market|11|||
24948677|NCT00239356|50040616|FG001|Overall Study|Drug available on market|2|||
24948678|NCT00393510|50040624|FG000|Overall Study|Physician Decision|3|||
24948679|NCT00393510|50040625|FG001|Overall Study|Physician Decision|9|||
24964620|NCT00431951|50054452|FG003|Overall Study|Lost to Follow-up|0|||
25160026|NCT01725308|50280066|FG000|Treatment Period I|Insufficient Response|7|||
25160027|NCT01725308|50280067|FG001|Treatment Period I|Insufficient Response|0|||
24948680|NCT00425438|50040633|FG000|Overall Study|Termination by Sponsor|25|||
25038495|NCT03120949|50138912|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
25038496|NCT03120949|50138911|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
24948681|NCT00425438|50040634|FG001|Overall Study|Termination by Sponsor|27|||
24948682|NCT00275002|50040642|FG000|Overall Study|Death|1|||
24948683|NCT00275002|50040643|FG001|Overall Study|Death|0|||
24948684|NCT00275002|50040642|FG000|Overall Study|Disease progression|21|||
24948685|NCT00275002|50040643|FG001|Overall Study|Disease progression|15|||
24948686|NCT00275002|50040642|FG000|Overall Study|Adverse Event|0|||
24948687|NCT00275002|50040643|FG001|Overall Study|Adverse Event|1|||
24948688|NCT00433004|50040651|FG000|Overall Study|Lost to Follow-up|5|||
24948689|NCT00433004|50040652|FG001|Overall Study|Lost to Follow-up|7|||
24948690|NCT00238264|50040658|FG000|Overall Study|Death|7|||
24948691|NCT00238264|50040658|FG000|Overall Study|Lost to Follow-up|18|||
24948692|NCT00238264|50040658|FG000|Overall Study|Withdrawal by Subject|4|||
24948693|NCT00238264|50040658|FG000|Overall Study|Ineligible|7|||
24948694|NCT00414596|50040662|FG000|Overall Study|Protocol Violation|2|||
24948695|NCT00393042|50040666|FG000|First Intervention|Withdrawal by Subject|1|||
24948696|NCT00393042|50040667|FG001|First Intervention|Withdrawal by Subject|2|||
24948697|NCT00393042|50040666|FG000|First Intervention|Lost to Follow-up|3|||
24948698|NCT00393042|50040667|FG001|First Intervention|Lost to Follow-up|3|||
24948699|NCT00393042|50040666|FG000|First Intervention|Protocol Violation|1|||
24948700|NCT00393042|50040667|FG001|First Intervention|Protocol Violation|0|||
24948701|NCT00393042|50040666|FG000|First Intervention|Adverse Event|0|||
25160028|NCT01725308|50280068|FG002|Treatment Period I|Insufficient Response|5|||
25186261|NCT01457924|50336267|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
24948702|NCT00393042|50040667|FG001|First Intervention|Adverse Event|1|||
24948703|NCT00393042|50040666|FG000|Second Intervetion|Adverse Event|0|||
24948704|NCT00393042|50040667|FG001|Second Intervetion|Adverse Event|3|||
24948705|NCT00393042|50040666|FG000|Second Intervetion|Withdrawal by Subject|0|||
24948706|NCT00393042|50040667|FG001|Second Intervetion|Withdrawal by Subject|2|||
24948707|NCT00393042|50040666|FG000|Second Intervetion|Lack of Efficacy|1|||
24948708|NCT00393042|50040667|FG001|Second Intervetion|Lack of Efficacy|0|||
24948709|NCT00393042|50040666|FG000|Second Intervetion|Lost to Follow-up|0|||
24948710|NCT00393042|50040667|FG001|Second Intervetion|Lost to Follow-up|2|||
24948711|NCT00393042|50040666|FG000|Second Intervetion|Protocol Violation|1|||
24948712|NCT00393042|50040667|FG001|Second Intervetion|Protocol Violation|1|||
24948713|NCT00392808|50040725|FG000|Overall Study|Lost to Follow-up|3|||
24948714|NCT00392808|50040726|FG001|Overall Study|Lost to Follow-up|2|||
24948715|NCT00392808|50040727|FG002|Overall Study|Lost to Follow-up|1|||
24948716|NCT00392808|50040728|FG003|Overall Study|Lost to Follow-up|2|||
24948717|NCT00392808|50040725|FG000|Overall Study|Unable to withdraw blood|3|||
24948718|NCT00392808|50040726|FG001|Overall Study|Unable to withdraw blood|1|||
24948719|NCT00392808|50040727|FG002|Overall Study|Unable to withdraw blood|1|||
24948720|NCT00392808|50040728|FG003|Overall Study|Unable to withdraw blood|2|||
25275740|NCT01233869|50589543|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
25275741|NCT01233869|50589544|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
25275742|NCT01233869|50589545|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
25275743|NCT01233869|50589546|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
25275744|NCT01233869|50589543|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
25275745|NCT01233869|50589544|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
25275746|NCT01233869|50589545|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
25275747|NCT01233869|50589546|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
25275748|NCT01233869|50589543|FG000|Extended Treatment Period (46 Months)|Other|3|||
25275749|NCT01233869|50589544|FG001|Extended Treatment Period (46 Months)|Other|0|||
25275750|NCT01233869|50589545|FG002|Extended Treatment Period (46 Months)|Other|0|||
25275751|NCT01233869|50589546|FG003|Extended Treatment Period (46 Months)|Other|3|||
25275752|NCT01233869|50589543|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
25275753|NCT01233869|50589544|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
25275754|NCT01233869|50589545|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
25275755|NCT01233869|50589546|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
25275756|NCT00992992|50589556|FG000|Overall Study|Lost to Follow-up|3|||
25275757|NCT00992992|50589556|FG000|Overall Study|Death|16|||
25275758|NCT00992992|50589556|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
25275759|NCT00992992|50589556|FG000|Overall Study|Sponsor Closed the Study|4|||
25275760|NCT00992836|50589560|FG000|Overall Study|Lost to Follow-up|1|||
25275761|NCT00992836|50589560|FG000|Overall Study|Withdrawal by Subject|2|||
25275762|NCT00992836|50589560|FG000|Overall Study|Protocol Violation|2|||
25275763|NCT00992446|50589570|FG000|Overall Study|Disease Progression|1|||
25275764|NCT00992446|50589570|FG000|Overall Study|Withdrawal by Subject|2|||
25275765|NCT00992446|50589570|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
25275766|NCT00970294|50589574|FG000|Overall Study|Physician Decision|4|||
25275767|NCT00970294|50589574|FG000|Overall Study|Withdrawal by Subject|1|||
25160029|NCT01725308|50280066|FG000|Treatment Period I|Worsening of the Target Disease|8|||
25160030|NCT01725308|50280067|FG001|Treatment Period I|Worsening of the Target Disease|0|||
25275768|NCT00969436|50589581|FG000|Overall Study|Protocol Violation|1|||
25275769|NCT00969436|50589582|FG001|Overall Study|Protocol Violation|3|||
25275770|NCT00969436|50589583|FG002|Overall Study|Protocol Violation|0|||
25275771|NCT00969436|50589581|FG000|Overall Study|Migrated/moved from study area|12|||
25275772|NCT00969436|50589582|FG001|Overall Study|Migrated/moved from study area|10|||
25275773|NCT00969436|50589583|FG002|Overall Study|Migrated/moved from study area|2|||
25275774|NCT00969436|50589581|FG000|Overall Study|Father - serious health problem|0|||
25275775|NCT00969436|50589582|FG001|Overall Study|Father - serious health problem|0|||
25275776|NCT00969436|50589583|FG002|Overall Study|Father - serious health problem|1|||
25275777|NCT00969436|50589581|FG000|Overall Study|Parents personal problem|0|||
24948760|NCT00274846|50040759|FG000|Overall Study|Did not receive adequate NK cells|1|||
24948761|NCT00237796|50040766|FG000|Overall Study|Baseline and one other ILSS required|10|||
24948762|NCT00237796|50040767|FG001|Overall Study|Baseline and one other ILSS required|5|||
24948763|NCT00414440|50040776|FG000|Core Period|Withdrawal by Subject|70|||
24948764|NCT00414440|50040777|FG001|Core Period|Withdrawal by Subject|32|||
24948765|NCT00414440|50040776|FG000|Extension Period|Lost to Follow-up|44|||
24948766|NCT00414440|50040777|FG001|Extension Period|Lost to Follow-up|52|||
24948767|NCT00414440|50040776|FG000|Extension Period|Did not consent to continue follow up|61|||
24948768|NCT00414440|50040777|FG001|Extension Period|Did not consent to continue follow up|54|||
24948769|NCT00414440|50040776|FG000|Extension Period|Other|1|||
24948770|NCT00414440|50040777|FG001|Extension Period|Other|1|||
24948771|NCT00414440|50040776|FG000|Extension Period|Administrative|16|||
24948772|NCT00414440|50040777|FG001|Extension Period|Administrative|16|||
24948773|NCT00414440|50040776|FG000|Extension Period|Death|1|||
24948774|NCT00414440|50040777|FG001|Extension Period|Death|2|||
24948775|NCT00414440|50040776|FG000|Extension Period|Withdrawal by Subject|9|||
25038497|NCT03120949|50138912|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
25038498|NCT03120949|50138911|FG000|Overall Study|Other: Adverse Event|0|||
25038499|NCT03120949|50138912|FG001|Overall Study|Other: Adverse Event|1|||
25038500|NCT03120949|50138911|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
25038501|NCT03120949|50138912|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
25038502|NCT03120949|50138911|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
25038503|NCT03120949|50138912|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
25160031|NCT01725308|50280068|FG002|Treatment Period I|Worsening of the Target Disease|2|||
25160032|NCT01725308|50280066|FG000|Treatment Period I|Changes in the Episodes|3|||
25160033|NCT01725308|50280067|FG001|Treatment Period I|Changes in the Episodes|0|||
25160034|NCT01725308|50280068|FG002|Treatment Period I|Changes in the Episodes|2|||
25160035|NCT01725308|50280066|FG000|Treatment Period I|Withdrawal of Consent|12|||
25160036|NCT01725308|50280067|FG001|Treatment Period I|Withdrawal of Consent|7|||
25160037|NCT01725308|50280068|FG002|Treatment Period I|Withdrawal of Consent|5|||
25160038|NCT01725308|50280066|FG000|Treatment Period I|Lost to Follow-up|3|||
25160039|NCT01725308|50280067|FG001|Treatment Period I|Lost to Follow-up|2|||
25160040|NCT01725308|50280068|FG002|Treatment Period I|Lost to Follow-up|2|||
25160041|NCT01725308|50280066|FG000|Treatment Period I|Protocol Deviations|3|||
25160042|NCT01725308|50280067|FG001|Treatment Period I|Protocol Deviations|1|||
25160043|NCT01725308|50280068|FG002|Treatment Period I|Protocol Deviations|1|||
25160044|NCT01725308|50280066|FG000|Treatment Period I|Miscellaneous|2|||
25160045|NCT01725308|50280067|FG001|Treatment Period I|Miscellaneous|0|||
25160046|NCT01725308|50280068|FG002|Treatment Period I|Miscellaneous|3|||
25160047|NCT01725308|50280066|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
25275778|NCT00969436|50589582|FG001|Overall Study|Parents personal problem|0|||
25275779|NCT00969436|50589583|FG002|Overall Study|Parents personal problem|1|||
25275780|NCT00969436|50589581|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
25275781|NCT00969436|50589582|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
24948776|NCT00414440|50040777|FG001|Extension Period|Withdrawal by Subject|7|||
25160048|NCT01725308|50280067|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
25186262|NCT01457924|50336263|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
25186263|NCT01457924|50336264|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
25186264|NCT01457924|50336265|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
25186265|NCT01457924|50336266|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
25186266|NCT01457924|50336267|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
25186267|NCT01457924|50336263|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
25186268|NCT01457924|50336264|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
25186269|NCT01457924|50336265|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
25186270|NCT01457924|50336266|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
25186271|NCT01457924|50336267|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
25186272|NCT01457924|50336263|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
25186273|NCT01457924|50336264|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
25186274|NCT01457924|50336265|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
25186275|NCT01457924|50336266|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
25186276|NCT01457924|50336267|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
25186277|NCT01457924|50336263|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
25160049|NCT01725308|50280068|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
25160050|NCT01725308|50280066|FG000|Treatment Period II|Did Not Receive Drug|4|||
25160051|NCT01725308|50280067|FG001|Treatment Period II|Did Not Receive Drug|0|||
25160052|NCT01725308|50280068|FG002|Treatment Period II|Did Not Receive Drug|0|||
25160053|NCT01725308|50280066|FG000|Treatment Period II|Adverse Event|13|||
25160054|NCT01725308|50280067|FG001|Treatment Period II|Adverse Event|8|||
25160055|NCT01725308|50280068|FG002|Treatment Period II|Adverse Event|20|||
25160056|NCT01725308|50280066|FG000|Treatment Period II|Insufficient Response|2|||
25160057|NCT01725308|50280067|FG001|Treatment Period II|Insufficient Response|4|||
25160058|NCT01725308|50280068|FG002|Treatment Period II|Insufficient Response|6|||
25160059|NCT01725308|50280066|FG000|Treatment Period II|Worsening of the Target Disease|1|||
25160060|NCT01725308|50280067|FG001|Treatment Period II|Worsening of the Target Disease|4|||
25160061|NCT01725308|50280068|FG002|Treatment Period II|Worsening of the Target Disease|2|||
25160062|NCT01725308|50280066|FG000|Treatment Period II|Changes in the Episodes|1|||
25160063|NCT01725308|50280067|FG001|Treatment Period II|Changes in the Episodes|0|||
25160064|NCT01725308|50280068|FG002|Treatment Period II|Changes in the Episodes|5|||
25160065|NCT01725308|50280066|FG000|Treatment Period II|Withdrawal of Consent|28|||
25160066|NCT01725308|50280067|FG001|Treatment Period II|Withdrawal of Consent|2|||
25160067|NCT01725308|50280068|FG002|Treatment Period II|Withdrawal of Consent|16|||
25160068|NCT01725308|50280066|FG000|Treatment Period II|Lost to Follow-up|1|||
25186278|NCT01457924|50336264|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
25186279|NCT01457924|50336265|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
24948777|NCT00414440|50040776|FG000|Extension Period|Not included in follow up period|18|||
25186280|NCT01457924|50336266|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
25160069|NCT01725308|50280067|FG001|Treatment Period II|Lost to Follow-up|5|||
25160070|NCT01725308|50280068|FG002|Treatment Period II|Lost to Follow-up|3|||
24948778|NCT00414440|50040777|FG001|Extension Period|Not included in follow up period|8|||
24948779|NCT00209560|50040785|FG000|Overall Study|Lack of Efficacy|1|||
24948780|NCT00209560|50040786|FG001|Overall Study|Lack of Efficacy|0|||
24948781|NCT00236080|50040797|FG000|Overall Study|Adverse Event|0|||
24948782|NCT00236080|50040798|FG001|Overall Study|Adverse Event|0|||
24948783|NCT00236080|50040799|FG002|Overall Study|Adverse Event|3|||
24948784|NCT00236080|50040800|FG003|Overall Study|Adverse Event|1|||
24948785|NCT00236080|50040801|FG004|Overall Study|Adverse Event|0|||
24948786|NCT00236080|50040797|FG000|Overall Study|Lost to Follow-up|0|||
24948787|NCT00236080|50040798|FG001|Overall Study|Lost to Follow-up|1|||
24948788|NCT00236080|50040799|FG002|Overall Study|Lost to Follow-up|0|||
24948789|NCT00236080|50040800|FG003|Overall Study|Lost to Follow-up|0|||
24948790|NCT00236080|50040801|FG004|Overall Study|Lost to Follow-up|0|||
24948791|NCT00236080|50040797|FG000|Overall Study|Physician Decision|1|||
24948792|NCT00236080|50040798|FG001|Overall Study|Physician Decision|0|||
24948793|NCT00236080|50040799|FG002|Overall Study|Physician Decision|1|||
24948794|NCT00236080|50040800|FG003|Overall Study|Physician Decision|1|||
24948795|NCT00236080|50040801|FG004|Overall Study|Physician Decision|1|||
24948796|NCT00236080|50040797|FG000|Overall Study|Withdrawal by Subject|1|||
24948797|NCT00236080|50040798|FG001|Overall Study|Withdrawal by Subject|0|||
24948798|NCT00236080|50040799|FG002|Overall Study|Withdrawal by Subject|0|||
24948799|NCT00236080|50040800|FG003|Overall Study|Withdrawal by Subject|0|||
24948800|NCT00236080|50040801|FG004|Overall Study|Withdrawal by Subject|0|||
24948801|NCT00236080|50040797|FG000|Overall Study|Miscellaneous|0|||
24948802|NCT00236080|50040798|FG001|Overall Study|Miscellaneous|0|||
24948803|NCT00236080|50040799|FG002|Overall Study|Miscellaneous|1|||
24948804|NCT00236080|50040800|FG003|Overall Study|Miscellaneous|0|||
25038504|NCT03120949|50138911|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
24948805|NCT00236080|50040801|FG004|Overall Study|Miscellaneous|0|||
24948806|NCT00432380|50040816|FG000|Overall Study|Migrated/moved from study area|3|||
24948807|NCT00432380|50040817|FG001|Overall Study|Migrated/moved from study area|4|||
24948808|NCT00432380|50040818|FG002|Overall Study|Migrated/moved from study area|1|||
24948809|NCT00432380|50040816|FG000|Overall Study|Adverse Event|1|||
24948810|NCT00432380|50040817|FG001|Overall Study|Adverse Event|0|||
24948811|NCT00432380|50040818|FG002|Overall Study|Adverse Event|0|||
24948812|NCT00234052|50040827|FG000|Treatment|Withdrawal by Subject|3|||
24948813|NCT00234052|50040827|FG000|Treatment|Adverse Event|5|||
25160071|NCT01725308|50280066|FG000|Treatment Period II|Protocol Deviations|0|||
25160072|NCT01725308|50280067|FG001|Treatment Period II|Protocol Deviations|0|||
25160073|NCT01725308|50280068|FG002|Treatment Period II|Protocol Deviations|1|||
25160074|NCT01725308|50280066|FG000|Treatment Period II|Miscellaneous|5|||
25160075|NCT01725308|50280067|FG001|Treatment Period II|Miscellaneous|3|||
25160076|NCT01725308|50280068|FG002|Treatment Period II|Miscellaneous|7|||
25160077|NCT01724528|50280085|FG000|Overall Study|Death|3|||
25160078|NCT01724528|50280086|FG001|Overall Study|Death|0|||
25160079|NCT01724528|50280085|FG000|Overall Study|Withdrawal by Subject|0|||
25160080|NCT01724528|50280086|FG001|Overall Study|Withdrawal by Subject|2|||
25160081|NCT01724528|50280085|FG000|Overall Study|Protocol Violation|0|||
25160082|NCT01724528|50280086|FG001|Overall Study|Protocol Violation|1|||
25160083|NCT01724528|50280085|FG000|Overall Study|Patient refused to attend last visit|1|||
25160084|NCT01724528|50280086|FG001|Overall Study|Patient refused to attend last visit|0|||
25160085|NCT01779440|50280094|FG000|Overall Study|Withdrawal by Subject|3|||
25160086|NCT01779440|50280095|FG001|Overall Study|Withdrawal by Subject|5|||
25160087|NCT01750346|50280104|FG000|Overall Study|Adverse Event|1|||
25160088|NCT01750346|50280105|FG001|Overall Study|Adverse Event|0|||
25160089|NCT01750346|50280106|FG002|Overall Study|Adverse Event|0|||
25160090|NCT01750268|50280116|FG000|Overall Study|Lost to Follow-up|0|||
25160091|NCT01750268|50280117|FG001|Overall Study|Lost to Follow-up|2|||
25160092|NCT01750268|50280116|FG000|Overall Study|Physician Decision|0|||
25160093|NCT01750268|50280117|FG001|Overall Study|Physician Decision|3|||
25160094|NCT01750268|50280116|FG000|Overall Study|Withdrawal by Subject|2|||
25160095|NCT01750268|50280117|FG001|Overall Study|Withdrawal by Subject|0|||
25160096|NCT01880437|50280126|FG000|Overall Study|Death|12|||
25160097|NCT01880437|50280127|FG001|Overall Study|Death|4|||
25160098|NCT01880437|50280128|FG002|Overall Study|Death|17|||
25160099|NCT01880437|50280126|FG000|Overall Study|Study terminated by Sponsor|3|||
25160100|NCT01880437|50280127|FG001|Overall Study|Study terminated by Sponsor|0|||
25160101|NCT01880437|50280128|FG002|Overall Study|Study terminated by Sponsor|2|||
25160102|NCT01861717|50280138|FG000|Overall Study|Lost to Follow-up|1|||
25160103|NCT01861717|50280138|FG000|Overall Study|Withdrawal by Subject|1|||
25160104|NCT01834729|50280147|FG000|Overall Study|Did not return bowel diaries|0|||
25160105|NCT01834729|50280148|FG001|Overall Study|Did not return bowel diaries|0|||
25160106|NCT01834729|50280149|FG002|Overall Study|Did not return bowel diaries|3|||
25186281|NCT01457924|50336267|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
24948814|NCT00234052|50040827|FG000|Treatment|Death|2|||
24948815|NCT00234052|50040827|FG000|Treatment|Progressive Disease|11|||
24948816|NCT00234052|50040827|FG000|Follow-up for 5 Years|Death|41|||
24948817|NCT00234052|50040827|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
24948818|NCT00234052|50040827|FG000|Follow-up for 5 Years|Other|7|||
24948819|NCT00408408|50040837|FG000|Overall Study|No follow up data|2|||
24948820|NCT00408408|50040838|FG001|Overall Study|No follow up data|3|||
24948821|NCT00408408|50040839|FG002|Overall Study|No follow up data|0|||
24948822|NCT00408408|50040840|FG003|Overall Study|No follow up data|7|||
24948823|NCT00408408|50040841|FG004|Overall Study|No follow up data|5|||
24948824|NCT00408408|50040842|FG005|Overall Study|No follow up data|3|||
24948825|NCT00414050|50040860|FG000|Overall Study|Adverse Event|1|||
24948826|NCT00414050|50040861|FG001|Overall Study|Adverse Event|1|||
24948827|NCT00414050|50040862|FG002|Overall Study|Adverse Event|1|||
24948828|NCT00414050|50040863|FG003|Overall Study|Adverse Event|1|||
24948829|NCT00414050|50040860|FG000|Overall Study|Lost to Follow-up|2|||
25160107|NCT01834729|50280150|FG003|Overall Study|Did not return bowel diaries|0|||
25160108|NCT01834729|50280147|FG000|Overall Study|Withdrawal by Subject|1|||
25160109|NCT01834729|50280148|FG001|Overall Study|Withdrawal by Subject|1|||
25160110|NCT01834729|50280149|FG002|Overall Study|Withdrawal by Subject|0|||
25160111|NCT01834729|50280150|FG003|Overall Study|Withdrawal by Subject|0|||
25160112|NCT01834729|50280147|FG000|Overall Study|Adverse Event|0|||
25186282|NCT01457924|50336263|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
24948830|NCT00414050|50040861|FG001|Overall Study|Lost to Follow-up|2|||
24948831|NCT00414050|50040862|FG002|Overall Study|Lost to Follow-up|1|||
24948832|NCT00414050|50040863|FG003|Overall Study|Lost to Follow-up|1|||
24948833|NCT00414050|50040860|FG000|Overall Study|Withdrawal by Subject|5|||
24948834|NCT00414050|50040861|FG001|Overall Study|Withdrawal by Subject|3|||
24948835|NCT00414050|50040862|FG002|Overall Study|Withdrawal by Subject|2|||
24948836|NCT00414050|50040863|FG003|Overall Study|Withdrawal by Subject|4|||
24948837|NCT00414050|50040860|FG000|Overall Study|Subject discontinued for other reason|1|||
24948838|NCT00414050|50040861|FG001|Overall Study|Subject discontinued for other reason|2|||
24948839|NCT00414050|50040862|FG002|Overall Study|Subject discontinued for other reason|2|||
24948840|NCT00414050|50040863|FG003|Overall Study|Subject discontinued for other reason|1|||
24948841|NCT00414050|50040860|FG000|Overall Study|Subject Moved|0|||
24948842|NCT00414050|50040861|FG001|Overall Study|Subject Moved|0|||
24948843|NCT00414050|50040862|FG002|Overall Study|Subject Moved|0|||
24948844|NCT00414050|50040863|FG003|Overall Study|Subject Moved|1|||
24948845|NCT00413972|50040877|FG000|Overall Study|Adverse Event|2|||
24948846|NCT00413972|50040878|FG001|Overall Study|Adverse Event|1|||
24948847|NCT00413972|50040879|FG002|Overall Study|Adverse Event|0|||
24948848|NCT00413972|50040880|FG003|Overall Study|Adverse Event|0|||
24948849|NCT00413972|50040877|FG000|Overall Study|Lost to Follow-up|1|||
24948850|NCT00413972|50040878|FG001|Overall Study|Lost to Follow-up|2|||
24948851|NCT00413972|50040879|FG002|Overall Study|Lost to Follow-up|1|||
24948852|NCT00413972|50040880|FG003|Overall Study|Lost to Follow-up|0|||
24948853|NCT00413972|50040877|FG000|Overall Study|Withdrawal by Subject|4|||
24948854|NCT00413972|50040878|FG001|Overall Study|Withdrawal by Subject|5|||
24948855|NCT00413972|50040879|FG002|Overall Study|Withdrawal by Subject|7|||
24948856|NCT00413972|50040880|FG003|Overall Study|Withdrawal by Subject|2|||
24948857|NCT00413972|50040877|FG000|Overall Study|Protocol Violation|0|||
24948858|NCT00413972|50040878|FG001|Overall Study|Protocol Violation|0|||
24948859|NCT00413972|50040879|FG002|Overall Study|Protocol Violation|2|||
24948860|NCT00413972|50040880|FG003|Overall Study|Protocol Violation|0|||
24948861|NCT00413972|50040877|FG000|Overall Study|Other|0|||
24948862|NCT00413972|50040878|FG001|Overall Study|Other|0|||
24948863|NCT00413972|50040879|FG002|Overall Study|Other|0|||
24948864|NCT00413972|50040880|FG003|Overall Study|Other|1|||
24948865|NCT00259012|50040892|FG000|Overall Study|Adverse Event|0|||
24948866|NCT00259012|50040893|FG001|Overall Study|Adverse Event|1|||
24948867|NCT00259012|50040892|FG000|Overall Study|Withdrawal by Subject|1|||
24948868|NCT00259012|50040893|FG001|Overall Study|Withdrawal by Subject|0|||
24948869|NCT00259012|50040892|FG000|Overall Study|Physician Decision|0|||
24948870|NCT00259012|50040893|FG001|Overall Study|Physician Decision|1|||
24948871|NCT00259012|50040892|FG000|Overall Study|Lost to Follow-up|0|||
24948872|NCT00259012|50040893|FG001|Overall Study|Lost to Follow-up|1|||
24948873|NCT00259012|50040892|FG000|Overall Study|Protocol Violation|1|||
24948874|NCT00259012|50040893|FG001|Overall Study|Protocol Violation|1|||
24948875|NCT00209170|50040901|FG000|Overall Study|Adverse Event|0|||
24948876|NCT00209170|50040902|FG001|Overall Study|Adverse Event|1|||
24948877|NCT00209170|50040901|FG000|Overall Study|Withdrawal by Subject|2|||
24948878|NCT00209170|50040902|FG001|Overall Study|Withdrawal by Subject|1|||
24948879|NCT00209170|50040901|FG000|Overall Study|Lack of Efficacy|0|||
24948880|NCT00209170|50040902|FG001|Overall Study|Lack of Efficacy|1|||
24948881|NCT00413894|50040908|FG000|Overall Study|Withdrawal by Subject|10|||
24948882|NCT00413894|50040908|FG000|Overall Study|Administrative Reasons|1|||
24948883|NCT00413894|50040908|FG000|Overall Study|Hb <10 grams/deciliter|12|||
24948884|NCT00413894|50040908|FG000|Overall Study|Adverse Event|28|||
24948885|NCT00413894|50040908|FG000|Overall Study|Protocol Violation|11|||
24948886|NCT00413894|50040908|FG000|Overall Study|Other|18|||
24948887|NCT00407550|50040917|FG000|Overall Study|Adverse Event|0|||
24948888|NCT00407550|50040918|FG001|Overall Study|Adverse Event|1|||
24948889|NCT00407550|50040917|FG000|Overall Study|Withdrawal by Subject|0|||
25160113|NCT01834729|50280148|FG001|Overall Study|Adverse Event|0|||
25160114|NCT01834729|50280149|FG002|Overall Study|Adverse Event|0|||
25160115|NCT01834729|50280150|FG003|Overall Study|Adverse Event|2|||
24948890|NCT00407550|50040918|FG001|Overall Study|Withdrawal by Subject|2|||
24948891|NCT00407550|50040917|FG000|Overall Study|Death|1|||
24948892|NCT00407550|50040918|FG001|Overall Study|Death|0|||
24948893|NCT00407550|50040917|FG000|Overall Study|Insurance or Other medical condition|2|||
25038505|NCT03120949|50138912|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
25160116|NCT01860703|50280161|FG000|Overall Study|Adverse Event|1|||
25160117|NCT01860703|50280162|FG001|Overall Study|Adverse Event|4|||
24948894|NCT00407550|50040918|FG001|Overall Study|Insurance or Other medical condition|1|||
25038506|NCT03120949|50138911|FG000|Overall Study|Personal Reasons|0|||
25160118|NCT01860703|50280163|FG002|Overall Study|Adverse Event|0|||
24948895|NCT00209092|50040926|FG000|Overall Study|Progression of disease|7|||
24948896|NCT00209092|50040927|FG001|Overall Study|Progression of disease|1|||
24948897|NCT00209092|50040926|FG000|Overall Study|Adverse Event|0|||
24948898|NCT00209092|50040927|FG001|Overall Study|Adverse Event|1|||
24948899|NCT00209092|50040926|FG000|Overall Study|Withdrawal by Subject|1|||
24948900|NCT00209092|50040927|FG001|Overall Study|Withdrawal by Subject|0|||
24948901|NCT00403494|50040935|FG000|Overall Study|Adverse Event|10|||
24948902|NCT00403494|50040936|FG001|Overall Study|Adverse Event|8|||
24948903|NCT00403494|50040935|FG000|Overall Study|Withdrew Consent|3|||
24948904|NCT00403494|50040936|FG001|Overall Study|Withdrew Consent|2|||
24948905|NCT00403494|50040935|FG000|Overall Study|Inappropriately enrolled|0|||
24948906|NCT00403494|50040936|FG001|Overall Study|Inappropriately enrolled|1|||
24948907|NCT00403494|50040935|FG000|Overall Study|Lost to Follow-up|0|||
24948908|NCT00403494|50040936|FG001|Overall Study|Lost to Follow-up|2|||
24948909|NCT00403494|50040935|FG000|Overall Study|Protocol noncompliance|0|||
24948910|NCT00403494|50040936|FG001|Overall Study|Protocol noncompliance|1|||
24948911|NCT00403494|50040935|FG000|Overall Study|Death|1|||
24948912|NCT00403494|50040936|FG001|Overall Study|Death|0|||
24948913|NCT00403494|50040935|FG000|Overall Study|Sponsor Request|1|||
24948914|NCT00403494|50040936|FG001|Overall Study|Sponsor Request|0|||
24948915|NCT00403260|50040946|FG000|Overall Study|Adverse Event|5|||
24948916|NCT00403260|50040947|FG001|Overall Study|Adverse Event|4|||
24948917|NCT00403260|50040946|FG000|Overall Study|Withdrawal by Subject|5|||
24948918|NCT00403260|50040947|FG001|Overall Study|Withdrawal by Subject|6|||
24948919|NCT00403260|50040946|FG000|Overall Study|Lost to Follow-up|49|||
24948920|NCT00403260|50040947|FG001|Overall Study|Lost to Follow-up|25|||
24948921|NCT00403260|50040946|FG000|Overall Study|Re-appearance of P. falciparum|34|||
24948922|NCT00403260|50040947|FG001|Overall Study|Re-appearance of P. falciparum|25|||
24948923|NCT00403260|50040946|FG000|Overall Study|P. vivax infection|26|||
24948924|NCT00403260|50040947|FG001|Overall Study|P. vivax infection|4|||
25038507|NCT03120949|50138912|FG001|Overall Study|Personal Reasons|1|||
25038508|NCT03120949|50138911|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
25038509|NCT03120949|50138912|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
25038510|NCT03120949|50138911|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
25038511|NCT03120949|50138912|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
25038512|NCT03120949|50138911|FG000|Overall Study|Compliance With Medication|0|||
25038513|NCT03120949|50138912|FG001|Overall Study|Compliance With Medication|1|||
25186283|NCT01457924|50336264|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
24948925|NCT00403260|50040946|FG000|Overall Study|Mixed infection with P. vivax|2|||
24948926|NCT00403260|50040947|FG001|Overall Study|Mixed infection with P. vivax|0|||
24948927|NCT00403260|50040946|FG000|Overall Study|Mixed infection with P. falciparum|1|||
24948928|NCT00403260|50040947|FG001|Overall Study|Mixed infection with P. falciparum|0|||
24948929|NCT00403260|50040946|FG000|Overall Study|P. vivax infection at screening|1|||
24948930|NCT00403260|50040947|FG001|Overall Study|P. vivax infection at screening|0|||
24948931|NCT00403260|50040946|FG000|Overall Study|P. ovale infection|1|||
24948932|NCT00403260|50040947|FG001|Overall Study|P. ovale infection|0|||
24948933|NCT00403260|50040946|FG000|Overall Study|Gametocyte re-appearance|1|||
24948934|NCT00403260|50040947|FG001|Overall Study|Gametocyte re-appearance|1|||
24948935|NCT00403260|50040946|FG000|Overall Study|Withdrawn from study accidentally|0|||
24948936|NCT00403260|50040947|FG001|Overall Study|Withdrawn from study accidentally|1|||
24948937|NCT00406848|50040955|FG000|Overall Study|Withdrawal by Subject|27|||
24948938|NCT00406848|50040956|FG001|Overall Study|Withdrawal by Subject|22|||
24948939|NCT00406848|50040955|FG000|Overall Study|Adverse Event|38|||
24948940|NCT00406848|50040956|FG001|Overall Study|Adverse Event|7|||
24948941|NCT00406848|50040955|FG000|Overall Study|Lack of Efficacy|9|||
24948942|NCT00406848|50040956|FG001|Overall Study|Lack of Efficacy|14|||
24948943|NCT00406848|50040955|FG000|Overall Study|Protocol Violation|10|||
24948944|NCT00406848|50040956|FG001|Overall Study|Protocol Violation|6|||
24948945|NCT00406848|50040955|FG000|Overall Study|Lost to Follow-up|6|||
24948946|NCT00406848|50040956|FG001|Overall Study|Lost to Follow-up|2|||
24948947|NCT00406848|50040955|FG000|Overall Study|Physician Decision|2|||
24948948|NCT00406848|50040956|FG001|Overall Study|Physician Decision|2|||
24948949|NCT00406848|50040955|FG000|Overall Study|Sponsor Decision|1|||
24948950|NCT00406848|50040956|FG001|Overall Study|Sponsor Decision|1|||
24948951|NCT00406692|50040965|FG000|Overall Study|Withdrawal by Subject|4|||
24948952|NCT00406692|50040965|FG000|Overall Study|Physician Decision|1|||
24948953|NCT00406692|50040965|FG000|Overall Study|Adverse Event|1|||
24948954|NCT00406692|50040965|FG000|Overall Study|Lack of Efficacy|1|||
24948955|NCT00315705|50040971|FG000|Phase 1|Refused further treatment|1|||
24948956|NCT00315705|50040971|FG000|Phase 1|Failure to achieve response|8|||
24948957|NCT00315705|50040971|FG000|Phase 1|Disease relapse|4|||
24948958|NCT00315705|50040971|FG000|Phase 1|Scheduled for transplant|9|||
24948959|NCT00315705|50040971|FG000|Phase 1|Death|3|||
24948960|NCT00315705|50040971|FG000|Phase 2|Physician Decision|4|||
24948961|NCT00315705|50040971|FG000|Phase 2|Adverse Event|1|||
24948962|NCT00315705|50040971|FG000|Phase 2|Failure to achieve response|3|||
24948963|NCT00315705|50040971|FG000|Phase 2|Disease relapse|1|||
24948964|NCT00315705|50040971|FG000|Phase 2|Scheduled for transplant|8|||
24948965|NCT00315705|50040971|FG000|Phase 2|Other|1|||
24948966|NCT00315705|50040971|FG000|Phase 2|Death|7|||
24948967|NCT00307125|50040990|FG000|Screening Phase|Adverse Event|1|||
24948968|NCT00307125|50040991|FG001|Screening Phase|Adverse Event|0|||
25038514|NCT03120949|50138911|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
25038515|NCT03120949|50138912|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
25038516|NCT03120949|50138911|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
25038517|NCT03120949|50138912|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
24948969|NCT00307125|50040992|FG002|Screening Phase|Adverse Event|0|||
24948970|NCT00307125|50040990|FG000|Screening Phase|Protocol Violation|27|||
24948971|NCT00307125|50040991|FG001|Screening Phase|Protocol Violation|0|||
24948972|NCT00307125|50040992|FG002|Screening Phase|Protocol Violation|0|||
24948973|NCT00307125|50040990|FG000|Screening Phase|Lost to Follow-up|87|||
24948974|NCT00307125|50040991|FG001|Screening Phase|Lost to Follow-up|0|||
24948975|NCT00307125|50040992|FG002|Screening Phase|Lost to Follow-up|0|||
24948976|NCT00307125|50040990|FG000|Screening Phase|Death|10|||
24948977|NCT00307125|50040991|FG001|Screening Phase|Death|0|||
24948978|NCT00307125|50040992|FG002|Screening Phase|Death|0|||
24948979|NCT00307125|50040990|FG000|Screening Phase|Withdrawal by Subject|77|||
24948980|NCT00307125|50040991|FG001|Screening Phase|Withdrawal by Subject|0|||
24948981|NCT00307125|50040992|FG002|Screening Phase|Withdrawal by Subject|0|||
24948982|NCT00307125|50040990|FG000|Screening Phase|Physician Decision|26|||
24948983|NCT00307125|50040991|FG001|Screening Phase|Physician Decision|0|||
24948984|NCT00307125|50040992|FG002|Screening Phase|Physician Decision|0|||
24948985|NCT00307125|50040990|FG000|Screening Phase|Sponsor Decision|4|||
24948986|NCT00307125|50040991|FG001|Screening Phase|Sponsor Decision|0|||
24948987|NCT00307125|50040992|FG002|Screening Phase|Sponsor Decision|0|||
24948988|NCT00307125|50040990|FG000|Screening Phase|Study Terminated|17|||
24948989|NCT00307125|50040991|FG001|Screening Phase|Study Terminated|0|||
24948990|NCT00307125|50040992|FG002|Screening Phase|Study Terminated|0|||
24948991|NCT00307125|50040990|FG000|Screening Phase|Graft Loss|3|||
24948992|NCT00307125|50040991|FG001|Screening Phase|Graft Loss|0|||
24948993|NCT00307125|50040992|FG002|Screening Phase|Graft Loss|0|||
24948994|NCT00307125|50040990|FG000|Screening Phase|Graft Failure|8|||
24948995|NCT00307125|50040991|FG001|Screening Phase|Graft Failure|0|||
24948996|NCT00307125|50040992|FG002|Screening Phase|Graft Failure|0|||
24948997|NCT00307125|50040990|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
24948998|NCT00307125|50040991|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
24948999|NCT00307125|50040992|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
24949000|NCT00307125|50040990|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
24949001|NCT00307125|50040991|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
24949002|NCT00307125|50040992|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
24949003|NCT00307125|50040990|FG000|Screening Phase|Moved or transferred facilities|34|||
24949004|NCT00307125|50040991|FG001|Screening Phase|Moved or transferred facilities|0|||
24949005|NCT00307125|50040992|FG002|Screening Phase|Moved or transferred facilities|0|||
24949006|NCT00307125|50040990|FG000|Screening Phase|Received Pancreas Transplant|8|||
24949007|NCT00307125|50040991|FG001|Screening Phase|Received Pancreas Transplant|0|||
24949008|NCT00307125|50040992|FG002|Screening Phase|Received Pancreas Transplant|0|||
24949009|NCT00307125|50040990|FG000|Screening Phase|Ineligible for pilot|4|||
25038518|NCT03120949|50138911|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
25038519|NCT03120949|50138912|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
24949010|NCT00307125|50040991|FG001|Screening Phase|Ineligible for pilot|0|||
24949011|NCT00307125|50040992|FG002|Screening Phase|Ineligible for pilot|0|||
24949012|NCT00307125|50040990|FG000|Screening Phase|Try to get pregnant|1|||
25038520|NCT03124537|50138931|FG000|Overall Study|Lost to Follow-up|3|||
25038521|NCT03124537|50138932|FG001|Overall Study|Lost to Follow-up|5|||
24949013|NCT00307125|50040991|FG001|Screening Phase|Try to get pregnant|0|||
24949014|NCT00307125|50040992|FG002|Screening Phase|Try to get pregnant|0|||
24949015|NCT00307125|50040990|FG000|Screening Phase|Developed acute leukemia|1|||
24949016|NCT00307125|50040991|FG001|Screening Phase|Developed acute leukemia|0|||
24949017|NCT00307125|50040992|FG002|Screening Phase|Developed acute leukemia|0|||
24949018|NCT00307125|50040990|FG000|Screening Phase|Metastatic colon cancer|1|||
24949019|NCT00307125|50040991|FG001|Screening Phase|Metastatic colon cancer|0|||
24949020|NCT00307125|50040992|FG002|Screening Phase|Metastatic colon cancer|0|||
24949021|NCT00307125|50040990|FG000|Screening Phase|Malignancy|1|||
24949022|NCT00307125|50040991|FG001|Screening Phase|Malignancy|0|||
24949023|NCT00307125|50040992|FG002|Screening Phase|Malignancy|0|||
24949024|NCT00307125|50040990|FG000|Screening Phase|PAK|1|||
25038522|NCT03124537|50138931|FG000|Overall Study|App Crash, Incomplete Data|7|||
25038523|NCT03124537|50138932|FG001|Overall Study|App Crash, Incomplete Data|8|||
24949025|NCT00307125|50040991|FG001|Screening Phase|PAK|0|||
24949026|NCT00307125|50040992|FG002|Screening Phase|PAK|0|||
24949027|NCT00307125|50040990|FG000|Screening Phase|Ineligible|1|||
24949028|NCT00307125|50040991|FG001|Screening Phase|Ineligible|0|||
24949029|NCT00307125|50040992|FG002|Screening Phase|Ineligible|0|||
24949030|NCT00307125|50040990|FG000|Screening Phase|Screen Error|1|||
24949031|NCT00307125|50040991|FG001|Screening Phase|Screen Error|0|||
24949032|NCT00307125|50040992|FG002|Screening Phase|Screen Error|0|||
24949033|NCT00307125|50040990|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
24949034|NCT00307125|50040991|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
24949035|NCT00307125|50040992|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
24949036|NCT00307125|50040990|FG000|Screening Phase|AMR and treated with rituximab|1|||
24949037|NCT00307125|50040991|FG001|Screening Phase|AMR and treated with rituximab|0|||
24949038|NCT00307125|50040992|FG002|Screening Phase|AMR and treated with rituximab|0|||
24949039|NCT00307125|50040990|FG000|Screening Phase|Coronary artery bypass|1|||
24949040|NCT00307125|50040991|FG001|Screening Phase|Coronary artery bypass|0|||
24949041|NCT00307125|50040992|FG002|Screening Phase|Coronary artery bypass|0|||
24949042|NCT00307125|50040990|FG000|Pilot Phase|Lost to Follow-up|0|||
24949043|NCT00307125|50040991|FG001|Pilot Phase|Lost to Follow-up|1|||
24949044|NCT00307125|50040992|FG002|Pilot Phase|Lost to Follow-up|0|||
24949045|NCT00307125|50040990|FG000|Pilot Phase|Withdrawal by Subject|0|||
24949046|NCT00307125|50040991|FG001|Pilot Phase|Withdrawal by Subject|1|||
24949047|NCT00307125|50040992|FG002|Pilot Phase|Withdrawal by Subject|1|||
24949048|NCT00307047|50041004|FG000|Overall Study|Lost to Follow-up|35|||
24949049|NCT00307047|50041005|FG001|Overall Study|Lost to Follow-up|24|||
24949050|NCT00307047|50041004|FG000|Overall Study|Withdrawal by Subject|6|||
24949051|NCT00307047|50041005|FG001|Overall Study|Withdrawal by Subject|6|||
24949052|NCT00307047|50041004|FG000|Overall Study|Physician Decision|1|||
25038524|NCT03118297|50138940|FG000|Overall Study|Lost to Follow-up|0|||
25038525|NCT03118297|50138941|FG001|Overall Study|Lost to Follow-up|2|||
25038526|NCT03117361|50138947|FG000|Overall Study|Progressive disease|5|||
25038527|NCT03117361|50138947|FG000|Overall Study|Death|1|||
25038528|NCT03117361|50138947|FG000|Overall Study|Physician Decision|2|||
25038529|NCT03117361|50138947|FG000|Overall Study|On study treatment at the end of study|1|||
25038530|NCT03117361|50138947|FG000|Overall Study|Treatment-related adverse event|1|||
25038531|NCT01368614|50138951|FG000|Screening Period|Screen Failure|58|||
25038532|NCT01368614|50138952|FG001|Screening Period|Screen Failure|0|||
25038533|NCT01368614|50138953|FG002|Screening Period|Screen Failure|0|||
25038534|NCT01368614|50138954|FG003|Screening Period|Screen Failure|0|||
25038535|NCT01368614|50138951|FG000|Study Period|Withdrawal by Subject|0|||
25038536|NCT01368614|50138952|FG001|Study Period|Withdrawal by Subject|1|||
25038537|NCT01368614|50138953|FG002|Study Period|Withdrawal by Subject|1|||
25038538|NCT01368614|50138954|FG003|Study Period|Withdrawal by Subject|3|||
25038539|NCT01368614|50138951|FG000|Study Period|Lost to Follow-up|0|||
25160119|NCT01860703|50280164|FG003|Overall Study|Adverse Event|2|||
24949053|NCT00307047|50041005|FG001|Overall Study|Physician Decision|2|||
24949054|NCT00307047|50041004|FG000|Overall Study|Lost to follow-up for other reasons|0|||
24949055|NCT00307047|50041005|FG001|Overall Study|Lost to follow-up for other reasons|1|||
25038540|NCT01368614|50138952|FG001|Study Period|Lost to Follow-up|0|||
25160120|NCT01860703|50280161|FG000|Overall Study|Withdrawal by Subject|0|||
24949056|NCT00307047|50041004|FG000|Overall Study|All death, all MI, all Revascularization|27|||
24949057|NCT00307047|50041005|FG001|Overall Study|All death, all MI, all Revascularization|16|||
24949058|NCT00306891|50041015|FG000|Part A|Withdrawal by Subject|1|||
24949059|NCT00306891|50041016|FG001|Part A|Withdrawal by Subject|1|||
24949060|NCT00306891|50041017|FG002|Part A|Withdrawal by Subject|0|||
25038541|NCT01368614|50138953|FG002|Study Period|Lost to Follow-up|1|||
25038542|NCT01368614|50138954|FG003|Study Period|Lost to Follow-up|0|||
25038543|NCT03053427|50138964|FG000|Overall Study|Adverse Event|4|||
25038544|NCT03053427|50138965|FG001|Overall Study|Adverse Event|4|||
25038545|NCT03053427|50138964|FG000|Overall Study|Lack of Efficacy|1|||
25038546|NCT03053427|50138965|FG001|Overall Study|Lack of Efficacy|3|||
25038547|NCT03053427|50138964|FG000|Overall Study|Lost to Follow-up|2|||
25038548|NCT03053427|50138965|FG001|Overall Study|Lost to Follow-up|2|||
25038549|NCT03053427|50138964|FG000|Overall Study|Worsening of the target disease|0|||
25038550|NCT03053427|50138965|FG001|Overall Study|Worsening of the target disease|1|||
25038551|NCT03053427|50138964|FG000|Overall Study|Protocol Deviation|3|||
25038552|NCT03053427|50138965|FG001|Overall Study|Protocol Deviation|3|||
25038553|NCT03053427|50138964|FG000|Overall Study|Withdrawal by Subject|3|||
24949061|NCT00306891|50041018|FG003|Part A|Withdrawal by Subject|0|||
24949062|NCT00306891|50041015|FG000|Part A|Condition under investigation worsened|2|||
24949063|NCT00306891|50041016|FG001|Part A|Condition under investigation worsened|2|||
24949064|NCT00306891|50041017|FG002|Part A|Condition under investigation worsened|0|||
24949065|NCT00306891|50041018|FG003|Part A|Condition under investigation worsened|0|||
24949066|NCT00306891|50041015|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
24949067|NCT00306891|50041016|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
24949068|NCT00306891|50041017|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
24949069|NCT00306891|50041018|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
24949070|NCT00306891|50041015|FG000|Part A|Partial bowel obstruction|1|||
24949071|NCT00306891|50041016|FG001|Part A|Partial bowel obstruction|0|||
24949072|NCT00306891|50041017|FG002|Part A|Partial bowel obstruction|0|||
24949073|NCT00306891|50041018|FG003|Part A|Partial bowel obstruction|0|||
24949074|NCT00306891|50041015|FG000|Part A|Reaccumul. of ascites following drainage|0|||
24949075|NCT00306891|50041016|FG001|Part A|Reaccumul. of ascites following drainage|1|||
24949076|NCT00306891|50041017|FG002|Part A|Reaccumul. of ascites following drainage|0|||
24949077|NCT00306891|50041018|FG003|Part A|Reaccumul. of ascites following drainage|0|||
24949078|NCT00306891|50041015|FG000|Part A|Suspicion of second malignancy|0|||
24949079|NCT00306891|50041016|FG001|Part A|Suspicion of second malignancy|1|||
24949080|NCT00306891|50041017|FG002|Part A|Suspicion of second malignancy|0|||
24949081|NCT00306891|50041018|FG003|Part A|Suspicion of second malignancy|0|||
24949082|NCT00306891|50041015|FG000|Part A|QTC interval outwith elig. criteria|1|||
24949083|NCT00306891|50041016|FG001|Part A|QTC interval outwith elig. criteria|0|||
24949084|NCT00306891|50041017|FG002|Part A|QTC interval outwith elig. criteria|0|||
24949085|NCT00306891|50041018|FG003|Part A|QTC interval outwith elig. criteria|0|||
24949086|NCT00306891|50041015|FG000|Part B|Death|0|||
24949087|NCT00306891|50041016|FG001|Part B|Death|0|||
24949088|NCT00306891|50041017|FG002|Part B|Death|1|||
24949089|NCT00306891|50041018|FG003|Part B|Death|2|||
24949090|NCT00306891|50041015|FG000|Part B|Adverse Event|0|||
24949091|NCT00306891|50041016|FG001|Part B|Adverse Event|0|||
24949092|NCT00306891|50041017|FG002|Part B|Adverse Event|5|||
24949093|NCT00306891|50041018|FG003|Part B|Adverse Event|5|||
24949094|NCT00306891|50041015|FG000|Part B|Withdrawal by Subject|0|||
24949095|NCT00306891|50041016|FG001|Part B|Withdrawal by Subject|0|||
24949096|NCT00306891|50041017|FG002|Part B|Withdrawal by Subject|3|||
24949097|NCT00306891|50041018|FG003|Part B|Withdrawal by Subject|1|||
24949098|NCT00306891|50041015|FG000|Part B|Condition under investigation worsened|0|||
24949099|NCT00306891|50041016|FG001|Part B|Condition under investigation worsened|0|||
24949100|NCT00306891|50041017|FG002|Part B|Condition under investigation worsened|2|||
24949101|NCT00306891|50041018|FG003|Part B|Condition under investigation worsened|8|||
24949102|NCT00306891|50041015|FG000|Part B|Development of study specific disc crit.|0|||
24949103|NCT00306891|50041016|FG001|Part B|Development of study specific disc crit.|0|||
24949104|NCT00306891|50041017|FG002|Part B|Development of study specific disc crit.|0|||
24949105|NCT00306891|50041018|FG003|Part B|Development of study specific disc crit.|1|||
24949106|NCT00314145|50041031|FG000|Overall Study|Withdrawal by Subject|8|||
24949107|NCT00314145|50041032|FG001|Overall Study|Withdrawal by Subject|10|||
24949108|NCT00314145|50041031|FG000|Overall Study|Lost to Follow-up|5|||
24949109|NCT00314145|50041032|FG001|Overall Study|Lost to Follow-up|12|||
24949110|NCT00314145|50041031|FG000|Overall Study|Physician Decision|3|||
25038554|NCT03053427|50138965|FG001|Overall Study|Withdrawal by Subject|2|||
24949111|NCT00314145|50041032|FG001|Overall Study|Physician Decision|4|||
24949112|NCT00314145|50041031|FG000|Overall Study|Adverse Event|0|||
25038555|NCT03053427|50138964|FG000|Overall Study|Miscellaneous|0|||
25038556|NCT03053427|50138965|FG001|Overall Study|Miscellaneous|1|||
25160121|NCT01860703|50280162|FG001|Overall Study|Withdrawal by Subject|1|||
25160122|NCT01860703|50280163|FG002|Overall Study|Withdrawal by Subject|0|||
24949113|NCT00314145|50041032|FG001|Overall Study|Adverse Event|3|||
24949114|NCT00314145|50041031|FG000|Overall Study|Protocol Violation|3|||
24949115|NCT00314145|50041032|FG001|Overall Study|Protocol Violation|0|||
24949116|NCT00314145|50041031|FG000|Overall Study|Sponsor Decision|2|||
24949117|NCT00314145|50041032|FG001|Overall Study|Sponsor Decision|0|||
24949118|NCT00313911|50041041|FG000|Overall Study|Serious adverse event|6|||
24949119|NCT00313911|50041042|FG001|Overall Study|Serious adverse event|1|||
24949120|NCT00313911|50041041|FG000|Overall Study|Adverse Event|2|||
24949121|NCT00313911|50041042|FG001|Overall Study|Adverse Event|3|||
24949122|NCT00313911|50041041|FG000|Overall Study|Protocol Violation|19|||
24949123|NCT00313911|50041042|FG001|Overall Study|Protocol Violation|10|||
24949124|NCT00313911|50041041|FG000|Overall Study|Lost to Follow-up|27|||
24949125|NCT00313911|50041042|FG001|Overall Study|Lost to Follow-up|14|||
24949126|NCT00313911|50041041|FG000|Overall Study|Withdrawal by Subject|39|||
24949127|NCT00313911|50041042|FG001|Overall Study|Withdrawal by Subject|12|||
24949128|NCT00313911|50041041|FG000|Overall Study|Did not meet age criteria|1|||
24949129|NCT00313911|50041042|FG001|Overall Study|Did not meet age criteria|1|||
24949130|NCT00391872|50041050|FG000|Overall Study|Protocol Violation|7|||
24949131|NCT00391872|50041051|FG001|Overall Study|Protocol Violation|2|||
24949132|NCT00391872|50041050|FG000|Overall Study|Withdrawal by Subject|296|||
24949133|NCT00391872|50041051|FG001|Overall Study|Withdrawal by Subject|249|||
24949134|NCT00391872|50041050|FG000|Overall Study|Reason unknown|2|||
24949135|NCT00391872|50041051|FG001|Overall Study|Reason unknown|4|||
24949136|NCT00391872|50041050|FG000|Overall Study|Lost to Follow-up|2|||
24949137|NCT00391872|50041051|FG001|Overall Study|Lost to Follow-up|0|||
24949138|NCT00391170|50041059|FG000|Overall Study|Withdrawal by Subject|1|||
25275782|NCT00969436|50589583|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
25275783|NCT00969436|50589581|FG000|Overall Study|Withdrawal by Subject|3|||
25275784|NCT00969436|50589582|FG001|Overall Study|Withdrawal by Subject|0|||
25275785|NCT00969436|50589583|FG002|Overall Study|Withdrawal by Subject|2|||
25275786|NCT00969436|50589581|FG000|Overall Study|Lost to Follow-up|8|||
25275787|NCT00969436|50589582|FG001|Overall Study|Lost to Follow-up|8|||
25275788|NCT00969436|50589583|FG002|Overall Study|Lost to Follow-up|5|||
25275789|NCT00900757|50589591|FG000|Overall Study|screen failure|19|||
25275790|NCT00969280|50589597|FG000|Overall Study|Protocol Violation|2|||
25275791|NCT00969280|50589598|FG001|Overall Study|Protocol Violation|1|||
25275792|NCT00969280|50589597|FG000|Overall Study|Withdrawal by Subject|0|||
25275793|NCT00969280|50589598|FG001|Overall Study|Withdrawal by Subject|1|||
25275794|NCT00969280|50589597|FG000|Overall Study|infection of influenza A(H1N1)|0|||
25275795|NCT00969280|50589598|FG001|Overall Study|infection of influenza A(H1N1)|1|||
24949139|NCT00391170|50041060|FG001|Overall Study|Withdrawal by Subject|0|||
24949140|NCT00391170|50041059|FG000|Overall Study|Adverse Event|3|||
24949141|NCT00391170|50041060|FG001|Overall Study|Adverse Event|2|||
24949142|NCT00391170|50041059|FG000|Overall Study|Physician Decision|2|||
24949143|NCT00391170|50041060|FG001|Overall Study|Physician Decision|2|||
24949144|NCT00402324|50041068|FG000|Overall Study|Lost to Follow-up|11|||
24949145|NCT00402324|50041069|FG001|Overall Study|Lost to Follow-up|11|||
24949146|NCT00402324|50041068|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
24949147|NCT00402324|50041069|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
24949148|NCT00402324|50041068|FG000|Overall Study|Protocol Violation|8|||
24949149|NCT00402324|50041069|FG001|Overall Study|Protocol Violation|7|||
24949150|NCT00402324|50041068|FG000|Overall Study|Withdrawal by Subject|5|||
24949151|NCT00402324|50041069|FG001|Overall Study|Withdrawal by Subject|2|||
24949152|NCT00402324|50041068|FG000|Overall Study|Physician Decision|2|||
24949153|NCT00402324|50041069|FG001|Overall Study|Physician Decision|4|||
24949154|NCT00402324|50041068|FG000|Overall Study|Sponsor Decision|4|||
24949155|NCT00402324|50041069|FG001|Overall Study|Sponsor Decision|5|||
24949156|NCT00402324|50041068|FG000|Overall Study|Lack of Efficacy|1|||
24949157|NCT00402324|50041069|FG001|Overall Study|Lack of Efficacy|4|||
24949158|NCT00402324|50041068|FG000|Overall Study|Adverse Event|6|||
24949159|NCT00402324|50041069|FG001|Overall Study|Adverse Event|4|||
24949160|NCT00402324|50041068|FG000|Overall Study|Death|1|||
24949161|NCT00402324|50041069|FG001|Overall Study|Death|0|||
24949162|NCT00294723|50041078|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
24949163|NCT00294723|50041079|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
24949164|NCT00294723|50041080|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
24949165|NCT00294723|50041078|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
24949166|NCT00294723|50041079|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
24949167|NCT00294723|50041080|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
24949168|NCT00294723|50041078|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
24949169|NCT00294723|50041079|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
24949170|NCT00294723|50041080|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
25275796|NCT00969124|50589604|FG000|Overall Study|Protocol Violation|2|||
25275797|NCT00969124|50589604|FG000|Overall Study|Inadequate bowel preparation|15|||
24949171|NCT00294723|50041078|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
24949172|NCT00294723|50041079|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
24949173|NCT00294723|50041080|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
24949174|NCT00294723|50041078|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
24949175|NCT00294723|50041079|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
24949176|NCT00294723|50041080|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
24949177|NCT00294723|50041078|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
24949178|NCT00294723|50041079|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
24949179|NCT00294723|50041080|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
24949180|NCT00294723|50041078|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
24949181|NCT00294723|50041079|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
24949182|NCT00294723|50041080|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
24949183|NCT00294723|50041078|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
24949184|NCT00294723|50041079|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
24949185|NCT00294723|50041080|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
24949186|NCT00294723|50041078|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
24949187|NCT00294723|50041079|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
24949188|NCT00294723|50041080|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
24949189|NCT00294723|50041078|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
24949190|NCT00294723|50041079|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
24949191|NCT00294723|50041080|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
24949192|NCT00294723|50041078|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
24949193|NCT00294723|50041079|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
24949194|NCT00294723|50041080|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
24949195|NCT00294723|50041078|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
24949196|NCT00294723|50041079|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
24949197|NCT00294723|50041080|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
24949198|NCT00402246|50041093|FG000|Overall Study|Death|62|||
24949199|NCT00402246|50041094|FG001|Overall Study|Death|58|||
24949200|NCT00402246|50041093|FG000|Overall Study|Lost to Follow-up|20|||
24949201|NCT00402246|50041094|FG001|Overall Study|Lost to Follow-up|28|||
24949202|NCT00402246|50041093|FG000|Overall Study|Withdrawal by Subject|72|||
24949203|NCT00402246|50041094|FG001|Overall Study|Withdrawal by Subject|87|||
24949204|NCT00402246|50041093|FG000|Overall Study|Physician Decision|24|||
24949205|NCT00402246|50041094|FG001|Overall Study|Physician Decision|26|||
24949206|NCT00402246|50041093|FG000|Overall Study|Protocol Violation|25|||
24949207|NCT00402246|50041094|FG001|Overall Study|Protocol Violation|24|||
24949208|NCT00402246|50041093|FG000|Overall Study|Missed Final Visit|1|||
24949209|NCT00402246|50041094|FG001|Overall Study|Missed Final Visit|2|||
24949210|NCT00402246|50041093|FG000|Overall Study|Insurance Issues|2|||
24949211|NCT00402246|50041094|FG001|Overall Study|Insurance Issues|1|||
24949212|NCT00402246|50041093|FG000|Overall Study|Heart Transplant|0|||
24949213|NCT00402246|50041094|FG001|Overall Study|Heart Transplant|1|||
24949214|NCT00402246|50041093|FG000|Overall Study|Patient's device explanted|6|||
24949215|NCT00402246|50041094|FG001|Overall Study|Patient's device explanted|2|||
24949216|NCT00402246|50041093|FG000|Overall Study|Center Closure|5|||
24949217|NCT00402246|50041094|FG001|Overall Study|Center Closure|3|||
25038557|NCT03052959|50138982|FG000|Overall Study|Lost to Follow-up|4|||
25038558|NCT03052959|50138983|FG001|Overall Study|Lost to Follow-up|5|||
25038559|NCT03120013|50138990|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
25038560|NCT03120013|50138991|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
25038561|NCT01845649|50138999|FG000|Overall Study|Adverse Event|7|||
25038562|NCT01845649|50139000|FG001|Overall Study|Adverse Event|10|||
25038563|NCT01845649|50138999|FG000|Overall Study|Lack of Efficacy|1|||
25038564|NCT01845649|50139000|FG001|Overall Study|Lack of Efficacy|1|||
25038565|NCT01845649|50138999|FG000|Overall Study|Lost to Follow-up|2|||
25038566|NCT01845649|50139000|FG001|Overall Study|Lost to Follow-up|2|||
25038567|NCT01845649|50138999|FG000|Overall Study|Withdrew Consent|12|||
25038568|NCT01845649|50139000|FG001|Overall Study|Withdrew Consent|4|||
25038569|NCT01845649|50138999|FG000|Overall Study|Protocol Deviation|7|||
25038570|NCT01845649|50139000|FG001|Overall Study|Protocol Deviation|4|||
25038571|NCT01845649|50138999|FG000|Overall Study|Reason not Specified|2|||
25186284|NCT01457924|50336265|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
25186285|NCT01457924|50336266|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
24949218|NCT00402246|50041093|FG000|Overall Study|Deterioriating Condition|3|||
24949219|NCT00402246|50041094|FG001|Overall Study|Deterioriating Condition|2|||
24949220|NCT00375492|50041104|FG000|Overall Study|Adverse Event|4|||
24949221|NCT00375492|50041105|FG001|Overall Study|Adverse Event|5|||
24949222|NCT00375492|50041104|FG000|Overall Study|Entry Criteria Not Met|0|||
24949223|NCT00375492|50041105|FG001|Overall Study|Entry Criteria Not Met|1|||
24949224|NCT00375492|50041104|FG000|Overall Study|Loss of Glucose Control|0|||
25038572|NCT01845649|50139000|FG001|Overall Study|Reason not Specified|1|||
25038573|NCT01345929|50139008|FG000|Overall Study|Withdrawal by Subject|9|||
25038574|NCT01345929|50139009|FG001|Overall Study|Withdrawal by Subject|8|||
25038575|NCT01345929|50139008|FG000|Overall Study|Lost to Follow-up|9|||
25038576|NCT01345929|50139009|FG001|Overall Study|Lost to Follow-up|9|||
25038577|NCT01345929|50139008|FG000|Overall Study|Adverse Event|0|||
25038578|NCT01345929|50139009|FG001|Overall Study|Adverse Event|1|||
25038579|NCT01345929|50139008|FG000|Overall Study|Didn't meet eligibility criteria|2|||
25038580|NCT01345929|50139009|FG001|Overall Study|Didn't meet eligibility criteria|0|||
25038581|NCT01345929|50139008|FG000|Overall Study|40,000 CFU/ML|1|||
25038582|NCT01345929|50139009|FG001|Overall Study|40,000 CFU/ML|0|||
25038583|NCT01345929|50139008|FG000|Overall Study|Patient withdrawal|0|||
25038584|NCT01345929|50139009|FG001|Overall Study|Patient withdrawal|1|||
25038585|NCT01343901|50139015|FG000|Overall Study|Death|85|||
25038586|NCT01343901|50139015|FG000|Overall Study|Physician Decision|4|||
25038587|NCT01343901|50139015|FG000|Overall Study|Lost to Follow-up|12|||
25038588|NCT01343901|50139015|FG000|Overall Study|Management by another medical team|11|||
25038589|NCT01343901|50139015|FG000|Overall Study|Participant decision|1|||
25038590|NCT03053271|50139019|FG000|Overall Study|Did not meet randomization criteria|3|||
25038591|NCT03053271|50139019|FG000|Overall Study|Withdrawal by Subject|1|||
24949225|NCT00375492|50041105|FG001|Overall Study|Loss of Glucose Control|1|||
24949226|NCT00375492|50041104|FG000|Overall Study|Lost to Follow-up|10|||
24949227|NCT00375492|50041105|FG001|Overall Study|Lost to Follow-up|5|||
24949228|NCT00375492|50041104|FG000|Overall Study|Physician Decision|0|||
24949229|NCT00375492|50041105|FG001|Overall Study|Physician Decision|4|||
24949230|NCT00375492|50041104|FG000|Overall Study|Protocol Violation|6|||
24949231|NCT00375492|50041105|FG001|Overall Study|Protocol Violation|3|||
24949232|NCT00375492|50041104|FG000|Overall Study|Sponsor Decision|0|||
24949233|NCT00375492|50041105|FG001|Overall Study|Sponsor Decision|1|||
24949234|NCT00375492|50041104|FG000|Overall Study|Withdrawal by Subject|6|||
24949235|NCT00375492|50041105|FG001|Overall Study|Withdrawal by Subject|6|||
24949236|NCT00306189|50041115|FG000|Overall Study|Physician Decision|0|||
24949237|NCT00306189|50041116|FG001|Overall Study|Physician Decision|0|||
24949238|NCT00306189|50041117|FG002|Overall Study|Physician Decision|0|||
24949239|NCT00306189|50041118|FG003|Overall Study|Physician Decision|1|||
24949240|NCT00306189|50041115|FG000|Overall Study|Adverse Event|3|||
24949241|NCT00306189|50041116|FG001|Overall Study|Adverse Event|3|||
24949242|NCT00306189|50041117|FG002|Overall Study|Adverse Event|2|||
24949243|NCT00306189|50041118|FG003|Overall Study|Adverse Event|2|||
24949244|NCT00306189|50041115|FG000|Overall Study|Withdrawal by Subject|4|||
24949245|NCT00306189|50041116|FG001|Overall Study|Withdrawal by Subject|2|||
24949246|NCT00306189|50041117|FG002|Overall Study|Withdrawal by Subject|8|||
24949247|NCT00306189|50041118|FG003|Overall Study|Withdrawal by Subject|1|||
24949248|NCT00306189|50041115|FG000|Overall Study|Ineligibility determined|1|||
24949249|NCT00306189|50041116|FG001|Overall Study|Ineligibility determined|1|||
24949250|NCT00306189|50041117|FG002|Overall Study|Ineligibility determined|1|||
24949251|NCT00306189|50041118|FG003|Overall Study|Ineligibility determined|1|||
24949252|NCT00306189|50041115|FG000|Overall Study|Other|1|||
24949253|NCT00306189|50041116|FG001|Overall Study|Other|0|||
24949254|NCT00306189|50041117|FG002|Overall Study|Other|0|||
24949255|NCT00306189|50041118|FG003|Overall Study|Other|0|||
24949256|NCT00312897|50041130|FG000|Overall Study|Adverse Event|1|||
24949257|NCT00312897|50041131|FG001|Overall Study|Adverse Event|0|||
24949258|NCT00312897|50041130|FG000|Overall Study|Lost to Follow-up|2|||
24949259|NCT00312897|50041131|FG001|Overall Study|Lost to Follow-up|0|||
24949260|NCT00312897|50041130|FG000|Overall Study|Physician Decision|1|||
24949261|NCT00312897|50041131|FG001|Overall Study|Physician Decision|0|||
24949262|NCT00312897|50041130|FG000|Overall Study|Withdrawal by Subject|1|||
24949263|NCT00312897|50041131|FG001|Overall Study|Withdrawal by Subject|3|||
24949264|NCT00312897|50041130|FG000|Overall Study|Pregnancy|1|||
24949265|NCT00312897|50041131|FG001|Overall Study|Pregnancy|0|||
24949266|NCT00312897|50041130|FG000|Overall Study|discontinued prior to getting treatment|0|||
24949267|NCT00312897|50041131|FG001|Overall Study|discontinued prior to getting treatment|3|||
24949268|NCT00312663|50041140|FG000|Immunization Phase|Adverse Event|0|||
24949269|NCT00312663|50041141|FG001|Immunization Phase|Adverse Event|1|||
24949270|NCT00312663|50041142|FG002|Immunization Phase|Adverse Event|0|||
24949271|NCT00294645|50041153|FG000|Overall Study|Death|10|||
24949272|NCT00294645|50041154|FG001|Overall Study|Death|18|||
24949273|NCT00294645|50041153|FG000|Overall Study|Lost to Follow-up|1|||
24949274|NCT00294645|50041154|FG001|Overall Study|Lost to Follow-up|10|||
24949275|NCT00294645|50041153|FG000|Overall Study|Withdrawal by Subject|18|||
24949276|NCT00294645|50041154|FG001|Overall Study|Withdrawal by Subject|34|||
24949277|NCT00294645|50041153|FG000|Overall Study|Physician Decision|15|||
24949278|NCT00294645|50041154|FG001|Overall Study|Physician Decision|20|||
24949279|NCT00294645|50041153|FG000|Overall Study|Other|4|||
25038592|NCT01343823|50139027|FG000|Overall Study|Study Terminated|1|||
24949280|NCT00294645|50041154|FG001|Overall Study|Other|10|||
24949281|NCT00305877|50041162|FG000|Overall Study|Lack of Efficacy|6|||
24949282|NCT00305877|50041163|FG001|Overall Study|Lack of Efficacy|9|||
25038593|NCT01343823|50139028|FG001|Overall Study|Study Terminated|0|||
24949283|NCT00305877|50041162|FG000|Overall Study|Adverse Event|9|||
24949284|NCT00305877|50041163|FG001|Overall Study|Adverse Event|14|||
24949285|NCT00305877|50041162|FG000|Overall Study|Death|0|||
24949286|NCT00305877|50041163|FG001|Overall Study|Death|1|||
24949287|NCT00305877|50041162|FG000|Overall Study|Withdrawal by Subject|4|||
24949288|NCT00305877|50041163|FG001|Overall Study|Withdrawal by Subject|2|||
24949289|NCT00305877|50041162|FG000|Overall Study|Physician Decision|1|||
24949290|NCT00305877|50041163|FG001|Overall Study|Physician Decision|1|||
24949291|NCT00305877|50041162|FG000|Overall Study|Never start treatment|2|||
24949292|NCT00305877|50041163|FG001|Overall Study|Never start treatment|5|||
24949293|NCT00305877|50041162|FG000|Overall Study|Ineligible|2|||
24949294|NCT00305877|50041163|FG001|Overall Study|Ineligible|1|||
24949295|NCT00305877|50041162|FG000|Overall Study|Transportation issue with daily RT|0|||
24949296|NCT00305877|50041163|FG001|Overall Study|Transportation issue with daily RT|1|||
24949297|NCT00312195|50041171|FG000|Overall Study|Adverse Event|4|||
24949298|NCT00312195|50041172|FG001|Overall Study|Adverse Event|6|||
24949299|NCT00312195|50041171|FG000|Overall Study|Lost to Follow-up|1|||
24949300|NCT00312195|50041172|FG001|Overall Study|Lost to Follow-up|0|||
24949301|NCT00312195|50041171|FG000|Overall Study|Protocol Violation|1|||
24949302|NCT00312195|50041172|FG001|Overall Study|Protocol Violation|0|||
24949303|NCT00305253|50041182|FG000|Overall Study|Withdrawal by Subject|0|||
24949304|NCT00305253|50041183|FG001|Overall Study|Withdrawal by Subject|1|||
24949305|NCT00293709|50041189|FG000|Overall Study|Other|47|||
24949306|NCT00311181|50041193|FG000|Overall Study|Final DFTs were not obtained|96|||
24949307|NCT00293397|50041197|FG000|Overall Study|Death|2|||
24949308|NCT00290745|50041202|FG000|Overall Study|Withdrawal by Subject|4|||
24949309|NCT00290745|50041202|FG000|Overall Study|Physician Decision|2|||
24949310|NCT00290745|50041202|FG000|Overall Study|Surgery after 3 months for progression|3|||
24949311|NCT00290745|50041202|FG000|Overall Study|Baseline MRI not available|3|||
24949312|NCT00402168|50041208|FG000|Randomized|Lost to Follow-up|1|||
24949313|NCT00402168|50041209|FG001|Randomized|Lost to Follow-up|0|||
24949314|NCT00402168|50041208|FG000|Randomized|Withdrawal by Subject|0|||
24949315|NCT00402168|50041209|FG001|Randomized|Withdrawal by Subject|1|||
25038594|NCT01343823|50139029|FG002|Overall Study|Study Terminated|0|||
25038595|NCT01343823|50139030|FG003|Overall Study|Study Terminated|1|||
24949316|NCT00402168|50041208|FG000|Treatment (up to 12 Months)|Death|0|||
24949317|NCT00402168|50041209|FG001|Treatment (up to 12 Months)|Death|1|||
24949318|NCT00402168|50041208|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
24949319|NCT00402168|50041209|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
24949320|NCT00402168|50041208|FG000|Treatment (up to 12 Months)|non-specified|0|||
24949321|NCT00402168|50041209|FG001|Treatment (up to 12 Months)|non-specified|1|||
24949322|NCT00402168|50041208|FG000|Long Term (LT)|Adverse Event|1|||
24949323|NCT00402168|50041209|FG001|Long Term (LT)|Adverse Event|5|||
24949324|NCT00402168|50041208|FG000|Long Term (LT)|Withdrawal by Subject|4|||
24949325|NCT00402168|50041209|FG001|Long Term (LT)|Withdrawal by Subject|7|||
24949326|NCT00402168|50041208|FG000|Long Term (LT)|Pregnancy|0|||
24949327|NCT00402168|50041209|FG001|Long Term (LT)|Pregnancy|1|||
24949328|NCT00402168|50041208|FG000|Long Term (LT)|Lost to Follow-up|1|||
24949329|NCT00402168|50041209|FG001|Long Term (LT)|Lost to Follow-up|0|||
24949330|NCT00402168|50041208|FG000|Long Term (LT)|Death|4|||
24949331|NCT00402168|50041209|FG001|Long Term (LT)|Death|0|||
24949332|NCT00402168|50041208|FG000|Long Term (LT)|Lack of Efficacy|0|||
24949333|NCT00402168|50041209|FG001|Long Term (LT)|Lack of Efficacy|2|||
24949334|NCT00402168|50041208|FG000|Long Term (LT)|non-specified|1|||
24949335|NCT00402168|50041209|FG001|Long Term (LT)|non-specified|2|||
24949336|NCT00402168|50041208|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
24949337|NCT00402168|50041209|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
24949338|NCT00402168|50041208|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
24949339|NCT00402168|50041209|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
24949340|NCT00290589|50041225|FG000|Overall Study|Lost to Follow-up|2|||
24949341|NCT00290589|50041226|FG001|Overall Study|Lost to Follow-up|2|||
24949342|NCT00290511|50041232|FG000|Overall Study|Adverse Event|1|||
24949343|NCT00290511|50041232|FG000|Overall Study|Death|1|||
24949344|NCT00290511|50041232|FG000|Overall Study|Physician Decision|1|||
24949345|NCT00290511|50041232|FG000|Overall Study|Withdrawal by Subject|1|||
24949346|NCT00290433|50041236|FG000|Overall Study|Disease Progression|13|||
24949347|NCT00290433|50041236|FG000|Overall Study|Adverse Event|14|||
25038596|NCT01343823|50139027|FG000|Overall Study|Withdrawal by Subject|1|||
25038597|NCT01343823|50139028|FG001|Overall Study|Withdrawal by Subject|0|||
24949348|NCT00290433|50041236|FG000|Overall Study|Withdrawal by Subject|1|||
24949349|NCT00290433|50041236|FG000|Overall Study|Non-Compliance|1|||
24949350|NCT00290433|50041236|FG000|Overall Study|Congestive Heart Failure|1|||
24949351|NCT00290433|50041236|FG000|Overall Study|Transplant in CR|5|||
24949352|NCT00290433|50041236|FG000|Overall Study|Unrelated Infection/Death|1|||
25038598|NCT01343823|50139029|FG002|Overall Study|Withdrawal by Subject|0|||
24949353|NCT00304083|50041242|FG000|Overall Study|Withdrawal by Subject|4|||
25038599|NCT01343823|50139030|FG003|Overall Study|Withdrawal by Subject|0|||
24949354|NCT00304083|50041243|FG001|Overall Study|Withdrawal by Subject|2|||
24949355|NCT00304083|50041242|FG000|Overall Study|Physician Decision|8|||
24949356|NCT00304083|50041243|FG001|Overall Study|Physician Decision|3|||
24949357|NCT00304083|50041242|FG000|Overall Study|Disease Progression|5|||
24949358|NCT00304083|50041243|FG001|Overall Study|Disease Progression|1|||
24949359|NCT00304083|50041242|FG000|Overall Study|Other|5|||
24949360|NCT00304083|50041243|FG001|Overall Study|Other|2|||
24949361|NCT00293241|50041251|FG000|Overall Study|Lost to Follow-up|9|||
24949362|NCT00293241|50041252|FG001|Overall Study|Lost to Follow-up|16|||
24949363|NCT00293241|50041251|FG000|Overall Study|Physician Decision|23|||
24949364|NCT00293241|50041252|FG001|Overall Study|Physician Decision|17|||
24949365|NCT00293241|50041251|FG000|Overall Study|Withdrawal by Subject|4|||
24949366|NCT00293241|50041252|FG001|Overall Study|Withdrawal by Subject|8|||
24949367|NCT00391092|50041263|FG000|Overall Study|Death|78|||
24949368|NCT00391092|50041264|FG001|Overall Study|Death|81|||
24949369|NCT00391092|50041263|FG000|Overall Study|Lost to Follow-up|13|||
24949370|NCT00391092|50041264|FG001|Overall Study|Lost to Follow-up|18|||
25038600|NCT01318083|50139043|FG000|Overall Study|Adverse Event|4|||
25038601|NCT01318083|50139044|FG001|Overall Study|Adverse Event|1|||
24949371|NCT00391092|50041263|FG000|Overall Study|Alive on treatment|29|||
24949372|NCT00391092|50041264|FG001|Overall Study|Alive on treatment|33|||
24949373|NCT00391092|50041263|FG000|Overall Study|Alive in follow-up|88|||
24949374|NCT00391092|50041264|FG001|Overall Study|Alive in follow-up|84|||
24949375|NCT00374868|50041270|FG000|Overall Study|Adverse Event|12|||
24949376|NCT00374868|50041270|FG000|Overall Study|Progressive Disease|7|||
24949377|NCT00374868|50041270|FG000|Overall Study|Physician Decision|13|||
24949378|NCT00374868|50041270|FG000|Overall Study|Lost to Follow-up|1|||
24949379|NCT00374868|50041270|FG000|Overall Study|Death|2|||
24949380|NCT00374868|50041270|FG000|Overall Study|Other - Not Specified|1|||
24949381|NCT00374556|50041276|FG000|Overall Study|Lost to Follow-up|1|||
24949382|NCT00374556|50041277|FG001|Overall Study|Lost to Follow-up|0|||
24949383|NCT00374556|50041276|FG000|Overall Study|Removed at baseline due to medical cond|0|||
24949384|NCT00374556|50041277|FG001|Overall Study|Removed at baseline due to medical cond|1|||
24949385|NCT00290355|50041285|FG000|Overall Study|Serious adverse event|7|||
24949386|NCT00290355|50041286|FG001|Overall Study|Serious adverse event|4|||
24949387|NCT00290355|50041285|FG000|Overall Study|Study product reactogenicity|1|||
24949388|NCT00290355|50041286|FG001|Overall Study|Study product reactogenicity|0|||
24949389|NCT00290355|50041285|FG000|Overall Study|Protocol Violation|1|||
24949390|NCT00290355|50041286|FG001|Overall Study|Protocol Violation|0|||
24949391|NCT00290355|50041285|FG000|Overall Study|Withdrawal by Subject|2|||
24949392|NCT00290355|50041286|FG001|Overall Study|Withdrawal by Subject|0|||
24949393|NCT00290355|50041285|FG000|Overall Study|Migrated / moved from the study area|1|||
24949394|NCT00290355|50041286|FG001|Overall Study|Migrated / moved from the study area|0|||
24949395|NCT00290355|50041285|FG000|Overall Study|Lost to Follow-up|3|||
24949396|NCT00290355|50041286|FG001|Overall Study|Lost to Follow-up|1|||
24949397|NCT00290355|50041285|FG000|Overall Study|Other|2|||
24949398|NCT00290355|50041286|FG001|Overall Study|Other|0|||
24949399|NCT00374322|50041294|FG000|Overall Study|Lost to Follow-up|92|||
24949400|NCT00374322|50041295|FG001|Overall Study|Lost to Follow-up|90|||
24949401|NCT00374322|50041294|FG000|Overall Study|Protocol Violation|8|||
24949402|NCT00374322|50041295|FG001|Overall Study|Protocol Violation|3|||
24949403|NCT00374322|50041294|FG000|Overall Study|Withdrawal by Subject|235|||
24949404|NCT00374322|50041295|FG001|Overall Study|Withdrawal by Subject|167|||
24949405|NCT00374322|50041294|FG000|Overall Study|Sponsor Terminated Study|866|||
24949406|NCT00374322|50041295|FG001|Overall Study|Sponsor Terminated Study|990|||
24949407|NCT00374322|50041294|FG000|Overall Study|Physician Decision|36|||
24949408|NCT00374322|50041295|FG001|Overall Study|Physician Decision|32|||
24949409|NCT00374322|50041294|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
24949410|NCT00374322|50041295|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
25038602|NCT01318083|50139045|FG002|Overall Study|Adverse Event|2|||
25038603|NCT01318083|50139043|FG000|Overall Study|Withdrawal by Subject|1|||
24949411|NCT00374322|50041294|FG000|Overall Study|Sponsor Decision|2|||
24949412|NCT00374322|50041295|FG001|Overall Study|Sponsor Decision|3|||
24949413|NCT00374322|50041294|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
24949414|NCT00374322|50041295|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
24949415|NCT00374322|50041294|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
24949416|NCT00374322|50041295|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
24949417|NCT00374322|50041294|FG000|Overall Study|Severe Toxicity|1|||
24949418|NCT00374322|50041295|FG001|Overall Study|Severe Toxicity|0|||
24949419|NCT00374322|50041294|FG000|Overall Study|Site Closed|2|||
25038604|NCT01318083|50139044|FG001|Overall Study|Withdrawal by Subject|0|||
25038605|NCT01318083|50139045|FG002|Overall Study|Withdrawal by Subject|2|||
25038606|NCT01318083|50139043|FG000|Overall Study|Lack of Efficacy|0|||
25038607|NCT01318083|50139044|FG001|Overall Study|Lack of Efficacy|0|||
25038608|NCT01318083|50139045|FG002|Overall Study|Lack of Efficacy|1|||
25038609|NCT01318083|50139043|FG000|Overall Study|Treatment Complications|1|||
25038610|NCT01318083|50139044|FG001|Overall Study|Treatment Complications|0|||
25038611|NCT01318083|50139045|FG002|Overall Study|Treatment Complications|0|||
25038612|NCT01318083|50139043|FG000|Overall Study|Lack of Study Medication Compliance|0|||
25038613|NCT01318083|50139044|FG001|Overall Study|Lack of Study Medication Compliance|1|||
25038614|NCT01318083|50139045|FG002|Overall Study|Lack of Study Medication Compliance|0|||
25038615|NCT01376323|50139058|FG000|Overall Study|Adverse Event|1|||
25038616|NCT01376323|50139059|FG001|Overall Study|Adverse Event|0|||
25038617|NCT01376323|50139060|FG002|Overall Study|Adverse Event|0|||
25038618|NCT01376323|50139061|FG003|Overall Study|Adverse Event|2|||
25038619|NCT01376323|50139062|FG004|Overall Study|Adverse Event|0|||
25038620|NCT01376323|50139058|FG000|Overall Study|Lost to Follow-up|0|||
25038621|NCT01376323|50139059|FG001|Overall Study|Lost to Follow-up|0|||
25038622|NCT01376323|50139060|FG002|Overall Study|Lost to Follow-up|0|||
25038623|NCT01376323|50139061|FG003|Overall Study|Lost to Follow-up|2|||
24949420|NCT00374322|50041295|FG001|Overall Study|Site Closed|2|||
25038624|NCT01376323|50139062|FG004|Overall Study|Lost to Follow-up|0|||
25160123|NCT01860703|50280164|FG003|Overall Study|Withdrawal by Subject|0|||
25160124|NCT01860703|50280161|FG000|Overall Study|Personal reason|1|||
24949421|NCT00374322|50041294|FG000|Overall Study|Participant Changed Physician|1|||
25038625|NCT01376323|50139058|FG000|Overall Study|Physician Decision|1|||
25038626|NCT01376323|50139059|FG001|Overall Study|Physician Decision|0|||
25038627|NCT01376323|50139060|FG002|Overall Study|Physician Decision|2|||
25038628|NCT01376323|50139061|FG003|Overall Study|Physician Decision|1|||
25038629|NCT01376323|50139062|FG004|Overall Study|Physician Decision|1|||
25038630|NCT01376323|50139058|FG000|Overall Study|Withdrawal by Subject|0|||
25038631|NCT01376323|50139059|FG001|Overall Study|Withdrawal by Subject|1|||
25038632|NCT01376323|50139060|FG002|Overall Study|Withdrawal by Subject|1|||
24949422|NCT00374322|50041295|FG001|Overall Study|Participant Changed Physician|0|||
24949423|NCT00374322|50041294|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
24949424|NCT00374322|50041295|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
25038633|NCT01376323|50139061|FG003|Overall Study|Withdrawal by Subject|0|||
25038634|NCT01376323|50139062|FG004|Overall Study|Withdrawal by Subject|0|||
25038635|NCT03725293|50139099|FG000|Overall Study|Physician Decision|9|||
25038636|NCT03725293|50139100|FG001|Overall Study|Physician Decision|6|||
25038637|NCT03725293|50139099|FG000|Overall Study|alternative vascular access needs|1|||
25038638|NCT03725293|50139100|FG001|Overall Study|alternative vascular access needs|2|||
25038639|NCT03725293|50139099|FG000|Overall Study|venous anatomy screen failures|2|||
24949425|NCT00374322|50041294|FG000|Overall Study|Noncompliance with Study Requirements|0|||
24949426|NCT00374322|50041295|FG001|Overall Study|Noncompliance with Study Requirements|1|||
24949427|NCT00374322|50041294|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
24949428|NCT00374322|50041295|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
24949429|NCT00374322|50041294|FG000|Overall Study|Did Not Receive Study Medication|8|||
24949430|NCT00374322|50041295|FG001|Overall Study|Did Not Receive Study Medication|6|||
24949431|NCT00303459|50041304|FG000|Overall Study|Death|33|||
24949432|NCT00303459|50041305|FG001|Overall Study|Death|44|||
24949433|NCT00303459|50041304|FG000|Overall Study|Withdrawal of consent|32|||
25038640|NCT03725293|50139100|FG001|Overall Study|venous anatomy screen failures|1|||
25038641|NCT01368536|50139109|FG000|Overall Study|Adverse Event|5|||
25038642|NCT01368536|50139110|FG001|Overall Study|Adverse Event|6|||
25038643|NCT01368536|50139111|FG002|Overall Study|Adverse Event|8|||
25038644|NCT01368536|50139109|FG000|Overall Study|Abnormal laboratory value(s)|0|||
25038645|NCT01368536|50139110|FG001|Overall Study|Abnormal laboratory value(s)|1|||
25038646|NCT01368536|50139111|FG002|Overall Study|Abnormal laboratory value(s)|2|||
25038647|NCT01368536|50139109|FG000|Overall Study|Abnormal test procedure result(s)|0|||
25038648|NCT01368536|50139110|FG001|Overall Study|Abnormal test procedure result(s)|0|||
25038649|NCT01368536|50139111|FG002|Overall Study|Abnormal test procedure result(s)|1|||
25038650|NCT01368536|50139109|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
24949434|NCT00303459|50041305|FG001|Overall Study|Withdrawal of consent|26|||
24949435|NCT00303459|50041304|FG000|Overall Study|Lost to Follow-up|5|||
24949436|NCT00303459|50041305|FG001|Overall Study|Lost to Follow-up|4|||
24949437|NCT00303459|50041304|FG000|Overall Study|Administrative reason|7|||
24949438|NCT00303459|50041305|FG001|Overall Study|Administrative reason|7|||
24949439|NCT00303459|50041304|FG000|Overall Study|Decision by the investigator|5|||
24949440|NCT00303459|50041305|FG001|Overall Study|Decision by the investigator|7|||
24949441|NCT00303459|50041304|FG000|Overall Study|Lung transplantation|1|||
24949442|NCT00303459|50041305|FG001|Overall Study|Lung transplantation|1|||
24949443|NCT00289887|50041314|FG000|Overall Study|Adverse Event|3|||
24949444|NCT00289887|50041315|FG001|Overall Study|Adverse Event|3|||
24949445|NCT00289887|50041314|FG000|Overall Study|Lack of Efficacy|3|||
24949446|NCT00289887|50041315|FG001|Overall Study|Lack of Efficacy|11|||
24949447|NCT00289887|50041314|FG000|Overall Study|Lost to Follow-up|3|||
25038651|NCT01368536|50139110|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
25038652|NCT01368536|50139111|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
25038653|NCT01368536|50139109|FG000|Overall Study|No longer required study medication|0|||
25038654|NCT01368536|50139110|FG001|Overall Study|No longer required study medication|0|||
24949448|NCT00289887|50041315|FG001|Overall Study|Lost to Follow-up|3|||
24949449|NCT00289887|50041314|FG000|Overall Study|Protocol Violation|3|||
24949450|NCT00289887|50041315|FG001|Overall Study|Protocol Violation|1|||
24949451|NCT00289887|50041314|FG000|Overall Study|Withdrawal by Subject|3|||
24949452|NCT00289887|50041315|FG001|Overall Study|Withdrawal by Subject|8|||
24949453|NCT00289887|50041314|FG000|Overall Study|Other|7|||
24949454|NCT00289887|50041315|FG001|Overall Study|Other|3|||
24949455|NCT00303069|50041325|FG000|Overall Study|Lost to Follow-up|1|||
24949456|NCT00303069|50041326|FG001|Overall Study|Lost to Follow-up|0|||
24949457|NCT00303069|50041327|FG002|Overall Study|Lost to Follow-up|0|||
24949458|NCT00303069|50041328|FG003|Overall Study|Lost to Follow-up|2|||
24949459|NCT00303069|50041325|FG000|Overall Study|subject moved|1|||
24949460|NCT00303069|50041326|FG001|Overall Study|subject moved|0|||
24949461|NCT00303069|50041327|FG002|Overall Study|subject moved|0|||
24949462|NCT00303069|50041328|FG003|Overall Study|subject moved|0|||
24949463|NCT00303069|50041325|FG000|Overall Study|Recruitment into Army Reserves|0|||
24949464|NCT00303069|50041326|FG001|Overall Study|Recruitment into Army Reserves|0|||
24949465|NCT00303069|50041327|FG002|Overall Study|Recruitment into Army Reserves|1|||
24949466|NCT00303069|50041328|FG003|Overall Study|Recruitment into Army Reserves|0|||
24949467|NCT00401544|50041342|FG000|Overall Study|Adverse Event|5|||
24949468|NCT00401544|50041343|FG001|Overall Study|Adverse Event|1|||
24949469|NCT00401544|50041344|FG002|Overall Study|Adverse Event|1|||
24949470|NCT00401544|50041345|FG003|Overall Study|Adverse Event|1|||
24949471|NCT00401544|50041342|FG000|Overall Study|Death|3|||
24949472|NCT00401544|50041343|FG001|Overall Study|Death|6|||
24949473|NCT00401544|50041344|FG002|Overall Study|Death|2|||
24949474|NCT00401544|50041345|FG003|Overall Study|Death|5|||
24949475|NCT00401544|50041342|FG000|Overall Study|Lost to Follow-up|2|||
24949476|NCT00401544|50041343|FG001|Overall Study|Lost to Follow-up|0|||
24949477|NCT00401544|50041344|FG002|Overall Study|Lost to Follow-up|1|||
24949478|NCT00401544|50041345|FG003|Overall Study|Lost to Follow-up|1|||
24949479|NCT00401544|50041342|FG000|Overall Study|Withdrawal by Subject|7|||
24949480|NCT00401544|50041343|FG001|Overall Study|Withdrawal by Subject|6|||
24949481|NCT00401544|50041344|FG002|Overall Study|Withdrawal by Subject|6|||
24949482|NCT00401544|50041345|FG003|Overall Study|Withdrawal by Subject|5|||
24949483|NCT00401544|50041342|FG000|Overall Study|Physician Decision|1|||
24949484|NCT00401544|50041343|FG001|Overall Study|Physician Decision|3|||
24949485|NCT00401544|50041344|FG002|Overall Study|Physician Decision|0|||
24949486|NCT00401544|50041345|FG003|Overall Study|Physician Decision|0|||
24949487|NCT00401544|50041342|FG000|Overall Study|Ineligibility determined|0|||
24949488|NCT00401544|50041343|FG001|Overall Study|Ineligibility determined|1|||
24949489|NCT00401544|50041344|FG002|Overall Study|Ineligibility determined|0|||
24949490|NCT00401544|50041345|FG003|Overall Study|Ineligibility determined|2|||
24949491|NCT00401544|50041342|FG000|Overall Study|Disease progression|0|||
24949492|NCT00401544|50041343|FG001|Overall Study|Disease progression|1|||
24949493|NCT00401544|50041344|FG002|Overall Study|Disease progression|0|||
24949494|NCT00401544|50041345|FG003|Overall Study|Disease progression|0|||
24949495|NCT00401544|50041342|FG000|Overall Study|Other|0|||
24949496|NCT00401544|50041343|FG001|Overall Study|Other|0|||
24949497|NCT00401544|50041344|FG002|Overall Study|Other|2|||
24949498|NCT00401544|50041345|FG003|Overall Study|Other|2|||
24949499|NCT00289731|50041363|FG000|Overall Study|Adverse Event|1|||
24949500|NCT00289731|50041364|FG001|Overall Study|Adverse Event|2|||
24949501|NCT00289731|50041365|FG002|Overall Study|Adverse Event|2|||
24949502|NCT00289731|50041363|FG000|Overall Study|Other|1|||
24949503|NCT00289731|50041364|FG001|Overall Study|Other|0|||
24949504|NCT00289731|50041365|FG002|Overall Study|Other|0|||
24949505|NCT00289185|50041377|FG000|Overall Study|Withdrawal by Subject|4|||
24949506|NCT00289185|50041378|FG001|Overall Study|Withdrawal by Subject|8|||
24949507|NCT00289185|50041377|FG000|Overall Study|Lost to Follow-up|23|||
24949508|NCT00289185|50041378|FG001|Overall Study|Lost to Follow-up|17|||
24949509|NCT00289185|50041377|FG000|Overall Study|Death|1|||
24949510|NCT00289185|50041378|FG001|Overall Study|Death|1|||
24949511|NCT00292461|50041387|FG000|Overall Study|Adverse Event|4|||
24949512|NCT00292461|50041388|FG001|Overall Study|Adverse Event|2|||
24949513|NCT00292461|50041387|FG000|Overall Study|Lack of Efficacy|1|||
24949514|NCT00292461|50041388|FG001|Overall Study|Lack of Efficacy|0|||
25160125|NCT01860703|50280162|FG001|Overall Study|Personal reason|0|||
24949515|NCT00292461|50041387|FG000|Overall Study|Withdrawal by Subject|0|||
24949516|NCT00292461|50041388|FG001|Overall Study|Withdrawal by Subject|1|||
24949517|NCT00292461|50041387|FG000|Overall Study|Protocol Violation|4|||
24949518|NCT00292461|50041388|FG001|Overall Study|Protocol Violation|3|||
24949519|NCT00292461|50041387|FG000|Overall Study|Lost to Follow-up|1|||
24949520|NCT00292461|50041388|FG001|Overall Study|Lost to Follow-up|0|||
24949521|NCT00288639|50041394|FG000|Overall Study|Adverse Event|5|||
24949522|NCT00288639|50041394|FG000|Overall Study|Lack of Efficacy|4|||
24949523|NCT00288639|50041394|FG000|Overall Study|Withdrawal by Subject|2|||
25160126|NCT01860703|50280163|FG002|Overall Study|Personal reason|1|||
24949524|NCT00288639|50041394|FG000|Overall Study|Other|1|||
24949525|NCT00390858|50041400|FG000|Overall Study|Adverse Event|6|||
24949526|NCT00390858|50041401|FG001|Overall Study|Adverse Event|2|||
24949527|NCT00390858|50041400|FG000|Overall Study|Lack of Efficacy|0|||
24949528|NCT00390858|50041401|FG001|Overall Study|Lack of Efficacy|1|||
24949529|NCT00390858|50041400|FG000|Overall Study|Withdrawal by Subject|3|||
24949530|NCT00390858|50041401|FG001|Overall Study|Withdrawal by Subject|4|||
24949531|NCT00390780|50041409|FG000|Overall Study|Not completed|10|||
24949532|NCT00390780|50041410|FG001|Overall Study|Not completed|4|||
24949533|NCT00390780|50041409|FG000|Overall Study|Protocol Violation|6|||
24949534|NCT00390780|50041410|FG001|Overall Study|Protocol Violation|4|||
24949535|NCT00390780|50041409|FG000|Overall Study|Lost to Follow-up|3|||
24949536|NCT00390780|50041410|FG001|Overall Study|Lost to Follow-up|6|||
24949537|NCT00390780|50041409|FG000|Overall Study|Adverse Event|2|||
24949538|NCT00390780|50041410|FG001|Overall Study|Adverse Event|3|||
24949539|NCT00390780|50041409|FG000|Overall Study|Death|1|||
24949540|NCT00390780|50041410|FG001|Overall Study|Death|3|||
24949541|NCT00390780|50041409|FG000|Overall Study|Withdrawal by Subject|1|||
24949542|NCT00390780|50041410|FG001|Overall Study|Withdrawal by Subject|2|||
24949543|NCT00390780|50041409|FG000|Overall Study|Inclusion criteria not satisfied|0|||
24949544|NCT00390780|50041410|FG001|Overall Study|Inclusion criteria not satisfied|2|||
24949545|NCT00390780|50041409|FG000|Overall Study|Lost to follow up and other reasons|0|||
24949546|NCT00390780|50041410|FG001|Overall Study|Lost to follow up and other reasons|1|||
24949547|NCT00390780|50041409|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
24949548|NCT00390780|50041410|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
24949549|NCT00390780|50041409|FG000|Overall Study|SAE, death|0|||
24949550|NCT00390780|50041410|FG001|Overall Study|SAE, death|1|||
24949551|NCT00390546|50041418|FG000|Overall Study|Renal impairment|1|||
24949552|NCT00390546|50041419|FG001|Overall Study|Renal impairment|0|||
24949553|NCT00390546|50041418|FG000|Overall Study|Physician Decision|5|||
24949554|NCT00390546|50041419|FG001|Overall Study|Physician Decision|5|||
24949555|NCT00390468|50041426|FG000|Overall Study|Protocol Violation|2|||
24949556|NCT00390468|50041426|FG000|Overall Study|Lack of Efficacy|1|||
24949557|NCT00400764|50041435|FG000|Phase Ib|Adverse Event|1|||
24949558|NCT00400764|50041436|FG001|Phase Ib|Adverse Event|0|||
24949559|NCT00400764|50041437|FG002|Phase Ib|Adverse Event|0|||
24949560|NCT00400764|50041438|FG003|Phase Ib|Adverse Event|0|||
24949561|NCT00400764|50041439|FG004|Phase Ib|Adverse Event|0|||
24949562|NCT00400764|50041435|FG000|Phase Ib|Death|1|||
24949563|NCT00400764|50041436|FG001|Phase Ib|Death|0|||
24949564|NCT00400764|50041437|FG002|Phase Ib|Death|0|||
24949565|NCT00400764|50041438|FG003|Phase Ib|Death|0|||
24949566|NCT00400764|50041439|FG004|Phase Ib|Death|0|||
24949567|NCT00400764|50041435|FG000|Phase Ib|Disease Progression|4|||
24949568|NCT00400764|50041436|FG001|Phase Ib|Disease Progression|4|||
24949569|NCT00400764|50041437|FG002|Phase Ib|Disease Progression|0|||
24949570|NCT00400764|50041438|FG003|Phase Ib|Disease Progression|0|||
24949571|NCT00400764|50041439|FG004|Phase Ib|Disease Progression|0|||
24949572|NCT00400764|50041435|FG000|Phase II|Death|0|||
24949573|NCT00400764|50041436|FG001|Phase II|Death|0|||
24949574|NCT00400764|50041437|FG002|Phase II|Death|1|||
24949575|NCT00400764|50041438|FG003|Phase II|Death|2|||
24949576|NCT00400764|50041439|FG004|Phase II|Death|0|||
24949577|NCT00400764|50041435|FG000|Phase II|Lost to Follow-up|0|||
24949578|NCT00400764|50041436|FG001|Phase II|Lost to Follow-up|0|||
24949579|NCT00400764|50041437|FG002|Phase II|Lost to Follow-up|1|||
24949580|NCT00400764|50041438|FG003|Phase II|Lost to Follow-up|0|||
24949581|NCT00400764|50041439|FG004|Phase II|Lost to Follow-up|0|||
24949582|NCT00400764|50041435|FG000|Phase II|Physician Decision|0|||
24949583|NCT00400764|50041436|FG001|Phase II|Physician Decision|0|||
24949584|NCT00400764|50041437|FG002|Phase II|Physician Decision|1|||
24949585|NCT00400764|50041438|FG003|Phase II|Physician Decision|1|||
24949586|NCT00400764|50041439|FG004|Phase II|Physician Decision|0|||
24949587|NCT00400764|50041435|FG000|Phase II|Sponsor's decision to terminate|0|||
24949588|NCT00400764|50041436|FG001|Phase II|Sponsor's decision to terminate|0|||
24949589|NCT00400764|50041437|FG002|Phase II|Sponsor's decision to terminate|18|||
24949590|NCT00400764|50041438|FG003|Phase II|Sponsor's decision to terminate|22|||
24949591|NCT00400764|50041439|FG004|Phase II|Sponsor's decision to terminate|11|||
24949592|NCT00400764|50041435|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
24949593|NCT00400764|50041436|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
24949594|NCT00400764|50041437|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
24949595|NCT00400764|50041438|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
24949596|NCT00400764|50041439|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
24949597|NCT00400764|50041435|FG000|Phase II|Withdrawal by Subject|0|||
24949598|NCT00400764|50041436|FG001|Phase II|Withdrawal by Subject|0|||
24949599|NCT00400764|50041437|FG002|Phase II|Withdrawal by Subject|1|||
24949600|NCT00400764|50041438|FG003|Phase II|Withdrawal by Subject|1|||
24949601|NCT00400764|50041439|FG004|Phase II|Withdrawal by Subject|0|||
24949602|NCT00302211|50041459|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
24949603|NCT00302211|50041460|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
24949604|NCT00302211|50041461|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
24949605|NCT00302211|50041462|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
24949606|NCT00302211|50041463|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
24949607|NCT00302211|50041459|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
24949608|NCT00302211|50041460|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
24949609|NCT00302211|50041461|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
24949610|NCT00302211|50041462|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
24949611|NCT00302211|50041463|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
24949612|NCT00302211|50041459|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
24949613|NCT00302211|50041460|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
24949614|NCT00302211|50041461|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
24949615|NCT00302211|50041462|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
24949616|NCT00302211|50041463|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
24949617|NCT00302211|50041459|FG000|Double Blind Period (New Patients)|Disease progression|0|||
24949618|NCT00302211|50041460|FG001|Double Blind Period (New Patients)|Disease progression|1|||
24949619|NCT00302211|50041461|FG002|Double Blind Period (New Patients)|Disease progression|1|||
25038655|NCT01368536|50139111|FG002|Overall Study|No longer required study medication|1|||
25038656|NCT01368536|50139109|FG000|Overall Study|Withdrawal by Subject|2|||
25038657|NCT01368536|50139110|FG001|Overall Study|Withdrawal by Subject|5|||
25038658|NCT01368536|50139111|FG002|Overall Study|Withdrawal by Subject|4|||
25038659|NCT01368536|50139109|FG000|Overall Study|Lost to Follow-up|3|||
25038660|NCT01368536|50139110|FG001|Overall Study|Lost to Follow-up|3|||
25038661|NCT01368536|50139111|FG002|Overall Study|Lost to Follow-up|5|||
25038662|NCT01368536|50139109|FG000|Overall Study|Administrative problems|34|||
25038663|NCT01368536|50139110|FG001|Overall Study|Administrative problems|39|||
25038664|NCT01368536|50139111|FG002|Overall Study|Administrative problems|35|||
25038665|NCT01368536|50139109|FG000|Overall Study|Protocol deviation|0|||
25038666|NCT01368536|50139110|FG001|Overall Study|Protocol deviation|3|||
25038667|NCT01368536|50139111|FG002|Overall Study|Protocol deviation|1|||
25038668|NCT03051165|50139120|FG000|Overall Study|Withdrawal by Subject|1|||
25038669|NCT03051165|50139120|FG000|Overall Study|Early termination of study|12|||
25038670|NCT01319929|50139126|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
25038671|NCT01319929|50139127|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
25038672|NCT01319929|50139126|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
25038673|NCT01319929|50139127|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
25038674|NCT01319929|50139126|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
25038675|NCT01319929|50139127|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
25038676|NCT01319929|50139126|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
25038677|NCT01319929|50139127|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
25038678|NCT01319929|50139126|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
25038679|NCT01319929|50139127|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
25038680|NCT03110185|50139136|FG000|Overall Study|Death|0|||
25038681|NCT03110185|50139137|FG001|Overall Study|Death|1|||
25038682|NCT03110185|50139136|FG000|Overall Study|Withdrawal by Subject|2|||
25038683|NCT03110185|50139137|FG001|Overall Study|Withdrawal by Subject|7|||
25038684|NCT03110185|50139136|FG000|Overall Study|Time Constraints|0|||
25038685|NCT03110185|50139137|FG001|Overall Study|Time Constraints|6|||
25038686|NCT03110185|50139136|FG000|Overall Study|Conflict with care|5|||
25038687|NCT03110185|50139137|FG001|Overall Study|Conflict with care|12|||
25038688|NCT03110185|50139136|FG000|Overall Study|Protocol Violation|1|||
25038689|NCT03110185|50139137|FG001|Overall Study|Protocol Violation|4|||
25038690|NCT03110185|50139136|FG000|Overall Study|MRI Incompatible|2|||
25038691|NCT03110185|50139137|FG001|Overall Study|MRI Incompatible|0|||
25038692|NCT03110185|50139136|FG000|Overall Study|Patient Refusal|0|||
25038693|NCT03110185|50139137|FG001|Overall Study|Patient Refusal|1|||
25038694|NCT02858076|50139148|FG000|Overall Study|Death|6|||
25038695|NCT02858076|50139149|FG001|Overall Study|Death|3|||
25038696|NCT02858076|50139148|FG000|Overall Study|Withdrawal by Subject|1|||
25038697|NCT02858076|50139149|FG001|Overall Study|Withdrawal by Subject|5|||
25038698|NCT02858076|50139148|FG000|Overall Study|Lost to Follow-up|2|||
25038699|NCT02858076|50139149|FG001|Overall Study|Lost to Follow-up|7|||
25038700|NCT02858076|50139148|FG000|Overall Study|Completed Out of Window|1|||
25038701|NCT02858076|50139149|FG001|Overall Study|Completed Out of Window|3|||
25038702|NCT04594759|50139157|FG000|Overall Study|Lost to Follow-up|3|||
25038703|NCT02856282|50139161|FG000|Overall Study|Withdrawal by Subject|1|||
25186286|NCT01457924|50336267|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
25186287|NCT01457924|50336263|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
25186288|NCT01457924|50336264|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
25038704|NCT03833817|50139167|FG000|Overall Study|Withdrawal by Subject|3|||
25038705|NCT03833817|50139168|FG001|Overall Study|Withdrawal by Subject|3|||
25038706|NCT03833817|50139167|FG000|Overall Study|Lost to Follow-up|3|||
25038707|NCT03833817|50139168|FG001|Overall Study|Lost to Follow-up|3|||
25038708|NCT03119701|50139176|FG000|6-day Dosing|Death|4|||
25038709|NCT03119701|50139177|FG001|6-day Dosing|Death|1|||
25038710|NCT03119701|50139176|FG000|6-day Dosing|Adverse Event|3|||
25038711|NCT03119701|50139177|FG001|6-day Dosing|Adverse Event|0|||
25038712|NCT03119701|50139176|FG000|6-day Dosing|Physician Decision|0|||
25038713|NCT03119701|50139177|FG001|6-day Dosing|Physician Decision|1|||
25038714|NCT03119701|50139176|FG000|6-day Dosing|Withdrawal by Subject|0|||
25038715|NCT03119701|50139177|FG001|6-day Dosing|Withdrawal by Subject|1|||
25038716|NCT03119701|50139176|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
25038717|NCT03119701|50139177|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
25038718|NCT02679781|50139191|FG000|Overall Study|Lost to Follow-up|1|||
25038719|NCT02679781|50139192|FG001|Overall Study|Lost to Follow-up|2|||
25038720|NCT02679781|50139191|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
25038721|NCT02679781|50139192|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
24949620|NCT00302211|50041462|FG003|Double Blind Period (New Patients)|Disease progression|0|||
24949621|NCT00302211|50041463|FG004|Double Blind Period (New Patients)|Disease progression|0|||
24949622|NCT00302211|50041459|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
24949623|NCT00302211|50041460|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
24949624|NCT00302211|50041461|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
24949625|NCT00302211|50041462|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
24949626|NCT00302211|50041463|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
24949627|NCT00302211|50041459|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
24949628|NCT00302211|50041460|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
24949629|NCT00302211|50041461|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
24949630|NCT00302211|50041462|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
24949631|NCT00302211|50041463|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
24949632|NCT00302211|50041459|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
24949633|NCT00302211|50041460|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
24949634|NCT00302211|50041461|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
24949635|NCT00302211|50041462|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
24949636|NCT00302211|50041463|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
24949637|NCT00302211|50041459|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
24949638|NCT00302211|50041460|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
24949639|NCT00302211|50041461|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
24949640|NCT00302211|50041462|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
24949641|NCT00302211|50041463|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
24949642|NCT00302211|50041459|FG000|Open Label-Patients From Double-Blind|Death|0|||
24949643|NCT00302211|50041460|FG001|Open Label-Patients From Double-Blind|Death|0|||
24949644|NCT00302211|50041461|FG002|Open Label-Patients From Double-Blind|Death|0|||
24949645|NCT00302211|50041462|FG003|Open Label-Patients From Double-Blind|Death|1|||
24949646|NCT00302211|50041463|FG004|Open Label-Patients From Double-Blind|Death|1|||
24949647|NCT00302211|50041459|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
24949648|NCT00302211|50041460|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
24949649|NCT00302211|50041461|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
24949650|NCT00302211|50041462|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
24949651|NCT00302211|50041463|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
24949652|NCT00302211|50041459|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
25038722|NCT02624869|50139201|FG000|Overall Study|Lost to Follow-up|0|||
25038723|NCT02624869|50139202|FG001|Overall Study|Lost to Follow-up|0|||
25038724|NCT02624869|50139203|FG002|Overall Study|Lost to Follow-up|1|||
25038725|NCT02624869|50139201|FG000|Overall Study|Withdrawal by Subject|1|||
25038726|NCT02624869|50139202|FG001|Overall Study|Withdrawal by Subject|3|||
25038727|NCT02624869|50139203|FG002|Overall Study|Withdrawal by Subject|1|||
25038728|NCT03110029|50139223|FG000|Overall Study|Withdrawal by Subject|1|||
25038729|NCT03110029|50139224|FG001|Overall Study|Withdrawal by Subject|1|||
25038730|NCT02747004|50139233|FG000|Overall Study|Withdrawal by Subject|8|||
25038731|NCT02747004|50139234|FG001|Overall Study|Withdrawal by Subject|5|||
25038732|NCT02747004|50139235|FG002|Overall Study|Withdrawal by Subject|4|||
25038733|NCT02747004|50139233|FG000|Overall Study|Lost to Follow-up|1|||
25038734|NCT02747004|50139234|FG001|Overall Study|Lost to Follow-up|2|||
25038735|NCT02747004|50139235|FG002|Overall Study|Lost to Follow-up|2|||
25038736|NCT02747004|50139233|FG000|Overall Study|on study treatment/follow-up|48|||
25038737|NCT02747004|50139234|FG001|Overall Study|on study treatment/follow-up|42|||
25160127|NCT01860703|50280164|FG003|Overall Study|Personal reason|0|||
25038738|NCT02747004|50139235|FG002|Overall Study|on study treatment/follow-up|41|||
25038739|NCT04207749|50139245|FG000|Overall Study|Lost to Follow-up|0|||
25038740|NCT04207749|50139246|FG001|Overall Study|Lost to Follow-up|2|||
25038741|NCT04207749|50139245|FG000|Overall Study|Protocol Violation|0|||
25038742|NCT04207749|50139246|FG001|Overall Study|Protocol Violation|1|||
25038743|NCT04207749|50139245|FG000|Overall Study|Withdrawal by Subject|3|||
24949653|NCT00302211|50041460|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
24949654|NCT00302211|50041461|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
24949655|NCT00302211|50041462|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
24949656|NCT00302211|50041463|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
24949657|NCT00302211|50041459|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
24949658|NCT00302211|50041460|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
24949659|NCT00302211|50041461|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
24949660|NCT00302211|50041462|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
24949661|NCT00302211|50041463|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
24949662|NCT00288015|50041475|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
24949663|NCT00288015|50041475|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
24949664|NCT00288015|50041475|FG000|First Response Assessment|Withdrawal by Subject|1|||
24949665|NCT00288015|50041475|FG000|First Response Assessment|Death|1|||
24949666|NCT00288015|50041475|FG000|First Response Assessment|Physician Decision|2|||
24949667|NCT00288015|50041475|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
24949668|NCT00288015|50041475|FG000|Follow up for Survival x 2 Years|Death|13|||
24949669|NCT00288015|50041475|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
24949670|NCT00288015|50041475|FG000|Follow up for Survival x 2 Years|Other|9|||
24949671|NCT00389064|50041481|FG000|Overall Study|Adverse Event|11|||
24949672|NCT00389064|50041482|FG001|Overall Study|Adverse Event|3|||
24949673|NCT00389064|50041481|FG000|Overall Study|Lack of Efficacy|3|||
24949674|NCT00389064|50041482|FG001|Overall Study|Lack of Efficacy|14|||
24949675|NCT00389064|50041481|FG000|Overall Study|Withdrawal by Subject|17|||
24949676|NCT00389064|50041482|FG001|Overall Study|Withdrawal by Subject|27|||
24949677|NCT00389064|50041481|FG000|Overall Study|Physician Decision|2|||
24949678|NCT00389064|50041482|FG001|Overall Study|Physician Decision|2|||
24949679|NCT00389064|50041481|FG000|Overall Study|Lost to Follow-up|1|||
24949680|NCT00389064|50041482|FG001|Overall Study|Lost to Follow-up|2|||
24949681|NCT00389064|50041481|FG000|Overall Study|Protocol Violation|2|||
24949682|NCT00389064|50041482|FG001|Overall Study|Protocol Violation|0|||
24949683|NCT00389064|50041481|FG000|Overall Study|Multiple Reasons|9|||
24949684|NCT00389064|50041482|FG001|Overall Study|Multiple Reasons|11|||
24949685|NCT00388674|50041490|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
24949686|NCT00388674|50041491|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
24949687|NCT00388674|50041490|FG000|Initial Treatment|Adverse Event|22|||
24949688|NCT00388674|50041491|FG001|Initial Treatment|Adverse Event|87|||
24949689|NCT00388674|50041490|FG000|Initial Treatment|Death|215|||
24949690|NCT00388674|50041491|FG001|Initial Treatment|Death|216|||
24949691|NCT00388674|50041490|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
24949692|NCT00388674|50041491|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
24949693|NCT00388674|50041490|FG000|Initial Treatment|HCC|12|||
24949694|NCT00388674|50041491|FG001|Initial Treatment|HCC|20|||
24949695|NCT00388674|50041490|FG000|Initial Treatment|Lost to Follow-up|526|||
24949696|NCT00388674|50041491|FG001|Initial Treatment|Lost to Follow-up|624|||
24949697|NCT00388674|50041490|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
24949698|NCT00388674|50041491|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
24949699|NCT00388674|50041490|FG000|Initial Treatment|Never Treated with Study Medication|1|||
24949700|NCT00388674|50041491|FG001|Initial Treatment|Never Treated with Study Medication|7|||
24949701|NCT00388674|50041490|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
24949702|NCT00388674|50041491|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
24949703|NCT00388674|50041490|FG000|Initial Treatment|Not Defined|125|||
24949704|NCT00388674|50041491|FG001|Initial Treatment|Not Defined|172|||
24949705|NCT00388674|50041490|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
24949706|NCT00388674|50041491|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
24949707|NCT00388674|50041490|FG000|Initial Treatment|Pregnancy|26|||
24949708|NCT00388674|50041491|FG001|Initial Treatment|Pregnancy|16|||
24949709|NCT00388674|50041490|FG000|Initial Treatment|Study Drug Toxicity|5|||
25038744|NCT04207749|50139246|FG001|Overall Study|Withdrawal by Subject|0|||
25038745|NCT04207749|50139245|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
25038746|NCT04207749|50139246|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
25038747|NCT03043365|50139257|FG000|Weeks 0 to Week 8|Adverse Event|1|||
24949710|NCT00388674|50041491|FG001|Initial Treatment|Study Drug Toxicity|92|||
24949711|NCT00388674|50041490|FG000|Initial Treatment|Participant Request|501|||
24949712|NCT00388674|50041491|FG001|Initial Treatment|Participant Request|673|||
24949713|NCT00388674|50041490|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
24949714|NCT00388674|50041491|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
24949715|NCT00388674|50041490|FG000|Initial Treatment|Not Reported|10|||
24949716|NCT00388674|50041491|FG001|Initial Treatment|Not Reported|12|||
24949717|NCT00388674|50041490|FG000|End of Study|Administrative Reason By Sponsor|299|||
24949718|NCT00388674|50041491|FG001|End of Study|Administrative Reason By Sponsor|253|||
24949719|NCT00388674|50041490|FG000|End of Study|Death|239|||
24949720|NCT00388674|50041491|FG001|End of Study|Death|262|||
24949721|NCT00388674|50041490|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
24949722|NCT00388674|50041491|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
24949723|NCT00388674|50041490|FG000|End of Study|HCC|8|||
24949724|NCT00388674|50041491|FG001|End of Study|HCC|7|||
24949725|NCT00388674|50041490|FG000|End of Study|Lost to Follow-up|587|||
24949726|NCT00388674|50041491|FG001|End of Study|Lost to Follow-up|715|||
24949727|NCT00388674|50041490|FG000|End of Study|Malignancy (Non-HCC)|1|||
24949728|NCT00388674|50041491|FG001|End of Study|Malignancy (Non-HCC)|1|||
24949729|NCT00388674|50041490|FG000|End of Study|Non-Study Related Comorbidities|3|||
24949730|NCT00388674|50041491|FG001|End of Study|Non-Study Related Comorbidities|4|||
25038748|NCT03043365|50139258|FG001|Weeks 0 to Week 8|Adverse Event|3|||
25038749|NCT03043365|50139257|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
25038750|NCT03043365|50139258|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
25038751|NCT03043365|50139257|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
25038752|NCT03043365|50139258|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
25038753|NCT03108157|50139268|FG000|Overall Study|Protocol Violation|15|||
25038754|NCT03108157|50139269|FG001|Overall Study|Protocol Violation|4|||
25038755|NCT04421131|50139276|FG000|Overall Study|Lost to Follow-up|1|||
25038756|NCT04421131|50139276|FG000|Overall Study|Protocol Violation|2|||
25038757|NCT04421131|50139276|FG000|Overall Study|App crashed|5|||
25038758|NCT04167345|50139285|FG000|Overall Study|Other|1|||
25038759|NCT04167345|50139286|FG001|Overall Study|Other|1|||
25038760|NCT04167345|50139287|FG002|Overall Study|Other|0|||
25038761|NCT04167345|50139288|FG003|Overall Study|Other|0|||
25038762|NCT04167345|50139289|FG004|Overall Study|Other|0|||
25038763|NCT02854800|50139308|FG000|Overall Study|Protocol Violation|16|||
25038764|NCT02854800|50139309|FG001|Overall Study|Protocol Violation|11|||
25038765|NCT02854800|50139310|FG002|Overall Study|Protocol Violation|3|||
25038766|NCT02854800|50139308|FG000|Overall Study|Withdrawal by Subject|4|||
25038767|NCT02854800|50139309|FG001|Overall Study|Withdrawal by Subject|2|||
25038768|NCT02854800|50139310|FG002|Overall Study|Withdrawal by Subject|3|||
25038769|NCT02931539|50139323|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
25038770|NCT02931539|50139324|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
25038771|NCT02931539|50139325|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
25038772|NCT02931539|50139323|FG000|Period 1: Treatment Phase|Adverse Event|5|||
25038773|NCT02931539|50139324|FG001|Period 1: Treatment Phase|Adverse Event|1|||
25038774|NCT02931539|50139325|FG002|Period 1: Treatment Phase|Adverse Event|0|||
25038775|NCT02931539|50139323|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
25038776|NCT02931539|50139324|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
25038777|NCT02931539|50139325|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
25038778|NCT02931539|50139323|FG000|Period 1: Treatment Phase|Death|8|||
25038779|NCT02931539|50139324|FG001|Period 1: Treatment Phase|Death|24|||
25038780|NCT02931539|50139325|FG002|Period 1: Treatment Phase|Death|0|||
25038781|NCT02931539|50139323|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
25038782|NCT02931539|50139324|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
25038783|NCT02931539|50139325|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
25038784|NCT02931539|50139323|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
25038785|NCT02931539|50139324|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
25038786|NCT02931539|50139325|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
25038787|NCT02931539|50139323|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
25038788|NCT02931539|50139324|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
25038789|NCT02931539|50139325|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
25038790|NCT02931539|50139323|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
25038791|NCT02931539|50139324|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
25038792|NCT02931539|50139325|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
25038793|NCT04042077|50139342|FG000|Overall Study|Adverse Event|0|||
25038794|NCT04042077|50139343|FG001|Overall Study|Adverse Event|1|||
25038795|NCT04042077|50139342|FG000|Overall Study|Death|2|||
25038796|NCT04042077|50139343|FG001|Overall Study|Death|1|||
25038797|NCT04042077|50139342|FG000|Overall Study|Physician Decision|2|||
24949731|NCT00388674|50041490|FG000|End of Study|Not Defined|135|||
24949732|NCT00388674|50041491|FG001|End of Study|Not Defined|214|||
25038798|NCT04042077|50139343|FG001|Overall Study|Physician Decision|0|||
25038799|NCT04042077|50139342|FG000|Overall Study|Withdrawal by Subject|3|||
25038800|NCT04042077|50139343|FG001|Overall Study|Withdrawal by Subject|2|||
25038801|NCT04042077|50139342|FG000|Overall Study|Lack of Efficacy|0|||
25038802|NCT04042077|50139343|FG001|Overall Study|Lack of Efficacy|1|||
25038803|NCT02853318|50139364|FG000|Overall Study|Withdrawal by Subject|1|||
24949733|NCT00388674|50041490|FG000|End of Study|Participant Withdrew Consent|437|||
25038804|NCT03113071|50139374|FG000|Overall Study|Withdrawal by Subject|1|||
25038805|NCT03113071|50139375|FG001|Overall Study|Withdrawal by Subject|0|||
25038806|NCT03050307|50139383|FG000|Overall Study|Adverse Event|4|||
25038807|NCT03050307|50139384|FG001|Overall Study|Adverse Event|2|||
25038808|NCT03050307|50139383|FG000|Overall Study|Significant Protocol Deviation|0|||
25038809|NCT03050307|50139384|FG001|Overall Study|Significant Protocol Deviation|1|||
25038810|NCT03050307|50139383|FG000|Overall Study|Lost to Follow-up|0|||
25038811|NCT03050307|50139384|FG001|Overall Study|Lost to Follow-up|1|||
25038812|NCT03050307|50139383|FG000|Overall Study|Voluntary Withdrawal|3|||
25038813|NCT03050307|50139384|FG001|Overall Study|Voluntary Withdrawal|4|||
25038814|NCT03050307|50139383|FG000|Overall Study|Reason not Specified|1|||
25038815|NCT03050307|50139384|FG001|Overall Study|Reason not Specified|1|||
25038816|NCT03118765|50139410|FG000|Overall Study|Withdrawal by Subject|0|||
25038817|NCT03118765|50139411|FG001|Overall Study|Withdrawal by Subject|0|||
25038818|NCT03118765|50139412|FG002|Overall Study|Withdrawal by Subject|1|||
25038819|NCT03118765|50139413|FG003|Overall Study|Withdrawal by Subject|0|||
25160128|NCT01399593|50280182|FG000|Overall Study|Physician Decision|1|||
25160129|NCT01399593|50280183|FG001|Overall Study|Physician Decision|0|||
25160130|NCT01399593|50280182|FG000|Overall Study|Adverse Event|1|||
25038820|NCT03118765|50139414|FG004|Overall Study|Withdrawal by Subject|0|||
25038821|NCT03118765|50139410|FG000|Overall Study|Adverse Event|1|||
25038822|NCT03118765|50139411|FG001|Overall Study|Adverse Event|1|||
25038823|NCT03118765|50139412|FG002|Overall Study|Adverse Event|1|||
25038824|NCT03118765|50139413|FG003|Overall Study|Adverse Event|1|||
25038825|NCT03118765|50139414|FG004|Overall Study|Adverse Event|1|||
25038826|NCT03118765|50139410|FG000|Overall Study|Non compliance with Study Procedures|0|||
25038827|NCT03118765|50139411|FG001|Overall Study|Non compliance with Study Procedures|0|||
25038828|NCT03118765|50139412|FG002|Overall Study|Non compliance with Study Procedures|0|||
25038829|NCT03118765|50139413|FG003|Overall Study|Non compliance with Study Procedures|1|||
25038830|NCT03118765|50139414|FG004|Overall Study|Non compliance with Study Procedures|0|||
25038831|NCT03118765|50139410|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
25038832|NCT03118765|50139411|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
25038833|NCT03118765|50139412|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
25038834|NCT03118765|50139413|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
25038835|NCT03118765|50139414|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
25038836|NCT03118765|50139410|FG000|Overall Study|COPD Exacerbation|1|||
25038837|NCT03118765|50139411|FG001|Overall Study|COPD Exacerbation|0|||
25038838|NCT03118765|50139412|FG002|Overall Study|COPD Exacerbation|0|||
25038839|NCT03118765|50139413|FG003|Overall Study|COPD Exacerbation|1|||
25038840|NCT03118765|50139414|FG004|Overall Study|COPD Exacerbation|0|||
25038841|NCT03118765|50139410|FG000|Overall Study|Lost to Follow-up|1|||
25038842|NCT03118765|50139411|FG001|Overall Study|Lost to Follow-up|0|||
25038843|NCT03118765|50139412|FG002|Overall Study|Lost to Follow-up|1|||
25038844|NCT03118765|50139413|FG003|Overall Study|Lost to Follow-up|0|||
25038845|NCT03118765|50139414|FG004|Overall Study|Lost to Follow-up|0|||
25038846|NCT03118765|50139410|FG000|Overall Study|Sponsor Decision|1|||
25038847|NCT03118765|50139411|FG001|Overall Study|Sponsor Decision|0|||
25038848|NCT03118765|50139412|FG002|Overall Study|Sponsor Decision|1|||
25038849|NCT03118765|50139413|FG003|Overall Study|Sponsor Decision|0|||
25038850|NCT03118765|50139414|FG004|Overall Study|Sponsor Decision|1|||
25038851|NCT05222880|50139429|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
25038852|NCT05222880|50139429|FG000|Overall Study|Withdrew Consent during Study|1|||
25038853|NCT05222880|50139429|FG000|Overall Study|COVID-19 Related|1|||
25038854|NCT04606134|50139471|FG000|Overall Study|Adverse Event|0|||
25038855|NCT04606134|50139472|FG001|Overall Study|Adverse Event|1|||
25038856|NCT04426825|50139478|FG000|Overall Study|Continuing on study|6|||
25038857|NCT04426825|50139478|FG000|Overall Study|Death|17|||
25038858|NCT04399538|50139487|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
25038859|NCT04399538|50139488|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
25038860|NCT04399538|50139489|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
25038861|NCT04399538|50139490|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
25038862|NCT04399538|50139491|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
25038863|NCT04399538|50139487|FG000|Double-Blind Treatment|Adverse Event|0|||
25038864|NCT04399538|50139488|FG001|Double-Blind Treatment|Adverse Event|0|||
25038865|NCT04399538|50139489|FG002|Double-Blind Treatment|Adverse Event|0|||
25038866|NCT04399538|50139490|FG003|Double-Blind Treatment|Adverse Event|0|||
25038867|NCT04399538|50139491|FG004|Double-Blind Treatment|Adverse Event|1|||
25160131|NCT01399593|50280183|FG001|Overall Study|Adverse Event|0|||
25160132|NCT01399593|50280182|FG000|Overall Study|Death|1|||
25038868|NCT04399538|50139487|FG000|Follow-Up|Adverse Event|0|||
25038869|NCT04399538|50139488|FG001|Follow-Up|Adverse Event|0|||
25038870|NCT04399538|50139489|FG002|Follow-Up|Adverse Event|0|||
25160133|NCT01399593|50280183|FG001|Overall Study|Death|1|||
25160134|NCT01399593|50280182|FG000|Overall Study|Transplantectomy|0|||
25038871|NCT04399538|50139490|FG003|Follow-Up|Adverse Event|0|||
25038872|NCT04399538|50139491|FG004|Follow-Up|Adverse Event|1|||
25038873|NCT04399538|50139487|FG000|Follow-Up|Withdrawal by Subject|0|||
25038874|NCT04399538|50139488|FG001|Follow-Up|Withdrawal by Subject|0|||
25038875|NCT04399538|50139489|FG002|Follow-Up|Withdrawal by Subject|0|||
25038876|NCT04399538|50139490|FG003|Follow-Up|Withdrawal by Subject|2|||
25038877|NCT04399538|50139491|FG004|Follow-Up|Withdrawal by Subject|0|||
25038878|NCT03875235|50139509|FG000|Overall Study|Ongoing study treatment|63|||
25038879|NCT03875235|50139510|FG001|Overall Study|Ongoing study treatment|20|||
25038880|NCT03875235|50139509|FG000|Overall Study|Off treatment|77|||
24949734|NCT00388674|50041491|FG001|End of Study|Participant Withdrew Consent|673|||
24949735|NCT00388674|50041490|FG000|End of Study|No Off-Treatment Status Data|22|||
24949736|NCT00388674|50041491|FG001|End of Study|No Off-Treatment Status Data|30|||
24949737|NCT00388674|50041490|FG000|End of Study|Not Reported|0|||
24949738|NCT00388674|50041491|FG001|End of Study|Not Reported|1|||
24949739|NCT00388362|50041497|FG000|Enrolled|Ineligible|1|||
24949740|NCT00388362|50041497|FG000|Enrolled|Adverse Event|9|||
24949741|NCT00388362|50041497|FG000|Enrolled|Death|1|||
24949742|NCT00388362|50041497|FG000|Enrolled|Loss insurance|1|||
24949743|NCT00388362|50041497|FG000|Enrolled|Withdrawal by Subject|1|||
24949744|NCT00388362|50041497|FG000|Remained on Study Median of 514 Days|Death|2|||
24949745|NCT00387894|50041501|FG000|Overall Study|Withdrawal by Subject|1|||
24949746|NCT00387426|50041505|FG000|Overall Study|Lack of Response|7|||
24949747|NCT00387426|50041505|FG000|Overall Study|Toxicities|4|||
24949748|NCT00387426|50041505|FG000|Overall Study|Disease Progression|3|||
24949749|NCT00387348|50041512|FG000|Overall Study|Death|1|||
24949750|NCT00387348|50041513|FG001|Overall Study|Death|1|||
24949751|NCT00387348|50041514|FG002|Overall Study|Death|0|||
24949752|NCT00387348|50041512|FG000|Overall Study|Physician Decision|1|||
24949753|NCT00387348|50041513|FG001|Overall Study|Physician Decision|0|||
24949754|NCT00387348|50041514|FG002|Overall Study|Physician Decision|1|||
24949755|NCT00387348|50041512|FG000|Overall Study|Withdrawal by Subject|0|||
24949756|NCT00387348|50041513|FG001|Overall Study|Withdrawal by Subject|2|||
24949757|NCT00387348|50041514|FG002|Overall Study|Withdrawal by Subject|2|||
24949758|NCT00387348|50041512|FG000|Overall Study|Adverse Event|1|||
24949759|NCT00387348|50041513|FG001|Overall Study|Adverse Event|0|||
24949760|NCT00387348|50041514|FG002|Overall Study|Adverse Event|1|||
24949761|NCT00413660|50041534|FG000|Up To Week 12|Adverse Event|1|||
24949762|NCT00413660|50041535|FG001|Up To Week 12|Adverse Event|3|||
24949763|NCT00413660|50041536|FG002|Up To Week 12|Adverse Event|1|||
24949764|NCT00413660|50041537|FG003|Up To Week 12|Adverse Event|4|||
24949765|NCT00413660|50041538|FG004|Up To Week 12|Adverse Event|6|||
24949766|NCT00413660|50041539|FG005|Up To Week 12|Adverse Event|4|||
24949767|NCT00413660|50041540|FG006|Up To Week 12|Adverse Event|1|||
24949768|NCT00413660|50041541|FG007|Up To Week 12|Adverse Event|0|||
24949769|NCT00413660|50041542|FG008|Up To Week 12|Adverse Event|0|||
25038881|NCT03875235|50139510|FG001|Overall Study|Off treatment|91|||
25038882|NCT03875235|50139509|FG000|Overall Study|Withdrawal by Subject|3|||
25038883|NCT03875235|50139510|FG001|Overall Study|Withdrawal by Subject|10|||
25038884|NCT03875235|50139509|FG000|Overall Study|Death|198|||
25038885|NCT03875235|50139510|FG001|Overall Study|Death|223|||
25038886|NCT03775486|50139518|FG000|Initial Therapy Phase|Other reason provided|0|||
25038887|NCT03775486|50139519|FG001|Initial Therapy Phase|Other reason provided|15|||
25038888|NCT03775486|50139518|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
24949770|NCT00413660|50041543|FG009|Up To Week 12|Adverse Event|0|||
24949771|NCT00413660|50041544|FG010|Up To Week 12|Adverse Event|0|||
24949772|NCT00413660|50041534|FG000|Up To Week 12|Lack of Efficacy|2|||
24949773|NCT00413660|50041535|FG001|Up To Week 12|Lack of Efficacy|0|||
24949774|NCT00413660|50041536|FG002|Up To Week 12|Lack of Efficacy|0|||
24949775|NCT00413660|50041537|FG003|Up To Week 12|Lack of Efficacy|0|||
24949776|NCT00413660|50041538|FG004|Up To Week 12|Lack of Efficacy|0|||
24949777|NCT00413660|50041539|FG005|Up To Week 12|Lack of Efficacy|0|||
24949778|NCT00413660|50041540|FG006|Up To Week 12|Lack of Efficacy|5|||
24949779|NCT00413660|50041541|FG007|Up To Week 12|Lack of Efficacy|0|||
24949780|NCT00413660|50041542|FG008|Up To Week 12|Lack of Efficacy|0|||
24949781|NCT00413660|50041543|FG009|Up To Week 12|Lack of Efficacy|0|||
24949782|NCT00413660|50041544|FG010|Up To Week 12|Lack of Efficacy|0|||
24949783|NCT00413660|50041534|FG000|Up To Week 12|Lost to Follow-up|0|||
24949784|NCT00413660|50041535|FG001|Up To Week 12|Lost to Follow-up|1|||
24949785|NCT00413660|50041536|FG002|Up To Week 12|Lost to Follow-up|0|||
24949786|NCT00413660|50041537|FG003|Up To Week 12|Lost to Follow-up|0|||
24949787|NCT00413660|50041538|FG004|Up To Week 12|Lost to Follow-up|1|||
24949788|NCT00413660|50041539|FG005|Up To Week 12|Lost to Follow-up|0|||
24949789|NCT00413660|50041540|FG006|Up To Week 12|Lost to Follow-up|0|||
24949790|NCT00413660|50041541|FG007|Up To Week 12|Lost to Follow-up|0|||
24949791|NCT00413660|50041542|FG008|Up To Week 12|Lost to Follow-up|0|||
24949792|NCT00413660|50041543|FG009|Up To Week 12|Lost to Follow-up|0|||
24949793|NCT00413660|50041544|FG010|Up To Week 12|Lost to Follow-up|0|||
24949794|NCT00413660|50041534|FG000|Up To Week 12|Withdrawal by Subject|0|||
25038889|NCT03775486|50139519|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
25160135|NCT01399593|50280183|FG001|Overall Study|Transplantectomy|1|||
25160136|NCT01833169|50280189|FG000|Overall Study|Disease Progression|99|||
24949795|NCT00413660|50041535|FG001|Up To Week 12|Withdrawal by Subject|2|||
24949796|NCT00413660|50041536|FG002|Up To Week 12|Withdrawal by Subject|0|||
24949797|NCT00413660|50041537|FG003|Up To Week 12|Withdrawal by Subject|2|||
24949798|NCT00413660|50041538|FG004|Up To Week 12|Withdrawal by Subject|0|||
24949799|NCT00413660|50041539|FG005|Up To Week 12|Withdrawal by Subject|2|||
24949800|NCT00413660|50041540|FG006|Up To Week 12|Withdrawal by Subject|2|||
24949801|NCT00413660|50041541|FG007|Up To Week 12|Withdrawal by Subject|0|||
24949802|NCT00413660|50041542|FG008|Up To Week 12|Withdrawal by Subject|0|||
24949803|NCT00413660|50041543|FG009|Up To Week 12|Withdrawal by Subject|0|||
24949804|NCT00413660|50041544|FG010|Up To Week 12|Withdrawal by Subject|0|||
24949805|NCT00413660|50041534|FG000|Up To Week 12|Randomized, Not Treated|1|||
24949806|NCT00413660|50041535|FG001|Up To Week 12|Randomized, Not Treated|0|||
24949807|NCT00413660|50041536|FG002|Up To Week 12|Randomized, Not Treated|0|||
24949808|NCT00413660|50041537|FG003|Up To Week 12|Randomized, Not Treated|1|||
24949809|NCT00413660|50041538|FG004|Up To Week 12|Randomized, Not Treated|0|||
24949810|NCT00413660|50041539|FG005|Up To Week 12|Randomized, Not Treated|0|||
24949811|NCT00413660|50041540|FG006|Up To Week 12|Randomized, Not Treated|0|||
24949812|NCT00413660|50041541|FG007|Up To Week 12|Randomized, Not Treated|0|||
24949813|NCT00413660|50041542|FG008|Up To Week 12|Randomized, Not Treated|0|||
24949814|NCT00413660|50041543|FG009|Up To Week 12|Randomized, Not Treated|0|||
24949815|NCT00413660|50041544|FG010|Up To Week 12|Randomized, Not Treated|0|||
24949816|NCT00413660|50041534|FG000|Up To Week 12|Other|3|||
24949817|NCT00413660|50041535|FG001|Up To Week 12|Other|1|||
24949818|NCT00413660|50041536|FG002|Up To Week 12|Other|6|||
24949819|NCT00413660|50041537|FG003|Up To Week 12|Other|1|||
24949820|NCT00413660|50041538|FG004|Up To Week 12|Other|2|||
24949821|NCT00413660|50041539|FG005|Up To Week 12|Other|4|||
24949822|NCT00413660|50041540|FG006|Up To Week 12|Other|3|||
24949823|NCT00413660|50041541|FG007|Up To Week 12|Other|0|||
24949824|NCT00413660|50041542|FG008|Up To Week 12|Other|0|||
24949825|NCT00413660|50041543|FG009|Up To Week 12|Other|0|||
24949826|NCT00413660|50041544|FG010|Up To Week 12|Other|0|||
24949827|NCT00413660|50041534|FG000|Post Week 12|Adverse Event|2|||
24949828|NCT00413660|50041535|FG001|Post Week 12|Adverse Event|0|||
24949829|NCT00413660|50041536|FG002|Post Week 12|Adverse Event|2|||
24949830|NCT00413660|50041537|FG003|Post Week 12|Adverse Event|1|||
24949831|NCT00413660|50041538|FG004|Post Week 12|Adverse Event|4|||
24949832|NCT00413660|50041539|FG005|Post Week 12|Adverse Event|2|||
24949833|NCT00413660|50041540|FG006|Post Week 12|Adverse Event|2|||
24949834|NCT00413660|50041541|FG007|Post Week 12|Adverse Event|0|||
24949835|NCT00413660|50041542|FG008|Post Week 12|Adverse Event|0|||
24949836|NCT00413660|50041543|FG009|Post Week 12|Adverse Event|0|||
24949837|NCT00413660|50041544|FG010|Post Week 12|Adverse Event|0|||
24949838|NCT00413660|50041534|FG000|Post Week 12|Lack of Efficacy|0|||
24949839|NCT00413660|50041535|FG001|Post Week 12|Lack of Efficacy|0|||
24949840|NCT00413660|50041536|FG002|Post Week 12|Lack of Efficacy|1|||
24949841|NCT00413660|50041537|FG003|Post Week 12|Lack of Efficacy|0|||
24949842|NCT00413660|50041538|FG004|Post Week 12|Lack of Efficacy|0|||
24949843|NCT00413660|50041539|FG005|Post Week 12|Lack of Efficacy|0|||
24949844|NCT00413660|50041540|FG006|Post Week 12|Lack of Efficacy|0|||
24949845|NCT00413660|50041541|FG007|Post Week 12|Lack of Efficacy|0|||
24949846|NCT00413660|50041542|FG008|Post Week 12|Lack of Efficacy|0|||
24949847|NCT00413660|50041543|FG009|Post Week 12|Lack of Efficacy|1|||
24949848|NCT00413660|50041544|FG010|Post Week 12|Lack of Efficacy|0|||
24949849|NCT00413660|50041534|FG000|Post Week 12|Lost to Follow-up|0|||
24949850|NCT00413660|50041535|FG001|Post Week 12|Lost to Follow-up|1|||
24949851|NCT00413660|50041536|FG002|Post Week 12|Lost to Follow-up|1|||
24949852|NCT00413660|50041537|FG003|Post Week 12|Lost to Follow-up|0|||
24949853|NCT00413660|50041538|FG004|Post Week 12|Lost to Follow-up|0|||
24949854|NCT00413660|50041539|FG005|Post Week 12|Lost to Follow-up|0|||
24949855|NCT00413660|50041540|FG006|Post Week 12|Lost to Follow-up|0|||
24949856|NCT00413660|50041541|FG007|Post Week 12|Lost to Follow-up|0|||
24949857|NCT00413660|50041542|FG008|Post Week 12|Lost to Follow-up|0|||
24949858|NCT00413660|50041543|FG009|Post Week 12|Lost to Follow-up|0|||
24949859|NCT00413660|50041544|FG010|Post Week 12|Lost to Follow-up|0|||
24949860|NCT00413660|50041534|FG000|Post Week 12|Withdrawal by Subject|0|||
24949861|NCT00413660|50041535|FG001|Post Week 12|Withdrawal by Subject|1|||
24949862|NCT00413660|50041536|FG002|Post Week 12|Withdrawal by Subject|1|||
24949863|NCT00413660|50041537|FG003|Post Week 12|Withdrawal by Subject|0|||
24949864|NCT00413660|50041538|FG004|Post Week 12|Withdrawal by Subject|1|||
24949865|NCT00413660|50041539|FG005|Post Week 12|Withdrawal by Subject|0|||
24949866|NCT00413660|50041540|FG006|Post Week 12|Withdrawal by Subject|0|||
24949867|NCT00413660|50041541|FG007|Post Week 12|Withdrawal by Subject|0|||
24949868|NCT00413660|50041542|FG008|Post Week 12|Withdrawal by Subject|0|||
24949869|NCT00413660|50041543|FG009|Post Week 12|Withdrawal by Subject|0|||
24949870|NCT00413660|50041544|FG010|Post Week 12|Withdrawal by Subject|1|||
24949871|NCT00413660|50041534|FG000|Post Week 12|Other|1|||
24949872|NCT00413660|50041535|FG001|Post Week 12|Other|2|||
24949873|NCT00413660|50041536|FG002|Post Week 12|Other|3|||
24949874|NCT00413660|50041537|FG003|Post Week 12|Other|0|||
24949875|NCT00413660|50041538|FG004|Post Week 12|Other|1|||
24949876|NCT00413660|50041539|FG005|Post Week 12|Other|1|||
24949877|NCT00413660|50041540|FG006|Post Week 12|Other|1|||
24949878|NCT00413660|50041541|FG007|Post Week 12|Other|0|||
24949879|NCT00413660|50041542|FG008|Post Week 12|Other|0|||
24949880|NCT00413660|50041543|FG009|Post Week 12|Other|0|||
24949881|NCT00413660|50041544|FG010|Post Week 12|Other|0|||
24949882|NCT00431834|50041578|FG000|Overall Study|Withdrawal by Subject|7|||
24949883|NCT00431834|50041578|FG000|Overall Study|Death|3|||
24949884|NCT00431834|50041578|FG000|Overall Study|Missed Endpoint Visit|2|||
24949885|NCT00431834|50041578|FG000|Overall Study|Lost to Follow-up|1|||
24949886|NCT00431444|50041587|FG000|Overall Study|Protocol Violation|1|||
24949887|NCT00431444|50041588|FG001|Overall Study|Protocol Violation|4|||
24949888|NCT00431444|50041587|FG000|Overall Study|Adverse Event|2|||
24949889|NCT00431444|50041588|FG001|Overall Study|Adverse Event|1|||
24949890|NCT00431444|50041587|FG000|Overall Study|Withdrawal by Subject|1|||
24949891|NCT00431444|50041588|FG001|Overall Study|Withdrawal by Subject|1|||
24949892|NCT00431444|50041587|FG000|Overall Study|Lost to Follow-up|1|||
24949893|NCT00431444|50041588|FG001|Overall Study|Lost to Follow-up|0|||
24949894|NCT00431444|50041587|FG000|Overall Study|Administrative Problems|0|||
24949895|NCT00431444|50041588|FG001|Overall Study|Administrative Problems|1|||
24949896|NCT00430352|50041594|FG000|Overall Study|Disease progression|58|||
24949897|NCT00430352|50041594|FG000|Overall Study|Withdrawal by Subject|11|||
24949898|NCT00430352|50041594|FG000|Overall Study|Adverse Event|16|||
24949899|NCT00430352|50041594|FG000|Overall Study|Death|5|||
24949900|NCT00430352|50041594|FG000|Overall Study|Other|48|||
24949901|NCT00287469|50041600|FG000|Overall Study|serious adverse event|1|||
24949902|NCT00287469|50041601|FG001|Overall Study|serious adverse event|6|||
24949903|NCT00287469|50041600|FG000|Overall Study|Adverse Event|1|||
24949904|NCT00287469|50041601|FG001|Overall Study|Adverse Event|1|||
24949905|NCT00287469|50041600|FG000|Overall Study|moved from area|144|||
24949906|NCT00287469|50041601|FG001|Overall Study|moved from area|138|||
24949907|NCT00287469|50041600|FG000|Overall Study|Lost to Follow-up|74|||
24949908|NCT00287469|50041601|FG001|Overall Study|Lost to Follow-up|69|||
24949909|NCT00429572|50041609|FG000|Overall Study|Disease progression|1|||
24949910|NCT00287079|50041615|FG000|Overall Study|Qualifying relapse|12|||
24949911|NCT00287079|50041616|FG001|Overall Study|Qualifying relapse|1|||
24949912|NCT00287079|50041615|FG000|Overall Study|Non-qualifying relapse|1|||
24949913|NCT00287079|50041616|FG001|Overall Study|Non-qualifying relapse|0|||
24949914|NCT00287079|50041615|FG000|Overall Study|Adverse Event|5|||
24949915|NCT00287079|50041616|FG001|Overall Study|Adverse Event|0|||
24949916|NCT00287079|50041615|FG000|Overall Study|Protocol Violation|1|||
24949917|NCT00287079|50041616|FG001|Overall Study|Protocol Violation|0|||
24949918|NCT00287079|50041615|FG000|Overall Study|Other|3|||
24949919|NCT00287079|50041616|FG001|Overall Study|Other|0|||
24949920|NCT00429494|50041622|FG000|Overall Study|Withdrawal by Subject|9|||
24949921|NCT00429494|50041622|FG000|Overall Study|Death|6|||
24949922|NCT00429416|50041626|FG000|Overall Study|Death|1|||
24949923|NCT00429182|50041630|FG000|Overall Study|Not evaluable, Disease Progression|2|||
24949924|NCT00429182|50041630|FG000|Overall Study|Not eligible|5|||
24949925|NCT00429104|50041634|FG000|Overall Study|Protocol Violation|1|||
24949926|NCT00429026|50041638|FG000|Overall Study|Inevaluable for response.|40|||
24949927|NCT00301821|50041642|FG000|Overall Study|Ineligible|25|||
24949928|NCT00301821|50041642|FG000|Overall Study|Cancel|1|||
24949929|NCT00372996|50041648|FG000|Overall Study|Death|11|||
24949930|NCT00372996|50041649|FG001|Overall Study|Death|4|||
24949931|NCT00372996|50041650|FG002|Overall Study|Death|8|||
24949932|NCT00372996|50041651|FG003|Overall Study|Death|7|||
24949933|NCT00372996|50041648|FG000|Overall Study|Lost to Follow-up|0|||
24949934|NCT00372996|50041649|FG001|Overall Study|Lost to Follow-up|2|||
24949935|NCT00372996|50041650|FG002|Overall Study|Lost to Follow-up|0|||
24949936|NCT00372996|50041651|FG003|Overall Study|Lost to Follow-up|1|||
24949937|NCT00372996|50041648|FG000|Overall Study|Withdrawal by Subject|12|||
24949938|NCT00372996|50041649|FG001|Overall Study|Withdrawal by Subject|6|||
24949939|NCT00372996|50041650|FG002|Overall Study|Withdrawal by Subject|9|||
24949940|NCT00372996|50041651|FG003|Overall Study|Withdrawal by Subject|5|||
24949941|NCT00372996|50041648|FG000|Overall Study|Study Terminated by Sponsor|4|||
24949942|NCT00372996|50041649|FG001|Overall Study|Study Terminated by Sponsor|0|||
24949943|NCT00372996|50041650|FG002|Overall Study|Study Terminated by Sponsor|4|||
24949944|NCT00372996|50041651|FG003|Overall Study|Study Terminated by Sponsor|0|||
24949945|NCT00372996|50041648|FG000|Overall Study|Other|10|||
24949946|NCT00372996|50041649|FG001|Overall Study|Other|2|||
24949947|NCT00372996|50041650|FG002|Overall Study|Other|7|||
24949948|NCT00372996|50041651|FG003|Overall Study|Other|7|||
25038890|NCT03775486|50139518|FG000|Initial Therapy Phase|Protocol Violation|0|||
25038891|NCT03775486|50139519|FG001|Initial Therapy Phase|Protocol Violation|2|||
24949949|NCT00399516|50041661|FG000|Overall Study|Lost to Follow-up|2|||
24949950|NCT00399360|50041669|FG000|Overall Study|Lost to Follow-up|2|||
24949951|NCT00399360|50041670|FG001|Overall Study|Lost to Follow-up|1|||
24949952|NCT00399360|50041671|FG002|Overall Study|Lost to Follow-up|2|||
24949953|NCT00399360|50041672|FG003|Overall Study|Lost to Follow-up|4|||
24949954|NCT00399360|50041669|FG000|Overall Study|Adverse Event|0|||
24949955|NCT00399360|50041670|FG001|Overall Study|Adverse Event|0|||
24949956|NCT00399360|50041671|FG002|Overall Study|Adverse Event|1|||
24949957|NCT00399360|50041672|FG003|Overall Study|Adverse Event|0|||
24949958|NCT00399360|50041669|FG000|Overall Study|Withdrawal by Subject|0|||
25160137|NCT01833169|50280189|FG000|Overall Study|Adverse Event|33|||
24949959|NCT00399360|50041670|FG001|Overall Study|Withdrawal by Subject|2|||
24949960|NCT00399360|50041671|FG002|Overall Study|Withdrawal by Subject|0|||
24949961|NCT00399360|50041672|FG003|Overall Study|Withdrawal by Subject|2|||
24949962|NCT00428948|50041689|FG000|Overall Study|Lost to Follow-up|15|||
24949963|NCT00428948|50041690|FG001|Overall Study|Lost to Follow-up|8|||
24949964|NCT00428948|50041689|FG000|Overall Study|Adverse Event|148|||
24949965|NCT00428948|50041690|FG001|Overall Study|Adverse Event|24|||
24949966|NCT00428948|50041689|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
24949967|NCT00428948|50041690|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
24949968|NCT00428948|50041689|FG000|Overall Study|Investigator Withdrew Subject|3|||
24949969|NCT00428948|50041690|FG001|Overall Study|Investigator Withdrew Subject|4|||
24949970|NCT00428948|50041689|FG000|Overall Study|Subject Withdrew Consent|50|||
24949971|NCT00428948|50041690|FG001|Overall Study|Subject Withdrew Consent|30|||
24949972|NCT00428948|50041689|FG000|Overall Study|Protocol Deviation|1|||
24949973|NCT00428948|50041690|FG001|Overall Study|Protocol Deviation|1|||
24949974|NCT00428792|50041698|FG000|Overall Study|Lack of Efficacy|1|||
24949975|NCT00428792|50041699|FG001|Overall Study|Lack of Efficacy|3|||
24949976|NCT00428792|50041698|FG000|Overall Study|Lost to Follow-up|0|||
24949977|NCT00428792|50041699|FG001|Overall Study|Lost to Follow-up|1|||
24949978|NCT00300885|50041707|FG000|Treatment|Adverse Event|134|||
24949979|NCT00300885|50041708|FG001|Treatment|Adverse Event|82|||
24949980|NCT00300885|50041707|FG000|Treatment|Death|20|||
24949981|NCT00300885|50041708|FG001|Treatment|Death|7|||
24949982|NCT00300885|50041707|FG000|Treatment|Lack of Efficacy|1|||
24949983|NCT00300885|50041708|FG001|Treatment|Lack of Efficacy|1|||
24949984|NCT00300885|50041707|FG000|Treatment|Lost to Follow-up|3|||
24949985|NCT00300885|50041708|FG001|Treatment|Lost to Follow-up|2|||
24949986|NCT00300885|50041707|FG000|Treatment|Physician Decision|4|||
24949987|NCT00300885|50041708|FG001|Treatment|Physician Decision|5|||
24949988|NCT00300885|50041707|FG000|Treatment|Protocol Violation|11|||
24949989|NCT00300885|50041708|FG001|Treatment|Protocol Violation|11|||
24949990|NCT00300885|50041707|FG000|Treatment|Withdrawal by Subject|26|||
24949991|NCT00300885|50041708|FG001|Treatment|Withdrawal by Subject|23|||
24949992|NCT00300885|50041707|FG000|Treatment|Disease progression|171|||
24949993|NCT00300885|50041708|FG001|Treatment|Disease progression|238|||
24949994|NCT00300885|50041707|FG000|Treatment|Random code broken (subject died)|0|||
24949995|NCT00300885|50041708|FG001|Treatment|Random code broken (subject died)|1|||
24949996|NCT00300885|50041707|FG000|Treatment|Non-compliant with study medication|3|||
24949997|NCT00300885|50041708|FG001|Treatment|Non-compliant with study medication|4|||
24949998|NCT00300885|50041707|FG000|Follow-up|Death|141|||
24949999|NCT00300885|50041708|FG001|Follow-up|Death|163|||
24950000|NCT00300885|50041707|FG000|Follow-up|Lost to Follow-up|11|||
24950001|NCT00300885|50041708|FG001|Follow-up|Lost to Follow-up|7|||
24950002|NCT00300885|50041707|FG000|Follow-up|Withdrawal by Subject|26|||
24950003|NCT00300885|50041708|FG001|Follow-up|Withdrawal by Subject|25|||
24950004|NCT00386334|50041716|FG000|Double Blind Period|Adverse Event|9|||
25186289|NCT01457924|50336265|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
25275798|NCT00969124|50589604|FG000|Overall Study|Inability to reach cecum|9|||
25275799|NCT00969124|50589604|FG000|Overall Study|Previously unrecognized disease|3|||
25275800|NCT00969124|50589604|FG000|Overall Study|Technical error|1|||
25275801|NCT00900601|50589609|FG000|Overall Study|Physician Decision|1|||
25275802|NCT00901927|50589636|FG000|Overall Study|Lack of Efficacy|1|||
25275803|NCT00901927|50589636|FG000|Overall Study|Protocol Violation|3|||
25275804|NCT00901927|50589636|FG000|Overall Study|Withdrawal by Subject|2|||
25275805|NCT00968968|50589642|FG000|Overall Study|Study closed/terminated|10|||
25275806|NCT00968968|50589643|FG001|Overall Study|Study closed/terminated|10|||
25275807|NCT00968968|50589642|FG000|Overall Study|Protocol defined stopping criteria|3|||
25275808|NCT00968968|50589643|FG001|Overall Study|Protocol defined stopping criteria|1|||
25275809|NCT00968968|50589642|FG000|Overall Study|Withdrawal by Subject|2|||
25275810|NCT00968968|50589643|FG001|Overall Study|Withdrawal by Subject|0|||
25275811|NCT00968968|50589642|FG000|Overall Study|Physician Decision|1|||
25275812|NCT00968968|50589643|FG001|Overall Study|Physician Decision|2|||
24950005|NCT00386334|50041717|FG001|Double Blind Period|Adverse Event|14|||
24950006|NCT00386334|50041716|FG000|Double Blind Period|Protocol Violation|1|||
24950007|NCT00386334|50041717|FG001|Double Blind Period|Protocol Violation|1|||
24950008|NCT00386334|50041716|FG000|Double Blind Period|Withdrawal by Subject|9|||
24950009|NCT00386334|50041717|FG001|Double Blind Period|Withdrawal by Subject|13|||
24950010|NCT00386334|50041716|FG000|Double Blind Period|Lack of Efficacy|20|||
25186290|NCT01457924|50336266|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
25186291|NCT01457924|50336267|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
25186292|NCT01457924|50336263|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
25186293|NCT01457924|50336264|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
25186294|NCT01457924|50336265|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
25186295|NCT01457924|50336266|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
25186296|NCT01457924|50336267|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
24950011|NCT00386334|50041717|FG001|Double Blind Period|Lack of Efficacy|11|||
25186297|NCT01457924|50336263|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
25186298|NCT01457924|50336264|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
25275813|NCT00968968|50589642|FG000|Overall Study|Lost to Follow-up|0|||
25275814|NCT00968968|50589643|FG001|Overall Study|Lost to Follow-up|1|||
25275815|NCT00973102|50589652|FG000|Overall Study|Protocol Violation|1|||
25275816|NCT00973102|50589653|FG001|Overall Study|Protocol Violation|0|||
25275817|NCT00973102|50589652|FG000|Overall Study|Prisoner|0|||
25275818|NCT00973102|50589653|FG001|Overall Study|Prisoner|1|||
25275819|NCT00901459|50589659|FG000|Overall Study|Withdrawal by Subject|6|||
24950012|NCT00386334|50041716|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
24950013|NCT00386334|50041717|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
24950014|NCT00386334|50041716|FG000|Double Blind Period|Other|3|||
24950015|NCT00386334|50041717|FG001|Double Blind Period|Other|3|||
24950016|NCT00386334|50041716|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
24950017|NCT00386334|50041717|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
24950018|NCT00428714|50041734|FG000|Overall Study|Progressive Disease|28|||
24950019|NCT00428714|50041735|FG001|Overall Study|Progressive Disease|36|||
24950020|NCT00428714|50041734|FG000|Overall Study|Withdrawal by Subject|0|||
24950021|NCT00428714|50041735|FG001|Overall Study|Withdrawal by Subject|3|||
24950022|NCT00428714|50041734|FG000|Overall Study|Adverse Event|0|||
24950023|NCT00428714|50041735|FG001|Overall Study|Adverse Event|2|||
24950024|NCT00428714|50041734|FG000|Overall Study|Physician Decision|1|||
24950025|NCT00428714|50041735|FG001|Overall Study|Physician Decision|1|||
24950026|NCT00428714|50041734|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
24950027|NCT00428714|50041735|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
24950028|NCT00428714|50041734|FG000|Overall Study|Death due to other then PD|1|||
24950029|NCT00428714|50041735|FG001|Overall Study|Death due to other then PD|0|||
24950030|NCT00292227|50041744|FG000|Patch Period|Adverse Event|1|||
24950031|NCT00292227|50041745|FG001|Patch Period|Adverse Event|0|||
24950032|NCT00292227|50041746|FG002|Patch Period|Adverse Event|2|||
24950033|NCT00292227|50041744|FG000|Patch Period|Withdrawal by Subject|0|||
24950034|NCT00292227|50041745|FG001|Patch Period|Withdrawal by Subject|0|||
24950035|NCT00292227|50041746|FG002|Patch Period|Withdrawal by Subject|1|||
24950036|NCT00386100|50041756|FG000|Overall Study|Did not receive study medication|6|||
24950037|NCT00386100|50041757|FG001|Overall Study|Did not receive study medication|4|||
24950038|NCT00386100|50041756|FG000|Overall Study|Adverse Event|15|||
24950039|NCT00386100|50041757|FG001|Overall Study|Adverse Event|25|||
24950040|NCT00386100|50041756|FG000|Overall Study|Death|0|||
24950041|NCT00386100|50041757|FG001|Overall Study|Death|1|||
24950042|NCT00386100|50041756|FG000|Overall Study|Insufficient therapeutic effect|30|||
24950043|NCT00386100|50041757|FG001|Overall Study|Insufficient therapeutic effect|6|||
24950044|NCT00386100|50041756|FG000|Overall Study|Lost to Follow-up|29|||
24950045|NCT00386100|50041757|FG001|Overall Study|Lost to Follow-up|29|||
24950046|NCT00386100|50041756|FG000|Overall Study|Non-compliance|18|||
24950047|NCT00386100|50041757|FG001|Overall Study|Non-compliance|19|||
24950048|NCT00386100|50041756|FG000|Overall Study|Protocol Violation|5|||
24950049|NCT00386100|50041757|FG001|Overall Study|Protocol Violation|3|||
24950050|NCT00386100|50041756|FG000|Overall Study|Withdrawal by Subject|32|||
24950051|NCT00386100|50041757|FG001|Overall Study|Withdrawal by Subject|31|||
24950052|NCT00386100|50041756|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
24950053|NCT00386100|50041757|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
24950054|NCT00386100|50041756|FG000|Overall Study|BMD <2.5|1|||
24950055|NCT00386100|50041757|FG001|Overall Study|BMD <2.5|0|||
24950056|NCT00386100|50041756|FG000|Overall Study|Consecutive elevated Hba1C|1|||
24950057|NCT00386100|50041757|FG001|Overall Study|Consecutive elevated Hba1C|0|||
24950058|NCT00386100|50041756|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
24950059|NCT00386100|50041757|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
24950060|NCT00386100|50041756|FG000|Overall Study|Laboratory findings|1|||
24950061|NCT00386100|50041757|FG001|Overall Study|Laboratory findings|0|||
24950062|NCT00386100|50041756|FG000|Overall Study|Participant's concern due to CPK levels|1|||
24950063|NCT00386100|50041757|FG001|Overall Study|Participant's concern due to CPK levels|0|||
24950064|NCT00386100|50041756|FG000|Overall Study|Participant moving out of state|2|||
24950065|NCT00386100|50041757|FG001|Overall Study|Participant moving out of state|0|||
24950066|NCT00386100|50041756|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
24950067|NCT00386100|50041757|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
24950068|NCT00386100|50041756|FG000|Overall Study|Didn't meet entry criteria|1|||
24950069|NCT00386100|50041757|FG001|Overall Study|Didn't meet entry criteria|1|||
24950070|NCT00386100|50041756|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
24950071|NCT00386100|50041757|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
24950072|NCT00386100|50041756|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
24950073|NCT00386100|50041757|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
24950074|NCT00386100|50041756|FG000|Overall Study|Bad metabolic control & patient security|1|||
24950075|NCT00386100|50041757|FG001|Overall Study|Bad metabolic control & patient security|0|||
24950076|NCT00386100|50041756|FG000|Overall Study|Bone loss by DXA bone scan|1|||
25275820|NCT00896233|50589670|FG000|Overall Study|Claustrophobia during MRI|1|||
25275821|NCT00899431|50589695|FG000|Overall Study|Physician Decision|1|||
25275822|NCT00899431|50589696|FG001|Overall Study|Physician Decision|0|||
24950077|NCT00386100|50041757|FG001|Overall Study|Bone loss by DXA bone scan|0|||
24950078|NCT00386100|50041756|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
24950079|NCT00386100|50041757|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
24950080|NCT00386100|50041756|FG000|Overall Study|7.6% bone loss|1|||
24950081|NCT00386100|50041757|FG001|Overall Study|7.6% bone loss|0|||
24950082|NCT00386100|50041756|FG000|Overall Study|Osteoporosis|0|||
24950083|NCT00386100|50041757|FG001|Overall Study|Osteoporosis|1|||
24950084|NCT00386100|50041756|FG000|Overall Study|Positive pregnancy test|1|||
24950085|NCT00386100|50041757|FG001|Overall Study|Positive pregnancy test|3|||
24950086|NCT00386100|50041756|FG000|Overall Study|Out of country for 5 months|1|||
24950087|NCT00386100|50041757|FG001|Overall Study|Out of country for 5 months|0|||
24950088|NCT00386100|50041756|FG000|Overall Study|Hb1Ac >8%|0|||
24950089|NCT00386100|50041757|FG001|Overall Study|Hb1Ac >8%|1|||
24950090|NCT00386100|50041756|FG000|Overall Study|Participant randomized in error|1|||
24950091|NCT00386100|50041757|FG001|Overall Study|Participant randomized in error|0|||
24950092|NCT00300495|50041765|FG000|Overall Study|Protocol Violation|4|||
24950093|NCT00300495|50041766|FG001|Overall Study|Protocol Violation|1|||
24950094|NCT00386022|50041774|FG000|Plus Estrogen|Lost to Follow-up|2|||
24950095|NCT00386022|50041775|FG001|Plus Estrogen|Lost to Follow-up|0|||
24950096|NCT00386022|50041774|FG000|Plus Estrogen|Adverse Event|0|||
24950097|NCT00386022|50041775|FG001|Plus Estrogen|Adverse Event|1|||
24950098|NCT00286455|50041786|FG000|Overall Study|Hyperglycemia rescue|19|||
24950099|NCT00286455|50041787|FG001|Overall Study|Hyperglycemia rescue|13|||
24950100|NCT00286455|50041788|FG002|Overall Study|Hyperglycemia rescue|10|||
24950101|NCT00286455|50041786|FG000|Overall Study|Adverse Event|1|||
24950102|NCT00286455|50041787|FG001|Overall Study|Adverse Event|3|||
24950103|NCT00286455|50041788|FG002|Overall Study|Adverse Event|2|||
24950104|NCT00286455|50041786|FG000|Overall Study|Lost to Follow-up|0|||
24950105|NCT00286455|50041787|FG001|Overall Study|Lost to Follow-up|3|||
24950106|NCT00286455|50041788|FG002|Overall Study|Lost to Follow-up|3|||
24950107|NCT00286455|50041786|FG000|Overall Study|Physician Decision|3|||
24950108|NCT00286455|50041787|FG001|Overall Study|Physician Decision|0|||
24950109|NCT00286455|50041788|FG002|Overall Study|Physician Decision|2|||
24950110|NCT00286455|50041786|FG000|Overall Study|Protocol Violation|1|||
24950111|NCT00286455|50041787|FG001|Overall Study|Protocol Violation|1|||
24950112|NCT00286455|50041788|FG002|Overall Study|Protocol Violation|0|||
24950113|NCT00286455|50041786|FG000|Overall Study|Participant Non-compliance|1|||
24950114|NCT00286455|50041787|FG001|Overall Study|Participant Non-compliance|0|||
24950115|NCT00286455|50041788|FG002|Overall Study|Participant Non-compliance|0|||
24950116|NCT00286455|50041786|FG000|Overall Study|Withdrawal by Subject|0|||
24950117|NCT00286455|50041787|FG001|Overall Study|Withdrawal by Subject|8|||
24950118|NCT00286455|50041788|FG002|Overall Study|Withdrawal by Subject|7|||
24950119|NCT00385944|50041798|FG000|1st Maintenance Dose Period|Physician Decision|1|||
24950120|NCT00385944|50041799|FG001|1st Maintenance Dose Period|Physician Decision|0|||
24950121|NCT00385944|50041800|FG002|1st Maintenance Dose Period|Physician Decision|0|||
24950122|NCT00385944|50041798|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
24950123|NCT00385944|50041799|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
24950124|NCT00385944|50041800|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
24950125|NCT00385944|50041798|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
24950126|NCT00385944|50041799|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
24950127|NCT00385944|50041800|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
24950128|NCT00385944|50041798|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
24950129|NCT00385944|50041799|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
24950130|NCT00385944|50041800|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
24950131|NCT00286221|50041819|FG000|Overall Study|Protocol Violation|2|||
24950132|NCT00286221|50041820|FG001|Overall Study|Protocol Violation|1|||
24950133|NCT00286221|50041821|FG002|Overall Study|Protocol Violation|6|||
24950134|NCT00286221|50041822|FG003|Overall Study|Protocol Violation|4|||
24950135|NCT00286221|50041819|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
24950136|NCT00286221|50041820|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
24950137|NCT00286221|50041821|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
24950138|NCT00286221|50041822|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
24950139|NCT00286221|50041819|FG000|Overall Study|Inability to trigger PCA|2|||
24950140|NCT00286221|50041820|FG001|Overall Study|Inability to trigger PCA|0|||
24950141|NCT00286221|50041821|FG002|Overall Study|Inability to trigger PCA|0|||
24950142|NCT00286221|50041822|FG003|Overall Study|Inability to trigger PCA|0|||
24950143|NCT00286221|50041819|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
24950144|NCT00286221|50041820|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
24950145|NCT00286221|50041821|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
24950146|NCT00286221|50041822|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
24950147|NCT00285207|50041834|FG000|Overall Study|Lost to Follow-up|3|||
24950148|NCT00285207|50041835|FG001|Overall Study|Lost to Follow-up|2|||
24950149|NCT00285207|50041834|FG000|Overall Study|Withdrawal by Subject|5|||
24950150|NCT00285207|50041835|FG001|Overall Study|Withdrawal by Subject|2|||
25038892|NCT03775486|50139518|FG000|Initial Therapy Phase|Adverse Event|0|||
24950151|NCT00285207|50041834|FG000|Overall Study|Pregnancy|1|||
24950152|NCT00285207|50041835|FG001|Overall Study|Pregnancy|1|||
24950153|NCT00285207|50041834|FG000|Overall Study|non-compliance|0|||
24950154|NCT00285207|50041835|FG001|Overall Study|non-compliance|1|||
24950155|NCT00398112|50041841|FG000|Overall Study|Adverse Event|4|||
24950156|NCT00398112|50041841|FG000|Overall Study|Disease progression|9|||
24950157|NCT00398112|50041841|FG000|Overall Study|Alternative treatment|1|||
24950158|NCT00398112|50041841|FG000|Overall Study|Withdrawal by Subject|3|||
24950159|NCT00398112|50041841|FG000|Overall Study|Death|1|||
24950160|NCT00424346|50041849|FG000|Core Study|Adverse Event|5|||
24950161|NCT00424346|50041850|FG001|Core Study|Adverse Event|3|||
24950162|NCT00424346|50041851|FG002|Core Study|Adverse Event|1|||
24950163|NCT00424346|50041852|FG003|Core Study|Adverse Event|1|||
24950164|NCT00424346|50041849|FG000|Core Study|Abnormal Laboratory Values|0|||
24950165|NCT00424346|50041850|FG001|Core Study|Abnormal Laboratory Values|1|||
24950166|NCT00424346|50041851|FG002|Core Study|Abnormal Laboratory Values|0|||
24950167|NCT00424346|50041852|FG003|Core Study|Abnormal Laboratory Values|0|||
24950168|NCT00424346|50041849|FG000|Core Study|Lack of Efficacy|1|||
24950169|NCT00424346|50041850|FG001|Core Study|Lack of Efficacy|3|||
24950170|NCT00424346|50041851|FG002|Core Study|Lack of Efficacy|0|||
24950171|NCT00424346|50041852|FG003|Core Study|Lack of Efficacy|4|||
24950172|NCT00424346|50041849|FG000|Core Study|Withdrawal by Subject|1|||
24950173|NCT00424346|50041850|FG001|Core Study|Withdrawal by Subject|0|||
24950174|NCT00424346|50041851|FG002|Core Study|Withdrawal by Subject|0|||
24950175|NCT00424346|50041852|FG003|Core Study|Withdrawal by Subject|2|||
24950176|NCT00424346|50041849|FG000|Core Study|Lost to Follow-up|1|||
24950177|NCT00424346|50041850|FG001|Core Study|Lost to Follow-up|1|||
24950178|NCT00424346|50041851|FG002|Core Study|Lost to Follow-up|0|||
24950179|NCT00424346|50041852|FG003|Core Study|Lost to Follow-up|0|||
24950180|NCT00424346|50041849|FG000|Core Study|Administrative Problems|1|||
24950181|NCT00424346|50041850|FG001|Core Study|Administrative Problems|0|||
24950182|NCT00424346|50041851|FG002|Core Study|Administrative Problems|1|||
24950183|NCT00424346|50041852|FG003|Core Study|Administrative Problems|0|||
24950184|NCT00424346|50041849|FG000|Core Study|Protocol Violation|0|||
24950185|NCT00424346|50041850|FG001|Core Study|Protocol Violation|0|||
24950186|NCT00424346|50041851|FG002|Core Study|Protocol Violation|2|||
24950187|NCT00424346|50041852|FG003|Core Study|Protocol Violation|0|||
24950188|NCT00424346|50041849|FG000|Extension Phase|Adverse Event|0|||
24950189|NCT00424346|50041850|FG001|Extension Phase|Adverse Event|9|||
24950190|NCT00424346|50041851|FG002|Extension Phase|Adverse Event|5|||
24950191|NCT00424346|50041852|FG003|Extension Phase|Adverse Event|4|||
24950192|NCT00424346|50041849|FG000|Extension Phase|Lack of Efficacy|0|||
24950193|NCT00424346|50041850|FG001|Extension Phase|Lack of Efficacy|16|||
24950194|NCT00424346|50041851|FG002|Extension Phase|Lack of Efficacy|14|||
24950195|NCT00424346|50041852|FG003|Extension Phase|Lack of Efficacy|11|||
24950196|NCT00424346|50041849|FG000|Extension Phase|Withdrawal by Subject|0|||
24950197|NCT00424346|50041850|FG001|Extension Phase|Withdrawal by Subject|5|||
24950198|NCT00424346|50041851|FG002|Extension Phase|Withdrawal by Subject|3|||
24950199|NCT00424346|50041852|FG003|Extension Phase|Withdrawal by Subject|4|||
24950200|NCT00424346|50041849|FG000|Extension Phase|Lost to Follow-up|0|||
24950201|NCT00424346|50041850|FG001|Extension Phase|Lost to Follow-up|2|||
24950202|NCT00424346|50041851|FG002|Extension Phase|Lost to Follow-up|0|||
24950203|NCT00424346|50041852|FG003|Extension Phase|Lost to Follow-up|0|||
24950204|NCT00424346|50041849|FG000|Extension Phase|Administrative Problems|0|||
24950205|NCT00424346|50041850|FG001|Extension Phase|Administrative Problems|69|||
24950206|NCT00424346|50041851|FG002|Extension Phase|Administrative Problems|32|||
24950207|NCT00424346|50041852|FG003|Extension Phase|Administrative Problems|35|||
24950208|NCT00424346|50041849|FG000|Extension Phase|Death|0|||
24950209|NCT00424346|50041850|FG001|Extension Phase|Death|0|||
24950210|NCT00424346|50041851|FG002|Extension Phase|Death|0|||
24950211|NCT00424346|50041852|FG003|Extension Phase|Death|1|||
24950212|NCT00424346|50041849|FG000|Extension Phase|Protocol Violation|0|||
24950213|NCT00424346|50041850|FG001|Extension Phase|Protocol Violation|1|||
24950214|NCT00424346|50041851|FG002|Extension Phase|Protocol Violation|1|||
24950215|NCT00424346|50041852|FG003|Extension Phase|Protocol Violation|0|||
24950216|NCT00283959|50041865|FG000|Extension Period|Low Compliance|1|||
24950217|NCT00372528|50041869|FG000|Overall Study|Lack of Efficacy|1|||
24950218|NCT00372528|50041869|FG000|Overall Study|Adverse Event|1|||
24950219|NCT00372528|50041869|FG000|Overall Study|Study Terminated by Sponsor|18|||
24950220|NCT00372528|50041869|FG000|Overall Study|Other|1|||
24950221|NCT00283803|50041873|FG000|Overall Study|Physician Decision|9|||
24950222|NCT00283803|50041873|FG000|Overall Study|Withdrawal by Subject|4|||
24950223|NCT00397488|50041877|FG000|Overall Study|Withdrawal by Subject|3|||
24950224|NCT00397488|50041877|FG000|Overall Study|Adverse Event|3|||
24950225|NCT00397488|50041877|FG000|Overall Study|Death|1|||
24950226|NCT00424190|50041883|FG000|Overall Study|Withdrew consent|3|||
24950227|NCT00424190|50041884|FG001|Overall Study|Withdrew consent|4|||
24950228|NCT00424190|50041883|FG000|Overall Study|Death|3|||
24950229|NCT00424190|50041884|FG001|Overall Study|Death|0|||
24950230|NCT00424190|50041883|FG000|Overall Study|Noncompliance|1|||
24950231|NCT00424190|50041884|FG001|Overall Study|Noncompliance|2|||
24950232|NCT00424190|50041883|FG000|Overall Study|Request of sponsor or investigator|0|||
24950233|NCT00424190|50041884|FG001|Overall Study|Request of sponsor or investigator|2|||
24950234|NCT00424190|50041883|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
24950235|NCT00424190|50041884|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
24950236|NCT00424190|50041883|FG000|Overall Study|Other|15|||
25038893|NCT03775486|50139519|FG001|Initial Therapy Phase|Adverse Event|34|||
25038894|NCT03775486|50139518|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
24950237|NCT00424190|50041884|FG001|Overall Study|Other|21|||
24950238|NCT00428246|50041893|FG000|Overall Study|Withdrawal by Subject|0|||
24950239|NCT00428246|50041894|FG001|Overall Study|Withdrawal by Subject|0|||
24950240|NCT00428246|50041895|FG002|Overall Study|Withdrawal by Subject|1|||
24950241|NCT00428246|50041893|FG000|Overall Study|Adverse Event|1|||
24950242|NCT00428246|50041894|FG001|Overall Study|Adverse Event|0|||
24950243|NCT00428246|50041895|FG002|Overall Study|Adverse Event|0|||
24950244|NCT00274287|50041903|FG000|Overall Study|Withdrawal by Subject|1|||
24950245|NCT00274287|50041903|FG000|Overall Study|subject non-compliance|1|||
24950246|NCT00423800|50041910|FG000|Overall Study|Protocol Violation|0|||
24950247|NCT00423800|50041911|FG001|Overall Study|Protocol Violation|1|||
24950248|NCT00405548|50041920|FG000|Overall Study|Cognitive Memory problems on study day|1|||
24950249|NCT00405548|50041921|FG001|Overall Study|Cognitive Memory problems on study day|0|||
24950250|NCT00405548|50041920|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
24950251|NCT00405548|50041921|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
24950252|NCT00405548|50041920|FG000|Overall Study|Unable to self-administer shots|1|||
24950253|NCT00405548|50041921|FG001|Overall Study|Unable to self-administer shots|0|||
24950254|NCT00405548|50041920|FG000|Overall Study|Venous access failed during study day|1|||
24950255|NCT00405548|50041921|FG001|Overall Study|Venous access failed during study day|0|||
24950256|NCT00405548|50041920|FG000|Overall Study|Withdrawal by Subject|1|||
24950257|NCT00405548|50041921|FG001|Overall Study|Withdrawal by Subject|0|||
24950258|NCT00405392|50041929|FG000|Overall Study|Adverse Event|15|||
24950259|NCT00405392|50041930|FG001|Overall Study|Adverse Event|14|||
24950260|NCT00405392|50041929|FG000|Overall Study|Did not meet Eligibility criteria|7|||
24950261|NCT00405392|50041930|FG001|Overall Study|Did not meet Eligibility criteria|2|||
24950262|NCT00405392|50041929|FG000|Overall Study|Withdrawal by Subject|4|||
24950263|NCT00405392|50041930|FG001|Overall Study|Withdrawal by Subject|3|||
24950264|NCT00405392|50041929|FG000|Overall Study|Lost to Follow-up|1|||
24950265|NCT00405392|50041930|FG001|Overall Study|Lost to Follow-up|2|||
24950266|NCT00405392|50041929|FG000|Overall Study|Data missing|2|||
24950267|NCT00405392|50041930|FG001|Overall Study|Data missing|0|||
24950268|NCT00405392|50041929|FG000|Overall Study|Non-compliance|0|||
24950269|NCT00405392|50041930|FG001|Overall Study|Non-compliance|1|||
24950270|NCT00405392|50041929|FG000|Overall Study|Other|1|||
24950271|NCT00405392|50041930|FG001|Overall Study|Other|5|||
24950272|NCT00282243|50041936|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
24950273|NCT00282243|50041936|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
24950274|NCT00282243|50041936|FG000|Extension Treatment Period|Adverse Event|15|||
24950275|NCT00282243|50041936|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
24950276|NCT00282243|50041936|FG000|Extension Treatment Period|Non-compliance|2|||
24950277|NCT00282243|50041936|FG000|Extension Treatment Period|Physician Decision|1|||
24950278|NCT00272961|50041945|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
24950279|NCT00272961|50041946|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
24950280|NCT00272961|50041947|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
24950281|NCT00272961|50041948|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
24950282|NCT00272961|50041949|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
24950283|NCT00272961|50041945|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
24950284|NCT00272961|50041946|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
24950285|NCT00272961|50041947|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
24950286|NCT00272961|50041948|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
24950287|NCT00272961|50041949|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
24950288|NCT00272961|50041945|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
24950289|NCT00272961|50041946|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
24950290|NCT00272961|50041947|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
24950291|NCT00272961|50041948|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
24950292|NCT00272961|50041949|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
24950293|NCT00272961|50041945|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
24950294|NCT00272961|50041946|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
24950295|NCT00272961|50041947|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
24950296|NCT00272961|50041948|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
24950297|NCT00272961|50041949|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
24950298|NCT00272961|50041945|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
24950299|NCT00272961|50041946|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
24950300|NCT00272961|50041947|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
24950301|NCT00272961|50041948|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
24950302|NCT00272961|50041949|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
24950303|NCT00272961|50041945|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
24950304|NCT00272961|50041946|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
24950305|NCT00272961|50041947|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
24950306|NCT00272961|50041948|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
24950307|NCT00272961|50041949|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
24950308|NCT00272961|50041945|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
24950309|NCT00272961|50041946|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
24950310|NCT00272961|50041947|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
24950311|NCT00272961|50041948|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
24950312|NCT00272961|50041949|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
24950313|NCT00272961|50041945|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
24950314|NCT00272961|50041946|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
24950315|NCT00272961|50041947|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
24950316|NCT00272961|50041948|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
24950317|NCT00272961|50041949|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
24950318|NCT00282087|50041961|FG000|Overall Study|Death|1|||
24950319|NCT00404924|50041968|FG000|Overall Study|Adverse Event|75|||
24950320|NCT00404924|50041969|FG001|Overall Study|Adverse Event|16|||
24950321|NCT00404924|50041968|FG000|Overall Study|Condition under investigation worsened|475|||
24950322|NCT00404924|50041969|FG001|Overall Study|Condition under investigation worsened|264|||
24950323|NCT00404924|50041968|FG000|Overall Study|Lost to Follow-up|1|||
24950324|NCT00404924|50041969|FG001|Overall Study|Lost to Follow-up|1|||
24950325|NCT00404924|50041968|FG000|Overall Study|Withdrawal by Subject|26|||
24950326|NCT00404924|50041969|FG001|Overall Study|Withdrawal by Subject|13|||
24950327|NCT00404924|50041968|FG000|Overall Study|Other|25|||
24950328|NCT00404924|50041969|FG001|Overall Study|Other|11|||
24950329|NCT00404924|50041968|FG000|Overall Study|Randomised but not received treatment|1|||
24950330|NCT00404924|50041969|FG001|Overall Study|Randomised but not received treatment|1|||
24950331|NCT00281697|50041977|FG000|Overall Study|> 60 days since last dose of study drug|4|||
25038895|NCT03775486|50139519|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
25038896|NCT03775486|50139518|FG000|Maintenance Phase|Withdrawal by Subject|13|||
25038897|NCT03775486|50139519|FG001|Maintenance Phase|Withdrawal by Subject|12|||
25038898|NCT03775486|50139518|FG000|Maintenance Phase|Death|44|||
25038899|NCT03775486|50139519|FG001|Maintenance Phase|Death|45|||
25038900|NCT03094832|50139556|FG000|Overall Study|Lost to Follow-up|0|||
25038901|NCT03094832|50139557|FG001|Overall Study|Lost to Follow-up|0|||
25038902|NCT03094832|50139558|FG002|Overall Study|Lost to Follow-up|0|||
25038903|NCT03094832|50139559|FG003|Overall Study|Lost to Follow-up|1|||
24950332|NCT00281697|50041978|FG001|Overall Study|> 60 days since last dose of study drug|4|||
24950333|NCT00281697|50041977|FG000|Overall Study|Adverse Event|54|||
24950334|NCT00281697|50041978|FG001|Overall Study|Adverse Event|15|||
24950335|NCT00281697|50041977|FG000|Overall Study|Death|8|||
24950336|NCT00281697|50041978|FG001|Overall Study|Death|3|||
24950337|NCT00281697|50041977|FG000|Overall Study|Disease progression|279|||
24950338|NCT00281697|50041978|FG001|Overall Study|Disease progression|149|||
24950339|NCT00281697|50041977|FG000|Overall Study|Other|5|||
24950340|NCT00281697|50041978|FG001|Overall Study|Other|6|||
24950341|NCT00281697|50041977|FG000|Overall Study|Physician's decision to withdraw|15|||
24950342|NCT00281697|50041978|FG001|Overall Study|Physician's decision to withdraw|12|||
24950343|NCT00281697|50041977|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
24950344|NCT00281697|50041978|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
24950345|NCT00281697|50041977|FG000|Overall Study|Did not receive study drug|3|||
24950346|NCT00281697|50041978|FG001|Overall Study|Did not receive study drug|2|||
24950347|NCT00271947|50041984|FG000|Overall Study|Lost to Follow-up|1|||
24950348|NCT00232180|50041990|FG000|Double-blind (DB) Phase|Death|186|||
24950349|NCT00232180|50041991|FG001|Double-blind (DB) Phase|Death|222|||
24950350|NCT00232180|50041992|FG002|Double-blind (DB) Phase|Death|0|||
24950351|NCT00232180|50041990|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
24950352|NCT00232180|50041991|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
25038904|NCT03094832|50139560|FG004|Overall Study|Lost to Follow-up|1|||
25038905|NCT03094832|50139556|FG000|Overall Study|Death|1|||
25038906|NCT03094832|50139557|FG001|Overall Study|Death|0|||
24950353|NCT00232180|50041992|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
24950354|NCT00232180|50041990|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
24950355|NCT00232180|50041991|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
25038907|NCT03094832|50139558|FG002|Overall Study|Death|0|||
25038908|NCT03094832|50139559|FG003|Overall Study|Death|0|||
24950356|NCT00232180|50041992|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
24950357|NCT00232180|50041990|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
24950358|NCT00232180|50041991|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
24950359|NCT00232180|50041992|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
24950360|NCT00232180|50041990|FG000|Double-blind (DB) Phase|Adverse Event|83|||
24950361|NCT00232180|50041991|FG001|Double-blind (DB) Phase|Adverse Event|100|||
24950362|NCT00232180|50041992|FG002|Double-blind (DB) Phase|Adverse Event|0|||
24950363|NCT00232180|50041990|FG000|Double-blind (DB) Phase|Other|70|||
24950364|NCT00232180|50041991|FG001|Double-blind (DB) Phase|Other|75|||
24950365|NCT00232180|50041992|FG002|Double-blind (DB) Phase|Other|0|||
24950366|NCT00232180|50041990|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
24950367|NCT00232180|50041991|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
24950368|NCT00232180|50041992|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
24950369|NCT00232180|50041990|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
24950370|NCT00232180|50041991|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
24950371|NCT00232180|50041992|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
25038909|NCT03094832|50139560|FG004|Overall Study|Death|0|||
25038910|NCT03094832|50139556|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
25038911|NCT03094832|50139557|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
25038912|NCT03094832|50139558|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
25038913|NCT03094832|50139559|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
25038914|NCT03094832|50139560|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
25038915|NCT03094832|50139556|FG000|Overall Study|Other|13|||
25038916|NCT03094832|50139557|FG001|Overall Study|Other|20|||
25038917|NCT03094832|50139558|FG002|Overall Study|Other|1|||
25038918|NCT03094832|50139559|FG003|Overall Study|Other|7|||
25038919|NCT03094832|50139560|FG004|Overall Study|Other|1|||
25038920|NCT03091192|50139574|FG000|Overall Study|Study terminated by sponsor|21|||
25038921|NCT03091192|50139575|FG001|Overall Study|Study terminated by sponsor|14|||
25038922|NCT03091192|50139574|FG000|Overall Study|Death|9|||
25038923|NCT03091192|50139575|FG001|Overall Study|Death|13|||
25038924|NCT03091192|50139574|FG000|Overall Study|Withdrawal by Subject|2|||
25038925|NCT03091192|50139575|FG001|Overall Study|Withdrawal by Subject|0|||
25038926|NCT03091192|50139574|FG000|Overall Study|Lost to Follow-up|1|||
25038927|NCT03091192|50139575|FG001|Overall Study|Lost to Follow-up|0|||
25038928|NCT03036579|50139583|FG000|2 Years|Lost to Follow-up|1|||
25038929|NCT03036579|50139584|FG001|2 Years|Lost to Follow-up|0|||
25038930|NCT03036579|50139583|FG000|3 Years|Lost to Follow-up|0|||
25038931|NCT03036579|50139584|FG001|3 Years|Lost to Follow-up|1|||
25038932|NCT02867761|50139592|FG000|Overall Study|Participant withdrawn by investigator|0|||
25038933|NCT02867761|50139593|FG001|Overall Study|Participant withdrawn by investigator|1|||
25038934|NCT02867761|50139592|FG000|Overall Study|Lost to Follow-up|25|||
25038935|NCT02867761|50139593|FG001|Overall Study|Lost to Follow-up|18|||
25038936|NCT02867761|50139592|FG000|Overall Study|Unable to complete protocol|3|||
25038937|NCT02867761|50139593|FG001|Overall Study|Unable to complete protocol|7|||
25038938|NCT02719990|50139608|FG000|Overall Study|Physician Decision|2|||
25038939|NCT02719990|50139608|FG000|Overall Study|Withdrawal by Subject|2|||
25038940|NCT02719990|50139608|FG000|Overall Study|Study Terminated By Sponsor|32|||
25038941|NCT02494583|50139615|FG000|Overall Study|Death|224|||
25038942|NCT02494583|50139616|FG001|Overall Study|Death|214|||
25038943|NCT02494583|50139617|FG002|Overall Study|Death|225|||
25038944|NCT02494583|50139615|FG000|Overall Study|Lost to Follow-up|1|||
25038945|NCT02494583|50139616|FG001|Overall Study|Lost to Follow-up|0|||
25038946|NCT02494583|50139617|FG002|Overall Study|Lost to Follow-up|0|||
25038947|NCT02494583|50139615|FG000|Overall Study|Protocol Violation|1|||
25038948|NCT02494583|50139616|FG001|Overall Study|Protocol Violation|2|||
25038949|NCT02494583|50139617|FG002|Overall Study|Protocol Violation|0|||
25038950|NCT02494583|50139615|FG000|Overall Study|Screen Failure|0|||
25038951|NCT02494583|50139616|FG001|Overall Study|Screen Failure|1|||
25038952|NCT02494583|50139617|FG002|Overall Study|Screen Failure|0|||
25038953|NCT02494583|50139615|FG000|Overall Study|Transferred to Extension Study|15|||
25038954|NCT02494583|50139616|FG001|Overall Study|Transferred to Extension Study|15|||
25038955|NCT02494583|50139617|FG002|Overall Study|Transferred to Extension Study|6|||
25038956|NCT02494583|50139615|FG000|Overall Study|Did Not Continue on Extension Study|8|||
24950372|NCT00232180|50041990|FG000|Open Label Phase|Death|0|||
24950373|NCT00232180|50041991|FG001|Open Label Phase|Death|0|||
24950374|NCT00232180|50041992|FG002|Open Label Phase|Death|48|||
24950375|NCT00232180|50041990|FG000|Open Label Phase|Lost to Follow-up|0|||
24950376|NCT00232180|50041991|FG001|Open Label Phase|Lost to Follow-up|0|||
24950377|NCT00232180|50041992|FG002|Open Label Phase|Lost to Follow-up|5|||
25038957|NCT02494583|50139616|FG001|Overall Study|Did Not Continue on Extension Study|10|||
25038958|NCT02494583|50139617|FG002|Overall Study|Did Not Continue on Extension Study|4|||
25038959|NCT02494583|50139615|FG000|Overall Study|Withdrawal by Subject|7|||
25038960|NCT02494583|50139616|FG001|Overall Study|Withdrawal by Subject|15|||
25038961|NCT02494583|50139617|FG002|Overall Study|Withdrawal by Subject|15|||
25038962|NCT02322814|50139632|FG000|Overall Study|Death|7|||
25275823|NCT00899431|50589697|FG002|Overall Study|Physician Decision|0|||
25038963|NCT02322814|50139633|FG001|Overall Study|Death|29|||
24950378|NCT00232180|50041990|FG000|Open Label Phase|Protocol Violation|0|||
24950379|NCT00232180|50041991|FG001|Open Label Phase|Protocol Violation|0|||
25038964|NCT02322814|50139634|FG002|Overall Study|Death|32|||
25038965|NCT02322814|50139635|FG003|Overall Study|Death|23|||
25038966|NCT02322814|50139636|FG004|Overall Study|Death|14|||
25038967|NCT02322814|50139632|FG000|Overall Study|Lost to Follow-up|1|||
24950380|NCT00232180|50041992|FG002|Open Label Phase|Protocol Violation|3|||
24950381|NCT00232180|50041990|FG000|Open Label Phase|Study terminated by sponsor|0|||
25038968|NCT02322814|50139633|FG001|Overall Study|Lost to Follow-up|3|||
25038969|NCT02322814|50139634|FG002|Overall Study|Lost to Follow-up|3|||
25038970|NCT02322814|50139635|FG003|Overall Study|Lost to Follow-up|1|||
25038971|NCT02322814|50139636|FG004|Overall Study|Lost to Follow-up|0|||
25038972|NCT02322814|50139632|FG000|Overall Study|Various Reasons|2|||
25038973|NCT02322814|50139633|FG001|Overall Study|Various Reasons|0|||
25038974|NCT02322814|50139634|FG002|Overall Study|Various Reasons|1|||
25038975|NCT02322814|50139635|FG003|Overall Study|Various Reasons|1|||
24950382|NCT00232180|50041991|FG001|Open Label Phase|Study terminated by sponsor|0|||
24950383|NCT00232180|50041992|FG002|Open Label Phase|Study terminated by sponsor|3|||
24950384|NCT00232180|50041990|FG000|Open Label Phase|Withdrawal by Subject|0|||
24950385|NCT00232180|50041991|FG001|Open Label Phase|Withdrawal by Subject|0|||
24950386|NCT00232180|50041992|FG002|Open Label Phase|Withdrawal by Subject|37|||
24950387|NCT00232180|50041990|FG000|Open Label Phase|Other|0|||
24950388|NCT00232180|50041991|FG001|Open Label Phase|Other|0|||
24950389|NCT00232180|50041992|FG002|Open Label Phase|Other|16|||
24950390|NCT00232180|50041990|FG000|Open Label Phase|Adverse Event|0|||
24950391|NCT00232180|50041991|FG001|Open Label Phase|Adverse Event|0|||
24950392|NCT00232180|50041992|FG002|Open Label Phase|Adverse Event|25|||
25275824|NCT00899353|50589708|FG000|Overall Study|Adverse Event|2|||
25275825|NCT00899353|50589708|FG000|Overall Study|Lost to Follow-up|1|||
24950393|NCT00232180|50041990|FG000|Open Label Phase|Laboratory abnormality|0|||
24950394|NCT00232180|50041991|FG001|Open Label Phase|Laboratory abnormality|0|||
24950395|NCT00232180|50041992|FG002|Open Label Phase|Laboratory abnormality|10|||
24950396|NCT00232180|50041990|FG000|Open Label Phase|Randomized but not treated|0|||
24950397|NCT00232180|50041991|FG001|Open Label Phase|Randomized but not treated|0|||
24950398|NCT00232180|50041992|FG002|Open Label Phase|Randomized but not treated|1|||
24950399|NCT00280917|50042005|FG000|Overall Study|Adverse Event|1|||
24950400|NCT00280917|50042006|FG001|Overall Study|Adverse Event|1|||
24950401|NCT00280917|50042007|FG002|Overall Study|Adverse Event|4|||
24950402|NCT00280917|50042008|FG003|Overall Study|Adverse Event|1|||
24950403|NCT00280917|50042005|FG000|Overall Study|Change Therapy|1|||
24950404|NCT00280917|50042006|FG001|Overall Study|Change Therapy|2|||
24950405|NCT00280917|50042007|FG002|Overall Study|Change Therapy|0|||
24950406|NCT00280917|50042008|FG003|Overall Study|Change Therapy|0|||
24950407|NCT00280917|50042005|FG000|Overall Study|Withdrawal by Subject|0|||
24950408|NCT00280917|50042006|FG001|Overall Study|Withdrawal by Subject|2|||
24950409|NCT00280917|50042007|FG002|Overall Study|Withdrawal by Subject|0|||
24950410|NCT00280917|50042008|FG003|Overall Study|Withdrawal by Subject|1|||
24950411|NCT00280917|50042005|FG000|Overall Study|Noncompliance|0|||
24950412|NCT00280917|50042006|FG001|Overall Study|Noncompliance|1|||
24950413|NCT00280917|50042007|FG002|Overall Study|Noncompliance|2|||
24950414|NCT00280917|50042008|FG003|Overall Study|Noncompliance|0|||
24950415|NCT00280683|50042020|FG000|Overall Study|Withdrawal by Subject|1|||
24950416|NCT00280683|50042021|FG001|Overall Study|Withdrawal by Subject|2|||
24950417|NCT00280683|50042020|FG000|Overall Study|Adverse Event|1|||
24950418|NCT00280683|50042021|FG001|Overall Study|Adverse Event|1|||
24950419|NCT00270855|50042031|FG000|Overall Study|Withdrawal by Subject|8|||
24950420|NCT00270855|50042032|FG001|Overall Study|Withdrawal by Subject|8|||
24950421|NCT00404768|50042044|FG000|Part A and B|Withdrawn due to labor progression|1|||
24950422|NCT00404768|50042045|FG001|Part A and B|Withdrawn due to labor progression|0|||
24950423|NCT00404768|50042046|FG002|Part A and B|Withdrawn due to labor progression|0|||
24950424|NCT00404768|50042047|FG003|Part A and B|Withdrawn due to labor progression|0|||
24950425|NCT00404768|50042044|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
24950426|NCT00404768|50042045|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
24950427|NCT00404768|50042046|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
24950428|NCT00404768|50042047|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
24950429|NCT00404768|50042044|FG000|Part C|Adverse Event|0|||
24950430|NCT00404768|50042045|FG001|Part C|Adverse Event|0|||
24950431|NCT00404768|50042046|FG002|Part C|Adverse Event|0|||
24950432|NCT00404768|50042047|FG003|Part C|Adverse Event|3|||
24950433|NCT00404768|50042044|FG000|Part C|Lost to Follow-up|0|||
24950434|NCT00404768|50042045|FG001|Part C|Lost to Follow-up|0|||
24950435|NCT00404768|50042046|FG002|Part C|Lost to Follow-up|3|||
24950436|NCT00404768|50042047|FG003|Part C|Lost to Follow-up|1|||
24950437|NCT00404768|50042044|FG000|Part C|Withdrawal by Subject|0|||
24950438|NCT00404768|50042045|FG001|Part C|Withdrawal by Subject|0|||
24950439|NCT00404768|50042046|FG002|Part C|Withdrawal by Subject|2|||
24950440|NCT00404768|50042047|FG003|Part C|Withdrawal by Subject|1|||
24950441|NCT00404768|50042044|FG000|Part C|Early withdrawal from study medication|0|||
24950442|NCT00404768|50042045|FG001|Part C|Early withdrawal from study medication|0|||
24950443|NCT00404768|50042046|FG002|Part C|Early withdrawal from study medication|1|||
24950444|NCT00404768|50042047|FG003|Part C|Early withdrawal from study medication|0|||
24950445|NCT00404768|50042044|FG000|Part C|Participant did not respond to therapy|0|||
24950446|NCT00404768|50042045|FG001|Part C|Participant did not respond to therapy|0|||
24950447|NCT00404768|50042046|FG002|Part C|Participant did not respond to therapy|1|||
24950448|NCT00404768|50042047|FG003|Part C|Participant did not respond to therapy|1|||
24950449|NCT00404768|50042044|FG000|Part C|Physician withdrew the study medication|0|||
24950450|NCT00404768|50042045|FG001|Part C|Physician withdrew the study medication|0|||
24950451|NCT00404768|50042046|FG002|Part C|Physician withdrew the study medication|1|||
24950452|NCT00404768|50042047|FG003|Part C|Physician withdrew the study medication|0|||
24950453|NCT00404768|50042044|FG000|Part C|Participant delivered baby|0|||
24950454|NCT00404768|50042045|FG001|Part C|Participant delivered baby|0|||
24950455|NCT00404768|50042046|FG002|Part C|Participant delivered baby|0|||
24950456|NCT00404768|50042047|FG003|Part C|Participant delivered baby|1|||
24950457|NCT00404768|50042044|FG000|Part C|Unsatisfactory uterine response to IP|0|||
24950458|NCT00404768|50042045|FG001|Part C|Unsatisfactory uterine response to IP|0|||
24950459|NCT00404768|50042046|FG002|Part C|Unsatisfactory uterine response to IP|0|||
24950460|NCT00404768|50042047|FG003|Part C|Unsatisfactory uterine response to IP|1|||
24950461|NCT00404768|50042044|FG000|Part C|Active labor|0|||
24950462|NCT00404768|50042045|FG001|Part C|Active labor|0|||
24950463|NCT00404768|50042046|FG002|Part C|Active labor|0|||
24950464|NCT00404768|50042047|FG003|Part C|Active labor|1|||
24950465|NCT00404768|50042044|FG000|Part C|Lack of Efficacy|0|||
24950466|NCT00404768|50042045|FG001|Part C|Lack of Efficacy|0|||
24950467|NCT00404768|50042046|FG002|Part C|Lack of Efficacy|0|||
24950468|NCT00404768|50042047|FG003|Part C|Lack of Efficacy|2|||
24950469|NCT00404768|50042044|FG000|Part C|Treatment failure|0|||
24950470|NCT00404768|50042045|FG001|Part C|Treatment failure|0|||
24950471|NCT00404768|50042046|FG002|Part C|Treatment failure|0|||
24950472|NCT00404768|50042047|FG003|Part C|Treatment failure|1|||
24950473|NCT00404768|50042044|FG000|Part C|Investigator discretion|0|||
24950474|NCT00404768|50042045|FG001|Part C|Investigator discretion|0|||
24950475|NCT00404768|50042046|FG002|Part C|Investigator discretion|0|||
24950476|NCT00404768|50042047|FG003|Part C|Investigator discretion|1|||
24950477|NCT00404768|50042044|FG000|Part C|Researcher suspended study medication|0|||
24950478|NCT00404768|50042045|FG001|Part C|Researcher suspended study medication|0|||
24950479|NCT00404768|50042046|FG002|Part C|Researcher suspended study medication|0|||
24950480|NCT00404768|50042047|FG003|Part C|Researcher suspended study medication|1|||
24950481|NCT00270231|50042062|FG000|First Intervention|Lost to Follow-up|1|||
24950482|NCT00270231|50042063|FG001|First Intervention|Lost to Follow-up|1|||
24950483|NCT00270231|50042062|FG000|Washout Period|Lost to Follow-up|1|||
24950484|NCT00270231|50042063|FG001|Washout Period|Lost to Follow-up|0|||
24950485|NCT00270231|50042062|FG000|Second Intervention|Lost to Follow-up|0|||
24950486|NCT00270231|50042063|FG001|Second Intervention|Lost to Follow-up|1|||
24950487|NCT00258856|50042073|FG000|Overall Study|Lost to Follow-up|1|||
24950488|NCT00258856|50042074|FG001|Overall Study|Lost to Follow-up|0|||
24950489|NCT00258856|50042075|FG002|Overall Study|Lost to Follow-up|2|||
24950490|NCT00258856|50042076|FG003|Overall Study|Lost to Follow-up|0|||
24950491|NCT00258856|50042073|FG000|Overall Study|Non-compliance|2|||
24950492|NCT00258856|50042074|FG001|Overall Study|Non-compliance|0|||
24950493|NCT00258856|50042075|FG002|Overall Study|Non-compliance|0|||
24950494|NCT00258856|50042076|FG003|Overall Study|Non-compliance|1|||
24950495|NCT00269919|50042086|FG000|Overall Study|Other|26|||
25038976|NCT02322814|50139636|FG004|Overall Study|Various Reasons|0|||
24950496|NCT00269919|50042086|FG000|Overall Study|Started but not treated|1|||
24950497|NCT00258154|50042093|FG000|Overall Study|Adverse Event|1|||
24950498|NCT00258154|50042094|FG001|Overall Study|Adverse Event|0|||
24950499|NCT00258154|50042093|FG000|Overall Study|Lost to Follow-up|0|||
24950500|NCT00258154|50042094|FG001|Overall Study|Lost to Follow-up|1|||
25038977|NCT02322814|50139632|FG000|Overall Study|Progressive Disease|0|||
24950501|NCT00258154|50042093|FG000|Overall Study|Protocol Violation|2|||
24950502|NCT00258154|50042094|FG001|Overall Study|Protocol Violation|1|||
24950503|NCT00258154|50042093|FG000|Overall Study|Withdrawal by Subject|3|||
24950504|NCT00258154|50042094|FG001|Overall Study|Withdrawal by Subject|4|||
24950505|NCT00258154|50042093|FG000|Overall Study|Patient Moved|3|||
24950506|NCT00258154|50042094|FG001|Overall Study|Patient Moved|1|||
24950507|NCT00257920|50042102|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
24950508|NCT00257920|50042103|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
24950509|NCT00257920|50042102|FG000|Period: Second Intervention|Other|2|||
24950510|NCT00257920|50042103|FG001|Period: Second Intervention|Other|1|||
24950511|NCT00268983|50042112|FG000|Overall Study|Death|3|||
24950512|NCT00268983|50042113|FG001|Overall Study|Death|0|||
24950513|NCT00257608|50042121|FG000|Chemotherapy Phase|Adverse Event|138|||
24950514|NCT00257608|50042122|FG001|Chemotherapy Phase|Adverse Event|0|||
24950515|NCT00257608|50042123|FG002|Chemotherapy Phase|Adverse Event|0|||
24950516|NCT00257608|50042121|FG000|Chemotherapy Phase|Disease progression|139|||
24950517|NCT00257608|50042122|FG001|Chemotherapy Phase|Disease progression|0|||
24950518|NCT00257608|50042123|FG002|Chemotherapy Phase|Disease progression|0|||
24950519|NCT00257608|50042121|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
24950520|NCT00257608|50042122|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
24950521|NCT00257608|50042123|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
24950522|NCT00257608|50042121|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
24950523|NCT00257608|50042122|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
24950524|NCT00257608|50042123|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
24950525|NCT00257608|50042121|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
24950526|NCT00257608|50042122|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
24950527|NCT00257608|50042123|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
24950528|NCT00257608|50042121|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
24950529|NCT00257608|50042122|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
24950530|NCT00257608|50042123|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
24950531|NCT00257608|50042121|FG000|Chemotherapy Phase|Physician Decision|28|||
24950532|NCT00257608|50042122|FG001|Chemotherapy Phase|Physician Decision|0|||
24950533|NCT00257608|50042123|FG002|Chemotherapy Phase|Physician Decision|0|||
24950534|NCT00257608|50042121|FG000|Post Chemotherapy Phase|Adverse Event|0|||
24950535|NCT00257608|50042122|FG001|Post Chemotherapy Phase|Adverse Event|34|||
24950536|NCT00257608|50042123|FG002|Post Chemotherapy Phase|Adverse Event|38|||
24950537|NCT00257608|50042121|FG000|Post Chemotherapy Phase|Disease progression|0|||
24950538|NCT00257608|50042122|FG001|Post Chemotherapy Phase|Disease progression|204|||
24950539|NCT00257608|50042123|FG002|Post Chemotherapy Phase|Disease progression|168|||
24950540|NCT00257608|50042121|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
24950541|NCT00257608|50042122|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
24950542|NCT00257608|50042123|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
24950543|NCT00257608|50042121|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
24950544|NCT00257608|50042122|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
24950545|NCT00257608|50042123|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
24950546|NCT00257608|50042121|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
24950547|NCT00257608|50042122|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
24950548|NCT00257608|50042123|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
24950549|NCT00257608|50042121|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
24950550|NCT00257608|50042122|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
24950551|NCT00257608|50042123|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
24950552|NCT00257608|50042121|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
24950553|NCT00257608|50042122|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
24950554|NCT00257608|50042123|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
24950555|NCT00257608|50042121|FG000|Post Chemotherapy Phase|Physician Decision|0|||
24950556|NCT00257608|50042122|FG001|Post Chemotherapy Phase|Physician Decision|8|||
24950557|NCT00257608|50042123|FG002|Post Chemotherapy Phase|Physician Decision|11|||
24950558|NCT00257608|50042121|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
24950559|NCT00257608|50042122|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
24950560|NCT00257608|50042123|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
24950561|NCT00257608|50042121|FG000|Post Chemotherapy Phase|Not treated|0|||
24950562|NCT00257608|50042122|FG001|Post Chemotherapy Phase|Not treated|4|||
25038978|NCT02322814|50139633|FG001|Overall Study|Progressive Disease|0|||
25038979|NCT02322814|50139634|FG002|Overall Study|Progressive Disease|0|||
25038980|NCT02322814|50139635|FG003|Overall Study|Progressive Disease|1|||
25038981|NCT02322814|50139636|FG004|Overall Study|Progressive Disease|1|||
25038982|NCT02322814|50139632|FG000|Overall Study|Protocol Violation|1|||
25038983|NCT02322814|50139633|FG001|Overall Study|Protocol Violation|0|||
25038984|NCT02322814|50139634|FG002|Overall Study|Protocol Violation|0|||
25038985|NCT02322814|50139635|FG003|Overall Study|Protocol Violation|0|||
25038986|NCT02322814|50139636|FG004|Overall Study|Protocol Violation|0|||
25038987|NCT02322814|50139632|FG000|Overall Study|Study Terminated by Sponsor|0|||
25038988|NCT02322814|50139633|FG001|Overall Study|Study Terminated by Sponsor|7|||
25038989|NCT02322814|50139634|FG002|Overall Study|Study Terminated by Sponsor|9|||
25038990|NCT02322814|50139635|FG003|Overall Study|Study Terminated by Sponsor|5|||
25038991|NCT02322814|50139636|FG004|Overall Study|Study Terminated by Sponsor|13|||
25038992|NCT02322814|50139632|FG000|Overall Study|Withdrawal by Subject|5|||
25038993|NCT02322814|50139633|FG001|Overall Study|Withdrawal by Subject|4|||
25038994|NCT02322814|50139634|FG002|Overall Study|Withdrawal by Subject|2|||
25038995|NCT02322814|50139635|FG003|Overall Study|Withdrawal by Subject|1|||
25038996|NCT02322814|50139636|FG004|Overall Study|Withdrawal by Subject|3|||
25038997|NCT02136134|50139658|FG000|Overall Study|Death|35|||
25038998|NCT02136134|50139659|FG001|Overall Study|Death|29|||
25038999|NCT02136134|50139658|FG000|Overall Study|Withdrawal by Subject|14|||
25039000|NCT02136134|50139659|FG001|Overall Study|Withdrawal by Subject|4|||
25039001|NCT02136134|50139658|FG000|Overall Study|Other|3|||
25039002|NCT02136134|50139659|FG001|Overall Study|Other|3|||
25039003|NCT02136134|50139658|FG000|Overall Study|Ongoing|185|||
25039004|NCT02136134|50139659|FG001|Overall Study|Ongoing|207|||
24950563|NCT00257608|50042123|FG002|Post Chemotherapy Phase|Not treated|7|||
24950564|NCT00231478|50042138|FG000|Overall Study|Protocol Violation|3|||
24950565|NCT00231478|50042139|FG001|Overall Study|Protocol Violation|2|||
24950566|NCT00231478|50042138|FG000|Overall Study|Refused Treatment|1|||
24950567|NCT00231478|50042139|FG001|Overall Study|Refused Treatment|1|||
24950568|NCT00231478|50042138|FG000|Overall Study|Withdrawal by Subject|1|||
24950569|NCT00231478|50042139|FG001|Overall Study|Withdrawal by Subject|0|||
24950570|NCT00231478|50042138|FG000|Overall Study|Adverse Event|0|||
24950571|NCT00231478|50042139|FG001|Overall Study|Adverse Event|1|||
24950572|NCT00231478|50042138|FG000|Overall Study|Administrative|3|||
24950573|NCT00231478|50042139|FG001|Overall Study|Administrative|2|||
24950574|NCT00413192|50042149|FG000|Overall Study|Disease progression|26|||
24950575|NCT00413192|50042150|FG001|Overall Study|Disease progression|31|||
24950576|NCT00413192|50042151|FG002|Overall Study|Disease progression|16|||
24950577|NCT00413192|50042152|FG003|Overall Study|Disease progression|25|||
24950578|NCT00413192|50042149|FG000|Overall Study|Toxicity|3|||
24950579|NCT00413192|50042150|FG001|Overall Study|Toxicity|2|||
24950580|NCT00413192|50042151|FG002|Overall Study|Toxicity|2|||
24950581|NCT00413192|50042152|FG003|Overall Study|Toxicity|2|||
24950582|NCT00413192|50042149|FG000|Overall Study|Withdrawal by Subject|3|||
24950583|NCT00413192|50042150|FG001|Overall Study|Withdrawal by Subject|5|||
24950584|NCT00413192|50042151|FG002|Overall Study|Withdrawal by Subject|0|||
24950585|NCT00413192|50042152|FG003|Overall Study|Withdrawal by Subject|1|||
24950586|NCT00413192|50042149|FG000|Overall Study|Intercurrent illness|0|||
24950587|NCT00413192|50042150|FG001|Overall Study|Intercurrent illness|0|||
24950588|NCT00413192|50042151|FG002|Overall Study|Intercurrent illness|0|||
24950589|NCT00413192|50042152|FG003|Overall Study|Intercurrent illness|1|||
24950590|NCT00413192|50042149|FG000|Overall Study|Intercurrent death|0|||
24950591|NCT00413192|50042150|FG001|Overall Study|Intercurrent death|1|||
24950592|NCT00413192|50042151|FG002|Overall Study|Intercurrent death|0|||
24950593|NCT00413192|50042152|FG003|Overall Study|Intercurrent death|0|||
24950594|NCT00413192|50042149|FG000|Overall Study|Other|5|||
24950595|NCT00413192|50042150|FG001|Overall Study|Other|1|||
24950596|NCT00413192|50042151|FG002|Overall Study|Other|1|||
24950597|NCT00413192|50042152|FG003|Overall Study|Other|2|||
24950598|NCT00413192|50042149|FG000|Overall Study|Not treated|0|||
25039005|NCT02136134|50139658|FG000|Overall Study|Subjects randomized but not treated|10|||
25039006|NCT02136134|50139659|FG001|Overall Study|Subjects randomized but not treated|8|||
24950599|NCT00413192|50042150|FG001|Overall Study|Not treated|0|||
24950600|NCT00413192|50042151|FG002|Overall Study|Not treated|0|||
24950601|NCT00413192|50042152|FG003|Overall Study|Not treated|1|||
25039007|NCT02108964|50139673|FG000|Overall Study|Progressive disease|12|||
25039008|NCT02108964|50139674|FG001|Overall Study|Progressive disease|25|||
25039009|NCT02108964|50139675|FG002|Overall Study|Progressive disease|50|||
25039010|NCT02108964|50139676|FG003|Overall Study|Progressive disease|6|||
25039011|NCT02108964|50139677|FG004|Overall Study|Progressive disease|18|||
24950602|NCT00207142|50042165|FG000|Induction Phase|Adverse Event|9|||
24950603|NCT00207142|50042166|FG001|Induction Phase|Adverse Event|0|||
24950604|NCT00207142|50042167|FG002|Induction Phase|Adverse Event|0|||
24950605|NCT00207142|50042168|FG003|Induction Phase|Adverse Event|0|||
25039012|NCT02108964|50139678|FG005|Overall Study|Progressive disease|5|||
24950606|NCT00207142|50042165|FG000|Induction Phase|Death|1|||
24950607|NCT00207142|50042166|FG001|Induction Phase|Death|0|||
24950608|NCT00207142|50042167|FG002|Induction Phase|Death|0|||
24950609|NCT00207142|50042168|FG003|Induction Phase|Death|0|||
24950610|NCT00207142|50042165|FG000|Induction Phase|Lack of Efficacy|1|||
24950611|NCT00207142|50042166|FG001|Induction Phase|Lack of Efficacy|0|||
24950612|NCT00207142|50042167|FG002|Induction Phase|Lack of Efficacy|0|||
24950613|NCT00207142|50042168|FG003|Induction Phase|Lack of Efficacy|0|||
24950614|NCT00207142|50042165|FG000|Induction Phase|Lost to Follow-up|5|||
24950615|NCT00207142|50042166|FG001|Induction Phase|Lost to Follow-up|0|||
24950616|NCT00207142|50042167|FG002|Induction Phase|Lost to Follow-up|0|||
24950617|NCT00207142|50042168|FG003|Induction Phase|Lost to Follow-up|0|||
24950618|NCT00207142|50042165|FG000|Induction Phase|Physician Decision|2|||
24950619|NCT00207142|50042166|FG001|Induction Phase|Physician Decision|0|||
24950620|NCT00207142|50042167|FG002|Induction Phase|Physician Decision|0|||
24950621|NCT00207142|50042168|FG003|Induction Phase|Physician Decision|0|||
24950622|NCT00207142|50042165|FG000|Induction Phase|Poor/noncompliance|2|||
24950623|NCT00207142|50042166|FG001|Induction Phase|Poor/noncompliance|0|||
24950624|NCT00207142|50042167|FG002|Induction Phase|Poor/noncompliance|0|||
24950625|NCT00207142|50042168|FG003|Induction Phase|Poor/noncompliance|0|||
24950626|NCT00207142|50042165|FG000|Induction Phase|Pregnancy|1|||
24950627|NCT00207142|50042166|FG001|Induction Phase|Pregnancy|0|||
24950628|NCT00207142|50042167|FG002|Induction Phase|Pregnancy|0|||
24950629|NCT00207142|50042168|FG003|Induction Phase|Pregnancy|0|||
24950630|NCT00207142|50042165|FG000|Induction Phase|Subject no longer meets study criteria|3|||
24950631|NCT00207142|50042166|FG001|Induction Phase|Subject no longer meets study criteria|0|||
24950632|NCT00207142|50042167|FG002|Induction Phase|Subject no longer meets study criteria|0|||
24950633|NCT00207142|50042168|FG003|Induction Phase|Subject no longer meets study criteria|0|||
24950634|NCT00207142|50042165|FG000|Induction Phase|Withdrawal by Subject|4|||
24950635|NCT00207142|50042166|FG001|Induction Phase|Withdrawal by Subject|0|||
24950636|NCT00207142|50042167|FG002|Induction Phase|Withdrawal by Subject|0|||
24950637|NCT00207142|50042168|FG003|Induction Phase|Withdrawal by Subject|0|||
24950638|NCT00207142|50042165|FG000|Induction Phase|Incarceration|1|||
24950639|NCT00207142|50042166|FG001|Induction Phase|Incarceration|0|||
24950640|NCT00207142|50042167|FG002|Induction Phase|Incarceration|0|||
24950641|NCT00207142|50042168|FG003|Induction Phase|Incarceration|0|||
24950642|NCT00207142|50042165|FG000|Induction Phase|Missing lab data|1|||
24950643|NCT00207142|50042166|FG001|Induction Phase|Missing lab data|0|||
24950644|NCT00207142|50042167|FG002|Induction Phase|Missing lab data|0|||
24950645|NCT00207142|50042168|FG003|Induction Phase|Missing lab data|0|||
24950646|NCT00207142|50042165|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
24950647|NCT00207142|50042166|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
24950648|NCT00207142|50042167|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
24950649|NCT00207142|50042168|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
24950650|NCT00207142|50042165|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
24950651|NCT00207142|50042166|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
24950652|NCT00207142|50042167|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
24950653|NCT00207142|50042168|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
24950654|NCT00207142|50042165|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
24950655|NCT00207142|50042166|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
24950656|NCT00207142|50042167|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
24950657|NCT00207142|50042168|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
24950658|NCT00207142|50042165|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
24950659|NCT00207142|50042166|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
24950660|NCT00207142|50042167|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
24950661|NCT00207142|50042168|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
24950662|NCT00207142|50042165|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
24950663|NCT00207142|50042166|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
24950664|NCT00207142|50042167|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
24950665|NCT00207142|50042168|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
24950666|NCT00207142|50042165|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
24950667|NCT00207142|50042166|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
24950668|NCT00207142|50042167|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
24950669|NCT00207142|50042168|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
24950670|NCT00207142|50042165|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
24950671|NCT00207142|50042166|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
24950672|NCT00207142|50042167|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
24950673|NCT00207142|50042168|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
24950674|NCT00207142|50042165|FG000|Maintenance Phase/Rescue Phase|Death|0|||
24950675|NCT00207142|50042166|FG001|Maintenance Phase/Rescue Phase|Death|0|||
24950676|NCT00207142|50042167|FG002|Maintenance Phase/Rescue Phase|Death|0|||
24950677|NCT00207142|50042168|FG003|Maintenance Phase/Rescue Phase|Death|1|||
25039013|NCT02108964|50139679|FG006|Overall Study|Progressive disease|7|||
24950678|NCT00207142|50042165|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
24950679|NCT00207142|50042166|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
24950680|NCT00207142|50042167|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
24950681|NCT00207142|50042168|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
24950682|NCT00268905|50042186|FG000|Overall Study|Adverse Event|3|||
24950683|NCT00268905|50042187|FG001|Overall Study|Adverse Event|0|||
24950684|NCT00268905|50042188|FG002|Overall Study|Adverse Event|4|||
24950685|NCT00268905|50042186|FG000|Overall Study|Lost to Follow-up|0|||
24950686|NCT00268905|50042187|FG001|Overall Study|Lost to Follow-up|1|||
24950687|NCT00268905|50042188|FG002|Overall Study|Lost to Follow-up|0|||
24950688|NCT00268905|50042186|FG000|Overall Study|Withdrawal by Subject|0|||
24950689|NCT00268905|50042187|FG001|Overall Study|Withdrawal by Subject|0|||
24950690|NCT00268905|50042188|FG002|Overall Study|Withdrawal by Subject|3|||
24950691|NCT00268905|50042186|FG000|Overall Study|Progressive Disease|28|||
24950692|NCT00268905|50042187|FG001|Overall Study|Progressive Disease|4|||
24950693|NCT00268905|50042188|FG002|Overall Study|Progressive Disease|3|||
24950694|NCT00268905|50042186|FG000|Overall Study|Physician Decision|3|||
24950695|NCT00268905|50042187|FG001|Overall Study|Physician Decision|0|||
24950696|NCT00268905|50042188|FG002|Overall Study|Physician Decision|1|||
24950697|NCT00268905|50042186|FG000|Overall Study|Clinical Progression|9|||
24950698|NCT00268905|50042187|FG001|Overall Study|Clinical Progression|4|||
24950699|NCT00268905|50042188|FG002|Overall Study|Clinical Progression|1|||
24950700|NCT00206518|50042198|FG000|Overall Study|Lack of Efficacy|6|||
24950701|NCT00206518|50042199|FG001|Overall Study|Lack of Efficacy|4|||
24950702|NCT00206518|50042198|FG000|Overall Study|Adverse Event|2|||
24950703|NCT00206518|50042199|FG001|Overall Study|Adverse Event|1|||
24950704|NCT00206518|50042198|FG000|Overall Study|Physician Decision|1|||
24950705|NCT00206518|50042199|FG001|Overall Study|Physician Decision|0|||
24950706|NCT00206518|50042198|FG000|Overall Study|Protocol Violation|1|||
24950707|NCT00206518|50042199|FG001|Overall Study|Protocol Violation|1|||
24950708|NCT00423722|50042207|FG000|Overall Study|Death|4|||
24950709|NCT00423722|50042208|FG001|Overall Study|Death|4|||
24950710|NCT00423722|50042207|FG000|Overall Study|Declined to participate|2|||
24950711|NCT00423722|50042208|FG001|Overall Study|Declined to participate|3|||
24950712|NCT00423722|50042207|FG000|Overall Study|Unable to complete questionnaires|4|||
24950713|NCT00423722|50042208|FG001|Overall Study|Unable to complete questionnaires|4|||
24950714|NCT00423722|50042207|FG000|Overall Study|Withdrawal by Subject|4|||
24950715|NCT00423722|50042208|FG001|Overall Study|Withdrawal by Subject|2|||
24950716|NCT00206440|50042222|FG000|Overall Study|Protocol Violation|1|||
24950717|NCT00206440|50042223|FG001|Overall Study|Protocol Violation|2|||
24950718|NCT00206440|50042222|FG000|Overall Study|Adverse Event|4|||
24950719|NCT00206440|50042223|FG001|Overall Study|Adverse Event|2|||
24950720|NCT00268437|50042229|FG000|Overall Study|Ineligible|1|||
24950721|NCT00423488|50042236|FG000|Overall Study|No evidence of study drug intake|2|||
24950722|NCT00423488|50042237|FG001|Overall Study|No evidence of study drug intake|1|||
24950723|NCT00423488|50042236|FG000|Overall Study|No post baseline data|3|||
24950724|NCT00423488|50042237|FG001|Overall Study|No post baseline data|0|||
24950725|NCT00404066|50042243|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
24950726|NCT00404066|50042243|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
24950727|NCT00423332|50042249|FG000|Overall Study|Adverse Event|6|||
24950728|NCT00423332|50042250|FG001|Overall Study|Adverse Event|2|||
24950729|NCT00423332|50042249|FG000|Overall Study|Withdrawal by Subject|1|||
24950730|NCT00423332|50042250|FG001|Overall Study|Withdrawal by Subject|0|||
24950731|NCT00423332|50042249|FG000|Overall Study|Condition under investigation worsened|1|||
24950732|NCT00423332|50042250|FG001|Overall Study|Condition under investigation worsened|1|||
24950733|NCT00423332|50042249|FG000|Overall Study|Progressive at Week 6|0|||
24950734|NCT00423332|50042250|FG001|Overall Study|Progressive at Week 6|1|||
24950735|NCT00423332|50042249|FG000|Overall Study|Unblinded before 12 weeks|1|||
24950736|NCT00423332|50042250|FG001|Overall Study|Unblinded before 12 weeks|3|||
24950737|NCT00413036|50042257|FG000|Overall Study|Adverse Event|44|||
24950738|NCT00413036|50042257|FG000|Overall Study|Lack of Efficacy|129|||
24950739|NCT00413036|50042257|FG000|Overall Study|Withdrawal by Subject|7|||
24950740|NCT00413036|50042257|FG000|Overall Study|Death|9|||
24950741|NCT00413036|50042257|FG000|Overall Study|Other|26|||
24950742|NCT00413036|50042257|FG000|Overall Study|Missing|2|||
24950743|NCT00412958|50042265|FG000|Overall Study|Withdrawal by Subject|3|||
24950744|NCT00412958|50042266|FG001|Overall Study|Withdrawal by Subject|0|||
24950745|NCT00412958|50042267|FG002|Overall Study|Withdrawal by Subject|0|||
24950746|NCT00412958|50042268|FG003|Overall Study|Withdrawal by Subject|1|||
24950747|NCT00412958|50042265|FG000|Overall Study|Adverse Event|0|||
24950748|NCT00412958|50042266|FG001|Overall Study|Adverse Event|1|||
24950749|NCT00412958|50042267|FG002|Overall Study|Adverse Event|0|||
24950750|NCT00412958|50042268|FG003|Overall Study|Adverse Event|0|||
24950751|NCT00412958|50042265|FG000|Overall Study|Lost to Follow-up|0|||
24950752|NCT00412958|50042266|FG001|Overall Study|Lost to Follow-up|1|||
24950753|NCT00412958|50042267|FG002|Overall Study|Lost to Follow-up|0|||
24950754|NCT00412958|50042268|FG003|Overall Study|Lost to Follow-up|0|||
24950755|NCT00412958|50042265|FG000|Overall Study|Death|0|||
24950756|NCT00412958|50042266|FG001|Overall Study|Death|1|||
24950757|NCT00412958|50042267|FG002|Overall Study|Death|0|||
24950758|NCT00412958|50042268|FG003|Overall Study|Death|0|||
24950759|NCT00412958|50042265|FG000|Overall Study|Transport issue|0|||
24950760|NCT00412958|50042266|FG001|Overall Study|Transport issue|1|||
24950761|NCT00412958|50042267|FG002|Overall Study|Transport issue|0|||
24950762|NCT00412958|50042268|FG003|Overall Study|Transport issue|0|||
24950763|NCT00423176|50042280|FG000|Overall Study|Adverse Event|4|||
24950764|NCT00423176|50042281|FG001|Overall Study|Adverse Event|6|||
24950765|NCT00423176|50042280|FG000|Overall Study|Treatment Failure|1|||
24950766|NCT00423176|50042281|FG001|Overall Study|Treatment Failure|6|||
24950767|NCT00423176|50042280|FG000|Overall Study|Lost to Follow-up|4|||
24950768|NCT00423176|50042281|FG001|Overall Study|Lost to Follow-up|7|||
24950769|NCT00423176|50042280|FG000|Overall Study|Withdrawal by Subject|4|||
24950770|NCT00423176|50042281|FG001|Overall Study|Withdrawal by Subject|3|||
24950771|NCT00423176|50042280|FG000|Overall Study|Protocol Violation|1|||
24950772|NCT00423176|50042281|FG001|Overall Study|Protocol Violation|3|||
24950773|NCT00423176|50042280|FG000|Overall Study|Did not meet protocol eligibility|2|||
24950774|NCT00423176|50042281|FG001|Overall Study|Did not meet protocol eligibility|4|||
24950775|NCT00412880|50042287|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
24950776|NCT00412880|50042287|FG000|Overall Study|Consent withdrawn|1|||
24950777|NCT00412880|50042287|FG000|Overall Study|Adverse Event|1|||
24950778|NCT00412880|50042287|FG000|Overall Study|Progressive disease|20|||
24950779|NCT00268203|50042291|FG000|Overall Study|Lost to Follow-up|92|||
24950780|NCT00268203|50042291|FG000|Overall Study|Withdrawal by Subject|9|||
24950781|NCT00268203|50042291|FG000|Overall Study|Received Other NHL Therapy|7|||
24950782|NCT00268203|50042291|FG000|Overall Study|Progressive Disease|359|||
24950783|NCT00268203|50042291|FG000|Overall Study|Death|84|||
24950784|NCT00268203|50042291|FG000|Overall Study|Reason Not Specified|34|||
24950785|NCT00268203|50042291|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
24950786|NCT00384930|50042300|FG000|Overall Study|Adverse Event|5|||
24950787|NCT00384930|50042301|FG001|Overall Study|Adverse Event|4|||
24950788|NCT00384930|50042302|FG002|Overall Study|Adverse Event|12|||
24950789|NCT00384930|50042303|FG003|Overall Study|Adverse Event|11|||
24950790|NCT00384930|50042304|FG004|Overall Study|Adverse Event|14|||
24950791|NCT00384930|50042300|FG000|Overall Study|Entry Criteria Not Met|2|||
24950792|NCT00384930|50042301|FG001|Overall Study|Entry Criteria Not Met|6|||
24950793|NCT00384930|50042302|FG002|Overall Study|Entry Criteria Not Met|7|||
24950794|NCT00384930|50042303|FG003|Overall Study|Entry Criteria Not Met|8|||
24950795|NCT00384930|50042304|FG004|Overall Study|Entry Criteria Not Met|4|||
24950796|NCT00384930|50042300|FG000|Overall Study|Lack of Efficacy|1|||
24950797|NCT00384930|50042301|FG001|Overall Study|Lack of Efficacy|1|||
24950798|NCT00384930|50042302|FG002|Overall Study|Lack of Efficacy|2|||
24950799|NCT00384930|50042303|FG003|Overall Study|Lack of Efficacy|1|||
24950800|NCT00384930|50042304|FG004|Overall Study|Lack of Efficacy|2|||
24950801|NCT00384930|50042300|FG000|Overall Study|Lost to Follow-up|5|||
24950802|NCT00384930|50042301|FG001|Overall Study|Lost to Follow-up|3|||
24950803|NCT00384930|50042302|FG002|Overall Study|Lost to Follow-up|0|||
24950804|NCT00384930|50042303|FG003|Overall Study|Lost to Follow-up|4|||
24950805|NCT00384930|50042304|FG004|Overall Study|Lost to Follow-up|6|||
25186299|NCT01457924|50336265|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
25186300|NCT01457924|50336266|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
25186301|NCT01457924|50336267|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
25186302|NCT01457924|50336263|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
25186303|NCT01457924|50336264|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
25186304|NCT01457924|50336265|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
25186305|NCT01457924|50336266|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
25275826|NCT00899353|50589708|FG000|Overall Study|Withdrawal by Subject|2|||
24950806|NCT00384930|50042300|FG000|Overall Study|Physician Decision|0|||
24950807|NCT00384930|50042301|FG001|Overall Study|Physician Decision|1|||
24950808|NCT00384930|50042302|FG002|Overall Study|Physician Decision|1|||
24950809|NCT00384930|50042303|FG003|Overall Study|Physician Decision|0|||
24950810|NCT00384930|50042304|FG004|Overall Study|Physician Decision|1|||
24950811|NCT00384930|50042300|FG000|Overall Study|Protocol Violation|1|||
24950812|NCT00384930|50042301|FG001|Overall Study|Protocol Violation|0|||
24950813|NCT00384930|50042302|FG002|Overall Study|Protocol Violation|1|||
24950814|NCT00384930|50042303|FG003|Overall Study|Protocol Violation|6|||
25275827|NCT00898807|50589731|FG000|Overall Study|Withdrawal by Subject|5|||
24950815|NCT00384930|50042304|FG004|Overall Study|Protocol Violation|4|||
24950816|NCT00384930|50042300|FG000|Overall Study|Sponsor Decision|3|||
24950817|NCT00384930|50042301|FG001|Overall Study|Sponsor Decision|4|||
24950818|NCT00384930|50042302|FG002|Overall Study|Sponsor Decision|0|||
24950819|NCT00384930|50042303|FG003|Overall Study|Sponsor Decision|5|||
24950820|NCT00384930|50042304|FG004|Overall Study|Sponsor Decision|0|||
24950821|NCT00384930|50042300|FG000|Overall Study|Withdrawal by Subject|9|||
24950822|NCT00384930|50042301|FG001|Overall Study|Withdrawal by Subject|7|||
24950823|NCT00384930|50042302|FG002|Overall Study|Withdrawal by Subject|7|||
24950824|NCT00384930|50042303|FG003|Overall Study|Withdrawal by Subject|6|||
24950825|NCT00384930|50042304|FG004|Overall Study|Withdrawal by Subject|16|||
24950826|NCT00384930|50042300|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
24950827|NCT00384930|50042301|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
24950828|NCT00384930|50042302|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
24950829|NCT00384930|50042303|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
24950830|NCT00384930|50042304|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
24950831|NCT00423098|50042321|FG000|Overall Study|Adverse Event|1|||
24950832|NCT00423098|50042322|FG001|Overall Study|Adverse Event|2|||
24950833|NCT00423098|50042321|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
24950834|NCT00423098|50042322|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
24950835|NCT00423098|50042321|FG000|Overall Study|Administrative problems|0|||
24950836|NCT00423098|50042322|FG001|Overall Study|Administrative problems|1|||
24950837|NCT00423098|50042321|FG000|Overall Study|Death|2|||
24950838|NCT00423098|50042322|FG001|Overall Study|Death|0|||
24950839|NCT00411788|50042337|FG000|Overall Study|Protocol Violation|1|||
24950840|NCT00411788|50042337|FG000|Overall Study|Adverse Event|1|||
24950841|NCT00422942|50042341|FG000|Overall Study|Study terminated by Sponsor|3|||
24950842|NCT00422162|50042347|FG000|Overall Study|Adverse Event|11|||
24950843|NCT00422162|50042348|FG001|Overall Study|Adverse Event|9|||
24950844|NCT00422162|50042347|FG000|Overall Study|Lack of Efficacy|4|||
24950845|NCT00422162|50042348|FG001|Overall Study|Lack of Efficacy|10|||
24950846|NCT00422162|50042347|FG000|Overall Study|Withdrawal by Subject|7|||
24950847|NCT00422162|50042348|FG001|Overall Study|Withdrawal by Subject|6|||
24950848|NCT00422162|50042347|FG000|Overall Study|Lost to Follow-up|1|||
24950849|NCT00422162|50042348|FG001|Overall Study|Lost to Follow-up|2|||
24950850|NCT00422162|50042347|FG000|Overall Study|Non-Compliant with Protocol|1|||
24950851|NCT00422162|50042348|FG001|Overall Study|Non-Compliant with Protocol|1|||
24950852|NCT00422162|50042347|FG000|Overall Study|Other|0|||
24950853|NCT00422162|50042348|FG001|Overall Study|Other|1|||
24950854|NCT00422162|50042347|FG000|Overall Study|Didn't Receive Treatment|0|||
24950855|NCT00422162|50042348|FG001|Overall Study|Didn't Receive Treatment|1|||
24950856|NCT00411632|50042364|FG000|Overall Study|Death|1|||
24950857|NCT00422084|50042370|FG000|Overall Study|Adverse Event|21|||
24950858|NCT00422084|50042371|FG001|Overall Study|Adverse Event|7|||
24950859|NCT00422084|50042370|FG000|Overall Study|Withdrawal by Subject|12|||
24950860|NCT00422084|50042371|FG001|Overall Study|Withdrawal by Subject|9|||
24950861|NCT00422084|50042370|FG000|Overall Study|Lost to Follow-up|14|||
24950862|NCT00422084|50042371|FG001|Overall Study|Lost to Follow-up|9|||
24950863|NCT00422084|50042370|FG000|Overall Study|Protocol Violation|4|||
24950864|NCT00422084|50042371|FG001|Overall Study|Protocol Violation|1|||
24950865|NCT00422084|50042370|FG000|Overall Study|Lack of Efficacy|40|||
24950866|NCT00422084|50042371|FG001|Overall Study|Lack of Efficacy|42|||
25039014|NCT02108964|50139680|FG007|Overall Study|Progressive disease|9|||
25039015|NCT02108964|50139673|FG000|Overall Study|Physician Decision|1|||
25039016|NCT02108964|50139674|FG001|Overall Study|Physician Decision|5|||
25039017|NCT02108964|50139675|FG002|Overall Study|Physician Decision|6|||
25039018|NCT02108964|50139676|FG003|Overall Study|Physician Decision|0|||
25039019|NCT02108964|50139677|FG004|Overall Study|Physician Decision|1|||
25039020|NCT02108964|50139678|FG005|Overall Study|Physician Decision|0|||
25039021|NCT02108964|50139679|FG006|Overall Study|Physician Decision|0|||
25039022|NCT02108964|50139680|FG007|Overall Study|Physician Decision|0|||
25039023|NCT02108964|50139673|FG000|Overall Study|Adverse Event|0|||
25039024|NCT02108964|50139674|FG001|Overall Study|Adverse Event|0|||
25039025|NCT02108964|50139675|FG002|Overall Study|Adverse Event|4|||
25039026|NCT02108964|50139676|FG003|Overall Study|Adverse Event|0|||
25039027|NCT02108964|50139677|FG004|Overall Study|Adverse Event|1|||
25039028|NCT02108964|50139678|FG005|Overall Study|Adverse Event|0|||
25039029|NCT02108964|50139679|FG006|Overall Study|Adverse Event|3|||
25160138|NCT01833169|50280189|FG000|Overall Study|Withdrawal by Subject|9|||
24950867|NCT00422084|50042370|FG000|Overall Study|P. vivax infection|3|||
24950868|NCT00422084|50042371|FG001|Overall Study|P. vivax infection|6|||
24950869|NCT00422084|50042370|FG000|Overall Study|Cyesis|1|||
24950870|NCT00422084|50042371|FG001|Overall Study|Cyesis|0|||
24950871|NCT00422084|50042370|FG000|Overall Study|Withdrawn from study accidentally|1|||
24950872|NCT00422084|50042371|FG001|Overall Study|Withdrawn from study accidentally|0|||
25039030|NCT02108964|50139680|FG007|Overall Study|Adverse Event|1|||
25039031|NCT02108964|50139673|FG000|Overall Study|Death|1|||
24950873|NCT00422084|50042370|FG000|Overall Study|Non-compliance|1|||
24950874|NCT00422084|50042371|FG001|Overall Study|Non-compliance|0|||
24950875|NCT00422084|50042370|FG000|Overall Study|Re-location|0|||
25039032|NCT02108964|50139674|FG001|Overall Study|Death|1|||
25160139|NCT01833169|50280189|FG000|Overall Study|Death|3|||
24950876|NCT00422084|50042371|FG001|Overall Study|Re-location|1|||
24950877|NCT00422084|50042370|FG000|Overall Study|Not defined|1|||
24950878|NCT00422084|50042371|FG001|Overall Study|Not defined|1|||
24950879|NCT00421928|50042380|FG000|Overall Study|Adverse Event|61|||
24950880|NCT00421928|50042381|FG001|Overall Study|Adverse Event|140|||
24950881|NCT00421928|50042382|FG002|Overall Study|Adverse Event|22|||
24950882|NCT00421928|50042380|FG000|Overall Study|Lost to Follow-up|5|||
24950883|NCT00421928|50042381|FG001|Overall Study|Lost to Follow-up|0|||
24950884|NCT00421928|50042382|FG002|Overall Study|Lost to Follow-up|3|||
24950885|NCT00421928|50042380|FG000|Overall Study|Withdrawal by Subject|50|||
24950886|NCT00421928|50042381|FG001|Overall Study|Withdrawal by Subject|48|||
24950887|NCT00421928|50042382|FG002|Overall Study|Withdrawal by Subject|43|||
24950888|NCT00421928|50042380|FG000|Overall Study|Lack of Efficacy|15|||
24950889|NCT00421928|50042381|FG001|Overall Study|Lack of Efficacy|7|||
24950890|NCT00421928|50042382|FG002|Overall Study|Lack of Efficacy|35|||
24950891|NCT00421928|50042380|FG000|Overall Study|Study drug non-compliant|6|||
24950892|NCT00421928|50042381|FG001|Overall Study|Study drug non-compliant|7|||
24950893|NCT00421928|50042382|FG002|Overall Study|Study drug non-compliant|4|||
24950894|NCT00421928|50042380|FG000|Overall Study|All other|26|||
24950895|NCT00421928|50042381|FG001|Overall Study|All other|21|||
24950896|NCT00421928|50042382|FG002|Overall Study|All other|27|||
24950897|NCT00421928|50042380|FG000|Overall Study|Death|0|||
24950898|NCT00421928|50042381|FG001|Overall Study|Death|1|||
24950899|NCT00421928|50042382|FG002|Overall Study|Death|0|||
24950900|NCT00383292|50042393|FG000|Overall Study|Adverse Event|4|||
24950901|NCT00383292|50042394|FG001|Overall Study|Adverse Event|1|||
24950902|NCT00383292|50042395|FG002|Overall Study|Adverse Event|2|||
24950903|NCT00383292|50042393|FG000|Overall Study|Death|3|||
24950904|NCT00383292|50042394|FG001|Overall Study|Death|3|||
24950905|NCT00383292|50042395|FG002|Overall Study|Death|3|||
24950906|NCT00383292|50042393|FG000|Overall Study|Physician Decision|4|||
24950907|NCT00383292|50042394|FG001|Overall Study|Physician Decision|0|||
24950908|NCT00383292|50042395|FG002|Overall Study|Physician Decision|1|||
24950909|NCT00383292|50042393|FG000|Overall Study|Withdrawal by Subject|3|||
24950910|NCT00383292|50042394|FG001|Overall Study|Withdrawal by Subject|2|||
24950911|NCT00383292|50042395|FG002|Overall Study|Withdrawal by Subject|2|||
24950912|NCT00383292|50042393|FG000|Overall Study|Other|1|||
24950913|NCT00383292|50042394|FG001|Overall Study|Other|0|||
24950914|NCT00383292|50042395|FG002|Overall Study|Other|0|||
24950915|NCT00372060|50042406|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
24950916|NCT00372060|50042407|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
24950917|NCT00372060|50042406|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
24950918|NCT00372060|50042407|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
24950919|NCT00372060|50042406|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
24950920|NCT00372060|50042407|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
24950921|NCT00372060|50042406|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
24950922|NCT00372060|50042407|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
24950923|NCT00372060|50042406|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
24950924|NCT00372060|50042407|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
24950925|NCT00372060|50042406|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
24950926|NCT00372060|50042407|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
24950927|NCT00421304|50042419|FG000|Overall Study|Lost to Follow-up|5|||
24950928|NCT00421304|50042420|FG001|Overall Study|Lost to Follow-up|2|||
24950929|NCT00421304|50042421|FG002|Overall Study|Lost to Follow-up|5|||
24950930|NCT00421304|50042419|FG000|Overall Study|Withdrawal by Subject|2|||
24950931|NCT00421304|50042420|FG001|Overall Study|Withdrawal by Subject|2|||
24950932|NCT00421304|50042421|FG002|Overall Study|Withdrawal by Subject|2|||
24950933|NCT00421304|50042419|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
24950934|NCT00421304|50042420|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
24950935|NCT00421304|50042421|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
24950936|NCT00421304|50042419|FG000|Overall Study|Did not attend Day 360 visit|0|||
24950937|NCT00421304|50042420|FG001|Overall Study|Did not attend Day 360 visit|0|||
24950938|NCT00421304|50042421|FG002|Overall Study|Did not attend Day 360 visit|1|||
24950939|NCT00396630|50042433|FG000|Overall Study|Lost to Follow-up|1|||
24950940|NCT00396630|50042434|FG001|Overall Study|Lost to Follow-up|1|||
24950941|NCT00396630|50042433|FG000|Overall Study|Withdrawal by Subject|1|||
24950942|NCT00396630|50042434|FG001|Overall Study|Withdrawal by Subject|1|||
24950943|NCT00396630|50042433|FG000|Overall Study|Not vaccinated at Visit 3|3|||
24950944|NCT00396630|50042434|FG001|Overall Study|Not vaccinated at Visit 3|3|||
24950945|NCT00396318|50042441|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
24950946|NCT00396162|50042447|FG000|Overall Study|Withdrawal by Subject|2|||
24950947|NCT00396162|50042448|FG001|Overall Study|Withdrawal by Subject|3|||
24950948|NCT00381888|50042458|FG000|Overall Study|Death|1|||
24950949|NCT00381888|50042458|FG000|Overall Study|Withdrawal by Subject|1|||
24950950|NCT00381888|50042458|FG000|Overall Study|Physician Decision|1|||
24950951|NCT00381888|50042458|FG000|Overall Study|Protocol Violation|9|||
24950952|NCT00381888|50042458|FG000|Overall Study|Had laparoscopic surgery|2|||
24950953|NCT00381888|50042458|FG000|Overall Study|Surgery was cancelled|2|||
24950954|NCT00381888|50042458|FG000|Overall Study|Adverse Event|1|||
24950955|NCT00267969|50042465|FG000|Controlled Period|Adverse Event|6|||
24950956|NCT00267969|50042466|FG001|Controlled Period|Adverse Event|0|||
24950957|NCT00267969|50042467|FG002|Controlled Period|Adverse Event|2|||
24950958|NCT00267969|50042468|FG003|Controlled Period|Adverse Event|0|||
24950959|NCT00267969|50042469|FG004|Controlled Period|Adverse Event|0|||
24950960|NCT00267969|50042470|FG005|Controlled Period|Adverse Event|0|||
24950961|NCT00267969|50042471|FG006|Controlled Period|Adverse Event|0|||
24950962|NCT00267969|50042465|FG000|Controlled Period|Lack of Efficacy|3|||
24950963|NCT00267969|50042466|FG001|Controlled Period|Lack of Efficacy|0|||
24950964|NCT00267969|50042467|FG002|Controlled Period|Lack of Efficacy|1|||
24950965|NCT00267969|50042468|FG003|Controlled Period|Lack of Efficacy|0|||
24950966|NCT00267969|50042469|FG004|Controlled Period|Lack of Efficacy|0|||
24950967|NCT00267969|50042470|FG005|Controlled Period|Lack of Efficacy|0|||
24950968|NCT00267969|50042471|FG006|Controlled Period|Lack of Efficacy|0|||
24950969|NCT00267969|50042465|FG000|Controlled Period|Lost to Follow-up|1|||
24950970|NCT00267969|50042466|FG001|Controlled Period|Lost to Follow-up|0|||
24950971|NCT00267969|50042467|FG002|Controlled Period|Lost to Follow-up|1|||
24950972|NCT00267969|50042468|FG003|Controlled Period|Lost to Follow-up|0|||
24950973|NCT00267969|50042469|FG004|Controlled Period|Lost to Follow-up|0|||
24950974|NCT00267969|50042470|FG005|Controlled Period|Lost to Follow-up|0|||
24950975|NCT00267969|50042471|FG006|Controlled Period|Lost to Follow-up|0|||
24950976|NCT00267969|50042465|FG000|Controlled Period|Randomized but not treated|0|||
24950977|NCT00267969|50042466|FG001|Controlled Period|Randomized but not treated|0|||
24950978|NCT00267969|50042467|FG002|Controlled Period|Randomized but not treated|1|||
24950979|NCT00267969|50042468|FG003|Controlled Period|Randomized but not treated|0|||
24950980|NCT00267969|50042469|FG004|Controlled Period|Randomized but not treated|0|||
24950981|NCT00267969|50042470|FG005|Controlled Period|Randomized but not treated|0|||
24950982|NCT00267969|50042471|FG006|Controlled Period|Randomized but not treated|0|||
24950983|NCT00267969|50042465|FG000|Controlled Period|Other|2|||
24950984|NCT00267969|50042466|FG001|Controlled Period|Other|1|||
24950985|NCT00267969|50042467|FG002|Controlled Period|Other|6|||
24950986|NCT00267969|50042468|FG003|Controlled Period|Other|0|||
24950987|NCT00267969|50042469|FG004|Controlled Period|Other|0|||
24950988|NCT00267969|50042470|FG005|Controlled Period|Other|0|||
24950989|NCT00267969|50042471|FG006|Controlled Period|Other|0|||
24950990|NCT00267969|50042465|FG000|After Controlled Period|Adverse Event|0|||
24950991|NCT00267969|50042466|FG001|After Controlled Period|Adverse Event|0|||
24950992|NCT00267969|50042467|FG002|After Controlled Period|Adverse Event|0|||
24950993|NCT00267969|50042468|FG003|After Controlled Period|Adverse Event|7|||
25039033|NCT02108964|50139675|FG002|Overall Study|Death|2|||
25039034|NCT02108964|50139676|FG003|Overall Study|Death|0|||
25039035|NCT02108964|50139677|FG004|Overall Study|Death|3|||
24950994|NCT00267969|50042469|FG004|After Controlled Period|Adverse Event|8|||
24950995|NCT00267969|50042470|FG005|After Controlled Period|Adverse Event|23|||
24950996|NCT00267969|50042471|FG006|After Controlled Period|Adverse Event|21|||
24950997|NCT00267969|50042465|FG000|After Controlled Period|Death|0|||
24950998|NCT00267969|50042466|FG001|After Controlled Period|Death|0|||
24950999|NCT00267969|50042467|FG002|After Controlled Period|Death|0|||
24951000|NCT00267969|50042468|FG003|After Controlled Period|Death|1|||
24951001|NCT00267969|50042469|FG004|After Controlled Period|Death|2|||
24951002|NCT00267969|50042470|FG005|After Controlled Period|Death|0|||
24951003|NCT00267969|50042471|FG006|After Controlled Period|Death|1|||
25039036|NCT02108964|50139678|FG005|Overall Study|Death|0|||
25039037|NCT02108964|50139679|FG006|Overall Study|Death|0|||
25039038|NCT02108964|50139680|FG007|Overall Study|Death|1|||
24951004|NCT00267969|50042465|FG000|After Controlled Period|Lack of Efficacy|0|||
24951005|NCT00267969|50042466|FG001|After Controlled Period|Lack of Efficacy|0|||
24951006|NCT00267969|50042467|FG002|After Controlled Period|Lack of Efficacy|0|||
24951007|NCT00267969|50042468|FG003|After Controlled Period|Lack of Efficacy|10|||
24951008|NCT00267969|50042469|FG004|After Controlled Period|Lack of Efficacy|6|||
25039039|NCT02108964|50139673|FG000|Overall Study|Subject/Guardian decision|0|||
25039040|NCT02108964|50139674|FG001|Overall Study|Subject/Guardian decision|1|||
24951009|NCT00267969|50042470|FG005|After Controlled Period|Lack of Efficacy|28|||
24951010|NCT00267969|50042471|FG006|After Controlled Period|Lack of Efficacy|15|||
24951011|NCT00267969|50042465|FG000|After Controlled Period|Lost to Follow-up|0|||
24951012|NCT00267969|50042466|FG001|After Controlled Period|Lost to Follow-up|0|||
24951013|NCT00267969|50042467|FG002|After Controlled Period|Lost to Follow-up|0|||
24951014|NCT00267969|50042468|FG003|After Controlled Period|Lost to Follow-up|5|||
24951015|NCT00267969|50042469|FG004|After Controlled Period|Lost to Follow-up|8|||
24951016|NCT00267969|50042470|FG005|After Controlled Period|Lost to Follow-up|9|||
24951017|NCT00267969|50042471|FG006|After Controlled Period|Lost to Follow-up|10|||
24951018|NCT00267969|50042465|FG000|After Controlled Period|Other|0|||
24951019|NCT00267969|50042466|FG001|After Controlled Period|Other|0|||
24951020|NCT00267969|50042467|FG002|After Controlled Period|Other|0|||
24951021|NCT00267969|50042468|FG003|After Controlled Period|Other|13|||
24951022|NCT00267969|50042469|FG004|After Controlled Period|Other|11|||
24951023|NCT00267969|50042470|FG005|After Controlled Period|Other|22|||
24951024|NCT00267969|50042471|FG006|After Controlled Period|Other|25|||
24951025|NCT00280293|50042491|FG000|Overall Study|Protocol Violation|3|||
24951026|NCT00280293|50042492|FG001|Overall Study|Protocol Violation|0|||
24951027|NCT00280293|50042491|FG000|Overall Study|Physician Decision|5|||
24951028|NCT00280293|50042492|FG001|Overall Study|Physician Decision|4|||
24951029|NCT00280293|50042491|FG000|Overall Study|Lost to Follow-up|14|||
24951030|NCT00280293|50042492|FG001|Overall Study|Lost to Follow-up|12|||
24951031|NCT00280293|50042491|FG000|Overall Study|Withdrawal by Subject|3|||
24951032|NCT00280293|50042492|FG001|Overall Study|Withdrawal by Subject|5|||
24951033|NCT00280293|50042491|FG000|Overall Study|Incarceration/Legal Reasons|1|||
24951034|NCT00280293|50042492|FG001|Overall Study|Incarceration/Legal Reasons|1|||
24951035|NCT00280293|50042491|FG000|Overall Study|Adverse Event|0|||
24951036|NCT00280293|50042492|FG001|Overall Study|Adverse Event|1|||
24951037|NCT00421148|50042518|FG000|Overall Study|Lost to Follow-up|0|||
24951038|NCT00421148|50042519|FG001|Overall Study|Lost to Follow-up|0|||
24951039|NCT00421148|50042520|FG002|Overall Study|Lost to Follow-up|0|||
24951040|NCT00421148|50042521|FG003|Overall Study|Lost to Follow-up|0|||
24951041|NCT00421148|50042522|FG004|Overall Study|Lost to Follow-up|0|||
24951042|NCT00421148|50042523|FG005|Overall Study|Lost to Follow-up|0|||
24951043|NCT00421148|50042524|FG006|Overall Study|Lost to Follow-up|0|||
24951044|NCT00421148|50042525|FG007|Overall Study|Lost to Follow-up|0|||
24951045|NCT00421148|50042526|FG008|Overall Study|Lost to Follow-up|0|||
24951046|NCT00421148|50042527|FG009|Overall Study|Lost to Follow-up|0|||
24951047|NCT00421148|50042528|FG010|Overall Study|Lost to Follow-up|0|||
24951048|NCT00421148|50042529|FG011|Overall Study|Lost to Follow-up|0|||
24951049|NCT00421148|50042530|FG012|Overall Study|Lost to Follow-up|0|||
24951050|NCT00421148|50042531|FG013|Overall Study|Lost to Follow-up|0|||
24951051|NCT00421148|50042532|FG014|Overall Study|Lost to Follow-up|0|||
24951052|NCT00421148|50042533|FG015|Overall Study|Lost to Follow-up|0|||
24951053|NCT00421148|50042534|FG016|Overall Study|Lost to Follow-up|0|||
25039041|NCT02108964|50139675|FG002|Overall Study|Subject/Guardian decision|3|||
25039042|NCT02108964|50139676|FG003|Overall Study|Subject/Guardian decision|0|||
25039043|NCT02108964|50139677|FG004|Overall Study|Subject/Guardian decision|2|||
25039044|NCT02108964|50139678|FG005|Overall Study|Subject/Guardian decision|0|||
25039045|NCT02108964|50139679|FG006|Overall Study|Subject/Guardian decision|1|||
25039046|NCT02108964|50139680|FG007|Overall Study|Subject/Guardian decision|1|||
25039047|NCT01333033|50139701|FG000|Overall Study|Ineligible|0|||
25039048|NCT01333033|50139702|FG001|Overall Study|Ineligible|0|||
25039049|NCT01333033|50139703|FG002|Overall Study|Ineligible|0|||
25039050|NCT01333033|50139704|FG003|Overall Study|Ineligible|0|||
25039051|NCT01333033|50139705|FG004|Overall Study|Ineligible|6|||
25039052|NCT01333033|50139706|FG005|Overall Study|Ineligible|8|||
25039053|NCT01333033|50139701|FG000|Overall Study|Withdrawal by Subject|0|||
24951054|NCT00421148|50042535|FG017|Overall Study|Lost to Follow-up|1|||
24951055|NCT00421148|50042536|FG018|Overall Study|Lost to Follow-up|0|||
24951056|NCT00421148|50042537|FG019|Overall Study|Lost to Follow-up|0|||
24951057|NCT00421148|50042518|FG000|Overall Study|Withdrawal by Subject|0|||
24951058|NCT00421148|50042519|FG001|Overall Study|Withdrawal by Subject|0|||
24951059|NCT00421148|50042520|FG002|Overall Study|Withdrawal by Subject|0|||
24951060|NCT00421148|50042521|FG003|Overall Study|Withdrawal by Subject|0|||
24951061|NCT00421148|50042522|FG004|Overall Study|Withdrawal by Subject|0|||
24951062|NCT00421148|50042523|FG005|Overall Study|Withdrawal by Subject|0|||
24951063|NCT00421148|50042524|FG006|Overall Study|Withdrawal by Subject|0|||
24951064|NCT00421148|50042525|FG007|Overall Study|Withdrawal by Subject|0|||
25039054|NCT01333033|50139702|FG001|Overall Study|Withdrawal by Subject|0|||
25039055|NCT01333033|50139703|FG002|Overall Study|Withdrawal by Subject|0|||
25160140|NCT01833169|50280189|FG000|Overall Study|Physician Decision|2|||
25160141|NCT01860079|50280195|FG000|Overall Study|Physician Decision|14|||
24951065|NCT00421148|50042526|FG008|Overall Study|Withdrawal by Subject|0|||
24951066|NCT00421148|50042527|FG009|Overall Study|Withdrawal by Subject|0|||
24951067|NCT00421148|50042528|FG010|Overall Study|Withdrawal by Subject|0|||
24951068|NCT00421148|50042529|FG011|Overall Study|Withdrawal by Subject|0|||
24951069|NCT00421148|50042530|FG012|Overall Study|Withdrawal by Subject|0|||
24951070|NCT00421148|50042531|FG013|Overall Study|Withdrawal by Subject|0|||
24951071|NCT00421148|50042532|FG014|Overall Study|Withdrawal by Subject|0|||
24951072|NCT00421148|50042533|FG015|Overall Study|Withdrawal by Subject|0|||
24951073|NCT00421148|50042534|FG016|Overall Study|Withdrawal by Subject|0|||
24951074|NCT00421148|50042535|FG017|Overall Study|Withdrawal by Subject|1|||
24951075|NCT00421148|50042536|FG018|Overall Study|Withdrawal by Subject|0|||
24951076|NCT00421148|50042537|FG019|Overall Study|Withdrawal by Subject|0|||
24951077|NCT00421148|50042518|FG000|Overall Study|Protocol Violation|0|||
24951078|NCT00421148|50042519|FG001|Overall Study|Protocol Violation|0|||
24951079|NCT00421148|50042520|FG002|Overall Study|Protocol Violation|0|||
25039056|NCT01333033|50139704|FG003|Overall Study|Withdrawal by Subject|0|||
25039057|NCT01333033|50139705|FG004|Overall Study|Withdrawal by Subject|4|||
25039058|NCT01333033|50139706|FG005|Overall Study|Withdrawal by Subject|2|||
25039059|NCT01333033|50139701|FG000|Overall Study|PET inevaluable|0|||
25039060|NCT01333033|50139702|FG001|Overall Study|PET inevaluable|0|||
25039061|NCT01333033|50139703|FG002|Overall Study|PET inevaluable|0|||
25039062|NCT01333033|50139704|FG003|Overall Study|PET inevaluable|0|||
25039063|NCT01333033|50139705|FG004|Overall Study|PET inevaluable|2|||
25039064|NCT01333033|50139706|FG005|Overall Study|PET inevaluable|4|||
25039065|NCT01333033|50139701|FG000|Overall Study|Adverse Event|0|||
25039066|NCT01333033|50139702|FG001|Overall Study|Adverse Event|0|||
25039067|NCT01333033|50139703|FG002|Overall Study|Adverse Event|0|||
24951080|NCT00421148|50042521|FG003|Overall Study|Protocol Violation|0|||
24951081|NCT00421148|50042522|FG004|Overall Study|Protocol Violation|0|||
24951082|NCT00421148|50042523|FG005|Overall Study|Protocol Violation|1|||
24951083|NCT00421148|50042524|FG006|Overall Study|Protocol Violation|0|||
24951084|NCT00421148|50042525|FG007|Overall Study|Protocol Violation|0|||
24951085|NCT00421148|50042526|FG008|Overall Study|Protocol Violation|0|||
24951086|NCT00421148|50042527|FG009|Overall Study|Protocol Violation|0|||
24951087|NCT00421148|50042528|FG010|Overall Study|Protocol Violation|0|||
24951088|NCT00421148|50042529|FG011|Overall Study|Protocol Violation|0|||
24951089|NCT00421148|50042530|FG012|Overall Study|Protocol Violation|0|||
24951090|NCT00421148|50042531|FG013|Overall Study|Protocol Violation|0|||
24951091|NCT00421148|50042532|FG014|Overall Study|Protocol Violation|0|||
24951092|NCT00421148|50042533|FG015|Overall Study|Protocol Violation|0|||
24951093|NCT00421148|50042534|FG016|Overall Study|Protocol Violation|0|||
24951094|NCT00421148|50042535|FG017|Overall Study|Protocol Violation|0|||
24951095|NCT00421148|50042536|FG018|Overall Study|Protocol Violation|1|||
24951096|NCT00421148|50042537|FG019|Overall Study|Protocol Violation|0|||
24951097|NCT00403754|50042579|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
24951098|NCT00403754|50042580|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
24951099|NCT00403754|50042581|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
24951100|NCT00403754|50042582|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
24951101|NCT00403754|50042579|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
24951102|NCT00403754|50042580|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
24951103|NCT00403754|50042581|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
24951104|NCT00403754|50042582|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
24951105|NCT00280059|50042596|FG000|Efficacy Assessment Phase|Death|2|||
24951106|NCT00280059|50042597|FG001|Efficacy Assessment Phase|Death|0|||
24951107|NCT00280059|50042596|FG000|Efficacy Assessment Phase|Adverse Event|33|||
25039068|NCT01333033|50139704|FG003|Overall Study|Adverse Event|0|||
24951108|NCT00280059|50042597|FG001|Efficacy Assessment Phase|Adverse Event|31|||
24951109|NCT00280059|50042596|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
24951110|NCT00280059|50042597|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
25039069|NCT01333033|50139705|FG004|Overall Study|Adverse Event|2|||
25039070|NCT01333033|50139706|FG005|Overall Study|Adverse Event|1|||
24951111|NCT00280059|50042596|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
24951112|NCT00280059|50042597|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
24951113|NCT00280059|50042596|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
24951114|NCT00280059|50042597|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
24951115|NCT00280059|50042596|FG000|Efficacy Assessment Phase|Other|7|||
24951116|NCT00280059|50042597|FG001|Efficacy Assessment Phase|Other|8|||
24951117|NCT00280059|50042596|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
24951118|NCT00280059|50042597|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
25039071|NCT01333033|50139701|FG000|Overall Study|Progression|0|||
25039072|NCT01333033|50139702|FG001|Overall Study|Progression|0|||
25039073|NCT01333033|50139703|FG002|Overall Study|Progression|0|||
25039074|NCT01333033|50139704|FG003|Overall Study|Progression|0|||
25039075|NCT01333033|50139705|FG004|Overall Study|Progression|0|||
25039076|NCT01333033|50139706|FG005|Overall Study|Progression|1|||
25039077|NCT01333033|50139701|FG000|Overall Study|MD Decision|0|||
25039078|NCT01333033|50139702|FG001|Overall Study|MD Decision|0|||
24951119|NCT00403130|50042611|FG000|2 Years From Start of Treatment|Not Eligible|3|||
24951120|NCT00403130|50042611|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
24951121|NCT00403130|50042611|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
24951122|NCT00403130|50042611|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
24951123|NCT00402740|50042615|FG000|Overall Study|Withdrawal by Subject|18|||
24951124|NCT00402740|50042615|FG000|Overall Study|Death|50|||
24951125|NCT00402740|50042615|FG000|Overall Study|Lost to Follow-up|6|||
24951126|NCT00402740|50042615|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
24951127|NCT00402740|50042615|FG000|Overall Study|Subject disposition unknown.|1|||
24951128|NCT00420290|50042625|FG000|Overall Study|Adverse Event|3|||
24951129|NCT00420290|50042626|FG001|Overall Study|Adverse Event|1|||
24951130|NCT00420290|50042625|FG000|Overall Study|Withdrawal by Subject|0|||
24951131|NCT00420290|50042626|FG001|Overall Study|Withdrawal by Subject|2|||
24951132|NCT00420290|50042625|FG000|Overall Study|did not meet inclusion/exclusion|1|||
24951133|NCT00420290|50042626|FG001|Overall Study|did not meet inclusion/exclusion|1|||
24951134|NCT00267189|50042634|FG000|Overall Study|Patient withdrew consent|1|||
24951135|NCT00267189|50042635|FG001|Overall Study|Patient withdrew consent|1|||
24951136|NCT00267189|50042634|FG000|Overall Study|Death|1|||
24951137|NCT00267189|50042635|FG001|Overall Study|Death|0|||
24951138|NCT00267189|50042634|FG000|Overall Study|Missing|3|||
24951139|NCT00267189|50042635|FG001|Overall Study|Missing|0|||
24951140|NCT03834350|50042641|FG000|Overall Study|Withdrawal by Subject|1|||
24951141|NCT00402116|50042649|FG000|Overall Study|Jaw infection after surgery-other|1|||
24951142|NCT00402116|50042650|FG001|Overall Study|Jaw infection after surgery-other|0|||
24951143|NCT00402116|50042651|FG002|Overall Study|Jaw infection after surgery-other|0|||
24951144|NCT00402116|50042649|FG000|Overall Study|Withdrawal by Subject|1|||
24951145|NCT00402116|50042650|FG001|Overall Study|Withdrawal by Subject|0|||
24951146|NCT00402116|50042651|FG002|Overall Study|Withdrawal by Subject|5|||
24951147|NCT00402116|50042649|FG000|Overall Study|Treatment completed per protocol|1|||
24951148|NCT00402116|50042650|FG001|Overall Study|Treatment completed per protocol|1|||
24951149|NCT00402116|50042651|FG002|Overall Study|Treatment completed per protocol|2|||
24951150|NCT00402116|50042649|FG000|Overall Study|other complicating disease|0|||
24951151|NCT00402116|50042650|FG001|Overall Study|other complicating disease|0|||
24951152|NCT00402116|50042651|FG002|Overall Study|other complicating disease|2|||
24951153|NCT00402116|50042649|FG000|Overall Study|Disease Progression|0|||
24951154|NCT00402116|50042650|FG001|Overall Study|Disease Progression|4|||
24951155|NCT00402116|50042651|FG002|Overall Study|Disease Progression|38|||
24951156|NCT00402116|50042649|FG000|Overall Study|mistaken thrombocytopenia|0|||
24951157|NCT00402116|50042650|FG001|Overall Study|mistaken thrombocytopenia|0|||
24951158|NCT00402116|50042651|FG002|Overall Study|mistaken thrombocytopenia|1|||
24951159|NCT00402116|50042649|FG000|Overall Study|decline related hyponatremia/tumor|0|||
24951160|NCT00402116|50042650|FG001|Overall Study|decline related hyponatremia/tumor|0|||
24951161|NCT00402116|50042651|FG002|Overall Study|decline related hyponatremia/tumor|1|||
24951162|NCT00402116|50042649|FG000|Overall Study|Adverse Event|0|||
24951163|NCT00402116|50042650|FG001|Overall Study|Adverse Event|1|||
24951164|NCT00402116|50042651|FG002|Overall Study|Adverse Event|6|||
24951165|NCT00401960|50042681|FG000|Overall Study|Lost to Follow-up|3|||
24951166|NCT00401960|50042682|FG001|Overall Study|Lost to Follow-up|0|||
24951167|NCT00401960|50042681|FG000|Overall Study|Death|2|||
25039079|NCT01333033|50139703|FG002|Overall Study|MD Decision|0|||
25039080|NCT01333033|50139704|FG003|Overall Study|MD Decision|0|||
25039081|NCT01333033|50139705|FG004|Overall Study|MD Decision|0|||
24951168|NCT00401960|50042682|FG001|Overall Study|Death|0|||
24951169|NCT00401726|50042692|FG000|Overall Study|Adverse Event|34|||
24951170|NCT00401726|50042693|FG001|Overall Study|Adverse Event|45|||
25039082|NCT01333033|50139706|FG005|Overall Study|MD Decision|2|||
25039083|NCT01192776|50139728|FG000|Overall Study|Death|8|||
25039084|NCT01192776|50139729|FG001|Overall Study|Death|15|||
25039085|NCT01192776|50139730|FG002|Overall Study|Death|18|||
25039086|NCT01192776|50139731|FG003|Overall Study|Death|15|||
25039087|NCT01192776|50139728|FG000|Overall Study|Lost to Follow-up|3|||
25160142|NCT01860079|50280196|FG001|Overall Study|Physician Decision|22|||
24951171|NCT00401726|50042692|FG000|Overall Study|Death|0|||
24951172|NCT00401726|50042693|FG001|Overall Study|Death|3|||
24951173|NCT00401726|50042692|FG000|Overall Study|Sponsor Request|0|||
24951174|NCT00401726|50042693|FG001|Overall Study|Sponsor Request|1|||
24951175|NCT00401726|50042692|FG000|Overall Study|Physician Decision|3|||
24951176|NCT00401726|50042693|FG001|Overall Study|Physician Decision|6|||
24951177|NCT00401726|50042692|FG000|Overall Study|Lost to Follow-up|23|||
24951178|NCT00401726|50042693|FG001|Overall Study|Lost to Follow-up|20|||
24951179|NCT00401726|50042692|FG000|Overall Study|Protocol Violation|6|||
24951180|NCT00401726|50042693|FG001|Overall Study|Protocol Violation|3|||
24951181|NCT00401726|50042692|FG000|Overall Study|Withdrawal by Subject|18|||
24951182|NCT00401726|50042693|FG001|Overall Study|Withdrawal by Subject|24|||
24951183|NCT00401726|50042692|FG000|Overall Study|Lack of Efficacy|4|||
24951184|NCT00401726|50042693|FG001|Overall Study|Lack of Efficacy|6|||
24951185|NCT00401726|50042692|FG000|Overall Study|Protocol Deviation|9|||
24951186|NCT00401726|50042693|FG001|Overall Study|Protocol Deviation|4|||
24951187|NCT00371826|50042702|FG000|Core Phase (12 Months)|Adverse Event|15|||
24951188|NCT00371826|50042703|FG001|Core Phase (12 Months)|Adverse Event|4|||
24951189|NCT00371826|50042704|FG002|Core Phase (12 Months)|Adverse Event|9|||
24951190|NCT00371826|50042702|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
24951191|NCT00371826|50042703|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
24951192|NCT00371826|50042704|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
24951193|NCT00371826|50042702|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
25160143|NCT01388985|50280204|FG000|Overall Study|Death|0|||
25160144|NCT01388985|50280205|FG001|Overall Study|Death|1|||
25160145|NCT01388985|50280204|FG000|Overall Study|Lost to Follow-up|30|||
25160146|NCT01388985|50280205|FG001|Overall Study|Lost to Follow-up|30|||
25160147|NCT01388985|50280204|FG000|Overall Study|Withdrawal by Subject|13|||
24951194|NCT00371826|50042703|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
24951195|NCT00371826|50042704|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
24951196|NCT00371826|50042702|FG000|Core Phase (12 Months)|Protocol Violation|1|||
24951197|NCT00371826|50042703|FG001|Core Phase (12 Months)|Protocol Violation|0|||
24951198|NCT00371826|50042704|FG002|Core Phase (12 Months)|Protocol Violation|1|||
24951199|NCT00371826|50042702|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
24951200|NCT00371826|50042703|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
24951201|NCT00371826|50042704|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
24951202|NCT00371826|50042702|FG000|Core Phase (12 Months)|Administrative problems|1|||
24951203|NCT00371826|50042703|FG001|Core Phase (12 Months)|Administrative problems|0|||
24951204|NCT00371826|50042704|FG002|Core Phase (12 Months)|Administrative problems|8|||
24951205|NCT00371826|50042702|FG000|Core Phase (12 Months)|Graft Loss|0|||
24951206|NCT00371826|50042703|FG001|Core Phase (12 Months)|Graft Loss|1|||
24951207|NCT00371826|50042704|FG002|Core Phase (12 Months)|Graft Loss|0|||
24951208|NCT00371826|50042702|FG000|Extension Phase (24 Months)|Adverse Event|4|||
24951209|NCT00371826|50042703|FG001|Extension Phase (24 Months)|Adverse Event|5|||
24951210|NCT00371826|50042704|FG002|Extension Phase (24 Months)|Adverse Event|0|||
24951211|NCT00371826|50042702|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
24951212|NCT00371826|50042703|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
24951213|NCT00371826|50042704|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
24951214|NCT00371826|50042702|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
24951215|NCT00371826|50042703|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
24951216|NCT00371826|50042704|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
24951217|NCT00371826|50042702|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
24951218|NCT00371826|50042703|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
24951219|NCT00371826|50042704|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
24951220|NCT00371826|50042702|FG000|Extension Phase (24 Months)|Administrative problems|0|||
24951221|NCT00371826|50042703|FG001|Extension Phase (24 Months)|Administrative problems|0|||
24951222|NCT00371826|50042704|FG002|Extension Phase (24 Months)|Administrative problems|2|||
24951223|NCT00396084|50042718|FG000|Overall Study|Adverse Event|0|||
24951224|NCT00396084|50042719|FG001|Overall Study|Adverse Event|0|||
24951225|NCT00396084|50042720|FG002|Overall Study|Adverse Event|0|||
24951226|NCT00396084|50042721|FG003|Overall Study|Adverse Event|0|||
24951227|NCT00396084|50042722|FG004|Overall Study|Adverse Event|1|||
24951228|NCT00396084|50042723|FG005|Overall Study|Adverse Event|2|||
24951229|NCT00396084|50042718|FG000|Overall Study|Withdrawal by Subject|0|||
24951230|NCT00396084|50042719|FG001|Overall Study|Withdrawal by Subject|0|||
24951231|NCT00396084|50042720|FG002|Overall Study|Withdrawal by Subject|0|||
24951232|NCT00396084|50042721|FG003|Overall Study|Withdrawal by Subject|1|||
24951233|NCT00396084|50042722|FG004|Overall Study|Withdrawal by Subject|0|||
24951234|NCT00396084|50042723|FG005|Overall Study|Withdrawal by Subject|0|||
25160148|NCT01388985|50280205|FG001|Overall Study|Withdrawal by Subject|4|||
24951235|NCT00395850|50042745|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
24951236|NCT00395850|50042746|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
25160149|NCT01388985|50280204|FG000|Overall Study|Subject unavailable|1|||
24951237|NCT00395850|50042747|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
24951238|NCT00395850|50042748|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
24951239|NCT00395850|50042745|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
25039088|NCT01192776|50139729|FG001|Overall Study|Lost to Follow-up|6|||
24951240|NCT00395850|50042746|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
24951241|NCT00395850|50042747|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
24951242|NCT00395850|50042748|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
24951243|NCT00395850|50042745|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
24951244|NCT00395850|50042746|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
24951245|NCT00395850|50042747|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
25039089|NCT01192776|50139730|FG002|Overall Study|Lost to Follow-up|3|||
25160150|NCT01388985|50280205|FG001|Overall Study|Subject unavailable|1|||
25160151|NCT01388985|50280204|FG000|Overall Study|Other (no reason)|0|||
24951246|NCT00395850|50042748|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
24951247|NCT00395850|50042745|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
24951248|NCT00395850|50042746|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
24951249|NCT00395850|50042747|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
24951250|NCT00395850|50042748|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
24951251|NCT00395850|50042745|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
24951252|NCT00395850|50042746|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
24951253|NCT00395850|50042747|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
24951254|NCT00395850|50042748|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
24951255|NCT00395850|50042745|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
24951256|NCT00395850|50042746|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
24951257|NCT00395850|50042747|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
24951258|NCT00395850|50042748|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
24951259|NCT00395850|50042745|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
24951260|NCT00395850|50042746|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
24951261|NCT00395850|50042747|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
24951262|NCT00395850|50042748|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
24951263|NCT00420212|50042761|FG000|Overall Study|Adverse Event|22|||
24951264|NCT00420212|50042762|FG001|Overall Study|Adverse Event|40|||
24951265|NCT00420212|50042763|FG002|Overall Study|Adverse Event|36|||
24951266|NCT00420212|50042761|FG000|Overall Study|Lost to Follow-up|9|||
24951267|NCT00420212|50042762|FG001|Overall Study|Lost to Follow-up|11|||
24951268|NCT00420212|50042763|FG002|Overall Study|Lost to Follow-up|11|||
24951269|NCT00420212|50042761|FG000|Overall Study|Withdrawal by Subject|31|||
24951270|NCT00420212|50042762|FG001|Overall Study|Withdrawal by Subject|22|||
24951271|NCT00420212|50042763|FG002|Overall Study|Withdrawal by Subject|19|||
24951272|NCT00420212|50042761|FG000|Overall Study|Physician Decision|4|||
24951273|NCT00420212|50042762|FG001|Overall Study|Physician Decision|4|||
24951274|NCT00420212|50042763|FG002|Overall Study|Physician Decision|3|||
24951275|NCT00420212|50042761|FG000|Overall Study|Protocol Violation|4|||
24951276|NCT00420212|50042762|FG001|Overall Study|Protocol Violation|4|||
24951277|NCT00420212|50042763|FG002|Overall Study|Protocol Violation|8|||
25160152|NCT01388985|50280205|FG001|Overall Study|Other (no reason)|1|||
24951278|NCT00420212|50042761|FG000|Overall Study|Death|0|||
24951279|NCT00420212|50042762|FG001|Overall Study|Death|0|||
25039090|NCT01192776|50139731|FG003|Overall Study|Lost to Follow-up|5|||
24951280|NCT00420212|50042763|FG002|Overall Study|Death|1|||
24951281|NCT00420212|50042761|FG000|Overall Study|Other-Unspecified|21|||
24951282|NCT00420212|50042762|FG001|Overall Study|Other-Unspecified|14|||
24951283|NCT00420212|50042763|FG002|Overall Study|Other-Unspecified|18|||
24951284|NCT00401258|50042774|FG000|Overall Study|Adverse Event|7|||
24951285|NCT00380874|50042780|FG000|Overall Study|Adverse Event|7|||
24951286|NCT00380874|50042781|FG001|Overall Study|Adverse Event|7|||
24951287|NCT00380874|50042780|FG000|Overall Study|Death|1|||
24951288|NCT00380874|50042781|FG001|Overall Study|Death|0|||
24951289|NCT00380874|50042780|FG000|Overall Study|Withdrawal by Subject|2|||
24951290|NCT00380874|50042781|FG001|Overall Study|Withdrawal by Subject|1|||
24951291|NCT00380874|50042780|FG000|Overall Study|Not related to study drug|3|||
24951292|NCT00380874|50042781|FG001|Overall Study|Not related to study drug|2|||
24951293|NCT00420056|50042787|FG000|Overall Study|Objective progression or relapse|17|||
24951294|NCT00411554|50042793|FG000|Overall Study|Adverse Event|2|||
24951295|NCT00411554|50042794|FG001|Overall Study|Adverse Event|4|||
24951296|NCT00411554|50042793|FG000|Overall Study|Lack of Efficacy|2|||
24951297|NCT00411554|50042794|FG001|Overall Study|Lack of Efficacy|5|||
24951298|NCT00411554|50042793|FG000|Overall Study|Withdrawal by Subject|3|||
24951299|NCT00411554|50042794|FG001|Overall Study|Withdrawal by Subject|0|||
24951300|NCT00411554|50042793|FG000|Overall Study|Patient Moved|1|||
24951301|NCT00411554|50042794|FG001|Overall Study|Patient Moved|0|||
24951302|NCT00400712|50042802|FG000|Overall Study|Death|1|||
24951303|NCT00400712|50042803|FG001|Overall Study|Death|0|||
24951304|NCT00400712|50042802|FG000|Overall Study|Withdrawal by Subject|11|||
24951305|NCT00400712|50042803|FG001|Overall Study|Withdrawal by Subject|12|||
24951306|NCT00400712|50042802|FG000|Overall Study|Physician Decision|5|||
24951307|NCT00400712|50042803|FG001|Overall Study|Physician Decision|4|||
24951308|NCT00380718|50042811|FG000|Overall Study|Adverse Event|1|||
24951309|NCT00380718|50042811|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
24951310|NCT00380250|50042817|FG000|Overall Study|Withdrawal by Subject|39|||
24951311|NCT00380250|50042818|FG001|Overall Study|Withdrawal by Subject|28|||
24951312|NCT00380250|50042817|FG000|Overall Study|Adverse Event|20|||
24951313|NCT00380250|50042818|FG001|Overall Study|Adverse Event|9|||
24951314|NCT00380250|50042817|FG000|Overall Study|Lack of Efficacy|10|||
24951315|NCT00380250|50042818|FG001|Overall Study|Lack of Efficacy|8|||
24951316|NCT00380250|50042817|FG000|Overall Study|Protocol Violation|15|||
24951317|NCT00380250|50042818|FG001|Overall Study|Protocol Violation|5|||
24951318|NCT00380250|50042817|FG000|Overall Study|Lost to Follow-up|14|||
24951319|NCT00380250|50042818|FG001|Overall Study|Lost to Follow-up|5|||
24951320|NCT00380250|50042817|FG000|Overall Study|Physician Decision|1|||
24951321|NCT00380250|50042818|FG001|Overall Study|Physician Decision|0|||
24951322|NCT00400400|50042826|FG000|Overall Study|Adverse Event|9|||
24951323|NCT00400400|50042827|FG001|Overall Study|Adverse Event|8|||
24951324|NCT00400400|50042826|FG000|Overall Study|Protocol Violation|2|||
24951325|NCT00400400|50042827|FG001|Overall Study|Protocol Violation|0|||
24951326|NCT00400400|50042826|FG000|Overall Study|Withdrawal by Subject|1|||
24951327|NCT00400400|50042827|FG001|Overall Study|Withdrawal by Subject|3|||
24951328|NCT00400400|50042826|FG000|Overall Study|Administrative Problem|1|||
24951329|NCT00400400|50042827|FG001|Overall Study|Administrative Problem|0|||
24951330|NCT00400400|50042826|FG000|Overall Study|Lost to Follow-up|0|||
24951331|NCT00400400|50042827|FG001|Overall Study|Lost to Follow-up|1|||
24951332|NCT00400400|50042826|FG000|Overall Study|Did not receive study drug|1|||
24951333|NCT00400400|50042827|FG001|Overall Study|Did not receive study drug|3|||
24951334|NCT00395694|50042835|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
24951335|NCT00395694|50042836|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
24951336|NCT00395694|50042835|FG000|Continuation Phase|Adverse Event|1|||
24951337|NCT00395694|50042836|FG001|Continuation Phase|Adverse Event|0|||
24951338|NCT00395694|50042835|FG000|Continuation Phase|Lack of Efficacy|12|||
24951339|NCT00395694|50042836|FG001|Continuation Phase|Lack of Efficacy|11|||
25186306|NCT01457924|50336267|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
25186307|NCT01457924|50336263|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
24951340|NCT00395694|50042835|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
24951341|NCT00395694|50042836|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
24951342|NCT00395694|50042835|FG000|Continuation Phase|Poor Compliance|1|||
24951343|NCT00395694|50042836|FG001|Continuation Phase|Poor Compliance|0|||
24951344|NCT00395694|50042835|FG000|Continuation Phase|Withdrawal by Subject|0|||
24951345|NCT00395694|50042836|FG001|Continuation Phase|Withdrawal by Subject|2|||
24951346|NCT00419744|50042848|FG000|Overall Study|Adverse Event|39|||
24951347|NCT00419744|50042849|FG001|Overall Study|Adverse Event|40|||
24951348|NCT00419744|50042850|FG002|Overall Study|Adverse Event|50|||
24951349|NCT00419744|50042848|FG000|Overall Study|Withdrawal by Subject|45|||
24951350|NCT00419744|50042849|FG001|Overall Study|Withdrawal by Subject|49|||
25186308|NCT01457924|50336264|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
24951351|NCT00419744|50042850|FG002|Overall Study|Withdrawal by Subject|52|||
24951352|NCT00419744|50042848|FG000|Overall Study|Lost to Follow-up|8|||
24951353|NCT00419744|50042849|FG001|Overall Study|Lost to Follow-up|10|||
24951354|NCT00419744|50042850|FG002|Overall Study|Lost to Follow-up|6|||
24951355|NCT00419744|50042848|FG000|Overall Study|Protocol Violation|4|||
24951356|NCT00419744|50042849|FG001|Overall Study|Protocol Violation|7|||
24951357|NCT00419744|50042850|FG002|Overall Study|Protocol Violation|8|||
24951358|NCT00419744|50042848|FG000|Overall Study|Randomized in error|9|||
24951359|NCT00419744|50042849|FG001|Overall Study|Randomized in error|6|||
24951360|NCT00419744|50042850|FG002|Overall Study|Randomized in error|7|||
24951361|NCT00419744|50042848|FG000|Overall Study|Moving out of state|2|||
24951362|NCT00419744|50042849|FG001|Overall Study|Moving out of state|0|||
24951363|NCT00419744|50042850|FG002|Overall Study|Moving out of state|1|||
24951364|NCT00419744|50042848|FG000|Overall Study|Physician Decision|10|||
24951365|NCT00419744|50042849|FG001|Overall Study|Physician Decision|5|||
24951366|NCT00419744|50042850|FG002|Overall Study|Physician Decision|6|||
24951367|NCT00419744|50042848|FG000|Overall Study|Spirometry mouthpiece issues|0|||
24951368|NCT00419744|50042849|FG001|Overall Study|Spirometry mouthpiece issues|1|||
24951369|NCT00419744|50042850|FG002|Overall Study|Spirometry mouthpiece issues|2|||
24951370|NCT00419744|50042848|FG000|Overall Study|Incorrect medication kit dispensed|0|||
25039091|NCT01367834|50139764|FG000|Overall Study|Withdrawal by Subject|2|||
25039092|NCT01367834|50139765|FG001|Overall Study|Withdrawal by Subject|2|||
25039093|NCT01367834|50139764|FG000|Overall Study|Study was ended.|0|||
24951371|NCT00419744|50042849|FG001|Overall Study|Incorrect medication kit dispensed|0|||
24951372|NCT00419744|50042850|FG002|Overall Study|Incorrect medication kit dispensed|1|||
24951373|NCT00395538|50042861|FG000|Overall Study|Did not re-consent to revised protocol|1|||
24951374|NCT00395538|50042862|FG001|Overall Study|Did not re-consent to revised protocol|10|||
25039094|NCT01367834|50139765|FG001|Overall Study|Study was ended.|1|||
25039095|NCT03106753|50139773|FG000|Overall Study|Withdrawal by Subject|0|||
25039096|NCT03106753|50139774|FG001|Overall Study|Withdrawal by Subject|1|||
25039097|NCT03045081|50139784|FG000|Overall Study|Withdrawal by Subject|6|||
25039098|NCT03045081|50139785|FG001|Overall Study|Withdrawal by Subject|11|||
25039099|NCT03107377|50139793|FG000|Overall Study|Adverse Event|3|||
25039100|NCT03107377|50139794|FG001|Overall Study|Adverse Event|3|||
25039101|NCT03107377|50139793|FG000|Overall Study|Protocol Violation|9|||
25039102|NCT03107377|50139794|FG001|Overall Study|Protocol Violation|12|||
25039103|NCT03107377|50139793|FG000|Overall Study|Physician Decision|3|||
24951375|NCT00395538|50042863|FG002|Overall Study|Did not re-consent to revised protocol|0|||
24951376|NCT00395538|50042861|FG000|Overall Study|FDA partial hold on PTH|0|||
24951377|NCT00395538|50042862|FG001|Overall Study|FDA partial hold on PTH|0|||
24951378|NCT00395538|50042863|FG002|Overall Study|FDA partial hold on PTH|11|||
24951379|NCT00395538|50042861|FG000|Overall Study|Failed screening|0|||
24951380|NCT00395538|50042862|FG001|Overall Study|Failed screening|0|||
24951381|NCT00395538|50042863|FG002|Overall Study|Failed screening|4|||
24951382|NCT00395538|50042861|FG000|Overall Study|Switch to Natpara|0|||
24951383|NCT00395538|50042862|FG001|Overall Study|Switch to Natpara|0|||
24951384|NCT00395538|50042863|FG002|Overall Study|Switch to Natpara|3|||
24951385|NCT00395538|50042861|FG000|Overall Study|Adverse Event|1|||
24951386|NCT00395538|50042862|FG001|Overall Study|Adverse Event|0|||
24951387|NCT00395538|50042863|FG002|Overall Study|Adverse Event|2|||
24951388|NCT00395538|50042861|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
24951389|NCT00395538|50042862|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
24951390|NCT00395538|50042863|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
24951391|NCT00395538|50042861|FG000|Overall Study|Non-compliance with study protocol|0|||
24951392|NCT00395538|50042862|FG001|Overall Study|Non-compliance with study protocol|1|||
24951393|NCT00395538|50042863|FG002|Overall Study|Non-compliance with study protocol|0|||
24951394|NCT00395538|50042861|FG000|Overall Study|PTH resistance|0|||
24951395|NCT00395538|50042862|FG001|Overall Study|PTH resistance|0|||
24951396|NCT00395538|50042863|FG002|Overall Study|PTH resistance|1|||
24951397|NCT00395538|50042861|FG000|Overall Study|Pregnancy|1|||
24951398|NCT00395538|50042862|FG001|Overall Study|Pregnancy|0|||
24951399|NCT00395538|50042863|FG002|Overall Study|Pregnancy|0|||
24951400|NCT00395538|50042861|FG000|Overall Study|Partial recovery of parathyroid function|0|||
24951401|NCT00395538|50042862|FG001|Overall Study|Partial recovery of parathyroid function|0|||
24951402|NCT00395538|50042863|FG002|Overall Study|Partial recovery of parathyroid function|1|||
24951403|NCT00395538|50042861|FG000|Overall Study|Participant elected to discontinue|0|||
24951404|NCT00395538|50042862|FG001|Overall Study|Participant elected to discontinue|0|||
24951405|NCT00395538|50042863|FG002|Overall Study|Participant elected to discontinue|1|||
24951406|NCT00395460|50042873|FG000|Overall Study|Withdrawal by Subject|1|||
25039104|NCT03107377|50139794|FG001|Overall Study|Physician Decision|6|||
24951407|NCT00395460|50042874|FG001|Overall Study|Withdrawal by Subject|0|||
24951408|NCT00395304|50042880|FG000|Treatment Period 1|Withdrawal by Subject|0|||
24951409|NCT00395304|50042881|FG001|Treatment Period 1|Withdrawal by Subject|3|||
24951410|NCT00395304|50042882|FG002|Treatment Period 1|Withdrawal by Subject|0|||
24951411|NCT00395304|50042883|FG003|Treatment Period 1|Withdrawal by Subject|2|||
24951412|NCT00395304|50042884|FG004|Treatment Period 1|Withdrawal by Subject|1|||
24951413|NCT00395304|50042885|FG005|Treatment Period 1|Withdrawal by Subject|1|||
25039105|NCT03107377|50139793|FG000|Overall Study|Pregnancy|7|||
25039106|NCT03107377|50139794|FG001|Overall Study|Pregnancy|7|||
25039107|NCT03107377|50139793|FG000|Overall Study|Withdrawal by Subject|16|||
24951414|NCT00395304|50042880|FG000|Treatment Period 1|Lost to Follow-up|1|||
24951415|NCT00395304|50042881|FG001|Treatment Period 1|Lost to Follow-up|0|||
24951416|NCT00395304|50042882|FG002|Treatment Period 1|Lost to Follow-up|0|||
24951417|NCT00395304|50042883|FG003|Treatment Period 1|Lost to Follow-up|1|||
24951418|NCT00395304|50042884|FG004|Treatment Period 1|Lost to Follow-up|0|||
24951419|NCT00395304|50042885|FG005|Treatment Period 1|Lost to Follow-up|1|||
24951420|NCT00395304|50042880|FG000|Treatment Period 1|Physician Decision|0|||
24951421|NCT00395304|50042881|FG001|Treatment Period 1|Physician Decision|1|||
24951422|NCT00395304|50042882|FG002|Treatment Period 1|Physician Decision|0|||
24951423|NCT00395304|50042883|FG003|Treatment Period 1|Physician Decision|0|||
24951424|NCT00395304|50042884|FG004|Treatment Period 1|Physician Decision|0|||
25039108|NCT03107377|50139794|FG001|Overall Study|Withdrawal by Subject|22|||
25039109|NCT03107377|50139793|FG000|Overall Study|Lost to Follow-up|37|||
25039110|NCT03107377|50139794|FG001|Overall Study|Lost to Follow-up|34|||
25039111|NCT03107377|50139793|FG000|Overall Study|Other reason not specified|16|||
25039112|NCT03107377|50139794|FG001|Overall Study|Other reason not specified|15|||
25039113|NCT02545283|50139802|FG000|Overall Study|Lost to Follow-up|2|||
25039114|NCT02545283|50139803|FG001|Overall Study|Lost to Follow-up|4|||
25039115|NCT02545283|50139802|FG000|Overall Study|Withdrawal by Subject|5|||
25039116|NCT02545283|50139803|FG001|Overall Study|Withdrawal by Subject|9|||
25039117|NCT02545283|50139802|FG000|Overall Study|Death|109|||
25160153|NCT01388985|50280204|FG000|Overall Study|Error of nurse|5|||
24951425|NCT00395304|50042885|FG005|Treatment Period 1|Physician Decision|0|||
24951426|NCT00395304|50042880|FG000|Treatment Period 2|Withdrawal by Subject|0|||
24951427|NCT00395304|50042881|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25039118|NCT02545283|50139803|FG001|Overall Study|Death|211|||
25160154|NCT01388985|50280205|FG001|Overall Study|Error of nurse|1|||
25039119|NCT02545283|50139802|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
25039120|NCT02545283|50139803|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
25039121|NCT02545283|50139802|FG000|Overall Study|Study Terminated By Sponsor|33|||
25039122|NCT02545283|50139803|FG001|Overall Study|Study Terminated By Sponsor|71|||
25039123|NCT03282565|50139814|FG000|Overall Study|COVID-19 Research Shutdown|0|||
25039124|NCT03282565|50139815|FG001|Overall Study|COVID-19 Research Shutdown|2|||
25039125|NCT03282565|50139816|FG002|Overall Study|COVID-19 Research Shutdown|2|||
25039126|NCT02875613|50139824|FG000|Overall Study|Withdrawal by Subject|1|||
25039127|NCT02815267|50139834|FG000|Double-Blind Phase|Adverse Event|0|||
25039128|NCT02815267|50139835|FG001|Double-Blind Phase|Adverse Event|3|||
25039129|NCT02815267|50139834|FG000|Double-Blind Phase|Lost to Follow-up|17|||
25039130|NCT02815267|50139835|FG001|Double-Blind Phase|Lost to Follow-up|9|||
25039131|NCT02815267|50139834|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
25039132|NCT02815267|50139835|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
25039133|NCT02815267|50139834|FG000|Double-Blind Phase|Protocol Violation|3|||
25039134|NCT02815267|50139835|FG001|Double-Blind Phase|Protocol Violation|2|||
25039135|NCT02815267|50139834|FG000|Double-Blind Phase|Site withdrawal|1|||
25039136|NCT02815267|50139835|FG001|Double-Blind Phase|Site withdrawal|6|||
25039137|NCT02815267|50139834|FG000|Double-Blind Phase|Received a disallowed medication|1|||
25039138|NCT02815267|50139835|FG001|Double-Blind Phase|Received a disallowed medication|1|||
25039139|NCT02815267|50139834|FG000|Open-Label Phase|Adverse Event|1|||
25039140|NCT02815267|50139835|FG001|Open-Label Phase|Adverse Event|1|||
25039141|NCT02815267|50139834|FG000|Open-Label Phase|Lost to Follow-up|23|||
25039142|NCT02815267|50139835|FG001|Open-Label Phase|Lost to Follow-up|9|||
25039143|NCT02815267|50139834|FG000|Open-Label Phase|Withdrawal by Subject|24|||
25039144|NCT02815267|50139835|FG001|Open-Label Phase|Withdrawal by Subject|13|||
25039145|NCT02815267|50139834|FG000|Open-Label Phase|Protocol Violation|0|||
25039146|NCT02815267|50139835|FG001|Open-Label Phase|Protocol Violation|1|||
25039147|NCT02815267|50139834|FG000|Open-Label Phase|Administrative|21|||
25039148|NCT02815267|50139835|FG001|Open-Label Phase|Administrative|12|||
25039149|NCT02815267|50139834|FG000|Open-Label Phase|Other|2|||
25039150|NCT02815267|50139835|FG001|Open-Label Phase|Other|5|||
25039151|NCT02930837|50139845|FG000|Overall Study|Adverse Event|6|||
25039152|NCT02930837|50139845|FG000|Overall Study|Lost to Follow-up|5|||
25039153|NCT02930837|50139845|FG000|Overall Study|Withdrawal by Subject|1|||
25039154|NCT01343277|50139851|FG000|Overall Study|Other|3|||
25039155|NCT01343277|50139852|FG001|Overall Study|Other|3|||
25039156|NCT01343277|50139851|FG000|Overall Study|Withdrawal by Subject|18|||
25039157|NCT01343277|50139852|FG001|Overall Study|Withdrawal by Subject|13|||
25039158|NCT01343277|50139851|FG000|Overall Study|Physician Decision|1|||
25039159|NCT01343277|50139852|FG001|Overall Study|Physician Decision|2|||
25039160|NCT01343277|50139851|FG000|Overall Study|Death|10|||
25039161|NCT01343277|50139852|FG001|Overall Study|Death|1|||
25039162|NCT01343277|50139851|FG000|Overall Study|Adverse Event|67|||
25039163|NCT01343277|50139852|FG001|Overall Study|Adverse Event|13|||
25039164|NCT01343277|50139851|FG000|Overall Study|Disease progression|270|||
25039165|NCT01343277|50139852|FG001|Overall Study|Disease progression|138|||
25039166|NCT01343277|50139851|FG000|Overall Study|Randomized not treated|6|||
25039167|NCT01343277|50139852|FG001|Overall Study|Randomized not treated|21|||
25039168|NCT01343277|50139851|FG000|Overall Study|Treatment ongoing|8|||
25039169|NCT01343277|50139852|FG001|Overall Study|Treatment ongoing|2|||
25039170|NCT01343277|50139851|FG000|Overall Study|Subsequent anticancer therapy|1|||
25039171|NCT01343277|50139852|FG001|Overall Study|Subsequent anticancer therapy|0|||
25039172|NCT03135899|50139866|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
25039173|NCT03135899|50139867|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
25039174|NCT03135899|50139868|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
25039175|NCT03135899|50139869|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
25039176|NCT03135899|50139870|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
25039177|NCT03135899|50139871|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
25039178|NCT03135899|50139872|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
25039179|NCT03135899|50139873|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
25039180|NCT03135899|50139866|FG000|Overall Study|Withdrawal by Subject|0|||
25039181|NCT03135899|50139867|FG001|Overall Study|Withdrawal by Subject|0|||
25039182|NCT03135899|50139868|FG002|Overall Study|Withdrawal by Subject|0|||
24951428|NCT00395304|50042882|FG002|Treatment Period 2|Withdrawal by Subject|0|||
24951429|NCT00395304|50042883|FG003|Treatment Period 2|Withdrawal by Subject|1|||
24951430|NCT00395304|50042884|FG004|Treatment Period 2|Withdrawal by Subject|0|||
24951431|NCT00395304|50042885|FG005|Treatment Period 2|Withdrawal by Subject|2|||
24951432|NCT00395304|50042880|FG000|Treatment Period 2|Lost to Follow-up|0|||
24951433|NCT00395304|50042881|FG001|Treatment Period 2|Lost to Follow-up|3|||
24951434|NCT00395304|50042882|FG002|Treatment Period 2|Lost to Follow-up|0|||
25039183|NCT03135899|50139869|FG003|Overall Study|Withdrawal by Subject|0|||
25039184|NCT03135899|50139870|FG004|Overall Study|Withdrawal by Subject|0|||
25160155|NCT01388907|50280213|FG000|Overall Study|Adverse Event|2|||
24951435|NCT00395304|50042883|FG003|Treatment Period 2|Lost to Follow-up|0|||
25039185|NCT03135899|50139871|FG005|Overall Study|Withdrawal by Subject|2|||
25039186|NCT03135899|50139872|FG006|Overall Study|Withdrawal by Subject|0|||
25039187|NCT03135899|50139873|FG007|Overall Study|Withdrawal by Subject|0|||
25039188|NCT02487979|50139887|FG000|Overall Study|Physician Decision|2|||
25039189|NCT02487979|50139887|FG000|Overall Study|Withdrawal by Subject|2|||
25039190|NCT02487979|50139887|FG000|Overall Study|Progressive Disease|17|||
25039191|NCT03103087|50139898|FG000|Overall Study|Did not receive any study drug|1|||
25039192|NCT03103087|50139899|FG001|Overall Study|Did not receive any study drug|0|||
25039193|NCT03103087|50139900|FG002|Overall Study|Did not receive any study drug|0|||
25039194|NCT03103087|50139898|FG000|Overall Study|Protocol Violation|1|||
25039195|NCT03103087|50139899|FG001|Overall Study|Protocol Violation|2|||
25039196|NCT03103087|50139900|FG002|Overall Study|Protocol Violation|1|||
25039197|NCT03103087|50139898|FG000|Overall Study|Lack of Efficacy|2|||
24951436|NCT00395304|50042884|FG004|Treatment Period 2|Lost to Follow-up|0|||
24951437|NCT00395304|50042885|FG005|Treatment Period 2|Lost to Follow-up|0|||
24951438|NCT00395304|50042880|FG000|Treatment Period 2|Physician Decision|0|||
24951439|NCT00395304|50042881|FG001|Treatment Period 2|Physician Decision|0|||
24951440|NCT00395304|50042882|FG002|Treatment Period 2|Physician Decision|1|||
24951441|NCT00395304|50042883|FG003|Treatment Period 2|Physician Decision|0|||
24951442|NCT00395304|50042884|FG004|Treatment Period 2|Physician Decision|0|||
24951443|NCT00395304|50042885|FG005|Treatment Period 2|Physician Decision|0|||
25039198|NCT03103087|50139899|FG001|Overall Study|Lack of Efficacy|1|||
25039199|NCT03103087|50139900|FG002|Overall Study|Lack of Efficacy|1|||
25039200|NCT03103087|50139898|FG000|Overall Study|Pregnancy|0|||
25039201|NCT03103087|50139899|FG001|Overall Study|Pregnancy|0|||
25039202|NCT03103087|50139900|FG002|Overall Study|Pregnancy|1|||
25039203|NCT03103087|50139898|FG000|Overall Study|Adverse Event|2|||
25039204|NCT03103087|50139899|FG001|Overall Study|Adverse Event|15|||
25039205|NCT03103087|50139900|FG002|Overall Study|Adverse Event|6|||
25039206|NCT03103087|50139898|FG000|Overall Study|Withdrawal by Subject|13|||
25039207|NCT03103087|50139899|FG001|Overall Study|Withdrawal by Subject|6|||
25039208|NCT03103087|50139900|FG002|Overall Study|Withdrawal by Subject|6|||
25039209|NCT03103087|50139898|FG000|Overall Study|Lost to Follow-up|4|||
25039210|NCT03103087|50139899|FG001|Overall Study|Lost to Follow-up|2|||
25039211|NCT03103087|50139900|FG002|Overall Study|Lost to Follow-up|7|||
25039212|NCT03103087|50139898|FG000|Overall Study|Other reason not reported|1|||
25039213|NCT03103087|50139899|FG001|Overall Study|Other reason not reported|3|||
25039214|NCT03103087|50139900|FG002|Overall Study|Other reason not reported|5|||
25039215|NCT03132467|50139910|FG000|Overall Study|Adverse Event|2|||
25039216|NCT03132467|50139910|FG000|Overall Study|Withdrawal by Subject|2|||
25039217|NCT03131999|50139917|FG000|Overall Study|Withdrawal by Subject|0|||
25039218|NCT03131999|50139918|FG001|Overall Study|Withdrawal by Subject|1|||
25039219|NCT02263885|50139933|FG000|Overall Study|Withdrawal by Subject|7|||
25039220|NCT02263885|50139933|FG000|Overall Study|Alternative Treatment|3|||
25039221|NCT02000219|50139938|FG000|14-Week Study Period|Physician Decision|1|||
25039222|NCT02000219|50139938|FG000|14-Week Study Period|Adverse Event|1|||
25039223|NCT02000219|50139938|FG000|14-Week Study Period|Underwent transplantation|1|||
25039224|NCT02000219|50139938|FG000|Continuation Period|Withdrawal by Subject|1|||
25039225|NCT02000219|50139938|FG000|Continuation Period|Had liver transplant|2|||
25039226|NCT02000219|50139938|FG000|Continuation Period|Non-compliance with study drug|2|||
25039227|NCT03101371|50139944|FG000|Overall Study|Physician Decision|0|||
25039228|NCT03101371|50139945|FG001|Overall Study|Physician Decision|1|||
25039229|NCT03101371|50139944|FG000|Overall Study|Lost to Follow-up|1|||
25039230|NCT03101371|50139945|FG001|Overall Study|Lost to Follow-up|4|||
25039231|NCT03101371|50139944|FG000|Overall Study|Did not meet eligibility criteria|2|||
25039232|NCT03101371|50139945|FG001|Overall Study|Did not meet eligibility criteria|1|||
25039233|NCT02850276|50139951|FG000|Overall Study|screen failure|43|||
25039234|NCT02850276|50139951|FG000|Overall Study|Withdrawal by Subject|14|||
25039235|NCT02850276|50139951|FG000|Overall Study|Physician Decision|2|||
25039236|NCT02850276|50139951|FG000|Overall Study|Lost to Follow-up|2|||
25039237|NCT02783768|50139956|FG000|Overall Study|Lost to Follow-up|1|||
25039238|NCT02783768|50139957|FG001|Overall Study|Lost to Follow-up|0|||
25039239|NCT03131687|50139969|FG000|Overall Study|Adverse Event|0|||
25039240|NCT03131687|50139970|FG001|Overall Study|Adverse Event|1|||
25039241|NCT03131687|50139971|FG002|Overall Study|Adverse Event|0|||
25039242|NCT03131687|50139972|FG003|Overall Study|Adverse Event|1|||
25039243|NCT03131687|50139973|FG004|Overall Study|Adverse Event|2|||
24951444|NCT00395304|50042880|FG000|Treatment Period 2|Other|0|||
25039244|NCT03131687|50139974|FG005|Overall Study|Adverse Event|2|||
25039245|NCT03131687|50139969|FG000|Overall Study|Death|1|||
25039246|NCT03131687|50139970|FG001|Overall Study|Death|0|||
25039247|NCT03131687|50139971|FG002|Overall Study|Death|0|||
24951445|NCT00395304|50042881|FG001|Treatment Period 2|Other|1|||
25039248|NCT03131687|50139972|FG003|Overall Study|Death|0|||
25039249|NCT03131687|50139973|FG004|Overall Study|Death|0|||
25039250|NCT03131687|50139974|FG005|Overall Study|Death|0|||
25039251|NCT03131687|50139969|FG000|Overall Study|Withdrawal by Subject|3|||
25039252|NCT03131687|50139970|FG001|Overall Study|Withdrawal by Subject|3|||
25039253|NCT03131687|50139971|FG002|Overall Study|Withdrawal by Subject|3|||
25039254|NCT03131687|50139972|FG003|Overall Study|Withdrawal by Subject|1|||
25039255|NCT03131687|50139973|FG004|Overall Study|Withdrawal by Subject|2|||
25039256|NCT03131687|50139974|FG005|Overall Study|Withdrawal by Subject|1|||
25039257|NCT03131687|50139969|FG000|Overall Study|Lost to Follow-up|1|||
24951446|NCT00395304|50042882|FG002|Treatment Period 2|Other|0|||
24951447|NCT00395304|50042883|FG003|Treatment Period 2|Other|0|||
24951448|NCT00395304|50042884|FG004|Treatment Period 2|Other|0|||
24951449|NCT00395304|50042885|FG005|Treatment Period 2|Other|0|||
24951450|NCT00395304|50042880|FG000|Treatment Period 3|Withdrawal by Subject|0|||
24951451|NCT00395304|50042881|FG001|Treatment Period 3|Withdrawal by Subject|0|||
24951452|NCT00395304|50042882|FG002|Treatment Period 3|Withdrawal by Subject|0|||
24951453|NCT00395304|50042883|FG003|Treatment Period 3|Withdrawal by Subject|1|||
24951454|NCT00395304|50042884|FG004|Treatment Period 3|Withdrawal by Subject|0|||
24951455|NCT00395304|50042885|FG005|Treatment Period 3|Withdrawal by Subject|1|||
24951456|NCT00395304|50042880|FG000|Treatment Period 3|Lost to Follow-up|1|||
24951457|NCT00395304|50042881|FG001|Treatment Period 3|Lost to Follow-up|1|||
24951458|NCT00395304|50042882|FG002|Treatment Period 3|Lost to Follow-up|0|||
24951459|NCT00395304|50042883|FG003|Treatment Period 3|Lost to Follow-up|0|||
24951460|NCT00395304|50042884|FG004|Treatment Period 3|Lost to Follow-up|0|||
24951461|NCT00395304|50042885|FG005|Treatment Period 3|Lost to Follow-up|0|||
24951462|NCT00395304|50042880|FG000|Treatment Period 3|Physician Decision|0|||
24951463|NCT00395304|50042881|FG001|Treatment Period 3|Physician Decision|1|||
24951464|NCT00395304|50042882|FG002|Treatment Period 3|Physician Decision|0|||
24951465|NCT00395304|50042883|FG003|Treatment Period 3|Physician Decision|0|||
24951466|NCT00395304|50042884|FG004|Treatment Period 3|Physician Decision|0|||
24951467|NCT00395304|50042885|FG005|Treatment Period 3|Physician Decision|0|||
24951468|NCT00395304|50042880|FG000|Treatment Period 3|Other|0|||
24951469|NCT00395304|50042881|FG001|Treatment Period 3|Other|0|||
24951470|NCT00395304|50042882|FG002|Treatment Period 3|Other|0|||
25039258|NCT03131687|50139970|FG001|Overall Study|Lost to Follow-up|4|||
25039259|NCT03131687|50139971|FG002|Overall Study|Lost to Follow-up|0|||
25039260|NCT03131687|50139972|FG003|Overall Study|Lost to Follow-up|1|||
25039261|NCT03131687|50139973|FG004|Overall Study|Lost to Follow-up|4|||
25039262|NCT03131687|50139974|FG005|Overall Study|Lost to Follow-up|2|||
24951471|NCT00395304|50042883|FG003|Treatment Period 3|Other|1|||
24951472|NCT00395304|50042884|FG004|Treatment Period 3|Other|0|||
24951473|NCT00395304|50042885|FG005|Treatment Period 3|Other|0|||
24951474|NCT00395226|50042894|FG000|Overall Study|Adverse Event|4|||
24951475|NCT00395226|50042895|FG001|Overall Study|Adverse Event|3|||
24951476|NCT00395226|50042894|FG000|Overall Study|Withdrawal by Subject|0|||
24951477|NCT00395226|50042895|FG001|Overall Study|Withdrawal by Subject|1|||
24951478|NCT00395226|50042894|FG000|Overall Study|Lost to Follow-up|0|||
24951479|NCT00395226|50042895|FG001|Overall Study|Lost to Follow-up|1|||
25039263|NCT03131687|50139969|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
25039264|NCT03131687|50139970|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
25039265|NCT03131687|50139971|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
25039266|NCT03131687|50139972|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
25039267|NCT03131687|50139973|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
25039268|NCT03131687|50139974|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
25039269|NCT03131687|50139969|FG000|Overall Study|Principle Investigator Decision|0|||
25039270|NCT03131687|50139970|FG001|Overall Study|Principle Investigator Decision|1|||
25039271|NCT03131687|50139971|FG002|Overall Study|Principle Investigator Decision|0|||
24951480|NCT00394914|50042903|FG000|Treatment Period|Adverse Event|0|||
24951481|NCT00394914|50042904|FG001|Treatment Period|Adverse Event|3|||
24951482|NCT00394914|50042905|FG002|Treatment Period|Adverse Event|1|||
25039272|NCT03131687|50139972|FG003|Overall Study|Principle Investigator Decision|0|||
25039273|NCT03131687|50139973|FG004|Overall Study|Principle Investigator Decision|0|||
25039274|NCT03131687|50139974|FG005|Overall Study|Principle Investigator Decision|0|||
25039275|NCT03131687|50139969|FG000|Overall Study|Inadvertent Enrollment|0|||
25039276|NCT03131687|50139970|FG001|Overall Study|Inadvertent Enrollment|0|||
25039277|NCT03131687|50139971|FG002|Overall Study|Inadvertent Enrollment|0|||
25039278|NCT03131687|50139972|FG003|Overall Study|Inadvertent Enrollment|1|||
25039279|NCT03131687|50139973|FG004|Overall Study|Inadvertent Enrollment|0|||
25039280|NCT03131687|50139974|FG005|Overall Study|Inadvertent Enrollment|0|||
25039281|NCT03101293|50140003|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
24951483|NCT00394914|50042903|FG000|Treatment Period|Lost to Follow-up|0|||
25039282|NCT03101293|50140004|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
25039283|NCT02850978|50140010|FG000|Overall Study|Uncollectable CRF|27|||
25039284|NCT02850978|50140010|FG000|Overall Study|No visit since the first visit|35|||
24951484|NCT00394914|50042904|FG001|Treatment Period|Lost to Follow-up|1|||
24951485|NCT00394914|50042905|FG002|Treatment Period|Lost to Follow-up|0|||
24951486|NCT00394914|50042903|FG000|Treatment Period|Withdrawal by Subject|0|||
24951487|NCT00394914|50042904|FG001|Treatment Period|Withdrawal by Subject|2|||
24951488|NCT00394914|50042905|FG002|Treatment Period|Withdrawal by Subject|2|||
24951489|NCT00394914|50042903|FG000|Treatment Period|Noncompliance with protocol|0|||
24951490|NCT00394914|50042904|FG001|Treatment Period|Noncompliance with protocol|3|||
24951491|NCT00394914|50042905|FG002|Treatment Period|Noncompliance with protocol|2|||
24951492|NCT00394914|50042903|FG000|Treatment Period|Did not meet protocol eligibility|0|||
24951493|NCT00394914|50042904|FG001|Treatment Period|Did not meet protocol eligibility|1|||
24951494|NCT00394914|50042905|FG002|Treatment Period|Did not meet protocol eligibility|1|||
24951495|NCT00366444|50042913|FG000|Overall Study|Withdrawal by Subject|1|||
24951496|NCT00366444|50042914|FG001|Overall Study|Withdrawal by Subject|1|||
24951497|NCT00366444|50042913|FG000|Overall Study|Lack of Efficacy|0|||
24951498|NCT00366444|50042914|FG001|Overall Study|Lack of Efficacy|1|||
24951499|NCT00365976|50042922|FG000|Overall Study|Withdrawal by Subject|1|||
24951500|NCT00365976|50042923|FG001|Overall Study|Withdrawal by Subject|5|||
24951501|NCT00379236|50042931|FG000|Double-blind|Adverse Event|11|||
24951502|NCT00379236|50042932|FG001|Double-blind|Adverse Event|6|||
24951503|NCT00379236|50042933|FG002|Double-blind|Adverse Event|0|||
24951504|NCT00379236|50042931|FG000|Double-blind|Protocol Violation|3|||
24951505|NCT00379236|50042932|FG001|Double-blind|Protocol Violation|3|||
24951506|NCT00379236|50042933|FG002|Double-blind|Protocol Violation|0|||
24951507|NCT00379236|50042931|FG000|Double-blind|Withdrawal by Subject|12|||
24951508|NCT00379236|50042932|FG001|Double-blind|Withdrawal by Subject|13|||
24951509|NCT00379236|50042933|FG002|Double-blind|Withdrawal by Subject|0|||
24951510|NCT00379236|50042931|FG000|Double-blind|Lost to Follow-up|4|||
24951511|NCT00379236|50042932|FG001|Double-blind|Lost to Follow-up|3|||
24951512|NCT00379236|50042933|FG002|Double-blind|Lost to Follow-up|0|||
24951513|NCT00379236|50042931|FG000|Double-blind|Use of exclusionary medication|1|||
24951514|NCT00379236|50042932|FG001|Double-blind|Use of exclusionary medication|2|||
24951515|NCT00379236|50042933|FG002|Double-blind|Use of exclusionary medication|0|||
24951516|NCT00379236|50042931|FG000|Double-blind|Other|3|||
24951517|NCT00379236|50042932|FG001|Double-blind|Other|7|||
24951518|NCT00379236|50042933|FG002|Double-blind|Other|0|||
24951519|NCT00379236|50042931|FG000|Double-blind|Data could not be retrieved|2|||
24951520|NCT00379236|50042932|FG001|Double-blind|Data could not be retrieved|2|||
24951521|NCT00379236|50042933|FG002|Double-blind|Data could not be retrieved|0|||
24951522|NCT00379236|50042931|FG000|Open-label Extension|Adverse Event|0|||
24951523|NCT00379236|50042932|FG001|Open-label Extension|Adverse Event|0|||
24951524|NCT00379236|50042933|FG002|Open-label Extension|Adverse Event|13|||
24951525|NCT00379236|50042931|FG000|Open-label Extension|Protocol Violation|0|||
24951526|NCT00379236|50042932|FG001|Open-label Extension|Protocol Violation|0|||
24951527|NCT00379236|50042933|FG002|Open-label Extension|Protocol Violation|7|||
24951528|NCT00379236|50042931|FG000|Open-label Extension|Withdrawal by Subject|0|||
24951529|NCT00379236|50042932|FG001|Open-label Extension|Withdrawal by Subject|0|||
24951530|NCT00379236|50042933|FG002|Open-label Extension|Withdrawal by Subject|13|||
24951531|NCT00379236|50042931|FG000|Open-label Extension|Lost to Follow-up|0|||
24951532|NCT00379236|50042932|FG001|Open-label Extension|Lost to Follow-up|0|||
24951533|NCT00379236|50042933|FG002|Open-label Extension|Lost to Follow-up|12|||
24951534|NCT00379236|50042931|FG000|Open-label Extension|Use of exclusionary medication|0|||
24951535|NCT00379236|50042932|FG001|Open-label Extension|Use of exclusionary medication|0|||
24951536|NCT00379236|50042933|FG002|Open-label Extension|Use of exclusionary medication|3|||
24951537|NCT00379236|50042931|FG000|Open-label Extension|Other|0|||
24951538|NCT00379236|50042932|FG001|Open-label Extension|Other|0|||
24951539|NCT00379236|50042933|FG002|Open-label Extension|Other|7|||
24951540|NCT00379080|50042948|FG000|Overall Study|Withdrawal by Subject|0|||
24951541|NCT00379080|50042949|FG001|Overall Study|Withdrawal by Subject|4|||
24951542|NCT00379080|50042950|FG002|Overall Study|Withdrawal by Subject|0|||
24951543|NCT00378534|50042975|FG000|Overall Study|Participants did not receive transplant|3|||
24951544|NCT00378534|50042976|FG001|Overall Study|Participants did not receive transplant|0|||
24951545|NCT00377676|50042983|FG000|Overall Study|Adverse Event|498|||
24951546|NCT00377676|50042984|FG001|Overall Study|Adverse Event|107|||
24951547|NCT00377676|50042983|FG000|Overall Study|Protocol Violation|33|||
24951548|NCT00377676|50042984|FG001|Overall Study|Protocol Violation|27|||
24951549|NCT00377676|50042983|FG000|Overall Study|Death|5|||
24951550|NCT00377676|50042984|FG001|Overall Study|Death|2|||
25275828|NCT00898807|50589732|FG001|Overall Study|Withdrawal by Subject|3|||
24951551|NCT00377676|50042983|FG000|Overall Study|Withdrawal by Subject|187|||
25039285|NCT02850978|50140010|FG000|Overall Study|Adverse Event|81|||
25039286|NCT02850978|50140010|FG000|Overall Study|Lack of Efficacy|40|||
25039287|NCT02850978|50140010|FG000|Overall Study|Improvement in condition|34|||
25039288|NCT02850978|50140010|FG000|Overall Study|Lost to Follow-up|121|||
25039289|NCT02850978|50140010|FG000|Overall Study|Reason not listed|88|||
25039290|NCT03135431|50140016|FG000|Overall Study|Study Surgeon not available|2|||
25039291|NCT03135431|50140017|FG001|Overall Study|Study Surgeon not available|0|||
25039292|NCT04534517|50140039|FG000|Overall Study|Adverse Event|1|||
25039293|NCT04534517|50140039|FG000|Overall Study|Withdrawal by Subject|1|||
25039294|NCT04534517|50140039|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
24951552|NCT00377676|50042984|FG001|Overall Study|Withdrawal by Subject|72|||
24951553|NCT00377676|50042983|FG000|Overall Study|Lost to Follow-up|120|||
24951554|NCT00377676|50042984|FG001|Overall Study|Lost to Follow-up|56|||
24951555|NCT00377676|50042983|FG000|Overall Study|Other|118|||
24951556|NCT00377676|50042984|FG001|Overall Study|Other|58|||
24951557|NCT00377520|50042990|FG000|Overall Study|Ineligible (Prior radiation)|1|||
24951558|NCT00377364|50042996|FG000|Overall Study|Lost to Follow-up|1|||
25039295|NCT04534517|50140039|FG000|Overall Study|COVID-19 Related|1|||
25039296|NCT02831257|50140043|FG000|Overall Study|Lack of Efficacy|3|||
25039297|NCT02831257|50140043|FG000|Overall Study|Adverse Event|2|||
25039298|NCT02831257|50140043|FG000|Overall Study|Physician Decision|1|||
25039299|NCT02831257|50140043|FG000|Overall Study|Withdrawal by Subject|6|||
25160156|NCT01388907|50280214|FG001|Overall Study|Adverse Event|0|||
25160157|NCT01388361|50280225|FG000|Overall Study|Adverse Event|0|||
25160158|NCT01388361|50280226|FG001|Overall Study|Adverse Event|5|||
25160159|NCT01388361|50280227|FG002|Overall Study|Adverse Event|1|||
25160160|NCT01388361|50280225|FG000|Overall Study|Protocol Violation|0|||
25160161|NCT01388361|50280226|FG001|Overall Study|Protocol Violation|0|||
25160162|NCT01388361|50280227|FG002|Overall Study|Protocol Violation|2|||
24951559|NCT00377364|50042997|FG001|Overall Study|Lost to Follow-up|0|||
24951560|NCT00377364|50042996|FG000|Overall Study|Withdrawal by Subject|1|||
24951561|NCT00377364|50042997|FG001|Overall Study|Withdrawal by Subject|0|||
24951562|NCT03831282|50043005|FG000|Overall Study|Could not place sensor|1|||
25039300|NCT03100825|50140047|FG000|Overall Study|Participant/Guardian Decision|7|||
25039301|NCT03100825|50140047|FG000|Overall Study|Physician Decision|1|||
25039302|NCT02250534|50140054|FG000|Overall Study|Lost to Follow-up|18|||
25039303|NCT02250534|50140055|FG001|Overall Study|Lost to Follow-up|28|||
25160163|NCT01388361|50280225|FG000|Overall Study|Withdrawal criteria|12|||
25039304|NCT02250534|50140056|FG002|Overall Study|Lost to Follow-up|33|||
24951563|NCT00365508|50043011|FG000|Overall Study|Lost to Follow-up|139|||
24951564|NCT00365508|50043012|FG001|Overall Study|Lost to Follow-up|154|||
24951565|NCT00365352|50043021|FG000|Overall Study|Adverse Event|6|||
24951566|NCT00365352|50043022|FG001|Overall Study|Adverse Event|7|||
24951567|NCT00365352|50043023|FG002|Overall Study|Adverse Event|8|||
24951568|NCT00365352|50043021|FG000|Overall Study|Participant Withdrew Consent|8|||
24951569|NCT00365352|50043022|FG001|Overall Study|Participant Withdrew Consent|3|||
24951570|NCT00365352|50043023|FG002|Overall Study|Participant Withdrew Consent|4|||
24951571|NCT00365352|50043021|FG000|Overall Study|Lack of Efficacy|3|||
24951572|NCT00365352|50043022|FG001|Overall Study|Lack of Efficacy|0|||
24951573|NCT00365352|50043023|FG002|Overall Study|Lack of Efficacy|0|||
24951574|NCT00365352|50043021|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
24951575|NCT00365352|50043022|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
24951576|NCT00365352|50043023|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
24951577|NCT00365352|50043021|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
24951578|NCT00365352|50043022|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
24951579|NCT00365352|50043023|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
24951580|NCT00365352|50043021|FG000|Overall Study|Lost to Follow-up|1|||
24951581|NCT00365352|50043022|FG001|Overall Study|Lost to Follow-up|1|||
24951582|NCT00365352|50043023|FG002|Overall Study|Lost to Follow-up|0|||
24951583|NCT00365352|50043021|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
24951584|NCT00365352|50043022|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
24951585|NCT00365352|50043023|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
24951586|NCT00376506|50043036|FG000|Overall Study|Death|0|||
24951587|NCT00376506|50043037|FG001|Overall Study|Death|2|||
24951588|NCT00410384|50043049|FG000|Overall Study|Withdrawal by Subject|28|||
24951589|NCT00410384|50043050|FG001|Overall Study|Withdrawal by Subject|17|||
24951590|NCT00410384|50043051|FG002|Overall Study|Withdrawal by Subject|20|||
24951591|NCT00410384|50043049|FG000|Overall Study|Adverse Event|23|||
24951592|NCT00410384|50043050|FG001|Overall Study|Adverse Event|18|||
24951593|NCT00410384|50043051|FG002|Overall Study|Adverse Event|23|||
24951594|NCT00410384|50043049|FG000|Overall Study|Lack of Efficacy|20|||
24951595|NCT00410384|50043050|FG001|Overall Study|Lack of Efficacy|12|||
24951596|NCT00410384|50043051|FG002|Overall Study|Lack of Efficacy|17|||
24951597|NCT00410384|50043049|FG000|Overall Study|Lack of Compliance|2|||
24951598|NCT00410384|50043050|FG001|Overall Study|Lack of Compliance|2|||
24951599|NCT00410384|50043051|FG002|Overall Study|Lack of Compliance|2|||
24951600|NCT00410384|50043049|FG000|Overall Study|Lost to Follow-up|4|||
24951601|NCT00410384|50043050|FG001|Overall Study|Lost to Follow-up|6|||
24951602|NCT00410384|50043051|FG002|Overall Study|Lost to Follow-up|6|||
24951603|NCT00410384|50043049|FG000|Overall Study|Protocol Violation|6|||
24951604|NCT00410384|50043050|FG001|Overall Study|Protocol Violation|6|||
24951605|NCT00410384|50043051|FG002|Overall Study|Protocol Violation|6|||
24951606|NCT00410384|50043049|FG000|Overall Study|Physician Decision|3|||
24951607|NCT00410384|50043050|FG001|Overall Study|Physician Decision|3|||
24951608|NCT00410384|50043051|FG002|Overall Study|Physician Decision|4|||
24951609|NCT00410384|50043049|FG000|Overall Study|Other|3|||
24951610|NCT00410384|50043050|FG001|Overall Study|Other|8|||
24951611|NCT00410384|50043051|FG002|Overall Study|Other|4|||
24951612|NCT00370032|50043061|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
24951613|NCT00370032|50043062|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
24951614|NCT00370032|50043061|FG000|Washout Period|Withdrawal by Subject|0|||
24951615|NCT00370032|50043062|FG001|Washout Period|Withdrawal by Subject|1|||
24951616|NCT00370032|50043061|FG000|Washout Period|Lost to Follow-up|0|||
24951617|NCT00370032|50043062|FG001|Washout Period|Lost to Follow-up|1|||
24951618|NCT00370032|50043061|FG000|Washout Period|Adverse Event|1|||
24951619|NCT00370032|50043062|FG001|Washout Period|Adverse Event|0|||
24951620|NCT00370032|50043061|FG000|Follow-up Period|Withdrawal by Subject|1|||
24951621|NCT00370032|50043062|FG001|Follow-up Period|Withdrawal by Subject|0|||
24951622|NCT00410072|50043079|FG000|Day 1 to Week 48|Adverse Event|1|||
24951623|NCT00410072|50043080|FG001|Day 1 to Week 48|Adverse Event|2|||
24951624|NCT00410072|50043079|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
24951625|NCT00410072|50043080|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
24951626|NCT00410072|50043079|FG000|Day 1 to Week 48|Other|0|||
24951627|NCT00410072|50043080|FG001|Day 1 to Week 48|Other|1|||
24951628|NCT00410072|50043079|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
24951629|NCT00410072|50043080|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
24951630|NCT00410072|50043079|FG000|Day 1 to Week 48|Pregnancy|0|||
24951631|NCT00410072|50043080|FG001|Day 1 to Week 48|Pregnancy|2|||
24951632|NCT00410072|50043079|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
24951633|NCT00410072|50043080|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
24951634|NCT00410072|50043079|FG000|After Week 48 to Week 96|Adverse Event|1|||
24951635|NCT00410072|50043080|FG001|After Week 48 to Week 96|Adverse Event|2|||
24951636|NCT00410072|50043079|FG000|After Week 48 to Week 96|Death|0|||
24951637|NCT00410072|50043080|FG001|After Week 48 to Week 96|Death|1|||
24951638|NCT00410072|50043079|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
24951639|NCT00410072|50043080|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
24951640|NCT00410072|50043079|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
24951641|NCT00410072|50043080|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
24951642|NCT00410072|50043079|FG000|After Week 48 to Week 96|Other|2|||
24951643|NCT00410072|50043080|FG001|After Week 48 to Week 96|Other|0|||
24951644|NCT00410072|50043079|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
24951645|NCT00410072|50043080|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
24951646|NCT00410072|50043079|FG000|After Week 48 to Week 96|Pregnancy|0|||
24951647|NCT00410072|50043080|FG001|After Week 48 to Week 96|Pregnancy|2|||
24951648|NCT00410072|50043079|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
24951649|NCT00410072|50043080|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
24951650|NCT00409838|50043088|FG000|Short-term Period|Adverse Event|0|||
24951651|NCT00409838|50043089|FG001|Short-term Period|Adverse Event|1|||
24951652|NCT00409838|50043088|FG000|Short-term Period|Lost to Follow-up|0|||
24951653|NCT00409838|50043089|FG001|Short-term Period|Lost to Follow-up|1|||
24951654|NCT00409838|50043088|FG000|Short-term Period|Withdrawal by Subject|2|||
24951655|NCT00409838|50043089|FG001|Short-term Period|Withdrawal by Subject|3|||
24951656|NCT00409838|50043088|FG000|Short-term Period|Never Treated|1|||
24951657|NCT00409838|50043089|FG001|Short-term Period|Never Treated|0|||
24951658|NCT00409838|50043088|FG000|Long-term Extension Period|Adverse Event|10|||
24951659|NCT00409838|50043089|FG001|Long-term Extension Period|Adverse Event|0|||
24951660|NCT00409838|50043088|FG000|Long-term Extension Period|Death|1|||
24951661|NCT00409838|50043089|FG001|Long-term Extension Period|Death|0|||
24951662|NCT00409838|50043088|FG000|Long-term Extension Period|Lack of Efficacy|2|||
24951663|NCT00409838|50043089|FG001|Long-term Extension Period|Lack of Efficacy|0|||
24951664|NCT00409838|50043088|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
24951665|NCT00409838|50043089|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
24951666|NCT00409838|50043088|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
24951667|NCT00409838|50043089|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
24951668|NCT00409838|50043088|FG000|Long-term Extension Period|Pregnancy|1|||
24951669|NCT00409838|50043089|FG001|Long-term Extension Period|Pregnancy|0|||
24951670|NCT00399542|50043114|FG000|Overall Study|Adverse Event|18|||
24951671|NCT00399542|50043115|FG001|Overall Study|Adverse Event|15|||
24951672|NCT00399542|50043114|FG000|Overall Study|Protocol Violation|13|||
24951673|NCT00399542|50043115|FG001|Overall Study|Protocol Violation|3|||
24951674|NCT00399542|50043114|FG000|Overall Study|Withdrawal by Subject|28|||
24951675|NCT00399542|50043115|FG001|Overall Study|Withdrawal by Subject|10|||
24951676|NCT00399542|50043114|FG000|Overall Study|Lack of Efficacy|18|||
24951677|NCT00399542|50043115|FG001|Overall Study|Lack of Efficacy|8|||
24951678|NCT00399542|50043114|FG000|Overall Study|Lost to Follow-up|6|||
24951679|NCT00399542|50043115|FG001|Overall Study|Lost to Follow-up|6|||
24951680|NCT00399542|50043114|FG000|Overall Study|Other|1|||
24951681|NCT00399542|50043115|FG001|Overall Study|Other|0|||
24951682|NCT00399542|50043114|FG000|Overall Study|Physician Decision|0|||
24951683|NCT00399542|50043115|FG001|Overall Study|Physician Decision|1|||
24951684|NCT00409682|50043124|FG000|Open-label Induction Period|Adverse Event|1|||
24951685|NCT00409682|50043125|FG001|Open-label Induction Period|Adverse Event|0|||
24951686|NCT00409682|50043126|FG002|Open-label Induction Period|Adverse Event|0|||
24951687|NCT00409682|50043124|FG000|Open-label Induction Period|Lack of Efficacy|1|||
25160164|NCT01388361|50280226|FG001|Overall Study|Withdrawal criteria|7|||
25160165|NCT01388361|50280227|FG002|Overall Study|Withdrawal criteria|10|||
25160166|NCT01388361|50280225|FG000|Overall Study|Unclassified|0|||
25160167|NCT01388361|50280226|FG001|Overall Study|Unclassified|0|||
25160168|NCT01388361|50280227|FG002|Overall Study|Unclassified|1|||
25160169|NCT01399125|50280237|FG000|Overall Study|Adverse Event|32|||
25160170|NCT01399125|50280238|FG001|Overall Study|Adverse Event|30|||
25160171|NCT01399125|50280237|FG000|Overall Study|Abnormal Lab values|0|||
25160172|NCT01399125|50280238|FG001|Overall Study|Abnormal Lab values|1|||
25160173|NCT01399125|50280237|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
25160174|NCT01399125|50280238|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
25160175|NCT01399125|50280237|FG000|Overall Study|Withdrawal by Subject|5|||
25160176|NCT01399125|50280238|FG001|Overall Study|Withdrawal by Subject|8|||
25160177|NCT01399125|50280237|FG000|Overall Study|Lost to Follow-up|2|||
25160178|NCT01399125|50280238|FG001|Overall Study|Lost to Follow-up|3|||
25160179|NCT01399125|50280237|FG000|Overall Study|Administrative Problems|7|||
25160180|NCT01399125|50280238|FG001|Overall Study|Administrative Problems|11|||
25160181|NCT01399125|50280237|FG000|Overall Study|Death|0|||
25160182|NCT01399125|50280238|FG001|Overall Study|Death|1|||
24951688|NCT00409682|50043125|FG001|Open-label Induction Period|Lack of Efficacy|0|||
24951689|NCT00409682|50043126|FG002|Open-label Induction Period|Lack of Efficacy|0|||
24951690|NCT00409682|50043124|FG000|Open-label Induction Period|Protocol Violation|1|||
24951691|NCT00409682|50043125|FG001|Open-label Induction Period|Protocol Violation|0|||
24951692|NCT00409682|50043126|FG002|Open-label Induction Period|Protocol Violation|0|||
24951693|NCT00409682|50043124|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
24951694|NCT00409682|50043125|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
24951695|NCT00409682|50043126|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
24951696|NCT00409682|50043124|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
24951697|NCT00409682|50043125|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
24951698|NCT00409682|50043126|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
24951699|NCT00409682|50043124|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
24951700|NCT00409682|50043125|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
24951701|NCT00409682|50043126|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
24951702|NCT00409682|50043124|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
24951703|NCT00409682|50043125|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
24951704|NCT00409682|50043126|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
24951705|NCT00409682|50043124|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
25039305|NCT02250534|50140054|FG000|Overall Study|Personal reasons|7|||
25039306|NCT02250534|50140055|FG001|Overall Study|Personal reasons|8|||
25039307|NCT02250534|50140056|FG002|Overall Study|Personal reasons|14|||
25039308|NCT02250534|50140054|FG000|Overall Study|Adverse Event|6|||
25039309|NCT02250534|50140055|FG001|Overall Study|Adverse Event|3|||
24951706|NCT00409682|50043125|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
24951707|NCT00409682|50043126|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
24951708|NCT00409682|50043124|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
24951709|NCT00409682|50043125|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
24951710|NCT00409682|50043126|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
24951711|NCT00409682|50043124|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
24951712|NCT00409682|50043125|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
24951713|NCT00409682|50043126|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
24951714|NCT00398216|50043138|FG000|Overall Study|Adverse Event|4|||
24951715|NCT00398216|50043139|FG001|Overall Study|Adverse Event|2|||
24951716|NCT00398216|50043140|FG002|Overall Study|Adverse Event|5|||
24951717|NCT00398216|50043141|FG003|Overall Study|Adverse Event|7|||
24951718|NCT00398216|50043142|FG004|Overall Study|Adverse Event|2|||
24951719|NCT00398216|50043138|FG000|Overall Study|Protocol Violation|2|||
24951720|NCT00398216|50043139|FG001|Overall Study|Protocol Violation|4|||
24951721|NCT00398216|50043140|FG002|Overall Study|Protocol Violation|5|||
24951722|NCT00398216|50043141|FG003|Overall Study|Protocol Violation|7|||
24951723|NCT00398216|50043142|FG004|Overall Study|Protocol Violation|5|||
24951724|NCT00398216|50043138|FG000|Overall Study|Lost to Follow-up|1|||
24951725|NCT00398216|50043139|FG001|Overall Study|Lost to Follow-up|6|||
24951726|NCT00398216|50043140|FG002|Overall Study|Lost to Follow-up|4|||
24951727|NCT00398216|50043141|FG003|Overall Study|Lost to Follow-up|4|||
24951728|NCT00398216|50043142|FG004|Overall Study|Lost to Follow-up|1|||
24951729|NCT00398216|50043138|FG000|Overall Study|Death|0|||
24951730|NCT00398216|50043139|FG001|Overall Study|Death|3|||
24951731|NCT00398216|50043140|FG002|Overall Study|Death|0|||
24951732|NCT00398216|50043141|FG003|Overall Study|Death|0|||
24951733|NCT00398216|50043142|FG004|Overall Study|Death|0|||
24951734|NCT00398216|50043138|FG000|Overall Study|Withdrawal by Subject|1|||
24951735|NCT00398216|50043139|FG001|Overall Study|Withdrawal by Subject|0|||
24951736|NCT00398216|50043140|FG002|Overall Study|Withdrawal by Subject|3|||
24951737|NCT00398216|50043141|FG003|Overall Study|Withdrawal by Subject|1|||
24951738|NCT00398216|50043142|FG004|Overall Study|Withdrawal by Subject|2|||
24951739|NCT00398216|50043138|FG000|Overall Study|administrative reasons|3|||
24951740|NCT00398216|50043139|FG001|Overall Study|administrative reasons|4|||
25039310|NCT02250534|50140056|FG002|Overall Study|Adverse Event|8|||
25039311|NCT02250534|50140054|FG000|Overall Study|incarcerated|2|||
25039312|NCT02250534|50140055|FG001|Overall Study|incarcerated|1|||
24951741|NCT00398216|50043140|FG002|Overall Study|administrative reasons|4|||
25039313|NCT02250534|50140056|FG002|Overall Study|incarcerated|2|||
24951742|NCT00398216|50043141|FG003|Overall Study|administrative reasons|3|||
25039314|NCT02250534|50140054|FG000|Overall Study|Withdrawal by Subject|0|||
25039315|NCT02250534|50140055|FG001|Overall Study|Withdrawal by Subject|1|||
25039316|NCT02250534|50140056|FG002|Overall Study|Withdrawal by Subject|2|||
25039317|NCT02250534|50140054|FG000|Overall Study|Death|0|||
24951743|NCT00398216|50043142|FG004|Overall Study|administrative reasons|3|||
24951744|NCT00398216|50043138|FG000|Overall Study|entrance criteria|0|||
24951745|NCT00398216|50043139|FG001|Overall Study|entrance criteria|0|||
24951746|NCT00398216|50043140|FG002|Overall Study|entrance criteria|0|||
24951747|NCT00398216|50043141|FG003|Overall Study|entrance criteria|0|||
24951748|NCT00398216|50043142|FG004|Overall Study|entrance criteria|2|||
24951749|NCT00398138|50043154|FG000|Overall Study|Adverse Event|2|||
24951750|NCT00397982|50043158|FG000|Overall Study|Withdrawal by Subject|1|||
24951751|NCT00397982|50043158|FG000|Overall Study|Adverse Event|1|||
24951752|NCT00397982|50043158|FG000|Overall Study|noncompliance|1|||
24951753|NCT00397982|50043158|FG000|Overall Study|Unrelated health issues|1|||
24951754|NCT00408902|50043163|FG000|Overall Study|Lack of Efficacy|7|||
24951755|NCT00408902|50043163|FG000|Overall Study|Adverse Event|3|||
24951756|NCT00397514|50043168|FG000|Overall Study|Withdrawal by Subject|1|||
24951757|NCT00397514|50043168|FG000|Overall Study|Pacing wire malfunction|1|||
24951758|NCT00397514|50043168|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
24951759|NCT00397514|50043168|FG000|Overall Study|early extubation|2|||
24951760|NCT00397514|50043168|FG000|Overall Study|poor echocardiographic windows|1|||
24951761|NCT00397046|50043182|FG000|Overall Study|Disease Progression|3|||
24951762|NCT00397046|50043183|FG001|Overall Study|Disease Progression|3|||
24951763|NCT00397046|50043184|FG002|Overall Study|Disease Progression|10|||
24951764|NCT00397046|50043185|FG003|Overall Study|Disease Progression|5|||
24951765|NCT00396812|50043196|FG000|Overall Study|Physician Decision|1|||
25039318|NCT02250534|50140055|FG001|Overall Study|Death|1|||
25039319|NCT02250534|50140056|FG002|Overall Study|Death|1|||
25039320|NCT02250534|50140054|FG000|Overall Study|Physician Decision|1|||
25039321|NCT02250534|50140055|FG001|Overall Study|Physician Decision|3|||
25039322|NCT02250534|50140056|FG002|Overall Study|Physician Decision|1|||
25039323|NCT02250534|50140054|FG000|Overall Study|Protocol Violation|1|||
25039324|NCT02250534|50140055|FG001|Overall Study|Protocol Violation|0|||
24951766|NCT00396656|50043200|FG000|First Treatment Period|Withdrawal by Subject|0|||
24951767|NCT00396656|50043201|FG001|First Treatment Period|Withdrawal by Subject|2|||
24951768|NCT00396656|50043200|FG000|Second Treatment Period|Adverse Event|0|||
24951769|NCT00396656|50043201|FG001|Second Treatment Period|Adverse Event|1|||
24951770|NCT00408434|50043214|FG000|Overall Study|Adverse Event|0|||
24951771|NCT00408434|50043215|FG001|Overall Study|Adverse Event|0|||
24951772|NCT00408434|50043216|FG002|Overall Study|Adverse Event|1|||
24951773|NCT00408434|50043217|FG003|Overall Study|Adverse Event|0|||
24951774|NCT00408434|50043218|FG004|Overall Study|Adverse Event|0|||
24951775|NCT00408434|50043219|FG005|Overall Study|Adverse Event|0|||
24951776|NCT00408434|50043220|FG006|Overall Study|Adverse Event|0|||
24951777|NCT00408434|50043214|FG000|Overall Study|Progressive disease|6|||
24951778|NCT00408434|50043215|FG001|Overall Study|Progressive disease|3|||
24951779|NCT00408434|50043216|FG002|Overall Study|Progressive disease|4|||
24951780|NCT00408434|50043217|FG003|Overall Study|Progressive disease|3|||
24951781|NCT00408434|50043218|FG004|Overall Study|Progressive disease|3|||
25039325|NCT02250534|50140056|FG002|Overall Study|Protocol Violation|1|||
25039326|NCT02250534|50140054|FG000|Overall Study|Reason unknown|1|||
25039327|NCT02250534|50140055|FG001|Overall Study|Reason unknown|0|||
25039328|NCT02250534|50140056|FG002|Overall Study|Reason unknown|0|||
24951782|NCT00408434|50043219|FG005|Overall Study|Progressive disease|1|||
24951783|NCT00408434|50043220|FG006|Overall Study|Progressive disease|4|||
24951784|NCT00408434|50043214|FG000|Overall Study|Other|0|||
25039329|NCT02848326|50140070|FG000|Treatment Period|Adverse Event|5|||
25039330|NCT02848326|50140071|FG001|Treatment Period|Adverse Event|4|||
25039331|NCT02848326|50140072|FG002|Treatment Period|Adverse Event|11|||
25039332|NCT02848326|50140073|FG003|Treatment Period|Adverse Event|6|||
25039333|NCT02848326|50140074|FG004|Treatment Period|Adverse Event|5|||
25039334|NCT02848326|50140075|FG005|Treatment Period|Adverse Event|7|||
25039335|NCT02848326|50140070|FG000|Treatment Period|Withdrawal of Consent|20|||
25039336|NCT02848326|50140071|FG001|Treatment Period|Withdrawal of Consent|6|||
25039337|NCT02848326|50140072|FG002|Treatment Period|Withdrawal of Consent|9|||
25039338|NCT02848326|50140073|FG003|Treatment Period|Withdrawal of Consent|6|||
25039339|NCT02848326|50140074|FG004|Treatment Period|Withdrawal of Consent|9|||
25039340|NCT02848326|50140075|FG005|Treatment Period|Withdrawal of Consent|6|||
25039341|NCT02848326|50140070|FG000|Treatment Period|Lost to Follow-up|5|||
25039342|NCT02848326|50140071|FG001|Treatment Period|Lost to Follow-up|1|||
25039343|NCT02848326|50140072|FG002|Treatment Period|Lost to Follow-up|11|||
25039344|NCT02848326|50140073|FG003|Treatment Period|Lost to Follow-up|7|||
25039345|NCT02848326|50140074|FG004|Treatment Period|Lost to Follow-up|2|||
25039346|NCT02848326|50140075|FG005|Treatment Period|Lost to Follow-up|3|||
24951785|NCT00408434|50043215|FG001|Overall Study|Other|0|||
25039347|NCT02848326|50140070|FG000|Treatment Period|Pregnancy|0|||
25039348|NCT02848326|50140071|FG001|Treatment Period|Pregnancy|0|||
25039349|NCT02848326|50140072|FG002|Treatment Period|Pregnancy|1|||
25039350|NCT02848326|50140073|FG003|Treatment Period|Pregnancy|1|||
25039351|NCT02848326|50140074|FG004|Treatment Period|Pregnancy|0|||
25039352|NCT02848326|50140075|FG005|Treatment Period|Pregnancy|1|||
25039353|NCT02848326|50140070|FG000|Treatment Period|Protocol Violation|4|||
24951786|NCT00408434|50043216|FG002|Overall Study|Other|1|||
24951787|NCT00408434|50043217|FG003|Overall Study|Other|0|||
24951788|NCT00408434|50043218|FG004|Overall Study|Other|2|||
24951789|NCT00408434|50043219|FG005|Overall Study|Other|1|||
24951790|NCT00408434|50043220|FG006|Overall Study|Other|0|||
24951791|NCT00408434|50043214|FG000|Overall Study|Terminated by Investigator|0|||
24951792|NCT00408434|50043215|FG001|Overall Study|Terminated by Investigator|0|||
25160183|NCT01399125|50280237|FG000|Overall Study|Protocol Deviation|5|||
24951793|NCT00408434|50043216|FG002|Overall Study|Terminated by Investigator|0|||
24951794|NCT00408434|50043217|FG003|Overall Study|Terminated by Investigator|0|||
24951795|NCT00408434|50043218|FG004|Overall Study|Terminated by Investigator|1|||
24951796|NCT00408434|50043219|FG005|Overall Study|Terminated by Investigator|1|||
24951797|NCT00408434|50043220|FG006|Overall Study|Terminated by Investigator|0|||
24951798|NCT00418886|50043239|FG000|Overall Study|discontinue treatment survival follow up|90|||
25039354|NCT02848326|50140071|FG001|Treatment Period|Protocol Violation|3|||
25039355|NCT02848326|50140072|FG002|Treatment Period|Protocol Violation|4|||
24951799|NCT00418886|50043240|FG001|Overall Study|discontinue treatment survival follow up|91|||
24951800|NCT00418886|50043239|FG000|Overall Study|Death|122|||
24951801|NCT00418886|50043240|FG001|Overall Study|Death|147|||
24951802|NCT00418886|50043239|FG000|Overall Study|Withdrawal by Subject|9|||
25039356|NCT02848326|50140073|FG003|Treatment Period|Protocol Violation|2|||
25039357|NCT02848326|50140074|FG004|Treatment Period|Protocol Violation|3|||
25039358|NCT02848326|50140075|FG005|Treatment Period|Protocol Violation|3|||
25039359|NCT02848326|50140070|FG000|Treatment Period|Non-compliance with Study Drug|4|||
24951803|NCT00418886|50043240|FG001|Overall Study|Withdrawal by Subject|10|||
24951804|NCT00418886|50043239|FG000|Overall Study|Lost to Follow-up|4|||
24951805|NCT00418886|50043240|FG001|Overall Study|Lost to Follow-up|6|||
24951806|NCT00418886|50043239|FG000|Overall Study|withdrawn due to other reason|1|||
24951807|NCT00418886|50043240|FG001|Overall Study|withdrawn due to other reason|0|||
24951808|NCT00418886|50043239|FG000|Overall Study|randomised but no treatment received|0|||
24951809|NCT00418886|50043240|FG001|Overall Study|randomised but no treatment received|1|||
24951810|NCT00418184|50043248|FG000|Double-blind Phase|Withdrawal by Subject|22|||
24951811|NCT00418184|50043249|FG001|Double-blind Phase|Withdrawal by Subject|9|||
24951812|NCT00418184|50043248|FG000|Double-blind Phase|Adverse Event|2|||
24951813|NCT00418184|50043249|FG001|Double-blind Phase|Adverse Event|1|||
24951814|NCT00418184|50043248|FG000|Double-blind Phase|Poor compliance|3|||
24951815|NCT00418184|50043249|FG001|Double-blind Phase|Poor compliance|1|||
24951816|NCT00407030|50043258|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
24951817|NCT00407030|50043259|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
24951818|NCT00407030|50043260|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
24951819|NCT00407030|50043258|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
24951820|NCT00407030|50043259|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
24951821|NCT00407030|50043260|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
24951822|NCT00407030|50043258|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
24951823|NCT00407030|50043259|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
24951824|NCT00407030|50043260|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
25039360|NCT02848326|50140071|FG001|Treatment Period|Non-compliance with Study Drug|0|||
24951825|NCT00407030|50043258|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
24951826|NCT00407030|50043259|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
25039361|NCT02848326|50140072|FG002|Treatment Period|Non-compliance with Study Drug|0|||
25039362|NCT02848326|50140073|FG003|Treatment Period|Non-compliance with Study Drug|1|||
25039363|NCT02848326|50140074|FG004|Treatment Period|Non-compliance with Study Drug|0|||
25039364|NCT02848326|50140075|FG005|Treatment Period|Non-compliance with Study Drug|0|||
25039365|NCT02848326|50140070|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
25039366|NCT02848326|50140071|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
25039367|NCT02848326|50140072|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
25039368|NCT02848326|50140073|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
25039369|NCT02848326|50140074|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
25039370|NCT02848326|50140075|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
25039371|NCT02848326|50140070|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
25039372|NCT02848326|50140071|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
25039373|NCT02848326|50140072|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
25039374|NCT02848326|50140073|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
25039375|NCT02848326|50140074|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
25039376|NCT02848326|50140075|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
25039377|NCT03128723|50140089|FG000|Overall Study|Withdrawal by Subject|2|||
25039378|NCT03128411|50140093|FG000|Treatment Phase|Adverse Event|21|||
25039379|NCT03128411|50140093|FG000|Treatment Phase|Physician Decision|1|||
25039380|NCT03128411|50140093|FG000|Treatment Phase|Other|2|||
25039381|NCT03128411|50140093|FG000|Long Term Follow-up Phase|Death|2|||
25039382|NCT02847858|50140099|FG000|Overall Study|Lost to Follow-up|401|||
25039383|NCT02847858|50140100|FG001|Overall Study|Lost to Follow-up|269|||
25039384|NCT03124199|50140111|FG000|Overall Study|Lost to Follow-up|4|||
25039385|NCT04465916|50140117|FG000|Overall Study|Withdrawal by Subject|0|||
25039386|NCT04465916|50140118|FG001|Overall Study|Withdrawal by Subject|1|||
25039387|NCT05090852|50140124|FG000|Overall Study|Physician Decision|5|||
25160184|NCT01399125|50280238|FG001|Overall Study|Protocol Deviation|2|||
24951827|NCT00407030|50043260|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
24951828|NCT00407030|50043258|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
24951829|NCT00407030|50043259|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
24951830|NCT00407030|50043260|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
24951831|NCT00407030|50043258|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
24951832|NCT00407030|50043259|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
24951833|NCT00407030|50043260|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
24951834|NCT00407030|50043258|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
24951835|NCT00407030|50043259|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
24951836|NCT00407030|50043260|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
24951837|NCT00407030|50043258|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
24951838|NCT00407030|50043259|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
24951839|NCT00407030|50043260|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
24951840|NCT00407030|50043258|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
24951841|NCT00407030|50043259|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
24951842|NCT00407030|50043260|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
24951843|NCT00407030|50043258|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
24951844|NCT00407030|50043259|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
24951845|NCT00407030|50043260|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
24951846|NCT00407030|50043258|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
24951847|NCT00407030|50043259|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
24951848|NCT00407030|50043260|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
24951849|NCT00407030|50043258|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
24951850|NCT00407030|50043259|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
24951851|NCT00407030|50043260|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
24951852|NCT00407030|50043258|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
24951853|NCT00407030|50043259|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
24951854|NCT00407030|50043260|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
24951855|NCT00406718|50043273|FG000|Overall Study|Withdrawal by Subject|2|||
24951856|NCT00406718|50043274|FG001|Overall Study|Withdrawal by Subject|9|||
24951857|NCT00406718|50043275|FG002|Overall Study|Withdrawal by Subject|4|||
24951858|NCT00406718|50043273|FG000|Overall Study|Lost to Follow-up|2|||
24951859|NCT00406718|50043274|FG001|Overall Study|Lost to Follow-up|5|||
24951860|NCT00406718|50043275|FG002|Overall Study|Lost to Follow-up|4|||
24951861|NCT00406640|50043287|FG000|Acute Phase|Adverse Event|18|||
24951862|NCT00406640|50043288|FG001|Acute Phase|Adverse Event|13|||
24951863|NCT00406640|50043287|FG000|Acute Phase|Failed to Return|5|||
24951864|NCT00406640|50043288|FG001|Acute Phase|Failed to Return|1|||
24951865|NCT00406640|50043287|FG000|Acute Phase|Physician Decision|0|||
24951866|NCT00406640|50043288|FG001|Acute Phase|Physician Decision|1|||
24951867|NCT00406640|50043287|FG000|Acute Phase|Lost to Follow-up|7|||
24951868|NCT00406640|50043288|FG001|Acute Phase|Lost to Follow-up|4|||
24951869|NCT00406640|50043287|FG000|Acute Phase|Protocol deviation|4|||
25039388|NCT00075816|50140139|FG000|Overall Study|Did not undergo transplantation|14|||
25039389|NCT00075816|50140140|FG001|Overall Study|Did not undergo transplantation|11|||
25039390|NCT00109772|50140154|FG000|Double-blind Treatment|Adverse Event|14|||
25039391|NCT00109772|50140155|FG001|Double-blind Treatment|Adverse Event|5|||
25039392|NCT00109772|50140154|FG000|Double-blind Treatment|Lack of Efficacy|1|||
25039393|NCT00109772|50140155|FG001|Double-blind Treatment|Lack of Efficacy|0|||
25039394|NCT00109772|50140154|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
25039395|NCT00109772|50140155|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
25039396|NCT00109772|50140154|FG000|Double-blind Treatment|Lost to Follow-up|2|||
25039397|NCT00109772|50140155|FG001|Double-blind Treatment|Lost to Follow-up|3|||
25039398|NCT00109772|50140154|FG000|Double-blind Treatment|Protocol Violation|0|||
25039399|NCT00109772|50140155|FG001|Double-blind Treatment|Protocol Violation|1|||
24951870|NCT00406640|50043288|FG001|Acute Phase|Protocol deviation|10|||
24951871|NCT00406640|50043287|FG000|Acute Phase|Protocol Violation|3|||
24951872|NCT00406640|50043288|FG001|Acute Phase|Protocol Violation|2|||
24951873|NCT00406640|50043287|FG000|Acute Phase|Withdrawal by Subject|11|||
24951874|NCT00406640|50043288|FG001|Acute Phase|Withdrawal by Subject|9|||
24951875|NCT00406640|50043287|FG000|Acute Phase|Lack of Efficacy|3|||
24951876|NCT00406640|50043288|FG001|Acute Phase|Lack of Efficacy|3|||
24951877|NCT00406640|50043287|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
25039400|NCT00109772|50140154|FG000|Double-blind Treatment|Other|0|||
25039401|NCT00109772|50140155|FG001|Double-blind Treatment|Other|4|||
25039402|NCT00109772|50140154|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
25039403|NCT00109772|50140155|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
25039404|NCT00109772|50140154|FG000|Open-label Extension|Adverse Event|10|||
24951878|NCT00406640|50043288|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
25039405|NCT00109772|50140155|FG001|Open-label Extension|Adverse Event|19|||
25039406|NCT00109772|50140154|FG000|Open-label Extension|Lack of Efficacy|19|||
25039407|NCT00109772|50140155|FG001|Open-label Extension|Lack of Efficacy|11|||
24951879|NCT00406640|50043287|FG000|DB Continuation Phase for Responders|Death|1|||
24951880|NCT00406640|50043288|FG001|DB Continuation Phase for Responders|Death|0|||
24951881|NCT00406640|50043287|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
24951882|NCT00406640|50043288|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
24951883|NCT00406640|50043287|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
24951884|NCT00406640|50043288|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
24951885|NCT00406640|50043287|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
24951886|NCT00406640|50043288|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
24951887|NCT00406640|50043287|FG000|DB Continuation Phase for Responders|non-compliance|7|||
24951888|NCT00406640|50043288|FG001|DB Continuation Phase for Responders|non-compliance|5|||
24951889|NCT00406640|50043287|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
24951890|NCT00406640|50043288|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
24951891|NCT00406640|50043287|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
24951892|NCT00406640|50043288|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
24951893|NCT00406640|50043287|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
24951894|NCT00406640|50043288|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
24951895|NCT00406640|50043287|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
24951896|NCT00406640|50043288|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
24951897|NCT00406640|50043287|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
24951898|NCT00406640|50043288|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
24951899|NCT00406640|50043287|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
24951900|NCT00406640|50043288|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
24951901|NCT00406640|50043287|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
25186309|NCT01457924|50336265|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
25275829|NCT00898807|50589731|FG000|Overall Study|Family pressure to discontinue|2|||
25275830|NCT00898807|50589732|FG001|Overall Study|Family pressure to discontinue|2|||
25275831|NCT00898807|50589731|FG000|Overall Study|Lost to Follow-up|1|||
25275832|NCT00898807|50589732|FG001|Overall Study|Lost to Follow-up|3|||
25275833|NCT00898807|50589731|FG000|Overall Study|Death|0|||
25275834|NCT00898807|50589732|FG001|Overall Study|Death|1|||
24951902|NCT00406640|50043288|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
24951903|NCT00406640|50043287|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
24951904|NCT00406640|50043288|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
24951905|NCT00406640|50043287|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
24951906|NCT00406640|50043288|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
24951907|NCT00406640|50043287|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
24951908|NCT00406640|50043288|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
24951909|NCT00394706|50043308|FG000|Overall Study|Withdrawal by Subject|2|||
24951910|NCT00394706|50043309|FG001|Overall Study|Withdrawal by Subject|0|||
24951911|NCT00394706|50043310|FG002|Overall Study|Withdrawal by Subject|1|||
24951912|NCT00394706|50043311|FG003|Overall Study|Withdrawal by Subject|0|||
24951913|NCT00394706|50043312|FG004|Overall Study|Withdrawal by Subject|0|||
24951914|NCT00394706|50043313|FG005|Overall Study|Withdrawal by Subject|2|||
24951915|NCT00394706|50043314|FG006|Overall Study|Withdrawal by Subject|1|||
24951916|NCT00394706|50043315|FG007|Overall Study|Withdrawal by Subject|0|||
24951917|NCT00394706|50043308|FG000|Overall Study|Lost to Follow-up|2|||
24951918|NCT00394706|50043309|FG001|Overall Study|Lost to Follow-up|2|||
24951919|NCT00394706|50043310|FG002|Overall Study|Lost to Follow-up|8|||
24951920|NCT00394706|50043311|FG003|Overall Study|Lost to Follow-up|1|||
24951921|NCT00394706|50043312|FG004|Overall Study|Lost to Follow-up|2|||
24951922|NCT00394706|50043313|FG005|Overall Study|Lost to Follow-up|5|||
24951923|NCT00394706|50043314|FG006|Overall Study|Lost to Follow-up|2|||
24951924|NCT00394706|50043315|FG007|Overall Study|Lost to Follow-up|0|||
24951925|NCT00394472|50043331|FG000|Overall Study|Protocol Violation|1|||
24951926|NCT00394472|50043332|FG001|Overall Study|Protocol Violation|3|||
24951927|NCT00394472|50043331|FG000|Overall Study|incorrect enrolment|4|||
24951928|NCT00394472|50043332|FG001|Overall Study|incorrect enrolment|2|||
24951929|NCT00394472|50043331|FG000|Overall Study|Adverse Event|4|||
24951930|NCT00394472|50043332|FG001|Overall Study|Adverse Event|2|||
24951931|NCT00394472|50043331|FG000|Overall Study|Withdrawal by Subject|0|||
24951932|NCT00394472|50043332|FG001|Overall Study|Withdrawal by Subject|2|||
24951933|NCT00394472|50043331|FG000|Overall Study|Physician Decision|0|||
24951934|NCT00394472|50043332|FG001|Overall Study|Physician Decision|1|||
24951935|NCT00394472|50043331|FG000|Overall Study|Lost to Follow-up|0|||
24951936|NCT00394472|50043332|FG001|Overall Study|Lost to Follow-up|1|||
24951937|NCT00419120|50043338|FG000|Long Term Follow up Period|study ongoing|10|||
25186310|NCT01457924|50336266|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
25186311|NCT01457924|50336267|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
25186312|NCT01457924|50336263|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
25186313|NCT01457924|50336264|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
25186314|NCT01457924|50336265|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
25186315|NCT01457924|50336266|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
25186316|NCT01457924|50336267|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
25186317|NCT01457924|50336263|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
25186318|NCT01457924|50336264|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
25275835|NCT01229267|50589743|FG000|Overall Study|Adverse Event|4|||
24951938|NCT00395642|50043342|FG000|Overall Study|Death|4|||
24951939|NCT00395642|50043342|FG000|Overall Study|Lost to Follow-up|1|||
24951940|NCT00395642|50043342|FG000|Overall Study|Physician Decision|7|||
24951941|NCT00395642|50043342|FG000|Overall Study|Withdrawal by Subject|1|||
24951942|NCT00395486|50043348|FG000|Overall Study|Adverse Event|1|||
25039408|NCT00109772|50140154|FG000|Open-label Extension|Withdrawal by Subject|9|||
24951943|NCT00395486|50043349|FG001|Overall Study|Adverse Event|2|||
24951944|NCT00395486|50043348|FG000|Overall Study|Withdrawal by Subject|5|||
25039409|NCT00109772|50140155|FG001|Open-label Extension|Withdrawal by Subject|6|||
24951945|NCT00395486|50043349|FG001|Overall Study|Withdrawal by Subject|2|||
25039410|NCT00109772|50140154|FG000|Open-label Extension|Lost to Follow-up|1|||
25039411|NCT00109772|50140155|FG001|Open-label Extension|Lost to Follow-up|0|||
25039412|NCT00109772|50140154|FG000|Open-label Extension|Death|0|||
25186319|NCT01457924|50336265|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
25275836|NCT01229267|50589744|FG001|Overall Study|Adverse Event|6|||
25275837|NCT01229267|50589745|FG002|Overall Study|Adverse Event|3|||
25275838|NCT01229267|50589746|FG003|Overall Study|Adverse Event|2|||
25275839|NCT01229267|50589747|FG004|Overall Study|Adverse Event|10|||
25275840|NCT01229267|50589743|FG000|Overall Study|Death|40|||
25275841|NCT01229267|50589744|FG001|Overall Study|Death|37|||
25275842|NCT01229267|50589745|FG002|Overall Study|Death|35|||
25275843|NCT01229267|50589746|FG003|Overall Study|Death|13|||
25275844|NCT01229267|50589747|FG004|Overall Study|Death|103|||
25275845|NCT01229267|50589743|FG000|Overall Study|Withdrawal by Subject|23|||
25275846|NCT01229267|50589744|FG001|Overall Study|Withdrawal by Subject|22|||
25275847|NCT01229267|50589745|FG002|Overall Study|Withdrawal by Subject|32|||
25275848|NCT01229267|50589746|FG003|Overall Study|Withdrawal by Subject|14|||
25275849|NCT01229267|50589747|FG004|Overall Study|Withdrawal by Subject|59|||
25275850|NCT01229267|50589743|FG000|Overall Study|Protocol Violation|0|||
25275851|NCT01229267|50589744|FG001|Overall Study|Protocol Violation|1|||
25275852|NCT01229267|50589745|FG002|Overall Study|Protocol Violation|0|||
25275853|NCT01229267|50589746|FG003|Overall Study|Protocol Violation|0|||
25275854|NCT01229267|50589747|FG004|Overall Study|Protocol Violation|0|||
25275855|NCT01229267|50589743|FG000|Overall Study|Progressive disease|0|||
25275856|NCT01229267|50589744|FG001|Overall Study|Progressive disease|0|||
25275857|NCT01229267|50589745|FG002|Overall Study|Progressive disease|0|||
25275858|NCT01229267|50589746|FG003|Overall Study|Progressive disease|0|||
25275859|NCT01229267|50589747|FG004|Overall Study|Progressive disease|1|||
25275860|NCT01229267|50589743|FG000|Overall Study|Physician Decision|8|||
25275861|NCT01229267|50589744|FG001|Overall Study|Physician Decision|11|||
25275862|NCT01229267|50589745|FG002|Overall Study|Physician Decision|8|||
25275863|NCT01229267|50589746|FG003|Overall Study|Physician Decision|3|||
25275864|NCT01229267|50589747|FG004|Overall Study|Physician Decision|25|||
25275865|NCT01229267|50589743|FG000|Overall Study|Lost to Follow-up|6|||
25275866|NCT01229267|50589744|FG001|Overall Study|Lost to Follow-up|5|||
25275867|NCT01229267|50589745|FG002|Overall Study|Lost to Follow-up|8|||
25275868|NCT01229267|50589746|FG003|Overall Study|Lost to Follow-up|3|||
25275869|NCT01229267|50589747|FG004|Overall Study|Lost to Follow-up|22|||
25275870|NCT00897715|50589756|FG000|Overall Study|Lost to Follow-up|0|||
25275871|NCT00897715|50589757|FG001|Overall Study|Lost to Follow-up|1|||
25275872|NCT00897715|50589756|FG000|Overall Study|Physician Decision|1|||
24951946|NCT00395486|50043348|FG000|Overall Study|Lost to Follow-up|0|||
24951947|NCT00395486|50043349|FG001|Overall Study|Lost to Follow-up|1|||
25186320|NCT01457924|50336266|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
25186321|NCT01457924|50336267|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
25186322|NCT01399619|50336288|FG000|Overall Study|Adverse Event|10|||
25186323|NCT01399619|50336289|FG001|Overall Study|Adverse Event|0|||
25186324|NCT01399619|50336290|FG002|Overall Study|Adverse Event|4|||
25186325|NCT01399619|50336291|FG003|Overall Study|Adverse Event|10|||
25186326|NCT01399619|50336288|FG000|Overall Study|Lack of Efficacy|9|||
25186327|NCT01399619|50336289|FG001|Overall Study|Lack of Efficacy|0|||
25275873|NCT00897715|50589757|FG001|Overall Study|Physician Decision|0|||
25275874|NCT00897715|50589756|FG000|Overall Study|increased risk of infection|1|||
25275875|NCT00897715|50589757|FG001|Overall Study|increased risk of infection|0|||
25275876|NCT01229111|50589763|FG000|Overall Study|Death|1|||
25275877|NCT00894361|50589769|FG000|Overall Study|deaths and less than 2 years followup|24|||
25275878|NCT00894361|50589770|FG001|Overall Study|deaths and less than 2 years followup|64|||
25275879|NCT01228175|50589780|FG000|Overall Study|Lost to Follow-up|64|||
25275880|NCT01228175|50589781|FG001|Overall Study|Lost to Follow-up|50|||
25275881|NCT01228175|50589780|FG000|Overall Study|Withdrawal by Subject|1|||
25275882|NCT01228175|50589781|FG001|Overall Study|Withdrawal by Subject|2|||
25275883|NCT01228175|50589780|FG000|Overall Study|Physician Decision|1|||
25275884|NCT01228175|50589781|FG001|Overall Study|Physician Decision|1|||
25275885|NCT01228019|50589787|FG000|Overall Study|Dose Violation|70|||
25275886|NCT01228019|50589787|FG000|Overall Study|Duplicate enrollment|1|||
25275887|NCT01228019|50589787|FG000|Overall Study|Missing pre-treatment data|72|||
25275888|NCT01228019|50589787|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
25275889|NCT01228019|50589787|FG000|Overall Study|Violation of Entry Criterion|9|||
25275890|NCT02987959|50589791|FG000|Overall Study|Grantor stopped supply of drugs|6|||
25275891|NCT01227707|50589795|FG000|Overall Study|Adverse Event|10|||
25275892|NCT01227707|50589795|FG000|Overall Study|Progression of disease|3|||
25275893|NCT01227707|50589795|FG000|Overall Study|Withdrawal by Subject|1|||
25275894|NCT01227707|50589795|FG000|Overall Study|Patient non-compliance|3|||
25275895|NCT01227707|50589795|FG000|Overall Study|Medical decision|6|||
25275896|NCT01227707|50589795|FG000|Overall Study|Death|1|||
25275897|NCT00895843|50589801|FG000|Overall Study|Protocol Violation|12|||
25275898|NCT00895843|50589802|FG001|Overall Study|Protocol Violation|12|||
25275899|NCT00895453|50589811|FG000|Overall Study|Lost to Follow-up|25|||
25275900|NCT00895453|50589812|FG001|Overall Study|Lost to Follow-up|25|||
25275901|NCT00895453|50589813|FG002|Overall Study|Lost to Follow-up|23|||
25275902|NCT00893971|50589821|FG000|Overall Study|Physician Decision|3|||
25275903|NCT00893737|50589834|FG000|Overall Study|Adverse Event|4|||
25275904|NCT00893737|50589834|FG000|Overall Study|Withdrawal by Subject|2|||
25275905|NCT00893737|50589834|FG000|Overall Study|Lost to Follow-up|6|||
25275906|NCT00893113|50589840|FG000|Overall Study|Lost to Follow-up|4|||
25275907|NCT00893113|50589841|FG001|Overall Study|Lost to Follow-up|8|||
25275908|NCT00893113|50589840|FG000|Overall Study|Early Termination|1|||
25275909|NCT00893113|50589841|FG001|Overall Study|Early Termination|1|||
25275910|NCT00893113|50589840|FG000|Overall Study|Withdrew Consent|8|||
25275911|NCT00893113|50589841|FG001|Overall Study|Withdrew Consent|7|||
25275912|NCT00892957|50589849|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
25275913|NCT00892957|50589850|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
25275914|NCT00892957|50589849|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
25275915|NCT00892957|50589850|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
25275916|NCT00968812|50589873|FG000|Overall Study|Adverse Event|30|||
25275917|NCT00968812|50589874|FG001|Overall Study|Adverse Event|46|||
25275918|NCT00968812|50589875|FG002|Overall Study|Adverse Event|33|||
25275919|NCT00968812|50589873|FG000|Overall Study|Death|2|||
25275920|NCT00968812|50589874|FG001|Overall Study|Death|2|||
25275921|NCT00968812|50589875|FG002|Overall Study|Death|1|||
25275922|NCT00968812|50589873|FG000|Overall Study|Lack of Efficacy|9|||
25275923|NCT00968812|50589874|FG001|Overall Study|Lack of Efficacy|7|||
25275924|NCT00968812|50589875|FG002|Overall Study|Lack of Efficacy|16|||
25275925|NCT00968812|50589873|FG000|Overall Study|Lost to Follow-up|17|||
25275926|NCT00968812|50589874|FG001|Overall Study|Lost to Follow-up|12|||
24951948|NCT00395018|50043355|FG000|On-Treatment|Death|4|||
24951949|NCT00395018|50043355|FG000|On-Treatment|Other Reason|2|||
24951950|NCT00395018|50043355|FG000|On-Treatment|Poor/non-compliance|2|||
24951951|NCT00395018|50043355|FG000|On-Treatment|Subject no longer meets study criteria|2|||
24951952|NCT00395018|50043355|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
24951953|NCT00395018|50043355|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
24951954|NCT00395018|50043355|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
24951955|NCT00375518|50043361|FG000|Overall Study|Withdrawal by Subject|2|||
24951956|NCT00375518|50043362|FG001|Overall Study|Withdrawal by Subject|10|||
24951957|NCT00375518|50043361|FG000|Overall Study|Patient Not Treated|6|||
24951958|NCT00375518|50043362|FG001|Overall Study|Patient Not Treated|6|||
24951959|NCT00375518|50043361|FG000|Overall Study|Death|0|||
24951960|NCT00375518|50043362|FG001|Overall Study|Death|1|||
24951961|NCT00256750|50043371|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
24951962|NCT00256750|50043372|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
24951963|NCT00256750|50043373|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
24951964|NCT00256750|50043371|FG000|Transplanted Pre-Treatment|Other|2|||
24951965|NCT00256750|50043372|FG001|Transplanted Pre-Treatment|Other|0|||
25275927|NCT00968812|50589875|FG002|Overall Study|Lost to Follow-up|11|||
25275928|NCT00968812|50589873|FG000|Overall Study|Physician Decision|8|||
25275929|NCT00968812|50589874|FG001|Overall Study|Physician Decision|5|||
25275930|NCT00968812|50589875|FG002|Overall Study|Physician Decision|9|||
24951966|NCT00256750|50043373|FG002|Transplanted Pre-Treatment|Other|0|||
24951967|NCT00256750|50043371|FG000|Transplanted Pre-Treatment|Death|1|||
24951968|NCT00256750|50043372|FG001|Transplanted Pre-Treatment|Death|0|||
24951969|NCT00256750|50043373|FG002|Transplanted Pre-Treatment|Death|0|||
25039413|NCT00109772|50140155|FG001|Open-label Extension|Death|1|||
25275931|NCT00968812|50589873|FG000|Overall Study|Protocol Violation|7|||
25275932|NCT00968812|50589874|FG001|Overall Study|Protocol Violation|4|||
25275933|NCT00968812|50589875|FG002|Overall Study|Protocol Violation|3|||
25275934|NCT00968812|50589873|FG000|Overall Study|Withdrawal by Subject|17|||
25275935|NCT00968812|50589874|FG001|Overall Study|Withdrawal by Subject|23|||
25275936|NCT00968812|50589875|FG002|Overall Study|Withdrawal by Subject|25|||
25275937|NCT00968812|50589873|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
25275938|NCT00968812|50589874|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
25275939|NCT00968812|50589875|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
25275940|NCT00968812|50589873|FG000|Overall Study|Noncompliance with study drug|4|||
25275941|NCT00968812|50589874|FG001|Overall Study|Noncompliance with study drug|1|||
25275942|NCT00968812|50589875|FG002|Overall Study|Noncompliance with study drug|6|||
25275943|NCT00968812|50589873|FG000|Overall Study|Unable to take rescue therapy|12|||
25275944|NCT00968812|50589874|FG001|Overall Study|Unable to take rescue therapy|12|||
25275945|NCT00968812|50589875|FG002|Overall Study|Unable to take rescue therapy|17|||
25275946|NCT00968812|50589873|FG000|Overall Study|Other|25|||
25275947|NCT00968812|50589874|FG001|Overall Study|Other|37|||
25275948|NCT00968812|50589875|FG002|Overall Study|Other|40|||
25275949|NCT00992056|50589888|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
25275950|NCT00992056|50589889|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
25275951|NCT00992056|50589888|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
25275952|NCT00992056|50589889|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
25275953|NCT00972322|50589897|FG000|Overall Study|Adverse Event|2|||
25275954|NCT00972322|50589898|FG001|Overall Study|Adverse Event|1|||
25275955|NCT00972322|50589897|FG000|Overall Study|Positive drug screen|0|||
25275956|NCT00972322|50589898|FG001|Overall Study|Positive drug screen|1|||
25275957|NCT00972322|50589897|FG000|Overall Study|Lost to Follow-up|0|||
25275958|NCT00972322|50589898|FG001|Overall Study|Lost to Follow-up|1|||
25275959|NCT00972322|50589897|FG000|Overall Study|Consistently high glucose values|1|||
25275960|NCT00972322|50589898|FG001|Overall Study|Consistently high glucose values|0|||
25275961|NCT00967798|50589906|FG000|Overall Study|Withdrawal by Subject|5|||
25275962|NCT00967798|50589907|FG001|Overall Study|Withdrawal by Subject|2|||
25275963|NCT00967798|50589906|FG000|Overall Study|Lost to Follow-up|4|||
25275964|NCT00967798|50589907|FG001|Overall Study|Lost to Follow-up|1|||
25275965|NCT00965458|50589915|FG000|Overall Study|Adverse Event|1|||
25275966|NCT00965458|50589916|FG001|Overall Study|Adverse Event|0|||
25275967|NCT00965458|50589915|FG000|Overall Study|Lost to Follow-up|1|||
25275968|NCT00965458|50589916|FG001|Overall Study|Lost to Follow-up|3|||
25275969|NCT00965458|50589915|FG000|Overall Study|Withdrawal by Subject|0|||
25275970|NCT00965458|50589916|FG001|Overall Study|Withdrawal by Subject|1|||
25275971|NCT00972244|50589929|FG000|Overall Study|Incorrect Enrolment|1|||
25275972|NCT00972244|50589930|FG001|Overall Study|Incorrect Enrolment|0|||
25275973|NCT00972244|50589931|FG002|Overall Study|Incorrect Enrolment|0|||
25275974|NCT00972244|50589932|FG003|Overall Study|Incorrect Enrolment|0|||
25275975|NCT00972244|50589933|FG004|Overall Study|Incorrect Enrolment|0|||
25275976|NCT00972244|50589929|FG000|Overall Study|Adverse Event|0|||
25275977|NCT00972244|50589930|FG001|Overall Study|Adverse Event|1|||
25275978|NCT00972244|50589931|FG002|Overall Study|Adverse Event|1|||
25275979|NCT00972244|50589932|FG003|Overall Study|Adverse Event|0|||
25275980|NCT00972244|50589933|FG004|Overall Study|Adverse Event|0|||
25275981|NCT00972244|50589929|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
25275982|NCT00972244|50589930|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
25275983|NCT00972244|50589931|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
25275984|NCT00972244|50589932|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
25275985|NCT00972244|50589933|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
25275986|NCT00972244|50589929|FG000|Overall Study|Withdrawal by Subject|1|||
25275987|NCT00972244|50589930|FG001|Overall Study|Withdrawal by Subject|2|||
25275988|NCT00972244|50589931|FG002|Overall Study|Withdrawal by Subject|1|||
25275989|NCT00972244|50589932|FG003|Overall Study|Withdrawal by Subject|0|||
25275990|NCT00972244|50589933|FG004|Overall Study|Withdrawal by Subject|1|||
25275991|NCT00972244|50589929|FG000|Overall Study|Safety|0|||
25275992|NCT00972244|50589930|FG001|Overall Study|Safety|0|||
25275993|NCT00972244|50589931|FG002|Overall Study|Safety|0|||
25275994|NCT00972244|50589932|FG003|Overall Study|Safety|0|||
25275995|NCT00972244|50589933|FG004|Overall Study|Safety|1|||
25275996|NCT00972244|50589929|FG000|Overall Study|Death|1|||
25275997|NCT00972244|50589930|FG001|Overall Study|Death|0|||
25275998|NCT00972244|50589931|FG002|Overall Study|Death|0|||
25275999|NCT00972244|50589932|FG003|Overall Study|Death|0|||
25276000|NCT00972244|50589933|FG004|Overall Study|Death|0|||
25276001|NCT00972244|50589929|FG000|Overall Study|Various|0|||
25276002|NCT00972244|50589930|FG001|Overall Study|Various|0|||
25276003|NCT00972244|50589931|FG002|Overall Study|Various|0|||
25276004|NCT00972244|50589932|FG003|Overall Study|Various|0|||
25276005|NCT00972244|50589933|FG004|Overall Study|Various|2|||
25276006|NCT00892723|50589948|FG000|Overall Study|Lost to Follow-up|1|||
25276007|NCT00892723|50589949|FG001|Overall Study|Lost to Follow-up|3|||
25276008|NCT00892723|50589950|FG002|Overall Study|Lost to Follow-up|1|||
25276009|NCT00892723|50589948|FG000|Overall Study|Withdrawal by Subject|1|||
25276010|NCT00892723|50589949|FG001|Overall Study|Withdrawal by Subject|1|||
25276011|NCT00892723|50589950|FG002|Overall Study|Withdrawal by Subject|1|||
25276012|NCT03811912|50589993|FG000|Overall Study|Withdrew Consent|4|||
25276013|NCT03811912|50589994|FG001|Overall Study|Withdrew Consent|2|||
25276014|NCT00971932|50590000|FG000|Overall Study|Withdrawal by Subject|1|||
25276015|NCT00971932|50590000|FG000|Overall Study|Investigator's decision|2|||
25276016|NCT00971932|50590000|FG000|Overall Study|Ongoing|4|||
25276017|NCT00970684|50590004|FG000|Overall Study|Lack of Efficacy|5|||
25276018|NCT00970684|50590004|FG000|Overall Study|Adverse Event|4|||
25276019|NCT00970684|50590004|FG000|Overall Study|Withdrawal by Subject|1|||
25276020|NCT00967330|50590010|FG000|Overall Study|Protocol Violation|3|||
25276021|NCT00967330|50590011|FG001|Overall Study|Protocol Violation|4|||
25276022|NCT00967330|50590010|FG000|Overall Study|Regular|10|||
25276023|NCT00967330|50590011|FG001|Overall Study|Regular|3|||
25276024|NCT00967330|50590010|FG000|Overall Study|Withdrawal by Subject|6|||
25276025|NCT00967330|50590011|FG001|Overall Study|Withdrawal by Subject|0|||
25276026|NCT00967330|50590010|FG000|Overall Study|Lost to Follow-up|1|||
25276027|NCT00967330|50590011|FG001|Overall Study|Lost to Follow-up|1|||
25276028|NCT00967330|50590010|FG000|Overall Study|Death|102|||
25276029|NCT00967330|50590011|FG001|Overall Study|Death|51|||
25276030|NCT00967330|50590010|FG000|Overall Study|Severe protocol deviation|0|||
25276031|NCT00967330|50590011|FG001|Overall Study|Severe protocol deviation|1|||
25276032|NCT00967018|50590017|FG000|Overall Study|Adverse Event|2|||
25276033|NCT00967018|50590017|FG000|Overall Study|Physician Decision|7|||
25276034|NCT00967018|50590017|FG000|Overall Study|Lost to Follow-up|2|||
25276035|NCT00967018|50590017|FG000|Overall Study|Withdrawal by Subject|1|||
25276036|NCT00967018|50590017|FG000|Overall Study|Miscellaneous Reasons|9|||
25276037|NCT00965146|50590021|FG000|Overall Study|Death|7|||
25276038|NCT00965146|50590021|FG000|Overall Study|Lost to Follow-up|22|||
25276039|NCT00965146|50590021|FG000|Overall Study|Withdrawal by Subject|17|||
25276040|NCT00965146|50590021|FG000|Overall Study|Unable to return|1|||
25276041|NCT00965146|50590021|FG000|Overall Study|Unwilling to return|11|||
25276042|NCT00965146|50590021|FG000|Overall Study|Intercurrent illness|1|||
25276043|NCT00965146|50590021|FG000|Overall Study|Revision / Removal of Study Implant|6|||
25276044|NCT00965146|50590021|FG000|Overall Study|Overall Study Termination|145|||
25276045|NCT00966940|50590027|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
25276046|NCT00966940|50590028|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
25276047|NCT00966940|50590027|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
25276048|NCT00966940|50590028|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
25276049|NCT00965848|50590034|FG000|Overall Study|Protocol Violation|3|||
25276050|NCT00965848|50590035|FG001|Overall Study|Protocol Violation|0|||
25276051|NCT00965848|50590036|FG002|Overall Study|Protocol Violation|1|||
25276052|NCT00965848|50590034|FG000|Overall Study|Death|11|||
25276053|NCT00965848|50590035|FG001|Overall Study|Death|1|||
25276054|NCT00965848|50590036|FG002|Overall Study|Death|5|||
25276055|NCT00965848|50590034|FG000|Overall Study|Lost to Follow-up|0|||
25276056|NCT00965848|50590035|FG001|Overall Study|Lost to Follow-up|0|||
25276057|NCT00965848|50590036|FG002|Overall Study|Lost to Follow-up|1|||
25276058|NCT00965848|50590034|FG000|Overall Study|Withdrawal by Subject|1|||
25276059|NCT00965848|50590035|FG001|Overall Study|Withdrawal by Subject|0|||
25276060|NCT00965848|50590036|FG002|Overall Study|Withdrawal by Subject|0|||
25276061|NCT00965848|50590034|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
25276062|NCT00965848|50590035|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
25276063|NCT00965848|50590036|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
25276064|NCT00965848|50590034|FG000|Overall Study|Not Clinically Evaluable|7|||
25276065|NCT00965848|50590035|FG001|Overall Study|Not Clinically Evaluable|1|||
25276066|NCT00965848|50590036|FG002|Overall Study|Not Clinically Evaluable|1|||
25276067|NCT00965848|50590034|FG000|Overall Study|Other|5|||
25276068|NCT00965848|50590035|FG001|Overall Study|Other|0|||
25276069|NCT00965848|50590036|FG002|Overall Study|Other|1|||
25276070|NCT00961636|50590047|FG000|Overall Study|Adverse Event|35|||
25276071|NCT00961636|50590048|FG001|Overall Study|Adverse Event|54|||
25276072|NCT00961636|50590049|FG002|Overall Study|Adverse Event|13|||
25276073|NCT00961636|50590047|FG000|Overall Study|Flushing Symptoms|29|||
24951970|NCT00256750|50043371|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
24951971|NCT00256750|50043372|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
25276074|NCT00961636|50590048|FG001|Overall Study|Flushing Symptoms|46|||
25276075|NCT00961636|50590049|FG002|Overall Study|Flushing Symptoms|3|||
25276076|NCT00961636|50590047|FG000|Overall Study|Lost to Follow-up|2|||
25276077|NCT00961636|50590048|FG001|Overall Study|Lost to Follow-up|3|||
25276078|NCT00961636|50590049|FG002|Overall Study|Lost to Follow-up|1|||
25276079|NCT00961636|50590047|FG000|Overall Study|Physician Decision|3|||
25276080|NCT00961636|50590048|FG001|Overall Study|Physician Decision|1|||
25276081|NCT00961636|50590049|FG002|Overall Study|Physician Decision|1|||
25276082|NCT00961636|50590047|FG000|Overall Study|Protocol Violation|9|||
25276083|NCT00961636|50590048|FG001|Overall Study|Protocol Violation|5|||
25276084|NCT00961636|50590049|FG002|Overall Study|Protocol Violation|1|||
25276085|NCT00961636|50590047|FG000|Overall Study|Withdrawal by Subject|29|||
25276086|NCT00961636|50590048|FG001|Overall Study|Withdrawal by Subject|22|||
25276087|NCT00961636|50590049|FG002|Overall Study|Withdrawal by Subject|13|||
25276088|NCT00964678|50590057|FG000|Overall Study|Physician Decision|4|||
25276089|NCT00964366|50590064|FG000|Overall Study|Did not qualify at Day 1|1|||
25276090|NCT00964366|50590065|FG001|Overall Study|Did not qualify at Day 1|0|||
25276091|NCT00964366|50590064|FG000|Overall Study|Withdrawal by Subject|0|||
25276092|NCT00964366|50590065|FG001|Overall Study|Withdrawal by Subject|1|||
25276093|NCT00960154|50590073|FG000|Overall Study|Study termination|25|||
25276094|NCT00960154|50590074|FG001|Overall Study|Study termination|25|||
25276095|NCT00960076|50590082|FG000|Overall Study|Adverse Event|1|||
25276096|NCT00960076|50590083|FG001|Overall Study|Adverse Event|7|||
25276097|NCT00960076|50590082|FG000|Overall Study|No longer met study criteria|1|||
25276098|NCT00960076|50590083|FG001|Overall Study|No longer met study criteria|5|||
25276099|NCT00960076|50590082|FG000|Overall Study|Withdrawal by Subject|1|||
25276100|NCT00960076|50590083|FG001|Overall Study|Withdrawal by Subject|2|||
25276101|NCT00960076|50590082|FG000|Overall Study|Lost to Follow-up|3|||
25276102|NCT00960076|50590083|FG001|Overall Study|Lost to Follow-up|3|||
25276103|NCT00960076|50590082|FG000|Overall Study|Severe non-compliance to protocol|1|||
25276104|NCT00960076|50590083|FG001|Overall Study|Severe non-compliance to protocol|2|||
25276105|NCT00960076|50590082|FG000|Overall Study|Hyperglycemia|1|||
25276106|NCT00960076|50590083|FG001|Overall Study|Hyperglycemia|5|||
25276107|NCT00960076|50590082|FG000|Overall Study|Did not attend the termination visit|0|||
25276108|NCT00960076|50590083|FG001|Overall Study|Did not attend the termination visit|1|||
25276109|NCT01227629|50590099|FG000|Overall Study|Adverse Event|2|||
25276110|NCT01227629|50590100|FG001|Overall Study|Adverse Event|2|||
25276111|NCT01227629|50590101|FG002|Overall Study|Adverse Event|1|||
25276112|NCT01227629|50590102|FG003|Overall Study|Adverse Event|6|||
25276113|NCT01227629|50590103|FG004|Overall Study|Adverse Event|1|||
25276114|NCT01227629|50590104|FG005|Overall Study|Adverse Event|1|||
25276115|NCT01227629|50590105|FG006|Overall Study|Adverse Event|6|||
25276116|NCT01227629|50590106|FG007|Overall Study|Adverse Event|6|||
25276117|NCT01227629|50590107|FG008|Overall Study|Adverse Event|4|||
25276118|NCT01227629|50590108|FG009|Overall Study|Adverse Event|0|||
25276119|NCT01227629|50590099|FG000|Overall Study|Protocol Violation|0|||
25276120|NCT01227629|50590100|FG001|Overall Study|Protocol Violation|0|||
25276121|NCT01227629|50590101|FG002|Overall Study|Protocol Violation|0|||
25276122|NCT01227629|50590102|FG003|Overall Study|Protocol Violation|1|||
25276123|NCT01227629|50590103|FG004|Overall Study|Protocol Violation|0|||
25276124|NCT01227629|50590104|FG005|Overall Study|Protocol Violation|0|||
25276125|NCT01227629|50590105|FG006|Overall Study|Protocol Violation|0|||
25276126|NCT01227629|50590106|FG007|Overall Study|Protocol Violation|0|||
25276127|NCT01227629|50590107|FG008|Overall Study|Protocol Violation|0|||
25276128|NCT01227629|50590108|FG009|Overall Study|Protocol Violation|0|||
25276129|NCT01227629|50590099|FG000|Overall Study|Lost to Follow-up|0|||
25276130|NCT01227629|50590100|FG001|Overall Study|Lost to Follow-up|0|||
25276131|NCT01227629|50590101|FG002|Overall Study|Lost to Follow-up|0|||
25276132|NCT01227629|50590102|FG003|Overall Study|Lost to Follow-up|0|||
25276133|NCT01227629|50590103|FG004|Overall Study|Lost to Follow-up|1|||
25276134|NCT01227629|50590104|FG005|Overall Study|Lost to Follow-up|0|||
25276135|NCT01227629|50590105|FG006|Overall Study|Lost to Follow-up|0|||
25276136|NCT01227629|50590106|FG007|Overall Study|Lost to Follow-up|0|||
25276137|NCT01227629|50590107|FG008|Overall Study|Lost to Follow-up|0|||
25276138|NCT01227629|50590108|FG009|Overall Study|Lost to Follow-up|0|||
25276139|NCT01227629|50590099|FG000|Overall Study|Withdrawal by Subject|0|||
25160185|NCT01399047|50280246|FG000|Overall Study|Withdrawal by Subject|0|||
25160186|NCT01399047|50280247|FG001|Overall Study|Withdrawal by Subject|1|||
25160187|NCT01387737|50280257|FG000|Overall Study|Adverse Event|20|||
25160188|NCT01387737|50280258|FG001|Overall Study|Adverse Event|30|||
25160189|NCT01387737|50280257|FG000|Overall Study|Lack of Efficacy|1|||
25160190|NCT01387737|50280258|FG001|Overall Study|Lack of Efficacy|0|||
25160191|NCT01387737|50280257|FG000|Overall Study|Physician Decision|3|||
25160192|NCT01387737|50280258|FG001|Overall Study|Physician Decision|10|||
25276140|NCT01227629|50590100|FG001|Overall Study|Withdrawal by Subject|0|||
25276141|NCT01227629|50590101|FG002|Overall Study|Withdrawal by Subject|0|||
25276142|NCT01227629|50590102|FG003|Overall Study|Withdrawal by Subject|0|||
25276143|NCT01227629|50590103|FG004|Overall Study|Withdrawal by Subject|0|||
25276144|NCT01227629|50590104|FG005|Overall Study|Withdrawal by Subject|0|||
25276145|NCT01227629|50590105|FG006|Overall Study|Withdrawal by Subject|2|||
25160193|NCT01387737|50280257|FG000|Overall Study|Withdrawal by Subject|27|||
25160194|NCT01387737|50280258|FG001|Overall Study|Withdrawal by Subject|31|||
25160195|NCT01387737|50280257|FG000|Overall Study|Clearly not eligible for the study|1|||
25160196|NCT01387737|50280258|FG001|Overall Study|Clearly not eligible for the study|3|||
25276146|NCT01227629|50590106|FG007|Overall Study|Withdrawal by Subject|0|||
25276147|NCT01227629|50590107|FG008|Overall Study|Withdrawal by Subject|0|||
25276148|NCT01227629|50590108|FG009|Overall Study|Withdrawal by Subject|1|||
25276149|NCT01227629|50590099|FG000|Overall Study|Other|0|||
25276150|NCT01227629|50590100|FG001|Overall Study|Other|0|||
25276151|NCT01227629|50590101|FG002|Overall Study|Other|0|||
25276152|NCT01227629|50590102|FG003|Overall Study|Other|1|||
25276153|NCT01227629|50590103|FG004|Overall Study|Other|0|||
25276154|NCT01227629|50590104|FG005|Overall Study|Other|0|||
25276155|NCT01227629|50590105|FG006|Overall Study|Other|0|||
25276156|NCT01227629|50590106|FG007|Overall Study|Other|0|||
25276157|NCT01227629|50590107|FG008|Overall Study|Other|2|||
25276158|NCT01227629|50590108|FG009|Overall Study|Other|1|||
25276159|NCT00963820|50590154|FG000|Dose Escalation Phase|Progressive Disease|3|||
25276160|NCT00963820|50590155|FG001|Dose Escalation Phase|Progressive Disease|3|||
24951972|NCT00256750|50043373|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
24951973|NCT00256750|50043371|FG000|Post-Transplant Treated (12 Months)|Death|3|||
24951974|NCT00256750|50043372|FG001|Post-Transplant Treated (12 Months)|Death|2|||
24951975|NCT00256750|50043373|FG002|Post-Transplant Treated (12 Months)|Death|4|||
24951976|NCT00256750|50043371|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
24951977|NCT00256750|50043372|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
24951978|NCT00256750|50043373|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
24951979|NCT00256750|50043371|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
24951980|NCT00256750|50043372|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
24951981|NCT00256750|50043373|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
25039414|NCT00109772|50140154|FG000|Open-label Extension|Protocol Violation|2|||
25039415|NCT00109772|50140155|FG001|Open-label Extension|Protocol Violation|2|||
25039416|NCT00109772|50140154|FG000|Open-label Extension|Other|4|||
25039417|NCT00109772|50140155|FG001|Open-label Extension|Other|10|||
25039418|NCT02783066|50140161|FG000|Overall Study|Withdrawal by Subject|13|||
25039419|NCT01371305|50140172|FG000|Overall Study|Adverse Event|0|||
25039420|NCT01371305|50140173|FG001|Overall Study|Adverse Event|0|||
25039421|NCT01371305|50140174|FG002|Overall Study|Adverse Event|0|||
25039422|NCT01371305|50140175|FG003|Overall Study|Adverse Event|2|||
25039423|NCT01371305|50140176|FG004|Overall Study|Adverse Event|1|||
25039424|NCT01371305|50140177|FG005|Overall Study|Adverse Event|0|||
25039425|NCT01371305|50140172|FG000|Overall Study|Study terminated by sponsor|0|||
25039426|NCT01371305|50140173|FG001|Overall Study|Study terminated by sponsor|0|||
25039427|NCT01371305|50140174|FG002|Overall Study|Study terminated by sponsor|0|||
25039428|NCT01371305|50140175|FG003|Overall Study|Study terminated by sponsor|0|||
25039429|NCT01371305|50140176|FG004|Overall Study|Study terminated by sponsor|3|||
25039430|NCT01371305|50140177|FG005|Overall Study|Study terminated by sponsor|1|||
25039431|NCT01371305|50140172|FG000|Overall Study|Subject request|0|||
25039432|NCT01371305|50140173|FG001|Overall Study|Subject request|0|||
25039433|NCT01371305|50140174|FG002|Overall Study|Subject request|0|||
25039434|NCT01371305|50140175|FG003|Overall Study|Subject request|0|||
25039435|NCT01371305|50140176|FG004|Overall Study|Subject request|0|||
25039436|NCT01371305|50140177|FG005|Overall Study|Subject request|1|||
25039437|NCT00109928|50140192|FG000|Overall Study|Adverse Event|2|||
25039438|NCT00109928|50140192|FG000|Overall Study|Progression|6|||
25160197|NCT01387347|50280266|FG000|Overall Study|Lost to Follow-up|2|||
25276161|NCT00963820|50590156|FG002|Dose Escalation Phase|Progressive Disease|3|||
24951982|NCT00256750|50043371|FG000|Post-Transplant Treated (12 Months)|Other|5|||
24951983|NCT00256750|50043372|FG001|Post-Transplant Treated (12 Months)|Other|4|||
25276162|NCT00963820|50590157|FG003|Dose Escalation Phase|Progressive Disease|3|||
25276163|NCT00963820|50590158|FG004|Dose Escalation Phase|Progressive Disease|4|||
25039439|NCT00109928|50140192|FG000|Overall Study|Death|2|||
25039440|NCT00109928|50140192|FG000|Overall Study|not protocol specified|2|||
25039441|NCT00109928|50140192|FG000|Overall Study|not eligible|1|||
25039442|NCT00109850|50140197|FG000|Overall Study|Adverse Event|1|||
24951984|NCT00256750|50043373|FG002|Post-Transplant Treated (12 Months)|Other|2|||
24951985|NCT00256750|50043371|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
24951986|NCT00256750|50043372|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
24951987|NCT00256750|50043373|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
24951988|NCT00256750|50043371|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
24951989|NCT00256750|50043372|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
24951990|NCT00256750|50043373|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
24951991|NCT00256750|50043371|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
24951992|NCT00256750|50043372|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
24951993|NCT00256750|50043373|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
24951994|NCT00256750|50043371|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
24951995|NCT00256750|50043372|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
24951996|NCT00256750|50043373|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
24951997|NCT00256750|50043371|FG000|Post-Transplant Treated (24 Months)|Death|3|||
24951998|NCT00256750|50043372|FG001|Post-Transplant Treated (24 Months)|Death|0|||
24951999|NCT00256750|50043373|FG002|Post-Transplant Treated (24 Months)|Death|0|||
24952000|NCT00256750|50043371|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
24952001|NCT00256750|50043372|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
24952002|NCT00256750|50043373|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
24952003|NCT00256750|50043371|FG000|Post-Transplant Treated (24 Months)|Other|2|||
24952004|NCT00256750|50043372|FG001|Post-Transplant Treated (24 Months)|Other|0|||
24952005|NCT00256750|50043373|FG002|Post-Transplant Treated (24 Months)|Other|1|||
24952006|NCT00256750|50043371|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
24952007|NCT00256750|50043372|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
24952008|NCT00256750|50043373|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
24952009|NCT00256750|50043371|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
24952010|NCT00256750|50043372|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
24952011|NCT00256750|50043373|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
24952012|NCT00256750|50043371|FG000|Post-Transplant Treated (36 Months)|Death|0|||
24952013|NCT00256750|50043372|FG001|Post-Transplant Treated (36 Months)|Death|2|||
24952014|NCT00256750|50043373|FG002|Post-Transplant Treated (36 Months)|Death|1|||
24952015|NCT00256750|50043371|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
24952016|NCT00256750|50043372|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
24952017|NCT00256750|50043373|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
24952018|NCT00256750|50043371|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
24952019|NCT00256750|50043372|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
24952020|NCT00256750|50043373|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
25039443|NCT00109850|50140197|FG000|Overall Study|Death|2|||
25039444|NCT00109850|50140197|FG000|Overall Study|Ineligible|1|||
25039445|NCT01342926|50140205|FG000|Overall Study|Adverse Event|5|||
25039446|NCT01342926|50140206|FG001|Overall Study|Adverse Event|8|||
25039447|NCT01342926|50140207|FG002|Overall Study|Adverse Event|10|||
25039448|NCT01342926|50140208|FG003|Overall Study|Adverse Event|7|||
25039449|NCT01342926|50140205|FG000|Overall Study|Lost to Follow-up|0|||
25039450|NCT01342926|50140206|FG001|Overall Study|Lost to Follow-up|1|||
25039451|NCT01342926|50140207|FG002|Overall Study|Lost to Follow-up|1|||
25039452|NCT01342926|50140208|FG003|Overall Study|Lost to Follow-up|0|||
25039453|NCT01342926|50140205|FG000|Overall Study|Investigator Discretion|2|||
25039454|NCT01342926|50140206|FG001|Overall Study|Investigator Discretion|2|||
25039455|NCT01342926|50140207|FG002|Overall Study|Investigator Discretion|0|||
25039456|NCT01342926|50140208|FG003|Overall Study|Investigator Discretion|0|||
25039457|NCT01342926|50140205|FG000|Overall Study|Withdrawal by Subject|2|||
25039458|NCT01342926|50140206|FG001|Overall Study|Withdrawal by Subject|4|||
25039459|NCT01342926|50140207|FG002|Overall Study|Withdrawal by Subject|3|||
25039460|NCT01342926|50140208|FG003|Overall Study|Withdrawal by Subject|5|||
25039461|NCT01810016|50140221|FG000|Overall Study|Progressive disease|1|||
25039462|NCT01810016|50140222|FG001|Overall Study|Progressive disease|1|||
25039463|NCT01810016|50140223|FG002|Overall Study|Progressive disease|0|||
25039464|NCT01810016|50140221|FG000|Overall Study|Death|0|||
25039465|NCT01810016|50140222|FG001|Overall Study|Death|0|||
25039466|NCT01810016|50140223|FG002|Overall Study|Death|1|||
25039467|NCT02843178|50140235|FG000|Overall Study|Lost to Follow-up|8|||
25039468|NCT02843178|50140236|FG001|Overall Study|Lost to Follow-up|8|||
25160198|NCT01387347|50280267|FG001|Overall Study|Lost to Follow-up|1|||
25160199|NCT01859923|50280281|FG000|Overall Study|Adverse Event|0|||
25160200|NCT01859923|50280282|FG001|Overall Study|Adverse Event|0|||
25276164|NCT00963820|50590159|FG005|Dose Escalation Phase|Progressive Disease|3|||
25039469|NCT02843178|50140237|FG002|Overall Study|Lost to Follow-up|6|||
25039470|NCT02843178|50140238|FG003|Overall Study|Lost to Follow-up|3|||
25039471|NCT02843178|50140235|FG000|Overall Study|Withdrawal by Subject|0|||
25039472|NCT02843178|50140236|FG001|Overall Study|Withdrawal by Subject|0|||
25160201|NCT01859923|50280283|FG002|Overall Study|Adverse Event|1|||
25039473|NCT02843178|50140237|FG002|Overall Study|Withdrawal by Subject|1|||
25039474|NCT02843178|50140238|FG003|Overall Study|Withdrawal by Subject|1|||
24952021|NCT00256750|50043371|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
24952022|NCT00256750|50043372|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
24952023|NCT00256750|50043373|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
24952024|NCT00256750|50043371|FG000|Post-Transplant Treated (36 Months)|Other|0|||
24952025|NCT00256750|50043372|FG001|Post-Transplant Treated (36 Months)|Other|1|||
24952026|NCT00256750|50043373|FG002|Post-Transplant Treated (36 Months)|Other|1|||
24952027|NCT00256750|50043371|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
24952028|NCT00256750|50043372|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
24952029|NCT00256750|50043373|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
24952030|NCT00256750|50043371|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
24952031|NCT00256750|50043372|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
24952032|NCT00256750|50043373|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
24952033|NCT00256750|50043371|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
24952034|NCT00256750|50043372|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
24952035|NCT00256750|50043373|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
24952036|NCT00256750|50043371|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
24952037|NCT00256750|50043372|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
24952038|NCT00256750|50043373|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
24952039|NCT00256750|50043371|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
24952040|NCT00256750|50043372|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
24952041|NCT00256750|50043373|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
24952042|NCT00256750|50043371|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
24952043|NCT00256750|50043372|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
24952044|NCT00256750|50043373|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
24952045|NCT00256750|50043371|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
24952046|NCT00256750|50043372|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
24952047|NCT00256750|50043373|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
24952048|NCT00256750|50043371|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
24952049|NCT00256750|50043372|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
24952050|NCT00256750|50043373|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
24952051|NCT00256750|50043371|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
24952052|NCT00256750|50043372|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
24952053|NCT00256750|50043373|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
24952054|NCT00279201|50043384|FG000|Initiation|Death|1|||
24952055|NCT00279201|50043385|FG001|Initiation|Death|5|||
24952056|NCT00279201|50043386|FG002|Initiation|Death|0|||
24952057|NCT00279201|50043387|FG003|Initiation|Death|0|||
24952058|NCT00279201|50043388|FG004|Initiation|Death|0|||
24952059|NCT00279201|50043389|FG005|Initiation|Death|0|||
24952060|NCT00279201|50043384|FG000|Initiation|Adverse Event|6|||
24952061|NCT00279201|50043385|FG001|Initiation|Adverse Event|15|||
24952062|NCT00279201|50043386|FG002|Initiation|Adverse Event|0|||
24952063|NCT00279201|50043387|FG003|Initiation|Adverse Event|0|||
24952064|NCT00279201|50043388|FG004|Initiation|Adverse Event|0|||
24952065|NCT00279201|50043389|FG005|Initiation|Adverse Event|0|||
24952066|NCT00279201|50043384|FG000|Initiation|Lost to Follow-up|42|||
24952067|NCT00279201|50043385|FG001|Initiation|Lost to Follow-up|41|||
24952068|NCT00279201|50043386|FG002|Initiation|Lost to Follow-up|0|||
24952069|NCT00279201|50043387|FG003|Initiation|Lost to Follow-up|0|||
24952070|NCT00279201|50043388|FG004|Initiation|Lost to Follow-up|0|||
24952071|NCT00279201|50043389|FG005|Initiation|Lost to Follow-up|0|||
24952072|NCT00279201|50043384|FG000|Initiation|Entry Criteria Exclusion|7|||
24952073|NCT00279201|50043385|FG001|Initiation|Entry Criteria Exclusion|9|||
24952074|NCT00279201|50043386|FG002|Initiation|Entry Criteria Exclusion|0|||
24952075|NCT00279201|50043387|FG003|Initiation|Entry Criteria Exclusion|0|||
24952076|NCT00279201|50043388|FG004|Initiation|Entry Criteria Exclusion|0|||
24952077|NCT00279201|50043389|FG005|Initiation|Entry Criteria Exclusion|0|||
24952078|NCT00279201|50043384|FG000|Initiation|Protocol Violation|9|||
24952079|NCT00279201|50043385|FG001|Initiation|Protocol Violation|10|||
25039475|NCT01722266|50140252|FG000|Overall Study|Withdrawal by Subject|1|||
25039476|NCT01722266|50140253|FG001|Overall Study|Withdrawal by Subject|2|||
25039477|NCT01722266|50140254|FG002|Overall Study|Withdrawal by Subject|0|||
25039478|NCT01722266|50140255|FG003|Overall Study|Withdrawal by Subject|0|||
25039479|NCT01722266|50140252|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
25039480|NCT01722266|50140253|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
24952080|NCT00279201|50043386|FG002|Initiation|Protocol Violation|0|||
24952081|NCT00279201|50043387|FG003|Initiation|Protocol Violation|0|||
24952082|NCT00279201|50043388|FG004|Initiation|Protocol Violation|0|||
24952083|NCT00279201|50043389|FG005|Initiation|Protocol Violation|0|||
24952084|NCT00279201|50043384|FG000|Initiation|Withdrawal by Subject|35|||
24952085|NCT00279201|50043385|FG001|Initiation|Withdrawal by Subject|41|||
25039481|NCT01722266|50140254|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
25039482|NCT01722266|50140255|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
25039483|NCT01722266|50140252|FG000|Overall Study|Dropped out due to Nausea|0|||
25039484|NCT01722266|50140253|FG001|Overall Study|Dropped out due to Nausea|0|||
25039485|NCT01722266|50140254|FG002|Overall Study|Dropped out due to Nausea|2|||
25039486|NCT01722266|50140255|FG003|Overall Study|Dropped out due to Nausea|0|||
25039487|NCT03123185|50140279|FG000|Overall Study|Withdrawal by Subject|0|||
25039488|NCT03123185|50140280|FG001|Overall Study|Withdrawal by Subject|0|||
25039489|NCT03123185|50140281|FG002|Overall Study|Withdrawal by Subject|0|||
25039490|NCT03123185|50140282|FG003|Overall Study|Withdrawal by Subject|0|||
25039491|NCT03123185|50140283|FG004|Overall Study|Withdrawal by Subject|0|||
25039492|NCT03123185|50140284|FG005|Overall Study|Withdrawal by Subject|0|||
25039493|NCT03123185|50140285|FG006|Overall Study|Withdrawal by Subject|0|||
24952086|NCT00279201|50043386|FG002|Initiation|Withdrawal by Subject|0|||
24952087|NCT00279201|50043387|FG003|Initiation|Withdrawal by Subject|0|||
24952088|NCT00279201|50043388|FG004|Initiation|Withdrawal by Subject|0|||
24952089|NCT00279201|50043389|FG005|Initiation|Withdrawal by Subject|0|||
24952090|NCT00279201|50043384|FG000|Initiation|Physician Decision|15|||
24952091|NCT00279201|50043385|FG001|Initiation|Physician Decision|18|||
24952092|NCT00279201|50043386|FG002|Initiation|Physician Decision|0|||
24952093|NCT00279201|50043387|FG003|Initiation|Physician Decision|0|||
24952094|NCT00279201|50043388|FG004|Initiation|Physician Decision|0|||
24952095|NCT00279201|50043389|FG005|Initiation|Physician Decision|0|||
24952096|NCT00279201|50043384|FG000|Initiation|Sponsor Decision|13|||
24952097|NCT00279201|50043385|FG001|Initiation|Sponsor Decision|5|||
24952098|NCT00279201|50043386|FG002|Initiation|Sponsor Decision|0|||
24952099|NCT00279201|50043387|FG003|Initiation|Sponsor Decision|0|||
24952100|NCT00279201|50043388|FG004|Initiation|Sponsor Decision|0|||
24952101|NCT00279201|50043389|FG005|Initiation|Sponsor Decision|0|||
24952102|NCT00279201|50043384|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
24952103|NCT00279201|50043385|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
24952104|NCT00279201|50043386|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
24952105|NCT00279201|50043387|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
24952106|NCT00279201|50043388|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
24952107|NCT00279201|50043389|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
24952108|NCT00279201|50043384|FG000|Maintenance|Lack of Efficacy|32|||
24952109|NCT00279201|50043385|FG001|Maintenance|Lack of Efficacy|30|||
24952110|NCT00279201|50043386|FG002|Maintenance|Lack of Efficacy|0|||
24952111|NCT00279201|50043387|FG003|Maintenance|Lack of Efficacy|0|||
24952112|NCT00279201|50043388|FG004|Maintenance|Lack of Efficacy|0|||
24952113|NCT00279201|50043389|FG005|Maintenance|Lack of Efficacy|0|||
24952114|NCT00279201|50043384|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
24952115|NCT00279201|50043385|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
24952116|NCT00279201|50043386|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
24952117|NCT00279201|50043387|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
25039494|NCT03123185|50140286|FG007|Overall Study|Withdrawal by Subject|0|||
25039495|NCT03123185|50140287|FG008|Overall Study|Withdrawal by Subject|0|||
25039496|NCT03123185|50140288|FG009|Overall Study|Withdrawal by Subject|0|||
25039497|NCT03123185|50140289|FG010|Overall Study|Withdrawal by Subject|0|||
25039498|NCT03123185|50140290|FG011|Overall Study|Withdrawal by Subject|0|||
25039499|NCT03123185|50140291|FG012|Overall Study|Withdrawal by Subject|1|||
25039500|NCT03123185|50140292|FG013|Overall Study|Withdrawal by Subject|0|||
25039501|NCT02842866|50140351|FG000|Overall Study|Serious Adverse Event|0|||
25039502|NCT02842866|50140352|FG001|Overall Study|Serious Adverse Event|1|||
25039503|NCT02842866|50140351|FG000|Overall Study|Protocol Violation|4|||
25039504|NCT02842866|50140352|FG001|Overall Study|Protocol Violation|2|||
25039505|NCT02842866|50140351|FG000|Overall Study|Lost to Follow-up|2|||
25039506|NCT02842866|50140352|FG001|Overall Study|Lost to Follow-up|0|||
25039507|NCT02842866|50140351|FG000|Overall Study|Withdrawal by Subject|1|||
25039508|NCT02842866|50140352|FG001|Overall Study|Withdrawal by Subject|0|||
25039509|NCT01316913|50140362|FG000|Overall Study|Adverse Event|17|||
25039510|NCT01316913|50140363|FG001|Overall Study|Adverse Event|20|||
25039511|NCT01316913|50140364|FG002|Overall Study|Adverse Event|15|||
25039512|NCT01316913|50140365|FG003|Overall Study|Adverse Event|11|||
25039513|NCT01316913|50140362|FG000|Overall Study|Lack of Efficacy|22|||
25039514|NCT01316913|50140363|FG001|Overall Study|Lack of Efficacy|12|||
25039515|NCT01316913|50140364|FG002|Overall Study|Lack of Efficacy|9|||
25160202|NCT01859923|50280284|FG003|Overall Study|Adverse Event|1|||
24952118|NCT00279201|50043388|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
24952119|NCT00279201|50043389|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
24952120|NCT00279201|50043384|FG000|Maintenance|Adverse Event|4|||
24952121|NCT00279201|50043385|FG001|Maintenance|Adverse Event|4|||
24952122|NCT00279201|50043386|FG002|Maintenance|Adverse Event|0|||
24952123|NCT00279201|50043387|FG003|Maintenance|Adverse Event|0|||
24952124|NCT00279201|50043388|FG004|Maintenance|Adverse Event|0|||
25039516|NCT01316913|50140365|FG003|Overall Study|Lack of Efficacy|13|||
25039517|NCT01316913|50140362|FG000|Overall Study|Protocol Violation|1|||
25039518|NCT01316913|50140363|FG001|Overall Study|Protocol Violation|4|||
25039519|NCT01316913|50140364|FG002|Overall Study|Protocol Violation|4|||
25039520|NCT01316913|50140365|FG003|Overall Study|Protocol Violation|1|||
25039521|NCT01316913|50140362|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
25039522|NCT01316913|50140363|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
25039523|NCT01316913|50140364|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
25039524|NCT01316913|50140365|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
25039525|NCT01316913|50140362|FG000|Overall Study|Lost to Follow-up|0|||
25039526|NCT01316913|50140363|FG001|Overall Study|Lost to Follow-up|1|||
25039527|NCT01316913|50140364|FG002|Overall Study|Lost to Follow-up|0|||
25039528|NCT01316913|50140365|FG003|Overall Study|Lost to Follow-up|2|||
25039529|NCT01316913|50140362|FG000|Overall Study|Withdrawal by Subject|10|||
25039530|NCT01316913|50140363|FG001|Overall Study|Withdrawal by Subject|9|||
25039531|NCT01316913|50140364|FG002|Overall Study|Withdrawal by Subject|10|||
25039532|NCT01316913|50140365|FG003|Overall Study|Withdrawal by Subject|6|||
25039533|NCT02875067|50140376|FG000|Overall Study|Withdrawal by Subject|1|||
25039534|NCT02875067|50140376|FG000|Overall Study|Withdrawal by Termination of Study|5|||
25039535|NCT02781506|50140380|FG000|Overall Study|Adverse Event|5|||
24952125|NCT00279201|50043389|FG005|Maintenance|Adverse Event|0|||
24952126|NCT00279201|50043384|FG000|Maintenance|Death|4|||
24952127|NCT00279201|50043385|FG001|Maintenance|Death|4|||
24952128|NCT00279201|50043386|FG002|Maintenance|Death|0|||
24952129|NCT00279201|50043387|FG003|Maintenance|Death|0|||
24952130|NCT00279201|50043388|FG004|Maintenance|Death|0|||
24952131|NCT00279201|50043389|FG005|Maintenance|Death|0|||
24952132|NCT00279201|50043384|FG000|Maintenance|Lost to Follow-up|17|||
24952133|NCT00279201|50043385|FG001|Maintenance|Lost to Follow-up|13|||
24952134|NCT00279201|50043386|FG002|Maintenance|Lost to Follow-up|0|||
24952135|NCT00279201|50043387|FG003|Maintenance|Lost to Follow-up|0|||
24952136|NCT00279201|50043388|FG004|Maintenance|Lost to Follow-up|0|||
24952137|NCT00279201|50043389|FG005|Maintenance|Lost to Follow-up|0|||
25039536|NCT03132753|50140386|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
25039537|NCT03132753|50140387|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
25039538|NCT03132753|50140386|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
25039539|NCT03132753|50140387|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
25039540|NCT01468454|50140393|FG000|Overall Study|Did not have surgery after PET|9|||
25039541|NCT03067077|50140398|FG000|Overall Study|Did not receive surgery|4|||
25039542|NCT03067077|50140399|FG001|Overall Study|Did not receive surgery|5|||
25039543|NCT03067077|50140398|FG000|Overall Study|Lost to Follow-up|3|||
25039544|NCT03067077|50140399|FG001|Overall Study|Lost to Follow-up|2|||
25039545|NCT03096847|50140408|FG000|Overall Study|Other|2|||
25039546|NCT03096847|50140409|FG001|Overall Study|Other|1|||
25039547|NCT03096847|50140410|FG002|Overall Study|Other|2|||
24952138|NCT00279201|50043384|FG000|Maintenance|Entry Criteria Exclusion|1|||
24952139|NCT00279201|50043385|FG001|Maintenance|Entry Criteria Exclusion|4|||
24952140|NCT00279201|50043386|FG002|Maintenance|Entry Criteria Exclusion|0|||
24952141|NCT00279201|50043387|FG003|Maintenance|Entry Criteria Exclusion|0|||
24952142|NCT00279201|50043388|FG004|Maintenance|Entry Criteria Exclusion|0|||
24952143|NCT00279201|50043389|FG005|Maintenance|Entry Criteria Exclusion|0|||
24952144|NCT00279201|50043384|FG000|Maintenance|Protocol Violation|16|||
25039548|NCT03096847|50140408|FG000|Overall Study|Lost to Follow-up|1|||
25039549|NCT03096847|50140409|FG001|Overall Study|Lost to Follow-up|0|||
25039550|NCT03096847|50140410|FG002|Overall Study|Lost to Follow-up|1|||
25039551|NCT03096847|50140408|FG000|Overall Study|Death|6|||
25039552|NCT03096847|50140409|FG001|Overall Study|Death|0|||
24952145|NCT00279201|50043385|FG001|Maintenance|Protocol Violation|24|||
24952146|NCT00279201|50043386|FG002|Maintenance|Protocol Violation|0|||
25039553|NCT03096847|50140410|FG002|Overall Study|Death|2|||
25039554|NCT03096847|50140408|FG000|Overall Study|Protocol Violation|3|||
24952147|NCT00279201|50043387|FG003|Maintenance|Protocol Violation|0|||
24952148|NCT00279201|50043388|FG004|Maintenance|Protocol Violation|0|||
24952149|NCT00279201|50043389|FG005|Maintenance|Protocol Violation|0|||
24952150|NCT00279201|50043384|FG000|Maintenance|Withdrawal by Subject|18|||
24952151|NCT00279201|50043385|FG001|Maintenance|Withdrawal by Subject|18|||
24952152|NCT00279201|50043386|FG002|Maintenance|Withdrawal by Subject|0|||
24952153|NCT00279201|50043387|FG003|Maintenance|Withdrawal by Subject|0|||
24952154|NCT00279201|50043388|FG004|Maintenance|Withdrawal by Subject|0|||
24952155|NCT00279201|50043389|FG005|Maintenance|Withdrawal by Subject|0|||
24952156|NCT00279201|50043384|FG000|Maintenance|Physician Decision|9|||
24952157|NCT00279201|50043385|FG001|Maintenance|Physician Decision|9|||
24952158|NCT00279201|50043386|FG002|Maintenance|Physician Decision|0|||
24952159|NCT00279201|50043387|FG003|Maintenance|Physician Decision|0|||
24952160|NCT00279201|50043388|FG004|Maintenance|Physician Decision|0|||
24952161|NCT00279201|50043389|FG005|Maintenance|Physician Decision|0|||
24952162|NCT00279201|50043384|FG000|Maintenance|Sponsor Decision|4|||
24952163|NCT00279201|50043385|FG001|Maintenance|Sponsor Decision|0|||
24952164|NCT00279201|50043386|FG002|Maintenance|Sponsor Decision|0|||
24952165|NCT00279201|50043387|FG003|Maintenance|Sponsor Decision|0|||
24952166|NCT00279201|50043388|FG004|Maintenance|Sponsor Decision|0|||
24952167|NCT00279201|50043389|FG005|Maintenance|Sponsor Decision|0|||
24952168|NCT00279201|50043384|FG000|Maintenance|HbA1c>7.5%|123|||
24952169|NCT00279201|50043385|FG001|Maintenance|HbA1c>7.5%|126|||
24952170|NCT00279201|50043386|FG002|Maintenance|HbA1c>7.5%|0|||
24952171|NCT00279201|50043387|FG003|Maintenance|HbA1c>7.5%|0|||
24952172|NCT00279201|50043388|FG004|Maintenance|HbA1c>7.5%|0|||
24952173|NCT00279201|50043389|FG005|Maintenance|HbA1c>7.5%|0|||
24952174|NCT00279201|50043384|FG000|Intensification Addendum|Withdrawal by Subject|0|||
24952175|NCT00279201|50043385|FG001|Intensification Addendum|Withdrawal by Subject|0|||
24952176|NCT00279201|50043386|FG002|Intensification Addendum|Withdrawal by Subject|12|||
24952177|NCT00279201|50043387|FG003|Intensification Addendum|Withdrawal by Subject|14|||
24952178|NCT00279201|50043388|FG004|Intensification Addendum|Withdrawal by Subject|9|||
24952179|NCT00279201|50043389|FG005|Intensification Addendum|Withdrawal by Subject|18|||
24952180|NCT00279201|50043384|FG000|Intensification Addendum|Lost to Follow-up|0|||
24952181|NCT00279201|50043385|FG001|Intensification Addendum|Lost to Follow-up|0|||
24952182|NCT00279201|50043386|FG002|Intensification Addendum|Lost to Follow-up|4|||
24952183|NCT00279201|50043387|FG003|Intensification Addendum|Lost to Follow-up|6|||
24952184|NCT00279201|50043388|FG004|Intensification Addendum|Lost to Follow-up|7|||
25039555|NCT03096847|50140409|FG001|Overall Study|Protocol Violation|0|||
25039556|NCT03096847|50140410|FG002|Overall Study|Protocol Violation|6|||
25039557|NCT03096847|50140408|FG000|Overall Study|Physician Decision|12|||
25039558|NCT03096847|50140409|FG001|Overall Study|Physician Decision|2|||
24952185|NCT00279201|50043389|FG005|Intensification Addendum|Lost to Follow-up|7|||
24952186|NCT00279201|50043384|FG000|Intensification Addendum|Protocol Violation|0|||
24952187|NCT00279201|50043385|FG001|Intensification Addendum|Protocol Violation|0|||
24952188|NCT00279201|50043386|FG002|Intensification Addendum|Protocol Violation|2|||
24952189|NCT00279201|50043387|FG003|Intensification Addendum|Protocol Violation|2|||
24952190|NCT00279201|50043388|FG004|Intensification Addendum|Protocol Violation|6|||
25039559|NCT03096847|50140410|FG002|Overall Study|Physician Decision|8|||
25160203|NCT01832155|50280299|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
24952191|NCT00279201|50043389|FG005|Intensification Addendum|Protocol Violation|6|||
24952192|NCT00279201|50043384|FG000|Intensification Addendum|Adverse Event|0|||
24952193|NCT00279201|50043385|FG001|Intensification Addendum|Adverse Event|0|||
24952194|NCT00279201|50043386|FG002|Intensification Addendum|Adverse Event|0|||
24952195|NCT00279201|50043387|FG003|Intensification Addendum|Adverse Event|4|||
24952196|NCT00279201|50043388|FG004|Intensification Addendum|Adverse Event|1|||
24952197|NCT00279201|50043389|FG005|Intensification Addendum|Adverse Event|3|||
24952198|NCT00279201|50043384|FG000|Intensification Addendum|Physician Decision|0|||
24952199|NCT00279201|50043385|FG001|Intensification Addendum|Physician Decision|0|||
24952200|NCT00279201|50043386|FG002|Intensification Addendum|Physician Decision|4|||
24952201|NCT00279201|50043387|FG003|Intensification Addendum|Physician Decision|1|||
24952202|NCT00279201|50043388|FG004|Intensification Addendum|Physician Decision|3|||
24952203|NCT00279201|50043389|FG005|Intensification Addendum|Physician Decision|2|||
24952204|NCT00279201|50043384|FG000|Intensification Addendum|Sponsor Decision|0|||
24952205|NCT00279201|50043385|FG001|Intensification Addendum|Sponsor Decision|0|||
25039560|NCT03096847|50140408|FG000|Overall Study|Withdrawal by Subject|24|||
25039561|NCT03096847|50140409|FG001|Overall Study|Withdrawal by Subject|1|||
25039562|NCT03096847|50140410|FG002|Overall Study|Withdrawal by Subject|12|||
24952206|NCT00279201|50043386|FG002|Intensification Addendum|Sponsor Decision|0|||
24952207|NCT00279201|50043387|FG003|Intensification Addendum|Sponsor Decision|0|||
24952208|NCT00279201|50043388|FG004|Intensification Addendum|Sponsor Decision|1|||
24952209|NCT00279201|50043389|FG005|Intensification Addendum|Sponsor Decision|1|||
24952210|NCT00279201|50043384|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
24952211|NCT00279201|50043385|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
24952212|NCT00279201|50043386|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
24952213|NCT00279201|50043387|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
24952214|NCT00279201|50043388|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
24952215|NCT00279201|50043389|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
24952216|NCT00279201|50043384|FG000|Intensification Addendum|Lack of Efficacy|0|||
24952217|NCT00279201|50043385|FG001|Intensification Addendum|Lack of Efficacy|0|||
24952218|NCT00279201|50043386|FG002|Intensification Addendum|Lack of Efficacy|0|||
24952219|NCT00279201|50043387|FG003|Intensification Addendum|Lack of Efficacy|1|||
24952220|NCT00279201|50043388|FG004|Intensification Addendum|Lack of Efficacy|1|||
24952221|NCT00279201|50043389|FG005|Intensification Addendum|Lack of Efficacy|0|||
24952222|NCT00279201|50043384|FG000|Intensification Addendum|Death|0|||
24952223|NCT00279201|50043385|FG001|Intensification Addendum|Death|0|||
24952224|NCT00279201|50043386|FG002|Intensification Addendum|Death|0|||
24952225|NCT00279201|50043387|FG003|Intensification Addendum|Death|0|||
24952226|NCT00279201|50043388|FG004|Intensification Addendum|Death|1|||
24952227|NCT00279201|50043389|FG005|Intensification Addendum|Death|0|||
24952228|NCT00203476|50043425|FG000|Overall Study|Lost to Follow-up|1|||
24952229|NCT00203476|50043426|FG001|Overall Study|Lost to Follow-up|0|||
24952230|NCT00203476|50043427|FG002|Overall Study|Lost to Follow-up|0|||
24952231|NCT00203476|50043425|FG000|Overall Study|Withdrawal by Subject|0|||
24952232|NCT00203476|50043426|FG001|Overall Study|Withdrawal by Subject|1|||
24952233|NCT00203476|50043427|FG002|Overall Study|Withdrawal by Subject|0|||
24952234|NCT00203242|50043435|FG000|Overall Study|Lost to Follow-up|1|||
24952235|NCT00200356|50043441|FG000|Overall Study|Lack of Efficacy|3|||
24952236|NCT00200356|50043442|FG001|Overall Study|Lack of Efficacy|3|||
24952237|NCT00200356|50043441|FG000|Overall Study|Protocol Violation|4|||
24952238|NCT00200356|50043442|FG001|Overall Study|Protocol Violation|4|||
24952239|NCT00200356|50043441|FG000|Overall Study|Nontreatment|1|||
24952240|NCT00200356|50043442|FG001|Overall Study|Nontreatment|0|||
25039563|NCT03096847|50140408|FG000|Overall Study|Adverse Event|72|||
24952241|NCT00227344|50043450|FG000|Overall Study|study terminated early|12|||
24952242|NCT00227344|50043451|FG001|Overall Study|study terminated early|5|||
24952243|NCT00227266|50043460|FG000|Overall Study|Withdrawal by Subject|0|||
24952244|NCT00227266|50043461|FG001|Overall Study|Withdrawal by Subject|0|||
24952245|NCT00227266|50043462|FG002|Overall Study|Withdrawal by Subject|1|||
24952246|NCT00227266|50043460|FG000|Overall Study|Protocol Violation|1|||
25039564|NCT03096847|50140409|FG001|Overall Study|Adverse Event|6|||
25039565|NCT03096847|50140410|FG002|Overall Study|Adverse Event|28|||
25039566|NCT03096847|50140408|FG000|Overall Study|Progressive disease|97|||
25039567|NCT03096847|50140409|FG001|Overall Study|Progressive disease|10|||
25039568|NCT03096847|50140410|FG002|Overall Study|Progressive disease|78|||
25039569|NCT03096847|50140408|FG000|Overall Study|Non-compliance with study medication|1|||
25039570|NCT03096847|50140409|FG001|Overall Study|Non-compliance with study medication|0|||
25039571|NCT03096847|50140410|FG002|Overall Study|Non-compliance with study medication|0|||
25039572|NCT03096847|50140408|FG000|Overall Study|New therapy for study indication|1|||
25039573|NCT03096847|50140409|FG001|Overall Study|New therapy for study indication|0|||
25039574|NCT03096847|50140410|FG002|Overall Study|New therapy for study indication|1|||
25039575|NCT01365182|50140429|FG000|Overall Study|Withdrawal by Subject|10|||
25039576|NCT01365182|50140430|FG001|Overall Study|Withdrawal by Subject|13|||
25039577|NCT01365182|50140431|FG002|Overall Study|Withdrawal by Subject|12|||
25039578|NCT03128099|50140449|FG000|Overall Study|High dose task was too long|0|||
25186328|NCT01399619|50336290|FG002|Overall Study|Lack of Efficacy|5|||
24952247|NCT00227266|50043461|FG001|Overall Study|Protocol Violation|0|||
24952248|NCT00227266|50043462|FG002|Overall Study|Protocol Violation|1|||
24952249|NCT00227266|50043460|FG000|Overall Study|Excessive weight gain|0|||
24952250|NCT00227266|50043461|FG001|Overall Study|Excessive weight gain|0|||
24952251|NCT00227266|50043462|FG002|Overall Study|Excessive weight gain|2|||
24952252|NCT00256282|50043473|FG000|Overall Study|Disease progression, relapse during acti|12|||
24952253|NCT00256282|50043473|FG000|Overall Study|Adverse Event|3|||
24952254|NCT00256282|50043473|FG000|Overall Study|Physician Decision|1|||
24952255|NCT00266877|50043480|FG000|Overall Study|Death|1|||
24952256|NCT00266877|50043481|FG001|Overall Study|Death|1|||
24952257|NCT00266877|50043482|FG002|Overall Study|Death|1|||
24952258|NCT00266877|50043480|FG000|Overall Study|Adverse Event|6|||
24952259|NCT00266877|50043481|FG001|Overall Study|Adverse Event|4|||
24952260|NCT00266877|50043482|FG002|Overall Study|Adverse Event|1|||
24952261|NCT00266877|50043480|FG000|Overall Study|Physician Decision|2|||
24952262|NCT00266877|50043481|FG001|Overall Study|Physician Decision|1|||
24952263|NCT00266877|50043482|FG002|Overall Study|Physician Decision|1|||
24952264|NCT00266877|50043480|FG000|Overall Study|Withdrawal by Subject|3|||
24952265|NCT00266877|50043481|FG001|Overall Study|Withdrawal by Subject|1|||
24952266|NCT00266877|50043482|FG002|Overall Study|Withdrawal by Subject|1|||
24952267|NCT00266877|50043480|FG000|Overall Study|Disease Progression|72|||
24952268|NCT00266877|50043481|FG001|Overall Study|Disease Progression|37|||
24952269|NCT00266877|50043482|FG002|Overall Study|Disease Progression|23|||
24952270|NCT00266877|50043480|FG000|Overall Study|Symptomatic Deterioration|6|||
24952271|NCT00266877|50043481|FG001|Overall Study|Symptomatic Deterioration|3|||
24952272|NCT00266877|50043482|FG002|Overall Study|Symptomatic Deterioration|1|||
24952273|NCT00266877|50043480|FG000|Overall Study|Hospitalization|1|||
24952274|NCT00266877|50043481|FG001|Overall Study|Hospitalization|0|||
24952275|NCT00266877|50043482|FG002|Overall Study|Hospitalization|0|||
24952276|NCT00266877|50043480|FG000|Overall Study|Concomitant Radiotherapy|0|||
24952277|NCT00266877|50043481|FG001|Overall Study|Concomitant Radiotherapy|1|||
24952278|NCT00266877|50043482|FG002|Overall Study|Concomitant Radiotherapy|0|||
24952279|NCT00256204|50043494|FG000|Overall Study|Adverse Event|10|||
24952280|NCT00256204|50043495|FG001|Overall Study|Adverse Event|14|||
24952281|NCT00256204|50043496|FG002|Overall Study|Adverse Event|16|||
24952282|NCT00256204|50043497|FG003|Overall Study|Adverse Event|14|||
24952283|NCT00256204|50043494|FG000|Overall Study|Death|0|||
24952284|NCT00256204|50043495|FG001|Overall Study|Death|1|||
24952285|NCT00256204|50043496|FG002|Overall Study|Death|0|||
24952286|NCT00256204|50043497|FG003|Overall Study|Death|0|||
24952287|NCT00256204|50043494|FG000|Overall Study|Lost to Follow-up|1|||
24952288|NCT00256204|50043495|FG001|Overall Study|Lost to Follow-up|1|||
24952289|NCT00256204|50043496|FG002|Overall Study|Lost to Follow-up|1|||
24952290|NCT00256204|50043497|FG003|Overall Study|Lost to Follow-up|2|||
24952291|NCT00256204|50043494|FG000|Overall Study|Protocol Violation|1|||
24952292|NCT00256204|50043495|FG001|Overall Study|Protocol Violation|0|||
24952293|NCT00256204|50043496|FG002|Overall Study|Protocol Violation|2|||
24952294|NCT00256204|50043497|FG003|Overall Study|Protocol Violation|1|||
25039579|NCT03128099|50140450|FG001|Overall Study|High dose task was too long|4|||
25039580|NCT03128099|50140451|FG002|Overall Study|High dose task was too long|0|||
25039581|NCT03128099|50140449|FG000|Overall Study|Participant got a full time job.|1|||
25039582|NCT03128099|50140450|FG001|Overall Study|Participant got a full time job.|0|||
25039583|NCT03128099|50140451|FG002|Overall Study|Participant got a full time job.|0|||
25039584|NCT03128099|50140449|FG000|Overall Study|Became homeless and lost contact|1|||
25039585|NCT03128099|50140450|FG001|Overall Study|Became homeless and lost contact|0|||
25039586|NCT03128099|50140451|FG002|Overall Study|Became homeless and lost contact|0|||
25039587|NCT03128099|50140449|FG000|Overall Study|Did not complete all the assessments|0|||
25039588|NCT03128099|50140450|FG001|Overall Study|Did not complete all the assessments|0|||
25039589|NCT03128099|50140451|FG002|Overall Study|Did not complete all the assessments|1|||
25039590|NCT02886494|50140459|FG000|Overall Study|Adverse Event|1|||
25039591|NCT02886494|50140460|FG001|Overall Study|Adverse Event|0|||
25276165|NCT00963820|50590160|FG006|Dose Escalation Phase|Progressive Disease|3|||
25039592|NCT02886494|50140459|FG000|Overall Study|Withdrawal by Subject|12|||
25039593|NCT02886494|50140460|FG001|Overall Study|Withdrawal by Subject|3|||
25039594|NCT02886494|50140459|FG000|Overall Study|Protocol Violation|4|||
24952295|NCT00256204|50043494|FG000|Overall Study|Physician Decision|0|||
24952296|NCT00256204|50043495|FG001|Overall Study|Physician Decision|0|||
24952297|NCT00256204|50043496|FG002|Overall Study|Physician Decision|1|||
24952298|NCT00256204|50043497|FG003|Overall Study|Physician Decision|2|||
24952299|NCT00256204|50043494|FG000|Overall Study|Withdrawal by Subject|17|||
24952300|NCT00256204|50043495|FG001|Overall Study|Withdrawal by Subject|6|||
24952301|NCT00256204|50043496|FG002|Overall Study|Withdrawal by Subject|7|||
24952302|NCT00256204|50043497|FG003|Overall Study|Withdrawal by Subject|5|||
25039595|NCT02886494|50140460|FG001|Overall Study|Protocol Violation|1|||
25039596|NCT02846532|50140472|FG000|Overall Study|Lost to Follow-up|0|||
24952303|NCT00256204|50043494|FG000|Overall Study|Need for additional prohibited treatment|38|||
24952304|NCT00256204|50043495|FG001|Overall Study|Need for additional prohibited treatment|28|||
24952305|NCT00256204|50043496|FG002|Overall Study|Need for additional prohibited treatment|27|||
24952306|NCT00256204|50043497|FG003|Overall Study|Need for additional prohibited treatment|25|||
25039597|NCT02846532|50140473|FG001|Overall Study|Lost to Follow-up|1|||
25039598|NCT02846532|50140474|FG002|Overall Study|Lost to Follow-up|1|||
25039599|NCT02846532|50140472|FG000|Overall Study|Withdrawal by Subject|1|||
25039600|NCT02846532|50140473|FG001|Overall Study|Withdrawal by Subject|2|||
25039601|NCT02846532|50140474|FG002|Overall Study|Withdrawal by Subject|0|||
25039602|NCT00842348|50140493|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
24952307|NCT00256126|50043512|FG000|Overall Study|Adverse Event|1|||
24952308|NCT00256126|50043513|FG001|Overall Study|Adverse Event|0|||
25039603|NCT00842348|50140494|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
25039604|NCT00842348|50140493|FG000|Study 729|Disease progression/death|19|||
25039605|NCT00842348|50140494|FG001|Study 729|Disease progression/death|30|||
25039606|NCT00842348|50140493|FG000|Study 729|Adverse Event|1|||
25039607|NCT00842348|50140494|FG001|Study 729|Adverse Event|1|||
25039608|NCT00842348|50140493|FG000|Study 729|Protocol Violation|1|||
25039609|NCT00842348|50140494|FG001|Study 729|Protocol Violation|1|||
25039610|NCT00842348|50140493|FG000|Study 729|Withdrawal by Subject|2|||
25039611|NCT00842348|50140494|FG001|Study 729|Withdrawal by Subject|4|||
25039612|NCT00842348|50140493|FG000|Study 729|Due to Sponsor stopping the study|1|||
25039613|NCT00842348|50140494|FG001|Study 729|Due to Sponsor stopping the study|1|||
25039614|NCT00842348|50140493|FG000|Study 729|Due to non-availability of IP|0|||
25039615|NCT00842348|50140494|FG001|Study 729|Due to non-availability of IP|1|||
25039616|NCT00842348|50140493|FG000|Study 729|Sponsor's decision|1|||
25039617|NCT00842348|50140494|FG001|Study 729|Sponsor's decision|0|||
25039618|NCT00842348|50140493|FG000|Study 729|Surgical resection|1|||
25039619|NCT00842348|50140494|FG001|Study 729|Surgical resection|0|||
25039620|NCT03095599|50140506|FG000|Overall Study|Withdrawal by Subject|1|||
25039621|NCT03095599|50140507|FG001|Overall Study|Withdrawal by Subject|0|||
25039622|NCT03095599|50140506|FG000|Overall Study|Lost to Follow-up|1|||
25039623|NCT03095599|50140507|FG001|Overall Study|Lost to Follow-up|0|||
24952309|NCT00256126|50043512|FG000|Overall Study|Other|1|||
24952310|NCT00256126|50043513|FG001|Overall Study|Other|2|||
24952311|NCT00278889|50043522|FG000|Overall Study|Withdrawal by Subject|0|||
24952312|NCT00278889|50043523|FG001|Overall Study|Withdrawal by Subject|5|||
24952313|NCT00278889|50043524|FG002|Overall Study|Withdrawal by Subject|3|||
24952314|NCT00278889|50043522|FG000|Overall Study|Lost to Follow-up|1|||
24952315|NCT00278889|50043523|FG001|Overall Study|Lost to Follow-up|1|||
24952316|NCT00278889|50043524|FG002|Overall Study|Lost to Follow-up|0|||
24952317|NCT00278889|50043522|FG000|Overall Study|Death|24|||
24952318|NCT00278889|50043523|FG001|Overall Study|Death|21|||
24952319|NCT00278889|50043524|FG002|Overall Study|Death|17|||
24952320|NCT00278109|50043532|FG000|Overall Study|Adverse Event|3|||
24952321|NCT00278109|50043532|FG000|Overall Study|social circumstances|1|||
24952322|NCT00296517|50043538|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
24952323|NCT00296517|50043539|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
24952324|NCT00296517|50043538|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
24952325|NCT00296517|50043539|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
24952326|NCT00296517|50043538|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
24952327|NCT00296517|50043539|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
24952328|NCT00296517|50043538|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
24952329|NCT00296517|50043539|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
25039624|NCT03095599|50140506|FG000|Overall Study|Withdrawal prior to vaccination|1|||
25039625|NCT03095599|50140507|FG001|Overall Study|Withdrawal prior to vaccination|0|||
25039626|NCT03095521|50140517|FG000|Overall Study|Withdrawal by Subject|0|||
25039627|NCT03095521|50140518|FG001|Overall Study|Withdrawal by Subject|1|||
25039628|NCT03095521|50140517|FG000|Overall Study|Lost to Follow-up|0|||
25039629|NCT03095521|50140518|FG001|Overall Study|Lost to Follow-up|1|||
25039630|NCT03033875|50140527|FG000|Overall Study|Withdrawal by Subject|5|||
25039631|NCT03033875|50140528|FG001|Overall Study|Withdrawal by Subject|9|||
25039632|NCT03033875|50140529|FG002|Overall Study|Withdrawal by Subject|4|||
24952330|NCT00296517|50043538|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
24952331|NCT00296517|50043539|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
25039633|NCT03033875|50140527|FG000|Overall Study|Other|14|||
25039634|NCT03033875|50140528|FG001|Overall Study|Other|15|||
25039635|NCT03033875|50140529|FG002|Overall Study|Other|8|||
25039636|NCT01968785|50140547|FG000|Overall Study|Withdrawal by Subject|1|||
25039637|NCT01968785|50140548|FG001|Overall Study|Withdrawal by Subject|0|||
24952332|NCT00296517|50043538|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
24952333|NCT00296517|50043539|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
24952334|NCT00296517|50043538|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
24952335|NCT00296517|50043539|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
25039638|NCT03095287|50140554|FG000|Overall Study|Treatment Failure|1|||
25039639|NCT03095287|50140554|FG000|Overall Study|Adverse Event|1|||
25039640|NCT02839746|50140572|FG000|Overall Study|Not met selection criteria|12|||
25039641|NCT00033293|50140578|FG000|Overall Study|Death|0|||
25039642|NCT00033293|50140579|FG001|Overall Study|Death|1|||
24952336|NCT00296517|50043538|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
24952337|NCT00296517|50043539|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
24952338|NCT00296517|50043538|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
24952339|NCT00296517|50043539|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
24952340|NCT00224770|50043548|FG000|Overall Study|Lost to Follow-up|4|||
24952341|NCT00224770|50043549|FG001|Overall Study|Lost to Follow-up|2|||
24952342|NCT00224770|50043550|FG002|Overall Study|Lost to Follow-up|0|||
24952343|NCT00266409|50043563|FG000|Overall Study|Lack of Efficacy|2|||
24952344|NCT00266409|50043564|FG001|Overall Study|Lack of Efficacy|6|||
24952345|NCT00266409|50043565|FG002|Overall Study|Lack of Efficacy|1|||
24952346|NCT00266409|50043566|FG003|Overall Study|Lack of Efficacy|2|||
24952347|NCT00266409|50043563|FG000|Overall Study|Adverse Event|7|||
25039643|NCT00033293|50140578|FG000|Overall Study|Lack of Efficacy|5|||
25039644|NCT00033293|50140579|FG001|Overall Study|Lack of Efficacy|8|||
25039645|NCT00033293|50140578|FG000|Overall Study|Lost to Follow-up|0|||
25039646|NCT00033293|50140579|FG001|Overall Study|Lost to Follow-up|1|||
25039647|NCT00033293|50140578|FG000|Overall Study|Physician Decision|3|||
25039648|NCT00033293|50140579|FG001|Overall Study|Physician Decision|1|||
25039649|NCT00033293|50140578|FG000|Overall Study|Withdrawal by Subject|1|||
25039650|NCT00033293|50140579|FG001|Overall Study|Withdrawal by Subject|0|||
25039651|NCT00033293|50140578|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
25039652|NCT00033293|50140579|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
25039653|NCT00033293|50140578|FG000|Overall Study|Treatment refused|0|||
25039654|NCT00033293|50140579|FG001|Overall Study|Treatment refused|6|||
25039655|NCT02836236|50140589|FG000|Overall Study|Randomized but Never Treated|1|||
25039656|NCT02836236|50140590|FG001|Overall Study|Randomized but Never Treated|0|||
25039657|NCT02836236|50140589|FG000|Overall Study|Withdrew Consent|2|||
25039658|NCT02836236|50140590|FG001|Overall Study|Withdrew Consent|0|||
25039659|NCT02836236|50140589|FG000|Overall Study|Adverse Event|0|||
24952348|NCT00266409|50043564|FG001|Overall Study|Adverse Event|2|||
24952349|NCT00266409|50043565|FG002|Overall Study|Adverse Event|1|||
24952350|NCT00266409|50043566|FG003|Overall Study|Adverse Event|1|||
24952351|NCT00266409|50043563|FG000|Overall Study|Lost to Follow-up|18|||
24952352|NCT00266409|50043564|FG001|Overall Study|Lost to Follow-up|21|||
24952353|NCT00266409|50043565|FG002|Overall Study|Lost to Follow-up|6|||
24952354|NCT00266409|50043566|FG003|Overall Study|Lost to Follow-up|8|||
24952355|NCT00266409|50043563|FG000|Overall Study|Withdrawal by Subject|6|||
24952356|NCT00266409|50043564|FG001|Overall Study|Withdrawal by Subject|10|||
24952357|NCT00266409|50043565|FG002|Overall Study|Withdrawal by Subject|3|||
24952358|NCT00266409|50043566|FG003|Overall Study|Withdrawal by Subject|9|||
24952359|NCT00266409|50043563|FG000|Overall Study|Protocol Violation|5|||
24952360|NCT00266409|50043564|FG001|Overall Study|Protocol Violation|3|||
24952361|NCT00266409|50043565|FG002|Overall Study|Protocol Violation|4|||
24952362|NCT00266409|50043566|FG003|Overall Study|Protocol Violation|2|||
24952363|NCT00266409|50043563|FG000|Overall Study|Other|7|||
24952364|NCT00266409|50043564|FG001|Overall Study|Other|4|||
24952365|NCT00266409|50043565|FG002|Overall Study|Other|2|||
24952366|NCT00266409|50043566|FG003|Overall Study|Other|0|||
24952367|NCT00277095|50043576|FG000|Overall Study|Death|2|||
24952368|NCT00277095|50043576|FG000|Overall Study|Explanted|7|||
24952369|NCT00277095|50043576|FG000|Overall Study|Lost to Follow-up|2|||
24952370|NCT00277095|50043576|FG000|Overall Study|Missed Follow-up|9|||
24952371|NCT00277095|50043576|FG000|Overall Study|Physician Decision|1|||
24952372|NCT00265785|50043580|FG000|Overall Study|Adverse Event|4|||
24952373|NCT00265785|50043580|FG000|Overall Study|Withdrawal by Subject|3|||
24952374|NCT00265785|50043580|FG000|Overall Study|Progression/Relapse|15|||
24952375|NCT00265785|50043580|FG000|Overall Study|Not protocol specified|2|||
24952376|NCT00265785|50043580|FG000|Overall Study|Ineligible|1|||
24952377|NCT00265785|50043580|FG000|Overall Study|Did not receive protocol treatment|2|||
24952378|NCT00276159|50043584|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
25039660|NCT02836236|50140590|FG001|Overall Study|Adverse Event|1|||
25039661|NCT02836236|50140589|FG000|Overall Study|Investigator's Discretion|1|||
25039662|NCT02836236|50140590|FG001|Overall Study|Investigator's Discretion|0|||
24952379|NCT00265395|50043590|FG000|Overall Study|Adverse Event|3|||
24952380|NCT00265395|50043591|FG001|Overall Study|Adverse Event|6|||
24952381|NCT00265395|50043590|FG000|Overall Study|Lost to Follow-up|2|||
25160204|NCT01832155|50280300|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
24952382|NCT00265395|50043591|FG001|Overall Study|Lost to Follow-up|1|||
24952383|NCT00265395|50043590|FG000|Overall Study|Withdrawal by Subject|1|||
24952384|NCT00265395|50043591|FG001|Overall Study|Withdrawal by Subject|6|||
24952385|NCT00265395|50043590|FG000|Overall Study|Protocol Violation|2|||
24952386|NCT00265395|50043591|FG001|Overall Study|Protocol Violation|2|||
24952387|NCT00265395|50043590|FG000|Overall Study|Lack of Efficacy|0|||
24952388|NCT00265395|50043591|FG001|Overall Study|Lack of Efficacy|1|||
24952389|NCT00265395|50043590|FG000|Overall Study|Administrative|0|||
24952390|NCT00265395|50043591|FG001|Overall Study|Administrative|1|||
24952391|NCT00195442|50043596|FG000|Overall Study|Less than expected therapeutic effect|38|||
24952392|NCT00195442|50043596|FG000|Overall Study|Lost to Follow-up|27|||
24952393|NCT00195442|50043596|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
24952394|NCT00195442|50043596|FG000|Overall Study|Intermittent product shortage|21|||
24952395|NCT00195442|50043596|FG000|Overall Study|Death|7|||
24952396|NCT00195442|50043596|FG000|Overall Study|No reason specified|4|||
24952397|NCT00195442|50043596|FG000|Overall Study|Poor cooperation|2|||
24952398|NCT00195442|50043596|FG000|Overall Study|Other|14|||
24952399|NCT00275301|50043600|FG000|Overall Study|Adverse Event|5|||
24952400|NCT00251745|50043607|FG000|Overall Study|Adverse Event|7|||
24952401|NCT00251745|50043608|FG001|Overall Study|Adverse Event|9|||
24952402|NCT00251745|50043609|FG002|Overall Study|Adverse Event|11|||
24952403|NCT00251745|50043607|FG000|Overall Study|Lost to Follow-up|4|||
24952404|NCT00251745|50043608|FG001|Overall Study|Lost to Follow-up|2|||
24952405|NCT00251745|50043609|FG002|Overall Study|Lost to Follow-up|5|||
24952406|NCT00251745|50043607|FG000|Overall Study|Withdrawal by Subject|13|||
24952407|NCT00251745|50043608|FG001|Overall Study|Withdrawal by Subject|7|||
24952408|NCT00251745|50043609|FG002|Overall Study|Withdrawal by Subject|3|||
24952409|NCT00251745|50043607|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
24952410|NCT00251745|50043608|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
24952411|NCT00251745|50043609|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
24952412|NCT00251745|50043607|FG000|Overall Study|Lack of Efficacy|3|||
24952413|NCT00251745|50043608|FG001|Overall Study|Lack of Efficacy|0|||
24952414|NCT00251745|50043609|FG002|Overall Study|Lack of Efficacy|0|||
24952415|NCT00251745|50043607|FG000|Overall Study|Noncompliant|0|||
24952416|NCT00251745|50043608|FG001|Overall Study|Noncompliant|2|||
24952417|NCT00251745|50043609|FG002|Overall Study|Noncompliant|2|||
24952418|NCT00251745|50043607|FG000|Overall Study|Pregnancy|0|||
24952419|NCT00251745|50043608|FG001|Overall Study|Pregnancy|1|||
24952420|NCT00251745|50043609|FG002|Overall Study|Pregnancy|0|||
24952421|NCT00251745|50043607|FG000|Overall Study|Per Subject Request|0|||
24952422|NCT00251745|50043608|FG001|Overall Study|Per Subject Request|0|||
24952423|NCT00251745|50043609|FG002|Overall Study|Per Subject Request|1|||
25039663|NCT02836236|50140589|FG000|Overall Study|Still on Study|101|||
25039664|NCT02836236|50140590|FG001|Overall Study|Still on Study|49|||
25039665|NCT02039674|50140610|FG000|Overall Study|Adverse Event|0|||
25039666|NCT02039674|50140611|FG001|Overall Study|Adverse Event|0|||
25039667|NCT02039674|50140612|FG002|Overall Study|Adverse Event|0|||
25039668|NCT02039674|50140613|FG003|Overall Study|Adverse Event|1|||
25039669|NCT02039674|50140614|FG004|Overall Study|Adverse Event|0|||
25039670|NCT02039674|50140615|FG005|Overall Study|Adverse Event|0|||
25039671|NCT02039674|50140616|FG006|Overall Study|Adverse Event|0|||
25039672|NCT02039674|50140617|FG007|Overall Study|Adverse Event|0|||
25039673|NCT02039674|50140618|FG008|Overall Study|Adverse Event|2|||
25039674|NCT02039674|50140619|FG009|Overall Study|Adverse Event|1|||
25039675|NCT02039674|50140620|FG010|Overall Study|Adverse Event|0|||
25039676|NCT02039674|50140621|FG011|Overall Study|Adverse Event|2|||
25039677|NCT02039674|50140622|FG012|Overall Study|Adverse Event|3|||
25039678|NCT02039674|50140623|FG013|Overall Study|Adverse Event|1|||
25039679|NCT02039674|50140610|FG000|Overall Study|Death|2|||
25039680|NCT02039674|50140611|FG001|Overall Study|Death|0|||
25039681|NCT02039674|50140612|FG002|Overall Study|Death|2|||
25039682|NCT02039674|50140613|FG003|Overall Study|Death|3|||
25039683|NCT02039674|50140614|FG004|Overall Study|Death|0|||
25039684|NCT02039674|50140615|FG005|Overall Study|Death|0|||
25039685|NCT02039674|50140616|FG006|Overall Study|Death|1|||
25039686|NCT02039674|50140617|FG007|Overall Study|Death|0|||
25039687|NCT02039674|50140618|FG008|Overall Study|Death|2|||
25039688|NCT02039674|50140619|FG009|Overall Study|Death|0|||
25039689|NCT02039674|50140620|FG010|Overall Study|Death|1|||
25039690|NCT02039674|50140621|FG011|Overall Study|Death|3|||
24952424|NCT00251745|50043607|FG000|Overall Study|Per Investigator Request|1|||
24952425|NCT00251745|50043608|FG001|Overall Study|Per Investigator Request|0|||
24952426|NCT00251745|50043609|FG002|Overall Study|Per Investigator Request|0|||
24952427|NCT00255190|50043619|FG000|Overall Study|Adverse Event|17|||
25039691|NCT02039674|50140622|FG012|Overall Study|Death|2|||
24952428|NCT00255190|50043620|FG001|Overall Study|Adverse Event|36|||
24952429|NCT00255190|50043619|FG000|Overall Study|Protocol Violation|2|||
24952430|NCT00255190|50043620|FG001|Overall Study|Protocol Violation|2|||
25039692|NCT02039674|50140623|FG013|Overall Study|Death|8|||
25039693|NCT02039674|50140610|FG000|Overall Study|Excluded Medication|1|||
25039694|NCT02039674|50140611|FG001|Overall Study|Excluded Medication|1|||
24952431|NCT00255190|50043619|FG000|Overall Study|Lost to Follow-up|10|||
25039695|NCT02039674|50140612|FG002|Overall Study|Excluded Medication|0|||
25039696|NCT02039674|50140613|FG003|Overall Study|Excluded Medication|1|||
25039697|NCT02039674|50140614|FG004|Overall Study|Excluded Medication|0|||
25039698|NCT02039674|50140615|FG005|Overall Study|Excluded Medication|1|||
25039699|NCT02039674|50140616|FG006|Overall Study|Excluded Medication|0|||
25039700|NCT02039674|50140617|FG007|Overall Study|Excluded Medication|0|||
24952432|NCT00255190|50043620|FG001|Overall Study|Lost to Follow-up|27|||
24952433|NCT00255190|50043619|FG000|Overall Study|Withdrew Consent|17|||
24952434|NCT00255190|50043620|FG001|Overall Study|Withdrew Consent|48|||
24952435|NCT00255190|50043619|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
24952436|NCT00255190|50043620|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
24952437|NCT00255190|50043619|FG000|Overall Study|Erosive esophagitis not healed|0|||
24952438|NCT00255190|50043620|FG001|Overall Study|Erosive esophagitis not healed|20|||
24952439|NCT00255190|50043619|FG000|Overall Study|Various|4|||
24952440|NCT00255190|50043620|FG001|Overall Study|Various|23|||
24952441|NCT00359424|50043628|FG000|Overall Study|Death|99|||
24952442|NCT00359424|50043629|FG001|Overall Study|Death|58|||
24952443|NCT00359424|50043628|FG000|Overall Study|Lost to Follow-up|19|||
25039701|NCT02039674|50140618|FG008|Overall Study|Excluded Medication|2|||
25039702|NCT02039674|50140619|FG009|Overall Study|Excluded Medication|3|||
25039703|NCT02039674|50140620|FG010|Overall Study|Excluded Medication|5|||
25039704|NCT02039674|50140621|FG011|Overall Study|Excluded Medication|6|||
25039705|NCT02039674|50140622|FG012|Overall Study|Excluded Medication|8|||
25039706|NCT02039674|50140623|FG013|Overall Study|Excluded Medication|3|||
25039707|NCT02039674|50140610|FG000|Overall Study|Lost to Follow-up|0|||
25039708|NCT02039674|50140611|FG001|Overall Study|Lost to Follow-up|0|||
25039709|NCT02039674|50140612|FG002|Overall Study|Lost to Follow-up|0|||
25039710|NCT02039674|50140613|FG003|Overall Study|Lost to Follow-up|0|||
25039711|NCT02039674|50140614|FG004|Overall Study|Lost to Follow-up|1|||
25039712|NCT02039674|50140615|FG005|Overall Study|Lost to Follow-up|1|||
25039713|NCT02039674|50140616|FG006|Overall Study|Lost to Follow-up|0|||
25039714|NCT02039674|50140617|FG007|Overall Study|Lost to Follow-up|0|||
25039715|NCT02039674|50140618|FG008|Overall Study|Lost to Follow-up|0|||
25039716|NCT02039674|50140619|FG009|Overall Study|Lost to Follow-up|0|||
25039717|NCT02039674|50140620|FG010|Overall Study|Lost to Follow-up|0|||
25039718|NCT02039674|50140621|FG011|Overall Study|Lost to Follow-up|2|||
25039719|NCT02039674|50140622|FG012|Overall Study|Lost to Follow-up|2|||
25039720|NCT02039674|50140623|FG013|Overall Study|Lost to Follow-up|1|||
25039721|NCT02039674|50140610|FG000|Overall Study|Physician Decision|0|||
25039722|NCT02039674|50140611|FG001|Overall Study|Physician Decision|0|||
25039723|NCT02039674|50140612|FG002|Overall Study|Physician Decision|0|||
25039724|NCT02039674|50140613|FG003|Overall Study|Physician Decision|0|||
25039725|NCT02039674|50140614|FG004|Overall Study|Physician Decision|0|||
25039726|NCT02039674|50140615|FG005|Overall Study|Physician Decision|0|||
25039727|NCT02039674|50140616|FG006|Overall Study|Physician Decision|0|||
25039728|NCT02039674|50140617|FG007|Overall Study|Physician Decision|0|||
24952444|NCT00359424|50043629|FG001|Overall Study|Lost to Follow-up|7|||
24952445|NCT00359424|50043628|FG000|Overall Study|Withdrawal by Subject|10|||
24952446|NCT00359424|50043629|FG001|Overall Study|Withdrawal by Subject|2|||
24952447|NCT00359424|50043628|FG000|Overall Study|follow up not conducted|2|||
24952448|NCT00359424|50043629|FG001|Overall Study|follow up not conducted|0|||
24952449|NCT00255034|50043637|FG000|Overall Study|Withdrawal by Subject|15|||
24952450|NCT00255034|50043638|FG001|Overall Study|Withdrawal by Subject|38|||
24952451|NCT00254566|50043646|FG000|Overall Study|Death|1|||
24952452|NCT00254566|50043647|FG001|Overall Study|Death|0|||
24952453|NCT00254566|50043646|FG000|Overall Study|Adverse Event|5|||
24952454|NCT00254566|50043647|FG001|Overall Study|Adverse Event|4|||
24952455|NCT00254566|50043646|FG000|Overall Study|Lack of Efficacy|12|||
24952456|NCT00254566|50043647|FG001|Overall Study|Lack of Efficacy|9|||
24952457|NCT00254566|50043646|FG000|Overall Study|Other|1|||
24952458|NCT00254566|50043647|FG001|Overall Study|Other|5|||
24952459|NCT00254566|50043646|FG000|Overall Study|Withdrawal by Subject|5|||
24952460|NCT00254566|50043647|FG001|Overall Study|Withdrawal by Subject|6|||
24952461|NCT00254566|50043646|FG000|Overall Study|Lost to Follow-up|7|||
25039729|NCT02039674|50140618|FG008|Overall Study|Physician Decision|0|||
25039730|NCT02039674|50140619|FG009|Overall Study|Physician Decision|0|||
25039731|NCT02039674|50140620|FG010|Overall Study|Physician Decision|0|||
25039732|NCT02039674|50140621|FG011|Overall Study|Physician Decision|1|||
24952462|NCT00254566|50043647|FG001|Overall Study|Lost to Follow-up|2|||
24952463|NCT00358956|50043653|FG000|Overall Study|Adverse Event|3|||
24952464|NCT00358956|50043653|FG000|Overall Study|condition under investigation worsened|4|||
24952465|NCT00358956|50043653|FG000|Overall Study|Withdrawal by Subject|1|||
24952466|NCT03830892|50043659|FG000|Overall Study|Physician Decision|2|||
24952467|NCT03830892|50043660|FG001|Overall Study|Physician Decision|3|||
24952468|NCT03830892|50043659|FG000|Overall Study|Study terminated due to COVID|4|||
24952469|NCT03830892|50043660|FG001|Overall Study|Study terminated due to COVID|0|||
24952470|NCT03830892|50043659|FG000|Overall Study|Protocol Violation|0|||
24952471|NCT03830892|50043660|FG001|Overall Study|Protocol Violation|1|||
24952472|NCT03830892|50043659|FG000|Overall Study|Withdrawal by Subject|0|||
24952473|NCT03830892|50043660|FG001|Overall Study|Withdrawal by Subject|2|||
24952474|NCT00253630|50043666|FG000|Overall Study|ineligible|2|||
24952475|NCT00358644|50043670|FG000|Overall Study|Progressive Disease|21|||
24952476|NCT00358644|50043670|FG000|Overall Study|Adverse Event|7|||
24952477|NCT00358644|50043670|FG000|Overall Study|Death|11|||
24952478|NCT00358644|50043670|FG000|Overall Study|Withdrawal by Subject|4|||
24952479|NCT00358644|50043670|FG000|Overall Study|Physician Decision|6|||
24952480|NCT00358644|50043670|FG000|Overall Study|Patient not eligible for study|1|||
24952481|NCT00364182|50043677|FG000|First Intervention|Secondary prophylaxis|1|||
24952482|NCT00364182|50043678|FG001|First Intervention|Secondary prophylaxis|0|||
24952483|NCT00364182|50043679|FG002|First Intervention|Secondary prophylaxis|0|||
24952484|NCT00364182|50043677|FG000|First Intervention|Withdrawal by Subject|2|||
24952485|NCT00364182|50043678|FG001|First Intervention|Withdrawal by Subject|0|||
24952486|NCT00364182|50043679|FG002|First Intervention|Withdrawal by Subject|0|||
24952487|NCT00364182|50043677|FG000|Second Intervention|non-compliance|0|||
24952488|NCT00364182|50043678|FG001|Second Intervention|non-compliance|1|||
24952489|NCT00364182|50043679|FG002|Second Intervention|non-compliance|1|||
24952490|NCT00364182|50043677|FG000|Second Intervention|Protocol Violation|0|||
24952491|NCT00364182|50043678|FG001|Second Intervention|Protocol Violation|1|||
24952492|NCT00364182|50043679|FG002|Second Intervention|Protocol Violation|0|||
24952493|NCT00364182|50043677|FG000|Second Intervention|Adverse Event|0|||
24952494|NCT00364182|50043678|FG001|Second Intervention|Adverse Event|0|||
24952495|NCT00364182|50043679|FG002|Second Intervention|Adverse Event|1|||
24952496|NCT00364182|50043677|FG000|Third Intervention|non-compliance|0|||
25039733|NCT02039674|50140622|FG012|Overall Study|Physician Decision|1|||
24952497|NCT00364182|50043678|FG001|Third Intervention|non-compliance|1|||
24952498|NCT00364182|50043679|FG002|Third Intervention|non-compliance|0|||
24952499|NCT00364182|50043677|FG000|Third Intervention|Lost to Follow-up|0|||
24952500|NCT00364182|50043678|FG001|Third Intervention|Lost to Follow-up|0|||
24952501|NCT00364182|50043679|FG002|Third Intervention|Lost to Follow-up|1|||
24952502|NCT00369486|50043694|FG000|4-Week Visit|Missed visit|2|||
24952503|NCT00369486|50043695|FG001|4-Week Visit|Missed visit|2|||
24952504|NCT00369486|50043696|FG002|4-Week Visit|Missed visit|0|||
25039734|NCT02039674|50140623|FG013|Overall Study|Physician Decision|0|||
24952505|NCT00369486|50043697|FG003|4-Week Visit|Missed visit|2|||
24952506|NCT00369486|50043698|FG004|4-Week Visit|Missed visit|1|||
24952507|NCT00369486|50043694|FG000|4-Week Visit|Dropped|0|||
24952508|NCT00369486|50043695|FG001|4-Week Visit|Dropped|0|||
24952509|NCT00369486|50043696|FG002|4-Week Visit|Dropped|1|||
24952510|NCT00369486|50043697|FG003|4-Week Visit|Dropped|0|||
24952511|NCT00369486|50043698|FG004|4-Week Visit|Dropped|0|||
24952512|NCT00369486|50043694|FG000|8-Week Visit|Missed visit|0|||
24952513|NCT00369486|50043695|FG001|8-Week Visit|Missed visit|1|||
25039735|NCT02039674|50140610|FG000|Overall Study|Progressive Disease|8|||
25039736|NCT02039674|50140611|FG001|Overall Study|Progressive Disease|8|||
25039737|NCT02039674|50140612|FG002|Overall Study|Progressive Disease|6|||
25039738|NCT02039674|50140613|FG003|Overall Study|Progressive Disease|7|||
25039739|NCT02039674|50140614|FG004|Overall Study|Progressive Disease|9|||
25039740|NCT02039674|50140615|FG005|Overall Study|Progressive Disease|10|||
25039741|NCT02039674|50140616|FG006|Overall Study|Progressive Disease|1|||
25039742|NCT02039674|50140617|FG007|Overall Study|Progressive Disease|3|||
25039743|NCT02039674|50140618|FG008|Overall Study|Progressive Disease|6|||
25039744|NCT02039674|50140619|FG009|Overall Study|Progressive Disease|4|||
25039745|NCT02039674|50140620|FG010|Overall Study|Progressive Disease|0|||
24952514|NCT00369486|50043696|FG002|8-Week Visit|Missed visit|0|||
24952515|NCT00369486|50043697|FG003|8-Week Visit|Missed visit|0|||
24952516|NCT00369486|50043698|FG004|8-Week Visit|Missed visit|1|||
24952517|NCT00369486|50043694|FG000|8-Week Visit|Dropped|0|||
24952518|NCT00369486|50043695|FG001|8-Week Visit|Dropped|0|||
24952519|NCT00369486|50043696|FG002|8-Week Visit|Dropped|0|||
25039746|NCT02039674|50140621|FG011|Overall Study|Progressive Disease|34|||
25039747|NCT02039674|50140622|FG012|Overall Study|Progressive Disease|34|||
25039748|NCT02039674|50140623|FG013|Overall Study|Progressive Disease|18|||
25039749|NCT02039674|50140610|FG000|Overall Study|Withdrawal by Subject|1|||
25039750|NCT02039674|50140611|FG001|Overall Study|Withdrawal by Subject|2|||
25039751|NCT02039674|50140612|FG002|Overall Study|Withdrawal by Subject|3|||
25039752|NCT02039674|50140613|FG003|Overall Study|Withdrawal by Subject|0|||
25039753|NCT02039674|50140614|FG004|Overall Study|Withdrawal by Subject|1|||
25276166|NCT00963820|50590161|FG007|Dose Escalation Phase|Progressive Disease|2|||
24952520|NCT00369486|50043697|FG003|8-Week Visit|Dropped|1|||
24952521|NCT00369486|50043698|FG004|8-Week Visit|Dropped|0|||
24952522|NCT00369486|50043694|FG000|17-Week Visit|Missed visit|0|||
25039754|NCT02039674|50140615|FG005|Overall Study|Withdrawal by Subject|0|||
24952523|NCT00369486|50043695|FG001|17-Week Visit|Missed visit|0|||
25039755|NCT02039674|50140616|FG006|Overall Study|Withdrawal by Subject|0|||
24952524|NCT00369486|50043696|FG002|17-Week Visit|Missed visit|1|||
24952525|NCT00369486|50043697|FG003|17-Week Visit|Missed visit|1|||
24952526|NCT00369486|50043698|FG004|17-Week Visit|Missed visit|1|||
24952527|NCT00369486|50043694|FG000|34-Week Visit|Dropped|0|||
24952528|NCT00369486|50043695|FG001|34-Week Visit|Dropped|1|||
25039756|NCT02039674|50140617|FG007|Overall Study|Withdrawal by Subject|0|||
24952529|NCT00369486|50043696|FG002|34-Week Visit|Dropped|1|||
24952530|NCT00369486|50043697|FG003|34-Week Visit|Dropped|3|||
24952531|NCT00369486|50043698|FG004|34-Week Visit|Dropped|3|||
24952532|NCT00363480|50043710|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
24952533|NCT00363480|50043710|FG000|Overall Study|Adverse Event|4|||
24952534|NCT00363480|50043710|FG000|Overall Study|Lost to Follow-up|5|||
24952535|NCT00363480|50043710|FG000|Overall Study|Withdrawal by Subject|5|||
24952536|NCT00363480|50043710|FG000|Overall Study|Non-compliance of subject|1|||
24952537|NCT00363480|50043710|FG000|Overall Study|Participant discontinued on its own|1|||
24952538|NCT00363246|50043714|FG000|Overall Study|Death|40|||
24952539|NCT00363246|50043714|FG000|Overall Study|Withdrawal by Subject|19|||
24952540|NCT00363246|50043714|FG000|Overall Study|Lost to Follow-up|14|||
24952541|NCT00363246|50043714|FG000|Overall Study|Bad health|6|||
24952542|NCT00363246|50043714|FG000|Overall Study|Stopped using wheelchair|11|||
24952543|NCT00363246|50043714|FG000|Overall Study|Subject expressed security concerns|2|||
24952544|NCT00363246|50043714|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
24952545|NCT00223990|50043721|FG000|Overall Study|Moved from area|2|||
24952546|NCT00223990|50043722|FG001|Overall Study|Moved from area|1|||
24952547|NCT00223990|50043721|FG000|Overall Study|Withdrawal by Subject|4|||
24952548|NCT00223990|50043722|FG001|Overall Study|Withdrawal by Subject|8|||
24952549|NCT00223990|50043721|FG000|Overall Study|Lost to Follow-up|1|||
24952550|NCT00223990|50043722|FG001|Overall Study|Lost to Follow-up|0|||
24952551|NCT00221104|50043730|FG000|Overall Study|Adverse Event|1|||
24952552|NCT00221104|50043731|FG001|Overall Study|Adverse Event|0|||
24952553|NCT00221104|50043730|FG000|Overall Study|Physician Decision|1|||
24952554|NCT00221104|50043731|FG001|Overall Study|Physician Decision|0|||
24952555|NCT00221104|50043730|FG000|Overall Study|Protocol Violation|2|||
24952556|NCT00221104|50043731|FG001|Overall Study|Protocol Violation|0|||
24952557|NCT00221104|50043730|FG000|Overall Study|Withdrawal by Subject|42|||
24952558|NCT00221104|50043731|FG001|Overall Study|Withdrawal by Subject|29|||
24952559|NCT00221104|50043730|FG000|Overall Study|Others|37|||
24952560|NCT00221104|50043731|FG001|Overall Study|Others|47|||
24952561|NCT00189202|50043739|FG000|Overall Study|Physician Decision|5|||
24952562|NCT00187486|50043743|FG000|Overall Study|Protocol Violation|1|||
24952563|NCT00220636|50043747|FG000|Overall Study|Withdrawal by Subject|4|||
24952564|NCT00362232|50043754|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
24952565|NCT00362232|50043755|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
25039757|NCT02039674|50140618|FG008|Overall Study|Withdrawal by Subject|0|||
25039758|NCT02039674|50140619|FG009|Overall Study|Withdrawal by Subject|1|||
25039759|NCT02039674|50140620|FG010|Overall Study|Withdrawal by Subject|1|||
25039760|NCT02039674|50140621|FG011|Overall Study|Withdrawal by Subject|4|||
25039761|NCT02039674|50140622|FG012|Overall Study|Withdrawal by Subject|6|||
25039762|NCT02039674|50140623|FG013|Overall Study|Withdrawal by Subject|2|||
25039763|NCT02039674|50140610|FG000|Overall Study|Clinical Progression|0|||
25276167|NCT00963820|50590162|FG008|Dose Escalation Phase|Progressive Disease|0|||
24952566|NCT00362232|50043754|FG000|Treatment (12 +/- 2 Days)|Death|1|||
24952567|NCT00362232|50043755|FG001|Treatment (12 +/- 2 Days)|Death|3|||
24952568|NCT00362232|50043754|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
24952569|NCT00362232|50043755|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
24952570|NCT00362232|50043754|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
24952571|NCT00362232|50043755|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
24952572|NCT00362232|50043754|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
24952573|NCT00362232|50043755|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
24952574|NCT00362232|50043754|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
24952575|NCT00362232|50043755|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
24952576|NCT00362232|50043754|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
25276168|NCT00963820|50590163|FG009|Dose Escalation Phase|Progressive Disease|0|||
24952577|NCT00362232|50043755|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
24952578|NCT00362232|50043754|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
24952579|NCT00362232|50043755|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
24952580|NCT00362232|50043754|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
24952581|NCT00362232|50043755|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
24952582|NCT00362232|50043754|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
25039764|NCT02039674|50140611|FG001|Overall Study|Clinical Progression|0|||
24952583|NCT00362232|50043755|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
24952584|NCT00362232|50043754|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
24952585|NCT00362232|50043755|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
24952586|NCT00362232|50043754|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
24952587|NCT00362232|50043755|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
24952588|NCT00362232|50043754|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
24952589|NCT00362232|50043755|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
24952590|NCT00219544|50043761|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
24952591|NCT00219544|50043762|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
24952592|NCT00219544|50043761|FG000|Single Blind Treatment Period|Adverse Event|9|||
24952593|NCT00219544|50043762|FG001|Single Blind Treatment Period|Adverse Event|0|||
24952594|NCT00219544|50043761|FG000|Single Blind Treatment Period|Protocol Violation|4|||
24952595|NCT00219544|50043762|FG001|Single Blind Treatment Period|Protocol Violation|0|||
24952596|NCT00219544|50043761|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
24952597|NCT00219544|50043762|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
24952598|NCT00219544|50043761|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
24952599|NCT00219544|50043762|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
24952600|NCT00219544|50043761|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
24952601|NCT00219544|50043762|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
24952602|NCT00357552|50043770|FG000|Screening|Did not meet eligibility criteria|84|||
24952603|NCT00357552|50043770|FG000|Weeks 0 to 24|Death|1|||
24952604|NCT00357552|50043770|FG000|Weeks 24 to 104|Death|3|||
24952605|NCT00357552|50043770|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
24952606|NCT00187096|50043781|FG000|Overall Study|unacceptable toxicity|0|||
24952607|NCT00187096|50043782|FG001|Overall Study|unacceptable toxicity|0|||
24952608|NCT00187096|50043783|FG002|Overall Study|unacceptable toxicity|1|||
24952609|NCT00357396|50043793|FG000|Overall Study|Adverse Event|1|||
24952610|NCT00357396|50043794|FG001|Overall Study|Adverse Event|0|||
24952611|NCT00186628|50043799|FG000|Overall Study|Death|2|||
24952612|NCT00186628|50043799|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
24952613|NCT00368550|50043807|FG000|Overall Study|Adverse Event|7|||
24952614|NCT00368550|50043808|FG001|Overall Study|Adverse Event|4|||
24952615|NCT00368550|50043807|FG000|Overall Study|Lack of Efficacy|4|||
25039765|NCT02039674|50140612|FG002|Overall Study|Clinical Progression|0|||
24952616|NCT00368550|50043808|FG001|Overall Study|Lack of Efficacy|9|||
24952617|NCT00368550|50043807|FG000|Overall Study|Withdrawal by Subject|17|||
24952618|NCT00368550|50043808|FG001|Overall Study|Withdrawal by Subject|10|||
24952619|NCT00368472|50043814|FG000|Overall Study|Adverse Event|22|||
24952620|NCT00368472|50043814|FG000|Overall Study|Medication non-compliance|4|||
24952621|NCT00368472|50043814|FG000|Overall Study|Protocol Violation|2|||
24952622|NCT00368472|50043814|FG000|Overall Study|Request of Investigator or Sponsor|3|||
24952623|NCT00368472|50043814|FG000|Overall Study|Withdrawal by Subject|40|||
24952624|NCT00368472|50043814|FG000|Overall Study|Diary non-compliance|1|||
25039766|NCT02039674|50140613|FG003|Overall Study|Clinical Progression|0|||
24952625|NCT00368472|50043814|FG000|Overall Study|Other|32|||
24952626|NCT00368472|50043814|FG000|Overall Study|Missing Final Disposition Date|1|||
24952627|NCT00357006|50043821|FG000|Overall Study|Lost to Follow-up|1|||
24952628|NCT00357006|50043822|FG001|Overall Study|Lost to Follow-up|2|||
24952629|NCT00357006|50043823|FG002|Overall Study|Lost to Follow-up|1|||
24952630|NCT00357006|50043821|FG000|Overall Study|Withdrawal by Subject|1|||
24952631|NCT00357006|50043822|FG001|Overall Study|Withdrawal by Subject|3|||
24952632|NCT00357006|50043823|FG002|Overall Study|Withdrawal by Subject|2|||
24952633|NCT00165646|50043834|FG000|Overall Study|Adverse Event|1|||
24952634|NCT00165646|50043835|FG001|Overall Study|Adverse Event|1|||
24952635|NCT00165646|50043836|FG002|Overall Study|Adverse Event|1|||
24952636|NCT00165646|50043834|FG000|Overall Study|Lack of Efficacy|1|||
24952637|NCT00165646|50043835|FG001|Overall Study|Lack of Efficacy|2|||
24952638|NCT00165646|50043836|FG002|Overall Study|Lack of Efficacy|0|||
24952639|NCT00165646|50043834|FG000|Overall Study|Withdrawal by Subject|0|||
24952640|NCT00165646|50043835|FG001|Overall Study|Withdrawal by Subject|2|||
24952641|NCT00165646|50043836|FG002|Overall Study|Withdrawal by Subject|1|||
24952642|NCT00165646|50043834|FG000|Overall Study|Physician Decision|2|||
24952643|NCT00165646|50043835|FG001|Overall Study|Physician Decision|0|||
24952644|NCT00165646|50043836|FG002|Overall Study|Physician Decision|2|||
24952645|NCT00165646|50043834|FG000|Overall Study|Protocol Violation|1|||
25039767|NCT02039674|50140614|FG004|Overall Study|Clinical Progression|0|||
25039768|NCT02039674|50140615|FG005|Overall Study|Clinical Progression|0|||
24952646|NCT00165646|50043835|FG001|Overall Study|Protocol Violation|0|||
24952647|NCT00165646|50043836|FG002|Overall Study|Protocol Violation|0|||
24952648|NCT00367770|50043844|FG000|Overall Study|Adverse Event|1|||
24952649|NCT00367770|50043844|FG000|Overall Study|Withdrawal by Subject|1|||
24952650|NCT00185614|50043848|FG000|Inter-treatment Period|Physician Decision|1|||
24952651|NCT00185614|50043848|FG000|Inter-treatment Period|Relapse|2|||
24952652|NCT00185614|50043848|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
24952653|NCT00162370|50043852|FG000|Efficacy Population|Lost to Follow-up|51|||
24952654|NCT00361842|50043861|FG000|Overall Study|Withdrawal by Subject|2|||
24952655|NCT00361842|50043862|FG001|Overall Study|Withdrawal by Subject|3|||
24952656|NCT00361842|50043861|FG000|Overall Study|Death|2|||
24952657|NCT00361842|50043862|FG001|Overall Study|Death|1|||
24952658|NCT00361842|50043861|FG000|Overall Study|Disease progression|19|||
24952659|NCT00361842|50043862|FG001|Overall Study|Disease progression|20|||
24952660|NCT00361842|50043861|FG000|Overall Study|Adverse Event|2|||
24952661|NCT00361842|50043862|FG001|Overall Study|Adverse Event|3|||
24952662|NCT00361842|50043861|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
24952663|NCT00361842|50043862|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
24952664|NCT00361842|50043861|FG000|Overall Study|Other|1|||
24952665|NCT00361842|50043862|FG001|Overall Study|Other|0|||
24952666|NCT00361842|50043861|FG000|Overall Study|Other|0|||
24952667|NCT00361842|50043862|FG001|Overall Study|Other|2|||
24952668|NCT00361296|50043870|FG000|Overall Study|Physician Decision|1|||
24952669|NCT00361296|50043870|FG000|Overall Study|Lack of Efficacy|2|||
24952670|NCT00356148|50043876|FG000|Overall Study|Reoperation within 30 days|2|||
24952671|NCT00356148|50043877|FG001|Overall Study|Reoperation within 30 days|1|||
24952672|NCT00361218|50043884|FG000|Overall Study|Lost to Follow-up|11|||
24952673|NCT00361218|50043884|FG000|Overall Study|Personal Reasons|7|||
24952674|NCT00361218|50043884|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
25039769|NCT02039674|50140616|FG006|Overall Study|Clinical Progression|1|||
25039770|NCT02039674|50140617|FG007|Overall Study|Clinical Progression|0|||
24952675|NCT00367458|50043890|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
24952676|NCT00367458|50043891|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
24952677|NCT00162136|50043903|FG000|Overall Study|Adverse Event|1|||
24952678|NCT00162136|50043903|FG000|Overall Study|Death|1|||
24952679|NCT00162136|50043903|FG000|Overall Study|Disease Progression/Relapse|23|||
24952680|NCT00162136|50043903|FG000|Overall Study|Investigator Request|5|||
24952681|NCT00162136|50043903|FG000|Overall Study|Study Drug Toxicity|4|||
24952682|NCT00162136|50043903|FG000|Overall Study|Withdrawal by Subject|1|||
25039771|NCT02039674|50140618|FG008|Overall Study|Clinical Progression|0|||
25039772|NCT02039674|50140619|FG009|Overall Study|Clinical Progression|0|||
25039773|NCT02039674|50140620|FG010|Overall Study|Clinical Progression|0|||
25039774|NCT02039674|50140621|FG011|Overall Study|Clinical Progression|0|||
25039775|NCT02039674|50140622|FG012|Overall Study|Clinical Progression|1|||
25039776|NCT02039674|50140623|FG013|Overall Study|Clinical Progression|0|||
25039777|NCT02039674|50140610|FG000|Overall Study|Sponsor Decision|1|||
25039778|NCT02039674|50140611|FG001|Overall Study|Sponsor Decision|1|||
25039779|NCT02039674|50140612|FG002|Overall Study|Sponsor Decision|1|||
25039780|NCT02039674|50140613|FG003|Overall Study|Sponsor Decision|1|||
25039781|NCT02039674|50140614|FG004|Overall Study|Sponsor Decision|1|||
25039782|NCT02039674|50140615|FG005|Overall Study|Sponsor Decision|0|||
25039783|NCT02039674|50140616|FG006|Overall Study|Sponsor Decision|0|||
25039784|NCT02039674|50140617|FG007|Overall Study|Sponsor Decision|0|||
25039785|NCT02039674|50140618|FG008|Overall Study|Sponsor Decision|0|||
25039786|NCT02039674|50140619|FG009|Overall Study|Sponsor Decision|3|||
24952683|NCT00252694|50043929|FG000|Overall Study|Withdrawal by Subject|83|||
24952684|NCT00252694|50043930|FG001|Overall Study|Withdrawal by Subject|91|||
24952685|NCT00252694|50043929|FG000|Overall Study|Death|36|||
24952686|NCT00252694|50043930|FG001|Overall Study|Death|34|||
24952687|NCT00252694|50043929|FG000|Overall Study|Mostly Lost to Follow Up|8|||
25039787|NCT02039674|50140620|FG010|Overall Study|Sponsor Decision|0|||
24952688|NCT00252694|50043930|FG001|Overall Study|Mostly Lost to Follow Up|13|||
24952689|NCT00252694|50043929|FG000|Overall Study|Patient Moving|17|||
24952690|NCT00252694|50043930|FG001|Overall Study|Patient Moving|16|||
24952691|NCT00185458|50043936|FG000|Contraception Phase|Adverse Event|37|||
24952692|NCT00185458|50043936|FG000|Contraception Phase|Lost to Follow-up|10|||
24952693|NCT00185458|50043936|FG000|Contraception Phase|Protocol Violation|2|||
24952694|NCT00185458|50043936|FG000|Contraception Phase|Physician Decision|2|||
24952695|NCT00185458|50043936|FG000|Contraception Phase|Withdrawal by Subject|7|||
24952696|NCT00185458|50043936|FG000|HRT Phase|Adverse Event|18|||
24952697|NCT00185458|50043936|FG000|HRT Phase|Lost to Follow-up|4|||
25039788|NCT02039674|50140621|FG011|Overall Study|Sponsor Decision|8|||
25039789|NCT02039674|50140622|FG012|Overall Study|Sponsor Decision|5|||
25039790|NCT02039674|50140623|FG013|Overall Study|Sponsor Decision|0|||
24952698|NCT00185458|50043936|FG000|HRT Phase|Protocol Violation|2|||
24952699|NCT00185458|50043936|FG000|HRT Phase|Withdrawal by Subject|3|||
25039791|NCT02039674|50140610|FG000|Overall Study|Other|0|||
25039792|NCT02039674|50140611|FG001|Overall Study|Other|0|||
24952700|NCT00185380|50043951|FG000|Overall Study|Adverse Event|41|||
24952701|NCT00185380|50043952|FG001|Overall Study|Adverse Event|43|||
24952702|NCT00185380|50043953|FG002|Overall Study|Adverse Event|48|||
24952703|NCT00185380|50043951|FG000|Overall Study|Lost to Follow-up|0|||
24952704|NCT00185380|50043952|FG001|Overall Study|Lost to Follow-up|4|||
24952705|NCT00185380|50043953|FG002|Overall Study|Lost to Follow-up|3|||
24952706|NCT00185380|50043951|FG000|Overall Study|Pregnancy|1|||
25039793|NCT02039674|50140612|FG002|Overall Study|Other|0|||
25039794|NCT02039674|50140613|FG003|Overall Study|Other|0|||
25039795|NCT02039674|50140614|FG004|Overall Study|Other|0|||
25039796|NCT02039674|50140615|FG005|Overall Study|Other|0|||
24952707|NCT00185380|50043952|FG001|Overall Study|Pregnancy|4|||
24952708|NCT00185380|50043953|FG002|Overall Study|Pregnancy|0|||
24952709|NCT00185380|50043951|FG000|Overall Study|Protocol Violation|2|||
24952710|NCT00185380|50043952|FG001|Overall Study|Protocol Violation|2|||
24952711|NCT00185380|50043953|FG002|Overall Study|Protocol Violation|1|||
24952712|NCT00185380|50043951|FG000|Overall Study|Withdrawal by Subject|1|||
24952713|NCT00185380|50043952|FG001|Overall Study|Withdrawal by Subject|2|||
24952714|NCT00185380|50043953|FG002|Overall Study|Withdrawal by Subject|0|||
24952715|NCT00185380|50043951|FG000|Overall Study|Failed insertion|1|||
24952716|NCT00185380|50043952|FG001|Overall Study|Failed insertion|1|||
24952717|NCT00185380|50043953|FG002|Overall Study|Failed insertion|2|||
24952718|NCT00185380|50043951|FG000|Overall Study|Planned pregnancy|9|||
24952719|NCT00185380|50043952|FG001|Overall Study|Planned pregnancy|12|||
24952720|NCT00185380|50043953|FG002|Overall Study|Planned pregnancy|12|||
24952721|NCT00185380|50043951|FG000|Overall Study|No need for contraception|3|||
24952722|NCT00185380|50043952|FG001|Overall Study|No need for contraception|3|||
24952723|NCT00185380|50043953|FG002|Overall Study|No need for contraception|3|||
24952724|NCT00185380|50043951|FG000|Overall Study|Could not attend visits|2|||
24952725|NCT00185380|50043952|FG001|Overall Study|Could not attend visits|0|||
24952726|NCT00185380|50043953|FG002|Overall Study|Could not attend visits|4|||
24952727|NCT00185380|50043951|FG000|Overall Study|personal reason|6|||
24952728|NCT00185380|50043952|FG001|Overall Study|personal reason|1|||
24952729|NCT00185380|50043953|FG002|Overall Study|personal reason|1|||
24952730|NCT00160654|50043961|FG000|Overall Study|Adverse Event|14|||
24952731|NCT00160654|50043961|FG000|Overall Study|Lack of Efficacy|4|||
24952732|NCT00160654|50043961|FG000|Overall Study|Lost to Follow-up|2|||
24952733|NCT00160654|50043961|FG000|Overall Study|Intake of expired drug|7|||
24952734|NCT00160654|50043961|FG000|Overall Study|Psychological trauma|1|||
24952735|NCT00160654|50043961|FG000|Overall Study|Sponsor decision|1|||
24952736|NCT00160654|50043961|FG000|Overall Study|Patient met exclusion criteria|1|||
24952737|NCT00160654|50043961|FG000|Overall Study|Patient decision|1|||
24952738|NCT00160654|50043961|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
24952739|NCT00160654|50043961|FG000|Overall Study|Met exclusion criteria|1|||
24952740|NCT00366678|50043967|FG000|Infant Series|Withdrawal by Subject|8|||
24952741|NCT00366678|50043968|FG001|Infant Series|Withdrawal by Subject|6|||
24952742|NCT00366678|50043969|FG002|Infant Series|Withdrawal by Subject|0|||
24952743|NCT00366678|50043967|FG000|Infant Series|Protocol Violation|4|||
24952744|NCT00366678|50043968|FG001|Infant Series|Protocol Violation|3|||
24952745|NCT00366678|50043969|FG002|Infant Series|Protocol Violation|0|||
24952746|NCT00366678|50043967|FG000|Infant Series|Failed to return|1|||
24952747|NCT00366678|50043968|FG001|Infant Series|Failed to return|1|||
24952748|NCT00366678|50043969|FG002|Infant Series|Failed to return|0|||
24952749|NCT00366678|50043967|FG000|Infant Series|Adverse Event|1|||
25039797|NCT02039674|50140616|FG006|Overall Study|Other|0|||
25039798|NCT02039674|50140617|FG007|Overall Study|Other|0|||
24952750|NCT00366678|50043968|FG001|Infant Series|Adverse Event|0|||
24952751|NCT00366678|50043969|FG002|Infant Series|Adverse Event|0|||
24952752|NCT00366678|50043967|FG000|After Infant|Withdrawal by Subject|8|||
24952753|NCT00366678|50043968|FG001|After Infant|Withdrawal by Subject|4|||
24952754|NCT00366678|50043969|FG002|After Infant|Withdrawal by Subject|0|||
24952755|NCT00366678|50043967|FG000|After Infant|Lost to Follow-up|2|||
24952756|NCT00366678|50043968|FG001|After Infant|Lost to Follow-up|1|||
24952757|NCT00366678|50043969|FG002|After Infant|Lost to Follow-up|0|||
24952758|NCT00366678|50043967|FG000|After Infant|Failed to return|5|||
24952759|NCT00366678|50043968|FG001|After Infant|Failed to return|5|||
24952760|NCT00366678|50043969|FG002|After Infant|Failed to return|0|||
24952761|NCT00366678|50043967|FG000|After Infant|Adverse Event|1|||
24952762|NCT00366678|50043968|FG001|After Infant|Adverse Event|0|||
24952763|NCT00366678|50043969|FG002|After Infant|Adverse Event|0|||
24952764|NCT00366678|50043967|FG000|After Infant|Protocol Violation|1|||
25160205|NCT01832155|50280299|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
24952765|NCT00366678|50043968|FG001|After Infant|Protocol Violation|0|||
24952766|NCT00366678|50043969|FG002|After Infant|Protocol Violation|0|||
25039799|NCT02039674|50140618|FG008|Overall Study|Other|0|||
24952767|NCT00366678|50043967|FG000|Toddler Dose|Protocol Violation|2|||
24952768|NCT00366678|50043968|FG001|Toddler Dose|Protocol Violation|1|||
24952769|NCT00366678|50043969|FG002|Toddler Dose|Protocol Violation|0|||
24952770|NCT00366678|50043967|FG000|Toddler Dose|Failed to return|1|||
24952771|NCT00366678|50043968|FG001|Toddler Dose|Failed to return|0|||
24952772|NCT00366678|50043969|FG002|Toddler Dose|Failed to return|0|||
24952773|NCT00366678|50043967|FG000|Toddler Dose|Withdrawal by Subject|1|||
24952774|NCT00366678|50043968|FG001|Toddler Dose|Withdrawal by Subject|0|||
24952775|NCT00366678|50043969|FG002|Toddler Dose|Withdrawal by Subject|0|||
24952776|NCT00366678|50043967|FG000|Toddler Dose|protocol deviation|1|||
24952777|NCT00366678|50043968|FG001|Toddler Dose|protocol deviation|0|||
24952778|NCT00366678|50043969|FG002|Toddler Dose|protocol deviation|0|||
24952779|NCT00355368|50044016|FG000|Overall Study|Protocol Violation|8|||
24952780|NCT00355368|50044017|FG001|Overall Study|Protocol Violation|7|||
24952781|NCT00355368|50044016|FG000|Overall Study|cardiac arrest prior to intubation|2|||
24952782|NCT00355368|50044017|FG001|Overall Study|cardiac arrest prior to intubation|2|||
24952783|NCT00360282|50044023|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
24952784|NCT00360282|50044024|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
24952785|NCT00360282|50044025|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
24952786|NCT00360282|50044026|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
24952787|NCT00360282|50044023|FG000|Second Intervention|Adverse Event|0|||
24952788|NCT00360282|50044024|FG001|Second Intervention|Adverse Event|1|||
24952789|NCT00360282|50044025|FG002|Second Intervention|Adverse Event|0|||
24952790|NCT00360282|50044026|FG003|Second Intervention|Adverse Event|0|||
24952791|NCT00373958|50044036|FG000|Infant Series|Withdrawal by Subject|13|||
24952792|NCT00373958|50044037|FG001|Infant Series|Withdrawal by Subject|15|||
24952793|NCT00373958|50044036|FG000|Infant Series|Failed to return|8|||
24952794|NCT00373958|50044037|FG001|Infant Series|Failed to return|13|||
24952795|NCT00373958|50044036|FG000|Infant Series|Lost to Follow-up|6|||
24952796|NCT00373958|50044037|FG001|Infant Series|Lost to Follow-up|5|||
24952797|NCT00373958|50044036|FG000|Infant Series|Protocol Violation|3|||
24952798|NCT00373958|50044037|FG001|Infant Series|Protocol Violation|7|||
24952799|NCT00373958|50044036|FG000|Infant Series|Lost Kaiser coverage|4|||
25039800|NCT02039674|50140619|FG009|Overall Study|Other|0|||
25039801|NCT02039674|50140620|FG010|Overall Study|Other|0|||
25039802|NCT02039674|50140621|FG011|Overall Study|Other|0|||
25039803|NCT02039674|50140622|FG012|Overall Study|Other|1|||
25039804|NCT02039674|50140623|FG013|Overall Study|Other|0|||
24952800|NCT00373958|50044037|FG001|Infant Series|Lost Kaiser coverage|0|||
24952801|NCT00373958|50044036|FG000|Infant Series|Child relocated|1|||
24952802|NCT00373958|50044037|FG001|Infant Series|Child relocated|0|||
24952803|NCT00373958|50044036|FG000|Infant Series|Consent was not received|1|||
24952804|NCT00373958|50044037|FG001|Infant Series|Consent was not received|0|||
24952805|NCT00373958|50044036|FG000|Infant Series|Adverse Event|3|||
24952806|NCT00373958|50044037|FG001|Infant Series|Adverse Event|1|||
24952807|NCT00373958|50044036|FG000|Infant Series|Physician Decision|1|||
24952808|NCT00373958|50044037|FG001|Infant Series|Physician Decision|1|||
24952809|NCT00373958|50044036|FG000|Toddler Dose|Lost to Follow-up|5|||
24952810|NCT00373958|50044037|FG001|Toddler Dose|Lost to Follow-up|8|||
24952811|NCT00373958|50044036|FG000|Toddler Dose|Withdrawal by Subject|2|||
24952812|NCT00373958|50044037|FG001|Toddler Dose|Withdrawal by Subject|2|||
24952813|NCT00373958|50044036|FG000|Toddler Dose|Failed to return|1|||
24952814|NCT00373958|50044037|FG001|Toddler Dose|Failed to return|2|||
24952815|NCT00373958|50044036|FG000|Toddler Dose|Protocol Violation|0|||
24952816|NCT00373958|50044037|FG001|Toddler Dose|Protocol Violation|1|||
24952817|NCT00373958|50044036|FG000|Toddler Dose|Withdrawn after infant series|22|||
24952818|NCT00373958|50044037|FG001|Toddler Dose|Withdrawn after infant series|25|||
24952819|NCT00373880|50044066|FG000|Overall Study|Physician Decision|3|||
24952820|NCT00373880|50044066|FG000|Overall Study|Arrested|1|||
24952821|NCT00373880|50044066|FG000|Overall Study|Protocol Violation|14|||
24952822|NCT00184600|50044081|FG000|Overall Study|Adverse Event|9|||
24952823|NCT00184600|50044082|FG001|Overall Study|Adverse Event|0|||
24952824|NCT00184600|50044083|FG002|Overall Study|Adverse Event|5|||
24952825|NCT00184600|50044081|FG000|Overall Study|Death|3|||
24952826|NCT00184600|50044082|FG001|Overall Study|Death|9|||
24952827|NCT00184600|50044083|FG002|Overall Study|Death|7|||
24952828|NCT00184600|50044081|FG000|Overall Study|Lack of Efficacy|3|||
24952829|NCT00184600|50044082|FG001|Overall Study|Lack of Efficacy|1|||
24952830|NCT00184600|50044083|FG002|Overall Study|Lack of Efficacy|3|||
24952831|NCT00184600|50044081|FG000|Overall Study|Lost to Follow-up|4|||
24952832|NCT00184600|50044082|FG001|Overall Study|Lost to Follow-up|6|||
24952833|NCT00184600|50044083|FG002|Overall Study|Lost to Follow-up|1|||
24952834|NCT00184600|50044081|FG000|Overall Study|Protocol Violation|2|||
24952835|NCT00184600|50044082|FG001|Overall Study|Protocol Violation|2|||
24952836|NCT00184600|50044083|FG002|Overall Study|Protocol Violation|3|||
24952837|NCT00184600|50044081|FG000|Overall Study|Withdrawal by Subject|20|||
24952838|NCT00184600|50044082|FG001|Overall Study|Withdrawal by Subject|28|||
24952839|NCT00184600|50044083|FG002|Overall Study|Withdrawal by Subject|12|||
25039805|NCT03126227|50140663|FG000|Overall Study|Adverse Event|43|||
25039806|NCT03126227|50140664|FG001|Overall Study|Adverse Event|4|||
24952840|NCT00184600|50044081|FG000|Overall Study|Unclassified|4|||
24952841|NCT00184600|50044082|FG001|Overall Study|Unclassified|5|||
24952842|NCT00184600|50044083|FG002|Overall Study|Unclassified|3|||
24952843|NCT00265317|50044095|FG000|Lead-In|Objective progression or relapse|6|||
24952844|NCT00265317|50044096|FG001|Lead-In|Objective progression or relapse|11|||
25039807|NCT03126227|50140663|FG000|Overall Study|Death|0|||
25039808|NCT03126227|50140664|FG001|Overall Study|Death|1|||
25039809|NCT03126227|50140663|FG000|Overall Study|Lost to Follow-up|0|||
25039810|NCT03126227|50140664|FG001|Overall Study|Lost to Follow-up|1|||
25039811|NCT03126227|50140663|FG000|Overall Study|Physician Decision|2|||
25039812|NCT03126227|50140664|FG001|Overall Study|Physician Decision|0|||
25039813|NCT03126227|50140663|FG000|Overall Study|Protocol Violation|1|||
25039814|NCT03126227|50140664|FG001|Overall Study|Protocol Violation|0|||
25039815|NCT03126227|50140663|FG000|Overall Study|Withdrawal by Subject|19|||
25039816|NCT03126227|50140664|FG001|Overall Study|Withdrawal by Subject|3|||
25039817|NCT03126227|50140663|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
25039818|NCT03126227|50140664|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
25039819|NCT03126227|50140663|FG000|Overall Study|Lack of dosing compliance|2|||
25039820|NCT03126227|50140664|FG001|Overall Study|Lack of dosing compliance|0|||
25039821|NCT03126227|50140663|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
25039822|NCT03126227|50140664|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
25039823|NCT03126227|50140663|FG000|Overall Study|Scheduling conflict|1|||
25039824|NCT03126227|50140664|FG001|Overall Study|Scheduling conflict|0|||
25039825|NCT03099187|50140672|FG000|Double-blind Treatment|Adverse Event|19|||
25039826|NCT03099187|50140673|FG001|Double-blind Treatment|Adverse Event|1|||
25039827|NCT03099187|50140674|FG002|Double-blind Treatment|Adverse Event|0|||
25039828|NCT03099187|50140675|FG003|Double-blind Treatment|Adverse Event|0|||
25039829|NCT03099187|50140672|FG000|Double-blind Treatment|Death|1|||
25039830|NCT03099187|50140673|FG001|Double-blind Treatment|Death|3|||
25039831|NCT03099187|50140674|FG002|Double-blind Treatment|Death|0|||
25039832|NCT03099187|50140675|FG003|Double-blind Treatment|Death|0|||
25039833|NCT03099187|50140672|FG000|Double-blind Treatment|Lack of Efficacy|1|||
25039834|NCT03099187|50140673|FG001|Double-blind Treatment|Lack of Efficacy|0|||
25039835|NCT03099187|50140674|FG002|Double-blind Treatment|Lack of Efficacy|0|||
25039836|NCT03099187|50140675|FG003|Double-blind Treatment|Lack of Efficacy|0|||
25039837|NCT03099187|50140672|FG000|Double-blind Treatment|Physician Decision|2|||
24952845|NCT00265317|50044097|FG002|Lead-In|Objective progression or relapse|0|||
24952846|NCT00265317|50044098|FG003|Lead-In|Objective progression or relapse|0|||
24952847|NCT00265317|50044095|FG000|Lead-In|Adverse Event|2|||
24952848|NCT00265317|50044096|FG001|Lead-In|Adverse Event|1|||
24952849|NCT00265317|50044097|FG002|Lead-In|Adverse Event|0|||
25039838|NCT03099187|50140673|FG001|Double-blind Treatment|Physician Decision|1|||
25039839|NCT03099187|50140674|FG002|Double-blind Treatment|Physician Decision|0|||
25039840|NCT03099187|50140675|FG003|Double-blind Treatment|Physician Decision|0|||
25039841|NCT03099187|50140672|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
25039842|NCT03099187|50140673|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
25039843|NCT03099187|50140674|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
24952850|NCT00265317|50044098|FG003|Lead-In|Adverse Event|0|||
24952851|NCT00265317|50044095|FG000|Lead-In|Death|3|||
24952852|NCT00265317|50044096|FG001|Lead-In|Death|5|||
24952853|NCT00265317|50044097|FG002|Lead-In|Death|0|||
24952854|NCT00265317|50044098|FG003|Lead-In|Death|0|||
24952855|NCT00265317|50044095|FG000|Lead-In|Withdrawal/other than adverse event|1|||
24952856|NCT00265317|50044096|FG001|Lead-In|Withdrawal/other than adverse event|0|||
24952857|NCT00265317|50044097|FG002|Lead-In|Withdrawal/other than adverse event|0|||
24952858|NCT00265317|50044098|FG003|Lead-In|Withdrawal/other than adverse event|0|||
24952859|NCT00265317|50044095|FG000|Phase 2|Objective progression or relapse|0|||
24952860|NCT00265317|50044096|FG001|Phase 2|Objective progression or relapse|0|||
24952861|NCT00265317|50044097|FG002|Phase 2|Objective progression or relapse|37|||
24952862|NCT00265317|50044098|FG003|Phase 2|Objective progression or relapse|38|||
24952863|NCT00265317|50044095|FG000|Phase 2|Global deterioration of health status|0|||
24952864|NCT00265317|50044096|FG001|Phase 2|Global deterioration of health status|0|||
24952865|NCT00265317|50044097|FG002|Phase 2|Global deterioration of health status|3|||
24952866|NCT00265317|50044098|FG003|Phase 2|Global deterioration of health status|0|||
24952867|NCT00265317|50044095|FG000|Phase 2|Adverse Event|0|||
24952868|NCT00265317|50044096|FG001|Phase 2|Adverse Event|0|||
24952869|NCT00265317|50044097|FG002|Phase 2|Adverse Event|7|||
24952870|NCT00265317|50044098|FG003|Phase 2|Adverse Event|5|||
24952871|NCT00265317|50044095|FG000|Phase 2|Death|0|||
24952872|NCT00265317|50044096|FG001|Phase 2|Death|0|||
24952873|NCT00265317|50044097|FG002|Phase 2|Death|12|||
24952874|NCT00265317|50044098|FG003|Phase 2|Death|15|||
24952875|NCT00265317|50044095|FG000|Phase 2|Protocol Violation|0|||
24952876|NCT00265317|50044096|FG001|Phase 2|Protocol Violation|0|||
24952877|NCT00265317|50044097|FG002|Phase 2|Protocol Violation|1|||
24952878|NCT00265317|50044098|FG003|Phase 2|Protocol Violation|4|||
24952879|NCT00265317|50044095|FG000|Phase 2|Lost to Follow-up|0|||
24952880|NCT00265317|50044096|FG001|Phase 2|Lost to Follow-up|0|||
24952881|NCT00265317|50044097|FG002|Phase 2|Lost to Follow-up|0|||
24952882|NCT00265317|50044098|FG003|Phase 2|Lost to Follow-up|1|||
24952883|NCT00265317|50044095|FG000|Phase 2|Withdrawal/other than adverse event|0|||
24952884|NCT00265317|50044096|FG001|Phase 2|Withdrawal/other than adverse event|0|||
24952885|NCT00265317|50044097|FG002|Phase 2|Withdrawal/other than adverse event|2|||
24952886|NCT00265317|50044098|FG003|Phase 2|Withdrawal/other than adverse event|1|||
24952887|NCT00265317|50044095|FG000|Phase 2|Study terminated by sponsor|0|||
24952888|NCT00265317|50044096|FG001|Phase 2|Study terminated by sponsor|0|||
24952889|NCT00265317|50044097|FG002|Phase 2|Study terminated by sponsor|1|||
24952890|NCT00265317|50044098|FG003|Phase 2|Study terminated by sponsor|0|||
24952891|NCT00265317|50044095|FG000|Phase 2|Other|0|||
24952892|NCT00265317|50044096|FG001|Phase 2|Other|0|||
24952893|NCT00265317|50044097|FG002|Phase 2|Other|1|||
24952894|NCT00265317|50044098|FG003|Phase 2|Other|1|||
24952895|NCT00373490|50044119|FG000|Overall Study|Adverse Event|0|||
24952896|NCT00373490|50044120|FG001|Overall Study|Adverse Event|1|||
24952897|NCT00373490|50044119|FG000|Overall Study|Lack of Efficacy|9|||
24952898|NCT00373490|50044120|FG001|Overall Study|Lack of Efficacy|4|||
24952899|NCT00373490|50044119|FG000|Overall Study|Withdrawal by Subject|0|||
24952900|NCT00373490|50044120|FG001|Overall Study|Withdrawal by Subject|1|||
24952901|NCT00251589|50044130|FG000|Overall Study|Adverse Event|5|||
24952902|NCT00251589|50044131|FG001|Overall Study|Adverse Event|1|||
24952903|NCT00251589|50044132|FG002|Overall Study|Adverse Event|2|||
24952904|NCT00251589|50044133|FG003|Overall Study|Adverse Event|1|||
24952905|NCT00251589|50044130|FG000|Overall Study|Withdrawal by Subject|1|||
24952906|NCT00251589|50044131|FG001|Overall Study|Withdrawal by Subject|1|||
24952907|NCT00251589|50044132|FG002|Overall Study|Withdrawal by Subject|0|||
24952908|NCT00251589|50044133|FG003|Overall Study|Withdrawal by Subject|0|||
24952909|NCT00251589|50044130|FG000|Overall Study|Discontinued due to progressive disease|9|||
24952910|NCT00251589|50044131|FG001|Overall Study|Discontinued due to progressive disease|1|||
24952911|NCT00251589|50044132|FG002|Overall Study|Discontinued due to progressive disease|0|||
24952912|NCT00251589|50044133|FG003|Overall Study|Discontinued due to progressive disease|1|||
24952913|NCT00265239|50044145|FG000|Overall Study|Adverse Event|2|||
24952914|NCT00265239|50044146|FG001|Overall Study|Adverse Event|1|||
25186329|NCT01399619|50336291|FG003|Overall Study|Lack of Efficacy|0|||
24952915|NCT00350298|50044154|FG000|Overall Study|Death|7|||
24952916|NCT00350298|50044155|FG001|Overall Study|Death|8|||
24952917|NCT00350298|50044154|FG000|Overall Study|Lost to Follow-up|1|||
24952918|NCT00350298|50044155|FG001|Overall Study|Lost to Follow-up|2|||
24952919|NCT00350298|50044154|FG000|Overall Study|Withdrawal by Subject|1|||
24952920|NCT00350298|50044155|FG001|Overall Study|Withdrawal by Subject|3|||
24952921|NCT00159874|50044168|FG000|Overall Study|Adverse Event|2|||
24952922|NCT00159874|50044169|FG001|Overall Study|Adverse Event|2|||
24952923|NCT00159874|50044170|FG002|Overall Study|Adverse Event|5|||
24952924|NCT00159874|50044171|FG003|Overall Study|Adverse Event|1|||
24952925|NCT00159874|50044172|FG004|Overall Study|Adverse Event|1|||
24952926|NCT00159874|50044173|FG005|Overall Study|Adverse Event|2|||
24952927|NCT00159874|50044174|FG006|Overall Study|Adverse Event|0|||
24952928|NCT00159874|50044168|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
25160206|NCT01832155|50280300|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
25039844|NCT03099187|50140675|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
25039845|NCT03099187|50140672|FG000|Double-blind Treatment|Lung transplantation|0|||
25039846|NCT03099187|50140673|FG001|Double-blind Treatment|Lung transplantation|1|||
25039847|NCT03099187|50140674|FG002|Double-blind Treatment|Lung transplantation|0|||
25039848|NCT03099187|50140675|FG003|Double-blind Treatment|Lung transplantation|0|||
25039849|NCT03099187|50140672|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
24952929|NCT00159874|50044169|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
24952930|NCT00159874|50044170|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
24952931|NCT00159874|50044171|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
24952932|NCT00159874|50044172|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
24952933|NCT00159874|50044173|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
24952934|NCT00159874|50044174|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
24952935|NCT00159874|50044168|FG000|Overall Study|Lack of Efficacy|2|||
24952936|NCT00159874|50044169|FG001|Overall Study|Lack of Efficacy|0|||
24952937|NCT00159874|50044170|FG002|Overall Study|Lack of Efficacy|1|||
24952938|NCT00159874|50044171|FG003|Overall Study|Lack of Efficacy|1|||
24952939|NCT00159874|50044172|FG004|Overall Study|Lack of Efficacy|0|||
24952940|NCT00159874|50044173|FG005|Overall Study|Lack of Efficacy|3|||
24952941|NCT00159874|50044174|FG006|Overall Study|Lack of Efficacy|0|||
24952942|NCT00159874|50044168|FG000|Overall Study|Lost to Follow-up|1|||
24952943|NCT00159874|50044169|FG001|Overall Study|Lost to Follow-up|0|||
24952944|NCT00159874|50044170|FG002|Overall Study|Lost to Follow-up|3|||
24952945|NCT00159874|50044171|FG003|Overall Study|Lost to Follow-up|0|||
24952946|NCT00159874|50044172|FG004|Overall Study|Lost to Follow-up|1|||
24952947|NCT00159874|50044173|FG005|Overall Study|Lost to Follow-up|2|||
24952948|NCT00159874|50044174|FG006|Overall Study|Lost to Follow-up|1|||
24952949|NCT00159874|50044168|FG000|Overall Study|Other|8|||
24952950|NCT00159874|50044169|FG001|Overall Study|Other|8|||
24952951|NCT00159874|50044170|FG002|Overall Study|Other|8|||
25039850|NCT03099187|50140673|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
25039851|NCT03099187|50140674|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
25039852|NCT03099187|50140675|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
25039853|NCT03099187|50140672|FG000|Double-blind Treatment|Disease progression|0|||
25039854|NCT03099187|50140673|FG001|Double-blind Treatment|Disease progression|1|||
25039855|NCT03099187|50140674|FG002|Double-blind Treatment|Disease progression|0|||
25039856|NCT03099187|50140675|FG003|Double-blind Treatment|Disease progression|0|||
25039857|NCT03099187|50140672|FG000|Double-blind Treatment|Randomization error|0|||
25039858|NCT03099187|50140673|FG001|Double-blind Treatment|Randomization error|2|||
25039859|NCT03099187|50140674|FG002|Double-blind Treatment|Randomization error|0|||
25039860|NCT03099187|50140675|FG003|Double-blind Treatment|Randomization error|0|||
25039861|NCT03099187|50140672|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
25039862|NCT03099187|50140673|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
25039863|NCT03099187|50140674|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
25039864|NCT03099187|50140675|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
25039865|NCT03099187|50140672|FG000|12-month Safety Follow-up|Adverse Event|0|||
25039866|NCT03099187|50140673|FG001|12-month Safety Follow-up|Adverse Event|0|||
25039867|NCT03099187|50140674|FG002|12-month Safety Follow-up|Adverse Event|5|||
25039868|NCT03099187|50140675|FG003|12-month Safety Follow-up|Adverse Event|12|||
25039869|NCT03099187|50140672|FG000|12-month Safety Follow-up|Death|0|||
25039870|NCT03099187|50140673|FG001|12-month Safety Follow-up|Death|0|||
25039871|NCT03099187|50140674|FG002|12-month Safety Follow-up|Death|7|||
25039872|NCT03099187|50140675|FG003|12-month Safety Follow-up|Death|9|||
25039873|NCT03099187|50140672|FG000|12-month Safety Follow-up|Lung transplantation|0|||
25039874|NCT03099187|50140673|FG001|12-month Safety Follow-up|Lung transplantation|0|||
24952952|NCT00159874|50044171|FG003|Overall Study|Other|0|||
24952953|NCT00159874|50044172|FG004|Overall Study|Other|2|||
24952954|NCT00159874|50044173|FG005|Overall Study|Other|1|||
24952955|NCT00159874|50044174|FG006|Overall Study|Other|3|||
24952956|NCT00159874|50044168|FG000|Overall Study|Protocol Violation|0|||
24952957|NCT00159874|50044169|FG001|Overall Study|Protocol Violation|5|||
24952958|NCT00159874|50044170|FG002|Overall Study|Protocol Violation|2|||
24952959|NCT00159874|50044171|FG003|Overall Study|Protocol Violation|0|||
24952960|NCT00159874|50044172|FG004|Overall Study|Protocol Violation|0|||
24952961|NCT00159874|50044173|FG005|Overall Study|Protocol Violation|0|||
24952962|NCT00159874|50044174|FG006|Overall Study|Protocol Violation|0|||
24952963|NCT00159874|50044168|FG000|Overall Study|Death|3|||
24952964|NCT00159874|50044169|FG001|Overall Study|Death|8|||
24952965|NCT00159874|50044170|FG002|Overall Study|Death|15|||
24952966|NCT00159874|50044171|FG003|Overall Study|Death|0|||
24952967|NCT00159874|50044172|FG004|Overall Study|Death|1|||
24952968|NCT00159874|50044173|FG005|Overall Study|Death|2|||
24952969|NCT00159874|50044174|FG006|Overall Study|Death|0|||
24952970|NCT00159874|50044168|FG000|Overall Study|Withdrawal by Subject|2|||
24952971|NCT00159874|50044169|FG001|Overall Study|Withdrawal by Subject|6|||
24952972|NCT00159874|50044170|FG002|Overall Study|Withdrawal by Subject|8|||
24952973|NCT00159874|50044171|FG003|Overall Study|Withdrawal by Subject|4|||
24952974|NCT00159874|50044172|FG004|Overall Study|Withdrawal by Subject|3|||
24952975|NCT00159874|50044173|FG005|Overall Study|Withdrawal by Subject|2|||
24952976|NCT00159874|50044174|FG006|Overall Study|Withdrawal by Subject|1|||
24952977|NCT00159874|50044168|FG000|Overall Study|Pregnancy|1|||
24952978|NCT00159874|50044169|FG001|Overall Study|Pregnancy|1|||
24952979|NCT00159874|50044170|FG002|Overall Study|Pregnancy|0|||
24952980|NCT00159874|50044171|FG003|Overall Study|Pregnancy|0|||
24952981|NCT00159874|50044172|FG004|Overall Study|Pregnancy|0|||
24952982|NCT00159874|50044173|FG005|Overall Study|Pregnancy|0|||
24952983|NCT00159874|50044174|FG006|Overall Study|Pregnancy|0|||
24952984|NCT00349908|50044192|FG000|Overall Study|Withdrawal by Subject|0|||
24952985|NCT00349908|50044193|FG001|Overall Study|Withdrawal by Subject|4|||
24952986|NCT00184054|50044200|FG000|Overall Study|Adverse Event|1|||
24952987|NCT00183430|50044206|FG000|Overall Study|Adverse Event|1|||
24952988|NCT00183430|50044207|FG001|Overall Study|Adverse Event|0|||
24952989|NCT00183430|50044206|FG000|Overall Study|Lost to Follow-up|3|||
24952990|NCT00183430|50044207|FG001|Overall Study|Lost to Follow-up|0|||
24952991|NCT00183430|50044206|FG000|Overall Study|did not meet inclusion criteria|1|||
24952992|NCT00183430|50044207|FG001|Overall Study|did not meet inclusion criteria|0|||
24952993|NCT00183430|50044206|FG000|Overall Study|Withdrawal by Subject|1|||
24952994|NCT00183430|50044207|FG001|Overall Study|Withdrawal by Subject|0|||
24952995|NCT00183274|50044213|FG000|Phase 1: Open-Label|Adverse Event|31|||
24952996|NCT00183274|50044214|FG001|Phase 1: Open-Label|Adverse Event|0|||
24952997|NCT00183274|50044215|FG002|Phase 1: Open-Label|Adverse Event|0|||
24952998|NCT00183274|50044216|FG003|Phase 1: Open-Label|Adverse Event|0|||
24952999|NCT00183274|50044217|FG004|Phase 1: Open-Label|Adverse Event|0|||
24953000|NCT00183274|50044218|FG005|Phase 1: Open-Label|Adverse Event|0|||
24953001|NCT00183274|50044213|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
24953002|NCT00183274|50044214|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
24953003|NCT00183274|50044215|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
24953004|NCT00183274|50044216|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
24953005|NCT00183274|50044217|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
24953006|NCT00183274|50044218|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
24953007|NCT00183274|50044213|FG000|Phase 1: Open-Label|Protocol Violation|11|||
24953008|NCT00183274|50044214|FG001|Phase 1: Open-Label|Protocol Violation|0|||
24953009|NCT00183274|50044215|FG002|Phase 1: Open-Label|Protocol Violation|0|||
24953010|NCT00183274|50044216|FG003|Phase 1: Open-Label|Protocol Violation|0|||
24953011|NCT00183274|50044217|FG004|Phase 1: Open-Label|Protocol Violation|0|||
24953012|NCT00183274|50044218|FG005|Phase 1: Open-Label|Protocol Violation|0|||
24953013|NCT00183274|50044213|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
24953014|NCT00183274|50044214|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
24953015|NCT00183274|50044215|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
24953016|NCT00183274|50044216|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
24953017|NCT00183274|50044217|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
24953018|NCT00183274|50044218|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
24953019|NCT00183274|50044213|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
24953020|NCT00183274|50044214|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
24953021|NCT00183274|50044215|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
24953022|NCT00183274|50044216|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
24953023|NCT00183274|50044217|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
24953024|NCT00183274|50044218|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
24953025|NCT00183274|50044213|FG000|Phase 1: Open-Label|Other|9|||
24953026|NCT00183274|50044214|FG001|Phase 1: Open-Label|Other|0|||
24953027|NCT00183274|50044215|FG002|Phase 1: Open-Label|Other|0|||
24953028|NCT00183274|50044216|FG003|Phase 1: Open-Label|Other|0|||
24953029|NCT00183274|50044217|FG004|Phase 1: Open-Label|Other|0|||
24953030|NCT00183274|50044218|FG005|Phase 1: Open-Label|Other|0|||
24953031|NCT00183274|50044213|FG000|Phase 2: Double-Blind|Relapsed|0|||
24953032|NCT00183274|50044214|FG001|Phase 2: Double-Blind|Relapsed|8|||
24953033|NCT00183274|50044215|FG002|Phase 2: Double-Blind|Relapsed|29|||
24953034|NCT00183274|50044216|FG003|Phase 2: Double-Blind|Relapsed|0|||
24953035|NCT00183274|50044217|FG004|Phase 2: Double-Blind|Relapsed|0|||
24953036|NCT00183274|50044218|FG005|Phase 2: Double-Blind|Relapsed|0|||
24953037|NCT00183274|50044213|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
24953038|NCT00183274|50044214|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
24953039|NCT00183274|50044215|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
24953040|NCT00183274|50044216|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
24953041|NCT00183274|50044217|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
24953042|NCT00183274|50044218|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
24953043|NCT00183274|50044213|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
24953044|NCT00183274|50044214|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
24953045|NCT00183274|50044215|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
24953046|NCT00183274|50044216|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
24953047|NCT00183274|50044217|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
24953048|NCT00183274|50044218|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
24953049|NCT00183274|50044213|FG000|Phase 3: Double-Blind|Relapsed|0|||
24953050|NCT00183274|50044214|FG001|Phase 3: Double-Blind|Relapsed|0|||
24953051|NCT00183274|50044215|FG002|Phase 3: Double-Blind|Relapsed|0|||
24953052|NCT00183274|50044216|FG003|Phase 3: Double-Blind|Relapsed|1|||
24953053|NCT00183274|50044217|FG004|Phase 3: Double-Blind|Relapsed|11|||
24953054|NCT00183274|50044218|FG005|Phase 3: Double-Blind|Relapsed|2|||
24953055|NCT00183196|50044236|FG000|Overall Study|Withdrawal by Subject|18|||
24953056|NCT00183196|50044237|FG001|Overall Study|Withdrawal by Subject|11|||
25039875|NCT03099187|50140674|FG002|12-month Safety Follow-up|Lung transplantation|2|||
25039876|NCT03099187|50140675|FG003|12-month Safety Follow-up|Lung transplantation|1|||
25039877|NCT03099187|50140672|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
25039878|NCT03099187|50140673|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
25039879|NCT03099187|50140674|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
25039880|NCT03099187|50140675|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
25039881|NCT03099187|50140672|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
25039882|NCT03099187|50140673|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
25039883|NCT03099187|50140674|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
25039884|NCT03099187|50140675|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
25039885|NCT03099187|50140672|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
25039886|NCT03099187|50140673|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
25039887|NCT03099187|50140674|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
25039888|NCT03099187|50140675|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
25039889|NCT03099187|50140672|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
25039890|NCT03099187|50140673|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
25039891|NCT03099187|50140674|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
25039892|NCT03099187|50140675|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
25039893|NCT04535453|50140697|FG000|Overall Study|Death|0|||
25039894|NCT04535453|50140698|FG001|Overall Study|Death|1|||
25039895|NCT04535453|50140699|FG002|Overall Study|Death|0|||
25039896|NCT04535453|50140700|FG003|Overall Study|Death|0|||
25039897|NCT04535453|50140701|FG004|Overall Study|Death|0|||
25039898|NCT04535453|50140702|FG005|Overall Study|Death|0|||
25039899|NCT04535453|50140703|FG006|Overall Study|Death|0|||
25039900|NCT04535453|50140704|FG007|Overall Study|Death|0|||
25039901|NCT04535453|50140705|FG008|Overall Study|Death|0|||
25039902|NCT04535453|50140706|FG009|Overall Study|Death|0|||
25039903|NCT04535453|50140707|FG010|Overall Study|Death|0|||
25039904|NCT04535453|50140708|FG011|Overall Study|Death|0|||
25039905|NCT04535453|50140697|FG000|Overall Study|Lost to Follow-up|1|||
25039906|NCT04535453|50140698|FG001|Overall Study|Lost to Follow-up|1|||
25039907|NCT04535453|50140699|FG002|Overall Study|Lost to Follow-up|1|||
25039908|NCT04535453|50140700|FG003|Overall Study|Lost to Follow-up|0|||
25039909|NCT04535453|50140701|FG004|Overall Study|Lost to Follow-up|3|||
25039910|NCT04535453|50140702|FG005|Overall Study|Lost to Follow-up|1|||
25039911|NCT04535453|50140703|FG006|Overall Study|Lost to Follow-up|0|||
25039912|NCT04535453|50140704|FG007|Overall Study|Lost to Follow-up|0|||
25039913|NCT04535453|50140705|FG008|Overall Study|Lost to Follow-up|1|||
25039914|NCT04535453|50140706|FG009|Overall Study|Lost to Follow-up|1|||
25039915|NCT04535453|50140707|FG010|Overall Study|Lost to Follow-up|0|||
25039916|NCT04535453|50140708|FG011|Overall Study|Lost to Follow-up|0|||
25039917|NCT04535453|50140697|FG000|Overall Study|Physician Decision|0|||
25039918|NCT04535453|50140698|FG001|Overall Study|Physician Decision|0|||
25039919|NCT04535453|50140699|FG002|Overall Study|Physician Decision|0|||
25039920|NCT04535453|50140700|FG003|Overall Study|Physician Decision|1|||
25039921|NCT04535453|50140701|FG004|Overall Study|Physician Decision|0|||
25039922|NCT04535453|50140702|FG005|Overall Study|Physician Decision|0|||
25039923|NCT04535453|50140703|FG006|Overall Study|Physician Decision|0|||
25039924|NCT04535453|50140704|FG007|Overall Study|Physician Decision|0|||
25039925|NCT04535453|50140705|FG008|Overall Study|Physician Decision|0|||
25039926|NCT04535453|50140706|FG009|Overall Study|Physician Decision|0|||
25039927|NCT04535453|50140707|FG010|Overall Study|Physician Decision|0|||
25039928|NCT04535453|50140708|FG011|Overall Study|Physician Decision|0|||
25039929|NCT04535453|50140697|FG000|Overall Study|Withdrawal by Subject|3|||
25039930|NCT04535453|50140698|FG001|Overall Study|Withdrawal by Subject|6|||
25039931|NCT04535453|50140699|FG002|Overall Study|Withdrawal by Subject|3|||
24953057|NCT00183196|50044238|FG002|Overall Study|Withdrawal by Subject|13|||
25039932|NCT04535453|50140700|FG003|Overall Study|Withdrawal by Subject|3|||
25039933|NCT04535453|50140701|FG004|Overall Study|Withdrawal by Subject|2|||
25039934|NCT04535453|50140702|FG005|Overall Study|Withdrawal by Subject|1|||
25039935|NCT04535453|50140703|FG006|Overall Study|Withdrawal by Subject|1|||
25039936|NCT04535453|50140704|FG007|Overall Study|Withdrawal by Subject|1|||
25039937|NCT04535453|50140705|FG008|Overall Study|Withdrawal by Subject|1|||
25039938|NCT04535453|50140706|FG009|Overall Study|Withdrawal by Subject|1|||
25039939|NCT04535453|50140707|FG010|Overall Study|Withdrawal by Subject|0|||
25039940|NCT04535453|50140708|FG011|Overall Study|Withdrawal by Subject|1|||
25039941|NCT04535453|50140697|FG000|Overall Study|Other|0|||
25039942|NCT04535453|50140698|FG001|Overall Study|Other|0|||
25039943|NCT04535453|50140699|FG002|Overall Study|Other|1|||
25039944|NCT04535453|50140700|FG003|Overall Study|Other|0|||
25039945|NCT04535453|50140701|FG004|Overall Study|Other|1|||
25039946|NCT04535453|50140702|FG005|Overall Study|Other|0|||
25039947|NCT04535453|50140703|FG006|Overall Study|Other|1|||
25039948|NCT04535453|50140704|FG007|Overall Study|Other|1|||
25039949|NCT04535453|50140705|FG008|Overall Study|Other|1|||
25039950|NCT04535453|50140706|FG009|Overall Study|Other|0|||
25039951|NCT04535453|50140707|FG010|Overall Study|Other|0|||
25039952|NCT04535453|50140708|FG011|Overall Study|Other|0|||
25039953|NCT04463069|50140751|FG000|Overall Study|Withdrawal by Subject|2|||
24953058|NCT00183196|50044236|FG000|Overall Study|Adverse Event|1|||
24953059|NCT00183196|50044237|FG001|Overall Study|Adverse Event|2|||
24953060|NCT00183196|50044238|FG002|Overall Study|Adverse Event|2|||
24953061|NCT00183196|50044236|FG000|Overall Study|Legal event|1|||
24953062|NCT00183196|50044237|FG001|Overall Study|Legal event|1|||
24953063|NCT00183196|50044238|FG002|Overall Study|Legal event|1|||
24953064|NCT00183196|50044236|FG000|Overall Study|Required more intensive care|0|||
24953065|NCT00183196|50044237|FG001|Overall Study|Required more intensive care|1|||
24953066|NCT00183196|50044238|FG002|Overall Study|Required more intensive care|2|||
24953067|NCT00349752|50044248|FG000|Overall Study|Adverse Event|8|||
24953068|NCT00349752|50044249|FG001|Overall Study|Adverse Event|12|||
24953069|NCT00349752|50044248|FG000|Overall Study|Lack of Efficacy|37|||
24953070|NCT00349752|50044249|FG001|Overall Study|Lack of Efficacy|42|||
24953071|NCT00349752|50044248|FG000|Overall Study|Lost to Follow-up|4|||
24953072|NCT00349752|50044249|FG001|Overall Study|Lost to Follow-up|2|||
24953073|NCT00349752|50044248|FG000|Overall Study|Personal reasons|6|||
24953074|NCT00349752|50044249|FG001|Overall Study|Personal reasons|5|||
24953075|NCT00349752|50044248|FG000|Overall Study|Other: Required exclusionary medication|0|||
24953076|NCT00349752|50044249|FG001|Overall Study|Other: Required exclusionary medication|1|||
25039954|NCT04463069|50140752|FG001|Overall Study|Withdrawal by Subject|10|||
25039955|NCT04463069|50140751|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
25039956|NCT04463069|50140752|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
25039957|NCT03521687|50140758|FG000|Overall Study|Adverse Event|4|||
25039958|NCT03521687|50140758|FG000|Overall Study|Physician Decision|1|||
25039959|NCT03125915|50140766|FG000|1 Month Follow up|Lost to Follow-up|3|||
25039960|NCT03125915|50140767|FG001|1 Month Follow up|Lost to Follow-up|3|||
25039961|NCT03125915|50140768|FG002|1 Month Follow up|Lost to Follow-up|2|||
25039962|NCT03125915|50140769|FG003|1 Month Follow up|Lost to Follow-up|3|||
24953077|NCT00349752|50044248|FG000|Overall Study|Other: Non compliance|0|||
25039963|NCT03125915|50140766|FG000|3 Month Follow-up|Lost to Follow-up|6|||
25039964|NCT03125915|50140767|FG001|3 Month Follow-up|Lost to Follow-up|4|||
24953078|NCT00349752|50044249|FG001|Overall Study|Other: Non compliance|1|||
24953079|NCT00349752|50044248|FG000|Overall Study|Other: Patient stopped steroids|0|||
24953080|NCT00349752|50044249|FG001|Overall Study|Other: Patient stopped steroids|1|||
25039965|NCT03125915|50140768|FG002|3 Month Follow-up|Lost to Follow-up|4|||
25039966|NCT03125915|50140769|FG003|3 Month Follow-up|Lost to Follow-up|2|||
25039967|NCT03125915|50140766|FG000|6 Month Follow-up|Lost to Follow-up|7|||
25039968|NCT03125915|50140767|FG001|6 Month Follow-up|Lost to Follow-up|3|||
25039969|NCT03125915|50140768|FG002|6 Month Follow-up|Lost to Follow-up|6|||
24953081|NCT00349752|50044248|FG000|Overall Study|Other: Patient's steroid use|1|||
24953082|NCT00349752|50044249|FG001|Overall Study|Other: Patient's steroid use|0|||
24953083|NCT00349752|50044248|FG000|Overall Study|Other: Ineligible|1|||
24953084|NCT00349752|50044249|FG001|Overall Study|Other: Ineligible|0|||
24953085|NCT00349752|50044248|FG000|Overall Study|Other: Inadvertently unblinded|1|||
24953086|NCT00349752|50044249|FG001|Overall Study|Other: Inadvertently unblinded|0|||
24953087|NCT00349752|50044248|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
24953088|NCT00349752|50044249|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
24953089|NCT00174460|50044257|FG000|Overall Study|Withdrawal by Subject|0|||
24953090|NCT00174460|50044258|FG001|Overall Study|Withdrawal by Subject|1|||
25039970|NCT03125915|50140769|FG003|6 Month Follow-up|Lost to Follow-up|3|||
25039971|NCT03122171|50140779|FG000|Overall Study|Withdrawal by Subject|1|||
25039972|NCT01427725|50140783|FG000|Overall Study|Lost to Follow-up|17|||
25039973|NCT01427725|50140783|FG000|Overall Study|Protocol Violation|1|||
25039974|NCT01427725|50140783|FG000|Overall Study|Drug not administered|1|||
25039975|NCT01427725|50140783|FG000|Overall Study|Failure to visit|7|||
24953091|NCT00348816|50044265|FG000|Overall Study|Noncompliance with radiation treatment|1|||
24953092|NCT00265083|50044274|FG000|Overall Study|Adverse Event|5|||
24953093|NCT00265083|50044275|FG001|Overall Study|Adverse Event|13|||
24953094|NCT00265083|50044276|FG002|Overall Study|Adverse Event|15|||
24953095|NCT00265083|50044274|FG000|Overall Study|Lost to Follow-up|3|||
24953096|NCT00265083|50044275|FG001|Overall Study|Lost to Follow-up|4|||
24953097|NCT00265083|50044276|FG002|Overall Study|Lost to Follow-up|4|||
24953098|NCT00265083|50044274|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
24953099|NCT00265083|50044275|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
24953100|NCT00265083|50044276|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
24953101|NCT00265083|50044274|FG000|Overall Study|Other|1|||
24953102|NCT00265083|50044275|FG001|Overall Study|Other|12|||
24953103|NCT00265083|50044276|FG002|Overall Study|Other|9|||
24953104|NCT00264849|50044287|FG000|Overall Study|Adverse Event|7|||
24953105|NCT00264849|50044288|FG001|Overall Study|Adverse Event|2|||
24953106|NCT00264849|50044287|FG000|Overall Study|Withdrawal by Subject|7|||
24953107|NCT00264849|50044288|FG001|Overall Study|Withdrawal by Subject|11|||
24953108|NCT00264849|50044287|FG000|Overall Study|Protocol Violation|5|||
24953109|NCT00264849|50044288|FG001|Overall Study|Protocol Violation|3|||
24953110|NCT00264849|50044287|FG000|Overall Study|Lack of Efficacy|1|||
24953111|NCT00264849|50044288|FG001|Overall Study|Lack of Efficacy|6|||
24953112|NCT00264849|50044287|FG000|Overall Study|Lost to Follow-up|0|||
25039976|NCT01427725|50140783|FG000|Overall Study|Adverse Event|46|||
25039977|NCT01427725|50140783|FG000|Overall Study|Failure to visit after administration|40|||
25039978|NCT01427725|50140783|FG000|Overall Study|Patient's rejection|27|||
25039979|NCT01427725|50140783|FG000|Overall Study|Transfer to a different hospital|17|||
25039980|NCT01427725|50140783|FG000|Overall Study|Lack of Efficacy|8|||
25039981|NCT01427725|50140783|FG000|Overall Study|Death|7|||
25039982|NCT01427725|50140783|FG000|Overall Study|Symptom improvement|6|||
25039983|NCT01427725|50140783|FG000|Overall Study|AE and Patient's rejection|5|||
25039984|NCT01427725|50140783|FG000|Overall Study|Physician Decision|5|||
25039985|NCT01427725|50140783|FG000|Overall Study|Exacerbation of underlying disease|5|||
25039986|NCT01427725|50140783|FG000|Overall Study|Oral feeding difficulty|5|||
25039987|NCT01427725|50140783|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
25039988|NCT01427725|50140783|FG000|Overall Study|Forgetting prescription|1|||
25039989|NCT01427725|50140783|FG000|Overall Study|Other|2|||
25039990|NCT02839200|50140794|FG000|Overall Study|Withdrawal by Subject|2|||
25039991|NCT02839200|50140795|FG001|Overall Study|Withdrawal by Subject|0|||
25039992|NCT02839200|50140796|FG002|Overall Study|Withdrawal by Subject|1|||
24953113|NCT00264849|50044288|FG001|Overall Study|Lost to Follow-up|2|||
24953114|NCT00264849|50044287|FG000|Overall Study|Death|0|||
24953115|NCT00264849|50044288|FG001|Overall Study|Death|1|||
24953116|NCT00264849|50044287|FG000|Overall Study|Administrative Problems|2|||
24953117|NCT00264849|50044288|FG001|Overall Study|Administrative Problems|0|||
24953118|NCT00211809|50044294|FG000|Overall Study|Lack of Efficacy|1|||
24953119|NCT00211809|50044294|FG000|Overall Study|Lost to Follow-up|2|||
24953120|NCT00211809|50044294|FG000|Overall Study|Pregnancy|1|||
24953121|NCT00211809|50044294|FG000|Overall Study|side effects|2|||
24953122|NCT00129766|50044302|FG000|Overall Study|Death|3|||
24953123|NCT00129766|50044303|FG001|Overall Study|Death|8|||
24953124|NCT00129766|50044302|FG000|Overall Study|Withdrawal of consent|31|||
24953125|NCT00129766|50044303|FG001|Overall Study|Withdrawal of consent|30|||
24953126|NCT00129766|50044302|FG000|Overall Study|Lost to Follow-up|26|||
24953127|NCT00129766|50044303|FG001|Overall Study|Lost to Follow-up|21|||
25039993|NCT02839200|50140797|FG003|Overall Study|Withdrawal by Subject|0|||
25039994|NCT02839200|50140798|FG004|Overall Study|Withdrawal by Subject|0|||
25039995|NCT02839200|50140799|FG005|Overall Study|Withdrawal by Subject|1|||
24953128|NCT00150592|50044312|FG000|Overall Study|Adverse Event|4|||
24953129|NCT00150592|50044313|FG001|Overall Study|Adverse Event|1|||
24953130|NCT00150592|50044312|FG000|Overall Study|Protocol Violation|1|||
25039996|NCT02839200|50140794|FG000|Overall Study|Lost to Follow-up|2|||
25039997|NCT02839200|50140795|FG001|Overall Study|Lost to Follow-up|0|||
24953131|NCT00150592|50044313|FG001|Overall Study|Protocol Violation|0|||
24953132|NCT00150592|50044312|FG000|Overall Study|Withdrawal by Subject|1|||
24953133|NCT00150592|50044313|FG001|Overall Study|Withdrawal by Subject|2|||
24953134|NCT00150592|50044312|FG000|Overall Study|Non-compliance|1|||
24953135|NCT00150592|50044313|FG001|Overall Study|Non-compliance|0|||
24953136|NCT00149890|50044321|FG000|Overall Study|Adverse Event|1|||
24953137|NCT00149890|50044322|FG001|Overall Study|Adverse Event|8|||
24953138|NCT00149890|50044321|FG000|Overall Study|Lack of Efficacy|8|||
24953139|NCT00149890|50044322|FG001|Overall Study|Lack of Efficacy|9|||
24953140|NCT00149890|50044321|FG000|Overall Study|Protocol Violation|1|||
24953141|NCT00149890|50044322|FG001|Overall Study|Protocol Violation|0|||
24953142|NCT00149890|50044321|FG000|Overall Study|Lost to Follow-up|1|||
24953143|NCT00149890|50044322|FG001|Overall Study|Lost to Follow-up|0|||
24953144|NCT00149890|50044321|FG000|Overall Study|Graft Loss|2|||
24953145|NCT00149890|50044322|FG001|Overall Study|Graft Loss|1|||
24953146|NCT00174382|50044328|FG000|Overall Study|Death|2|||
24953147|NCT00174382|50044328|FG000|Overall Study|Adverse Event|19|||
24953148|NCT00174382|50044328|FG000|Overall Study|Withdrawal by Subject|6|||
24953149|NCT00174382|50044328|FG000|Overall Study|Protocol Violation|3|||
24953150|NCT00174382|50044328|FG000|Overall Study|Arrived early for last visit in error|1|||
24953151|NCT00174382|50044328|FG000|Overall Study|Subject felt pill not effective enough|1|||
24953152|NCT00174382|50044328|FG000|Overall Study|Lost to Follow-up|1|||
24953153|NCT00355134|50044337|FG000|Core Phase|Withdrawal by Subject|35|||
24953154|NCT00355134|50044338|FG001|Core Phase|Withdrawal by Subject|24|||
24953155|NCT00355134|50044339|FG002|Core Phase|Withdrawal by Subject|35|||
24953156|NCT00355134|50044340|FG003|Core Phase|Withdrawal by Subject|0|||
24953157|NCT00355134|50044341|FG004|Core Phase|Withdrawal by Subject|0|||
24953158|NCT00355134|50044337|FG000|Core Phase|Adverse Event|28|||
24953159|NCT00355134|50044338|FG001|Core Phase|Adverse Event|22|||
24953160|NCT00355134|50044339|FG002|Core Phase|Adverse Event|16|||
24953161|NCT00355134|50044340|FG003|Core Phase|Adverse Event|0|||
24953162|NCT00355134|50044341|FG004|Core Phase|Adverse Event|0|||
24953163|NCT00355134|50044337|FG000|Core Phase|Lost to Follow-up|17|||
24953164|NCT00355134|50044338|FG001|Core Phase|Lost to Follow-up|13|||
24953165|NCT00355134|50044339|FG002|Core Phase|Lost to Follow-up|21|||
24953166|NCT00355134|50044340|FG003|Core Phase|Lost to Follow-up|0|||
24953167|NCT00355134|50044341|FG004|Core Phase|Lost to Follow-up|0|||
24953168|NCT00355134|50044337|FG000|Core Phase|Abnormal laboratory value(s)|19|||
24953169|NCT00355134|50044338|FG001|Core Phase|Abnormal laboratory value(s)|14|||
24953170|NCT00355134|50044339|FG002|Core Phase|Abnormal laboratory value(s)|2|||
24953171|NCT00355134|50044340|FG003|Core Phase|Abnormal laboratory value(s)|0|||
24953172|NCT00355134|50044341|FG004|Core Phase|Abnormal laboratory value(s)|0|||
24953173|NCT00355134|50044337|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
24953174|NCT00355134|50044338|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
24953175|NCT00355134|50044339|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
24953176|NCT00355134|50044340|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
24953177|NCT00355134|50044341|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
24953178|NCT00355134|50044337|FG000|Core Phase|Administrative problems|5|||
24953179|NCT00355134|50044338|FG001|Core Phase|Administrative problems|3|||
24953180|NCT00355134|50044339|FG002|Core Phase|Administrative problems|5|||
24953181|NCT00355134|50044340|FG003|Core Phase|Administrative problems|0|||
24953182|NCT00355134|50044341|FG004|Core Phase|Administrative problems|0|||
24953183|NCT00355134|50044337|FG000|Core Phase|Protocol Violation|3|||
24953184|NCT00355134|50044338|FG001|Core Phase|Protocol Violation|2|||
24953185|NCT00355134|50044339|FG002|Core Phase|Protocol Violation|2|||
24953186|NCT00355134|50044340|FG003|Core Phase|Protocol Violation|0|||
24953187|NCT00355134|50044341|FG004|Core Phase|Protocol Violation|0|||
24953188|NCT00355134|50044337|FG000|Core Phase|Abnormal test procedure result(s)|1|||
24953189|NCT00355134|50044338|FG001|Core Phase|Abnormal test procedure result(s)|2|||
24953190|NCT00355134|50044339|FG002|Core Phase|Abnormal test procedure result(s)|1|||
24953191|NCT00355134|50044340|FG003|Core Phase|Abnormal test procedure result(s)|0|||
25039998|NCT02839200|50140796|FG002|Overall Study|Lost to Follow-up|0|||
25039999|NCT02839200|50140797|FG003|Overall Study|Lost to Follow-up|0|||
25040000|NCT02839200|50140798|FG004|Overall Study|Lost to Follow-up|1|||
25040001|NCT02839200|50140799|FG005|Overall Study|Lost to Follow-up|0|||
25040002|NCT02839200|50140794|FG000|Overall Study|Adverse Event|0|||
25040003|NCT02839200|50140795|FG001|Overall Study|Adverse Event|0|||
24953192|NCT00355134|50044341|FG004|Core Phase|Abnormal test procedure result(s)|0|||
24953193|NCT00355134|50044337|FG000|Core Phase|Condition no longer requires study drug|1|||
24953194|NCT00355134|50044338|FG001|Core Phase|Condition no longer requires study drug|0|||
24953195|NCT00355134|50044339|FG002|Core Phase|Condition no longer requires study drug|1|||
24953196|NCT00355134|50044340|FG003|Core Phase|Condition no longer requires study drug|0|||
24953197|NCT00355134|50044341|FG004|Core Phase|Condition no longer requires study drug|0|||
24953198|NCT00355134|50044337|FG000|Extension Phase|Withdrawal by Subject|7|||
24953199|NCT00355134|50044338|FG001|Extension Phase|Withdrawal by Subject|11|||
24953200|NCT00355134|50044339|FG002|Extension Phase|Withdrawal by Subject|0|||
24953201|NCT00355134|50044340|FG003|Extension Phase|Withdrawal by Subject|7|||
24953202|NCT00355134|50044341|FG004|Extension Phase|Withdrawal by Subject|5|||
24953203|NCT00355134|50044337|FG000|Extension Phase|Adverse Event|13|||
24953204|NCT00355134|50044338|FG001|Extension Phase|Adverse Event|9|||
24953205|NCT00355134|50044339|FG002|Extension Phase|Adverse Event|0|||
24953206|NCT00355134|50044340|FG003|Extension Phase|Adverse Event|3|||
24953207|NCT00355134|50044341|FG004|Extension Phase|Adverse Event|5|||
24953208|NCT00355134|50044337|FG000|Extension Phase|Lost to Follow-up|2|||
24953209|NCT00355134|50044338|FG001|Extension Phase|Lost to Follow-up|6|||
24953210|NCT00355134|50044339|FG002|Extension Phase|Lost to Follow-up|0|||
24953211|NCT00355134|50044340|FG003|Extension Phase|Lost to Follow-up|2|||
24953212|NCT00355134|50044341|FG004|Extension Phase|Lost to Follow-up|4|||
24953213|NCT00355134|50044337|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
24953214|NCT00355134|50044338|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
24953215|NCT00355134|50044339|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
24953216|NCT00355134|50044340|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
24953217|NCT00355134|50044341|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
24953218|NCT00355134|50044337|FG000|Extension Phase|Administrative problems|2|||
24953219|NCT00355134|50044338|FG001|Extension Phase|Administrative problems|4|||
24953220|NCT00355134|50044339|FG002|Extension Phase|Administrative problems|0|||
24953221|NCT00355134|50044340|FG003|Extension Phase|Administrative problems|1|||
24953222|NCT00355134|50044341|FG004|Extension Phase|Administrative problems|1|||
24953223|NCT00355134|50044337|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
24953224|NCT00355134|50044338|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
24953225|NCT00355134|50044339|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
24953226|NCT00355134|50044340|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
24953227|NCT00355134|50044341|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
24953228|NCT00355134|50044337|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
24953229|NCT00355134|50044338|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
24953230|NCT00355134|50044339|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
24953231|NCT00355134|50044340|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
24953232|NCT00355134|50044341|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
24953233|NCT00355134|50044337|FG000|Extension Phase|Protocol Violation|0|||
24953234|NCT00355134|50044338|FG001|Extension Phase|Protocol Violation|0|||
24953235|NCT00355134|50044339|FG002|Extension Phase|Protocol Violation|0|||
24953236|NCT00355134|50044340|FG003|Extension Phase|Protocol Violation|1|||
24953237|NCT00355134|50044341|FG004|Extension Phase|Protocol Violation|0|||
24953238|NCT00171730|50044351|FG000|Overall Study|Adverse Event|3|||
24953239|NCT00171730|50044351|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
24953240|NCT00171730|50044351|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
24953241|NCT00171730|50044351|FG000|Overall Study|Withdrawal by Subject|3|||
24953242|NCT00355056|50044363|FG000|Randomization Period|Early Termination|4|||
24953243|NCT00355056|50044364|FG001|Randomization Period|Early Termination|6|||
24953244|NCT00348348|50044380|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
24953245|NCT00348348|50044381|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
24953246|NCT00348348|50044380|FG000|Overall Study|Lack of Efficacy|1|||
24953247|NCT00348348|50044381|FG001|Overall Study|Lack of Efficacy|1|||
24953248|NCT00348348|50044380|FG000|Overall Study|Lost to Follow-up|8|||
24953249|NCT00348348|50044381|FG001|Overall Study|Lost to Follow-up|10|||
24953250|NCT00348348|50044380|FG000|Overall Study|Withdrawal by Subject|4|||
24953251|NCT00348348|50044381|FG001|Overall Study|Withdrawal by Subject|1|||
24953252|NCT00348348|50044380|FG000|Overall Study|Other|7|||
25040004|NCT02839200|50140796|FG002|Overall Study|Adverse Event|0|||
24953253|NCT00348348|50044381|FG001|Overall Study|Other|4|||
24953254|NCT00348348|50044380|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
24953255|NCT00348348|50044381|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
25040005|NCT02839200|50140797|FG003|Overall Study|Adverse Event|0|||
25160207|NCT01879579|50280314|FG000|Overall Study|Phone incompatible with texting platform|3|||
25160208|NCT01879579|50280315|FG001|Overall Study|Phone incompatible with texting platform|0|||
25160209|NCT01879579|50280314|FG000|Overall Study|Did not enroll in texting platform|1|||
25160210|NCT01879579|50280315|FG001|Overall Study|Did not enroll in texting platform|0|||
24953256|NCT00348348|50044380|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
24953257|NCT00348348|50044381|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
24953258|NCT00348348|50044380|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
25040006|NCT02839200|50140798|FG004|Overall Study|Adverse Event|1|||
25040007|NCT02839200|50140799|FG005|Overall Study|Adverse Event|0|||
25040008|NCT02839200|50140794|FG000|Overall Study|Randomized in error|0|||
25040009|NCT02839200|50140795|FG001|Overall Study|Randomized in error|1|||
25040010|NCT02839200|50140796|FG002|Overall Study|Randomized in error|0|||
25040011|NCT02839200|50140797|FG003|Overall Study|Randomized in error|0|||
25040012|NCT02839200|50140798|FG004|Overall Study|Randomized in error|0|||
25040013|NCT02839200|50140799|FG005|Overall Study|Randomized in error|0|||
25040014|NCT03118739|50140815|FG000|Overall Study|Physician Decision|0|||
25040015|NCT03118739|50140816|FG001|Overall Study|Physician Decision|1|||
25040016|NCT03118739|50140815|FG000|Overall Study|Withdrawal by Subject|5|||
25040017|NCT03118739|50140816|FG001|Overall Study|Withdrawal by Subject|3|||
25040018|NCT03118739|50140815|FG000|Overall Study|Lost to Follow-up|2|||
25040019|NCT03118739|50140816|FG001|Overall Study|Lost to Follow-up|0|||
25040020|NCT03094195|50140825|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
25040021|NCT03094195|50140826|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
25040022|NCT03094195|50140827|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
25040023|NCT03094195|50140828|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
25040024|NCT03094195|50140829|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
25040025|NCT03094195|50140830|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
25040026|NCT03094195|50140831|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
25040027|NCT03094195|50140832|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
25040028|NCT03094195|50140825|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
25040029|NCT03094195|50140826|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
25040030|NCT03094195|50140827|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
25040031|NCT03094195|50140828|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
24953259|NCT00348348|50044381|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
24953260|NCT00348348|50044380|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
24953261|NCT00348348|50044381|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
24953262|NCT00348348|50044380|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
24953263|NCT00348348|50044381|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
24953264|NCT00348348|50044380|FG000|Overall Study|Adverse event probably related to study|1|||
24953265|NCT00348348|50044381|FG001|Overall Study|Adverse event probably related to study|0|||
24953266|NCT00347958|50044387|FG000|Overall Study|Adverse Event|1|||
24953267|NCT00347958|50044387|FG000|Overall Study|Protocol Violation|2|||
24953268|NCT00347958|50044387|FG000|Overall Study|Withdrawal by Subject|1|||
24953269|NCT00354744|50044391|FG000|Overall Study|Adverse Event|2|||
24953270|NCT00354744|50044391|FG000|Overall Study|Death|2|||
24953271|NCT00354744|50044391|FG000|Overall Study|Lack of Efficacy|11|||
24953272|NCT00354744|50044391|FG000|Overall Study|Lost to Follow-up|2|||
24953273|NCT00354744|50044391|FG000|Overall Study|Physician Decision|11|||
24953274|NCT00354744|50044391|FG000|Overall Study|Withdrawal by Subject|14|||
24953275|NCT00373256|50044399|FG000|Overall Study|Adverse Event (AE)|1|||
24953276|NCT00373256|50044400|FG001|Overall Study|Adverse Event (AE)|5|||
24953277|NCT00373256|50044399|FG000|Overall Study|Lost to Follow-up|2|||
24953278|NCT00373256|50044400|FG001|Overall Study|Lost to Follow-up|1|||
24953279|NCT00373256|50044399|FG000|Overall Study|Death|9|||
24953280|NCT00373256|50044400|FG001|Overall Study|Death|8|||
25040032|NCT03094195|50140829|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
25040033|NCT03094195|50140830|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
25040034|NCT03094195|50140831|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
25040035|NCT03094195|50140832|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
25040036|NCT03094195|50140825|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
25040037|NCT03094195|50140826|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
24953281|NCT00373256|50044399|FG000|Overall Study|Objective Progression or Relapse|111|||
24953282|NCT00373256|50044400|FG001|Overall Study|Objective Progression or Relapse|104|||
24953283|NCT00373256|50044399|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
24953284|NCT00373256|50044400|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
24953285|NCT00373256|50044399|FG000|Overall Study|Other|73|||
24953286|NCT00373256|50044400|FG001|Overall Study|Other|107|||
24953287|NCT00373256|50044399|FG000|Overall Study|Protocol Violation|0|||
24953288|NCT00373256|50044400|FG001|Overall Study|Protocol Violation|2|||
24953289|NCT00373256|50044399|FG000|Overall Study|Study Terminated by Sponsor|41|||
24953290|NCT00373256|50044400|FG001|Overall Study|Study Terminated by Sponsor|13|||
24953291|NCT00394082|50044406|FG000|Overall Study|Unacceptable toxicity|15|||
24953292|NCT00394082|50044406|FG000|Overall Study|Adverse Event|4|||
24953293|NCT00394082|50044406|FG000|Overall Study|Physician Decision|4|||
24953294|NCT00394082|50044406|FG000|Overall Study|Withdrawal by Subject|2|||
25040038|NCT03094195|50140827|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
25040039|NCT03094195|50140828|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
25040040|NCT03094195|50140829|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
25040041|NCT03094195|50140830|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
25040042|NCT03094195|50140831|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
25040043|NCT03094195|50140832|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
25040044|NCT03094195|50140825|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
25040045|NCT03094195|50140826|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
25040046|NCT03094195|50140827|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
25040047|NCT03094195|50140828|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
25040048|NCT03094195|50140829|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
25040049|NCT03094195|50140830|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
25040050|NCT03094195|50140831|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
25040051|NCT03094195|50140832|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
25040052|NCT02835690|50140853|FG000|Overall Study|Death|12|||
25040053|NCT02835690|50140854|FG001|Overall Study|Death|11|||
25040054|NCT02835690|50140855|FG002|Overall Study|Death|13|||
25040055|NCT02835690|50140853|FG000|Overall Study|Transferred to Extension Study|2|||
25040056|NCT02835690|50140854|FG001|Overall Study|Transferred to Extension Study|2|||
25040057|NCT02835690|50140855|FG002|Overall Study|Transferred to Extension Study|1|||
25040058|NCT02835690|50140853|FG000|Overall Study|Did Not Continue on Extension Study|0|||
25040059|NCT02835690|50140854|FG001|Overall Study|Did Not Continue on Extension Study|0|||
25040060|NCT02835690|50140855|FG002|Overall Study|Did Not Continue on Extension Study|1|||
25040061|NCT02835690|50140853|FG000|Overall Study|Not Treated|0|||
25040062|NCT02835690|50140854|FG001|Overall Study|Not Treated|2|||
25040063|NCT02835690|50140855|FG002|Overall Study|Not Treated|0|||
25040064|NCT02837952|50140866|FG000|Overall Study|Adverse Event|0|||
24953295|NCT00394082|50044406|FG000|Overall Study|Other|1|||
24953296|NCT00393848|50044414|FG000|Overall Study|Surgical schedule|0|||
24953297|NCT00393848|50044415|FG001|Overall Study|Surgical schedule|0|||
24953298|NCT00393848|50044416|FG002|Overall Study|Surgical schedule|0|||
24953299|NCT00393848|50044417|FG003|Overall Study|Surgical schedule|1|||
24953300|NCT00393848|50044414|FG000|Overall Study|Personal reasons|0|||
24953301|NCT00393848|50044415|FG001|Overall Study|Personal reasons|0|||
24953302|NCT00393848|50044416|FG002|Overall Study|Personal reasons|2|||
24953303|NCT00393848|50044417|FG003|Overall Study|Personal reasons|0|||
24953304|NCT00393458|50044432|FG000|Overall Study|Adverse Event|35|||
24953305|NCT00393458|50044433|FG001|Overall Study|Adverse Event|24|||
24953306|NCT00393458|50044434|FG002|Overall Study|Adverse Event|40|||
24953307|NCT00393458|50044435|FG003|Overall Study|Adverse Event|35|||
24953308|NCT00393458|50044432|FG000|Overall Study|Subject withdrew consent|27|||
24953309|NCT00393458|50044433|FG001|Overall Study|Subject withdrew consent|40|||
24953310|NCT00393458|50044434|FG002|Overall Study|Subject withdrew consent|33|||
24953311|NCT00393458|50044435|FG003|Overall Study|Subject withdrew consent|50|||
24953312|NCT00393458|50044432|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
24953313|NCT00393458|50044433|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
24953314|NCT00393458|50044434|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
24953315|NCT00393458|50044435|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
24953316|NCT00393458|50044432|FG000|Overall Study|Protocol deviation|11|||
25040065|NCT02837952|50140867|FG001|Overall Study|Adverse Event|1|||
25040066|NCT02837952|50140866|FG000|Overall Study|Withdrawal by Subject|4|||
25040067|NCT02837952|50140867|FG001|Overall Study|Withdrawal by Subject|5|||
25040068|NCT02837952|50140866|FG000|Overall Study|Medication Error|1|||
25160211|NCT01879579|50280314|FG000|Overall Study|Did not initiate insulin treatment|1|||
24953317|NCT00393458|50044433|FG001|Overall Study|Protocol deviation|11|||
24953318|NCT00393458|50044434|FG002|Overall Study|Protocol deviation|11|||
25040069|NCT02837952|50140867|FG001|Overall Study|Medication Error|0|||
25160212|NCT01879579|50280315|FG001|Overall Study|Did not initiate insulin treatment|0|||
25040070|NCT02832167|50140873|FG000|Treatment Period 1|Disease progression|90|||
24953319|NCT00393458|50044435|FG003|Overall Study|Protocol deviation|10|||
24953320|NCT00393458|50044432|FG000|Overall Study|Administrative problems|7|||
24953321|NCT00393458|50044433|FG001|Overall Study|Administrative problems|8|||
24953322|NCT00393458|50044434|FG002|Overall Study|Administrative problems|5|||
25040071|NCT02832167|50140873|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
25040072|NCT02832167|50140873|FG000|Treatment Period 1|Death|2|||
25040073|NCT02832167|50140873|FG000|Treatment Period 1|Study Drug Toxicity|6|||
25040074|NCT02832167|50140873|FG000|Treatment Period 1|Participant request to discontinue|9|||
25040075|NCT02832167|50140873|FG000|Treatment Period 1|No longer meet study criteria|1|||
25040076|NCT02832167|50140873|FG000|Treatment Period 1|Participant withdrew consent|3|||
25040077|NCT02832167|50140873|FG000|Treatment Period 1|Other reasons|6|||
25040078|NCT02832167|50140873|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
25040079|NCT02832167|50140873|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
25040080|NCT02832167|50140873|FG000|Transition From Period 1 to Period 2|Death|2|||
25040081|NCT02832167|50140873|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
25040082|NCT02832167|50140873|FG000|Treatment Period 2|Disease progression|69|||
25040083|NCT02832167|50140873|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
25040084|NCT02832167|50140873|FG000|Treatment Period 2|Maximum clinical benefit|1|||
25040085|NCT02832167|50140873|FG000|Treatment Period 2|Study Drug Toxicity|5|||
25040086|NCT02832167|50140873|FG000|Treatment Period 2|Participant request to discontinue|2|||
25040087|NCT02832167|50140873|FG000|Treatment Period 2|Participant withdrew consent|3|||
25040088|NCT02832167|50140873|FG000|Treatment Period 2|Other reasons|3|||
25040089|NCT02674529|50140879|FG000|Overall Study|Lost to Follow-up|1|||
25040090|NCT02674529|50140880|FG001|Overall Study|Lost to Follow-up|2|||
24953323|NCT00393458|50044435|FG003|Overall Study|Administrative problems|2|||
24953324|NCT00393458|50044432|FG000|Overall Study|Lost to Follow-up|5|||
24953325|NCT00393458|50044433|FG001|Overall Study|Lost to Follow-up|6|||
24953326|NCT00393458|50044434|FG002|Overall Study|Lost to Follow-up|5|||
24953327|NCT00393458|50044435|FG003|Overall Study|Lost to Follow-up|3|||
24953328|NCT00393458|50044432|FG000|Overall Study|Abnormal laboratory value(s)|1|||
24953329|NCT00393458|50044433|FG001|Overall Study|Abnormal laboratory value(s)|1|||
24953330|NCT00393458|50044434|FG002|Overall Study|Abnormal laboratory value(s)|0|||
24953331|NCT00393458|50044435|FG003|Overall Study|Abnormal laboratory value(s)|0|||
25040091|NCT02674529|50140879|FG000|Overall Study|Withdrawal by Subject|2|||
25040092|NCT02674529|50140880|FG001|Overall Study|Withdrawal by Subject|1|||
25040093|NCT02674529|50140879|FG000|Overall Study|Physician Decision|0|||
25040094|NCT02674529|50140880|FG001|Overall Study|Physician Decision|1|||
25040095|NCT02674529|50140879|FG000|Overall Study|Protocol Violation|0|||
25040096|NCT02674529|50140880|FG001|Overall Study|Protocol Violation|1|||
25040097|NCT02626949|50140891|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
25040098|NCT02626949|50140892|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
25040099|NCT02626949|50140891|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
25040100|NCT02626949|50140892|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
25040101|NCT02626949|50140891|FG000|Enrolled|Lost to Follow-up|7|||
25040102|NCT02626949|50140892|FG001|Enrolled|Lost to Follow-up|6|||
25040103|NCT02626949|50140891|FG000|Enrolled|Withdrawal by Subject|3|||
25040104|NCT02626949|50140892|FG001|Enrolled|Withdrawal by Subject|2|||
25040105|NCT03116399|50140900|FG000|Overall Study|Death|8|||
25040106|NCT03116399|50140901|FG001|Overall Study|Death|3|||
25040107|NCT03116399|50140900|FG000|Overall Study|Lost to Follow-up|7|||
25040108|NCT03116399|50140901|FG001|Overall Study|Lost to Follow-up|11|||
25040109|NCT03116399|50140900|FG000|Overall Study|Investigator Decision|1|||
25040110|NCT03116399|50140901|FG001|Overall Study|Investigator Decision|1|||
25040111|NCT03116399|50140900|FG000|Overall Study|Withdrawal by Subject|24|||
25040112|NCT03116399|50140901|FG001|Overall Study|Withdrawal by Subject|9|||
24953332|NCT00393458|50044432|FG000|Overall Study|Death|1|||
24953333|NCT00393458|50044433|FG001|Overall Study|Death|1|||
24953334|NCT00393458|50044434|FG002|Overall Study|Death|5|||
24953335|NCT00393458|50044435|FG003|Overall Study|Death|5|||
25040113|NCT03097861|50140910|FG000|Overall Study|Adverse Event|3|||
25040114|NCT03097861|50140911|FG001|Overall Study|Adverse Event|8|||
25040115|NCT03097861|50140912|FG002|Overall Study|Adverse Event|4|||
25040116|NCT03097861|50140910|FG000|Overall Study|Investigator Decision|0|||
24953336|NCT00393458|50044432|FG000|Overall Study|Abnormal test procedure result(s)|0|||
25040117|NCT03097861|50140911|FG001|Overall Study|Investigator Decision|1|||
24953337|NCT00393458|50044433|FG001|Overall Study|Abnormal test procedure result(s)|1|||
24953338|NCT00393458|50044434|FG002|Overall Study|Abnormal test procedure result(s)|1|||
24953339|NCT00393458|50044435|FG003|Overall Study|Abnormal test procedure result(s)|2|||
24953340|NCT00393458|50044432|FG000|Overall Study|Subject no longer requires study drug|0|||
24953341|NCT00393458|50044433|FG001|Overall Study|Subject no longer requires study drug|1|||
24953342|NCT00393458|50044434|FG002|Overall Study|Subject no longer requires study drug|0|||
24953343|NCT00393458|50044435|FG003|Overall Study|Subject no longer requires study drug|0|||
24953344|NCT00417482|50044448|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
24953345|NCT00417482|50044449|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
24953346|NCT00417482|50044450|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
24953347|NCT00417482|50044448|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
24953348|NCT00417482|50044449|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
24953349|NCT00417482|50044450|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
24953350|NCT00417482|50044448|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
24953351|NCT00417482|50044449|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
24953352|NCT00417482|50044450|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
24953353|NCT00417482|50044448|FG000|Phase B 1st 16 Weeks|Death|1|||
24953354|NCT00417482|50044449|FG001|Phase B 1st 16 Weeks|Death|0|||
24953355|NCT00417482|50044450|FG002|Phase B 1st 16 Weeks|Death|0|||
24953356|NCT00417482|50044448|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
24953357|NCT00417482|50044449|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
24953358|NCT00417482|50044450|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
24953359|NCT00417482|50044448|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
24953360|NCT00417482|50044449|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
24953361|NCT00417482|50044450|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
24953362|NCT00417482|50044448|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
24953363|NCT00417482|50044449|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
24953364|NCT00417482|50044450|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
24953365|NCT00417482|50044448|FG000|Phase B 2nd 16 Weeks|Death|1|||
24953366|NCT00417482|50044449|FG001|Phase B 2nd 16 Weeks|Death|1|||
24953367|NCT00417482|50044450|FG002|Phase B 2nd 16 Weeks|Death|0|||
24953368|NCT00417248|50044464|FG000|Overall Study|Study Terminated|6|||
24953369|NCT00417248|50044464|FG000|Overall Study|Death|1|||
24953370|NCT00417248|50044464|FG000|Overall Study|Lack of Efficacy|1|||
24953371|NCT00392288|50044472|FG000|Overall Study|Adverse Event|17|||
24953372|NCT00392288|50044473|FG001|Overall Study|Adverse Event|7|||
24953373|NCT00392288|50044474|FG002|Overall Study|Adverse Event|8|||
24953374|NCT00392288|50044472|FG000|Overall Study|Lack of Efficacy|8|||
24953375|NCT00392288|50044473|FG001|Overall Study|Lack of Efficacy|5|||
24953376|NCT00392288|50044474|FG002|Overall Study|Lack of Efficacy|3|||
24953377|NCT00392288|50044472|FG000|Overall Study|Protocol Violation|1|||
24953378|NCT00392288|50044473|FG001|Overall Study|Protocol Violation|3|||
24953379|NCT00392288|50044474|FG002|Overall Study|Protocol Violation|1|||
24953380|NCT00392288|50044472|FG000|Overall Study|Lost to Follow-up|1|||
24953381|NCT00392288|50044473|FG001|Overall Study|Lost to Follow-up|1|||
24953382|NCT00392288|50044474|FG002|Overall Study|Lost to Follow-up|1|||
24953383|NCT00392288|50044472|FG000|Overall Study|Withdrawal by Subject|1|||
24953384|NCT00392288|50044473|FG001|Overall Study|Withdrawal by Subject|0|||
24953385|NCT00392288|50044474|FG002|Overall Study|Withdrawal by Subject|2|||
24953386|NCT00392288|50044472|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
24953387|NCT00392288|50044473|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
24953388|NCT00392288|50044474|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
24953389|NCT00392288|50044472|FG000|Overall Study|Other|3|||
24953390|NCT00392288|50044473|FG001|Overall Study|Other|4|||
24953391|NCT00392288|50044474|FG002|Overall Study|Other|1|||
24953392|NCT00417170|50044484|FG000|Overall Study|Adverse Event|1|||
24953393|NCT00417170|50044485|FG001|Overall Study|Adverse Event|1|||
24953394|NCT00417170|50044484|FG000|Overall Study|Withdrawal by Subject|1|||
24953395|NCT00417170|50044485|FG001|Overall Study|Withdrawal by Subject|1|||
24953396|NCT00417170|50044484|FG000|Overall Study|Lost to Follow-up|0|||
24953397|NCT00417170|50044485|FG001|Overall Study|Lost to Follow-up|1|||
24953398|NCT00392990|50044493|FG000|Treatment on Study|Adverse Event|3|||
24953399|NCT00392990|50044494|FG001|Treatment on Study|Adverse Event|1|||
24953400|NCT00392990|50044493|FG000|Follow up for 2 Years|Death|4|||
24953401|NCT00392990|50044494|FG001|Follow up for 2 Years|Death|0|||
24953402|NCT00249873|50044502|FG000|Overall Study|Not treated|7|||
24953403|NCT00249873|50044503|FG001|Overall Study|Not treated|8|||
24953404|NCT00249873|50044502|FG000|Overall Study|Significant thrombocytopenia|9|||
24953405|NCT00249873|50044503|FG001|Overall Study|Significant thrombocytopenia|8|||
24953406|NCT00249873|50044502|FG000|Overall Study|Severe allergic reaction|8|||
24953407|NCT00249873|50044503|FG001|Overall Study|Severe allergic reaction|1|||
24953408|NCT00249873|50044502|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
24953409|NCT00249873|50044503|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
24953410|NCT00249873|50044502|FG000|Overall Study|Other Serious Adverse Event|86|||
24953411|NCT00249873|50044503|FG001|Overall Study|Other Serious Adverse Event|97|||
24953412|NCT00249873|50044502|FG000|Overall Study|Qualifying condition not present|20|||
24953413|NCT00249873|50044503|FG001|Overall Study|Qualifying condition not present|23|||
24953414|NCT00249873|50044502|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
24953415|NCT00249873|50044503|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
24953416|NCT00249873|50044502|FG000|Overall Study|Withdrawal by Subject|504|||
24953417|NCT00249873|50044503|FG001|Overall Study|Withdrawal by Subject|466|||
24953418|NCT00249873|50044502|FG000|Overall Study|Lost to Follow-up|4|||
24953419|NCT00249873|50044503|FG001|Overall Study|Lost to Follow-up|7|||
24953420|NCT00249873|50044502|FG000|Overall Study|Minor bleeding|99|||
24953421|NCT00249873|50044503|FG001|Overall Study|Minor bleeding|37|||
24953422|NCT00249873|50044502|FG000|Overall Study|Non-compliance|41|||
24953423|NCT00249873|50044503|FG001|Overall Study|Non-compliance|46|||
24953424|NCT00249873|50044502|FG000|Overall Study|Other non serious Adverse Event|112|||
24953425|NCT00249873|50044503|FG001|Overall Study|Other non serious Adverse Event|108|||
24953426|NCT00249873|50044502|FG000|Overall Study|Other contraindicated medication|1|||
24953427|NCT00249873|50044503|FG001|Overall Study|Other contraindicated medication|0|||
24953428|NCT00249873|50044502|FG000|Overall Study|Patient not wish to continue after May08|3|||
24953429|NCT00249873|50044503|FG001|Overall Study|Patient not wish to continue after May08|4|||
24953430|NCT00249873|50044502|FG000|Overall Study|Physician withdrew consent|59|||
24953431|NCT00249873|50044503|FG001|Overall Study|Physician withdrew consent|60|||
24953432|NCT00249873|50044502|FG000|Overall Study|Open label clopidogrel required|31|||
24953433|NCT00249873|50044503|FG001|Overall Study|Open label clopidogrel required|42|||
24953434|NCT00249873|50044502|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
24953435|NCT00249873|50044503|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
24953436|NCT00249873|50044502|FG000|Overall Study|Oral anticoagulant required|159|||
24953437|NCT00249873|50044503|FG001|Overall Study|Oral anticoagulant required|157|||
24953438|NCT00249873|50044502|FG000|Overall Study|Study drug intolerance|5|||
24953439|NCT00249873|50044503|FG001|Overall Study|Study drug intolerance|0|||
24953440|NCT00249873|50044502|FG000|Overall Study|Surgery/ procedure|9|||
24953441|NCT00249873|50044503|FG001|Overall Study|Surgery/ procedure|9|||
24953442|NCT00249873|50044502|FG000|Overall Study|Event related to cardiac condition|12|||
24953443|NCT00249873|50044503|FG001|Overall Study|Event related to cardiac condition|21|||
24953444|NCT00249873|50044502|FG000|Overall Study|Thromboembolic/outcome event|82|||
24953445|NCT00249873|50044503|FG001|Overall Study|Thromboembolic/outcome event|122|||
24953446|NCT00392210|50044511|FG000|First Voiding Trial|Physician Decision|2|||
24953447|NCT00392210|50044512|FG001|First Voiding Trial|Physician Decision|2|||
24953448|NCT00391976|50044521|FG000|Overall Study|Adverse Event|0|||
24953449|NCT00391976|50044522|FG001|Overall Study|Adverse Event|0|||
24953450|NCT00391976|50044523|FG002|Overall Study|Adverse Event|1|||
24953451|NCT00391976|50044521|FG000|Overall Study|Withdrawal of consent|0|||
24953452|NCT00391976|50044522|FG001|Overall Study|Withdrawal of consent|1|||
24953453|NCT00391976|50044523|FG002|Overall Study|Withdrawal of consent|1|||
24953454|NCT00391976|50044521|FG000|Overall Study|Lost to Follow-up|1|||
25040118|NCT03097861|50140912|FG002|Overall Study|Investigator Decision|0|||
25040119|NCT03097861|50140910|FG000|Overall Study|Lost to Follow-up|0|||
25040120|NCT03097861|50140911|FG001|Overall Study|Lost to Follow-up|7|||
25040121|NCT03097861|50140912|FG002|Overall Study|Lost to Follow-up|1|||
25040122|NCT03097861|50140910|FG000|Overall Study|Withdrawal by Subject|1|||
25040123|NCT03097861|50140911|FG001|Overall Study|Withdrawal by Subject|5|||
25040124|NCT03097861|50140912|FG002|Overall Study|Withdrawal by Subject|3|||
25040125|NCT03097861|50140910|FG000|Overall Study|Reason not provided|3|||
25040126|NCT03097861|50140911|FG001|Overall Study|Reason not provided|1|||
24953455|NCT00391976|50044522|FG001|Overall Study|Lost to Follow-up|2|||
24953456|NCT00391976|50044523|FG002|Overall Study|Lost to Follow-up|0|||
24953457|NCT00391976|50044521|FG000|Overall Study|Inappropriate enrollment|1|||
24953458|NCT00391976|50044522|FG001|Overall Study|Inappropriate enrollment|1|||
24953459|NCT00391976|50044523|FG002|Overall Study|Inappropriate enrollment|0|||
24953460|NCT00391976|50044521|FG000|Overall Study|Protocol deviation/violation|4|||
25040127|NCT03097861|50140912|FG002|Overall Study|Reason not provided|1|||
25040128|NCT03910673|50140927|FG000|Overall Study|Adverse Event|0|||
25040129|NCT03910673|50140928|FG001|Overall Study|Adverse Event|0|||
25040130|NCT03910673|50140929|FG002|Overall Study|Adverse Event|0|||
24953461|NCT00391976|50044522|FG001|Overall Study|Protocol deviation/violation|2|||
24953462|NCT00391976|50044523|FG002|Overall Study|Protocol deviation/violation|1|||
24953463|NCT00391976|50044521|FG000|Overall Study|Recurrence/no eradication of infection|21|||
24953464|NCT00391976|50044522|FG001|Overall Study|Recurrence/no eradication of infection|19|||
24953465|NCT00391976|50044523|FG002|Overall Study|Recurrence/no eradication of infection|0|||
24953466|NCT00391976|50044521|FG000|Overall Study|Unable to classify|0|||
24953467|NCT00391976|50044522|FG001|Overall Study|Unable to classify|0|||
24953468|NCT00391976|50044523|FG002|Overall Study|Unable to classify|1|||
25040131|NCT03910673|50140930|FG003|Overall Study|Adverse Event|2|||
25040132|NCT03910673|50140931|FG004|Overall Study|Adverse Event|0|||
24953469|NCT00391976|50044521|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
25040133|NCT01816139|50140937|FG000|Overall Study|Adverse Event|6|||
25040134|NCT01816139|50140938|FG001|Overall Study|Adverse Event|8|||
24953470|NCT00391976|50044522|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
25040135|NCT01816139|50140937|FG000|Overall Study|Lack of Efficacy|1|||
25040136|NCT01816139|50140938|FG001|Overall Study|Lack of Efficacy|2|||
25040137|NCT01816139|50140937|FG000|Overall Study|Lost to Follow-up|5|||
25040138|NCT01816139|50140938|FG001|Overall Study|Lost to Follow-up|3|||
25040139|NCT01816139|50140937|FG000|Overall Study|Withdrew Consent|6|||
25040140|NCT01816139|50140938|FG001|Overall Study|Withdrew Consent|4|||
25040141|NCT01816139|50140937|FG000|Overall Study|Protocol Violation|6|||
25040142|NCT01816139|50140938|FG001|Overall Study|Protocol Violation|3|||
25040143|NCT01816139|50140937|FG000|Overall Study|Reason not Specified|4|||
25040144|NCT01816139|50140938|FG001|Overall Study|Reason not Specified|2|||
25040145|NCT02833350|50140981|FG000|Overall Study|Adverse Event|0|||
25040146|NCT02833350|50140982|FG001|Overall Study|Adverse Event|3|||
25040147|NCT02833350|50140983|FG002|Overall Study|Adverse Event|4|||
25040148|NCT02833350|50140984|FG003|Overall Study|Adverse Event|4|||
25040149|NCT02833350|50140985|FG004|Overall Study|Adverse Event|1|||
25040150|NCT02833350|50140986|FG005|Overall Study|Adverse Event|0|||
25040151|NCT02833350|50140987|FG006|Overall Study|Adverse Event|1|||
25040152|NCT02833350|50140981|FG000|Overall Study|Death|0|||
25040153|NCT02833350|50140982|FG001|Overall Study|Death|0|||
25040154|NCT02833350|50140983|FG002|Overall Study|Death|1|||
25040155|NCT02833350|50140984|FG003|Overall Study|Death|0|||
25040156|NCT02833350|50140985|FG004|Overall Study|Death|0|||
25040157|NCT02833350|50140986|FG005|Overall Study|Death|0|||
25040158|NCT02833350|50140987|FG006|Overall Study|Death|0|||
25040159|NCT02833350|50140981|FG000|Overall Study|Lack of Efficacy|0|||
25040160|NCT02833350|50140982|FG001|Overall Study|Lack of Efficacy|2|||
25040161|NCT02833350|50140983|FG002|Overall Study|Lack of Efficacy|1|||
25040162|NCT02833350|50140984|FG003|Overall Study|Lack of Efficacy|4|||
25040163|NCT02833350|50140985|FG004|Overall Study|Lack of Efficacy|0|||
24953471|NCT00391976|50044523|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
24953472|NCT00391898|50044535|FG000|Overall Study|Adverse Event|3|||
24953473|NCT00391898|50044536|FG001|Overall Study|Adverse Event|0|||
25040164|NCT02833350|50140986|FG005|Overall Study|Lack of Efficacy|1|||
25040165|NCT02833350|50140987|FG006|Overall Study|Lack of Efficacy|1|||
25040166|NCT02833350|50140981|FG000|Overall Study|Lost to Follow-up|0|||
25040167|NCT02833350|50140982|FG001|Overall Study|Lost to Follow-up|1|||
25040168|NCT02833350|50140983|FG002|Overall Study|Lost to Follow-up|0|||
25040169|NCT02833350|50140984|FG003|Overall Study|Lost to Follow-up|0|||
25040170|NCT02833350|50140985|FG004|Overall Study|Lost to Follow-up|0|||
25040171|NCT02833350|50140986|FG005|Overall Study|Lost to Follow-up|0|||
25040172|NCT02833350|50140987|FG006|Overall Study|Lost to Follow-up|1|||
25040173|NCT02833350|50140981|FG000|Overall Study|Withdrawal by Subject|3|||
25040174|NCT02833350|50140982|FG001|Overall Study|Withdrawal by Subject|3|||
25040175|NCT02833350|50140983|FG002|Overall Study|Withdrawal by Subject|2|||
25040176|NCT02833350|50140984|FG003|Overall Study|Withdrawal by Subject|0|||
25040177|NCT02833350|50140985|FG004|Overall Study|Withdrawal by Subject|2|||
25040178|NCT02833350|50140986|FG005|Overall Study|Withdrawal by Subject|0|||
25040179|NCT02833350|50140987|FG006|Overall Study|Withdrawal by Subject|2|||
25040180|NCT01343043|50141010|FG000|Overall Study|Disease progression before treatment|1|||
25040181|NCT01343043|50141011|FG001|Overall Study|Disease progression before treatment|0|||
25040182|NCT01343043|50141012|FG002|Overall Study|Disease progression before treatment|0|||
25040183|NCT01343043|50141013|FG003|Overall Study|Disease progression before treatment|0|||
25040184|NCT01343043|50141010|FG000|Overall Study|Withdrawal by Subject|1|||
25040185|NCT01343043|50141011|FG001|Overall Study|Withdrawal by Subject|0|||
25040186|NCT01343043|50141012|FG002|Overall Study|Withdrawal by Subject|0|||
25040187|NCT01343043|50141013|FG003|Overall Study|Withdrawal by Subject|0|||
24953474|NCT00391898|50044535|FG000|Overall Study|Other|8|||
24953475|NCT00391898|50044536|FG001|Overall Study|Other|10|||
24953476|NCT00391586|50044542|FG000|Overall Study|Progressive disease|13|||
24953477|NCT00391586|50044542|FG000|Overall Study|Adverse Event|5|||
24953478|NCT00391586|50044542|FG000|Overall Study|Physician Decision|2|||
24953479|NCT00391586|50044542|FG000|Overall Study|Death|4|||
24953480|NCT00391430|50044549|FG000|Overall Study|Withdrawal by Subject|3|||
24953481|NCT00391430|50044550|FG001|Overall Study|Withdrawal by Subject|0|||
24953482|NCT00391430|50044551|FG002|Overall Study|Withdrawal by Subject|12|||
24953483|NCT00391274|50044561|FG000|Overall Study|Death Due to Study Disease|55|||
24953484|NCT00391274|50044562|FG001|Overall Study|Death Due to Study Disease|45|||
24953485|NCT00391274|50044561|FG000|Overall Study|Lost to Follow-up|0|||
25040188|NCT01343043|50141010|FG000|Overall Study|Death|1|||
25040189|NCT01343043|50141011|FG001|Overall Study|Death|1|||
25040190|NCT01343043|50141012|FG002|Overall Study|Death|0|||
25040191|NCT01343043|50141013|FG003|Overall Study|Death|1|||
25040192|NCT03548987|50141028|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
25040193|NCT03548987|50141029|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
24953486|NCT00391274|50044562|FG001|Overall Study|Lost to Follow-up|3|||
24953487|NCT00391274|50044561|FG000|Overall Study|Physician Decision|4|||
24953488|NCT00391274|50044562|FG001|Overall Study|Physician Decision|2|||
25040194|NCT03548987|50141028|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
24953489|NCT00391274|50044561|FG000|Overall Study|Withdrawal by Subject|0|||
24953490|NCT00391274|50044562|FG001|Overall Study|Withdrawal by Subject|3|||
25040195|NCT03548987|50141029|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
25040196|NCT03548987|50141028|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
25040197|NCT03548987|50141029|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
25040198|NCT03548987|50141028|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
25040199|NCT03548987|50141029|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
25040200|NCT03548987|50141028|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
25040201|NCT03548987|50141029|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
25040202|NCT03548987|50141028|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
25040203|NCT03548987|50141029|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
25040204|NCT03548987|50141028|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
25040205|NCT03548987|50141029|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
25040206|NCT03548987|50141028|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
25040207|NCT03548987|50141029|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
25040208|NCT03548987|50141028|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
25040209|NCT03548987|50141029|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
25040210|NCT03548987|50141028|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
25040211|NCT03548987|50141029|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
25040212|NCT03548987|50141028|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
25040213|NCT03548987|50141029|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
25040214|NCT03548987|50141028|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
25040215|NCT03548987|50141029|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
25040216|NCT03548987|50141028|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
25040217|NCT03548987|50141029|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
25040218|NCT03548987|50141028|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
25040219|NCT03548987|50141029|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
25040220|NCT01358760|50141039|FG000|Overall Study|Adverse Event|3|||
25040221|NCT01358760|50141040|FG001|Overall Study|Adverse Event|4|||
25040222|NCT01358760|50141041|FG002|Overall Study|Adverse Event|3|||
25040223|NCT01358760|50141039|FG000|Overall Study|Lost to Follow-up|1|||
25040224|NCT01358760|50141040|FG001|Overall Study|Lost to Follow-up|1|||
25040225|NCT01358760|50141041|FG002|Overall Study|Lost to Follow-up|3|||
24953491|NCT00391274|50044561|FG000|Overall Study|Death Due to Adverse Event|1|||
24953492|NCT00391274|50044562|FG001|Overall Study|Death Due to Adverse Event|3|||
24953493|NCT00391274|50044561|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
24953494|NCT00391274|50044562|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
24953495|NCT00391274|50044561|FG000|Overall Study|Death Not Study Related|0|||
24953496|NCT00391274|50044562|FG001|Overall Study|Death Not Study Related|1|||
24953497|NCT00391118|50044571|FG000|Overall Study|Adverse Event|3|||
24953498|NCT00391118|50044572|FG001|Overall Study|Adverse Event|10|||
24953499|NCT00391118|50044573|FG002|Overall Study|Adverse Event|7|||
24953500|NCT00391118|50044571|FG000|Overall Study|Lost to Follow-up|0|||
24953501|NCT00391118|50044572|FG001|Overall Study|Lost to Follow-up|2|||
24953502|NCT00391118|50044573|FG002|Overall Study|Lost to Follow-up|3|||
24953503|NCT00391118|50044571|FG000|Overall Study|Withdrawal by Subject|0|||
24953504|NCT00391118|50044572|FG001|Overall Study|Withdrawal by Subject|9|||
24953505|NCT00391118|50044573|FG002|Overall Study|Withdrawal by Subject|1|||
24953506|NCT00391118|50044571|FG000|Overall Study|Death|0|||
24953507|NCT00391118|50044572|FG001|Overall Study|Death|1|||
24953508|NCT00391118|50044573|FG002|Overall Study|Death|0|||
24953509|NCT00391118|50044571|FG000|Overall Study|Physician Decision|0|||
24953510|NCT00391118|50044572|FG001|Overall Study|Physician Decision|3|||
24953511|NCT00391118|50044573|FG002|Overall Study|Physician Decision|0|||
24953512|NCT00391118|50044571|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
24953513|NCT00391118|50044572|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
24953514|NCT00391118|50044573|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
24953515|NCT00391118|50044571|FG000|Overall Study|Progressive Disease|7|||
24953516|NCT00391118|50044572|FG001|Overall Study|Progressive Disease|26|||
24953517|NCT00391118|50044573|FG002|Overall Study|Progressive Disease|43|||
24953518|NCT00391118|50044571|FG000|Overall Study|Sponsor Decision|0|||
24953519|NCT00391118|50044572|FG001|Overall Study|Sponsor Decision|1|||
24953520|NCT00391118|50044573|FG002|Overall Study|Sponsor Decision|3|||
24953521|NCT00391118|50044571|FG000|Overall Study|Protocol Violation|1|||
24953522|NCT00391118|50044572|FG001|Overall Study|Protocol Violation|0|||
24953523|NCT00391118|50044573|FG002|Overall Study|Protocol Violation|0|||
24953524|NCT00390884|50044586|FG000|Overall Study|Withdrawal by Subject|2|||
24953525|NCT00390884|50044587|FG001|Overall Study|Withdrawal by Subject|2|||
25040226|NCT01358760|50141039|FG000|Overall Study|Withdrawal by Subject|5|||
25040227|NCT01358760|50141040|FG001|Overall Study|Withdrawal by Subject|3|||
25040228|NCT01358760|50141041|FG002|Overall Study|Withdrawal by Subject|2|||
24953526|NCT00365846|50044593|FG000|Overall Study|Lost to Follow-up|1|||
24953527|NCT00264537|50044603|FG000|Overall Study|Death|0|||
24953528|NCT00264537|50044604|FG001|Overall Study|Death|3|||
25040229|NCT01358760|50141039|FG000|Overall Study|Physician Decision|1|||
25040230|NCT01358760|50141040|FG001|Overall Study|Physician Decision|0|||
25040231|NCT01358760|50141041|FG002|Overall Study|Physician Decision|1|||
25040232|NCT01358760|50141039|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
25040233|NCT01358760|50141040|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
25040234|NCT01358760|50141041|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
25040235|NCT01341990|50141051|FG000|Overall Study|Adverse Event|0|||
25040236|NCT01341990|50141052|FG001|Overall Study|Adverse Event|1|||
25040237|NCT01341990|50141051|FG000|Overall Study|Torn Study Lens|1|||
25040238|NCT01341990|50141052|FG001|Overall Study|Torn Study Lens|0|||
25040239|NCT01341990|50141051|FG000|Overall Study|Withdrawal by Subject|2|||
25040240|NCT01341990|50141052|FG001|Overall Study|Withdrawal by Subject|0|||
25040241|NCT03048747|50141058|FG000|Overall Study|Adverse Event|2|||
25040242|NCT03048747|50141058|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
25040243|NCT03048747|50141058|FG000|Overall Study|Physician Decision|1|||
25040244|NCT01991067|50141120|FG000|Overall Study|Lost to Follow-up|6|||
25040245|NCT01991067|50141121|FG001|Overall Study|Lost to Follow-up|5|||
25040246|NCT01709331|50141127|FG000|Overall Study|Adverse Event|1|||
25040247|NCT03255083|50141135|FG000|Overall Study|Clinical progression|1|||
25040248|NCT03255083|50141136|FG001|Overall Study|Clinical progression|0|||
25040249|NCT03255083|50141137|FG002|Overall Study|Clinical progression|0|||
25040250|NCT03255083|50141138|FG003|Overall Study|Clinical progression|0|||
25040251|NCT03255083|50141135|FG000|Overall Study|Adverse Event|0|||
25040252|NCT03255083|50141136|FG001|Overall Study|Adverse Event|1|||
25040253|NCT03255083|50141137|FG002|Overall Study|Adverse Event|0|||
25040254|NCT03255083|50141138|FG003|Overall Study|Adverse Event|0|||
25040255|NCT03255083|50141135|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
25040256|NCT03255083|50141136|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
25040257|NCT03255083|50141137|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
25040258|NCT03255083|50141138|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
25040259|NCT03255083|50141135|FG000|Overall Study|Withdrawal by Subject|1|||
25040260|NCT03255083|50141136|FG001|Overall Study|Withdrawal by Subject|1|||
25040261|NCT03255083|50141137|FG002|Overall Study|Withdrawal by Subject|1|||
25040262|NCT03255083|50141138|FG003|Overall Study|Withdrawal by Subject|0|||
25040263|NCT04552587|50141154|FG000|Overall Study|Lost to Follow-up|4|||
25040264|NCT01316055|50141170|FG000|Overall Study|Lost to Follow-up|1|||
25040265|NCT01316055|50141171|FG001|Overall Study|Lost to Follow-up|0|||
25040266|NCT01316055|50141172|FG002|Overall Study|Lost to Follow-up|0|||
25040267|NCT01340976|50141189|FG000|Overall Study|Physician Decision|2|||
25040268|NCT01340976|50141190|FG001|Overall Study|Physician Decision|0|||
25040269|NCT01340976|50141191|FG002|Overall Study|Physician Decision|1|||
24953529|NCT00264537|50044605|FG002|Overall Study|Death|3|||
24953530|NCT00264537|50044606|FG003|Overall Study|Death|2|||
24953531|NCT00264537|50044603|FG000|Overall Study|Lost to Follow-up|3|||
24953532|NCT00264537|50044604|FG001|Overall Study|Lost to Follow-up|4|||
24953533|NCT00264537|50044605|FG002|Overall Study|Lost to Follow-up|7|||
24953534|NCT00264537|50044606|FG003|Overall Study|Lost to Follow-up|6|||
24953535|NCT00264537|50044603|FG000|Overall Study|Adverse Event|21|||
24953536|NCT00264537|50044604|FG001|Overall Study|Adverse Event|32|||
24953537|NCT00264537|50044605|FG002|Overall Study|Adverse Event|24|||
24953538|NCT00264537|50044606|FG003|Overall Study|Adverse Event|34|||
24953539|NCT00264537|50044603|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
24953540|NCT00264537|50044604|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
24953541|NCT00264537|50044605|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
24953542|NCT00264537|50044606|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
24953543|NCT00264537|50044603|FG000|Overall Study|Other|21|||
24953544|NCT00264537|50044604|FG001|Overall Study|Other|11|||
24953545|NCT00264537|50044605|FG002|Overall Study|Other|10|||
24953546|NCT00264537|50044606|FG003|Overall Study|Other|11|||
24953547|NCT00264537|50044603|FG000|Overall Study|Not treated|0|||
24953548|NCT00264537|50044604|FG001|Overall Study|Not treated|2|||
24953549|NCT00264537|50044605|FG002|Overall Study|Not treated|1|||
24953550|NCT00264537|50044606|FG003|Overall Study|Not treated|0|||
24953551|NCT00371462|50044620|FG000|Overall Study|Withdrawal by Subject|1|||
24953552|NCT00371462|50044621|FG001|Overall Study|Withdrawal by Subject|0|||
24953553|NCT00371462|50044620|FG000|Overall Study|Other|7|||
24953554|NCT00371462|50044621|FG001|Overall Study|Other|8|||
24953555|NCT00371150|50044629|FG000|Overall Study|Lost to Follow-up|3|||
24953556|NCT00371150|50044630|FG001|Overall Study|Lost to Follow-up|2|||
24953557|NCT00264303|50044642|FG000|Overall Study|Adverse Event|4|||
24953558|NCT00264303|50044643|FG001|Overall Study|Adverse Event|3|||
25040270|NCT01340976|50141192|FG003|Overall Study|Physician Decision|1|||
25040271|NCT01340976|50141193|FG004|Overall Study|Physician Decision|1|||
25040272|NCT01340976|50141194|FG005|Overall Study|Physician Decision|0|||
25040273|NCT01340976|50141189|FG000|Overall Study|Death|0|||
25040274|NCT01340976|50141190|FG001|Overall Study|Death|1|||
25040275|NCT01340976|50141191|FG002|Overall Study|Death|0|||
25040276|NCT01340976|50141192|FG003|Overall Study|Death|0|||
25040277|NCT01340976|50141193|FG004|Overall Study|Death|0|||
24953559|NCT00264303|50044642|FG000|Overall Study|Lack of Efficacy|10|||
24953560|NCT00264303|50044643|FG001|Overall Study|Lack of Efficacy|13|||
24953561|NCT00264303|50044642|FG000|Overall Study|Lost to Follow-up|3|||
24953562|NCT00264303|50044643|FG001|Overall Study|Lost to Follow-up|3|||
24953563|NCT00264303|50044642|FG000|Overall Study|Withdrawal by Subject|2|||
24953564|NCT00264303|50044643|FG001|Overall Study|Withdrawal by Subject|3|||
24953565|NCT00264303|50044642|FG000|Overall Study|Various reasons listed in study report|6|||
24953566|NCT00264303|50044643|FG001|Overall Study|Various reasons listed in study report|7|||
24953567|NCT00370682|50044652|FG000|Overall Study|Moved from area|0|||
24953568|NCT00370682|50044653|FG001|Overall Study|Moved from area|2|||
24953569|NCT00370682|50044654|FG002|Overall Study|Moved from area|0|||
24953570|NCT00370682|50044652|FG000|Overall Study|Lost to Follow-up|0|||
24953571|NCT00370682|50044653|FG001|Overall Study|Lost to Follow-up|1|||
24953572|NCT00370682|50044654|FG002|Overall Study|Lost to Follow-up|1|||
24953573|NCT00264147|50044671|FG000|Treatment I Period|Adverse Event|3|||
24953574|NCT00264147|50044672|FG001|Treatment I Period|Adverse Event|6|||
25040278|NCT01340976|50141194|FG005|Overall Study|Death|0|||
25040279|NCT01340976|50141189|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
25040280|NCT01340976|50141190|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
25040281|NCT01340976|50141191|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
25040282|NCT01340976|50141192|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
25040283|NCT01340976|50141193|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
25040284|NCT01340976|50141194|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
25040285|NCT01340976|50141189|FG000|Overall Study|Withdrawal by Subject|0|||
25040286|NCT01340976|50141190|FG001|Overall Study|Withdrawal by Subject|0|||
24953575|NCT00264147|50044673|FG002|Treatment I Period|Adverse Event|3|||
24953576|NCT00264147|50044674|FG003|Treatment I Period|Adverse Event|5|||
24953577|NCT00264147|50044675|FG004|Treatment I Period|Adverse Event|7|||
24953578|NCT00264147|50044676|FG005|Treatment I Period|Adverse Event|0|||
24953579|NCT00264147|50044671|FG000|Treatment I Period|Laboratory Adverse Event|0|||
24953580|NCT00264147|50044672|FG001|Treatment I Period|Laboratory Adverse Event|0|||
24953581|NCT00264147|50044673|FG002|Treatment I Period|Laboratory Adverse Event|0|||
24953582|NCT00264147|50044674|FG003|Treatment I Period|Laboratory Adverse Event|1|||
24953583|NCT00264147|50044675|FG004|Treatment I Period|Laboratory Adverse Event|0|||
24953584|NCT00264147|50044676|FG005|Treatment I Period|Laboratory Adverse Event|0|||
24953585|NCT00264147|50044671|FG000|Treatment I Period|Lack of Efficacy|6|||
24953586|NCT00264147|50044672|FG001|Treatment I Period|Lack of Efficacy|2|||
24953587|NCT00264147|50044673|FG002|Treatment I Period|Lack of Efficacy|8|||
24953588|NCT00264147|50044674|FG003|Treatment I Period|Lack of Efficacy|0|||
24953589|NCT00264147|50044675|FG004|Treatment I Period|Lack of Efficacy|1|||
24953590|NCT00264147|50044676|FG005|Treatment I Period|Lack of Efficacy|0|||
24953591|NCT00264147|50044671|FG000|Treatment I Period|Lost to Follow-up|1|||
24953592|NCT00264147|50044672|FG001|Treatment I Period|Lost to Follow-up|0|||
24953593|NCT00264147|50044673|FG002|Treatment I Period|Lost to Follow-up|0|||
24953594|NCT00264147|50044674|FG003|Treatment I Period|Lost to Follow-up|1|||
24953595|NCT00264147|50044675|FG004|Treatment I Period|Lost to Follow-up|1|||
24953596|NCT00264147|50044676|FG005|Treatment I Period|Lost to Follow-up|0|||
24953597|NCT00264147|50044671|FG000|Treatment I Period|Protocol Violation|2|||
24953598|NCT00264147|50044672|FG001|Treatment I Period|Protocol Violation|2|||
24953599|NCT00264147|50044673|FG002|Treatment I Period|Protocol Violation|0|||
24953600|NCT00264147|50044674|FG003|Treatment I Period|Protocol Violation|0|||
24953601|NCT00264147|50044675|FG004|Treatment I Period|Protocol Violation|0|||
24953602|NCT00264147|50044676|FG005|Treatment I Period|Protocol Violation|0|||
24953603|NCT00264147|50044671|FG000|Treatment I Period|Withdrawal by Subject|2|||
24953604|NCT00264147|50044672|FG001|Treatment I Period|Withdrawal by Subject|0|||
24953605|NCT00264147|50044673|FG002|Treatment I Period|Withdrawal by Subject|0|||
24953606|NCT00264147|50044674|FG003|Treatment I Period|Withdrawal by Subject|2|||
24953607|NCT00264147|50044675|FG004|Treatment I Period|Withdrawal by Subject|2|||
24953608|NCT00264147|50044676|FG005|Treatment I Period|Withdrawal by Subject|0|||
24953609|NCT00264147|50044671|FG000|Treatment I Period|Patient out of town for an extended time|0|||
24953610|NCT00264147|50044672|FG001|Treatment I Period|Patient out of town for an extended time|1|||
24953611|NCT00264147|50044673|FG002|Treatment I Period|Patient out of town for an extended time|0|||
25040287|NCT01340976|50141191|FG002|Overall Study|Withdrawal by Subject|0|||
25040288|NCT01340976|50141192|FG003|Overall Study|Withdrawal by Subject|1|||
25040289|NCT01340976|50141193|FG004|Overall Study|Withdrawal by Subject|1|||
25040290|NCT01340976|50141194|FG005|Overall Study|Withdrawal by Subject|0|||
25040291|NCT01340976|50141189|FG000|Overall Study|Other anemia treatment|1|||
25040292|NCT01340976|50141190|FG001|Overall Study|Other anemia treatment|0|||
25040293|NCT01340976|50141191|FG002|Overall Study|Other anemia treatment|2|||
25040294|NCT01340976|50141192|FG003|Overall Study|Other anemia treatment|1|||
25040295|NCT01340976|50141193|FG004|Overall Study|Other anemia treatment|0|||
25040296|NCT01340976|50141194|FG005|Overall Study|Other anemia treatment|1|||
25040297|NCT01340976|50141189|FG000|Overall Study|Adverse Event|0|||
25040298|NCT01340976|50141190|FG001|Overall Study|Adverse Event|1|||
25040299|NCT01340976|50141191|FG002|Overall Study|Adverse Event|0|||
25040300|NCT01340976|50141192|FG003|Overall Study|Adverse Event|0|||
25040301|NCT01340976|50141193|FG004|Overall Study|Adverse Event|0|||
25040302|NCT01340976|50141194|FG005|Overall Study|Adverse Event|0|||
25040303|NCT01680016|50141216|FG000|Overall Study|Adverse Event|0|||
25040304|NCT01680016|50141217|FG001|Overall Study|Adverse Event|0|||
25040305|NCT01680016|50141218|FG002|Overall Study|Adverse Event|1|||
25040306|NCT01680016|50141219|FG003|Overall Study|Adverse Event|4|||
25040307|NCT01680016|50141216|FG000|Overall Study|The Subject went out of The Trial|1|||
25040308|NCT01680016|50141217|FG001|Overall Study|The Subject went out of The Trial|0|||
25040309|NCT01680016|50141218|FG002|Overall Study|The Subject went out of The Trial|3|||
25040310|NCT01680016|50141219|FG003|Overall Study|The Subject went out of The Trial|0|||
25040311|NCT01680016|50141216|FG000|Overall Study|Protocol Violation|0|||
25040312|NCT01680016|50141217|FG001|Overall Study|Protocol Violation|1|||
25040313|NCT01680016|50141218|FG002|Overall Study|Protocol Violation|0|||
25040314|NCT01680016|50141219|FG003|Overall Study|Protocol Violation|0|||
25040315|NCT01680016|50141216|FG000|Overall Study|Withdrawal by Subject|5|||
25040316|NCT01680016|50141217|FG001|Overall Study|Withdrawal by Subject|7|||
25040317|NCT01680016|50141218|FG002|Overall Study|Withdrawal by Subject|1|||
25040318|NCT01680016|50141219|FG003|Overall Study|Withdrawal by Subject|1|||
25040319|NCT01340898|50141244|FG000|Primary Phase|Serious Adverse Events|0|||
25040320|NCT01340898|50141245|FG001|Primary Phase|Serious Adverse Events|0|||
25040321|NCT01340898|50141246|FG002|Primary Phase|Serious Adverse Events|1|||
25040322|NCT01340898|50141244|FG000|Primary Phase|Withdrawal by Subject|8|||
25040323|NCT01340898|50141245|FG001|Primary Phase|Withdrawal by Subject|7|||
25040324|NCT01340898|50141246|FG002|Primary Phase|Withdrawal by Subject|5|||
25040325|NCT01340898|50141244|FG000|Primary Phase|Migrated/moved from study area|4|||
25040326|NCT01340898|50141245|FG001|Primary Phase|Migrated/moved from study area|1|||
25040327|NCT01340898|50141246|FG002|Primary Phase|Migrated/moved from study area|0|||
25040328|NCT01340898|50141244|FG000|Primary Phase|Lost to Follow-up|4|||
25040329|NCT01340898|50141245|FG001|Primary Phase|Lost to Follow-up|1|||
25040330|NCT01340898|50141246|FG002|Primary Phase|Lost to Follow-up|0|||
25040331|NCT01340898|50141244|FG000|Booster Phase|Withdrawal by Subject|3|||
25040332|NCT01340898|50141245|FG001|Booster Phase|Withdrawal by Subject|0|||
25040333|NCT01340898|50141246|FG002|Booster Phase|Withdrawal by Subject|4|||
25040334|NCT01340898|50141244|FG000|Booster Phase|Migrated/moved from study area|3|||
25040335|NCT01340898|50141245|FG001|Booster Phase|Migrated/moved from study area|0|||
25040336|NCT01340898|50141246|FG002|Booster Phase|Migrated/moved from study area|0|||
25040337|NCT01340898|50141244|FG000|Booster Phase|Lost to Follow-up|4|||
25040338|NCT01340898|50141245|FG001|Booster Phase|Lost to Follow-up|2|||
25040339|NCT01340898|50141246|FG002|Booster Phase|Lost to Follow-up|3|||
25040340|NCT02470585|50141259|FG000|Overall Study|Death|82|||
25040341|NCT02470585|50141260|FG001|Overall Study|Death|87|||
25040342|NCT02470585|50141261|FG002|Overall Study|Death|86|||
25040343|NCT02470585|50141259|FG000|Overall Study|Withdrawal by Subject|19|||
25040344|NCT02470585|50141260|FG001|Overall Study|Withdrawal by Subject|21|||
25040345|NCT02470585|50141261|FG002|Overall Study|Withdrawal by Subject|29|||
25040346|NCT02470585|50141259|FG000|Overall Study|Lost to Follow-up|2|||
25040347|NCT02470585|50141260|FG001|Overall Study|Lost to Follow-up|5|||
25040348|NCT02470585|50141261|FG002|Overall Study|Lost to Follow-up|4|||
25040349|NCT02470585|50141259|FG000|Overall Study|Other|4|||
25040350|NCT02470585|50141260|FG001|Overall Study|Other|4|||
25040351|NCT02470585|50141261|FG002|Overall Study|Other|6|||
25040352|NCT02744898|50141280|FG000|Overall Study|Progressive Disease|2|||
25040353|NCT02744898|50141280|FG000|Overall Study|Physician Decision|1|||
25040354|NCT02744898|50141280|FG000|Overall Study|Toxicity|1|||
25040355|NCT03036813|50141287|FG000|Overall Study|Adverse Event|6|||
25040356|NCT03036813|50141288|FG001|Overall Study|Adverse Event|11|||
25040357|NCT03036813|50141289|FG002|Overall Study|Adverse Event|6|||
25040358|NCT03036813|50141287|FG000|Overall Study|Withdrawal by Subject|12|||
25040359|NCT03036813|50141288|FG001|Overall Study|Withdrawal by Subject|6|||
25040360|NCT03036813|50141289|FG002|Overall Study|Withdrawal by Subject|10|||
25040361|NCT03036813|50141287|FG000|Overall Study|Lost to Follow-up|1|||
25040362|NCT03036813|50141288|FG001|Overall Study|Lost to Follow-up|1|||
25040363|NCT03036813|50141289|FG002|Overall Study|Lost to Follow-up|0|||
25040364|NCT03036813|50141287|FG000|Overall Study|Physician Decision|2|||
25040365|NCT03036813|50141288|FG001|Overall Study|Physician Decision|1|||
25040366|NCT03036813|50141289|FG002|Overall Study|Physician Decision|1|||
25040367|NCT03036813|50141287|FG000|Overall Study|Non-Compliance|1|||
25040368|NCT03036813|50141288|FG001|Overall Study|Non-Compliance|5|||
25040369|NCT03036813|50141289|FG002|Overall Study|Non-Compliance|3|||
25040370|NCT03036813|50141287|FG000|Overall Study|Pregnancy|0|||
25040371|NCT03036813|50141288|FG001|Overall Study|Pregnancy|0|||
25040372|NCT03036813|50141289|FG002|Overall Study|Pregnancy|1|||
25040373|NCT03036813|50141287|FG000|Overall Study|Other|0|||
25040374|NCT03036813|50141288|FG001|Overall Study|Other|3|||
25040375|NCT03036813|50141289|FG002|Overall Study|Other|5|||
25040376|NCT03097315|50141300|FG000|Overall Study|Withdrawal by Subject|1|||
25040377|NCT03039699|50141306|FG000|Overall Study|Incorrect inclusion|5|||
25040378|NCT03039699|50141307|FG001|Overall Study|Incorrect inclusion|4|||
25040379|NCT03039699|50141306|FG000|Overall Study|Lack of data to assess study endpoint|5|||
25040380|NCT03039699|50141307|FG001|Overall Study|Lack of data to assess study endpoint|3|||
25040381|NCT03039699|50141306|FG000|Overall Study|Bacterial infection|12|||
25040382|NCT03039699|50141307|FG001|Overall Study|Bacterial infection|28|||
25040383|NCT02833974|50141315|FG000|Overall Study|Lost to Follow-up|1|||
25040384|NCT02833974|50141316|FG001|Overall Study|Lost to Follow-up|0|||
25040385|NCT02833974|50141315|FG000|Overall Study|Adverse Event|0|||
25040386|NCT02833974|50141316|FG001|Overall Study|Adverse Event|3|||
25040387|NCT03093415|50141325|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
25040388|NCT03093415|50141326|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
25040389|NCT03093415|50141327|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
25040390|NCT03093415|50141325|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
24953612|NCT00264147|50044674|FG003|Treatment I Period|Patient out of town for an extended time|0|||
24953613|NCT00264147|50044675|FG004|Treatment I Period|Patient out of town for an extended time|0|||
24953614|NCT00264147|50044676|FG005|Treatment I Period|Patient out of town for an extended time|0|||
24953615|NCT00264147|50044671|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
24953616|NCT00264147|50044672|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
24953617|NCT00264147|50044673|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
24953618|NCT00264147|50044674|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
24953619|NCT00264147|50044675|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
24953620|NCT00264147|50044676|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
24953621|NCT00264147|50044671|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
24953622|NCT00264147|50044672|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
24953623|NCT00264147|50044673|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
24953624|NCT00264147|50044674|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
24953625|NCT00264147|50044675|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
24953626|NCT00264147|50044676|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
24953627|NCT00264147|50044671|FG000|Treatment II Period|Adverse Event|0|||
24953628|NCT00264147|50044672|FG001|Treatment II Period|Adverse Event|0|||
24953629|NCT00264147|50044673|FG002|Treatment II Period|Adverse Event|0|||
24953630|NCT00264147|50044674|FG003|Treatment II Period|Adverse Event|0|||
24953631|NCT00264147|50044675|FG004|Treatment II Period|Adverse Event|9|||
24953632|NCT00264147|50044676|FG005|Treatment II Period|Adverse Event|9|||
24953633|NCT00264147|50044671|FG000|Treatment II Period|Laboratory Adverse Event|0|||
24953634|NCT00264147|50044672|FG001|Treatment II Period|Laboratory Adverse Event|0|||
24953635|NCT00264147|50044673|FG002|Treatment II Period|Laboratory Adverse Event|0|||
24953636|NCT00264147|50044674|FG003|Treatment II Period|Laboratory Adverse Event|0|||
24953637|NCT00264147|50044675|FG004|Treatment II Period|Laboratory Adverse Event|0|||
24953638|NCT00264147|50044676|FG005|Treatment II Period|Laboratory Adverse Event|1|||
24953639|NCT00264147|50044671|FG000|Treatment II Period|Lack of Efficacy|0|||
24953640|NCT00264147|50044672|FG001|Treatment II Period|Lack of Efficacy|0|||
24953641|NCT00264147|50044673|FG002|Treatment II Period|Lack of Efficacy|0|||
25040391|NCT03093415|50141326|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
25040392|NCT03093415|50141327|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
25040393|NCT03093415|50141325|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
25040394|NCT03093415|50141326|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
25040395|NCT03093415|50141327|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
25040396|NCT03093415|50141325|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
25040397|NCT03093415|50141326|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
25040398|NCT03093415|50141327|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
25040399|NCT03093415|50141325|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
25040400|NCT03093415|50141326|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
25040401|NCT03093415|50141327|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
25040402|NCT03093415|50141325|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
25040403|NCT03093415|50141326|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
25040404|NCT03093415|50141327|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
25040405|NCT03093415|50141325|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
25040406|NCT03093415|50141326|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
25040407|NCT03093415|50141327|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
25040408|NCT03093415|50141325|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
25040409|NCT03093415|50141326|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
25040410|NCT03093415|50141327|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
25040411|NCT03093415|50141325|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
25040412|NCT03093415|50141326|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
25040413|NCT03093415|50141327|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
25040414|NCT03093415|50141325|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
25040415|NCT03093415|50141326|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
25040416|NCT03093415|50141327|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
25040417|NCT03093415|50141325|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
25040418|NCT03093415|50141326|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
25040419|NCT03093415|50141327|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
25040420|NCT01358526|50141337|FG000|Open-label Titration Period|Adverse Event|95|||
25040421|NCT01358526|50141338|FG001|Open-label Titration Period|Adverse Event|0|||
25040422|NCT01358526|50141339|FG002|Open-label Titration Period|Adverse Event|0|||
25040423|NCT01358526|50141337|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
25040424|NCT01358526|50141338|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
25040425|NCT01358526|50141339|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
25040426|NCT01358526|50141337|FG000|Open-label Titration Period|Lost to Follow-up|25|||
25040427|NCT01358526|50141338|FG001|Open-label Titration Period|Lost to Follow-up|0|||
25040428|NCT01358526|50141339|FG002|Open-label Titration Period|Lost to Follow-up|0|||
25040429|NCT01358526|50141337|FG000|Open-label Titration Period|Lack of Efficacy|107|||
25040430|NCT01358526|50141338|FG001|Open-label Titration Period|Lack of Efficacy|0|||
25040431|NCT01358526|50141339|FG002|Open-label Titration Period|Lack of Efficacy|0|||
25040432|NCT01358526|50141337|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
25040433|NCT01358526|50141338|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
25040434|NCT01358526|50141339|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
25040435|NCT01358526|50141337|FG000|Open-label Titration Period|Administrative|8|||
25040436|NCT01358526|50141338|FG001|Open-label Titration Period|Administrative|0|||
25040437|NCT01358526|50141339|FG002|Open-label Titration Period|Administrative|0|||
25040438|NCT01358526|50141337|FG000|Open-label Titration Period|Did not qualify|178|||
25040439|NCT01358526|50141338|FG001|Open-label Titration Period|Did not qualify|0|||
25040440|NCT01358526|50141339|FG002|Open-label Titration Period|Did not qualify|0|||
25040441|NCT01358526|50141337|FG000|Double-blind Phase|Adverse Event|0|||
25040442|NCT01358526|50141338|FG001|Double-blind Phase|Adverse Event|24|||
25040443|NCT01358526|50141339|FG002|Double-blind Phase|Adverse Event|23|||
25040444|NCT01358526|50141337|FG000|Double-blind Phase|Withdrawal by Subject|0|||
25040445|NCT01358526|50141338|FG001|Double-blind Phase|Withdrawal by Subject|10|||
25040446|NCT01358526|50141339|FG002|Double-blind Phase|Withdrawal by Subject|8|||
25040447|NCT01358526|50141337|FG000|Double-blind Phase|Lost to Follow-up|0|||
25040448|NCT01358526|50141338|FG001|Double-blind Phase|Lost to Follow-up|4|||
25040449|NCT01358526|50141339|FG002|Double-blind Phase|Lost to Follow-up|1|||
25040450|NCT01358526|50141337|FG000|Double-blind Phase|Lack of Efficacy|0|||
25040451|NCT01358526|50141338|FG001|Double-blind Phase|Lack of Efficacy|31|||
25040452|NCT01358526|50141339|FG002|Double-blind Phase|Lack of Efficacy|73|||
25040453|NCT01358526|50141337|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
25040454|NCT01358526|50141338|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
25040455|NCT01358526|50141339|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
25040456|NCT01358526|50141337|FG000|Double-blind Phase|Administrative|0|||
25040457|NCT01358526|50141338|FG001|Double-blind Phase|Administrative|6|||
25040458|NCT01358526|50141339|FG002|Double-blind Phase|Administrative|10|||
25040459|NCT02830776|50141346|FG000|Overall Study|Lost to Follow-up|1|||
25040460|NCT03039621|50141353|FG000|Overall Study|Violation of inclusion criteria|3|||
25040461|NCT03039621|50141354|FG001|Overall Study|Violation of inclusion criteria|2|||
25040462|NCT03039621|50141353|FG000|Overall Study|Non-compliance with protocol requirement|4|||
25040463|NCT03039621|50141354|FG001|Overall Study|Non-compliance with protocol requirement|5|||
25040464|NCT03039621|50141353|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
25040465|NCT03039621|50141354|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
25040466|NCT03039621|50141353|FG000|Overall Study|Violation of non-inclusion criteria|1|||
25040467|NCT03039621|50141354|FG001|Overall Study|Violation of non-inclusion criteria|2|||
25040468|NCT03041181|50141362|FG000|Overall Study|Disease Progression|1|||
25040469|NCT03041181|50141363|FG001|Overall Study|Disease Progression|2|||
25040470|NCT02828436|50141369|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
25040471|NCT02828436|50141370|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
25040472|NCT02828436|50141369|FG000|Period 1|Lost to Follow-up|0|||
25040473|NCT02828436|50141370|FG001|Period 1|Lost to Follow-up|1|||
25040474|NCT02828436|50141369|FG000|Period 2|Withdrawal by Subject|4|||
25040475|NCT02828436|50141370|FG001|Period 2|Withdrawal by Subject|0|||
25040476|NCT02828436|50141369|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
25040477|NCT02828436|50141370|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
25040478|NCT02828436|50141369|FG000|Period 2|Lost to Follow-up|1|||
25040479|NCT02828436|50141370|FG001|Period 2|Lost to Follow-up|0|||
25040480|NCT02828124|50141384|FG000|Overall Study|Disease Progression|1|||
25040481|NCT02828124|50141385|FG001|Overall Study|Disease Progression|2|||
25040482|NCT02828124|50141386|FG002|Overall Study|Disease Progression|1|||
25040483|NCT02828124|50141387|FG003|Overall Study|Disease Progression|4|||
25040484|NCT02828124|50141384|FG000|Overall Study|AE Unrelated to Study Drug|0|||
25040485|NCT02828124|50141385|FG001|Overall Study|AE Unrelated to Study Drug|0|||
25040486|NCT02828124|50141386|FG002|Overall Study|AE Unrelated to Study Drug|0|||
25040487|NCT02828124|50141387|FG003|Overall Study|AE Unrelated to Study Drug|1|||
25040488|NCT02828124|50141384|FG000|Overall Study|Subject Withdrew Consent|0|||
25040489|NCT02828124|50141385|FG001|Overall Study|Subject Withdrew Consent|0|||
25040490|NCT02828124|50141386|FG002|Overall Study|Subject Withdrew Consent|0|||
25040491|NCT02828124|50141387|FG003|Overall Study|Subject Withdrew Consent|1|||
25040492|NCT02829996|50141402|FG000|Overall Study|Withdrawal by Subject|1|||
25040493|NCT02829996|50141403|FG001|Overall Study|Withdrawal by Subject|0|||
25040494|NCT02829996|50141404|FG002|Overall Study|Withdrawal by Subject|0|||
25040495|NCT02829996|50141405|FG003|Overall Study|Withdrawal by Subject|0|||
25040496|NCT02829996|50141406|FG004|Overall Study|Withdrawal by Subject|0|||
25040497|NCT02827500|50141420|FG000|Overall Study|Death|7|||
25040498|NCT02827500|50141421|FG001|Overall Study|Death|3|||
25040499|NCT02827500|50141420|FG000|Overall Study|Lost to Follow-up|1|||
25040500|NCT02827500|50141421|FG001|Overall Study|Lost to Follow-up|1|||
25040501|NCT02827500|50141420|FG000|Overall Study|Withdrawal by Subject|3|||
25040502|NCT02827500|50141421|FG001|Overall Study|Withdrawal by Subject|1|||
25040503|NCT02827500|50141420|FG000|Overall Study|Missing primary endpoint data|3|||
25040504|NCT02827500|50141421|FG001|Overall Study|Missing primary endpoint data|1|||
25040505|NCT02827500|50141420|FG000|Overall Study|Other|5|||
25040506|NCT02827500|50141421|FG001|Overall Study|Other|1|||
25040507|NCT02826798|50141432|FG000|Overall Study|Withdrawal by Subject|0|||
25040508|NCT02826798|50141433|FG001|Overall Study|Withdrawal by Subject|1|||
25040509|NCT02826798|50141434|FG002|Overall Study|Withdrawal by Subject|0|||
25040510|NCT02826798|50141435|FG003|Overall Study|Withdrawal by Subject|1|||
25040511|NCT02826798|50141436|FG004|Overall Study|Withdrawal by Subject|0|||
25040512|NCT02829138|50141450|FG000|Overall Study|Withdrawal by Subject|1|||
25040513|NCT02829138|50141451|FG001|Overall Study|Withdrawal by Subject|0|||
25040514|NCT02825550|50141457|FG000|Overall Study|Physician Decision|1|||
25040515|NCT02744040|50141466|FG000|Overall Study|Withdrawal by Subject|3|||
25040516|NCT02744040|50141467|FG001|Overall Study|Withdrawal by Subject|2|||
25040517|NCT02744040|50141468|FG002|Overall Study|Withdrawal by Subject|2|||
25040518|NCT02744040|50141466|FG000|Overall Study|Physician Decision|0|||
25040519|NCT02744040|50141467|FG001|Overall Study|Physician Decision|8|||
25040520|NCT02744040|50141468|FG002|Overall Study|Physician Decision|13|||
25040521|NCT02744040|50141466|FG000|Overall Study|Lost to Follow-up|3|||
25040522|NCT02744040|50141467|FG001|Overall Study|Lost to Follow-up|1|||
25040523|NCT02744040|50141468|FG002|Overall Study|Lost to Follow-up|7|||
25040524|NCT02743962|50141478|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
24953642|NCT00264147|50044674|FG003|Treatment II Period|Lack of Efficacy|0|||
24953643|NCT00264147|50044675|FG004|Treatment II Period|Lack of Efficacy|20|||
24953644|NCT00264147|50044676|FG005|Treatment II Period|Lack of Efficacy|19|||
24953645|NCT00264147|50044671|FG000|Treatment II Period|Lost to Follow-up|0|||
24953646|NCT00264147|50044672|FG001|Treatment II Period|Lost to Follow-up|0|||
24953647|NCT00264147|50044673|FG002|Treatment II Period|Lost to Follow-up|0|||
24953648|NCT00264147|50044674|FG003|Treatment II Period|Lost to Follow-up|0|||
24953649|NCT00264147|50044675|FG004|Treatment II Period|Lost to Follow-up|1|||
24953650|NCT00264147|50044676|FG005|Treatment II Period|Lost to Follow-up|1|||
25040525|NCT02743962|50141479|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
24953651|NCT00264147|50044671|FG000|Treatment II Period|Withdrawal by Subject|0|||
25040526|NCT03094416|50141488|FG000|Run-in|Screening failure|8|||
25040527|NCT03094416|50141488|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
25040528|NCT03094416|50141488|FG000|Run-in|Withdrawal by Subject|3|||
25040529|NCT03094416|50141488|FG000|Treatment Period|Withdrawal by Subject|2|||
25040530|NCT03041025|50141496|FG000|Overall Study|Adverse Event|0|||
24953652|NCT00264147|50044672|FG001|Treatment II Period|Withdrawal by Subject|0|||
24953653|NCT00264147|50044673|FG002|Treatment II Period|Withdrawal by Subject|0|||
24953654|NCT00264147|50044674|FG003|Treatment II Period|Withdrawal by Subject|0|||
24953655|NCT00264147|50044675|FG004|Treatment II Period|Withdrawal by Subject|3|||
24953656|NCT00264147|50044676|FG005|Treatment II Period|Withdrawal by Subject|2|||
24953657|NCT00264147|50044671|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
25040531|NCT03041025|50141497|FG001|Overall Study|Adverse Event|0|||
25040532|NCT03041025|50141498|FG002|Overall Study|Adverse Event|1|||
25040533|NCT03041025|50141496|FG000|Overall Study|Lost to Follow-up|1|||
25040534|NCT03041025|50141497|FG001|Overall Study|Lost to Follow-up|0|||
25040535|NCT03041025|50141498|FG002|Overall Study|Lost to Follow-up|0|||
25040536|NCT03041025|50141496|FG000|Overall Study|Withdrawal by Subject|0|||
25040537|NCT03041025|50141497|FG001|Overall Study|Withdrawal by Subject|0|||
25040538|NCT03041025|50141498|FG002|Overall Study|Withdrawal by Subject|1|||
25040539|NCT01338870|50141515|FG000|Overall Study|Lost to Follow-up|0|||
25040540|NCT01338870|50141516|FG001|Overall Study|Lost to Follow-up|0|||
25040541|NCT01338870|50141517|FG002|Overall Study|Lost to Follow-up|1|||
25040542|NCT01338870|50141518|FG003|Overall Study|Lost to Follow-up|0|||
25040543|NCT01338870|50141519|FG004|Overall Study|Lost to Follow-up|1|||
25040544|NCT01338870|50141520|FG005|Overall Study|Lost to Follow-up|0|||
25040545|NCT01338870|50141515|FG000|Overall Study|Withdrawal by Subject|2|||
25040546|NCT01338870|50141516|FG001|Overall Study|Withdrawal by Subject|3|||
25040547|NCT01338870|50141517|FG002|Overall Study|Withdrawal by Subject|4|||
25040548|NCT01338870|50141518|FG003|Overall Study|Withdrawal by Subject|0|||
24953658|NCT00264147|50044672|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
25040549|NCT01338870|50141519|FG004|Overall Study|Withdrawal by Subject|0|||
25040550|NCT01338870|50141520|FG005|Overall Study|Withdrawal by Subject|2|||
25040551|NCT01338870|50141515|FG000|Overall Study|Other|3|||
25040552|NCT01338870|50141516|FG001|Overall Study|Other|3|||
25040553|NCT01338870|50141517|FG002|Overall Study|Other|3|||
25040554|NCT01338870|50141518|FG003|Overall Study|Other|2|||
25040555|NCT01338870|50141519|FG004|Overall Study|Other|0|||
25040556|NCT01338870|50141520|FG005|Overall Study|Other|2|||
25040557|NCT01338870|50141515|FG000|Overall Study|Protocol Violation|0|||
25040558|NCT01338870|50141516|FG001|Overall Study|Protocol Violation|2|||
24953659|NCT00264147|50044673|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
24953660|NCT00264147|50044674|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
24953661|NCT00264147|50044675|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
24953662|NCT00264147|50044676|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
24953663|NCT00263757|50044692|FG000|Overall Study|Withdrawal by Subject|5|||
24953664|NCT00263757|50044693|FG001|Overall Study|Withdrawal by Subject|4|||
24953665|NCT00263757|50044692|FG000|Overall Study|Screen failure|0|||
24953666|NCT00263757|50044693|FG001|Overall Study|Screen failure|1|||
25040559|NCT01338870|50141517|FG002|Overall Study|Protocol Violation|2|||
25040560|NCT01338870|50141518|FG003|Overall Study|Protocol Violation|2|||
25040561|NCT01338870|50141519|FG004|Overall Study|Protocol Violation|1|||
25040562|NCT01338870|50141520|FG005|Overall Study|Protocol Violation|1|||
25040563|NCT01338870|50141515|FG000|Overall Study|Adverse Event|4|||
25040564|NCT01338870|50141516|FG001|Overall Study|Adverse Event|4|||
25040565|NCT01338870|50141517|FG002|Overall Study|Adverse Event|1|||
25040566|NCT01338870|50141518|FG003|Overall Study|Adverse Event|5|||
25040567|NCT01338870|50141519|FG004|Overall Study|Adverse Event|4|||
25040568|NCT01338870|50141520|FG005|Overall Study|Adverse Event|1|||
25040569|NCT02824224|50141536|FG000|Overall Study|Discontinued, IUS expulsion|0|||
25040570|NCT02824224|50141537|FG001|Overall Study|Discontinued, IUS expulsion|1|||
25040571|NCT02824224|50141536|FG000|Overall Study|Did not show up for allocation visit|2|||
25040572|NCT02824224|50141537|FG001|Overall Study|Did not show up for allocation visit|0|||
24953667|NCT00263757|50044692|FG000|Overall Study|Adverse Event|3|||
24953668|NCT00263757|50044693|FG001|Overall Study|Adverse Event|3|||
24953669|NCT00263211|50044701|FG000|Overall Study|Death|1|||
24953670|NCT00263211|50044702|FG001|Overall Study|Death|0|||
24953671|NCT00263211|50044701|FG000|Overall Study|Withdrawal by Subject|3|||
24953672|NCT00263211|50044702|FG001|Overall Study|Withdrawal by Subject|0|||
24953673|NCT00263211|50044701|FG000|Overall Study|Protocol Violation|1|||
24953674|NCT00263211|50044702|FG001|Overall Study|Protocol Violation|0|||
24953675|NCT00263211|50044701|FG000|Overall Study|Disease Progression|0|||
24953676|NCT00263211|50044702|FG001|Overall Study|Disease Progression|1|||
24953677|NCT00248625|50044713|FG000|Overall Study|Withdrawal by Subject|0|||
25040573|NCT01338792|50141543|FG000|Overall Study|Adverse Event|2|||
24953678|NCT00248625|50044714|FG001|Overall Study|Withdrawal by Subject|2|||
25040574|NCT01338792|50141543|FG000|Overall Study|Death|1|||
25040575|NCT01338792|50141543|FG000|Overall Study|Withdrawal by Subject|1|||
25040576|NCT01314105|50141549|FG000|Overall Study|Progressive Disease|6|||
25040577|NCT01314105|50141550|FG001|Overall Study|Progressive Disease|10|||
25040578|NCT01314105|50141549|FG000|Overall Study|Refused to continue taking medication|0|||
25160213|NCT01879579|50280314|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
24953679|NCT00262821|50044722|FG000|Overall Study|Ineligible - wrong stage|0|||
24953680|NCT00262821|50044723|FG001|Overall Study|Ineligible - wrong stage|3|||
24953681|NCT00262821|50044722|FG000|Overall Study|Ineligible - wrong cell type|2|||
24953682|NCT00262821|50044723|FG001|Overall Study|Ineligible - wrong cell type|2|||
24953683|NCT00262821|50044722|FG000|Overall Study|Ineligible - wrong primary|0|||
24953684|NCT00262821|50044723|FG001|Overall Study|Ineligible - wrong primary|1|||
24953685|NCT00262821|50044722|FG000|Overall Study|Ineligible - inadequate pathology|1|||
24953686|NCT00262821|50044723|FG001|Overall Study|Ineligible - inadequate pathology|3|||
24953687|NCT00262821|50044722|FG000|Overall Study|Ineligible - elevated creatinine|0|||
24953688|NCT00262821|50044723|FG001|Overall Study|Ineligible - elevated creatinine|2|||
24953689|NCT00262821|50044722|FG000|Overall Study|Ineligible - required test not done|1|||
24953690|NCT00262821|50044723|FG001|Overall Study|Ineligible - required test not done|4|||
24953691|NCT00262821|50044722|FG000|Overall Study|Inevaluable - inadequate data|0|||
24953692|NCT00262821|50044723|FG001|Overall Study|Inevaluable - inadequate data|4|||
24953693|NCT00262743|50044731|FG000|Overall Study|Adverse Event|0|||
24953694|NCT00262743|50044732|FG001|Overall Study|Adverse Event|9|||
24953695|NCT00262743|50044731|FG000|Overall Study|Disease progression|0|||
24953696|NCT00262743|50044732|FG001|Overall Study|Disease progression|3|||
24953697|NCT00262119|50044739|FG000|Overall Study|Lost to Follow-up|38|||
24953698|NCT00262119|50044740|FG001|Overall Study|Lost to Follow-up|51|||
24953699|NCT00262119|50044741|FG002|Overall Study|Lost to Follow-up|42|||
24953700|NCT00262119|50044739|FG000|Overall Study|Death|20|||
24953701|NCT00262119|50044740|FG001|Overall Study|Death|19|||
24953702|NCT00262119|50044741|FG002|Overall Study|Death|16|||
24953703|NCT00170950|50044751|FG000|Overall Study|Death|236|||
24953704|NCT00170950|50044752|FG001|Overall Study|Death|274|||
24953705|NCT00170950|50044751|FG000|Overall Study|Withdrawal by Subject|496|||
24953706|NCT00170950|50044752|FG001|Overall Study|Withdrawal by Subject|498|||
24953707|NCT00170950|50044751|FG000|Overall Study|Lost to Follow-up|134|||
24953708|NCT00170950|50044752|FG001|Overall Study|Lost to Follow-up|115|||
24953709|NCT00170950|50044751|FG000|Overall Study|Missing|2|||
24953710|NCT00170950|50044752|FG001|Overall Study|Missing|1|||
24953711|NCT00170950|50044751|FG000|Overall Study|Termination Data Not Recorded|17|||
24953712|NCT00170950|50044752|FG001|Overall Study|Termination Data Not Recorded|22|||
24953713|NCT00239577|50044762|FG000|Primary Phase|Adverse Event|0|||
24953714|NCT00239577|50044763|FG001|Primary Phase|Adverse Event|0|||
24953715|NCT00239577|50044764|FG002|Primary Phase|Adverse Event|1|||
24953716|NCT00239577|50044765|FG003|Primary Phase|Adverse Event|0|||
24953717|NCT00239577|50044762|FG000|Primary Phase|Other|5|||
25040579|NCT01314105|50141550|FG001|Overall Study|Refused to continue taking medication|1|||
25040580|NCT01314105|50141549|FG000|Overall Study|Other Adverse Event|1|||
25160214|NCT01879579|50280315|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
24953718|NCT00239577|50044763|FG001|Primary Phase|Other|3|||
24953719|NCT00239577|50044764|FG002|Primary Phase|Other|2|||
24953720|NCT00239577|50044765|FG003|Primary Phase|Other|0|||
24953721|NCT00262041|50044781|FG000|Overall Study|Withdrawal by Subject|0|||
24953722|NCT00262041|50044782|FG001|Overall Study|Withdrawal by Subject|3|||
24953723|NCT00262041|50044783|FG002|Overall Study|Withdrawal by Subject|1|||
25040581|NCT01314105|50141550|FG001|Overall Study|Other Adverse Event|1|||
25040582|NCT03040713|50141558|FG000|Overall Study|Positive amyloid scan|3|||
24953724|NCT00262041|50044781|FG000|Overall Study|Lost to Follow-up|1|||
24953725|NCT00262041|50044782|FG001|Overall Study|Lost to Follow-up|1|||
24953726|NCT00262041|50044783|FG002|Overall Study|Lost to Follow-up|5|||
24953727|NCT00262041|50044781|FG000|Overall Study|Unable to classify|1|||
24953728|NCT00262041|50044782|FG001|Overall Study|Unable to classify|0|||
24953729|NCT00262041|50044783|FG002|Overall Study|Unable to classify|0|||
24953730|NCT00208767|50044799|FG000|Overall Study|Adverse Event|9|||
24953731|NCT00208767|50044800|FG001|Overall Study|Adverse Event|1|||
24953732|NCT00208767|50044799|FG000|Overall Study|Withdrawal by Subject|14|||
24953733|NCT00208767|50044800|FG001|Overall Study|Withdrawal by Subject|3|||
24953734|NCT00208767|50044799|FG000|Overall Study|Death|1|||
24953735|NCT00208767|50044800|FG001|Overall Study|Death|0|||
24953736|NCT00208767|50044799|FG000|Overall Study|Lost to Follow-up|3|||
24953737|NCT00208767|50044800|FG001|Overall Study|Lost to Follow-up|3|||
24953738|NCT00390806|50044808|FG000|Overall Study|Lost to Follow-up|7|||
24953739|NCT00390806|50044809|FG001|Overall Study|Lost to Follow-up|6|||
24953740|NCT00390806|50044808|FG000|Overall Study|Protocol Violation|2|||
24953741|NCT00390806|50044809|FG001|Overall Study|Protocol Violation|2|||
24953742|NCT00390806|50044808|FG000|Overall Study|Withdrawal by Subject|12|||
24953743|NCT00390806|50044809|FG001|Overall Study|Withdrawal by Subject|15|||
24953744|NCT00390806|50044808|FG000|Overall Study|Investigator Decision|4|||
24953745|NCT00390806|50044809|FG001|Overall Study|Investigator Decision|6|||
24953746|NCT00390806|50044808|FG000|Overall Study|Death|1|||
24953747|NCT00390806|50044809|FG001|Overall Study|Death|0|||
24953748|NCT00390806|50044808|FG000|Overall Study|Physician Decision|0|||
24953749|NCT00390806|50044809|FG001|Overall Study|Physician Decision|1|||
24953750|NCT00390806|50044808|FG000|Overall Study|Ongoing|4|||
24953751|NCT00390806|50044809|FG001|Overall Study|Ongoing|2|||
24953752|NCT00390572|50044817|FG000|Overall Study|Lost to Follow-up|8|||
24953753|NCT00390572|50044818|FG001|Overall Study|Lost to Follow-up|4|||
24953754|NCT00390572|50044817|FG000|Overall Study|health condition|0|||
24953755|NCT00390572|50044818|FG001|Overall Study|health condition|1|||
24953756|NCT00390416|50044828|FG000|Overall Study|Withdrawal by Subject|1|||
24953757|NCT00390416|50044828|FG000|Overall Study|Not treated|3|||
25040583|NCT01966471|50141564|FG000|Overall Study|Death|44|||
25040584|NCT01966471|50141565|FG001|Overall Study|Death|56|||
25040585|NCT01966471|50141564|FG000|Overall Study|Lost to Follow-up|46|||
25040586|NCT01966471|50141565|FG001|Overall Study|Lost to Follow-up|39|||
25040587|NCT01966471|50141564|FG000|Overall Study|Various reasons|4|||
25040588|NCT01966471|50141565|FG001|Overall Study|Various reasons|4|||
25040589|NCT01966471|50141564|FG000|Overall Study|Physician Decision|7|||
24953758|NCT00261495|50044834|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
24953759|NCT00261495|50044835|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
24953760|NCT00261495|50044834|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
24953761|NCT00261495|50044835|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
24953762|NCT00261495|50044834|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
25040590|NCT01966471|50141565|FG001|Overall Study|Physician Decision|5|||
24953763|NCT00261495|50044835|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
25040591|NCT01966471|50141564|FG000|Overall Study|Study Terminated By Sponsor|758|||
25040592|NCT01966471|50141565|FG001|Overall Study|Study Terminated By Sponsor|773|||
25040593|NCT01966471|50141564|FG000|Overall Study|Withdrawal by Subject|59|||
25040594|NCT01966471|50141565|FG001|Overall Study|Withdrawal by Subject|51|||
25040595|NCT03227471|50141586|FG000|Overall Study|Withdrawal by Subject|0|||
25040596|NCT03227471|50141587|FG001|Overall Study|Withdrawal by Subject|0|||
25040597|NCT03227471|50141588|FG002|Overall Study|Withdrawal by Subject|0|||
25040598|NCT03227471|50141589|FG003|Overall Study|Withdrawal by Subject|0|||
25040599|NCT03227471|50141590|FG004|Overall Study|Withdrawal by Subject|1|||
25040600|NCT03227471|50141591|FG005|Overall Study|Withdrawal by Subject|0|||
25040601|NCT03227471|50141592|FG006|Overall Study|Withdrawal by Subject|0|||
25040602|NCT03227471|50141593|FG007|Overall Study|Withdrawal by Subject|0|||
25040603|NCT03227471|50141594|FG008|Overall Study|Withdrawal by Subject|0|||
25040604|NCT03227471|50141595|FG009|Overall Study|Withdrawal by Subject|0|||
25040605|NCT03227471|50141596|FG010|Overall Study|Withdrawal by Subject|0|||
25040606|NCT03227471|50141597|FG011|Overall Study|Withdrawal by Subject|0|||
24953764|NCT00261495|50044834|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
24953765|NCT00261495|50044835|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
24953766|NCT00261495|50044834|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
24953767|NCT00261495|50044835|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
24953768|NCT00261495|50044834|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
24953769|NCT00261495|50044835|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
24953770|NCT00261495|50044834|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
24953771|NCT00261495|50044835|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
24953772|NCT00261495|50044834|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
24953773|NCT00261495|50044835|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
24953774|NCT00261495|50044834|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
24953775|NCT00261495|50044835|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
24953776|NCT00261495|50044834|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
24953777|NCT00261495|50044835|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
24953778|NCT00261495|50044834|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
24953779|NCT00261495|50044835|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
24953780|NCT00261495|50044834|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
24953781|NCT00261495|50044835|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
24953782|NCT00261495|50044834|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
24953783|NCT00261495|50044835|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
24953784|NCT00261495|50044834|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
24953785|NCT00261495|50044835|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
24953786|NCT00261495|50044834|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
24953787|NCT00261495|50044835|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
24953788|NCT00261495|50044834|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
24953789|NCT00261495|50044835|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
24953790|NCT00261495|50044834|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
25040607|NCT03227471|50141598|FG012|Overall Study|Withdrawal by Subject|1|||
25040608|NCT03227471|50141599|FG013|Overall Study|Withdrawal by Subject|0|||
25040609|NCT03227471|50141600|FG014|Overall Study|Withdrawal by Subject|0|||
25040610|NCT03227471|50141586|FG000|Overall Study|Randomized, Never Dosed|0|||
25040611|NCT03227471|50141587|FG001|Overall Study|Randomized, Never Dosed|0|||
25040612|NCT03227471|50141588|FG002|Overall Study|Randomized, Never Dosed|0|||
25040613|NCT03227471|50141589|FG003|Overall Study|Randomized, Never Dosed|0|||
25040614|NCT03227471|50141590|FG004|Overall Study|Randomized, Never Dosed|0|||
25040615|NCT03227471|50141591|FG005|Overall Study|Randomized, Never Dosed|0|||
25040616|NCT03227471|50141592|FG006|Overall Study|Randomized, Never Dosed|0|||
25040617|NCT03227471|50141593|FG007|Overall Study|Randomized, Never Dosed|0|||
25040618|NCT03227471|50141594|FG008|Overall Study|Randomized, Never Dosed|0|||
25040619|NCT03227471|50141595|FG009|Overall Study|Randomized, Never Dosed|0|||
25040620|NCT03227471|50141596|FG010|Overall Study|Randomized, Never Dosed|0|||
25040621|NCT03227471|50141597|FG011|Overall Study|Randomized, Never Dosed|0|||
25040622|NCT03227471|50141598|FG012|Overall Study|Randomized, Never Dosed|0|||
25040623|NCT03227471|50141599|FG013|Overall Study|Randomized, Never Dosed|0|||
25040624|NCT03227471|50141600|FG014|Overall Study|Randomized, Never Dosed|1|||
25040625|NCT01354314|50141665|FG000|Overall Study|Lost to Follow-up|1|||
25040626|NCT01354314|50141666|FG001|Overall Study|Lost to Follow-up|0|||
25040627|NCT01354314|50141667|FG002|Overall Study|Lost to Follow-up|1|||
25040628|NCT01354314|50141668|FG003|Overall Study|Lost to Follow-up|1|||
25040629|NCT01354314|50141665|FG000|Overall Study|Withdrawal by Subject|0|||
25040630|NCT01354314|50141666|FG001|Overall Study|Withdrawal by Subject|0|||
25040631|NCT01354314|50141667|FG002|Overall Study|Withdrawal by Subject|1|||
24953791|NCT00261495|50044835|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
24953792|NCT00261495|50044834|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
24953793|NCT00261495|50044835|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
25040632|NCT01354314|50141668|FG003|Overall Study|Withdrawal by Subject|0|||
25040633|NCT01354314|50141665|FG000|Overall Study|Adverse Event|0|||
25040634|NCT01354314|50141666|FG001|Overall Study|Adverse Event|0|||
25040635|NCT01354314|50141667|FG002|Overall Study|Adverse Event|0|||
25040636|NCT01354314|50141668|FG003|Overall Study|Adverse Event|1|||
25040637|NCT01354314|50141665|FG000|Overall Study|Protocol Violation|1|||
25040638|NCT01354314|50141666|FG001|Overall Study|Protocol Violation|1|||
25040639|NCT01354314|50141667|FG002|Overall Study|Protocol Violation|0|||
25040640|NCT01354314|50141668|FG003|Overall Study|Protocol Violation|0|||
25040641|NCT01354314|50141665|FG000|Overall Study|Less than 90% Adherence|4|||
25040642|NCT01354314|50141666|FG001|Overall Study|Less than 90% Adherence|2|||
25040643|NCT01354314|50141667|FG002|Overall Study|Less than 90% Adherence|6|||
25040644|NCT01354314|50141668|FG003|Overall Study|Less than 90% Adherence|4|||
25040645|NCT03194321|50141680|FG000|Overall Study|Withdrawal by Subject|1|||
25040646|NCT03194321|50141680|FG000|Overall Study|Lost to Follow-up|1|||
25040647|NCT03194321|50141680|FG000|Overall Study|Travel for Follow-up|1|||
25040648|NCT01354938|50141684|FG000|Overall Study|Lost to Follow-up|1|||
25040649|NCT03092791|50141707|FG000|Overall Study|Lost to Follow-up|0|||
25040650|NCT03092791|50141708|FG001|Overall Study|Lost to Follow-up|0|||
25040651|NCT03092791|50141709|FG002|Overall Study|Lost to Follow-up|0|||
25040652|NCT03092791|50141710|FG003|Overall Study|Lost to Follow-up|0|||
24953794|NCT00261495|50044834|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
24953795|NCT00261495|50044835|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
24953796|NCT00261495|50044834|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
24953797|NCT00261495|50044835|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
24953798|NCT00261495|50044834|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
24953799|NCT00261495|50044835|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
24953800|NCT00168844|50044844|FG000|Overall Study|Adverse Event|31|||
24953801|NCT00168844|50044845|FG001|Overall Study|Adverse Event|32|||
24953802|NCT00168844|50044846|FG002|Overall Study|Adverse Event|48|||
24953803|NCT00168844|50044844|FG000|Overall Study|Lost to Follow-up|4|||
24953804|NCT00168844|50044845|FG001|Overall Study|Lost to Follow-up|5|||
25040653|NCT03092791|50141711|FG004|Overall Study|Lost to Follow-up|0|||
25040654|NCT03092791|50141712|FG005|Overall Study|Lost to Follow-up|0|||
25040655|NCT03092791|50141713|FG006|Overall Study|Lost to Follow-up|1|||
25040656|NCT03092791|50141714|FG007|Overall Study|Lost to Follow-up|0|||
25040657|NCT03092791|50141707|FG000|Overall Study|Withdrawal of Consent|0|||
25040658|NCT03092791|50141708|FG001|Overall Study|Withdrawal of Consent|0|||
25040659|NCT03092791|50141709|FG002|Overall Study|Withdrawal of Consent|0|||
25040660|NCT03092791|50141710|FG003|Overall Study|Withdrawal of Consent|0|||
25040661|NCT03092791|50141711|FG004|Overall Study|Withdrawal of Consent|4|||
25040662|NCT03092791|50141712|FG005|Overall Study|Withdrawal of Consent|12|||
25040663|NCT03092791|50141713|FG006|Overall Study|Withdrawal of Consent|6|||
25040664|NCT03092791|50141714|FG007|Overall Study|Withdrawal of Consent|4|||
24953805|NCT00168844|50044846|FG002|Overall Study|Lost to Follow-up|11|||
24953806|NCT00168844|50044844|FG000|Overall Study|Withdrawal by Subject|12|||
24953807|NCT00168844|50044845|FG001|Overall Study|Withdrawal by Subject|9|||
24953808|NCT00168844|50044846|FG002|Overall Study|Withdrawal by Subject|19|||
24953809|NCT00168844|50044844|FG000|Overall Study|Protocol Violation|2|||
24953810|NCT00168844|50044845|FG001|Overall Study|Protocol Violation|2|||
24953811|NCT00168844|50044846|FG002|Overall Study|Protocol Violation|4|||
24953812|NCT00168844|50044844|FG000|Overall Study|Other|6|||
24953813|NCT00168844|50044845|FG001|Overall Study|Other|7|||
24953814|NCT00168844|50044846|FG002|Overall Study|Other|9|||
24953815|NCT00365456|50044854|FG000|Trial Period I (12 Months)|Adverse Event|84|||
24953816|NCT00365456|50044855|FG001|Trial Period I (12 Months)|Adverse Event|0|||
24953817|NCT00365456|50044854|FG000|Trial Period I (12 Months)|Non-compliance|3|||
24953818|NCT00365456|50044855|FG001|Trial Period I (12 Months)|Non-compliance|0|||
24953819|NCT00365456|50044854|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
24953820|NCT00365456|50044855|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
24953821|NCT00365456|50044854|FG000|Trial Period I (12 Months)|Other|11|||
24953822|NCT00365456|50044855|FG001|Trial Period I (12 Months)|Other|0|||
25040665|NCT03092791|50141707|FG000|Overall Study|Study Termination|0|||
25040666|NCT03092791|50141708|FG001|Overall Study|Study Termination|0|||
25040667|NCT03092791|50141709|FG002|Overall Study|Study Termination|0|||
24953823|NCT00365456|50044854|FG000|Trial Period II (12 Months)|Adverse Event|0|||
25040668|NCT03092791|50141710|FG003|Overall Study|Study Termination|0|||
25040669|NCT03092791|50141711|FG004|Overall Study|Study Termination|55|||
25040670|NCT03092791|50141712|FG005|Overall Study|Study Termination|46|||
25040671|NCT03092791|50141713|FG006|Overall Study|Study Termination|53|||
25040672|NCT03092791|50141714|FG007|Overall Study|Study Termination|55|||
25040673|NCT03092791|50141707|FG000|Overall Study|Death|0|||
25040674|NCT03092791|50141708|FG001|Overall Study|Death|0|||
25040675|NCT03092791|50141709|FG002|Overall Study|Death|0|||
25040676|NCT03092791|50141710|FG003|Overall Study|Death|0|||
25040677|NCT03092791|50141711|FG004|Overall Study|Death|0|||
25040678|NCT03092791|50141712|FG005|Overall Study|Death|1|||
25040679|NCT03092791|50141713|FG006|Overall Study|Death|0|||
25040680|NCT03092791|50141714|FG007|Overall Study|Death|1|||
25040681|NCT03092791|50141707|FG000|Overall Study|Reason Not Specified|0|||
25040682|NCT03092791|50141708|FG001|Overall Study|Reason Not Specified|0|||
24953824|NCT00365456|50044855|FG001|Trial Period II (12 Months)|Adverse Event|6|||
24953825|NCT00365456|50044854|FG000|Trial Period II (12 Months)|Non-compliance|0|||
24953826|NCT00365456|50044855|FG001|Trial Period II (12 Months)|Non-compliance|2|||
24953827|NCT00365456|50044854|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
24953828|NCT00365456|50044855|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
24953829|NCT00365456|50044854|FG000|Trial Period II (12 Months)|Other|0|||
24953830|NCT00365456|50044855|FG001|Trial Period II (12 Months)|Other|1|||
24953831|NCT00365456|50044854|FG000|Trial Period III (12 Months)|Adverse Event|13|||
25040683|NCT03092791|50141709|FG002|Overall Study|Reason Not Specified|0|||
25040684|NCT03092791|50141710|FG003|Overall Study|Reason Not Specified|0|||
25040685|NCT03092791|50141711|FG004|Overall Study|Reason Not Specified|1|||
25040686|NCT03092791|50141712|FG005|Overall Study|Reason Not Specified|1|||
25040687|NCT03092791|50141713|FG006|Overall Study|Reason Not Specified|0|||
25040688|NCT03092791|50141714|FG007|Overall Study|Reason Not Specified|0|||
25040689|NCT04283461|50141742|FG000|Overall Study|Enrolled in separate trial|0|||
25040690|NCT04283461|50141743|FG001|Overall Study|Enrolled in separate trial|0|||
25040691|NCT04283461|50141744|FG002|Overall Study|Enrolled in separate trial|8|||
25040692|NCT04283461|50141745|FG003|Overall Study|Enrolled in separate trial|13|||
25040693|NCT04283461|50141746|FG004|Overall Study|Enrolled in separate trial|12|||
25040694|NCT04283461|50141747|FG005|Overall Study|Enrolled in separate trial|0|||
25040695|NCT04283461|50141748|FG006|Overall Study|Enrolled in separate trial|0|||
25040696|NCT04283461|50141749|FG007|Overall Study|Enrolled in separate trial|8|||
25040697|NCT04283461|50141750|FG008|Overall Study|Enrolled in separate trial|0|||
25040698|NCT04283461|50141751|FG009|Overall Study|Enrolled in separate trial|0|||
25040699|NCT04283461|50141752|FG010|Overall Study|Enrolled in separate trial|0|||
25040700|NCT04283461|50141753|FG011|Overall Study|Enrolled in separate trial|7|||
25040701|NCT04283461|50141754|FG012|Overall Study|Enrolled in separate trial|0|||
25040702|NCT02505425|50141785|FG000|Overall Study|Lost to Follow-up|41|||
25040703|NCT02505425|50141786|FG001|Overall Study|Lost to Follow-up|61|||
25040704|NCT02505425|50141787|FG002|Overall Study|Lost to Follow-up|31|||
25040705|NCT02505425|50141788|FG003|Overall Study|Lost to Follow-up|19|||
25040706|NCT02505425|50141785|FG000|Overall Study|Withdrawal by Subject|39|||
25040707|NCT02505425|50141786|FG001|Overall Study|Withdrawal by Subject|9|||
25040708|NCT02505425|50141787|FG002|Overall Study|Withdrawal by Subject|19|||
25040709|NCT02505425|50141788|FG003|Overall Study|Withdrawal by Subject|7|||
25040710|NCT02505425|50141785|FG000|Overall Study|Death|8|||
25040711|NCT02505425|50141786|FG001|Overall Study|Death|12|||
25040712|NCT02505425|50141787|FG002|Overall Study|Death|0|||
25040713|NCT02505425|50141788|FG003|Overall Study|Death|0|||
25040714|NCT03089047|50141800|FG000|Overall Study|Lost to Follow-up|1|||
25160215|NCT01879579|50280314|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
24953832|NCT00365456|50044855|FG001|Trial Period III (12 Months)|Adverse Event|3|||
24953833|NCT00365456|50044854|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
24953834|NCT00365456|50044855|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
24953835|NCT00365456|50044854|FG000|Trial Period III (12 Months)|Other|1|||
24953836|NCT00365456|50044855|FG001|Trial Period III (12 Months)|Other|1|||
24953837|NCT00147238|50044861|FG000|Overall Study|Inevaluable|8|||
24953838|NCT00206427|50044865|FG000|Overall Study|Adverse Event|2|||
24953839|NCT00146848|50044872|FG000|Pre-randomization|Death|19|||
24953840|NCT00146848|50044873|FG001|Pre-randomization|Death|0|||
24953841|NCT00146848|50044874|FG002|Pre-randomization|Death|0|||
24953842|NCT00146848|50044872|FG000|Pre-randomization|Lost to Follow-up|70|||
24953843|NCT00146848|50044873|FG001|Pre-randomization|Lost to Follow-up|0|||
24953844|NCT00146848|50044874|FG002|Pre-randomization|Lost to Follow-up|0|||
24953845|NCT00146848|50044872|FG000|Pre-randomization|Physician Decision|8|||
24953846|NCT00146848|50044873|FG001|Pre-randomization|Physician Decision|0|||
25040715|NCT03089047|50141801|FG001|Overall Study|Lost to Follow-up|0|||
25040716|NCT01371006|50141809|FG000|Overall Study|Adverse Event|1|||
25040717|NCT01371006|50141810|FG001|Overall Study|Adverse Event|0|||
25040718|NCT01371552|50141845|FG000|Part 1, First 3 Days|Inconvenience|0|||
25040719|NCT01371552|50141846|FG001|Part 1, First 3 Days|Inconvenience|0|||
25040720|NCT01371552|50141847|FG002|Part 1, First 3 Days|Inconvenience|1|||
25040721|NCT01371552|50141848|FG003|Part 1, First 3 Days|Inconvenience|0|||
25040722|NCT01371552|50141849|FG004|Part 1, First 3 Days|Inconvenience|0|||
25040723|NCT01371552|50141850|FG005|Part 1, First 3 Days|Inconvenience|0|||
25040724|NCT02819310|50141859|FG000|Overall Study|Withdrawal by Subject|37|||
25040725|NCT02819310|50141859|FG000|Overall Study|Lost to Follow-up|16|||
25040726|NCT02819310|50141859|FG000|Overall Study|Adverse Event|13|||
25040727|NCT02819310|50141859|FG000|Overall Study|Lack of Efficacy|5|||
25040728|NCT02819310|50141859|FG000|Overall Study|Physician Decision|8|||
25040729|NCT02819310|50141859|FG000|Overall Study|Protocol Violation|30|||
25040730|NCT03087643|50141865|FG000|Overall Study|Withdrawal by Subject|2|||
25040731|NCT03087643|50141866|FG001|Overall Study|Withdrawal by Subject|4|||
25040732|NCT03087643|50141865|FG000|Overall Study|Death|2|||
25040733|NCT03087643|50141866|FG001|Overall Study|Death|2|||
25040734|NCT02821962|50141874|FG000|Overall Study|Lost to Follow-up|2|||
25040735|NCT02821962|50141875|FG001|Overall Study|Lost to Follow-up|0|||
25040736|NCT03092479|50141883|FG000|Overall Study|Lost to Follow-up|3|||
25040737|NCT03092479|50141884|FG001|Overall Study|Lost to Follow-up|2|||
25040738|NCT03092479|50141883|FG000|Overall Study|Withdrawal by Subject|4|||
25040739|NCT03092479|50141884|FG001|Overall Study|Withdrawal by Subject|0|||
25040740|NCT03086551|50141892|FG000|First Intervention|Failure to meet inclusion criterion|1|||
25040741|NCT03086551|50141893|FG001|First Intervention|Failure to meet inclusion criterion|0|||
25040742|NCT03086551|50141892|FG000|First Intervention|Lost to Follow-up|0|||
25040743|NCT03086551|50141893|FG001|First Intervention|Lost to Follow-up|1|||
25040744|NCT03086551|50141892|FG000|Washout|Lost to Follow-up|1|||
25040745|NCT03086551|50141893|FG001|Washout|Lost to Follow-up|2|||
25040746|NCT03086551|50141892|FG000|Washout|Withdrawal by Subject|2|||
25040747|NCT03086551|50141893|FG001|Washout|Withdrawal by Subject|1|||
25040748|NCT03265249|50141901|FG000|Overall Study|Withdrawal by Subject|0|||
25040749|NCT03265249|50141902|FG001|Overall Study|Withdrawal by Subject|1|||
25040750|NCT02951767|50141908|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|54|||
25040751|NCT02951767|50141908|FG000|Overall Study|Withdrawal by Subject|5|||
25040752|NCT02951767|50141908|FG000|Overall Study|Death|59|||
25040753|NCT02951767|50141908|FG000|Overall Study|Lost to Follow-up|1|||
25040754|NCT03093181|50141915|FG000|Overall Study|Withdrawal by Subject|2|||
25040755|NCT03093181|50141916|FG001|Overall Study|Withdrawal by Subject|1|||
25040756|NCT03093181|50141917|FG002|Overall Study|Withdrawal by Subject|2|||
25040757|NCT03093181|50141915|FG000|Overall Study|Other (Not specified)|1|||
25040758|NCT03093181|50141916|FG001|Overall Study|Other (Not specified)|0|||
25040759|NCT03093181|50141917|FG002|Overall Study|Other (Not specified)|0|||
25040760|NCT03093181|50141915|FG000|Overall Study|Adverse Event|0|||
25040761|NCT03093181|50141916|FG001|Overall Study|Adverse Event|1|||
25040762|NCT03093181|50141917|FG002|Overall Study|Adverse Event|0|||
25040763|NCT03093181|50141915|FG000|Overall Study|Other (Protocol violation)|0|||
25040764|NCT03093181|50141916|FG001|Overall Study|Other (Protocol violation)|0|||
25040765|NCT03093181|50141917|FG002|Overall Study|Other (Protocol violation)|1|||
25040766|NCT03091777|50141928|FG000|Overall Study|Pregnancy|2|||
25040767|NCT03091777|50141929|FG001|Overall Study|Pregnancy|1|||
25040768|NCT03091777|50141930|FG002|Overall Study|Pregnancy|0|||
25040769|NCT03091777|50141928|FG000|Overall Study|Adverse Event|2|||
25040770|NCT03091777|50141929|FG001|Overall Study|Adverse Event|1|||
25040771|NCT03091777|50141930|FG002|Overall Study|Adverse Event|4|||
25040772|NCT03091777|50141928|FG000|Overall Study|Withdrawal by Subject|4|||
25040773|NCT03091777|50141929|FG001|Overall Study|Withdrawal by Subject|2|||
25040774|NCT03091777|50141930|FG002|Overall Study|Withdrawal by Subject|6|||
25040775|NCT03091777|50141928|FG000|Overall Study|Protocol Violation|2|||
25040776|NCT03091777|50141929|FG001|Overall Study|Protocol Violation|1|||
25040777|NCT03091777|50141930|FG002|Overall Study|Protocol Violation|1|||
25040778|NCT03091777|50141928|FG000|Overall Study|Lost to Follow-up|12|||
25040779|NCT03091777|50141929|FG001|Overall Study|Lost to Follow-up|14|||
25040780|NCT03091777|50141930|FG002|Overall Study|Lost to Follow-up|7|||
25040781|NCT03091777|50141928|FG000|Overall Study|Lack of Efficacy|0|||
25040782|NCT03091777|50141929|FG001|Overall Study|Lack of Efficacy|0|||
25040783|NCT03091777|50141930|FG002|Overall Study|Lack of Efficacy|5|||
25040784|NCT03091777|50141928|FG000|Overall Study|Noncompliance with study drug|2|||
25040785|NCT03091777|50141929|FG001|Overall Study|Noncompliance with study drug|3|||
25040786|NCT03091777|50141930|FG002|Overall Study|Noncompliance with study drug|1|||
25040787|NCT03091777|50141928|FG000|Overall Study|Physician Decision|1|||
25040788|NCT03091777|50141929|FG001|Overall Study|Physician Decision|0|||
25040789|NCT03091777|50141930|FG002|Overall Study|Physician Decision|1|||
25040790|NCT03091777|50141928|FG000|Overall Study|Abnormal Laboratory Value|7|||
25040791|NCT03091777|50141929|FG001|Overall Study|Abnormal Laboratory Value|11|||
25040792|NCT03091777|50141930|FG002|Overall Study|Abnormal Laboratory Value|12|||
25040793|NCT02818998|50141941|FG000|Overall Study|Adverse Event|3|||
25040794|NCT02818998|50141942|FG001|Overall Study|Adverse Event|2|||
25040795|NCT02818998|50141943|FG002|Overall Study|Adverse Event|1|||
25040796|NCT02818998|50141941|FG000|Overall Study|Lost to Follow-up|4|||
25040797|NCT02818998|50141942|FG001|Overall Study|Lost to Follow-up|1|||
25040798|NCT02818998|50141943|FG002|Overall Study|Lost to Follow-up|2|||
25040799|NCT02818998|50141941|FG000|Overall Study|Withdrawal by sponsor|0|||
25040800|NCT02818998|50141942|FG001|Overall Study|Withdrawal by sponsor|1|||
25040801|NCT02818998|50141943|FG002|Overall Study|Withdrawal by sponsor|1|||
25040802|NCT02818998|50141941|FG000|Overall Study|Death|3|||
25040803|NCT02818998|50141942|FG001|Overall Study|Death|6|||
25040804|NCT02818998|50141943|FG002|Overall Study|Death|8|||
25040805|NCT02818998|50141941|FG000|Overall Study|Withdrawal by Subject|7|||
25040806|NCT02818998|50141942|FG001|Overall Study|Withdrawal by Subject|6|||
25040807|NCT02818998|50141943|FG002|Overall Study|Withdrawal by Subject|6|||
25040808|NCT02818998|50141941|FG000|Overall Study|Physician Decision|1|||
25040809|NCT02818998|50141942|FG001|Overall Study|Physician Decision|0|||
25040810|NCT02818998|50141943|FG002|Overall Study|Physician Decision|0|||
25040811|NCT02821416|50141953|FG000|Overall Study|Adverse Event|0|||
25040812|NCT02821416|50141954|FG001|Overall Study|Adverse Event|1|||
25040813|NCT02821416|50141953|FG000|Overall Study|Withdrawal by Subject|2|||
25040814|NCT02821416|50141954|FG001|Overall Study|Withdrawal by Subject|0|||
25040815|NCT02821416|50141953|FG000|Overall Study|Lost to Follow-up|1|||
25040816|NCT02821416|50141954|FG001|Overall Study|Lost to Follow-up|0|||
25040817|NCT03108521|50141963|FG000|Overall Study|Lost to Follow-up|3|||
25040818|NCT03108521|50141964|FG001|Overall Study|Lost to Follow-up|0|||
25040819|NCT03108521|50141963|FG000|Overall Study|Lack of Efficacy|2|||
25040820|NCT03108521|50141964|FG001|Overall Study|Lack of Efficacy|0|||
25040821|NCT03108521|50141963|FG000|Overall Study|Physician Decision|4|||
25040822|NCT03108521|50141964|FG001|Overall Study|Physician Decision|0|||
25040823|NCT03108521|50141963|FG000|Overall Study|Adverse Event|3|||
25040824|NCT03108521|50141964|FG001|Overall Study|Adverse Event|0|||
25040825|NCT02817828|50141987|FG000|Overall Study|Lost to Follow-up|41|||
25040826|NCT02817828|50141987|FG000|Overall Study|Adverse event not related to bleeding|104|||
25040827|NCT02817828|50141987|FG000|Overall Study|Adverse event related to bleeding|53|||
25040828|NCT02817828|50141987|FG000|Overall Study|Protocol Violation|11|||
25040829|NCT02817828|50141987|FG000|Overall Study|Pregnancy|7|||
25040830|NCT02817828|50141987|FG000|Overall Study|Pregnancy wish|15|||
25040831|NCT02817828|50141987|FG000|Overall Study|Withdrawal by Subject|78|||
25040832|NCT02817828|50141987|FG000|Overall Study|Other|26|||
25040833|NCT02817906|50141998|FG000|Overall Study|Adverse Event|3|||
25040834|NCT02817906|50141999|FG001|Overall Study|Adverse Event|0|||
25040835|NCT02817906|50141998|FG000|Overall Study|Lack of Efficacy|1|||
25040836|NCT02817906|50141999|FG001|Overall Study|Lack of Efficacy|0|||
25040837|NCT02817906|50141998|FG000|Overall Study|Protocol Violation|1|||
25040838|NCT02817906|50141999|FG001|Overall Study|Protocol Violation|1|||
25040839|NCT02817906|50141998|FG000|Overall Study|Study Terminated by Sponsor|2|||
25040840|NCT02817906|50141999|FG001|Overall Study|Study Terminated by Sponsor|2|||
25040841|NCT02817906|50141998|FG000|Overall Study|Withdrawal by Subject|7|||
25040842|NCT02817906|50141999|FG001|Overall Study|Withdrawal by Subject|0|||
25040843|NCT02817906|50141998|FG000|Overall Study|Other|2|||
25040844|NCT02817906|50141999|FG001|Overall Study|Other|2|||
25040845|NCT02817594|50142010|FG000|Overall Study|Withdrawal by Subject|1|||
25040846|NCT02817594|50142010|FG000|Overall Study|Other|1|||
25040847|NCT02817594|50142010|FG000|Overall Study|Did Not Receive Treatment|1|||
25040848|NCT02813694|50142020|FG000|Overall Study|Physician Decision|0|||
25040849|NCT02813694|50142021|FG001|Overall Study|Physician Decision|1|||
25040850|NCT02813694|50142020|FG000|Overall Study|Withdrawal by Subject|10|||
25040851|NCT02813694|50142021|FG001|Overall Study|Withdrawal by Subject|9|||
25040852|NCT02813694|50142020|FG000|Overall Study|Lost to Follow-up|1|||
25040853|NCT02813694|50142021|FG001|Overall Study|Lost to Follow-up|1|||
25040854|NCT02813694|50142020|FG000|Overall Study|Death|3|||
25040855|NCT02813694|50142021|FG001|Overall Study|Death|3|||
25040856|NCT02813694|50142020|FG000|Overall Study|Randomized- did not receive study drug|2|||
25160216|NCT01879579|50280315|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
25160217|NCT01386645|50280327|FG000|Overall Study|Physician Decision|0|||
24953847|NCT00146848|50044874|FG002|Pre-randomization|Physician Decision|0|||
24953848|NCT00146848|50044872|FG000|Pre-randomization|Protocol Violation|172|||
24953849|NCT00146848|50044873|FG001|Pre-randomization|Protocol Violation|0|||
24953850|NCT00146848|50044874|FG002|Pre-randomization|Protocol Violation|0|||
24953851|NCT00146848|50044872|FG000|Pre-randomization|Withdrawal by Subject|40|||
24953852|NCT00146848|50044873|FG001|Pre-randomization|Withdrawal by Subject|0|||
24953853|NCT00146848|50044874|FG002|Pre-randomization|Withdrawal by Subject|0|||
24953854|NCT00146848|50044872|FG000|Post-randomization|Lost to Follow-up|12|||
24953855|NCT00146848|50044873|FG001|Post-randomization|Lost to Follow-up|15|||
24953856|NCT00146848|50044874|FG002|Post-randomization|Lost to Follow-up|12|||
25040857|NCT02813694|50142021|FG001|Overall Study|Randomized- did not receive study drug|0|||
25040858|NCT02813694|50142020|FG000|Overall Study|Patient hospitalized|1|||
25040859|NCT02813694|50142021|FG001|Overall Study|Patient hospitalized|0|||
25040860|NCT03103919|50142029|FG000|Overall Study|Adverse Event|2|||
25040861|NCT03103919|50142030|FG001|Overall Study|Adverse Event|2|||
25040862|NCT02810964|50142040|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
25040863|NCT02810964|50142041|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
25040864|NCT02810964|50142040|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
25040865|NCT02810964|50142041|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
25040866|NCT02810964|50142040|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
25040867|NCT02810964|50142041|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
25040868|NCT02810964|50142040|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
25040869|NCT02810964|50142041|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
25040870|NCT03103763|50142050|FG000|Overall Study|Death|15|||
25040871|NCT03103763|50142051|FG001|Overall Study|Death|5|||
25040872|NCT03103763|50142052|FG002|Overall Study|Death|5|||
25040873|NCT03103763|50142050|FG000|Overall Study|Withdrawal by Subject|0|||
25040874|NCT03103763|50142051|FG001|Overall Study|Withdrawal by Subject|3|||
25040875|NCT03103763|50142052|FG002|Overall Study|Withdrawal by Subject|2|||
25040876|NCT03101267|50142076|FG000|Primary Study Period|Withdrawal by Subject|1|||
25040877|NCT03101267|50142077|FG001|Primary Study Period|Withdrawal by Subject|2|||
25040878|NCT03101267|50142078|FG002|Primary Study Period|Withdrawal by Subject|3|||
25040879|NCT03101267|50142076|FG000|Primary Study Period|Miscellaneous|2|||
25040880|NCT03101267|50142077|FG001|Primary Study Period|Miscellaneous|0|||
25040881|NCT03101267|50142078|FG002|Primary Study Period|Miscellaneous|0|||
25040882|NCT02810418|50142093|FG000|Arm A Dose Escalation|Adverse Event|2|||
25040883|NCT02810418|50142094|FG001|Arm A Dose Escalation|Adverse Event|1|||
25040884|NCT02810418|50142095|FG002|Arm A Dose Escalation|Adverse Event|0|||
25040885|NCT02810418|50142096|FG003|Arm A Dose Escalation|Adverse Event|0|||
25040886|NCT02810418|50142097|FG004|Arm A Dose Escalation|Adverse Event|0|||
25040887|NCT02810418|50142098|FG005|Arm A Dose Escalation|Adverse Event|0|||
25040888|NCT02810418|50142099|FG006|Arm A Dose Escalation|Adverse Event|0|||
25040889|NCT02810418|50142093|FG000|Dose Expansion|Adverse Event|0|||
25040890|NCT02810418|50142094|FG001|Dose Expansion|Adverse Event|1|||
25040891|NCT02810418|50142095|FG002|Dose Expansion|Adverse Event|1|||
25040892|NCT02810418|50142096|FG003|Dose Expansion|Adverse Event|0|||
25040893|NCT02810418|50142097|FG004|Dose Expansion|Adverse Event|0|||
25040894|NCT02810418|50142098|FG005|Dose Expansion|Adverse Event|0|||
24953857|NCT00146848|50044872|FG000|Post-randomization|Withdrawn|26|||
24953858|NCT00146848|50044873|FG001|Post-randomization|Withdrawn|32|||
24953859|NCT00146848|50044874|FG002|Post-randomization|Withdrawn|27|||
24953860|NCT00205881|50044882|FG000|Overall Study|Withdrawal by Subject|16|||
24953861|NCT00365378|50044889|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
24953862|NCT00365378|50044890|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
24953863|NCT00365378|50044891|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
24953864|NCT00365378|50044889|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
24953865|NCT00365378|50044890|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
24953866|NCT00365378|50044891|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
24953867|NCT00365378|50044889|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
24953868|NCT00365378|50044890|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
24953869|NCT00365378|50044891|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
24953870|NCT00365378|50044889|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
24953871|NCT00365378|50044890|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
24953872|NCT00365378|50044891|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
24953873|NCT00365378|50044889|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
24953874|NCT00365378|50044890|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
24953875|NCT00365378|50044891|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
25040895|NCT02810418|50142099|FG006|Dose Expansion|Adverse Event|0|||
25040896|NCT02810418|50142093|FG000|Dose Expansion|Physician Decision|0|||
24953876|NCT00365378|50044889|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
25040897|NCT02810418|50142094|FG001|Dose Expansion|Physician Decision|0|||
25040898|NCT02810418|50142095|FG002|Dose Expansion|Physician Decision|2|||
25040899|NCT02810418|50142096|FG003|Dose Expansion|Physician Decision|0|||
25040900|NCT02810418|50142097|FG004|Dose Expansion|Physician Decision|0|||
25040901|NCT02810418|50142098|FG005|Dose Expansion|Physician Decision|0|||
24953877|NCT00365378|50044890|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
24953878|NCT00365378|50044891|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
24953879|NCT00365378|50044889|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
24953880|NCT00365378|50044890|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
25040902|NCT02810418|50142099|FG006|Dose Expansion|Physician Decision|0|||
25040903|NCT02810418|50142093|FG000|Arm B Dose Escalation|Adverse Event|0|||
25040904|NCT02810418|50142094|FG001|Arm B Dose Escalation|Adverse Event|0|||
25040905|NCT02810418|50142095|FG002|Arm B Dose Escalation|Adverse Event|0|||
25040906|NCT02810418|50142096|FG003|Arm B Dose Escalation|Adverse Event|0|||
25040907|NCT02810418|50142097|FG004|Arm B Dose Escalation|Adverse Event|1|||
25040908|NCT02810418|50142098|FG005|Arm B Dose Escalation|Adverse Event|2|||
25040909|NCT02810418|50142099|FG006|Arm B Dose Escalation|Adverse Event|0|||
25040910|NCT02810340|50142165|FG000|Overall Study|Withdrawal by Subject|1|||
25040911|NCT02810340|50142166|FG001|Overall Study|Withdrawal by Subject|0|||
25040912|NCT02810340|50142167|FG002|Overall Study|Withdrawal by Subject|0|||
25040913|NCT02810340|50142165|FG000|Overall Study|Incarceration|0|||
25040914|NCT02810340|50142166|FG001|Overall Study|Incarceration|1|||
25040915|NCT02810340|50142167|FG002|Overall Study|Incarceration|0|||
25040916|NCT02810340|50142165|FG000|Overall Study|Lost to Follow-up|0|||
25040917|NCT02810340|50142166|FG001|Overall Study|Lost to Follow-up|0|||
25040918|NCT02810340|50142167|FG002|Overall Study|Lost to Follow-up|1|||
25040919|NCT02817516|50142179|FG000|Overall Study|Other|0|||
25040920|NCT02817516|50142180|FG001|Overall Study|Other|0|||
25040921|NCT02817516|50142181|FG002|Overall Study|Other|1|||
25040922|NCT02817516|50142182|FG003|Overall Study|Other|0|||
25040923|NCT02928029|50142197|FG000|Overall Study|Withdrawal by Subject|0|||
25040924|NCT02928029|50142198|FG001|Overall Study|Withdrawal by Subject|1|||
25040925|NCT02928029|50142197|FG000|Overall Study|Radiological progression|1|||
25040926|NCT02928029|50142198|FG001|Overall Study|Radiological progression|0|||
25040927|NCT02928029|50142197|FG000|Overall Study|Clinical progression|1|||
25040928|NCT02928029|50142198|FG001|Overall Study|Clinical progression|2|||
25040929|NCT02928029|50142197|FG000|Overall Study|AE not related to clinical progression|1|||
25040930|NCT02928029|50142198|FG001|Overall Study|AE not related to clinical progression|1|||
25040931|NCT02806986|50142204|FG000|Treatment Stage 1|Adverse Event|1|||
25040932|NCT02806986|50142204|FG000|Treatment Stage 2|Adverse Event|3|||
25040933|NCT02806986|50142204|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
25040934|NCT03095651|50142220|FG000|Overall Study|Lost to Follow-up|1|||
25040935|NCT03095651|50142221|FG001|Overall Study|Lost to Follow-up|1|||
25040936|NCT03095651|50142222|FG002|Overall Study|Lost to Follow-up|0|||
25040937|NCT03095651|50142223|FG003|Overall Study|Lost to Follow-up|1|||
24953881|NCT00365378|50044891|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
24953882|NCT00365378|50044889|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
24953883|NCT00365378|50044890|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
24953884|NCT00365378|50044891|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
24953885|NCT00365378|50044889|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
24953886|NCT00365378|50044890|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
24953887|NCT00365378|50044891|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
24953888|NCT00365378|50044889|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
24953889|NCT00365378|50044890|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
24953890|NCT00365378|50044891|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
24953891|NCT00365378|50044889|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
24953892|NCT00365378|50044890|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
25040938|NCT03095651|50142224|FG004|Overall Study|Lost to Follow-up|0|||
25040939|NCT03095651|50142225|FG005|Overall Study|Lost to Follow-up|0|||
25040940|NCT03095651|50142226|FG006|Overall Study|Lost to Follow-up|0|||
25040941|NCT03095651|50142227|FG007|Overall Study|Lost to Follow-up|0|||
24953893|NCT00365378|50044891|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
24953894|NCT00365378|50044889|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
24953895|NCT00365378|50044890|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
24953896|NCT00365378|50044891|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
24953897|NCT00365378|50044889|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
24953898|NCT00365378|50044890|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
25040942|NCT03095651|50142220|FG000|Overall Study|Withdrawal by Subject|0|||
25040943|NCT03095651|50142221|FG001|Overall Study|Withdrawal by Subject|0|||
25040944|NCT03095651|50142222|FG002|Overall Study|Withdrawal by Subject|0|||
25040945|NCT03095651|50142223|FG003|Overall Study|Withdrawal by Subject|0|||
25040946|NCT03095651|50142224|FG004|Overall Study|Withdrawal by Subject|0|||
24953899|NCT00365378|50044891|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
24953900|NCT00365378|50044889|FG000|Extension|Adverse Event|0|||
24953901|NCT00365378|50044890|FG001|Extension|Adverse Event|0|||
24953902|NCT00365378|50044891|FG002|Extension|Adverse Event|1|||
24953903|NCT00365378|50044889|FG000|Extension|Moved|0|||
24953904|NCT00365378|50044890|FG001|Extension|Moved|0|||
24953905|NCT00365378|50044891|FG002|Extension|Moved|8|||
24953906|NCT00365378|50044889|FG000|Extension|Lost to Follow-up|0|||
24953907|NCT00365378|50044890|FG001|Extension|Lost to Follow-up|0|||
24953908|NCT00365378|50044891|FG002|Extension|Lost to Follow-up|57|||
24953909|NCT00365378|50044889|FG000|Extension|Protocol Violation|0|||
24953910|NCT00365378|50044890|FG001|Extension|Protocol Violation|0|||
24953911|NCT00365378|50044891|FG002|Extension|Protocol Violation|2|||
24953912|NCT00365378|50044889|FG000|Extension|Withdrawal by Subject|0|||
24953913|NCT00365378|50044890|FG001|Extension|Withdrawal by Subject|0|||
24953914|NCT00365378|50044891|FG002|Extension|Withdrawal by Subject|98|||
24953915|NCT00365378|50044889|FG000|Extension|Other|0|||
24953916|NCT00365378|50044890|FG001|Extension|Other|0|||
24953917|NCT00365378|50044891|FG002|Extension|Other|31|||
24953918|NCT00389324|50044898|FG000|Run-In Phase|Adverse Event|1|||
24953919|NCT00389324|50044898|FG000|Run-In Phase|Lost to Follow-up|1|||
24953920|NCT00389324|50044898|FG000|Run-In Phase|Withdrawal by Subject|1|||
24953921|NCT00389324|50044898|FG000|Subcutaneous Phase|Adverse Event|2|||
24953922|NCT00389324|50044898|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
24953923|NCT00389324|50044898|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
24953924|NCT00389324|50044898|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
24953925|NCT00365300|50044907|FG000|Open-label Phase|Adverse Event|4|||
24953926|NCT00365300|50044908|FG001|Open-label Phase|Adverse Event|0|||
24953927|NCT00365300|50044907|FG000|Open-label Phase|Failed to Return|1|||
24953928|NCT00365300|50044908|FG001|Open-label Phase|Failed to Return|0|||
24953929|NCT00365300|50044907|FG000|Open-label Phase|Physician Decision|1|||
24953930|NCT00365300|50044908|FG001|Open-label Phase|Physician Decision|0|||
24953931|NCT00365300|50044907|FG000|Open-label Phase|Noncompliance|9|||
24953932|NCT00365300|50044908|FG001|Open-label Phase|Noncompliance|0|||
24953933|NCT00365300|50044907|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
24953934|NCT00365300|50044908|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
24953935|NCT00365300|50044907|FG000|Open-label Phase|Protocol Violation|1|||
24953936|NCT00365300|50044908|FG001|Open-label Phase|Protocol Violation|0|||
24953937|NCT00365300|50044907|FG000|Open-label Phase|Lack of Efficacy|1|||
24953938|NCT00365300|50044908|FG001|Open-label Phase|Lack of Efficacy|0|||
24953939|NCT00365300|50044907|FG000|Open-label Phase|Patient skipped open label phase|1|||
24953940|NCT00365300|50044908|FG001|Open-label Phase|Patient skipped open label phase|0|||
25040947|NCT03095651|50142225|FG005|Overall Study|Withdrawal by Subject|1|||
25040948|NCT03095651|50142226|FG006|Overall Study|Withdrawal by Subject|0|||
25040949|NCT03095651|50142227|FG007|Overall Study|Withdrawal by Subject|0|||
25040950|NCT02808312|50142250|FG000|Overall Study|Enrolled but Never Treated|0|||
25040951|NCT02808312|50142251|FG001|Overall Study|Enrolled but Never Treated|0|||
25040952|NCT02808312|50142252|FG002|Overall Study|Enrolled but Never Treated|1|||
25040953|NCT02808312|50142253|FG003|Overall Study|Enrolled but Never Treated|0|||
25040954|NCT02808312|50142254|FG004|Overall Study|Enrolled but Never Treated|0|||
25040955|NCT03099161|50142274|FG000|Overall Study|Adverse Event|0|||
25040956|NCT03099161|50142275|FG001|Overall Study|Adverse Event|0|||
25040957|NCT03099161|50142276|FG002|Overall Study|Adverse Event|2|||
25040958|NCT03099161|50142274|FG000|Overall Study|Physician Decision|2|||
25040959|NCT03099161|50142275|FG001|Overall Study|Physician Decision|0|||
25040960|NCT03099161|50142276|FG002|Overall Study|Physician Decision|0|||
24953941|NCT00365300|50044907|FG000|Double-blind Phase|Failed to return|1|||
24953942|NCT00365300|50044908|FG001|Double-blind Phase|Failed to return|0|||
24953943|NCT00365300|50044907|FG000|Double-blind Phase|Noncompliance|1|||
25040961|NCT03099161|50142274|FG000|Overall Study|Progressive Disease|1|||
25186330|NCT01399619|50336288|FG000|Overall Study|Withdrawal by Subject|6|||
24953944|NCT00365300|50044908|FG001|Double-blind Phase|Noncompliance|1|||
24953945|NCT00365300|50044907|FG000|Double-blind Phase|Withdrawal by Subject|0|||
24953946|NCT00365300|50044908|FG001|Double-blind Phase|Withdrawal by Subject|1|||
24953947|NCT00365300|50044907|FG000|Double-blind Phase|Protocol Violation|3|||
25040962|NCT03099161|50142275|FG001|Overall Study|Progressive Disease|4|||
25040963|NCT03099161|50142276|FG002|Overall Study|Progressive Disease|1|||
24953948|NCT00365300|50044908|FG001|Double-blind Phase|Protocol Violation|1|||
25040964|NCT03095027|50142284|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
25040965|NCT03095027|50142285|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
25040966|NCT04227197|50142293|FG000|Randomization|Protocol Violation|1|||
25040967|NCT04227197|50142294|FG001|Randomization|Protocol Violation|0|||
25040968|NCT04227197|50142293|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
25040969|NCT04227197|50142294|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
25040970|NCT04227197|50142293|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
25040971|NCT04227197|50142294|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
25040972|NCT04227197|50142293|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
25040973|NCT04227197|50142294|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
25040974|NCT04227197|50142293|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
25040975|NCT04227197|50142294|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
25040976|NCT04227197|50142293|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
25040977|NCT04227197|50142294|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
25160218|NCT01386645|50280328|FG001|Overall Study|Physician Decision|0|||
24953949|NCT00365300|50044907|FG000|Double-blind Phase|Lack of Efficacy|6|||
24953950|NCT00365300|50044908|FG001|Double-blind Phase|Lack of Efficacy|6|||
24953951|NCT00370292|50044919|FG000|Overall Study|Disease Progression|4|||
24953952|NCT00370292|50044919|FG000|Overall Study|Adverse Event|7|||
24953953|NCT00370292|50044919|FG000|Overall Study|Physician Decision|2|||
24953954|NCT00369824|50044936|FG000|Overall Study|Adverse Event|0|||
24953955|NCT00369824|50044937|FG001|Overall Study|Adverse Event|2|||
24953956|NCT00369824|50044938|FG002|Overall Study|Adverse Event|0|||
24953957|NCT00369824|50044939|FG003|Overall Study|Adverse Event|0|||
24953958|NCT00369824|50044940|FG004|Overall Study|Adverse Event|1|||
24953959|NCT00369824|50044941|FG005|Overall Study|Adverse Event|0|||
24953960|NCT00369824|50044936|FG000|Overall Study|Protocol Violation|0|||
24953961|NCT00369824|50044937|FG001|Overall Study|Protocol Violation|1|||
24953962|NCT00369824|50044938|FG002|Overall Study|Protocol Violation|0|||
24953963|NCT00369824|50044939|FG003|Overall Study|Protocol Violation|1|||
24953964|NCT00369824|50044940|FG004|Overall Study|Protocol Violation|1|||
24953965|NCT00369824|50044941|FG005|Overall Study|Protocol Violation|0|||
24953966|NCT00369824|50044936|FG000|Overall Study|Withdrawal by Subject|9|||
24953967|NCT00369824|50044937|FG001|Overall Study|Withdrawal by Subject|5|||
24953968|NCT00369824|50044938|FG002|Overall Study|Withdrawal by Subject|5|||
24953969|NCT00369824|50044939|FG003|Overall Study|Withdrawal by Subject|4|||
24953970|NCT00369824|50044940|FG004|Overall Study|Withdrawal by Subject|6|||
24953971|NCT00369824|50044941|FG005|Overall Study|Withdrawal by Subject|2|||
24953972|NCT00369824|50044936|FG000|Overall Study|Lost to Follow-up|6|||
24953973|NCT00369824|50044937|FG001|Overall Study|Lost to Follow-up|11|||
24953974|NCT00369824|50044938|FG002|Overall Study|Lost to Follow-up|7|||
24953975|NCT00369824|50044939|FG003|Overall Study|Lost to Follow-up|8|||
24953976|NCT00369824|50044940|FG004|Overall Study|Lost to Follow-up|9|||
24953977|NCT00369824|50044941|FG005|Overall Study|Lost to Follow-up|6|||
24953978|NCT00369824|50044936|FG000|Overall Study|Other|0|||
24953979|NCT00369824|50044937|FG001|Overall Study|Other|0|||
24953980|NCT00369824|50044938|FG002|Overall Study|Other|0|||
24953981|NCT00369824|50044939|FG003|Overall Study|Other|2|||
24953982|NCT00369824|50044940|FG004|Overall Study|Other|1|||
24953983|NCT00369824|50044941|FG005|Overall Study|Other|3|||
24953984|NCT00369668|50044958|FG000|Overall Study|Lack of Efficacy|4|||
24953985|NCT00369668|50044959|FG001|Overall Study|Lack of Efficacy|5|||
24953986|NCT00369668|50044960|FG002|Overall Study|Lack of Efficacy|7|||
24953987|NCT00388154|50044971|FG000|Overall Study|Withdrawal by Subject|1|||
24953988|NCT00387764|50044975|FG000|Overall Study|Adverse Event|12|||
24953989|NCT00387764|50044975|FG000|Overall Study|Withdrawal by Subject|8|||
24953990|NCT00387764|50044975|FG000|Overall Study|Sponsor Terminated Study|1|||
24953991|NCT00387764|50044975|FG000|Overall Study|Physician Decision|1|||
24953992|NCT00387764|50044975|FG000|Overall Study|Other|2|||
24953993|NCT00387764|50044975|FG000|Overall Study|Death|7|||
24953994|NCT00386360|50044981|FG000|Overall Study|Adverse Event|4|||
24953995|NCT00386360|50044982|FG001|Overall Study|Adverse Event|2|||
24953996|NCT00386360|50044981|FG000|Overall Study|Physician Decision|2|||
24953997|NCT00386360|50044982|FG001|Overall Study|Physician Decision|2|||
24953998|NCT00386360|50044981|FG000|Overall Study|Lost to Follow-up|0|||
24953999|NCT00386360|50044982|FG001|Overall Study|Lost to Follow-up|2|||
24954000|NCT00386360|50044981|FG000|Overall Study|Protocol Violation|0|||
24954001|NCT00386360|50044982|FG001|Overall Study|Protocol Violation|3|||
24954002|NCT00386360|50044981|FG000|Overall Study|Withdrawal by Subject|3|||
24954003|NCT00386360|50044982|FG001|Overall Study|Withdrawal by Subject|6|||
24954004|NCT00386360|50044981|FG000|Overall Study|Did not take any study medication|0|||
24954005|NCT00386360|50044982|FG001|Overall Study|Did not take any study medication|2|||
24954006|NCT00369278|50044990|FG000|Overall Study|Adverse Event|14|||
24954007|NCT00369278|50044991|FG001|Overall Study|Adverse Event|11|||
24954008|NCT00369278|50044990|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
24954009|NCT00369278|50044991|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
24954010|NCT00369278|50044990|FG000|Overall Study|Protocol Violation|2|||
24954011|NCT00369278|50044991|FG001|Overall Study|Protocol Violation|1|||
24954012|NCT00369278|50044990|FG000|Overall Study|Withdrawal by Subject|2|||
24954013|NCT00369278|50044991|FG001|Overall Study|Withdrawal by Subject|2|||
24954014|NCT00369278|50044990|FG000|Overall Study|Lost to Follow-up|1|||
24954015|NCT00369278|50044991|FG001|Overall Study|Lost to Follow-up|0|||
24954016|NCT00369278|50044990|FG000|Overall Study|Graft loss|1|||
24954017|NCT00369278|50044991|FG001|Overall Study|Graft loss|2|||
24954018|NCT00529373|50044999|FG000|Base Study|Adverse Event|525|||
24954019|NCT00529373|50045000|FG001|Base Study|Adverse Event|470|||
24954020|NCT00529373|50044999|FG000|Base Study|Lack of Efficacy|16|||
24954021|NCT00529373|50045000|FG001|Base Study|Lack of Efficacy|75|||
24954022|NCT00529373|50044999|FG000|Base Study|Lost to Follow-up|221|||
24954023|NCT00529373|50045000|FG001|Base Study|Lost to Follow-up|208|||
24954024|NCT00529373|50044999|FG000|Base Study|Other Protocol Specified Criteria|19|||
24954025|NCT00529373|50045000|FG001|Base Study|Other Protocol Specified Criteria|20|||
24954026|NCT00529373|50044999|FG000|Base Study|Physician Decision|60|||
24954027|NCT00529373|50045000|FG001|Base Study|Physician Decision|52|||
24954028|NCT00529373|50044999|FG000|Base Study|Protocol Violation|48|||
24954029|NCT00529373|50045000|FG001|Base Study|Protocol Violation|38|||
24954030|NCT00529373|50044999|FG000|Base Study|Withdrawal by Subject|1062|||
24954031|NCT00529373|50045000|FG001|Base Study|Withdrawal by Subject|967|||
24954032|NCT00529373|50044999|FG000|Base Study|Did not continue into Extension|1795|||
24954033|NCT00529373|50045000|FG001|Base Study|Did not continue into Extension|2238|||
24954034|NCT00529373|50044999|FG000|First Extension Study|Adverse Event|162|||
25040978|NCT04227197|50142293|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
25040979|NCT04227197|50142294|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
25040980|NCT03080935|50142305|FG000|Overall Study|Death|34|||
25040981|NCT03080935|50142306|FG001|Overall Study|Death|50|||
25040982|NCT03080935|50142305|FG000|Overall Study|Lost to Follow-up|5|||
24954035|NCT00529373|50045000|FG001|First Extension Study|Adverse Event|142|||
24954036|NCT00529373|50044999|FG000|First Extension Study|Lack of Efficacy|65|||
24954037|NCT00529373|50045000|FG001|First Extension Study|Lack of Efficacy|427|||
24954038|NCT00529373|50044999|FG000|First Extension Study|Lost to Follow-up|41|||
24954039|NCT00529373|50045000|FG001|First Extension Study|Lost to Follow-up|37|||
24954040|NCT00529373|50044999|FG000|First Extension Study|Other|27|||
24954041|NCT00529373|50045000|FG001|First Extension Study|Other|47|||
25040983|NCT03080935|50142306|FG001|Overall Study|Lost to Follow-up|4|||
25040984|NCT03080935|50142305|FG000|Overall Study|Withdrawal by Subject|11|||
25040985|NCT03080935|50142306|FG001|Overall Study|Withdrawal by Subject|15|||
25040986|NCT02921789|50142318|FG000|Overall Study|Adverse Event|0|||
25040987|NCT02921789|50142319|FG001|Overall Study|Adverse Event|1|||
25040988|NCT02921789|50142318|FG000|Overall Study|Lost to Follow-up|1|||
25040989|NCT02921789|50142319|FG001|Overall Study|Lost to Follow-up|0|||
25040990|NCT02921789|50142318|FG000|Overall Study|Protocol Deviation|2|||
25040991|NCT02921789|50142319|FG001|Overall Study|Protocol Deviation|0|||
25040992|NCT02921789|50142318|FG000|Overall Study|Withdrawal by Subject|2|||
25040993|NCT02921789|50142319|FG001|Overall Study|Withdrawal by Subject|1|||
25040994|NCT02921789|50142318|FG000|Overall Study|Miscellaneous|3|||
24954042|NCT00529373|50044999|FG000|First Extension Study|Physician Decision|50|||
24954043|NCT00529373|50045000|FG001|First Extension Study|Physician Decision|45|||
25040995|NCT02921789|50142319|FG001|Overall Study|Miscellaneous|2|||
25040996|NCT02564900|50142340|FG000|Dose Escalation|Progressive disease per RECIST|2|||
24954044|NCT00529373|50044999|FG000|First Extension Study|Protocol Violation|16|||
24954045|NCT00529373|50045000|FG001|First Extension Study|Protocol Violation|13|||
24954046|NCT00529373|50044999|FG000|First Extension Study|Withdrawal by Subject|296|||
24954047|NCT00529373|50045000|FG001|First Extension Study|Withdrawal by Subject|287|||
24954048|NCT00529373|50044999|FG000|First Extension Study|Disposition record non-existing|0|||
24954049|NCT00529373|50045000|FG001|First Extension Study|Disposition record non-existing|1|||
24954050|NCT00529373|50044999|FG000|First Extension Study|Discontinued after 5 years completion|208|||
24954051|NCT00529373|50045000|FG001|First Extension Study|Discontinued after 5 years completion|346|||
24954052|NCT00529373|50044999|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
25040997|NCT02564900|50142341|FG001|Dose Escalation|Progressive disease per RECIST|3|||
25040998|NCT02564900|50142342|FG002|Dose Escalation|Progressive disease per RECIST|3|||
25040999|NCT02564900|50142343|FG003|Dose Escalation|Progressive disease per RECIST|3|||
25041000|NCT02564900|50142344|FG004|Dose Escalation|Progressive disease per RECIST|3|||
25041001|NCT02564900|50142345|FG005|Dose Escalation|Progressive disease per RECIST|1|||
25041002|NCT02564900|50142346|FG006|Dose Escalation|Progressive disease per RECIST|0|||
25041003|NCT02564900|50142347|FG007|Dose Escalation|Progressive disease per RECIST|0|||
25041004|NCT02564900|50142348|FG008|Dose Escalation|Progressive disease per RECIST|0|||
24954053|NCT00529373|50045000|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
25041005|NCT02564900|50142349|FG009|Dose Escalation|Progressive disease per RECIST|0|||
25041006|NCT02564900|50142350|FG010|Dose Escalation|Progressive disease per RECIST|0|||
25041007|NCT02564900|50142351|FG011|Dose Escalation|Progressive disease per RECIST|0|||
25041008|NCT02564900|50142352|FG012|Dose Escalation|Progressive disease per RECIST|0|||
24954054|NCT00529373|50044999|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
24954055|NCT00529373|50045000|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
24954056|NCT00529373|50044999|FG000|Second Extension Study|Adverse Event|101|||
25041009|NCT02564900|50142353|FG013|Dose Escalation|Progressive disease per RECIST|0|||
25041010|NCT02564900|50142354|FG014|Dose Escalation|Progressive disease per RECIST|0|||
25041011|NCT02564900|50142340|FG000|Dose Escalation|Ongoing|1|||
25041012|NCT02564900|50142341|FG001|Dose Escalation|Ongoing|0|||
25041013|NCT02564900|50142342|FG002|Dose Escalation|Ongoing|0|||
25041014|NCT02564900|50142343|FG003|Dose Escalation|Ongoing|2|||
25041015|NCT02564900|50142344|FG004|Dose Escalation|Ongoing|2|||
25041016|NCT02564900|50142345|FG005|Dose Escalation|Ongoing|2|||
25041017|NCT02564900|50142346|FG006|Dose Escalation|Ongoing|0|||
25041018|NCT02564900|50142347|FG007|Dose Escalation|Ongoing|0|||
25041019|NCT02564900|50142348|FG008|Dose Escalation|Ongoing|0|||
25041020|NCT02564900|50142349|FG009|Dose Escalation|Ongoing|0|||
25041021|NCT02564900|50142350|FG010|Dose Escalation|Ongoing|0|||
25041022|NCT02564900|50142351|FG011|Dose Escalation|Ongoing|0|||
25041023|NCT02564900|50142352|FG012|Dose Escalation|Ongoing|0|||
25041024|NCT02564900|50142353|FG013|Dose Escalation|Ongoing|0|||
25041025|NCT02564900|50142354|FG014|Dose Escalation|Ongoing|0|||
25041026|NCT02564900|50142340|FG000|Dose Escalation|Adverse Event|0|||
25041027|NCT02564900|50142341|FG001|Dose Escalation|Adverse Event|0|||
25041028|NCT02564900|50142342|FG002|Dose Escalation|Adverse Event|0|||
25041029|NCT02564900|50142343|FG003|Dose Escalation|Adverse Event|1|||
25041030|NCT02564900|50142344|FG004|Dose Escalation|Adverse Event|1|||
25041031|NCT02564900|50142345|FG005|Dose Escalation|Adverse Event|3|||
25041032|NCT02564900|50142346|FG006|Dose Escalation|Adverse Event|0|||
25041033|NCT02564900|50142347|FG007|Dose Escalation|Adverse Event|0|||
25041034|NCT02564900|50142348|FG008|Dose Escalation|Adverse Event|0|||
25041035|NCT02564900|50142349|FG009|Dose Escalation|Adverse Event|0|||
25041036|NCT02564900|50142350|FG010|Dose Escalation|Adverse Event|0|||
25041037|NCT02564900|50142351|FG011|Dose Escalation|Adverse Event|0|||
25041038|NCT02564900|50142352|FG012|Dose Escalation|Adverse Event|0|||
25041039|NCT02564900|50142353|FG013|Dose Escalation|Adverse Event|0|||
25041040|NCT02564900|50142354|FG014|Dose Escalation|Adverse Event|0|||
25041041|NCT02564900|50142340|FG000|Dose Expansion|Progressive disease per RECIST|0|||
25041042|NCT02564900|50142341|FG001|Dose Expansion|Progressive disease per RECIST|0|||
24954057|NCT00529373|50045000|FG001|Second Extension Study|Adverse Event|51|||
24954058|NCT00529373|50044999|FG000|Second Extension Study|Lack of Efficacy|7|||
24954059|NCT00529373|50045000|FG001|Second Extension Study|Lack of Efficacy|15|||
24954060|NCT00529373|50044999|FG000|Second Extension Study|Lost to Follow-up|18|||
24954061|NCT00529373|50045000|FG001|Second Extension Study|Lost to Follow-up|12|||
24954062|NCT00529373|50044999|FG000|Second Extension Study|Other|7|||
24954063|NCT00529373|50045000|FG001|Second Extension Study|Other|12|||
24954064|NCT00529373|50044999|FG000|Second Extension Study|Physician Decision|63|||
24954065|NCT00529373|50045000|FG001|Second Extension Study|Physician Decision|26|||
24954066|NCT00529373|50044999|FG000|Second Extension Study|Protocol Violation|2|||
24954067|NCT00529373|50045000|FG001|Second Extension Study|Protocol Violation|1|||
24954068|NCT00529373|50044999|FG000|Second Extension Study|Withdrawal by Subject|97|||
24954069|NCT00529373|50045000|FG001|Second Extension Study|Withdrawal by Subject|75|||
24954070|NCT00529373|50044999|FG000|Second Extension Study|Status Missing|5|||
24954071|NCT00529373|50045000|FG001|Second Extension Study|Status Missing|5|||
24954072|NCT00369122|50045014|FG000|Overall Study|Ineligible|10|||
24954073|NCT00369122|50045014|FG000|Overall Study|No protocol treatment|1|||
24954074|NCT03687125|50045020|FG000|Overall Study|Progressive Disease|2|||
24954075|NCT03687125|50045021|FG001|Overall Study|Progressive Disease|1|||
24954076|NCT03687125|50045020|FG000|Overall Study|Protocol Violation|1|||
24954077|NCT03687125|50045021|FG001|Overall Study|Protocol Violation|0|||
24954078|NCT03872843|50045031|FG000|Overall Study|Lost to Follow-up|5|||
24954079|NCT03872843|50045032|FG001|Overall Study|Lost to Follow-up|7|||
24954080|NCT00146770|50045040|FG000|Overall Study|Adverse Event|2|||
24954081|NCT00146770|50045041|FG001|Overall Study|Adverse Event|0|||
24954082|NCT00146770|50045040|FG000|Overall Study|Pregnancy|1|||
24954083|NCT00146770|50045041|FG001|Overall Study|Pregnancy|0|||
25041043|NCT02564900|50142342|FG002|Dose Expansion|Progressive disease per RECIST|0|||
25041044|NCT02564900|50142343|FG003|Dose Expansion|Progressive disease per RECIST|0|||
25041045|NCT02564900|50142344|FG004|Dose Expansion|Progressive disease per RECIST|0|||
25041046|NCT02564900|50142345|FG005|Dose Expansion|Progressive disease per RECIST|0|||
25041047|NCT02564900|50142346|FG006|Dose Expansion|Progressive disease per RECIST|19|||
24954084|NCT00146770|50045040|FG000|Overall Study|Withdrawal by Subject|2|||
24954085|NCT00146770|50045041|FG001|Overall Study|Withdrawal by Subject|0|||
24954086|NCT03874013|50045049|FG000|Overall Study|Adverse Event|0|||
24954087|NCT03874013|50045050|FG001|Overall Study|Adverse Event|1|||
24954088|NCT00168064|50045058|FG000|Overall Study|Adverse Event|26|||
24954089|NCT00168064|50045059|FG001|Overall Study|Adverse Event|22|||
24954090|NCT00168064|50045058|FG000|Overall Study|Withdrawal by Subject|3|||
25041048|NCT02564900|50142347|FG007|Dose Expansion|Progressive disease per RECIST|17|||
24954091|NCT00168064|50045059|FG001|Overall Study|Withdrawal by Subject|4|||
25041049|NCT02564900|50142348|FG008|Dose Expansion|Progressive disease per RECIST|8|||
25041050|NCT02564900|50142349|FG009|Dose Expansion|Progressive disease per RECIST|16|||
24954092|NCT00168064|50045058|FG000|Overall Study|Lack of Efficacy|4|||
24954093|NCT00168064|50045059|FG001|Overall Study|Lack of Efficacy|4|||
24954094|NCT00168064|50045058|FG000|Overall Study|Lost to Follow-up|4|||
24954095|NCT00168064|50045059|FG001|Overall Study|Lost to Follow-up|3|||
24954096|NCT00168064|50045058|FG000|Overall Study|Non-compliance|2|||
24954097|NCT00168064|50045059|FG001|Overall Study|Non-compliance|3|||
24954098|NCT00168064|50045058|FG000|Overall Study|Concurrent Illness|4|||
24954099|NCT00168064|50045059|FG001|Overall Study|Concurrent Illness|3|||
24954100|NCT00168064|50045058|FG000|Overall Study|Subject's Best interest|2|||
24954101|NCT00168064|50045059|FG001|Overall Study|Subject's Best interest|2|||
24954102|NCT00168064|50045058|FG000|Overall Study|Various|4|||
24954103|NCT00168064|50045059|FG001|Overall Study|Various|3|||
24954104|NCT00166114|50045069|FG000|Overall Study|Protocol Violation|2|||
24954105|NCT00166114|50045070|FG001|Overall Study|Protocol Violation|1|||
24954106|NCT00166114|50045069|FG000|Overall Study|Withdrawal by Subject|10|||
24954107|NCT00166114|50045070|FG001|Overall Study|Withdrawal by Subject|4|||
24954108|NCT00166114|50045069|FG000|Overall Study|Adverse Event|2|||
24954109|NCT00166114|50045070|FG001|Overall Study|Adverse Event|1|||
24954110|NCT03686969|50045078|FG000|Overall Study|Study terminated|1|||
24954111|NCT03686969|50045079|FG001|Overall Study|Study terminated|0|||
24954112|NCT00145600|50045089|FG000|Overall Study|Death|1|||
24954113|NCT00145600|50045090|FG001|Overall Study|Death|2|||
24954114|NCT00145600|50045091|FG002|Overall Study|Death|2|||
24954115|NCT00145600|50045092|FG003|Overall Study|Death|6|||
24954116|NCT00145600|50045089|FG000|Overall Study|Ineligible|3|||
24954117|NCT00145600|50045090|FG001|Overall Study|Ineligible|0|||
24954118|NCT00145600|50045091|FG002|Overall Study|Ineligible|1|||
24954119|NCT00145600|50045092|FG003|Overall Study|Ineligible|5|||
24954120|NCT00145600|50045089|FG000|Overall Study|Lost to Follow-up|2|||
24954121|NCT00145600|50045090|FG001|Overall Study|Lost to Follow-up|6|||
24954122|NCT00145600|50045091|FG002|Overall Study|Lost to Follow-up|2|||
24954123|NCT00145600|50045092|FG003|Overall Study|Lost to Follow-up|4|||
24954124|NCT00145600|50045089|FG000|Overall Study|Noncompliance|1|||
24954125|NCT00145600|50045090|FG001|Overall Study|Noncompliance|0|||
25041051|NCT02564900|50142350|FG010|Dose Expansion|Progressive disease per RECIST|13|||
25041052|NCT02564900|50142351|FG011|Dose Expansion|Progressive disease per RECIST|19|||
25041053|NCT02564900|50142352|FG012|Dose Expansion|Progressive disease per RECIST|10|||
25041054|NCT02564900|50142353|FG013|Dose Expansion|Progressive disease per RECIST|13|||
25041055|NCT02564900|50142354|FG014|Dose Expansion|Progressive disease per RECIST|11|||
25041056|NCT02564900|50142340|FG000|Dose Expansion|Clinical progression|0|||
25041057|NCT02564900|50142341|FG001|Dose Expansion|Clinical progression|0|||
25041058|NCT02564900|50142342|FG002|Dose Expansion|Clinical progression|0|||
25041059|NCT02564900|50142343|FG003|Dose Expansion|Clinical progression|0|||
25041060|NCT02564900|50142344|FG004|Dose Expansion|Clinical progression|0|||
25041061|NCT02564900|50142345|FG005|Dose Expansion|Clinical progression|0|||
25041062|NCT02564900|50142346|FG006|Dose Expansion|Clinical progression|5|||
25041063|NCT02564900|50142347|FG007|Dose Expansion|Clinical progression|12|||
25041064|NCT02564900|50142348|FG008|Dose Expansion|Clinical progression|0|||
25041065|NCT02564900|50142349|FG009|Dose Expansion|Clinical progression|3|||
25041066|NCT02564900|50142350|FG010|Dose Expansion|Clinical progression|2|||
24954126|NCT00145600|50045091|FG002|Overall Study|Noncompliance|0|||
24954127|NCT00145600|50045092|FG003|Overall Study|Noncompliance|0|||
24954128|NCT00145600|50045089|FG000|Overall Study|Withdrawal by Subject|1|||
24954129|NCT00145600|50045090|FG001|Overall Study|Withdrawal by Subject|2|||
24954130|NCT00145600|50045091|FG002|Overall Study|Withdrawal by Subject|0|||
24954131|NCT00145600|50045092|FG003|Overall Study|Withdrawal by Subject|1|||
24954132|NCT00129376|50045116|FG000|Overall Study|Adverse Event|1|||
24954133|NCT00129376|50045116|FG000|Overall Study|Lack of Efficacy|1|||
24954134|NCT00129220|50045123|FG000|Study Period II|Adverse Event|9|||
24954135|NCT00129220|50045124|FG001|Study Period II|Adverse Event|5|||
24954136|NCT00129220|50045125|FG002|Study Period II|Adverse Event|7|||
24954137|NCT00129220|50045123|FG000|Study Period II|Lack of Efficacy|15|||
24954138|NCT00129220|50045124|FG001|Study Period II|Lack of Efficacy|1|||
24954139|NCT00129220|50045125|FG002|Study Period II|Lack of Efficacy|28|||
24954140|NCT00129220|50045123|FG000|Study Period II|Entry Criteria Not Met|2|||
24954141|NCT00129220|50045124|FG001|Study Period II|Entry Criteria Not Met|0|||
24954142|NCT00129220|50045125|FG002|Study Period II|Entry Criteria Not Met|2|||
24954143|NCT00129220|50045123|FG000|Study Period II|Protocol Violation|4|||
24954144|NCT00129220|50045124|FG001|Study Period II|Protocol Violation|2|||
25041067|NCT02564900|50142351|FG011|Dose Expansion|Clinical progression|0|||
25041068|NCT02564900|50142352|FG012|Dose Expansion|Clinical progression|1|||
25041069|NCT02564900|50142353|FG013|Dose Expansion|Clinical progression|3|||
24954145|NCT00129220|50045125|FG002|Study Period II|Protocol Violation|1|||
24954146|NCT00129220|50045123|FG000|Study Period II|Physician Decision|0|||
24954147|NCT00129220|50045124|FG001|Study Period II|Physician Decision|1|||
24954148|NCT00129220|50045125|FG002|Study Period II|Physician Decision|0|||
24954149|NCT00129220|50045123|FG000|Study Period II|Withdrawal by Subject|1|||
24954150|NCT00129220|50045124|FG001|Study Period II|Withdrawal by Subject|3|||
24954151|NCT00129220|50045125|FG002|Study Period II|Withdrawal by Subject|4|||
24954152|NCT00129220|50045123|FG000|Study Period II|Reason Not Specified|2|||
24954153|NCT00129220|50045124|FG001|Study Period II|Reason Not Specified|0|||
24954154|NCT00129220|50045125|FG002|Study Period II|Reason Not Specified|5|||
24954155|NCT00129220|50045123|FG000|Study Period III|Adverse Event|1|||
24954156|NCT00129220|50045124|FG001|Study Period III|Adverse Event|0|||
24954157|NCT00129220|50045125|FG002|Study Period III|Adverse Event|3|||
24954158|NCT00129220|50045123|FG000|Study Period III|Protocol Violation|1|||
24954159|NCT00129220|50045124|FG001|Study Period III|Protocol Violation|1|||
24954160|NCT00129220|50045125|FG002|Study Period III|Protocol Violation|2|||
24954161|NCT00129220|50045123|FG000|Study Period III|Withdrawal by Subject|1|||
24954162|NCT00129220|50045124|FG001|Study Period III|Withdrawal by Subject|0|||
24954163|NCT00129220|50045125|FG002|Study Period III|Withdrawal by Subject|3|||
24954164|NCT00129220|50045123|FG000|Study Period III|Sponsor Decision|1|||
24954165|NCT00129220|50045124|FG001|Study Period III|Sponsor Decision|0|||
24954166|NCT00129220|50045125|FG002|Study Period III|Sponsor Decision|0|||
24954167|NCT00129220|50045123|FG000|Study Period III|Reason Not Specified|9|||
24954168|NCT00129220|50045124|FG001|Study Period III|Reason Not Specified|0|||
24954169|NCT00129220|50045125|FG002|Study Period III|Reason Not Specified|2|||
24954170|NCT00128830|50045145|FG000|Overall Study|Adverse Event|10|||
24954171|NCT00128830|50045145|FG000|Overall Study|Withdrawal by Subject|14|||
24954172|NCT00128830|50045145|FG000|Overall Study|Lost to Follow-up|4|||
24954173|NCT00128830|50045145|FG000|Overall Study|Reached a virologic endpoint|29|||
24954174|NCT00128830|50045145|FG000|Overall Study|Non-compliant|4|||
24954175|NCT00128830|50045145|FG000|Overall Study|Discontinued or ineligible for study|2|||
24954176|NCT00128830|50045145|FG000|Overall Study|Other|9|||
25041070|NCT02564900|50142354|FG014|Dose Expansion|Clinical progression|1|||
25041071|NCT02564900|50142340|FG000|Dose Expansion|Adverse Event|0|||
25041072|NCT02564900|50142341|FG001|Dose Expansion|Adverse Event|0|||
24954177|NCT03686033|50045151|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
24954178|NCT03686033|50045152|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
24954179|NCT03686033|50045153|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
24954180|NCT03686033|50045154|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
24954181|NCT03686033|50045155|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
24954182|NCT03686033|50045156|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
24954183|NCT00128206|50045172|FG000|Overall Study|Lost to Follow-up|137|||
24954184|NCT00128206|50045173|FG001|Overall Study|Lost to Follow-up|118|||
24954185|NCT00128206|50045172|FG000|Overall Study|Adverse Event|0|||
24954186|NCT00128206|50045173|FG001|Overall Study|Adverse Event|2|||
24954187|NCT03685643|50045181|FG000|Overall Study|Lost to Follow-up|14|||
24954188|NCT03685643|50045182|FG001|Overall Study|Lost to Follow-up|22|||
24954189|NCT03823378|50045194|FG000|Overall Study|Adverse Event|2|||
24954190|NCT03823378|50045195|FG001|Overall Study|Adverse Event|2|||
24954191|NCT03823378|50045196|FG002|Overall Study|Adverse Event|0|||
24954192|NCT03823378|50045197|FG003|Overall Study|Adverse Event|0|||
24954193|NCT03823378|50045198|FG004|Overall Study|Adverse Event|0|||
24954194|NCT03823378|50045199|FG005|Overall Study|Adverse Event|0|||
24954195|NCT03823378|50045194|FG000|Overall Study|Lost to Follow-up|0|||
24954196|NCT03823378|50045195|FG001|Overall Study|Lost to Follow-up|1|||
24954197|NCT03823378|50045196|FG002|Overall Study|Lost to Follow-up|0|||
24954198|NCT03823378|50045197|FG003|Overall Study|Lost to Follow-up|0|||
24954199|NCT03823378|50045198|FG004|Overall Study|Lost to Follow-up|1|||
24954200|NCT03823378|50045199|FG005|Overall Study|Lost to Follow-up|0|||
24954201|NCT03823378|50045194|FG000|Overall Study|Withdrawal by Subject|0|||
24954202|NCT03823378|50045195|FG001|Overall Study|Withdrawal by Subject|1|||
24954203|NCT03823378|50045196|FG002|Overall Study|Withdrawal by Subject|4|||
24954204|NCT03823378|50045197|FG003|Overall Study|Withdrawal by Subject|2|||
24954205|NCT03823378|50045198|FG004|Overall Study|Withdrawal by Subject|0|||
24954206|NCT03823378|50045199|FG005|Overall Study|Withdrawal by Subject|1|||
24954207|NCT03823378|50045194|FG000|Overall Study|Other, not specified|19|||
24954208|NCT03823378|50045195|FG001|Overall Study|Other, not specified|12|||
25041073|NCT02564900|50142342|FG002|Dose Expansion|Adverse Event|0|||
24954209|NCT03823378|50045196|FG002|Overall Study|Other, not specified|6|||
24954210|NCT03823378|50045197|FG003|Overall Study|Other, not specified|8|||
24954211|NCT03823378|50045198|FG004|Overall Study|Other, not specified|17|||
24954212|NCT03823378|50045199|FG005|Overall Study|Other, not specified|7|||
24954213|NCT00142792|50045216|FG000|Overall Study|Death|0|||
24954214|NCT00142792|50045217|FG001|Overall Study|Death|0|||
24954215|NCT00142792|50045218|FG002|Overall Study|Death|1|||
24954216|NCT00142792|50045216|FG000|Overall Study|Withdrawal by Subject|3|||
24954217|NCT00142792|50045217|FG001|Overall Study|Withdrawal by Subject|2|||
24954218|NCT00142792|50045218|FG002|Overall Study|Withdrawal by Subject|3|||
24954219|NCT00142792|50045216|FG000|Overall Study|Lost to Follow-up|8|||
24954220|NCT00142792|50045217|FG001|Overall Study|Lost to Follow-up|11|||
24954221|NCT00142792|50045218|FG002|Overall Study|Lost to Follow-up|7|||
24954222|NCT00142792|50045216|FG000|Overall Study|No category|1|||
25041074|NCT02564900|50142343|FG003|Dose Expansion|Adverse Event|0|||
24954223|NCT00142792|50045217|FG001|Overall Study|No category|2|||
24954224|NCT00142792|50045218|FG002|Overall Study|No category|1|||
24954225|NCT00141778|50045229|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
24954226|NCT00141778|50045230|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
24954227|NCT00141778|50045231|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
24954228|NCT00141778|50045229|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
24954229|NCT00141778|50045230|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
24954230|NCT00141778|50045231|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
24954231|NCT00141778|50045229|FG000|Started Study Medication|Withdrawal by Subject|0|||
24954232|NCT00141778|50045230|FG001|Started Study Medication|Withdrawal by Subject|2|||
24954233|NCT00141778|50045231|FG002|Started Study Medication|Withdrawal by Subject|0|||
24954234|NCT00141778|50045229|FG000|Started Study Medication|Difficulty Swallowing|0|||
24954235|NCT00141778|50045230|FG001|Started Study Medication|Difficulty Swallowing|1|||
24954236|NCT00141778|50045231|FG002|Started Study Medication|Difficulty Swallowing|0|||
24954237|NCT00141778|50045229|FG000|Started Study Medication|Chest Discomfort|0|||
24954238|NCT00141778|50045230|FG001|Started Study Medication|Chest Discomfort|0|||
24954239|NCT00141778|50045231|FG002|Started Study Medication|Chest Discomfort|1|||
24954240|NCT00127660|50045243|FG000|Overall Study|Protocol Violation|3|||
24954241|NCT00127660|50045244|FG001|Overall Study|Protocol Violation|3|||
24954242|NCT00127660|50045245|FG002|Overall Study|Protocol Violation|5|||
24954243|NCT00127660|50045246|FG003|Overall Study|Protocol Violation|0|||
24954244|NCT03817528|50045256|FG000|Overall Study|Withdrawal by Subject|1|||
25041075|NCT02564900|50142344|FG004|Dose Expansion|Adverse Event|0|||
25041076|NCT02564900|50142345|FG005|Dose Expansion|Adverse Event|0|||
25041077|NCT02564900|50142346|FG006|Dose Expansion|Adverse Event|9|||
25041078|NCT02564900|50142347|FG007|Dose Expansion|Adverse Event|22|||
25041079|NCT02564900|50142348|FG008|Dose Expansion|Adverse Event|0|||
25041080|NCT02564900|50142349|FG009|Dose Expansion|Adverse Event|11|||
25041081|NCT02564900|50142350|FG010|Dose Expansion|Adverse Event|0|||
25041082|NCT02564900|50142351|FG011|Dose Expansion|Adverse Event|5|||
25041083|NCT02564900|50142352|FG012|Dose Expansion|Adverse Event|2|||
25041084|NCT02564900|50142353|FG013|Dose Expansion|Adverse Event|2|||
25041085|NCT02564900|50142354|FG014|Dose Expansion|Adverse Event|1|||
25041086|NCT02564900|50142340|FG000|Dose Expansion|Ongoing|0|||
25041087|NCT02564900|50142341|FG001|Dose Expansion|Ongoing|0|||
25041088|NCT02564900|50142342|FG002|Dose Expansion|Ongoing|0|||
25041089|NCT02564900|50142343|FG003|Dose Expansion|Ongoing|0|||
25041090|NCT02564900|50142344|FG004|Dose Expansion|Ongoing|0|||
25041091|NCT02564900|50142345|FG005|Dose Expansion|Ongoing|0|||
25041092|NCT02564900|50142346|FG006|Dose Expansion|Ongoing|9|||
25041093|NCT02564900|50142347|FG007|Dose Expansion|Ongoing|10|||
25041094|NCT02564900|50142348|FG008|Dose Expansion|Ongoing|11|||
25041095|NCT02564900|50142349|FG009|Dose Expansion|Ongoing|3|||
25041096|NCT02564900|50142350|FG010|Dose Expansion|Ongoing|0|||
25041097|NCT02564900|50142351|FG011|Dose Expansion|Ongoing|0|||
25041098|NCT02564900|50142352|FG012|Dose Expansion|Ongoing|4|||
25041099|NCT02564900|50142353|FG013|Dose Expansion|Ongoing|0|||
25041100|NCT02564900|50142354|FG014|Dose Expansion|Ongoing|6|||
25041101|NCT02564900|50142340|FG000|Dose Expansion|Death|0|||
24954245|NCT03817528|50045256|FG000|Overall Study|Adverse Event|2|||
24954246|NCT00115336|50045262|FG000|Overall Study|Hospital discharge before study drug|0|||
24954247|NCT00115336|50045263|FG001|Overall Study|Hospital discharge before study drug|1|||
24954248|NCT00205803|50045273|FG000|Infant Series|Lost to Follow-up|10|||
24954249|NCT00205803|50045274|FG001|Infant Series|Lost to Follow-up|4|||
24954250|NCT00205803|50045273|FG000|Infant Series|Withdrawal by Subject|2|||
24954251|NCT00205803|50045274|FG001|Infant Series|Withdrawal by Subject|5|||
24954252|NCT00205803|50045273|FG000|Infant Series|Physician Decision|3|||
25041102|NCT02564900|50142341|FG001|Dose Expansion|Death|0|||
25041103|NCT02564900|50142342|FG002|Dose Expansion|Death|0|||
25041104|NCT02564900|50142343|FG003|Dose Expansion|Death|0|||
24954253|NCT00205803|50045274|FG001|Infant Series|Physician Decision|1|||
24954254|NCT00205803|50045273|FG000|Infant Series|Protocol Violation|1|||
24954255|NCT00205803|50045274|FG001|Infant Series|Protocol Violation|0|||
24954256|NCT00205803|50045273|FG000|Infant Series|Lost Kaiser coverage|0|||
24954257|NCT00205803|50045274|FG001|Infant Series|Lost Kaiser coverage|1|||
24954258|NCT00205803|50045273|FG000|Infant Series|Non-compliant|1|||
24954259|NCT00205803|50045274|FG001|Infant Series|Non-compliant|0|||
24954260|NCT00205803|50045273|FG000|Infant Series|Sponsor request|1|||
25041105|NCT02564900|50142344|FG004|Dose Expansion|Death|0|||
25041106|NCT02564900|50142345|FG005|Dose Expansion|Death|0|||
25041107|NCT02564900|50142346|FG006|Dose Expansion|Death|1|||
25041108|NCT02564900|50142347|FG007|Dose Expansion|Death|0|||
25041109|NCT02564900|50142348|FG008|Dose Expansion|Death|0|||
24954261|NCT00205803|50045274|FG001|Infant Series|Sponsor request|0|||
24954262|NCT00205803|50045273|FG000|After Infant Series|Adverse Event|1|||
24954263|NCT00205803|50045274|FG001|After Infant Series|Adverse Event|1|||
24954264|NCT00205803|50045273|FG000|After Infant Series|Protocol Violation|1|||
25041110|NCT02564900|50142349|FG009|Dose Expansion|Death|0|||
25041111|NCT02564900|50142350|FG010|Dose Expansion|Death|1|||
25041112|NCT02564900|50142351|FG011|Dose Expansion|Death|0|||
24954265|NCT00205803|50045274|FG001|After Infant Series|Protocol Violation|1|||
24954266|NCT00205803|50045273|FG000|After Infant Series|Lost to Follow-up|2|||
24954267|NCT00205803|50045274|FG001|After Infant Series|Lost to Follow-up|1|||
25041113|NCT02564900|50142352|FG012|Dose Expansion|Death|1|||
25041114|NCT02564900|50142353|FG013|Dose Expansion|Death|1|||
25041115|NCT02564900|50142354|FG014|Dose Expansion|Death|0|||
25041116|NCT02564900|50142340|FG000|Dose Expansion|Withdrawal by Subject|0|||
25041117|NCT02564900|50142341|FG001|Dose Expansion|Withdrawal by Subject|0|||
25041118|NCT02564900|50142342|FG002|Dose Expansion|Withdrawal by Subject|0|||
25041119|NCT02564900|50142343|FG003|Dose Expansion|Withdrawal by Subject|0|||
25041120|NCT02564900|50142344|FG004|Dose Expansion|Withdrawal by Subject|0|||
25041121|NCT02564900|50142345|FG005|Dose Expansion|Withdrawal by Subject|0|||
25041122|NCT02564900|50142346|FG006|Dose Expansion|Withdrawal by Subject|4|||
25041123|NCT02564900|50142347|FG007|Dose Expansion|Withdrawal by Subject|0|||
24954268|NCT00205803|50045273|FG000|After Infant Series|Physician Decision|3|||
24954269|NCT00205803|50045274|FG001|After Infant Series|Physician Decision|2|||
25041124|NCT02564900|50142348|FG008|Dose Expansion|Withdrawal by Subject|0|||
25041125|NCT02564900|50142349|FG009|Dose Expansion|Withdrawal by Subject|0|||
25041126|NCT02564900|50142350|FG010|Dose Expansion|Withdrawal by Subject|1|||
25041127|NCT02564900|50142351|FG011|Dose Expansion|Withdrawal by Subject|0|||
25041128|NCT02564900|50142352|FG012|Dose Expansion|Withdrawal by Subject|0|||
25041129|NCT02564900|50142353|FG013|Dose Expansion|Withdrawal by Subject|1|||
25041130|NCT02564900|50142354|FG014|Dose Expansion|Withdrawal by Subject|1|||
25041131|NCT02564900|50142340|FG000|Dose Expansion|Other|0|||
24954270|NCT00205803|50045273|FG000|After Infant Series|Withdrawal by Subject|1|||
24954271|NCT00205803|50045274|FG001|After Infant Series|Withdrawal by Subject|4|||
24954272|NCT00205803|50045273|FG000|After Infant Series|Other|10|||
24954273|NCT00205803|50045274|FG001|After Infant Series|Other|4|||
24954274|NCT00205803|50045273|FG000|Toddler Dose|Lost to Follow-up|2|||
24954275|NCT00205803|50045274|FG001|Toddler Dose|Lost to Follow-up|3|||
24954276|NCT00127192|50045303|FG000|Overall Study|Adverse Event|0|||
24954277|NCT00127192|50045304|FG001|Overall Study|Adverse Event|1|||
24954278|NCT00127192|50045305|FG002|Overall Study|Adverse Event|1|||
24954279|NCT00127192|50045306|FG003|Overall Study|Adverse Event|1|||
24954280|NCT00127192|50045307|FG004|Overall Study|Adverse Event|0|||
24954281|NCT00127192|50045303|FG000|Overall Study|Lack of Efficacy|2|||
24954282|NCT00127192|50045304|FG001|Overall Study|Lack of Efficacy|0|||
24954283|NCT00127192|50045305|FG002|Overall Study|Lack of Efficacy|0|||
25041132|NCT02564900|50142341|FG001|Dose Expansion|Other|0|||
25041133|NCT02564900|50142342|FG002|Dose Expansion|Other|0|||
25041134|NCT02564900|50142343|FG003|Dose Expansion|Other|0|||
25041135|NCT02564900|50142344|FG004|Dose Expansion|Other|0|||
25041136|NCT02564900|50142345|FG005|Dose Expansion|Other|0|||
24954284|NCT00127192|50045306|FG003|Overall Study|Lack of Efficacy|0|||
24954285|NCT00127192|50045307|FG004|Overall Study|Lack of Efficacy|2|||
24954286|NCT00127192|50045303|FG000|Overall Study|Withdrawal by Subject|0|||
24954287|NCT00127192|50045304|FG001|Overall Study|Withdrawal by Subject|0|||
24954288|NCT00127192|50045305|FG002|Overall Study|Withdrawal by Subject|1|||
24954289|NCT00127192|50045306|FG003|Overall Study|Withdrawal by Subject|0|||
24954290|NCT00127192|50045307|FG004|Overall Study|Withdrawal by Subject|3|||
24954291|NCT00127192|50045303|FG000|Overall Study|Adverse event in pre-treatment period|1|||
24954292|NCT00127192|50045304|FG001|Overall Study|Adverse event in pre-treatment period|0|||
24954293|NCT00127192|50045305|FG002|Overall Study|Adverse event in pre-treatment period|0|||
24954294|NCT00127192|50045306|FG003|Overall Study|Adverse event in pre-treatment period|0|||
24954295|NCT00127192|50045307|FG004|Overall Study|Adverse event in pre-treatment period|0|||
24954296|NCT00205179|50045321|FG000|Overall Study|Death|0|||
24954297|NCT00205179|50045322|FG001|Overall Study|Death|2|||
24954298|NCT00205179|50045321|FG000|Overall Study|Physician Decision|1|||
24954299|NCT00205179|50045322|FG001|Overall Study|Physician Decision|1|||
24954300|NCT00205179|50045321|FG000|Overall Study|Adverse Event|1|||
24954301|NCT00205179|50045322|FG001|Overall Study|Adverse Event|1|||
24954302|NCT00127036|50045331|FG000|Overall Study|Insufficient Data for Analysis|6|||
24954303|NCT00127036|50045332|FG001|Overall Study|Insufficient Data for Analysis|11|||
24954304|NCT00127036|50045331|FG000|Overall Study|Screen Failure|2|||
24954305|NCT00127036|50045332|FG001|Overall Study|Screen Failure|0|||
24954306|NCT00259857|50045340|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
24954307|NCT00259857|50045341|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
24954308|NCT00259857|50045340|FG000|24 Months Treatment|Lost to Follow-up|0|||
24954309|NCT00259857|50045341|FG001|24 Months Treatment|Lost to Follow-up|3|||
24954310|NCT00203307|50045349|FG000|First Intervention|Adverse Event|2|||
24954311|NCT00203307|50045350|FG001|First Intervention|Adverse Event|0|||
25160219|NCT01386645|50280329|FG002|Overall Study|Physician Decision|1|||
25160220|NCT01386645|50280327|FG000|Overall Study|Withdrawal by Subject|0|||
25160221|NCT01386645|50280328|FG001|Overall Study|Withdrawal by Subject|1|||
25160222|NCT01386645|50280329|FG002|Overall Study|Withdrawal by Subject|1|||
25160223|NCT01387269|50280339|FG000|Overall Study|Death|38|||
25186331|NCT01399619|50336289|FG001|Overall Study|Withdrawal by Subject|0|||
25186332|NCT01399619|50336290|FG002|Overall Study|Withdrawal by Subject|3|||
25186333|NCT01399619|50336291|FG003|Overall Study|Withdrawal by Subject|4|||
25186334|NCT01399619|50336288|FG000|Overall Study|Protocol Violation|0|||
25186335|NCT01399619|50336289|FG001|Overall Study|Protocol Violation|0|||
25186336|NCT01399619|50336290|FG002|Overall Study|Protocol Violation|0|||
25186337|NCT01399619|50336291|FG003|Overall Study|Protocol Violation|1|||
25186338|NCT01399619|50336288|FG000|Overall Study|Not treated|0|||
25186339|NCT01399619|50336289|FG001|Overall Study|Not treated|0|||
25186340|NCT01399619|50336290|FG002|Overall Study|Not treated|0|||
25186341|NCT01399619|50336291|FG003|Overall Study|Not treated|2|||
25186342|NCT01496456|50336306|FG000|Overall Study|Protocol Violation|1|||
25186343|NCT01496456|50336306|FG000|Overall Study|Lost to Follow-up|7|||
25186344|NCT04999111|50336469|FG000|Overall Study|Lost to Follow-up|0|||
25186345|NCT04999111|50336470|FG001|Overall Study|Lost to Follow-up|3|||
25186346|NCT04999111|50336471|FG002|Overall Study|Lost to Follow-up|1|||
25186347|NCT04999111|50336472|FG003|Overall Study|Lost to Follow-up|1|||
25186348|NCT04999111|50336473|FG004|Overall Study|Lost to Follow-up|1|||
25186349|NCT04999111|50336474|FG005|Overall Study|Lost to Follow-up|1|||
25186350|NCT04999111|50336469|FG000|Overall Study|Physician Decision|0|||
25186351|NCT04999111|50336470|FG001|Overall Study|Physician Decision|0|||
25186352|NCT04999111|50336471|FG002|Overall Study|Physician Decision|0|||
25186353|NCT04999111|50336472|FG003|Overall Study|Physician Decision|1|||
25186354|NCT04999111|50336473|FG004|Overall Study|Physician Decision|0|||
25186355|NCT04999111|50336474|FG005|Overall Study|Physician Decision|0|||
24954312|NCT00126568|50045356|FG000|Overall Study|Death|2|||
24954313|NCT00114634|50045361|FG000|Overall Study|failure to return forms|3|||
24954314|NCT00202839|50045369|FG000|Overall Study|Adverse Event|1|||
25160224|NCT01387269|50280340|FG001|Overall Study|Death|20|||
25160225|NCT01387269|50280339|FG000|Overall Study|Other|8|||
25160226|NCT01387269|50280340|FG001|Overall Study|Other|7|||
25160227|NCT01387269|50280339|FG000|Overall Study|Unrelated AE|12|||
25160228|NCT01387269|50280340|FG001|Overall Study|Unrelated AE|3|||
25186356|NCT04999111|50336469|FG000|Overall Study|Withdrawal by Subject|3|||
25186357|NCT04999111|50336470|FG001|Overall Study|Withdrawal by Subject|3|||
25186358|NCT04999111|50336471|FG002|Overall Study|Withdrawal by Subject|2|||
25186359|NCT04999111|50336472|FG003|Overall Study|Withdrawal by Subject|1|||
25186360|NCT04999111|50336473|FG004|Overall Study|Withdrawal by Subject|3|||
25186361|NCT04999111|50336474|FG005|Overall Study|Withdrawal by Subject|0|||
25186362|NCT04999111|50336469|FG000|Overall Study|Other|1|||
24954315|NCT00202839|50045370|FG001|Overall Study|Adverse Event|5|||
24954316|NCT00202839|50045369|FG000|Overall Study|Physician Decision|12|||
24954317|NCT00202839|50045370|FG001|Overall Study|Physician Decision|0|||
24954318|NCT00202839|50045369|FG000|Overall Study|Withdrawal by Subject|6|||
24954319|NCT00202839|50045370|FG001|Overall Study|Withdrawal by Subject|2|||
24954320|NCT00202839|50045369|FG000|Overall Study|Protocol Violation|2|||
24954321|NCT00202839|50045370|FG001|Overall Study|Protocol Violation|1|||
24954322|NCT00202839|50045369|FG000|Overall Study|Lost to Follow-up|3|||
24954323|NCT00202839|50045370|FG001|Overall Study|Lost to Follow-up|2|||
24954324|NCT00201201|50045378|FG000|Overall Study|Death|0|||
24954325|NCT00201201|50045379|FG001|Overall Study|Death|2|||
24954326|NCT00201201|50045378|FG000|Overall Study|Withdrawal by Subject|5|||
24954327|NCT00201201|50045379|FG001|Overall Study|Withdrawal by Subject|5|||
24954328|NCT00126490|50045385|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
24954329|NCT00346632|50045391|FG000|Overall Study|Progressive Disease|2|||
24954330|NCT00346632|50045392|FG001|Overall Study|Progressive Disease|2|||
24954331|NCT00346632|50045393|FG002|Overall Study|Progressive Disease|4|||
24954332|NCT00346632|50045394|FG003|Overall Study|Progressive Disease|3|||
24954333|NCT00346632|50045395|FG004|Overall Study|Progressive Disease|3|||
24954334|NCT00346632|50045396|FG005|Overall Study|Progressive Disease|1|||
24954335|NCT00346632|50045397|FG006|Overall Study|Progressive Disease|2|||
24954336|NCT00346632|50045398|FG007|Overall Study|Progressive Disease|2|||
24954337|NCT00346632|50045399|FG008|Overall Study|Progressive Disease|2|||
24954338|NCT00346632|50045400|FG009|Overall Study|Progressive Disease|2|||
24954339|NCT00346632|50045391|FG000|Overall Study|Adverse Event|0|||
24954340|NCT00346632|50045392|FG001|Overall Study|Adverse Event|0|||
24954341|NCT00346632|50045393|FG002|Overall Study|Adverse Event|0|||
24954342|NCT00346632|50045394|FG003|Overall Study|Adverse Event|0|||
24954343|NCT00346632|50045395|FG004|Overall Study|Adverse Event|1|||
24954344|NCT00346632|50045396|FG005|Overall Study|Adverse Event|1|||
24954345|NCT00346632|50045397|FG006|Overall Study|Adverse Event|1|||
25186363|NCT04999111|50336470|FG001|Overall Study|Other|1|||
24954346|NCT00346632|50045398|FG007|Overall Study|Adverse Event|0|||
24954347|NCT00346632|50045399|FG008|Overall Study|Adverse Event|0|||
24954348|NCT00346632|50045400|FG009|Overall Study|Adverse Event|0|||
24954349|NCT00346632|50045391|FG000|Overall Study|Death|0|||
24954350|NCT00346632|50045392|FG001|Overall Study|Death|0|||
24954351|NCT00346632|50045393|FG002|Overall Study|Death|1|||
24954352|NCT00346632|50045394|FG003|Overall Study|Death|0|||
24954353|NCT00346632|50045395|FG004|Overall Study|Death|0|||
24954354|NCT00346632|50045396|FG005|Overall Study|Death|0|||
24954355|NCT00346632|50045397|FG006|Overall Study|Death|0|||
24954356|NCT00346632|50045398|FG007|Overall Study|Death|0|||
24954357|NCT00346632|50045399|FG008|Overall Study|Death|0|||
24954358|NCT00346632|50045400|FG009|Overall Study|Death|0|||
24954359|NCT00346632|50045391|FG000|Overall Study|Protocol Violation|0|||
24954360|NCT00346632|50045392|FG001|Overall Study|Protocol Violation|0|||
24954361|NCT00346632|50045393|FG002|Overall Study|Protocol Violation|0|||
24954362|NCT00346632|50045394|FG003|Overall Study|Protocol Violation|0|||
24954363|NCT00346632|50045395|FG004|Overall Study|Protocol Violation|0|||
24954364|NCT00346632|50045396|FG005|Overall Study|Protocol Violation|0|||
24954365|NCT00346632|50045397|FG006|Overall Study|Protocol Violation|1|||
24954366|NCT00346632|50045398|FG007|Overall Study|Protocol Violation|0|||
24954367|NCT00346632|50045399|FG008|Overall Study|Protocol Violation|0|||
24954368|NCT00346632|50045400|FG009|Overall Study|Protocol Violation|0|||
24954369|NCT00346632|50045391|FG000|Overall Study|Withdrawal by Subject|0|||
24954370|NCT00346632|50045392|FG001|Overall Study|Withdrawal by Subject|0|||
24954371|NCT00346632|50045393|FG002|Overall Study|Withdrawal by Subject|0|||
25186364|NCT04999111|50336471|FG002|Overall Study|Other|1|||
25186365|NCT04999111|50336472|FG003|Overall Study|Other|0|||
25186366|NCT04999111|50336473|FG004|Overall Study|Other|0|||
25186367|NCT04999111|50336474|FG005|Overall Study|Other|0|||
25186368|NCT04999111|50336469|FG000|Overall Study|Ongoing|326|||
25186369|NCT04999111|50336470|FG001|Overall Study|Ongoing|321|||
24954372|NCT00346632|50045394|FG003|Overall Study|Withdrawal by Subject|0|||
24954373|NCT00346632|50045395|FG004|Overall Study|Withdrawal by Subject|0|||
24954374|NCT00346632|50045396|FG005|Overall Study|Withdrawal by Subject|0|||
24954375|NCT00346632|50045397|FG006|Overall Study|Withdrawal by Subject|1|||
24954376|NCT00346632|50045398|FG007|Overall Study|Withdrawal by Subject|0|||
24954377|NCT00346632|50045399|FG008|Overall Study|Withdrawal by Subject|0|||
24954378|NCT00346632|50045400|FG009|Overall Study|Withdrawal by Subject|0|||
24954379|NCT00346632|50045391|FG000|Overall Study|Switched to alternative treatment|0|||
24954380|NCT00346632|50045392|FG001|Overall Study|Switched to alternative treatment|0|||
24954381|NCT00346632|50045393|FG002|Overall Study|Switched to alternative treatment|1|||
24954382|NCT00346632|50045394|FG003|Overall Study|Switched to alternative treatment|0|||
24954383|NCT00346632|50045395|FG004|Overall Study|Switched to alternative treatment|0|||
24954384|NCT00346632|50045396|FG005|Overall Study|Switched to alternative treatment|0|||
24954385|NCT00346632|50045397|FG006|Overall Study|Switched to alternative treatment|0|||
24954386|NCT00346632|50045398|FG007|Overall Study|Switched to alternative treatment|0|||
24954387|NCT00346632|50045399|FG008|Overall Study|Switched to alternative treatment|0|||
24954388|NCT00346632|50045400|FG009|Overall Study|Switched to alternative treatment|0|||
24954389|NCT00346632|50045391|FG000|Overall Study|Not Stated|1|||
24954390|NCT00346632|50045392|FG001|Overall Study|Not Stated|1|||
25186370|NCT04999111|50336471|FG002|Overall Study|Ongoing|112|||
24954391|NCT00346632|50045393|FG002|Overall Study|Not Stated|0|||
24954392|NCT00346632|50045394|FG003|Overall Study|Not Stated|0|||
24954393|NCT00346632|50045395|FG004|Overall Study|Not Stated|0|||
24954394|NCT00346632|50045396|FG005|Overall Study|Not Stated|0|||
24954395|NCT00346632|50045397|FG006|Overall Study|Not Stated|0|||
25186371|NCT04999111|50336472|FG003|Overall Study|Ongoing|323|||
25186372|NCT04999111|50336473|FG004|Overall Study|Ongoing|322|||
24954396|NCT00346632|50045398|FG007|Overall Study|Not Stated|2|||
25186373|NCT04999111|50336474|FG005|Overall Study|Ongoing|105|||
25186374|NCT04999111|50336469|FG000|Overall Study|Randomized but not vaccinated|1|||
25186375|NCT04999111|50336470|FG001|Overall Study|Randomized but not vaccinated|2|||
25186376|NCT04999111|50336471|FG002|Overall Study|Randomized but not vaccinated|0|||
25186377|NCT04999111|50336472|FG003|Overall Study|Randomized but not vaccinated|3|||
25186378|NCT04999111|50336473|FG004|Overall Study|Randomized but not vaccinated|3|||
25186379|NCT04999111|50336474|FG005|Overall Study|Randomized but not vaccinated|0|||
25186380|NCT01673646|50336535|FG000|Overall Study|Adverse Event|2|||
25186381|NCT01673646|50336536|FG001|Overall Study|Adverse Event|1|||
25186382|NCT01673646|50336537|FG002|Overall Study|Adverse Event|1|||
25186383|NCT01673646|50336535|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25186384|NCT01673646|50336536|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
25186385|NCT01673646|50336537|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
25186386|NCT01673646|50336535|FG000|Overall Study|Condition no longer requires study drug|0|||
24954397|NCT00346632|50045399|FG008|Overall Study|Not Stated|2|||
24954398|NCT00346632|50045400|FG009|Overall Study|Not Stated|1|||
24954399|NCT00200967|50045464|FG000|First Treatment Period|Withdrawal by Subject|5|||
24954400|NCT00200967|50045465|FG001|First Treatment Period|Withdrawal by Subject|1|||
24954401|NCT00200967|50045464|FG000|First Treatment Period|Pregnancy|1|||
24954402|NCT00200967|50045465|FG001|First Treatment Period|Pregnancy|0|||
24954403|NCT00200967|50045464|FG000|Wash-out Period|Lost to Follow-up|0|||
24954404|NCT00200967|50045465|FG001|Wash-out Period|Lost to Follow-up|1|||
24954405|NCT00200967|50045464|FG000|Second Treatment Period|Withdrawal by Subject|1|||
24954406|NCT00200967|50045465|FG001|Second Treatment Period|Withdrawal by Subject|2|||
24954407|NCT00200967|50045464|FG000|Run-out Period|Lost to Follow-up|1|||
24954408|NCT00200967|50045465|FG001|Run-out Period|Lost to Follow-up|0|||
24954409|NCT00354432|50045475|FG000|Overall Study|Adverse Event|3|||
24954410|NCT00354432|50045476|FG001|Overall Study|Adverse Event|1|||
24954411|NCT00354432|50045477|FG002|Overall Study|Adverse Event|5|||
24954412|NCT00354432|50045478|FG003|Overall Study|Adverse Event|5|||
24954413|NCT00354432|50045475|FG000|Overall Study|Off/Toxicity|3|||
24954414|NCT00354432|50045476|FG001|Overall Study|Off/Toxicity|7|||
24954415|NCT00354432|50045477|FG002|Overall Study|Off/Toxicity|5|||
24954416|NCT00354432|50045478|FG003|Overall Study|Off/Toxicity|5|||
24954417|NCT00140140|50045491|FG000|Overall Study|Unacceptable toxicity|1|||
24954418|NCT00140140|50045492|FG001|Overall Study|Unacceptable toxicity|1|||
24954419|NCT00140140|50045493|FG002|Overall Study|Unacceptable toxicity|2|||
24954420|NCT00140140|50045491|FG000|Overall Study|Physician Decision|1|||
24954421|NCT00140140|50045492|FG001|Overall Study|Physician Decision|1|||
24954422|NCT00140140|50045493|FG002|Overall Study|Physician Decision|0|||
24954423|NCT00346398|50045502|FG000|Overall Study|Lost to Follow-up|3|||
24954424|NCT00346398|50045503|FG001|Overall Study|Lost to Follow-up|0|||
24954425|NCT00346398|50045502|FG000|Overall Study|Withdrawal by Subject|0|||
24954426|NCT00346398|50045503|FG001|Overall Study|Withdrawal by Subject|2|||
24954427|NCT00346164|50045513|FG000|Overall Study|Adverse Event|0|||
24954428|NCT00346164|50045514|FG001|Overall Study|Adverse Event|0|||
24954429|NCT00346164|50045515|FG002|Overall Study|Adverse Event|0|||
24954430|NCT00346164|50045516|FG003|Overall Study|Adverse Event|1|||
24954431|NCT00346164|50045513|FG000|Overall Study|Lack of Efficacy|0|||
24954432|NCT00346164|50045514|FG001|Overall Study|Lack of Efficacy|1|||
24954433|NCT00346164|50045515|FG002|Overall Study|Lack of Efficacy|7|||
25041137|NCT02564900|50142346|FG006|Dose Expansion|Other|1|||
25041138|NCT02564900|50142347|FG007|Dose Expansion|Other|0|||
25041139|NCT02564900|50142348|FG008|Dose Expansion|Other|1|||
25041140|NCT02564900|50142349|FG009|Dose Expansion|Other|0|||
25041141|NCT02564900|50142350|FG010|Dose Expansion|Other|0|||
25041142|NCT02564900|50142351|FG011|Dose Expansion|Other|0|||
25041143|NCT02564900|50142352|FG012|Dose Expansion|Other|0|||
25041144|NCT02564900|50142353|FG013|Dose Expansion|Other|0|||
25041145|NCT02564900|50142354|FG014|Dose Expansion|Other|1|||
25186387|NCT01673646|50336536|FG001|Overall Study|Condition no longer requires study drug|1|||
25186388|NCT01673646|50336537|FG002|Overall Study|Condition no longer requires study drug|0|||
25186389|NCT01673646|50336535|FG000|Overall Study|Withdrawal by Subject|0|||
25186390|NCT01673646|50336536|FG001|Overall Study|Withdrawal by Subject|2|||
25186391|NCT01673646|50336537|FG002|Overall Study|Withdrawal by Subject|2|||
25186392|NCT01673646|50336535|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
25186393|NCT01673646|50336536|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
25186394|NCT01673646|50336537|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
25186395|NCT02647944|50336577|FG000|Overall Study|Withdrawal by Subject|0|||
24954434|NCT00346164|50045516|FG003|Overall Study|Lack of Efficacy|25|||
24954435|NCT00346164|50045513|FG000|Overall Study|Physician Decision|0|||
24954436|NCT00346164|50045514|FG001|Overall Study|Physician Decision|1|||
24954437|NCT00346164|50045515|FG002|Overall Study|Physician Decision|2|||
24954438|NCT00346164|50045516|FG003|Overall Study|Physician Decision|27|||
24954439|NCT00346164|50045513|FG000|Overall Study|Protocol Violation|6|||
24954440|NCT00346164|50045514|FG001|Overall Study|Protocol Violation|2|||
25041146|NCT02564900|50142340|FG000|Dose Expansion|Did not receive treatment|0|||
25041147|NCT02564900|50142341|FG001|Dose Expansion|Did not receive treatment|0|||
25186396|NCT02647944|50336578|FG001|Overall Study|Withdrawal by Subject|3|||
25186397|NCT02647944|50336577|FG000|Overall Study|Adverse Event|2|||
25186398|NCT02647944|50336578|FG001|Overall Study|Adverse Event|0|||
25186399|NCT01397825|50336633|FG000|Overall Study|Progressive Disease|10|||
25186400|NCT01397825|50336634|FG001|Overall Study|Progressive Disease|3|||
25186401|NCT01397825|50336635|FG002|Overall Study|Progressive Disease|11|||
25186402|NCT01397825|50336636|FG003|Overall Study|Progressive Disease|1|||
25186403|NCT01397825|50336637|FG004|Overall Study|Progressive Disease|0|||
25186404|NCT01397825|50336633|FG000|Overall Study|Symptomatic Deterioration|2|||
25186405|NCT01397825|50336634|FG001|Overall Study|Symptomatic Deterioration|0|||
25186406|NCT01397825|50336635|FG002|Overall Study|Symptomatic Deterioration|4|||
25186407|NCT01397825|50336636|FG003|Overall Study|Symptomatic Deterioration|0|||
25186408|NCT01397825|50336637|FG004|Overall Study|Symptomatic Deterioration|0|||
25186409|NCT01397825|50336633|FG000|Overall Study|Adverse Event|0|||
25186410|NCT01397825|50336634|FG001|Overall Study|Adverse Event|1|||
25186411|NCT01397825|50336635|FG002|Overall Study|Adverse Event|5|||
25186412|NCT01397825|50336636|FG003|Overall Study|Adverse Event|1|||
25186413|NCT01397825|50336637|FG004|Overall Study|Adverse Event|0|||
25186414|NCT01397825|50336633|FG000|Overall Study|Withdrawal by Subject|1|||
25186415|NCT01397825|50336634|FG001|Overall Study|Withdrawal by Subject|0|||
25186416|NCT01397825|50336635|FG002|Overall Study|Withdrawal by Subject|5|||
25186417|NCT01397825|50336636|FG003|Overall Study|Withdrawal by Subject|1|||
25186418|NCT01397825|50336637|FG004|Overall Study|Withdrawal by Subject|0|||
24954441|NCT00346164|50045515|FG002|Overall Study|Protocol Violation|10|||
24954442|NCT00346164|50045516|FG003|Overall Study|Protocol Violation|4|||
24954443|NCT00346164|50045513|FG000|Overall Study|Withdrawal by Subject|0|||
24954444|NCT00346164|50045514|FG001|Overall Study|Withdrawal by Subject|0|||
24954445|NCT00346164|50045515|FG002|Overall Study|Withdrawal by Subject|2|||
24954446|NCT00346164|50045516|FG003|Overall Study|Withdrawal by Subject|0|||
24954447|NCT00346164|50045513|FG000|Overall Study|Ineligible|11|||
24954448|NCT00346164|50045514|FG001|Overall Study|Ineligible|2|||
24954449|NCT00346164|50045515|FG002|Overall Study|Ineligible|2|||
24954450|NCT00346164|50045516|FG003|Overall Study|Ineligible|23|||
24954451|NCT00346164|50045513|FG000|Overall Study|Refusal of further protocol therapy|0|||
24954452|NCT00346164|50045514|FG001|Overall Study|Refusal of further protocol therapy|1|||
24954453|NCT00346164|50045515|FG002|Overall Study|Refusal of further protocol therapy|3|||
24954454|NCT00346164|50045516|FG003|Overall Study|Refusal of further protocol therapy|15|||
24954455|NCT00346164|50045513|FG000|Overall Study|Inability to start week 16 tx on time|0|||
24954456|NCT00346164|50045514|FG001|Overall Study|Inability to start week 16 tx on time|0|||
24954457|NCT00346164|50045515|FG002|Overall Study|Inability to start week 16 tx on time|0|||
24954458|NCT00346164|50045516|FG003|Overall Study|Inability to start week 16 tx on time|11|||
24954459|NCT00114244|50045544|FG000|Overall Study|Adverse Event|2|||
24954460|NCT00114244|50045545|FG001|Overall Study|Adverse Event|5|||
24954461|NCT00114244|50045544|FG000|Overall Study|Withdrawal by Subject|0|||
24954462|NCT00114244|50045545|FG001|Overall Study|Withdrawal by Subject|2|||
24954463|NCT00138658|50045551|FG000|Overall Study|Adverse Event|23|||
24954464|NCT00138658|50045551|FG000|Overall Study|Death|1|||
24954465|NCT00138658|50045551|FG000|Overall Study|Disease Progression|21|||
24954466|NCT00138658|50045551|FG000|Overall Study|Physician Decision|11|||
24954467|NCT00138658|50045551|FG000|Overall Study|Withdrawal by Subject|5|||
24954468|NCT00337662|50045560|FG000|Study Period II|Lost to Follow-up|0|||
24954469|NCT00337662|50045561|FG001|Study Period II|Lost to Follow-up|0|||
24954470|NCT00337662|50045562|FG002|Study Period II|Lost to Follow-up|0|||
24954471|NCT00337662|50045563|FG003|Study Period II|Lost to Follow-up|35|||
24954472|NCT00337662|50045560|FG000|Study Period II|Withdrawal by Subject|0|||
24954473|NCT00337662|50045561|FG001|Study Period II|Withdrawal by Subject|0|||
24954474|NCT00337662|50045562|FG002|Study Period II|Withdrawal by Subject|0|||
24954475|NCT00337662|50045563|FG003|Study Period II|Withdrawal by Subject|20|||
24954476|NCT00337662|50045560|FG000|Study Period II|Adverse Event|0|||
24954477|NCT00337662|50045561|FG001|Study Period II|Adverse Event|0|||
24954478|NCT00337662|50045562|FG002|Study Period II|Adverse Event|0|||
24954479|NCT00337662|50045563|FG003|Study Period II|Adverse Event|16|||
24954480|NCT00337662|50045560|FG000|Study Period II|Physician Decision|0|||
24954481|NCT00337662|50045561|FG001|Study Period II|Physician Decision|0|||
25041148|NCT02564900|50142342|FG002|Dose Expansion|Did not receive treatment|0|||
25041149|NCT02564900|50142343|FG003|Dose Expansion|Did not receive treatment|0|||
25041150|NCT02564900|50142344|FG004|Dose Expansion|Did not receive treatment|0|||
25186419|NCT01397747|50336660|FG000|Overall Study|Multitarget DNA test excluded|689|||
24954482|NCT00337662|50045562|FG002|Study Period II|Physician Decision|0|||
24954483|NCT00337662|50045563|FG003|Study Period II|Physician Decision|13|||
24954484|NCT00337662|50045560|FG000|Study Period II|Entry Criteria Not Met|0|||
24954485|NCT00337662|50045561|FG001|Study Period II|Entry Criteria Not Met|0|||
24954486|NCT00337662|50045562|FG002|Study Period II|Entry Criteria Not Met|0|||
24954487|NCT00337662|50045563|FG003|Study Period II|Entry Criteria Not Met|6|||
25186420|NCT01397747|50336660|FG000|Overall Study|Colonoscopy excluded|304|||
25186421|NCT01397747|50336660|FG000|Overall Study|FIT excluded|34|||
25186422|NCT01397201|50336698|FG000|Overall Study|Not treated|0|||
25186423|NCT01397201|50336699|FG001|Overall Study|Not treated|0|||
25186424|NCT01397201|50336700|FG002|Overall Study|Not treated|1|||
25186425|NCT01397201|50336701|FG003|Overall Study|Not treated|0|||
25186426|NCT01397201|50336702|FG004|Overall Study|Not treated|0|||
25186427|NCT01397201|50336698|FG000|Overall Study|Not yet defined|3|||
25186428|NCT01397201|50336699|FG001|Overall Study|Not yet defined|6|||
25186429|NCT01397201|50336700|FG002|Overall Study|Not yet defined|5|||
25186430|NCT01397201|50336701|FG003|Overall Study|Not yet defined|5|||
25186431|NCT01397201|50336702|FG004|Overall Study|Not yet defined|4|||
25186432|NCT01397201|50336698|FG000|Overall Study|Adverse Event|2|||
25186433|NCT01397201|50336699|FG001|Overall Study|Adverse Event|0|||
25186434|NCT01397201|50336700|FG002|Overall Study|Adverse Event|0|||
25186435|NCT01397201|50336701|FG003|Overall Study|Adverse Event|0|||
25186436|NCT01397201|50336702|FG004|Overall Study|Adverse Event|0|||
25186437|NCT01393613|50336736|FG000|Overall Study|Adverse Event|11|||
25276169|NCT00963820|50590164|FG010|Dose Escalation Phase|Progressive Disease|0|||
25276170|NCT00963820|50590165|FG011|Dose Escalation Phase|Progressive Disease|0|||
25276171|NCT00963820|50590154|FG000|Dose Escalation Phase|Adverse Event|0|||
25276172|NCT00963820|50590155|FG001|Dose Escalation Phase|Adverse Event|0|||
25276173|NCT00963820|50590156|FG002|Dose Escalation Phase|Adverse Event|0|||
25276174|NCT00963820|50590157|FG003|Dose Escalation Phase|Adverse Event|0|||
25276175|NCT00963820|50590158|FG004|Dose Escalation Phase|Adverse Event|0|||
25041151|NCT02564900|50142345|FG005|Dose Expansion|Did not receive treatment|0|||
25041152|NCT02564900|50142346|FG006|Dose Expansion|Did not receive treatment|1|||
25041153|NCT02564900|50142347|FG007|Dose Expansion|Did not receive treatment|1|||
25041154|NCT02564900|50142348|FG008|Dose Expansion|Did not receive treatment|0|||
25041155|NCT02564900|50142349|FG009|Dose Expansion|Did not receive treatment|0|||
25041156|NCT02564900|50142350|FG010|Dose Expansion|Did not receive treatment|0|||
25041157|NCT02564900|50142351|FG011|Dose Expansion|Did not receive treatment|0|||
25041158|NCT02564900|50142352|FG012|Dose Expansion|Did not receive treatment|0|||
25041159|NCT02564900|50142353|FG013|Dose Expansion|Did not receive treatment|0|||
25041160|NCT02564900|50142354|FG014|Dose Expansion|Did not receive treatment|1|||
25041161|NCT03364673|50142404|FG000|Overall Study|Withdrawal by Subject|2|||
25041162|NCT03364673|50142404|FG000|Overall Study|Injury unrelated to study|3|||
25041163|NCT03097289|50142408|FG000|Overall Study|Adverse Event|1|||
25041164|NCT03097289|50142408|FG000|Overall Study|Equipment failure|2|||
25041165|NCT03097289|50142408|FG000|Overall Study|Collected platelet product unusable|3|||
25041166|NCT02419742|50142430|FG000|Overall Study|Adverse Event|2|||
25041167|NCT02419742|50142431|FG001|Overall Study|Adverse Event|0|||
25041168|NCT02419742|50142430|FG000|Overall Study|Disease Progression|0|||
25041169|NCT02419742|50142431|FG001|Overall Study|Disease Progression|1|||
25276176|NCT00963820|50590159|FG005|Dose Escalation Phase|Adverse Event|0|||
25276177|NCT00963820|50590160|FG006|Dose Escalation Phase|Adverse Event|3|||
25276178|NCT00963820|50590161|FG007|Dose Escalation Phase|Adverse Event|1|||
25276179|NCT00963820|50590162|FG008|Dose Escalation Phase|Adverse Event|0|||
25276180|NCT00963820|50590163|FG009|Dose Escalation Phase|Adverse Event|0|||
25276181|NCT00963820|50590164|FG010|Dose Escalation Phase|Adverse Event|0|||
25276182|NCT00963820|50590165|FG011|Dose Escalation Phase|Adverse Event|0|||
25276183|NCT00963820|50590154|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
25276184|NCT00963820|50590155|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
25276185|NCT00963820|50590156|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
25276186|NCT00963820|50590157|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
25276187|NCT00963820|50590158|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
25276188|NCT00963820|50590159|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
25276189|NCT00963820|50590160|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
25276190|NCT00963820|50590161|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
25276191|NCT00963820|50590162|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
25041170|NCT02419742|50142430|FG000|Overall Study|Withdrew Consent|2|||
25041171|NCT02419742|50142431|FG001|Overall Study|Withdrew Consent|1|||
25041172|NCT02419742|50142430|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
25041173|NCT02419742|50142431|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
25160229|NCT01387269|50280339|FG000|Overall Study|Withdrawal by patient|32|||
25160230|NCT01387269|50280340|FG001|Overall Study|Withdrawal by patient|10|||
25160231|NCT01387269|50280339|FG000|Overall Study|Study drug-related AE|1|||
25160232|NCT01387269|50280340|FG001|Overall Study|Study drug-related AE|0|||
25160233|NCT01387269|50280339|FG000|Overall Study|Lost to Follow-up|1|||
25160234|NCT01387269|50280340|FG001|Overall Study|Lost to Follow-up|0|||
25160235|NCT01859143|50280348|FG000|Overall Study|Lost to Follow-up|2|||
25160236|NCT01859143|50280349|FG001|Overall Study|Lost to Follow-up|0|||
25186438|NCT01393613|50336737|FG001|Overall Study|Adverse Event|11|||
25186439|NCT01393613|50336738|FG002|Overall Study|Adverse Event|13|||
25041174|NCT02898077|50142439|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
25041175|NCT02898077|50142440|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
25160237|NCT01878253|50280356|FG000|Overall Study|Death|1|||
25186440|NCT01393613|50336739|FG003|Overall Study|Adverse Event|22|||
25041176|NCT02898077|50142439|FG000|Overall Study|Lost to Follow-up|4|||
25041177|NCT02898077|50142440|FG001|Overall Study|Lost to Follow-up|3|||
25041178|NCT02898077|50142439|FG000|Overall Study|Physician Decision|0|||
25041179|NCT02898077|50142440|FG001|Overall Study|Physician Decision|2|||
25041180|NCT02898077|50142439|FG000|Overall Study|Sponsor Decision|32|||
25041181|NCT02898077|50142440|FG001|Overall Study|Sponsor Decision|13|||
25041182|NCT02898077|50142439|FG000|Overall Study|Withdrawal by Subject|6|||
25041183|NCT02898077|50142440|FG001|Overall Study|Withdrawal by Subject|3|||
25186441|NCT01393613|50336736|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
25186442|NCT01393613|50336737|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
25041184|NCT02898077|50142439|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
25041185|NCT02898077|50142440|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
25041186|NCT02898077|50142439|FG000|Overall Study|Ended extension period|3|||
25041187|NCT02898077|50142440|FG001|Overall Study|Ended extension period|0|||
25041188|NCT03097133|50142448|FG000|Overall Study|Lost to Follow-up|3|||
25041189|NCT03097133|50142449|FG001|Overall Study|Lost to Follow-up|2|||
25041190|NCT03097133|50142448|FG000|Overall Study|Withdrawal by Subject|2|||
25041191|NCT03097133|50142449|FG001|Overall Study|Withdrawal by Subject|5|||
25041192|NCT03097133|50142448|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
25041193|NCT03097133|50142449|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
25041194|NCT03097133|50142448|FG000|Overall Study|Other|3|||
25041195|NCT03097133|50142449|FG001|Overall Study|Other|2|||
25041196|NCT03097133|50142448|FG000|Overall Study|Adverse Event|1|||
25041197|NCT03097133|50142449|FG001|Overall Study|Adverse Event|0|||
25041198|NCT03889639|50142463|FG000|Overall Study|Withdrawal by Subject|0|||
25041199|NCT03889639|50142464|FG001|Overall Study|Withdrawal by Subject|0|||
25041200|NCT03889639|50142465|FG002|Overall Study|Withdrawal by Subject|0|||
25186443|NCT01393613|50336738|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
25186444|NCT01393613|50336739|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
25186445|NCT01393613|50336736|FG000|Overall Study|Physician Decision|2|||
25186446|NCT01393613|50336737|FG001|Overall Study|Physician Decision|0|||
25186447|NCT01393613|50336738|FG002|Overall Study|Physician Decision|0|||
25186448|NCT01393613|50336739|FG003|Overall Study|Physician Decision|1|||
25186449|NCT01393613|50336736|FG000|Overall Study|Withdrawal by Subject|15|||
25186450|NCT01393613|50336737|FG001|Overall Study|Withdrawal by Subject|25|||
25186451|NCT01393613|50336738|FG002|Overall Study|Withdrawal by Subject|23|||
25186452|NCT01393613|50336739|FG003|Overall Study|Withdrawal by Subject|21|||
25186453|NCT01393613|50336736|FG000|Overall Study|Protocol Deviation|2|||
25186454|NCT01393613|50336737|FG001|Overall Study|Protocol Deviation|1|||
25186455|NCT01393613|50336738|FG002|Overall Study|Protocol Deviation|0|||
25186456|NCT01393613|50336739|FG003|Overall Study|Protocol Deviation|0|||
25186457|NCT01393613|50336736|FG000|Overall Study|Lack of Efficacy|9|||
25186458|NCT01393613|50336737|FG001|Overall Study|Lack of Efficacy|20|||
25186459|NCT01393613|50336738|FG002|Overall Study|Lack of Efficacy|16|||
25186460|NCT01393613|50336739|FG003|Overall Study|Lack of Efficacy|21|||
25186461|NCT01396421|50336789|FG000|Overall Study|Lost to Follow-up|0|||
25186462|NCT01396421|50336790|FG001|Overall Study|Lost to Follow-up|0|||
24954488|NCT00337662|50045560|FG000|Study Period II|Protocol Violation|0|||
24954489|NCT00337662|50045561|FG001|Study Period II|Protocol Violation|0|||
24954490|NCT00337662|50045562|FG002|Study Period II|Protocol Violation|0|||
24954491|NCT00337662|50045563|FG003|Study Period II|Protocol Violation|6|||
24954492|NCT00337662|50045560|FG000|Study Period II|Lack of Efficacy|0|||
24954493|NCT00337662|50045561|FG001|Study Period II|Lack of Efficacy|0|||
24954494|NCT00337662|50045562|FG002|Study Period II|Lack of Efficacy|0|||
24954495|NCT00337662|50045563|FG003|Study Period II|Lack of Efficacy|7|||
24954496|NCT00337662|50045560|FG000|Study Period II|Sponsor Decision|0|||
24954497|NCT00337662|50045561|FG001|Study Period II|Sponsor Decision|0|||
24954498|NCT00337662|50045562|FG002|Study Period II|Sponsor Decision|0|||
24954499|NCT00337662|50045563|FG003|Study Period II|Sponsor Decision|2|||
24954500|NCT00337662|50045560|FG000|Study Period II|Parent/Caregiver Decision|0|||
24954501|NCT00337662|50045561|FG001|Study Period II|Parent/Caregiver Decision|0|||
24954502|NCT00337662|50045562|FG002|Study Period II|Parent/Caregiver Decision|0|||
24954503|NCT00337662|50045563|FG003|Study Period II|Parent/Caregiver Decision|1|||
24954504|NCT00337662|50045560|FG000|Study Period III|Lost to Follow-up|14|||
25041201|NCT03889639|50142466|FG003|Overall Study|Withdrawal by Subject|0|||
25041202|NCT03889639|50142467|FG004|Overall Study|Withdrawal by Subject|0|||
25186463|NCT01396421|50336791|FG002|Overall Study|Lost to Follow-up|0|||
25186464|NCT01396421|50336792|FG003|Overall Study|Lost to Follow-up|1|||
25186465|NCT01396421|50336789|FG000|Overall Study|Adverse Event|17|||
25186466|NCT01396421|50336790|FG001|Overall Study|Adverse Event|15|||
24954505|NCT00337662|50045561|FG001|Study Period III|Lost to Follow-up|16|||
24954506|NCT00337662|50045562|FG002|Study Period III|Lost to Follow-up|14|||
24954507|NCT00337662|50045563|FG003|Study Period III|Lost to Follow-up|0|||
24954508|NCT00337662|50045560|FG000|Study Period III|Withdrawal by Subject|18|||
24954509|NCT00337662|50045561|FG001|Study Period III|Withdrawal by Subject|14|||
24954510|NCT00337662|50045562|FG002|Study Period III|Withdrawal by Subject|12|||
24954511|NCT00337662|50045563|FG003|Study Period III|Withdrawal by Subject|0|||
24954512|NCT00337662|50045560|FG000|Study Period III|Adverse Event|9|||
24954513|NCT00337662|50045561|FG001|Study Period III|Adverse Event|10|||
24954514|NCT00337662|50045562|FG002|Study Period III|Adverse Event|8|||
24954515|NCT00337662|50045563|FG003|Study Period III|Adverse Event|0|||
24954516|NCT00337662|50045560|FG000|Study Period III|Protocol Violation|3|||
25186467|NCT01396421|50336791|FG002|Overall Study|Adverse Event|12|||
25186468|NCT01396421|50336792|FG003|Overall Study|Adverse Event|32|||
25186469|NCT01396421|50336789|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
25186470|NCT01396421|50336790|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
25186471|NCT01396421|50336791|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
25186472|NCT01396421|50336792|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
25186473|NCT01396421|50336789|FG000|Overall Study|Physician Decision|1|||
25186474|NCT01396421|50336790|FG001|Overall Study|Physician Decision|1|||
24954517|NCT00337662|50045561|FG001|Study Period III|Protocol Violation|8|||
24954518|NCT00337662|50045562|FG002|Study Period III|Protocol Violation|2|||
24954519|NCT00337662|50045563|FG003|Study Period III|Protocol Violation|0|||
24954520|NCT00337662|50045560|FG000|Study Period III|Physician Decision|6|||
24954521|NCT00337662|50045561|FG001|Study Period III|Physician Decision|5|||
24954522|NCT00337662|50045562|FG002|Study Period III|Physician Decision|0|||
24954523|NCT00337662|50045563|FG003|Study Period III|Physician Decision|0|||
24954524|NCT00337662|50045560|FG000|Study Period III|Entry Criteria Not Met|4|||
25186475|NCT01396421|50336791|FG002|Overall Study|Physician Decision|0|||
25186476|NCT01396421|50336792|FG003|Overall Study|Physician Decision|3|||
25186477|NCT01396421|50336789|FG000|Overall Study|Withdrawal by Subject|31|||
25186478|NCT01396421|50336790|FG001|Overall Study|Withdrawal by Subject|24|||
25186479|NCT01396421|50336791|FG002|Overall Study|Withdrawal by Subject|13|||
25186480|NCT01396421|50336792|FG003|Overall Study|Withdrawal by Subject|21|||
25186481|NCT01396421|50336789|FG000|Overall Study|Protocol Deviation|2|||
25186482|NCT01396421|50336790|FG001|Overall Study|Protocol Deviation|1|||
25186483|NCT01396421|50336791|FG002|Overall Study|Protocol Deviation|1|||
25186484|NCT01396421|50336792|FG003|Overall Study|Protocol Deviation|0|||
25186485|NCT01396421|50336789|FG000|Overall Study|Lack of Efficacy|7|||
25186486|NCT01396421|50336790|FG001|Overall Study|Lack of Efficacy|17|||
25186487|NCT01396421|50336791|FG002|Overall Study|Lack of Efficacy|7|||
25186488|NCT01396421|50336792|FG003|Overall Study|Lack of Efficacy|18|||
25186489|NCT01396265|50336850|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
25186490|NCT02647866|50336895|FG000|Overall Study|Adverse Event|0|||
25186491|NCT02647866|50336896|FG001|Overall Study|Adverse Event|0|||
25186492|NCT02647866|50336897|FG002|Overall Study|Adverse Event|2|||
25186493|NCT02647866|50336898|FG003|Overall Study|Adverse Event|2|||
25186494|NCT02647866|50336899|FG004|Overall Study|Adverse Event|1|||
25186495|NCT02647866|50336895|FG000|Overall Study|Disease Worsening|3|||
25186496|NCT02647866|50336896|FG001|Overall Study|Disease Worsening|1|||
25186497|NCT02647866|50336897|FG002|Overall Study|Disease Worsening|0|||
25186498|NCT02647866|50336898|FG003|Overall Study|Disease Worsening|0|||
25186499|NCT02647866|50336899|FG004|Overall Study|Disease Worsening|1|||
25186500|NCT02647866|50336895|FG000|Overall Study|Withdrawal by Subject|1|||
24954525|NCT00337662|50045561|FG001|Study Period III|Entry Criteria Not Met|1|||
24954526|NCT00337662|50045562|FG002|Study Period III|Entry Criteria Not Met|3|||
24954527|NCT00337662|50045563|FG003|Study Period III|Entry Criteria Not Met|0|||
24954528|NCT00337662|50045560|FG000|Study Period III|Lack of Efficacy|4|||
24954529|NCT00337662|50045561|FG001|Study Period III|Lack of Efficacy|4|||
24954530|NCT00337662|50045562|FG002|Study Period III|Lack of Efficacy|2|||
24954531|NCT00337662|50045563|FG003|Study Period III|Lack of Efficacy|0|||
24954532|NCT00337662|50045560|FG000|Study Period III|Parent/Caregiver Decision|0|||
24954533|NCT00337662|50045561|FG001|Study Period III|Parent/Caregiver Decision|0|||
24954534|NCT00337662|50045562|FG002|Study Period III|Parent/Caregiver Decision|2|||
24954535|NCT00337662|50045563|FG003|Study Period III|Parent/Caregiver Decision|0|||
24954536|NCT00337662|50045560|FG000|Study Period III|Sponsor Decision|1|||
24954537|NCT00337662|50045561|FG001|Study Period III|Sponsor Decision|0|||
24954538|NCT00337662|50045562|FG002|Study Period III|Sponsor Decision|1|||
25160238|NCT01878253|50280356|FG000|Overall Study|SIdus System Removal|3|||
25160239|NCT01878253|50280356|FG000|Overall Study|Withdrawal by Subject|1|||
25160240|NCT01878253|50280356|FG000|Overall Study|Lost to Follow-up|2|||
24954539|NCT00337662|50045563|FG003|Study Period III|Sponsor Decision|0|||
24954540|NCT00337662|50045560|FG000|Study Period III|Clinical Relapse|1|||
25160241|NCT01878253|50280356|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
25160242|NCT01878175|50280365|FG000|Overall Study|Developed contraindicated health problem|2|||
25160243|NCT01878097|50280372|FG000|Baseline|Surveys not fully completed|2497|||
25160244|NCT01878097|50280373|FG001|Baseline|Surveys not fully completed|1800|||
25160245|NCT01878097|50280372|FG000|Implementation Year 1|Surveys not fully completed|3202|||
24954541|NCT00337662|50045561|FG001|Study Period III|Clinical Relapse|0|||
24954542|NCT00337662|50045562|FG002|Study Period III|Clinical Relapse|0|||
24954543|NCT00337662|50045563|FG003|Study Period III|Clinical Relapse|0|||
24954544|NCT00138424|50045578|FG000|Overall Study|Physician Decision|0|||
24954545|NCT00138424|50045579|FG001|Overall Study|Physician Decision|1|||
24954546|NCT00138424|50045580|FG002|Overall Study|Physician Decision|0|||
24954547|NCT00138424|50045581|FG003|Overall Study|Physician Decision|0|||
24954548|NCT00368966|50045595|FG000|Infant Series|Withdrawal by Subject|11|||
24954549|NCT00368966|50045596|FG001|Infant Series|Withdrawal by Subject|6|||
24954550|NCT00368966|50045595|FG000|Infant Series|Protocol Violation|2|||
24954551|NCT00368966|50045596|FG001|Infant Series|Protocol Violation|1|||
24954552|NCT00368966|50045595|FG000|Infant Series|Lost to Follow-up|2|||
24954553|NCT00368966|50045596|FG001|Infant Series|Lost to Follow-up|0|||
24954554|NCT00368966|50045595|FG000|Infant Series|Randomization error|0|||
24954555|NCT00368966|50045596|FG001|Infant Series|Randomization error|1|||
24954556|NCT00368966|50045595|FG000|Infant Series|Failed to meet eligibility criteria|0|||
24954557|NCT00368966|50045596|FG001|Infant Series|Failed to meet eligibility criteria|1|||
24954558|NCT00368966|50045595|FG000|Infant Series|Adverse Event|0|||
24954559|NCT00368966|50045596|FG001|Infant Series|Adverse Event|1|||
24954560|NCT00368966|50045595|FG000|Infant Series|Failed to return|1|||
24954561|NCT00368966|50045596|FG001|Infant Series|Failed to return|0|||
24954562|NCT00368966|50045595|FG000|After Infant|Failed to return|3|||
24954563|NCT00368966|50045596|FG001|After Infant|Failed to return|1|||
24954564|NCT00368966|50045595|FG000|After Infant|Adverse Event|1|||
24954565|NCT00368966|50045596|FG001|After Infant|Adverse Event|2|||
24954566|NCT00368966|50045595|FG000|After Infant|Withdrawal by Subject|1|||
24954567|NCT00368966|50045596|FG001|After Infant|Withdrawal by Subject|1|||
24954568|NCT00368966|50045595|FG000|After Infant|Death|1|||
24954569|NCT00368966|50045596|FG001|After Infant|Death|0|||
24954570|NCT00368966|50045595|FG000|After Infant|Lost to Follow-up|0|||
24954571|NCT00368966|50045596|FG001|After Infant|Lost to Follow-up|1|||
24954572|NCT00368966|50045595|FG000|Toddler Dose|Withdrawal by Subject|1|||
24954573|NCT00368966|50045596|FG001|Toddler Dose|Withdrawal by Subject|1|||
24954574|NCT00368966|50045595|FG000|Toddler Dose|Lost to Follow-up|0|||
24954575|NCT00368966|50045596|FG001|Toddler Dose|Lost to Follow-up|2|||
24954576|NCT00114166|50045629|FG000|Overall Study|Wrong primary|0|||
24954577|NCT00114166|50045630|FG001|Overall Study|Wrong primary|1|||
24954578|NCT00125242|50045640|FG000|Overall Study|did not qualify|7|||
24954579|NCT00125242|50045641|FG001|Overall Study|did not qualify|2|||
24954580|NCT00337428|50045648|FG000|Overall Study|Withdrawal by Subject|1|||
24954581|NCT00337428|50045649|FG001|Overall Study|Withdrawal by Subject|2|||
24954582|NCT00337428|50045648|FG000|Overall Study|Lack of Time|1|||
24954583|NCT00337428|50045649|FG001|Overall Study|Lack of Time|1|||
24954584|NCT00337428|50045648|FG000|Overall Study|Unwilling to Continue|1|||
24954585|NCT00337428|50045649|FG001|Overall Study|Unwilling to Continue|0|||
24954586|NCT00337428|50045648|FG000|Overall Study|Anorexia|1|||
24954587|NCT00337428|50045649|FG001|Overall Study|Anorexia|0|||
24954588|NCT00235989|50045659|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
24954589|NCT00235989|50045660|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
24954590|NCT00235989|50045661|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
24954591|NCT00235989|50045662|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
24954592|NCT00235989|50045663|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
24954593|NCT00235989|50045664|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
24954594|NCT00235989|50045659|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
24954595|NCT00235989|50045660|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
24954596|NCT00235989|50045661|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
24954597|NCT00235989|50045662|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
24954598|NCT00235989|50045663|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
24954599|NCT00235989|50045664|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
24954600|NCT00235989|50045659|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
24954601|NCT00235989|50045660|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
24954602|NCT00235989|50045661|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
24954603|NCT00235989|50045662|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
24954604|NCT00235989|50045663|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
24954605|NCT00235989|50045664|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
24954606|NCT00235989|50045659|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
24954607|NCT00235989|50045660|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
24954608|NCT00235989|50045661|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
24954609|NCT00235989|50045662|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
24954610|NCT00235989|50045663|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
24954611|NCT00235989|50045664|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
24954612|NCT00235989|50045659|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
24954613|NCT00235989|50045660|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
24954614|NCT00235989|50045661|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
24954615|NCT00235989|50045662|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
24954616|NCT00235989|50045663|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
24954617|NCT00235989|50045664|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
24954618|NCT00113386|50045676|FG000|Overall Study|Withdrawal by Subject|1|||
24954619|NCT00113386|50045677|FG001|Overall Study|Withdrawal by Subject|0|||
24954620|NCT00113386|50045676|FG000|Overall Study|Physician Decision|0|||
24954621|NCT00113386|50045677|FG001|Overall Study|Physician Decision|1|||
24954622|NCT00113386|50045676|FG000|Overall Study|Toxicity|3|||
24954623|NCT00113386|50045677|FG001|Overall Study|Toxicity|0|||
24954624|NCT00113386|50045676|FG000|Overall Study|Ineligible|1|||
24954625|NCT00113386|50045677|FG001|Overall Study|Ineligible|2|||
24954626|NCT00113386|50045676|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
24954627|NCT00113386|50045677|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
24954628|NCT00353262|50045683|FG000|Overall Study|Adverse Event|8|||
24954629|NCT00353262|50045683|FG000|Overall Study|Withdrawal by Subject|2|||
24954630|NCT00353262|50045683|FG000|Overall Study|Insufficient Therapeutic Response|13|||
24954631|NCT00353262|50045683|FG000|Overall Study|Progression|1|||
24954632|NCT00353262|50045683|FG000|Overall Study|Surgery|4|||
24954633|NCT00353262|50045683|FG000|Overall Study|Break from Chemotherapy|1|||
24954634|NCT00337272|50045689|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
24954635|NCT00337272|50045690|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
24954636|NCT00337272|50045689|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
24954637|NCT00337272|50045690|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
24954638|NCT00337272|50045689|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
24954639|NCT00337272|50045690|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
24954640|NCT00337272|50045689|FG000|Treatment Period|Non-compliance|1|||
24954641|NCT00337272|50045690|FG001|Treatment Period|Non-compliance|1|||
24954642|NCT00337272|50045689|FG000|Treatment Period|Withdrawal by Subject|0|||
24954643|NCT00337272|50045690|FG001|Treatment Period|Withdrawal by Subject|1|||
24954644|NCT00337272|50045689|FG000|Withdrawal Period|Non-compliance|0|||
24954645|NCT00337272|50045690|FG001|Withdrawal Period|Non-compliance|1|||
24954646|NCT00125164|50045700|FG000|Overall Study|Adverse Event|0|||
24954647|NCT00125164|50045701|FG001|Overall Study|Adverse Event|0|||
24954648|NCT00125164|50045702|FG002|Overall Study|Adverse Event|2|||
24954649|NCT00125164|50045703|FG003|Overall Study|Adverse Event|4|||
24954650|NCT00125164|50045700|FG000|Overall Study|Lost to Follow-up|0|||
24954651|NCT00125164|50045701|FG001|Overall Study|Lost to Follow-up|0|||
24954652|NCT00125164|50045702|FG002|Overall Study|Lost to Follow-up|1|||
24954653|NCT00125164|50045703|FG003|Overall Study|Lost to Follow-up|1|||
24954654|NCT00125164|50045700|FG000|Overall Study|Withdrawal by Subject|2|||
24954655|NCT00125164|50045701|FG001|Overall Study|Withdrawal by Subject|0|||
24954656|NCT00125164|50045702|FG002|Overall Study|Withdrawal by Subject|1|||
24954657|NCT00125164|50045703|FG003|Overall Study|Withdrawal by Subject|1|||
24954658|NCT00136318|50045715|FG000|Overall Study|Adverse Event|5|||
24954659|NCT00136318|50045716|FG001|Overall Study|Adverse Event|5|||
24954660|NCT00136318|50045715|FG000|Overall Study|Withdrawal by Subject|2|||
24954661|NCT00136318|50045716|FG001|Overall Study|Withdrawal by Subject|2|||
24954662|NCT00136084|50045725|FG000|Overall Study|Death|12|||
24954663|NCT00136084|50045726|FG001|Overall Study|Death|5|||
24954664|NCT00136084|50045725|FG000|Overall Study|Unacceptable toxicity|8|||
24954665|NCT00136084|50045726|FG001|Overall Study|Unacceptable toxicity|11|||
24954666|NCT00136084|50045725|FG000|Overall Study|Relapse|20|||
24954667|NCT00136084|50045726|FG001|Overall Study|Relapse|23|||
24954668|NCT00136084|50045725|FG000|Overall Study|Lost to Follow-up|2|||
24954669|NCT00136084|50045726|FG001|Overall Study|Lost to Follow-up|0|||
24954670|NCT00136084|50045725|FG000|Overall Study|No Response|1|||
24954671|NCT00136084|50045726|FG001|Overall Study|No Response|2|||
24954672|NCT00136084|50045725|FG000|Overall Study|Withdrawal by Subject|5|||
24954673|NCT00136084|50045726|FG001|Overall Study|Withdrawal by Subject|1|||
24954674|NCT00364832|50045747|FG000|Core Period|Early Withdrawals|2|||
24954675|NCT00364832|50045748|FG001|Core Period|Early Withdrawals|2|||
24954676|NCT00364832|50045749|FG002|Core Period|Early Withdrawals|1|||
24954677|NCT00364832|50045750|FG003|Core Period|Early Withdrawals|1|||
24954678|NCT00364832|50045751|FG004|Core Period|Early Withdrawals|0|||
24954679|NCT00364832|50045752|FG005|Core Period|Early Withdrawals|0|||
24954680|NCT00364832|50045753|FG006|Core Period|Early Withdrawals|4|||
24954681|NCT00364832|50045754|FG007|Core Period|Early Withdrawals|1|||
24954682|NCT00364832|50045755|FG008|Core Period|Early Withdrawals|0|||
24954683|NCT00364832|50045756|FG009|Core Period|Early Withdrawals|0|||
24954684|NCT00364832|50045757|FG010|Core Period|Early Withdrawals|0|||
24954685|NCT00364832|50045758|FG011|Core Period|Early Withdrawals|0|||
24954686|NCT00364832|50045747|FG000|Extension Year 1|Early Withdrawals|0|||
24954687|NCT00364832|50045748|FG001|Extension Year 1|Early Withdrawals|0|||
24954688|NCT00364832|50045749|FG002|Extension Year 1|Early Withdrawals|0|||
24954689|NCT00364832|50045750|FG003|Extension Year 1|Early Withdrawals|0|||
24954690|NCT00364832|50045751|FG004|Extension Year 1|Early Withdrawals|0|||
24954691|NCT00364832|50045752|FG005|Extension Year 1|Early Withdrawals|0|||
24954692|NCT00364832|50045753|FG006|Extension Year 1|Early Withdrawals|0|||
24954693|NCT00364832|50045754|FG007|Extension Year 1|Early Withdrawals|0|||
24954694|NCT00364832|50045755|FG008|Extension Year 1|Early Withdrawals|0|||
24954695|NCT00364832|50045756|FG009|Extension Year 1|Early Withdrawals|4|||
24954696|NCT00364832|50045757|FG010|Extension Year 1|Early Withdrawals|2|||
24954697|NCT00364832|50045758|FG011|Extension Year 1|Early Withdrawals|10|||
24954698|NCT00364832|50045747|FG000|Extension Year 2|Early Withdrawals|0|||
24954699|NCT00364832|50045748|FG001|Extension Year 2|Early Withdrawals|0|||
24954700|NCT00364832|50045749|FG002|Extension Year 2|Early Withdrawals|0|||
24954701|NCT00364832|50045750|FG003|Extension Year 2|Early Withdrawals|0|||
24954702|NCT00364832|50045751|FG004|Extension Year 2|Early Withdrawals|0|||
24954703|NCT00364832|50045752|FG005|Extension Year 2|Early Withdrawals|0|||
24954704|NCT00364832|50045753|FG006|Extension Year 2|Early Withdrawals|0|||
24954705|NCT00364832|50045754|FG007|Extension Year 2|Early Withdrawals|0|||
24954706|NCT00364832|50045755|FG008|Extension Year 2|Early Withdrawals|0|||
24954707|NCT00364832|50045756|FG009|Extension Year 2|Early Withdrawals|5|||
24954708|NCT00364832|50045757|FG010|Extension Year 2|Early Withdrawals|5|||
24954709|NCT00364832|50045758|FG011|Extension Year 2|Early Withdrawals|3|||
24954710|NCT00235755|50045778|FG000|4-Week Titration Phase|Adverse Event|6|||
24954711|NCT00235755|50045779|FG001|4-Week Titration Phase|Adverse Event|14|||
24954712|NCT00235755|50045780|FG002|4-Week Titration Phase|Adverse Event|20|||
24954713|NCT00235755|50045778|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
24954714|NCT00235755|50045779|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
24954715|NCT00235755|50045780|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
24954716|NCT00235755|50045778|FG000|4-Week Titration Phase|Protocol Violation|2|||
24954717|NCT00235755|50045779|FG001|4-Week Titration Phase|Protocol Violation|2|||
24954718|NCT00235755|50045780|FG002|4-Week Titration Phase|Protocol Violation|1|||
24954719|NCT00235755|50045778|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
24954720|NCT00235755|50045779|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
24954721|NCT00235755|50045780|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
24954722|NCT00235755|50045778|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
24954723|NCT00235755|50045779|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
24954724|NCT00235755|50045780|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
24954725|NCT00235755|50045778|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
24954726|NCT00235755|50045779|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
24954727|NCT00235755|50045780|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
24954728|NCT00235755|50045778|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
24954729|NCT00235755|50045779|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
24954730|NCT00235755|50045780|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
24954731|NCT00235755|50045778|FG000|12-Week Maintenance Phase|Adverse Event|8|||
24954732|NCT00235755|50045779|FG001|12-Week Maintenance Phase|Adverse Event|12|||
24954733|NCT00235755|50045780|FG002|12-Week Maintenance Phase|Adverse Event|26|||
24954734|NCT00235755|50045778|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
24954735|NCT00235755|50045779|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
24954736|NCT00235755|50045780|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
24954737|NCT00235755|50045778|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
24954738|NCT00235755|50045779|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
24954739|NCT00235755|50045780|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
24954740|NCT00235755|50045778|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
24954741|NCT00235755|50045779|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
24954742|NCT00235755|50045780|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
24954743|NCT00235755|50045778|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
24954744|NCT00235755|50045779|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
24954745|NCT00235755|50045780|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
24954746|NCT00235755|50045778|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
24954747|NCT00235755|50045779|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
24954748|NCT00235755|50045780|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
24954749|NCT00337194|50045805|FG000|Overall Study|Adverse Event|5|||
24954750|NCT00337194|50045806|FG001|Overall Study|Adverse Event|1|||
24954751|NCT00337194|50045805|FG000|Overall Study|Death|2|||
24954752|NCT00337194|50045806|FG001|Overall Study|Death|0|||
24954753|NCT00337194|50045805|FG000|Overall Study|Withdrawal by Subject|1|||
24954754|NCT00337194|50045806|FG001|Overall Study|Withdrawal by Subject|0|||
24954755|NCT00337194|50045805|FG000|Overall Study|Disease progression|1|||
24954756|NCT00337194|50045806|FG001|Overall Study|Disease progression|2|||
24954757|NCT00337194|50045805|FG000|Overall Study|Subsequent non-protocol therapy|3|||
24954758|NCT00337194|50045806|FG001|Overall Study|Subsequent non-protocol therapy|1|||
24954759|NCT03826914|50045816|FG000|Overall Study|Withdrawal by Subject|1|||
24954760|NCT03826914|50045817|FG001|Overall Study|Withdrawal by Subject|1|||
24954761|NCT00385736|50045828|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
24954762|NCT00385736|50045829|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
25160246|NCT01878097|50280373|FG001|Implementation Year 1|Surveys not fully completed|2549|||
24954763|NCT00385736|50045830|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
24954764|NCT00385736|50045828|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
24954765|NCT00385736|50045829|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
24954766|NCT00385736|50045830|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
24954767|NCT00385736|50045828|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
24954768|NCT00385736|50045829|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
24954769|NCT00385736|50045830|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
24954770|NCT00385736|50045828|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
24954771|NCT00385736|50045829|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
24954772|NCT00385736|50045830|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
24954773|NCT00385736|50045828|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
24954774|NCT00385736|50045829|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
24954775|NCT00385736|50045830|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
24954776|NCT00385736|50045828|FG000|Efficacy Analysis Set - Induction|Other|0|||
24954777|NCT00385736|50045829|FG001|Efficacy Analysis Set - Induction|Other|0|||
24954778|NCT00385736|50045830|FG002|Efficacy Analysis Set - Induction|Other|1|||
24954779|NCT00385736|50045828|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
24954780|NCT00385736|50045829|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
24954781|NCT00385736|50045830|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
24954782|NCT00385736|50045828|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
24954783|NCT00385736|50045829|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
24954784|NCT00385736|50045830|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
24954785|NCT00385736|50045828|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
24954786|NCT00385736|50045829|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
24954787|NCT00385736|50045830|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
24954788|NCT00385736|50045828|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
24954789|NCT00385736|50045829|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
24954790|NCT00385736|50045830|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
24954791|NCT00385736|50045828|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
24954792|NCT00385736|50045829|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
24954793|NCT00385736|50045830|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
24954794|NCT00385736|50045828|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
24954795|NCT00385736|50045829|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
24954796|NCT00385736|50045830|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
24954797|NCT00385736|50045828|FG000|Safety Analysis Set|Adverse Event|23|||
24954798|NCT00385736|50045829|FG001|Safety Analysis Set|Adverse Event|15|||
24954799|NCT00385736|50045830|FG002|Safety Analysis Set|Adverse Event|23|||
24954800|NCT00385736|50045828|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
24954801|NCT00385736|50045829|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
24954802|NCT00385736|50045830|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
24954803|NCT00385736|50045828|FG000|Safety Analysis Set|Lost to Follow-up|0|||
24954804|NCT00385736|50045829|FG001|Safety Analysis Set|Lost to Follow-up|2|||
24954805|NCT00385736|50045830|FG002|Safety Analysis Set|Lost to Follow-up|2|||
24954806|NCT00385736|50045828|FG000|Safety Analysis Set|Lack of Efficacy|38|||
24954807|NCT00385736|50045829|FG001|Safety Analysis Set|Lack of Efficacy|16|||
24954808|NCT00385736|50045830|FG002|Safety Analysis Set|Lack of Efficacy|31|||
24954809|NCT00385736|50045828|FG000|Safety Analysis Set|Protocol Violation|2|||
24954810|NCT00385736|50045829|FG001|Safety Analysis Set|Protocol Violation|1|||
24954811|NCT00385736|50045830|FG002|Safety Analysis Set|Protocol Violation|6|||
25160247|NCT01878097|50280372|FG000|Implementation Year 2|Surveys not fully completed|3281|||
24954812|NCT00385736|50045828|FG000|Safety Analysis Set|Other|1|||
24954813|NCT00385736|50045829|FG001|Safety Analysis Set|Other|4|||
24954814|NCT00385736|50045830|FG002|Safety Analysis Set|Other|4|||
24954815|NCT00195819|50045841|FG000|Double-Blind|Withdrawal by Subject|1|||
24954816|NCT00195819|50045842|FG001|Double-Blind|Withdrawal by Subject|0|||
24954817|NCT00195819|50045841|FG000|Double-Blind|Moved|1|||
24954818|NCT00195819|50045842|FG001|Double-Blind|Moved|0|||
24954819|NCT00195819|50045841|FG000|Open-label|Adverse Event|0|||
24954820|NCT00195819|50045842|FG001|Open-label|Adverse Event|9|||
24954821|NCT00195819|50045841|FG000|Open-label|Lack of Efficacy|0|||
24954822|NCT00195819|50045842|FG001|Open-label|Lack of Efficacy|2|||
24954823|NCT00195819|50045841|FG000|Open-label|Pregnancy|0|||
24954824|NCT00195819|50045842|FG001|Open-label|Pregnancy|1|||
24954825|NCT00195819|50045841|FG000|Open-label|Protocol Violation|0|||
24954826|NCT00195819|50045842|FG001|Open-label|Protocol Violation|2|||
24954827|NCT00195819|50045841|FG000|Open-label|Moved|0|||
24954828|NCT00195819|50045842|FG001|Open-label|Moved|1|||
24954829|NCT00195819|50045841|FG000|Open-label|Withdrawal by Subject|0|||
24954830|NCT00195819|50045842|FG001|Open-label|Withdrawal by Subject|5|||
24954831|NCT00527735|50045857|FG000|Overall Study|Disease progression|47|||
24954832|NCT00527735|50045858|FG001|Overall Study|Disease progression|61|||
24954833|NCT00527735|50045859|FG002|Overall Study|Disease progression|53|||
24954834|NCT00527735|50045857|FG000|Overall Study|Death|23|||
24954835|NCT00527735|50045858|FG001|Overall Study|Death|13|||
24954836|NCT00527735|50045859|FG002|Overall Study|Death|15|||
24954837|NCT00527735|50045857|FG000|Overall Study|Completed treatment in treatment phase|14|||
24954838|NCT00527735|50045858|FG001|Overall Study|Completed treatment in treatment phase|13|||
24954839|NCT00527735|50045859|FG002|Overall Study|Completed treatment in treatment phase|18|||
24954840|NCT00527735|50045857|FG000|Overall Study|Adverse Event|10|||
24954841|NCT00527735|50045858|FG001|Overall Study|Adverse Event|6|||
24954842|NCT00527735|50045859|FG002|Overall Study|Adverse Event|7|||
24954843|NCT00527735|50045857|FG000|Overall Study|Not identified|5|||
24954844|NCT00527735|50045858|FG001|Overall Study|Not identified|5|||
24954845|NCT00527735|50045859|FG002|Overall Study|Not identified|5|||
24954846|NCT00527735|50045857|FG000|Overall Study|Withdrawal by Subject|5|||
24954847|NCT00527735|50045858|FG001|Overall Study|Withdrawal by Subject|4|||
24954848|NCT00527735|50045859|FG002|Overall Study|Withdrawal by Subject|3|||
24954849|NCT00527735|50045857|FG000|Overall Study|No longer met study criteria|2|||
24954850|NCT00527735|50045858|FG001|Overall Study|No longer met study criteria|2|||
24954851|NCT00527735|50045859|FG002|Overall Study|No longer met study criteria|1|||
24954852|NCT00527735|50045857|FG000|Overall Study|Lost to Follow-up|0|||
24954853|NCT00527735|50045858|FG001|Overall Study|Lost to Follow-up|0|||
24954854|NCT00527735|50045859|FG002|Overall Study|Lost to Follow-up|3|||
24954855|NCT00527735|50045857|FG000|Overall Study|Poor compliance or noncompliance|0|||
24954856|NCT00527735|50045858|FG001|Overall Study|Poor compliance or noncompliance|1|||
25160248|NCT01878097|50280373|FG001|Implementation Year 2|Surveys not fully completed|2841|||
25160249|NCT01878097|50280372|FG000|Implementation Year 3|Surveys not fully completed|3494|||
25160250|NCT01878097|50280373|FG001|Implementation Year 3|Surveys not fully completed|2980|||
25160251|NCT01878097|50280372|FG000|Implementation Year 4|Surveys not fully completed|3604|||
25160252|NCT01878097|50280373|FG001|Implementation Year 4|Surveys not fully completed|3007|||
25160253|NCT01750190|50280381|FG000|Overall Study|Adverse Event|47|||
25160254|NCT01750190|50280382|FG001|Overall Study|Adverse Event|19|||
25160255|NCT01750190|50280381|FG000|Overall Study|Death|38|||
25160256|NCT01750190|50280382|FG001|Overall Study|Death|11|||
25160257|NCT01750190|50280381|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
25160258|NCT01750190|50280382|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
25160259|NCT01750190|50280381|FG000|Overall Study|Lost to Follow-up|28|||
25160260|NCT01750190|50280382|FG001|Overall Study|Lost to Follow-up|7|||
25160261|NCT01750190|50280381|FG000|Overall Study|Physician Decision|16|||
25160262|NCT01750190|50280382|FG001|Overall Study|Physician Decision|17|||
25160263|NCT01750190|50280381|FG000|Overall Study|Protocol Violation|6|||
25160264|NCT01750190|50280382|FG001|Overall Study|Protocol Violation|5|||
25160265|NCT01750190|50280381|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
25160266|NCT01750190|50280382|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
25160267|NCT01750190|50280381|FG000|Overall Study|Withdrawal by Subject|83|||
25160268|NCT01750190|50280382|FG001|Overall Study|Withdrawal by Subject|89|||
24954857|NCT00527735|50045859|FG002|Overall Study|Poor compliance or noncompliance|1|||
24954858|NCT00527735|50045857|FG000|Overall Study|Completed treatment during maintenance|2|||
24954859|NCT00527735|50045858|FG001|Overall Study|Completed treatment during maintenance|2|||
24954860|NCT00527735|50045859|FG002|Overall Study|Completed treatment during maintenance|1|||
24954861|NCT00336492|50045882|FG000|Overall Study|Adverse Event|4|||
25160269|NCT01750190|50280381|FG000|Overall Study|Kidney Transplant|8|||
25160270|NCT01750190|50280382|FG001|Overall Study|Kidney Transplant|4|||
25160271|NCT01750190|50280381|FG000|Overall Study|Dialysis|22|||
24954862|NCT00336492|50045883|FG001|Overall Study|Adverse Event|3|||
24954863|NCT00336492|50045884|FG002|Overall Study|Adverse Event|6|||
24954864|NCT00336492|50045882|FG000|Overall Study|Lack of Efficacy|6|||
24954865|NCT00336492|50045883|FG001|Overall Study|Lack of Efficacy|1|||
24954866|NCT00336492|50045884|FG002|Overall Study|Lack of Efficacy|4|||
24954867|NCT00336492|50045882|FG000|Overall Study|Other|5|||
24954868|NCT00336492|50045883|FG001|Overall Study|Other|0|||
24954869|NCT00336492|50045884|FG002|Overall Study|Other|1|||
25160272|NCT01750190|50280382|FG001|Overall Study|Dialysis|8|||
25160273|NCT01750190|50280381|FG000|Overall Study|Other than Specified|13|||
25160274|NCT01750190|50280382|FG001|Overall Study|Other than Specified|4|||
25160275|NCT01831765|50280391|FG000|Overall Study|Lack of Efficacy|1|||
25160276|NCT01831765|50280392|FG001|Overall Study|Lack of Efficacy|0|||
25160277|NCT01831765|50280393|FG002|Overall Study|Lack of Efficacy|0|||
24954870|NCT00194025|50045892|FG000|Overall Study|Adverse Event|1|||
24954871|NCT00194025|50045892|FG000|Overall Study|non-adherence with study medication|4|||
24954872|NCT00368108|50045899|FG000|Overall Study|Adverse Event|38|||
24954873|NCT00368108|50045900|FG001|Overall Study|Adverse Event|26|||
24954874|NCT00368108|50045901|FG002|Overall Study|Adverse Event|44|||
24954875|NCT00368108|50045899|FG000|Overall Study|Abnormal Laboratory Value|0|||
24954876|NCT00368108|50045900|FG001|Overall Study|Abnormal Laboratory Value|0|||
24954877|NCT00368108|50045901|FG002|Overall Study|Abnormal Laboratory Value|3|||
24954878|NCT00368108|50045899|FG000|Overall Study|Protocol Violation|5|||
24954879|NCT00368108|50045900|FG001|Overall Study|Protocol Violation|9|||
24954880|NCT00368108|50045901|FG002|Overall Study|Protocol Violation|9|||
24954881|NCT00368108|50045899|FG000|Overall Study|Withdrawal by Subject|9|||
24954882|NCT00368108|50045900|FG001|Overall Study|Withdrawal by Subject|3|||
24954883|NCT00368108|50045901|FG002|Overall Study|Withdrawal by Subject|5|||
24954884|NCT00368108|50045899|FG000|Overall Study|Lack of Efficacy|7|||
24954885|NCT00368108|50045900|FG001|Overall Study|Lack of Efficacy|8|||
24954886|NCT00368108|50045901|FG002|Overall Study|Lack of Efficacy|5|||
24954887|NCT00368108|50045899|FG000|Overall Study|Physician Decision|2|||
25041203|NCT03889639|50142468|FG005|Overall Study|Withdrawal by Subject|0|||
25041204|NCT03889639|50142469|FG006|Overall Study|Withdrawal by Subject|0|||
25041205|NCT03889639|50142470|FG007|Overall Study|Withdrawal by Subject|1|||
25041206|NCT03265145|50142493|FG000|Overall Study|Protocol Violation|2|||
25041207|NCT03265145|50142494|FG001|Overall Study|Protocol Violation|0|||
25041208|NCT03265145|50142493|FG000|Overall Study|Adverse Event|1|||
25041209|NCT03265145|50142494|FG001|Overall Study|Adverse Event|0|||
25041210|NCT03265145|50142493|FG000|Overall Study|Withdrawal by Subject|23|||
25041211|NCT03265145|50142494|FG001|Overall Study|Withdrawal by Subject|19|||
25041212|NCT03265145|50142493|FG000|Overall Study|Death|12|||
25041213|NCT03265145|50142494|FG001|Overall Study|Death|12|||
25041214|NCT03265145|50142493|FG000|Overall Study|Lost to Follow-up|13|||
25041215|NCT03265145|50142494|FG001|Overall Study|Lost to Follow-up|9|||
25041216|NCT03265145|50142493|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
25041217|NCT03265145|50142494|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
25041218|NCT03265145|50142493|FG000|Overall Study|Switched back to previous medication|1|||
25041219|NCT03265145|50142494|FG001|Overall Study|Switched back to previous medication|0|||
25041220|NCT03265145|50142493|FG000|Overall Study|Did not want to take medication|1|||
25041221|NCT03265145|50142494|FG001|Overall Study|Did not want to take medication|0|||
25041222|NCT03265145|50142493|FG000|Overall Study|Subject could not afford medication|0|||
25041223|NCT03265145|50142494|FG001|Overall Study|Subject could not afford medication|1|||
24954888|NCT00368108|50045900|FG001|Overall Study|Physician Decision|0|||
24954889|NCT00368108|50045901|FG002|Overall Study|Physician Decision|1|||
24954890|NCT00368108|50045899|FG000|Overall Study|Other|3|||
24954891|NCT00368108|50045900|FG001|Overall Study|Other|7|||
24954892|NCT00368108|50045901|FG002|Overall Study|Other|1|||
24954893|NCT00364130|50045911|FG000|Intervention Period|Lost to Follow-up|4|||
24954894|NCT00364130|50045912|FG001|Intervention Period|Lost to Follow-up|3|||
24954895|NCT00364130|50045911|FG000|Intervention Period|Pregnancy|1|||
24954896|NCT00364130|50045912|FG001|Intervention Period|Pregnancy|0|||
25041224|NCT03265145|50142493|FG000|Overall Study|Site closed|2|||
25041225|NCT03265145|50142494|FG001|Overall Study|Site closed|3|||
25160278|NCT01831765|50280391|FG000|Overall Study|Other, sponsor withdrew subject|0|||
24954897|NCT00364130|50045911|FG000|Intervention Period|Withdrawal by Subject|4|||
24954898|NCT00364130|50045912|FG001|Intervention Period|Withdrawal by Subject|5|||
24954899|NCT00364130|50045911|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
24954900|NCT00364130|50045912|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
25276192|NCT00963820|50590163|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
25276193|NCT00963820|50590164|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
25276194|NCT00963820|50590165|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
25276195|NCT00963820|50590154|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25276196|NCT00963820|50590155|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25276197|NCT00963820|50590156|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25276198|NCT00963820|50590157|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25276199|NCT00963820|50590158|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
24954901|NCT00521339|50045920|FG000|Treatment Phase|Adverse Event|2|||
24954902|NCT00521339|50045921|FG001|Treatment Phase|Adverse Event|0|||
24954903|NCT00521339|50045922|FG002|Treatment Phase|Adverse Event|0|||
25276200|NCT00963820|50590159|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
24954904|NCT00521339|50045920|FG000|Treatment Phase|Intolerability to study drug|2|||
24954905|NCT00521339|50045921|FG001|Treatment Phase|Intolerability to study drug|0|||
24954906|NCT00521339|50045922|FG002|Treatment Phase|Intolerability to study drug|0|||
24954907|NCT00521339|50045920|FG000|Treatment Phase|Lack of Efficacy|3|||
24954908|NCT00521339|50045921|FG001|Treatment Phase|Lack of Efficacy|0|||
24954909|NCT00521339|50045922|FG002|Treatment Phase|Lack of Efficacy|0|||
24954910|NCT00521339|50045920|FG000|Treatment Phase|Withdrawal by Subject|3|||
24954911|NCT00521339|50045921|FG001|Treatment Phase|Withdrawal by Subject|0|||
24954912|NCT00521339|50045922|FG002|Treatment Phase|Withdrawal by Subject|0|||
24954913|NCT00521339|50045920|FG000|Treatment Phase|Lost to Follow-up|1|||
24954914|NCT00521339|50045921|FG001|Treatment Phase|Lost to Follow-up|0|||
24954915|NCT00521339|50045922|FG002|Treatment Phase|Lost to Follow-up|0|||
24954916|NCT00521339|50045920|FG000|Treatment Phase|Protocol Violation|1|||
24954917|NCT00521339|50045921|FG001|Treatment Phase|Protocol Violation|0|||
24954918|NCT00521339|50045922|FG002|Treatment Phase|Protocol Violation|0|||
24954919|NCT00521339|50045920|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
24954920|NCT00521339|50045921|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
24954921|NCT00521339|50045922|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
24954922|NCT00521339|50045920|FG000|Treatment Extension Phase|Death|0|||
24954923|NCT00521339|50045921|FG001|Treatment Extension Phase|Death|0|||
24954924|NCT00521339|50045922|FG002|Treatment Extension Phase|Death|1|||
24954925|NCT00363896|50045945|FG000|Overall Study|Withdrawal by Subject|29|||
24954926|NCT00363896|50045946|FG001|Overall Study|Withdrawal by Subject|16|||
24954927|NCT00363896|50045945|FG000|Overall Study|Adverse Event|24|||
24954928|NCT00363896|50045946|FG001|Overall Study|Adverse Event|13|||
24954929|NCT00363896|50045945|FG000|Overall Study|COPD exacerbation|13|||
24954930|NCT00363896|50045946|FG001|Overall Study|COPD exacerbation|7|||
24954931|NCT00363896|50045945|FG000|Overall Study|Lack of Efficacy|12|||
24954932|NCT00363896|50045946|FG001|Overall Study|Lack of Efficacy|8|||
24954933|NCT00363896|50045945|FG000|Overall Study|Protocol Violation|6|||
24954934|NCT00363896|50045946|FG001|Overall Study|Protocol Violation|1|||
24954935|NCT00363896|50045945|FG000|Overall Study|Lost to Follow-up|3|||
24954936|NCT00363896|50045946|FG001|Overall Study|Lost to Follow-up|0|||
24954937|NCT00363896|50045945|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
24954938|NCT00363896|50045946|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
24954939|NCT00363896|50045945|FG000|Overall Study|Other|1|||
24954940|NCT00363896|50045946|FG001|Overall Study|Other|2|||
24954941|NCT00527423|50045955|FG000|Overall Study|Protocol Violation|1|||
24954942|NCT00527423|50045955|FG000|Overall Study|Adverse Event|5|||
24954943|NCT00527423|50045955|FG000|Overall Study|Physician Decision|4|||
24954944|NCT00527423|50045955|FG000|Overall Study|Withdrawal by Subject|10|||
24954945|NCT00527423|50045955|FG000|Overall Study|Lost to Follow-up|4|||
24954946|NCT00527423|50045955|FG000|Overall Study|OTHER|4|||
24954947|NCT00527423|50045955|FG000|Overall Study|Death|9|||
24954948|NCT00527111|50045963|FG000|Overall Study|Adverse Event|14|||
24954949|NCT00527111|50045964|FG001|Overall Study|Adverse Event|13|||
24954950|NCT00527111|50045963|FG000|Overall Study|Death|0|||
24954951|NCT00527111|50045964|FG001|Overall Study|Death|1|||
24954952|NCT00527111|50045963|FG000|Overall Study|Investigator Request|2|||
24954953|NCT00527111|50045964|FG001|Overall Study|Investigator Request|1|||
25041226|NCT03265145|50142493|FG000|Overall Study|Incorrectly randomized|16|||
25041227|NCT03265145|50142494|FG001|Overall Study|Incorrectly randomized|6|||
25041228|NCT03265145|50142493|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
25041229|NCT03265145|50142494|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
24954954|NCT00527111|50045963|FG000|Overall Study|Patient Request|2|||
24954955|NCT00527111|50045964|FG001|Overall Study|Patient Request|5|||
24954956|NCT00527111|50045963|FG000|Overall Study|Other|2|||
24954957|NCT00527111|50045964|FG001|Overall Study|Other|2|||
24954958|NCT00336024|50045972|FG000|Overall Study|Death|2|||
24954959|NCT00336024|50045973|FG001|Overall Study|Death|1|||
24954960|NCT00336024|50045972|FG000|Overall Study|Physician Decision|4|||
24954961|NCT00336024|50045973|FG001|Overall Study|Physician Decision|1|||
24954962|NCT00336024|50045972|FG000|Overall Study|Protocol Violation|1|||
24954963|NCT00336024|50045973|FG001|Overall Study|Protocol Violation|0|||
24954964|NCT00336024|50045972|FG000|Overall Study|Withdrawal by Subject|1|||
24954965|NCT00336024|50045973|FG001|Overall Study|Withdrawal by Subject|2|||
24954966|NCT00336024|50045972|FG000|Overall Study|Failure to fulfill consolidation|1|||
24954967|NCT00336024|50045973|FG001|Overall Study|Failure to fulfill consolidation|1|||
25041230|NCT03265145|50142493|FG000|Overall Study|Physician Decision|0|||
25041231|NCT03265145|50142494|FG001|Overall Study|Physician Decision|3|||
25041232|NCT03265145|50142493|FG000|Overall Study|Subject transferred to another facility|0|||
25041233|NCT03265145|50142494|FG001|Overall Study|Subject transferred to another facility|1|||
25041234|NCT03064763|50142501|FG000|Overall Study|Ongoing in study|10|||
25041235|NCT03064763|50142501|FG000|Overall Study|Death|8|||
25041236|NCT02782676|50142505|FG000|Overall Study|Lost to Follow-up|0|||
25041237|NCT02782676|50142506|FG001|Overall Study|Lost to Follow-up|1|||
25041238|NCT02471339|50142514|FG000|Overall Study|Did not provide follow-up data|2|||
25041239|NCT02471339|50142515|FG001|Overall Study|Did not provide follow-up data|0|||
25041240|NCT00107978|50142523|FG000|Overall Study|Adverse Event|1|||
25041241|NCT00107978|50142524|FG001|Overall Study|Adverse Event|5|||
25041242|NCT00107978|50142523|FG000|Overall Study|Death|3|||
25041243|NCT00107978|50142524|FG001|Overall Study|Death|3|||
25041244|NCT00107978|50142523|FG000|Overall Study|Lost to Follow-up|20|||
25041245|NCT00107978|50142524|FG001|Overall Study|Lost to Follow-up|28|||
25041246|NCT00107978|50142523|FG000|Overall Study|Withdrawal by Subject|4|||
25041247|NCT00107978|50142524|FG001|Overall Study|Withdrawal by Subject|9|||
25041248|NCT00107978|50142523|FG000|Overall Study|Protocol Violation|0|||
25041249|NCT00107978|50142524|FG001|Overall Study|Protocol Violation|1|||
25041250|NCT00107978|50142523|FG000|Overall Study|Other|5|||
25041251|NCT00107978|50142524|FG001|Overall Study|Other|4|||
25041252|NCT02781818|50142533|FG000|Overall Study|Lost to Follow-up|4|||
25041253|NCT02781818|50142534|FG001|Overall Study|Lost to Follow-up|2|||
25041254|NCT02781818|50142535|FG002|Overall Study|Lost to Follow-up|1|||
25041255|NCT02927873|50142549|FG000|Overall Study|Lost to Follow-up|0|||
25041256|NCT02927873|50142550|FG001|Overall Study|Lost to Follow-up|1|||
25041257|NCT02927873|50142551|FG002|Overall Study|Lost to Follow-up|0|||
25041258|NCT02927873|50142552|FG003|Overall Study|Lost to Follow-up|0|||
25041259|NCT02927873|50142553|FG004|Overall Study|Lost to Follow-up|0|||
25041260|NCT02927873|50142554|FG005|Overall Study|Lost to Follow-up|0|||
25041261|NCT02927873|50142549|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
25041262|NCT02927873|50142550|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
25041263|NCT02927873|50142551|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
25041264|NCT02927873|50142552|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
25041265|NCT02927873|50142553|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
25041266|NCT02927873|50142554|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
25041267|NCT02927873|50142549|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
25041268|NCT02927873|50142550|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
25041269|NCT02927873|50142551|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
25041270|NCT02927873|50142552|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
25041271|NCT02927873|50142553|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
25041272|NCT02927873|50142554|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
25041273|NCT02927873|50142549|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
25041274|NCT02927873|50142550|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
25041275|NCT02927873|50142551|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
25041276|NCT02927873|50142552|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
25041277|NCT02927873|50142553|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
25041278|NCT02927873|50142554|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
25041279|NCT02927873|50142549|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
25041280|NCT02927873|50142550|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
25041281|NCT02927873|50142551|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
25041282|NCT02927873|50142552|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
25041283|NCT02927873|50142553|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
25041284|NCT02927873|50142554|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
25041285|NCT02927873|50142549|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
25041286|NCT02927873|50142550|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
25041287|NCT02927873|50142551|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
25041288|NCT02927873|50142552|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
25041289|NCT02927873|50142553|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
25041290|NCT02927873|50142554|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
25041291|NCT01220999|50142573|FG000|Overall Study|Progressive disease|0|||
25041292|NCT01220999|50142574|FG001|Overall Study|Progressive disease|0|||
24954968|NCT00336024|50045972|FG000|Overall Study|Progressive Disease|4|||
24954969|NCT00336024|50045973|FG001|Overall Study|Progressive Disease|7|||
24954970|NCT00336024|50045972|FG000|Overall Study|Ineligible|7|||
24954971|NCT00336024|50045973|FG001|Overall Study|Ineligible|7|||
24954972|NCT00384956|50045979|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
24954973|NCT00367640|50045987|FG000|Overall Study|Adverse Event|3|||
24954974|NCT00367640|50045988|FG001|Overall Study|Adverse Event|6|||
24954975|NCT00367640|50045989|FG002|Overall Study|Adverse Event|8|||
25041293|NCT01220999|50142575|FG002|Overall Study|Progressive disease|1|||
25041294|NCT01220999|50142576|FG003|Overall Study|Progressive disease|0|||
25041295|NCT01220999|50142577|FG004|Overall Study|Progressive disease|0|||
25041296|NCT00142415|50142595|FG000|Overall Study|Physician Decision|0|||
25041297|NCT00142415|50142596|FG001|Overall Study|Physician Decision|0|||
25041298|NCT00142415|50142597|FG002|Overall Study|Physician Decision|0|||
25041299|NCT00142415|50142598|FG003|Overall Study|Physician Decision|0|||
25041300|NCT00142415|50142599|FG004|Overall Study|Physician Decision|1|||
25041301|NCT00142415|50142600|FG005|Overall Study|Physician Decision|2|||
25041302|NCT02781584|50142642|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
25041303|NCT02781584|50142643|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
25041304|NCT02781584|50142644|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
25041305|NCT02781584|50142645|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
25041306|NCT02781584|50142646|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
25041307|NCT02781584|50142647|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
25041308|NCT02781584|50142648|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
25041309|NCT02781584|50142649|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
25041310|NCT02781584|50142650|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
25041311|NCT02781584|50142651|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
25041312|NCT02781584|50142652|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
25041313|NCT02781584|50142653|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
25041314|NCT02781584|50142654|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
25041315|NCT02781584|50142642|FG000|Pre-treatment Phase|Adverse Event|0|||
25041316|NCT02781584|50142643|FG001|Pre-treatment Phase|Adverse Event|0|||
25041317|NCT02781584|50142644|FG002|Pre-treatment Phase|Adverse Event|0|||
25041318|NCT02781584|50142645|FG003|Pre-treatment Phase|Adverse Event|0|||
25041319|NCT02781584|50142646|FG004|Pre-treatment Phase|Adverse Event|0|||
25041320|NCT02781584|50142647|FG005|Pre-treatment Phase|Adverse Event|0|||
25041321|NCT02781584|50142648|FG006|Pre-treatment Phase|Adverse Event|0|||
25041322|NCT02781584|50142649|FG007|Pre-treatment Phase|Adverse Event|0|||
25041323|NCT02781584|50142650|FG008|Pre-treatment Phase|Adverse Event|0|||
25041324|NCT02781584|50142651|FG009|Pre-treatment Phase|Adverse Event|0|||
25041325|NCT02781584|50142652|FG010|Pre-treatment Phase|Adverse Event|0|||
25041326|NCT02781584|50142653|FG011|Pre-treatment Phase|Adverse Event|1|||
25041327|NCT02781584|50142654|FG012|Pre-treatment Phase|Adverse Event|0|||
25041328|NCT02781584|50142642|FG000|Treatment Phase|Withdrew Consent|0|||
25041329|NCT02781584|50142643|FG001|Treatment Phase|Withdrew Consent|0|||
25041330|NCT02781584|50142644|FG002|Treatment Phase|Withdrew Consent|0|||
25041331|NCT02781584|50142645|FG003|Treatment Phase|Withdrew Consent|0|||
25041332|NCT02781584|50142646|FG004|Treatment Phase|Withdrew Consent|0|||
25041333|NCT02781584|50142647|FG005|Treatment Phase|Withdrew Consent|1|||
25041334|NCT02781584|50142648|FG006|Treatment Phase|Withdrew Consent|0|||
25041335|NCT02781584|50142649|FG007|Treatment Phase|Withdrew Consent|0|||
25041336|NCT02781584|50142650|FG008|Treatment Phase|Withdrew Consent|0|||
25041337|NCT02781584|50142651|FG009|Treatment Phase|Withdrew Consent|0|||
25041338|NCT02781584|50142652|FG010|Treatment Phase|Withdrew Consent|1|||
25041339|NCT02781584|50142653|FG011|Treatment Phase|Withdrew Consent|2|||
25041340|NCT02781584|50142654|FG012|Treatment Phase|Withdrew Consent|0|||
25041341|NCT02781584|50142642|FG000|Treatment Phase|Adverse Event|0|||
25041342|NCT02781584|50142643|FG001|Treatment Phase|Adverse Event|0|||
25041343|NCT02781584|50142644|FG002|Treatment Phase|Adverse Event|0|||
25041344|NCT02781584|50142645|FG003|Treatment Phase|Adverse Event|0|||
25041345|NCT02781584|50142646|FG004|Treatment Phase|Adverse Event|0|||
25041346|NCT02781584|50142647|FG005|Treatment Phase|Adverse Event|0|||
25041347|NCT02781584|50142648|FG006|Treatment Phase|Adverse Event|0|||
25041348|NCT02781584|50142649|FG007|Treatment Phase|Adverse Event|1|||
25041349|NCT02781584|50142650|FG008|Treatment Phase|Adverse Event|0|||
24954976|NCT00367640|50045990|FG003|Overall Study|Adverse Event|0|||
24954977|NCT00367640|50045987|FG000|Overall Study|Withdrawal by Subject|8|||
24954978|NCT00367640|50045988|FG001|Overall Study|Withdrawal by Subject|11|||
24954979|NCT00367640|50045989|FG002|Overall Study|Withdrawal by Subject|8|||
24954980|NCT00367640|50045990|FG003|Overall Study|Withdrawal by Subject|6|||
24954981|NCT00367640|50045987|FG000|Overall Study|Any other reason not above-mentioned|7|||
24954982|NCT00367640|50045988|FG001|Overall Study|Any other reason not above-mentioned|5|||
24954983|NCT00367640|50045989|FG002|Overall Study|Any other reason not above-mentioned|3|||
25041350|NCT02781584|50142651|FG009|Treatment Phase|Adverse Event|0|||
25041351|NCT02781584|50142652|FG010|Treatment Phase|Adverse Event|0|||
25041352|NCT02781584|50142653|FG011|Treatment Phase|Adverse Event|0|||
25041353|NCT02781584|50142654|FG012|Treatment Phase|Adverse Event|0|||
25041354|NCT02776670|50142684|FG000|Overall Study|Adverse Event|0|||
25041355|NCT02776670|50142685|FG001|Overall Study|Adverse Event|2|||
25041356|NCT02776670|50142684|FG000|Overall Study|Protocol Violation|0|||
24954984|NCT00367640|50045990|FG003|Overall Study|Any other reason not above-mentioned|4|||
25041357|NCT02776670|50142685|FG001|Overall Study|Protocol Violation|2|||
25041358|NCT02776670|50142684|FG000|Overall Study|Withdrawal by Subject|0|||
25041359|NCT02776670|50142685|FG001|Overall Study|Withdrawal by Subject|1|||
25041360|NCT02776670|50142684|FG000|Overall Study|Other - Reason not given|0|||
25041361|NCT02776670|50142685|FG001|Overall Study|Other - Reason not given|1|||
25041362|NCT01307423|50142694|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
25041363|NCT01307423|50142695|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
25041364|NCT01307423|50142696|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
25041365|NCT01307423|50142697|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25041366|NCT01307423|50142698|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25041367|NCT01307423|50142699|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25041368|NCT01307423|50142700|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25041369|NCT01307423|50142701|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25041370|NCT01307423|50142702|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25041371|NCT01307423|50142694|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
25041372|NCT01307423|50142695|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
25041373|NCT01307423|50142696|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
24954985|NCT00367484|50046000|FG000|Overall Study|Adverse Event|7|||
24954986|NCT00367484|50046000|FG000|Overall Study|Withdrew informed consent|5|||
24954987|NCT00367484|50046000|FG000|Overall Study|Travel to USA|1|||
24954988|NCT00367484|50046000|FG000|Overall Study|Lost to Follow-up|1|||
24954989|NCT00367484|50046000|FG000|Overall Study|Protocol Violation|1|||
24954990|NCT00367484|50046000|FG000|Overall Study|The choice of the patient|1|||
25041374|NCT01307423|50142697|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25041375|NCT01307423|50142698|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25041376|NCT01307423|50142699|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25041377|NCT01307423|50142700|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25041378|NCT01307423|50142701|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25041379|NCT01307423|50142702|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25041380|NCT01307423|50142694|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
25041381|NCT01307423|50142695|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
24954991|NCT00367484|50046000|FG000|Overall Study|Lack of Efficacy|1|||
24954992|NCT00526799|50046006|FG000|Overall Study|Withdrawal by Subject|1|||
24954993|NCT00526799|50046007|FG001|Overall Study|Withdrawal by Subject|0|||
24954994|NCT00526799|50046006|FG000|Overall Study|Intercurrent Complicating Disease|0|||
24954995|NCT00526799|50046007|FG001|Overall Study|Intercurrent Complicating Disease|1|||
24954996|NCT00526331|50046013|FG000|Overall Study|Sponsor Termination|55|||
24954997|NCT00520481|50046019|FG000|Overall Study|Adverse Event|4|||
24954998|NCT00520481|50046020|FG001|Overall Study|Adverse Event|1|||
24954999|NCT00520481|50046019|FG000|Overall Study|Withdrawal by Subject|3|||
24955000|NCT00520481|50046020|FG001|Overall Study|Withdrawal by Subject|0|||
24955001|NCT00520403|50046028|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
24955002|NCT00520403|50046028|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
24955003|NCT00520403|50046028|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
24955004|NCT00520403|50046028|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
24955005|NCT00520403|50046028|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
24955006|NCT00520403|50046028|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
24955007|NCT00520403|50046028|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
24955008|NCT00520403|50046028|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
24955009|NCT00520013|50046035|FG000|Overall Study|Withdrawal by Subject|0|||
24955010|NCT00520013|50046036|FG001|Overall Study|Withdrawal by Subject|0|||
24955011|NCT00520013|50046037|FG002|Overall Study|Withdrawal by Subject|1|||
24955012|NCT00520013|50046035|FG000|Overall Study|Adverse Event|2|||
24955013|NCT00520013|50046036|FG001|Overall Study|Adverse Event|10|||
24955014|NCT00520013|50046037|FG002|Overall Study|Adverse Event|7|||
24955015|NCT00520013|50046035|FG000|Overall Study|Progressive Disease|7|||
24955016|NCT00520013|50046036|FG001|Overall Study|Progressive Disease|3|||
24955017|NCT00520013|50046037|FG002|Overall Study|Progressive Disease|0|||
24955018|NCT00520013|50046035|FG000|Overall Study|Clinical Progression|3|||
24955019|NCT00520013|50046036|FG001|Overall Study|Clinical Progression|1|||
24955020|NCT00520013|50046037|FG002|Overall Study|Clinical Progression|0|||
24955021|NCT00520013|50046035|FG000|Overall Study|Death|0|||
24955022|NCT00520013|50046036|FG001|Overall Study|Death|1|||
24955023|NCT00520013|50046037|FG002|Overall Study|Death|0|||
24955024|NCT00520013|50046035|FG000|Overall Study|Physician Decision|0|||
24955025|NCT00520013|50046036|FG001|Overall Study|Physician Decision|0|||
25041382|NCT01307423|50142696|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
25041383|NCT01307423|50142697|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
25160279|NCT01831765|50280392|FG001|Overall Study|Other, sponsor withdrew subject|1|||
24955026|NCT00520013|50046037|FG002|Overall Study|Physician Decision|3|||
24955027|NCT00519779|50046045|FG000|Overall Study|Withdrawal by Subject|0|||
24955028|NCT00519779|50046046|FG001|Overall Study|Withdrawal by Subject|1|||
24955029|NCT00526097|50046054|FG000|Overall Study|Adverse Event|6|||
24955030|NCT00526097|50046055|FG001|Overall Study|Adverse Event|44|||
24955031|NCT00526097|50046054|FG000|Overall Study|Protocol Violation|4|||
24955032|NCT00526097|50046055|FG001|Overall Study|Protocol Violation|10|||
24955033|NCT00526097|50046054|FG000|Overall Study|Withdrawal by Subject|3|||
25041384|NCT01307423|50142698|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
25041385|NCT01307423|50142699|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
25041386|NCT01307423|50142700|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
25041387|NCT01307423|50142701|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
24955034|NCT00526097|50046055|FG001|Overall Study|Withdrawal by Subject|1|||
25041388|NCT01307423|50142702|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
25041389|NCT01307423|50142694|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
25041390|NCT01307423|50142695|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
25041391|NCT01307423|50142696|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
25041392|NCT01307423|50142697|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
25041393|NCT01307423|50142698|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
25041394|NCT01307423|50142699|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
25041395|NCT01307423|50142700|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
25041396|NCT01307423|50142701|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
25041397|NCT01307423|50142702|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
25041398|NCT01307423|50142694|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
25041399|NCT01307423|50142695|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
25041400|NCT01307423|50142696|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
25041401|NCT01307423|50142697|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25041402|NCT01307423|50142698|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25041403|NCT01307423|50142699|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25041404|NCT01307423|50142700|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25041405|NCT01307423|50142701|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25041406|NCT01307423|50142702|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25041407|NCT01307423|50142694|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
25041408|NCT01307423|50142695|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25041409|NCT01307423|50142696|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25041410|NCT01307423|50142697|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25041411|NCT01307423|50142698|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25041412|NCT01307423|50142699|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25041413|NCT01307423|50142700|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25041414|NCT01307423|50142701|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25041415|NCT01307423|50142702|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25041416|NCT01307423|50142694|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
25041417|NCT01307423|50142695|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
25041418|NCT01307423|50142696|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
25041419|NCT01307423|50142697|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
25041420|NCT01307423|50142698|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
25041421|NCT01307423|50142699|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
25041422|NCT01307423|50142700|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
25041423|NCT01307423|50142701|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
25041424|NCT01307423|50142702|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
25041425|NCT01307423|50142694|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
25041426|NCT01307423|50142695|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
25041427|NCT01307423|50142696|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
25041428|NCT01307423|50142697|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
25041429|NCT01307423|50142698|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
24955035|NCT00526097|50046054|FG000|Overall Study|Other|2|||
24955036|NCT00526097|50046055|FG001|Overall Study|Other|1|||
24955037|NCT00525785|50046061|FG000|Overall Study|Withdrawal by Subject|1|||
24955038|NCT00525785|50046061|FG000|Overall Study|Lack of Efficacy|1|||
24955039|NCT00525785|50046061|FG000|Overall Study|Physician Decision|1|||
24955040|NCT00525161|50046065|FG000|Overall Study|Adverse Event|1|||
25276201|NCT00963820|50590160|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
24955041|NCT00524771|50046071|FG000|Overall Study|Protocol Violation|220|||
24955042|NCT00524771|50046072|FG001|Overall Study|Protocol Violation|585|||
24955043|NCT00135694|50046082|FG000|Overall Study|Adverse Event|17|||
24955044|NCT00135694|50046083|FG001|Overall Study|Adverse Event|4|||
24955045|NCT00135694|50046084|FG002|Overall Study|Adverse Event|0|||
25041430|NCT01307423|50142699|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
25041431|NCT01307423|50142700|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
25041432|NCT01307423|50142701|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
25041433|NCT01307423|50142702|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
25041434|NCT01307423|50142694|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
25041435|NCT01307423|50142695|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
25041436|NCT01307423|50142696|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
25041437|NCT01307423|50142697|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
25041438|NCT01307423|50142698|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
25041439|NCT01307423|50142699|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
25041440|NCT01307423|50142700|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
25041441|NCT01307423|50142701|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
25041442|NCT01307423|50142702|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
25041443|NCT01307423|50142694|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
25041444|NCT01307423|50142695|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
25041445|NCT01307423|50142696|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
25041446|NCT01307423|50142697|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
25041447|NCT01307423|50142698|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
25041448|NCT01307423|50142699|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
25041449|NCT01307423|50142700|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
25041450|NCT01307423|50142701|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
25041451|NCT01307423|50142702|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
25041452|NCT01307423|50142694|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
25041453|NCT01307423|50142695|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
25041454|NCT01307423|50142696|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
25041455|NCT01307423|50142697|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
25041456|NCT01307423|50142698|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
25041457|NCT01307423|50142699|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
25041458|NCT01307423|50142700|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
24955046|NCT00135694|50046082|FG000|Overall Study|Death|14|||
24955047|NCT00135694|50046083|FG001|Overall Study|Death|1|||
25041459|NCT01307423|50142701|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
25041460|NCT01307423|50142702|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
25041461|NCT01307423|50142694|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
25041462|NCT01307423|50142695|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
25041463|NCT01307423|50142696|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
25041464|NCT01307423|50142697|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
25041465|NCT01307423|50142698|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
25041466|NCT01307423|50142699|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
25041467|NCT01307423|50142700|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
25041468|NCT01307423|50142701|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
25041469|NCT01307423|50142702|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
25041470|NCT01307423|50142694|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
25041471|NCT01307423|50142695|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
24955048|NCT00135694|50046084|FG002|Overall Study|Death|2|||
24955049|NCT00135694|50046082|FG000|Overall Study|Lost to Follow-up|8|||
24955050|NCT00135694|50046083|FG001|Overall Study|Lost to Follow-up|7|||
24955051|NCT00135694|50046084|FG002|Overall Study|Lost to Follow-up|1|||
25041472|NCT01307423|50142696|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
25041473|NCT01307423|50142697|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
25041474|NCT01307423|50142698|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
25041475|NCT01307423|50142699|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
25041476|NCT01307423|50142700|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
25041477|NCT01307423|50142701|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
25041478|NCT01307423|50142702|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
25041479|NCT01307423|50142694|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
25041480|NCT01307423|50142695|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
25041481|NCT01307423|50142696|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
25041482|NCT01307423|50142697|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
25041483|NCT01307423|50142698|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
24955052|NCT00135694|50046082|FG000|Overall Study|Withdrawal by Subject|41|||
24955053|NCT00135694|50046083|FG001|Overall Study|Withdrawal by Subject|7|||
25041484|NCT01307423|50142699|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
25041485|NCT01307423|50142700|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
24955054|NCT00135694|50046084|FG002|Overall Study|Withdrawal by Subject|4|||
24955055|NCT00135694|50046082|FG000|Overall Study|Protocol Violation|19|||
24955056|NCT00135694|50046083|FG001|Overall Study|Protocol Violation|1|||
25041486|NCT01307423|50142701|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
25041487|NCT01307423|50142702|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
25041488|NCT01307423|50142694|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
25041489|NCT01307423|50142695|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
25041490|NCT01307423|50142696|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
25041491|NCT01307423|50142697|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
25041492|NCT01307423|50142698|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
25041493|NCT01307423|50142699|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
25041494|NCT01307423|50142700|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
25041495|NCT01307423|50142701|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
25041496|NCT01307423|50142702|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
25041497|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
25041498|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
25041499|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
25041500|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
25041501|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
25041502|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
25041503|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
25041504|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
25041505|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
25041506|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
25041507|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
25041508|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
25041509|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
25041510|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
25041511|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
25041512|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
25041513|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
25041514|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
25041515|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
25041516|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
25041517|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
25041518|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
25041519|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
25041520|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
25041521|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
25041522|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
25041523|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
25041524|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
25041525|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
25041526|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
24955057|NCT00135694|50046084|FG002|Overall Study|Protocol Violation|0|||
24955058|NCT00135694|50046082|FG000|Overall Study|Hepatitis C related reasons|39|||
24955059|NCT00135694|50046083|FG001|Overall Study|Hepatitis C related reasons|1|||
24955060|NCT00135694|50046084|FG002|Overall Study|Hepatitis C related reasons|0|||
24955061|NCT00135694|50046082|FG000|Overall Study|Ineligible for Random assignment|42|||
24955062|NCT00135694|50046083|FG001|Overall Study|Ineligible for Random assignment|0|||
24955063|NCT00135694|50046084|FG002|Overall Study|Ineligible for Random assignment|0|||
25041527|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
25041528|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
25041529|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
25041530|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
25041531|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
25041532|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
25041533|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
25041534|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
25041535|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
25041536|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
25041537|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
25041538|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
25041539|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
25041540|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
25041541|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
25041542|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
25041543|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
25041544|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
24955064|NCT00524459|50046092|FG000|Overall Study|Withdrawal by Subject|1|||
25041545|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
25041546|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
25041547|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
25041548|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
25041549|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
25041550|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
25041551|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
25041552|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
24955065|NCT00524459|50046092|FG000|Overall Study|Other|1|||
24955066|NCT00519623|50046096|FG000|Overall Study|Adverse Event|1|||
24955067|NCT00519077|50046100|FG000|Overall Study|Death|6|||
24955068|NCT00519077|50046100|FG000|Overall Study|Other|2|||
24955069|NCT00124618|50046104|FG000|Overall Study|Ineligible|1|||
24955070|NCT00124462|50046110|FG000|Overall Study|Lost to Follow-up|3|||
25041553|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
25041554|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
25041555|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
25041556|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
25041557|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
25041558|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
25041559|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
25041560|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
25041561|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
25041562|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
25041563|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
25041564|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
25041565|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
25041566|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
25041567|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
25041568|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
25041569|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
25041570|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
25041571|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
25041572|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
25041573|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
25041574|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
25041575|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
25041576|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
25041577|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
25041578|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
25041579|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
25041580|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
25041581|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
25041582|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
25041583|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
25041584|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
25041585|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
25041586|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
25041587|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
25041588|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
25041589|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
25041590|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
25041591|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
25041592|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
25041593|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
25041594|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
25041595|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
25041596|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
24955071|NCT00124462|50046111|FG001|Overall Study|Lost to Follow-up|3|||
24955072|NCT00124462|50046110|FG000|Overall Study|Physician Decision|3|||
24955073|NCT00124462|50046111|FG001|Overall Study|Physician Decision|4|||
24955074|NCT00124462|50046110|FG000|Overall Study|Withdrawal by Subject|4|||
25041597|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
25041598|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
25041599|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
25041600|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
25041601|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
24955075|NCT00124462|50046111|FG001|Overall Study|Withdrawal by Subject|5|||
24955076|NCT00124462|50046110|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
25041602|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
25041603|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
25041604|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
25041605|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
25041606|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
25041607|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
25041608|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
25041609|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
24955077|NCT00124462|50046111|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
24955078|NCT00124072|50046121|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
24955079|NCT00124072|50046122|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
24955080|NCT00124072|50046123|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
24955081|NCT00124072|50046124|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
24955082|NCT00124072|50046121|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
25041610|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
25041611|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
25041612|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
25041613|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
25041614|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
25041615|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
25041616|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
25041617|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
25041618|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
25041619|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
25041620|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
25041621|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
25041622|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
25041623|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
25041624|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
25041625|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
25041626|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
25041627|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
25041628|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
25041629|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
25041630|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
25041631|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
25041632|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
25041633|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
25041634|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
25041635|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
25041636|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
25041637|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
25041638|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
25041639|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
25041640|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
25041641|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
24955083|NCT00124072|50046122|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
24955084|NCT00124072|50046123|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
24955085|NCT00124072|50046124|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
24955086|NCT00124072|50046121|FG000|Overall Study|Death|499|||
24955087|NCT00124072|50046122|FG001|Overall Study|Death|484|||
24955088|NCT00124072|50046123|FG002|Overall Study|Death|471|||
24955089|NCT00124072|50046124|FG003|Overall Study|Death|480|||
24955090|NCT00362648|50046138|FG000|Overall Study|Adverse Event|12|||
24955091|NCT00362648|50046139|FG001|Overall Study|Adverse Event|21|||
24955092|NCT00362648|50046140|FG002|Overall Study|Adverse Event|1|||
24955093|NCT00362648|50046141|FG003|Overall Study|Adverse Event|0|||
24955094|NCT00362648|50046138|FG000|Overall Study|Lost to Follow-up|62|||
24955095|NCT00362648|50046139|FG001|Overall Study|Lost to Follow-up|69|||
25276202|NCT00963820|50590161|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
24955096|NCT00362648|50046140|FG002|Overall Study|Lost to Follow-up|4|||
24955097|NCT00362648|50046141|FG003|Overall Study|Lost to Follow-up|3|||
24955098|NCT00362648|50046138|FG000|Overall Study|Protocol Violation|4|||
24955099|NCT00362648|50046139|FG001|Overall Study|Protocol Violation|2|||
24955100|NCT00362648|50046140|FG002|Overall Study|Protocol Violation|2|||
24955101|NCT00362648|50046141|FG003|Overall Study|Protocol Violation|2|||
24955102|NCT00362648|50046138|FG000|Overall Study|Withdrawal by Subject|48|||
24955103|NCT00362648|50046139|FG001|Overall Study|Withdrawal by Subject|42|||
24955104|NCT00362648|50046140|FG002|Overall Study|Withdrawal by Subject|2|||
24955105|NCT00362648|50046141|FG003|Overall Study|Withdrawal by Subject|6|||
24955106|NCT00524303|50046158|FG000|Overall Study|Lost to Follow-up|6|||
24955107|NCT00524303|50046159|FG001|Overall Study|Lost to Follow-up|0|||
24955108|NCT00524303|50046160|FG002|Overall Study|Lost to Follow-up|3|||
24955109|NCT00524303|50046158|FG000|Overall Study|Protocol Violation|0|||
24955110|NCT00524303|50046159|FG001|Overall Study|Protocol Violation|1|||
24955111|NCT00524303|50046160|FG002|Overall Study|Protocol Violation|1|||
24955112|NCT00524303|50046158|FG000|Overall Study|Withdrawal by Subject|3|||
24955113|NCT00524303|50046159|FG001|Overall Study|Withdrawal by Subject|0|||
24955114|NCT00524303|50046160|FG002|Overall Study|Withdrawal by Subject|4|||
24955115|NCT00524303|50046158|FG000|Overall Study|Death|0|||
24955116|NCT00524303|50046159|FG001|Overall Study|Death|2|||
24955117|NCT00524303|50046160|FG002|Overall Study|Death|3|||
24955118|NCT00524303|50046158|FG000|Overall Study|Adverse Event|1|||
24955119|NCT00524303|50046159|FG001|Overall Study|Adverse Event|2|||
24955120|NCT00524303|50046160|FG002|Overall Study|Adverse Event|3|||
24955121|NCT00524303|50046158|FG000|Overall Study|Did not Complete Study Dosing|1|||
24955122|NCT00524303|50046159|FG001|Overall Study|Did not Complete Study Dosing|0|||
25041642|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
24955123|NCT00524303|50046160|FG002|Overall Study|Did not Complete Study Dosing|0|||
24955124|NCT00524303|50046158|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
24955125|NCT00524303|50046159|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
24955126|NCT00524303|50046160|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
24955127|NCT00524303|50046158|FG000|Overall Study|Disease Progression|0|||
24955128|NCT00524303|50046159|FG001|Overall Study|Disease Progression|4|||
24955129|NCT00524303|50046160|FG002|Overall Study|Disease Progression|1|||
25041643|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
25041644|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
25041645|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
25041646|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
25041647|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
25041648|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
25041649|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
25041650|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
25041651|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
25041652|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
25041653|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
25041654|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
25041655|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
25041656|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
25041657|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
25041658|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
25041659|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
25041660|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
25041661|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
25041662|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
25041663|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
25041664|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
25041665|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
25041666|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
25041667|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
25041668|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
25041669|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
25041670|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
25041671|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
25041672|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
25041673|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
25041674|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
25041675|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
25041676|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
25041677|NCT01307423|50142694|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
25041678|NCT01307423|50142695|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
25041679|NCT01307423|50142696|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
25041680|NCT01307423|50142697|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
25041681|NCT01307423|50142698|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
25041682|NCT01307423|50142699|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
25041683|NCT01307423|50142700|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
25041684|NCT01307423|50142701|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
25041685|NCT01307423|50142702|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
25160280|NCT01831765|50280393|FG002|Overall Study|Other, sponsor withdrew subject|0|||
25160281|NCT01831765|50280391|FG000|Overall Study|Pregnancy|1|||
25160282|NCT01831765|50280392|FG001|Overall Study|Pregnancy|1|||
24955130|NCT00524303|50046158|FG000|Overall Study|Disease Recurrence|0|||
24955131|NCT00524303|50046159|FG001|Overall Study|Disease Recurrence|1|||
24955132|NCT00524303|50046160|FG002|Overall Study|Disease Recurrence|0|||
24955133|NCT00524303|50046158|FG000|Overall Study|Sponsor Request|0|||
24955134|NCT00524303|50046159|FG001|Overall Study|Sponsor Request|0|||
24955135|NCT00524303|50046160|FG002|Overall Study|Sponsor Request|1|||
24955136|NCT00524303|50046158|FG000|Overall Study|Physician Decision|0|||
24955137|NCT00524303|50046159|FG001|Overall Study|Physician Decision|0|||
24955138|NCT00524303|50046160|FG002|Overall Study|Physician Decision|1|||
24955139|NCT00524303|50046158|FG000|Overall Study|Completed 5 years|0|||
25160283|NCT01831765|50280393|FG002|Overall Study|Pregnancy|2|||
24955140|NCT00524303|50046159|FG001|Overall Study|Completed 5 years|0|||
24955141|NCT00524303|50046160|FG002|Overall Study|Completed 5 years|1|||
24955142|NCT00335556|50046177|FG000|Overall Study|Death|0|||
25041686|NCT02778074|50142736|FG000|Overall Study|Lost to Follow-up|7|||
25041687|NCT02778074|50142737|FG001|Overall Study|Lost to Follow-up|10|||
25041688|NCT02768792|50142752|FG000|Overall Study|Adverse Event|1|||
25041689|NCT02775344|50142758|FG000|Overall Study|No ovarian cyst identified|3|||
25041690|NCT02775344|50142759|FG001|Overall Study|No ovarian cyst identified|2|||
25041691|NCT02777918|50142767|FG000|Overall Study|Medical reasons|1|||
25041692|NCT02777918|50142768|FG001|Overall Study|Medical reasons|2|||
25041693|NCT02777918|50142767|FG000|Overall Study|Too busy / stressed|1|||
25041694|NCT02777918|50142768|FG001|Overall Study|Too busy / stressed|1|||
25041695|NCT02777918|50142767|FG000|Overall Study|Withdrawal by Subject|1|||
25041696|NCT02777918|50142768|FG001|Overall Study|Withdrawal by Subject|1|||
25041697|NCT02927795|50142774|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
25041698|NCT02927795|50142774|FG000|Overall Study|Not Treated|4|||
25041699|NCT02767856|50142780|FG000|Overall Study|Lost to Follow-up|9|||
25041700|NCT02767856|50142781|FG001|Overall Study|Lost to Follow-up|1|||
25041701|NCT02767856|50142780|FG000|Overall Study|Withdrawal by Subject|2|||
25041702|NCT02767856|50142781|FG001|Overall Study|Withdrawal by Subject|1|||
25041703|NCT03087851|50142790|FG000|Overall Study|Withdraw on medical grounds|0|||
25041704|NCT03087851|50142791|FG001|Overall Study|Withdraw on medical grounds|1|||
25041705|NCT03087851|50142792|FG002|Overall Study|Withdraw on medical grounds|2|||
25041706|NCT03092375|50142804|FG000|Overall Study|Lack of Efficacy|0|||
25041707|NCT03092375|50142805|FG001|Overall Study|Lack of Efficacy|1|||
25041708|NCT03092375|50142806|FG002|Overall Study|Lack of Efficacy|1|||
25041709|NCT03092375|50142807|FG003|Overall Study|Lack of Efficacy|0|||
25041710|NCT01995513|50142824|FG000|Open Label Treatment Period|Other|9|||
25041711|NCT01995513|50142825|FG001|Open Label Treatment Period|Other|0|||
25041712|NCT01995513|50142826|FG002|Open Label Treatment Period|Other|0|||
25041713|NCT01995513|50142824|FG000|Open Label Treatment Period|Withdrawal by Subject|14|||
25041714|NCT01995513|50142825|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
25041715|NCT01995513|50142826|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
25041716|NCT01995513|50142824|FG000|Open Label Treatment Period|Protocol Violation|1|||
25041717|NCT01995513|50142825|FG001|Open Label Treatment Period|Protocol Violation|0|||
25041718|NCT01995513|50142826|FG002|Open Label Treatment Period|Protocol Violation|0|||
25041719|NCT01995513|50142824|FG000|Open Label Treatment Period|Disease Progression|64|||
25041720|NCT01995513|50142825|FG001|Open Label Treatment Period|Disease Progression|0|||
25041721|NCT01995513|50142826|FG002|Open Label Treatment Period|Disease Progression|0|||
25041722|NCT01995513|50142824|FG000|Open Label Treatment Period|No PSA response at week 13|43|||
25041723|NCT01995513|50142825|FG001|Open Label Treatment Period|No PSA response at week 13|0|||
25041724|NCT01995513|50142826|FG002|Open Label Treatment Period|No PSA response at week 13|0|||
25041725|NCT01995513|50142824|FG000|Open Label Treatment Period|Adverse Event|35|||
25041726|NCT01995513|50142825|FG001|Open Label Treatment Period|Adverse Event|0|||
25041727|NCT01995513|50142826|FG002|Open Label Treatment Period|Adverse Event|0|||
25041728|NCT01995513|50142824|FG000|Open Label Treatment Period|Death|8|||
25041729|NCT01995513|50142825|FG001|Open Label Treatment Period|Death|0|||
25041730|NCT01995513|50142826|FG002|Open Label Treatment Period|Death|0|||
25041731|NCT01995513|50142824|FG000|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84|||
25041732|NCT01995513|50142825|FG001|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
25041733|NCT01995513|50142826|FG002|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
25041734|NCT01995513|50142824|FG000|Double Blind Treatment Period|Adverse Event|0|||
25041735|NCT01995513|50142825|FG001|Double Blind Treatment Period|Adverse Event|12|||
25041736|NCT01995513|50142826|FG002|Double Blind Treatment Period|Adverse Event|5|||
25041737|NCT01995513|50142824|FG000|Double Blind Treatment Period|Other|0|||
25041738|NCT01995513|50142825|FG001|Double Blind Treatment Period|Other|1|||
25041739|NCT01995513|50142826|FG002|Double Blind Treatment Period|Other|2|||
25041740|NCT01995513|50142824|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
25041741|NCT01995513|50142825|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
25041742|NCT01995513|50142826|FG002|Double Blind Treatment Period|Withdrawal by Subject|6|||
25041743|NCT01995513|50142824|FG000|Double Blind Treatment Period|Death|0|||
24955143|NCT00335556|50046178|FG001|Overall Study|Death|5|||
24955144|NCT00335556|50046179|FG002|Overall Study|Death|0|||
24955145|NCT00335556|50046180|FG003|Overall Study|Death|0|||
24955146|NCT00335556|50046181|FG004|Overall Study|Death|1|||
24955147|NCT00335556|50046182|FG005|Overall Study|Death|0|||
24955148|NCT00335556|50046177|FG000|Overall Study|Lack of Efficacy|0|||
24955149|NCT00335556|50046178|FG001|Overall Study|Lack of Efficacy|19|||
24955150|NCT00335556|50046179|FG002|Overall Study|Lack of Efficacy|3|||
25041744|NCT01995513|50142825|FG001|Double Blind Treatment Period|Death|0|||
25041745|NCT01995513|50142826|FG002|Double Blind Treatment Period|Death|1|||
25041746|NCT01995513|50142824|FG000|Double Blind Treatment Period|Disease Progression|0|||
25041747|NCT01995513|50142825|FG001|Double Blind Treatment Period|Disease Progression|82|||
24955151|NCT00335556|50046180|FG003|Overall Study|Lack of Efficacy|3|||
24955152|NCT00335556|50046181|FG004|Overall Study|Lack of Efficacy|0|||
24955153|NCT00335556|50046182|FG005|Overall Study|Lack of Efficacy|1|||
24955154|NCT00335556|50046177|FG000|Overall Study|Physician Decision|0|||
24955155|NCT00335556|50046178|FG001|Overall Study|Physician Decision|6|||
25041748|NCT01995513|50142826|FG002|Double Blind Treatment Period|Disease Progression|93|||
25041749|NCT01995513|50142824|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0|||
25041750|NCT01995513|50142825|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27|||
25041751|NCT01995513|50142826|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18|||
25041752|NCT02927171|50142838|FG000|Overall Study|Lost to Follow-up|0|||
25041753|NCT02927171|50142839|FG001|Overall Study|Lost to Follow-up|1|||
25041754|NCT03087617|50142849|FG000|Overall Study|Lost to Follow-up|32|||
25041755|NCT03087617|50142850|FG001|Overall Study|Lost to Follow-up|30|||
25041756|NCT03087617|50142851|FG002|Overall Study|Lost to Follow-up|30|||
25041757|NCT03087617|50142852|FG003|Overall Study|Lost to Follow-up|39|||
25041758|NCT00103610|50142864|FG000|Overall Study|Entered Rescue Procedure|10|||
25041759|NCT00103610|50142865|FG001|Overall Study|Entered Rescue Procedure|52|||
25041760|NCT00103610|50142864|FG000|Overall Study|Death|16|||
25041761|NCT00103610|50142865|FG001|Overall Study|Death|12|||
25041762|NCT00103610|50142864|FG000|Overall Study|Elective Withdrawal|4|||
25041763|NCT00103610|50142865|FG001|Overall Study|Elective Withdrawal|0|||
25041764|NCT00103610|50142864|FG000|Overall Study|Lost to Follow-up|3|||
25041765|NCT00103610|50142865|FG001|Overall Study|Lost to Follow-up|1|||
25041766|NCT00103610|50142864|FG000|Overall Study|Adverse Event|2|||
25041767|NCT00103610|50142865|FG001|Overall Study|Adverse Event|2|||
25041768|NCT00103610|50142864|FG000|Overall Study|Other|2|||
25041769|NCT00103610|50142865|FG001|Overall Study|Other|7|||
25041770|NCT00103610|50142864|FG000|Overall Study|Failed mobilization|1|||
25041771|NCT00103610|50142865|FG001|Overall Study|Failed mobilization|5|||
25041772|NCT00103610|50142864|FG000|Overall Study|Noncompliance|0|||
25041773|NCT00103610|50142865|FG001|Overall Study|Noncompliance|1|||
25041774|NCT03091439|50142874|FG000|Overall Study|Study Terminated by the Sponsor|1|||
25041775|NCT03091439|50142875|FG001|Overall Study|Study Terminated by the Sponsor|0|||
25041776|NCT03086447|50142883|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
25041777|NCT03086447|50142884|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
25041778|NCT03086447|50142883|FG000|Overall Study|Lost Lens|2|||
25041779|NCT03086447|50142884|FG001|Overall Study|Lost Lens|5|||
25041780|NCT03086447|50142883|FG000|Overall Study|Product quality complaint|0|||
25041781|NCT03086447|50142884|FG001|Overall Study|Product quality complaint|1|||
25041782|NCT03086447|50142883|FG000|Overall Study|Lens Damage|1|||
25041783|NCT03086447|50142884|FG001|Overall Study|Lens Damage|6|||
25041784|NCT03086447|50142883|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
25041785|NCT03086447|50142884|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
25041786|NCT03086447|50142883|FG000|Overall Study|Test Article No Longer Available|1|||
25041787|NCT03086447|50142884|FG001|Overall Study|Test Article No Longer Available|0|||
25041788|NCT03086447|50142883|FG000|Overall Study|Protocol Violation|2|||
25041789|NCT03086447|50142884|FG001|Overall Study|Protocol Violation|4|||
25041790|NCT03086447|50142883|FG000|Overall Study|Lost to Follow-up|0|||
25041791|NCT03086447|50142884|FG001|Overall Study|Lost to Follow-up|1|||
25041792|NCT03086447|50142883|FG000|Overall Study|Adverse Event|3|||
25041793|NCT03086447|50142884|FG001|Overall Study|Adverse Event|0|||
25041794|NCT03086447|50142883|FG000|Overall Study|Lens Discomfort|2|||
25041795|NCT03086447|50142884|FG001|Overall Study|Lens Discomfort|1|||
25041796|NCT03083639|50142915|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
25041797|NCT03083639|50142916|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
25041798|NCT03083639|50142915|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
25041799|NCT03083639|50142916|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
25041800|NCT02927431|50142925|FG000|Overall Study|Withdrawal by Subject|0|||
25041801|NCT02927431|50142926|FG001|Overall Study|Withdrawal by Subject|0|||
25041802|NCT02927431|50142927|FG002|Overall Study|Withdrawal by Subject|1|||
25041803|NCT03083483|50142940|FG000|Overall Study|Adverse Event|1|||
25041804|NCT03083483|50142941|FG001|Overall Study|Adverse Event|1|||
25041805|NCT03083483|50142942|FG002|Overall Study|Adverse Event|1|||
25041806|NCT03083483|50142940|FG000|Overall Study|Lost to Follow-up|2|||
25041807|NCT03083483|50142941|FG001|Overall Study|Lost to Follow-up|1|||
25041808|NCT03083483|50142942|FG002|Overall Study|Lost to Follow-up|1|||
24955156|NCT00335556|50046179|FG002|Overall Study|Physician Decision|2|||
24955157|NCT00335556|50046180|FG003|Overall Study|Physician Decision|1|||
24955158|NCT00335556|50046181|FG004|Overall Study|Physician Decision|0|||
24955159|NCT00335556|50046182|FG005|Overall Study|Physician Decision|0|||
24955160|NCT00335556|50046177|FG000|Overall Study|Ineligible|2|||
24955161|NCT00335556|50046178|FG001|Overall Study|Ineligible|0|||
24955162|NCT00335556|50046179|FG002|Overall Study|Ineligible|0|||
24955163|NCT00335556|50046180|FG003|Overall Study|Ineligible|0|||
24955164|NCT00335556|50046181|FG004|Overall Study|Ineligible|0|||
25041809|NCT03083483|50142940|FG000|Overall Study|technological issues|1|||
25041810|NCT03083483|50142941|FG001|Overall Study|technological issues|0|||
25041811|NCT03083483|50142942|FG002|Overall Study|technological issues|1|||
25041812|NCT03085927|50142954|FG000|Overall Study|Withdrawal by Subject|1|||
25041813|NCT03085927|50142955|FG001|Overall Study|Withdrawal by Subject|4|||
25041814|NCT03085927|50142954|FG000|Overall Study|Lost to Follow-up|3|||
24955165|NCT00335556|50046182|FG005|Overall Study|Ineligible|0|||
24955166|NCT00335556|50046177|FG000|Overall Study|Refusal of further protocol therapy|0|||
25160284|NCT01831765|50280391|FG000|Overall Study|Death|0|||
25160285|NCT01831765|50280392|FG001|Overall Study|Death|1|||
25160286|NCT01831765|50280393|FG002|Overall Study|Death|1|||
25160287|NCT01831765|50280391|FG000|Overall Study|Other, site closed|1|||
25160288|NCT01831765|50280392|FG001|Overall Study|Other, site closed|1|||
24955167|NCT00335556|50046178|FG001|Overall Study|Refusal of further protocol therapy|4|||
24955168|NCT00335556|50046179|FG002|Overall Study|Refusal of further protocol therapy|0|||
24955169|NCT00335556|50046180|FG003|Overall Study|Refusal of further protocol therapy|1|||
24955170|NCT00335556|50046181|FG004|Overall Study|Refusal of further protocol therapy|0|||
24955171|NCT00335556|50046182|FG005|Overall Study|Refusal of further protocol therapy|0|||
24955172|NCT00518687|50046203|FG000|Overall Study|Adverse Event|201|||
25160289|NCT01831765|50280393|FG002|Overall Study|Other, site closed|0|||
24955173|NCT00518687|50046204|FG001|Overall Study|Adverse Event|177|||
24955174|NCT00518687|50046203|FG000|Overall Study|Lost to Follow-up|144|||
24955175|NCT00518687|50046204|FG001|Overall Study|Lost to Follow-up|155|||
24955176|NCT00518687|50046203|FG000|Overall Study|Physician Decision|42|||
24955177|NCT00518687|50046204|FG001|Overall Study|Physician Decision|48|||
24955178|NCT00518687|50046203|FG000|Overall Study|Progressive disease|2|||
24955179|NCT00518687|50046204|FG001|Overall Study|Progressive disease|2|||
24955180|NCT00518687|50046203|FG000|Overall Study|Protocol Violation|8|||
24955181|NCT00518687|50046204|FG001|Overall Study|Protocol Violation|10|||
24955182|NCT00518687|50046203|FG000|Overall Study|Study terminated by sponsor|930|||
24955183|NCT00518687|50046204|FG001|Overall Study|Study terminated by sponsor|918|||
24955184|NCT00518687|50046203|FG000|Overall Study|Withdrawal by Subject|110|||
24955185|NCT00518687|50046204|FG001|Overall Study|Withdrawal by Subject|110|||
24955186|NCT00134056|50046212|FG000|Randomization|Not eligible for assigned treatment|22|||
24955187|NCT00134056|50046213|FG001|Randomization|Not eligible for assigned treatment|20|||
24955188|NCT00134056|50046212|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
24955189|NCT00134056|50046213|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
24955190|NCT00134056|50046212|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
24955191|NCT00134056|50046213|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
24955192|NCT00134056|50046212|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
24955193|NCT00134056|50046213|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
24955194|NCT00134056|50046212|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
24955195|NCT00134056|50046213|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
24955196|NCT00518531|50046224|FG000|Treatment Period 1|Adverse Event|5|||
24955197|NCT00518531|50046225|FG001|Treatment Period 1|Adverse Event|0|||
24955198|NCT00518531|50046224|FG000|Treatment Period 1|Lost to Follow-up|5|||
24955199|NCT00518531|50046225|FG001|Treatment Period 1|Lost to Follow-up|3|||
24955200|NCT00518531|50046224|FG000|Treatment Period 1|Physician Decision|1|||
24955201|NCT00518531|50046225|FG001|Treatment Period 1|Physician Decision|0|||
24955202|NCT00518531|50046224|FG000|Treatment Period 1|Protocol Violation|2|||
24955203|NCT00518531|50046225|FG001|Treatment Period 1|Protocol Violation|0|||
24955204|NCT00518531|50046224|FG000|Treatment Period 1|Withdrawal by Subject|4|||
24955205|NCT00518531|50046225|FG001|Treatment Period 1|Withdrawal by Subject|6|||
24955206|NCT00518531|50046224|FG000|Treatment Period 1|Early crossover|1|||
24955207|NCT00518531|50046225|FG001|Treatment Period 1|Early crossover|3|||
24955208|NCT00518531|50046224|FG000|Treatment Period 2|Withdrawal by Subject|0|||
24955209|NCT00518531|50046225|FG001|Treatment Period 2|Withdrawal by Subject|8|||
24955210|NCT00518531|50046224|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
24955211|NCT00518531|50046225|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
24955212|NCT00518531|50046224|FG000|Treatment Period 2|Adverse Event|1|||
24955213|NCT00518531|50046225|FG001|Treatment Period 2|Adverse Event|7|||
24955214|NCT00518531|50046224|FG000|Treatment Period 2|Protocol-specified criteria|0|||
24955215|NCT00518531|50046225|FG001|Treatment Period 2|Protocol-specified criteria|1|||
24955216|NCT00518531|50046224|FG000|Treatment Period 2|Non-compliance|1|||
24955217|NCT00518531|50046225|FG001|Treatment Period 2|Non-compliance|2|||
24955218|NCT00351468|50046233|FG000|Overall Study|Adverse Event|42|||
24955219|NCT00351468|50046233|FG000|Overall Study|Withdrawal by Subject|39|||
24955220|NCT00351468|50046233|FG000|Overall Study|Various -follow up w clinical team|39|||
24955221|NCT00351468|50046233|FG000|Overall Study|Lack of Efficacy|32|||
24955222|NCT00351468|50046233|FG000|Overall Study|Non-compliance|8|||
24955223|NCT00351468|50046233|FG000|Overall Study|Lost to Follow-up|4|||
24955224|NCT00351468|50046233|FG000|Overall Study|Protocol Violation|3|||
24955225|NCT00523991|50046240|FG000|Overall Study|Adverse Event|6|||
24955226|NCT00523991|50046241|FG001|Overall Study|Adverse Event|5|||
24955227|NCT00523991|50046240|FG000|Overall Study|Protocol Violation|1|||
24955228|NCT00523991|50046241|FG001|Overall Study|Protocol Violation|4|||
24955229|NCT00523991|50046240|FG000|Overall Study|Lost to Follow-up|4|||
24955230|NCT00523991|50046241|FG001|Overall Study|Lost to Follow-up|1|||
25160290|NCT01831765|50280391|FG000|Overall Study|Adverse Event|5|||
24955231|NCT00523991|50046240|FG000|Overall Study|Withdrawal by Subject|7|||
24955232|NCT00523991|50046241|FG001|Overall Study|Withdrawal by Subject|17|||
24955233|NCT00523991|50046240|FG000|Overall Study|Other reason (not specified)|3|||
24955234|NCT00523991|50046241|FG001|Overall Study|Other reason (not specified)|0|||
25160291|NCT01831765|50280392|FG001|Overall Study|Adverse Event|3|||
25160292|NCT01831765|50280393|FG002|Overall Study|Adverse Event|3|||
25160293|NCT01831765|50280391|FG000|Overall Study|Withdrawal by Subject|22|||
25160294|NCT01831765|50280392|FG001|Overall Study|Withdrawal by Subject|7|||
25160295|NCT01831765|50280393|FG002|Overall Study|Withdrawal by Subject|17|||
25160296|NCT01831765|50280391|FG000|Overall Study|Withdrawal criteria|12|||
25160297|NCT01831765|50280392|FG001|Overall Study|Withdrawal criteria|10|||
25160298|NCT01831765|50280393|FG002|Overall Study|Withdrawal criteria|16|||
24955235|NCT00350844|50046247|FG000|Overall Study|Lost to Follow-up|1|||
24955236|NCT00345540|50046251|FG000|Overall Study|Withdrawal by Subject|1|||
24955237|NCT00335322|50046258|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
24955238|NCT00335322|50046259|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
24955239|NCT00335322|50046260|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
24955240|NCT00523367|50046271|FG000|Overall Study|19 screen failures|19|||
24955241|NCT00523367|50046271|FG000|Overall Study|4 Withdrawn by PI|4|||
24955242|NCT03755765|50046278|FG000|Overall Study|Withdrawal by Subject|2|||
24955243|NCT03755765|50046279|FG001|Overall Study|Withdrawal by Subject|4|||
24955244|NCT03755765|50046280|FG002|Overall Study|Withdrawal by Subject|4|||
24955245|NCT00344448|50046288|FG000|Screening|Withdrawal by Subject|0|||
24955246|NCT00344448|50046289|FG001|Screening|Withdrawal by Subject|1|||
24955247|NCT00344448|50046288|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
24955248|NCT00344448|50046289|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
24955249|NCT00344448|50046288|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
24955250|NCT00344448|50046289|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
24955251|NCT00344448|50046288|FG000|Open Label|Withdrawal by Subject|1|||
24955252|NCT00344448|50046289|FG001|Open Label|Withdrawal by Subject|1|||
24955253|NCT00344448|50046288|FG000|Open Label|Study terminated|1|||
24955254|NCT00344448|50046289|FG001|Open Label|Study terminated|0|||
24955255|NCT00324168|50046297|FG000|Overall Study|Lost to Follow-up|19|||
24955256|NCT00324168|50046298|FG001|Overall Study|Lost to Follow-up|18|||
24955257|NCT00324168|50046297|FG000|Overall Study|Death|3|||
24955258|NCT00324168|50046298|FG001|Overall Study|Death|3|||
24955259|NCT00324168|50046297|FG000|Overall Study|Patient did not visit in f/u window|6|||
24955260|NCT00324168|50046298|FG001|Overall Study|Patient did not visit in f/u window|9|||
24955261|NCT00517829|50046306|FG000|Overall Study|Adverse Event|22|||
24955262|NCT00517829|50046307|FG001|Overall Study|Adverse Event|34|||
24955263|NCT00517829|50046306|FG000|Overall Study|Disease Progression|39|||
24955264|NCT00517829|50046307|FG001|Overall Study|Disease Progression|32|||
24955265|NCT00517829|50046306|FG000|Overall Study|Patient Request|6|||
24955266|NCT00517829|50046307|FG001|Overall Study|Patient Request|5|||
24955267|NCT00517829|50046306|FG000|Overall Study|Investigator Request|5|||
24955268|NCT00517829|50046307|FG001|Overall Study|Investigator Request|3|||
24955269|NCT00517829|50046306|FG000|Overall Study|Other|3|||
24955270|NCT00517829|50046307|FG001|Overall Study|Other|1|||
24955271|NCT00343512|50046313|FG000|Overall Study|Withdrawal by Subject|2|||
24955272|NCT00334542|50046318|FG000|Overall Study|Adverse Event|3|||
24955273|NCT00334542|50046318|FG000|Overall Study|Withdrawal by Subject|1|||
24955274|NCT00334542|50046318|FG000|Overall Study|New cancer diagnosis|1|||
24955275|NCT00112294|50046325|FG000|Overall Study|Still on study|5|||
24955276|NCT00112294|50046326|FG001|Overall Study|Still on study|0|||
24955277|NCT00235443|50046338|FG000|Overall Study|Adverse Event|4|||
24955278|NCT00235443|50046339|FG001|Overall Study|Adverse Event|12|||
24955279|NCT00235443|50046340|FG002|Overall Study|Adverse Event|17|||
24955280|NCT00235443|50046341|FG003|Overall Study|Adverse Event|44|||
24955281|NCT00235443|50046342|FG004|Overall Study|Adverse Event|10|||
24955282|NCT00235443|50046343|FG005|Overall Study|Adverse Event|15|||
24955283|NCT00235443|50046338|FG000|Overall Study|Lack of Efficacy|0|||
24955284|NCT00235443|50046339|FG001|Overall Study|Lack of Efficacy|1|||
25041815|NCT03085927|50142955|FG001|Overall Study|Lost to Follow-up|1|||
25041816|NCT03085927|50142954|FG000|Overall Study|Death|1|||
25041817|NCT03085927|50142955|FG001|Overall Study|Death|0|||
25041818|NCT03085927|50142954|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
25041819|NCT03085927|50142955|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
25041820|NCT03085927|50142954|FG000|Overall Study|Dyad Became Ineligible|0|||
25041821|NCT03085927|50142955|FG001|Overall Study|Dyad Became Ineligible|1|||
25041822|NCT04392583|50142963|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
25041823|NCT04497987|50142969|FG000|Overall Study|Adverse Event|1|||
25041824|NCT04497987|50142970|FG001|Overall Study|Adverse Event|0|||
25041825|NCT04497987|50142969|FG000|Overall Study|Death|21|||
25041826|NCT04497987|50142970|FG001|Overall Study|Death|13|||
25041827|NCT04497987|50142969|FG000|Overall Study|Lost to Follow-up|19|||
25041828|NCT04497987|50142970|FG001|Overall Study|Lost to Follow-up|17|||
25041829|NCT04497987|50142969|FG000|Overall Study|Other - as reported by the investigator|22|||
25041830|NCT04497987|50142970|FG001|Overall Study|Other - as reported by the investigator|16|||
25041831|NCT04497987|50142969|FG000|Overall Study|Physician Decision|1|||
25041832|NCT04497987|50142970|FG001|Overall Study|Physician Decision|0|||
25041833|NCT04497987|50142969|FG000|Overall Study|Withdrawal by Subject|35|||
25041834|NCT04497987|50142970|FG001|Overall Study|Withdrawal by Subject|21|||
25041835|NCT00974571|50142980|FG000|Overall Study|Adverse Event|31|||
25041836|NCT00974571|50142981|FG001|Overall Study|Adverse Event|4|||
25041837|NCT00974571|50142982|FG002|Overall Study|Adverse Event|27|||
25041838|NCT00974571|50142980|FG000|Overall Study|Lack of Efficacy|3|||
25041839|NCT00974571|50142981|FG001|Overall Study|Lack of Efficacy|2|||
25041840|NCT00974571|50142982|FG002|Overall Study|Lack of Efficacy|9|||
25041841|NCT00974571|50142980|FG000|Overall Study|Lost to Follow-up|2|||
25041842|NCT00974571|50142981|FG001|Overall Study|Lost to Follow-up|1|||
25041843|NCT00974571|50142982|FG002|Overall Study|Lost to Follow-up|2|||
25041844|NCT00974571|50142980|FG000|Overall Study|Protocol Violation|13|||
25041845|NCT00974571|50142981|FG001|Overall Study|Protocol Violation|4|||
25041846|NCT00974571|50142982|FG002|Overall Study|Protocol Violation|18|||
25041847|NCT00974571|50142980|FG000|Overall Study|Withdrawal by Subject|14|||
25041848|NCT00974571|50142981|FG001|Overall Study|Withdrawal by Subject|5|||
25041849|NCT00974571|50142982|FG002|Overall Study|Withdrawal by Subject|16|||
25041850|NCT00974571|50142980|FG000|Overall Study|Patient Moved|1|||
25041851|NCT00974571|50142981|FG001|Overall Study|Patient Moved|0|||
25041852|NCT00974571|50142982|FG002|Overall Study|Patient Moved|1|||
25041853|NCT00974571|50142980|FG000|Overall Study|Other|4|||
25041854|NCT00974571|50142981|FG001|Overall Study|Other|0|||
25041855|NCT00974571|50142982|FG002|Overall Study|Other|10|||
25041856|NCT02766608|50142995|FG000|Overall Study|Adverse Event|27|||
25041857|NCT02766608|50142996|FG001|Overall Study|Adverse Event|22|||
25041858|NCT02766608|50142997|FG002|Overall Study|Adverse Event|17|||
25041859|NCT02766608|50142998|FG003|Overall Study|Adverse Event|13|||
25041860|NCT02766608|50142999|FG004|Overall Study|Adverse Event|12|||
25041861|NCT02766608|50142995|FG000|Overall Study|Withdrawal by Subject|21|||
25041862|NCT02766608|50142996|FG001|Overall Study|Withdrawal by Subject|20|||
25041863|NCT02766608|50142997|FG002|Overall Study|Withdrawal by Subject|24|||
25041864|NCT02766608|50142998|FG003|Overall Study|Withdrawal by Subject|13|||
25041865|NCT02766608|50142999|FG004|Overall Study|Withdrawal by Subject|10|||
24955285|NCT00235443|50046340|FG002|Overall Study|Lack of Efficacy|5|||
24955286|NCT00235443|50046341|FG003|Overall Study|Lack of Efficacy|12|||
24955287|NCT00235443|50046342|FG004|Overall Study|Lack of Efficacy|2|||
24955288|NCT00235443|50046343|FG005|Overall Study|Lack of Efficacy|9|||
24955289|NCT00235443|50046338|FG000|Overall Study|Withdrawal by Subject|3|||
24955290|NCT00235443|50046339|FG001|Overall Study|Withdrawal by Subject|9|||
24955291|NCT00235443|50046340|FG002|Overall Study|Withdrawal by Subject|25|||
24955292|NCT00235443|50046341|FG003|Overall Study|Withdrawal by Subject|24|||
24955293|NCT00235443|50046342|FG004|Overall Study|Withdrawal by Subject|10|||
24955294|NCT00235443|50046343|FG005|Overall Study|Withdrawal by Subject|12|||
24955295|NCT00235443|50046338|FG000|Overall Study|Lost to Follow-up|0|||
25041866|NCT02766608|50142995|FG000|Overall Study|Lack of Efficacy|16|||
25041867|NCT02766608|50142996|FG001|Overall Study|Lack of Efficacy|15|||
25041868|NCT02766608|50142997|FG002|Overall Study|Lack of Efficacy|32|||
25041869|NCT02766608|50142998|FG003|Overall Study|Lack of Efficacy|8|||
25041870|NCT02766608|50142999|FG004|Overall Study|Lack of Efficacy|2|||
25041871|NCT02766608|50142995|FG000|Overall Study|Lost to Follow-up|6|||
25041872|NCT02766608|50142996|FG001|Overall Study|Lost to Follow-up|3|||
24955296|NCT00235443|50046339|FG001|Overall Study|Lost to Follow-up|8|||
24955297|NCT00235443|50046340|FG002|Overall Study|Lost to Follow-up|6|||
24955298|NCT00235443|50046341|FG003|Overall Study|Lost to Follow-up|6|||
24955299|NCT00235443|50046342|FG004|Overall Study|Lost to Follow-up|4|||
24955300|NCT00235443|50046343|FG005|Overall Study|Lost to Follow-up|3|||
25041873|NCT02766608|50142997|FG002|Overall Study|Lost to Follow-up|5|||
25041874|NCT02766608|50142998|FG003|Overall Study|Lost to Follow-up|2|||
25041875|NCT02766608|50142999|FG004|Overall Study|Lost to Follow-up|2|||
25041876|NCT02766608|50142995|FG000|Overall Study|Physician Decision|3|||
25041877|NCT02766608|50142996|FG001|Overall Study|Physician Decision|2|||
25041878|NCT02766608|50142997|FG002|Overall Study|Physician Decision|3|||
25041879|NCT02766608|50142998|FG003|Overall Study|Physician Decision|1|||
25041880|NCT02766608|50142999|FG004|Overall Study|Physician Decision|2|||
25041881|NCT02766608|50142995|FG000|Overall Study|Protocol disc criteria|3|||
25041882|NCT02766608|50142996|FG001|Overall Study|Protocol disc criteria|3|||
25041883|NCT02766608|50142997|FG002|Overall Study|Protocol disc criteria|4|||
25041884|NCT02766608|50142998|FG003|Overall Study|Protocol disc criteria|0|||
25041885|NCT02766608|50142999|FG004|Overall Study|Protocol disc criteria|0|||
24955301|NCT00235443|50046338|FG000|Overall Study|Unsatisfactory compliance|0|||
24955302|NCT00235443|50046339|FG001|Overall Study|Unsatisfactory compliance|2|||
24955303|NCT00235443|50046340|FG002|Overall Study|Unsatisfactory compliance|3|||
24955304|NCT00235443|50046341|FG003|Overall Study|Unsatisfactory compliance|4|||
24955305|NCT00235443|50046342|FG004|Overall Study|Unsatisfactory compliance|1|||
24955306|NCT00235443|50046343|FG005|Overall Study|Unsatisfactory compliance|0|||
24955307|NCT00235443|50046338|FG000|Overall Study|Other reasons for premature termination|1|||
24955308|NCT00235443|50046339|FG001|Overall Study|Other reasons for premature termination|6|||
25041886|NCT02766608|50142995|FG000|Overall Study|Protocol Violation|0|||
25041887|NCT02766608|50142996|FG001|Overall Study|Protocol Violation|4|||
25041888|NCT02766608|50142997|FG002|Overall Study|Protocol Violation|4|||
25041889|NCT02766608|50142998|FG003|Overall Study|Protocol Violation|0|||
25041890|NCT02766608|50142999|FG004|Overall Study|Protocol Violation|1|||
25041891|NCT02766608|50142995|FG000|Overall Study|Administrative Reasons|3|||
25041892|NCT02766608|50142996|FG001|Overall Study|Administrative Reasons|1|||
25041893|NCT02766608|50142997|FG002|Overall Study|Administrative Reasons|1|||
25041894|NCT02766608|50142998|FG003|Overall Study|Administrative Reasons|0|||
25041895|NCT02766608|50142999|FG004|Overall Study|Administrative Reasons|0|||
25041896|NCT00960141|50143017|FG000|Overall Study|Adverse Event|4|||
25041897|NCT00960141|50143018|FG001|Overall Study|Adverse Event|8|||
25041898|NCT00960141|50143019|FG002|Overall Study|Adverse Event|2|||
25041899|NCT00960141|50143017|FG000|Overall Study|Lack of Efficacy|3|||
25041900|NCT00960141|50143018|FG001|Overall Study|Lack of Efficacy|4|||
25041901|NCT00960141|50143019|FG002|Overall Study|Lack of Efficacy|2|||
25041902|NCT00960141|50143017|FG000|Overall Study|Lost to Follow-up|1|||
25041903|NCT00960141|50143018|FG001|Overall Study|Lost to Follow-up|0|||
25041904|NCT00960141|50143019|FG002|Overall Study|Lost to Follow-up|0|||
25041905|NCT00960141|50143017|FG000|Overall Study|Protocol Violation|1|||
25041906|NCT00960141|50143018|FG001|Overall Study|Protocol Violation|3|||
25041907|NCT00960141|50143019|FG002|Overall Study|Protocol Violation|2|||
25041908|NCT00960141|50143017|FG000|Overall Study|Withdrawal by Subject|1|||
25041909|NCT00960141|50143018|FG001|Overall Study|Withdrawal by Subject|2|||
25160299|NCT01831765|50280391|FG000|Overall Study|Lost to Follow-up|2|||
25041910|NCT00960141|50143019|FG002|Overall Study|Withdrawal by Subject|1|||
25041911|NCT02771522|50143027|FG000|Overall Study|Lost to Follow-up|3|||
25041912|NCT02771522|50143027|FG000|Overall Study|Withdrawal by Subject|2|||
25041913|NCT02771522|50143027|FG000|Overall Study|No white spot lesions|3|||
25041914|NCT00759655|50143036|FG000|Overall Study|Termination of the study by sponsor|1|||
25041915|NCT02771366|50143042|FG000|Period 1|Withdrawal by Subject|0|||
25041916|NCT02771366|50143043|FG001|Period 1|Withdrawal by Subject|2|||
25041917|NCT02771366|50143042|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
25041918|NCT02771366|50143043|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
25041919|NCT03396471|50143050|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
25041920|NCT03396471|50143050|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
25041921|NCT03396471|50143050|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
25041922|NCT03396471|50143050|FG000|Study Treatment - Up to 22 Months|Death|2|||
25041923|NCT03396471|50143050|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
25041924|NCT03396471|50143050|FG000|Follow up - Up to 2 Years|Death|9|||
25041925|NCT03396471|50143050|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
25160300|NCT01831765|50280392|FG001|Overall Study|Lost to Follow-up|3|||
25041926|NCT03396471|50143050|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
25160301|NCT01831765|50280393|FG002|Overall Study|Lost to Follow-up|3|||
25041927|NCT03396471|50143050|FG000|Follow up - Up to 2 Years|study terminated|1|||
24955309|NCT00235443|50046340|FG002|Overall Study|Other reasons for premature termination|6|||
24955310|NCT00235443|50046341|FG003|Overall Study|Other reasons for premature termination|7|||
24955311|NCT00235443|50046342|FG004|Overall Study|Other reasons for premature termination|3|||
24955312|NCT00235443|50046343|FG005|Overall Study|Other reasons for premature termination|6|||
24955313|NCT00234039|50046359|FG000|Overall Study|Adverse Event|2|||
24955314|NCT00234039|50046359|FG000|Overall Study|Progression/relapse|34|||
24955315|NCT00234039|50046359|FG000|Overall Study|Other - Not Protocol Specified|3|||
24955316|NCT00234039|50046359|FG000|Overall Study|Ineligible|9|||
25041928|NCT03396471|50143050|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
25041929|NCT03396471|50143050|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
25041930|NCT00103142|50143056|FG000|Overall Study|Adverse Event|1|||
25041931|NCT00103142|50143057|FG001|Overall Study|Adverse Event|0|||
24955317|NCT00234039|50046359|FG000|Overall Study|No Protocol Treatment Received|2|||
24955318|NCT00323622|50046371|FG000|Overall Study|Other|30|||
24955319|NCT00323622|50046372|FG001|Overall Study|Other|91|||
24955320|NCT00323622|50046373|FG002|Overall Study|Other|4|||
24955321|NCT00323622|50046374|FG003|Overall Study|Other|12|||
24955322|NCT00323622|50046375|FG004|Overall Study|Other|32|||
24955323|NCT00323622|50046376|FG005|Overall Study|Other|74|||
24955324|NCT00323622|50046377|FG006|Overall Study|Other|5|||
24955325|NCT00323622|50046378|FG007|Overall Study|Other|13|||
24955326|NCT00323622|50046371|FG000|Overall Study|Death|1|||
24955327|NCT00323622|50046372|FG001|Overall Study|Death|1|||
24955328|NCT00323622|50046373|FG002|Overall Study|Death|0|||
24955329|NCT00323622|50046374|FG003|Overall Study|Death|0|||
24955330|NCT00323622|50046375|FG004|Overall Study|Death|7|||
24955331|NCT00323622|50046376|FG005|Overall Study|Death|0|||
24955332|NCT00323622|50046377|FG006|Overall Study|Death|0|||
24955333|NCT00323622|50046378|FG007|Overall Study|Death|2|||
24955334|NCT00189423|50046406|FG000|Overall Study|Death|746|||
24955335|NCT00189423|50046407|FG001|Overall Study|Death|747|||
24955336|NCT00189423|50046406|FG000|Overall Study|Withdrawal by Subject|9|||
24955337|NCT00189423|50046407|FG001|Overall Study|Withdrawal by Subject|9|||
24955338|NCT00189423|50046406|FG000|Overall Study|Lost to Follow-up|10|||
24955339|NCT00189423|50046407|FG001|Overall Study|Lost to Follow-up|10|||
24955340|NCT00323310|50046413|FG000|Overall Study|Withdrawal by Subject|1|||
24955341|NCT00323310|50046413|FG000|Overall Study|a parent refused blood draw|1|||
24955342|NCT00323310|50046413|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
24955343|NCT00186537|50046420|FG000|Overall Study|Withdrawal by Subject|4|||
24955344|NCT00186537|50046421|FG001|Overall Study|Withdrawal by Subject|0|||
24955345|NCT00186537|50046422|FG002|Overall Study|Withdrawal by Subject|3|||
24955346|NCT00186537|50046420|FG000|Overall Study|ALT > 1.5 x ULN|3|||
24955347|NCT00186537|50046421|FG001|Overall Study|ALT > 1.5 x ULN|0|||
24955348|NCT00186537|50046422|FG002|Overall Study|ALT > 1.5 x ULN|0|||
24955349|NCT00517751|50046430|FG000|Overall Study|Death|3|||
25041932|NCT00103142|50143056|FG000|Overall Study|Progression of disease|2|||
25041933|NCT00103142|50143057|FG001|Overall Study|Progression of disease|1|||
25041934|NCT00943683|50143067|FG000|Overall Study|Adverse Event|3|||
25041935|NCT00943683|50143068|FG001|Overall Study|Adverse Event|3|||
25041936|NCT00943683|50143067|FG000|Overall Study|Lost to Follow-up|1|||
25041937|NCT00943683|50143068|FG001|Overall Study|Lost to Follow-up|1|||
25041938|NCT00943683|50143067|FG000|Overall Study|Protocol Violation|1|||
25041939|NCT00943683|50143068|FG001|Overall Study|Protocol Violation|2|||
25041940|NCT00943683|50143067|FG000|Overall Study|Withdrawal by Subject|1|||
25041941|NCT00943683|50143068|FG001|Overall Study|Withdrawal by Subject|0|||
25041942|NCT00943683|50143067|FG000|Overall Study|Patient Moved|1|||
25041943|NCT00943683|50143068|FG001|Overall Study|Patient Moved|0|||
25041944|NCT00911547|50143078|FG000|Overall Study|Adverse Event|8|||
24955350|NCT00517751|50046430|FG000|Overall Study|Withdrawal by Subject|37|||
24955351|NCT00517751|50046430|FG000|Overall Study|Lost to Follow-up|4|||
24955352|NCT00517751|50046430|FG000|Overall Study|patient not over due|6|||
24955353|NCT00517751|50046430|FG000|Overall Study|Patient not due for visit|76|||
24955354|NCT00517751|50046430|FG000|Overall Study|Missing|3|||
24955355|NCT00322842|50046436|FG000|Overall Study|Withdrawal by Subject|0|||
24955356|NCT00322842|50046437|FG001|Overall Study|Withdrawal by Subject|1|||
24955357|NCT00322842|50046436|FG000|Overall Study|Lost to Follow-up|0|||
25041945|NCT00911547|50143079|FG001|Overall Study|Adverse Event|27|||
24955358|NCT00322842|50046437|FG001|Overall Study|Lost to Follow-up|1|||
24955359|NCT00322842|50046436|FG000|Overall Study|Refused transplant|1|||
24955360|NCT00322842|50046437|FG001|Overall Study|Refused transplant|0|||
24955361|NCT00322842|50046436|FG000|Overall Study|Death|1|||
24955362|NCT00322842|50046437|FG001|Overall Study|Death|0|||
24955363|NCT00255723|50046446|FG000|Overall Study|Adverse Event|1|||
24955364|NCT00255723|50046447|FG001|Overall Study|Adverse Event|1|||
24955365|NCT00255723|50046446|FG000|Overall Study|Death|0|||
24955366|NCT00255723|50046447|FG001|Overall Study|Death|1|||
24955367|NCT00255723|50046446|FG000|Overall Study|Response Data Not Available|1|||
24955368|NCT00255723|50046447|FG001|Overall Study|Response Data Not Available|0|||
24955369|NCT00132808|50046456|FG000|Stratum I|Adverse Event|2|||
24955370|NCT00132808|50046457|FG001|Stratum I|Adverse Event|1|||
24955371|NCT00132808|50046458|FG002|Stratum I|Adverse Event|0|||
24955372|NCT00132808|50046456|FG000|Stratum I|Lost to Follow-up|3|||
24955373|NCT00132808|50046457|FG001|Stratum I|Lost to Follow-up|4|||
24955374|NCT00132808|50046458|FG002|Stratum I|Lost to Follow-up|1|||
24955375|NCT00132808|50046456|FG000|Stratum I|Withdrawal by Subject|4|||
24955376|NCT00132808|50046457|FG001|Stratum I|Withdrawal by Subject|7|||
24955377|NCT00132808|50046458|FG002|Stratum I|Withdrawal by Subject|3|||
24955378|NCT00132808|50046456|FG000|Stratum I|Abnormal test procedure result (s)|0|||
24955379|NCT00132808|50046457|FG001|Stratum I|Abnormal test procedure result (s)|0|||
24955380|NCT00132808|50046458|FG002|Stratum I|Abnormal test procedure result (s)|1|||
24955381|NCT00132808|50046456|FG000|Stratum II|Adverse Event|1|||
24955382|NCT00132808|50046457|FG001|Stratum II|Adverse Event|2|||
24955383|NCT00132808|50046458|FG002|Stratum II|Adverse Event|1|||
24955384|NCT00132808|50046456|FG000|Stratum II|Death|1|||
24955385|NCT00132808|50046457|FG001|Stratum II|Death|0|||
24955386|NCT00132808|50046458|FG002|Stratum II|Death|0|||
24955387|NCT00132808|50046456|FG000|Stratum II|Lost to Follow-up|2|||
24955388|NCT00132808|50046457|FG001|Stratum II|Lost to Follow-up|2|||
24955389|NCT00132808|50046458|FG002|Stratum II|Lost to Follow-up|1|||
24955390|NCT00132808|50046456|FG000|Stratum II|Protocol Violation|0|||
24955391|NCT00132808|50046457|FG001|Stratum II|Protocol Violation|2|||
24955392|NCT00132808|50046458|FG002|Stratum II|Protocol Violation|1|||
24955393|NCT00132808|50046456|FG000|Stratum II|Withdrawal by Subject|4|||
24955394|NCT00132808|50046457|FG001|Stratum II|Withdrawal by Subject|9|||
24955395|NCT00132808|50046458|FG002|Stratum II|Withdrawal by Subject|6|||
24955396|NCT00517361|50046466|FG000|Overall Study|Death|6|||
24955397|NCT00517361|50046466|FG000|Overall Study|The study was terminated|5|||
25041946|NCT00911547|50143080|FG002|Overall Study|Adverse Event|11|||
25041947|NCT00911547|50143081|FG003|Overall Study|Adverse Event|6|||
25041948|NCT00911547|50143078|FG000|Overall Study|Lost to Follow-up|0|||
25041949|NCT00911547|50143079|FG001|Overall Study|Lost to Follow-up|0|||
24955398|NCT00516893|50046470|FG000|Overall Study|Lost to Follow-up|4|||
24955399|NCT00516893|50046470|FG000|Overall Study|Adverse Event|3|||
24955400|NCT00516893|50046470|FG000|Overall Study|Withdrawal by Subject|2|||
24955401|NCT00516893|50046470|FG000|Overall Study|Noncompliance|2|||
24955402|NCT00516893|50046470|FG000|Overall Study|Death|1|||
24955403|NCT00516893|50046470|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
24955404|NCT00516893|50046470|FG000|Overall Study|Relocated|1|||
24955405|NCT00516893|50046470|FG000|Overall Study|Pregnancy|1|||
24955406|NCT00516893|50046470|FG000|Overall Study|Received Medication From Another Study|1|||
24955407|NCT00522431|50046474|FG000|Overall Study|Adverse Event|5|||
24955408|NCT00522431|50046474|FG000|Overall Study|Protocol Violation|2|||
24955409|NCT00522431|50046474|FG000|Overall Study|Withdrawal by Subject|2|||
24955410|NCT00522431|50046474|FG000|Overall Study|Subject non-compliance|1|||
25041950|NCT00911547|50143080|FG002|Overall Study|Lost to Follow-up|2|||
25041951|NCT00911547|50143081|FG003|Overall Study|Lost to Follow-up|1|||
24955411|NCT00522431|50046474|FG000|Overall Study|Other/unknown|1|||
24955412|NCT00185211|50046480|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
24955413|NCT00185211|50046481|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
24955414|NCT00185211|50046480|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
24955415|NCT00185211|50046481|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
24955416|NCT00185211|50046480|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
24955417|NCT00185211|50046481|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
24955418|NCT00185211|50046480|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
24955419|NCT00185211|50046481|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
24955420|NCT00185211|50046480|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
24955421|NCT00185211|50046481|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
24955422|NCT00185211|50046480|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
24955423|NCT00185211|50046481|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
24955424|NCT00185211|50046480|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
24955425|NCT00185211|50046481|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
24955426|NCT00185211|50046480|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
24955427|NCT00185211|50046481|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
24955428|NCT00185211|50046480|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
24955429|NCT00185211|50046481|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
24955430|NCT00185211|50046480|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
24955431|NCT00185211|50046481|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
24955432|NCT00185211|50046480|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
24955433|NCT00185211|50046481|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
24955434|NCT00185211|50046480|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
24955435|NCT00185211|50046481|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
24955436|NCT00516737|50046490|FG000|Overall Study|Lost to Follow-up|2|||
24955437|NCT00516737|50046491|FG001|Overall Study|Lost to Follow-up|0|||
24955438|NCT00516737|50046490|FG000|Overall Study|Physician Decision|0|||
24955439|NCT00516737|50046491|FG001|Overall Study|Physician Decision|1|||
24955440|NCT00516737|50046490|FG000|Overall Study|Withdrawal by Subject|0|||
24955441|NCT00516737|50046491|FG001|Overall Study|Withdrawal by Subject|1|||
24955442|NCT00516737|50046490|FG000|Overall Study|Lack of Qualifying Event|9|||
24955443|NCT00516737|50046491|FG001|Overall Study|Lack of Qualifying Event|6|||
24955444|NCT00132730|50046501|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
24955445|NCT00132730|50046502|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
24955446|NCT00132730|50046503|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
24955447|NCT00132730|50046504|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
24955448|NCT00132730|50046505|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
24955449|NCT00132730|50046506|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
24955450|NCT00132730|50046501|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
24955451|NCT00132730|50046502|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
24955452|NCT00132730|50046503|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
24955453|NCT00132730|50046504|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
24955454|NCT00132730|50046505|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
24955455|NCT00132730|50046506|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
24955456|NCT00132730|50046501|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
24955457|NCT00132730|50046502|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
24955458|NCT00132730|50046503|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
24955459|NCT00132730|50046504|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
24955460|NCT00132730|50046505|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
24955461|NCT00132730|50046506|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
24955462|NCT00132730|50046501|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
24955463|NCT00132730|50046502|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
24955464|NCT00132730|50046503|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
24955465|NCT00132730|50046504|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
24955466|NCT00132730|50046505|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
24955467|NCT00132730|50046506|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
24955468|NCT00132730|50046501|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
24955469|NCT00132730|50046502|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
24955470|NCT00132730|50046503|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
24955471|NCT00132730|50046504|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
24955472|NCT00132730|50046505|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
24955473|NCT00132730|50046506|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
24955474|NCT00132730|50046501|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
25041952|NCT00911547|50143078|FG000|Overall Study|Protocol Violation|0|||
24955475|NCT00132730|50046502|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
24955476|NCT00132730|50046503|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
24955477|NCT00132730|50046504|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
24955478|NCT00132730|50046505|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
24955479|NCT00132730|50046506|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
24955480|NCT00132730|50046501|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
24955481|NCT00132730|50046502|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
24955482|NCT00132730|50046503|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
24955483|NCT00132730|50046504|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
24955484|NCT00132730|50046505|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
24955485|NCT00132730|50046506|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
24955486|NCT00132730|50046501|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
24955487|NCT00132730|50046502|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
24955488|NCT00132730|50046503|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
24955489|NCT00132730|50046504|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
24955490|NCT00132730|50046505|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
24955491|NCT00132730|50046506|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
24955492|NCT00132730|50046501|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
24955493|NCT00132730|50046502|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
24955494|NCT00132730|50046503|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
24955495|NCT00132730|50046504|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
24955496|NCT00132730|50046505|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
24955497|NCT00132730|50046506|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
24955498|NCT00132730|50046501|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
24955499|NCT00132730|50046502|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
24955500|NCT00132730|50046503|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
24955501|NCT00132730|50046504|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
24955502|NCT00132730|50046505|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
24955503|NCT00132730|50046506|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
24955504|NCT00132730|50046501|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
24955505|NCT00132730|50046502|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
24955506|NCT00132730|50046503|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
24955507|NCT00132730|50046504|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
24955508|NCT00132730|50046505|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
24955509|NCT00132730|50046506|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
24955510|NCT00132730|50046501|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
24955511|NCT00132730|50046502|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
24955512|NCT00132730|50046503|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
24955513|NCT00132730|50046504|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
24955514|NCT00132730|50046505|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
24955515|NCT00132730|50046506|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
24955516|NCT00232557|50046522|FG000|Overall Study|Lost to Follow-up|3|||
24955517|NCT00232557|50046523|FG001|Overall Study|Lost to Follow-up|5|||
24955518|NCT00522275|50046529|FG000|Overall Study|Adverse Event|35|||
24955519|NCT00522275|50046529|FG000|Overall Study|Lack of Efficacy|80|||
24955520|NCT00522275|50046529|FG000|Overall Study|Subject withdrew consent|16|||
24955521|NCT00522275|50046529|FG000|Overall Study|Protocol deviation|1|||
24955522|NCT00522275|50046529|FG000|Overall Study|Unsatisfactory compliance|11|||
24955523|NCT00522275|50046529|FG000|Overall Study|Lost to Follow-up|8|||
24955524|NCT00522275|50046529|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
24955525|NCT00522275|50046529|FG000|Overall Study|Other: Subject is pregnant|2|||
24955526|NCT00522275|50046529|FG000|Overall Study|Other: Subject relocated|2|||
24955527|NCT00522275|50046529|FG000|Overall Study|Other: Subject arrested|1|||
24955528|NCT00522275|50046529|FG000|Overall Study|Other: Site / clinic closed|4|||
24955529|NCT00522275|50046529|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
24955530|NCT00522275|50046529|FG000|Overall Study|Other: Sponsor request|2|||
24955531|NCT00522275|50046529|FG000|Overall Study|Other: Subject ran out of medication|1|||
24955532|NCT00522275|50046529|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
24955533|NCT00522041|50046535|FG000|Overall Study|Adverse Event|9|||
24955534|NCT00522041|50046536|FG001|Overall Study|Adverse Event|3|||
24955535|NCT00522041|50046535|FG000|Overall Study|Protocol Violation|2|||
24955536|NCT00522041|50046536|FG001|Overall Study|Protocol Violation|0|||
24955537|NCT00522041|50046535|FG000|Overall Study|Lost to Follow-up|1|||
24955538|NCT00522041|50046536|FG001|Overall Study|Lost to Follow-up|4|||
25160302|NCT01749800|50280406|FG000|Overall Study|not meeting inclusion criteria|3|||
25160303|NCT01749800|50280407|FG001|Overall Study|not meeting inclusion criteria|0|||
25160304|NCT01749800|50280408|FG002|Overall Study|not meeting inclusion criteria|0|||
24955539|NCT00522041|50046535|FG000|Overall Study|Voluntary withdrawal|5|||
24955540|NCT00522041|50046536|FG001|Overall Study|Voluntary withdrawal|4|||
24955541|NCT00522041|50046535|FG000|Overall Study|Did not receive treatment|0|||
24955542|NCT00522041|50046536|FG001|Overall Study|Did not receive treatment|1|||
24955543|NCT00122980|50046545|FG000|Overall Study|Death|0|||
24955544|NCT00122980|50046546|FG001|Overall Study|Death|1|||
24955545|NCT00122980|50046545|FG000|Overall Study|Physician Decision|2|||
24955546|NCT00122980|50046546|FG001|Overall Study|Physician Decision|0|||
24955547|NCT00122980|50046545|FG000|Overall Study|Protocol Violation|5|||
24955548|NCT00122980|50046546|FG001|Overall Study|Protocol Violation|1|||
24955549|NCT00122980|50046545|FG000|Overall Study|Withdrawal by Subject|2|||
24955550|NCT00122980|50046546|FG001|Overall Study|Withdrawal by Subject|3|||
24955551|NCT00122980|50046545|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
24955552|NCT00122980|50046546|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
24955553|NCT00122980|50046545|FG000|Overall Study|Study termination|27|||
24955554|NCT00122980|50046546|FG001|Overall Study|Study termination|35|||
24955555|NCT03868631|50046554|FG000|Baseline to Week 6|Adverse Event|0|||
24955556|NCT03868631|50046555|FG001|Baseline to Week 6|Adverse Event|3|||
24955557|NCT03868631|50046554|FG000|Baseline to Week 6|Protocol Violation|1|||
24955558|NCT03868631|50046555|FG001|Baseline to Week 6|Protocol Violation|1|||
24955559|NCT03868631|50046554|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
24955560|NCT03868631|50046555|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
24955561|NCT03868631|50046554|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
24955562|NCT03868631|50046555|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
24955563|NCT03868631|50046554|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
24955564|NCT03868631|50046555|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
24955565|NCT03868631|50046554|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
24955566|NCT03868631|50046555|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
24955567|NCT00340704|50046570|FG000|PK Study|Adverse Event|0|||
24955568|NCT00340704|50046571|FG001|PK Study|Adverse Event|1|||
24955569|NCT00340704|50046572|FG002|PK Study|Adverse Event|0|||
24955570|NCT00340704|50046573|FG003|PK Study|Adverse Event|0|||
24955571|NCT00340704|50046574|FG004|PK Study|Adverse Event|0|||
24955572|NCT00340704|50046575|FG005|PK Study|Adverse Event|0|||
24955573|NCT00340704|50046576|FG006|PK Study|Adverse Event|0|||
24955574|NCT00340704|50046577|FG007|PK Study|Adverse Event|0|||
24955575|NCT00340704|50046578|FG008|PK Study|Adverse Event|0|||
24955576|NCT00340704|50046570|FG000|PK Study|Not treated|0|||
24955577|NCT00340704|50046571|FG001|PK Study|Not treated|0|||
24955578|NCT00340704|50046572|FG002|PK Study|Not treated|1|||
24955579|NCT00340704|50046573|FG003|PK Study|Not treated|0|||
24955580|NCT00340704|50046574|FG004|PK Study|Not treated|0|||
24955581|NCT00340704|50046575|FG005|PK Study|Not treated|0|||
24955582|NCT00340704|50046576|FG006|PK Study|Not treated|0|||
25041953|NCT00911547|50143079|FG001|Overall Study|Protocol Violation|5|||
25041954|NCT00911547|50143080|FG002|Overall Study|Protocol Violation|5|||
25041955|NCT00911547|50143081|FG003|Overall Study|Protocol Violation|1|||
25041956|NCT00911547|50143078|FG000|Overall Study|Withdrawal by Subject|3|||
25041957|NCT00911547|50143079|FG001|Overall Study|Withdrawal by Subject|10|||
25041958|NCT00911547|50143080|FG002|Overall Study|Withdrawal by Subject|4|||
25041959|NCT00911547|50143081|FG003|Overall Study|Withdrawal by Subject|8|||
25041960|NCT00899379|50143096|FG000|Overall Study|Adverse Event|2|||
25041961|NCT00899379|50143097|FG001|Overall Study|Adverse Event|2|||
25041962|NCT00899379|50143098|FG002|Overall Study|Adverse Event|1|||
25041963|NCT00899379|50143099|FG003|Overall Study|Adverse Event|1|||
25041964|NCT00899379|50143100|FG004|Overall Study|Adverse Event|2|||
25041965|NCT00899379|50143096|FG000|Overall Study|Lack of Efficacy|0|||
25041966|NCT00899379|50143097|FG001|Overall Study|Lack of Efficacy|4|||
25041967|NCT00899379|50143098|FG002|Overall Study|Lack of Efficacy|3|||
25041968|NCT00899379|50143099|FG003|Overall Study|Lack of Efficacy|0|||
25041969|NCT00899379|50143100|FG004|Overall Study|Lack of Efficacy|1|||
25041970|NCT00899379|50143096|FG000|Overall Study|Lost to Follow-up|9|||
25041971|NCT00899379|50143097|FG001|Overall Study|Lost to Follow-up|3|||
25041972|NCT00899379|50143098|FG002|Overall Study|Lost to Follow-up|0|||
24955583|NCT00340704|50046577|FG007|PK Study|Not treated|0|||
24955584|NCT00340704|50046578|FG008|PK Study|Not treated|0|||
24955585|NCT00340704|50046570|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
24955586|NCT00340704|50046571|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
24955587|NCT00340704|50046572|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
24955588|NCT00340704|50046573|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
24955589|NCT00340704|50046574|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
24955590|NCT00340704|50046575|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
24955591|NCT00340704|50046576|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
24955592|NCT00340704|50046577|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
24955593|NCT00340704|50046578|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
24955594|NCT00340704|50046570|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
24955595|NCT00340704|50046571|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
24955596|NCT00340704|50046572|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
24955597|NCT00340704|50046573|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
24955598|NCT00340704|50046574|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
24955599|NCT00340704|50046575|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
24955600|NCT00340704|50046576|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
24955601|NCT00340704|50046577|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
24955602|NCT00340704|50046578|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
24955603|NCT00340704|50046570|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
24955604|NCT00340704|50046571|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
24955605|NCT00340704|50046572|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
24955606|NCT00340704|50046573|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
24955607|NCT00340704|50046574|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
25041973|NCT00899379|50143099|FG003|Overall Study|Lost to Follow-up|6|||
25041974|NCT00899379|50143100|FG004|Overall Study|Lost to Follow-up|2|||
25276203|NCT00963820|50590162|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25041975|NCT00899379|50143096|FG000|Overall Study|Protocol Violation|0|||
25041976|NCT00899379|50143097|FG001|Overall Study|Protocol Violation|0|||
25041977|NCT00899379|50143098|FG002|Overall Study|Protocol Violation|1|||
25041978|NCT00899379|50143099|FG003|Overall Study|Protocol Violation|1|||
25041979|NCT00899379|50143100|FG004|Overall Study|Protocol Violation|0|||
25041980|NCT00899379|50143096|FG000|Overall Study|Withdrawal by Subject|2|||
25041981|NCT00899379|50143097|FG001|Overall Study|Withdrawal by Subject|4|||
25041982|NCT00899379|50143098|FG002|Overall Study|Withdrawal by Subject|2|||
25041983|NCT00899379|50143099|FG003|Overall Study|Withdrawal by Subject|3|||
25041984|NCT00899379|50143100|FG004|Overall Study|Withdrawal by Subject|6|||
25041985|NCT00899379|50143096|FG000|Overall Study|Pregnancy|0|||
25041986|NCT00899379|50143097|FG001|Overall Study|Pregnancy|0|||
25041987|NCT00899379|50143098|FG002|Overall Study|Pregnancy|1|||
25041988|NCT00899379|50143099|FG003|Overall Study|Pregnancy|0|||
25041989|NCT00899379|50143100|FG004|Overall Study|Pregnancy|1|||
25041990|NCT00899379|50143096|FG000|Overall Study|Patient Uncooperative|0|||
25041991|NCT00899379|50143097|FG001|Overall Study|Patient Uncooperative|1|||
25041992|NCT00899379|50143098|FG002|Overall Study|Patient Uncooperative|0|||
25041993|NCT00899379|50143099|FG003|Overall Study|Patient Uncooperative|1|||
25041994|NCT00899379|50143100|FG004|Overall Study|Patient Uncooperative|2|||
25041995|NCT00899379|50143096|FG000|Overall Study|Abnormal Baseline ECG|0|||
25041996|NCT00899379|50143097|FG001|Overall Study|Abnormal Baseline ECG|0|||
25041997|NCT00899379|50143098|FG002|Overall Study|Abnormal Baseline ECG|0|||
25041998|NCT00899379|50143099|FG003|Overall Study|Abnormal Baseline ECG|1|||
25041999|NCT00899379|50143100|FG004|Overall Study|Abnormal Baseline ECG|0|||
25042000|NCT00899379|50143096|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
25042001|NCT00899379|50143097|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
25042002|NCT00899379|50143098|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
25042003|NCT00899379|50143099|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
25042004|NCT00899379|50143100|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
25042005|NCT00899379|50143096|FG000|Overall Study|Not Completed/Entered Extn|5|||
25042006|NCT00899379|50143097|FG001|Overall Study|Not Completed/Entered Extn|1|||
25042007|NCT00899379|50143098|FG002|Overall Study|Not Completed/Entered Extn|6|||
25042008|NCT00899379|50143099|FG003|Overall Study|Not Completed/Entered Extn|4|||
25042009|NCT00899379|50143100|FG004|Overall Study|Not Completed/Entered Extn|3|||
25042010|NCT00899379|50143096|FG000|Overall Study|Study Terminated|3|||
25042011|NCT00899379|50143097|FG001|Overall Study|Study Terminated|0|||
25042012|NCT00899379|50143098|FG002|Overall Study|Study Terminated|3|||
25042013|NCT00899379|50143099|FG003|Overall Study|Study Terminated|3|||
25042014|NCT00899379|50143100|FG004|Overall Study|Study Terminated|1|||
25042015|NCT00899379|50143096|FG000|Overall Study|Lost to Follow-up|3|||
25042016|NCT00899379|50143097|FG001|Overall Study|Lost to Follow-up|1|||
25042017|NCT00899379|50143098|FG002|Overall Study|Lost to Follow-up|0|||
25042018|NCT00899379|50143099|FG003|Overall Study|Lost to Follow-up|2|||
25042019|NCT00899379|50143100|FG004|Overall Study|Lost to Follow-up|5|||
25042020|NCT00899379|50143096|FG000|Overall Study|Withdrawal by Subject|4|||
25042021|NCT00899379|50143097|FG001|Overall Study|Withdrawal by Subject|7|||
25042022|NCT00899379|50143098|FG002|Overall Study|Withdrawal by Subject|4|||
25042023|NCT00899379|50143099|FG003|Overall Study|Withdrawal by Subject|7|||
25042024|NCT00899379|50143100|FG004|Overall Study|Withdrawal by Subject|2|||
25042025|NCT00899379|50143096|FG000|Overall Study|Pregnancy|1|||
25042026|NCT00899379|50143097|FG001|Overall Study|Pregnancy|0|||
25042027|NCT00899379|50143098|FG002|Overall Study|Pregnancy|0|||
25042028|NCT00899379|50143099|FG003|Overall Study|Pregnancy|0|||
25042029|NCT00899379|50143100|FG004|Overall Study|Pregnancy|0|||
25042030|NCT00899379|50143096|FG000|Overall Study|Patient Uncooperative|0|||
25042031|NCT00899379|50143097|FG001|Overall Study|Patient Uncooperative|0|||
25042032|NCT00899379|50143098|FG002|Overall Study|Patient Uncooperative|0|||
25042033|NCT00899379|50143099|FG003|Overall Study|Patient Uncooperative|1|||
25042034|NCT00899379|50143100|FG004|Overall Study|Patient Uncooperative|0|||
25042035|NCT00899379|50143096|FG000|Overall Study|Abnormal Prestudy Labs|0|||
25042036|NCT00899379|50143097|FG001|Overall Study|Abnormal Prestudy Labs|0|||
25042037|NCT00899379|50143098|FG002|Overall Study|Abnormal Prestudy Labs|0|||
24955608|NCT00340704|50046575|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
25042038|NCT00899379|50143099|FG003|Overall Study|Abnormal Prestudy Labs|0|||
25042039|NCT00899379|50143100|FG004|Overall Study|Abnormal Prestudy Labs|2|||
25042040|NCT00899379|50143096|FG000|Overall Study|Abnormal Baseline ECG|0|||
25042041|NCT00899379|50143097|FG001|Overall Study|Abnormal Baseline ECG|0|||
25042042|NCT00899379|50143098|FG002|Overall Study|Abnormal Baseline ECG|1|||
25042043|NCT00899379|50143099|FG003|Overall Study|Abnormal Baseline ECG|1|||
25042044|NCT00899379|50143100|FG004|Overall Study|Abnormal Baseline ECG|0|||
25042045|NCT00899379|50143096|FG000|Overall Study|No Attack Pretreatment|3|||
25042046|NCT00899379|50143097|FG001|Overall Study|No Attack Pretreatment|5|||
25042047|NCT00899379|50143098|FG002|Overall Study|No Attack Pretreatment|5|||
25042048|NCT00899379|50143099|FG003|Overall Study|No Attack Pretreatment|6|||
25042049|NCT00899379|50143100|FG004|Overall Study|No Attack Pretreatment|4|||
25042050|NCT00899379|50143096|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
25042051|NCT00899379|50143097|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
25042052|NCT00899379|50143098|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
25042053|NCT00899379|50143099|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
25042054|NCT00899379|50143100|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
25042055|NCT00899379|50143096|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
25042056|NCT00899379|50143097|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
25042057|NCT00899379|50143098|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
25042058|NCT00899379|50143099|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
25042059|NCT00899379|50143100|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
25042060|NCT04326439|50143108|FG000|Overall Study|Withdrawal by Subject|1|||
25042061|NCT04326439|50143109|FG001|Overall Study|Withdrawal by Subject|0|||
25042062|NCT04326439|50143108|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
25042063|NCT04326439|50143109|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
25042064|NCT04326439|50143108|FG000|Overall Study|Relapse after Induction 2|0|||
25042065|NCT04326439|50143109|FG001|Overall Study|Relapse after Induction 2|1|||
25042066|NCT04326439|50143108|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
25042067|NCT04326439|50143109|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
24955609|NCT00340704|50046576|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
24955610|NCT00340704|50046577|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
24955611|NCT00340704|50046578|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
24955612|NCT00340704|50046570|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
24955613|NCT00340704|50046571|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
24955614|NCT00340704|50046572|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
25042068|NCT00145795|50143123|FG000|Overall Study|Adverse Event|1|||
25042069|NCT00145795|50143124|FG001|Overall Study|Adverse Event|0|||
25042070|NCT02771210|50143132|FG000|Period 1|Adverse Event|5|||
25042071|NCT02771210|50143133|FG001|Period 1|Adverse Event|3|||
25042072|NCT02771210|50143132|FG000|Period 1|Lack of Efficacy|3|||
25042073|NCT02771210|50143133|FG001|Period 1|Lack of Efficacy|6|||
25042074|NCT02771210|50143132|FG000|Period 1|Lost to Follow-up|2|||
25042075|NCT02771210|50143133|FG001|Period 1|Lost to Follow-up|0|||
25042076|NCT02771210|50143132|FG000|Period 1|Physician Decision|0|||
25042077|NCT02771210|50143133|FG001|Period 1|Physician Decision|1|||
25042078|NCT02771210|50143132|FG000|Period 1|Withdrawal by Subject|0|||
25042079|NCT02771210|50143133|FG001|Period 1|Withdrawal by Subject|3|||
25042080|NCT02771210|50143132|FG000|Period 1|Withdrawal of informed consent|1|||
25042081|NCT02771210|50143133|FG001|Period 1|Withdrawal of informed consent|5|||
25042082|NCT02771210|50143132|FG000|Period 2|Adverse Event|1|||
25042083|NCT02771210|50143133|FG001|Period 2|Adverse Event|0|||
25042084|NCT02771210|50143132|FG000|Period 2|Lack of Efficacy|0|||
25276204|NCT00963820|50590163|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25276205|NCT00963820|50590164|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25042085|NCT02771210|50143133|FG001|Period 2|Lack of Efficacy|1|||
25042086|NCT02771210|50143132|FG000|Period 2|Withdrawal by Subject|1|||
25042087|NCT02771210|50143133|FG001|Period 2|Withdrawal by Subject|0|||
25042088|NCT02771210|50143132|FG000|Period 2|Withdrawal of informed consent|0|||
25042089|NCT02771210|50143133|FG001|Period 2|Withdrawal of informed consent|2|||
25042090|NCT00898677|50143143|FG000|Overall Study|Adverse Event|0|||
25042091|NCT00898677|50143144|FG001|Overall Study|Adverse Event|0|||
25042092|NCT00898677|50143145|FG002|Overall Study|Adverse Event|1|||
25042093|NCT00898677|50143146|FG003|Overall Study|Adverse Event|0|||
25042094|NCT00898677|50143143|FG000|Overall Study|Lost to Follow-up|0|||
25042095|NCT00898677|50143144|FG001|Overall Study|Lost to Follow-up|0|||
25042096|NCT00898677|50143145|FG002|Overall Study|Lost to Follow-up|2|||
25042097|NCT00898677|50143146|FG003|Overall Study|Lost to Follow-up|0|||
25042098|NCT00898677|50143143|FG000|Overall Study|Protocol Violation|1|||
25042099|NCT00898677|50143144|FG001|Overall Study|Protocol Violation|1|||
24955615|NCT00340704|50046573|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
24955616|NCT00340704|50046574|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
24955617|NCT00340704|50046575|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
24955618|NCT00340704|50046576|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
24955619|NCT00340704|50046577|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
24955620|NCT00340704|50046578|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
24955621|NCT00132496|50046606|FG000|Overall Study|Withdrawal by Subject|1|||
24955622|NCT00132496|50046607|FG001|Overall Study|Withdrawal by Subject|2|||
24955623|NCT00132496|50046606|FG000|Overall Study|Physician Decision|1|||
24955624|NCT00132496|50046607|FG001|Overall Study|Physician Decision|0|||
24955625|NCT00231777|50046615|FG000|Overall Study|Lost to Follow-up|3|||
24955626|NCT00231777|50046616|FG001|Overall Study|Lost to Follow-up|0|||
24955627|NCT00231777|50046615|FG000|Overall Study|Other|3|||
24955628|NCT00231777|50046616|FG001|Overall Study|Other|2|||
24955629|NCT00231465|50046622|FG000|Overall Study|Completed only one cycle|1|||
24955630|NCT00231465|50046622|FG000|Overall Study|Did not have follow up CT scans|1|||
24955631|NCT00254397|50046630|FG000|Overall Study|Disease Progression|4|||
24955632|NCT00254397|50046631|FG001|Overall Study|Disease Progression|1|||
24955633|NCT00254397|50046632|FG002|Overall Study|Disease Progression|16|||
24955634|NCT00254397|50046633|FG003|Overall Study|Disease Progression|23|||
24955635|NCT00254397|50046630|FG000|Overall Study|Non-Compliant|0|||
24955636|NCT00254397|50046631|FG001|Overall Study|Non-Compliant|0|||
24955637|NCT00254397|50046632|FG002|Overall Study|Non-Compliant|0|||
24955638|NCT00254397|50046633|FG003|Overall Study|Non-Compliant|1|||
24955639|NCT00254397|50046630|FG000|Overall Study|Adverse Event|2|||
24955640|NCT00254397|50046631|FG001|Overall Study|Adverse Event|0|||
24955641|NCT00254397|50046632|FG002|Overall Study|Adverse Event|3|||
24955642|NCT00254397|50046633|FG003|Overall Study|Adverse Event|1|||
24955643|NCT00254163|50046644|FG000|Overall Study|Adverse Event|29|||
24955644|NCT00254163|50046645|FG001|Overall Study|Adverse Event|26|||
24955645|NCT00254163|50046644|FG000|Overall Study|Patient request/withdrew consent|6|||
24955646|NCT00254163|50046645|FG001|Overall Study|Patient request/withdrew consent|4|||
24955647|NCT00254163|50046644|FG000|Overall Study|Investigator request|1|||
24955648|NCT00254163|50046645|FG001|Overall Study|Investigator request|3|||
24955649|NCT00254163|50046644|FG000|Overall Study|Failed entry|1|||
24955650|NCT00254163|50046645|FG001|Overall Study|Failed entry|3|||
24955651|NCT00254163|50046644|FG000|Overall Study|Progressive disease|0|||
24955652|NCT00254163|50046645|FG001|Overall Study|Progressive disease|1|||
24955653|NCT00254163|50046644|FG000|Overall Study|Death|0|||
24955654|NCT00254163|50046645|FG001|Overall Study|Death|1|||
24955655|NCT00254163|50046644|FG000|Overall Study|Other|8|||
24955656|NCT00254163|50046645|FG001|Overall Study|Other|8|||
24955657|NCT03869333|50046655|FG000|Overall Study|Lost to Follow-up|1|||
24955658|NCT03869333|50046656|FG001|Overall Study|Lost to Follow-up|0|||
24955659|NCT03869333|50046657|FG002|Overall Study|Lost to Follow-up|0|||
24955660|NCT03869333|50046658|FG003|Overall Study|Lost to Follow-up|0|||
24955661|NCT03869333|50046655|FG000|Overall Study|Pregnancy|1|||
24955662|NCT03869333|50046656|FG001|Overall Study|Pregnancy|0|||
24955663|NCT03869333|50046657|FG002|Overall Study|Pregnancy|0|||
24955664|NCT03869333|50046658|FG003|Overall Study|Pregnancy|0|||
24955665|NCT03869333|50046655|FG000|Overall Study|Physician Decision|0|||
24955666|NCT03869333|50046656|FG001|Overall Study|Physician Decision|1|||
24955667|NCT03869333|50046657|FG002|Overall Study|Physician Decision|0|||
24955668|NCT03869333|50046658|FG003|Overall Study|Physician Decision|0|||
24955669|NCT00110890|50046670|FG000|Overall Study|Adverse Event|30|||
24955670|NCT00110890|50046671|FG001|Overall Study|Adverse Event|7|||
24955671|NCT00110890|50046670|FG000|Overall Study|Death|16|||
24955672|NCT00110890|50046671|FG001|Overall Study|Death|9|||
24955673|NCT00110890|50046670|FG000|Overall Study|Lost to Follow-up|3|||
24955674|NCT00110890|50046671|FG001|Overall Study|Lost to Follow-up|1|||
25042100|NCT00898677|50143145|FG002|Overall Study|Protocol Violation|2|||
25042101|NCT00898677|50143146|FG003|Overall Study|Protocol Violation|0|||
25042102|NCT00898677|50143143|FG000|Overall Study|Withdrawal by Subject|0|||
25042103|NCT00898677|50143144|FG001|Overall Study|Withdrawal by Subject|0|||
24955675|NCT00110890|50046670|FG000|Overall Study|Physician Decision|4|||
24955676|NCT00110890|50046671|FG001|Overall Study|Physician Decision|5|||
24955677|NCT00110890|50046670|FG000|Overall Study|Withdrawal by Subject|17|||
24955678|NCT00110890|50046671|FG001|Overall Study|Withdrawal by Subject|5|||
24955679|NCT00110890|50046670|FG000|Overall Study|Protocol Deviation|1|||
24955680|NCT00110890|50046671|FG001|Overall Study|Protocol Deviation|0|||
24955681|NCT00110890|50046670|FG000|Overall Study|Noncompliance|10|||
24955682|NCT00110890|50046671|FG001|Overall Study|Noncompliance|0|||
24955683|NCT00110890|50046670|FG000|Overall Study|Kidney Transplant|16|||
24955684|NCT00110890|50046671|FG001|Overall Study|Kidney Transplant|12|||
24955685|NCT00110890|50046670|FG000|Overall Study|Invest. Product Commercially Available|217|||
24955686|NCT00110890|50046671|FG001|Overall Study|Invest. Product Commercially Available|110|||
24955687|NCT00110890|50046670|FG000|Overall Study|Other|34|||
24955688|NCT00110890|50046671|FG001|Overall Study|Other|23|||
24955689|NCT00110890|50046670|FG000|Overall Study|Ineligibility determined|3|||
24955690|NCT00110890|50046671|FG001|Overall Study|Ineligibility determined|0|||
24955691|NCT00110890|50046670|FG000|Overall Study|Requirement for alternative therapy|0|||
24955692|NCT00110890|50046671|FG001|Overall Study|Requirement for alternative therapy|1|||
24955693|NCT00110890|50046670|FG000|Overall Study|Disease progression|0|||
24955694|NCT00110890|50046671|FG001|Overall Study|Disease progression|1|||
24955695|NCT00110890|50046670|FG000|Overall Study|Parathyroidectomy|0|||
24955696|NCT00110890|50046671|FG001|Overall Study|Parathyroidectomy|1|||
24955697|NCT00110890|50046670|FG000|Overall Study|Did not enter follow-up phase|10|||
24955698|NCT00110890|50046671|FG001|Overall Study|Did not enter follow-up phase|4|||
24955699|NCT00182637|50046677|FG000|Overall Study|Adverse Event|2|||
24955700|NCT00182637|50046677|FG000|Overall Study|Disease Progression|1|||
24955701|NCT00182325|50046684|FG000|Overall Study|Lost to Follow-up|7|||
24955702|NCT00182325|50046685|FG001|Overall Study|Lost to Follow-up|7|||
24955703|NCT00182325|50046684|FG000|Overall Study|Miscarriage|5|||
24955704|NCT00182325|50046685|FG001|Overall Study|Miscarriage|3|||
24955705|NCT00182325|50046684|FG000|Overall Study|Did not complete survey|22|||
24955706|NCT00182325|50046685|FG001|Overall Study|Did not complete survey|43|||
24955707|NCT00122278|50046693|FG000|Overall Study|Lost to Follow-up|2|||
24955708|NCT00122278|50046694|FG001|Overall Study|Lost to Follow-up|0|||
24955709|NCT00182091|50046704|FG000|Overall Study|Withdrawal by Subject|1|||
24955710|NCT00182091|50046705|FG001|Overall Study|Withdrawal by Subject|0|||
24955711|NCT00182091|50046706|FG002|Overall Study|Withdrawal by Subject|0|||
24955712|NCT00182091|50046707|FG003|Overall Study|Withdrawal by Subject|0|||
24955713|NCT00181155|50046715|FG000|Overall Study|Physician Decision|1|||
24955714|NCT00181155|50046716|FG001|Overall Study|Physician Decision|0|||
24955715|NCT00181155|50046715|FG000|Overall Study|Withdrawal by Subject|1|||
24955716|NCT00181155|50046716|FG001|Overall Study|Withdrawal by Subject|0|||
24955717|NCT00322452|50046725|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
24955718|NCT00322452|50046726|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
24955719|NCT00322452|50046725|FG000|Overall Study|Lost to Follow-up|5|||
24955720|NCT00322452|50046726|FG001|Overall Study|Lost to Follow-up|2|||
25042104|NCT00898677|50143145|FG002|Overall Study|Withdrawal by Subject|0|||
25042105|NCT00898677|50143146|FG003|Overall Study|Withdrawal by Subject|1|||
25042106|NCT00898677|50143143|FG000|Overall Study|Not Treated: Adverse Event|0|||
25042107|NCT00898677|50143144|FG001|Overall Study|Not Treated: Adverse Event|2|||
25042108|NCT00898677|50143145|FG002|Overall Study|Not Treated: Adverse Event|1|||
25042109|NCT00898677|50143146|FG003|Overall Study|Not Treated: Adverse Event|0|||
25042110|NCT00898677|50143143|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
25042111|NCT00898677|50143144|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
25042112|NCT00898677|50143145|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
25042113|NCT00898677|50143146|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
25042114|NCT00898677|50143143|FG000|Overall Study|Not Treated: Pregnancy|0|||
25160305|NCT01749800|50280406|FG000|Overall Study|Withdrawal by Subject|0|||
24955721|NCT00322452|50046725|FG000|Overall Study|Withdrawal by Subject|19|||
24955722|NCT00322452|50046726|FG001|Overall Study|Withdrawal by Subject|46|||
24955723|NCT00322452|50046725|FG000|Overall Study|Death|223|||
24955724|NCT00322452|50046726|FG001|Overall Study|Death|227|||
24955725|NCT00110812|50046735|FG000|Main Study|Death|0|||
24955726|NCT00110812|50046736|FG001|Main Study|Death|0|||
24955727|NCT00110812|50046737|FG002|Main Study|Death|2|||
25042115|NCT00898677|50143144|FG001|Overall Study|Not Treated: Pregnancy|0|||
25042116|NCT00898677|50143145|FG002|Overall Study|Not Treated: Pregnancy|1|||
25042117|NCT00898677|50143146|FG003|Overall Study|Not Treated: Pregnancy|0|||
25042118|NCT00898677|50143143|FG000|Overall Study|Not Treated: Protocol Violation|2|||
25042119|NCT00898677|50143144|FG001|Overall Study|Not Treated: Protocol Violation|0|||
25042120|NCT00898677|50143145|FG002|Overall Study|Not Treated: Protocol Violation|2|||
24955728|NCT00110812|50046735|FG000|Main Study|Withdrawal by Subject|0|||
24955729|NCT00110812|50046736|FG001|Main Study|Withdrawal by Subject|0|||
24955730|NCT00110812|50046737|FG002|Main Study|Withdrawal by Subject|1|||
24955731|NCT00110812|50046735|FG000|Main Study|Lost to Follow-up|8|||
24955732|NCT00110812|50046736|FG001|Main Study|Lost to Follow-up|11|||
24955733|NCT00110812|50046737|FG002|Main Study|Lost to Follow-up|10|||
24955734|NCT00110812|50046735|FG000|Extended Follow-up|Death|1|||
25042121|NCT00898677|50143146|FG003|Overall Study|Not Treated: Protocol Violation|0|||
25042122|NCT00898677|50143143|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
25042123|NCT00898677|50143144|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
25042124|NCT00898677|50143145|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
25042125|NCT00898677|50143146|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
25042126|NCT00898677|50143143|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
25042127|NCT00898677|50143144|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
25042128|NCT00898677|50143145|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
25042129|NCT00898677|50143146|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
25042130|NCT00898677|50143143|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
25042131|NCT00898677|50143144|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
25042132|NCT00898677|50143145|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
25042133|NCT00898677|50143146|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
25042134|NCT00898677|50143143|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
25042135|NCT00898677|50143144|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
25042136|NCT00898677|50143145|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
25042137|NCT00898677|50143146|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
25042138|NCT00898677|50143143|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
25042139|NCT00898677|50143144|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
24955735|NCT00110812|50046736|FG001|Extended Follow-up|Death|0|||
24955736|NCT00110812|50046737|FG002|Extended Follow-up|Death|3|||
24955737|NCT00110812|50046735|FG000|Extended Follow-up|Withdrawal by Subject|0|||
24955738|NCT00110812|50046736|FG001|Extended Follow-up|Withdrawal by Subject|1|||
24955739|NCT00110812|50046737|FG002|Extended Follow-up|Withdrawal by Subject|0|||
24955740|NCT00110812|50046735|FG000|Extended Follow-up|Lost to Follow-up|1|||
24955741|NCT00110812|50046736|FG001|Extended Follow-up|Lost to Follow-up|3|||
24955742|NCT00110812|50046737|FG002|Extended Follow-up|Lost to Follow-up|1|||
24955743|NCT00516269|50046752|FG000|Overall Study|Adverse Event|2|||
24955744|NCT00516269|50046753|FG001|Overall Study|Adverse Event|1|||
24955745|NCT00516269|50046752|FG000|Overall Study|Lost to Follow-up|0|||
24955746|NCT00516269|50046753|FG001|Overall Study|Lost to Follow-up|1|||
24955747|NCT00516269|50046752|FG000|Overall Study|Protocol Violation|0|||
24955748|NCT00516269|50046753|FG001|Overall Study|Protocol Violation|1|||
24955749|NCT00229203|50046761|FG000|Overall Study|Progressive disease|18|||
24955750|NCT00229203|50046762|FG001|Overall Study|Progressive disease|9|||
24955751|NCT00229203|50046761|FG000|Overall Study|Toxicity|6|||
24955752|NCT00229203|50046762|FG001|Overall Study|Toxicity|1|||
24955753|NCT00229203|50046761|FG000|Overall Study|Death|4|||
24955754|NCT00229203|50046762|FG001|Overall Study|Death|2|||
24955755|NCT00229203|50046761|FG000|Overall Study|Other|3|||
24955756|NCT00229203|50046762|FG001|Overall Study|Other|3|||
24955757|NCT00229203|50046761|FG000|Overall Study|Withdrawal by Subject|1|||
24955758|NCT00229203|50046762|FG001|Overall Study|Withdrawal by Subject|4|||
24955759|NCT00228813|50046768|FG000|Overall Study|Death|4|||
24955760|NCT00322374|50046775|FG000|Starting Dose|Physician Decision|2|||
24955761|NCT00322374|50046776|FG001|Starting Dose|Physician Decision|0|||
24955762|NCT00322374|50046777|FG002|Starting Dose|Physician Decision|0|||
24955763|NCT00322374|50046778|FG003|Starting Dose|Physician Decision|0|||
24955764|NCT00322374|50046775|FG000|Starting Dose|Study Drug Toxicity|4|||
24955765|NCT00322374|50046776|FG001|Starting Dose|Study Drug Toxicity|0|||
24955766|NCT00322374|50046777|FG002|Starting Dose|Study Drug Toxicity|0|||
24955767|NCT00322374|50046778|FG003|Starting Dose|Study Drug Toxicity|0|||
24955768|NCT00322374|50046775|FG000|First Escalation|Documented Disease Progression|0|||
24955769|NCT00322374|50046776|FG001|First Escalation|Documented Disease Progression|6|||
25042140|NCT00898677|50143145|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
24955770|NCT00322374|50046777|FG002|First Escalation|Documented Disease Progression|0|||
24955771|NCT00322374|50046778|FG003|First Escalation|Documented Disease Progression|0|||
24955772|NCT00322374|50046775|FG000|First Escalation|Physician Decision|0|||
25042141|NCT00898677|50143146|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
24955773|NCT00322374|50046776|FG001|First Escalation|Physician Decision|12|||
24955774|NCT00322374|50046777|FG002|First Escalation|Physician Decision|0|||
24955775|NCT00322374|50046778|FG003|First Escalation|Physician Decision|0|||
24955776|NCT00322374|50046775|FG000|First Escalation|Study Drug Toxicity|0|||
24955777|NCT00322374|50046776|FG001|First Escalation|Study Drug Toxicity|11|||
24955778|NCT00322374|50046777|FG002|First Escalation|Study Drug Toxicity|0|||
24955779|NCT00322374|50046778|FG003|First Escalation|Study Drug Toxicity|0|||
24955780|NCT00322374|50046775|FG000|First Escalation|Participant Request|0|||
24955781|NCT00322374|50046776|FG001|First Escalation|Participant Request|1|||
24955782|NCT00322374|50046777|FG002|First Escalation|Participant Request|0|||
24955783|NCT00322374|50046778|FG003|First Escalation|Participant Request|0|||
24955784|NCT00322374|50046775|FG000|Second Escalation|Physician Decision|0|||
24955785|NCT00322374|50046776|FG001|Second Escalation|Physician Decision|0|||
24955786|NCT00322374|50046777|FG002|Second Escalation|Physician Decision|5|||
24955787|NCT00322374|50046778|FG003|Second Escalation|Physician Decision|0|||
24955788|NCT00322374|50046775|FG000|Second Escalation|Study Drug Toxicity|0|||
24955789|NCT00322374|50046776|FG001|Second Escalation|Study Drug Toxicity|0|||
24955790|NCT00322374|50046777|FG002|Second Escalation|Study Drug Toxicity|1|||
24955791|NCT00322374|50046778|FG003|Second Escalation|Study Drug Toxicity|0|||
24955792|NCT00174447|50046791|FG000|Overall Study|Adverse Event|19|||
24955793|NCT00174447|50046791|FG000|Overall Study|Withdrawal by Subject|15|||
25042142|NCT00898677|50143143|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
25042143|NCT00898677|50143144|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
25042144|NCT00898677|50143145|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
25042145|NCT00898677|50143146|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
25042146|NCT00898677|50143143|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
25042147|NCT00898677|50143144|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
25042148|NCT00898677|50143145|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
25042149|NCT00898677|50143146|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
25042150|NCT02770820|50143156|FG000|Overall Study|Death|1|||
25042151|NCT02770820|50143156|FG000|Overall Study|Physician Decision|2|||
24955794|NCT00174447|50046791|FG000|Overall Study|Protocol Violation|1|||
24955795|NCT00174447|50046791|FG000|Overall Study|Lack of Efficacy|1|||
24955796|NCT00174447|50046791|FG000|Overall Study|Administrative reason/Other|2|||
24955797|NCT00321984|50046798|FG000|Overall Study|Adverse Event|9|||
24955798|NCT00321984|50046799|FG001|Overall Study|Adverse Event|6|||
24955799|NCT00321984|50046800|FG002|Overall Study|Adverse Event|8|||
24955800|NCT00321984|50046798|FG000|Overall Study|Protocol Violation|0|||
24955801|NCT00321984|50046799|FG001|Overall Study|Protocol Violation|1|||
24955802|NCT00321984|50046800|FG002|Overall Study|Protocol Violation|1|||
24955803|NCT00321984|50046798|FG000|Overall Study|Lost to Follow-up|2|||
24955804|NCT00321984|50046799|FG001|Overall Study|Lost to Follow-up|4|||
24955805|NCT00321984|50046800|FG002|Overall Study|Lost to Follow-up|2|||
24955806|NCT00321984|50046798|FG000|Overall Study|Withdrawal by Subject|8|||
24955807|NCT00321984|50046799|FG001|Overall Study|Withdrawal by Subject|6|||
24955808|NCT00321984|50046800|FG002|Overall Study|Withdrawal by Subject|5|||
24955809|NCT00321984|50046798|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
24955810|NCT00321984|50046799|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
24955811|NCT00321984|50046800|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
24955812|NCT00321984|50046798|FG000|Overall Study|Lack of Efficacy|3|||
24955813|NCT00321984|50046799|FG001|Overall Study|Lack of Efficacy|1|||
24955814|NCT00321984|50046800|FG002|Overall Study|Lack of Efficacy|3|||
24955815|NCT00321984|50046798|FG000|Overall Study|Noncompliant|0|||
24955816|NCT00321984|50046799|FG001|Overall Study|Noncompliant|0|||
24955817|NCT00321984|50046800|FG002|Overall Study|Noncompliant|2|||
24955818|NCT00321984|50046798|FG000|Overall Study|Pregnancy|0|||
24955819|NCT00321984|50046799|FG001|Overall Study|Pregnancy|1|||
24955820|NCT00321984|50046800|FG002|Overall Study|Pregnancy|0|||
24955821|NCT00321984|50046798|FG000|Overall Study|Per Subject Request|1|||
24955822|NCT00321984|50046799|FG001|Overall Study|Per Subject Request|0|||
25042152|NCT03082729|50143160|FG000|Overall Study|Lost to Follow-up|7|||
25042153|NCT03082729|50143160|FG000|Overall Study|Physician Decision|2|||
25042154|NCT03082729|50143160|FG000|Overall Study|Withdrawal by Subject|1|||
25042155|NCT03082729|50143160|FG000|Overall Study|Lack of Efficacy|9|||
25042156|NCT03082729|50143160|FG000|Overall Study|Adverse Event|4|||
25042157|NCT03082729|50143160|FG000|Overall Study|Protocol Violation|6|||
25042158|NCT03082729|50143160|FG000|Overall Study|Fear of study procedure|1|||
25042159|NCT03082729|50143160|FG000|Overall Study|Scheduling conflict|1|||
25042160|NCT02764190|50143172|FG000|Overall Study|Lost to Follow-up|17|||
24955823|NCT00321984|50046800|FG002|Overall Study|Per Subject Request|0|||
25042161|NCT02764190|50143173|FG001|Overall Study|Lost to Follow-up|13|||
25042162|NCT03077659|50143182|FG000|Overall Study|Withdrawal by Subject|0|||
25042163|NCT03077659|50143183|FG001|Overall Study|Withdrawal by Subject|0|||
24955824|NCT00321984|50046798|FG000|Overall Study|Per Investigator Request|1|||
24955825|NCT00321984|50046799|FG001|Overall Study|Per Investigator Request|0|||
24955826|NCT00321984|50046800|FG002|Overall Study|Per Investigator Request|0|||
24955827|NCT00321984|50046798|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
24955828|NCT00321984|50046799|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
24955829|NCT00321984|50046800|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
24955830|NCT00515099|50046810|FG000|Overall Study|Lost to Follow-up|0|||
24955831|NCT00515099|50046811|FG001|Overall Study|Lost to Follow-up|4|||
24955832|NCT00515099|50046810|FG000|Overall Study|Withdrawal by Subject|2|||
24955833|NCT00515099|50046811|FG001|Overall Study|Withdrawal by Subject|0|||
24955834|NCT00515099|50046810|FG000|Overall Study|IRB Recommendation|1|||
24955835|NCT00515099|50046811|FG001|Overall Study|IRB Recommendation|0|||
24955836|NCT00110266|50046817|FG000|Overall Study|Adverse Event|27|||
24955837|NCT00110266|50046817|FG000|Overall Study|Abnormal laboratory value|15|||
24955838|NCT00110266|50046817|FG000|Overall Study|Withdrawal by Subject|16|||
24955839|NCT00110266|50046817|FG000|Overall Study|Death|17|||
24955840|NCT00110266|50046817|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
24955841|NCT00110266|50046817|FG000|Overall Study|Participant condition no longer requires study drug|1|||
24955842|NCT00174291|50046824|FG000|Overall Study|Lost to Follow-up|1|||
24955843|NCT00174291|50046825|FG001|Overall Study|Lost to Follow-up|1|||
24955844|NCT00174291|50046824|FG000|Overall Study|Protocol Violation|0|||
24955845|NCT00174291|50046825|FG001|Overall Study|Protocol Violation|2|||
24955846|NCT00174291|50046824|FG000|Overall Study|Study terminated by sponsor|1|||
24955847|NCT00174291|50046825|FG001|Overall Study|Study terminated by sponsor|0|||
24955848|NCT00174291|50046824|FG000|Overall Study|Withdrawal by Subject|3|||
24955849|NCT00174291|50046825|FG001|Overall Study|Withdrawal by Subject|3|||
24955850|NCT00366548|50046833|FG000|Infant Series|Adverse Event|1|||
24955851|NCT00366548|50046834|FG001|Infant Series|Adverse Event|3|||
24955852|NCT00366548|50046833|FG000|Infant Series|Protocol Violation|0|||
24955853|NCT00366548|50046834|FG001|Infant Series|Protocol Violation|1|||
24955854|NCT00366548|50046833|FG000|Infant Series|Withdrawal by Subject|3|||
24955855|NCT00366548|50046834|FG001|Infant Series|Withdrawal by Subject|1|||
24955856|NCT00366548|50046833|FG000|After Infant Series|Withdrawal by Subject|3|||
24955857|NCT00366548|50046834|FG001|After Infant Series|Withdrawal by Subject|1|||
24955858|NCT00366548|50046833|FG000|After Infant Series|Adverse Event|2|||
24955859|NCT00366548|50046834|FG001|After Infant Series|Adverse Event|0|||
24955860|NCT00366548|50046833|FG000|After Infant Series|Lost to Follow-up|1|||
24955861|NCT00366548|50046834|FG001|After Infant Series|Lost to Follow-up|0|||
24955862|NCT00252057|50046860|FG000|Overall Study|Withdrawal by Subject|2|||
24955863|NCT00252057|50046861|FG001|Overall Study|Withdrawal by Subject|5|||
24955864|NCT00252057|50046860|FG000|Overall Study|Death|1|||
24955865|NCT00252057|50046861|FG001|Overall Study|Death|2|||
24955866|NCT00252057|50046860|FG000|Overall Study|Participant previously enrolled|0|||
24955867|NCT00252057|50046861|FG001|Overall Study|Participant previously enrolled|1|||
24955868|NCT00132028|50046867|FG000|Overall Study|Adverse Event|7|||
24955869|NCT00132028|50046867|FG000|Overall Study|Death|2|||
24955870|NCT00132028|50046867|FG000|Overall Study|Lack of Efficacy|11|||
24955871|NCT00132028|50046867|FG000|Overall Study|Withdrawal by Subject|2|||
24955872|NCT00132028|50046867|FG000|Overall Study|not eligible|2|||
24955873|NCT00132028|50046867|FG000|Overall Study|Physician Decision|3|||
24955874|NCT00131248|50046871|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
24955875|NCT00131248|50046872|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
24955876|NCT00362414|50046878|FG000|Overall Study|Death|2|||
24955877|NCT00362414|50046878|FG000|Overall Study|Adverse Event|1|||
25042164|NCT03077659|50143184|FG002|Overall Study|Withdrawal by Subject|1|||
24955878|NCT00096382|50046887|FG000|Overall Study|Not treated|1|||
24955879|NCT00096382|50046888|FG001|Overall Study|Not treated|0|||
24955880|NCT00096382|50046887|FG000|Overall Study|Death during treatment|1|||
24955881|NCT00096382|50046888|FG001|Overall Study|Death during treatment|0|||
24955882|NCT00359294|50046899|FG000|Overall Study|Progressive disease|1|||
24955883|NCT00359294|50046900|FG001|Overall Study|Progressive disease|1|||
24955884|NCT00359294|50046901|FG002|Overall Study|Progressive disease|2|||
24955885|NCT00359294|50046902|FG003|Overall Study|Progressive disease|3|||
24955886|NCT00359294|50046903|FG004|Overall Study|Progressive disease|2|||
24955887|NCT00359294|50046899|FG000|Overall Study|Withdrawal by Subject|0|||
24955888|NCT00359294|50046900|FG001|Overall Study|Withdrawal by Subject|0|||
24955889|NCT00359294|50046901|FG002|Overall Study|Withdrawal by Subject|0|||
24955890|NCT00359294|50046902|FG003|Overall Study|Withdrawal by Subject|0|||
24955891|NCT00359294|50046903|FG004|Overall Study|Withdrawal by Subject|1|||
24955892|NCT00359294|50046899|FG000|Overall Study|Not treated|0|||
24955893|NCT00359294|50046900|FG001|Overall Study|Not treated|0|||
24955894|NCT00359294|50046901|FG002|Overall Study|Not treated|0|||
24955895|NCT00359294|50046902|FG003|Overall Study|Not treated|1|||
24955896|NCT00359294|50046903|FG004|Overall Study|Not treated|0|||
24955897|NCT00359294|50046899|FG000|Overall Study|Physician Decision|0|||
24955898|NCT00359294|50046900|FG001|Overall Study|Physician Decision|0|||
24955899|NCT00359294|50046901|FG002|Overall Study|Physician Decision|1|||
24955900|NCT00359294|50046902|FG003|Overall Study|Physician Decision|0|||
24955901|NCT00359294|50046903|FG004|Overall Study|Physician Decision|0|||
24955902|NCT00384332|50046913|FG000|Overall Study|Lost to Follow-up|4|||
24955903|NCT00384332|50046914|FG001|Overall Study|Lost to Follow-up|0|||
24955904|NCT00096226|50046922|FG000|Overall Study|Ineligible|2|||
24955905|NCT00096226|50046922|FG000|Overall Study|Protocol treatment not started|1|||
24955906|NCT00105508|50046928|FG000|Overall Study|Prephase Dropout|1|||
24955907|NCT00105508|50046929|FG001|Overall Study|Prephase Dropout|0|||
24955908|NCT00105508|50046928|FG000|Overall Study|Adverse Event|16|||
25042165|NCT02807883|50143195|FG000|Overall Study|Withdrawal by Subject|2|||
25042166|NCT03082261|50143199|FG000|Overall Study|Death|4|||
25042167|NCT03082261|50143199|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
25042168|NCT03082261|50143199|FG000|Overall Study|Insurance denial|1|||
24955909|NCT00105508|50046929|FG001|Overall Study|Adverse Event|19|||
24955910|NCT00105508|50046928|FG000|Overall Study|Insufficient Efficacy|1|||
24955911|NCT00105508|50046929|FG001|Overall Study|Insufficient Efficacy|0|||
24955912|NCT00105508|50046928|FG000|Overall Study|Withdrawal by Subject|10|||
24955913|NCT00105508|50046929|FG001|Overall Study|Withdrawal by Subject|6|||
24955914|NCT00105508|50046928|FG000|Overall Study|Lost to Follow-up|3|||
24955915|NCT00105508|50046929|FG001|Overall Study|Lost to Follow-up|0|||
24955916|NCT00105508|50046928|FG000|Overall Study|Protocol Violation|1|||
24955917|NCT00105508|50046929|FG001|Overall Study|Protocol Violation|2|||
24955918|NCT00105508|50046928|FG000|Overall Study|Other|8|||
24955919|NCT00105508|50046929|FG001|Overall Study|Other|9|||
24955920|NCT00105196|50046937|FG000|Overall Study|Lack of Efficacy|2|||
24955921|NCT00105196|50046938|FG001|Overall Study|Lack of Efficacy|3|||
25042169|NCT03082261|50143199|FG000|Overall Study|Peripheral lead added|1|||
25042170|NCT03082261|50143199|FG000|Overall Study|Withdrawal by Subject|40|||
25042171|NCT03082261|50143199|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
25042172|NCT03082261|50143199|FG000|Overall Study|Subject implanted with device other than study device|1|||
25042173|NCT03082261|50143199|FG000|Overall Study|Lost to Follow-up|14|||
25042174|NCT03082261|50143199|FG000|Overall Study|Subject moved to a different state|1|||
25042175|NCT03082261|50143199|FG000|Overall Study|Subject non-compliance|2|||
25042176|NCT03082261|50143199|FG000|Overall Study|Subject participation terminated by investigator|9|||
25042177|NCT03082261|50143199|FG000|Overall Study|Subject participation terminated by sponsor|4|||
25042178|NCT03082261|50143199|FG000|Overall Study|System explant|19|||
25042179|NCT03082261|50143199|FG000|Overall Study|Unable to place lead(s)|2|||
25042180|NCT03082261|50143199|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
25042181|NCT00102440|50143206|FG000|Overall Study|Lost to Follow-up|25|||
25042182|NCT00102440|50143207|FG001|Overall Study|Lost to Follow-up|18|||
25042183|NCT00102440|50143208|FG002|Overall Study|Lost to Follow-up|21|||
25042184|NCT00102440|50143206|FG000|Overall Study|Adverse Event|16|||
25042185|NCT00102440|50143207|FG001|Overall Study|Adverse Event|23|||
25042186|NCT00102440|50143208|FG002|Overall Study|Adverse Event|8|||
25042187|NCT00102440|50143206|FG000|Overall Study|Gout Flare|10|||
25042188|NCT00102440|50143207|FG001|Overall Study|Gout Flare|28|||
25042189|NCT00102440|50143208|FG002|Overall Study|Gout Flare|9|||
25042190|NCT00102440|50143206|FG000|Overall Study|Personal Reason(s)|19|||
25042191|NCT00102440|50143207|FG001|Overall Study|Personal Reason(s)|13|||
25042192|NCT00102440|50143208|FG002|Overall Study|Personal Reason(s)|13|||
25042193|NCT00102440|50143206|FG000|Overall Study|Other|11|||
25042194|NCT00102440|50143207|FG001|Overall Study|Other|14|||
25042195|NCT00102440|50143208|FG002|Overall Study|Other|14|||
25042196|NCT00102440|50143206|FG000|Overall Study|Protocol Violation|7|||
25042197|NCT00102440|50143207|FG001|Overall Study|Protocol Violation|2|||
25042198|NCT00102440|50143208|FG002|Overall Study|Protocol Violation|1|||
24955922|NCT00105196|50046937|FG000|Overall Study|Adverse Event|11|||
24955923|NCT00105196|50046938|FG001|Overall Study|Adverse Event|3|||
24955924|NCT00105196|50046937|FG000|Overall Study|Withdrawal by Subject|6|||
24955925|NCT00105196|50046938|FG001|Overall Study|Withdrawal by Subject|6|||
24955926|NCT00105196|50046937|FG000|Overall Study|Lost to Follow-up|3|||
24955927|NCT00105196|50046938|FG001|Overall Study|Lost to Follow-up|2|||
24955928|NCT00105196|50046937|FG000|Overall Study|Poor/noncompliance|3|||
24955929|NCT00105196|50046938|FG001|Overall Study|Poor/noncompliance|4|||
24955930|NCT00105196|50046937|FG000|Overall Study|Protocol Violation|5|||
24955931|NCT00105196|50046938|FG001|Overall Study|Protocol Violation|2|||
25042199|NCT02762084|50143232|FG000|Overall Study|Withdrawal by Subject|1|||
25042200|NCT02762084|50143233|FG001|Overall Study|Withdrawal by Subject|0|||
25042201|NCT02762084|50143234|FG002|Overall Study|Withdrawal by Subject|0|||
25042202|NCT02762084|50143232|FG000|Overall Study|Adverse Event|0|||
25042203|NCT02762084|50143233|FG001|Overall Study|Adverse Event|0|||
25042204|NCT02762084|50143234|FG002|Overall Study|Adverse Event|1|||
24955932|NCT00105196|50046937|FG000|Overall Study|pending surgery|0|||
24955933|NCT00105196|50046938|FG001|Overall Study|pending surgery|1|||
24955934|NCT00105196|50046937|FG000|Overall Study|marijuana use|0|||
24955935|NCT00105196|50046938|FG001|Overall Study|marijuana use|1|||
24955936|NCT00105196|50046937|FG000|Overall Study|Subject became unblinded|0|||
24955937|NCT00105196|50046938|FG001|Overall Study|Subject became unblinded|1|||
24955938|NCT03820024|50046946|FG000|Overall Study|Physician Decision|1|||
24955939|NCT03820024|50046947|FG001|Overall Study|Physician Decision|2|||
24955940|NCT03819634|50046953|FG000|Overall Study|Physician Decision|2|||
24955941|NCT00104572|50046960|FG000|Overall Study|Withdrawal by Subject|3|||
24955942|NCT00104572|50046961|FG001|Overall Study|Withdrawal by Subject|3|||
24955943|NCT00104572|50046962|FG002|Overall Study|Withdrawal by Subject|0|||
24955944|NCT00514943|50046972|FG000|Stage 1|Progressive disease|4|||
24955945|NCT00514943|50046973|FG001|Stage 1|Progressive disease|8|||
24955946|NCT00514943|50046972|FG000|Stage 1|Other Adverse Event|16|||
24955947|NCT00514943|50046973|FG001|Stage 1|Other Adverse Event|6|||
24955948|NCT00514943|50046972|FG000|Stage 1|Not treated|1|||
24955949|NCT00514943|50046973|FG001|Stage 1|Not treated|2|||
24955950|NCT00514943|50046972|FG000|Stage 1|Patient refused to continue study meds|8|||
24955951|NCT00514943|50046973|FG001|Stage 1|Patient refused to continue study meds|3|||
24955952|NCT00514943|50046972|FG000|Stage 1|Other than stated above|1|||
24955953|NCT00514943|50046973|FG001|Stage 1|Other than stated above|7|||
24955954|NCT00514943|50046972|FG000|Stage 2|Progressive disease|27|||
24955955|NCT00514943|50046973|FG001|Stage 2|Progressive disease|24|||
24955956|NCT00514943|50046972|FG000|Stage 2|Other Adverse Event|3|||
24955957|NCT00514943|50046973|FG001|Stage 2|Other Adverse Event|10|||
24955958|NCT00514943|50046972|FG000|Stage 2|Patient refused to continue study meds|2|||
24955959|NCT00514943|50046973|FG001|Stage 2|Patient refused to continue study meds|0|||
24955960|NCT00514943|50046972|FG000|Stage 2|Other than stated above|0|||
25042205|NCT02763644|50143246|FG000|Overall Study|Patient/guardian decision|1|||
25042206|NCT02763644|50143247|FG001|Overall Study|Patient/guardian decision|0|||
25042207|NCT02763644|50143246|FG000|Overall Study|Death|1|||
24955961|NCT00514943|50046973|FG001|Stage 2|Other than stated above|2|||
24955962|NCT03864653|50046994|FG000|Overall Study|Withdrawal by Subject|1|||
24955963|NCT00103402|50047000|FG000|Overall Study|Adverse Event|3|||
24955964|NCT00103402|50047001|FG001|Overall Study|Adverse Event|4|||
24955965|NCT00103402|50047000|FG000|Overall Study|Lost to Follow-up|8|||
24955966|NCT00103402|50047001|FG001|Overall Study|Lost to Follow-up|7|||
24955967|NCT00103402|50047000|FG000|Overall Study|Dissatisfied/No longer interested|6|||
24955968|NCT00103402|50047001|FG001|Overall Study|Dissatisfied/No longer interested|6|||
25042208|NCT02763644|50143247|FG001|Overall Study|Death|1|||
25042209|NCT02763644|50143246|FG000|Overall Study|Adverse Event|1|||
25042210|NCT02763644|50143247|FG001|Overall Study|Adverse Event|1|||
25042211|NCT02807844|50143265|FG000|Overall Study|Physician Decision|0|||
25042212|NCT02807844|50143266|FG001|Overall Study|Physician Decision|0|||
25042213|NCT02807844|50143267|FG002|Overall Study|Physician Decision|0|||
25042214|NCT02807844|50143268|FG003|Overall Study|Physician Decision|0|||
25042215|NCT02807844|50143269|FG004|Overall Study|Physician Decision|0|||
25042216|NCT02807844|50143270|FG005|Overall Study|Physician Decision|0|||
25042217|NCT02807844|50143271|FG006|Overall Study|Physician Decision|3|||
25042218|NCT02807844|50143272|FG007|Overall Study|Physician Decision|0|||
25042219|NCT02807844|50143273|FG008|Overall Study|Physician Decision|1|||
25042220|NCT02807844|50143274|FG009|Overall Study|Physician Decision|2|||
25042221|NCT02807844|50143265|FG000|Overall Study|Death|0|||
25042222|NCT02807844|50143266|FG001|Overall Study|Death|0|||
25042223|NCT02807844|50143267|FG002|Overall Study|Death|2|||
25042224|NCT02807844|50143268|FG003|Overall Study|Death|4|||
25042225|NCT02807844|50143269|FG004|Overall Study|Death|1|||
25042226|NCT02807844|50143270|FG005|Overall Study|Death|2|||
25042227|NCT02807844|50143271|FG006|Overall Study|Death|1|||
25042228|NCT02807844|50143272|FG007|Overall Study|Death|2|||
25042229|NCT02807844|50143273|FG008|Overall Study|Death|0|||
25042230|NCT02807844|50143274|FG009|Overall Study|Death|1|||
25042231|NCT02807844|50143265|FG000|Overall Study|Withdrawal by Subject|0|||
25042232|NCT02807844|50143266|FG001|Overall Study|Withdrawal by Subject|0|||
25042233|NCT02807844|50143267|FG002|Overall Study|Withdrawal by Subject|2|||
25042234|NCT02807844|50143268|FG003|Overall Study|Withdrawal by Subject|1|||
25042235|NCT02807844|50143269|FG004|Overall Study|Withdrawal by Subject|1|||
24955969|NCT00103402|50047000|FG000|Overall Study|Personal constraints/Other|5|||
24955970|NCT00103402|50047001|FG001|Overall Study|Personal constraints/Other|0|||
24955971|NCT03864341|50047007|FG000|Overall Study|Withdrawal by Subject|1|||
24955972|NCT01739309|50047011|FG000|Overall Study|On study treatment|3|||
24955973|NCT00095836|50047017|FG000|Overall Study|Lost to Follow-up|1|||
24955974|NCT00095836|50047017|FG000|Overall Study|Adverse Event|1|||
24955975|NCT00095836|50047017|FG000|Overall Study|Death|2|||
24955976|NCT00168831|50047024|FG000|Overall Study|Adverse Event|36|||
24955977|NCT00168831|50047025|FG001|Overall Study|Adverse Event|47|||
24955978|NCT00168831|50047026|FG002|Overall Study|Adverse Event|74|||
24955979|NCT00168831|50047024|FG000|Overall Study|Lost to Follow-up|5|||
24955980|NCT00168831|50047025|FG001|Overall Study|Lost to Follow-up|6|||
24955981|NCT00168831|50047026|FG002|Overall Study|Lost to Follow-up|4|||
25042236|NCT02807844|50143270|FG005|Overall Study|Withdrawal by Subject|0|||
25042237|NCT02807844|50143271|FG006|Overall Study|Withdrawal by Subject|1|||
25042238|NCT02807844|50143272|FG007|Overall Study|Withdrawal by Subject|0|||
25042239|NCT02807844|50143273|FG008|Overall Study|Withdrawal by Subject|0|||
25042240|NCT02807844|50143274|FG009|Overall Study|Withdrawal by Subject|0|||
25042241|NCT02807844|50143265|FG000|Overall Study|Progressive disease|5|||
25042242|NCT02807844|50143266|FG001|Overall Study|Progressive disease|12|||
25042243|NCT02807844|50143267|FG002|Overall Study|Progressive disease|8|||
25042244|NCT02807844|50143268|FG003|Overall Study|Progressive disease|8|||
25042245|NCT02807844|50143269|FG004|Overall Study|Progressive disease|3|||
25042246|NCT02807844|50143270|FG005|Overall Study|Progressive disease|8|||
25042247|NCT02807844|50143271|FG006|Overall Study|Progressive disease|14|||
25042248|NCT02807844|50143272|FG007|Overall Study|Progressive disease|17|||
25042249|NCT02807844|50143273|FG008|Overall Study|Progressive disease|19|||
25042250|NCT02807844|50143274|FG009|Overall Study|Progressive disease|15|||
25042251|NCT02807844|50143265|FG000|Overall Study|Adverse Event|1|||
25042252|NCT02807844|50143266|FG001|Overall Study|Adverse Event|0|||
25042253|NCT02807844|50143267|FG002|Overall Study|Adverse Event|0|||
25042254|NCT02807844|50143268|FG003|Overall Study|Adverse Event|0|||
25042255|NCT02807844|50143269|FG004|Overall Study|Adverse Event|1|||
25042256|NCT02807844|50143270|FG005|Overall Study|Adverse Event|1|||
25042257|NCT02807844|50143271|FG006|Overall Study|Adverse Event|1|||
25042258|NCT02807844|50143272|FG007|Overall Study|Adverse Event|1|||
25042259|NCT02807844|50143273|FG008|Overall Study|Adverse Event|1|||
24955982|NCT00168831|50047024|FG000|Overall Study|Withdrawal by Subject|7|||
25042260|NCT02807844|50143274|FG009|Overall Study|Adverse Event|2|||
25042261|NCT02763566|50143304|FG000|Overall Study|Lost to Follow-up|1|||
25042262|NCT02763566|50143305|FG001|Overall Study|Lost to Follow-up|4|||
25042263|NCT02763566|50143306|FG002|Overall Study|Lost to Follow-up|0|||
25042264|NCT02763566|50143307|FG003|Overall Study|Lost to Follow-up|1|||
25042265|NCT02763566|50143304|FG000|Overall Study|On study treatment at study conclusion|114|||
24955983|NCT00168831|50047025|FG001|Overall Study|Withdrawal by Subject|14|||
24955984|NCT00168831|50047026|FG002|Overall Study|Withdrawal by Subject|19|||
24955985|NCT00168831|50047024|FG000|Overall Study|Protocol Violation|6|||
25042266|NCT02763566|50143305|FG001|Overall Study|On study treatment at study conclusion|34|||
25042267|NCT02763566|50143306|FG002|Overall Study|On study treatment at study conclusion|54|||
25042268|NCT02763566|50143307|FG003|Overall Study|On study treatment at study conclusion|13|||
25042269|NCT02763566|50143304|FG000|Overall Study|Withdrawal by Subject|3|||
25042270|NCT02763566|50143305|FG001|Overall Study|Withdrawal by Subject|1|||
25042271|NCT02763566|50143306|FG002|Overall Study|Withdrawal by Subject|0|||
25042272|NCT02763566|50143307|FG003|Overall Study|Withdrawal by Subject|0|||
25042273|NCT02763254|50143321|FG000|Overall Study|Adverse Event|1|||
25042274|NCT02805972|50143327|FG000|Washout Period|Lost to Follow-up|3|||
25042275|NCT02805972|50143328|FG001|Washout Period|Lost to Follow-up|0|||
25042276|NCT03032523|50143346|FG000|Overall Study|Withdrawal by Subject|2|||
25160306|NCT01749800|50280407|FG001|Overall Study|Withdrawal by Subject|1|||
24955986|NCT00168831|50047025|FG001|Overall Study|Protocol Violation|11|||
24955987|NCT00168831|50047026|FG002|Overall Study|Protocol Violation|11|||
24955988|NCT00168831|50047024|FG000|Overall Study|Other|6|||
24955989|NCT00168831|50047025|FG001|Overall Study|Other|3|||
24955990|NCT00168831|50047026|FG002|Overall Study|Other|6|||
25160307|NCT01749800|50280408|FG002|Overall Study|Withdrawal by Subject|0|||
25160308|NCT01830595|50280416|FG000|First Period|Withdrawal by Subject|1|||
25160309|NCT01830595|50280417|FG001|First Period|Withdrawal by Subject|3|||
25160310|NCT01830595|50280416|FG000|Washout|Withdrawal by Subject|2|||
25160311|NCT01830595|50280417|FG001|Washout|Withdrawal by Subject|2|||
25160312|NCT01748552|50280435|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
25160313|NCT01748552|50280436|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
25160314|NCT01748552|50280437|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
25160315|NCT01748552|50280438|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
25160316|NCT01748552|50280439|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
25160317|NCT01748552|50280440|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
25160318|NCT01748552|50280441|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
25160319|NCT01748552|50280442|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
25160320|NCT01748552|50280443|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
25160321|NCT01748552|50280444|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
25160322|NCT01748552|50280445|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
25160323|NCT01748552|50280446|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
24955991|NCT00103012|50047037|FG000|Overall Study|Withdrawal by Subject|2|||
24955992|NCT00103012|50047038|FG001|Overall Study|Withdrawal by Subject|1|||
25042277|NCT03032523|50143347|FG001|Overall Study|Withdrawal by Subject|2|||
25042278|NCT03032523|50143346|FG000|Overall Study|Physician Decision|1|||
25042279|NCT03032523|50143347|FG001|Overall Study|Physician Decision|0|||
25042280|NCT03031899|50143354|FG000|Overall Study|Protocol Violation|1|||
25042281|NCT03031899|50143354|FG000|Overall Study|lesion disappeared after stopping habit|1|||
25042282|NCT03086369|50143367|FG000|Overall Study|Lost to Follow-up|1|||
25042283|NCT03086369|50143368|FG001|Overall Study|Lost to Follow-up|0|||
25042284|NCT03086369|50143369|FG002|Overall Study|Lost to Follow-up|0|||
24955993|NCT00103012|50047039|FG002|Overall Study|Withdrawal by Subject|2|||
24955994|NCT00103012|50047037|FG000|Overall Study|Pregnancy|1|||
24955995|NCT00103012|50047038|FG001|Overall Study|Pregnancy|0|||
24955996|NCT00103012|50047039|FG002|Overall Study|Pregnancy|0|||
24955997|NCT00103012|50047037|FG000|Overall Study|Adverse Event|0|||
24955998|NCT00103012|50047038|FG001|Overall Study|Adverse Event|0|||
24955999|NCT00103012|50047039|FG002|Overall Study|Adverse Event|1|||
24956000|NCT00103012|50047037|FG000|Overall Study|Subject non-compliant with medications|0|||
24956001|NCT00103012|50047038|FG001|Overall Study|Subject non-compliant with medications|0|||
24956002|NCT00103012|50047039|FG002|Overall Study|Subject non-compliant with medications|1|||
24956003|NCT00512135|50047047|FG000|Overall Study|Not Treated|5|||
24956004|NCT00512135|50047047|FG000|Overall Study|Lack of Efficacy|2|||
24956005|NCT00512135|50047047|FG000|Overall Study|Adverse Event|6|||
24956006|NCT00512135|50047047|FG000|Overall Study|Withdrawal by Subject|22|||
24956007|NCT00512135|50047047|FG000|Overall Study|Lost to Follow-up|27|||
25042285|NCT03086369|50143370|FG003|Overall Study|Lost to Follow-up|2|||
25042286|NCT03086369|50143371|FG004|Overall Study|Lost to Follow-up|1|||
25042287|NCT03086369|50143367|FG000|Overall Study|Physician Decision|0|||
25042288|NCT03086369|50143368|FG001|Overall Study|Physician Decision|0|||
25042289|NCT03086369|50143369|FG002|Overall Study|Physician Decision|0|||
25042290|NCT03086369|50143370|FG003|Overall Study|Physician Decision|1|||
25042291|NCT03086369|50143371|FG004|Overall Study|Physician Decision|2|||
25042292|NCT03086369|50143367|FG000|Overall Study|Withdrawal by Subject|0|||
25042293|NCT03086369|50143368|FG001|Overall Study|Withdrawal by Subject|0|||
25042294|NCT03086369|50143369|FG002|Overall Study|Withdrawal by Subject|0|||
25042295|NCT03086369|50143370|FG003|Overall Study|Withdrawal by Subject|5|||
25042296|NCT03086369|50143371|FG004|Overall Study|Withdrawal by Subject|3|||
25160324|NCT01748552|50280435|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
25160325|NCT01748552|50280436|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
25186501|NCT02647866|50336896|FG001|Overall Study|Withdrawal by Subject|1|||
25276206|NCT00963820|50590165|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25042297|NCT03086369|50143367|FG000|Overall Study|Progressive Disease|0|||
24956008|NCT00512135|50047047|FG000|Overall Study|Other|22|||
24956009|NCT00251979|50047054|FG000|Overall Study|Protocol Violation|3|||
24956010|NCT00251979|50047055|FG001|Overall Study|Protocol Violation|5|||
24956011|NCT00251979|50047054|FG000|Overall Study|Adverse Event|11|||
25042298|NCT03086369|50143368|FG001|Overall Study|Progressive Disease|0|||
25042299|NCT03086369|50143369|FG002|Overall Study|Progressive Disease|0|||
25042300|NCT03086369|50143370|FG003|Overall Study|Progressive Disease|1|||
24956012|NCT00251979|50047055|FG001|Overall Study|Adverse Event|17|||
24956013|NCT00251979|50047054|FG000|Overall Study|Withdrawal by Subject|13|||
25160326|NCT01748552|50280437|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
24956014|NCT00251979|50047055|FG001|Overall Study|Withdrawal by Subject|7|||
24956015|NCT00251979|50047054|FG000|Overall Study|Lost to Follow-up|8|||
24956016|NCT00251979|50047055|FG001|Overall Study|Lost to Follow-up|6|||
24956017|NCT00251979|50047054|FG000|Overall Study|Death|3|||
24956018|NCT00251979|50047055|FG001|Overall Study|Death|5|||
24956019|NCT00511901|50047063|FG000|Overall Study|Withdrawal by Subject|1|||
24956020|NCT00511901|50047064|FG001|Overall Study|Withdrawal by Subject|3|||
24956021|NCT03862625|50047072|FG000|Overall Study|Lost to Follow-up|0|||
24956022|NCT03862625|50047073|FG001|Overall Study|Lost to Follow-up|1|||
24956023|NCT00163215|50047079|FG000|Overall Study|Lack of Efficacy|3|||
24956024|NCT00163215|50047079|FG000|Overall Study|Withdrawal by Subject|5|||
24956025|NCT00163215|50047079|FG000|Overall Study|Other|7|||
24956026|NCT00228423|50047085|FG000|Overall Study|Adverse Event|2|||
24956027|NCT00228423|50047086|FG001|Overall Study|Adverse Event|5|||
24956028|NCT00228423|50047085|FG000|Overall Study|Withdrawal by Subject|7|||
24956029|NCT00228423|50047086|FG001|Overall Study|Withdrawal by Subject|3|||
24956030|NCT00228423|50047085|FG000|Overall Study|Protocol Violation|1|||
24956031|NCT00228423|50047086|FG001|Overall Study|Protocol Violation|3|||
24956032|NCT00228423|50047085|FG000|Overall Study|Physician Decision|0|||
24956033|NCT00228423|50047086|FG001|Overall Study|Physician Decision|1|||
24956034|NCT00511667|50047094|FG000|Overall Study|Adverse Event|1|||
24956035|NCT00511667|50047095|FG001|Overall Study|Adverse Event|0|||
24956036|NCT00511667|50047094|FG000|Overall Study|Protocol Violation|1|||
25042301|NCT03086369|50143371|FG004|Overall Study|Progressive Disease|1|||
24956037|NCT00511667|50047095|FG001|Overall Study|Protocol Violation|1|||
24956038|NCT00511667|50047094|FG000|Overall Study|Withdrawal by Subject|2|||
24956039|NCT00511667|50047095|FG001|Overall Study|Withdrawal by Subject|0|||
24956040|NCT00511667|50047094|FG000|Overall Study|Site terminated|6|||
24956041|NCT00511667|50047095|FG001|Overall Study|Site terminated|1|||
24956042|NCT00511667|50047094|FG000|Overall Study|Other|2|||
24956043|NCT00511667|50047095|FG001|Overall Study|Other|1|||
24956044|NCT00227877|50047111|FG000|Pre-visit Assessment|Technical difficulties|7|||
24956045|NCT00227877|50047112|FG001|Pre-visit Assessment|Technical difficulties|3|||
24956046|NCT00227877|50047113|FG002|Pre-visit Assessment|Technical difficulties|0|||
24956047|NCT00227877|50047114|FG003|Pre-visit Assessment|Technical difficulties|0|||
24956048|NCT00227877|50047111|FG000|Post-visit Checklist|Lost to Follow-up|24|||
24956049|NCT00227877|50047112|FG001|Post-visit Checklist|Lost to Follow-up|13|||
24956050|NCT00227877|50047113|FG002|Post-visit Checklist|Lost to Follow-up|1|||
25042302|NCT00101582|50143387|FG000|Overall Study|Ineligibility determined|0|||
25042303|NCT00101582|50143388|FG001|Overall Study|Ineligibility determined|1|||
25160327|NCT01748552|50280438|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
25160328|NCT01748552|50280439|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
25160329|NCT01748552|50280440|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
25160330|NCT01748552|50280441|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
25160331|NCT01748552|50280442|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
25160332|NCT01748552|50280443|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
24956051|NCT00227877|50047114|FG003|Post-visit Checklist|Lost to Follow-up|0|||
25160333|NCT01748552|50280444|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
25160334|NCT01748552|50280445|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
25160335|NCT01748552|50280446|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
25160336|NCT01748162|50280488|FG000|Overall Study|no additional croup episodes to evaluate|2|||
24956052|NCT00227877|50047111|FG000|3-months Follow-up|Completed late|135|||
24956053|NCT00227877|50047112|FG001|3-months Follow-up|Completed late|128|||
24956054|NCT00227877|50047113|FG002|3-months Follow-up|Completed late|34|||
24956055|NCT00227877|50047114|FG003|3-months Follow-up|Completed late|8|||
24956056|NCT00227877|50047111|FG000|3-months Follow-up|Lost to Follow-up|178|||
24956057|NCT00227877|50047112|FG001|3-months Follow-up|Lost to Follow-up|139|||
24956058|NCT00227877|50047113|FG002|3-months Follow-up|Lost to Follow-up|18|||
25042304|NCT00101582|50143387|FG000|Overall Study|Adverse Event|1|||
25042305|NCT00101582|50143388|FG001|Overall Study|Adverse Event|4|||
24956059|NCT00227877|50047114|FG003|3-months Follow-up|Lost to Follow-up|13|||
24956060|NCT00227877|50047111|FG000|12-months Follow-up|Completed late|78|||
24956061|NCT00227877|50047112|FG001|12-months Follow-up|Completed late|74|||
24956062|NCT00227877|50047113|FG002|12-months Follow-up|Completed late|1|||
24956063|NCT00227877|50047114|FG003|12-months Follow-up|Completed late|0|||
24956064|NCT00227877|50047111|FG000|12-months Follow-up|Lost to Follow-up|232|||
24956065|NCT00227877|50047112|FG001|12-months Follow-up|Lost to Follow-up|189|||
24956066|NCT00227877|50047113|FG002|12-months Follow-up|Lost to Follow-up|30|||
24956067|NCT00227877|50047114|FG003|12-months Follow-up|Lost to Follow-up|26|||
24956068|NCT00513695|50047126|FG000|Overall Study|Discontinued therapy|2|||
24956069|NCT00513695|50047126|FG000|Overall Study|Progression prior to surgery|3|||
24956070|NCT00162981|50047132|FG000|Overall Study|Adverse Event|2|||
24956071|NCT00162981|50047133|FG001|Overall Study|Adverse Event|5|||
25042306|NCT00101582|50143387|FG000|Overall Study|Withdrawal by Subject|6|||
25042307|NCT00101582|50143388|FG001|Overall Study|Withdrawal by Subject|4|||
25042308|NCT00101582|50143387|FG000|Overall Study|Physician Decision|1|||
25042309|NCT00101582|50143388|FG001|Overall Study|Physician Decision|0|||
25042310|NCT00101582|50143387|FG000|Overall Study|Death|3|||
25042311|NCT00101582|50143388|FG001|Overall Study|Death|5|||
25042312|NCT00101582|50143387|FG000|Overall Study|Other|0|||
25042313|NCT00101582|50143388|FG001|Overall Study|Other|1|||
25042314|NCT03086135|50143419|FG000|Overall Study|Adverse Event|1|||
25042315|NCT03086135|50143419|FG000|Overall Study|Lost to Follow-up|2|||
25042316|NCT02762708|50143436|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
25042317|NCT02762708|50143437|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
25160337|NCT01748162|50280489|FG001|Overall Study|no additional croup episodes to evaluate|2|||
25160338|NCT01748162|50280488|FG000|Overall Study|participant consented but did not begin|0|||
25160339|NCT01748162|50280489|FG001|Overall Study|participant consented but did not begin|1|||
25160340|NCT01748162|50280488|FG000|Overall Study|reasons not available|3|||
25042318|NCT02762708|50143438|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
25042319|NCT02762708|50143439|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
25042320|NCT02760602|50143451|FG000|Overall Study|Withdrawal by Subject|1|||
25042321|NCT02760602|50143452|FG001|Overall Study|Withdrawal by Subject|0|||
25042322|NCT02760602|50143451|FG000|Overall Study|Terminated by sponsor|12|||
25042323|NCT02760602|50143452|FG001|Overall Study|Terminated by sponsor|13|||
25042324|NCT03852719|50143461|FG000|Overall Study|Still on study|50|||
25042325|NCT03852719|50143462|FG001|Overall Study|Still on study|48|||
24956072|NCT00162981|50047132|FG000|Overall Study|Withdrawal by Subject|1|||
24956073|NCT00162981|50047133|FG001|Overall Study|Withdrawal by Subject|1|||
25042326|NCT03852719|50143463|FG002|Overall Study|Still on study|47|||
25042327|NCT03852719|50143461|FG000|Overall Study|Withdrawal of consent|0|||
25042328|NCT03852719|50143462|FG001|Overall Study|Withdrawal of consent|1|||
25042329|NCT03852719|50143463|FG002|Overall Study|Withdrawal of consent|2|||
25042330|NCT03852719|50143461|FG000|Overall Study|Physician Decision|0|||
25042331|NCT03852719|50143462|FG001|Overall Study|Physician Decision|0|||
25042332|NCT03852719|50143463|FG002|Overall Study|Physician Decision|1|||
25042333|NCT03852719|50143461|FG000|Overall Study|Pregnancy|1|||
25042334|NCT03852719|50143462|FG001|Overall Study|Pregnancy|0|||
25042335|NCT03852719|50143463|FG002|Overall Study|Pregnancy|0|||
25042336|NCT00210249|50143471|FG000|Overall Study|Lost to Follow-up|5|||
25042337|NCT00210249|50143471|FG000|Overall Study|Protocol Violation|11|||
24956074|NCT00162981|50047132|FG000|Overall Study|Physician Decision|1|||
24956075|NCT00162981|50047133|FG001|Overall Study|Physician Decision|0|||
24956076|NCT00511433|50047141|FG000|Overall Study|Adverse Event|5|||
24956077|NCT00511433|50047142|FG001|Overall Study|Adverse Event|0|||
24956078|NCT00511433|50047141|FG000|Overall Study|Other Reason|1|||
24956079|NCT00511433|50047142|FG001|Overall Study|Other Reason|1|||
25042338|NCT03086057|50143479|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
25160341|NCT01748162|50280489|FG001|Overall Study|reasons not available|2|||
25160342|NCT01724216|50280495|FG000|Overall Study|Scan was not completed|1|||
25160343|NCT01723904|50280499|FG000|Overall Study|Noncompliant|3|||
24956080|NCT00099268|50047152|FG000|Overall Study|Withdrawal by Subject|46|||
24956081|NCT00099268|50047153|FG001|Overall Study|Withdrawal by Subject|28|||
24956082|NCT00099268|50047152|FG000|Overall Study|Adverse Event|19|||
24956083|NCT00099268|50047153|FG001|Overall Study|Adverse Event|19|||
24956084|NCT00099268|50047152|FG000|Overall Study|Protocol Violation|9|||
24956085|NCT00099268|50047153|FG001|Overall Study|Protocol Violation|8|||
24956086|NCT00099268|50047152|FG000|Overall Study|Lost to Follow-up|6|||
24956087|NCT00099268|50047153|FG001|Overall Study|Lost to Follow-up|4|||
25042339|NCT03086057|50143480|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
25042340|NCT03086057|50143481|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
25042341|NCT03086057|50143482|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
24956088|NCT00099268|50047152|FG000|Overall Study|Lack of Efficacy|5|||
24956089|NCT00099268|50047153|FG001|Overall Study|Lack of Efficacy|18|||
25042342|NCT03086057|50143479|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
25042343|NCT03086057|50143480|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
25160344|NCT01723904|50280499|FG000|Overall Study|Adverse Event|5|||
25160345|NCT01723904|50280499|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
25160346|NCT01747772|50280503|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
24956090|NCT00099268|50047152|FG000|Overall Study|Administrative problems|4|||
24956091|NCT00099268|50047153|FG001|Overall Study|Administrative problems|4|||
25042344|NCT03086057|50143481|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
25042345|NCT03086057|50143482|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
25042346|NCT03086057|50143479|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
25042347|NCT03086057|50143480|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
25042348|NCT03086057|50143481|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
25042349|NCT03086057|50143482|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
25042350|NCT03086057|50143479|FG000|Stage 1: PrEP Uptake|Death|1|||
25042351|NCT03086057|50143480|FG001|Stage 1: PrEP Uptake|Death|0|||
25042352|NCT03086057|50143481|FG002|Stage 1: PrEP Uptake|Death|0|||
25042353|NCT03086057|50143482|FG003|Stage 1: PrEP Uptake|Death|0|||
25042354|NCT03086057|50143479|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
25042355|NCT03086057|50143480|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
24956092|NCT00099268|50047152|FG000|Overall Study|Death|3|||
24956093|NCT00099268|50047153|FG001|Overall Study|Death|1|||
24956094|NCT00511355|50047161|FG000|Overall Study|Adverse Event|4|||
25042356|NCT03086057|50143481|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
25042357|NCT03086057|50143482|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
25042358|NCT03086057|50143479|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
25042359|NCT03086057|50143480|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
25042360|NCT03086057|50143481|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
25042361|NCT03086057|50143482|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
25042362|NCT03086057|50143479|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
25042363|NCT03086057|50143480|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
24956095|NCT00511355|50047162|FG001|Overall Study|Adverse Event|4|||
24956096|NCT00511355|50047161|FG000|Overall Study|Pregnancy Wish|1|||
24956097|NCT00511355|50047162|FG001|Overall Study|Pregnancy Wish|0|||
24956098|NCT00511355|50047161|FG000|Overall Study|Lost to Follow-up|2|||
24956099|NCT00511355|50047162|FG001|Overall Study|Lost to Follow-up|1|||
24956100|NCT00511355|50047161|FG000|Overall Study|Other Reason|0|||
24956101|NCT00511355|50047162|FG001|Overall Study|Other Reason|1|||
25042364|NCT03086057|50143481|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
25042365|NCT03086057|50143482|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
25042366|NCT02759120|50143494|FG000|Overall Study|Death|34|||
25042367|NCT02759120|50143495|FG001|Overall Study|Death|36|||
25042368|NCT02759120|50143494|FG000|Overall Study|Lost to Follow-up|4|||
25042369|NCT02759120|50143495|FG001|Overall Study|Lost to Follow-up|7|||
25042370|NCT02759120|50143494|FG000|Overall Study|Physician Decision|3|||
25042371|NCT02759120|50143495|FG001|Overall Study|Physician Decision|0|||
25042372|NCT02759120|50143494|FG000|Overall Study|Withdrawal by Subject|28|||
25042373|NCT02759120|50143495|FG001|Overall Study|Withdrawal by Subject|15|||
25042374|NCT02759120|50143494|FG000|Overall Study|Moved out of area|3|||
25042375|NCT02759120|50143495|FG001|Overall Study|Moved out of area|4|||
25042376|NCT02759120|50143494|FG000|Overall Study|Lung transplant|3|||
25042377|NCT02759120|50143495|FG001|Overall Study|Lung transplant|5|||
25042378|NCT02759120|50143494|FG000|Overall Study|Other reason not completed|10|||
25042379|NCT02759120|50143495|FG001|Overall Study|Other reason not completed|12|||
25042380|NCT00101192|50143501|FG000|Overall Study|Ineligible|6|||
25042381|NCT00101192|50143501|FG000|Overall Study|Inevaluable|1|||
25042382|NCT03031431|50143505|FG000|Overall Study|Infant removed by maternal request|1|||
25042383|NCT03029247|50143511|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
25042384|NCT03029247|50143512|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
25042385|NCT03029247|50143511|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
25042386|NCT03029247|50143512|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
25042387|NCT03029247|50143511|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
25042388|NCT03029247|50143512|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
25042389|NCT03029247|50143511|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
25042390|NCT03029247|50143512|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
25042391|NCT04313283|50143518|FG000|Overall Study|did not complete intervention|4|||
25042392|NCT02760368|50143525|FG000|Overall Study|Withdrawal by Subject|12|||
25042393|NCT02760368|50143526|FG001|Overall Study|Withdrawal by Subject|8|||
25042394|NCT02760368|50143527|FG002|Overall Study|Withdrawal by Subject|9|||
25042395|NCT02760368|50143525|FG000|Overall Study|Screen Failure|0|||
25042396|NCT02760368|50143526|FG001|Overall Study|Screen Failure|0|||
25160347|NCT01830127|50280513|FG000|Overall Study|Adverse Event|1|||
24956102|NCT00511355|50047161|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
25042397|NCT02760368|50143527|FG002|Overall Study|Screen Failure|1|||
25160348|NCT01830127|50280514|FG001|Overall Study|Adverse Event|6|||
24956103|NCT00511355|50047162|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
25042398|NCT02760368|50143525|FG000|Overall Study|Death|1|||
25042399|NCT02760368|50143526|FG001|Overall Study|Death|0|||
24956104|NCT00511355|50047161|FG000|Overall Study|Withdrawal of informed consent|0|||
25042400|NCT02760368|50143527|FG002|Overall Study|Death|0|||
25042401|NCT02760368|50143525|FG000|Overall Study|Withdrawal by Sponsor|0|||
25042402|NCT02760368|50143526|FG001|Overall Study|Withdrawal by Sponsor|0|||
25042403|NCT02760368|50143527|FG002|Overall Study|Withdrawal by Sponsor|1|||
25042404|NCT02754440|50143539|FG000|Overall Study|Protocol Violation|3|||
25042405|NCT02754440|50143540|FG001|Overall Study|Protocol Violation|2|||
25042406|NCT02754440|50143541|FG002|Overall Study|Protocol Violation|2|||
25042407|NCT02754440|50143542|FG003|Overall Study|Protocol Violation|6|||
25042408|NCT02754440|50143539|FG000|Overall Study|Adverse Event|3|||
25042409|NCT02754440|50143540|FG001|Overall Study|Adverse Event|1|||
25042410|NCT02754440|50143541|FG002|Overall Study|Adverse Event|0|||
25042411|NCT02754440|50143542|FG003|Overall Study|Adverse Event|9|||
25042412|NCT02754440|50143539|FG000|Overall Study|Withdrawal by Subject|0|||
25160349|NCT01830127|50280513|FG000|Overall Study|Lack of Efficacy|3|||
25160350|NCT01830127|50280514|FG001|Overall Study|Lack of Efficacy|0|||
25160351|NCT01830127|50280513|FG000|Overall Study|Withdrawal by Subject|1|||
25160352|NCT01830127|50280514|FG001|Overall Study|Withdrawal by Subject|1|||
25160353|NCT01830127|50280513|FG000|Overall Study|Other reason not defined above|0|||
25160354|NCT01830127|50280514|FG001|Overall Study|Other reason not defined above|2|||
25160355|NCT01614067|50280522|FG000|Overall Study|Pregnancy|1|||
25160356|NCT01614067|50280523|FG001|Overall Study|Pregnancy|0|||
25160357|NCT01614067|50280522|FG000|Overall Study|Physician Decision|6|||
25160358|NCT01614067|50280523|FG001|Overall Study|Physician Decision|5|||
25160359|NCT01614067|50280522|FG000|Overall Study|Withdrawal by Subject|0|||
25160360|NCT01614067|50280523|FG001|Overall Study|Withdrawal by Subject|1|||
25160361|NCT01614067|50280522|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
25160362|NCT01614067|50280523|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
25160363|NCT01777490|50280533|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
25160364|NCT01777490|50280534|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
25160365|NCT01777490|50280535|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
25160366|NCT01777490|50280536|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
25160367|NCT01397409|50280558|FG000|Stage 2|Adverse Event|0|||
25160368|NCT01397409|50280559|FG001|Stage 2|Adverse Event|0|||
25160369|NCT01397409|50280560|FG002|Stage 2|Adverse Event|0|||
25160370|NCT01397409|50280561|FG003|Stage 2|Adverse Event|0|||
25160371|NCT01397409|50280562|FG004|Stage 2|Adverse Event|6|||
25160372|NCT01397409|50280563|FG005|Stage 2|Adverse Event|3|||
25160373|NCT01397409|50280564|FG006|Stage 2|Adverse Event|0|||
25160374|NCT01397409|50280565|FG007|Stage 2|Adverse Event|0|||
25160375|NCT01397409|50280566|FG008|Stage 2|Adverse Event|0|||
25160376|NCT01397409|50280567|FG009|Stage 2|Adverse Event|0|||
25160377|NCT01397409|50280558|FG000|Stage 2|Personal Reasons|0|||
25160378|NCT01397409|50280559|FG001|Stage 2|Personal Reasons|0|||
25160379|NCT01397409|50280560|FG002|Stage 2|Personal Reasons|0|||
25160380|NCT01397409|50280561|FG003|Stage 2|Personal Reasons|0|||
25160381|NCT01397409|50280562|FG004|Stage 2|Personal Reasons|1|||
25160382|NCT01397409|50280563|FG005|Stage 2|Personal Reasons|0|||
25160383|NCT01397409|50280564|FG006|Stage 2|Personal Reasons|0|||
25160384|NCT01397409|50280565|FG007|Stage 2|Personal Reasons|0|||
25160385|NCT01397409|50280566|FG008|Stage 2|Personal Reasons|0|||
25160386|NCT01397409|50280567|FG009|Stage 2|Personal Reasons|0|||
25160387|NCT01397409|50280558|FG000|Stage 2|Other Miscellaneous Reasons|0|||
25160388|NCT01397409|50280559|FG001|Stage 2|Other Miscellaneous Reasons|0|||
25160389|NCT01397409|50280560|FG002|Stage 2|Other Miscellaneous Reasons|0|||
25160390|NCT01397409|50280561|FG003|Stage 2|Other Miscellaneous Reasons|0|||
25160391|NCT01397409|50280562|FG004|Stage 2|Other Miscellaneous Reasons|1|||
25160392|NCT01397409|50280563|FG005|Stage 2|Other Miscellaneous Reasons|1|||
25160393|NCT01397409|50280564|FG006|Stage 2|Other Miscellaneous Reasons|0|||
25160394|NCT01397409|50280565|FG007|Stage 2|Other Miscellaneous Reasons|0|||
25160395|NCT01397409|50280566|FG008|Stage 2|Other Miscellaneous Reasons|0|||
25160396|NCT01397409|50280567|FG009|Stage 2|Other Miscellaneous Reasons|0|||
25160397|NCT01397409|50280558|FG000|Stage 3|Adverse Event|0|||
24956105|NCT00511355|50047162|FG001|Overall Study|Withdrawal of informed consent|1|||
24956106|NCT00511355|50047161|FG000|Overall Study|Other reason pre-treatment|0|||
24956107|NCT00511355|50047162|FG001|Overall Study|Other reason pre-treatment|1|||
24956108|NCT00095212|50047172|FG000|Overall Study|Withdrawal by Subject|1|||
24956109|NCT00095212|50047173|FG001|Overall Study|Withdrawal by Subject|3|||
24956110|NCT00120874|50047181|FG000|Overall Study|Death|0|||
24956111|NCT00120874|50047182|FG001|Overall Study|Death|1|||
25042413|NCT02754440|50143540|FG001|Overall Study|Withdrawal by Subject|0|||
25160398|NCT01397409|50280559|FG001|Stage 3|Adverse Event|0|||
25160399|NCT01397409|50280560|FG002|Stage 3|Adverse Event|0|||
24956112|NCT00120406|50047190|FG000|Overall Study|Death|9|||
25042414|NCT02754440|50143541|FG002|Overall Study|Withdrawal by Subject|0|||
25042415|NCT02754440|50143542|FG003|Overall Study|Withdrawal by Subject|1|||
25042416|NCT02754440|50143539|FG000|Overall Study|Equipment failure|0|||
25160400|NCT01397409|50280561|FG003|Stage 3|Adverse Event|0|||
25160401|NCT01397409|50280562|FG004|Stage 3|Adverse Event|0|||
25160402|NCT01397409|50280563|FG005|Stage 3|Adverse Event|0|||
24956113|NCT00120406|50047191|FG001|Overall Study|Death|4|||
25160403|NCT01397409|50280564|FG006|Stage 3|Adverse Event|0|||
25160404|NCT01397409|50280565|FG007|Stage 3|Adverse Event|1|||
25042417|NCT02754440|50143540|FG001|Overall Study|Equipment failure|5|||
25042418|NCT02754440|50143541|FG002|Overall Study|Equipment failure|5|||
25042419|NCT02754440|50143542|FG003|Overall Study|Equipment failure|7|||
25042420|NCT02754440|50143539|FG000|Overall Study|Subject issues not resulting in AE|0|||
25042421|NCT02754440|50143540|FG001|Overall Study|Subject issues not resulting in AE|0|||
25042422|NCT02754440|50143541|FG002|Overall Study|Subject issues not resulting in AE|0|||
25042423|NCT02754440|50143542|FG003|Overall Study|Subject issues not resulting in AE|12|||
25042424|NCT02753816|50143554|FG000|Overall Study|Protocol Violation|0|||
25042425|NCT02753816|50143555|FG001|Overall Study|Protocol Violation|1|||
25042426|NCT02753816|50143556|FG002|Overall Study|Protocol Violation|0|||
25042427|NCT02752802|50143564|FG000|Overall Study|Contrast Volume Not Collected|1|||
25042428|NCT02752802|50143565|FG001|Overall Study|Contrast Volume Not Collected|0|||
25042429|NCT02756078|50143582|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
25042430|NCT02756078|50143583|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
25042431|NCT02756078|50143582|FG000|Period 1|Lost to Follow-up|0|||
25042432|NCT02756078|50143583|FG001|Period 1|Lost to Follow-up|2|||
25042433|NCT02756078|50143582|FG000|Period 1|Protocol Violation|0|||
25042434|NCT02756078|50143583|FG001|Period 1|Protocol Violation|1|||
25042435|NCT02756078|50143582|FG000|Period 1|Adverse Event|1|||
25042436|NCT02756078|50143583|FG001|Period 1|Adverse Event|10|||
24956114|NCT00120406|50047190|FG000|Overall Study|Withdrawal by Subject|5|||
24956115|NCT00120406|50047191|FG001|Overall Study|Withdrawal by Subject|7|||
24956116|NCT00120406|50047190|FG000|Overall Study|Lost to Follow-up|5|||
24956117|NCT00120406|50047191|FG001|Overall Study|Lost to Follow-up|2|||
24956118|NCT00120406|50047190|FG000|Overall Study|received non-study stent|0|||
25042437|NCT02756078|50143582|FG000|Period 1|Withdrawal by Subject|6|||
25042438|NCT02756078|50143583|FG001|Period 1|Withdrawal by Subject|6|||
25042439|NCT02756078|50143582|FG000|Period 1|Lens Discomfort|2|||
25042440|NCT02756078|50143583|FG001|Period 1|Lens Discomfort|2|||
25042441|NCT02756078|50143582|FG000|Period 2|Adverse Event|3|||
25042442|NCT02756078|50143583|FG001|Period 2|Adverse Event|5|||
25042443|NCT02756078|50143582|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
25042444|NCT02756078|50143583|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
25042445|NCT02756078|50143582|FG000|Period 2|Withdrawal by Subject|3|||
25042446|NCT02756078|50143583|FG001|Period 2|Withdrawal by Subject|1|||
25042447|NCT03813147|50143591|FG000|Overall Study|Lack of Efficacy|4|||
25042448|NCT03813147|50143592|FG001|Overall Study|Lack of Efficacy|4|||
25042449|NCT03813147|50143591|FG000|Overall Study|Physician Decision|2|||
25042450|NCT03813147|50143592|FG001|Overall Study|Physician Decision|1|||
25042451|NCT02752958|50143598|FG000|Overall Study|Adverse Event|3|||
25042452|NCT02752958|50143598|FG000|Overall Study|Lost to Follow-up|1|||
25042453|NCT02752958|50143598|FG000|Overall Study|Protocol Violation|1|||
25042454|NCT02752958|50143598|FG000|Overall Study|Withdrawal by Subject|2|||
25042455|NCT02752958|50143598|FG000|Overall Study|Other (Reason not specified)|2|||
25042456|NCT02805660|50143611|FG000|Overall Study|Death|5|||
25042457|NCT02805660|50143612|FG001|Overall Study|Death|2|||
25042458|NCT02805660|50143613|FG002|Overall Study|Death|9|||
25042459|NCT02805660|50143614|FG003|Overall Study|Death|5|||
25042460|NCT02805660|50143615|FG004|Overall Study|Death|0|||
25042461|NCT02805660|50143616|FG005|Overall Study|Death|14|||
24956119|NCT00120406|50047191|FG001|Overall Study|received non-study stent|2|||
24956120|NCT00120406|50047190|FG000|Overall Study|patient moved but has not withdrawn|0|||
25042462|NCT02805660|50143617|FG006|Overall Study|Death|12|||
25042463|NCT02805660|50143611|FG000|Overall Study|Lost to Follow-up|0|||
25042464|NCT02805660|50143612|FG001|Overall Study|Lost to Follow-up|1|||
25042465|NCT02805660|50143613|FG002|Overall Study|Lost to Follow-up|1|||
25042466|NCT02805660|50143614|FG003|Overall Study|Lost to Follow-up|2|||
25042467|NCT02805660|50143615|FG004|Overall Study|Lost to Follow-up|0|||
25160405|NCT01397409|50280566|FG008|Stage 3|Adverse Event|0|||
25160406|NCT01397409|50280567|FG009|Stage 3|Adverse Event|0|||
24956121|NCT00120406|50047191|FG001|Overall Study|patient moved but has not withdrawn|1|||
24956122|NCT00120250|50047197|FG000|Overall Study|Lost to Follow-up|1|||
24956123|NCT00120250|50047198|FG001|Overall Study|Lost to Follow-up|1|||
24956124|NCT00120250|50047197|FG000|Overall Study|Protocol Violation|0|||
25042468|NCT02805660|50143616|FG005|Overall Study|Lost to Follow-up|0|||
25160407|NCT01397409|50280558|FG000|Stage 3|Other Miscellaneous Reasons|0|||
24956125|NCT00120250|50047198|FG001|Overall Study|Protocol Violation|1|||
24956126|NCT00511199|50047207|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
24956127|NCT00511199|50047208|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
25042469|NCT02805660|50143617|FG006|Overall Study|Lost to Follow-up|0|||
25042470|NCT02805660|50143611|FG000|Overall Study|Withdrawal by Subject|0|||
25042471|NCT02805660|50143612|FG001|Overall Study|Withdrawal by Subject|0|||
25042472|NCT02805660|50143613|FG002|Overall Study|Withdrawal by Subject|0|||
25042473|NCT02805660|50143614|FG003|Overall Study|Withdrawal by Subject|3|||
25160408|NCT01397409|50280559|FG001|Stage 3|Other Miscellaneous Reasons|0|||
25042474|NCT02805660|50143615|FG004|Overall Study|Withdrawal by Subject|1|||
25042475|NCT02805660|50143616|FG005|Overall Study|Withdrawal by Subject|0|||
24956128|NCT00511199|50047207|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
25160409|NCT01397409|50280560|FG002|Stage 3|Other Miscellaneous Reasons|0|||
25160410|NCT01397409|50280561|FG003|Stage 3|Other Miscellaneous Reasons|0|||
25160411|NCT01397409|50280562|FG004|Stage 3|Other Miscellaneous Reasons|0|||
25160412|NCT01397409|50280563|FG005|Stage 3|Other Miscellaneous Reasons|0|||
25160413|NCT01397409|50280564|FG006|Stage 3|Other Miscellaneous Reasons|0|||
24956129|NCT00511199|50047208|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
24956130|NCT00511199|50047207|FG000|Overall Study|Withdrawal of Informed Consent|19|||
24956131|NCT00511199|50047208|FG001|Overall Study|Withdrawal of Informed Consent|4|||
24956132|NCT00511199|50047207|FG000|Overall Study|Pregnancy|6|||
24956133|NCT00511199|50047208|FG001|Overall Study|Pregnancy|3|||
24956134|NCT00511199|50047207|FG000|Overall Study|Pregnancy Wish|16|||
24956135|NCT00511199|50047208|FG001|Overall Study|Pregnancy Wish|8|||
24956136|NCT00511199|50047207|FG000|Overall Study|Lost to Follow-up|40|||
24956137|NCT00511199|50047208|FG001|Overall Study|Lost to Follow-up|17|||
25042476|NCT02805660|50143617|FG006|Overall Study|Withdrawal by Subject|2|||
25042477|NCT02805660|50143611|FG000|Overall Study|Study terminated by Sponsor|0|||
25042478|NCT02805660|50143612|FG001|Overall Study|Study terminated by Sponsor|0|||
25042479|NCT02805660|50143613|FG002|Overall Study|Study terminated by Sponsor|1|||
25042480|NCT02805660|50143614|FG003|Overall Study|Study terminated by Sponsor|4|||
25042481|NCT02805660|50143615|FG004|Overall Study|Study terminated by Sponsor|2|||
25042482|NCT02805660|50143616|FG005|Overall Study|Study terminated by Sponsor|3|||
25042483|NCT02805660|50143617|FG006|Overall Study|Study terminated by Sponsor|1|||
25042484|NCT02805660|50143611|FG000|Overall Study|Miscellaneous|0|||
25042485|NCT02805660|50143612|FG001|Overall Study|Miscellaneous|1|||
25042486|NCT02805660|50143613|FG002|Overall Study|Miscellaneous|0|||
25042487|NCT02805660|50143614|FG003|Overall Study|Miscellaneous|4|||
25042488|NCT02805660|50143615|FG004|Overall Study|Miscellaneous|0|||
25042489|NCT02805660|50143616|FG005|Overall Study|Miscellaneous|6|||
25042490|NCT02805660|50143617|FG006|Overall Study|Miscellaneous|4|||
25042491|NCT02807376|50143648|FG000|Overall Study|Intra-operative exclusion criteria|3|||
25042492|NCT02807376|50143649|FG001|Overall Study|Intra-operative exclusion criteria|0|||
25042493|NCT02807376|50143648|FG000|Overall Study|Lost to Follow-up|0|||
25042494|NCT02807376|50143649|FG001|Overall Study|Lost to Follow-up|1|||
25042495|NCT02804178|50143668|FG000|Overall Study|Adverse Event|1|||
25042496|NCT02917941|50143672|FG000|Treatment Period|Adverse Event|11|||
25160414|NCT01397409|50280565|FG007|Stage 3|Other Miscellaneous Reasons|1|||
25160415|NCT01397409|50280566|FG008|Stage 3|Other Miscellaneous Reasons|0|||
25160416|NCT01397409|50280567|FG009|Stage 3|Other Miscellaneous Reasons|0|||
24956138|NCT00511199|50047207|FG000|Overall Study|Other Reason|78|||
24956139|NCT00511199|50047208|FG001|Overall Study|Other Reason|37|||
24956140|NCT00384176|50047219|FG000|Overall Study|Death|239|||
24956141|NCT00384176|50047220|FG001|Overall Study|Death|247|||
24956142|NCT00384176|50047221|FG002|Overall Study|Death|105|||
24956143|NCT00384176|50047219|FG000|Overall Study|Withdrawal by Subject|52|||
24956144|NCT00384176|50047220|FG001|Overall Study|Withdrawal by Subject|48|||
25160417|NCT01397253|50280592|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
25276207|NCT00963820|50590154|FG000|Expansion Phase|Progressive Disease|0|||
24956145|NCT00384176|50047221|FG002|Overall Study|Withdrawal by Subject|22|||
24956146|NCT00384176|50047219|FG000|Overall Study|Lost to Follow-up|16|||
24956147|NCT00384176|50047220|FG001|Overall Study|Lost to Follow-up|18|||
24956148|NCT00384176|50047221|FG002|Overall Study|Lost to Follow-up|4|||
24956149|NCT00384176|50047219|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
24956150|NCT00384176|50047220|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
24956151|NCT00384176|50047221|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
25042497|NCT02917941|50143672|FG000|Treatment Period|Progressive Disease|11|||
25042498|NCT02917941|50143672|FG000|Treatment Period|Reason not Specified|2|||
25042499|NCT02917941|50143672|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
25042500|NCT02917941|50143672|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
25160418|NCT01397253|50280593|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
25160419|NCT01777334|50280601|FG000|Overall Study|Adverse Event|18|||
24956152|NCT00384176|50047219|FG000|Overall Study|Longer QTC as Visit 1|1|||
24956153|NCT00384176|50047220|FG001|Overall Study|Longer QTC as Visit 1|0|||
25160420|NCT01777334|50280602|FG001|Overall Study|Adverse Event|14|||
24956154|NCT00384176|50047221|FG002|Overall Study|Longer QTC as Visit 1|0|||
25160421|NCT01777334|50280601|FG000|Overall Study|Lack of Efficacy|15|||
25160422|NCT01777334|50280602|FG001|Overall Study|Lack of Efficacy|29|||
25160423|NCT01777334|50280601|FG000|Overall Study|Protocol Violation|3|||
25160424|NCT01777334|50280602|FG001|Overall Study|Protocol Violation|7|||
25160425|NCT01777334|50280601|FG000|Overall Study|Lost to Follow-up|3|||
25160426|NCT01777334|50280602|FG001|Overall Study|Lost to Follow-up|2|||
25160427|NCT01777334|50280601|FG000|Overall Study|Withdrawal by Subject|14|||
25160428|NCT01777334|50280602|FG001|Overall Study|Withdrawal by Subject|11|||
25160429|NCT01383993|50280611|FG000|Overall Study|Adverse Event|1|||
25160430|NCT01383993|50280612|FG001|Overall Study|Adverse Event|1|||
25042501|NCT01333956|50143680|FG000|Overall Study|Lost to Follow-up|1|||
25042502|NCT01333956|50143681|FG001|Overall Study|Lost to Follow-up|2|||
25042503|NCT01333956|50143682|FG002|Overall Study|Lost to Follow-up|0|||
25042504|NCT01333956|50143683|FG003|Overall Study|Lost to Follow-up|1|||
25042505|NCT01333956|50143680|FG000|Overall Study|Unable to complete study procedure|1|||
25042506|NCT01333956|50143681|FG001|Overall Study|Unable to complete study procedure|0|||
25042507|NCT01333956|50143682|FG002|Overall Study|Unable to complete study procedure|0|||
25042508|NCT01333956|50143683|FG003|Overall Study|Unable to complete study procedure|1|||
25042509|NCT01333956|50143680|FG000|Overall Study|Withdrawal by Subject|0|||
25042510|NCT01333956|50143681|FG001|Overall Study|Withdrawal by Subject|2|||
25042511|NCT01333956|50143682|FG002|Overall Study|Withdrawal by Subject|1|||
25042512|NCT01333956|50143683|FG003|Overall Study|Withdrawal by Subject|0|||
25160431|NCT01383993|50280613|FG002|Overall Study|Adverse Event|0|||
25160432|NCT01383993|50280611|FG000|Overall Study|Withdrawal by Subject|0|||
25160433|NCT01383993|50280612|FG001|Overall Study|Withdrawal by Subject|0|||
25160434|NCT01383993|50280613|FG002|Overall Study|Withdrawal by Subject|1|||
24956155|NCT00384176|50047219|FG000|Overall Study|Toxicity of treatment|1|||
24956156|NCT00384176|50047220|FG001|Overall Study|Toxicity of treatment|0|||
24956157|NCT00384176|50047221|FG002|Overall Study|Toxicity of treatment|0|||
24956158|NCT00384176|50047219|FG000|Overall Study|Did not receive study treatment|0|||
24956159|NCT00384176|50047220|FG001|Overall Study|Did not receive study treatment|1|||
24956160|NCT00384176|50047221|FG002|Overall Study|Did not receive study treatment|1|||
24956161|NCT00384176|50047219|FG000|Overall Study|Physician Decision|0|||
24956162|NCT00384176|50047220|FG001|Overall Study|Physician Decision|2|||
24956163|NCT00384176|50047221|FG002|Overall Study|Physician Decision|0|||
24956164|NCT00384176|50047219|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
24956165|NCT00384176|50047220|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
24956166|NCT00384176|50047221|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
24956167|NCT00513305|50047231|FG000|Overall Study|Adverse Event|6|||
25042513|NCT01333722|50143696|FG000|Overall Study|Lack of Efficacy|0|||
25160435|NCT01383993|50280611|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
25160436|NCT01383993|50280612|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
24956168|NCT00513305|50047232|FG001|Overall Study|Adverse Event|2|||
24956169|NCT00513305|50047231|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
24956170|NCT00513305|50047232|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
24956171|NCT00513305|50047231|FG000|Overall Study|Lack of Efficacy|8|||
24956172|NCT00513305|50047232|FG001|Overall Study|Lack of Efficacy|13|||
25160437|NCT01383993|50280613|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
25160438|NCT01396395|50280624|FG000|Overall Study|Withdrawal by Subject|10|||
24956173|NCT00513305|50047231|FG000|Overall Study|Withdrawal by Subject|1|||
24956174|NCT00513305|50047232|FG001|Overall Study|Withdrawal by Subject|2|||
24956175|NCT00513305|50047231|FG000|Overall Study|Disease progression|8|||
24956176|NCT00513305|50047232|FG001|Overall Study|Disease progression|5|||
24956177|NCT00513305|50047231|FG000|Overall Study|Eligible for stem cell transplant|1|||
24956178|NCT00513305|50047232|FG001|Overall Study|Eligible for stem cell transplant|0|||
24956179|NCT00513305|50047231|FG000|Overall Study|Hematologic counts did not recover|1|||
25160439|NCT01396395|50280625|FG001|Overall Study|Withdrawal by Subject|12|||
25186502|NCT02647866|50336897|FG002|Overall Study|Withdrawal by Subject|2|||
25186503|NCT02647866|50336898|FG003|Overall Study|Withdrawal by Subject|4|||
25186504|NCT02647866|50336899|FG004|Overall Study|Withdrawal by Subject|4|||
24956180|NCT00513305|50047232|FG001|Overall Study|Hematologic counts did not recover|0|||
24956181|NCT00513305|50047231|FG000|Overall Study|Physician Decision|1|||
24956182|NCT00513305|50047232|FG001|Overall Study|Physician Decision|0|||
24956183|NCT00513305|50047231|FG000|Overall Study|Persistent hypocellularity|0|||
25042514|NCT01333722|50143697|FG001|Overall Study|Lack of Efficacy|2|||
25042515|NCT01333722|50143696|FG000|Overall Study|Withdrawal by Subject|0|||
25160440|NCT01396395|50280624|FG000|Overall Study|Protocol Violation|3|||
25186505|NCT02647866|50336895|FG000|Overall Study|Physician Decision|0|||
25186506|NCT02647866|50336896|FG001|Overall Study|Physician Decision|1|||
24956184|NCT00513305|50047232|FG001|Overall Study|Persistent hypocellularity|1|||
24956185|NCT00513305|50047231|FG000|Overall Study|Sponsor Decision|0|||
24956186|NCT00513305|50047232|FG001|Overall Study|Sponsor Decision|2|||
24956187|NCT00513071|50047238|FG000|Overall Study|Adverse Event|1|||
25160441|NCT01396395|50280625|FG001|Overall Study|Protocol Violation|1|||
25186507|NCT02647866|50336897|FG002|Overall Study|Physician Decision|1|||
24956188|NCT00513071|50047238|FG000|Overall Study|Withdrawal by Subject|1|||
24956189|NCT00513071|50047238|FG000|Overall Study|Physician Decision|3|||
24956190|NCT00510887|50047242|FG000|Overall Study|Lost to Follow-up|1|||
24956191|NCT00358826|50047250|FG000|Core Study|Adverse Event|1|||
24956192|NCT00358826|50047251|FG001|Core Study|Adverse Event|3|||
24956193|NCT00358826|50047252|FG002|Core Study|Adverse Event|1|||
24956194|NCT00358826|50047253|FG003|Core Study|Adverse Event|1|||
25042516|NCT01333722|50143697|FG001|Overall Study|Withdrawal by Subject|1|||
25042517|NCT01370694|50143705|FG000|Overall Study|Switched to rituximab|4|||
25042518|NCT01370694|50143705|FG000|Overall Study|Progressive disease|2|||
25042519|NCT03315143|50143711|FG000|Overall Study|Death|240|||
25042520|NCT03315143|50143712|FG001|Overall Study|Death|246|||
25042521|NCT03315143|50143711|FG000|Overall Study|Withdrawal by Subject|57|||
25042522|NCT03315143|50143712|FG001|Overall Study|Withdrawal by Subject|68|||
25042523|NCT03315143|50143711|FG000|Overall Study|Site Terminated by Sponsor|256|||
25042524|NCT03315143|50143712|FG001|Overall Study|Site Terminated by Sponsor|282|||
25042525|NCT03315143|50143711|FG000|Overall Study|Study Terminated by Sponsor|4723|||
25042526|NCT03315143|50143712|FG001|Overall Study|Study Terminated by Sponsor|4664|||
25042527|NCT03315143|50143711|FG000|Overall Study|Reason not Specified|16|||
25042528|NCT03315143|50143712|FG001|Overall Study|Reason not Specified|32|||
25042529|NCT02797080|50143718|FG000|Overall Study|Lost to Follow-up|1|||
25042530|NCT02797080|50143718|FG000|Overall Study|Withdrawal by Subject|1|||
25042531|NCT02915835|50143724|FG000|Overall Study|Physician Decision|1|||
25042532|NCT02915835|50143725|FG001|Overall Study|Physician Decision|0|||
25042533|NCT02915835|50143724|FG000|Overall Study|Withdrawal by Subject|0|||
25042534|NCT02915835|50143725|FG001|Overall Study|Withdrawal by Subject|1|||
25042535|NCT01370616|50143733|FG000|Overall Study|Adverse Event|11|||
25042536|NCT01370616|50143734|FG001|Overall Study|Adverse Event|16|||
25042537|NCT01370616|50143733|FG000|Overall Study|Death|1|||
25042538|NCT01370616|50143734|FG001|Overall Study|Death|0|||
25042539|NCT01370616|50143733|FG000|Overall Study|Lack of Efficacy|6|||
25042540|NCT01370616|50143734|FG001|Overall Study|Lack of Efficacy|2|||
25042541|NCT01370616|50143733|FG000|Overall Study|Lost to Follow-up|0|||
25042542|NCT01370616|50143734|FG001|Overall Study|Lost to Follow-up|3|||
25042543|NCT01370616|50143733|FG000|Overall Study|Physician Decision|6|||
25042544|NCT01370616|50143734|FG001|Overall Study|Physician Decision|6|||
25276208|NCT00963820|50590155|FG001|Expansion Phase|Progressive Disease|0|||
25276209|NCT00963820|50590156|FG002|Expansion Phase|Progressive Disease|0|||
25160442|NCT01396395|50280624|FG000|Overall Study|Adverse Event|10|||
25276210|NCT00963820|50590157|FG003|Expansion Phase|Progressive Disease|0|||
25276211|NCT00963820|50590158|FG004|Expansion Phase|Progressive Disease|0|||
25276212|NCT00963820|50590159|FG005|Expansion Phase|Progressive Disease|0|||
24956195|NCT00358826|50047254|FG004|Core Study|Adverse Event|0|||
24956196|NCT00358826|50047255|FG005|Core Study|Adverse Event|0|||
24956197|NCT00358826|50047256|FG006|Core Study|Adverse Event|0|||
24956198|NCT00358826|50047257|FG007|Core Study|Adverse Event|0|||
24956199|NCT00358826|50047250|FG000|Core Study|Withdrawal by Subject|2|||
25042545|NCT01370616|50143733|FG000|Overall Study|Progressive Disease|0|||
25042546|NCT01370616|50143734|FG001|Overall Study|Progressive Disease|1|||
25276213|NCT00963820|50590160|FG006|Expansion Phase|Progressive Disease|0|||
25276214|NCT00963820|50590161|FG007|Expansion Phase|Progressive Disease|0|||
25276215|NCT00963820|50590162|FG008|Expansion Phase|Progressive Disease|8|||
25276216|NCT00963820|50590163|FG009|Expansion Phase|Progressive Disease|6|||
25276217|NCT00963820|50590164|FG010|Expansion Phase|Progressive Disease|4|||
24956200|NCT00358826|50047251|FG001|Core Study|Withdrawal by Subject|2|||
25042547|NCT01370616|50143733|FG000|Overall Study|Recovery|1|||
25042548|NCT01370616|50143734|FG001|Overall Study|Recovery|0|||
25042549|NCT01370616|50143733|FG000|Overall Study|Technical Problems|3|||
25042550|NCT01370616|50143734|FG001|Overall Study|Technical Problems|5|||
25042551|NCT01370616|50143733|FG000|Overall Study|Withdrawal by Subject|34|||
25042552|NCT01370616|50143734|FG001|Overall Study|Withdrawal by Subject|34|||
25042553|NCT02916927|50143747|FG000|Overall Study|Discharged prior to study drug receipt|0|||
25042554|NCT02916927|50143748|FG001|Overall Study|Discharged prior to study drug receipt|2|||
25042555|NCT02916927|50143747|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
25160443|NCT01396395|50280625|FG001|Overall Study|Adverse Event|2|||
25160444|NCT01396395|50280624|FG000|Overall Study|Lost to Follow-up|17|||
24956201|NCT00358826|50047252|FG002|Core Study|Withdrawal by Subject|0|||
24956202|NCT00358826|50047253|FG003|Core Study|Withdrawal by Subject|0|||
25160445|NCT01396395|50280625|FG001|Overall Study|Lost to Follow-up|11|||
25276218|NCT00963820|50590165|FG011|Expansion Phase|Progressive Disease|2|||
24956203|NCT00358826|50047254|FG004|Core Study|Withdrawal by Subject|0|||
24956204|NCT00358826|50047255|FG005|Core Study|Withdrawal by Subject|0|||
25042556|NCT02916927|50143748|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
24956205|NCT00358826|50047256|FG006|Core Study|Withdrawal by Subject|0|||
24956206|NCT00358826|50047257|FG007|Core Study|Withdrawal by Subject|0|||
24956207|NCT00358826|50047250|FG000|Core Study|Lost to Follow-up|0|||
25042557|NCT02916927|50143747|FG000|Overall Study|Withdrawal before first time point|1|||
25042558|NCT02916927|50143748|FG001|Overall Study|Withdrawal before first time point|0|||
25042559|NCT02916693|50143754|FG000|Overall Study|Lost to Follow-up|7|||
24956208|NCT00358826|50047251|FG001|Core Study|Lost to Follow-up|0|||
24956209|NCT00358826|50047252|FG002|Core Study|Lost to Follow-up|0|||
24956210|NCT00358826|50047253|FG003|Core Study|Lost to Follow-up|1|||
24956211|NCT00358826|50047254|FG004|Core Study|Lost to Follow-up|0|||
24956212|NCT00358826|50047255|FG005|Core Study|Lost to Follow-up|0|||
24956213|NCT00358826|50047256|FG006|Core Study|Lost to Follow-up|0|||
24956214|NCT00358826|50047257|FG007|Core Study|Lost to Follow-up|0|||
24956215|NCT00358826|50047250|FG000|Core Study|Physician Decision|0|||
24956216|NCT00358826|50047251|FG001|Core Study|Physician Decision|0|||
24956217|NCT00358826|50047252|FG002|Core Study|Physician Decision|1|||
24956218|NCT00358826|50047253|FG003|Core Study|Physician Decision|0|||
24956219|NCT00358826|50047254|FG004|Core Study|Physician Decision|0|||
24956220|NCT00358826|50047255|FG005|Core Study|Physician Decision|0|||
24956221|NCT00358826|50047256|FG006|Core Study|Physician Decision|0|||
24956222|NCT00358826|50047257|FG007|Core Study|Physician Decision|0|||
24956223|NCT00358826|50047250|FG000|MDCT Substudy|Adverse Event|0|||
24956224|NCT00358826|50047251|FG001|MDCT Substudy|Adverse Event|0|||
24956225|NCT00358826|50047252|FG002|MDCT Substudy|Adverse Event|0|||
24956226|NCT00358826|50047253|FG003|MDCT Substudy|Adverse Event|0|||
24956227|NCT00358826|50047254|FG004|MDCT Substudy|Adverse Event|1|||
24956228|NCT00358826|50047255|FG005|MDCT Substudy|Adverse Event|0|||
24956229|NCT00358826|50047256|FG006|MDCT Substudy|Adverse Event|0|||
25042560|NCT02574455|50143764|FG000|Overall Study|Death|197|||
25042561|NCT02574455|50143765|FG001|Overall Study|Death|210|||
25042562|NCT02574455|50143764|FG000|Overall Study|Withdrawal of Consent|11|||
25042563|NCT02574455|50143765|FG001|Overall Study|Withdrawal of Consent|28|||
24956230|NCT00358826|50047257|FG007|MDCT Substudy|Adverse Event|0|||
24956231|NCT00358826|50047250|FG000|MDCT Substudy|Lost to Follow-up|0|||
24956232|NCT00358826|50047251|FG001|MDCT Substudy|Lost to Follow-up|0|||
24956233|NCT00358826|50047252|FG002|MDCT Substudy|Lost to Follow-up|0|||
24956234|NCT00358826|50047253|FG003|MDCT Substudy|Lost to Follow-up|0|||
24956235|NCT00358826|50047254|FG004|MDCT Substudy|Lost to Follow-up|0|||
24956236|NCT00358826|50047255|FG005|MDCT Substudy|Lost to Follow-up|1|||
24956237|NCT00358826|50047256|FG006|MDCT Substudy|Lost to Follow-up|0|||
24956238|NCT00358826|50047257|FG007|MDCT Substudy|Lost to Follow-up|0|||
24956239|NCT00358826|50047250|FG000|MDCT Substudy|Withdrawal by Subject|0|||
24956240|NCT00358826|50047251|FG001|MDCT Substudy|Withdrawal by Subject|0|||
24956241|NCT00358826|50047252|FG002|MDCT Substudy|Withdrawal by Subject|0|||
24956242|NCT00358826|50047253|FG003|MDCT Substudy|Withdrawal by Subject|0|||
24956243|NCT00358826|50047254|FG004|MDCT Substudy|Withdrawal by Subject|0|||
24956244|NCT00358826|50047255|FG005|MDCT Substudy|Withdrawal by Subject|1|||
24956245|NCT00358826|50047256|FG006|MDCT Substudy|Withdrawal by Subject|0|||
24956246|NCT00358826|50047257|FG007|MDCT Substudy|Withdrawal by Subject|0|||
25042564|NCT02574455|50143764|FG000|Overall Study|Lost to Follow-up|4|||
25042565|NCT02574455|50143765|FG001|Overall Study|Lost to Follow-up|4|||
25042566|NCT02574455|50143764|FG000|Overall Study|Sponsor's Decision|55|||
25042567|NCT02574455|50143765|FG001|Overall Study|Sponsor's Decision|20|||
25042568|NCT02795832|50143777|FG000|Overall Study|Adverse Event|0|||
25042569|NCT02795832|50143778|FG001|Overall Study|Adverse Event|0|||
25042570|NCT02795832|50143779|FG002|Overall Study|Adverse Event|0|||
25042571|NCT02795832|50143780|FG003|Overall Study|Adverse Event|0|||
25042572|NCT02795832|50143781|FG004|Overall Study|Adverse Event|0|||
25042573|NCT02795832|50143782|FG005|Overall Study|Adverse Event|3|||
25042574|NCT02794974|50143806|FG000|Overall Study|Physician Decision|0|||
25042575|NCT02794974|50143807|FG001|Overall Study|Physician Decision|1|||
25042576|NCT02419417|50143824|FG000|Overall Study|Disease progression|5|||
25042577|NCT02419417|50143825|FG001|Overall Study|Disease progression|4|||
25042578|NCT02419417|50143826|FG002|Overall Study|Disease progression|13|||
24956247|NCT00510653|50047271|FG000|Overall Study|Withdrawal by Subject|8|||
24956248|NCT00510653|50047271|FG000|Overall Study|Monetary|3|||
24956249|NCT00362336|50047278|FG000|Overall Study|Serious Adverse Event|1|||
24956250|NCT00362336|50047279|FG001|Overall Study|Serious Adverse Event|0|||
24956251|NCT00362336|50047280|FG002|Overall Study|Serious Adverse Event|1|||
24956252|NCT00362336|50047278|FG000|Overall Study|Protocol Violation|0|||
25042579|NCT02419417|50143827|FG003|Overall Study|Disease progression|10|||
25042580|NCT02419417|50143828|FG004|Overall Study|Disease progression|10|||
24956253|NCT00362336|50047279|FG001|Overall Study|Protocol Violation|0|||
25042581|NCT02419417|50143829|FG005|Overall Study|Disease progression|3|||
25160446|NCT01396395|50280624|FG000|Overall Study|Other|0|||
24956254|NCT00362336|50047280|FG002|Overall Study|Protocol Violation|1|||
25042582|NCT02419417|50143830|FG006|Overall Study|Disease progression|4|||
25160447|NCT01396395|50280625|FG001|Overall Study|Other|1|||
25160448|NCT01396317|50280635|FG000|Overall Study|Adverse Event|1|||
25160449|NCT01396317|50280636|FG001|Overall Study|Adverse Event|0|||
25160450|NCT01396161|50280651|FG000|Overall Study|Withdrawal by Subject|0|||
25160451|NCT01396161|50280652|FG001|Overall Study|Withdrawal by Subject|0|||
25160452|NCT01396161|50280653|FG002|Overall Study|Withdrawal by Subject|0|||
25160453|NCT01396161|50280654|FG003|Overall Study|Withdrawal by Subject|0|||
25160454|NCT01396161|50280655|FG004|Overall Study|Withdrawal by Subject|1|||
24956255|NCT00362336|50047278|FG000|Overall Study|Lost to Follow-up|6|||
24956256|NCT00362336|50047279|FG001|Overall Study|Lost to Follow-up|4|||
24956257|NCT00362336|50047280|FG002|Overall Study|Lost to Follow-up|0|||
24956258|NCT00362336|50047278|FG000|Overall Study|Withdrawal by Subject|3|||
24956259|NCT00362336|50047279|FG001|Overall Study|Withdrawal by Subject|3|||
24956260|NCT00362336|50047280|FG002|Overall Study|Withdrawal by Subject|1|||
24956261|NCT00506285|50047297|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
24956262|NCT00506285|50047298|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
25042583|NCT02419417|50143831|FG007|Overall Study|Disease progression|5|||
25160455|NCT01396161|50280656|FG005|Overall Study|Withdrawal by Subject|0|||
25160456|NCT01396161|50280657|FG006|Overall Study|Withdrawal by Subject|0|||
25160457|NCT01396161|50280651|FG000|Overall Study|Other|0|||
25160458|NCT01396161|50280652|FG001|Overall Study|Other|0|||
25160459|NCT01396161|50280653|FG002|Overall Study|Other|0|||
25160460|NCT01396161|50280654|FG003|Overall Study|Other|0|||
25160461|NCT01396161|50280655|FG004|Overall Study|Other|0|||
25160462|NCT01396161|50280656|FG005|Overall Study|Other|0|||
25160463|NCT01396161|50280657|FG006|Overall Study|Other|1|||
25160464|NCT01396083|50280680|FG000|Overall Study|Adverse Event|2|||
25160465|NCT01396083|50280681|FG001|Overall Study|Adverse Event|28|||
25160466|NCT01396083|50280680|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
25160467|NCT01396083|50280681|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
25160468|NCT01396083|50280680|FG000|Overall Study|Consent withdrawn|4|||
25160469|NCT01396083|50280681|FG001|Overall Study|Consent withdrawn|5|||
25160470|NCT01396083|50280680|FG000|Overall Study|Protocol deviation(s)|0|||
25160471|NCT01396083|50280681|FG001|Overall Study|Protocol deviation(s)|1|||
25160472|NCT01396083|50280680|FG000|Overall Study|Abnormal laboratory value(s)|1|||
25160473|NCT01396083|50280681|FG001|Overall Study|Abnormal laboratory value(s)|0|||
25160474|NCT01396083|50280680|FG000|Overall Study|Administrative problems|1|||
25160475|NCT01396083|50280681|FG001|Overall Study|Administrative problems|0|||
25160476|NCT01396083|50280680|FG000|Overall Study|Lost to Follow-up|1|||
25042584|NCT02419417|50143832|FG008|Overall Study|Disease progression|13|||
24956263|NCT00506285|50047297|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
25160477|NCT01396083|50280681|FG001|Overall Study|Lost to Follow-up|0|||
25160478|NCT01723826|50280691|FG000|Overall Study|Adverse Event|4|||
24956264|NCT00506285|50047298|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
25042585|NCT02419417|50143833|FG009|Overall Study|Disease progression|9|||
25160479|NCT01723826|50280692|FG001|Overall Study|Adverse Event|1|||
25160480|NCT01723826|50280693|FG002|Overall Study|Adverse Event|4|||
25160481|NCT01723826|50280694|FG003|Overall Study|Adverse Event|5|||
25160482|NCT01723826|50280691|FG000|Overall Study|Death according to AE eCRF|2|||
25160483|NCT01723826|50280692|FG001|Overall Study|Death according to AE eCRF|3|||
24956265|NCT00506285|50047297|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
25042586|NCT02419417|50143834|FG010|Overall Study|Disease progression|0|||
25160484|NCT01723826|50280693|FG002|Overall Study|Death according to AE eCRF|3|||
25160485|NCT01723826|50280694|FG003|Overall Study|Death according to AE eCRF|7|||
25160486|NCT01723826|50280691|FG000|Overall Study|Lost to Follow-up|1|||
25160487|NCT01723826|50280692|FG001|Overall Study|Lost to Follow-up|3|||
25160488|NCT01723826|50280693|FG002|Overall Study|Lost to Follow-up|1|||
25160489|NCT01723826|50280694|FG003|Overall Study|Lost to Follow-up|1|||
25160490|NCT01723826|50280691|FG000|Overall Study|Non-compliance|0|||
25160491|NCT01723826|50280692|FG001|Overall Study|Non-compliance|1|||
25160492|NCT01723826|50280693|FG002|Overall Study|Non-compliance|3|||
25160493|NCT01723826|50280694|FG003|Overall Study|Non-compliance|3|||
25160494|NCT01723826|50280691|FG000|Overall Study|Non-compliance With Study Drug|0|||
25160495|NCT01723826|50280692|FG001|Overall Study|Non-compliance With Study Drug|1|||
25160496|NCT01723826|50280693|FG002|Overall Study|Non-compliance With Study Drug|0|||
25160497|NCT01723826|50280694|FG003|Overall Study|Non-compliance With Study Drug|0|||
25160498|NCT01723826|50280691|FG000|Overall Study|Other Reason|8|||
25160499|NCT01723826|50280692|FG001|Overall Study|Other Reason|6|||
25160500|NCT01723826|50280693|FG002|Overall Study|Other Reason|12|||
25160501|NCT01723826|50280694|FG003|Overall Study|Other Reason|14|||
25160502|NCT01723826|50280691|FG000|Overall Study|Physician Decision|1|||
25160503|NCT01723826|50280692|FG001|Overall Study|Physician Decision|3|||
25160504|NCT01723826|50280693|FG002|Overall Study|Physician Decision|4|||
25160505|NCT01723826|50280694|FG003|Overall Study|Physician Decision|11|||
25160506|NCT01723826|50280691|FG000|Overall Study|Protocol Violation|1|||
25160507|NCT01723826|50280692|FG001|Overall Study|Protocol Violation|1|||
25160508|NCT01723826|50280693|FG002|Overall Study|Protocol Violation|3|||
25160509|NCT01723826|50280694|FG003|Overall Study|Protocol Violation|1|||
25160510|NCT01723826|50280691|FG000|Overall Study|Withdrawal by Subject|10|||
25160511|NCT01723826|50280692|FG001|Overall Study|Withdrawal by Subject|17|||
25160512|NCT01723826|50280693|FG002|Overall Study|Withdrawal by Subject|27|||
25160513|NCT01723826|50280694|FG003|Overall Study|Withdrawal by Subject|48|||
25160514|NCT01721954|50280706|FG000|Overall Study|Death|58|||
25160515|NCT01721954|50280707|FG001|Overall Study|Death|64|||
25160516|NCT01721954|50280706|FG000|Overall Study|Withdrawal by Subject|8|||
25160517|NCT01721954|50280707|FG001|Overall Study|Withdrawal by Subject|4|||
25160518|NCT01721954|50280706|FG000|Overall Study|Adverse Event|2|||
25160519|NCT01721954|50280707|FG001|Overall Study|Adverse Event|0|||
25160520|NCT01721954|50280706|FG000|Overall Study|Lost to Follow-up|2|||
25160521|NCT01721954|50280707|FG001|Overall Study|Lost to Follow-up|1|||
25160522|NCT01776554|50280715|FG000|Overall Study|Adverse Event|1|||
25160523|NCT01776554|50280716|FG001|Overall Study|Adverse Event|0|||
25160524|NCT01776554|50280715|FG000|Overall Study|Withdrawal by Subject|3|||
25160525|NCT01776554|50280716|FG001|Overall Study|Withdrawal by Subject|8|||
25160526|NCT01776554|50280715|FG000|Overall Study|Lost to Follow-up|6|||
25160527|NCT01776554|50280716|FG001|Overall Study|Lost to Follow-up|9|||
25160528|NCT01776554|50280715|FG000|Overall Study|Administrative Reason|2|||
25160529|NCT01776554|50280716|FG001|Overall Study|Administrative Reason|5|||
25160530|NCT01776554|50280715|FG000|Overall Study|Protocol Violation|1|||
25160531|NCT01776554|50280716|FG001|Overall Study|Protocol Violation|0|||
25160532|NCT01776554|50280715|FG000|Overall Study|Unclassified|4|||
25160533|NCT01776554|50280716|FG001|Overall Study|Unclassified|1|||
24956266|NCT00506285|50047298|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
24956267|NCT00506285|50047297|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
25042587|NCT02419417|50143824|FG000|Overall Study|Study drug toxicity|0|||
25042588|NCT02419417|50143825|FG001|Overall Study|Study drug toxicity|0|||
25160534|NCT01776008|50280723|FG000|Overall Study|ineligible|2|||
25160535|NCT01746368|50280729|FG000|Overall Study|Lost to Follow-up|2|||
25160536|NCT01746368|50280730|FG001|Overall Study|Lost to Follow-up|0|||
25160537|NCT01746368|50280729|FG000|Overall Study|Withdrawal by Subject|0|||
25160538|NCT01746368|50280730|FG001|Overall Study|Withdrawal by Subject|1|||
25160539|NCT01381575|50280739|FG000|Overall Study|Serious Adverse Event|1|||
25160540|NCT01381575|50280740|FG001|Overall Study|Serious Adverse Event|0|||
25160541|NCT01381575|50280741|FG002|Overall Study|Serious Adverse Event|0|||
24956268|NCT00506285|50047298|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
24956269|NCT00506285|50047297|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
24956270|NCT00506285|50047298|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
24956271|NCT00506129|50047306|FG000|Overall Study|Disease Progression/Relapse|15|||
24956272|NCT00506129|50047306|FG000|Overall Study|Death|7|||
24956273|NCT00358670|50047312|FG000|Overall Study|Adverse Event|26|||
24956274|NCT00358670|50047313|FG001|Overall Study|Adverse Event|29|||
24956275|NCT00358670|50047312|FG000|Overall Study|Lack of Efficacy|20|||
24956276|NCT00358670|50047313|FG001|Overall Study|Lack of Efficacy|23|||
24956277|NCT00358670|50047312|FG000|Overall Study|Protocol Violation|6|||
24956278|NCT00358670|50047313|FG001|Overall Study|Protocol Violation|9|||
24956279|NCT00358670|50047312|FG000|Overall Study|Lost to Follow-up|4|||
24956280|NCT00358670|50047313|FG001|Overall Study|Lost to Follow-up|5|||
25160542|NCT01381575|50280739|FG000|Overall Study|Non-Serious Adverse Event|0|||
25160543|NCT01381575|50280740|FG001|Overall Study|Non-Serious Adverse Event|0|||
25160544|NCT01381575|50280741|FG002|Overall Study|Non-Serious Adverse Event|1|||
25160545|NCT01381575|50280739|FG000|Overall Study|Protocol Violation|0|||
25160546|NCT01381575|50280740|FG001|Overall Study|Protocol Violation|1|||
25160547|NCT01381575|50280741|FG002|Overall Study|Protocol Violation|1|||
25160548|NCT01381575|50280739|FG000|Overall Study|Withdrawal by Subject|15|||
25160549|NCT01381575|50280740|FG001|Overall Study|Withdrawal by Subject|9|||
25160550|NCT01381575|50280741|FG002|Overall Study|Withdrawal by Subject|7|||
25160551|NCT01381575|50280739|FG000|Overall Study|Migrated/moved from study area|2|||
25160552|NCT01381575|50280740|FG001|Overall Study|Migrated/moved from study area|12|||
25160553|NCT01381575|50280741|FG002|Overall Study|Migrated/moved from study area|2|||
24956281|NCT00358670|50047312|FG000|Overall Study|Withdrawal by Subject|13|||
24956282|NCT00358670|50047313|FG001|Overall Study|Withdrawal by Subject|24|||
24956283|NCT00358670|50047312|FG000|Overall Study|Protocol Defined Clinical Event|0|||
24956284|NCT00358670|50047313|FG001|Overall Study|Protocol Defined Clinical Event|1|||
24956285|NCT00358670|50047312|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
24956286|NCT00358670|50047313|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
24956287|NCT00358670|50047312|FG000|Overall Study|Administrative|153|||
24956288|NCT00358670|50047313|FG001|Overall Study|Administrative|125|||
24956289|NCT00505661|50047319|FG000|Overall Study|Not Eligible|4|||
24956290|NCT00383786|50047325|FG000|Overall Study|Protocol Violation|2|||
24956291|NCT00383786|50047326|FG001|Overall Study|Protocol Violation|6|||
24956292|NCT00383786|50047325|FG000|Overall Study|Withdrawal by Subject|2|||
24956293|NCT00383786|50047326|FG001|Overall Study|Withdrawal by Subject|5|||
24956294|NCT00383786|50047325|FG000|Overall Study|Physician Decision|0|||
24956295|NCT00383786|50047326|FG001|Overall Study|Physician Decision|1|||
24956296|NCT00383708|50047332|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
24956297|NCT00383708|50047332|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
24956298|NCT00383708|50047332|FG000|Run-in Period|Protocol Violation|4|||
24956299|NCT00383708|50047332|FG000|Run-in Period|Adverse Event|2|||
24956300|NCT00383708|50047332|FG000|Run-in Period|Claustrophobia|1|||
24956301|NCT00383708|50047332|FG000|Co-administration Period|Adverse Event|5|||
24956302|NCT00504881|50047339|FG000|Overall Study|Lack of Efficacy|1|||
24956303|NCT00504881|50047340|FG001|Overall Study|Lack of Efficacy|5|||
24956304|NCT00504881|50047339|FG000|Overall Study|Lost to Follow-up|0|||
24956305|NCT00504881|50047340|FG001|Overall Study|Lost to Follow-up|2|||
24956306|NCT00504881|50047339|FG000|Overall Study|Withdrawal by Subject|1|||
24956307|NCT00504881|50047340|FG001|Overall Study|Withdrawal by Subject|4|||
24956308|NCT00504881|50047339|FG000|Overall Study|Non-Compliance|1|||
24956309|NCT00504881|50047340|FG001|Overall Study|Non-Compliance|0|||
24956310|NCT00504881|50047339|FG000|Overall Study|No Birth Control|0|||
24956311|NCT00504881|50047340|FG001|Overall Study|No Birth Control|1|||
24956312|NCT00504881|50047339|FG000|Overall Study|Safety Visit not performed|0|||
24956313|NCT00504881|50047340|FG001|Overall Study|Safety Visit not performed|1|||
24956314|NCT00504881|50047339|FG000|Overall Study|AE, serious fatal|0|||
24956315|NCT00504881|50047340|FG001|Overall Study|AE, serious fatal|1|||
24956316|NCT00504881|50047339|FG000|Overall Study|SAE, non-fatal|2|||
24956317|NCT00504881|50047340|FG001|Overall Study|SAE, non-fatal|6|||
24956318|NCT00504881|50047339|FG000|Overall Study|AE, non-serious non-fatal|4|||
25042589|NCT02419417|50143826|FG002|Overall Study|Study drug toxicity|0|||
25042590|NCT02419417|50143827|FG003|Overall Study|Study drug toxicity|0|||
25042591|NCT02419417|50143828|FG004|Overall Study|Study drug toxicity|1|||
25042592|NCT02419417|50143829|FG005|Overall Study|Study drug toxicity|0|||
25042593|NCT02419417|50143830|FG006|Overall Study|Study drug toxicity|0|||
25160554|NCT01381575|50280739|FG000|Overall Study|Lost to Follow-up|8|||
25160555|NCT01381575|50280740|FG001|Overall Study|Lost to Follow-up|17|||
25160556|NCT01381575|50280741|FG002|Overall Study|Lost to Follow-up|9|||
25160557|NCT01858363|50280752|FG000|Overall Study|Death|35|||
25160558|NCT01858363|50280753|FG001|Overall Study|Death|9|||
25160559|NCT01858363|50280752|FG000|Overall Study|Withdrawal by Subject|28|||
25160560|NCT01858363|50280753|FG001|Overall Study|Withdrawal by Subject|14|||
25160561|NCT01858363|50280752|FG000|Overall Study|Lost to Follow-up|13|||
25160562|NCT01858363|50280753|FG001|Overall Study|Lost to Follow-up|3|||
24956319|NCT00504881|50047340|FG001|Overall Study|AE, non-serious non-fatal|14|||
25042594|NCT02419417|50143831|FG007|Overall Study|Study drug toxicity|0|||
25042595|NCT02419417|50143832|FG008|Overall Study|Study drug toxicity|0|||
25042596|NCT02419417|50143833|FG009|Overall Study|Study drug toxicity|0|||
25042597|NCT02419417|50143834|FG010|Overall Study|Study drug toxicity|0|||
25042598|NCT02419417|50143824|FG000|Overall Study|Adverse event unrelated to study drug|0|||
25042599|NCT02419417|50143825|FG001|Overall Study|Adverse event unrelated to study drug|0|||
25042600|NCT02419417|50143826|FG002|Overall Study|Adverse event unrelated to study drug|0|||
25042601|NCT02419417|50143827|FG003|Overall Study|Adverse event unrelated to study drug|0|||
24956320|NCT00504881|50047339|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
24956321|NCT00504881|50047340|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
24956322|NCT00504881|50047339|FG000|Overall Study|AE of unknown type|1|||
24956323|NCT00504881|50047340|FG001|Overall Study|AE of unknown type|0|||
24956324|NCT00504725|50047350|FG000|Overall Study|Protocol Violation|1|||
24956325|NCT00504725|50047351|FG001|Overall Study|Protocol Violation|0|||
24956326|NCT00383240|50047361|FG000|Overall Study|Adverse Event|4|||
24956327|NCT00383240|50047362|FG001|Overall Study|Adverse Event|6|||
24956328|NCT00383240|50047363|FG002|Overall Study|Adverse Event|9|||
24956329|NCT00383240|50047364|FG003|Overall Study|Adverse Event|7|||
24956330|NCT00383240|50047361|FG000|Overall Study|Treatment Failure|8|||
24956331|NCT00383240|50047362|FG001|Overall Study|Treatment Failure|13|||
24956332|NCT00383240|50047363|FG002|Overall Study|Treatment Failure|47|||
24956333|NCT00383240|50047364|FG003|Overall Study|Treatment Failure|46|||
24956334|NCT00383240|50047361|FG000|Overall Study|Lost to Follow-up|3|||
24956335|NCT00383240|50047362|FG001|Overall Study|Lost to Follow-up|0|||
24956336|NCT00383240|50047363|FG002|Overall Study|Lost to Follow-up|0|||
24956337|NCT00383240|50047364|FG003|Overall Study|Lost to Follow-up|2|||
24956338|NCT00383240|50047361|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
24956339|NCT00383240|50047362|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
24956340|NCT00383240|50047363|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
24956341|NCT00383240|50047364|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
24956342|NCT00383240|50047361|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
24956343|NCT00383240|50047362|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
24956344|NCT00383240|50047363|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
24956345|NCT00383240|50047364|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
24956346|NCT00383240|50047361|FG000|Overall Study|Protocol Violation|4|||
24956347|NCT00383240|50047362|FG001|Overall Study|Protocol Violation|5|||
24956348|NCT00383240|50047363|FG002|Overall Study|Protocol Violation|9|||
25042602|NCT02419417|50143828|FG004|Overall Study|Adverse event unrelated to study drug|2|||
25042603|NCT02419417|50143829|FG005|Overall Study|Adverse event unrelated to study drug|1|||
25042604|NCT02419417|50143830|FG006|Overall Study|Adverse event unrelated to study drug|0|||
25042605|NCT02419417|50143831|FG007|Overall Study|Adverse event unrelated to study drug|1|||
25042606|NCT02419417|50143832|FG008|Overall Study|Adverse event unrelated to study drug|0|||
25042607|NCT02419417|50143833|FG009|Overall Study|Adverse event unrelated to study drug|0|||
25160563|NCT01877551|50280761|FG000|Overall Study|Physician Decision|0|||
25160564|NCT01877551|50280762|FG001|Overall Study|Physician Decision|1|||
24956349|NCT00383240|50047364|FG003|Overall Study|Protocol Violation|6|||
24956350|NCT00383240|50047361|FG000|Overall Study|Did not meet protocol eligibility|9|||
24956351|NCT00383240|50047362|FG001|Overall Study|Did not meet protocol eligibility|4|||
24956352|NCT00383240|50047363|FG002|Overall Study|Did not meet protocol eligibility|9|||
24956353|NCT00383240|50047364|FG003|Overall Study|Did not meet protocol eligibility|3|||
24956354|NCT00383240|50047361|FG000|Overall Study|Administrative|1|||
24956355|NCT00383240|50047362|FG001|Overall Study|Administrative|1|||
24956356|NCT00383240|50047363|FG002|Overall Study|Administrative|0|||
24956357|NCT00383240|50047364|FG003|Overall Study|Administrative|0|||
24956358|NCT00362180|50047384|FG000|Treated Period|Withdrawal by Subject|1|||
24956359|NCT00362180|50047385|FG001|Treated Period|Withdrawal by Subject|0|||
24956360|NCT00362180|50047386|FG002|Treated Period|Withdrawal by Subject|0|||
24956361|NCT00362180|50047387|FG003|Treated Period|Withdrawal by Subject|0|||
24956362|NCT00362180|50047388|FG004|Treated Period|Withdrawal by Subject|0|||
24956363|NCT00362180|50047389|FG005|Treated Period|Withdrawal by Subject|0|||
24956364|NCT00362180|50047390|FG006|Treated Period|Withdrawal by Subject|0|||
24956365|NCT00362180|50047391|FG007|Treated Period|Withdrawal by Subject|0|||
24956366|NCT00362180|50047392|FG008|Treated Period|Withdrawal by Subject|0|||
24956367|NCT00362180|50047384|FG000|Treated Period|Adverse Event|0|||
24956368|NCT00362180|50047385|FG001|Treated Period|Adverse Event|0|||
24956369|NCT00362180|50047386|FG002|Treated Period|Adverse Event|0|||
24956370|NCT00362180|50047387|FG003|Treated Period|Adverse Event|0|||
24956371|NCT00362180|50047388|FG004|Treated Period|Adverse Event|0|||
24956372|NCT00362180|50047389|FG005|Treated Period|Adverse Event|1|||
24956373|NCT00362180|50047390|FG006|Treated Period|Adverse Event|0|||
24956374|NCT00362180|50047391|FG007|Treated Period|Adverse Event|1|||
24956375|NCT00362180|50047392|FG008|Treated Period|Adverse Event|0|||
24956376|NCT00383162|50047410|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
24956377|NCT00383162|50047411|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
24956378|NCT00383162|50047410|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
25160565|NCT01396005|50280770|FG000|Overall Study|Withdrawal by Subject|0|||
25160566|NCT01396005|50280771|FG001|Overall Study|Withdrawal by Subject|1|||
24956379|NCT00383162|50047411|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
24956380|NCT00383162|50047410|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
24956381|NCT00383162|50047411|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
24956382|NCT00383162|50047410|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
24956383|NCT00383162|50047411|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
24956384|NCT00383162|50047410|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
24956385|NCT00383162|50047411|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
24956386|NCT00383162|50047410|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
24956387|NCT00383162|50047411|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
24956388|NCT00383162|50047410|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
24956389|NCT00383162|50047411|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
24956390|NCT00383162|50047410|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
25160567|NCT01396005|50280770|FG000|Overall Study|Non-compliance with protocol|0|||
25160568|NCT01396005|50280771|FG001|Overall Study|Non-compliance with protocol|1|||
25160569|NCT01877239|50280779|FG000|Overall Study|Adverse Event|4|||
25160570|NCT01877239|50280779|FG000|Overall Study|Disease Remission|1|||
25160571|NCT01877239|50280779|FG000|Overall Study|Withdrawal by Subject|4|||
25160572|NCT01877239|50280779|FG000|Overall Study|Other|2|||
25160573|NCT01877239|50280779|FG000|Overall Study|Lack of Efficacy|4|||
25160574|NCT01877239|50280779|FG000|Overall Study|Data not available|35|||
25160575|NCT01877083|50280783|FG000|Treatment Phase|Disease Progression|10|||
25160576|NCT01877083|50280783|FG000|Treatment Phase|Clinical Progression|1|||
25160577|NCT01877083|50280783|FG000|Treatment Phase|Adverse Event|6|||
25160578|NCT01877083|50280783|FG000|Treatment Phase|Withdrawal by Subject|2|||
25160579|NCT01877083|50280783|FG000|Treatment Phase|Lost to Follow-up|1|||
25160580|NCT01877083|50280783|FG000|Extension Phase|Disease Progression|3|||
25160581|NCT01877083|50280783|FG000|Extension Phase|Adverse Event|2|||
25160582|NCT01380327|50280790|FG000|Overall Study|Lost to Follow-up|0|||
25160583|NCT01380327|50280791|FG001|Overall Study|Lost to Follow-up|1|||
24956391|NCT00383162|50047411|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
24956392|NCT00383162|50047410|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
24956393|NCT00383162|50047411|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
25160584|NCT01380327|50280792|FG002|Overall Study|Lost to Follow-up|1|||
24956394|NCT00358436|50047419|FG000|Overall Study|Adverse Event|29|||
24956395|NCT00358436|50047420|FG001|Overall Study|Adverse Event|13|||
24956396|NCT00358436|50047419|FG000|Overall Study|Lack of Efficacy|34|||
24956397|NCT00358436|50047420|FG001|Overall Study|Lack of Efficacy|36|||
25160585|NCT01380327|50280790|FG000|Overall Study|Protocol Violation|3|||
25160586|NCT01380327|50280791|FG001|Overall Study|Protocol Violation|2|||
25160587|NCT01380327|50280792|FG002|Overall Study|Protocol Violation|3|||
25160588|NCT01380327|50280790|FG000|Overall Study|Withdrawal by Subject|0|||
24956398|NCT00358436|50047419|FG000|Overall Study|Lost to Follow-up|11|||
24956399|NCT00358436|50047420|FG001|Overall Study|Lost to Follow-up|6|||
24956400|NCT00358436|50047419|FG000|Overall Study|Protocol Violation|8|||
24956401|NCT00358436|50047420|FG001|Overall Study|Protocol Violation|3|||
24956402|NCT00358436|50047419|FG000|Overall Study|Withdrawal by Subject|40|||
24956403|NCT00358436|50047420|FG001|Overall Study|Withdrawal by Subject|17|||
25160589|NCT01380327|50280791|FG001|Overall Study|Withdrawal by Subject|0|||
24956404|NCT00358436|50047419|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
25160590|NCT01380327|50280792|FG002|Overall Study|Withdrawal by Subject|1|||
25160591|NCT01380327|50280790|FG000|Overall Study|Housing situation precluded ability to k|0|||
25160592|NCT01380327|50280791|FG001|Overall Study|Housing situation precluded ability to k|0|||
25160593|NCT01380327|50280792|FG002|Overall Study|Housing situation precluded ability to k|1|||
24956405|NCT00358436|50047420|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
24956406|NCT00358436|50047419|FG000|Overall Study|COPD exacerbation|22|||
24956407|NCT00358436|50047420|FG001|Overall Study|COPD exacerbation|10|||
24956408|NCT00358436|50047419|FG000|Overall Study|Other|6|||
24956409|NCT00358436|50047420|FG001|Overall Study|Other|1|||
24956410|NCT00383084|50047430|FG000|Overall Study|Withdrawal by Subject|12|||
24956411|NCT00383084|50047431|FG001|Overall Study|Withdrawal by Subject|10|||
24956412|NCT00361634|50047437|FG000|Overall Study|Lost to Follow-up|1|||
24956413|NCT00361634|50047437|FG000|Overall Study|Withdrawal by Subject|1|||
24956414|NCT00357968|50047443|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
24956415|NCT00357968|50047444|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
24956416|NCT00357968|50047443|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
24956417|NCT00357968|50047444|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
24956418|NCT00357656|50047467|FG000|Overall Study|Other, No surgery performed|0|||
24956419|NCT00357656|50047468|FG001|Overall Study|Other, No surgery performed|3|||
24956420|NCT00357500|50047486|FG000|Overall Study|Adverse Event|3|||
24956421|NCT00357500|50047486|FG000|Overall Study|Withdrawal by Subject|5|||
25042608|NCT02419417|50143834|FG010|Overall Study|Adverse event unrelated to study drug|0|||
25042609|NCT02419417|50143824|FG000|Overall Study|Participant request to discontinue|0|||
25042610|NCT02419417|50143825|FG001|Overall Study|Participant request to discontinue|0|||
25042611|NCT02419417|50143826|FG002|Overall Study|Participant request to discontinue|0|||
25042612|NCT02419417|50143827|FG003|Overall Study|Participant request to discontinue|0|||
25042613|NCT02419417|50143828|FG004|Overall Study|Participant request to discontinue|0|||
25042614|NCT02419417|50143829|FG005|Overall Study|Participant request to discontinue|0|||
25042615|NCT02419417|50143830|FG006|Overall Study|Participant request to discontinue|0|||
25042616|NCT02419417|50143831|FG007|Overall Study|Participant request to discontinue|0|||
25042617|NCT02419417|50143832|FG008|Overall Study|Participant request to discontinue|0|||
25042618|NCT02419417|50143833|FG009|Overall Study|Participant request to discontinue|1|||
25042619|NCT02419417|50143834|FG010|Overall Study|Participant request to discontinue|0|||
25042620|NCT02419417|50143824|FG000|Overall Study|Withdrawal by Subject|0|||
25042621|NCT02419417|50143825|FG001|Overall Study|Withdrawal by Subject|0|||
25042622|NCT02419417|50143826|FG002|Overall Study|Withdrawal by Subject|0|||
25042623|NCT02419417|50143827|FG003|Overall Study|Withdrawal by Subject|0|||
25042624|NCT02419417|50143828|FG004|Overall Study|Withdrawal by Subject|0|||
25042625|NCT02419417|50143829|FG005|Overall Study|Withdrawal by Subject|0|||
25042626|NCT02419417|50143830|FG006|Overall Study|Withdrawal by Subject|0|||
25042627|NCT02419417|50143831|FG007|Overall Study|Withdrawal by Subject|0|||
25042628|NCT02419417|50143832|FG008|Overall Study|Withdrawal by Subject|0|||
25042629|NCT02419417|50143833|FG009|Overall Study|Withdrawal by Subject|0|||
25042630|NCT02419417|50143834|FG010|Overall Study|Withdrawal by Subject|1|||
25042631|NCT00777491|50143875|FG000|Overall Study|Protocol Violation|0|||
25042632|NCT00777491|50143876|FG001|Overall Study|Protocol Violation|2|||
25042633|NCT00777491|50143875|FG000|Overall Study|Did not receive any protocol treatment|2|||
25042634|NCT00777491|50143876|FG001|Overall Study|Did not receive any protocol treatment|0|||
25160594|NCT01380327|50280790|FG000|Overall Study|Questionable onset of epilepsy|0|||
25160595|NCT01380327|50280791|FG001|Overall Study|Questionable onset of epilepsy|0|||
24956422|NCT00357500|50047486|FG000|Overall Study|Progressive Disease|65|||
25042635|NCT03077711|50143888|FG000|Overall Study|Lost to Follow-up|2|||
25042636|NCT03077711|50143889|FG001|Overall Study|Lost to Follow-up|2|||
24956423|NCT00357500|50047486|FG000|Overall Study|Not Started Protocol Therapy|4|||
24956424|NCT00357110|50047492|FG000|Overall Study|Early study termination|5|||
25042637|NCT03077711|50143888|FG000|Overall Study|noncompliant taking medication|2|||
25042638|NCT03077711|50143889|FG001|Overall Study|noncompliant taking medication|0|||
25042639|NCT04311463|50143916|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
25042640|NCT04311463|50143917|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
25042641|NCT04311463|50143916|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
25042642|NCT04311463|50143917|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
25042643|NCT04311463|50143916|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
25042644|NCT04311463|50143917|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
25042645|NCT01370538|50143930|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
25042646|NCT01370538|50143931|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
25042647|NCT01370538|50143930|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
25042648|NCT01370538|50143931|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
25042649|NCT01370538|50143930|FG000|Overall Study|Adverse Event|1|||
25042650|NCT01370538|50143931|FG001|Overall Study|Adverse Event|0|||
25042651|NCT01370538|50143930|FG000|Overall Study|Protocol Violation|8|||
25042652|NCT01370538|50143931|FG001|Overall Study|Protocol Violation|5|||
25042653|NCT01370538|50143930|FG000|Overall Study|Development of study specific withdrawal|1|||
24956425|NCT00357110|50047493|FG001|Overall Study|Early study termination|5|||
24956426|NCT00098722|50047502|FG000|Double Blind Phase|Adverse Event|7|||
24956427|NCT00098722|50047503|FG001|Double Blind Phase|Adverse Event|7|||
24956428|NCT00098722|50047504|FG002|Double Blind Phase|Adverse Event|3|||
24956429|NCT00098722|50047505|FG003|Double Blind Phase|Adverse Event|0|||
24956430|NCT00098722|50047506|FG004|Double Blind Phase|Adverse Event|0|||
24956431|NCT00098722|50047507|FG005|Double Blind Phase|Adverse Event|0|||
24956432|NCT00098722|50047508|FG006|Double Blind Phase|Adverse Event|0|||
24956433|NCT00098722|50047502|FG000|Double Blind Phase|Death|2|||
24956434|NCT00098722|50047503|FG001|Double Blind Phase|Death|5|||
24956435|NCT00098722|50047504|FG002|Double Blind Phase|Death|0|||
24956436|NCT00098722|50047505|FG003|Double Blind Phase|Death|0|||
24956437|NCT00098722|50047506|FG004|Double Blind Phase|Death|0|||
24956438|NCT00098722|50047507|FG005|Double Blind Phase|Death|0|||
24956439|NCT00098722|50047508|FG006|Double Blind Phase|Death|0|||
24956440|NCT00098722|50047502|FG000|Double Blind Phase|Lack of Efficacy|21|||
24956441|NCT00098722|50047503|FG001|Double Blind Phase|Lack of Efficacy|23|||
24956442|NCT00098722|50047504|FG002|Double Blind Phase|Lack of Efficacy|15|||
24956443|NCT00098722|50047505|FG003|Double Blind Phase|Lack of Efficacy|0|||
24956444|NCT00098722|50047506|FG004|Double Blind Phase|Lack of Efficacy|0|||
24956445|NCT00098722|50047507|FG005|Double Blind Phase|Lack of Efficacy|0|||
24956446|NCT00098722|50047508|FG006|Double Blind Phase|Lack of Efficacy|0|||
24956447|NCT00098722|50047502|FG000|Double Blind Phase|Participant defaulted|16|||
24956448|NCT00098722|50047503|FG001|Double Blind Phase|Participant defaulted|11|||
24956449|NCT00098722|50047504|FG002|Double Blind Phase|Participant defaulted|9|||
24956450|NCT00098722|50047505|FG003|Double Blind Phase|Participant defaulted|0|||
24956451|NCT00098722|50047506|FG004|Double Blind Phase|Participant defaulted|0|||
24956452|NCT00098722|50047507|FG005|Double Blind Phase|Participant defaulted|0|||
24956453|NCT00098722|50047508|FG006|Double Blind Phase|Participant defaulted|0|||
24956454|NCT00098722|50047502|FG000|Double Blind Phase|Pregnancy|1|||
24956455|NCT00098722|50047503|FG001|Double Blind Phase|Pregnancy|0|||
24956456|NCT00098722|50047504|FG002|Double Blind Phase|Pregnancy|0|||
24956457|NCT00098722|50047505|FG003|Double Blind Phase|Pregnancy|0|||
24956458|NCT00098722|50047506|FG004|Double Blind Phase|Pregnancy|0|||
24956459|NCT00098722|50047507|FG005|Double Blind Phase|Pregnancy|0|||
24956460|NCT00098722|50047508|FG006|Double Blind Phase|Pregnancy|0|||
24956461|NCT00098722|50047502|FG000|Double Blind Phase|Randomized, not treated|4|||
24956462|NCT00098722|50047503|FG001|Double Blind Phase|Randomized, not treated|3|||
24956463|NCT00098722|50047504|FG002|Double Blind Phase|Randomized, not treated|3|||
24956464|NCT00098722|50047505|FG003|Double Blind Phase|Randomized, not treated|0|||
24956465|NCT00098722|50047506|FG004|Double Blind Phase|Randomized, not treated|0|||
24956466|NCT00098722|50047507|FG005|Double Blind Phase|Randomized, not treated|0|||
24956467|NCT00098722|50047508|FG006|Double Blind Phase|Randomized, not treated|0|||
24956468|NCT00098722|50047502|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
24956469|NCT00098722|50047503|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
24956470|NCT00098722|50047504|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
24956471|NCT00098722|50047505|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
24956472|NCT00098722|50047506|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
24956473|NCT00098722|50047507|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
24956474|NCT00098722|50047508|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
24956475|NCT00098722|50047502|FG000|Double Blind Phase|Other|7|||
24956476|NCT00098722|50047503|FG001|Double Blind Phase|Other|8|||
24956477|NCT00098722|50047504|FG002|Double Blind Phase|Other|7|||
24956478|NCT00098722|50047505|FG003|Double Blind Phase|Other|0|||
24956479|NCT00098722|50047506|FG004|Double Blind Phase|Other|0|||
24956480|NCT00098722|50047507|FG005|Double Blind Phase|Other|0|||
24956481|NCT00098722|50047508|FG006|Double Blind Phase|Other|0|||
24956482|NCT00098722|50047502|FG000|Open Label Phase|Adverse Event|0|||
24956483|NCT00098722|50047503|FG001|Open Label Phase|Adverse Event|0|||
24956484|NCT00098722|50047504|FG002|Open Label Phase|Adverse Event|0|||
25042654|NCT01370538|50143931|FG001|Overall Study|Development of study specific withdrawal|1|||
25042655|NCT01370538|50143930|FG000|Overall Study|Lost to follow up|6|||
25042656|NCT01370538|50143931|FG001|Overall Study|Lost to follow up|10|||
25042657|NCT03402841|50143950|FG000|Overall Study|Withdrawal by Subject|3|||
24956485|NCT00098722|50047505|FG003|Open Label Phase|Adverse Event|5|||
24956486|NCT00098722|50047506|FG004|Open Label Phase|Adverse Event|0|||
24956487|NCT00098722|50047507|FG005|Open Label Phase|Adverse Event|0|||
24956488|NCT00098722|50047508|FG006|Open Label Phase|Adverse Event|0|||
24956489|NCT00098722|50047502|FG000|Open Label Phase|Death|0|||
24956490|NCT00098722|50047503|FG001|Open Label Phase|Death|0|||
24956491|NCT00098722|50047504|FG002|Open Label Phase|Death|0|||
25042658|NCT03402841|50143950|FG000|Overall Study|Lost to Follow-up|2|||
25042659|NCT03402841|50143950|FG000|Overall Study|Death|146|||
25042660|NCT02881957|50143965|FG000|Overall Study|Comfort care|0|||
25042661|NCT02881957|50143966|FG001|Overall Study|Comfort care|1|||
25042662|NCT02881957|50143965|FG000|Overall Study|Concurrent trial enrollment|0|||
25042663|NCT02881957|50143966|FG001|Overall Study|Concurrent trial enrollment|1|||
25042664|NCT02881957|50143965|FG000|Overall Study|Discharged within 48 hours|0|||
25042665|NCT02881957|50143966|FG001|Overall Study|Discharged within 48 hours|1|||
25042666|NCT02881957|50143965|FG000|Overall Study|Withdrawal by Subject|2|||
25042667|NCT02881957|50143966|FG001|Overall Study|Withdrawal by Subject|1|||
25042668|NCT02881957|50143965|FG000|Overall Study|Protocol Violation|1|||
25042669|NCT02881957|50143966|FG001|Overall Study|Protocol Violation|0|||
25042670|NCT03022461|50143972|FG000|Overall Study|Death|3|||
25042671|NCT02750930|50143977|FG000|Overall Study|Study closed/terminated|8|||
25042672|NCT03078907|50143983|FG000|Overall Study|Adverse Event|2|||
25042673|NCT03078907|50143984|FG001|Overall Study|Adverse Event|0|||
25042674|NCT03078907|50143983|FG000|Overall Study|Other|1|||
25042675|NCT03078907|50143984|FG001|Overall Study|Other|0|||
25042676|NCT03078907|50143983|FG000|Overall Study|Protocol Violation|0|||
25042677|NCT03078907|50143984|FG001|Overall Study|Protocol Violation|1|||
25042678|NCT03249714|50143992|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
25042679|NCT03249714|50143993|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
25042680|NCT03249714|50143992|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
25042681|NCT03249714|50143993|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
25042682|NCT03249714|50143992|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
25042683|NCT03249714|50143993|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
25042684|NCT03249714|50143992|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
25042685|NCT03249714|50143993|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
25042686|NCT02925117|50144019|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
25042687|NCT02925117|50144020|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
25042688|NCT02925117|50144021|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
25042689|NCT02925117|50144022|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
25042690|NCT02925117|50144023|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
25042691|NCT02925117|50144024|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
25042692|NCT02925117|50144025|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
25042693|NCT02925117|50144026|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
25160596|NCT01380327|50280792|FG002|Overall Study|Questionable onset of epilepsy|1|||
25160597|NCT01829425|50280802|FG000|Overall Study|Withdrawal by Subject|4|||
25160598|NCT01829425|50280803|FG001|Overall Study|Withdrawal by Subject|3|||
25160599|NCT01829425|50280802|FG000|Overall Study|Lost to Follow-up|2|||
25160600|NCT01829425|50280803|FG001|Overall Study|Lost to Follow-up|1|||
25160601|NCT01394991|50280820|FG000|Overall Study|Adverse Event|0|||
25160602|NCT01394991|50280821|FG001|Overall Study|Adverse Event|4|||
25160603|NCT01394991|50280820|FG000|Overall Study|Lack of Efficacy|5|||
25042694|NCT02925117|50144027|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
25042695|NCT02925117|50144028|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
25160604|NCT01394991|50280821|FG001|Overall Study|Lack of Efficacy|7|||
25160605|NCT01394991|50280820|FG000|Overall Study|Lost to Follow-up|6|||
25160606|NCT01394991|50280821|FG001|Overall Study|Lost to Follow-up|8|||
25276219|NCT00963820|50590154|FG000|Expansion Phase|Adverse Event|0|||
25042696|NCT02925117|50144029|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
25042697|NCT02925117|50144030|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
25042698|NCT02925117|50144019|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
25276220|NCT00963820|50590155|FG001|Expansion Phase|Adverse Event|0|||
25276221|NCT00963820|50590156|FG002|Expansion Phase|Adverse Event|0|||
24956492|NCT00098722|50047505|FG003|Open Label Phase|Death|2|||
24956493|NCT00098722|50047506|FG004|Open Label Phase|Death|0|||
24956494|NCT00098722|50047507|FG005|Open Label Phase|Death|0|||
24956495|NCT00098722|50047508|FG006|Open Label Phase|Death|0|||
25160607|NCT01394991|50280820|FG000|Overall Study|Physician Decision|1|||
25160608|NCT01394991|50280821|FG001|Overall Study|Physician Decision|3|||
25160609|NCT01394991|50280820|FG000|Overall Study|Protocol Violation|1|||
25160610|NCT01394991|50280821|FG001|Overall Study|Protocol Violation|1|||
25160611|NCT01394991|50280820|FG000|Overall Study|Withdrawal by Subject|20|||
25160612|NCT01394991|50280821|FG001|Overall Study|Withdrawal by Subject|17|||
25160613|NCT01394991|50280820|FG000|Overall Study|Chemotherapy Termination|10|||
25160614|NCT01394991|50280821|FG001|Overall Study|Chemotherapy Termination|15|||
25160615|NCT01394991|50280820|FG000|Overall Study|Disease Progression|7|||
25160616|NCT01394991|50280821|FG001|Overall Study|Disease Progression|7|||
25160617|NCT01394991|50280820|FG000|Overall Study|Prematurely Termination of Trial|9|||
25042699|NCT02925117|50144020|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
25042700|NCT02925117|50144021|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
25042701|NCT02925117|50144022|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
25042702|NCT02925117|50144023|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
24956496|NCT00098722|50047502|FG000|Open Label Phase|Lack of Efficacy|0|||
24956497|NCT00098722|50047503|FG001|Open Label Phase|Lack of Efficacy|0|||
24956498|NCT00098722|50047504|FG002|Open Label Phase|Lack of Efficacy|0|||
24956499|NCT00098722|50047505|FG003|Open Label Phase|Lack of Efficacy|8|||
24956500|NCT00098722|50047506|FG004|Open Label Phase|Lack of Efficacy|0|||
24956501|NCT00098722|50047507|FG005|Open Label Phase|Lack of Efficacy|0|||
24956502|NCT00098722|50047508|FG006|Open Label Phase|Lack of Efficacy|0|||
24956503|NCT00098722|50047502|FG000|Open Label Phase|Pregnancy|0|||
24956504|NCT00098722|50047503|FG001|Open Label Phase|Pregnancy|0|||
24956505|NCT00098722|50047504|FG002|Open Label Phase|Pregnancy|0|||
24956506|NCT00098722|50047505|FG003|Open Label Phase|Pregnancy|1|||
24956507|NCT00098722|50047506|FG004|Open Label Phase|Pregnancy|0|||
24956508|NCT00098722|50047507|FG005|Open Label Phase|Pregnancy|0|||
24956509|NCT00098722|50047508|FG006|Open Label Phase|Pregnancy|0|||
24956510|NCT00098722|50047502|FG000|Open Label Phase|Participant defaulted|0|||
24956511|NCT00098722|50047503|FG001|Open Label Phase|Participant defaulted|0|||
24956512|NCT00098722|50047504|FG002|Open Label Phase|Participant defaulted|0|||
24956513|NCT00098722|50047505|FG003|Open Label Phase|Participant defaulted|18|||
24956514|NCT00098722|50047506|FG004|Open Label Phase|Participant defaulted|0|||
24956515|NCT00098722|50047507|FG005|Open Label Phase|Participant defaulted|0|||
24956516|NCT00098722|50047508|FG006|Open Label Phase|Participant defaulted|0|||
24956517|NCT00098722|50047502|FG000|Open Label Phase|Ongoing at cut-off date|0|||
24956518|NCT00098722|50047503|FG001|Open Label Phase|Ongoing at cut-off date|0|||
24956519|NCT00098722|50047504|FG002|Open Label Phase|Ongoing at cut-off date|0|||
24956520|NCT00098722|50047505|FG003|Open Label Phase|Ongoing at cut-off date|220|||
24956521|NCT00098722|50047506|FG004|Open Label Phase|Ongoing at cut-off date|50|||
24956522|NCT00098722|50047507|FG005|Open Label Phase|Ongoing at cut-off date|0|||
24956523|NCT00098722|50047508|FG006|Open Label Phase|Ongoing at cut-off date|0|||
24956524|NCT00098722|50047502|FG000|Open Label Phase|Other|0|||
24956525|NCT00098722|50047503|FG001|Open Label Phase|Other|0|||
24956526|NCT00098722|50047504|FG002|Open Label Phase|Other|0|||
24956527|NCT00098722|50047505|FG003|Open Label Phase|Other|18|||
24956528|NCT00098722|50047506|FG004|Open Label Phase|Other|0|||
24956529|NCT00098722|50047507|FG005|Open Label Phase|Other|0|||
24956530|NCT00098722|50047508|FG006|Open Label Phase|Other|0|||
24956531|NCT00098722|50047502|FG000|Observation Phase|Death|0|||
24956532|NCT00098722|50047503|FG001|Observation Phase|Death|0|||
24956533|NCT00098722|50047504|FG002|Observation Phase|Death|0|||
24956534|NCT00098722|50047505|FG003|Observation Phase|Death|0|||
24956535|NCT00098722|50047506|FG004|Observation Phase|Death|0|||
24956536|NCT00098722|50047507|FG005|Observation Phase|Death|5|||
24956537|NCT00098722|50047508|FG006|Observation Phase|Death|3|||
25160618|NCT01394991|50280821|FG001|Overall Study|Prematurely Termination of Trial|10|||
25160619|NCT01829347|50280829|FG000|VTI-210|Death|5|||
25160620|NCT01829347|50280830|FG001|VTI-210|Death|3|||
25160621|NCT01829347|50280829|FG000|VTI-210|Withdrawal by Subject|1|||
25160622|NCT01829347|50280830|FG001|VTI-210|Withdrawal by Subject|0|||
25160623|NCT01829347|50280829|FG000|VTI-210E|Death|2|||
25160624|NCT01829347|50280830|FG001|VTI-210E|Death|1|||
25042703|NCT02925117|50144024|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
25160625|NCT01829347|50280829|FG000|VTI-210E|Study terminated prematurely|1|||
24956538|NCT00098722|50047502|FG000|Observation Phase|Lack of Efficacy|0|||
24956539|NCT00098722|50047503|FG001|Observation Phase|Lack of Efficacy|0|||
24956540|NCT00098722|50047504|FG002|Observation Phase|Lack of Efficacy|0|||
24956541|NCT00098722|50047505|FG003|Observation Phase|Lack of Efficacy|0|||
24956542|NCT00098722|50047506|FG004|Observation Phase|Lack of Efficacy|0|||
25042704|NCT02925117|50144025|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
24956543|NCT00098722|50047507|FG005|Observation Phase|Lack of Efficacy|2|||
24956544|NCT00098722|50047508|FG006|Observation Phase|Lack of Efficacy|0|||
24956545|NCT00098722|50047502|FG000|Observation Phase|Participant defaulted|0|||
24956546|NCT00098722|50047503|FG001|Observation Phase|Participant defaulted|0|||
24956547|NCT00098722|50047504|FG002|Observation Phase|Participant defaulted|0|||
24956548|NCT00098722|50047505|FG003|Observation Phase|Participant defaulted|0|||
25160626|NCT01829347|50280830|FG001|VTI-210E|Study terminated prematurely|5|||
25160627|NCT01394523|50280839|FG000|Overall Study|Unable to place block|1|||
25160628|NCT01394523|50280840|FG001|Overall Study|Unable to place block|0|||
25160629|NCT01394523|50280841|FG002|Overall Study|Unable to place block|0|||
25160630|NCT01857973|50280849|FG000|Overall Study|Subject did not meet required BG range|3|||
25160631|NCT01857973|50280849|FG000|Overall Study|drop out after 3 failed attempts|1|||
25160632|NCT01857973|50280849|FG000|Overall Study|Physician Decision|1|||
25160633|NCT01857583|50280857|FG000|Overall Study|Adverse Event|0|||
24956549|NCT00098722|50047506|FG004|Observation Phase|Participant defaulted|0|||
24956550|NCT00098722|50047507|FG005|Observation Phase|Participant defaulted|17|||
24956551|NCT00098722|50047508|FG006|Observation Phase|Participant defaulted|4|||
24956552|NCT00098722|50047502|FG000|Observation Phase|Other|0|||
24956553|NCT00098722|50047503|FG001|Observation Phase|Other|0|||
24956554|NCT00098722|50047504|FG002|Observation Phase|Other|0|||
24956555|NCT00098722|50047505|FG003|Observation Phase|Other|0|||
24956556|NCT00098722|50047506|FG004|Observation Phase|Other|0|||
24956557|NCT00098722|50047507|FG005|Observation Phase|Other|21|||
24956558|NCT00098722|50047508|FG006|Observation Phase|Other|10|||
24956559|NCT00098254|50047520|FG000|Overall Study|Adverse Event|2|||
24956560|NCT00098254|50047520|FG000|Overall Study|Death|1|||
24956561|NCT00095056|50047526|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
24956562|NCT00095056|50047527|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
24956563|NCT00095056|50047526|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
24956564|NCT00095056|50047527|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
24956565|NCT00095056|50047526|FG000|Phase A (Weeks 0-12)|Death|1|||
24956566|NCT00095056|50047527|FG001|Phase A (Weeks 0-12)|Death|0|||
24956567|NCT00095056|50047526|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
24956568|NCT00095056|50047527|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
24956569|NCT00095056|50047526|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
24956570|NCT00095056|50047527|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
24956571|NCT00095056|50047526|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
24956572|NCT00095056|50047527|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
24956573|NCT00095056|50047526|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
25160634|NCT01857583|50280858|FG001|Overall Study|Adverse Event|0|||
24956574|NCT00095056|50047527|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
24956575|NCT00095056|50047526|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
25160635|NCT01857583|50280859|FG002|Overall Study|Adverse Event|1|||
25160636|NCT01857583|50280860|FG003|Overall Study|Adverse Event|1|||
25160637|NCT01857583|50280857|FG000|Overall Study|Death|0|||
25160638|NCT01857583|50280858|FG001|Overall Study|Death|1|||
24956576|NCT00095056|50047527|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
24956577|NCT00095056|50047526|FG000|Phase B (Weeks 12-54)|Death|3|||
24956578|NCT00095056|50047527|FG001|Phase B (Weeks 12-54)|Death|1|||
24956579|NCT00095056|50047526|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
24956580|NCT00095056|50047527|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
24956581|NCT00095056|50047526|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
24956582|NCT00095056|50047527|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
24956583|NCT00098020|50047533|FG000|Overall Study|Adverse Event|2|||
24956584|NCT00098020|50047533|FG000|Overall Study|Lost to Follow-up|1|||
24956585|NCT00098020|50047533|FG000|Overall Study|elevated liver enzymes|1|||
24956586|NCT00098020|50047533|FG000|Overall Study|Low urine PCR|1|||
24956587|NCT00098020|50047533|FG000|Overall Study|Low epidermal growth factor receptor|1|||
24956588|NCT00381680|50047539|FG000|Overall Study|Adverse Event|9|||
24956589|NCT00381680|50047540|FG001|Overall Study|Adverse Event|3|||
24956590|NCT00381680|50047539|FG000|Overall Study|Death|10|||
24956591|NCT00381680|50047540|FG001|Overall Study|Death|7|||
24956592|NCT00381680|50047539|FG000|Overall Study|Lost to Follow-up|3|||
24956593|NCT00381680|50047540|FG001|Overall Study|Lost to Follow-up|2|||
24956594|NCT00381680|50047539|FG000|Overall Study|Physician Decision|25|||
24956595|NCT00381680|50047540|FG001|Overall Study|Physician Decision|6|||
24956596|NCT00381680|50047539|FG000|Overall Study|Withdrawal by Subject|3|||
24956597|NCT00381680|50047540|FG001|Overall Study|Withdrawal by Subject|1|||
24956598|NCT00381680|50047539|FG000|Overall Study|Entry onto another COG Trial|1|||
24956599|NCT00381680|50047540|FG001|Overall Study|Entry onto another COG Trial|2|||
24956600|NCT00381680|50047539|FG000|Overall Study|Alternative Therapy|11|||
24956601|NCT00381680|50047540|FG001|Overall Study|Alternative Therapy|5|||
24956602|NCT00381680|50047539|FG000|Overall Study|Secondary Malignancy|3|||
24956603|NCT00381680|50047540|FG001|Overall Study|Secondary Malignancy|0|||
24956604|NCT00381680|50047539|FG000|Overall Study|Delay initiation|1|||
24956605|NCT00381680|50047540|FG001|Overall Study|Delay initiation|0|||
24956606|NCT00381680|50047539|FG000|Overall Study|Stem Cell Transplant|26|||
24956607|NCT00381680|50047540|FG001|Overall Study|Stem Cell Transplant|10|||
24956608|NCT00381680|50047539|FG000|Overall Study|Relapse|18|||
24956609|NCT00381680|50047540|FG001|Overall Study|Relapse|9|||
24956610|NCT00381680|50047539|FG000|Overall Study|Induction Failure|4|||
24956611|NCT00381680|50047540|FG001|Overall Study|Induction Failure|1|||
25276222|NCT00963820|50590157|FG003|Expansion Phase|Adverse Event|0|||
24956612|NCT00381680|50047539|FG000|Overall Study|Progression|1|||
25160639|NCT01857583|50280859|FG002|Overall Study|Death|1|||
25276223|NCT00963820|50590158|FG004|Expansion Phase|Adverse Event|0|||
24956613|NCT00381680|50047540|FG001|Overall Study|Progression|1|||
25276224|NCT00963820|50590159|FG005|Expansion Phase|Adverse Event|0|||
24956614|NCT00381680|50047539|FG000|Overall Study|Other not otherwise specified|7|||
24956615|NCT00381680|50047540|FG001|Overall Study|Other not otherwise specified|2|||
24956616|NCT00381680|50047539|FG000|Overall Study|Ineligible|3|||
25276225|NCT00963820|50590160|FG006|Expansion Phase|Adverse Event|0|||
25160640|NCT01857583|50280860|FG003|Overall Study|Death|0|||
25160641|NCT01857583|50280857|FG000|Overall Study|Physician Decision|0|||
25160642|NCT01857583|50280858|FG001|Overall Study|Physician Decision|0|||
25160643|NCT01857583|50280859|FG002|Overall Study|Physician Decision|0|||
25160644|NCT01857583|50280860|FG003|Overall Study|Physician Decision|1|||
25160645|NCT01857583|50280857|FG000|Overall Study|Withdrawal by Subject|1|||
25276226|NCT00963820|50590161|FG007|Expansion Phase|Adverse Event|0|||
25276227|NCT00963820|50590162|FG008|Expansion Phase|Adverse Event|1|||
25276228|NCT00963820|50590163|FG009|Expansion Phase|Adverse Event|3|||
25276229|NCT00963820|50590164|FG010|Expansion Phase|Adverse Event|0|||
25276230|NCT00963820|50590165|FG011|Expansion Phase|Adverse Event|0|||
25276231|NCT00963820|50590154|FG000|Expansion Phase|Withdrawal by Subject|0|||
25276232|NCT00963820|50590155|FG001|Expansion Phase|Withdrawal by Subject|0|||
25276233|NCT00963820|50590156|FG002|Expansion Phase|Withdrawal by Subject|0|||
25276234|NCT00963820|50590157|FG003|Expansion Phase|Withdrawal by Subject|0|||
25276235|NCT00963820|50590158|FG004|Expansion Phase|Withdrawal by Subject|0|||
25276236|NCT00963820|50590159|FG005|Expansion Phase|Withdrawal by Subject|0|||
25276237|NCT00963820|50590160|FG006|Expansion Phase|Withdrawal by Subject|0|||
25276238|NCT00963820|50590161|FG007|Expansion Phase|Withdrawal by Subject|0|||
25276239|NCT00963820|50590162|FG008|Expansion Phase|Withdrawal by Subject|1|||
25276240|NCT00963820|50590163|FG009|Expansion Phase|Withdrawal by Subject|0|||
25276241|NCT00963820|50590164|FG010|Expansion Phase|Withdrawal by Subject|1|||
25276242|NCT00963820|50590165|FG011|Expansion Phase|Withdrawal by Subject|1|||
25276243|NCT00963820|50590154|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25276244|NCT00963820|50590155|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25276245|NCT00963820|50590156|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25276246|NCT00963820|50590157|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25276247|NCT00963820|50590158|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25276248|NCT00963820|50590159|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25276249|NCT00963820|50590160|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25276250|NCT00963820|50590161|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25276251|NCT00963820|50590162|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25160646|NCT01857583|50280858|FG001|Overall Study|Withdrawal by Subject|0|||
25160647|NCT01857583|50280859|FG002|Overall Study|Withdrawal by Subject|1|||
25160648|NCT01857583|50280860|FG003|Overall Study|Withdrawal by Subject|2|||
25160649|NCT01829191|50280872|FG000|Overall Study|Relocation|0|||
25160650|NCT01829191|50280873|FG001|Overall Study|Relocation|1|||
25160651|NCT01829191|50280872|FG000|Overall Study|Lens discomfort|0|||
25160652|NCT01829191|50280873|FG001|Overall Study|Lens discomfort|3|||
25160653|NCT01829191|50280872|FG000|Overall Study|Lens handling difficulty|1|||
25160654|NCT01829191|50280873|FG001|Overall Study|Lens handling difficulty|4|||
25160655|NCT01829191|50280872|FG000|Overall Study|Protocol Violation|4|||
25160656|NCT01829191|50280873|FG001|Overall Study|Protocol Violation|1|||
25160657|NCT01829191|50280872|FG000|Overall Study|Withdrawal by Subject|2|||
25160658|NCT01829191|50280873|FG001|Overall Study|Withdrawal by Subject|3|||
25160659|NCT01829191|50280872|FG000|Overall Study|Lost to Follow-up|0|||
25160660|NCT01829191|50280873|FG001|Overall Study|Lost to Follow-up|1|||
25160661|NCT01829191|50280872|FG000|Overall Study|Subject was fit for ortho - k|0|||
25160662|NCT01829191|50280873|FG001|Overall Study|Subject was fit for ortho - k|1|||
25160663|NCT00211185|50280878|FG000|Overall Study|Death|2|||
25160664|NCT00211185|50280878|FG000|Overall Study|Disease progression|7|||
25160665|NCT00211185|50280878|FG000|Overall Study|Withdrawal by Subject|6|||
25160666|NCT00211185|50280878|FG000|Overall Study|Physician Decision|5|||
25160667|NCT00210639|50280884|FG000|Overall Study|Lost to Follow-up|37|||
25160668|NCT00210639|50280885|FG001|Overall Study|Lost to Follow-up|29|||
25160669|NCT00210639|50280884|FG000|Overall Study|Withdrawal by Subject|8|||
25160670|NCT00210639|50280885|FG001|Overall Study|Withdrawal by Subject|1|||
25160671|NCT00210639|50280884|FG000|Overall Study|Other|18|||
25160672|NCT00210639|50280885|FG001|Overall Study|Other|12|||
25160673|NCT01829113|50280893|FG000|Overall Study|Disease Progression|37|||
25160674|NCT01829113|50280894|FG001|Overall Study|Disease Progression|48|||
25160675|NCT01829113|50280893|FG000|Overall Study|Adverse Event|14|||
25276252|NCT00963820|50590163|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25160676|NCT01829113|50280894|FG001|Overall Study|Adverse Event|10|||
25160677|NCT01829113|50280893|FG000|Overall Study|Withdrawal by Subject|17|||
25276253|NCT00963820|50590164|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25276254|NCT00963820|50590165|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
24956617|NCT00381680|50047540|FG001|Overall Study|Ineligible|1|||
25160678|NCT01829113|50280894|FG001|Overall Study|Withdrawal by Subject|10|||
25160679|NCT01829113|50280893|FG000|Overall Study|Death|4|||
25160680|NCT01829113|50280894|FG001|Overall Study|Death|6|||
25160681|NCT01829113|50280893|FG000|Overall Study|Sponsor Decision|1|||
25160682|NCT01829113|50280894|FG001|Overall Study|Sponsor Decision|1|||
25160683|NCT01829113|50280893|FG000|Overall Study|No Study Treatment Received|3|||
25160684|NCT01829113|50280894|FG001|Overall Study|No Study Treatment Received|2|||
25160685|NCT01829113|50280893|FG000|Overall Study|Physician Decision|1|||
25160686|NCT01829113|50280894|FG001|Overall Study|Physician Decision|1|||
25276255|NCT01227395|50590184|FG000|Overall Study|Protocol Violation|0|||
25276256|NCT01227395|50590185|FG001|Overall Study|Protocol Violation|1|||
25276257|NCT01226459|50590212|FG000|Overall Study|Adverse Event|2|||
25276258|NCT01226459|50590213|FG001|Overall Study|Adverse Event|8|||
25276259|NCT01226459|50590212|FG000|Overall Study|Protocol Violation|4|||
25276260|NCT01226459|50590213|FG001|Overall Study|Protocol Violation|3|||
25276261|NCT01226459|50590212|FG000|Overall Study|Withdrawal by Subject|10|||
25276262|NCT01226459|50590213|FG001|Overall Study|Withdrawal by Subject|13|||
25276263|NCT01226459|50590212|FG000|Overall Study|Lost to Follow-up|4|||
25276264|NCT01226459|50590213|FG001|Overall Study|Lost to Follow-up|8|||
25276265|NCT01226459|50590212|FG000|Overall Study|Pregnancy|1|||
25276266|NCT01226459|50590213|FG001|Overall Study|Pregnancy|0|||
25276267|NCT01225991|50590219|FG000|Overall Study|Withdrawal by Subject|6|||
25276268|NCT00959374|50590223|FG000|Overall Study|Withdrawal by Subject|2|||
25276269|NCT00959374|50590223|FG000|Overall Study|Lost to Follow-up|14|||
25042705|NCT02925117|50144026|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
25276270|NCT00959374|50590223|FG000|Overall Study|Death|1|||
25276271|NCT00959374|50590223|FG000|Overall Study|Protocol Violation|1|||
25160687|NCT01857271|50280902|FG000|Overall Study|Lost to Follow-up|1|||
25160688|NCT01745120|50280908|FG000|Overall Study|Investigator decision|1|||
25160689|NCT01745120|50280909|FG001|Overall Study|Investigator decision|0|||
25160690|NCT01828567|50280920|FG000|Overall Study|Lost to Follow-up|27|||
25160691|NCT01828567|50280921|FG001|Overall Study|Lost to Follow-up|9|||
25160692|NCT01828567|50280920|FG000|Overall Study|Excluded - did not meet criteria|4|||
25160693|NCT01828567|50280921|FG001|Overall Study|Excluded - did not meet criteria|1|||
25276272|NCT00959374|50590223|FG000|Overall Study|Implant Removed/Not Replaced|4|||
25276273|NCT00959374|50590223|FG000|Overall Study|Physician Decision|1|||
25276274|NCT01225835|50590233|FG000|Overall Study|Completed protocol|2|||
25276275|NCT01225835|50590234|FG001|Overall Study|Completed protocol|1|||
25276276|NCT01225835|50590233|FG000|Overall Study|Did not meet hCG criterion|2|||
25276277|NCT01225835|50590234|FG001|Overall Study|Did not meet hCG criterion|0|||
25160694|NCT01721486|50280929|FG000|Overall Study|Protocol Violation|1|||
25160695|NCT01721486|50280930|FG001|Overall Study|Protocol Violation|0|||
25160696|NCT01721486|50280929|FG000|Overall Study|Physician Decision|0|||
25160697|NCT01721486|50280930|FG001|Overall Study|Physician Decision|1|||
25160698|NCT01775930|50280936|FG000|Overall Study|Futility stopping boundary met|1|||
25160699|NCT01856569|50280940|FG000|Overall Study|Other|1|||
25160700|NCT01856569|50280940|FG000|Overall Study|Changed Site/Structure|1|||
25160701|NCT01856569|50280940|FG000|Overall Study|Lost to Follow-up|3|||
25160702|NCT01856569|50280940|FG000|Overall Study|Did not met inclusion criteria|8|||
25160703|NCT01721408|50280946|FG000|Overall Study|Adverse Event|6|||
25160704|NCT01721408|50280947|FG001|Overall Study|Adverse Event|1|||
25276278|NCT01225835|50590233|FG000|Overall Study|Adverse Event|2|||
24956618|NCT00360698|50047552|FG000|Run-In|Physician Decision|0|||
24956619|NCT00360698|50047553|FG001|Run-In|Physician Decision|1|||
24956620|NCT00360698|50047552|FG000|Run-In|Withdrawal by Subject|0|||
24956621|NCT00360698|50047553|FG001|Run-In|Withdrawal by Subject|2|||
24956622|NCT00360698|50047552|FG000|Run-In|Non compliance with treatment procedure|0|||
24956623|NCT00360698|50047553|FG001|Run-In|Non compliance with treatment procedure|1|||
24956624|NCT00360698|50047552|FG000|Run-In|Sponsor request|0|||
24956625|NCT00360698|50047553|FG001|Run-In|Sponsor request|2|||
24956626|NCT00360698|50047552|FG000|Run-In|Patient did not meet inclusion criteria|0|||
24956627|NCT00360698|50047553|FG001|Run-In|Patient did not meet inclusion criteria|1|||
24956628|NCT00360698|50047552|FG000|Run-In|Patient personal reasons|0|||
24956629|NCT00360698|50047553|FG001|Run-In|Patient personal reasons|2|||
24956630|NCT00360698|50047552|FG000|Run-In|Need of insulin with meals|0|||
24956631|NCT00360698|50047553|FG001|Run-In|Need of insulin with meals|1|||
24956632|NCT00360698|50047552|FG000|Treatment Period|Non compliance with treatment procedure|1|||
24956633|NCT00360698|50047553|FG001|Treatment Period|Non compliance with treatment procedure|0|||
24956634|NCT00360698|50047552|FG000|Treatment Period|Early termination by error|0|||
24956635|NCT00360698|50047553|FG001|Treatment Period|Early termination by error|1|||
24956636|NCT00380978|50047561|FG000|Overall Study|Refused allocated intervention|0|||
25042706|NCT02925117|50144027|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
25042707|NCT02925117|50144028|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
25042708|NCT02925117|50144029|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
25160705|NCT01721408|50280946|FG000|Overall Study|Death|1|||
25160706|NCT01721408|50280947|FG001|Overall Study|Death|0|||
25160707|NCT01721408|50280946|FG000|Overall Study|Insufficient clinical response|15|||
25160708|NCT01721408|50280947|FG001|Overall Study|Insufficient clinical response|6|||
25160709|NCT01721408|50280946|FG000|Overall Study|No longer willing to participate study|9|||
25160710|NCT01721408|50280947|FG001|Overall Study|No longer willing to participate study|10|||
25160711|NCT01721408|50280946|FG000|Overall Study|Protocol Violation|0|||
25160712|NCT01721408|50280947|FG001|Overall Study|Protocol Violation|2|||
25160713|NCT01721408|50280946|FG000|Overall Study|Other|3|||
25160714|NCT01721408|50280947|FG001|Overall Study|Other|3|||
25160715|NCT01721408|50280946|FG000|Overall Study|Lost to Follow-up|1|||
25276279|NCT01225835|50590234|FG001|Overall Study|Adverse Event|1|||
24956637|NCT00380978|50047562|FG001|Overall Study|Refused allocated intervention|6|||
24956638|NCT00380978|50047561|FG000|Overall Study|Wrong study envelope|0|||
25276280|NCT01225835|50590233|FG000|Overall Study|Other|1|||
24956639|NCT00380978|50047562|FG001|Overall Study|Wrong study envelope|2|||
24956640|NCT00380978|50047561|FG000|Overall Study|Allocation prior to analgesia request|1|||
25160716|NCT01721408|50280947|FG001|Overall Study|Lost to Follow-up|2|||
25160717|NCT01721408|50280946|FG000|Overall Study|Does not meet entrance criteria|1|||
25160718|NCT01721408|50280947|FG001|Overall Study|Does not meet entrance criteria|0|||
25160719|NCT01744496|50280955|FG000|Titration Period|Adverse Event|2|||
25276281|NCT01225835|50590234|FG001|Overall Study|Other|1|||
25276282|NCT02923180|50590246|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
25276283|NCT02923180|50590246|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
24956641|NCT00380978|50047562|FG001|Overall Study|Allocation prior to analgesia request|2|||
25160720|NCT01744496|50280956|FG001|Titration Period|Adverse Event|1|||
25160721|NCT01744496|50280955|FG000|Titration Period|Personal reasons|0|||
25160722|NCT01744496|50280956|FG001|Titration Period|Personal reasons|1|||
25160723|NCT01744496|50280955|FG000|Maintenance Period|Adverse Event|1|||
25160724|NCT01744496|50280956|FG001|Maintenance Period|Adverse Event|3|||
25160725|NCT01744496|50280955|FG000|Maintenance Period|Protocol Violation|1|||
25160726|NCT01744496|50280956|FG001|Maintenance Period|Protocol Violation|0|||
25160727|NCT01744496|50280955|FG000|Maintenance Period|Withdrawal by Subject|1|||
25160728|NCT01744496|50280956|FG001|Maintenance Period|Withdrawal by Subject|1|||
25160729|NCT01744496|50280955|FG000|Maintenance Period|Subject left town|1|||
25160730|NCT01744496|50280956|FG001|Maintenance Period|Subject left town|0|||
25160731|NCT01721330|50280964|FG000|Overall Study|Withdrawal by Subject|0|||
25160732|NCT01721330|50280965|FG001|Overall Study|Withdrawal by Subject|1|||
25160733|NCT01828021|50280981|FG000|Overall Study|Adverse Event|5|||
25160734|NCT01828021|50280981|FG000|Overall Study|Lack of Efficacy|17|||
25160735|NCT01828021|50280981|FG000|Overall Study|Withdrawal by Subject|2|||
25160736|NCT01828021|50280981|FG000|Overall Study|Ileal obstruction, unrelated|1|||
25160737|NCT01827943|50280985|FG000|Overall Study|Protocol Violation|8|||
25160738|NCT01827943|50280985|FG000|Overall Study|Never treated because of an rapid progression|1|||
25160739|NCT00217971|50280991|FG000|Overall Study|Adverse Event|1|||
25160740|NCT00217971|50280992|FG001|Overall Study|Adverse Event|1|||
25160741|NCT00217971|50280991|FG000|Overall Study|Lost to Follow-up|15|||
25160742|NCT00217971|50280992|FG001|Overall Study|Lost to Follow-up|19|||
25160743|NCT00217971|50280991|FG000|Overall Study|Physician Decision|0|||
25160744|NCT00217971|50280992|FG001|Overall Study|Physician Decision|1|||
25160745|NCT00217971|50280991|FG000|Overall Study|Withdrawal by Subject|7|||
25160746|NCT00217971|50280992|FG001|Overall Study|Withdrawal by Subject|12|||
25160747|NCT00217971|50280991|FG000|Overall Study|non compliant|1|||
25160748|NCT00217971|50280992|FG001|Overall Study|non compliant|0|||
25160749|NCT00217581|50280998|FG000|Overall Study|Withdrawal by Subject|1|||
25160750|NCT01856257|50281006|FG000|Overall Study|Death|2|||
25160751|NCT01856257|50281007|FG001|Overall Study|Death|0|||
24956642|NCT00380978|50047561|FG000|Overall Study|Parous patient|1|||
24956643|NCT00380978|50047562|FG001|Overall Study|Parous patient|0|||
24956644|NCT00162123|50047576|FG000|Overall Study|Disease progression|27|||
24956645|NCT00162123|50047577|FG001|Overall Study|Disease progression|19|||
24956646|NCT00162123|50047578|FG002|Overall Study|Disease progression|10|||
24956647|NCT00162123|50047579|FG003|Overall Study|Disease progression|4|||
24956648|NCT00162123|50047580|FG004|Overall Study|Disease progression|8|||
24956649|NCT00162123|50047581|FG005|Overall Study|Disease progression|3|||
24956650|NCT00162123|50047582|FG006|Overall Study|Disease progression|1|||
24956651|NCT00162123|50047583|FG007|Overall Study|Disease progression|0|||
24956652|NCT00162123|50047576|FG000|Overall Study|Study drug toxicity|6|||
24956653|NCT00162123|50047577|FG001|Overall Study|Study drug toxicity|1|||
24956654|NCT00162123|50047578|FG002|Overall Study|Study drug toxicity|5|||
24956655|NCT00162123|50047579|FG003|Overall Study|Study drug toxicity|0|||
24956656|NCT00162123|50047580|FG004|Overall Study|Study drug toxicity|4|||
24956657|NCT00162123|50047581|FG005|Overall Study|Study drug toxicity|1|||
24956658|NCT00162123|50047582|FG006|Overall Study|Study drug toxicity|1|||
24956659|NCT00162123|50047583|FG007|Overall Study|Study drug toxicity|0|||
24956660|NCT00162123|50047576|FG000|Overall Study|Death|3|||
25042709|NCT02925117|50144030|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
25042710|NCT02925117|50144019|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
25042711|NCT02925117|50144020|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
25042712|NCT02925117|50144021|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
24956661|NCT00162123|50047577|FG001|Overall Study|Death|3|||
24956662|NCT00162123|50047578|FG002|Overall Study|Death|1|||
24956663|NCT00162123|50047579|FG003|Overall Study|Death|1|||
25042713|NCT02925117|50144022|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
25160752|NCT01856257|50281008|FG002|Overall Study|Death|0|||
24956664|NCT00162123|50047580|FG004|Overall Study|Death|1|||
25042714|NCT02925117|50144023|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
25042715|NCT02925117|50144024|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
25276284|NCT00962650|50590250|FG000|Overall Study|Transgastric DP was not completed|2|||
25042716|NCT02925117|50144025|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
25042717|NCT02925117|50144026|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
24956665|NCT00162123|50047581|FG005|Overall Study|Death|1|||
24956666|NCT00162123|50047582|FG006|Overall Study|Death|0|||
24956667|NCT00162123|50047583|FG007|Overall Study|Death|0|||
24956668|NCT00162123|50047576|FG000|Overall Study|Withdrawal by Subject|2|||
25042718|NCT02925117|50144027|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
25160753|NCT01856257|50281009|FG003|Overall Study|Death|0|||
25160754|NCT01856257|50281006|FG000|Overall Study|Physician Decision|0|||
24956669|NCT00162123|50047577|FG001|Overall Study|Withdrawal by Subject|0|||
24956670|NCT00162123|50047578|FG002|Overall Study|Withdrawal by Subject|2|||
25160755|NCT01856257|50281007|FG001|Overall Study|Physician Decision|0|||
25160756|NCT01856257|50281008|FG002|Overall Study|Physician Decision|0|||
25160757|NCT01856257|50281009|FG003|Overall Study|Physician Decision|1|||
25160758|NCT01856257|50281006|FG000|Overall Study|Withdrawal by Subject|1|||
25160759|NCT01856257|50281007|FG001|Overall Study|Withdrawal by Subject|1|||
25042719|NCT02925117|50144028|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
25042720|NCT02925117|50144029|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
25042721|NCT02925117|50144030|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
25042722|NCT02925117|50144019|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
25042723|NCT02925117|50144020|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
25042724|NCT02925117|50144021|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
25042725|NCT02925117|50144022|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
24956671|NCT00162123|50047579|FG003|Overall Study|Withdrawal by Subject|1|||
24956672|NCT00162123|50047580|FG004|Overall Study|Withdrawal by Subject|1|||
25042726|NCT02925117|50144023|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
25042727|NCT02925117|50144024|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
25042728|NCT02925117|50144025|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
25042729|NCT02925117|50144026|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
25042730|NCT02925117|50144027|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
25042731|NCT02925117|50144028|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
25042732|NCT02925117|50144029|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
25042733|NCT02925117|50144030|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
25042734|NCT02925117|50144019|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
25042735|NCT02925117|50144020|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
25042736|NCT02925117|50144021|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
25042737|NCT02925117|50144022|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
25042738|NCT02925117|50144023|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
25042739|NCT02925117|50144024|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
25042740|NCT02925117|50144025|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
25042741|NCT02925117|50144026|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
25042742|NCT02925117|50144027|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
25042743|NCT02925117|50144028|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
25042744|NCT02925117|50144029|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
25042745|NCT02925117|50144030|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
25042746|NCT02925117|50144019|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
25042747|NCT02925117|50144020|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
25042748|NCT02925117|50144021|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
25042749|NCT02925117|50144022|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
25042750|NCT02925117|50144023|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
25042751|NCT02925117|50144024|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
25042752|NCT02925117|50144025|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
25042753|NCT02925117|50144026|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
25042754|NCT02925117|50144027|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
25042755|NCT02925117|50144028|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
25042756|NCT02925117|50144029|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
25042757|NCT02925117|50144030|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
25042758|NCT02925117|50144019|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
25042759|NCT02925117|50144020|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
25042760|NCT02925117|50144021|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
25042761|NCT02925117|50144022|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
25042762|NCT02925117|50144023|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
25042763|NCT02925117|50144024|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
25042764|NCT02925117|50144025|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
25160760|NCT01856257|50281008|FG002|Overall Study|Withdrawal by Subject|0|||
25160761|NCT01856257|50281009|FG003|Overall Study|Withdrawal by Subject|0|||
25186508|NCT02647866|50336898|FG003|Overall Study|Physician Decision|0|||
24956673|NCT00162123|50047581|FG005|Overall Study|Withdrawal by Subject|2|||
24956674|NCT00162123|50047582|FG006|Overall Study|Withdrawal by Subject|1|||
24956675|NCT00162123|50047583|FG007|Overall Study|Withdrawal by Subject|0|||
24956676|NCT00162123|50047576|FG000|Overall Study|Deterioration without progression|2|||
24956677|NCT00162123|50047577|FG001|Overall Study|Deterioration without progression|2|||
24956678|NCT00162123|50047578|FG002|Overall Study|Deterioration without progression|3|||
24956679|NCT00162123|50047579|FG003|Overall Study|Deterioration without progression|0|||
24956680|NCT00162123|50047580|FG004|Overall Study|Deterioration without progression|1|||
24956681|NCT00162123|50047581|FG005|Overall Study|Deterioration without progression|0|||
24956682|NCT00162123|50047582|FG006|Overall Study|Deterioration without progression|0|||
24956683|NCT00162123|50047583|FG007|Overall Study|Deterioration without progression|0|||
24956684|NCT00162123|50047576|FG000|Overall Study|Adverse Event|1|||
25042765|NCT02925117|50144026|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
25042766|NCT02925117|50144027|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
25042767|NCT02925117|50144028|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
25042768|NCT02925117|50144029|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
25042769|NCT02925117|50144030|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
25160762|NCT01856257|50281006|FG000|Overall Study|Donor complication|0|||
25160763|NCT01856257|50281007|FG001|Overall Study|Donor complication|0|||
25160764|NCT01856257|50281008|FG002|Overall Study|Donor complication|0|||
25160765|NCT01856257|50281009|FG003|Overall Study|Donor complication|1|||
25160766|NCT00215943|50281020|FG000|Overall Study|Disease Progression|3|||
25160767|NCT00215943|50281021|FG001|Overall Study|Disease Progression|5|||
25160768|NCT00215943|50281020|FG000|Overall Study|Alternate therapy|0|||
25160769|NCT00215943|50281021|FG001|Overall Study|Alternate therapy|1|||
25160770|NCT00215943|50281020|FG000|Overall Study|Adverse Event|3|||
25160771|NCT00215943|50281021|FG001|Overall Study|Adverse Event|6|||
25160772|NCT00215943|50281020|FG000|Overall Study|Other disease|0|||
25160773|NCT00215943|50281021|FG001|Overall Study|Other disease|1|||
25160774|NCT00215943|50281020|FG000|Overall Study|Other complications|3|||
25160775|NCT00215943|50281021|FG001|Overall Study|Other complications|1|||
25160776|NCT01827319|50281027|FG000|Overall Study|Lost to Follow-up|3|||
25160777|NCT01827163|50281031|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
25160778|NCT01827163|50281031|FG000|Overall Study|Adverse Event|9|||
25160779|NCT00215553|50281042|FG000|Overall Study|Adverse Event|0|||
25160780|NCT00215553|50281043|FG001|Overall Study|Adverse Event|1|||
25160781|NCT00215553|50281044|FG002|Overall Study|Adverse Event|2|||
25160782|NCT00215553|50281045|FG003|Overall Study|Adverse Event|1|||
25276285|NCT00958828|50590258|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
25276286|NCT00958828|50590259|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
24956685|NCT00162123|50047577|FG001|Overall Study|Adverse Event|2|||
24956686|NCT00162123|50047578|FG002|Overall Study|Adverse Event|0|||
24956687|NCT00162123|50047579|FG003|Overall Study|Adverse Event|2|||
24956688|NCT00162123|50047580|FG004|Overall Study|Adverse Event|1|||
24956689|NCT00162123|50047581|FG005|Overall Study|Adverse Event|0|||
24956690|NCT00162123|50047582|FG006|Overall Study|Adverse Event|0|||
24956691|NCT00162123|50047583|FG007|Overall Study|Adverse Event|0|||
24956692|NCT00162123|50047576|FG000|Overall Study|Not specified (before treatment)|2|||
25160783|NCT00215553|50281046|FG004|Overall Study|Adverse Event|2|||
25160784|NCT00215553|50281047|FG005|Overall Study|Adverse Event|6|||
25160785|NCT00215553|50281048|FG006|Overall Study|Adverse Event|0|||
25160786|NCT00214461|50281068|FG000|Overall Study|Adverse Event|0|||
25042770|NCT02925117|50144019|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
25042771|NCT02925117|50144020|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
25042772|NCT02925117|50144021|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
25042773|NCT02925117|50144022|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
25042774|NCT02925117|50144023|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
25042775|NCT02925117|50144024|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
25042776|NCT02925117|50144025|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
25042777|NCT02925117|50144026|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
25042778|NCT02925117|50144027|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
25042779|NCT02925117|50144028|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
25042780|NCT02925117|50144029|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
25042781|NCT02925117|50144030|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
25042782|NCT03075163|50144054|FG000|Overall Study|not eligible for treatment limb|138|||
25042783|NCT03075163|50144055|FG001|Overall Study|not eligible for treatment limb|138|||
25042784|NCT03078751|50144063|FG000|Overall Study|Adverse Event|4|||
25160787|NCT00214461|50281069|FG001|Overall Study|Adverse Event|0|||
25042785|NCT03078751|50144064|FG001|Overall Study|Adverse Event|0|||
25042786|NCT03078751|50144063|FG000|Overall Study|Physician Decision|1|||
25042787|NCT03078751|50144064|FG001|Overall Study|Physician Decision|0|||
25042788|NCT03078751|50144063|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
25042789|NCT03078751|50144064|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
25042790|NCT03078751|50144063|FG000|Overall Study|Subject/guardian decision|8|||
25042791|NCT03078751|50144064|FG001|Overall Study|Subject/guardian decision|1|||
25042792|NCT03078751|50144063|FG000|Overall Study|Untreated|0|||
25042793|NCT03078751|50144064|FG001|Overall Study|Untreated|4|||
25042794|NCT02924883|50144072|FG000|Overall Study|Death|39|||
25042795|NCT02924883|50144073|FG001|Overall Study|Death|20|||
25042796|NCT02924883|50144072|FG000|Overall Study|Lost to Follow-up|1|||
25042797|NCT02924883|50144073|FG001|Overall Study|Lost to Follow-up|0|||
25042798|NCT02924883|50144072|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
25042799|NCT02924883|50144073|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
25042800|NCT02924883|50144072|FG000|Overall Study|Protocol Violation|1|||
25042801|NCT02924883|50144073|FG001|Overall Study|Protocol Violation|0|||
25042802|NCT02924883|50144072|FG000|Overall Study|Withdrawal by Subject|22|||
25042803|NCT02924883|50144073|FG001|Overall Study|Withdrawal by Subject|16|||
25042804|NCT02924883|50144072|FG000|Overall Study|Progressive Disease|1|||
24956693|NCT00162123|50047577|FG001|Overall Study|Not specified (before treatment)|0|||
24956694|NCT00162123|50047578|FG002|Overall Study|Not specified (before treatment)|0|||
24956695|NCT00162123|50047579|FG003|Overall Study|Not specified (before treatment)|0|||
24956696|NCT00162123|50047580|FG004|Overall Study|Not specified (before treatment)|12|||
24956697|NCT00162123|50047581|FG005|Overall Study|Not specified (before treatment)|1|||
24956698|NCT00162123|50047582|FG006|Overall Study|Not specified (before treatment)|0|||
25042805|NCT02924883|50144073|FG001|Overall Study|Progressive Disease|0|||
25042806|NCT02924883|50144072|FG000|Overall Study|Study Terminated by Sponsor|69|||
25042807|NCT02924883|50144073|FG001|Overall Study|Study Terminated by Sponsor|32|||
25042808|NCT01369680|50144096|FG000|Overall Study|Lost to Follow-up|0|||
25042809|NCT01369680|50144097|FG001|Overall Study|Lost to Follow-up|0|||
25042810|NCT01369680|50144098|FG002|Overall Study|Lost to Follow-up|1|||
25160788|NCT00214461|50281070|FG002|Overall Study|Adverse Event|1|||
25160789|NCT00214461|50281071|FG003|Overall Study|Adverse Event|1|||
25160790|NCT00214461|50281068|FG000|Overall Study|Withdrawal by Subject|0|||
25160791|NCT00214461|50281069|FG001|Overall Study|Withdrawal by Subject|0|||
25160792|NCT00214461|50281070|FG002|Overall Study|Withdrawal by Subject|1|||
25160793|NCT00214461|50281071|FG003|Overall Study|Withdrawal by Subject|0|||
24956699|NCT00162123|50047583|FG007|Overall Study|Not specified (before treatment)|0|||
24956700|NCT00162123|50047576|FG000|Overall Study|Not specified (after start of treatment)|0|||
24956701|NCT00162123|50047577|FG001|Overall Study|Not specified (after start of treatment)|0|||
24956702|NCT00162123|50047578|FG002|Overall Study|Not specified (after start of treatment)|0|||
24956703|NCT00162123|50047579|FG003|Overall Study|Not specified (after start of treatment)|0|||
24956704|NCT00162123|50047580|FG004|Overall Study|Not specified (after start of treatment)|3|||
24956705|NCT00162123|50047581|FG005|Overall Study|Not specified (after start of treatment)|0|||
24956706|NCT00162123|50047582|FG006|Overall Study|Not specified (after start of treatment)|0|||
24956707|NCT00162123|50047583|FG007|Overall Study|Not specified (after start of treatment)|0|||
25042811|NCT01369680|50144099|FG003|Overall Study|Lost to Follow-up|2|||
25042812|NCT03074149|50144131|FG000|Overall Study|Reason unknown|22|||
25160794|NCT00214383|50281083|FG000|Overall Study|Lost to Follow-up|16|||
25042813|NCT03074149|50144132|FG001|Overall Study|Reason unknown|35|||
25042814|NCT03074149|50144131|FG000|Overall Study|Death|10|||
25042815|NCT03074149|50144132|FG001|Overall Study|Death|45|||
25042816|NCT02751320|50144140|FG000|Overall Study|Adverse Event|2|||
25042817|NCT02751320|50144140|FG000|Overall Study|Withdrawal by Subject|1|||
25042818|NCT02206035|50144168|FG000|Overall Study|Physician Decision|10|||
25042819|NCT02206035|50144169|FG001|Overall Study|Physician Decision|0|||
25042820|NCT02206035|50144170|FG002|Overall Study|Physician Decision|175|||
25042821|NCT02746471|50144177|FG000|Overall Study|Death|43|||
25160795|NCT00214383|50281084|FG001|Overall Study|Lost to Follow-up|26|||
24956708|NCT00162123|50047576|FG000|Overall Study|Physician Decision|1|||
24956709|NCT00162123|50047577|FG001|Overall Study|Physician Decision|2|||
24956710|NCT00162123|50047578|FG002|Overall Study|Physician Decision|0|||
24956711|NCT00162123|50047579|FG003|Overall Study|Physician Decision|0|||
24956712|NCT00162123|50047580|FG004|Overall Study|Physician Decision|0|||
24956713|NCT00162123|50047581|FG005|Overall Study|Physician Decision|1|||
24956714|NCT00162123|50047582|FG006|Overall Study|Physician Decision|1|||
24956715|NCT00162123|50047583|FG007|Overall Study|Physician Decision|0|||
24956716|NCT00162123|50047576|FG000|Overall Study|Tumor assessment only (not treated)|0|||
25160796|NCT00212355|50281090|FG000|Overall Study|Adverse Event|1|||
25160797|NCT00212355|50281090|FG000|Overall Study|Withdrawal by Subject|1|||
25160798|NCT00212355|50281090|FG000|Overall Study|A change of address|1|||
25160799|NCT00211887|50281097|FG000|Overall Study|Adverse Event|8|||
25160800|NCT00211887|50281098|FG001|Overall Study|Adverse Event|4|||
25160801|NCT00211887|50281099|FG002|Overall Study|Adverse Event|6|||
25160802|NCT00211887|50281097|FG000|Overall Study|Death|1|||
25160803|NCT00211887|50281098|FG001|Overall Study|Death|1|||
25160804|NCT00211887|50281099|FG002|Overall Study|Death|1|||
25160805|NCT00211887|50281097|FG000|Overall Study|Lost to Follow-up|28|||
25160806|NCT00211887|50281098|FG001|Overall Study|Lost to Follow-up|13|||
25160807|NCT00211887|50281099|FG002|Overall Study|Lost to Follow-up|9|||
25160808|NCT00211887|50281097|FG000|Overall Study|Non-medical reason|31|||
25160809|NCT00211887|50281098|FG001|Overall Study|Non-medical reason|14|||
25160810|NCT00211887|50281099|FG002|Overall Study|Non-medical reason|8|||
25160811|NCT00211887|50281097|FG000|Overall Study|Other medical reason|15|||
25160812|NCT00211887|50281098|FG001|Overall Study|Other medical reason|11|||
24956717|NCT00162123|50047577|FG001|Overall Study|Tumor assessment only (not treated)|0|||
24956718|NCT00162123|50047578|FG002|Overall Study|Tumor assessment only (not treated)|0|||
24956719|NCT00162123|50047579|FG003|Overall Study|Tumor assessment only (not treated)|0|||
24956720|NCT00162123|50047580|FG004|Overall Study|Tumor assessment only (not treated)|0|||
24956721|NCT00162123|50047581|FG005|Overall Study|Tumor assessment only (not treated)|0|||
24956722|NCT00162123|50047582|FG006|Overall Study|Tumor assessment only (not treated)|0|||
24956723|NCT00162123|50047583|FG007|Overall Study|Tumor assessment only (not treated)|1|||
24956724|NCT00162123|50047576|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
24956725|NCT00162123|50047577|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
24956726|NCT00162123|50047578|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
24956727|NCT00162123|50047579|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
24956728|NCT00162123|50047580|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
24956729|NCT00162123|50047581|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
24956730|NCT00162123|50047582|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
24956731|NCT00162123|50047583|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
24956732|NCT00227721|50047602|FG000|Overall Study|On study, but never treated.|1|||
25160813|NCT00211887|50281099|FG002|Overall Study|Other medical reason|7|||
25160814|NCT00211887|50281097|FG000|Overall Study|Side effects|19|||
25160815|NCT00211887|50281098|FG001|Overall Study|Side effects|13|||
25160816|NCT00211887|50281099|FG002|Overall Study|Side effects|5|||
25160817|NCT01855945|50281119|FG000|Overall Study|Adverse Event|0|||
25160818|NCT01855945|50281120|FG001|Overall Study|Adverse Event|0|||
25160819|NCT01855945|50281121|FG002|Overall Study|Adverse Event|0|||
25160820|NCT01855945|50281122|FG003|Overall Study|Adverse Event|0|||
25160821|NCT01855945|50281123|FG004|Overall Study|Adverse Event|0|||
25160822|NCT01855945|50281124|FG005|Overall Study|Adverse Event|0|||
25160823|NCT01855945|50281125|FG006|Overall Study|Adverse Event|1|||
24956733|NCT00226941|50047610|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
24956734|NCT00226941|50047611|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
24956735|NCT00226941|50047612|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
25042822|NCT02746471|50144177|FG000|Overall Study|Exited before 36 months|1119|||
25160824|NCT01855945|50281126|FG007|Overall Study|Adverse Event|0|||
25160825|NCT01855945|50281127|FG008|Overall Study|Adverse Event|0|||
25160826|NCT01855945|50281128|FG009|Overall Study|Adverse Event|0|||
25160827|NCT01855945|50281129|FG010|Overall Study|Adverse Event|0|||
25160828|NCT01855945|50281130|FG011|Overall Study|Adverse Event|0|||
25160829|NCT01855945|50281119|FG000|Overall Study|Death|0|||
25160830|NCT01855945|50281120|FG001|Overall Study|Death|0|||
25160831|NCT01855945|50281121|FG002|Overall Study|Death|0|||
25160832|NCT01855945|50281122|FG003|Overall Study|Death|0|||
25160833|NCT01855945|50281123|FG004|Overall Study|Death|0|||
25160834|NCT01855945|50281124|FG005|Overall Study|Death|0|||
25160835|NCT01855945|50281125|FG006|Overall Study|Death|2|||
25160836|NCT01855945|50281126|FG007|Overall Study|Death|0|||
25160837|NCT01855945|50281127|FG008|Overall Study|Death|0|||
25160838|NCT01855945|50281128|FG009|Overall Study|Death|0|||
25160839|NCT01855945|50281129|FG010|Overall Study|Death|0|||
25160840|NCT01855945|50281130|FG011|Overall Study|Death|0|||
25160841|NCT01855945|50281119|FG000|Overall Study|Lost to Follow-up|11|||
25160842|NCT01855945|50281120|FG001|Overall Study|Lost to Follow-up|10|||
25160843|NCT01855945|50281121|FG002|Overall Study|Lost to Follow-up|7|||
25160844|NCT01855945|50281122|FG003|Overall Study|Lost to Follow-up|3|||
25160845|NCT01855945|50281123|FG004|Overall Study|Lost to Follow-up|0|||
25160846|NCT01855945|50281124|FG005|Overall Study|Lost to Follow-up|3|||
25160847|NCT01855945|50281125|FG006|Overall Study|Lost to Follow-up|4|||
25160848|NCT01855945|50281126|FG007|Overall Study|Lost to Follow-up|7|||
25160849|NCT01855945|50281127|FG008|Overall Study|Lost to Follow-up|2|||
25160850|NCT01855945|50281128|FG009|Overall Study|Lost to Follow-up|0|||
25160851|NCT01855945|50281129|FG010|Overall Study|Lost to Follow-up|0|||
25160852|NCT01855945|50281130|FG011|Overall Study|Lost to Follow-up|2|||
25160853|NCT01855945|50281119|FG000|Overall Study|Other - Unclassified|1|||
25160854|NCT01855945|50281120|FG001|Overall Study|Other - Unclassified|1|||
25160855|NCT01855945|50281121|FG002|Overall Study|Other - Unclassified|1|||
25160856|NCT01855945|50281122|FG003|Overall Study|Other - Unclassified|0|||
25160857|NCT01855945|50281123|FG004|Overall Study|Other - Unclassified|0|||
25160858|NCT01855945|50281124|FG005|Overall Study|Other - Unclassified|0|||
25160859|NCT01855945|50281125|FG006|Overall Study|Other - Unclassified|2|||
25160860|NCT01855945|50281126|FG007|Overall Study|Other - Unclassified|1|||
25160861|NCT01855945|50281127|FG008|Overall Study|Other - Unclassified|0|||
25160862|NCT01855945|50281128|FG009|Overall Study|Other - Unclassified|0|||
25160863|NCT01855945|50281129|FG010|Overall Study|Other - Unclassified|1|||
24956736|NCT00226941|50047613|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
24956737|NCT00226941|50047610|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
24956738|NCT00226941|50047611|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
24956739|NCT00226941|50047612|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
25160864|NCT01855945|50281130|FG011|Overall Study|Other - Unclassified|0|||
25160865|NCT01855945|50281119|FG000|Overall Study|Withdrawal by Subject|4|||
25160866|NCT01855945|50281120|FG001|Overall Study|Withdrawal by Subject|0|||
25160867|NCT01855945|50281121|FG002|Overall Study|Withdrawal by Subject|4|||
25160868|NCT01855945|50281122|FG003|Overall Study|Withdrawal by Subject|1|||
25160869|NCT01855945|50281123|FG004|Overall Study|Withdrawal by Subject|1|||
25160870|NCT01855945|50281124|FG005|Overall Study|Withdrawal by Subject|0|||
25160871|NCT01855945|50281125|FG006|Overall Study|Withdrawal by Subject|1|||
25160872|NCT01855945|50281126|FG007|Overall Study|Withdrawal by Subject|0|||
25160873|NCT01855945|50281127|FG008|Overall Study|Withdrawal by Subject|0|||
25160874|NCT01855945|50281128|FG009|Overall Study|Withdrawal by Subject|2|||
25160875|NCT01855945|50281129|FG010|Overall Study|Withdrawal by Subject|4|||
25160876|NCT01855945|50281130|FG011|Overall Study|Withdrawal by Subject|1|||
25160877|NCT01855789|50281193|FG000|1) Baseline up to Week 24|Adverse Event|37|||
25160878|NCT01855789|50281194|FG001|1) Baseline up to Week 24|Adverse Event|0|||
25160879|NCT01855789|50281195|FG002|1) Baseline up to Week 24|Adverse Event|0|||
25160880|NCT01855789|50281196|FG003|1) Baseline up to Week 24|Adverse Event|0|||
25160881|NCT01855789|50281193|FG000|1) Baseline up to Week 24|Death|2|||
25160882|NCT01855789|50281194|FG001|1) Baseline up to Week 24|Death|0|||
25160883|NCT01855789|50281195|FG002|1) Baseline up to Week 24|Death|0|||
25160884|NCT01855789|50281196|FG003|1) Baseline up to Week 24|Death|0|||
25160885|NCT01855789|50281193|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
25160886|NCT01855789|50281194|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
25160887|NCT01855789|50281195|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
25160888|NCT01855789|50281196|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
25160889|NCT01855789|50281193|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
25160890|NCT01855789|50281194|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
24956740|NCT00226941|50047613|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
25160891|NCT01855789|50281195|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
25276287|NCT00958828|50590258|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
25160892|NCT01855789|50281196|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
25160893|NCT01855789|50281193|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
25160894|NCT01855789|50281194|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
25160895|NCT01855789|50281195|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
25160896|NCT01855789|50281196|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
25160897|NCT01855789|50281193|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
25160898|NCT01855789|50281194|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
25160899|NCT01855789|50281195|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
25160900|NCT01855789|50281196|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
25160901|NCT01855789|50281193|FG000|1) Baseline up to Week 24|Physician Decision|4|||
25160902|NCT01855789|50281194|FG001|1) Baseline up to Week 24|Physician Decision|0|||
25160903|NCT01855789|50281195|FG002|1) Baseline up to Week 24|Physician Decision|0|||
25160904|NCT01855789|50281196|FG003|1) Baseline up to Week 24|Physician Decision|0|||
25160905|NCT01855789|50281193|FG000|1) Baseline up to Week 24|Pregnancy|1|||
25160906|NCT01855789|50281194|FG001|1) Baseline up to Week 24|Pregnancy|0|||
25160907|NCT01855789|50281195|FG002|1) Baseline up to Week 24|Pregnancy|0|||
25160908|NCT01855789|50281196|FG003|1) Baseline up to Week 24|Pregnancy|0|||
25160909|NCT01855789|50281193|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
25160910|NCT01855789|50281194|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
25160911|NCT01855789|50281195|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
25160912|NCT01855789|50281196|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
25160913|NCT01855789|50281193|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
25160914|NCT01855789|50281194|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
25160915|NCT01855789|50281195|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
24956741|NCT00356408|50047633|FG000|Overall Study|Adverse Event|9|||
25160916|NCT01855789|50281196|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
25160917|NCT01855789|50281193|FG000|1) Baseline up to Week 24|Other|4|||
25160918|NCT01855789|50281194|FG001|1) Baseline up to Week 24|Other|0|||
25160919|NCT01855789|50281195|FG002|1) Baseline up to Week 24|Other|0|||
25160920|NCT01855789|50281196|FG003|1) Baseline up to Week 24|Other|0|||
25160921|NCT01855789|50281193|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
25160922|NCT01855789|50281194|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
25160923|NCT01855789|50281195|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
25160924|NCT01855789|50281196|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
25160925|NCT01855789|50281193|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
24956742|NCT00356408|50047633|FG000|Overall Study|Lack of Efficacy|36|||
24956743|NCT00356408|50047633|FG000|Overall Study|Lost to Follow-up|2|||
24956744|NCT00356408|50047633|FG000|Overall Study|Withdrawal by Subject|6|||
25042823|NCT02591953|50144184|FG000|Overall Study|Lost to Follow-up|6|||
25042824|NCT02591953|50144185|FG001|Overall Study|Lost to Follow-up|6|||
25042825|NCT03073213|50144193|FG000|Multiple Dose Period|Protocol Violation|0|||
25042826|NCT03073213|50144194|FG001|Multiple Dose Period|Protocol Violation|0|||
25042827|NCT03073213|50144195|FG002|Multiple Dose Period|Protocol Violation|1|||
25042828|NCT03070483|50144204|FG000|Overall Study|Lost to Follow-up|2|||
25042829|NCT02231762|50144209|FG000|Combination Phase|Adverse Event|10|||
25160926|NCT01855789|50281194|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
25160927|NCT01855789|50281195|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
25276288|NCT00958828|50590259|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
25042830|NCT02231762|50144210|FG001|Combination Phase|Adverse Event|0|||
25042831|NCT02231762|50144211|FG002|Combination Phase|Adverse Event|0|||
25042832|NCT02231762|50144212|FG003|Combination Phase|Adverse Event|0|||
25042833|NCT02231762|50144209|FG000|Combination Phase|Withdrawal by Subject|2|||
25042834|NCT02231762|50144210|FG001|Combination Phase|Withdrawal by Subject|0|||
25042835|NCT02231762|50144211|FG002|Combination Phase|Withdrawal by Subject|0|||
25042836|NCT02231762|50144212|FG003|Combination Phase|Withdrawal by Subject|0|||
25042837|NCT02231762|50144209|FG000|Combination Phase|Disease Progression|6|||
25042838|NCT02231762|50144210|FG001|Combination Phase|Disease Progression|0|||
25042839|NCT02231762|50144211|FG002|Combination Phase|Disease Progression|0|||
25042840|NCT02231762|50144212|FG003|Combination Phase|Disease Progression|0|||
25042841|NCT02231762|50144209|FG000|Combination Phase|Did not meet inclusion criteria|1|||
25042842|NCT02231762|50144210|FG001|Combination Phase|Did not meet inclusion criteria|0|||
25042843|NCT02231762|50144211|FG002|Combination Phase|Did not meet inclusion criteria|0|||
25042844|NCT02231762|50144212|FG003|Combination Phase|Did not meet inclusion criteria|0|||
25160928|NCT01855789|50281196|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
25276289|NCT00960934|50590271|FG000|Overall Study|Adverse Event|2|||
25160929|NCT01855789|50281193|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
25160930|NCT01855789|50281194|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
25160931|NCT01855789|50281195|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
25160932|NCT01855789|50281196|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
25160933|NCT01855789|50281193|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
25160934|NCT01855789|50281194|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
25160935|NCT01855789|50281195|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
25160936|NCT01855789|50281196|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
25160937|NCT01855789|50281193|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
25160938|NCT01855789|50281194|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
25160939|NCT01855789|50281195|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
25160940|NCT01855789|50281196|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
25160941|NCT01855789|50281193|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
25160942|NCT01855789|50281194|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
25160943|NCT01855789|50281195|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
25160944|NCT01855789|50281196|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
25160945|NCT01855789|50281193|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
25160946|NCT01855789|50281194|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
25160947|NCT01855789|50281195|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
25160948|NCT01855789|50281196|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
25160949|NCT01855789|50281193|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
25160950|NCT01855789|50281194|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
25160951|NCT01855789|50281195|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
25160952|NCT01855789|50281196|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
25160953|NCT01855789|50281193|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
25160954|NCT01855789|50281194|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
25160955|NCT01855789|50281195|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
25160956|NCT01855789|50281196|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
25160957|NCT01855789|50281193|FG000|2) Week 24 up to End of Study|Other|0|||
25160958|NCT01855789|50281194|FG001|2) Week 24 up to End of Study|Other|0|||
25160959|NCT01855789|50281195|FG002|2) Week 24 up to End of Study|Other|0|||
25160960|NCT01855789|50281196|FG003|2) Week 24 up to End of Study|Other|1|||
25160961|NCT01610791|50281202|FG000|Overall Study|Lost to Follow-up|7|||
25160962|NCT01610791|50281202|FG000|Overall Study|Adverse Event|6|||
25160963|NCT01610791|50281202|FG000|Overall Study|Physician Decision|1|||
24956745|NCT00356408|50047633|FG000|Overall Study|Other: Principal investigator discretion|3|||
24956746|NCT00356408|50047633|FG000|Overall Study|Other: Sponsor request|1|||
24956747|NCT00356408|50047633|FG000|Overall Study|Other: Azathioprine stopped|1|||
24956748|NCT00356408|50047633|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
24956749|NCT00356408|50047633|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
24956750|NCT00509795|50047648|FG000|Overall Study|Adverse Event|4|||
24956751|NCT00509795|50047649|FG001|Overall Study|Adverse Event|3|||
24956752|NCT00509795|50047650|FG002|Overall Study|Adverse Event|5|||
24956753|NCT00509795|50047651|FG003|Overall Study|Adverse Event|4|||
24956754|NCT00509795|50047648|FG000|Overall Study|Death|3|||
24956755|NCT00509795|50047649|FG001|Overall Study|Death|1|||
25042845|NCT02231762|50144209|FG000|Combination Phase|Protocol Violation|1|||
25042846|NCT02231762|50144210|FG001|Combination Phase|Protocol Violation|0|||
25042847|NCT02231762|50144211|FG002|Combination Phase|Protocol Violation|0|||
25042848|NCT02231762|50144212|FG003|Combination Phase|Protocol Violation|0|||
25042849|NCT02231762|50144209|FG000|Maintenance Phase|Disease progression|0|||
25042850|NCT02231762|50144210|FG001|Maintenance Phase|Disease progression|3|||
25042851|NCT02231762|50144211|FG002|Maintenance Phase|Disease progression|4|||
25160964|NCT01610791|50281202|FG000|Overall Study|Adverse event and Investigator decision|1|||
25160965|NCT01610791|50281202|FG000|Overall Study|Death|1|||
25160966|NCT01610791|50281202|FG000|Overall Study|Not determined|5|||
25042852|NCT02231762|50144212|FG003|Maintenance Phase|Disease progression|3|||
25042853|NCT02231762|50144209|FG000|Maintenance Phase|Adverse Event|0|||
25160967|NCT01876381|50281206|FG000|Overall Study|Lack of Efficacy|5|||
25160968|NCT01876381|50281206|FG000|Overall Study|Physician Decision|1|||
25160969|NCT01876381|50281206|FG000|Overall Study|Withdrawal by Subject|1|||
25160970|NCT01855399|50281221|FG000|6 Month|Lost to Follow-up|12|||
25160971|NCT01855399|50281222|FG001|6 Month|Lost to Follow-up|9|||
25160972|NCT01855399|50281221|FG000|6 Month|Withdrawal by Subject|8|||
25042854|NCT02231762|50144210|FG001|Maintenance Phase|Adverse Event|0|||
25042855|NCT02231762|50144211|FG002|Maintenance Phase|Adverse Event|1|||
25042856|NCT02231762|50144212|FG003|Maintenance Phase|Adverse Event|2|||
25042857|NCT03023397|50144229|FG000|Run-In|Failed screening allergen challenge|1|||
25042858|NCT03023397|50144230|FG001|Run-In|Failed screening allergen challenge|0|||
25042859|NCT03023397|50144231|FG002|Run-In|Failed screening allergen challenge|0|||
25042860|NCT03023397|50144229|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
25042861|NCT03023397|50144230|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
25042862|NCT03023397|50144231|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
25042863|NCT04325906|50144242|FG000|Overall Study|Withdrawal by Subject|2|||
25042864|NCT04325906|50144243|FG001|Overall Study|Withdrawal by Subject|0|||
25042865|NCT03068455|50144251|FG000|Pre-treatment Period|Disease progression|0|||
25042866|NCT03068455|50144252|FG001|Pre-treatment Period|Disease progression|1|||
25042867|NCT03068455|50144251|FG000|Pre-treatment Period|Participant withdrew consent|1|||
25042868|NCT03068455|50144252|FG001|Pre-treatment Period|Participant withdrew consent|1|||
25042869|NCT03068455|50144251|FG000|Pre-treatment Period|Poor/non-compliance|0|||
25042870|NCT03068455|50144252|FG001|Pre-treatment Period|Poor/non-compliance|1|||
25042871|NCT03068455|50144251|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
25042872|NCT03068455|50144252|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
25042873|NCT03068455|50144251|FG000|Pre-treatment Period|Not reported|2|||
25042874|NCT03068455|50144252|FG001|Pre-treatment Period|Not reported|1|||
25042875|NCT03068455|50144251|FG000|Treatment Period|Disease progression|166|||
25042876|NCT03068455|50144252|FG001|Treatment Period|Disease progression|208|||
25042877|NCT03068455|50144251|FG000|Treatment Period|Study drug toxicity|317|||
25042878|NCT03068455|50144252|FG001|Treatment Period|Study drug toxicity|104|||
25042879|NCT03068455|50144251|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
25042880|NCT03068455|50144252|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
25042881|NCT03068455|50144251|FG000|Treatment Period|Participant request to stop therapy|33|||
25042882|NCT03068455|50144252|FG001|Treatment Period|Participant request to stop therapy|20|||
25042883|NCT03068455|50144251|FG000|Treatment Period|Participant withdrew consent|5|||
25042884|NCT03068455|50144252|FG001|Treatment Period|Participant withdrew consent|10|||
25042885|NCT03068455|50144251|FG000|Treatment Period|Poor/non-compliance|3|||
25042886|NCT03068455|50144252|FG001|Treatment Period|Poor/non-compliance|0|||
25042887|NCT03068455|50144251|FG000|Treatment Period|Participant no longer meets study criteria|1|||
25042888|NCT03068455|50144252|FG001|Treatment Period|Participant no longer meets study criteria|3|||
25042889|NCT03068455|50144251|FG000|Treatment Period|Other reasons|12|||
25042890|NCT03068455|50144252|FG001|Treatment Period|Other reasons|4|||
25042891|NCT03067987|50144260|FG000|Overall Study|Lost to Follow-up|7|||
25042892|NCT03067987|50144261|FG001|Overall Study|Lost to Follow-up|10|||
25042893|NCT03067987|50144260|FG000|Overall Study|Protocol Violation|1|||
25042894|NCT03067987|50144261|FG001|Overall Study|Protocol Violation|2|||
25042895|NCT03067987|50144260|FG000|Overall Study|Withdrawal by Subject|2|||
25042896|NCT03067987|50144261|FG001|Overall Study|Withdrawal by Subject|1|||
25160973|NCT01855399|50281222|FG001|6 Month|Withdrawal by Subject|6|||
25160974|NCT01855399|50281221|FG000|12 Month|Lost to Follow-up|7|||
25042897|NCT03197870|50144270|FG000|Overall Study|Adverse Event|9|||
25042898|NCT03197870|50144271|FG001|Overall Study|Adverse Event|4|||
25042899|NCT03197870|50144272|FG002|Overall Study|Adverse Event|6|||
25042900|NCT03197870|50144270|FG000|Overall Study|Withdrawal by Subject|2|||
25042901|NCT03197870|50144271|FG001|Overall Study|Withdrawal by Subject|3|||
25042902|NCT03197870|50144272|FG002|Overall Study|Withdrawal by Subject|0|||
25042903|NCT03197870|50144270|FG000|Overall Study|Lost to Follow-up|2|||
25042904|NCT03197870|50144271|FG001|Overall Study|Lost to Follow-up|2|||
25042905|NCT03197870|50144272|FG002|Overall Study|Lost to Follow-up|0|||
25042906|NCT03197870|50144270|FG000|Overall Study|data not available|1|||
25042907|NCT03197870|50144271|FG001|Overall Study|data not available|1|||
25042908|NCT03197870|50144272|FG002|Overall Study|data not available|0|||
25042909|NCT04889222|50144283|FG000|Overall Study|Did not meet eligibility criteria|8|||
25042910|NCT04889222|50144283|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
25160975|NCT01855399|50281222|FG001|12 Month|Lost to Follow-up|11|||
25160976|NCT01875991|50281230|FG000|Overall Study|Withdrawal by Subject|6|||
25160977|NCT01875991|50281231|FG001|Overall Study|Withdrawal by Subject|6|||
25042911|NCT04889222|50144283|FG000|Overall Study|Did not proceed due to time constraints|5|||
25042912|NCT03067441|50144306|FG000|Overall Study|Withdrawal by Subject|16|||
25042913|NCT03067441|50144307|FG001|Overall Study|Withdrawal by Subject|34|||
25042914|NCT03067441|50144306|FG000|Overall Study|Lost to Follow-up|7|||
25042915|NCT03067441|50144307|FG001|Overall Study|Lost to Follow-up|5|||
25042916|NCT03067441|50144306|FG000|Overall Study|Adverse Event|7|||
25160978|NCT01875991|50281230|FG000|Overall Study|Sponsor Decision|1|||
25160979|NCT01875991|50281231|FG001|Overall Study|Sponsor Decision|0|||
25042917|NCT03067441|50144307|FG001|Overall Study|Adverse Event|14|||
25042918|NCT03067441|50144306|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
25042919|NCT03067441|50144307|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
25042920|NCT03067441|50144306|FG000|Overall Study|Physician Decision|1|||
25042921|NCT03067441|50144307|FG001|Overall Study|Physician Decision|3|||
25042922|NCT03067441|50144306|FG000|Overall Study|Other|1|||
25042923|NCT03067441|50144307|FG001|Overall Study|Other|1|||
25042924|NCT02600923|50144316|FG000|Overall Study|Death|10|||
24956756|NCT00509795|50047650|FG002|Overall Study|Death|2|||
24956757|NCT00509795|50047651|FG003|Overall Study|Death|7|||
24956758|NCT00509795|50047648|FG000|Overall Study|Lack of Efficacy|0|||
24956759|NCT00509795|50047649|FG001|Overall Study|Lack of Efficacy|0|||
24956760|NCT00509795|50047650|FG002|Overall Study|Lack of Efficacy|2|||
24956761|NCT00509795|50047651|FG003|Overall Study|Lack of Efficacy|2|||
25042925|NCT02600923|50144316|FG000|Overall Study|Adverse Event|3|||
25042926|NCT02600923|50144316|FG000|Overall Study|Global deterioration of health status|2|||
25042927|NCT02600923|50144316|FG000|Overall Study|Insufficient clinical response|6|||
25042928|NCT02600923|50144316|FG000|Overall Study|Lost to Follow-up|1|||
25042929|NCT02600923|50144316|FG000|Overall Study|Withdrawal by Subject|5|||
25042930|NCT02600923|50144316|FG000|Overall Study|Objective progression or relapse|50|||
25042931|NCT02600923|50144316|FG000|Overall Study|Study terminated by Sponsor|53|||
25042932|NCT02600923|50144316|FG000|Overall Study|Not treated|1|||
25042933|NCT03070171|50144322|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
25042934|NCT03070171|50144323|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
25042935|NCT03070171|50144322|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
25042936|NCT03070171|50144323|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
25042937|NCT01084252|50144343|FG000|Phase 1 (120 Weeks)|Adverse Event|0|||
24956762|NCT00509795|50047648|FG000|Overall Study|Lost to Follow-up|1|||
24956763|NCT00509795|50047649|FG001|Overall Study|Lost to Follow-up|2|||
25042938|NCT01084252|50144344|FG001|Phase 1 (120 Weeks)|Adverse Event|0|||
25160980|NCT01855243|50281243|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
25160981|NCT01855243|50281244|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
25160982|NCT01855243|50281245|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
25160983|NCT01825837|50281257|FG000|PART I|Withdrawal by Subject|0|||
25160984|NCT01825837|50281258|FG001|PART I|Withdrawal by Subject|0|||
25160985|NCT01825837|50281259|FG002|PART I|Withdrawal by Subject|0|||
25160986|NCT01825837|50281260|FG003|PART I|Withdrawal by Subject|6|||
25160987|NCT01825837|50281257|FG000|PART I|Patient non-compliance|0|||
25160988|NCT01825837|50281258|FG001|PART I|Patient non-compliance|0|||
25160989|NCT01825837|50281259|FG002|PART I|Patient non-compliance|0|||
25160990|NCT01825837|50281260|FG003|PART I|Patient non-compliance|1|||
25160991|NCT01825837|50281257|FG000|PART I|Treatment failure|0|||
25160992|NCT01825837|50281258|FG001|PART I|Treatment failure|0|||
25042939|NCT01084252|50144345|FG002|Phase 1 (120 Weeks)|Adverse Event|1|||
25042940|NCT01084252|50144346|FG003|Phase 1 (120 Weeks)|Adverse Event|1|||
25042941|NCT01084252|50144347|FG004|Phase 1 (120 Weeks)|Adverse Event|1|||
25042942|NCT01084252|50144348|FG005|Phase 1 (120 Weeks)|Adverse Event|0|||
25042943|NCT01084252|50144349|FG006|Phase 1 (120 Weeks)|Adverse Event|1|||
25042944|NCT01084252|50144350|FG007|Phase 1 (120 Weeks)|Adverse Event|0|||
25042945|NCT01084252|50144351|FG008|Phase 1 (120 Weeks)|Adverse Event|0|||
24956764|NCT00509795|50047650|FG002|Overall Study|Lost to Follow-up|4|||
24956765|NCT00509795|50047651|FG003|Overall Study|Lost to Follow-up|4|||
24956766|NCT00509795|50047648|FG000|Overall Study|OTHER|1|||
24956767|NCT00509795|50047649|FG001|Overall Study|OTHER|0|||
24956768|NCT00509795|50047650|FG002|Overall Study|OTHER|4|||
24956769|NCT00509795|50047651|FG003|Overall Study|OTHER|1|||
24956770|NCT00509795|50047648|FG000|Overall Study|Protocol Violation|3|||
24956771|NCT00509795|50047649|FG001|Overall Study|Protocol Violation|0|||
24956772|NCT00509795|50047650|FG002|Overall Study|Protocol Violation|3|||
24956773|NCT00509795|50047651|FG003|Overall Study|Protocol Violation|1|||
25042946|NCT01084252|50144352|FG009|Phase 1 (120 Weeks)|Adverse Event|0|||
25042947|NCT01084252|50144353|FG010|Phase 1 (120 Weeks)|Adverse Event|0|||
25042948|NCT01084252|50144354|FG011|Phase 1 (120 Weeks)|Adverse Event|0|||
25042949|NCT01084252|50144355|FG012|Phase 1 (120 Weeks)|Adverse Event|0|||
25042950|NCT01084252|50144356|FG013|Phase 1 (120 Weeks)|Adverse Event|0|||
25042951|NCT01084252|50144343|FG000|Phase 1 (120 Weeks)|Progressive disease|15|||
25042952|NCT01084252|50144344|FG001|Phase 1 (120 Weeks)|Progressive disease|5|||
25042953|NCT01084252|50144345|FG002|Phase 1 (120 Weeks)|Progressive disease|2|||
25042954|NCT01084252|50144346|FG003|Phase 1 (120 Weeks)|Progressive disease|22|||
25160993|NCT01825837|50281259|FG002|PART I|Treatment failure|0|||
25160994|NCT01825837|50281260|FG003|PART I|Treatment failure|7|||
24956774|NCT00509795|50047648|FG000|Overall Study|Withdrawal by Subject|10|||
24956775|NCT00509795|50047649|FG001|Overall Study|Withdrawal by Subject|5|||
24956776|NCT00509795|50047650|FG002|Overall Study|Withdrawal by Subject|7|||
24956777|NCT00509795|50047651|FG003|Overall Study|Withdrawal by Subject|8|||
25042955|NCT01084252|50144347|FG004|Phase 1 (120 Weeks)|Progressive disease|16|||
25160995|NCT01825837|50281257|FG000|PART I|reason unspecified|0|||
25160996|NCT01825837|50281258|FG001|PART I|reason unspecified|0|||
24956778|NCT00165789|50047666|FG000|Overall Study|Adverse Event|0|||
25042956|NCT01084252|50144348|FG005|Phase 1 (120 Weeks)|Progressive disease|6|||
25042957|NCT01084252|50144349|FG006|Phase 1 (120 Weeks)|Progressive disease|5|||
25042958|NCT01084252|50144350|FG007|Phase 1 (120 Weeks)|Progressive disease|6|||
25042959|NCT01084252|50144351|FG008|Phase 1 (120 Weeks)|Progressive disease|0|||
25042960|NCT01084252|50144352|FG009|Phase 1 (120 Weeks)|Progressive disease|0|||
25042961|NCT01084252|50144353|FG010|Phase 1 (120 Weeks)|Progressive disease|0|||
25042962|NCT01084252|50144354|FG011|Phase 1 (120 Weeks)|Progressive disease|0|||
25042963|NCT01084252|50144355|FG012|Phase 1 (120 Weeks)|Progressive disease|0|||
25042964|NCT01084252|50144356|FG013|Phase 1 (120 Weeks)|Progressive disease|0|||
25042965|NCT01084252|50144343|FG000|Phase 1 (120 Weeks)|Other than specified above|1|||
25042966|NCT01084252|50144344|FG001|Phase 1 (120 Weeks)|Other than specified above|1|||
25042967|NCT01084252|50144345|FG002|Phase 1 (120 Weeks)|Other than specified above|0|||
25042968|NCT01084252|50144346|FG003|Phase 1 (120 Weeks)|Other than specified above|3|||
25042969|NCT01084252|50144347|FG004|Phase 1 (120 Weeks)|Other than specified above|1|||
25042970|NCT01084252|50144348|FG005|Phase 1 (120 Weeks)|Other than specified above|0|||
25042971|NCT01084252|50144349|FG006|Phase 1 (120 Weeks)|Other than specified above|1|||
25042972|NCT01084252|50144350|FG007|Phase 1 (120 Weeks)|Other than specified above|1|||
25042973|NCT01084252|50144351|FG008|Phase 1 (120 Weeks)|Other than specified above|0|||
25042974|NCT01084252|50144352|FG009|Phase 1 (120 Weeks)|Other than specified above|0|||
25042975|NCT01084252|50144353|FG010|Phase 1 (120 Weeks)|Other than specified above|0|||
25042976|NCT01084252|50144354|FG011|Phase 1 (120 Weeks)|Other than specified above|0|||
25042977|NCT01084252|50144355|FG012|Phase 1 (120 Weeks)|Other than specified above|0|||
25042978|NCT01084252|50144356|FG013|Phase 1 (120 Weeks)|Other than specified above|0|||
25042979|NCT01084252|50144343|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
25042980|NCT01084252|50144344|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
25042981|NCT01084252|50144345|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
25042982|NCT01084252|50144346|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
25042983|NCT01084252|50144347|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
25042984|NCT01084252|50144348|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
25042985|NCT01084252|50144349|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
25042986|NCT01084252|50144350|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
25042987|NCT01084252|50144351|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
25042988|NCT01084252|50144352|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
25042989|NCT01084252|50144353|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
25042990|NCT01084252|50144354|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1|||
25042991|NCT01084252|50144355|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
25042992|NCT01084252|50144356|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
25042993|NCT01084252|50144343|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
25042994|NCT01084252|50144344|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
25042995|NCT01084252|50144345|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
25042996|NCT01084252|50144346|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
25042997|NCT01084252|50144347|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
25042998|NCT01084252|50144348|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
25042999|NCT01084252|50144349|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
25043000|NCT01084252|50144350|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
25043001|NCT01084252|50144351|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20|||
25043002|NCT01084252|50144352|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18|||
25043003|NCT01084252|50144353|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17|||
25043004|NCT01084252|50144354|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19|||
25043005|NCT01084252|50144355|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
25043006|NCT01084252|50144356|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
25043007|NCT01084252|50144343|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
25043008|NCT01084252|50144344|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
25043009|NCT01084252|50144345|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
25043010|NCT01084252|50144346|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
25043011|NCT01084252|50144347|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
25043012|NCT01084252|50144348|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
25043013|NCT01084252|50144349|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
25043014|NCT01084252|50144350|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
25043015|NCT01084252|50144351|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2|||
25043016|NCT01084252|50144352|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
25160997|NCT01825837|50281259|FG002|PART I|reason unspecified|0|||
25160998|NCT01825837|50281260|FG003|PART I|reason unspecified|3|||
25043017|NCT01084252|50144353|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4|||
25043018|NCT01084252|50144354|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3|||
25160999|NCT01825837|50281257|FG000|PART II|Withdrawal by Subject|3|||
25043019|NCT01084252|50144355|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
25043020|NCT01084252|50144356|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
25043021|NCT01084252|50144343|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
25043022|NCT01084252|50144344|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
25043023|NCT01084252|50144345|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
25043024|NCT01084252|50144346|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
25043025|NCT01084252|50144347|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
25043026|NCT01084252|50144348|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
24956779|NCT00165789|50047667|FG001|Overall Study|Adverse Event|3|||
24956780|NCT00165789|50047668|FG002|Overall Study|Adverse Event|0|||
24956781|NCT00165789|50047669|FG003|Overall Study|Adverse Event|12|||
24956782|NCT00165789|50047666|FG000|Overall Study|Withdrawal by Subject|0|||
25043027|NCT01084252|50144349|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
25043028|NCT01084252|50144350|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
25043029|NCT01084252|50144351|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1|||
25043030|NCT01084252|50144352|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4|||
25043031|NCT01084252|50144353|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
25043032|NCT01084252|50144354|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
24956783|NCT00165789|50047667|FG001|Overall Study|Withdrawal by Subject|1|||
24956784|NCT00165789|50047668|FG002|Overall Study|Withdrawal by Subject|1|||
24956785|NCT00165789|50047669|FG003|Overall Study|Withdrawal by Subject|2|||
24956786|NCT00504257|50047679|FG000|Overall Study|Withdrawal by Subject|2|||
24956787|NCT00504257|50047679|FG000|Overall Study|ineligible histology|2|||
24956788|NCT00509093|50047683|FG000|Overall Study|Adverse Event|10|||
24956789|NCT00509093|50047683|FG000|Overall Study|Disease Progression|9|||
24956790|NCT00509093|50047683|FG000|Overall Study|Transformed into MDS|1|||
24956791|NCT00509093|50047683|FG000|Overall Study|Withdrawal by Subject|3|||
24956792|NCT00509093|50047683|FG000|Overall Study|Physician Decision|1|||
24956793|NCT00160641|50047687|FG000|Overall Study|Adverse Event|102|||
24956794|NCT00160641|50047687|FG000|Overall Study|Withdrawal by Subject|87|||
24956795|NCT00160641|50047687|FG000|Overall Study|Lost to Follow-up|8|||
24956796|NCT00160641|50047687|FG000|Overall Study|Lack of Efficacy|12|||
24956797|NCT00160641|50047687|FG000|Overall Study|Protocol Violation|3|||
24956798|NCT00160641|50047687|FG000|Overall Study|Other|9|||
24956799|NCT00493025|50047691|FG000|Overall Study|Physician Decision|19|||
25043033|NCT01084252|50144355|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
25043034|NCT01084252|50144356|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
25043035|NCT01084252|50144343|FG000|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
25161000|NCT01825837|50281258|FG001|PART II|Withdrawal by Subject|3|||
25161001|NCT01825837|50281259|FG002|PART II|Withdrawal by Subject|7|||
24956800|NCT00160563|50047699|FG000|Overall Study|Adverse Event|1|||
25043036|NCT01084252|50144344|FG001|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
25043037|NCT01084252|50144345|FG002|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
25043038|NCT01084252|50144346|FG003|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
25043039|NCT01084252|50144347|FG004|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
25043040|NCT01084252|50144348|FG005|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
25043041|NCT01084252|50144349|FG006|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
25043042|NCT01084252|50144350|FG007|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
25043043|NCT01084252|50144351|FG008|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
25043044|NCT01084252|50144352|FG009|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
25043045|NCT01084252|50144353|FG010|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
25043046|NCT01084252|50144354|FG011|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
25043047|NCT01084252|50144355|FG012|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13|||
25043048|NCT01084252|50144356|FG013|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5|||
25043049|NCT01084252|50144343|FG000|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
25043050|NCT01084252|50144344|FG001|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
25043051|NCT01084252|50144345|FG002|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
25043052|NCT01084252|50144346|FG003|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
25043053|NCT01084252|50144347|FG004|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
25043054|NCT01084252|50144348|FG005|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
25043055|NCT01084252|50144349|FG006|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
25043056|NCT01084252|50144350|FG007|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
25043057|NCT01084252|50144351|FG008|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
25043058|NCT01084252|50144352|FG009|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
25161002|NCT01825837|50281260|FG003|PART II|Withdrawal by Subject|0|||
24956801|NCT00160563|50047700|FG001|Overall Study|Adverse Event|1|||
24956802|NCT00160563|50047701|FG002|Overall Study|Adverse Event|1|||
24956803|NCT00160563|50047699|FG000|Overall Study|Lost to Follow-up|1|||
25043059|NCT01084252|50144353|FG010|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
25043060|NCT01084252|50144354|FG011|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
25043061|NCT01084252|50144355|FG012|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70|||
24956804|NCT00160563|50047700|FG001|Overall Study|Lost to Follow-up|1|||
25043062|NCT01084252|50144356|FG013|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33|||
25043063|NCT01084252|50144343|FG000|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
25043064|NCT01084252|50144344|FG001|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
25043065|NCT01084252|50144345|FG002|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
25043066|NCT01084252|50144346|FG003|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
25043067|NCT01084252|50144347|FG004|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
25043068|NCT01084252|50144348|FG005|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
25043069|NCT01084252|50144349|FG006|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
25043070|NCT01084252|50144350|FG007|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
25043071|NCT01084252|50144351|FG008|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
25043072|NCT01084252|50144352|FG009|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
25043073|NCT01084252|50144353|FG010|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
25043074|NCT01084252|50144354|FG011|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
25043075|NCT01084252|50144355|FG012|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1|||
25043076|NCT01084252|50144356|FG013|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
25043077|NCT01084252|50144343|FG000|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
25043078|NCT01084252|50144344|FG001|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
25043079|NCT01084252|50144345|FG002|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
25043080|NCT01084252|50144346|FG003|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
25043081|NCT01084252|50144347|FG004|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
25043082|NCT01084252|50144348|FG005|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
25043083|NCT01084252|50144349|FG006|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
25043084|NCT01084252|50144350|FG007|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
25043085|NCT01084252|50144351|FG008|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
25043086|NCT01084252|50144352|FG009|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
25043087|NCT01084252|50144353|FG010|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
25043088|NCT01084252|50144354|FG011|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
25043089|NCT01084252|50144355|FG012|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12|||
25043090|NCT01084252|50144356|FG013|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2|||
25043091|NCT01084252|50144343|FG000|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
25043092|NCT01084252|50144344|FG001|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
25043093|NCT01084252|50144345|FG002|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
25043094|NCT01084252|50144346|FG003|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
25161003|NCT01825837|50281257|FG000|PART II|Patient non-compliance|5|||
25161004|NCT01825837|50281258|FG001|PART II|Patient non-compliance|2|||
25161005|NCT01825837|50281259|FG002|PART II|Patient non-compliance|4|||
24956805|NCT00160563|50047701|FG002|Overall Study|Lost to Follow-up|2|||
24956806|NCT00160563|50047699|FG000|Overall Study|Protocol Violation|0|||
24956807|NCT00160563|50047700|FG001|Overall Study|Protocol Violation|0|||
24956808|NCT00160563|50047701|FG002|Overall Study|Protocol Violation|3|||
24956809|NCT00160563|50047699|FG000|Overall Study|Withdrawal by Subject|1|||
24956810|NCT00160563|50047700|FG001|Overall Study|Withdrawal by Subject|2|||
24956811|NCT00160563|50047701|FG002|Overall Study|Withdrawal by Subject|3|||
24956812|NCT00160563|50047699|FG000|Overall Study|Other (listed in the study report)|48|||
24956813|NCT00160563|50047700|FG001|Overall Study|Other (listed in the study report)|40|||
24956814|NCT00160563|50047701|FG002|Overall Study|Other (listed in the study report)|81|||
24956815|NCT00160563|50047699|FG000|Overall Study|Missing reason|0|||
24956816|NCT00160563|50047700|FG001|Overall Study|Missing reason|1|||
24956817|NCT00160563|50047701|FG002|Overall Study|Missing reason|0|||
24956818|NCT00380744|50047717|FG000|Overall Study|Death|0|||
24956819|NCT00380744|50047718|FG001|Overall Study|Death|0|||
24956820|NCT00380744|50047719|FG002|Overall Study|Death|0|||
24956821|NCT00380744|50047720|FG003|Overall Study|Death|0|||
24956822|NCT00380744|50047721|FG004|Overall Study|Death|0|||
24956823|NCT00380744|50047722|FG005|Overall Study|Death|0|||
24956824|NCT00380744|50047723|FG006|Overall Study|Death|1|||
24956825|NCT00380744|50047717|FG000|Overall Study|Withdrawal by Subject|1|||
24956826|NCT00380744|50047718|FG001|Overall Study|Withdrawal by Subject|0|||
24956827|NCT00380744|50047719|FG002|Overall Study|Withdrawal by Subject|0|||
24956828|NCT00380744|50047720|FG003|Overall Study|Withdrawal by Subject|0|||
24956829|NCT00380744|50047721|FG004|Overall Study|Withdrawal by Subject|0|||
24956830|NCT00380744|50047722|FG005|Overall Study|Withdrawal by Subject|0|||
24956831|NCT00380744|50047723|FG006|Overall Study|Withdrawal by Subject|0|||
24956832|NCT00380588|50047742|FG000|Overall Study|Unequivocal Disease Progression|25|||
24956833|NCT00380588|50047743|FG001|Overall Study|Unequivocal Disease Progression|34|||
24956834|NCT00380588|50047742|FG000|Overall Study|Next Cycle Not Started|4|||
24956835|NCT00380588|50047743|FG001|Overall Study|Next Cycle Not Started|0|||
24956836|NCT00380588|50047742|FG000|Overall Study|Adverse Event|7|||
24956837|NCT00380588|50047743|FG001|Overall Study|Adverse Event|3|||
25043095|NCT01084252|50144347|FG004|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
25043096|NCT01084252|50144348|FG005|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
25043097|NCT01084252|50144349|FG006|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
25161006|NCT01825837|50281260|FG003|PART II|Patient non-compliance|0|||
25161007|NCT01825837|50281257|FG000|PART II|Adverse Event|3|||
25161008|NCT01825837|50281258|FG001|PART II|Adverse Event|3|||
25161009|NCT01825837|50281259|FG002|PART II|Adverse Event|1|||
25161010|NCT01825837|50281260|FG003|PART II|Adverse Event|0|||
25161011|NCT01825837|50281257|FG000|PART II|Treatment failure|6|||
25161012|NCT01825837|50281258|FG001|PART II|Treatment failure|4|||
25161013|NCT01825837|50281259|FG002|PART II|Treatment failure|5|||
25161014|NCT01825837|50281260|FG003|PART II|Treatment failure|0|||
25161015|NCT01825837|50281257|FG000|PART II|reason unspecified|2|||
25161016|NCT01825837|50281258|FG001|PART II|reason unspecified|2|||
25161017|NCT01825837|50281259|FG002|PART II|reason unspecified|2|||
25161018|NCT01825837|50281260|FG003|PART II|reason unspecified|0|||
25161019|NCT01854697|50281273|FG000|Overall Study|Adverse Event|1|||
25161020|NCT01854697|50281274|FG001|Overall Study|Adverse Event|0|||
25161021|NCT01854697|50281275|FG002|Overall Study|Adverse Event|0|||
25161022|NCT01854697|50281276|FG003|Overall Study|Adverse Event|0|||
25161023|NCT01854697|50281277|FG004|Overall Study|Adverse Event|1|||
25161024|NCT01854697|50281273|FG000|Overall Study|Lost to Follow-up|4|||
25161025|NCT01854697|50281274|FG001|Overall Study|Lost to Follow-up|1|||
25161026|NCT01854697|50281275|FG002|Overall Study|Lost to Follow-up|1|||
25161027|NCT01854697|50281276|FG003|Overall Study|Lost to Follow-up|2|||
25161028|NCT01854697|50281277|FG004|Overall Study|Lost to Follow-up|0|||
25161029|NCT01854697|50281273|FG000|Overall Study|To enter another AbbVie study|1|||
25161030|NCT01854697|50281274|FG001|Overall Study|To enter another AbbVie study|0|||
25161031|NCT01854697|50281275|FG002|Overall Study|To enter another AbbVie study|0|||
25161032|NCT01854697|50281276|FG003|Overall Study|To enter another AbbVie study|0|||
25161033|NCT01854697|50281277|FG004|Overall Study|To enter another AbbVie study|1|||
25161034|NCT01854697|50281273|FG000|Overall Study|Withdrew Consent|0|||
25161035|NCT01854697|50281274|FG001|Overall Study|Withdrew Consent|1|||
25161036|NCT01854697|50281275|FG002|Overall Study|Withdrew Consent|0|||
25161037|NCT01854697|50281276|FG003|Overall Study|Withdrew Consent|1|||
25161038|NCT01854697|50281277|FG004|Overall Study|Withdrew Consent|0|||
25161039|NCT01854697|50281273|FG000|Overall Study|Other|0|||
25161040|NCT01854697|50281274|FG001|Overall Study|Other|1|||
25161041|NCT01854697|50281275|FG002|Overall Study|Other|1|||
25161042|NCT01854697|50281276|FG003|Overall Study|Other|0|||
25161043|NCT01854697|50281277|FG004|Overall Study|Other|0|||
25161044|NCT01824979|50281289|FG000|Overall Study|Withdrawal by Subject|5|||
25161045|NCT01824979|50281290|FG001|Overall Study|Withdrawal by Subject|0|||
25161046|NCT01824979|50281289|FG000|Overall Study|Physician Decision|2|||
25161047|NCT01824979|50281290|FG001|Overall Study|Physician Decision|0|||
25161048|NCT01824979|50281289|FG000|Overall Study|Protocol Violation|6|||
25161049|NCT01824979|50281290|FG001|Overall Study|Protocol Violation|13|||
25043098|NCT01084252|50144350|FG007|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
25043099|NCT01084252|50144351|FG008|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
25043100|NCT01084252|50144352|FG009|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
25043101|NCT01084252|50144353|FG010|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
25043102|NCT01084252|50144354|FG011|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
25043103|NCT01084252|50144355|FG012|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13|||
25043104|NCT01084252|50144356|FG013|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15|||
25043105|NCT01084252|50144343|FG000|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
25043106|NCT01084252|50144344|FG001|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
25043107|NCT01084252|50144345|FG002|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
25043108|NCT01084252|50144346|FG003|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
25043109|NCT01084252|50144347|FG004|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
25043110|NCT01084252|50144348|FG005|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
25043111|NCT01084252|50144349|FG006|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
25043112|NCT01084252|50144350|FG007|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
25043113|NCT01084252|50144351|FG008|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
25043114|NCT01084252|50144352|FG009|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
25043115|NCT01084252|50144353|FG010|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
25043116|NCT01084252|50144354|FG011|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
25043117|NCT01084252|50144355|FG012|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1|||
25161050|NCT01824823|50281298|FG000|Overall Study|Lack of Efficacy|1|||
25161051|NCT01824823|50281299|FG001|Overall Study|Lack of Efficacy|1|||
25161052|NCT01824823|50281298|FG000|Overall Study|Off-treatment reason not submitted|1|||
25161053|NCT01824823|50281299|FG001|Overall Study|Off-treatment reason not submitted|0|||
25161054|NCT01875367|50281307|FG000|Overall Study|Not complete at least 2 questionaries|4|||
25161055|NCT01875367|50281308|FG001|Overall Study|Not complete at least 2 questionaries|2|||
25161056|NCT01875367|50281307|FG000|Overall Study|Not receive study treatment|1|||
25161057|NCT01875367|50281308|FG001|Overall Study|Not receive study treatment|0|||
25186509|NCT02647866|50336899|FG004|Overall Study|Physician Decision|2|||
25161058|NCT01853839|50281318|FG000|Overall Study|Violated inclusion criteria|2|||
25161059|NCT01853839|50281318|FG000|Overall Study|Not meet ITT population definition|58|||
25161060|NCT01853839|50281318|FG000|Overall Study|End of treatment visit too early|33|||
25161061|NCT01853839|50281318|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
25161062|NCT01874665|50281328|FG000|Overall Study|Adverse Event|6|||
25161063|NCT01874665|50281329|FG001|Overall Study|Adverse Event|2|||
25161064|NCT01874665|50281328|FG000|Overall Study|Withdrawal by Subject|4|||
25161065|NCT01874665|50281329|FG001|Overall Study|Withdrawal by Subject|1|||
25161066|NCT01874665|50281328|FG000|Overall Study|Physician Decision|3|||
25161067|NCT01874665|50281329|FG001|Overall Study|Physician Decision|0|||
25161068|NCT01874665|50281328|FG000|Overall Study|Clinical Progressive Disease|4|||
25161069|NCT01874665|50281329|FG001|Overall Study|Clinical Progressive Disease|3|||
25161070|NCT01874665|50281328|FG000|Overall Study|Study Terminated by Sponsor|0|||
25161071|NCT01874665|50281329|FG001|Overall Study|Study Terminated by Sponsor|2|||
25161072|NCT01874665|50281328|FG000|Overall Study|Documented Progressive Disease|11|||
25161073|NCT01874665|50281329|FG001|Overall Study|Documented Progressive Disease|7|||
25161074|NCT01874665|50281328|FG000|Overall Study|Other|2|||
25161075|NCT01874665|50281329|FG001|Overall Study|Other|0|||
25161076|NCT01874431|50281344|FG000|Overall Study|Physician Decision|0|||
25161077|NCT01874431|50281345|FG001|Overall Study|Physician Decision|0|||
25161078|NCT01874431|50281346|FG002|Overall Study|Physician Decision|1|||
25161079|NCT01874431|50281347|FG003|Overall Study|Physician Decision|0|||
25161080|NCT01874431|50281348|FG004|Overall Study|Physician Decision|0|||
25161081|NCT01874431|50281349|FG005|Overall Study|Physician Decision|0|||
25161082|NCT01874431|50281350|FG006|Overall Study|Physician Decision|0|||
25161083|NCT01874431|50281351|FG007|Overall Study|Physician Decision|0|||
25161084|NCT01874431|50281344|FG000|Overall Study|Adverse Event|5|||
25161085|NCT01874431|50281345|FG001|Overall Study|Adverse Event|4|||
25161086|NCT01874431|50281346|FG002|Overall Study|Adverse Event|6|||
25161087|NCT01874431|50281347|FG003|Overall Study|Adverse Event|5|||
25161088|NCT01874431|50281348|FG004|Overall Study|Adverse Event|2|||
25043118|NCT01084252|50144356|FG013|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
25043119|NCT03644017|50144420|FG000|Overall Study|Access Abandonment|5|||
25043120|NCT03644017|50144420|FG000|Overall Study|Kidney Transplant|2|||
25043121|NCT00158054|50144426|FG000|Overall Study|Refused to continue|3|||
25043122|NCT00158054|50144427|FG001|Overall Study|Refused to continue|0|||
25043123|NCT00158054|50144426|FG000|Overall Study|Unavailable for follow up|7|||
25043124|NCT00158054|50144427|FG001|Overall Study|Unavailable for follow up|3|||
25043125|NCT01337960|50144436|FG000|Overall Study|Lost to Follow-up|1|||
25043126|NCT01337960|50144437|FG001|Overall Study|Lost to Follow-up|0|||
25043127|NCT01337960|50144438|FG002|Overall Study|Lost to Follow-up|0|||
25043128|NCT01337960|50144436|FG000|Overall Study|Withdrawal by Subject|1|||
25043129|NCT01337960|50144437|FG001|Overall Study|Withdrawal by Subject|0|||
25043130|NCT01337960|50144438|FG002|Overall Study|Withdrawal by Subject|0|||
25043131|NCT02750306|50144457|FG000|Overall Study|Withdrawal by Subject|5|||
25043132|NCT02750306|50144458|FG001|Overall Study|Withdrawal by Subject|2|||
25043133|NCT02750306|50144457|FG000|Overall Study|Protocol Violation|1|||
25043134|NCT02750306|50144458|FG001|Overall Study|Protocol Violation|0|||
25043135|NCT01816165|50144466|FG000|Overall Study|Adverse Event|1|||
25161089|NCT01874431|50281349|FG005|Overall Study|Adverse Event|8|||
25161090|NCT01874431|50281350|FG006|Overall Study|Adverse Event|2|||
25161091|NCT01874431|50281351|FG007|Overall Study|Adverse Event|3|||
25161092|NCT01874431|50281344|FG000|Overall Study|Protocol Violation|1|||
25161093|NCT01874431|50281345|FG001|Overall Study|Protocol Violation|1|||
25161094|NCT01874431|50281346|FG002|Overall Study|Protocol Violation|1|||
25161095|NCT01874431|50281347|FG003|Overall Study|Protocol Violation|0|||
25161096|NCT01874431|50281348|FG004|Overall Study|Protocol Violation|3|||
25161097|NCT01874431|50281349|FG005|Overall Study|Protocol Violation|2|||
25161098|NCT01874431|50281350|FG006|Overall Study|Protocol Violation|1|||
25161099|NCT01874431|50281351|FG007|Overall Study|Protocol Violation|1|||
25161100|NCT01874431|50281344|FG000|Overall Study|Non-compliance|0|||
25161101|NCT01874431|50281345|FG001|Overall Study|Non-compliance|0|||
25161102|NCT01874431|50281346|FG002|Overall Study|Non-compliance|0|||
25161103|NCT01874431|50281347|FG003|Overall Study|Non-compliance|0|||
25161104|NCT01874431|50281348|FG004|Overall Study|Non-compliance|1|||
25161105|NCT01874431|50281349|FG005|Overall Study|Non-compliance|0|||
25161106|NCT01874431|50281350|FG006|Overall Study|Non-compliance|1|||
25043136|NCT01816165|50144467|FG001|Overall Study|Adverse Event|0|||
25161107|NCT01874431|50281351|FG007|Overall Study|Non-compliance|0|||
25161108|NCT01874431|50281344|FG000|Overall Study|Logistical difficulties|0|||
25161109|NCT01874431|50281345|FG001|Overall Study|Logistical difficulties|0|||
25161110|NCT01874431|50281346|FG002|Overall Study|Logistical difficulties|0|||
25043137|NCT01816165|50144468|FG002|Overall Study|Adverse Event|0|||
25043138|NCT01816165|50144469|FG003|Overall Study|Adverse Event|0|||
25043139|NCT01677988|50144498|FG000|Overall Study|Lack of Efficacy|2|||
25043140|NCT02926573|50144505|FG000|Overall Study|Nausea|1|||
25043141|NCT02926573|50144506|FG001|Overall Study|Nausea|0|||
25161111|NCT01874431|50281347|FG003|Overall Study|Logistical difficulties|0|||
25161112|NCT01874431|50281348|FG004|Overall Study|Logistical difficulties|0|||
25161113|NCT01874431|50281349|FG005|Overall Study|Logistical difficulties|0|||
25161114|NCT01874431|50281350|FG006|Overall Study|Logistical difficulties|1|||
25161115|NCT01874431|50281351|FG007|Overall Study|Logistical difficulties|0|||
25161116|NCT01874431|50281344|FG000|Overall Study|Withdrawal by Subject|0|||
25161117|NCT01874431|50281345|FG001|Overall Study|Withdrawal by Subject|0|||
25161118|NCT01874431|50281346|FG002|Overall Study|Withdrawal by Subject|1|||
25161119|NCT01874431|50281347|FG003|Overall Study|Withdrawal by Subject|2|||
25161120|NCT01874431|50281348|FG004|Overall Study|Withdrawal by Subject|1|||
25161121|NCT01874431|50281349|FG005|Overall Study|Withdrawal by Subject|1|||
25161122|NCT01874431|50281350|FG006|Overall Study|Withdrawal by Subject|3|||
25161123|NCT01874431|50281351|FG007|Overall Study|Withdrawal by Subject|0|||
25161124|NCT01874431|50281344|FG000|Overall Study|Sponsor decision|0|||
25161125|NCT01874431|50281345|FG001|Overall Study|Sponsor decision|0|||
25161126|NCT01874431|50281346|FG002|Overall Study|Sponsor decision|0|||
25161127|NCT01874431|50281347|FG003|Overall Study|Sponsor decision|0|||
25161128|NCT01874431|50281348|FG004|Overall Study|Sponsor decision|1|||
25161129|NCT01874431|50281349|FG005|Overall Study|Sponsor decision|0|||
25161130|NCT01874431|50281350|FG006|Overall Study|Sponsor decision|0|||
25161131|NCT01874431|50281351|FG007|Overall Study|Sponsor decision|0|||
25161132|NCT01874431|50281344|FG000|Overall Study|Lost to Follow-up|0|||
25161133|NCT01874431|50281345|FG001|Overall Study|Lost to Follow-up|0|||
25161134|NCT01874431|50281346|FG002|Overall Study|Lost to Follow-up|1|||
25161135|NCT01874431|50281347|FG003|Overall Study|Lost to Follow-up|0|||
25161136|NCT01874431|50281348|FG004|Overall Study|Lost to Follow-up|0|||
25161137|NCT01874431|50281349|FG005|Overall Study|Lost to Follow-up|0|||
25161138|NCT01874431|50281350|FG006|Overall Study|Lost to Follow-up|0|||
25161139|NCT01874431|50281351|FG007|Overall Study|Lost to Follow-up|0|||
25161140|NCT01824355|50281369|FG000|Overall Study|Adverse Event|2|||
25161141|NCT01824355|50281369|FG000|Overall Study|unevaluable reference method results per|1|||
25161142|NCT01823341|50281377|FG000|Overall Study|Failed run-in|7|||
25161143|NCT01823341|50281377|FG000|Overall Study|Withdrawal by Subject|7|||
25161144|NCT01823341|50281377|FG000|Overall Study|Adverse Event|1|||
25161145|NCT01853137|50281386|FG000|Overall Study|Lost to Follow-up|4|||
25161146|NCT01853137|50281387|FG001|Overall Study|Lost to Follow-up|1|||
25161147|NCT01823107|50281394|FG000|Overall Study|Withdrawal by Subject|1|||
25161148|NCT01874275|50281400|FG000|Overall Study|Lost to Follow-up|1|||
25161149|NCT01874275|50281401|FG001|Overall Study|Lost to Follow-up|0|||
25161150|NCT01873729|50281413|FG000|Overall Study|Withdrawal by Subject|1|||
25161151|NCT01873495|50281417|FG000|Overall Study|Withdrawal by Subject|1|||
25161152|NCT01873495|50281417|FG000|Overall Study|Physician Decision|3|||
25161153|NCT01873495|50281417|FG000|Overall Study|Adverse Event|1|||
25161154|NCT01873495|50281417|FG000|Overall Study|Removed for Transplantation|1|||
25161155|NCT01873495|50281417|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
25161156|NCT01852825|50281424|FG000|Overall Study|Withdrawal by Subject|2|||
25161157|NCT01852825|50281425|FG001|Overall Study|Withdrawal by Subject|0|||
25161158|NCT01852825|50281426|FG002|Overall Study|Withdrawal by Subject|0|||
24956838|NCT00380588|50047742|FG000|Overall Study|Withdrawal by Subject|1|||
25043142|NCT02926573|50144505|FG000|Overall Study|Remain intubated|2|||
25043143|NCT02926573|50144506|FG001|Overall Study|Remain intubated|2|||
25043144|NCT02926573|50144505|FG000|Overall Study|Change in surgery plan|3|||
25043145|NCT02926573|50144506|FG001|Overall Study|Change in surgery plan|1|||
25043146|NCT02926573|50144505|FG000|Overall Study|Change to outpatient status|5|||
25043147|NCT02926573|50144506|FG001|Overall Study|Change to outpatient status|1|||
25043148|NCT02926573|50144505|FG000|Overall Study|Withdrawal by Subject|0|||
25043149|NCT02926573|50144506|FG001|Overall Study|Withdrawal by Subject|2|||
25043150|NCT02926573|50144505|FG000|Overall Study|Return to operating room|0|||
25161159|NCT01822561|50281434|FG000|Overall Study|Withdrawal by Subject|2|||
25161160|NCT01852591|50281459|FG000|Overall Study|Withdrawal by Subject|2|||
25161161|NCT01852591|50281459|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
25161162|NCT01852045|50281466|FG000|Overall Study|Adverse Event|1|||
25161163|NCT01852045|50281467|FG001|Overall Study|Adverse Event|0|||
25161164|NCT01852045|50281468|FG002|Overall Study|Adverse Event|0|||
24956839|NCT00380588|50047743|FG001|Overall Study|Withdrawal by Subject|3|||
24956840|NCT00380588|50047742|FG000|Overall Study|Physician Decision|2|||
24956841|NCT00380588|50047743|FG001|Overall Study|Physician Decision|0|||
24956842|NCT00379808|50047749|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
24956843|NCT00379808|50047750|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
24956844|NCT00355784|50047759|FG000|Overall Study|Withdrawal by Subject|0|||
24956845|NCT00355784|50047760|FG001|Overall Study|Withdrawal by Subject|0|||
24956846|NCT00355784|50047761|FG002|Overall Study|Withdrawal by Subject|2|||
24956847|NCT00355472|50047770|FG000|Overall Study|Physician Decision|1|||
24956848|NCT00492557|50047784|FG000|Overall Study|Subject request|12|||
24956849|NCT00492557|50047785|FG001|Overall Study|Subject request|11|||
24956850|NCT00492557|50047784|FG000|Overall Study|Protocol Violation|7|||
25043151|NCT02926573|50144506|FG001|Overall Study|Return to operating room|2|||
25161165|NCT01852045|50281466|FG000|Overall Study|Lack of Efficacy|3|||
25161166|NCT01852045|50281467|FG001|Overall Study|Lack of Efficacy|0|||
25161167|NCT01852045|50281468|FG002|Overall Study|Lack of Efficacy|0|||
25161168|NCT01852045|50281466|FG000|Overall Study|Lost to Follow-up|0|||
25161169|NCT01852045|50281467|FG001|Overall Study|Lost to Follow-up|1|||
25043152|NCT02926573|50144505|FG000|Overall Study|Delirium|0|||
25043153|NCT02926573|50144506|FG001|Overall Study|Delirium|1|||
25043154|NCT00158860|50144514|FG000|Overall Study|Adverse Event|3|||
25043155|NCT00158860|50144515|FG001|Overall Study|Adverse Event|6|||
25043156|NCT00158860|50144514|FG000|Overall Study|Lost to Follow-up|11|||
25043157|NCT00158860|50144515|FG001|Overall Study|Lost to Follow-up|17|||
25043158|NCT00158860|50144514|FG000|Overall Study|Protocol Violation|8|||
25043159|NCT00158860|50144515|FG001|Overall Study|Protocol Violation|23|||
25043160|NCT00158860|50144514|FG000|Overall Study|Withdrawal by Subject|7|||
25043161|NCT00158860|50144515|FG001|Overall Study|Withdrawal by Subject|17|||
25043162|NCT00158860|50144514|FG000|Overall Study|MOVING OUT OF STATE|1|||
25043163|NCT00158860|50144515|FG001|Overall Study|MOVING OUT OF STATE|0|||
25043164|NCT00158860|50144514|FG000|Overall Study|Pregnancy|3|||
25043165|NCT00158860|50144515|FG001|Overall Study|Pregnancy|3|||
25043166|NCT00158860|50144514|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
25043167|NCT00158860|50144515|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
25043168|NCT00158860|50144514|FG000|Overall Study|SPONSOR REQUEST|0|||
25043169|NCT00158860|50144515|FG001|Overall Study|SPONSOR REQUEST|1|||
25043170|NCT00158860|50144514|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
25043171|NCT00158860|50144515|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
25043172|NCT00158860|50144514|FG000|Overall Study|Closed per sponsor|0|||
25043173|NCT00158860|50144515|FG001|Overall Study|Closed per sponsor|1|||
25043174|NCT03067129|50144526|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
25043175|NCT03067129|50144527|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
25043176|NCT03067129|50144528|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
25043177|NCT03067129|50144529|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
25043178|NCT03067129|50144526|FG000|Overall Study|Withdrawal by Subject|0|||
25043179|NCT03067129|50144527|FG001|Overall Study|Withdrawal by Subject|0|||
25043180|NCT03067129|50144528|FG002|Overall Study|Withdrawal by Subject|1|||
25043181|NCT03067129|50144529|FG003|Overall Study|Withdrawal by Subject|2|||
25043182|NCT03067129|50144526|FG000|Overall Study|Lost to Follow-up|5|||
25043183|NCT03067129|50144527|FG001|Overall Study|Lost to Follow-up|5|||
25043184|NCT03067129|50144528|FG002|Overall Study|Lost to Follow-up|4|||
25043185|NCT03067129|50144529|FG003|Overall Study|Lost to Follow-up|3|||
25043186|NCT01679236|50144551|FG000|Overall Study|Lost to Follow-up|15|||
25043187|NCT01679236|50144552|FG001|Overall Study|Lost to Follow-up|15|||
25043188|NCT01679002|50144561|FG000|Overall Study|Adverse Event|1|||
25043189|NCT01679002|50144562|FG001|Overall Study|Adverse Event|1|||
25043190|NCT01679002|50144563|FG002|Overall Study|Adverse Event|0|||
25161170|NCT01852045|50281468|FG002|Overall Study|Lost to Follow-up|1|||
25161171|NCT01852045|50281466|FG000|Overall Study|Withdrawal by Subject|1|||
25161172|NCT01852045|50281467|FG001|Overall Study|Withdrawal by Subject|0|||
25161173|NCT01852045|50281468|FG002|Overall Study|Withdrawal by Subject|1|||
25161174|NCT01852045|50281466|FG000|Overall Study|Other Miscellaneous Reasons|1|||
25161175|NCT01852045|50281467|FG001|Overall Study|Other Miscellaneous Reasons|3|||
25161176|NCT01852045|50281468|FG002|Overall Study|Other Miscellaneous Reasons|2|||
25161177|NCT01821937|50281487|FG000|Overall Study|Adverse Event|0|||
25161178|NCT01821937|50281488|FG001|Overall Study|Adverse Event|3|||
25161179|NCT01821625|50281496|FG000|Overall Study|Withdrawal by Subject|2|||
25161180|NCT01821625|50281496|FG000|Overall Study|Lack of Efficacy|2|||
25161181|NCT01821625|50281496|FG000|Overall Study|Adverse Event|1|||
25161182|NCT01821625|50281496|FG000|Overall Study|Medical contraindication|1|||
25161183|NCT01821391|50281502|FG000|Overall Study|Adverse Event|1|||
25161184|NCT01821391|50281503|FG001|Overall Study|Adverse Event|0|||
25161185|NCT01873417|50281511|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
25161186|NCT01873417|50281511|FG000|Overall Study|Adverse Event|24|||
25161187|NCT01873417|50281511|FG000|Overall Study|Lost to Follow-up|2|||
25161188|NCT01873417|50281511|FG000|Overall Study|Withdrawal by Subject|2|||
25161189|NCT01873417|50281511|FG000|Overall Study|Physician Decision|3|||
25161190|NCT01872715|50281515|FG000|Overall Study|Adverse Event|1|||
25161191|NCT01872715|50281515|FG000|Overall Study|Protocol Violation|1|||
25161192|NCT01872715|50281515|FG000|Overall Study|Withdrawal by Subject|2|||
25161193|NCT01871545|50281531|FG000|Overall Study|Death|2|||
25161194|NCT01871545|50281532|FG001|Overall Study|Death|0|||
25043191|NCT04409509|50144573|FG000|Overall Study|Failure to meet randomization requirement|1|||
25043192|NCT04409509|50144574|FG001|Overall Study|Failure to meet randomization requirement|0|||
25043193|NCT04409509|50144573|FG000|Overall Study|Adverse Event|0|||
25161195|NCT01871545|50281531|FG000|Overall Study|Lack of Efficacy|11|||
25161196|NCT01871545|50281532|FG001|Overall Study|Lack of Efficacy|2|||
25161197|NCT01871545|50281531|FG000|Overall Study|Physician Decision|4|||
25161198|NCT01871545|50281532|FG001|Overall Study|Physician Decision|0|||
25161199|NCT01871545|50281531|FG000|Overall Study|Withdrawal by Subject|0|||
25161200|NCT01871545|50281532|FG001|Overall Study|Withdrawal by Subject|1|||
25161201|NCT01613599|50281541|FG000|Overall Study|Death|9|||
25043194|NCT04409509|50144574|FG001|Overall Study|Adverse Event|1|||
25043195|NCT04409509|50144573|FG000|Overall Study|Death|11|||
25043196|NCT04409509|50144574|FG001|Overall Study|Death|10|||
25043197|NCT04409509|50144573|FG000|Overall Study|Non-compliance with study drug|0|||
25161202|NCT01613599|50281541|FG000|Overall Study|Lost to Follow-up|5|||
25161203|NCT01613599|50281541|FG000|Overall Study|Withdrawal by Subject|8|||
25161204|NCT01613599|50281541|FG000|Overall Study|Reason not specified|3|||
25161205|NCT01850641|50281545|FG000|Overall Study|Physician Decision|1|||
25161206|NCT01850641|50281545|FG000|Overall Study|Decrease in serum phosphorus|1|||
25161207|NCT01850641|50281545|FG000|Overall Study|Decrease in serum calcium|2|||
25161208|NCT01850641|50281545|FG000|Overall Study|Increase in serum ferritin|1|||
25161209|NCT01850563|50281551|FG000|Overall Study|Not eligible|3|||
25161210|NCT01850563|50281552|FG001|Overall Study|Not eligible|0|||
25161211|NCT01819129|50281565|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
25161212|NCT01819129|50281566|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
25161213|NCT01819129|50281565|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
25161214|NCT01819129|50281566|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
25161215|NCT01819129|50281565|FG000|Overall Study|Other, Subject moved out of the country|0|||
25043198|NCT04409509|50144574|FG001|Overall Study|Non-compliance with study drug|1|||
25043199|NCT04409509|50144573|FG000|Overall Study|Lost to Follow-up|0|||
25161216|NCT01819129|50281566|FG001|Overall Study|Other, Subject moved out of the country|1|||
25161217|NCT01819129|50281565|FG000|Overall Study|Withdrawal by Subject|15|||
25043200|NCT04409509|50144574|FG001|Overall Study|Lost to Follow-up|3|||
25043201|NCT04409509|50144573|FG000|Overall Study|Withdrawal by Subject|0|||
25043202|NCT04409509|50144574|FG001|Overall Study|Withdrawal by Subject|3|||
25043203|NCT04409509|50144573|FG000|Overall Study|Randomized by mistake|0|||
25043204|NCT04409509|50144574|FG001|Overall Study|Randomized by mistake|1|||
25161218|NCT01819129|50281566|FG001|Overall Study|Withdrawal by Subject|15|||
25161219|NCT01819129|50281565|FG000|Overall Study|Lost to Follow-up|5|||
25161220|NCT01819129|50281566|FG001|Overall Study|Lost to Follow-up|2|||
25161221|NCT01819129|50281565|FG000|Overall Study|Lack of Efficacy|0|||
25161222|NCT01819129|50281566|FG001|Overall Study|Lack of Efficacy|1|||
25161223|NCT01819129|50281565|FG000|Overall Study|Adverse Event|1|||
25161224|NCT01819129|50281566|FG001|Overall Study|Adverse Event|4|||
25161225|NCT01819129|50281565|FG000|Overall Study|Death|1|||
25161226|NCT01819129|50281566|FG001|Overall Study|Death|1|||
25161227|NCT01819129|50281565|FG000|Overall Study|Withdrawal Criteria|20|||
25161228|NCT01819129|50281566|FG001|Overall Study|Withdrawal Criteria|15|||
25161229|NCT04022889|50281574|FG000|Stage 1: Period 1|Adverse Event|1|||
25161230|NCT04022889|50281575|FG001|Stage 1: Period 1|Adverse Event|0|||
25161231|NCT04022889|50281576|FG002|Stage 1: Period 1|Adverse Event|0|||
25161232|NCT04022889|50281574|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
25161233|NCT04022889|50281575|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
25161234|NCT04022889|50281576|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
25161235|NCT04022889|50281574|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
25161236|NCT04022889|50281575|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
25161237|NCT04022889|50281576|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
25161238|NCT04022889|50281574|FG000|Stage 2|Screen Failure|0|||
25161239|NCT04022889|50281575|FG001|Stage 2|Screen Failure|0|||
25161240|NCT04022889|50281576|FG002|Stage 2|Screen Failure|3|||
25161241|NCT04022889|50281574|FG000|Stage 2|Ineligible for apheresis donation|0|||
25161242|NCT04022889|50281575|FG001|Stage 2|Ineligible for apheresis donation|0|||
25161243|NCT04022889|50281576|FG002|Stage 2|Ineligible for apheresis donation|2|||
24956851|NCT00492557|50047785|FG001|Overall Study|Protocol Violation|8|||
24956852|NCT00492557|50047784|FG000|Overall Study|Other|2|||
24956853|NCT00492557|50047785|FG001|Overall Study|Other|2|||
24956854|NCT00492557|50047784|FG000|Overall Study|Death|1|||
24956855|NCT00492557|50047785|FG001|Overall Study|Death|1|||
24956856|NCT00492557|50047784|FG000|Overall Study|Adverse Event|1|||
24956857|NCT00492557|50047785|FG001|Overall Study|Adverse Event|0|||
24956858|NCT00492557|50047784|FG000|Overall Study|Failed to return|1|||
24956859|NCT00492557|50047785|FG001|Overall Study|Failed to return|0|||
24956860|NCT00492557|50047784|FG000|Overall Study|Lost to Follow-up|0|||
24956861|NCT00492557|50047785|FG001|Overall Study|Lost to Follow-up|1|||
24956862|NCT00508391|50047796|FG000|First Treatment|Withdrawal by Subject|6|||
24956863|NCT00508391|50047797|FG001|First Treatment|Withdrawal by Subject|3|||
24956864|NCT00508391|50047796|FG000|Second Treatment|Withdrawal by Subject|2|||
24956865|NCT00508391|50047797|FG001|Second Treatment|Withdrawal by Subject|0|||
24956866|NCT00508157|50047807|FG000|Overall Study|Adverse Event|0|||
24956867|NCT00508157|50047808|FG001|Overall Study|Adverse Event|1|||
24956868|NCT00508157|50047807|FG000|Overall Study|Subject Withdrew Consent|1|||
24956869|NCT00508157|50047808|FG001|Overall Study|Subject Withdrew Consent|0|||
24956870|NCT00508157|50047807|FG000|Overall Study|Lost to Follow-up|1|||
25043205|NCT04409509|50144573|FG000|Overall Study|Other|1|||
25043206|NCT04409509|50144574|FG001|Overall Study|Other|1|||
25161244|NCT04022889|50281574|FG000|Stage 2|Adverse Event|0|||
25161245|NCT04022889|50281575|FG001|Stage 2|Adverse Event|0|||
25161246|NCT04022889|50281576|FG002|Stage 2|Adverse Event|2|||
25161247|NCT04022889|50281574|FG000|Stage 2|Protocol Violation|0|||
25161248|NCT04022889|50281575|FG001|Stage 2|Protocol Violation|0|||
25161249|NCT04022889|50281576|FG002|Stage 2|Protocol Violation|1|||
25043207|NCT01678924|50144585|FG000|Overall Study|Adverse Event|1|||
25043208|NCT01678924|50144586|FG001|Overall Study|Adverse Event|1|||
25043209|NCT01678924|50144587|FG002|Overall Study|Adverse Event|0|||
25043210|NCT01678924|50144588|FG003|Overall Study|Adverse Event|1|||
25043211|NCT01678924|50144585|FG000|Overall Study|Lack of Efficacy|7|||
25043212|NCT01678924|50144586|FG001|Overall Study|Lack of Efficacy|2|||
25161250|NCT04022889|50281574|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
25161251|NCT04022889|50281575|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
25161252|NCT04022889|50281576|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
25161253|NCT01849783|50281608|FG000|Overall Study|Adverse Event|5|||
25161254|NCT01849783|50281608|FG000|Overall Study|Death|2|||
25161255|NCT01849783|50281608|FG000|Overall Study|Physician Decision|1|||
25161256|NCT01849783|50281608|FG000|Overall Study|Withdrawal by Subject|1|||
25161257|NCT01849783|50281608|FG000|Overall Study|Unable to comply|2|||
25161258|NCT01849783|50281608|FG000|Overall Study|Disease progression|11|||
25161259|NCT01611883|50281620|FG000|Overall Study|Adverse Event|1|||
25161260|NCT01611883|50281621|FG001|Overall Study|Adverse Event|1|||
25161261|NCT01848457|50281631|FG000|Overall Study|Death|1|||
25161262|NCT01848457|50281632|FG001|Overall Study|Death|0|||
25043213|NCT01678924|50144587|FG002|Overall Study|Lack of Efficacy|0|||
25043214|NCT01678924|50144588|FG003|Overall Study|Lack of Efficacy|5|||
25161263|NCT01848457|50281633|FG002|Overall Study|Death|0|||
25161264|NCT01848457|50281634|FG003|Overall Study|Death|0|||
25161265|NCT01817959|50281654|FG000|Overall Study|Graft loss|1|||
25161266|NCT01817959|50281655|FG001|Overall Study|Graft loss|1|||
25161267|NCT01817959|50281654|FG000|Overall Study|forbidden medication|1|||
25161268|NCT01817959|50281655|FG001|Overall Study|forbidden medication|1|||
25161269|NCT01817959|50281654|FG000|Overall Study|Adverse Event|1|||
25161270|NCT01817959|50281655|FG001|Overall Study|Adverse Event|0|||
25161271|NCT01817959|50281654|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
25161272|NCT01817959|50281655|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
24956871|NCT00508157|50047808|FG001|Overall Study|Lost to Follow-up|0|||
24956872|NCT00508157|50047807|FG000|Overall Study|Subject no longer met study criteria|0|||
24956873|NCT00508157|50047808|FG001|Overall Study|Subject no longer met study criteria|1|||
24956874|NCT00508157|50047807|FG000|Overall Study|Other known cause|0|||
24956875|NCT00508157|50047808|FG001|Overall Study|Other known cause|1|||
24956876|NCT00378560|50047816|FG000|Overall Study|Adverse Event|1|||
25161273|NCT01817725|50281661|FG000|Overall Study|Withdrawal by Subject|1|||
24956877|NCT00378560|50047817|FG001|Overall Study|Adverse Event|0|||
24956878|NCT00378560|50047816|FG000|Overall Study|Lost to Follow-up|24|||
24956879|NCT00378560|50047817|FG001|Overall Study|Lost to Follow-up|29|||
24956880|NCT00378560|50047816|FG000|Overall Study|Protocol Violation|2|||
24956881|NCT00378560|50047817|FG001|Overall Study|Protocol Violation|0|||
24956882|NCT00378560|50047816|FG000|Overall Study|Withdrawal by Subject|17|||
24956883|NCT00378560|50047817|FG001|Overall Study|Withdrawal by Subject|21|||
24956884|NCT00378560|50047816|FG000|Overall Study|Moved|4|||
24956885|NCT00378560|50047817|FG001|Overall Study|Moved|3|||
24956886|NCT00378560|50047816|FG000|Overall Study|Pregnancy|7|||
24956887|NCT00378560|50047817|FG001|Overall Study|Pregnancy|5|||
24956888|NCT00378560|50047816|FG000|Overall Study|Laboratory test values abnormal|1|||
24956889|NCT00378560|50047817|FG001|Overall Study|Laboratory test values abnormal|0|||
24956890|NCT00508001|50047826|FG000|Overall Study|Adverse Event|2|||
24956891|NCT00508001|50047827|FG001|Overall Study|Adverse Event|0|||
24956892|NCT00508001|50047828|FG002|Overall Study|Adverse Event|4|||
24956893|NCT00508001|50047826|FG000|Overall Study|condition under investigation worsened|13|||
25043215|NCT01678924|50144585|FG000|Overall Study|Lost to Follow-up|0|||
25043216|NCT01678924|50144586|FG001|Overall Study|Lost to Follow-up|4|||
25161274|NCT01870999|50281668|FG000|Overall Study|Adverse Event|0|||
25161275|NCT01870999|50281669|FG001|Overall Study|Adverse Event|4|||
25161276|NCT01870999|50281670|FG002|Overall Study|Adverse Event|1|||
25161277|NCT01870999|50281668|FG000|Overall Study|Subject met withdrawal criteria|3|||
25161278|NCT01870999|50281669|FG001|Overall Study|Subject met withdrawal criteria|2|||
25161279|NCT01870999|50281670|FG002|Overall Study|Subject met withdrawal criteria|0|||
25161280|NCT01870999|50281668|FG000|Overall Study|Subject withdrawn by Investigator|1|||
25276290|NCT00960934|50590272|FG001|Overall Study|Adverse Event|3|||
24956894|NCT00508001|50047827|FG001|Overall Study|condition under investigation worsened|7|||
24956895|NCT00508001|50047828|FG002|Overall Study|condition under investigation worsened|1|||
24956896|NCT00508001|50047826|FG000|Overall Study|Death|0|||
24956897|NCT00508001|50047827|FG001|Overall Study|Death|1|||
24956898|NCT00508001|50047828|FG002|Overall Study|Death|1|||
24956899|NCT00508001|50047826|FG000|Overall Study|Withdrawal by Subject|4|||
25043217|NCT01678924|50144587|FG002|Overall Study|Lost to Follow-up|0|||
25043218|NCT01678924|50144588|FG003|Overall Study|Lost to Follow-up|2|||
25161281|NCT01870999|50281669|FG001|Overall Study|Subject withdrawn by Investigator|0|||
25161282|NCT01870999|50281670|FG002|Overall Study|Subject withdrawn by Investigator|0|||
25161283|NCT01870999|50281668|FG000|Overall Study|Withdrawal by Subject|0|||
25161284|NCT01870999|50281669|FG001|Overall Study|Withdrawal by Subject|2|||
25161285|NCT01870999|50281670|FG002|Overall Study|Withdrawal by Subject|5|||
24956900|NCT00508001|50047827|FG001|Overall Study|Withdrawal by Subject|4|||
24956901|NCT00508001|50047828|FG002|Overall Study|Withdrawal by Subject|1|||
24956902|NCT00507689|50047839|FG000|Pre-Randomization Period|Adverse Event|1|||
24956903|NCT00507689|50047840|FG001|Pre-Randomization Period|Adverse Event|0|||
24956904|NCT00507689|50047839|FG000|Pre-Randomization Period|Physician Decision|1|||
24956905|NCT00507689|50047840|FG001|Pre-Randomization Period|Physician Decision|0|||
24956906|NCT00507689|50047839|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
24956907|NCT00507689|50047840|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
24956908|NCT00507689|50047839|FG000|Randomized Period|Adverse Event|1|||
24956909|NCT00507689|50047840|FG001|Randomized Period|Adverse Event|1|||
24956910|NCT00507689|50047839|FG000|Randomized Period|Withdrawal by Subject|0|||
24956911|NCT00507689|50047840|FG001|Randomized Period|Withdrawal by Subject|1|||
24956912|NCT00491387|50047847|FG000|Overall Study|study terminated|20|||
24956913|NCT00491075|50047851|FG000|Overall Study|Withdrawal by Subject|1|||
24956914|NCT00491075|50047851|FG000|Overall Study|Physician Decision|1|||
24956915|NCT00507455|50047858|FG000|Overall Study|Adverse Event|3|||
24956916|NCT00507455|50047859|FG001|Overall Study|Adverse Event|3|||
24956917|NCT00507455|50047860|FG002|Overall Study|Adverse Event|6|||
24956918|NCT00507455|50047858|FG000|Overall Study|Withdrawal by Subject|2|||
24956919|NCT00507455|50047859|FG001|Overall Study|Withdrawal by Subject|1|||
24956920|NCT00507455|50047860|FG002|Overall Study|Withdrawal by Subject|2|||
25043219|NCT01678924|50144585|FG000|Overall Study|Personal Reasons|2|||
25161286|NCT01870999|50281668|FG000|Overall Study|Protocol Violation|0|||
25161287|NCT01870999|50281669|FG001|Overall Study|Protocol Violation|0|||
25161288|NCT01870999|50281670|FG002|Overall Study|Protocol Violation|1|||
25161289|NCT01870921|50281678|FG000|Overall Study|Subject decision|80|||
25161290|NCT01870921|50281678|FG000|Overall Study|Severe non-compliance to protocol|7|||
25161291|NCT01870921|50281678|FG000|Overall Study|Subject Lost to Follow up|2|||
25161292|NCT01870921|50281678|FG000|Overall Study|Other|1|||
25161293|NCT01848145|50281691|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
25161294|NCT01848145|50281691|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
25161295|NCT01848145|50281691|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
25161296|NCT01848145|50281691|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
25161297|NCT01848145|50281691|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
25161298|NCT01848145|50281691|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
25161299|NCT01848145|50281691|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
25161300|NCT01847755|50281695|FG000|Overall Study|Adverse Event|2|||
25161301|NCT01847755|50281695|FG000|Overall Study|Withdrawal by Subject|2|||
25161302|NCT01847755|50281695|FG000|Overall Study|Physician Decision|1|||
24956921|NCT00507455|50047858|FG000|Overall Study|Protocol Violation|4|||
24956922|NCT00507455|50047859|FG001|Overall Study|Protocol Violation|1|||
25043220|NCT01678924|50144586|FG001|Overall Study|Personal Reasons|2|||
25043221|NCT01678924|50144587|FG002|Overall Study|Personal Reasons|2|||
25043222|NCT01678924|50144588|FG003|Overall Study|Personal Reasons|7|||
25043223|NCT01678924|50144585|FG000|Overall Study|Withdrawal by Subject|0|||
25043224|NCT01678924|50144586|FG001|Overall Study|Withdrawal by Subject|3|||
25043225|NCT01678924|50144587|FG002|Overall Study|Withdrawal by Subject|0|||
25043226|NCT01678924|50144588|FG003|Overall Study|Withdrawal by Subject|2|||
25043227|NCT01678924|50144585|FG000|Overall Study|Unable to attend scheduled visits|0|||
25043228|NCT01678924|50144586|FG001|Overall Study|Unable to attend scheduled visits|0|||
25043229|NCT01678924|50144587|FG002|Overall Study|Unable to attend scheduled visits|0|||
25043230|NCT01678924|50144588|FG003|Overall Study|Unable to attend scheduled visits|1|||
25043231|NCT02925793|50144602|FG000|Overall Study|Adverse Event|3|||
25043232|NCT02925793|50144603|FG001|Overall Study|Adverse Event|3|||
25043233|NCT02925793|50144604|FG002|Overall Study|Adverse Event|6|||
25043234|NCT02925793|50144602|FG000|Overall Study|Withdrawal by Subject|16|||
25043235|NCT02925793|50144603|FG001|Overall Study|Withdrawal by Subject|15|||
25043236|NCT02925793|50144604|FG002|Overall Study|Withdrawal by Subject|13|||
25043237|NCT02925793|50144602|FG000|Overall Study|Investigator Discretion|0|||
25043238|NCT02925793|50144603|FG001|Overall Study|Investigator Discretion|1|||
25043239|NCT02925793|50144604|FG002|Overall Study|Investigator Discretion|1|||
25043240|NCT02925793|50144602|FG000|Overall Study|Lost to Follow-up|2|||
25043241|NCT02925793|50144603|FG001|Overall Study|Lost to Follow-up|3|||
25043242|NCT02925793|50144604|FG002|Overall Study|Lost to Follow-up|1|||
25043243|NCT02925793|50144602|FG000|Overall Study|Lack of Efficacy|2|||
25043244|NCT02925793|50144603|FG001|Overall Study|Lack of Efficacy|6|||
25043245|NCT02925793|50144604|FG002|Overall Study|Lack of Efficacy|4|||
25161303|NCT01847443|50281726|FG000|Study Period 1|Withdrawal by Subject|0|||
25161304|NCT01847443|50281727|FG001|Study Period 1|Withdrawal by Subject|1|||
25161305|NCT01847443|50281728|FG002|Study Period 1|Withdrawal by Subject|0|||
25161306|NCT01847443|50281729|FG003|Study Period 1|Withdrawal by Subject|0|||
25043246|NCT02925793|50144602|FG000|Overall Study|Other:|2|||
25043247|NCT02925793|50144603|FG001|Overall Study|Other:|1|||
25043248|NCT02925793|50144604|FG002|Overall Study|Other:|3|||
25043249|NCT03071263|50144614|FG000|Overall Study|Adverse Event|1|||
25043250|NCT03071263|50144615|FG001|Overall Study|Adverse Event|3|||
25043251|NCT03071263|50144614|FG000|Overall Study|Withdrawal by Subject|1|||
25043252|NCT03071263|50144615|FG001|Overall Study|Withdrawal by Subject|3|||
25043253|NCT03071263|50144614|FG000|Overall Study|Physician Decision|1|||
25043254|NCT03071263|50144615|FG001|Overall Study|Physician Decision|0|||
25043255|NCT03071263|50144614|FG000|Overall Study|Participant moved to another city|0|||
25043256|NCT03071263|50144615|FG001|Overall Study|Participant moved to another city|1|||
25043257|NCT00157196|50144627|FG000|Overall Study|Ongoing at data cut-off|9|||
25043258|NCT03066193|50144631|FG000|Overall Study|Withdrawal by Subject|1|||
25043259|NCT03922321|50144635|FG000|Overall Study|Participant Moved|1|||
25043260|NCT03922321|50144635|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
25043261|NCT01677910|50144642|FG000|Double-Blind Treatment Period|Adverse Event|6|||
25043262|NCT01677910|50144643|FG001|Double-Blind Treatment Period|Adverse Event|2|||
25043263|NCT01677910|50144644|FG002|Double-Blind Treatment Period|Adverse Event|3|||
25043264|NCT01677910|50144645|FG003|Double-Blind Treatment Period|Adverse Event|0|||
25043265|NCT01677910|50144642|FG000|Double-Blind Treatment Period|Physician Decision|0|||
25043266|NCT01677910|50144643|FG001|Double-Blind Treatment Period|Physician Decision|0|||
25043267|NCT01677910|50144644|FG002|Double-Blind Treatment Period|Physician Decision|1|||
25043268|NCT01677910|50144645|FG003|Double-Blind Treatment Period|Physician Decision|0|||
25043269|NCT01677910|50144642|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
25043270|NCT01677910|50144643|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
25043271|NCT01677910|50144644|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
25043272|NCT01677910|50144645|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
25043273|NCT01677910|50144642|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
25043274|NCT01677910|50144643|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
25043275|NCT01677910|50144644|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
25043276|NCT01677910|50144645|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
24956923|NCT00507455|50047860|FG002|Overall Study|Protocol Violation|1|||
24956924|NCT00507455|50047858|FG000|Overall Study|Lost to Follow-up|2|||
24956925|NCT00507455|50047859|FG001|Overall Study|Lost to Follow-up|0|||
24956926|NCT00507455|50047860|FG002|Overall Study|Lost to Follow-up|2|||
24956927|NCT00507455|50047858|FG000|Overall Study|Lack of Efficacy|0|||
24956928|NCT00507455|50047859|FG001|Overall Study|Lack of Efficacy|1|||
24956929|NCT00507455|50047860|FG002|Overall Study|Lack of Efficacy|0|||
24956930|NCT00507455|50047858|FG000|Overall Study|Other - miscellaneous reason|1|||
24956931|NCT00507455|50047859|FG001|Overall Study|Other - miscellaneous reason|0|||
24956932|NCT00507455|50047860|FG002|Overall Study|Other - miscellaneous reason|1|||
24956933|NCT00506831|50047868|FG000|Overall Study|Death|1|||
24956934|NCT00506831|50047868|FG000|Overall Study|Withdrawal by Subject|1|||
24956935|NCT00506753|50047874|FG000|Overall Study|Lost to Follow-up|21|||
24956936|NCT00506753|50047875|FG001|Overall Study|Lost to Follow-up|15|||
24956937|NCT00490919|50047883|FG000|Open-label Run-in Period|Adverse Event|239|||
24956938|NCT00490919|50047884|FG001|Open-label Run-in Period|Adverse Event|0|||
25043277|NCT01677910|50144642|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
24956939|NCT00490919|50047885|FG002|Open-label Run-in Period|Adverse Event|0|||
25161307|NCT01847443|50281726|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
25186510|NCT02647866|50336895|FG000|Overall Study|Death|0|||
24956940|NCT00490919|50047883|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
24956941|NCT00490919|50047884|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
24956942|NCT00490919|50047885|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
25043278|NCT01677910|50144643|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
25043279|NCT01677910|50144644|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
25043280|NCT01677910|50144645|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
25043281|NCT01677910|50144642|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
25043282|NCT01677910|50144643|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
25043283|NCT01677910|50144644|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
25043284|NCT01677910|50144645|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
25043285|NCT01677910|50144642|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
25043286|NCT01677910|50144643|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
25043287|NCT01677910|50144644|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
24956943|NCT00490919|50047883|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
24956944|NCT00490919|50047884|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
24956945|NCT00490919|50047885|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
25043288|NCT01677910|50144645|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
24956946|NCT00490919|50047883|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
24956947|NCT00490919|50047884|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
25043289|NCT01677910|50144642|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
25043290|NCT01677910|50144643|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
25043291|NCT01677910|50144644|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
25043292|NCT01677910|50144645|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
24956948|NCT00490919|50047885|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
24956949|NCT00490919|50047883|FG000|Open-label Run-in Period|Administrative|40|||
25043293|NCT01677910|50144642|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
25043294|NCT01677910|50144643|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
25043295|NCT01677910|50144644|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
25043296|NCT01677910|50144645|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
25043297|NCT01677910|50144642|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
25043298|NCT01677910|50144643|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
25043299|NCT01677910|50144644|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
25043300|NCT01677910|50144645|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
25043301|NCT03911713|50144660|FG000|Overall Study|Lost to Follow-up|0|||
25043302|NCT03911713|50144661|FG001|Overall Study|Lost to Follow-up|2|||
25043303|NCT03911713|50144662|FG002|Overall Study|Lost to Follow-up|0|||
25043304|NCT03911713|50144663|FG003|Overall Study|Lost to Follow-up|0|||
25043305|NCT03911713|50144664|FG004|Overall Study|Lost to Follow-up|0|||
25043306|NCT03911713|50144660|FG000|Overall Study|Other|0|||
25043307|NCT03911713|50144661|FG001|Overall Study|Other|0|||
25043308|NCT03911713|50144662|FG002|Overall Study|Other|0|||
25043309|NCT03911713|50144663|FG003|Overall Study|Other|1|||
25043310|NCT03911713|50144664|FG004|Overall Study|Other|0|||
25043311|NCT03911713|50144660|FG000|Overall Study|Randomized, Never Dosed|1|||
25043312|NCT03911713|50144661|FG001|Overall Study|Randomized, Never Dosed|0|||
25043313|NCT03911713|50144662|FG002|Overall Study|Randomized, Never Dosed|0|||
25043314|NCT03911713|50144663|FG003|Overall Study|Randomized, Never Dosed|1|||
25043315|NCT03911713|50144664|FG004|Overall Study|Randomized, Never Dosed|0|||
25043316|NCT03065023|50144682|FG000|Overall Study|Progressive Disease|0|||
25043317|NCT03065023|50144683|FG001|Overall Study|Progressive Disease|1|||
25043318|NCT03065023|50144684|FG002|Overall Study|Progressive Disease|0|||
25043319|NCT03065023|50144685|FG003|Overall Study|Progressive Disease|0|||
25043320|NCT03065023|50144686|FG004|Overall Study|Progressive Disease|0|||
25043321|NCT03065023|50144682|FG000|Overall Study|Death|2|||
25043322|NCT03065023|50144683|FG001|Overall Study|Death|0|||
25043323|NCT03065023|50144684|FG002|Overall Study|Death|1|||
25043324|NCT03065023|50144685|FG003|Overall Study|Death|1|||
25043325|NCT03065023|50144686|FG004|Overall Study|Death|0|||
25043326|NCT03065023|50144682|FG000|Overall Study|Lost to Follow-up|0|||
25043327|NCT03065023|50144683|FG001|Overall Study|Lost to Follow-up|1|||
25043328|NCT03065023|50144684|FG002|Overall Study|Lost to Follow-up|0|||
25043329|NCT03065023|50144685|FG003|Overall Study|Lost to Follow-up|0|||
25043330|NCT03065023|50144686|FG004|Overall Study|Lost to Follow-up|0|||
25043331|NCT03065023|50144682|FG000|Overall Study|Participant Decision|0|||
25043332|NCT03065023|50144683|FG001|Overall Study|Participant Decision|0|||
25043333|NCT03065023|50144684|FG002|Overall Study|Participant Decision|0|||
25043334|NCT03065023|50144685|FG003|Overall Study|Participant Decision|1|||
25043335|NCT03065023|50144686|FG004|Overall Study|Participant Decision|0|||
25043336|NCT03065023|50144682|FG000|Overall Study|Withdrawal by Subject|0|||
25161308|NCT01847443|50281727|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
25161309|NCT01847443|50281728|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
25161310|NCT01847443|50281729|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
25161311|NCT01847443|50281726|FG000|Washout Period Before Study Period 2|Other reason|1|||
25161312|NCT01847443|50281727|FG001|Washout Period Before Study Period 2|Other reason|0|||
25161313|NCT01847443|50281728|FG002|Washout Period Before Study Period 2|Other reason|0|||
25161314|NCT01847443|50281729|FG003|Washout Period Before Study Period 2|Other reason|0|||
25161315|NCT01847443|50281726|FG000|Washout Period Before Study Period 3|Other reason|1|||
25161316|NCT01847443|50281727|FG001|Washout Period Before Study Period 3|Other reason|0|||
25276291|NCT00960934|50590273|FG002|Overall Study|Adverse Event|3|||
24956950|NCT00490919|50047884|FG001|Open-label Run-in Period|Administrative|0|||
24956951|NCT00490919|50047885|FG002|Open-label Run-in Period|Administrative|0|||
24956952|NCT00490919|50047883|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
24956953|NCT00490919|50047884|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
24956954|NCT00490919|50047885|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
24956955|NCT00490919|50047883|FG000|Double-blind Phase|Adverse Event|0|||
24956956|NCT00490919|50047884|FG001|Double-blind Phase|Adverse Event|40|||
24956957|NCT00490919|50047885|FG002|Double-blind Phase|Adverse Event|20|||
24956958|NCT00490919|50047883|FG000|Double-blind Phase|Withdrawal by Subject|0|||
24956959|NCT00490919|50047884|FG001|Double-blind Phase|Withdrawal by Subject|10|||
24956960|NCT00490919|50047885|FG002|Double-blind Phase|Withdrawal by Subject|11|||
25043337|NCT03065023|50144683|FG001|Overall Study|Withdrawal by Subject|0|||
25043338|NCT03065023|50144684|FG002|Overall Study|Withdrawal by Subject|0|||
25043339|NCT03065023|50144685|FG003|Overall Study|Withdrawal by Subject|1|||
25043340|NCT03065023|50144686|FG004|Overall Study|Withdrawal by Subject|0|||
25043341|NCT03614923|50144699|FG000|Overall Study|Withdrawal by Subject|2|||
25043342|NCT03614923|50144700|FG001|Overall Study|Withdrawal by Subject|1|||
25043343|NCT03614923|50144701|FG002|Overall Study|Withdrawal by Subject|1|||
25043344|NCT03614923|50144699|FG000|Overall Study|Adverse Event|0|||
25043345|NCT03614923|50144700|FG001|Overall Study|Adverse Event|2|||
25043346|NCT03614923|50144701|FG002|Overall Study|Adverse Event|1|||
25161317|NCT01847443|50281728|FG002|Washout Period Before Study Period 3|Other reason|0|||
25161318|NCT01847443|50281729|FG003|Washout Period Before Study Period 3|Other reason|0|||
25161319|NCT01847443|50281726|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
25161320|NCT01847443|50281727|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
25161321|NCT01847443|50281728|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
25161322|NCT01847443|50281729|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
25161323|NCT01847443|50281726|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
25161324|NCT01847443|50281727|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
25161325|NCT01847443|50281728|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
25161326|NCT01847443|50281729|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
25161327|NCT01847209|50281748|FG000|Overall Study|Withdrawal by Subject|1|||
25161328|NCT01847209|50281748|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
25161329|NCT01846741|50281752|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
25161330|NCT01870843|50281791|FG000|Overall Study|Adverse Event|10|||
25161331|NCT01870843|50281791|FG000|Overall Study|Lost to Follow-up|24|||
25161332|NCT01870843|50281791|FG000|Overall Study|Death|1|||
25161333|NCT01870843|50281791|FG000|Overall Study|Withdrawal by Subject|18|||
25161334|NCT01816477|50281797|FG000|Overall Study|Withdrawal by Subject|13|||
25043347|NCT03614923|50144699|FG000|Overall Study|Lost to Follow-up|1|||
25043348|NCT03614923|50144700|FG001|Overall Study|Lost to Follow-up|0|||
25043349|NCT03614923|50144701|FG002|Overall Study|Lost to Follow-up|1|||
25043350|NCT03614923|50144699|FG000|Overall Study|Lack of Efficacy|2|||
25043351|NCT03614923|50144700|FG001|Overall Study|Lack of Efficacy|0|||
24956961|NCT00490919|50047883|FG000|Double-blind Phase|Lost to Follow-up|0|||
24956962|NCT00490919|50047884|FG001|Double-blind Phase|Lost to Follow-up|8|||
24956963|NCT00490919|50047885|FG002|Double-blind Phase|Lost to Follow-up|11|||
24956964|NCT00490919|50047883|FG000|Double-blind Phase|Lack of Efficacy|0|||
24956965|NCT00490919|50047884|FG001|Double-blind Phase|Lack of Efficacy|22|||
24956966|NCT00490919|50047885|FG002|Double-blind Phase|Lack of Efficacy|36|||
24956967|NCT00490919|50047883|FG000|Double-blind Phase|Administrative|0|||
24956968|NCT00490919|50047884|FG001|Double-blind Phase|Administrative|6|||
24956969|NCT00490919|50047885|FG002|Double-blind Phase|Administrative|6|||
24956970|NCT00503867|50047892|FG000|Overall Study|Lost to Follow-up|1|||
24956971|NCT00503867|50047892|FG000|Overall Study|Adverse Event|1|||
24956972|NCT00503399|50047898|FG000|Overall Study|Death|2|||
24956973|NCT00503399|50047899|FG001|Overall Study|Death|1|||
25043352|NCT03614923|50144701|FG002|Overall Study|Lack of Efficacy|1|||
25043353|NCT03614923|50144699|FG000|Overall Study|Non-compliance|0|||
25043354|NCT03614923|50144700|FG001|Overall Study|Non-compliance|1|||
25043355|NCT03614923|50144701|FG002|Overall Study|Non-compliance|0|||
25043356|NCT03614923|50144699|FG000|Overall Study|Other|0|||
25043357|NCT03614923|50144700|FG001|Overall Study|Other|1|||
25043358|NCT03614923|50144701|FG002|Overall Study|Other|1|||
25161335|NCT01816477|50281798|FG001|Overall Study|Withdrawal by Subject|1|||
25161336|NCT01816477|50281797|FG000|Overall Study|Unable to tolerate catheter placement|3|||
25161337|NCT01816477|50281798|FG001|Overall Study|Unable to tolerate catheter placement|0|||
25161338|NCT01846507|50281804|FG000|Overall Study|Lost to Follow-up|4|||
25161339|NCT01846507|50281804|FG000|Overall Study|Protocol Violation|1|||
25161340|NCT01846507|50281804|FG000|Overall Study|Missing data|2|||
25161341|NCT01846039|50281810|FG000|Overall Study|Protocol Violation|1|||
25161342|NCT01846039|50281810|FG000|Overall Study|Subject Withdrew Consent|1|||
25161343|NCT01610167|50281817|FG000|Overall Study|Scheduling conflict.|0|||
25161344|NCT01610167|50281818|FG001|Overall Study|Scheduling conflict.|0|||
25161345|NCT01610167|50281819|FG002|Overall Study|Scheduling conflict.|2|||
25161346|NCT01816243|50281827|FG000|Overall Study|Adverse Event|6|||
25161347|NCT01816243|50281827|FG000|Overall Study|Lost to Follow-up|1|||
25161348|NCT01816243|50281827|FG000|Overall Study|Lack of Efficacy|1|||
25161349|NCT01816243|50281827|FG000|Overall Study|Not eligible for the study|1|||
25161350|NCT01816243|50281827|FG000|Overall Study|Amputation|3|||
25161351|NCT01845805|50281833|FG000|Overall Study|Withdrawal by Subject|1|||
25276292|NCT00960934|50590274|FG003|Overall Study|Adverse Event|2|||
24956974|NCT00503399|50047898|FG000|Overall Study|Protocol Violation|1|||
24956975|NCT00503399|50047899|FG001|Overall Study|Protocol Violation|0|||
24956976|NCT00503399|50047898|FG000|Overall Study|Withdrawal by Subject|4|||
24956977|NCT00503399|50047899|FG001|Overall Study|Withdrawal by Subject|2|||
24956978|NCT00503399|50047898|FG000|Overall Study|Adverse Event|0|||
24956979|NCT00503399|50047899|FG001|Overall Study|Adverse Event|3|||
25043359|NCT02915016|50144717|FG000|Overall Study|Lost to Follow-up|4|||
25043360|NCT02915016|50144718|FG001|Overall Study|Lost to Follow-up|2|||
25161352|NCT01845805|50281834|FG001|Overall Study|Withdrawal by Subject|2|||
25161353|NCT01845805|50281833|FG000|Overall Study|Disease Progression|13|||
25161354|NCT01845805|50281834|FG001|Overall Study|Disease Progression|14|||
25161355|NCT01845805|50281833|FG000|Overall Study|Drug-related Toxicity|4|||
25161356|NCT01845805|50281834|FG001|Overall Study|Drug-related Toxicity|0|||
25161357|NCT01845025|50281842|FG000|Overall Study|Adverse Event|6|||
24956980|NCT00503399|50047898|FG000|Overall Study|Lost to Follow-up|0|||
25043361|NCT02915016|50144719|FG002|Overall Study|Lost to Follow-up|5|||
25161358|NCT01845025|50281843|FG001|Overall Study|Adverse Event|3|||
25161359|NCT01845025|50281842|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
25161360|NCT01845025|50281843|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
25161361|NCT01845025|50281842|FG000|Overall Study|Withdrawal by Subject|48|||
25161362|NCT01845025|50281843|FG001|Overall Study|Withdrawal by Subject|44|||
25161363|NCT01845025|50281842|FG000|Overall Study|Lost to Follow-up|13|||
25161364|NCT01845025|50281843|FG001|Overall Study|Lost to Follow-up|13|||
25161365|NCT01845025|50281842|FG000|Overall Study|Administrative problems|8|||
25161366|NCT01845025|50281843|FG001|Overall Study|Administrative problems|8|||
25161367|NCT01845025|50281842|FG000|Overall Study|Death|2|||
25161368|NCT01845025|50281843|FG001|Overall Study|Death|0|||
25161369|NCT01845025|50281842|FG000|Overall Study|Protocol deviation|3|||
25161370|NCT01845025|50281843|FG001|Overall Study|Protocol deviation|6|||
25161371|NCT01845025|50281842|FG000|Overall Study|Missing|1|||
25161372|NCT01845025|50281843|FG001|Overall Study|Missing|1|||
25161373|NCT01870297|50281884|FG000|Overall Study|Adverse Event|0|||
25161374|NCT01870297|50281885|FG001|Overall Study|Adverse Event|0|||
24956981|NCT00503399|50047899|FG001|Overall Study|Lost to Follow-up|2|||
24956982|NCT00506519|50047908|FG000|Overall Study|Death|4|||
24956983|NCT00506519|50047909|FG001|Overall Study|Death|6|||
24956984|NCT00506519|50047910|FG002|Overall Study|Death|0|||
25043362|NCT02915016|50144720|FG003|Overall Study|Lost to Follow-up|3|||
25043363|NCT02915016|50144721|FG004|Overall Study|Lost to Follow-up|5|||
25043364|NCT02915016|50144722|FG005|Overall Study|Lost to Follow-up|2|||
25043365|NCT02915016|50144723|FG006|Overall Study|Lost to Follow-up|8|||
25043366|NCT02915016|50144724|FG007|Overall Study|Lost to Follow-up|2|||
25043367|NCT02915016|50144717|FG000|Overall Study|Physician Decision|0|||
25043368|NCT02915016|50144718|FG001|Overall Study|Physician Decision|0|||
25043369|NCT02915016|50144719|FG002|Overall Study|Physician Decision|1|||
25043370|NCT02915016|50144720|FG003|Overall Study|Physician Decision|0|||
25043371|NCT02915016|50144721|FG004|Overall Study|Physician Decision|0|||
25043372|NCT02915016|50144722|FG005|Overall Study|Physician Decision|1|||
25043373|NCT02915016|50144723|FG006|Overall Study|Physician Decision|2|||
25043374|NCT02915016|50144724|FG007|Overall Study|Physician Decision|0|||
25043375|NCT02915016|50144717|FG000|Overall Study|Withdrawal by Subject|2|||
25043376|NCT02915016|50144718|FG001|Overall Study|Withdrawal by Subject|0|||
25043377|NCT02915016|50144719|FG002|Overall Study|Withdrawal by Subject|1|||
24956985|NCT00506519|50047908|FG000|Overall Study|Adverse Event|1|||
24956986|NCT00506519|50047909|FG001|Overall Study|Adverse Event|0|||
24956987|NCT00506519|50047910|FG002|Overall Study|Adverse Event|0|||
24956988|NCT00503009|50047924|FG000|Overall Study|Protocol Violation|1|||
24956989|NCT00503009|50047925|FG001|Overall Study|Protocol Violation|0|||
24956990|NCT00503009|50047926|FG002|Overall Study|Protocol Violation|1|||
24956991|NCT00503009|50047924|FG000|Overall Study|Withdrawal by Subject|0|||
24956992|NCT00503009|50047925|FG001|Overall Study|Withdrawal by Subject|1|||
24956993|NCT00503009|50047926|FG002|Overall Study|Withdrawal by Subject|1|||
24956994|NCT00503009|50047924|FG000|Overall Study|Physician Decision|0|||
24956995|NCT00503009|50047925|FG001|Overall Study|Physician Decision|1|||
24956996|NCT00503009|50047926|FG002|Overall Study|Physician Decision|1|||
24956997|NCT00160251|50047940|FG000|Prior to Amendment 2|Adverse Event|2|||
24956998|NCT00160251|50047941|FG001|Prior to Amendment 2|Adverse Event|1|||
24956999|NCT00160251|50047942|FG002|Prior to Amendment 2|Adverse Event|3|||
24957000|NCT00160251|50047943|FG003|Prior to Amendment 2|Adverse Event|1|||
24957001|NCT00160251|50047944|FG004|Prior to Amendment 2|Adverse Event|1|||
24957002|NCT00160251|50047945|FG005|Prior to Amendment 2|Adverse Event|1|||
24957003|NCT00160251|50047946|FG006|Prior to Amendment 2|Adverse Event|1|||
24957004|NCT00160251|50047947|FG007|Prior to Amendment 2|Adverse Event|0|||
24957005|NCT00160251|50047940|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
24957006|NCT00160251|50047941|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
24957007|NCT00160251|50047942|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
24957008|NCT00160251|50047943|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
24957009|NCT00160251|50047944|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
24957010|NCT00160251|50047945|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
24957011|NCT00160251|50047946|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
25043378|NCT02915016|50144720|FG003|Overall Study|Withdrawal by Subject|0|||
24957012|NCT00160251|50047947|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
24957013|NCT00160251|50047940|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
24957014|NCT00160251|50047941|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
24957015|NCT00160251|50047942|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
25043379|NCT02915016|50144721|FG004|Overall Study|Withdrawal by Subject|1|||
25043380|NCT02915016|50144722|FG005|Overall Study|Withdrawal by Subject|3|||
25043381|NCT02915016|50144723|FG006|Overall Study|Withdrawal by Subject|1|||
25161375|NCT01870297|50281886|FG002|Overall Study|Adverse Event|0|||
25161376|NCT01870297|50281887|FG003|Overall Study|Adverse Event|0|||
25161377|NCT01870297|50281888|FG004|Overall Study|Adverse Event|2|||
25161378|NCT01870297|50281889|FG005|Overall Study|Adverse Event|0|||
24957016|NCT00160251|50047943|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
24957017|NCT00160251|50047944|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
25161379|NCT01870297|50281890|FG006|Overall Study|Adverse Event|0|||
25161380|NCT01870297|50281884|FG000|Overall Study|Lost to Follow-up|0|||
25161381|NCT01870297|50281885|FG001|Overall Study|Lost to Follow-up|1|||
25161382|NCT01870297|50281886|FG002|Overall Study|Lost to Follow-up|1|||
25161383|NCT01870297|50281887|FG003|Overall Study|Lost to Follow-up|0|||
25161384|NCT01870297|50281888|FG004|Overall Study|Lost to Follow-up|0|||
25161385|NCT01870297|50281889|FG005|Overall Study|Lost to Follow-up|0|||
25161386|NCT01870297|50281890|FG006|Overall Study|Lost to Follow-up|0|||
25161387|NCT01870297|50281884|FG000|Overall Study|Withdrawal by Subject|0|||
25161388|NCT01870297|50281885|FG001|Overall Study|Withdrawal by Subject|0|||
25161389|NCT01870297|50281886|FG002|Overall Study|Withdrawal by Subject|0|||
25161390|NCT01870297|50281887|FG003|Overall Study|Withdrawal by Subject|0|||
25161391|NCT01870297|50281888|FG004|Overall Study|Withdrawal by Subject|1|||
25161392|NCT01870297|50281889|FG005|Overall Study|Withdrawal by Subject|1|||
25161393|NCT01870297|50281890|FG006|Overall Study|Withdrawal by Subject|1|||
25161394|NCT01870297|50281884|FG000|Overall Study|Sponsor Decision|0|||
25161395|NCT01870297|50281885|FG001|Overall Study|Sponsor Decision|6|||
25161396|NCT01870297|50281886|FG002|Overall Study|Sponsor Decision|0|||
25161397|NCT01870297|50281887|FG003|Overall Study|Sponsor Decision|0|||
25161398|NCT01870297|50281888|FG004|Overall Study|Sponsor Decision|0|||
25161399|NCT01870297|50281889|FG005|Overall Study|Sponsor Decision|0|||
25161400|NCT01870297|50281890|FG006|Overall Study|Sponsor Decision|1|||
25161401|NCT01814761|50281917|FG000|Overall Study|Other Reasons|1|||
25161402|NCT01814761|50281918|FG001|Overall Study|Other Reasons|10|||
25161403|NCT01814761|50281917|FG000|Overall Study|Ocular Adverse Event|6|||
25161404|NCT01814761|50281918|FG001|Overall Study|Ocular Adverse Event|15|||
25161405|NCT01814761|50281917|FG000|Overall Study|Lost to Follow-up|1|||
25161406|NCT01814761|50281918|FG001|Overall Study|Lost to Follow-up|5|||
25161407|NCT01843933|50281926|FG000|Overall Study|Data lost|6|||
25161408|NCT01843933|50281927|FG001|Overall Study|Data lost|4|||
25161409|NCT01814371|50281935|FG000|Overall Study|Lost to Follow-up|30|||
25161410|NCT01814371|50281936|FG001|Overall Study|Lost to Follow-up|27|||
25161411|NCT01814137|50282010|FG000|Overall Study|Adverse Event|0|||
25161412|NCT01814137|50282011|FG001|Overall Study|Adverse Event|1|||
25161413|NCT01814137|50282010|FG000|Overall Study|Withdrawal by Subject|2|||
25161414|NCT01814137|50282011|FG001|Overall Study|Withdrawal by Subject|2|||
25161415|NCT01814137|50282010|FG000|Overall Study|Physician Decision|1|||
25161416|NCT01814137|50282011|FG001|Overall Study|Physician Decision|1|||
25161417|NCT01814137|50282010|FG000|Overall Study|Unclassified|2|||
25043382|NCT02915016|50144724|FG007|Overall Study|Withdrawal by Subject|1|||
25043383|NCT02915016|50144717|FG000|Overall Study|Elected not to continue|0|||
25043384|NCT02915016|50144718|FG001|Overall Study|Elected not to continue|0|||
25043385|NCT02915016|50144719|FG002|Overall Study|Elected not to continue|0|||
25043386|NCT02915016|50144720|FG003|Overall Study|Elected not to continue|1|||
25043387|NCT02915016|50144721|FG004|Overall Study|Elected not to continue|0|||
25043388|NCT02915016|50144722|FG005|Overall Study|Elected not to continue|0|||
25161418|NCT01814137|50282011|FG001|Overall Study|Unclassified|1|||
25161419|NCT01813435|50282028|FG000|Overall Study|did not finish experimental regimen|1902|||
25161420|NCT01813435|50282029|FG001|Overall Study|did not finish experimental regimen|770|||
25161421|NCT01813435|50282028|FG000|Overall Study|Lost to Follow-up|268|||
25161422|NCT01813435|50282029|FG001|Overall Study|Lost to Follow-up|237|||
25161423|NCT01813357|50282037|FG000|Overall Study|Lost to Follow-up|5|||
25161424|NCT01813357|50282038|FG001|Overall Study|Lost to Follow-up|6|||
25161425|NCT01812655|50282047|FG000|Overall Study|Protocol Violation|1|||
25161426|NCT01812655|50282048|FG001|Overall Study|Protocol Violation|1|||
25161427|NCT01812655|50282049|FG002|Overall Study|Protocol Violation|0|||
25161428|NCT01812109|50282070|FG000|Overall Study|research personnel delay|16|||
25161429|NCT01812109|50282070|FG000|Overall Study|NIRS Unattainable|17|||
25161430|NCT01811953|50282080|FG000|Overall Study|Adverse Event|0|||
25161431|NCT01811953|50282081|FG001|Overall Study|Adverse Event|0|||
25161432|NCT01811953|50282082|FG002|Overall Study|Adverse Event|0|||
25161433|NCT01811953|50282083|FG003|Overall Study|Adverse Event|1|||
25276293|NCT00960934|50590275|FG004|Overall Study|Adverse Event|4|||
25043389|NCT02915016|50144723|FG006|Overall Study|Elected not to continue|1|||
25043390|NCT02915016|50144724|FG007|Overall Study|Elected not to continue|0|||
25043391|NCT02915016|50144717|FG000|Overall Study|HIV infection|1|||
25161434|NCT01811953|50282084|FG004|Overall Study|Adverse Event|0|||
25161435|NCT01811953|50282085|FG005|Overall Study|Adverse Event|1|||
25161436|NCT01811953|50282080|FG000|Overall Study|Protocol Violation|0|||
25161437|NCT01811953|50282081|FG001|Overall Study|Protocol Violation|0|||
25161438|NCT01811953|50282082|FG002|Overall Study|Protocol Violation|0|||
25161439|NCT01811953|50282083|FG003|Overall Study|Protocol Violation|0|||
25161440|NCT01811953|50282084|FG004|Overall Study|Protocol Violation|1|||
25161441|NCT01811953|50282085|FG005|Overall Study|Protocol Violation|0|||
25161442|NCT01811563|50282101|FG000|Overall Study|Lost to Follow-up|5|||
25161443|NCT01811563|50282102|FG001|Overall Study|Lost to Follow-up|2|||
25161444|NCT01811563|50282101|FG000|Overall Study|Incorrect Randomization procedure|0|||
25161445|NCT01811563|50282102|FG001|Overall Study|Incorrect Randomization procedure|1|||
25161446|NCT01811485|50282111|FG000|Overall Study|Adverse Event|1|||
25161447|NCT01811485|50282112|FG001|Overall Study|Adverse Event|3|||
25043392|NCT02915016|50144718|FG001|Overall Study|HIV infection|1|||
25043393|NCT02915016|50144719|FG002|Overall Study|HIV infection|1|||
25043394|NCT02915016|50144720|FG003|Overall Study|HIV infection|0|||
25161448|NCT01811485|50282113|FG002|Overall Study|Adverse Event|2|||
25161449|NCT01811485|50282111|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25161450|NCT01811485|50282112|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
25161451|NCT01811485|50282113|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
25161452|NCT01811485|50282111|FG000|Overall Study|Administrative problems|1|||
25161453|NCT01811485|50282112|FG001|Overall Study|Administrative problems|0|||
25161454|NCT01811485|50282113|FG002|Overall Study|Administrative problems|0|||
25161455|NCT01811485|50282111|FG000|Overall Study|Protocol Deviation|0|||
25161456|NCT01811485|50282112|FG001|Overall Study|Protocol Deviation|1|||
25161457|NCT01811485|50282113|FG002|Overall Study|Protocol Deviation|0|||
25161458|NCT01810939|50282124|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
25161459|NCT01810939|50282125|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
25161460|NCT01810939|50282126|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
25161461|NCT01810939|50282124|FG000|Part A Treatment Period|Protocol Violation|2|||
25161462|NCT01810939|50282125|FG001|Part A Treatment Period|Protocol Violation|0|||
25161463|NCT01810939|50282126|FG002|Part A Treatment Period|Protocol Violation|0|||
25161464|NCT01810939|50282124|FG000|Part A Treatment Period|Adverse Event|10|||
25161465|NCT01810939|50282125|FG001|Part A Treatment Period|Adverse Event|0|||
25161466|NCT01810939|50282126|FG002|Part A Treatment Period|Adverse Event|0|||
25161467|NCT01810939|50282124|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
25161468|NCT01810939|50282125|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
25161469|NCT01810939|50282126|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
25161470|NCT01810939|50282124|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
25161471|NCT01810939|50282125|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
25161472|NCT01810939|50282126|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
25161473|NCT01810939|50282124|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
25161474|NCT01810939|50282125|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
25161475|NCT01810939|50282126|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
25161476|NCT01810939|50282124|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
25161477|NCT01810939|50282125|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
25161478|NCT01810939|50282126|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
25161479|NCT01810939|50282124|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
25161480|NCT01810939|50282125|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
25161481|NCT01810939|50282126|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
25161482|NCT01810939|50282124|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
25161483|NCT01810939|50282125|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
25161484|NCT01810939|50282126|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
25161485|NCT01810939|50282124|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
25161486|NCT01810939|50282125|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
25161487|NCT01810939|50282126|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
25161488|NCT01810939|50282124|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
25161489|NCT01810939|50282125|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
25161490|NCT01810939|50282126|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
25161491|NCT01810939|50282124|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
25161492|NCT01810939|50282125|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
25161493|NCT01810939|50282126|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
25161494|NCT01810939|50282124|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
25161495|NCT01810939|50282125|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
25161496|NCT01810939|50282126|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
24957018|NCT00160251|50047945|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
24957019|NCT00160251|50047946|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
24957020|NCT00160251|50047947|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
24957021|NCT00160251|50047940|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
24957022|NCT00160251|50047941|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
24957023|NCT00160251|50047942|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
24957024|NCT00160251|50047943|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
24957025|NCT00160251|50047944|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
24957026|NCT00160251|50047945|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
24957027|NCT00160251|50047946|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
25043395|NCT02915016|50144721|FG004|Overall Study|HIV infection|1|||
25043396|NCT02915016|50144722|FG005|Overall Study|HIV infection|0|||
25043397|NCT02915016|50144723|FG006|Overall Study|HIV infection|0|||
25161497|NCT01810939|50282124|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
25161498|NCT01810939|50282125|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
25161499|NCT01810939|50282126|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
25043398|NCT02915016|50144724|FG007|Overall Study|HIV infection|0|||
25161500|NCT01810939|50282124|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
25161501|NCT01810939|50282125|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
25161502|NCT01810939|50282126|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
25161503|NCT01810939|50282124|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
25161504|NCT01810939|50282125|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
25161505|NCT01810939|50282126|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
25161506|NCT01810939|50282124|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
25161507|NCT01810939|50282125|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
25161508|NCT01810939|50282126|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
25161509|NCT01810783|50282145|FG000|Overall Study|Adverse Event|32|||
25161510|NCT01810783|50282145|FG000|Overall Study|Withdrawal by Subject|22|||
25161511|NCT01810783|50282145|FG000|Overall Study|Lack of Efficacy|12|||
25161512|NCT01810783|50282145|FG000|Overall Study|Lost to Follow-up|10|||
25161513|NCT01810783|50282145|FG000|Overall Study|Protocol Violation|5|||
25161514|NCT01810783|50282145|FG000|Overall Study|Non-compliance with IMP|4|||
25161515|NCT01810783|50282145|FG000|Overall Study|Adminstrative or other reason(s)|23|||
25161516|NCT01810783|50282145|FG000|Overall Study|Enrolled, not treated|1|||
25161517|NCT01808209|50282166|FG000|Overall Study|Lost to Follow-up|0|||
25161518|NCT01808209|50282167|FG001|Overall Study|Lost to Follow-up|1|||
25161519|NCT01807117|50282177|FG000|Overall Study|Physician Decision|2|||
25161520|NCT01807117|50282177|FG000|Overall Study|Disease diagnosis not a study disease|1|||
25161521|NCT01806961|50282183|FG000|Overall Study|sponsor decision|16|||
25161522|NCT01613131|50282189|FG000|Overall Study|Withdrawal by Subject|3|||
25161523|NCT01613131|50282190|FG001|Overall Study|Withdrawal by Subject|5|||
25161524|NCT01868893|50282196|FG000|Overall Study|Adverse Event|2|||
25161525|NCT01868893|50282196|FG000|Overall Study|Commercial availability of study drug|17|||
25161526|NCT01868893|50282196|FG000|Overall Study|Neutropenia|1|||
25161527|NCT01868503|50282202|FG000|Overall Study|Withdrawal by Subject|1|||
25161528|NCT01868503|50282202|FG000|Overall Study|Protocol Violation|1|||
25161529|NCT01868035|50282212|FG000|Overall Study|Lost to Follow-up|3|||
25161530|NCT01868035|50282212|FG000|Overall Study|Withdrawal by Subject|1|||
25161531|NCT01868035|50282212|FG000|Overall Study|Progressive Disease|2|||
25161532|NCT01868035|50282212|FG000|Overall Study|Non-compliance|1|||
25161533|NCT01609933|50282216|FG000|Overall Study|Adverse Event|1|||
25161534|NCT01609933|50282216|FG000|Overall Study|Withdrawal by Subject|3|||
25161535|NCT01843777|50282224|FG000|Overall Study|Withdrawal by Subject|1|||
25161536|NCT01843777|50282225|FG001|Overall Study|Withdrawal by Subject|0|||
25161537|NCT01842607|50282231|FG000|Overall Study|Adverse Event|11|||
25161538|NCT01842607|50282231|FG000|Overall Study|Lack of Efficacy|19|||
25161539|NCT01842607|50282231|FG000|Overall Study|Protocol Violation|8|||
25161540|NCT01842607|50282231|FG000|Overall Study|Protocol defined stopping criteria|2|||
25161541|NCT01842607|50282231|FG000|Overall Study|Lost to Follow-up|3|||
25161542|NCT01842607|50282231|FG000|Overall Study|Physician Decision|9|||
25161543|NCT01842607|50282231|FG000|Overall Study|Withdrawal by Subject|14|||
25161544|NCT01803607|50282237|FG000|Overall Study|Adverse Event|5|||
25161545|NCT01803607|50282238|FG001|Overall Study|Adverse Event|3|||
25161546|NCT01803607|50282237|FG000|Overall Study|Lack of Efficacy|0|||
25161547|NCT01803607|50282238|FG001|Overall Study|Lack of Efficacy|1|||
25161548|NCT01803607|50282237|FG000|Overall Study|Protocol Violation|3|||
25161549|NCT01803607|50282238|FG001|Overall Study|Protocol Violation|2|||
25161550|NCT01803607|50282237|FG000|Overall Study|Study terminated by sponsor|54|||
25161551|NCT01803607|50282238|FG001|Overall Study|Study terminated by sponsor|56|||
25161552|NCT01803607|50282237|FG000|Overall Study|Withdrawal by Subject|6|||
25161553|NCT01803607|50282238|FG001|Overall Study|Withdrawal by Subject|5|||
25161554|NCT01867021|50282246|FG000|Overall Study|Adverse Event|0|||
25161555|NCT01867021|50282247|FG001|Overall Study|Adverse Event|1|||
25161556|NCT01867021|50282246|FG000|Overall Study|Not Eligible|0|||
25161557|NCT01867021|50282247|FG001|Overall Study|Not Eligible|1|||
24957028|NCT00160251|50047947|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
25043399|NCT02915016|50144717|FG000|Overall Study|Participant unable to adhere|0|||
25161558|NCT01867021|50282246|FG000|Overall Study|Death|1|||
25161559|NCT01867021|50282247|FG001|Overall Study|Death|0|||
25161560|NCT01867021|50282246|FG000|Overall Study|Lost to Follow-up|0|||
25161561|NCT01867021|50282247|FG001|Overall Study|Lost to Follow-up|2|||
25161562|NCT01867021|50282246|FG000|Overall Study|Withdrawal by Subject|1|||
25161563|NCT01867021|50282247|FG001|Overall Study|Withdrawal by Subject|6|||
25161564|NCT01866709|50282260|FG000|Overall Study|Adverse Event|1|||
25161565|NCT01866709|50282261|FG001|Overall Study|Adverse Event|0|||
24957029|NCT00160251|50047940|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
24957030|NCT00160251|50047941|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
24957031|NCT00160251|50047942|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
24957032|NCT00160251|50047943|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
25161566|NCT01841593|50282269|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
25161567|NCT01841593|50282270|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
25276294|NCT00960934|50590276|FG005|Overall Study|Adverse Event|3|||
25043400|NCT02915016|50144718|FG001|Overall Study|Participant unable to adhere|0|||
25161568|NCT01841593|50282269|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
25161569|NCT01841593|50282270|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
25161570|NCT01866319|50282538|FG000|Overall Study|Adverse Event|12|||
25161571|NCT01866319|50282539|FG001|Overall Study|Adverse Event|5|||
25161572|NCT01866319|50282540|FG002|Overall Study|Adverse Event|9|||
25161573|NCT01866319|50282538|FG000|Overall Study|Clinical progression|3|||
25161574|NCT01866319|50282539|FG001|Overall Study|Clinical progression|2|||
25161575|NCT01866319|50282540|FG002|Overall Study|Clinical progression|2|||
25161576|NCT01866319|50282538|FG000|Overall Study|Death|153|||
25161577|NCT01866319|50282539|FG001|Overall Study|Death|154|||
25161578|NCT01866319|50282540|FG002|Overall Study|Death|147|||
25161579|NCT01866319|50282538|FG000|Overall Study|Lost to Follow-up|6|||
25161580|NCT01866319|50282539|FG001|Overall Study|Lost to Follow-up|3|||
25161581|NCT01866319|50282540|FG002|Overall Study|Lost to Follow-up|8|||
25161582|NCT01866319|50282538|FG000|Overall Study|Physician Decision|1|||
25161583|NCT01866319|50282539|FG001|Overall Study|Physician Decision|0|||
25161584|NCT01866319|50282540|FG002|Overall Study|Physician Decision|1|||
25161585|NCT01866319|50282538|FG000|Overall Study|Protocol Violation|0|||
25161586|NCT01866319|50282539|FG001|Overall Study|Protocol Violation|0|||
25161587|NCT01866319|50282540|FG002|Overall Study|Protocol Violation|1|||
25161588|NCT01866319|50282538|FG000|Overall Study|Withdrawal by Subject|32|||
25161589|NCT01866319|50282539|FG001|Overall Study|Withdrawal by Subject|14|||
25161590|NCT01866319|50282540|FG002|Overall Study|Withdrawal by Subject|12|||
25161591|NCT01802515|50282567|FG000|Overall Study|Withdrawal by Subject|3|||
25161592|NCT01802515|50282568|FG001|Overall Study|Withdrawal by Subject|0|||
25161593|NCT01802515|50282569|FG002|Overall Study|Withdrawal by Subject|0|||
25161594|NCT01802437|50282579|FG000|Overall Study|Lost to Follow-up|1|||
25161595|NCT01802437|50282580|FG001|Overall Study|Lost to Follow-up|0|||
25161596|NCT01802437|50282579|FG000|Overall Study|Withdrawal by Subject|3|||
25161597|NCT01802437|50282580|FG001|Overall Study|Withdrawal by Subject|4|||
25161598|NCT01801735|50282687|FG000|Overall Study|Adverse Event|79|||
24957033|NCT00160251|50047944|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
24957034|NCT00160251|50047945|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
24957035|NCT00160251|50047946|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
24957036|NCT00160251|50047947|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
24957037|NCT00160251|50047940|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
24957038|NCT00160251|50047941|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
24957039|NCT00160251|50047942|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
24957040|NCT00160251|50047943|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
24957041|NCT00160251|50047944|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
24957042|NCT00160251|50047945|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
24957043|NCT00160251|50047946|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
24957044|NCT00160251|50047947|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
24957045|NCT00160251|50047940|FG000|Post-amendment 2|Adverse Event|0|||
24957046|NCT00160251|50047941|FG001|Post-amendment 2|Adverse Event|0|||
24957047|NCT00160251|50047942|FG002|Post-amendment 2|Adverse Event|0|||
24957048|NCT00160251|50047943|FG003|Post-amendment 2|Adverse Event|0|||
24957049|NCT00160251|50047944|FG004|Post-amendment 2|Adverse Event|0|||
24957050|NCT00160251|50047945|FG005|Post-amendment 2|Adverse Event|0|||
24957051|NCT00160251|50047946|FG006|Post-amendment 2|Adverse Event|0|||
24957052|NCT00160251|50047947|FG007|Post-amendment 2|Adverse Event|20|||
24957053|NCT00160251|50047940|FG000|Post-amendment 2|Lack of Efficacy|0|||
24957054|NCT00160251|50047941|FG001|Post-amendment 2|Lack of Efficacy|0|||
24957055|NCT00160251|50047942|FG002|Post-amendment 2|Lack of Efficacy|0|||
24957056|NCT00160251|50047943|FG003|Post-amendment 2|Lack of Efficacy|0|||
24957057|NCT00160251|50047944|FG004|Post-amendment 2|Lack of Efficacy|0|||
24957058|NCT00160251|50047945|FG005|Post-amendment 2|Lack of Efficacy|0|||
24957059|NCT00160251|50047946|FG006|Post-amendment 2|Lack of Efficacy|0|||
24957060|NCT00160251|50047947|FG007|Post-amendment 2|Lack of Efficacy|24|||
24957061|NCT00160251|50047940|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
24957062|NCT00160251|50047941|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
24957063|NCT00160251|50047942|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
24957064|NCT00160251|50047943|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
24957065|NCT00160251|50047944|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
24957066|NCT00160251|50047945|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
24957067|NCT00160251|50047946|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
25161599|NCT01801735|50282687|FG000|Overall Study|Lack of Efficacy|28|||
24957068|NCT00160251|50047947|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
25043401|NCT02915016|50144719|FG002|Overall Study|Participant unable to adhere|0|||
25161600|NCT01801735|50282687|FG000|Overall Study|Withdrawal by Subject|27|||
24957069|NCT00506441|50048004|FG000|Period 1; Open-label Period|Adverse Event|21|||
24957070|NCT00506441|50048005|FG001|Period 1; Open-label Period|Adverse Event|0|||
24957071|NCT00506441|50048004|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
25161601|NCT01801735|50282687|FG000|Overall Study|Protocol Violation|25|||
25161602|NCT01801735|50282687|FG000|Overall Study|Lost to Follow-up|15|||
25161603|NCT01801735|50282687|FG000|Overall Study|Non-compliance with Trial Drug|13|||
25161604|NCT01801735|50282687|FG000|Overall Study|Physician Decision|3|||
25161605|NCT01801735|50282687|FG000|Overall Study|Death|1|||
25161606|NCT01801735|50282687|FG000|Overall Study|Other, including site closure|19|||
25276295|NCT00960934|50590271|FG000|Overall Study|Lack of Efficacy|1|||
25276296|NCT00960934|50590272|FG001|Overall Study|Lack of Efficacy|0|||
25276297|NCT00960934|50590273|FG002|Overall Study|Lack of Efficacy|0|||
25276298|NCT00960934|50590274|FG003|Overall Study|Lack of Efficacy|0|||
25161611|NCT01840579|50283460|FG000|Overall Study|Status not recorded|0|||
25161612|NCT01840579|50283461|FG001|Overall Study|Status not recorded|0|||
25161613|NCT01840579|50283462|FG002|Overall Study|Status not recorded|2|||
25161614|NCT01840579|50283463|FG003|Overall Study|Status not recorded|3|||
25161615|NCT01840579|50283464|FG004|Overall Study|Status not recorded|4|||
25161616|NCT01840579|50283465|FG005|Overall Study|Status not recorded|3|||
25161617|NCT01840579|50283466|FG006|Overall Study|Status not recorded|0|||
25161618|NCT01840579|50283467|FG007|Overall Study|Status not recorded|3|||
25161619|NCT01840579|50283468|FG008|Overall Study|Status not recorded|3|||
25161620|NCT01840579|50283469|FG009|Overall Study|Status not recorded|3|||
25161621|NCT01840579|50283460|FG000|Overall Study|Progressive disease|3|||
25161622|NCT01840579|50283461|FG001|Overall Study|Progressive disease|5|||
25161623|NCT01840579|50283462|FG002|Overall Study|Progressive disease|0|||
25161624|NCT01840579|50283463|FG003|Overall Study|Progressive disease|0|||
25161625|NCT01840579|50283464|FG004|Overall Study|Progressive disease|0|||
25161626|NCT01840579|50283465|FG005|Overall Study|Progressive disease|0|||
25161627|NCT01840579|50283466|FG006|Overall Study|Progressive disease|0|||
25161628|NCT01840579|50283467|FG007|Overall Study|Progressive disease|0|||
25161629|NCT01840579|50283468|FG008|Overall Study|Progressive disease|0|||
25161630|NCT01840579|50283469|FG009|Overall Study|Progressive disease|0|||
25161631|NCT01840579|50283460|FG000|Overall Study|Ongoing in study|0|||
25043402|NCT02915016|50144720|FG003|Overall Study|Participant unable to adhere|0|||
25043403|NCT02915016|50144721|FG004|Overall Study|Participant unable to adhere|0|||
25043404|NCT02915016|50144722|FG005|Overall Study|Participant unable to adhere|0|||
25043405|NCT02915016|50144723|FG006|Overall Study|Participant unable to adhere|0|||
25043406|NCT02915016|50144724|FG007|Overall Study|Participant unable to adhere|1|||
25161632|NCT01840579|50283461|FG001|Overall Study|Ongoing in study|1|||
25161633|NCT01840579|50283462|FG002|Overall Study|Ongoing in study|0|||
25161634|NCT01840579|50283463|FG003|Overall Study|Ongoing in study|0|||
25161635|NCT01840579|50283464|FG004|Overall Study|Ongoing in study|0|||
25161636|NCT01840579|50283465|FG005|Overall Study|Ongoing in study|0|||
25161637|NCT01840579|50283466|FG006|Overall Study|Ongoing in study|0|||
25161638|NCT01840579|50283467|FG007|Overall Study|Ongoing in study|0|||
25161639|NCT01840579|50283468|FG008|Overall Study|Ongoing in study|0|||
25161640|NCT01840579|50283469|FG009|Overall Study|Ongoing in study|0|||
25161641|NCT01840579|50283460|FG000|Overall Study|Death|0|||
25161642|NCT01840579|50283461|FG001|Overall Study|Death|0|||
25161643|NCT01840579|50283462|FG002|Overall Study|Death|0|||
25161644|NCT01840579|50283463|FG003|Overall Study|Death|0|||
25161645|NCT01840579|50283464|FG004|Overall Study|Death|0|||
25161646|NCT01840579|50283465|FG005|Overall Study|Death|1|||
25161647|NCT01840579|50283466|FG006|Overall Study|Death|0|||
25161648|NCT01840579|50283467|FG007|Overall Study|Death|0|||
25161649|NCT01840579|50283468|FG008|Overall Study|Death|0|||
25161650|NCT01840579|50283469|FG009|Overall Study|Death|0|||
25161651|NCT01840579|50283460|FG000|Overall Study|Adverse Event|0|||
25161652|NCT01840579|50283461|FG001|Overall Study|Adverse Event|1|||
25161653|NCT01840579|50283462|FG002|Overall Study|Adverse Event|0|||
25161654|NCT01840579|50283463|FG003|Overall Study|Adverse Event|0|||
25161655|NCT01840579|50283464|FG004|Overall Study|Adverse Event|0|||
24957072|NCT00506441|50048005|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
24957073|NCT00506441|50048004|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
24957074|NCT00506441|50048005|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
24957075|NCT00506441|50048004|FG000|Period 1; Open-label Period|Physician Decision|5|||
24957076|NCT00506441|50048005|FG001|Period 1; Open-label Period|Physician Decision|0|||
24957077|NCT00506441|50048004|FG000|Period 1; Open-label Period|Protocol Violation|9|||
24957078|NCT00506441|50048005|FG001|Period 1; Open-label Period|Protocol Violation|0|||
24957079|NCT00506441|50048004|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
24957080|NCT00506441|50048005|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
24957081|NCT00506441|50048004|FG000|Period 1; Open-label Period|Other Reasons|13|||
24957082|NCT00506441|50048005|FG001|Period 1; Open-label Period|Other Reasons|0|||
25043407|NCT03323749|50144744|FG000|Double-blind Period|Lost to Follow-up|4|||
25161656|NCT01840579|50283465|FG005|Overall Study|Adverse Event|0|||
25161657|NCT01840579|50283466|FG006|Overall Study|Adverse Event|0|||
25161658|NCT01840579|50283467|FG007|Overall Study|Adverse Event|0|||
25161659|NCT01840579|50283468|FG008|Overall Study|Adverse Event|0|||
25161660|NCT01840579|50283469|FG009|Overall Study|Adverse Event|0|||
25161661|NCT01840579|50283460|FG000|Overall Study|Follow-up ended by Sponsor|0|||
25161662|NCT01840579|50283461|FG001|Overall Study|Follow-up ended by Sponsor|0|||
25161663|NCT01840579|50283462|FG002|Overall Study|Follow-up ended by Sponsor|0|||
25276299|NCT00960934|50590275|FG004|Overall Study|Lack of Efficacy|0|||
25161664|NCT01840579|50283463|FG003|Overall Study|Follow-up ended by Sponsor|0|||
25161665|NCT01840579|50283464|FG004|Overall Study|Follow-up ended by Sponsor|0|||
25161666|NCT01840579|50283465|FG005|Overall Study|Follow-up ended by Sponsor|0|||
25043408|NCT03323749|50144745|FG001|Double-blind Period|Lost to Follow-up|5|||
25043409|NCT03323749|50144744|FG000|Double-blind Period|Adverse Event|3|||
25043410|NCT03323749|50144745|FG001|Double-blind Period|Adverse Event|1|||
25043411|NCT03323749|50144744|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
25043412|NCT03323749|50144745|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
25043413|NCT03323749|50144744|FG000|Open-Label Period|Adverse Event|3|||
25043414|NCT03323749|50144745|FG001|Open-Label Period|Adverse Event|10|||
25043415|NCT03323749|50144744|FG000|Open-Label Period|Withdrawal by Subject|7|||
25043416|NCT03323749|50144745|FG001|Open-Label Period|Withdrawal by Subject|5|||
25043417|NCT02208024|50144764|FG000|Overall Study|Withdrawal by Subject|1|||
25043418|NCT02660086|50144770|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
25043419|NCT02660086|50144771|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
25043420|NCT02660086|50144770|FG000|Overall Study- 12-month|Left full-time employment|12|||
25043421|NCT02660086|50144771|FG001|Overall Study- 12-month|Left full-time employment|20|||
25043422|NCT02660086|50144770|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
25043423|NCT02660086|50144771|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
25043424|NCT02660086|50144770|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
25043425|NCT02660086|50144771|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
25043426|NCT02660086|50144770|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
25043427|NCT02660086|50144771|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
25043428|NCT02660086|50144770|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
25043429|NCT02660086|50144771|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
25043430|NCT01678144|50144777|FG000|Stage 1: MAR Classic|Adverse Event|1|||
25043431|NCT00153920|50144781|FG000|Overall Study|Adverse Event|9|||
25043432|NCT00153920|50144781|FG000|Overall Study|Progressive Disease|9|||
25043433|NCT00153920|50144781|FG000|Overall Study|Physician Decision|3|||
25043434|NCT00153920|50144781|FG000|Overall Study|Lack of Response|3|||
25043435|NCT00153920|50144781|FG000|Overall Study|Death|2|||
25043436|NCT00153920|50144781|FG000|Overall Study|Withdrawal by Subject|1|||
25043437|NCT00153920|50144781|FG000|Overall Study|Non-Protocol Therapy|1|||
25043438|NCT00153920|50144781|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
25043439|NCT00153920|50144781|FG000|Overall Study|Progressive Disease before Trt|1|||
25043440|NCT02660242|50144785|FG000|Glucose Tabs|Lost to Follow-up|1|||
25043441|NCT02660242|50144785|FG000|Glucagon Injection|Lost to Follow-up|1|||
25161667|NCT01840579|50283466|FG006|Overall Study|Follow-up ended by Sponsor|2|||
25161668|NCT01840579|50283467|FG007|Overall Study|Follow-up ended by Sponsor|0|||
25161669|NCT01840579|50283468|FG008|Overall Study|Follow-up ended by Sponsor|0|||
25161670|NCT01840579|50283469|FG009|Overall Study|Follow-up ended by Sponsor|0|||
25161671|NCT01801111|50283548|FG000|Overall Study|Adverse Event|12|||
25161672|NCT01801111|50283548|FG000|Overall Study|Death|8|||
25161673|NCT01801111|50283548|FG000|Overall Study|Physician Decision|5|||
25161674|NCT01801111|50283548|FG000|Overall Study|Other|1|||
25161675|NCT01801111|50283548|FG000|Overall Study|Withdrawal by Subject|4|||
25161676|NCT01801111|50283548|FG000|Overall Study|Study Terminated by Sponsor|27|||
24957083|NCT00506441|50048004|FG000|Period 2; Double-blind Period|Adverse Event|0|||
24957084|NCT00506441|50048005|FG001|Period 2; Double-blind Period|Adverse Event|1|||
24957085|NCT00506441|50048004|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
24957086|NCT00506441|50048005|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
24957087|NCT00506441|50048004|FG000|Period 2; Double-blind Period|Physician Decision|1|||
24957088|NCT00506441|50048005|FG001|Period 2; Double-blind Period|Physician Decision|1|||
24957089|NCT00506441|50048004|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
24957090|NCT00506441|50048005|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
24957091|NCT00506441|50048004|FG000|Period 2; Double-blind Period|Other Reason|1|||
25043442|NCT03072043|50144801|FG000|Overall Study|Death|0|||
25043443|NCT03072043|50144802|FG001|Overall Study|Death|0|||
25043444|NCT03072043|50144803|FG002|Overall Study|Death|3|||
25043445|NCT03072043|50144801|FG000|Overall Study|Adverse Event|0|||
25043446|NCT03072043|50144802|FG001|Overall Study|Adverse Event|0|||
25043447|NCT03072043|50144803|FG002|Overall Study|Adverse Event|2|||
25161677|NCT01801111|50283548|FG000|Overall Study|Progressive Disease|81|||
25043448|NCT03072043|50144801|FG000|Overall Study|Withdrawal by Subject|0|||
25043449|NCT03072043|50144802|FG001|Overall Study|Withdrawal by Subject|0|||
25043450|NCT03072043|50144803|FG002|Overall Study|Withdrawal by Subject|4|||
25043451|NCT03069313|50144815|FG000|Overall Study|Adverse Event|5|||
25043452|NCT03068767|50144821|FG000|Overall Study|Lost to Follow-up|7|||
25043453|NCT03068767|50144822|FG001|Overall Study|Lost to Follow-up|3|||
25043454|NCT03068767|50144821|FG000|Overall Study|Protocol Violation|3|||
25043455|NCT03068767|50144822|FG001|Overall Study|Protocol Violation|0|||
25043456|NCT03020745|50144836|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
25043457|NCT03020745|50144837|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
25043458|NCT03020745|50144838|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
25043459|NCT03020745|50144839|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
25043460|NCT03020745|50144840|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
25043461|NCT03020745|50144841|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
25043462|NCT03020745|50144842|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
25043463|NCT03020745|50144843|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
25043464|NCT03020745|50144844|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
25043465|NCT03020745|50144845|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
25043466|NCT03020745|50144836|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
25043467|NCT03020745|50144837|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
25043468|NCT03020745|50144838|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
25043469|NCT03020745|50144839|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
25043470|NCT03020745|50144840|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
25043471|NCT03020745|50144841|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
25043472|NCT03020745|50144842|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
25043473|NCT03020745|50144843|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
25043474|NCT03020745|50144844|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
25043475|NCT03020745|50144845|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
25043476|NCT03020745|50144836|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
25043477|NCT03020745|50144837|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
25043478|NCT03020745|50144838|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
25161678|NCT01773967|50283580|FG000|Overall Study|Lost to Follow-up|15|||
25161679|NCT01773967|50283581|FG001|Overall Study|Lost to Follow-up|13|||
25161680|NCT01773889|50283591|FG000|Overall Study|lack of funding|2|||
24957092|NCT00506441|50048005|FG001|Period 2; Double-blind Period|Other Reason|1|||
24957093|NCT00378014|50048032|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
24957094|NCT00378014|50048033|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
24957095|NCT00378014|50048032|FG000|Core (Randomization to Month 11)|Graft loss|1|||
24957096|NCT00378014|50048033|FG001|Core (Randomization to Month 11)|Graft loss|2|||
25161681|NCT01839487|50283769|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
25161682|NCT01839487|50283770|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
24957097|NCT00378014|50048032|FG000|Core (Randomization to Month 11)|Death|5|||
24957098|NCT00378014|50048033|FG001|Core (Randomization to Month 11)|Death|3|||
24957099|NCT00378014|50048032|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
25043479|NCT03020745|50144839|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
25043480|NCT03020745|50144840|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
25043481|NCT03020745|50144841|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
25161683|NCT01839487|50283771|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
25161684|NCT01839487|50283772|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
25161685|NCT01839487|50283773|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
25161686|NCT01839487|50283774|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
25161687|NCT01839487|50283769|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
25161688|NCT01839487|50283770|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
25161689|NCT01839487|50283771|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
25161690|NCT01839487|50283772|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
25043482|NCT03020745|50144842|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
25043483|NCT03020745|50144843|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
25043484|NCT03020745|50144844|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
25043485|NCT03020745|50144845|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
25043486|NCT03020745|50144836|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
25043487|NCT03020745|50144837|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
25043488|NCT03020745|50144838|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
25043489|NCT03020745|50144839|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
25043490|NCT03020745|50144840|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
25043491|NCT03020745|50144841|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
25043492|NCT03020745|50144842|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
25043493|NCT03020745|50144843|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
25043494|NCT03020745|50144844|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
25043495|NCT03020745|50144845|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
25043496|NCT03019965|50144880|FG000|Overall Study|Withdrawal by Subject|1|||
25043497|NCT03019965|50144881|FG001|Overall Study|Withdrawal by Subject|0|||
25043498|NCT03019965|50144880|FG000|Overall Study|Protocol Violation|1|||
25043499|NCT03019965|50144881|FG001|Overall Study|Protocol Violation|3|||
25043500|NCT03019965|50144880|FG000|Overall Study|viral or fungal infection|3|||
25161691|NCT01839487|50283773|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
25161692|NCT01839487|50283774|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
25161693|NCT01839487|50283769|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
25161694|NCT01839487|50283770|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
25161695|NCT01839487|50283771|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
25161696|NCT01839487|50283772|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
25161697|NCT01839487|50283773|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
25161698|NCT01839487|50283774|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
25161699|NCT01839487|50283769|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
25161700|NCT01839487|50283770|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
25161701|NCT01839487|50283771|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
25161702|NCT01839487|50283772|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
25161703|NCT01839487|50283773|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
25161704|NCT01839487|50283774|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
25161705|NCT01839487|50283769|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
25161706|NCT01839487|50283770|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
25161707|NCT01839487|50283771|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
25161708|NCT01839487|50283772|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
25161709|NCT01839487|50283773|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
25161710|NCT01839487|50283774|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
25161711|NCT01839487|50283769|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
25161712|NCT01839487|50283770|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
25161713|NCT01839487|50283771|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
25161714|NCT01839487|50283772|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
25161715|NCT01839487|50283773|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
25161716|NCT01839487|50283774|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
25161717|NCT01839487|50283769|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
25161718|NCT01839487|50283770|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
25161719|NCT01839487|50283771|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
25161720|NCT01839487|50283772|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
25161721|NCT01839487|50283773|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
24957100|NCT00378014|50048033|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
24957101|NCT00378014|50048032|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
24957102|NCT00378014|50048033|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
24957103|NCT00378014|50048032|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
24957104|NCT00378014|50048033|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
24957105|NCT00378014|50048032|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
24957106|NCT00378014|50048033|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
24957107|NCT00378014|50048032|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
25043501|NCT03019965|50144881|FG001|Overall Study|viral or fungal infection|4|||
25161722|NCT01839487|50283774|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
25161723|NCT01839487|50283769|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
25161724|NCT01839487|50283770|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
25161725|NCT01839487|50283771|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
25161726|NCT01839487|50283772|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
25161727|NCT01839487|50283773|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
25161728|NCT01839487|50283774|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
25161729|NCT01839487|50283769|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
25161730|NCT01839487|50283770|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
25161731|NCT01839487|50283771|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
25161732|NCT01839487|50283772|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
25161733|NCT01839487|50283773|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
25161734|NCT01839487|50283774|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
25161735|NCT01799941|50283801|FG000|Overall Study|Adverse Event|34|||
25161736|NCT01799941|50283801|FG000|Overall Study|Withdrawal by Subject|21|||
25161737|NCT01799941|50283801|FG000|Overall Study|Death|2|||
25161738|NCT01799941|50283801|FG000|Overall Study|Investigator Decision|4|||
25161739|NCT01799941|50283801|FG000|Overall Study|Lack of Efficacy|3|||
25161740|NCT01799941|50283801|FG000|Overall Study|Lost to Follow-up|17|||
24957108|NCT00378014|50048033|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
24957109|NCT00378014|50048032|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
24957110|NCT00378014|50048033|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
24957111|NCT00378014|50048032|FG000|Extension (Month 12 to Month 59)|Death|1|||
24957112|NCT00378014|50048033|FG001|Extension (Month 12 to Month 59)|Death|2|||
24957113|NCT00378014|50048032|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
24957114|NCT00378014|50048033|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
24957115|NCT00378014|50048032|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
24957116|NCT00378014|50048033|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
24957117|NCT00378014|50048032|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
24957118|NCT00378014|50048033|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
24957119|NCT00378014|50048032|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
24957120|NCT00378014|50048033|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
24957121|NCT00485303|50048041|FG000|Overall Study|Adverse Event|5|||
24957122|NCT00485303|50048041|FG000|Overall Study|Progressive Disease|44|||
24957123|NCT00485303|50048041|FG000|Overall Study|Other|3|||
24957124|NCT00485303|50048041|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
24957125|NCT00485303|50048041|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
25186511|NCT02647866|50336896|FG001|Overall Study|Death|1|||
25186512|NCT02647866|50336897|FG002|Overall Study|Death|0|||
24957126|NCT00490841|50048045|FG000|Overall Study|Death|5|||
25161741|NCT01799941|50283801|FG000|Overall Study|Other|15|||
25161742|NCT01799239|50283829|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
25161743|NCT01799239|50283830|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
25161744|NCT01799239|50283829|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
25161745|NCT01799239|50283830|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
25161746|NCT01799239|50283829|FG000|Period 1 (7 Days)|Protocol Violation|0|||
25161747|NCT01799239|50283830|FG001|Period 1 (7 Days)|Protocol Violation|1|||
25161748|NCT01799239|50283829|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
25161749|NCT01799239|50283830|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
25161750|NCT01799239|50283829|FG000|Period 2 (7 Days)|Protocol Violation|1|||
25161751|NCT01799239|50283830|FG001|Period 2 (7 Days)|Protocol Violation|0|||
25161752|NCT02999854|50283846|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
25043502|NCT03019965|50144880|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
25043503|NCT03019965|50144881|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
25043504|NCT03019965|50144880|FG000|Overall Study|Physician Decision|1|||
25043505|NCT03019965|50144881|FG001|Overall Study|Physician Decision|1|||
25043506|NCT01675882|50144900|FG000|Overall Study|Adverse Event|0|||
25043507|NCT01675882|50144901|FG001|Overall Study|Adverse Event|2|||
25043508|NCT01675882|50144902|FG002|Overall Study|Adverse Event|1|||
25161753|NCT02999854|50283847|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
25161754|NCT02999854|50283846|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
25161755|NCT02999854|50283847|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
25161756|NCT02999854|50283846|FG000|Active Study Phase (up to 18 Months)|Death|7|||
24957127|NCT00490841|50048045|FG000|Overall Study|Withdrawal by Subject|4|||
24957128|NCT00490841|50048045|FG000|Overall Study|Lost to Follow-up|1|||
24957129|NCT00490841|50048045|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
24957130|NCT00377858|50048052|FG000|Overall Study|Withdrawal by Subject|12|||
25161757|NCT02999854|50283847|FG001|Active Study Phase (up to 18 Months)|Death|5|||
25161758|NCT02999854|50283846|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
25161759|NCT02999854|50283847|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
25161760|NCT02999854|50283846|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
25161761|NCT02999854|50283847|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
25161762|NCT02999854|50283846|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
25161763|NCT02999854|50283847|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
25161764|NCT02999854|50283846|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
25161765|NCT02999854|50283847|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
24957131|NCT00377858|50048053|FG001|Overall Study|Withdrawal by Subject|11|||
24957132|NCT00377858|50048052|FG000|Overall Study|Lost to Follow-up|6|||
25161766|NCT02999854|50283846|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
25161767|NCT02999854|50283847|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
25161768|NCT04146363|50283980|FG000|Induction Period|Adverse Event|1|||
25161769|NCT04146363|50283981|FG001|Induction Period|Adverse Event|2|||
24957133|NCT00377858|50048053|FG001|Overall Study|Lost to Follow-up|1|||
24957134|NCT00377858|50048052|FG000|Overall Study|Physician Decision|5|||
25161770|NCT04146363|50283982|FG002|Induction Period|Adverse Event|0|||
25161771|NCT04146363|50283983|FG003|Induction Period|Adverse Event|0|||
25161772|NCT04146363|50283984|FG004|Induction Period|Adverse Event|0|||
25161773|NCT04146363|50283985|FG005|Induction Period|Adverse Event|0|||
25161774|NCT04146363|50283986|FG006|Induction Period|Adverse Event|0|||
24957135|NCT00377858|50048053|FG001|Overall Study|Physician Decision|5|||
24957136|NCT00377858|50048052|FG000|Overall Study|Protocol Violation|3|||
24957137|NCT00377858|50048053|FG001|Overall Study|Protocol Violation|4|||
24957138|NCT00377858|50048052|FG000|Overall Study|Adverse Event|2|||
24957139|NCT00377858|50048053|FG001|Overall Study|Adverse Event|1|||
24957140|NCT00377858|50048052|FG000|Overall Study|Entry Criteria Not Met|2|||
24957141|NCT00377858|50048053|FG001|Overall Study|Entry Criteria Not Met|0|||
24957142|NCT00377858|50048052|FG000|Overall Study|Sponsor Decision|1|||
24957143|NCT00377858|50048053|FG001|Overall Study|Sponsor Decision|2|||
24957144|NCT00377858|50048052|FG000|Overall Study|Death|0|||
24957145|NCT00377858|50048053|FG001|Overall Study|Death|3|||
24957146|NCT00502775|50048062|FG000|Overall Study|Adverse Event|1|||
24957147|NCT00502775|50048063|FG001|Overall Study|Adverse Event|2|||
24957148|NCT00502775|50048064|FG002|Overall Study|Adverse Event|1|||
24957149|NCT00502775|50048062|FG000|Overall Study|Protocol Violation|1|||
25043509|NCT01675882|50144903|FG003|Overall Study|Adverse Event|0|||
25043510|NCT01675882|50144900|FG000|Overall Study|Participant unwilling to continue|2|||
24957150|NCT00502775|50048063|FG001|Overall Study|Protocol Violation|5|||
24957151|NCT00502775|50048064|FG002|Overall Study|Protocol Violation|2|||
24957152|NCT00502775|50048062|FG000|Overall Study|Withdrawal by Subject|1|||
24957153|NCT00502775|50048063|FG001|Overall Study|Withdrawal by Subject|1|||
25043511|NCT01675882|50144901|FG001|Overall Study|Participant unwilling to continue|4|||
25161775|NCT04146363|50283987|FG007|Induction Period|Adverse Event|0|||
24957154|NCT00502775|50048064|FG002|Overall Study|Withdrawal by Subject|2|||
24957155|NCT00502775|50048062|FG000|Overall Study|Sponsor Terminated Study|1|||
25043512|NCT01675882|50144902|FG002|Overall Study|Participant unwilling to continue|2|||
25043513|NCT01675882|50144903|FG003|Overall Study|Participant unwilling to continue|1|||
25043514|NCT01675882|50144900|FG000|Overall Study|Lost to Follow-up|0|||
25043515|NCT01675882|50144901|FG001|Overall Study|Lost to Follow-up|1|||
25043516|NCT01675882|50144902|FG002|Overall Study|Lost to Follow-up|0|||
25043517|NCT01675882|50144903|FG003|Overall Study|Lost to Follow-up|0|||
25043518|NCT01675882|50144900|FG000|Overall Study|Non-compliance|0|||
25043519|NCT01675882|50144901|FG001|Overall Study|Non-compliance|0|||
25043520|NCT01675882|50144902|FG002|Overall Study|Non-compliance|0|||
25043521|NCT01675882|50144903|FG003|Overall Study|Non-compliance|1|||
25161776|NCT04146363|50283988|FG008|Induction Period|Adverse Event|0|||
25161777|NCT04146363|50283989|FG009|Induction Period|Adverse Event|0|||
25161778|NCT04146363|50283990|FG010|Induction Period|Adverse Event|0|||
25161779|NCT04146363|50283980|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
25161780|NCT04146363|50283981|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
25161781|NCT04146363|50283982|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
25161782|NCT04146363|50283983|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
25161783|NCT04146363|50283984|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
25161784|NCT04146363|50283985|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
25161785|NCT04146363|50283986|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
25161786|NCT04146363|50283987|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
25161787|NCT04146363|50283988|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
25161788|NCT04146363|50283989|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
25161789|NCT04146363|50283990|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
25161790|NCT04146363|50283980|FG000|Induction Period|Lack of Efficacy|7|||
25161791|NCT04146363|50283981|FG001|Induction Period|Lack of Efficacy|2|||
25161792|NCT04146363|50283982|FG002|Induction Period|Lack of Efficacy|0|||
25161793|NCT04146363|50283983|FG003|Induction Period|Lack of Efficacy|0|||
25161794|NCT04146363|50283984|FG004|Induction Period|Lack of Efficacy|0|||
25161795|NCT04146363|50283985|FG005|Induction Period|Lack of Efficacy|0|||
25161796|NCT04146363|50283986|FG006|Induction Period|Lack of Efficacy|0|||
25161797|NCT04146363|50283987|FG007|Induction Period|Lack of Efficacy|0|||
25161798|NCT04146363|50283988|FG008|Induction Period|Lack of Efficacy|0|||
25161799|NCT04146363|50283989|FG009|Induction Period|Lack of Efficacy|0|||
25161800|NCT04146363|50283990|FG010|Induction Period|Lack of Efficacy|0|||
25161801|NCT04146363|50283980|FG000|Induction Period|Lost to Follow-up|1|||
25161802|NCT04146363|50283981|FG001|Induction Period|Lost to Follow-up|4|||
25161803|NCT04146363|50283982|FG002|Induction Period|Lost to Follow-up|0|||
25161804|NCT04146363|50283983|FG003|Induction Period|Lost to Follow-up|0|||
25161805|NCT04146363|50283984|FG004|Induction Period|Lost to Follow-up|0|||
25161806|NCT04146363|50283985|FG005|Induction Period|Lost to Follow-up|0|||
25161807|NCT04146363|50283986|FG006|Induction Period|Lost to Follow-up|0|||
25161808|NCT04146363|50283987|FG007|Induction Period|Lost to Follow-up|0|||
25161809|NCT04146363|50283988|FG008|Induction Period|Lost to Follow-up|0|||
25161810|NCT04146363|50283989|FG009|Induction Period|Lost to Follow-up|0|||
25161811|NCT04146363|50283990|FG010|Induction Period|Lost to Follow-up|0|||
25161812|NCT04146363|50283980|FG000|Induction Period|Positive quantiferon test|0|||
25161813|NCT04146363|50283981|FG001|Induction Period|Positive quantiferon test|1|||
25161814|NCT04146363|50283982|FG002|Induction Period|Positive quantiferon test|0|||
25161815|NCT04146363|50283983|FG003|Induction Period|Positive quantiferon test|0|||
25161816|NCT04146363|50283984|FG004|Induction Period|Positive quantiferon test|0|||
25161817|NCT04146363|50283985|FG005|Induction Period|Positive quantiferon test|0|||
25161818|NCT04146363|50283986|FG006|Induction Period|Positive quantiferon test|0|||
25161819|NCT04146363|50283987|FG007|Induction Period|Positive quantiferon test|0|||
25161820|NCT04146363|50283988|FG008|Induction Period|Positive quantiferon test|0|||
25161821|NCT04146363|50283989|FG009|Induction Period|Positive quantiferon test|0|||
25161822|NCT04146363|50283990|FG010|Induction Period|Positive quantiferon test|0|||
25161823|NCT04146363|50283980|FG000|Induction Period|Protocol Deviation|5|||
25161824|NCT04146363|50283981|FG001|Induction Period|Protocol Deviation|6|||
25161825|NCT04146363|50283982|FG002|Induction Period|Protocol Deviation|0|||
25161826|NCT04146363|50283983|FG003|Induction Period|Protocol Deviation|0|||
25161827|NCT04146363|50283984|FG004|Induction Period|Protocol Deviation|0|||
25161828|NCT04146363|50283985|FG005|Induction Period|Protocol Deviation|0|||
25161829|NCT04146363|50283986|FG006|Induction Period|Protocol Deviation|0|||
25043522|NCT03018249|50144915|FG000|Overall Study|Withdrawal by Subject|2|||
25161830|NCT04146363|50283987|FG007|Induction Period|Protocol Deviation|0|||
25161831|NCT04146363|50283988|FG008|Induction Period|Protocol Deviation|0|||
25161832|NCT04146363|50283989|FG009|Induction Period|Protocol Deviation|0|||
25161833|NCT04146363|50283990|FG010|Induction Period|Protocol Deviation|0|||
25161834|NCT04146363|50283980|FG000|Induction Period|Withdrawal by Subject|6|||
25161835|NCT04146363|50283981|FG001|Induction Period|Withdrawal by Subject|3|||
25161836|NCT04146363|50283982|FG002|Induction Period|Withdrawal by Subject|0|||
25161837|NCT04146363|50283983|FG003|Induction Period|Withdrawal by Subject|0|||
25161838|NCT04146363|50283984|FG004|Induction Period|Withdrawal by Subject|0|||
25161839|NCT04146363|50283985|FG005|Induction Period|Withdrawal by Subject|0|||
25161840|NCT04146363|50283986|FG006|Induction Period|Withdrawal by Subject|0|||
25161841|NCT04146363|50283987|FG007|Induction Period|Withdrawal by Subject|0|||
25161842|NCT04146363|50283988|FG008|Induction Period|Withdrawal by Subject|0|||
25161843|NCT04146363|50283989|FG009|Induction Period|Withdrawal by Subject|0|||
25161844|NCT04146363|50283990|FG010|Induction Period|Withdrawal by Subject|0|||
25161845|NCT04146363|50283980|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
25161846|NCT04146363|50283981|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
25161847|NCT04146363|50283982|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
25161848|NCT04146363|50283983|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
25161849|NCT04146363|50283984|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
25161850|NCT04146363|50283985|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
25161851|NCT04146363|50283986|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
25161852|NCT04146363|50283987|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
25161853|NCT04146363|50283988|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
25161854|NCT04146363|50283989|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
25161855|NCT04146363|50283990|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
25161856|NCT04146363|50283980|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25161857|NCT04146363|50283981|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25161858|NCT04146363|50283982|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25161859|NCT04146363|50283983|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25161860|NCT04146363|50283984|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25161861|NCT04146363|50283985|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25161862|NCT04146363|50283986|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25161863|NCT04146363|50283987|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
25161864|NCT04146363|50283988|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25161865|NCT04146363|50283989|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25161866|NCT04146363|50283990|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25161867|NCT04146363|50283980|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25161868|NCT04146363|50283981|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25161869|NCT04146363|50283982|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25161870|NCT04146363|50283983|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25161871|NCT04146363|50283984|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25161872|NCT04146363|50283985|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25161873|NCT04146363|50283986|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
25161874|NCT04146363|50283987|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
25161875|NCT04146363|50283988|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25161876|NCT04146363|50283989|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25161877|NCT04146363|50283990|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25161878|NCT04146363|50283980|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
25161879|NCT04146363|50283981|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
25161880|NCT04146363|50283982|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
25161881|NCT04146363|50283983|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
25161882|NCT04146363|50283984|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
25161883|NCT04146363|50283985|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
25161884|NCT04146363|50283986|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
25161885|NCT04146363|50283987|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
25161886|NCT04146363|50283988|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
25161887|NCT04146363|50283989|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
25161888|NCT04146363|50283990|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
25161889|NCT04146363|50283980|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
25161890|NCT04146363|50283981|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
25161891|NCT04146363|50283982|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
25161892|NCT04146363|50283983|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
25186513|NCT02647866|50336898|FG003|Overall Study|Death|0|||
25161893|NCT04146363|50283984|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
25161894|NCT04146363|50283985|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
25161895|NCT04146363|50283986|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
25161896|NCT04146363|50283987|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
25161897|NCT04146363|50283988|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
25161898|NCT04146363|50283989|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
25161899|NCT04146363|50283990|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
25161900|NCT04146363|50283980|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
25161901|NCT04146363|50283981|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
25161902|NCT04146363|50283982|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
25161903|NCT04146363|50283983|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
25161904|NCT04146363|50283984|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
25161905|NCT04146363|50283985|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
25161906|NCT04146363|50283986|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
25161907|NCT04146363|50283987|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
25161908|NCT04146363|50283988|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
25161909|NCT04146363|50283989|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
25161910|NCT04146363|50283990|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
25161911|NCT04146363|50283980|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
25161912|NCT04146363|50283981|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
25161913|NCT04146363|50283982|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
25161914|NCT04146363|50283983|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
25161915|NCT04146363|50283984|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
25161916|NCT04146363|50283985|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
25161917|NCT04146363|50283986|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
25161918|NCT04146363|50283987|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
25161919|NCT04146363|50283988|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
25161920|NCT04146363|50283989|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
25276300|NCT00960934|50590276|FG005|Overall Study|Lack of Efficacy|0|||
25043523|NCT03018249|50144916|FG001|Overall Study|Withdrawal by Subject|2|||
25043524|NCT02923245|50144934|FG000|Overall Study|ultrasound order was cancelled|2|||
25043525|NCT02923245|50144935|FG001|Overall Study|ultrasound order was cancelled|1|||
25043526|NCT00905606|50144951|FG000|Period 1|Adverse Event|0|||
25043527|NCT00905606|50144952|FG001|Period 1|Adverse Event|1|||
25043528|NCT00905606|50144951|FG000|Washout|Withdrawal by Subject|1|||
25043529|NCT00905606|50144952|FG001|Washout|Withdrawal by Subject|0|||
25043530|NCT01676896|50144959|FG000|Overall Study|Withdrawal by Subject|12|||
25043531|NCT01676896|50144960|FG001|Overall Study|Withdrawal by Subject|7|||
25043532|NCT01676896|50144961|FG002|Overall Study|Withdrawal by Subject|19|||
25043533|NCT03017235|50144971|FG000|Overall Study|Withdrawal by Subject|4|||
25043534|NCT03017235|50144972|FG001|Overall Study|Withdrawal by Subject|3|||
25043535|NCT03017235|50144971|FG000|Overall Study|Lost to Follow-up|2|||
25043536|NCT03017235|50144972|FG001|Overall Study|Lost to Follow-up|7|||
25043537|NCT03017235|50144971|FG000|Overall Study|Adverse Event|0|||
25043538|NCT03017235|50144972|FG001|Overall Study|Adverse Event|1|||
25043539|NCT03017235|50144971|FG000|Overall Study|Protocol Violation|2|||
25043540|NCT03017235|50144972|FG001|Overall Study|Protocol Violation|1|||
25043541|NCT03017235|50144971|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
25043542|NCT03017235|50144972|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
25043543|NCT03017079|50144980|FG000|Overall Study|Physician Decision|1|||
25043544|NCT03017079|50144981|FG001|Overall Study|Physician Decision|1|||
25161921|NCT04146363|50283990|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
25161922|NCT04146363|50283980|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
25161923|NCT04146363|50283981|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
25161924|NCT04146363|50283982|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
25161925|NCT04146363|50283983|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
25161926|NCT04146363|50283984|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
25161927|NCT04146363|50283985|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
25161928|NCT04146363|50283986|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
25161929|NCT04146363|50283987|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
25161930|NCT04146363|50283988|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
25161931|NCT04146363|50283989|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
25161932|NCT04146363|50283990|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
25161933|NCT04146363|50283980|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25161934|NCT04146363|50283981|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25161935|NCT04146363|50283982|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25161936|NCT04146363|50283983|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25161937|NCT04146363|50283984|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25161938|NCT04146363|50283985|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25161939|NCT04146363|50283986|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25161940|NCT04146363|50283987|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25161941|NCT04146363|50283988|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
25161942|NCT04146363|50283989|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
25161943|NCT04146363|50283990|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25161944|NCT04146363|50283980|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
25161945|NCT04146363|50283981|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
24957156|NCT00502775|50048063|FG001|Overall Study|Sponsor Terminated Study|0|||
24957157|NCT00502775|50048064|FG002|Overall Study|Sponsor Terminated Study|1|||
25161946|NCT04146363|50283982|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
25161947|NCT04146363|50283983|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
25161948|NCT04146363|50283984|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
25161949|NCT04146363|50283985|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
25161950|NCT04146363|50283986|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
25161951|NCT04146363|50283987|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
25161952|NCT04146363|50283988|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
25161953|NCT04146363|50283989|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
25161954|NCT04146363|50283990|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
25161955|NCT04146363|50283980|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
25161956|NCT04146363|50283981|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
25161957|NCT04146363|50283982|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
25161958|NCT04146363|50283983|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
25161959|NCT04146363|50283984|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
25161960|NCT04146363|50283985|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
25043545|NCT03017079|50144980|FG000|Overall Study|Death|3|||
25043546|NCT03017079|50144981|FG001|Overall Study|Death|2|||
25043547|NCT03017079|50144980|FG000|Overall Study|Lack of Efficacy|2|||
25161961|NCT04146363|50283986|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
25161962|NCT04146363|50283987|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
25161963|NCT04146363|50283988|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
25161964|NCT04146363|50283989|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
25161965|NCT04146363|50283990|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
25161966|NCT04146363|50283980|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
25161967|NCT04146363|50283981|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
25161968|NCT04146363|50283982|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
25161969|NCT04146363|50283983|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
25161970|NCT04146363|50283984|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
25161971|NCT04146363|50283985|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
25161972|NCT04146363|50283986|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
25161973|NCT04146363|50283987|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
25161974|NCT04146363|50283988|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
25161975|NCT04146363|50283989|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
25161976|NCT04146363|50283990|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
25161977|NCT04146363|50283980|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
25161978|NCT04146363|50283981|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
25161979|NCT04146363|50283982|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
25161980|NCT04146363|50283983|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
25161981|NCT04146363|50283984|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
25161982|NCT04146363|50283985|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
25161983|NCT04146363|50283986|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
25161984|NCT04146363|50283987|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
25161985|NCT04146363|50283988|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
24957158|NCT00502775|50048062|FG000|Overall Study|Non-compliance with eDiary|4|||
24957159|NCT00502775|50048063|FG001|Overall Study|Non-compliance with eDiary|1|||
24957160|NCT00502775|50048064|FG002|Overall Study|Non-compliance with eDiary|1|||
24957161|NCT00502775|50048062|FG000|Overall Study|Subject unable to swallow capsule|1|||
24957162|NCT00502775|50048063|FG001|Overall Study|Subject unable to swallow capsule|0|||
24957163|NCT00502775|50048064|FG002|Overall Study|Subject unable to swallow capsule|1|||
24957164|NCT00502775|50048062|FG000|Overall Study|Logpad compliance <80%|1|||
24957165|NCT00502775|50048063|FG001|Overall Study|Logpad compliance <80%|0|||
24957166|NCT00502775|50048064|FG002|Overall Study|Logpad compliance <80%|0|||
24957167|NCT00502775|50048062|FG000|Overall Study|Randomized in error|0|||
24957168|NCT00502775|50048063|FG001|Overall Study|Randomized in error|1|||
24957169|NCT00502775|50048064|FG002|Overall Study|Randomized in error|1|||
24957170|NCT00502775|50048062|FG000|Overall Study|Non-compliance|0|||
24957171|NCT00502775|50048063|FG001|Overall Study|Non-compliance|2|||
24957172|NCT00502775|50048064|FG002|Overall Study|Non-compliance|2|||
25043548|NCT03017079|50144981|FG001|Overall Study|Lack of Efficacy|2|||
25276301|NCT00960934|50590271|FG000|Overall Study|Lost to Follow-up|0|||
24957173|NCT00502775|50048062|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
24957174|NCT00502775|50048063|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
25161986|NCT04146363|50283989|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
25161987|NCT04146363|50283990|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
25161988|NCT01838941|50284015|FG000|Overall Study|Adverse Event|1|||
25161989|NCT01838941|50284015|FG000|Overall Study|Withdrawal by Subject|1|||
25161990|NCT01773109|50284020|FG000|Overall Study|Symptomatic Progression|2|||
25161991|NCT01773109|50284020|FG000|Overall Study|Death|1|||
25161992|NCT01772719|50284024|FG000|Overall Study|Withdrawal by Subject|3|||
25161993|NCT01772719|50284024|FG000|Overall Study|Adverse Event|2|||
25161994|NCT01772719|50284024|FG000|Overall Study|Protocol Violation|1|||
25161995|NCT01772719|50284024|FG000|Overall Study|Lost to Follow-up|1|||
25161996|NCT01798927|50284031|FG000|Overall Study|Withdrawal by Subject|1|||
25161997|NCT01276288|50284100|FG000|Overall Study|Adverse Event|1|||
25161998|NCT01276288|50284101|FG001|Overall Study|Adverse Event|1|||
25161999|NCT01276288|50284102|FG002|Overall Study|Adverse Event|0|||
25162000|NCT01276288|50284103|FG003|Overall Study|Adverse Event|0|||
25162001|NCT01276288|50284100|FG000|Overall Study|not treated|1|||
25186514|NCT02647866|50336899|FG004|Overall Study|Death|0|||
25186515|NCT02647866|50336895|FG000|Overall Study|Subject moved to different country|1|||
25162002|NCT01276288|50284101|FG001|Overall Study|not treated|0|||
25162003|NCT01276288|50284102|FG002|Overall Study|not treated|0|||
25276302|NCT00960934|50590272|FG001|Overall Study|Lost to Follow-up|1|||
25162004|NCT01276288|50284103|FG003|Overall Study|not treated|0|||
25162005|NCT02702271|50284127|FG000|Overall Study|Death|36|||
25162006|NCT02702271|50284128|FG001|Overall Study|Death|7|||
25162007|NCT02702271|50284127|FG000|Overall Study|Lost to Follow-up|12|||
25162008|NCT02702271|50284128|FG001|Overall Study|Lost to Follow-up|0|||
25162009|NCT02702271|50284127|FG000|Overall Study|Withdrawal by Subject|8|||
25162010|NCT02702271|50284128|FG001|Overall Study|Withdrawal by Subject|1|||
25162011|NCT02702271|50284127|FG000|Overall Study|Physician Decision|2|||
25162012|NCT02702271|50284128|FG001|Overall Study|Physician Decision|0|||
25162013|NCT02702271|50284127|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
25162014|NCT02702271|50284128|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
25162015|NCT01276054|50284213|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
25162016|NCT01276054|50284214|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
25162017|NCT01798849|50284223|FG000|Overall Study|Physician Decision|0|||
25162018|NCT01798849|50284224|FG001|Overall Study|Physician Decision|0|||
25162019|NCT01798849|50284225|FG002|Overall Study|Physician Decision|1|||
25162020|NCT01797835|50284305|FG000|Overall Study|Lost to Follow-up|31|||
25162021|NCT01797835|50284306|FG001|Overall Study|Lost to Follow-up|27|||
25162022|NCT01275430|50284312|FG000|Overall Study|Adverse Event|1|||
25162023|NCT01275430|50284312|FG000|Overall Study|No Contrast Injection|6|||
25162024|NCT01275430|50284312|FG000|Overall Study|Device Malfunction|1|||
25043549|NCT03017079|50144980|FG000|Overall Study|Protocol Violation|0|||
25043550|NCT03017079|50144981|FG001|Overall Study|Protocol Violation|1|||
25043551|NCT03015363|50144994|FG000|Overall Study|Physician Decision|14|||
25043552|NCT03015363|50144994|FG000|Overall Study|Withdrawal by Subject|3|||
25162025|NCT01275430|50284312|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
25162026|NCT01838551|50284317|FG000|Overall Study|Adverse Event|16|||
25162027|NCT01838551|50284317|FG000|Overall Study|Death|1|||
25162028|NCT01838551|50284317|FG000|Overall Study|Lack of Efficacy|10|||
25162029|NCT01838551|50284317|FG000|Overall Study|Physician Decision|4|||
25162030|NCT01838551|50284317|FG000|Overall Study|Withdrawal by Subject|10|||
25162031|NCT01838551|50284317|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
25162032|NCT01797445|50284323|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
25162033|NCT01797445|50284324|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
25162034|NCT01797445|50284323|FG000|Double-Blind Phase|Adverse Event|3|||
25162035|NCT01797445|50284324|FG001|Double-Blind Phase|Adverse Event|0|||
25162036|NCT01797445|50284323|FG000|Double-Blind Phase|Death|5|||
25162037|NCT01797445|50284324|FG001|Double-Blind Phase|Death|4|||
25162038|NCT01797445|50284323|FG000|Double-Blind Phase|Pregnancy|0|||
25162039|NCT01797445|50284324|FG001|Double-Blind Phase|Pregnancy|1|||
25162040|NCT01797445|50284323|FG000|Double-Blind Phase|Lack of Efficacy|1|||
25162041|NCT01797445|50284324|FG001|Double-Blind Phase|Lack of Efficacy|2|||
25162042|NCT01797445|50284323|FG000|Double-Blind Phase|Investigator's Discretion|15|||
25162043|NCT01797445|50284324|FG001|Double-Blind Phase|Investigator's Discretion|17|||
25162044|NCT01797445|50284323|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
25162045|NCT01797445|50284324|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
25162046|NCT01797445|50284323|FG000|Double-Blind Phase|Protocol Violation|0|||
25043553|NCT02880371|50145006|FG000|Phase 1b|Lost to Follow-up|1|||
25043554|NCT02880371|50145007|FG001|Phase 1b|Lost to Follow-up|0|||
25043555|NCT02880371|50145008|FG002|Phase 1b|Lost to Follow-up|0|||
25043556|NCT02880371|50145009|FG003|Phase 1b|Lost to Follow-up|0|||
25162047|NCT01797445|50284324|FG001|Double-Blind Phase|Protocol Violation|1|||
25162048|NCT01797445|50284323|FG000|Double-Blind Phase|Withdrew Consent|20|||
25162049|NCT01797445|50284324|FG001|Double-Blind Phase|Withdrew Consent|35|||
25162050|NCT01797445|50284323|FG000|Double-Blind Phase|Lost to Follow-up|34|||
25162051|NCT01797445|50284324|FG001|Double-Blind Phase|Lost to Follow-up|26|||
24957175|NCT00502775|50048064|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
24957176|NCT00502775|50048062|FG000|Overall Study|Declining pollen counts|0|||
24957177|NCT00502775|50048063|FG001|Overall Study|Declining pollen counts|1|||
24957178|NCT00502775|50048064|FG002|Overall Study|Declining pollen counts|1|||
24957179|NCT00502775|50048062|FG000|Overall Study|Subject in jail|0|||
24957180|NCT00502775|50048063|FG001|Overall Study|Subject in jail|1|||
24957181|NCT00502775|50048064|FG002|Overall Study|Subject in jail|0|||
24957182|NCT00502775|50048062|FG000|Overall Study|Subject took disallowed drug|0|||
24957183|NCT00502775|50048063|FG001|Overall Study|Subject took disallowed drug|0|||
24957184|NCT00502775|50048064|FG002|Overall Study|Subject took disallowed drug|1|||
24957185|NCT00502697|50048074|FG000|Overall Study|Withdrawal by Subject|3|||
25162052|NCT01797445|50284323|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
24957186|NCT00502697|50048075|FG001|Overall Study|Withdrawal by Subject|1|||
24957187|NCT00502697|50048074|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
25043557|NCT02880371|50145010|FG004|Phase 1b|Lost to Follow-up|0|||
25162053|NCT01797445|50284324|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
25162054|NCT01611259|50284332|FG000|Overall Study|Physician Decision|1|||
25162055|NCT01611259|50284332|FG000|Overall Study|Lack of Efficacy|2|||
24957188|NCT00502697|50048075|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
25162056|NCT01611259|50284332|FG000|Overall Study|Adverse Event|4|||
25162057|NCT01611259|50284332|FG000|Overall Study|Withdrawal by Subject|7|||
25162058|NCT01796197|50284336|FG000|Overall Study|Lost to Follow-up|1|||
25162059|NCT01796197|50284336|FG000|Overall Study|Lack of Efficacy|1|||
25162060|NCT01795495|50284343|FG000|Overall Study|Protocol Violation|1|||
25162061|NCT01795495|50284344|FG001|Overall Study|Protocol Violation|0|||
25162062|NCT01795495|50284345|FG002|Overall Study|Protocol Violation|1|||
25162063|NCT01795495|50284343|FG000|Overall Study|Physician Decision|0|||
25162064|NCT01795495|50284344|FG001|Overall Study|Physician Decision|0|||
25162065|NCT01795495|50284345|FG002|Overall Study|Physician Decision|1|||
25162066|NCT01794949|50284355|FG000|Overall Study|Lost to Follow-up|1|||
25162067|NCT01794949|50284356|FG001|Overall Study|Lost to Follow-up|0|||
25162068|NCT01770379|50284365|FG000|Overall Study|Technical issues|1|||
25162069|NCT01770379|50284366|FG001|Overall Study|Technical issues|0|||
25162070|NCT01770379|50284367|FG002|Overall Study|Technical issues|0|||
25162071|NCT01770379|50284365|FG000|Overall Study|Withdrawal by Subject|7|||
25162072|NCT01770379|50284366|FG001|Overall Study|Withdrawal by Subject|10|||
25162073|NCT01770379|50284367|FG002|Overall Study|Withdrawal by Subject|7|||
25162074|NCT01770379|50284365|FG000|Overall Study|study terminated by sponsor|22|||
25162075|NCT01770379|50284366|FG001|Overall Study|study terminated by sponsor|23|||
25162076|NCT01770379|50284367|FG002|Overall Study|study terminated by sponsor|22|||
25162077|NCT01770379|50284365|FG000|Overall Study|Protocol Violation|0|||
25162078|NCT01770379|50284366|FG001|Overall Study|Protocol Violation|1|||
25162079|NCT01770379|50284367|FG002|Overall Study|Protocol Violation|1|||
25162080|NCT01770379|50284365|FG000|Overall Study|Physician Decision|0|||
25162081|NCT01770379|50284366|FG001|Overall Study|Physician Decision|1|||
25162082|NCT01770379|50284367|FG002|Overall Study|Physician Decision|2|||
25162083|NCT01770379|50284365|FG000|Overall Study|Lost to Follow-up|0|||
25162084|NCT01770379|50284366|FG001|Overall Study|Lost to Follow-up|0|||
25162085|NCT01770379|50284367|FG002|Overall Study|Lost to Follow-up|2|||
25162086|NCT01770379|50284365|FG000|Overall Study|Lack of Efficacy|8|||
25162087|NCT01770379|50284366|FG001|Overall Study|Lack of Efficacy|6|||
25162088|NCT01770379|50284367|FG002|Overall Study|Lack of Efficacy|6|||
25162089|NCT01770379|50284365|FG000|Overall Study|Adverse Event|1|||
25162090|NCT01770379|50284366|FG001|Overall Study|Adverse Event|3|||
25162091|NCT01770379|50284367|FG002|Overall Study|Adverse Event|2|||
25162092|NCT01986881|50284380|FG000|Overall Study|Death|228|||
25162093|NCT01986881|50284381|FG001|Overall Study|Death|233|||
25162094|NCT01986881|50284382|FG002|Overall Study|Death|247|||
25162095|NCT01986881|50284380|FG000|Overall Study|Lost to Follow-up|51|||
25162096|NCT01986881|50284381|FG001|Overall Study|Lost to Follow-up|44|||
25162097|NCT01986881|50284382|FG002|Overall Study|Lost to Follow-up|55|||
25162098|NCT01986881|50284380|FG000|Overall Study|Physician Decision|7|||
25162099|NCT01986881|50284381|FG001|Overall Study|Physician Decision|4|||
25162100|NCT01986881|50284382|FG002|Overall Study|Physician Decision|6|||
25162101|NCT01986881|50284380|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
25162102|NCT01986881|50284381|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
25162103|NCT01986881|50284382|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
25162104|NCT01986881|50284380|FG000|Overall Study|Withdrawal by Subject|41|||
25162105|NCT01986881|50284381|FG001|Overall Study|Withdrawal by Subject|60|||
25162106|NCT01986881|50284382|FG002|Overall Study|Withdrawal by Subject|45|||
25162107|NCT01986881|50284380|FG000|Overall Study|Subject Moved|0|||
25162108|NCT01986881|50284381|FG001|Overall Study|Subject Moved|1|||
25162109|NCT01986881|50284382|FG002|Overall Study|Subject Moved|0|||
25162110|NCT01986881|50284380|FG000|Overall Study|Other|1|||
25162111|NCT01986881|50284381|FG001|Overall Study|Other|2|||
25162112|NCT01986881|50284382|FG002|Overall Study|Other|2|||
25162113|NCT01770145|50284413|FG000|Baseline|Adverse Event|20|||
25162114|NCT01770145|50284413|FG000|Baseline|Withdrawal by Subject|1|||
25162115|NCT01770145|50284413|FG000|Baseline|Lost to Follow-up|1|||
25162116|NCT01770145|50284413|FG000|Baseline|Unable to define optimal dose|4|||
25162117|NCT01770145|50284413|FG000|Treatment|Adverse Event|3|||
25162118|NCT01770145|50284413|FG000|Treatment|Withdrawal by Subject|1|||
25162119|NCT01609543|50284417|FG000|Overall Study|Disease Progression|28|||
25162120|NCT01609543|50284417|FG000|Overall Study|Adverse Event|5|||
25162121|NCT01609543|50284417|FG000|Overall Study|Withdrawal by Subject|1|||
25162122|NCT01609543|50284417|FG000|Overall Study|Protocol Violation|1|||
25162123|NCT01609543|50284417|FG000|Overall Study|Death|7|||
25162124|NCT02003183|50284424|FG000|Overall Study|Lost to Follow-up|0|||
25162125|NCT02003183|50284425|FG001|Overall Study|Lost to Follow-up|2|||
25162126|NCT01986647|50284435|FG000|Overall Study|Lost to Follow-up|4|||
25162127|NCT01986647|50284436|FG001|Overall Study|Lost to Follow-up|1|||
25162128|NCT01986647|50284437|FG002|Overall Study|Lost to Follow-up|4|||
25162129|NCT01986647|50284438|FG003|Overall Study|Lost to Follow-up|4|||
25162130|NCT01986647|50284435|FG000|Overall Study|Withdrawal by Subject|1|||
25162131|NCT01986647|50284436|FG001|Overall Study|Withdrawal by Subject|3|||
25162132|NCT01986647|50284437|FG002|Overall Study|Withdrawal by Subject|2|||
25162133|NCT01986647|50284438|FG003|Overall Study|Withdrawal by Subject|3|||
25162134|NCT01986647|50284435|FG000|Overall Study|Health|5|||
25162135|NCT01986647|50284436|FG001|Overall Study|Health|3|||
25162136|NCT01986647|50284437|FG002|Overall Study|Health|6|||
25162137|NCT01986647|50284438|FG003|Overall Study|Health|4|||
25162138|NCT02002091|50284454|FG000|Screening|Lost to Follow-up|10|||
25162139|NCT02002091|50284455|FG001|Screening|Lost to Follow-up|12|||
25162140|NCT02002091|50284454|FG000|Screening|Death|3|||
25162141|NCT02002091|50284455|FG001|Screening|Death|2|||
25162142|NCT01985321|50284492|FG000|Overall Study|Protocol Violation|4|||
25162143|NCT01985321|50284493|FG001|Overall Study|Protocol Violation|3|||
25162144|NCT01985321|50284492|FG000|Overall Study|Withdrawal by Subject|1|||
25162145|NCT01985321|50284493|FG001|Overall Study|Withdrawal by Subject|0|||
25162146|NCT01985321|50284492|FG000|Overall Study|Lost to Follow-up|5|||
25162147|NCT01985321|50284493|FG001|Overall Study|Lost to Follow-up|2|||
25162148|NCT01985321|50284492|FG000|Overall Study|Subject treated wrong type of sore|1|||
25162149|NCT01985321|50284493|FG001|Overall Study|Subject treated wrong type of sore|0|||
25162150|NCT02000921|50284502|FG000|Overall Study|Withdrawal by Subject|3|||
25162151|NCT02000921|50284503|FG001|Overall Study|Withdrawal by Subject|10|||
25162152|NCT02000921|50284504|FG002|Overall Study|Withdrawal by Subject|5|||
25162153|NCT02000921|50284502|FG000|Overall Study|Lost to Follow-up|2|||
25162154|NCT02000921|50284503|FG001|Overall Study|Lost to Follow-up|4|||
25162155|NCT02000921|50284504|FG002|Overall Study|Lost to Follow-up|5|||
25162156|NCT02000921|50284502|FG000|Overall Study|Physician Decision|0|||
25162157|NCT02000921|50284503|FG001|Overall Study|Physician Decision|2|||
25162158|NCT02000921|50284504|FG002|Overall Study|Physician Decision|0|||
25162159|NCT01836523|50284550|FG000|Overall Study|Adverse Event|15|||
25162160|NCT01836523|50284551|FG001|Overall Study|Adverse Event|41|||
25162161|NCT01836523|50284552|FG002|Overall Study|Adverse Event|49|||
25162162|NCT01836523|50284553|FG003|Overall Study|Adverse Event|14|||
25162163|NCT01836523|50284550|FG000|Overall Study|Protocol Violation|6|||
25162164|NCT01836523|50284551|FG001|Overall Study|Protocol Violation|3|||
25162165|NCT01836523|50284552|FG002|Overall Study|Protocol Violation|2|||
25162166|NCT01836523|50284553|FG003|Overall Study|Protocol Violation|4|||
25162167|NCT01836523|50284550|FG000|Overall Study|Met Withdrawal Criteria|13|||
25162168|NCT01836523|50284551|FG001|Overall Study|Met Withdrawal Criteria|13|||
25162169|NCT01836523|50284552|FG002|Overall Study|Met Withdrawal Criteria|21|||
25162170|NCT01836523|50284553|FG003|Overall Study|Met Withdrawal Criteria|27|||
25162171|NCT01836523|50284550|FG000|Overall Study|Unclassified|17|||
25162172|NCT01836523|50284551|FG001|Overall Study|Unclassified|28|||
25162173|NCT01836523|50284552|FG002|Overall Study|Unclassified|19|||
25162174|NCT01836523|50284553|FG003|Overall Study|Unclassified|29|||
25162175|NCT01275196|50284565|FG000|Overall Study|Adverse Event|3|||
25162176|NCT01275196|50284566|FG001|Overall Study|Adverse Event|5|||
25162177|NCT01275196|50284565|FG000|Overall Study|Withdrawal by Subject|4|||
25162178|NCT01275196|50284566|FG001|Overall Study|Withdrawal by Subject|5|||
25162179|NCT01275196|50284565|FG000|Overall Study|Lost to Follow-up|1|||
25162180|NCT01275196|50284566|FG001|Overall Study|Lost to Follow-up|0|||
25162181|NCT01275196|50284565|FG000|Overall Study|Disease Progression|6|||
25162182|NCT01275196|50284566|FG001|Overall Study|Disease Progression|5|||
25162183|NCT01275196|50284565|FG000|Overall Study|Protocol Violation|1|||
25162184|NCT01275196|50284566|FG001|Overall Study|Protocol Violation|0|||
25162185|NCT01275196|50284565|FG000|Overall Study|Suboptimal response/treatment failure|5|||
25162186|NCT01275196|50284566|FG001|Overall Study|Suboptimal response/treatment failure|6|||
25162187|NCT01984697|50284579|FG000|Overall Study|Adverse Event|0|||
24957189|NCT00502697|50048074|FG000|Overall Study|found not to meet eligibility criteria|3|||
24957190|NCT00502697|50048075|FG001|Overall Study|found not to meet eligibility criteria|4|||
24957191|NCT00502697|50048074|FG000|Overall Study|did not meet assignment criteria|4|||
24957192|NCT00502697|50048075|FG001|Overall Study|did not meet assignment criteria|2|||
24957193|NCT00485069|50048083|FG000|Overall Study|Adverse Event|10|||
24957194|NCT00485069|50048084|FG001|Overall Study|Adverse Event|4|||
24957195|NCT00485069|50048083|FG000|Overall Study|Lack of Efficacy|2|||
24957196|NCT00485069|50048084|FG001|Overall Study|Lack of Efficacy|1|||
24957197|NCT00485069|50048083|FG000|Overall Study|Protocol Violation|0|||
24957198|NCT00485069|50048084|FG001|Overall Study|Protocol Violation|1|||
24957199|NCT00485069|50048083|FG000|Overall Study|Withdrawal by Subject|6|||
24957200|NCT00485069|50048084|FG001|Overall Study|Withdrawal by Subject|6|||
24957201|NCT00355082|50048099|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
24957202|NCT00355082|50048100|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
24957203|NCT00355082|50048101|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
24957204|NCT00355082|50048099|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
24957205|NCT00355082|50048100|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
24957206|NCT00355082|50048101|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
25162188|NCT01984697|50284580|FG001|Overall Study|Adverse Event|0|||
25162189|NCT01984697|50284581|FG002|Overall Study|Adverse Event|2|||
25162190|NCT01984697|50284582|FG003|Overall Study|Adverse Event|0|||
25162191|NCT01984697|50284583|FG004|Overall Study|Adverse Event|0|||
24957207|NCT00355082|50048099|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
25162192|NCT01984697|50284579|FG000|Overall Study|Lost to Follow-up|14|||
25162193|NCT01984697|50284580|FG001|Overall Study|Lost to Follow-up|5|||
25162194|NCT01984697|50284581|FG002|Overall Study|Lost to Follow-up|10|||
25162195|NCT01984697|50284582|FG003|Overall Study|Lost to Follow-up|6|||
25162196|NCT01984697|50284583|FG004|Overall Study|Lost to Follow-up|21|||
25162197|NCT01984697|50284579|FG000|Overall Study|Physician Decision|3|||
25162198|NCT01984697|50284580|FG001|Overall Study|Physician Decision|0|||
25162199|NCT01984697|50284581|FG002|Overall Study|Physician Decision|0|||
25162200|NCT01984697|50284582|FG003|Overall Study|Physician Decision|1|||
25162201|NCT01984697|50284583|FG004|Overall Study|Physician Decision|0|||
25162202|NCT01984697|50284579|FG000|Overall Study|Protocol Violation|8|||
25162203|NCT01984697|50284580|FG001|Overall Study|Protocol Violation|5|||
25162204|NCT01984697|50284581|FG002|Overall Study|Protocol Violation|3|||
25162205|NCT01984697|50284582|FG003|Overall Study|Protocol Violation|2|||
25162206|NCT01984697|50284583|FG004|Overall Study|Protocol Violation|0|||
25162207|NCT01984697|50284579|FG000|Overall Study|Withdrawal by Subject|15|||
25162208|NCT01984697|50284580|FG001|Overall Study|Withdrawal by Subject|21|||
25162209|NCT01984697|50284581|FG002|Overall Study|Withdrawal by Subject|13|||
25162210|NCT01984697|50284582|FG003|Overall Study|Withdrawal by Subject|11|||
24957208|NCT00355082|50048100|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
24957209|NCT00355082|50048101|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
24957210|NCT00355082|50048099|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
25162211|NCT01984697|50284583|FG004|Overall Study|Withdrawal by Subject|13|||
25162212|NCT01984697|50284579|FG000|Overall Study|Missed last follow-up visit|1|||
25162213|NCT01984697|50284580|FG001|Overall Study|Missed last follow-up visit|0|||
25162214|NCT01984697|50284581|FG002|Overall Study|Missed last follow-up visit|0|||
25162215|NCT01984697|50284582|FG003|Overall Study|Missed last follow-up visit|0|||
25162216|NCT01984697|50284583|FG004|Overall Study|Missed last follow-up visit|0|||
25043558|NCT02880371|50145011|FG005|Phase 1b|Lost to Follow-up|0|||
25043559|NCT02880371|50145012|FG006|Phase 1b|Lost to Follow-up|0|||
25043560|NCT02880371|50145013|FG007|Phase 1b|Lost to Follow-up|0|||
25043561|NCT02880371|50145006|FG000|Phase 1b|Participants terminated by Sponsor|1|||
25043562|NCT02880371|50145007|FG001|Phase 1b|Participants terminated by Sponsor|0|||
25043563|NCT02880371|50145008|FG002|Phase 1b|Participants terminated by Sponsor|0|||
25043564|NCT02880371|50145009|FG003|Phase 1b|Participants terminated by Sponsor|0|||
25043565|NCT02880371|50145010|FG004|Phase 1b|Participants terminated by Sponsor|0|||
25043566|NCT02880371|50145011|FG005|Phase 1b|Participants terminated by Sponsor|0|||
25162217|NCT01984697|50284579|FG000|Overall Study|Death|0|||
25162218|NCT01984697|50284580|FG001|Overall Study|Death|0|||
25162219|NCT01984697|50284581|FG002|Overall Study|Death|0|||
25162220|NCT01984697|50284582|FG003|Overall Study|Death|1|||
25162221|NCT01984697|50284583|FG004|Overall Study|Death|0|||
25162222|NCT01984697|50284579|FG000|Overall Study|Pregnancy|2|||
25162223|NCT01984697|50284580|FG001|Overall Study|Pregnancy|0|||
25162224|NCT01984697|50284581|FG002|Overall Study|Pregnancy|1|||
25162225|NCT01984697|50284582|FG003|Overall Study|Pregnancy|0|||
25162226|NCT01984697|50284583|FG004|Overall Study|Pregnancy|1|||
25162227|NCT02000531|50284597|FG000|Overall Study|Lost to Follow-up|1|||
25162228|NCT02000531|50284598|FG001|Overall Study|Lost to Follow-up|0|||
25162229|NCT02000531|50284597|FG000|Overall Study|Discontinued due to data cut-off|3|||
25162230|NCT02000531|50284598|FG001|Overall Study|Discontinued due to data cut-off|8|||
25162231|NCT01609231|50284606|FG000|Overall Study|Adverse Event|1|||
25162232|NCT01609231|50284607|FG001|Overall Study|Adverse Event|3|||
25162233|NCT01609231|50284606|FG000|Overall Study|Physician Decision|1|||
25162234|NCT01609231|50284607|FG001|Overall Study|Physician Decision|0|||
25162235|NCT01609231|50284606|FG000|Overall Study|Withdrawal by Subject|1|||
25162236|NCT01609231|50284607|FG001|Overall Study|Withdrawal by Subject|0|||
25162237|NCT01793935|50284615|FG000|Overall Study|Pregnancy|1|||
25162238|NCT01793935|50284616|FG001|Overall Study|Pregnancy|0|||
25162239|NCT01793935|50284615|FG000|Overall Study|Protocol Violation|2|||
25162240|NCT01793935|50284616|FG001|Overall Study|Protocol Violation|1|||
25162241|NCT01793935|50284615|FG000|Overall Study|Adverse Event|2|||
25162242|NCT01793935|50284616|FG001|Overall Study|Adverse Event|0|||
25162243|NCT01793935|50284615|FG000|Overall Study|Patient did not take study medication|1|||
25162244|NCT01793935|50284616|FG001|Overall Study|Patient did not take study medication|1|||
25162245|NCT01793935|50284615|FG000|Overall Study|Lost to Follow-up|0|||
25162246|NCT01793935|50284616|FG001|Overall Study|Lost to Follow-up|1|||
25162247|NCT02092025|50284622|FG000|Overall Study|Case Report Forms Uncollected|44|||
25162248|NCT02092025|50284622|FG000|Overall Study|Protocol Deviation|24|||
25162249|NCT01769443|50284628|FG000|Overall Study|Study closure|1|||
25162250|NCT01769443|50284629|FG001|Overall Study|Study closure|0|||
25162251|NCT01768117|50284636|FG000|Overall Study|Lost to Follow-up|1|||
25162252|NCT01768117|50284636|FG000|Overall Study|Withdrawal by Subject|2|||
24957211|NCT00355082|50048100|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
24957212|NCT00355082|50048101|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
24957213|NCT00355082|50048099|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
24957214|NCT00355082|50048100|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
24957215|NCT00355082|50048101|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
24957216|NCT00355082|50048099|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
24957217|NCT00355082|50048100|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
24957218|NCT00355082|50048101|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
24957219|NCT00355082|50048099|FG000|Continuation Phase|Adverse Event|2|||
24957220|NCT00355082|50048100|FG001|Continuation Phase|Adverse Event|0|||
24957221|NCT00355082|50048101|FG002|Continuation Phase|Adverse Event|1|||
24957222|NCT00355082|50048099|FG000|Continuation Phase|Lost to Follow-up|2|||
24957223|NCT00355082|50048100|FG001|Continuation Phase|Lost to Follow-up|0|||
24957224|NCT00355082|50048101|FG002|Continuation Phase|Lost to Follow-up|1|||
25043567|NCT02880371|50145012|FG006|Phase 1b|Participants terminated by Sponsor|0|||
25043568|NCT02880371|50145013|FG007|Phase 1b|Participants terminated by Sponsor|0|||
25162253|NCT01768117|50284636|FG000|Overall Study|Protocol Violation|3|||
25162254|NCT01767493|50284640|FG000|Overall Study|screen failures|3|||
25162255|NCT01274182|50284647|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
24957225|NCT00355082|50048099|FG000|Continuation Phase|Protocol Violation|1|||
24957226|NCT00355082|50048100|FG001|Continuation Phase|Protocol Violation|0|||
25043569|NCT02880371|50145006|FG000|Phase 1b|Withdrawal by Subject|0|||
25162256|NCT01274182|50284648|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
25162257|NCT01274182|50284649|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
25162258|NCT01274182|50284647|FG000|Overall Study|Adverse Event|4|||
25162259|NCT01274182|50284648|FG001|Overall Study|Adverse Event|5|||
25162260|NCT01274182|50284649|FG002|Overall Study|Adverse Event|3|||
25162261|NCT01274182|50284647|FG000|Overall Study|Withdrawal by Subject|5|||
25162262|NCT01274182|50284648|FG001|Overall Study|Withdrawal by Subject|5|||
25162263|NCT01274182|50284649|FG002|Overall Study|Withdrawal by Subject|3|||
25162264|NCT01274182|50284647|FG000|Overall Study|Lost to Follow-up|2|||
25162265|NCT01274182|50284648|FG001|Overall Study|Lost to Follow-up|3|||
25162266|NCT01274182|50284649|FG002|Overall Study|Lost to Follow-up|1|||
25043570|NCT02880371|50145007|FG001|Phase 1b|Withdrawal by Subject|0|||
25043571|NCT02880371|50145008|FG002|Phase 1b|Withdrawal by Subject|1|||
25043572|NCT02880371|50145009|FG003|Phase 1b|Withdrawal by Subject|0|||
25043573|NCT02880371|50145010|FG004|Phase 1b|Withdrawal by Subject|0|||
25043574|NCT02880371|50145011|FG005|Phase 1b|Withdrawal by Subject|0|||
25043575|NCT02880371|50145012|FG006|Phase 1b|Withdrawal by Subject|0|||
25043576|NCT02880371|50145013|FG007|Phase 1b|Withdrawal by Subject|0|||
25043577|NCT02880371|50145006|FG000|Phase 1b|Death|4|||
25043578|NCT02880371|50145007|FG001|Phase 1b|Death|6|||
25043579|NCT02880371|50145008|FG002|Phase 1b|Death|5|||
25043580|NCT02880371|50145009|FG003|Phase 1b|Death|1|||
25043581|NCT02880371|50145010|FG004|Phase 1b|Death|0|||
25043582|NCT02880371|50145011|FG005|Phase 1b|Death|0|||
25043583|NCT02880371|50145012|FG006|Phase 1b|Death|0|||
25043584|NCT02880371|50145013|FG007|Phase 1b|Death|0|||
25043585|NCT02880371|50145006|FG000|Phase 1b|Enrolled but not Treated|0|||
25043586|NCT02880371|50145007|FG001|Phase 1b|Enrolled but not Treated|1|||
25043587|NCT02880371|50145008|FG002|Phase 1b|Enrolled but not Treated|0|||
25043588|NCT02880371|50145009|FG003|Phase 1b|Enrolled but not Treated|0|||
25043589|NCT02880371|50145010|FG004|Phase 1b|Enrolled but not Treated|0|||
25043590|NCT02880371|50145011|FG005|Phase 1b|Enrolled but not Treated|0|||
25043591|NCT02880371|50145012|FG006|Phase 1b|Enrolled but not Treated|0|||
25043592|NCT02880371|50145013|FG007|Phase 1b|Enrolled but not Treated|0|||
25043593|NCT02880371|50145006|FG000|Phase 2|Enrolled but not Treated|0|||
25162267|NCT01274182|50284647|FG000|Overall Study|Protocol Violation|3|||
25162268|NCT01274182|50284648|FG001|Overall Study|Protocol Violation|2|||
25162269|NCT01274182|50284649|FG002|Overall Study|Protocol Violation|0|||
25162270|NCT01274182|50284647|FG000|Overall Study|Death|1|||
25162271|NCT01274182|50284648|FG001|Overall Study|Death|0|||
25162272|NCT01274182|50284649|FG002|Overall Study|Death|1|||
25162273|NCT01984229|50284663|FG000|Safety Follow-up Period|Adverse Event|1|||
25162274|NCT01984229|50284664|FG001|Safety Follow-up Period|Adverse Event|1|||
25162275|NCT01984229|50284663|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
25162276|NCT01984229|50284664|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
25162277|NCT01835899|50284679|FG000|Overall Study|Adverse Event|0|||
25162278|NCT01835899|50284680|FG001|Overall Study|Adverse Event|0|||
25162279|NCT01835899|50284681|FG002|Overall Study|Adverse Event|1|||
25162280|NCT01835899|50284679|FG000|Overall Study|Other than stated above|0|||
25162281|NCT01835899|50284680|FG001|Overall Study|Other than stated above|1|||
25162282|NCT01835899|50284681|FG002|Overall Study|Other than stated above|0|||
25162283|NCT01766401|50284693|FG000|Overall Study|Adverse Event|7|||
25162284|NCT01766401|50284694|FG001|Overall Study|Adverse Event|22|||
25186516|NCT02647866|50336896|FG001|Overall Study|Subject moved to different country|0|||
25043594|NCT02880371|50145007|FG001|Phase 2|Enrolled but not Treated|0|||
25043595|NCT02880371|50145008|FG002|Phase 2|Enrolled but not Treated|0|||
25043596|NCT02880371|50145009|FG003|Phase 2|Enrolled but not Treated|0|||
25162285|NCT01766401|50284693|FG000|Overall Study|Lack of Efficacy|1|||
25162286|NCT01766401|50284694|FG001|Overall Study|Lack of Efficacy|2|||
25043597|NCT02880371|50145010|FG004|Phase 2|Enrolled but not Treated|0|||
25043598|NCT02880371|50145011|FG005|Phase 2|Enrolled but not Treated|1|||
25043599|NCT02880371|50145012|FG006|Phase 2|Enrolled but not Treated|1|||
25043600|NCT02880371|50145013|FG007|Phase 2|Enrolled but not Treated|0|||
25043601|NCT02880371|50145006|FG000|Phase 2|Other|0|||
25043602|NCT02880371|50145007|FG001|Phase 2|Other|0|||
25043603|NCT02880371|50145008|FG002|Phase 2|Other|0|||
25043604|NCT02880371|50145009|FG003|Phase 2|Other|0|||
25162287|NCT01766401|50284693|FG000|Overall Study|Protocol Violation|3|||
25162288|NCT01766401|50284694|FG001|Overall Study|Protocol Violation|8|||
25162289|NCT01766401|50284693|FG000|Overall Study|Withdrawal by Subject|15|||
25162290|NCT01766401|50284694|FG001|Overall Study|Withdrawal by Subject|12|||
25162291|NCT01766401|50284693|FG000|Overall Study|Lost to Follow-up|10|||
25162292|NCT01766401|50284694|FG001|Overall Study|Lost to Follow-up|11|||
25162293|NCT01766401|50284693|FG000|Overall Study|Pregnancy|1|||
25162294|NCT01766401|50284694|FG001|Overall Study|Pregnancy|1|||
25162295|NCT01272934|50284702|FG000|Overall Study|Adverse Event|0|||
25162296|NCT01272934|50284703|FG001|Overall Study|Adverse Event|1|||
25162297|NCT01272934|50284702|FG000|Overall Study|Abnormal Laboratory Value|0|||
25162298|NCT01272934|50284703|FG001|Overall Study|Abnormal Laboratory Value|1|||
25162299|NCT01983683|50284721|FG000|Overall Study|Withdrawal by Subject|14|||
25162300|NCT01983683|50284722|FG001|Overall Study|Withdrawal by Subject|18|||
25162301|NCT01983683|50284721|FG000|Overall Study|Death|11|||
25162302|NCT01983683|50284722|FG001|Overall Study|Death|15|||
25162303|NCT01983683|50284721|FG000|Overall Study|Physician Decision|8|||
25162304|NCT01983683|50284722|FG001|Overall Study|Physician Decision|9|||
25162305|NCT01983683|50284721|FG000|Overall Study|Lost to Follow-up|4|||
25162306|NCT01983683|50284722|FG001|Overall Study|Lost to Follow-up|8|||
25162307|NCT01983683|50284721|FG000|Overall Study|Sponsor Decision|1|||
25162308|NCT01983683|50284722|FG001|Overall Study|Sponsor Decision|1|||
25162309|NCT01998893|50284728|FG000|Overall Study|Adverse Event|2|||
25162310|NCT01998893|50284728|FG000|Overall Study|Death|1|||
25162311|NCT01998893|50284728|FG000|Overall Study|Lost to Follow-up|8|||
25162312|NCT01998893|50284728|FG000|Overall Study|Physician Decision|2|||
25162313|NCT01998893|50284728|FG000|Overall Study|Protocol Violation|2|||
25162314|NCT01998893|50284728|FG000|Overall Study|Withdrawal by Subject|1|||
25162315|NCT01998893|50284728|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
25162316|NCT01791985|50284732|FG000|Overall Study|Adverse Event|7|||
25162317|NCT01791985|50284732|FG000|Overall Study|Withdrawal by Subject|1|||
25162318|NCT01998737|50284739|FG000|Overall Study|Corrupted database|23|||
25162319|NCT01998737|50284740|FG001|Overall Study|Corrupted database|0|||
25162320|NCT01791517|50284749|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
25162321|NCT01791517|50284750|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
25162322|NCT01791517|50284751|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
25162323|NCT01791517|50284752|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
25162324|NCT01791517|50284753|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
25162325|NCT01791517|50284754|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
25162326|NCT01791517|50284755|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
25162327|NCT01791517|50284756|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
25162328|NCT01791517|50284757|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
25162329|NCT01791517|50284758|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
25162330|NCT01791517|50284759|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
25162331|NCT01791517|50284760|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
25162332|NCT01791517|50284749|FG000|Phase I: Period 1|Adverse Event|0|||
25162333|NCT01791517|50284750|FG001|Phase I: Period 1|Adverse Event|0|||
25162334|NCT01791517|50284751|FG002|Phase I: Period 1|Adverse Event|1|||
25162335|NCT01791517|50284752|FG003|Phase I: Period 1|Adverse Event|1|||
25162336|NCT01791517|50284753|FG004|Phase I: Period 1|Adverse Event|0|||
25162337|NCT01791517|50284754|FG005|Phase I: Period 1|Adverse Event|0|||
25162338|NCT01791517|50284755|FG006|Phase I: Period 1|Adverse Event|0|||
25162339|NCT01791517|50284756|FG007|Phase I: Period 1|Adverse Event|0|||
25162340|NCT01791517|50284757|FG008|Phase I: Period 1|Adverse Event|0|||
25162341|NCT01791517|50284758|FG009|Phase I: Period 1|Adverse Event|0|||
25162342|NCT01791517|50284759|FG010|Phase I: Period 1|Adverse Event|0|||
25162343|NCT01791517|50284760|FG011|Phase I: Period 1|Adverse Event|0|||
25162344|NCT01791517|50284749|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
25162345|NCT01791517|50284750|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
25162346|NCT01791517|50284751|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
25162347|NCT01791517|50284752|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
25162348|NCT01791517|50284753|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
24957227|NCT00355082|50048101|FG002|Continuation Phase|Protocol Violation|1|||
24957228|NCT00355082|50048099|FG000|Continuation Phase|Withdrawal by Subject|4|||
24957229|NCT00355082|50048100|FG001|Continuation Phase|Withdrawal by Subject|0|||
24957230|NCT00355082|50048101|FG002|Continuation Phase|Withdrawal by Subject|0|||
24957231|NCT00355082|50048099|FG000|Continuation Phase|Lack of Efficacy|5|||
24957232|NCT00355082|50048100|FG001|Continuation Phase|Lack of Efficacy|0|||
24957233|NCT00355082|50048101|FG002|Continuation Phase|Lack of Efficacy|0|||
24957234|NCT00355082|50048099|FG000|Continuation Phase|Site Closed by Sponsor|8|||
24957235|NCT00355082|50048100|FG001|Continuation Phase|Site Closed by Sponsor|0|||
24957236|NCT00355082|50048101|FG002|Continuation Phase|Site Closed by Sponsor|0|||
25162349|NCT01791517|50284754|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
25162350|NCT01791517|50284755|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
25162351|NCT01791517|50284756|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
25162352|NCT01791517|50284757|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
25162353|NCT01791517|50284758|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
25162354|NCT01791517|50284759|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
25162355|NCT01791517|50284760|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
25162356|NCT01791517|50284749|FG000|Phase I: Period 1|Protocol Violation|0|||
25162357|NCT01791517|50284750|FG001|Phase I: Period 1|Protocol Violation|1|||
25162358|NCT01791517|50284751|FG002|Phase I: Period 1|Protocol Violation|0|||
25162359|NCT01791517|50284752|FG003|Phase I: Period 1|Protocol Violation|0|||
25162360|NCT01791517|50284753|FG004|Phase I: Period 1|Protocol Violation|0|||
25162361|NCT01791517|50284754|FG005|Phase I: Period 1|Protocol Violation|0|||
25162362|NCT01791517|50284755|FG006|Phase I: Period 1|Protocol Violation|0|||
25162363|NCT01791517|50284756|FG007|Phase I: Period 1|Protocol Violation|0|||
25162364|NCT01791517|50284757|FG008|Phase I: Period 1|Protocol Violation|0|||
25162365|NCT01791517|50284758|FG009|Phase I: Period 1|Protocol Violation|0|||
25162366|NCT01791517|50284759|FG010|Phase I: Period 1|Protocol Violation|0|||
25162367|NCT01791517|50284760|FG011|Phase I: Period 1|Protocol Violation|0|||
25162368|NCT01791517|50284749|FG000|Phase I: Period 1|Lost to Follow-up|0|||
25162369|NCT01791517|50284750|FG001|Phase I: Period 1|Lost to Follow-up|0|||
25162370|NCT01791517|50284751|FG002|Phase I: Period 1|Lost to Follow-up|0|||
25162371|NCT01791517|50284752|FG003|Phase I: Period 1|Lost to Follow-up|1|||
25162372|NCT01791517|50284753|FG004|Phase I: Period 1|Lost to Follow-up|0|||
25162373|NCT01791517|50284754|FG005|Phase I: Period 1|Lost to Follow-up|0|||
25162374|NCT01791517|50284755|FG006|Phase I: Period 1|Lost to Follow-up|1|||
25162375|NCT01791517|50284756|FG007|Phase I: Period 1|Lost to Follow-up|0|||
25162376|NCT01791517|50284757|FG008|Phase I: Period 1|Lost to Follow-up|1|||
25162377|NCT01791517|50284758|FG009|Phase I: Period 1|Lost to Follow-up|1|||
25162378|NCT01791517|50284759|FG010|Phase I: Period 1|Lost to Follow-up|0|||
25162379|NCT01791517|50284760|FG011|Phase I: Period 1|Lost to Follow-up|0|||
25162380|NCT01791517|50284749|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
25162381|NCT01791517|50284750|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
25162382|NCT01791517|50284751|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
25162383|NCT01791517|50284752|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
25162384|NCT01791517|50284753|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
25162385|NCT01791517|50284754|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
25162386|NCT01791517|50284755|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
25162387|NCT01791517|50284756|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
25162388|NCT01791517|50284757|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
25043605|NCT02880371|50145010|FG004|Phase 2|Other|0|||
25162389|NCT01791517|50284758|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
25162390|NCT01791517|50284759|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
25043606|NCT02880371|50145011|FG005|Phase 2|Other|1|||
25043607|NCT02880371|50145012|FG006|Phase 2|Other|2|||
25043608|NCT02880371|50145013|FG007|Phase 2|Other|1|||
25043609|NCT02880371|50145006|FG000|Phase 2|Participants terminated by Sponsor|0|||
25043610|NCT02880371|50145007|FG001|Phase 2|Participants terminated by Sponsor|0|||
25043611|NCT02880371|50145008|FG002|Phase 2|Participants terminated by Sponsor|0|||
25162391|NCT01791517|50284760|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
25043612|NCT02880371|50145009|FG003|Phase 2|Participants terminated by Sponsor|0|||
25043613|NCT02880371|50145010|FG004|Phase 2|Participants terminated by Sponsor|1|||
25043614|NCT02880371|50145011|FG005|Phase 2|Participants terminated by Sponsor|6|||
25043615|NCT02880371|50145012|FG006|Phase 2|Participants terminated by Sponsor|1|||
25043616|NCT02880371|50145013|FG007|Phase 2|Participants terminated by Sponsor|5|||
25043617|NCT02880371|50145006|FG000|Phase 2|Death|0|||
25043618|NCT02880371|50145007|FG001|Phase 2|Death|0|||
25043619|NCT02880371|50145008|FG002|Phase 2|Death|0|||
25043620|NCT02880371|50145009|FG003|Phase 2|Death|0|||
25043621|NCT02880371|50145010|FG004|Phase 2|Death|1|||
25043622|NCT02880371|50145011|FG005|Phase 2|Death|10|||
25043623|NCT02880371|50145012|FG006|Phase 2|Death|20|||
25043624|NCT02880371|50145013|FG007|Phase 2|Death|5|||
25043625|NCT02880371|50145006|FG000|Phase 2|Lost to Follow-up|0|||
25043626|NCT02880371|50145007|FG001|Phase 2|Lost to Follow-up|0|||
25043627|NCT02880371|50145008|FG002|Phase 2|Lost to Follow-up|0|||
25043628|NCT02880371|50145009|FG003|Phase 2|Lost to Follow-up|0|||
24957237|NCT00355082|50048099|FG000|Continuation Phase|Scheduling Error|1|||
24957238|NCT00355082|50048100|FG001|Continuation Phase|Scheduling Error|0|||
25043629|NCT02880371|50145010|FG004|Phase 2|Lost to Follow-up|0|||
25043630|NCT02880371|50145011|FG005|Phase 2|Lost to Follow-up|0|||
24957239|NCT00355082|50048101|FG002|Continuation Phase|Scheduling Error|0|||
24957240|NCT00355082|50048099|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
24957241|NCT00355082|50048100|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
24957242|NCT00355082|50048101|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
24957243|NCT00502307|50048112|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
24957244|NCT00502307|50048113|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
24957245|NCT00502307|50048114|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
25043631|NCT02880371|50145012|FG006|Phase 2|Lost to Follow-up|3|||
25043632|NCT02880371|50145013|FG007|Phase 2|Lost to Follow-up|0|||
25276303|NCT00960934|50590273|FG002|Overall Study|Lost to Follow-up|0|||
24957246|NCT00502307|50048112|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
25043633|NCT02880371|50145006|FG000|Phase 2|Withdrawal by Subject|0|||
25043634|NCT02880371|50145007|FG001|Phase 2|Withdrawal by Subject|0|||
25043635|NCT02880371|50145008|FG002|Phase 2|Withdrawal by Subject|0|||
25162392|NCT01791517|50284749|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
25162393|NCT01791517|50284750|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
25043636|NCT02880371|50145009|FG003|Phase 2|Withdrawal by Subject|0|||
25043637|NCT02880371|50145010|FG004|Phase 2|Withdrawal by Subject|0|||
25043638|NCT02880371|50145011|FG005|Phase 2|Withdrawal by Subject|1|||
25043639|NCT02880371|50145012|FG006|Phase 2|Withdrawal by Subject|1|||
25043640|NCT02880371|50145013|FG007|Phase 2|Withdrawal by Subject|0|||
25043641|NCT02880371|50145006|FG000|Phase 2|End of Study page not completed by error|0|||
25043642|NCT02880371|50145007|FG001|Phase 2|End of Study page not completed by error|0|||
25162394|NCT01791517|50284751|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
25162395|NCT01791517|50284752|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
25043643|NCT02880371|50145008|FG002|Phase 2|End of Study page not completed by error|0|||
25043644|NCT02880371|50145009|FG003|Phase 2|End of Study page not completed by error|0|||
25043645|NCT02880371|50145010|FG004|Phase 2|End of Study page not completed by error|0|||
25043646|NCT02880371|50145011|FG005|Phase 2|End of Study page not completed by error|1|||
25043647|NCT02880371|50145012|FG006|Phase 2|End of Study page not completed by error|0|||
25043648|NCT02880371|50145013|FG007|Phase 2|End of Study page not completed by error|0|||
25043649|NCT02837029|50145036|FG000|Screening|Failed to meet screening requirements.|7|||
25043650|NCT02837029|50145037|FG001|Screening|Failed to meet screening requirements.|3|||
25043651|NCT02837029|50145038|FG002|Screening|Failed to meet screening requirements.|0|||
25043652|NCT02837029|50145036|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
25043653|NCT02837029|50145037|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
25043654|NCT02837029|50145038|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
25043655|NCT02837029|50145036|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
25043656|NCT02837029|50145037|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
25043657|NCT02837029|50145038|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
25043658|NCT02837029|50145036|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
25043659|NCT02837029|50145037|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
25043660|NCT02837029|50145038|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
25043661|NCT02837029|50145036|FG000|Cycle 2 and Beyond|Adverse Event|1|||
25043662|NCT02837029|50145037|FG001|Cycle 2 and Beyond|Adverse Event|0|||
25043663|NCT02837029|50145038|FG002|Cycle 2 and Beyond|Adverse Event|0|||
25043664|NCT02837029|50145036|FG000|2 Year Follow-up|Death|6|||
25043665|NCT02837029|50145037|FG001|2 Year Follow-up|Death|7|||
25162396|NCT01791517|50284753|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
25043666|NCT02837029|50145038|FG002|2 Year Follow-up|Death|0|||
25043667|NCT02642965|50145047|FG000|Overall Study|Lack of Efficacy|4|||
25043668|NCT02642965|50145047|FG000|Overall Study|Physician Decision|9|||
25043669|NCT03010527|50145054|FG000|Overall Study|Death|0|||
25043670|NCT03010527|50145055|FG001|Overall Study|Death|0|||
25043671|NCT03010527|50145056|FG002|Overall Study|Death|1|||
25043672|NCT03010527|50145054|FG000|Overall Study|Adverse Event|0|||
25043673|NCT03010527|50145055|FG001|Overall Study|Adverse Event|4|||
25043674|NCT03010527|50145056|FG002|Overall Study|Adverse Event|2|||
25043675|NCT03010527|50145054|FG000|Overall Study|Protocol Violation|0|||
25043676|NCT03010527|50145055|FG001|Overall Study|Protocol Violation|1|||
25043677|NCT03010527|50145056|FG002|Overall Study|Protocol Violation|0|||
25043678|NCT03010527|50145054|FG000|Overall Study|Lost to Follow-up|0|||
25043679|NCT03010527|50145055|FG001|Overall Study|Lost to Follow-up|2|||
25043680|NCT03010527|50145056|FG002|Overall Study|Lost to Follow-up|1|||
25043681|NCT03010527|50145054|FG000|Overall Study|Withdrawal by Subject|0|||
25043682|NCT03010527|50145055|FG001|Overall Study|Withdrawal by Subject|3|||
25043683|NCT03010527|50145056|FG002|Overall Study|Withdrawal by Subject|4|||
25043684|NCT03010527|50145054|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
25043685|NCT03010527|50145055|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
25043686|NCT03010527|50145056|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
25162397|NCT01791517|50284754|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
25043687|NCT03010527|50145054|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
25043688|NCT03010527|50145055|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
25043689|NCT03010527|50145056|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
25043690|NCT03010527|50145054|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
25043691|NCT03010527|50145055|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
25043692|NCT03010527|50145056|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
25043693|NCT00794924|50145089|FG000|Overall Study|Lost to Follow-up|6|||
25043694|NCT00794924|50145090|FG001|Overall Study|Lost to Follow-up|8|||
25043695|NCT00794924|50145089|FG000|Overall Study|Withdrawal by Subject|48|||
25043696|NCT00794924|50145090|FG001|Overall Study|Withdrawal by Subject|60|||
25043697|NCT00794924|50145089|FG000|Overall Study|Adverse Event|6|||
25043698|NCT00794924|50145090|FG001|Overall Study|Adverse Event|2|||
25043699|NCT02914275|50145096|FG000|Overall Study|Lost to Follow-up|84|||
25043700|NCT02914275|50145097|FG001|Overall Study|Lost to Follow-up|29|||
25043701|NCT02914275|50145096|FG000|Overall Study|Withdrawal by Subject|26|||
25043702|NCT02914275|50145097|FG001|Overall Study|Withdrawal by Subject|10|||
25043703|NCT02914275|50145096|FG000|Overall Study|Protocol Violation|1|||
25043704|NCT02914275|50145097|FG001|Overall Study|Protocol Violation|1|||
25043705|NCT02914275|50145096|FG000|Overall Study|Physician Decision|3|||
25043706|NCT02914275|50145097|FG001|Overall Study|Physician Decision|1|||
25043707|NCT02914275|50145096|FG000|Overall Study|Other|4|||
25043708|NCT02914275|50145097|FG001|Overall Study|Other|1|||
25043709|NCT02914275|50145096|FG000|Overall Study|Excluded due to invalid informed consent|3|||
25043710|NCT02914275|50145097|FG001|Overall Study|Excluded due to invalid informed consent|0|||
25162398|NCT01791517|50284755|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
25162399|NCT01791517|50284756|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
25162400|NCT01791517|50284757|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
25162401|NCT01791517|50284758|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
25162402|NCT01791517|50284759|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
25162403|NCT01791517|50284760|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
25162404|NCT01791517|50284749|FG000|Phase I: Period 2|Protocol Violation|0|||
25162405|NCT01791517|50284750|FG001|Phase I: Period 2|Protocol Violation|0|||
25162406|NCT01791517|50284751|FG002|Phase I: Period 2|Protocol Violation|0|||
25162407|NCT01791517|50284752|FG003|Phase I: Period 2|Protocol Violation|1|||
24957247|NCT00502307|50048113|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
24957248|NCT00502307|50048114|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
24957249|NCT00502307|50048112|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
24957250|NCT00502307|50048113|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
24957251|NCT00502307|50048114|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
24957252|NCT00502307|50048112|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
24957253|NCT00502307|50048113|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
24957254|NCT00502307|50048114|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
24957255|NCT00502307|50048112|FG000|Maintenance Period|Progressive disease|80|||
24957256|NCT00502307|50048113|FG001|Maintenance Period|Progressive disease|0|||
24957257|NCT00502307|50048114|FG002|Maintenance Period|Progressive disease|0|||
24957258|NCT00502307|50048112|FG000|Maintenance Period|Discontinued due to other reasons|68|||
24957259|NCT00502307|50048113|FG001|Maintenance Period|Discontinued due to other reasons|0|||
24957260|NCT00502307|50048114|FG002|Maintenance Period|Discontinued due to other reasons|0|||
25043711|NCT00792116|50145109|FG000|Overall Study|Lost to Follow-up|0|||
25043712|NCT00792116|50145110|FG001|Overall Study|Lost to Follow-up|1|||
25043713|NCT00792116|50145109|FG000|Overall Study|Discontnued intervention|1|||
25043714|NCT00792116|50145110|FG001|Overall Study|Discontnued intervention|0|||
25043715|NCT00489827|50145125|FG000|Overall Study|Intraoperative exclusion criteria|1|||
25162408|NCT01791517|50284753|FG004|Phase I: Period 2|Protocol Violation|0|||
25162409|NCT01791517|50284754|FG005|Phase I: Period 2|Protocol Violation|0|||
25162410|NCT01791517|50284755|FG006|Phase I: Period 2|Protocol Violation|0|||
25162411|NCT01791517|50284756|FG007|Phase I: Period 2|Protocol Violation|0|||
25162412|NCT01791517|50284757|FG008|Phase I: Period 2|Protocol Violation|0|||
25162413|NCT01791517|50284758|FG009|Phase I: Period 2|Protocol Violation|0|||
25162414|NCT01791517|50284759|FG010|Phase I: Period 2|Protocol Violation|0|||
25162415|NCT01791517|50284760|FG011|Phase I: Period 2|Protocol Violation|0|||
25162416|NCT01791517|50284749|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
25162417|NCT01791517|50284750|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
25162418|NCT01791517|50284751|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
25162419|NCT01791517|50284752|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
25162420|NCT01791517|50284753|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
25162421|NCT01791517|50284754|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
25162422|NCT01791517|50284755|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
25162423|NCT01791517|50284756|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
25162424|NCT01791517|50284757|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
25162425|NCT01791517|50284758|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
25043716|NCT00489827|50145126|FG001|Overall Study|Intraoperative exclusion criteria|1|||
25043717|NCT00489827|50145125|FG000|Overall Study|Intraoperative exclusion criteria|1|||
25043718|NCT00489827|50145126|FG001|Overall Study|Intraoperative exclusion criteria|1|||
25043719|NCT03007953|50145134|FG000|Overall Study|Withdrawal by Subject|5|||
25043720|NCT03007953|50145135|FG001|Overall Study|Withdrawal by Subject|2|||
25043721|NCT03007953|50145134|FG000|Overall Study|Death|5|||
25043722|NCT03007953|50145135|FG001|Overall Study|Death|7|||
25043723|NCT03007953|50145134|FG000|Overall Study|Lost to Follow-up|3|||
25043724|NCT03007953|50145135|FG001|Overall Study|Lost to Follow-up|2|||
25162426|NCT01791517|50284759|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
25162427|NCT01791517|50284760|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
25162428|NCT01791517|50284749|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
25162429|NCT01791517|50284750|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
25162430|NCT01791517|50284751|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
25162431|NCT01791517|50284752|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
25162432|NCT01791517|50284753|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
25043725|NCT03007953|50145134|FG000|Overall Study|Enrolled in Hospice|3|||
25043726|NCT03007953|50145135|FG001|Overall Study|Enrolled in Hospice|2|||
24957261|NCT00484679|50048131|FG000|Overall Study|Withdrawal by Subject|3|||
24957262|NCT00377312|50048137|FG000|Overall Study|Adverse Event|1|||
24957263|NCT00377312|50048138|FG001|Overall Study|Adverse Event|1|||
24957264|NCT00377234|50048146|FG000|Overall Study|Adverse Event|14|||
24957265|NCT00377234|50048147|FG001|Overall Study|Adverse Event|17|||
24957266|NCT00377234|50048146|FG000|Overall Study|Withdrawal by Subject|11|||
25043727|NCT02604433|50145143|FG000|Overall Study|Withdrawal by Subject|37|||
25043728|NCT02604433|50145144|FG001|Overall Study|Withdrawal by Subject|16|||
25043729|NCT02604433|50145143|FG000|Overall Study|Adverse Event|4|||
25043730|NCT02604433|50145144|FG001|Overall Study|Adverse Event|0|||
25043731|NCT02604433|50145143|FG000|Overall Study|Other reasons|3|||
25043732|NCT02604433|50145144|FG001|Overall Study|Other reasons|5|||
25043733|NCT02604433|50145143|FG000|Overall Study|Death|4|||
25043734|NCT02604433|50145144|FG001|Overall Study|Death|1|||
25043735|NCT02604433|50145143|FG000|Overall Study|Transition to Rollover Protocol|169|||
25162433|NCT01791517|50284754|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
25162434|NCT01791517|50284755|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
24957267|NCT00377234|50048147|FG001|Overall Study|Withdrawal by Subject|9|||
24957268|NCT00377234|50048146|FG000|Overall Study|Lost to Follow-up|4|||
24957269|NCT00377234|50048147|FG001|Overall Study|Lost to Follow-up|2|||
24957270|NCT00377234|50048146|FG000|Overall Study|Administrative|2|||
24957271|NCT00377234|50048147|FG001|Overall Study|Administrative|1|||
24957272|NCT00377234|50048146|FG000|Overall Study|Not assigned|3|||
24957273|NCT00377234|50048147|FG001|Overall Study|Not assigned|2|||
24957274|NCT00377156|50048161|FG000|Overall Study|Death|23|||
24957275|NCT00377156|50048162|FG001|Overall Study|Death|19|||
24957276|NCT00377156|50048161|FG000|Overall Study|Withdrawal by Subject|16|||
25043736|NCT02604433|50145144|FG001|Overall Study|Transition to Rollover Protocol|82|||
25043737|NCT02604433|50145143|FG000|Overall Study|Physician Decision|1|||
25043738|NCT02604433|50145144|FG001|Overall Study|Physician Decision|1|||
25043739|NCT02604433|50145143|FG000|Overall Study|Lack of Efficacy|0|||
25043740|NCT02604433|50145144|FG001|Overall Study|Lack of Efficacy|1|||
25043741|NCT02659150|50145150|FG000|Subject Enrollment|Physician Decision|3|||
25043742|NCT02659150|50145150|FG000|Subject Enrollment|Withdrawal by Subject|2|||
25043743|NCT02659150|50145150|FG000|Baseline Imaging|Withdrawal by Subject|1|||
25043744|NCT02659150|50145150|FG000|Baseline Imaging|Physician Decision|1|||
25043745|NCT02659150|50145150|FG000|Study Drug Dosing|Adverse Event|1|||
25043746|NCT03006393|50145157|FG000|Overall Study|Withdrawal by Subject|1|||
25043747|NCT03006393|50145158|FG001|Overall Study|Withdrawal by Subject|1|||
25043748|NCT03006393|50145157|FG000|Overall Study|Pregnancy|0|||
25043749|NCT03006393|50145158|FG001|Overall Study|Pregnancy|1|||
25043750|NCT03006393|50145157|FG000|Overall Study|Lost to Follow-up|0|||
25043751|NCT03006393|50145158|FG001|Overall Study|Lost to Follow-up|1|||
25043752|NCT00882440|50145175|FG000|Overall Study|Adverse Event|2|||
25043753|NCT00882440|50145176|FG001|Overall Study|Adverse Event|2|||
25043754|NCT00882440|50145177|FG002|Overall Study|Adverse Event|2|||
25162435|NCT01791517|50284756|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
25043755|NCT00882440|50145178|FG003|Overall Study|Adverse Event|1|||
25043756|NCT00882440|50145179|FG004|Overall Study|Adverse Event|1|||
25043757|NCT00882440|50145180|FG005|Overall Study|Adverse Event|4|||
25043758|NCT00882440|50145181|FG006|Overall Study|Adverse Event|2|||
25043759|NCT00882440|50145175|FG000|Overall Study|Lack of Efficacy|3|||
25043760|NCT00882440|50145176|FG001|Overall Study|Lack of Efficacy|5|||
25043761|NCT00882440|50145177|FG002|Overall Study|Lack of Efficacy|2|||
25043762|NCT00882440|50145178|FG003|Overall Study|Lack of Efficacy|0|||
24957277|NCT00377156|50048162|FG001|Overall Study|Withdrawal by Subject|24|||
24957278|NCT00377156|50048161|FG000|Overall Study|Had follow-up <90 d|3|||
25043763|NCT00882440|50145179|FG004|Overall Study|Lack of Efficacy|0|||
25043764|NCT00882440|50145180|FG005|Overall Study|Lack of Efficacy|3|||
25043765|NCT00882440|50145181|FG006|Overall Study|Lack of Efficacy|0|||
25043766|NCT00882440|50145175|FG000|Overall Study|Lost to Follow-up|2|||
25043767|NCT00882440|50145176|FG001|Overall Study|Lost to Follow-up|0|||
25043768|NCT00882440|50145177|FG002|Overall Study|Lost to Follow-up|1|||
25043769|NCT00882440|50145178|FG003|Overall Study|Lost to Follow-up|1|||
25043770|NCT00882440|50145179|FG004|Overall Study|Lost to Follow-up|1|||
25043771|NCT00882440|50145180|FG005|Overall Study|Lost to Follow-up|0|||
25043772|NCT00882440|50145181|FG006|Overall Study|Lost to Follow-up|1|||
25043773|NCT00882440|50145175|FG000|Overall Study|Protocol Violation|0|||
25043774|NCT00882440|50145176|FG001|Overall Study|Protocol Violation|0|||
25043775|NCT00882440|50145177|FG002|Overall Study|Protocol Violation|1|||
25043776|NCT00882440|50145178|FG003|Overall Study|Protocol Violation|1|||
25043777|NCT00882440|50145179|FG004|Overall Study|Protocol Violation|1|||
25043778|NCT00882440|50145180|FG005|Overall Study|Protocol Violation|0|||
25043779|NCT00882440|50145181|FG006|Overall Study|Protocol Violation|0|||
25043780|NCT00882440|50145175|FG000|Overall Study|Withdrawal by Subject|2|||
25043781|NCT00882440|50145176|FG001|Overall Study|Withdrawal by Subject|1|||
25043782|NCT00882440|50145177|FG002|Overall Study|Withdrawal by Subject|1|||
25043783|NCT00882440|50145178|FG003|Overall Study|Withdrawal by Subject|0|||
25043784|NCT00882440|50145179|FG004|Overall Study|Withdrawal by Subject|6|||
25043785|NCT00882440|50145180|FG005|Overall Study|Withdrawal by Subject|0|||
25043786|NCT00882440|50145181|FG006|Overall Study|Withdrawal by Subject|1|||
25043787|NCT00882440|50145175|FG000|Overall Study|Patient Uncooperative|2|||
25043788|NCT00882440|50145176|FG001|Overall Study|Patient Uncooperative|0|||
25043789|NCT00882440|50145177|FG002|Overall Study|Patient Uncooperative|0|||
25043790|NCT00882440|50145178|FG003|Overall Study|Patient Uncooperative|0|||
25043791|NCT00882440|50145179|FG004|Overall Study|Patient Uncooperative|1|||
25043792|NCT00882440|50145180|FG005|Overall Study|Patient Uncooperative|0|||
25043793|NCT00882440|50145181|FG006|Overall Study|Patient Uncooperative|0|||
25043794|NCT03005067|50145192|FG000|Overall Study|Withdrawal by Subject|3|||
25043795|NCT03005067|50145193|FG001|Overall Study|Withdrawal by Subject|2|||
25043796|NCT03005067|50145192|FG000|Overall Study|Adverse Event|4|||
25043797|NCT03005067|50145193|FG001|Overall Study|Adverse Event|3|||
25043798|NCT03005067|50145192|FG000|Overall Study|Other (reason not specified)|3|||
25043799|NCT03005067|50145193|FG001|Overall Study|Other (reason not specified)|1|||
24957279|NCT00377156|50048162|FG001|Overall Study|Had follow-up <90 d|6|||
24957280|NCT00377156|50048161|FG000|Overall Study|Cancellation|1|||
24957281|NCT00377156|50048162|FG001|Overall Study|Cancellation|0|||
24957282|NCT00377156|50048161|FG000|Overall Study|Refused testing|0|||
25043800|NCT03005067|50145192|FG000|Overall Study|Protocol Violation|0|||
24957283|NCT00377156|50048162|FG001|Overall Study|Refused testing|1|||
24957284|NCT00377156|50048161|FG000|Overall Study|Ineligible|0|||
25043801|NCT03005067|50145193|FG001|Overall Study|Protocol Violation|1|||
25043802|NCT02658448|50145199|FG000|Overall Study|Lost to Follow-up|1|||
25043803|NCT03075761|50145205|FG000|Overall Study|Lost to Follow-up|1|||
25043804|NCT03075761|50145206|FG001|Overall Study|Lost to Follow-up|6|||
25043805|NCT03000075|50145220|FG000|Part A|Adverse Event|4|||
25043806|NCT03000075|50145221|FG001|Part A|Adverse Event|0|||
25043807|NCT03000075|50145222|FG002|Part A|Adverse Event|0|||
24957285|NCT00377156|50048162|FG001|Overall Study|Ineligible|1|||
25043808|NCT03000075|50145223|FG003|Part A|Adverse Event|0|||
25043809|NCT03000075|50145224|FG004|Part A|Adverse Event|0|||
25043810|NCT03000075|50145225|FG005|Part A|Adverse Event|0|||
25043811|NCT03000075|50145226|FG006|Part A|Adverse Event|0|||
25043812|NCT03000075|50145220|FG000|Part B|Not dosed due to AE|0|||
25043813|NCT03000075|50145221|FG001|Part B|Not dosed due to AE|0|||
25043814|NCT03000075|50145222|FG002|Part B|Not dosed due to AE|0|||
25043815|NCT03000075|50145223|FG003|Part B|Not dosed due to AE|0|||
25043816|NCT03000075|50145224|FG004|Part B|Not dosed due to AE|0|||
25043817|NCT03000075|50145225|FG005|Part B|Not dosed due to AE|2|||
25043818|NCT03000075|50145226|FG006|Part B|Not dosed due to AE|1|||
25043819|NCT03000075|50145220|FG000|Part B|Adverse Event|0|||
24957286|NCT00377156|50048161|FG000|Overall Study|Disability or language problem|0|||
24957287|NCT00377156|50048162|FG001|Overall Study|Disability or language problem|1|||
24957288|NCT00377156|50048161|FG000|Overall Study|Other|5|||
24957289|NCT00377156|50048162|FG001|Overall Study|Other|2|||
24957290|NCT00376688|50048170|FG000|Overall Study|Adverse Event|3|||
24957291|NCT00376688|50048170|FG000|Overall Study|Death|1|||
24957292|NCT00376532|50048176|FG000|Overall Study|Lack sufficient blood sample|6|||
24957293|NCT00376532|50048177|FG001|Overall Study|Lack sufficient blood sample|6|||
24957294|NCT00376220|50048185|FG000|Overall Study|Lost to Follow-up|7|||
24957295|NCT00376220|50048186|FG001|Overall Study|Lost to Follow-up|10|||
24957296|NCT00376220|50048185|FG000|Overall Study|Withdrawal by Subject|3|||
24957297|NCT00376220|50048186|FG001|Overall Study|Withdrawal by Subject|2|||
24957298|NCT00375752|50048194|FG000|Overall Study|Lack of Efficacy|4|||
24957299|NCT00375752|50048195|FG001|Overall Study|Lack of Efficacy|4|||
24957300|NCT00375752|50048194|FG000|Overall Study|Adverse Event|1|||
24957301|NCT00375752|50048195|FG001|Overall Study|Adverse Event|6|||
24957302|NCT00375752|50048194|FG000|Overall Study|Withdrawal by Subject|6|||
24957303|NCT00375752|50048195|FG001|Overall Study|Withdrawal by Subject|1|||
24957304|NCT00375752|50048194|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
24957305|NCT00375752|50048195|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
24957306|NCT00375752|50048194|FG000|Overall Study|Protocol Violation|0|||
24957307|NCT00375752|50048195|FG001|Overall Study|Protocol Violation|2|||
24957308|NCT00375752|50048194|FG000|Overall Study|Administrative Problems|0|||
24957309|NCT00375752|50048195|FG001|Overall Study|Administrative Problems|1|||
24957310|NCT00484289|50048204|FG000|Long Term Phase|Adverse Event|1|||
24957311|NCT00484289|50048205|FG001|Long Term Phase|Adverse Event|17|||
24957312|NCT00484289|50048206|FG002|Long Term Phase|Adverse Event|5|||
24957313|NCT00484289|50048204|FG000|Long Term Phase|Withdrawal by Subject|0|||
24957314|NCT00484289|50048205|FG001|Long Term Phase|Withdrawal by Subject|7|||
24957315|NCT00484289|50048206|FG002|Long Term Phase|Withdrawal by Subject|6|||
24957316|NCT00484289|50048204|FG000|Long Term Phase|Inadequate response|2|||
24957317|NCT00484289|50048205|FG001|Long Term Phase|Inadequate response|7|||
24957318|NCT00484289|50048206|FG002|Long Term Phase|Inadequate response|4|||
24957319|NCT00484289|50048204|FG000|Long Term Phase|Other Reason|0|||
24957320|NCT00484289|50048205|FG001|Long Term Phase|Other Reason|5|||
24957321|NCT00484289|50048206|FG002|Long Term Phase|Other Reason|1|||
24957322|NCT00484289|50048204|FG000|Post Marketing Phase|Adverse Event|0|||
24957323|NCT00484289|50048205|FG001|Post Marketing Phase|Adverse Event|1|||
24957324|NCT00484289|50048206|FG002|Post Marketing Phase|Adverse Event|0|||
24957325|NCT00490529|50048215|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
24957326|NCT00490529|50048215|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
24957327|NCT00490529|50048215|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
24957328|NCT00490529|50048215|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
24957329|NCT00490529|50048215|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
24957330|NCT00490529|50048215|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
24957331|NCT00333840|50048221|FG000|First-line Treatment Period|Adverse Event|38|||
24957332|NCT00333840|50048222|FG001|First-line Treatment Period|Adverse Event|37|||
24957333|NCT00333840|50048223|FG002|First-line Treatment Period|Adverse Event|0|||
24957334|NCT00333840|50048224|FG003|First-line Treatment Period|Adverse Event|0|||
24957335|NCT00333840|50048221|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
24957336|NCT00333840|50048222|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
24957337|NCT00333840|50048223|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
24957338|NCT00333840|50048224|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
24957339|NCT00333840|50048221|FG000|First-line Treatment Period|Abnormal procedure|2|||
24957340|NCT00333840|50048222|FG001|First-line Treatment Period|Abnormal procedure|0|||
24957341|NCT00333840|50048223|FG002|First-line Treatment Period|Abnormal procedure|0|||
24957342|NCT00333840|50048224|FG003|First-line Treatment Period|Abnormal procedure|0|||
24957343|NCT00333840|50048221|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
24957344|NCT00333840|50048222|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
25043820|NCT03000075|50145221|FG001|Part B|Adverse Event|0|||
25043821|NCT03000075|50145222|FG002|Part B|Adverse Event|0|||
25043822|NCT03000075|50145223|FG003|Part B|Adverse Event|0|||
25043823|NCT03000075|50145224|FG004|Part B|Adverse Event|1|||
25043824|NCT03000075|50145225|FG005|Part B|Adverse Event|0|||
24957345|NCT00333840|50048223|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
24957346|NCT00333840|50048224|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
24957347|NCT00333840|50048221|FG000|First-line Treatment Period|No longer required study drug|21|||
24957348|NCT00333840|50048222|FG001|First-line Treatment Period|No longer required study drug|8|||
24957349|NCT00333840|50048223|FG002|First-line Treatment Period|No longer required study drug|0|||
24957350|NCT00333840|50048224|FG003|First-line Treatment Period|No longer required study drug|0|||
24957351|NCT00333840|50048221|FG000|First-line Treatment Period|Protocol Violation|17|||
24957352|NCT00333840|50048222|FG001|First-line Treatment Period|Protocol Violation|17|||
24957353|NCT00333840|50048223|FG002|First-line Treatment Period|Protocol Violation|0|||
24957354|NCT00333840|50048224|FG003|First-line Treatment Period|Protocol Violation|0|||
24957355|NCT00333840|50048221|FG000|First-line Treatment Period|Subject withdrew consent|57|||
24957356|NCT00333840|50048222|FG001|First-line Treatment Period|Subject withdrew consent|77|||
24957357|NCT00333840|50048223|FG002|First-line Treatment Period|Subject withdrew consent|0|||
24957358|NCT00333840|50048224|FG003|First-line Treatment Period|Subject withdrew consent|0|||
24957359|NCT00333840|50048221|FG000|First-line Treatment Period|Lost to Follow-up|15|||
24957360|NCT00333840|50048222|FG001|First-line Treatment Period|Lost to Follow-up|6|||
24957361|NCT00333840|50048223|FG002|First-line Treatment Period|Lost to Follow-up|0|||
24957362|NCT00333840|50048224|FG003|First-line Treatment Period|Lost to Follow-up|0|||
24957363|NCT00333840|50048221|FG000|First-line Treatment Period|Administrative problems|12|||
24957364|NCT00333840|50048222|FG001|First-line Treatment Period|Administrative problems|6|||
24957365|NCT00333840|50048223|FG002|First-line Treatment Period|Administrative problems|0|||
24957366|NCT00333840|50048224|FG003|First-line Treatment Period|Administrative problems|0|||
24957367|NCT00333840|50048221|FG000|First-line Treatment Period|Death|19|||
24957368|NCT00333840|50048222|FG001|First-line Treatment Period|Death|2|||
24957369|NCT00333840|50048223|FG002|First-line Treatment Period|Death|0|||
24957370|NCT00333840|50048224|FG003|First-line Treatment Period|Death|0|||
24957371|NCT00333840|50048221|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
24957372|NCT00333840|50048222|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
24957373|NCT00333840|50048223|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
24957374|NCT00333840|50048224|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
24957375|NCT00333840|50048221|FG000|Second-line Treatment Period|Adverse Event|0|||
24957376|NCT00333840|50048222|FG001|Second-line Treatment Period|Adverse Event|0|||
24957377|NCT00333840|50048223|FG002|Second-line Treatment Period|Adverse Event|3|||
24957378|NCT00333840|50048224|FG003|Second-line Treatment Period|Adverse Event|34|||
24957379|NCT00333840|50048221|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
25043825|NCT03000075|50145226|FG006|Part B|Adverse Event|0|||
25043826|NCT03073109|50145244|FG000|Overall Study|Adverse Event|0|||
25043827|NCT03073109|50145245|FG001|Overall Study|Adverse Event|1|||
25043828|NCT03073109|50145244|FG000|Overall Study|Other|2|||
25043829|NCT03073109|50145245|FG001|Overall Study|Other|0|||
25043830|NCT03073109|50145244|FG000|Overall Study|Lost to Follow-up|8|||
25043831|NCT03073109|50145245|FG001|Overall Study|Lost to Follow-up|1|||
25043832|NCT02371889|50145267|FG000|Overall Study|Adverse medication effect|11|||
25043833|NCT02371889|50145268|FG001|Overall Study|Adverse medication effect|2|||
25043834|NCT02371889|50145267|FG000|Overall Study|Lost to Follow-up|6|||
25043835|NCT02371889|50145268|FG001|Overall Study|Lost to Follow-up|5|||
25043836|NCT02371889|50145267|FG000|Overall Study|Personal time constraints|2|||
25043837|NCT02371889|50145268|FG001|Overall Study|Personal time constraints|4|||
25043838|NCT02371889|50145267|FG000|Overall Study|Lack of Efficacy|0|||
25043839|NCT02371889|50145268|FG001|Overall Study|Lack of Efficacy|2|||
25043840|NCT02371889|50145267|FG000|Overall Study|Relapse|0|||
25043841|NCT02371889|50145268|FG001|Overall Study|Relapse|1|||
24957380|NCT00333840|50048222|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
24957381|NCT00333840|50048223|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
24957382|NCT00333840|50048224|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
24957383|NCT00333840|50048221|FG000|Second-line Treatment Period|Abnormal procedure|0|||
25043842|NCT03072875|50145278|FG000|Overall Study|Lost to Follow-up|1|||
25043843|NCT04250077|50145286|FG000|Overall Study|Withdrawal by Subject|0|||
25043844|NCT04250077|50145287|FG001|Overall Study|Withdrawal by Subject|1|||
25043845|NCT04250077|50145288|FG002|Overall Study|Withdrawal by Subject|0|||
25043846|NCT04250077|50145286|FG000|Overall Study|Lost to Follow-up|2|||
25043847|NCT04250077|50145287|FG001|Overall Study|Lost to Follow-up|3|||
25043848|NCT04250077|50145288|FG002|Overall Study|Lost to Follow-up|0|||
25043849|NCT00859430|50145300|FG000|First Intervention|Withdrawal by Subject|0|||
25043850|NCT00859430|50145301|FG001|First Intervention|Withdrawal by Subject|1|||
25043851|NCT02913105|50145318|FG000|Overall Study|Adverse Event|11|||
25043852|NCT02913105|50145319|FG001|Overall Study|Adverse Event|0|||
25043853|NCT02913105|50145320|FG002|Overall Study|Adverse Event|4|||
25043854|NCT02913105|50145318|FG000|Overall Study|Non-Compliance With Study Drug|0|||
25043855|NCT02913105|50145319|FG001|Overall Study|Non-Compliance With Study Drug|0|||
25043856|NCT02913105|50145320|FG002|Overall Study|Non-Compliance With Study Drug|1|||
25043857|NCT02913105|50145318|FG000|Overall Study|Reason Not Specified|3|||
25043858|NCT02913105|50145319|FG001|Overall Study|Reason Not Specified|1|||
25043859|NCT02913105|50145320|FG002|Overall Study|Reason Not Specified|1|||
25043860|NCT02913105|50145318|FG000|Overall Study|Physician Decision|1|||
25043861|NCT02913105|50145319|FG001|Overall Study|Physician Decision|1|||
25043862|NCT02913105|50145320|FG002|Overall Study|Physician Decision|0|||
25043863|NCT02913105|50145318|FG000|Overall Study|Withdrawal by Subject|0|||
25043864|NCT02913105|50145319|FG001|Overall Study|Withdrawal by Subject|3|||
25043865|NCT02913105|50145320|FG002|Overall Study|Withdrawal by Subject|1|||
25043866|NCT00840632|50145338|FG000|First Intervention|Withdrawal by Subject|0|||
24957384|NCT00333840|50048222|FG001|Second-line Treatment Period|Abnormal procedure|0|||
24957385|NCT00333840|50048223|FG002|Second-line Treatment Period|Abnormal procedure|0|||
24957386|NCT00333840|50048224|FG003|Second-line Treatment Period|Abnormal procedure|1|||
24957387|NCT00333840|50048221|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
24957388|NCT00333840|50048222|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
24957389|NCT00333840|50048223|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
24957390|NCT00333840|50048224|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
24957391|NCT00333840|50048221|FG000|Second-line Treatment Period|No longer required study drug|0|||
25043867|NCT00840632|50145339|FG001|First Intervention|Withdrawal by Subject|1|||
25043868|NCT00840632|50145338|FG000|Washout|Withdrawal by Subject|1|||
25043869|NCT00840632|50145339|FG001|Washout|Withdrawal by Subject|1|||
25043870|NCT01602562|50145356|FG000|Overall Study|Adverse Event|3|||
25043871|NCT01602562|50145357|FG001|Overall Study|Adverse Event|1|||
25043872|NCT01602562|50145356|FG000|Overall Study|Physician Decision|1|||
25043873|NCT01602562|50145357|FG001|Overall Study|Physician Decision|1|||
25043874|NCT01602562|50145356|FG000|Overall Study|Withdrawal by Subject|1|||
25043875|NCT01602562|50145357|FG001|Overall Study|Withdrawal by Subject|1|||
25043876|NCT01945775|50145366|FG000|Overall Study|Death|214|||
25043877|NCT01945775|50145367|FG001|Overall Study|Death|98|||
25043878|NCT01945775|50145366|FG000|Overall Study|Lost to Follow-up|12|||
25043879|NCT01945775|50145367|FG001|Overall Study|Lost to Follow-up|7|||
25043880|NCT01945775|50145366|FG000|Overall Study|Withdrawal by Subject|11|||
25043881|NCT01945775|50145367|FG001|Overall Study|Withdrawal by Subject|21|||
25043882|NCT01945775|50145366|FG000|Overall Study|Other|50|||
25043883|NCT01945775|50145367|FG001|Overall Study|Other|18|||
25043884|NCT03072719|50145395|FG000|Overall Study|Adverse Event|1|||
25043885|NCT03072719|50145396|FG001|Overall Study|Adverse Event|1|||
25043886|NCT00835796|50145404|FG000|First Intervention|Withdrawal by Subject|0|||
25043887|NCT00835796|50145405|FG001|First Intervention|Withdrawal by Subject|1|||
25043888|NCT00835640|50145411|FG000|Second Intervention|Protocol Violation|1|||
25043889|NCT00835640|50145412|FG001|Second Intervention|Protocol Violation|0|||
25043890|NCT02942017|50145418|FG000|Overall Study|Adverse Event|0|||
25043891|NCT02942017|50145419|FG001|Overall Study|Adverse Event|1|||
25043892|NCT02942017|50145418|FG000|Overall Study|Withdrawal by Subject|0|||
25043893|NCT02942017|50145419|FG001|Overall Study|Withdrawal by Subject|1|||
25043894|NCT02942017|50145418|FG000|Overall Study|Lost to Follow-up|1|||
25043895|NCT02942017|50145419|FG001|Overall Study|Lost to Follow-up|1|||
25043896|NCT02942017|50145418|FG000|Overall Study|Randomized but not dosed|1|||
25043897|NCT02942017|50145419|FG001|Overall Study|Randomized but not dosed|3|||
25043898|NCT00835406|50145434|FG000|Period: First Intervention|Adverse Event|0|||
25043899|NCT00835406|50145435|FG001|Period: First Intervention|Adverse Event|1|||
25043900|NCT00835406|50145434|FG000|Period: First Intervention|Withdrawal by Subject|2|||
25043901|NCT00835406|50145435|FG001|Period: First Intervention|Withdrawal by Subject|0|||
25043902|NCT00835406|50145434|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
25043903|NCT00835406|50145435|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
25276304|NCT00960934|50590274|FG003|Overall Study|Lost to Follow-up|0|||
25043904|NCT00835172|50145441|FG000|Washout|Protocol Violation|0|||
25043905|NCT00835172|50145442|FG001|Washout|Protocol Violation|1|||
25043906|NCT01676116|50145448|FG000|Overall Study|Withdrawal criteria|2|||
25043907|NCT01676116|50145449|FG001|Overall Study|Withdrawal criteria|14|||
25043908|NCT01676116|50145448|FG000|Overall Study|Adverse Event|1|||
25043909|NCT01676116|50145449|FG001|Overall Study|Adverse Event|2|||
25043910|NCT01676116|50145448|FG000|Overall Study|Unclassified|4|||
25043911|NCT01676116|50145449|FG001|Overall Study|Unclassified|10|||
25043912|NCT01676116|50145448|FG000|Overall Study|Protocol Violation|9|||
25043913|NCT01676116|50145449|FG001|Overall Study|Protocol Violation|3|||
25043914|NCT00740480|50145455|FG000|Overall Study|Adverse Event|1|||
25043915|NCT00740480|50145455|FG000|Overall Study|Physician Decision|1|||
25043916|NCT02743520|50145458|FG000|Overall Study|Withdrawal by Subject|1|||
25043917|NCT03001557|50145477|FG000|Core Phase|Randomized but not treated|0|||
25043918|NCT03001557|50145478|FG001|Core Phase|Randomized but not treated|0|||
25043919|NCT03001557|50145479|FG002|Core Phase|Randomized but not treated|1|||
25043920|NCT03001557|50145480|FG003|Core Phase|Randomized but not treated|0|||
25043921|NCT03001557|50145481|FG004|Core Phase|Randomized but not treated|0|||
25043922|NCT03001557|50145482|FG005|Core Phase|Randomized but not treated|0|||
24957392|NCT00333840|50048222|FG001|Second-line Treatment Period|No longer required study drug|0|||
24957393|NCT00333840|50048223|FG002|Second-line Treatment Period|No longer required study drug|1|||
24957394|NCT00333840|50048224|FG003|Second-line Treatment Period|No longer required study drug|14|||
24957395|NCT00333840|50048221|FG000|Second-line Treatment Period|Protocol Violation|0|||
24957396|NCT00333840|50048222|FG001|Second-line Treatment Period|Protocol Violation|0|||
24957397|NCT00333840|50048223|FG002|Second-line Treatment Period|Protocol Violation|1|||
24957398|NCT00333840|50048224|FG003|Second-line Treatment Period|Protocol Violation|10|||
24957399|NCT00333840|50048221|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
24957400|NCT00333840|50048222|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
24957401|NCT00333840|50048223|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
24957402|NCT00333840|50048224|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
25043923|NCT03001557|50145483|FG006|Core Phase|Randomized but not treated|0|||
25043924|NCT03001557|50145484|FG007|Core Phase|Randomized but not treated|0|||
25043925|NCT03001557|50145477|FG000|Extension Phase|Adverse Event|0|||
25043926|NCT03001557|50145478|FG001|Extension Phase|Adverse Event|0|||
25043927|NCT03001557|50145479|FG002|Extension Phase|Adverse Event|0|||
25043928|NCT03001557|50145480|FG003|Extension Phase|Adverse Event|0|||
25043929|NCT03001557|50145481|FG004|Extension Phase|Adverse Event|0|||
25043930|NCT03001557|50145482|FG005|Extension Phase|Adverse Event|2|||
25043931|NCT03001557|50145483|FG006|Extension Phase|Adverse Event|0|||
25043932|NCT03001557|50145484|FG007|Extension Phase|Adverse Event|0|||
25043933|NCT03001557|50145477|FG000|Extension Phase|Withdrawal by Subject|0|||
25043934|NCT03001557|50145478|FG001|Extension Phase|Withdrawal by Subject|0|||
25043935|NCT03001557|50145479|FG002|Extension Phase|Withdrawal by Subject|0|||
25043936|NCT03001557|50145480|FG003|Extension Phase|Withdrawal by Subject|0|||
25043937|NCT03001557|50145481|FG004|Extension Phase|Withdrawal by Subject|0|||
25043938|NCT03001557|50145482|FG005|Extension Phase|Withdrawal by Subject|1|||
25043939|NCT03001557|50145483|FG006|Extension Phase|Withdrawal by Subject|5|||
25043940|NCT03001557|50145484|FG007|Extension Phase|Withdrawal by Subject|2|||
25043941|NCT03001557|50145477|FG000|Extension Phase|Lost to Follow-up|0|||
25043942|NCT03001557|50145478|FG001|Extension Phase|Lost to Follow-up|0|||
25043943|NCT03001557|50145479|FG002|Extension Phase|Lost to Follow-up|0|||
25043944|NCT03001557|50145480|FG003|Extension Phase|Lost to Follow-up|0|||
25043945|NCT03001557|50145481|FG004|Extension Phase|Lost to Follow-up|0|||
25043946|NCT03001557|50145482|FG005|Extension Phase|Lost to Follow-up|0|||
25043947|NCT03001557|50145483|FG006|Extension Phase|Lost to Follow-up|2|||
25043948|NCT03001557|50145484|FG007|Extension Phase|Lost to Follow-up|1|||
25043949|NCT03001557|50145477|FG000|Extension Phase|Administrative Reason|0|||
25043950|NCT03001557|50145478|FG001|Extension Phase|Administrative Reason|0|||
25043951|NCT03001557|50145479|FG002|Extension Phase|Administrative Reason|0|||
25043952|NCT03001557|50145480|FG003|Extension Phase|Administrative Reason|0|||
25043953|NCT03001557|50145481|FG004|Extension Phase|Administrative Reason|0|||
25043954|NCT03001557|50145482|FG005|Extension Phase|Administrative Reason|1|||
25043955|NCT03001557|50145483|FG006|Extension Phase|Administrative Reason|3|||
25043956|NCT03001557|50145484|FG007|Extension Phase|Administrative Reason|3|||
25043957|NCT03001557|50145477|FG000|Extension Phase|Loss of caregiver|0|||
25043958|NCT03001557|50145478|FG001|Extension Phase|Loss of caregiver|0|||
25043959|NCT03001557|50145479|FG002|Extension Phase|Loss of caregiver|0|||
25043960|NCT03001557|50145480|FG003|Extension Phase|Loss of caregiver|0|||
25043961|NCT03001557|50145481|FG004|Extension Phase|Loss of caregiver|0|||
25043962|NCT03001557|50145482|FG005|Extension Phase|Loss of caregiver|0|||
25043963|NCT03001557|50145483|FG006|Extension Phase|Loss of caregiver|1|||
25043964|NCT03001557|50145484|FG007|Extension Phase|Loss of caregiver|0|||
25043965|NCT03001557|50145477|FG000|Extension Phase|Others|0|||
24957403|NCT00333840|50048221|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
25043966|NCT03001557|50145478|FG001|Extension Phase|Others|0|||
25043967|NCT03001557|50145479|FG002|Extension Phase|Others|0|||
25043968|NCT03001557|50145480|FG003|Extension Phase|Others|0|||
25043969|NCT03001557|50145481|FG004|Extension Phase|Others|0|||
25043970|NCT03001557|50145482|FG005|Extension Phase|Others|1|||
25043971|NCT03001557|50145483|FG006|Extension Phase|Others|3|||
25043972|NCT03001557|50145484|FG007|Extension Phase|Others|0|||
25043973|NCT00830336|50145521|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
25043974|NCT00830336|50145522|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
25043975|NCT00830258|50145528|FG000|First Intervention|Adverse Event|1|||
25043976|NCT00830258|50145529|FG001|First Intervention|Adverse Event|0|||
25043977|NCT00830258|50145528|FG000|Washout: 7 Days|Protocol Violation|1|||
25043978|NCT00830258|50145529|FG001|Washout: 7 Days|Protocol Violation|0|||
25043979|NCT03349775|50145535|FG000|Overall Study|Side Effects|1|||
25043980|NCT03349775|50145536|FG001|Overall Study|Side Effects|2|||
25043981|NCT03349775|50145535|FG000|Overall Study|Withdrawal by Subject|1|||
25043982|NCT03349775|50145536|FG001|Overall Study|Withdrawal by Subject|1|||
25043983|NCT03349775|50145535|FG000|Overall Study|No primary outcome measurements|0|||
25043984|NCT03349775|50145536|FG001|Overall Study|No primary outcome measurements|1|||
25043985|NCT00830024|50145544|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
25043986|NCT00830024|50145545|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
25043987|NCT00829868|50145551|FG000|Washout|Physician Decision|1|||
25043988|NCT00829868|50145552|FG001|Washout|Physician Decision|0|||
25043989|NCT00829790|50145558|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
25043990|NCT00829790|50145559|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
25043991|NCT03207815|50145565|FG000|Overall Study|Protocol Violation|3|||
25043992|NCT03207815|50145566|FG001|Overall Study|Protocol Violation|1|||
25043993|NCT03207815|50145565|FG000|Overall Study|Adverse Event|1|||
25043994|NCT03207815|50145566|FG001|Overall Study|Adverse Event|2|||
25043995|NCT03207815|50145565|FG000|Overall Study|Lost to Follow-up|1|||
25043996|NCT03207815|50145566|FG001|Overall Study|Lost to Follow-up|2|||
25043997|NCT03207815|50145565|FG000|Overall Study|Investigator's Discretion|1|||
25043998|NCT03207815|50145566|FG001|Overall Study|Investigator's Discretion|1|||
25043999|NCT03207815|50145565|FG000|Overall Study|Lack of Efficacy|0|||
25044000|NCT03207815|50145566|FG001|Overall Study|Lack of Efficacy|1|||
25044001|NCT03207815|50145565|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
25044002|NCT03207815|50145566|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
25044003|NCT03207815|50145565|FG000|Overall Study|Withdrew Consent|1|||
25044004|NCT03207815|50145566|FG001|Overall Study|Withdrew Consent|0|||
25044005|NCT02911935|50145574|FG000|Overall Study|Lost to Follow-up|5|||
25044006|NCT02911935|50145575|FG001|Overall Study|Lost to Follow-up|7|||
24957404|NCT00333840|50048222|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
24957405|NCT00333840|50048223|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
24957406|NCT00333840|50048224|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
24957407|NCT00333840|50048221|FG000|Second-line Treatment Period|Administrative problems|0|||
24957408|NCT00333840|50048222|FG001|Second-line Treatment Period|Administrative problems|0|||
24957409|NCT00333840|50048223|FG002|Second-line Treatment Period|Administrative problems|0|||
24957410|NCT00333840|50048224|FG003|Second-line Treatment Period|Administrative problems|7|||
24957411|NCT00333840|50048221|FG000|Second-line Treatment Period|Death|0|||
24957412|NCT00333840|50048222|FG001|Second-line Treatment Period|Death|0|||
24957413|NCT00333840|50048223|FG002|Second-line Treatment Period|Death|0|||
24957414|NCT00333840|50048224|FG003|Second-line Treatment Period|Death|9|||
24957415|NCT00490451|50048240|FG000|Overall Study|Adverse Event|3|||
24957416|NCT00490451|50048241|FG001|Overall Study|Adverse Event|3|||
24957417|NCT00490451|50048240|FG000|Overall Study|Death|3|||
24957418|NCT00490451|50048241|FG001|Overall Study|Death|1|||
24957419|NCT00490451|50048240|FG000|Overall Study|Withdrawal by Subject|2|||
24957420|NCT00490451|50048241|FG001|Overall Study|Withdrawal by Subject|0|||
24957421|NCT00490451|50048240|FG000|Overall Study|Investigator Decision|1|||
24957422|NCT00490451|50048241|FG001|Overall Study|Investigator Decision|0|||
24957423|NCT00490451|50048240|FG000|Overall Study|Protocol Violation|1|||
24957424|NCT00490451|50048241|FG001|Overall Study|Protocol Violation|0|||
24957425|NCT00490451|50048240|FG000|Overall Study|Progressive Disease|53|||
24957426|NCT00490451|50048241|FG001|Overall Study|Progressive Disease|34|||
24957427|NCT00321906|50048249|FG000|Overall Study|Adverse Event|36|||
24957428|NCT00321906|50048250|FG001|Overall Study|Adverse Event|44|||
24957429|NCT00321906|50048249|FG000|Overall Study|Death|9|||
24957430|NCT00321906|50048250|FG001|Overall Study|Death|6|||
24957431|NCT00321906|50048249|FG000|Overall Study|Lost to Follow-up|1|||
24957432|NCT00321906|50048250|FG001|Overall Study|Lost to Follow-up|2|||
24957433|NCT00321906|50048249|FG000|Overall Study|Withdrawal by Subject|0|||
24957434|NCT00321906|50048250|FG001|Overall Study|Withdrawal by Subject|4|||
24957435|NCT00339144|50048259|FG000|Overall Study|Disease progression|5|||
24957436|NCT00339144|50048260|FG001|Overall Study|Disease progression|2|||
24957437|NCT00339144|50048261|FG002|Overall Study|Disease progression|2|||
24957438|NCT00339144|50048259|FG000|Overall Study|Study drug toxicity|3|||
25044007|NCT00829712|50145583|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
24957439|NCT00339144|50048260|FG001|Overall Study|Study drug toxicity|1|||
25044008|NCT00829712|50145584|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
25044009|NCT03069989|50145599|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
25044010|NCT03069989|50145600|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
24957440|NCT00339144|50048261|FG002|Overall Study|Study drug toxicity|1|||
24957441|NCT00339144|50048259|FG000|Overall Study|Participant's request to discontinuation|1|||
24957442|NCT00339144|50048260|FG001|Overall Study|Participant's request to discontinuation|0|||
25044011|NCT02698163|50145627|FG000|Overall Study|Lost to Follow-up|0|||
25044012|NCT02698163|50145628|FG001|Overall Study|Lost to Follow-up|1|||
25044013|NCT03817190|50145636|FG000|Overall Study|Early Termination|13|||
24957443|NCT00339144|50048261|FG002|Overall Study|Participant's request to discontinuation|1|||
24957444|NCT00321828|50048270|FG000|Overall Study|Ineligible|3|||
24957445|NCT00321828|50048270|FG000|Overall Study|No follow up data|1|||
25044014|NCT03817190|50145637|FG001|Overall Study|Early Termination|20|||
25044015|NCT03817190|50145636|FG000|Overall Study|Adverse Event|10|||
25044016|NCT03817190|50145637|FG001|Overall Study|Adverse Event|17|||
25044017|NCT03817190|50145636|FG000|Overall Study|Withdrawal by Subject|12|||
25044018|NCT03817190|50145637|FG001|Overall Study|Withdrawal by Subject|8|||
25044019|NCT03817190|50145636|FG000|Overall Study|Lost to Follow-up|11|||
25044020|NCT03817190|50145637|FG001|Overall Study|Lost to Follow-up|7|||
25044021|NCT03817190|50145636|FG000|Overall Study|Lack of Efficacy|7|||
25044022|NCT03817190|50145637|FG001|Overall Study|Lack of Efficacy|5|||
25044023|NCT03817190|50145636|FG000|Overall Study|Investigator Decision|5|||
25044024|NCT03817190|50145637|FG001|Overall Study|Investigator Decision|1|||
25044025|NCT03817190|50145636|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
25044026|NCT03817190|50145637|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
25044027|NCT03817190|50145636|FG000|Overall Study|Lack of Contact|1|||
25044028|NCT03817190|50145637|FG001|Overall Study|Lack of Contact|0|||
25044029|NCT03817190|50145636|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
25044030|NCT03817190|50145637|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
25044031|NCT03797222|50145656|FG000|Overall Study|Withdrawal by Subject|1|||
25044032|NCT02742818|50145666|FG000|Overall Study|Adverse Event|0|||
25044033|NCT02742818|50145667|FG001|Overall Study|Adverse Event|1|||
25044034|NCT02742818|50145666|FG000|Overall Study|Protocol Violation|0|||
25044035|NCT02742818|50145667|FG001|Overall Study|Protocol Violation|1|||
25044036|NCT03069365|50145675|FG000|Overall Study|Adverse Event|1|||
25044037|NCT03065933|50145679|FG000|Overall Study|study terminated|5|||
25044038|NCT04256629|50145689|FG000|Overall Study|Adverse Event|0|||
25044039|NCT04256629|50145690|FG001|Overall Study|Adverse Event|0|||
25044040|NCT04256629|50145691|FG002|Overall Study|Adverse Event|0|||
25044041|NCT04256629|50145692|FG003|Overall Study|Adverse Event|0|||
25044042|NCT04256629|50145693|FG004|Overall Study|Adverse Event|0|||
25044043|NCT04256629|50145694|FG005|Overall Study|Adverse Event|1|||
25044044|NCT04256629|50145689|FG000|Overall Study|Protocol Violation|0|||
25044045|NCT04256629|50145690|FG001|Overall Study|Protocol Violation|1|||
25044046|NCT04256629|50145691|FG002|Overall Study|Protocol Violation|0|||
25044047|NCT04256629|50145692|FG003|Overall Study|Protocol Violation|0|||
25044048|NCT04256629|50145693|FG004|Overall Study|Protocol Violation|0|||
25044049|NCT04256629|50145694|FG005|Overall Study|Protocol Violation|0|||
25044050|NCT01346293|50145704|FG000|Overall Study|Protocol Violation|30|||
25044051|NCT01346293|50145705|FG001|Overall Study|Protocol Violation|9|||
25044052|NCT01346293|50145704|FG000|Overall Study|Lost to Follow-up|21|||
25044053|NCT01346293|50145705|FG001|Overall Study|Lost to Follow-up|8|||
25044054|NCT01346293|50145704|FG000|Overall Study|Withdrawal by Subject|15|||
25044055|NCT01346293|50145705|FG001|Overall Study|Withdrawal by Subject|4|||
25044056|NCT01346293|50145704|FG000|Overall Study|Other|1|||
25044057|NCT01346293|50145705|FG001|Overall Study|Other|0|||
25044058|NCT03502187|50145716|FG000|Overall Study|Withdrawal by Subject|4|||
25044059|NCT03502187|50145717|FG001|Overall Study|Withdrawal by Subject|3|||
25044060|NCT03502187|50145718|FG002|Overall Study|Withdrawal by Subject|3|||
25044061|NCT03502187|50145716|FG000|Overall Study|Lost to Follow-up|5|||
25044062|NCT03502187|50145717|FG001|Overall Study|Lost to Follow-up|4|||
25044063|NCT03502187|50145718|FG002|Overall Study|Lost to Follow-up|5|||
25044064|NCT03058705|50145726|FG000|Overall Study|Withdrawal by Subject|2|||
25044065|NCT03058705|50145726|FG000|Overall Study|Physician Decision|2|||
25044066|NCT02998671|50145735|FG000|Period 1|Study Terminated By Sponsor|2|||
25044067|NCT02998671|50145736|FG001|Period 1|Study Terminated By Sponsor|1|||
25044068|NCT02998671|50145737|FG002|Period 1|Study Terminated By Sponsor|0|||
25044069|NCT02998671|50145738|FG003|Period 1|Study Terminated By Sponsor|0|||
25044070|NCT02998671|50145739|FG004|Period 1|Study Terminated By Sponsor|1|||
25044071|NCT02998671|50145735|FG000|Period 1|Withdrawal by Subject|1|||
25044072|NCT02998671|50145736|FG001|Period 1|Withdrawal by Subject|2|||
25044073|NCT02998671|50145737|FG002|Period 1|Withdrawal by Subject|0|||
25044074|NCT02998671|50145738|FG003|Period 1|Withdrawal by Subject|0|||
25044075|NCT02998671|50145739|FG004|Period 1|Withdrawal by Subject|2|||
25044076|NCT02998671|50145735|FG000|Period 1|Pregnancy|1|||
25044077|NCT02998671|50145736|FG001|Period 1|Pregnancy|0|||
25276305|NCT00960934|50590275|FG004|Overall Study|Lost to Follow-up|0|||
24957446|NCT00333138|50048277|FG000|Core Study (6 Months)|Adverse Event|4|||
24957447|NCT00333138|50048278|FG001|Core Study (6 Months)|Adverse Event|5|||
24957448|NCT00333138|50048279|FG002|Core Study (6 Months)|Adverse Event|8|||
24957449|NCT00333138|50048277|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
24957450|NCT00333138|50048278|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
24957451|NCT00333138|50048279|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
24957452|NCT00333138|50048277|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
24957453|NCT00333138|50048278|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
25044078|NCT02998671|50145737|FG002|Period 1|Pregnancy|0|||
25044079|NCT02998671|50145738|FG003|Period 1|Pregnancy|0|||
25044080|NCT02998671|50145739|FG004|Period 1|Pregnancy|0|||
25044081|NCT02998671|50145735|FG000|Period 1|Adverse Event|0|||
25044082|NCT02998671|50145736|FG001|Period 1|Adverse Event|0|||
25044083|NCT02998671|50145737|FG002|Period 1|Adverse Event|0|||
25044084|NCT02998671|50145738|FG003|Period 1|Adverse Event|0|||
25044085|NCT02998671|50145739|FG004|Period 1|Adverse Event|1|||
25044086|NCT02998671|50145735|FG000|Period 2|Adverse Event|0|||
25044087|NCT02998671|50145736|FG001|Period 2|Adverse Event|1|||
25044088|NCT02998671|50145737|FG002|Period 2|Adverse Event|0|||
25044089|NCT02998671|50145738|FG003|Period 2|Adverse Event|0|||
25044090|NCT02998671|50145739|FG004|Period 2|Adverse Event|0|||
25044091|NCT02998671|50145735|FG000|Period 2|Study Terminated By Sponsor|3|||
25044092|NCT02998671|50145736|FG001|Period 2|Study Terminated By Sponsor|5|||
25044093|NCT02998671|50145737|FG002|Period 2|Study Terminated By Sponsor|1|||
25044094|NCT02998671|50145738|FG003|Period 2|Study Terminated By Sponsor|3|||
25044095|NCT02998671|50145739|FG004|Period 2|Study Terminated By Sponsor|0|||
25044096|NCT02998671|50145735|FG000|Period 2|Withdrawal by Subject|0|||
25044097|NCT02998671|50145736|FG001|Period 2|Withdrawal by Subject|1|||
25044098|NCT02998671|50145737|FG002|Period 2|Withdrawal by Subject|0|||
25044099|NCT02998671|50145738|FG003|Period 2|Withdrawal by Subject|0|||
25044100|NCT02998671|50145739|FG004|Period 2|Withdrawal by Subject|0|||
25044101|NCT02998671|50145735|FG000|Period 2|Lost to Follow-up|0|||
25044102|NCT02998671|50145736|FG001|Period 2|Lost to Follow-up|0|||
25044103|NCT02998671|50145737|FG002|Period 2|Lost to Follow-up|0|||
25044104|NCT02998671|50145738|FG003|Period 2|Lost to Follow-up|1|||
25044105|NCT02998671|50145739|FG004|Period 2|Lost to Follow-up|0|||
25044106|NCT02660827|50145759|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
25044107|NCT02660827|50145759|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
25044108|NCT02660827|50145759|FG000|From Study to End of Continued Access|Adverse Event|3|||
25044109|NCT02660827|50145759|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
25044110|NCT02660827|50145759|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
25044111|NCT02660827|50145759|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
25044112|NCT02660827|50145759|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
25044113|NCT02660827|50145759|FG000|Period 2: Continued Access Period|Adverse Event|3|||
25044114|NCT01069419|50145780|FG000|Overall Study|Adverse Event|233|||
25044115|NCT01069419|50145780|FG000|Overall Study|Lack of Efficacy|332|||
25044116|NCT01069419|50145780|FG000|Overall Study|Lost to Follow-up|49|||
25044117|NCT01069419|50145780|FG000|Overall Study|Remission of disease|11|||
25044118|NCT01069419|50145780|FG000|Overall Study|Withdrawal by Subject|34|||
25044119|NCT01069419|50145780|FG000|Overall Study|Other Reason|43|||
25044120|NCT01069419|50145780|FG000|Overall Study|Missing termination information|13|||
25044121|NCT01069341|50145784|FG000|Overall Study|Lost to Follow-up|1|||
25044122|NCT02996097|50145788|FG000|Overall Study|Lost to Follow-up|11|||
25044123|NCT02996097|50145789|FG001|Overall Study|Lost to Follow-up|11|||
25044124|NCT02992899|50145796|FG000|Overall Study|Withdrawal by Subject|1|||
25044125|NCT02992899|50145797|FG001|Overall Study|Withdrawal by Subject|0|||
25044126|NCT02992899|50145796|FG000|Overall Study|Lost to Follow-up|1|||
25044127|NCT02992899|50145797|FG001|Overall Study|Lost to Follow-up|3|||
25044128|NCT01602484|50145805|FG000|Overall Study|Airway issues unrelated to study|0|||
25044129|NCT01602484|50145806|FG001|Overall Study|Airway issues unrelated to study|1|||
25044130|NCT02989389|50145826|FG000|Period 1|Lost to Follow-up|0|||
25044131|NCT02989389|50145827|FG001|Period 1|Lost to Follow-up|1|||
24957454|NCT00333138|50048279|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
24957455|NCT00333138|50048277|FG000|Core Study (6 Months)|Protocol Violation|1|||
24957456|NCT00333138|50048278|FG001|Core Study (6 Months)|Protocol Violation|0|||
24957457|NCT00333138|50048279|FG002|Core Study (6 Months)|Protocol Violation|1|||
24957458|NCT00333138|50048277|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
24957459|NCT00333138|50048278|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
24957460|NCT00333138|50048279|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
24957461|NCT00333138|50048277|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
24957462|NCT00333138|50048278|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
24957463|NCT00333138|50048279|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
24957464|NCT00333138|50048277|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
24957465|NCT00333138|50048278|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
24957466|NCT00333138|50048279|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
24957467|NCT00333138|50048277|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
24957468|NCT00333138|50048278|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
24957469|NCT00333138|50048279|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
24957470|NCT00333138|50048277|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
25044132|NCT02989389|50145828|FG002|Period 1|Lost to Follow-up|0|||
25044133|NCT02989389|50145829|FG003|Period 1|Lost to Follow-up|0|||
25044134|NCT02989389|50145830|FG004|Period 1|Lost to Follow-up|0|||
25044135|NCT02989389|50145831|FG005|Period 1|Lost to Follow-up|0|||
25162436|NCT01791517|50284757|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
24957471|NCT00333138|50048278|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
25044136|NCT02989389|50145832|FG006|Period 1|Lost to Follow-up|0|||
25044137|NCT02989389|50145833|FG007|Period 1|Lost to Follow-up|0|||
25044138|NCT02989389|50145834|FG008|Period 1|Lost to Follow-up|0|||
24957472|NCT00333138|50048279|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
24957473|NCT00333138|50048277|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
24957474|NCT00333138|50048278|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
24957475|NCT00333138|50048279|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
24957476|NCT00333138|50048277|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
24957477|NCT00333138|50048278|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
24957478|NCT00333138|50048279|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
24957479|NCT00333138|50048277|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
24957480|NCT00333138|50048278|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
24957481|NCT00333138|50048279|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
25044139|NCT02989389|50145835|FG009|Period 1|Lost to Follow-up|0|||
25044140|NCT02989389|50145826|FG000|Period 1|Physician Decision|0|||
25044141|NCT02989389|50145827|FG001|Period 1|Physician Decision|0|||
25044142|NCT02989389|50145828|FG002|Period 1|Physician Decision|0|||
25044143|NCT02989389|50145829|FG003|Period 1|Physician Decision|0|||
25044144|NCT02989389|50145830|FG004|Period 1|Physician Decision|0|||
25044145|NCT02989389|50145831|FG005|Period 1|Physician Decision|0|||
25044146|NCT02989389|50145832|FG006|Period 1|Physician Decision|0|||
25044147|NCT02989389|50145833|FG007|Period 1|Physician Decision|0|||
25044148|NCT02989389|50145834|FG008|Period 1|Physician Decision|1|||
25044149|NCT02989389|50145835|FG009|Period 1|Physician Decision|0|||
25044150|NCT02653300|50145875|FG000|Overall Study|Withdrawal by Subject|2|||
25044151|NCT01757665|50145881|FG000|Overall Study|Still on Study - Visit Completed|240|||
25044152|NCT01757665|50145882|FG001|Overall Study|Still on Study - Visit Completed|30|||
25044153|NCT01757665|50145881|FG000|Overall Study|Still on Study - Visit Pending|398|||
25044154|NCT01757665|50145882|FG001|Overall Study|Still on Study - Visit Pending|40|||
25044155|NCT01757665|50145881|FG000|Overall Study|Still on Study - Missed Visit|14|||
25044156|NCT01757665|50145882|FG001|Overall Study|Still on Study - Missed Visit|1|||
25044157|NCT01757665|50145881|FG000|Overall Study|Death|25|||
25044158|NCT01757665|50145882|FG001|Overall Study|Death|8|||
25044159|NCT01757665|50145881|FG000|Overall Study|Explant|1|||
25044160|NCT01757665|50145882|FG001|Overall Study|Explant|2|||
25044161|NCT01757665|50145881|FG000|Overall Study|Withdrawal by Subject|10|||
25044162|NCT01757665|50145882|FG001|Overall Study|Withdrawal by Subject|0|||
25044163|NCT01757665|50145881|FG000|Overall Study|Lost to Follow-up|1|||
25044164|NCT01757665|50145882|FG001|Overall Study|Lost to Follow-up|1|||
25044165|NCT01757665|50145881|FG000|Overall Study|Not Implanted with Device|5|||
25044166|NCT01757665|50145882|FG001|Overall Study|Not Implanted with Device|1|||
25044167|NCT00430508|50145907|FG000|Overall Study|Adverse Event|2|||
25044168|NCT00430508|50145908|FG001|Overall Study|Adverse Event|3|||
25044169|NCT00430508|50145909|FG002|Overall Study|Adverse Event|5|||
25044170|NCT00430508|50145910|FG003|Overall Study|Adverse Event|3|||
25044171|NCT00430508|50145907|FG000|Overall Study|Withdrawal by Subject|0|||
25044172|NCT00430508|50145908|FG001|Overall Study|Withdrawal by Subject|1|||
25044173|NCT00430508|50145909|FG002|Overall Study|Withdrawal by Subject|1|||
25044174|NCT00430508|50145910|FG003|Overall Study|Withdrawal by Subject|1|||
25044175|NCT00430508|50145907|FG000|Overall Study|responder at visit 4|0|||
24957482|NCT00333138|50048277|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
24957483|NCT00333138|50048278|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
24957484|NCT00333138|50048279|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
24957485|NCT00333138|50048277|FG000|Extension Study (Month6 to End of Study)|Death|0|||
24957486|NCT00333138|50048278|FG001|Extension Study (Month6 to End of Study)|Death|1|||
24957487|NCT00333138|50048279|FG002|Extension Study (Month6 to End of Study)|Death|0|||
24957488|NCT00332202|50048291|FG000|Overall Study|Adverse Event|72|||
24957489|NCT00332202|50048292|FG001|Overall Study|Adverse Event|28|||
24957490|NCT00332202|50048291|FG000|Overall Study|Lost to Follow-up|2|||
24957491|NCT00332202|50048292|FG001|Overall Study|Lost to Follow-up|1|||
24957492|NCT00332202|50048291|FG000|Overall Study|Physician Decision|6|||
24957493|NCT00332202|50048292|FG001|Overall Study|Physician Decision|8|||
24957494|NCT00332202|50048291|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
24957495|NCT00332202|50048292|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
24957496|NCT00332202|50048291|FG000|Overall Study|Protocol Violation|7|||
25044176|NCT00430508|50145908|FG001|Overall Study|responder at visit 4|0|||
25044177|NCT00430508|50145909|FG002|Overall Study|responder at visit 4|2|||
25044178|NCT00430508|50145910|FG003|Overall Study|responder at visit 4|0|||
25044179|NCT00430508|50145907|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
24957497|NCT00332202|50048292|FG001|Overall Study|Protocol Violation|2|||
24957498|NCT00332202|50048291|FG000|Overall Study|Sponsor Decision|1|||
25044180|NCT00430508|50145908|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
25044181|NCT00430508|50145909|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
25044182|NCT00430508|50145910|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
25044183|NCT00430508|50145907|FG000|Overall Study|Other|1|||
25044184|NCT00430508|50145908|FG001|Overall Study|Other|1|||
25044185|NCT00430508|50145909|FG002|Overall Study|Other|3|||
25044186|NCT00430508|50145910|FG003|Overall Study|Other|0|||
25044187|NCT02988219|50145918|FG000|Overall Study|Lack of Efficacy|1|||
25044188|NCT02988219|50145919|FG001|Overall Study|Lack of Efficacy|1|||
25044189|NCT02988219|50145918|FG000|Overall Study|Withdrawal by Subject|0|||
25044190|NCT02988219|50145919|FG001|Overall Study|Withdrawal by Subject|2|||
25044191|NCT01346059|50145927|FG000|Overall Study|Withdrawal by Subject|1|||
24957499|NCT00332202|50048292|FG001|Overall Study|Sponsor Decision|2|||
24957500|NCT00332202|50048291|FG000|Overall Study|Withdrawal by Subject|36|||
24957501|NCT00332202|50048292|FG001|Overall Study|Withdrawal by Subject|17|||
24957502|NCT00332202|50048291|FG000|Overall Study|Progressive Disease|106|||
24957503|NCT00332202|50048292|FG001|Overall Study|Progressive Disease|60|||
24957504|NCT00332202|50048291|FG000|Overall Study|Death|5|||
25044192|NCT01346059|50145928|FG001|Overall Study|Withdrawal by Subject|0|||
25044193|NCT01318915|50145934|FG000|Overall Study|Lost to Follow-up|1|||
25044194|NCT02987205|50145940|FG000|Overall Study|Adverse Event|1|||
25044195|NCT02987205|50145940|FG000|Overall Study|Withdrawal by Subject|3|||
25044196|NCT02926937|50145962|FG000|Overall Study|Adverse Event|0|||
25044197|NCT02926937|50145963|FG001|Overall Study|Adverse Event|1|||
25044198|NCT02926937|50145964|FG002|Overall Study|Adverse Event|1|||
25044199|NCT02926937|50145962|FG000|Overall Study|Poor Compliance to Protocol|1|||
25044200|NCT02926937|50145963|FG001|Overall Study|Poor Compliance to Protocol|0|||
25044201|NCT02926937|50145964|FG002|Overall Study|Poor Compliance to Protocol|0|||
25044202|NCT02926937|50145962|FG000|Overall Study|Lost to Follow-up|4|||
25044203|NCT02926937|50145963|FG001|Overall Study|Lost to Follow-up|5|||
25044204|NCT02926937|50145964|FG002|Overall Study|Lost to Follow-up|0|||
25044205|NCT02926937|50145962|FG000|Overall Study|At the Participant's own Request|11|||
25044206|NCT02926937|50145963|FG001|Overall Study|At the Participant's own Request|5|||
25044207|NCT02926937|50145964|FG002|Overall Study|At the Participant's own Request|8|||
25044208|NCT02926937|50145962|FG000|Overall Study|Reason not Specified|3|||
25044209|NCT02926937|50145963|FG001|Overall Study|Reason not Specified|4|||
25044210|NCT02926937|50145964|FG002|Overall Study|Reason not Specified|2|||
25044211|NCT04189588|50145975|FG000|Overall Study|Death|0|||
25044212|NCT04189588|50145976|FG001|Overall Study|Death|1|||
25044213|NCT04189588|50145975|FG000|Overall Study|Lost to Follow-up|0|||
25044214|NCT04189588|50145976|FG001|Overall Study|Lost to Follow-up|1|||
25044215|NCT00151892|50145984|FG000|Overall Study|Lack of Efficacy|50|||
25044216|NCT00151892|50145985|FG001|Overall Study|Lack of Efficacy|57|||
25044217|NCT00151892|50145984|FG000|Overall Study|Patient request|10|||
25044218|NCT00151892|50145985|FG001|Overall Study|Patient request|7|||
25044219|NCT00151892|50145984|FG000|Overall Study|Lost to Follow-up|5|||
25044220|NCT00151892|50145985|FG001|Overall Study|Lost to Follow-up|10|||
25044221|NCT00151892|50145984|FG000|Overall Study|Adverse Event|6|||
25044222|NCT00151892|50145985|FG001|Overall Study|Adverse Event|3|||
25044223|NCT00151892|50145984|FG000|Overall Study|Protocol Violation|3|||
25044224|NCT00151892|50145985|FG001|Overall Study|Protocol Violation|3|||
25044225|NCT00151892|50145984|FG000|Overall Study|Non-compliance|0|||
25044226|NCT00151892|50145985|FG001|Overall Study|Non-compliance|1|||
25044227|NCT00151892|50145984|FG000|Overall Study|Pregnancy|0|||
25044228|NCT00151892|50145985|FG001|Overall Study|Pregnancy|1|||
25044229|NCT00151892|50145984|FG000|Overall Study|Did not return for a visit|1|||
25044230|NCT00151892|50145985|FG001|Overall Study|Did not return for a visit|0|||
25044231|NCT00151892|50145984|FG000|Overall Study|Used prohibited corticosteroids|1|||
25044232|NCT00151892|50145985|FG001|Overall Study|Used prohibited corticosteroids|0|||
25044233|NCT00151892|50145984|FG000|Overall Study|Lack of study medication at center|0|||
25044234|NCT00151892|50145985|FG001|Overall Study|Lack of study medication at center|1|||
24957505|NCT00332202|50048292|FG001|Overall Study|Death|2|||
24957506|NCT00331422|50048307|FG000|Overall Study|Did not receive entire study regimen|5|||
24957507|NCT00331344|50048312|FG000|Phase I|Adverse Event|0|||
24957508|NCT00331344|50048313|FG001|Phase I|Adverse Event|0|||
24957509|NCT00331344|50048314|FG002|Phase I|Adverse Event|0|||
24957510|NCT00331344|50048315|FG003|Phase I|Adverse Event|1|||
25044235|NCT03055195|50146009|FG000|Overall Study|Lack of Efficacy|1|||
25044236|NCT03055195|50146010|FG001|Overall Study|Lack of Efficacy|0|||
25044237|NCT03055195|50146009|FG000|Overall Study|Withdrawal by Subject|6|||
25044238|NCT03055195|50146010|FG001|Overall Study|Withdrawal by Subject|7|||
25044239|NCT03055195|50146009|FG000|Overall Study|Study Terminated by Sponsor|2|||
25044240|NCT03055195|50146010|FG001|Overall Study|Study Terminated by Sponsor|6|||
25044241|NCT03055195|50146009|FG000|Overall Study|Protocol Violation|2|||
25044242|NCT03055195|50146010|FG001|Overall Study|Protocol Violation|1|||
25044243|NCT03055195|50146009|FG000|Overall Study|Physician Decision|1|||
25044244|NCT03055195|50146010|FG001|Overall Study|Physician Decision|0|||
25044245|NCT02921919|50146018|FG000|Overall Study|Other|5|||
25044246|NCT02921919|50146019|FG001|Overall Study|Other|6|||
25044247|NCT02921919|50146018|FG000|Overall Study|Lost to Follow-up|0|||
25044248|NCT02921919|50146019|FG001|Overall Study|Lost to Follow-up|1|||
25044249|NCT02921919|50146018|FG000|Overall Study|Withdrawal by Subject|5|||
24957511|NCT00331344|50048316|FG004|Phase I|Adverse Event|2|||
24957512|NCT00331344|50048317|FG005|Phase I|Adverse Event|2|||
25044250|NCT02921919|50146019|FG001|Overall Study|Withdrawal by Subject|1|||
25044251|NCT02921919|50146018|FG000|Overall Study|Disease Progression|47|||
25044252|NCT02921919|50146019|FG001|Overall Study|Disease Progression|38|||
25044253|NCT02921919|50146018|FG000|Overall Study|Physician Decision|3|||
25044254|NCT02921919|50146019|FG001|Overall Study|Physician Decision|2|||
25044255|NCT02921919|50146018|FG000|Overall Study|Adverse Event|6|||
25044256|NCT02921919|50146019|FG001|Overall Study|Adverse Event|4|||
25044257|NCT02910219|50146041|FG000|Overall Study|Withdrawal by Subject|1|||
25044258|NCT02910219|50146042|FG001|Overall Study|Withdrawal by Subject|1|||
25044259|NCT01068717|50146048|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
25044260|NCT01068717|50146049|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
25044261|NCT01068717|50146050|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
25044262|NCT01068717|50146051|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
25044263|NCT02921763|50146065|FG000|Overall Study|Adverse Event|4|||
25044264|NCT02921763|50146065|FG000|Overall Study|Lost to Follow-up|4|||
25044265|NCT02921763|50146065|FG000|Overall Study|Lack of Efficacy|3|||
25044266|NCT02921763|50146065|FG000|Overall Study|Protocol Violation|2|||
25044267|NCT02921763|50146065|FG000|Overall Study|Withdrawal by Subject|2|||
25044268|NCT02921763|50146065|FG000|Overall Study|Physician Decision|1|||
25044269|NCT02921763|50146065|FG000|Overall Study|No data obtained|2|||
25044270|NCT01318135|50146087|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
25044271|NCT01318135|50146088|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
25044272|NCT01318135|50146089|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
25044273|NCT01318135|50146090|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
25044274|NCT01318135|50146091|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
25044275|NCT01318135|50146092|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
25044276|NCT01318135|50146093|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
25044277|NCT01318135|50146094|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
25044278|NCT01318135|50146087|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
25044279|NCT01318135|50146088|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
25044280|NCT01318135|50146089|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
25044281|NCT01318135|50146090|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
25044282|NCT01318135|50146091|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
25044283|NCT01318135|50146092|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
25044284|NCT01318135|50146093|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
25044285|NCT01318135|50146094|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
25044286|NCT01318135|50146087|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
25044287|NCT01318135|50146088|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
25044288|NCT01318135|50146089|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
25044289|NCT01318135|50146090|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
25044290|NCT01318135|50146091|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
25044291|NCT01318135|50146092|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
25044292|NCT01318135|50146093|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
25044293|NCT01318135|50146094|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
25044294|NCT01318135|50146087|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
25044295|NCT01318135|50146088|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
24957513|NCT00331344|50048318|FG006|Phase I|Adverse Event|0|||
24957514|NCT00331344|50048319|FG007|Phase I|Adverse Event|1|||
24957515|NCT00331344|50048320|FG008|Phase I|Adverse Event|0|||
24957516|NCT00331344|50048312|FG000|Phase II|Death|0|||
24957517|NCT00331344|50048313|FG001|Phase II|Death|0|||
24957518|NCT00331344|50048314|FG002|Phase II|Death|0|||
24957519|NCT00331344|50048315|FG003|Phase II|Death|0|||
24957520|NCT00331344|50048316|FG004|Phase II|Death|0|||
24957521|NCT00331344|50048317|FG005|Phase II|Death|0|||
24957522|NCT00331344|50048318|FG006|Phase II|Death|0|||
24957523|NCT00331344|50048319|FG007|Phase II|Death|0|||
24957524|NCT00331344|50048320|FG008|Phase II|Death|4|||
24957525|NCT00321672|50048337|FG000|Overall Study|Withdrawal by Subject|5|||
24957526|NCT00321672|50048338|FG001|Overall Study|Withdrawal by Subject|1|||
24957527|NCT00321672|50048339|FG002|Overall Study|Withdrawal by Subject|2|||
24957528|NCT00321672|50048340|FG003|Overall Study|Withdrawal by Subject|0|||
24957529|NCT00321672|50048337|FG000|Overall Study|Noncompliance|1|||
24957530|NCT00321672|50048338|FG001|Overall Study|Noncompliance|2|||
24957531|NCT00321672|50048339|FG002|Overall Study|Noncompliance|1|||
25044296|NCT01318135|50146089|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
25044297|NCT01318135|50146090|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
25044298|NCT01318135|50146091|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
25044299|NCT01318135|50146092|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
24957532|NCT00321672|50048340|FG003|Overall Study|Noncompliance|0|||
24957533|NCT00321672|50048337|FG000|Overall Study|Adverse Event|1|||
24957534|NCT00321672|50048338|FG001|Overall Study|Adverse Event|1|||
24957535|NCT00321672|50048339|FG002|Overall Study|Adverse Event|0|||
24957536|NCT00321672|50048340|FG003|Overall Study|Adverse Event|0|||
24957537|NCT00321672|50048337|FG000|Overall Study|Lack of Efficacy|1|||
24957538|NCT00321672|50048338|FG001|Overall Study|Lack of Efficacy|1|||
24957539|NCT00321672|50048339|FG002|Overall Study|Lack of Efficacy|0|||
24957540|NCT00321672|50048340|FG003|Overall Study|Lack of Efficacy|0|||
24957541|NCT00321672|50048337|FG000|Overall Study|Lost to Follow-up|2|||
24957542|NCT00321672|50048338|FG001|Overall Study|Lost to Follow-up|0|||
24957543|NCT00321672|50048339|FG002|Overall Study|Lost to Follow-up|4|||
24957544|NCT00321672|50048340|FG003|Overall Study|Lost to Follow-up|2|||
24957545|NCT00321672|50048337|FG000|Overall Study|Death|1|||
24957546|NCT00321672|50048338|FG001|Overall Study|Death|0|||
24957547|NCT00321672|50048339|FG002|Overall Study|Death|0|||
24957548|NCT00321672|50048340|FG003|Overall Study|Death|0|||
24957549|NCT00321672|50048337|FG000|Overall Study|Too far to travel for visits|1|||
24957550|NCT00321672|50048338|FG001|Overall Study|Too far to travel for visits|0|||
24957551|NCT00321672|50048339|FG002|Overall Study|Too far to travel for visits|0|||
24957552|NCT00321672|50048340|FG003|Overall Study|Too far to travel for visits|0|||
24957553|NCT00321672|50048337|FG000|Overall Study|Incarcerated|0|||
24957554|NCT00321672|50048338|FG001|Overall Study|Incarcerated|0|||
24957555|NCT00321672|50048339|FG002|Overall Study|Incarcerated|2|||
24957556|NCT00321672|50048340|FG003|Overall Study|Incarcerated|0|||
24957557|NCT00321672|50048337|FG000|Overall Study|Moved out of state|0|||
24957558|NCT00321672|50048338|FG001|Overall Study|Moved out of state|1|||
24957559|NCT00321672|50048339|FG002|Overall Study|Moved out of state|1|||
24957560|NCT00321672|50048340|FG003|Overall Study|Moved out of state|0|||
24957561|NCT00321672|50048337|FG000|Overall Study|Protocol Violation|0|||
24957562|NCT00321672|50048338|FG001|Overall Study|Protocol Violation|0|||
24957563|NCT00321672|50048339|FG002|Overall Study|Protocol Violation|1|||
24957564|NCT00321672|50048340|FG003|Overall Study|Protocol Violation|0|||
24957565|NCT00321672|50048337|FG000|Overall Study|Diagnosis of testicular cancer|0|||
24957566|NCT00321672|50048338|FG001|Overall Study|Diagnosis of testicular cancer|1|||
24957567|NCT00321672|50048339|FG002|Overall Study|Diagnosis of testicular cancer|0|||
24957568|NCT00321672|50048340|FG003|Overall Study|Diagnosis of testicular cancer|0|||
24957569|NCT00321672|50048337|FG000|Overall Study|Extensive travel required for new job|0|||
24957570|NCT00321672|50048338|FG001|Overall Study|Extensive travel required for new job|1|||
24957571|NCT00321672|50048339|FG002|Overall Study|Extensive travel required for new job|0|||
24957572|NCT00321672|50048340|FG003|Overall Study|Extensive travel required for new job|0|||
24957573|NCT00321048|50048356|FG000|Overall Study|Withdrawal by Subject|6|||
24957574|NCT00321048|50048357|FG001|Overall Study|Withdrawal by Subject|8|||
24957575|NCT00330174|50048365|FG000|Overall Study|Withdrawal by Subject|7|||
24957576|NCT00330174|50048366|FG001|Overall Study|Withdrawal by Subject|7|||
24957577|NCT00330174|50048365|FG000|Overall Study|Lost to Follow-up|4|||
24957578|NCT00330174|50048366|FG001|Overall Study|Lost to Follow-up|1|||
24957579|NCT00330174|50048365|FG000|Overall Study|Clinical deterioration|1|||
24957580|NCT00330174|50048366|FG001|Overall Study|Clinical deterioration|2|||
24957581|NCT00330174|50048365|FG000|Overall Study|Excessive missed visits|3|||
24957582|NCT00330174|50048366|FG001|Overall Study|Excessive missed visits|8|||
24957583|NCT00330174|50048365|FG000|Overall Study|Miscellaneous reasons|7|||
24957584|NCT00330174|50048366|FG001|Overall Study|Miscellaneous reasons|1|||
24957585|NCT00320424|50048372|FG000|Overall Study|Adverse Event|3|||
24957586|NCT00320424|50048372|FG000|Overall Study|Other|3|||
24957587|NCT00338286|50048378|FG000|Overall Study|Withdrawal by Subject|50|||
24957588|NCT00338286|50048379|FG001|Overall Study|Withdrawal by Subject|54|||
24957589|NCT00338286|50048378|FG000|Overall Study|Lost to Follow-up|80|||
24957590|NCT00338286|50048379|FG001|Overall Study|Lost to Follow-up|66|||
24957591|NCT00338286|50048378|FG000|Overall Study|Other|103|||
24957592|NCT00338286|50048379|FG001|Overall Study|Other|93|||
24957593|NCT00329784|50048389|FG000|Overall Study|Lost to Follow-up|0|||
24957594|NCT00329784|50048390|FG001|Overall Study|Lost to Follow-up|1|||
24957595|NCT00329784|50048391|FG002|Overall Study|Lost to Follow-up|0|||
24957596|NCT00329784|50048392|FG003|Overall Study|Lost to Follow-up|0|||
24957597|NCT00329784|50048389|FG000|Overall Study|Withdrawal by Subject|4|||
24957598|NCT00329784|50048390|FG001|Overall Study|Withdrawal by Subject|2|||
24957599|NCT00329784|50048391|FG002|Overall Study|Withdrawal by Subject|0|||
24957600|NCT00329784|50048392|FG003|Overall Study|Withdrawal by Subject|0|||
24957601|NCT00329784|50048389|FG000|Overall Study|Other|1|||
24957602|NCT00329784|50048390|FG001|Overall Study|Other|2|||
24957603|NCT00329784|50048391|FG002|Overall Study|Other|0|||
25044300|NCT01318135|50146093|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
25044301|NCT01318135|50146094|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
25044302|NCT01318135|50146087|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
25044303|NCT01318135|50146088|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
25044304|NCT01318135|50146089|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
25044305|NCT01318135|50146090|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
25044306|NCT01318135|50146091|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
25044307|NCT01318135|50146092|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
25044308|NCT01318135|50146093|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
25044309|NCT01318135|50146094|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
25044310|NCT01318135|50146087|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
25044311|NCT01318135|50146088|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
25044312|NCT01318135|50146089|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
25044313|NCT01318135|50146090|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
25044314|NCT01318135|50146091|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
25044315|NCT01318135|50146092|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
25044316|NCT01318135|50146093|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
25044317|NCT01318135|50146094|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
25044318|NCT01318135|50146087|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
25044319|NCT01318135|50146088|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
25044320|NCT01318135|50146089|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
25044321|NCT01318135|50146090|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
25044322|NCT01318135|50146091|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
25044323|NCT01318135|50146092|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
25044324|NCT01318135|50146093|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
25044325|NCT01318135|50146094|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
25044326|NCT02922153|50146106|FG000|Overall Study|Death|8|||
25044327|NCT02922153|50146107|FG001|Overall Study|Death|1|||
25044328|NCT02922153|50146106|FG000|Overall Study|Lost to Follow-up|1|||
25044329|NCT02922153|50146107|FG001|Overall Study|Lost to Follow-up|0|||
25044330|NCT02922153|50146106|FG000|Overall Study|Physician Decision|1|||
25044331|NCT02922153|50146107|FG001|Overall Study|Physician Decision|1|||
25044332|NCT02920983|50146113|FG000|Dispense 1|Unacceptable Lens Fit|0|||
25044333|NCT02920983|50146114|FG001|Dispense 1|Unacceptable Lens Fit|0|||
25044334|NCT02920983|50146115|FG002|Dispense 1|Unacceptable Lens Fit|0|||
25044335|NCT02920983|50146116|FG003|Dispense 1|Unacceptable Lens Fit|0|||
25044336|NCT02920983|50146117|FG004|Dispense 1|Unacceptable Lens Fit|1|||
25044337|NCT02920983|50146118|FG005|Dispense 1|Unacceptable Lens Fit|0|||
25044338|NCT02920983|50146113|FG000|Dispense 2|Unscceptable lens fit|1|||
25044339|NCT02920983|50146114|FG001|Dispense 2|Unscceptable lens fit|0|||
25044340|NCT02920983|50146115|FG002|Dispense 2|Unscceptable lens fit|0|||
25044341|NCT02920983|50146116|FG003|Dispense 2|Unscceptable lens fit|0|||
25044342|NCT02920983|50146117|FG004|Dispense 2|Unscceptable lens fit|1|||
25044343|NCT02920983|50146118|FG005|Dispense 2|Unscceptable lens fit|0|||
25044344|NCT02920983|50146113|FG000|Dispense 3|Unacceptable Lens Fit|1|||
25044345|NCT02920983|50146114|FG001|Dispense 3|Unacceptable Lens Fit|1|||
25044346|NCT02920983|50146115|FG002|Dispense 3|Unacceptable Lens Fit|0|||
25044347|NCT02920983|50146116|FG003|Dispense 3|Unacceptable Lens Fit|0|||
25044348|NCT02920983|50146117|FG004|Dispense 3|Unacceptable Lens Fit|1|||
25044349|NCT02920983|50146118|FG005|Dispense 3|Unacceptable Lens Fit|0|||
25044350|NCT02654002|50146135|FG000|Overall Study|Adverse Event|0|||
25044351|NCT02654002|50146136|FG001|Overall Study|Adverse Event|0|||
25044352|NCT02654002|50146137|FG002|Overall Study|Adverse Event|0|||
25044353|NCT02654002|50146138|FG003|Overall Study|Adverse Event|0|||
25044354|NCT02654002|50146139|FG004|Overall Study|Adverse Event|0|||
25044355|NCT02654002|50146140|FG005|Overall Study|Adverse Event|0|||
25044356|NCT02654002|50146141|FG006|Overall Study|Adverse Event|1|||
25044357|NCT02654002|50146142|FG007|Overall Study|Adverse Event|0|||
25044358|NCT02654002|50146143|FG008|Overall Study|Adverse Event|0|||
25044359|NCT02654002|50146135|FG000|Overall Study|Withdrew Consent|0|||
25044360|NCT02654002|50146136|FG001|Overall Study|Withdrew Consent|0|||
25044361|NCT02654002|50146137|FG002|Overall Study|Withdrew Consent|0|||
25044362|NCT02654002|50146138|FG003|Overall Study|Withdrew Consent|0|||
25044363|NCT02654002|50146139|FG004|Overall Study|Withdrew Consent|0|||
25044364|NCT02654002|50146140|FG005|Overall Study|Withdrew Consent|1|||
25044365|NCT02654002|50146141|FG006|Overall Study|Withdrew Consent|0|||
25044366|NCT02654002|50146142|FG007|Overall Study|Withdrew Consent|1|||
25044367|NCT02654002|50146143|FG008|Overall Study|Withdrew Consent|0|||
25044368|NCT01675492|50146178|FG000|Overall Study|study completed early - product approval|42|||
25044369|NCT03924622|50146189|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
25044370|NCT03924622|50146190|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
25044371|NCT03924622|50146191|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
25276306|NCT00960934|50590276|FG005|Overall Study|Lost to Follow-up|0|||
25044372|NCT03924622|50146192|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
25044373|NCT03924622|50146193|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
25044374|NCT03924622|50146194|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
25044375|NCT04044664|50146211|FG000|Stage 1|Adverse Event|3|||
25044376|NCT04044664|50146212|FG001|Stage 1|Adverse Event|3|||
25044377|NCT04044664|50146213|FG002|Stage 1|Adverse Event|1|||
25044378|NCT04044664|50146211|FG000|Stage 1|Lost to Follow-up|3|||
25044379|NCT04044664|50146212|FG001|Stage 1|Lost to Follow-up|2|||
25044380|NCT04044664|50146213|FG002|Stage 1|Lost to Follow-up|2|||
25044381|NCT04044664|50146211|FG000|Stage 1|Withdrawal by Subject|9|||
25044382|NCT04044664|50146212|FG001|Stage 1|Withdrawal by Subject|1|||
25044383|NCT04044664|50146213|FG002|Stage 1|Withdrawal by Subject|0|||
25044384|NCT04044664|50146211|FG000|Stage 1|noncompliance, personal reason|2|||
25044385|NCT04044664|50146212|FG001|Stage 1|noncompliance, personal reason|0|||
25044386|NCT04044664|50146213|FG002|Stage 1|noncompliance, personal reason|0|||
25044387|NCT04044664|50146211|FG000|Stage 1|randomization error|0|||
25044388|NCT04044664|50146212|FG001|Stage 1|randomization error|1|||
25044389|NCT04044664|50146213|FG002|Stage 1|randomization error|0|||
25044390|NCT04044664|50146211|FG000|Stage 2|Adverse Event|2|||
25044391|NCT04044664|50146212|FG001|Stage 2|Adverse Event|0|||
25044392|NCT04044664|50146213|FG002|Stage 2|Adverse Event|0|||
25044393|NCT04044664|50146211|FG000|Stage 2|Lost to Follow-up|3|||
25044394|NCT04044664|50146212|FG001|Stage 2|Lost to Follow-up|2|||
25044395|NCT04044664|50146213|FG002|Stage 2|Lost to Follow-up|1|||
25044396|NCT04044664|50146211|FG000|Stage 2|Withdrawal by Subject|3|||
25044397|NCT04044664|50146212|FG001|Stage 2|Withdrawal by Subject|0|||
25044398|NCT04044664|50146213|FG002|Stage 2|Withdrawal by Subject|0|||
25044399|NCT04044664|50146211|FG000|Stage 2|protocol deviation|1|||
25044400|NCT04044664|50146212|FG001|Stage 2|protocol deviation|0|||
25044401|NCT04044664|50146213|FG002|Stage 2|protocol deviation|0|||
25044402|NCT00150176|50146223|FG000|Overall Study|Adverse Event|16|||
25044403|NCT00150176|50146224|FG001|Overall Study|Adverse Event|53|||
25044404|NCT00150176|50146223|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
25044405|NCT00150176|50146224|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
25044406|NCT00150176|50146223|FG000|Overall Study|Withdrawal by Subject|19|||
25044407|NCT00150176|50146224|FG001|Overall Study|Withdrawal by Subject|12|||
25044408|NCT00150176|50146223|FG000|Overall Study|Lost to Follow-up|3|||
25044409|NCT00150176|50146224|FG001|Overall Study|Lost to Follow-up|3|||
25044410|NCT00150176|50146223|FG000|Overall Study|OTHER|11|||
25044411|NCT00150176|50146224|FG001|Overall Study|OTHER|13|||
25044412|NCT02985879|50146234|FG000|Overall Study|Adverse Event|7|||
25044413|NCT02985879|50146235|FG001|Overall Study|Adverse Event|9|||
24957604|NCT00329784|50048392|FG003|Overall Study|Other|0|||
24957605|NCT00337818|50048407|FG000|Overall Study|Lost to Follow-up|289|||
24957606|NCT00337818|50048408|FG001|Overall Study|Lost to Follow-up|91|||
25044414|NCT02985879|50146236|FG002|Overall Study|Adverse Event|7|||
25044415|NCT02985879|50146234|FG000|Overall Study|Withdrew consent|6|||
24957607|NCT00337818|50048409|FG002|Overall Study|Lost to Follow-up|107|||
24957608|NCT00329550|50048420|FG000|Overall Study|Adverse Event|3|||
24957609|NCT00329550|50048421|FG001|Overall Study|Adverse Event|4|||
24957610|NCT00329550|50048422|FG002|Overall Study|Adverse Event|2|||
24957611|NCT00329550|50048420|FG000|Overall Study|Withdrawal of Consent|1|||
24957612|NCT00329550|50048421|FG001|Overall Study|Withdrawal of Consent|0|||
24957613|NCT00329550|50048422|FG002|Overall Study|Withdrawal of Consent|1|||
24957614|NCT00329550|50048420|FG000|Overall Study|Due to Relocation|0|||
24957615|NCT00329550|50048421|FG001|Overall Study|Due to Relocation|0|||
24957616|NCT00329550|50048422|FG002|Overall Study|Due to Relocation|1|||
24957617|NCT00375674|50048434|FG000|Overall Study|Other|26|||
24957618|NCT00375674|50048435|FG001|Overall Study|Other|18|||
24957619|NCT00375674|50048434|FG000|Overall Study|Death|67|||
24957620|NCT00375674|50048435|FG001|Overall Study|Death|76|||
24957621|NCT00375674|50048434|FG000|Overall Study|Participants refused further follow-up|31|||
24957622|NCT00375674|50048435|FG001|Overall Study|Participants refused further follow-up|30|||
24957623|NCT00375674|50048434|FG000|Overall Study|Lost to Follow-up|17|||
24957624|NCT00375674|50048435|FG001|Overall Study|Lost to Follow-up|15|||
24957625|NCT00375674|50048434|FG000|Overall Study|Enrolled but not treated|3|||
24957626|NCT00375674|50048435|FG001|Overall Study|Enrolled but not treated|2|||
24957627|NCT00350402|50048443|FG000|Overall Study|Lost to Follow-up|1|||
25044416|NCT02985879|50146235|FG001|Overall Study|Withdrew consent|8|||
25044417|NCT02985879|50146236|FG002|Overall Study|Withdrew consent|10|||
24957628|NCT00350402|50048444|FG001|Overall Study|Lost to Follow-up|1|||
25044418|NCT02985879|50146234|FG000|Overall Study|Lost to Follow-up|1|||
25044419|NCT02985879|50146235|FG001|Overall Study|Lost to Follow-up|0|||
25044420|NCT02985879|50146236|FG002|Overall Study|Lost to Follow-up|2|||
25044421|NCT02985879|50146234|FG000|Overall Study|Other, not specified|62|||
25044422|NCT02985879|50146235|FG001|Overall Study|Other, not specified|58|||
25044423|NCT02985879|50146236|FG002|Overall Study|Other, not specified|58|||
25044424|NCT01067469|50146252|FG000|Overall Study|Withdrawal by Subject|0|||
25044425|NCT01067469|50146253|FG001|Overall Study|Withdrawal by Subject|1|||
25044426|NCT01067469|50146252|FG000|Overall Study|Disease Progression|0|||
25044427|NCT01067469|50146253|FG001|Overall Study|Disease Progression|1|||
25044428|NCT02985021|50146259|FG000|Overall Study|Inability to comply with study procedures|1|||
25044429|NCT01066923|50146267|FG000|Overall Study|Withdrawal by Subject|3|||
25044430|NCT01066923|50146268|FG001|Overall Study|Withdrawal by Subject|3|||
25044431|NCT01066923|50146269|FG002|Overall Study|Withdrawal by Subject|8|||
25044432|NCT01066923|50146270|FG003|Overall Study|Withdrawal by Subject|8|||
25044433|NCT02919267|50146295|FG000|Overall Study|Protocol Violation|0|||
25044434|NCT02919267|50146296|FG001|Overall Study|Protocol Violation|3|||
25044435|NCT02919267|50146297|FG002|Overall Study|Protocol Violation|3|||
25044436|NCT02919267|50146298|FG003|Overall Study|Protocol Violation|4|||
25044437|NCT01368900|50146308|FG000|Overall Study|Lost to Follow-up|7|||
25044438|NCT02910063|50146314|FG000|Phase 2|Withdrawal by Subject|3|||
25044439|NCT02910063|50146315|FG001|Phase 2|Withdrawal by Subject|0|||
25044440|NCT02910063|50146316|FG002|Phase 2|Withdrawal by Subject|0|||
25044441|NCT02910063|50146314|FG000|Phase 2|Lost to Follow-up|1|||
25044442|NCT02910063|50146315|FG001|Phase 2|Lost to Follow-up|0|||
25044443|NCT02910063|50146316|FG002|Phase 2|Lost to Follow-up|0|||
25044444|NCT02910063|50146314|FG000|Phase 2|Death|24|||
25044445|NCT02910063|50146315|FG001|Phase 2|Death|0|||
25044446|NCT02910063|50146316|FG002|Phase 2|Death|0|||
25044447|NCT02909907|50146327|FG000|Overall Study|Withdrawal by Subject|0|||
25044448|NCT02909907|50146328|FG001|Overall Study|Withdrawal by Subject|1|||
25044449|NCT02651194|50146334|FG000|Overall Study|Lost to Follow-up|3|||
25044450|NCT02651194|50146334|FG000|Overall Study|Other|2|||
25044451|NCT02907177|50146340|FG000|Overall Study|Death|0|||
25044452|NCT02907177|50146341|FG001|Overall Study|Death|1|||
25044453|NCT02907177|50146340|FG000|Overall Study|Physician Decision|3|||
25044454|NCT02907177|50146341|FG001|Overall Study|Physician Decision|3|||
25044455|NCT02907177|50146340|FG000|Overall Study|Withdrawal by Subject|15|||
25044456|NCT02907177|50146341|FG001|Overall Study|Withdrawal by Subject|7|||
25044457|NCT02907177|50146340|FG000|Overall Study|Sponsor's Decision|50|||
25044458|NCT02907177|50146341|FG001|Overall Study|Sponsor's Decision|57|||
25044459|NCT02652442|50146347|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
25044460|NCT02906709|50146361|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
25044461|NCT02906709|50146362|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
25044462|NCT02906709|50146361|FG000|Phase A (Week 0 to Week 16)|Death|0|||
25044463|NCT02906709|50146362|FG001|Phase A (Week 0 to Week 16)|Death|1|||
25044464|NCT02906709|50146361|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
25044465|NCT02906709|50146362|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
25044466|NCT02906709|50146361|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
25162437|NCT01791517|50284758|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
24957629|NCT00320190|50048458|FG000|First 12 Months|Completed but did not enter extension|5|||
24957630|NCT00320190|50048459|FG001|First 12 Months|Completed but did not enter extension|3|||
24957631|NCT00320190|50048458|FG000|First 12 Months|Sponsor terminated study|2|||
24957632|NCT00320190|50048459|FG001|First 12 Months|Sponsor terminated study|2|||
24957633|NCT00320190|50048458|FG000|First 12 Months|Lost to Follow-up|0|||
24957634|NCT00320190|50048459|FG001|First 12 Months|Lost to Follow-up|1|||
24957635|NCT00320190|50048458|FG000|First 12 Months|Enrollment failure|0|||
24957636|NCT00320190|50048459|FG001|First 12 Months|Enrollment failure|1|||
24957637|NCT00320190|50048458|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
24957638|NCT00320190|50048459|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
24957639|NCT00320190|50048458|FG000|First 12 Months|Investigator request|0|||
24957640|NCT00320190|50048459|FG001|First 12 Months|Investigator request|1|||
25162438|NCT01791517|50284759|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
25044467|NCT02906709|50146362|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
25044468|NCT00318656|50146376|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
25044469|NCT00318656|50146377|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
25044470|NCT00318656|50146376|FG000|Overall Study|Did not receive any treatment|0|||
25162439|NCT01791517|50284760|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
25044471|NCT00318656|50146377|FG001|Overall Study|Did not receive any treatment|1|||
25044472|NCT02908347|50146383|FG000|Overall Study|Adverse Event|0|||
25044473|NCT02908347|50146384|FG001|Overall Study|Adverse Event|1|||
25044474|NCT02908347|50146383|FG000|Overall Study|Lost to Follow-up|1|||
25044475|NCT02908347|50146384|FG001|Overall Study|Lost to Follow-up|0|||
25044476|NCT02983305|50146406|FG000|Overall Study|incomplete data|2|||
25044477|NCT02983305|50146407|FG001|Overall Study|incomplete data|0|||
25044478|NCT03663166|50146413|FG000|Overall Study|Withdrawal by Subject|1|||
25044479|NCT02983227|50146420|FG000|Overall Study|Adverse Event|21|||
25044480|NCT02983227|50146421|FG001|Overall Study|Adverse Event|3|||
25044481|NCT02983227|50146420|FG000|Overall Study|Death|3|||
25044482|NCT02983227|50146421|FG001|Overall Study|Death|0|||
25044483|NCT02983227|50146420|FG000|Overall Study|Lack of Efficacy|8|||
25044484|NCT02983227|50146421|FG001|Overall Study|Lack of Efficacy|1|||
25044485|NCT02983227|50146420|FG000|Overall Study|Lost to Follow-up|3|||
25044486|NCT02983227|50146421|FG001|Overall Study|Lost to Follow-up|0|||
25044487|NCT02983227|50146420|FG000|Overall Study|Multiple Reasons|2|||
25044488|NCT02983227|50146421|FG001|Overall Study|Multiple Reasons|1|||
25044489|NCT02983227|50146420|FG000|Overall Study|Physician Decision|3|||
25044490|NCT02983227|50146421|FG001|Overall Study|Physician Decision|1|||
25044491|NCT02983227|50146420|FG000|Overall Study|Withdrawal by Subject|19|||
25044492|NCT02983227|50146421|FG001|Overall Study|Withdrawal by Subject|8|||
25044493|NCT00301262|50146429|FG000|Double Blind Phase (DB)|Adverse Event|1|||
25044494|NCT00301262|50146430|FG001|Double Blind Phase (DB)|Adverse Event|0|||
25044495|NCT00301262|50146429|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
25044496|NCT00301262|50146430|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
25044497|NCT00301262|50146429|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
25044498|NCT00301262|50146430|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
25044499|NCT00301262|50146429|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
25276307|NCT00960934|50590271|FG000|Overall Study|Other|2|||
24957641|NCT00320190|50048458|FG000|First 12 Months|Study drug toxicity|0|||
24957642|NCT00320190|50048459|FG001|First 12 Months|Study drug toxicity|1|||
24957643|NCT00320190|50048458|FG000|First 12 Months|Withdrawal by Subject|0|||
24957644|NCT00320190|50048459|FG001|First 12 Months|Withdrawal by Subject|1|||
24957645|NCT00320190|50048458|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
24957646|NCT00320190|50048459|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
24957647|NCT00320190|50048458|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
24957648|NCT00320190|50048459|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
24957649|NCT00320190|50048458|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
24957650|NCT00320190|50048459|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
24957651|NCT00320112|50048467|FG000|Overall Study|Lost to Follow-up|3|||
24957652|NCT00320112|50048468|FG001|Overall Study|Lost to Follow-up|4|||
24957653|NCT00320112|50048467|FG000|Overall Study|Withdrawal by Subject|3|||
24957654|NCT00320112|50048468|FG001|Overall Study|Withdrawal by Subject|0|||
24957655|NCT00320112|50048467|FG000|Overall Study|Death|2|||
24957656|NCT00320112|50048468|FG001|Overall Study|Death|1|||
24957657|NCT00319956|50048482|FG000|Overall Study|Death|20|||
24957658|NCT00319956|50048483|FG001|Overall Study|Death|24|||
24957659|NCT00349622|50048491|FG000|Overall Study|Death|168|||
24957660|NCT00349622|50048492|FG001|Overall Study|Death|86|||
24957661|NCT00349622|50048491|FG000|Overall Study|Lost to Follow-up|5|||
24957662|NCT00349622|50048492|FG001|Overall Study|Lost to Follow-up|1|||
24957663|NCT00349622|50048491|FG000|Overall Study|Withdrawal by Subject|5|||
24957664|NCT00349622|50048492|FG001|Overall Study|Withdrawal by Subject|9|||
24957665|NCT00354614|50048498|FG000|Overall Study|Lack of Efficacy|28|||
24957666|NCT00360308|50048505|FG000|Overall Study|Adverse Event|15|||
24957667|NCT00360308|50048506|FG001|Overall Study|Adverse Event|14|||
24957668|NCT00360308|50048507|FG002|Overall Study|Adverse Event|25|||
24957669|NCT00360308|50048505|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
24957670|NCT00360308|50048506|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
24957671|NCT00360308|50048507|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
24957672|NCT00360308|50048505|FG000|Overall Study|Protocol Violation|2|||
24957673|NCT00360308|50048506|FG001|Overall Study|Protocol Violation|1|||
24957674|NCT00360308|50048507|FG002|Overall Study|Protocol Violation|2|||
24957675|NCT00360308|50048505|FG000|Overall Study|Withdrawal by Subject|11|||
24957676|NCT00360308|50048506|FG001|Overall Study|Withdrawal by Subject|7|||
24957677|NCT00360308|50048507|FG002|Overall Study|Withdrawal by Subject|14|||
24957678|NCT00360308|50048505|FG000|Overall Study|Lack of Efficacy|3|||
24957679|NCT00360308|50048506|FG001|Overall Study|Lack of Efficacy|0|||
25044500|NCT00301262|50146430|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
25044501|NCT00301262|50146429|FG000|Double Blind Phase (DB)|Other|1|||
25044502|NCT00301262|50146430|FG001|Double Blind Phase (DB)|Other|4|||
25044503|NCT00301262|50146429|FG000|Open Label Phase (OL)|Adverse Event|1|||
25044504|NCT00301262|50146430|FG001|Open Label Phase (OL)|Adverse Event|0|||
25044505|NCT00301262|50146429|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
25276308|NCT00960934|50590272|FG001|Overall Study|Other|1|||
24957680|NCT00360308|50048507|FG002|Overall Study|Lack of Efficacy|2|||
24957681|NCT00360308|50048505|FG000|Overall Study|Other|2|||
24957682|NCT00360308|50048506|FG001|Overall Study|Other|1|||
24957683|NCT00360308|50048507|FG002|Overall Study|Other|1|||
24957684|NCT00360308|50048505|FG000|Overall Study|Study termination by sponsor|43|||
24957685|NCT00360308|50048506|FG001|Overall Study|Study termination by sponsor|55|||
24957686|NCT00360308|50048507|FG002|Overall Study|Study termination by sponsor|44|||
24957687|NCT00348686|50048519|FG000|Overall Study|Withdrawal by Subject|45|||
24957688|NCT00348686|50048519|FG000|Overall Study|Adverse Event|5|||
24957689|NCT00348686|50048519|FG000|Overall Study|Protocol Violation|6|||
24957690|NCT00348686|50048519|FG000|Overall Study|Lost to Follow-up|2|||
24957691|NCT00348686|50048519|FG000|Overall Study|Multiple Reasons|8|||
24957692|NCT00360230|50048530|FG000|Overall Study|Withdrawal by Subject|1|||
24957693|NCT00360230|50048531|FG001|Overall Study|Withdrawal by Subject|1|||
24957694|NCT00360230|50048532|FG002|Overall Study|Withdrawal by Subject|0|||
24957695|NCT00360230|50048533|FG003|Overall Study|Withdrawal by Subject|1|||
24957696|NCT00360230|50048534|FG004|Overall Study|Withdrawal by Subject|1|||
24957697|NCT00360230|50048535|FG005|Overall Study|Withdrawal by Subject|1|||
24957698|NCT00360230|50048536|FG006|Overall Study|Withdrawal by Subject|0|||
24957699|NCT00360230|50048530|FG000|Overall Study|Migrated|4|||
24957700|NCT00360230|50048531|FG001|Overall Study|Migrated|1|||
24957701|NCT00360230|50048532|FG002|Overall Study|Migrated|3|||
24957702|NCT00360230|50048533|FG003|Overall Study|Migrated|1|||
24957703|NCT00360230|50048534|FG004|Overall Study|Migrated|4|||
24957704|NCT00360230|50048535|FG005|Overall Study|Migrated|1|||
24957705|NCT00360230|50048536|FG006|Overall Study|Migrated|1|||
24957706|NCT00360230|50048530|FG000|Overall Study|Other|1|||
24957707|NCT00360230|50048531|FG001|Overall Study|Other|0|||
24957708|NCT00360230|50048532|FG002|Overall Study|Other|0|||
24957709|NCT00360230|50048533|FG003|Overall Study|Other|0|||
24957710|NCT00360230|50048534|FG004|Overall Study|Other|0|||
24957711|NCT00360230|50048535|FG005|Overall Study|Other|0|||
24957712|NCT00360230|50048536|FG006|Overall Study|Other|0|||
24957713|NCT00360230|50048530|FG000|Overall Study|Protocol Violation|0|||
24957714|NCT00360230|50048531|FG001|Overall Study|Protocol Violation|0|||
24957715|NCT00360230|50048532|FG002|Overall Study|Protocol Violation|0|||
24957716|NCT00360230|50048533|FG003|Overall Study|Protocol Violation|0|||
24957717|NCT00360230|50048534|FG004|Overall Study|Protocol Violation|0|||
24957718|NCT00360230|50048535|FG005|Overall Study|Protocol Violation|1|||
24957719|NCT00360230|50048536|FG006|Overall Study|Protocol Violation|0|||
24957720|NCT00360230|50048530|FG000|Overall Study|Death|0|||
24957721|NCT00360230|50048531|FG001|Overall Study|Death|1|||
24957722|NCT00360230|50048532|FG002|Overall Study|Death|0|||
24957723|NCT00360230|50048533|FG003|Overall Study|Death|0|||
24957724|NCT00360230|50048534|FG004|Overall Study|Death|0|||
24957725|NCT00360230|50048535|FG005|Overall Study|Death|1|||
24957726|NCT00360230|50048536|FG006|Overall Study|Death|1|||
24957727|NCT00348374|50048556|FG000|Overall Study|Adverse Event|1|||
24957728|NCT00348374|50048557|FG001|Overall Study|Adverse Event|4|||
24957729|NCT00348374|50048556|FG000|Overall Study|Lost to Follow-up|1|||
24957730|NCT00348374|50048557|FG001|Overall Study|Lost to Follow-up|3|||
24957731|NCT00348374|50048556|FG000|Overall Study|Withdrawal by Subject|5|||
24957732|NCT00348374|50048557|FG001|Overall Study|Withdrawal by Subject|5|||
24957733|NCT00348374|50048556|FG000|Overall Study|Other|11|||
24957734|NCT00348374|50048557|FG001|Overall Study|Other|12|||
24957735|NCT00348374|50048556|FG000|Overall Study|ongoing at date of cutoff|1|||
25044506|NCT00301262|50146430|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
25044507|NCT00301262|50146429|FG000|Open Label Phase (OL)|Other|2|||
25044508|NCT00301262|50146430|FG001|Open Label Phase (OL)|Other|0|||
25044509|NCT02905149|50146457|FG000|Overall Study|Lost to Follow-up|2|||
25044510|NCT02905149|50146458|FG001|Overall Study|Lost to Follow-up|0|||
25044511|NCT02790606|50146464|FG000|Overall Study|Death|27|||
25044512|NCT02790606|50146464|FG000|Overall Study|Lost to Follow-up|4|||
25044513|NCT02790606|50146464|FG000|Overall Study|Physician Decision|3|||
25044514|NCT02790606|50146464|FG000|Overall Study|Withdrawal by Subject|1|||
25044515|NCT03077620|50146472|FG000|Overall Study|Unable to place lumbar catheter|1|||
25044516|NCT03077620|50146473|FG001|Overall Study|Unable to place lumbar catheter|0|||
25044517|NCT03077620|50146474|FG002|Overall Study|Unable to place lumbar catheter|1|||
25044518|NCT03077620|50146475|FG003|Overall Study|Unable to place lumbar catheter|0|||
25044519|NCT03077620|50146472|FG000|Overall Study|Withdrawal by Subject|0|||
24957736|NCT00348374|50048557|FG001|Overall Study|ongoing at date of cutoff|1|||
24957737|NCT00348374|50048556|FG000|Overall Study|randomized but did not receive treatment|0|||
24957738|NCT00348374|50048557|FG001|Overall Study|randomized but did not receive treatment|7|||
24957739|NCT00353366|50048564|FG000|Overall Study|Adverse Event|8|||
24957740|NCT00353366|50048564|FG000|Overall Study|Protocol Violation|12|||
24957741|NCT00353366|50048564|FG000|Overall Study|Withdrawal by Subject|12|||
24957742|NCT00353366|50048564|FG000|Overall Study|Lost to Follow-up|92|||
24957743|NCT00353366|50048564|FG000|Overall Study|Other|19|||
25044520|NCT03077620|50146473|FG001|Overall Study|Withdrawal by Subject|1|||
25044521|NCT03077620|50146474|FG002|Overall Study|Withdrawal by Subject|0|||
24957744|NCT00352664|50048570|FG000|Overall Study|Withdrawal by Subject|7|||
24957745|NCT00352664|50048571|FG001|Overall Study|Withdrawal by Subject|0|||
25044522|NCT03077620|50146475|FG003|Overall Study|Withdrawal by Subject|0|||
25044523|NCT03077620|50146472|FG000|Overall Study|Physician Decision|0|||
25044524|NCT03077620|50146473|FG001|Overall Study|Physician Decision|0|||
25044525|NCT03077620|50146474|FG002|Overall Study|Physician Decision|1|||
25044526|NCT03077620|50146475|FG003|Overall Study|Physician Decision|0|||
25044527|NCT02982213|50146496|FG000|Overall Study|Did not complete follow up questionnaire|5|||
25044528|NCT02982213|50146497|FG001|Overall Study|Did not complete follow up questionnaire|1|||
25044529|NCT02649634|50146505|FG000|Overall Study|Withdrawal by Subject|3|||
25044530|NCT02649634|50146506|FG001|Overall Study|Withdrawal by Subject|5|||
25044531|NCT02649634|50146505|FG000|Overall Study|Lost to Follow-up|0|||
25044532|NCT02649634|50146506|FG001|Overall Study|Lost to Follow-up|1|||
25044533|NCT01066143|50146512|FG000|Overall Study|ineligible for the study|8|||
25044534|NCT02980107|50146518|FG000|Overall Study|Withdrawal by Subject|51|||
25044535|NCT02980107|50146519|FG001|Overall Study|Withdrawal by Subject|62|||
25044536|NCT02652130|50146525|FG000|Overall Study|Death|1|||
25044537|NCT02979639|50146529|FG000|Overall Study|Withdrawal based on medical judgement|1|||
25044538|NCT02979639|50146529|FG000|Overall Study|Lost to Follow-up|8|||
25044539|NCT02979639|50146529|FG000|Overall Study|Withdrawal by Subject|3|||
25044540|NCT02979639|50146529|FG000|Overall Study|Adverse Event|2|||
25044541|NCT01674634|50146533|FG000|Overall Study|Withdrawal by Subject|3|||
25044542|NCT01674634|50146533|FG000|Overall Study|Lost to Follow-up|3|||
25044543|NCT02979249|50146541|FG000|Overall Study|Lost to Follow-up|2|||
25044544|NCT02979249|50146541|FG000|Overall Study|Withdrawal by Subject|4|||
25044545|NCT02976519|50146552|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
25044546|NCT02976519|50146553|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
25044547|NCT02976519|50146554|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
25044548|NCT02976519|50146555|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
25044549|NCT02976519|50146556|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
25044550|NCT02976519|50146557|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
25044551|NCT02976519|50146558|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
25044552|NCT02976519|50146552|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
25044553|NCT02976519|50146553|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
25044554|NCT02976519|50146554|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
25044555|NCT02976519|50146555|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
25044556|NCT02976519|50146556|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
25044557|NCT02976519|50146557|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
24957746|NCT00490139|50048581|FG000|Overall Study|Death|106|||
24957747|NCT00490139|50048582|FG001|Overall Study|Death|119|||
24957748|NCT00490139|50048583|FG002|Overall Study|Death|168|||
24957749|NCT00490139|50048584|FG003|Overall Study|Death|135|||
24957750|NCT00490139|50048581|FG000|Overall Study|Lost to Follow-up|56|||
25044558|NCT02976519|50146558|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
25044559|NCT02976519|50146552|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
25044560|NCT02976519|50146553|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
25044561|NCT02976519|50146554|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
24957751|NCT00490139|50048582|FG001|Overall Study|Lost to Follow-up|46|||
24957752|NCT00490139|50048583|FG002|Overall Study|Lost to Follow-up|58|||
24957753|NCT00490139|50048584|FG003|Overall Study|Lost to Follow-up|56|||
24957754|NCT00490139|50048581|FG000|Overall Study|Participant Withdrew Consent|146|||
24957755|NCT00490139|50048582|FG001|Overall Study|Participant Withdrew Consent|110|||
24957756|NCT00490139|50048583|FG002|Overall Study|Participant Withdrew Consent|208|||
25044562|NCT02976519|50146555|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
25044563|NCT02976519|50146556|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
25044564|NCT02976519|50146557|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
25044565|NCT02976519|50146558|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
25044566|NCT02976519|50146552|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
25044567|NCT02976519|50146553|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
25044568|NCT02976519|50146554|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
25044569|NCT02976519|50146555|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
25044570|NCT02976519|50146556|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
25044571|NCT02976519|50146557|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
25044572|NCT02976519|50146558|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
25044573|NCT02976519|50146552|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
25044574|NCT02976519|50146553|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
25044575|NCT02976519|50146554|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
25044576|NCT02976519|50146555|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
25044577|NCT02976519|50146556|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
25044578|NCT02976519|50146557|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
25044579|NCT02976519|50146558|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
25044580|NCT02975973|50146663|FG000|Overall Study|Adverse Event|1|||
25044581|NCT02975973|50146664|FG001|Overall Study|Adverse Event|1|||
25044582|NCT02975973|50146665|FG002|Overall Study|Adverse Event|1|||
25044583|NCT02975973|50146666|FG003|Overall Study|Adverse Event|0|||
25044584|NCT01362322|50146678|FG000|Overall Study|Withdrawal by Subject|3|||
25044585|NCT01362322|50146679|FG001|Overall Study|Withdrawal by Subject|1|||
25044586|NCT01362322|50146678|FG000|Overall Study|Lost to Follow-up|2|||
25044587|NCT01362322|50146679|FG001|Overall Study|Lost to Follow-up|6|||
25044588|NCT02918877|50146687|FG000|Overall Study|Withdrawal by Subject|2|||
25044589|NCT02918877|50146688|FG001|Overall Study|Withdrawal by Subject|2|||
25044590|NCT02918877|50146687|FG000|Overall Study|Surgery cancelled|1|||
25044591|NCT02918877|50146688|FG001|Overall Study|Surgery cancelled|0|||
25044592|NCT02918877|50146687|FG000|Overall Study|Physician Decision|1|||
25044593|NCT02918877|50146688|FG001|Overall Study|Physician Decision|0|||
25044594|NCT02918877|50146687|FG000|Overall Study|Received intraoperative steroids|1|||
25044595|NCT02918877|50146688|FG001|Overall Study|Received intraoperative steroids|0|||
25044596|NCT02918877|50146687|FG000|Overall Study|Unable to obtain lab samples|1|||
25044597|NCT02918877|50146688|FG001|Overall Study|Unable to obtain lab samples|0|||
25044598|NCT02918877|50146687|FG000|Overall Study|Unsafe to perform BAL|0|||
25044599|NCT02918877|50146688|FG001|Overall Study|Unsafe to perform BAL|1|||
25044600|NCT01674712|50146699|FG000|Overall Study|Adverse Event|5|||
25044601|NCT01674712|50146700|FG001|Overall Study|Adverse Event|6|||
25044602|NCT01674712|50146701|FG002|Overall Study|Adverse Event|3|||
25044603|NCT01674712|50146702|FG003|Overall Study|Adverse Event|4|||
25044604|NCT01674712|50146703|FG004|Overall Study|Adverse Event|6|||
25044605|NCT01674712|50146699|FG000|Overall Study|Lost to Follow-up|1|||
25044606|NCT01674712|50146700|FG001|Overall Study|Lost to Follow-up|0|||
25044607|NCT01674712|50146701|FG002|Overall Study|Lost to Follow-up|0|||
25044608|NCT01674712|50146702|FG003|Overall Study|Lost to Follow-up|0|||
25044609|NCT01674712|50146703|FG004|Overall Study|Lost to Follow-up|0|||
25044610|NCT01674712|50146699|FG000|Overall Study|Protocol Violation|2|||
25044611|NCT01674712|50146700|FG001|Overall Study|Protocol Violation|0|||
25044612|NCT01674712|50146701|FG002|Overall Study|Protocol Violation|0|||
25044613|NCT01674712|50146702|FG003|Overall Study|Protocol Violation|0|||
25044614|NCT01674712|50146703|FG004|Overall Study|Protocol Violation|0|||
25044615|NCT01674712|50146699|FG000|Overall Study|Withdrawal by Subject|2|||
25044616|NCT01674712|50146700|FG001|Overall Study|Withdrawal by Subject|2|||
25044617|NCT01674712|50146701|FG002|Overall Study|Withdrawal by Subject|5|||
25044618|NCT01674712|50146702|FG003|Overall Study|Withdrawal by Subject|4|||
25044619|NCT01674712|50146703|FG004|Overall Study|Withdrawal by Subject|3|||
25044620|NCT01674712|50146699|FG000|Overall Study|Administrative|0|||
25044621|NCT01674712|50146700|FG001|Overall Study|Administrative|1|||
25044622|NCT01674712|50146701|FG002|Overall Study|Administrative|0|||
25044623|NCT01674712|50146702|FG003|Overall Study|Administrative|0|||
25044624|NCT01674712|50146703|FG004|Overall Study|Administrative|1|||
25044625|NCT01674712|50146699|FG000|Overall Study|Lack of Efficacy|0|||
25044626|NCT01674712|50146700|FG001|Overall Study|Lack of Efficacy|0|||
25044627|NCT01674712|50146701|FG002|Overall Study|Lack of Efficacy|1|||
25044628|NCT01674712|50146702|FG003|Overall Study|Lack of Efficacy|0|||
25044629|NCT01674712|50146703|FG004|Overall Study|Lack of Efficacy|1|||
25044630|NCT01368432|50146717|FG000|Overall Study|Lost to Follow-up|0|||
25044631|NCT01368432|50146718|FG001|Overall Study|Lost to Follow-up|1|||
25044632|NCT01063881|50146741|FG000|Overall Study|Adverse Event|12|||
25044633|NCT01063881|50146742|FG001|Overall Study|Adverse Event|2|||
25044634|NCT01063881|50146743|FG002|Overall Study|Adverse Event|0|||
25044635|NCT01063881|50146741|FG000|Overall Study|Lost to Follow-up|13|||
25044636|NCT01063881|50146742|FG001|Overall Study|Lost to Follow-up|7|||
25044637|NCT01063881|50146743|FG002|Overall Study|Lost to Follow-up|1|||
25044638|NCT01063881|50146741|FG000|Overall Study|Withdrawal by Subject|25|||
25044639|NCT01063881|50146742|FG001|Overall Study|Withdrawal by Subject|1|||
25044640|NCT01063881|50146743|FG002|Overall Study|Withdrawal by Subject|0|||
25044641|NCT01063881|50146741|FG000|Overall Study|Reason for not completed not specified|5|||
25044642|NCT01063881|50146742|FG001|Overall Study|Reason for not completed not specified|1|||
25044643|NCT01063881|50146743|FG002|Overall Study|Reason for not completed not specified|0|||
25044644|NCT01062555|50146760|FG000|Phase 1|Death|10|||
25044645|NCT01062555|50146761|FG001|Phase 1|Death|17|||
25044646|NCT01062555|50146762|FG002|Phase 1|Death|0|||
25044647|NCT01062555|50146763|FG003|Phase 1|Death|0|||
25044648|NCT01062555|50146760|FG000|Phase 1|Graft Failure|12|||
25044649|NCT01062555|50146761|FG001|Phase 1|Graft Failure|8|||
25044650|NCT01062555|50146762|FG002|Phase 1|Graft Failure|0|||
25044651|NCT01062555|50146763|FG003|Phase 1|Graft Failure|0|||
25044652|NCT01062555|50146760|FG000|Phase 1|Withdrawal by Subject|1|||
25044653|NCT01062555|50146761|FG001|Phase 1|Withdrawal by Subject|1|||
25044654|NCT01062555|50146762|FG002|Phase 1|Withdrawal by Subject|0|||
25044655|NCT01062555|50146763|FG003|Phase 1|Withdrawal by Subject|0|||
25044656|NCT01062555|50146760|FG000|Phase 2|Death|0|||
25044657|NCT01062555|50146761|FG001|Phase 2|Death|0|||
25044658|NCT01062555|50146762|FG002|Phase 2|Death|8|||
25044659|NCT01062555|50146763|FG003|Phase 2|Death|3|||
25044660|NCT01062555|50146760|FG000|Phase 2|Graft failure|0|||
25044661|NCT01062555|50146761|FG001|Phase 2|Graft failure|0|||
25044662|NCT01062555|50146762|FG002|Phase 2|Graft failure|7|||
25044663|NCT01062555|50146763|FG003|Phase 2|Graft failure|4|||
25044664|NCT01062555|50146760|FG000|Phase 2|Withdrawal by Subject|0|||
25044665|NCT01062555|50146761|FG001|Phase 2|Withdrawal by Subject|0|||
25044666|NCT01062555|50146762|FG002|Phase 2|Withdrawal by Subject|0|||
25044667|NCT01062555|50146763|FG003|Phase 2|Withdrawal by Subject|7|||
25044668|NCT01062555|50146760|FG000|Phase 2|Protocol Violation|0|||
25044669|NCT01062555|50146761|FG001|Phase 2|Protocol Violation|0|||
25044670|NCT01062555|50146762|FG002|Phase 2|Protocol Violation|0|||
25044671|NCT01062555|50146763|FG003|Phase 2|Protocol Violation|3|||
25044672|NCT01062555|50146760|FG000|Phase 2|Physician Decision|0|||
25044673|NCT01062555|50146761|FG001|Phase 2|Physician Decision|0|||
25044674|NCT01062555|50146762|FG002|Phase 2|Physician Decision|0|||
25044675|NCT01062555|50146763|FG003|Phase 2|Physician Decision|17|||
25044676|NCT01064817|50146775|FG000|Study Completion|Physician Decision|1|||
25044677|NCT01064817|50146776|FG001|Study Completion|Physician Decision|0|||
25044678|NCT01064817|50146775|FG000|Study Completion|Withdrawal by Subject|1|||
25044679|NCT01064817|50146776|FG001|Study Completion|Withdrawal by Subject|0|||
25044680|NCT01368276|50146784|FG000|Overall Study|Death|1|||
25044681|NCT01368276|50146785|FG001|Overall Study|Death|10|||
25044682|NCT01064739|50146791|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
25044683|NCT02741570|50146803|FG000|Pre-Treatment Period|Other reasons|0|||
25044684|NCT02741570|50146804|FG001|Pre-Treatment Period|Other reasons|3|||
25044685|NCT02741570|50146803|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
25044686|NCT02741570|50146804|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
25044687|NCT02741570|50146803|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
25044688|NCT02741570|50146804|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
25044689|NCT02741570|50146803|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
25044690|NCT02741570|50146804|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
24957757|NCT00490139|50048584|FG003|Overall Study|Participant Withdrew Consent|116|||
24957758|NCT00348140|50048599|FG000|Overall Study|Adverse Event|46|||
24957759|NCT00348140|50048600|FG001|Overall Study|Adverse Event|49|||
24957760|NCT00348140|50048601|FG002|Overall Study|Adverse Event|78|||
24957761|NCT00348140|50048599|FG000|Overall Study|Lost to Follow-up|4|||
24957762|NCT00348140|50048600|FG001|Overall Study|Lost to Follow-up|4|||
24957763|NCT00348140|50048601|FG002|Overall Study|Lost to Follow-up|4|||
24957764|NCT00348140|50048599|FG000|Overall Study|Protocol Violation|12|||
24957765|NCT00348140|50048600|FG001|Overall Study|Protocol Violation|13|||
24957766|NCT00348140|50048601|FG002|Overall Study|Protocol Violation|14|||
24957767|NCT00348140|50048599|FG000|Overall Study|Withdrawal by Subject|32|||
24957768|NCT00348140|50048600|FG001|Overall Study|Withdrawal by Subject|40|||
24957769|NCT00348140|50048601|FG002|Overall Study|Withdrawal by Subject|40|||
24957770|NCT00348140|50048599|FG000|Overall Study|Non-compliance|8|||
24957771|NCT00348140|50048600|FG001|Overall Study|Non-compliance|13|||
24957772|NCT00348140|50048601|FG002|Overall Study|Non-compliance|5|||
25044691|NCT02741570|50146803|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
25044692|NCT02741570|50146804|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
25044693|NCT02741570|50146803|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
25044694|NCT02741570|50146804|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
25044695|NCT02741570|50146803|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
25044696|NCT02741570|50146804|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
25044697|NCT02741570|50146803|FG000|Pre-Treatment Period|Death|0|||
24957773|NCT00348140|50048599|FG000|Overall Study|Participant at risk due to study drug|2|||
24957774|NCT00348140|50048600|FG001|Overall Study|Participant at risk due to study drug|0|||
25044698|NCT02741570|50146804|FG001|Pre-Treatment Period|Death|1|||
25044699|NCT02741570|50146803|FG000|Pre-Treatment Period|Disease progression|0|||
25044700|NCT02741570|50146804|FG001|Pre-Treatment Period|Disease progression|1|||
25044701|NCT02741570|50146803|FG000|Treatment Period|Other reasons|47|||
25044702|NCT02741570|50146804|FG001|Treatment Period|Other reasons|8|||
25044703|NCT02741570|50146803|FG000|Treatment Period|Poor/non-compliance|0|||
25044704|NCT02741570|50146804|FG001|Treatment Period|Poor/non-compliance|1|||
25044705|NCT02741570|50146803|FG000|Treatment Period|Maximum clinical benefit|3|||
25044706|NCT02741570|50146804|FG001|Treatment Period|Maximum clinical benefit|5|||
25044707|NCT02741570|50146803|FG000|Treatment Period|Lost to Follow-up|1|||
25044708|NCT02741570|50146804|FG001|Treatment Period|Lost to Follow-up|3|||
25044709|NCT02741570|50146803|FG000|Treatment Period|Participant withdrew consent|9|||
25044710|NCT02741570|50146804|FG001|Treatment Period|Participant withdrew consent|13|||
25044711|NCT02741570|50146803|FG000|Treatment Period|Participant request to discontinue treatment|8|||
25044712|NCT02741570|50146804|FG001|Treatment Period|Participant request to discontinue treatment|23|||
25044713|NCT02741570|50146803|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
25044714|NCT02741570|50146804|FG001|Treatment Period|Adverse event unrelated to study drug|25|||
25044715|NCT02741570|50146803|FG000|Treatment Period|Death|9|||
25044716|NCT02741570|50146804|FG001|Treatment Period|Death|7|||
25044717|NCT02741570|50146803|FG000|Treatment Period|Study drug toxicity|55|||
25044718|NCT02741570|50146804|FG001|Treatment Period|Study drug toxicity|45|||
25044719|NCT02741570|50146803|FG000|Treatment Period|Disease progression|295|||
25044720|NCT02741570|50146804|FG001|Treatment Period|Disease progression|304|||
25044721|NCT01061775|50146810|FG000|Overall Study|Physician Decision|2|||
25044722|NCT01061775|50146810|FG000|Overall Study|Lost to Follow-up|1|||
25044723|NCT02651116|50146817|FG000|Overall Study|Adverse Event|0|||
25044724|NCT02651116|50146818|FG001|Overall Study|Adverse Event|1|||
25044725|NCT02651116|50146817|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
25044726|NCT02651116|50146818|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
25044727|NCT01061385|50146826|FG000|Overall Study|Lost to Follow-up|1|||
25044728|NCT01061385|50146827|FG001|Overall Study|Lost to Follow-up|0|||
25044729|NCT01061385|50146826|FG000|Overall Study|subject decision not related to AE|0|||
25044730|NCT01061385|50146827|FG001|Overall Study|subject decision not related to AE|1|||
25044731|NCT02973477|50146836|FG000|First Intervention|Lost to Follow-up|0|||
25044732|NCT02973477|50146837|FG001|First Intervention|Lost to Follow-up|2|||
25044733|NCT02973477|50146836|FG000|Washout|Withdrawal by Subject|1|||
25044734|NCT02973477|50146837|FG001|Washout|Withdrawal by Subject|0|||
25044735|NCT02973477|50146836|FG000|Second Intervention|Lost to Follow-up|1|||
25044736|NCT02973477|50146837|FG001|Second Intervention|Lost to Follow-up|0|||
25044737|NCT02788656|50146851|FG000|Overall Study|Withdrawal by Subject|1|||
25044738|NCT02788656|50146852|FG001|Overall Study|Withdrawal by Subject|0|||
25044739|NCT00283868|50146860|FG000|Overall Study|Lost to Follow-up|7|||
25044740|NCT00283868|50146861|FG001|Overall Study|Lost to Follow-up|8|||
24957775|NCT00348140|50048601|FG002|Overall Study|Participant at risk due to study drug|0|||
24957776|NCT00348140|50048599|FG000|Overall Study|Conditional medication increased dose|1|||
24957777|NCT00348140|50048600|FG001|Overall Study|Conditional medication increased dose|0|||
24957778|NCT00348140|50048601|FG002|Overall Study|Conditional medication increased dose|0|||
24957779|NCT00348140|50048599|FG000|Overall Study|Caregiver related|4|||
24957780|NCT00348140|50048600|FG001|Overall Study|Caregiver related|7|||
24957781|NCT00348140|50048601|FG002|Overall Study|Caregiver related|3|||
24957782|NCT00348140|50048599|FG000|Overall Study|Participant hospitalised|3|||
24957783|NCT00348140|50048600|FG001|Overall Study|Participant hospitalised|0|||
24957784|NCT00348140|50048601|FG002|Overall Study|Participant hospitalised|0|||
24957785|NCT00348140|50048599|FG000|Overall Study|Efficacy related|1|||
24957786|NCT00348140|50048600|FG001|Overall Study|Efficacy related|1|||
24957787|NCT00348140|50048601|FG002|Overall Study|Efficacy related|0|||
24957788|NCT00348140|50048599|FG000|Overall Study|Administration related|3|||
24957789|NCT00348140|50048600|FG001|Overall Study|Administration related|1|||
24957790|NCT00348140|50048601|FG002|Overall Study|Administration related|1|||
24957791|NCT00348140|50048599|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
24957792|NCT00348140|50048600|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
24957793|NCT00348140|50048601|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
24957794|NCT00348140|50048599|FG000|Overall Study|Participant unwell|1|||
24957795|NCT00348140|50048600|FG001|Overall Study|Participant unwell|0|||
25044741|NCT02973087|50146867|FG000|Overall Study|Withdrawal by Subject|2|||
25044742|NCT02973087|50146868|FG001|Overall Study|Withdrawal by Subject|1|||
25044743|NCT02973087|50146867|FG000|Overall Study|Adverse Event|1|||
24957796|NCT00348140|50048601|FG002|Overall Study|Participant unwell|0|||
24957797|NCT00348140|50048599|FG000|Overall Study|Screen failure|1|||
25044744|NCT02973087|50146868|FG001|Overall Study|Adverse Event|0|||
25044745|NCT02973087|50146867|FG000|Overall Study|other|1|||
25044746|NCT02973087|50146868|FG001|Overall Study|other|1|||
24957798|NCT00348140|50048600|FG001|Overall Study|Screen failure|0|||
24957799|NCT00348140|50048601|FG002|Overall Study|Screen failure|0|||
25162440|NCT01791517|50284749|FG000|Phase I: Period 2|Lens Discomfort|0|||
24957800|NCT00348140|50048599|FG000|Overall Study|Investigator decided to discontinue|4|||
24957801|NCT00348140|50048600|FG001|Overall Study|Investigator decided to discontinue|1|||
24957802|NCT00348140|50048601|FG002|Overall Study|Investigator decided to discontinue|4|||
24957803|NCT00348140|50048599|FG000|Overall Study|Decided to discontinue on their own|1|||
24957804|NCT00348140|50048600|FG001|Overall Study|Decided to discontinue on their own|4|||
24957805|NCT00348140|50048601|FG002|Overall Study|Decided to discontinue on their own|1|||
24957806|NCT00348140|50048599|FG000|Overall Study|Use of prohibited drug|1|||
24957807|NCT00348140|50048600|FG001|Overall Study|Use of prohibited drug|0|||
24957808|NCT00348140|50048601|FG002|Overall Study|Use of prohibited drug|2|||
24957809|NCT00348140|50048599|FG000|Overall Study|Disease progression|1|||
24957810|NCT00348140|50048600|FG001|Overall Study|Disease progression|2|||
24957811|NCT00348140|50048601|FG002|Overall Study|Disease progression|5|||
24957812|NCT00348140|50048599|FG000|Overall Study|Increased risk of cardiac infarction|0|||
24957813|NCT00348140|50048600|FG001|Overall Study|Increased risk of cardiac infarction|1|||
24957814|NCT00348140|50048601|FG002|Overall Study|Increased risk of cardiac infarction|0|||
24957815|NCT00348140|50048599|FG000|Overall Study|Serious adverse event|0|||
24957816|NCT00348140|50048600|FG001|Overall Study|Serious adverse event|1|||
24957817|NCT00348140|50048601|FG002|Overall Study|Serious adverse event|0|||
24957818|NCT00348140|50048599|FG000|Overall Study|Abnormal ECG|0|||
24957819|NCT00348140|50048600|FG001|Overall Study|Abnormal ECG|1|||
24957820|NCT00348140|50048601|FG002|Overall Study|Abnormal ECG|3|||
24957821|NCT00348140|50048599|FG000|Overall Study|Participant died|0|||
24957822|NCT00348140|50048600|FG001|Overall Study|Participant died|1|||
24957823|NCT00348140|50048601|FG002|Overall Study|Participant died|0|||
24957824|NCT00348140|50048599|FG000|Overall Study|Exclusion criteria met|0|||
24957825|NCT00348140|50048600|FG001|Overall Study|Exclusion criteria met|0|||
24957826|NCT00348140|50048601|FG002|Overall Study|Exclusion criteria met|1|||
24957827|NCT00348140|50048599|FG000|Overall Study|Memory declined|0|||
24957828|NCT00348140|50048600|FG001|Overall Study|Memory declined|0|||
24957829|NCT00348140|50048601|FG002|Overall Study|Memory declined|1|||
24957830|NCT00490061|50048610|FG000|Overall Study|Physician Decision|1|||
24957831|NCT00483119|50048616|FG000|Overall Study|Adverse Event|0|||
24957832|NCT00483119|50048617|FG001|Overall Study|Adverse Event|1|||
24957833|NCT00483119|50048616|FG000|Overall Study|Physician Decision|1|||
24957834|NCT00483119|50048617|FG001|Overall Study|Physician Decision|0|||
24957835|NCT00483041|50048625|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
24957836|NCT00483041|50048626|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
24957837|NCT00501293|50048634|FG000|Optimization Period|Enrolled in error|1|||
24957838|NCT00501293|50048635|FG001|Optimization Period|Enrolled in error|0|||
24957839|NCT00501293|50048634|FG000|Maintenance Period|Withdrawal by Subject|14|||
24957840|NCT00501293|50048635|FG001|Maintenance Period|Withdrawal by Subject|13|||
24957841|NCT00501293|50048634|FG000|Maintenance Period|Lost to Follow-up|12|||
24957842|NCT00501293|50048635|FG001|Maintenance Period|Lost to Follow-up|7|||
24957843|NCT00501293|50048634|FG000|Maintenance Period|Adverse Event|6|||
24957844|NCT00501293|50048635|FG001|Maintenance Period|Adverse Event|6|||
24957845|NCT00501293|50048634|FG000|Maintenance Period|Protocol Violation|2|||
24957846|NCT00501293|50048635|FG001|Maintenance Period|Protocol Violation|1|||
24957847|NCT00501293|50048634|FG000|Maintenance Period|Lack of Efficacy|4|||
24957848|NCT00501293|50048635|FG001|Maintenance Period|Lack of Efficacy|1|||
24957849|NCT00501293|50048634|FG000|Maintenance Period|Noncompliant with study medication|5|||
24957850|NCT00501293|50048635|FG001|Maintenance Period|Noncompliant with study medication|0|||
24957851|NCT00501293|50048634|FG000|Maintenance Period|Went into rehabilitation|1|||
24957852|NCT00501293|50048635|FG001|Maintenance Period|Went into rehabilitation|0|||
24957853|NCT00501293|50048634|FG000|Maintenance Period|Would not wear patch|1|||
24957854|NCT00501293|50048635|FG001|Maintenance Period|Would not wear patch|0|||
24957855|NCT00501293|50048634|FG000|Maintenance Period|Application site reaction|1|||
24957856|NCT00501293|50048635|FG001|Maintenance Period|Application site reaction|0|||
24957857|NCT00482729|50048644|FG000|Overall Study|Adverse Event|29|||
24957858|NCT00482729|50048645|FG001|Overall Study|Adverse Event|33|||
24957859|NCT00482729|50048644|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
24957860|NCT00482729|50048645|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
24957861|NCT00482729|50048644|FG000|Overall Study|Hyperglycemia Criteria|7|||
24957862|NCT00482729|50048645|FG001|Overall Study|Hyperglycemia Criteria|5|||
24957863|NCT00482729|50048644|FG000|Overall Study|Lack of Efficacy|4|||
24957864|NCT00482729|50048645|FG001|Overall Study|Lack of Efficacy|16|||
24957865|NCT00482729|50048644|FG000|Overall Study|Lost to Follow-up|86|||
24957866|NCT00482729|50048645|FG001|Overall Study|Lost to Follow-up|66|||
24957867|NCT00482729|50048644|FG000|Overall Study|Physician Decision|10|||
24957868|NCT00482729|50048645|FG001|Overall Study|Physician Decision|7|||
24957869|NCT00482729|50048644|FG000|Overall Study|Pregnancy|4|||
24957870|NCT00482729|50048645|FG001|Overall Study|Pregnancy|2|||
24957871|NCT00482729|50048644|FG000|Overall Study|Protocol Violation|10|||
24957872|NCT00482729|50048645|FG001|Overall Study|Protocol Violation|18|||
24957873|NCT00482729|50048644|FG000|Overall Study|Withdrawal by Subject|67|||
24957874|NCT00482729|50048645|FG001|Overall Study|Withdrawal by Subject|69|||
24957875|NCT00359762|50048653|FG000|Period II|Adverse Event|17|||
24957876|NCT00359762|50048654|FG001|Period II|Adverse Event|0|||
25044747|NCT00271544|50146888|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
25044748|NCT00271544|50146888|FG000|Overall Study|Model 4196 lead not attempted|9|||
25044749|NCT00271544|50146888|FG000|Overall Study|Implant not attempted|4|||
25044750|NCT05342532|50146906|FG000|Overall Study|Adverse Event|5|||
25044751|NCT05342532|50146907|FG001|Overall Study|Adverse Event|20|||
25044752|NCT05342532|50146906|FG000|Overall Study|Lost to Follow-up|10|||
25044753|NCT05342532|50146907|FG001|Overall Study|Lost to Follow-up|15|||
25044754|NCT02971683|50146915|FG000|Overall Study|Other reasons|0|||
25044755|NCT02971683|50146916|FG001|Overall Study|Other reasons|1|||
25044756|NCT02971683|50146915|FG000|Overall Study|Poor/Non-Compliance|0|||
25044757|NCT02971683|50146916|FG001|Overall Study|Poor/Non-Compliance|1|||
25044758|NCT02971683|50146915|FG000|Overall Study|Lost to Follow-up|1|||
25044759|NCT02971683|50146916|FG001|Overall Study|Lost to Follow-up|0|||
25044760|NCT02971683|50146915|FG000|Overall Study|Participant withdrew consent|1|||
25044761|NCT02971683|50146916|FG001|Overall Study|Participant withdrew consent|1|||
25044762|NCT02971683|50146915|FG000|Overall Study|Participant request to discontinue study treatment|1|||
25044763|NCT02971683|50146916|FG001|Overall Study|Participant request to discontinue study treatment|1|||
25044764|NCT02971683|50146915|FG000|Overall Study|Adverse Event|1|||
25044765|NCT02971683|50146916|FG001|Overall Study|Adverse Event|2|||
25044766|NCT02971683|50146915|FG000|Overall Study|Lack of Efficacy|2|||
25044767|NCT02971683|50146916|FG001|Overall Study|Lack of Efficacy|2|||
25044768|NCT02984943|50146922|FG000|Overall Study|Withdrawal by Subject|3|||
25044769|NCT02984943|50146922|FG000|Overall Study|Physician Decision|1|||
25044770|NCT02787408|50146926|FG000|Overall Study|Death|16|||
25044771|NCT02787408|50146926|FG000|Overall Study|Withdrawal by Subject|1|||
25044772|NCT02787408|50146926|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
25044773|NCT02971605|50146930|FG000|Overall Study|Withdrawal by Subject|1|||
25044774|NCT03054337|50146942|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
25044775|NCT03054337|50146943|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
25044776|NCT03054337|50146944|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
25044777|NCT03054337|50146945|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
25044778|NCT03054337|50146946|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
25044779|NCT03054337|50146947|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
25044780|NCT01060059|50146980|FG000|Overall Study|Adverse Event|1|||
25044781|NCT01060059|50146981|FG001|Overall Study|Adverse Event|1|||
25044782|NCT01060059|50146980|FG000|Overall Study|Death|2|||
25044783|NCT01060059|50146981|FG001|Overall Study|Death|3|||
25044784|NCT01060059|50146980|FG000|Overall Study|Lost to Follow-up|18|||
25044785|NCT01060059|50146981|FG001|Overall Study|Lost to Follow-up|34|||
25044786|NCT01060059|50146980|FG000|Overall Study|entry criteria not met|4|||
25044787|NCT01060059|50146981|FG001|Overall Study|entry criteria not met|3|||
25044788|NCT01060059|50146980|FG000|Overall Study|Withdrawal by Subject|35|||
25044789|NCT01060059|50146981|FG001|Overall Study|Withdrawal by Subject|23|||
25044790|NCT01060059|50146980|FG000|Overall Study|lack of glycemic control|2|||
25044791|NCT01060059|50146981|FG001|Overall Study|lack of glycemic control|1|||
25044792|NCT01060059|50146980|FG000|Overall Study|lack of compliance|5|||
25044793|NCT01060059|50146981|FG001|Overall Study|lack of compliance|2|||
25044794|NCT02648932|50146995|FG000|Overall Study|No transplant|3|||
25044795|NCT02648932|50146996|FG001|Overall Study|No transplant|1|||
25044796|NCT02122458|50147009|FG000|Overall Study|Withdrawal by Subject|0|||
25044797|NCT02122458|50147010|FG001|Overall Study|Withdrawal by Subject|0|||
25044798|NCT02122458|50147011|FG002|Overall Study|Withdrawal by Subject|0|||
25044799|NCT02122458|50147012|FG003|Overall Study|Withdrawal by Subject|4|||
25044800|NCT02122458|50147013|FG004|Overall Study|Withdrawal by Subject|4|||
25044801|NCT02122458|50147014|FG005|Overall Study|Withdrawal by Subject|4|||
25044802|NCT02122458|50147015|FG006|Overall Study|Withdrawal by Subject|0|||
25044803|NCT02122458|50147009|FG000|Overall Study|Lost to Follow-up|1|||
25044804|NCT02122458|50147010|FG001|Overall Study|Lost to Follow-up|3|||
25044805|NCT02122458|50147011|FG002|Overall Study|Lost to Follow-up|0|||
25044806|NCT02122458|50147012|FG003|Overall Study|Lost to Follow-up|7|||
25044807|NCT02122458|50147013|FG004|Overall Study|Lost to Follow-up|5|||
25044808|NCT02122458|50147014|FG005|Overall Study|Lost to Follow-up|15|||
25162441|NCT01791517|50284750|FG001|Phase I: Period 2|Lens Discomfort|0|||
24957877|NCT00359762|50048655|FG002|Period II|Adverse Event|0|||
24957878|NCT00359762|50048656|FG003|Period II|Adverse Event|0|||
24957879|NCT00359762|50048657|FG004|Period II|Adverse Event|49|||
24957880|NCT00359762|50048653|FG000|Period II|Protocol Violation|18|||
24957881|NCT00359762|50048654|FG001|Period II|Protocol Violation|0|||
24957882|NCT00359762|50048655|FG002|Period II|Protocol Violation|0|||
24957883|NCT00359762|50048656|FG003|Period II|Protocol Violation|0|||
24957884|NCT00359762|50048657|FG004|Period II|Protocol Violation|11|||
24957885|NCT00359762|50048653|FG000|Period II|Physician Decision|17|||
25162442|NCT01791517|50284751|FG002|Phase I: Period 2|Lens Discomfort|0|||
25162443|NCT01791517|50284752|FG003|Phase I: Period 2|Lens Discomfort|0|||
24957886|NCT00359762|50048654|FG001|Period II|Physician Decision|0|||
24957887|NCT00359762|50048655|FG002|Period II|Physician Decision|0|||
25044809|NCT02122458|50147015|FG006|Overall Study|Lost to Follow-up|1|||
25044810|NCT02122458|50147009|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
25044811|NCT02122458|50147010|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
25044812|NCT02122458|50147011|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
25044813|NCT02122458|50147012|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
25044814|NCT02122458|50147013|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
25044815|NCT02122458|50147014|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
25044816|NCT02122458|50147015|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
25044817|NCT02122458|50147009|FG000|Overall Study|Adverse Event|1|||
25044818|NCT02122458|50147010|FG001|Overall Study|Adverse Event|0|||
25044819|NCT02122458|50147011|FG002|Overall Study|Adverse Event|0|||
25044820|NCT02122458|50147012|FG003|Overall Study|Adverse Event|0|||
25044821|NCT02122458|50147013|FG004|Overall Study|Adverse Event|0|||
25044822|NCT02122458|50147014|FG005|Overall Study|Adverse Event|0|||
25044823|NCT02122458|50147015|FG006|Overall Study|Adverse Event|0|||
25044824|NCT02122458|50147009|FG000|Overall Study|Experimental Error|0|||
25044825|NCT02122458|50147010|FG001|Overall Study|Experimental Error|0|||
25044826|NCT02122458|50147011|FG002|Overall Study|Experimental Error|0|||
25044827|NCT02122458|50147012|FG003|Overall Study|Experimental Error|0|||
25044828|NCT02122458|50147013|FG004|Overall Study|Experimental Error|3|||
25044829|NCT02122458|50147014|FG005|Overall Study|Experimental Error|0|||
25044830|NCT02122458|50147015|FG006|Overall Study|Experimental Error|0|||
25044831|NCT02122458|50147009|FG000|Overall Study|Deployed or Moved|0|||
25044832|NCT02122458|50147010|FG001|Overall Study|Deployed or Moved|0|||
25044833|NCT02122458|50147011|FG002|Overall Study|Deployed or Moved|0|||
25044834|NCT02122458|50147012|FG003|Overall Study|Deployed or Moved|0|||
25044835|NCT02122458|50147013|FG004|Overall Study|Deployed or Moved|1|||
25044836|NCT02122458|50147014|FG005|Overall Study|Deployed or Moved|0|||
25044837|NCT02122458|50147015|FG006|Overall Study|Deployed or Moved|0|||
25044838|NCT02122458|50147009|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
25044839|NCT02122458|50147010|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
25044840|NCT02122458|50147011|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
25044841|NCT02122458|50147012|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
25044842|NCT02122458|50147013|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
25044843|NCT02122458|50147014|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
25044844|NCT02122458|50147015|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
25044845|NCT02122458|50147009|FG000|Overall Study|Noncompliance|0|||
25044846|NCT02122458|50147010|FG001|Overall Study|Noncompliance|1|||
25044847|NCT02122458|50147011|FG002|Overall Study|Noncompliance|0|||
24957888|NCT00359762|50048656|FG003|Period II|Physician Decision|0|||
25044848|NCT02122458|50147012|FG003|Overall Study|Noncompliance|0|||
25044849|NCT02122458|50147013|FG004|Overall Study|Noncompliance|0|||
25044850|NCT02122458|50147014|FG005|Overall Study|Noncompliance|0|||
25044851|NCT02122458|50147015|FG006|Overall Study|Noncompliance|0|||
25044852|NCT02903511|50147031|FG000|Overall Study|Withdrawal by Subject|1|||
25044853|NCT02903511|50147032|FG001|Overall Study|Withdrawal by Subject|0|||
25044854|NCT02903511|50147031|FG000|Overall Study|Lost to Follow-up|3|||
25044855|NCT02903511|50147032|FG001|Overall Study|Lost to Follow-up|2|||
25044856|NCT01368042|50147049|FG000|Overall Study|Death|14|||
24957889|NCT00359762|50048657|FG004|Period II|Physician Decision|23|||
24957890|NCT00359762|50048653|FG000|Period II|Death|2|||
24957891|NCT00359762|50048654|FG001|Period II|Death|0|||
24957892|NCT00359762|50048655|FG002|Period II|Death|0|||
24957893|NCT00359762|50048656|FG003|Period II|Death|0|||
24957894|NCT00359762|50048657|FG004|Period II|Death|4|||
25044857|NCT01368042|50147049|FG000|Overall Study|Protocol Violation|11|||
25044858|NCT01368042|50147049|FG000|Overall Study|Lost to Follow-up|4|||
25044859|NCT01368042|50147049|FG000|Overall Study|Transplanted|1|||
25044860|NCT00126776|50147055|FG000|Overall Study|follow up complete on all patients|0|||
25044861|NCT00126776|50147056|FG001|Overall Study|follow up complete on all patients|0|||
25044862|NCT01674010|50147060|FG000|Open Treatment Phase 1|Adverse Event|10|||
25044863|NCT01674010|50147061|FG001|Open Treatment Phase 1|Adverse Event|0|||
25044864|NCT01674010|50147062|FG002|Open Treatment Phase 1|Adverse Event|0|||
25044865|NCT01674010|50147060|FG000|Open Treatment Phase 1|Death|1|||
25044866|NCT01674010|50147061|FG001|Open Treatment Phase 1|Death|0|||
25044867|NCT01674010|50147062|FG002|Open Treatment Phase 1|Death|0|||
25044868|NCT01674010|50147060|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
25044869|NCT01674010|50147061|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
25044870|NCT01674010|50147062|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
25044871|NCT01674010|50147060|FG000|Open Treatment Phase 1|Physician Decision|9|||
25276309|NCT00960934|50590273|FG002|Overall Study|Other|5|||
25044872|NCT01674010|50147061|FG001|Open Treatment Phase 1|Physician Decision|0|||
25276310|NCT00960934|50590274|FG003|Overall Study|Other|4|||
24957895|NCT00359762|50048653|FG000|Period II|Lack of Efficacy|11|||
24957896|NCT00359762|50048654|FG001|Period II|Lack of Efficacy|0|||
24957897|NCT00359762|50048655|FG002|Period II|Lack of Efficacy|0|||
25276311|NCT00960934|50590275|FG004|Overall Study|Other|2|||
25044873|NCT01674010|50147062|FG002|Open Treatment Phase 1|Physician Decision|0|||
25044874|NCT01674010|50147060|FG000|Open Treatment Phase 1|Protocol Violation|7|||
25044875|NCT01674010|50147061|FG001|Open Treatment Phase 1|Protocol Violation|0|||
25044876|NCT01674010|50147062|FG002|Open Treatment Phase 1|Protocol Violation|0|||
25044877|NCT01674010|50147060|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
25044878|NCT01674010|50147061|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
25044879|NCT01674010|50147062|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
25044880|NCT01674010|50147060|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
25044881|NCT01674010|50147061|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
25044882|NCT01674010|50147062|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
25044883|NCT01674010|50147060|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
24957898|NCT00359762|50048656|FG003|Period II|Lack of Efficacy|0|||
24957899|NCT00359762|50048657|FG004|Period II|Lack of Efficacy|8|||
24957900|NCT00359762|50048653|FG000|Period II|Lost to follow up|5|||
24957901|NCT00359762|50048654|FG001|Period II|Lost to follow up|0|||
24957902|NCT00359762|50048655|FG002|Period II|Lost to follow up|0|||
24957903|NCT00359762|50048656|FG003|Period II|Lost to follow up|0|||
24957904|NCT00359762|50048657|FG004|Period II|Lost to follow up|5|||
24957905|NCT00359762|50048653|FG000|Period II|Entry Criteria Not Met|8|||
24957906|NCT00359762|50048654|FG001|Period II|Entry Criteria Not Met|0|||
24957907|NCT00359762|50048655|FG002|Period II|Entry Criteria Not Met|0|||
24957908|NCT00359762|50048656|FG003|Period II|Entry Criteria Not Met|0|||
24957909|NCT00359762|50048657|FG004|Period II|Entry Criteria Not Met|4|||
24957910|NCT00359762|50048653|FG000|Period II|Subject Decision|50|||
24957911|NCT00359762|50048654|FG001|Period II|Subject Decision|0|||
24957912|NCT00359762|50048655|FG002|Period II|Subject Decision|0|||
24957913|NCT00359762|50048656|FG003|Period II|Subject Decision|0|||
24957914|NCT00359762|50048657|FG004|Period II|Subject Decision|70|||
24957915|NCT00359762|50048653|FG000|Period III|Protocol Violation|0|||
24957916|NCT00359762|50048654|FG001|Period III|Protocol Violation|5|||
24957917|NCT00359762|50048655|FG002|Period III|Protocol Violation|3|||
24957918|NCT00359762|50048656|FG003|Period III|Protocol Violation|8|||
25044884|NCT01674010|50147061|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
25044885|NCT01674010|50147062|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
24957919|NCT00359762|50048657|FG004|Period III|Protocol Violation|0|||
25276312|NCT00960934|50590276|FG005|Overall Study|Other|2|||
24957920|NCT00359762|50048653|FG000|Period III|Adverse Event|0|||
24957921|NCT00359762|50048654|FG001|Period III|Adverse Event|3|||
24957922|NCT00359762|50048655|FG002|Period III|Adverse Event|4|||
24957923|NCT00359762|50048656|FG003|Period III|Adverse Event|10|||
24957924|NCT00359762|50048657|FG004|Period III|Adverse Event|0|||
24957925|NCT00359762|50048653|FG000|Period III|Physician Decision|0|||
24957926|NCT00359762|50048654|FG001|Period III|Physician Decision|5|||
24957927|NCT00359762|50048655|FG002|Period III|Physician Decision|9|||
24957928|NCT00359762|50048656|FG003|Period III|Physician Decision|15|||
25044886|NCT01674010|50147060|FG000|Randomization Phase 2|Adverse Event|0|||
25044887|NCT01674010|50147061|FG001|Randomization Phase 2|Adverse Event|1|||
25044888|NCT01674010|50147062|FG002|Randomization Phase 2|Adverse Event|1|||
25044889|NCT01674010|50147060|FG000|Randomization Phase 2|Lost to Follow-up|0|||
25044890|NCT01674010|50147061|FG001|Randomization Phase 2|Lost to Follow-up|1|||
25044891|NCT01674010|50147062|FG002|Randomization Phase 2|Lost to Follow-up|2|||
25044892|NCT01674010|50147060|FG000|Randomization Phase 2|Mood episode recurrence|0|||
25044893|NCT01674010|50147061|FG001|Randomization Phase 2|Mood episode recurrence|8|||
25044894|NCT01674010|50147062|FG002|Randomization Phase 2|Mood episode recurrence|2|||
25044895|NCT01674010|50147060|FG000|Randomization Phase 2|Physician Decision|0|||
25044896|NCT01674010|50147061|FG001|Randomization Phase 2|Physician Decision|0|||
25044897|NCT01674010|50147062|FG002|Randomization Phase 2|Physician Decision|2|||
25044898|NCT01674010|50147060|FG000|Randomization Phase 2|Pregnancy|0|||
25044899|NCT01674010|50147061|FG001|Randomization Phase 2|Pregnancy|1|||
25044900|NCT01674010|50147062|FG002|Randomization Phase 2|Pregnancy|1|||
25044901|NCT01674010|50147060|FG000|Randomization Phase 2|Protocol Violation|0|||
25044902|NCT01674010|50147061|FG001|Randomization Phase 2|Protocol Violation|1|||
25044903|NCT01674010|50147062|FG002|Randomization Phase 2|Protocol Violation|1|||
24957929|NCT00359762|50048657|FG004|Period III|Physician Decision|0|||
24957930|NCT00359762|50048653|FG000|Period III|Lack of Efficacy|0|||
24957931|NCT00359762|50048654|FG001|Period III|Lack of Efficacy|7|||
24957932|NCT00359762|50048655|FG002|Period III|Lack of Efficacy|5|||
25044904|NCT01674010|50147060|FG000|Randomization Phase 2|Sponsor Decision|0|||
25044905|NCT01674010|50147061|FG001|Randomization Phase 2|Sponsor Decision|42|||
25044906|NCT01674010|50147062|FG002|Randomization Phase 2|Sponsor Decision|45|||
25044907|NCT01674010|50147060|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
25044908|NCT01674010|50147061|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
25044909|NCT01674010|50147062|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
25044910|NCT01345669|50147072|FG000|Overall Study|Primary tumour recurrence|53|||
25044911|NCT01345669|50147073|FG001|Overall Study|Primary tumour recurrence|32|||
25044912|NCT01345669|50147072|FG000|Overall Study|Second primary tumour|4|||
25044913|NCT01345669|50147073|FG001|Overall Study|Second primary tumour|3|||
25044914|NCT01345669|50147072|FG000|Overall Study|Adverse Event|63|||
25044915|NCT01345669|50147073|FG001|Overall Study|Adverse Event|9|||
25044916|NCT01345669|50147072|FG000|Overall Study|Protocol Violation|3|||
25044917|NCT01345669|50147073|FG001|Overall Study|Protocol Violation|1|||
25044918|NCT01345669|50147072|FG000|Overall Study|Lost to Follow-up|1|||
25044919|NCT01345669|50147073|FG001|Overall Study|Lost to Follow-up|1|||
25044920|NCT01345669|50147072|FG000|Overall Study|Withdrawal by Subject|52|||
25044921|NCT01345669|50147073|FG001|Overall Study|Withdrawal by Subject|13|||
25044922|NCT01345669|50147072|FG000|Overall Study|Other Reasons|111|||
25044923|NCT01345669|50147073|FG001|Overall Study|Other Reasons|60|||
25044924|NCT05334212|50147079|FG000|Overall Study|Study terminated prematurely|7|||
25044925|NCT01673854|50147083|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
25044926|NCT01673854|50147083|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
25044927|NCT01673854|50147083|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
25044928|NCT01673854|50147083|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
25044929|NCT01673854|50147083|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
25044930|NCT01673854|50147083|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
25044931|NCT01673854|50147083|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
25044932|NCT01673854|50147083|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
25044933|NCT01673854|50147083|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
25044934|NCT01673854|50147083|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
25044935|NCT01673854|50147083|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
25044936|NCT01673854|50147083|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
25044937|NCT01343407|50147087|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
24957933|NCT00359762|50048656|FG003|Period III|Lack of Efficacy|9|||
25044938|NCT01343407|50147088|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
25044939|NCT01343407|50147089|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
25044940|NCT01343407|50147090|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
25044941|NCT01343407|50147091|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
25044942|NCT01343407|50147092|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
25044943|NCT01343407|50147087|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
25044944|NCT01343407|50147088|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
25044945|NCT01343407|50147089|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
25276313|NCT00960934|50590271|FG000|Overall Study|Physician Decision|0|||
24957934|NCT00359762|50048657|FG004|Period III|Lack of Efficacy|0|||
24957935|NCT00359762|50048653|FG000|Period III|Lost to follow up|0|||
24957936|NCT00359762|50048654|FG001|Period III|Lost to follow up|1|||
24957937|NCT00359762|50048655|FG002|Period III|Lost to follow up|1|||
24957938|NCT00359762|50048656|FG003|Period III|Lost to follow up|2|||
24957939|NCT00359762|50048657|FG004|Period III|Lost to follow up|0|||
24957940|NCT00359762|50048653|FG000|Period III|Entry Criteria Not Met|0|||
24957941|NCT00359762|50048654|FG001|Period III|Entry Criteria Not Met|1|||
24957942|NCT00359762|50048655|FG002|Period III|Entry Criteria Not Met|0|||
24957943|NCT00359762|50048656|FG003|Period III|Entry Criteria Not Met|1|||
24957944|NCT00359762|50048657|FG004|Period III|Entry Criteria Not Met|0|||
24957945|NCT00359762|50048653|FG000|Period III|Subject Decision|0|||
24957946|NCT00359762|50048654|FG001|Period III|Subject Decision|7|||
24957947|NCT00359762|50048655|FG002|Period III|Subject Decision|8|||
24957948|NCT00359762|50048656|FG003|Period III|Subject Decision|20|||
24957949|NCT00359762|50048657|FG004|Period III|Subject Decision|0|||
24957950|NCT00347438|50048671|FG000|Overall Study|Withdrawal by Subject|1|||
24957951|NCT00347438|50048671|FG000|Overall Study|Physician Decision|1|||
24957952|NCT00329238|50048677|FG000|Overall Study|Adverse Event|147|||
24957953|NCT00329238|50048678|FG001|Overall Study|Adverse Event|129|||
24957954|NCT00329238|50048677|FG000|Overall Study|Protocol Violation|23|||
24957955|NCT00329238|50048678|FG001|Overall Study|Protocol Violation|34|||
24957956|NCT00329238|50048677|FG000|Overall Study|Lost to Follow-up|2|||
24957957|NCT00329238|50048678|FG001|Overall Study|Lost to Follow-up|6|||
24957958|NCT00329238|50048677|FG000|Overall Study|Withdrawal by Subject|64|||
24957959|NCT00329238|50048678|FG001|Overall Study|Withdrawal by Subject|58|||
24957960|NCT00329238|50048677|FG000|Overall Study|Other reason (not specified)|40|||
24957961|NCT00329238|50048678|FG001|Overall Study|Other reason (not specified)|54|||
24957962|NCT00329160|50048686|FG000|Overall Study|Adverse Event|27|||
24957963|NCT00329160|50048686|FG000|Overall Study|Withdrawal by Subject|13|||
24957964|NCT00329160|50048686|FG000|Overall Study|Protocol Violation|2|||
24957965|NCT00329160|50048686|FG000|Overall Study|Did not Receive Study Drug|1|||
24957966|NCT00329160|50048686|FG000|Overall Study|Incomplete IVUS|45|||
24957967|NCT00328926|50048693|FG000|Overall Study|Pregnancy|2|||
24957968|NCT00328926|50048694|FG001|Overall Study|Pregnancy|1|||
24957969|NCT00328926|50048695|FG002|Overall Study|Pregnancy|0|||
24957970|NCT00328926|50048693|FG000|Overall Study|Lost to Follow-up|0|||
24957971|NCT00328926|50048694|FG001|Overall Study|Lost to Follow-up|1|||
24957972|NCT00328926|50048695|FG002|Overall Study|Lost to Follow-up|0|||
24957973|NCT00328926|50048693|FG000|Overall Study|Death|0|||
24957974|NCT00328926|50048694|FG001|Overall Study|Death|0|||
24957975|NCT00328926|50048695|FG002|Overall Study|Death|1|||
24957976|NCT00328926|50048693|FG000|Overall Study|In vitro fertilization treatment|0|||
24957977|NCT00328926|50048694|FG001|Overall Study|In vitro fertilization treatment|0|||
24957978|NCT00328926|50048695|FG002|Overall Study|In vitro fertilization treatment|1|||
24957979|NCT00328926|50048693|FG000|Overall Study|Lack of ovarian response|0|||
24957980|NCT00328926|50048694|FG001|Overall Study|Lack of ovarian response|1|||
24957981|NCT00328926|50048695|FG002|Overall Study|Lack of ovarian response|0|||
24957982|NCT00319254|50048703|FG000|Overall Study|Withdrawal by Subject|4|||
24957983|NCT00319254|50048703|FG000|Overall Study|Death|46|||
24957984|NCT00319254|50048703|FG000|Overall Study|Lost to Follow-up|2|||
24957985|NCT00319254|50048703|FG000|Overall Study|Enrolled, Not Treated|2|||
24957986|NCT00319098|50048711|FG000|Overall Study|Serious adverse event|3|||
24957987|NCT00319098|50048712|FG001|Overall Study|Serious adverse event|0|||
24957988|NCT00319098|50048711|FG000|Overall Study|Adverse Event|20|||
24957989|NCT00319098|50048712|FG001|Overall Study|Adverse Event|1|||
24957990|NCT00319098|50048711|FG000|Overall Study|Withdrawal by Subject|37|||
24957991|NCT00319098|50048712|FG001|Overall Study|Withdrawal by Subject|8|||
24957992|NCT00319098|50048711|FG000|Overall Study|Migrated/moved from study area|2|||
24957993|NCT00319098|50048712|FG001|Overall Study|Migrated/moved from study area|1|||
24957994|NCT00319098|50048711|FG000|Overall Study|Lost to Follow-up|37|||
24957995|NCT00319098|50048712|FG001|Overall Study|Lost to Follow-up|13|||
24957996|NCT00319098|50048711|FG000|Overall Study|Others|33|||
24957997|NCT00319098|50048712|FG001|Overall Study|Others|8|||
24957998|NCT00319098|50048711|FG000|Overall Study|Protocol Violation|3|||
24957999|NCT00319098|50048712|FG001|Overall Study|Protocol Violation|1|||
24958000|NCT00347360|50048737|FG000|Overall Study|Adverse Event|1|||
24958001|NCT00347360|50048738|FG001|Overall Study|Adverse Event|2|||
24958002|NCT00347360|50048739|FG002|Overall Study|Adverse Event|0|||
24958003|NCT00347360|50048740|FG003|Overall Study|Adverse Event|4|||
24958004|NCT00347360|50048741|FG004|Overall Study|Adverse Event|1|||
24958005|NCT00347360|50048742|FG005|Overall Study|Adverse Event|2|||
24958006|NCT00347360|50048743|FG006|Overall Study|Adverse Event|2|||
24958007|NCT00347360|50048744|FG007|Overall Study|Adverse Event|0|||
24958008|NCT00347360|50048745|FG008|Overall Study|Adverse Event|2|||
24958009|NCT00347360|50048746|FG009|Overall Study|Adverse Event|3|||
24958010|NCT00347360|50048747|FG010|Overall Study|Adverse Event|3|||
24958011|NCT00347360|50048748|FG011|Overall Study|Adverse Event|1|||
24958012|NCT00347360|50048749|FG012|Overall Study|Adverse Event|3|||
24958013|NCT00347360|50048750|FG013|Overall Study|Adverse Event|2|||
24958014|NCT00347360|50048751|FG014|Overall Study|Adverse Event|2|||
24958015|NCT00347360|50048737|FG000|Overall Study|Lost to Follow-up|0|||
24958016|NCT00347360|50048738|FG001|Overall Study|Lost to Follow-up|0|||
25044946|NCT01343407|50147090|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
25044947|NCT01343407|50147091|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
25044948|NCT01343407|50147092|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
25044949|NCT01367886|50147100|FG000|Overall Study|Lost to Follow-up|4|||
25044950|NCT01367886|50147100|FG000|Overall Study|Lack of Efficacy|2|||
25044951|NCT01367886|50147100|FG000|Overall Study|Death|1|||
25044952|NCT01673698|50147107|FG000|Overall Study|Lost to Follow-up|51|||
25044953|NCT01673698|50147108|FG001|Overall Study|Lost to Follow-up|13|||
25044954|NCT02786004|50147117|FG000|Overall Study|Withdrawal by Subject|0|||
25044955|NCT02786004|50147118|FG001|Overall Study|Withdrawal by Subject|1|||
25044956|NCT03051607|50147126|FG000|Overall Study|Adverse Event|66|||
25044957|NCT01062399|50147135|FG000|Overall Study|Protocol Violation|0|||
25044958|NCT01062399|50147136|FG001|Overall Study|Protocol Violation|1|||
25044959|NCT01062399|50147137|FG002|Overall Study|Protocol Violation|0|||
25044960|NCT01062399|50147138|FG003|Overall Study|Protocol Violation|6|||
25044961|NCT01062399|50147139|FG004|Overall Study|Protocol Violation|4|||
25044962|NCT01317277|50147153|FG000|Overall Study|Lost to Follow-up|3|||
25044963|NCT01317277|50147154|FG001|Overall Study|Lost to Follow-up|1|||
25044964|NCT01317277|50147153|FG000|Overall Study|Lost MEMS|1|||
25044965|NCT01317277|50147154|FG001|Overall Study|Lost MEMS|1|||
25044966|NCT01317277|50147153|FG000|Overall Study|Unable to comply with intervention|1|||
25044967|NCT01317277|50147154|FG001|Overall Study|Unable to comply with intervention|0|||
25044968|NCT01317277|50147153|FG000|Overall Study|Withdrawal by Subject|1|||
25044969|NCT01317277|50147154|FG001|Overall Study|Withdrawal by Subject|0|||
25044970|NCT01317277|50147153|FG000|Overall Study|Adverse Event|1|||
25044971|NCT01317277|50147154|FG001|Overall Study|Adverse Event|0|||
25044972|NCT02740478|50147160|FG000|Overall Study|Withdrawal by Subject|1|||
25044973|NCT02969655|50147166|FG000|Overall Study|Withdrawal by Subject|3|||
25044974|NCT02969655|50147167|FG001|Overall Study|Withdrawal by Subject|2|||
25044975|NCT02969655|50147166|FG000|Overall Study|Physician Decision|4|||
25044976|NCT02969655|50147167|FG001|Overall Study|Physician Decision|3|||
25044977|NCT02969655|50147166|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
25044978|NCT02969655|50147167|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
25044979|NCT02969655|50147166|FG000|Overall Study|Adverse Event|10|||
25044980|NCT02969655|50147167|FG001|Overall Study|Adverse Event|8|||
25044981|NCT01317199|50147178|FG000|Dose-escalation Phase 1|Physician Decision|5|||
25044982|NCT01317199|50147179|FG001|Dose-escalation Phase 1|Physician Decision|0|||
25044983|NCT01317199|50147180|FG002|Dose-escalation Phase 1|Physician Decision|0|||
25044984|NCT01317199|50147181|FG003|Dose-escalation Phase 1|Physician Decision|0|||
25044985|NCT01317199|50147178|FG000|Dose-escalation Phase 1|Disease progression|1|||
25044986|NCT01317199|50147179|FG001|Dose-escalation Phase 1|Disease progression|0|||
25044987|NCT01317199|50147180|FG002|Dose-escalation Phase 1|Disease progression|0|||
25044988|NCT01317199|50147181|FG003|Dose-escalation Phase 1|Disease progression|0|||
25044989|NCT01317199|50147178|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
25044990|NCT01317199|50147179|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
25044991|NCT01317199|50147180|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
25044992|NCT01317199|50147181|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
25044993|NCT01317199|50147178|FG000|Randomized Phase 2|Disease progression|0|||
25044994|NCT01317199|50147179|FG001|Randomized Phase 2|Disease progression|3|||
25044995|NCT01317199|50147180|FG002|Randomized Phase 2|Disease progression|7|||
25044996|NCT01317199|50147181|FG003|Randomized Phase 2|Disease progression|5|||
25044997|NCT01317199|50147178|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
25044998|NCT01317199|50147179|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
25044999|NCT01317199|50147180|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
25045000|NCT01317199|50147181|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
25045001|NCT01317199|50147178|FG000|Randomized Phase 2|Adverse Event|0|||
25162444|NCT01791517|50284753|FG004|Phase I: Period 2|Lens Discomfort|0|||
25276314|NCT00960934|50590272|FG001|Overall Study|Physician Decision|1|||
24958017|NCT00347360|50048739|FG002|Overall Study|Lost to Follow-up|0|||
24958018|NCT00347360|50048740|FG003|Overall Study|Lost to Follow-up|2|||
24958019|NCT00347360|50048741|FG004|Overall Study|Lost to Follow-up|1|||
24958020|NCT00347360|50048742|FG005|Overall Study|Lost to Follow-up|1|||
24958021|NCT00347360|50048743|FG006|Overall Study|Lost to Follow-up|0|||
24958022|NCT00347360|50048744|FG007|Overall Study|Lost to Follow-up|1|||
24958023|NCT00347360|50048745|FG008|Overall Study|Lost to Follow-up|1|||
24958024|NCT00347360|50048746|FG009|Overall Study|Lost to Follow-up|2|||
24958025|NCT00347360|50048747|FG010|Overall Study|Lost to Follow-up|0|||
25045002|NCT01317199|50147179|FG001|Randomized Phase 2|Adverse Event|0|||
25045003|NCT01317199|50147180|FG002|Randomized Phase 2|Adverse Event|0|||
25045004|NCT01317199|50147181|FG003|Randomized Phase 2|Adverse Event|1|||
25045005|NCT01317199|50147178|FG000|Randomized Phase 2|Comorbidities|0|||
25045006|NCT01317199|50147179|FG001|Randomized Phase 2|Comorbidities|2|||
24958026|NCT00347360|50048748|FG011|Overall Study|Lost to Follow-up|0|||
24958027|NCT00347360|50048749|FG012|Overall Study|Lost to Follow-up|1|||
24958028|NCT00347360|50048750|FG013|Overall Study|Lost to Follow-up|0|||
24958029|NCT00347360|50048751|FG014|Overall Study|Lost to Follow-up|0|||
25045007|NCT01317199|50147180|FG002|Randomized Phase 2|Comorbidities|2|||
25045008|NCT01317199|50147181|FG003|Randomized Phase 2|Comorbidities|2|||
25045009|NCT01317199|50147178|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
25045010|NCT01317199|50147179|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
25045011|NCT01317199|50147180|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
25045012|NCT01317199|50147181|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
25045013|NCT01317199|50147178|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
25045014|NCT01317199|50147179|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
25045015|NCT01317199|50147180|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
25045016|NCT01317199|50147181|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
25045017|NCT01317199|50147178|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
25045018|NCT01317199|50147179|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
25045019|NCT01317199|50147180|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
25045020|NCT01317199|50147181|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
25045021|NCT01317199|50147178|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
25045022|NCT01317199|50147179|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
25045023|NCT01317199|50147180|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
25045024|NCT01317199|50147181|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
25045025|NCT02648698|50147200|FG000|Overall Study|Protocol Violation|1|||
25045026|NCT02648698|50147201|FG001|Overall Study|Protocol Violation|5|||
25045027|NCT02970669|50147209|FG000|Double-blind Period|Adverse Event|4|||
25045028|NCT02970669|50147210|FG001|Double-blind Period|Adverse Event|0|||
25045029|NCT02970669|50147209|FG000|Double-blind Period|Death|1|||
25045030|NCT02970669|50147210|FG001|Double-blind Period|Death|0|||
25045031|NCT02970669|50147209|FG000|Double-blind Period|Study terminated by sponsor|1|||
25045032|NCT02970669|50147210|FG001|Double-blind Period|Study terminated by sponsor|2|||
25045033|NCT02970669|50147209|FG000|Double-blind Period|Physician Decision|0|||
25045034|NCT02970669|50147210|FG001|Double-blind Period|Physician Decision|2|||
25045035|NCT02970669|50147209|FG000|Double-blind Period|Withdrawal by Subject|2|||
25045036|NCT02970669|50147210|FG001|Double-blind Period|Withdrawal by Subject|2|||
25045037|NCT02970669|50147209|FG000|Open-label Period|Withdrawal by Subject|2|||
25045038|NCT02970669|50147210|FG001|Open-label Period|Withdrawal by Subject|2|||
25045039|NCT02970669|50147209|FG000|Open-label Period|Adverse Event|1|||
25045040|NCT02970669|50147210|FG001|Open-label Period|Adverse Event|0|||
25045041|NCT02970669|50147209|FG000|Open-label Period|Physician Decision|1|||
25045042|NCT02970669|50147210|FG001|Open-label Period|Physician Decision|0|||
25045043|NCT02902965|50147218|FG000|Overall Study|Withdrawal by Subject|10|||
25045044|NCT02902809|50147223|FG000|Overall Study|Discontinuation of asthma program|28|||
25045045|NCT01362244|50147229|FG000|Overall Study|Adverse Event|3|||
25045046|NCT01362244|50147230|FG001|Overall Study|Adverse Event|5|||
25045047|NCT01362244|50147229|FG000|Overall Study|Lack of Efficacy|5|||
25045048|NCT01362244|50147230|FG001|Overall Study|Lack of Efficacy|11|||
25045049|NCT01362244|50147229|FG000|Overall Study|Lost to Follow-up|0|||
25045050|NCT01362244|50147230|FG001|Overall Study|Lost to Follow-up|2|||
25045051|NCT01362244|50147229|FG000|Overall Study|Protocol Violation|5|||
25045052|NCT01362244|50147230|FG001|Overall Study|Protocol Violation|1|||
25045053|NCT01362244|50147229|FG000|Overall Study|Withdrawal by Subject|2|||
25045054|NCT01362244|50147230|FG001|Overall Study|Withdrawal by Subject|1|||
25276315|NCT00960934|50590273|FG002|Overall Study|Physician Decision|0|||
24958030|NCT00347360|50048737|FG000|Overall Study|Protocol Violation|2|||
24958031|NCT00347360|50048738|FG001|Overall Study|Protocol Violation|3|||
24958032|NCT00347360|50048739|FG002|Overall Study|Protocol Violation|1|||
24958033|NCT00347360|50048740|FG003|Overall Study|Protocol Violation|2|||
24958034|NCT00347360|50048741|FG004|Overall Study|Protocol Violation|1|||
24958035|NCT00347360|50048742|FG005|Overall Study|Protocol Violation|2|||
24958036|NCT00347360|50048743|FG006|Overall Study|Protocol Violation|0|||
24958037|NCT00347360|50048744|FG007|Overall Study|Protocol Violation|0|||
24958038|NCT00347360|50048745|FG008|Overall Study|Protocol Violation|1|||
24958039|NCT00347360|50048746|FG009|Overall Study|Protocol Violation|2|||
24958040|NCT00347360|50048747|FG010|Overall Study|Protocol Violation|0|||
24958041|NCT00347360|50048748|FG011|Overall Study|Protocol Violation|0|||
24958042|NCT00347360|50048749|FG012|Overall Study|Protocol Violation|0|||
25045055|NCT01362244|50147229|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
25045056|NCT01362244|50147230|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
25045057|NCT01362244|50147229|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
25045058|NCT01362244|50147230|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
25045059|NCT02969187|50147238|FG000|Overall Study|Physician Decision|12|||
25045060|NCT02969187|50147239|FG001|Overall Study|Physician Decision|13|||
25045061|NCT03050359|50147249|FG000|Overall Study|Randomized But Not Treated|2|||
25045062|NCT03050359|50147250|FG001|Overall Study|Randomized But Not Treated|0|||
25045063|NCT03050359|50147249|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
25045064|NCT03050359|50147250|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
25045065|NCT03050359|50147249|FG000|Overall Study|Significant Protocol Deviation|2|||
25045066|NCT03050359|50147250|FG001|Overall Study|Significant Protocol Deviation|3|||
25045067|NCT03050359|50147249|FG000|Overall Study|Lost to Follow-up|2|||
25045068|NCT03050359|50147250|FG001|Overall Study|Lost to Follow-up|1|||
25045069|NCT03050359|50147249|FG000|Overall Study|Voluntary Withdrawal|4|||
25045070|NCT03050359|50147250|FG001|Overall Study|Voluntary Withdrawal|6|||
25045071|NCT03050359|50147249|FG000|Overall Study|Pregnancy|1|||
25045072|NCT03050359|50147250|FG001|Overall Study|Pregnancy|0|||
25045073|NCT03050359|50147249|FG000|Overall Study|Reason Not Specified|1|||
25045074|NCT03050359|50147250|FG001|Overall Study|Reason Not Specified|0|||
25045075|NCT02785770|50147258|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
25045076|NCT02785770|50147259|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
25045077|NCT02785770|50147260|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
25045078|NCT02785770|50147261|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
25045079|NCT02785770|50147258|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
25045080|NCT02785770|50147259|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
25045081|NCT02785770|50147260|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
25045082|NCT02785770|50147261|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
25045083|NCT02785770|50147258|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
25045084|NCT02785770|50147259|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
25045085|NCT02785770|50147260|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
25045086|NCT02785770|50147261|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
25045087|NCT02965833|50147274|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
24958043|NCT00347360|50048750|FG013|Overall Study|Protocol Violation|1|||
24958044|NCT00347360|50048751|FG014|Overall Study|Protocol Violation|0|||
24958045|NCT00347360|50048737|FG000|Overall Study|Withdrawal by Subject|0|||
24958046|NCT00347360|50048738|FG001|Overall Study|Withdrawal by Subject|1|||
24958047|NCT00347360|50048739|FG002|Overall Study|Withdrawal by Subject|2|||
24958048|NCT00347360|50048740|FG003|Overall Study|Withdrawal by Subject|4|||
25045088|NCT02965833|50147275|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
25045089|NCT02965833|50147274|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
25045090|NCT02965833|50147275|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
25045091|NCT02965833|50147274|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
25045092|NCT02965833|50147275|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
25045093|NCT02965833|50147274|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
25045094|NCT02965833|50147275|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
25045095|NCT02965833|50147274|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
25045096|NCT02965833|50147275|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
25045097|NCT02968173|50147281|FG000|Overall Study|Withdrawal by Subject|1|||
25045098|NCT02785458|50147288|FG000|1 Month|Withdrawal by Subject|2|||
25045099|NCT02785458|50147289|FG001|1 Month|Withdrawal by Subject|1|||
25045100|NCT02785458|50147288|FG000|1 Month|Lost to Follow-up|38|||
25045101|NCT02785458|50147289|FG001|1 Month|Lost to Follow-up|31|||
24958049|NCT00347360|50048741|FG004|Overall Study|Withdrawal by Subject|1|||
24958050|NCT00347360|50048742|FG005|Overall Study|Withdrawal by Subject|2|||
24958051|NCT00347360|50048743|FG006|Overall Study|Withdrawal by Subject|1|||
24958052|NCT00347360|50048744|FG007|Overall Study|Withdrawal by Subject|1|||
24958053|NCT00347360|50048745|FG008|Overall Study|Withdrawal by Subject|1|||
24958054|NCT00347360|50048746|FG009|Overall Study|Withdrawal by Subject|1|||
24958055|NCT00347360|50048747|FG010|Overall Study|Withdrawal by Subject|0|||
24958056|NCT00347360|50048748|FG011|Overall Study|Withdrawal by Subject|3|||
24958057|NCT00347360|50048749|FG012|Overall Study|Withdrawal by Subject|4|||
25045102|NCT02785458|50147288|FG000|1 Month|Deemed Ineligible|1|||
25045103|NCT02785458|50147289|FG001|1 Month|Deemed Ineligible|0|||
25045104|NCT02785458|50147288|FG000|1 Month|Completed Evaluation by Baseline|42|||
25045105|NCT02785458|50147289|FG001|1 Month|Completed Evaluation by Baseline|39|||
25045106|NCT02785458|50147288|FG000|1 Month|Partial Interview|0|||
25045107|NCT02785458|50147289|FG001|1 Month|Partial Interview|4|||
25045108|NCT02785458|50147288|FG000|3 Months|Withdrawal by Subject|3|||
24958058|NCT00347360|50048750|FG013|Overall Study|Withdrawal by Subject|2|||
25045109|NCT02785458|50147289|FG001|3 Months|Withdrawal by Subject|1|||
25045110|NCT02785458|50147288|FG000|3 Months|Lost to Follow-up|25|||
25276316|NCT00960934|50590274|FG003|Overall Study|Physician Decision|0|||
24958059|NCT00347360|50048751|FG014|Overall Study|Withdrawal by Subject|1|||
25045111|NCT02785458|50147289|FG001|3 Months|Lost to Follow-up|21|||
25045112|NCT02785458|50147288|FG000|3 Months|Completed Evaluation at 1 Month|100|||
25045113|NCT02785458|50147289|FG001|3 Months|Completed Evaluation at 1 Month|89|||
25045114|NCT02784834|50147295|FG000|Overall Study|Lack of Efficacy|1|||
25045115|NCT02966223|50147312|FG000|Overall Study|Physician Decision|3|||
25045116|NCT02966223|50147312|FG000|Overall Study|Withdrawal by Subject|11|||
25045117|NCT02966223|50147312|FG000|Overall Study|Lost to Follow-up|1|||
25045118|NCT03049735|50147319|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
25045119|NCT03049735|50147320|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
25045120|NCT03049735|50147321|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
25045121|NCT03049735|50147319|FG000|Overall Study|Other|5|||
25045122|NCT03049735|50147320|FG001|Overall Study|Other|3|||
25045123|NCT03049735|50147321|FG002|Overall Study|Other|1|||
25045124|NCT03049735|50147319|FG000|Overall Study|Lack of Efficacy|4|||
25045125|NCT03049735|50147320|FG001|Overall Study|Lack of Efficacy|0|||
25045126|NCT03049735|50147321|FG002|Overall Study|Lack of Efficacy|3|||
25045127|NCT03049735|50147319|FG000|Overall Study|Protocol deviation|1|||
25045128|NCT03049735|50147320|FG001|Overall Study|Protocol deviation|0|||
25045129|NCT03049735|50147321|FG002|Overall Study|Protocol deviation|0|||
25045130|NCT03049735|50147319|FG000|Overall Study|Pregnancy|0|||
25045131|NCT03049735|50147320|FG001|Overall Study|Pregnancy|0|||
25045132|NCT03049735|50147321|FG002|Overall Study|Pregnancy|1|||
25045133|NCT03049735|50147319|FG000|Overall Study|Adverse Event|7|||
25045134|NCT03049735|50147320|FG001|Overall Study|Adverse Event|18|||
25045135|NCT03049735|50147321|FG002|Overall Study|Adverse Event|5|||
25045136|NCT03049735|50147319|FG000|Overall Study|Withdrawal by Subject|10|||
25045137|NCT03049735|50147320|FG001|Overall Study|Withdrawal by Subject|3|||
25045138|NCT03049735|50147321|FG002|Overall Study|Withdrawal by Subject|7|||
25045139|NCT03049735|50147319|FG000|Overall Study|Lost to Follow-up|1|||
25045140|NCT03049735|50147320|FG001|Overall Study|Lost to Follow-up|5|||
25045141|NCT03049735|50147321|FG002|Overall Study|Lost to Follow-up|5|||
25045142|NCT01295944|50147329|FG000|Overall Study|Switched to alternative treatment|1|||
24958060|NCT00347360|50048737|FG000|Overall Study|Lack of Efficacy|1|||
24958061|NCT00347360|50048738|FG001|Overall Study|Lack of Efficacy|1|||
24958062|NCT00347360|50048739|FG002|Overall Study|Lack of Efficacy|3|||
24958063|NCT00347360|50048740|FG003|Overall Study|Lack of Efficacy|1|||
24958064|NCT00347360|50048741|FG004|Overall Study|Lack of Efficacy|0|||
24958065|NCT00347360|50048742|FG005|Overall Study|Lack of Efficacy|1|||
24958066|NCT00347360|50048743|FG006|Overall Study|Lack of Efficacy|0|||
24958067|NCT00347360|50048744|FG007|Overall Study|Lack of Efficacy|1|||
25045143|NCT01295944|50147329|FG000|Overall Study|Ineligible|9|||
25045144|NCT01295944|50147329|FG000|Overall Study|Withdrawal by Subject|4|||
25045145|NCT01295944|50147329|FG000|Overall Study|Participant chose to be treated in Peru|1|||
25045146|NCT01295944|50147329|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
25045147|NCT01295944|50147329|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
25045148|NCT01295944|50147329|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
25045149|NCT02965599|50147335|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
25045150|NCT02965599|50147336|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
25045151|NCT02898597|50147345|FG000|Overall Study|Protocol Violation|4|||
25045152|NCT02898597|50147346|FG001|Overall Study|Protocol Violation|2|||
25045153|NCT02898597|50147345|FG000|Overall Study|Lost to Follow-up|0|||
25045154|NCT02898597|50147346|FG001|Overall Study|Lost to Follow-up|9|||
25045155|NCT02898597|50147345|FG000|Overall Study|Death|0|||
25045156|NCT02898597|50147346|FG001|Overall Study|Death|1|||
25045157|NCT02899377|50147354|FG000|Overall Study|Adverse Event|1|||
25045158|NCT02899377|50147355|FG001|Overall Study|Adverse Event|0|||
25045159|NCT01316887|50147366|FG000|Overall Study|Adverse Event|13|||
25276317|NCT00960934|50590275|FG004|Overall Study|Physician Decision|0|||
24958068|NCT00347360|50048745|FG008|Overall Study|Lack of Efficacy|1|||
24958069|NCT00347360|50048746|FG009|Overall Study|Lack of Efficacy|0|||
24958070|NCT00347360|50048747|FG010|Overall Study|Lack of Efficacy|0|||
24958071|NCT00347360|50048748|FG011|Overall Study|Lack of Efficacy|0|||
24958072|NCT00347360|50048749|FG012|Overall Study|Lack of Efficacy|0|||
24958073|NCT00347360|50048750|FG013|Overall Study|Lack of Efficacy|0|||
24958074|NCT00347360|50048751|FG014|Overall Study|Lack of Efficacy|0|||
24958075|NCT00347360|50048737|FG000|Overall Study|Reason not listed/blank|1|||
24958076|NCT00347360|50048738|FG001|Overall Study|Reason not listed/blank|0|||
24958077|NCT00347360|50048739|FG002|Overall Study|Reason not listed/blank|0|||
24958078|NCT00347360|50048740|FG003|Overall Study|Reason not listed/blank|0|||
24958079|NCT00347360|50048741|FG004|Overall Study|Reason not listed/blank|0|||
24958080|NCT00347360|50048742|FG005|Overall Study|Reason not listed/blank|0|||
24958081|NCT00347360|50048743|FG006|Overall Study|Reason not listed/blank|1|||
24958082|NCT00347360|50048744|FG007|Overall Study|Reason not listed/blank|0|||
24958083|NCT00347360|50048745|FG008|Overall Study|Reason not listed/blank|0|||
25045160|NCT01316887|50147367|FG001|Overall Study|Adverse Event|21|||
25045161|NCT01316887|50147368|FG002|Overall Study|Adverse Event|17|||
25045162|NCT01316887|50147366|FG000|Overall Study|Lack of Efficacy|9|||
25045163|NCT01316887|50147367|FG001|Overall Study|Lack of Efficacy|3|||
25045164|NCT01316887|50147368|FG002|Overall Study|Lack of Efficacy|1|||
25045165|NCT01316887|50147366|FG000|Overall Study|Protocol Violation|2|||
25045166|NCT01316887|50147367|FG001|Overall Study|Protocol Violation|6|||
25045167|NCT01316887|50147368|FG002|Overall Study|Protocol Violation|6|||
25045168|NCT01316887|50147366|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
25045169|NCT01316887|50147367|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
25045170|NCT01316887|50147368|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
25045171|NCT01316887|50147366|FG000|Overall Study|Study Closed/Terminated|2|||
25045172|NCT01316887|50147367|FG001|Overall Study|Study Closed/Terminated|4|||
25045173|NCT01316887|50147368|FG002|Overall Study|Study Closed/Terminated|3|||
25045174|NCT01316887|50147366|FG000|Overall Study|Lost to Follow-up|1|||
25045175|NCT01316887|50147367|FG001|Overall Study|Lost to Follow-up|7|||
25045176|NCT01316887|50147368|FG002|Overall Study|Lost to Follow-up|5|||
25045177|NCT01316887|50147366|FG000|Overall Study|Withdrawal by Subject|8|||
25045178|NCT01316887|50147367|FG001|Overall Study|Withdrawal by Subject|16|||
25045179|NCT01316887|50147368|FG002|Overall Study|Withdrawal by Subject|15|||
25045180|NCT02897349|50147379|FG000|Overall Study|Lost to Follow-up|2|||
25045181|NCT02897349|50147380|FG001|Overall Study|Lost to Follow-up|2|||
25045182|NCT02897349|50147379|FG000|Overall Study|Adverse Event|3|||
25045183|NCT02897349|50147380|FG001|Overall Study|Adverse Event|3|||
25045184|NCT02897349|50147379|FG000|Overall Study|Other than listed above|0|||
25045185|NCT02897349|50147380|FG001|Overall Study|Other than listed above|1|||
25045186|NCT03047551|50147388|FG000|Overall Study|Did not receive TAS|1|||
25045187|NCT03047551|50147389|FG001|Overall Study|Did not receive TAS|0|||
25045188|NCT03047551|50147388|FG000|Overall Study|Physician Decision|1|||
25045189|NCT03047551|50147389|FG001|Overall Study|Physician Decision|0|||
25045190|NCT03047551|50147388|FG000|Overall Study|Withdrawal by Subject|0|||
25045191|NCT03047551|50147389|FG001|Overall Study|Withdrawal by Subject|1|||
25045192|NCT03047551|50147388|FG000|Overall Study|Probe malfunction|0|||
25045193|NCT03047551|50147389|FG001|Overall Study|Probe malfunction|1|||
25045194|NCT03047551|50147388|FG000|Overall Study|Ineligible|0|||
25045195|NCT03047551|50147389|FG001|Overall Study|Ineligible|1|||
25045196|NCT02964741|50147398|FG000|Overall Study|Protocol Violation|1|||
25045197|NCT02964741|50147399|FG001|Overall Study|Protocol Violation|0|||
25045198|NCT02964741|50147400|FG002|Overall Study|Protocol Violation|0|||
25045199|NCT02964741|50147398|FG000|Overall Study|Withdrawal by Subject|0|||
25045200|NCT02964741|50147399|FG001|Overall Study|Withdrawal by Subject|1|||
25045201|NCT02964741|50147400|FG002|Overall Study|Withdrawal by Subject|0|||
25045202|NCT02964741|50147398|FG000|Overall Study|claustrophobia|1|||
25045203|NCT02964741|50147399|FG001|Overall Study|claustrophobia|0|||
25045204|NCT02964741|50147400|FG002|Overall Study|claustrophobia|0|||
25045205|NCT01316419|50147406|FG000|Overall Study|Not treated|103|||
25045206|NCT01316419|50147406|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
25045207|NCT01316419|50147406|FG000|Overall Study|Lost to Follow-up|19|||
25045208|NCT02964039|50147413|FG000|Overall Study|Medical reason unrelated to study participation|1|||
25045209|NCT02964039|50147414|FG001|Overall Study|Medical reason unrelated to study participation|0|||
25045210|NCT02964039|50147415|FG002|Overall Study|Medical reason unrelated to study participation|3|||
25045211|NCT02964039|50147413|FG000|Overall Study|Research shutdown due to pandemic|2|||
25045212|NCT02964039|50147414|FG001|Overall Study|Research shutdown due to pandemic|0|||
25045213|NCT02964039|50147415|FG002|Overall Study|Research shutdown due to pandemic|1|||
24958084|NCT00347360|50048746|FG009|Overall Study|Reason not listed/blank|0|||
24958085|NCT00347360|50048747|FG010|Overall Study|Reason not listed/blank|0|||
24958086|NCT00347360|50048748|FG011|Overall Study|Reason not listed/blank|0|||
24958087|NCT00347360|50048749|FG012|Overall Study|Reason not listed/blank|0|||
24958088|NCT00347360|50048750|FG013|Overall Study|Reason not listed/blank|1|||
24958089|NCT00347360|50048751|FG014|Overall Study|Reason not listed/blank|0|||
24958090|NCT00347360|50048737|FG000|Overall Study|Per sponsors instruction|0|||
24958091|NCT00347360|50048738|FG001|Overall Study|Per sponsors instruction|1|||
24958092|NCT00347360|50048739|FG002|Overall Study|Per sponsors instruction|0|||
24958093|NCT00347360|50048740|FG003|Overall Study|Per sponsors instruction|0|||
24958094|NCT00347360|50048741|FG004|Overall Study|Per sponsors instruction|0|||
25045214|NCT02964039|50147413|FG000|Overall Study|Withdrawal by Subject|0|||
25045215|NCT02964039|50147414|FG001|Overall Study|Withdrawal by Subject|1|||
25045216|NCT02964039|50147415|FG002|Overall Study|Withdrawal by Subject|0|||
25045217|NCT02964039|50147413|FG000|Overall Study|Lost to Follow-up|1|||
25045218|NCT02964039|50147414|FG001|Overall Study|Lost to Follow-up|0|||
25045219|NCT02964039|50147415|FG002|Overall Study|Lost to Follow-up|1|||
25045220|NCT02897115|50147425|FG000|Overall Study|Early termination of study by sponsor|11|||
25045221|NCT02897115|50147426|FG001|Overall Study|Early termination of study by sponsor|8|||
24958095|NCT00347360|50048742|FG005|Overall Study|Per sponsors instruction|0|||
24958096|NCT00347360|50048743|FG006|Overall Study|Per sponsors instruction|0|||
24958097|NCT00347360|50048744|FG007|Overall Study|Per sponsors instruction|0|||
25045222|NCT02896569|50147434|FG000|Overall Study|Lost to Follow-up|2|||
25045223|NCT02896569|50147435|FG001|Overall Study|Lost to Follow-up|1|||
25045224|NCT02896569|50147434|FG000|Overall Study|Physician Decision|1|||
25045225|NCT02896569|50147435|FG001|Overall Study|Physician Decision|3|||
25045226|NCT02896569|50147434|FG000|Overall Study|Adverse Event|0|||
25045227|NCT02896569|50147435|FG001|Overall Study|Adverse Event|1|||
25045228|NCT02896569|50147434|FG000|Overall Study|Withdrawal by Subject|1|||
25045229|NCT02896569|50147435|FG001|Overall Study|Withdrawal by Subject|0|||
25045230|NCT04030195|50147444|FG000|Overall Study|Withdrawal by Subject|2|||
25045231|NCT04030195|50147445|FG001|Overall Study|Withdrawal by Subject|0|||
24958098|NCT00347360|50048745|FG008|Overall Study|Per sponsors instruction|0|||
24958099|NCT00347360|50048746|FG009|Overall Study|Per sponsors instruction|0|||
24958100|NCT00347360|50048747|FG010|Overall Study|Per sponsors instruction|0|||
24958101|NCT00347360|50048748|FG011|Overall Study|Per sponsors instruction|0|||
24958102|NCT00347360|50048749|FG012|Overall Study|Per sponsors instruction|0|||
24958103|NCT00347360|50048750|FG013|Overall Study|Per sponsors instruction|0|||
24958104|NCT00347360|50048751|FG014|Overall Study|Per sponsors instruction|0|||
24958105|NCT00347360|50048737|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
24958106|NCT00347360|50048738|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
24958107|NCT00347360|50048739|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
24958108|NCT00347360|50048740|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
24958109|NCT00347360|50048741|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
25045232|NCT04030195|50147446|FG002|Overall Study|Withdrawal by Subject|0|||
25045233|NCT01673620|50147457|FG000|Overall Study|Adverse Event|1|||
25045234|NCT01673620|50147458|FG001|Overall Study|Adverse Event|0|||
25045235|NCT03044197|50147472|FG000|Overall Study|Withdrawal by Subject|3|||
25045236|NCT03044197|50147473|FG001|Overall Study|Withdrawal by Subject|1|||
25045237|NCT03575325|50147492|FG000|Overall Study|Death|1|||
25045238|NCT03043651|50147507|FG000|Overall Study|Death|1|||
25045239|NCT03043651|50147507|FG000|Overall Study|Progressive Disease|2|||
25045240|NCT03043651|50147507|FG000|Overall Study|Adverse Event|2|||
25045241|NCT03043651|50147507|FG000|Overall Study|Withdrawal by Subject|4|||
25045242|NCT03043651|50147507|FG000|Overall Study|Study Terminated by Sponsor|39|||
25045243|NCT03536143|50147511|FG000|Overall Study|Early termination, Sponsor decision|1|||
25045244|NCT01344759|50147521|FG000|Overall Study|Patients failed to reach sedation level|0|||
25045245|NCT01344759|50147522|FG001|Overall Study|Patients failed to reach sedation level|2|||
25045246|NCT05027451|50147545|FG000|Overall Study|Lost to Follow-up|1|||
25045247|NCT05027451|50147546|FG001|Overall Study|Lost to Follow-up|1|||
25045248|NCT04757649|50147578|FG000|Overall Study|Withdrawal by Subject|1|||
25045249|NCT04757649|50147578|FG000|Overall Study|Adverse Event|1|||
25045250|NCT04621786|50147582|FG000|Overall Study|Lost to Follow-up|9|||
25045251|NCT04621786|50147582|FG000|Overall Study|Protocol Violation|3|||
25045252|NCT04549454|50147588|FG000|T1 to T2|Lost to Follow-up|22|||
25045253|NCT04549454|50147589|FG001|T1 to T2|Lost to Follow-up|26|||
25045254|NCT04549454|50147588|FG000|T1 to T3|Lost to Follow-up|31|||
25045255|NCT04549454|50147589|FG001|T1 to T3|Lost to Follow-up|36|||
25045256|NCT04089865|50147618|FG000|Overall Study|Withdrawal by Subject|2|||
24958110|NCT00347360|50048742|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
24958111|NCT00347360|50048743|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
24958112|NCT00347360|50048744|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
24958113|NCT00347360|50048745|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
24958114|NCT00347360|50048746|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
24958115|NCT00347360|50048747|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
24958116|NCT00347360|50048748|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
24958117|NCT00347360|50048749|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
24958118|NCT00347360|50048750|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
24958119|NCT00347360|50048751|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
24958120|NCT00347360|50048737|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
24958121|NCT00347360|50048738|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
25045257|NCT04089865|50147619|FG001|Overall Study|Withdrawal by Subject|2|||
25045258|NCT04089865|50147620|FG002|Overall Study|Withdrawal by Subject|7|||
25045259|NCT04089865|50147621|FG003|Overall Study|Withdrawal by Subject|2|||
25045260|NCT03818035|50147640|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
25045261|NCT03818035|50147641|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
25045262|NCT03818035|50147642|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
25045263|NCT03818035|50147643|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
25045264|NCT03818035|50147640|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
25045265|NCT03818035|50147641|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
25045266|NCT03818035|50147642|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
25045267|NCT03818035|50147643|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
25045268|NCT03818035|50147640|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
25045269|NCT03818035|50147641|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
25045270|NCT03818035|50147642|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
25045271|NCT03818035|50147643|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
25045272|NCT03818035|50147640|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
25045273|NCT03818035|50147641|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
25045274|NCT03818035|50147642|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
25045275|NCT03818035|50147643|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
25045276|NCT03818035|50147640|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
25045277|NCT03818035|50147641|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
25045278|NCT03818035|50147642|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
25045279|NCT03818035|50147643|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
25045280|NCT03818035|50147640|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
25045281|NCT03818035|50147641|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
25045282|NCT03818035|50147642|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
25045283|NCT03818035|50147643|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
25045284|NCT03818035|50147640|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
25045285|NCT03818035|50147641|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
25045286|NCT03818035|50147642|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
25045287|NCT03818035|50147643|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
25045288|NCT03818035|50147640|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
25045289|NCT03818035|50147641|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
25045290|NCT03818035|50147642|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
25045291|NCT03818035|50147643|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
25045292|NCT03818035|50147640|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
25045293|NCT03818035|50147641|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
25045294|NCT03818035|50147642|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
25045295|NCT03818035|50147643|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
25045296|NCT03818035|50147640|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
25045297|NCT03818035|50147641|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
25045298|NCT03818035|50147642|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
25045299|NCT03818035|50147643|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
25045300|NCT03818035|50147640|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
25045301|NCT03818035|50147641|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
25045302|NCT03818035|50147642|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
25045303|NCT03818035|50147643|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
25045304|NCT03818035|50147640|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
25045305|NCT03818035|50147641|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
25045306|NCT03818035|50147642|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
25162445|NCT01791517|50284754|FG005|Phase I: Period 2|Lens Discomfort|1|||
24958122|NCT00347360|50048739|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
24958123|NCT00347360|50048740|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
24958124|NCT00347360|50048741|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
24958125|NCT00347360|50048742|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
24958126|NCT00347360|50048743|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
24958127|NCT00347360|50048744|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
24958128|NCT00347360|50048745|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
24958129|NCT00347360|50048746|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
24958130|NCT00347360|50048747|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
24958131|NCT00347360|50048748|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
24958132|NCT00347360|50048749|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
24958133|NCT00347360|50048750|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
24958134|NCT00347360|50048751|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
24958135|NCT00347360|50048737|FG000|Overall Study|Abnormal lab values|0|||
24958136|NCT00347360|50048738|FG001|Overall Study|Abnormal lab values|0|||
24958137|NCT00347360|50048739|FG002|Overall Study|Abnormal lab values|0|||
24958138|NCT00347360|50048740|FG003|Overall Study|Abnormal lab values|0|||
24958139|NCT00347360|50048741|FG004|Overall Study|Abnormal lab values|0|||
24958140|NCT00347360|50048742|FG005|Overall Study|Abnormal lab values|0|||
24958141|NCT00347360|50048743|FG006|Overall Study|Abnormal lab values|1|||
25045307|NCT03818035|50147643|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
25045308|NCT03818035|50147640|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
25045309|NCT03818035|50147641|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
25045310|NCT03818035|50147642|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
25045311|NCT03818035|50147643|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
25162446|NCT01791517|50284755|FG006|Phase I: Period 2|Lens Discomfort|0|||
25045312|NCT03818035|50147640|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
25045313|NCT03818035|50147641|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
25045314|NCT03818035|50147642|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
25045315|NCT03818035|50147643|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
25045316|NCT03818035|50147640|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
25045317|NCT03818035|50147641|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
25045318|NCT03818035|50147642|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
25045319|NCT03818035|50147643|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
25276318|NCT00960934|50590276|FG005|Overall Study|Physician Decision|0|||
24958142|NCT00347360|50048744|FG007|Overall Study|Abnormal lab values|0|||
24958143|NCT00347360|50048745|FG008|Overall Study|Abnormal lab values|0|||
24958144|NCT00347360|50048746|FG009|Overall Study|Abnormal lab values|0|||
24958145|NCT00347360|50048747|FG010|Overall Study|Abnormal lab values|0|||
24958146|NCT00347360|50048748|FG011|Overall Study|Abnormal lab values|0|||
24958147|NCT00347360|50048749|FG012|Overall Study|Abnormal lab values|0|||
24958148|NCT00347360|50048750|FG013|Overall Study|Abnormal lab values|0|||
24958149|NCT00347360|50048751|FG014|Overall Study|Abnormal lab values|0|||
24958150|NCT00347360|50048737|FG000|Overall Study|PI recommended early withdrawal|0|||
24958151|NCT00347360|50048738|FG001|Overall Study|PI recommended early withdrawal|0|||
24958152|NCT00347360|50048739|FG002|Overall Study|PI recommended early withdrawal|0|||
24958153|NCT00347360|50048740|FG003|Overall Study|PI recommended early withdrawal|0|||
24958154|NCT00347360|50048741|FG004|Overall Study|PI recommended early withdrawal|0|||
24958155|NCT00347360|50048742|FG005|Overall Study|PI recommended early withdrawal|0|||
24958156|NCT00347360|50048743|FG006|Overall Study|PI recommended early withdrawal|0|||
24958157|NCT00347360|50048744|FG007|Overall Study|PI recommended early withdrawal|0|||
24958158|NCT00347360|50048745|FG008|Overall Study|PI recommended early withdrawal|0|||
24958159|NCT00347360|50048746|FG009|Overall Study|PI recommended early withdrawal|1|||
25276319|NCT00960934|50590271|FG000|Overall Study|Progressive Disease|1|||
25276320|NCT00960934|50590272|FG001|Overall Study|Progressive Disease|1|||
25276321|NCT00960934|50590273|FG002|Overall Study|Progressive Disease|0|||
25276322|NCT00960934|50590274|FG003|Overall Study|Progressive Disease|0|||
25276323|NCT00960934|50590275|FG004|Overall Study|Progressive Disease|1|||
25045326|NCT03519256|50147674|FG000|Overall Study|Disease recurrence|4|||
25045327|NCT03519256|50147675|FG001|Overall Study|Disease recurrence|4|||
25045328|NCT03519256|50147676|FG002|Overall Study|Disease recurrence|5|||
25045329|NCT03519256|50147677|FG003|Overall Study|Disease recurrence|2|||
25045330|NCT03519256|50147674|FG000|Overall Study|Study drug toxicity|0|||
25045331|NCT03519256|50147675|FG001|Overall Study|Study drug toxicity|2|||
25045332|NCT03519256|50147676|FG002|Overall Study|Study drug toxicity|5|||
25045333|NCT03519256|50147677|FG003|Overall Study|Study drug toxicity|2|||
25045334|NCT03519256|50147674|FG000|Overall Study|Adverse event unrelated to study drug|0|||
25045335|NCT03519256|50147675|FG001|Overall Study|Adverse event unrelated to study drug|1|||
25045336|NCT03519256|50147676|FG002|Overall Study|Adverse event unrelated to study drug|1|||
25045337|NCT03519256|50147677|FG003|Overall Study|Adverse event unrelated to study drug|0|||
25045338|NCT03519256|50147674|FG000|Overall Study|Participant request to discontinue study treatment|0|||
25045339|NCT03519256|50147675|FG001|Overall Study|Participant request to discontinue study treatment|0|||
25045340|NCT03519256|50147676|FG002|Overall Study|Participant request to discontinue study treatment|0|||
25045341|NCT03519256|50147677|FG003|Overall Study|Participant request to discontinue study treatment|2|||
25045342|NCT03519256|50147674|FG000|Overall Study|Other reasons|0|||
25045343|NCT03519256|50147675|FG001|Overall Study|Other reasons|0|||
25045344|NCT03519256|50147676|FG002|Overall Study|Other reasons|2|||
25045345|NCT03519256|50147677|FG003|Overall Study|Other reasons|0|||
25045346|NCT03519256|50147674|FG000|Overall Study|Disease progression|6|||
25045347|NCT03519256|50147675|FG001|Overall Study|Disease progression|3|||
25045348|NCT03519256|50147676|FG002|Overall Study|Disease progression|2|||
25045349|NCT03519256|50147677|FG003|Overall Study|Disease progression|1|||
25045350|NCT03519256|50147674|FG000|Overall Study|Lost to Follow-up|0|||
25045351|NCT03519256|50147675|FG001|Overall Study|Lost to Follow-up|1|||
25045352|NCT03519256|50147676|FG002|Overall Study|Lost to Follow-up|0|||
25045353|NCT03519256|50147677|FG003|Overall Study|Lost to Follow-up|0|||
25186517|NCT02647866|50336897|FG002|Overall Study|Subject moved to different country|0|||
25186518|NCT02647866|50336898|FG003|Overall Study|Subject moved to different country|0|||
24958160|NCT00347360|50048747|FG010|Overall Study|PI recommended early withdrawal|0|||
24958161|NCT00347360|50048748|FG011|Overall Study|PI recommended early withdrawal|0|||
24958162|NCT00347360|50048749|FG012|Overall Study|PI recommended early withdrawal|0|||
25045354|NCT03343054|50147700|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
25045355|NCT03343054|50147701|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
25045356|NCT03343054|50147702|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
25045357|NCT03343054|50147700|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
25045358|NCT03343054|50147701|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
25045359|NCT03343054|50147702|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
24958163|NCT00347360|50048750|FG013|Overall Study|PI recommended early withdrawal|0|||
24958164|NCT00347360|50048751|FG014|Overall Study|PI recommended early withdrawal|0|||
24958165|NCT00347360|50048737|FG000|Overall Study|Did not meet criteria before ABPM|0|||
24958166|NCT00347360|50048738|FG001|Overall Study|Did not meet criteria before ABPM|0|||
24958167|NCT00347360|50048739|FG002|Overall Study|Did not meet criteria before ABPM|0|||
24958168|NCT00347360|50048740|FG003|Overall Study|Did not meet criteria before ABPM|0|||
24958169|NCT00347360|50048741|FG004|Overall Study|Did not meet criteria before ABPM|0|||
24958170|NCT00347360|50048742|FG005|Overall Study|Did not meet criteria before ABPM|0|||
24958171|NCT00347360|50048743|FG006|Overall Study|Did not meet criteria before ABPM|0|||
24958172|NCT00347360|50048744|FG007|Overall Study|Did not meet criteria before ABPM|0|||
25045360|NCT03343054|50147700|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
25045361|NCT03343054|50147701|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
25045362|NCT03343054|50147702|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
25045363|NCT03343054|50147700|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
24958173|NCT00347360|50048745|FG008|Overall Study|Did not meet criteria before ABPM|0|||
24958174|NCT00347360|50048746|FG009|Overall Study|Did not meet criteria before ABPM|0|||
24958175|NCT00347360|50048747|FG010|Overall Study|Did not meet criteria before ABPM|1|||
24958176|NCT00347360|50048748|FG011|Overall Study|Did not meet criteria before ABPM|0|||
24958177|NCT00347360|50048749|FG012|Overall Study|Did not meet criteria before ABPM|0|||
24958178|NCT00347360|50048750|FG013|Overall Study|Did not meet criteria before ABPM|0|||
24958179|NCT00347360|50048751|FG014|Overall Study|Did not meet criteria before ABPM|0|||
24958180|NCT00347360|50048737|FG000|Overall Study|Randomized in error|0|||
24958181|NCT00347360|50048738|FG001|Overall Study|Randomized in error|0|||
24958182|NCT00347360|50048739|FG002|Overall Study|Randomized in error|0|||
24958183|NCT00347360|50048740|FG003|Overall Study|Randomized in error|0|||
24958184|NCT00347360|50048741|FG004|Overall Study|Randomized in error|0|||
24958185|NCT00347360|50048742|FG005|Overall Study|Randomized in error|0|||
24958186|NCT00347360|50048743|FG006|Overall Study|Randomized in error|0|||
24958187|NCT00347360|50048744|FG007|Overall Study|Randomized in error|0|||
24958188|NCT00347360|50048745|FG008|Overall Study|Randomized in error|0|||
24958189|NCT00347360|50048746|FG009|Overall Study|Randomized in error|0|||
24958190|NCT00347360|50048747|FG010|Overall Study|Randomized in error|0|||
24958191|NCT00347360|50048748|FG011|Overall Study|Randomized in error|1|||
24958192|NCT00347360|50048749|FG012|Overall Study|Randomized in error|0|||
24958193|NCT00347360|50048750|FG013|Overall Study|Randomized in error|0|||
24958194|NCT00347360|50048751|FG014|Overall Study|Randomized in error|0|||
24958195|NCT00347360|50048737|FG000|Overall Study|Failed inclusion criteria #4|0|||
24958196|NCT00347360|50048738|FG001|Overall Study|Failed inclusion criteria #4|0|||
24958197|NCT00347360|50048739|FG002|Overall Study|Failed inclusion criteria #4|0|||
24958198|NCT00347360|50048740|FG003|Overall Study|Failed inclusion criteria #4|0|||
24958199|NCT00347360|50048741|FG004|Overall Study|Failed inclusion criteria #4|0|||
24958200|NCT00347360|50048742|FG005|Overall Study|Failed inclusion criteria #4|0|||
24958201|NCT00347360|50048743|FG006|Overall Study|Failed inclusion criteria #4|0|||
24958202|NCT00347360|50048744|FG007|Overall Study|Failed inclusion criteria #4|0|||
24958203|NCT00347360|50048745|FG008|Overall Study|Failed inclusion criteria #4|0|||
24958204|NCT00347360|50048746|FG009|Overall Study|Failed inclusion criteria #4|0|||
24958205|NCT00347360|50048747|FG010|Overall Study|Failed inclusion criteria #4|0|||
24958206|NCT00347360|50048748|FG011|Overall Study|Failed inclusion criteria #4|1|||
24958207|NCT00347360|50048749|FG012|Overall Study|Failed inclusion criteria #4|0|||
24958208|NCT00347360|50048750|FG013|Overall Study|Failed inclusion criteria #4|0|||
24958209|NCT00347360|50048751|FG014|Overall Study|Failed inclusion criteria #4|0|||
24958210|NCT00347360|50048737|FG000|Overall Study|Prolonged duration between visits|0|||
24958211|NCT00347360|50048738|FG001|Overall Study|Prolonged duration between visits|0|||
24958212|NCT00347360|50048739|FG002|Overall Study|Prolonged duration between visits|0|||
24958213|NCT00347360|50048740|FG003|Overall Study|Prolonged duration between visits|0|||
24958214|NCT00347360|50048741|FG004|Overall Study|Prolonged duration between visits|0|||
24958215|NCT00347360|50048742|FG005|Overall Study|Prolonged duration between visits|0|||
24958216|NCT00347360|50048743|FG006|Overall Study|Prolonged duration between visits|0|||
24958217|NCT00347360|50048744|FG007|Overall Study|Prolonged duration between visits|0|||
24958218|NCT00347360|50048745|FG008|Overall Study|Prolonged duration between visits|0|||
24958219|NCT00347360|50048746|FG009|Overall Study|Prolonged duration between visits|0|||
24958220|NCT00347360|50048747|FG010|Overall Study|Prolonged duration between visits|0|||
24958221|NCT00347360|50048748|FG011|Overall Study|Prolonged duration between visits|0|||
24958222|NCT00347360|50048749|FG012|Overall Study|Prolonged duration between visits|1|||
24958223|NCT00347360|50048750|FG013|Overall Study|Prolonged duration between visits|0|||
24958224|NCT00347360|50048751|FG014|Overall Study|Prolonged duration between visits|0|||
24958225|NCT00347360|50048737|FG000|Overall Study|Subject left town, ran out of study drug|0|||
24958226|NCT00347360|50048738|FG001|Overall Study|Subject left town, ran out of study drug|0|||
24958227|NCT00347360|50048739|FG002|Overall Study|Subject left town, ran out of study drug|0|||
24958228|NCT00347360|50048740|FG003|Overall Study|Subject left town, ran out of study drug|0|||
24958229|NCT00347360|50048741|FG004|Overall Study|Subject left town, ran out of study drug|0|||
25045364|NCT03343054|50147701|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
25045365|NCT03343054|50147702|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
25045366|NCT03330847|50147714|FG000|Overall Study|Patients ongoing study|62|||
25045367|NCT03330847|50147715|FG001|Overall Study|Patients ongoing study|65|||
25045368|NCT03330847|50147716|FG002|Overall Study|Patients ongoing study|15|||
25045369|NCT02799602|50147742|FG000|Overall Study|Protocol Violation|1|||
25045370|NCT02799602|50147743|FG001|Overall Study|Protocol Violation|0|||
25045371|NCT02799602|50147742|FG000|Overall Study|Physician Decision|3|||
25045372|NCT02799602|50147743|FG001|Overall Study|Physician Decision|7|||
25045373|NCT02799602|50147742|FG000|Overall Study|COVID-19 pandemic related other reason|0|||
25045374|NCT02799602|50147743|FG001|Overall Study|COVID-19 pandemic related other reason|1|||
25045375|NCT02799602|50147742|FG000|Overall Study|Lost to Follow-up|4|||
25045376|NCT02799602|50147743|FG001|Overall Study|Lost to Follow-up|1|||
25045377|NCT02799602|50147742|FG000|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|11|||
25045378|NCT02799602|50147743|FG001|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|6|||
25045379|NCT02799602|50147742|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|14|||
25045380|NCT02799602|50147743|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|12|||
25045381|NCT02799602|50147742|FG000|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|24|||
25045382|NCT02799602|50147743|FG001|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|26|||
25045383|NCT02799602|50147742|FG000|Overall Study|Withdrawal by Subject|25|||
25045384|NCT02799602|50147743|FG001|Overall Study|Withdrawal by Subject|37|||
25045385|NCT02799602|50147742|FG000|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|48|||
25045386|NCT02799602|50147743|FG001|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|27|||
25045387|NCT02799602|50147742|FG000|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|84|||
25045388|NCT02799602|50147743|FG001|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|132|||
25045389|NCT02799602|50147742|FG000|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|127|||
25045390|NCT02799602|50147743|FG001|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|272|||
25045391|NCT02799602|50147742|FG000|Overall Study|Death|8|||
25045392|NCT02799602|50147743|FG001|Overall Study|Death|5|||
25045393|NCT02799602|50147742|FG000|Overall Study|Other|3|||
25045394|NCT02799602|50147743|FG001|Overall Study|Other|3|||
25045395|NCT02799602|50147742|FG000|Overall Study|GCP violation|1|||
25045396|NCT02799602|50147743|FG001|Overall Study|GCP violation|0|||
25045397|NCT02243709|50147760|FG000|Phase 1|Lost to Follow-up|0|||
25045398|NCT02243709|50147761|FG001|Phase 1|Lost to Follow-up|1|||
25045399|NCT02243709|50147760|FG000|Phase 1|Withdrawal by Subject|1|||
25045400|NCT02243709|50147761|FG001|Phase 1|Withdrawal by Subject|0|||
25045401|NCT02243709|50147760|FG000|Phase 1|Protocol Violation|0|||
25045402|NCT02243709|50147761|FG001|Phase 1|Protocol Violation|1|||
25045403|NCT02243709|50147760|FG000|Phase 1|Adverse Event|0|||
25045404|NCT02243709|50147761|FG001|Phase 1|Adverse Event|1|||
25045405|NCT01891396|50147773|FG000|Overall Study|Withdrawal by Subject|4|||
25045406|NCT01891396|50147774|FG001|Overall Study|Withdrawal by Subject|4|||
25045407|NCT01891396|50147775|FG002|Overall Study|Withdrawal by Subject|3|||
25045408|NCT01891396|50147773|FG000|Overall Study|Lost to Follow-up|0|||
25045409|NCT01891396|50147774|FG001|Overall Study|Lost to Follow-up|1|||
25045410|NCT01891396|50147775|FG002|Overall Study|Lost to Follow-up|0|||
25045411|NCT01746225|50147790|FG000|Overall Study|Death|1|||
25045412|NCT01746225|50147791|FG001|Overall Study|Death|0|||
25045413|NCT01746225|50147792|FG002|Overall Study|Death|1|||
25045414|NCT01746225|50147790|FG000|Overall Study|Withdrawal by Subject|5|||
25045415|NCT01746225|50147791|FG001|Overall Study|Withdrawal by Subject|15|||
25045416|NCT01746225|50147792|FG002|Overall Study|Withdrawal by Subject|19|||
25045417|NCT01746225|50147790|FG000|Overall Study|Physician Decision|14|||
25045418|NCT01746225|50147791|FG001|Overall Study|Physician Decision|11|||
25045419|NCT01746225|50147792|FG002|Overall Study|Physician Decision|3|||
25045420|NCT01746225|50147790|FG000|Overall Study|Adverse Event|15|||
25045421|NCT01746225|50147791|FG001|Overall Study|Adverse Event|12|||
25045422|NCT01746225|50147792|FG002|Overall Study|Adverse Event|17|||
25045423|NCT01746225|50147790|FG000|Overall Study|Continuing Treatment|5|||
25045424|NCT01746225|50147791|FG001|Overall Study|Continuing Treatment|8|||
25045425|NCT01746225|50147792|FG002|Overall Study|Continuing Treatment|3|||
25045426|NCT01471522|50147813|FG000|Overall Study|Withdrawal by Subject|28|||
25045427|NCT01471522|50147814|FG001|Overall Study|Withdrawal by Subject|22|||
25045428|NCT01471522|50147813|FG000|Overall Study|Lost to Follow-up|36|||
25045429|NCT01471522|50147814|FG001|Overall Study|Lost to Follow-up|26|||
25276324|NCT00960934|50590276|FG005|Overall Study|Progressive Disease|1|||
25276325|NCT00960934|50590271|FG000|Overall Study|Protocol Violation|3|||
25276326|NCT00960934|50590272|FG001|Overall Study|Protocol Violation|4|||
25276327|NCT00960934|50590273|FG002|Overall Study|Protocol Violation|0|||
25276328|NCT00960934|50590274|FG003|Overall Study|Protocol Violation|3|||
25276329|NCT00960934|50590275|FG004|Overall Study|Protocol Violation|3|||
25276330|NCT00960934|50590276|FG005|Overall Study|Protocol Violation|2|||
25276331|NCT00960934|50590271|FG000|Overall Study|Withdrawal by Subject|5|||
25276332|NCT00960934|50590272|FG001|Overall Study|Withdrawal by Subject|6|||
25276333|NCT00960934|50590273|FG002|Overall Study|Withdrawal by Subject|4|||
25045440|NCT01191008|50147830|FG000|Overall Study|Protocol Violation|7|||
25045441|NCT01191008|50147830|FG000|Overall Study|Lost to Follow-up|8|||
25045442|NCT01063517|50147836|FG000|Overall Study|Consent withdrawal|1|||
25045443|NCT01063517|50147837|FG001|Overall Study|Consent withdrawal|0|||
24958230|NCT00347360|50048742|FG005|Overall Study|Subject left town, ran out of study drug|0|||
24958231|NCT00347360|50048743|FG006|Overall Study|Subject left town, ran out of study drug|0|||
25045444|NCT01063517|50147836|FG000|Overall Study|Study reached data cut-off|19|||
25045445|NCT01063517|50147837|FG001|Overall Study|Study reached data cut-off|7|||
25045446|NCT01063517|50147836|FG000|Overall Study|Lost to Follow-up|4|||
25045447|NCT01063517|50147837|FG001|Overall Study|Lost to Follow-up|3|||
25045448|NCT01063517|50147836|FG000|Overall Study|Withdrawal by Subject|1|||
25045449|NCT01063517|50147837|FG001|Overall Study|Withdrawal by Subject|2|||
25045450|NCT01063517|50147836|FG000|Overall Study|Death|33|||
25045451|NCT01063517|50147837|FG001|Overall Study|Death|48|||
24958232|NCT00347360|50048744|FG007|Overall Study|Subject left town, ran out of study drug|0|||
24958233|NCT00347360|50048745|FG008|Overall Study|Subject left town, ran out of study drug|0|||
24958234|NCT00347360|50048746|FG009|Overall Study|Subject left town, ran out of study drug|0|||
24958235|NCT00347360|50048747|FG010|Overall Study|Subject left town, ran out of study drug|0|||
24958236|NCT00347360|50048748|FG011|Overall Study|Subject left town, ran out of study drug|0|||
24958237|NCT00347360|50048749|FG012|Overall Study|Subject left town, ran out of study drug|0|||
24958238|NCT00347360|50048750|FG013|Overall Study|Subject left town, ran out of study drug|1|||
24958239|NCT00347360|50048751|FG014|Overall Study|Subject left town, ran out of study drug|0|||
24958240|NCT00347360|50048737|FG000|Overall Study|Subject refuse to sign updated consent|0|||
24958241|NCT00347360|50048738|FG001|Overall Study|Subject refuse to sign updated consent|0|||
24958242|NCT00347360|50048739|FG002|Overall Study|Subject refuse to sign updated consent|0|||
24958243|NCT00347360|50048740|FG003|Overall Study|Subject refuse to sign updated consent|0|||
24958244|NCT00347360|50048741|FG004|Overall Study|Subject refuse to sign updated consent|0|||
24958245|NCT00347360|50048742|FG005|Overall Study|Subject refuse to sign updated consent|0|||
24958246|NCT00347360|50048743|FG006|Overall Study|Subject refuse to sign updated consent|0|||
24958247|NCT00347360|50048744|FG007|Overall Study|Subject refuse to sign updated consent|0|||
24958248|NCT00347360|50048745|FG008|Overall Study|Subject refuse to sign updated consent|0|||
24958249|NCT00347360|50048746|FG009|Overall Study|Subject refuse to sign updated consent|0|||
24958250|NCT00347360|50048747|FG010|Overall Study|Subject refuse to sign updated consent|0|||
24958251|NCT00347360|50048748|FG011|Overall Study|Subject refuse to sign updated consent|0|||
24958252|NCT00347360|50048749|FG012|Overall Study|Subject refuse to sign updated consent|0|||
24958253|NCT00347360|50048750|FG013|Overall Study|Subject refuse to sign updated consent|0|||
24958254|NCT00347360|50048751|FG014|Overall Study|Subject refuse to sign updated consent|1|||
24958255|NCT00347360|50048737|FG000|Overall Study|Visits conflicted with new job|0|||
24958256|NCT00347360|50048738|FG001|Overall Study|Visits conflicted with new job|0|||
24958257|NCT00347360|50048739|FG002|Overall Study|Visits conflicted with new job|0|||
24958258|NCT00347360|50048740|FG003|Overall Study|Visits conflicted with new job|0|||
24958259|NCT00347360|50048741|FG004|Overall Study|Visits conflicted with new job|0|||
24958260|NCT00347360|50048742|FG005|Overall Study|Visits conflicted with new job|0|||
24958261|NCT00347360|50048743|FG006|Overall Study|Visits conflicted with new job|1|||
24958262|NCT00347360|50048744|FG007|Overall Study|Visits conflicted with new job|0|||
24958263|NCT00347360|50048745|FG008|Overall Study|Visits conflicted with new job|0|||
24958264|NCT00347360|50048746|FG009|Overall Study|Visits conflicted with new job|0|||
24958265|NCT00347360|50048747|FG010|Overall Study|Visits conflicted with new job|0|||
24958266|NCT00347360|50048748|FG011|Overall Study|Visits conflicted with new job|0|||
24958267|NCT00347360|50048749|FG012|Overall Study|Visits conflicted with new job|0|||
24958268|NCT00347360|50048750|FG013|Overall Study|Visits conflicted with new job|0|||
24958269|NCT00347360|50048751|FG014|Overall Study|Visits conflicted with new job|0|||
24958270|NCT00319020|50048785|FG000|Overall Study|Death|2|||
24958271|NCT00319020|50048786|FG001|Overall Study|Death|2|||
24958272|NCT00319020|50048785|FG000|Overall Study|Withdrawal by Subject|4|||
24958273|NCT00319020|50048786|FG001|Overall Study|Withdrawal by Subject|1|||
24958274|NCT00319020|50048785|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
24958275|NCT00319020|50048786|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
25045452|NCT00821587|50147845|FG000|Overall Study|Physician Decision|0|||
24958276|NCT00319020|50048785|FG000|Overall Study|Administrative reason|0|||
24958277|NCT00319020|50048786|FG001|Overall Study|Administrative reason|5|||
24958278|NCT00319020|50048785|FG000|Overall Study|Disease progression|0|||
24958279|NCT00319020|50048786|FG001|Overall Study|Disease progression|2|||
25045453|NCT00821587|50147846|FG001|Overall Study|Physician Decision|1|||
25045454|NCT00645801|50147854|FG000|Overall Study|unclear if patient took all the medication.|1|||
25045455|NCT00645801|50147855|FG001|Overall Study|unclear if patient took all the medication.|0|||
25045456|NCT00645801|50147854|FG000|Overall Study|Lost to Follow-up|19|||
25045457|NCT00645801|50147855|FG001|Overall Study|Lost to Follow-up|15|||
25045458|NCT00424099|50147869|FG000|Overall Study|Adverse Event|0|||
25045459|NCT00424099|50147870|FG001|Overall Study|Adverse Event|1|||
25045460|NCT00424099|50147871|FG002|Overall Study|Adverse Event|1|||
25045461|NCT00424099|50147872|FG003|Overall Study|Adverse Event|0|||
25045462|NCT00424099|50147869|FG000|Overall Study|Death|0|||
25045463|NCT00424099|50147870|FG001|Overall Study|Death|1|||
25045464|NCT00424099|50147871|FG002|Overall Study|Death|0|||
25045465|NCT00424099|50147872|FG003|Overall Study|Death|0|||
25045466|NCT00424099|50147869|FG000|Overall Study|Illness|2|||
25045467|NCT00424099|50147870|FG001|Overall Study|Illness|0|||
25045468|NCT00424099|50147871|FG002|Overall Study|Illness|1|||
25045469|NCT00424099|50147872|FG003|Overall Study|Illness|4|||
25045470|NCT00424099|50147869|FG000|Overall Study|Lost to Follow-up|0|||
25045471|NCT00424099|50147870|FG001|Overall Study|Lost to Follow-up|0|||
25045472|NCT00424099|50147871|FG002|Overall Study|Lost to Follow-up|3|||
25045473|NCT00424099|50147872|FG003|Overall Study|Lost to Follow-up|0|||
25045474|NCT00424099|50147869|FG000|Overall Study|Hospitalized|1|||
25045475|NCT00424099|50147870|FG001|Overall Study|Hospitalized|2|||
25045476|NCT00424099|50147871|FG002|Overall Study|Hospitalized|1|||
25045477|NCT00424099|50147872|FG003|Overall Study|Hospitalized|3|||
25045478|NCT00424099|50147869|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
25045479|NCT00424099|50147870|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
25045480|NCT00424099|50147871|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
25045481|NCT00424099|50147872|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
25045482|NCT00424099|50147869|FG000|Overall Study|Withdrawal by Subject|1|||
25045483|NCT00424099|50147870|FG001|Overall Study|Withdrawal by Subject|9|||
25045484|NCT00424099|50147871|FG002|Overall Study|Withdrawal by Subject|4|||
25045485|NCT00424099|50147872|FG003|Overall Study|Withdrawal by Subject|6|||
25045486|NCT00424099|50147869|FG000|Overall Study|Physician Decision|0|||
25045487|NCT00424099|50147870|FG001|Overall Study|Physician Decision|0|||
25045488|NCT00424099|50147871|FG002|Overall Study|Physician Decision|1|||
25045489|NCT00424099|50147872|FG003|Overall Study|Physician Decision|0|||
25045490|NCT00424099|50147869|FG000|Overall Study|Missing|0|||
25045491|NCT00424099|50147870|FG001|Overall Study|Missing|0|||
25045492|NCT00424099|50147871|FG002|Overall Study|Missing|1|||
25045493|NCT00424099|50147872|FG003|Overall Study|Missing|0|||
25045494|NCT02988661|50147899|FG000|Overall Study|Death|2|||
25045495|NCT02988661|50147900|FG001|Overall Study|Death|18|||
25045496|NCT02988661|50147899|FG000|Overall Study|Lost to Follow-up|0|||
25045497|NCT02988661|50147900|FG001|Overall Study|Lost to Follow-up|33|||
24958280|NCT00319020|50048785|FG000|Overall Study|Transplant|0|||
24958281|NCT00319020|50048786|FG001|Overall Study|Transplant|1|||
24958282|NCT00319020|50048785|FG000|Overall Study|Treatment failure|0|||
24958283|NCT00319020|50048786|FG001|Overall Study|Treatment failure|1|||
24958284|NCT00319020|50048785|FG000|Overall Study|Adverse Event|0|||
24958285|NCT00319020|50048786|FG001|Overall Study|Adverse Event|1|||
24958286|NCT00352118|50048794|FG000|Overall Study|Physician Decision|4|||
24958287|NCT00318474|50048800|FG000|Overall Study|Adverse Event|1|||
24958288|NCT00318474|50048801|FG001|Overall Study|Adverse Event|1|||
25045498|NCT02988661|50147899|FG000|Overall Study|Withdrawal by Subject|0|||
25045499|NCT02988661|50147900|FG001|Overall Study|Withdrawal by Subject|6|||
25045500|NCT02988661|50147899|FG000|Overall Study|Unable to complete the 18-month survey|1|||
25045501|NCT02988661|50147900|FG001|Overall Study|Unable to complete the 18-month survey|27|||
25045502|NCT03738397|50147908|FG000|Overall Study|Adverse Event|3|||
24958289|NCT00318474|50048800|FG000|Overall Study|Lost to Follow-up|0|||
25045503|NCT03738397|50147909|FG001|Overall Study|Adverse Event|7|||
25045504|NCT03738397|50147908|FG000|Overall Study|Withdrawal by Subject|8|||
25045505|NCT03738397|50147909|FG001|Overall Study|Withdrawal by Subject|11|||
25045506|NCT03738397|50147908|FG000|Overall Study|Lost to Follow-up|8|||
25045507|NCT03738397|50147909|FG001|Overall Study|Lost to Follow-up|5|||
25045508|NCT03738397|50147908|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
25045509|NCT03738397|50147909|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
25045510|NCT03738397|50147908|FG000|Overall Study|Other|4|||
25045511|NCT03738397|50147909|FG001|Overall Study|Other|6|||
25045512|NCT02960217|50147917|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
25045513|NCT02960217|50147918|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
25045514|NCT02960217|50147917|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
25045515|NCT02960217|50147918|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
25045516|NCT02960217|50147917|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
25045517|NCT02960217|50147918|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
25045518|NCT02960217|50147917|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
25045519|NCT02960217|50147918|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
25045520|NCT02960217|50147917|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
25045521|NCT02960217|50147918|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
25045522|NCT02960217|50147917|FG000|Open-Label Extension Phase|Adverse Event|1|||
25045523|NCT02960217|50147918|FG001|Open-Label Extension Phase|Adverse Event|0|||
25045524|NCT02960217|50147917|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
25045525|NCT02960217|50147918|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
25045526|NCT02960217|50147917|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
25045527|NCT02960217|50147918|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
25045528|NCT02960217|50147917|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
25045529|NCT02960217|50147918|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
25045530|NCT02959983|50147930|FG000|Overall Study|Protocol Violation|0|||
25045531|NCT02959983|50147931|FG001|Overall Study|Protocol Violation|1|||
25045532|NCT02959983|50147930|FG000|Overall Study|Lack of Efficacy|0|||
25045533|NCT02959983|50147931|FG001|Overall Study|Lack of Efficacy|1|||
25045534|NCT02959983|50147930|FG000|Overall Study|Lost to Follow-up|12|||
25045535|NCT02959983|50147931|FG001|Overall Study|Lost to Follow-up|9|||
25045536|NCT02959983|50147930|FG000|Overall Study|Other|1|||
25045537|NCT02959983|50147931|FG001|Overall Study|Other|1|||
25045538|NCT02959983|50147930|FG000|Overall Study|Physician Decision|1|||
25045539|NCT02959983|50147931|FG001|Overall Study|Physician Decision|0|||
25045540|NCT02959983|50147930|FG000|Overall Study|Adverse Event|5|||
25045541|NCT02959983|50147931|FG001|Overall Study|Adverse Event|1|||
25045542|NCT02959983|50147930|FG000|Overall Study|Withdrawal by Subject|7|||
25045543|NCT02959983|50147931|FG001|Overall Study|Withdrawal by Subject|12|||
25045544|NCT01344447|50147937|FG000|Overall Study|Adverse Event|1|||
25045545|NCT01344447|50147937|FG000|Overall Study|Protocol Violation|1|||
25045546|NCT01344447|50147937|FG000|Overall Study|Withdrawal by Subject|1|||
25045547|NCT01344447|50147937|FG000|Overall Study|The contrast was not seen|1|||
25045548|NCT01344447|50147937|FG000|Overall Study|Physician Decision|1|||
25045549|NCT01344447|50147937|FG000|Overall Study|MRA unsuccessful|1|||
25045550|NCT01344447|50147937|FG000|Overall Study|Bolus tracking failed|1|||
25045551|NCT01344447|50147937|FG000|Overall Study|Error of power injector|1|||
25045552|NCT03513068|50147947|FG000|Overall Study|Death|1|||
25045553|NCT03513068|50147948|FG001|Overall Study|Death|0|||
25045554|NCT03513068|50147947|FG000|Overall Study|Withdrawal by Subject|4|||
25045555|NCT03513068|50147948|FG001|Overall Study|Withdrawal by Subject|6|||
25045556|NCT01348425|50147956|FG000|Overall Study|Imaging was not taken.|1|||
25045557|NCT01348425|50147957|FG001|Overall Study|Imaging was not taken.|1|||
25045558|NCT03041701|50147965|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
25045559|NCT03041701|50147966|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
25045560|NCT03041701|50147967|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
25045561|NCT03041701|50147965|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
25045562|NCT03041701|50147966|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
25045563|NCT03041701|50147967|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
25045564|NCT02956629|50147984|FG000|Overall Study|Adverse Event|0|||
25045565|NCT02956629|50147985|FG001|Overall Study|Adverse Event|0|||
25045566|NCT02956629|50147986|FG002|Overall Study|Adverse Event|1|||
25045567|NCT02956629|50147987|FG003|Overall Study|Adverse Event|0|||
25045568|NCT02956629|50147988|FG004|Overall Study|Adverse Event|0|||
25045569|NCT02956629|50147989|FG005|Overall Study|Adverse Event|0|||
25045570|NCT02956629|50147984|FG000|Overall Study|Lost to Follow-up|2|||
25045571|NCT02956629|50147985|FG001|Overall Study|Lost to Follow-up|5|||
25045572|NCT02956629|50147986|FG002|Overall Study|Lost to Follow-up|3|||
25045573|NCT02956629|50147987|FG003|Overall Study|Lost to Follow-up|1|||
25045574|NCT02956629|50147988|FG004|Overall Study|Lost to Follow-up|0|||
25045575|NCT02956629|50147989|FG005|Overall Study|Lost to Follow-up|1|||
25045576|NCT02956629|50147984|FG000|Overall Study|Withdrawal by Subject|3|||
25045577|NCT02956629|50147985|FG001|Overall Study|Withdrawal by Subject|1|||
25045578|NCT02956629|50147986|FG002|Overall Study|Withdrawal by Subject|0|||
25045579|NCT02956629|50147987|FG003|Overall Study|Withdrawal by Subject|0|||
25045580|NCT02956629|50147988|FG004|Overall Study|Withdrawal by Subject|0|||
25045581|NCT02956629|50147989|FG005|Overall Study|Withdrawal by Subject|0|||
25045582|NCT01348347|50148006|FG000|Overall Study|Withdrawal by Subject|1|||
25045583|NCT01348347|50148007|FG001|Overall Study|Withdrawal by Subject|1|||
25045584|NCT01348347|50148008|FG002|Overall Study|Withdrawal by Subject|1|||
25045585|NCT01348347|50148006|FG000|Overall Study|Progressive disease|2|||
25045586|NCT01348347|50148007|FG001|Overall Study|Progressive disease|5|||
25045587|NCT01348347|50148008|FG002|Overall Study|Progressive disease|5|||
25045588|NCT02959671|50148017|FG000|Overall Study|Adverse Event|2|||
25045589|NCT02959671|50148017|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
25045590|NCT01597258|50148021|FG000|Overall Study|No Drug Administration|1|||
25045591|NCT02958267|50148027|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
25045592|NCT02958267|50148028|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
24958290|NCT00318474|50048801|FG001|Overall Study|Lost to Follow-up|1|||
24958291|NCT00318474|50048800|FG000|Overall Study|Pregnancy|0|||
24958292|NCT00318474|50048801|FG001|Overall Study|Pregnancy|2|||
24958293|NCT00318474|50048800|FG000|Overall Study|Protocol Violation|1|||
24958294|NCT00318474|50048801|FG001|Overall Study|Protocol Violation|0|||
24958295|NCT00318474|50048800|FG000|Overall Study|Withdrawal by Subject|3|||
24958296|NCT00318474|50048801|FG001|Overall Study|Withdrawal by Subject|2|||
24958297|NCT00318474|50048800|FG000|Overall Study|Fall in GFR|3|||
24958298|NCT00318474|50048801|FG001|Overall Study|Fall in GFR|3|||
24958299|NCT00318474|50048800|FG000|Overall Study|Post-therapy hyperflycemia|0|||
24958300|NCT00318474|50048801|FG001|Overall Study|Post-therapy hyperflycemia|1|||
24958301|NCT00318474|50048800|FG000|Overall Study|Trial terminated|10|||
24958302|NCT00318474|50048801|FG001|Overall Study|Trial terminated|7|||
25045593|NCT02958267|50148027|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
25045594|NCT02958267|50148028|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
25045595|NCT02958267|50148027|FG000|Follow-up Visits|Additional treatment pursued|2|||
25045596|NCT02958267|50148028|FG001|Follow-up Visits|Additional treatment pursued|1|||
25045597|NCT01952574|50148038|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
25045598|NCT01952574|50148039|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
25045599|NCT01952574|50148040|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
25045600|NCT01952574|50148041|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
25045601|NCT01952574|50148042|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
25045602|NCT01952574|50148043|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
25045603|NCT01952574|50148044|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
25045604|NCT01952574|50148038|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
25045605|NCT01952574|50148039|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
25045606|NCT01952574|50148040|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
25045607|NCT01952574|50148041|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
25045608|NCT01952574|50148042|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
25045609|NCT01952574|50148043|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
25045610|NCT01952574|50148044|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
25045611|NCT01952574|50148038|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
25045612|NCT01952574|50148039|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
25045613|NCT01952574|50148040|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
25045614|NCT01952574|50148041|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
25045615|NCT01952574|50148042|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
25045616|NCT01952574|50148043|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
25045617|NCT01952574|50148044|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
25045618|NCT01952574|50148038|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
25045619|NCT01952574|50148039|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
25045620|NCT01952574|50148040|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
25045621|NCT01952574|50148041|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
25045622|NCT01952574|50148042|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
25045623|NCT01952574|50148043|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
25045624|NCT01952574|50148044|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
25045625|NCT01952574|50148038|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
25045626|NCT01952574|50148039|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
25045627|NCT01952574|50148040|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
25045628|NCT01952574|50148041|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
25045629|NCT01952574|50148042|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
25045630|NCT01952574|50148043|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
25045631|NCT01952574|50148044|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
25045632|NCT01952574|50148038|FG000|Open-label Treatment Phase|Missing|0|||
25045633|NCT01952574|50148039|FG001|Open-label Treatment Phase|Missing|0|||
25045634|NCT01952574|50148040|FG002|Open-label Treatment Phase|Missing|0|||
25162447|NCT01791517|50284756|FG007|Phase I: Period 2|Lens Discomfort|0|||
24958303|NCT00350870|50048811|FG000|Overall Study|Withdrawal by Subject|21|||
24958304|NCT00350870|50048812|FG001|Overall Study|Withdrawal by Subject|17|||
24958305|NCT00350870|50048813|FG002|Overall Study|Withdrawal by Subject|15|||
24958306|NCT00350870|50048814|FG003|Overall Study|Withdrawal by Subject|14|||
25045635|NCT01952574|50148041|FG003|Open-label Treatment Phase|Missing|0|||
25045636|NCT01952574|50148042|FG004|Open-label Treatment Phase|Missing|4|||
25045637|NCT01952574|50148043|FG005|Open-label Treatment Phase|Missing|0|||
25045638|NCT01952574|50148044|FG006|Open-label Treatment Phase|Missing|0|||
25045639|NCT01952574|50148038|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
25045640|NCT01952574|50148039|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
25045641|NCT01952574|50148040|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
25045642|NCT01952574|50148041|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
25045643|NCT01952574|50148042|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
25045644|NCT01952574|50148043|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
25045645|NCT01952574|50148044|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
25045646|NCT01952574|50148038|FG000|Open-label Treatment Phase|Death|0|||
25045647|NCT01952574|50148039|FG001|Open-label Treatment Phase|Death|0|||
25045648|NCT01952574|50148040|FG002|Open-label Treatment Phase|Death|0|||
25045649|NCT01952574|50148041|FG003|Open-label Treatment Phase|Death|0|||
25045650|NCT01952574|50148042|FG004|Open-label Treatment Phase|Death|1|||
25045651|NCT01952574|50148043|FG005|Open-label Treatment Phase|Death|0|||
25045652|NCT01952574|50148044|FG006|Open-label Treatment Phase|Death|0|||
25045653|NCT01952574|50148038|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
24958307|NCT00350870|50048811|FG000|Overall Study|Physician Decision|1|||
24958308|NCT00350870|50048812|FG001|Overall Study|Physician Decision|0|||
24958309|NCT00350870|50048813|FG002|Overall Study|Physician Decision|1|||
24958310|NCT00350870|50048814|FG003|Overall Study|Physician Decision|1|||
24958311|NCT00350792|50048824|FG000|Overall Study|Adverse Event|11|||
24958312|NCT00350792|50048824|FG000|Overall Study|Death from Study Disease|1|||
24958313|NCT00350792|50048824|FG000|Overall Study|Death from Study Drug Toxicity|1|||
24958314|NCT00350792|50048824|FG000|Overall Study|Death Not Study Drug Related|2|||
24958315|NCT00350792|50048824|FG000|Overall Study|Protocol Violation|1|||
24958316|NCT00350792|50048824|FG000|Overall Study|Withdrawal by Subject|4|||
24958317|NCT00350792|50048824|FG000|Overall Study|Physician Decision|2|||
24958318|NCT00350792|50048824|FG000|Overall Study|Lack of Efficacy|11|||
24958319|NCT00317772|50048832|FG000|Overall Study|Adverse Event|0|||
24958320|NCT00317772|50048833|FG001|Overall Study|Adverse Event|0|||
24958321|NCT00317772|50048834|FG002|Overall Study|Adverse Event|0|||
24958322|NCT00317772|50048835|FG003|Overall Study|Adverse Event|2|||
24958323|NCT00317772|50048832|FG000|Overall Study|Disease Progression|2|||
24958324|NCT00317772|50048833|FG001|Overall Study|Disease Progression|2|||
24958325|NCT00317772|50048834|FG002|Overall Study|Disease Progression|1|||
24958326|NCT00317772|50048835|FG003|Overall Study|Disease Progression|7|||
24958327|NCT00350636|50048848|FG000|Overall Study|Adverse Event|19|||
24958328|NCT00350636|50048849|FG001|Overall Study|Adverse Event|13|||
24958329|NCT00350636|50048848|FG000|Overall Study|Protocol Violation|1|||
24958330|NCT00350636|50048849|FG001|Overall Study|Protocol Violation|3|||
24958331|NCT00350636|50048848|FG000|Overall Study|Withdrawal by Subject|13|||
24958332|NCT00350636|50048849|FG001|Overall Study|Withdrawal by Subject|17|||
24958333|NCT00350636|50048848|FG000|Overall Study|Lost to Follow-up|9|||
24958334|NCT00350636|50048849|FG001|Overall Study|Lost to Follow-up|8|||
24958335|NCT00350636|50048848|FG000|Overall Study|Physician Decision|0|||
24958336|NCT00350636|50048849|FG001|Overall Study|Physician Decision|2|||
24958337|NCT00350636|50048848|FG000|Overall Study|Other|1|||
24958338|NCT00350636|50048849|FG001|Overall Study|Other|2|||
24958339|NCT00346268|50048857|FG000|Overall Study|Adverse Event|1|||
24958340|NCT00346268|50048858|FG001|Overall Study|Adverse Event|0|||
24958341|NCT00346268|50048857|FG000|Overall Study|Protocol Violation|1|||
24958342|NCT00346268|50048858|FG001|Overall Study|Protocol Violation|0|||
24958343|NCT00346268|50048857|FG000|Overall Study|Participant refused|0|||
24958344|NCT00346268|50048858|FG001|Overall Study|Participant refused|3|||
24958345|NCT00327444|50048866|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
24958346|NCT00327444|50048867|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
24958347|NCT00327444|50048866|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
24958348|NCT00327444|50048867|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
24958349|NCT00327444|50048866|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
24958350|NCT00327444|50048867|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
25045654|NCT01952574|50148039|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
24958351|NCT00327444|50048866|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
25045655|NCT01952574|50148040|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
25045656|NCT01952574|50148041|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
25045657|NCT01952574|50148042|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
25045658|NCT01952574|50148043|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
25045659|NCT01952574|50148044|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
25045660|NCT01952574|50148038|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
25045661|NCT01952574|50148039|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
25045662|NCT01952574|50148040|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
25045663|NCT01952574|50148041|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
24958352|NCT00327444|50048867|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
24958353|NCT00327444|50048866|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
24958354|NCT00327444|50048867|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
25045664|NCT01952574|50148042|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
25045665|NCT01952574|50148043|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
25045666|NCT01952574|50148044|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
25045667|NCT02959437|50148073|FG000|Overall Study|Death|33|||
25045668|NCT02959437|50148074|FG001|Overall Study|Death|3|||
25045669|NCT02959437|50148075|FG002|Overall Study|Death|0|||
25045670|NCT02959437|50148076|FG003|Overall Study|Death|0|||
25045671|NCT02959437|50148073|FG000|Overall Study|Lost to Follow-up|3|||
25045672|NCT02959437|50148074|FG001|Overall Study|Lost to Follow-up|1|||
25045673|NCT02959437|50148075|FG002|Overall Study|Lost to Follow-up|0|||
25045674|NCT02959437|50148076|FG003|Overall Study|Lost to Follow-up|0|||
25045675|NCT02959437|50148073|FG000|Overall Study|Withdrawal by Subject|11|||
24958355|NCT00327444|50048866|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
24958356|NCT00327444|50048867|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
25045676|NCT02959437|50148074|FG001|Overall Study|Withdrawal by Subject|3|||
25045677|NCT02959437|50148075|FG002|Overall Study|Withdrawal by Subject|0|||
25045678|NCT02959437|50148076|FG003|Overall Study|Withdrawal by Subject|0|||
25045679|NCT02959437|50148073|FG000|Overall Study|Progressive Disease|9|||
25045680|NCT02959437|50148074|FG001|Overall Study|Progressive Disease|1|||
25045681|NCT02959437|50148075|FG002|Overall Study|Progressive Disease|0|||
25045682|NCT02959437|50148076|FG003|Overall Study|Progressive Disease|0|||
25045683|NCT02959437|50148073|FG000|Overall Study|Study Terminated by Sponsor|4|||
25045684|NCT02959437|50148074|FG001|Overall Study|Study Terminated by Sponsor|0|||
25045685|NCT02959437|50148075|FG002|Overall Study|Study Terminated by Sponsor|0|||
25045686|NCT02959437|50148076|FG003|Overall Study|Study Terminated by Sponsor|0|||
25045687|NCT02959437|50148073|FG000|Overall Study|Other Unspecified|2|||
25045688|NCT02959437|50148074|FG001|Overall Study|Other Unspecified|0|||
25045689|NCT02959437|50148075|FG002|Overall Study|Other Unspecified|0|||
25045690|NCT02959437|50148076|FG003|Overall Study|Other Unspecified|0|||
25045691|NCT02957331|50148089|FG000|Overall Study|Protocol Violation|1|||
25045692|NCT02957331|50148090|FG001|Overall Study|Protocol Violation|0|||
25045693|NCT05212883|50148096|FG000|Overall Study|Invalid test result|125|||
25045694|NCT04995055|50148104|FG000|Period 1|COVID-19 Related|1|||
25045695|NCT04995055|50148105|FG001|Period 1|COVID-19 Related|0|||
25045696|NCT04995055|50148104|FG000|Period 1|Withdrawal by Subject|0|||
25045697|NCT04995055|50148105|FG001|Period 1|Withdrawal by Subject|1|||
25045698|NCT04995055|50148104|FG000|Period 1|Subject discontinued due to timing|4|||
25045699|NCT04995055|50148105|FG001|Period 1|Subject discontinued due to timing|4|||
25045700|NCT04778592|50148113|FG000|Overall Study|Adverse Event|1|||
25045701|NCT04778592|50148114|FG001|Overall Study|Adverse Event|2|||
25045702|NCT04778592|50148113|FG000|Overall Study|Withdrawal by Subject|1|||
25045703|NCT04778592|50148114|FG001|Overall Study|Withdrawal by Subject|2|||
25045704|NCT04743635|50148122|FG000|Overall Study|Lost to Follow-up|2|||
25045705|NCT04743635|50148123|FG001|Overall Study|Lost to Follow-up|0|||
25045706|NCT04712110|50148130|FG000|Overall Study|Lost to Follow-up|0|||
25162448|NCT01791517|50284757|FG008|Phase I: Period 2|Lens Discomfort|0|||
24958357|NCT00327444|50048866|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
24958358|NCT00327444|50048867|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
24958359|NCT00327444|50048866|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
24958360|NCT00327444|50048867|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
24958361|NCT00337610|50048877|FG000|Overall Study|Adverse Event|2|||
24958362|NCT00337610|50048878|FG001|Overall Study|Adverse Event|2|||
24958363|NCT00337610|50048877|FG000|Overall Study|Death|0|||
24958364|NCT00337610|50048878|FG001|Overall Study|Death|1|||
24958365|NCT00337610|50048877|FG000|Overall Study|Lack of Efficacy|6|||
24958366|NCT00337610|50048878|FG001|Overall Study|Lack of Efficacy|3|||
24958367|NCT00337610|50048877|FG000|Overall Study|Lost to Follow-up|3|||
25045707|NCT04712110|50148131|FG001|Overall Study|Lost to Follow-up|1|||
25045708|NCT04712110|50148130|FG000|Overall Study|Withdrawal by Subject|0|||
25045709|NCT04712110|50148131|FG001|Overall Study|Withdrawal by Subject|4|||
25162449|NCT01791517|50284758|FG009|Phase I: Period 2|Lens Discomfort|0|||
24958368|NCT00337610|50048878|FG001|Overall Study|Lost to Follow-up|3|||
24958369|NCT00337610|50048877|FG000|Overall Study|Withdrawal by Subject|6|||
25045710|NCT04712110|50148130|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
25045711|NCT04712110|50148131|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
25045712|NCT04696055|50148139|FG000|Overall Study|Adverse Event|10|||
25045713|NCT04696055|50148140|FG001|Overall Study|Adverse Event|0|||
25045714|NCT04696055|50148139|FG000|Overall Study|Death|2|||
25045715|NCT04696055|50148140|FG001|Overall Study|Death|1|||
25045716|NCT04696055|50148139|FG000|Overall Study|Other|4|||
25045717|NCT04696055|50148140|FG001|Overall Study|Other|0|||
25045718|NCT04696055|50148139|FG000|Overall Study|Physician Decision|1|||
25045719|NCT04696055|50148140|FG001|Overall Study|Physician Decision|0|||
25045720|NCT04696055|50148139|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
25045721|NCT04696055|50148140|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
25045722|NCT04696055|50148139|FG000|Overall Study|Progressive Disease - Radiological Progression|36|||
25045723|NCT04696055|50148140|FG001|Overall Study|Progressive Disease - Radiological Progression|13|||
25045724|NCT04696055|50148139|FG000|Overall Study|Subject Decision|1|||
25045725|NCT04696055|50148140|FG001|Overall Study|Subject Decision|2|||
25045726|NCT04696055|50148139|FG000|Overall Study|Ongoing with study treatment|13|||
25045727|NCT04696055|50148140|FG001|Overall Study|Ongoing with study treatment|10|||
25045728|NCT04476017|50148148|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
25045729|NCT04476017|50148149|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
25045730|NCT04143594|50148164|FG000|Overall Study|Still on study|48|||
25045731|NCT04143594|50148165|FG001|Overall Study|Still on study|42|||
25045732|NCT04143594|50148166|FG002|Overall Study|Still on study|48|||
25045733|NCT04143594|50148167|FG003|Overall Study|Still on study|18|||
25045734|NCT04143594|50148164|FG000|Overall Study|Withdrew consent|0|||
25045735|NCT04143594|50148165|FG001|Overall Study|Withdrew consent|6|||
25045736|NCT04143594|50148166|FG002|Overall Study|Withdrew consent|1|||
25045737|NCT04143594|50148167|FG003|Overall Study|Withdrew consent|1|||
25045738|NCT04143594|50148164|FG000|Overall Study|Lost to Follow-up|2|||
25045739|NCT04143594|50148165|FG001|Overall Study|Lost to Follow-up|2|||
25045740|NCT04143594|50148166|FG002|Overall Study|Lost to Follow-up|3|||
25045741|NCT04143594|50148167|FG003|Overall Study|Lost to Follow-up|0|||
25045742|NCT04143594|50148164|FG000|Overall Study|Investigator's discretion|1|||
25045743|NCT04143594|50148165|FG001|Overall Study|Investigator's discretion|2|||
25045744|NCT04143594|50148166|FG002|Overall Study|Investigator's discretion|0|||
25045745|NCT04143594|50148167|FG003|Overall Study|Investigator's discretion|0|||
25045746|NCT04143594|50148164|FG000|Overall Study|Lack of Efficacy|0|||
25045747|NCT04143594|50148165|FG001|Overall Study|Lack of Efficacy|1|||
25045748|NCT04143594|50148166|FG002|Overall Study|Lack of Efficacy|0|||
25045749|NCT04143594|50148167|FG003|Overall Study|Lack of Efficacy|0|||
25045750|NCT04143594|50148164|FG000|Overall Study|Protocol Violation|0|||
25045751|NCT04143594|50148165|FG001|Overall Study|Protocol Violation|0|||
25045752|NCT04143594|50148166|FG002|Overall Study|Protocol Violation|0|||
25045753|NCT04143594|50148167|FG003|Overall Study|Protocol Violation|1|||
25045754|NCT03877510|50148193|FG000|Overall Study|Death|6|||
25045755|NCT03877510|50148193|FG000|Overall Study|Lost to Follow-up|2|||
25045756|NCT03877510|50148193|FG000|Overall Study|Non-compliance with study drug|2|||
25045757|NCT03877510|50148193|FG000|Overall Study|Lack of Efficacy|14|||
25045758|NCT03877510|50148193|FG000|Overall Study|Adverse Event|20|||
25045759|NCT03877510|50148193|FG000|Overall Study|Withdrawal by Subject|22|||
25045760|NCT03877510|50148193|FG000|Overall Study|Miscellaneous|1|||
25045761|NCT03846427|50148197|FG000|Overall Study|Death|13|||
25045762|NCT03846427|50148197|FG000|Overall Study|Withdrawal by Subject|3|||
25045763|NCT03846427|50148197|FG000|Overall Study|Physician Decision|1|||
25045764|NCT03706079|50148226|FG000|Predecessor Study|Death|0|||
25045765|NCT03706079|50148227|FG001|Predecessor Study|Death|2|||
25045766|NCT03706079|50148228|FG002|Predecessor Study|Death|0|||
25045767|NCT03706079|50148229|FG003|Predecessor Study|Death|1|||
25045768|NCT03706079|50148230|FG004|Predecessor Study|Death|0|||
25045769|NCT03706079|50148231|FG005|Predecessor Study|Death|0|||
25045770|NCT03706079|50148226|FG000|Predecessor Study|Lost to Follow-up|5|||
25045771|NCT03706079|50148227|FG001|Predecessor Study|Lost to Follow-up|2|||
25045772|NCT03706079|50148228|FG002|Predecessor Study|Lost to Follow-up|0|||
25045773|NCT03706079|50148229|FG003|Predecessor Study|Lost to Follow-up|0|||
25045774|NCT03706079|50148230|FG004|Predecessor Study|Lost to Follow-up|1|||
25045775|NCT03706079|50148231|FG005|Predecessor Study|Lost to Follow-up|0|||
25045776|NCT03706079|50148226|FG000|Predecessor Study|Withdrawal by Subject|8|||
25045777|NCT03706079|50148227|FG001|Predecessor Study|Withdrawal by Subject|15|||
25045778|NCT03706079|50148228|FG002|Predecessor Study|Withdrawal by Subject|0|||
25045779|NCT03706079|50148229|FG003|Predecessor Study|Withdrawal by Subject|5|||
25045780|NCT03706079|50148230|FG004|Predecessor Study|Withdrawal by Subject|2|||
25045781|NCT03706079|50148231|FG005|Predecessor Study|Withdrawal by Subject|0|||
25045782|NCT03706079|50148226|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
25045783|NCT03706079|50148227|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
25162450|NCT01791517|50284759|FG010|Phase I: Period 2|Lens Discomfort|0|||
25162451|NCT01791517|50284760|FG011|Phase I: Period 2|Lens Discomfort|0|||
25045784|NCT03706079|50148228|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
25045785|NCT03706079|50148229|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
25045786|NCT03706079|50148230|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
25045787|NCT03706079|50148231|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
25045788|NCT03706079|50148226|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
25045789|NCT03706079|50148227|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
25045790|NCT03706079|50148228|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
25045791|NCT03706079|50148229|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
25045792|NCT03706079|50148230|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
25045793|NCT03706079|50148231|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
25045794|NCT03706079|50148226|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
25045795|NCT03706079|50148227|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
25045796|NCT03706079|50148228|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
25045797|NCT03706079|50148229|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
25045798|NCT03706079|50148230|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
25045799|NCT03706079|50148231|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
25045800|NCT03706079|50148226|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
25045801|NCT03706079|50148227|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
25045802|NCT03706079|50148228|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
25045803|NCT03706079|50148229|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
25045804|NCT03706079|50148230|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
25045805|NCT03706079|50148231|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
25045806|NCT03706079|50148226|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
25045807|NCT03706079|50148227|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
25045808|NCT03706079|50148228|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
25045809|NCT03706079|50148229|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
25045810|NCT03706079|50148230|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
25045811|NCT03706079|50148231|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
25045812|NCT03706079|50148226|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
25045813|NCT03706079|50148227|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
25045814|NCT03706079|50148228|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
25045815|NCT03706079|50148229|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
25045816|NCT03706079|50148230|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
25045817|NCT03706079|50148231|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
25045818|NCT03706079|50148226|FG000|Long Term Extension (DESTINATION)|Death|8|||
25045819|NCT03706079|50148227|FG001|Long Term Extension (DESTINATION)|Death|2|||
25045820|NCT03706079|50148228|FG002|Long Term Extension (DESTINATION)|Death|2|||
25045821|NCT03706079|50148229|FG003|Long Term Extension (DESTINATION)|Death|1|||
25045822|NCT03706079|50148230|FG004|Long Term Extension (DESTINATION)|Death|0|||
25045823|NCT03706079|50148231|FG005|Long Term Extension (DESTINATION)|Death|0|||
25045824|NCT03657160|50148245|FG000|Overall Study|Adverse Event|5|||
25045825|NCT03657160|50148246|FG001|Overall Study|Adverse Event|6|||
25045826|NCT03657160|50148245|FG000|Overall Study|Protocol Deviation|3|||
25045827|NCT03657160|50148246|FG001|Overall Study|Protocol Deviation|0|||
25045828|NCT03657160|50148245|FG000|Overall Study|Withdrawal by Subject|18|||
25045829|NCT03657160|50148246|FG001|Overall Study|Withdrawal by Subject|16|||
25045830|NCT03657160|50148245|FG000|Overall Study|Site Termination|1|||
25045831|NCT03657160|50148246|FG001|Overall Study|Site Termination|0|||
25045832|NCT03657160|50148245|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
25045833|NCT03657160|50148246|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
25045834|NCT03657160|50148245|FG000|Overall Study|Death|33|||
25045835|NCT03657160|50148246|FG001|Overall Study|Death|26|||
25045836|NCT03657160|50148245|FG000|Overall Study|Death (COVID-19-Related)|1|||
25045837|NCT03657160|50148246|FG001|Overall Study|Death (COVID-19-Related)|0|||
25045838|NCT03657160|50148245|FG000|Overall Study|Reason Not Specified|5|||
25045839|NCT03657160|50148246|FG001|Overall Study|Reason Not Specified|5|||
25045840|NCT03657160|50148245|FG000|Overall Study|Other (COVID-19-Related)|0|||
25045841|NCT03657160|50148246|FG001|Overall Study|Other (COVID-19-Related)|1|||
25045842|NCT03635320|50148256|FG000|Overall Study|not implanted the device|1|||
25045843|NCT03635320|50148257|FG001|Overall Study|not implanted the device|2|||
25045844|NCT03635320|50148256|FG000|Overall Study|Withdrawal by Subject|11|||
25045845|NCT03635320|50148257|FG001|Overall Study|Withdrawal by Subject|6|||
25045846|NCT03508726|50148274|FG000|Overall Study|Withdrawal by Subject|0|||
25045847|NCT03508726|50148275|FG001|Overall Study|Withdrawal by Subject|1|||
25045848|NCT03499964|50148284|FG000|Overall Study|Lack of Efficacy|6|||
25045849|NCT03499964|50148285|FG001|Overall Study|Lack of Efficacy|26|||
25045850|NCT03499964|50148284|FG000|Overall Study|Adverse Event|1|||
25045851|NCT03499964|50148285|FG001|Overall Study|Adverse Event|0|||
25045852|NCT03499964|50148284|FG000|Overall Study|Death|1|||
25045853|NCT03499964|50148285|FG001|Overall Study|Death|0|||
25045854|NCT03499964|50148284|FG000|Overall Study|Withdrawal by Subject|2|||
25045855|NCT03499964|50148285|FG001|Overall Study|Withdrawal by Subject|1|||
25045856|NCT03499964|50148284|FG000|Overall Study|Lost to Follow-up|1|||
25045857|NCT03499964|50148285|FG001|Overall Study|Lost to Follow-up|0|||
25045858|NCT03345784|50148293|FG000|Overall Study|Withdrawal by Subject|2|||
25045859|NCT03345784|50148294|FG001|Overall Study|Withdrawal by Subject|1|||
25045860|NCT03279692|50148300|FG000|Overall Study|Withdrawal by Subject|1|||
25045861|NCT03001882|50148317|FG000|Overall Study|Death|1|||
25045862|NCT03001882|50148318|FG001|Overall Study|Death|0|||
25045863|NCT03001882|50148319|FG002|Overall Study|Death|0|||
25045864|NCT03001882|50148320|FG003|Overall Study|Death|3|||
25045865|NCT03001882|50148317|FG000|Overall Study|Participant withdrew consent|0|||
25045866|NCT03001882|50148318|FG001|Overall Study|Participant withdrew consent|1|||
25045867|NCT03001882|50148319|FG002|Overall Study|Participant withdrew consent|0|||
25045868|NCT03001882|50148320|FG003|Overall Study|Participant withdrew consent|5|||
25045869|NCT03001882|50148317|FG000|Overall Study|Other reasons|1|||
25045870|NCT03001882|50148318|FG001|Overall Study|Other reasons|2|||
25045871|NCT03001882|50148319|FG002|Overall Study|Other reasons|0|||
25045872|NCT03001882|50148320|FG003|Overall Study|Other reasons|5|||
25045873|NCT03001882|50148317|FG000|Overall Study|Administrative reason by sponsor|0|||
25045874|NCT03001882|50148318|FG001|Overall Study|Administrative reason by sponsor|0|||
25045875|NCT03001882|50148319|FG002|Overall Study|Administrative reason by sponsor|0|||
25045876|NCT03001882|50148320|FG003|Overall Study|Administrative reason by sponsor|1|||
25045877|NCT03001882|50148317|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
25045878|NCT03001882|50148318|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
25045879|NCT03001882|50148319|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
25045880|NCT03001882|50148320|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
25045881|NCT03001882|50148317|FG000|Overall Study|Not reported|0|||
25045882|NCT03001882|50148318|FG001|Overall Study|Not reported|0|||
25045883|NCT03001882|50148319|FG002|Overall Study|Not reported|0|||
25045884|NCT03001882|50148320|FG003|Overall Study|Not reported|6|||
25045885|NCT03001882|50148317|FG000|Overall Study|Maximum clinical benefit|1|||
25045886|NCT03001882|50148318|FG001|Overall Study|Maximum clinical benefit|2|||
25045887|NCT03001882|50148319|FG002|Overall Study|Maximum clinical benefit|0|||
25045888|NCT03001882|50148320|FG003|Overall Study|Maximum clinical benefit|10|||
25045889|NCT03001882|50148317|FG000|Overall Study|AE unrelated to study drug|3|||
25045890|NCT03001882|50148318|FG001|Overall Study|AE unrelated to study drug|3|||
25045891|NCT03001882|50148319|FG002|Overall Study|AE unrelated to study drug|0|||
25045892|NCT03001882|50148320|FG003|Overall Study|AE unrelated to study drug|11|||
25045893|NCT03001882|50148317|FG000|Overall Study|Study Drug Toxicity|8|||
25045894|NCT03001882|50148318|FG001|Overall Study|Study Drug Toxicity|5|||
25045895|NCT03001882|50148319|FG002|Overall Study|Study Drug Toxicity|0|||
25045896|NCT03001882|50148320|FG003|Overall Study|Study Drug Toxicity|37|||
25045897|NCT03001882|50148317|FG000|Overall Study|Disease progression|15|||
25045898|NCT03001882|50148318|FG001|Overall Study|Disease progression|14|||
25045899|NCT03001882|50148319|FG002|Overall Study|Disease progression|2|||
25045900|NCT03001882|50148320|FG003|Overall Study|Disease progression|90|||
25045901|NCT02985151|50148337|FG000|Original Randomization|Withdrawal by Subject|0|||
25045902|NCT02985151|50148338|FG001|Original Randomization|Withdrawal by Subject|1|||
25045903|NCT02603432|50148410|FG000|Overall Study|Ongoing|184|||
25045904|NCT02603432|50148411|FG001|Overall Study|Ongoing|144|||
25045905|NCT02603432|50148410|FG000|Overall Study|Adverse Event|1|||
25045906|NCT02603432|50148411|FG001|Overall Study|Adverse Event|0|||
25045907|NCT02603432|50148410|FG000|Overall Study|Death|144|||
25045908|NCT02603432|50148411|FG001|Overall Study|Death|177|||
25045909|NCT02603432|50148410|FG000|Overall Study|Lost to Follow-up|4|||
25045910|NCT02603432|50148411|FG001|Overall Study|Lost to Follow-up|6|||
25045911|NCT02603432|50148410|FG000|Overall Study|Progressive Disease|5|||
25045912|NCT02603432|50148411|FG001|Overall Study|Progressive Disease|5|||
25045913|NCT02603432|50148410|FG000|Overall Study|Withdrawal by Subject|9|||
25045914|NCT02603432|50148411|FG001|Overall Study|Withdrawal by Subject|17|||
25045915|NCT02603432|50148410|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
25045916|NCT02603432|50148411|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
25045917|NCT02603432|50148410|FG000|Overall Study|Other|0|||
25045918|NCT02603432|50148411|FG001|Overall Study|Other|1|||
25045919|NCT02582866|50148417|FG000|Overall Study|Death|1|||
25045920|NCT02582866|50148417|FG000|Overall Study|Lack of Efficacy|2|||
25045921|NCT02582866|50148417|FG000|Overall Study|Lost to Follow-up|2|||
25045922|NCT02582866|50148417|FG000|Overall Study|Withdrawal by Subject|7|||
25045923|NCT02582866|50148417|FG000|Overall Study|Investigator decision|5|||
25045924|NCT02582866|50148417|FG000|Overall Study|Participant wants to get pregnant|1|||
25045925|NCT02582866|50148417|FG000|Overall Study|Pregnancy|2|||
25045926|NCT02582866|50148417|FG000|Overall Study|Sponsor decision|1|||
25045927|NCT02582866|50148417|FG000|Overall Study|Withdrawal due to personal reasons|1|||
25045928|NCT02562235|50148421|FG000|Overall Study|Adverse Event|3|||
25045929|NCT02395666|50148432|FG000|Overall Study|Physician Decision|3|||
25045930|NCT02395666|50148433|FG001|Overall Study|Physician Decision|0|||
25045931|NCT02395666|50148432|FG000|Overall Study|Lost to Follow-up|1|||
25045932|NCT02395666|50148433|FG001|Overall Study|Lost to Follow-up|0|||
25045933|NCT02395666|50148432|FG000|Overall Study|Withdrawal by Subject|2|||
25045934|NCT02395666|50148433|FG001|Overall Study|Withdrawal by Subject|1|||
25045935|NCT02180867|50148450|FG000|Overall Study|Adverse Event|3|||
25045936|NCT02180867|50148451|FG001|Overall Study|Adverse Event|4|||
25045937|NCT02180867|50148452|FG002|Overall Study|Adverse Event|1|||
25045938|NCT02180867|50148453|FG003|Overall Study|Adverse Event|5|||
25045939|NCT02180867|50148454|FG004|Overall Study|Adverse Event|0|||
25045940|NCT02180867|50148455|FG005|Overall Study|Adverse Event|0|||
25045941|NCT02180867|50148456|FG006|Overall Study|Adverse Event|0|||
25045942|NCT02180867|50148450|FG000|Overall Study|Death|0|||
25045943|NCT02180867|50148451|FG001|Overall Study|Death|0|||
25045944|NCT02180867|50148452|FG002|Overall Study|Death|0|||
25045945|NCT02180867|50148453|FG003|Overall Study|Death|0|||
25045946|NCT02180867|50148454|FG004|Overall Study|Death|1|||
25045947|NCT02180867|50148455|FG005|Overall Study|Death|0|||
25045948|NCT02180867|50148456|FG006|Overall Study|Death|0|||
25045949|NCT02180867|50148450|FG000|Overall Study|Lack of Efficacy|0|||
25045950|NCT02180867|50148451|FG001|Overall Study|Lack of Efficacy|2|||
25045951|NCT02180867|50148452|FG002|Overall Study|Lack of Efficacy|0|||
25045952|NCT02180867|50148453|FG003|Overall Study|Lack of Efficacy|1|||
25045953|NCT02180867|50148454|FG004|Overall Study|Lack of Efficacy|6|||
25045954|NCT02180867|50148455|FG005|Overall Study|Lack of Efficacy|0|||
25045955|NCT02180867|50148456|FG006|Overall Study|Lack of Efficacy|1|||
25045956|NCT02180867|50148450|FG000|Overall Study|Physician Decision|1|||
25045957|NCT02180867|50148451|FG001|Overall Study|Physician Decision|3|||
25045958|NCT02180867|50148452|FG002|Overall Study|Physician Decision|1|||
25045959|NCT02180867|50148453|FG003|Overall Study|Physician Decision|10|||
25045960|NCT02180867|50148454|FG004|Overall Study|Physician Decision|9|||
25045961|NCT02180867|50148455|FG005|Overall Study|Physician Decision|3|||
25045962|NCT02180867|50148456|FG006|Overall Study|Physician Decision|4|||
25045963|NCT02180867|50148450|FG000|Overall Study|Withdrawal by Subject|0|||
25045964|NCT02180867|50148451|FG001|Overall Study|Withdrawal by Subject|0|||
25045965|NCT02180867|50148452|FG002|Overall Study|Withdrawal by Subject|0|||
25045966|NCT02180867|50148453|FG003|Overall Study|Withdrawal by Subject|1|||
25045967|NCT02180867|50148454|FG004|Overall Study|Withdrawal by Subject|1|||
25045968|NCT02180867|50148455|FG005|Overall Study|Withdrawal by Subject|0|||
25045969|NCT02180867|50148456|FG006|Overall Study|Withdrawal by Subject|0|||
25045970|NCT02180867|50148450|FG000|Overall Study|Ineligible|1|||
25045971|NCT02180867|50148451|FG001|Overall Study|Ineligible|2|||
25045972|NCT02180867|50148452|FG002|Overall Study|Ineligible|0|||
25045973|NCT02180867|50148453|FG003|Overall Study|Ineligible|3|||
25045974|NCT02180867|50148454|FG004|Overall Study|Ineligible|5|||
25045975|NCT02180867|50148455|FG005|Overall Study|Ineligible|0|||
25045976|NCT02180867|50148456|FG006|Overall Study|Ineligible|0|||
25045977|NCT02180867|50148450|FG000|Overall Study|Repeat Eligibility Studies|0|||
25045978|NCT02180867|50148451|FG001|Overall Study|Repeat Eligibility Studies|0|||
25045979|NCT02180867|50148452|FG002|Overall Study|Repeat Eligibility Studies|0|||
25045980|NCT02180867|50148453|FG003|Overall Study|Repeat Eligibility Studies|0|||
25045981|NCT02180867|50148454|FG004|Overall Study|Repeat Eligibility Studies|1|||
25045982|NCT02180867|50148455|FG005|Overall Study|Repeat Eligibility Studies|0|||
25045983|NCT02180867|50148456|FG006|Overall Study|Repeat Eligibility Studies|0|||
25045984|NCT02180867|50148450|FG000|Overall Study|Refusal of further protocol therapy|1|||
25045985|NCT02180867|50148451|FG001|Overall Study|Refusal of further protocol therapy|0|||
25045986|NCT02180867|50148452|FG002|Overall Study|Refusal of further protocol therapy|2|||
25045987|NCT02180867|50148453|FG003|Overall Study|Refusal of further protocol therapy|6|||
25045988|NCT02180867|50148454|FG004|Overall Study|Refusal of further protocol therapy|4|||
25045989|NCT02180867|50148455|FG005|Overall Study|Refusal of further protocol therapy|0|||
25045990|NCT02180867|50148456|FG006|Overall Study|Refusal of further protocol therapy|0|||
25045991|NCT01734928|50148490|FG000|Randomization|Physician Decision|0|||
25045992|NCT01734928|50148491|FG001|Randomization|Physician Decision|1|||
25045993|NCT01734928|50148490|FG000|Randomization|clinical progression|0|||
25045994|NCT01734928|50148491|FG001|Randomization|clinical progression|1|||
25045995|NCT01734928|50148490|FG000|Randomization|progressive disease|0|||
25045996|NCT01734928|50148491|FG001|Randomization|progressive disease|2|||
25045997|NCT01734928|50148490|FG000|Randomization|Withdrew informed consent|0|||
25045998|NCT01734928|50148491|FG001|Randomization|Withdrew informed consent|4|||
25045999|NCT01734928|50148490|FG000|Randomization|Death|1|||
25046000|NCT01734928|50148491|FG001|Randomization|Death|0|||
25046001|NCT01734928|50148490|FG000|Randomization|Randomization error|1|||
25046002|NCT01734928|50148491|FG001|Randomization|Randomization error|0|||
25046003|NCT01734928|50148490|FG000|Randomization|Lost to Follow-up|1|||
25046004|NCT01734928|50148491|FG001|Randomization|Lost to Follow-up|0|||
25046005|NCT01734928|50148490|FG000|Treatment Period|Lost to Follow-up|0|||
25046006|NCT01734928|50148491|FG001|Treatment Period|Lost to Follow-up|2|||
25046007|NCT01734928|50148490|FG000|Treatment Period|Progressive Disease|167|||
25046008|NCT01734928|50148491|FG001|Treatment Period|Progressive Disease|165|||
25046009|NCT01734928|50148490|FG000|Treatment Period|Adverse Event|39|||
25046010|NCT01734928|50148491|FG001|Treatment Period|Adverse Event|52|||
25046011|NCT01734928|50148490|FG000|Treatment Period|Withdrawal of Consent|25|||
25046012|NCT01734928|50148491|FG001|Treatment Period|Withdrawal of Consent|22|||
25046013|NCT01734928|50148490|FG000|Treatment Period|Death|20|||
25046014|NCT01734928|50148491|FG001|Treatment Period|Death|9|||
25046015|NCT01734928|50148490|FG000|Treatment Period|Other Reasons|27|||
25046016|NCT01734928|50148491|FG001|Treatment Period|Other Reasons|19|||
25046017|NCT01734928|50148490|FG000|Treatment Period|Pregnancy|0|||
25046018|NCT01734928|50148491|FG001|Treatment Period|Pregnancy|1|||
25046019|NCT00667459|50148508|FG000|Overall Study|Death|0|||
25046020|NCT00667459|50148509|FG001|Overall Study|Death|2|||
25046021|NCT00667459|50148508|FG000|Overall Study|Lost to Follow-up|8|||
25046022|NCT00667459|50148509|FG001|Overall Study|Lost to Follow-up|43|||
25046023|NCT00453544|50148523|FG000|Overall Study|Withdrawal by Subject|1|||
25046024|NCT00453544|50148524|FG001|Overall Study|Withdrawal by Subject|0|||
25046025|NCT00453544|50148525|FG002|Overall Study|Withdrawal by Subject|0|||
25046026|NCT00453544|50148526|FG003|Overall Study|Withdrawal by Subject|0|||
25046027|NCT00453544|50148523|FG000|Overall Study|Primary outcome measure not completed|1|||
25046028|NCT00453544|50148524|FG001|Overall Study|Primary outcome measure not completed|1|||
25046029|NCT00453544|50148525|FG002|Overall Study|Primary outcome measure not completed|0|||
24958370|NCT00337610|50048878|FG001|Overall Study|Withdrawal by Subject|5|||
24958371|NCT00316914|50048886|FG000|Overall Study|Withdrawal by Subject|5|||
24958372|NCT00316914|50048887|FG001|Overall Study|Withdrawal by Subject|3|||
24958373|NCT00316914|50048886|FG000|Overall Study|Adverse Event|8|||
24958374|NCT00316914|50048887|FG001|Overall Study|Adverse Event|7|||
24958375|NCT00316914|50048886|FG000|Overall Study|Other Problems|6|||
24958376|NCT00316914|50048887|FG001|Overall Study|Other Problems|11|||
24958377|NCT00316914|50048886|FG000|Overall Study|Missing end of treatment documentation|14|||
24958378|NCT00316914|50048887|FG001|Overall Study|Missing end of treatment documentation|15|||
25046030|NCT00453544|50148526|FG003|Overall Study|Primary outcome measure not completed|1|||
25046031|NCT02646124|50148550|FG000|Overall Study|Lost to Follow-up|0|||
25046032|NCT02646124|50148551|FG001|Overall Study|Lost to Follow-up|2|||
25276334|NCT00960934|50590274|FG003|Overall Study|Withdrawal by Subject|5|||
25276335|NCT00960934|50590275|FG004|Overall Study|Withdrawal by Subject|5|||
25276336|NCT00960934|50590276|FG005|Overall Study|Withdrawal by Subject|7|||
25276337|NCT00960934|50590271|FG000|Overall Study|Study Terminated by Sponsor|50|||
25276338|NCT00960934|50590272|FG001|Overall Study|Study Terminated by Sponsor|46|||
25276339|NCT00960934|50590273|FG002|Overall Study|Study Terminated by Sponsor|52|||
25276340|NCT00960934|50590274|FG003|Overall Study|Study Terminated by Sponsor|50|||
25276341|NCT00960934|50590275|FG004|Overall Study|Study Terminated by Sponsor|49|||
25276342|NCT00960934|50590276|FG005|Overall Study|Study Terminated by Sponsor|49|||
25276343|NCT00892177|50590293|FG000|Phase II|Ineligible|0|||
25276344|NCT00892177|50590294|FG001|Phase II|Ineligible|0|||
25276345|NCT00892177|50590295|FG002|Phase II|Ineligible|0|||
25046045|NCT01597492|50148570|FG000|Overall Study|Withdrawal by Subject|1|||
25046046|NCT01597492|50148571|FG001|Overall Study|Withdrawal by Subject|2|||
25046047|NCT01597492|50148570|FG000|Overall Study|Adverse Event|3|||
25046048|NCT01597492|50148571|FG001|Overall Study|Adverse Event|0|||
25046049|NCT01597492|50148570|FG000|Overall Study|Lost to Follow-up|0|||
25046050|NCT01597492|50148571|FG001|Overall Study|Lost to Follow-up|2|||
25046051|NCT01597492|50148570|FG000|Overall Study|Other Reason|2|||
25046052|NCT01597492|50148571|FG001|Overall Study|Other Reason|0|||
25046053|NCT03423602|50148577|FG000|Overall Study|Death|1|||
25046054|NCT03423602|50148577|FG000|Overall Study|Lost to Follow-up|6|||
25046055|NCT03423602|50148577|FG000|Overall Study|Protocol Violation|1|||
25046056|NCT03423602|50148577|FG000|Overall Study|Withdrawal by Subject|4|||
25046057|NCT00109590|50148584|FG000|Overall Study|Lost to Follow-up|1|||
25046058|NCT00109590|50148585|FG001|Overall Study|Lost to Follow-up|0|||
25046059|NCT00109590|50148586|FG002|Overall Study|Lost to Follow-up|1|||
25046060|NCT00109590|50148584|FG000|Overall Study|Never Started Treatment|1|||
25046061|NCT00109590|50148585|FG001|Overall Study|Never Started Treatment|2|||
25046062|NCT00109590|50148586|FG002|Overall Study|Never Started Treatment|3|||
25046063|NCT02781558|50148610|FG000|Overall Study|Lost to Follow-up|2|||
25046064|NCT02781558|50148611|FG001|Overall Study|Lost to Follow-up|2|||
25046065|NCT02781558|50148610|FG000|Overall Study|Adverse Event|1|||
25046066|NCT02781558|50148611|FG001|Overall Study|Adverse Event|0|||
25046067|NCT03041311|50148620|FG000|Overall Study|Death|39|||
25046068|NCT03041311|50148621|FG001|Overall Study|Death|42|||
25046069|NCT03041311|50148620|FG000|Overall Study|Lost to Follow-up|0|||
25046070|NCT03041311|50148621|FG001|Overall Study|Lost to Follow-up|1|||
25046071|NCT03041311|50148620|FG000|Overall Study|Withdrawal by Subject|8|||
25046072|NCT03041311|50148621|FG001|Overall Study|Withdrawal by Subject|5|||
25046073|NCT03041311|50148620|FG000|Overall Study|Sponsor Terminated Study|2|||
25046074|NCT03041311|50148621|FG001|Overall Study|Sponsor Terminated Study|4|||
25046075|NCT03041311|50148620|FG000|Overall Study|Disease Progression|3|||
25046076|NCT03041311|50148621|FG001|Overall Study|Disease Progression|1|||
25046077|NCT03041311|50148620|FG000|Overall Study|Randomized in error, did not receive drug|2|||
25276346|NCT00892177|50590296|FG003|Phase II|Ineligible|0|||
24958379|NCT00336284|50048895|FG000|Overall Study|Death|52|||
25046078|NCT03041311|50148621|FG001|Overall Study|Randomized in error, did not receive drug|0|||
25046079|NCT02644096|50148637|FG000|Overall Study|Withdrawal by Subject|28|||
25046080|NCT02644096|50148638|FG001|Overall Study|Withdrawal by Subject|25|||
25046081|NCT02643628|50148646|FG000|Overall Study|Lost to Follow-up|1|||
25046082|NCT02643628|50148647|FG001|Overall Study|Lost to Follow-up|4|||
25046083|NCT02643628|50148646|FG000|Overall Study|Withdrawal by Subject|0|||
25046084|NCT02643628|50148647|FG001|Overall Study|Withdrawal by Subject|1|||
25046085|NCT02643628|50148646|FG000|Overall Study|Relocated out of state|0|||
25046086|NCT02643628|50148647|FG001|Overall Study|Relocated out of state|1|||
25046087|NCT02643472|50148657|FG000|Overall Study|Death|2|||
25046088|NCT02643472|50148658|FG001|Overall Study|Death|5|||
25046089|NCT02643472|50148657|FG000|Overall Study|Withdrawal by Subject|3|||
25046090|NCT02643472|50148658|FG001|Overall Study|Withdrawal by Subject|2|||
25046091|NCT02643472|50148657|FG000|Overall Study|Protocol Violation|0|||
25046092|NCT02643472|50148658|FG001|Overall Study|Protocol Violation|1|||
25046093|NCT02643472|50148657|FG000|Overall Study|Lost to Follow-up|22|||
25046094|NCT02643472|50148658|FG001|Overall Study|Lost to Follow-up|26|||
25046095|NCT02738840|50148666|FG000|Overall Study|MRI Scan not Performed|5|||
25046096|NCT02738840|50148666|FG000|Overall Study|Lost to Follow-up|1|||
25046097|NCT02738840|50148666|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
25046098|NCT02738840|50148666|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
25046099|NCT02643394|50148672|FG000|Overall Study|Protocol Violation|4|||
25046100|NCT02643394|50148673|FG001|Overall Study|Protocol Violation|5|||
25046101|NCT03538158|50148681|FG000|Overall Study|Lost to Follow-up|13|||
25046102|NCT03538158|50148682|FG001|Overall Study|Lost to Follow-up|7|||
25046103|NCT03538158|50148681|FG000|Overall Study|Withdrawal by Subject|2|||
25046104|NCT03538158|50148682|FG001|Overall Study|Withdrawal by Subject|1|||
25046105|NCT02643082|50148688|FG000|Period 1|Adverse Event|1|||
25046106|NCT02643082|50148689|FG001|Period 1|Adverse Event|0|||
25046107|NCT00353496|50148698|FG000|Overall Study|Adverse Event|1|||
25046108|NCT00353496|50148699|FG001|Overall Study|Adverse Event|0|||
25046109|NCT00353496|50148698|FG000|Overall Study|Protocol Violation|2|||
25046110|NCT00353496|50148699|FG001|Overall Study|Protocol Violation|2|||
25046111|NCT00353496|50148698|FG000|Overall Study|Withdrawal by Subject|3|||
25046112|NCT00353496|50148699|FG001|Overall Study|Withdrawal by Subject|4|||
25046113|NCT00353496|50148698|FG000|Overall Study|Physician Decision|6|||
25046114|NCT00353496|50148699|FG001|Overall Study|Physician Decision|9|||
25046115|NCT00353496|50148698|FG000|Overall Study|Not otherwise specified|4|||
25046116|NCT00353496|50148699|FG001|Overall Study|Not otherwise specified|2|||
25046117|NCT01361464|50148715|FG000|Overall Study|Death|1|||
25046118|NCT01361464|50148715|FG000|Overall Study|Withdrawal by Subject|2|||
25046119|NCT03486912|50148723|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
25046120|NCT03486912|50148724|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
25046121|NCT03486912|50148725|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
25046122|NCT03486912|50148726|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
25046123|NCT03486912|50148723|FG000|Treatment Period|Withdrawal by Subject|3|||
25046124|NCT03486912|50148724|FG001|Treatment Period|Withdrawal by Subject|3|||
25046125|NCT03486912|50148725|FG002|Treatment Period|Withdrawal by Subject|3|||
25046126|NCT03486912|50148726|FG003|Treatment Period|Withdrawal by Subject|2|||
25046127|NCT03486912|50148723|FG000|Treatment Period|Other Reasons|0|||
25046128|NCT03486912|50148724|FG001|Treatment Period|Other Reasons|2|||
25046129|NCT03486912|50148725|FG002|Treatment Period|Other Reasons|1|||
25046130|NCT03486912|50148726|FG003|Treatment Period|Other Reasons|1|||
25046131|NCT03486912|50148723|FG000|Treatment Period|Adverse Event|0|||
25046132|NCT03486912|50148724|FG001|Treatment Period|Adverse Event|1|||
25046133|NCT03486912|50148725|FG002|Treatment Period|Adverse Event|1|||
25046134|NCT03486912|50148726|FG003|Treatment Period|Adverse Event|0|||
25046135|NCT03486912|50148723|FG000|Treatment Period|Lost to Follow-up|1|||
25046136|NCT03486912|50148724|FG001|Treatment Period|Lost to Follow-up|0|||
25046137|NCT03486912|50148725|FG002|Treatment Period|Lost to Follow-up|0|||
25046138|NCT03486912|50148726|FG003|Treatment Period|Lost to Follow-up|2|||
25046139|NCT03345342|50148736|FG000|Open-Label Phase|Adverse Event|30|||
25046140|NCT03345342|50148737|FG001|Open-Label Phase|Adverse Event|0|||
25046141|NCT03345342|50148738|FG002|Open-Label Phase|Adverse Event|0|||
25046142|NCT03345342|50148739|FG003|Open-Label Phase|Adverse Event|0|||
25046143|NCT03345342|50148740|FG004|Open-Label Phase|Adverse Event|0|||
25046144|NCT03345342|50148736|FG000|Open-Label Phase|Death|1|||
25046145|NCT03345342|50148737|FG001|Open-Label Phase|Death|0|||
25046146|NCT03345342|50148738|FG002|Open-Label Phase|Death|0|||
25046147|NCT03345342|50148739|FG003|Open-Label Phase|Death|0|||
25046148|NCT03345342|50148740|FG004|Open-Label Phase|Death|0|||
25046149|NCT03345342|50148736|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
25046150|NCT03345342|50148737|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
25046151|NCT03345342|50148738|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
25046152|NCT03345342|50148739|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
25046153|NCT03345342|50148740|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
25046154|NCT03345342|50148736|FG000|Open-Label Phase|Lack of Efficacy|6|||
25046155|NCT03345342|50148737|FG001|Open-Label Phase|Lack of Efficacy|0|||
25046156|NCT03345342|50148738|FG002|Open-Label Phase|Lack of Efficacy|0|||
25046157|NCT03345342|50148739|FG003|Open-Label Phase|Lack of Efficacy|0|||
25046158|NCT03345342|50148740|FG004|Open-Label Phase|Lack of Efficacy|0|||
25046159|NCT03345342|50148736|FG000|Open-Label Phase|Lost to Follow-up|9|||
25046160|NCT03345342|50148737|FG001|Open-Label Phase|Lost to Follow-up|0|||
25046161|NCT03345342|50148738|FG002|Open-Label Phase|Lost to Follow-up|0|||
25046162|NCT03345342|50148739|FG003|Open-Label Phase|Lost to Follow-up|0|||
25046163|NCT03345342|50148740|FG004|Open-Label Phase|Lost to Follow-up|0|||
25046164|NCT03345342|50148736|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
25046165|NCT03345342|50148737|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
25046166|NCT03345342|50148738|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
25046167|NCT03345342|50148739|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
25046168|NCT03345342|50148740|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
25046169|NCT03345342|50148736|FG000|Open-Label Phase|Physician Decision|4|||
25046170|NCT03345342|50148737|FG001|Open-Label Phase|Physician Decision|0|||
25046171|NCT03345342|50148738|FG002|Open-Label Phase|Physician Decision|0|||
25046172|NCT03345342|50148739|FG003|Open-Label Phase|Physician Decision|0|||
25046173|NCT03345342|50148740|FG004|Open-Label Phase|Physician Decision|0|||
25046174|NCT03345342|50148736|FG000|Open-Label Phase|Protocol Violation|8|||
25046175|NCT03345342|50148737|FG001|Open-Label Phase|Protocol Violation|0|||
25046176|NCT03345342|50148738|FG002|Open-Label Phase|Protocol Violation|0|||
25046177|NCT03345342|50148739|FG003|Open-Label Phase|Protocol Violation|0|||
25046178|NCT03345342|50148740|FG004|Open-Label Phase|Protocol Violation|0|||
25046179|NCT03345342|50148736|FG000|Open-Label Phase|Withdrawal by Subject|57|||
25046180|NCT03345342|50148737|FG001|Open-Label Phase|Withdrawal by Subject|0|||
25046181|NCT03345342|50148738|FG002|Open-Label Phase|Withdrawal by Subject|0|||
25046182|NCT03345342|50148739|FG003|Open-Label Phase|Withdrawal by Subject|0|||
25046183|NCT03345342|50148740|FG004|Open-Label Phase|Withdrawal by Subject|0|||
25046184|NCT03345342|50148736|FG000|Open-Label Phase|Other|15|||
25046185|NCT03345342|50148737|FG001|Open-Label Phase|Other|0|||
25046186|NCT03345342|50148738|FG002|Open-Label Phase|Other|0|||
25046187|NCT03345342|50148739|FG003|Open-Label Phase|Other|0|||
25046188|NCT03345342|50148740|FG004|Open-Label Phase|Other|0|||
24958380|NCT00336284|50048896|FG001|Overall Study|Death|26|||
24958381|NCT00336284|50048895|FG000|Overall Study|Lost to Follow-up|82|||
24958382|NCT00336284|50048896|FG001|Overall Study|Lost to Follow-up|61|||
24958383|NCT00336284|50048895|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
24958384|NCT00336284|50048896|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
24958385|NCT00316602|50048904|FG000|Overall Study|Withdrawal by Subject|3|||
24958386|NCT00316602|50048905|FG001|Overall Study|Withdrawal by Subject|2|||
24958387|NCT00316602|50048904|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
24958388|NCT00316602|50048905|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
24958389|NCT00316602|50048904|FG000|Overall Study|Adverse Event|1|||
24958390|NCT00316602|50048905|FG001|Overall Study|Adverse Event|0|||
24958391|NCT00316602|50048904|FG000|Overall Study|Other|3|||
24958392|NCT00316602|50048905|FG001|Overall Study|Other|6|||
24958393|NCT00335972|50048913|FG000|Overall Study|not given treatments|0|||
24958394|NCT00335972|50048914|FG001|Overall Study|not given treatments|3|||
24958395|NCT00346034|50048920|FG000|Overall Study|Adverse Event|34|||
24958396|NCT00346034|50048920|FG000|Overall Study|Lack of Efficacy|8|||
24958397|NCT00346034|50048920|FG000|Overall Study|Withdrawal by Subject|13|||
24958398|NCT00346034|50048920|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
24958399|NCT00346034|50048920|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
24958400|NCT00345878|50048926|FG000|Overall Study|Adverse Event|1|||
24958401|NCT00345878|50048927|FG001|Overall Study|Adverse Event|0|||
24958402|NCT00345878|50048926|FG000|Overall Study|Lost to Follow-up|2|||
24958403|NCT00345878|50048927|FG001|Overall Study|Lost to Follow-up|1|||
24958404|NCT00345878|50048926|FG000|Overall Study|Other|1|||
24958405|NCT00345878|50048927|FG001|Overall Study|Other|0|||
24958406|NCT00335738|50048935|FG000|Overall Study|Physician Decision|6|||
24958407|NCT00335738|50048936|FG001|Overall Study|Physician Decision|0|||
24958408|NCT00335738|50048935|FG000|Overall Study|Withdrawal by Subject|2|||
24958409|NCT00335738|50048936|FG001|Overall Study|Withdrawal by Subject|0|||
24958410|NCT00335738|50048935|FG000|Overall Study|Ineligible|3|||
24958411|NCT00335738|50048936|FG001|Overall Study|Ineligible|4|||
24958412|NCT00334958|50048954|FG000|Overall Study|Medication Noncompliance|0|||
24958413|NCT00334958|50048955|FG001|Overall Study|Medication Noncompliance|3|||
24958414|NCT00334958|50048954|FG000|Overall Study|Protocol Violation|2|||
24958415|NCT00334958|50048955|FG001|Overall Study|Protocol Violation|2|||
24958416|NCT00334958|50048954|FG000|Overall Study|Request of the investigator or sponsor|0|||
24958417|NCT00334958|50048955|FG001|Overall Study|Request of the investigator or sponsor|1|||
24958418|NCT00334958|50048954|FG000|Overall Study|Withdrawal by Subject|7|||
24958419|NCT00334958|50048955|FG001|Overall Study|Withdrawal by Subject|4|||
24958420|NCT00334958|50048954|FG000|Overall Study|Adverse Event|27|||
24958421|NCT00334958|50048955|FG001|Overall Study|Adverse Event|12|||
24958422|NCT00334958|50048954|FG000|Overall Study|Other|1|||
25046189|NCT03345342|50148736|FG000|Double-Blind Phase|Adverse Event|0|||
25046190|NCT03345342|50148737|FG001|Double-Blind Phase|Adverse Event|1|||
25046191|NCT03345342|50148738|FG002|Double-Blind Phase|Adverse Event|6|||
25046192|NCT03345342|50148739|FG003|Double-Blind Phase|Adverse Event|0|||
25046193|NCT03345342|50148740|FG004|Double-Blind Phase|Adverse Event|0|||
25046194|NCT03345342|50148736|FG000|Double-Blind Phase|Death|0|||
25046195|NCT03345342|50148737|FG001|Double-Blind Phase|Death|2|||
25046196|NCT03345342|50148738|FG002|Double-Blind Phase|Death|1|||
25046197|NCT03345342|50148739|FG003|Double-Blind Phase|Death|0|||
25046198|NCT03345342|50148740|FG004|Double-Blind Phase|Death|0|||
25046199|NCT03345342|50148736|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
25046200|NCT03345342|50148737|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
25046201|NCT03345342|50148738|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
25046202|NCT03345342|50148739|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
25046203|NCT03345342|50148740|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
25046204|NCT03345342|50148736|FG000|Double-Blind Phase|Lost to Follow-up|0|||
25046205|NCT03345342|50148737|FG001|Double-Blind Phase|Lost to Follow-up|1|||
25046206|NCT03345342|50148738|FG002|Double-Blind Phase|Lost to Follow-up|7|||
25046207|NCT03345342|50148739|FG003|Double-Blind Phase|Lost to Follow-up|0|||
25046208|NCT03345342|50148740|FG004|Double-Blind Phase|Lost to Follow-up|0|||
25046209|NCT03345342|50148736|FG000|Double-Blind Phase|Physician Decision|0|||
25046210|NCT03345342|50148737|FG001|Double-Blind Phase|Physician Decision|1|||
25046211|NCT03345342|50148738|FG002|Double-Blind Phase|Physician Decision|4|||
25046212|NCT03345342|50148739|FG003|Double-Blind Phase|Physician Decision|0|||
25046213|NCT03345342|50148740|FG004|Double-Blind Phase|Physician Decision|0|||
25046214|NCT03345342|50148736|FG000|Double-Blind Phase|Protocol Violation|0|||
25046215|NCT03345342|50148737|FG001|Double-Blind Phase|Protocol Violation|0|||
25046216|NCT03345342|50148738|FG002|Double-Blind Phase|Protocol Violation|1|||
25046217|NCT03345342|50148739|FG003|Double-Blind Phase|Protocol Violation|0|||
25046218|NCT03345342|50148740|FG004|Double-Blind Phase|Protocol Violation|0|||
25046219|NCT03345342|50148736|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
25046220|NCT03345342|50148737|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
25046221|NCT03345342|50148738|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
25046222|NCT03345342|50148739|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
25046223|NCT03345342|50148740|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
25046224|NCT03345342|50148736|FG000|Double-Blind Phase|Other|0|||
25046225|NCT03345342|50148737|FG001|Double-Blind Phase|Other|1|||
25046226|NCT03345342|50148738|FG002|Double-Blind Phase|Other|3|||
25046227|NCT03345342|50148739|FG003|Double-Blind Phase|Other|0|||
25046228|NCT03345342|50148740|FG004|Double-Blind Phase|Other|0|||
25046229|NCT03345342|50148736|FG000|Follow-Up Phase|Adverse Event|0|||
25046230|NCT03345342|50148737|FG001|Follow-Up Phase|Adverse Event|0|||
25046231|NCT03345342|50148738|FG002|Follow-Up Phase|Adverse Event|0|||
25046232|NCT03345342|50148739|FG003|Follow-Up Phase|Adverse Event|0|||
25046233|NCT03345342|50148740|FG004|Follow-Up Phase|Adverse Event|4|||
25046234|NCT03345342|50148736|FG000|Follow-Up Phase|Lost to Follow-up|0|||
25046235|NCT03345342|50148737|FG001|Follow-Up Phase|Lost to Follow-up|0|||
25046236|NCT03345342|50148738|FG002|Follow-Up Phase|Lost to Follow-up|0|||
25046237|NCT03345342|50148739|FG003|Follow-Up Phase|Lost to Follow-up|0|||
25046238|NCT03345342|50148740|FG004|Follow-Up Phase|Lost to Follow-up|6|||
25046239|NCT03345342|50148736|FG000|Follow-Up Phase|Physician Decision|0|||
24958423|NCT00334958|50048955|FG001|Overall Study|Other|2|||
24958424|NCT00326898|50048964|FG000|Overall Study|Disease progression|52|||
24958425|NCT00326898|50048965|FG001|Overall Study|Disease progression|54|||
24958426|NCT00326898|50048966|FG002|Overall Study|Disease progression|102|||
24958427|NCT00326898|50048964|FG000|Overall Study|Adverse Event|124|||
24958428|NCT00326898|50048965|FG001|Overall Study|Adverse Event|128|||
24958429|NCT00326898|50048966|FG002|Overall Study|Adverse Event|33|||
24958430|NCT00326898|50048964|FG000|Overall Study|Death|2|||
24958431|NCT00326898|50048965|FG001|Overall Study|Death|0|||
24958432|NCT00326898|50048966|FG002|Overall Study|Death|0|||
24958433|NCT00326898|50048964|FG000|Overall Study|Withdrawal by Subject|134|||
24958434|NCT00326898|50048965|FG001|Overall Study|Withdrawal by Subject|128|||
24958435|NCT00326898|50048966|FG002|Overall Study|Withdrawal by Subject|32|||
24958436|NCT00326898|50048964|FG000|Overall Study|Alternative therapy|1|||
24958437|NCT00326898|50048965|FG001|Overall Study|Alternative therapy|0|||
25046240|NCT03345342|50148737|FG001|Follow-Up Phase|Physician Decision|0|||
24958438|NCT00326898|50048966|FG002|Overall Study|Alternative therapy|0|||
25046241|NCT03345342|50148738|FG002|Follow-Up Phase|Physician Decision|0|||
25046242|NCT03345342|50148739|FG003|Follow-Up Phase|Physician Decision|0|||
25046243|NCT03345342|50148740|FG004|Follow-Up Phase|Physician Decision|5|||
25046244|NCT03345342|50148736|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
25162452|NCT01791517|50284749|FG000|Phase I: Period 2|Lost to Follow-up|0|||
24958439|NCT00326898|50048964|FG000|Overall Study|Other complicating disease|5|||
25046245|NCT03345342|50148737|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
25046246|NCT03345342|50148738|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
25046247|NCT03345342|50148739|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
25276347|NCT00892177|50590297|FG004|Phase II|Ineligible|1|||
25046248|NCT03345342|50148740|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
25046249|NCT03345342|50148736|FG000|Follow-Up Phase|Other|0|||
25046250|NCT03345342|50148737|FG001|Follow-Up Phase|Other|0|||
25046251|NCT03345342|50148738|FG002|Follow-Up Phase|Other|0|||
25046252|NCT03345342|50148739|FG003|Follow-Up Phase|Other|3|||
25046253|NCT03345342|50148740|FG004|Follow-Up Phase|Other|1|||
25046254|NCT02642614|50148756|FG000|Overall Study|Adverse Event|1|||
25046255|NCT02642614|50148757|FG001|Overall Study|Adverse Event|1|||
25046256|NCT02642614|50148758|FG002|Overall Study|Adverse Event|2|||
25046257|NCT02642614|50148759|FG003|Overall Study|Adverse Event|2|||
25046258|NCT02642614|50148756|FG000|Overall Study|Lost to Follow-up|1|||
25046259|NCT02642614|50148757|FG001|Overall Study|Lost to Follow-up|0|||
25046260|NCT02642614|50148758|FG002|Overall Study|Lost to Follow-up|0|||
25046261|NCT02642614|50148759|FG003|Overall Study|Lost to Follow-up|0|||
25046262|NCT02642614|50148756|FG000|Overall Study|Withdrawal by Subject|1|||
25046263|NCT02642614|50148757|FG001|Overall Study|Withdrawal by Subject|1|||
25046264|NCT02642614|50148758|FG002|Overall Study|Withdrawal by Subject|0|||
25046265|NCT02642614|50148759|FG003|Overall Study|Withdrawal by Subject|0|||
25046266|NCT02781324|50148774|FG000|Overall Study|Withdrawal by Subject|1|||
25046267|NCT02781324|50148775|FG001|Overall Study|Withdrawal by Subject|0|||
25046268|NCT02781324|50148774|FG000|Overall Study|Physician Decision|1|||
25046269|NCT02781324|50148775|FG001|Overall Study|Physician Decision|2|||
25046270|NCT03292146|50148785|FG000|Baseline to 12 Months|Relocation|1|||
25046271|NCT03292146|50148786|FG001|Baseline to 12 Months|Relocation|0|||
25046272|NCT03292146|50148785|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
25276348|NCT00892177|50590298|FG005|Phase II|Ineligible|1|||
25276349|NCT00892177|50590293|FG000|Phase II|Withdrawal by Subject|0|||
25276350|NCT00892177|50590294|FG001|Phase II|Withdrawal by Subject|0|||
25276351|NCT00892177|50590295|FG002|Phase II|Withdrawal by Subject|0|||
25276352|NCT00892177|50590296|FG003|Phase II|Withdrawal by Subject|0|||
25276353|NCT00892177|50590297|FG004|Phase II|Withdrawal by Subject|4|||
25276354|NCT00892177|50590298|FG005|Phase II|Withdrawal by Subject|1|||
25276355|NCT00962104|50590315|FG000|Overall Study|Adverse Event|10|||
25276356|NCT00962104|50590316|FG001|Overall Study|Adverse Event|3|||
25276357|NCT00962104|50590315|FG000|Overall Study|Entry Criteria Not Met|1|||
25276358|NCT00962104|50590316|FG001|Overall Study|Entry Criteria Not Met|2|||
25276359|NCT00962104|50590315|FG000|Overall Study|Lack of Efficacy|0|||
25276360|NCT00962104|50590316|FG001|Overall Study|Lack of Efficacy|1|||
25276361|NCT00962104|50590315|FG000|Overall Study|Lost to Follow-up|10|||
25276362|NCT00962104|50590316|FG001|Overall Study|Lost to Follow-up|4|||
25276363|NCT00962104|50590315|FG000|Overall Study|Physician Decision|1|||
25276364|NCT00962104|50590316|FG001|Overall Study|Physician Decision|0|||
25276365|NCT00962104|50590315|FG000|Overall Study|Protocol Violation|6|||
25276366|NCT00962104|50590316|FG001|Overall Study|Protocol Violation|8|||
25276367|NCT00962104|50590315|FG000|Overall Study|Sponsor Decision|0|||
25276368|NCT00962104|50590316|FG001|Overall Study|Sponsor Decision|1|||
25276369|NCT00962104|50590315|FG000|Overall Study|Withdrawal by Subject|10|||
25276370|NCT00962104|50590316|FG001|Overall Study|Withdrawal by Subject|6|||
25276371|NCT00962104|50590315|FG000|Overall Study|Other|2|||
25276372|NCT00962104|50590316|FG001|Overall Study|Other|0|||
25046273|NCT03292146|50148786|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
25186519|NCT02647866|50336899|FG004|Overall Study|Subject moved to different country|0|||
25186520|NCT01396187|50336959|FG000|Overall Study|Adverse Event|0|||
25186521|NCT01396187|50336960|FG001|Overall Study|Adverse Event|1|||
25186522|NCT01396187|50336961|FG002|Overall Study|Adverse Event|0|||
25186523|NCT01396187|50336962|FG003|Overall Study|Adverse Event|0|||
25186524|NCT01396187|50336963|FG004|Overall Study|Adverse Event|0|||
25186525|NCT01396187|50336959|FG000|Overall Study|Withdrawal by Subject|0|||
25186526|NCT01396187|50336960|FG001|Overall Study|Withdrawal by Subject|1|||
25186527|NCT01396187|50336961|FG002|Overall Study|Withdrawal by Subject|1|||
25186528|NCT01396187|50336962|FG003|Overall Study|Withdrawal by Subject|0|||
25186529|NCT01396187|50336963|FG004|Overall Study|Withdrawal by Subject|0|||
25186530|NCT01396187|50336959|FG000|Overall Study|Other|1|||
25186531|NCT01396187|50336960|FG001|Overall Study|Other|1|||
25186532|NCT01396187|50336961|FG002|Overall Study|Other|0|||
25186533|NCT01396187|50336962|FG003|Overall Study|Other|0|||
25186534|NCT01396187|50336963|FG004|Overall Study|Other|1|||
25186535|NCT01392677|50337010|FG000|Overall Study|Adverse Event|3|||
25186536|NCT01392677|50337011|FG001|Overall Study|Adverse Event|1|||
25186537|NCT01392677|50337010|FG000|Overall Study|Withdrawal by Subject|0|||
25186538|NCT01392677|50337011|FG001|Overall Study|Withdrawal by Subject|2|||
25186539|NCT01392677|50337010|FG000|Overall Study|Incorrect enrollment|2|||
25186540|NCT01392677|50337011|FG001|Overall Study|Incorrect enrollment|3|||
25186541|NCT01392677|50337010|FG000|Overall Study|Other reason|3|||
25186542|NCT01392677|50337011|FG001|Overall Study|Other reason|2|||
25186543|NCT01392443|50337060|FG000|Overall Study|Disease progression|30|||
25186544|NCT01392443|50337060|FG000|Overall Study|Adverse Event|24|||
25186545|NCT01392443|50337060|FG000|Overall Study|Death|7|||
25276373|NCT02821000|50590322|FG000|Overall Study|Death|44|||
25186546|NCT01392443|50337060|FG000|Overall Study|Withdrawal by Subject|5|||
25276374|NCT02821000|50590322|FG000|Overall Study|Withdrawal by Subject|1|||
25276375|NCT02821000|50590322|FG000|Overall Study|Ongoing in Study|58|||
25276376|NCT00892099|50590329|FG000|Overall Study|Death|1|||
25276377|NCT00892099|50590330|FG001|Overall Study|Death|0|||
25276378|NCT00892099|50590331|FG002|Overall Study|Death|1|||
25276379|NCT00892099|50590329|FG000|Overall Study|Adverse Event|1|||
25276380|NCT00892099|50590330|FG001|Overall Study|Adverse Event|0|||
25276381|NCT00892099|50590331|FG002|Overall Study|Adverse Event|0|||
25276382|NCT00892099|50590329|FG000|Overall Study|replocated|1|||
25276383|NCT00892099|50590330|FG001|Overall Study|replocated|0|||
25276384|NCT00892099|50590331|FG002|Overall Study|replocated|2|||
25276385|NCT00892099|50590329|FG000|Overall Study|Prolonged hospitalization|1|||
25276386|NCT00892099|50590330|FG001|Overall Study|Prolonged hospitalization|0|||
25276387|NCT00892099|50590331|FG002|Overall Study|Prolonged hospitalization|1|||
25276388|NCT00892099|50590329|FG000|Overall Study|no further details|1|||
25276389|NCT00892099|50590330|FG001|Overall Study|no further details|0|||
25276390|NCT00892099|50590331|FG002|Overall Study|no further details|1|||
25276391|NCT00892099|50590329|FG000|Overall Study|kidney function recovered|0|||
25276392|NCT00892099|50590330|FG001|Overall Study|kidney function recovered|1|||
25276393|NCT00892099|50590331|FG002|Overall Study|kidney function recovered|0|||
25276394|NCT00892099|50590329|FG000|Overall Study|investigator decision|0|||
25276395|NCT00892099|50590330|FG001|Overall Study|investigator decision|0|||
25276396|NCT00892099|50590331|FG002|Overall Study|investigator decision|1|||
25276397|NCT00892099|50590329|FG000|Overall Study|Lost to Follow-up|0|||
25276398|NCT00892099|50590330|FG001|Overall Study|Lost to Follow-up|0|||
25276399|NCT00892099|50590331|FG002|Overall Study|Lost to Follow-up|1|||
25276400|NCT00960856|50590339|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
25276401|NCT00960856|50590340|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
25276402|NCT00960856|50590341|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
25276403|NCT00960856|50590342|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
25046274|NCT03292146|50148785|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
24958440|NCT00326898|50048965|FG001|Overall Study|Other complicating disease|5|||
24958441|NCT00326898|50048966|FG002|Overall Study|Other complicating disease|4|||
25046275|NCT03292146|50148786|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
25046276|NCT03292146|50148785|FG000|12 Months to 24 Months|Planning pregnancy|2|||
25046277|NCT03292146|50148786|FG001|12 Months to 24 Months|Planning pregnancy|2|||
25046278|NCT03292146|50148785|FG000|12 Months to 24 Months|Personal reasons|1|||
25162453|NCT01791517|50284750|FG001|Phase I: Period 2|Lost to Follow-up|3|||
25162454|NCT01791517|50284751|FG002|Phase I: Period 2|Lost to Follow-up|2|||
25276404|NCT00960856|50590339|FG000|Washout Period of 7 Days|Adverse Event|0|||
25276405|NCT00960856|50590340|FG001|Washout Period of 7 Days|Adverse Event|0|||
24958442|NCT00326898|50048964|FG000|Overall Study|Other/Missing/Unknown|33|||
24958443|NCT00326898|50048965|FG001|Overall Study|Other/Missing/Unknown|28|||
24958444|NCT00326898|50048966|FG002|Overall Study|Other/Missing/Unknown|32|||
24958445|NCT00326118|50048976|FG000|Active Phase|Withdrawal by Subject|4|||
24958446|NCT00326118|50048977|FG001|Active Phase|Withdrawal by Subject|1|||
24958447|NCT00334802|50048986|FG000|Overall Study|Progressive Disease|2|||
24958448|NCT00334802|50048987|FG001|Overall Study|Progressive Disease|24|||
24958449|NCT00334802|50048986|FG000|Overall Study|Toxicity|1|||
24958450|NCT00334802|50048987|FG001|Overall Study|Toxicity|5|||
24958451|NCT00334802|50048986|FG000|Overall Study|Lack of Efficacy|1|||
24958452|NCT00334802|50048987|FG001|Overall Study|Lack of Efficacy|3|||
24958453|NCT00334802|50048986|FG000|Overall Study|Patient Condition Aggrevated|1|||
25276406|NCT00960856|50590341|FG002|Washout Period of 7 Days|Adverse Event|1|||
25276407|NCT00960856|50590342|FG003|Washout Period of 7 Days|Adverse Event|0|||
24958454|NCT00334802|50048987|FG001|Overall Study|Patient Condition Aggrevated|0|||
24958455|NCT00334802|50048986|FG000|Overall Study|Physician Decision|1|||
24958456|NCT00334802|50048987|FG001|Overall Study|Physician Decision|0|||
25276408|NCT00958438|50590355|FG000|Overall Study|Protocol Violation|3|||
25276409|NCT00958438|50590356|FG001|Overall Study|Protocol Violation|2|||
25276410|NCT00958438|50590357|FG002|Overall Study|Protocol Violation|2|||
25046279|NCT03292146|50148786|FG001|12 Months to 24 Months|Personal reasons|0|||
24958457|NCT00334802|50048986|FG000|Overall Study|Withdrawal by Subject|0|||
24958458|NCT00334802|50048987|FG001|Overall Study|Withdrawal by Subject|4|||
24958459|NCT00334802|50048986|FG000|Overall Study|Adverse Event|0|||
24958460|NCT00334802|50048987|FG001|Overall Study|Adverse Event|3|||
24958461|NCT00334802|50048986|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
24958462|NCT00334802|50048987|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
24958463|NCT00307164|50048998|FG000|Overall Study|Death|1|||
24958464|NCT00307164|50048999|FG001|Overall Study|Death|0|||
24958465|NCT00307164|50048998|FG000|Overall Study|Severe debilitation, unable to continue|1|||
24958466|NCT00307164|50048999|FG001|Overall Study|Severe debilitation, unable to continue|0|||
24958467|NCT00307164|50048998|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
24958468|NCT00307164|50048999|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
24958469|NCT00307164|50048998|FG000|Overall Study|Withdrawal by Subject|1|||
24958470|NCT00307164|50048999|FG001|Overall Study|Withdrawal by Subject|8|||
24958471|NCT00307164|50048998|FG000|Overall Study|Not compliant with requirements|4|||
24958472|NCT00307164|50048999|FG001|Overall Study|Not compliant with requirements|4|||
24958473|NCT00307164|50048998|FG000|Overall Study|Lost to Follow-up|6|||
24958474|NCT00307164|50048999|FG001|Overall Study|Lost to Follow-up|1|||
24958475|NCT03827564|50049007|FG000|Overall Study|Discontinued due to Study Termination|1|||
24958476|NCT03827564|50049008|FG001|Overall Study|Discontinued due to Study Termination|0|||
24958477|NCT00307086|50049014|FG000|Overall Study|ineligible|5|||
24958478|NCT00325416|50049020|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
24958479|NCT00325416|50049021|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
24958480|NCT00325416|50049020|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
24958481|NCT00325416|50049021|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
24958482|NCT00325416|50049020|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
24958483|NCT00325416|50049021|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
24958484|NCT00325416|50049020|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
24958485|NCT00325416|50049021|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
24958486|NCT00325416|50049020|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
24958487|NCT00325416|50049021|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
24958488|NCT00325416|50049020|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
24958489|NCT00325416|50049021|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
24958490|NCT00314808|50049027|FG000|Overall Study|Disease Progression without AE|4|||
24958491|NCT00314808|50049027|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
24958492|NCT00314574|50049033|FG000|Overall Study|Death|3|||
24958493|NCT00314574|50049034|FG001|Overall Study|Death|0|||
24958494|NCT00314574|50049033|FG000|Overall Study|Adverse Event|11|||
24958495|NCT00314574|50049034|FG001|Overall Study|Adverse Event|16|||
24958496|NCT00314574|50049033|FG000|Overall Study|Lost to Follow-up|19|||
24958497|NCT00314574|50049034|FG001|Overall Study|Lost to Follow-up|25|||
24958498|NCT00314574|50049033|FG000|Overall Study|Withdrawal by Subject|33|||
24958499|NCT00314574|50049034|FG001|Overall Study|Withdrawal by Subject|22|||
24958500|NCT00314574|50049033|FG000|Overall Study|Physician Decision|22|||
24958501|NCT00314574|50049034|FG001|Overall Study|Physician Decision|15|||
24958502|NCT00314574|50049033|FG000|Overall Study|Pregnancy|6|||
24958503|NCT00314574|50049034|FG001|Overall Study|Pregnancy|4|||
24958504|NCT00314574|50049033|FG000|Overall Study|Data unknown at database lock|0|||
24958505|NCT00314574|50049034|FG001|Overall Study|Data unknown at database lock|1|||
24958506|NCT00314340|50049040|FG000|Overall Study|lost interest|1|||
24958507|NCT00306852|50049048|FG000|Overall Study|Death|14|||
24958508|NCT00306852|50049049|FG001|Overall Study|Death|14|||
24958509|NCT00306852|50049048|FG000|Overall Study|Lost to Follow-up|15|||
24958510|NCT00306852|50049049|FG001|Overall Study|Lost to Follow-up|24|||
24958511|NCT00314262|50049055|FG000|Overall Study|Adverse Event|2|||
24958512|NCT00314262|50049055|FG000|Overall Study|Withdrawal by Subject|2|||
24958513|NCT00314262|50049055|FG000|Overall Study|Physician Decision|1|||
24958514|NCT00333866|50049063|FG000|Overall Study|Adverse Event|23|||
24958515|NCT00333866|50049064|FG001|Overall Study|Adverse Event|37|||
24958516|NCT00333866|50049065|FG002|Overall Study|Adverse Event|38|||
24958517|NCT00333866|50049066|FG003|Overall Study|Adverse Event|47|||
24958518|NCT00333866|50049063|FG000|Overall Study|Other|3|||
24958519|NCT00333866|50049064|FG001|Overall Study|Other|2|||
24958520|NCT00333866|50049065|FG002|Overall Study|Other|2|||
24958521|NCT00333866|50049066|FG003|Overall Study|Other|2|||
24958522|NCT00333866|50049063|FG000|Overall Study|Lack of Efficacy|8|||
24958523|NCT00333866|50049064|FG001|Overall Study|Lack of Efficacy|6|||
24958524|NCT00333866|50049065|FG002|Overall Study|Lack of Efficacy|3|||
24958525|NCT00333866|50049066|FG003|Overall Study|Lack of Efficacy|5|||
24958526|NCT00333866|50049063|FG000|Overall Study|Lost to Follow-up|1|||
25186547|NCT01392443|50337060|FG000|Overall Study|Lost to Follow-up|1|||
25276411|NCT00958438|50590355|FG000|Overall Study|Withdrawal by Subject|4|||
25276412|NCT00958438|50590356|FG001|Overall Study|Withdrawal by Subject|2|||
25276413|NCT00958438|50590357|FG002|Overall Study|Withdrawal by Subject|1|||
25276414|NCT00958438|50590355|FG000|Overall Study|Adverse Event|0|||
25276415|NCT00958438|50590356|FG001|Overall Study|Adverse Event|3|||
25276416|NCT00958438|50590357|FG002|Overall Study|Adverse Event|0|||
25276417|NCT00958438|50590355|FG000|Overall Study|Physician Decision|1|||
25276418|NCT00958438|50590356|FG001|Overall Study|Physician Decision|0|||
25276419|NCT00958438|50590357|FG002|Overall Study|Physician Decision|1|||
25276420|NCT00958438|50590355|FG000|Overall Study|Other than specified above|2|||
25046280|NCT03292146|50148785|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
25046281|NCT03292146|50148786|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
25046282|NCT01360996|50148795|FG000|Overall Study|Withdrawal by Subject|4|||
25046283|NCT01360996|50148796|FG001|Overall Study|Withdrawal by Subject|3|||
25046284|NCT01360996|50148797|FG002|Overall Study|Withdrawal by Subject|2|||
25046285|NCT01360996|50148795|FG000|Overall Study|Noncompliant|2|||
25046286|NCT01360996|50148796|FG001|Overall Study|Noncompliant|0|||
25046287|NCT01360996|50148797|FG002|Overall Study|Noncompliant|0|||
25046288|NCT01951885|50148806|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
25046289|NCT01951885|50148807|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
25046290|NCT01951885|50148806|FG000|Overall Study|Adverse Event|1|||
25046291|NCT01951885|50148807|FG001|Overall Study|Adverse Event|0|||
25046292|NCT01951885|50148806|FG000|Overall Study|Withdrawal by Subject|0|||
25046293|NCT01951885|50148807|FG001|Overall Study|Withdrawal by Subject|1|||
25046294|NCT01951885|50148806|FG000|Overall Study|ineligible due to a change in donor|0|||
25046295|NCT01951885|50148807|FG001|Overall Study|ineligible due to a change in donor|1|||
25046296|NCT01951885|50148806|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
25046297|NCT01951885|50148807|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
25046298|NCT02639338|50148815|FG000|Overall Study|Lost to Follow-up|2|||
25046299|NCT02639338|50148816|FG001|Overall Study|Lost to Follow-up|2|||
25046300|NCT02639338|50148815|FG000|Overall Study|Withdrew Consent|1|||
25046301|NCT02639338|50148816|FG001|Overall Study|Withdrew Consent|2|||
25046302|NCT02639338|50148815|FG000|Overall Study|Death|1|||
25046303|NCT02639338|50148816|FG001|Overall Study|Death|0|||
25046304|NCT02639338|50148815|FG000|Overall Study|Randomized but Not Treated|0|||
25046305|NCT02639338|50148816|FG001|Overall Study|Randomized but Not Treated|1|||
25046306|NCT01754857|50148822|FG000|Overall Study|Adverse Event|7|||
25046307|NCT01754857|50148822|FG000|Overall Study|Disease progression|3|||
25046308|NCT01754857|50148822|FG000|Overall Study|Physician Decision|2|||
25046309|NCT01754857|50148822|FG000|Overall Study|Withdrawal by Subject|3|||
25046310|NCT01754857|50148822|FG000|Overall Study|other complicating disease|1|||
25046311|NCT01754857|50148822|FG000|Overall Study|ineligible to continue onto maintenance|1|||
25046312|NCT01754857|50148822|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
25046313|NCT01754857|50148822|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
25046314|NCT02900352|50148828|FG000|Overall Study|Lost to Follow-up|28|||
25046315|NCT02900352|50148829|FG001|Overall Study|Lost to Follow-up|17|||
25046316|NCT03040687|50148838|FG000|Overall Study|Withdrawal by Subject|1|||
25046317|NCT03040687|50148839|FG001|Overall Study|Withdrawal by Subject|0|||
25046318|NCT03040687|50148840|FG002|Overall Study|Withdrawal by Subject|0|||
25046319|NCT03042559|50148850|FG000|Overall Study|drop out|1|||
25046320|NCT03042559|50148851|FG001|Overall Study|drop out|1|||
25046321|NCT02780856|50148857|FG000|Overall Study|Lost to Follow-up|1|||
25046322|NCT00108732|50148886|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
25046323|NCT00108732|50148886|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
25046324|NCT00108732|50148886|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
25046325|NCT00108732|50148886|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
25046326|NCT00108732|50148886|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
25046327|NCT00108732|50148886|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
25046328|NCT00108732|50148886|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
25046329|NCT00107952|50148892|FG000|Overall Study|Death|75|||
25046330|NCT00107952|50148893|FG001|Overall Study|Death|61|||
25046331|NCT00107952|50148892|FG000|Overall Study|Lost to Follow-up|0|||
25046332|NCT00107952|50148893|FG001|Overall Study|Lost to Follow-up|3|||
25046333|NCT00107952|50148892|FG000|Overall Study|Withdrawal by Subject|9|||
25046334|NCT00107952|50148893|FG001|Overall Study|Withdrawal by Subject|6|||
25046335|NCT00107952|50148892|FG000|Overall Study|Other|2|||
25046336|NCT00107952|50148893|FG001|Overall Study|Other|5|||
25046337|NCT00107952|50148892|FG000|Overall Study|Never received study treatment|9|||
25046338|NCT00107952|50148893|FG001|Overall Study|Never received study treatment|6|||
25046339|NCT01366638|50148911|FG000|Overall Study|Withdrawal by Subject|0|||
25046340|NCT01366638|50148912|FG001|Overall Study|Withdrawal by Subject|0|||
24958527|NCT00333866|50049064|FG001|Overall Study|Lost to Follow-up|2|||
24958528|NCT00333866|50049065|FG002|Overall Study|Lost to Follow-up|2|||
24958529|NCT00333866|50049066|FG003|Overall Study|Lost to Follow-up|2|||
24958530|NCT00333866|50049063|FG000|Overall Study|Withdrawal by Subject|8|||
24958531|NCT00333866|50049064|FG001|Overall Study|Withdrawal by Subject|14|||
24958532|NCT00333866|50049065|FG002|Overall Study|Withdrawal by Subject|4|||
24958533|NCT00333866|50049066|FG003|Overall Study|Withdrawal by Subject|9|||
24958534|NCT00333866|50049063|FG000|Overall Study|Randomized but not Treated|5|||
24958535|NCT00333866|50049064|FG001|Overall Study|Randomized but not Treated|3|||
24958536|NCT00333866|50049065|FG002|Overall Study|Randomized but not Treated|2|||
24958537|NCT00333866|50049066|FG003|Overall Study|Randomized but not Treated|1|||
24958538|NCT00324740|50049076|FG000|Overall Study|Withdrawal by Subject|1|||
24958539|NCT00324740|50049077|FG001|Overall Study|Withdrawal by Subject|0|||
25046341|NCT01366638|50148913|FG002|Overall Study|Withdrawal by Subject|6|||
25046342|NCT01366638|50148911|FG000|Overall Study|Other|1|||
25046343|NCT01366638|50148912|FG001|Overall Study|Other|0|||
25046344|NCT01366638|50148913|FG002|Overall Study|Other|0|||
25046345|NCT02780700|50148921|FG000|Overall Study|Progressive disease|1|||
25046346|NCT04230122|50148959|FG000|Overall Study|Lost to Follow-up|1|||
25046347|NCT04230122|50148960|FG001|Overall Study|Lost to Follow-up|0|||
25046348|NCT02780388|50148971|FG000|Overall Study|Lost to Follow-up|0|||
25046349|NCT02780388|50148972|FG001|Overall Study|Lost to Follow-up|1|||
25046350|NCT02780388|50148973|FG002|Overall Study|Lost to Follow-up|0|||
25046351|NCT02780388|50148974|FG003|Overall Study|Lost to Follow-up|0|||
25046352|NCT02780388|50148975|FG004|Overall Study|Lost to Follow-up|0|||
25046353|NCT02780388|50148971|FG000|Overall Study|Withdrawal by Subject|1|||
25046354|NCT02780388|50148972|FG001|Overall Study|Withdrawal by Subject|1|||
25046355|NCT02780388|50148973|FG002|Overall Study|Withdrawal by Subject|0|||
25046356|NCT02780388|50148974|FG003|Overall Study|Withdrawal by Subject|0|||
25046357|NCT02780388|50148975|FG004|Overall Study|Withdrawal by Subject|0|||
25046358|NCT02224573|50148993|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
25046359|NCT02224573|50148994|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
25046360|NCT02224573|50148993|FG000|Treatment Phase|Started on Other IMP|1|||
25046361|NCT02224573|50148994|FG001|Treatment Phase|Started on Other IMP|0|||
25046362|NCT02224573|50148993|FG000|Treatment Phase|Participant Discontinued IMP|0|||
25046363|NCT02224573|50148994|FG001|Treatment Phase|Participant Discontinued IMP|1|||
25046364|NCT02224573|50148993|FG000|Treatment Phase|Lack of Efficacy|15|||
25046365|NCT02224573|50148994|FG001|Treatment Phase|Lack of Efficacy|8|||
25046366|NCT02224573|50148993|FG000|Treatment Phase|Began Commercial Product|1|||
25046367|NCT02224573|50148994|FG001|Treatment Phase|Began Commercial Product|0|||
25046368|NCT02224573|50148993|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
25046369|NCT02224573|50148994|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
25046370|NCT02224573|50148993|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
25046371|NCT02224573|50148994|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
25046372|NCT02224573|50148993|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
25046373|NCT02224573|50148994|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
25046374|NCT02224573|50148993|FG000|Treatment Phase|Continued Compassionate Use|1|||
25046375|NCT02224573|50148994|FG001|Treatment Phase|Continued Compassionate Use|0|||
25046376|NCT02224573|50148993|FG000|Treatment Phase|Lack of Efficiency|2|||
25046377|NCT02224573|50148994|FG001|Treatment Phase|Lack of Efficiency|1|||
25046378|NCT02224573|50148993|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
24958540|NCT00324740|50049078|FG002|Overall Study|Withdrawal by Subject|1|||
24958541|NCT00333788|50049085|FG000|Overall Study|Adverse Event|44|||
24958542|NCT00333788|50049085|FG000|Overall Study|Lack of Efficacy|80|||
24958543|NCT00333788|50049085|FG000|Overall Study|Lost to Follow-up|2|||
24958544|NCT00333788|50049085|FG000|Overall Study|Withdrawal by Subject|24|||
24958545|NCT00333788|50049085|FG000|Overall Study|Other: Non-compliance|2|||
25046379|NCT02224573|50148994|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
25046380|NCT02224573|50148993|FG000|Treatment Phase|Participant Moved|2|||
25046381|NCT02224573|50148994|FG001|Treatment Phase|Participant Moved|0|||
25046382|NCT02224573|50148993|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
25046383|NCT02224573|50148994|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
25046384|NCT02224573|50148993|FG000|Treatment Phase|Refused Medication|1|||
25046385|NCT02224573|50148994|FG001|Treatment Phase|Refused Medication|1|||
25046386|NCT02224573|50148993|FG000|Treatment Phase|Adverse Event|26|||
25046387|NCT02224573|50148994|FG001|Treatment Phase|Adverse Event|38|||
25046388|NCT02224573|50148993|FG000|Treatment Phase|Placed in Group Home|0|||
25046389|NCT02224573|50148994|FG001|Treatment Phase|Placed in Group Home|1|||
24958546|NCT00333788|50049085|FG000|Overall Study|Other: Moved|2|||
24958547|NCT00333788|50049085|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
24958548|NCT00333788|50049085|FG000|Overall Study|Other: Investigator decision|1|||
24958549|NCT00333788|50049085|FG000|Overall Study|Other: Quality of life concern|1|||
24958550|NCT00333788|50049085|FG000|Overall Study|Other: Sponsor decision|1|||
24958551|NCT00333788|50049085|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
24958552|NCT00333788|50049085|FG000|Overall Study|Other: Medical monitor decision|1|||
25046390|NCT02224573|50148993|FG000|Treatment Phase|Pursued Other Trials|1|||
25046391|NCT02224573|50148994|FG001|Treatment Phase|Pursued Other Trials|0|||
25046392|NCT02224573|50148993|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
25046393|NCT02224573|50148994|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
25046394|NCT02224573|50148993|FG000|Treatment Phase|Lost to Follow-up|2|||
25046395|NCT02224573|50148994|FG001|Treatment Phase|Lost to Follow-up|1|||
25046396|NCT02224573|50148993|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
25046397|NCT02224573|50148994|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
25046398|NCT02224573|50148993|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
24958553|NCT00333788|50049085|FG000|Overall Study|Other: Physician decision|1|||
25046399|NCT02224573|50148994|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
24958554|NCT00333788|50049085|FG000|Overall Study|Other: Signed consent for another study|1|||
25046400|NCT02224573|50148993|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
25046401|NCT02224573|50148994|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
25046402|NCT02224573|50148993|FG000|Taper Phase|Adverse Event|1|||
25046403|NCT02224573|50148994|FG001|Taper Phase|Adverse Event|1|||
25046404|NCT01360840|50149004|FG000|Overall Study|Ongoing at data cut-off|10|||
25046405|NCT01360840|50149005|FG001|Overall Study|Ongoing at data cut-off|10|||
25046406|NCT01360840|50149006|FG002|Overall Study|Ongoing at data cut-off|9|||
25046407|NCT03350984|50149018|FG000|Overall Study|Death|1|||
25046408|NCT03350984|50149019|FG001|Overall Study|Death|0|||
25046409|NCT03350984|50149018|FG000|Overall Study|Lost to Follow-up|5|||
25046410|NCT03350984|50149019|FG001|Overall Study|Lost to Follow-up|6|||
25046411|NCT03350984|50149018|FG000|Overall Study|Protocol Violation|1|||
25046412|NCT03350984|50149019|FG001|Overall Study|Protocol Violation|2|||
25046413|NCT03350984|50149018|FG000|Overall Study|Physician Decision|1|||
25046414|NCT03350984|50149019|FG001|Overall Study|Physician Decision|0|||
25046415|NCT05176717|50149037|FG000|Overall Study|Sponsor Decision|1|||
25046416|NCT05176717|50149038|FG001|Overall Study|Sponsor Decision|2|||
25046417|NCT05176717|50149039|FG002|Overall Study|Sponsor Decision|2|||
25046418|NCT02770248|50149049|FG000|Overall Study|Adverse Event|0|||
25046419|NCT02770248|50149050|FG001|Overall Study|Adverse Event|1|||
25046420|NCT02770248|50149049|FG000|Overall Study|Randomized in error, prior to treatment|0|||
25162455|NCT01791517|50284752|FG003|Phase I: Period 2|Lost to Follow-up|0|||
25162456|NCT01791517|50284753|FG004|Phase I: Period 2|Lost to Follow-up|0|||
25162457|NCT01791517|50284754|FG005|Phase I: Period 2|Lost to Follow-up|0|||
25276421|NCT00958438|50590356|FG001|Overall Study|Other than specified above|3|||
25276422|NCT00958438|50590357|FG002|Overall Study|Other than specified above|2|||
25276423|NCT00958360|50590367|FG000|Overall Study|Withdrawal by Subject|3|||
25276424|NCT00958360|50590368|FG001|Overall Study|Withdrawal by Subject|1|||
25276425|NCT00958360|50590367|FG000|Overall Study|Death|6|||
25276426|NCT00958360|50590368|FG001|Overall Study|Death|7|||
25276427|NCT00958360|50590367|FG000|Overall Study|Physician Decision|2|||
24958555|NCT00324116|50049089|FG000|Overall Study|Adverse Event|5|||
24958556|NCT00324116|50049089|FG000|Overall Study|Lack of Efficacy|17|||
24958557|NCT00324116|50049089|FG000|Overall Study|Withdrawal by Subject|5|||
24958558|NCT00324116|50049089|FG000|Overall Study|Other|5|||
24958559|NCT00332696|50049095|FG000|Overall Study|Death|24|||
24958560|NCT00332696|50049096|FG001|Overall Study|Death|14|||
24958561|NCT00332696|50049095|FG000|Overall Study|Insufficient therapeutic effect|4|||
24958562|NCT00332696|50049096|FG001|Overall Study|Insufficient therapeutic effect|11|||
24958563|NCT00332696|50049095|FG000|Overall Study|Adverse Event|1|||
24958564|NCT00332696|50049096|FG001|Overall Study|Adverse Event|2|||
24958565|NCT00332696|50049095|FG000|Overall Study|Condition does not justify treatment|0|||
24958566|NCT00332696|50049096|FG001|Overall Study|Condition does not justify treatment|2|||
24958567|NCT00332696|50049095|FG000|Overall Study|Lost to Follow-up|0|||
24958568|NCT00332696|50049096|FG001|Overall Study|Lost to Follow-up|1|||
24958569|NCT00332696|50049095|FG000|Overall Study|Withdrawal by Subject|1|||
24958570|NCT00332696|50049096|FG001|Overall Study|Withdrawal by Subject|0|||
24958571|NCT00313716|50049108|FG000|Overall Study|Death|3|||
24958572|NCT00313716|50049109|FG001|Overall Study|Death|2|||
24958573|NCT00313716|50049110|FG002|Overall Study|Death|9|||
24958574|NCT00313716|50049111|FG003|Overall Study|Death|3|||
24958575|NCT00313716|50049112|FG004|Overall Study|Death|5|||
24958576|NCT00313716|50049113|FG005|Overall Study|Death|9|||
24958577|NCT00313716|50049108|FG000|Overall Study|Lost to Follow-up|2|||
24958578|NCT00313716|50049109|FG001|Overall Study|Lost to Follow-up|5|||
24958579|NCT00313716|50049110|FG002|Overall Study|Lost to Follow-up|2|||
24958580|NCT00313716|50049111|FG003|Overall Study|Lost to Follow-up|1|||
24958581|NCT00313716|50049112|FG004|Overall Study|Lost to Follow-up|0|||
24958582|NCT00313716|50049113|FG005|Overall Study|Lost to Follow-up|4|||
24958583|NCT00313716|50049108|FG000|Overall Study|Withdrawal by Subject|0|||
24958584|NCT00313716|50049109|FG001|Overall Study|Withdrawal by Subject|1|||
25046421|NCT02770248|50149050|FG001|Overall Study|Randomized in error, prior to treatment|1|||
25046422|NCT01344369|50149058|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
25046423|NCT01344369|50149059|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
24958585|NCT00313716|50049110|FG002|Overall Study|Withdrawal by Subject|1|||
24958586|NCT00313716|50049111|FG003|Overall Study|Withdrawal by Subject|0|||
24958587|NCT00313716|50049112|FG004|Overall Study|Withdrawal by Subject|1|||
24958588|NCT00313716|50049113|FG005|Overall Study|Withdrawal by Subject|0|||
24958589|NCT00313170|50049134|FG000|Overall Study|Death|2|||
25046424|NCT01344369|50149058|FG000|Washout of 28 Days|Physician Decision|0|||
25046425|NCT01344369|50149059|FG001|Washout of 28 Days|Physician Decision|1|||
25276428|NCT00958360|50590368|FG001|Overall Study|Physician Decision|1|||
25046426|NCT01344369|50149058|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
25046427|NCT01344369|50149059|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
25046428|NCT03179462|50149068|FG000|Overall Study|screening failure|1|||
25046429|NCT03179462|50149069|FG001|Overall Study|screening failure|2|||
25046430|NCT03179462|50149070|FG002|Overall Study|screening failure|0|||
25046431|NCT01314703|50149078|FG000|Overall Study|screen failure and closed enrollment|8|||
25046432|NCT01360762|50149083|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
25046433|NCT01360762|50149083|FG000|Main Study Period (12-month Treatment)|Death|5|||
25046434|NCT01360762|50149083|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
25046435|NCT01360762|50149083|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
25046436|NCT01360762|50149083|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
25046437|NCT01360762|50149083|FG000|Whole Study Period|Lost to Follow-up|10|||
25046438|NCT01360762|50149083|FG000|Whole Study Period|Death|7|||
25046439|NCT01360762|50149083|FG000|Whole Study Period|Patient relapsed|18|||
25046440|NCT01360762|50149083|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
25046441|NCT04382924|50149090|FG000|Overall Study|Death|2|||
25046442|NCT04382924|50149091|FG001|Overall Study|Death|5|||
25046443|NCT04382924|50149092|FG002|Overall Study|Death|4|||
25046444|NCT04382924|50149090|FG000|Overall Study|Protocol Violation|0|||
25046445|NCT04382924|50149091|FG001|Overall Study|Protocol Violation|1|||
25046446|NCT04382924|50149092|FG002|Overall Study|Protocol Violation|1|||
25046447|NCT04382924|50149090|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
25046448|NCT04382924|50149091|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
25046449|NCT04382924|50149092|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
25046450|NCT04382924|50149090|FG000|Overall Study|Withdrawal by Subject|6|||
25046451|NCT04382924|50149091|FG001|Overall Study|Withdrawal by Subject|3|||
25046452|NCT04382924|50149092|FG002|Overall Study|Withdrawal by Subject|6|||
25046453|NCT03044431|50149106|FG000|Overall Study|Lost to Follow-up|59|||
25046454|NCT02770170|50149114|FG000|Overall Study|Withdrawal by Subject|0|||
25046455|NCT02770170|50149115|FG001|Overall Study|Withdrawal by Subject|0|||
25046456|NCT02770170|50149116|FG002|Overall Study|Withdrawal by Subject|0|||
25046457|NCT02770170|50149117|FG003|Overall Study|Withdrawal by Subject|2|||
25046458|NCT02770170|50149114|FG000|Overall Study|due to pregnancy|1|||
25046459|NCT02770170|50149115|FG001|Overall Study|due to pregnancy|0|||
25046460|NCT02770170|50149116|FG002|Overall Study|due to pregnancy|0|||
25046461|NCT02770170|50149117|FG003|Overall Study|due to pregnancy|0|||
25046462|NCT02770170|50149114|FG000|Overall Study|Lack of Efficacy|2|||
25046463|NCT02770170|50149115|FG001|Overall Study|Lack of Efficacy|0|||
25046464|NCT02770170|50149116|FG002|Overall Study|Lack of Efficacy|0|||
25046465|NCT02770170|50149117|FG003|Overall Study|Lack of Efficacy|1|||
25046466|NCT02770170|50149114|FG000|Overall Study|Adverse Event|4|||
25046467|NCT02770170|50149115|FG001|Overall Study|Adverse Event|3|||
25046468|NCT02770170|50149116|FG002|Overall Study|Adverse Event|5|||
25046469|NCT02770170|50149117|FG003|Overall Study|Adverse Event|3|||
25046470|NCT02770170|50149114|FG000|Overall Study|due to disease worsening|0|||
25046471|NCT02770170|50149115|FG001|Overall Study|due to disease worsening|0|||
25046472|NCT02770170|50149116|FG002|Overall Study|due to disease worsening|0|||
25046473|NCT02770170|50149117|FG003|Overall Study|due to disease worsening|1|||
25046474|NCT02769858|50149127|FG000|Overall Study|Withdrawal by Subject|2|||
25046475|NCT02769624|50149131|FG000|Overall Study|Lost to Follow-up|0|||
25046476|NCT02769624|50149132|FG001|Overall Study|Lost to Follow-up|1|||
25046477|NCT03446768|50149140|FG000|Overall Study|Withdrawal by Subject|0|||
25046478|NCT03446768|50149141|FG001|Overall Study|Withdrawal by Subject|1|||
25046479|NCT02676284|50149147|FG000|Overall Study|Withdrawal by Subject|1|||
25046480|NCT02769312|50149153|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
25046481|NCT02769312|50149154|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
25046482|NCT02769312|50149153|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
25046483|NCT02769312|50149154|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
25046484|NCT02769312|50149153|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
25046485|NCT02769312|50149154|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
25046486|NCT02769312|50149153|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
25046487|NCT02769312|50149154|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
25046488|NCT02769312|50149153|FG000|Follow-up|Lost to Follow-up|1|||
25046489|NCT02769312|50149154|FG001|Follow-up|Lost to Follow-up|1|||
25046490|NCT01673386|50149161|FG000|Overall Study|Study terminated by sponsor|16|||
25046491|NCT01673386|50149162|FG001|Overall Study|Study terminated by sponsor|22|||
25046492|NCT01673386|50149161|FG000|Overall Study|Adverse Event|5|||
25046493|NCT01673386|50149162|FG001|Overall Study|Adverse Event|2|||
25046494|NCT01673386|50149161|FG000|Overall Study|Progressive disease|4|||
25046495|NCT01673386|50149162|FG001|Overall Study|Progressive disease|1|||
25046496|NCT01673386|50149161|FG000|Overall Study|Withdrawal by Subject|0|||
25046497|NCT01673386|50149162|FG001|Overall Study|Withdrawal by Subject|2|||
25046498|NCT00103740|50149170|FG000|Period 1 - Core|Adverse Event|1|||
25046499|NCT00103740|50149171|FG001|Period 1 - Core|Adverse Event|0|||
25046500|NCT00103740|50149170|FG000|Period 1 - Core|Protocol Violation|3|||
25046501|NCT00103740|50149171|FG001|Period 1 - Core|Protocol Violation|2|||
25046502|NCT00103740|50149170|FG000|Period 1 - Core|Patient withdrew consent|3|||
25046503|NCT00103740|50149171|FG001|Period 1 - Core|Patient withdrew consent|2|||
25046504|NCT00103740|50149170|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
25046505|NCT00103740|50149171|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
25046506|NCT00103740|50149170|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
25046507|NCT00103740|50149171|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
25046508|NCT00103740|50149170|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
25162458|NCT01791517|50284755|FG006|Phase I: Period 2|Lost to Follow-up|0|||
25162459|NCT01791517|50284756|FG007|Phase I: Period 2|Lost to Follow-up|0|||
24958590|NCT00313170|50049135|FG001|Overall Study|Death|4|||
24958591|NCT00313170|50049136|FG002|Overall Study|Death|2|||
24958592|NCT00313170|50049134|FG000|Overall Study|Adverse Event|1|||
24958593|NCT00313170|50049135|FG001|Overall Study|Adverse Event|2|||
24958594|NCT00313170|50049136|FG002|Overall Study|Adverse Event|0|||
24958595|NCT00313170|50049134|FG000|Overall Study|Disease progression|31|||
24958596|NCT00313170|50049135|FG001|Overall Study|Disease progression|26|||
24958597|NCT00313170|50049136|FG002|Overall Study|Disease progression|27|||
24958598|NCT00313170|50049134|FG000|Overall Study|Withdrawal by Subject|1|||
24958599|NCT00313170|50049135|FG001|Overall Study|Withdrawal by Subject|0|||
24958600|NCT00313170|50049136|FG002|Overall Study|Withdrawal by Subject|1|||
24958601|NCT00313170|50049134|FG000|Overall Study|Incorrect enrollment|0|||
24958602|NCT00313170|50049135|FG001|Overall Study|Incorrect enrollment|2|||
24958603|NCT00313170|50049136|FG002|Overall Study|Incorrect enrollment|1|||
24958604|NCT00313170|50049134|FG000|Overall Study|Lost to Follow-up|0|||
24958605|NCT00313170|50049135|FG001|Overall Study|Lost to Follow-up|0|||
24958606|NCT00313170|50049136|FG002|Overall Study|Lost to Follow-up|1|||
24958607|NCT00313170|50049134|FG000|Overall Study|Progression (investigators opinion)|1|||
24958608|NCT00313170|50049135|FG001|Overall Study|Progression (investigators opinion)|0|||
24958609|NCT00313170|50049136|FG002|Overall Study|Progression (investigators opinion)|0|||
24958610|NCT00332462|50049145|FG000|Overall Study|Adverse Event|5|||
24958611|NCT00332462|50049145|FG000|Overall Study|Abnormal Lab Value|1|||
24958612|NCT00332462|50049145|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
24958613|NCT00332462|50049145|FG000|Overall Study|no longer requires study drug|1|||
24958614|NCT00332462|50049145|FG000|Overall Study|Death|3|||
24958615|NCT00332462|50049145|FG000|Overall Study|Graft Loss|2|||
24958616|NCT00324038|50049154|FG000|Overall Study|Adverse Event|38|||
24958617|NCT00324038|50049155|FG001|Overall Study|Adverse Event|23|||
24958618|NCT00324038|50049154|FG000|Overall Study|Lack of Efficacy|5|||
24958619|NCT00324038|50049155|FG001|Overall Study|Lack of Efficacy|13|||
24958620|NCT00324038|50049154|FG000|Overall Study|Lost to Follow-up|0|||
24958621|NCT00324038|50049155|FG001|Overall Study|Lost to Follow-up|2|||
24958622|NCT00324038|50049154|FG000|Overall Study|Other|6|||
24958623|NCT00324038|50049155|FG001|Overall Study|Other|13|||
24958624|NCT00159861|50049163|FG000|Core Study - 16 Weeks|Death|3|||
24958625|NCT00159861|50049164|FG001|Core Study - 16 Weeks|Death|0|||
24958626|NCT00159861|50049163|FG000|Core Study - 16 Weeks|Adverse Event|12|||
24958627|NCT00159861|50049164|FG001|Core Study - 16 Weeks|Adverse Event|6|||
24958628|NCT00159861|50049163|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
24958629|NCT00159861|50049164|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
24958630|NCT00159861|50049163|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
24958631|NCT00159861|50049164|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
24958632|NCT00159861|50049163|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
24958633|NCT00159861|50049164|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
24958634|NCT00159861|50049163|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
24958635|NCT00159861|50049164|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
24958636|NCT00159861|50049163|FG000|Extension Study - up to 3 Years|Death|24|||
24958637|NCT00159861|50049164|FG001|Extension Study - up to 3 Years|Death|28|||
24958638|NCT00159861|50049163|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
24958639|NCT00159861|50049164|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
24958640|NCT00159861|50049163|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
24958641|NCT00159861|50049164|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
24958642|NCT00159861|50049163|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
24958643|NCT00159861|50049164|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
24958644|NCT00159861|50049163|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
24958645|NCT00159861|50049164|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
24958646|NCT00331760|50049177|FG000|Overall Study|Ineligible / no protocol treatment|15|||
24958647|NCT00331760|50049178|FG001|Overall Study|Ineligible / no protocol treatment|8|||
24958648|NCT00225147|50049189|FG000|Open-label Phase|Lost to Follow-up|0|||
24958649|NCT00225147|50049190|FG001|Open-label Phase|Lost to Follow-up|0|||
24958650|NCT00225147|50049191|FG002|Open-label Phase|Lost to Follow-up|0|||
24958651|NCT00225147|50049192|FG003|Open-label Phase|Lost to Follow-up|4|||
24958652|NCT00225147|50049189|FG000|Open-label Phase|Withdrawal by Subject|0|||
24958653|NCT00225147|50049190|FG001|Open-label Phase|Withdrawal by Subject|0|||
24958654|NCT00225147|50049191|FG002|Open-label Phase|Withdrawal by Subject|0|||
25046509|NCT00103740|50149171|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
25046510|NCT00103740|50149170|FG000|Period 2 - Extended Observation Period|Death|6|||
25046511|NCT00103740|50149171|FG001|Period 2 - Extended Observation Period|Death|2|||
25046512|NCT00103740|50149170|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
25046513|NCT00103740|50149171|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
25046514|NCT01281644|50149177|FG000|Overall Study|Lost to Follow-up|3|||
25046515|NCT01281644|50149177|FG000|Overall Study|Withdrawal by Subject|2|||
25046516|NCT02869893|50149183|FG000|Overall Study|participant aversion to IV|5|||
25046517|NCT02869893|50149183|FG000|Overall Study|participant fear of MRI scanner|2|||
25046518|NCT02872311|50149220|FG000|Overall Study|Death|2|||
25046519|NCT02872311|50149221|FG001|Overall Study|Death|0|||
25046520|NCT02872311|50149222|FG002|Overall Study|Death|0|||
25046521|NCT02872311|50149223|FG003|Overall Study|Death|0|||
25046522|NCT02872311|50149224|FG004|Overall Study|Death|0|||
25046523|NCT02872311|50149220|FG000|Overall Study|Lost to Follow-up|2|||
25046524|NCT02872311|50149221|FG001|Overall Study|Lost to Follow-up|0|||
25046525|NCT02872311|50149222|FG002|Overall Study|Lost to Follow-up|0|||
25046526|NCT02872311|50149223|FG003|Overall Study|Lost to Follow-up|0|||
25046527|NCT02872311|50149224|FG004|Overall Study|Lost to Follow-up|0|||
25046528|NCT02872311|50149220|FG000|Overall Study|Protocol Violation|0|||
25046529|NCT02872311|50149221|FG001|Overall Study|Protocol Violation|2|||
25046530|NCT02872311|50149222|FG002|Overall Study|Protocol Violation|1|||
25046531|NCT02872311|50149223|FG003|Overall Study|Protocol Violation|0|||
25046532|NCT02872311|50149224|FG004|Overall Study|Protocol Violation|0|||
25046533|NCT02871375|50149252|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
25046534|NCT02871375|50149253|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
25046535|NCT02867709|50149264|FG000|Treatment Period|Adverse Event|1|||
25046536|NCT02867709|50149265|FG001|Treatment Period|Adverse Event|1|||
25046537|NCT02867709|50149266|FG002|Treatment Period|Adverse Event|2|||
25046538|NCT02867709|50149264|FG000|Treatment Period|Withdrawal of Consent|7|||
25046539|NCT02867709|50149265|FG001|Treatment Period|Withdrawal of Consent|9|||
25046540|NCT02867709|50149266|FG002|Treatment Period|Withdrawal of Consent|8|||
25046541|NCT02867709|50149264|FG000|Treatment Period|Lost to Follow-up|17|||
25046542|NCT02867709|50149265|FG001|Treatment Period|Lost to Follow-up|20|||
25046543|NCT02867709|50149266|FG002|Treatment Period|Lost to Follow-up|20|||
25046544|NCT02867709|50149264|FG000|Treatment Period|Lack of Qualifying Event|42|||
25162460|NCT01791517|50284757|FG008|Phase I: Period 2|Lost to Follow-up|0|||
24958655|NCT00225147|50049192|FG003|Open-label Phase|Withdrawal by Subject|6|||
24958656|NCT00313014|50049207|FG000|Overall Study|Withdrawal by Subject|11|||
24958657|NCT00313014|50049208|FG001|Overall Study|Withdrawal by Subject|7|||
24958658|NCT00313014|50049209|FG002|Overall Study|Withdrawal by Subject|5|||
24958659|NCT00313014|50049207|FG000|Overall Study|Adverse Event|14|||
24958660|NCT00313014|50049208|FG001|Overall Study|Adverse Event|29|||
24958661|NCT00313014|50049209|FG002|Overall Study|Adverse Event|16|||
24958662|NCT00313014|50049207|FG000|Overall Study|Lost to Follow-up|7|||
24958663|NCT00313014|50049208|FG001|Overall Study|Lost to Follow-up|6|||
24958664|NCT00313014|50049209|FG002|Overall Study|Lost to Follow-up|10|||
24958665|NCT00313014|50049207|FG000|Overall Study|Administrative|9|||
24958666|NCT00313014|50049208|FG001|Overall Study|Administrative|6|||
24958667|NCT00313014|50049209|FG002|Overall Study|Administrative|14|||
24958668|NCT00313014|50049207|FG000|Overall Study|Lack of Efficacy|52|||
24958669|NCT00313014|50049208|FG001|Overall Study|Lack of Efficacy|25|||
24958670|NCT00313014|50049209|FG002|Overall Study|Lack of Efficacy|16|||
24958671|NCT00157209|50049220|FG000|Overall Study|Ongoing at data cut-off|10|||
24958672|NCT00157209|50049221|FG001|Overall Study|Ongoing at data cut-off|0|||
24958673|NCT00312858|50049229|FG000|Overall Study|Adverse Event|0|||
24958674|NCT00312858|50049230|FG001|Overall Study|Adverse Event|1|||
24958675|NCT00312858|50049229|FG000|Overall Study|Lost to Follow-up|25|||
24958676|NCT00312858|50049230|FG001|Overall Study|Lost to Follow-up|42|||
24958677|NCT00312858|50049229|FG000|Overall Study|Protocol Violation|3|||
24958678|NCT00312858|50049230|FG001|Overall Study|Protocol Violation|8|||
24958679|NCT00312858|50049229|FG000|Overall Study|Withdraw by Participant|20|||
24958680|NCT00312858|50049230|FG001|Overall Study|Withdraw by Participant|20|||
24958681|NCT00312858|50049229|FG000|Overall Study|Participant Moved|11|||
24958682|NCT00312858|50049230|FG001|Overall Study|Participant Moved|10|||
24958683|NCT00312858|50049229|FG000|Overall Study|Other|9|||
24958684|NCT00312858|50049230|FG001|Overall Study|Other|12|||
24958685|NCT00312702|50049239|FG000|Immunization Phase|Lost to Follow-up|0|||
24958686|NCT00312702|50049240|FG001|Immunization Phase|Lost to Follow-up|1|||
24958687|NCT00312702|50049241|FG002|Immunization Phase|Lost to Follow-up|0|||
24958688|NCT00156819|50049252|FG000|Overall Study|Lost to Follow-up|1|||
24958689|NCT00156819|50049253|FG001|Overall Study|Lost to Follow-up|1|||
24958690|NCT00156819|50049254|FG002|Overall Study|Lost to Follow-up|3|||
25046545|NCT02867709|50149265|FG001|Treatment Period|Lack of Qualifying Event|55|||
25046546|NCT02867709|50149266|FG002|Treatment Period|Lack of Qualifying Event|42|||
25046547|NCT02867709|50149264|FG000|Treatment Period|Protocol Violation|3|||
25046548|NCT02867709|50149265|FG001|Treatment Period|Protocol Violation|2|||
25046549|NCT02867709|50149266|FG002|Treatment Period|Protocol Violation|3|||
25046550|NCT02867709|50149264|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
25046551|NCT02867709|50149265|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
25046552|NCT02867709|50149266|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
25046553|NCT02867709|50149264|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
25046554|NCT02867709|50149265|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
25046555|NCT02867709|50149266|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
25046556|NCT02867709|50149264|FG000|Safety Follow-up Period|Pregnancy|0|||
25046557|NCT02867709|50149265|FG001|Safety Follow-up Period|Pregnancy|1|||
25046558|NCT02867709|50149266|FG002|Safety Follow-up Period|Pregnancy|0|||
25046559|NCT02867709|50149264|FG000|Safety Follow-up Period|Protocol Violation|0|||
25046560|NCT02867709|50149265|FG001|Safety Follow-up Period|Protocol Violation|1|||
25046561|NCT02867709|50149266|FG002|Safety Follow-up Period|Protocol Violation|1|||
25046562|NCT03044353|50149277|FG000|Overall Study|Adverse Event|0|||
25046563|NCT03044353|50149278|FG001|Overall Study|Adverse Event|1|||
25046564|NCT03044353|50149279|FG002|Overall Study|Adverse Event|0|||
25046565|NCT01361308|50149288|FG000|Overall Study|Withdrawal by Subject|9|||
25162461|NCT01791517|50284758|FG009|Phase I: Period 2|Lost to Follow-up|0|||
24958691|NCT03825042|50049264|FG000|Overall Study|Adverse Event|1|||
24958692|NCT03825042|50049265|FG001|Overall Study|Adverse Event|0|||
24958693|NCT03825042|50049264|FG000|Overall Study|Withdrawal by Subject|1|||
24958694|NCT03825042|50049265|FG001|Overall Study|Withdrawal by Subject|0|||
24958695|NCT00129987|50049273|FG000|1st Educational Session|Withdrawal by Subject|141|||
24958696|NCT00129987|50049274|FG001|1st Educational Session|Withdrawal by Subject|109|||
24958697|NCT00129987|50049273|FG000|1 Year|Withdrawal by Subject|32|||
24958698|NCT00129987|50049274|FG001|1 Year|Withdrawal by Subject|21|||
24958699|NCT00224133|50049280|FG000|Overall Study|Adverse Event|93|||
24958700|NCT00224133|50049280|FG000|Overall Study|Protocol Violation|6|||
24958701|NCT00224133|50049280|FG000|Overall Study|Withdrawal by Subject|33|||
24958702|NCT00224133|50049280|FG000|Overall Study|Lack of Efficacy|58|||
24958703|NCT00224133|50049280|FG000|Overall Study|Lost to Follow-up|21|||
24958704|NCT00224133|50049280|FG000|Overall Study|Physician Decision|1|||
24958705|NCT00224133|50049280|FG000|Overall Study|Other|14|||
24958706|NCT00224055|50049286|FG000|Overall Study|Adverse Event|9|||
24958707|NCT00224055|50049287|FG001|Overall Study|Adverse Event|3|||
24958708|NCT00224055|50049286|FG000|Overall Study|Lost to Follow-up|1|||
24958709|NCT00224055|50049287|FG001|Overall Study|Lost to Follow-up|2|||
24958710|NCT00224055|50049286|FG000|Overall Study|Protocol Violation|1|||
24958711|NCT00224055|50049287|FG001|Overall Study|Protocol Violation|1|||
24958712|NCT00224055|50049286|FG000|Overall Study|Inclusion Violation|3|||
24958713|NCT00224055|50049287|FG001|Overall Study|Inclusion Violation|6|||
24958714|NCT00224055|50049286|FG000|Overall Study|Withdrawal by Subject|0|||
24958715|NCT00224055|50049287|FG001|Overall Study|Withdrawal by Subject|2|||
24958716|NCT00224055|50049286|FG000|Overall Study|Other|1|||
24958717|NCT00224055|50049287|FG001|Overall Study|Other|0|||
24958718|NCT00150969|50049295|FG000|24 Month Main Study|Adverse Event|3|||
24958719|NCT00150969|50049296|FG001|24 Month Main Study|Adverse Event|4|||
24958720|NCT00150969|50049295|FG000|24 Month Main Study|Death|1|||
24958721|NCT00150969|50049296|FG001|24 Month Main Study|Death|1|||
24958722|NCT00150969|50049295|FG000|24 Month Main Study|Lack of Efficacy|1|||
24958723|NCT00150969|50049296|FG001|24 Month Main Study|Lack of Efficacy|8|||
24958724|NCT00150969|50049295|FG000|24 Month Main Study|Lost to Follow-up|3|||
24958725|NCT00150969|50049296|FG001|24 Month Main Study|Lost to Follow-up|2|||
25162462|NCT01791517|50284759|FG010|Phase I: Period 2|Lost to Follow-up|0|||
24958726|NCT00150969|50049295|FG000|24 Month Main Study|Protocol Violation|4|||
24958727|NCT00150969|50049296|FG001|24 Month Main Study|Protocol Violation|2|||
24958728|NCT00150969|50049295|FG000|24 Month Main Study|Withdrawal by Subject|7|||
24958729|NCT00150969|50049296|FG001|24 Month Main Study|Withdrawal by Subject|4|||
25046566|NCT01361308|50149289|FG001|Overall Study|Withdrawal by Subject|13|||
25046567|NCT01361308|50149288|FG000|Overall Study|Physician Decision|3|||
25046568|NCT01361308|50149289|FG001|Overall Study|Physician Decision|3|||
25046569|NCT01361308|50149288|FG000|Overall Study|Lack of Efficacy|2|||
25046570|NCT01361308|50149289|FG001|Overall Study|Lack of Efficacy|0|||
25046571|NCT01361308|50149288|FG000|Overall Study|Protocol Violation|1|||
25046572|NCT01361308|50149289|FG001|Overall Study|Protocol Violation|0|||
25046573|NCT01361308|50149288|FG000|Overall Study|Lost to Follow-up|5|||
25046574|NCT01361308|50149289|FG001|Overall Study|Lost to Follow-up|4|||
25046575|NCT01361308|50149288|FG000|Overall Study|Adverse Event|8|||
25046576|NCT01361308|50149289|FG001|Overall Study|Adverse Event|4|||
25046577|NCT01361308|50149288|FG000|Overall Study|Eligibility Criteria Not Met|2|||
25046578|NCT01361308|50149289|FG001|Overall Study|Eligibility Criteria Not Met|3|||
25046579|NCT01361308|50149288|FG000|Overall Study|Failed C-SSRS|5|||
25046580|NCT01361308|50149289|FG001|Overall Study|Failed C-SSRS|2|||
25046581|NCT01361308|50149288|FG000|Overall Study|Other|0|||
25046582|NCT01361308|50149289|FG001|Overall Study|Other|1|||
25046583|NCT02872935|50149301|FG000|Overall Study|Other|0|||
25046584|NCT02872935|50149302|FG001|Overall Study|Other|1|||
25046585|NCT00103662|50149310|FG000|Overall Study|Entered Rescue Procedure|0|||
25046586|NCT00103662|50149311|FG001|Overall Study|Entered Rescue Procedure|7|||
25046587|NCT00103662|50149310|FG000|Overall Study|Death|7|||
25046588|NCT00103662|50149311|FG001|Overall Study|Death|7|||
25046589|NCT00103662|50149310|FG000|Overall Study|Elective Withdrawal|5|||
25046590|NCT00103662|50149311|FG001|Overall Study|Elective Withdrawal|5|||
25046591|NCT00103662|50149310|FG000|Overall Study|Lost to Follow-up|0|||
25046592|NCT00103662|50149311|FG001|Overall Study|Lost to Follow-up|1|||
25046593|NCT00103662|50149310|FG000|Overall Study|Other|6|||
25046594|NCT00103662|50149311|FG001|Overall Study|Other|9|||
25046595|NCT00103662|50149310|FG000|Overall Study|Failed mobilization|0|||
25046596|NCT00103662|50149311|FG001|Overall Study|Failed mobilization|4|||
25046597|NCT00103662|50149310|FG000|Overall Study|Intercurrent illness|1|||
25046598|NCT00103662|50149311|FG001|Overall Study|Intercurrent illness|0|||
25046599|NCT02865915|50149319|FG000|Overall Study|Pregnancy|1|||
25046600|NCT02865915|50149320|FG001|Overall Study|Pregnancy|0|||
25046601|NCT02865915|50149319|FG000|Overall Study|Withdrawal by Subject|1|||
25046602|NCT02865915|50149320|FG001|Overall Study|Withdrawal by Subject|1|||
25046603|NCT02865915|50149319|FG000|Overall Study|Adverse Event|0|||
25046604|NCT02865915|50149320|FG001|Overall Study|Adverse Event|4|||
25046605|NCT02865915|50149319|FG000|Overall Study|Lost to Follow-up|0|||
25046606|NCT02865915|50149320|FG001|Overall Study|Lost to Follow-up|1|||
25046607|NCT02865915|50149319|FG000|Overall Study|Protocol Violation|0|||
25046608|NCT02865915|50149320|FG001|Overall Study|Protocol Violation|1|||
25046609|NCT02865915|50149319|FG000|Overall Study|Study terminated by sponsor|23|||
25046610|NCT02865915|50149320|FG001|Overall Study|Study terminated by sponsor|18|||
25046611|NCT02865915|50149319|FG000|Overall Study|Dosing group discontinued|0|||
25046612|NCT02865915|50149320|FG001|Overall Study|Dosing group discontinued|5|||
24958730|NCT00150969|50049295|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
24958731|NCT00150969|50049296|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
24958732|NCT00150969|50049295|FG000|24-48 Month Extension|Lack of Efficacy|0|||
24958733|NCT00150969|50049296|FG001|24-48 Month Extension|Lack of Efficacy|1|||
24958734|NCT00150969|50049295|FG000|24-48 Month Extension|Adverse Event|1|||
24958735|NCT00150969|50049296|FG001|24-48 Month Extension|Adverse Event|3|||
24958736|NCT00150969|50049295|FG000|24-48 Month Extension|Other Reason|81|||
25046613|NCT00104676|50149328|FG000|Overall Study|Death|3|||
25046614|NCT00104676|50149329|FG001|Overall Study|Death|2|||
25046615|NCT00104676|50149328|FG000|Overall Study|Withdrawal by Subject|0|||
24958737|NCT00150969|50049296|FG001|24-48 Month Extension|Other Reason|91|||
24958738|NCT00150345|50049305|FG000|Overall Study|Death|5|||
25046616|NCT00104676|50149329|FG001|Overall Study|Withdrawal by Subject|2|||
25046617|NCT00104676|50149328|FG000|Overall Study|treatment interruption|4|||
24958739|NCT00150345|50049306|FG001|Overall Study|Death|2|||
25046618|NCT00104676|50149329|FG001|Overall Study|treatment interruption|10|||
25046619|NCT00354835|50149337|FG000|Overall Study|Death|1|||
25046620|NCT00354835|50149338|FG001|Overall Study|Death|1|||
25046621|NCT00354835|50149337|FG000|Overall Study|Physician Decision|8|||
25046622|NCT00354835|50149338|FG001|Overall Study|Physician Decision|13|||
25046623|NCT00354835|50149337|FG000|Overall Study|Withdrawal by Subject|2|||
24958740|NCT00150345|50049305|FG000|Overall Study|Adverse Event|8|||
24958741|NCT00150345|50049306|FG001|Overall Study|Adverse Event|6|||
24958742|NCT00150345|50049305|FG000|Overall Study|Lack of Efficacy|5|||
24958743|NCT00150345|50049306|FG001|Overall Study|Lack of Efficacy|4|||
24958744|NCT00150345|50049305|FG000|Overall Study|Withdrawal by Subject|3|||
24958745|NCT00150345|50049306|FG001|Overall Study|Withdrawal by Subject|4|||
24958746|NCT00150345|50049305|FG000|Overall Study|Laboratory abnormality|1|||
24958747|NCT00150345|50049306|FG001|Overall Study|Laboratory abnormality|2|||
24958748|NCT00150345|50049305|FG000|Overall Study|Other|12|||
24958749|NCT00150345|50049306|FG001|Overall Study|Other|14|||
24958750|NCT00223977|50049316|FG000|Overall Study|Adverse Event|7|||
24958751|NCT00223977|50049317|FG001|Overall Study|Adverse Event|10|||
24958752|NCT00223977|50049318|FG002|Overall Study|Adverse Event|0|||
24958753|NCT00223977|50049316|FG000|Overall Study|Protocol Violation|0|||
24958754|NCT00223977|50049317|FG001|Overall Study|Protocol Violation|0|||
24958755|NCT00223977|50049318|FG002|Overall Study|Protocol Violation|1|||
24958756|NCT00223977|50049316|FG000|Overall Study|Withdrawal by Subject|1|||
24958757|NCT00223977|50049317|FG001|Overall Study|Withdrawal by Subject|1|||
24958758|NCT00223977|50049318|FG002|Overall Study|Withdrawal by Subject|2|||
24958759|NCT00223977|50049316|FG000|Overall Study|Other|1|||
24958760|NCT00223977|50049317|FG001|Overall Study|Other|0|||
24958761|NCT00223977|50049318|FG002|Overall Study|Other|0|||
24958762|NCT00148941|50049330|FG000|Overall Study|Lost to Follow-up|17|||
24958763|NCT00148941|50049331|FG001|Overall Study|Lost to Follow-up|24|||
24958764|NCT00148941|50049332|FG002|Overall Study|Lost to Follow-up|18|||
24958765|NCT00148941|50049333|FG003|Overall Study|Lost to Follow-up|22|||
24958766|NCT00148941|50049330|FG000|Overall Study|Withdrawal by Subject|1|||
24958767|NCT00148941|50049331|FG001|Overall Study|Withdrawal by Subject|0|||
24958768|NCT00148941|50049332|FG002|Overall Study|Withdrawal by Subject|1|||
24958769|NCT00148941|50049333|FG003|Overall Study|Withdrawal by Subject|0|||
24958770|NCT00148941|50049330|FG000|Overall Study|Other|0|||
24958771|NCT00148941|50049331|FG001|Overall Study|Other|0|||
24958772|NCT00148941|50049332|FG002|Overall Study|Other|1|||
24958773|NCT00148941|50049333|FG003|Overall Study|Other|2|||
24958774|NCT00148317|50049343|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
24958775|NCT00148317|50049343|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
24958776|NCT00148317|50049343|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
24958777|NCT00323882|50049355|FG000|Overall Study|Adverse Event|2|||
24958778|NCT00323882|50049356|FG001|Overall Study|Adverse Event|1|||
24958779|NCT00323882|50049357|FG002|Overall Study|Adverse Event|1|||
24958780|NCT00323882|50049358|FG003|Overall Study|Adverse Event|1|||
24958781|NCT00323882|50049359|FG004|Overall Study|Adverse Event|3|||
24958782|NCT00323882|50049355|FG000|Overall Study|Disease Progression|6|||
24958783|NCT00323882|50049356|FG001|Overall Study|Disease Progression|4|||
24958784|NCT00323882|50049357|FG002|Overall Study|Disease Progression|10|||
24958785|NCT00323882|50049358|FG003|Overall Study|Disease Progression|5|||
24958786|NCT00323882|50049359|FG004|Overall Study|Disease Progression|22|||
24958787|NCT00323882|50049355|FG000|Overall Study|Death|0|||
24958788|NCT00323882|50049356|FG001|Overall Study|Death|1|||
24958789|NCT00323882|50049357|FG002|Overall Study|Death|1|||
24958790|NCT00323882|50049358|FG003|Overall Study|Death|0|||
24958791|NCT00323882|50049359|FG004|Overall Study|Death|5|||
24958792|NCT00323882|50049355|FG000|Overall Study|Lost to Follow-up|0|||
24958793|NCT00323882|50049356|FG001|Overall Study|Lost to Follow-up|0|||
24958794|NCT00323882|50049357|FG002|Overall Study|Lost to Follow-up|1|||
24958795|NCT00323882|50049358|FG003|Overall Study|Lost to Follow-up|0|||
24958796|NCT00323882|50049359|FG004|Overall Study|Lost to Follow-up|1|||
24958797|NCT00323882|50049355|FG000|Overall Study|Other|0|||
24958798|NCT00323882|50049356|FG001|Overall Study|Other|0|||
24958799|NCT00323882|50049357|FG002|Overall Study|Other|0|||
24958800|NCT00323882|50049358|FG003|Overall Study|Other|1|||
24958801|NCT00323882|50049359|FG004|Overall Study|Other|1|||
24958802|NCT00331682|50049380|FG000|Overall Study|Adverse Event|1|||
25046624|NCT00354835|50149338|FG001|Overall Study|Withdrawal by Subject|1|||
25046625|NCT00354835|50149337|FG000|Overall Study|Ineligible|17|||
25046626|NCT00354835|50149338|FG001|Overall Study|Ineligible|16|||
25046627|NCT00354835|50149337|FG000|Overall Study|Disease progression or relapse|15|||
25046628|NCT00354835|50149338|FG001|Overall Study|Disease progression or relapse|22|||
25046629|NCT00354835|50149337|FG000|Overall Study|Adverse Event|6|||
25046630|NCT00354835|50149338|FG001|Overall Study|Adverse Event|0|||
25046631|NCT00354835|50149337|FG000|Overall Study|Refusal of further therapy|3|||
25046632|NCT00354835|50149338|FG001|Overall Study|Refusal of further therapy|8|||
25046633|NCT02768298|50149361|FG000|Overall Study|Adverse Event|1|||
25046634|NCT02768298|50149362|FG001|Overall Study|Adverse Event|4|||
25046635|NCT02768298|50149361|FG000|Overall Study|Death|2|||
25046636|NCT02768298|50149362|FG001|Overall Study|Death|1|||
25046637|NCT02768298|50149361|FG000|Overall Study|Non-compliance with study treatment|0|||
25046638|NCT02768298|50149362|FG001|Overall Study|Non-compliance with study treatment|1|||
25046639|NCT02768298|50149361|FG000|Overall Study|Subject/guardian decision|1|||
25046640|NCT02768298|50149362|FG001|Overall Study|Subject/guardian decision|0|||
25046641|NCT02768298|50149361|FG000|Overall Study|Withdrawal of informed consent|0|||
25046642|NCT02768298|50149362|FG001|Overall Study|Withdrawal of informed consent|1|||
25046643|NCT02775864|50149372|FG000|Overall Study|Data ended end of 2010|1764|||
25046644|NCT02775864|50149373|FG001|Overall Study|Data ended end of 2010|2880|||
25046645|NCT02775864|50149374|FG002|Overall Study|Data ended end of 2010|1140|||
25046646|NCT02775864|50149375|FG003|Overall Study|Data ended end of 2010|1194|||
25046647|NCT02775864|50149372|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
25046648|NCT02775864|50149373|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
25046649|NCT02775864|50149374|FG002|Overall Study|Medicaid eligibility discontinued|720|||
25046650|NCT02775864|50149375|FG003|Overall Study|Medicaid eligibility discontinued|890|||
25046651|NCT02964273|50149388|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
25046652|NCT02964273|50149389|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
25046653|NCT02964273|50149390|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
25046654|NCT02964273|50149391|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
25046655|NCT02964273|50149388|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
25046656|NCT02964273|50149389|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
25046657|NCT02964273|50149390|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
25046658|NCT02964273|50149391|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
25046659|NCT02964273|50149388|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
25046660|NCT02964273|50149389|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
25046661|NCT02964273|50149390|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
25046662|NCT02964273|50149391|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
25046663|NCT02964273|50149388|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
25046664|NCT02964273|50149389|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
25046665|NCT02964273|50149390|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
25046666|NCT02964273|50149391|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
24958803|NCT00323492|50049386|FG000|Study Phase 1|Adverse Event|2|||
24958804|NCT00323492|50049387|FG001|Study Phase 1|Adverse Event|0|||
24958805|NCT00323492|50049388|FG002|Study Phase 1|Adverse Event|0|||
24958806|NCT00323492|50049386|FG000|Study Phase 2|Adverse Event|1|||
24958807|NCT00323492|50049387|FG001|Study Phase 2|Adverse Event|0|||
24958808|NCT00323492|50049388|FG002|Study Phase 2|Adverse Event|0|||
24958809|NCT00323492|50049386|FG000|Study Phase 2|Physician Decision|1|||
24958810|NCT00323492|50049387|FG001|Study Phase 2|Physician Decision|0|||
24958811|NCT00323492|50049388|FG002|Study Phase 2|Physician Decision|0|||
24958812|NCT00323492|50049386|FG000|Study Phase 2|Lost to Follow-up|1|||
24958813|NCT00323492|50049387|FG001|Study Phase 2|Lost to Follow-up|0|||
24958814|NCT00323492|50049388|FG002|Study Phase 2|Lost to Follow-up|0|||
24958815|NCT00323492|50049386|FG000|Study Phase 2|Withdrawal by Subject|0|||
24958816|NCT00323492|50049387|FG001|Study Phase 2|Withdrawal by Subject|1|||
24958817|NCT00323492|50049388|FG002|Study Phase 2|Withdrawal by Subject|0|||
24958818|NCT00323492|50049386|FG000|Study Phase 2|Noncompliance with study schedule|0|||
24958819|NCT00323492|50049387|FG001|Study Phase 2|Noncompliance with study schedule|0|||
24958820|NCT00323492|50049388|FG002|Study Phase 2|Noncompliance with study schedule|1|||
24958821|NCT00323492|50049386|FG000|Study Phase 2|Protocol Violation|1|||
24958822|NCT00323492|50049387|FG001|Study Phase 2|Protocol Violation|0|||
24958823|NCT00323492|50049388|FG002|Study Phase 2|Protocol Violation|0|||
24958824|NCT00331136|50049399|FG000|Overall Study|Adverse Event|3|||
24958825|NCT00331136|50049400|FG001|Overall Study|Adverse Event|5|||
24958826|NCT00331136|50049401|FG002|Overall Study|Adverse Event|0|||
24958827|NCT00331136|50049402|FG003|Overall Study|Adverse Event|1|||
24958828|NCT00331136|50049399|FG000|Overall Study|Withdrawal by Subject|0|||
24958829|NCT00331136|50049400|FG001|Overall Study|Withdrawal by Subject|1|||
24958830|NCT00331136|50049401|FG002|Overall Study|Withdrawal by Subject|0|||
25046667|NCT02964273|50149388|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
25046668|NCT02964273|50149389|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
25046669|NCT02964273|50149390|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
25046670|NCT02964273|50149391|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
25046671|NCT02964273|50149388|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
25046672|NCT02964273|50149389|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
25046673|NCT02964273|50149390|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
25046674|NCT02964273|50149391|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
25046675|NCT02773446|50149410|FG000|First Admission|Withdrawal by Subject|0|||
25046676|NCT02773446|50149411|FG001|First Admission|Withdrawal by Subject|0|||
25046677|NCT02773446|50149412|FG002|First Admission|Withdrawal by Subject|0|||
25046678|NCT02773446|50149413|FG003|First Admission|Withdrawal by Subject|1|||
25046679|NCT02773446|50149414|FG004|First Admission|Withdrawal by Subject|0|||
25046680|NCT02773446|50149415|FG005|First Admission|Withdrawal by Subject|0|||
25046681|NCT02773446|50149410|FG000|First Admission|Lost to Follow-up|1|||
25046682|NCT02773446|50149411|FG001|First Admission|Lost to Follow-up|0|||
25046683|NCT02773446|50149412|FG002|First Admission|Lost to Follow-up|0|||
25046684|NCT02773446|50149413|FG003|First Admission|Lost to Follow-up|0|||
25046685|NCT02773446|50149414|FG004|First Admission|Lost to Follow-up|0|||
25046686|NCT02773446|50149415|FG005|First Admission|Lost to Follow-up|0|||
25046687|NCT02773368|50149434|FG000|Overall Study|Lost to Follow-up|4|||
25046688|NCT02773368|50149435|FG001|Overall Study|Lost to Follow-up|1|||
25046689|NCT02773368|50149434|FG000|Overall Study|Withdrawal by Subject|5|||
25046690|NCT02773368|50149435|FG001|Overall Study|Withdrawal by Subject|1|||
25046691|NCT02773368|50149434|FG000|Overall Study|Unclassified|1|||
25046692|NCT02773368|50149435|FG001|Overall Study|Unclassified|1|||
25046693|NCT02773368|50149434|FG000|Overall Study|Missing|0|||
25046694|NCT02773368|50149435|FG001|Overall Study|Missing|1|||
25046695|NCT01336647|50149444|FG000|Overall Study|Lost to Follow-up|4|||
25046696|NCT01336647|50149445|FG001|Overall Study|Lost to Follow-up|1|||
25046697|NCT01336647|50149446|FG002|Overall Study|Lost to Follow-up|3|||
25046698|NCT01336569|50149456|FG000|Overall Study|Lost to Follow-up|4|||
25046699|NCT02772978|50149460|FG000|Overall Study|Withdrawal by Subject|1|||
25046700|NCT02772978|50149461|FG001|Overall Study|Withdrawal by Subject|1|||
25046701|NCT00104052|50149466|FG000|Overall Study|Adverse Event|1|||
25046702|NCT00104052|50149466|FG000|Overall Study|Lack of Efficacy|26|||
25046703|NCT00104052|50149466|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
25046704|NCT02777970|50149473|FG000|Overall Study|Lost to Follow-up|0|||
25046705|NCT02777970|50149474|FG001|Overall Study|Lost to Follow-up|1|||
25046706|NCT02777970|50149475|FG002|Overall Study|Lost to Follow-up|0|||
25046707|NCT02777970|50149473|FG000|Overall Study|Protocol Violation|1|||
25046708|NCT02777970|50149474|FG001|Overall Study|Protocol Violation|0|||
25046709|NCT02777970|50149475|FG002|Overall Study|Protocol Violation|0|||
25046710|NCT03037489|50149487|FG000|Overall Study|Adverse Event|4|||
25046711|NCT03037489|50149488|FG001|Overall Study|Adverse Event|0|||
25046712|NCT03037489|50149487|FG000|Overall Study|Withdrawal by Subject|3|||
25046713|NCT03037489|50149488|FG001|Overall Study|Withdrawal by Subject|0|||
25046714|NCT01336023|50149497|FG000|Week 0 to Week 26|Adverse Event|8|||
25046715|NCT01336023|50149498|FG001|Week 0 to Week 26|Adverse Event|10|||
25046716|NCT01336023|50149499|FG002|Week 0 to Week 26|Adverse Event|24|||
25046717|NCT01336023|50149497|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
25046718|NCT01336023|50149498|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
25046719|NCT01336023|50149499|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
25046720|NCT01336023|50149497|FG000|Week 0 to Week 26|Protocol Violation|1|||
25046721|NCT01336023|50149498|FG001|Week 0 to Week 26|Protocol Violation|2|||
25046722|NCT01336023|50149499|FG002|Week 0 to Week 26|Protocol Violation|0|||
25046723|NCT01336023|50149497|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
25046724|NCT01336023|50149498|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
25046725|NCT01336023|50149499|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
25046726|NCT01336023|50149497|FG000|Week 0 to Week 26|Unclassified|5|||
25162463|NCT01791517|50284760|FG011|Phase I: Period 2|Lost to Follow-up|0|||
25046727|NCT01336023|50149498|FG001|Week 0 to Week 26|Unclassified|16|||
25046728|NCT01336023|50149499|FG002|Week 0 to Week 26|Unclassified|9|||
25046729|NCT01336023|50149497|FG000|Week 27 to 52|Adverse Event|1|||
25046730|NCT01336023|50149498|FG001|Week 27 to 52|Adverse Event|5|||
25046731|NCT01336023|50149499|FG002|Week 27 to 52|Adverse Event|2|||
25046732|NCT01336023|50149497|FG000|Week 27 to 52|Protocol Violation|0|||
25046733|NCT01336023|50149498|FG001|Week 27 to 52|Protocol Violation|2|||
25046734|NCT01336023|50149499|FG002|Week 27 to 52|Protocol Violation|1|||
25046735|NCT01336023|50149497|FG000|Week 27 to 52|Withdrawal Criteria|14|||
25046736|NCT01336023|50149498|FG001|Week 27 to 52|Withdrawal Criteria|19|||
25046737|NCT01336023|50149499|FG002|Week 27 to 52|Withdrawal Criteria|16|||
25046738|NCT01336023|50149497|FG000|Week 27 to 52|Unclassified|13|||
25046739|NCT01336023|50149498|FG001|Week 27 to 52|Unclassified|18|||
25046740|NCT01336023|50149499|FG002|Week 27 to 52|Unclassified|9|||
25046741|NCT03039283|50149507|FG000|Overall Study|Protocol Violation|2|||
25046742|NCT02863575|50149529|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
25046743|NCT02863575|50149530|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
25046744|NCT02863575|50149531|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
25046745|NCT02863575|50149529|FG000|Overall Study|Withdrawal by Subject|0|||
25046746|NCT02863575|50149530|FG001|Overall Study|Withdrawal by Subject|1|||
25046747|NCT02863575|50149531|FG002|Overall Study|Withdrawal by Subject|1|||
25046748|NCT02863575|50149529|FG000|Overall Study|Adverse Event|0|||
25046749|NCT02863575|50149530|FG001|Overall Study|Adverse Event|1|||
25046750|NCT02863575|50149531|FG002|Overall Study|Adverse Event|0|||
25046751|NCT01227187|50149543|FG000|Overall Study|Physician Decision|0|||
25046752|NCT01227187|50149544|FG001|Overall Study|Physician Decision|0|||
25046753|NCT01227187|50149545|FG002|Overall Study|Physician Decision|0|||
25046754|NCT01227187|50149546|FG003|Overall Study|Physician Decision|1|||
25046755|NCT02638012|50149567|FG000|Overall Study|Lost to Follow-up|1|||
25046756|NCT00103506|50149573|FG000|Overall Study|Study closed by sponsor|34|||
25046757|NCT00103506|50149574|FG001|Overall Study|Study closed by sponsor|37|||
25046758|NCT00103506|50149573|FG000|Overall Study|Death|257|||
25046759|NCT00103506|50149574|FG001|Overall Study|Death|253|||
25046760|NCT00103506|50149573|FG000|Overall Study|Lost to Follow-up|13|||
25046761|NCT00103506|50149574|FG001|Overall Study|Lost to Follow-up|13|||
25046762|NCT00103506|50149573|FG000|Overall Study|Withdrawal by Subject|18|||
25046763|NCT00103506|50149574|FG001|Overall Study|Withdrawal by Subject|21|||
25046764|NCT02765490|50149582|FG000|Overall Study|Lost to Follow-up|1|||
25046765|NCT02765490|50149583|FG001|Overall Study|Lost to Follow-up|1|||
25046766|NCT02765490|50149582|FG000|Overall Study|Other|0|||
25046767|NCT02765490|50149583|FG001|Overall Study|Other|1|||
25046768|NCT02765490|50149582|FG000|Overall Study|Death|0|||
25046769|NCT02765490|50149583|FG001|Overall Study|Death|1|||
25046770|NCT02762370|50149591|FG000|Overall Study|Protocol Violation|1|||
25046771|NCT02762370|50149592|FG001|Overall Study|Protocol Violation|0|||
25046772|NCT02639182|50149602|FG000|Overall Study|Disease Progression|50|||
25046773|NCT02639182|50149603|FG001|Overall Study|Disease Progression|49|||
25046774|NCT02639182|50149602|FG000|Overall Study|Adverse Event|7|||
25046775|NCT02639182|50149603|FG001|Overall Study|Adverse Event|5|||
25046776|NCT02639182|50149602|FG000|Overall Study|Physician Decision|3|||
25046777|NCT02639182|50149603|FG001|Overall Study|Physician Decision|3|||
25046778|NCT02639182|50149602|FG000|Overall Study|Withdrew Consent|5|||
25046779|NCT02639182|50149603|FG001|Overall Study|Withdrew Consent|4|||
25046780|NCT02639182|50149602|FG000|Overall Study|Lost to Follow-up|0|||
25046781|NCT02639182|50149603|FG001|Overall Study|Lost to Follow-up|1|||
25046782|NCT02639182|50149602|FG000|Overall Study|Study Closure|1|||
25046783|NCT02639182|50149603|FG001|Overall Study|Study Closure|2|||
25046784|NCT02639182|50149602|FG000|Overall Study|Sponsor Ended Study|0|||
25046785|NCT02639182|50149603|FG001|Overall Study|Sponsor Ended Study|1|||
25046786|NCT02639182|50149602|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
25046787|NCT02639182|50149603|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
25046788|NCT02863419|50149612|FG000|Overall Study|Lost to Follow-up|0|||
25046789|NCT02863419|50149613|FG001|Overall Study|Lost to Follow-up|1|||
25046790|NCT02863419|50149614|FG002|Overall Study|Lost to Follow-up|4|||
25046791|NCT02863419|50149612|FG000|Overall Study|Withdrawal by Subject|5|||
25046792|NCT02863419|50149613|FG001|Overall Study|Withdrawal by Subject|5|||
25046793|NCT02863419|50149614|FG002|Overall Study|Withdrawal by Subject|3|||
25046794|NCT02863419|50149612|FG000|Overall Study|Died|3|||
25046795|NCT02863419|50149613|FG001|Overall Study|Died|4|||
25046796|NCT02863419|50149614|FG002|Overall Study|Died|1|||
25046797|NCT02765100|50149624|FG000|Overall Study|subject found ineligible after baseline|1|||
25046798|NCT02765100|50149625|FG001|Overall Study|subject found ineligible after baseline|1|||
25046799|NCT02765100|50149624|FG000|Overall Study|Lost to Follow-up|0|||
25046800|NCT02765100|50149625|FG001|Overall Study|Lost to Follow-up|1|||
25046801|NCT02761980|50149635|FG000|Overall Study|Adverse Event|4|||
25046802|NCT02761980|50149636|FG001|Overall Study|Adverse Event|6|||
25046803|NCT02761980|50149637|FG002|Overall Study|Adverse Event|5|||
25046804|NCT02761980|50149638|FG003|Overall Study|Adverse Event|6|||
25046805|NCT02761980|50149635|FG000|Overall Study|Withdrawal by Subject|0|||
25046806|NCT02761980|50149636|FG001|Overall Study|Withdrawal by Subject|1|||
25046807|NCT02761980|50149637|FG002|Overall Study|Withdrawal by Subject|0|||
25046808|NCT02761980|50149638|FG003|Overall Study|Withdrawal by Subject|0|||
25046809|NCT02761980|50149635|FG000|Overall Study|Other|0|||
25046810|NCT02761980|50149636|FG001|Overall Study|Other|0|||
25046811|NCT02761980|50149637|FG002|Overall Study|Other|1|||
25046812|NCT02761980|50149638|FG003|Overall Study|Other|0|||
25046813|NCT02862171|50149657|FG000|Overall Study|Death|1|||
25046814|NCT02862171|50149657|FG000|Overall Study|Lost to Follow-up|13|||
25046815|NCT02862171|50149657|FG000|Overall Study|Withdrawal by Subject|57|||
25046816|NCT02862171|50149657|FG000|Overall Study|Non-compliance|4|||
25046817|NCT02862171|50149657|FG000|Overall Study|HIV-1 seroconversion|18|||
25046818|NCT02638948|50149665|FG000|Overall Study|Withdrawal by Subject|4|||
25046819|NCT02638948|50149666|FG001|Overall Study|Withdrawal by Subject|5|||
25046820|NCT02638948|50149667|FG002|Overall Study|Withdrawal by Subject|3|||
25046821|NCT02638948|50149668|FG003|Overall Study|Withdrawal by Subject|1|||
25046822|NCT02638948|50149665|FG000|Overall Study|Administrative Reason by Sponsor|0|||
25046823|NCT02638948|50149666|FG001|Overall Study|Administrative Reason by Sponsor|1|||
25046824|NCT02638948|50149667|FG002|Overall Study|Administrative Reason by Sponsor|0|||
25046825|NCT02638948|50149668|FG003|Overall Study|Administrative Reason by Sponsor|4|||
25046826|NCT02638948|50149665|FG000|Overall Study|Adverse Event|0|||
25046827|NCT02638948|50149666|FG001|Overall Study|Adverse Event|0|||
25046828|NCT02638948|50149667|FG002|Overall Study|Adverse Event|1|||
25046829|NCT02638948|50149668|FG003|Overall Study|Adverse Event|1|||
25046830|NCT02638948|50149665|FG000|Overall Study|Lack of Efficacy|1|||
25046831|NCT02638948|50149666|FG001|Overall Study|Lack of Efficacy|1|||
24958831|NCT00331136|50049402|FG003|Overall Study|Withdrawal by Subject|0|||
24958832|NCT00331136|50049399|FG000|Overall Study|Lost to Follow-up|0|||
24958833|NCT00331136|50049400|FG001|Overall Study|Lost to Follow-up|1|||
24958834|NCT00331136|50049401|FG002|Overall Study|Lost to Follow-up|0|||
24958835|NCT00331136|50049402|FG003|Overall Study|Lost to Follow-up|0|||
24958836|NCT00331136|50049399|FG000|Overall Study|Protocol Violation|1|||
24958837|NCT00331136|50049400|FG001|Overall Study|Protocol Violation|0|||
24958838|NCT00331136|50049401|FG002|Overall Study|Protocol Violation|0|||
25046832|NCT02638948|50149667|FG002|Overall Study|Lack of Efficacy|0|||
25046833|NCT02638948|50149668|FG003|Overall Study|Lack of Efficacy|0|||
25046834|NCT02638948|50149665|FG000|Overall Study|Lost to Follow-up|0|||
25046835|NCT02638948|50149666|FG001|Overall Study|Lost to Follow-up|0|||
25046836|NCT02638948|50149667|FG002|Overall Study|Lost to Follow-up|1|||
25046837|NCT02638948|50149668|FG003|Overall Study|Lost to Follow-up|1|||
25046838|NCT02638948|50149665|FG000|Overall Study|Poor/Non-Compliance|0|||
25046839|NCT02638948|50149666|FG001|Overall Study|Poor/Non-Compliance|2|||
25046840|NCT02638948|50149667|FG002|Overall Study|Poor/Non-Compliance|1|||
25046841|NCT02638948|50149668|FG003|Overall Study|Poor/Non-Compliance|0|||
25046842|NCT02638948|50149665|FG000|Overall Study|Participant no longer met study criteria|0|||
24958839|NCT00331136|50049402|FG003|Overall Study|Protocol Violation|0|||
24958840|NCT00331136|50049399|FG000|Overall Study|Not treated|1|||
24958841|NCT00331136|50049400|FG001|Overall Study|Not treated|0|||
25046843|NCT02638948|50149666|FG001|Overall Study|Participant no longer met study criteria|1|||
25046844|NCT02638948|50149667|FG002|Overall Study|Participant no longer met study criteria|0|||
25046845|NCT02638948|50149668|FG003|Overall Study|Participant no longer met study criteria|0|||
25046846|NCT02638948|50149665|FG000|Overall Study|Other than specified above|4|||
25046847|NCT02638948|50149666|FG001|Overall Study|Other than specified above|1|||
25046848|NCT02638948|50149667|FG002|Overall Study|Other than specified above|1|||
25046849|NCT02638948|50149668|FG003|Overall Study|Other than specified above|1|||
25046850|NCT00102960|50149684|FG000|Overall Study|Death|23|||
25046851|NCT00102960|50149685|FG001|Overall Study|Death|11|||
25046852|NCT00102960|50149686|FG002|Overall Study|Death|11|||
25046853|NCT00102960|50149684|FG000|Overall Study|Lost to Follow-up|6|||
25046854|NCT00102960|50149685|FG001|Overall Study|Lost to Follow-up|12|||
25046855|NCT00102960|50149686|FG002|Overall Study|Lost to Follow-up|16|||
25046856|NCT00102960|50149684|FG000|Overall Study|Withdrawal by Subject|1|||
25046857|NCT00102960|50149685|FG001|Overall Study|Withdrawal by Subject|0|||
25046858|NCT00102960|50149686|FG002|Overall Study|Withdrawal by Subject|1|||
25046859|NCT02858895|50149698|FG000|Overall Study|Disease progression|31|||
25046860|NCT02858895|50149698|FG000|Overall Study|Death|2|||
24958842|NCT00331136|50049401|FG002|Overall Study|Not treated|0|||
25046861|NCT02858895|50149698|FG000|Overall Study|Adverse Event|1|||
25046862|NCT02858895|50149698|FG000|Overall Study|Withdrawal by Subject|3|||
24958843|NCT00331136|50049402|FG003|Overall Study|Not treated|0|||
24958844|NCT00323414|50049414|FG000|Overall Study|Withdrawal by Subject|0|||
25046863|NCT02858895|50149698|FG000|Overall Study|hospice,|1|||
25046864|NCT02858895|50149698|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
25046865|NCT02637856|50149709|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
25046866|NCT02637856|50149710|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
25046867|NCT02637856|50149709|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
25046868|NCT02637856|50149710|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
24958845|NCT00323414|50049415|FG001|Overall Study|Withdrawal by Subject|1|||
25046869|NCT02637856|50149709|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
25046870|NCT02637856|50149710|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
25046871|NCT02637856|50149709|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
25046872|NCT02637856|50149710|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
25046873|NCT02637856|50149709|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
25046874|NCT02637856|50149710|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
25046875|NCT02637856|50149709|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
25046876|NCT02637856|50149710|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
25046877|NCT02637856|50149709|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
25046878|NCT02637856|50149710|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
25046879|NCT02637856|50149709|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
25046880|NCT02637856|50149710|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
25046881|NCT02637856|50149709|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
25046882|NCT02637856|50149710|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
25046883|NCT02637856|50149709|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
25046884|NCT02637856|50149710|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
25046885|NCT02637856|50149709|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
25046886|NCT02637856|50149710|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
25046887|NCT02637856|50149709|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
25046888|NCT02637856|50149710|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
25046889|NCT02637856|50149709|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
25046890|NCT02637856|50149710|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
25046891|NCT02858037|50149716|FG000|Overall Study|Death|1|||
25046892|NCT02858037|50149716|FG000|Overall Study|Withdrawal by Subject|18|||
25046893|NCT02858037|50149716|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
25046894|NCT02858037|50149716|FG000|Overall Study|Lost to Follow-up|3|||
25046895|NCT02858037|50149716|FG000|Overall Study|Other|4|||
24958846|NCT00330668|50049421|FG000|BID Dosing Period|Adverse Event|1|||
24958847|NCT00330668|50049421|FG000|BID Dosing Period|Lost to Follow-up|7|||
24958848|NCT00330668|50049421|FG000|BID Dosing Period|Non-Compliance|5|||
24958849|NCT00330668|50049421|FG000|BID Dosing Period|Withdrawal by Subject|19|||
24958850|NCT00330668|50049421|FG000|BID Dosing Period|Sponsor's decision|1|||
24958851|NCT00330668|50049421|FG000|BID Dosing Period|Other|3|||
24958852|NCT00330668|50049421|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
24958853|NCT00330668|50049421|FG000|QD Dosing Period|Other|1|||
25046896|NCT02856555|50149723|FG000|Overall Study|Adverse Event|1|||
25046897|NCT02856555|50149724|FG001|Overall Study|Adverse Event|0|||
25046898|NCT02856555|50149725|FG002|Overall Study|Adverse Event|0|||
25046899|NCT02856555|50149723|FG000|Overall Study|Lost to Follow-up|1|||
25046900|NCT02856555|50149724|FG001|Overall Study|Lost to Follow-up|3|||
25046901|NCT02856555|50149725|FG002|Overall Study|Lost to Follow-up|0|||
25046902|NCT02856555|50149723|FG000|Overall Study|Withdrawal by Subject|3|||
25046903|NCT02856555|50149724|FG001|Overall Study|Withdrawal by Subject|0|||
25046904|NCT02856555|50149725|FG002|Overall Study|Withdrawal by Subject|0|||
25046905|NCT02856555|50149723|FG000|Overall Study|Randomized but Never Treated|0|||
25046906|NCT02856555|50149724|FG001|Overall Study|Randomized but Never Treated|1|||
25046907|NCT02856555|50149725|FG002|Overall Study|Randomized but Never Treated|0|||
25046908|NCT02637232|50149763|FG000|Overall Study|Lost to Follow-up|42|||
25046909|NCT02637232|50149763|FG000|Overall Study|Adverse Event|11|||
25046910|NCT02637232|50149763|FG000|Overall Study|patient 's decision|2|||
25046911|NCT02855541|50149767|FG000|Overall Study|Change in health status|2|||
25046912|NCT02855541|50149767|FG000|Overall Study|Withdrawal by Subject|2|||
25046913|NCT02635984|50149773|FG000|Overall Study|Lost to Follow-up|2|||
24958854|NCT00330668|50049421|FG000|QD Dosing Period|Withdrawal by Subject|1|||
24958855|NCT00330668|50049421|FG000|QD Dosing Period|Lost to Follow-up|2|||
24958856|NCT00306384|50049428|FG000|Overall Study|Adverse Event|103|||
25046914|NCT02635984|50149774|FG001|Overall Study|Lost to Follow-up|4|||
25046915|NCT02635984|50149773|FG000|Overall Study|Study Arm Closed|1|||
25046916|NCT02635984|50149774|FG001|Overall Study|Study Arm Closed|0|||
25046917|NCT01147653|50149782|FG000|Year 2|Withdrawal by Subject|2|||
25046918|NCT01147653|50149783|FG001|Year 2|Withdrawal by Subject|3|||
25046919|NCT02747043|50149804|FG000|Overall Study|Other|1|||
25046920|NCT02747043|50149805|FG001|Overall Study|Other|1|||
25046921|NCT02747043|50149804|FG000|Overall Study|Adverse Event|3|||
25046922|NCT02747043|50149805|FG001|Overall Study|Adverse Event|1|||
25046923|NCT02747043|50149804|FG000|Overall Study|Withdrawal by Subject|1|||
25046924|NCT02747043|50149805|FG001|Overall Study|Withdrawal by Subject|1|||
25046925|NCT02747043|50149804|FG000|Overall Study|Physician Decision|1|||
25046926|NCT02747043|50149805|FG001|Overall Study|Physician Decision|1|||
25046927|NCT02747043|50149804|FG000|Overall Study|Protocol Violation|0|||
25046928|NCT02747043|50149805|FG001|Overall Study|Protocol Violation|1|||
25046929|NCT02747043|50149804|FG000|Overall Study|Disease progression|4|||
25046930|NCT02747043|50149805|FG001|Overall Study|Disease progression|0|||
24958857|NCT00306384|50049429|FG001|Overall Study|Adverse Event|87|||
24958858|NCT00306384|50049430|FG002|Overall Study|Adverse Event|40|||
25046931|NCT02637076|50149813|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
25162464|NCT01791517|50284749|FG000|Phase I: Period 3|Lens Discomfort|0|||
24958859|NCT00306384|50049428|FG000|Overall Study|Major protocol deviation|43|||
24958860|NCT00306384|50049429|FG001|Overall Study|Major protocol deviation|51|||
24958861|NCT00306384|50049430|FG002|Overall Study|Major protocol deviation|18|||
24958862|NCT00306384|50049428|FG000|Overall Study|Lost to Follow-up|57|||
24958863|NCT00306384|50049429|FG001|Overall Study|Lost to Follow-up|41|||
24958864|NCT00306384|50049430|FG002|Overall Study|Lost to Follow-up|35|||
24958865|NCT00306384|50049428|FG000|Overall Study|Voluntary withdrawal|199|||
25046932|NCT02637076|50149814|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
25046933|NCT02637076|50149813|FG000|Overall Study|Withdrawal by Subject|0|||
25046934|NCT02637076|50149814|FG001|Overall Study|Withdrawal by Subject|4|||
25046935|NCT02854605|50149823|FG000|Overall Study|Adverse Event|1|||
25046936|NCT02854605|50149824|FG001|Overall Study|Adverse Event|5|||
25046937|NCT02854605|50149825|FG002|Overall Study|Adverse Event|2|||
25046938|NCT02854605|50149823|FG000|Overall Study|Lost to Follow-up|0|||
25046939|NCT02854605|50149824|FG001|Overall Study|Lost to Follow-up|2|||
25046940|NCT02854605|50149825|FG002|Overall Study|Lost to Follow-up|0|||
25046941|NCT02854605|50149823|FG000|Overall Study|Withdrew Consent|1|||
25046942|NCT02854605|50149824|FG001|Overall Study|Withdrew Consent|0|||
25046943|NCT02854605|50149825|FG002|Overall Study|Withdrew Consent|1|||
25046944|NCT02854605|50149823|FG000|Overall Study|Investigator's Discretion|1|||
25046945|NCT02854605|50149824|FG001|Overall Study|Investigator's Discretion|0|||
25046946|NCT02854605|50149825|FG002|Overall Study|Investigator's Discretion|0|||
25046947|NCT02854605|50149823|FG000|Overall Study|Protocol Violation|0|||
25046948|NCT02854605|50149824|FG001|Overall Study|Protocol Violation|0|||
25046949|NCT02854605|50149825|FG002|Overall Study|Protocol Violation|1|||
25046950|NCT02854527|50149843|FG000|Overall Study|Adverse Event|0|||
25046951|NCT02854527|50149844|FG001|Overall Study|Adverse Event|0|||
25046952|NCT02854527|50149845|FG002|Overall Study|Adverse Event|0|||
25046953|NCT02854527|50149846|FG003|Overall Study|Adverse Event|0|||
25046954|NCT02854527|50149847|FG004|Overall Study|Adverse Event|1|||
25046955|NCT02854527|50149848|FG005|Overall Study|Adverse Event|0|||
25046956|NCT02854527|50149849|FG006|Overall Study|Adverse Event|0|||
25046957|NCT02854527|50149850|FG007|Overall Study|Adverse Event|0|||
25046958|NCT02854527|50149851|FG008|Overall Study|Adverse Event|0|||
25046959|NCT02854527|50149852|FG009|Overall Study|Adverse Event|0|||
25046960|NCT02854527|50149843|FG000|Overall Study|Lost to Follow-up|0|||
25046961|NCT02854527|50149844|FG001|Overall Study|Lost to Follow-up|0|||
25046962|NCT02854527|50149845|FG002|Overall Study|Lost to Follow-up|0|||
25046963|NCT02854527|50149846|FG003|Overall Study|Lost to Follow-up|1|||
25046964|NCT02854527|50149847|FG004|Overall Study|Lost to Follow-up|0|||
25046965|NCT02854527|50149848|FG005|Overall Study|Lost to Follow-up|0|||
24958866|NCT00306384|50049429|FG001|Overall Study|Voluntary withdrawal|187|||
24958867|NCT00306384|50049430|FG002|Overall Study|Voluntary withdrawal|91|||
25046966|NCT02854527|50149849|FG006|Overall Study|Lost to Follow-up|0|||
25046967|NCT02854527|50149850|FG007|Overall Study|Lost to Follow-up|0|||
25046968|NCT02854527|50149851|FG008|Overall Study|Lost to Follow-up|0|||
25046969|NCT02854527|50149852|FG009|Overall Study|Lost to Follow-up|0|||
25046970|NCT02853435|50149879|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
25046971|NCT02853435|50149880|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
25046972|NCT02853435|50149881|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
25046973|NCT02853435|50149882|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
25046974|NCT02853435|50149883|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
25046975|NCT02853435|50149884|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
25046976|NCT02635204|50149916|FG000|Overall Study|Adverse Event|1|||
25046977|NCT02635204|50149917|FG001|Overall Study|Adverse Event|0|||
25046978|NCT02635204|50149916|FG000|Overall Study|Lost to Follow-up|1|||
25046979|NCT02635204|50149917|FG001|Overall Study|Lost to Follow-up|1|||
25046980|NCT00102804|50149925|FG000|Overall Study|Progressive Disease (PD)|307|||
25046981|NCT00102804|50149926|FG001|Overall Study|Progressive Disease (PD)|196|||
25046982|NCT00102804|50149925|FG000|Overall Study|Withdrawal by Subject|46|||
25046983|NCT00102804|50149926|FG001|Overall Study|Withdrawal by Subject|7|||
25046984|NCT00102804|50149925|FG000|Overall Study|Adverse Event|37|||
24958868|NCT00306384|50049428|FG000|Overall Study|Study termination|1|||
24958869|NCT00306384|50049429|FG001|Overall Study|Study termination|0|||
24958870|NCT00306384|50049430|FG002|Overall Study|Study termination|1|||
24958871|NCT00306384|50049428|FG000|Overall Study|Pregnancy|3|||
24958872|NCT00306384|50049429|FG001|Overall Study|Pregnancy|1|||
24958873|NCT00306384|50049430|FG002|Overall Study|Pregnancy|1|||
24958874|NCT00306384|50049428|FG000|Overall Study|Lack of Efficacy|26|||
24958875|NCT00306384|50049429|FG001|Overall Study|Lack of Efficacy|40|||
24958876|NCT00306384|50049430|FG002|Overall Study|Lack of Efficacy|38|||
24958877|NCT00306384|50049428|FG000|Overall Study|Investigator discretion|28|||
24958878|NCT00306384|50049429|FG001|Overall Study|Investigator discretion|31|||
25046985|NCT00102804|50149926|FG001|Overall Study|Adverse Event|3|||
25046986|NCT00102804|50149925|FG000|Overall Study|Physician Decision|24|||
25046987|NCT00102804|50149926|FG001|Overall Study|Physician Decision|6|||
25046988|NCT00102804|50149925|FG000|Overall Study|Death|5|||
25046989|NCT00102804|50149926|FG001|Overall Study|Death|6|||
25046990|NCT00102804|50149925|FG000|Overall Study|Enrollment Criteria Not Met|6|||
25046991|NCT00102804|50149926|FG001|Overall Study|Enrollment Criteria Not Met|0|||
25046992|NCT00102804|50149925|FG000|Overall Study|Lost to Follow-up|4|||
25046993|NCT00102804|50149926|FG001|Overall Study|Lost to Follow-up|1|||
25046994|NCT00102804|50149925|FG000|Overall Study|Protocol Violation|2|||
25046995|NCT00102804|50149926|FG001|Overall Study|Protocol Violation|1|||
24958879|NCT00306384|50049430|FG002|Overall Study|Investigator discretion|21|||
25046996|NCT00102804|50149925|FG000|Overall Study|Satisfactory Response|2|||
25046997|NCT00102804|50149926|FG001|Overall Study|Satisfactory Response|0|||
25046998|NCT00102804|50149925|FG000|Overall Study|Sponsor Decision|1|||
25046999|NCT00102804|50149926|FG001|Overall Study|Sponsor Decision|0|||
25047000|NCT00102804|50149925|FG000|Overall Study|Alive, Receiving Treatment|7|||
25047001|NCT00102804|50149926|FG001|Overall Study|Alive, Receiving Treatment|2|||
25047002|NCT01814072|50149964|FG000|Overall Study|Lost to Follow-up|2|||
25047003|NCT01814072|50149965|FG001|Overall Study|Lost to Follow-up|2|||
25047004|NCT01814072|50149966|FG002|Overall Study|Lost to Follow-up|2|||
25047005|NCT01814072|50149967|FG003|Overall Study|Lost to Follow-up|0|||
25047006|NCT01814072|50149968|FG004|Overall Study|Lost to Follow-up|2|||
25047007|NCT01814072|50149969|FG005|Overall Study|Lost to Follow-up|3|||
25047008|NCT01814072|50149970|FG006|Overall Study|Lost to Follow-up|3|||
25047009|NCT01814072|50149971|FG007|Overall Study|Lost to Follow-up|1|||
25047010|NCT01814072|50149972|FG008|Overall Study|Lost to Follow-up|2|||
25047011|NCT01814072|50149973|FG009|Overall Study|Lost to Follow-up|3|||
25047012|NCT01814072|50149974|FG010|Overall Study|Lost to Follow-up|1|||
25047013|NCT01814072|50149975|FG011|Overall Study|Lost to Follow-up|2|||
25047014|NCT01814072|50149976|FG012|Overall Study|Lost to Follow-up|2|||
25047015|NCT01814072|50149977|FG013|Overall Study|Lost to Follow-up|1|||
25047016|NCT01814072|50149978|FG014|Overall Study|Lost to Follow-up|2|||
25047017|NCT01814072|50149979|FG015|Overall Study|Lost to Follow-up|1|||
25047018|NCT01814072|50149980|FG016|Overall Study|Lost to Follow-up|3|||
25047019|NCT01814072|50149981|FG017|Overall Study|Lost to Follow-up|1|||
25047020|NCT01814072|50149982|FG018|Overall Study|Lost to Follow-up|3|||
25047021|NCT01814072|50149983|FG019|Overall Study|Lost to Follow-up|3|||
24958880|NCT00306384|50049428|FG000|Overall Study|Other|80|||
24958881|NCT00306384|50049429|FG001|Overall Study|Other|70|||
25047022|NCT01814072|50149984|FG020|Overall Study|Lost to Follow-up|2|||
25047023|NCT01814072|50149985|FG021|Overall Study|Lost to Follow-up|1|||
25047024|NCT01814072|50149986|FG022|Overall Study|Lost to Follow-up|3|||
25047025|NCT01814072|50149987|FG023|Overall Study|Lost to Follow-up|1|||
25047026|NCT01814072|50149988|FG024|Overall Study|Lost to Follow-up|4|||
25047027|NCT01814072|50149989|FG025|Overall Study|Lost to Follow-up|1|||
25047028|NCT01814072|50149990|FG026|Overall Study|Lost to Follow-up|1|||
25047029|NCT01814072|50149991|FG027|Overall Study|Lost to Follow-up|2|||
25047030|NCT01814072|50149992|FG028|Overall Study|Lost to Follow-up|3|||
25047031|NCT01814072|50149993|FG029|Overall Study|Lost to Follow-up|3|||
25047032|NCT01814072|50149994|FG030|Overall Study|Lost to Follow-up|2|||
25047033|NCT01814072|50149995|FG031|Overall Study|Lost to Follow-up|0|||
25047034|NCT01814072|50149964|FG000|Overall Study|Withdrawal by Subject|2|||
25047035|NCT01814072|50149965|FG001|Overall Study|Withdrawal by Subject|0|||
25047036|NCT01814072|50149966|FG002|Overall Study|Withdrawal by Subject|1|||
25047037|NCT01814072|50149967|FG003|Overall Study|Withdrawal by Subject|0|||
25047038|NCT01814072|50149968|FG004|Overall Study|Withdrawal by Subject|2|||
25047039|NCT01814072|50149969|FG005|Overall Study|Withdrawal by Subject|3|||
25047040|NCT01814072|50149970|FG006|Overall Study|Withdrawal by Subject|1|||
25047041|NCT01814072|50149971|FG007|Overall Study|Withdrawal by Subject|0|||
25047042|NCT01814072|50149972|FG008|Overall Study|Withdrawal by Subject|1|||
25047043|NCT01814072|50149973|FG009|Overall Study|Withdrawal by Subject|2|||
25047044|NCT01814072|50149974|FG010|Overall Study|Withdrawal by Subject|0|||
25047045|NCT01814072|50149975|FG011|Overall Study|Withdrawal by Subject|0|||
25047046|NCT01814072|50149976|FG012|Overall Study|Withdrawal by Subject|1|||
25047047|NCT01814072|50149977|FG013|Overall Study|Withdrawal by Subject|1|||
25047048|NCT01814072|50149978|FG014|Overall Study|Withdrawal by Subject|1|||
25047049|NCT01814072|50149979|FG015|Overall Study|Withdrawal by Subject|1|||
25047050|NCT01814072|50149980|FG016|Overall Study|Withdrawal by Subject|0|||
25186548|NCT01392443|50337060|FG000|Overall Study|Protocol Violation|1|||
24958882|NCT00306384|50049430|FG002|Overall Study|Other|32|||
24958883|NCT00306384|50049428|FG000|Overall Study|Site closure|2|||
24958884|NCT00306384|50049429|FG001|Overall Study|Site closure|0|||
24958885|NCT00306384|50049430|FG002|Overall Study|Site closure|0|||
24958886|NCT00305604|50049440|FG000|Overall Study|Adverse Event|6|||
24958887|NCT00305604|50049441|FG001|Overall Study|Adverse Event|3|||
24958888|NCT00305604|50049440|FG000|Overall Study|Lack of Efficacy|11|||
24958889|NCT00305604|50049441|FG001|Overall Study|Lack of Efficacy|18|||
24958890|NCT00305604|50049440|FG000|Overall Study|Lost to Follow-up|0|||
24958891|NCT00305604|50049441|FG001|Overall Study|Lost to Follow-up|4|||
25047051|NCT01814072|50149981|FG017|Overall Study|Withdrawal by Subject|0|||
25047052|NCT01814072|50149982|FG018|Overall Study|Withdrawal by Subject|0|||
25047053|NCT01814072|50149983|FG019|Overall Study|Withdrawal by Subject|2|||
25047054|NCT01814072|50149984|FG020|Overall Study|Withdrawal by Subject|0|||
25047055|NCT01814072|50149985|FG021|Overall Study|Withdrawal by Subject|0|||
25047056|NCT01814072|50149986|FG022|Overall Study|Withdrawal by Subject|1|||
25047057|NCT01814072|50149987|FG023|Overall Study|Withdrawal by Subject|0|||
25047058|NCT01814072|50149988|FG024|Overall Study|Withdrawal by Subject|2|||
25047059|NCT01814072|50149989|FG025|Overall Study|Withdrawal by Subject|1|||
24958892|NCT00305604|50049440|FG000|Overall Study|Protocol Violation|2|||
25047060|NCT01814072|50149990|FG026|Overall Study|Withdrawal by Subject|1|||
25047061|NCT01814072|50149991|FG027|Overall Study|Withdrawal by Subject|2|||
25047062|NCT01814072|50149992|FG028|Overall Study|Withdrawal by Subject|1|||
25047063|NCT01814072|50149993|FG029|Overall Study|Withdrawal by Subject|0|||
25047064|NCT01814072|50149994|FG030|Overall Study|Withdrawal by Subject|0|||
25047065|NCT01814072|50149995|FG031|Overall Study|Withdrawal by Subject|0|||
25047066|NCT03038113|50150050|FG000|Overall Study|Withdrawal by Subject|0|||
25047067|NCT03038113|50150051|FG001|Overall Study|Withdrawal by Subject|0|||
25047068|NCT03038113|50150052|FG002|Overall Study|Withdrawal by Subject|1|||
25047069|NCT03038113|50150053|FG003|Overall Study|Withdrawal by Subject|0|||
25047070|NCT03038113|50150054|FG004|Overall Study|Withdrawal by Subject|0|||
25047071|NCT03038113|50150055|FG005|Overall Study|Withdrawal by Subject|0|||
25047072|NCT03038113|50150056|FG006|Overall Study|Withdrawal by Subject|0|||
25047073|NCT03038113|50150057|FG007|Overall Study|Withdrawal by Subject|0|||
25047074|NCT03038113|50150058|FG008|Overall Study|Withdrawal by Subject|0|||
25047075|NCT03038113|50150059|FG009|Overall Study|Withdrawal by Subject|0|||
25047076|NCT03038113|50150060|FG010|Overall Study|Withdrawal by Subject|0|||
25047077|NCT03038113|50150061|FG011|Overall Study|Withdrawal by Subject|0|||
25047078|NCT03038113|50150062|FG012|Overall Study|Withdrawal by Subject|0|||
25047079|NCT03038113|50150063|FG013|Overall Study|Withdrawal by Subject|1|||
25047080|NCT03038113|50150050|FG000|Overall Study|Lost to Follow-up|0|||
25047081|NCT03038113|50150051|FG001|Overall Study|Lost to Follow-up|0|||
25047082|NCT03038113|50150052|FG002|Overall Study|Lost to Follow-up|0|||
25047083|NCT03038113|50150053|FG003|Overall Study|Lost to Follow-up|0|||
25047084|NCT03038113|50150054|FG004|Overall Study|Lost to Follow-up|0|||
25047085|NCT03038113|50150055|FG005|Overall Study|Lost to Follow-up|0|||
25047086|NCT03038113|50150056|FG006|Overall Study|Lost to Follow-up|1|||
25047087|NCT03038113|50150057|FG007|Overall Study|Lost to Follow-up|0|||
25047088|NCT03038113|50150058|FG008|Overall Study|Lost to Follow-up|0|||
25047089|NCT03038113|50150059|FG009|Overall Study|Lost to Follow-up|0|||
25047090|NCT03038113|50150060|FG010|Overall Study|Lost to Follow-up|0|||
25047091|NCT03038113|50150061|FG011|Overall Study|Lost to Follow-up|0|||
24958893|NCT00305604|50049441|FG001|Overall Study|Protocol Violation|1|||
24958894|NCT00305604|50049440|FG000|Overall Study|Withdrawal by Subject|12|||
24958895|NCT00305604|50049441|FG001|Overall Study|Withdrawal by Subject|21|||
25047092|NCT03038113|50150062|FG012|Overall Study|Lost to Follow-up|0|||
25047093|NCT03038113|50150063|FG013|Overall Study|Lost to Follow-up|0|||
25047094|NCT00968149|50150112|FG000|Overall Study|Adverse Event|5|||
25047095|NCT00968149|50150113|FG001|Overall Study|Adverse Event|1|||
25047096|NCT00968149|50150112|FG000|Overall Study|Lack of Efficacy|0|||
25047097|NCT00968149|50150113|FG001|Overall Study|Lack of Efficacy|4|||
25047098|NCT00968149|50150112|FG000|Overall Study|Lost to Follow-up|0|||
25047099|NCT00968149|50150113|FG001|Overall Study|Lost to Follow-up|1|||
25047100|NCT00968149|50150112|FG000|Overall Study|Protocol Violation|4|||
25047101|NCT00968149|50150113|FG001|Overall Study|Protocol Violation|0|||
25047102|NCT00968149|50150112|FG000|Overall Study|Withdrawal by Subject|2|||
25047103|NCT00968149|50150113|FG001|Overall Study|Withdrawal by Subject|0|||
25047104|NCT00963469|50150122|FG000|Overall Study|Adverse Event|15|||
25047105|NCT00963469|50150123|FG001|Overall Study|Adverse Event|11|||
25047106|NCT00963469|50150124|FG002|Overall Study|Adverse Event|1|||
25047107|NCT00963469|50150122|FG000|Overall Study|Lack of Efficacy|10|||
25047108|NCT00963469|50150123|FG001|Overall Study|Lack of Efficacy|7|||
25047109|NCT00963469|50150124|FG002|Overall Study|Lack of Efficacy|2|||
25047110|NCT00963469|50150122|FG000|Overall Study|Lost to Follow-up|1|||
25047111|NCT00963469|50150123|FG001|Overall Study|Lost to Follow-up|1|||
25047112|NCT00963469|50150124|FG002|Overall Study|Lost to Follow-up|0|||
25047113|NCT00963469|50150122|FG000|Overall Study|Protocol Violation|5|||
25047114|NCT00963469|50150123|FG001|Overall Study|Protocol Violation|5|||
24958896|NCT00305604|50049440|FG000|Overall Study|Patient moved|1|||
24958897|NCT00305604|50049441|FG001|Overall Study|Patient moved|0|||
24958898|NCT00501059|50049449|FG000|Overall Study|Protocol Violation|80|||
24958899|NCT00501059|50049450|FG001|Overall Study|Protocol Violation|69|||
24958900|NCT00501059|50049449|FG000|Overall Study|Death|140|||
24958901|NCT00501059|50049450|FG001|Overall Study|Death|137|||
25047115|NCT00963469|50150124|FG002|Overall Study|Protocol Violation|3|||
25047116|NCT00963469|50150122|FG000|Overall Study|Withdrawal by Subject|4|||
25047117|NCT00963469|50150123|FG001|Overall Study|Withdrawal by Subject|1|||
25047118|NCT00963469|50150124|FG002|Overall Study|Withdrawal by Subject|1|||
25047119|NCT00963469|50150122|FG000|Overall Study|Pre-randomization Adverse Event|1|||
25047120|NCT00963469|50150123|FG001|Overall Study|Pre-randomization Adverse Event|2|||
25047121|NCT00963469|50150124|FG002|Overall Study|Pre-randomization Adverse Event|0|||
25276429|NCT00958360|50590367|FG000|Overall Study|Lost to Follow-up|0|||
25047122|NCT00963469|50150122|FG000|Overall Study|Moved|1|||
25047123|NCT00963469|50150123|FG001|Overall Study|Moved|0|||
25047124|NCT00963469|50150124|FG002|Overall Study|Moved|0|||
25047125|NCT00963469|50150122|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
25047126|NCT00963469|50150123|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
25162465|NCT01791517|50284750|FG001|Phase I: Period 3|Lens Discomfort|0|||
24958902|NCT00501059|50049449|FG000|Overall Study|Other|236|||
24958903|NCT00501059|50049450|FG001|Overall Study|Other|239|||
25047127|NCT00963469|50150124|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
25047128|NCT00897949|50150135|FG000|Overall Study|Adverse Event|1|||
25047129|NCT00897949|50150136|FG001|Overall Study|Adverse Event|1|||
25047130|NCT00897949|50150137|FG002|Overall Study|Adverse Event|0|||
25047131|NCT00897949|50150135|FG000|Overall Study|Lost to Follow-up|0|||
25047132|NCT00897949|50150136|FG001|Overall Study|Lost to Follow-up|2|||
25047133|NCT00897949|50150137|FG002|Overall Study|Lost to Follow-up|1|||
25047134|NCT00897949|50150135|FG000|Overall Study|Protocol Violation|6|||
25047135|NCT00897949|50150136|FG001|Overall Study|Protocol Violation|3|||
25047136|NCT00897949|50150137|FG002|Overall Study|Protocol Violation|1|||
25047137|NCT00897949|50150135|FG000|Overall Study|Withdrawal by Subject|1|||
25047138|NCT00897949|50150136|FG001|Overall Study|Withdrawal by Subject|2|||
25047139|NCT00897949|50150137|FG002|Overall Study|Withdrawal by Subject|0|||
25047140|NCT00897949|50150135|FG000|Overall Study|Patient Uncoorperative|0|||
25047141|NCT00897949|50150136|FG001|Overall Study|Patient Uncoorperative|2|||
25047142|NCT00897949|50150137|FG002|Overall Study|Patient Uncoorperative|1|||
25047143|NCT00897949|50150135|FG000|Overall Study|Lost to Follow-up|30|||
25047144|NCT00897949|50150136|FG001|Overall Study|Lost to Follow-up|23|||
25047145|NCT00897949|50150137|FG002|Overall Study|Lost to Follow-up|17|||
25047146|NCT00897949|50150135|FG000|Overall Study|Withdrawal by Subject|24|||
25047147|NCT00897949|50150136|FG001|Overall Study|Withdrawal by Subject|31|||
25047148|NCT00897949|50150137|FG002|Overall Study|Withdrawal by Subject|17|||
25047149|NCT00897949|50150135|FG000|Overall Study|Abnormal Prestudy Labs|2|||
25047150|NCT00897949|50150136|FG001|Overall Study|Abnormal Prestudy Labs|3|||
25047151|NCT00897949|50150137|FG002|Overall Study|Abnormal Prestudy Labs|4|||
25047152|NCT00897949|50150135|FG000|Overall Study|Abnormal Baseline ECG|2|||
25047153|NCT00897949|50150136|FG001|Overall Study|Abnormal Baseline ECG|2|||
25047154|NCT00897949|50150137|FG002|Overall Study|Abnormal Baseline ECG|4|||
25047155|NCT00897949|50150135|FG000|Overall Study|Need for Concom. Med.|0|||
25047156|NCT00897949|50150136|FG001|Overall Study|Need for Concom. Med.|1|||
25047157|NCT00897949|50150137|FG002|Overall Study|Need for Concom. Med.|1|||
25047158|NCT00897949|50150135|FG000|Overall Study|Lack of Migraine Attack|29|||
25047159|NCT00897949|50150136|FG001|Overall Study|Lack of Migraine Attack|30|||
25047160|NCT00897949|50150137|FG002|Overall Study|Lack of Migraine Attack|19|||
25047161|NCT00897949|50150135|FG000|Overall Study|Did not take study drug|9|||
25047162|NCT00897949|50150136|FG001|Overall Study|Did not take study drug|3|||
25047163|NCT00897949|50150137|FG002|Overall Study|Did not take study drug|4|||
25047164|NCT02760810|50150151|FG000|Overall Study|Protocol Violation|1|||
25047165|NCT02760654|50150157|FG000|Overall Study|Lost to Follow-up|3|||
25047166|NCT02760654|50150158|FG001|Overall Study|Lost to Follow-up|3|||
25047167|NCT02760654|50150157|FG000|Overall Study|Withdrawal by Subject|4|||
25047168|NCT02760654|50150158|FG001|Overall Study|Withdrawal by Subject|3|||
25047169|NCT00725491|50150166|FG000|Overall Study|Adverse Event|3|||
25047170|NCT00725491|50150167|FG001|Overall Study|Adverse Event|2|||
25047171|NCT00725491|50150166|FG000|Overall Study|Pregnancy|0|||
25047172|NCT00725491|50150167|FG001|Overall Study|Pregnancy|3|||
25047173|NCT00725491|50150166|FG000|Overall Study|Risk for hyperstimulation|2|||
25047174|NCT00725491|50150167|FG001|Overall Study|Risk for hyperstimulation|9|||
25047175|NCT00725491|50150166|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
25047176|NCT00725491|50150167|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
25047177|NCT00725491|50150166|FG000|Overall Study|Fertilization failure|0|||
25047178|NCT00725491|50150167|FG001|Overall Study|Fertilization failure|1|||
25047179|NCT00725491|50150166|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
25047180|NCT00725491|50150167|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
25047181|NCT02634580|50150177|FG000|Double-blind Treatment Period|Subject Request|1|||
25047182|NCT02634580|50150178|FG001|Double-blind Treatment Period|Subject Request|0|||
25047183|NCT02634580|50150179|FG002|Double-blind Treatment Period|Subject Request|1|||
25047184|NCT02634580|50150180|FG003|Double-blind Treatment Period|Subject Request|1|||
25047185|NCT02634580|50150177|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
25047186|NCT02634580|50150178|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
25047187|NCT02634580|50150179|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
25047188|NCT02634580|50150180|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
25047189|NCT02225366|50150191|FG000|Overall Study|Lack of Efficacy|1|||
25162466|NCT01791517|50284751|FG002|Phase I: Period 3|Lens Discomfort|0|||
25047190|NCT02225366|50150192|FG001|Overall Study|Lack of Efficacy|0|||
25047191|NCT00697255|50150200|FG000|Stage 1a|Insufficient ovarian response|1|||
25047192|NCT00697255|50150201|FG001|Stage 1a|Insufficient ovarian response|0|||
25047193|NCT00697255|50150200|FG000|Stage 1a|Multifollicular growth|1|||
25047194|NCT00697255|50150201|FG001|Stage 1a|Multifollicular growth|0|||
25047195|NCT00697255|50150200|FG000|Stage 1a|Not growing of dominant follicle|1|||
25047196|NCT00697255|50150201|FG001|Stage 1a|Not growing of dominant follicle|0|||
25047197|NCT00697255|50150200|FG000|Stage 1b|Not growing of dominant follicle|0|||
25047198|NCT00697255|50150201|FG001|Stage 1b|Not growing of dominant follicle|1|||
25047199|NCT00697255|50150200|FG000|Stage 1b|Insufficient ovarian response|0|||
25162467|NCT01791517|50284752|FG003|Phase I: Period 3|Lens Discomfort|0|||
25162468|NCT01791517|50284753|FG004|Phase I: Period 3|Lens Discomfort|0|||
25047200|NCT00697255|50150201|FG001|Stage 1b|Insufficient ovarian response|1|||
25047201|NCT02764320|50150209|FG000|Overall Study|Withdrawal by Subject|35|||
25047202|NCT02764320|50150210|FG001|Overall Study|Withdrawal by Subject|38|||
25047203|NCT02764320|50150209|FG000|Overall Study|Protocol Violation|11|||
25047204|NCT02764320|50150210|FG001|Overall Study|Protocol Violation|6|||
25047205|NCT02764320|50150209|FG000|Overall Study|Adverse Event|2|||
25047206|NCT02764320|50150210|FG001|Overall Study|Adverse Event|0|||
25047207|NCT02764320|50150209|FG000|Overall Study|Health Issues unable to continue|2|||
25047208|NCT02764320|50150210|FG001|Overall Study|Health Issues unable to continue|0|||
25047209|NCT02764320|50150209|FG000|Overall Study|Did not meet inclusion criteria|1|||
25047210|NCT02764320|50150210|FG001|Overall Study|Did not meet inclusion criteria|0|||
25047211|NCT02764320|50150209|FG000|Overall Study|Subject moved|0|||
25047212|NCT02764320|50150210|FG001|Overall Study|Subject moved|2|||
25047213|NCT02764320|50150209|FG000|Overall Study|Overused medication unavailable|0|||
25047214|NCT02764320|50150210|FG001|Overall Study|Overused medication unavailable|1|||
25047215|NCT02764320|50150209|FG000|Overall Study|Seeking care outside site|0|||
25047216|NCT02764320|50150210|FG001|Overall Study|Seeking care outside site|1|||
25047217|NCT02764320|50150209|FG000|Overall Study|Technology barriers|0|||
25047218|NCT02764320|50150210|FG001|Overall Study|Technology barriers|1|||
25047219|NCT02851407|50150218|FG000|Overall Study|Withdrawal by parent/guardian|2|||
25047220|NCT02851407|50150219|FG001|Overall Study|Withdrawal by parent/guardian|7|||
25047221|NCT02851407|50150218|FG000|Overall Study|Protocol deviation|0|||
25047222|NCT02851407|50150219|FG001|Overall Study|Protocol deviation|1|||
25047223|NCT02851407|50150218|FG000|Overall Study|Transferred to another hospital to continue|1|||
25047224|NCT02851407|50150219|FG001|Overall Study|Transferred to another hospital to continue|0|||
25047225|NCT02851407|50150218|FG000|Overall Study|Other Death|30|||
25047226|NCT02851407|50150219|FG001|Overall Study|Other Death|20|||
25047227|NCT02851407|50150218|FG000|Overall Study|Adverse event, serious fatal|6|||
25047228|NCT02851407|50150219|FG001|Overall Study|Adverse event, serious fatal|8|||
25047229|NCT02851407|50150218|FG000|Overall Study|Consent withdrawn by participant|5|||
25047230|NCT02851407|50150219|FG001|Overall Study|Consent withdrawn by participant|3|||
25047231|NCT02851407|50150218|FG000|Overall Study|Screen failure|2|||
25047232|NCT02851407|50150219|FG001|Overall Study|Screen failure|1|||
25047233|NCT02851407|50150218|FG000|Overall Study|Disease relapse|9|||
25047234|NCT02851407|50150219|FG001|Overall Study|Disease relapse|6|||
25047235|NCT02851407|50150218|FG000|Overall Study|Physician Decision|7|||
25047236|NCT02851407|50150219|FG001|Overall Study|Physician Decision|6|||
25047237|NCT02851407|50150218|FG000|Overall Study|Transferred to hospital closer to home|0|||
25047238|NCT02851407|50150219|FG001|Overall Study|Transferred to hospital closer to home|1|||
25047239|NCT02851407|50150218|FG000|Overall Study|Enrolled in an investigational study|0|||
25047240|NCT02851407|50150219|FG001|Overall Study|Enrolled in an investigational study|1|||
25047241|NCT02851407|50150218|FG000|Overall Study|Early recovery|1|||
25047242|NCT02851407|50150219|FG001|Overall Study|Early recovery|0|||
25047243|NCT02851407|50150218|FG000|Overall Study|Adverse event, non-fatal|7|||
25047244|NCT02851407|50150219|FG001|Overall Study|Adverse event, non-fatal|5|||
25047245|NCT02851407|50150218|FG000|Overall Study|Lost to Follow-up|0|||
25047246|NCT02851407|50150219|FG001|Overall Study|Lost to Follow-up|2|||
25047247|NCT02636608|50150225|FG000|Overall Study|Failure to Return|4|||
24958904|NCT00501059|50049449|FG000|Overall Study|Missing end-of-study page|91|||
24958905|NCT00501059|50049450|FG001|Overall Study|Missing end-of-study page|92|||
24958906|NCT00501059|50049449|FG000|Overall Study|Clinical endpoint reached|110|||
24958907|NCT00501059|50049450|FG001|Overall Study|Clinical endpoint reached|123|||
24958908|NCT00501059|50049449|FG000|Overall Study|Insufficient therapeutic effect|4|||
24958909|NCT00501059|50049450|FG001|Overall Study|Insufficient therapeutic effect|5|||
24958910|NCT00501059|50049449|FG000|Overall Study|Consent withdrawn by subject|817|||
24958911|NCT00501059|50049450|FG001|Overall Study|Consent withdrawn by subject|873|||
24958912|NCT00501059|50049449|FG000|Overall Study|Non-compliant with study treatment|23|||
24958913|NCT00501059|50049450|FG001|Overall Study|Non-compliant with study treatment|16|||
24958914|NCT00501059|50049449|FG000|Overall Study|Reason not given|3|||
24958915|NCT00501059|50049450|FG001|Overall Study|Reason not given|1|||
24958916|NCT00501059|50049449|FG000|Overall Study|Adverse Event|129|||
24958917|NCT00501059|50049450|FG001|Overall Study|Adverse Event|122|||
24958918|NCT00501059|50049449|FG000|Overall Study|Lost to Follow-up|210|||
25047248|NCT02636608|50150225|FG000|Overall Study|Insufficient Virological Response|1|||
25047249|NCT02636608|50150225|FG000|Overall Study|Death|3|||
25047250|NCT02636608|50150225|FG000|Overall Study|Other|2|||
25047251|NCT02636608|50150225|FG000|Overall Study|Did Not Receive Treatment|1|||
25047252|NCT02759562|50150234|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
25047253|NCT02759562|50150235|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
25047254|NCT02759562|50150234|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
25047255|NCT02759562|50150235|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
24958919|NCT00501059|50049450|FG001|Overall Study|Lost to Follow-up|198|||
24958920|NCT00501059|50049449|FG000|Overall Study|Not treated|25|||
25047256|NCT02746575|50150242|FG000|Overall Study|Surgery cancelled or time chaned|13|||
24958921|NCT00501059|50049450|FG001|Overall Study|Not treated|17|||
24958922|NCT00344318|50049462|FG000|Overall Study|Adverse Event|0|||
24958923|NCT00344318|50049463|FG001|Overall Study|Adverse Event|3|||
24958924|NCT00344318|50049464|FG002|Overall Study|Adverse Event|0|||
24958925|NCT00344318|50049465|FG003|Overall Study|Adverse Event|1|||
24958926|NCT00344318|50049462|FG000|Overall Study|Withdrawal by Subject|2|||
24958927|NCT00344318|50049463|FG001|Overall Study|Withdrawal by Subject|2|||
24958928|NCT00344318|50049464|FG002|Overall Study|Withdrawal by Subject|0|||
24958929|NCT00344318|50049465|FG003|Overall Study|Withdrawal by Subject|2|||
24958930|NCT00344318|50049462|FG000|Overall Study|Lost to Follow-up|2|||
24958931|NCT00344318|50049463|FG001|Overall Study|Lost to Follow-up|0|||
24958932|NCT00344318|50049464|FG002|Overall Study|Lost to Follow-up|1|||
24958933|NCT00344318|50049465|FG003|Overall Study|Lost to Follow-up|0|||
24958934|NCT00323258|50049479|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
24958935|NCT00323258|50049480|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
24958936|NCT00323258|50049479|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
24958937|NCT00323258|50049480|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
24958938|NCT00323258|50049479|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
25047257|NCT02746575|50150242|FG000|Overall Study|Received epidural|10|||
25047258|NCT02746575|50150242|FG000|Overall Study|Withdrawal by Subject|3|||
25047259|NCT02746575|50150242|FG000|Overall Study|Bradycardia/hypotension|9|||
25047260|NCT02746575|50150242|FG000|Overall Study|Study paused|8|||
25047261|NCT02746575|50150242|FG000|Overall Study|put on beta-blocker|3|||
25047262|NCT02746575|50150242|FG000|Overall Study|type of surgery|1|||
25047263|NCT02746575|50150242|FG000|Overall Study|typ of surgery|1|||
25047264|NCT02746575|50150242|FG000|Overall Study|PI unavailable|1|||
25047265|NCT02746575|50150242|FG000|Overall Study|Unknown history of CVA|1|||
25047266|NCT03625466|50150248|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
25047267|NCT03625466|50150249|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
25047268|NCT03625466|50150250|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
25047269|NCT03625466|50150248|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
25047270|NCT03625466|50150249|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
25047271|NCT03625466|50150250|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
25047272|NCT03625466|50150248|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
25047273|NCT03625466|50150249|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
25047274|NCT03625466|50150250|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
25047275|NCT02853123|50150257|FG000|Treatment Period 1|Adverse Event|0|||
25047276|NCT02853123|50150258|FG001|Treatment Period 1|Adverse Event|3|||
25047277|NCT02853123|50150257|FG000|Washout Period|Worsening of COPD|0|||
25047278|NCT02853123|50150258|FG001|Washout Period|Worsening of COPD|3|||
25047279|NCT02853123|50150257|FG000|Washout Period|Adverse Event|1|||
25047280|NCT02853123|50150258|FG001|Washout Period|Adverse Event|0|||
25047281|NCT02634346|50150268|FG000|Overall Study|Withdrawal by Subject|8|||
25047282|NCT02634346|50150269|FG001|Overall Study|Withdrawal by Subject|9|||
25047283|NCT02634346|50150270|FG002|Overall Study|Withdrawal by Subject|8|||
25047284|NCT02634346|50150268|FG000|Overall Study|Adverse Event|2|||
25047285|NCT02634346|50150269|FG001|Overall Study|Adverse Event|2|||
25047286|NCT02634346|50150270|FG002|Overall Study|Adverse Event|7|||
25047287|NCT02634346|50150268|FG000|Overall Study|Lack of Efficacy|1|||
25047288|NCT02634346|50150269|FG001|Overall Study|Lack of Efficacy|2|||
25047289|NCT02634346|50150270|FG002|Overall Study|Lack of Efficacy|8|||
25047290|NCT02634346|50150268|FG000|Overall Study|Lost to Follow-up|1|||
25047291|NCT02634346|50150269|FG001|Overall Study|Lost to Follow-up|0|||
25047292|NCT02634346|50150270|FG002|Overall Study|Lost to Follow-up|0|||
25047293|NCT02634346|50150268|FG000|Overall Study|Protocol Violation|0|||
25047294|NCT02634346|50150269|FG001|Overall Study|Protocol Violation|1|||
25047295|NCT02634346|50150270|FG002|Overall Study|Protocol Violation|0|||
25047296|NCT00849147|50150278|FG000|Overall Study|Withdrawal by Subject|1|||
25047297|NCT00849147|50150278|FG000|Overall Study|Protocol Violation|2|||
25047298|NCT00849147|50150278|FG000|Overall Study|Disease Relapse/Progression|2|||
25047299|NCT00101166|50150282|FG000|Overall Study|progressive disease|10|||
25047300|NCT02759016|50150288|FG000|Overall Study|Not treated with BI 836826|1|||
25047301|NCT02759016|50150289|FG001|Overall Study|Not treated with BI 836826|0|||
25047302|NCT02759016|50150288|FG000|Overall Study|Progressive disease|1|||
25047303|NCT02759016|50150289|FG001|Overall Study|Progressive disease|0|||
25047304|NCT02759016|50150288|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
25047305|NCT02759016|50150289|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
25047306|NCT02759016|50150288|FG000|Overall Study|Other not defined above|2|||
25047307|NCT02759016|50150289|FG001|Overall Study|Other not defined above|1|||
25047308|NCT02852967|50150301|FG000|Overall Study|Adverse Event|3|||
25047309|NCT02852967|50150302|FG001|Overall Study|Adverse Event|1|||
25047310|NCT02852967|50150303|FG002|Overall Study|Adverse Event|0|||
25047311|NCT02852967|50150304|FG003|Overall Study|Adverse Event|1|||
25047312|NCT02852967|50150305|FG004|Overall Study|Adverse Event|0|||
25047313|NCT02852967|50150301|FG000|Overall Study|Death|1|||
25047314|NCT02852967|50150302|FG001|Overall Study|Death|0|||
25047315|NCT02852967|50150303|FG002|Overall Study|Death|0|||
25047316|NCT02852967|50150304|FG003|Overall Study|Death|0|||
25047317|NCT02852967|50150305|FG004|Overall Study|Death|0|||
25047318|NCT02852967|50150301|FG000|Overall Study|Lost to Follow-up|1|||
25047319|NCT02852967|50150302|FG001|Overall Study|Lost to Follow-up|2|||
25047320|NCT02852967|50150303|FG002|Overall Study|Lost to Follow-up|3|||
25047321|NCT02852967|50150304|FG003|Overall Study|Lost to Follow-up|4|||
25047322|NCT02852967|50150305|FG004|Overall Study|Lost to Follow-up|4|||
25047323|NCT02852967|50150301|FG000|Overall Study|Withdrawal by Subject|6|||
25047324|NCT02852967|50150302|FG001|Overall Study|Withdrawal by Subject|12|||
25047325|NCT02852967|50150303|FG002|Overall Study|Withdrawal by Subject|7|||
25047326|NCT02852967|50150304|FG003|Overall Study|Withdrawal by Subject|10|||
25047327|NCT02852967|50150305|FG004|Overall Study|Withdrawal by Subject|10|||
25047328|NCT02852967|50150301|FG000|Overall Study|SAE|0|||
25047329|NCT02852967|50150302|FG001|Overall Study|SAE|0|||
25047330|NCT02852967|50150303|FG002|Overall Study|SAE|0|||
25047331|NCT02852967|50150304|FG003|Overall Study|SAE|3|||
25047332|NCT02852967|50150305|FG004|Overall Study|SAE|0|||
25047333|NCT02852967|50150301|FG000|Overall Study|Elevated Liver Enzymes|2|||
25047334|NCT02852967|50150302|FG001|Overall Study|Elevated Liver Enzymes|0|||
25047335|NCT02852967|50150303|FG002|Overall Study|Elevated Liver Enzymes|0|||
25047336|NCT02852967|50150304|FG003|Overall Study|Elevated Liver Enzymes|2|||
25047337|NCT02852967|50150305|FG004|Overall Study|Elevated Liver Enzymes|2|||
25047338|NCT02852967|50150301|FG000|Overall Study|Physician Decision|0|||
24958939|NCT00323258|50049480|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
24958940|NCT00323258|50049479|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
25047339|NCT02852967|50150302|FG001|Overall Study|Physician Decision|0|||
25047340|NCT02852967|50150303|FG002|Overall Study|Physician Decision|0|||
25047341|NCT02852967|50150304|FG003|Overall Study|Physician Decision|1|||
25047342|NCT02852967|50150305|FG004|Overall Study|Physician Decision|0|||
25047343|NCT02852967|50150301|FG000|Overall Study|Lack of Efficacy|0|||
25047344|NCT02852967|50150302|FG001|Overall Study|Lack of Efficacy|1|||
25047345|NCT02852967|50150303|FG002|Overall Study|Lack of Efficacy|0|||
25047346|NCT02852967|50150304|FG003|Overall Study|Lack of Efficacy|0|||
25047347|NCT02852967|50150305|FG004|Overall Study|Lack of Efficacy|0|||
25047348|NCT02852967|50150301|FG000|Overall Study|Non-compliance|0|||
24958941|NCT00323258|50049480|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
24958942|NCT00323258|50049479|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
24958943|NCT00323258|50049480|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
24958944|NCT00323258|50049479|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
24958945|NCT00323258|50049480|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
24958946|NCT00323258|50049479|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
24958947|NCT00323258|50049480|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
24958948|NCT00322868|50049486|FG000|Overall Study|disease progression|1|||
24958949|NCT00322712|50049491|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
24958950|NCT00343382|50049498|FG000|Overall Study|Adverse Event|2|||
25047349|NCT02852967|50150302|FG001|Overall Study|Non-compliance|0|||
25047350|NCT02852967|50150303|FG002|Overall Study|Non-compliance|1|||
24958951|NCT00343382|50049499|FG001|Overall Study|Adverse Event|10|||
25047351|NCT02852967|50150304|FG003|Overall Study|Non-compliance|1|||
25047352|NCT02852967|50150305|FG004|Overall Study|Non-compliance|0|||
25047353|NCT02852967|50150301|FG000|Overall Study|Dispensing Drug Violation|0|||
25047354|NCT02852967|50150302|FG001|Overall Study|Dispensing Drug Violation|0|||
25047355|NCT02852967|50150303|FG002|Overall Study|Dispensing Drug Violation|1|||
24958952|NCT00343382|50049500|FG002|Overall Study|Adverse Event|7|||
24958953|NCT00343382|50049498|FG000|Overall Study|Withdrawal by Subject|1|||
24958954|NCT00343382|50049499|FG001|Overall Study|Withdrawal by Subject|2|||
24958955|NCT00343382|50049500|FG002|Overall Study|Withdrawal by Subject|6|||
24958956|NCT00343382|50049498|FG000|Overall Study|Other Reason Not Specified|1|||
24958957|NCT00343382|50049499|FG001|Overall Study|Other Reason Not Specified|2|||
24958958|NCT00343382|50049500|FG002|Overall Study|Other Reason Not Specified|4|||
24958959|NCT00481871|50049513|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
24958960|NCT00481871|50049514|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
24958961|NCT00481871|50049515|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
24958962|NCT00481871|50049516|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
25047356|NCT02852967|50150304|FG003|Overall Study|Dispensing Drug Violation|0|||
25047357|NCT02852967|50150305|FG004|Overall Study|Dispensing Drug Violation|0|||
25047358|NCT02852967|50150301|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
25047359|NCT02852967|50150302|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
25047360|NCT02852967|50150303|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
25047361|NCT02852967|50150304|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
25047362|NCT02852967|50150305|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
25047363|NCT02762994|50150333|FG000|Overall Study|Withdrawal by Subject|0|||
25047364|NCT02762994|50150334|FG001|Overall Study|Withdrawal by Subject|1|||
25047365|NCT02762994|50150335|FG002|Overall Study|Withdrawal by Subject|2|||
25047366|NCT02762994|50150336|FG003|Overall Study|Withdrawal by Subject|0|||
25047367|NCT02762994|50150333|FG000|Overall Study|Protocol Violation|1|||
25047368|NCT02762994|50150334|FG001|Overall Study|Protocol Violation|0|||
25047369|NCT02762994|50150335|FG002|Overall Study|Protocol Violation|0|||
24958963|NCT00481871|50049517|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
24958964|NCT00329420|50049528|FG000|Re-induction Phase|Lack of Efficacy|0|||
24958965|NCT00329420|50049529|FG001|Re-induction Phase|Lack of Efficacy|1|||
24958966|NCT00329420|50049530|FG002|Re-induction Phase|Lack of Efficacy|0|||
24958967|NCT00329420|50049528|FG000|Re-induction Phase|Withdrawal of Consent|0|||
24958968|NCT00329420|50049529|FG001|Re-induction Phase|Withdrawal of Consent|0|||
24958969|NCT00329420|50049530|FG002|Re-induction Phase|Withdrawal of Consent|1|||
25047370|NCT02762994|50150336|FG003|Overall Study|Protocol Violation|2|||
25047371|NCT02852265|50150352|FG000|3-month Follow-up|Lost to Follow-up|1|||
25047372|NCT02852265|50150353|FG001|3-month Follow-up|Lost to Follow-up|1|||
25047373|NCT02633800|50150365|FG000|Overall Study|Death|3|||
25047374|NCT02633800|50150366|FG001|Overall Study|Death|3|||
25047375|NCT02633800|50150365|FG000|Overall Study|Reason not provided|1|||
25047376|NCT02633800|50150366|FG001|Overall Study|Reason not provided|0|||
25047377|NCT02633800|50150365|FG000|Overall Study|Radiologic(al) progression|23|||
25047378|NCT02633800|50150366|FG001|Overall Study|Radiologic(al) progression|23|||
25047379|NCT02633800|50150365|FG000|Overall Study|Clinical progression|3|||
25047380|NCT02633800|50150366|FG001|Overall Study|Clinical progression|6|||
25047381|NCT02633800|50150365|FG000|Overall Study|Study terminated by sponsor|6|||
25047382|NCT02633800|50150366|FG001|Overall Study|Study terminated by sponsor|5|||
25047383|NCT02633800|50150365|FG000|Overall Study|Adverse event, non-fatal|7|||
25047384|NCT02633800|50150366|FG001|Overall Study|Adverse event, non-fatal|2|||
25047385|NCT02633800|50150365|FG000|Overall Study|Withdrawal by Subject|0|||
25047386|NCT02633800|50150366|FG001|Overall Study|Withdrawal by Subject|3|||
25047387|NCT02633800|50150365|FG000|Overall Study|Patient Request|1|||
25047388|NCT02633800|50150366|FG001|Overall Study|Patient Request|1|||
25047389|NCT03829657|50150375|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
25047390|NCT03829657|50150376|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
25047391|NCT03829657|50150377|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
25047392|NCT03829657|50150378|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
24958970|NCT00329420|50049528|FG000|Re-induction Phase|Did not respond to re-induction|6|||
24958971|NCT00329420|50049529|FG001|Re-induction Phase|Did not respond to re-induction|5|||
24958972|NCT00329420|50049530|FG002|Re-induction Phase|Did not respond to re-induction|7|||
24958973|NCT00329420|50049528|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
25047393|NCT03829657|50150379|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
25047394|NCT03829657|50150375|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
25047395|NCT03829657|50150376|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
25047396|NCT03829657|50150377|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
25047397|NCT03829657|50150378|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
25047398|NCT03829657|50150379|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
25047399|NCT03829657|50150375|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
25047400|NCT03829657|50150376|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
25047401|NCT03829657|50150377|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
25047402|NCT03829657|50150378|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
25047403|NCT03829657|50150379|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
25047404|NCT03829657|50150375|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
25047405|NCT03829657|50150376|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
25047406|NCT03829657|50150377|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
25047407|NCT03829657|50150378|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
25047408|NCT03829657|50150379|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
25047409|NCT03829657|50150375|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
25047410|NCT03829657|50150376|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
25047411|NCT03829657|50150377|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
25047412|NCT03829657|50150378|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
25047413|NCT03829657|50150379|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
25047414|NCT03829657|50150375|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
25047415|NCT03829657|50150376|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
25047416|NCT03829657|50150377|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
25047417|NCT03829657|50150378|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
25047418|NCT03829657|50150379|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
25047419|NCT03829657|50150375|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
25047420|NCT03829657|50150376|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
25047421|NCT03829657|50150377|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
25047422|NCT03829657|50150378|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
25047423|NCT03829657|50150379|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
25047424|NCT03829657|50150375|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
25047425|NCT03829657|50150376|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
25047426|NCT03829657|50150377|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
25047427|NCT03829657|50150378|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
25047428|NCT03829657|50150379|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
25047429|NCT03829657|50150375|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
25047430|NCT03829657|50150376|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
25047431|NCT03829657|50150377|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
25047432|NCT03829657|50150378|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
25047433|NCT03829657|50150379|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
24958974|NCT00329420|50049529|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
24958975|NCT00329420|50049530|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
24958976|NCT00329420|50049528|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
24958977|NCT00329420|50049529|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
24958978|NCT00329420|50049530|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
24958979|NCT00329420|50049528|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
24958980|NCT00329420|50049529|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
24958981|NCT00329420|50049530|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
24958982|NCT00329108|50049542|FG000|Overall Study|Adverse Event|2|||
24958983|NCT00329108|50049543|FG001|Overall Study|Adverse Event|2|||
24958984|NCT00329108|50049542|FG000|Overall Study|Lack of Efficacy|3|||
25047434|NCT03829657|50150375|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
25047435|NCT03829657|50150376|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
25047436|NCT03829657|50150377|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
25047437|NCT03829657|50150378|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
25047438|NCT03829657|50150379|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
25162469|NCT01791517|50284754|FG005|Phase I: Period 3|Lens Discomfort|0|||
25162470|NCT01791517|50284755|FG006|Phase I: Period 3|Lens Discomfort|0|||
25162471|NCT01791517|50284756|FG007|Phase I: Period 3|Lens Discomfort|0|||
24958985|NCT00329108|50049543|FG001|Overall Study|Lack of Efficacy|3|||
24958986|NCT00329108|50049542|FG000|Overall Study|Withdrawal by Subject|0|||
24958987|NCT00329108|50049543|FG001|Overall Study|Withdrawal by Subject|2|||
25047439|NCT03035227|50150390|FG000|Overall Study|study stopped due to PI leaving institut|1|||
25047440|NCT03035227|50150391|FG001|Overall Study|study stopped due to PI leaving institut|1|||
25047441|NCT00100932|50150401|FG000|Overall Study|Adverse Event|11|||
25047442|NCT00100932|50150402|FG001|Overall Study|Adverse Event|2|||
25047443|NCT00100932|50150401|FG000|Overall Study|Withdrawal by Subject|6|||
25047444|NCT00100932|50150402|FG001|Overall Study|Withdrawal by Subject|0|||
25047445|NCT00100932|50150401|FG000|Overall Study|Progressive Disease|44|||
25047446|NCT00100932|50150402|FG001|Overall Study|Progressive Disease|18|||
25047447|NCT00100932|50150401|FG000|Overall Study|Physician Decision|7|||
25047448|NCT00100932|50150402|FG001|Overall Study|Physician Decision|5|||
25047449|NCT00100932|50150401|FG000|Overall Study|Other|5|||
25047450|NCT00100932|50150402|FG001|Overall Study|Other|2|||
25047451|NCT03180307|50150410|FG000|Overall Study|Lost to Follow-up|2|||
25047452|NCT03180307|50150411|FG001|Overall Study|Lost to Follow-up|0|||
25047453|NCT03180307|50150410|FG000|Overall Study|Death|1|||
25047454|NCT03180307|50150411|FG001|Overall Study|Death|0|||
25047455|NCT03180307|50150410|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
25047456|NCT03180307|50150411|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
25047457|NCT02848833|50150415|FG000|Overall Study|subject who are duplicated|1|||
25047458|NCT02848833|50150415|FG000|Overall Study|have not taken the study drug|11|||
25047459|NCT02848833|50150415|FG000|Overall Study|follow-up failure|6|||
25047460|NCT02848833|50150415|FG000|Overall Study|Protocol Violation|119|||
25047461|NCT03361189|50150421|FG000|Overall Study|Received heart transplant|1|||
25047462|NCT03361189|50150422|FG001|Overall Study|Received heart transplant|0|||
25047463|NCT03361189|50150421|FG000|Overall Study|Pacemake replacement|0|||
25047464|NCT03361189|50150422|FG001|Overall Study|Pacemake replacement|1|||
25047465|NCT00092131|50150430|FG000|Treatment Period I|Adverse Event|1|||
25047466|NCT00092131|50150431|FG001|Treatment Period I|Adverse Event|0|||
25047467|NCT00092131|50150430|FG000|Treatment Period II|Adverse Event|0|||
25047468|NCT00092131|50150431|FG001|Treatment Period II|Adverse Event|1|||
25047469|NCT02668783|50150439|FG000|Overall Study|Pregnancy|0|||
25047470|NCT02668783|50150440|FG001|Overall Study|Pregnancy|1|||
25047471|NCT02668783|50150439|FG000|Overall Study|Protocol Violation|2|||
25047472|NCT02668783|50150440|FG001|Overall Study|Protocol Violation|1|||
25047473|NCT02668783|50150439|FG000|Overall Study|Study terminated by sponsor|9|||
25047474|NCT02668783|50150440|FG001|Overall Study|Study terminated by sponsor|10|||
25047475|NCT02668783|50150439|FG000|Overall Study|Subject moved|1|||
25047476|NCT02668783|50150440|FG001|Overall Study|Subject moved|0|||
25047477|NCT02668783|50150439|FG000|Overall Study|Withdrawal by Subject|1|||
25047478|NCT02668783|50150440|FG001|Overall Study|Withdrawal by Subject|0|||
25047479|NCT00101010|50150446|FG000|Overall Study|Physician Decision|1|||
25047480|NCT02848599|50150452|FG000|Overall Study|Protocol Violation|7|||
25047481|NCT02848599|50150453|FG001|Overall Study|Protocol Violation|9|||
25047482|NCT00778999|50150484|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
25047483|NCT00778999|50150485|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
25047484|NCT00778999|50150484|FG000|Overall Study|Did not receive recFSH|14|||
25047485|NCT00778999|50150485|FG001|Overall Study|Did not receive recFSH|20|||
25047486|NCT02631850|50150495|FG000|Treatment Period|Lost to Follow-up|0|||
25047487|NCT02631850|50150496|FG001|Treatment Period|Lost to Follow-up|1|||
25047488|NCT02631850|50150497|FG002|Treatment Period|Lost to Follow-up|0|||
25047489|NCT02631850|50150498|FG003|Treatment Period|Lost to Follow-up|0|||
25047490|NCT02631850|50150495|FG000|Treatment Period|Protocol Violation|1|||
25047491|NCT02631850|50150496|FG001|Treatment Period|Protocol Violation|0|||
25047492|NCT02631850|50150497|FG002|Treatment Period|Protocol Violation|0|||
25047493|NCT02631850|50150498|FG003|Treatment Period|Protocol Violation|0|||
25047494|NCT02631850|50150495|FG000|Treatment Period|Withdrawal by Subject|0|||
24958988|NCT00329108|50049542|FG000|Overall Study|symptomatic deterioration|1|||
24958989|NCT00329108|50049543|FG001|Overall Study|symptomatic deterioration|1|||
24958990|NCT00329108|50049542|FG000|Overall Study|Subject no longer willing to participate|2|||
24958991|NCT00329108|50049543|FG001|Overall Study|Subject no longer willing to participate|2|||
24958992|NCT00329108|50049542|FG000|Overall Study|study terminated by sponsor|1|||
24958993|NCT00329108|50049543|FG001|Overall Study|study terminated by sponsor|0|||
24958994|NCT00329108|50049542|FG000|Overall Study|withdrew patient after SAE resolved|1|||
24958995|NCT00329108|50049543|FG001|Overall Study|withdrew patient after SAE resolved|0|||
25047495|NCT02631850|50150496|FG001|Treatment Period|Withdrawal by Subject|5|||
25047496|NCT02631850|50150497|FG002|Treatment Period|Withdrawal by Subject|2|||
25047497|NCT02631850|50150498|FG003|Treatment Period|Withdrawal by Subject|2|||
25047498|NCT02631850|50150495|FG000|Treatment Period|Adverse Event|1|||
25047499|NCT02631850|50150496|FG001|Treatment Period|Adverse Event|0|||
25047500|NCT02631850|50150497|FG002|Treatment Period|Adverse Event|2|||
24958996|NCT00329108|50049542|FG000|Overall Study|Protocol Violation|0|||
24958997|NCT00329108|50049543|FG001|Overall Study|Protocol Violation|2|||
25047501|NCT02631850|50150498|FG003|Treatment Period|Adverse Event|3|||
25047502|NCT02631850|50150495|FG000|Treatment Period|Family medical issue|1|||
25047503|NCT02631850|50150496|FG001|Treatment Period|Family medical issue|0|||
25047504|NCT02631850|50150497|FG002|Treatment Period|Family medical issue|0|||
24958998|NCT00329030|50049551|FG000|Overall Study|Withdrawal by Subject|1|||
24958999|NCT00329030|50049552|FG001|Overall Study|Withdrawal by Subject|3|||
24959000|NCT00329030|50049551|FG000|Overall Study|Progressive Disease|6|||
24959001|NCT00329030|50049552|FG001|Overall Study|Progressive Disease|2|||
24959002|NCT00329030|50049551|FG000|Overall Study|Ineligible Pathology|1|||
24959003|NCT00329030|50049552|FG001|Overall Study|Ineligible Pathology|1|||
25047505|NCT02631850|50150498|FG003|Treatment Period|Family medical issue|0|||
25047506|NCT02631850|50150495|FG000|6 Month Follow up|Lost to Follow-up|5|||
25047507|NCT02631850|50150496|FG001|6 Month Follow up|Lost to Follow-up|8|||
25047508|NCT02631850|50150497|FG002|6 Month Follow up|Lost to Follow-up|3|||
25047509|NCT02631850|50150498|FG003|6 Month Follow up|Lost to Follow-up|5|||
25047510|NCT02631850|50150495|FG000|6 Month Follow up|Withdrawal by Subject|1|||
25047511|NCT02631850|50150496|FG001|6 Month Follow up|Withdrawal by Subject|0|||
25047512|NCT02631850|50150497|FG002|6 Month Follow up|Withdrawal by Subject|0|||
25047513|NCT02631850|50150498|FG003|6 Month Follow up|Withdrawal by Subject|2|||
25047514|NCT02631850|50150495|FG000|6 Month Follow up|Adverse Event|1|||
25047515|NCT02631850|50150496|FG001|6 Month Follow up|Adverse Event|4|||
25047516|NCT02631850|50150497|FG002|6 Month Follow up|Adverse Event|1|||
25047517|NCT02631850|50150498|FG003|6 Month Follow up|Adverse Event|3|||
25047518|NCT02631850|50150495|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
25047519|NCT02631850|50150496|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
25047520|NCT02631850|50150497|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
25047521|NCT02631850|50150498|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
25047522|NCT00103038|50150509|FG000|Overall Study|Withdrawal by Subject|8|||
25047523|NCT00103038|50150509|FG000|Overall Study|Screen failure|3|||
25047524|NCT00103038|50150509|FG000|Overall Study|Death|1|||
25047525|NCT00103038|50150509|FG000|Overall Study|Physician Decision|1|||
25047526|NCT00620035|50150516|FG000|Overall Study|Adverse Event|106|||
25047527|NCT00620035|50150516|FG000|Overall Study|Withdrawal of Informed Consent|1|||
25047528|NCT00620035|50150516|FG000|Overall Study|Other Reason|38|||
25047529|NCT02763579|50150522|FG000|Overall Study|Death|101|||
25047530|NCT02763579|50150523|FG001|Overall Study|Death|132|||
25047531|NCT02763579|50150522|FG000|Overall Study|Lost to Follow-up|3|||
25047532|NCT02763579|50150523|FG001|Overall Study|Lost to Follow-up|1|||
25047533|NCT02763579|50150522|FG000|Overall Study|Withdrawal by Subject|18|||
25047534|NCT02763579|50150523|FG001|Overall Study|Withdrawal by Subject|9|||
24959004|NCT00328562|50049558|FG000|Overall Study|Disease progression|1|||
24959005|NCT00328172|50049567|FG000|Overall Study|Adverse Event|3|||
24959006|NCT00328172|50049568|FG001|Overall Study|Adverse Event|2|||
24959007|NCT00328172|50049569|FG002|Overall Study|Adverse Event|1|||
24959008|NCT00328172|50049570|FG003|Overall Study|Adverse Event|2|||
24959009|NCT00328172|50049571|FG004|Overall Study|Adverse Event|1|||
24959010|NCT00328172|50049567|FG000|Overall Study|Protocol Violation|0|||
24959011|NCT00328172|50049568|FG001|Overall Study|Protocol Violation|1|||
24959012|NCT00328172|50049569|FG002|Overall Study|Protocol Violation|1|||
24959013|NCT00328172|50049570|FG003|Overall Study|Protocol Violation|0|||
24959014|NCT00328172|50049571|FG004|Overall Study|Protocol Violation|0|||
24959015|NCT00328172|50049567|FG000|Overall Study|Lost to Follow-up|1|||
24959016|NCT00328172|50049568|FG001|Overall Study|Lost to Follow-up|1|||
24959017|NCT00328172|50049569|FG002|Overall Study|Lost to Follow-up|2|||
24959018|NCT00328172|50049570|FG003|Overall Study|Lost to Follow-up|1|||
24959019|NCT00328172|50049571|FG004|Overall Study|Lost to Follow-up|1|||
24959020|NCT00328172|50049567|FG000|Overall Study|Withdrawal by Subject|1|||
25047535|NCT02763579|50150522|FG000|Overall Study|Physician Decision|2|||
25047536|NCT02763579|50150523|FG001|Overall Study|Physician Decision|0|||
25047537|NCT02763579|50150522|FG000|Overall Study|On-going in study|77|||
25047538|NCT02763579|50150523|FG001|Overall Study|On-going in study|60|||
24959021|NCT00328172|50049568|FG001|Overall Study|Withdrawal by Subject|1|||
24959022|NCT00328172|50049569|FG002|Overall Study|Withdrawal by Subject|1|||
25047539|NCT03034057|50150529|FG000|Overall Study|Withdrawal by Subject|10|||
25047540|NCT03034057|50150529|FG000|Overall Study|Protocol Violation|1|||
24959023|NCT00328172|50049570|FG003|Overall Study|Withdrawal by Subject|6|||
25047541|NCT03034057|50150529|FG000|Overall Study|Not defined|2|||
25047542|NCT03034057|50150529|FG000|Overall Study|Lost to Follow-up|19|||
25047543|NCT03034057|50150529|FG000|Overall Study|Adverse Event|22|||
25162472|NCT01791517|50284757|FG008|Phase I: Period 3|Lens Discomfort|0|||
25047544|NCT03034057|50150529|FG000|Overall Study|Medication error without associated AE|1|||
25047545|NCT02757768|50150535|FG000|Overall Study|Randomized Never Received Study Drug|3|||
25047546|NCT02757768|50150536|FG001|Overall Study|Randomized Never Received Study Drug|4|||
25047547|NCT02757768|50150535|FG000|Overall Study|Adverse Event|5|||
25047548|NCT02757768|50150536|FG001|Overall Study|Adverse Event|3|||
25047549|NCT02757768|50150535|FG000|Overall Study|Lack of Efficacy|2|||
25047550|NCT02757768|50150536|FG001|Overall Study|Lack of Efficacy|1|||
25047551|NCT02757768|50150535|FG000|Overall Study|Lost to Follow-up|1|||
25047552|NCT02757768|50150536|FG001|Overall Study|Lost to Follow-up|0|||
25047553|NCT02757768|50150535|FG000|Overall Study|Protocol Deviation|2|||
25047554|NCT02757768|50150536|FG001|Overall Study|Protocol Deviation|9|||
25047555|NCT02757768|50150535|FG000|Overall Study|Withdrawal by Subject|16|||
25047556|NCT02757768|50150536|FG001|Overall Study|Withdrawal by Subject|9|||
25047557|NCT02757768|50150535|FG000|Overall Study|Miscellaneous|4|||
25047558|NCT02757768|50150536|FG001|Overall Study|Miscellaneous|2|||
25047559|NCT02753946|50150546|FG000|Overall Study|Adverse Event|7|||
25047560|NCT02753946|50150547|FG001|Overall Study|Adverse Event|6|||
25047561|NCT02753946|50150546|FG000|Overall Study|Withdrawal by Subject|6|||
25047562|NCT02753946|50150547|FG001|Overall Study|Withdrawal by Subject|1|||
25047563|NCT02753946|50150546|FG000|Overall Study|Lack of Efficacy|1|||
25047564|NCT02753946|50150547|FG001|Overall Study|Lack of Efficacy|0|||
25047565|NCT02753946|50150546|FG000|Overall Study|Physician Decision|0|||
25047566|NCT02753946|50150547|FG001|Overall Study|Physician Decision|2|||
25047567|NCT02756832|50150553|FG000|Overall Study|Lost for Observation after Baseline|6|||
25047568|NCT02756832|50150553|FG000|Overall Study|Lost for Observation|13|||
25047569|NCT02756832|50150553|FG000|Overall Study|Patient's Unwillingness|12|||
25047570|NCT02756832|50150553|FG000|Overall Study|Insufficient Efficacy|2|||
25047571|NCT02756832|50150553|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
25047572|NCT02756832|50150553|FG000|Overall Study|Reason not Specified|9|||
25047573|NCT02756832|50150553|FG000|Overall Study|Protocol Deviation|10|||
25047574|NCT00106080|50150559|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
25047575|NCT00106080|50150560|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
25047576|NCT02633020|50150568|FG000|Overall Study|Adverse Event|1|||
25047577|NCT02633020|50150569|FG001|Overall Study|Adverse Event|0|||
25047578|NCT00106626|50150579|FG000|Overall Study|Adverse Event|5|||
25047579|NCT00106626|50150580|FG001|Overall Study|Adverse Event|4|||
25047580|NCT00106626|50150581|FG002|Overall Study|Adverse Event|3|||
25047581|NCT00106626|50150582|FG003|Overall Study|Adverse Event|3|||
25047582|NCT00106626|50150579|FG000|Overall Study|Progressive Disease|4|||
25047583|NCT00106626|50150580|FG001|Overall Study|Progressive Disease|1|||
25047584|NCT00106626|50150581|FG002|Overall Study|Progressive Disease|9|||
25047585|NCT00106626|50150582|FG003|Overall Study|Progressive Disease|10|||
25047586|NCT00106626|50150579|FG000|Overall Study|Received radiation on new therapy|1|||
25047587|NCT00106626|50150580|FG001|Overall Study|Received radiation on new therapy|0|||
25047588|NCT00106626|50150581|FG002|Overall Study|Received radiation on new therapy|0|||
25047589|NCT00106626|50150582|FG003|Overall Study|Received radiation on new therapy|0|||
25047590|NCT00106626|50150579|FG000|Overall Study|> 14 day delay in therapy start|0|||
25047591|NCT00106626|50150580|FG001|Overall Study|> 14 day delay in therapy start|1|||
25047592|NCT00106626|50150581|FG002|Overall Study|> 14 day delay in therapy start|0|||
25047593|NCT00106626|50150582|FG003|Overall Study|> 14 day delay in therapy start|0|||
25047594|NCT02632786|50150599|FG000|Overall Study|Adverse Event|2|||
25047595|NCT02632786|50150600|FG001|Overall Study|Adverse Event|1|||
25047596|NCT02632786|50150599|FG000|Overall Study|Death|3|||
25047597|NCT02632786|50150600|FG001|Overall Study|Death|2|||
25047598|NCT02632786|50150599|FG000|Overall Study|Physician Decision|5|||
25047599|NCT02632786|50150600|FG001|Overall Study|Physician Decision|4|||
25047600|NCT02632786|50150599|FG000|Overall Study|Withdrawal by Subject|1|||
25047601|NCT02632786|50150600|FG001|Overall Study|Withdrawal by Subject|0|||
25047602|NCT02755818|50150611|FG000|Overall Study|Withdrawal by Subject|0|||
25047603|NCT02755818|50150612|FG001|Overall Study|Withdrawal by Subject|0|||
25047604|NCT02755818|50150613|FG002|Overall Study|Withdrawal by Subject|0|||
25047605|NCT02755818|50150614|FG003|Overall Study|Withdrawal by Subject|2|||
25047606|NCT02755818|50150611|FG000|Overall Study|withdrawal by PI|0|||
25047607|NCT02755818|50150612|FG001|Overall Study|withdrawal by PI|0|||
25047608|NCT02755818|50150613|FG002|Overall Study|withdrawal by PI|1|||
25047609|NCT02755818|50150614|FG003|Overall Study|withdrawal by PI|1|||
25047610|NCT03033745|50150629|FG000|Overall Study|Protocol Violation|0|||
25047611|NCT03033745|50150630|FG001|Overall Study|Protocol Violation|0|||
25047612|NCT03033745|50150631|FG002|Overall Study|Protocol Violation|1|||
25047613|NCT03033745|50150629|FG000|Overall Study|Adverse Event|1|||
25047614|NCT03033745|50150630|FG001|Overall Study|Adverse Event|0|||
25047615|NCT03033745|50150631|FG002|Overall Study|Adverse Event|1|||
25047616|NCT03033745|50150629|FG000|Overall Study|Withdrawal by Subject|0|||
25047617|NCT03033745|50150630|FG001|Overall Study|Withdrawal by Subject|1|||
25047618|NCT03033745|50150631|FG002|Overall Study|Withdrawal by Subject|0|||
25047619|NCT01672294|50150650|FG000|Overall Study|Withdrawal by Subject|4|||
24959024|NCT00328172|50049571|FG004|Overall Study|Withdrawal by Subject|0|||
24959025|NCT00328172|50049567|FG000|Overall Study|Lack of Efficacy|14|||
24959026|NCT00328172|50049568|FG001|Overall Study|Lack of Efficacy|9|||
24959027|NCT00328172|50049569|FG002|Overall Study|Lack of Efficacy|4|||
24959028|NCT00328172|50049570|FG003|Overall Study|Lack of Efficacy|4|||
24959029|NCT00328172|50049571|FG004|Overall Study|Lack of Efficacy|3|||
24959030|NCT00328172|50049567|FG000|Overall Study|Other reason (not specified)|3|||
24959031|NCT00328172|50049568|FG001|Overall Study|Other reason (not specified)|0|||
24959032|NCT00328172|50049569|FG002|Overall Study|Other reason (not specified)|1|||
24959033|NCT00328172|50049570|FG003|Overall Study|Other reason (not specified)|0|||
24959034|NCT00328172|50049571|FG004|Overall Study|Other reason (not specified)|0|||
24959035|NCT00328094|50049585|FG000|Overall Study|Physician Decision|3|||
24959036|NCT00328094|50049586|FG001|Overall Study|Physician Decision|3|||
24959037|NCT00500903|50049595|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
24959038|NCT00500903|50049596|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
24959039|NCT00500903|50049597|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
24959040|NCT00500903|50049595|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
24959041|NCT00500903|50049596|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
25047620|NCT01672294|50150651|FG001|Overall Study|Withdrawal by Subject|4|||
25047621|NCT01672294|50150652|FG002|Overall Study|Withdrawal by Subject|4|||
25047622|NCT01672294|50150653|FG003|Overall Study|Withdrawal by Subject|4|||
25047623|NCT01672294|50150650|FG000|Overall Study|Excluded by study|1|||
25047624|NCT01672294|50150651|FG001|Overall Study|Excluded by study|1|||
25047625|NCT01672294|50150652|FG002|Overall Study|Excluded by study|0|||
25047626|NCT01672294|50150653|FG003|Overall Study|Excluded by study|0|||
25047627|NCT01672294|50150650|FG000|Overall Study|Lost to Follow-up|1|||
25047628|NCT01672294|50150651|FG001|Overall Study|Lost to Follow-up|16|||
25047629|NCT01672294|50150652|FG002|Overall Study|Lost to Follow-up|7|||
25047630|NCT01672294|50150653|FG003|Overall Study|Lost to Follow-up|9|||
25047631|NCT02755116|50150665|FG000|Overall Study|surgery converted to open, pt admitted|3|||
25047632|NCT02755116|50150666|FG001|Overall Study|surgery converted to open, pt admitted|1|||
25047633|NCT02754492|50150676|FG000|Overall Study|Protocol Violation|2|||
25047634|NCT02754492|50150677|FG001|Overall Study|Protocol Violation|2|||
25047635|NCT02754492|50150678|FG002|Overall Study|Protocol Violation|0|||
25047636|NCT02754492|50150679|FG003|Overall Study|Protocol Violation|1|||
25047637|NCT02754492|50150676|FG000|Overall Study|Withdrawal by Subject|2|||
25047638|NCT02754492|50150677|FG001|Overall Study|Withdrawal by Subject|0|||
25047639|NCT02754492|50150678|FG002|Overall Study|Withdrawal by Subject|0|||
25047640|NCT02754492|50150679|FG003|Overall Study|Withdrawal by Subject|0|||
25047641|NCT02754492|50150676|FG000|Overall Study|Equipment malfuntion|0|||
25047642|NCT02754492|50150677|FG001|Overall Study|Equipment malfuntion|0|||
25047643|NCT02754492|50150678|FG002|Overall Study|Equipment malfuntion|2|||
25047644|NCT02754492|50150679|FG003|Overall Study|Equipment malfuntion|5|||
25047645|NCT02754492|50150676|FG000|Overall Study|Adverse Event|0|||
25047646|NCT02754492|50150677|FG001|Overall Study|Adverse Event|0|||
25047647|NCT02754492|50150678|FG002|Overall Study|Adverse Event|0|||
25047648|NCT02754492|50150679|FG003|Overall Study|Adverse Event|13|||
25047649|NCT02754492|50150676|FG000|Overall Study|Venous access issues not resulting in AE|0|||
25047650|NCT02754492|50150677|FG001|Overall Study|Venous access issues not resulting in AE|0|||
25047651|NCT02754492|50150678|FG002|Overall Study|Venous access issues not resulting in AE|0|||
25047652|NCT02754492|50150679|FG003|Overall Study|Venous access issues not resulting in AE|4|||
25047653|NCT04068688|50150698|FG000|Overall Study|Lost to Follow-up|1|||
25047654|NCT04068688|50150699|FG001|Overall Study|Lost to Follow-up|1|||
25047655|NCT04068688|50150700|FG002|Overall Study|Lost to Follow-up|0|||
25047656|NCT04068688|50150701|FG003|Overall Study|Lost to Follow-up|0|||
25047657|NCT04068688|50150702|FG004|Overall Study|Lost to Follow-up|5|||
25047658|NCT04068688|50150703|FG005|Overall Study|Lost to Follow-up|5|||
25047659|NCT04068688|50150704|FG006|Overall Study|Lost to Follow-up|0|||
25047660|NCT04068688|50150705|FG007|Overall Study|Lost to Follow-up|0|||
25047661|NCT04068688|50150706|FG008|Overall Study|Lost to Follow-up|1|||
25047662|NCT04068688|50150707|FG009|Overall Study|Lost to Follow-up|0|||
25047663|NCT04068688|50150698|FG000|Overall Study|Withdrawal by Subject|1|||
25047664|NCT04068688|50150699|FG001|Overall Study|Withdrawal by Subject|1|||
25047665|NCT04068688|50150700|FG002|Overall Study|Withdrawal by Subject|0|||
25047666|NCT04068688|50150701|FG003|Overall Study|Withdrawal by Subject|0|||
25047667|NCT04068688|50150702|FG004|Overall Study|Withdrawal by Subject|0|||
25047668|NCT04068688|50150703|FG005|Overall Study|Withdrawal by Subject|0|||
25047669|NCT04068688|50150704|FG006|Overall Study|Withdrawal by Subject|0|||
25047670|NCT04068688|50150705|FG007|Overall Study|Withdrawal by Subject|0|||
25047671|NCT04068688|50150706|FG008|Overall Study|Withdrawal by Subject|0|||
25047672|NCT04068688|50150707|FG009|Overall Study|Withdrawal by Subject|0|||
25047673|NCT04068688|50150698|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
25047674|NCT04068688|50150699|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
25047675|NCT04068688|50150700|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
25047676|NCT04068688|50150701|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
25047677|NCT04068688|50150702|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
25047678|NCT04068688|50150703|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
25047679|NCT04068688|50150704|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
25162473|NCT01791517|50284758|FG009|Phase I: Period 3|Lens Discomfort|0|||
24959042|NCT00500903|50049597|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
24959043|NCT00500903|50049595|FG000|Overall Study|Progressive Disease|41|||
24959044|NCT00500903|50049596|FG001|Overall Study|Progressive Disease|2|||
24959045|NCT00500903|50049597|FG002|Overall Study|Progressive Disease|15|||
24959046|NCT00500903|50049595|FG000|Overall Study|Patient Declined Further Treatment|0|||
24959047|NCT00500903|50049596|FG001|Overall Study|Patient Declined Further Treatment|0|||
24959048|NCT00500903|50049597|FG002|Overall Study|Patient Declined Further Treatment|3|||
24959049|NCT00500903|50049595|FG000|Overall Study|Symptomatic Deterioration|2|||
24959050|NCT00500903|50049596|FG001|Overall Study|Symptomatic Deterioration|0|||
24959051|NCT00500903|50049597|FG002|Overall Study|Symptomatic Deterioration|0|||
24959052|NCT00500903|50049595|FG000|Overall Study|Reason Not Specified|10|||
24959053|NCT00500903|50049596|FG001|Overall Study|Reason Not Specified|0|||
24959054|NCT00500903|50049597|FG002|Overall Study|Reason Not Specified|2|||
24959055|NCT00295932|50049646|FG000|Overall Study|Not Treated|0|||
24959056|NCT00295932|50049647|FG001|Overall Study|Not Treated|0|||
24959057|NCT00295932|50049648|FG002|Overall Study|Not Treated|0|||
24959058|NCT00295932|50049649|FG003|Overall Study|Not Treated|0|||
24959059|NCT00295932|50049650|FG004|Overall Study|Not Treated|0|||
24959060|NCT00295932|50049651|FG005|Overall Study|Not Treated|0|||
24959061|NCT00295932|50049652|FG006|Overall Study|Not Treated|0|||
24959062|NCT00295932|50049653|FG007|Overall Study|Not Treated|0|||
24959063|NCT00295932|50049654|FG008|Overall Study|Not Treated|0|||
24959064|NCT00295932|50049655|FG009|Overall Study|Not Treated|0|||
24959065|NCT00295932|50049656|FG010|Overall Study|Not Treated|1|||
24959066|NCT00305448|50049685|FG000|Overall Study|Protocol Violation|0|||
24959067|NCT00305448|50049686|FG001|Overall Study|Protocol Violation|1|||
24959068|NCT00305448|50049687|FG002|Overall Study|Protocol Violation|0|||
24959069|NCT00305448|50049685|FG000|Overall Study|Withdrawal by Subject|2|||
24959070|NCT00305448|50049686|FG001|Overall Study|Withdrawal by Subject|0|||
24959071|NCT00305448|50049687|FG002|Overall Study|Withdrawal by Subject|1|||
24959072|NCT00305448|50049685|FG000|Overall Study|Adverse Event|1|||
24959073|NCT00305448|50049686|FG001|Overall Study|Adverse Event|0|||
24959074|NCT00305448|50049687|FG002|Overall Study|Adverse Event|1|||
24959075|NCT00305448|50049685|FG000|Overall Study|Disease Progression|27|||
24959076|NCT00305448|50049686|FG001|Overall Study|Disease Progression|31|||
24959077|NCT00305448|50049687|FG002|Overall Study|Disease Progression|28|||
24959078|NCT00305448|50049685|FG000|Overall Study|Subjective Disease Progression|1|||
24959079|NCT00305448|50049686|FG001|Overall Study|Subjective Disease Progression|2|||
24959080|NCT00305448|50049687|FG002|Overall Study|Subjective Disease Progression|2|||
24959081|NCT00305448|50049685|FG000|Overall Study|Tumor Marker Elevation|0|||
24959082|NCT00305448|50049686|FG001|Overall Study|Tumor Marker Elevation|0|||
24959083|NCT00305448|50049687|FG002|Overall Study|Tumor Marker Elevation|1|||
24959084|NCT00305058|50049698|FG000|Overall Study|Participant too young|1|||
24959085|NCT00305058|50049699|FG001|Overall Study|Participant too young|0|||
24959086|NCT00305058|50049698|FG000|Overall Study|Missing data collection instrument|3|||
24959087|NCT00305058|50049699|FG001|Overall Study|Missing data collection instrument|2|||
24959088|NCT00305058|50049698|FG000|Overall Study|Missing outcome data|3|||
24959089|NCT00305058|50049699|FG001|Overall Study|Missing outcome data|2|||
24959090|NCT00295854|50049708|FG000|Overall Study|Adverse Event|7|||
24959091|NCT00295854|50049709|FG001|Overall Study|Adverse Event|7|||
24959092|NCT00295854|50049710|FG002|Overall Study|Adverse Event|6|||
24959093|NCT00295854|50049708|FG000|Overall Study|Protocol Violation|1|||
24959094|NCT00295854|50049709|FG001|Overall Study|Protocol Violation|1|||
24959095|NCT00295854|50049710|FG002|Overall Study|Protocol Violation|1|||
24959096|NCT00295854|50049708|FG000|Overall Study|Lost to Follow-up|2|||
24959097|NCT00295854|50049709|FG001|Overall Study|Lost to Follow-up|0|||
24959098|NCT00295854|50049710|FG002|Overall Study|Lost to Follow-up|1|||
24959099|NCT00295854|50049708|FG000|Overall Study|Withdrawal by Subject|3|||
24959100|NCT00295854|50049709|FG001|Overall Study|Withdrawal by Subject|7|||
24959101|NCT00295854|50049710|FG002|Overall Study|Withdrawal by Subject|4|||
24959102|NCT00295854|50049708|FG000|Overall Study|did not continue to meet criteria|1|||
24959103|NCT00295854|50049709|FG001|Overall Study|did not continue to meet criteria|1|||
24959104|NCT00295854|50049710|FG002|Overall Study|did not continue to meet criteria|2|||
24959105|NCT00295854|50049708|FG000|Overall Study|required a prohibited medication|1|||
25047680|NCT04068688|50150705|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
25047681|NCT04068688|50150706|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
25047682|NCT04068688|50150707|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
25047683|NCT01671748|50150735|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
25047684|NCT01671748|50150736|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
25047685|NCT01671748|50150735|FG000|4 Week run-in Phase|Adverse Event|1|||
25047686|NCT01671748|50150736|FG001|4 Week run-in Phase|Adverse Event|0|||
25047687|NCT01671748|50150735|FG000|4 Week run-in Phase|Not eligible|9|||
25047688|NCT01671748|50150736|FG001|4 Week run-in Phase|Not eligible|0|||
25047689|NCT02657889|50150746|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
25047690|NCT02657889|50150747|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
25047691|NCT02657889|50150748|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
25047692|NCT02657889|50150749|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
25047693|NCT02657889|50150746|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
24959106|NCT00295854|50049709|FG001|Overall Study|required a prohibited medication|0|||
24959107|NCT00295854|50049710|FG002|Overall Study|required a prohibited medication|0|||
24959108|NCT00295854|50049708|FG000|Overall Study|Other|3|||
24959109|NCT00295854|50049709|FG001|Overall Study|Other|5|||
24959110|NCT00295854|50049710|FG002|Overall Study|Other|1|||
24959111|NCT00327470|50049720|FG000|Overall Study|Randomized, but not treated|0|||
24959112|NCT00327470|50049721|FG001|Overall Study|Randomized, but not treated|2|||
24959113|NCT00327470|50049720|FG000|Overall Study|Adverse Event|9|||
24959114|NCT00327470|50049721|FG001|Overall Study|Adverse Event|14|||
24959115|NCT00327470|50049720|FG000|Overall Study|Lack of Efficacy|7|||
24959116|NCT00327470|50049721|FG001|Overall Study|Lack of Efficacy|19|||
24959117|NCT00327470|50049720|FG000|Overall Study|Other|5|||
24959118|NCT00327470|50049721|FG001|Overall Study|Other|9|||
24959119|NCT00327470|50049720|FG000|Overall Study|Lost to Follow-up|1|||
24959120|NCT00327470|50049721|FG001|Overall Study|Lost to Follow-up|3|||
24959121|NCT00327470|50049720|FG000|Overall Study|Withdrawal by Subject|6|||
24959122|NCT00327470|50049721|FG001|Overall Study|Withdrawal by Subject|12|||
24959123|NCT00327470|50049720|FG000|Overall Study|Death|1|||
24959124|NCT00327470|50049721|FG001|Overall Study|Death|4|||
24959125|NCT00322556|50049727|FG000|Overall Study|Adverse Event|1|||
24959126|NCT00322556|50049727|FG000|Overall Study|Withdrawal by Subject|1|||
24959127|NCT00322556|50049727|FG000|Overall Study|Lost to Follow-up|3|||
24959128|NCT00322556|50049727|FG000|Overall Study|Other Reason|7|||
24959129|NCT00321932|50049736|FG000|Overall Study|Death|3|||
24959130|NCT00321932|50049737|FG001|Overall Study|Death|6|||
24959131|NCT00321932|50049736|FG000|Overall Study|Withdrawal by Subject|3|||
24959132|NCT00321932|50049737|FG001|Overall Study|Withdrawal by Subject|6|||
24959133|NCT00321932|50049736|FG000|Overall Study|Early relapse|2|||
24959134|NCT00321932|50049737|FG001|Overall Study|Early relapse|8|||
24959135|NCT00321932|50049736|FG000|Overall Study|Missing data|2|||
24959136|NCT00321932|50049737|FG001|Overall Study|Missing data|1|||
24959137|NCT00326612|50049746|FG000|Overall Study|They did not have a seizure requiring tx|129|||
24959138|NCT00326612|50049747|FG001|Overall Study|They did not have a seizure requiring tx|137|||
25047694|NCT02657889|50150747|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
25047695|NCT02657889|50150748|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
25047696|NCT02657889|50150749|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
25047697|NCT02657889|50150746|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
25047698|NCT02657889|50150747|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
25047699|NCT02657889|50150748|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
25047700|NCT02657889|50150749|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
25047701|NCT02657889|50150746|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
25047702|NCT02657889|50150747|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
25047703|NCT02657889|50150748|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
25047704|NCT02657889|50150749|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
25047705|NCT02657889|50150746|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
25047706|NCT02657889|50150747|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
25047707|NCT02657889|50150748|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
25047708|NCT02657889|50150749|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
25047709|NCT02657889|50150746|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
25047710|NCT02657889|50150747|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
25047711|NCT02657889|50150748|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
25047712|NCT02657889|50150749|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
25047713|NCT02657889|50150746|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
25047714|NCT02657889|50150747|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
25047715|NCT02657889|50150748|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
25047716|NCT02657889|50150749|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
25047717|NCT02657889|50150746|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
25047718|NCT02657889|50150747|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
25047719|NCT02657889|50150748|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
25047720|NCT02657889|50150749|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
25047721|NCT02657889|50150746|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
25047722|NCT02657889|50150747|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
25047723|NCT02657889|50150748|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
25047724|NCT02657889|50150749|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
25047725|NCT02657889|50150746|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
25047726|NCT02657889|50150747|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
25047727|NCT02657889|50150748|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
25047728|NCT02657889|50150749|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
25047729|NCT02657889|50150746|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
25047730|NCT02657889|50150747|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
25047731|NCT02657889|50150748|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
25047732|NCT02657889|50150749|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
25047733|NCT02657889|50150746|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
25047734|NCT02657889|50150747|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
25047735|NCT02657889|50150748|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
25047736|NCT02657889|50150749|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
25047737|NCT03034915|50150764|FG000|Overall Study|Adverse Event|29|||
25047738|NCT03034915|50150765|FG001|Overall Study|Adverse Event|32|||
25047739|NCT03034915|50150766|FG002|Overall Study|Adverse Event|22|||
25047740|NCT03034915|50150764|FG000|Overall Study|Lost to Follow-up|5|||
25047741|NCT03034915|50150765|FG001|Overall Study|Lost to Follow-up|13|||
25047742|NCT03034915|50150766|FG002|Overall Study|Lost to Follow-up|3|||
25047743|NCT03034915|50150764|FG000|Overall Study|Withdrawal by Subject|29|||
25047744|NCT03034915|50150765|FG001|Overall Study|Withdrawal by Subject|46|||
25047745|NCT03034915|50150766|FG002|Overall Study|Withdrawal by Subject|41|||
25047746|NCT03034915|50150764|FG000|Overall Study|Protocol Deviation|2|||
25047747|NCT03034915|50150765|FG001|Overall Study|Protocol Deviation|14|||
25047748|NCT03034915|50150766|FG002|Overall Study|Protocol Deviation|7|||
25047749|NCT03034915|50150764|FG000|Overall Study|Lack of Efficacy|8|||
25047750|NCT03034915|50150765|FG001|Overall Study|Lack of Efficacy|16|||
25047751|NCT03034915|50150766|FG002|Overall Study|Lack of Efficacy|18|||
25047752|NCT03034915|50150764|FG000|Overall Study|Site closed|2|||
25047753|NCT03034915|50150765|FG001|Overall Study|Site closed|2|||
25047754|NCT03034915|50150766|FG002|Overall Study|Site closed|4|||
25047755|NCT03034915|50150764|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
25047756|NCT03034915|50150765|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
25047757|NCT03034915|50150766|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
25047758|NCT03034915|50150764|FG000|Overall Study|Physician Decision|1|||
25162474|NCT01791517|50284759|FG010|Phase I: Period 3|Lens Discomfort|0|||
25162475|NCT01791517|50284760|FG011|Phase I: Period 3|Lens Discomfort|1|||
25162476|NCT01791517|50284749|FG000|Phase I: Period 3|Lost to Follow-up|0|||
25162477|NCT01791517|50284750|FG001|Phase I: Period 3|Lost to Follow-up|1|||
24959139|NCT00325130|50049759|FG000|Overall Study|Lost to Follow-up|6|||
24959140|NCT00325130|50049760|FG001|Overall Study|Lost to Follow-up|14|||
24959141|NCT00325130|50049759|FG000|Overall Study|Withdrawal by Subject|12|||
24959142|NCT00325130|50049760|FG001|Overall Study|Withdrawal by Subject|14|||
24959143|NCT00325130|50049759|FG000|Overall Study|Protocol Deviation|0|||
24959144|NCT00325130|50049760|FG001|Overall Study|Protocol Deviation|1|||
24959145|NCT00325130|50049759|FG000|Overall Study|Moved|0|||
24959146|NCT00325130|50049760|FG001|Overall Study|Moved|1|||
24959147|NCT00325130|50049759|FG000|Overall Study|Patient Discontinued for Other|1|||
24959148|NCT00325130|50049760|FG001|Overall Study|Patient Discontinued for Other|0|||
24959149|NCT00321854|50049768|FG000|Overall Study|Adverse Event|41|||
24959150|NCT00321854|50049769|FG001|Overall Study|Adverse Event|43|||
24959151|NCT00321854|50049768|FG000|Overall Study|Lack of Efficacy|9|||
24959152|NCT00321854|50049769|FG001|Overall Study|Lack of Efficacy|14|||
24959153|NCT00321854|50049768|FG000|Overall Study|Protocol Violation|6|||
24959154|NCT00321854|50049769|FG001|Overall Study|Protocol Violation|5|||
24959155|NCT00321854|50049768|FG000|Overall Study|Lost to Follow-up|0|||
24959156|NCT00321854|50049769|FG001|Overall Study|Lost to Follow-up|2|||
24959157|NCT00321854|50049768|FG000|Overall Study|Withdrawal by Subject|6|||
24959158|NCT00321854|50049769|FG001|Overall Study|Withdrawal by Subject|17|||
24959159|NCT00321854|50049768|FG000|Overall Study|Other|1|||
24959160|NCT00321854|50049769|FG001|Overall Study|Other|1|||
24959161|NCT00310388|50049777|FG000|Primary Reporting Phase|Adverse Event|101|||
24959162|NCT00310388|50049778|FG001|Primary Reporting Phase|Adverse Event|0|||
24959163|NCT00310388|50049777|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
24959164|NCT00310388|50049778|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
24959165|NCT00310388|50049777|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
24959166|NCT00310388|50049778|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
24959167|NCT00310388|50049777|FG000|Primary Reporting Phase|Protocol Violation|10|||
24959168|NCT00310388|50049778|FG001|Primary Reporting Phase|Protocol Violation|0|||
24959169|NCT00310388|50049777|FG000|Primary Reporting Phase|Pregnancy|3|||
24959170|NCT00310388|50049778|FG001|Primary Reporting Phase|Pregnancy|0|||
24959171|NCT00310388|50049777|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
24959172|NCT00310388|50049778|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
24959173|NCT00310388|50049777|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
24959174|NCT00310388|50049778|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
24959175|NCT00310388|50049777|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
24959176|NCT00310388|50049778|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
24959177|NCT00310388|50049777|FG000|Primary Reporting Phase|Physician Decision|2|||
25162478|NCT01791517|50284751|FG002|Phase I: Period 3|Lost to Follow-up|0|||
25162479|NCT01791517|50284752|FG003|Phase I: Period 3|Lost to Follow-up|0|||
25162480|NCT01791517|50284753|FG004|Phase I: Period 3|Lost to Follow-up|1|||
25162481|NCT01791517|50284754|FG005|Phase I: Period 3|Lost to Follow-up|0|||
25162482|NCT01791517|50284755|FG006|Phase I: Period 3|Lost to Follow-up|0|||
25162483|NCT01791517|50284756|FG007|Phase I: Period 3|Lost to Follow-up|0|||
24959178|NCT00310388|50049778|FG001|Primary Reporting Phase|Physician Decision|0|||
24959179|NCT00310388|50049777|FG000|Primary Reporting Phase|Request of the sponsor|19|||
25047759|NCT03034915|50150765|FG001|Overall Study|Physician Decision|5|||
25047760|NCT03034915|50150766|FG002|Overall Study|Physician Decision|2|||
25047761|NCT02631538|50150778|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
25162484|NCT01791517|50284757|FG008|Phase I: Period 3|Lost to Follow-up|0|||
25162485|NCT01791517|50284758|FG009|Phase I: Period 3|Lost to Follow-up|0|||
24959180|NCT00310388|50049778|FG001|Primary Reporting Phase|Request of the sponsor|0|||
25047762|NCT02631538|50150779|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
25047763|NCT02631538|50150780|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
25047764|NCT02631538|50150781|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
25047765|NCT02631538|50150778|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
25047766|NCT02631538|50150779|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
25047767|NCT02631538|50150780|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
25047768|NCT02631538|50150781|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
25047769|NCT02631538|50150778|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
25047770|NCT02631538|50150779|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
25047771|NCT02631538|50150780|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
25047772|NCT02631538|50150781|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
25047773|NCT02631538|50150778|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
25047774|NCT02631538|50150779|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
25047775|NCT02631538|50150780|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
25047776|NCT02631538|50150781|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
25047777|NCT02631538|50150778|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
25047778|NCT02631538|50150779|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
25047779|NCT02631538|50150780|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
25047780|NCT02631538|50150781|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
25047781|NCT02631538|50150778|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
25047782|NCT02631538|50150779|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
25047783|NCT02631538|50150780|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
25047784|NCT02631538|50150781|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
25047785|NCT02631148|50150804|FG000|Overall Study|8 were ineligible|8|||
25047786|NCT02631148|50150805|FG001|Overall Study|8 were ineligible|0|||
25047787|NCT02631148|50150804|FG000|Overall Study|Withdrawal by Subject|1|||
25047788|NCT02631148|50150805|FG001|Overall Study|Withdrawal by Subject|0|||
25047789|NCT02631148|50150804|FG000|Overall Study|PAH not available to study participant|1|||
25047790|NCT02631148|50150805|FG001|Overall Study|PAH not available to study participant|0|||
25047791|NCT02753400|50150813|FG000|Overall Study|Adverse Event|3|||
25047792|NCT02753400|50150814|FG001|Overall Study|Adverse Event|0|||
25047793|NCT02753400|50150813|FG000|Overall Study|Withdrawal by Subject|2|||
25047794|NCT02753400|50150814|FG001|Overall Study|Withdrawal by Subject|1|||
25047795|NCT03943147|50150831|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
25047796|NCT03943147|50150832|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
25047797|NCT03943147|50150831|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
25047798|NCT03943147|50150832|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
25047799|NCT03943147|50150831|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
25047800|NCT03943147|50150832|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
25047801|NCT03943147|50150831|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
25047802|NCT03943147|50150832|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
25047803|NCT03943147|50150831|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
25047804|NCT03943147|50150832|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
25047805|NCT03943147|50150831|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
25047806|NCT03943147|50150832|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
25047807|NCT03730987|50150850|FG000|Overall Study|Lost to Follow-up|2|||
25047808|NCT03730987|50150851|FG001|Overall Study|Lost to Follow-up|0|||
25047809|NCT03730987|50150852|FG002|Overall Study|Lost to Follow-up|2|||
25047810|NCT03730987|50150853|FG003|Overall Study|Lost to Follow-up|0|||
25047811|NCT03556891|50150864|FG000|Overall Study|Adverse Event|4|||
25047812|NCT03556891|50150864|FG000|Overall Study|MRI Need|3|||
25047813|NCT03556891|50150864|FG000|Overall Study|Device Failure|1|||
25047814|NCT03556891|50150864|FG000|Overall Study|Death|1|||
25047815|NCT03556891|50150864|FG000|Overall Study|Lost to Follow-up|1|||
25047816|NCT03556891|50150864|FG000|Overall Study|Missing at random|1|||
25047817|NCT03556891|50150864|FG000|Overall Study|Missing due to COVID|1|||
25047818|NCT03556891|50150864|FG000|Overall Study|Protocol Violation|1|||
25047819|NCT02844543|50150868|FG000|Overall Study|Withdrawal by Subject|4|||
25047820|NCT02844543|50150868|FG000|Overall Study|Did not meet eligibility criteria|1|||
25047821|NCT03034135|50150872|FG000|Overall Study|Withdrawal by Subject|2|||
25047822|NCT01671280|50150876|FG000|Overall Study|Withdrawal by Subject|2|||
25047823|NCT01405963|50150882|FG000|Overall Study|Moved Away|2|||
25047824|NCT01405963|50150883|FG001|Overall Study|Moved Away|0|||
25047825|NCT01405963|50150882|FG000|Overall Study|Adverse Event|0|||
25186549|NCT01391819|50337064|FG000|Overall Study|Withdrawal by Subject|56|||
25047826|NCT01405963|50150883|FG001|Overall Study|Adverse Event|1|||
25047827|NCT01405963|50150882|FG000|Overall Study|Lost to Follow-up|0|||
25047828|NCT01405963|50150883|FG001|Overall Study|Lost to Follow-up|1|||
25047829|NCT02846415|50150892|FG000|Overall Study|Lost to Follow-up|2|||
25047830|NCT02846415|50150893|FG001|Overall Study|Lost to Follow-up|0|||
25047831|NCT02846415|50150892|FG000|Overall Study|Withdrawal by Subject|1|||
25047832|NCT02846415|50150893|FG001|Overall Study|Withdrawal by Subject|1|||
25047833|NCT02628418|50150912|FG000|Overall Study|Lost to Follow-up|1|||
25047834|NCT02628418|50150913|FG001|Overall Study|Lost to Follow-up|2|||
25047835|NCT02752776|50150941|FG000|Overall Study|Adverse Event|15|||
25047836|NCT02752776|50150942|FG001|Overall Study|Adverse Event|23|||
25047837|NCT02752776|50150943|FG002|Overall Study|Adverse Event|11|||
25047838|NCT02752776|50150941|FG000|Overall Study|Lack of Efficacy|2|||
25047839|NCT02752776|50150942|FG001|Overall Study|Lack of Efficacy|6|||
25047840|NCT02752776|50150943|FG002|Overall Study|Lack of Efficacy|14|||
25047841|NCT02752776|50150941|FG000|Overall Study|Lost to Follow-up|11|||
25047842|NCT02752776|50150942|FG001|Overall Study|Lost to Follow-up|12|||
25047843|NCT02752776|50150943|FG002|Overall Study|Lost to Follow-up|4|||
25047844|NCT02752776|50150941|FG000|Overall Study|Non-compliance with study treatment|0|||
25047845|NCT02752776|50150942|FG001|Overall Study|Non-compliance with study treatment|0|||
25047846|NCT02752776|50150943|FG002|Overall Study|Non-compliance with study treatment|1|||
25047847|NCT02752776|50150941|FG000|Overall Study|Physician Decision|2|||
25047848|NCT02752776|50150942|FG001|Overall Study|Physician Decision|6|||
25047849|NCT02752776|50150943|FG002|Overall Study|Physician Decision|2|||
25047850|NCT02752776|50150941|FG000|Overall Study|Pregnancy|1|||
25047851|NCT02752776|50150942|FG001|Overall Study|Pregnancy|6|||
25047852|NCT02752776|50150943|FG002|Overall Study|Pregnancy|3|||
25047853|NCT02752776|50150941|FG000|Overall Study|Protocol Violation|10|||
25047854|NCT02752776|50150942|FG001|Overall Study|Protocol Violation|13|||
25047855|NCT02752776|50150943|FG002|Overall Study|Protocol Violation|6|||
25047856|NCT02752776|50150941|FG000|Overall Study|Subject/guardian decision|8|||
25047857|NCT02752776|50150942|FG001|Overall Study|Subject/guardian decision|6|||
25047858|NCT02752776|50150943|FG002|Overall Study|Subject/guardian decision|4|||
25047859|NCT02752776|50150941|FG000|Overall Study|Death|0|||
25047860|NCT02752776|50150942|FG001|Overall Study|Death|0|||
25047861|NCT02752776|50150943|FG002|Overall Study|Death|1|||
25047862|NCT02752776|50150941|FG000|Overall Study|Withdrawal by Subject|3|||
25047863|NCT02752776|50150942|FG001|Overall Study|Withdrawal by Subject|4|||
25047864|NCT02752776|50150943|FG002|Overall Study|Withdrawal by Subject|2|||
24959181|NCT00310388|50049777|FG000|Primary Reporting Phase|Failed to return|8|||
24959182|NCT00310388|50049778|FG001|Primary Reporting Phase|Failed to return|0|||
24959183|NCT00310388|50049777|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
24959184|NCT00310388|50049778|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
24959185|NCT00310388|50049777|FG000|Primary Reporting Phase|Participant request|2|||
24959186|NCT00310388|50049778|FG001|Primary Reporting Phase|Participant request|0|||
24959187|NCT00310388|50049777|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
24959188|NCT00310388|50049778|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
24959189|NCT00310388|50049777|FG000|Primary Reporting Phase|Discontinuation of study|1|||
24959190|NCT00310388|50049778|FG001|Primary Reporting Phase|Discontinuation of study|0|||
24959191|NCT00310388|50049777|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
24959192|NCT00310388|50049778|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
24959193|NCT00310388|50049777|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
24959194|NCT00310388|50049778|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
24959195|NCT00310388|50049777|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
24959196|NCT00310388|50049778|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
24959197|NCT00310388|50049777|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
24959198|NCT00310388|50049778|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
24959199|NCT00310388|50049777|FG000|Primary Reporting Phase|Participant passed away|1|||
24959200|NCT00310388|50049778|FG001|Primary Reporting Phase|Participant passed away|0|||
24959201|NCT00310388|50049777|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
25047865|NCT01342965|50150955|FG000|Overall Study|Death|58|||
25047866|NCT01342965|50150956|FG001|Overall Study|Death|57|||
25047867|NCT01342965|50150955|FG000|Overall Study|Lost to Follow-up|5|||
25047868|NCT01342965|50150956|FG001|Overall Study|Lost to Follow-up|3|||
25047869|NCT01342965|50150955|FG000|Overall Study|Other Reasons- Unspecified|44|||
25047870|NCT01342965|50150956|FG001|Overall Study|Other Reasons- Unspecified|38|||
25047871|NCT01342965|50150955|FG000|Overall Study|Withdrawal by Subject|2|||
25047872|NCT01342965|50150956|FG001|Overall Study|Withdrawal by Subject|9|||
24959202|NCT00310388|50049778|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
24959203|NCT00310388|50049777|FG000|Primary Reporting Phase|Missing|1|||
25047873|NCT02629822|50150962|FG000|Base Study|Lost to Follow-up|2|||
25047874|NCT02629822|50150962|FG000|Base Study|Non-Compliance With Study Drug|1|||
25047875|NCT02629822|50150962|FG000|Extension Study|Adverse Event|1|||
25047876|NCT02629822|50150962|FG000|Extension Study|Lost to Follow-up|1|||
25047877|NCT02840721|50150967|FG000|Treatment Period|Adverse Event|1|||
25047878|NCT02840721|50150967|FG000|Follow-Up|Lack of Efficacy|1|||
25047879|NCT02840721|50150967|FG000|Follow-Up|Withdrawal by Subject|4|||
25047880|NCT02840721|50150967|FG000|Follow-Up|Withdrawal of Consent|2|||
25047881|NCT03462706|50150975|FG000|Overall Study|Polyp was pedunculated|1|||
25047882|NCT03462706|50150976|FG001|Overall Study|Polyp was pedunculated|0|||
25047883|NCT03462706|50150977|FG002|Overall Study|Polyp was pedunculated|1|||
25047884|NCT03462706|50150978|FG003|Overall Study|Polyp was pedunculated|0|||
25047885|NCT03462706|50150975|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
25047886|NCT03462706|50150976|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
25047887|NCT03462706|50150977|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
25047888|NCT03462706|50150978|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
25047889|NCT02840253|50150988|FG000|Overall Study|Unsuccessful block|4|||
24959204|NCT00310388|50049778|FG001|Primary Reporting Phase|Missing|0|||
25047890|NCT02752074|50150994|FG000|Overall Study|Lost to Follow-up|1|||
25047891|NCT02752074|50150995|FG001|Overall Study|Lost to Follow-up|4|||
25047892|NCT02752074|50150994|FG000|Overall Study|Death|146|||
25047893|NCT02752074|50150995|FG001|Overall Study|Death|129|||
25047894|NCT02752074|50150994|FG000|Overall Study|Withdrawal by Subject|9|||
25047895|NCT02752074|50150995|FG001|Overall Study|Withdrawal by Subject|10|||
24959205|NCT00310388|50049777|FG000|Primary Reporting Phase|Other|1|||
24959206|NCT00310388|50049778|FG001|Primary Reporting Phase|Other|0|||
24959207|NCT00310388|50049777|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
24959208|NCT00310388|50049778|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
24959209|NCT00310388|50049777|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
24959210|NCT00310388|50049778|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
24959211|NCT00310388|50049777|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
24959212|NCT00310388|50049778|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
25047896|NCT02835495|50151003|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
24959213|NCT00310388|50049777|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
24959214|NCT00310388|50049778|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
24959215|NCT00500357|50049783|FG000|Overall Study|Death|1|||
24959216|NCT00309842|50049798|FG000|Overall Study|Lost to Follow-up|1|||
24959217|NCT00325754|50049804|FG000|Overall Study|Adverse Event|4|||
24959218|NCT00325754|50049805|FG001|Overall Study|Adverse Event|1|||
24959219|NCT00499889|50049811|FG000|Overall Study|Infection prior to treatment|1|||
24959220|NCT00309608|50049820|FG000|Overall Study|Adverse Event|1|||
24959221|NCT00309608|50049821|FG001|Overall Study|Adverse Event|5|||
24959222|NCT00309608|50049822|FG002|Overall Study|Adverse Event|3|||
24959223|NCT00309608|50049823|FG003|Overall Study|Adverse Event|2|||
24959224|NCT00309608|50049824|FG004|Overall Study|Adverse Event|3|||
24959225|NCT00309608|50049820|FG000|Overall Study|Protocol Violation|2|||
24959226|NCT00309608|50049821|FG001|Overall Study|Protocol Violation|0|||
24959227|NCT00309608|50049822|FG002|Overall Study|Protocol Violation|0|||
24959228|NCT00309608|50049823|FG003|Overall Study|Protocol Violation|0|||
24959229|NCT00309608|50049824|FG004|Overall Study|Protocol Violation|0|||
24959230|NCT00309608|50049820|FG000|Overall Study|Lost to Follow-up|0|||
24959231|NCT00309608|50049821|FG001|Overall Study|Lost to Follow-up|0|||
24959232|NCT00309608|50049822|FG002|Overall Study|Lost to Follow-up|2|||
24959233|NCT00309608|50049823|FG003|Overall Study|Lost to Follow-up|0|||
24959234|NCT00309608|50049824|FG004|Overall Study|Lost to Follow-up|1|||
24959235|NCT00309608|50049820|FG000|Overall Study|Withdrawal by Subject|1|||
24959236|NCT00309608|50049821|FG001|Overall Study|Withdrawal by Subject|4|||
24959237|NCT00309608|50049822|FG002|Overall Study|Withdrawal by Subject|2|||
24959238|NCT00309608|50049823|FG003|Overall Study|Withdrawal by Subject|0|||
24959239|NCT00309608|50049824|FG004|Overall Study|Withdrawal by Subject|0|||
24959240|NCT00309608|50049820|FG000|Overall Study|Other incl. Lack of efficacy|10|||
24959241|NCT00309608|50049821|FG001|Overall Study|Other incl. Lack of efficacy|4|||
24959242|NCT00309608|50049822|FG002|Overall Study|Other incl. Lack of efficacy|3|||
24959243|NCT00309608|50049823|FG003|Overall Study|Other incl. Lack of efficacy|4|||
24959244|NCT00309608|50049824|FG004|Overall Study|Other incl. Lack of efficacy|0|||
24959245|NCT00309452|50049838|FG000|Overall Study|Withdrawal by Subject|3|||
25047897|NCT02835495|50151004|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
25047898|NCT02835495|50151003|FG000|Overall Study|Declined in-person follow-up visit|4|||
25047899|NCT02835495|50151004|FG001|Overall Study|Declined in-person follow-up visit|2|||
25047900|NCT02835339|50151014|FG000|Overall Study|Did not receive allocated intervention|13|||
25162486|NCT01791517|50284759|FG010|Phase I: Period 3|Lost to Follow-up|0|||
24959246|NCT00309452|50049839|FG001|Overall Study|Withdrawal by Subject|0|||
24959247|NCT00308750|50049848|FG000|Overall Study|Adverse Event|9|||
24959248|NCT00308750|50049849|FG001|Overall Study|Adverse Event|9|||
24959249|NCT00308750|50049850|FG002|Overall Study|Adverse Event|13|||
25047901|NCT02835339|50151015|FG001|Overall Study|Did not receive allocated intervention|16|||
25047902|NCT02832063|50151023|FG000|Overall Study|Adverse Event|2|||
25162487|NCT01791517|50284760|FG011|Phase I: Period 3|Lost to Follow-up|0|||
24959250|NCT00308750|50049848|FG000|Overall Study|Withdrawal by Subject|6|||
24959251|NCT00308750|50049849|FG001|Overall Study|Withdrawal by Subject|2|||
25047903|NCT02832063|50151024|FG001|Overall Study|Adverse Event|1|||
25047904|NCT02832063|50151023|FG000|Overall Study|Physician Decision|5|||
25047905|NCT02832063|50151024|FG001|Overall Study|Physician Decision|7|||
25047906|NCT02832063|50151023|FG000|Overall Study|Lost to Follow-up|15|||
25047907|NCT02832063|50151024|FG001|Overall Study|Lost to Follow-up|8|||
25047908|NCT02832063|50151023|FG000|Overall Study|Withdrawal by Subject|10|||
25047909|NCT02832063|50151024|FG001|Overall Study|Withdrawal by Subject|21|||
25047910|NCT02832063|50151023|FG000|Overall Study|Other|2|||
25047911|NCT02832063|50151024|FG001|Overall Study|Other|1|||
25047912|NCT03125902|50151043|FG000|Overall Study|Death|52|||
25047913|NCT03125902|50151044|FG001|Overall Study|Death|123|||
25047914|NCT03125902|50151043|FG000|Overall Study|Lost to Follow-up|1|||
25047915|NCT03125902|50151044|FG001|Overall Study|Lost to Follow-up|0|||
25047916|NCT03125902|50151043|FG000|Overall Study|Mastectomy|0|||
25047917|NCT03125902|50151044|FG001|Overall Study|Mastectomy|1|||
25047918|NCT03125902|50151043|FG000|Overall Study|Physician Decision|1|||
25047919|NCT03125902|50151044|FG001|Overall Study|Physician Decision|0|||
25047920|NCT03125902|50151043|FG000|Overall Study|Withdrawal by Subject|13|||
25047921|NCT03125902|50151044|FG001|Overall Study|Withdrawal by Subject|25|||
25047922|NCT03125902|50151043|FG000|Overall Study|Study is ongoing|153|||
25047923|NCT03125902|50151044|FG001|Overall Study|Study is ongoing|282|||
25047924|NCT04412707|50151053|FG000|Cycle 1|Death|0|||
25047925|NCT04412707|50151054|FG001|Cycle 1|Death|3|||
25047926|NCT04412707|50151053|FG000|Cycle 1|Disease progression|1|||
25047927|NCT04412707|50151054|FG001|Cycle 1|Disease progression|2|||
25047928|NCT04412707|50151053|FG000|Cycle 2|Death|0|||
25047929|NCT04412707|50151054|FG001|Cycle 2|Death|1|||
25047930|NCT04412707|50151053|FG000|Cycle 2|Disease progression|3|||
25047931|NCT04412707|50151054|FG001|Cycle 2|Disease progression|0|||
25047932|NCT04412707|50151053|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
25047933|NCT04412707|50151054|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
25047934|NCT04412707|50151053|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
25047935|NCT04412707|50151054|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
25047936|NCT04412707|50151053|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
24959252|NCT00308750|50049850|FG002|Overall Study|Withdrawal by Subject|3|||
24959253|NCT00308750|50049848|FG000|Overall Study|Physician Decision|3|||
24959254|NCT00308750|50049849|FG001|Overall Study|Physician Decision|4|||
24959255|NCT00308750|50049850|FG002|Overall Study|Physician Decision|3|||
24959256|NCT00308750|50049848|FG000|Overall Study|Sponsor Decision|1|||
24959257|NCT00308750|50049849|FG001|Overall Study|Sponsor Decision|0|||
24959258|NCT00308750|50049850|FG002|Overall Study|Sponsor Decision|0|||
24959259|NCT00308750|50049848|FG000|Overall Study|Disease Progression|47|||
24959260|NCT00308750|50049849|FG001|Overall Study|Disease Progression|24|||
24959261|NCT00308750|50049850|FG002|Overall Study|Disease Progression|28|||
24959262|NCT00308750|50049848|FG000|Overall Study|Unrelated Complication|3|||
24959263|NCT00308750|50049849|FG001|Overall Study|Unrelated Complication|0|||
24959264|NCT00308750|50049850|FG002|Overall Study|Unrelated Complication|1|||
24959265|NCT00308750|50049848|FG000|Overall Study|Death|1|||
24959266|NCT00308750|50049849|FG001|Overall Study|Death|0|||
24959267|NCT00308750|50049850|FG002|Overall Study|Death|1|||
24959268|NCT00308750|50049848|FG000|Overall Study|Protocol Violation|1|||
24959269|NCT00308750|50049849|FG001|Overall Study|Protocol Violation|0|||
24959270|NCT00308750|50049850|FG002|Overall Study|Protocol Violation|0|||
24959271|NCT00308750|50049848|FG000|Overall Study|New Primary Disease Identified|1|||
24959272|NCT00308750|50049849|FG001|Overall Study|New Primary Disease Identified|1|||
24959273|NCT00308750|50049850|FG002|Overall Study|New Primary Disease Identified|0|||
24959274|NCT00489359|50049861|FG000|Overall Study|Death|0|||
24959275|NCT00489359|50049862|FG001|Overall Study|Death|2|||
24959276|NCT00489359|50049861|FG000|Overall Study|Progressive Disease|5|||
24959277|NCT00489359|50049862|FG001|Overall Study|Progressive Disease|6|||
24959278|NCT00489359|50049861|FG000|Overall Study|Lost to Follow-up|1|||
24959279|NCT00489359|50049862|FG001|Overall Study|Lost to Follow-up|0|||
24959280|NCT00489359|50049861|FG000|Overall Study|Withdrawal by Subject|1|||
24959281|NCT00489359|50049862|FG001|Overall Study|Withdrawal by Subject|5|||
24959282|NCT00489359|50049861|FG000|Overall Study|Adverse Event|0|||
25047937|NCT04412707|50151054|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
25047938|NCT04412707|50151053|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
25047939|NCT04412707|50151054|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
25047940|NCT01358721|50151073|FG000|Overall Study|Withdrawal by Subject|0|||
25047941|NCT01358721|50151074|FG001|Overall Study|Withdrawal by Subject|0|||
24959283|NCT00489359|50049862|FG001|Overall Study|Adverse Event|16|||
24959284|NCT00481247|50049875|FG000|Overall Study|Death|0|||
24959285|NCT00481247|50049876|FG001|Overall Study|Death|1|||
24959286|NCT00481247|50049875|FG000|Overall Study|Disease progression|18|||
24959287|NCT00481247|50049876|FG001|Overall Study|Disease progression|22|||
24959288|NCT00481247|50049875|FG000|Overall Study|Intolerance|42|||
24959289|NCT00481247|50049876|FG001|Overall Study|Intolerance|17|||
24959290|NCT00481247|50049875|FG000|Overall Study|Treatment failure|10|||
25047942|NCT01358721|50151075|FG002|Overall Study|Withdrawal by Subject|0|||
25047943|NCT01358721|50151076|FG003|Overall Study|Withdrawal by Subject|1|||
25047944|NCT01358721|50151073|FG000|Overall Study|Death|0|||
25047945|NCT01358721|50151074|FG001|Overall Study|Death|2|||
25047946|NCT01358721|50151075|FG002|Overall Study|Death|0|||
25047947|NCT01358721|50151076|FG003|Overall Study|Death|0|||
25047948|NCT01358721|50151073|FG000|Overall Study|Study Drug Toxicity|1|||
25047949|NCT01358721|50151074|FG001|Overall Study|Study Drug Toxicity|3|||
25047950|NCT01358721|50151075|FG002|Overall Study|Study Drug Toxicity|4|||
25047951|NCT01358721|50151076|FG003|Overall Study|Study Drug Toxicity|5|||
25047952|NCT01358721|50151073|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
25047953|NCT01358721|50151074|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
25047954|NCT01358721|50151075|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
25047955|NCT01358721|50151076|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
25047956|NCT01358721|50151073|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
25047957|NCT01358721|50151074|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
25047958|NCT01358721|50151075|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
25047959|NCT01358721|50151076|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
25047960|NCT01358721|50151073|FG000|Overall Study|Adverse Event related to study drug|1|||
25047961|NCT01358721|50151074|FG001|Overall Study|Adverse Event related to study drug|0|||
25047962|NCT01358721|50151075|FG002|Overall Study|Adverse Event related to study drug|0|||
25047963|NCT01358721|50151076|FG003|Overall Study|Adverse Event related to study drug|1|||
25047964|NCT01358721|50151073|FG000|Overall Study|Disease Progression|19|||
25047965|NCT01358721|50151074|FG001|Overall Study|Disease Progression|15|||
25047966|NCT01358721|50151075|FG002|Overall Study|Disease Progression|17|||
25047967|NCT01358721|50151076|FG003|Overall Study|Disease Progression|15|||
25047968|NCT01358721|50151073|FG000|Overall Study|Out of State/Unmet Criteria|0|||
25047969|NCT01358721|50151074|FG001|Overall Study|Out of State/Unmet Criteria|0|||
25047970|NCT01358721|50151075|FG002|Overall Study|Out of State/Unmet Criteria|1|||
25047971|NCT01358721|50151076|FG003|Overall Study|Out of State/Unmet Criteria|0|||
25047972|NCT01341639|50151088|FG000|Infant Series|Protocol Violation|1|||
25047973|NCT01341639|50151089|FG001|Infant Series|Protocol Violation|0|||
25047974|NCT01341639|50151088|FG000|Infant Series|Not Vaccinated|0|||
25047975|NCT01341639|50151089|FG001|Infant Series|Not Vaccinated|1|||
25047976|NCT01341639|50151088|FG000|Infant Series|Adverse Event|0|||
25047977|NCT01341639|50151089|FG001|Infant Series|Adverse Event|5|||
25047978|NCT01341639|50151088|FG000|Infant Series|Withdrawal by Subject|11|||
25047979|NCT01341639|50151089|FG001|Infant Series|Withdrawal by Subject|8|||
25047980|NCT01341639|50151088|FG000|Infant Series|Lost to Follow-up|0|||
25047981|NCT01341639|50151089|FG001|Infant Series|Lost to Follow-up|2|||
25047982|NCT01341639|50151088|FG000|Infant Series|Site 0048 Participants|17|||
25047983|NCT01341639|50151089|FG001|Infant Series|Site 0048 Participants|16|||
25047984|NCT01341639|50151088|FG000|Interim Period|Withdrawal by Subject|6|||
25047985|NCT01341639|50151089|FG001|Interim Period|Withdrawal by Subject|7|||
25047986|NCT01341639|50151088|FG000|Interim Period|Lost to Follow-up|2|||
25047987|NCT01341639|50151089|FG001|Interim Period|Lost to Follow-up|0|||
25047988|NCT01341639|50151088|FG000|Interim Period|Physician Decision|0|||
25047989|NCT01341639|50151089|FG001|Interim Period|Physician Decision|1|||
25047990|NCT01341639|50151088|FG000|Interim Period|Protocol Violation|0|||
25047991|NCT01341639|50151089|FG001|Interim Period|Protocol Violation|1|||
25047992|NCT01341639|50151088|FG000|Post-Treatment|Withdrawal by Subject|0|||
25047993|NCT01341639|50151089|FG001|Post-Treatment|Withdrawal by Subject|1|||
25047994|NCT01341639|50151088|FG000|Post-Treatment|Adverse Event|0|||
25047995|NCT01341639|50151089|FG001|Post-Treatment|Adverse Event|2|||
25047996|NCT02628028|50151103|FG000|Dosing Period|Withdrawal by Subject|0|||
25047997|NCT02628028|50151104|FG001|Dosing Period|Withdrawal by Subject|0|||
25047998|NCT02628028|50151105|FG002|Dosing Period|Withdrawal by Subject|1|||
25047999|NCT02628028|50151106|FG003|Dosing Period|Withdrawal by Subject|0|||
25048000|NCT02628028|50151107|FG004|Dosing Period|Withdrawal by Subject|2|||
25048001|NCT02628028|50151108|FG005|Dosing Period|Withdrawal by Subject|4|||
25048002|NCT02628028|50151109|FG006|Dosing Period|Withdrawal by Subject|1|||
25048003|NCT02628028|50151110|FG007|Dosing Period|Withdrawal by Subject|1|||
25048004|NCT02628028|50151103|FG000|Dosing Period|Adverse Event|0|||
25048005|NCT02628028|50151104|FG001|Dosing Period|Adverse Event|0|||
25048006|NCT02628028|50151105|FG002|Dosing Period|Adverse Event|0|||
25048007|NCT02628028|50151106|FG003|Dosing Period|Adverse Event|0|||
25048008|NCT02628028|50151107|FG004|Dosing Period|Adverse Event|2|||
25048009|NCT02628028|50151108|FG005|Dosing Period|Adverse Event|1|||
25048010|NCT02628028|50151109|FG006|Dosing Period|Adverse Event|3|||
25048011|NCT02628028|50151110|FG007|Dosing Period|Adverse Event|2|||
25048012|NCT02628028|50151103|FG000|Dosing Period|Death|0|||
25048013|NCT02628028|50151104|FG001|Dosing Period|Death|0|||
25048014|NCT02628028|50151105|FG002|Dosing Period|Death|0|||
25048015|NCT02628028|50151106|FG003|Dosing Period|Death|0|||
25162488|NCT01791517|50284749|FG000|Phase I: Period 3|Adverse Event|0|||
25048016|NCT02628028|50151107|FG004|Dosing Period|Death|0|||
25048017|NCT02628028|50151108|FG005|Dosing Period|Death|0|||
25048018|NCT02628028|50151109|FG006|Dosing Period|Death|0|||
25048019|NCT02628028|50151110|FG007|Dosing Period|Death|1|||
25048020|NCT02628028|50151103|FG000|Dosing Period|Lack of Efficacy|0|||
25048021|NCT02628028|50151104|FG001|Dosing Period|Lack of Efficacy|0|||
25048022|NCT02628028|50151105|FG002|Dosing Period|Lack of Efficacy|0|||
25048023|NCT02628028|50151106|FG003|Dosing Period|Lack of Efficacy|0|||
25048024|NCT02628028|50151107|FG004|Dosing Period|Lack of Efficacy|3|||
25048025|NCT02628028|50151108|FG005|Dosing Period|Lack of Efficacy|0|||
25048026|NCT02628028|50151109|FG006|Dosing Period|Lack of Efficacy|1|||
25048027|NCT02628028|50151110|FG007|Dosing Period|Lack of Efficacy|0|||
25048028|NCT02628028|50151103|FG000|Dosing Period|Study Terminated by Sponsor|0|||
25048029|NCT02628028|50151104|FG001|Dosing Period|Study Terminated by Sponsor|0|||
25048030|NCT02628028|50151105|FG002|Dosing Period|Study Terminated by Sponsor|0|||
25048031|NCT02628028|50151106|FG003|Dosing Period|Study Terminated by Sponsor|0|||
25048032|NCT02628028|50151107|FG004|Dosing Period|Study Terminated by Sponsor|7|||
25048033|NCT02628028|50151108|FG005|Dosing Period|Study Terminated by Sponsor|6|||
25048034|NCT02628028|50151109|FG006|Dosing Period|Study Terminated by Sponsor|7|||
25048035|NCT02628028|50151110|FG007|Dosing Period|Study Terminated by Sponsor|7|||
25048036|NCT02628028|50151103|FG000|Dosing Period|Physician Decision|0|||
25048037|NCT02628028|50151104|FG001|Dosing Period|Physician Decision|0|||
25048038|NCT02628028|50151105|FG002|Dosing Period|Physician Decision|0|||
25048039|NCT02628028|50151106|FG003|Dosing Period|Physician Decision|0|||
25048040|NCT02628028|50151107|FG004|Dosing Period|Physician Decision|0|||
25048041|NCT02628028|50151108|FG005|Dosing Period|Physician Decision|1|||
25048042|NCT02628028|50151109|FG006|Dosing Period|Physician Decision|0|||
25048043|NCT02628028|50151110|FG007|Dosing Period|Physician Decision|0|||
25048044|NCT02628028|50151103|FG000|Dosing Period|Site Terminated by Sponsor|0|||
25048045|NCT02628028|50151104|FG001|Dosing Period|Site Terminated by Sponsor|0|||
25048046|NCT02628028|50151105|FG002|Dosing Period|Site Terminated by Sponsor|0|||
25048047|NCT02628028|50151106|FG003|Dosing Period|Site Terminated by Sponsor|0|||
25048048|NCT02628028|50151107|FG004|Dosing Period|Site Terminated by Sponsor|0|||
25048049|NCT02628028|50151108|FG005|Dosing Period|Site Terminated by Sponsor|1|||
25048050|NCT02628028|50151109|FG006|Dosing Period|Site Terminated by Sponsor|1|||
25048051|NCT02628028|50151110|FG007|Dosing Period|Site Terminated by Sponsor|0|||
25048052|NCT02628028|50151103|FG000|Dosing Period|Lost to Follow-up|0|||
25048053|NCT02628028|50151104|FG001|Dosing Period|Lost to Follow-up|0|||
25048054|NCT02628028|50151105|FG002|Dosing Period|Lost to Follow-up|0|||
25048055|NCT02628028|50151106|FG003|Dosing Period|Lost to Follow-up|0|||
25048056|NCT02628028|50151107|FG004|Dosing Period|Lost to Follow-up|0|||
25048057|NCT02628028|50151108|FG005|Dosing Period|Lost to Follow-up|0|||
25048058|NCT02628028|50151109|FG006|Dosing Period|Lost to Follow-up|1|||
24959291|NCT00481247|50049876|FG001|Overall Study|Treatment failure|14|||
24959292|NCT00481247|50049875|FG000|Overall Study|AE unrelated to study drug|13|||
25048059|NCT02628028|50151110|FG007|Dosing Period|Lost to Follow-up|0|||
25048060|NCT02628028|50151103|FG000|Dosing Period|Other|0|||
25048061|NCT02628028|50151104|FG001|Dosing Period|Other|0|||
25048062|NCT02628028|50151105|FG002|Dosing Period|Other|0|||
25048063|NCT02628028|50151106|FG003|Dosing Period|Other|0|||
25048064|NCT02628028|50151107|FG004|Dosing Period|Other|2|||
25048065|NCT02628028|50151108|FG005|Dosing Period|Other|1|||
25048066|NCT02628028|50151109|FG006|Dosing Period|Other|2|||
25048067|NCT02628028|50151110|FG007|Dosing Period|Other|4|||
25048068|NCT02628028|50151103|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
25048069|NCT02628028|50151104|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
25048070|NCT02628028|50151105|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
25048071|NCT02628028|50151106|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
25048072|NCT02628028|50151107|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
25276430|NCT00958360|50590368|FG001|Overall Study|Lost to Follow-up|1|||
24959293|NCT00481247|50049876|FG001|Overall Study|AE unrelated to study drug|4|||
24959294|NCT00481247|50049875|FG000|Overall Study|Withdrawal by Subject|8|||
24959295|NCT00481247|50049876|FG001|Overall Study|Withdrawal by Subject|13|||
24959296|NCT00481247|50049875|FG000|Overall Study|Pregnancy|2|||
24959297|NCT00481247|50049876|FG001|Overall Study|Pregnancy|1|||
24959298|NCT00481247|50049875|FG000|Overall Study|Lost to Follow-up|1|||
24959299|NCT00481247|50049876|FG001|Overall Study|Lost to Follow-up|2|||
24959300|NCT00481247|50049875|FG000|Overall Study|Poor compliance/noncompliance|1|||
24959301|NCT00481247|50049876|FG001|Overall Study|Poor compliance/noncompliance|7|||
24959302|NCT00481247|50049875|FG000|Overall Study|Administrative reason by sponsor|157|||
24959303|NCT00481247|50049876|FG001|Overall Study|Administrative reason by sponsor|162|||
24959304|NCT00481247|50049875|FG000|Overall Study|Varied|6|||
24959305|NCT00481247|50049876|FG001|Overall Study|Varied|15|||
24959306|NCT00481247|50049875|FG000|Overall Study|Did not receive treatment|1|||
25048073|NCT02628028|50151108|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
25048074|NCT02628028|50151109|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
25048075|NCT02628028|50151110|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
25048076|NCT02628028|50151103|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
25048077|NCT02628028|50151104|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
25048078|NCT02628028|50151105|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
25048079|NCT02628028|50151106|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
25048080|NCT02628028|50151107|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
25048081|NCT02628028|50151108|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
24959307|NCT00481247|50049876|FG001|Overall Study|Did not receive treatment|2|||
24959308|NCT00480857|50049882|FG000|Overall Study|Lack of Efficacy|2|||
24959309|NCT00480779|50049888|FG000|Overall Study|Other|2|||
24959310|NCT00480779|50049889|FG001|Overall Study|Other|0|||
24959311|NCT00480779|50049888|FG000|Overall Study|Job and Health-related|0|||
24959312|NCT00480779|50049889|FG001|Overall Study|Job and Health-related|3|||
24959313|NCT00499031|50049895|FG000|Overall Study|Improper pre-protocol treatment|1|||
24959314|NCT00499031|50049895|FG000|Overall Study|Required test not done|1|||
24959315|NCT00499031|50049895|FG000|Overall Study|Never treated|1|||
24959316|NCT00498797|50049901|FG000|Overall Study|Withdrawal by Subject|4|||
24959317|NCT00498797|50049902|FG001|Overall Study|Withdrawal by Subject|2|||
24959318|NCT00498797|50049901|FG000|Overall Study|Adverse Event|12|||
24959319|NCT00498797|50049902|FG001|Overall Study|Adverse Event|5|||
24959320|NCT00498797|50049901|FG000|Overall Study|Condition under investigation worsened|19|||
25048082|NCT02628028|50151109|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
25048083|NCT02628028|50151110|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
25048084|NCT02628028|50151103|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
25048085|NCT02628028|50151104|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
25048086|NCT02628028|50151105|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
25048087|NCT02628028|50151106|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
25048088|NCT02628028|50151107|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
25048089|NCT02628028|50151108|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
25048090|NCT02628028|50151109|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
25048091|NCT02628028|50151110|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
25048092|NCT02628028|50151103|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
25048093|NCT02628028|50151104|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
25048094|NCT02628028|50151105|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
25048095|NCT02628028|50151106|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
25048096|NCT02628028|50151107|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
25048097|NCT02628028|50151108|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
25048098|NCT02628028|50151109|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
25048099|NCT02628028|50151110|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
25048100|NCT02628028|50151103|FG000|Long-term Extension (LTE) Period|Other|0|||
25048101|NCT02628028|50151104|FG001|Long-term Extension (LTE) Period|Other|0|||
25048102|NCT02628028|50151105|FG002|Long-term Extension (LTE) Period|Other|0|||
25048103|NCT02628028|50151106|FG003|Long-term Extension (LTE) Period|Other|0|||
25048104|NCT02628028|50151107|FG004|Long-term Extension (LTE) Period|Other|0|||
25048105|NCT02628028|50151108|FG005|Long-term Extension (LTE) Period|Other|3|||
25048106|NCT02628028|50151109|FG006|Long-term Extension (LTE) Period|Other|4|||
25048107|NCT02628028|50151110|FG007|Long-term Extension (LTE) Period|Other|3|||
25048108|NCT03977701|50151142|FG000|Overall Study|COVID-19 pandemic|0|||
25048109|NCT03977701|50151143|FG001|Overall Study|COVID-19 pandemic|0|||
25048110|NCT03977701|50151144|FG002|Overall Study|COVID-19 pandemic|0|||
25048111|NCT03977701|50151145|FG003|Overall Study|COVID-19 pandemic|0|||
25048112|NCT03977701|50151146|FG004|Overall Study|COVID-19 pandemic|0|||
25048113|NCT03977701|50151147|FG005|Overall Study|COVID-19 pandemic|1|||
25048114|NCT03977701|50151148|FG006|Overall Study|COVID-19 pandemic|0|||
25048115|NCT03977701|50151149|FG007|Overall Study|COVID-19 pandemic|1|||
25048116|NCT03977701|50151150|FG008|Overall Study|COVID-19 pandemic|0|||
25048117|NCT03977701|50151151|FG009|Overall Study|COVID-19 pandemic|0|||
25048118|NCT02814526|50151190|FG000|Overall Study|Adverse Event|4|||
25048119|NCT02814526|50151191|FG001|Overall Study|Adverse Event|3|||
25048120|NCT02814526|50151190|FG000|Overall Study|Death|1|||
25048121|NCT02814526|50151191|FG001|Overall Study|Death|1|||
25048122|NCT02814526|50151190|FG000|Overall Study|Lost to Follow-up|3|||
25048123|NCT02814526|50151191|FG001|Overall Study|Lost to Follow-up|4|||
25048124|NCT02814526|50151190|FG000|Overall Study|non site physician decision|1|||
25048125|NCT02814526|50151191|FG001|Overall Study|non site physician decision|0|||
25048126|NCT02814526|50151190|FG000|Overall Study|participant noncompliance|1|||
25048127|NCT02814526|50151191|FG001|Overall Study|participant noncompliance|1|||
25048128|NCT02814526|50151190|FG000|Overall Study|Withdrawal by Subject|20|||
25048129|NCT02814526|50151191|FG001|Overall Study|Withdrawal by Subject|14|||
25048130|NCT02814526|50151190|FG000|Overall Study|safety risk|2|||
25048131|NCT02814526|50151191|FG001|Overall Study|safety risk|1|||
25048132|NCT02814526|50151190|FG000|Overall Study|early termination-study terminated|1|||
24959321|NCT00498797|50049902|FG001|Overall Study|Condition under investigation worsened|21|||
25048133|NCT02814526|50151191|FG001|Overall Study|early termination-study terminated|2|||
24959322|NCT00498797|50049901|FG000|Overall Study|Other|3|||
24959323|NCT00498797|50049902|FG001|Overall Study|Other|1|||
25048134|NCT02814526|50151190|FG000|Overall Study|Other|0|||
25048135|NCT02814526|50151191|FG001|Overall Study|Other|4|||
25048136|NCT02329834|50151199|FG000|Overall Study|Physician Decision|1|||
24959324|NCT00498485|50049910|FG000|Overall Study|Adverse Event|1|||
24959325|NCT00498485|50049911|FG001|Overall Study|Adverse Event|5|||
25048137|NCT02329834|50151200|FG001|Overall Study|Physician Decision|0|||
25048138|NCT01340937|50151211|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
25048139|NCT01340937|50151212|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
25048140|NCT01340937|50151213|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
25276431|NCT00888433|50590376|FG000|Overall Study|Withdrawal by Subject|1|||
25276432|NCT00888433|50590377|FG001|Overall Study|Withdrawal by Subject|2|||
25276433|NCT00888433|50590376|FG000|Overall Study|Missed Visit|2|||
25276434|NCT00888433|50590377|FG001|Overall Study|Missed Visit|1|||
25276435|NCT01243424|50590385|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
25276436|NCT01243424|50590386|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
25276437|NCT01243424|50590385|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
25276438|NCT01243424|50590386|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
25276439|NCT01243424|50590385|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
24959326|NCT00480077|50049921|FG000|Overall Study|Death|19|||
24959327|NCT00480077|50049922|FG001|Overall Study|Death|15|||
24959328|NCT00480077|50049921|FG000|Overall Study|early exit|12|||
25048141|NCT01340937|50151214|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
25048142|NCT01340937|50151211|FG000|Period 1: Infant Series|Adverse Event|0|||
25048143|NCT01340937|50151212|FG001|Period 1: Infant Series|Adverse Event|1|||
25048144|NCT01340937|50151213|FG002|Period 1: Infant Series|Adverse Event|4|||
24959329|NCT00480077|50049922|FG001|Overall Study|early exit|11|||
24959330|NCT00498173|50049930|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
24959331|NCT00498173|50049931|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
24959332|NCT00498173|50049932|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
24959333|NCT00295620|50049942|FG000|Overall Study|Lost to Follow-up|9|||
24959334|NCT00295620|50049943|FG001|Overall Study|Lost to Follow-up|5|||
24959335|NCT00295620|50049942|FG000|Overall Study|Withdrawal by Subject|37|||
25048145|NCT01340937|50151214|FG003|Period 1: Infant Series|Adverse Event|0|||
25048146|NCT01340937|50151211|FG000|Period 1: Infant Series|Death|2|||
25048147|NCT01340937|50151212|FG001|Period 1: Infant Series|Death|0|||
25048148|NCT01340937|50151213|FG002|Period 1: Infant Series|Death|2|||
25048149|NCT01340937|50151214|FG003|Period 1: Infant Series|Death|0|||
25048150|NCT01340937|50151211|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
25048151|NCT01340937|50151212|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
25048152|NCT01340937|50151213|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
25048153|NCT01340937|50151214|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
25048154|NCT01340937|50151211|FG000|Period 1: Infant Series|Physician Decision|2|||
25048155|NCT01340937|50151212|FG001|Period 1: Infant Series|Physician Decision|3|||
25048156|NCT01340937|50151213|FG002|Period 1: Infant Series|Physician Decision|1|||
25048157|NCT01340937|50151214|FG003|Period 1: Infant Series|Physician Decision|0|||
25048158|NCT01340937|50151211|FG000|Period 1: Infant Series|Protocol Violation|1|||
25048159|NCT01340937|50151212|FG001|Period 1: Infant Series|Protocol Violation|4|||
25048160|NCT01340937|50151213|FG002|Period 1: Infant Series|Protocol Violation|4|||
25048161|NCT01340937|50151214|FG003|Period 1: Infant Series|Protocol Violation|3|||
25048162|NCT01340937|50151211|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
25048163|NCT01340937|50151212|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
25048164|NCT01340937|50151213|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
24959336|NCT00295620|50049943|FG001|Overall Study|Withdrawal by Subject|50|||
24959337|NCT00295620|50049942|FG000|Overall Study|Death|206|||
24959338|NCT00295620|50049943|FG001|Overall Study|Death|207|||
24959339|NCT00295620|50049942|FG000|Overall Study|Other reasons|10|||
24959340|NCT00295620|50049943|FG001|Overall Study|Other reasons|9|||
24959341|NCT00295620|50049942|FG000|Overall Study|Discontinuation by sponsor|580|||
25048165|NCT01340937|50151214|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
25048166|NCT01340937|50151211|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
25048167|NCT01340937|50151212|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
25048168|NCT01340937|50151213|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
25048169|NCT01340937|50151214|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
25048170|NCT01340937|50151211|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
25048171|NCT01340937|50151212|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
25048172|NCT01340937|50151213|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
25048173|NCT01340937|50151214|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
25048174|NCT01340937|50151211|FG000|Period 2: Interim Period|Adverse Event|1|||
25048175|NCT01340937|50151212|FG001|Period 2: Interim Period|Adverse Event|0|||
25048176|NCT01340937|50151213|FG002|Period 2: Interim Period|Adverse Event|1|||
25048177|NCT01340937|50151214|FG003|Period 2: Interim Period|Adverse Event|0|||
25048178|NCT01340937|50151211|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
25048179|NCT01340937|50151212|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
25048180|NCT01340937|50151213|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
24959342|NCT00295620|50049943|FG001|Overall Study|Discontinuation by sponsor|593|||
25048181|NCT01340937|50151214|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
25162489|NCT01791517|50284750|FG001|Phase I: Period 3|Adverse Event|0|||
25048182|NCT01340937|50151211|FG000|Period 2: Interim Period|Physician Decision|0|||
25048183|NCT01340937|50151212|FG001|Period 2: Interim Period|Physician Decision|1|||
25048184|NCT01340937|50151213|FG002|Period 2: Interim Period|Physician Decision|1|||
25048185|NCT01340937|50151214|FG003|Period 2: Interim Period|Physician Decision|0|||
24959343|NCT00295620|50049942|FG000|Overall Study|Protocol Violation|30|||
24959344|NCT00295620|50049943|FG001|Overall Study|Protocol Violation|32|||
24959345|NCT00310440|50049951|FG000|Overall Study|Lost to Follow-up|17|||
24959346|NCT00310440|50049952|FG001|Overall Study|Lost to Follow-up|8|||
24959347|NCT00310440|50049951|FG000|Overall Study|Withdrawal by Subject|2|||
24959348|NCT00310440|50049952|FG001|Overall Study|Withdrawal by Subject|1|||
24959349|NCT00310440|50049951|FG000|Overall Study|Missed 12 Month Visit|7|||
24959350|NCT00310440|50049952|FG001|Overall Study|Missed 12 Month Visit|4|||
24959351|NCT00304356|50049958|FG000|Nitazoxanide|Physician Decision|5|||
24959352|NCT00304356|50049958|FG000|Nitazoxanide|Physician Decision|1|||
24959353|NCT00304356|50049958|FG000|Nitazoxanide|number is 0|1|||
24959354|NCT00304356|50049958|FG000|Nitazoxanide|Physician Decision|1|||
24959355|NCT00304356|50049958|FG000|Nitazoxanide|Physician Decision|1|||
24959356|NCT00304356|50049958|FG000|Nitazoxanide|Physician Decision|1|||
24959357|NCT00321620|50049964|FG000|Overall Study|Death|269|||
24959358|NCT00321620|50049965|FG001|Overall Study|Death|294|||
24959359|NCT00321620|50049964|FG000|Overall Study|Withdrawal by Subject|164|||
24959360|NCT00321620|50049965|FG001|Overall Study|Withdrawal by Subject|147|||
24959361|NCT00321620|50049964|FG000|Overall Study|Disease progression|113|||
24959362|NCT00321620|50049965|FG001|Overall Study|Disease progression|117|||
24959363|NCT00321620|50049964|FG000|Overall Study|Adverse Event|43|||
24959364|NCT00321620|50049965|FG001|Overall Study|Adverse Event|56|||
24959365|NCT00321620|50049964|FG000|Overall Study|Lost to Follow-up|13|||
24959366|NCT00321620|50049965|FG001|Overall Study|Lost to Follow-up|9|||
24959367|NCT00321620|50049964|FG000|Overall Study|Physician Decision|4|||
24959368|NCT00321620|50049965|FG001|Overall Study|Physician Decision|1|||
24959369|NCT00321620|50049964|FG000|Overall Study|Noncompliance|14|||
24959370|NCT00321620|50049965|FG001|Overall Study|Noncompliance|7|||
24959371|NCT00321620|50049964|FG000|Overall Study|Protocol deviation|4|||
24959372|NCT00321620|50049965|FG001|Overall Study|Protocol deviation|3|||
24959373|NCT00321620|50049964|FG000|Overall Study|Ineligibility determined|2|||
24959374|NCT00321620|50049965|FG001|Overall Study|Ineligibility determined|3|||
24959375|NCT00321620|50049964|FG000|Overall Study|Participant request|75|||
24959376|NCT00321620|50049965|FG001|Overall Study|Participant request|52|||
24959377|NCT00321620|50049964|FG000|Overall Study|Other|42|||
24959378|NCT00321620|50049965|FG001|Overall Study|Other|33|||
24959379|NCT00304278|50049971|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
24959380|NCT00304278|50049971|FG000|Overall Study|PT had medical condition preventing TX|1|||
24959381|NCT00291018|50049978|FG000|Overall Study|Not Consented or Declined PAS|12|||
24959382|NCT00291018|50049979|FG001|Overall Study|Not Consented or Declined PAS|15|||
24959383|NCT00291018|50049980|FG002|Overall Study|Not Consented or Declined PAS|15|||
24959384|NCT00291018|50049978|FG000|Overall Study|Death|3|||
24959385|NCT00291018|50049979|FG001|Overall Study|Death|3|||
24959386|NCT00291018|50049980|FG002|Overall Study|Death|4|||
24959387|NCT00291018|50049978|FG000|Overall Study|Withdrawal by Subject|2|||
24959388|NCT00291018|50049979|FG001|Overall Study|Withdrawal by Subject|8|||
24959389|NCT00291018|50049980|FG002|Overall Study|Withdrawal by Subject|1|||
24959390|NCT00291018|50049978|FG000|Overall Study|Failures|5|||
24959391|NCT00291018|50049979|FG001|Overall Study|Failures|12|||
24959392|NCT00291018|50049980|FG002|Overall Study|Failures|5|||
24959393|NCT00291018|50049978|FG000|Overall Study|Lost to Follow-up|3|||
24959394|NCT00291018|50049979|FG001|Overall Study|Lost to Follow-up|4|||
24959395|NCT00291018|50049980|FG002|Overall Study|Lost to Follow-up|18|||
24959396|NCT00320606|50049991|FG000|Overall Study|Adverse Event|1|||
24959397|NCT00320606|50049991|FG000|Overall Study|Protocol Violation|1|||
24959398|NCT00320606|50049991|FG000|Overall Study|Withdrawal by Subject|1|||
24959399|NCT00307736|50049996|FG000|Overall Study|Adverse Event|0|||
24959400|NCT00307736|50049997|FG001|Overall Study|Adverse Event|0|||
25048186|NCT01340937|50151211|FG000|Period 2: Interim Period|Protocol Violation|5|||
25048187|NCT01340937|50151212|FG001|Period 2: Interim Period|Protocol Violation|3|||
25048188|NCT01340937|50151213|FG002|Period 2: Interim Period|Protocol Violation|6|||
25048189|NCT01340937|50151214|FG003|Period 2: Interim Period|Protocol Violation|3|||
25048190|NCT01340937|50151211|FG000|Period 2: Interim Period|Technical problems|4|||
25048191|NCT01340937|50151212|FG001|Period 2: Interim Period|Technical problems|4|||
24959401|NCT00307736|50049998|FG002|Overall Study|Adverse Event|1|||
24959402|NCT00307736|50049999|FG003|Overall Study|Adverse Event|3|||
24959403|NCT00307736|50049996|FG000|Overall Study|Withdrawal by Subject|0|||
24959404|NCT00307736|50049997|FG001|Overall Study|Withdrawal by Subject|0|||
24959405|NCT00307736|50049998|FG002|Overall Study|Withdrawal by Subject|2|||
24959406|NCT00307736|50049999|FG003|Overall Study|Withdrawal by Subject|0|||
24959407|NCT00320528|50050013|FG000|Study Period II|Adverse Event|3|||
24959408|NCT00320528|50050014|FG001|Study Period II|Adverse Event|4|||
24959409|NCT00320528|50050015|FG002|Study Period II|Adverse Event|8|||
24959410|NCT00320528|50050013|FG000|Study Period II|Parent/Caregiver Decision|8|||
24959411|NCT00320528|50050014|FG001|Study Period II|Parent/Caregiver Decision|3|||
24959412|NCT00320528|50050015|FG002|Study Period II|Parent/Caregiver Decision|11|||
24959413|NCT00320528|50050013|FG000|Study Period II|Withdrawal by Subject|0|||
24959414|NCT00320528|50050014|FG001|Study Period II|Withdrawal by Subject|1|||
24959415|NCT00320528|50050015|FG002|Study Period II|Withdrawal by Subject|1|||
24959416|NCT00320528|50050013|FG000|Study Period II|Entry Criteria Exclusion|0|||
24959417|NCT00320528|50050014|FG001|Study Period II|Entry Criteria Exclusion|2|||
24959418|NCT00320528|50050015|FG002|Study Period II|Entry Criteria Exclusion|2|||
24959419|NCT00320528|50050013|FG000|Study Period III|Adverse Event|1|||
24959420|NCT00320528|50050014|FG001|Study Period III|Adverse Event|0|||
24959421|NCT00320528|50050015|FG002|Study Period III|Adverse Event|0|||
24959422|NCT00320528|50050013|FG000|Study Period III|Lost to Follow-up|1|||
24959423|NCT00320528|50050014|FG001|Study Period III|Lost to Follow-up|0|||
24959424|NCT00320528|50050015|FG002|Study Period III|Lost to Follow-up|0|||
24959425|NCT00320528|50050013|FG000|Study Period III|Withdrawal by Subject|1|||
24959426|NCT00320528|50050014|FG001|Study Period III|Withdrawal by Subject|1|||
24959427|NCT00320528|50050015|FG002|Study Period III|Withdrawal by Subject|2|||
24959428|NCT00320528|50050013|FG000|Study Period III|Lack of Efficacy|2|||
24959429|NCT00320528|50050014|FG001|Study Period III|Lack of Efficacy|0|||
24959430|NCT00320528|50050015|FG002|Study Period III|Lack of Efficacy|0|||
24959431|NCT00320528|50050013|FG000|Study Period III|Parent/Caregiver Decision|14|||
24959432|NCT00320528|50050014|FG001|Study Period III|Parent/Caregiver Decision|3|||
24959433|NCT00320528|50050015|FG002|Study Period III|Parent/Caregiver Decision|11|||
24959434|NCT00320528|50050013|FG000|Study Period III|Protocol Violation|0|||
24959435|NCT00320528|50050014|FG001|Study Period III|Protocol Violation|1|||
24959436|NCT00320528|50050015|FG002|Study Period III|Protocol Violation|0|||
24959437|NCT00320528|50050013|FG000|Study Period III|Physician Decision|0|||
24959438|NCT00320528|50050014|FG001|Study Period III|Physician Decision|1|||
24959439|NCT00320528|50050015|FG002|Study Period III|Physician Decision|2|||
24959440|NCT00320528|50050013|FG000|Study Period III|Sponsor Decision|0|||
24959441|NCT00320528|50050014|FG001|Study Period III|Sponsor Decision|0|||
24959442|NCT00320528|50050015|FG002|Study Period III|Sponsor Decision|1|||
24959443|NCT00320528|50050013|FG000|Study Period III|Atomoxetine Commercially Available|68|||
24959444|NCT00320528|50050014|FG001|Study Period III|Atomoxetine Commercially Available|25|||
24959445|NCT00320528|50050015|FG002|Study Period III|Atomoxetine Commercially Available|90|||
24959446|NCT00320372|50050026|FG000|Overall Study|Physician Decision|4|||
24959447|NCT00320372|50050027|FG001|Overall Study|Physician Decision|7|||
24959448|NCT00320372|50050026|FG000|Overall Study|Death|7|||
24959449|NCT00320372|50050027|FG001|Overall Study|Death|8|||
24959450|NCT00320372|50050026|FG000|Overall Study|Withdrawal by Subject|55|||
24959451|NCT00320372|50050027|FG001|Overall Study|Withdrawal by Subject|37|||
24959452|NCT00320372|50050026|FG000|Overall Study|Non-Compliance|40|||
24959453|NCT00320372|50050027|FG001|Overall Study|Non-Compliance|39|||
24959454|NCT00320372|50050026|FG000|Overall Study|Did not Meet (I/E)|3|||
24959455|NCT00320372|50050027|FG001|Overall Study|Did not Meet (I/E)|1|||
24959456|NCT00320372|50050026|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
24959457|NCT00320372|50050027|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
24959458|NCT00294762|50050043|FG000|Overall Study|Did not receive study treatment|3|||
25162490|NCT01791517|50284751|FG002|Phase I: Period 3|Adverse Event|0|||
24959459|NCT00294762|50050044|FG001|Overall Study|Did not receive study treatment|3|||
24959460|NCT00294684|50050052|FG000|Overall Study|Lost to Follow-up|5|||
24959461|NCT00294684|50050053|FG001|Overall Study|Lost to Follow-up|8|||
24959462|NCT00307034|50050061|FG000|Overall Study|Adverse Event|1|||
24959463|NCT00307034|50050062|FG001|Overall Study|Adverse Event|2|||
24959464|NCT00307034|50050061|FG000|Overall Study|Withdrawal by Subject|1|||
24959465|NCT00307034|50050062|FG001|Overall Study|Withdrawal by Subject|2|||
24959466|NCT00307034|50050061|FG000|Overall Study|Lost to Follow-up|0|||
24959467|NCT00307034|50050062|FG001|Overall Study|Lost to Follow-up|3|||
24959468|NCT00320216|50050073|FG000|Overall Study|Adverse Event|0|||
24959469|NCT00320216|50050074|FG001|Overall Study|Adverse Event|6|||
24959470|NCT00320216|50050075|FG002|Overall Study|Adverse Event|0|||
24959471|NCT00320216|50050076|FG003|Overall Study|Adverse Event|2|||
24959472|NCT00320216|50050077|FG004|Overall Study|Adverse Event|2|||
24959473|NCT00320216|50050073|FG000|Overall Study|Lack of Efficacy|6|||
24959474|NCT00320216|50050074|FG001|Overall Study|Lack of Efficacy|2|||
24959475|NCT00320216|50050075|FG002|Overall Study|Lack of Efficacy|1|||
24959476|NCT00320216|50050076|FG003|Overall Study|Lack of Efficacy|0|||
24959477|NCT00320216|50050077|FG004|Overall Study|Lack of Efficacy|1|||
24959478|NCT00320216|50050073|FG000|Overall Study|Lost to Follow-up|3|||
24959479|NCT00320216|50050074|FG001|Overall Study|Lost to Follow-up|0|||
24959480|NCT00320216|50050075|FG002|Overall Study|Lost to Follow-up|0|||
24959481|NCT00320216|50050076|FG003|Overall Study|Lost to Follow-up|0|||
24959482|NCT00320216|50050077|FG004|Overall Study|Lost to Follow-up|0|||
24959483|NCT00320216|50050073|FG000|Overall Study|Other|7|||
24959484|NCT00320216|50050074|FG001|Overall Study|Other|2|||
24959485|NCT00320216|50050075|FG002|Overall Study|Other|5|||
24959486|NCT00320216|50050076|FG003|Overall Study|Other|1|||
24959487|NCT00320216|50050077|FG004|Overall Study|Other|3|||
24959488|NCT00290706|50050098|FG000|Overall Study|Withdrawal by Subject|2|||
24959489|NCT00290706|50050099|FG001|Overall Study|Withdrawal by Subject|0|||
24959490|NCT00290706|50050100|FG002|Overall Study|Withdrawal by Subject|0|||
24959491|NCT00290706|50050101|FG003|Overall Study|Withdrawal by Subject|0|||
24959492|NCT00290706|50050098|FG000|Overall Study|Progressive Disease|3|||
24959493|NCT00290706|50050099|FG001|Overall Study|Progressive Disease|5|||
24959494|NCT00290706|50050100|FG002|Overall Study|Progressive Disease|4|||
24959495|NCT00290706|50050101|FG003|Overall Study|Progressive Disease|10|||
24959496|NCT00290706|50050098|FG000|Overall Study|Adverse Event|0|||
24959497|NCT00290706|50050099|FG001|Overall Study|Adverse Event|1|||
24959498|NCT00290706|50050100|FG002|Overall Study|Adverse Event|2|||
24959499|NCT00290706|50050101|FG003|Overall Study|Adverse Event|0|||
24959500|NCT00290706|50050098|FG000|Overall Study|Receive auto transplant or radiation|0|||
24959501|NCT00290706|50050099|FG001|Overall Study|Receive auto transplant or radiation|0|||
24959502|NCT00290706|50050100|FG002|Overall Study|Receive auto transplant or radiation|0|||
24959503|NCT00290706|50050101|FG003|Overall Study|Receive auto transplant or radiation|1|||
24959504|NCT00290706|50050098|FG000|Overall Study|Physician Decision|0|||
24959505|NCT00290706|50050099|FG001|Overall Study|Physician Decision|0|||
24959506|NCT00290706|50050100|FG002|Overall Study|Physician Decision|0|||
24959507|NCT00290706|50050101|FG003|Overall Study|Physician Decision|1|||
24959508|NCT00303186|50050112|FG000|Overall Study|Other|52|||
24959509|NCT00294060|50050116|FG000|Overall Study|Death|225|||
24959510|NCT00294060|50050116|FG000|Overall Study|Other|59|||
24959511|NCT00294060|50050116|FG000|Overall Study|Lost to Follow-up|55|||
24959512|NCT00294060|50050116|FG000|Overall Study|Withdrawal by Subject|11|||
24959513|NCT00294060|50050116|FG000|Overall Study|Physician Decision|797|||
24959514|NCT00294060|50050116|FG000|Overall Study|Medical condition|3|||
24959515|NCT00294060|50050116|FG000|Overall Study|Device explanted/not replaced|23|||
24959516|NCT00303108|50050123|FG000|Overall Study|Adverse Event|5|||
24959517|NCT00303108|50050124|FG001|Overall Study|Adverse Event|6|||
24959518|NCT00303108|50050125|FG002|Overall Study|Adverse Event|7|||
24959519|NCT00303108|50050123|FG000|Overall Study|Patient Request|4|||
24959520|NCT00303108|50050124|FG001|Overall Study|Patient Request|2|||
24959521|NCT00303108|50050125|FG002|Overall Study|Patient Request|8|||
24959522|NCT00303108|50050123|FG000|Overall Study|Failed Entry|1|||
24959523|NCT00303108|50050124|FG001|Overall Study|Failed Entry|0|||
24959524|NCT00303108|50050125|FG002|Overall Study|Failed Entry|1|||
24959525|NCT00303108|50050123|FG000|Overall Study|ineligible|2|||
24959526|NCT00303108|50050124|FG001|Overall Study|ineligible|1|||
24959527|NCT00303108|50050125|FG002|Overall Study|ineligible|0|||
24959528|NCT00302952|50050134|FG000|Overall Study|Physician Decision|1|||
24959529|NCT00302952|50050135|FG001|Overall Study|Physician Decision|1|||
24959530|NCT00302952|50050134|FG000|Overall Study|Withdrawal by Subject|2|||
24959531|NCT00302952|50050135|FG001|Overall Study|Withdrawal by Subject|3|||
24959532|NCT00302952|50050134|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
24959533|NCT00302952|50050135|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
24959534|NCT00302718|50050145|FG000|Overall Study|Participant left the hospital|1|||
24959535|NCT00302718|50050146|FG001|Overall Study|Participant left the hospital|0|||
24959536|NCT00302718|50050147|FG002|Overall Study|Participant left the hospital|0|||
24959537|NCT00302718|50050148|FG003|Overall Study|Participant left the hospital|1|||
24959538|NCT00302718|50050145|FG000|Overall Study|Withdrawal by Subject|0|||
24959539|NCT00302718|50050146|FG001|Overall Study|Withdrawal by Subject|1|||
24959540|NCT00302718|50050147|FG002|Overall Study|Withdrawal by Subject|0|||
24959541|NCT00302718|50050148|FG003|Overall Study|Withdrawal by Subject|0|||
24959542|NCT00302718|50050145|FG000|Overall Study|Participant left primary care setting|0|||
24959543|NCT00302718|50050146|FG001|Overall Study|Participant left primary care setting|0|||
24959544|NCT00302718|50050147|FG002|Overall Study|Participant left primary care setting|2|||
24959545|NCT00302718|50050148|FG003|Overall Study|Participant left primary care setting|1|||
24959546|NCT00302328|50050166|FG000|Overall Study|Physician Decision|0|||
24959547|NCT00302328|50050167|FG001|Overall Study|Physician Decision|1|||
24959548|NCT00302328|50050168|FG002|Overall Study|Physician Decision|0|||
24959549|NCT00301080|50050179|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
24959550|NCT00301080|50050180|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
24959551|NCT00301080|50050181|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
24959552|NCT00301080|50050182|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
24959553|NCT00301080|50050183|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
24959554|NCT00290238|50050194|FG000|Overall Study|Study terminated|27|||
24959555|NCT00290238|50050195|FG001|Overall Study|Study terminated|27|||
24959556|NCT00290238|50050194|FG000|Overall Study|Lost to Follow-up|0|||
24959557|NCT00290238|50050195|FG001|Overall Study|Lost to Follow-up|1|||
24959558|NCT00290238|50050194|FG000|Overall Study|Withdrawal by Subject|15|||
24959559|NCT00290238|50050195|FG001|Overall Study|Withdrawal by Subject|13|||
24959560|NCT00289848|50050203|FG000|Overall Study|Adverse Event|6|||
24959561|NCT00289848|50050204|FG001|Overall Study|Adverse Event|4|||
24959562|NCT00289848|50050203|FG000|Overall Study|Death|1|||
24959563|NCT00289848|50050204|FG001|Overall Study|Death|0|||
24959564|NCT00289848|50050203|FG000|Overall Study|Lack of Efficacy|20|||
24959565|NCT00289848|50050204|FG001|Overall Study|Lack of Efficacy|24|||
24959566|NCT00289848|50050203|FG000|Overall Study|Lost to Follow-up|3|||
24959567|NCT00289848|50050204|FG001|Overall Study|Lost to Follow-up|1|||
24959568|NCT00289848|50050203|FG000|Overall Study|Protocol Violation|5|||
24959569|NCT00289848|50050204|FG001|Overall Study|Protocol Violation|2|||
24959570|NCT00289848|50050203|FG000|Overall Study|Withdrawal by Subject|5|||
24959571|NCT00289848|50050204|FG001|Overall Study|Withdrawal by Subject|11|||
24959572|NCT00289848|50050203|FG000|Overall Study|Patient Moved|6|||
24959573|NCT00289848|50050204|FG001|Overall Study|Patient Moved|2|||
24959574|NCT00289848|50050203|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
24959575|NCT00289848|50050204|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
24959576|NCT00289770|50050210|FG000|Year 15|Withdrawal by Subject|1|||
24959577|NCT00289536|50050214|FG000|Period 3|Lost to Follow-up|0|||
24959578|NCT00289536|50050215|FG001|Period 3|Lost to Follow-up|0|||
24959579|NCT00289536|50050216|FG002|Period 3|Lost to Follow-up|1|||
24959580|NCT00289458|50050225|FG000|Overall Study|Death|1|||
24959581|NCT00289458|50050226|FG001|Overall Study|Death|0|||
24959582|NCT00289458|50050227|FG002|Overall Study|Death|0|||
24959583|NCT00289458|50050225|FG000|Overall Study|Physician Decision|3|||
24959584|NCT00289458|50050226|FG001|Overall Study|Physician Decision|4|||
24959585|NCT00289458|50050227|FG002|Overall Study|Physician Decision|2|||
24959586|NCT00289458|50050225|FG000|Overall Study|Withdrawal by Subject|2|||
24959587|NCT00289458|50050226|FG001|Overall Study|Withdrawal by Subject|2|||
24959588|NCT00289458|50050227|FG002|Overall Study|Withdrawal by Subject|4|||
24959589|NCT00288912|50050238|FG000|Overall Study|Developed exclusion criterion|4|||
24959590|NCT00288912|50050239|FG001|Overall Study|Developed exclusion criterion|6|||
24959591|NCT00288912|50050240|FG002|Overall Study|Developed exclusion criterion|7|||
24959592|NCT00288912|50050238|FG000|Overall Study|Lost to Follow-up|9|||
24959593|NCT00288912|50050239|FG001|Overall Study|Lost to Follow-up|6|||
24959594|NCT00288912|50050240|FG002|Overall Study|Lost to Follow-up|9|||
24959595|NCT00288912|50050238|FG000|Overall Study|Withdrawal by Subject|4|||
24959596|NCT00288912|50050239|FG001|Overall Study|Withdrawal by Subject|5|||
24959597|NCT00288912|50050240|FG002|Overall Study|Withdrawal by Subject|12|||
24959598|NCT00305864|50050252|FG000|Overall Study|Ineligible / No protocol treatment|0|||
24959599|NCT00305864|50050253|FG001|Overall Study|Ineligible / No protocol treatment|1|||
24959600|NCT00305864|50050254|FG002|Overall Study|Ineligible / No protocol treatment|1|||
24959601|NCT00305864|50050255|FG003|Overall Study|Ineligible / No protocol treatment|13|||
24959602|NCT00295880|50050265|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
24959603|NCT00295880|50050265|FG000|Overall Study|Unit randomization did not occur|1|||
24959604|NCT00319982|50050271|FG000|Overall Study|Withdrawal by Subject|1|||
24959605|NCT00319982|50050272|FG001|Overall Study|Withdrawal by Subject|0|||
24959606|NCT00319592|50050280|FG000|Overall Study|Protocol Violation|1|||
24959607|NCT00319592|50050281|FG001|Overall Study|Protocol Violation|0|||
24959608|NCT00319592|50050280|FG000|Overall Study|Physician Decision|0|||
24959609|NCT00319592|50050281|FG001|Overall Study|Physician Decision|1|||
24959610|NCT00295490|50050291|FG000|Overall Study|Protocol Violation|0|||
24959611|NCT00295490|50050292|FG001|Overall Study|Protocol Violation|0|||
24959612|NCT00295490|50050293|FG002|Overall Study|Protocol Violation|3|||
24959613|NCT00295490|50050294|FG003|Overall Study|Protocol Violation|3|||
24959614|NCT00295490|50050291|FG000|Overall Study|Withdrawal by Subject|0|||
24959615|NCT00295490|50050292|FG001|Overall Study|Withdrawal by Subject|2|||
24959616|NCT00295490|50050293|FG002|Overall Study|Withdrawal by Subject|0|||
24959617|NCT00295490|50050294|FG003|Overall Study|Withdrawal by Subject|1|||
24959618|NCT00295490|50050291|FG000|Overall Study|Lost to Follow-up|0|||
24959619|NCT00295490|50050292|FG001|Overall Study|Lost to Follow-up|0|||
24959620|NCT00295490|50050293|FG002|Overall Study|Lost to Follow-up|1|||
24959621|NCT00295490|50050294|FG003|Overall Study|Lost to Follow-up|0|||
24959622|NCT00295490|50050291|FG000|Overall Study|Adverse Event|1|||
24959623|NCT00295490|50050292|FG001|Overall Study|Adverse Event|0|||
24959624|NCT00295490|50050293|FG002|Overall Study|Adverse Event|0|||
24959625|NCT00295490|50050294|FG003|Overall Study|Adverse Event|0|||
24959626|NCT00295490|50050291|FG000|Overall Study|Other|0|||
24959627|NCT00295490|50050292|FG001|Overall Study|Other|2|||
24959628|NCT00295490|50050293|FG002|Overall Study|Other|0|||
24959629|NCT00295490|50050294|FG003|Overall Study|Other|1|||
24959630|NCT00305006|50050306|FG000|Overall Study|Withdrawal by Subject|1|||
24959631|NCT00305006|50050307|FG001|Overall Study|Withdrawal by Subject|0|||
24959632|NCT00305006|50050306|FG000|Overall Study|Failure to complete pretest|0|||
24959633|NCT00305006|50050307|FG001|Overall Study|Failure to complete pretest|1|||
24959634|NCT00319436|50050315|FG000|Overall Study|Withdrawal by Subject|6|||
24959635|NCT00319436|50050316|FG001|Overall Study|Withdrawal by Subject|7|||
24959636|NCT00319046|50050322|FG000|Overall Study|withdrawal of subject's consent|7|||
24959637|NCT00319046|50050322|FG000|Overall Study|administrative reason|1|||
24959638|NCT00303602|50050328|FG000|Overall Study|Adverse Event|2|||
24959639|NCT00303602|50050329|FG001|Overall Study|Adverse Event|2|||
24959640|NCT00303602|50050328|FG000|Overall Study|Withdrawal by Subject|5|||
24959641|NCT00303602|50050329|FG001|Overall Study|Withdrawal by Subject|6|||
24959642|NCT00303602|50050328|FG000|Overall Study|Lost to Follow-up|5|||
24959643|NCT00303602|50050329|FG001|Overall Study|Lost to Follow-up|2|||
24959644|NCT00303602|50050328|FG000|Overall Study|Protocol entry criteria not met|2|||
24959645|NCT00303602|50050329|FG001|Overall Study|Protocol entry criteria not met|2|||
24959646|NCT00303602|50050328|FG000|Overall Study|Physician Decision|2|||
24959647|NCT00303602|50050329|FG001|Overall Study|Physician Decision|1|||
24959648|NCT00303602|50050328|FG000|Overall Study|Noncompliance|2|||
24959649|NCT00303602|50050329|FG001|Overall Study|Noncompliance|2|||
24959650|NCT00303602|50050328|FG000|Overall Study|Protocol Violation|1|||
24959651|NCT00303602|50050329|FG001|Overall Study|Protocol Violation|0|||
24959652|NCT00299130|50050338|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
24959653|NCT00299130|50050339|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
24959654|NCT00299130|50050340|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
24959655|NCT00299130|50050338|FG000|Treatment Period (up to 5 Years)|Death|1|||
24959656|NCT00299130|50050339|FG001|Treatment Period (up to 5 Years)|Death|3|||
24959657|NCT00299130|50050340|FG002|Treatment Period (up to 5 Years)|Death|1|||
24959658|NCT00299130|50050338|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
24959659|NCT00299130|50050339|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
24959660|NCT00299130|50050340|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
24959661|NCT00299130|50050338|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
24959662|NCT00299130|50050339|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
24959663|NCT00299130|50050340|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
24959664|NCT00299130|50050338|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
24959665|NCT00299130|50050339|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
24959666|NCT00299130|50050340|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
24959667|NCT00299130|50050338|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
24959668|NCT00299130|50050339|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
24959669|NCT00299130|50050340|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
24959670|NCT00299130|50050338|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
24959671|NCT00299130|50050339|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
24959672|NCT00299130|50050340|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
24959673|NCT00299130|50050338|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
24959674|NCT00299130|50050339|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
24959675|NCT00299130|50050340|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
24959676|NCT00299130|50050338|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
24959677|NCT00299130|50050339|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
24959678|NCT00299130|50050340|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
24959679|NCT00299130|50050338|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
24959680|NCT00299130|50050339|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
24959681|NCT00299130|50050340|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
24959682|NCT00299130|50050338|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
24959683|NCT00299130|50050339|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
24959684|NCT00299130|50050340|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
24959685|NCT00299130|50050338|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
25162491|NCT01791517|50284752|FG003|Phase I: Period 3|Adverse Event|1|||
24959686|NCT00299130|50050339|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
24959687|NCT00299130|50050340|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
24959688|NCT00299130|50050338|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
24959689|NCT00299130|50050339|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
24959690|NCT00299130|50050340|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
24959691|NCT00299130|50050338|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
24959692|NCT00299130|50050339|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
24959693|NCT00299130|50050340|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
24959694|NCT00299130|50050338|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
24959695|NCT00299130|50050339|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
24959696|NCT00299130|50050340|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
24959697|NCT00299130|50050338|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
24959698|NCT00299130|50050339|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
24959699|NCT00299130|50050340|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
24959700|NCT00299130|50050338|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
24959701|NCT00299130|50050339|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
24959702|NCT00299130|50050340|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
24959703|NCT00288054|50050355|FG000|Overall Study|Protocol Violation|2|||
24959704|NCT00288054|50050355|FG000|Overall Study|Lack of Efficacy|16|||
24959705|NCT00288054|50050355|FG000|Overall Study|Adverse Event|3|||
24959706|NCT00288054|50050355|FG000|Overall Study|Withdrawal by Subject|1|||
24959707|NCT00288054|50050355|FG000|Overall Study|Not protocol specified|2|||
24959708|NCT00287586|50050363|FG000|Overall Study|Withdrew Consent|19|||
24959709|NCT00287586|50050364|FG001|Overall Study|Withdrew Consent|30|||
24959710|NCT00287586|50050363|FG000|Overall Study|Lost to Follow-up|5|||
24959711|NCT00287586|50050364|FG001|Overall Study|Lost to Follow-up|4|||
24959712|NCT00287586|50050363|FG000|Overall Study|Death|2|||
24959713|NCT00287586|50050364|FG001|Overall Study|Death|3|||
24959714|NCT00287586|50050363|FG000|Overall Study|Elevated Hematocrit|3|||
24959715|NCT00287586|50050364|FG001|Overall Study|Elevated Hematocrit|0|||
24959716|NCT00287586|50050363|FG000|Overall Study|Rash|3|||
24959717|NCT00287586|50050364|FG001|Overall Study|Rash|0|||
24959718|NCT00287586|50050363|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
24959719|NCT00287586|50050364|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
24959720|NCT00287586|50050363|FG000|Overall Study|Stroke|2|||
24959721|NCT00287586|50050364|FG001|Overall Study|Stroke|0|||
24959722|NCT00287586|50050363|FG000|Overall Study|Myocardial Infarction|1|||
24959723|NCT00287586|50050364|FG001|Overall Study|Myocardial Infarction|0|||
24959724|NCT00287586|50050363|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
24959725|NCT00287586|50050364|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
24959726|NCT00287586|50050363|FG000|Overall Study|Cognitive Impairment|1|||
24959727|NCT00287586|50050364|FG001|Overall Study|Cognitive Impairment|0|||
24959728|NCT00287586|50050363|FG000|Overall Study|Pancreatic Cancer|1|||
24959729|NCT00287586|50050364|FG001|Overall Study|Pancreatic Cancer|3|||
24959730|NCT00287586|50050363|FG000|Overall Study|Sleep Apnea|1|||
24959731|NCT00287586|50050364|FG001|Overall Study|Sleep Apnea|0|||
24959732|NCT00287586|50050363|FG000|Overall Study|Shoulder Pain|1|||
24959733|NCT00287586|50050364|FG001|Overall Study|Shoulder Pain|0|||
24959734|NCT00287586|50050363|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
24959735|NCT00287586|50050364|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
24959736|NCT00287586|50050363|FG000|Overall Study|Nonadherence|1|||
24959737|NCT00287586|50050364|FG001|Overall Study|Nonadherence|1|||
24959738|NCT00287586|50050363|FG000|Overall Study|Enrolled in Another Study|1|||
24959739|NCT00287586|50050364|FG001|Overall Study|Enrolled in Another Study|0|||
24959740|NCT00287586|50050363|FG000|Overall Study|Major Depression|0|||
24959741|NCT00287586|50050364|FG001|Overall Study|Major Depression|2|||
24959742|NCT00287586|50050363|FG000|Overall Study|Lung Cancer|0|||
24959743|NCT00287586|50050364|FG001|Overall Study|Lung Cancer|2|||
24959744|NCT00287586|50050363|FG000|Overall Study|Elevated IPSS Score|0|||
24959745|NCT00287586|50050364|FG001|Overall Study|Elevated IPSS Score|1|||
24959746|NCT00287586|50050363|FG000|Overall Study|Retroperitoneal Cancer|0|||
24959747|NCT00287586|50050364|FG001|Overall Study|Retroperitoneal Cancer|1|||
24959748|NCT00287586|50050363|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
24959749|NCT00287586|50050364|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
25162492|NCT01791517|50284753|FG004|Phase I: Period 3|Adverse Event|0|||
25162493|NCT01791517|50284754|FG005|Phase I: Period 3|Adverse Event|0|||
24959750|NCT00287586|50050363|FG000|Overall Study|Mood Swings and Irritability|0|||
24959751|NCT00287586|50050364|FG001|Overall Study|Mood Swings and Irritability|1|||
24959752|NCT00287586|50050363|FG000|Overall Study|Bradycardia|0|||
25162494|NCT01791517|50284755|FG006|Phase I: Period 3|Adverse Event|0|||
25162495|NCT01791517|50284756|FG007|Phase I: Period 3|Adverse Event|0|||
24959753|NCT00287586|50050364|FG001|Overall Study|Bradycardia|1|||
24959754|NCT00287586|50050363|FG000|Overall Study|Itchy Swollen Eyes|0|||
24959755|NCT00287586|50050364|FG001|Overall Study|Itchy Swollen Eyes|1|||
25276440|NCT01243424|50590386|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
24959756|NCT00287586|50050363|FG000|Overall Study|Recurrent Melanoma|0|||
24959757|NCT00287586|50050364|FG001|Overall Study|Recurrent Melanoma|1|||
24959758|NCT00287118|50050370|FG000|Overall Study|Adverse Event|30|||
24959759|NCT00287118|50050370|FG000|Overall Study|Death|1|||
24959760|NCT00287118|50050370|FG000|Overall Study|Lack of Efficacy|11|||
24959761|NCT00287118|50050370|FG000|Overall Study|Lost to Follow-up|1|||
24959762|NCT00287118|50050370|FG000|Overall Study|Protocol Violation|2|||
24959763|NCT00287118|50050370|FG000|Overall Study|Other|7|||
24959764|NCT00293202|50050376|FG000|Overall Study|Withdrawal by Subject|1|||
24959765|NCT00293202|50050377|FG001|Overall Study|Withdrawal by Subject|2|||
24959766|NCT00293202|50050376|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
24959767|NCT00293202|50050377|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
24959768|NCT00293202|50050376|FG000|Overall Study|on-hold due to fistula maturation time|1|||
24959769|NCT00293202|50050377|FG001|Overall Study|on-hold due to fistula maturation time|0|||
24959770|NCT00298896|50050387|FG000|Overall Study|Death|3|||
24959771|NCT00298896|50050387|FG000|Overall Study|Physician Decision|2|||
24959772|NCT00298896|50050387|FG000|Overall Study|Intercurrent Illness|1|||
24959773|NCT00298896|50050387|FG000|Overall Study|Disease Progression|41|||
24959774|NCT00298896|50050387|FG000|Overall Study|Withdrawal by Subject|2|||
24959775|NCT00298896|50050387|FG000|Overall Study|Assigned to treatment in error|1|||
24959776|NCT00286494|50050394|FG000|Overall Study|Hyperglycemic rescue|12|||
24959777|NCT00286494|50050395|FG001|Overall Study|Hyperglycemic rescue|19|||
24959778|NCT00286494|50050396|FG002|Overall Study|Hyperglycemic rescue|18|||
24959779|NCT00286494|50050394|FG000|Overall Study|Withdrawal by Subject|2|||
24959780|NCT00286494|50050395|FG001|Overall Study|Withdrawal by Subject|10|||
24959781|NCT00286494|50050396|FG002|Overall Study|Withdrawal by Subject|9|||
24959782|NCT00286494|50050394|FG000|Overall Study|Adverse Event|3|||
24959783|NCT00286494|50050395|FG001|Overall Study|Adverse Event|8|||
24959784|NCT00286494|50050396|FG002|Overall Study|Adverse Event|6|||
24959785|NCT00286494|50050394|FG000|Overall Study|Physician Decision|5|||
24959786|NCT00286494|50050395|FG001|Overall Study|Physician Decision|5|||
24959787|NCT00286494|50050396|FG002|Overall Study|Physician Decision|1|||
24959788|NCT00286494|50050394|FG000|Overall Study|Lost to Follow-up|3|||
24959789|NCT00286494|50050395|FG001|Overall Study|Lost to Follow-up|1|||
24959790|NCT00286494|50050396|FG002|Overall Study|Lost to Follow-up|3|||
24959791|NCT00286494|50050394|FG000|Overall Study|Protocol Violation|1|||
24959792|NCT00286494|50050395|FG001|Overall Study|Protocol Violation|1|||
24959793|NCT00286494|50050396|FG002|Overall Study|Protocol Violation|2|||
24959794|NCT00298740|50050404|FG000|Overall Study|Lack of Efficacy|6|||
24959795|NCT00298740|50050404|FG000|Overall Study|Withdrawal by Subject|3|||
24959796|NCT00285012|50050410|FG000|Assigned to Study Treatment (Tx)|Other|2|||
24959797|NCT00285012|50050411|FG001|Assigned to Study Treatment (Tx)|Other|3|||
24959798|NCT00285012|50050410|FG000|Received Study Tx|Death|2|||
24959799|NCT00285012|50050411|FG001|Received Study Tx|Death|1|||
24959800|NCT00285012|50050410|FG000|Received Study Tx|Adverse Event|5|||
24959801|NCT00285012|50050411|FG001|Received Study Tx|Adverse Event|11|||
24959802|NCT00285012|50050410|FG000|Received Study Tx|Lack of Efficacy|0|||
24959803|NCT00285012|50050411|FG001|Received Study Tx|Lack of Efficacy|3|||
24959804|NCT00285012|50050410|FG000|Received Study Tx|Lost to Follow-up|29|||
24959805|NCT00285012|50050411|FG001|Received Study Tx|Lost to Follow-up|31|||
24959806|NCT00285012|50050410|FG000|Received Study Tx|Withdrawal by Subject|31|||
24959807|NCT00285012|50050411|FG001|Received Study Tx|Withdrawal by Subject|43|||
24959808|NCT00285012|50050410|FG000|Received Study Tx|Other|5|||
24959809|NCT00285012|50050411|FG001|Received Study Tx|Other|5|||
24959810|NCT00284934|50050419|FG000|Overall Study|Adverse Event|1|||
24959811|NCT00284934|50050420|FG001|Overall Study|Adverse Event|2|||
24959812|NCT00284934|50050419|FG000|Overall Study|Other reasons|3|||
24959813|NCT00284934|50050420|FG001|Overall Study|Other reasons|1|||
24959814|NCT00284856|50050429|FG000|Overall Study|Adverse Event|3|||
24959815|NCT00284856|50050430|FG001|Overall Study|Adverse Event|3|||
24959816|NCT00284856|50050431|FG002|Overall Study|Adverse Event|3|||
25048192|NCT01340937|50151213|FG002|Period 2: Interim Period|Technical problems|6|||
24959817|NCT00284856|50050429|FG000|Overall Study|Lack of Efficacy|2|||
24959818|NCT00284856|50050430|FG001|Overall Study|Lack of Efficacy|1|||
24959819|NCT00284856|50050431|FG002|Overall Study|Lack of Efficacy|8|||
24959820|NCT00284856|50050429|FG000|Overall Study|Lost to Follow-up|25|||
24959821|NCT00284856|50050430|FG001|Overall Study|Lost to Follow-up|21|||
24959822|NCT00284856|50050431|FG002|Overall Study|Lost to Follow-up|22|||
24959823|NCT00284856|50050429|FG000|Overall Study|Protocol Violation|5|||
24959824|NCT00284856|50050430|FG001|Overall Study|Protocol Violation|4|||
24959825|NCT00284856|50050431|FG002|Overall Study|Protocol Violation|5|||
24959826|NCT00284856|50050429|FG000|Overall Study|Withdrawal by Subject|12|||
24959827|NCT00284856|50050430|FG001|Overall Study|Withdrawal by Subject|16|||
24959828|NCT00284856|50050431|FG002|Overall Study|Withdrawal by Subject|18|||
24959829|NCT00284856|50050429|FG000|Overall Study|Other|4|||
24959830|NCT00284856|50050430|FG001|Overall Study|Other|5|||
24959831|NCT00284856|50050431|FG002|Overall Study|Other|4|||
24959832|NCT00298272|50050441|FG000|Double-blind Phase|Adverse Event|2|||
24959833|NCT00298272|50050442|FG001|Double-blind Phase|Adverse Event|0|||
24959834|NCT00298272|50050441|FG000|Double-blind Phase|Failure to Return|2|||
24959835|NCT00298272|50050442|FG001|Double-blind Phase|Failure to Return|0|||
24959836|NCT00298272|50050441|FG000|Double-blind Phase|Protocol Violation|2|||
24959837|NCT00298272|50050442|FG001|Double-blind Phase|Protocol Violation|0|||
24959838|NCT00298272|50050441|FG000|Double-blind Phase|Withdrawal by Subject|2|||
24959839|NCT00298272|50050442|FG001|Double-blind Phase|Withdrawal by Subject|0|||
24959840|NCT00298272|50050441|FG000|Open Label Retreatment Phase|Adverse Event|1|||
24959841|NCT00298272|50050442|FG001|Open Label Retreatment Phase|Adverse Event|2|||
24959842|NCT00298272|50050441|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
24959843|NCT00298272|50050442|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
24959844|NCT00298272|50050441|FG000|Open Label Retreatment Phase|Failure to Return|1|||
24959845|NCT00298272|50050442|FG001|Open Label Retreatment Phase|Failure to Return|0|||
24959846|NCT00298272|50050441|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
24959847|NCT00298272|50050442|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
24959848|NCT00298272|50050441|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
24959849|NCT00298272|50050442|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
24959850|NCT00298272|50050441|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
24959851|NCT00298272|50050442|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
24959852|NCT00298272|50050441|FG000|Safety Follow-up Phase|Failure to Return|1|||
24959853|NCT00298272|50050442|FG001|Safety Follow-up Phase|Failure to Return|1|||
24959854|NCT00298272|50050441|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
24959855|NCT00298272|50050442|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
24959856|NCT00298272|50050441|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
24959857|NCT00298272|50050442|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
24959858|NCT00283842|50050456|FG000|Overall Study|Adverse Event|8|||
24959859|NCT00283842|50050457|FG001|Overall Study|Adverse Event|7|||
24959860|NCT00283842|50050458|FG002|Overall Study|Adverse Event|21|||
24959861|NCT00283842|50050459|FG003|Overall Study|Adverse Event|21|||
24959862|NCT00283842|50050460|FG004|Overall Study|Adverse Event|5|||
24959863|NCT00283842|50050456|FG000|Overall Study|Protocol Violation|1|||
24959864|NCT00283842|50050457|FG001|Overall Study|Protocol Violation|5|||
24959865|NCT00283842|50050458|FG002|Overall Study|Protocol Violation|4|||
25048193|NCT01340937|50151214|FG003|Period 2: Interim Period|Technical problems|3|||
25048194|NCT01340937|50151211|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
25048195|NCT01340937|50151212|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
25048196|NCT01340937|50151213|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
25048197|NCT01340937|50151214|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
25048198|NCT01340937|50151211|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
25048199|NCT01340937|50151212|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
25048200|NCT01340937|50151213|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
25048201|NCT01340937|50151214|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
25048202|NCT01340937|50151211|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
25048203|NCT01340937|50151212|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
25048204|NCT01340937|50151213|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
25048205|NCT01340937|50151214|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
25048206|NCT01340937|50151211|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
25048207|NCT01340937|50151212|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
25048208|NCT01340937|50151213|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
25048209|NCT01340937|50151214|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
25048210|NCT03029143|50151230|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
25048211|NCT03029143|50151231|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
25048212|NCT03029143|50151232|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
25048213|NCT03029143|50151230|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
25048214|NCT03029143|50151231|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
25048215|NCT03029143|50151232|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
25048216|NCT03029143|50151230|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
25048217|NCT03029143|50151231|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
25048218|NCT03029143|50151232|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
24959866|NCT00283842|50050459|FG003|Overall Study|Protocol Violation|0|||
25048219|NCT03029143|50151230|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
25048220|NCT03029143|50151231|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
25276954|NCT01040403|50590902|FG000|Overall Study|Other reason not defined above|6|||
25048221|NCT03029143|50151232|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
25048222|NCT03029143|50151230|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
25048223|NCT03029143|50151231|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
25048224|NCT03029143|50151232|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
25048225|NCT03029143|50151230|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
25048226|NCT03029143|50151231|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
25048227|NCT03029143|50151232|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
25048228|NCT03029143|50151230|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
25048229|NCT03029143|50151231|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
25048230|NCT03029143|50151232|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
25048231|NCT03029143|50151230|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
25048232|NCT03029143|50151231|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
25048233|NCT03029143|50151232|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
25048234|NCT03029143|50151230|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
25048235|NCT03029143|50151231|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
25048236|NCT03029143|50151232|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
25162496|NCT01791517|50284757|FG008|Phase I: Period 3|Adverse Event|0|||
24959867|NCT00283842|50050460|FG004|Overall Study|Protocol Violation|0|||
24959868|NCT00283842|50050456|FG000|Overall Study|Protocol deviation|0|||
24959869|NCT00283842|50050457|FG001|Overall Study|Protocol deviation|0|||
24959870|NCT00283842|50050458|FG002|Overall Study|Protocol deviation|0|||
24959871|NCT00283842|50050459|FG003|Overall Study|Protocol deviation|0|||
24959872|NCT00283842|50050460|FG004|Overall Study|Protocol deviation|2|||
24959873|NCT00283842|50050456|FG000|Overall Study|Withdrawal by Subject|2|||
24959874|NCT00283842|50050457|FG001|Overall Study|Withdrawal by Subject|1|||
24959875|NCT00283842|50050458|FG002|Overall Study|Withdrawal by Subject|1|||
24959876|NCT00283842|50050459|FG003|Overall Study|Withdrawal by Subject|5|||
24959877|NCT00283842|50050460|FG004|Overall Study|Withdrawal by Subject|4|||
24959878|NCT00283842|50050456|FG000|Overall Study|Lack of Efficacy|1|||
24959879|NCT00283842|50050457|FG001|Overall Study|Lack of Efficacy|3|||
24959880|NCT00283842|50050458|FG002|Overall Study|Lack of Efficacy|1|||
24959881|NCT00283842|50050459|FG003|Overall Study|Lack of Efficacy|0|||
24959882|NCT00283842|50050460|FG004|Overall Study|Lack of Efficacy|3|||
24959883|NCT00283842|50050456|FG000|Overall Study|Lost to Follow-up|0|||
24959884|NCT00283842|50050457|FG001|Overall Study|Lost to Follow-up|2|||
24959885|NCT00283842|50050458|FG002|Overall Study|Lost to Follow-up|4|||
24959886|NCT00283842|50050459|FG003|Overall Study|Lost to Follow-up|1|||
24959887|NCT00283842|50050460|FG004|Overall Study|Lost to Follow-up|1|||
24959888|NCT00298038|50050474|FG000|Overall Study|Lost to Follow-up|0|||
24959889|NCT00298038|50050475|FG001|Overall Study|Lost to Follow-up|1|||
24959890|NCT00298038|50050474|FG000|Overall Study|Liver Transplant|0|||
24959891|NCT00298038|50050475|FG001|Overall Study|Liver Transplant|1|||
24959892|NCT00298038|50050474|FG000|Overall Study|Protocol Violation|1|||
24959893|NCT00298038|50050475|FG001|Overall Study|Protocol Violation|3|||
24959894|NCT00298038|50050474|FG000|Overall Study|Death|6|||
24959895|NCT00298038|50050475|FG001|Overall Study|Death|3|||
24959896|NCT00298038|50050474|FG000|Overall Study|Withdrawal by Subject|6|||
24959897|NCT00298038|50050475|FG001|Overall Study|Withdrawal by Subject|9|||
24959898|NCT00298038|50050474|FG000|Overall Study|Adverse Event|8|||
24959899|NCT00298038|50050475|FG001|Overall Study|Adverse Event|7|||
24959900|NCT00298038|50050474|FG000|Overall Study|Breakthrough overt HE episode|28|||
24959901|NCT00298038|50050475|FG001|Overall Study|Breakthrough overt HE episode|69|||
24959902|NCT00298038|50050474|FG000|Overall Study|Noncompliance|1|||
24959903|NCT00298038|50050475|FG001|Overall Study|Noncompliance|0|||
24959904|NCT00298038|50050474|FG000|Overall Study|Cocaine Abuse|1|||
25162497|NCT01791517|50284758|FG009|Phase I: Period 3|Adverse Event|0|||
24959905|NCT00298038|50050475|FG001|Overall Study|Cocaine Abuse|0|||
24959906|NCT00298038|50050474|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
24959907|NCT00298038|50050475|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
24959908|NCT00283686|50050485|FG000|Overall Study|Death|1|||
24959909|NCT00283686|50050486|FG001|Overall Study|Death|1|||
24959910|NCT00283686|50050487|FG002|Overall Study|Death|1|||
24959911|NCT00283686|50050488|FG003|Overall Study|Death|0|||
24959912|NCT00283686|50050485|FG000|Overall Study|Lost to Follow-up|21|||
24959913|NCT00283686|50050486|FG001|Overall Study|Lost to Follow-up|31|||
24959914|NCT00283686|50050487|FG002|Overall Study|Lost to Follow-up|26|||
24959915|NCT00283686|50050488|FG003|Overall Study|Lost to Follow-up|20|||
24959916|NCT00283686|50050485|FG000|Overall Study|Less than full participation|7|||
24959917|NCT00283686|50050486|FG001|Overall Study|Less than full participation|9|||
24959918|NCT00283686|50050487|FG002|Overall Study|Less than full participation|6|||
24959919|NCT00283686|50050488|FG003|Overall Study|Less than full participation|12|||
24959920|NCT00297882|50050500|FG000|Day 14|Lack of Efficacy|12|||
24959921|NCT00297882|50050501|FG001|Day 14|Lack of Efficacy|49|||
24959922|NCT00297882|50050500|FG000|Day 28|Lost to Follow-up|13|||
24959923|NCT00297882|50050501|FG001|Day 28|Lost to Follow-up|23|||
24959924|NCT00297882|50050500|FG000|Day 28|Lack of Efficacy|3|||
24959925|NCT00297882|50050501|FG001|Day 28|Lack of Efficacy|0|||
24959926|NCT00297648|50050509|FG000|Overall Study|Adverse Event|13|||
24959927|NCT00297648|50050509|FG000|Overall Study|Lack of Efficacy|18|||
24959928|NCT00297648|50050509|FG000|Overall Study|Lost to Follow-up|1|||
24959929|NCT00297648|50050509|FG000|Overall Study|Withdrawal by Subject|3|||
24959930|NCT00297648|50050509|FG000|Overall Study|Other: Incompliance|1|||
24959931|NCT00283296|50050513|FG000|Overall Study|in-home trial not completed|5|||
24959932|NCT00297492|50050521|FG000|Set Quit Date|Lost to Follow-up|7|||
24959933|NCT00297492|50050522|FG001|Set Quit Date|Lost to Follow-up|13|||
24959934|NCT00297492|50050523|FG002|Set Quit Date|Lost to Follow-up|5|||
24959935|NCT00297492|50050521|FG000|6 Month Follow-up|Lost to Follow-up|63|||
24959936|NCT00297492|50050522|FG001|6 Month Follow-up|Lost to Follow-up|49|||
24959937|NCT00297492|50050523|FG002|6 Month Follow-up|Lost to Follow-up|27|||
24959938|NCT00297258|50050531|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
24959939|NCT00297258|50050531|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
24959940|NCT00297258|50050531|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
24959941|NCT00297258|50050531|FG000|Overall Study|Intercurrent Illness|3|||
24959942|NCT00297258|50050531|FG000|Overall Study|Intercurrent Death|2|||
24959943|NCT00297258|50050531|FG000|Overall Study|Deteriorization of General Condition|1|||
24959944|NCT00297258|50050531|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
24959945|NCT00297258|50050531|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
24959946|NCT00297258|50050531|FG000|Overall Study|Switch to Commercial Treatment|1|||
24959947|NCT00297258|50050531|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
24959948|NCT00496769|50050540|FG000|Double Blind|>=1 reason assigned per patient|558|||
24959949|NCT00496769|50050541|FG001|Double Blind|>=1 reason assigned per patient|649|||
24959950|NCT00496769|50050542|FG002|Double Blind|>=1 reason assigned per patient|0|||
24959951|NCT00496769|50050540|FG000|Open Label|>=1 reason assigned per patient|0|||
25048237|NCT03029143|50151230|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
25048238|NCT03029143|50151231|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
25048239|NCT03029143|50151232|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
25048240|NCT03029143|50151230|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
25048241|NCT03029143|50151231|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
25048242|NCT03029143|50151232|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
25048243|NCT03028129|50151243|FG000|Overall Study|Adverse Event|13|||
25048244|NCT03028129|50151244|FG001|Overall Study|Adverse Event|2|||
25048245|NCT03028129|50151243|FG000|Overall Study|Lost to Follow-up|50|||
25048246|NCT03028129|50151244|FG001|Overall Study|Lost to Follow-up|38|||
25048247|NCT03028129|50151243|FG000|Overall Study|Physician Decision|0|||
25048248|NCT03028129|50151244|FG001|Overall Study|Physician Decision|1|||
25048249|NCT03028129|50151243|FG000|Overall Study|Protocol Violation|1|||
25048250|NCT03028129|50151244|FG001|Overall Study|Protocol Violation|1|||
25048251|NCT03028129|50151243|FG000|Overall Study|Withdrawal by Subject|62|||
25048252|NCT03028129|50151244|FG001|Overall Study|Withdrawal by Subject|45|||
25048253|NCT01309672|50151250|FG000|Overall Study|Lack of Efficacy|20|||
25048254|NCT01309672|50151250|FG000|Overall Study|Other|9|||
25048255|NCT01309672|50151250|FG000|Overall Study|Adverse Event|5|||
25048256|NCT01309672|50151250|FG000|Overall Study|Withdrawal by Subject|3|||
25048257|NCT03026257|50151261|FG000|Overall Study|Adverse Event|3|||
25048258|NCT03026257|50151262|FG001|Overall Study|Adverse Event|0|||
25162498|NCT01791517|50284759|FG010|Phase I: Period 3|Adverse Event|0|||
25162499|NCT01791517|50284760|FG011|Phase I: Period 3|Adverse Event|0|||
25162500|NCT01791517|50284749|FG000|Phase II|Lost to Follow-up|1|||
24959952|NCT00496769|50050541|FG001|Open Label|>=1 reason assigned per patient|0|||
24959953|NCT00496769|50050542|FG002|Open Label|>=1 reason assigned per patient|1011|||
24959954|NCT00478673|50050551|FG000|30-Days Post-Procedure|Death|2|||
24959955|NCT00478673|50050551|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
24959956|NCT00478673|50050551|FG000|30-Days Post-Procedure|Missed Visit|7|||
24959957|NCT00478673|50050551|FG000|12-Months Post-Procedure|Death|23|||
25048259|NCT03026257|50151263|FG002|Overall Study|Adverse Event|0|||
25048260|NCT03026257|50151264|FG003|Overall Study|Adverse Event|0|||
25048261|NCT03026257|50151265|FG004|Overall Study|Adverse Event|0|||
25048262|NCT03026257|50151266|FG005|Overall Study|Adverse Event|0|||
25048263|NCT03026257|50151261|FG000|Overall Study|Lost to Follow-up|1|||
25048264|NCT03026257|50151262|FG001|Overall Study|Lost to Follow-up|0|||
25048265|NCT03026257|50151263|FG002|Overall Study|Lost to Follow-up|0|||
25048266|NCT03026257|50151264|FG003|Overall Study|Lost to Follow-up|0|||
25048267|NCT03026257|50151265|FG004|Overall Study|Lost to Follow-up|0|||
25048268|NCT03026257|50151266|FG005|Overall Study|Lost to Follow-up|0|||
25048269|NCT03026257|50151261|FG000|Overall Study|Protocol Violation|1|||
25048270|NCT03026257|50151262|FG001|Overall Study|Protocol Violation|0|||
25048271|NCT03026257|50151263|FG002|Overall Study|Protocol Violation|0|||
25048272|NCT03026257|50151264|FG003|Overall Study|Protocol Violation|1|||
25048273|NCT03026257|50151265|FG004|Overall Study|Protocol Violation|1|||
25048274|NCT03026257|50151266|FG005|Overall Study|Protocol Violation|0|||
25048275|NCT03026257|50151261|FG000|Overall Study|Withdrawal by Subject|1|||
25162501|NCT01791517|50284750|FG001|Phase II|Lost to Follow-up|0|||
25162502|NCT01791517|50284751|FG002|Phase II|Lost to Follow-up|1|||
25162503|NCT01791517|50284752|FG003|Phase II|Lost to Follow-up|0|||
25048276|NCT03026257|50151262|FG001|Overall Study|Withdrawal by Subject|1|||
25048277|NCT03026257|50151263|FG002|Overall Study|Withdrawal by Subject|0|||
25048278|NCT03026257|50151264|FG003|Overall Study|Withdrawal by Subject|0|||
25048279|NCT03026257|50151265|FG004|Overall Study|Withdrawal by Subject|0|||
25048280|NCT03026257|50151266|FG005|Overall Study|Withdrawal by Subject|0|||
25048281|NCT01670188|50151282|FG000|Overall Study|Death|0|||
25048282|NCT01670188|50151283|FG001|Overall Study|Death|1|||
25048283|NCT01933048|50151291|FG000|Overall Study|Lost to Follow-up|15|||
25048284|NCT01933048|50151292|FG001|Overall Study|Lost to Follow-up|18|||
25048285|NCT01933048|50151291|FG000|Overall Study|personal reasons|1|||
25048286|NCT01933048|50151292|FG001|Overall Study|personal reasons|1|||
25048287|NCT01933048|50151291|FG000|Overall Study|Protocol Violation|7|||
25048288|NCT01933048|50151292|FG001|Overall Study|Protocol Violation|8|||
25048289|NCT01933048|50151291|FG000|Overall Study|Physician Decision|1|||
25048290|NCT01933048|50151292|FG001|Overall Study|Physician Decision|0|||
25048291|NCT01933048|50151291|FG000|Overall Study|unknown reasons|1|||
25048292|NCT01933048|50151292|FG001|Overall Study|unknown reasons|1|||
25162504|NCT01791517|50284753|FG004|Phase II|Lost to Follow-up|1|||
25162505|NCT01791517|50284754|FG005|Phase II|Lost to Follow-up|2|||
25162506|NCT01791517|50284755|FG006|Phase II|Lost to Follow-up|0|||
25162507|NCT01791517|50284756|FG007|Phase II|Lost to Follow-up|1|||
25162508|NCT01791517|50284757|FG008|Phase II|Lost to Follow-up|1|||
25162509|NCT01791517|50284758|FG009|Phase II|Lost to Follow-up|1|||
25162510|NCT01791517|50284759|FG010|Phase II|Lost to Follow-up|0|||
25162511|NCT01791517|50284760|FG011|Phase II|Lost to Follow-up|0|||
25162512|NCT01791517|50284749|FG000|Phase II|Withdrawal by Subject|1|||
25162513|NCT01791517|50284750|FG001|Phase II|Withdrawal by Subject|0|||
25162514|NCT01791517|50284751|FG002|Phase II|Withdrawal by Subject|0|||
25162515|NCT01791517|50284752|FG003|Phase II|Withdrawal by Subject|0|||
25162516|NCT01791517|50284753|FG004|Phase II|Withdrawal by Subject|0|||
25162517|NCT01791517|50284754|FG005|Phase II|Withdrawal by Subject|2|||
25162518|NCT01791517|50284755|FG006|Phase II|Withdrawal by Subject|0|||
25162519|NCT01791517|50284756|FG007|Phase II|Withdrawal by Subject|1|||
25162520|NCT01791517|50284757|FG008|Phase II|Withdrawal by Subject|0|||
25162521|NCT01791517|50284758|FG009|Phase II|Withdrawal by Subject|0|||
25162522|NCT01791517|50284759|FG010|Phase II|Withdrawal by Subject|1|||
25162523|NCT01791517|50284760|FG011|Phase II|Withdrawal by Subject|0|||
25048293|NCT02751450|50151303|FG000|Overall Study|Adverse Event|1|||
25048294|NCT02751450|50151304|FG001|Overall Study|Adverse Event|0|||
25048295|NCT01515748|50151314|FG000|Overall Study|Withdrawal by Subject|32|||
25048296|NCT01515748|50151315|FG001|Overall Study|Withdrawal by Subject|41|||
25048297|NCT01515748|50151314|FG000|Overall Study|Lost to Follow-up|2|||
25048298|NCT01515748|50151315|FG001|Overall Study|Lost to Follow-up|4|||
25048299|NCT01515748|50151314|FG000|Overall Study|Ongoing|86|||
25048300|NCT01515748|50151315|FG001|Overall Study|Ongoing|90|||
25162524|NCT01791517|50284749|FG000|Phase II|Lack of Efficacy|0|||
25162525|NCT01791517|50284750|FG001|Phase II|Lack of Efficacy|0|||
25162526|NCT01791517|50284751|FG002|Phase II|Lack of Efficacy|0|||
25162527|NCT01791517|50284752|FG003|Phase II|Lack of Efficacy|0|||
25048301|NCT01358175|50151325|FG000|Overall Study|Death|1|||
25048302|NCT01358175|50151326|FG001|Overall Study|Death|0|||
25048303|NCT01358175|50151327|FG002|Overall Study|Death|1|||
25048304|NCT01358175|50151325|FG000|Overall Study|Withdrawal by Subject|9|||
25048305|NCT01358175|50151326|FG001|Overall Study|Withdrawal by Subject|5|||
25048306|NCT01358175|50151327|FG002|Overall Study|Withdrawal by Subject|10|||
25048307|NCT01358175|50151325|FG000|Overall Study|Technical issues|0|||
25048308|NCT01358175|50151326|FG001|Overall Study|Technical issues|1|||
25048309|NCT01358175|50151327|FG002|Overall Study|Technical issues|0|||
25048310|NCT01358175|50151325|FG000|Overall Study|Pregnancy|0|||
25048311|NCT01358175|50151326|FG001|Overall Study|Pregnancy|1|||
25162528|NCT01791517|50284753|FG004|Phase II|Lack of Efficacy|1|||
25162529|NCT01791517|50284754|FG005|Phase II|Lack of Efficacy|0|||
25162530|NCT01791517|50284755|FG006|Phase II|Lack of Efficacy|0|||
25162531|NCT01791517|50284756|FG007|Phase II|Lack of Efficacy|0|||
25048312|NCT01358175|50151327|FG002|Overall Study|Pregnancy|0|||
25048313|NCT01358175|50151325|FG000|Overall Study|Physician Decision|1|||
25048314|NCT01358175|50151326|FG001|Overall Study|Physician Decision|0|||
25048315|NCT01358175|50151327|FG002|Overall Study|Physician Decision|0|||
25048316|NCT01358175|50151325|FG000|Overall Study|Non Compliance with Study Treatment|0|||
25048317|NCT01358175|50151326|FG001|Overall Study|Non Compliance with Study Treatment|1|||
25048318|NCT01358175|50151327|FG002|Overall Study|Non Compliance with Study Treatment|1|||
25048319|NCT01358175|50151325|FG000|Overall Study|Lost to Follow-up|1|||
25048320|NCT01358175|50151326|FG001|Overall Study|Lost to Follow-up|1|||
25048321|NCT01358175|50151327|FG002|Overall Study|Lost to Follow-up|3|||
25048322|NCT01358175|50151325|FG000|Overall Study|Lack of Efficacy|3|||
25048323|NCT01358175|50151326|FG001|Overall Study|Lack of Efficacy|8|||
25048324|NCT01358175|50151327|FG002|Overall Study|Lack of Efficacy|6|||
25048325|NCT01358175|50151325|FG000|Overall Study|Adverse Event|6|||
25048326|NCT01358175|50151326|FG001|Overall Study|Adverse Event|11|||
25048327|NCT01358175|50151327|FG002|Overall Study|Adverse Event|11|||
25048328|NCT04116229|50151341|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
25048329|NCT04116229|50151342|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
25048330|NCT04116229|50151341|FG000|Overall Study|Scheduling not possible.|0|||
25048331|NCT04116229|50151342|FG001|Overall Study|Scheduling not possible.|1|||
25048332|NCT02833077|50151350|FG000|Overall Study|Adverse Event|1|||
25048333|NCT02833077|50151351|FG001|Overall Study|Adverse Event|2|||
25048334|NCT02833077|50151350|FG000|Overall Study|Lost to Follow-up|10|||
25048335|NCT02833077|50151351|FG001|Overall Study|Lost to Follow-up|1|||
25048336|NCT02833077|50151350|FG000|Overall Study|Personal Reasons|6|||
25048337|NCT02833077|50151351|FG001|Overall Study|Personal Reasons|4|||
25048338|NCT02833077|50151350|FG000|Overall Study|Protocol Deviation|0|||
25048339|NCT02833077|50151351|FG001|Overall Study|Protocol Deviation|1|||
25048340|NCT01355679|50151358|FG000|Overall Study|benign tumor types found at biopsy|2|||
25048341|NCT02832375|50151365|FG000|Overall Study|Lost to Follow-up|1|||
25048342|NCT02832375|50151366|FG001|Overall Study|Lost to Follow-up|0|||
25048343|NCT02832375|50151365|FG000|Overall Study|Withdrawal of Consent|1|||
25048344|NCT02832375|50151366|FG001|Overall Study|Withdrawal of Consent|0|||
25048345|NCT02925403|50151375|FG000|Overall Study|Lost to Follow-up|0|||
25048346|NCT02925403|50151376|FG001|Overall Study|Lost to Follow-up|1|||
25048347|NCT02626780|50151382|FG000|Overall Study|Withdrawal by Subject|3|||
25048348|NCT02831673|50151397|FG000|Overall Study|Adverse Event|6|||
25048349|NCT02831673|50151398|FG001|Overall Study|Adverse Event|4|||
25048350|NCT02831673|50151397|FG000|Overall Study|Lack of Efficacy|3|||
25048351|NCT02831673|50151398|FG001|Overall Study|Lack of Efficacy|1|||
24959958|NCT00478673|50050551|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
24959959|NCT00478673|50050551|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
24959960|NCT00478673|50050551|FG000|12-Months Post-Procedure|Missed Visit|25|||
24959961|NCT00478673|50050551|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
24959962|NCT00488345|50050558|FG000|Overall Study|Adverse Event|0|||
24959963|NCT00488345|50050559|FG001|Overall Study|Adverse Event|1|||
24959964|NCT00488345|50050560|FG002|Overall Study|Adverse Event|1|||
24959965|NCT00488345|50050558|FG000|Overall Study|Unable to administer antibiotics at home|0|||
24959966|NCT00488345|50050559|FG001|Overall Study|Unable to administer antibiotics at home|1|||
24959967|NCT00488345|50050560|FG002|Overall Study|Unable to administer antibiotics at home|0|||
24959968|NCT00488345|50050558|FG000|Overall Study|Institutional Review Board review|0|||
24959969|NCT00488345|50050559|FG001|Overall Study|Institutional Review Board review|0|||
25048352|NCT02831673|50151397|FG000|Overall Study|Protocol Violation|5|||
25048353|NCT02831673|50151398|FG001|Overall Study|Protocol Violation|4|||
25048354|NCT02831673|50151397|FG000|Overall Study|Protocol Withdrawal Criterion Met|1|||
25048355|NCT02831673|50151398|FG001|Overall Study|Protocol Withdrawal Criterion Met|6|||
25048356|NCT02831673|50151397|FG000|Overall Study|Lost to Follow-up|9|||
25048357|NCT02831673|50151398|FG001|Overall Study|Lost to Follow-up|6|||
25048358|NCT02831673|50151397|FG000|Overall Study|Physician Decision|6|||
25048359|NCT02831673|50151398|FG001|Overall Study|Physician Decision|3|||
25048360|NCT02831673|50151397|FG000|Overall Study|Withdrawal by Subject|6|||
25048361|NCT02831673|50151398|FG001|Overall Study|Withdrawal by Subject|4|||
25048362|NCT02831673|50151397|FG000|Overall Study|Ongoing at Week 48 primary analysis.|320|||
25048363|NCT02831673|50151398|FG001|Overall Study|Ongoing at Week 48 primary analysis.|330|||
25048364|NCT02830893|50151406|FG000|Overall Study|Relocation to out of the country|1|||
25048365|NCT02830893|50151407|FG001|Overall Study|Relocation to out of the country|0|||
25048366|NCT02830893|50151406|FG000|Overall Study|Lost to Follow-up|0|||
25048367|NCT02830893|50151407|FG001|Overall Study|Lost to Follow-up|2|||
25048368|NCT02830893|50151406|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
25048369|NCT02830893|50151407|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
25048370|NCT02625922|50151415|FG000|Overall Study|Non-availability of IMP|1|||
25048371|NCT02625922|50151416|FG001|Overall Study|Non-availability of IMP|1|||
25048372|NCT02625922|50151415|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
25048373|NCT02625922|50151416|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
25048374|NCT03350035|50151428|FG000|Overall Study|Lack of Efficacy|2|||
25048375|NCT03350035|50151429|FG001|Overall Study|Lack of Efficacy|0|||
25048376|NCT03350035|50151430|FG002|Overall Study|Lack of Efficacy|0|||
25048377|NCT03350035|50151428|FG000|Overall Study|Subject discharged to hospice|0|||
25048378|NCT03350035|50151429|FG001|Overall Study|Subject discharged to hospice|0|||
25048379|NCT03350035|50151430|FG002|Overall Study|Subject discharged to hospice|1|||
25048380|NCT01358331|50151464|FG000|Overall Study|Lost to Follow-up|0|||
25048381|NCT01358331|50151465|FG001|Overall Study|Lost to Follow-up|0|||
25048382|NCT01358331|50151466|FG002|Overall Study|Lost to Follow-up|0|||
25048383|NCT01358331|50151467|FG003|Overall Study|Lost to Follow-up|1|||
25048384|NCT01358331|50151468|FG004|Overall Study|Lost to Follow-up|0|||
25048385|NCT01358331|50151469|FG005|Overall Study|Lost to Follow-up|0|||
25048386|NCT01358331|50151464|FG000|Overall Study|Withdrawal by Subject|0|||
25048387|NCT01358331|50151465|FG001|Overall Study|Withdrawal by Subject|0|||
24959970|NCT00488345|50050560|FG002|Overall Study|Institutional Review Board review|1|||
24959971|NCT00488345|50050558|FG000|Overall Study|Surgical team recommendation|0|||
24959972|NCT00488345|50050559|FG001|Overall Study|Surgical team recommendation|1|||
24959973|NCT00488345|50050560|FG002|Overall Study|Surgical team recommendation|0|||
25048388|NCT01358331|50151466|FG002|Overall Study|Withdrawal by Subject|0|||
25048389|NCT01358331|50151467|FG003|Overall Study|Withdrawal by Subject|1|||
25048390|NCT01358331|50151468|FG004|Overall Study|Withdrawal by Subject|1|||
25048391|NCT01358331|50151469|FG005|Overall Study|Withdrawal by Subject|1|||
25048392|NCT01358331|50151464|FG000|Overall Study|Adverse Events|1|||
25048393|NCT01358331|50151465|FG001|Overall Study|Adverse Events|1|||
25048394|NCT01358331|50151466|FG002|Overall Study|Adverse Events|1|||
25048395|NCT01358331|50151467|FG003|Overall Study|Adverse Events|0|||
25048396|NCT01358331|50151468|FG004|Overall Study|Adverse Events|1|||
25048397|NCT01358331|50151469|FG005|Overall Study|Adverse Events|5|||
25048398|NCT01358331|50151464|FG000|Overall Study|Symptomatic Deterioration|0|||
25048399|NCT01358331|50151465|FG001|Overall Study|Symptomatic Deterioration|0|||
24959974|NCT00488345|50050558|FG000|Overall Study|Parent/legal guardian request|0|||
24959975|NCT00488345|50050559|FG001|Overall Study|Parent/legal guardian request|1|||
24959976|NCT00488345|50050560|FG002|Overall Study|Parent/legal guardian request|1|||
24959977|NCT00283062|50050573|FG000|Overall Study|Did not receive any study medication|5|||
25048400|NCT01358331|50151466|FG002|Overall Study|Symptomatic Deterioration|0|||
25048401|NCT01358331|50151467|FG003|Overall Study|Symptomatic Deterioration|0|||
25048402|NCT01358331|50151468|FG004|Overall Study|Symptomatic Deterioration|1|||
25048403|NCT01358331|50151469|FG005|Overall Study|Symptomatic Deterioration|0|||
25048404|NCT01358331|50151464|FG000|Overall Study|Participants did not wish to continue|0|||
25048405|NCT01358331|50151465|FG001|Overall Study|Participants did not wish to continue|0|||
25048406|NCT01358331|50151466|FG002|Overall Study|Participants did not wish to continue|0|||
25048407|NCT01358331|50151467|FG003|Overall Study|Participants did not wish to continue|0|||
25048408|NCT01358331|50151468|FG004|Overall Study|Participants did not wish to continue|1|||
25048409|NCT01358331|50151469|FG005|Overall Study|Participants did not wish to continue|0|||
25048410|NCT01358331|50151464|FG000|Overall Study|Progress of disease under investigation|1|||
25048411|NCT01358331|50151465|FG001|Overall Study|Progress of disease under investigation|2|||
25048412|NCT01358331|50151466|FG002|Overall Study|Progress of disease under investigation|3|||
25048413|NCT01358331|50151467|FG003|Overall Study|Progress of disease under investigation|1|||
25048414|NCT01358331|50151468|FG004|Overall Study|Progress of disease under investigation|3|||
25048415|NCT01358331|50151469|FG005|Overall Study|Progress of disease under investigation|0|||
25048416|NCT02828241|50151485|FG000|Overall Study|Adverse Event|7|||
25048417|NCT02828241|50151486|FG001|Overall Study|Adverse Event|2|||
25048418|NCT02828241|50151485|FG000|Overall Study|Protocol Violation|1|||
25048419|NCT02828241|50151486|FG001|Overall Study|Protocol Violation|0|||
25048420|NCT01355523|50151495|FG000|Overall Study|Withdrawal by Subject|1|||
25048421|NCT01355523|50151496|FG001|Overall Study|Withdrawal by Subject|4|||
25048422|NCT01355523|50151495|FG000|Overall Study|Lost to Follow-up|0|||
25048423|NCT01355523|50151496|FG001|Overall Study|Lost to Follow-up|2|||
25048424|NCT01355523|50151495|FG000|Overall Study|Protocol Violation|0|||
25048425|NCT01355523|50151496|FG001|Overall Study|Protocol Violation|2|||
25048426|NCT01355523|50151495|FG000|Overall Study|Adverse Event|0|||
25048427|NCT01355523|50151496|FG001|Overall Study|Adverse Event|2|||
25048428|NCT02625220|50151502|FG000|Overall Study|Adverse Event|2|||
25048429|NCT02625220|50151502|FG000|Overall Study|Lost to Follow-up|2|||
25048430|NCT02625220|50151502|FG000|Overall Study|Protocol Violation|1|||
25048431|NCT02625220|50151502|FG000|Overall Study|Study discontinued at site|2|||
25048432|NCT02826603|50151508|FG000|Overall Study|Adverse Event|17|||
25048433|NCT02826603|50151509|FG001|Overall Study|Adverse Event|9|||
25048434|NCT02826603|50151508|FG000|Overall Study|Lack of Efficacy|4|||
25048435|NCT02826603|50151509|FG001|Overall Study|Lack of Efficacy|9|||
25048436|NCT02826603|50151508|FG000|Overall Study|Lost to Follow-up|13|||
25048437|NCT02826603|50151509|FG001|Overall Study|Lost to Follow-up|12|||
25048438|NCT02826603|50151508|FG000|Overall Study|Noncompliance with treatment|0|||
25048439|NCT02826603|50151509|FG001|Overall Study|Noncompliance with treatment|2|||
25048440|NCT02826603|50151508|FG000|Overall Study|Physician Decision|1|||
25048441|NCT02826603|50151509|FG001|Overall Study|Physician Decision|7|||
25048442|NCT02826603|50151508|FG000|Overall Study|Pregnancy|1|||
25048443|NCT02826603|50151509|FG001|Overall Study|Pregnancy|2|||
25048444|NCT02826603|50151508|FG000|Overall Study|Protocol Violation|3|||
25048445|NCT02826603|50151509|FG001|Overall Study|Protocol Violation|3|||
25048446|NCT02826603|50151508|FG000|Overall Study|Withdrawal by Subject|20|||
25048447|NCT02826603|50151509|FG001|Overall Study|Withdrawal by Subject|19|||
25048448|NCT02826603|50151508|FG000|Overall Study|Death|2|||
25048449|NCT02826603|50151509|FG001|Overall Study|Death|0|||
25048450|NCT02826603|50151508|FG000|Overall Study|New therapy for study indication|0|||
25048451|NCT02826603|50151509|FG001|Overall Study|New therapy for study indication|1|||
25048452|NCT01329900|50151516|FG000|Overall Study|Elevated creatinine/renal function|1|||
25048453|NCT02825043|50151520|FG000|Overall Study|Lost to Follow-up|4|||
25048454|NCT02750592|50151535|FG000|Overall Study|Adverse Event|3|||
25048455|NCT02750592|50151535|FG000|Overall Study|Lack of Efficacy|2|||
25048456|NCT02624986|50151547|FG000|Overall Study|Death|0|||
25048457|NCT02624986|50151548|FG001|Overall Study|Death|1|||
25048458|NCT02624986|50151549|FG002|Overall Study|Death|2|||
25048459|NCT02624986|50151550|FG003|Overall Study|Death|2|||
25048460|NCT02624986|50151551|FG004|Overall Study|Death|2|||
25048461|NCT02624986|50151552|FG005|Overall Study|Death|0|||
25048462|NCT02624986|50151553|FG006|Overall Study|Death|0|||
25048463|NCT02624986|50151554|FG007|Overall Study|Death|1|||
25048464|NCT02624986|50151547|FG000|Overall Study|Study Terminated by Sponsor|1|||
24959978|NCT00283062|50050574|FG001|Overall Study|Did not receive any study medication|4|||
24959979|NCT00283062|50050575|FG002|Overall Study|Did not receive any study medication|36|||
24959980|NCT00283062|50050576|FG003|Overall Study|Did not receive any study medication|45|||
24959981|NCT00283062|50050573|FG000|Overall Study|Adverse Event|2|||
24959982|NCT00283062|50050574|FG001|Overall Study|Adverse Event|0|||
24959983|NCT00283062|50050575|FG002|Overall Study|Adverse Event|1|||
24959984|NCT00283062|50050576|FG003|Overall Study|Adverse Event|0|||
24959985|NCT00283062|50050573|FG000|Overall Study|Lost to Follow-up|1|||
24959986|NCT00283062|50050574|FG001|Overall Study|Lost to Follow-up|0|||
24959987|NCT00283062|50050575|FG002|Overall Study|Lost to Follow-up|1|||
24959988|NCT00283062|50050576|FG003|Overall Study|Lost to Follow-up|0|||
24959989|NCT00283062|50050573|FG000|Overall Study|Progressive disease|0|||
24959990|NCT00283062|50050574|FG001|Overall Study|Progressive disease|0|||
25048465|NCT02624986|50151548|FG001|Overall Study|Study Terminated by Sponsor|1|||
25048466|NCT02624986|50151549|FG002|Overall Study|Study Terminated by Sponsor|0|||
25048467|NCT02624986|50151550|FG003|Overall Study|Study Terminated by Sponsor|1|||
25048468|NCT02624986|50151551|FG004|Overall Study|Study Terminated by Sponsor|2|||
25048469|NCT02624986|50151552|FG005|Overall Study|Study Terminated by Sponsor|2|||
25048470|NCT02624986|50151553|FG006|Overall Study|Study Terminated by Sponsor|4|||
25048471|NCT02624986|50151554|FG007|Overall Study|Study Terminated by Sponsor|3|||
25048472|NCT02624986|50151547|FG000|Overall Study|Progressive Disease|0|||
25048473|NCT02624986|50151548|FG001|Overall Study|Progressive Disease|1|||
25048474|NCT02624986|50151549|FG002|Overall Study|Progressive Disease|0|||
25048475|NCT02624986|50151550|FG003|Overall Study|Progressive Disease|0|||
25048476|NCT02624986|50151551|FG004|Overall Study|Progressive Disease|0|||
25048477|NCT02624986|50151552|FG005|Overall Study|Progressive Disease|0|||
25048478|NCT02624986|50151553|FG006|Overall Study|Progressive Disease|0|||
25048479|NCT02624986|50151554|FG007|Overall Study|Progressive Disease|0|||
25048480|NCT02624986|50151547|FG000|Overall Study|Protocol Violation|1|||
25048481|NCT02624986|50151548|FG001|Overall Study|Protocol Violation|0|||
25048482|NCT02624986|50151549|FG002|Overall Study|Protocol Violation|0|||
25048483|NCT02624986|50151550|FG003|Overall Study|Protocol Violation|0|||
25048484|NCT02624986|50151551|FG004|Overall Study|Protocol Violation|0|||
25048485|NCT02624986|50151552|FG005|Overall Study|Protocol Violation|0|||
24959991|NCT00283062|50050575|FG002|Overall Study|Progressive disease|1|||
24959992|NCT00283062|50050576|FG003|Overall Study|Progressive disease|0|||
24959993|NCT00283062|50050573|FG000|Overall Study|Participant did not wish to continue|3|||
24959994|NCT00283062|50050574|FG001|Overall Study|Participant did not wish to continue|2|||
25048486|NCT02624986|50151553|FG006|Overall Study|Protocol Violation|0|||
25048487|NCT02624986|50151554|FG007|Overall Study|Protocol Violation|0|||
25048488|NCT02624986|50151547|FG000|Overall Study|Withdrawal by Subject|0|||
25048489|NCT02624986|50151548|FG001|Overall Study|Withdrawal by Subject|0|||
25048490|NCT02624986|50151549|FG002|Overall Study|Withdrawal by Subject|0|||
25048491|NCT02624986|50151550|FG003|Overall Study|Withdrawal by Subject|0|||
25048492|NCT02624986|50151551|FG004|Overall Study|Withdrawal by Subject|0|||
25048493|NCT02624986|50151552|FG005|Overall Study|Withdrawal by Subject|0|||
25048494|NCT02624986|50151553|FG006|Overall Study|Withdrawal by Subject|0|||
25048495|NCT02624986|50151554|FG007|Overall Study|Withdrawal by Subject|1|||
25048496|NCT02587598|50151587|FG000|Overall Study|Death|4|||
25048497|NCT02587598|50151588|FG001|Overall Study|Death|8|||
25048498|NCT02587598|50151589|FG002|Overall Study|Death|4|||
25048499|NCT02587598|50151590|FG003|Overall Study|Death|16|||
25048500|NCT02587598|50151591|FG004|Overall Study|Death|9|||
25048501|NCT02587598|50151592|FG005|Overall Study|Death|4|||
25048502|NCT02587598|50151593|FG006|Overall Study|Death|6|||
25048503|NCT02587598|50151594|FG007|Overall Study|Death|7|||
25048504|NCT02587598|50151595|FG008|Overall Study|Death|9|||
25048505|NCT02587598|50151596|FG009|Overall Study|Death|1|||
25048506|NCT02587598|50151597|FG010|Overall Study|Death|3|||
25048507|NCT02587598|50151587|FG000|Overall Study|Study Terminated by the Sponsor|0|||
25048508|NCT02587598|50151588|FG001|Overall Study|Study Terminated by the Sponsor|1|||
24959995|NCT00283062|50050575|FG002|Overall Study|Participant did not wish to continue|1|||
24959996|NCT00283062|50050576|FG003|Overall Study|Participant did not wish to continue|0|||
24959997|NCT00283062|50050573|FG000|Overall Study|Undefined|0|||
24959998|NCT00283062|50050574|FG001|Overall Study|Undefined|1|||
24959999|NCT00283062|50050575|FG002|Overall Study|Undefined|1|||
24960000|NCT00283062|50050576|FG003|Overall Study|Undefined|4|||
24960001|NCT00283062|50050573|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
24960002|NCT00283062|50050574|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
24960003|NCT00283062|50050575|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
24960004|NCT00283062|50050576|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
24960005|NCT00282984|50050588|FG000|Overall Study|Death|2|||
24960006|NCT00282984|50050589|FG001|Overall Study|Death|5|||
24960007|NCT00282984|50050588|FG000|Overall Study|Adverse Event|8|||
24960008|NCT00282984|50050589|FG001|Overall Study|Adverse Event|5|||
24960009|NCT00282984|50050588|FG000|Overall Study|Lack of Efficacy|0|||
24960010|NCT00282984|50050589|FG001|Overall Study|Lack of Efficacy|2|||
24960011|NCT00282984|50050588|FG000|Overall Study|Lost to Follow-up|14|||
24960012|NCT00282984|50050589|FG001|Overall Study|Lost to Follow-up|10|||
24960013|NCT00282984|50050588|FG000|Overall Study|Withdrawal by Participant|22|||
24960014|NCT00282984|50050589|FG001|Overall Study|Withdrawal by Participant|34|||
24960015|NCT00282984|50050588|FG000|Overall Study|Participant stopped study medication|2|||
24960016|NCT00282984|50050589|FG001|Overall Study|Participant stopped study medication|2|||
24960017|NCT00282984|50050588|FG000|Overall Study|Participant only allowed phone follow-up|0|||
24960018|NCT00282984|50050589|FG001|Overall Study|Participant only allowed phone follow-up|1|||
24960019|NCT00282984|50050588|FG000|Overall Study|Participant used antipsychosis meds|0|||
24960020|NCT00282984|50050589|FG001|Overall Study|Participant used antipsychosis meds|1|||
24960021|NCT00282984|50050588|FG000|Overall Study|lack of motivation|1|||
24960022|NCT00282984|50050589|FG001|Overall Study|lack of motivation|0|||
24960023|NCT00282984|50050588|FG000|Overall Study|in prison|0|||
24960024|NCT00282984|50050589|FG001|Overall Study|in prison|1|||
24960025|NCT00282984|50050588|FG000|Overall Study|Protocol Violation|2|||
24960026|NCT00282984|50050589|FG001|Overall Study|Protocol Violation|0|||
24960027|NCT00282438|50050597|FG000|Overall Study|Lack of Efficacy|1|||
24960028|NCT00282438|50050598|FG001|Overall Study|Lack of Efficacy|0|||
24960029|NCT00282438|50050597|FG000|Overall Study|Death|0|||
24960030|NCT00282438|50050598|FG001|Overall Study|Death|1|||
24960031|NCT00296400|50050607|FG000|Overall Study|Adverse Event|7|||
24960032|NCT00296400|50050608|FG001|Overall Study|Adverse Event|7|||
24960033|NCT00296400|50050609|FG002|Overall Study|Adverse Event|7|||
24960034|NCT00296400|50050607|FG000|Overall Study|Withdrawal by Subject|5|||
24960035|NCT00296400|50050608|FG001|Overall Study|Withdrawal by Subject|6|||
24960036|NCT00296400|50050609|FG002|Overall Study|Withdrawal by Subject|2|||
25048509|NCT02587598|50151589|FG002|Overall Study|Study Terminated by the Sponsor|0|||
24960037|NCT00296400|50050607|FG000|Overall Study|Incorrect enrollment|2|||
24960038|NCT00296400|50050608|FG001|Overall Study|Incorrect enrollment|0|||
24960039|NCT00296400|50050609|FG002|Overall Study|Incorrect enrollment|0|||
24960040|NCT00296400|50050607|FG000|Overall Study|Protocol Violation|1|||
25048510|NCT02587598|50151590|FG003|Overall Study|Study Terminated by the Sponsor|3|||
25048511|NCT02587598|50151591|FG004|Overall Study|Study Terminated by the Sponsor|0|||
25048512|NCT02587598|50151592|FG005|Overall Study|Study Terminated by the Sponsor|1|||
25048513|NCT02587598|50151593|FG006|Overall Study|Study Terminated by the Sponsor|0|||
25048514|NCT02587598|50151594|FG007|Overall Study|Study Terminated by the Sponsor|0|||
25048515|NCT02587598|50151595|FG008|Overall Study|Study Terminated by the Sponsor|0|||
25048516|NCT02587598|50151596|FG009|Overall Study|Study Terminated by the Sponsor|1|||
25162532|NCT01791517|50284757|FG008|Phase II|Lack of Efficacy|0|||
24960041|NCT00296400|50050608|FG001|Overall Study|Protocol Violation|1|||
24960042|NCT00296400|50050609|FG002|Overall Study|Protocol Violation|1|||
24960043|NCT00296400|50050607|FG000|Overall Study|Lost to Follow-up|1|||
25048517|NCT02587598|50151597|FG010|Overall Study|Study Terminated by the Sponsor|6|||
25048518|NCT02587598|50151587|FG000|Overall Study|Reason for study withdrawal not specified|0|||
25048519|NCT02587598|50151588|FG001|Overall Study|Reason for study withdrawal not specified|1|||
25048520|NCT02587598|50151589|FG002|Overall Study|Reason for study withdrawal not specified|0|||
24960044|NCT00296400|50050608|FG001|Overall Study|Lost to Follow-up|1|||
24960045|NCT00296400|50050609|FG002|Overall Study|Lost to Follow-up|2|||
24960046|NCT00296400|50050607|FG000|Overall Study|Study specific discontinuation criteria|0|||
25048521|NCT02587598|50151590|FG003|Overall Study|Reason for study withdrawal not specified|0|||
25048522|NCT02587598|50151591|FG004|Overall Study|Reason for study withdrawal not specified|0|||
25048523|NCT02587598|50151592|FG005|Overall Study|Reason for study withdrawal not specified|0|||
25048524|NCT02587598|50151593|FG006|Overall Study|Reason for study withdrawal not specified|0|||
25048525|NCT02587598|50151594|FG007|Overall Study|Reason for study withdrawal not specified|0|||
25048526|NCT02587598|50151595|FG008|Overall Study|Reason for study withdrawal not specified|0|||
25048527|NCT02587598|50151596|FG009|Overall Study|Reason for study withdrawal not specified|0|||
25048528|NCT02587598|50151597|FG010|Overall Study|Reason for study withdrawal not specified|0|||
25048529|NCT02587598|50151587|FG000|Overall Study|Withdrawal by Subject|0|||
25048530|NCT02587598|50151588|FG001|Overall Study|Withdrawal by Subject|1|||
25048531|NCT02587598|50151589|FG002|Overall Study|Withdrawal by Subject|0|||
25048532|NCT02587598|50151590|FG003|Overall Study|Withdrawal by Subject|2|||
25048533|NCT02587598|50151591|FG004|Overall Study|Withdrawal by Subject|3|||
25048534|NCT02587598|50151592|FG005|Overall Study|Withdrawal by Subject|1|||
25048535|NCT02587598|50151593|FG006|Overall Study|Withdrawal by Subject|0|||
25048536|NCT02587598|50151594|FG007|Overall Study|Withdrawal by Subject|0|||
25048537|NCT02587598|50151595|FG008|Overall Study|Withdrawal by Subject|0|||
25048538|NCT02587598|50151596|FG009|Overall Study|Withdrawal by Subject|1|||
25048539|NCT02587598|50151597|FG010|Overall Study|Withdrawal by Subject|2|||
25048540|NCT02587598|50151587|FG000|Overall Study|Physician Decision|0|||
25048541|NCT02587598|50151588|FG001|Overall Study|Physician Decision|0|||
25048542|NCT02587598|50151589|FG002|Overall Study|Physician Decision|0|||
25048543|NCT02587598|50151590|FG003|Overall Study|Physician Decision|0|||
25048544|NCT02587598|50151591|FG004|Overall Study|Physician Decision|0|||
25048545|NCT02587598|50151592|FG005|Overall Study|Physician Decision|0|||
25048546|NCT02587598|50151593|FG006|Overall Study|Physician Decision|0|||
25048547|NCT02587598|50151594|FG007|Overall Study|Physician Decision|0|||
25048548|NCT02587598|50151595|FG008|Overall Study|Physician Decision|0|||
25048549|NCT02587598|50151596|FG009|Overall Study|Physician Decision|0|||
25048550|NCT02587598|50151597|FG010|Overall Study|Physician Decision|3|||
25048551|NCT02485574|50151633|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
25048552|NCT02624284|50151645|FG000|Overall Study|Withdrawal by Subject|3|||
25048553|NCT02624284|50151646|FG001|Overall Study|Withdrawal by Subject|6|||
25048554|NCT02624284|50151647|FG002|Overall Study|Withdrawal by Subject|3|||
25048555|NCT02624284|50151645|FG000|Overall Study|Protocol Violation|9|||
25048556|NCT02624284|50151646|FG001|Overall Study|Protocol Violation|10|||
25048557|NCT02624284|50151647|FG002|Overall Study|Protocol Violation|7|||
25048558|NCT02624284|50151645|FG000|Overall Study|Revealed exclusionary condition|2|||
25048559|NCT02624284|50151646|FG001|Overall Study|Revealed exclusionary condition|2|||
25048560|NCT02624284|50151647|FG002|Overall Study|Revealed exclusionary condition|0|||
25048561|NCT02624284|50151645|FG000|Overall Study|Adverse Event|0|||
25048562|NCT02624284|50151646|FG001|Overall Study|Adverse Event|0|||
25048563|NCT02624284|50151647|FG002|Overall Study|Adverse Event|1|||
25048564|NCT02738450|50151659|FG000|Overall Study|Withdrawal by Subject|0|||
25048565|NCT02738450|50151660|FG001|Overall Study|Withdrawal by Subject|2|||
25048566|NCT02738450|50151661|FG002|Overall Study|Withdrawal by Subject|0|||
25048567|NCT02624050|50151672|FG000|Overall Study|Physician Decision|4|||
25048568|NCT02624050|50151673|FG001|Overall Study|Physician Decision|0|||
25048569|NCT02624050|50151672|FG000|Overall Study|Protocol Violation|2|||
25048570|NCT02624050|50151673|FG001|Overall Study|Protocol Violation|0|||
25048571|NCT01338987|50151689|FG000|Overall Study|enrolled on new protocol|0|||
25048572|NCT01338987|50151690|FG001|Overall Study|enrolled on new protocol|0|||
25048573|NCT01338987|50151691|FG002|Overall Study|enrolled on new protocol|1|||
25048574|NCT01338987|50151692|FG003|Overall Study|enrolled on new protocol|0|||
25048575|NCT01338987|50151693|FG004|Overall Study|enrolled on new protocol|0|||
25048576|NCT01338987|50151689|FG000|Overall Study|Disease progression on study|2|||
25048577|NCT01338987|50151690|FG001|Overall Study|Disease progression on study|1|||
25048578|NCT01338987|50151691|FG002|Overall Study|Disease progression on study|1|||
25048579|NCT01338987|50151692|FG003|Overall Study|Disease progression on study|0|||
25048580|NCT01338987|50151693|FG004|Overall Study|Disease progression on study|0|||
24960047|NCT00296400|50050608|FG001|Overall Study|Study specific discontinuation criteria|0|||
24960048|NCT00296400|50050609|FG002|Overall Study|Study specific discontinuation criteria|1|||
24960049|NCT00296400|50050607|FG000|Overall Study|Visit 10 was performed earlier|0|||
24960050|NCT00296400|50050608|FG001|Overall Study|Visit 10 was performed earlier|1|||
24960051|NCT00296400|50050609|FG002|Overall Study|Visit 10 was performed earlier|0|||
24960052|NCT00296400|50050607|FG000|Overall Study|Pregnancy|1|||
24960053|NCT00296400|50050608|FG001|Overall Study|Pregnancy|2|||
25048581|NCT03706430|50151707|FG000|Overall Study|No A-Line placed|5|||
25048582|NCT03706430|50151707|FG000|Overall Study|Subject had gel nail polish|1|||
25048583|NCT03706430|50151707|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
25048584|NCT03706430|50151707|FG000|Overall Study|Cancelled Case|6|||
25048585|NCT03706430|50151707|FG000|Overall Study|Physician Decision|2|||
25048586|NCT02738138|50151729|FG000|Overall Study|Adverse Event|0|||
25048587|NCT02738138|50151730|FG001|Overall Study|Adverse Event|1|||
25048588|NCT02738138|50151729|FG000|Overall Study|Lost to Follow-up|2|||
25048589|NCT02738138|50151730|FG001|Overall Study|Lost to Follow-up|0|||
25048590|NCT02738138|50151729|FG000|Overall Study|Other - not further specified|1|||
25048591|NCT02738138|50151730|FG001|Overall Study|Other - not further specified|0|||
25048592|NCT01355289|50151739|FG000|Core Study|Adverse Event, Non-Fatal|1|||
25048593|NCT01355289|50151740|FG001|Core Study|Adverse Event, Non-Fatal|0|||
25048594|NCT01355289|50151741|FG002|Core Study|Adverse Event, Non-Fatal|0|||
25048595|NCT01355289|50151742|FG003|Core Study|Adverse Event, Non-Fatal|0|||
25048596|NCT01355289|50151743|FG004|Core Study|Adverse Event, Non-Fatal|0|||
25048597|NCT01355289|50151739|FG000|Core Study|Inadequate Therapeutic Effect|0|||
25048598|NCT01355289|50151740|FG001|Core Study|Inadequate Therapeutic Effect|0|||
25048599|NCT01355289|50151741|FG002|Core Study|Inadequate Therapeutic Effect|0|||
25048600|NCT01355289|50151742|FG003|Core Study|Inadequate Therapeutic Effect|1|||
25048601|NCT01355289|50151743|FG004|Core Study|Inadequate Therapeutic Effect|0|||
25048602|NCT01355289|50151739|FG000|Core Study|Other|0|||
25048603|NCT01355289|50151740|FG001|Core Study|Other|0|||
25048604|NCT01355289|50151741|FG002|Core Study|Other|0|||
25048605|NCT01355289|50151742|FG003|Core Study|Other|1|||
25048606|NCT01355289|50151743|FG004|Core Study|Other|0|||
25048607|NCT01355289|50151739|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
25048608|NCT01355289|50151740|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
25048609|NCT01355289|50151741|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
25048610|NCT01355289|50151742|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
25048611|NCT01355289|50151743|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
25048612|NCT01355289|50151739|FG000|Open Label Extension|Lost to Follow-up|0|||
25048613|NCT01355289|50151740|FG001|Open Label Extension|Lost to Follow-up|0|||
25048614|NCT01355289|50151741|FG002|Open Label Extension|Lost to Follow-up|0|||
25048615|NCT01355289|50151742|FG003|Open Label Extension|Lost to Follow-up|0|||
25048616|NCT01355289|50151743|FG004|Open Label Extension|Lost to Follow-up|1|||
25048617|NCT01355289|50151739|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
25048618|NCT01355289|50151740|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
25048619|NCT01355289|50151741|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
25048620|NCT01355289|50151742|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
25048621|NCT01355289|50151743|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
25048622|NCT01355289|50151739|FG000|Open Label Extension|Other|0|||
25048623|NCT01355289|50151740|FG001|Open Label Extension|Other|0|||
25048624|NCT01355289|50151741|FG002|Open Label Extension|Other|0|||
25048625|NCT01355289|50151742|FG003|Open Label Extension|Other|0|||
25048626|NCT01355289|50151743|FG004|Open Label Extension|Other|3|||
25048627|NCT02737592|50151756|FG000|Overall Study|Withdrawal by Subject|1|||
25276441|NCT01243424|50590385|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
24960054|NCT00296400|50050609|FG002|Overall Study|Pregnancy|0|||
24960055|NCT00296244|50050622|FG000|Overall Study|Underwent retransplant|0|||
24960056|NCT00296244|50050623|FG001|Overall Study|Underwent retransplant|1|||
24960057|NCT00274716|50050640|FG000|Phase A|Other non-reported reason|4|||
24960058|NCT00274716|50050641|FG001|Phase A|Other non-reported reason|2|||
24960059|NCT00274716|50050642|FG002|Phase A|Other non-reported reason|1|||
24960060|NCT00274716|50050643|FG003|Phase A|Other non-reported reason|2|||
24960061|NCT00274716|50050644|FG004|Phase A|Other non-reported reason|0|||
24960062|NCT00274716|50050645|FG005|Phase A|Other non-reported reason|1|||
24960063|NCT00274716|50050640|FG000|Phase A|Participant moved|0|||
24960064|NCT00274716|50050641|FG001|Phase A|Participant moved|0|||
24960065|NCT00274716|50050642|FG002|Phase A|Participant moved|1|||
24960066|NCT00274716|50050643|FG003|Phase A|Participant moved|0|||
24960067|NCT00274716|50050644|FG004|Phase A|Participant moved|0|||
24960068|NCT00274716|50050645|FG005|Phase A|Participant moved|1|||
24960069|NCT00274716|50050640|FG000|Phase A|Site Terminated|0|||
24960070|NCT00274716|50050641|FG001|Phase A|Site Terminated|0|||
24960071|NCT00274716|50050642|FG002|Phase A|Site Terminated|0|||
24960072|NCT00274716|50050643|FG003|Phase A|Site Terminated|1|||
24960073|NCT00274716|50050644|FG004|Phase A|Site Terminated|0|||
24960074|NCT00274716|50050645|FG005|Phase A|Site Terminated|0|||
24960075|NCT00274716|50050640|FG000|Phase A|Protocol Violation|1|||
25048628|NCT02737358|50151783|FG000|Overall Study|Withdrawal by Subject|7|||
25048629|NCT02737358|50151784|FG001|Overall Study|Withdrawal by Subject|12|||
25048630|NCT02737358|50151783|FG000|Overall Study|Lost to Follow-up|2|||
25048631|NCT02737358|50151784|FG001|Overall Study|Lost to Follow-up|3|||
24960076|NCT00274716|50050641|FG001|Phase A|Protocol Violation|0|||
24960077|NCT00274716|50050642|FG002|Phase A|Protocol Violation|0|||
25048632|NCT01354431|50151793|FG000|Pre-Treatment Period|Not reported|1|||
24960078|NCT00274716|50050643|FG003|Phase A|Protocol Violation|1|||
25048633|NCT01354431|50151794|FG001|Pre-Treatment Period|Not reported|0|||
25048634|NCT01354431|50151795|FG002|Pre-Treatment Period|Not reported|0|||
24960079|NCT00274716|50050644|FG004|Phase A|Protocol Violation|0|||
24960080|NCT00274716|50050645|FG005|Phase A|Protocol Violation|0|||
25048635|NCT01354431|50151793|FG000|Treatment Period|Disease Progression|50|||
25048636|NCT01354431|50151794|FG001|Treatment Period|Disease Progression|40|||
25048637|NCT01354431|50151795|FG002|Treatment Period|Disease Progression|44|||
25048638|NCT01354431|50151793|FG000|Treatment Period|Study Drug Toxicity|5|||
25048639|NCT01354431|50151794|FG001|Treatment Period|Study Drug Toxicity|8|||
25048640|NCT01354431|50151795|FG002|Treatment Period|Study Drug Toxicity|4|||
25048641|NCT01354431|50151793|FG000|Treatment Period|Death|0|||
25048642|NCT01354431|50151794|FG001|Treatment Period|Death|1|||
25048643|NCT01354431|50151795|FG002|Treatment Period|Death|0|||
25048644|NCT01354431|50151793|FG000|Treatment Period|AE unrelated to study drug|1|||
24960081|NCT00274716|50050640|FG000|Phase A|Met criteria for discontinuation|1|||
24960082|NCT00274716|50050641|FG001|Phase A|Met criteria for discontinuation|1|||
24960083|NCT00274716|50050642|FG002|Phase A|Met criteria for discontinuation|0|||
24960084|NCT00274716|50050643|FG003|Phase A|Met criteria for discontinuation|0|||
24960085|NCT00274716|50050644|FG004|Phase A|Met criteria for discontinuation|0|||
24960086|NCT00274716|50050645|FG005|Phase A|Met criteria for discontinuation|0|||
24960087|NCT00274716|50050640|FG000|Phase A|Withdrawal by Subject|2|||
24960088|NCT00274716|50050641|FG001|Phase A|Withdrawal by Subject|2|||
24960089|NCT00274716|50050642|FG002|Phase A|Withdrawal by Subject|1|||
24960090|NCT00274716|50050643|FG003|Phase A|Withdrawal by Subject|3|||
24960091|NCT00274716|50050644|FG004|Phase A|Withdrawal by Subject|0|||
24960092|NCT00274716|50050645|FG005|Phase A|Withdrawal by Subject|1|||
24960093|NCT00274716|50050640|FG000|Phase A|Adverse Event|2|||
24960094|NCT00274716|50050641|FG001|Phase A|Adverse Event|3|||
24960095|NCT00274716|50050642|FG002|Phase A|Adverse Event|3|||
24960096|NCT00274716|50050643|FG003|Phase A|Adverse Event|0|||
24960097|NCT00274716|50050644|FG004|Phase A|Adverse Event|2|||
24960098|NCT00274716|50050645|FG005|Phase A|Adverse Event|0|||
24960099|NCT00274716|50050640|FG000|Phase A|Completed but did not enter Phase B|1|||
24960100|NCT00274716|50050641|FG001|Phase A|Completed but did not enter Phase B|2|||
24960101|NCT00274716|50050642|FG002|Phase A|Completed but did not enter Phase B|2|||
24960102|NCT00274716|50050643|FG003|Phase A|Completed but did not enter Phase B|2|||
24960103|NCT00274716|50050644|FG004|Phase A|Completed but did not enter Phase B|1|||
24960104|NCT00274716|50050645|FG005|Phase A|Completed but did not enter Phase B|1|||
24960105|NCT00274716|50050640|FG000|Phase B|Adverse Event|0|||
24960106|NCT00274716|50050641|FG001|Phase B|Adverse Event|0|||
24960107|NCT00274716|50050642|FG002|Phase B|Adverse Event|2|||
24960108|NCT00274716|50050643|FG003|Phase B|Adverse Event|0|||
24960109|NCT00274716|50050644|FG004|Phase B|Adverse Event|0|||
24960110|NCT00274716|50050645|FG005|Phase B|Adverse Event|1|||
24960111|NCT00274716|50050640|FG000|Phase B|Protocol Violation|0|||
24960112|NCT00274716|50050641|FG001|Phase B|Protocol Violation|2|||
24960113|NCT00274716|50050642|FG002|Phase B|Protocol Violation|0|||
24960114|NCT00274716|50050643|FG003|Phase B|Protocol Violation|0|||
24960115|NCT00274716|50050644|FG004|Phase B|Protocol Violation|0|||
24960116|NCT00274716|50050645|FG005|Phase B|Protocol Violation|0|||
24960117|NCT00274716|50050640|FG000|Phase B|Withdrawal by Subject|0|||
24960118|NCT00274716|50050641|FG001|Phase B|Withdrawal by Subject|1|||
24960119|NCT00274716|50050642|FG002|Phase B|Withdrawal by Subject|0|||
24960120|NCT00274716|50050643|FG003|Phase B|Withdrawal by Subject|0|||
24960121|NCT00274716|50050644|FG004|Phase B|Withdrawal by Subject|0|||
24960122|NCT00274716|50050645|FG005|Phase B|Withdrawal by Subject|0|||
24960123|NCT00274716|50050640|FG000|Phase B|Participant moved|1|||
24960124|NCT00274716|50050641|FG001|Phase B|Participant moved|0|||
24960125|NCT00274716|50050642|FG002|Phase B|Participant moved|0|||
24960126|NCT00274716|50050643|FG003|Phase B|Participant moved|0|||
24960127|NCT00274716|50050644|FG004|Phase B|Participant moved|0|||
24960128|NCT00274716|50050645|FG005|Phase B|Participant moved|0|||
24960129|NCT00274716|50050640|FG000|Phase B|Other non-reported reason|0|||
24960130|NCT00274716|50050641|FG001|Phase B|Other non-reported reason|0|||
24960131|NCT00274716|50050642|FG002|Phase B|Other non-reported reason|1|||
24960132|NCT00274716|50050643|FG003|Phase B|Other non-reported reason|1|||
24960133|NCT00274716|50050644|FG004|Phase B|Other non-reported reason|0|||
24960134|NCT00274716|50050645|FG005|Phase B|Other non-reported reason|0|||
24960135|NCT00274716|50050640|FG000|Phase B|Lost to Follow-up|0|||
24960136|NCT00274716|50050641|FG001|Phase B|Lost to Follow-up|1|||
24960137|NCT00274716|50050642|FG002|Phase B|Lost to Follow-up|0|||
24960138|NCT00274716|50050643|FG003|Phase B|Lost to Follow-up|0|||
24960139|NCT00274716|50050644|FG004|Phase B|Lost to Follow-up|0|||
24960140|NCT00274716|50050645|FG005|Phase B|Lost to Follow-up|0|||
24960141|NCT00282048|50050663|FG000|Overall Study|Lack of Efficacy|30|||
25048645|NCT01354431|50151794|FG001|Treatment Period|AE unrelated to study drug|2|||
25048646|NCT01354431|50151795|FG002|Treatment Period|AE unrelated to study drug|5|||
24960142|NCT00282048|50050663|FG000|Overall Study|Adverse Event|22|||
24960143|NCT00282048|50050663|FG000|Overall Study|Withdrawal by Subject|1|||
24960144|NCT00282048|50050663|FG000|Overall Study|Other|8|||
24960145|NCT00282048|50050663|FG000|Overall Study|Ongoing|1|||
25048647|NCT01354431|50151793|FG000|Treatment Period|Participant request to discontinue|2|||
24960146|NCT00474539|50050669|FG000|Infant Series|Withdrawal by Subject|3|||
25048648|NCT01354431|50151794|FG001|Treatment Period|Participant request to discontinue|2|||
25048649|NCT01354431|50151795|FG002|Treatment Period|Participant request to discontinue|1|||
25048650|NCT01354431|50151793|FG000|Treatment Period|Participant withdrew consent|0|||
25048651|NCT01354431|50151794|FG001|Treatment Period|Participant withdrew consent|1|||
25048652|NCT01354431|50151795|FG002|Treatment Period|Participant withdrew consent|0|||
25048653|NCT01354431|50151793|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
25048654|NCT01354431|50151794|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
25048655|NCT01354431|50151795|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
25048656|NCT02736578|50151805|FG000|Overall Study|Adverse Event|1|||
25048657|NCT02736578|50151806|FG001|Overall Study|Adverse Event|0|||
25048658|NCT02622724|50151818|FG000|Overall Study|Death|51|||
25048659|NCT02622724|50151819|FG001|Overall Study|Death|53|||
25048660|NCT02622724|50151818|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
25048661|NCT02622724|50151819|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
25048662|NCT02622724|50151818|FG000|Overall Study|Early termination of study|38|||
25048663|NCT02622724|50151819|FG001|Overall Study|Early termination of study|43|||
25048664|NCT01354353|50151837|FG000|Overall Study|Adverse Event|1|||
25048665|NCT01354353|50151838|FG001|Overall Study|Adverse Event|0|||
25048666|NCT01354353|50151839|FG002|Overall Study|Adverse Event|0|||
25048667|NCT01354353|50151840|FG003|Overall Study|Adverse Event|4|||
25048668|NCT01354353|50151841|FG004|Overall Study|Adverse Event|0|||
25048669|NCT01354353|50151842|FG005|Overall Study|Adverse Event|5|||
25048670|NCT01354353|50151837|FG000|Overall Study|Entry Criteria Not Met|0|||
25048671|NCT01354353|50151838|FG001|Overall Study|Entry Criteria Not Met|0|||
25048672|NCT01354353|50151839|FG002|Overall Study|Entry Criteria Not Met|0|||
25048673|NCT01354353|50151840|FG003|Overall Study|Entry Criteria Not Met|1|||
25048674|NCT01354353|50151841|FG004|Overall Study|Entry Criteria Not Met|1|||
25048675|NCT01354353|50151842|FG005|Overall Study|Entry Criteria Not Met|0|||
25048676|NCT01354353|50151837|FG000|Overall Study|Physician Decision|0|||
25048677|NCT01354353|50151838|FG001|Overall Study|Physician Decision|1|||
25048678|NCT01354353|50151839|FG002|Overall Study|Physician Decision|1|||
25048679|NCT01354353|50151840|FG003|Overall Study|Physician Decision|0|||
25048680|NCT01354353|50151841|FG004|Overall Study|Physician Decision|0|||
25048681|NCT01354353|50151842|FG005|Overall Study|Physician Decision|0|||
25048682|NCT01354353|50151837|FG000|Overall Study|Withdrawal by Subject|2|||
25048683|NCT01354353|50151838|FG001|Overall Study|Withdrawal by Subject|0|||
25048684|NCT01354353|50151839|FG002|Overall Study|Withdrawal by Subject|1|||
25048685|NCT01354353|50151840|FG003|Overall Study|Withdrawal by Subject|0|||
25048686|NCT01354353|50151841|FG004|Overall Study|Withdrawal by Subject|0|||
25048687|NCT01354353|50151842|FG005|Overall Study|Withdrawal by Subject|1|||
25048688|NCT02622568|50151865|FG000|Overall Study|Lost to Follow-up|5|||
25048689|NCT02622568|50151866|FG001|Overall Study|Lost to Follow-up|5|||
25048690|NCT01354899|50151872|FG000|Overall Study|discharge from the hospital|2|||
25048691|NCT01354899|50151872|FG000|Overall Study|Protocol Violation|1|||
25048692|NCT01353963|50151876|FG000|Overall Study|Adverse Event|2|||
25048693|NCT02820597|50151885|FG000|Overall Study|Lost to Follow-up|12|||
25048694|NCT02822235|50151891|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
25048695|NCT02822235|50151892|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
25048696|NCT02822235|50151891|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
25048697|NCT02822235|50151892|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
25048698|NCT02822235|50151891|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
25048699|NCT02822235|50151892|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
25048700|NCT02822235|50151891|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
25048701|NCT02822235|50151892|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
25048702|NCT02822235|50151891|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
25048703|NCT02822235|50151892|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
25048704|NCT02822235|50151891|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
25048705|NCT02822235|50151892|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
25048706|NCT02817555|50151907|FG000|Overall Study|Death|1|||
25048707|NCT02817555|50151908|FG001|Overall Study|Death|3|||
25048708|NCT02817555|50151907|FG000|Overall Study|moved away|1|||
25048709|NCT02817555|50151908|FG001|Overall Study|moved away|0|||
25048710|NCT02817555|50151907|FG000|Overall Study|transplant|1|||
25048711|NCT02817555|50151908|FG001|Overall Study|transplant|1|||
25048712|NCT02817555|50151907|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
25048713|NCT02817555|50151908|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
25048714|NCT02817087|50151916|FG000|Overall Study|Withdrawal by Subject|2|||
25048715|NCT02817087|50151917|FG001|Overall Study|Withdrawal by Subject|0|||
25048716|NCT02813577|50151923|FG000|Overall Study|Study terminated|4|||
25048717|NCT02815293|50151930|FG000|Overall Study|Study termination by sponsor|10|||
25048718|NCT02815293|50151931|FG001|Overall Study|Study termination by sponsor|7|||
25048719|NCT02815293|50151932|FG002|Overall Study|Study termination by sponsor|0|||
25162533|NCT01791517|50284758|FG009|Phase II|Lack of Efficacy|0|||
25048720|NCT02815293|50151930|FG000|Overall Study|Participants not randomized|0|||
25048721|NCT02815293|50151931|FG001|Overall Study|Participants not randomized|0|||
25048722|NCT02815293|50151932|FG002|Overall Study|Participants not randomized|18|||
25048723|NCT02815293|50151930|FG000|Overall Study|Adverse Event|0|||
25048724|NCT02815293|50151931|FG001|Overall Study|Adverse Event|1|||
25048725|NCT02815293|50151932|FG002|Overall Study|Adverse Event|0|||
25048726|NCT02813421|50151940|FG000|Overall Study|Withdrawal by Subject|1|||
25048727|NCT02813421|50151941|FG001|Overall Study|Withdrawal by Subject|2|||
25048728|NCT02813421|50151940|FG000|Overall Study|Lost to Follow-up|1|||
25048729|NCT02813421|50151941|FG001|Overall Study|Lost to Follow-up|1|||
25048730|NCT03672188|50151962|FG000|Overall Study|Withdrawal by Subject|0|||
25048731|NCT03672188|50151963|FG001|Overall Study|Withdrawal by Subject|0|||
25048732|NCT03672188|50151964|FG002|Overall Study|Withdrawal by Subject|0|||
25048733|NCT03672188|50151965|FG003|Overall Study|Withdrawal by Subject|3|||
25048734|NCT03672188|50151966|FG004|Overall Study|Withdrawal by Subject|0|||
25048735|NCT03672188|50151967|FG005|Overall Study|Withdrawal by Subject|0|||
25048736|NCT03672188|50151968|FG006|Overall Study|Withdrawal by Subject|0|||
25048737|NCT03672188|50151969|FG007|Overall Study|Withdrawal by Subject|0|||
25048738|NCT03672188|50151970|FG008|Overall Study|Withdrawal by Subject|0|||
25048739|NCT03672188|50151971|FG009|Overall Study|Withdrawal by Subject|0|||
25048740|NCT03672188|50151972|FG010|Overall Study|Withdrawal by Subject|0|||
25048741|NCT03672188|50151973|FG011|Overall Study|Withdrawal by Subject|0|||
25048742|NCT03672188|50151974|FG012|Overall Study|Withdrawal by Subject|0|||
25048743|NCT03672188|50151975|FG013|Overall Study|Withdrawal by Subject|0|||
25048744|NCT03672188|50151976|FG014|Overall Study|Withdrawal by Subject|0|||
25048745|NCT03672188|50151962|FG000|Overall Study|Death|0|||
25048746|NCT03672188|50151963|FG001|Overall Study|Death|0|||
25048747|NCT03672188|50151964|FG002|Overall Study|Death|0|||
25048748|NCT03672188|50151965|FG003|Overall Study|Death|0|||
25048749|NCT03672188|50151966|FG004|Overall Study|Death|0|||
25048750|NCT03672188|50151967|FG005|Overall Study|Death|0|||
25048751|NCT03672188|50151968|FG006|Overall Study|Death|0|||
25048752|NCT03672188|50151969|FG007|Overall Study|Death|0|||
25048753|NCT03672188|50151970|FG008|Overall Study|Death|0|||
25048754|NCT03672188|50151971|FG009|Overall Study|Death|0|||
25048755|NCT03672188|50151972|FG010|Overall Study|Death|0|||
25048756|NCT03672188|50151973|FG011|Overall Study|Death|0|||
25048757|NCT03672188|50151974|FG012|Overall Study|Death|1|||
25048758|NCT03672188|50151975|FG013|Overall Study|Death|0|||
25048759|NCT03672188|50151976|FG014|Overall Study|Death|0|||
25048760|NCT03672188|50151962|FG000|Overall Study|Lost to Follow-up|0|||
25048761|NCT03672188|50151963|FG001|Overall Study|Lost to Follow-up|0|||
24960147|NCT00474539|50050670|FG001|Infant Series|Withdrawal by Subject|4|||
24960148|NCT00474539|50050669|FG000|Infant Series|Randomization error|5|||
24960149|NCT00474539|50050670|FG001|Infant Series|Randomization error|0|||
24960150|NCT00474539|50050669|FG000|Infant Series|Lost to Follow-up|2|||
24960151|NCT00474539|50050670|FG001|Infant Series|Lost to Follow-up|1|||
24960152|NCT00474539|50050669|FG000|Infant Series|Protocol Violation|0|||
24960153|NCT00474539|50050670|FG001|Infant Series|Protocol Violation|1|||
24960154|NCT00474539|50050669|FG000|After Infant Series|Lost to Follow-up|3|||
24960155|NCT00474539|50050670|FG001|After Infant Series|Lost to Follow-up|0|||
24960156|NCT00474539|50050669|FG000|After Infant Series|Withdrawal by Subject|1|||
24960157|NCT00474539|50050670|FG001|After Infant Series|Withdrawal by Subject|0|||
25048762|NCT03672188|50151964|FG002|Overall Study|Lost to Follow-up|1|||
25048763|NCT03672188|50151965|FG003|Overall Study|Lost to Follow-up|0|||
25048764|NCT03672188|50151966|FG004|Overall Study|Lost to Follow-up|0|||
25048765|NCT03672188|50151967|FG005|Overall Study|Lost to Follow-up|0|||
25048766|NCT03672188|50151968|FG006|Overall Study|Lost to Follow-up|0|||
25048767|NCT03672188|50151969|FG007|Overall Study|Lost to Follow-up|0|||
25048768|NCT03672188|50151970|FG008|Overall Study|Lost to Follow-up|0|||
25048769|NCT03672188|50151971|FG009|Overall Study|Lost to Follow-up|0|||
25048770|NCT03672188|50151972|FG010|Overall Study|Lost to Follow-up|0|||
25048771|NCT03672188|50151973|FG011|Overall Study|Lost to Follow-up|0|||
25048772|NCT03672188|50151974|FG012|Overall Study|Lost to Follow-up|0|||
24960158|NCT00474539|50050669|FG000|Toddler Dose|Protocol Violation|1|||
24960159|NCT00474539|50050670|FG001|Toddler Dose|Protocol Violation|0|||
24960160|NCT00281580|50050717|FG000|Overall Study|Adverse Event|2|||
24960161|NCT00281580|50050718|FG001|Overall Study|Adverse Event|0|||
24960162|NCT00281580|50050719|FG002|Overall Study|Adverse Event|2|||
25048773|NCT03672188|50151975|FG013|Overall Study|Lost to Follow-up|0|||
25048774|NCT03672188|50151976|FG014|Overall Study|Lost to Follow-up|0|||
25048775|NCT02620384|50152044|FG000|Overall Study|Adverse Event|2|||
25048776|NCT02620384|50152045|FG001|Overall Study|Adverse Event|1|||
25048777|NCT02620384|50152044|FG000|Overall Study|Discharged prior to 2nd dose|2|||
25048778|NCT02620384|50152045|FG001|Overall Study|Discharged prior to 2nd dose|5|||
25048779|NCT02620384|50152044|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
25048780|NCT02620384|50152045|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
25048781|NCT03915860|50152051|FG000|Overall Study|Adverse Event|3|||
25048782|NCT03915860|50152051|FG000|Overall Study|Withdrawal by Subject|6|||
25048783|NCT03915860|50152051|FG000|Overall Study|Lost to Follow-up|2|||
25048784|NCT03915860|50152051|FG000|Overall Study|Other than specified|3|||
25048785|NCT03786380|50152060|FG000|Overall Study|Adverse Event|1|||
25048786|NCT03786380|50152061|FG001|Overall Study|Adverse Event|0|||
24960163|NCT00281580|50050720|FG003|Overall Study|Adverse Event|4|||
24960164|NCT00281580|50050721|FG004|Overall Study|Adverse Event|1|||
24960165|NCT00281580|50050722|FG005|Overall Study|Adverse Event|0|||
24960166|NCT00281580|50050723|FG006|Overall Study|Adverse Event|1|||
24960167|NCT00281580|50050724|FG007|Overall Study|Adverse Event|0|||
24960168|NCT00281580|50050725|FG008|Overall Study|Adverse Event|1|||
24960169|NCT00281580|50050726|FG009|Overall Study|Adverse Event|6|||
24960170|NCT00281580|50050727|FG010|Overall Study|Adverse Event|0|||
24960171|NCT00281580|50050728|FG011|Overall Study|Adverse Event|5|||
24960172|NCT00281580|50050729|FG012|Overall Study|Adverse Event|8|||
25048787|NCT03786380|50152062|FG002|Overall Study|Adverse Event|0|||
25048788|NCT03786380|50152063|FG003|Overall Study|Adverse Event|3|||
25048789|NCT03786380|50152064|FG004|Overall Study|Adverse Event|1|||
25048790|NCT03786380|50152060|FG000|Overall Study|Lack of Efficacy|0|||
25048791|NCT03786380|50152061|FG001|Overall Study|Lack of Efficacy|0|||
25048792|NCT03786380|50152062|FG002|Overall Study|Lack of Efficacy|0|||
25048793|NCT03786380|50152063|FG003|Overall Study|Lack of Efficacy|0|||
25048794|NCT03786380|50152064|FG004|Overall Study|Lack of Efficacy|1|||
25048795|NCT03786380|50152060|FG000|Overall Study|Withdrawal by Subject|1|||
25048796|NCT03786380|50152061|FG001|Overall Study|Withdrawal by Subject|2|||
25048797|NCT03786380|50152062|FG002|Overall Study|Withdrawal by Subject|2|||
25048798|NCT03786380|50152063|FG003|Overall Study|Withdrawal by Subject|1|||
25048799|NCT03786380|50152064|FG004|Overall Study|Withdrawal by Subject|2|||
25048800|NCT03786380|50152060|FG000|Overall Study|Lost to Follow-up|3|||
25048801|NCT03786380|50152061|FG001|Overall Study|Lost to Follow-up|0|||
25048802|NCT03786380|50152062|FG002|Overall Study|Lost to Follow-up|1|||
25048803|NCT03786380|50152063|FG003|Overall Study|Lost to Follow-up|2|||
25048804|NCT03786380|50152064|FG004|Overall Study|Lost to Follow-up|0|||
25048805|NCT03786380|50152060|FG000|Overall Study|Physician Decision|0|||
25048806|NCT03786380|50152061|FG001|Overall Study|Physician Decision|0|||
25048807|NCT03786380|50152062|FG002|Overall Study|Physician Decision|1|||
25048808|NCT03786380|50152063|FG003|Overall Study|Physician Decision|0|||
25048809|NCT03786380|50152064|FG004|Overall Study|Physician Decision|0|||
25048810|NCT03786380|50152060|FG000|Overall Study|Study Terminated by the Sponsor|30|||
25048811|NCT03786380|50152061|FG001|Overall Study|Study Terminated by the Sponsor|20|||
25048812|NCT03786380|50152062|FG002|Overall Study|Study Terminated by the Sponsor|50|||
25048813|NCT03786380|50152063|FG003|Overall Study|Study Terminated by the Sponsor|57|||
25048814|NCT03786380|50152064|FG004|Overall Study|Study Terminated by the Sponsor|23|||
25048815|NCT03786380|50152060|FG000|Overall Study|Reason Not Specified|0|||
25048816|NCT03786380|50152061|FG001|Overall Study|Reason Not Specified|0|||
25048817|NCT03786380|50152062|FG002|Overall Study|Reason Not Specified|0|||
24960173|NCT00281580|50050730|FG013|Overall Study|Adverse Event|2|||
24960174|NCT00281580|50050731|FG014|Overall Study|Adverse Event|3|||
24960175|NCT00281580|50050732|FG015|Overall Study|Adverse Event|3|||
25048818|NCT03786380|50152063|FG003|Overall Study|Reason Not Specified|0|||
25048819|NCT03786380|50152064|FG004|Overall Study|Reason Not Specified|1|||
25048820|NCT02626000|50152076|FG000|Overall Study|Decision by Sponsor|1|||
25048821|NCT02626000|50152076|FG000|Overall Study|Death|29|||
25048822|NCT02736890|50152092|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
25048823|NCT02736890|50152093|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
25048824|NCT02736890|50152092|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
25276442|NCT01243424|50590386|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
24960176|NCT00281580|50050717|FG000|Overall Study|Protocol Violation|0|||
25048825|NCT02736890|50152093|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
25048826|NCT02779556|50152101|FG000|Baseline|Partial baseline interview completed|1|||
25048827|NCT02779556|50152102|FG001|Baseline|Partial baseline interview completed|0|||
25048828|NCT02779556|50152101|FG000|3 Months|Lost to Follow-up|40|||
25048829|NCT02779556|50152102|FG001|3 Months|Lost to Follow-up|29|||
25048830|NCT02779556|50152101|FG000|3 Months|Missed 3 month clinic visit|27|||
25048831|NCT02779556|50152102|FG001|3 Months|Missed 3 month clinic visit|19|||
25048832|NCT02779556|50152101|FG000|6 Month|Lost to Follow-up|33|||
25276443|NCT01243424|50590385|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
25048833|NCT02779556|50152102|FG001|6 Month|Lost to Follow-up|39|||
25048834|NCT02779556|50152101|FG000|6 Month HbA1c|No value collected during window|69|||
25276955|NCT00957034|50590924|FG000|Overall Study|Adverse Event|0|||
24960177|NCT00281580|50050718|FG001|Overall Study|Protocol Violation|0|||
25048835|NCT02779556|50152102|FG001|6 Month HbA1c|No value collected during window|50|||
25048836|NCT02779556|50152101|FG000|12 Month HbA1c|No value collected during window|138|||
25048837|NCT02779556|50152102|FG001|12 Month HbA1c|No value collected during window|102|||
25048838|NCT01669798|50152108|FG000|Overall Study|Physician Decision|5|||
25048839|NCT02334722|50152114|FG000|Overall Study|Lost to Follow-up|4|||
25048840|NCT02334722|50152115|FG001|Overall Study|Lost to Follow-up|0|||
25048841|NCT02334722|50152114|FG000|Overall Study|6 week questionnaire not completed|2|||
25048842|NCT02334722|50152115|FG001|Overall Study|6 week questionnaire not completed|0|||
25048843|NCT02334722|50152114|FG000|Overall Study|Unable to obtain medication|1|||
25048844|NCT02334722|50152115|FG001|Overall Study|Unable to obtain medication|1|||
25048845|NCT02334722|50152114|FG000|Overall Study|Withdrawal by Subject|0|||
25048846|NCT02334722|50152115|FG001|Overall Study|Withdrawal by Subject|3|||
25048847|NCT02334722|50152114|FG000|Overall Study|Adverse Event|0|||
25048848|NCT02334722|50152115|FG001|Overall Study|Adverse Event|2|||
25048849|NCT02334722|50152114|FG000|Overall Study|Physician Decision|0|||
25048850|NCT02334722|50152115|FG001|Overall Study|Physician Decision|1|||
25048851|NCT00812708|50152130|FG000|Overall Study|Device could not be implanted|2|||
25048852|NCT00812708|50152130|FG000|Overall Study|Lack of medical insurance|1|||
25048853|NCT00812708|50152130|FG000|Overall Study|Switched to another study|1|||
25048854|NCT00812708|50152130|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
25048855|NCT00812708|50152130|FG000|Overall Study|Signed consent but later withdrew|3|||
25048856|NCT03761810|50152146|FG000|Overall Study|Adverse Event|12|||
25048857|NCT03761810|50152147|FG001|Overall Study|Adverse Event|0|||
24960178|NCT00281580|50050719|FG002|Overall Study|Protocol Violation|1|||
25048858|NCT03761810|50152146|FG000|Overall Study|Lost to Follow-up|15|||
25048859|NCT03761810|50152147|FG001|Overall Study|Lost to Follow-up|7|||
25048860|NCT03761810|50152146|FG000|Overall Study|Pregnancy|1|||
25048861|NCT03761810|50152147|FG001|Overall Study|Pregnancy|0|||
25048862|NCT03761810|50152146|FG000|Overall Study|Withdrawal by Subject|14|||
25048863|NCT03761810|50152147|FG001|Overall Study|Withdrawal by Subject|5|||
25048864|NCT03761810|50152146|FG000|Overall Study|Physician Decision|1|||
25048865|NCT03761810|50152147|FG001|Overall Study|Physician Decision|0|||
25048866|NCT03761810|50152146|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
25048867|NCT03761810|50152147|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
25048868|NCT03761810|50152146|FG000|Overall Study|Other Than Specified|1|||
24960179|NCT00281580|50050720|FG003|Overall Study|Protocol Violation|1|||
24960180|NCT00281580|50050721|FG004|Overall Study|Protocol Violation|0|||
24960181|NCT00281580|50050722|FG005|Overall Study|Protocol Violation|0|||
24960182|NCT00281580|50050723|FG006|Overall Study|Protocol Violation|1|||
24960183|NCT00281580|50050724|FG007|Overall Study|Protocol Violation|0|||
24960184|NCT00281580|50050725|FG008|Overall Study|Protocol Violation|2|||
24960185|NCT00281580|50050726|FG009|Overall Study|Protocol Violation|0|||
24960186|NCT00281580|50050727|FG010|Overall Study|Protocol Violation|1|||
24960187|NCT00281580|50050728|FG011|Overall Study|Protocol Violation|2|||
24960188|NCT00281580|50050729|FG012|Overall Study|Protocol Violation|0|||
24960189|NCT00281580|50050730|FG013|Overall Study|Protocol Violation|1|||
24960190|NCT00281580|50050731|FG014|Overall Study|Protocol Violation|1|||
24960191|NCT00281580|50050732|FG015|Overall Study|Protocol Violation|3|||
24960192|NCT00281580|50050717|FG000|Overall Study|Withdrawal by Subject|3|||
24960193|NCT00281580|50050718|FG001|Overall Study|Withdrawal by Subject|0|||
24960194|NCT00281580|50050719|FG002|Overall Study|Withdrawal by Subject|1|||
24960195|NCT00281580|50050720|FG003|Overall Study|Withdrawal by Subject|1|||
24960196|NCT00281580|50050721|FG004|Overall Study|Withdrawal by Subject|1|||
24960197|NCT00281580|50050722|FG005|Overall Study|Withdrawal by Subject|2|||
24960198|NCT00281580|50050723|FG006|Overall Study|Withdrawal by Subject|2|||
24960199|NCT00281580|50050724|FG007|Overall Study|Withdrawal by Subject|0|||
24960200|NCT00281580|50050725|FG008|Overall Study|Withdrawal by Subject|1|||
24960201|NCT00281580|50050726|FG009|Overall Study|Withdrawal by Subject|4|||
24960202|NCT00281580|50050727|FG010|Overall Study|Withdrawal by Subject|1|||
24960203|NCT00281580|50050728|FG011|Overall Study|Withdrawal by Subject|1|||
24960204|NCT00281580|50050729|FG012|Overall Study|Withdrawal by Subject|2|||
24960205|NCT00281580|50050730|FG013|Overall Study|Withdrawal by Subject|2|||
24960206|NCT00281580|50050731|FG014|Overall Study|Withdrawal by Subject|1|||
24960207|NCT00281580|50050732|FG015|Overall Study|Withdrawal by Subject|5|||
24960208|NCT00281580|50050717|FG000|Overall Study|Lack of Efficacy|2|||
24960209|NCT00281580|50050718|FG001|Overall Study|Lack of Efficacy|1|||
24960210|NCT00281580|50050719|FG002|Overall Study|Lack of Efficacy|1|||
25048869|NCT03761810|50152147|FG001|Overall Study|Other Than Specified|0|||
25048870|NCT02811861|50152161|FG000|Overall Study|Radiological Disease Progression|123|||
25276444|NCT01243424|50590386|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
25048871|NCT02811861|50152162|FG001|Overall Study|Radiological Disease Progression|97|||
25048872|NCT02811861|50152163|FG002|Overall Study|Radiological Disease Progression|174|||
24960211|NCT00281580|50050720|FG003|Overall Study|Lack of Efficacy|6|||
24960212|NCT00281580|50050721|FG004|Overall Study|Lack of Efficacy|2|||
24960213|NCT00281580|50050722|FG005|Overall Study|Lack of Efficacy|0|||
24960214|NCT00281580|50050723|FG006|Overall Study|Lack of Efficacy|0|||
24960215|NCT00281580|50050724|FG007|Overall Study|Lack of Efficacy|0|||
24960216|NCT00281580|50050725|FG008|Overall Study|Lack of Efficacy|0|||
24960217|NCT00281580|50050726|FG009|Overall Study|Lack of Efficacy|0|||
24960218|NCT00281580|50050727|FG010|Overall Study|Lack of Efficacy|0|||
24960219|NCT00281580|50050728|FG011|Overall Study|Lack of Efficacy|1|||
24960220|NCT00281580|50050729|FG012|Overall Study|Lack of Efficacy|0|||
24960221|NCT00281580|50050730|FG013|Overall Study|Lack of Efficacy|2|||
24960222|NCT00281580|50050731|FG014|Overall Study|Lack of Efficacy|1|||
24960223|NCT00281580|50050732|FG015|Overall Study|Lack of Efficacy|0|||
24960224|NCT00281580|50050717|FG000|Overall Study|Lost to Follow-up|0|||
24960225|NCT00281580|50050718|FG001|Overall Study|Lost to Follow-up|0|||
24960226|NCT00281580|50050719|FG002|Overall Study|Lost to Follow-up|0|||
24960227|NCT00281580|50050720|FG003|Overall Study|Lost to Follow-up|3|||
24960228|NCT00281580|50050721|FG004|Overall Study|Lost to Follow-up|0|||
24960229|NCT00281580|50050722|FG005|Overall Study|Lost to Follow-up|1|||
24960230|NCT00281580|50050723|FG006|Overall Study|Lost to Follow-up|0|||
24960231|NCT00281580|50050724|FG007|Overall Study|Lost to Follow-up|1|||
24960232|NCT00281580|50050725|FG008|Overall Study|Lost to Follow-up|2|||
25048873|NCT02811861|50152161|FG000|Overall Study|Clinical Disease Progression|20|||
25048874|NCT02811861|50152162|FG001|Overall Study|Clinical Disease Progression|19|||
25048875|NCT02811861|50152163|FG002|Overall Study|Clinical Disease Progression|22|||
25048876|NCT02811861|50152161|FG000|Overall Study|Adverse Event|63|||
25048877|NCT02811861|50152162|FG001|Overall Study|Adverse Event|60|||
25048878|NCT02811861|50152163|FG002|Overall Study|Adverse Event|41|||
25048879|NCT02811861|50152161|FG000|Overall Study|Lost to Follow-up|0|||
25048880|NCT02811861|50152162|FG001|Overall Study|Lost to Follow-up|0|||
25048881|NCT02811861|50152163|FG002|Overall Study|Lost to Follow-up|1|||
25048882|NCT02811861|50152161|FG000|Overall Study|Subject Choice|29|||
25048883|NCT02811861|50152162|FG001|Overall Study|Subject Choice|17|||
25048884|NCT02811861|50152163|FG002|Overall Study|Subject Choice|23|||
25048885|NCT02811861|50152161|FG000|Overall Study|Withdrawal by Subject|4|||
25048886|NCT02811861|50152162|FG001|Overall Study|Withdrawal by Subject|4|||
25048887|NCT02811861|50152163|FG002|Overall Study|Withdrawal by Subject|9|||
25048888|NCT02811861|50152161|FG000|Overall Study|Other|4|||
25048889|NCT02811861|50152162|FG001|Overall Study|Other|13|||
24960233|NCT00281580|50050726|FG009|Overall Study|Lost to Follow-up|1|||
24960234|NCT00281580|50050727|FG010|Overall Study|Lost to Follow-up|1|||
24960235|NCT00281580|50050728|FG011|Overall Study|Lost to Follow-up|0|||
24960236|NCT00281580|50050729|FG012|Overall Study|Lost to Follow-up|1|||
24960237|NCT00281580|50050730|FG013|Overall Study|Lost to Follow-up|0|||
24960238|NCT00281580|50050731|FG014|Overall Study|Lost to Follow-up|0|||
24960239|NCT00281580|50050732|FG015|Overall Study|Lost to Follow-up|0|||
24960240|NCT00281580|50050717|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
24960241|NCT00281580|50050718|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
24960242|NCT00281580|50050719|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
24960243|NCT00281580|50050720|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
24960244|NCT00281580|50050721|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
24960245|NCT00281580|50050722|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
24960246|NCT00281580|50050723|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
24960247|NCT00281580|50050724|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
24960248|NCT00281580|50050725|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
24960249|NCT00281580|50050726|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
24960250|NCT00281580|50050727|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
25048890|NCT02811861|50152163|FG002|Overall Study|Other|3|||
25048891|NCT02811861|50152161|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
25048892|NCT02811861|50152162|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
25048893|NCT02811861|50152163|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
25048894|NCT02811861|50152161|FG000|Overall Study|Randomized but not treated|2|||
25048895|NCT02811861|50152162|FG001|Overall Study|Randomized but not treated|3|||
25048896|NCT02811861|50152163|FG002|Overall Study|Randomized but not treated|17|||
25048897|NCT02811159|50152171|FG000|Treatment Course 1|Lost to Follow-up|1|||
25048898|NCT01889186|50152177|FG000|Overall Study|Adverse event- not related to progression|18|||
25048899|NCT01889186|50152178|FG001|Overall Study|Adverse event- not related to progression|5|||
25048900|NCT01889186|50152177|FG000|Overall Study|Adverse event- related to progression|7|||
25048901|NCT01889186|50152178|FG001|Overall Study|Adverse event- related to progression|2|||
25048902|NCT01889186|50152177|FG000|Overall Study|COVID-19 logistical restrictions|1|||
25048903|NCT01889186|50152178|FG001|Overall Study|COVID-19 logistical restrictions|0|||
25048904|NCT01889186|50152177|FG000|Overall Study|Investigator request|1|||
24960251|NCT00281580|50050728|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
24960252|NCT00281580|50050729|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
24960253|NCT00281580|50050730|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
25048905|NCT01889186|50152178|FG001|Overall Study|Investigator request|1|||
25048906|NCT01889186|50152177|FG000|Overall Study|Progressive disease- Richter's|12|||
25048907|NCT01889186|50152178|FG001|Overall Study|Progressive disease- Richter's|7|||
25048908|NCT01889186|50152177|FG000|Overall Study|Progressive disease per protocol|46|||
25162534|NCT01791517|50284759|FG010|Phase II|Lack of Efficacy|0|||
25048909|NCT01889186|50152178|FG001|Overall Study|Progressive disease per protocol|17|||
25048910|NCT01889186|50152177|FG000|Overall Study|Stem cell transplant|2|||
25048911|NCT01889186|50152178|FG001|Overall Study|Stem cell transplant|1|||
25048912|NCT01889186|50152177|FG000|Overall Study|Withdrew consent|2|||
25048913|NCT01889186|50152178|FG001|Overall Study|Withdrew consent|3|||
25048914|NCT01889186|50152177|FG000|Overall Study|Other, not specified|18|||
25048915|NCT01889186|50152178|FG001|Overall Study|Other, not specified|15|||
25048916|NCT01510184|50152188|FG000|Overall Study|Sponsor discretion|28|||
25048917|NCT01510184|50152189|FG001|Overall Study|Sponsor discretion|28|||
25048918|NCT01510184|50152188|FG000|Overall Study|Death|1|||
25048919|NCT01510184|50152189|FG001|Overall Study|Death|2|||
25048920|NCT01510184|50152188|FG000|Overall Study|Withdrawal by Subject|1|||
25048921|NCT01510184|50152189|FG001|Overall Study|Withdrawal by Subject|4|||
25048922|NCT01510184|50152188|FG000|Overall Study|Other|0|||
25048923|NCT01510184|50152189|FG001|Overall Study|Other|1|||
25048924|NCT02809833|50152214|FG000|Overall Study|Death|3|||
25048925|NCT02809833|50152214|FG000|Overall Study|Intolerance|54|||
25048926|NCT02809833|50152214|FG000|Overall Study|Lack of Efficacy|89|||
25048927|NCT02809833|50152214|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
25048928|NCT02809833|50152214|FG000|Overall Study|Noncompliance|1|||
25048929|NCT02809833|50152214|FG000|Overall Study|Withdrawal by Subject|34|||
25048930|NCT02809833|50152214|FG000|Overall Study|Lost to Follow-up|35|||
25048931|NCT02809833|50152214|FG000|Overall Study|Adverse Event (AE)|24|||
25048932|NCT02809833|50152214|FG000|Overall Study|Other|5|||
25048933|NCT02809833|50152214|FG000|Overall Study|Missing Information|52|||
25048934|NCT02797262|50152220|FG000|Overall Study|Withdrawal by Subject|5|||
25048935|NCT02797262|50152221|FG001|Overall Study|Withdrawal by Subject|1|||
25048936|NCT02797262|50152220|FG000|Overall Study|Lost to Follow-up|10|||
25048937|NCT02797262|50152221|FG001|Overall Study|Lost to Follow-up|7|||
25048938|NCT02797262|50152220|FG000|Overall Study|Death|1|||
25048939|NCT02797262|50152221|FG001|Overall Study|Death|2|||
25048940|NCT02797262|50152220|FG000|Overall Study|Adverse Event|1|||
25048941|NCT02797262|50152221|FG001|Overall Study|Adverse Event|0|||
25048942|NCT02797262|50152220|FG000|Overall Study|COVID-19|2|||
25048943|NCT02797262|50152221|FG001|Overall Study|COVID-19|1|||
25048944|NCT02797262|50152220|FG000|Overall Study|Out-of-country|1|||
25048945|NCT02797262|50152221|FG001|Overall Study|Out-of-country|0|||
25048946|NCT02809053|50152229|FG000|Overall Study|Death|0|||
25048947|NCT02809053|50152230|FG001|Overall Study|Death|1|||
25048948|NCT02809053|50152229|FG000|Overall Study|Lost to Follow-up|3|||
25048949|NCT02809053|50152230|FG001|Overall Study|Lost to Follow-up|1|||
25048950|NCT02809053|50152229|FG000|Overall Study|Withdrawal by Subject|2|||
25048951|NCT02809053|50152230|FG001|Overall Study|Withdrawal by Subject|3|||
25048952|NCT02809053|50152229|FG000|Overall Study|Disease Progression|2|||
25048953|NCT02809053|50152230|FG001|Overall Study|Disease Progression|1|||
25048954|NCT02808975|50152238|FG000|Overall Study|Adverse Event|3|||
25048955|NCT02808975|50152239|FG001|Overall Study|Adverse Event|4|||
25048956|NCT02808975|50152238|FG000|Overall Study|Withdrew consent|9|||
25048957|NCT02808975|50152239|FG001|Overall Study|Withdrew consent|8|||
25048958|NCT02808975|50152238|FG000|Overall Study|Lost to Follow-up|4|||
25186550|NCT01391819|50337064|FG000|Overall Study|Migrated/moved from study area|82|||
25186551|NCT01391819|50337064|FG000|Overall Study|Lost to Follow-up|252|||
25186552|NCT01391819|50337064|FG000|Overall Study|Death|3|||
24960254|NCT00281580|50050731|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
24960255|NCT00281580|50050732|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
24960256|NCT00495755|50050801|FG000|Overall Study|Adverse Event|3|||
24960257|NCT00495677|50050813|FG000|Stage 1 (25 Days)|Adverse Event|0|||
24960258|NCT00495677|50050814|FG001|Stage 1 (25 Days)|Adverse Event|0|||
24960259|NCT00495677|50050815|FG002|Stage 1 (25 Days)|Adverse Event|1|||
24960260|NCT00495677|50050816|FG003|Stage 1 (25 Days)|Adverse Event|0|||
24960261|NCT00495677|50050817|FG004|Stage 1 (25 Days)|Adverse Event|0|||
24960262|NCT00495677|50050818|FG005|Stage 1 (25 Days)|Adverse Event|0|||
24960263|NCT00495677|50050819|FG006|Stage 1 (25 Days)|Adverse Event|0|||
24960264|NCT00495521|50050837|FG000|Overall Study|Physician Decision|0|||
24960265|NCT00495521|50050838|FG001|Overall Study|Physician Decision|1|||
24960266|NCT00273858|50050844|FG000|Overall Study|Not completed 24 month observation time|334|||
24960267|NCT00273858|50050844|FG000|Overall Study|Lost to Follow-up|101|||
24960268|NCT00273858|50050844|FG000|Overall Study|Withdrawal by Subject|21|||
24960269|NCT00273858|50050844|FG000|Overall Study|Adverse Event|81|||
24960270|NCT00494507|50050852|FG000|Double-Blind Phase|Adverse Event|2|||
24960271|NCT00494507|50050853|FG001|Double-Blind Phase|Adverse Event|0|||
24960272|NCT00494507|50050854|FG002|Double-Blind Phase|Adverse Event|1|||
24960273|NCT00494507|50050855|FG003|Double-Blind Phase|Adverse Event|0|||
25048959|NCT02808975|50152239|FG001|Overall Study|Lost to Follow-up|6|||
25048960|NCT02808975|50152238|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
25048961|NCT02808975|50152239|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
25048962|NCT02808975|50152238|FG000|Overall Study|Other, not specified|5|||
25048963|NCT02808975|50152239|FG001|Overall Study|Other, not specified|1|||
25048964|NCT02976038|50152245|FG000|Overall Study|Physician Decision|22|||
25186553|NCT01391819|50337064|FG000|Overall Study|Other|9|||
24960274|NCT00494507|50050852|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
24960275|NCT00494507|50050853|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
24960276|NCT00494507|50050854|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
24960277|NCT00494507|50050855|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
25048965|NCT02976038|50152245|FG000|Overall Study|Withdrawal by Subject|3|||
25048966|NCT02976038|50152245|FG000|Overall Study|Lost to Follow-up|2|||
25048967|NCT02976038|50152245|FG000|Overall Study|Adverse Event|1|||
25162535|NCT01791517|50284760|FG011|Phase II|Lack of Efficacy|0|||
25162536|NCT01791517|50284749|FG000|Phase II|Adverse Event|0|||
25162537|NCT01791517|50284750|FG001|Phase II|Adverse Event|0|||
25162538|NCT01791517|50284751|FG002|Phase II|Adverse Event|0|||
25162539|NCT01791517|50284752|FG003|Phase II|Adverse Event|0|||
25162540|NCT01791517|50284753|FG004|Phase II|Adverse Event|0|||
25162541|NCT01791517|50284754|FG005|Phase II|Adverse Event|0|||
25048968|NCT02808819|50152270|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
25048969|NCT02808819|50152271|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
25048970|NCT02808819|50152270|FG000|Overall Study|Withdrawal by Subject|10|||
25048971|NCT02808819|50152271|FG001|Overall Study|Withdrawal by Subject|13|||
25048972|NCT02808819|50152270|FG000|Overall Study|Site terminated by sponsor|2|||
25048973|NCT02808819|50152271|FG001|Overall Study|Site terminated by sponsor|0|||
25048974|NCT02808819|50152270|FG000|Overall Study|Pregnancy|1|||
25048975|NCT02808819|50152271|FG001|Overall Study|Pregnancy|0|||
25048976|NCT02808819|50152270|FG000|Overall Study|Lost to Follow-up|1|||
25048977|NCT02808819|50152271|FG001|Overall Study|Lost to Follow-up|6|||
25048978|NCT02808819|50152270|FG000|Overall Study|Protocol Violation|0|||
25048979|NCT02808819|50152271|FG001|Overall Study|Protocol Violation|1|||
25048980|NCT02808819|50152270|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
25048981|NCT02808819|50152271|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
25048982|NCT02808819|50152270|FG000|Overall Study|Death|1|||
25048983|NCT02808819|50152271|FG001|Overall Study|Death|0|||
25048984|NCT02808819|50152270|FG000|Overall Study|Adverse Event|3|||
25048985|NCT02808819|50152271|FG001|Overall Study|Adverse Event|4|||
25048986|NCT02808429|50152281|FG000|Overall Study|Lost to Follow-up|1|||
25162542|NCT01791517|50284755|FG006|Phase II|Adverse Event|2|||
25162543|NCT01791517|50284756|FG007|Phase II|Adverse Event|1|||
25186554|NCT03845023|50337075|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
25276956|NCT00957034|50590925|FG001|Overall Study|Adverse Event|1|||
25048987|NCT02808429|50152282|FG001|Overall Study|Lost to Follow-up|0|||
25048988|NCT02808429|50152283|FG002|Overall Study|Lost to Follow-up|0|||
25048989|NCT02808429|50152281|FG000|Overall Study|Protocol Violation|0|||
25048990|NCT02808429|50152282|FG001|Overall Study|Protocol Violation|1|||
25048991|NCT02808429|50152283|FG002|Overall Study|Protocol Violation|0|||
25162544|NCT01791517|50284757|FG008|Phase II|Adverse Event|0|||
25048992|NCT02808429|50152281|FG000|Overall Study|Premature study termination by sponsor|2|||
25048993|NCT02808429|50152282|FG001|Overall Study|Premature study termination by sponsor|0|||
25048994|NCT02808429|50152283|FG002|Overall Study|Premature study termination by sponsor|1|||
25048995|NCT02808429|50152281|FG000|Overall Study|Relocation|0|||
25048996|NCT02808429|50152282|FG001|Overall Study|Relocation|0|||
25048997|NCT02808429|50152283|FG002|Overall Study|Relocation|1|||
25048998|NCT01594762|50152293|FG000|Overall Study|Withdrawal by Subject|1|||
25048999|NCT01594762|50152294|FG001|Overall Study|Withdrawal by Subject|0|||
25049000|NCT01594762|50152293|FG000|Overall Study|Lost to Follow-up|10|||
25049001|NCT01594762|50152294|FG001|Overall Study|Lost to Follow-up|10|||
25162545|NCT01791517|50284758|FG009|Phase II|Adverse Event|1|||
25162546|NCT01791517|50284759|FG010|Phase II|Adverse Event|0|||
25162547|NCT01791517|50284760|FG011|Phase II|Adverse Event|0|||
25162548|NCT01791517|50284749|FG000|Phase II|Lens Handling Difficulties|0|||
25162549|NCT01791517|50284750|FG001|Phase II|Lens Handling Difficulties|0|||
25162550|NCT01791517|50284751|FG002|Phase II|Lens Handling Difficulties|0|||
25162551|NCT01791517|50284752|FG003|Phase II|Lens Handling Difficulties|0|||
25162552|NCT01791517|50284753|FG004|Phase II|Lens Handling Difficulties|0|||
25186555|NCT03845023|50337076|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
25186556|NCT03845023|50337077|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
25049002|NCT02615470|50152302|FG000|Overall Study|Lost to Follow-up|21|||
25049003|NCT02615470|50152303|FG001|Overall Study|Lost to Follow-up|32|||
25049004|NCT02806947|50152311|FG000|Overall Study|Withdrawal by Subject|5|||
25049005|NCT02806947|50152312|FG001|Overall Study|Withdrawal by Subject|1|||
25049006|NCT02806713|50152320|FG000|Overall Study|Urethral injury during procedure|1|||
25049007|NCT02806713|50152321|FG001|Overall Study|Urethral injury during procedure|0|||
25049008|NCT02806713|50152320|FG000|Overall Study|cancelled surgery|1|||
25049009|NCT02806713|50152321|FG001|Overall Study|cancelled surgery|2|||
25049010|NCT02807493|50152329|FG000|Overall Study|Adverse Event|5|||
25049011|NCT02807493|50152330|FG001|Overall Study|Adverse Event|2|||
25049012|NCT02807493|50152329|FG000|Overall Study|Lost to Follow-up|6|||
25049013|NCT02807493|50152330|FG001|Overall Study|Lost to Follow-up|0|||
25049014|NCT02807493|50152329|FG000|Overall Study|Physician Decision|4|||
25049015|NCT02807493|50152330|FG001|Overall Study|Physician Decision|1|||
25049016|NCT02807493|50152329|FG000|Overall Study|Protocol Violation|7|||
25049017|NCT02807493|50152330|FG001|Overall Study|Protocol Violation|0|||
25049018|NCT02807493|50152329|FG000|Overall Study|Withdrawal by Subject|17|||
25049019|NCT02807493|50152330|FG001|Overall Study|Withdrawal by Subject|10|||
25049020|NCT02807493|50152329|FG000|Overall Study|Other withdrawal|17|||
25049021|NCT02807493|50152330|FG001|Overall Study|Other withdrawal|0|||
25049022|NCT02807493|50152329|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
25049023|NCT02807493|50152330|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
25049024|NCT02807259|50152338|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
25049025|NCT02807259|50152339|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
25049026|NCT02807259|50152338|FG000|Midline (3 Months)|migration, refusal, not available|30|||
25049027|NCT02807259|50152339|FG001|Midline (3 Months)|migration, refusal, not available|34|||
25049028|NCT02807259|50152338|FG000|Endline (3 Months)|migration, refusal, not available|35|||
25049029|NCT02807259|50152339|FG001|Endline (3 Months)|migration, refusal, not available|87|||
25049030|NCT02802345|50152349|FG000|Overall Study|Not Treated|0|||
25049031|NCT02802345|50152350|FG001|Overall Study|Not Treated|1|||
25049032|NCT02802345|50152349|FG000|Overall Study|Adverse Event|28|||
24960278|NCT00494507|50050852|FG000|Double-Blind Phase|Subject Non-compliance|0|||
24960279|NCT00494507|50050853|FG001|Double-Blind Phase|Subject Non-compliance|0|||
24960280|NCT00494507|50050854|FG002|Double-Blind Phase|Subject Non-compliance|1|||
25049033|NCT02802345|50152350|FG001|Overall Study|Adverse Event|20|||
25049034|NCT02802345|50152349|FG000|Overall Study|Withdrawal by Subject|3|||
25049035|NCT02802345|50152350|FG001|Overall Study|Withdrawal by Subject|3|||
25049036|NCT02802345|50152349|FG000|Overall Study|Protocol Violation|0|||
25049037|NCT02802345|50152350|FG001|Overall Study|Protocol Violation|1|||
25049038|NCT02802345|50152349|FG000|Overall Study|Other than listed|1|||
25049039|NCT02802345|50152350|FG001|Overall Study|Other than listed|5|||
25049040|NCT02801877|50152360|FG000|Overall Study|Lost to Follow-up|1|||
25049041|NCT02801877|50152361|FG001|Overall Study|Lost to Follow-up|1|||
25049042|NCT02801877|50152362|FG002|Overall Study|Lost to Follow-up|2|||
25162553|NCT01791517|50284754|FG005|Phase II|Lens Handling Difficulties|0|||
25186557|NCT03845023|50337078|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
25049043|NCT02801877|50152363|FG003|Overall Study|Lost to Follow-up|0|||
25049044|NCT02801877|50152360|FG000|Overall Study|Never Started Treatment|2|||
25049045|NCT02801877|50152361|FG001|Overall Study|Never Started Treatment|0|||
25049046|NCT02801877|50152362|FG002|Overall Study|Never Started Treatment|4|||
25049047|NCT02801877|50152363|FG003|Overall Study|Never Started Treatment|0|||
25049048|NCT02805309|50152376|FG000|Overall Study|Lost to Follow-up|2|||
25049049|NCT02805309|50152377|FG001|Overall Study|Lost to Follow-up|2|||
25049050|NCT02805309|50152378|FG002|Overall Study|Lost to Follow-up|2|||
25049051|NCT02805309|50152376|FG000|Overall Study|Post-Randomization Exclusion|0|||
25049052|NCT02805309|50152377|FG001|Overall Study|Post-Randomization Exclusion|2|||
25049053|NCT02805309|50152378|FG002|Overall Study|Post-Randomization Exclusion|1|||
25049054|NCT02804763|50152390|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
25049055|NCT02804763|50152391|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
25049056|NCT02804763|50152392|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
25049057|NCT02804763|50152393|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
25049058|NCT02804763|50152390|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
25049059|NCT02804763|50152391|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
25049060|NCT02804763|50152392|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
25049061|NCT02804763|50152393|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
25049062|NCT02804763|50152390|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
25049063|NCT02804763|50152391|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
25049064|NCT02804763|50152392|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
25049065|NCT02804763|50152393|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
25049066|NCT02804763|50152390|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
25049067|NCT02804763|50152391|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
25049068|NCT02804763|50152392|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
25049069|NCT02804763|50152393|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
25049070|NCT02804763|50152390|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
25049071|NCT02804763|50152391|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
25049072|NCT02804763|50152392|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
25049073|NCT02804763|50152393|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
25049074|NCT02804763|50152390|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
25049075|NCT02804763|50152391|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
25049076|NCT02804763|50152392|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
25049077|NCT02804763|50152393|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
25049078|NCT02748057|50152409|FG000|Overall Study|Adverse Event|1|||
25049079|NCT02748057|50152410|FG001|Overall Study|Adverse Event|0|||
25049080|NCT02748057|50152409|FG000|Overall Study|Physician Decision|0|||
25049081|NCT02748057|50152410|FG001|Overall Study|Physician Decision|1|||
25049082|NCT02748057|50152409|FG000|Overall Study|Protocol Violation|2|||
25049083|NCT02748057|50152410|FG001|Overall Study|Protocol Violation|1|||
25049084|NCT02748057|50152409|FG000|Overall Study|Participant Moved|1|||
25049085|NCT02748057|50152410|FG001|Overall Study|Participant Moved|0|||
24960281|NCT00494507|50050855|FG003|Double-Blind Phase|Subject Non-compliance|0|||
25049086|NCT02748057|50152409|FG000|Overall Study|Withdrawal by Subject|1|||
25049087|NCT02748057|50152410|FG001|Overall Study|Withdrawal by Subject|0|||
25049088|NCT02748213|50152418|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
25049089|NCT02748213|50152419|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
25049090|NCT02748213|50152418|FG000|Overall Study|Abnormal Laboratory Test|1|||
25049091|NCT02748213|50152419|FG001|Overall Study|Abnormal Laboratory Test|0|||
25049092|NCT02748213|50152418|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
25049093|NCT02748213|50152419|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
25049094|NCT02748213|50152418|FG000|Overall Study|Death|5|||
24960282|NCT00494507|50050852|FG000|Double-Blind Phase|Negative DNA test|0|||
24960283|NCT00494507|50050853|FG001|Double-Blind Phase|Negative DNA test|0|||
24960284|NCT00494507|50050854|FG002|Double-Blind Phase|Negative DNA test|0|||
24960285|NCT00494507|50050855|FG003|Double-Blind Phase|Negative DNA test|1|||
24960286|NCT00494507|50050852|FG000|Open-Label Phase|Adverse Event|0|||
24960287|NCT00494507|50050853|FG001|Open-Label Phase|Adverse Event|1|||
24960288|NCT00494507|50050854|FG002|Open-Label Phase|Adverse Event|5|||
24960289|NCT00494507|50050855|FG003|Open-Label Phase|Adverse Event|3|||
24960290|NCT00494507|50050852|FG000|Open-Label Phase|Worsening Disease|0|||
24960291|NCT00494507|50050853|FG001|Open-Label Phase|Worsening Disease|0|||
24960292|NCT00494507|50050854|FG002|Open-Label Phase|Worsening Disease|0|||
24960293|NCT00494507|50050855|FG003|Open-Label Phase|Worsening Disease|2|||
25049095|NCT02748213|50152419|FG001|Overall Study|Death|3|||
25049096|NCT02748213|50152418|FG000|Overall Study|Insufficient Therapeutic Response|56|||
25162554|NCT01791517|50284755|FG006|Phase II|Lens Handling Difficulties|0|||
24960294|NCT00292188|50050877|FG000|Single-Blind|Adverse Event|14|||
24960295|NCT00292188|50050878|FG001|Single-Blind|Adverse Event|0|||
24960296|NCT00292188|50050879|FG002|Single-Blind|Adverse Event|0|||
25049097|NCT02748213|50152419|FG001|Overall Study|Insufficient Therapeutic Response|57|||
25049098|NCT02748213|50152418|FG000|Overall Study|Violation of Selection Criteria|2|||
25049099|NCT02748213|50152419|FG001|Overall Study|Violation of Selection Criteria|0|||
25049100|NCT02748213|50152418|FG000|Overall Study|Protocol Violation|6|||
25049101|NCT02748213|50152419|FG001|Overall Study|Protocol Violation|4|||
25049102|NCT02748213|50152418|FG000|Overall Study|Refused Treatment*|6|||
25049103|NCT02748213|50152419|FG001|Overall Study|Refused Treatment*|6|||
25049104|NCT02748213|50152418|FG000|Overall Study|Failure to Return|1|||
25049105|NCT02748213|50152419|FG001|Overall Study|Failure to Return|0|||
25049106|NCT02748213|50152418|FG000|Overall Study|Other|30|||
25049107|NCT02748213|50152419|FG001|Overall Study|Other|29|||
25049108|NCT02613910|50152425|FG000|Overall Study|Termination of study|1|||
25049109|NCT02802735|50152432|FG000|Overall Study|Withdrawal by Subject|0|||
25049110|NCT02802735|50152433|FG001|Overall Study|Withdrawal by Subject|1|||
25049111|NCT02802735|50152434|FG002|Overall Study|Withdrawal by Subject|0|||
25049112|NCT02802735|50152435|FG003|Overall Study|Withdrawal by Subject|0|||
25049113|NCT02802735|50152436|FG004|Overall Study|Withdrawal by Subject|0|||
25049114|NCT02799381|50152466|FG000|Overall Study|Withdrew consent|3|||
25049115|NCT02799381|50152467|FG001|Overall Study|Withdrew consent|2|||
25049116|NCT02799381|50152466|FG000|Overall Study|Adverse Event|0|||
25049117|NCT02799381|50152467|FG001|Overall Study|Adverse Event|1|||
25049118|NCT02799381|50152466|FG000|Overall Study|Participant did not take any study drug|1|||
25049119|NCT02799381|50152467|FG001|Overall Study|Participant did not take any study drug|0|||
25049120|NCT01333059|50152475|FG000|Overall Study|Physician Decision|3|||
25049121|NCT01333059|50152476|FG001|Overall Study|Physician Decision|3|||
25049122|NCT01333059|50152475|FG000|Overall Study|Protocol Violation|3|||
25049123|NCT01333059|50152476|FG001|Overall Study|Protocol Violation|0|||
25049124|NCT01370733|50152486|FG000|Overall Study|Withdrawal by Subject|8|||
25049125|NCT01370733|50152487|FG001|Overall Study|Withdrawal by Subject|8|||
25049126|NCT01370733|50152486|FG000|Overall Study|Lost to Follow-up|3|||
25049127|NCT01370733|50152487|FG001|Overall Study|Lost to Follow-up|0|||
25049128|NCT01370733|50152486|FG000|Overall Study|Adverse Event|2|||
25049129|NCT01370733|50152487|FG001|Overall Study|Adverse Event|4|||
25049130|NCT01370733|50152486|FG000|Overall Study|Lack of Efficacy|3|||
25049131|NCT01370733|50152487|FG001|Overall Study|Lack of Efficacy|5|||
25049132|NCT01370733|50152486|FG000|Overall Study|Physician Decision|0|||
25049133|NCT01370733|50152487|FG001|Overall Study|Physician Decision|2|||
25049134|NCT01370733|50152486|FG000|Overall Study|Protocol Violation|1|||
25049135|NCT01370733|50152487|FG001|Overall Study|Protocol Violation|3|||
25049136|NCT02613364|50152496|FG000|Overall Study|Other|19|||
25049137|NCT02613364|50152497|FG001|Overall Study|Other|29|||
25049138|NCT02613364|50152498|FG002|Overall Study|Other|17|||
25049139|NCT02613364|50152496|FG000|Overall Study|Too time consuming|21|||
25049140|NCT02613364|50152497|FG001|Overall Study|Too time consuming|26|||
25049141|NCT02613364|50152498|FG002|Overall Study|Too time consuming|26|||
25049142|NCT02613364|50152496|FG000|Overall Study|Withdrawal by Subject|13|||
25049143|NCT02613364|50152497|FG001|Overall Study|Withdrawal by Subject|18|||
25049144|NCT02613364|50152498|FG002|Overall Study|Withdrawal by Subject|17|||
25049145|NCT02613364|50152496|FG000|Overall Study|Medical|12|||
25049146|NCT02613364|50152497|FG001|Overall Study|Medical|13|||
25049147|NCT02613364|50152498|FG002|Overall Study|Medical|9|||
25049148|NCT02613364|50152496|FG000|Overall Study|Disliked Study Procedure|1|||
25049149|NCT02613364|50152497|FG001|Overall Study|Disliked Study Procedure|1|||
25049150|NCT02613364|50152498|FG002|Overall Study|Disliked Study Procedure|4|||
25049151|NCT02613364|50152496|FG000|Overall Study|Disliked Intervention|0|||
25049152|NCT02613364|50152497|FG001|Overall Study|Disliked Intervention|3|||
25049153|NCT02613364|50152498|FG002|Overall Study|Disliked Intervention|3|||
25049154|NCT01370655|50152518|FG000|Period 1|Adverse Event|2|||
25049155|NCT01370655|50152519|FG001|Period 1|Adverse Event|0|||
25049156|NCT01370655|50152520|FG002|Period 1|Adverse Event|0|||
25049157|NCT01370655|50152521|FG003|Period 1|Adverse Event|0|||
25049158|NCT01370655|50152522|FG004|Period 1|Adverse Event|0|||
25049159|NCT01370655|50152523|FG005|Period 1|Adverse Event|0|||
25049160|NCT01370655|50152524|FG006|Period 1|Adverse Event|1|||
25049161|NCT01370655|50152525|FG007|Period 1|Adverse Event|0|||
25049162|NCT01370655|50152526|FG008|Period 1|Adverse Event|0|||
25049163|NCT01370655|50152527|FG009|Period 1|Adverse Event|0|||
25049164|NCT01370655|50152528|FG010|Period 1|Adverse Event|0|||
25049165|NCT01370655|50152529|FG011|Period 1|Adverse Event|0|||
25049166|NCT01370655|50152518|FG000|Period 2|Adverse Event|0|||
25049167|NCT01370655|50152519|FG001|Period 2|Adverse Event|0|||
25049168|NCT01370655|50152520|FG002|Period 2|Adverse Event|1|||
25049169|NCT01370655|50152521|FG003|Period 2|Adverse Event|0|||
25049170|NCT01370655|50152522|FG004|Period 2|Adverse Event|1|||
25049171|NCT01370655|50152523|FG005|Period 2|Adverse Event|0|||
25049172|NCT01370655|50152524|FG006|Period 2|Adverse Event|0|||
24960297|NCT00292188|50050877|FG000|Single-Blind|Lack of Efficacy|2|||
24960298|NCT00292188|50050878|FG001|Single-Blind|Lack of Efficacy|0|||
24960299|NCT00292188|50050879|FG002|Single-Blind|Lack of Efficacy|0|||
24960300|NCT00292188|50050877|FG000|Single-Blind|Laboratory Abnormality|5|||
24960301|NCT00292188|50050878|FG001|Single-Blind|Laboratory Abnormality|0|||
24960302|NCT00292188|50050879|FG002|Single-Blind|Laboratory Abnormality|0|||
24960303|NCT00292188|50050877|FG000|Single-Blind|Lost to Follow-up|3|||
24960304|NCT00292188|50050878|FG001|Single-Blind|Lost to Follow-up|0|||
24960305|NCT00292188|50050879|FG002|Single-Blind|Lost to Follow-up|0|||
24960306|NCT00292188|50050877|FG000|Single-Blind|Other|77|||
24960307|NCT00292188|50050878|FG001|Single-Blind|Other|0|||
24960308|NCT00292188|50050879|FG002|Single-Blind|Other|0|||
24960309|NCT00292188|50050877|FG000|Single-Blind|Withdrawal by Subject|12|||
24960310|NCT00292188|50050878|FG001|Single-Blind|Withdrawal by Subject|0|||
24960311|NCT00292188|50050879|FG002|Single-Blind|Withdrawal by Subject|0|||
24960312|NCT00292188|50050877|FG000|Single-Blind|Did not receive treatment|1|||
24960313|NCT00292188|50050878|FG001|Single-Blind|Did not receive treatment|0|||
24960314|NCT00292188|50050879|FG002|Single-Blind|Did not receive treatment|0|||
24960315|NCT00292188|50050877|FG000|Double-Blind|Adverse Event|0|||
24960316|NCT00292188|50050878|FG001|Double-Blind|Adverse Event|25|||
24960317|NCT00292188|50050879|FG002|Double-Blind|Adverse Event|9|||
24960318|NCT00292188|50050877|FG000|Double-Blind|Lack of Efficacy|0|||
24960319|NCT00292188|50050878|FG001|Double-Blind|Lack of Efficacy|2|||
24960320|NCT00292188|50050879|FG002|Double-Blind|Lack of Efficacy|12|||
24960321|NCT00292188|50050877|FG000|Double-Blind|Lost to Follow-up|0|||
24960322|NCT00292188|50050878|FG001|Double-Blind|Lost to Follow-up|1|||
24960323|NCT00292188|50050879|FG002|Double-Blind|Lost to Follow-up|0|||
24960324|NCT00292188|50050877|FG000|Double-Blind|Other|0|||
24960325|NCT00292188|50050878|FG001|Double-Blind|Other|3|||
24960326|NCT00292188|50050879|FG002|Double-Blind|Other|4|||
24960327|NCT00292188|50050877|FG000|Double-Blind|Withdrawal by Subject|0|||
24960328|NCT00292188|50050878|FG001|Double-Blind|Withdrawal by Subject|0|||
24960329|NCT00292188|50050879|FG002|Double-Blind|Withdrawal by Subject|3|||
24960330|NCT00292188|50050877|FG000|Double-Blind|Laboratory Abnormality|0|||
24960331|NCT00292188|50050878|FG001|Double-Blind|Laboratory Abnormality|0|||
24960332|NCT00292188|50050879|FG002|Double-Blind|Laboratory Abnormality|1|||
24960333|NCT00272844|50050886|FG000|Overall Study|Withdrawal by Subject|5|||
24960334|NCT00271596|50050892|FG000|Overall Study|Protocol Violation|1|||
24960335|NCT00271596|50050893|FG001|Overall Study|Protocol Violation|0|||
24960336|NCT00271596|50050892|FG000|Overall Study|Withdrawal by Subject|0|||
24960337|NCT00271596|50050893|FG001|Overall Study|Withdrawal by Subject|1|||
24960338|NCT00291642|50050904|FG000|Overall Study|Adverse Event|1|||
24960339|NCT00291642|50050905|FG001|Overall Study|Adverse Event|0|||
24960340|NCT00291642|50050906|FG002|Overall Study|Adverse Event|1|||
24960341|NCT00291642|50050907|FG003|Overall Study|Adverse Event|0|||
24960342|NCT00291642|50050908|FG004|Overall Study|Adverse Event|1|||
24960343|NCT00291642|50050904|FG000|Overall Study|Patient missed visit|0|||
24960344|NCT00291642|50050905|FG001|Overall Study|Patient missed visit|0|||
25049173|NCT01370655|50152525|FG007|Period 2|Adverse Event|1|||
25049174|NCT01370655|50152526|FG008|Period 2|Adverse Event|0|||
25049175|NCT01370655|50152527|FG009|Period 2|Adverse Event|0|||
25049176|NCT01370655|50152528|FG010|Period 2|Adverse Event|0|||
25049177|NCT01370655|50152529|FG011|Period 2|Adverse Event|0|||
25049178|NCT01370655|50152518|FG000|Period 2|met protocol specified stopping criteria|0|||
25049179|NCT01370655|50152519|FG001|Period 2|met protocol specified stopping criteria|0|||
25049180|NCT01370655|50152520|FG002|Period 2|met protocol specified stopping criteria|1|||
25049181|NCT01370655|50152521|FG003|Period 2|met protocol specified stopping criteria|0|||
25049182|NCT01370655|50152522|FG004|Period 2|met protocol specified stopping criteria|0|||
25049183|NCT01370655|50152523|FG005|Period 2|met protocol specified stopping criteria|0|||
25049184|NCT01370655|50152524|FG006|Period 2|met protocol specified stopping criteria|1|||
25049185|NCT01370655|50152525|FG007|Period 2|met protocol specified stopping criteria|0|||
25049186|NCT01370655|50152526|FG008|Period 2|met protocol specified stopping criteria|1|||
25049187|NCT01370655|50152527|FG009|Period 2|met protocol specified stopping criteria|0|||
25049188|NCT01370655|50152528|FG010|Period 2|met protocol specified stopping criteria|1|||
25049189|NCT01370655|50152529|FG011|Period 2|met protocol specified stopping criteria|0|||
25049190|NCT01370655|50152518|FG000|Period 2|Withdrawal by Subject|0|||
25049191|NCT01370655|50152519|FG001|Period 2|Withdrawal by Subject|0|||
25049192|NCT01370655|50152520|FG002|Period 2|Withdrawal by Subject|0|||
25049193|NCT01370655|50152521|FG003|Period 2|Withdrawal by Subject|0|||
25049194|NCT01370655|50152522|FG004|Period 2|Withdrawal by Subject|0|||
25049195|NCT01370655|50152523|FG005|Period 2|Withdrawal by Subject|0|||
25049196|NCT01370655|50152524|FG006|Period 2|Withdrawal by Subject|0|||
25049197|NCT01370655|50152525|FG007|Period 2|Withdrawal by Subject|0|||
25049198|NCT01370655|50152526|FG008|Period 2|Withdrawal by Subject|1|||
25049199|NCT01370655|50152527|FG009|Period 2|Withdrawal by Subject|0|||
25049200|NCT01370655|50152528|FG010|Period 2|Withdrawal by Subject|0|||
25049201|NCT01370655|50152529|FG011|Period 2|Withdrawal by Subject|0|||
25049202|NCT02612194|50152542|FG000|Overall Study|Death|5|||
25049203|NCT02612194|50152543|FG001|Overall Study|Death|0|||
25049204|NCT02612194|50152544|FG002|Overall Study|Death|2|||
25049205|NCT02612194|50152542|FG000|Overall Study|Early Study Termination|1|||
25049206|NCT02612194|50152543|FG001|Overall Study|Early Study Termination|0|||
25049207|NCT02612194|50152544|FG002|Overall Study|Early Study Termination|0|||
25049208|NCT02798211|50152554|FG000|Period 1|Adverse Event|1|||
25049209|NCT02798211|50152555|FG001|Period 1|Adverse Event|1|||
25049210|NCT02798211|50152556|FG002|Period 1|Adverse Event|0|||
25049211|NCT02798211|50152557|FG003|Period 1|Adverse Event|0|||
25049212|NCT02798211|50152558|FG004|Period 1|Adverse Event|0|||
25049213|NCT02798211|50152559|FG005|Period 1|Adverse Event|0|||
25049214|NCT02798211|50152554|FG000|Period 1|Lost to Follow-up|2|||
25049215|NCT02798211|50152555|FG001|Period 1|Lost to Follow-up|1|||
25049216|NCT02798211|50152556|FG002|Period 1|Lost to Follow-up|0|||
25049217|NCT02798211|50152557|FG003|Period 1|Lost to Follow-up|0|||
25049218|NCT02798211|50152558|FG004|Period 1|Lost to Follow-up|0|||
25049219|NCT02798211|50152559|FG005|Period 1|Lost to Follow-up|0|||
25049220|NCT02798211|50152554|FG000|Period 1|Protocol Violation|0|||
25049221|NCT02798211|50152555|FG001|Period 1|Protocol Violation|0|||
25049222|NCT02798211|50152556|FG002|Period 1|Protocol Violation|2|||
25049223|NCT02798211|50152557|FG003|Period 1|Protocol Violation|0|||
25049224|NCT02798211|50152558|FG004|Period 1|Protocol Violation|0|||
24960345|NCT00291642|50050906|FG002|Overall Study|Patient missed visit|1|||
24960346|NCT00291642|50050907|FG003|Overall Study|Patient missed visit|0|||
24960347|NCT00291642|50050908|FG004|Overall Study|Patient missed visit|0|||
24960348|NCT00291642|50050904|FG000|Overall Study|Intake of prohibited medication|1|||
24960349|NCT00291642|50050905|FG001|Overall Study|Intake of prohibited medication|0|||
24960350|NCT00291642|50050906|FG002|Overall Study|Intake of prohibited medication|0|||
24960351|NCT00291642|50050907|FG003|Overall Study|Intake of prohibited medication|0|||
24960352|NCT00291642|50050908|FG004|Overall Study|Intake of prohibited medication|0|||
24960353|NCT00280566|50050922|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
24960354|NCT00280566|50050923|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
24960355|NCT00280566|50050924|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
24960356|NCT00280566|50050922|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
24960357|NCT00280566|50050923|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
24960358|NCT00280566|50050924|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
24960359|NCT00280566|50050922|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
24960360|NCT00280566|50050923|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
24960361|NCT00280566|50050924|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
24960362|NCT00280566|50050922|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
24960363|NCT00280566|50050923|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
25049225|NCT02798211|50152559|FG005|Period 1|Protocol Violation|0|||
25049226|NCT02798211|50152554|FG000|Period 1|Withdrawal by Subject|1|||
25049227|NCT02798211|50152555|FG001|Period 1|Withdrawal by Subject|1|||
25049228|NCT02798211|50152556|FG002|Period 1|Withdrawal by Subject|0|||
25049229|NCT02798211|50152557|FG003|Period 1|Withdrawal by Subject|0|||
25049230|NCT02798211|50152558|FG004|Period 1|Withdrawal by Subject|0|||
25049231|NCT02798211|50152559|FG005|Period 1|Withdrawal by Subject|0|||
24960364|NCT00280566|50050924|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
24960365|NCT00280566|50050922|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
25049232|NCT02798211|50152554|FG000|Period 1|Death|0|||
25049233|NCT02798211|50152555|FG001|Period 1|Death|0|||
25049234|NCT02798211|50152556|FG002|Period 1|Death|1|||
25049235|NCT02798211|50152557|FG003|Period 1|Death|0|||
25049236|NCT02798211|50152558|FG004|Period 1|Death|0|||
25049237|NCT02798211|50152559|FG005|Period 1|Death|0|||
25049238|NCT02798211|50152554|FG000|Period 1|Withdrawal of Informed Consent|2|||
25049239|NCT02798211|50152555|FG001|Period 1|Withdrawal of Informed Consent|7|||
25049240|NCT02798211|50152556|FG002|Period 1|Withdrawal of Informed Consent|3|||
25049241|NCT02798211|50152557|FG003|Period 1|Withdrawal of Informed Consent|0|||
25049242|NCT02798211|50152558|FG004|Period 1|Withdrawal of Informed Consent|0|||
25049243|NCT02798211|50152559|FG005|Period 1|Withdrawal of Informed Consent|0|||
25049244|NCT02798211|50152554|FG000|Period 2|Withdrawal by Subject|2|||
25049245|NCT02798211|50152555|FG001|Period 2|Withdrawal by Subject|0|||
25049246|NCT02798211|50152556|FG002|Period 2|Withdrawal by Subject|0|||
25049247|NCT02798211|50152557|FG003|Period 2|Withdrawal by Subject|0|||
25049248|NCT02798211|50152558|FG004|Period 2|Withdrawal by Subject|2|||
25049249|NCT02798211|50152559|FG005|Period 2|Withdrawal by Subject|2|||
25049250|NCT02798211|50152554|FG000|Period 2|Adverse Event|5|||
25049251|NCT02798211|50152555|FG001|Period 2|Adverse Event|0|||
25049252|NCT02798211|50152556|FG002|Period 2|Adverse Event|0|||
25049253|NCT02798211|50152557|FG003|Period 2|Adverse Event|0|||
25049254|NCT02798211|50152558|FG004|Period 2|Adverse Event|1|||
25049255|NCT02798211|50152559|FG005|Period 2|Adverse Event|0|||
25049256|NCT02798211|50152554|FG000|Period 2|Lack of Efficacy|1|||
25049257|NCT02798211|50152555|FG001|Period 2|Lack of Efficacy|0|||
25049258|NCT02798211|50152556|FG002|Period 2|Lack of Efficacy|0|||
25049259|NCT02798211|50152557|FG003|Period 2|Lack of Efficacy|1|||
25049260|NCT02798211|50152558|FG004|Period 2|Lack of Efficacy|0|||
25049261|NCT02798211|50152559|FG005|Period 2|Lack of Efficacy|1|||
25049262|NCT02798211|50152554|FG000|Period 2|Lost to Follow-up|3|||
25049263|NCT02798211|50152555|FG001|Period 2|Lost to Follow-up|0|||
25049264|NCT02798211|50152556|FG002|Period 2|Lost to Follow-up|0|||
25049265|NCT02798211|50152557|FG003|Period 2|Lost to Follow-up|0|||
25049266|NCT02798211|50152558|FG004|Period 2|Lost to Follow-up|2|||
25049267|NCT02798211|50152559|FG005|Period 2|Lost to Follow-up|0|||
25049268|NCT02798211|50152554|FG000|Period 2|Physician Decision|1|||
25049269|NCT02798211|50152555|FG001|Period 2|Physician Decision|0|||
25049270|NCT02798211|50152556|FG002|Period 2|Physician Decision|0|||
25049271|NCT02798211|50152557|FG003|Period 2|Physician Decision|1|||
25049272|NCT02798211|50152558|FG004|Period 2|Physician Decision|1|||
25049273|NCT02798211|50152559|FG005|Period 2|Physician Decision|0|||
25049274|NCT02798211|50152554|FG000|Period 2|Pregnancy|0|||
25049275|NCT02798211|50152555|FG001|Period 2|Pregnancy|0|||
25049276|NCT02798211|50152556|FG002|Period 2|Pregnancy|0|||
25049277|NCT02798211|50152557|FG003|Period 2|Pregnancy|2|||
25049278|NCT02798211|50152558|FG004|Period 2|Pregnancy|0|||
25049279|NCT02798211|50152559|FG005|Period 2|Pregnancy|0|||
25049280|NCT02798211|50152554|FG000|Period 2|Technical problems|1|||
25049281|NCT02798211|50152555|FG001|Period 2|Technical problems|0|||
25049282|NCT02798211|50152556|FG002|Period 2|Technical problems|0|||
25049283|NCT02798211|50152557|FG003|Period 2|Technical problems|1|||
25049284|NCT02798211|50152558|FG004|Period 2|Technical problems|0|||
25049285|NCT02798211|50152559|FG005|Period 2|Technical problems|0|||
25049286|NCT02798211|50152554|FG000|Period 2|Withdrawal of Informed Consent|1|||
25049287|NCT02798211|50152555|FG001|Period 2|Withdrawal of Informed Consent|0|||
25049288|NCT02798211|50152556|FG002|Period 2|Withdrawal of Informed Consent|0|||
25049289|NCT02798211|50152557|FG003|Period 2|Withdrawal of Informed Consent|2|||
25049290|NCT02798211|50152558|FG004|Period 2|Withdrawal of Informed Consent|2|||
25049291|NCT02798211|50152559|FG005|Period 2|Withdrawal of Informed Consent|3|||
25049292|NCT02799069|50152574|FG000|Overall Study|Adverse Event|0|||
25049293|NCT02799069|50152575|FG001|Overall Study|Adverse Event|2|||
25049294|NCT02799069|50152576|FG002|Overall Study|Adverse Event|2|||
25049295|NCT02799069|50152574|FG000|Overall Study|Lack of Efficacy|2|||
25049296|NCT02799069|50152575|FG001|Overall Study|Lack of Efficacy|0|||
25049297|NCT02799069|50152576|FG002|Overall Study|Lack of Efficacy|0|||
25049298|NCT02799069|50152574|FG000|Overall Study|Lost to Follow-up|1|||
25049299|NCT02799069|50152575|FG001|Overall Study|Lost to Follow-up|1|||
25049300|NCT02799069|50152576|FG002|Overall Study|Lost to Follow-up|0|||
25049301|NCT02799069|50152574|FG000|Overall Study|Withdrawal by Subject|4|||
25049302|NCT02799069|50152575|FG001|Overall Study|Withdrawal by Subject|4|||
25049303|NCT02799069|50152576|FG002|Overall Study|Withdrawal by Subject|3|||
25049304|NCT02799069|50152574|FG000|Overall Study|Protocol Violation|1|||
25049305|NCT02799069|50152575|FG001|Overall Study|Protocol Violation|0|||
25049306|NCT02799069|50152576|FG002|Overall Study|Protocol Violation|2|||
25049307|NCT01669174|50152586|FG000|Overall Study|Subject withdrew consent|2|||
25049308|NCT01669174|50152587|FG001|Overall Study|Subject withdrew consent|2|||
25049309|NCT01669174|50152586|FG000|Overall Study|Lost to Follow-up|1|||
25049310|NCT01669174|50152587|FG001|Overall Study|Lost to Follow-up|0|||
25049311|NCT01669174|50152586|FG000|Overall Study|Adverse Event|2|||
25049312|NCT01669174|50152587|FG001|Overall Study|Adverse Event|2|||
25049313|NCT01669174|50152586|FG000|Overall Study|Administrative problems|1|||
25049314|NCT01669174|50152587|FG001|Overall Study|Administrative problems|2|||
25049315|NCT02798835|50152596|FG000|Overall Study|Protocol Violation|0|||
25049316|NCT02798835|50152597|FG001|Overall Study|Protocol Violation|0|||
25049317|NCT02798835|50152598|FG002|Overall Study|Protocol Violation|3|||
25049318|NCT02611882|50152609|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
25049319|NCT02611882|50152610|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
25049320|NCT02611882|50152611|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
25049321|NCT02796963|50152622|FG000|Overall Study|Lost to Follow-up|89|||
25049322|NCT02796963|50152623|FG001|Overall Study|Lost to Follow-up|76|||
25049323|NCT02796963|50152624|FG002|Overall Study|Lost to Follow-up|69|||
25049324|NCT02796963|50152625|FG003|Overall Study|Lost to Follow-up|72|||
25049325|NCT02796651|50152635|FG000|Overall Study|Adverse Event|6|||
25049326|NCT02796651|50152635|FG000|Overall Study|Lost to Follow-up|1|||
25049327|NCT02796651|50152635|FG000|Overall Study|Withdrawal by Subject|4|||
25049328|NCT02796651|50152635|FG000|Overall Study|Protocol Violation|4|||
25049329|NCT02796651|50152635|FG000|Overall Study|Lack of Efficacy|1|||
25049330|NCT02796651|50152635|FG000|Overall Study|Other|10|||
24960366|NCT00280566|50050923|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
24960367|NCT00280566|50050924|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
24960368|NCT00280566|50050922|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
24960369|NCT00280566|50050923|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
24960370|NCT00280566|50050924|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
24960371|NCT00280566|50050922|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
24960372|NCT00280566|50050923|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
24960373|NCT00280566|50050924|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
24960374|NCT00280566|50050922|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
24960375|NCT00280566|50050923|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
24960376|NCT00280566|50050924|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
24960377|NCT00280566|50050922|FG000|Period 2 Double Blind|Adverse Event|0|||
24960378|NCT00280566|50050923|FG001|Period 2 Double Blind|Adverse Event|11|||
24960379|NCT00280566|50050924|FG002|Period 2 Double Blind|Adverse Event|15|||
24960380|NCT00280566|50050922|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
24960381|NCT00280566|50050923|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
25049331|NCT02613208|50152650|FG000|Overall Study|Withdrawal by Subject|1|||
25049332|NCT02613208|50152650|FG000|Overall Study|Change of address|2|||
25049333|NCT02613208|50152650|FG000|Overall Study|Physician Decision|2|||
25049334|NCT02613208|50152650|FG000|Overall Study|Lost to Follow-up|5|||
25049335|NCT02613208|50152650|FG000|Overall Study|Death|37|||
25049336|NCT01668784|50152656|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
25049337|NCT01668784|50152657|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
25049338|NCT01668784|50152656|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
25049339|NCT01668784|50152657|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
25049340|NCT01668784|50152656|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
25049341|NCT01668784|50152657|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
25049342|NCT01668784|50152656|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
25049343|NCT01668784|50152657|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
25049344|NCT01668784|50152656|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
25049345|NCT01668784|50152657|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
24960382|NCT00280566|50050924|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
24960383|NCT00280566|50050922|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
24960384|NCT00280566|50050923|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
24960385|NCT00280566|50050924|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
24960386|NCT00280566|50050922|FG000|Period 2 Double Blind|miscellaneous|0|||
24960387|NCT00280566|50050923|FG001|Period 2 Double Blind|miscellaneous|10|||
24960388|NCT00280566|50050924|FG002|Period 2 Double Blind|miscellaneous|5|||
24960389|NCT00270894|50050931|FG000|Overall Study|Adverse Event|1|||
24960390|NCT00270894|50050931|FG000|Overall Study|Withdrawal by Subject|1|||
24960391|NCT00317642|50050937|FG000|Overall Study|Not Received Either Study Drug|1|||
24960392|NCT00317642|50050938|FG001|Overall Study|Not Received Either Study Drug|3|||
24960393|NCT00317642|50050937|FG000|Overall Study|Physician Decision|15|||
24960394|NCT00317642|50050938|FG001|Overall Study|Physician Decision|7|||
25049346|NCT01668784|50152656|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
25049347|NCT01668784|50152657|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
25049348|NCT01668784|50152656|FG000|Treatment Period|Disease Progression|316|||
25049349|NCT01668784|50152657|FG001|Treatment Period|Disease Progression|293|||
25049350|NCT01668784|50152656|FG000|Treatment Period|Study Drug Toxicity|46|||
25049351|NCT01668784|50152657|FG001|Treatment Period|Study Drug Toxicity|53|||
25049352|NCT01668784|50152656|FG000|Treatment Period|Death|1|||
25276445|NCT01243424|50590385|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
25049353|NCT01668784|50152657|FG001|Treatment Period|Death|1|||
25049354|NCT01668784|50152656|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
25049355|NCT01668784|50152657|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
25049356|NCT01668784|50152656|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
25049357|NCT01668784|50152657|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
25049358|NCT01668784|50152656|FG000|Treatment Period|Withdrawal by Subject|5|||
25049359|NCT01668784|50152657|FG001|Treatment Period|Withdrawal by Subject|3|||
25049360|NCT01668784|50152656|FG000|Treatment Period|Maximal Clinical Benefit|3|||
25049361|NCT01668784|50152657|FG001|Treatment Period|Maximal Clinical Benefit|3|||
25049362|NCT01668784|50152656|FG000|Treatment Period|Other|2|||
25049363|NCT01668784|50152657|FG001|Treatment Period|Other|8|||
25049364|NCT01668784|50152656|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
25049365|NCT01668784|50152657|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
25049366|NCT02750514|50152668|FG000|Track 1|Disease progression|20|||
25049367|NCT02750514|50152669|FG001|Track 1|Disease progression|1|||
25049368|NCT02750514|50152670|FG002|Track 1|Disease progression|0|||
25049369|NCT02750514|50152671|FG003|Track 1|Disease progression|1|||
25049370|NCT02750514|50152672|FG004|Track 1|Disease progression|0|||
25049371|NCT02750514|50152668|FG000|Track 1|Adverse event unrelated to study drug|1|||
25049372|NCT02750514|50152669|FG001|Track 1|Adverse event unrelated to study drug|0|||
25049373|NCT02750514|50152670|FG002|Track 1|Adverse event unrelated to study drug|0|||
25049374|NCT02750514|50152671|FG003|Track 1|Adverse event unrelated to study drug|0|||
25049375|NCT02750514|50152672|FG004|Track 1|Adverse event unrelated to study drug|0|||
25049376|NCT02750514|50152668|FG000|Track 1|Study drug toxicity|4|||
25049377|NCT02750514|50152669|FG001|Track 1|Study drug toxicity|1|||
25049378|NCT02750514|50152670|FG002|Track 1|Study drug toxicity|0|||
25049379|NCT02750514|50152671|FG003|Track 1|Study drug toxicity|1|||
25049380|NCT02750514|50152672|FG004|Track 1|Study drug toxicity|0|||
25049381|NCT02750514|50152668|FG000|Track 1|Participant request to discontinue|1|||
25049382|NCT02750514|50152669|FG001|Track 1|Participant request to discontinue|0|||
25049383|NCT02750514|50152670|FG002|Track 1|Participant request to discontinue|0|||
25049384|NCT02750514|50152671|FG003|Track 1|Participant request to discontinue|0|||
25049385|NCT02750514|50152672|FG004|Track 1|Participant request to discontinue|0|||
25049386|NCT02750514|50152668|FG000|Track 1|Other reasons|1|||
25049387|NCT02750514|50152669|FG001|Track 1|Other reasons|0|||
25049388|NCT02750514|50152670|FG002|Track 1|Other reasons|0|||
25049389|NCT02750514|50152671|FG003|Track 1|Other reasons|0|||
25049390|NCT02750514|50152672|FG004|Track 1|Other reasons|0|||
25049391|NCT02750514|50152668|FG000|Track 2|Disease progression|4|||
25049392|NCT02750514|50152669|FG001|Track 2|Disease progression|5|||
25049393|NCT02750514|50152670|FG002|Track 2|Disease progression|2|||
25049394|NCT02750514|50152671|FG003|Track 2|Disease progression|5|||
24960395|NCT00317642|50050937|FG000|Overall Study|Participant declined treatment|14|||
24960396|NCT00317642|50050938|FG001|Overall Study|Participant declined treatment|3|||
24960397|NCT00317642|50050937|FG000|Overall Study|Adverse Event|17|||
24960398|NCT00317642|50050938|FG001|Overall Study|Adverse Event|5|||
24960399|NCT00317642|50050937|FG000|Overall Study|Treatment Failure|56|||
24960400|NCT00317642|50050938|FG001|Overall Study|Treatment Failure|102|||
24960401|NCT00317642|50050937|FG000|Overall Study|Disease Recurrence|1|||
24960402|NCT00317642|50050938|FG001|Overall Study|Disease Recurrence|2|||
24960403|NCT00317642|50050937|FG000|Overall Study|Death|14|||
24960404|NCT00317642|50050938|FG001|Overall Study|Death|7|||
24960405|NCT00317642|50050937|FG000|Overall Study|Not Continue to Consolidation|2|||
24960406|NCT00317642|50050938|FG001|Overall Study|Not Continue to Consolidation|0|||
25049395|NCT02750514|50152672|FG004|Track 2|Disease progression|0|||
25049396|NCT02750514|50152668|FG000|Track 2|Adverse event unrelated to study drug|1|||
25049397|NCT02750514|50152669|FG001|Track 2|Adverse event unrelated to study drug|0|||
25049398|NCT02750514|50152670|FG002|Track 2|Adverse event unrelated to study drug|0|||
25049399|NCT02750514|50152671|FG003|Track 2|Adverse event unrelated to study drug|0|||
25049400|NCT02750514|50152672|FG004|Track 2|Adverse event unrelated to study drug|0|||
25049401|NCT02750514|50152668|FG000|Track 2|Study drug toxicity|1|||
25049402|NCT02750514|50152669|FG001|Track 2|Study drug toxicity|2|||
25049403|NCT02750514|50152670|FG002|Track 2|Study drug toxicity|0|||
25049404|NCT02750514|50152671|FG003|Track 2|Study drug toxicity|2|||
25049405|NCT02750514|50152672|FG004|Track 2|Study drug toxicity|0|||
25049406|NCT02750514|50152668|FG000|Track 2|Participant withdrew consent|0|||
25049407|NCT02750514|50152669|FG001|Track 2|Participant withdrew consent|1|||
25049408|NCT02750514|50152670|FG002|Track 2|Participant withdrew consent|0|||
25049409|NCT02750514|50152671|FG003|Track 2|Participant withdrew consent|0|||
25049410|NCT02750514|50152672|FG004|Track 2|Participant withdrew consent|0|||
25049411|NCT02750514|50152668|FG000|Track 3|Disease progression|0|||
25049412|NCT02750514|50152669|FG001|Track 3|Disease progression|24|||
25049413|NCT02750514|50152670|FG002|Track 3|Disease progression|13|||
25049414|NCT02750514|50152671|FG003|Track 3|Disease progression|14|||
25049415|NCT02750514|50152672|FG004|Track 3|Disease progression|0|||
25049416|NCT02750514|50152668|FG000|Track 3|Adverse event unrelated to study drug|0|||
25049417|NCT02750514|50152669|FG001|Track 3|Adverse event unrelated to study drug|1|||
24960407|NCT00317642|50050937|FG000|Overall Study|Withdrawal by Subject|0|||
24960408|NCT00317642|50050938|FG001|Overall Study|Withdrawal by Subject|1|||
24960409|NCT00317642|50050937|FG000|Overall Study|Referred For Transplantation|1|||
25049418|NCT02750514|50152670|FG002|Track 3|Adverse event unrelated to study drug|1|||
25049419|NCT02750514|50152671|FG003|Track 3|Adverse event unrelated to study drug|1|||
25049420|NCT02750514|50152672|FG004|Track 3|Adverse event unrelated to study drug|0|||
25049421|NCT02750514|50152668|FG000|Track 3|Study drug toxicity|0|||
25049422|NCT02750514|50152669|FG001|Track 3|Study drug toxicity|3|||
25049423|NCT02750514|50152670|FG002|Track 3|Study drug toxicity|0|||
25049424|NCT02750514|50152671|FG003|Track 3|Study drug toxicity|1|||
25049425|NCT02750514|50152672|FG004|Track 3|Study drug toxicity|0|||
25049426|NCT02750514|50152668|FG000|Track 3|Participant request to discontinue|0|||
25049427|NCT02750514|50152669|FG001|Track 3|Participant request to discontinue|2|||
25049428|NCT02750514|50152670|FG002|Track 3|Participant request to discontinue|0|||
25049429|NCT02750514|50152671|FG003|Track 3|Participant request to discontinue|0|||
25049430|NCT02750514|50152672|FG004|Track 3|Participant request to discontinue|0|||
25049431|NCT02750514|50152668|FG000|Track 3|Participant withdrew consent|0|||
25049432|NCT02750514|50152669|FG001|Track 3|Participant withdrew consent|3|||
25049433|NCT02750514|50152670|FG002|Track 3|Participant withdrew consent|1|||
25049434|NCT02750514|50152671|FG003|Track 3|Participant withdrew consent|0|||
25049435|NCT02750514|50152672|FG004|Track 3|Participant withdrew consent|0|||
25049436|NCT02750514|50152668|FG000|Track 3|Other reasons|0|||
25049437|NCT02750514|50152669|FG001|Track 3|Other reasons|3|||
25049438|NCT02750514|50152670|FG002|Track 3|Other reasons|0|||
25049439|NCT02750514|50152671|FG003|Track 3|Other reasons|0|||
25049440|NCT02750514|50152672|FG004|Track 3|Other reasons|0|||
25049441|NCT02750514|50152668|FG000|Track 4|Study drug toxicity|0|||
25049442|NCT02750514|50152669|FG001|Track 4|Study drug toxicity|6|||
25049443|NCT02750514|50152670|FG002|Track 4|Study drug toxicity|0|||
25049444|NCT02750514|50152671|FG003|Track 4|Study drug toxicity|5|||
25049445|NCT02750514|50152672|FG004|Track 4|Study drug toxicity|0|||
25049446|NCT02750514|50152668|FG000|Track 4|Participant request to discontinue|0|||
25049447|NCT02750514|50152669|FG001|Track 4|Participant request to discontinue|1|||
25049448|NCT02750514|50152670|FG002|Track 4|Participant request to discontinue|0|||
25049449|NCT02750514|50152671|FG003|Track 4|Participant request to discontinue|1|||
25049450|NCT02750514|50152672|FG004|Track 4|Participant request to discontinue|0|||
25049451|NCT02750514|50152668|FG000|Track 4|Participant withdrew consent|0|||
25049452|NCT02750514|50152669|FG001|Track 4|Participant withdrew consent|1|||
25049453|NCT02750514|50152670|FG002|Track 4|Participant withdrew consent|0|||
25049454|NCT02750514|50152671|FG003|Track 4|Participant withdrew consent|0|||
25049455|NCT02750514|50152672|FG004|Track 4|Participant withdrew consent|0|||
25049456|NCT02750514|50152668|FG000|Track 4|Other reasons|0|||
25049457|NCT02750514|50152669|FG001|Track 4|Other reasons|5|||
25049458|NCT02750514|50152670|FG002|Track 4|Other reasons|0|||
25049459|NCT02750514|50152671|FG003|Track 4|Other reasons|3|||
25049460|NCT02750514|50152672|FG004|Track 4|Other reasons|0|||
25049461|NCT02750514|50152668|FG000|Track 4|Disease progression|0|||
25049462|NCT02750514|50152669|FG001|Track 4|Disease progression|33|||
25049463|NCT02750514|50152670|FG002|Track 4|Disease progression|0|||
25049464|NCT02750514|50152671|FG003|Track 4|Disease progression|32|||
25049465|NCT02750514|50152672|FG004|Track 4|Disease progression|0|||
25049466|NCT02750514|50152668|FG000|Track 4|Adverse event unrelated to study drug|0|||
25049467|NCT02750514|50152669|FG001|Track 4|Adverse event unrelated to study drug|5|||
25049468|NCT02750514|50152670|FG002|Track 4|Adverse event unrelated to study drug|0|||
25049469|NCT02750514|50152671|FG003|Track 4|Adverse event unrelated to study drug|0|||
25049470|NCT02750514|50152672|FG004|Track 4|Adverse event unrelated to study drug|0|||
25049471|NCT02750514|50152668|FG000|Track 4|Death|0|||
25049472|NCT02750514|50152669|FG001|Track 4|Death|0|||
25049473|NCT02750514|50152670|FG002|Track 4|Death|0|||
25049474|NCT02750514|50152671|FG003|Track 4|Death|1|||
25049475|NCT02750514|50152672|FG004|Track 4|Death|0|||
25049476|NCT02750514|50152668|FG000|Track 5|Disease progression|0|||
25049477|NCT02750514|50152669|FG001|Track 5|Disease progression|0|||
25049478|NCT02750514|50152670|FG002|Track 5|Disease progression|0|||
25049479|NCT02750514|50152671|FG003|Track 5|Disease progression|0|||
25049480|NCT02750514|50152672|FG004|Track 5|Disease progression|34|||
25049481|NCT02750514|50152668|FG000|Track 5|Adverse event unrelated to study drug|0|||
25049482|NCT02750514|50152669|FG001|Track 5|Adverse event unrelated to study drug|0|||
25049483|NCT02750514|50152670|FG002|Track 5|Adverse event unrelated to study drug|0|||
25049484|NCT02750514|50152671|FG003|Track 5|Adverse event unrelated to study drug|0|||
25049485|NCT02750514|50152672|FG004|Track 5|Adverse event unrelated to study drug|2|||
25049486|NCT02750514|50152668|FG000|Track 5|Study drug toxicity|0|||
25049487|NCT02750514|50152669|FG001|Track 5|Study drug toxicity|0|||
25049488|NCT02750514|50152670|FG002|Track 5|Study drug toxicity|0|||
25049489|NCT02750514|50152671|FG003|Track 5|Study drug toxicity|0|||
25049490|NCT02750514|50152672|FG004|Track 5|Study drug toxicity|2|||
25049491|NCT02750514|50152668|FG000|Track 5|Participant request to discontinue|0|||
25049492|NCT02750514|50152669|FG001|Track 5|Participant request to discontinue|0|||
25049493|NCT02750514|50152670|FG002|Track 5|Participant request to discontinue|0|||
25049494|NCT02750514|50152671|FG003|Track 5|Participant request to discontinue|0|||
25049495|NCT02750514|50152672|FG004|Track 5|Participant request to discontinue|3|||
25049496|NCT02750514|50152668|FG000|Track 5|Other reasons|0|||
25049497|NCT02750514|50152669|FG001|Track 5|Other reasons|0|||
25049498|NCT02750514|50152670|FG002|Track 5|Other reasons|0|||
25049499|NCT02750514|50152671|FG003|Track 5|Other reasons|0|||
25049500|NCT02750514|50152672|FG004|Track 5|Other reasons|2|||
25049501|NCT02612428|50152694|FG000|VTL-308|Death|14|||
25049502|NCT02612428|50152695|FG001|VTL-308|Death|16|||
25049503|NCT02612428|50152694|FG000|VTL-308|Withdrawal by Subject|0|||
25049504|NCT02612428|50152695|FG001|VTL-308|Withdrawal by Subject|1|||
25049505|NCT02612428|50152694|FG000|VTL-308E|Death|9|||
25049506|NCT02612428|50152695|FG001|VTL-308E|Death|7|||
25049507|NCT02612428|50152694|FG000|VTL-308E|Lost to Follow-up|2|||
25049508|NCT02612428|50152695|FG001|VTL-308E|Lost to Follow-up|0|||
25049509|NCT03679884|50152706|FG000|Overall Study|Other|12|||
25049510|NCT03679884|50152707|FG001|Overall Study|Other|12|||
25049511|NCT03679884|50152708|FG002|Overall Study|Other|12|||
25049512|NCT03679884|50152709|FG003|Overall Study|Other|7|||
25049513|NCT03679884|50152710|FG004|Overall Study|Other|8|||
25049514|NCT03679884|50152706|FG000|Overall Study|Lack of Efficacy|15|||
25049515|NCT03679884|50152707|FG001|Overall Study|Lack of Efficacy|29|||
25049516|NCT03679884|50152708|FG002|Overall Study|Lack of Efficacy|13|||
25049517|NCT03679884|50152709|FG003|Overall Study|Lack of Efficacy|29|||
25049518|NCT03679884|50152710|FG004|Overall Study|Lack of Efficacy|10|||
25049519|NCT03679884|50152706|FG000|Overall Study|Death|1|||
25049520|NCT03679884|50152707|FG001|Overall Study|Death|0|||
25049521|NCT03679884|50152708|FG002|Overall Study|Death|0|||
25049522|NCT03679884|50152709|FG003|Overall Study|Death|0|||
25049523|NCT03679884|50152710|FG004|Overall Study|Death|0|||
25049524|NCT03679884|50152706|FG000|Overall Study|Adverse Event|2|||
25049525|NCT03679884|50152707|FG001|Overall Study|Adverse Event|10|||
25049526|NCT03679884|50152708|FG002|Overall Study|Adverse Event|9|||
25049527|NCT03679884|50152709|FG003|Overall Study|Adverse Event|6|||
25049528|NCT03679884|50152710|FG004|Overall Study|Adverse Event|6|||
25049529|NCT03679884|50152706|FG000|Overall Study|Withdrawal by Subject|12|||
25049530|NCT03679884|50152707|FG001|Overall Study|Withdrawal by Subject|23|||
25049531|NCT03679884|50152708|FG002|Overall Study|Withdrawal by Subject|8|||
25049532|NCT03679884|50152709|FG003|Overall Study|Withdrawal by Subject|8|||
25049533|NCT03679884|50152710|FG004|Overall Study|Withdrawal by Subject|9|||
25049534|NCT03679884|50152706|FG000|Overall Study|Lost to Follow-up|1|||
25049535|NCT03679884|50152707|FG001|Overall Study|Lost to Follow-up|4|||
25049536|NCT03679884|50152708|FG002|Overall Study|Lost to Follow-up|2|||
25049537|NCT03679884|50152709|FG003|Overall Study|Lost to Follow-up|0|||
25049538|NCT03679884|50152710|FG004|Overall Study|Lost to Follow-up|3|||
25049539|NCT01329978|50152725|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
25049540|NCT01329978|50152726|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
25049541|NCT01329978|50152727|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
25049542|NCT01329978|50152728|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
25049543|NCT01329978|50152729|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
25049544|NCT01329978|50152725|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
24960410|NCT00317642|50050938|FG001|Overall Study|Referred For Transplantation|0|||
24960411|NCT00317642|50050937|FG000|Overall Study|AML Not Centrally Confirmed|1|||
24960412|NCT00317642|50050938|FG001|Overall Study|AML Not Centrally Confirmed|5|||
24960413|NCT00295022|50050954|FG000|Overall Study|Adverse Event|1|||
24960414|NCT00295022|50050955|FG001|Overall Study|Adverse Event|1|||
24960415|NCT00295022|50050956|FG002|Overall Study|Adverse Event|2|||
24960416|NCT00295022|50050954|FG000|Overall Study|Lost to Follow-up|0|||
24960417|NCT00295022|50050955|FG001|Overall Study|Lost to Follow-up|0|||
24960418|NCT00295022|50050956|FG002|Overall Study|Lost to Follow-up|1|||
24960419|NCT00295022|50050954|FG000|Overall Study|Withdrawal by Subject|0|||
24960420|NCT00295022|50050955|FG001|Overall Study|Withdrawal by Subject|0|||
24960421|NCT00295022|50050956|FG002|Overall Study|Withdrawal by Subject|2|||
24960422|NCT00303446|50050968|FG000|Overall Study|Withdrawal by Subject|2|||
24960423|NCT00303446|50050969|FG001|Overall Study|Withdrawal by Subject|2|||
24960424|NCT00303446|50050968|FG000|Overall Study|Death|0|||
25049545|NCT01329978|50152726|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
25049546|NCT01329978|50152727|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
25049547|NCT01329978|50152728|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
25049548|NCT01329978|50152729|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
25049549|NCT01329978|50152725|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
25049550|NCT01329978|50152726|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
25049551|NCT01329978|50152727|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
25049552|NCT01329978|50152728|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
25049553|NCT01329978|50152729|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
25049554|NCT01329978|50152725|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
25049555|NCT01329978|50152726|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
25186558|NCT03845023|50337075|FG000|Follow-Up (14 Days)|Adverse Event|0|||
25049556|NCT01329978|50152727|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
25049557|NCT01329978|50152728|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
25049558|NCT01329978|50152729|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
25049559|NCT01329978|50152725|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
25049560|NCT01329978|50152726|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
25049561|NCT01329978|50152727|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
25049562|NCT01329978|50152728|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
25049563|NCT01329978|50152729|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
25049564|NCT01329978|50152725|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
25049565|NCT01329978|50152726|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
25049566|NCT01329978|50152727|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
25049567|NCT01329978|50152728|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
25049568|NCT01329978|50152729|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
25049569|NCT01329978|50152725|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
25049570|NCT01329978|50152726|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
25049571|NCT01329978|50152727|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
25049572|NCT01329978|50152728|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
25049573|NCT01329978|50152729|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
25049574|NCT01338012|50152741|FG000|Overall Study|Death|4|||
25049575|NCT01338012|50152741|FG000|Overall Study|Study terminated|4|||
25049576|NCT04905498|50152747|FG000|Overall Study|Lost to Follow-up|0|||
25049577|NCT04905498|50152748|FG001|Overall Study|Lost to Follow-up|2|||
25049578|NCT04905498|50152747|FG000|Overall Study|COVID lockdown|1|||
25049579|NCT04905498|50152748|FG001|Overall Study|COVID lockdown|0|||
25049580|NCT02607280|50152756|FG000|Overall Study|Adverse Event|4|||
25049581|NCT02607280|50152757|FG001|Overall Study|Adverse Event|0|||
25049582|NCT02607280|50152756|FG000|Overall Study|Decrease in CrCl <15|0|||
25049583|NCT02607280|50152757|FG001|Overall Study|Decrease in CrCl <15|1|||
25049584|NCT02202434|50152767|FG000|Overall Study|Death|70|||
25049585|NCT02202434|50152768|FG001|Overall Study|Death|39|||
25049586|NCT02202434|50152769|FG002|Overall Study|Death|13|||
25049587|NCT02202434|50152770|FG003|Overall Study|Death|27|||
25049588|NCT02202434|50152767|FG000|Overall Study|Lost to Follow-up|1|||
25049589|NCT02202434|50152768|FG001|Overall Study|Lost to Follow-up|1|||
25049590|NCT02202434|50152769|FG002|Overall Study|Lost to Follow-up|1|||
25049591|NCT02202434|50152770|FG003|Overall Study|Lost to Follow-up|0|||
25049592|NCT02202434|50152767|FG000|Overall Study|Physician Decision|2|||
25049593|NCT02202434|50152768|FG001|Overall Study|Physician Decision|3|||
25049594|NCT02202434|50152769|FG002|Overall Study|Physician Decision|0|||
25049595|NCT02202434|50152770|FG003|Overall Study|Physician Decision|0|||
25049596|NCT02202434|50152767|FG000|Overall Study|Withdrawal by Subject|13|||
25049597|NCT02202434|50152768|FG001|Overall Study|Withdrawal by Subject|14|||
25049598|NCT02202434|50152769|FG002|Overall Study|Withdrawal by Subject|1|||
25049599|NCT02202434|50152770|FG003|Overall Study|Withdrawal by Subject|4|||
25276957|NCT00957034|50590926|FG002|Overall Study|Adverse Event|1|||
25049600|NCT02202434|50152767|FG000|Overall Study|Completed Study|1|||
25049601|NCT02202434|50152768|FG001|Overall Study|Completed Study|0|||
25049602|NCT02202434|50152769|FG002|Overall Study|Completed Study|0|||
25049603|NCT02202434|50152770|FG003|Overall Study|Completed Study|0|||
25049604|NCT02202434|50152767|FG000|Overall Study|Visit Missed|21|||
25049605|NCT02202434|50152768|FG001|Overall Study|Visit Missed|12|||
25049606|NCT02202434|50152769|FG002|Overall Study|Visit Missed|0|||
25049607|NCT02202434|50152770|FG003|Overall Study|Visit Missed|5|||
25049608|NCT02202434|50152767|FG000|Overall Study|Other|1|||
25049609|NCT02202434|50152768|FG001|Overall Study|Other|0|||
25049610|NCT02202434|50152769|FG002|Overall Study|Other|0|||
25049611|NCT02202434|50152770|FG003|Overall Study|Other|1|||
25049612|NCT02784288|50152780|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
25049613|NCT01230242|50152785|FG000|Overall Study|Physician Decision|2|||
25049614|NCT01230242|50152785|FG000|Overall Study|Withdrawal by Subject|1|||
25049615|NCT02608450|50152791|FG000|Overall Study|Lost to Follow-up|39|||
25049616|NCT02608450|50152792|FG001|Overall Study|Lost to Follow-up|32|||
25049617|NCT02608450|50152791|FG000|Overall Study|Withdrawal by Subject|21|||
25049618|NCT02608450|50152792|FG001|Overall Study|Withdrawal by Subject|15|||
25049619|NCT02608450|50152791|FG000|Overall Study|Adverse Event|3|||
25049620|NCT02608450|50152792|FG001|Overall Study|Adverse Event|6|||
25049621|NCT02608450|50152791|FG000|Overall Study|Withdrawal by parent|2|||
25049622|NCT02608450|50152792|FG001|Overall Study|Withdrawal by parent|3|||
25049623|NCT02608450|50152791|FG000|Overall Study|Lack of Efficacy|0|||
25049624|NCT02608450|50152792|FG001|Overall Study|Lack of Efficacy|3|||
25049625|NCT02608450|50152791|FG000|Overall Study|Noncompliance with study drug|0|||
25049626|NCT02608450|50152792|FG001|Overall Study|Noncompliance with study drug|2|||
25049627|NCT02608450|50152791|FG000|Overall Study|Physician Decision|0|||
25049628|NCT02608450|50152792|FG001|Overall Study|Physician Decision|1|||
25049629|NCT02608450|50152791|FG000|Overall Study|Pregnancy|0|||
25049630|NCT02608450|50152792|FG001|Overall Study|Pregnancy|1|||
25049631|NCT02608450|50152791|FG000|Overall Study|Progressive disease|1|||
25049632|NCT02608450|50152792|FG001|Overall Study|Progressive disease|0|||
25049633|NCT02608450|50152791|FG000|Overall Study|Multiple reasons|0|||
25049634|NCT02608450|50152792|FG001|Overall Study|Multiple reasons|2|||
25049635|NCT01668004|50152798|FG000|Overall Study|Adverse Event|7|||
25049636|NCT01668004|50152798|FG000|Overall Study|Withdrawal by Subject|2|||
25049637|NCT01668004|50152798|FG000|Overall Study|Lost to Follow-up|5|||
25049638|NCT01668004|50152798|FG000|Overall Study|Lack of Efficacy|9|||
25049639|NCT01668004|50152798|FG000|Overall Study|Non-compliance with treatment|2|||
25049640|NCT01667926|50152806|FG000|Overall Study|Withdrawal by Subject|1|||
25049641|NCT01667926|50152807|FG001|Overall Study|Withdrawal by Subject|2|||
25049642|NCT01667926|50152808|FG002|Overall Study|Withdrawal by Subject|2|||
25049643|NCT01667926|50152806|FG000|Overall Study|Physician Decision|0|||
25049644|NCT01667926|50152807|FG001|Overall Study|Physician Decision|0|||
25049645|NCT01667926|50152808|FG002|Overall Study|Physician Decision|1|||
25049646|NCT01667926|50152806|FG000|Overall Study|Time committment|0|||
25049647|NCT01667926|50152807|FG001|Overall Study|Time committment|0|||
25049648|NCT01667926|50152808|FG002|Overall Study|Time committment|2|||
25049649|NCT01667926|50152806|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
25049650|NCT01667926|50152807|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
25049651|NCT01667926|50152808|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
25049652|NCT01667926|50152806|FG000|Overall Study|Lost to Follow-up|1|||
25049653|NCT01667926|50152807|FG001|Overall Study|Lost to Follow-up|2|||
25049654|NCT01667926|50152808|FG002|Overall Study|Lost to Follow-up|1|||
25049655|NCT01667926|50152806|FG000|Overall Study|Side effects|3|||
25049656|NCT01667926|50152807|FG001|Overall Study|Side effects|0|||
25049657|NCT01667926|50152808|FG002|Overall Study|Side effects|0|||
25049658|NCT02604160|50152816|FG000|Overall Study|Protocol Violation|0|||
25049659|NCT02604160|50152817|FG001|Overall Study|Protocol Violation|1|||
25049660|NCT02604160|50152816|FG000|Overall Study|Physician Decision|0|||
25049661|NCT02604160|50152817|FG001|Overall Study|Physician Decision|1|||
25049662|NCT01359904|50152827|FG000|Overall Study|Withdrawal by Subject|1|||
25049663|NCT01359904|50152828|FG001|Overall Study|Withdrawal by Subject|0|||
25049664|NCT00157248|50152857|FG000|Overall Study|Adverse Event|36|||
25049665|NCT00157248|50152858|FG001|Overall Study|Adverse Event|25|||
25049666|NCT00157248|50152859|FG002|Overall Study|Adverse Event|13|||
25049667|NCT00157248|50152860|FG003|Overall Study|Adverse Event|33|||
25049668|NCT00157248|50152857|FG000|Overall Study|Protocol Violation|4|||
25049669|NCT00157248|50152858|FG001|Overall Study|Protocol Violation|0|||
25049670|NCT00157248|50152859|FG002|Overall Study|Protocol Violation|2|||
25049671|NCT00157248|50152860|FG003|Overall Study|Protocol Violation|2|||
25049672|NCT00157248|50152857|FG000|Overall Study|Lost to Follow-up|0|||
25049673|NCT00157248|50152858|FG001|Overall Study|Lost to Follow-up|1|||
25049674|NCT00157248|50152859|FG002|Overall Study|Lost to Follow-up|0|||
25049675|NCT00157248|50152860|FG003|Overall Study|Lost to Follow-up|0|||
25049676|NCT00157248|50152857|FG000|Overall Study|Withdrawal by Subject|1|||
25049677|NCT00157248|50152858|FG001|Overall Study|Withdrawal by Subject|4|||
25049678|NCT00157248|50152859|FG002|Overall Study|Withdrawal by Subject|3|||
25049679|NCT00157248|50152860|FG003|Overall Study|Withdrawal by Subject|3|||
25049680|NCT00157248|50152857|FG000|Overall Study|site closures, subject moving|7|||
25049681|NCT00157248|50152858|FG001|Overall Study|site closures, subject moving|7|||
25049682|NCT00157248|50152859|FG002|Overall Study|site closures, subject moving|3|||
25049683|NCT00157248|50152860|FG003|Overall Study|site closures, subject moving|9|||
25276446|NCT01243424|50590386|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
25276447|NCT01243424|50590385|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
25276448|NCT01243424|50590386|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
25049688|NCT01328756|50152894|FG000|Overall Study|Protocol Violation|4|||
25049689|NCT01328756|50152894|FG000|Overall Study|Adverse Event|39|||
25049690|NCT01328756|50152894|FG000|Overall Study|Lack of Efficacy|5|||
25049691|NCT01328756|50152894|FG000|Overall Study|Withdrawal by Subject|41|||
25049692|NCT01328756|50152894|FG000|Overall Study|Lost to Follow-up|5|||
25049693|NCT01328756|50152894|FG000|Overall Study|Other|29|||
25049694|NCT03922308|50152901|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
25049695|NCT03922308|50152902|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
25049696|NCT03922308|50152903|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
25049697|NCT03922308|50152901|FG000|Overall Study|Lost to Follow-up|1|||
25049698|NCT03922308|50152902|FG001|Overall Study|Lost to Follow-up|0|||
25049699|NCT03922308|50152903|FG002|Overall Study|Lost to Follow-up|0|||
25049700|NCT03922308|50152901|FG000|Overall Study|Reason not Specified|0|||
25049701|NCT03922308|50152902|FG001|Overall Study|Reason not Specified|2|||
25049702|NCT03922308|50152903|FG002|Overall Study|Reason not Specified|1|||
25049703|NCT02607930|50152916|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
25049704|NCT02607930|50152917|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
25049705|NCT02607930|50152918|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
25049706|NCT02607930|50152919|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
25049707|NCT02607930|50152916|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
25049708|NCT02607930|50152917|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
25049709|NCT02607930|50152918|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
25049710|NCT02607930|50152919|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
25049711|NCT02607930|50152916|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
25049712|NCT02607930|50152917|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
25049713|NCT02607930|50152918|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
25049714|NCT02607930|50152919|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
25049715|NCT02607930|50152916|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
25049716|NCT02607930|50152917|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
25049717|NCT02607930|50152918|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
25049718|NCT02607930|50152919|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
25049719|NCT02607930|50152916|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
25049720|NCT02607930|50152917|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
25049721|NCT02607930|50152918|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
25049722|NCT02607930|50152919|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
25049723|NCT02607930|50152916|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
25049724|NCT02607930|50152917|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
25049725|NCT02607930|50152918|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
25049726|NCT02607930|50152919|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
25049727|NCT02607930|50152916|FG000|Double-Blinded Treatment Phase|Death|2|||
25049728|NCT02607930|50152917|FG001|Double-Blinded Treatment Phase|Death|1|||
25049729|NCT02607930|50152918|FG002|Double-Blinded Treatment Phase|Death|0|||
25049730|NCT02607930|50152919|FG003|Double-Blinded Treatment Phase|Death|0|||
25049731|NCT02607930|50152916|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
25049732|NCT02607930|50152917|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
25049733|NCT02607930|50152918|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
25049734|NCT02607930|50152919|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
25049735|NCT02607930|50152916|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
25049736|NCT02607930|50152917|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
25049737|NCT02607930|50152918|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
25049738|NCT02607930|50152919|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
25049739|NCT02607930|50152916|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
25049740|NCT02607930|50152917|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
25049741|NCT02607930|50152918|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
25049742|NCT02607930|50152919|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
25049743|NCT02607930|50152916|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
25049744|NCT02607930|50152917|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
25162555|NCT01791517|50284756|FG007|Phase II|Lens Handling Difficulties|0|||
25162556|NCT01791517|50284757|FG008|Phase II|Lens Handling Difficulties|1|||
25162557|NCT01791517|50284758|FG009|Phase II|Lens Handling Difficulties|0|||
25162558|NCT01791517|50284759|FG010|Phase II|Lens Handling Difficulties|0|||
25162559|NCT01791517|50284760|FG011|Phase II|Lens Handling Difficulties|0|||
25162560|NCT01791517|50284749|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
25162561|NCT01791517|50284750|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
25162562|NCT01791517|50284751|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
25049745|NCT02607930|50152918|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
25049746|NCT02607930|50152919|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
25049747|NCT02607930|50152916|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
25049748|NCT02607930|50152917|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
25162563|NCT01791517|50284752|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
24960425|NCT00303446|50050969|FG001|Overall Study|Death|1|||
24960426|NCT00303446|50050968|FG000|Overall Study|Physician Decision|0|||
25049749|NCT02607930|50152918|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
25049750|NCT02607930|50152919|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
25049751|NCT02607930|50152916|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
25049752|NCT02607930|50152917|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
25049753|NCT02607930|50152918|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
25049754|NCT02607930|50152919|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
25049755|NCT02607930|50152916|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
25049756|NCT02607930|50152917|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
25049757|NCT02607930|50152918|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
25049758|NCT02607930|50152919|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
25049759|NCT02607930|50152916|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
25049760|NCT02607930|50152917|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
25049761|NCT02607930|50152918|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
25049762|NCT02607930|50152919|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
25049763|NCT02607930|50152916|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
25049764|NCT02607930|50152917|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
25049765|NCT02607930|50152918|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
25049766|NCT02607930|50152919|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
25049767|NCT02101034|50152938|FG000|Overall Study|Enrolled but did not start treatment|0|||
25049768|NCT02101034|50152939|FG001|Overall Study|Enrolled but did not start treatment|0|||
25049769|NCT02101034|50152940|FG002|Overall Study|Enrolled but did not start treatment|1|||
25049770|NCT02101034|50152941|FG003|Overall Study|Enrolled but did not start treatment|0|||
25049771|NCT02101034|50152942|FG004|Overall Study|Enrolled but did not start treatment|0|||
25049772|NCT02736188|50152977|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
25049773|NCT02736188|50152977|FG000|Overall Study|Adverse Event|1|||
25049774|NCT02736188|50152977|FG000|Overall Study|Withdrawal by Subject|1|||
25049775|NCT02736188|50152977|FG000|Overall Study|Other|6|||
25049776|NCT00154284|50152985|FG000|Overall Study|Adverse Event|6|||
25049777|NCT00154284|50152986|FG001|Overall Study|Adverse Event|9|||
25049778|NCT00154284|50152985|FG000|Overall Study|Abnormal laboratory value(s)|0|||
25049779|NCT00154284|50152986|FG001|Overall Study|Abnormal laboratory value(s)|1|||
25049780|NCT00154284|50152985|FG000|Overall Study|Lack of Efficacy|1|||
25049781|NCT00154284|50152986|FG001|Overall Study|Lack of Efficacy|2|||
25049782|NCT00154284|50152985|FG000|Overall Study|Protocol Violation|0|||
25049783|NCT00154284|50152986|FG001|Overall Study|Protocol Violation|1|||
25049784|NCT02735096|50152994|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
25049785|NCT00905346|50153007|FG000|Period 1|Withdrawal by Subject|1|||
25049786|NCT00905346|50153008|FG001|Period 1|Withdrawal by Subject|0|||
25049787|NCT01328444|50153021|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
25049788|NCT01328444|50153022|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
25049789|NCT01328444|50153023|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
25049790|NCT01328444|50153024|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
25049791|NCT01328444|50153025|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
25049792|NCT01328444|50153026|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
25049793|NCT01328444|50153021|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
25049794|NCT01328444|50153022|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
25049795|NCT01328444|50153023|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
25186559|NCT03845023|50337076|FG001|Follow-Up (14 Days)|Adverse Event|0|||
24960427|NCT00303446|50050969|FG001|Overall Study|Physician Decision|1|||
24960428|NCT00316706|50050977|FG000|Overall Study|Lost to Follow-up|38|||
24960429|NCT00316706|50050978|FG001|Overall Study|Lost to Follow-up|48|||
24960430|NCT00291486|50050989|FG000|Overall Study|Adverse Event|0|||
24960431|NCT00291486|50050990|FG001|Overall Study|Adverse Event|3|||
24960432|NCT00291486|50050991|FG002|Overall Study|Adverse Event|0|||
24960433|NCT00291486|50050992|FG003|Overall Study|Adverse Event|1|||
24960434|NCT00291486|50050993|FG004|Overall Study|Adverse Event|0|||
25049796|NCT01328444|50153024|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
25049797|NCT01328444|50153025|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
25049798|NCT01328444|50153026|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
25049799|NCT01328444|50153021|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
25186560|NCT03845023|50337077|FG002|Follow-Up (14 Days)|Adverse Event|1|||
24960435|NCT00291486|50050989|FG000|Overall Study|Withdrawal by Subject|0|||
24960436|NCT00291486|50050990|FG001|Overall Study|Withdrawal by Subject|0|||
25049800|NCT01328444|50153022|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
25049801|NCT01328444|50153023|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
25049802|NCT01328444|50153024|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
25049803|NCT01328444|50153025|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
25049804|NCT01328444|50153026|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
25049805|NCT01328444|50153021|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
25049806|NCT01328444|50153022|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
25049807|NCT01328444|50153023|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
25049808|NCT01328444|50153024|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
25049809|NCT01328444|50153025|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
25049810|NCT01328444|50153026|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
25049811|NCT01328444|50153021|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
25049812|NCT01328444|50153022|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
25049813|NCT01328444|50153023|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
25049814|NCT01328444|50153024|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
25049815|NCT01328444|50153025|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
25049816|NCT01328444|50153026|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
25049817|NCT01328444|50153021|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
25049818|NCT01328444|50153022|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
25049819|NCT01328444|50153023|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
25049820|NCT01328444|50153024|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
25049821|NCT01328444|50153025|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
25049822|NCT01328444|50153026|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
25049823|NCT01328444|50153021|FG000|Washout Period (14 Days)|Adverse Event|1|||
25049824|NCT01328444|50153022|FG001|Washout Period (14 Days)|Adverse Event|1|||
25049825|NCT01328444|50153023|FG002|Washout Period (14 Days)|Adverse Event|0|||
25049826|NCT01328444|50153024|FG003|Washout Period (14 Days)|Adverse Event|1|||
25049827|NCT01328444|50153025|FG004|Washout Period (14 Days)|Adverse Event|1|||
25049828|NCT01328444|50153026|FG005|Washout Period (14 Days)|Adverse Event|2|||
25049829|NCT01328444|50153021|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
25049830|NCT01328444|50153022|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
25049831|NCT01328444|50153023|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
25049832|NCT01328444|50153024|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
25049833|NCT01328444|50153025|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
25049834|NCT01328444|50153026|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
25049835|NCT01328444|50153021|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
25049836|NCT01328444|50153022|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
25049837|NCT01328444|50153023|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
25049838|NCT01328444|50153024|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
25049839|NCT01328444|50153025|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
25049840|NCT01328444|50153026|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
25049841|NCT01328444|50153021|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
25049842|NCT01328444|50153022|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
24960437|NCT00291486|50050991|FG002|Overall Study|Withdrawal by Subject|0|||
24960438|NCT00291486|50050992|FG003|Overall Study|Withdrawal by Subject|0|||
24960439|NCT00291486|50050993|FG004|Overall Study|Withdrawal by Subject|1|||
24960440|NCT00291486|50050989|FG000|Overall Study|Disease progression|1|||
24960441|NCT00291486|50050990|FG001|Overall Study|Disease progression|0|||
24960442|NCT00291486|50050991|FG002|Overall Study|Disease progression|1|||
24960443|NCT00291486|50050992|FG003|Overall Study|Disease progression|0|||
24960444|NCT00291486|50050993|FG004|Overall Study|Disease progression|0|||
24960445|NCT00301964|50051014|FG000|Overall Study|Second primary|2|||
24960446|NCT00301964|50051014|FG000|Overall Study|Wrong primary|1|||
24960447|NCT00301964|50051014|FG000|Overall Study|Inadequate pathology|1|||
24960448|NCT00268242|50051024|FG000|Overall Study|Death|1|||
24960449|NCT00294554|50051030|FG000|Overall Study|Lack of Efficacy|0|||
24960450|NCT00294554|50051031|FG001|Overall Study|Lack of Efficacy|1|||
24960451|NCT00294554|50051030|FG000|Overall Study|Physician Decision|0|||
24960452|NCT00294554|50051031|FG001|Overall Study|Physician Decision|1|||
24960453|NCT00294398|50051039|FG000|Overall Study|Lost to Follow-up|21|||
24960454|NCT00294398|50051040|FG001|Overall Study|Lost to Follow-up|26|||
25049843|NCT01328444|50153023|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
25049844|NCT01328444|50153024|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
25049845|NCT01328444|50153025|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
25049846|NCT01328444|50153026|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
25162564|NCT01791517|50284753|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
24960455|NCT00279708|50051048|FG000|Overall Study|Withdrawal by Subject|2|||
24960456|NCT00279708|50051049|FG001|Overall Study|Withdrawal by Subject|3|||
24960457|NCT00279708|50051048|FG000|Overall Study|Adverse Event|1|||
24960458|NCT00279708|50051049|FG001|Overall Study|Adverse Event|1|||
24960459|NCT00299702|50051057|FG000|Overall Study|Death|1|||
24960460|NCT00299702|50051058|FG001|Overall Study|Death|0|||
25049847|NCT01328444|50153021|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
25049848|NCT01328444|50153022|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
25049849|NCT01328444|50153023|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
25049850|NCT01328444|50153024|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
25049851|NCT01328444|50153025|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
25049852|NCT01328444|50153026|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
25049853|NCT01328444|50153021|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
25049854|NCT01328444|50153022|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
25049855|NCT01328444|50153023|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
25049856|NCT01328444|50153024|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
25049857|NCT01328444|50153025|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
25049858|NCT01328444|50153026|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
25049859|NCT01328444|50153021|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
25049860|NCT01328444|50153022|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
25049861|NCT01328444|50153023|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
25049862|NCT01328444|50153024|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
25049863|NCT01328444|50153025|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
25049864|NCT01328444|50153026|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
25049865|NCT01328444|50153021|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
25049866|NCT01328444|50153022|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
25049867|NCT01328444|50153023|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
25049868|NCT01328444|50153024|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
25049869|NCT01328444|50153025|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
25049870|NCT01328444|50153026|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
25049871|NCT01328444|50153021|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
25049872|NCT01328444|50153022|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
25049873|NCT01328444|50153023|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
25049874|NCT01328444|50153024|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
25049875|NCT01328444|50153025|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
25049876|NCT01328444|50153026|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
25049877|NCT00887250|50153043|FG000|Overall Study|Adverse Event|3|||
25049878|NCT00887250|50153044|FG001|Overall Study|Adverse Event|0|||
25049879|NCT00887250|50153045|FG002|Overall Study|Adverse Event|7|||
25049880|NCT00887250|50153043|FG000|Overall Study|Lack of Efficacy|9|||
25049881|NCT00887250|50153044|FG001|Overall Study|Lack of Efficacy|6|||
25049882|NCT00887250|50153045|FG002|Overall Study|Lack of Efficacy|1|||
25049883|NCT00887250|50153043|FG000|Overall Study|Lost to Follow-up|2|||
25049884|NCT00887250|50153044|FG001|Overall Study|Lost to Follow-up|3|||
25049885|NCT00887250|50153045|FG002|Overall Study|Lost to Follow-up|1|||
25049886|NCT00887250|50153043|FG000|Overall Study|Protocol Violation|2|||
25049887|NCT00887250|50153044|FG001|Overall Study|Protocol Violation|2|||
25049888|NCT00887250|50153045|FG002|Overall Study|Protocol Violation|1|||
25049889|NCT00887250|50153043|FG000|Overall Study|Withdrawal by Subject|2|||
25049890|NCT00887250|50153044|FG001|Overall Study|Withdrawal by Subject|1|||
25049891|NCT00887250|50153045|FG002|Overall Study|Withdrawal by Subject|2|||
25049892|NCT00887250|50153043|FG000|Overall Study|Patient uncooperative|0|||
25049893|NCT00887250|50153044|FG001|Overall Study|Patient uncooperative|0|||
25049894|NCT00887250|50153045|FG002|Overall Study|Patient uncooperative|1|||
25049895|NCT02599402|50153050|FG000|Overall Study|Disease progression|153|||
25049896|NCT02599402|50153050|FG000|Overall Study|Study drug toxicity|201|||
25049897|NCT02599402|50153050|FG000|Overall Study|Death|26|||
25049898|NCT02599402|50153050|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
25049899|NCT02599402|50153050|FG000|Overall Study|Participant request to discontinue study treatment|13|||
25049900|NCT02599402|50153050|FG000|Overall Study|Participant withdrew consent|5|||
25049901|NCT02599402|50153050|FG000|Overall Study|Lost to Follow-up|1|||
25049902|NCT02599402|50153050|FG000|Overall Study|Maximum Clinical Benefit|7|||
25049903|NCT02599402|50153050|FG000|Overall Study|Poor/non-compliance|1|||
25049904|NCT02599402|50153050|FG000|Overall Study|Pregnancy|1|||
25049905|NCT02599402|50153050|FG000|Overall Study|Participant no longer met study criteria|7|||
25049906|NCT02599402|50153050|FG000|Overall Study|Other Reasons|95|||
25049907|NCT02734862|50153090|FG000|Part A|Death|3|||
25049908|NCT02734862|50153091|FG001|Part A|Death|4|||
25049909|NCT02734862|50153092|FG002|Part A|Death|6|||
25049910|NCT02734862|50153090|FG000|Part A|Lost to Follow-up|2|||
25049911|NCT02734862|50153091|FG001|Part A|Lost to Follow-up|1|||
25049912|NCT02734862|50153092|FG002|Part A|Lost to Follow-up|1|||
25049913|NCT02734862|50153090|FG000|Part A|Withdrawal by Subject|1|||
25049914|NCT02734862|50153091|FG001|Part A|Withdrawal by Subject|1|||
25049915|NCT02734862|50153092|FG002|Part A|Withdrawal by Subject|2|||
25049916|NCT02734862|50153090|FG000|Part A|Physician Decision|2|||
25049917|NCT02734862|50153091|FG001|Part A|Physician Decision|0|||
25049918|NCT02734862|50153092|FG002|Part A|Physician Decision|1|||
25162565|NCT01791517|50284754|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
25049919|NCT02734862|50153090|FG000|Part A|Adverse Event|2|||
25049920|NCT02734862|50153091|FG001|Part A|Adverse Event|0|||
25049921|NCT02734862|50153092|FG002|Part A|Adverse Event|1|||
25049922|NCT02734862|50153090|FG000|Part A|Noncompliance|1|||
25049923|NCT02734862|50153091|FG001|Part A|Noncompliance|1|||
25049924|NCT02734862|50153092|FG002|Part A|Noncompliance|0|||
25049925|NCT02734862|50153090|FG000|Part A|Other|1|||
25049926|NCT02734862|50153091|FG001|Part A|Other|1|||
25049927|NCT02734862|50153092|FG002|Part A|Other|3|||
25049928|NCT02734862|50153090|FG000|Part B|Death|8|||
25049929|NCT02734862|50153091|FG001|Part B|Death|3|||
25049930|NCT02734862|50153092|FG002|Part B|Death|5|||
25049931|NCT02734862|50153090|FG000|Part B|Lost to Follow-up|2|||
25049932|NCT02734862|50153091|FG001|Part B|Lost to Follow-up|2|||
25049933|NCT02734862|50153092|FG002|Part B|Lost to Follow-up|0|||
25049934|NCT02734862|50153090|FG000|Part B|Withdrawal by Subject|3|||
25049935|NCT02734862|50153091|FG001|Part B|Withdrawal by Subject|1|||
25049936|NCT02734862|50153092|FG002|Part B|Withdrawal by Subject|0|||
25049937|NCT02734862|50153090|FG000|Part B|Other|0|||
25049938|NCT02734862|50153091|FG001|Part B|Other|1|||
25049939|NCT02734862|50153092|FG002|Part B|Other|0|||
25049940|NCT00858702|50153103|FG000|Overall Study|Lack of Efficacy|1|||
25049941|NCT00858702|50153104|FG001|Overall Study|Lack of Efficacy|0|||
25049942|NCT00858702|50153103|FG000|Overall Study|Protocol Violation|1|||
25049943|NCT00858702|50153104|FG001|Overall Study|Protocol Violation|1|||
25049944|NCT00858702|50153103|FG000|Overall Study|Other|2|||
25049945|NCT00858702|50153104|FG001|Overall Study|Other|1|||
25049946|NCT00858702|50153103|FG000|Overall Study|Withdrawal by Subject|1|||
25049947|NCT00858702|50153104|FG001|Overall Study|Withdrawal by Subject|0|||
25049948|NCT02598934|50153112|FG000|Overall Study|Adverse Event|11|||
25049949|NCT02598934|50153113|FG001|Overall Study|Adverse Event|13|||
25049950|NCT02598934|50153112|FG000|Overall Study|Failure to Return|3|||
25276449|NCT01243424|50590385|FG000|Discontinuation From Treatment|Not treated|5|||
25276450|NCT01243424|50590386|FG001|Discontinuation From Treatment|Not treated|4|||
25276451|NCT01243424|50590385|FG000|Discontinuation From Treatment|Adverse Event|457|||
25276452|NCT01243424|50590386|FG001|Discontinuation From Treatment|Adverse Event|523|||
25276453|NCT01243424|50590385|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
25276454|NCT01243424|50590386|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
25276455|NCT01243424|50590385|FG000|Discontinuation From Treatment|Protocol Violation|46|||
25276456|NCT01243424|50590386|FG001|Discontinuation From Treatment|Protocol Violation|47|||
25276457|NCT01243424|50590385|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
25276458|NCT01243424|50590386|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
25276459|NCT01243424|50590385|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
25276460|NCT01243424|50590386|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
25276461|NCT01243424|50590385|FG000|Discontinuation From Treatment|Other than listed above|230|||
25276462|NCT01243424|50590386|FG001|Discontinuation From Treatment|Other than listed above|211|||
25276463|NCT00887809|50590395|FG000|Overall Study|Patient Not Treated|3|||
25276464|NCT00887809|50590396|FG001|Overall Study|Patient Not Treated|0|||
25276465|NCT00887809|50590395|FG000|Overall Study|Death|1|||
25276466|NCT00887809|50590396|FG001|Overall Study|Death|0|||
25276467|NCT00958126|50590410|FG000|Overall Study|Serious Adverse Event|0|||
25276468|NCT00958126|50590411|FG001|Overall Study|Serious Adverse Event|2|||
25276469|NCT00958126|50590412|FG002|Overall Study|Serious Adverse Event|0|||
25276470|NCT00958126|50590413|FG003|Overall Study|Serious Adverse Event|0|||
25276471|NCT00958126|50590414|FG004|Overall Study|Serious Adverse Event|0|||
25276472|NCT00958126|50590415|FG005|Overall Study|Serious Adverse Event|0|||
25276473|NCT00958126|50590416|FG006|Overall Study|Serious Adverse Event|1|||
25276474|NCT00958126|50590417|FG007|Overall Study|Serious Adverse Event|0|||
25276475|NCT00958126|50590410|FG000|Overall Study|Withdrawal by Subject|0|||
25276476|NCT00958126|50590411|FG001|Overall Study|Withdrawal by Subject|2|||
25276477|NCT00958126|50590412|FG002|Overall Study|Withdrawal by Subject|0|||
25276478|NCT00958126|50590413|FG003|Overall Study|Withdrawal by Subject|0|||
25276479|NCT00958126|50590414|FG004|Overall Study|Withdrawal by Subject|0|||
25276480|NCT00958126|50590415|FG005|Overall Study|Withdrawal by Subject|0|||
25276481|NCT00958126|50590416|FG006|Overall Study|Withdrawal by Subject|0|||
25049951|NCT02598934|50153113|FG001|Overall Study|Failure to Return|3|||
25049952|NCT02598934|50153112|FG000|Overall Study|Withdrawal by Subject|2|||
25049953|NCT02598934|50153113|FG001|Overall Study|Withdrawal by Subject|3|||
25049954|NCT02598934|50153112|FG000|Overall Study|Administrative|2|||
25049955|NCT02598934|50153113|FG001|Overall Study|Administrative|1|||
25049956|NCT02598934|50153112|FG000|Overall Study|Protocol Violation|1|||
25049957|NCT02598934|50153113|FG001|Overall Study|Protocol Violation|2|||
25049958|NCT02598622|50153121|FG000|Overall Study|Withdrawal by Subject|3|||
25049959|NCT02598622|50153122|FG001|Overall Study|Withdrawal by Subject|0|||
25049960|NCT02598622|50153121|FG000|Overall Study|Physician Decision|3|||
25049961|NCT02598622|50153122|FG001|Overall Study|Physician Decision|0|||
25049962|NCT00841698|50153130|FG000|First Intervention|Withdrawal by Subject|1|||
25049963|NCT00841698|50153131|FG001|First Intervention|Withdrawal by Subject|0|||
25049964|NCT00841542|50153137|FG000|Period 1|Adverse Event|1|||
25049965|NCT00841542|50153138|FG001|Period 1|Adverse Event|0|||
24960461|NCT00299702|50051057|FG000|Overall Study|Adverse Event|0|||
24960462|NCT00299702|50051058|FG001|Overall Study|Adverse Event|4|||
24960463|NCT00299702|50051057|FG000|Overall Study|Lost to Follow-up|18|||
24960464|NCT00299702|50051058|FG001|Overall Study|Lost to Follow-up|10|||
25049966|NCT00840216|50153160|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
25049967|NCT00840216|50153161|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
25049968|NCT00836706|50153171|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
25049969|NCT00836706|50153172|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
25049970|NCT00836472|50153178|FG000|Washout|Adverse Event|1|||
24960465|NCT00299702|50051057|FG000|Overall Study|Withdrawal by Subject|25|||
24960466|NCT00299702|50051058|FG001|Overall Study|Withdrawal by Subject|23|||
24960467|NCT00299702|50051057|FG000|Overall Study|Pregnancy|0|||
25049971|NCT00836472|50153179|FG001|Washout|Adverse Event|2|||
25049972|NCT00836472|50153178|FG000|Washout|Withdrawal by Subject|1|||
25049973|NCT00836472|50153179|FG001|Washout|Withdrawal by Subject|1|||
25049974|NCT02598388|50153195|FG000|Overall Study|Lost to Follow-up|1|||
25049975|NCT02598388|50153196|FG001|Overall Study|Lost to Follow-up|0|||
25049976|NCT02598388|50153197|FG002|Overall Study|Lost to Follow-up|1|||
25049977|NCT02598388|50153198|FG003|Overall Study|Lost to Follow-up|0|||
25049978|NCT02598388|50153199|FG004|Overall Study|Lost to Follow-up|5|||
25049979|NCT02598388|50153200|FG005|Overall Study|Lost to Follow-up|1|||
25049980|NCT02598388|50153201|FG006|Overall Study|Lost to Follow-up|2|||
25049981|NCT02598388|50153202|FG007|Overall Study|Lost to Follow-up|1|||
25049982|NCT02598388|50153203|FG008|Overall Study|Lost to Follow-up|0|||
25049983|NCT02598388|50153204|FG009|Overall Study|Lost to Follow-up|0|||
25049984|NCT02598388|50153205|FG010|Overall Study|Lost to Follow-up|1|||
25049985|NCT02598388|50153206|FG011|Overall Study|Lost to Follow-up|0|||
25049986|NCT02598388|50153195|FG000|Overall Study|Withdrawal by Subject|0|||
25049987|NCT02598388|50153196|FG001|Overall Study|Withdrawal by Subject|0|||
25049988|NCT02598388|50153197|FG002|Overall Study|Withdrawal by Subject|0|||
25049989|NCT02598388|50153198|FG003|Overall Study|Withdrawal by Subject|0|||
25049990|NCT02598388|50153199|FG004|Overall Study|Withdrawal by Subject|2|||
25049991|NCT02598388|50153200|FG005|Overall Study|Withdrawal by Subject|0|||
25049992|NCT02598388|50153201|FG006|Overall Study|Withdrawal by Subject|2|||
25049993|NCT02598388|50153202|FG007|Overall Study|Withdrawal by Subject|0|||
25049994|NCT02598388|50153203|FG008|Overall Study|Withdrawal by Subject|0|||
25049995|NCT02598388|50153204|FG009|Overall Study|Withdrawal by Subject|1|||
25049996|NCT02598388|50153205|FG010|Overall Study|Withdrawal by Subject|0|||
25049997|NCT02598388|50153206|FG011|Overall Study|Withdrawal by Subject|0|||
25049998|NCT02598388|50153195|FG000|Overall Study|Other|0|||
25049999|NCT02598388|50153196|FG001|Overall Study|Other|0|||
25050000|NCT02598388|50153197|FG002|Overall Study|Other|1|||
25050001|NCT02598388|50153198|FG003|Overall Study|Other|0|||
25050002|NCT02598388|50153199|FG004|Overall Study|Other|3|||
25050003|NCT02598388|50153200|FG005|Overall Study|Other|0|||
24960468|NCT00299702|50051058|FG001|Overall Study|Pregnancy|1|||
24960469|NCT00299702|50051057|FG000|Overall Study|Insufficient Response|4|||
24960470|NCT00299702|50051058|FG001|Overall Study|Insufficient Response|3|||
24960471|NCT00299702|50051057|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
25050004|NCT02598388|50153201|FG006|Overall Study|Other|1|||
25050005|NCT02598388|50153202|FG007|Overall Study|Other|0|||
25050006|NCT02598388|50153203|FG008|Overall Study|Other|0|||
25050007|NCT02598388|50153204|FG009|Overall Study|Other|0|||
25050008|NCT02598388|50153205|FG010|Overall Study|Other|0|||
24960472|NCT00299702|50051058|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
24960473|NCT00291330|50051066|FG000|Overall Study|Adverse Event|47|||
24960474|NCT00291330|50051067|FG001|Overall Study|Adverse Event|40|||
24960475|NCT00291330|50051066|FG000|Overall Study|Protocol Violation|13|||
24960476|NCT00291330|50051067|FG001|Overall Study|Protocol Violation|20|||
25050009|NCT02598388|50153206|FG011|Overall Study|Other|0|||
25186561|NCT03845023|50337078|FG003|Follow-Up (14 Days)|Adverse Event|1|||
25186562|NCT01395017|50337140|FG000|Overall Study|Lost to Follow-up|1|||
25186563|NCT01395017|50337141|FG001|Overall Study|Lost to Follow-up|0|||
25186564|NCT01395017|50337140|FG000|Overall Study|Adverse Event|26|||
25276482|NCT00958126|50590417|FG007|Overall Study|Withdrawal by Subject|0|||
25276483|NCT00958126|50590410|FG000|Overall Study|Moved away from study area|0|||
25050010|NCT00835692|50153246|FG000|First Intervention|Withdrawal by Subject|1|||
25050011|NCT00835692|50153247|FG001|First Intervention|Withdrawal by Subject|0|||
25050012|NCT00835536|50153260|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
25050013|NCT00835536|50153261|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
25050014|NCT03865316|50153265|FG000|Overall Study|Procedure Cancelled|4|||
25050015|NCT03865316|50153265|FG000|Overall Study|Equipment failure|4|||
24960477|NCT00291330|50051066|FG000|Overall Study|Lost to Follow-up|16|||
24960478|NCT00291330|50051067|FG001|Overall Study|Lost to Follow-up|11|||
24960479|NCT00291330|50051066|FG000|Overall Study|Withdrawal by Subject|22|||
24960480|NCT00291330|50051067|FG001|Overall Study|Withdrawal by Subject|25|||
24960481|NCT00291330|50051066|FG000|Overall Study|Other|3|||
25050016|NCT02598076|50153271|FG000|Overall Study|Lost to Follow-up|2|||
25050017|NCT02598076|50153272|FG001|Overall Study|Lost to Follow-up|3|||
25186565|NCT01395017|50337141|FG001|Overall Study|Adverse Event|12|||
25050018|NCT02602288|50153280|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
25050019|NCT02602288|50153281|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
25050020|NCT02602288|50153280|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
25050021|NCT02602288|50153281|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
25050022|NCT02602288|50153280|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
25050023|NCT02602288|50153281|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
25050024|NCT02602288|50153280|FG000|12 Month Follow-up|Lost to Follow-up|0|||
25050025|NCT02602288|50153281|FG001|12 Month Follow-up|Lost to Follow-up|4|||
25050026|NCT02602288|50153280|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
25050027|NCT02602288|50153281|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
25050028|NCT02601820|50153287|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
25050029|NCT02601820|50153287|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
25050030|NCT02601820|50153287|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
25050031|NCT02601820|50153287|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
25050032|NCT02807454|50153306|FG000|Overall Study|Adverse Event|1|||
25050033|NCT02807454|50153307|FG001|Overall Study|Adverse Event|0|||
25050034|NCT02807454|50153306|FG000|Overall Study|Withdrawal by Subject|0|||
25050035|NCT02807454|50153307|FG001|Overall Study|Withdrawal by Subject|1|||
25050036|NCT02807454|50153306|FG000|Overall Study|Progressive Disease|30|||
25050037|NCT02807454|50153307|FG001|Overall Study|Progressive Disease|3|||
25050038|NCT02807454|50153306|FG000|Overall Study|Other Reasons|1|||
25050039|NCT02807454|50153307|FG001|Overall Study|Other Reasons|1|||
25050040|NCT02597920|50153322|FG000|Overall Study|Worsening of other pre-existing disease|0|||
25050041|NCT02597920|50153323|FG001|Overall Study|Worsening of other pre-existing disease|1|||
25050042|NCT02597920|50153324|FG002|Overall Study|Worsening of other pre-existing disease|0|||
25050043|NCT02597920|50153322|FG000|Overall Study|Other adverse event|20|||
25050044|NCT02597920|50153323|FG001|Overall Study|Other adverse event|30|||
25050045|NCT02597920|50153324|FG002|Overall Study|Other adverse event|0|||
25050046|NCT02597920|50153322|FG000|Overall Study|Lost to Follow-up|7|||
25050047|NCT02597920|50153323|FG001|Overall Study|Lost to Follow-up|9|||
25050048|NCT02597920|50153324|FG002|Overall Study|Lost to Follow-up|0|||
25050049|NCT02597920|50153322|FG000|Overall Study|Refuse to continue in the study|3|||
25050050|NCT02597920|50153323|FG001|Overall Study|Refuse to continue in the study|13|||
25050051|NCT02597920|50153324|FG002|Overall Study|Refuse to continue in the study|1|||
25050052|NCT02597920|50153322|FG000|Overall Study|Other than specified|10|||
25050053|NCT02597920|50153323|FG001|Overall Study|Other than specified|31|||
25050054|NCT02597920|50153324|FG002|Overall Study|Other than specified|5|||
25050055|NCT02597920|50153322|FG000|Overall Study|Other|1|||
25050056|NCT02597920|50153323|FG001|Overall Study|Other|0|||
25050057|NCT02597920|50153324|FG002|Overall Study|Other|0|||
25050058|NCT01235234|50153344|FG000|Overall Study|Adverse Event|2|||
25050059|NCT01235234|50153345|FG001|Overall Study|Adverse Event|2|||
25050060|NCT01235234|50153346|FG002|Overall Study|Adverse Event|1|||
25050061|NCT02597452|50153361|FG000|Overall Study|testing incomplete|30|||
25050062|NCT02597062|50153365|FG000|Overall Study|Ineligible|1|||
25050063|NCT00834756|50153371|FG000|First Intervention|Adverse Event|1|||
25050064|NCT00834756|50153372|FG001|First Intervention|Adverse Event|0|||
25050065|NCT00834756|50153371|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
25050066|NCT00834756|50153372|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
25050067|NCT00828854|50153376|FG000|Overall Study|Disease Progression|17|||
25050068|NCT00828854|50153376|FG000|Overall Study|Adverse Event|9|||
25050069|NCT00828854|50153376|FG000|Overall Study|Reason not Specified|1|||
25050070|NCT00834522|50153382|FG000|Washout|Adverse Event|1|||
25050071|NCT00834522|50153383|FG001|Washout|Adverse Event|0|||
25050072|NCT00834522|50153382|FG000|Washout|Withdrawal by Subject|2|||
25050073|NCT00834522|50153383|FG001|Washout|Withdrawal by Subject|1|||
25050074|NCT00834444|50153389|FG000|First Intervention|Adverse Event|1|||
25050075|NCT00834444|50153390|FG001|First Intervention|Adverse Event|0|||
25050076|NCT00834444|50153389|FG000|First Intervention|Intolerance to Venopuncture|0|||
25050077|NCT00834444|50153390|FG001|First Intervention|Intolerance to Venopuncture|1|||
25050078|NCT00834444|50153389|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
25050079|NCT00834444|50153390|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
25050080|NCT00834444|50153389|FG000|Second Intervention|Adverse Event|1|||
25050081|NCT00834444|50153390|FG001|Second Intervention|Adverse Event|0|||
25050082|NCT02605954|50153410|FG000|Overall Study|Adverse Event|5|||
25050083|NCT02605954|50153411|FG001|Overall Study|Adverse Event|1|||
25050084|NCT02605954|50153410|FG000|Overall Study|Investigator's Discretion|1|||
25050085|NCT02605954|50153411|FG001|Overall Study|Investigator's Discretion|0|||
25050086|NCT02605954|50153410|FG000|Overall Study|Non-Compliance with Study Drug|1|||
25050087|NCT02605954|50153411|FG001|Overall Study|Non-Compliance with Study Drug|0|||
25050088|NCT02605954|50153410|FG000|Overall Study|Withdrew Consent|2|||
25050089|NCT02605954|50153411|FG001|Overall Study|Withdrew Consent|2|||
25050090|NCT02605954|50153410|FG000|Overall Study|Lost to Follow-up|3|||
25050091|NCT02605954|50153411|FG001|Overall Study|Lost to Follow-up|0|||
25050092|NCT02605954|50153410|FG000|Overall Study|Randomized but not treated|0|||
25050093|NCT02605954|50153411|FG001|Overall Study|Randomized but not treated|1|||
25050094|NCT00724698|50153420|FG000|Overall Study|Adverse Event|9|||
25050095|NCT00724698|50153420|FG000|Overall Study|Failure of Therapy|4|||
25050096|NCT00724698|50153420|FG000|Overall Study|Poor Compliance|16|||
25050097|NCT00724698|50153420|FG000|Overall Study|Lost to Follow-up|36|||
25050098|NCT00724698|50153420|FG000|Overall Study|No Info|25|||
25050099|NCT00829998|50153425|FG000|Washout|Adverse Event|0|||
25050100|NCT00829998|50153426|FG001|Washout|Adverse Event|1|||
25050101|NCT00829764|50153437|FG000|First Intervention|Adverse Event|1|||
25050102|NCT00829764|50153438|FG001|First Intervention|Adverse Event|0|||
25050103|NCT00829764|50153437|FG000|First Intervention|Withdrawal by Subject|1|||
25050104|NCT00829764|50153438|FG001|First Intervention|Withdrawal by Subject|1|||
25050105|NCT00829530|50153460|FG000|First Intervention|Adverse Event|0|||
25050106|NCT00829530|50153461|FG001|First Intervention|Adverse Event|1|||
25050107|NCT00829530|50153460|FG000|First Intervention|Intolerance to Venopuncture|0|||
25050108|NCT00829530|50153461|FG001|First Intervention|Intolerance to Venopuncture|1|||
25050109|NCT00829530|50153460|FG000|Second Intervention|Intolerance to Venopuncture|1|||
25050110|NCT00829530|50153461|FG001|Second Intervention|Intolerance to Venopuncture|0|||
25050111|NCT01377194|50153468|FG000|Overall Study|Adverse Event|3|||
25050112|NCT01377194|50153469|FG001|Overall Study|Adverse Event|12|||
25050113|NCT01377194|50153470|FG002|Overall Study|Adverse Event|19|||
25050114|NCT01377194|50153468|FG000|Overall Study|Lack of Efficacy|3|||
25050115|NCT01377194|50153469|FG001|Overall Study|Lack of Efficacy|3|||
25050116|NCT01377194|50153470|FG002|Overall Study|Lack of Efficacy|3|||
25050117|NCT01377194|50153468|FG000|Overall Study|Protocol Violation|4|||
25050118|NCT01377194|50153469|FG001|Overall Study|Protocol Violation|10|||
25050119|NCT01377194|50153470|FG002|Overall Study|Protocol Violation|6|||
25050120|NCT01377194|50153468|FG000|Overall Study|Withdrawal by Subject|8|||
25050121|NCT01377194|50153469|FG001|Overall Study|Withdrawal by Subject|10|||
25050122|NCT01377194|50153470|FG002|Overall Study|Withdrawal by Subject|7|||
25050123|NCT01377194|50153468|FG000|Overall Study|Lost to Follow-up|14|||
25050124|NCT01377194|50153469|FG001|Overall Study|Lost to Follow-up|8|||
25050125|NCT01377194|50153470|FG002|Overall Study|Lost to Follow-up|11|||
25050126|NCT00829452|50153483|FG000|First Intervention|Withdrawal by Subject|0|||
25050127|NCT00829452|50153484|FG001|First Intervention|Withdrawal by Subject|1|||
25050128|NCT00829452|50153483|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
25050129|NCT00829452|50153484|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
25050130|NCT00829452|50153483|FG000|Second Intervention|Physician Decision|0|||
25050131|NCT00829452|50153484|FG001|Second Intervention|Physician Decision|1|||
25050132|NCT04600076|50153488|FG000|Overall Study|Lost to Follow-up|3|||
24960482|NCT00291330|50051067|FG001|Overall Study|Other|1|||
24960483|NCT00267150|50051073|FG000|Overall Study|Adverse Event|1|||
24960484|NCT00278148|50051077|FG000|Phase II - Expansion Phase|Disease progression|0|||
24960485|NCT00278148|50051078|FG001|Phase II - Expansion Phase|Disease progression|0|||
24960486|NCT00278148|50051079|FG002|Phase II - Expansion Phase|Disease progression|4|||
24960487|NCT00278148|50051077|FG000|Phase II - Expansion Phase|Adverse Event|0|||
24960488|NCT00278148|50051078|FG001|Phase II - Expansion Phase|Adverse Event|0|||
24960489|NCT00278148|50051079|FG002|Phase II - Expansion Phase|Adverse Event|2|||
24960490|NCT00299546|50051089|FG000|Overall Study|Death|3|||
24960491|NCT00299546|50051090|FG001|Overall Study|Death|2|||
24960492|NCT00299546|50051091|FG002|Overall Study|Death|0|||
24960493|NCT00299546|50051089|FG000|Overall Study|Lost to Follow-up|2|||
24960494|NCT00299546|50051090|FG001|Overall Study|Lost to Follow-up|2|||
24960495|NCT00299546|50051091|FG002|Overall Study|Lost to Follow-up|5|||
24960496|NCT00299546|50051089|FG000|Overall Study|Adverse Event|37|||
24960497|NCT00299546|50051090|FG001|Overall Study|Adverse Event|22|||
24960498|NCT00299546|50051091|FG002|Overall Study|Adverse Event|27|||
24960499|NCT00299546|50051089|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
24960500|NCT00299546|50051090|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
24960501|NCT00299546|50051091|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
24960502|NCT00299546|50051089|FG000|Overall Study|Other|24|||
24960503|NCT00299546|50051090|FG001|Overall Study|Other|26|||
25050133|NCT02064387|50153504|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
25050134|NCT02064387|50153505|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
25050135|NCT02064387|50153506|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
25050136|NCT02064387|50153507|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
25050137|NCT02064387|50153508|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
25050138|NCT02064387|50153509|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
25050139|NCT02064387|50153510|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
25050140|NCT02064387|50153511|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
24960504|NCT00299546|50051091|FG002|Overall Study|Other|19|||
24960505|NCT00299546|50051089|FG000|Overall Study|Not treated|0|||
24960506|NCT00299546|50051090|FG001|Overall Study|Not treated|1|||
24960507|NCT00299546|50051091|FG002|Overall Study|Not treated|1|||
24960508|NCT00299156|50051103|FG000|Period 2 (Randomized)|Screen Failure|0|||
25050141|NCT02064387|50153512|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
25050142|NCT02064387|50153513|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
25050143|NCT02064387|50153514|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
25050144|NCT02064387|50153515|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
25050145|NCT02064387|50153504|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
25050146|NCT02064387|50153505|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
25050147|NCT02064387|50153506|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
25050148|NCT02064387|50153507|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
25050149|NCT02064387|50153508|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
25050150|NCT02064387|50153509|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
25050151|NCT02064387|50153510|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
25050152|NCT02064387|50153511|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
25050153|NCT02064387|50153512|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
25050154|NCT02064387|50153513|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
25050155|NCT02064387|50153514|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
25050156|NCT02064387|50153515|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
25050157|NCT02064387|50153504|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
25050158|NCT02064387|50153505|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
25050159|NCT02064387|50153506|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
25050160|NCT02064387|50153507|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
25050161|NCT02064387|50153508|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
25050162|NCT02064387|50153509|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
25050163|NCT02064387|50153510|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
25050164|NCT02064387|50153511|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
25050165|NCT02064387|50153512|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
25050166|NCT02064387|50153513|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
25050167|NCT02064387|50153514|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
25050168|NCT02064387|50153515|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
25050169|NCT02064387|50153504|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
25050170|NCT02064387|50153505|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
25050171|NCT02064387|50153506|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
25050172|NCT02064387|50153507|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
25050173|NCT02064387|50153508|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
24960509|NCT00299156|50051104|FG001|Period 2 (Randomized)|Screen Failure|1|||
24960510|NCT00299156|50051105|FG002|Period 2 (Randomized)|Screen Failure|0|||
24960511|NCT00277212|50051113|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
24960512|NCT00277212|50051114|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
25050174|NCT02064387|50153509|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
25050175|NCT02064387|50153510|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
25050176|NCT02064387|50153511|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
25050177|NCT02064387|50153512|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
25050178|NCT02064387|50153513|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
25050179|NCT02064387|50153514|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
25050180|NCT02064387|50153515|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
25050181|NCT02064387|50153504|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
25050182|NCT02064387|50153505|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
25050183|NCT02064387|50153506|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
25050184|NCT02064387|50153507|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
25050185|NCT02064387|50153508|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
25050186|NCT02064387|50153509|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
25050187|NCT02064387|50153510|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
25050188|NCT02064387|50153511|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
25050189|NCT02064387|50153512|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
25050190|NCT02064387|50153513|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
25050191|NCT02064387|50153514|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
25050192|NCT02064387|50153515|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
25050193|NCT01328366|50153554|FG000|Overall Study|Death|1|||
25050194|NCT01328366|50153554|FG000|Overall Study|Withdrawal by Subject|2|||
25050195|NCT01328366|50153554|FG000|Overall Study|Lost to Follow-up|7|||
25050196|NCT03256344|50153560|FG000|Overall Study|Death|6|||
25050197|NCT03256344|50153561|FG001|Overall Study|Death|22|||
25050198|NCT03256344|50153560|FG000|Overall Study|Withdrawal by Subject|3|||
25050199|NCT03256344|50153561|FG001|Overall Study|Withdrawal by Subject|3|||
25050200|NCT03256344|50153560|FG000|Overall Study|Sponsor Decision|1|||
25050201|NCT03256344|50153561|FG001|Overall Study|Sponsor Decision|0|||
25162566|NCT01791517|50284755|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
25162567|NCT01791517|50284756|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
25186566|NCT01395017|50337140|FG000|Overall Study|Physician Decision|11|||
24960513|NCT00277212|50051115|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
25050202|NCT01370499|50153569|FG000|Overall Study|Adverse Event|38|||
25050203|NCT01370499|50153570|FG001|Overall Study|Adverse Event|12|||
25050204|NCT01370499|50153569|FG000|Overall Study|Lack of Efficacy|4|||
25050205|NCT01370499|50153570|FG001|Overall Study|Lack of Efficacy|2|||
25050206|NCT01370499|50153569|FG000|Overall Study|Lost to Follow-up|2|||
25050207|NCT01370499|50153570|FG001|Overall Study|Lost to Follow-up|1|||
25050208|NCT01370499|50153569|FG000|Overall Study|Physician Decision|3|||
25050209|NCT01370499|50153570|FG001|Overall Study|Physician Decision|3|||
25050210|NCT01370499|50153569|FG000|Overall Study|Protocol Violation|5|||
25050211|NCT01370499|50153570|FG001|Overall Study|Protocol Violation|4|||
25050212|NCT01370499|50153569|FG000|Overall Study|Withdrawal by Subject|18|||
25050213|NCT01370499|50153570|FG001|Overall Study|Withdrawal by Subject|7|||
25050214|NCT01370499|50153569|FG000|Overall Study|Sponsor Decision|41|||
25050215|NCT01370499|50153570|FG001|Overall Study|Sponsor Decision|15|||
25050216|NCT01370265|50153578|FG000|First Intervention|Adverse Event|1|||
25050217|NCT01370265|50153579|FG001|First Intervention|Adverse Event|1|||
25050218|NCT01359592|50153592|FG000|Initial Registration|Adverse Event|1|||
25050219|NCT01359592|50153593|FG001|Initial Registration|Adverse Event|0|||
25050220|NCT01359592|50153594|FG002|Initial Registration|Adverse Event|0|||
25050221|NCT01359592|50153595|FG003|Initial Registration|Adverse Event|0|||
25050222|NCT01359592|50153592|FG000|Initial Registration|Death|1|||
25050223|NCT01359592|50153593|FG001|Initial Registration|Death|0|||
25050224|NCT01359592|50153594|FG002|Initial Registration|Death|0|||
25050225|NCT01359592|50153595|FG003|Initial Registration|Death|0|||
25050226|NCT01359592|50153592|FG000|Initial Registration|Other reason not protocol specified|1|||
25050227|NCT01359592|50153593|FG001|Initial Registration|Other reason not protocol specified|0|||
25050228|NCT01359592|50153594|FG002|Initial Registration|Other reason not protocol specified|0|||
25050229|NCT01359592|50153595|FG003|Initial Registration|Other reason not protocol specified|0|||
25050230|NCT01359592|50153592|FG000|Initial Registration|Ineligible|26|||
25050231|NCT01359592|50153593|FG001|Initial Registration|Ineligible|0|||
25050232|NCT01359592|50153594|FG002|Initial Registration|Ineligible|0|||
25050233|NCT01359592|50153595|FG003|Initial Registration|Ineligible|0|||
25050234|NCT01359592|50153592|FG000|PET-Directed Therapy|Adverse Event|0|||
25050235|NCT01359592|50153593|FG001|PET-Directed Therapy|Adverse Event|0|||
25050236|NCT01359592|50153594|FG002|PET-Directed Therapy|Adverse Event|1|||
25050237|NCT01359592|50153595|FG003|PET-Directed Therapy|Adverse Event|0|||
25050238|NCT01359592|50153592|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
25050239|NCT01359592|50153593|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
25050240|NCT01359592|50153594|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
25050241|NCT01359592|50153595|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
25050242|NCT01359592|50153592|FG000|PET-Directed Therapy|Ineligible|0|||
25050243|NCT01359592|50153593|FG001|PET-Directed Therapy|Ineligible|0|||
25050244|NCT01359592|50153594|FG002|PET-Directed Therapy|Ineligible|24|||
25050245|NCT01359592|50153595|FG003|PET-Directed Therapy|Ineligible|0|||
25050246|NCT02792829|50153618|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
25050247|NCT02792829|50153619|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
24960514|NCT00277212|50051113|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
24960515|NCT00277212|50051114|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
25050248|NCT02792829|50153620|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
25050249|NCT02792829|50153621|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
25050250|NCT02792829|50153622|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
24960516|NCT00277212|50051115|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
24960517|NCT00277212|50051113|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
24960518|NCT00277212|50051114|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
24960519|NCT00277212|50051115|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
24960520|NCT00277212|50051113|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
24960521|NCT00277212|50051114|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
24960522|NCT00277212|50051115|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
24960523|NCT00277212|50051113|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
24960524|NCT00277212|50051114|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
24960525|NCT00277212|50051115|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
24960526|NCT00277212|50051113|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
24960527|NCT00277212|50051114|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
24960528|NCT00277212|50051115|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
24960529|NCT00277212|50051113|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
24960530|NCT00277212|50051114|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
25050251|NCT02792829|50153623|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
25050252|NCT02792829|50153624|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
24960531|NCT00277212|50051115|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
24960532|NCT00277212|50051113|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
25050253|NCT02792829|50153625|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
25050254|NCT02792829|50153618|FG000|Treatment Period 2|Adverse Event|0|||
25050255|NCT02792829|50153619|FG001|Treatment Period 2|Adverse Event|0|||
25050256|NCT02792829|50153620|FG002|Treatment Period 2|Adverse Event|0|||
25050257|NCT02792829|50153621|FG003|Treatment Period 2|Adverse Event|0|||
25050258|NCT02792829|50153622|FG004|Treatment Period 2|Adverse Event|1|||
25050259|NCT02792829|50153623|FG005|Treatment Period 2|Adverse Event|0|||
25050260|NCT02792829|50153624|FG006|Treatment Period 2|Adverse Event|1|||
25050261|NCT02792829|50153625|FG007|Treatment Period 2|Adverse Event|1|||
25050262|NCT02792829|50153618|FG000|Treatment Period 2|Use of proscribed medications|0|||
25050263|NCT02792829|50153619|FG001|Treatment Period 2|Use of proscribed medications|0|||
25050264|NCT02792829|50153620|FG002|Treatment Period 2|Use of proscribed medications|0|||
25050265|NCT02792829|50153621|FG003|Treatment Period 2|Use of proscribed medications|0|||
25050266|NCT02792829|50153622|FG004|Treatment Period 2|Use of proscribed medications|0|||
25050267|NCT02792829|50153623|FG005|Treatment Period 2|Use of proscribed medications|0|||
25050268|NCT02792829|50153624|FG006|Treatment Period 2|Use of proscribed medications|0|||
25050269|NCT02792829|50153625|FG007|Treatment Period 2|Use of proscribed medications|1|||
25050270|NCT02867592|50153657|FG000|Overall Study|Adverse Event|3|||
25050271|NCT02867592|50153658|FG001|Overall Study|Adverse Event|0|||
25050272|NCT02867592|50153659|FG002|Overall Study|Adverse Event|2|||
25050273|NCT02867592|50153660|FG003|Overall Study|Adverse Event|1|||
25050274|NCT02867592|50153661|FG004|Overall Study|Adverse Event|1|||
25050275|NCT02867592|50153662|FG005|Overall Study|Adverse Event|5|||
25050276|NCT02867592|50153657|FG000|Overall Study|Death|0|||
25050277|NCT02867592|50153658|FG001|Overall Study|Death|0|||
25050278|NCT02867592|50153659|FG002|Overall Study|Death|0|||
25050279|NCT02867592|50153660|FG003|Overall Study|Death|1|||
25050280|NCT02867592|50153661|FG004|Overall Study|Death|0|||
25050281|NCT02867592|50153662|FG005|Overall Study|Death|1|||
25050282|NCT02867592|50153657|FG000|Overall Study|Lack of Efficacy|8|||
25050283|NCT02867592|50153658|FG001|Overall Study|Lack of Efficacy|10|||
25050284|NCT02867592|50153659|FG002|Overall Study|Lack of Efficacy|8|||
25050285|NCT02867592|50153660|FG003|Overall Study|Lack of Efficacy|8|||
25050286|NCT02867592|50153661|FG004|Overall Study|Lack of Efficacy|12|||
25050287|NCT02867592|50153662|FG005|Overall Study|Lack of Efficacy|17|||
25050288|NCT02867592|50153657|FG000|Overall Study|Physician Decision|1|||
25050289|NCT02867592|50153658|FG001|Overall Study|Physician Decision|2|||
25050290|NCT02867592|50153659|FG002|Overall Study|Physician Decision|2|||
25050291|NCT02867592|50153660|FG003|Overall Study|Physician Decision|0|||
25050292|NCT02867592|50153661|FG004|Overall Study|Physician Decision|5|||
25050293|NCT02867592|50153662|FG005|Overall Study|Physician Decision|1|||
25050294|NCT02867592|50153657|FG000|Overall Study|Protocol Violation|0|||
25050295|NCT02867592|50153658|FG001|Overall Study|Protocol Violation|0|||
25050296|NCT02867592|50153659|FG002|Overall Study|Protocol Violation|0|||
25050297|NCT02867592|50153660|FG003|Overall Study|Protocol Violation|0|||
25050298|NCT02867592|50153661|FG004|Overall Study|Protocol Violation|1|||
25050299|NCT02867592|50153662|FG005|Overall Study|Protocol Violation|1|||
25050300|NCT02867592|50153657|FG000|Overall Study|Withdrawal by Subject|0|||
25050301|NCT02867592|50153658|FG001|Overall Study|Withdrawal by Subject|1|||
25050302|NCT02867592|50153659|FG002|Overall Study|Withdrawal by Subject|0|||
25050303|NCT02867592|50153660|FG003|Overall Study|Withdrawal by Subject|1|||
25050304|NCT02867592|50153661|FG004|Overall Study|Withdrawal by Subject|3|||
25050305|NCT02867592|50153662|FG005|Overall Study|Withdrawal by Subject|3|||
25050306|NCT02867592|50153657|FG000|Overall Study|Ineligible|1|||
25050307|NCT02867592|50153658|FG001|Overall Study|Ineligible|1|||
25050308|NCT02867592|50153659|FG002|Overall Study|Ineligible|0|||
25050309|NCT02867592|50153660|FG003|Overall Study|Ineligible|0|||
25050310|NCT02867592|50153661|FG004|Overall Study|Ineligible|2|||
25050311|NCT02867592|50153662|FG005|Overall Study|Ineligible|0|||
25050312|NCT02867592|50153657|FG000|Overall Study|No Treatment|1|||
25050313|NCT02867592|50153658|FG001|Overall Study|No Treatment|0|||
25050314|NCT02867592|50153659|FG002|Overall Study|No Treatment|0|||
25050315|NCT02867592|50153660|FG003|Overall Study|No Treatment|0|||
25050316|NCT02867592|50153661|FG004|Overall Study|No Treatment|0|||
25050317|NCT02867592|50153662|FG005|Overall Study|No Treatment|0|||
25050318|NCT02867592|50153657|FG000|Overall Study|Still on Therapy|0|||
25050319|NCT02867592|50153658|FG001|Overall Study|Still on Therapy|0|||
25050320|NCT02867592|50153659|FG002|Overall Study|Still on Therapy|0|||
25186567|NCT01395017|50337141|FG001|Overall Study|Physician Decision|15|||
25050321|NCT02867592|50153660|FG003|Overall Study|Still on Therapy|0|||
25050322|NCT02867592|50153661|FG004|Overall Study|Still on Therapy|1|||
25050323|NCT02867592|50153662|FG005|Overall Study|Still on Therapy|0|||
25050324|NCT02867592|50153657|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
25050325|NCT02867592|50153658|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
25050326|NCT02867592|50153659|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
25050327|NCT02867592|50153660|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
25050328|NCT02867592|50153661|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
25050329|NCT02867592|50153662|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
25050330|NCT02867592|50153657|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
25050331|NCT02867592|50153658|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
25050332|NCT02867592|50153659|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
25050333|NCT02867592|50153660|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
25050334|NCT02867592|50153661|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
25050335|NCT02867592|50153662|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
25050336|NCT00676494|50153678|FG000|Overall Study|Missed Visit|8|||
25050337|NCT00676494|50153678|FG000|Overall Study|Withdrawal by Subject|6|||
25050338|NCT02605642|50153683|FG000|Overall Study|Other|11|||
25050339|NCT02605642|50153684|FG001|Overall Study|Other|1|||
25050340|NCT02605642|50153683|FG000|Overall Study|Participant non-compliance|2|||
25050341|NCT02605642|50153684|FG001|Overall Study|Participant non-compliance|4|||
25050342|NCT02605642|50153683|FG000|Overall Study|Physician Decision|10|||
25050343|NCT02605642|50153684|FG001|Overall Study|Physician Decision|0|||
25050344|NCT02605642|50153683|FG000|Overall Study|Lost to Follow-up|12|||
25050345|NCT02605642|50153684|FG001|Overall Study|Lost to Follow-up|1|||
25050346|NCT02605642|50153683|FG000|Overall Study|Adverse Event|14|||
25050347|NCT02605642|50153684|FG001|Overall Study|Adverse Event|2|||
25050348|NCT02605642|50153683|FG000|Overall Study|Withdrawal by Subject|23|||
25050349|NCT02605642|50153684|FG001|Overall Study|Withdrawal by Subject|2|||
25050350|NCT02605642|50153683|FG000|Overall Study|Lack of response|24|||
25050351|NCT02605642|50153684|FG001|Overall Study|Lack of response|11|||
25050352|NCT02253810|50153692|FG000|Overall Study|Withdrawal by Subject|2|||
25050353|NCT02253810|50153693|FG001|Overall Study|Withdrawal by Subject|1|||
25050354|NCT02253810|50153692|FG000|Overall Study|Unknown concomitant procedure|3|||
25050355|NCT02253810|50153693|FG001|Overall Study|Unknown concomitant procedure|2|||
25050356|NCT03915470|50153714|FG000|Overall Study|Death|3|||
25050357|NCT03915470|50153715|FG001|Overall Study|Death|1|||
25050358|NCT03915470|50153714|FG000|Overall Study|Adverse Event|1|||
25050359|NCT03915470|50153715|FG001|Overall Study|Adverse Event|0|||
25050360|NCT03915470|50153714|FG000|Overall Study|Physician Decision|1|||
25050361|NCT03915470|50153715|FG001|Overall Study|Physician Decision|0|||
25050362|NCT03915470|50153714|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
25050363|NCT03915470|50153715|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
25050364|NCT02732912|50153726|FG000|Overall Study|Discharged before night|2|||
25050365|NCT02732912|50153727|FG001|Overall Study|Discharged before night|6|||
25050366|NCT02732912|50153726|FG000|Overall Study|Incomplete completion of questionnaire|2|||
25050367|NCT02732912|50153727|FG001|Overall Study|Incomplete completion of questionnaire|3|||
25050368|NCT02732912|50153726|FG000|Overall Study|No outcome; discharged or refused|6|||
25050369|NCT02732912|50153727|FG001|Overall Study|No outcome; discharged or refused|9|||
25050370|NCT02792517|50153733|FG000|Overall Study|Withdrawal by Subject|10|||
25050371|NCT02792517|50153733|FG000|Overall Study|Decision by Sponsor|7|||
25050372|NCT02792517|50153733|FG000|Overall Study|Lost to Follow-up|3|||
25050373|NCT01369485|50153768|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
25050374|NCT01369485|50153769|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
25050375|NCT01369485|50153768|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
25050376|NCT01369485|50153769|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
25050377|NCT01369485|50153768|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
25050378|NCT01369485|50153769|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
25050379|NCT01369485|50153768|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
25050380|NCT01369485|50153769|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
24960533|NCT00277212|50051114|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
24960534|NCT00277212|50051115|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
24960535|NCT00277212|50051113|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
24960536|NCT00277212|50051114|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
24960537|NCT00277212|50051115|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
24960538|NCT00277212|50051113|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
24960539|NCT00277212|50051114|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
24960540|NCT00277212|50051115|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
24960541|NCT00277212|50051113|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
25050381|NCT01369485|50153768|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
24960542|NCT00277212|50051114|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
24960543|NCT00277212|50051115|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
24960544|NCT00277212|50051113|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
25050382|NCT01369485|50153769|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
25050383|NCT01369485|50153768|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
25050384|NCT01369485|50153769|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
25050385|NCT01369485|50153768|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
25050386|NCT01369485|50153769|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
25050387|NCT01369485|50153768|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
25050388|NCT01369485|50153769|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
25050389|NCT01369485|50153768|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
25050390|NCT01369485|50153769|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
25050391|NCT01369485|50153768|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
25050392|NCT01369485|50153769|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
25050393|NCT02886572|50153796|FG000|Overall Study|Death|8|||
25050394|NCT02741700|50153809|FG000|Overall Study|Lost to Follow-up|17|||
25050395|NCT02741700|50153810|FG001|Overall Study|Lost to Follow-up|8|||
25050396|NCT02741700|50153809|FG000|Overall Study|Withdrawal by Subject|2|||
25050397|NCT02741700|50153810|FG001|Overall Study|Withdrawal by Subject|5|||
25050398|NCT02741700|50153809|FG000|Overall Study|Physician Decision|3|||
25050399|NCT02741700|50153810|FG001|Overall Study|Physician Decision|0|||
25050400|NCT02741700|50153809|FG000|Overall Study|Moved out of State|0|||
25050401|NCT02741700|50153810|FG001|Overall Study|Moved out of State|1|||
25050402|NCT02741700|50153809|FG000|Overall Study|Death|4|||
25050403|NCT02741700|50153810|FG001|Overall Study|Death|5|||
25050404|NCT00430950|50153818|FG000|Overall Study|Adverse Event|7|||
25050405|NCT00430950|50153819|FG001|Overall Study|Adverse Event|6|||
25050406|NCT00430950|50153818|FG000|Overall Study|Withdrawal by Subject|1|||
25050407|NCT00430950|50153819|FG001|Overall Study|Withdrawal by Subject|0|||
25050408|NCT00430950|50153818|FG000|Overall Study|concomitant medication,etc.|5|||
25050409|NCT00430950|50153819|FG001|Overall Study|concomitant medication,etc.|7|||
25050410|NCT02081391|50153827|FG000|12-hour Treatment|Withdrawal by Subject|3|||
24960545|NCT00277212|50051114|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
24960546|NCT00277212|50051115|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
25050411|NCT02081391|50153828|FG001|12-hour Treatment|Withdrawal by Subject|2|||
25050412|NCT02081391|50153829|FG002|12-hour Treatment|Withdrawal by Subject|0|||
25050413|NCT02081391|50153830|FG003|12-hour Treatment|Withdrawal by Subject|0|||
25050414|NCT02081391|50153827|FG000|12-hour Treatment|Physician Decision|4|||
25050415|NCT02081391|50153828|FG001|12-hour Treatment|Physician Decision|1|||
25050416|NCT02081391|50153829|FG002|12-hour Treatment|Physician Decision|0|||
25050417|NCT02081391|50153830|FG003|12-hour Treatment|Physician Decision|0|||
25050418|NCT02081391|50153827|FG000|12-hour Treatment|Lack of Efficacy|3|||
25050419|NCT02081391|50153828|FG001|12-hour Treatment|Lack of Efficacy|0|||
25050420|NCT02081391|50153829|FG002|12-hour Treatment|Lack of Efficacy|0|||
25050421|NCT02081391|50153830|FG003|12-hour Treatment|Lack of Efficacy|0|||
25050422|NCT02081391|50153827|FG000|12-hour Treatment|Adverse Event|4|||
25050423|NCT02081391|50153828|FG001|12-hour Treatment|Adverse Event|2|||
25050424|NCT02081391|50153829|FG002|12-hour Treatment|Adverse Event|0|||
25050425|NCT02081391|50153830|FG003|12-hour Treatment|Adverse Event|0|||
25050426|NCT02081391|50153827|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
25050427|NCT02081391|50153828|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
25050428|NCT02081391|50153829|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
25050429|NCT02081391|50153830|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
25050430|NCT02081391|50153827|FG000|12-hour Treatment|Further reasons|2|||
25050431|NCT02081391|50153828|FG001|12-hour Treatment|Further reasons|1|||
25050432|NCT02081391|50153829|FG002|12-hour Treatment|Further reasons|0|||
25050433|NCT02081391|50153830|FG003|12-hour Treatment|Further reasons|0|||
25050434|NCT02081391|50153827|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
25050435|NCT02081391|50153828|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
25050436|NCT02081391|50153829|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
25050437|NCT02081391|50153830|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
25050438|NCT02081391|50153827|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
25050439|NCT02081391|50153828|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
25162568|NCT01791517|50284757|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
24960547|NCT00277212|50051113|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
24960548|NCT00277212|50051114|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
24960549|NCT00277212|50051115|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
25050440|NCT02081391|50153829|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
25050441|NCT02081391|50153830|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
25050442|NCT02081391|50153827|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
25162569|NCT01791517|50284758|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
25162570|NCT01791517|50284759|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
25050443|NCT02081391|50153828|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
25050444|NCT02081391|50153829|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
25050445|NCT02081391|50153830|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
25050446|NCT02081391|50153827|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
25050447|NCT02081391|50153828|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
25050448|NCT02081391|50153829|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
25050449|NCT02081391|50153830|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
25050450|NCT02081391|50153827|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
25050451|NCT02081391|50153828|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
25050452|NCT02081391|50153829|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
25050453|NCT02081391|50153830|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
25050454|NCT02081391|50153827|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
25050455|NCT02081391|50153828|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
25050456|NCT02081391|50153829|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
25050457|NCT02081391|50153830|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
25050458|NCT00430092|50153853|FG000|Overall Study|Adverse Event|0|||
25050459|NCT00430092|50153854|FG001|Overall Study|Adverse Event|0|||
25050460|NCT00430092|50153855|FG002|Overall Study|Adverse Event|1|||
25050461|NCT00430092|50153853|FG000|Overall Study|Lack of Efficacy|5|||
25050462|NCT00430092|50153854|FG001|Overall Study|Lack of Efficacy|2|||
25050463|NCT00430092|50153855|FG002|Overall Study|Lack of Efficacy|54|||
25050464|NCT00430092|50153853|FG000|Overall Study|Lost to Follow-up|1|||
25050465|NCT00430092|50153854|FG001|Overall Study|Lost to Follow-up|0|||
25050466|NCT00430092|50153855|FG002|Overall Study|Lost to Follow-up|0|||
25050467|NCT00430092|50153853|FG000|Overall Study|Protocol Violation|0|||
25050468|NCT00430092|50153854|FG001|Overall Study|Protocol Violation|1|||
25050469|NCT00430092|50153855|FG002|Overall Study|Protocol Violation|1|||
25050470|NCT00430092|50153853|FG000|Overall Study|Withdrawal by Subject|0|||
25050471|NCT00430092|50153854|FG001|Overall Study|Withdrawal by Subject|1|||
25050472|NCT00430092|50153855|FG002|Overall Study|Withdrawal by Subject|1|||
25050473|NCT00425100|50153860|FG000|Overall Study|Adverse Event|36|||
25050474|NCT00425100|50153860|FG000|Overall Study|Lack of Efficacy|4|||
25050475|NCT00425100|50153860|FG000|Overall Study|Lost to Follow-up|2|||
25050476|NCT00425100|50153860|FG000|Overall Study|Protocol Violation|4|||
25050477|NCT00425100|50153860|FG000|Overall Study|Withdrawal by Subject|7|||
25050478|NCT00412932|50153865|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
25050479|NCT00412932|50153865|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
25050480|NCT00412932|50153865|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
25050481|NCT00412932|50153865|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
25050482|NCT00412932|50153865|FG000|Olmesartan (Olm) 20 mg|Other|1|||
25050483|NCT00412932|50153865|FG000|Olmesartan 40 mg|Adverse Event|4|||
25050484|NCT00412932|50153865|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
25050485|NCT00412932|50153865|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
25050486|NCT00412932|50153865|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
25050487|NCT00412932|50153865|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
25050488|NCT00412932|50153865|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
25050489|NCT00412932|50153865|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
24960550|NCT00277212|50051113|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
24960551|NCT00277212|50051114|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
24960552|NCT00277212|50051115|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
24960553|NCT00277212|50051113|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
24960554|NCT00277212|50051114|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
24960555|NCT00277212|50051115|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
24960556|NCT00277212|50051113|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
24960557|NCT00277212|50051114|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
24960558|NCT00277212|50051115|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
24960559|NCT00277212|50051113|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
24960560|NCT00277212|50051114|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
24960561|NCT00277212|50051115|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
24960562|NCT00277212|50051113|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
25050490|NCT02696031|50153871|FG000|Up to Week 24|Adverse Event|2|||
25050491|NCT02696031|50153872|FG001|Up to Week 24|Adverse Event|4|||
25050492|NCT02696031|50153873|FG002|Up to Week 24|Adverse Event|2|||
25050493|NCT02696031|50153874|FG003|Up to Week 24|Adverse Event|0|||
25050494|NCT02696031|50153875|FG004|Up to Week 24|Adverse Event|0|||
25050495|NCT02696031|50153876|FG005|Up to Week 24|Adverse Event|0|||
24960563|NCT00277212|50051114|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
25050496|NCT02696031|50153871|FG000|Up to Week 24|Lack of Efficacy|2|||
25050497|NCT02696031|50153872|FG001|Up to Week 24|Lack of Efficacy|1|||
25050498|NCT02696031|50153873|FG002|Up to Week 24|Lack of Efficacy|2|||
25050499|NCT02696031|50153874|FG003|Up to Week 24|Lack of Efficacy|0|||
25050500|NCT02696031|50153875|FG004|Up to Week 24|Lack of Efficacy|0|||
25050501|NCT02696031|50153876|FG005|Up to Week 24|Lack of Efficacy|0|||
25050502|NCT02696031|50153871|FG000|Up to Week 24|Lost to Follow-up|0|||
25050503|NCT02696031|50153872|FG001|Up to Week 24|Lost to Follow-up|1|||
25050504|NCT02696031|50153873|FG002|Up to Week 24|Lost to Follow-up|1|||
24960564|NCT00277212|50051115|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
24960565|NCT00276744|50051123|FG000|PART A|Reason unknown|98|||
24960566|NCT00251316|50051129|FG000|Overall Study|Physician Decision|2|||
24960567|NCT00251316|50051130|FG001|Overall Study|Physician Decision|3|||
24960568|NCT00293462|50051139|FG000|Overall Study|Withdrawal by Subject|4|||
24960569|NCT00293462|50051140|FG001|Overall Study|Withdrawal by Subject|3|||
24960570|NCT00293462|50051141|FG002|Overall Study|Withdrawal by Subject|8|||
24960571|NCT00293462|50051139|FG000|Overall Study|Death|1|||
24960572|NCT00293462|50051140|FG001|Overall Study|Death|0|||
24960573|NCT00293462|50051141|FG002|Overall Study|Death|0|||
25050505|NCT02696031|50153874|FG003|Up to Week 24|Lost to Follow-up|0|||
25050506|NCT02696031|50153875|FG004|Up to Week 24|Lost to Follow-up|0|||
25050507|NCT02696031|50153876|FG005|Up to Week 24|Lost to Follow-up|0|||
25050508|NCT02696031|50153871|FG000|Up to Week 24|Physician Decision|1|||
25050509|NCT02696031|50153872|FG001|Up to Week 24|Physician Decision|0|||
25050510|NCT02696031|50153873|FG002|Up to Week 24|Physician Decision|1|||
25050511|NCT02696031|50153874|FG003|Up to Week 24|Physician Decision|0|||
25050512|NCT02696031|50153875|FG004|Up to Week 24|Physician Decision|0|||
25050513|NCT02696031|50153876|FG005|Up to Week 24|Physician Decision|0|||
25050514|NCT02696031|50153871|FG000|Up to Week 24|Protocol Violation|1|||
25050515|NCT02696031|50153872|FG001|Up to Week 24|Protocol Violation|0|||
25050516|NCT02696031|50153873|FG002|Up to Week 24|Protocol Violation|0|||
25050517|NCT02696031|50153874|FG003|Up to Week 24|Protocol Violation|0|||
25050518|NCT02696031|50153875|FG004|Up to Week 24|Protocol Violation|0|||
25050519|NCT02696031|50153876|FG005|Up to Week 24|Protocol Violation|0|||
25050520|NCT02696031|50153871|FG000|Up to Week 24|Withdrawal by Subject|4|||
25050521|NCT02696031|50153872|FG001|Up to Week 24|Withdrawal by Subject|1|||
25050522|NCT02696031|50153873|FG002|Up to Week 24|Withdrawal by Subject|5|||
25050523|NCT02696031|50153874|FG003|Up to Week 24|Withdrawal by Subject|0|||
25050524|NCT02696031|50153875|FG004|Up to Week 24|Withdrawal by Subject|0|||
25050525|NCT02696031|50153876|FG005|Up to Week 24|Withdrawal by Subject|0|||
25050526|NCT02696031|50153871|FG000|Up to Week 52|Adverse Event|4|||
25050527|NCT02696031|50153872|FG001|Up to Week 52|Adverse Event|5|||
24960574|NCT00293462|50051139|FG000|Overall Study|Lost to Follow-up|0|||
24960575|NCT00293462|50051140|FG001|Overall Study|Lost to Follow-up|1|||
24960576|NCT00293462|50051141|FG002|Overall Study|Lost to Follow-up|0|||
24960577|NCT00293462|50051139|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
24960578|NCT00293462|50051140|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
24960579|NCT00293462|50051141|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
24960580|NCT00293462|50051139|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
25050528|NCT02696031|50153873|FG002|Up to Week 52|Adverse Event|3|||
25050529|NCT02696031|50153874|FG003|Up to Week 52|Adverse Event|0|||
25050530|NCT02696031|50153875|FG004|Up to Week 52|Adverse Event|0|||
25050531|NCT02696031|50153876|FG005|Up to Week 52|Adverse Event|0|||
25050532|NCT02696031|50153871|FG000|Up to Week 52|Lack of Efficacy|10|||
25050533|NCT02696031|50153872|FG001|Up to Week 52|Lack of Efficacy|7|||
25050534|NCT02696031|50153873|FG002|Up to Week 52|Lack of Efficacy|11|||
25050535|NCT02696031|50153874|FG003|Up to Week 52|Lack of Efficacy|0|||
25050536|NCT02696031|50153875|FG004|Up to Week 52|Lack of Efficacy|0|||
25050537|NCT02696031|50153876|FG005|Up to Week 52|Lack of Efficacy|0|||
25050538|NCT02696031|50153871|FG000|Up to Week 52|Lost to Follow-up|1|||
25050539|NCT02696031|50153872|FG001|Up to Week 52|Lost to Follow-up|1|||
25050540|NCT02696031|50153873|FG002|Up to Week 52|Lost to Follow-up|1|||
25050541|NCT02696031|50153874|FG003|Up to Week 52|Lost to Follow-up|0|||
25050542|NCT02696031|50153875|FG004|Up to Week 52|Lost to Follow-up|0|||
25050543|NCT02696031|50153876|FG005|Up to Week 52|Lost to Follow-up|0|||
25050544|NCT02696031|50153871|FG000|Up to Week 52|Physician Decision|1|||
25050545|NCT02696031|50153872|FG001|Up to Week 52|Physician Decision|1|||
25050546|NCT02696031|50153873|FG002|Up to Week 52|Physician Decision|2|||
25050547|NCT02696031|50153874|FG003|Up to Week 52|Physician Decision|0|||
25050548|NCT02696031|50153875|FG004|Up to Week 52|Physician Decision|0|||
25050549|NCT02696031|50153876|FG005|Up to Week 52|Physician Decision|0|||
25050550|NCT02696031|50153871|FG000|Up to Week 52|Pregnancy|0|||
25050551|NCT02696031|50153872|FG001|Up to Week 52|Pregnancy|2|||
25050552|NCT02696031|50153873|FG002|Up to Week 52|Pregnancy|0|||
25050553|NCT02696031|50153874|FG003|Up to Week 52|Pregnancy|0|||
25050554|NCT02696031|50153875|FG004|Up to Week 52|Pregnancy|0|||
25050555|NCT02696031|50153876|FG005|Up to Week 52|Pregnancy|0|||
25050556|NCT02696031|50153871|FG000|Up to Week 52|Protocol Violation|1|||
25050557|NCT02696031|50153872|FG001|Up to Week 52|Protocol Violation|0|||
25050558|NCT02696031|50153873|FG002|Up to Week 52|Protocol Violation|0|||
25050559|NCT02696031|50153874|FG003|Up to Week 52|Protocol Violation|0|||
25050560|NCT02696031|50153875|FG004|Up to Week 52|Protocol Violation|0|||
25050561|NCT02696031|50153876|FG005|Up to Week 52|Protocol Violation|0|||
25050562|NCT02696031|50153871|FG000|Up to Week 52|Withdrawal by Subject|12|||
25050563|NCT02696031|50153872|FG001|Up to Week 52|Withdrawal by Subject|3|||
25050564|NCT02696031|50153873|FG002|Up to Week 52|Withdrawal by Subject|9|||
25050565|NCT02696031|50153874|FG003|Up to Week 52|Withdrawal by Subject|0|||
25050566|NCT02696031|50153875|FG004|Up to Week 52|Withdrawal by Subject|0|||
25050567|NCT02696031|50153876|FG005|Up to Week 52|Withdrawal by Subject|0|||
25050568|NCT02696031|50153871|FG000|Up to Week 104|Pregnancy|0|||
25050569|NCT02696031|50153872|FG001|Up to Week 104|Pregnancy|2|||
25050570|NCT02696031|50153873|FG002|Up to Week 104|Pregnancy|1|||
25050571|NCT02696031|50153874|FG003|Up to Week 104|Pregnancy|0|||
25050572|NCT02696031|50153875|FG004|Up to Week 104|Pregnancy|0|||
25050573|NCT02696031|50153876|FG005|Up to Week 104|Pregnancy|0|||
25050574|NCT02696031|50153871|FG000|Up to Week 104|Withdrawal by Subject|15|||
25050575|NCT02696031|50153872|FG001|Up to Week 104|Withdrawal by Subject|10|||
25050576|NCT02696031|50153873|FG002|Up to Week 104|Withdrawal by Subject|16|||
25050577|NCT02696031|50153874|FG003|Up to Week 104|Withdrawal by Subject|0|||
25050578|NCT02696031|50153875|FG004|Up to Week 104|Withdrawal by Subject|0|||
25050579|NCT02696031|50153876|FG005|Up to Week 104|Withdrawal by Subject|0|||
25050580|NCT02696031|50153871|FG000|Up to Week 104|Protocol Violation|1|||
25050581|NCT02696031|50153872|FG001|Up to Week 104|Protocol Violation|0|||
25050582|NCT02696031|50153873|FG002|Up to Week 104|Protocol Violation|0|||
25050583|NCT02696031|50153874|FG003|Up to Week 104|Protocol Violation|0|||
25050584|NCT02696031|50153875|FG004|Up to Week 104|Protocol Violation|0|||
25050585|NCT02696031|50153876|FG005|Up to Week 104|Protocol Violation|0|||
25050586|NCT02696031|50153871|FG000|Up to Week 104|Physician Decision|1|||
25050587|NCT02696031|50153872|FG001|Up to Week 104|Physician Decision|2|||
25050588|NCT02696031|50153873|FG002|Up to Week 104|Physician Decision|3|||
25050589|NCT02696031|50153874|FG003|Up to Week 104|Physician Decision|0|||
25050590|NCT02696031|50153875|FG004|Up to Week 104|Physician Decision|0|||
25050591|NCT02696031|50153876|FG005|Up to Week 104|Physician Decision|0|||
25050592|NCT02696031|50153871|FG000|Up to Week 104|Lost to Follow-up|2|||
25050593|NCT02696031|50153872|FG001|Up to Week 104|Lost to Follow-up|3|||
25050594|NCT02696031|50153873|FG002|Up to Week 104|Lost to Follow-up|1|||
25050595|NCT02696031|50153874|FG003|Up to Week 104|Lost to Follow-up|0|||
25050596|NCT02696031|50153875|FG004|Up to Week 104|Lost to Follow-up|0|||
25050597|NCT02696031|50153876|FG005|Up to Week 104|Lost to Follow-up|0|||
25050598|NCT02696031|50153871|FG000|Up to Week 104|Lack of Efficacy|13|||
25050599|NCT02696031|50153872|FG001|Up to Week 104|Lack of Efficacy|12|||
25050600|NCT02696031|50153873|FG002|Up to Week 104|Lack of Efficacy|11|||
25050601|NCT02696031|50153874|FG003|Up to Week 104|Lack of Efficacy|0|||
25050602|NCT02696031|50153875|FG004|Up to Week 104|Lack of Efficacy|0|||
25050603|NCT02696031|50153876|FG005|Up to Week 104|Lack of Efficacy|0|||
25050604|NCT02696031|50153871|FG000|Up to Week 104|Adverse Event|7|||
25050605|NCT02696031|50153872|FG001|Up to Week 104|Adverse Event|11|||
25050606|NCT02696031|50153873|FG002|Up to Week 104|Adverse Event|5|||
25050607|NCT02696031|50153874|FG003|Up to Week 104|Adverse Event|0|||
25186568|NCT01395017|50337140|FG000|Overall Study|Withdrawal by Subject|14|||
25050608|NCT02696031|50153875|FG004|Up to Week 104|Adverse Event|0|||
25050609|NCT02696031|50153876|FG005|Up to Week 104|Adverse Event|0|||
25050610|NCT02696031|50153871|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
25050611|NCT02696031|50153872|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
25050612|NCT02696031|50153873|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
25050613|NCT02696031|50153874|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
25050614|NCT02696031|50153875|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
25050615|NCT02696031|50153876|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
25050616|NCT02696031|50153871|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
25050617|NCT02696031|50153872|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
25050618|NCT02696031|50153873|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
25050619|NCT02696031|50153874|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
25050620|NCT02696031|50153875|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
25050621|NCT02696031|50153876|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
25050622|NCT02696031|50153871|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
25050623|NCT02696031|50153872|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
25050624|NCT02696031|50153873|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
25050625|NCT02696031|50153874|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
25050626|NCT02696031|50153875|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
25050627|NCT02696031|50153876|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
25050628|NCT02696031|50153871|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
25050629|NCT02696031|50153872|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
25050630|NCT02696031|50153873|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
25050631|NCT02696031|50153874|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
25050632|NCT02696031|50153875|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
25050633|NCT02696031|50153876|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
25050634|NCT02696031|50153871|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
25050635|NCT02696031|50153872|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
25050636|NCT02696031|50153873|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
25050637|NCT02696031|50153874|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
25050638|NCT02696031|50153875|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
25050639|NCT02696031|50153876|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
25050640|NCT02696031|50153871|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
25050641|NCT02696031|50153872|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
25050642|NCT02696031|50153873|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
25050643|NCT02696031|50153874|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
25050644|NCT02696031|50153875|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
25050645|NCT02696031|50153876|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
25050646|NCT02696031|50153871|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
25050647|NCT02696031|50153872|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
25050648|NCT02696031|50153873|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
25050649|NCT02696031|50153874|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
25050650|NCT02696031|50153875|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
25050651|NCT02696031|50153876|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
25050652|NCT00397254|50153885|FG000|Overall Study|Lost to Follow-up|2|||
25050653|NCT00397254|50153886|FG001|Overall Study|Lost to Follow-up|2|||
25050654|NCT01369641|50153890|FG000|Overall Study|Withdrawal by Subject|1|||
25050655|NCT00529152|50153894|FG000|Overall Study|Adverse Event|2|||
25050656|NCT00529152|50153894|FG000|Overall Study|Withdrawal by Subject|2|||
25050657|NCT00529152|50153894|FG000|Overall Study|Lost to Follow-up|1|||
25050658|NCT02605174|50153901|FG000|Overall Study|Adverse Event|0|||
25050659|NCT02605174|50153902|FG001|Overall Study|Adverse Event|0|||
25050660|NCT02605174|50153903|FG002|Overall Study|Adverse Event|1|||
25050661|NCT02605174|50153904|FG003|Overall Study|Adverse Event|0|||
25050662|NCT02605174|50153905|FG004|Overall Study|Adverse Event|4|||
25050663|NCT02605174|50153906|FG005|Overall Study|Adverse Event|0|||
25050664|NCT02605174|50153907|FG006|Overall Study|Adverse Event|0|||
25050665|NCT02605174|50153901|FG000|Overall Study|Lost to Follow-up|20|||
25050666|NCT02605174|50153902|FG001|Overall Study|Lost to Follow-up|7|||
25050667|NCT02605174|50153903|FG002|Overall Study|Lost to Follow-up|27|||
25050668|NCT02605174|50153904|FG003|Overall Study|Lost to Follow-up|10|||
25050669|NCT02605174|50153905|FG004|Overall Study|Lost to Follow-up|20|||
25050670|NCT02605174|50153906|FG005|Overall Study|Lost to Follow-up|10|||
25050671|NCT02605174|50153907|FG006|Overall Study|Lost to Follow-up|29|||
25050672|NCT02605174|50153901|FG000|Overall Study|Protocol Violation|10|||
25050673|NCT02605174|50153902|FG001|Overall Study|Protocol Violation|4|||
25050674|NCT02605174|50153903|FG002|Overall Study|Protocol Violation|14|||
25050675|NCT02605174|50153904|FG003|Overall Study|Protocol Violation|6|||
25050676|NCT02605174|50153905|FG004|Overall Study|Protocol Violation|7|||
25050677|NCT02605174|50153906|FG005|Overall Study|Protocol Violation|7|||
25050678|NCT02605174|50153907|FG006|Overall Study|Protocol Violation|12|||
25050679|NCT02605174|50153901|FG000|Overall Study|Pregnancy|1|||
25050680|NCT02605174|50153902|FG001|Overall Study|Pregnancy|0|||
25050681|NCT02605174|50153903|FG002|Overall Study|Pregnancy|0|||
25050682|NCT02605174|50153904|FG003|Overall Study|Pregnancy|2|||
25050683|NCT02605174|50153905|FG004|Overall Study|Pregnancy|0|||
25050684|NCT02605174|50153906|FG005|Overall Study|Pregnancy|0|||
25050685|NCT02605174|50153907|FG006|Overall Study|Pregnancy|0|||
25050686|NCT02605174|50153901|FG000|Overall Study|Withdrawal by Subject|9|||
25050687|NCT02605174|50153902|FG001|Overall Study|Withdrawal by Subject|6|||
25050688|NCT02605174|50153903|FG002|Overall Study|Withdrawal by Subject|14|||
25050689|NCT02605174|50153904|FG003|Overall Study|Withdrawal by Subject|11|||
25050690|NCT02605174|50153905|FG004|Overall Study|Withdrawal by Subject|6|||
25050691|NCT02605174|50153906|FG005|Overall Study|Withdrawal by Subject|4|||
25050692|NCT02605174|50153907|FG006|Overall Study|Withdrawal by Subject|15|||
25050693|NCT02605174|50153901|FG000|Overall Study|Physician Decision|2|||
25050694|NCT02605174|50153902|FG001|Overall Study|Physician Decision|0|||
25050695|NCT02605174|50153903|FG002|Overall Study|Physician Decision|0|||
25050696|NCT02605174|50153904|FG003|Overall Study|Physician Decision|0|||
25050697|NCT02605174|50153905|FG004|Overall Study|Physician Decision|0|||
25050698|NCT02605174|50153906|FG005|Overall Study|Physician Decision|0|||
25050699|NCT02605174|50153907|FG006|Overall Study|Physician Decision|3|||
25050700|NCT02605174|50153901|FG000|Overall Study|Randomization Failure|22|||
25050701|NCT02605174|50153902|FG001|Overall Study|Randomization Failure|6|||
25050702|NCT02605174|50153903|FG002|Overall Study|Randomization Failure|20|||
25050703|NCT02605174|50153904|FG003|Overall Study|Randomization Failure|7|||
25050704|NCT02605174|50153905|FG004|Overall Study|Randomization Failure|16|||
25050705|NCT02605174|50153906|FG005|Overall Study|Randomization Failure|11|||
25050706|NCT02605174|50153907|FG006|Overall Study|Randomization Failure|30|||
25050707|NCT02604550|50153935|FG000|Overall Study|Lost to Follow-up|7|||
25050708|NCT02604550|50153936|FG001|Overall Study|Lost to Follow-up|6|||
25050709|NCT02604550|50153935|FG000|Overall Study|Withdrawal by Subject|0|||
25050710|NCT02604550|50153936|FG001|Overall Study|Withdrawal by Subject|1|||
25050711|NCT02604550|50153935|FG000|Overall Study|Incomplete data using paper journal|18|||
25050712|NCT02604550|50153936|FG001|Overall Study|Incomplete data using paper journal|19|||
25050713|NCT02591290|50153942|FG000|Overall Study|Withdrawal by Subject|2|||
25050714|NCT02791893|50153948|FG000|Blinded Phase|Lost to Follow-up|2|||
25050715|NCT02791893|50153949|FG001|Blinded Phase|Lost to Follow-up|2|||
25050716|NCT02791893|50153948|FG000|Blinded Phase|Withdrawal by Subject|1|||
25050717|NCT02791893|50153949|FG001|Blinded Phase|Withdrawal by Subject|2|||
25050718|NCT02791893|50153948|FG000|Open Label Phase|Lost to Follow-up|3|||
25050719|NCT02791893|50153949|FG001|Open Label Phase|Lost to Follow-up|0|||
25050720|NCT02791893|50153948|FG000|Open Label Phase|Withdrawal by Subject|0|||
25050721|NCT02791893|50153949|FG001|Open Label Phase|Withdrawal by Subject|2|||
25050722|NCT00120042|50153958|FG000|Overall Study|all completed protocl|0|||
25050723|NCT00120042|50153959|FG001|Overall Study|all completed protocl|0|||
25050724|NCT00120042|50153960|FG002|Overall Study|all completed protocl|0|||
25050725|NCT02476851|50153967|FG000|Overall Study|Protocol Violation|1|||
25050726|NCT02476851|50153968|FG001|Overall Study|Protocol Violation|1|||
25050727|NCT02595970|50153974|FG000|Overall Study|Withdrawal by Subject|2|||
25050728|NCT02595970|50153974|FG000|Overall Study|Physician Decision|2|||
25050729|NCT02595970|50153974|FG000|Overall Study|Protocol Violation|4|||
25050730|NCT02595970|50153974|FG000|Overall Study|Adverse Event|5|||
25050731|NCT02595970|50153974|FG000|Overall Study|Lack of Efficacy|7|||
25050732|NCT01866111|50153982|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
25050733|NCT01866111|50153983|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
25050734|NCT01866111|50153984|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
25050735|NCT01866111|50153985|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
25050736|NCT01866111|50153982|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
25050737|NCT01866111|50153983|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
25050738|NCT01866111|50153984|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
25050739|NCT01866111|50153985|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
25050740|NCT02595502|50153995|FG000|Period 1|Adverse Event|0|||
25050741|NCT02595502|50153996|FG001|Period 1|Adverse Event|1|||
25050742|NCT02595502|50153995|FG000|Period 1|Withdrawal by Subject|1|||
25050743|NCT02595502|50153996|FG001|Period 1|Withdrawal by Subject|0|||
25050744|NCT02595502|50153995|FG000|Period 1|Lost to Follow-up|0|||
25050745|NCT02595502|50153996|FG001|Period 1|Lost to Follow-up|1|||
25050746|NCT02595502|50153995|FG000|Period 2|Adverse Event|1|||
25050747|NCT02595502|50153996|FG001|Period 2|Adverse Event|1|||
25050748|NCT02595502|50153995|FG000|Period 2|Received incorrect lens at Period 1|0|||
25050749|NCT02595502|50153996|FG001|Period 2|Received incorrect lens at Period 1|1|||
25050750|NCT02595502|50153995|FG000|Period 3|Protocol Violation|0|||
25186569|NCT01395017|50337141|FG001|Overall Study|Withdrawal by Subject|8|||
25050751|NCT02595502|50153996|FG001|Period 3|Protocol Violation|1|||
25050752|NCT02595502|50153995|FG000|Period 3|Lost to Follow-up|1|||
25162571|NCT01791517|50284760|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
25186570|NCT01395017|50337140|FG000|Overall Study|Protocol deviation|1|||
25186571|NCT01395017|50337141|FG001|Overall Study|Protocol deviation|2|||
25050753|NCT02595502|50153996|FG001|Period 3|Lost to Follow-up|0|||
25050754|NCT02595502|50153995|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
25186572|NCT01395017|50337140|FG000|Overall Study|Death|4|||
25050755|NCT02595502|50153996|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
25050756|NCT01369329|50154005|FG000|Overall Study|Withdrawal by Subject|8|||
25050757|NCT01369329|50154006|FG001|Overall Study|Withdrawal by Subject|6|||
25050758|NCT01369329|50154007|FG002|Overall Study|Withdrawal by Subject|10|||
25050759|NCT01369329|50154005|FG000|Overall Study|Lost to Follow-up|2|||
25050760|NCT01369329|50154006|FG001|Overall Study|Lost to Follow-up|2|||
25050761|NCT01369329|50154007|FG002|Overall Study|Lost to Follow-up|2|||
25050762|NCT01369329|50154005|FG000|Overall Study|Other|2|||
25050763|NCT01369329|50154006|FG001|Overall Study|Other|3|||
25050764|NCT01369329|50154007|FG002|Overall Study|Other|2|||
25050765|NCT02791659|50154017|FG000|Overall Study|Protocol Violation|0|||
25050766|NCT02791659|50154018|FG001|Overall Study|Protocol Violation|1|||
25050767|NCT02594098|50154026|FG000|Overall Study|Lack of Efficacy|17|||
25050768|NCT02594098|50154027|FG001|Overall Study|Lack of Efficacy|6|||
25050769|NCT02594098|50154026|FG000|Overall Study|Withdrawal by Subject|1|||
25050770|NCT02594098|50154027|FG001|Overall Study|Withdrawal by Subject|3|||
25050771|NCT02594098|50154026|FG000|Overall Study|Terminated participation|6|||
25050772|NCT02594098|50154027|FG001|Overall Study|Terminated participation|2|||
25050773|NCT02594098|50154026|FG000|Overall Study|Seek alternative treatment|2|||
25050774|NCT02594098|50154027|FG001|Overall Study|Seek alternative treatment|1|||
25050775|NCT02594098|50154026|FG000|Overall Study|Other|0|||
25050776|NCT02594098|50154027|FG001|Overall Study|Other|1|||
25050777|NCT02593864|50154035|FG000|Overall Study|Withdrawal by Subject|3|||
25050778|NCT02593864|50154035|FG000|Overall Study|Lost to Follow-up|3|||
25050779|NCT02590588|50154039|FG000|Overall Study|Adverse Event|1|||
25050780|NCT01434602|50154048|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
25050781|NCT01434602|50154049|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
25050782|NCT01434602|50154050|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
25050783|NCT01434602|50154051|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
25050784|NCT01434602|50154052|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
25050785|NCT01434602|50154048|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
25050786|NCT01434602|50154049|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
25050787|NCT01434602|50154050|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
25050788|NCT01434602|50154051|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
25050789|NCT01434602|50154052|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
25050790|NCT01434602|50154048|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
25050791|NCT01434602|50154049|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
25050792|NCT01434602|50154050|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
25050793|NCT01434602|50154051|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
25050794|NCT01434602|50154052|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
25050795|NCT01434602|50154048|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
25050796|NCT01434602|50154049|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
25050797|NCT01434602|50154050|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
25050798|NCT01434602|50154051|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
25050799|NCT01434602|50154052|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
25050800|NCT01434602|50154048|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
25050801|NCT01434602|50154049|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
25050802|NCT01434602|50154050|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
25050803|NCT01434602|50154051|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
25050804|NCT01434602|50154052|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
25050805|NCT01434602|50154048|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
25050806|NCT01434602|50154049|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
25050807|NCT01434602|50154050|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
25050808|NCT01434602|50154051|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
25050809|NCT01434602|50154052|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
25050810|NCT01434602|50154048|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
25050811|NCT01434602|50154049|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
25276484|NCT00958126|50590411|FG001|Overall Study|Moved away from study area|0|||
25276485|NCT00958126|50590412|FG002|Overall Study|Moved away from study area|1|||
25050812|NCT01434602|50154050|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
25050813|NCT01434602|50154051|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
25050814|NCT01434602|50154052|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
25050815|NCT01434602|50154048|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
25050816|NCT01434602|50154049|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
25050817|NCT01434602|50154050|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
25050818|NCT01434602|50154051|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
25050819|NCT01434602|50154052|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
25050820|NCT01434602|50154048|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
25050821|NCT01434602|50154049|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
25050822|NCT01434602|50154050|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
25050823|NCT01434602|50154051|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
25050824|NCT01434602|50154052|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
25050825|NCT01434602|50154048|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
25050826|NCT01434602|50154049|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
25050827|NCT01434602|50154050|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
25050828|NCT01434602|50154051|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
25050829|NCT01434602|50154052|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
25050830|NCT01767129|50154074|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
25050831|NCT01767129|50154075|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
25050832|NCT02791269|50154084|FG000|Overall Study|Lost to Follow-up|0|||
25050833|NCT02791269|50154085|FG001|Overall Study|Lost to Follow-up|1|||
25050834|NCT02696564|50154095|FG000|Overall Study|Death|1|||
25050835|NCT02696564|50154096|FG001|Overall Study|Death|2|||
25050836|NCT02696564|50154095|FG000|Overall Study|Withdrawal by Subject|3|||
25050837|NCT02696564|50154096|FG001|Overall Study|Withdrawal by Subject|2|||
25050838|NCT02696564|50154095|FG000|Overall Study|Lost to Follow-up|3|||
25050839|NCT02696564|50154096|FG001|Overall Study|Lost to Follow-up|3|||
25050840|NCT02696564|50154095|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
25050841|NCT02696564|50154096|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
25050842|NCT02696564|50154095|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
25050843|NCT02696564|50154096|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
25050844|NCT02696564|50154095|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
25050845|NCT02696564|50154096|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
25050846|NCT02696564|50154095|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
25050847|NCT02696564|50154096|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
25050848|NCT02696564|50154095|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
25050849|NCT02696564|50154096|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
25050850|NCT02640950|50154102|FG000|Overall Study|Adverse Event|1|||
25050851|NCT02640950|50154102|FG000|Overall Study|Withdrawal by Subject|1|||
24960581|NCT00293462|50051140|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
24960582|NCT00293462|50051141|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
24960583|NCT00293462|50051139|FG000|Overall Study|Refuse Radiation Treatment|1|||
24960584|NCT00293462|50051140|FG001|Overall Study|Refuse Radiation Treatment|0|||
24960585|NCT00293462|50051141|FG002|Overall Study|Refuse Radiation Treatment|0|||
24960586|NCT00293462|50051139|FG000|Overall Study|No Show|0|||
24960587|NCT00293462|50051140|FG001|Overall Study|No Show|0|||
24960588|NCT00293462|50051141|FG002|Overall Study|No Show|1|||
24960589|NCT00293462|50051139|FG000|Overall Study|Went back to his home country|0|||
24960590|NCT00293462|50051140|FG001|Overall Study|Went back to his home country|0|||
24960591|NCT00293462|50051141|FG002|Overall Study|Went back to his home country|1|||
24960592|NCT00293462|50051139|FG000|Overall Study|Blood clot after chemotherapy|0|||
24960593|NCT00293462|50051140|FG001|Overall Study|Blood clot after chemotherapy|0|||
24960594|NCT00293462|50051141|FG002|Overall Study|Blood clot after chemotherapy|1|||
24960595|NCT00293462|50051139|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
24960596|NCT00293462|50051140|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
24960597|NCT00293462|50051141|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
24960598|NCT00293462|50051139|FG000|Overall Study|Possible Tracheostomy leakage|0|||
24960599|NCT00293462|50051140|FG001|Overall Study|Possible Tracheostomy leakage|1|||
24960600|NCT00293462|50051141|FG002|Overall Study|Possible Tracheostomy leakage|0|||
24960601|NCT00293462|50051139|FG000|Overall Study|Low radiation dose in oral cavity|0|||
24960602|NCT00293462|50051140|FG001|Overall Study|Low radiation dose in oral cavity|1|||
24960603|NCT00293462|50051141|FG002|Overall Study|Low radiation dose in oral cavity|0|||
24960604|NCT00293462|50051139|FG000|Overall Study|Physician Decision|0|||
24960605|NCT00293462|50051140|FG001|Overall Study|Physician Decision|1|||
24960606|NCT00293462|50051141|FG002|Overall Study|Physician Decision|0|||
24960607|NCT00316082|50051154|FG000|Overall Study|Lack of Efficacy|2|||
24960608|NCT00316082|50051155|FG001|Overall Study|Lack of Efficacy|3|||
24960609|NCT00316082|50051156|FG002|Overall Study|Lack of Efficacy|3|||
24960610|NCT00316082|50051157|FG003|Overall Study|Lack of Efficacy|4|||
24960611|NCT00316082|50051158|FG004|Overall Study|Lack of Efficacy|6|||
24960612|NCT00316082|50051154|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
25050852|NCT02593786|50154110|FG000|Overall Study|Disease progression|12|||
25050853|NCT02593786|50154111|FG001|Overall Study|Disease progression|16|||
25050854|NCT02593786|50154112|FG002|Overall Study|Disease progression|10|||
25050855|NCT02593786|50154113|FG003|Overall Study|Disease progression|7|||
25050856|NCT02593786|50154110|FG000|Overall Study|Study drug toxicity|1|||
25050857|NCT02593786|50154111|FG001|Overall Study|Study drug toxicity|0|||
25050858|NCT02593786|50154112|FG002|Overall Study|Study drug toxicity|0|||
25050859|NCT02593786|50154113|FG003|Overall Study|Study drug toxicity|0|||
25050860|NCT02593786|50154110|FG000|Overall Study|Adverse event unrelated to study drug|1|||
25050861|NCT02593786|50154111|FG001|Overall Study|Adverse event unrelated to study drug|1|||
25050862|NCT02593786|50154112|FG002|Overall Study|Adverse event unrelated to study drug|1|||
25050863|NCT02593786|50154113|FG003|Overall Study|Adverse event unrelated to study drug|0|||
25050864|NCT02593786|50154110|FG000|Overall Study|Participant request to discontinue study therapy|0|||
25050865|NCT02593786|50154111|FG001|Overall Study|Participant request to discontinue study therapy|2|||
25050866|NCT02593786|50154112|FG002|Overall Study|Participant request to discontinue study therapy|0|||
25050867|NCT02593786|50154113|FG003|Overall Study|Participant request to discontinue study therapy|0|||
25050868|NCT02593786|50154110|FG000|Overall Study|Other reasons|1|||
25050869|NCT02593786|50154111|FG001|Overall Study|Other reasons|1|||
25050870|NCT02593786|50154112|FG002|Overall Study|Other reasons|0|||
25050871|NCT02593786|50154113|FG003|Overall Study|Other reasons|5|||
25050872|NCT04829331|50154152|FG000|Overall Study|Lost to Follow-up|1|||
25050873|NCT04829331|50154153|FG001|Overall Study|Lost to Follow-up|0|||
25050874|NCT04602546|50154168|FG000|Overall Study|Training|2|||
25050875|NCT04602546|50154169|FG001|Overall Study|Training|2|||
25050876|NCT04602546|50154170|FG002|Overall Study|Training|1|||
25050877|NCT04602546|50154171|FG003|Overall Study|Training|2|||
25050878|NCT04602546|50154172|FG004|Overall Study|Training|0|||
25050879|NCT04602546|50154168|FG000|Overall Study|Randomized with disqualified data|2|||
25050880|NCT04602546|50154169|FG001|Overall Study|Randomized with disqualified data|0|||
24960613|NCT00316082|50051155|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
24960614|NCT00316082|50051156|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
24960615|NCT00316082|50051157|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
24960616|NCT00316082|50051158|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
24960617|NCT00316082|50051154|FG000|Overall Study|Lost to Follow-up|7|||
25162572|NCT01791517|50284749|FG000|Phase II|Pre-Existing Ocular Issue|0|||
24960618|NCT00316082|50051155|FG001|Overall Study|Lost to Follow-up|6|||
24960619|NCT00316082|50051156|FG002|Overall Study|Lost to Follow-up|7|||
24960620|NCT00316082|50051157|FG003|Overall Study|Lost to Follow-up|8|||
24960621|NCT00316082|50051158|FG004|Overall Study|Lost to Follow-up|6|||
24960622|NCT00316082|50051154|FG000|Overall Study|Poor/noncompliance|6|||
24960623|NCT00316082|50051155|FG001|Overall Study|Poor/noncompliance|1|||
24960624|NCT00316082|50051156|FG002|Overall Study|Poor/noncompliance|4|||
24960625|NCT00316082|50051157|FG003|Overall Study|Poor/noncompliance|1|||
24960626|NCT00316082|50051158|FG004|Overall Study|Poor/noncompliance|4|||
25162573|NCT01791517|50284750|FG001|Phase II|Pre-Existing Ocular Issue|0|||
25162574|NCT01791517|50284751|FG002|Phase II|Pre-Existing Ocular Issue|0|||
25162575|NCT01791517|50284752|FG003|Phase II|Pre-Existing Ocular Issue|0|||
25162576|NCT01791517|50284753|FG004|Phase II|Pre-Existing Ocular Issue|0|||
25162577|NCT01791517|50284754|FG005|Phase II|Pre-Existing Ocular Issue|0|||
25162578|NCT01791517|50284755|FG006|Phase II|Pre-Existing Ocular Issue|0|||
25162579|NCT01791517|50284756|FG007|Phase II|Pre-Existing Ocular Issue|0|||
25162580|NCT01791517|50284757|FG008|Phase II|Pre-Existing Ocular Issue|0|||
25162581|NCT01791517|50284758|FG009|Phase II|Pre-Existing Ocular Issue|0|||
25276486|NCT00958126|50590413|FG003|Overall Study|Moved away from study area|1|||
25050881|NCT04602546|50154170|FG002|Overall Study|Randomized with disqualified data|2|||
25050882|NCT04602546|50154171|FG003|Overall Study|Randomized with disqualified data|5|||
25050883|NCT04602546|50154172|FG004|Overall Study|Randomized with disqualified data|3|||
25050884|NCT04102189|50154202|FG000|Overall Study|Withdrawal by Subject|1|||
25050885|NCT04102189|50154203|FG001|Overall Study|Withdrawal by Subject|2|||
25050886|NCT04102189|50154202|FG000|Overall Study|Withdrawal by parent/guardian|0|||
25050887|NCT04102189|50154203|FG001|Overall Study|Withdrawal by parent/guardian|1|||
25050888|NCT04102189|50154202|FG000|Overall Study|Lost to Follow-up|1|||
25276487|NCT00958126|50590414|FG004|Overall Study|Moved away from study area|0|||
24960627|NCT00316082|50051154|FG000|Overall Study|Adverse Event|4|||
24960628|NCT00316082|50051155|FG001|Overall Study|Adverse Event|2|||
24960629|NCT00316082|50051156|FG002|Overall Study|Adverse Event|5|||
24960630|NCT00316082|50051157|FG003|Overall Study|Adverse Event|1|||
24960631|NCT00316082|50051158|FG004|Overall Study|Adverse Event|3|||
24960632|NCT00316082|50051154|FG000|Overall Study|Subject no longer meets study criteria|3|||
24960633|NCT00316082|50051155|FG001|Overall Study|Subject no longer meets study criteria|1|||
24960634|NCT00316082|50051156|FG002|Overall Study|Subject no longer meets study criteria|2|||
24960635|NCT00316082|50051157|FG003|Overall Study|Subject no longer meets study criteria|2|||
24960636|NCT00316082|50051158|FG004|Overall Study|Subject no longer meets study criteria|1|||
24960637|NCT00316082|50051154|FG000|Overall Study|Physician Decision|1|||
24960638|NCT00316082|50051155|FG001|Overall Study|Physician Decision|1|||
24960639|NCT00316082|50051156|FG002|Overall Study|Physician Decision|2|||
24960640|NCT00316082|50051157|FG003|Overall Study|Physician Decision|1|||
24960641|NCT00316082|50051158|FG004|Overall Study|Physician Decision|1|||
24960642|NCT00316082|50051154|FG000|Overall Study|Death|0|||
24960643|NCT00316082|50051155|FG001|Overall Study|Death|0|||
24960644|NCT00316082|50051156|FG002|Overall Study|Death|1|||
24960645|NCT00316082|50051157|FG003|Overall Study|Death|0|||
24960646|NCT00316082|50051158|FG004|Overall Study|Death|0|||
24960647|NCT00316082|50051154|FG000|Overall Study|Administrative reason by sponsor|0|||
24960648|NCT00316082|50051155|FG001|Overall Study|Administrative reason by sponsor|0|||
24960649|NCT00316082|50051156|FG002|Overall Study|Administrative reason by sponsor|1|||
24960650|NCT00316082|50051157|FG003|Overall Study|Administrative reason by sponsor|0|||
24960651|NCT00316082|50051158|FG004|Overall Study|Administrative reason by sponsor|0|||
24960652|NCT00316004|50051177|FG000|Overall Study|Subject was not given study fluid.|14|||
25050889|NCT04102189|50154203|FG001|Overall Study|Lost to Follow-up|0|||
25050890|NCT04004988|50154218|FG000|Period 1|Physician Decision|2|||
25050891|NCT04004988|50154219|FG001|Period 1|Physician Decision|0|||
25186573|NCT01395017|50337141|FG001|Overall Study|Death|3|||
24960653|NCT00316004|50051178|FG001|Overall Study|Subject was not given study fluid.|14|||
25050892|NCT04004988|50154218|FG000|Period 1|Withdrawal by Subject|0|||
25050893|NCT04004988|50154219|FG001|Period 1|Withdrawal by Subject|1|||
25050894|NCT04004988|50154218|FG000|Period 1|Adverse Event|1|||
25050895|NCT04004988|50154219|FG001|Period 1|Adverse Event|2|||
25050896|NCT03898700|50154226|FG000|Overall Study|Withdrawal by Subject|2|||
25050897|NCT03693300|50154232|FG000|Overall Study|Patients ongoing study|43|||
25050898|NCT03693300|50154233|FG001|Overall Study|Patients ongoing study|1|||
25050899|NCT03586973|50154252|FG000|Overall Study|Death|15|||
25050900|NCT03586973|50154253|FG001|Overall Study|Death|8|||
25050901|NCT03586973|50154252|FG000|Overall Study|Site Terminated by Sponsor|3|||
25050902|NCT03586973|50154253|FG001|Overall Study|Site Terminated by Sponsor|6|||
25050903|NCT03586973|50154252|FG000|Overall Study|Withdrawal by Subject|1|||
25050904|NCT03586973|50154253|FG001|Overall Study|Withdrawal by Subject|0|||
25050905|NCT03586973|50154252|FG000|Overall Study|Lost to Follow-up|1|||
25050906|NCT03586973|50154253|FG001|Overall Study|Lost to Follow-up|0|||
25162582|NCT01791517|50284759|FG010|Phase II|Pre-Existing Ocular Issue|0|||
25162583|NCT01791517|50284760|FG011|Phase II|Pre-Existing Ocular Issue|1|||
25162584|NCT01998581|50284780|FG000|Overall Study|Refused repeat treatment|20|||
25162585|NCT01998581|50284781|FG001|Overall Study|Refused repeat treatment|4|||
25162586|NCT01998581|50284780|FG000|Overall Study|Protocol Violation|1|||
25162587|NCT01998581|50284781|FG001|Overall Study|Protocol Violation|0|||
25162588|NCT01998581|50284780|FG000|Overall Study|Withdrawal by Subject|8|||
25162589|NCT01998581|50284781|FG001|Overall Study|Withdrawal by Subject|1|||
25162590|NCT01998581|50284780|FG000|Overall Study|Lost to Follow-up|12|||
25162591|NCT01998581|50284781|FG001|Overall Study|Lost to Follow-up|4|||
25162592|NCT01998581|50284780|FG000|Overall Study|Adverse Event|1|||
25050907|NCT03383692|50154261|FG000|Overall Study|Progressive disease as per RECIST|3|||
25050908|NCT03383692|50154262|FG001|Overall Study|Progressive disease as per RECIST|3|||
25050909|NCT03383692|50154261|FG000|Overall Study|Clinical progression|0|||
25050910|NCT03383692|50154262|FG001|Overall Study|Clinical progression|1|||
25162593|NCT01998581|50284781|FG001|Overall Study|Adverse Event|1|||
25162594|NCT01998581|50284780|FG000|Overall Study|Other reasons|3|||
25162595|NCT01998581|50284781|FG001|Overall Study|Other reasons|2|||
25162596|NCT01998581|50284780|FG000|Overall Study|Randomized but withdrew before treatment|1|||
25050911|NCT03383692|50154261|FG000|Overall Study|Adverse Event|3|||
25050912|NCT03383692|50154262|FG001|Overall Study|Adverse Event|0|||
25050913|NCT03334435|50154275|FG000|Overall Study|Ongoing as of Week 52|70|||
25050914|NCT03334435|50154276|FG001|Overall Study|Ongoing as of Week 52|32|||
25050915|NCT03334435|50154277|FG002|Overall Study|Ongoing as of Week 52|379|||
25050916|NCT03334435|50154278|FG003|Overall Study|Ongoing as of Week 52|519|||
25050917|NCT03334435|50154279|FG004|Overall Study|Ongoing as of Week 52|146|||
25050918|NCT03334435|50154275|FG000|Overall Study|Lack of Efficacy|3|||
25050919|NCT03334435|50154276|FG001|Overall Study|Lack of Efficacy|5|||
25050920|NCT03334435|50154277|FG002|Overall Study|Lack of Efficacy|76|||
25050921|NCT03334435|50154278|FG003|Overall Study|Lack of Efficacy|140|||
25050922|NCT03334435|50154279|FG004|Overall Study|Lack of Efficacy|61|||
25050923|NCT03334435|50154275|FG000|Overall Study|Adverse Event|2|||
25050924|NCT03334435|50154276|FG001|Overall Study|Adverse Event|1|||
25050925|NCT03334435|50154277|FG002|Overall Study|Adverse Event|9|||
25050926|NCT03334435|50154278|FG003|Overall Study|Adverse Event|23|||
25050927|NCT03334435|50154279|FG004|Overall Study|Adverse Event|13|||
25050928|NCT03334435|50154275|FG000|Overall Study|Withdrawal by Subject|11|||
25050929|NCT03334435|50154276|FG001|Overall Study|Withdrawal by Subject|4|||
25050930|NCT03334435|50154277|FG002|Overall Study|Withdrawal by Subject|38|||
25050931|NCT03334435|50154278|FG003|Overall Study|Withdrawal by Subject|42|||
25050932|NCT03334435|50154279|FG004|Overall Study|Withdrawal by Subject|20|||
25050933|NCT03334435|50154275|FG000|Overall Study|Lost to Follow-up|3|||
25050934|NCT03334435|50154276|FG001|Overall Study|Lost to Follow-up|0|||
25050935|NCT03334435|50154277|FG002|Overall Study|Lost to Follow-up|2|||
25050936|NCT03334435|50154278|FG003|Overall Study|Lost to Follow-up|1|||
25050937|NCT03334435|50154279|FG004|Overall Study|Lost to Follow-up|1|||
25050938|NCT03334435|50154275|FG000|Overall Study|Death|0|||
25050939|NCT03334435|50154276|FG001|Overall Study|Death|0|||
25050940|NCT03334435|50154277|FG002|Overall Study|Death|0|||
25050941|NCT03334435|50154278|FG003|Overall Study|Death|1|||
25050942|NCT03334435|50154279|FG004|Overall Study|Death|0|||
25050943|NCT03334435|50154275|FG000|Overall Study|Other|0|||
25050944|NCT03334435|50154276|FG001|Overall Study|Other|1|||
25050945|NCT03334435|50154277|FG002|Overall Study|Other|3|||
25050946|NCT03334435|50154278|FG003|Overall Study|Other|2|||
24960654|NCT00316004|50051179|FG002|Overall Study|Subject was not given study fluid.|21|||
24960655|NCT00298766|50051187|FG000|Overall Study|Adverse Event|18|||
24960656|NCT00298766|50051187|FG000|Overall Study|Death|2|||
24960657|NCT00298766|50051187|FG000|Overall Study|Withdrawal by Subject|9|||
24960658|NCT00298766|50051187|FG000|Overall Study|Treatment ongoing|4|||
24960659|NCT00298766|50051187|FG000|Overall Study|Progression of amyloid markers|4|||
24960660|NCT00298766|50051187|FG000|Overall Study|Deterioration in KPS and organ function|1|||
24960661|NCT00298766|50051187|FG000|Overall Study|Subjects overall condition deterioration|4|||
24960662|NCT00298766|50051187|FG000|Overall Study|Other|4|||
24960663|NCT00315458|50051193|FG000|Overall Study|Administrative|0|||
24960664|NCT00315458|50051194|FG001|Overall Study|Administrative|3|||
24960665|NCT00315458|50051195|FG002|Overall Study|Administrative|8|||
24960666|NCT00315458|50051196|FG003|Overall Study|Administrative|21|||
24960667|NCT00315458|50051193|FG000|Overall Study|Adverse Event|2|||
24960668|NCT00315458|50051194|FG001|Overall Study|Adverse Event|4|||
24960669|NCT00315458|50051195|FG002|Overall Study|Adverse Event|23|||
24960670|NCT00315458|50051196|FG003|Overall Study|Adverse Event|3|||
25050947|NCT03334435|50154279|FG004|Overall Study|Other|1|||
25050948|NCT02968849|50154311|FG000|Overall Study|Death|8|||
25050949|NCT02968849|50154312|FG001|Overall Study|Death|10|||
25050950|NCT02968849|50154311|FG000|Overall Study|Lost to Follow-up|31|||
25050951|NCT02968849|50154312|FG001|Overall Study|Lost to Follow-up|29|||
25050952|NCT02968849|50154311|FG000|Overall Study|Withdrawal by Subject|73|||
25050953|NCT02968849|50154312|FG001|Overall Study|Withdrawal by Subject|64|||
25050954|NCT02968849|50154311|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
25050955|NCT02968849|50154312|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
25050956|NCT02968849|50154311|FG000|Overall Study|Physician Decision|6|||
24960671|NCT00315458|50051193|FG000|Overall Study|Lost to Follow-up|1|||
25050957|NCT02968849|50154312|FG001|Overall Study|Physician Decision|9|||
25050958|NCT02968849|50154311|FG000|Overall Study|Other|16|||
25050959|NCT02968849|50154312|FG001|Overall Study|Other|10|||
25050960|NCT02669212|50154323|FG000|Overall Study|Lost to Follow-up|1|||
25050961|NCT02669212|50154324|FG001|Overall Study|Lost to Follow-up|0|||
25050962|NCT02669212|50154323|FG000|Overall Study|Medical Condition|3|||
25050963|NCT02669212|50154324|FG001|Overall Study|Medical Condition|4|||
25050964|NCT02669212|50154323|FG000|Overall Study|Withdrawal by Subject|0|||
25050965|NCT02669212|50154324|FG001|Overall Study|Withdrawal by Subject|2|||
25050966|NCT02669212|50154323|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
25050967|NCT02669212|50154324|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
25276488|NCT00958126|50590415|FG005|Overall Study|Moved away from study area|0|||
25276489|NCT00958126|50590416|FG006|Overall Study|Moved away from study area|0|||
25276490|NCT00958126|50590417|FG007|Overall Study|Moved away from study area|0|||
24960672|NCT00315458|50051194|FG001|Overall Study|Lost to Follow-up|2|||
25276491|NCT00958126|50590410|FG000|Overall Study|Lost to Follow-up|1|||
25276492|NCT00958126|50590411|FG001|Overall Study|Lost to Follow-up|5|||
25276493|NCT00958126|50590412|FG002|Overall Study|Lost to Follow-up|9|||
25276494|NCT00958126|50590413|FG003|Overall Study|Lost to Follow-up|8|||
25276495|NCT00958126|50590414|FG004|Overall Study|Lost to Follow-up|0|||
25276496|NCT00958126|50590415|FG005|Overall Study|Lost to Follow-up|0|||
25276497|NCT00958126|50590416|FG006|Overall Study|Lost to Follow-up|0|||
25276498|NCT00958126|50590417|FG007|Overall Study|Lost to Follow-up|0|||
25276499|NCT00958126|50590410|FG000|Overall Study|Sponsor/Investigator decision|0|||
25276500|NCT00958126|50590411|FG001|Overall Study|Sponsor/Investigator decision|0|||
25276501|NCT00958126|50590412|FG002|Overall Study|Sponsor/Investigator decision|0|||
25276502|NCT00958126|50590413|FG003|Overall Study|Sponsor/Investigator decision|1|||
25276503|NCT00958126|50590414|FG004|Overall Study|Sponsor/Investigator decision|0|||
25276504|NCT00958126|50590415|FG005|Overall Study|Sponsor/Investigator decision|0|||
25276505|NCT00958126|50590416|FG006|Overall Study|Sponsor/Investigator decision|0|||
25276506|NCT00958126|50590417|FG007|Overall Study|Sponsor/Investigator decision|0|||
25276507|NCT00958126|50590410|FG000|Overall Study|Other Reason|0|||
25276508|NCT00958126|50590411|FG001|Overall Study|Other Reason|0|||
25276509|NCT00958126|50590412|FG002|Overall Study|Other Reason|0|||
25276510|NCT00958126|50590413|FG003|Overall Study|Other Reason|1|||
25276511|NCT00958126|50590414|FG004|Overall Study|Other Reason|0|||
25276512|NCT00958126|50590415|FG005|Overall Study|Other Reason|1|||
25276513|NCT00958126|50590416|FG006|Overall Study|Other Reason|0|||
25276514|NCT00958126|50590417|FG007|Overall Study|Other Reason|0|||
25276515|NCT00887341|50590441|FG000|Overall Study|Refused treatment|1|||
25276516|NCT00887341|50590442|FG001|Overall Study|Refused treatment|0|||
25276517|NCT00887341|50590441|FG000|Overall Study|Withdrawal by Subject|1|||
25050998|NCT02536664|50154355|FG000|Overall Study|Inadequate completion of documentation|2|||
25050999|NCT02536664|50154356|FG001|Overall Study|Inadequate completion of documentation|4|||
25051000|NCT02536664|50154355|FG000|Overall Study|Progression|13|||
25051001|NCT02536664|50154356|FG001|Overall Study|Progression|18|||
25051002|NCT02536664|50154355|FG000|Overall Study|Death due to lymphoma|2|||
25051003|NCT02536664|50154356|FG001|Overall Study|Death due to lymphoma|1|||
25051004|NCT02536664|50154355|FG000|Overall Study|Death due to other reason|3|||
25051005|NCT02536664|50154356|FG001|Overall Study|Death due to other reason|2|||
25051006|NCT02536664|50154355|FG000|Overall Study|Intolerability|8|||
25051007|NCT02536664|50154356|FG001|Overall Study|Intolerability|6|||
25051008|NCT02536664|50154355|FG000|Overall Study|Withdrawal by Subject|8|||
25051009|NCT02536664|50154356|FG001|Overall Study|Withdrawal by Subject|5|||
25051010|NCT02536664|50154355|FG000|Overall Study|Other|18|||
25051011|NCT02536664|50154356|FG001|Overall Study|Other|24|||
25051012|NCT02536664|50154355|FG000|Overall Study|Missing|53|||
25051013|NCT02536664|50154356|FG001|Overall Study|Missing|20|||
25051014|NCT02426892|50154362|FG000|Overall Study|Adverse Event|2|||
25051015|NCT02426892|50154362|FG000|Overall Study|Lack of Efficacy|17|||
25051016|NCT02426892|50154362|FG000|Overall Study|Withdrawal by Subject|1|||
25051017|NCT02312687|50154366|FG000|Overall Study|Other, Not Specified|1|||
25051018|NCT02304367|50154370|FG000|Overall Study|Lack of Response to Bruosumab|1|||
25051019|NCT02304367|50154370|FG000|Overall Study|Sponsor Decision|3|||
25051020|NCT02304367|50154370|FG000|Overall Study|Death|2|||
25051021|NCT02304367|50154370|FG000|Overall Study|Physician Decision|1|||
25051022|NCT02304367|50154370|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
25051023|NCT02107703|50154383|FG000|Overall Study|Withdrawal by Subject|36|||
25051024|NCT02107703|50154384|FG001|Overall Study|Withdrawal by Subject|19|||
25051025|NCT02107703|50154383|FG000|Overall Study|Lost to Follow-up|6|||
25051026|NCT02107703|50154384|FG001|Overall Study|Lost to Follow-up|4|||
25051027|NCT02107703|50154383|FG000|Overall Study|On study treatment/follow up|319|||
25051028|NCT02107703|50154384|FG001|Overall Study|On study treatment/follow up|152|||
25051029|NCT02054520|50154399|FG000|Overall Study|Adverse Event|1|||
25051030|NCT02054520|50154400|FG001|Overall Study|Adverse Event|4|||
25051031|NCT02054520|50154401|FG002|Overall Study|Adverse Event|2|||
25051032|NCT02054520|50154402|FG003|Overall Study|Adverse Event|1|||
25051033|NCT02054520|50154403|FG004|Overall Study|Adverse Event|1|||
25051034|NCT02054520|50154404|FG005|Overall Study|Adverse Event|0|||
25051035|NCT02054520|50154399|FG000|Overall Study|Lack of Efficacy|7|||
25051036|NCT02054520|50154400|FG001|Overall Study|Lack of Efficacy|0|||
25051037|NCT02054520|50154401|FG002|Overall Study|Lack of Efficacy|2|||
25051038|NCT02054520|50154402|FG003|Overall Study|Lack of Efficacy|1|||
25051039|NCT02054520|50154403|FG004|Overall Study|Lack of Efficacy|3|||
25051040|NCT02054520|50154404|FG005|Overall Study|Lack of Efficacy|2|||
25051041|NCT02054520|50154399|FG000|Overall Study|Withdrawal by Subject|1|||
25051042|NCT02054520|50154400|FG001|Overall Study|Withdrawal by Subject|0|||
25051043|NCT02054520|50154401|FG002|Overall Study|Withdrawal by Subject|0|||
25051044|NCT02054520|50154402|FG003|Overall Study|Withdrawal by Subject|2|||
25051045|NCT02054520|50154403|FG004|Overall Study|Withdrawal by Subject|1|||
25051046|NCT02054520|50154404|FG005|Overall Study|Withdrawal by Subject|0|||
25051047|NCT02054520|50154399|FG000|Overall Study|Physician Decision|0|||
25276518|NCT00887341|50590442|FG001|Overall Study|Withdrawal by Subject|1|||
25276519|NCT00887341|50590441|FG000|Overall Study|Adverse Event|0|||
25051048|NCT02054520|50154400|FG001|Overall Study|Physician Decision|1|||
25051049|NCT02054520|50154401|FG002|Overall Study|Physician Decision|0|||
25051050|NCT02054520|50154402|FG003|Overall Study|Physician Decision|1|||
25051051|NCT02054520|50154403|FG004|Overall Study|Physician Decision|0|||
25051052|NCT02054520|50154404|FG005|Overall Study|Physician Decision|1|||
25051053|NCT02054520|50154399|FG000|Overall Study|Study terminated by Sponsor|0|||
25051054|NCT02054520|50154400|FG001|Overall Study|Study terminated by Sponsor|0|||
25051055|NCT02054520|50154401|FG002|Overall Study|Study terminated by Sponsor|2|||
25051056|NCT02054520|50154402|FG003|Overall Study|Study terminated by Sponsor|1|||
25051057|NCT02054520|50154403|FG004|Overall Study|Study terminated by Sponsor|0|||
25051058|NCT02054520|50154404|FG005|Overall Study|Study terminated by Sponsor|0|||
25051059|NCT01546987|50154433|FG000|Overall Study|Protocol Violation|3|||
25051060|NCT01546987|50154434|FG001|Overall Study|Protocol Violation|4|||
25051061|NCT00676715|50154459|FG000|Overall Study|Withdrawal by Subject|7|||
25051062|NCT00676715|50154460|FG001|Overall Study|Withdrawal by Subject|9|||
25051063|NCT00676715|50154461|FG002|Overall Study|Withdrawal by Subject|10|||
25051064|NCT00676715|50154462|FG003|Overall Study|Withdrawal by Subject|10|||
25051065|NCT00676715|50154459|FG000|Overall Study|Other|2|||
25051066|NCT00676715|50154460|FG001|Overall Study|Other|6|||
25051067|NCT00676715|50154461|FG002|Overall Study|Other|4|||
25051068|NCT00676715|50154462|FG003|Overall Study|Other|3|||
25051069|NCT00676715|50154459|FG000|Overall Study|Lost to Follow-up|1|||
25051070|NCT00676715|50154460|FG001|Overall Study|Lost to Follow-up|1|||
25051071|NCT00676715|50154461|FG002|Overall Study|Lost to Follow-up|7|||
25051072|NCT00676715|50154462|FG003|Overall Study|Lost to Follow-up|3|||
25051073|NCT00676715|50154459|FG000|Overall Study|Death|1|||
25051074|NCT00676715|50154460|FG001|Overall Study|Death|1|||
25051075|NCT00676715|50154461|FG002|Overall Study|Death|1|||
25051076|NCT00676715|50154462|FG003|Overall Study|Death|0|||
25051077|NCT00676715|50154459|FG000|Overall Study|Adverse Event|0|||
25051078|NCT00676715|50154460|FG001|Overall Study|Adverse Event|1|||
25051079|NCT00676715|50154461|FG002|Overall Study|Adverse Event|2|||
25051080|NCT00676715|50154462|FG003|Overall Study|Adverse Event|0|||
25051081|NCT00676715|50154459|FG000|Overall Study|Participants Ongoing|29|||
25051082|NCT00676715|50154460|FG001|Overall Study|Participants Ongoing|29|||
25051083|NCT00676715|50154461|FG002|Overall Study|Participants Ongoing|17|||
24960673|NCT00315458|50051195|FG002|Overall Study|Lost to Follow-up|0|||
24960674|NCT00315458|50051196|FG003|Overall Study|Lost to Follow-up|2|||
25051084|NCT00676715|50154462|FG003|Overall Study|Participants Ongoing|24|||
25051085|NCT00261443|50154474|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
25051086|NCT00261443|50154475|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
25051087|NCT00261443|50154476|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
25051088|NCT00261443|50154474|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
25051089|NCT00261443|50154475|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
25051090|NCT00261443|50154476|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
25051091|NCT00261443|50154474|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
25051092|NCT00261443|50154475|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
25051093|NCT00261443|50154476|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
25051094|NCT00261443|50154474|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
25051095|NCT00261443|50154475|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
25051096|NCT00261443|50154476|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
25051097|NCT00261443|50154474|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
24960675|NCT00315458|50051193|FG000|Overall Study|Withdrawal by Subject|0|||
24960676|NCT00315458|50051194|FG001|Overall Study|Withdrawal by Subject|3|||
24960677|NCT00315458|50051195|FG002|Overall Study|Withdrawal by Subject|0|||
24960678|NCT00315458|50051196|FG003|Overall Study|Withdrawal by Subject|2|||
24960679|NCT00315458|50051193|FG000|Overall Study|Lack of Efficacy|0|||
24960680|NCT00315458|50051194|FG001|Overall Study|Lack of Efficacy|0|||
24960681|NCT00315458|50051195|FG002|Overall Study|Lack of Efficacy|20|||
24960682|NCT00315458|50051196|FG003|Overall Study|Lack of Efficacy|1|||
24960683|NCT00315458|50051193|FG000|Overall Study|Did not qualify|0|||
24960684|NCT00315458|50051194|FG001|Overall Study|Did not qualify|0|||
24960685|NCT00315458|50051195|FG002|Overall Study|Did not qualify|1|||
24960686|NCT00315458|50051196|FG003|Overall Study|Did not qualify|0|||
24960687|NCT00293384|50051206|FG000|Overall Study|Non-compliance|2|||
24960688|NCT00293384|50051206|FG000|Overall Study|Missed dosage/study drug|1|||
24960689|NCT00293384|50051206|FG000|Overall Study|Ineligible|2|||
24960690|NCT00297830|50051213|FG000|6 Month Visit|Death|1|||
25051098|NCT00261443|50154475|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
25051099|NCT00261443|50154476|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
25051100|NCT00261443|50154474|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
25051101|NCT00261443|50154475|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
25067418|NCT02397460|50173042|FG005|Treatment Period 4|Physician Decision|0|||
24960691|NCT00297830|50051214|FG001|6 Month Visit|Death|0|||
24960692|NCT00297830|50051215|FG002|6 Month Visit|Death|2|||
24960693|NCT00297830|50051213|FG000|6 Month Visit|Withdrawal by Subject|2|||
25051102|NCT00261443|50154476|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
25051103|NCT00261443|50154474|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
25051104|NCT00261443|50154475|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
25051105|NCT00261443|50154476|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
25051106|NCT00261443|50154474|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
25051107|NCT00261443|50154475|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
25051108|NCT00261443|50154476|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
25051109|NCT00261443|50154474|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
25051110|NCT00261443|50154475|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
25051111|NCT00261443|50154476|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
25051112|NCT00261443|50154474|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
25051113|NCT00261443|50154475|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
25051114|NCT00261443|50154476|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
25051115|NCT00261443|50154474|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
25051116|NCT00261443|50154475|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
25051117|NCT00261443|50154476|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
25051118|NCT00261443|50154474|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
25051119|NCT00261443|50154475|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
25051120|NCT00261443|50154476|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
25051121|NCT00261443|50154474|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
25051122|NCT00261443|50154475|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
25051123|NCT00261443|50154476|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
25051124|NCT00261443|50154474|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
25051125|NCT00261443|50154475|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
25051126|NCT00261443|50154476|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
25051127|NCT00261443|50154474|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
25051128|NCT00261443|50154475|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
25051129|NCT00261443|50154476|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
25051130|NCT00261443|50154474|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
25051131|NCT00261443|50154475|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
25051132|NCT00261443|50154476|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
25051133|NCT00261443|50154474|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
25051134|NCT00261443|50154475|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
25051135|NCT00261443|50154476|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
25051136|NCT00261443|50154474|FG000|3: Assessment of Relapse|Adverse Event|0|||
25051137|NCT00261443|50154475|FG001|3: Assessment of Relapse|Adverse Event|15|||
25051138|NCT00261443|50154476|FG002|3: Assessment of Relapse|Adverse Event|19|||
25051139|NCT00261443|50154474|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
25051140|NCT00261443|50154475|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
25051141|NCT00261443|50154476|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
25051142|NCT00261443|50154474|FG000|3: Assessment of Relapse|Death|0|||
25051143|NCT00261443|50154475|FG001|3: Assessment of Relapse|Death|0|||
25051144|NCT00261443|50154476|FG002|3: Assessment of Relapse|Death|1|||
25051145|NCT00261443|50154474|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
25051146|NCT00261443|50154475|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
25051147|NCT00261443|50154476|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
25051148|NCT00261443|50154474|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
25051149|NCT00261443|50154475|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
25051150|NCT00261443|50154476|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
25051151|NCT00261443|50154474|FG000|3: Assessment of Relapse|Pregnancy|0|||
25051152|NCT00261443|50154475|FG001|3: Assessment of Relapse|Pregnancy|2|||
25051153|NCT00261443|50154476|FG002|3: Assessment of Relapse|Pregnancy|1|||
25051154|NCT00261443|50154474|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
25051155|NCT00261443|50154475|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
25051156|NCT00261443|50154476|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
25051157|NCT00261443|50154474|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
25051158|NCT00261443|50154475|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
25051159|NCT00261443|50154476|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
25051160|NCT00261443|50154474|FG000|3: Assessment of Relapse|Other Reasons|0|||
25051161|NCT00261443|50154475|FG001|3: Assessment of Relapse|Other Reasons|4|||
25051162|NCT00261443|50154476|FG002|3: Assessment of Relapse|Other Reasons|3|||
25051163|NCT00261443|50154474|FG000|4: Extension Phase|Adverse Event|0|||
25051164|NCT00261443|50154475|FG001|4: Extension Phase|Adverse Event|1|||
25051165|NCT00261443|50154476|FG002|4: Extension Phase|Adverse Event|0|||
25051166|NCT00261443|50154474|FG000|4: Extension Phase|Withdrawal by Subject|0|||
25051167|NCT00261443|50154475|FG001|4: Extension Phase|Withdrawal by Subject|1|||
25186574|NCT01395017|50337140|FG000|Overall Study|Disease progression|42|||
25186575|NCT01395017|50337141|FG001|Overall Study|Disease progression|58|||
25051168|NCT00261443|50154476|FG002|4: Extension Phase|Withdrawal by Subject|2|||
25051169|NCT00261443|50154474|FG000|4: Extension Phase|Lost to Follow-up|0|||
25051170|NCT00261443|50154475|FG001|4: Extension Phase|Lost to Follow-up|1|||
25051171|NCT00261443|50154476|FG002|4: Extension Phase|Lost to Follow-up|0|||
25051172|NCT02593318|50154493|FG000|Overall Study|Withdrawal by Subject|1|||
25051173|NCT02593318|50154494|FG001|Overall Study|Withdrawal by Subject|1|||
25051174|NCT00304070|50154509|FG000|Overall Study|Death|0|||
25051175|NCT00304070|50154510|FG001|Overall Study|Death|0|||
25051176|NCT00304070|50154511|FG002|Overall Study|Death|3|||
25051177|NCT00304070|50154509|FG000|Overall Study|Lost to Follow-up|0|||
25051178|NCT00304070|50154510|FG001|Overall Study|Lost to Follow-up|0|||
25051179|NCT00304070|50154511|FG002|Overall Study|Lost to Follow-up|1|||
25051180|NCT00304070|50154509|FG000|Overall Study|Physician Decision|0|||
25051181|NCT00304070|50154510|FG001|Overall Study|Physician Decision|0|||
25051182|NCT00304070|50154511|FG002|Overall Study|Physician Decision|3|||
25051183|NCT00304070|50154509|FG000|Overall Study|Withdrawal by Subject|0|||
25051184|NCT00304070|50154510|FG001|Overall Study|Withdrawal by Subject|0|||
25051185|NCT00304070|50154511|FG002|Overall Study|Withdrawal by Subject|1|||
25051186|NCT00304070|50154509|FG000|Overall Study|Progressive Disease|3|||
25051187|NCT00304070|50154510|FG001|Overall Study|Progressive Disease|7|||
25051188|NCT00304070|50154511|FG002|Overall Study|Progressive Disease|4|||
25051189|NCT02343302|50154525|FG000|Overall Study|Physician Decision|1|||
25051190|NCT02343302|50154526|FG001|Overall Study|Physician Decision|1|||
25051191|NCT02590432|50154534|FG000|Open-label Treatment Period|Adverse Event|97|||
25051192|NCT02590432|50154535|FG001|Open-label Treatment Period|Adverse Event|79|||
24960694|NCT00297830|50051214|FG001|6 Month Visit|Withdrawal by Subject|1|||
24960695|NCT00297830|50051215|FG002|6 Month Visit|Withdrawal by Subject|1|||
24960696|NCT00297830|50051213|FG000|6 Month Visit|Adverse Event|0|||
24960697|NCT00297830|50051214|FG001|6 Month Visit|Adverse Event|1|||
24960698|NCT00297830|50051215|FG002|6 Month Visit|Adverse Event|0|||
24960699|NCT00297830|50051213|FG000|12 Month Visit|Lost to Follow-up|1|||
24960700|NCT00297830|50051214|FG001|12 Month Visit|Lost to Follow-up|0|||
24960701|NCT00297830|50051215|FG002|12 Month Visit|Lost to Follow-up|0|||
24960702|NCT00297830|50051213|FG000|12 Month Visit|Adverse Event|0|||
24960703|NCT00297830|50051214|FG001|12 Month Visit|Adverse Event|3|||
24960704|NCT00297830|50051215|FG002|12 Month Visit|Adverse Event|0|||
24960705|NCT00297830|50051213|FG000|12 Month Visit|Withdrawal by Subject|0|||
24960706|NCT00297830|50051214|FG001|12 Month Visit|Withdrawal by Subject|3|||
24960707|NCT00297830|50051215|FG002|12 Month Visit|Withdrawal by Subject|0|||
24960708|NCT00296816|50051225|FG000|Overall Study|Disease Progression|37|||
24960709|NCT00296816|50051225|FG000|Overall Study|Adverse Event|18|||
24960710|NCT00296816|50051225|FG000|Overall Study|Investigator/Participant request|5|||
24960711|NCT00296816|50051225|FG000|Overall Study|Non-compliance|1|||
24960712|NCT00296816|50051225|FG000|Overall Study|Missing for end of treatment|4|||
24960713|NCT00296816|50051225|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
24960714|NCT00296816|50051225|FG000|Overall Study|Poor performance status|1|||
24960715|NCT00296816|50051225|FG000|Overall Study|Relocation to Florida|1|||
24960716|NCT00296816|50051225|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
24960717|NCT00296816|50051225|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
24960718|NCT00296816|50051225|FG000|Overall Study|Neuropathy/patient preference|1|||
24960719|NCT00296816|50051225|FG000|Overall Study|Proteinuria|1|||
24960720|NCT00296816|50051225|FG000|Overall Study|ineligibility due to radiation treatment|1|||
24960721|NCT00314132|50051231|FG000|Overall Study|Lost to Follow-up|3|||
24960722|NCT00314132|50051232|FG001|Overall Study|Lost to Follow-up|13|||
24960723|NCT00314132|50051231|FG000|Overall Study|Withdrawal by Subject|3|||
24960724|NCT00314132|50051232|FG001|Overall Study|Withdrawal by Subject|5|||
24960725|NCT00314132|50051231|FG000|Overall Study|Adverse Event|1|||
24960726|NCT00314132|50051232|FG001|Overall Study|Adverse Event|0|||
24960727|NCT00314132|50051231|FG000|Overall Study|Physician Decision|1|||
24960728|NCT00314132|50051232|FG001|Overall Study|Physician Decision|0|||
24960729|NCT00097786|50051244|FG000|Overall Study|lost to follow-up for all-cause death|296|||
24960730|NCT00097786|50051245|FG001|Overall Study|lost to follow-up for all-cause death|292|||
24960731|NCT00097786|50051246|FG002|Overall Study|lost to follow-up for all-cause death|313|||
24960732|NCT00097786|50051247|FG003|Overall Study|lost to follow-up for all-cause death|310|||
24960733|NCT00117988|50051257|FG000|Overall Study|Death|3|||
24960734|NCT00117988|50051257|FG000|Overall Study|Adverse Event|1|||
24960735|NCT00117676|50051263|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
24960736|NCT00117676|50051264|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
24960737|NCT00117676|50051263|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
24960738|NCT00117676|50051264|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
24960739|NCT00117676|50051263|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
24960740|NCT00117676|50051264|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
24960741|NCT00117676|50051263|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
24960742|NCT00117676|50051264|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
24960743|NCT00117676|50051263|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
25051193|NCT02590432|50154536|FG002|Open-label Treatment Period|Adverse Event|0|||
25051194|NCT02590432|50154537|FG003|Open-label Treatment Period|Adverse Event|0|||
25051195|NCT02590432|50154538|FG004|Open-label Treatment Period|Adverse Event|0|||
25051196|NCT02590432|50154539|FG005|Open-label Treatment Period|Adverse Event|0|||
25051197|NCT02590432|50154540|FG006|Open-label Treatment Period|Adverse Event|0|||
25051198|NCT02590432|50154541|FG007|Open-label Treatment Period|Adverse Event|0|||
25051199|NCT02590432|50154542|FG008|Open-label Treatment Period|Adverse Event|0|||
25051200|NCT02590432|50154534|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
25051201|NCT02590432|50154535|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
25051202|NCT02590432|50154536|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
25051203|NCT02590432|50154537|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
25051204|NCT02590432|50154538|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
25051205|NCT02590432|50154539|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
25051206|NCT02590432|50154540|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
25051207|NCT02590432|50154541|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
25051208|NCT02590432|50154542|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
25051209|NCT02590432|50154534|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
25051210|NCT02590432|50154535|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
25051211|NCT02590432|50154536|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
24960744|NCT00117676|50051264|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
24960745|NCT00117676|50051263|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
24960746|NCT00117676|50051264|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
24960747|NCT00117676|50051263|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
24960748|NCT00117676|50051264|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
25051212|NCT02590432|50154537|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
25051213|NCT02590432|50154538|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
25051214|NCT02590432|50154539|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
25051215|NCT02590432|50154540|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
25051216|NCT02590432|50154541|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
25051217|NCT02590432|50154542|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
25051218|NCT02590432|50154534|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
25051219|NCT02590432|50154535|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
25051220|NCT02590432|50154536|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
25051221|NCT02590432|50154537|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
25051222|NCT02590432|50154538|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
25051223|NCT02590432|50154539|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
25051224|NCT02590432|50154540|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
25051225|NCT02590432|50154541|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
25051226|NCT02590432|50154542|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
25051227|NCT02590432|50154534|FG000|Open-label Treatment Period|Protocol Violation|10|||
25051228|NCT02590432|50154535|FG001|Open-label Treatment Period|Protocol Violation|4|||
25051229|NCT02590432|50154536|FG002|Open-label Treatment Period|Protocol Violation|0|||
25051230|NCT02590432|50154537|FG003|Open-label Treatment Period|Protocol Violation|0|||
25051231|NCT02590432|50154538|FG004|Open-label Treatment Period|Protocol Violation|0|||
25051232|NCT02590432|50154539|FG005|Open-label Treatment Period|Protocol Violation|0|||
25051233|NCT02590432|50154540|FG006|Open-label Treatment Period|Protocol Violation|0|||
25051234|NCT02590432|50154541|FG007|Open-label Treatment Period|Protocol Violation|0|||
25051235|NCT02590432|50154542|FG008|Open-label Treatment Period|Protocol Violation|0|||
25051236|NCT02590432|50154534|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
25051237|NCT02590432|50154535|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
25051238|NCT02590432|50154536|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
25051239|NCT02590432|50154537|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
25051240|NCT02590432|50154538|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
25051241|NCT02590432|50154539|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
25051242|NCT02590432|50154540|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
25051243|NCT02590432|50154541|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
25051244|NCT02590432|50154542|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
25051245|NCT02590432|50154534|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
25051246|NCT02590432|50154535|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
25051247|NCT02590432|50154536|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
25051248|NCT02590432|50154537|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
25276520|NCT00887341|50590442|FG001|Overall Study|Adverse Event|1|||
24960749|NCT00117676|50051263|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
24960750|NCT00117676|50051264|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
24960751|NCT00117676|50051263|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
24960752|NCT00117676|50051264|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
24960753|NCT00117676|50051263|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
24960754|NCT00117676|50051264|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
25051249|NCT02590432|50154538|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
25051250|NCT02590432|50154539|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
25051251|NCT02590432|50154540|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
25051252|NCT02590432|50154541|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
25051253|NCT02590432|50154542|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
25051254|NCT02590432|50154534|FG000|Double-blind Treatment Period|Adverse Event|0|||
25051255|NCT02590432|50154535|FG001|Double-blind Treatment Period|Adverse Event|0|||
25051256|NCT02590432|50154536|FG002|Double-blind Treatment Period|Adverse Event|14|||
25051257|NCT02590432|50154537|FG003|Double-blind Treatment Period|Adverse Event|12|||
25051258|NCT02590432|50154538|FG004|Double-blind Treatment Period|Adverse Event|6|||
25051259|NCT02590432|50154539|FG005|Double-blind Treatment Period|Adverse Event|22|||
25051260|NCT02590432|50154540|FG006|Double-blind Treatment Period|Adverse Event|20|||
25051261|NCT02590432|50154541|FG007|Double-blind Treatment Period|Adverse Event|0|||
25051262|NCT02590432|50154542|FG008|Double-blind Treatment Period|Adverse Event|0|||
25051263|NCT02590432|50154534|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
25051264|NCT02590432|50154535|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
25051265|NCT02590432|50154536|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
25051266|NCT02590432|50154537|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
25051267|NCT02590432|50154538|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
25051268|NCT02590432|50154539|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
25051269|NCT02590432|50154540|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
25051270|NCT02590432|50154541|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
25051271|NCT02590432|50154542|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
25051272|NCT02590432|50154534|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
25051273|NCT02590432|50154535|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
25051274|NCT02590432|50154536|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
25051275|NCT02590432|50154537|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
25051276|NCT02590432|50154538|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
25051277|NCT02590432|50154539|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
25051278|NCT02590432|50154540|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
25051279|NCT02590432|50154541|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
25051280|NCT02590432|50154542|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
25051281|NCT02590432|50154534|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
25051282|NCT02590432|50154535|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
25051283|NCT02590432|50154536|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
25051284|NCT02590432|50154537|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
25051285|NCT02590432|50154538|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
25051286|NCT02590432|50154539|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
25051287|NCT02590432|50154540|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
25051288|NCT02590432|50154541|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
25051289|NCT02590432|50154542|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
25051290|NCT02590432|50154534|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
25051291|NCT02590432|50154535|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
25051292|NCT02590432|50154536|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
25051293|NCT02590432|50154537|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
25051294|NCT02590432|50154538|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
25051295|NCT02590432|50154539|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
25051296|NCT02590432|50154540|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
25051297|NCT02590432|50154541|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
25051298|NCT02590432|50154542|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
25051299|NCT02590432|50154534|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
25051300|NCT02590432|50154535|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
25051301|NCT02590432|50154536|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
25051302|NCT02590432|50154537|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
25051303|NCT02590432|50154538|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
25051304|NCT02590432|50154539|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
25051305|NCT02590432|50154540|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
25051306|NCT02590432|50154541|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
25162597|NCT01998581|50284781|FG001|Overall Study|Randomized but withdrew before treatment|0|||
25162598|NCT01983293|50284790|FG000|Overall Study|Withdrawal by Subject|29|||
24960755|NCT00117676|50051263|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
25051307|NCT02590432|50154542|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
25051308|NCT02590432|50154534|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
25051309|NCT02590432|50154535|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
25162599|NCT01983293|50284791|FG001|Overall Study|Withdrawal by Subject|15|||
25162600|NCT01983293|50284790|FG000|Overall Study|Missing 12-month visit|3|||
24960756|NCT00117676|50051264|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
25051310|NCT02590432|50154536|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
25051311|NCT02590432|50154537|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
25051312|NCT02590432|50154538|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
25051313|NCT02590432|50154539|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
25051314|NCT02590432|50154540|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
25051315|NCT02590432|50154541|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
25051316|NCT02590432|50154542|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
25051317|NCT02590432|50154534|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
25051318|NCT02590432|50154535|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
25051319|NCT02590432|50154536|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
25051320|NCT02590432|50154537|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
25051321|NCT02590432|50154538|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
25051322|NCT02590432|50154539|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
25051323|NCT02590432|50154540|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
25051324|NCT02590432|50154541|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
25051325|NCT02590432|50154542|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
25051326|NCT02590432|50154534|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
25051327|NCT02590432|50154535|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
25051328|NCT02590432|50154536|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
24960757|NCT00117676|50051263|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
24960758|NCT00117676|50051264|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
24960759|NCT00117676|50051263|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
24960760|NCT00117676|50051264|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
24960761|NCT00117676|50051263|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
24960762|NCT00117676|50051264|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
24960763|NCT00117676|50051263|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
24960764|NCT00117676|50051264|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
24960765|NCT00117676|50051263|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
24960766|NCT00117676|50051264|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
24960767|NCT00117676|50051263|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
24960768|NCT00117676|50051264|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
24960769|NCT00117676|50051263|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
24960770|NCT00117676|50051264|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
24960771|NCT00117676|50051263|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
24960772|NCT00117676|50051264|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
24960773|NCT00117676|50051263|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
24960774|NCT00117676|50051264|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
24960775|NCT00117676|50051263|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
24960776|NCT00117676|50051264|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
24960777|NCT00117676|50051263|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
24960778|NCT00117676|50051264|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
24960779|NCT00117676|50051263|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
24960780|NCT00117676|50051264|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
24960781|NCT00117676|50051263|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
24960782|NCT00117676|50051264|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
24960783|NCT00117676|50051263|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
24960784|NCT00117676|50051264|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
24960785|NCT00117676|50051263|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
24960786|NCT00117676|50051264|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
24960787|NCT00117676|50051263|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
24960788|NCT00117676|50051264|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
24960789|NCT00117676|50051263|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
24960790|NCT00117676|50051264|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
24960791|NCT00117676|50051263|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
24960792|NCT00117676|50051264|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
24960793|NCT00117676|50051263|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
24960794|NCT00117676|50051264|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
24960795|NCT00117676|50051263|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
24960796|NCT00117676|50051264|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
25276521|NCT00887341|50590441|FG000|Overall Study|Lost to Follow-up|0|||
24960797|NCT00117676|50051263|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
24960798|NCT00117676|50051264|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
24960799|NCT00117676|50051263|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
24960800|NCT00117676|50051264|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
24960801|NCT00117676|50051263|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
24960802|NCT00117676|50051264|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
24960803|NCT00117676|50051263|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
24960804|NCT00117676|50051264|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
24960805|NCT00251004|50051278|FG000|Overall Study|Withdrawal by Subject|23|||
24960806|NCT00251004|50051279|FG001|Overall Study|Withdrawal by Subject|16|||
24960807|NCT00251004|50051280|FG002|Overall Study|Withdrawal by Subject|14|||
24960808|NCT00251004|50051278|FG000|Overall Study|Death|9|||
24960809|NCT00251004|50051279|FG001|Overall Study|Death|10|||
24960810|NCT00251004|50051280|FG002|Overall Study|Death|8|||
24960811|NCT00251004|50051278|FG000|Overall Study|Lost to Follow-up|1|||
24960812|NCT00251004|50051279|FG001|Overall Study|Lost to Follow-up|2|||
24960813|NCT00251004|50051280|FG002|Overall Study|Lost to Follow-up|1|||
24960814|NCT00251004|50051278|FG000|Overall Study|Graft Loss|12|||
24960815|NCT00251004|50051279|FG001|Overall Study|Graft Loss|13|||
24960816|NCT00251004|50051280|FG002|Overall Study|Graft Loss|8|||
25051329|NCT02590432|50154537|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
25051330|NCT02590432|50154538|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
25051331|NCT02590432|50154539|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
25051332|NCT02590432|50154540|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
25051333|NCT02590432|50154541|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
25051334|NCT02590432|50154542|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
25051335|NCT02590432|50154534|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
25051336|NCT02590432|50154535|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
25051337|NCT02590432|50154536|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
25051338|NCT02590432|50154537|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
25051339|NCT02590432|50154538|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
25051340|NCT02590432|50154539|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
25051341|NCT02590432|50154540|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
25051342|NCT02590432|50154541|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
25051343|NCT02590432|50154542|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
25051344|NCT02590432|50154534|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
25051345|NCT02590432|50154535|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
25051346|NCT02590432|50154536|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
25051347|NCT02590432|50154537|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
25051348|NCT02590432|50154538|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
25051349|NCT02590432|50154539|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
25051350|NCT02590432|50154540|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
25051351|NCT02590432|50154541|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
25051352|NCT02590432|50154542|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
25051353|NCT02590432|50154534|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
25051354|NCT02590432|50154535|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
25051355|NCT02590432|50154536|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
25051356|NCT02590432|50154537|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
25051357|NCT02590432|50154538|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
25051358|NCT02590432|50154539|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
25051359|NCT02590432|50154540|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
25051360|NCT02590432|50154541|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
25051361|NCT02590432|50154542|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
25051362|NCT02590354|50154554|FG000|Phase 1|Active hepatitis B or C infection|1|||
25051363|NCT02590354|50154554|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
25051364|NCT02590354|50154554|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
25051365|NCT02590354|50154554|FG000|Phase 1|Subject does not want to participate|20|||
25051366|NCT02590354|50154554|FG000|Phase 1|Lost to Follow-up|1|||
25051367|NCT02590354|50154554|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
25051368|NCT01667224|50154561|FG000|Overall Study|Withdrawal by Subject|3|||
25051369|NCT01667224|50154562|FG001|Overall Study|Withdrawal by Subject|1|||
25051370|NCT01667224|50154561|FG000|Overall Study|Protocol Violation|1|||
25051371|NCT01667224|50154562|FG001|Overall Study|Protocol Violation|1|||
24960817|NCT00275340|50051290|FG000|Overall Study|Lost to Follow-up|2|||
24960818|NCT00275340|50051291|FG001|Overall Study|Lost to Follow-up|4|||
24960819|NCT00275262|50051297|FG000|Overall Study|Adverse Event|2|||
24960820|NCT00275262|50051298|FG001|Overall Study|Adverse Event|0|||
24960821|NCT00275262|50051297|FG000|Overall Study|Disease progression|2|||
24960822|NCT00275262|50051298|FG001|Overall Study|Disease progression|5|||
24960823|NCT00275262|50051297|FG000|Overall Study|Lost to Follow-up|0|||
25051372|NCT03923738|50154570|FG000|Period 1|Adverse Event|1|||
25051373|NCT03923738|50154570|FG000|Period 1|Withdrawal by Subject|1|||
25051374|NCT02588248|50154578|FG000|Overall Study|Physician Decision|4|||
25051375|NCT02588248|50154579|FG001|Overall Study|Physician Decision|3|||
25051376|NCT01328054|50154590|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
25051377|NCT01328054|50154591|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
25051378|NCT01328054|50154590|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
25051379|NCT01328054|50154591|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
25051380|NCT01328054|50154590|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
25051381|NCT01328054|50154591|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
25051382|NCT01849250|50154614|FG000|Overall Study|Withdrawal by Subject|1|||
25051383|NCT01849250|50154615|FG001|Overall Study|Withdrawal by Subject|0|||
24960824|NCT00275262|50051298|FG001|Overall Study|Lost to Follow-up|2|||
24960825|NCT00275262|50051297|FG000|Overall Study|Protocol Violation|0|||
24960826|NCT00275262|50051298|FG001|Overall Study|Protocol Violation|2|||
24960827|NCT00275262|50051297|FG000|Overall Study|Death|1|||
24960828|NCT00275262|50051298|FG001|Overall Study|Death|0|||
24960829|NCT00275262|50051297|FG000|Overall Study|Started Chemotherapy|1|||
24960830|NCT00275262|50051298|FG001|Overall Study|Started Chemotherapy|0|||
24960831|NCT00275028|50051304|FG000|Overall Study|Withdrew consent before treatment began|1|||
24960832|NCT00275028|50051304|FG000|Overall Study|Withdrawal by Subject|5|||
24960833|NCT00275028|50051304|FG000|Overall Study|Adverse Event|9|||
24960834|NCT00275028|50051304|FG000|Overall Study|Progressive Disease|30|||
24960835|NCT00275028|50051304|FG000|Overall Study|Physician Decision|2|||
24960836|NCT00471497|50051311|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
24960837|NCT00471497|50051312|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
24960838|NCT00471497|50051313|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
24960839|NCT00471497|50051311|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
24960840|NCT00471497|50051312|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
24960841|NCT00471497|50051313|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
24960842|NCT00471497|50051311|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
24960843|NCT00471497|50051312|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
24960844|NCT00471497|50051313|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
24960845|NCT00471497|50051311|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
24960846|NCT00471497|50051312|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
25051384|NCT01849250|50154614|FG000|Overall Study|Not Evaluable|5|||
25051385|NCT01849250|50154615|FG001|Overall Study|Not Evaluable|3|||
25051386|NCT01849250|50154614|FG000|Overall Study|Screen Failure|1|||
25051387|NCT01849250|50154615|FG001|Overall Study|Screen Failure|0|||
25051388|NCT02791191|50154625|FG000|Overall Study|Adverse Event|2|||
25051389|NCT02791191|50154626|FG001|Overall Study|Adverse Event|4|||
25051390|NCT02791191|50154627|FG002|Overall Study|Adverse Event|5|||
25051391|NCT02791191|50154625|FG000|Overall Study|Lack of Efficacy|0|||
25051392|NCT02791191|50154626|FG001|Overall Study|Lack of Efficacy|1|||
25051393|NCT02791191|50154627|FG002|Overall Study|Lack of Efficacy|0|||
25051394|NCT02791191|50154625|FG000|Overall Study|Study Drug Non-Compliance|0|||
25051395|NCT02791191|50154626|FG001|Overall Study|Study Drug Non-Compliance|2|||
25051396|NCT02791191|50154627|FG002|Overall Study|Study Drug Non-Compliance|0|||
25051397|NCT02791191|50154625|FG000|Overall Study|Site Closed by Sponsor|1|||
25051398|NCT02791191|50154626|FG001|Overall Study|Site Closed by Sponsor|1|||
25051399|NCT02791191|50154627|FG002|Overall Study|Site Closed by Sponsor|3|||
25051400|NCT02791191|50154625|FG000|Overall Study|Progressive Disease|1|||
25051401|NCT02791191|50154626|FG001|Overall Study|Progressive Disease|0|||
25051402|NCT02791191|50154627|FG002|Overall Study|Progressive Disease|0|||
25051403|NCT02791191|50154625|FG000|Overall Study|Study Terminated by Sponsor|29|||
25051404|NCT02791191|50154626|FG001|Overall Study|Study Terminated by Sponsor|101|||
25051405|NCT02791191|50154627|FG002|Overall Study|Study Terminated by Sponsor|109|||
25051406|NCT02791191|50154625|FG000|Overall Study|Withdrawal by Subject|3|||
25051407|NCT02791191|50154626|FG001|Overall Study|Withdrawal by Subject|1|||
25051408|NCT02791191|50154627|FG002|Overall Study|Withdrawal by Subject|3|||
25162601|NCT01983293|50284791|FG001|Overall Study|Missing 12-month visit|3|||
25051409|NCT02791191|50154625|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
25162602|NCT01983293|50284790|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
24960847|NCT00471497|50051313|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
24960848|NCT00471497|50051311|FG000|Core Treatment Phase|Lost to Follow-up|6|||
24960849|NCT00471497|50051312|FG001|Core Treatment Phase|Lost to Follow-up|6|||
24960850|NCT00471497|50051313|FG002|Core Treatment Phase|Lost to Follow-up|3|||
24960851|NCT00471497|50051311|FG000|Core Treatment Phase|Death|3|||
24960852|NCT00471497|50051312|FG001|Core Treatment Phase|Death|9|||
24960853|NCT00471497|50051313|FG002|Core Treatment Phase|Death|3|||
24960854|NCT00471497|50051311|FG000|Core Treatment Phase|Disease Progression|10|||
24960855|NCT00471497|50051312|FG001|Core Treatment Phase|Disease Progression|2|||
24960856|NCT00471497|50051313|FG002|Core Treatment Phase|Disease Progression|4|||
25051410|NCT02791191|50154626|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
25276522|NCT00887341|50590442|FG001|Overall Study|Lost to Follow-up|1|||
25051411|NCT02791191|50154627|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
25051412|NCT02114697|50154650|FG000|Overall Study|Study terminated|5|||
25051413|NCT02114697|50154651|FG001|Overall Study|Study terminated|4|||
25051414|NCT01330017|50154662|FG000|Overall Study|Adverse Event|0|||
25051415|NCT01330017|50154663|FG001|Overall Study|Adverse Event|1|||
25051416|NCT01330017|50154664|FG002|Overall Study|Adverse Event|1|||
25051417|NCT01330017|50154665|FG003|Overall Study|Adverse Event|4|||
25051418|NCT01330017|50154666|FG004|Overall Study|Adverse Event|0|||
25051419|NCT01330017|50154662|FG000|Overall Study|Withdrawal by Subject|0|||
25051420|NCT01330017|50154663|FG001|Overall Study|Withdrawal by Subject|0|||
25051421|NCT01330017|50154664|FG002|Overall Study|Withdrawal by Subject|1|||
25051422|NCT01330017|50154665|FG003|Overall Study|Withdrawal by Subject|0|||
25051423|NCT01330017|50154666|FG004|Overall Study|Withdrawal by Subject|1|||
25051424|NCT01330017|50154662|FG000|Overall Study|Lost to Follow-up|0|||
25051425|NCT01330017|50154663|FG001|Overall Study|Lost to Follow-up|0|||
25051426|NCT01330017|50154664|FG002|Overall Study|Lost to Follow-up|1|||
25051427|NCT01330017|50154665|FG003|Overall Study|Lost to Follow-up|0|||
25051428|NCT01330017|50154666|FG004|Overall Study|Lost to Follow-up|0|||
25051429|NCT01330017|50154662|FG000|Overall Study|Protocol Violation|0|||
25051430|NCT01330017|50154663|FG001|Overall Study|Protocol Violation|0|||
25051431|NCT01330017|50154664|FG002|Overall Study|Protocol Violation|0|||
25051432|NCT01330017|50154665|FG003|Overall Study|Protocol Violation|1|||
25051433|NCT01330017|50154666|FG004|Overall Study|Protocol Violation|0|||
25051434|NCT01330017|50154662|FG000|Overall Study|Unknown Reason|5|||
25051435|NCT01330017|50154663|FG001|Overall Study|Unknown Reason|3|||
25051436|NCT01330017|50154664|FG002|Overall Study|Unknown Reason|5|||
25051437|NCT01330017|50154665|FG003|Overall Study|Unknown Reason|7|||
25051438|NCT01330017|50154666|FG004|Overall Study|Unknown Reason|2|||
25051439|NCT00150462|50154689|FG000|Overall Study|Disease Progression or Relapse|3|||
25051440|NCT00150462|50154690|FG001|Overall Study|Disease Progression or Relapse|1|||
25051441|NCT00150462|50154691|FG002|Overall Study|Disease Progression or Relapse|2|||
25051442|NCT00150462|50154692|FG003|Overall Study|Disease Progression or Relapse|1|||
25051443|NCT00150462|50154693|FG004|Overall Study|Disease Progression or Relapse|2|||
25051444|NCT00150462|50154694|FG005|Overall Study|Disease Progression or Relapse|2|||
25051445|NCT00150462|50154695|FG006|Overall Study|Disease Progression or Relapse|3|||
25051446|NCT00150462|50154696|FG007|Overall Study|Disease Progression or Relapse|5|||
24960857|NCT00471497|50051311|FG000|Core Treatment Phase|Protocol Violation|6|||
24960858|NCT00471497|50051312|FG001|Core Treatment Phase|Protocol Violation|15|||
24960859|NCT00471497|50051313|FG002|Core Treatment Phase|Protocol Violation|11|||
24960860|NCT00471497|50051311|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
24960861|NCT00471497|50051312|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
24960862|NCT00471497|50051313|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
24960863|NCT00471497|50051311|FG000|Core Treatment Phase|Administrative problems|14|||
24960864|NCT00471497|50051312|FG001|Core Treatment Phase|Administrative problems|14|||
24960865|NCT00471497|50051313|FG002|Core Treatment Phase|Administrative problems|12|||
24960866|NCT00471497|50051311|FG000|Core Treatment Phase|Adverse Event|43|||
24960867|NCT00471497|50051312|FG001|Core Treatment Phase|Adverse Event|53|||
24960868|NCT00471497|50051313|FG002|Core Treatment Phase|Adverse Event|89|||
24960869|NCT00471497|50051311|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
24960870|NCT00471497|50051312|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
24960871|NCT00471497|50051313|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
24960872|NCT00471497|50051311|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
24960873|NCT00471497|50051312|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
24960874|NCT00471497|50051313|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
24960875|NCT00471497|50051311|FG000|Extension Phase|Adverse Event|9|||
24960876|NCT00471497|50051312|FG001|Extension Phase|Adverse Event|5|||
24960877|NCT00471497|50051313|FG002|Extension Phase|Adverse Event|1|||
24960878|NCT00471497|50051311|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
24960879|NCT00471497|50051312|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
24960880|NCT00471497|50051313|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
24960881|NCT00471497|50051311|FG000|Extension Phase|Withdrawal by Subject|3|||
24960882|NCT00471497|50051312|FG001|Extension Phase|Withdrawal by Subject|1|||
24960883|NCT00471497|50051313|FG002|Extension Phase|Withdrawal by Subject|0|||
25051447|NCT00150462|50154697|FG008|Overall Study|Disease Progression or Relapse|5|||
25051448|NCT00150462|50154698|FG009|Overall Study|Disease Progression or Relapse|3|||
25051449|NCT00150462|50154699|FG010|Overall Study|Disease Progression or Relapse|2|||
25051450|NCT00150462|50154689|FG000|Overall Study|Withdrawal by Subject|0|||
25051451|NCT00150462|50154690|FG001|Overall Study|Withdrawal by Subject|1|||
25051452|NCT00150462|50154691|FG002|Overall Study|Withdrawal by Subject|1|||
25051453|NCT00150462|50154692|FG003|Overall Study|Withdrawal by Subject|0|||
24960884|NCT00471497|50051311|FG000|Extension Phase|Lost to Follow-up|2|||
25051454|NCT00150462|50154693|FG004|Overall Study|Withdrawal by Subject|1|||
25051455|NCT00150462|50154694|FG005|Overall Study|Withdrawal by Subject|2|||
25051456|NCT00150462|50154695|FG006|Overall Study|Withdrawal by Subject|0|||
24960885|NCT00471497|50051312|FG001|Extension Phase|Lost to Follow-up|0|||
24960886|NCT00471497|50051313|FG002|Extension Phase|Lost to Follow-up|0|||
24960887|NCT00471497|50051311|FG000|Extension Phase|Death|1|||
24960888|NCT00471497|50051312|FG001|Extension Phase|Death|0|||
24960889|NCT00471497|50051313|FG002|Extension Phase|Death|0|||
24960890|NCT00471497|50051311|FG000|Extension Phase|Disease progression|2|||
24960891|NCT00471497|50051312|FG001|Extension Phase|Disease progression|0|||
24960892|NCT00471497|50051313|FG002|Extension Phase|Disease progression|0|||
24960893|NCT00471497|50051311|FG000|Extension Phase|Protocol Violation|2|||
24960894|NCT00471497|50051312|FG001|Extension Phase|Protocol Violation|2|||
24960895|NCT00471497|50051313|FG002|Extension Phase|Protocol Violation|0|||
24960896|NCT00493649|50051324|FG000|Overall Study|Adverse Event|44|||
24960897|NCT00493649|50051324|FG000|Overall Study|Patient Request|21|||
24960898|NCT00493649|50051324|FG000|Overall Study|Investigator Request|2|||
24960899|NCT00493649|50051324|FG000|Overall Study|Disease Progression|1|||
24960900|NCT00493649|50051324|FG000|Overall Study|Lost to Follow-up|1|||
24960901|NCT00493649|50051324|FG000|Overall Study|Other|13|||
24960902|NCT00471107|50051334|FG000|Overall Study|Technical problems/data loss|3|||
24960903|NCT00471107|50051335|FG001|Overall Study|Technical problems/data loss|1|||
24960904|NCT00471107|50051336|FG002|Overall Study|Technical problems/data loss|3|||
24960905|NCT00488033|50051346|FG000|Overall Study|Withdrawal by Subject|1|||
24960906|NCT00488033|50051347|FG001|Overall Study|Withdrawal by Subject|0|||
24960907|NCT00117598|50051356|FG000|Prior to Treatment Cross Over|Death|40|||
25051457|NCT00150462|50154696|FG007|Overall Study|Withdrawal by Subject|1|||
25051458|NCT00150462|50154697|FG008|Overall Study|Withdrawal by Subject|0|||
25051459|NCT00150462|50154698|FG009|Overall Study|Withdrawal by Subject|1|||
25051460|NCT00150462|50154699|FG010|Overall Study|Withdrawal by Subject|0|||
25051461|NCT00150462|50154689|FG000|Overall Study|Death|0|||
25051462|NCT00150462|50154690|FG001|Overall Study|Death|1|||
25051463|NCT00150462|50154691|FG002|Overall Study|Death|0|||
25051464|NCT00150462|50154692|FG003|Overall Study|Death|0|||
24960908|NCT00117598|50051357|FG001|Prior to Treatment Cross Over|Death|41|||
24960909|NCT00117598|50051358|FG002|Prior to Treatment Cross Over|Death|37|||
24960910|NCT00117598|50051359|FG003|Prior to Treatment Cross Over|Death|0|||
24960911|NCT00117598|50051360|FG004|Prior to Treatment Cross Over|Death|0|||
24960912|NCT00117598|50051356|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
24960913|NCT00117598|50051357|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
24960914|NCT00117598|50051358|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
24960915|NCT00117598|50051359|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
24960916|NCT00117598|50051360|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
24960917|NCT00117598|50051356|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
24960918|NCT00117598|50051357|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
24960919|NCT00117598|50051358|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
24960920|NCT00117598|50051359|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
25051465|NCT00150462|50154693|FG004|Overall Study|Death|0|||
25051466|NCT00150462|50154694|FG005|Overall Study|Death|0|||
25051467|NCT00150462|50154695|FG006|Overall Study|Death|0|||
25051468|NCT00150462|50154696|FG007|Overall Study|Death|0|||
25162603|NCT01983293|50284791|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
25162604|NCT01791205|50284799|FG000|Phase II|Lack of Efficacy|6|||
25162605|NCT01791205|50284800|FG001|Phase II|Lack of Efficacy|0|||
25162606|NCT01791205|50284799|FG000|Phase II|Adverse Event|2|||
25162607|NCT01791205|50284800|FG001|Phase II|Adverse Event|0|||
25162608|NCT01791205|50284799|FG000|Phase II|Safety|1|||
25162609|NCT01791205|50284800|FG001|Phase II|Safety|0|||
25162610|NCT01791205|50284799|FG000|Phase II|Lost to Follow-up|1|||
24960921|NCT00117598|50051360|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
24960922|NCT00117598|50051356|FG000|Prior to Treatment Cross Over|Other|15|||
24960923|NCT00117598|50051357|FG001|Prior to Treatment Cross Over|Other|9|||
24960924|NCT00117598|50051358|FG002|Prior to Treatment Cross Over|Other|9|||
24960925|NCT00117598|50051359|FG003|Prior to Treatment Cross Over|Other|0|||
24960926|NCT00117598|50051360|FG004|Prior to Treatment Cross Over|Other|0|||
24960927|NCT00117598|50051356|FG000|After Treament Cross Over|Death|0|||
24960928|NCT00117598|50051357|FG001|After Treament Cross Over|Death|0|||
24960929|NCT00117598|50051358|FG002|After Treament Cross Over|Death|0|||
24960930|NCT00117598|50051359|FG003|After Treament Cross Over|Death|1|||
24960931|NCT00117598|50051360|FG004|After Treament Cross Over|Death|2|||
24960932|NCT00117598|50051356|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
24960933|NCT00117598|50051357|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
24960934|NCT00117598|50051358|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
24960935|NCT00117598|50051359|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
24960936|NCT00117598|50051360|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
24960937|NCT00117598|50051356|FG000|After Treament Cross Over|Other|0|||
24960938|NCT00117598|50051357|FG001|After Treament Cross Over|Other|0|||
24960939|NCT00117598|50051358|FG002|After Treament Cross Over|Other|0|||
24960940|NCT00117598|50051359|FG003|After Treament Cross Over|Other|1|||
24960941|NCT00117598|50051360|FG004|After Treament Cross Over|Other|2|||
24960942|NCT00469859|50051372|FG000|Overall Study|Inevaluable|0|||
24960943|NCT00469859|50051373|FG001|Overall Study|Inevaluable|2|||
24960944|NCT00093808|50051379|FG000|Overall Study|Cancel participation before receiving tx|1|||
24960945|NCT00093808|50051379|FG000|Overall Study|Protocol Violation|1|||
24960946|NCT00469079|50051386|FG000|Overall Study|Lack of Efficacy|3|||
24960947|NCT00469079|50051387|FG001|Overall Study|Lack of Efficacy|8|||
24960948|NCT00469079|50051388|FG002|Overall Study|Lack of Efficacy|5|||
25051469|NCT00150462|50154697|FG008|Overall Study|Death|1|||
25051470|NCT00150462|50154698|FG009|Overall Study|Death|0|||
25051471|NCT00150462|50154699|FG010|Overall Study|Death|0|||
25051472|NCT00150462|50154689|FG000|Overall Study|Adverse Event|0|||
25051473|NCT00150462|50154690|FG001|Overall Study|Adverse Event|0|||
25051474|NCT00150462|50154691|FG002|Overall Study|Adverse Event|0|||
25051475|NCT00150462|50154692|FG003|Overall Study|Adverse Event|1|||
25051476|NCT00150462|50154693|FG004|Overall Study|Adverse Event|0|||
25051477|NCT00150462|50154694|FG005|Overall Study|Adverse Event|0|||
25051478|NCT00150462|50154695|FG006|Overall Study|Adverse Event|0|||
25051479|NCT00150462|50154696|FG007|Overall Study|Adverse Event|2|||
24960949|NCT00469079|50051386|FG000|Overall Study|Adverse Event|1|||
24960950|NCT00469079|50051387|FG001|Overall Study|Adverse Event|3|||
24960951|NCT00469079|50051388|FG002|Overall Study|Adverse Event|2|||
24960952|NCT00469079|50051386|FG000|Overall Study|Lost to Follow-up|4|||
25051480|NCT00150462|50154697|FG008|Overall Study|Adverse Event|0|||
25051481|NCT00150462|50154698|FG009|Overall Study|Adverse Event|1|||
25051482|NCT00150462|50154699|FG010|Overall Study|Adverse Event|0|||
25051483|NCT00150462|50154689|FG000|Overall Study|Physician Decision|0|||
25051484|NCT00150462|50154690|FG001|Overall Study|Physician Decision|0|||
25051485|NCT00150462|50154691|FG002|Overall Study|Physician Decision|1|||
25051486|NCT00150462|50154692|FG003|Overall Study|Physician Decision|1|||
25051487|NCT00150462|50154693|FG004|Overall Study|Physician Decision|0|||
25051488|NCT00150462|50154694|FG005|Overall Study|Physician Decision|0|||
25051489|NCT00150462|50154695|FG006|Overall Study|Physician Decision|0|||
25051490|NCT00150462|50154696|FG007|Overall Study|Physician Decision|0|||
25051491|NCT00150462|50154697|FG008|Overall Study|Physician Decision|0|||
25162611|NCT01791205|50284800|FG001|Phase II|Lost to Follow-up|0|||
25162612|NCT01791205|50284799|FG000|Phase II|Remission of disease|1|||
25162613|NCT01791205|50284800|FG001|Phase II|Remission of disease|0|||
25051492|NCT00150462|50154698|FG009|Overall Study|Physician Decision|0|||
25051493|NCT00150462|50154699|FG010|Overall Study|Physician Decision|0|||
25051494|NCT00150462|50154689|FG000|Overall Study|Other|0|||
25162614|NCT01791205|50284799|FG000|Phase II|Physician's decision|1|||
25051495|NCT00150462|50154690|FG001|Overall Study|Other|0|||
25051496|NCT00150462|50154691|FG002|Overall Study|Other|0|||
25051497|NCT00150462|50154692|FG003|Overall Study|Other|0|||
25051498|NCT00150462|50154693|FG004|Overall Study|Other|0|||
25051499|NCT00150462|50154694|FG005|Overall Study|Other|0|||
25051500|NCT00150462|50154695|FG006|Overall Study|Other|0|||
25051501|NCT00150462|50154696|FG007|Overall Study|Other|0|||
25051502|NCT00150462|50154697|FG008|Overall Study|Other|0|||
25051503|NCT00150462|50154698|FG009|Overall Study|Other|1|||
25051504|NCT00150462|50154699|FG010|Overall Study|Other|1|||
25051505|NCT01368081|50154739|FG000|Overall Study|Adverse Event|4|||
25051506|NCT01368081|50154740|FG001|Overall Study|Adverse Event|4|||
25051507|NCT01368081|50154741|FG002|Overall Study|Adverse Event|3|||
25051508|NCT01368081|50154742|FG003|Overall Study|Adverse Event|2|||
25051509|NCT01368081|50154743|FG004|Overall Study|Adverse Event|2|||
25051510|NCT01368081|50154744|FG005|Overall Study|Adverse Event|5|||
25051511|NCT01368081|50154745|FG006|Overall Study|Adverse Event|6|||
25051512|NCT01368081|50154746|FG007|Overall Study|Adverse Event|2|||
25051513|NCT01368081|50154747|FG008|Overall Study|Adverse Event|3|||
25051514|NCT01368081|50154748|FG009|Overall Study|Adverse Event|5|||
25051515|NCT01368081|50154749|FG010|Overall Study|Adverse Event|6|||
25051516|NCT01368081|50154750|FG011|Overall Study|Adverse Event|1|||
25051517|NCT01368081|50154751|FG012|Overall Study|Adverse Event|3|||
25051518|NCT01368081|50154739|FG000|Overall Study|Lack of Efficacy|0|||
25051519|NCT01368081|50154740|FG001|Overall Study|Lack of Efficacy|1|||
25162615|NCT01791205|50284800|FG001|Phase II|Physician's decision|0|||
25162616|NCT01272232|50284809|FG000|Weeks 0-56|Adverse Event|39|||
25162617|NCT01272232|50284810|FG001|Weeks 0-56|Adverse Event|18|||
25162618|NCT01272232|50284811|FG002|Weeks 0-56|Adverse Event|7|||
24960953|NCT00469079|50051387|FG001|Overall Study|Lost to Follow-up|8|||
25051520|NCT01368081|50154741|FG002|Overall Study|Lack of Efficacy|0|||
25051521|NCT01368081|50154742|FG003|Overall Study|Lack of Efficacy|1|||
25051522|NCT01368081|50154743|FG004|Overall Study|Lack of Efficacy|0|||
25051523|NCT01368081|50154744|FG005|Overall Study|Lack of Efficacy|0|||
25051524|NCT01368081|50154745|FG006|Overall Study|Lack of Efficacy|0|||
25051525|NCT01368081|50154746|FG007|Overall Study|Lack of Efficacy|2|||
25051526|NCT01368081|50154747|FG008|Overall Study|Lack of Efficacy|0|||
25162619|NCT01272232|50284809|FG000|Weeks 0-56|Lack of Efficacy|0|||
24960954|NCT00469079|50051388|FG002|Overall Study|Lost to Follow-up|10|||
24960955|NCT00469079|50051386|FG000|Overall Study|Withdrawal by Subject|1|||
24960956|NCT00469079|50051387|FG001|Overall Study|Withdrawal by Subject|2|||
24960957|NCT00469079|50051388|FG002|Overall Study|Withdrawal by Subject|2|||
24960958|NCT00469079|50051386|FG000|Overall Study|Ineligible|0|||
24960959|NCT00469079|50051387|FG001|Overall Study|Ineligible|1|||
24960960|NCT00469079|50051388|FG002|Overall Study|Ineligible|0|||
24960961|NCT00093496|50051404|FG000|Overall Study|Protocol Violation|1|||
24960962|NCT00093496|50051405|FG001|Overall Study|Protocol Violation|3|||
24960963|NCT00117286|50051412|FG000|Overall Study|Adverse Event|12|||
24960964|NCT00117286|50051413|FG001|Overall Study|Adverse Event|6|||
24960965|NCT00117286|50051412|FG000|Overall Study|Lost to Follow-up|2|||
24960966|NCT00117286|50051413|FG001|Overall Study|Lost to Follow-up|0|||
24960967|NCT00117286|50051412|FG000|Overall Study|Protocol Violation|3|||
25051527|NCT01368081|50154748|FG009|Overall Study|Lack of Efficacy|0|||
25051528|NCT01368081|50154749|FG010|Overall Study|Lack of Efficacy|0|||
25051529|NCT01368081|50154750|FG011|Overall Study|Lack of Efficacy|0|||
25162620|NCT01272232|50284810|FG001|Weeks 0-56|Lack of Efficacy|0|||
25162621|NCT01272232|50284811|FG002|Weeks 0-56|Lack of Efficacy|3|||
24960968|NCT00117286|50051413|FG001|Overall Study|Protocol Violation|3|||
24960969|NCT00117286|50051412|FG000|Overall Study|Withdrawal by Subject|6|||
24960970|NCT00117286|50051413|FG001|Overall Study|Withdrawal by Subject|2|||
24960971|NCT00117286|50051412|FG000|Overall Study|Physician Decision|3|||
24960972|NCT00117286|50051413|FG001|Overall Study|Physician Decision|7|||
24960973|NCT00117286|50051412|FG000|Overall Study|Lack of Efficacy|2|||
24960974|NCT00117286|50051413|FG001|Overall Study|Lack of Efficacy|1|||
25051530|NCT01368081|50154751|FG012|Overall Study|Lack of Efficacy|0|||
25051531|NCT01368081|50154739|FG000|Overall Study|Protocol Violation|0|||
25051532|NCT01368081|50154740|FG001|Overall Study|Protocol Violation|0|||
25051533|NCT01368081|50154741|FG002|Overall Study|Protocol Violation|0|||
25162622|NCT01272232|50284809|FG000|Weeks 0-56|Protocol Violation|12|||
24960975|NCT00117286|50051412|FG000|Overall Study|Research site closing|0|||
24960976|NCT00117286|50051413|FG001|Overall Study|Research site closing|2|||
24960977|NCT00265122|50051425|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
24960978|NCT00265122|50051426|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
24960979|NCT00265122|50051427|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
25051534|NCT01368081|50154742|FG003|Overall Study|Protocol Violation|0|||
25051535|NCT01368081|50154743|FG004|Overall Study|Protocol Violation|0|||
25051536|NCT01368081|50154744|FG005|Overall Study|Protocol Violation|1|||
25051537|NCT01368081|50154745|FG006|Overall Study|Protocol Violation|0|||
24960980|NCT00265122|50051428|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
24960981|NCT00265122|50051429|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
24960982|NCT00265122|50051430|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
24960983|NCT00265122|50051425|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
24960984|NCT00265122|50051426|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
24960985|NCT00265122|50051427|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
24960986|NCT00265122|50051428|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
24960987|NCT00265122|50051429|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
24960988|NCT00265122|50051430|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
24960989|NCT00265122|50051425|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
24960990|NCT00265122|50051426|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
24960991|NCT00265122|50051427|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
24960992|NCT00265122|50051428|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
24960993|NCT00265122|50051429|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
24960994|NCT00265122|50051430|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
24960995|NCT00265122|50051425|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
24960996|NCT00265122|50051426|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
24960997|NCT00265122|50051427|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
24960998|NCT00265122|50051428|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
24960999|NCT00265122|50051429|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
24961000|NCT00265122|50051430|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
24961001|NCT00265122|50051425|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
24961002|NCT00265122|50051426|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
24961003|NCT00265122|50051427|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
24961004|NCT00265122|50051428|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
24961005|NCT00265122|50051429|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
24961006|NCT00265122|50051430|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
24961007|NCT00265122|50051425|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
24961008|NCT00265122|50051426|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
24961009|NCT00265122|50051427|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
24961010|NCT00265122|50051428|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
24961011|NCT00265122|50051429|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
24961012|NCT00265122|50051430|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
24961013|NCT00116584|50051451|FG000|Overall Study|Withdrawal by Subject|1|||
24961014|NCT00116584|50051452|FG001|Overall Study|Withdrawal by Subject|0|||
25051538|NCT01368081|50154746|FG007|Overall Study|Protocol Violation|1|||
25051539|NCT01368081|50154747|FG008|Overall Study|Protocol Violation|0|||
25051540|NCT01368081|50154748|FG009|Overall Study|Protocol Violation|0|||
25051541|NCT01368081|50154749|FG010|Overall Study|Protocol Violation|0|||
25051542|NCT01368081|50154750|FG011|Overall Study|Protocol Violation|0|||
25051543|NCT01368081|50154751|FG012|Overall Study|Protocol Violation|0|||
25051544|NCT01368081|50154739|FG000|Overall Study|Lost to Follow-up|0|||
25051545|NCT01368081|50154740|FG001|Overall Study|Lost to Follow-up|0|||
25051546|NCT01368081|50154741|FG002|Overall Study|Lost to Follow-up|0|||
25051547|NCT01368081|50154742|FG003|Overall Study|Lost to Follow-up|0|||
25051548|NCT01368081|50154743|FG004|Overall Study|Lost to Follow-up|0|||
25051549|NCT01368081|50154744|FG005|Overall Study|Lost to Follow-up|0|||
24961015|NCT00116584|50051451|FG000|Overall Study|Protocol Violation|1|||
25051550|NCT01368081|50154745|FG006|Overall Study|Lost to Follow-up|0|||
25051551|NCT01368081|50154746|FG007|Overall Study|Lost to Follow-up|0|||
25051552|NCT01368081|50154747|FG008|Overall Study|Lost to Follow-up|0|||
25051553|NCT01368081|50154748|FG009|Overall Study|Lost to Follow-up|0|||
25051554|NCT01368081|50154749|FG010|Overall Study|Lost to Follow-up|0|||
25051555|NCT01368081|50154750|FG011|Overall Study|Lost to Follow-up|0|||
25051556|NCT01368081|50154751|FG012|Overall Study|Lost to Follow-up|1|||
25051557|NCT01368081|50154739|FG000|Overall Study|Withdrawal by Subject|4|||
25051558|NCT01368081|50154740|FG001|Overall Study|Withdrawal by Subject|4|||
25276523|NCT00886795|50590448|FG000|Overall Study|Lack of Efficacy|1|||
25276524|NCT00889681|50590465|FG000|Overall Study|Not meeting qualification Criteria|2|||
25051559|NCT01368081|50154741|FG002|Overall Study|Withdrawal by Subject|1|||
25051560|NCT01368081|50154742|FG003|Overall Study|Withdrawal by Subject|1|||
25051561|NCT01368081|50154743|FG004|Overall Study|Withdrawal by Subject|0|||
25276525|NCT00889681|50590465|FG000|Overall Study|Insurance disapproval|1|||
24961016|NCT00116584|50051452|FG001|Overall Study|Protocol Violation|1|||
24961017|NCT00096538|50051458|FG000|Overall Study|Withdrawal by Subject|1|||
24961018|NCT00239928|50051462|FG000|Overall Study|Lack of Efficacy|1|||
24961019|NCT00239928|50051462|FG000|Overall Study|Adverse Event|4|||
24961020|NCT00239928|50051462|FG000|Overall Study|Not need to continue study|3|||
24961021|NCT00239928|50051462|FG000|Overall Study|Withdrawal by Subject|2|||
24961022|NCT00116428|50051468|FG000|Overall Study|Withdrawal by Subject|2|||
24961023|NCT00116428|50051469|FG001|Overall Study|Withdrawal by Subject|5|||
24961024|NCT00116428|50051468|FG000|Overall Study|Did not meet inclusion criteria|1|||
24961025|NCT00116428|50051469|FG001|Overall Study|Did not meet inclusion criteria|0|||
24961026|NCT00468845|50051481|FG000|Overall Study|Adverse Event|9|||
24961027|NCT00468845|50051482|FG001|Overall Study|Adverse Event|14|||
24961028|NCT00468845|50051483|FG002|Overall Study|Adverse Event|11|||
24961029|NCT00468845|50051481|FG000|Overall Study|Lost to Follow-up|2|||
24961030|NCT00468845|50051482|FG001|Overall Study|Lost to Follow-up|1|||
24961031|NCT00468845|50051483|FG002|Overall Study|Lost to Follow-up|2|||
24961032|NCT00468845|50051481|FG000|Overall Study|Other|4|||
24961033|NCT00468845|50051482|FG001|Overall Study|Other|9|||
24961034|NCT00468845|50051483|FG002|Overall Study|Other|5|||
24961035|NCT00468845|50051481|FG000|Overall Study|No longer willing to participate|5|||
24961036|NCT00468845|50051482|FG001|Overall Study|No longer willing to participate|6|||
24961037|NCT00468845|50051483|FG002|Overall Study|No longer willing to participate|10|||
24961038|NCT00468845|50051481|FG000|Overall Study|Randomized, not treated|1|||
24961039|NCT00468845|50051482|FG001|Overall Study|Randomized, not treated|4|||
24961040|NCT00468845|50051483|FG002|Overall Study|Randomized, not treated|2|||
24961041|NCT00468299|50051493|FG000|Overall Study|Withdrawal by Subject|0|||
24961042|NCT00468299|50051494|FG001|Overall Study|Withdrawal by Subject|1|||
24961043|NCT00468143|50051502|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
24961044|NCT00468143|50051503|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
24961045|NCT00468143|50051502|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
24961046|NCT00468143|50051503|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
24961047|NCT00467831|50051509|FG000|Overall Study|Death|2|||
24961048|NCT00467831|50051509|FG000|Overall Study|Withdrawal by Subject|1|||
24961049|NCT00467753|50051515|FG000|Overall Study|Lost to Follow-up|1|||
24961050|NCT00467753|50051516|FG001|Overall Study|Lost to Follow-up|2|||
24961051|NCT00467753|50051515|FG000|Overall Study|Adverse Event|2|||
24961052|NCT00467753|50051516|FG001|Overall Study|Adverse Event|0|||
24961053|NCT00116272|50051528|FG000|Overall Study|Lost to Follow-up|11|||
24961054|NCT00116272|50051529|FG001|Overall Study|Lost to Follow-up|6|||
24961055|NCT00467597|50051541|FG000|Overall Study|Withdrawal by Subject|2|||
24961056|NCT00467597|50051542|FG001|Overall Study|Withdrawal by Subject|0|||
24961057|NCT00115804|50051552|FG000|Overall Study|Adverse Event|2|||
24961058|NCT00467519|50051560|FG000|Overall Study|Protocol Violation|8|||
24961059|NCT00467519|50051561|FG001|Overall Study|Protocol Violation|4|||
24961060|NCT00467519|50051560|FG000|Overall Study|Lost to Follow-up|2|||
24961061|NCT00467519|50051561|FG001|Overall Study|Lost to Follow-up|9|||
24961062|NCT00467519|50051560|FG000|Overall Study|Withdrawal by Subject|4|||
24961063|NCT00467519|50051561|FG001|Overall Study|Withdrawal by Subject|10|||
24961064|NCT00264810|50051569|FG000|Baseline|Withdrawal by Subject|10|||
24961065|NCT00264810|50051570|FG001|Baseline|Withdrawal by Subject|10|||
24961066|NCT00264810|50051569|FG000|Baseline|Physician Decision|7|||
24961067|NCT00264810|50051570|FG001|Baseline|Physician Decision|8|||
24961068|NCT00264810|50051569|FG000|Baseline|Subject Compliance Failure|3|||
24961069|NCT00264810|50051570|FG001|Baseline|Subject Compliance Failure|3|||
24961070|NCT00264810|50051569|FG000|Baseline|Insufficient Seizure Frequency|2|||
24961071|NCT00264810|50051570|FG001|Baseline|Insufficient Seizure Frequency|2|||
24961072|NCT00264810|50051569|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
24961073|NCT00264810|50051570|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
25276526|NCT00957658|50590469|FG000|Overall Study|Death|1|||
25276527|NCT00957658|50590469|FG000|Overall Study|Lost to Follow-up|4|||
25276528|NCT00957658|50590469|FG000|Overall Study|Withdrawal by Subject|12|||
24961074|NCT00264810|50051569|FG000|Baseline|Other|0|||
24961075|NCT00264810|50051570|FG001|Baseline|Other|1|||
24961076|NCT00264810|50051569|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
24961077|NCT00264810|50051570|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
24961078|NCT00264810|50051569|FG000|Stimulation Optimization Period|Death|0|||
24961079|NCT00264810|50051570|FG001|Stimulation Optimization Period|Death|1|||
25276529|NCT00957658|50590469|FG000|Overall Study|Revision|1|||
24961080|NCT00264810|50051569|FG000|Blinded Evaluation Period|Explant due to infection|1|||
24961081|NCT00264810|50051570|FG001|Blinded Evaluation Period|Explant due to infection|1|||
25051562|NCT01368081|50154744|FG005|Overall Study|Withdrawal by Subject|3|||
25051563|NCT01368081|50154745|FG006|Overall Study|Withdrawal by Subject|4|||
25051564|NCT01368081|50154746|FG007|Overall Study|Withdrawal by Subject|2|||
25051565|NCT01368081|50154747|FG008|Overall Study|Withdrawal by Subject|5|||
25051566|NCT01368081|50154748|FG009|Overall Study|Withdrawal by Subject|4|||
25051567|NCT01368081|50154749|FG010|Overall Study|Withdrawal by Subject|3|||
25051568|NCT01368081|50154750|FG011|Overall Study|Withdrawal by Subject|2|||
25051569|NCT01368081|50154751|FG012|Overall Study|Withdrawal by Subject|0|||
25051570|NCT01368081|50154739|FG000|Overall Study|Other reason not defined above|2|||
25051571|NCT01368081|50154740|FG001|Overall Study|Other reason not defined above|0|||
25051572|NCT01368081|50154741|FG002|Overall Study|Other reason not defined above|0|||
25051573|NCT01368081|50154742|FG003|Overall Study|Other reason not defined above|1|||
25051574|NCT01368081|50154743|FG004|Overall Study|Other reason not defined above|0|||
25051575|NCT01368081|50154744|FG005|Overall Study|Other reason not defined above|1|||
25051576|NCT01368081|50154745|FG006|Overall Study|Other reason not defined above|2|||
25051577|NCT01368081|50154746|FG007|Overall Study|Other reason not defined above|0|||
25051578|NCT01368081|50154747|FG008|Overall Study|Other reason not defined above|0|||
25051579|NCT01368081|50154748|FG009|Overall Study|Other reason not defined above|1|||
25051580|NCT01368081|50154749|FG010|Overall Study|Other reason not defined above|0|||
25051581|NCT01368081|50154750|FG011|Overall Study|Other reason not defined above|0|||
25051582|NCT01368081|50154751|FG012|Overall Study|Other reason not defined above|3|||
25051583|NCT00303498|50154781|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
25051584|NCT00303498|50154782|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
25051585|NCT00303498|50154781|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
25051586|NCT00303498|50154782|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
25051587|NCT00303498|50154781|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
25051588|NCT00303498|50154782|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
25051589|NCT00303498|50154781|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
25051590|NCT00303498|50154782|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
25051591|NCT00303498|50154781|FG000|Run-In-Phase (10 Weeks)|Other|4|||
24961082|NCT00264810|50051569|FG000|Open Label Evaluation Period|Explant due to infection|1|||
24961083|NCT00264810|50051570|FG001|Open Label Evaluation Period|Explant due to infection|1|||
24961084|NCT00264810|50051569|FG000|Open Label Evaluation Period|Death|3|||
24961085|NCT00264810|50051570|FG001|Open Label Evaluation Period|Death|2|||
24961086|NCT00264810|50051569|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
24961087|NCT00264810|50051570|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
24961088|NCT00467363|50051580|FG000|Overall Study|Lost to Follow-up|80|||
24961089|NCT00467363|50051581|FG001|Overall Study|Lost to Follow-up|70|||
24961090|NCT00091390|50051587|FG000|Overall Study|Protocol Violation|1|||
24961091|NCT00091390|50051587|FG000|Overall Study|No protocol treatment|3|||
24961092|NCT00239226|50051595|FG000|Overall Study|permAF during stabilization period|0|||
24961093|NCT00239226|50051596|FG001|Overall Study|permAF during stabilization period|0|||
24961094|NCT00239226|50051597|FG002|Overall Study|permAF during stabilization period|0|||
24961095|NCT00239226|50051598|FG003|Overall Study|permAF during stabilization period|3|||
24961096|NCT00239226|50051595|FG000|Overall Study|Lost to Follow-up|1|||
24961097|NCT00239226|50051596|FG001|Overall Study|Lost to Follow-up|0|||
24961098|NCT00239226|50051597|FG002|Overall Study|Lost to Follow-up|1|||
24961099|NCT00239226|50051598|FG003|Overall Study|Lost to Follow-up|0|||
25051592|NCT00303498|50154782|FG001|Run-In-Phase (10 Weeks)|Other|1|||
25051593|NCT00303498|50154781|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
25051594|NCT00303498|50154782|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
25051595|NCT00303498|50154781|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
25051596|NCT00303498|50154782|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
25051597|NCT00303498|50154781|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
25051598|NCT00303498|50154782|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
25051599|NCT00303498|50154781|FG000|Maintenance Phase (24 Weeks)|Death|1|||
25051600|NCT00303498|50154782|FG001|Maintenance Phase (24 Weeks)|Death|0|||
25051601|NCT00303498|50154781|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
25051602|NCT00303498|50154782|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
25051603|NCT00303498|50154781|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
25051604|NCT00303498|50154782|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
25051605|NCT00303498|50154781|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
25051606|NCT00303498|50154782|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
25051607|NCT00303498|50154781|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
25051608|NCT00303498|50154782|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
25051609|NCT00303498|50154781|FG000|Maintenance Phase (24 Weeks)|Other|1|||
25051610|NCT00303498|50154782|FG001|Maintenance Phase (24 Weeks)|Other|0|||
24961100|NCT00467285|50051610|FG000|Overall Study|Lost to Follow-up|4|||
24961101|NCT00467285|50051611|FG001|Overall Study|Lost to Follow-up|4|||
25051611|NCT00303498|50154781|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
25051612|NCT00303498|50154782|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
25051613|NCT00303498|50154781|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
25051614|NCT00303498|50154782|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
25051615|NCT02588092|50154798|FG000|Overall Study|Death|4|||
25051616|NCT02588092|50154799|FG001|Overall Study|Death|3|||
25051617|NCT02588092|50154800|FG002|Overall Study|Death|3|||
25051618|NCT02588092|50154801|FG003|Overall Study|Death|3|||
25051619|NCT02588092|50154802|FG004|Overall Study|Death|2|||
25051620|NCT02588092|50154803|FG005|Overall Study|Death|2|||
25051621|NCT02588092|50154804|FG006|Overall Study|Death|2|||
25051622|NCT02588092|50154805|FG007|Overall Study|Death|1|||
25051623|NCT02588092|50154806|FG008|Overall Study|Death|5|||
25051624|NCT02588092|50154807|FG009|Overall Study|Death|2|||
25051625|NCT02588092|50154798|FG000|Overall Study|Withdrawal by Subject|0|||
25051626|NCT02588092|50154799|FG001|Overall Study|Withdrawal by Subject|0|||
25051627|NCT02588092|50154800|FG002|Overall Study|Withdrawal by Subject|0|||
25051628|NCT02588092|50154801|FG003|Overall Study|Withdrawal by Subject|0|||
25051629|NCT02588092|50154802|FG004|Overall Study|Withdrawal by Subject|0|||
25051630|NCT02588092|50154803|FG005|Overall Study|Withdrawal by Subject|1|||
25051631|NCT02588092|50154804|FG006|Overall Study|Withdrawal by Subject|1|||
25051632|NCT02588092|50154805|FG007|Overall Study|Withdrawal by Subject|2|||
25051633|NCT02588092|50154806|FG008|Overall Study|Withdrawal by Subject|0|||
25051634|NCT02588092|50154807|FG009|Overall Study|Withdrawal by Subject|0|||
25051635|NCT02588092|50154798|FG000|Overall Study|Started Another Treatment|0|||
25051636|NCT02588092|50154799|FG001|Overall Study|Started Another Treatment|0|||
25051637|NCT02588092|50154800|FG002|Overall Study|Started Another Treatment|0|||
25051638|NCT02588092|50154801|FG003|Overall Study|Started Another Treatment|0|||
25051639|NCT02588092|50154802|FG004|Overall Study|Started Another Treatment|1|||
25051640|NCT02588092|50154803|FG005|Overall Study|Started Another Treatment|0|||
25051641|NCT02588092|50154804|FG006|Overall Study|Started Another Treatment|0|||
25051642|NCT02588092|50154805|FG007|Overall Study|Started Another Treatment|1|||
25051643|NCT02588092|50154806|FG008|Overall Study|Started Another Treatment|0|||
25051644|NCT02588092|50154807|FG009|Overall Study|Started Another Treatment|0|||
25051645|NCT02588092|50154798|FG000|Overall Study|Sponsor Decision|0|||
25051646|NCT02588092|50154799|FG001|Overall Study|Sponsor Decision|0|||
25051647|NCT02588092|50154800|FG002|Overall Study|Sponsor Decision|0|||
25051648|NCT02588092|50154801|FG003|Overall Study|Sponsor Decision|0|||
25051649|NCT02588092|50154802|FG004|Overall Study|Sponsor Decision|0|||
25051650|NCT02588092|50154803|FG005|Overall Study|Sponsor Decision|0|||
25051651|NCT02588092|50154804|FG006|Overall Study|Sponsor Decision|0|||
25051652|NCT02588092|50154805|FG007|Overall Study|Sponsor Decision|0|||
25051653|NCT02588092|50154806|FG008|Overall Study|Sponsor Decision|1|||
25051654|NCT02588092|50154807|FG009|Overall Study|Sponsor Decision|1|||
25051655|NCT01367847|50154835|FG000|Overall Study|Withdrawal by Subject|2|||
25051656|NCT01367847|50154836|FG001|Overall Study|Withdrawal by Subject|2|||
25051657|NCT00150618|50154848|FG000|Overall Study|Adverse Event|2|||
25051658|NCT00150618|50154849|FG001|Overall Study|Adverse Event|2|||
25051659|NCT00150618|50154850|FG002|Overall Study|Adverse Event|6|||
24961102|NCT00264576|50051621|FG000|Overall Study|Lost to Follow-up|1|||
24961103|NCT00264576|50051622|FG001|Overall Study|Lost to Follow-up|1|||
24961104|NCT00466505|50051629|FG000|Overall Study|disease progression|13|||
24961105|NCT00466505|50051629|FG000|Overall Study|Adverse Event|4|||
24961106|NCT00467051|50051633|FG000|Overall Study|Adverse Event|2|||
24961107|NCT00264498|50051640|FG000|Randomized Treatment|Death|0|||
24961108|NCT00264498|50051641|FG001|Randomized Treatment|Death|3|||
24961109|NCT00264498|50051640|FG000|Randomized Treatment|Withdrawal by Subject|0|||
24961110|NCT00264498|50051641|FG001|Randomized Treatment|Withdrawal by Subject|1|||
24961111|NCT00264498|50051640|FG000|Randomized Treatment|Objective disease Progression|13|||
24961112|NCT00264498|50051641|FG001|Randomized Treatment|Objective disease Progression|14|||
24961113|NCT00264498|50051640|FG000|Randomized Treatment|Physician Decision|1|||
24961114|NCT00264498|50051641|FG001|Randomized Treatment|Physician Decision|0|||
24961115|NCT00264498|50051640|FG000|Randomized Treatment|Incorrectly randomized|1|||
24961116|NCT00264498|50051641|FG001|Randomized Treatment|Incorrectly randomized|0|||
24961117|NCT00264498|50051640|FG000|Randomized Treatment|Study Closure|1|||
24961118|NCT00264498|50051641|FG001|Randomized Treatment|Study Closure|0|||
24961119|NCT00264498|50051640|FG000|Randomized Treatment|Protocol Violation|1|||
24961120|NCT00264498|50051641|FG001|Randomized Treatment|Protocol Violation|0|||
24961121|NCT00264498|50051640|FG000|Crossover Treatment|Death|1|||
24961122|NCT00264498|50051641|FG001|Crossover Treatment|Death|3|||
25051660|NCT00150618|50154851|FG003|Overall Study|Adverse Event|9|||
25051661|NCT00150618|50154852|FG004|Overall Study|Adverse Event|5|||
25051662|NCT00150618|50154848|FG000|Overall Study|Withdrawal by Subject|6|||
25051663|NCT00150618|50154849|FG001|Overall Study|Withdrawal by Subject|8|||
25051664|NCT00150618|50154850|FG002|Overall Study|Withdrawal by Subject|8|||
24961123|NCT00264498|50051640|FG000|Crossover Treatment|Objective disease progression|4|||
24961124|NCT00264498|50051641|FG001|Crossover Treatment|Objective disease progression|5|||
24961125|NCT00264498|50051640|FG000|Crossover Treatment|Study closure|0|||
24961126|NCT00264498|50051641|FG001|Crossover Treatment|Study closure|1|||
24961127|NCT00264498|50051640|FG000|Crossover Treatment|Withdrawal by Subject|1|||
24961128|NCT00264498|50051641|FG001|Crossover Treatment|Withdrawal by Subject|0|||
24961129|NCT00466193|50051649|FG000|Overall Study|Adverse Event|0|||
24961130|NCT00466193|50051650|FG001|Overall Study|Adverse Event|1|||
24961131|NCT00466193|50051649|FG000|Overall Study|Lost to Follow-up|2|||
25051665|NCT00150618|50154851|FG003|Overall Study|Withdrawal by Subject|4|||
25051666|NCT00150618|50154852|FG004|Overall Study|Withdrawal by Subject|5|||
25051667|NCT00150618|50154848|FG000|Overall Study|Lost to Follow-up|4|||
25051668|NCT00150618|50154849|FG001|Overall Study|Lost to Follow-up|1|||
25051669|NCT00150618|50154850|FG002|Overall Study|Lost to Follow-up|5|||
25051670|NCT00150618|50154851|FG003|Overall Study|Lost to Follow-up|8|||
25051671|NCT00150618|50154852|FG004|Overall Study|Lost to Follow-up|4|||
25051672|NCT00150618|50154848|FG000|Overall Study|Protocol Violation|1|||
25051673|NCT00150618|50154849|FG001|Overall Study|Protocol Violation|0|||
25051674|NCT00150618|50154850|FG002|Overall Study|Protocol Violation|0|||
25051675|NCT00150618|50154851|FG003|Overall Study|Protocol Violation|0|||
25051676|NCT00150618|50154852|FG004|Overall Study|Protocol Violation|1|||
25051677|NCT00150618|50154848|FG000|Overall Study|Lack of Efficacy|1|||
25051678|NCT00150618|50154849|FG001|Overall Study|Lack of Efficacy|4|||
25051679|NCT00150618|50154850|FG002|Overall Study|Lack of Efficacy|7|||
25051680|NCT00150618|50154851|FG003|Overall Study|Lack of Efficacy|4|||
25051681|NCT00150618|50154852|FG004|Overall Study|Lack of Efficacy|6|||
25051682|NCT00150618|50154848|FG000|Overall Study|No study meds|0|||
25051683|NCT00150618|50154849|FG001|Overall Study|No study meds|0|||
25051684|NCT00150618|50154850|FG002|Overall Study|No study meds|0|||
25051685|NCT00150618|50154851|FG003|Overall Study|No study meds|0|||
25051686|NCT00150618|50154852|FG004|Overall Study|No study meds|2|||
25051687|NCT00150618|50154848|FG000|Overall Study|Physician Decision|0|||
25051688|NCT00150618|50154849|FG001|Overall Study|Physician Decision|2|||
25051689|NCT00150618|50154850|FG002|Overall Study|Physician Decision|0|||
25051690|NCT00150618|50154851|FG003|Overall Study|Physician Decision|0|||
25051691|NCT00150618|50154852|FG004|Overall Study|Physician Decision|1|||
25051692|NCT00150618|50154848|FG000|Overall Study|Lack of compliance|2|||
25051693|NCT00150618|50154849|FG001|Overall Study|Lack of compliance|1|||
25051694|NCT00150618|50154850|FG002|Overall Study|Lack of compliance|1|||
25051695|NCT00150618|50154851|FG003|Overall Study|Lack of compliance|0|||
25051696|NCT00150618|50154852|FG004|Overall Study|Lack of compliance|1|||
25051697|NCT00150618|50154848|FG000|Overall Study|Abnormal ECG|1|||
25051698|NCT00150618|50154849|FG001|Overall Study|Abnormal ECG|0|||
25051699|NCT00150618|50154850|FG002|Overall Study|Abnormal ECG|0|||
25051700|NCT00150618|50154851|FG003|Overall Study|Abnormal ECG|0|||
25051701|NCT00150618|50154852|FG004|Overall Study|Abnormal ECG|0|||
25051702|NCT00150618|50154848|FG000|Overall Study|Sponsor's decision|0|||
25051703|NCT00150618|50154849|FG001|Overall Study|Sponsor's decision|0|||
25051704|NCT00150618|50154850|FG002|Overall Study|Sponsor's decision|0|||
25051705|NCT00150618|50154851|FG003|Overall Study|Sponsor's decision|1|||
25051706|NCT00150618|50154852|FG004|Overall Study|Sponsor's decision|0|||
25051707|NCT02587234|50154866|FG000|Overall Study|Withdrawal by Subject|1|||
25051708|NCT02587234|50154867|FG001|Overall Study|Withdrawal by Subject|1|||
25051709|NCT02587234|50154866|FG000|Overall Study|Lost to Follow-up|0|||
25051710|NCT02587234|50154867|FG001|Overall Study|Lost to Follow-up|2|||
25051711|NCT01359046|50154875|FG000|Overall Study|Did not receive allocated intervention|6|||
25051712|NCT01359046|50154876|FG001|Overall Study|Did not receive allocated intervention|6|||
25051713|NCT01359046|50154875|FG000|Overall Study|Physician Decision|1|||
25051714|NCT01359046|50154876|FG001|Overall Study|Physician Decision|11|||
25051715|NCT02741310|50154884|FG000|Overall Study|Sponsor Decision|2|||
25051716|NCT02741310|50154885|FG001|Overall Study|Sponsor Decision|2|||
25051717|NCT01367457|50154902|FG000|Overall Study|Death|2|||
25051718|NCT01367457|50154903|FG001|Overall Study|Death|0|||
25051719|NCT01367457|50154904|FG002|Overall Study|Death|0|||
25051720|NCT01367457|50154902|FG000|Overall Study|Investigator's decision|2|||
25051721|NCT01367457|50154903|FG001|Overall Study|Investigator's decision|0|||
25051722|NCT01367457|50154904|FG002|Overall Study|Investigator's decision|0|||
25051723|NCT01367457|50154902|FG000|Overall Study|Clinical decline (CD)|2|||
24961132|NCT00466193|50051650|FG001|Overall Study|Lost to Follow-up|4|||
25051724|NCT01367457|50154903|FG001|Overall Study|Clinical decline (CD)|0|||
25051725|NCT01367457|50154904|FG002|Overall Study|Clinical decline (CD)|0|||
25051726|NCT01367457|50154902|FG000|Overall Study|Progression and death|8|||
25051727|NCT01367457|50154903|FG001|Overall Study|Progression and death|0|||
25051728|NCT01367457|50154904|FG002|Overall Study|Progression and death|0|||
25051729|NCT01367457|50154902|FG000|Overall Study|Toxicity|16|||
24961133|NCT00466193|50051649|FG000|Overall Study|Physician Decision|1|||
25051730|NCT01367457|50154903|FG001|Overall Study|Toxicity|0|||
25051731|NCT01367457|50154904|FG002|Overall Study|Toxicity|0|||
25051732|NCT01367457|50154902|FG000|Overall Study|Progression|137|||
25051733|NCT01367457|50154903|FG001|Overall Study|Progression|0|||
25051734|NCT01367457|50154904|FG002|Overall Study|Progression|0|||
25051735|NCT01367457|50154902|FG000|Overall Study|Patient asks for rest + slow progression|1|||
25051736|NCT01367457|50154903|FG001|Overall Study|Patient asks for rest + slow progression|0|||
25051737|NCT01367457|50154904|FG002|Overall Study|Patient asks for rest + slow progression|0|||
25051738|NCT01367457|50154902|FG000|Overall Study|Investigator's opinion, stable disease|1|||
25051739|NCT01367457|50154903|FG001|Overall Study|Investigator's opinion, stable disease|0|||
25051740|NCT01367457|50154904|FG002|Overall Study|Investigator's opinion, stable disease|0|||
25051741|NCT01367457|50154902|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
25051742|NCT01367457|50154903|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
25051743|NCT01367457|50154904|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
25051744|NCT01367457|50154902|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
25051745|NCT01367457|50154903|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
25051746|NCT01367457|50154904|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
25051747|NCT01367457|50154902|FG000|Overall Study|low grade toxicities + stable disease|1|||
25051748|NCT01367457|50154903|FG001|Overall Study|low grade toxicities + stable disease|0|||
25051749|NCT01367457|50154904|FG002|Overall Study|low grade toxicities + stable disease|0|||
25051750|NCT01367457|50154902|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
25051751|NCT01367457|50154903|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
25051752|NCT01367457|50154904|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
25051753|NCT01367457|50154902|FG000|Overall Study|Withdrawal by Subject|1|||
25051754|NCT01367457|50154903|FG001|Overall Study|Withdrawal by Subject|0|||
25051755|NCT01367457|50154904|FG002|Overall Study|Withdrawal by Subject|0|||
25051756|NCT01367457|50154902|FG000|Overall Study|CD, associated leukaemia|1|||
25051757|NCT01367457|50154903|FG001|Overall Study|CD, associated leukaemia|0|||
25051758|NCT01367457|50154904|FG002|Overall Study|CD, associated leukaemia|0|||
25051759|NCT01367457|50154902|FG000|Overall Study|Uncontrolled pain|1|||
25051760|NCT01367457|50154903|FG001|Overall Study|Uncontrolled pain|0|||
25051761|NCT01367457|50154904|FG002|Overall Study|Uncontrolled pain|0|||
25051762|NCT01367457|50154902|FG000|Overall Study|Overall status worsens to grade 4|1|||
25051763|NCT01367457|50154903|FG001|Overall Study|Overall status worsens to grade 4|0|||
25051764|NCT01367457|50154904|FG002|Overall Study|Overall status worsens to grade 4|0|||
25051765|NCT01367457|50154902|FG000|Overall Study|Stabilisation + frequent infections|1|||
25051766|NCT01367457|50154903|FG001|Overall Study|Stabilisation + frequent infections|0|||
25051767|NCT01367457|50154904|FG002|Overall Study|Stabilisation + frequent infections|0|||
25051768|NCT01367457|50154902|FG000|Overall Study|No clinical benefit|1|||
25051769|NCT01367457|50154903|FG001|Overall Study|No clinical benefit|0|||
25051770|NCT01367457|50154904|FG002|Overall Study|No clinical benefit|0|||
25051771|NCT01367457|50154902|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
25051772|NCT01367457|50154903|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
25051773|NCT01367457|50154904|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
25051774|NCT01367457|50154902|FG000|Overall Study|Overall decline|1|||
25051775|NCT01367457|50154903|FG001|Overall Study|Overall decline|0|||
25051776|NCT01367457|50154904|FG002|Overall Study|Overall decline|0|||
25051777|NCT01367457|50154902|FG000|Overall Study|Rejection of treatment|1|||
25051778|NCT01367457|50154903|FG001|Overall Study|Rejection of treatment|0|||
25051779|NCT01367457|50154904|FG002|Overall Study|Rejection of treatment|0|||
25051780|NCT01367457|50154902|FG000|Overall Study|Lost to Follow-up|1|||
25051781|NCT01367457|50154903|FG001|Overall Study|Lost to Follow-up|0|||
25051782|NCT01367457|50154904|FG002|Overall Study|Lost to Follow-up|0|||
25051783|NCT01367457|50154902|FG000|Overall Study|Death from septic shock|1|||
25051784|NCT01367457|50154903|FG001|Overall Study|Death from septic shock|0|||
25051785|NCT01367457|50154904|FG002|Overall Study|Death from septic shock|0|||
25051786|NCT01367457|50154902|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
25051787|NCT01367457|50154903|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
25051788|NCT01367457|50154904|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
25051789|NCT01367457|50154902|FG000|Overall Study|Patient's Wish|1|||
25051790|NCT01367457|50154903|FG001|Overall Study|Patient's Wish|0|||
25051791|NCT01367457|50154904|FG002|Overall Study|Patient's Wish|0|||
25051792|NCT01367457|50154902|FG000|Overall Study|Palliative. Overall decline|1|||
25051793|NCT01367457|50154903|FG001|Overall Study|Palliative. Overall decline|0|||
25051794|NCT01367457|50154904|FG002|Overall Study|Palliative. Overall decline|0|||
25051795|NCT01367457|50154902|FG000|Overall Study|Suspected DP/suspected active infection|1|||
25051796|NCT01367457|50154903|FG001|Overall Study|Suspected DP/suspected active infection|0|||
25051797|NCT01367457|50154904|FG002|Overall Study|Suspected DP/suspected active infection|0|||
25051798|NCT00235326|50154914|FG000|Overall Study|Lost to Follow-up|746|||
25051799|NCT00235326|50154915|FG001|Overall Study|Lost to Follow-up|1400|||
25051800|NCT00162942|50154925|FG000|Overall Study|Adverse Event|10|||
25051801|NCT00162942|50154926|FG001|Overall Study|Adverse Event|6|||
25051802|NCT00162942|50154925|FG000|Overall Study|Death|1|||
25051803|NCT00162942|50154926|FG001|Overall Study|Death|0|||
25051804|NCT00162942|50154925|FG000|Overall Study|Withdrawal by Subject|3|||
25051805|NCT00162942|50154926|FG001|Overall Study|Withdrawal by Subject|6|||
25051806|NCT00162942|50154925|FG000|Overall Study|Physician Decision|1|||
25051807|NCT00162942|50154926|FG001|Overall Study|Physician Decision|0|||
25051808|NCT00162942|50154925|FG000|Overall Study|Enter Open-Label Study|76|||
25051809|NCT00162942|50154926|FG001|Overall Study|Enter Open-Label Study|35|||
25051810|NCT00162942|50154925|FG000|Overall Study|Alternate Therapy|6|||
25051811|NCT00162942|50154926|FG001|Overall Study|Alternate Therapy|2|||
25051812|NCT00162942|50154925|FG000|Overall Study|Lack of Efficacy|1|||
25051813|NCT00162942|50154926|FG001|Overall Study|Lack of Efficacy|0|||
25051814|NCT00162942|50154925|FG000|Overall Study|Flare During Active Treatment|7|||
25051815|NCT00162942|50154926|FG001|Overall Study|Flare During Active Treatment|3|||
25051816|NCT00162942|50154925|FG000|Overall Study|2 or more consecutive treatments missed|1|||
25051817|NCT00162942|50154926|FG001|Overall Study|2 or more consecutive treatments missed|0|||
25051818|NCT02786901|50154956|FG000|Overall Study|Adverse Event|1|||
25051819|NCT02786901|50154957|FG001|Overall Study|Adverse Event|1|||
25051820|NCT02786901|50154958|FG002|Overall Study|Adverse Event|2|||
25051821|NCT02786901|50154956|FG000|Overall Study|Physician Decision|1|||
24961134|NCT00466193|50051650|FG001|Overall Study|Physician Decision|0|||
24961135|NCT00466193|50051649|FG000|Overall Study|Protocol Violation|1|||
24961136|NCT00466193|50051650|FG001|Overall Study|Protocol Violation|1|||
24961137|NCT00466193|50051649|FG000|Overall Study|Withdrawal by Subject|7|||
24961138|NCT00466193|50051650|FG001|Overall Study|Withdrawal by Subject|2|||
24961139|NCT00466193|50051649|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
24961140|NCT00466193|50051650|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
24961141|NCT00263562|50051658|FG000|Overall Study|Protocol Violation|3|||
25051822|NCT02786901|50154957|FG001|Overall Study|Physician Decision|0|||
25051823|NCT02786901|50154958|FG002|Overall Study|Physician Decision|0|||
25051824|NCT02786901|50154956|FG000|Overall Study|Rescue Therapy Use|71|||
25051825|NCT02786901|50154957|FG001|Overall Study|Rescue Therapy Use|49|||
25051826|NCT02786901|50154958|FG002|Overall Study|Rescue Therapy Use|33|||
25051827|NCT02786901|50154956|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
25051828|NCT02786901|50154957|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
25051829|NCT02786901|50154958|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
25051830|NCT02786901|50154956|FG000|Overall Study|Disallowed medication|1|||
25051831|NCT02786901|50154957|FG001|Overall Study|Disallowed medication|1|||
25051832|NCT02786901|50154958|FG002|Overall Study|Disallowed medication|0|||
25051833|NCT02786901|50154956|FG000|Overall Study|Randomized in error|2|||
25051834|NCT02786901|50154957|FG001|Overall Study|Randomized in error|0|||
25051835|NCT02786901|50154958|FG002|Overall Study|Randomized in error|1|||
25051836|NCT02137239|50154968|FG000|Overall Study|Discontinued Study Treatment|0|||
24961142|NCT00263562|50051659|FG001|Overall Study|Protocol Violation|0|||
24961143|NCT00454181|50051669|FG000|Overall Study|Adverse Event|1|||
24961144|NCT00454181|50051670|FG001|Overall Study|Adverse Event|1|||
24961145|NCT00454181|50051669|FG000|Overall Study|Lost to Follow-up|11|||
24961146|NCT00454181|50051670|FG001|Overall Study|Lost to Follow-up|1|||
24961147|NCT00454181|50051669|FG000|Overall Study|Protocol Violation|1|||
24961148|NCT00454181|50051670|FG001|Overall Study|Protocol Violation|1|||
24961149|NCT00454181|50051669|FG000|Overall Study|Withdrawal by Subject|2|||
24961150|NCT00454181|50051670|FG001|Overall Study|Withdrawal by Subject|0|||
24961151|NCT00237744|50051679|FG000|Overall Study|Withdrawal by Subject|3|||
24961152|NCT00237744|50051680|FG001|Overall Study|Withdrawal by Subject|1|||
24961153|NCT00237744|50051681|FG002|Overall Study|Withdrawal by Subject|0|||
24961154|NCT00237042|50051695|FG000|Treatment|Became ineligible post-randomization|0|||
24961155|NCT00237042|50051696|FG001|Treatment|Became ineligible post-randomization|1|||
24961156|NCT00237042|50051697|FG002|Treatment|Became ineligible post-randomization|16|||
24961157|NCT00237042|50051695|FG000|Treatment|Moved out of state|1|||
24961158|NCT00237042|50051696|FG001|Treatment|Moved out of state|1|||
24961159|NCT00237042|50051697|FG002|Treatment|Moved out of state|1|||
24961160|NCT00237042|50051695|FG000|Treatment|Completed no treatment|5|||
24961161|NCT00237042|50051696|FG001|Treatment|Completed no treatment|5|||
24961162|NCT00237042|50051697|FG002|Treatment|Completed no treatment|21|||
24961163|NCT00237042|50051695|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
24961164|NCT00237042|50051696|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
24961165|NCT00237042|50051697|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
24961166|NCT00237042|50051695|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
24961167|NCT00237042|50051696|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
24961168|NCT00237042|50051697|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
24961169|NCT00465647|50051709|FG000|Overall Study|Administrative|2|||
24961170|NCT00465647|50051710|FG001|Overall Study|Administrative|2|||
25162623|NCT01272232|50284810|FG001|Weeks 0-56|Protocol Violation|8|||
24961171|NCT00465647|50051711|FG002|Overall Study|Administrative|3|||
24961172|NCT00465647|50051712|FG003|Overall Study|Administrative|2|||
24961173|NCT00465647|50051709|FG000|Overall Study|Adverse Event|2|||
24961174|NCT00465647|50051710|FG001|Overall Study|Adverse Event|0|||
24961175|NCT00465647|50051711|FG002|Overall Study|Adverse Event|3|||
24961176|NCT00465647|50051712|FG003|Overall Study|Adverse Event|2|||
24961177|NCT00465647|50051709|FG000|Overall Study|Withdrawal by Subject|1|||
24961178|NCT00465647|50051710|FG001|Overall Study|Withdrawal by Subject|2|||
24961179|NCT00465647|50051711|FG002|Overall Study|Withdrawal by Subject|2|||
24961180|NCT00465647|50051712|FG003|Overall Study|Withdrawal by Subject|7|||
24961181|NCT00465647|50051709|FG000|Overall Study|"The other reasons included loss of IV"|8|||
24961182|NCT00465647|50051710|FG001|Overall Study|"The other reasons included loss of IV"|4|||
24961183|NCT00465647|50051711|FG002|Overall Study|"The other reasons included loss of IV"|3|||
24961184|NCT00465647|50051712|FG003|Overall Study|"The other reasons included loss of IV"|2|||
24961185|NCT00465569|50051734|FG000|Overall Study|persistent eczema during dose escalation|1|||
24961186|NCT00465569|50051735|FG001|Overall Study|persistent eczema during dose escalation|0|||
24961187|NCT00090766|50051744|FG000|Overall Study|Nephrectomy Planned|0|||
24961188|NCT00090766|50051745|FG001|Overall Study|Nephrectomy Planned|0|||
25162624|NCT01272232|50284811|FG002|Weeks 0-56|Protocol Violation|13|||
25162625|NCT01272232|50284809|FG000|Weeks 0-56|Withdrawal criteria|32|||
25162626|NCT01272232|50284810|FG001|Weeks 0-56|Withdrawal criteria|14|||
25162627|NCT01272232|50284811|FG002|Weeks 0-56|Withdrawal criteria|37|||
25162628|NCT01272232|50284809|FG000|Weeks 0-56|Unclassified|16|||
25162629|NCT01272232|50284810|FG001|Weeks 0-56|Unclassified|7|||
25162630|NCT01272232|50284811|FG002|Weeks 0-56|Unclassified|12|||
25162631|NCT01272232|50284809|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
25162632|NCT01272232|50284810|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
25162633|NCT01272232|50284811|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
24961189|NCT00090766|50051746|FG002|Overall Study|Nephrectomy Planned|1|||
24961190|NCT00090766|50051744|FG000|Overall Study|Death|1|||
24961191|NCT00090766|50051745|FG001|Overall Study|Death|0|||
24961192|NCT00090766|50051746|FG002|Overall Study|Death|0|||
24961193|NCT00090766|50051744|FG000|Overall Study|Admin|0|||
24961194|NCT00090766|50051745|FG001|Overall Study|Admin|2|||
24961195|NCT00090766|50051746|FG002|Overall Study|Admin|0|||
25051837|NCT02137239|50154969|FG001|Overall Study|Discontinued Study Treatment|3|||
25051838|NCT02137239|50154968|FG000|Overall Study|Withdrew Consent|1|||
25051839|NCT02137239|50154969|FG001|Overall Study|Withdrew Consent|1|||
25051840|NCT02137239|50154968|FG000|Overall Study|Adverse Event|2|||
25051841|NCT02137239|50154969|FG001|Overall Study|Adverse Event|2|||
25051842|NCT02741076|50154988|FG000|Overall Study|Adverse Event|0|||
25051843|NCT02741076|50154989|FG001|Overall Study|Adverse Event|1|||
25051844|NCT02741076|50154990|FG002|Overall Study|Adverse Event|1|||
25051845|NCT02741076|50154991|FG003|Overall Study|Adverse Event|0|||
25051846|NCT02741076|50154988|FG000|Overall Study|Lack of Efficacy|1|||
24961196|NCT00090766|50051744|FG000|Overall Study|Lost to Follow-up|2|||
24961197|NCT00090766|50051745|FG001|Overall Study|Lost to Follow-up|0|||
24961198|NCT00090766|50051746|FG002|Overall Study|Lost to Follow-up|2|||
25051847|NCT02741076|50154989|FG001|Overall Study|Lack of Efficacy|0|||
25051848|NCT02741076|50154990|FG002|Overall Study|Lack of Efficacy|0|||
25051849|NCT02741076|50154991|FG003|Overall Study|Lack of Efficacy|0|||
25051850|NCT02741076|50154988|FG000|Overall Study|Withdrawal by Subject|0|||
25051851|NCT02741076|50154989|FG001|Overall Study|Withdrawal by Subject|1|||
25051852|NCT02741076|50154990|FG002|Overall Study|Withdrawal by Subject|0|||
25051853|NCT02741076|50154991|FG003|Overall Study|Withdrawal by Subject|0|||
25051854|NCT02741076|50154988|FG000|Overall Study|Sponsor Request|2|||
25051855|NCT02741076|50154989|FG001|Overall Study|Sponsor Request|3|||
25051856|NCT02741076|50154990|FG002|Overall Study|Sponsor Request|0|||
25051857|NCT02741076|50154991|FG003|Overall Study|Sponsor Request|1|||
24961199|NCT00465179|50051756|FG000|Overall Study|Adverse Event|4|||
24961200|NCT00465179|50051756|FG000|Overall Study|Withdrawal by Subject|2|||
25051858|NCT02741076|50154988|FG000|Overall Study|No additional information available|0|||
25051859|NCT02741076|50154989|FG001|Overall Study|No additional information available|0|||
25051860|NCT02741076|50154990|FG002|Overall Study|No additional information available|1|||
25051861|NCT02741076|50154991|FG003|Overall Study|No additional information available|1|||
25051862|NCT01666444|50155004|FG000|Overall Study|Did not initiate treatment|2|||
25162634|NCT01272232|50284809|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
25162635|NCT01272232|50284810|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
24961201|NCT00465179|50051756|FG000|Overall Study|Progression of Disease|47|||
25186576|NCT01395017|50337140|FG000|Overall Study|Sponsor discontinued study|1|||
25051863|NCT01666444|50155005|FG001|Overall Study|Did not initiate treatment|1|||
25051864|NCT05159622|50155013|FG000|Overall Study|Lost to Follow-up|4|||
24961202|NCT00465101|50051760|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
25051865|NCT05159622|50155014|FG001|Overall Study|Lost to Follow-up|5|||
25186577|NCT01395017|50337141|FG001|Overall Study|Sponsor discontinued study|4|||
25186578|NCT02647320|50337193|FG000|Overall Study|Adverse Event|0|||
25051866|NCT01665430|50155026|FG000|Overall Study|Adverse Event|1|||
25051867|NCT01665430|50155026|FG000|Overall Study|Withdrawal by Subject|6|||
25051868|NCT01665430|50155026|FG000|Overall Study|Other Unspecified|2|||
25051869|NCT02739594|50155032|FG000|Overall Study|Undesired Event|3|||
25051870|NCT02739594|50155033|FG001|Overall Study|Undesired Event|4|||
25051871|NCT02739594|50155032|FG000|Overall Study|Violation of Eligibility Criteria|1|||
25051872|NCT02739594|50155033|FG001|Overall Study|Violation of Eligibility Criteria|2|||
25051873|NCT02739594|50155032|FG000|Overall Study|Protocol Violation|5|||
25051874|NCT02739594|50155033|FG001|Overall Study|Protocol Violation|6|||
25051875|NCT02739594|50155032|FG000|Overall Study|Death|4|||
25051876|NCT02739594|50155033|FG001|Overall Study|Death|2|||
25051877|NCT02739594|50155032|FG000|Overall Study|Renal Insufficiency|4|||
25051878|NCT02739594|50155033|FG001|Overall Study|Renal Insufficiency|6|||
25051879|NCT02739594|50155032|FG000|Overall Study|Administrative Reasons|1|||
25051880|NCT02739594|50155033|FG001|Overall Study|Administrative Reasons|3|||
25051881|NCT02739594|50155032|FG000|Overall Study|Withdrawal by Subject|1|||
25051882|NCT02739594|50155033|FG001|Overall Study|Withdrawal by Subject|1|||
25051883|NCT02739594|50155032|FG000|Overall Study|Lost to Follow-up|0|||
25051884|NCT02739594|50155033|FG001|Overall Study|Lost to Follow-up|1|||
25051885|NCT02739594|50155032|FG000|Overall Study|Elevated Serum Creatinine|0|||
25051886|NCT02739594|50155033|FG001|Overall Study|Elevated Serum Creatinine|1|||
25051887|NCT02739594|50155032|FG000|Overall Study|Other|6|||
25051888|NCT02739594|50155033|FG001|Overall Study|Other|2|||
25051889|NCT03989232|50155042|FG000|Overall Study|Lost to Follow-up|3|||
25051890|NCT03989232|50155043|FG001|Overall Study|Lost to Follow-up|10|||
25051891|NCT03989232|50155042|FG000|Overall Study|Withdrawal by Subject|6|||
25051892|NCT03989232|50155043|FG001|Overall Study|Withdrawal by Subject|6|||
25051893|NCT03989232|50155042|FG000|Overall Study|Death|1|||
25051894|NCT03989232|50155043|FG001|Overall Study|Death|2|||
25051895|NCT02585830|50155049|FG000|Overall Study|Withdrawal by Subject|3|||
25051896|NCT02584504|50155056|FG000|Double-blind Treatment|Participant withdrew consent|0|||
25051897|NCT02584504|50155057|FG001|Double-blind Treatment|Participant withdrew consent|0|||
25051898|NCT02584504|50155058|FG002|Double-blind Treatment|Participant withdrew consent|1|||
25051899|NCT02584504|50155056|FG000|Double-blind Treatment|Adverse Event|0|||
25051900|NCT02584504|50155057|FG001|Double-blind Treatment|Adverse Event|1|||
25051901|NCT02584504|50155058|FG002|Double-blind Treatment|Adverse Event|0|||
25051902|NCT02584504|50155056|FG000|Double-blind Treatment|Family Matter|0|||
25051903|NCT02584504|50155057|FG001|Double-blind Treatment|Family Matter|1|||
25051904|NCT02584504|50155058|FG002|Double-blind Treatment|Family Matter|0|||
25051905|NCT02584504|50155056|FG000|Open-label Treatment|Participant withdrew consent|0|||
25051906|NCT02584504|50155057|FG001|Open-label Treatment|Participant withdrew consent|0|||
25051907|NCT02584504|50155058|FG002|Open-label Treatment|Participant withdrew consent|4|||
25051908|NCT02584504|50155056|FG000|Open-label Treatment|Adverse Event|2|||
25051909|NCT02584504|50155057|FG001|Open-label Treatment|Adverse Event|2|||
25051910|NCT02584504|50155058|FG002|Open-label Treatment|Adverse Event|3|||
25051911|NCT02584504|50155056|FG000|Open-label Treatment|Physician Decision|0|||
25051912|NCT02584504|50155057|FG001|Open-label Treatment|Physician Decision|1|||
25051913|NCT02584504|50155058|FG002|Open-label Treatment|Physician Decision|0|||
25051914|NCT02584504|50155056|FG000|Open-label Treatment|Entered but not treated|0|||
25051915|NCT02584504|50155057|FG001|Open-label Treatment|Entered but not treated|1|||
25051916|NCT02584504|50155058|FG002|Open-label Treatment|Entered but not treated|1|||
25051917|NCT04605094|50155085|FG000|Overall Study|Adverse Event|2|||
25051918|NCT04605094|50155086|FG001|Overall Study|Adverse Event|2|||
25051919|NCT04605094|50155085|FG000|Overall Study|Lost to Follow-up|1|||
25051920|NCT04605094|50155086|FG001|Overall Study|Lost to Follow-up|4|||
25051921|NCT04605094|50155085|FG000|Overall Study|Physician Decision|2|||
25051922|NCT04605094|50155086|FG001|Overall Study|Physician Decision|2|||
25051923|NCT04605094|50155085|FG000|Overall Study|Study terminated by Sponsor|31|||
25051924|NCT04605094|50155086|FG001|Overall Study|Study terminated by Sponsor|33|||
25051925|NCT04605094|50155085|FG000|Overall Study|Withdrawal by Subject|22|||
25051926|NCT04605094|50155086|FG001|Overall Study|Withdrawal by Subject|19|||
25051927|NCT04605094|50155085|FG000|Overall Study|Other|1|||
25051928|NCT04605094|50155086|FG001|Overall Study|Other|1|||
25051929|NCT04354155|50155093|FG000|Overall Study|Withdrawal by Subject|1|||
25051930|NCT04354155|50155093|FG000|Overall Study|Did not meet criteria for study intervention|1|||
25051931|NCT02586064|50155099|FG000|Overall Study|Other Obligations|6|||
25051932|NCT02586064|50155100|FG001|Overall Study|Other Obligations|6|||
25051933|NCT02586064|50155099|FG000|Overall Study|Other|3|||
25051934|NCT02586064|50155100|FG001|Overall Study|Other|7|||
25051935|NCT02586064|50155099|FG000|Overall Study|Never Started|3|||
25051936|NCT02586064|50155100|FG001|Overall Study|Never Started|3|||
25051937|NCT02586064|50155099|FG000|Overall Study|Lost Interest|1|||
25051938|NCT02586064|50155100|FG001|Overall Study|Lost Interest|4|||
25051939|NCT02586064|50155099|FG000|Overall Study|Miscellaneous Life Issues|0|||
25051940|NCT02586064|50155100|FG001|Overall Study|Miscellaneous Life Issues|5|||
25051941|NCT02586064|50155099|FG000|Overall Study|Infrequent Attendance|2|||
25051942|NCT02586064|50155100|FG001|Overall Study|Infrequent Attendance|1|||
25051943|NCT02586064|50155099|FG000|Overall Study|Timed Out|2|||
25051944|NCT02586064|50155100|FG001|Overall Study|Timed Out|0|||
25051945|NCT02586064|50155099|FG000|Overall Study|AUD relapse|0|||
25051946|NCT02586064|50155100|FG001|Overall Study|AUD relapse|2|||
25051947|NCT02586064|50155099|FG000|Overall Study|Legal Issue|1|||
25051948|NCT02586064|50155100|FG001|Overall Study|Legal Issue|0|||
25051949|NCT03810495|50155109|FG000|Overall Study|Lost to Follow-up|2|||
25051950|NCT03810495|50155109|FG000|Overall Study|Withdrawal by Subject|1|||
25051951|NCT02782923|50155113|FG000|Overall Study|Lost to Follow-up|15|||
25051952|NCT03760458|50155122|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
25051953|NCT03760458|50155123|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
25051954|NCT03760458|50155124|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
25051955|NCT03760458|50155125|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
25051956|NCT03760458|50155126|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
25051957|NCT02066415|50155141|FG000|Overall Study|Decision by Sponsor|5|||
25051958|NCT02066415|50155142|FG001|Overall Study|Decision by Sponsor|4|||
25051959|NCT02066415|50155143|FG002|Overall Study|Decision by Sponsor|2|||
25051960|NCT02066415|50155141|FG000|Overall Study|Withdrawal by Subject|9|||
25051961|NCT02066415|50155142|FG001|Overall Study|Withdrawal by Subject|1|||
24961203|NCT00465101|50051760|FG000|Overall Study|Change in health precluded follow up|4|||
24961204|NCT00465101|50051760|FG000|Overall Study|Did not meet study criteria|4|||
24961205|NCT00465101|50051760|FG000|Overall Study|Lost to Follow-up|5|||
24961206|NCT00465101|50051760|FG000|Overall Study|Other|6|||
24961207|NCT00465101|50051760|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
24961208|NCT00465101|50051760|FG000|Overall Study|Patient postponed procedure|1|||
24961209|NCT00465101|50051760|FG000|Overall Study|Site closed due to IRB expiration|1|||
24961210|NCT00465101|50051760|FG000|Overall Study|Unable to obtain IRB approval|1|||
24961211|NCT00465101|50051760|FG000|Overall Study|Death|3|||
24961212|NCT00465101|50051760|FG000|Overall Study|Withdrawal by Subject|25|||
24961213|NCT00465101|50051760|FG000|Overall Study|Physician Decision|1|||
24961214|NCT00465101|50051760|FG000|Overall Study|Withdrew consent prior to procedure|3|||
24961215|NCT00084136|50051789|FG000|PI Comparison|Death|10|||
24961216|NCT00084136|50051790|FG001|PI Comparison|Death|9|||
24961217|NCT00084136|50051791|FG002|PI Comparison|Death|0|||
24961218|NCT00084136|50051789|FG000|PI Comparison|Lost to Follow-up|11|||
24961219|NCT00084136|50051790|FG001|PI Comparison|Lost to Follow-up|8|||
24961220|NCT00084136|50051791|FG002|PI Comparison|Lost to Follow-up|0|||
24961221|NCT00084136|50051789|FG000|PI Comparison|Withdrawal by Subject|33|||
24961222|NCT00084136|50051790|FG001|PI Comparison|Withdrawal by Subject|30|||
24961223|NCT00084136|50051791|FG002|PI Comparison|Withdrawal by Subject|0|||
24961224|NCT00084136|50051789|FG000|PI Comparison|Clinic site closed|1|||
24961225|NCT00084136|50051790|FG001|PI Comparison|Clinic site closed|0|||
24961226|NCT00084136|50051791|FG002|PI Comparison|Clinic site closed|0|||
24961227|NCT00084136|50051789|FG000|NRTI Comparison|Death|20|||
24961228|NCT00084136|50051790|FG001|NRTI Comparison|Death|0|||
24961229|NCT00084136|50051791|FG002|NRTI Comparison|Death|18|||
24961230|NCT00084136|50051789|FG000|NRTI Comparison|Lost to Follow-up|14|||
24961231|NCT00084136|50051790|FG001|NRTI Comparison|Lost to Follow-up|0|||
24961232|NCT00084136|50051791|FG002|NRTI Comparison|Lost to Follow-up|12|||
24961233|NCT00084136|50051789|FG000|NRTI Comparison|Withdrawal by Subject|54|||
24961234|NCT00084136|50051790|FG001|NRTI Comparison|Withdrawal by Subject|0|||
24961235|NCT00084136|50051791|FG002|NRTI Comparison|Withdrawal by Subject|38|||
24961236|NCT00084136|50051789|FG000|NRTI Comparison|Clinic site closed|12|||
24961237|NCT00084136|50051790|FG001|NRTI Comparison|Clinic site closed|0|||
24961238|NCT00084136|50051791|FG002|NRTI Comparison|Clinic site closed|14|||
24961239|NCT00084136|50051789|FG000|NRTI Comparison|Not reason above|1|||
24961240|NCT00084136|50051790|FG001|NRTI Comparison|Not reason above|0|||
24961241|NCT00084136|50051791|FG002|NRTI Comparison|Not reason above|0|||
24961242|NCT03812380|50051802|FG000|Overall Study|Protocol Violation|3|||
24961243|NCT03812380|50051803|FG001|Overall Study|Protocol Violation|3|||
24961244|NCT03812380|50051802|FG000|Overall Study|Withdrawal by Subject|5|||
24961245|NCT03812380|50051803|FG001|Overall Study|Withdrawal by Subject|4|||
25051962|NCT02066415|50155143|FG002|Overall Study|Withdrawal by Subject|4|||
25051963|NCT02066415|50155141|FG000|Overall Study|Lost to Follow-up|7|||
25051964|NCT02066415|50155142|FG001|Overall Study|Lost to Follow-up|2|||
25051965|NCT02066415|50155143|FG002|Overall Study|Lost to Follow-up|2|||
25051966|NCT02583256|50155155|FG000|Overall Study|Withdrawal by Subject|0|||
25051967|NCT02583256|50155156|FG001|Overall Study|Withdrawal by Subject|1|||
24961246|NCT03812380|50051802|FG000|Overall Study|Early termination of study|14|||
24961247|NCT03812380|50051803|FG001|Overall Study|Early termination of study|14|||
24961248|NCT00464945|50051811|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
24961249|NCT00464945|50051812|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
24961250|NCT00464945|50051811|FG000|Infant Series|Protocol Violation|1|||
24961251|NCT00464945|50051812|FG001|Infant Series|Protocol Violation|0|||
25051968|NCT02583256|50155157|FG002|Overall Study|Withdrawal by Subject|1|||
25051969|NCT02583256|50155158|FG003|Overall Study|Withdrawal by Subject|0|||
25051970|NCT02583256|50155155|FG000|Overall Study|Lost to Follow-up|1|||
25051971|NCT02583256|50155156|FG001|Overall Study|Lost to Follow-up|1|||
25051972|NCT02583256|50155157|FG002|Overall Study|Lost to Follow-up|0|||
25051973|NCT02583256|50155158|FG003|Overall Study|Lost to Follow-up|1|||
25051974|NCT02583256|50155155|FG000|Overall Study|Administrative/Other|2|||
25051975|NCT02583256|50155156|FG001|Overall Study|Administrative/Other|0|||
25051976|NCT02583256|50155157|FG002|Overall Study|Administrative/Other|1|||
25051977|NCT02583256|50155158|FG003|Overall Study|Administrative/Other|2|||
25051978|NCT01981551|50155179|FG000|Overall Study|Refused further treatment|8|||
25051979|NCT01981551|50155179|FG000|Overall Study|Adverse Event|1|||
25051980|NCT02584660|50155185|FG000|Overall Study|Adverse Event|4|||
25051981|NCT02584660|50155186|FG001|Overall Study|Adverse Event|0|||
25051982|NCT02584660|50155185|FG000|Overall Study|Lost to Follow-up|3|||
25051983|NCT02584660|50155186|FG001|Overall Study|Lost to Follow-up|4|||
25051984|NCT02584660|50155185|FG000|Overall Study|Protocol Violation|0|||
25051985|NCT02584660|50155186|FG001|Overall Study|Protocol Violation|1|||
25051986|NCT02584660|50155185|FG000|Overall Study|Withdrawal by Subject|0|||
25051987|NCT02584660|50155186|FG001|Overall Study|Withdrawal by Subject|2|||
25051988|NCT02584660|50155185|FG000|Overall Study|Other|0|||
25051989|NCT02584660|50155186|FG001|Overall Study|Other|1|||
25051990|NCT02582632|50155217|FG000|Overall Study|Other|1|||
25051991|NCT02178722|50155226|FG000|Overall Study|Withdrawal by Subject|0|||
25051992|NCT02178722|50155227|FG001|Overall Study|Withdrawal by Subject|0|||
25051993|NCT02178722|50155228|FG002|Overall Study|Withdrawal by Subject|0|||
25051994|NCT02178722|50155229|FG003|Overall Study|Withdrawal by Subject|2|||
25051995|NCT02178722|50155230|FG004|Overall Study|Withdrawal by Subject|33|||
25051996|NCT02178722|50155226|FG000|Overall Study|Death|2|||
25051997|NCT02178722|50155227|FG001|Overall Study|Death|13|||
25051998|NCT02178722|50155228|FG002|Overall Study|Death|12|||
25051999|NCT02178722|50155229|FG003|Overall Study|Death|12|||
25052000|NCT02178722|50155230|FG004|Overall Study|Death|205|||
25052001|NCT02178722|50155226|FG000|Overall Study|Lost to Follow-up|0|||
25052002|NCT02178722|50155227|FG001|Overall Study|Lost to Follow-up|0|||
25052003|NCT02178722|50155228|FG002|Overall Study|Lost to Follow-up|0|||
25052004|NCT02178722|50155229|FG003|Overall Study|Lost to Follow-up|2|||
24961252|NCT00464945|50051811|FG000|Infant Series|Lost to Follow-up|1|||
24961253|NCT00464945|50051812|FG001|Infant Series|Lost to Follow-up|0|||
24961254|NCT00464945|50051811|FG000|After Infant Series|Withdrawal by Subject|0|||
24961255|NCT00464945|50051812|FG001|After Infant Series|Withdrawal by Subject|2|||
24961256|NCT00464945|50051811|FG000|Toddler Dose|Lost to Follow-up|0|||
24961257|NCT00464945|50051812|FG001|Toddler Dose|Lost to Follow-up|1|||
24961258|NCT00464087|50051837|FG000|Overall Study|No PCI per inclusion criteria|0|||
24961259|NCT00464087|50051838|FG001|Overall Study|No PCI per inclusion criteria|0|||
24961260|NCT00464087|50051839|FG002|Overall Study|No PCI per inclusion criteria|29|||
24961261|NCT00452699|50051849|FG000|Overall Study|Adverse Event|10|||
25052005|NCT02178722|50155230|FG004|Overall Study|Lost to Follow-up|11|||
25052006|NCT02178722|50155226|FG000|Overall Study|Study terminated by Sponsor|2|||
25052007|NCT02178722|50155227|FG001|Overall Study|Study terminated by Sponsor|7|||
25052008|NCT02178722|50155228|FG002|Overall Study|Study terminated by Sponsor|6|||
25052009|NCT02178722|50155229|FG003|Overall Study|Study terminated by Sponsor|4|||
25052010|NCT02178722|50155230|FG004|Overall Study|Study terminated by Sponsor|128|||
25052011|NCT02178722|50155226|FG000|Overall Study|Physician Decision|0|||
25052012|NCT02178722|50155227|FG001|Overall Study|Physician Decision|0|||
24961262|NCT00452699|50051850|FG001|Overall Study|Adverse Event|3|||
24961263|NCT00452699|50051849|FG000|Overall Study|Lack of Efficacy|6|||
24961264|NCT00452699|50051850|FG001|Overall Study|Lack of Efficacy|4|||
24961265|NCT00452699|50051849|FG000|Overall Study|Lost to Follow-up|6|||
24961266|NCT00452699|50051850|FG001|Overall Study|Lost to Follow-up|9|||
24961267|NCT00452699|50051849|FG000|Overall Study|Protocol Violation|21|||
24961268|NCT00452699|50051850|FG001|Overall Study|Protocol Violation|25|||
24961269|NCT00452699|50051849|FG000|Overall Study|Withdrawal by Subject|26|||
24961270|NCT00452699|50051850|FG001|Overall Study|Withdrawal by Subject|25|||
25052013|NCT02178722|50155228|FG002|Overall Study|Physician Decision|0|||
25052014|NCT02178722|50155229|FG003|Overall Study|Physician Decision|0|||
25052015|NCT02178722|50155230|FG004|Overall Study|Physician Decision|3|||
25052016|NCT02178722|50155226|FG000|Overall Study|Other|0|||
25052017|NCT02178722|50155227|FG001|Overall Study|Other|0|||
25052018|NCT02178722|50155228|FG002|Overall Study|Other|0|||
25052019|NCT02178722|50155229|FG003|Overall Study|Other|0|||
25052020|NCT02178722|50155230|FG004|Overall Study|Other|2|||
25052021|NCT00972309|50155247|FG000|Overall Study|Switched to alternative treatment|0|||
24961271|NCT00452699|50051849|FG000|Overall Study|Other|12|||
24961272|NCT00452699|50051850|FG001|Overall Study|Other|7|||
25052022|NCT00972309|50155248|FG001|Overall Study|Switched to alternative treatment|2|||
25052023|NCT00972309|50155247|FG000|Overall Study|Refused further treatment|0|||
25052024|NCT00972309|50155248|FG001|Overall Study|Refused further treatment|1|||
25052025|NCT00972309|50155247|FG000|Overall Study|Late determination of ineligibility|0|||
25052026|NCT00972309|50155248|FG001|Overall Study|Late determination of ineligibility|1|||
25052027|NCT00972309|50155247|FG000|Overall Study|Second malignancy|1|||
25052028|NCT00972309|50155248|FG001|Overall Study|Second malignancy|1|||
24961273|NCT00069784|50051858|FG000|Overall Study|Adverse Event|105|||
25052029|NCT00972309|50155247|FG000|Overall Study|Visa issues|0|||
25052030|NCT00972309|50155248|FG001|Overall Study|Visa issues|1|||
25052031|NCT00972309|50155247|FG000|Overall Study|Secondary cancer (SCC)|0|||
25052032|NCT00972309|50155248|FG001|Overall Study|Secondary cancer (SCC)|1|||
24961274|NCT00069784|50051859|FG001|Overall Study|Adverse Event|0|||
24961275|NCT00069784|50051858|FG000|Overall Study|Withdrawal by Subject|1090|||
24961276|NCT00069784|50051859|FG001|Overall Study|Withdrawal by Subject|0|||
24961277|NCT00069784|50051858|FG000|Overall Study|Other|17|||
24961278|NCT00069784|50051859|FG001|Overall Study|Other|0|||
24961279|NCT03811834|50051865|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
24961280|NCT00090610|50051880|FG000|Overall Study|Withdrawal by Subject|1|||
24961281|NCT00090610|50051881|FG001|Overall Study|Withdrawal by Subject|1|||
24961282|NCT00463385|50051891|FG000|Overall Study|Other|4|||
24961283|NCT00463385|50051892|FG001|Overall Study|Other|3|||
24961284|NCT00463385|50051893|FG002|Overall Study|Other|6|||
24961285|NCT00463385|50051894|FG003|Overall Study|Other|4|||
24961286|NCT00463385|50051891|FG000|Overall Study|Adverse Event|5|||
24961287|NCT00463385|50051892|FG001|Overall Study|Adverse Event|8|||
24961288|NCT00463385|50051893|FG002|Overall Study|Adverse Event|4|||
24961289|NCT00463385|50051894|FG003|Overall Study|Adverse Event|2|||
24961290|NCT00463385|50051891|FG000|Overall Study|Lack of Efficacy|6|||
24961291|NCT00463385|50051892|FG001|Overall Study|Lack of Efficacy|6|||
24961292|NCT00463385|50051893|FG002|Overall Study|Lack of Efficacy|7|||
24961293|NCT00463385|50051894|FG003|Overall Study|Lack of Efficacy|9|||
24961294|NCT00463385|50051891|FG000|Overall Study|Withdrawal by Subject|3|||
24961295|NCT00463385|50051892|FG001|Overall Study|Withdrawal by Subject|3|||
24961296|NCT00463385|50051893|FG002|Overall Study|Withdrawal by Subject|3|||
24961297|NCT00463385|50051894|FG003|Overall Study|Withdrawal by Subject|4|||
24961298|NCT00463385|50051891|FG000|Overall Study|Lost to Follow-up|0|||
24961299|NCT00463385|50051892|FG001|Overall Study|Lost to Follow-up|0|||
24961300|NCT00463385|50051893|FG002|Overall Study|Lost to Follow-up|0|||
24961301|NCT00463385|50051894|FG003|Overall Study|Lost to Follow-up|1|||
24961302|NCT00463385|50051891|FG000|Overall Study|Death|2|||
24961303|NCT00463385|50051892|FG001|Overall Study|Death|1|||
24961304|NCT00463385|50051893|FG002|Overall Study|Death|2|||
24961305|NCT00463385|50051894|FG003|Overall Study|Death|0|||
24961306|NCT00463385|50051891|FG000|Overall Study|Missing|2|||
24961307|NCT00463385|50051892|FG001|Overall Study|Missing|0|||
24961308|NCT00463385|50051893|FG002|Overall Study|Missing|0|||
24961309|NCT00463385|50051894|FG003|Overall Study|Missing|2|||
24961310|NCT00463385|50051891|FG000|Overall Study|1 participant received commercial drug|0|||
24961311|NCT00463385|50051892|FG001|Overall Study|1 participant received commercial drug|1|||
24961312|NCT00463385|50051893|FG002|Overall Study|1 participant received commercial drug|0|||
24961313|NCT00463385|50051894|FG003|Overall Study|1 participant received commercial drug|0|||
24961314|NCT00463229|50051914|FG000|Overall Study|Lost to Follow-up|5|||
24961315|NCT00463229|50051915|FG001|Overall Study|Lost to Follow-up|7|||
24961316|NCT00463229|50051914|FG000|Overall Study|Death|4|||
24961317|NCT00463229|50051915|FG001|Overall Study|Death|3|||
24961318|NCT03839693|50051925|FG000|Overall Study|Lost to Follow-up|0|||
24961319|NCT03839693|50051926|FG001|Overall Study|Lost to Follow-up|2|||
24961320|NCT03839693|50051927|FG002|Overall Study|Lost to Follow-up|2|||
24961321|NCT03839693|50051925|FG000|Overall Study|Withdrawal by Subject|1|||
24961322|NCT03839693|50051926|FG001|Overall Study|Withdrawal by Subject|0|||
25067419|NCT02397460|50173043|FG006|Treatment Period 4|Physician Decision|0|||
25186579|NCT02647320|50337194|FG001|Overall Study|Adverse Event|1|||
24961323|NCT03839693|50051927|FG002|Overall Study|Withdrawal by Subject|2|||
24961324|NCT03839693|50051925|FG000|Overall Study|subject moved out of the area|1|||
24961325|NCT03839693|50051926|FG001|Overall Study|subject moved out of the area|0|||
24961326|NCT03839693|50051927|FG002|Overall Study|subject moved out of the area|0|||
24961327|NCT00068692|50051940|FG000|Step 1: Registration|Disese progression/relapse|5|||
25052033|NCT00972309|50155247|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
25052034|NCT00972309|50155248|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
25052035|NCT00972309|50155247|FG000|Overall Study|Lost to Follow-up|1|||
25052036|NCT00972309|50155248|FG001|Overall Study|Lost to Follow-up|1|||
25052037|NCT00972309|50155247|FG000|Overall Study|Disease progression on study|10|||
25052038|NCT00972309|50155248|FG001|Overall Study|Disease progression on study|4|||
25052039|NCT02582242|50155267|FG000|Overall Study|Adverse Event|4|||
25052040|NCT02582242|50155268|FG001|Overall Study|Adverse Event|3|||
25052041|NCT02582242|50155267|FG000|Overall Study|Protocol Violation|3|||
25052042|NCT02582242|50155268|FG001|Overall Study|Protocol Violation|1|||
25052043|NCT02582242|50155267|FG000|Overall Study|Lost to Follow-up|0|||
25052044|NCT02582242|50155268|FG001|Overall Study|Lost to Follow-up|1|||
25052045|NCT02582242|50155267|FG000|Overall Study|Withdrawal by Subject|11|||
25052046|NCT02582242|50155268|FG001|Overall Study|Withdrawal by Subject|11|||
25052047|NCT02582242|50155267|FG000|Overall Study|Unclassified|2|||
25052048|NCT02582242|50155268|FG001|Overall Study|Unclassified|1|||
25052049|NCT00663351|50155276|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
25052050|NCT00663351|50155277|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
25052051|NCT00663351|50155276|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
25052052|NCT00663351|50155277|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
25052053|NCT00663351|50155276|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
25052054|NCT00663351|50155277|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
25052055|NCT00663351|50155276|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
25052056|NCT00663351|50155277|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
25052057|NCT00663351|50155276|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
25052058|NCT00663351|50155277|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
25052059|NCT00663351|50155276|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
25052060|NCT00663351|50155277|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
25052061|NCT00616941|50155286|FG000|Overall Study|Progressive Disease|1|||
25052062|NCT00616941|50155287|FG001|Overall Study|Progressive Disease|2|||
25052063|NCT00616941|50155288|FG002|Overall Study|Progressive Disease|1|||
25052064|NCT00616941|50155286|FG000|Overall Study|Adverse Event|0|||
25052065|NCT00616941|50155287|FG001|Overall Study|Adverse Event|1|||
25052066|NCT00616941|50155288|FG002|Overall Study|Adverse Event|1|||
25052067|NCT00616941|50155286|FG000|Overall Study|Subject Non-compliance|0|||
25052068|NCT00616941|50155287|FG001|Overall Study|Subject Non-compliance|0|||
24961328|NCT00068692|50051941|FG001|Step 1: Registration|Disese progression/relapse|0|||
24961329|NCT00068692|50051942|FG002|Step 1: Registration|Disese progression/relapse|0|||
24961330|NCT00068692|50051943|FG003|Step 1: Registration|Disese progression/relapse|0|||
24961331|NCT00068692|50051944|FG004|Step 1: Registration|Disese progression/relapse|0|||
24961332|NCT00068692|50051945|FG005|Step 1: Registration|Disese progression/relapse|0|||
24961333|NCT00068692|50051946|FG006|Step 1: Registration|Disese progression/relapse|0|||
25052069|NCT00616941|50155288|FG002|Overall Study|Subject Non-compliance|1|||
25052070|NCT00616941|50155286|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
25052071|NCT00616941|50155287|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
25052072|NCT00616941|50155288|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
25052073|NCT00616941|50155286|FG000|Overall Study|Vaccination Suspended|0|||
25052074|NCT00616941|50155287|FG001|Overall Study|Vaccination Suspended|0|||
25052075|NCT00616941|50155288|FG002|Overall Study|Vaccination Suspended|3|||
25052076|NCT02581930|50155296|FG000|Overall Study|Withdrawal by Subject|1|||
25052077|NCT02581930|50155296|FG000|Overall Study|patient declined further treatment|1|||
25052078|NCT00105560|50155300|FG000|Overall Study|Lost to Follow-up|1|||
25052079|NCT02577718|50155313|FG000|Overall Study|Death|6|||
25052080|NCT02577718|50155313|FG000|Overall Study|Withdrawal by Subject|2|||
25052081|NCT00520533|50155319|FG000|Overall Study|Death|1|||
25052082|NCT00520533|50155319|FG000|Overall Study|Suspension of the study for safety reasons|1|||
25052083|NCT00520533|50155319|FG000|Overall Study|Withdrawal by Subject|1|||
25052084|NCT00520533|50155319|FG000|Overall Study|Physician Decision|1|||
25052085|NCT01664104|50155328|FG000|Overall Study|Adverse Event|6|||
25052086|NCT01664104|50155328|FG000|Overall Study|Lack of Efficacy|2|||
25052087|NCT01664104|50155328|FG000|Overall Study|Withdrawal by Subject|1|||
25052088|NCT01664104|50155328|FG000|Overall Study|Lost to Follow-up|4|||
25052089|NCT01664104|50155328|FG000|Overall Study|Other|1|||
25052090|NCT01664104|50155328|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
25052091|NCT02739984|50155336|FG000|Overall Study|Sponsor Decision|1|||
25052092|NCT02739984|50155337|FG001|Overall Study|Sponsor Decision|0|||
25052093|NCT02739984|50155336|FG000|Overall Study|Withdrawal by Subject|1|||
25052094|NCT02739984|50155337|FG001|Overall Study|Withdrawal by Subject|1|||
25052095|NCT02739984|50155336|FG000|Overall Study|Death|0|||
25052096|NCT02739984|50155337|FG001|Overall Study|Death|1|||
25052097|NCT02739984|50155336|FG000|Overall Study|Lost to Follow-up|3|||
25052098|NCT02739984|50155337|FG001|Overall Study|Lost to Follow-up|0|||
24961334|NCT00068692|50051947|FG007|Step 1: Registration|Disese progression/relapse|0|||
25052099|NCT00496730|50155345|FG000|Overall Study|Lost to Follow-up|4|||
25052100|NCT00496730|50155346|FG001|Overall Study|Lost to Follow-up|3|||
25052101|NCT00496730|50155345|FG000|Overall Study|Withdrawal by Subject|2|||
25052102|NCT00496730|50155346|FG001|Overall Study|Withdrawal by Subject|2|||
25052103|NCT02739828|50155352|FG000|Overall Study|Adverse Event|1|||
25052104|NCT02739828|50155352|FG000|Overall Study|Lost to Follow-up|4|||
25052105|NCT04435808|50155358|FG000|Overall Study|Study stopped by DSMB|0|||
25052106|NCT04435808|50155359|FG001|Overall Study|Study stopped by DSMB|1|||
25052107|NCT01664494|50155382|FG000|Overall Study|Withdrawal by Subject|27|||
24961335|NCT00068692|50051940|FG000|Step 1: Registration|Adverse Event|7|||
25052108|NCT01664494|50155382|FG000|Overall Study|Death|18|||
25052109|NCT01664494|50155382|FG000|Overall Study|Other|49|||
25052110|NCT01664494|50155382|FG000|Overall Study|Lost to Follow-up|99|||
25052111|NCT02577016|50155388|FG000|Overall Study|Adverse Event|2|||
25052112|NCT02577016|50155389|FG001|Overall Study|Adverse Event|1|||
25052113|NCT02577016|50155388|FG000|Overall Study|Physician Decision|0|||
25052114|NCT02577016|50155389|FG001|Overall Study|Physician Decision|1|||
25052115|NCT05101252|50155397|FG000|Overall Study|Unsatisfactory Test Article|1|||
25052116|NCT05101252|50155398|FG001|Overall Study|Unsatisfactory Test Article|0|||
25052117|NCT05101252|50155397|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
25052118|NCT05101252|50155398|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
25052119|NCT05101252|50155397|FG000|Overall Study|Withdrew Consent during study|0|||
25052120|NCT05101252|50155398|FG001|Overall Study|Withdrew Consent during study|1|||
25052121|NCT05101252|50155397|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
25052122|NCT05101252|50155398|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
25052123|NCT03316586|50155404|FG000|Overall Study|Adverse Event|2|||
25052124|NCT03316586|50155404|FG000|Overall Study|Physician Decision|3|||
25052125|NCT03316586|50155404|FG000|Overall Study|Lack of Efficacy|10|||
25052126|NCT03316586|50155404|FG000|Overall Study|still on treatment|1|||
25052127|NCT03316586|50155404|FG000|Overall Study|Patient needed radiation therapy|1|||
25052128|NCT03316586|50155404|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
25052129|NCT02994927|50155410|FG000|Overall Study|Withdrawal by parent/guardian|0|||
25052130|NCT02994927|50155411|FG001|Overall Study|Withdrawal by parent/guardian|1|||
25052131|NCT02994927|50155410|FG000|Overall Study|Did not meet eligibility criteria|0|||
25052132|NCT02994927|50155411|FG001|Overall Study|Did not meet eligibility criteria|1|||
25052133|NCT02994927|50155410|FG000|Overall Study|Physician Decision|4|||
25052134|NCT02994927|50155411|FG001|Overall Study|Physician Decision|3|||
25052135|NCT02994927|50155410|FG000|Overall Study|Death|4|||
25052136|NCT02994927|50155411|FG001|Overall Study|Death|2|||
25052137|NCT02994927|50155410|FG000|Overall Study|Adverse Event|2|||
25052138|NCT02994927|50155411|FG001|Overall Study|Adverse Event|1|||
25052139|NCT02994927|50155410|FG000|Overall Study|Withdrawal by Subject|3|||
25052140|NCT02994927|50155411|FG001|Overall Study|Withdrawal by Subject|6|||
25052141|NCT02994927|50155410|FG000|Overall Study|Lost to Follow-up|2|||
25052142|NCT02994927|50155411|FG001|Overall Study|Lost to Follow-up|1|||
25052143|NCT00107991|50155417|FG000|Eligibility Assessment|Disease not severe enough|7|||
25052144|NCT00107991|50155417|FG000|Eligibility Assessment|Unwilling to participate|7|||
25052145|NCT00107991|50155417|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
25052146|NCT00107991|50155417|FG000|Eligibility Assessment|Abnormal labs|2|||
25052147|NCT00107991|50155417|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
25052148|NCT00107991|50155417|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
25052149|NCT00107991|50155417|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
25052150|NCT00107991|50155417|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
25052151|NCT00107991|50155417|FG000|12 Week Treatment Period|Adverse Event|1|||
25052152|NCT00107991|50155417|FG000|12 Week Treatment Period|Protocol Violation|1|||
25052153|NCT00107991|50155417|FG000|12 Week Treatment Period|Incarcerated|1|||
25052154|NCT00107991|50155417|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
25276530|NCT00957658|50590469|FG000|Overall Study|Incomplete 2 yr data|28|||
25276531|NCT00957658|50590469|FG000|Overall Study|Site termination|10|||
25276532|NCT00957658|50590469|FG000|Overall Study|unwilling/unable to return|2|||
25276533|NCT00957658|50590469|FG000|Overall Study|surgery cancelled|2|||
25276534|NCT00957658|50590469|FG000|Overall Study|Protocol Violation|5|||
25276535|NCT00953680|50590475|FG000|Period 1|Withdrawal by Subject|0|||
25052161|NCT00492856|50155430|FG000|Induction|Adverse Event|2|||
25052162|NCT00492856|50155431|FG001|Induction|Adverse Event|0|||
25052163|NCT00492856|50155432|FG002|Induction|Adverse Event|0|||
25052164|NCT00492856|50155433|FG003|Induction|Adverse Event|0|||
25052165|NCT00492856|50155430|FG000|Induction|Withdrawal by Subject|1|||
25052166|NCT00492856|50155431|FG001|Induction|Withdrawal by Subject|0|||
25052167|NCT00492856|50155432|FG002|Induction|Withdrawal by Subject|0|||
25052168|NCT00492856|50155433|FG003|Induction|Withdrawal by Subject|0|||
25052169|NCT00492856|50155430|FG000|Induction|Death|3|||
25052170|NCT00492856|50155431|FG001|Induction|Death|0|||
25052171|NCT00492856|50155432|FG002|Induction|Death|0|||
25052172|NCT00492856|50155433|FG003|Induction|Death|0|||
25052173|NCT00492856|50155430|FG000|Consolidation|Adverse Event|6|||
25052174|NCT00492856|50155431|FG001|Consolidation|Adverse Event|0|||
25052175|NCT00492856|50155432|FG002|Consolidation|Adverse Event|0|||
25052176|NCT00492856|50155433|FG003|Consolidation|Adverse Event|0|||
25052177|NCT00492856|50155430|FG000|Consolidation|Not protocol specified|2|||
24961336|NCT00068692|50051941|FG001|Step 1: Registration|Adverse Event|0|||
24961337|NCT00068692|50051942|FG002|Step 1: Registration|Adverse Event|0|||
24961338|NCT00068692|50051943|FG003|Step 1: Registration|Adverse Event|0|||
24961339|NCT00068692|50051944|FG004|Step 1: Registration|Adverse Event|0|||
24961340|NCT00068692|50051945|FG005|Step 1: Registration|Adverse Event|0|||
24961341|NCT00068692|50051946|FG006|Step 1: Registration|Adverse Event|0|||
24961342|NCT00068692|50051947|FG007|Step 1: Registration|Adverse Event|0|||
24961343|NCT00068692|50051940|FG000|Step 1: Registration|Death|1|||
24961344|NCT00068692|50051941|FG001|Step 1: Registration|Death|0|||
24961345|NCT00068692|50051942|FG002|Step 1: Registration|Death|0|||
25052178|NCT00492856|50155431|FG001|Consolidation|Not protocol specified|0|||
25052179|NCT00492856|50155432|FG002|Consolidation|Not protocol specified|0|||
25052180|NCT00492856|50155433|FG003|Consolidation|Not protocol specified|0|||
25052181|NCT00492856|50155430|FG000|Consolidation|Lost to Follow-up|1|||
25052182|NCT00492856|50155431|FG001|Consolidation|Lost to Follow-up|0|||
25052183|NCT00492856|50155432|FG002|Consolidation|Lost to Follow-up|0|||
25052184|NCT00492856|50155433|FG003|Consolidation|Lost to Follow-up|0|||
25052185|NCT00492856|50155430|FG000|Post-consolidation|Adverse Event|0|||
25052186|NCT00492856|50155431|FG001|Post-consolidation|Adverse Event|4|||
25052187|NCT00492856|50155432|FG002|Post-consolidation|Adverse Event|0|||
25052188|NCT00492856|50155433|FG003|Post-consolidation|Adverse Event|1|||
25052189|NCT00492856|50155430|FG000|Post-consolidation|Withdrawal by Subject|0|||
25052190|NCT00492856|50155431|FG001|Post-consolidation|Withdrawal by Subject|4|||
25052191|NCT00492856|50155432|FG002|Post-consolidation|Withdrawal by Subject|0|||
25052192|NCT00492856|50155433|FG003|Post-consolidation|Withdrawal by Subject|0|||
25052193|NCT00492856|50155430|FG000|Post-consolidation|Death|0|||
25052194|NCT00492856|50155431|FG001|Post-consolidation|Death|1|||
25052195|NCT00492856|50155432|FG002|Post-consolidation|Death|0|||
25052196|NCT00492856|50155433|FG003|Post-consolidation|Death|0|||
25052197|NCT00492856|50155430|FG000|Post-consolidation|Not protocol specified|0|||
25052198|NCT00492856|50155431|FG001|Post-consolidation|Not protocol specified|1|||
25052199|NCT00492856|50155432|FG002|Post-consolidation|Not protocol specified|0|||
25052200|NCT00492856|50155433|FG003|Post-consolidation|Not protocol specified|0|||
25052201|NCT00492856|50155430|FG000|Post-consolidation|Lost to Follow-up|0|||
25052202|NCT00492856|50155431|FG001|Post-consolidation|Lost to Follow-up|2|||
25052203|NCT00492856|50155432|FG002|Post-consolidation|Lost to Follow-up|0|||
25052204|NCT00492856|50155433|FG003|Post-consolidation|Lost to Follow-up|0|||
25052205|NCT00492856|50155430|FG000|Post-consolidation|Observation Arm|0|||
25052206|NCT00492856|50155431|FG001|Post-consolidation|Observation Arm|0|||
25052207|NCT00492856|50155432|FG002|Post-consolidation|Observation Arm|27|||
25052208|NCT00492856|50155433|FG003|Post-consolidation|Observation Arm|0|||
25052209|NCT02782377|50155445|FG000|Overall Study|Physician Decision|5|||
25052210|NCT02410629|50155452|FG000|Overall Study|Family cannot commit to the study|2|||
25052211|NCT02410629|50155453|FG001|Overall Study|Family cannot commit to the study|1|||
25052212|NCT02410629|50155452|FG000|Overall Study|Subject returned to work|1|||
25052213|NCT02410629|50155453|FG001|Overall Study|Subject returned to work|0|||
25052214|NCT02410629|50155452|FG000|Overall Study|Subject moved back to home country|0|||
25052215|NCT02410629|50155453|FG001|Overall Study|Subject moved back to home country|1|||
24961346|NCT00068692|50051943|FG003|Step 1: Registration|Death|0|||
25052216|NCT02410629|50155452|FG000|Overall Study|Subject underwent heart surgery|0|||
25052217|NCT02410629|50155453|FG001|Overall Study|Subject underwent heart surgery|1|||
25052218|NCT02252211|50155461|FG000|Overall Study|Adverse Event|0|||
25052219|NCT02252211|50155462|FG001|Overall Study|Adverse Event|1|||
25052220|NCT02252211|50155463|FG002|Overall Study|Adverse Event|0|||
25052221|NCT02252211|50155461|FG000|Overall Study|Progressive disease|3|||
25052222|NCT02252211|50155462|FG001|Overall Study|Progressive disease|2|||
25052223|NCT02252211|50155463|FG002|Overall Study|Progressive disease|0|||
25052224|NCT02252211|50155461|FG000|Overall Study|Withdrawal by Subject|1|||
25052225|NCT02252211|50155462|FG001|Overall Study|Withdrawal by Subject|0|||
25052226|NCT02252211|50155463|FG002|Overall Study|Withdrawal by Subject|0|||
25052227|NCT02252211|50155461|FG000|Overall Study|Serious Adverse Event During Screening|1|||
25052228|NCT02252211|50155462|FG001|Overall Study|Serious Adverse Event During Screening|0|||
25052229|NCT02252211|50155463|FG002|Overall Study|Serious Adverse Event During Screening|1|||
25052230|NCT02776683|50155470|FG000|Pre-switch Period|Protocol Violation|1|||
25052231|NCT02776683|50155471|FG001|Pre-switch Period|Protocol Violation|0|||
25052232|NCT02776683|50155470|FG000|Pre-switch Period|Adverse Event|21|||
25052233|NCT02776683|50155471|FG001|Pre-switch Period|Adverse Event|0|||
25052234|NCT02776683|50155470|FG000|Pre-switch Period|Withdrawal by Subject|9|||
25052235|NCT02776683|50155471|FG001|Pre-switch Period|Withdrawal by Subject|0|||
25052236|NCT02776683|50155470|FG000|Pre-switch Period|Physician Decision|7|||
25052237|NCT02776683|50155471|FG001|Pre-switch Period|Physician Decision|0|||
25052238|NCT02776683|50155470|FG000|Pre-switch Period|Progressive disease|39|||
25052239|NCT02776683|50155471|FG001|Pre-switch Period|Progressive disease|0|||
25052240|NCT02776683|50155470|FG000|Pre-switch Period|Other than listed|3|||
25052241|NCT02776683|50155471|FG001|Pre-switch Period|Other than listed|0|||
25052242|NCT02776683|50155470|FG000|Post-switch Period|Adverse Event|0|||
25052243|NCT02776683|50155471|FG001|Post-switch Period|Adverse Event|3|||
25052244|NCT02776683|50155470|FG000|Post-switch Period|Withdrawal by Subject|0|||
25052245|NCT02776683|50155471|FG001|Post-switch Period|Withdrawal by Subject|2|||
25052246|NCT02776683|50155470|FG000|Post-switch Period|Physician Decision|0|||
25052247|NCT02776683|50155471|FG001|Post-switch Period|Physician Decision|3|||
25052248|NCT02776683|50155470|FG000|Post-switch Period|Progressive disease|0|||
25052249|NCT02776683|50155471|FG001|Post-switch Period|Progressive disease|20|||
25052250|NCT02776683|50155470|FG000|Post-switch Period|Other than listed|0|||
24961347|NCT00068692|50051944|FG004|Step 1: Registration|Death|0|||
24961348|NCT00068692|50051945|FG005|Step 1: Registration|Death|0|||
25052251|NCT02776683|50155471|FG001|Post-switch Period|Other than listed|15|||
25052252|NCT02731742|50155479|FG000|Overall Study|Death|1|||
25052253|NCT02731742|50155480|FG001|Overall Study|Death|2|||
25052254|NCT02731742|50155481|FG002|Overall Study|Death|5|||
25052255|NCT02731742|50155482|FG003|Overall Study|Death|0|||
25052256|NCT02731742|50155479|FG000|Overall Study|Physician Decision|0|||
25052257|NCT02731742|50155480|FG001|Overall Study|Physician Decision|0|||
25052258|NCT02731742|50155481|FG002|Overall Study|Physician Decision|0|||
25052259|NCT02731742|50155482|FG003|Overall Study|Physician Decision|1|||
25052260|NCT02731742|50155479|FG000|Overall Study|Study Terminated by Sponsor|2|||
25052261|NCT02731742|50155480|FG001|Overall Study|Study Terminated by Sponsor|1|||
25052262|NCT02731742|50155481|FG002|Overall Study|Study Terminated by Sponsor|1|||
25052263|NCT02731742|50155482|FG003|Overall Study|Study Terminated by Sponsor|1|||
25052264|NCT00104871|50155505|FG000|Overall Study|Not evaluable|1|||
25052265|NCT03487796|50155513|FG000|Overall Study|Lost to Follow-up|18|||
25052266|NCT03487796|50155514|FG001|Overall Study|Lost to Follow-up|6|||
25052267|NCT02148705|50155529|FG000|Overall Study|Death|2|||
25052268|NCT02148705|50155530|FG001|Overall Study|Death|0|||
25052269|NCT02148705|50155531|FG002|Overall Study|Death|0|||
25052270|NCT02148705|50155529|FG000|Overall Study|Lost to Follow-up|13|||
25052271|NCT02148705|50155530|FG001|Overall Study|Lost to Follow-up|4|||
25052272|NCT02148705|50155531|FG002|Overall Study|Lost to Follow-up|10|||
25052273|NCT02148705|50155529|FG000|Overall Study|Withdrawal by Subject|3|||
25052274|NCT02148705|50155530|FG001|Overall Study|Withdrawal by Subject|0|||
25052275|NCT02148705|50155531|FG002|Overall Study|Withdrawal by Subject|2|||
25052276|NCT02148705|50155529|FG000|Overall Study|Not Treated|0|||
25052277|NCT02148705|50155530|FG001|Overall Study|Not Treated|1|||
25052278|NCT02148705|50155531|FG002|Overall Study|Not Treated|5|||
25052279|NCT03446612|50155541|FG000|Overall Study|Protocol defined stopping criteria|0|||
25052280|NCT03446612|50155542|FG001|Overall Study|Protocol defined stopping criteria|1|||
24961349|NCT00068692|50051946|FG006|Step 1: Registration|Death|0|||
24961350|NCT00068692|50051947|FG007|Step 1: Registration|Death|0|||
24961351|NCT00068692|50051940|FG000|Step 1: Registration|Withdrawal by Subject|11|||
24961352|NCT00068692|50051941|FG001|Step 1: Registration|Withdrawal by Subject|0|||
24961353|NCT00068692|50051942|FG002|Step 1: Registration|Withdrawal by Subject|0|||
24961354|NCT00068692|50051943|FG003|Step 1: Registration|Withdrawal by Subject|0|||
24961355|NCT00068692|50051944|FG004|Step 1: Registration|Withdrawal by Subject|0|||
24961356|NCT00068692|50051945|FG005|Step 1: Registration|Withdrawal by Subject|0|||
24961357|NCT00068692|50051946|FG006|Step 1: Registration|Withdrawal by Subject|0|||
24961358|NCT00068692|50051947|FG007|Step 1: Registration|Withdrawal by Subject|0|||
25052281|NCT02730728|50155553|FG000|Overall Study|Withdrawal by Subject|0|||
25052282|NCT02730728|50155554|FG001|Overall Study|Withdrawal by Subject|1|||
25052283|NCT02730728|50155555|FG002|Overall Study|Withdrawal by Subject|0|||
24961359|NCT00068692|50051940|FG000|Step 1: Registration|Alternative therapy|2|||
24961360|NCT00068692|50051941|FG001|Step 1: Registration|Alternative therapy|0|||
24961361|NCT00068692|50051942|FG002|Step 1: Registration|Alternative therapy|0|||
25052284|NCT02730728|50155553|FG000|Overall Study|Lack of Efficacy|0|||
25052285|NCT02730728|50155554|FG001|Overall Study|Lack of Efficacy|1|||
25052286|NCT02730728|50155555|FG002|Overall Study|Lack of Efficacy|1|||
25052287|NCT02580058|50155566|FG000|Overall Study|Lost to Follow-up|4|||
25052288|NCT02580058|50155567|FG001|Overall Study|Lost to Follow-up|5|||
24961362|NCT00068692|50051943|FG003|Step 1: Registration|Alternative therapy|0|||
25052289|NCT02580058|50155568|FG002|Overall Study|Lost to Follow-up|4|||
25052290|NCT02580058|50155566|FG000|Overall Study|Ongoing|51|||
25052291|NCT02580058|50155567|FG001|Overall Study|Ongoing|55|||
25052292|NCT02580058|50155568|FG002|Overall Study|Ongoing|46|||
25052293|NCT02580058|50155566|FG000|Overall Study|Withdrawal by Subject|24|||
25052294|NCT02580058|50155567|FG001|Overall Study|Withdrawal by Subject|26|||
25052295|NCT02580058|50155568|FG002|Overall Study|Withdrawal by Subject|36|||
25052296|NCT00104637|50155576|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
25052297|NCT00104637|50155577|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
25052298|NCT02768103|50155586|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
25052299|NCT02767323|50155595|FG000|Overall Study|Withdrawal by Subject|17|||
25052300|NCT02767323|50155596|FG001|Overall Study|Withdrawal by Subject|5|||
25052301|NCT02767323|50155597|FG002|Overall Study|Withdrawal by Subject|13|||
25052302|NCT02767323|50155598|FG003|Overall Study|Withdrawal by Subject|0|||
25052303|NCT02767323|50155595|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
25052304|NCT02767323|50155596|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
25052305|NCT02767323|50155597|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
25052306|NCT02767323|50155598|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
25052307|NCT04304950|50155613|FG000|Overall Study|Lost to Follow-up|1|||
25052308|NCT04304950|50155614|FG001|Overall Study|Lost to Follow-up|1|||
25052309|NCT02780115|50155628|FG000|Overall Study|Withdrawal by Subject|0|||
25052310|NCT02780115|50155629|FG001|Overall Study|Withdrawal by Subject|1|||
25052311|NCT02780115|50155630|FG002|Overall Study|Withdrawal by Subject|1|||
25052312|NCT02780115|50155631|FG003|Overall Study|Withdrawal by Subject|0|||
25052313|NCT02780115|50155632|FG004|Overall Study|Withdrawal by Subject|0|||
25052314|NCT02780115|50155628|FG000|Overall Study|Adverse Event|0|||
25052315|NCT02780115|50155629|FG001|Overall Study|Adverse Event|0|||
25052316|NCT02780115|50155630|FG002|Overall Study|Adverse Event|0|||
25052317|NCT02780115|50155631|FG003|Overall Study|Adverse Event|1|||
25052318|NCT02780115|50155632|FG004|Overall Study|Adverse Event|1|||
25052319|NCT02766777|50155644|FG000|Overall Study|Adverse Event|12|||
25052320|NCT02766777|50155644|FG000|Overall Study|Lost to Follow-up|16|||
25052321|NCT02766777|50155644|FG000|Overall Study|Non-Compliance With Study Drug|1|||
25052322|NCT02766777|50155644|FG000|Overall Study|Protocol Violation|1|||
25052323|NCT02766777|50155644|FG000|Overall Study|Withdrawal by Subject|4|||
25052324|NCT00157014|50155652|FG000|Overall Study|Death|4|||
25052325|NCT00157014|50155653|FG001|Overall Study|Death|2|||
25052326|NCT00157014|50155654|FG002|Overall Study|Death|1|||
25052327|NCT00157014|50155655|FG003|Overall Study|Death|1|||
25052328|NCT00157014|50155652|FG000|Overall Study|Physician Decision|0|||
25052329|NCT00157014|50155653|FG001|Overall Study|Physician Decision|1|||
25052330|NCT00157014|50155654|FG002|Overall Study|Physician Decision|0|||
25052331|NCT00157014|50155655|FG003|Overall Study|Physician Decision|0|||
25052332|NCT00157014|50155652|FG000|Overall Study|Medications withdrawn on family request|0|||
25052333|NCT00157014|50155653|FG001|Overall Study|Medications withdrawn on family request|1|||
25052334|NCT00157014|50155654|FG002|Overall Study|Medications withdrawn on family request|0|||
25052335|NCT00157014|50155655|FG003|Overall Study|Medications withdrawn on family request|0|||
25052336|NCT00157014|50155652|FG000|Overall Study|Patient withdrawn by investigator|1|||
24961363|NCT00068692|50051944|FG004|Step 1: Registration|Alternative therapy|0|||
24961364|NCT00068692|50051945|FG005|Step 1: Registration|Alternative therapy|0|||
24961365|NCT00068692|50051946|FG006|Step 1: Registration|Alternative therapy|0|||
24961366|NCT00068692|50051947|FG007|Step 1: Registration|Alternative therapy|0|||
24961367|NCT00068692|50051940|FG000|Step 1: Registration|Complicating disease|2|||
24961368|NCT00068692|50051941|FG001|Step 1: Registration|Complicating disease|0|||
24961369|NCT00068692|50051942|FG002|Step 1: Registration|Complicating disease|0|||
24961370|NCT00068692|50051943|FG003|Step 1: Registration|Complicating disease|0|||
24961371|NCT00068692|50051944|FG004|Step 1: Registration|Complicating disease|0|||
24961372|NCT00068692|50051945|FG005|Step 1: Registration|Complicating disease|0|||
24961373|NCT00068692|50051946|FG006|Step 1: Registration|Complicating disease|0|||
24961374|NCT00068692|50051947|FG007|Step 1: Registration|Complicating disease|0|||
24961375|NCT00068692|50051940|FG000|Step 1: Registration|Protocol Violation|1|||
24961376|NCT00068692|50051941|FG001|Step 1: Registration|Protocol Violation|0|||
24961377|NCT00068692|50051942|FG002|Step 1: Registration|Protocol Violation|0|||
24961378|NCT00068692|50051943|FG003|Step 1: Registration|Protocol Violation|0|||
24961379|NCT00068692|50051944|FG004|Step 1: Registration|Protocol Violation|0|||
24961380|NCT00068692|50051945|FG005|Step 1: Registration|Protocol Violation|0|||
24961381|NCT00068692|50051946|FG006|Step 1: Registration|Protocol Violation|0|||
25052337|NCT00157014|50155653|FG001|Overall Study|Patient withdrawn by investigator|0|||
25052338|NCT00157014|50155654|FG002|Overall Study|Patient withdrawn by investigator|0|||
25052339|NCT00157014|50155655|FG003|Overall Study|Patient withdrawn by investigator|0|||
25052340|NCT00157014|50155652|FG000|Overall Study|Patient unable to return in nursing home|1|||
25052341|NCT00157014|50155653|FG001|Overall Study|Patient unable to return in nursing home|0|||
25052342|NCT00157014|50155654|FG002|Overall Study|Patient unable to return in nursing home|0|||
25052343|NCT00157014|50155655|FG003|Overall Study|Patient unable to return in nursing home|0|||
25052344|NCT00157014|50155652|FG000|Overall Study|Patient would not receive transplant|0|||
25052345|NCT00157014|50155653|FG001|Overall Study|Patient would not receive transplant|1|||
25052346|NCT00157014|50155654|FG002|Overall Study|Patient would not receive transplant|0|||
25052347|NCT00157014|50155655|FG003|Overall Study|Patient would not receive transplant|0|||
25052348|NCT00157014|50155652|FG000|Overall Study|Withdrawal by Subject|1|||
25052349|NCT00157014|50155653|FG001|Overall Study|Withdrawal by Subject|0|||
25052350|NCT00157014|50155654|FG002|Overall Study|Withdrawal by Subject|0|||
25052351|NCT00157014|50155655|FG003|Overall Study|Withdrawal by Subject|0|||
25052352|NCT02778867|50155667|FG000|Phase 1|Withdrawal by Subject|2|||
25052353|NCT02778867|50155668|FG001|Phase 1|Withdrawal by Subject|3|||
25052354|NCT02778867|50155669|FG002|Phase 1|Withdrawal by Subject|0|||
25052355|NCT02778867|50155670|FG003|Phase 1|Withdrawal by Subject|0|||
25052356|NCT02778867|50155667|FG000|Phase 2|Withdrawal by Subject|0|||
25052357|NCT02778867|50155668|FG001|Phase 2|Withdrawal by Subject|0|||
25052358|NCT02778867|50155669|FG002|Phase 2|Withdrawal by Subject|1|||
24961382|NCT00068692|50051947|FG007|Step 1: Registration|Protocol Violation|0|||
24961383|NCT00068692|50051940|FG000|Step 1: Registration|Not eligible|6|||
24961384|NCT00068692|50051941|FG001|Step 1: Registration|Not eligible|0|||
24961385|NCT00068692|50051942|FG002|Step 1: Registration|Not eligible|0|||
24961386|NCT00068692|50051943|FG003|Step 1: Registration|Not eligible|0|||
24961387|NCT00068692|50051944|FG004|Step 1: Registration|Not eligible|0|||
24961388|NCT00068692|50051945|FG005|Step 1: Registration|Not eligible|0|||
24961389|NCT00068692|50051946|FG006|Step 1: Registration|Not eligible|0|||
24961390|NCT00068692|50051947|FG007|Step 1: Registration|Not eligible|0|||
24961391|NCT00068692|50051940|FG000|Step 1: Registration|Other|2|||
24961392|NCT00068692|50051941|FG001|Step 1: Registration|Other|0|||
24961393|NCT00068692|50051942|FG002|Step 1: Registration|Other|0|||
24961394|NCT00068692|50051943|FG003|Step 1: Registration|Other|0|||
24961395|NCT00068692|50051944|FG004|Step 1: Registration|Other|0|||
24961396|NCT00068692|50051945|FG005|Step 1: Registration|Other|0|||
24961397|NCT00068692|50051946|FG006|Step 1: Registration|Other|0|||
24961398|NCT00068692|50051947|FG007|Step 1: Registration|Other|0|||
25052359|NCT02778867|50155670|FG003|Phase 2|Withdrawal by Subject|0|||
25052360|NCT02778867|50155667|FG000|Phase 2|Physician Decision|0|||
25052361|NCT02778867|50155668|FG001|Phase 2|Physician Decision|0|||
25052362|NCT02778867|50155669|FG002|Phase 2|Physician Decision|0|||
25052363|NCT02778867|50155670|FG003|Phase 2|Physician Decision|1|||
25052364|NCT02778867|50155667|FG000|Phase 2|Adverse Event|0|||
25052365|NCT02778867|50155668|FG001|Phase 2|Adverse Event|0|||
25052366|NCT02778867|50155669|FG002|Phase 2|Adverse Event|0|||
25052367|NCT02778867|50155670|FG003|Phase 2|Adverse Event|1|||
25052368|NCT02778555|50155683|FG000|Overall Study|Withdrawal by Subject|55|||
25052369|NCT02778555|50155684|FG001|Overall Study|Withdrawal by Subject|32|||
25052370|NCT02778555|50155685|FG002|Overall Study|Withdrawal by Subject|107|||
25052371|NCT02778399|50155699|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
25052372|NCT02778399|50155700|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
25052373|NCT02778399|50155701|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
25052374|NCT02778399|50155702|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
25052375|NCT02778399|50155703|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
25052376|NCT02778399|50155704|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
25052377|NCT02778399|50155699|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
25052378|NCT02778399|50155700|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
25052379|NCT02778399|50155701|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
25052380|NCT02778399|50155702|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
25052381|NCT02778399|50155703|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
25052382|NCT02778399|50155704|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
25052383|NCT02778399|50155699|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
25052384|NCT02778399|50155700|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
25052385|NCT02778399|50155701|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
25052386|NCT02778399|50155702|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
25052387|NCT02778399|50155703|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
25052388|NCT02778399|50155704|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
25052389|NCT02778399|50155699|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
25052390|NCT02778399|50155700|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
25052391|NCT02778399|50155701|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
25052392|NCT02778399|50155702|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
25162636|NCT01272232|50284811|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
25162637|NCT01272232|50284809|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
25162638|NCT01272232|50284810|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
25052393|NCT02778399|50155703|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
25052394|NCT02778399|50155704|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
25052395|NCT02778399|50155699|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
24961399|NCT00068692|50051940|FG000|Step 1: Registration|Not start protocol therapy|3|||
24961400|NCT00068692|50051941|FG001|Step 1: Registration|Not start protocol therapy|0|||
25052396|NCT02778399|50155700|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
25052397|NCT02778399|50155701|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
25052398|NCT02778399|50155702|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
25052399|NCT02778399|50155703|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
25052400|NCT02778399|50155704|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
25052401|NCT02778399|50155699|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
25052402|NCT02778399|50155700|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
25052403|NCT02778399|50155701|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
25052404|NCT02778399|50155702|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
25052405|NCT02778399|50155703|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
25052406|NCT02778399|50155704|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
25052407|NCT02778399|50155699|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
25052408|NCT02778399|50155700|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
25052409|NCT02778399|50155701|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
25052410|NCT02778399|50155702|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
25052411|NCT02778399|50155703|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
25052412|NCT02778399|50155704|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
25052413|NCT02778399|50155699|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
25052414|NCT02778399|50155700|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
25052415|NCT02778399|50155701|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
25052416|NCT02778399|50155702|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
25052417|NCT02778399|50155703|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
25052418|NCT02778399|50155704|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
25052419|NCT02778399|50155699|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
24961401|NCT00068692|50051942|FG002|Step 1: Registration|Not start protocol therapy|0|||
24961402|NCT00068692|50051943|FG003|Step 1: Registration|Not start protocol therapy|0|||
24961403|NCT00068692|50051944|FG004|Step 1: Registration|Not start protocol therapy|0|||
24961404|NCT00068692|50051945|FG005|Step 1: Registration|Not start protocol therapy|0|||
24961405|NCT00068692|50051946|FG006|Step 1: Registration|Not start protocol therapy|0|||
24961406|NCT00068692|50051947|FG007|Step 1: Registration|Not start protocol therapy|0|||
24961407|NCT00068692|50051940|FG000|Step 1: Registration|Registered but not randomized|0|||
24961408|NCT00068692|50051941|FG001|Step 1: Registration|Registered but not randomized|1|||
24961409|NCT00068692|50051942|FG002|Step 1: Registration|Registered but not randomized|0|||
24961410|NCT00068692|50051943|FG003|Step 1: Registration|Registered but not randomized|0|||
24961411|NCT00068692|50051944|FG004|Step 1: Registration|Registered but not randomized|0|||
24961412|NCT00068692|50051945|FG005|Step 1: Registration|Registered but not randomized|0|||
24961413|NCT00068692|50051946|FG006|Step 1: Registration|Registered but not randomized|0|||
24961414|NCT00068692|50051947|FG007|Step 1: Registration|Registered but not randomized|0|||
24961415|NCT00068692|50051940|FG000|Step 2: Randomization|Disesae progression/replase|0|||
25052420|NCT02778399|50155700|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
25052421|NCT02778399|50155701|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
25052422|NCT02778399|50155702|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
25052423|NCT02778399|50155703|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
25052424|NCT02778399|50155704|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
24961416|NCT00068692|50051941|FG001|Step 2: Randomization|Disesae progression/replase|0|||
24961417|NCT00068692|50051942|FG002|Step 2: Randomization|Disesae progression/replase|1|||
24961418|NCT00068692|50051943|FG003|Step 2: Randomization|Disesae progression/replase|1|||
24961419|NCT00068692|50051944|FG004|Step 2: Randomization|Disesae progression/replase|0|||
25052425|NCT02778399|50155699|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
25052426|NCT02778399|50155700|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
25052427|NCT02778399|50155701|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
25052428|NCT02778399|50155702|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
25052429|NCT02778399|50155703|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
25052430|NCT02778399|50155704|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
25052431|NCT02778399|50155699|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
25052432|NCT02778399|50155700|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
25052433|NCT02778399|50155701|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
25052434|NCT02778399|50155702|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
25052435|NCT02778399|50155703|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
25052436|NCT02778399|50155704|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
25052437|NCT03656744|50155753|FG000|Overall Study|Adverse Event|1|||
25052438|NCT03656744|50155754|FG001|Overall Study|Adverse Event|4|||
25052439|NCT03656744|50155755|FG002|Overall Study|Adverse Event|1|||
25052440|NCT03656744|50155753|FG000|Overall Study|Protocol Violation|1|||
25052441|NCT03656744|50155754|FG001|Overall Study|Protocol Violation|0|||
25052442|NCT03656744|50155755|FG002|Overall Study|Protocol Violation|0|||
25052443|NCT03656744|50155753|FG000|Overall Study|Lost to Follow-up|2|||
25052444|NCT03656744|50155754|FG001|Overall Study|Lost to Follow-up|2|||
25052445|NCT03656744|50155755|FG002|Overall Study|Lost to Follow-up|0|||
25052446|NCT03656744|50155753|FG000|Overall Study|Withdrawal by Subject|0|||
25052447|NCT03656744|50155754|FG001|Overall Study|Withdrawal by Subject|1|||
25052448|NCT03656744|50155755|FG002|Overall Study|Withdrawal by Subject|0|||
25052449|NCT03656744|50155753|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
25052450|NCT03656744|50155754|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
25052451|NCT03656744|50155755|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
25052452|NCT02739360|50155763|FG000|Overall Study|Adverse Event|1|||
25052453|NCT02739360|50155763|FG000|Overall Study|Study terminated by Sponsor|2|||
25052454|NCT01822522|50155773|FG000|Overall Study|Adverse Event|1|||
25052455|NCT01822522|50155774|FG001|Overall Study|Adverse Event|1|||
25052456|NCT01822522|50155775|FG002|Overall Study|Adverse Event|1|||
25052457|NCT01822522|50155776|FG003|Overall Study|Adverse Event|0|||
25052458|NCT01822522|50155777|FG004|Overall Study|Adverse Event|0|||
25052459|NCT01822522|50155778|FG005|Overall Study|Adverse Event|1|||
25052460|NCT01822522|50155773|FG000|Overall Study|Death|3|||
25052461|NCT01822522|50155774|FG001|Overall Study|Death|0|||
25052462|NCT01822522|50155775|FG002|Overall Study|Death|2|||
25052463|NCT01822522|50155776|FG003|Overall Study|Death|0|||
25052464|NCT01822522|50155777|FG004|Overall Study|Death|0|||
25052465|NCT01822522|50155778|FG005|Overall Study|Death|0|||
25052466|NCT01822522|50155773|FG000|Overall Study|Lost to Follow-up|0|||
25052467|NCT01822522|50155774|FG001|Overall Study|Lost to Follow-up|0|||
25052468|NCT01822522|50155775|FG002|Overall Study|Lost to Follow-up|1|||
25052469|NCT01822522|50155776|FG003|Overall Study|Lost to Follow-up|1|||
25052470|NCT01822522|50155777|FG004|Overall Study|Lost to Follow-up|0|||
25052471|NCT01822522|50155778|FG005|Overall Study|Lost to Follow-up|1|||
25052472|NCT01822522|50155773|FG000|Overall Study|Withdrawal by Subject|0|||
25052473|NCT01822522|50155774|FG001|Overall Study|Withdrawal by Subject|0|||
25052474|NCT01822522|50155775|FG002|Overall Study|Withdrawal by Subject|0|||
25052475|NCT01822522|50155776|FG003|Overall Study|Withdrawal by Subject|1|||
25052476|NCT01822522|50155777|FG004|Overall Study|Withdrawal by Subject|0|||
25052477|NCT01822522|50155778|FG005|Overall Study|Withdrawal by Subject|0|||
24961420|NCT00068692|50051945|FG005|Step 2: Randomization|Disesae progression/replase|0|||
24961421|NCT00068692|50051946|FG006|Step 2: Randomization|Disesae progression/replase|0|||
24961422|NCT00068692|50051947|FG007|Step 2: Randomization|Disesae progression/replase|0|||
24961423|NCT00068692|50051940|FG000|Step 2: Randomization|Adverse Event|0|||
24961424|NCT00068692|50051941|FG001|Step 2: Randomization|Adverse Event|0|||
24961425|NCT00068692|50051942|FG002|Step 2: Randomization|Adverse Event|4|||
25052478|NCT01822522|50155773|FG000|Overall Study|Lack of Efficacy|0|||
25052479|NCT01822522|50155774|FG001|Overall Study|Lack of Efficacy|0|||
24961426|NCT00068692|50051943|FG003|Step 2: Randomization|Adverse Event|2|||
24961427|NCT00068692|50051944|FG004|Step 2: Randomization|Adverse Event|2|||
24961428|NCT00068692|50051945|FG005|Step 2: Randomization|Adverse Event|3|||
25052480|NCT01822522|50155775|FG002|Overall Study|Lack of Efficacy|0|||
25052481|NCT01822522|50155776|FG003|Overall Study|Lack of Efficacy|0|||
25052482|NCT01822522|50155777|FG004|Overall Study|Lack of Efficacy|0|||
25052483|NCT01822522|50155778|FG005|Overall Study|Lack of Efficacy|2|||
25052484|NCT00102687|50155822|FG000|Initial Period|Withdrawal by Subject|6|||
25052485|NCT00102687|50155823|FG001|Initial Period|Withdrawal by Subject|3|||
25052486|NCT00102687|50155824|FG002|Initial Period|Withdrawal by Subject|5|||
25052487|NCT00102687|50155825|FG003|Initial Period|Withdrawal by Subject|0|||
25052488|NCT00102687|50155826|FG004|Initial Period|Withdrawal by Subject|0|||
25052489|NCT00102687|50155822|FG000|Initial Period|Adverse Event|4|||
25052490|NCT00102687|50155823|FG001|Initial Period|Adverse Event|7|||
25052491|NCT00102687|50155824|FG002|Initial Period|Adverse Event|9|||
24961429|NCT00068692|50051946|FG006|Step 2: Randomization|Adverse Event|4|||
24961430|NCT00068692|50051947|FG007|Step 2: Randomization|Adverse Event|4|||
24961431|NCT00068692|50051940|FG000|Step 2: Randomization|Death|0|||
24961432|NCT00068692|50051941|FG001|Step 2: Randomization|Death|0|||
25052492|NCT00102687|50155825|FG003|Initial Period|Adverse Event|0|||
25052493|NCT00102687|50155826|FG004|Initial Period|Adverse Event|0|||
25052494|NCT00102687|50155822|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
25052495|NCT00102687|50155823|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
25052496|NCT00102687|50155824|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
25052497|NCT00102687|50155825|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
25052498|NCT00102687|50155826|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
25052499|NCT00102687|50155822|FG000|Initial Period|Protocol Violation|0|||
25052500|NCT00102687|50155823|FG001|Initial Period|Protocol Violation|0|||
25052501|NCT00102687|50155824|FG002|Initial Period|Protocol Violation|2|||
25052502|NCT00102687|50155825|FG003|Initial Period|Protocol Violation|0|||
25052503|NCT00102687|50155826|FG004|Initial Period|Protocol Violation|0|||
25052504|NCT00102687|50155822|FG000|Initial Period|Physician Decision|2|||
25052505|NCT00102687|50155823|FG001|Initial Period|Physician Decision|9|||
25052506|NCT00102687|50155824|FG002|Initial Period|Physician Decision|6|||
25052507|NCT00102687|50155825|FG003|Initial Period|Physician Decision|0|||
25052508|NCT00102687|50155826|FG004|Initial Period|Physician Decision|0|||
25052509|NCT00102687|50155822|FG000|Initial Period|Sponsor's decision|0|||
25052510|NCT00102687|50155823|FG001|Initial Period|Sponsor's decision|1|||
25052511|NCT00102687|50155824|FG002|Initial Period|Sponsor's decision|1|||
25052512|NCT00102687|50155825|FG003|Initial Period|Sponsor's decision|0|||
25052513|NCT00102687|50155826|FG004|Initial Period|Sponsor's decision|0|||
25052514|NCT00102687|50155822|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
25052515|NCT00102687|50155823|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
25052516|NCT00102687|50155824|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
25052517|NCT00102687|50155825|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
25052518|NCT00102687|50155826|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
25052519|NCT00102687|50155822|FG000|Initial Period|Death|1|||
25052520|NCT00102687|50155823|FG001|Initial Period|Death|1|||
24961433|NCT00068692|50051942|FG002|Step 2: Randomization|Death|0|||
24961434|NCT00068692|50051943|FG003|Step 2: Randomization|Death|0|||
24961435|NCT00068692|50051944|FG004|Step 2: Randomization|Death|1|||
24961436|NCT00068692|50051945|FG005|Step 2: Randomization|Death|0|||
24961437|NCT00068692|50051946|FG006|Step 2: Randomization|Death|0|||
24961438|NCT00068692|50051947|FG007|Step 2: Randomization|Death|1|||
24961439|NCT00068692|50051940|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
25052521|NCT00102687|50155824|FG002|Initial Period|Death|1|||
25162639|NCT01272232|50284811|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
25162640|NCT01272232|50284809|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
25162641|NCT01272232|50284810|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
25162642|NCT01272232|50284811|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
25162643|NCT01272232|50284809|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
24961440|NCT00068692|50051941|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
24961441|NCT00068692|50051942|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
24961442|NCT00068692|50051943|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
25052522|NCT00102687|50155825|FG003|Initial Period|Death|0|||
25052523|NCT00102687|50155826|FG004|Initial Period|Death|0|||
25052524|NCT00102687|50155822|FG000|Maintenance Period|Withdrawal by Subject|4|||
25052525|NCT00102687|50155823|FG001|Maintenance Period|Withdrawal by Subject|0|||
25052526|NCT00102687|50155824|FG002|Maintenance Period|Withdrawal by Subject|2|||
25052527|NCT00102687|50155825|FG003|Maintenance Period|Withdrawal by Subject|3|||
25052528|NCT00102687|50155826|FG004|Maintenance Period|Withdrawal by Subject|1|||
25052529|NCT00102687|50155822|FG000|Maintenance Period|Adverse Event|1|||
25052530|NCT00102687|50155823|FG001|Maintenance Period|Adverse Event|0|||
25052531|NCT00102687|50155824|FG002|Maintenance Period|Adverse Event|0|||
25052532|NCT00102687|50155825|FG003|Maintenance Period|Adverse Event|1|||
25052533|NCT00102687|50155826|FG004|Maintenance Period|Adverse Event|3|||
25052534|NCT00102687|50155822|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
25052535|NCT00102687|50155823|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
25052536|NCT00102687|50155824|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
25052537|NCT00102687|50155825|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
25052538|NCT00102687|50155826|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
25052539|NCT00102687|50155822|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
25052540|NCT00102687|50155823|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
25052541|NCT00102687|50155824|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
25052542|NCT00102687|50155825|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
25052543|NCT00102687|50155826|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
25052544|NCT00102687|50155822|FG000|Maintenance Period|Death|0|||
25052545|NCT00102687|50155823|FG001|Maintenance Period|Death|0|||
25052546|NCT00102687|50155824|FG002|Maintenance Period|Death|0|||
25052547|NCT00102687|50155825|FG003|Maintenance Period|Death|1|||
25052548|NCT00102687|50155826|FG004|Maintenance Period|Death|1|||
25052549|NCT00102687|50155822|FG000|Maintenance Period|Physician Decision|1|||
25052550|NCT00102687|50155823|FG001|Maintenance Period|Physician Decision|2|||
25052551|NCT00102687|50155824|FG002|Maintenance Period|Physician Decision|3|||
25052552|NCT00102687|50155825|FG003|Maintenance Period|Physician Decision|0|||
25052553|NCT00102687|50155826|FG004|Maintenance Period|Physician Decision|4|||
25052554|NCT00102531|50155844|FG000|Overall Study|Adverse Event|0|||
25052555|NCT00102531|50155845|FG001|Overall Study|Adverse Event|1|||
25052556|NCT00102531|50155844|FG000|Overall Study|Disease Progression|5|||
25052557|NCT00102531|50155845|FG001|Overall Study|Disease Progression|9|||
25052558|NCT00102531|50155844|FG000|Overall Study|Physician Decision|0|||
25052559|NCT00102531|50155845|FG001|Overall Study|Physician Decision|1|||
25052560|NCT02771145|50155851|FG000|Overall Study|Adverse Event|3|||
25052561|NCT02771145|50155851|FG000|Overall Study|Lost to Follow-up|1|||
25052562|NCT02578186|50155871|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
25052563|NCT02578186|50155872|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
25052564|NCT02578186|50155871|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
25052565|NCT02578186|50155872|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
25162644|NCT01272232|50284810|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
25162645|NCT01272232|50284811|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
25162646|NCT01791127|50284819|FG000|Overall Study|Death|356|||
25162647|NCT01791127|50284819|FG000|Overall Study|Patient has withdrawn from study|293|||
24961443|NCT00068692|50051944|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
24961444|NCT00068692|50051945|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
24961445|NCT00068692|50051946|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
24961446|NCT00068692|50051947|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
24961447|NCT00068692|50051940|FG000|Step 2: Randomization|alternative therapy|0|||
24961448|NCT00068692|50051941|FG001|Step 2: Randomization|alternative therapy|0|||
24961449|NCT00068692|50051942|FG002|Step 2: Randomization|alternative therapy|0|||
24961450|NCT00068692|50051943|FG003|Step 2: Randomization|alternative therapy|1|||
24961451|NCT00068692|50051944|FG004|Step 2: Randomization|alternative therapy|1|||
24961452|NCT00068692|50051945|FG005|Step 2: Randomization|alternative therapy|0|||
24961453|NCT00068692|50051946|FG006|Step 2: Randomization|alternative therapy|0|||
24961454|NCT00068692|50051947|FG007|Step 2: Randomization|alternative therapy|0|||
24961455|NCT00068692|50051940|FG000|Step 2: Randomization|Physician Decision|0|||
24961456|NCT00068692|50051941|FG001|Step 2: Randomization|Physician Decision|0|||
24961457|NCT00068692|50051942|FG002|Step 2: Randomization|Physician Decision|0|||
24961458|NCT00068692|50051943|FG003|Step 2: Randomization|Physician Decision|1|||
24961459|NCT00068692|50051944|FG004|Step 2: Randomization|Physician Decision|1|||
24961460|NCT00068692|50051945|FG005|Step 2: Randomization|Physician Decision|0|||
24961461|NCT00068692|50051946|FG006|Step 2: Randomization|Physician Decision|0|||
24961462|NCT00068692|50051947|FG007|Step 2: Randomization|Physician Decision|0|||
24961463|NCT00068692|50051940|FG000|Step 2: Randomization|Other|0|||
24961464|NCT00068692|50051941|FG001|Step 2: Randomization|Other|0|||
24961465|NCT00068692|50051942|FG002|Step 2: Randomization|Other|0|||
24961466|NCT00068692|50051943|FG003|Step 2: Randomization|Other|1|||
24961467|NCT00068692|50051944|FG004|Step 2: Randomization|Other|0|||
24961468|NCT00068692|50051945|FG005|Step 2: Randomization|Other|1|||
24961469|NCT00068692|50051946|FG006|Step 2: Randomization|Other|0|||
24961470|NCT00068692|50051947|FG007|Step 2: Randomization|Other|0|||
25052566|NCT00103311|50155880|FG000|Overall Study|Lost to Follow-up|1|||
25052567|NCT00103311|50155881|FG001|Overall Study|Lost to Follow-up|0|||
25162648|NCT01791127|50284819|FG000|Overall Study|Lost to Follow-up|42|||
24961471|NCT00068692|50051940|FG000|Step 2: Randomization|never start protocol therapy|0|||
24961472|NCT00068692|50051941|FG001|Step 2: Randomization|never start protocol therapy|0|||
24961473|NCT00068692|50051942|FG002|Step 2: Randomization|never start protocol therapy|1|||
24961474|NCT00068692|50051943|FG003|Step 2: Randomization|never start protocol therapy|0|||
24961475|NCT00068692|50051944|FG004|Step 2: Randomization|never start protocol therapy|1|||
24961476|NCT00068692|50051945|FG005|Step 2: Randomization|never start protocol therapy|0|||
24961477|NCT00068692|50051946|FG006|Step 2: Randomization|never start protocol therapy|0|||
24961478|NCT00068692|50051947|FG007|Step 2: Randomization|never start protocol therapy|0|||
24961479|NCT00463151|50051964|FG000|Overall Study|Adverse Event|0|||
24961480|NCT00463151|50051965|FG001|Overall Study|Adverse Event|0|||
24961481|NCT00463151|50051966|FG002|Overall Study|Adverse Event|1|||
24961482|NCT00463151|50051967|FG003|Overall Study|Adverse Event|0|||
24961483|NCT00463151|50051964|FG000|Overall Study|Lack of Efficacy|2|||
24961484|NCT00463151|50051965|FG001|Overall Study|Lack of Efficacy|5|||
24961485|NCT00463151|50051966|FG002|Overall Study|Lack of Efficacy|2|||
24961486|NCT00463151|50051967|FG003|Overall Study|Lack of Efficacy|5|||
25162649|NCT01791127|50284819|FG000|Overall Study|All Siello leads are explanted|31|||
25162650|NCT01791127|50284819|FG000|Overall Study|Completion of 30 day safety registry|1|||
24961487|NCT00463151|50051964|FG000|Overall Study|Protocol Violation|0|||
24961488|NCT00463151|50051965|FG001|Overall Study|Protocol Violation|0|||
24961489|NCT00463151|50051966|FG002|Overall Study|Protocol Violation|0|||
24961490|NCT00463151|50051967|FG003|Overall Study|Protocol Violation|1|||
24961491|NCT00463151|50051964|FG000|Overall Study|Withdrawal by Subject|0|||
24961492|NCT00463151|50051965|FG001|Overall Study|Withdrawal by Subject|0|||
24961493|NCT00463151|50051966|FG002|Overall Study|Withdrawal by Subject|0|||
24961494|NCT00463151|50051967|FG003|Overall Study|Withdrawal by Subject|1|||
24961495|NCT00068380|50051977|FG000|Overall Study|Withdrawal by Subject|3|||
24961496|NCT00068380|50051977|FG000|Overall Study|Adverse Event|2|||
24961497|NCT00067990|50051983|FG000|Overall Study|Death|5|||
24961498|NCT00067990|50051984|FG001|Overall Study|Death|7|||
24961499|NCT00067990|50051983|FG000|Overall Study|ESRD, Non IF/TA|1|||
24961500|NCT00067990|50051984|FG001|Overall Study|ESRD, Non IF/TA|3|||
24961501|NCT00067990|50051983|FG000|Overall Study|Withdrawal by Subject|4|||
24961502|NCT00067990|50051984|FG001|Overall Study|Withdrawal by Subject|12|||
24961503|NCT00090220|50051992|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
24961504|NCT00090220|50051993|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
24961505|NCT00090220|50051994|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
24961506|NCT00090220|50051995|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
24961507|NCT00090220|50051996|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
24961508|NCT00090220|50051997|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
24961509|NCT00090220|50051992|FG000|Base Study Vaccination Period|Adverse Event|6|||
24961510|NCT00090220|50051993|FG001|Base Study Vaccination Period|Adverse Event|1|||
24961511|NCT00090220|50051994|FG002|Base Study Vaccination Period|Adverse Event|0|||
24961512|NCT00090220|50051995|FG003|Base Study Vaccination Period|Adverse Event|0|||
24961513|NCT00090220|50051996|FG004|Base Study Vaccination Period|Adverse Event|0|||
24961514|NCT00090220|50051997|FG005|Base Study Vaccination Period|Adverse Event|0|||
24961515|NCT00090220|50051992|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
24961516|NCT00090220|50051993|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
24961517|NCT00090220|50051994|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
24961518|NCT00090220|50051995|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
24961519|NCT00090220|50051996|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
24961520|NCT00090220|50051997|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
24961521|NCT00090220|50051992|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
24961522|NCT00090220|50051993|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
24961523|NCT00090220|50051994|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
24961524|NCT00090220|50051995|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
24961525|NCT00090220|50051996|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
24961526|NCT00090220|50051997|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
24961527|NCT00090220|50051992|FG000|Base Study Vaccination Period|Patient Moved|6|||
24961528|NCT00090220|50051993|FG001|Base Study Vaccination Period|Patient Moved|2|||
24961529|NCT00090220|50051994|FG002|Base Study Vaccination Period|Patient Moved|0|||
24961530|NCT00090220|50051995|FG003|Base Study Vaccination Period|Patient Moved|0|||
24961531|NCT00090220|50051996|FG004|Base Study Vaccination Period|Patient Moved|0|||
24961532|NCT00090220|50051997|FG005|Base Study Vaccination Period|Patient Moved|0|||
24961533|NCT00090220|50051992|FG000|Base Study Vaccination Period|Other|4|||
24961534|NCT00090220|50051993|FG001|Base Study Vaccination Period|Other|4|||
24961535|NCT00090220|50051994|FG002|Base Study Vaccination Period|Other|0|||
24961536|NCT00090220|50051995|FG003|Base Study Vaccination Period|Other|0|||
24961537|NCT00090220|50051996|FG004|Base Study Vaccination Period|Other|0|||
24961538|NCT00090220|50051997|FG005|Base Study Vaccination Period|Other|0|||
24961539|NCT00090220|50051992|FG000|Base Study Follow-up Period|Adverse Event|6|||
24961540|NCT00090220|50051993|FG001|Base Study Follow-up Period|Adverse Event|1|||
24961541|NCT00090220|50051994|FG002|Base Study Follow-up Period|Adverse Event|0|||
24961542|NCT00090220|50051995|FG003|Base Study Follow-up Period|Adverse Event|0|||
24961543|NCT00090220|50051996|FG004|Base Study Follow-up Period|Adverse Event|0|||
24961544|NCT00090220|50051997|FG005|Base Study Follow-up Period|Adverse Event|0|||
24961545|NCT00090220|50051992|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
24961546|NCT00090220|50051993|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
24961547|NCT00090220|50051994|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
24961548|NCT00090220|50051995|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
24961549|NCT00090220|50051996|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
24961550|NCT00090220|50051997|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
24961551|NCT00090220|50051992|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
24961552|NCT00090220|50051993|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
24961553|NCT00090220|50051994|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
24961554|NCT00090220|50051995|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
24961555|NCT00090220|50051996|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
24961556|NCT00090220|50051997|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
24961557|NCT00090220|50051992|FG000|Base Study Follow-up Period|Patient Moved|20|||
24961558|NCT00090220|50051993|FG001|Base Study Follow-up Period|Patient Moved|28|||
24961559|NCT00090220|50051994|FG002|Base Study Follow-up Period|Patient Moved|0|||
24961560|NCT00090220|50051995|FG003|Base Study Follow-up Period|Patient Moved|0|||
24961561|NCT00090220|50051996|FG004|Base Study Follow-up Period|Patient Moved|0|||
24961562|NCT00090220|50051997|FG005|Base Study Follow-up Period|Patient Moved|0|||
24961563|NCT00090220|50051992|FG000|Base Study Follow-up Period|Other|19|||
24961564|NCT00090220|50051993|FG001|Base Study Follow-up Period|Other|21|||
24961565|NCT00090220|50051994|FG002|Base Study Follow-up Period|Other|0|||
24961566|NCT00090220|50051995|FG003|Base Study Follow-up Period|Other|0|||
24961567|NCT00090220|50051996|FG004|Base Study Follow-up Period|Other|0|||
24961568|NCT00090220|50051997|FG005|Base Study Follow-up Period|Other|0|||
24961569|NCT00090220|50051992|FG000|Extension 1 (EXT1)|Adverse Event|0|||
24961570|NCT00090220|50051993|FG001|Extension 1 (EXT1)|Adverse Event|0|||
24961571|NCT00090220|50051994|FG002|Extension 1 (EXT1)|Adverse Event|4|||
24961572|NCT00090220|50051995|FG003|Extension 1 (EXT1)|Adverse Event|0|||
24961573|NCT00090220|50051996|FG004|Extension 1 (EXT1)|Adverse Event|0|||
24961574|NCT00090220|50051997|FG005|Extension 1 (EXT1)|Adverse Event|0|||
24961575|NCT00090220|50051992|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
24961576|NCT00090220|50051993|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
24961577|NCT00090220|50051994|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
24961578|NCT00090220|50051995|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
24961579|NCT00090220|50051996|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
24961580|NCT00090220|50051997|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
24961581|NCT00090220|50051992|FG000|Extension 1 (EXT1)|Moved|0|||
24961582|NCT00090220|50051993|FG001|Extension 1 (EXT1)|Moved|0|||
24961583|NCT00090220|50051994|FG002|Extension 1 (EXT1)|Moved|2|||
24961584|NCT00090220|50051995|FG003|Extension 1 (EXT1)|Moved|1|||
24961585|NCT00090220|50051996|FG004|Extension 1 (EXT1)|Moved|0|||
24961586|NCT00090220|50051997|FG005|Extension 1 (EXT1)|Moved|0|||
24961587|NCT00090220|50051992|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
24961588|NCT00090220|50051993|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
24961589|NCT00090220|50051994|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
24961590|NCT00090220|50051995|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
24961591|NCT00090220|50051996|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
24961592|NCT00090220|50051997|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
24961593|NCT00090220|50051992|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
24961594|NCT00090220|50051993|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
24961595|NCT00090220|50051994|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
24961596|NCT00090220|50051995|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
24961597|NCT00090220|50051996|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
24961598|NCT00090220|50051997|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
24961599|NCT00090220|50051992|FG000|Extension 1 (EXT1)|Other reason|0|||
24961600|NCT00090220|50051993|FG001|Extension 1 (EXT1)|Other reason|0|||
24961601|NCT00090220|50051994|FG002|Extension 1 (EXT1)|Other reason|2|||
25052568|NCT00103311|50155880|FG000|Overall Study|Withdrawal by Subject|2|||
25052569|NCT00103311|50155881|FG001|Overall Study|Withdrawal by Subject|1|||
25052570|NCT00103311|50155880|FG000|Overall Study|Adverse Event|1|||
25052571|NCT00103311|50155881|FG001|Overall Study|Adverse Event|0|||
25052572|NCT02576938|50155894|FG000|Overall Study|Adverse Event|5|||
25052573|NCT02576938|50155895|FG001|Overall Study|Adverse Event|3|||
25052574|NCT02576938|50155896|FG002|Overall Study|Adverse Event|6|||
25052575|NCT02576938|50155894|FG000|Overall Study|Protocol Violation|1|||
25052576|NCT02576938|50155895|FG001|Overall Study|Protocol Violation|1|||
25052577|NCT02576938|50155896|FG002|Overall Study|Protocol Violation|1|||
25052578|NCT02576938|50155894|FG000|Overall Study|Withdrawal by Subject|3|||
25052579|NCT02576938|50155895|FG001|Overall Study|Withdrawal by Subject|2|||
25052580|NCT02576938|50155896|FG002|Overall Study|Withdrawal by Subject|4|||
25052581|NCT02576938|50155894|FG000|Overall Study|Lack of Efficacy|9|||
24961602|NCT00090220|50051995|FG003|Extension 1 (EXT1)|Other reason|0|||
25052582|NCT02576938|50155895|FG001|Overall Study|Lack of Efficacy|4|||
25052583|NCT02576938|50155896|FG002|Overall Study|Lack of Efficacy|0|||
25052584|NCT02576938|50155894|FG000|Overall Study|Lost to Follow-up|2|||
25052585|NCT02576938|50155895|FG001|Overall Study|Lost to Follow-up|0|||
24961603|NCT00090220|50051996|FG004|Extension 1 (EXT1)|Other reason|0|||
24961604|NCT00090220|50051997|FG005|Extension 1 (EXT1)|Other reason|0|||
24961605|NCT00090220|50051992|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
24961606|NCT00090220|50051993|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
24961607|NCT00090220|50051994|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
24961608|NCT00090220|50051995|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
24961609|NCT00090220|50051996|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
24961610|NCT00090220|50051997|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
24961611|NCT00090220|50051992|FG000|Long-term Follow-up (EXT2)|Death|0|||
24961612|NCT00090220|50051993|FG001|Long-term Follow-up (EXT2)|Death|0|||
24961613|NCT00090220|50051994|FG002|Long-term Follow-up (EXT2)|Death|0|||
24961614|NCT00090220|50051995|FG003|Long-term Follow-up (EXT2)|Death|0|||
24961615|NCT00090220|50051996|FG004|Long-term Follow-up (EXT2)|Death|1|||
24961616|NCT00090220|50051997|FG005|Long-term Follow-up (EXT2)|Death|1|||
24961617|NCT00090220|50051992|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
24961618|NCT00090220|50051993|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
24961619|NCT00090220|50051994|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
24961620|NCT00090220|50051995|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
24961621|NCT00090220|50051996|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
24961622|NCT00090220|50051997|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
24961623|NCT00090220|50051992|FG000|Long-term Follow-up (EXT2)|Other|0|||
24961624|NCT00090220|50051993|FG001|Long-term Follow-up (EXT2)|Other|0|||
24961625|NCT00090220|50051994|FG002|Long-term Follow-up (EXT2)|Other|0|||
24961626|NCT00090220|50051995|FG003|Long-term Follow-up (EXT2)|Other|0|||
24961627|NCT00090220|50051996|FG004|Long-term Follow-up (EXT2)|Other|1|||
24961628|NCT00090220|50051997|FG005|Long-term Follow-up (EXT2)|Other|0|||
24961629|NCT00263328|50052017|FG000|Overall Study|Death|0|||
24961630|NCT00263328|50052018|FG001|Overall Study|Death|0|||
24961631|NCT00263328|50052019|FG002|Overall Study|Death|1|||
24961632|NCT00263328|50052017|FG000|Overall Study|Lost to Follow-up|1|||
24961633|NCT00263328|50052018|FG001|Overall Study|Lost to Follow-up|1|||
24961634|NCT00263328|50052019|FG002|Overall Study|Lost to Follow-up|0|||
24961635|NCT00263328|50052017|FG000|Overall Study|Withdrawal by Subject|3|||
24961636|NCT00263328|50052018|FG001|Overall Study|Withdrawal by Subject|0|||
24961637|NCT00263328|50052019|FG002|Overall Study|Withdrawal by Subject|1|||
24961638|NCT00263328|50052017|FG000|Overall Study|Other|3|||
24961639|NCT00263328|50052018|FG001|Overall Study|Other|0|||
24961640|NCT00263328|50052019|FG002|Overall Study|Other|1|||
24961641|NCT00263328|50052017|FG000|Overall Study|Adverse Event|1|||
24961642|NCT00263328|50052018|FG001|Overall Study|Adverse Event|1|||
24961643|NCT00263328|50052019|FG002|Overall Study|Adverse Event|4|||
24961644|NCT00262860|50052029|FG000|Overall Study|Adverse Event|2|||
24961645|NCT00236184|50052035|FG000|Overall Study|Adverse Event|5|||
24961646|NCT00236184|50052036|FG001|Overall Study|Adverse Event|2|||
24961647|NCT00236184|50052035|FG000|Overall Study|Lack of Efficacy|0|||
24961648|NCT00236184|50052036|FG001|Overall Study|Lack of Efficacy|1|||
24961649|NCT00236184|50052035|FG000|Overall Study|Lost to Follow-up|3|||
24961650|NCT00236184|50052036|FG001|Overall Study|Lost to Follow-up|4|||
24961651|NCT00236184|50052035|FG000|Overall Study|Physician Decision|1|||
24961652|NCT00236184|50052036|FG001|Overall Study|Physician Decision|1|||
24961653|NCT00236184|50052035|FG000|Overall Study|Withdrawal by Subject|3|||
24961654|NCT00236184|50052036|FG001|Overall Study|Withdrawal by Subject|0|||
24961655|NCT00236184|50052035|FG000|Overall Study|Protocol Violation|3|||
24961656|NCT00236184|50052036|FG001|Overall Study|Protocol Violation|0|||
24961657|NCT00236184|50052035|FG000|Overall Study|non-compliance with study drug|2|||
24961658|NCT00236184|50052036|FG001|Overall Study|non-compliance with study drug|1|||
24961659|NCT00236184|50052035|FG000|Overall Study|other|1|||
24961660|NCT00236184|50052036|FG001|Overall Study|other|2|||
24961661|NCT00296504|50052050|FG000|Interim Analysis|Withdrawal by Subject|8|||
24961662|NCT00296504|50052051|FG001|Interim Analysis|Withdrawal by Subject|0|||
24961663|NCT00296504|50052052|FG002|Interim Analysis|Withdrawal by Subject|12|||
24961664|NCT00296504|50052053|FG003|Interim Analysis|Withdrawal by Subject|0|||
25162651|NCT01791127|50284819|FG000|Overall Study|Study terminated for EP Passion|749|||
25276536|NCT00953680|50590476|FG001|Period 1|Withdrawal by Subject|1|||
24961665|NCT00296504|50052054|FG004|Interim Analysis|Withdrawal by Subject|5|||
24961666|NCT00296504|50052055|FG005|Interim Analysis|Withdrawal by Subject|5|||
24961667|NCT00296504|50052056|FG006|Interim Analysis|Withdrawal by Subject|9|||
24961668|NCT00296504|50052057|FG007|Interim Analysis|Withdrawal by Subject|3|||
24961669|NCT00296504|50052058|FG008|Interim Analysis|Withdrawal by Subject|0|||
24961670|NCT00296504|50052050|FG000|Interim Analysis|Lost to Follow-up|13|||
24961671|NCT00296504|50052051|FG001|Interim Analysis|Lost to Follow-up|3|||
24961672|NCT00296504|50052052|FG002|Interim Analysis|Lost to Follow-up|26|||
24961673|NCT00296504|50052053|FG003|Interim Analysis|Lost to Follow-up|8|||
24961674|NCT00296504|50052054|FG004|Interim Analysis|Lost to Follow-up|14|||
24961675|NCT00296504|50052055|FG005|Interim Analysis|Lost to Follow-up|4|||
24961676|NCT00296504|50052056|FG006|Interim Analysis|Lost to Follow-up|11|||
24961677|NCT00296504|50052057|FG007|Interim Analysis|Lost to Follow-up|4|||
25052586|NCT02576938|50155896|FG002|Overall Study|Lost to Follow-up|1|||
25052587|NCT02576938|50155894|FG000|Overall Study|Physician Decision|0|||
25052588|NCT02576938|50155895|FG001|Overall Study|Physician Decision|1|||
25052589|NCT02576938|50155896|FG002|Overall Study|Physician Decision|0|||
25052590|NCT02576938|50155894|FG000|Overall Study|Met Exclusion Criteria|0|||
25052591|NCT02576938|50155895|FG001|Overall Study|Met Exclusion Criteria|1|||
25052592|NCT02576938|50155896|FG002|Overall Study|Met Exclusion Criteria|0|||
25052593|NCT02576860|50155908|FG000|Overall Study|Adverse Event|6|||
25052594|NCT02576860|50155909|FG001|Overall Study|Adverse Event|6|||
25052595|NCT02576860|50155908|FG000|Overall Study|Lost to Follow-up|5|||
25052596|NCT02576860|50155909|FG001|Overall Study|Lost to Follow-up|7|||
25052597|NCT02576860|50155908|FG000|Overall Study|Physician Decision|0|||
25052598|NCT02576860|50155909|FG001|Overall Study|Physician Decision|1|||
25052599|NCT02576860|50155908|FG000|Overall Study|Protocol Violation|0|||
25052600|NCT02576860|50155909|FG001|Overall Study|Protocol Violation|2|||
25052601|NCT02576860|50155908|FG000|Overall Study|Withdrawal by Subject|13|||
25052602|NCT02576860|50155909|FG001|Overall Study|Withdrawal by Subject|8|||
25052603|NCT02576860|50155908|FG000|Overall Study|Disallowed medication|1|||
25052604|NCT02576860|50155909|FG001|Overall Study|Disallowed medication|0|||
25052605|NCT02572570|50155916|FG000|Overall Study|Study Terminated|27|||
25052606|NCT00709202|50155925|FG000|Overall Study|Withdrawal by Subject|6|||
25052607|NCT00709202|50155926|FG001|Overall Study|Withdrawal by Subject|6|||
24961678|NCT00296504|50052058|FG008|Interim Analysis|Lost to Follow-up|0|||
24961679|NCT00296504|50052050|FG000|Interim Analysis|Clinical Progression|1|||
24961680|NCT00296504|50052051|FG001|Interim Analysis|Clinical Progression|0|||
24961681|NCT00296504|50052052|FG002|Interim Analysis|Clinical Progression|1|||
24961682|NCT00296504|50052053|FG003|Interim Analysis|Clinical Progression|1|||
24961683|NCT00296504|50052054|FG004|Interim Analysis|Clinical Progression|0|||
24961684|NCT00296504|50052055|FG005|Interim Analysis|Clinical Progression|2|||
24961685|NCT00296504|50052056|FG006|Interim Analysis|Clinical Progression|1|||
24961686|NCT00296504|50052057|FG007|Interim Analysis|Clinical Progression|2|||
24961687|NCT00296504|50052058|FG008|Interim Analysis|Clinical Progression|0|||
24961688|NCT00296504|50052050|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
24961689|NCT00296504|50052051|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
25052608|NCT00709124|50155935|FG000|Overall Study|Death|3|||
25052609|NCT00709124|50155936|FG001|Overall Study|Death|1|||
25052610|NCT00709124|50155935|FG000|Overall Study|encephalopathy; can't do assessment|1|||
25052611|NCT00709124|50155936|FG001|Overall Study|encephalopathy; can't do assessment|0|||
25052612|NCT02738580|50155948|FG000|Overall Study|Adverse Event|1|||
25052613|NCT02738580|50155949|FG001|Overall Study|Adverse Event|0|||
25052614|NCT02738580|50155948|FG000|Overall Study|Lack of Efficacy|3|||
25052615|NCT02738580|50155949|FG001|Overall Study|Lack of Efficacy|2|||
25052616|NCT02738580|50155948|FG000|Overall Study|Withdrawal by Subject|0|||
25052617|NCT02738580|50155949|FG001|Overall Study|Withdrawal by Subject|1|||
25052618|NCT02738580|50155948|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
25052619|NCT02738580|50155949|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
25052620|NCT02571244|50155957|FG000|Overall Study|Lost to Follow-up|0|||
25052621|NCT02571244|50155958|FG001|Overall Study|Lost to Follow-up|1|||
25052622|NCT02571244|50155957|FG000|Overall Study|Unable to reach out post discharge|3|||
25052623|NCT02571244|50155958|FG001|Overall Study|Unable to reach out post discharge|0|||
25052624|NCT02573350|50155969|FG000|Overall Study|Lost to Follow-up|2|||
25052625|NCT02573350|50155970|FG001|Overall Study|Lost to Follow-up|1|||
25052626|NCT02573350|50155969|FG000|Overall Study|Adverse Event|3|||
25052627|NCT02573350|50155970|FG001|Overall Study|Adverse Event|4|||
25052628|NCT02573350|50155969|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
24961690|NCT00296504|50052052|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
24961691|NCT00296504|50052053|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
24961692|NCT00296504|50052054|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
24961693|NCT00296504|50052055|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
24961694|NCT00296504|50052056|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
25052629|NCT02573350|50155970|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
25052630|NCT02573350|50155969|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
25052631|NCT02573350|50155970|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
25052632|NCT02573350|50155969|FG000|Overall Study|Subject withdrew consent to participate|6|||
25052633|NCT02573350|50155970|FG001|Overall Study|Subject withdrew consent to participate|1|||
25052634|NCT02573350|50155969|FG000|Overall Study|Protocol Deviation|1|||
25052635|NCT02573350|50155970|FG001|Overall Study|Protocol Deviation|1|||
25052636|NCT01376804|50155979|FG000|Treatment Period|Withdrawal by Subject|1|||
25052637|NCT01376804|50155979|FG000|Treatment Period|Adverse Event|6|||
25052638|NCT01376804|50155979|FG000|Treatment Period|Patient did not receive study drug|1|||
25052639|NCT02574520|50155987|FG000|Overall Study|Not dosed|2|||
25052640|NCT02574520|50155988|FG001|Overall Study|Not dosed|0|||
25052641|NCT02574520|50155989|FG002|Overall Study|Not dosed|5|||
25052642|NCT02574520|50155990|FG003|Overall Study|Not dosed|4|||
25052643|NCT02574520|50155987|FG000|Overall Study|Adverse Event|0|||
25052644|NCT02574520|50155988|FG001|Overall Study|Adverse Event|0|||
25052645|NCT02574520|50155989|FG002|Overall Study|Adverse Event|0|||
25052646|NCT02574520|50155990|FG003|Overall Study|Adverse Event|1|||
25052647|NCT02574520|50155987|FG000|Overall Study|Withdrawal by Subject|0|||
25052648|NCT02574520|50155988|FG001|Overall Study|Withdrawal by Subject|0|||
25052649|NCT02574520|50155989|FG002|Overall Study|Withdrawal by Subject|0|||
25052650|NCT02574520|50155990|FG003|Overall Study|Withdrawal by Subject|1|||
25052651|NCT02574520|50155987|FG000|Overall Study|Other|0|||
25052652|NCT02574520|50155988|FG001|Overall Study|Other|0|||
25052653|NCT02574520|50155989|FG002|Overall Study|Other|0|||
25052654|NCT02574520|50155990|FG003|Overall Study|Other|2|||
25052655|NCT00709592|50156002|FG000|Overall Study|Unable to proceed to transplant|0|||
25052656|NCT00709592|50156003|FG001|Overall Study|Unable to proceed to transplant|1|||
25052657|NCT02570152|50156009|FG000|Overall Study|Protocol Violation|2|||
25052658|NCT02570152|50156009|FG000|Overall Study|Migrated/moved from study area|13|||
25052659|NCT02570074|50156015|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
25052660|NCT02570074|50156016|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
25052661|NCT02569996|50156034|FG000|Overall Study|Adverse Event|6|||
25052662|NCT02569996|50156034|FG000|Overall Study|Physician Decision|3|||
25052663|NCT02569996|50156034|FG000|Overall Study|Progression of the disease|18|||
25052664|NCT02569996|50156034|FG000|Overall Study|New anti-lymphoma treatment|1|||
25052665|NCT02569996|50156034|FG000|Overall Study|Non-compliance|9|||
25052666|NCT02569996|50156034|FG000|Overall Study|Withdrawal by Subject|5|||
25052667|NCT02569996|50156034|FG000|Overall Study|Lost to Follow-up|5|||
25052668|NCT02569996|50156034|FG000|Overall Study|Complete remission|7|||
25052669|NCT02569996|50156034|FG000|Overall Study|Unknown reason|1|||
25052670|NCT02572882|50156038|FG000|Overall Study|Withdrawal by Subject|1|||
24961695|NCT00296504|50052057|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
24961696|NCT00296504|50052058|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
24961697|NCT00296504|50052050|FG000|Interim Analysis|Adverse Event|0|||
24961698|NCT00296504|50052051|FG001|Interim Analysis|Adverse Event|0|||
24961699|NCT00296504|50052052|FG002|Interim Analysis|Adverse Event|13|||
24961700|NCT00296504|50052053|FG003|Interim Analysis|Adverse Event|4|||
24961701|NCT00296504|50052054|FG004|Interim Analysis|Adverse Event|6|||
24961702|NCT00296504|50052055|FG005|Interim Analysis|Adverse Event|3|||
24961703|NCT00296504|50052056|FG006|Interim Analysis|Adverse Event|4|||
24961704|NCT00296504|50052057|FG007|Interim Analysis|Adverse Event|5|||
24961705|NCT00296504|50052058|FG008|Interim Analysis|Adverse Event|0|||
24961706|NCT00296504|50052050|FG000|Interim Analysis|Protocol Violation|0|||
25052671|NCT02572882|50156038|FG000|Overall Study|Participant received kidney transplant|1|||
25052672|NCT00708500|50156068|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
25052673|NCT00708500|50156069|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
25052674|NCT00708500|50156070|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
25052675|NCT00708500|50156068|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
25052676|NCT00708500|50156069|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
25052677|NCT00708500|50156070|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
25052678|NCT00708500|50156068|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
25052679|NCT00708500|50156069|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
25052680|NCT00708500|50156070|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
25052681|NCT00708500|50156068|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
25052682|NCT00708500|50156069|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
25052683|NCT00708500|50156070|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
25052684|NCT00708500|50156068|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
25052685|NCT00708500|50156069|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
25052686|NCT00708500|50156070|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
25162652|NCT01997333|50284850|FG000|Randomization and Treatment|Disease Progression|70|||
25162653|NCT01997333|50284851|FG001|Randomization and Treatment|Disease Progression|159|||
24961707|NCT00296504|50052051|FG001|Interim Analysis|Protocol Violation|0|||
24961708|NCT00296504|50052052|FG002|Interim Analysis|Protocol Violation|2|||
25052687|NCT00708500|50156068|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
25052688|NCT00708500|50156069|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
24961709|NCT00296504|50052053|FG003|Interim Analysis|Protocol Violation|0|||
24961710|NCT00296504|50052054|FG004|Interim Analysis|Protocol Violation|1|||
24961711|NCT00296504|50052055|FG005|Interim Analysis|Protocol Violation|0|||
24961712|NCT00296504|50052056|FG006|Interim Analysis|Protocol Violation|0|||
24961713|NCT00296504|50052057|FG007|Interim Analysis|Protocol Violation|1|||
24961714|NCT00296504|50052058|FG008|Interim Analysis|Protocol Violation|0|||
24961715|NCT00296504|50052050|FG000|Interim Analysis|Insufficient CD4 Response|0|||
24961716|NCT00296504|50052051|FG001|Interim Analysis|Insufficient CD4 Response|0|||
24961717|NCT00296504|50052052|FG002|Interim Analysis|Insufficient CD4 Response|0|||
24961718|NCT00296504|50052053|FG003|Interim Analysis|Insufficient CD4 Response|0|||
24961719|NCT00296504|50052054|FG004|Interim Analysis|Insufficient CD4 Response|1|||
24961720|NCT00296504|50052055|FG005|Interim Analysis|Insufficient CD4 Response|1|||
24961721|NCT00296504|50052056|FG006|Interim Analysis|Insufficient CD4 Response|0|||
24961722|NCT00296504|50052057|FG007|Interim Analysis|Insufficient CD4 Response|0|||
25052689|NCT00708500|50156070|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
25052690|NCT00708500|50156068|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
25052691|NCT00708500|50156069|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
25052692|NCT00708500|50156070|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
25052693|NCT00708500|50156068|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
25052694|NCT00708500|50156069|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
24961723|NCT00296504|50052058|FG008|Interim Analysis|Insufficient CD4 Response|0|||
24961724|NCT00296504|50052050|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
25052695|NCT00708500|50156070|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
25052696|NCT00708500|50156068|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
25052697|NCT00708500|50156069|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
25052698|NCT00708500|50156070|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
25052699|NCT00708500|50156068|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
25052700|NCT00708500|50156069|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
25052701|NCT00708500|50156070|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
25052702|NCT00708500|50156068|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
25052703|NCT00708500|50156069|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
25052704|NCT00708500|50156070|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
25052705|NCT00708500|50156068|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
25052706|NCT00708500|50156069|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
25052707|NCT00708500|50156070|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
25052708|NCT00708500|50156068|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
25052709|NCT00708500|50156069|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
25052710|NCT00708500|50156070|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
25052711|NCT00708500|50156068|FG000|FOLLOWUP|Adverse Event|0|||
25052712|NCT00708500|50156069|FG001|FOLLOWUP|Adverse Event|1|||
25052713|NCT00708500|50156070|FG002|FOLLOWUP|Adverse Event|0|||
25052714|NCT00708500|50156068|FG000|FOLLOWUP|Lost to Follow-up|1|||
25052715|NCT00708500|50156069|FG001|FOLLOWUP|Lost to Follow-up|6|||
25052716|NCT00708500|50156070|FG002|FOLLOWUP|Lost to Follow-up|4|||
25052717|NCT00708500|50156068|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
25052718|NCT00708500|50156069|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
25052719|NCT00708500|50156070|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
25052720|NCT00708500|50156068|FG000|FOLLOWUP|Subject withdrew consent|31|||
25052721|NCT00708500|50156069|FG001|FOLLOWUP|Subject withdrew consent|4|||
25052722|NCT00708500|50156070|FG002|FOLLOWUP|Subject withdrew consent|5|||
25052723|NCT00708500|50156068|FG000|FOLLOWUP|Non-compliance with protocol|5|||
25052724|NCT00708500|50156069|FG001|FOLLOWUP|Non-compliance with protocol|0|||
25052725|NCT00708500|50156070|FG002|FOLLOWUP|Non-compliance with protocol|1|||
25052726|NCT00708734|50156087|FG000|Overall Study|scheduling conflict|2|||
25052727|NCT00708734|50156087|FG000|Overall Study|moved|1|||
25052728|NCT00708734|50156087|FG000|Overall Study|leg injury|1|||
25052729|NCT00708734|50156087|FG000|Overall Study|knee replacement|1|||
25052730|NCT00708734|50156087|FG000|Overall Study|vertigo|1|||
25052731|NCT00708734|50156087|FG000|Overall Study|leg fracture|1|||
25052732|NCT04834362|50156093|FG000|Overall Study|Death|1|||
25052733|NCT04834362|50156094|FG001|Overall Study|Death|2|||
25052734|NCT00101907|50156106|FG000|Overall Study|Adverse Event|1|||
25052735|NCT00101907|50156107|FG001|Overall Study|Adverse Event|0|||
25052736|NCT00101907|50156108|FG002|Overall Study|Adverse Event|0|||
25052737|NCT00101907|50156109|FG003|Overall Study|Adverse Event|0|||
25052738|NCT00101907|50156110|FG004|Overall Study|Adverse Event|0|||
25052739|NCT00101907|50156111|FG005|Overall Study|Adverse Event|0|||
25052740|NCT00101907|50156106|FG000|Overall Study|Death|0|||
25052741|NCT00101907|50156107|FG001|Overall Study|Death|1|||
24961725|NCT00296504|50052051|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
25052742|NCT00101907|50156108|FG002|Overall Study|Death|0|||
25052743|NCT00101907|50156109|FG003|Overall Study|Death|0|||
25052744|NCT00101907|50156110|FG004|Overall Study|Death|3|||
25052745|NCT00101907|50156111|FG005|Overall Study|Death|0|||
25052746|NCT00101907|50156106|FG000|Overall Study|Physician Decision|0|||
25052747|NCT00101907|50156107|FG001|Overall Study|Physician Decision|0|||
25052748|NCT00101907|50156108|FG002|Overall Study|Physician Decision|0|||
25052749|NCT00101907|50156109|FG003|Overall Study|Physician Decision|1|||
25052750|NCT00101907|50156110|FG004|Overall Study|Physician Decision|1|||
25052751|NCT00101907|50156111|FG005|Overall Study|Physician Decision|0|||
25052752|NCT00101907|50156106|FG000|Overall Study|Withdrawal by Subject|1|||
25052753|NCT00101907|50156107|FG001|Overall Study|Withdrawal by Subject|0|||
25052754|NCT00101907|50156108|FG002|Overall Study|Withdrawal by Subject|1|||
25052755|NCT00101907|50156109|FG003|Overall Study|Withdrawal by Subject|0|||
25052756|NCT00101907|50156110|FG004|Overall Study|Withdrawal by Subject|1|||
25052757|NCT00101907|50156111|FG005|Overall Study|Withdrawal by Subject|0|||
25052758|NCT02565784|50156132|FG000|First Treatment|Adverse Event|1|||
25052759|NCT02565784|50156132|FG000|First Treatment|Withdrawal by Subject|1|||
25052760|NCT02565784|50156132|FG000|Second Treatment|Withdrawal by Subject|2|||
25052761|NCT04650204|50156166|FG000|Overall Study|Study was Terminated|2|||
25052762|NCT04650204|50156167|FG001|Overall Study|Study was Terminated|1|||
25052763|NCT02761629|50156175|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
25052764|NCT02761629|50156176|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
25052765|NCT02761629|50156175|FG000|Overall Study|Insufficient Therapeutic Response|2|||
25052766|NCT02761629|50156176|FG001|Overall Study|Insufficient Therapeutic Response|7|||
25052767|NCT02761629|50156175|FG000|Overall Study|Failure to Return|2|||
25052768|NCT02761629|50156176|FG001|Overall Study|Failure to Return|4|||
25052769|NCT02761629|50156175|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
25052770|NCT02761629|50156176|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
25052771|NCT02761629|50156175|FG000|Overall Study|Protocol Violation|2|||
25052772|NCT02761629|50156176|FG001|Overall Study|Protocol Violation|2|||
25052773|NCT02761629|50156175|FG000|Overall Study|Withdrawal by Subject|0|||
25052774|NCT02761629|50156176|FG001|Overall Study|Withdrawal by Subject|3|||
25052775|NCT02761629|50156175|FG000|Overall Study|Other|0|||
25052776|NCT02761629|50156176|FG001|Overall Study|Other|2|||
25052777|NCT02761629|50156175|FG000|Overall Study|Lost to Follow-up|4|||
25052778|NCT02761629|50156176|FG001|Overall Study|Lost to Follow-up|1|||
25052779|NCT02761629|50156175|FG000|Overall Study|Randomized But Not Treated|8|||
25052780|NCT02761629|50156176|FG001|Overall Study|Randomized But Not Treated|4|||
25052781|NCT02760927|50156182|FG000|Overall Study|Tube Slippage from Device|1|||
25052782|NCT00101439|50156188|FG000|Period 2|Withdrawal by Subject|0|||
25052783|NCT00101439|50156189|FG001|Period 2|Withdrawal by Subject|2|||
25052784|NCT04033068|50156199|FG000|Overall Study|Withdrawal by Subject|0|||
25052785|NCT04033068|50156200|FG001|Overall Study|Withdrawal by Subject|0|||
25052786|NCT04033068|50156201|FG002|Overall Study|Withdrawal by Subject|1|||
25052787|NCT04033068|50156202|FG003|Overall Study|Withdrawal by Subject|0|||
25052788|NCT04033068|50156199|FG000|Overall Study|Lost to Follow-up|0|||
25052789|NCT04033068|50156200|FG001|Overall Study|Lost to Follow-up|1|||
25052790|NCT04033068|50156201|FG002|Overall Study|Lost to Follow-up|0|||
25052791|NCT04033068|50156202|FG003|Overall Study|Lost to Follow-up|0|||
25052792|NCT04033068|50156199|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
25052793|NCT04033068|50156200|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
25052794|NCT04033068|50156201|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
25052795|NCT04033068|50156202|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
25052796|NCT00101283|50156214|FG000|Overall Study|Withdrawal by Subject|0|||
25052797|NCT00101283|50156215|FG001|Overall Study|Withdrawal by Subject|1|||
24961726|NCT00296504|50052052|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
25052798|NCT00101283|50156214|FG000|Overall Study|Insurance Refusal|0|||
25052799|NCT00101283|50156215|FG001|Overall Study|Insurance Refusal|1|||
25052800|NCT00101283|50156214|FG000|Overall Study|Prostate Cancer Recurrence|0|||
25052801|NCT00101283|50156215|FG001|Overall Study|Prostate Cancer Recurrence|1|||
25052802|NCT02762565|50156221|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
25052803|NCT02757963|50156234|FG000|Overall Study|Adverse Event|3|||
25052804|NCT02757963|50156234|FG000|Overall Study|Reached Stopping Criteria|1054|||
25052805|NCT02757963|50156234|FG000|Overall Study|Lost to Follow-up|5|||
25052806|NCT02757963|50156234|FG000|Overall Study|Physician Decision|1|||
25052807|NCT02757963|50156234|FG000|Overall Study|Withdrawal by Subject|34|||
25052808|NCT03111732|50156249|FG000|Overall Study|Enrolled in different study|1|||
25186580|NCT02647320|50337195|FG002|Overall Study|Adverse Event|3|||
25052809|NCT03111732|50156249|FG000|Overall Study|Progressive disease|3|||
25052810|NCT03111732|50156249|FG000|Overall Study|Withdrawal by Subject|1|||
25052811|NCT01663714|50156258|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
25052812|NCT01663714|50156258|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
25052813|NCT01663714|50156258|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
25052814|NCT01663714|50156258|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
25052815|NCT01663714|50156258|FG000|Long-Term Follow-Up|Death|4|||
25052816|NCT01663714|50156258|FG000|Long-Term Follow-Up|Non-compliance|1|||
25052817|NCT01663636|50156280|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
25052818|NCT01663636|50156281|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
25052819|NCT03065244|50156289|FG000|Overall Study|Lost to Follow-up|1|||
25052820|NCT03065244|50156290|FG001|Overall Study|Lost to Follow-up|1|||
25052821|NCT03065244|50156289|FG000|Overall Study|Diagnosed with a different disease|1|||
25052822|NCT03065244|50156290|FG001|Overall Study|Diagnosed with a different disease|1|||
25052823|NCT03065244|50156289|FG000|Overall Study|Protocol Violation|0|||
25052824|NCT03065244|50156290|FG001|Overall Study|Protocol Violation|1|||
25052825|NCT03065244|50156289|FG000|Overall Study|Withdrawal by Subject|1|||
25052826|NCT03065244|50156290|FG001|Overall Study|Withdrawal by Subject|1|||
25052827|NCT00100815|50156296|FG000|Overall Study|Progression|24|||
25052828|NCT00100815|50156296|FG000|Overall Study|Adverse Event|18|||
25052829|NCT00100815|50156296|FG000|Overall Study|Death|4|||
25052830|NCT00100815|50156296|FG000|Overall Study|Other|3|||
25052831|NCT00708422|50156302|FG000|Overall Study|Adverse Event|3|||
25052832|NCT00708422|50156303|FG001|Overall Study|Adverse Event|1|||
24961727|NCT00296504|50052053|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
24961728|NCT00296504|50052054|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
24961729|NCT00296504|50052055|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
24961730|NCT00296504|50052056|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
24961731|NCT00296504|50052057|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
24961732|NCT00296504|50052058|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
24961733|NCT00296504|50052050|FG000|Interim Analysis|Pregnancy|4|||
24961734|NCT00296504|50052051|FG001|Interim Analysis|Pregnancy|1|||
24961735|NCT00296504|50052052|FG002|Interim Analysis|Pregnancy|4|||
24961736|NCT00296504|50052053|FG003|Interim Analysis|Pregnancy|2|||
24961737|NCT00296504|50052054|FG004|Interim Analysis|Pregnancy|0|||
24961738|NCT00296504|50052055|FG005|Interim Analysis|Pregnancy|1|||
24961739|NCT00296504|50052056|FG006|Interim Analysis|Pregnancy|1|||
24961740|NCT00296504|50052057|FG007|Interim Analysis|Pregnancy|1|||
24961741|NCT00296504|50052058|FG008|Interim Analysis|Pregnancy|0|||
24961742|NCT00296504|50052050|FG000|Interim Analysis|Death|1|||
24961743|NCT00296504|50052051|FG001|Interim Analysis|Death|0|||
24961744|NCT00296504|50052052|FG002|Interim Analysis|Death|3|||
24961745|NCT00296504|50052053|FG003|Interim Analysis|Death|0|||
25052833|NCT00708422|50156302|FG000|Overall Study|Withdrawal by Subject|1|||
25052834|NCT00708422|50156303|FG001|Overall Study|Withdrawal by Subject|0|||
25052835|NCT02760069|50156312|FG000|Overall Study|Withdrawal by Subject|0|||
25052836|NCT02760069|50156313|FG001|Overall Study|Withdrawal by Subject|1|||
25052837|NCT02760069|50156314|FG002|Overall Study|Withdrawal by Subject|1|||
25052838|NCT00707486|50156322|FG000|Overall Study|Withdrawal by Subject|1|||
25052839|NCT02759055|50156330|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
25052840|NCT02759055|50156331|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
25052841|NCT04634253|50156340|FG000|Overall Study|Adverse Event|1|||
25052842|NCT04634253|50156341|FG001|Overall Study|Adverse Event|1|||
25052843|NCT04634253|50156342|FG002|Overall Study|Adverse Event|0|||
25052844|NCT04634253|50156340|FG000|Overall Study|Physician Decision|0|||
25052845|NCT04634253|50156341|FG001|Overall Study|Physician Decision|1|||
25052846|NCT04634253|50156342|FG002|Overall Study|Physician Decision|0|||
25052847|NCT04634253|50156340|FG000|Overall Study|Withdrawal by Subject|1|||
24961746|NCT00296504|50052054|FG004|Interim Analysis|Death|0|||
24961747|NCT00296504|50052055|FG005|Interim Analysis|Death|0|||
24961748|NCT00296504|50052056|FG006|Interim Analysis|Death|0|||
24961749|NCT00296504|50052057|FG007|Interim Analysis|Death|0|||
24961750|NCT00296504|50052058|FG008|Interim Analysis|Death|0|||
24961751|NCT00296504|50052050|FG000|Interim Analysis|Participant Non-compliant|0|||
24961752|NCT00296504|50052051|FG001|Interim Analysis|Participant Non-compliant|1|||
24961753|NCT00296504|50052052|FG002|Interim Analysis|Participant Non-compliant|2|||
24961754|NCT00296504|50052053|FG003|Interim Analysis|Participant Non-compliant|1|||
25052848|NCT04634253|50156341|FG001|Overall Study|Withdrawal by Subject|0|||
25052849|NCT04634253|50156342|FG002|Overall Study|Withdrawal by Subject|3|||
25052850|NCT02756637|50156354|FG000|Overall Study|Not eligible for initial SWOG study|10|||
25052851|NCT02756637|50156355|FG001|Overall Study|Not eligible for initial SWOG study|10|||
25052852|NCT02756637|50156354|FG000|Overall Study|No available NLR value|44|||
25052853|NCT02756637|50156355|FG001|Overall Study|No available NLR value|44|||
25052854|NCT02756637|50156354|FG000|Overall Study|Did not complete curative therapy|33|||
25052855|NCT02756637|50156355|FG001|Overall Study|Did not complete curative therapy|0|||
25052856|NCT00708032|50156363|FG000|Overall Study|Adverse Event|0|||
25052857|NCT00708032|50156364|FG001|Overall Study|Adverse Event|2|||
25052858|NCT00708032|50156363|FG000|Overall Study|Lost to Follow-up|1|||
25052859|NCT00708032|50156364|FG001|Overall Study|Lost to Follow-up|2|||
25052860|NCT00708032|50156363|FG000|Overall Study|Pregnancy|0|||
24961755|NCT00296504|50052054|FG004|Interim Analysis|Participant Non-compliant|1|||
24961756|NCT00296504|50052055|FG005|Interim Analysis|Participant Non-compliant|3|||
24961757|NCT00296504|50052056|FG006|Interim Analysis|Participant Non-compliant|6|||
24961758|NCT00296504|50052057|FG007|Interim Analysis|Participant Non-compliant|2|||
24961759|NCT00296504|50052058|FG008|Interim Analysis|Participant Non-compliant|0|||
24961760|NCT00296504|50052050|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
24961761|NCT00296504|50052051|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
25052861|NCT00708032|50156364|FG001|Overall Study|Pregnancy|1|||
25052862|NCT00708032|50156363|FG000|Overall Study|Poor vision|0|||
25052863|NCT00708032|50156364|FG001|Overall Study|Poor vision|6|||
25052864|NCT00708032|50156363|FG000|Overall Study|Visit out of range at month 12|4|||
25052865|NCT00708032|50156364|FG001|Overall Study|Visit out of range at month 12|1|||
25052866|NCT00708032|50156363|FG000|Overall Study|Did not meet protocol criteria|1|||
25052867|NCT00708032|50156364|FG001|Overall Study|Did not meet protocol criteria|2|||
25052868|NCT00708032|50156363|FG000|Overall Study|Protocol Violation|4|||
25052869|NCT00708032|50156364|FG001|Overall Study|Protocol Violation|1|||
25052870|NCT00708032|50156363|FG000|Overall Study|Withdrawal by Subject|0|||
25052871|NCT00708032|50156364|FG001|Overall Study|Withdrawal by Subject|1|||
25052872|NCT00707174|50156372|FG000|Overall Study|Adverse Event|1|||
25052873|NCT00707174|50156373|FG001|Overall Study|Adverse Event|6|||
25052874|NCT00707174|50156372|FG000|Overall Study|Withdrawal by Subject|4|||
24961762|NCT00296504|50052052|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
24961763|NCT00296504|50052053|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
24961764|NCT00296504|50052054|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
24961765|NCT00296504|50052055|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
24961766|NCT00296504|50052056|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
24961767|NCT00296504|50052057|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
24961768|NCT00296504|50052058|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
24961769|NCT00296504|50052050|FG000|Interim Analysis|To Simplify Treatment|0|||
24961770|NCT00296504|50052051|FG001|Interim Analysis|To Simplify Treatment|0|||
24961771|NCT00296504|50052052|FG002|Interim Analysis|To Simplify Treatment|1|||
24961772|NCT00296504|50052053|FG003|Interim Analysis|To Simplify Treatment|0|||
24961773|NCT00296504|50052054|FG004|Interim Analysis|To Simplify Treatment|0|||
25052875|NCT00707174|50156373|FG001|Overall Study|Withdrawal by Subject|1|||
25052876|NCT02756403|50156383|FG000|Overall Study|Unable to swallow medication|0|||
25052877|NCT02756403|50156384|FG001|Overall Study|Unable to swallow medication|1|||
25052878|NCT02756403|50156385|FG002|Overall Study|Unable to swallow medication|1|||
25052879|NCT02756403|50156386|FG003|Overall Study|Unable to swallow medication|1|||
25052880|NCT02756403|50156383|FG000|Overall Study|Did not complete Procedure|0|||
25052881|NCT02756403|50156384|FG001|Overall Study|Did not complete Procedure|1|||
25052882|NCT02756403|50156385|FG002|Overall Study|Did not complete Procedure|0|||
24961774|NCT00296504|50052055|FG005|Interim Analysis|To Simplify Treatment|0|||
24961775|NCT00296504|50052056|FG006|Interim Analysis|To Simplify Treatment|2|||
25186581|NCT02647320|50337196|FG003|Overall Study|Adverse Event|2|||
25052883|NCT02756403|50156386|FG003|Overall Study|Did not complete Procedure|0|||
25052884|NCT02756403|50156383|FG000|Overall Study|Changed Mind About Procedure|0|||
25052885|NCT02756403|50156384|FG001|Overall Study|Changed Mind About Procedure|0|||
25052886|NCT02756403|50156385|FG002|Overall Study|Changed Mind About Procedure|1|||
25052887|NCT02756403|50156386|FG003|Overall Study|Changed Mind About Procedure|0|||
25052888|NCT02756403|50156383|FG000|Overall Study|Protocol Violation|0|||
25052889|NCT02756403|50156384|FG001|Overall Study|Protocol Violation|1|||
25052890|NCT02756403|50156385|FG002|Overall Study|Protocol Violation|0|||
25052891|NCT02756403|50156386|FG003|Overall Study|Protocol Violation|1|||
25052892|NCT02753595|50156398|FG000|Overall Study|Sponsor termination|2|||
25052893|NCT02753595|50156399|FG001|Overall Study|Sponsor termination|2|||
25052894|NCT00707954|50156422|FG000|Overall Study|Physician Decision|0|||
25052895|NCT00707954|50156423|FG001|Overall Study|Physician Decision|0|||
25052896|NCT00707954|50156424|FG002|Overall Study|Physician Decision|0|||
25052897|NCT00707954|50156425|FG003|Overall Study|Physician Decision|0|||
25052898|NCT00707954|50156426|FG004|Overall Study|Physician Decision|1|||
25052899|NCT02561962|50156447|FG000|Overall Study|Ongoing in study|1|||
25052900|NCT02561962|50156448|FG001|Overall Study|Ongoing in study|0|||
25052901|NCT02561962|50156449|FG002|Overall Study|Ongoing in study|0|||
25052902|NCT02561962|50156450|FG003|Overall Study|Ongoing in study|1|||
25052903|NCT02561962|50156451|FG004|Overall Study|Ongoing in study|0|||
25052904|NCT02561962|50156452|FG005|Overall Study|Ongoing in study|1|||
25052905|NCT02561962|50156453|FG006|Overall Study|Ongoing in study|0|||
25052906|NCT02561962|50156454|FG007|Overall Study|Ongoing in study|4|||
25052907|NCT02561962|50156455|FG008|Overall Study|Ongoing in study|1|||
25052908|NCT02561962|50156447|FG000|Overall Study|Withdrawal by Subject|1|||
25052909|NCT02561962|50156448|FG001|Overall Study|Withdrawal by Subject|0|||
24961776|NCT00296504|50052057|FG007|Interim Analysis|To Simplify Treatment|0|||
24961777|NCT00296504|50052058|FG008|Interim Analysis|To Simplify Treatment|0|||
24961778|NCT00296504|50052050|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
24961779|NCT00296504|50052051|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
24961780|NCT00296504|50052052|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
24961781|NCT00296504|50052053|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
24961782|NCT00296504|50052054|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
24961783|NCT00296504|50052055|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
24961784|NCT00296504|50052056|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
24961785|NCT00296504|50052057|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
24961786|NCT00296504|50052058|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
24961787|NCT00296504|50052050|FG000|Interim Analysis|Participant Moved|1|||
24961788|NCT00296504|50052051|FG001|Interim Analysis|Participant Moved|0|||
24961789|NCT00296504|50052052|FG002|Interim Analysis|Participant Moved|1|||
24961790|NCT00296504|50052053|FG003|Interim Analysis|Participant Moved|0|||
24961791|NCT00296504|50052054|FG004|Interim Analysis|Participant Moved|0|||
24961792|NCT00296504|50052055|FG005|Interim Analysis|Participant Moved|1|||
24961793|NCT00296504|50052056|FG006|Interim Analysis|Participant Moved|1|||
24961794|NCT00296504|50052057|FG007|Interim Analysis|Participant Moved|0|||
24961795|NCT00296504|50052058|FG008|Interim Analysis|Participant Moved|0|||
24961796|NCT00296504|50052050|FG000|Interim Analysis|Participant Was Incarcerated|2|||
24961797|NCT00296504|50052051|FG001|Interim Analysis|Participant Was Incarcerated|0|||
24961798|NCT00296504|50052052|FG002|Interim Analysis|Participant Was Incarcerated|1|||
24961799|NCT00296504|50052053|FG003|Interim Analysis|Participant Was Incarcerated|0|||
24961800|NCT00296504|50052054|FG004|Interim Analysis|Participant Was Incarcerated|0|||
24961801|NCT00296504|50052055|FG005|Interim Analysis|Participant Was Incarcerated|0|||
24961802|NCT00296504|50052056|FG006|Interim Analysis|Participant Was Incarcerated|0|||
24961803|NCT00296504|50052057|FG007|Interim Analysis|Participant Was Incarcerated|0|||
24961804|NCT00296504|50052058|FG008|Interim Analysis|Participant Was Incarcerated|0|||
24961805|NCT00296504|50052050|FG000|Interim Analysis|Resistance to FPV|0|||
25052910|NCT02561962|50156449|FG002|Overall Study|Withdrawal by Subject|0|||
25052911|NCT02561962|50156450|FG003|Overall Study|Withdrawal by Subject|0|||
25052912|NCT02561962|50156451|FG004|Overall Study|Withdrawal by Subject|1|||
25052913|NCT02561962|50156452|FG005|Overall Study|Withdrawal by Subject|1|||
25052914|NCT02561962|50156453|FG006|Overall Study|Withdrawal by Subject|2|||
25052915|NCT02561962|50156454|FG007|Overall Study|Withdrawal by Subject|1|||
25052916|NCT02561962|50156455|FG008|Overall Study|Withdrawal by Subject|0|||
25052917|NCT02561962|50156447|FG000|Overall Study|Decision by sponsor|0|||
24961806|NCT00296504|50052051|FG001|Interim Analysis|Resistance to FPV|0|||
24961807|NCT00296504|50052052|FG002|Interim Analysis|Resistance to FPV|1|||
25052918|NCT02561962|50156448|FG001|Overall Study|Decision by sponsor|0|||
25052919|NCT02561962|50156449|FG002|Overall Study|Decision by sponsor|0|||
24961808|NCT00296504|50052053|FG003|Interim Analysis|Resistance to FPV|0|||
24961809|NCT00296504|50052054|FG004|Interim Analysis|Resistance to FPV|0|||
24961810|NCT00296504|50052055|FG005|Interim Analysis|Resistance to FPV|0|||
24961811|NCT00296504|50052056|FG006|Interim Analysis|Resistance to FPV|0|||
25052920|NCT02561962|50156450|FG003|Overall Study|Decision by sponsor|0|||
24961812|NCT00296504|50052057|FG007|Interim Analysis|Resistance to FPV|0|||
24961813|NCT00296504|50052058|FG008|Interim Analysis|Resistance to FPV|0|||
24961814|NCT00296504|50052050|FG000|Interim Analysis|Physician Decision|0|||
25052921|NCT02561962|50156451|FG004|Overall Study|Decision by sponsor|1|||
25052922|NCT02561962|50156452|FG005|Overall Study|Decision by sponsor|1|||
25052923|NCT02561962|50156453|FG006|Overall Study|Decision by sponsor|0|||
25052924|NCT02561962|50156454|FG007|Overall Study|Decision by sponsor|3|||
25052925|NCT02561962|50156455|FG008|Overall Study|Decision by sponsor|0|||
25052926|NCT02561962|50156447|FG000|Overall Study|Lost to Follow-up|0|||
25052927|NCT02561962|50156448|FG001|Overall Study|Lost to Follow-up|0|||
25052928|NCT02561962|50156449|FG002|Overall Study|Lost to Follow-up|0|||
25052929|NCT02561962|50156450|FG003|Overall Study|Lost to Follow-up|0|||
25052930|NCT02561962|50156451|FG004|Overall Study|Lost to Follow-up|0|||
25052931|NCT02561962|50156452|FG005|Overall Study|Lost to Follow-up|1|||
25052932|NCT02561962|50156453|FG006|Overall Study|Lost to Follow-up|0|||
25052933|NCT02561962|50156454|FG007|Overall Study|Lost to Follow-up|0|||
25052934|NCT02561962|50156455|FG008|Overall Study|Lost to Follow-up|0|||
25052935|NCT02565706|50156479|FG000|Overall Study|Withdrawal by Subject|5|||
25052936|NCT02565706|50156480|FG001|Overall Study|Withdrawal by Subject|7|||
25052937|NCT02565706|50156481|FG002|Overall Study|Withdrawal by Subject|7|||
25052938|NCT02565706|50156482|FG003|Overall Study|Withdrawal by Subject|11|||
25052939|NCT02565706|50156479|FG000|Overall Study|Lost to Follow-up|72|||
24961815|NCT00296504|50052051|FG001|Interim Analysis|Physician Decision|0|||
24961816|NCT00296504|50052052|FG002|Interim Analysis|Physician Decision|1|||
24961817|NCT00296504|50052053|FG003|Interim Analysis|Physician Decision|0|||
24961818|NCT00296504|50052054|FG004|Interim Analysis|Physician Decision|0|||
24961819|NCT00296504|50052055|FG005|Interim Analysis|Physician Decision|0|||
24961820|NCT00296504|50052056|FG006|Interim Analysis|Physician Decision|0|||
24961821|NCT00296504|50052057|FG007|Interim Analysis|Physician Decision|0|||
24961822|NCT00296504|50052058|FG008|Interim Analysis|Physician Decision|0|||
24961823|NCT00296504|50052050|FG000|Interim Analysis|Principle Investigator Discretion|2|||
24961824|NCT00296504|50052051|FG001|Interim Analysis|Principle Investigator Discretion|0|||
24961825|NCT00296504|50052052|FG002|Interim Analysis|Principle Investigator Discretion|1|||
24961826|NCT00296504|50052053|FG003|Interim Analysis|Principle Investigator Discretion|1|||
24961827|NCT00296504|50052054|FG004|Interim Analysis|Principle Investigator Discretion|0|||
24961828|NCT00296504|50052055|FG005|Interim Analysis|Principle Investigator Discretion|0|||
24961829|NCT00296504|50052056|FG006|Interim Analysis|Principle Investigator Discretion|0|||
24961830|NCT00296504|50052057|FG007|Interim Analysis|Principle Investigator Discretion|0|||
24961831|NCT00296504|50052058|FG008|Interim Analysis|Principle Investigator Discretion|0|||
24961832|NCT00296504|50052050|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
24961833|NCT00296504|50052051|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
25052940|NCT02565706|50156480|FG001|Overall Study|Lost to Follow-up|75|||
25052941|NCT02565706|50156481|FG002|Overall Study|Lost to Follow-up|82|||
25052942|NCT02565706|50156482|FG003|Overall Study|Lost to Follow-up|74|||
25052943|NCT00706628|50156501|FG000|Overall Study|Other Adverse Event|16|||
25052944|NCT00706628|50156502|FG001|Overall Study|Other Adverse Event|5|||
25052945|NCT00706628|50156503|FG002|Overall Study|Other Adverse Event|5|||
25052946|NCT00706628|50156504|FG003|Overall Study|Other Adverse Event|2|||
25052947|NCT00706628|50156501|FG000|Overall Study|Non compliant with protocol|0|||
25052948|NCT00706628|50156502|FG001|Overall Study|Non compliant with protocol|1|||
25052949|NCT00706628|50156503|FG002|Overall Study|Non compliant with protocol|0|||
25052950|NCT00706628|50156504|FG003|Overall Study|Non compliant with protocol|0|||
25052951|NCT00706628|50156501|FG000|Overall Study|Consent withdrawn|6|||
25052952|NCT00706628|50156502|FG001|Overall Study|Consent withdrawn|1|||
25052953|NCT00706628|50156503|FG002|Overall Study|Consent withdrawn|3|||
25052954|NCT00706628|50156504|FG003|Overall Study|Consent withdrawn|0|||
25052955|NCT00706628|50156501|FG000|Overall Study|Progressive disease|20|||
25052956|NCT00706628|50156502|FG001|Overall Study|Progressive disease|13|||
25052957|NCT00706628|50156503|FG002|Overall Study|Progressive disease|8|||
24961834|NCT00296504|50052052|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
24961835|NCT00296504|50052053|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
25052958|NCT00706628|50156504|FG003|Overall Study|Progressive disease|1|||
25052959|NCT00706628|50156501|FG000|Overall Study|Other than those stated above|4|||
25052960|NCT00706628|50156502|FG001|Overall Study|Other than those stated above|0|||
25186582|NCT02647320|50337197|FG004|Overall Study|Adverse Event|1|||
25052961|NCT00706628|50156503|FG002|Overall Study|Other than those stated above|0|||
25052962|NCT00706628|50156504|FG003|Overall Study|Other than those stated above|0|||
25052963|NCT00706628|50156501|FG000|Overall Study|Not treated|1|||
25052964|NCT00706628|50156502|FG001|Overall Study|Not treated|1|||
25052965|NCT00706628|50156503|FG002|Overall Study|Not treated|0|||
25052966|NCT00706628|50156504|FG003|Overall Study|Not treated|0|||
25052967|NCT02561806|50156519|FG000|Induction Period|Adverse Event|0|||
25052968|NCT02561806|50156520|FG001|Induction Period|Adverse Event|2|||
25052969|NCT02561806|50156519|FG000|Induction Period|Lack of Efficacy|1|||
25052970|NCT02561806|50156520|FG001|Induction Period|Lack of Efficacy|0|||
25052971|NCT02561806|50156519|FG000|Induction Period|Withdrawal by Subject|0|||
25052972|NCT02561806|50156520|FG001|Induction Period|Withdrawal by Subject|2|||
25052973|NCT02561806|50156519|FG000|Induction Period|Site staff became unblinded|1|||
25052974|NCT02561806|50156520|FG001|Induction Period|Site staff became unblinded|0|||
25052975|NCT02561806|50156519|FG000|Induction Period|Randomized but not treated|0|||
25052976|NCT02561806|50156520|FG001|Induction Period|Randomized but not treated|1|||
25052977|NCT02561806|50156519|FG000|Maintenance Period|Adverse Event|2|||
25052978|NCT02561806|50156520|FG001|Maintenance Period|Adverse Event|1|||
25052979|NCT02561806|50156519|FG000|Maintenance Period|Lack of Efficacy|3|||
25052980|NCT02561806|50156520|FG001|Maintenance Period|Lack of Efficacy|1|||
25052981|NCT02561806|50156519|FG000|Maintenance Period|Lost to Follow-up|2|||
25052982|NCT02561806|50156520|FG001|Maintenance Period|Lost to Follow-up|2|||
25052983|NCT02561806|50156519|FG000|Maintenance Period|Protocol Violation|1|||
25052984|NCT02561806|50156520|FG001|Maintenance Period|Protocol Violation|0|||
25052985|NCT02561806|50156519|FG000|Maintenance Period|Withdrawal by Subject|5|||
25052986|NCT02561806|50156520|FG001|Maintenance Period|Withdrawal by Subject|3|||
25052987|NCT02561806|50156519|FG000|Maintenance Period|Site staff became unblinded|0|||
25052988|NCT02561806|50156520|FG001|Maintenance Period|Site staff became unblinded|1|||
25052989|NCT02561806|50156519|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
25052990|NCT02561806|50156520|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
25052991|NCT02561806|50156519|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
25052992|NCT02561806|50156520|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
25052993|NCT02561572|50156543|FG000|Overall Study|Inadequate time before surgery|2|||
25052994|NCT02561572|50156544|FG001|Overall Study|Inadequate time before surgery|1|||
25052995|NCT02561572|50156543|FG000|Overall Study|Protocol Violation|0|||
25052996|NCT02561572|50156544|FG001|Overall Study|Protocol Violation|1|||
25052997|NCT02180217|50156553|FG000|Overall Study|Adverse Event|3|||
25052998|NCT02180217|50156554|FG001|Overall Study|Adverse Event|2|||
25052999|NCT02180217|50156555|FG002|Overall Study|Adverse Event|22|||
25053000|NCT02180217|50156553|FG000|Overall Study|Death|1|||
25053001|NCT02180217|50156554|FG001|Overall Study|Death|1|||
25053002|NCT02180217|50156555|FG002|Overall Study|Death|0|||
25053003|NCT02180217|50156553|FG000|Overall Study|Withdrawal by Subject|1|||
25053004|NCT02180217|50156554|FG001|Overall Study|Withdrawal by Subject|1|||
25053005|NCT02180217|50156555|FG002|Overall Study|Withdrawal by Subject|4|||
25053006|NCT02180217|50156553|FG000|Overall Study|Subject/Guardian decision|5|||
25053007|NCT02180217|50156554|FG001|Overall Study|Subject/Guardian decision|3|||
25053008|NCT02180217|50156555|FG002|Overall Study|Subject/Guardian decision|6|||
25053009|NCT02180217|50156553|FG000|Overall Study|Physician Decision|1|||
25053010|NCT02180217|50156554|FG001|Overall Study|Physician Decision|1|||
25053011|NCT02180217|50156555|FG002|Overall Study|Physician Decision|6|||
25053012|NCT02180217|50156553|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25053013|NCT02180217|50156554|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
25053014|NCT02180217|50156555|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
25053015|NCT02560558|50156572|FG000|Overall Study|Adverse Event|1|||
25053016|NCT02560558|50156573|FG001|Overall Study|Adverse Event|0|||
25053017|NCT02560558|50156572|FG000|Overall Study|Death|0|||
25053018|NCT02560558|50156573|FG001|Overall Study|Death|2|||
25053019|NCT02560558|50156572|FG000|Overall Study|Lost to Follow-up|0|||
25053020|NCT02560558|50156573|FG001|Overall Study|Lost to Follow-up|4|||
25053021|NCT02560558|50156572|FG000|Overall Study|Protocol Violation|3|||
25053022|NCT02560558|50156573|FG001|Overall Study|Protocol Violation|0|||
25276537|NCT00890929|50590482|FG000|Overall Study|Death before treatment|2|||
25053023|NCT02560558|50156572|FG000|Overall Study|Withdrawal by Subject|3|||
25053024|NCT02560558|50156573|FG001|Overall Study|Withdrawal by Subject|0|||
25053025|NCT02568046|50156581|FG000|Overall Study|Adverse Event|0|||
25053026|NCT02568046|50156582|FG001|Overall Study|Adverse Event|1|||
25053027|NCT02568046|50156581|FG000|Overall Study|Death|2|||
25053028|NCT02568046|50156582|FG001|Overall Study|Death|0|||
25053029|NCT02568046|50156581|FG000|Overall Study|Progressive Disease|1|||
25053030|NCT02568046|50156582|FG001|Overall Study|Progressive Disease|0|||
25053031|NCT02568046|50156581|FG000|Overall Study|Withdrawal by Subject|2|||
25053032|NCT02568046|50156582|FG001|Overall Study|Withdrawal by Subject|1|||
25053033|NCT02568046|50156581|FG000|Overall Study|Other Events|0|||
25053034|NCT02568046|50156582|FG001|Overall Study|Other Events|1|||
25053035|NCT02567656|50156594|FG000|Overall Study|Premature discontinuation due to PD|1|||
25053036|NCT02567656|50156595|FG001|Overall Study|Premature discontinuation due to PD|1|||
25053037|NCT02567656|50156596|FG002|Overall Study|Premature discontinuation due to PD|2|||
25053038|NCT02567656|50156597|FG003|Overall Study|Premature discontinuation due to PD|0|||
25053039|NCT02567656|50156598|FG004|Overall Study|Premature discontinuation due to PD|0|||
25053040|NCT02567656|50156599|FG005|Overall Study|Premature discontinuation due to PD|0|||
25053041|NCT02560012|50156613|FG000|Overall Study|Study Terminated|2|||
25053042|NCT02567266|50156620|FG000|Overall Study|Withdrawal by Subject|10|||
25053043|NCT02567266|50156621|FG001|Overall Study|Withdrawal by Subject|7|||
24961836|NCT00296504|50052054|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
24961837|NCT00296504|50052055|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
24961838|NCT00296504|50052056|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
24961839|NCT00296504|50052057|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
24961840|NCT00296504|50052058|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
24961841|NCT00296504|50052050|FG000|Interim Analysis|Non-adherence|2|||
24961842|NCT00296504|50052051|FG001|Interim Analysis|Non-adherence|0|||
24961843|NCT00296504|50052052|FG002|Interim Analysis|Non-adherence|0|||
24961844|NCT00296504|50052053|FG003|Interim Analysis|Non-adherence|0|||
24961845|NCT00296504|50052054|FG004|Interim Analysis|Non-adherence|1|||
24961846|NCT00296504|50052055|FG005|Interim Analysis|Non-adherence|0|||
24961847|NCT00296504|50052056|FG006|Interim Analysis|Non-adherence|0|||
24961848|NCT00296504|50052057|FG007|Interim Analysis|Non-adherence|1|||
24961849|NCT00296504|50052058|FG008|Interim Analysis|Non-adherence|0|||
24961850|NCT00296504|50052050|FG000|Interim Analysis|Site Closing|1|||
24961851|NCT00296504|50052051|FG001|Interim Analysis|Site Closing|0|||
25053044|NCT02567266|50156622|FG002|Overall Study|Withdrawal by Subject|6|||
25053045|NCT02567266|50156620|FG000|Overall Study|Lost to Follow-up|13|||
25053046|NCT02567266|50156621|FG001|Overall Study|Lost to Follow-up|8|||
25053047|NCT02567266|50156622|FG002|Overall Study|Lost to Follow-up|10|||
25053048|NCT02567188|50156630|FG000|Overall Study|Death|10|||
25053049|NCT02567188|50156630|FG000|Overall Study|Terminated Mircera Treatment|9|||
25053050|NCT02567188|50156630|FG000|Overall Study|Lost to Follow-up|5|||
25053051|NCT02567188|50156630|FG000|Overall Study|Adverse Event|1|||
25053052|NCT02567188|50156630|FG000|Overall Study|Withdrawal by Subject|1|||
25053053|NCT02567188|50156630|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
25053054|NCT02567188|50156630|FG000|Overall Study|Moved and Changed Clinic|1|||
25053055|NCT02567188|50156630|FG000|Overall Study|Started Hemodialysis|2|||
24961852|NCT00296504|50052052|FG002|Interim Analysis|Site Closing|0|||
25053056|NCT02567188|50156630|FG000|Overall Study|Protocol Violation|5|||
25053057|NCT00706238|50156635|FG000|Overall Study|Disease progression|4|||
25053058|NCT00706238|50156635|FG000|Overall Study|Other|1|||
25053059|NCT04649164|50156642|FG000|Overall Study|Withdrawal by Subject|1|||
25053060|NCT04649164|50156643|FG001|Overall Study|Withdrawal by Subject|1|||
25053061|NCT04649164|50156644|FG002|Overall Study|Withdrawal by Subject|2|||
25053062|NCT04649164|50156642|FG000|Overall Study|Participant's care recipient expired|0|||
25053063|NCT04649164|50156643|FG001|Overall Study|Participant's care recipient expired|0|||
25053064|NCT04649164|50156644|FG002|Overall Study|Participant's care recipient expired|2|||
25053065|NCT02753127|50156654|FG000|Overall Study|Lost to Follow-up|13|||
25053066|NCT02753127|50156655|FG001|Overall Study|Lost to Follow-up|11|||
25053067|NCT02753127|50156654|FG000|Overall Study|Withdrawal by Subject|37|||
25053068|NCT02753127|50156655|FG001|Overall Study|Withdrawal by Subject|47|||
25053069|NCT02753127|50156654|FG000|Overall Study|Other|3|||
25053070|NCT02753127|50156655|FG001|Overall Study|Other|8|||
25053071|NCT02753127|50156654|FG000|Overall Study|Hospice|0|||
25053072|NCT02753127|50156655|FG001|Overall Study|Hospice|2|||
25053073|NCT00706004|50156687|FG000|Overall Study|Did not meet eligibility criteria|2|||
25053074|NCT02724644|50156694|FG000|Overall Study|Adverse Event|7|||
25053075|NCT02724644|50156695|FG001|Overall Study|Adverse Event|1|||
25053076|NCT02724644|50156694|FG000|Overall Study|Lost to Follow-up|6|||
25053077|NCT02724644|50156695|FG001|Overall Study|Lost to Follow-up|2|||
25053078|NCT02724644|50156694|FG000|Overall Study|Withdrawal by Subject|7|||
25053079|NCT02724644|50156695|FG001|Overall Study|Withdrawal by Subject|1|||
25053080|NCT02724644|50156694|FG000|Overall Study|Administrative|1|||
25053081|NCT02724644|50156695|FG001|Overall Study|Administrative|0|||
25053082|NCT02725268|50156705|FG000|Overall Study|Death|58|||
25053083|NCT02725268|50156706|FG001|Overall Study|Death|59|||
25053084|NCT02725268|50156707|FG002|Overall Study|Death|30|||
25053085|NCT02725268|50156708|FG003|Overall Study|Death|16|||
25053086|NCT02725268|50156705|FG000|Overall Study|Lost to Follow-up|4|||
25162654|NCT01997333|50284850|FG000|Randomization and Treatment|Adverse Event|10|||
25162655|NCT01997333|50284851|FG001|Randomization and Treatment|Adverse Event|32|||
24961853|NCT00296504|50052053|FG003|Interim Analysis|Site Closing|0|||
25053087|NCT02725268|50156706|FG001|Overall Study|Lost to Follow-up|3|||
25053088|NCT02725268|50156707|FG002|Overall Study|Lost to Follow-up|0|||
25186583|NCT02647320|50337193|FG000|Overall Study|Protocol Violation|0|||
24961854|NCT00296504|50052054|FG004|Interim Analysis|Site Closing|0|||
24961855|NCT00296504|50052055|FG005|Interim Analysis|Site Closing|1|||
24961856|NCT00296504|50052056|FG006|Interim Analysis|Site Closing|2|||
24961857|NCT00296504|50052057|FG007|Interim Analysis|Site Closing|0|||
24961858|NCT00296504|50052058|FG008|Interim Analysis|Site Closing|0|||
25053089|NCT02725268|50156708|FG003|Overall Study|Lost to Follow-up|1|||
25053090|NCT02725268|50156705|FG000|Overall Study|Site Terminated by Sponsor|0|||
25053091|NCT02725268|50156706|FG001|Overall Study|Site Terminated by Sponsor|1|||
25053092|NCT02725268|50156707|FG002|Overall Study|Site Terminated by Sponsor|0|||
25053093|NCT02725268|50156708|FG003|Overall Study|Site Terminated by Sponsor|0|||
25053094|NCT02725268|50156705|FG000|Overall Study|Withdrawal by Subject|8|||
25053095|NCT02725268|50156706|FG001|Overall Study|Withdrawal by Subject|6|||
25053096|NCT02725268|50156707|FG002|Overall Study|Withdrawal by Subject|8|||
25053097|NCT02725268|50156708|FG003|Overall Study|Withdrawal by Subject|1|||
25053098|NCT02725268|50156705|FG000|Overall Study|Reason not Specified|2|||
25053099|NCT02725268|50156706|FG001|Overall Study|Reason not Specified|1|||
25053100|NCT02725268|50156707|FG002|Overall Study|Reason not Specified|0|||
25053101|NCT02725268|50156708|FG003|Overall Study|Reason not Specified|0|||
25053102|NCT02724956|50156720|FG000|Overall Study|Physician Decision|1|||
25053103|NCT02724956|50156721|FG001|Overall Study|Physician Decision|0|||
25053104|NCT02724956|50156720|FG000|Overall Study|Lack of Efficacy|0|||
25053105|NCT02724956|50156721|FG001|Overall Study|Lack of Efficacy|1|||
25053106|NCT02724956|50156720|FG000|Overall Study|Withdrawal by Subject|0|||
25053107|NCT02724956|50156721|FG001|Overall Study|Withdrawal by Subject|1|||
25053108|NCT00705536|50156729|FG000|Start Period 1|Withdrawal by Subject|0|||
25053109|NCT00705536|50156730|FG001|Start Period 1|Withdrawal by Subject|0|||
25053110|NCT00705536|50156731|FG002|Start Period 1|Withdrawal by Subject|0|||
25053111|NCT00705536|50156732|FG003|Start Period 1|Withdrawal by Subject|1|||
25053112|NCT02724020|50156754|FG000|Overall Study|Death|16|||
25053113|NCT02724020|50156755|FG001|Overall Study|Death|18|||
25053114|NCT02724020|50156756|FG002|Overall Study|Death|19|||
25053115|NCT02724020|50156754|FG000|Overall Study|Lost to Follow-up|0|||
25053116|NCT02724020|50156755|FG001|Overall Study|Lost to Follow-up|3|||
25053117|NCT02724020|50156756|FG002|Overall Study|Lost to Follow-up|0|||
25053118|NCT02724020|50156754|FG000|Overall Study|Site Terminated by Sponsor|15|||
25053119|NCT02724020|50156755|FG001|Overall Study|Site Terminated by Sponsor|8|||
25053120|NCT02724020|50156756|FG002|Overall Study|Site Terminated by Sponsor|8|||
25053121|NCT02724020|50156754|FG000|Overall Study|Withdrawal by Subject|1|||
25053122|NCT02724020|50156755|FG001|Overall Study|Withdrawal by Subject|3|||
25053123|NCT02724020|50156756|FG002|Overall Study|Withdrawal by Subject|5|||
25053124|NCT02660034|50156778|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
25053125|NCT02660034|50156779|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
25053126|NCT02660034|50156780|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
25053127|NCT02660034|50156781|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
25053128|NCT02660034|50156782|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
25053129|NCT02660034|50156783|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
25053130|NCT02660034|50156784|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
25053131|NCT02660034|50156785|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
25053132|NCT02660034|50156786|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
25053133|NCT02660034|50156787|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
25053134|NCT02660034|50156788|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
25053135|NCT02660034|50156789|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
25053136|NCT02660034|50156790|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
25053137|NCT02660034|50156791|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
25053138|NCT02660034|50156778|FG000|Overall Study|Progressive Disease (Clinical)|7|||
24961859|NCT00296504|50052050|FG000|Interim Analysis|Lack of Personnel at Site|1|||
24961860|NCT00296504|50052051|FG001|Interim Analysis|Lack of Personnel at Site|0|||
24961861|NCT00296504|50052052|FG002|Interim Analysis|Lack of Personnel at Site|0|||
24961862|NCT00296504|50052053|FG003|Interim Analysis|Lack of Personnel at Site|0|||
24961863|NCT00296504|50052054|FG004|Interim Analysis|Lack of Personnel at Site|0|||
24961864|NCT00296504|50052055|FG005|Interim Analysis|Lack of Personnel at Site|0|||
24961865|NCT00296504|50052056|FG006|Interim Analysis|Lack of Personnel at Site|0|||
24961866|NCT00296504|50052057|FG007|Interim Analysis|Lack of Personnel at Site|0|||
24961867|NCT00296504|50052058|FG008|Interim Analysis|Lack of Personnel at Site|0|||
24961868|NCT00296504|50052050|FG000|Interim Analysis|Missed Schedule Date|1|||
24961869|NCT00296504|50052051|FG001|Interim Analysis|Missed Schedule Date|0|||
25053139|NCT02660034|50156779|FG001|Overall Study|Progressive Disease (Clinical)|8|||
25053140|NCT02660034|50156780|FG002|Overall Study|Progressive Disease (Clinical)|3|||
25053141|NCT02660034|50156781|FG003|Overall Study|Progressive Disease (Clinical)|9|||
25053142|NCT02660034|50156782|FG004|Overall Study|Progressive Disease (Clinical)|3|||
25053143|NCT02660034|50156783|FG005|Overall Study|Progressive Disease (Clinical)|0|||
25053144|NCT02660034|50156784|FG006|Overall Study|Progressive Disease (Clinical)|0|||
25053145|NCT02660034|50156785|FG007|Overall Study|Progressive Disease (Clinical)|0|||
24961870|NCT00296504|50052052|FG002|Interim Analysis|Missed Schedule Date|0|||
25053146|NCT02660034|50156786|FG008|Overall Study|Progressive Disease (Clinical)|0|||
25053147|NCT02660034|50156787|FG009|Overall Study|Progressive Disease (Clinical)|0|||
24961871|NCT00296504|50052053|FG003|Interim Analysis|Missed Schedule Date|0|||
24961872|NCT00296504|50052054|FG004|Interim Analysis|Missed Schedule Date|0|||
24961873|NCT00296504|50052055|FG005|Interim Analysis|Missed Schedule Date|0|||
24961874|NCT00296504|50052056|FG006|Interim Analysis|Missed Schedule Date|0|||
24961875|NCT00296504|50052057|FG007|Interim Analysis|Missed Schedule Date|0|||
24961876|NCT00296504|50052058|FG008|Interim Analysis|Missed Schedule Date|0|||
24961877|NCT00296504|50052050|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
24961878|NCT00296504|50052051|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
24961879|NCT00296504|50052052|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
24961880|NCT00296504|50052053|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
24961881|NCT00296504|50052054|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
25053148|NCT02660034|50156788|FG010|Overall Study|Progressive Disease (Clinical)|0|||
25053149|NCT02660034|50156789|FG011|Overall Study|Progressive Disease (Clinical)|0|||
25053150|NCT02660034|50156790|FG012|Overall Study|Progressive Disease (Clinical)|0|||
25053151|NCT02660034|50156791|FG013|Overall Study|Progressive Disease (Clinical)|0|||
24961882|NCT00296504|50052055|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
24961883|NCT00296504|50052056|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
24961884|NCT00296504|50052057|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
24961885|NCT00296504|50052058|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
25053152|NCT02660034|50156778|FG000|Overall Study|Lost to Follow-up|0|||
25053153|NCT02660034|50156779|FG001|Overall Study|Lost to Follow-up|0|||
25053154|NCT02660034|50156780|FG002|Overall Study|Lost to Follow-up|1|||
24961886|NCT00296504|50052050|FG000|Interim Analysis|Participant Stopped|0|||
24961887|NCT00296504|50052051|FG001|Interim Analysis|Participant Stopped|0|||
24961888|NCT00296504|50052052|FG002|Interim Analysis|Participant Stopped|0|||
24961889|NCT00296504|50052053|FG003|Interim Analysis|Participant Stopped|0|||
24961890|NCT00296504|50052054|FG004|Interim Analysis|Participant Stopped|1|||
24961891|NCT00296504|50052055|FG005|Interim Analysis|Participant Stopped|0|||
24961892|NCT00296504|50052056|FG006|Interim Analysis|Participant Stopped|0|||
24961893|NCT00296504|50052057|FG007|Interim Analysis|Participant Stopped|0|||
24961894|NCT00296504|50052058|FG008|Interim Analysis|Participant Stopped|0|||
25053155|NCT02660034|50156781|FG003|Overall Study|Lost to Follow-up|1|||
25053156|NCT02660034|50156782|FG004|Overall Study|Lost to Follow-up|0|||
25053157|NCT02660034|50156783|FG005|Overall Study|Lost to Follow-up|0|||
25053158|NCT02660034|50156784|FG006|Overall Study|Lost to Follow-up|0|||
25053159|NCT02660034|50156785|FG007|Overall Study|Lost to Follow-up|0|||
25053160|NCT02660034|50156786|FG008|Overall Study|Lost to Follow-up|0|||
25053161|NCT02660034|50156787|FG009|Overall Study|Lost to Follow-up|1|||
25053162|NCT02660034|50156788|FG010|Overall Study|Lost to Follow-up|1|||
25053163|NCT02660034|50156789|FG011|Overall Study|Lost to Follow-up|1|||
25053164|NCT02660034|50156790|FG012|Overall Study|Lost to Follow-up|0|||
25053165|NCT02660034|50156791|FG013|Overall Study|Lost to Follow-up|0|||
25053166|NCT02660034|50156778|FG000|Overall Study|Participant moved into special access scheme|1|||
25053167|NCT02660034|50156779|FG001|Overall Study|Participant moved into special access scheme|2|||
25053168|NCT02660034|50156780|FG002|Overall Study|Participant moved into special access scheme|0|||
25053169|NCT02660034|50156781|FG003|Overall Study|Participant moved into special access scheme|0|||
25053170|NCT02660034|50156782|FG004|Overall Study|Participant moved into special access scheme|0|||
25053171|NCT02660034|50156783|FG005|Overall Study|Participant moved into special access scheme|0|||
25053172|NCT02660034|50156784|FG006|Overall Study|Participant moved into special access scheme|0|||
25053173|NCT02660034|50156785|FG007|Overall Study|Participant moved into special access scheme|0|||
25053174|NCT02660034|50156786|FG008|Overall Study|Participant moved into special access scheme|0|||
25053175|NCT02660034|50156787|FG009|Overall Study|Participant moved into special access scheme|0|||
25053176|NCT02660034|50156788|FG010|Overall Study|Participant moved into special access scheme|0|||
25053177|NCT02660034|50156789|FG011|Overall Study|Participant moved into special access scheme|0|||
25053178|NCT02660034|50156790|FG012|Overall Study|Participant moved into special access scheme|0|||
25053179|NCT02660034|50156791|FG013|Overall Study|Participant moved into special access scheme|0|||
25053180|NCT02660034|50156778|FG000|Overall Study|Adverse Event|1|||
25053181|NCT02660034|50156779|FG001|Overall Study|Adverse Event|0|||
25053182|NCT02660034|50156780|FG002|Overall Study|Adverse Event|0|||
25053183|NCT02660034|50156781|FG003|Overall Study|Adverse Event|0|||
25053184|NCT02660034|50156782|FG004|Overall Study|Adverse Event|0|||
25053185|NCT02660034|50156783|FG005|Overall Study|Adverse Event|0|||
25053186|NCT02660034|50156784|FG006|Overall Study|Adverse Event|0|||
25053187|NCT02660034|50156785|FG007|Overall Study|Adverse Event|0|||
25053188|NCT02660034|50156786|FG008|Overall Study|Adverse Event|0|||
25053189|NCT02660034|50156787|FG009|Overall Study|Adverse Event|0|||
25053190|NCT02660034|50156788|FG010|Overall Study|Adverse Event|0|||
25053191|NCT02660034|50156789|FG011|Overall Study|Adverse Event|0|||
25053192|NCT02660034|50156790|FG012|Overall Study|Adverse Event|0|||
25053193|NCT02660034|50156791|FG013|Overall Study|Adverse Event|0|||
25053194|NCT02660034|50156778|FG000|Overall Study|Sponsor Decision|0|||
25053195|NCT02660034|50156779|FG001|Overall Study|Sponsor Decision|1|||
25053196|NCT02660034|50156780|FG002|Overall Study|Sponsor Decision|2|||
25053197|NCT02660034|50156781|FG003|Overall Study|Sponsor Decision|2|||
25053198|NCT02660034|50156782|FG004|Overall Study|Sponsor Decision|3|||
25053199|NCT02660034|50156783|FG005|Overall Study|Sponsor Decision|0|||
25053200|NCT02660034|50156784|FG006|Overall Study|Sponsor Decision|0|||
25053201|NCT02660034|50156785|FG007|Overall Study|Sponsor Decision|0|||
25053202|NCT02660034|50156786|FG008|Overall Study|Sponsor Decision|0|||
25053203|NCT02660034|50156787|FG009|Overall Study|Sponsor Decision|0|||
25053204|NCT02660034|50156788|FG010|Overall Study|Sponsor Decision|0|||
25053205|NCT02660034|50156789|FG011|Overall Study|Sponsor Decision|0|||
25053206|NCT02660034|50156790|FG012|Overall Study|Sponsor Decision|0|||
25053207|NCT02660034|50156791|FG013|Overall Study|Sponsor Decision|1|||
25053208|NCT02660034|50156778|FG000|Overall Study|Withdrawal by Subject|0|||
25053209|NCT02660034|50156779|FG001|Overall Study|Withdrawal by Subject|0|||
25053210|NCT02660034|50156780|FG002|Overall Study|Withdrawal by Subject|0|||
25053211|NCT02660034|50156781|FG003|Overall Study|Withdrawal by Subject|0|||
25053212|NCT02660034|50156782|FG004|Overall Study|Withdrawal by Subject|0|||
25053213|NCT02660034|50156783|FG005|Overall Study|Withdrawal by Subject|0|||
25053214|NCT02660034|50156784|FG006|Overall Study|Withdrawal by Subject|1|||
25053215|NCT02660034|50156785|FG007|Overall Study|Withdrawal by Subject|1|||
25162656|NCT01997333|50284850|FG000|Randomization and Treatment|Physician Decision|0|||
25162657|NCT01997333|50284851|FG001|Randomization and Treatment|Physician Decision|4|||
25162658|NCT01997333|50284850|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
25053216|NCT02660034|50156786|FG008|Overall Study|Withdrawal by Subject|1|||
25053217|NCT02660034|50156787|FG009|Overall Study|Withdrawal by Subject|0|||
25053218|NCT02660034|50156788|FG010|Overall Study|Withdrawal by Subject|0|||
25053219|NCT02660034|50156789|FG011|Overall Study|Withdrawal by Subject|1|||
25053220|NCT02660034|50156790|FG012|Overall Study|Withdrawal by Subject|2|||
25053221|NCT02660034|50156791|FG013|Overall Study|Withdrawal by Subject|0|||
25053222|NCT02660034|50156778|FG000|Overall Study|Death|0|||
25053223|NCT02660034|50156779|FG001|Overall Study|Death|0|||
25053224|NCT02660034|50156780|FG002|Overall Study|Death|0|||
25053225|NCT02660034|50156781|FG003|Overall Study|Death|0|||
25053226|NCT02660034|50156782|FG004|Overall Study|Death|0|||
25053227|NCT02660034|50156783|FG005|Overall Study|Death|13|||
25053228|NCT02660034|50156784|FG006|Overall Study|Death|14|||
25053229|NCT02660034|50156785|FG007|Overall Study|Death|10|||
25053230|NCT02660034|50156786|FG008|Overall Study|Death|9|||
25053231|NCT02660034|50156787|FG009|Overall Study|Death|21|||
25053232|NCT02660034|50156788|FG010|Overall Study|Death|17|||
25053233|NCT02660034|50156789|FG011|Overall Study|Death|15|||
25053234|NCT02660034|50156790|FG012|Overall Study|Death|18|||
25053235|NCT02660034|50156791|FG013|Overall Study|Death|7|||
25053236|NCT02660034|50156778|FG000|Overall Study|Physician Decision|0|||
25053237|NCT02660034|50156779|FG001|Overall Study|Physician Decision|0|||
25053238|NCT02660034|50156780|FG002|Overall Study|Physician Decision|0|||
25053239|NCT02660034|50156781|FG003|Overall Study|Physician Decision|0|||
25053240|NCT02660034|50156782|FG004|Overall Study|Physician Decision|0|||
25053241|NCT02660034|50156783|FG005|Overall Study|Physician Decision|0|||
25053242|NCT02660034|50156784|FG006|Overall Study|Physician Decision|0|||
24961895|NCT00296504|50052050|FG000|Interim Analysis|Physician and Participant Decision|0|||
24961896|NCT00296504|50052051|FG001|Interim Analysis|Physician and Participant Decision|0|||
24961897|NCT00296504|50052052|FG002|Interim Analysis|Physician and Participant Decision|0|||
24961898|NCT00296504|50052053|FG003|Interim Analysis|Physician and Participant Decision|0|||
24961899|NCT00296504|50052054|FG004|Interim Analysis|Physician and Participant Decision|0|||
24961900|NCT00296504|50052055|FG005|Interim Analysis|Physician and Participant Decision|1|||
24961901|NCT00296504|50052056|FG006|Interim Analysis|Physician and Participant Decision|0|||
25053243|NCT02660034|50156785|FG007|Overall Study|Physician Decision|0|||
25053244|NCT02660034|50156786|FG008|Overall Study|Physician Decision|0|||
25053245|NCT02660034|50156787|FG009|Overall Study|Physician Decision|0|||
25053246|NCT02660034|50156788|FG010|Overall Study|Physician Decision|0|||
25053247|NCT02660034|50156789|FG011|Overall Study|Physician Decision|0|||
25053248|NCT02660034|50156790|FG012|Overall Study|Physician Decision|0|||
25053249|NCT02660034|50156791|FG013|Overall Study|Physician Decision|1|||
25053250|NCT02660034|50156778|FG000|Overall Study|Participants transferred to LTE|0|||
25053251|NCT02660034|50156779|FG001|Overall Study|Participants transferred to LTE|0|||
25053252|NCT02660034|50156780|FG002|Overall Study|Participants transferred to LTE|0|||
25053253|NCT02660034|50156781|FG003|Overall Study|Participants transferred to LTE|0|||
25053254|NCT02660034|50156782|FG004|Overall Study|Participants transferred to LTE|0|||
25053255|NCT02660034|50156783|FG005|Overall Study|Participants transferred to LTE|10|||
25053256|NCT02660034|50156784|FG006|Overall Study|Participants transferred to LTE|8|||
25053257|NCT02660034|50156785|FG007|Overall Study|Participants transferred to LTE|8|||
25053258|NCT02660034|50156786|FG008|Overall Study|Participants transferred to LTE|10|||
25053259|NCT02660034|50156787|FG009|Overall Study|Participants transferred to LTE|1|||
25053260|NCT02660034|50156788|FG010|Overall Study|Participants transferred to LTE|2|||
25053261|NCT02660034|50156789|FG011|Overall Study|Participants transferred to LTE|4|||
25053262|NCT02660034|50156790|FG012|Overall Study|Participants transferred to LTE|1|||
25053263|NCT02660034|50156791|FG013|Overall Study|Participants transferred to LTE|1|||
25053264|NCT02193867|50156834|FG000|Overall Study|Death|2|||
25053265|NCT02193867|50156834|FG000|Overall Study|Sponsor Study Termination|2|||
25053266|NCT02200770|50156862|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
25053267|NCT02200770|50156863|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
25053268|NCT02200770|50156862|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
25053269|NCT02200770|50156863|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
25053270|NCT02200770|50156862|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
25053271|NCT02200770|50156863|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
25053272|NCT02200770|50156862|FG000|Randomized-controlled Period (RCP)|Other|1|||
25053273|NCT02200770|50156863|FG001|Randomized-controlled Period (RCP)|Other|2|||
25053274|NCT02200770|50156862|FG000|Open-label Period (OLP)|Adverse Event|1|||
25053275|NCT02200770|50156863|FG001|Open-label Period (OLP)|Adverse Event|2|||
25053276|NCT02200770|50156862|FG000|Open-label Period (OLP)|Death|1|||
25053277|NCT02200770|50156863|FG001|Open-label Period (OLP)|Death|2|||
25053278|NCT02200770|50156862|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
25053279|NCT02200770|50156863|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
25053280|NCT02200770|50156862|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
24961902|NCT00296504|50052057|FG007|Interim Analysis|Physician and Participant Decision|0|||
25053281|NCT02200770|50156863|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
25053282|NCT02200770|50156862|FG000|Open-label Period (OLP)|Other|6|||
25053283|NCT02200770|50156863|FG001|Open-label Period (OLP)|Other|15|||
25053284|NCT01186848|50156871|FG000|Overall Study|Lost to Follow-up|4|||
25053285|NCT01186848|50156871|FG000|Overall Study|Withdrawal by Subject|2|||
25053286|NCT01186848|50156871|FG000|Overall Study|Adverse Event|2|||
25053287|NCT01024608|50156879|FG000|Overall Study|Adverse Event|1|||
25053288|NCT01024608|50156880|FG001|Overall Study|Adverse Event|0|||
25053289|NCT01024608|50156879|FG000|Overall Study|Withdrawal by Subject|1|||
25053290|NCT01024608|50156880|FG001|Overall Study|Withdrawal by Subject|0|||
25053291|NCT01024608|50156879|FG000|Overall Study|Lost to Follow-up|0|||
25053292|NCT01024608|50156880|FG001|Overall Study|Lost to Follow-up|1|||
25053293|NCT01024608|50156879|FG000|Overall Study|Protocol Violation|0|||
25053294|NCT01024608|50156880|FG001|Overall Study|Protocol Violation|3|||
25053295|NCT01024608|50156879|FG000|Overall Study|Never received study treatment|2|||
25053296|NCT01024608|50156880|FG001|Overall Study|Never received study treatment|0|||
25053297|NCT00910650|50156886|FG000|Overall Study|Death|2|||
25053298|NCT03996876|50156921|FG000|Overall Study|Incomplete Data|2|||
25053299|NCT03996876|50156922|FG001|Overall Study|Incomplete Data|4|||
25053300|NCT01460160|50156929|FG000|Treatment Phase|Lack of Efficacy|3|||
25053301|NCT01460160|50156929|FG000|Treatment Phase|Study Drug Toxicity|2|||
25053302|NCT01460160|50156929|FG000|Treatment Phase|Adverse Event|8|||
25053303|NCT01460160|50156929|FG000|Treatment Phase|Withdrawal by Subject|4|||
25053304|NCT01460160|50156929|FG000|Treatment Phase|Death|2|||
25053305|NCT01460160|50156929|FG000|Treatment Phase|Other reasons|9|||
25053306|NCT01460160|50156929|FG000|Follow-up Phase|Withdrawal by Subject|4|||
25053307|NCT01460160|50156929|FG000|Follow-up Phase|Death|14|||
25053308|NCT01460160|50156929|FG000|Follow-up Phase|Lost to Follow-up|7|||
25053309|NCT01460160|50156929|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
25053310|NCT01460160|50156929|FG000|Follow-up Phase|Other and not reported reasons|5|||
25053311|NCT01170702|50156937|FG000|Overall Study|Exclusion criteria met after consent|1|||
25053312|NCT01170702|50156938|FG001|Overall Study|Exclusion criteria met after consent|2|||
25053313|NCT01170702|50156939|FG002|Overall Study|Exclusion criteria met after consent|0|||
25053314|NCT01170702|50156940|FG003|Overall Study|Exclusion criteria met after consent|2|||
25053315|NCT02723864|50156979|FG000|Overall Study|Refused further treatment|1|||
25053316|NCT02723864|50156980|FG001|Overall Study|Refused further treatment|0|||
25053317|NCT02723864|50156981|FG002|Overall Study|Refused further treatment|0|||
25053318|NCT02723864|50156982|FG003|Overall Study|Refused further treatment|0|||
25053319|NCT02723864|50156983|FG004|Overall Study|Refused further treatment|1|||
25053320|NCT02723864|50156984|FG005|Overall Study|Refused further treatment|2|||
25053321|NCT02723864|50156985|FG006|Overall Study|Refused further treatment|0|||
25053322|NCT02723864|50156979|FG000|Overall Study|Exceed treatment hold time|0|||
25053323|NCT02723864|50156980|FG001|Overall Study|Exceed treatment hold time|1|||
25053324|NCT02723864|50156981|FG002|Overall Study|Exceed treatment hold time|0|||
25053325|NCT02723864|50156982|FG003|Overall Study|Exceed treatment hold time|0|||
25053326|NCT02723864|50156983|FG004|Overall Study|Exceed treatment hold time|0|||
25053327|NCT02723864|50156984|FG005|Overall Study|Exceed treatment hold time|0|||
25053328|NCT02723864|50156985|FG006|Overall Study|Exceed treatment hold time|0|||
25053329|NCT02723864|50156979|FG000|Overall Study|Clinical progression|0|||
25053330|NCT02723864|50156980|FG001|Overall Study|Clinical progression|0|||
25053331|NCT02723864|50156981|FG002|Overall Study|Clinical progression|1|||
25053332|NCT02723864|50156982|FG003|Overall Study|Clinical progression|0|||
25053333|NCT02723864|50156983|FG004|Overall Study|Clinical progression|0|||
25053334|NCT02723864|50156984|FG005|Overall Study|Clinical progression|3|||
25053335|NCT02723864|50156985|FG006|Overall Study|Clinical progression|1|||
25053336|NCT02723864|50156979|FG000|Overall Study|Physician Decision|0|||
25053337|NCT02723864|50156980|FG001|Overall Study|Physician Decision|0|||
25053338|NCT02723864|50156981|FG002|Overall Study|Physician Decision|0|||
25053339|NCT02723864|50156982|FG003|Overall Study|Physician Decision|0|||
25053340|NCT02723864|50156983|FG004|Overall Study|Physician Decision|0|||
25053341|NCT02723864|50156984|FG005|Overall Study|Physician Decision|0|||
25053342|NCT02723864|50156985|FG006|Overall Study|Physician Decision|1|||
25053343|NCT02723864|50156979|FG000|Overall Study|Changes in patient condition|0|||
25053344|NCT02723864|50156980|FG001|Overall Study|Changes in patient condition|0|||
25053345|NCT02723864|50156981|FG002|Overall Study|Changes in patient condition|0|||
25053346|NCT02723864|50156982|FG003|Overall Study|Changes in patient condition|0|||
25053347|NCT02723864|50156983|FG004|Overall Study|Changes in patient condition|0|||
25053348|NCT02723864|50156984|FG005|Overall Study|Changes in patient condition|1|||
25053349|NCT02723864|50156985|FG006|Overall Study|Changes in patient condition|0|||
25053350|NCT02723864|50156979|FG000|Overall Study|Patient choice|0|||
25053351|NCT02723864|50156980|FG001|Overall Study|Patient choice|0|||
25053352|NCT02723864|50156981|FG002|Overall Study|Patient choice|0|||
25053353|NCT02723864|50156982|FG003|Overall Study|Patient choice|0|||
25053354|NCT02723864|50156983|FG004|Overall Study|Patient choice|0|||
25053355|NCT02723864|50156984|FG005|Overall Study|Patient choice|1|||
25053356|NCT02723864|50156985|FG006|Overall Study|Patient choice|0|||
25053357|NCT02723864|50156979|FG000|Overall Study|Adverse Event|0|||
25053358|NCT02723864|50156980|FG001|Overall Study|Adverse Event|0|||
25053359|NCT02723864|50156981|FG002|Overall Study|Adverse Event|0|||
25053360|NCT02723864|50156982|FG003|Overall Study|Adverse Event|0|||
25053361|NCT02723864|50156983|FG004|Overall Study|Adverse Event|0|||
25053362|NCT02723864|50156984|FG005|Overall Study|Adverse Event|1|||
25053363|NCT02723864|50156985|FG006|Overall Study|Adverse Event|0|||
25053364|NCT02723864|50156979|FG000|Overall Study|Started new treatment|0|||
25053365|NCT02723864|50156980|FG001|Overall Study|Started new treatment|0|||
25053366|NCT02723864|50156981|FG002|Overall Study|Started new treatment|0|||
25053367|NCT02723864|50156982|FG003|Overall Study|Started new treatment|0|||
24961903|NCT00296504|50052058|FG008|Interim Analysis|Physician and Participant Decision|0|||
24961904|NCT00296504|50052050|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
24961905|NCT00296504|50052051|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
24961906|NCT00296504|50052052|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
24961907|NCT00296504|50052053|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
24961908|NCT00296504|50052054|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
25053368|NCT02723864|50156983|FG004|Overall Study|Started new treatment|0|||
25053369|NCT02723864|50156984|FG005|Overall Study|Started new treatment|1|||
25053370|NCT02723864|50156985|FG006|Overall Study|Started new treatment|0|||
25053371|NCT02723864|50156979|FG000|Overall Study|Switched to alternative treatment|0|||
25053372|NCT02723864|50156980|FG001|Overall Study|Switched to alternative treatment|0|||
25053373|NCT02723864|50156981|FG002|Overall Study|Switched to alternative treatment|0|||
25053374|NCT02723864|50156982|FG003|Overall Study|Switched to alternative treatment|0|||
25053375|NCT02723864|50156983|FG004|Overall Study|Switched to alternative treatment|0|||
25053376|NCT02723864|50156984|FG005|Overall Study|Switched to alternative treatment|1|||
25053377|NCT02723864|50156985|FG006|Overall Study|Switched to alternative treatment|0|||
25053378|NCT02723864|50156979|FG000|Overall Study|Late determination of ineligibility|0|||
25053379|NCT02723864|50156980|FG001|Overall Study|Late determination of ineligibility|0|||
25053380|NCT02723864|50156981|FG002|Overall Study|Late determination of ineligibility|0|||
25053381|NCT02723864|50156982|FG003|Overall Study|Late determination of ineligibility|0|||
25053382|NCT02723864|50156983|FG004|Overall Study|Late determination of ineligibility|0|||
25053383|NCT02723864|50156984|FG005|Overall Study|Late determination of ineligibility|1|||
25053384|NCT02723864|50156985|FG006|Overall Study|Late determination of ineligibility|0|||
25053385|NCT00705146|50157024|FG000|Overall Study|Lost to Follow-up|1|||
25162659|NCT01997333|50284851|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
24961909|NCT00296504|50052055|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
24961910|NCT00296504|50052056|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
24961911|NCT00296504|50052057|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
24961912|NCT00296504|50052058|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
24961913|NCT00296504|50052050|FG000|Interim Analysis|Study Ended|0|||
24961914|NCT00296504|50052051|FG001|Interim Analysis|Study Ended|0|||
24961915|NCT00296504|50052052|FG002|Interim Analysis|Study Ended|0|||
24961916|NCT00296504|50052053|FG003|Interim Analysis|Study Ended|0|||
24961917|NCT00296504|50052054|FG004|Interim Analysis|Study Ended|0|||
24961918|NCT00296504|50052055|FG005|Interim Analysis|Study Ended|0|||
24961919|NCT00296504|50052056|FG006|Interim Analysis|Study Ended|1|||
24961920|NCT00296504|50052057|FG007|Interim Analysis|Study Ended|0|||
24961921|NCT00296504|50052058|FG008|Interim Analysis|Study Ended|0|||
24961922|NCT00296504|50052050|FG000|Interim Analysis|Participant Needed Interferon|0|||
25162660|NCT01997333|50284850|FG000|Randomization and Treatment|Did not receive treatment|17|||
24961923|NCT00296504|50052051|FG001|Interim Analysis|Participant Needed Interferon|0|||
24961924|NCT00296504|50052052|FG002|Interim Analysis|Participant Needed Interferon|0|||
24961925|NCT00296504|50052053|FG003|Interim Analysis|Participant Needed Interferon|0|||
24961926|NCT00296504|50052054|FG004|Interim Analysis|Participant Needed Interferon|0|||
24961927|NCT00296504|50052055|FG005|Interim Analysis|Participant Needed Interferon|0|||
25053386|NCT00705146|50157025|FG001|Overall Study|Lost to Follow-up|1|||
25053387|NCT03203642|50157033|FG000|Overall Study|Adverse Event|3|||
25053388|NCT03203642|50157034|FG001|Overall Study|Adverse Event|1|||
25053389|NCT03203642|50157033|FG000|Overall Study|Withdrawal by Subject|6|||
25053390|NCT03203642|50157034|FG001|Overall Study|Withdrawal by Subject|6|||
25053391|NCT03203642|50157033|FG000|Overall Study|Lost to Follow-up|2|||
25053392|NCT03203642|50157034|FG001|Overall Study|Lost to Follow-up|1|||
25053393|NCT03203642|50157033|FG000|Overall Study|Termination of the study by sponsor|1|||
25053394|NCT03203642|50157034|FG001|Overall Study|Termination of the study by sponsor|1|||
25053395|NCT03203642|50157033|FG000|Overall Study|Participant moved|0|||
25053396|NCT03203642|50157034|FG001|Overall Study|Participant moved|1|||
25053397|NCT03203642|50157033|FG000|Overall Study|Investigator's decision|3|||
25053398|NCT03203642|50157034|FG001|Overall Study|Investigator's decision|0|||
25053399|NCT03203642|50157033|FG000|Overall Study|Other than above specified|0|||
25053400|NCT03203642|50157034|FG001|Overall Study|Other than above specified|1|||
25053401|NCT02737722|50157044|FG000|Overall Study|Physician Decision|0|||
25053402|NCT02737722|50157045|FG001|Overall Study|Physician Decision|0|||
25053403|NCT02737722|50157046|FG002|Overall Study|Physician Decision|1|||
25053404|NCT02737722|50157047|FG003|Overall Study|Physician Decision|0|||
25053405|NCT03792750|50157057|FG000|Overall Study|Death|3|||
25053406|NCT02750709|50157062|FG000|Treatment Period 1|Adverse Event|0|||
25053407|NCT02750709|50157063|FG001|Treatment Period 1|Adverse Event|0|||
25053408|NCT02750709|50157064|FG002|Treatment Period 1|Adverse Event|0|||
25053409|NCT02750709|50157065|FG003|Treatment Period 1|Adverse Event|0|||
25053410|NCT02750709|50157066|FG004|Treatment Period 1|Adverse Event|0|||
25053411|NCT02750709|50157067|FG005|Treatment Period 1|Adverse Event|1|||
25053412|NCT02723786|50157075|FG000|Overall Study|Lost to Follow-up|1|||
25053413|NCT02723084|50157094|FG000|Overall Study|Withdrawal by Subject|1|||
25053414|NCT02723084|50157095|FG001|Overall Study|Withdrawal by Subject|1|||
25053415|NCT02723084|50157094|FG000|Overall Study|Lost to Follow-up|3|||
25053416|NCT02723084|50157095|FG001|Overall Study|Lost to Follow-up|0|||
25053417|NCT02750943|50157103|FG000|Overall Study|Lost to Follow-up|1|||
25053418|NCT02750943|50157104|FG001|Overall Study|Lost to Follow-up|2|||
25053419|NCT02750943|50157103|FG000|Overall Study|Withdrawal by Subject|5|||
25053420|NCT02750943|50157104|FG001|Overall Study|Withdrawal by Subject|7|||
25053421|NCT04730349|50157121|FG000|Overall Study|Participant withdrew consent|1|||
25053422|NCT04730349|50157122|FG001|Overall Study|Participant withdrew consent|0|||
25053423|NCT04730349|50157121|FG000|Overall Study|Disease progression|6|||
25053424|NCT04730349|50157122|FG001|Overall Study|Disease progression|4|||
25053425|NCT04730349|50157121|FG000|Overall Study|Study drug toxicity|0|||
24961928|NCT00296504|50052056|FG006|Interim Analysis|Participant Needed Interferon|0|||
24961929|NCT00296504|50052057|FG007|Interim Analysis|Participant Needed Interferon|1|||
25053426|NCT04730349|50157122|FG001|Overall Study|Study drug toxicity|1|||
25053427|NCT04307394|50157141|FG000|Overall Study|Lost to Follow-up|3|||
25053428|NCT04307394|50157141|FG000|Overall Study|Withdrawal by Subject|2|||
24961930|NCT00296504|50052058|FG008|Interim Analysis|Participant Needed Interferon|0|||
24961931|NCT00296504|50052050|FG000|Interim Analysis|Ongoing|32|||
24961932|NCT00296504|50052051|FG001|Interim Analysis|Ongoing|12|||
25053429|NCT03940742|50157167|FG000|Overall Study|Lost to Follow-up|0|||
25053430|NCT03940742|50157168|FG001|Overall Study|Lost to Follow-up|0|||
25053431|NCT03940742|50157169|FG002|Overall Study|Lost to Follow-up|0|||
25053432|NCT03940742|50157170|FG003|Overall Study|Lost to Follow-up|1|||
25053433|NCT03917654|50157192|FG000|Year 1|Withdrawal by Subject|1|||
25053434|NCT03917654|50157193|FG001|Year 1|Withdrawal by Subject|0|||
25053435|NCT03917654|50157194|FG002|Year 1|Withdrawal by Subject|0|||
25053436|NCT03917654|50157195|FG003|Year 1|Withdrawal by Subject|0|||
25053437|NCT03917654|50157196|FG004|Year 1|Withdrawal by Subject|0|||
25053438|NCT03917654|50157197|FG005|Year 1|Withdrawal by Subject|1|||
24961933|NCT00296504|50052052|FG002|Interim Analysis|Ongoing|16|||
24961934|NCT00296504|50052053|FG003|Interim Analysis|Ongoing|22|||
24961935|NCT00296504|50052054|FG004|Interim Analysis|Ongoing|0|||
24961936|NCT00296504|50052055|FG005|Interim Analysis|Ongoing|0|||
24961937|NCT00296504|50052056|FG006|Interim Analysis|Ongoing|30|||
24961938|NCT00296504|50052057|FG007|Interim Analysis|Ongoing|1|||
25053439|NCT03917654|50157198|FG006|Year 1|Withdrawal by Subject|6|||
25053440|NCT03917654|50157199|FG007|Year 1|Withdrawal by Subject|2|||
25053441|NCT03917654|50157200|FG008|Year 1|Withdrawal by Subject|5|||
25053442|NCT03917654|50157201|FG009|Year 1|Withdrawal by Subject|3|||
25053443|NCT03917654|50157202|FG010|Year 1|Withdrawal by Subject|1|||
25053444|NCT03917654|50157203|FG011|Year 1|Withdrawal by Subject|0|||
25053445|NCT03917654|50157192|FG000|Year 1|Travel|0|||
25053446|NCT03917654|50157193|FG001|Year 1|Travel|1|||
25053447|NCT03917654|50157194|FG002|Year 1|Travel|1|||
25053448|NCT03917654|50157195|FG003|Year 1|Travel|0|||
25053449|NCT03917654|50157196|FG004|Year 1|Travel|4|||
25053450|NCT03917654|50157197|FG005|Year 1|Travel|4|||
25053451|NCT03917654|50157198|FG006|Year 1|Travel|10|||
25053452|NCT03917654|50157199|FG007|Year 1|Travel|8|||
24961939|NCT00296504|50052058|FG008|Interim Analysis|Ongoing|0|||
24961940|NCT00296504|50052050|FG000|Final Analysis|Withdrawal by Subject|0|||
24961941|NCT00296504|50052051|FG001|Final Analysis|Withdrawal by Subject|0|||
24961942|NCT00296504|50052052|FG002|Final Analysis|Withdrawal by Subject|0|||
24961943|NCT00296504|50052053|FG003|Final Analysis|Withdrawal by Subject|0|||
24961944|NCT00296504|50052054|FG004|Final Analysis|Withdrawal by Subject|0|||
24961945|NCT00296504|50052055|FG005|Final Analysis|Withdrawal by Subject|0|||
24961946|NCT00296504|50052056|FG006|Final Analysis|Withdrawal by Subject|0|||
24961947|NCT00296504|50052057|FG007|Final Analysis|Withdrawal by Subject|0|||
24961948|NCT00296504|50052058|FG008|Final Analysis|Withdrawal by Subject|1|||
24961949|NCT00296504|50052050|FG000|Final Analysis|Lost to Follow-up|0|||
24961950|NCT00296504|50052051|FG001|Final Analysis|Lost to Follow-up|0|||
24961951|NCT00296504|50052052|FG002|Final Analysis|Lost to Follow-up|0|||
24961952|NCT00296504|50052053|FG003|Final Analysis|Lost to Follow-up|0|||
24961953|NCT00296504|50052054|FG004|Final Analysis|Lost to Follow-up|0|||
24961954|NCT00296504|50052055|FG005|Final Analysis|Lost to Follow-up|0|||
24961955|NCT00296504|50052056|FG006|Final Analysis|Lost to Follow-up|0|||
24961956|NCT00296504|50052057|FG007|Final Analysis|Lost to Follow-up|0|||
24961957|NCT00296504|50052058|FG008|Final Analysis|Lost to Follow-up|5|||
24961958|NCT00296504|50052050|FG000|Final Analysis|Insufficient Viral Load Response|0|||
24961959|NCT00296504|50052051|FG001|Final Analysis|Insufficient Viral Load Response|0|||
24961960|NCT00296504|50052052|FG002|Final Analysis|Insufficient Viral Load Response|0|||
24961961|NCT00296504|50052053|FG003|Final Analysis|Insufficient Viral Load Response|0|||
24961962|NCT00296504|50052054|FG004|Final Analysis|Insufficient Viral Load Response|0|||
24961963|NCT00296504|50052055|FG005|Final Analysis|Insufficient Viral Load Response|0|||
24961964|NCT00296504|50052056|FG006|Final Analysis|Insufficient Viral Load Response|0|||
24961965|NCT00296504|50052057|FG007|Final Analysis|Insufficient Viral Load Response|0|||
24961966|NCT00296504|50052058|FG008|Final Analysis|Insufficient Viral Load Response|6|||
24961967|NCT00296504|50052050|FG000|Final Analysis|Adverse Event|0|||
24961968|NCT00296504|50052051|FG001|Final Analysis|Adverse Event|0|||
24961969|NCT00296504|50052052|FG002|Final Analysis|Adverse Event|0|||
24961970|NCT00296504|50052053|FG003|Final Analysis|Adverse Event|0|||
24961971|NCT00296504|50052054|FG004|Final Analysis|Adverse Event|0|||
25053453|NCT03917654|50157200|FG008|Year 1|Travel|2|||
25053454|NCT03917654|50157201|FG009|Year 1|Travel|5|||
25053455|NCT03917654|50157202|FG010|Year 1|Travel|3|||
25053456|NCT03917654|50157203|FG011|Year 1|Travel|3|||
25053457|NCT03917654|50157192|FG000|Year 1|Subject moved away from site|0|||
25053458|NCT03917654|50157193|FG001|Year 1|Subject moved away from site|1|||
25053459|NCT03917654|50157194|FG002|Year 1|Subject moved away from site|0|||
25053460|NCT03917654|50157195|FG003|Year 1|Subject moved away from site|0|||
25053461|NCT03917654|50157196|FG004|Year 1|Subject moved away from site|0|||
25053462|NCT03917654|50157197|FG005|Year 1|Subject moved away from site|0|||
25053463|NCT03917654|50157198|FG006|Year 1|Subject moved away from site|1|||
25053464|NCT03917654|50157199|FG007|Year 1|Subject moved away from site|2|||
25053465|NCT03917654|50157200|FG008|Year 1|Subject moved away from site|1|||
25053466|NCT03917654|50157201|FG009|Year 1|Subject moved away from site|0|||
25053467|NCT03917654|50157202|FG010|Year 1|Subject moved away from site|0|||
25053468|NCT03917654|50157203|FG011|Year 1|Subject moved away from site|3|||
25053469|NCT03917654|50157192|FG000|Year 1|Spouse/Family member request|0|||
25053470|NCT03917654|50157193|FG001|Year 1|Spouse/Family member request|0|||
25053471|NCT03917654|50157194|FG002|Year 1|Spouse/Family member request|1|||
25053472|NCT03917654|50157195|FG003|Year 1|Spouse/Family member request|0|||
25053473|NCT03917654|50157196|FG004|Year 1|Spouse/Family member request|1|||
25053474|NCT03917654|50157197|FG005|Year 1|Spouse/Family member request|0|||
25053475|NCT03917654|50157198|FG006|Year 1|Spouse/Family member request|0|||
25053476|NCT03917654|50157199|FG007|Year 1|Spouse/Family member request|2|||
25053477|NCT03917654|50157200|FG008|Year 1|Spouse/Family member request|0|||
25053478|NCT03917654|50157201|FG009|Year 1|Spouse/Family member request|0|||
25053479|NCT03917654|50157202|FG010|Year 1|Spouse/Family member request|0|||
25053480|NCT03917654|50157203|FG011|Year 1|Spouse/Family member request|1|||
25053481|NCT03917654|50157192|FG000|Year 1|Death|0|||
25053482|NCT03917654|50157193|FG001|Year 1|Death|0|||
25053483|NCT03917654|50157194|FG002|Year 1|Death|0|||
25053484|NCT03917654|50157195|FG003|Year 1|Death|0|||
25053485|NCT03917654|50157196|FG004|Year 1|Death|0|||
25053486|NCT03917654|50157197|FG005|Year 1|Death|0|||
25053487|NCT03917654|50157198|FG006|Year 1|Death|0|||
25053488|NCT03917654|50157199|FG007|Year 1|Death|0|||
25053489|NCT03917654|50157200|FG008|Year 1|Death|1|||
25053490|NCT03917654|50157201|FG009|Year 1|Death|1|||
25053491|NCT03917654|50157202|FG010|Year 1|Death|0|||
25053492|NCT03917654|50157203|FG011|Year 1|Death|0|||
24961972|NCT00296504|50052055|FG005|Final Analysis|Adverse Event|0|||
24961973|NCT00296504|50052056|FG006|Final Analysis|Adverse Event|0|||
24961974|NCT00296504|50052057|FG007|Final Analysis|Adverse Event|0|||
24961975|NCT00296504|50052058|FG008|Final Analysis|Adverse Event|2|||
24961976|NCT00296504|50052050|FG000|Final Analysis|Pregnancy|0|||
24961977|NCT00296504|50052051|FG001|Final Analysis|Pregnancy|0|||
24961978|NCT00296504|50052052|FG002|Final Analysis|Pregnancy|0|||
24961979|NCT00296504|50052053|FG003|Final Analysis|Pregnancy|0|||
25053493|NCT03917654|50157192|FG000|Year 1|Lost to Follow-up|0|||
25053494|NCT03917654|50157193|FG001|Year 1|Lost to Follow-up|0|||
25053495|NCT03917654|50157194|FG002|Year 1|Lost to Follow-up|0|||
25053496|NCT03917654|50157195|FG003|Year 1|Lost to Follow-up|0|||
25053497|NCT03917654|50157196|FG004|Year 1|Lost to Follow-up|0|||
25053498|NCT03917654|50157197|FG005|Year 1|Lost to Follow-up|0|||
25053499|NCT03917654|50157198|FG006|Year 1|Lost to Follow-up|2|||
25053500|NCT03917654|50157199|FG007|Year 1|Lost to Follow-up|0|||
25053501|NCT03917654|50157200|FG008|Year 1|Lost to Follow-up|0|||
25053502|NCT03917654|50157201|FG009|Year 1|Lost to Follow-up|0|||
25053503|NCT03917654|50157202|FG010|Year 1|Lost to Follow-up|0|||
25053504|NCT03917654|50157203|FG011|Year 1|Lost to Follow-up|0|||
25053505|NCT03917654|50157192|FG000|Year 1|Missed visits|0|||
25053506|NCT03917654|50157193|FG001|Year 1|Missed visits|0|||
25053507|NCT03917654|50157194|FG002|Year 1|Missed visits|0|||
25053508|NCT03917654|50157195|FG003|Year 1|Missed visits|0|||
25053509|NCT03917654|50157196|FG004|Year 1|Missed visits|0|||
25053510|NCT03917654|50157197|FG005|Year 1|Missed visits|0|||
25053511|NCT03917654|50157198|FG006|Year 1|Missed visits|0|||
25053512|NCT03917654|50157199|FG007|Year 1|Missed visits|0|||
25053513|NCT03917654|50157200|FG008|Year 1|Missed visits|0|||
25053514|NCT03917654|50157201|FG009|Year 1|Missed visits|0|||
25053515|NCT03917654|50157202|FG010|Year 1|Missed visits|1|||
25053516|NCT03917654|50157203|FG011|Year 1|Missed visits|1|||
25053517|NCT03917654|50157192|FG000|Year 1|Pregnancy|0|||
25053518|NCT03917654|50157193|FG001|Year 1|Pregnancy|0|||
25053519|NCT03917654|50157194|FG002|Year 1|Pregnancy|0|||
25053520|NCT03917654|50157195|FG003|Year 1|Pregnancy|0|||
25053521|NCT03917654|50157196|FG004|Year 1|Pregnancy|0|||
25053522|NCT03917654|50157197|FG005|Year 1|Pregnancy|0|||
25053523|NCT03917654|50157198|FG006|Year 1|Pregnancy|0|||
25053524|NCT03917654|50157199|FG007|Year 1|Pregnancy|1|||
25053525|NCT03917654|50157200|FG008|Year 1|Pregnancy|0|||
25053526|NCT03917654|50157201|FG009|Year 1|Pregnancy|1|||
25053527|NCT03917654|50157202|FG010|Year 1|Pregnancy|0|||
25053528|NCT03917654|50157203|FG011|Year 1|Pregnancy|0|||
25053529|NCT03917654|50157192|FG000|Year 2|Travel|1|||
25053530|NCT03917654|50157193|FG001|Year 2|Travel|0|||
25053531|NCT03917654|50157194|FG002|Year 2|Travel|0|||
25053532|NCT03917654|50157195|FG003|Year 2|Travel|0|||
25053533|NCT03917654|50157196|FG004|Year 2|Travel|1|||
25053534|NCT03917654|50157197|FG005|Year 2|Travel|1|||
25053535|NCT03917654|50157198|FG006|Year 2|Travel|2|||
25053536|NCT03917654|50157199|FG007|Year 2|Travel|1|||
25053537|NCT03917654|50157200|FG008|Year 2|Travel|0|||
25053538|NCT03917654|50157201|FG009|Year 2|Travel|1|||
25053539|NCT03917654|50157202|FG010|Year 2|Travel|0|||
25053540|NCT03917654|50157203|FG011|Year 2|Travel|1|||
25053541|NCT03917654|50157192|FG000|Year 2|Married|1|||
25053542|NCT03917654|50157193|FG001|Year 2|Married|0|||
25053543|NCT03917654|50157194|FG002|Year 2|Married|0|||
25053544|NCT03917654|50157195|FG003|Year 2|Married|0|||
25053545|NCT03917654|50157196|FG004|Year 2|Married|0|||
25053546|NCT03917654|50157197|FG005|Year 2|Married|0|||
25053547|NCT03917654|50157198|FG006|Year 2|Married|1|||
25053548|NCT03917654|50157199|FG007|Year 2|Married|1|||
25053549|NCT03917654|50157200|FG008|Year 2|Married|0|||
25053550|NCT03917654|50157201|FG009|Year 2|Married|0|||
25053551|NCT03917654|50157202|FG010|Year 2|Married|0|||
25053552|NCT03917654|50157203|FG011|Year 2|Married|0|||
25053553|NCT03917654|50157192|FG000|Year 2|Subject moved away from site|1|||
25053554|NCT03917654|50157193|FG001|Year 2|Subject moved away from site|0|||
25053555|NCT03917654|50157194|FG002|Year 2|Subject moved away from site|0|||
25053556|NCT03917654|50157195|FG003|Year 2|Subject moved away from site|0|||
25053557|NCT03917654|50157196|FG004|Year 2|Subject moved away from site|1|||
25053558|NCT03917654|50157197|FG005|Year 2|Subject moved away from site|0|||
25053559|NCT03917654|50157198|FG006|Year 2|Subject moved away from site|2|||
25162661|NCT01997333|50284851|FG001|Randomization and Treatment|Did not receive treatment|5|||
25053560|NCT03917654|50157199|FG007|Year 2|Subject moved away from site|3|||
25053561|NCT03917654|50157200|FG008|Year 2|Subject moved away from site|0|||
25053562|NCT03917654|50157201|FG009|Year 2|Subject moved away from site|2|||
25053563|NCT03917654|50157202|FG010|Year 2|Subject moved away from site|0|||
25053564|NCT03917654|50157203|FG011|Year 2|Subject moved away from site|1|||
25053565|NCT03917654|50157192|FG000|Year 2|Year 2 Screening failure|0|||
25053566|NCT03917654|50157193|FG001|Year 2|Year 2 Screening failure|1|||
25053567|NCT03917654|50157194|FG002|Year 2|Year 2 Screening failure|0|||
25053568|NCT03917654|50157195|FG003|Year 2|Year 2 Screening failure|0|||
25053569|NCT03917654|50157196|FG004|Year 2|Year 2 Screening failure|2|||
25053570|NCT03917654|50157197|FG005|Year 2|Year 2 Screening failure|0|||
25053571|NCT03917654|50157198|FG006|Year 2|Year 2 Screening failure|4|||
25053572|NCT03917654|50157199|FG007|Year 2|Year 2 Screening failure|3|||
25053573|NCT03917654|50157200|FG008|Year 2|Year 2 Screening failure|10|||
25053574|NCT03917654|50157201|FG009|Year 2|Year 2 Screening failure|2|||
25053575|NCT03917654|50157202|FG010|Year 2|Year 2 Screening failure|1|||
25053576|NCT03917654|50157203|FG011|Year 2|Year 2 Screening failure|1|||
25053577|NCT03917654|50157192|FG000|Year 2|Death|0|||
25053578|NCT03917654|50157193|FG001|Year 2|Death|0|||
25053579|NCT03917654|50157194|FG002|Year 2|Death|0|||
25053580|NCT03917654|50157195|FG003|Year 2|Death|0|||
25053581|NCT03917654|50157196|FG004|Year 2|Death|0|||
25053582|NCT03917654|50157197|FG005|Year 2|Death|1|||
25053583|NCT03917654|50157198|FG006|Year 2|Death|0|||
25053584|NCT03917654|50157199|FG007|Year 2|Death|0|||
24961980|NCT00296504|50052054|FG004|Final Analysis|Pregnancy|0|||
24961981|NCT00296504|50052055|FG005|Final Analysis|Pregnancy|0|||
24961982|NCT00296504|50052056|FG006|Final Analysis|Pregnancy|0|||
24961983|NCT00296504|50052057|FG007|Final Analysis|Pregnancy|0|||
24961984|NCT00296504|50052058|FG008|Final Analysis|Pregnancy|4|||
24961985|NCT00296504|50052050|FG000|Final Analysis|Tuberculosis|0|||
24961986|NCT00296504|50052051|FG001|Final Analysis|Tuberculosis|0|||
24961987|NCT00296504|50052052|FG002|Final Analysis|Tuberculosis|0|||
24961988|NCT00296504|50052053|FG003|Final Analysis|Tuberculosis|0|||
24961989|NCT00296504|50052054|FG004|Final Analysis|Tuberculosis|0|||
24961990|NCT00296504|50052055|FG005|Final Analysis|Tuberculosis|0|||
24961991|NCT00296504|50052056|FG006|Final Analysis|Tuberculosis|0|||
24961992|NCT00296504|50052057|FG007|Final Analysis|Tuberculosis|0|||
24961993|NCT00296504|50052058|FG008|Final Analysis|Tuberculosis|1|||
24961994|NCT00296504|50052050|FG000|Final Analysis|Participant Moved to Another Country|0|||
24961995|NCT00296504|50052051|FG001|Final Analysis|Participant Moved to Another Country|0|||
24961996|NCT00296504|50052052|FG002|Final Analysis|Participant Moved to Another Country|0|||
24961997|NCT00296504|50052053|FG003|Final Analysis|Participant Moved to Another Country|0|||
24961998|NCT00296504|50052054|FG004|Final Analysis|Participant Moved to Another Country|0|||
24961999|NCT00296504|50052055|FG005|Final Analysis|Participant Moved to Another Country|0|||
24962000|NCT00296504|50052056|FG006|Final Analysis|Participant Moved to Another Country|0|||
24962001|NCT00296504|50052057|FG007|Final Analysis|Participant Moved to Another Country|0|||
24962002|NCT00296504|50052058|FG008|Final Analysis|Participant Moved to Another Country|1|||
24962003|NCT00296504|50052050|FG000|Final Analysis|Poor Adherence|0|||
24962004|NCT00296504|50052051|FG001|Final Analysis|Poor Adherence|0|||
24962005|NCT00296504|50052052|FG002|Final Analysis|Poor Adherence|0|||
24962006|NCT00296504|50052053|FG003|Final Analysis|Poor Adherence|0|||
24962007|NCT00296504|50052054|FG004|Final Analysis|Poor Adherence|0|||
24962008|NCT00296504|50052055|FG005|Final Analysis|Poor Adherence|0|||
24962009|NCT00296504|50052056|FG006|Final Analysis|Poor Adherence|0|||
24962010|NCT00296504|50052057|FG007|Final Analysis|Poor Adherence|0|||
24962011|NCT00296504|50052058|FG008|Final Analysis|Poor Adherence|1|||
25053585|NCT03917654|50157200|FG008|Year 2|Death|1|||
25053586|NCT03917654|50157201|FG009|Year 2|Death|1|||
25053587|NCT03917654|50157202|FG010|Year 2|Death|0|||
25053588|NCT03917654|50157203|FG011|Year 2|Death|0|||
25053589|NCT03917654|50157192|FG000|Year 2|Withdrawal by Subject|0|||
25053590|NCT03917654|50157193|FG001|Year 2|Withdrawal by Subject|0|||
25053591|NCT03917654|50157194|FG002|Year 2|Withdrawal by Subject|0|||
25053592|NCT03917654|50157195|FG003|Year 2|Withdrawal by Subject|0|||
25053593|NCT03917654|50157196|FG004|Year 2|Withdrawal by Subject|0|||
25053594|NCT03917654|50157197|FG005|Year 2|Withdrawal by Subject|0|||
25053595|NCT03917654|50157198|FG006|Year 2|Withdrawal by Subject|3|||
25053596|NCT03917654|50157199|FG007|Year 2|Withdrawal by Subject|0|||
25053597|NCT03917654|50157200|FG008|Year 2|Withdrawal by Subject|2|||
25053598|NCT03917654|50157201|FG009|Year 2|Withdrawal by Subject|5|||
25053599|NCT03917654|50157202|FG010|Year 2|Withdrawal by Subject|0|||
25053600|NCT03917654|50157203|FG011|Year 2|Withdrawal by Subject|0|||
25053601|NCT03917654|50157192|FG000|Year 2|Spouse/family member request|0|||
25053602|NCT03917654|50157193|FG001|Year 2|Spouse/family member request|0|||
25053603|NCT03917654|50157194|FG002|Year 2|Spouse/family member request|0|||
25053604|NCT03917654|50157195|FG003|Year 2|Spouse/family member request|0|||
25053605|NCT03917654|50157196|FG004|Year 2|Spouse/family member request|0|||
25053606|NCT03917654|50157197|FG005|Year 2|Spouse/family member request|0|||
25053607|NCT03917654|50157198|FG006|Year 2|Spouse/family member request|1|||
25053608|NCT03917654|50157199|FG007|Year 2|Spouse/family member request|0|||
25053609|NCT03917654|50157200|FG008|Year 2|Spouse/family member request|0|||
25053610|NCT03917654|50157201|FG009|Year 2|Spouse/family member request|0|||
25053611|NCT03917654|50157202|FG010|Year 2|Spouse/family member request|0|||
25053612|NCT03917654|50157203|FG011|Year 2|Spouse/family member request|0|||
25053613|NCT03917654|50157192|FG000|Year 2|Lost to Follow-up|0|||
25053614|NCT03917654|50157193|FG001|Year 2|Lost to Follow-up|0|||
25053615|NCT03917654|50157194|FG002|Year 2|Lost to Follow-up|0|||
24962012|NCT00313820|50052085|FG000|Assigned to Treatment|Other|1|||
24962013|NCT00313820|50052086|FG001|Assigned to Treatment|Other|0|||
24962014|NCT00313820|50052085|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
24962015|NCT00313820|50052086|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
24962016|NCT00313820|50052085|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
25053616|NCT03917654|50157195|FG003|Year 2|Lost to Follow-up|0|||
25053617|NCT03917654|50157196|FG004|Year 2|Lost to Follow-up|0|||
25053618|NCT03917654|50157197|FG005|Year 2|Lost to Follow-up|0|||
25053619|NCT03917654|50157198|FG006|Year 2|Lost to Follow-up|1|||
25053620|NCT03917654|50157199|FG007|Year 2|Lost to Follow-up|0|||
25053621|NCT03917654|50157200|FG008|Year 2|Lost to Follow-up|1|||
25053622|NCT03917654|50157201|FG009|Year 2|Lost to Follow-up|0|||
25053623|NCT03917654|50157202|FG010|Year 2|Lost to Follow-up|0|||
25053624|NCT03917654|50157203|FG011|Year 2|Lost to Follow-up|1|||
25053625|NCT03917654|50157192|FG000|Year 2|Adverse Event|0|||
25053626|NCT03917654|50157193|FG001|Year 2|Adverse Event|0|||
25053627|NCT03917654|50157194|FG002|Year 2|Adverse Event|0|||
25053628|NCT03917654|50157195|FG003|Year 2|Adverse Event|0|||
25053629|NCT03917654|50157196|FG004|Year 2|Adverse Event|0|||
25053630|NCT03917654|50157197|FG005|Year 2|Adverse Event|0|||
25053631|NCT03917654|50157198|FG006|Year 2|Adverse Event|0|||
25053632|NCT03917654|50157199|FG007|Year 2|Adverse Event|0|||
25053633|NCT03917654|50157200|FG008|Year 2|Adverse Event|0|||
25053634|NCT03917654|50157201|FG009|Year 2|Adverse Event|1|||
25053635|NCT03917654|50157202|FG010|Year 2|Adverse Event|0|||
25053636|NCT03917654|50157203|FG011|Year 2|Adverse Event|0|||
25053637|NCT03060577|50157249|FG000|Overall Study|Withdrawal by Subject|25|||
25053638|NCT03060577|50157250|FG001|Overall Study|Withdrawal by Subject|5|||
25053639|NCT03060577|50157249|FG000|Overall Study|Physician Decision|4|||
25053640|NCT03060577|50157250|FG001|Overall Study|Physician Decision|3|||
25053641|NCT03060577|50157249|FG000|Overall Study|Lost to Follow-up|3|||
25053642|NCT03060577|50157250|FG001|Overall Study|Lost to Follow-up|0|||
25053643|NCT03060577|50157249|FG000|Overall Study|Death|7|||
25053644|NCT03060577|50157250|FG001|Overall Study|Death|1|||
25053645|NCT03060577|50157249|FG000|Overall Study|Adverse Event|9|||
25053646|NCT03060577|50157250|FG001|Overall Study|Adverse Event|1|||
25053647|NCT03060577|50157249|FG000|Overall Study|Inclusion/Exclusion|1|||
25053648|NCT03060577|50157250|FG001|Overall Study|Inclusion/Exclusion|0|||
25053649|NCT03060577|50157249|FG000|Overall Study|Other|8|||
25053650|NCT03060577|50157250|FG001|Overall Study|Other|2|||
25053651|NCT02872714|50157261|FG000|Overall Study|Progressive Disease|1|||
25053652|NCT02872714|50157262|FG001|Overall Study|Progressive Disease|2|||
25053653|NCT02872714|50157263|FG002|Overall Study|Progressive Disease|0|||
25053654|NCT02872714|50157264|FG003|Overall Study|Progressive Disease|0|||
25053655|NCT02872714|50157265|FG004|Overall Study|Progressive Disease|0|||
25053656|NCT02872714|50157261|FG000|Overall Study|Death|87|||
25053657|NCT02872714|50157262|FG001|Overall Study|Death|36|||
25053658|NCT02872714|50157263|FG002|Overall Study|Death|8|||
25053659|NCT02872714|50157264|FG003|Overall Study|Death|81|||
25053660|NCT02872714|50157265|FG004|Overall Study|Death|2|||
25053661|NCT02872714|50157261|FG000|Overall Study|Lost to Follow-up|2|||
25053662|NCT02872714|50157262|FG001|Overall Study|Lost to Follow-up|1|||
25053663|NCT02872714|50157263|FG002|Overall Study|Lost to Follow-up|0|||
25053664|NCT02872714|50157264|FG003|Overall Study|Lost to Follow-up|3|||
25053665|NCT02872714|50157265|FG004|Overall Study|Lost to Follow-up|0|||
25053666|NCT02872714|50157261|FG000|Overall Study|Physician Decision|0|||
25053667|NCT02872714|50157262|FG001|Overall Study|Physician Decision|0|||
25053668|NCT02872714|50157263|FG002|Overall Study|Physician Decision|0|||
25053669|NCT02872714|50157264|FG003|Overall Study|Physician Decision|1|||
25053670|NCT02872714|50157265|FG004|Overall Study|Physician Decision|0|||
25053671|NCT02872714|50157261|FG000|Overall Study|Withdrawal by Subject|1|||
25053672|NCT02872714|50157262|FG001|Overall Study|Withdrawal by Subject|3|||
25053673|NCT02872714|50157263|FG002|Overall Study|Withdrawal by Subject|0|||
25053674|NCT02872714|50157264|FG003|Overall Study|Withdrawal by Subject|2|||
25053675|NCT02872714|50157265|FG004|Overall Study|Withdrawal by Subject|0|||
25053676|NCT02872714|50157261|FG000|Overall Study|Captured as Other|2|||
25053677|NCT02872714|50157262|FG001|Overall Study|Captured as Other|0|||
25053678|NCT02872714|50157263|FG002|Overall Study|Captured as Other|0|||
25053679|NCT02872714|50157264|FG003|Overall Study|Captured as Other|1|||
25053680|NCT02872714|50157265|FG004|Overall Study|Captured as Other|0|||
25053681|NCT02787005|50157285|FG000|Overall Study|Adverse Event|24|||
25053682|NCT02787005|50157286|FG001|Overall Study|Adverse Event|9|||
25053683|NCT02787005|50157287|FG002|Overall Study|Adverse Event|9|||
25053684|NCT02787005|50157288|FG003|Overall Study|Adverse Event|7|||
25053685|NCT02787005|50157289|FG004|Overall Study|Adverse Event|2|||
25053686|NCT02787005|50157285|FG000|Overall Study|Death|100|||
25053687|NCT02787005|50157286|FG001|Overall Study|Death|53|||
25053688|NCT02787005|50157287|FG002|Overall Study|Death|48|||
25053689|NCT02787005|50157288|FG003|Overall Study|Death|69|||
25053690|NCT02787005|50157289|FG004|Overall Study|Death|38|||
25053691|NCT02787005|50157285|FG000|Overall Study|Sponsor Decision|7|||
25053692|NCT02787005|50157286|FG001|Overall Study|Sponsor Decision|4|||
25053693|NCT02787005|50157287|FG002|Overall Study|Sponsor Decision|0|||
25053694|NCT02787005|50157288|FG003|Overall Study|Sponsor Decision|4|||
25053695|NCT02787005|50157289|FG004|Overall Study|Sponsor Decision|5|||
25053696|NCT02787005|50157285|FG000|Overall Study|Withdrawal by Subject|2|||
25053697|NCT02787005|50157286|FG001|Overall Study|Withdrawal by Subject|1|||
25053698|NCT02787005|50157287|FG002|Overall Study|Withdrawal by Subject|1|||
25186584|NCT02647320|50337194|FG001|Overall Study|Protocol Violation|0|||
25053699|NCT02787005|50157288|FG003|Overall Study|Withdrawal by Subject|0|||
25053700|NCT02787005|50157289|FG004|Overall Study|Withdrawal by Subject|1|||
25053701|NCT02787005|50157285|FG000|Overall Study|Screen Failure|0|||
25053702|NCT02787005|50157286|FG001|Overall Study|Screen Failure|2|||
25053703|NCT02787005|50157287|FG002|Overall Study|Screen Failure|0|||
25053704|NCT02787005|50157288|FG003|Overall Study|Screen Failure|0|||
25053705|NCT02787005|50157289|FG004|Overall Study|Screen Failure|1|||
25053706|NCT02787005|50157285|FG000|Overall Study|Lost to Follow-up|0|||
25053707|NCT02787005|50157286|FG001|Overall Study|Lost to Follow-up|0|||
25053708|NCT02787005|50157287|FG002|Overall Study|Lost to Follow-up|0|||
25053709|NCT02787005|50157288|FG003|Overall Study|Lost to Follow-up|1|||
25276538|NCT00890929|50590482|FG000|Overall Study|Withdrawal by Subject|3|||
25276539|NCT00890929|50590482|FG000|Overall Study|Physician Decision|1|||
25276540|NCT00886639|50590486|FG000|Overall Study|acute exacerbation|14|||
25276541|NCT00886639|50590486|FG000|Overall Study|non-compliance|2|||
25276542|NCT00889603|50590490|FG000|Overall Study|Adverse Event|7|||
25276543|NCT00889603|50590490|FG000|Overall Study|Death|3|||
25276544|NCT00889603|50590490|FG000|Overall Study|Lost to Follow-up|19|||
25276545|NCT00889603|50590490|FG000|Overall Study|No longer willing to participant in stud|4|||
25276546|NCT00889603|50590490|FG000|Overall Study|Other|4|||
25276547|NCT00886483|50590496|FG000|Overall Study|Lost to Follow-up|0|||
25276548|NCT00886483|50590497|FG001|Overall Study|Lost to Follow-up|1|||
24962017|NCT00313820|50052086|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
24962018|NCT00313820|50052085|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
24962019|NCT00313820|50052086|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
24962020|NCT00313820|50052085|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
24962021|NCT00313820|50052086|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
24962022|NCT00313820|50052085|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
24962023|NCT00313820|50052086|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
24962024|NCT00462761|50052092|FG000|Overall Study|Adverse Event|6|||
24962025|NCT00462761|50052092|FG000|Overall Study|Withdrawal by Subject|9|||
24962026|NCT00462761|50052092|FG000|Overall Study|Physician Decision|5|||
24962027|NCT00462761|50052092|FG000|Overall Study|Disease progression|43|||
24962028|NCT00462761|50052092|FG000|Overall Study|Death|12|||
24962029|NCT00462761|50052092|FG000|Overall Study|Other|1|||
24962030|NCT00235872|50052124|FG000|Overall Study|Adverse Event|34|||
24962031|NCT00235872|50052124|FG000|Overall Study|Death|1|||
25053710|NCT02787005|50157289|FG004|Overall Study|Lost to Follow-up|0|||
25276549|NCT00886483|50590496|FG000|Overall Study|Pursue medications|1|||
25276550|NCT00886483|50590497|FG001|Overall Study|Pursue medications|2|||
25053711|NCT02601313|50157323|FG000|Overall Study|Death|2|||
25053712|NCT02601313|50157324|FG001|Overall Study|Death|16|||
25053713|NCT02601313|50157325|FG002|Overall Study|Death|4|||
25053714|NCT02601313|50157323|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0|||
25053715|NCT02601313|50157324|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5|||
25053716|NCT02601313|50157325|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2|||
25053717|NCT02601313|50157323|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0|||
25053718|NCT02601313|50157324|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1|||
25053719|NCT02601313|50157325|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1|||
25276551|NCT00886483|50590496|FG000|Overall Study|Distance to center, poor grades|1|||
25276552|NCT00886483|50590497|FG001|Overall Study|Distance to center, poor grades|0|||
25276553|NCT00886015|50590513|FG000|Overall Study|Death|0|||
25276554|NCT00886015|50590514|FG001|Overall Study|Death|2|||
25276555|NCT00890695|50590522|FG000|Overall Study|Protocol Violation|1|||
25276556|NCT00890695|50590523|FG001|Overall Study|Protocol Violation|0|||
25276557|NCT00957580|50590532|FG000|Overall Study|Ongoing at data cut-off|0|||
25276558|NCT00957580|50590533|FG001|Overall Study|Ongoing at data cut-off|1|||
25276559|NCT00957580|50590534|FG002|Overall Study|Ongoing at data cut-off|0|||
25276560|NCT00957580|50590532|FG000|Overall Study|Enrolled but not treated|0|||
25276561|NCT00957580|50590533|FG001|Overall Study|Enrolled but not treated|1|||
25276562|NCT00957580|50590534|FG002|Overall Study|Enrolled but not treated|0|||
25276563|NCT00957424|50590555|FG000|Overall Study|Lost to Follow-up|19|||
25276564|NCT00957424|50590555|FG000|Overall Study|Protocol Violation|3|||
25276565|NCT00957424|50590555|FG000|Overall Study|Withdrawal by Subject|1|||
25276566|NCT01061151|50590563|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
24962032|NCT00235872|50052124|FG000|Overall Study|Lost to Follow-up|1|||
25053720|NCT02601313|50157323|FG000|Overall Study|Still on study|0|||
25053721|NCT02601313|50157324|FG001|Overall Study|Still on study|52|||
25053722|NCT02601313|50157325|FG002|Overall Study|Still on study|10|||
25053723|NCT02601313|50157323|FG000|Overall Study|Enrolled, did not initiate AC|4|||
25053724|NCT02601313|50157324|FG001|Overall Study|Enrolled, did not initiate AC|0|||
25276567|NCT01061151|50590564|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
25276568|NCT01061151|50590565|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
25276569|NCT01061151|50590566|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
25276570|NCT01061151|50590563|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
25276571|NCT01061151|50590564|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
25276572|NCT01061151|50590565|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
25276573|NCT01061151|50590566|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
24962033|NCT00235872|50052124|FG000|Overall Study|Withdrawal by Subject|50|||
24962034|NCT00235872|50052124|FG000|Overall Study|Administrative reason|61|||
24962035|NCT00461981|50052130|FG000|Overall Study|Lost to Follow-up|9|||
25053725|NCT02601313|50157325|FG002|Overall Study|Enrolled, did not initiate AC|0|||
25053726|NCT02514083|50157333|FG000|Overall Study|Adverse Event|1|||
25053727|NCT02395848|50157337|FG000|Overall Study|Lost to Follow-up|2|||
25053728|NCT02061761|50157354|FG000|Overall Study|Disease progression|2|||
25053729|NCT02061761|50157355|FG001|Overall Study|Disease progression|8|||
25053730|NCT02061761|50157356|FG002|Overall Study|Disease progression|4|||
25053731|NCT02061761|50157357|FG003|Overall Study|Disease progression|5|||
25053732|NCT02061761|50157358|FG004|Overall Study|Disease progression|9|||
25053733|NCT02061761|50157359|FG005|Overall Study|Disease progression|3|||
25053734|NCT02061761|50157360|FG006|Overall Study|Disease progression|1|||
25053735|NCT02061761|50157361|FG007|Overall Study|Disease progression|2|||
25053736|NCT02061761|50157362|FG008|Overall Study|Disease progression|28|||
25053737|NCT02061761|50157354|FG000|Overall Study|Study Drug toxicity|0|||
24962036|NCT00461981|50052131|FG001|Overall Study|Lost to Follow-up|6|||
24962037|NCT00461981|50052130|FG000|Overall Study|Withdrawal by Subject|2|||
24962038|NCT00461981|50052131|FG001|Overall Study|Withdrawal by Subject|3|||
24962039|NCT00296036|50052139|FG000|Overall Study|Withdrawal by Subject|1|||
24962040|NCT00296036|50052140|FG001|Overall Study|Withdrawal by Subject|0|||
24962041|NCT00296036|50052141|FG002|Overall Study|Withdrawal by Subject|2|||
25053738|NCT02061761|50157355|FG001|Overall Study|Study Drug toxicity|0|||
25053739|NCT02061761|50157356|FG002|Overall Study|Study Drug toxicity|0|||
25053740|NCT02061761|50157357|FG003|Overall Study|Study Drug toxicity|0|||
25053741|NCT02061761|50157358|FG004|Overall Study|Study Drug toxicity|0|||
24962042|NCT00296036|50052142|FG003|Overall Study|Withdrawal by Subject|1|||
24962043|NCT00296036|50052143|FG004|Overall Study|Withdrawal by Subject|2|||
24962044|NCT00296036|50052144|FG005|Overall Study|Withdrawal by Subject|1|||
24962045|NCT00296036|50052139|FG000|Overall Study|Protocol Violation|0|||
24962046|NCT00296036|50052140|FG001|Overall Study|Protocol Violation|0|||
24962047|NCT00296036|50052141|FG002|Overall Study|Protocol Violation|0|||
24962048|NCT00296036|50052142|FG003|Overall Study|Protocol Violation|0|||
24962049|NCT00296036|50052143|FG004|Overall Study|Protocol Violation|0|||
24962050|NCT00296036|50052144|FG005|Overall Study|Protocol Violation|3|||
24962051|NCT00089674|50052163|FG000|Overall Study|Physician Decision|4|||
24962052|NCT00089674|50052164|FG001|Overall Study|Physician Decision|2|||
24962053|NCT00089674|50052163|FG000|Overall Study|Adverse Event|23|||
24962054|NCT00089674|50052164|FG001|Overall Study|Adverse Event|29|||
24962055|NCT00089674|50052163|FG000|Overall Study|Withdrawal by Subject|143|||
24962056|NCT00089674|50052164|FG001|Overall Study|Withdrawal by Subject|127|||
24962057|NCT00089674|50052163|FG000|Overall Study|Death|43|||
24962058|NCT00089674|50052164|FG001|Overall Study|Death|43|||
24962059|NCT00089674|50052163|FG000|Overall Study|Disease progression|21|||
24962060|NCT00089674|50052164|FG001|Overall Study|Disease progression|23|||
24962061|NCT00089674|50052163|FG000|Overall Study|Ineligibility determined|8|||
24962062|NCT00089674|50052164|FG001|Overall Study|Ineligibility determined|10|||
24962063|NCT00089674|50052163|FG000|Overall Study|Lost to Follow-up|21|||
24962064|NCT00089674|50052164|FG001|Overall Study|Lost to Follow-up|17|||
24962065|NCT00089674|50052163|FG000|Overall Study|Noncompliance|7|||
24962066|NCT00089674|50052164|FG001|Overall Study|Noncompliance|3|||
24962067|NCT00089674|50052163|FG000|Overall Study|Other|5|||
24962068|NCT00089674|50052164|FG001|Overall Study|Other|9|||
24962069|NCT00089674|50052163|FG000|Overall Study|Requirement for alternative therapy|14|||
24962070|NCT00089674|50052164|FG001|Overall Study|Requirement for alternative therapy|4|||
24962071|NCT00313586|50052174|FG000|Overall Study|Disease progression|14|||
24962072|NCT00313586|50052175|FG001|Overall Study|Disease progression|19|||
24962073|NCT00313586|50052176|FG002|Overall Study|Disease progression|10|||
24962074|NCT00313586|50052177|FG003|Overall Study|Disease progression|3|||
24962075|NCT00313586|50052174|FG000|Overall Study|Adverse Event|12|||
24962076|NCT00313586|50052175|FG001|Overall Study|Adverse Event|18|||
24962077|NCT00313586|50052176|FG002|Overall Study|Adverse Event|3|||
24962078|NCT00313586|50052177|FG003|Overall Study|Adverse Event|10|||
24962079|NCT00313586|50052174|FG000|Overall Study|Death|11|||
24962080|NCT00313586|50052175|FG001|Overall Study|Death|8|||
24962081|NCT00313586|50052176|FG002|Overall Study|Death|1|||
24962082|NCT00313586|50052177|FG003|Overall Study|Death|7|||
24962083|NCT00313586|50052174|FG000|Overall Study|Withdrawal by Subject|13|||
24962084|NCT00313586|50052175|FG001|Overall Study|Withdrawal by Subject|6|||
25053742|NCT02061761|50157359|FG005|Overall Study|Study Drug toxicity|1|||
25186585|NCT02647320|50337195|FG002|Overall Study|Protocol Violation|3|||
25186586|NCT02647320|50337196|FG003|Overall Study|Protocol Violation|0|||
24962085|NCT00313586|50052176|FG002|Overall Study|Withdrawal by Subject|6|||
24962086|NCT00313586|50052177|FG003|Overall Study|Withdrawal by Subject|2|||
24962087|NCT00313586|50052174|FG000|Overall Study|Alternative therapy|3|||
24962088|NCT00313586|50052175|FG001|Overall Study|Alternative therapy|6|||
24962089|NCT00313586|50052176|FG002|Overall Study|Alternative therapy|2|||
24962090|NCT00313586|50052177|FG003|Overall Study|Alternative therapy|0|||
24962091|NCT00313586|50052174|FG000|Overall Study|Other complicating disease|2|||
24962092|NCT00313586|50052175|FG001|Overall Study|Other complicating disease|2|||
24962093|NCT00313586|50052176|FG002|Overall Study|Other complicating disease|0|||
24962094|NCT00313586|50052177|FG003|Overall Study|Other complicating disease|0|||
25053743|NCT02061761|50157360|FG006|Overall Study|Study Drug toxicity|0|||
25053744|NCT02061761|50157361|FG007|Overall Study|Study Drug toxicity|2|||
25053745|NCT02061761|50157362|FG008|Overall Study|Study Drug toxicity|6|||
25053746|NCT02061761|50157354|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
25053747|NCT02061761|50157355|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
25053748|NCT02061761|50157356|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
25053749|NCT02061761|50157357|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
25053750|NCT02061761|50157358|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
25053751|NCT02061761|50157359|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
25053752|NCT02061761|50157360|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
25053753|NCT02061761|50157361|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
25053754|NCT02061761|50157362|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
25053755|NCT02061761|50157354|FG000|Overall Study|Participant request to discontinue study treatment|0|||
25053756|NCT02061761|50157355|FG001|Overall Study|Participant request to discontinue study treatment|0|||
25053757|NCT02061761|50157356|FG002|Overall Study|Participant request to discontinue study treatment|2|||
25053758|NCT02061761|50157357|FG003|Overall Study|Participant request to discontinue study treatment|2|||
25053759|NCT02061761|50157358|FG004|Overall Study|Participant request to discontinue study treatment|0|||
25053760|NCT02061761|50157359|FG005|Overall Study|Participant request to discontinue study treatment|1|||
25053761|NCT02061761|50157360|FG006|Overall Study|Participant request to discontinue study treatment|0|||
25053762|NCT02061761|50157361|FG007|Overall Study|Participant request to discontinue study treatment|0|||
25053763|NCT02061761|50157362|FG008|Overall Study|Participant request to discontinue study treatment|2|||
25053764|NCT02061761|50157354|FG000|Overall Study|Withdrawal by Subject|0|||
25053765|NCT02061761|50157355|FG001|Overall Study|Withdrawal by Subject|0|||
25053766|NCT02061761|50157356|FG002|Overall Study|Withdrawal by Subject|0|||
25053767|NCT02061761|50157357|FG003|Overall Study|Withdrawal by Subject|0|||
25053768|NCT02061761|50157358|FG004|Overall Study|Withdrawal by Subject|0|||
25053769|NCT02061761|50157359|FG005|Overall Study|Withdrawal by Subject|0|||
25053770|NCT02061761|50157360|FG006|Overall Study|Withdrawal by Subject|0|||
25053771|NCT02061761|50157361|FG007|Overall Study|Withdrawal by Subject|0|||
25053772|NCT02061761|50157362|FG008|Overall Study|Withdrawal by Subject|2|||
25053773|NCT02061761|50157354|FG000|Overall Study|Maximum clinical benefit|0|||
25053774|NCT02061761|50157355|FG001|Overall Study|Maximum clinical benefit|0|||
25053775|NCT02061761|50157356|FG002|Overall Study|Maximum clinical benefit|0|||
25053776|NCT02061761|50157357|FG003|Overall Study|Maximum clinical benefit|1|||
25053777|NCT02061761|50157358|FG004|Overall Study|Maximum clinical benefit|0|||
25053778|NCT02061761|50157359|FG005|Overall Study|Maximum clinical benefit|0|||
25053779|NCT02061761|50157360|FG006|Overall Study|Maximum clinical benefit|0|||
25053780|NCT02061761|50157361|FG007|Overall Study|Maximum clinical benefit|0|||
25053781|NCT02061761|50157362|FG008|Overall Study|Maximum clinical benefit|6|||
25053782|NCT02061761|50157354|FG000|Overall Study|Participant no longer meets study criteria|0|||
25053783|NCT02061761|50157355|FG001|Overall Study|Participant no longer meets study criteria|0|||
25053784|NCT02061761|50157356|FG002|Overall Study|Participant no longer meets study criteria|0|||
25053785|NCT02061761|50157357|FG003|Overall Study|Participant no longer meets study criteria|0|||
25053786|NCT02061761|50157358|FG004|Overall Study|Participant no longer meets study criteria|0|||
25053787|NCT02061761|50157359|FG005|Overall Study|Participant no longer meets study criteria|0|||
25053788|NCT02061761|50157360|FG006|Overall Study|Participant no longer meets study criteria|0|||
25053789|NCT02061761|50157361|FG007|Overall Study|Participant no longer meets study criteria|0|||
25053790|NCT02061761|50157362|FG008|Overall Study|Participant no longer meets study criteria|1|||
25053791|NCT02061761|50157354|FG000|Overall Study|Other reasons|0|||
25053792|NCT02061761|50157355|FG001|Overall Study|Other reasons|0|||
25053793|NCT02061761|50157356|FG002|Overall Study|Other reasons|0|||
25053794|NCT02061761|50157357|FG003|Overall Study|Other reasons|0|||
25053795|NCT02061761|50157358|FG004|Overall Study|Other reasons|2|||
25053796|NCT02061761|50157359|FG005|Overall Study|Other reasons|0|||
25053797|NCT02061761|50157360|FG006|Overall Study|Other reasons|0|||
25053798|NCT02061761|50157361|FG007|Overall Study|Other reasons|0|||
25053799|NCT02061761|50157362|FG008|Overall Study|Other reasons|6|||
25053800|NCT01927068|50157390|FG000|Overall Study|Death|37|||
25053801|NCT01927068|50157391|FG001|Overall Study|Death|3|||
25053802|NCT01927068|50157390|FG000|Overall Study|Withdrawal by Subject|50|||
25053803|NCT01927068|50157391|FG001|Overall Study|Withdrawal by Subject|3|||
25053804|NCT01927068|50157390|FG000|Overall Study|Lost to Follow-up|10|||
25053805|NCT01927068|50157391|FG001|Overall Study|Lost to Follow-up|2|||
25053806|NCT01927068|50157390|FG000|Overall Study|Physician Decision|9|||
25053807|NCT01927068|50157391|FG001|Overall Study|Physician Decision|0|||
25053808|NCT01927068|50157390|FG000|Overall Study|Missed last follow-up visit|2|||
25053809|NCT01927068|50157391|FG001|Overall Study|Missed last follow-up visit|0|||
25053810|NCT01309230|50157400|FG000|Overall Study|Withdrawal by Subject|0|||
25053811|NCT01309230|50157401|FG001|Overall Study|Withdrawal by Subject|2|||
25053812|NCT01309230|50157400|FG000|Overall Study|Observation arm closed|0|||
25053813|NCT01309230|50157401|FG001|Overall Study|Observation arm closed|2|||
25053814|NCT00819832|50157413|FG000|Overall Study|Sponsor Termination of Study|3|||
25053815|NCT00819832|50157414|FG001|Overall Study|Sponsor Termination of Study|0|||
25053816|NCT00819832|50157415|FG002|Overall Study|Sponsor Termination of Study|0|||
25053817|NCT00819832|50157416|FG003|Overall Study|Sponsor Termination of Study|0|||
25053818|NCT00819832|50157417|FG004|Overall Study|Sponsor Termination of Study|0|||
25053819|NCT00819832|50157418|FG005|Overall Study|Sponsor Termination of Study|0|||
25053820|NCT00704522|50157434|FG000|Overall Study|Lack of Efficacy|65|||
25053821|NCT00704522|50157435|FG001|Overall Study|Lack of Efficacy|17|||
25053822|NCT00704522|50157434|FG000|Overall Study|Failure to appear again at hospital|56|||
25053823|NCT00704522|50157435|FG001|Overall Study|Failure to appear again at hospital|10|||
25053824|NCT00704522|50157434|FG000|Overall Study|Withdrawal by Subject|17|||
25053825|NCT00704522|50157435|FG001|Overall Study|Withdrawal by Subject|8|||
25053826|NCT00704522|50157434|FG000|Overall Study|Adverse Event|9|||
25053827|NCT00704522|50157435|FG001|Overall Study|Adverse Event|1|||
25053828|NCT00704522|50157434|FG000|Overall Study|Undefined causes|9|||
25053829|NCT00704522|50157435|FG001|Overall Study|Undefined causes|7|||
25053830|NCT00704522|50157434|FG000|Overall Study|No information on therapy end|27|||
25053831|NCT00704522|50157435|FG001|Overall Study|No information on therapy end|2|||
25053832|NCT02723630|50157446|FG000|Intervention Period 1|Adverse Event|1|||
25053833|NCT02723630|50157447|FG001|Intervention Period 1|Adverse Event|0|||
25053834|NCT02723630|50157448|FG002|Intervention Period 1|Adverse Event|0|||
25053835|NCT02723630|50157449|FG003|Intervention Period 1|Adverse Event|0|||
25053836|NCT02723630|50157450|FG004|Intervention Period 1|Adverse Event|0|||
25053837|NCT02723630|50157451|FG005|Intervention Period 1|Adverse Event|0|||
24962095|NCT00313586|50052174|FG000|Overall Study|Did not achieve HI-major/better response|10|||
24962096|NCT00313586|50052175|FG001|Overall Study|Did not achieve HI-major/better response|7|||
24962097|NCT00313586|50052176|FG002|Overall Study|Did not achieve HI-major/better response|2|||
24962098|NCT00313586|50052177|FG003|Overall Study|Did not achieve HI-major/better response|1|||
24962099|NCT00313586|50052174|FG000|Overall Study|Physician Decision|2|||
24962100|NCT00313586|50052175|FG001|Overall Study|Physician Decision|1|||
24962101|NCT00313586|50052176|FG002|Overall Study|Physician Decision|0|||
24962102|NCT00313586|50052177|FG003|Overall Study|Physician Decision|0|||
24962103|NCT00313586|50052174|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
24962104|NCT00313586|50052175|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
24962105|NCT00313586|50052176|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
24962106|NCT00313586|50052177|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
25053838|NCT02723630|50157446|FG000|Intervention Period 3|consumption of restricted item|0|||
25053839|NCT02723630|50157447|FG001|Intervention Period 3|consumption of restricted item|1|||
25053840|NCT02723630|50157448|FG002|Intervention Period 3|consumption of restricted item|0|||
25053841|NCT02723630|50157449|FG003|Intervention Period 3|consumption of restricted item|0|||
25053842|NCT02723630|50157450|FG004|Intervention Period 3|consumption of restricted item|0|||
25053843|NCT02723630|50157451|FG005|Intervention Period 3|consumption of restricted item|0|||
25053844|NCT04089735|50157494|FG000|Overall Study|Adverse Event|1|||
25053845|NCT04089735|50157495|FG001|Overall Study|Adverse Event|0|||
25053846|NCT04089735|50157496|FG002|Overall Study|Adverse Event|1|||
25053847|NCT04089735|50157497|FG003|Overall Study|Adverse Event|1|||
25053848|NCT04089735|50157498|FG004|Overall Study|Adverse Event|0|||
25053849|NCT04089735|50157499|FG005|Overall Study|Adverse Event|0|||
25053850|NCT04089735|50157494|FG000|Overall Study|Physician Decision|0|||
25276574|NCT01061151|50590563|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
24962107|NCT00313586|50052174|FG000|Overall Study|Lost insurance|0|||
24962108|NCT00313586|50052175|FG001|Overall Study|Lost insurance|1|||
24962109|NCT00313586|50052176|FG002|Overall Study|Lost insurance|0|||
24962110|NCT00313586|50052177|FG003|Overall Study|Lost insurance|0|||
24962111|NCT00313586|50052174|FG000|Overall Study|Moved|0|||
24962112|NCT00313586|50052175|FG001|Overall Study|Moved|1|||
24962113|NCT00313586|50052176|FG002|Overall Study|Moved|0|||
24962114|NCT00313586|50052177|FG003|Overall Study|Moved|0|||
24962115|NCT00313586|50052174|FG000|Overall Study|Death before starting treatment|1|||
25053851|NCT04089735|50157495|FG001|Overall Study|Physician Decision|3|||
25053852|NCT04089735|50157496|FG002|Overall Study|Physician Decision|0|||
25053853|NCT04089735|50157497|FG003|Overall Study|Physician Decision|0|||
25053854|NCT04089735|50157498|FG004|Overall Study|Physician Decision|0|||
25053855|NCT04089735|50157499|FG005|Overall Study|Physician Decision|0|||
25053856|NCT04089735|50157494|FG000|Overall Study|Withdrawal by Subject|0|||
25053857|NCT04089735|50157495|FG001|Overall Study|Withdrawal by Subject|0|||
25053858|NCT04089735|50157496|FG002|Overall Study|Withdrawal by Subject|1|||
25053859|NCT04089735|50157497|FG003|Overall Study|Withdrawal by Subject|0|||
25053860|NCT04089735|50157498|FG004|Overall Study|Withdrawal by Subject|0|||
25053861|NCT04089735|50157499|FG005|Overall Study|Withdrawal by Subject|0|||
25186587|NCT02647320|50337197|FG004|Overall Study|Protocol Violation|0|||
24962116|NCT00313586|50052175|FG001|Overall Study|Death before starting treatment|0|||
24962117|NCT00313586|50052176|FG002|Overall Study|Death before starting treatment|0|||
24962118|NCT00313586|50052177|FG003|Overall Study|Death before starting treatment|0|||
24962119|NCT00312572|50052187|FG000|Overall Study|Adverse Event|10|||
24962120|NCT00312572|50052188|FG001|Overall Study|Adverse Event|16|||
24962121|NCT00312572|50052187|FG000|Overall Study|Lost to Follow-up|1|||
24962122|NCT00312572|50052188|FG001|Overall Study|Lost to Follow-up|1|||
24962123|NCT00312572|50052187|FG000|Overall Study|Administrative|4|||
24962124|NCT00312572|50052188|FG001|Overall Study|Administrative|2|||
24962125|NCT00312572|50052187|FG000|Overall Study|Lack of Efficacy|1|||
24962126|NCT00312572|50052188|FG001|Overall Study|Lack of Efficacy|2|||
24962127|NCT00290888|50052198|FG000|Overall Study|Physician Decision|3|||
24962128|NCT00290888|50052199|FG001|Overall Study|Physician Decision|1|||
24962129|NCT00290732|50052208|FG000|Overall Study|Inability to instill drug intraductally.|0|||
24962130|NCT00290732|50052209|FG001|Overall Study|Inability to instill drug intraductally.|1|||
24962131|NCT00290732|50052210|FG002|Overall Study|Inability to instill drug intraductally.|1|||
24962132|NCT00290732|50052211|FG003|Overall Study|Inability to instill drug intraductally.|0|||
24962133|NCT00290732|50052212|FG004|Overall Study|Inability to instill drug intraductally.|0|||
24962134|NCT00312494|50052228|FG000|Overall Study|Randomized; not treated with study drug|9|||
24962135|NCT00312494|50052229|FG001|Overall Study|Randomized; not treated with study drug|10|||
24962136|NCT00312494|50052230|FG002|Overall Study|Randomized; not treated with study drug|5|||
24962137|NCT00312494|50052228|FG000|Overall Study|Adverse Event|33|||
24962138|NCT00312494|50052229|FG001|Overall Study|Adverse Event|15|||
24962139|NCT00312494|50052230|FG002|Overall Study|Adverse Event|11|||
24962140|NCT00312494|50052228|FG000|Overall Study|Lack of Efficacy|4|||
24962141|NCT00312494|50052229|FG001|Overall Study|Lack of Efficacy|6|||
24962142|NCT00312494|50052230|FG002|Overall Study|Lack of Efficacy|8|||
24962143|NCT00312494|50052228|FG000|Overall Study|Laboratory abnormality|1|||
24962144|NCT00312494|50052229|FG001|Overall Study|Laboratory abnormality|0|||
24962145|NCT00312494|50052230|FG002|Overall Study|Laboratory abnormality|0|||
24962146|NCT00312494|50052228|FG000|Overall Study|Lost to Follow-up|8|||
24962147|NCT00312494|50052229|FG001|Overall Study|Lost to Follow-up|8|||
25053862|NCT04089735|50157494|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
25053863|NCT04089735|50157495|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
24962148|NCT00312494|50052230|FG002|Overall Study|Lost to Follow-up|8|||
24962149|NCT00312494|50052228|FG000|Overall Study|Withdrawal by Subject|6|||
24962150|NCT00312494|50052229|FG001|Overall Study|Withdrawal by Subject|9|||
24962151|NCT00312494|50052230|FG002|Overall Study|Withdrawal by Subject|10|||
25053864|NCT04089735|50157496|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
25053865|NCT04089735|50157497|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
25053866|NCT04089735|50157498|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
25053867|NCT04089735|50157499|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
25053868|NCT01876784|50157515|FG000|Overall Study|Withdrawal by Subject|17|||
25053869|NCT01876784|50157516|FG001|Overall Study|Withdrawal by Subject|2|||
25053870|NCT01876784|50157515|FG000|Overall Study|Adverse Event|15|||
25053871|NCT01876784|50157516|FG001|Overall Study|Adverse Event|2|||
25053872|NCT01876784|50157515|FG000|Overall Study|Protocol Violation|1|||
25053873|NCT01876784|50157516|FG001|Overall Study|Protocol Violation|0|||
25053874|NCT01876784|50157515|FG000|Overall Study|Disease progression|37|||
25053875|NCT01876784|50157516|FG001|Overall Study|Disease progression|67|||
25053876|NCT01876784|50157515|FG000|Overall Study|Lost to Follow-up|0|||
25053877|NCT01876784|50157516|FG001|Overall Study|Lost to Follow-up|1|||
25053878|NCT01876784|50157515|FG000|Overall Study|Death|1|||
25053879|NCT01876784|50157516|FG001|Overall Study|Death|0|||
25053880|NCT01876784|50157515|FG000|Overall Study|Randomized but not treated|2|||
25053881|NCT01876784|50157516|FG001|Overall Study|Randomized but not treated|1|||
25053882|NCT01876784|50157515|FG000|Overall Study|Other than specified above|5|||
25053883|NCT01876784|50157516|FG001|Overall Study|Other than specified above|6|||
25276575|NCT01061151|50590564|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
24962152|NCT00312494|50052228|FG000|Overall Study|Other|10|||
24962153|NCT00312494|50052229|FG001|Overall Study|Other|10|||
24962154|NCT00312494|50052230|FG002|Overall Study|Other|1|||
24962155|NCT00312338|50052240|FG000|Overall Study|Adverse Event|7|||
24962156|NCT00312338|50052241|FG001|Overall Study|Adverse Event|2|||
24962157|NCT00312338|50052240|FG000|Overall Study|Lost to Follow-up|9|||
24962158|NCT00312338|50052241|FG001|Overall Study|Lost to Follow-up|1|||
24962159|NCT00312338|50052240|FG000|Overall Study|Withdrawal by Subject|4|||
24962160|NCT00312338|50052241|FG001|Overall Study|Withdrawal by Subject|0|||
24962161|NCT00312338|50052240|FG000|Overall Study|Subsequent infection|2|||
24962162|NCT00312338|50052241|FG001|Overall Study|Subsequent infection|0|||
24962163|NCT00290498|50052249|FG000|Overall Study|Death|2|||
24962164|NCT00290498|50052250|FG001|Overall Study|Death|0|||
24962165|NCT00290498|50052249|FG000|Overall Study|Physician Decision|1|||
24962166|NCT00290498|50052250|FG001|Overall Study|Physician Decision|0|||
24962167|NCT00290498|50052249|FG000|Overall Study|Withdrawal by Subject|1|||
24962168|NCT00290498|50052250|FG001|Overall Study|Withdrawal by Subject|0|||
24962169|NCT00290498|50052249|FG000|Overall Study|Ineligible|3|||
24962170|NCT00290498|50052250|FG001|Overall Study|Ineligible|0|||
24962171|NCT00290498|50052249|FG000|Overall Study|Non-Compliance|1|||
24962172|NCT00290498|50052250|FG001|Overall Study|Non-Compliance|0|||
24962173|NCT00451451|50052261|FG000|Overall Study|Adverse Event|11|||
24962174|NCT00451451|50052262|FG001|Overall Study|Adverse Event|21|||
24962175|NCT00451451|50052263|FG002|Overall Study|Adverse Event|26|||
24962176|NCT00451451|50052264|FG003|Overall Study|Adverse Event|10|||
24962177|NCT00451451|50052261|FG000|Overall Study|Lost to Follow-up|11|||
24962178|NCT00451451|50052262|FG001|Overall Study|Lost to Follow-up|9|||
24962179|NCT00451451|50052263|FG002|Overall Study|Lost to Follow-up|8|||
24962180|NCT00451451|50052264|FG003|Overall Study|Lost to Follow-up|11|||
24962181|NCT00451451|50052261|FG000|Overall Study|Consent Withdrawn|14|||
24962182|NCT00451451|50052262|FG001|Overall Study|Consent Withdrawn|9|||
24962183|NCT00451451|50052263|FG002|Overall Study|Consent Withdrawn|17|||
24962184|NCT00451451|50052264|FG003|Overall Study|Consent Withdrawn|17|||
24962185|NCT00451451|50052261|FG000|Overall Study|Investigator Decision|6|||
24962186|NCT00451451|50052262|FG001|Overall Study|Investigator Decision|2|||
24962187|NCT00451451|50052263|FG002|Overall Study|Investigator Decision|1|||
24962188|NCT00451451|50052264|FG003|Overall Study|Investigator Decision|2|||
24962189|NCT00451451|50052261|FG000|Overall Study|Subject Non-Compliance|8|||
24962190|NCT00451451|50052262|FG001|Overall Study|Subject Non-Compliance|4|||
24962191|NCT00451451|50052263|FG002|Overall Study|Subject Non-Compliance|3|||
24962192|NCT00451451|50052264|FG003|Overall Study|Subject Non-Compliance|3|||
24962193|NCT00451451|50052261|FG000|Overall Study|Death|1|||
24962194|NCT00451451|50052262|FG001|Overall Study|Death|0|||
24962195|NCT00451451|50052263|FG002|Overall Study|Death|0|||
25053884|NCT01876784|50157515|FG000|Overall Study|Ongoing|41|||
25053885|NCT01876784|50157516|FG001|Overall Study|Ongoing|40|||
25053886|NCT04205162|50157524|FG000|Overall Study|Lost to Follow-up|1|||
25053887|NCT04205162|50157525|FG001|Overall Study|Lost to Follow-up|0|||
25053888|NCT04205162|50157524|FG000|Overall Study|Withdrawal by Subject|2|||
25053889|NCT04205162|50157525|FG001|Overall Study|Withdrawal by Subject|0|||
25053890|NCT04205162|50157524|FG000|Overall Study|University closure due to COVID-19|1|||
25053891|NCT04205162|50157525|FG001|Overall Study|University closure due to COVID-19|0|||
25053892|NCT01329939|50157536|FG000|Overall Study|Lost to Follow-up|3|||
25053893|NCT01329939|50157537|FG001|Overall Study|Lost to Follow-up|0|||
25053894|NCT01329939|50157538|FG002|Overall Study|Lost to Follow-up|1|||
25053895|NCT01329939|50157539|FG003|Overall Study|Lost to Follow-up|2|||
25276576|NCT01061151|50590565|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
24962196|NCT00451451|50052264|FG003|Overall Study|Death|1|||
24962197|NCT00451451|50052261|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
24962198|NCT00451451|50052262|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
24962199|NCT00451451|50052263|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
24962200|NCT00451451|50052264|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
24962201|NCT03824912|50052279|FG000|Overall Study|Lost to Follow-up|18|||
24962202|NCT03824912|50052280|FG001|Overall Study|Lost to Follow-up|15|||
24962203|NCT03824912|50052281|FG002|Overall Study|Lost to Follow-up|8|||
24962204|NCT03824912|50052279|FG000|Overall Study|Negative Baseline Culture Result|118|||
24962205|NCT03824912|50052280|FG001|Overall Study|Negative Baseline Culture Result|112|||
24962206|NCT03824912|50052281|FG002|Overall Study|Negative Baseline Culture Result|57|||
24962207|NCT03824912|50052279|FG000|Overall Study|Non-Compliance with Study Drug|0|||
24962208|NCT03824912|50052280|FG001|Overall Study|Non-Compliance with Study Drug|0|||
24962209|NCT03824912|50052281|FG002|Overall Study|Non-Compliance with Study Drug|1|||
24962210|NCT03824912|50052279|FG000|Overall Study|Protocol Violation|1|||
24962211|NCT03824912|50052280|FG001|Overall Study|Protocol Violation|4|||
24962212|NCT03824912|50052281|FG002|Overall Study|Protocol Violation|1|||
24962213|NCT03824912|50052279|FG000|Overall Study|Withdrawal by Subject|3|||
24962214|NCT03824912|50052280|FG001|Overall Study|Withdrawal by Subject|2|||
24962215|NCT03824912|50052281|FG002|Overall Study|Withdrawal by Subject|1|||
24962216|NCT03824912|50052279|FG000|Overall Study|Participation in another study|0|||
24962217|NCT03824912|50052280|FG001|Overall Study|Participation in another study|1|||
24962218|NCT03824912|50052281|FG002|Overall Study|Participation in another study|0|||
24962219|NCT00461123|50052291|FG000|Overall Study|Adverse Event|1|||
24962220|NCT00461123|50052292|FG001|Overall Study|Adverse Event|0|||
24962221|NCT00461123|50052291|FG000|Overall Study|Lost to Follow-up|1|||
24962222|NCT00461123|50052292|FG001|Overall Study|Lost to Follow-up|1|||
24962223|NCT00461123|50052291|FG000|Overall Study|Protocol Violation|3|||
24962224|NCT00461123|50052292|FG001|Overall Study|Protocol Violation|2|||
24962225|NCT00461123|50052291|FG000|Overall Study|Withdrawal by Subject|1|||
24962226|NCT00461123|50052292|FG001|Overall Study|Withdrawal by Subject|3|||
24962227|NCT00290342|50052300|FG000|Overall Study|Other|0|||
24962228|NCT00290342|50052301|FG001|Overall Study|Other|1|||
24962229|NCT00290342|50052300|FG000|Overall Study|Withdrawal by Subject|6|||
24962230|NCT00290342|50052301|FG001|Overall Study|Withdrawal by Subject|4|||
25053896|NCT01329939|50157536|FG000|Overall Study|Withdrawal by Subject|0|||
25053897|NCT01329939|50157537|FG001|Overall Study|Withdrawal by Subject|1|||
25053898|NCT01329939|50157538|FG002|Overall Study|Withdrawal by Subject|0|||
24962231|NCT00290342|50052300|FG000|Overall Study|Lost to Follow-up|1|||
24962232|NCT00290342|50052301|FG001|Overall Study|Lost to Follow-up|0|||
24962233|NCT00460811|50052312|FG000|Overall Study|Adverse Event|4|||
24962234|NCT00460811|50052313|FG001|Overall Study|Adverse Event|6|||
24962235|NCT00460811|50052314|FG002|Overall Study|Adverse Event|3|||
24962236|NCT00460811|50052315|FG003|Overall Study|Adverse Event|10|||
25053899|NCT01329939|50157539|FG003|Overall Study|Withdrawal by Subject|0|||
25053900|NCT01329939|50157536|FG000|Overall Study|Adverse Event|0|||
25053901|NCT01329939|50157537|FG001|Overall Study|Adverse Event|0|||
25053902|NCT01329939|50157538|FG002|Overall Study|Adverse Event|0|||
25053903|NCT01329939|50157539|FG003|Overall Study|Adverse Event|3|||
25053904|NCT02499900|50157551|FG000|Core Study Period|Other|1|||
24962237|NCT00460811|50052316|FG004|Overall Study|Adverse Event|2|||
24962238|NCT00460811|50052312|FG000|Overall Study|Noncompliance|1|||
24962239|NCT00460811|50052313|FG001|Overall Study|Noncompliance|0|||
25053905|NCT02499900|50157552|FG001|Core Study Period|Other|4|||
25053906|NCT02499900|50157551|FG000|Core Study Period|Lost to Follow-up|1|||
24962240|NCT00460811|50052314|FG002|Overall Study|Noncompliance|0|||
24962241|NCT00460811|50052315|FG003|Overall Study|Noncompliance|2|||
24962242|NCT00460811|50052316|FG004|Overall Study|Noncompliance|1|||
24962243|NCT00460811|50052312|FG000|Overall Study|Withdrawal by Subject|7|||
24962244|NCT00460811|50052313|FG001|Overall Study|Withdrawal by Subject|7|||
24962245|NCT00460811|50052314|FG002|Overall Study|Withdrawal by Subject|6|||
24962246|NCT00460811|50052315|FG003|Overall Study|Withdrawal by Subject|3|||
24962247|NCT00460811|50052316|FG004|Overall Study|Withdrawal by Subject|11|||
24962248|NCT00460811|50052312|FG000|Overall Study|Physician Decision|1|||
24962249|NCT00460811|50052313|FG001|Overall Study|Physician Decision|0|||
24962250|NCT00460811|50052314|FG002|Overall Study|Physician Decision|0|||
25053907|NCT02499900|50157552|FG001|Core Study Period|Lost to Follow-up|2|||
25053908|NCT02499900|50157551|FG000|Core Study Period|Per sponsor request|0|||
25053909|NCT02499900|50157552|FG001|Core Study Period|Per sponsor request|1|||
25053910|NCT02499900|50157551|FG000|Core Study Period|Pregnancy|1|||
25053911|NCT02499900|50157552|FG001|Core Study Period|Pregnancy|0|||
25053912|NCT02499900|50157551|FG000|Core Study Period|Protocol Violation|3|||
24962251|NCT00460811|50052315|FG003|Overall Study|Physician Decision|0|||
24962252|NCT00460811|50052316|FG004|Overall Study|Physician Decision|0|||
24962253|NCT00460811|50052312|FG000|Overall Study|Lost to Follow-up|3|||
24962254|NCT00460811|50052313|FG001|Overall Study|Lost to Follow-up|2|||
24962255|NCT00460811|50052314|FG002|Overall Study|Lost to Follow-up|5|||
25053913|NCT02499900|50157552|FG001|Core Study Period|Protocol Violation|0|||
25053914|NCT02499900|50157551|FG000|Core Study Period|Withdrawal by Subject|11|||
25053915|NCT02499900|50157552|FG001|Core Study Period|Withdrawal by Subject|10|||
24962256|NCT00460811|50052315|FG003|Overall Study|Lost to Follow-up|3|||
24962257|NCT00460811|50052316|FG004|Overall Study|Lost to Follow-up|6|||
24962258|NCT00290186|50052335|FG000|Overall Study|Adverse Event|1|||
24962259|NCT00290186|50052336|FG001|Overall Study|Adverse Event|1|||
24962260|NCT00290186|50052335|FG000|Overall Study|Lost to Follow-up|3|||
25053916|NCT02499900|50157551|FG000|Core Study Period|Adverse Event|18|||
25053917|NCT02499900|50157552|FG001|Core Study Period|Adverse Event|14|||
25053918|NCT02499900|50157551|FG000|Core Study Period|Death|0|||
25053919|NCT02499900|50157552|FG001|Core Study Period|Death|1|||
25053920|NCT02499900|50157551|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
25053921|NCT02499900|50157552|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
25053922|NCT02499900|50157551|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
25053923|NCT02499900|50157552|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
25053924|NCT02499900|50157551|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
25053925|NCT02499900|50157552|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
25053926|NCT02499900|50157551|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
25053927|NCT02499900|50157552|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
25053928|NCT02499900|50157551|FG000|Extension Study Period|Adverse Event|2|||
25053929|NCT02499900|50157552|FG001|Extension Study Period|Adverse Event|4|||
25053930|NCT02499900|50157551|FG000|Extension Study Period|Withdrawal by Subject|5|||
25053931|NCT02499900|50157552|FG001|Extension Study Period|Withdrawal by Subject|2|||
25053932|NCT02499900|50157551|FG000|Extension Study Period|Physician Decision|2|||
25053933|NCT02499900|50157552|FG001|Extension Study Period|Physician Decision|5|||
25053934|NCT02499900|50157551|FG000|Extension Study Period|Pregnancy|1|||
24962261|NCT00290186|50052336|FG001|Overall Study|Lost to Follow-up|2|||
24962262|NCT00290186|50052335|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
24962263|NCT00290186|50052336|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
24962264|NCT00290186|50052335|FG000|Overall Study|Withdrawal by Subject|0|||
24962265|NCT00290186|50052336|FG001|Overall Study|Withdrawal by Subject|1|||
24962266|NCT00460655|50052346|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
24962267|NCT00460655|50052347|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
24962268|NCT00460655|50052348|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
24962269|NCT00460655|50052349|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
24962270|NCT00460655|50052346|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
24962271|NCT00460655|50052347|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
24962272|NCT00460655|50052348|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
24962273|NCT00460655|50052349|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
24962274|NCT00460655|50052346|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
24962275|NCT00460655|50052347|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
24962276|NCT00460655|50052348|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
24962277|NCT00460655|50052349|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
24962278|NCT00460655|50052346|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
24962279|NCT00460655|50052347|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
24962280|NCT00460655|50052348|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
24962281|NCT00460655|50052349|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
24962282|NCT00460655|50052346|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
24962283|NCT00460655|50052347|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
24962284|NCT00460655|50052348|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
24962285|NCT00460655|50052349|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
24962286|NCT00460655|50052346|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
24962287|NCT00460655|50052347|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
24962288|NCT00460655|50052348|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
24962289|NCT00460655|50052349|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
24962290|NCT00460577|50052361|FG000|Overall Study|Protocol Violation|2|||
24962291|NCT00460577|50052362|FG001|Overall Study|Protocol Violation|6|||
24962292|NCT00289016|50052368|FG000|Overall Study|Disease Progression|29|||
24962293|NCT00289016|50052368|FG000|Overall Study|Death|2|||
24962294|NCT00289016|50052368|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
24962295|NCT00289016|50052368|FG000|Overall Study|Withdrawal by Subject|2|||
24962296|NCT00289016|50052368|FG000|Overall Study|Adverse Event|1|||
24962297|NCT00289016|50052368|FG000|Overall Study|Other|1|||
24962298|NCT00288860|50052374|FG000|Overall Study|Did not complete intake|4|||
24962299|NCT00288860|50052375|FG001|Overall Study|Did not complete intake|8|||
24962300|NCT00288860|50052374|FG000|Overall Study|Death|4|||
24962301|NCT00288860|50052375|FG001|Overall Study|Death|3|||
24962302|NCT00288860|50052374|FG000|Overall Study|Withdrawal by Subject|20|||
24962303|NCT00288860|50052375|FG001|Overall Study|Withdrawal by Subject|15|||
24962304|NCT00288860|50052374|FG000|Overall Study|Lost to Follow-up|74|||
24962305|NCT00288860|50052375|FG001|Overall Study|Lost to Follow-up|71|||
24962306|NCT00288704|50052387|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
24962307|NCT00288704|50052388|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
24962308|NCT00288704|50052389|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
25053935|NCT02499900|50157552|FG001|Extension Study Period|Pregnancy|2|||
25053936|NCT02499900|50157551|FG000|Extension Study Period|Lost to Follow-up|2|||
24962309|NCT00288704|50052387|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
24962310|NCT00288704|50052388|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
24962311|NCT00288704|50052389|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
24962312|NCT00288704|50052387|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
24962313|NCT00288704|50052388|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
24962314|NCT00288704|50052389|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
24962315|NCT00288704|50052387|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
24962316|NCT00288704|50052388|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
24962317|NCT00288704|50052389|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
24962318|NCT00288704|50052387|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
24962319|NCT00288704|50052388|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
24962320|NCT00288704|50052389|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
24962321|NCT00288704|50052387|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
24962322|NCT00288704|50052388|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
24962323|NCT00288704|50052389|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
25053937|NCT02499900|50157552|FG001|Extension Study Period|Lost to Follow-up|5|||
25053938|NCT02499900|50157551|FG000|Extension Study Period|Other|0|||
25053939|NCT02499900|50157552|FG001|Extension Study Period|Other|2|||
25053940|NCT03505749|50157566|FG000|Overall Study|Lost to Follow-up|7|||
25053941|NCT03505749|50157567|FG001|Overall Study|Lost to Follow-up|11|||
25053942|NCT03505749|50157566|FG000|Overall Study|Withdrawal by Subject|6|||
25053943|NCT03505749|50157567|FG001|Overall Study|Withdrawal by Subject|0|||
25053944|NCT03505749|50157566|FG000|Overall Study|Discharged from treatment|3|||
24962324|NCT00288704|50052387|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
24962325|NCT00288704|50052388|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
24962326|NCT00288704|50052389|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
24962327|NCT00288626|50052396|FG000|Overall Study|Death|3|||
24962328|NCT00288626|50052396|FG000|Overall Study|Withdrawal by Subject|4|||
24962329|NCT00087490|50052404|FG000|Overall Study|Death|6|||
24962330|NCT00087490|50052405|FG001|Overall Study|Death|4|||
24962331|NCT00087490|50052404|FG000|Overall Study|Adverse Event|3|||
24962332|NCT00087490|50052405|FG001|Overall Study|Adverse Event|8|||
24962333|NCT00087490|50052404|FG000|Overall Study|Lack of Efficacy|0|||
24962334|NCT00087490|50052405|FG001|Overall Study|Lack of Efficacy|2|||
24962335|NCT00087490|50052404|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
24962336|NCT00087490|50052405|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
24962337|NCT00087490|50052404|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
24962338|NCT00087490|50052405|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
24962339|NCT00087490|50052404|FG000|Overall Study|Randomized but not treated|7|||
24962340|NCT00087490|50052405|FG001|Overall Study|Randomized but not treated|18|||
24962341|NCT00087178|50052413|FG000|Overall Study|No follow up data|5|||
24962342|NCT00087178|50052414|FG001|Overall Study|No follow up data|15|||
24962343|NCT00087178|50052413|FG000|Overall Study|No clinical assessment|1|||
24962344|NCT00087178|50052414|FG001|Overall Study|No clinical assessment|2|||
24962345|NCT00087178|50052413|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
24962346|NCT00087178|50052414|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
24962347|NCT00288080|50052422|FG000|Overall Study|Withdrawal by Subject|1|||
24962348|NCT00288080|50052423|FG001|Overall Study|Withdrawal by Subject|3|||
24962349|NCT00288080|50052422|FG000|Overall Study|Protocol Violation|25|||
24962350|NCT00288080|50052423|FG001|Overall Study|Protocol Violation|20|||
24962351|NCT00287690|50052431|FG000|Overall Study|Protocol Violation|20|||
24962352|NCT00287690|50052432|FG001|Overall Study|Protocol Violation|26|||
24962353|NCT00286754|50052441|FG000|Overall Study|Adverse Event|2|||
24962354|NCT00286754|50052442|FG001|Overall Study|Adverse Event|2|||
24962355|NCT00286754|50052443|FG002|Overall Study|Adverse Event|3|||
24962356|NCT00286754|50052441|FG000|Overall Study|Withdrawal by Subject|6|||
24962357|NCT00286754|50052442|FG001|Overall Study|Withdrawal by Subject|2|||
25186588|NCT02647320|50337193|FG000|Overall Study|Withdrawal by Subject|7|||
25186589|NCT02647320|50337194|FG001|Overall Study|Withdrawal by Subject|4|||
25186590|NCT02647320|50337195|FG002|Overall Study|Withdrawal by Subject|2|||
25186591|NCT02647320|50337196|FG003|Overall Study|Withdrawal by Subject|2|||
25186592|NCT02647320|50337197|FG004|Overall Study|Withdrawal by Subject|7|||
24962358|NCT00286754|50052443|FG002|Overall Study|Withdrawal by Subject|0|||
24962359|NCT00286754|50052441|FG000|Overall Study|Lost to Follow-up|12|||
24962360|NCT00286754|50052442|FG001|Overall Study|Lost to Follow-up|14|||
24962361|NCT00286754|50052443|FG002|Overall Study|Lost to Follow-up|6|||
24962362|NCT00286754|50052441|FG000|Overall Study|Moved out of state|0|||
24962363|NCT00286754|50052442|FG001|Overall Study|Moved out of state|0|||
25053945|NCT03505749|50157567|FG001|Overall Study|Discharged from treatment|6|||
25053946|NCT03710642|50157591|FG000|Overall Study|Adverse Event|5|||
25053947|NCT03710642|50157592|FG001|Overall Study|Adverse Event|1|||
25186593|NCT02647320|50337193|FG000|Overall Study|Persistent hyperglycemia|0|||
25186594|NCT02647320|50337194|FG001|Overall Study|Persistent hyperglycemia|1|||
24962364|NCT00286754|50052443|FG002|Overall Study|Moved out of state|1|||
24962365|NCT00066742|50052457|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
24962366|NCT00066742|50052457|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
24962367|NCT00066742|50052457|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
24962368|NCT00066742|50052457|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
25053948|NCT03710642|50157591|FG000|Overall Study|non-site physician recommendation|1|||
25053949|NCT03710642|50157592|FG001|Overall Study|non-site physician recommendation|0|||
25053950|NCT03710642|50157591|FG000|Overall Study|Participant unwilling or unable to participate|1|||
25053951|NCT03710642|50157592|FG001|Overall Study|Participant unwilling or unable to participate|1|||
25053952|NCT03710642|50157591|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
25053953|NCT03710642|50157592|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
25053954|NCT03710642|50157591|FG000|Overall Study|NA-no code provided|1|||
25053955|NCT03710642|50157592|FG001|Overall Study|NA-no code provided|0|||
25053956|NCT03710642|50157591|FG000|Overall Study|Withdrawal by Subject|1|||
24962369|NCT00066742|50052457|FG000|Induction Chemoradiotherapy|Ineligible|3|||
24962370|NCT00066742|50052457|FG000|Consolidation Chemotherapy|not protocol specified|1|||
24962371|NCT00066742|50052457|FG000|Consolidation Chemotherapy|Ineligible|2|||
24962372|NCT00460265|50052465|FG000|Overall Study|Lost to Follow-up|14|||
24962373|NCT00460265|50052466|FG001|Overall Study|Lost to Follow-up|15|||
24962374|NCT00460265|50052465|FG000|Overall Study|Physician Decision|1|||
24962375|NCT00460265|50052466|FG001|Overall Study|Physician Decision|2|||
24962376|NCT00460265|50052465|FG000|Overall Study|Withdrawal by Subject|10|||
24962377|NCT00460265|50052466|FG001|Overall Study|Withdrawal by Subject|25|||
25053957|NCT03710642|50157592|FG001|Overall Study|Withdrawal by Subject|0|||
25053958|NCT00705224|50157598|FG000|Overall Study|Adverse Event|1|||
25053959|NCT00705224|50157598|FG000|Overall Study|Lack of Efficacy|2|||
25053960|NCT00705224|50157598|FG000|Overall Study|Withdrawal by Subject|3|||
25053961|NCT00705224|50157598|FG000|Overall Study|Lost to Follow-up|5|||
25053962|NCT02722148|50157605|FG000|Overall Study|Lost to Follow-up|2|||
25053963|NCT02722148|50157605|FG000|Overall Study|Non compliant with treatment regimen|3|||
25053964|NCT00704132|50157611|FG000|Overall Study|Clinical Adverse Experience|1|||
25053965|NCT00704132|50157612|FG001|Overall Study|Clinical Adverse Experience|0|||
25053966|NCT00704132|50157611|FG000|Overall Study|Lack of Efficacy|0|||
25053967|NCT00704132|50157612|FG001|Overall Study|Lack of Efficacy|1|||
25053968|NCT00704132|50157611|FG000|Overall Study|Withdrawal by Subject|0|||
25053969|NCT00704132|50157612|FG001|Overall Study|Withdrawal by Subject|1|||
25053970|NCT01329549|50157627|FG000|Overall Study|Withdrawal by Subject|1|||
25053971|NCT01329549|50157627|FG000|Overall Study|Adverse Event|1|||
25053972|NCT02736474|50157633|FG000|Overall Study|Lost to Follow-up|0|||
25053973|NCT02736474|50157634|FG001|Overall Study|Lost to Follow-up|1|||
25053974|NCT00702650|50157656|FG000|Overall Study|Withdrawal by Subject|9|||
25053975|NCT00702650|50157656|FG000|Overall Study|Non-Compliance of Study Drug|3|||
25053976|NCT00702650|50157656|FG000|Overall Study|Lost to Follow-up|2|||
25053977|NCT00702650|50157656|FG000|Overall Study|Non-Compliance with Site Directives|1|||
25053978|NCT00702650|50157656|FG000|Overall Study|Sponsor Request|1|||
25053979|NCT00702650|50157656|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
25053980|NCT00702650|50157656|FG000|Overall Study|Adverse Event|3|||
25053981|NCT03230916|50157671|FG000|Overall Study|Withdrawal by Subject|0|||
25053982|NCT03230916|50157672|FG001|Overall Study|Withdrawal by Subject|0|||
25053983|NCT03230916|50157673|FG002|Overall Study|Withdrawal by Subject|0|||
25053984|NCT03230916|50157674|FG003|Overall Study|Withdrawal by Subject|0|||
25053985|NCT03230916|50157675|FG004|Overall Study|Withdrawal by Subject|0|||
25053986|NCT03230916|50157676|FG005|Overall Study|Withdrawal by Subject|1|||
25053987|NCT03230916|50157677|FG006|Overall Study|Withdrawal by Subject|0|||
25053988|NCT03230916|50157678|FG007|Overall Study|Withdrawal by Subject|0|||
25053989|NCT03230916|50157679|FG008|Overall Study|Withdrawal by Subject|0|||
25053990|NCT03230916|50157680|FG009|Overall Study|Withdrawal by Subject|0|||
25053991|NCT03230916|50157681|FG010|Overall Study|Withdrawal by Subject|0|||
25053992|NCT01337115|50157724|FG000|Overall Study|Protocol Violation|2|||
25053993|NCT01337115|50157725|FG001|Overall Study|Protocol Violation|0|||
25053994|NCT03761784|50157735|FG000|Overall Study|Adverse Event|4|||
25053995|NCT03761784|50157736|FG001|Overall Study|Adverse Event|0|||
25053996|NCT03761784|50157735|FG000|Overall Study|Lost to Follow-up|10|||
25053997|NCT03761784|50157736|FG001|Overall Study|Lost to Follow-up|7|||
25162662|NCT01997333|50284850|FG000|Survival Follow up|Withdrawal by Subject|15|||
25162663|NCT01997333|50284851|FG001|Survival Follow up|Withdrawal by Subject|6|||
25162664|NCT01997333|50284850|FG000|Survival Follow up|Lost to Follow-up|0|||
25162665|NCT01997333|50284851|FG001|Survival Follow up|Lost to Follow-up|6|||
25162666|NCT01997333|50284850|FG000|Survival Follow up|Various|1|||
25162667|NCT01997333|50284851|FG001|Survival Follow up|Various|2|||
25162668|NCT01982435|50284915|FG000|Overall Study|Adverse Event|1|||
25162669|NCT01982435|50284916|FG001|Overall Study|Adverse Event|0|||
25162670|NCT01620983|50284956|FG000|Overall Study|Lost to Follow-up|8|||
24962378|NCT00460265|50052465|FG000|Overall Study|Ongoing|60|||
24962379|NCT00460265|50052466|FG001|Overall Study|Ongoing|47|||
24962380|NCT00460109|50052472|FG000|Overall Study|Death|1|||
24962381|NCT00065260|50052478|FG000|Overall Study|Death|0|||
25053998|NCT03761784|50157735|FG000|Overall Study|Pregnancy|1|||
25053999|NCT03761784|50157736|FG001|Overall Study|Pregnancy|0|||
25054000|NCT03761784|50157735|FG000|Overall Study|Protocol Violation|2|||
25162671|NCT01620983|50284957|FG001|Overall Study|Lost to Follow-up|4|||
25054001|NCT03761784|50157736|FG001|Overall Study|Protocol Violation|0|||
25054002|NCT03761784|50157735|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
25054003|NCT03761784|50157736|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
25054004|NCT03761784|50157735|FG000|Overall Study|Withdrawal by Subject|9|||
25054005|NCT03761784|50157736|FG001|Overall Study|Withdrawal by Subject|4|||
25054006|NCT03761784|50157735|FG000|Overall Study|Physician Decision|1|||
25054007|NCT03761784|50157736|FG001|Overall Study|Physician Decision|0|||
25054008|NCT03761784|50157735|FG000|Overall Study|Other Than Specified|1|||
25054009|NCT03761784|50157736|FG001|Overall Study|Other Than Specified|0|||
25054010|NCT03195894|50157744|FG000|Overall Study|"An example is Started other treatment."|4|||
25054011|NCT03195894|50157745|FG001|Overall Study|"An example is Started other treatment."|5|||
25054012|NCT03195894|50157744|FG000|Overall Study|Withdrawal by Subject|15|||
25054013|NCT03195894|50157745|FG001|Overall Study|Withdrawal by Subject|4|||
25054014|NCT03195894|50157744|FG000|Overall Study|Lost to Follow-up|14|||
25054015|NCT03195894|50157745|FG001|Overall Study|Lost to Follow-up|19|||
25054016|NCT01337973|50157757|FG000|Overall Study|Lost to Follow-up|2|||
25054017|NCT01337973|50157758|FG001|Overall Study|Lost to Follow-up|4|||
25054018|NCT01337973|50157759|FG002|Overall Study|Lost to Follow-up|3|||
24962382|NCT00065260|50052479|FG001|Overall Study|Death|1|||
24962383|NCT00460031|50052485|FG000|Overall Study|Adverse Event|5|||
24962384|NCT00460031|50052485|FG000|Overall Study|Withdrawal by Subject|5|||
24962385|NCT00460031|50052485|FG000|Overall Study|Death|1|||
24962386|NCT00451217|50052493|FG000|Overall Study|Lost to Follow-up|0|||
24962387|NCT00451217|50052494|FG001|Overall Study|Lost to Follow-up|1|||
24962388|NCT00451217|50052495|FG002|Overall Study|Lost to Follow-up|1|||
24962389|NCT00451217|50052496|FG003|Overall Study|Lost to Follow-up|1|||
24962390|NCT00451217|50052493|FG000|Overall Study|Withdrawal by Subject|1|||
24962391|NCT00451217|50052494|FG001|Overall Study|Withdrawal by Subject|0|||
24962392|NCT00451217|50052495|FG002|Overall Study|Withdrawal by Subject|0|||
24962393|NCT00451217|50052496|FG003|Overall Study|Withdrawal by Subject|0|||
24962394|NCT00451217|50052493|FG000|Overall Study|Not Treated|1|||
24962395|NCT00451217|50052494|FG001|Overall Study|Not Treated|1|||
24962396|NCT00451217|50052495|FG002|Overall Study|Not Treated|3|||
25162672|NCT01620983|50284958|FG002|Overall Study|Lost to Follow-up|9|||
25162673|NCT01620983|50284956|FG000|Overall Study|Withdrawal by Subject|6|||
25162674|NCT01620983|50284957|FG001|Overall Study|Withdrawal by Subject|8|||
25162675|NCT01620983|50284958|FG002|Overall Study|Withdrawal by Subject|1|||
25162676|NCT01620983|50284956|FG000|Overall Study|Death|2|||
25162677|NCT01620983|50284957|FG001|Overall Study|Death|0|||
25162678|NCT01620983|50284958|FG002|Overall Study|Death|0|||
25162679|NCT01620983|50284956|FG000|Overall Study|Physician Decision|3|||
25162680|NCT01620983|50284957|FG001|Overall Study|Physician Decision|10|||
25162681|NCT01620983|50284958|FG002|Overall Study|Physician Decision|5|||
25162682|NCT01996709|50284968|FG000|Overall Study|Withdrawal by Subject|1|||
24962397|NCT00451217|50052496|FG003|Overall Study|Not Treated|4|||
24962398|NCT00459953|50052508|FG000|Overall Study|not analyzed-household member in study|1|||
24962399|NCT00459953|50052509|FG001|Overall Study|not analyzed-household member in study|1|||
24962400|NCT00459875|50052515|FG000|Overall Study|Ineligible participant|1|||
24962401|NCT00459875|50052515|FG000|Overall Study|Adverse Event|2|||
24962402|NCT00311402|50052521|FG000|Overall Study|Adverse Event|118|||
24962403|NCT00311402|50052522|FG001|Overall Study|Adverse Event|105|||
24962404|NCT00311402|50052521|FG000|Overall Study|Lost to Follow-up|0|||
24962405|NCT00311402|50052522|FG001|Overall Study|Lost to Follow-up|3|||
24962406|NCT00311402|50052521|FG000|Overall Study|Withdrawal by Subject|17|||
24962407|NCT00311402|50052522|FG001|Overall Study|Withdrawal by Subject|18|||
24962408|NCT00311402|50052521|FG000|Overall Study|Lack of Efficacy|58|||
24962409|NCT00311402|50052522|FG001|Overall Study|Lack of Efficacy|42|||
24962410|NCT00311402|50052521|FG000|Overall Study|Protocol Violation|7|||
24962411|NCT00311402|50052522|FG001|Overall Study|Protocol Violation|6|||
24962412|NCT00311402|50052521|FG000|Overall Study|IRB's rejection etc.|10|||
24962413|NCT00311402|50052522|FG001|Overall Study|IRB's rejection etc.|3|||
24962414|NCT00450749|50052531|FG000|Overall Study|Withdrawal by Subject|0|||
24962415|NCT00450749|50052532|FG001|Overall Study|Withdrawal by Subject|0|||
24962416|NCT00450749|50052533|FG002|Overall Study|Withdrawal by Subject|2|||
24962417|NCT00450749|50052531|FG000|Overall Study|Noncompliant|0|||
24962418|NCT00450749|50052532|FG001|Overall Study|Noncompliant|1|||
24962419|NCT00450749|50052533|FG002|Overall Study|Noncompliant|0|||
24962420|NCT00292370|50052544|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
24962421|NCT00292370|50052545|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
25162683|NCT01996709|50284969|FG001|Overall Study|Withdrawal by Subject|0|||
25162684|NCT01996709|50284968|FG000|Overall Study|Lost to Follow-up|3|||
24962422|NCT00292370|50052546|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
24962423|NCT00292370|50052544|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
24962424|NCT00292370|50052545|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
25054019|NCT01337973|50157757|FG000|Overall Study|Death|1|||
25162685|NCT01996709|50284969|FG001|Overall Study|Lost to Follow-up|0|||
25054020|NCT01337973|50157758|FG001|Overall Study|Death|2|||
25054021|NCT01337973|50157759|FG002|Overall Study|Death|1|||
24962425|NCT00292370|50052546|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
24962426|NCT00292370|50052544|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
24962427|NCT00292370|50052545|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
24962428|NCT00292370|50052546|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
24962429|NCT00292370|50052544|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
24962430|NCT00292370|50052545|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
24962431|NCT00292370|50052546|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
24962432|NCT00292370|50052544|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
24962433|NCT00292370|50052545|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
24962434|NCT00292370|50052546|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
24962435|NCT00292370|50052544|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
24962436|NCT00292370|50052545|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
24962437|NCT00292370|50052546|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
24962438|NCT00065182|50052555|FG000|Overall Study|Adverse Event|24|||
24962439|NCT00065182|50052556|FG001|Overall Study|Adverse Event|17|||
24962440|NCT00065182|50052555|FG000|Overall Study|Lost to Follow-up|0|||
24962441|NCT00065182|50052556|FG001|Overall Study|Lost to Follow-up|4|||
24962442|NCT00065182|50052555|FG000|Overall Study|Protocol Violation|3|||
24962443|NCT00065182|50052556|FG001|Overall Study|Protocol Violation|4|||
24962444|NCT00065182|50052555|FG000|Overall Study|Serious adverse events (SAE)|1|||
24962445|NCT00065182|50052556|FG001|Overall Study|Serious adverse events (SAE)|0|||
24962446|NCT00065182|50052555|FG000|Overall Study|Sponsor Decision|11|||
24962447|NCT00065182|50052556|FG001|Overall Study|Sponsor Decision|7|||
24962448|NCT00065182|50052555|FG000|Overall Study|Withdrawal by Subject|8|||
24962449|NCT00065182|50052556|FG001|Overall Study|Withdrawal by Subject|3|||
24962450|NCT00065182|50052555|FG000|Overall Study|No clinical benefit|1|||
24962451|NCT00065182|50052556|FG001|Overall Study|No clinical benefit|0|||
24962452|NCT00065182|50052555|FG000|Overall Study|Death|0|||
24962453|NCT00065182|50052556|FG001|Overall Study|Death|1|||
24962454|NCT00065182|50052555|FG000|Overall Study|Decline in Status|0|||
24962455|NCT00065182|50052556|FG001|Overall Study|Decline in Status|1|||
24962456|NCT00064792|50052564|FG000|Overall Study|Withdrawal by Subject|2|||
24962457|NCT00064792|50052565|FG001|Overall Study|Withdrawal by Subject|0|||
24962458|NCT00064792|50052564|FG000|Overall Study|Adverse Event|3|||
24962459|NCT00064792|50052565|FG001|Overall Study|Adverse Event|0|||
24962460|NCT00450437|50052573|FG000|Overall Study|Withdrawal by Subject|10|||
24962461|NCT00450437|50052574|FG001|Overall Study|Withdrawal by Subject|2|||
24962462|NCT00450437|50052575|FG002|Overall Study|Withdrawal by Subject|0|||
24962463|NCT00450437|50052576|FG003|Overall Study|Withdrawal by Subject|1|||
24962464|NCT00450437|50052573|FG000|Overall Study|Lost to Follow-up|31|||
24962465|NCT00450437|50052574|FG001|Overall Study|Lost to Follow-up|12|||
24962466|NCT00450437|50052575|FG002|Overall Study|Lost to Follow-up|19|||
24962467|NCT00450437|50052576|FG003|Overall Study|Lost to Follow-up|9|||
24962468|NCT00450437|50052573|FG000|Overall Study|Protocol Violation|0|||
24962469|NCT00450437|50052574|FG001|Overall Study|Protocol Violation|1|||
24962470|NCT00450437|50052575|FG002|Overall Study|Protocol Violation|0|||
24962471|NCT00450437|50052576|FG003|Overall Study|Protocol Violation|1|||
24962472|NCT00450437|50052573|FG000|Overall Study|Inappropriate enrollment|4|||
24962473|NCT00450437|50052574|FG001|Overall Study|Inappropriate enrollment|1|||
24962474|NCT00450437|50052575|FG002|Overall Study|Inappropriate enrollment|3|||
24962475|NCT00450437|50052576|FG003|Overall Study|Inappropriate enrollment|0|||
24962476|NCT00450437|50052573|FG000|Overall Study|Administrative reason|0|||
24962477|NCT00450437|50052574|FG001|Overall Study|Administrative reason|0|||
24962478|NCT00450437|50052575|FG002|Overall Study|Administrative reason|1|||
24962479|NCT00450437|50052576|FG003|Overall Study|Administrative reason|0|||
24962480|NCT00450437|50052573|FG000|Overall Study|Unable to Classify|1|||
24962481|NCT00450437|50052574|FG001|Overall Study|Unable to Classify|0|||
24962482|NCT00450437|50052575|FG002|Overall Study|Unable to Classify|1|||
25054022|NCT01337973|50157757|FG000|Overall Study|Withdrawal by Subject|10|||
25054023|NCT01337973|50157758|FG001|Overall Study|Withdrawal by Subject|8|||
25054024|NCT01337973|50157759|FG002|Overall Study|Withdrawal by Subject|4|||
25054025|NCT01337973|50157757|FG000|Overall Study|missing data on primary outcome|3|||
25054026|NCT01337973|50157758|FG001|Overall Study|missing data on primary outcome|1|||
25054027|NCT01337973|50157759|FG002|Overall Study|missing data on primary outcome|3|||
25054028|NCT02929056|50157769|FG000|Overall Study|Lost to Follow-up|0|||
25054029|NCT02929056|50157770|FG001|Overall Study|Lost to Follow-up|1|||
24962483|NCT00450437|50052576|FG003|Overall Study|Unable to Classify|0|||
24962484|NCT00286442|50052593|FG000|Overall Study|Hyperglycemic Rescue|19|||
24962485|NCT00286442|50052594|FG001|Overall Study|Hyperglycemic Rescue|17|||
25054030|NCT00157755|50157789|FG000|Overall Study|Death|2|||
25054031|NCT00157755|50157790|FG001|Overall Study|Death|3|||
25054032|NCT00157755|50157791|FG002|Overall Study|Death|3|||
25054033|NCT00157755|50157792|FG003|Overall Study|Death|2|||
25054034|NCT00157755|50157793|FG004|Overall Study|Death|0|||
25054035|NCT00157755|50157794|FG005|Overall Study|Death|0|||
25054036|NCT00157755|50157789|FG000|Overall Study|Lost to Follow-up|0|||
25054037|NCT00157755|50157790|FG001|Overall Study|Lost to Follow-up|0|||
25054038|NCT00157755|50157791|FG002|Overall Study|Lost to Follow-up|1|||
25054039|NCT00157755|50157792|FG003|Overall Study|Lost to Follow-up|0|||
25054040|NCT00157755|50157793|FG004|Overall Study|Lost to Follow-up|0|||
25054041|NCT00157755|50157794|FG005|Overall Study|Lost to Follow-up|0|||
25054042|NCT00157755|50157789|FG000|Overall Study|Withdrawal by Subject|0|||
25054043|NCT00157755|50157790|FG001|Overall Study|Withdrawal by Subject|0|||
25054044|NCT00157755|50157791|FG002|Overall Study|Withdrawal by Subject|1|||
25054045|NCT00157755|50157792|FG003|Overall Study|Withdrawal by Subject|1|||
25054046|NCT00157755|50157793|FG004|Overall Study|Withdrawal by Subject|1|||
25054047|NCT00157755|50157794|FG005|Overall Study|Withdrawal by Subject|2|||
25054048|NCT00157755|50157789|FG000|Overall Study|Explant due to infection|0|||
25054049|NCT00157755|50157790|FG001|Overall Study|Explant due to infection|0|||
25054050|NCT00157755|50157791|FG002|Overall Study|Explant due to infection|1|||
25054051|NCT00157755|50157792|FG003|Overall Study|Explant due to infection|0|||
25054052|NCT00157755|50157793|FG004|Overall Study|Explant due to infection|0|||
25054053|NCT00157755|50157794|FG005|Overall Study|Explant due to infection|0|||
25054054|NCT00157755|50157789|FG000|Overall Study|Medical reason|0|||
25054055|NCT00157755|50157790|FG001|Overall Study|Medical reason|0|||
25054056|NCT00157755|50157791|FG002|Overall Study|Medical reason|1|||
24962486|NCT00286442|50052595|FG002|Overall Study|Hyperglycemic Rescue|25|||
24962487|NCT00286442|50052593|FG000|Overall Study|Adverse Event|7|||
25054057|NCT00157755|50157792|FG003|Overall Study|Medical reason|1|||
25054058|NCT00157755|50157793|FG004|Overall Study|Medical reason|0|||
25054059|NCT00157755|50157794|FG005|Overall Study|Medical reason|0|||
25054060|NCT00157755|50157789|FG000|Overall Study|Study site closure|0|||
25054061|NCT00157755|50157790|FG001|Overall Study|Study site closure|1|||
25054062|NCT00157755|50157791|FG002|Overall Study|Study site closure|0|||
25054063|NCT00157755|50157792|FG003|Overall Study|Study site closure|0|||
24962488|NCT00286442|50052594|FG001|Overall Study|Adverse Event|6|||
24962489|NCT00286442|50052595|FG002|Overall Study|Adverse Event|1|||
24962490|NCT00286442|50052593|FG000|Overall Study|Protocol Violation|2|||
24962491|NCT00286442|50052594|FG001|Overall Study|Protocol Violation|4|||
24962492|NCT00286442|50052595|FG002|Overall Study|Protocol Violation|2|||
24962493|NCT00286442|50052593|FG000|Overall Study|Lost to Follow-up|5|||
24962494|NCT00286442|50052594|FG001|Overall Study|Lost to Follow-up|2|||
24962495|NCT00286442|50052595|FG002|Overall Study|Lost to Follow-up|1|||
24962496|NCT00286442|50052593|FG000|Overall Study|Physician Decision|1|||
24962497|NCT00286442|50052594|FG001|Overall Study|Physician Decision|1|||
24962498|NCT00286442|50052595|FG002|Overall Study|Physician Decision|1|||
24962499|NCT00286442|50052593|FG000|Overall Study|Administrative Error|1|||
24962500|NCT00286442|50052594|FG001|Overall Study|Administrative Error|1|||
24962501|NCT00286442|50052595|FG002|Overall Study|Administrative Error|0|||
24962502|NCT00286442|50052593|FG000|Overall Study|Withdrawal by Subject|2|||
24962503|NCT00286442|50052594|FG001|Overall Study|Withdrawal by Subject|14|||
24962504|NCT00286442|50052595|FG002|Overall Study|Withdrawal by Subject|2|||
24962505|NCT00063934|50052603|FG000|Overall Study|Ineligible|1|||
24962506|NCT00458783|50052609|FG000|Overall Study|Protocol Violation|1228|||
24962507|NCT00458783|50052610|FG001|Overall Study|Protocol Violation|1220|||
24962508|NCT00063154|50052616|FG000|Overall Study|Disease progression|27|||
24962509|NCT00063154|50052616|FG000|Overall Study|Adverse Event|2|||
24962510|NCT00063154|50052616|FG000|Overall Study|Physician Decision|10|||
24962511|NCT00063154|50052616|FG000|Overall Study|Death|3|||
24962512|NCT00063154|50052616|FG000|Overall Study|Reason unspecified|1|||
24962513|NCT00063154|50052616|FG000|Overall Study|Did not receive treatment|8|||
24962514|NCT00311168|50052622|FG000|First Intervention|Withdrawal by Subject|2|||
24962515|NCT00311168|50052623|FG001|First Intervention|Withdrawal by Subject|2|||
24962516|NCT00311168|50052622|FG000|First Intervention|Lost to Follow-up|1|||
24962517|NCT00311168|50052623|FG001|First Intervention|Lost to Follow-up|1|||
24962518|NCT00311168|50052622|FG000|First Intervention|Protocol Violation|1|||
24962519|NCT00311168|50052623|FG001|First Intervention|Protocol Violation|1|||
24962520|NCT00311168|50052622|FG000|First Intervention|Adverse Event|1|||
24962521|NCT00311168|50052623|FG001|First Intervention|Adverse Event|0|||
24962522|NCT00311168|50052622|FG000|First Intervention|Other|2|||
24962523|NCT00311168|50052623|FG001|First Intervention|Other|2|||
24962524|NCT00311168|50052622|FG000|Second Intervention|Lost to Follow-up|9|||
24962525|NCT00311168|50052623|FG001|Second Intervention|Lost to Follow-up|2|||
24962526|NCT00311168|50052622|FG000|Second Intervention|Withdrawal by Subject|0|||
24962527|NCT00311168|50052623|FG001|Second Intervention|Withdrawal by Subject|1|||
24962528|NCT00311168|50052622|FG000|Second Intervention|Other|1|||
24962529|NCT00311168|50052623|FG001|Second Intervention|Other|1|||
24962530|NCT00458705|50052631|FG000|Overall Study|Adverse Event|4|||
24962531|NCT00458705|50052631|FG000|Overall Study|Not Treated|1|||
24962532|NCT00062374|50052635|FG000|Overall Study|Not treated|12|||
24962533|NCT00285818|50052641|FG000|Overall Study|Withdrawal by Subject|3|||
24962534|NCT00285818|50052642|FG001|Overall Study|Withdrawal by Subject|2|||
24962535|NCT00285818|50052641|FG000|Overall Study|Lost to Follow-up|1|||
24962536|NCT00285818|50052642|FG001|Overall Study|Lost to Follow-up|0|||
24962537|NCT00285584|50052650|FG000|Month 3|Lost to Follow-up|3|||
24962538|NCT00285584|50052651|FG001|Month 3|Lost to Follow-up|3|||
24962539|NCT00285584|50052650|FG000|Month 3|Withdrawal by Subject|1|||
24962540|NCT00285584|50052651|FG001|Month 3|Withdrawal by Subject|0|||
24962541|NCT00285584|50052650|FG000|Month 6|Lost to Follow-up|0|||
24962542|NCT00285584|50052651|FG001|Month 6|Lost to Follow-up|1|||
24962543|NCT03807700|50052663|FG000|Overall Study|Withdrawal by Subject|2|||
24962544|NCT03807700|50052664|FG001|Overall Study|Withdrawal by Subject|1|||
24962545|NCT00291668|50052674|FG000|Overall Study|Lack of Efficacy|1|||
24962546|NCT00291668|50052675|FG001|Overall Study|Lack of Efficacy|0|||
24962547|NCT00291668|50052676|FG002|Overall Study|Lack of Efficacy|0|||
24962548|NCT00291668|50052674|FG000|Overall Study|SAE, non-fatal|1|||
24962549|NCT00291668|50052675|FG001|Overall Study|SAE, non-fatal|1|||
24962550|NCT00291668|50052676|FG002|Overall Study|SAE, non-fatal|1|||
24962551|NCT00291668|50052674|FG000|Overall Study|AE, non-serious non-fatal|1|||
24962552|NCT00291668|50052675|FG001|Overall Study|AE, non-serious non-fatal|0|||
24962553|NCT00291668|50052676|FG002|Overall Study|AE, non-serious non-fatal|0|||
24962554|NCT00291668|50052674|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
24962555|NCT00291668|50052675|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
24962556|NCT00291668|50052676|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
24962557|NCT00458393|50052686|FG000|Overall Study|Withdrawal by Subject|67|||
24962558|NCT00458393|50052687|FG001|Overall Study|Withdrawal by Subject|80|||
25276577|NCT01061151|50590566|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
25276578|NCT01061151|50590563|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
25276579|NCT01061151|50590564|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
25276580|NCT01061151|50590565|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
25276581|NCT01061151|50590566|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
25276582|NCT01061151|50590563|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
25276583|NCT01061151|50590564|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
25276584|NCT01061151|50590565|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
25276585|NCT01061151|50590566|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
25276586|NCT01061151|50590563|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
25276587|NCT01061151|50590564|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
25276588|NCT01061151|50590565|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
25276589|NCT01061151|50590566|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
25276590|NCT01061151|50590563|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
25276591|NCT01061151|50590564|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
25276592|NCT01061151|50590565|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
25276593|NCT01061151|50590566|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
25276594|NCT01061151|50590563|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
25276595|NCT01061151|50590564|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
25276596|NCT01061151|50590565|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
25276597|NCT01061151|50590566|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
25276598|NCT01061151|50590563|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
25276599|NCT01061151|50590564|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
25276600|NCT01061151|50590565|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
25276601|NCT01061151|50590566|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
25276602|NCT01061151|50590563|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
25276603|NCT01061151|50590564|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
25276604|NCT01061151|50590565|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
24962559|NCT00458393|50052686|FG000|Overall Study|Physician Decision|31|||
25276605|NCT01061151|50590566|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
25054064|NCT00157755|50157793|FG004|Overall Study|Study site closure|0|||
25054065|NCT00157755|50157794|FG005|Overall Study|Study site closure|0|||
25054066|NCT00157755|50157789|FG000|Overall Study|Subject non-compliance|0|||
25054067|NCT00157755|50157790|FG001|Overall Study|Subject non-compliance|0|||
25054068|NCT00157755|50157791|FG002|Overall Study|Subject non-compliance|0|||
25054069|NCT00157755|50157792|FG003|Overall Study|Subject non-compliance|0|||
25054070|NCT00157755|50157793|FG004|Overall Study|Subject non-compliance|0|||
25054071|NCT00157755|50157794|FG005|Overall Study|Subject non-compliance|1|||
25054072|NCT00157755|50157789|FG000|Overall Study|Study completion|0|||
25054073|NCT00157755|50157790|FG001|Overall Study|Study completion|0|||
25054074|NCT00157755|50157791|FG002|Overall Study|Study completion|0|||
25054075|NCT00157755|50157792|FG003|Overall Study|Study completion|0|||
25054076|NCT00157755|50157793|FG004|Overall Study|Study completion|1|||
25054077|NCT00157755|50157794|FG005|Overall Study|Study completion|2|||
25054078|NCT02723006|50157803|FG000|Overall Study|Withdrawal by Subject|0|||
25054079|NCT02723006|50157804|FG001|Overall Study|Withdrawal by Subject|1|||
25054080|NCT02723006|50157805|FG002|Overall Study|Withdrawal by Subject|1|||
25054081|NCT02723006|50157803|FG000|Overall Study|Study Terminated by Sponsor|1|||
25054082|NCT02723006|50157804|FG001|Overall Study|Study Terminated by Sponsor|6|||
25054083|NCT02723006|50157805|FG002|Overall Study|Study Terminated by Sponsor|6|||
25054084|NCT04003389|50157816|FG000|Overall Study|Adverse Event|27|||
25054085|NCT04003389|50157817|FG001|Overall Study|Adverse Event|34|||
25054086|NCT04003389|50157818|FG002|Overall Study|Adverse Event|28|||
25162686|NCT01996709|50284968|FG000|Overall Study|Subject Non-Compliant|1|||
25162687|NCT01996709|50284969|FG001|Overall Study|Subject Non-Compliant|0|||
25162688|NCT01996709|50284968|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
25054087|NCT04003389|50157816|FG000|Overall Study|Lost to Follow-up|39|||
25054088|NCT04003389|50157817|FG001|Overall Study|Lost to Follow-up|30|||
25054089|NCT04003389|50157818|FG002|Overall Study|Lost to Follow-up|33|||
25054090|NCT04003389|50157816|FG000|Overall Study|Protocol Violation|1|||
25054091|NCT04003389|50157817|FG001|Overall Study|Protocol Violation|6|||
25054092|NCT04003389|50157818|FG002|Overall Study|Protocol Violation|5|||
25054093|NCT04003389|50157816|FG000|Overall Study|Withdrawal by Subject|119|||
25054094|NCT04003389|50157817|FG001|Overall Study|Withdrawal by Subject|79|||
25054095|NCT04003389|50157818|FG002|Overall Study|Withdrawal by Subject|85|||
25054096|NCT04003389|50157816|FG000|Overall Study|Miscellaneous|14|||
25054097|NCT04003389|50157817|FG001|Overall Study|Miscellaneous|11|||
25054098|NCT04003389|50157818|FG002|Overall Study|Miscellaneous|14|||
25054099|NCT04003389|50157816|FG000|Overall Study|Participant did not receive study drug|1|||
24962560|NCT00458393|50052687|FG001|Overall Study|Physician Decision|22|||
25054100|NCT04003389|50157817|FG001|Overall Study|Participant did not receive study drug|0|||
25054101|NCT04003389|50157818|FG002|Overall Study|Participant did not receive study drug|0|||
25054102|NCT00702962|50157828|FG000|Overall Study|Progressive disease|0|||
25054103|NCT00702962|50157829|FG001|Overall Study|Progressive disease|1|||
25054104|NCT00702962|50157828|FG000|Overall Study|Hospitalized for other health disorder|1|||
25054105|NCT00702962|50157829|FG001|Overall Study|Hospitalized for other health disorder|0|||
25054106|NCT01379508|50157841|FG000|Treatment to Week 104|Adverse Event|2|||
25054107|NCT01379508|50157842|FG001|Treatment to Week 104|Adverse Event|0|||
25054108|NCT01379508|50157843|FG002|Treatment to Week 104|Adverse Event|5|||
25054109|NCT01379508|50157844|FG003|Treatment to Week 104|Adverse Event|0|||
25054110|NCT01379508|50157841|FG000|Treatment to Week 104|Abnormal lab value|1|||
25054111|NCT01379508|50157842|FG001|Treatment to Week 104|Abnormal lab value|0|||
25054112|NCT01379508|50157843|FG002|Treatment to Week 104|Abnormal lab value|0|||
25054113|NCT01379508|50157844|FG003|Treatment to Week 104|Abnormal lab value|0|||
25162689|NCT01996709|50284969|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
24962561|NCT00458393|50052686|FG000|Overall Study|Relocated|77|||
25054114|NCT01379508|50157841|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
25054115|NCT01379508|50157842|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
25054116|NCT01379508|50157843|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
25054117|NCT01379508|50157844|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
25054118|NCT01379508|50157841|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
25054119|NCT01379508|50157842|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
25054120|NCT01379508|50157843|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
25054121|NCT01379508|50157844|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
25054122|NCT01379508|50157841|FG000|Treatment to Week 104|Lost to Follow-up|5|||
25054123|NCT01379508|50157842|FG001|Treatment to Week 104|Lost to Follow-up|0|||
25054124|NCT01379508|50157843|FG002|Treatment to Week 104|Lost to Follow-up|3|||
25054125|NCT01379508|50157844|FG003|Treatment to Week 104|Lost to Follow-up|0|||
25054126|NCT01379508|50157841|FG000|Treatment to Week 104|Administrative problems|3|||
25054127|NCT01379508|50157842|FG001|Treatment to Week 104|Administrative problems|1|||
25054128|NCT01379508|50157843|FG002|Treatment to Week 104|Administrative problems|0|||
25054129|NCT01379508|50157844|FG003|Treatment to Week 104|Administrative problems|0|||
25054130|NCT01379508|50157841|FG000|Treatment to Week 104|Protocol Violation|1|||
25054131|NCT01379508|50157842|FG001|Treatment to Week 104|Protocol Violation|1|||
25054132|NCT01379508|50157843|FG002|Treatment to Week 104|Protocol Violation|1|||
25054133|NCT01379508|50157844|FG003|Treatment to Week 104|Protocol Violation|0|||
25054134|NCT01379508|50157841|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
25054135|NCT01379508|50157842|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
25054136|NCT01379508|50157843|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
25054137|NCT01379508|50157844|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
25054138|NCT01379508|50157841|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
25054139|NCT01379508|50157842|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
25054140|NCT01379508|50157843|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
25054141|NCT01379508|50157844|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
24962562|NCT00458393|50052687|FG001|Overall Study|Relocated|81|||
24962563|NCT00458393|50052686|FG000|Overall Study|Lost to Follow-up|115|||
24962564|NCT00458393|50052687|FG001|Overall Study|Lost to Follow-up|92|||
24962565|NCT00458393|50052686|FG000|Overall Study|Sites marked other on the form.|19|||
24962566|NCT00458393|50052687|FG001|Overall Study|Sites marked other on the form.|20|||
25054142|NCT01379508|50157841|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
25054143|NCT01379508|50157842|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
25054144|NCT01379508|50157843|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
25054145|NCT01379508|50157844|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
25054146|NCT01379508|50157841|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
25054147|NCT01379508|50157842|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
25054148|NCT01379508|50157843|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
25054149|NCT01379508|50157844|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
25054150|NCT02722928|50157860|FG000|Overall Study|Standard CT was not as required per prot|5|||
25054151|NCT02722928|50157861|FG001|Overall Study|Standard CT was not as required per prot|13|||
25054152|NCT02722928|50157860|FG000|Overall Study|Required Intraoperative MRI|5|||
25054153|NCT02722928|50157861|FG001|Overall Study|Required Intraoperative MRI|7|||
25276606|NCT01061151|50590563|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
25276607|NCT01061151|50590564|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
25054157|NCT02722304|50157880|FG000|Overall Study|Study Terminated by Sponsor|1|||
25054158|NCT02722304|50157881|FG001|Overall Study|Study Terminated by Sponsor|0|||
25054159|NCT02722304|50157882|FG002|Overall Study|Study Terminated by Sponsor|2|||
25054160|NCT02722304|50157883|FG003|Overall Study|Study Terminated by Sponsor|1|||
25054161|NCT02722304|50157884|FG004|Overall Study|Study Terminated by Sponsor|1|||
25054162|NCT02722304|50157880|FG000|Overall Study|Other|0|||
25054163|NCT02722304|50157881|FG001|Overall Study|Other|0|||
25054164|NCT02722304|50157882|FG002|Overall Study|Other|0|||
25054165|NCT02722304|50157883|FG003|Overall Study|Other|1|||
25054166|NCT02722304|50157884|FG004|Overall Study|Other|1|||
25054167|NCT00709956|50157900|FG000|Overall Study|Withdrawal by Subject|1|||
25054168|NCT00709956|50157901|FG001|Overall Study|Withdrawal by Subject|1|||
25054169|NCT00709956|50157900|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
25054170|NCT00709956|50157901|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
25054171|NCT02719028|50157931|FG000|Overall Study|Adverse Event|2|||
25054172|NCT02719028|50157932|FG001|Overall Study|Adverse Event|1|||
25054173|NCT02719028|50157933|FG002|Overall Study|Adverse Event|4|||
25054174|NCT02719028|50157934|FG003|Overall Study|Adverse Event|8|||
25054175|NCT02719028|50157931|FG000|Overall Study|Physician Decision|0|||
25054176|NCT02719028|50157932|FG001|Overall Study|Physician Decision|1|||
25054177|NCT02719028|50157933|FG002|Overall Study|Physician Decision|1|||
25054178|NCT02719028|50157934|FG003|Overall Study|Physician Decision|1|||
25054179|NCT02719028|50157931|FG000|Overall Study|Use of prohibited medication|0|||
25054180|NCT02719028|50157932|FG001|Overall Study|Use of prohibited medication|0|||
25162690|NCT01996319|50284994|FG000|Overall Study|Protocol Violation|1|||
25162691|NCT01996319|50284995|FG001|Overall Study|Protocol Violation|0|||
25054181|NCT02719028|50157933|FG002|Overall Study|Use of prohibited medication|1|||
25054182|NCT02719028|50157934|FG003|Overall Study|Use of prohibited medication|0|||
25054183|NCT02719028|50157931|FG000|Overall Study|Protocol Violation|0|||
25054184|NCT02719028|50157932|FG001|Overall Study|Protocol Violation|0|||
25054185|NCT02719028|50157933|FG002|Overall Study|Protocol Violation|0|||
25054186|NCT02719028|50157934|FG003|Overall Study|Protocol Violation|1|||
25054187|NCT02720510|50157946|FG000|Overall Study|Study Terminated by the sponsor|2|||
25054188|NCT02720510|50157947|FG001|Overall Study|Study Terminated by the sponsor|0|||
25054189|NCT02720510|50157946|FG000|Overall Study|Adverse Event|0|||
25054190|NCT02720510|50157947|FG001|Overall Study|Adverse Event|1|||
25054191|NCT02720510|50157946|FG000|Overall Study|Physician Decision|1|||
25054192|NCT02720510|50157947|FG001|Overall Study|Physician Decision|2|||
25054193|NCT02720198|50157955|FG000|Overall Study|Withdrawal by Subject|0|||
25054194|NCT02720198|50157956|FG001|Overall Study|Withdrawal by Subject|1|||
25054195|NCT00703118|50157978|FG000|Overall Study|Adverse Event|1|||
25054196|NCT00703118|50157979|FG001|Overall Study|Adverse Event|2|||
25054197|NCT00703118|50157980|FG002|Overall Study|Adverse Event|2|||
25054198|NCT00703118|50157978|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
25054199|NCT00703118|50157979|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
25054200|NCT00703118|50157980|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
25054201|NCT00703118|50157978|FG000|Overall Study|Lost to Follow-up|6|||
25054202|NCT00703118|50157979|FG001|Overall Study|Lost to Follow-up|4|||
25054203|NCT00703118|50157980|FG002|Overall Study|Lost to Follow-up|4|||
25054204|NCT00703118|50157978|FG000|Overall Study|Withdrawal by Subject|8|||
25054205|NCT00703118|50157979|FG001|Overall Study|Withdrawal by Subject|7|||
25054206|NCT00703118|50157980|FG002|Overall Study|Withdrawal by Subject|13|||
25054207|NCT00703118|50157978|FG000|Overall Study|Other|0|||
25054208|NCT00703118|50157979|FG001|Overall Study|Other|0|||
24962567|NCT00310856|50052698|FG000|Overall Study|Withdrawal by Subject|2|||
24962568|NCT00310856|50052699|FG001|Overall Study|Withdrawal by Subject|2|||
24962569|NCT00310856|50052700|FG002|Overall Study|Withdrawal by Subject|2|||
24962570|NCT00310856|50052698|FG000|Overall Study|Lost to Follow-up|1|||
24962571|NCT00310856|50052699|FG001|Overall Study|Lost to Follow-up|2|||
24962572|NCT00310856|50052700|FG002|Overall Study|Lost to Follow-up|6|||
24962573|NCT00310856|50052698|FG000|Overall Study|Inappropriate enrollment|1|||
24962574|NCT00310856|50052699|FG001|Overall Study|Inappropriate enrollment|1|||
25054209|NCT00703118|50157980|FG002|Overall Study|Other|1|||
25054210|NCT00909753|50158002|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
25054211|NCT00909753|50158003|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
25054212|NCT00909753|50158002|FG000|Period: Second Intervention|Protocol Violation|1|||
24962575|NCT00310856|50052700|FG002|Overall Study|Inappropriate enrollment|0|||
24962576|NCT00310856|50052698|FG000|Overall Study|Unable to classify|1|||
25054213|NCT00909753|50158003|FG001|Period: Second Intervention|Protocol Violation|0|||
25054214|NCT03745638|50158010|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
25054215|NCT03745638|50158011|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
25054216|NCT03745638|50158012|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
25054217|NCT03745638|50158013|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
25054218|NCT03745638|50158014|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
25054219|NCT03745638|50158015|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
25054220|NCT03745638|50158016|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
25054221|NCT03745638|50158010|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
25054222|NCT03745638|50158011|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25054223|NCT03745638|50158012|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25054224|NCT03745638|50158013|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25162692|NCT01996319|50284994|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
25162693|NCT01996319|50284995|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
24962577|NCT00310856|50052699|FG001|Overall Study|Unable to classify|0|||
24962578|NCT00310856|50052700|FG002|Overall Study|Unable to classify|0|||
24962579|NCT00283712|50052711|FG000|Overall Study|Death|0|||
24962580|NCT00283712|50052712|FG001|Overall Study|Death|1|||
24962581|NCT00048724|50052720|FG000|Overall Study|Adverse Event|53|||
24962582|NCT00048724|50052721|FG001|Overall Study|Adverse Event|12|||
24962583|NCT00048724|50052720|FG000|Overall Study|Withdrawal by Subject|34|||
24962584|NCT00048724|50052721|FG001|Overall Study|Withdrawal by Subject|54|||
24962585|NCT00048724|50052720|FG000|Overall Study|Lost to Follow-up|5|||
24962586|NCT00048724|50052721|FG001|Overall Study|Lost to Follow-up|5|||
24962587|NCT00048724|50052720|FG000|Overall Study|Protocol-defined Clinical Event|17|||
24962588|NCT00048724|50052721|FG001|Overall Study|Protocol-defined Clinical Event|32|||
24962589|NCT00048724|50052720|FG000|Overall Study|Noncompliance With Protocol|4|||
24962590|NCT00048724|50052721|FG001|Overall Study|Noncompliance With Protocol|12|||
24962591|NCT00048724|50052720|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
24962592|NCT00048724|50052721|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
24962593|NCT00048724|50052720|FG000|Overall Study|Administrative|1|||
24962594|NCT00048724|50052721|FG001|Overall Study|Administrative|1|||
24962595|NCT00449033|50052729|FG000|Treatment Period|Adverse Event|117|||
24962596|NCT00449033|50052730|FG001|Treatment Period|Adverse Event|83|||
24962597|NCT00449033|50052729|FG000|Treatment Period|Death|21|||
24962598|NCT00449033|50052730|FG001|Treatment Period|Death|12|||
24962599|NCT00449033|50052729|FG000|Treatment Period|Lost to Follow-up|0|||
24962600|NCT00449033|50052730|FG001|Treatment Period|Lost to Follow-up|2|||
24962601|NCT00449033|50052729|FG000|Treatment Period|Physician Decision|4|||
24962602|NCT00449033|50052730|FG001|Treatment Period|Physician Decision|5|||
24962603|NCT00449033|50052729|FG000|Treatment Period|Protocol Violation|8|||
24962604|NCT00449033|50052730|FG001|Treatment Period|Protocol Violation|7|||
24962605|NCT00449033|50052729|FG000|Treatment Period|Disease Progression|231|||
24962606|NCT00449033|50052730|FG001|Treatment Period|Disease Progression|288|||
24962607|NCT00449033|50052729|FG000|Treatment Period|Consent Withdrawn|36|||
24962608|NCT00449033|50052730|FG001|Treatment Period|Consent Withdrawn|20|||
24962609|NCT00449033|50052729|FG000|Treatment Period|Amended Protocol Criteria|22|||
24962610|NCT00449033|50052730|FG001|Treatment Period|Amended Protocol Criteria|18|||
24962611|NCT00449033|50052729|FG000|Treatment Period|Non-compliance|7|||
24962612|NCT00449033|50052730|FG001|Treatment Period|Non-compliance|8|||
24962613|NCT00449033|50052729|FG000|Treatment Period|Second Malignancy|0|||
24962614|NCT00449033|50052730|FG001|Treatment Period|Second Malignancy|1|||
24962615|NCT00449033|50052729|FG000|Treatment Period|Reason Missing|0|||
24962616|NCT00449033|50052730|FG001|Treatment Period|Reason Missing|4|||
24962617|NCT00449033|50052729|FG000|Treatment Period|Treatment Ongoing|6|||
24962618|NCT00449033|50052730|FG001|Treatment Period|Treatment Ongoing|4|||
24962619|NCT00449033|50052729|FG000|Follow-up Period|Death|299|||
24962620|NCT00449033|50052730|FG001|Follow-up Period|Death|311|||
24962621|NCT00449033|50052729|FG000|Follow-up Period|Lost to Follow-up|6|||
24962622|NCT00449033|50052730|FG001|Follow-up Period|Lost to Follow-up|10|||
24962623|NCT00449033|50052729|FG000|Follow-up Period|Reason Missing|120|||
25054225|NCT03745638|50158014|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25054226|NCT03745638|50158015|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25054227|NCT03745638|50158016|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25054228|NCT03745638|50158010|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
25162694|NCT01996319|50284994|FG000|Overall Study|Adverse Event|2|||
24962624|NCT00449033|50052730|FG001|Follow-up Period|Reason Missing|113|||
24962625|NCT00448019|50052736|FG000|Overall Study|Withdrawal by Subject|3|||
24962626|NCT00448019|50052736|FG000|Overall Study|Disease progression|1|||
24962627|NCT00448019|50052736|FG000|Overall Study|Death|2|||
24962628|NCT00448019|50052736|FG000|Overall Study|Insurance Issues|1|||
24962629|NCT00457691|50052742|FG000|Overall Study|Adverse Event|4|||
24962630|NCT00457691|50052743|FG001|Overall Study|Adverse Event|1|||
24962631|NCT00457691|50052742|FG000|Overall Study|Death|163|||
24962632|NCT00457691|50052743|FG001|Overall Study|Death|148|||
24962633|NCT00457691|50052742|FG000|Overall Study|Protocol Violation|1|||
24962634|NCT00457691|50052743|FG001|Overall Study|Protocol Violation|3|||
24962635|NCT00457691|50052742|FG000|Overall Study|Lost to Follow-up|23|||
24962636|NCT00457691|50052743|FG001|Overall Study|Lost to Follow-up|14|||
24962637|NCT00457691|50052742|FG000|Overall Study|Study terminated by Sponsor|1|||
24962638|NCT00457691|50052743|FG001|Overall Study|Study terminated by Sponsor|1|||
24962639|NCT00457691|50052742|FG000|Overall Study|Subject refused (reason other than AE)|14|||
24962640|NCT00457691|50052743|FG001|Overall Study|Subject refused (reason other than AE)|19|||
24962641|NCT00457691|50052742|FG000|Overall Study|Disease progression, study terminated|180|||
24962642|NCT00457691|50052743|FG001|Overall Study|Disease progression, study terminated|196|||
24962643|NCT00457301|50052751|FG000|Overall Study|Withdrawal by Subject|3|||
24962644|NCT00457301|50052752|FG001|Overall Study|Withdrawal by Subject|3|||
24962645|NCT00457301|50052751|FG000|Overall Study|Censored out of the study|15|||
24962646|NCT00457301|50052752|FG001|Overall Study|Censored out of the study|14|||
25054229|NCT03745638|50158011|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
25054230|NCT03745638|50158012|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
25054231|NCT03745638|50158013|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25054232|NCT03745638|50158014|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25054233|NCT03745638|50158015|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25054234|NCT03745638|50158016|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25162695|NCT01996319|50284995|FG001|Overall Study|Adverse Event|2|||
25162696|NCT01279486|50285001|FG000|Overall Study|Lost to Follow-up|1|||
24962647|NCT00457301|50052751|FG000|Overall Study|Death|5|||
24962648|NCT00457301|50052752|FG001|Overall Study|Death|7|||
24962649|NCT00456755|50052760|FG000|Overall Study|Lost to Follow-up|2|||
24962650|NCT00456755|50052761|FG001|Overall Study|Lost to Follow-up|1|||
24962651|NCT00447005|50052767|FG000|Overall Study|Adverse Event|1|||
24962652|NCT00447005|50052767|FG000|Overall Study|Lack of Efficacy|11|||
24962653|NCT00446849|50052771|FG000|Acute Phase|Lack of Efficacy|64|||
24962654|NCT00446849|50052771|FG000|Acute Phase|Protocol Violation|10|||
25054235|NCT03745638|50158010|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
25054236|NCT03745638|50158011|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
25054237|NCT03745638|50158012|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
25054238|NCT03745638|50158013|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
25054239|NCT03745638|50158014|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
25054240|NCT03745638|50158015|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
25054241|NCT03745638|50158016|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
25054242|NCT03745638|50158010|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
25054243|NCT03745638|50158011|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
25054244|NCT03745638|50158012|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
25054245|NCT03745638|50158013|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
25054246|NCT03745638|50158014|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
25054247|NCT03745638|50158015|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
25054248|NCT03745638|50158016|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
25054249|NCT03745638|50158010|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
25054250|NCT03745638|50158011|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
25054251|NCT03745638|50158012|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
25054252|NCT03745638|50158013|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
25054253|NCT03745638|50158014|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
25054254|NCT03745638|50158015|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
25054255|NCT03745638|50158016|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
25054256|NCT03745638|50158010|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
25054257|NCT03745638|50158011|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
25054258|NCT03745638|50158012|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
25054259|NCT03745638|50158013|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
25054260|NCT03745638|50158014|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
25054261|NCT03745638|50158015|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
25054262|NCT03745638|50158016|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
25054263|NCT03745638|50158010|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
25054264|NCT03745638|50158011|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
25054265|NCT03745638|50158012|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
25054266|NCT03745638|50158013|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
25054267|NCT03745638|50158014|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
25054268|NCT03745638|50158015|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
25054269|NCT03745638|50158016|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
25054270|NCT03745638|50158010|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
25054271|NCT03745638|50158011|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
25054272|NCT03745638|50158012|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
25054273|NCT03745638|50158013|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
25054274|NCT03745638|50158014|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
25054275|NCT03745638|50158015|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
25054276|NCT03745638|50158016|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
25054277|NCT03745638|50158010|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
25054278|NCT03745638|50158011|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
25054279|NCT03745638|50158012|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
25054280|NCT03745638|50158013|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
25054281|NCT03745638|50158014|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
25054282|NCT03745638|50158015|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
25054283|NCT03745638|50158016|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
25054284|NCT03745638|50158010|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
25054285|NCT03745638|50158011|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
25054286|NCT03745638|50158012|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
25054287|NCT03745638|50158013|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
25054288|NCT03745638|50158014|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
25054289|NCT03745638|50158015|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
25054290|NCT03745638|50158016|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
25054291|NCT03745638|50158010|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
25054292|NCT03745638|50158011|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
25162697|NCT01279954|50285007|FG000|Overall Study|Lack of Efficacy|3|||
25162698|NCT01279954|50285008|FG001|Overall Study|Lack of Efficacy|4|||
25054293|NCT03745638|50158012|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
25054294|NCT03745638|50158013|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
25162699|NCT01278862|50285019|FG000|Overall Study|Lost to Follow-up|1|||
25054295|NCT03745638|50158014|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
25054296|NCT03745638|50158015|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
25054297|NCT03745638|50158016|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
25054298|NCT03745638|50158010|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
25054299|NCT03745638|50158011|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
25054300|NCT03745638|50158012|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
25054301|NCT03745638|50158013|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
25054302|NCT03745638|50158014|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
25054303|NCT03745638|50158015|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
25054304|NCT03745638|50158016|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
25054305|NCT03745638|50158010|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
25054306|NCT03745638|50158011|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
25054307|NCT03745638|50158012|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
25054308|NCT03745638|50158013|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
25054309|NCT03745638|50158014|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
25054310|NCT03745638|50158015|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
25054311|NCT03745638|50158016|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
25054312|NCT03745638|50158010|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
25054313|NCT03745638|50158011|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
25054314|NCT03745638|50158012|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
25054315|NCT03745638|50158013|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
25054316|NCT03745638|50158014|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
25054317|NCT03745638|50158015|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
25054318|NCT03745638|50158016|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
25054319|NCT03715764|50158035|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
25054320|NCT03715764|50158036|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
25054321|NCT03715764|50158035|FG000|3 Month Follow-up|Lost to Follow-up|2|||
25054322|NCT03715764|50158036|FG001|3 Month Follow-up|Lost to Follow-up|2|||
25054323|NCT03715764|50158035|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
25054324|NCT03715764|50158036|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
25054325|NCT03715764|50158035|FG000|6 Month Follow-up|Lost to Follow-up|3|||
25054326|NCT03715764|50158036|FG001|6 Month Follow-up|Lost to Follow-up|0|||
25054327|NCT03715764|50158035|FG000|12 Month Follow-up|Lost to Follow-up|2|||
25054328|NCT03715764|50158036|FG001|12 Month Follow-up|Lost to Follow-up|3|||
25054329|NCT03715764|50158035|FG000|12 Month Follow-up|Pregnancy|0|||
25054330|NCT03715764|50158036|FG001|12 Month Follow-up|Pregnancy|1|||
25054331|NCT03715764|50158035|FG000|12 Month Follow-up|Surgery|2|||
25054332|NCT03715764|50158036|FG001|12 Month Follow-up|Surgery|0|||
25054333|NCT03715764|50158035|FG000|12 Month Follow-up|Wrong address|1|||
25054334|NCT03715764|50158036|FG001|12 Month Follow-up|Wrong address|0|||
25054335|NCT03715764|50158035|FG000|12 Month Follow-up|No symptoms|1|||
25054336|NCT03715764|50158036|FG001|12 Month Follow-up|No symptoms|0|||
25054337|NCT03715764|50158035|FG000|12 Month Follow-up|Changed primary care centre|0|||
25054338|NCT03715764|50158036|FG001|12 Month Follow-up|Changed primary care centre|1|||
25054339|NCT02718326|50158045|FG000|Overall Study|Adverse Event|4|||
25054340|NCT02718326|50158046|FG001|Overall Study|Adverse Event|9|||
25054341|NCT02718326|50158047|FG002|Overall Study|Adverse Event|0|||
25054342|NCT02718326|50158045|FG000|Overall Study|Death|8|||
25054343|NCT02718326|50158046|FG001|Overall Study|Death|1|||
25054344|NCT02718326|50158047|FG002|Overall Study|Death|2|||
25054345|NCT02718326|50158045|FG000|Overall Study|Withdrawal by Subject|4|||
25054346|NCT02718326|50158046|FG001|Overall Study|Withdrawal by Subject|9|||
24962655|NCT00446849|50052771|FG000|Acute Phase|Consent withdrawn|4|||
25054347|NCT02718326|50158047|FG002|Overall Study|Withdrawal by Subject|6|||
25054348|NCT02718326|50158045|FG000|Overall Study|Lost to Follow-up|18|||
25054349|NCT02718326|50158046|FG001|Overall Study|Lost to Follow-up|5|||
25054350|NCT02718326|50158047|FG002|Overall Study|Lost to Follow-up|14|||
25054351|NCT02718326|50158045|FG000|Overall Study|Protocol Deviation|1|||
25054352|NCT02718326|50158046|FG001|Overall Study|Protocol Deviation|0|||
25162700|NCT01278862|50285020|FG001|Overall Study|Lost to Follow-up|1|||
24962656|NCT00446849|50052771|FG000|Acute Phase|Lost to Follow-up|2|||
24962657|NCT00446849|50052771|FG000|Acute Phase|Physician Decision|1|||
24962658|NCT00446849|50052771|FG000|Acute Phase|noncompliance|1|||
24962659|NCT00446849|50052771|FG000|Maintenance Phase|Lack of Efficacy|40|||
24962660|NCT00446849|50052771|FG000|Maintenance Phase|Protocol Violation|7|||
24962661|NCT00446849|50052771|FG000|Maintenance Phase|Adverse Event|6|||
24962662|NCT00446849|50052771|FG000|Maintenance Phase|Consent withdrawn|5|||
24962663|NCT00446849|50052771|FG000|Maintenance Phase|Lost to Follow-up|3|||
24962664|NCT00446849|50052771|FG000|Maintenance Phase|Pregnancy|1|||
24962665|NCT00446849|50052771|FG000|Maintenance Phase|noncompliance|2|||
24962666|NCT00446849|50052771|FG000|Maintenance Phase|prohibited medication use|2|||
24962667|NCT00446849|50052771|FG000|Maintenance Phase|antibiotic use|1|||
24962668|NCT00446849|50052771|FG000|Maintenance Phase|study closure|1|||
24962669|NCT00446849|50052771|FG000|Maintenance Phase|hydrocodone use|1|||
24962670|NCT00446849|50052771|FG000|Maintenance Phase|concomitant medication use|1|||
24962671|NCT00446459|50052776|FG000|8 Months|Protocol Violation|12|||
24962672|NCT00446459|50052776|FG000|12 Months|Protocol Violation|4|||
24962673|NCT00446459|50052776|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
24962674|NCT00456599|50052780|FG000|Overall Study|Non-compliance|1|||
24962675|NCT00456599|50052780|FG000|Overall Study|Withdrawal by Subject|2|||
24962676|NCT00456521|50052786|FG000|Overall Study|Adverse Event|150|||
24962677|NCT00456521|50052787|FG001|Overall Study|Adverse Event|25|||
24962678|NCT00456521|50052786|FG000|Overall Study|Withdrawal by Subject|43|||
24962679|NCT00456521|50052787|FG001|Overall Study|Withdrawal by Subject|24|||
24962680|NCT00456521|50052786|FG000|Overall Study|Lost to Follow-up|22|||
24962681|NCT00456521|50052787|FG001|Overall Study|Lost to Follow-up|17|||
24962682|NCT00456521|50052786|FG000|Overall Study|Lack of Efficacy|3|||
24962683|NCT00456521|50052787|FG001|Overall Study|Lack of Efficacy|6|||
24962684|NCT00456521|50052786|FG000|Overall Study|Protocol Violation|4|||
24962685|NCT00456521|50052787|FG001|Overall Study|Protocol Violation|0|||
24962686|NCT00456521|50052786|FG000|Overall Study|Pregnancy|1|||
24962687|NCT00456521|50052787|FG001|Overall Study|Pregnancy|1|||
24962688|NCT00456521|50052786|FG000|Overall Study|Drug non-compliance, moved, other|26|||
24962689|NCT00456521|50052787|FG001|Overall Study|Drug non-compliance, moved, other|11|||
24962690|NCT00456365|50052796|FG000|Overall Study|Lost to Follow-up|1|||
24962691|NCT00456365|50052797|FG001|Overall Study|Lost to Follow-up|3|||
24962692|NCT00456365|50052796|FG000|Overall Study|Withdrawal by Subject|4|||
24962693|NCT00456365|50052797|FG001|Overall Study|Withdrawal by Subject|7|||
24962694|NCT00456365|50052796|FG000|Overall Study|Pregnancy|1|||
24962695|NCT00456365|50052797|FG001|Overall Study|Pregnancy|1|||
24962696|NCT00456365|50052796|FG000|Overall Study|oncologic diagnosis|1|||
24962697|NCT00456365|50052797|FG001|Overall Study|oncologic diagnosis|1|||
24962698|NCT00455741|50052807|FG000|Overall Study|Physician Decision|0|||
24962699|NCT00455741|50052808|FG001|Overall Study|Physician Decision|1|||
24962700|NCT00445679|50052828|FG000|Overall Study|Adverse Event|22|||
24962701|NCT00445679|50052829|FG001|Overall Study|Adverse Event|12|||
24962702|NCT00445679|50052830|FG002|Overall Study|Adverse Event|30|||
24962703|NCT00445679|50052831|FG003|Overall Study|Adverse Event|19|||
24962704|NCT00445679|50052828|FG000|Overall Study|Failed to return|1|||
24962705|NCT00445679|50052829|FG001|Overall Study|Failed to return|3|||
24962706|NCT00445679|50052830|FG002|Overall Study|Failed to return|2|||
24962707|NCT00445679|50052831|FG003|Overall Study|Failed to return|2|||
24962708|NCT00445679|50052828|FG000|Overall Study|Physician Decision|0|||
24962709|NCT00445679|50052829|FG001|Overall Study|Physician Decision|0|||
24962710|NCT00445679|50052830|FG002|Overall Study|Physician Decision|1|||
24962711|NCT00445679|50052831|FG003|Overall Study|Physician Decision|0|||
24962712|NCT00445679|50052828|FG000|Overall Study|Lost to Follow-up|10|||
24962713|NCT00445679|50052829|FG001|Overall Study|Lost to Follow-up|6|||
24962714|NCT00445679|50052830|FG002|Overall Study|Lost to Follow-up|6|||
24962715|NCT00445679|50052831|FG003|Overall Study|Lost to Follow-up|5|||
24962716|NCT00445679|50052828|FG000|Overall Study|Compliance|3|||
24962717|NCT00445679|50052829|FG001|Overall Study|Compliance|2|||
24962718|NCT00445679|50052830|FG002|Overall Study|Compliance|1|||
24962719|NCT00445679|50052831|FG003|Overall Study|Compliance|2|||
24962720|NCT00445679|50052828|FG000|Overall Study|Withdrawal of Informed Consent|0|||
24962721|NCT00445679|50052829|FG001|Overall Study|Withdrawal of Informed Consent|0|||
24962722|NCT00445679|50052830|FG002|Overall Study|Withdrawal of Informed Consent|1|||
24962723|NCT00445679|50052831|FG003|Overall Study|Withdrawal of Informed Consent|0|||
24962724|NCT00445679|50052828|FG000|Overall Study|Protocol Violation|2|||
24962725|NCT00445679|50052829|FG001|Overall Study|Protocol Violation|3|||
25054353|NCT02718326|50158047|FG002|Overall Study|Protocol Deviation|0|||
24962726|NCT00445679|50052830|FG002|Overall Study|Protocol Violation|3|||
24962727|NCT00445679|50052831|FG003|Overall Study|Protocol Violation|1|||
24962728|NCT00445679|50052828|FG000|Overall Study|Withdrawal by Subject|8|||
24962729|NCT00445679|50052829|FG001|Overall Study|Withdrawal by Subject|14|||
24962730|NCT00445679|50052830|FG002|Overall Study|Withdrawal by Subject|20|||
24962731|NCT00445679|50052831|FG003|Overall Study|Withdrawal by Subject|18|||
24962732|NCT00445679|50052828|FG000|Overall Study|Lack of Efficacy|2|||
24962733|NCT00445679|50052829|FG001|Overall Study|Lack of Efficacy|6|||
25054354|NCT02718326|50158045|FG000|Overall Study|Pregnancy|1|||
24962734|NCT00445679|50052830|FG002|Overall Study|Lack of Efficacy|2|||
24962735|NCT00445679|50052831|FG003|Overall Study|Lack of Efficacy|0|||
24962736|NCT00455429|50052845|FG000|Overall Study|Study Terminated by Sponsor|0|||
24962737|NCT00455429|50052846|FG001|Overall Study|Study Terminated by Sponsor|0|||
24962738|NCT00455429|50052847|FG002|Overall Study|Study Terminated by Sponsor|0|||
24962739|NCT00455429|50052848|FG003|Overall Study|Study Terminated by Sponsor|3|||
24962740|NCT00455429|50052845|FG000|Overall Study|Lost to Follow-up|1|||
24962741|NCT00455429|50052846|FG001|Overall Study|Lost to Follow-up|0|||
24962742|NCT00455429|50052847|FG002|Overall Study|Lost to Follow-up|0|||
24962743|NCT00455429|50052848|FG003|Overall Study|Lost to Follow-up|3|||
24962744|NCT00455429|50052845|FG000|Overall Study|Withdrawal by Subject|0|||
24962745|NCT00455429|50052846|FG001|Overall Study|Withdrawal by Subject|1|||
24962746|NCT00455429|50052847|FG002|Overall Study|Withdrawal by Subject|1|||
24962747|NCT00455429|50052848|FG003|Overall Study|Withdrawal by Subject|0|||
24962748|NCT00455429|50052845|FG000|Overall Study|Lack of Efficacy|0|||
24962749|NCT00455429|50052846|FG001|Overall Study|Lack of Efficacy|1|||
24962750|NCT00455429|50052847|FG002|Overall Study|Lack of Efficacy|0|||
24962751|NCT00455429|50052848|FG003|Overall Study|Lack of Efficacy|1|||
24962752|NCT00455429|50052845|FG000|Overall Study|Adverse Event|0|||
24962753|NCT00455429|50052846|FG001|Overall Study|Adverse Event|1|||
24962754|NCT00455429|50052847|FG002|Overall Study|Adverse Event|0|||
24962755|NCT00455429|50052848|FG003|Overall Study|Adverse Event|3|||
24962756|NCT00455429|50052845|FG000|Overall Study|Randomly assigned but not treated|0|||
24962757|NCT00455429|50052846|FG001|Overall Study|Randomly assigned but not treated|0|||
24962758|NCT00455429|50052847|FG002|Overall Study|Randomly assigned but not treated|0|||
24962759|NCT00455429|50052848|FG003|Overall Study|Randomly assigned but not treated|2|||
24962760|NCT00455429|50052845|FG000|Overall Study|Personal Reason|1|||
24962761|NCT00455429|50052846|FG001|Overall Study|Personal Reason|0|||
24962762|NCT00455429|50052847|FG002|Overall Study|Personal Reason|0|||
24962763|NCT00455429|50052848|FG003|Overall Study|Personal Reason|0|||
24962764|NCT00455429|50052845|FG000|Overall Study|Non-compliance|0|||
24962765|NCT00455429|50052846|FG001|Overall Study|Non-compliance|0|||
24962766|NCT00455429|50052847|FG002|Overall Study|Non-compliance|0|||
24962767|NCT00455429|50052848|FG003|Overall Study|Non-compliance|1|||
24962768|NCT00455429|50052845|FG000|Overall Study|Other|0|||
24962769|NCT00455429|50052846|FG001|Overall Study|Other|2|||
24962770|NCT00455429|50052847|FG002|Overall Study|Other|0|||
24962771|NCT00455429|50052848|FG003|Overall Study|Other|1|||
24962772|NCT00445601|50052863|FG000|Overall Study|Withdrawal by Subject|11|||
24962773|NCT00445601|50052864|FG001|Overall Study|Withdrawal by Subject|11|||
24962774|NCT00445601|50052863|FG000|Overall Study|TURBT Complication|12|||
24962775|NCT00445601|50052864|FG001|Overall Study|TURBT Complication|8|||
24962776|NCT00445601|50052863|FG000|Overall Study|Incorrect Disease Status|6|||
24962777|NCT00445601|50052864|FG001|Overall Study|Incorrect Disease Status|6|||
24962778|NCT00445601|50052863|FG000|Overall Study|Drug Delivery Issue|2|||
24962779|NCT00445601|50052864|FG001|Overall Study|Drug Delivery Issue|2|||
24962780|NCT00445601|50052863|FG000|Overall Study|Adverse Event|2|||
24962781|NCT00445601|50052864|FG001|Overall Study|Adverse Event|0|||
24962782|NCT00445601|50052863|FG000|Overall Study|Death prior to TURBT|0|||
24962783|NCT00445601|50052864|FG001|Overall Study|Death prior to TURBT|1|||
24962784|NCT00444587|50052876|FG000|Overall Study|Death|2|||
24962785|NCT00444587|50052877|FG001|Overall Study|Death|1|||
24962786|NCT00444587|50052876|FG000|Overall Study|Progression of the disease|73|||
24962787|NCT00444587|50052877|FG001|Overall Study|Progression of the disease|8|||
24962788|NCT00444587|50052876|FG000|Overall Study|Refused treatment/did not cooperate|4|||
24962789|NCT00444587|50052877|FG001|Overall Study|Refused treatment/did not cooperate|1|||
24962790|NCT00444587|50052876|FG000|Overall Study|Investigator decision|3|||
24962791|NCT00444587|50052877|FG001|Overall Study|Investigator decision|0|||
24962792|NCT00444587|50052876|FG000|Overall Study|Protocol Violation|1|||
24962793|NCT00444587|50052877|FG001|Overall Study|Protocol Violation|0|||
24962794|NCT00444587|50052876|FG000|Overall Study|Missing|0|||
24962795|NCT00444587|50052877|FG001|Overall Study|Missing|5|||
24962796|NCT00455195|50052887|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
24962797|NCT00455195|50052888|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
24962798|NCT00455195|50052887|FG000|Double-blind Study AGLU02704|Death|1|||
24962799|NCT00455195|50052888|FG001|Double-blind Study AGLU02704|Death|0|||
24962800|NCT00455195|50052887|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
24962801|NCT00455195|50052888|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
24962802|NCT00455195|50052887|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
24962803|NCT00455195|50052888|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
24962804|NCT00235716|50052898|FG000|Overall Study|Death|26|||
24962805|NCT00235716|50052899|FG001|Overall Study|Death|39|||
24962806|NCT00235716|50052900|FG002|Overall Study|Death|32|||
25054355|NCT02718326|50158046|FG001|Overall Study|Pregnancy|0|||
24962807|NCT00235716|50052901|FG003|Overall Study|Death|31|||
24962808|NCT00235716|50052898|FG000|Overall Study|Withdrawal by Subject|23|||
24962809|NCT00235716|50052899|FG001|Overall Study|Withdrawal by Subject|19|||
24962810|NCT00235716|50052900|FG002|Overall Study|Withdrawal by Subject|17|||
25054356|NCT02718326|50158047|FG002|Overall Study|Pregnancy|0|||
25054357|NCT03600714|50158057|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
25054358|NCT02720042|50158096|FG000|Overall Study|Death|3|||
25054359|NCT02720042|50158096|FG000|Overall Study|Lost to Follow-up|4|||
25054360|NCT02720042|50158096|FG000|Overall Study|Withdrawal by Subject|1|||
25054361|NCT02720042|50158096|FG000|Overall Study|Physician Decision|3|||
25054362|NCT02720042|50158096|FG000|Overall Study|Phasix Mesh explanted|1|||
25054363|NCT02720042|50158096|FG000|Overall Study|unable due to non-study-related illness|3|||
25054364|NCT01352793|50158102|FG000|Overall Study|Lost to Follow-up|289|||
25054365|NCT01352793|50158103|FG001|Overall Study|Lost to Follow-up|125|||
25054366|NCT01352793|50158102|FG000|Overall Study|Withdrawal by Subject|120|||
25054367|NCT01352793|50158103|FG001|Overall Study|Withdrawal by Subject|55|||
25054368|NCT01352793|50158102|FG000|Overall Study|Protocol Violation|44|||
25054369|NCT01352793|50158103|FG001|Overall Study|Protocol Violation|23|||
25054370|NCT01352793|50158102|FG000|Overall Study|Adverse Event|44|||
25054371|NCT01352793|50158103|FG001|Overall Study|Adverse Event|10|||
25054372|NCT01352793|50158102|FG000|Overall Study|Physician Decision|1|||
25054373|NCT01352793|50158103|FG001|Overall Study|Physician Decision|0|||
25054374|NCT01352793|50158102|FG000|Overall Study|Pregnancy|26|||
25054375|NCT01352793|50158103|FG001|Overall Study|Pregnancy|8|||
25054376|NCT01352793|50158102|FG000|Overall Study|Other|25|||
25054377|NCT01352793|50158103|FG001|Overall Study|Other|7|||
25054378|NCT01352793|50158102|FG000|Overall Study|Medication error|2|||
25054379|NCT01352793|50158103|FG001|Overall Study|Medication error|2|||
25054380|NCT01352793|50158102|FG000|Overall Study|Death|1|||
25054381|NCT01352793|50158103|FG001|Overall Study|Death|0|||
25054382|NCT01352793|50158102|FG000|Overall Study|Randomized but not vaccinated|8|||
25054383|NCT01352793|50158103|FG001|Overall Study|Randomized but not vaccinated|0|||
25054384|NCT01352793|50158102|FG000|Overall Study|No longer meets eligibility criteria|25|||
25054385|NCT01352793|50158103|FG001|Overall Study|No longer meets eligibility criteria|15|||
25054386|NCT02717546|50158109|FG000|Overall Study|Lost to Follow-up|12|||
25054387|NCT01378962|50158113|FG000|Overall Study|Death|14|||
25054388|NCT01378962|50158113|FG000|Overall Study|Lost to Follow-up|1|||
25054389|NCT01378962|50158113|FG000|Overall Study|Other|2|||
25054390|NCT00890409|50158119|FG000|Overall Study|Lost to Follow-up|20|||
25054391|NCT00890409|50158120|FG001|Overall Study|Lost to Follow-up|21|||
25054392|NCT04495478|50158131|FG000|Overall Study|Withdrawal by Subject|0|||
25054393|NCT04495478|50158132|FG001|Overall Study|Withdrawal by Subject|0|||
25054394|NCT04495478|50158133|FG002|Overall Study|Withdrawal by Subject|0|||
25054395|NCT04495478|50158134|FG003|Overall Study|Withdrawal by Subject|1|||
25054396|NCT04495478|50158135|FG004|Overall Study|Withdrawal by Subject|0|||
25054397|NCT04495478|50158136|FG005|Overall Study|Withdrawal by Subject|0|||
25054398|NCT04495478|50158137|FG006|Overall Study|Withdrawal by Subject|0|||
25054399|NCT04495478|50158131|FG000|Overall Study|Physician Decision|0|||
25054400|NCT04495478|50158132|FG001|Overall Study|Physician Decision|1|||
25054401|NCT04495478|50158133|FG002|Overall Study|Physician Decision|0|||
25054402|NCT04495478|50158134|FG003|Overall Study|Physician Decision|0|||
25054403|NCT04495478|50158135|FG004|Overall Study|Physician Decision|1|||
25054404|NCT04495478|50158136|FG005|Overall Study|Physician Decision|0|||
25054405|NCT04495478|50158137|FG006|Overall Study|Physician Decision|0|||
25054406|NCT00152763|50158163|FG000|Overall Study|Death|4|||
25054407|NCT00152763|50158164|FG001|Overall Study|Death|1|||
25054408|NCT00152763|50158165|FG002|Overall Study|Death|2|||
25054409|NCT00152763|50158166|FG003|Overall Study|Death|1|||
25054410|NCT00152763|50158163|FG000|Overall Study|Lost to Follow-up|6|||
25054411|NCT00152763|50158164|FG001|Overall Study|Lost to Follow-up|4|||
25276608|NCT01061151|50590565|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
25276609|NCT01061151|50590566|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
25276610|NCT01061151|50590563|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
25054412|NCT00152763|50158165|FG002|Overall Study|Lost to Follow-up|2|||
25276611|NCT01061151|50590564|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
25054413|NCT00152763|50158166|FG003|Overall Study|Lost to Follow-up|13|||
25054414|NCT03181542|50158180|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
25054415|NCT03181542|50158181|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
25054416|NCT00806403|50158189|FG000|Overall Study|Death|4|||
25054417|NCT00806403|50158190|FG001|Overall Study|Death|3|||
25054418|NCT00701558|50158207|FG000|Overall Study|Death|7|||
25054419|NCT00701558|50158207|FG000|Overall Study|Lost to Follow-up|8|||
25054420|NCT01663402|50158213|FG000|Overall Study|Randomized but not treated|19|||
25054421|NCT01663402|50158214|FG001|Overall Study|Randomized but not treated|11|||
25054422|NCT01663402|50158213|FG000|Overall Study|Adverse Event|347|||
25054423|NCT01663402|50158214|FG001|Overall Study|Adverse Event|362|||
25054424|NCT01663402|50158213|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
25054425|NCT01663402|50158214|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
25054426|NCT01663402|50158213|FG000|Overall Study|Poor compliance to protocol|529|||
25054427|NCT01663402|50158214|FG001|Overall Study|Poor compliance to protocol|454|||
25054428|NCT01663402|50158213|FG000|Overall Study|Physician Decision|77|||
25054429|NCT01663402|50158214|FG001|Overall Study|Physician Decision|62|||
25054430|NCT01663402|50158213|FG000|Overall Study|Site terminated by sponsor|1|||
25054431|NCT01663402|50158214|FG001|Overall Study|Site terminated by sponsor|3|||
25054432|NCT01663402|50158213|FG000|Overall Study|Participant moved|139|||
25054433|NCT01663402|50158214|FG001|Overall Study|Participant moved|104|||
25054434|NCT01663402|50158213|FG000|Overall Study|Withdrawal by Subject|118|||
25054435|NCT01663402|50158214|FG001|Overall Study|Withdrawal by Subject|91|||
25054436|NCT01663402|50158213|FG000|Overall Study|Related to study drug administration|96|||
25054437|NCT01663402|50158214|FG001|Overall Study|Related to study drug administration|105|||
25054438|NCT01663402|50158213|FG000|Overall Study|Lost to Follow-up|17|||
25054439|NCT01663402|50158214|FG001|Overall Study|Lost to Follow-up|15|||
25054440|NCT01663402|50158213|FG000|Overall Study|Other than specified above|172|||
25054441|NCT01663402|50158214|FG001|Overall Study|Other than specified above|147|||
25054442|NCT00859521|50158231|FG000|Washout|Withdrawal by Subject|0|||
25054443|NCT00859521|50158232|FG001|Washout|Withdrawal by Subject|1|||
25054444|NCT00841815|50158247|FG000|Washout|Withdrawal by Subject|0|||
25054445|NCT00841815|50158248|FG001|Washout|Withdrawal by Subject|1|||
25054446|NCT00841659|50158255|FG000|Washout: 2 Weeks|Protocol Violation|1|||
25054447|NCT00841659|50158256|FG001|Washout: 2 Weeks|Protocol Violation|0|||
25054448|NCT02716298|50158260|FG000|First Intervention (1 Month)|Lens discomfort|1|||
25054449|NCT02716298|50158261|FG001|First Intervention (1 Month)|Lens discomfort|1|||
25054450|NCT00840879|50158274|FG000|Second Intervention|Withdrawal by Subject|1|||
25054451|NCT00840879|50158275|FG001|Second Intervention|Withdrawal by Subject|0|||
25054452|NCT00840411|50158290|FG000|First Intervention|Adverse Event|1|||
25054453|NCT00840411|50158291|FG001|First Intervention|Adverse Event|0|||
25054454|NCT00840411|50158290|FG000|Washout|Withdrawal by Subject|1|||
25054455|NCT00840411|50158291|FG001|Washout|Withdrawal by Subject|0|||
25054456|NCT00836901|50158304|FG000|First Intervention|Withdrawal by Subject|1|||
25054457|NCT00836901|50158305|FG001|First Intervention|Withdrawal by Subject|0|||
25054458|NCT04466384|50158309|FG000|First Phase|Protocol Violation|1|||
25054459|NCT04466384|50158310|FG001|First Phase|Protocol Violation|0|||
25054460|NCT04466384|50158309|FG000|First Phase|Missing data|1|||
25054461|NCT04466384|50158310|FG001|First Phase|Missing data|0|||
25054462|NCT04466384|50158309|FG000|Cross Over Phase|Physician Decision|1|||
25054463|NCT04466384|50158310|FG001|Cross Over Phase|Physician Decision|0|||
25054464|NCT04466384|50158309|FG000|Cross Over Phase|Withdrawal by Subject|0|||
25054465|NCT04466384|50158310|FG001|Cross Over Phase|Withdrawal by Subject|1|||
25054466|NCT03050814|50158321|FG000|Overall Study|Screen failures|0|||
25054467|NCT03050814|50158322|FG001|Overall Study|Screen failures|0|||
25054468|NCT03050814|50158323|FG002|Overall Study|Screen failures|4|||
25054469|NCT00835575|50158331|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
25054470|NCT00835575|50158332|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
25054471|NCT04601194|50158336|FG000|Overall Study|Lost to Follow-up|7|||
25054472|NCT00835263|50158349|FG000|Second Intervention|Adverse Event|1|||
25054473|NCT00835263|50158350|FG001|Second Intervention|Adverse Event|0|||
25054474|NCT01963208|50158388|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
25054475|NCT01963208|50158389|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
25054476|NCT01963208|50158390|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
25054477|NCT01963208|50158391|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
25054478|NCT01963208|50158392|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
25054479|NCT01963208|50158393|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
25054480|NCT01963208|50158388|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
25054481|NCT01963208|50158389|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
25054482|NCT01963208|50158390|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
25054483|NCT01963208|50158391|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
25054484|NCT01963208|50158392|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
25054485|NCT01963208|50158393|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
25054486|NCT01963208|50158388|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
25054487|NCT01963208|50158389|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
25054488|NCT01963208|50158390|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
25054489|NCT01963208|50158391|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
25054490|NCT01963208|50158392|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
25054491|NCT01963208|50158393|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
25054492|NCT01963208|50158388|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
25054493|NCT01963208|50158389|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
25054494|NCT01963208|50158390|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
25054495|NCT01963208|50158391|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
25054496|NCT01963208|50158392|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
25276612|NCT01061151|50590565|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
24962811|NCT00235716|50052901|FG003|Overall Study|Withdrawal by Subject|18|||
25054497|NCT01963208|50158393|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
25054498|NCT01963208|50158388|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
25054499|NCT01963208|50158389|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
25054500|NCT01963208|50158390|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
25054501|NCT01963208|50158391|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
25054502|NCT01963208|50158392|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
25054503|NCT01963208|50158393|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
25054504|NCT01963208|50158388|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
25054505|NCT01963208|50158389|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
25054506|NCT01963208|50158390|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
25054507|NCT01963208|50158391|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
25054508|NCT01963208|50158392|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
25054509|NCT01963208|50158393|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
25054510|NCT01963208|50158388|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
25054511|NCT01963208|50158389|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
25054512|NCT01963208|50158390|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
25054513|NCT01963208|50158391|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
25054514|NCT01963208|50158392|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
25054515|NCT01963208|50158393|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
25054516|NCT01963208|50158388|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
25054517|NCT01963208|50158389|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
25054518|NCT01963208|50158390|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
25054519|NCT01963208|50158391|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
25054520|NCT01963208|50158392|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
25054521|NCT01963208|50158393|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
25054522|NCT01963208|50158388|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
25054523|NCT01963208|50158389|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
25054524|NCT01963208|50158390|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
25054525|NCT01963208|50158391|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
25054526|NCT01963208|50158392|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
25054527|NCT01963208|50158393|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
25054528|NCT01963208|50158388|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
25054529|NCT01963208|50158389|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
25054530|NCT01963208|50158390|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
25054531|NCT01963208|50158391|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
25054532|NCT01963208|50158392|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
25054533|NCT01963208|50158393|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
25054534|NCT01963208|50158388|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
25054535|NCT01963208|50158389|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
25054536|NCT01963208|50158390|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
25054537|NCT01963208|50158391|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
25054538|NCT01963208|50158392|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
25054539|NCT01963208|50158393|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
25054540|NCT01963208|50158388|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
25054541|NCT01963208|50158389|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
25054542|NCT01963208|50158390|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
25054543|NCT01963208|50158391|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
25054544|NCT01963208|50158392|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
25054545|NCT01963208|50158393|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
25054546|NCT01963208|50158388|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
25054547|NCT01963208|50158389|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
25054548|NCT01963208|50158390|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
25054549|NCT01963208|50158391|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
25054550|NCT01963208|50158392|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
25054551|NCT01963208|50158393|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
25054552|NCT01963208|50158388|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
25054553|NCT01963208|50158389|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
25054554|NCT01963208|50158390|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
25054555|NCT01963208|50158391|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
25054556|NCT01963208|50158392|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
25054557|NCT01963208|50158393|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
25054558|NCT00834873|50158405|FG000|First Intervention|Adverse Event|0|||
25054559|NCT00834873|50158406|FG001|First Intervention|Adverse Event|1|||
25054560|NCT01377480|50158414|FG000|Overall Study|Protocol Violation|0|||
25054561|NCT01377480|50158415|FG001|Overall Study|Protocol Violation|0|||
25054562|NCT01377480|50158416|FG002|Overall Study|Protocol Violation|0|||
25054563|NCT01377480|50158417|FG003|Overall Study|Protocol Violation|4|||
25054564|NCT01377480|50158414|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
25054565|NCT01377480|50158415|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
25054566|NCT01377480|50158416|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
25054567|NCT01377480|50158417|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
25054568|NCT01377480|50158414|FG000|Overall Study|Withdrawal by Subject|0|||
25054569|NCT01377480|50158415|FG001|Overall Study|Withdrawal by Subject|0|||
25054570|NCT01377480|50158416|FG002|Overall Study|Withdrawal by Subject|1|||
25054571|NCT01377480|50158417|FG003|Overall Study|Withdrawal by Subject|0|||
25054572|NCT01377480|50158414|FG000|Overall Study|Serious adverse event|0|||
25054573|NCT01377480|50158415|FG001|Overall Study|Serious adverse event|0|||
25054574|NCT01377480|50158416|FG002|Overall Study|Serious adverse event|1|||
25054575|NCT01377480|50158417|FG003|Overall Study|Serious adverse event|1|||
25054576|NCT01377480|50158414|FG000|Overall Study|Other|0|||
25054577|NCT01377480|50158415|FG001|Overall Study|Other|0|||
25054578|NCT01377480|50158416|FG002|Overall Study|Other|7|||
25054579|NCT01377480|50158417|FG003|Overall Study|Other|6|||
25054580|NCT00834795|50158429|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
25054581|NCT00834795|50158430|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
25054582|NCT00834795|50158429|FG000|Second Intervention|Adverse Event|1|||
25054583|NCT00834795|50158430|FG001|Second Intervention|Adverse Event|0|||
25054584|NCT00834717|50158436|FG000|First Intervention|Adverse Event|1|||
25054585|NCT00834717|50158437|FG001|First Intervention|Adverse Event|0|||
25054586|NCT00834717|50158436|FG000|First Intervention|Withdrawal by Subject|0|||
25054587|NCT00834717|50158437|FG001|First Intervention|Withdrawal by Subject|1|||
25054588|NCT00834639|50158443|FG000|Second Intervention|Physician Decision|0|||
25054589|NCT00834639|50158444|FG001|Second Intervention|Physician Decision|2|||
25054590|NCT00834249|50158464|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
25054591|NCT00834249|50158465|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
25054592|NCT00834249|50158464|FG000|Second Intervention|Adverse Event|1|||
25054593|NCT00834249|50158465|FG001|Second Intervention|Adverse Event|0|||
25054594|NCT00833937|50158471|FG000|Washout|Withdrawal by Subject|1|||
25054595|NCT00833937|50158472|FG001|Washout|Withdrawal by Subject|0|||
25054596|NCT00924170|50158478|FG000|Overall Study|Refused further treatment|0|||
25054597|NCT00924170|50158479|FG001|Overall Study|Refused further treatment|1|||
25054598|NCT00924170|50158478|FG000|Overall Study|Physician Decision|0|||
25054599|NCT00924170|50158479|FG001|Overall Study|Physician Decision|1|||
25054600|NCT00924170|50158478|FG000|Overall Study|Progressive disease|3|||
25054601|NCT00924170|50158479|FG001|Overall Study|Progressive disease|6|||
25054602|NCT00924170|50158478|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
25054603|NCT00924170|50158479|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
25054604|NCT00924170|50158478|FG000|Overall Study|Death|1|||
25054605|NCT00924170|50158479|FG001|Overall Study|Death|0|||
25054606|NCT00828321|50158493|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
25054607|NCT00828321|50158494|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
25054608|NCT00828321|50158493|FG000|Second Intervention|Protocol Violation|0|||
25054609|NCT00828321|50158494|FG001|Second Intervention|Protocol Violation|1|||
25054610|NCT01352715|50158500|FG000|Overall Study|Death|3|||
25054611|NCT01352715|50158501|FG001|Overall Study|Death|3|||
25054612|NCT01352715|50158500|FG000|Overall Study|Lost to Follow-up|5|||
25054613|NCT01352715|50158501|FG001|Overall Study|Lost to Follow-up|7|||
25054614|NCT01352715|50158500|FG000|Overall Study|Withdrawal by Subject|4|||
25054615|NCT01352715|50158501|FG001|Overall Study|Withdrawal by Subject|8|||
25186595|NCT02647320|50337195|FG002|Overall Study|Persistent hyperglycemia|1|||
25054616|NCT01352715|50158500|FG000|Overall Study|site closure|16|||
25054617|NCT01352715|50158501|FG001|Overall Study|site closure|15|||
25054618|NCT01352715|50158500|FG000|Overall Study|no final visit in closeout period|15|||
25054619|NCT01352715|50158501|FG001|Overall Study|no final visit in closeout period|12|||
25054620|NCT01352715|50158500|FG000|Overall Study|major ineligibility|2|||
25054621|NCT01352715|50158501|FG001|Overall Study|major ineligibility|1|||
25054622|NCT00919893|50158512|FG000|Overall Study|Protocol Violation|19|||
25054623|NCT00919893|50158513|FG001|Overall Study|Protocol Violation|9|||
25054624|NCT02559622|50158521|FG000|Overall Study|Progressive disease|0|||
25054625|NCT02559622|50158522|FG001|Overall Study|Progressive disease|1|||
25054626|NCT02559622|50158523|FG002|Overall Study|Progressive disease|0|||
25054627|NCT02559622|50158524|FG003|Overall Study|Progressive disease|0|||
25054628|NCT02559622|50158521|FG000|Overall Study|Adverse Event|0|||
25054629|NCT02559622|50158522|FG001|Overall Study|Adverse Event|2|||
25054630|NCT02559622|50158523|FG002|Overall Study|Adverse Event|2|||
25054631|NCT02559622|50158524|FG003|Overall Study|Adverse Event|2|||
25054632|NCT02559622|50158521|FG000|Overall Study|Patient/guardian decision|1|||
25054633|NCT02559622|50158522|FG001|Overall Study|Patient/guardian decision|2|||
25054634|NCT02559622|50158523|FG002|Overall Study|Patient/guardian decision|0|||
25054635|NCT02559622|50158524|FG003|Overall Study|Patient/guardian decision|1|||
25054636|NCT02559310|50158540|FG000|Overall Study|Death|4|||
25054637|NCT02559310|50158541|FG001|Overall Study|Death|3|||
25054638|NCT02559310|50158540|FG000|Overall Study|Lost to Follow-up|5|||
25054639|NCT02559310|50158541|FG001|Overall Study|Lost to Follow-up|3|||
25054640|NCT02559310|50158540|FG000|Overall Study|Physician Decision|2|||
25054641|NCT02559310|50158541|FG001|Overall Study|Physician Decision|1|||
25054642|NCT02559310|50158540|FG000|Overall Study|Withdrawal by Subject|13|||
25054643|NCT02559310|50158541|FG001|Overall Study|Withdrawal by Subject|9|||
25054644|NCT02559310|50158540|FG000|Overall Study|Sponsor Decision|0|||
25054645|NCT02559310|50158541|FG001|Overall Study|Sponsor Decision|1|||
25054646|NCT02559310|50158540|FG000|Overall Study|Randomized but not treated|3|||
25054647|NCT02559310|50158541|FG001|Overall Study|Randomized but not treated|2|||
25054648|NCT03517449|50158549|FG000|Overall Study|Death|184|||
25054649|NCT03517449|50158550|FG001|Overall Study|Death|236|||
25054650|NCT03517449|50158549|FG000|Overall Study|Lost to Follow-up|0|||
25054651|NCT03517449|50158550|FG001|Overall Study|Lost to Follow-up|2|||
25054652|NCT03517449|50158549|FG000|Overall Study|Withdrawal by Subject|7|||
25054653|NCT03517449|50158550|FG001|Overall Study|Withdrawal by Subject|26|||
25054654|NCT03517449|50158549|FG000|Overall Study|Participants Ongoing|220|||
25054655|NCT03517449|50158550|FG001|Overall Study|Participants Ongoing|152|||
25054656|NCT02555878|50158582|FG000|Overall Study|Lost to Follow-up|2|||
25054657|NCT02555878|50158583|FG001|Overall Study|Lost to Follow-up|3|||
25054658|NCT02555878|50158582|FG000|Overall Study|Withdrawal by Subject|48|||
25054659|NCT02555878|50158583|FG001|Overall Study|Withdrawal by Subject|48|||
25054660|NCT02555878|50158582|FG000|Overall Study|Adverse Event|12|||
25054661|NCT02555878|50158583|FG001|Overall Study|Adverse Event|8|||
25054662|NCT02555878|50158582|FG000|Overall Study|Death|74|||
25054663|NCT02555878|50158583|FG001|Overall Study|Death|59|||
25054664|NCT02555878|50158582|FG000|Overall Study|Protocol Violation|1|||
25054665|NCT02555878|50158583|FG001|Overall Study|Protocol Violation|2|||
25054666|NCT02555878|50158582|FG000|Overall Study|Physician Decision|12|||
25054667|NCT02555878|50158583|FG001|Overall Study|Physician Decision|13|||
25054668|NCT02555878|50158582|FG000|Overall Study|Other|17|||
25054669|NCT02555878|50158583|FG001|Overall Study|Other|17|||
25054670|NCT02555722|50158591|FG000|Week 2|Adverse Event|0|||
25054671|NCT02555722|50158592|FG001|Week 2|Adverse Event|1|||
25054672|NCT02555722|50158591|FG000|Week 2|Withdrawal by Subject|1|||
25054673|NCT02555722|50158592|FG001|Week 2|Withdrawal by Subject|0|||
25054674|NCT02555722|50158591|FG000|Month 1|Lens Discomfort|1|||
25054675|NCT02555722|50158592|FG001|Month 1|Lens Discomfort|0|||
25054676|NCT02555722|50158591|FG000|Month 2|Withdrawal by Subject|3|||
25054677|NCT02555722|50158592|FG001|Month 2|Withdrawal by Subject|0|||
25054678|NCT02555722|50158591|FG000|Month 2|Lost to Follow-up|1|||
25054679|NCT02555722|50158592|FG001|Month 2|Lost to Follow-up|0|||
25054680|NCT03287960|50158644|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
25054681|NCT03287960|50158644|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
25054682|NCT02558296|50158651|FG000|Completed the Study Through Week 24|Adverse Event|9|||
25054683|NCT02558296|50158652|FG001|Completed the Study Through Week 24|Adverse Event|3|||
25054684|NCT02558296|50158651|FG000|Completed the Study Through Week 24|Death|7|||
25054685|NCT02558296|50158652|FG001|Completed the Study Through Week 24|Death|7|||
25054686|NCT02558296|50158651|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
25054687|NCT02558296|50158652|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
25054688|NCT02558296|50158651|FG000|Completed the Study Through Week 24|Physician Decision|1|||
25054689|NCT02558296|50158652|FG001|Completed the Study Through Week 24|Physician Decision|0|||
25054690|NCT02558296|50158651|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
25054691|NCT02558296|50158652|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
25054692|NCT02558296|50158651|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
25054693|NCT02558296|50158652|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
25054694|NCT02558296|50158651|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
25054695|NCT02558296|50158652|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
25054696|NCT02558296|50158651|FG000|Completed the Study|Adverse Event|14|||
25054697|NCT02558296|50158652|FG001|Completed the Study|Adverse Event|5|||
25054698|NCT02558296|50158651|FG000|Completed the Study|Death|39|||
25054699|NCT02558296|50158652|FG001|Completed the Study|Death|25|||
25054700|NCT02558296|50158651|FG000|Completed the Study|Lost to Follow-up|31|||
25054701|NCT02558296|50158652|FG001|Completed the Study|Lost to Follow-up|23|||
25054702|NCT02558296|50158651|FG000|Completed the Study|Physician Decision|6|||
25054703|NCT02558296|50158652|FG001|Completed the Study|Physician Decision|0|||
25054704|NCT02558296|50158651|FG000|Completed the Study|Protocol Violation|2|||
25054705|NCT02558296|50158652|FG001|Completed the Study|Protocol Violation|1|||
25054706|NCT02558296|50158651|FG000|Completed the Study|Withdrawal by Subject|53|||
25054707|NCT02558296|50158652|FG001|Completed the Study|Withdrawal by Subject|31|||
25054708|NCT02558296|50158651|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
25054709|NCT02558296|50158652|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
25054710|NCT02737475|50158689|FG000|Overall Study|Other reasons|0|||
25054711|NCT02737475|50158690|FG001|Overall Study|Other reasons|0|||
25054712|NCT02737475|50158691|FG002|Overall Study|Other reasons|0|||
25054713|NCT02737475|50158692|FG003|Overall Study|Other reasons|0|||
25054714|NCT02737475|50158693|FG004|Overall Study|Other reasons|1|||
25054715|NCT02737475|50158694|FG005|Overall Study|Other reasons|1|||
25054716|NCT02737475|50158695|FG006|Overall Study|Other reasons|0|||
25054717|NCT02737475|50158696|FG007|Overall Study|Other reasons|0|||
25054718|NCT02737475|50158697|FG008|Overall Study|Other reasons|1|||
25054719|NCT02737475|50158698|FG009|Overall Study|Other reasons|0|||
25054720|NCT02737475|50158699|FG010|Overall Study|Other reasons|1|||
25054721|NCT02737475|50158700|FG011|Overall Study|Other reasons|0|||
25054722|NCT02737475|50158701|FG012|Overall Study|Other reasons|0|||
25054723|NCT02737475|50158702|FG013|Overall Study|Other reasons|0|||
25054724|NCT02737475|50158703|FG014|Overall Study|Other reasons|0|||
25054725|NCT02737475|50158704|FG015|Overall Study|Other reasons|0|||
25054726|NCT02737475|50158705|FG016|Overall Study|Other reasons|0|||
25054727|NCT02737475|50158706|FG017|Overall Study|Other reasons|0|||
25054728|NCT02737475|50158707|FG018|Overall Study|Other reasons|0|||
25054729|NCT02737475|50158708|FG019|Overall Study|Other reasons|0|||
25054730|NCT02737475|50158709|FG020|Overall Study|Other reasons|0|||
25054731|NCT02737475|50158710|FG021|Overall Study|Other reasons|1|||
25054732|NCT02737475|50158711|FG022|Overall Study|Other reasons|0|||
25054733|NCT02737475|50158712|FG023|Overall Study|Other reasons|1|||
25054734|NCT02737475|50158713|FG024|Overall Study|Other reasons|1|||
25054735|NCT02737475|50158714|FG025|Overall Study|Other reasons|1|||
25054736|NCT02737475|50158715|FG026|Overall Study|Other reasons|0|||
25054737|NCT02737475|50158689|FG000|Overall Study|Death|1|||
25054738|NCT02737475|50158690|FG001|Overall Study|Death|0|||
25054739|NCT02737475|50158691|FG002|Overall Study|Death|0|||
25054740|NCT02737475|50158692|FG003|Overall Study|Death|1|||
25054741|NCT02737475|50158693|FG004|Overall Study|Death|0|||
25054742|NCT02737475|50158694|FG005|Overall Study|Death|0|||
25054743|NCT02737475|50158695|FG006|Overall Study|Death|0|||
25054744|NCT02737475|50158696|FG007|Overall Study|Death|2|||
25054745|NCT02737475|50158697|FG008|Overall Study|Death|0|||
25054746|NCT02737475|50158698|FG009|Overall Study|Death|0|||
25054747|NCT02737475|50158699|FG010|Overall Study|Death|0|||
25054748|NCT02737475|50158700|FG011|Overall Study|Death|4|||
25054749|NCT02737475|50158701|FG012|Overall Study|Death|2|||
25054750|NCT02737475|50158702|FG013|Overall Study|Death|2|||
25054751|NCT02737475|50158703|FG014|Overall Study|Death|0|||
25054752|NCT02737475|50158704|FG015|Overall Study|Death|2|||
25054753|NCT02737475|50158705|FG016|Overall Study|Death|2|||
25054754|NCT02737475|50158706|FG017|Overall Study|Death|2|||
25054755|NCT02737475|50158707|FG018|Overall Study|Death|1|||
25054756|NCT02737475|50158708|FG019|Overall Study|Death|0|||
25054757|NCT02737475|50158709|FG020|Overall Study|Death|0|||
25054758|NCT02737475|50158710|FG021|Overall Study|Death|0|||
25054759|NCT02737475|50158711|FG022|Overall Study|Death|0|||
25054760|NCT02737475|50158712|FG023|Overall Study|Death|0|||
25054761|NCT02737475|50158713|FG024|Overall Study|Death|0|||
25054762|NCT02737475|50158714|FG025|Overall Study|Death|0|||
25054763|NCT02737475|50158715|FG026|Overall Study|Death|0|||
25054764|NCT02737475|50158689|FG000|Overall Study|Participant withdrew consent|0|||
25054765|NCT02737475|50158690|FG001|Overall Study|Participant withdrew consent|0|||
25054766|NCT02737475|50158691|FG002|Overall Study|Participant withdrew consent|0|||
25054767|NCT02737475|50158692|FG003|Overall Study|Participant withdrew consent|0|||
25054768|NCT02737475|50158693|FG004|Overall Study|Participant withdrew consent|0|||
25054769|NCT02737475|50158694|FG005|Overall Study|Participant withdrew consent|2|||
25054770|NCT02737475|50158695|FG006|Overall Study|Participant withdrew consent|0|||
25054771|NCT02737475|50158696|FG007|Overall Study|Participant withdrew consent|0|||
25054772|NCT02737475|50158697|FG008|Overall Study|Participant withdrew consent|0|||
25186596|NCT02647320|50337196|FG003|Overall Study|Persistent hyperglycemia|1|||
25186597|NCT02647320|50337197|FG004|Overall Study|Persistent hyperglycemia|1|||
25054773|NCT02737475|50158698|FG009|Overall Study|Participant withdrew consent|0|||
25054774|NCT02737475|50158699|FG010|Overall Study|Participant withdrew consent|0|||
25054775|NCT02737475|50158700|FG011|Overall Study|Participant withdrew consent|0|||
25054776|NCT02737475|50158701|FG012|Overall Study|Participant withdrew consent|0|||
25054777|NCT02737475|50158702|FG013|Overall Study|Participant withdrew consent|0|||
25054778|NCT02737475|50158703|FG014|Overall Study|Participant withdrew consent|1|||
25054779|NCT02737475|50158704|FG015|Overall Study|Participant withdrew consent|0|||
25054780|NCT02737475|50158705|FG016|Overall Study|Participant withdrew consent|0|||
25054781|NCT02737475|50158706|FG017|Overall Study|Participant withdrew consent|2|||
25054782|NCT02737475|50158707|FG018|Overall Study|Participant withdrew consent|1|||
25054783|NCT02737475|50158708|FG019|Overall Study|Participant withdrew consent|0|||
25054784|NCT02737475|50158709|FG020|Overall Study|Participant withdrew consent|2|||
25054785|NCT02737475|50158710|FG021|Overall Study|Participant withdrew consent|0|||
25054786|NCT02737475|50158711|FG022|Overall Study|Participant withdrew consent|0|||
25054787|NCT02737475|50158712|FG023|Overall Study|Participant withdrew consent|0|||
25054788|NCT02737475|50158713|FG024|Overall Study|Participant withdrew consent|0|||
25054789|NCT02737475|50158714|FG025|Overall Study|Participant withdrew consent|0|||
25054790|NCT02737475|50158715|FG026|Overall Study|Participant withdrew consent|0|||
25054791|NCT02737475|50158689|FG000|Overall Study|Lost to Follow-up|0|||
25054792|NCT02737475|50158690|FG001|Overall Study|Lost to Follow-up|0|||
25054793|NCT02737475|50158691|FG002|Overall Study|Lost to Follow-up|0|||
25054794|NCT02737475|50158692|FG003|Overall Study|Lost to Follow-up|0|||
25054795|NCT02737475|50158693|FG004|Overall Study|Lost to Follow-up|0|||
25054796|NCT02737475|50158694|FG005|Overall Study|Lost to Follow-up|0|||
25054797|NCT02737475|50158695|FG006|Overall Study|Lost to Follow-up|0|||
25054798|NCT02737475|50158696|FG007|Overall Study|Lost to Follow-up|0|||
25054799|NCT02737475|50158697|FG008|Overall Study|Lost to Follow-up|0|||
25054800|NCT02737475|50158698|FG009|Overall Study|Lost to Follow-up|0|||
25054801|NCT02737475|50158699|FG010|Overall Study|Lost to Follow-up|0|||
25054802|NCT02737475|50158700|FG011|Overall Study|Lost to Follow-up|0|||
25054803|NCT02737475|50158701|FG012|Overall Study|Lost to Follow-up|0|||
25054804|NCT02737475|50158702|FG013|Overall Study|Lost to Follow-up|0|||
25054805|NCT02737475|50158703|FG014|Overall Study|Lost to Follow-up|0|||
25054806|NCT02737475|50158704|FG015|Overall Study|Lost to Follow-up|1|||
25054807|NCT02737475|50158705|FG016|Overall Study|Lost to Follow-up|0|||
25054808|NCT02737475|50158706|FG017|Overall Study|Lost to Follow-up|0|||
25054809|NCT02737475|50158707|FG018|Overall Study|Lost to Follow-up|0|||
25054810|NCT02737475|50158708|FG019|Overall Study|Lost to Follow-up|0|||
25054811|NCT02737475|50158709|FG020|Overall Study|Lost to Follow-up|0|||
25054812|NCT02737475|50158710|FG021|Overall Study|Lost to Follow-up|0|||
25054813|NCT02737475|50158711|FG022|Overall Study|Lost to Follow-up|0|||
25054814|NCT02737475|50158712|FG023|Overall Study|Lost to Follow-up|0|||
25054815|NCT02737475|50158713|FG024|Overall Study|Lost to Follow-up|0|||
25054816|NCT02737475|50158714|FG025|Overall Study|Lost to Follow-up|0|||
25054817|NCT02737475|50158715|FG026|Overall Study|Lost to Follow-up|0|||
25054818|NCT02737475|50158689|FG000|Overall Study|Disease Progression|0|||
25054819|NCT02737475|50158690|FG001|Overall Study|Disease Progression|0|||
25054820|NCT02737475|50158691|FG002|Overall Study|Disease Progression|0|||
25054821|NCT02737475|50158692|FG003|Overall Study|Disease Progression|0|||
25054822|NCT02737475|50158693|FG004|Overall Study|Disease Progression|0|||
25054823|NCT02737475|50158694|FG005|Overall Study|Disease Progression|0|||
25054824|NCT02737475|50158695|FG006|Overall Study|Disease Progression|0|||
25054825|NCT02737475|50158696|FG007|Overall Study|Disease Progression|0|||
25054826|NCT02737475|50158697|FG008|Overall Study|Disease Progression|0|||
25054827|NCT02737475|50158698|FG009|Overall Study|Disease Progression|0|||
25054828|NCT02737475|50158699|FG010|Overall Study|Disease Progression|0|||
25054829|NCT02737475|50158700|FG011|Overall Study|Disease Progression|0|||
25054830|NCT02737475|50158701|FG012|Overall Study|Disease Progression|0|||
25054831|NCT02737475|50158702|FG013|Overall Study|Disease Progression|0|||
25054832|NCT02737475|50158703|FG014|Overall Study|Disease Progression|0|||
25054833|NCT02737475|50158704|FG015|Overall Study|Disease Progression|0|||
25054834|NCT02737475|50158705|FG016|Overall Study|Disease Progression|0|||
25054835|NCT02737475|50158706|FG017|Overall Study|Disease Progression|0|||
25054836|NCT02737475|50158707|FG018|Overall Study|Disease Progression|0|||
25054837|NCT02737475|50158708|FG019|Overall Study|Disease Progression|0|||
24962812|NCT00235716|50052898|FG000|Overall Study|Lost to Follow-up|12|||
24962813|NCT00235716|50052899|FG001|Overall Study|Lost to Follow-up|7|||
24962814|NCT00235716|50052900|FG002|Overall Study|Lost to Follow-up|14|||
24962815|NCT00235716|50052901|FG003|Overall Study|Lost to Follow-up|10|||
24962816|NCT00235716|50052898|FG000|Overall Study|Adverse Event|1|||
24962817|NCT00235716|50052899|FG001|Overall Study|Adverse Event|1|||
25054838|NCT02737475|50158709|FG020|Overall Study|Disease Progression|0|||
25054839|NCT02737475|50158710|FG021|Overall Study|Disease Progression|0|||
25054840|NCT02737475|50158711|FG022|Overall Study|Disease Progression|0|||
25054841|NCT02737475|50158712|FG023|Overall Study|Disease Progression|0|||
25162701|NCT01278394|50285035|FG000|Overall Study|Lost to Follow-up|1|||
25162702|NCT01981187|50285039|FG000|Overall Study|Participant/guardian decision|2|||
24962818|NCT00235716|50052900|FG002|Overall Study|Adverse Event|1|||
24962819|NCT00235716|50052901|FG003|Overall Study|Adverse Event|0|||
25054842|NCT02737475|50158713|FG024|Overall Study|Disease Progression|0|||
25054843|NCT02737475|50158714|FG025|Overall Study|Disease Progression|0|||
25054844|NCT02737475|50158715|FG026|Overall Study|Disease Progression|1|||
25054845|NCT02557672|50158805|FG000|Overall Study|Withdrawal by Subject|4|||
25054846|NCT02557672|50158806|FG001|Overall Study|Withdrawal by Subject|2|||
25054847|NCT02714426|50158818|FG000|Overall Study|Withdrawal by Subject|2|||
25054848|NCT02714426|50158819|FG001|Overall Study|Withdrawal by Subject|2|||
25054849|NCT02925923|50158832|FG000|Overall Study|blood samples hemolyzed|0|||
25054850|NCT02925923|50158833|FG001|Overall Study|blood samples hemolyzed|2|||
25054851|NCT02410343|50158841|FG000|Core Period (24 Weeks)|Adverse Event|1|||
25054852|NCT02410343|50158842|FG001|Core Period (24 Weeks)|Adverse Event|0|||
25054853|NCT02410343|50158841|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
25054854|NCT02410343|50158842|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
25054855|NCT02410343|50158841|FG000|Extension Period (12 Months)|Adverse Event|1|||
25054856|NCT02410343|50158842|FG001|Extension Period (12 Months)|Adverse Event|0|||
25054857|NCT02410343|50158841|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
25054858|NCT02410343|50158842|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
25054859|NCT03064841|50158849|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
25054860|NCT03064841|50158849|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
25054861|NCT03064841|50158849|FG000|Overall Study|Screen failure|2|||
25054862|NCT02045303|50158855|FG000|Overall Study|Protocol Violation|2|||
25054863|NCT02045303|50158856|FG001|Overall Study|Protocol Violation|1|||
25054864|NCT02045303|50158857|FG002|Overall Study|Protocol Violation|0|||
25054865|NCT02045303|50158855|FG000|Overall Study|Withdrawal by Subject|0|||
25054866|NCT02045303|50158856|FG001|Overall Study|Withdrawal by Subject|2|||
25054867|NCT02045303|50158857|FG002|Overall Study|Withdrawal by Subject|0|||
25054868|NCT03434379|50158868|FG000|Global Period|Lost to Follow-up|3|||
25054869|NCT03434379|50158869|FG001|Global Period|Lost to Follow-up|1|||
25054870|NCT03434379|50158870|FG002|Global Period|Lost to Follow-up|0|||
25054871|NCT03434379|50158871|FG003|Global Period|Lost to Follow-up|0|||
25054872|NCT03434379|50158868|FG000|Global Period|Death|99|||
25054873|NCT03434379|50158869|FG001|Global Period|Death|179|||
25054874|NCT03434379|50158870|FG002|Global Period|Death|0|||
25054875|NCT03434379|50158871|FG003|Global Period|Death|0|||
25054876|NCT03434379|50158868|FG000|Global Period|Withdrawal by Subject|20|||
25054877|NCT03434379|50158869|FG001|Global Period|Withdrawal by Subject|20|||
25054878|NCT03434379|50158870|FG002|Global Period|Withdrawal by Subject|0|||
25054879|NCT03434379|50158871|FG003|Global Period|Withdrawal by Subject|0|||
25054880|NCT03434379|50158868|FG000|Global Period|On Study|43|||
25054881|NCT03434379|50158869|FG001|Global Period|On Study|136|||
25054882|NCT03434379|50158870|FG002|Global Period|On Study|0|||
25054883|NCT03434379|50158871|FG003|Global Period|On Study|0|||
25054884|NCT03434379|50158868|FG000|China Extension Period|Lost to Follow-up|0|||
25054885|NCT03434379|50158869|FG001|China Extension Period|Lost to Follow-up|0|||
25054886|NCT03434379|50158870|FG002|China Extension Period|Lost to Follow-up|1|||
25054887|NCT03434379|50158871|FG003|China Extension Period|Lost to Follow-up|0|||
25054888|NCT03434379|50158868|FG000|China Extension Period|Death|0|||
25054889|NCT03434379|50158869|FG001|China Extension Period|Death|0|||
25054890|NCT03434379|50158870|FG002|China Extension Period|Death|38|||
25054891|NCT03434379|50158871|FG003|China Extension Period|Death|61|||
25054892|NCT03434379|50158868|FG000|China Extension Period|Withdrawal by Subject|0|||
25054893|NCT03434379|50158869|FG001|China Extension Period|Withdrawal by Subject|0|||
25054894|NCT03434379|50158870|FG002|China Extension Period|Withdrawal by Subject|7|||
25054895|NCT03434379|50158871|FG003|China Extension Period|Withdrawal by Subject|6|||
25054896|NCT03434379|50158868|FG000|China Extension Period|On Study|0|||
25054897|NCT03434379|50158869|FG001|China Extension Period|On Study|0|||
25054898|NCT03434379|50158870|FG002|China Extension Period|On Study|15|||
25054899|NCT03434379|50158871|FG003|China Extension Period|On Study|66|||
25054900|NCT03064451|50158887|FG000|Overall Study|Lost to Follow-up|1|||
24962820|NCT00235716|50052898|FG000|Overall Study|Physician Decision|0|||
24962821|NCT00235716|50052899|FG001|Overall Study|Physician Decision|1|||
24962822|NCT00235716|50052900|FG002|Overall Study|Physician Decision|1|||
24962823|NCT00235716|50052901|FG003|Overall Study|Physician Decision|3|||
24962824|NCT00274742|50052917|FG000|Overall Study|Adverse Event|0|||
24962825|NCT00274742|50052918|FG001|Overall Study|Adverse Event|4|||
24962826|NCT00274742|50052919|FG002|Overall Study|Adverse Event|1|||
24962827|NCT00274742|50052920|FG003|Overall Study|Adverse Event|4|||
24962828|NCT00274742|50052921|FG004|Overall Study|Adverse Event|12|||
25054901|NCT03064451|50158887|FG000|Overall Study|Mapping Failure|4|||
25054902|NCT03064451|50158887|FG000|Overall Study|Exited prior to procedure|8|||
25054903|NCT03064451|50158887|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
25054904|NCT03058679|50158893|FG000|Baseline to Week 6|Lost to Follow-up|3|||
25054905|NCT03058679|50158894|FG001|Baseline to Week 6|Lost to Follow-up|2|||
25054906|NCT03058679|50158893|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
25054907|NCT03058679|50158894|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
25054908|NCT03058679|50158893|FG000|Baseline to Week 6|Adverse Event|6|||
25054909|NCT03058679|50158894|FG001|Baseline to Week 6|Adverse Event|6|||
25054910|NCT03058679|50158893|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
25054911|NCT03058679|50158894|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
25054912|NCT03058679|50158893|FG000|Baseline to Week 6|Difficulty following the diet|0|||
25054913|NCT03058679|50158894|FG001|Baseline to Week 6|Difficulty following the diet|2|||
25054914|NCT03058679|50158893|FG000|Baseline to Week 6|Physician Decision|1|||
24962829|NCT00274742|50052922|FG005|Overall Study|Adverse Event|3|||
24962830|NCT00274742|50052917|FG000|Overall Study|Lost to Follow-up|0|||
25054915|NCT03058679|50158894|FG001|Baseline to Week 6|Physician Decision|0|||
25054916|NCT03058679|50158893|FG000|Week 6 to Week 12|Change in medication|5|||
25054917|NCT03058679|50158894|FG001|Week 6 to Week 12|Change in medication|7|||
25054918|NCT03058679|50158893|FG000|Week 6 to Week 12|Adverse Event|4|||
25054919|NCT03058679|50158894|FG001|Week 6 to Week 12|Adverse Event|3|||
25054920|NCT03058679|50158893|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
25054921|NCT03058679|50158894|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
25054922|NCT03058679|50158893|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
25054923|NCT03058679|50158894|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
25054924|NCT03382821|50158902|FG000|Overall Study|Did not receive allocated intervention.|0|||
25054925|NCT03382821|50158903|FG001|Overall Study|Did not receive allocated intervention.|3|||
25054926|NCT02557516|50158914|FG000|Overall Study|Adverse Event|1|||
25054927|NCT02557516|50158915|FG001|Overall Study|Adverse Event|0|||
25054928|NCT02557516|50158916|FG002|Overall Study|Adverse Event|2|||
25054929|NCT02557516|50158917|FG003|Overall Study|Adverse Event|1|||
25054930|NCT02557516|50158914|FG000|Overall Study|Disease progression|0|||
25054931|NCT02557516|50158915|FG001|Overall Study|Disease progression|2|||
25054932|NCT02557516|50158916|FG002|Overall Study|Disease progression|0|||
25054933|NCT02557516|50158917|FG003|Overall Study|Disease progression|0|||
25054934|NCT02557516|50158914|FG000|Overall Study|Physician Decision|0|||
25054935|NCT02557516|50158915|FG001|Overall Study|Physician Decision|2|||
25054936|NCT02557516|50158916|FG002|Overall Study|Physician Decision|0|||
25054937|NCT02557516|50158917|FG003|Overall Study|Physician Decision|0|||
25054938|NCT02557516|50158914|FG000|Overall Study|Sponsor decision|0|||
25054939|NCT02557516|50158915|FG001|Overall Study|Sponsor decision|1|||
25054940|NCT02557516|50158916|FG002|Overall Study|Sponsor decision|2|||
25054941|NCT02557516|50158917|FG003|Overall Study|Sponsor decision|8|||
25054942|NCT00711555|50158936|FG000|Overall Study|Adverse Event|3|||
25054943|NCT02713490|50158941|FG000|Overall Study|Withdrawal by Subject|2|||
25054944|NCT02713490|50158942|FG001|Overall Study|Withdrawal by Subject|1|||
25054945|NCT02713490|50158941|FG000|Overall Study|Did not receive study drug|1|||
25054946|NCT02713490|50158942|FG001|Overall Study|Did not receive study drug|0|||
25054947|NCT02713490|50158941|FG000|Overall Study|Met exclusion criteria|0|||
25054948|NCT02713490|50158942|FG001|Overall Study|Met exclusion criteria|1|||
25054949|NCT03772574|50158951|FG000|Overall Study|Protocol Violation|2|||
25054950|NCT03772574|50158952|FG001|Overall Study|Protocol Violation|0|||
25054951|NCT03772574|50158953|FG002|Overall Study|Protocol Violation|0|||
25054952|NCT03772574|50158951|FG000|Overall Study|Discomfort|0|||
25054953|NCT03772574|50158952|FG001|Overall Study|Discomfort|5|||
25054954|NCT03772574|50158953|FG002|Overall Study|Discomfort|4|||
25054955|NCT02743221|50158963|FG000|Overall Study|Progressive disease|29|||
25054956|NCT02743221|50158964|FG001|Overall Study|Progressive disease|38|||
25054957|NCT02743221|50158963|FG000|Overall Study|Adverse Event|17|||
25054958|NCT02743221|50158964|FG001|Overall Study|Adverse Event|14|||
25054959|NCT02743221|50158963|FG000|Overall Study|non medical reason|8|||
25054960|NCT02743221|50158964|FG001|Overall Study|non medical reason|2|||
25054961|NCT02743221|50158963|FG000|Overall Study|Physician Decision|2|||
25054962|NCT02743221|50158964|FG001|Overall Study|Physician Decision|5|||
25054963|NCT02743221|50158963|FG000|Overall Study|Patient not eligible, not treated|0|||
24962831|NCT00274742|50052918|FG001|Overall Study|Lost to Follow-up|0|||
24962832|NCT00274742|50052919|FG002|Overall Study|Lost to Follow-up|0|||
24962833|NCT00274742|50052920|FG003|Overall Study|Lost to Follow-up|0|||
24962834|NCT00274742|50052921|FG004|Overall Study|Lost to Follow-up|1|||
24962835|NCT00274742|50052922|FG005|Overall Study|Lost to Follow-up|0|||
24962836|NCT00274742|50052917|FG000|Overall Study|End of Study|0|||
25054964|NCT02743221|50158964|FG001|Overall Study|Patient not eligible, not treated|1|||
25162703|NCT01981187|50285039|FG000|Overall Study|Physician Decision|1|||
24962837|NCT00274742|50052918|FG001|Overall Study|End of Study|0|||
25054965|NCT03929757|50158972|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
25054966|NCT03929757|50158973|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
25054967|NCT03929757|50158974|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
25054968|NCT03929757|50158972|FG000|Main Study: Up to Day 365|Other|1|||
25054969|NCT03929757|50158973|FG001|Main Study: Up to Day 365|Other|0|||
25054970|NCT03929757|50158974|FG002|Main Study: Up to Day 365|Other|0|||
25054971|NCT03929757|50158972|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
25054972|NCT03929757|50158973|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
25054973|NCT03929757|50158974|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
24962838|NCT00274742|50052919|FG002|Overall Study|End of Study|0|||
24962839|NCT00274742|50052920|FG003|Overall Study|End of Study|1|||
24962840|NCT00274742|50052921|FG004|Overall Study|End of Study|0|||
24962841|NCT00274742|50052922|FG005|Overall Study|End of Study|0|||
24962842|NCT00274742|50052917|FG000|Overall Study|Disease Progression|0|||
24962843|NCT00274742|50052918|FG001|Overall Study|Disease Progression|1|||
25054974|NCT03836625|50158983|FG000|Overall Study|Lost to Follow-up|9|||
25054975|NCT03836625|50158984|FG001|Overall Study|Lost to Follow-up|9|||
25054976|NCT03836625|50158983|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
25054977|NCT03836625|50158984|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
25054978|NCT03836625|50158983|FG000|Overall Study|Death|0|||
25054979|NCT03836625|50158984|FG001|Overall Study|Death|1|||
25054980|NCT03836625|50158983|FG000|Overall Study|Refused follow-up|0|||
25054981|NCT03836625|50158984|FG001|Overall Study|Refused follow-up|1|||
25054982|NCT01358968|50158990|FG000|Period 2|Adverse Event|0|||
25054983|NCT01358968|50158991|FG001|Period 2|Adverse Event|1|||
25054984|NCT01358968|50158992|FG002|Period 2|Adverse Event|0|||
25054985|NCT01358968|50158993|FG003|Period 2|Adverse Event|0|||
25054986|NCT01358968|50158990|FG000|Continued Access Phase|Progression of Disease|0|||
25054987|NCT01358968|50158991|FG001|Continued Access Phase|Progression of Disease|0|||
25054988|NCT01358968|50158992|FG002|Continued Access Phase|Progression of Disease|8|||
25054989|NCT01358968|50158993|FG003|Continued Access Phase|Progression of Disease|4|||
25054990|NCT01358968|50158990|FG000|Continued Access Phase|Protocol Violation|0|||
25054991|NCT01358968|50158991|FG001|Continued Access Phase|Protocol Violation|0|||
25054992|NCT01358968|50158992|FG002|Continued Access Phase|Protocol Violation|0|||
25054993|NCT01358968|50158993|FG003|Continued Access Phase|Protocol Violation|2|||
25054994|NCT01358968|50158990|FG000|Continued Access Phase|Withdrawal by Subject|0|||
25054995|NCT01358968|50158991|FG001|Continued Access Phase|Withdrawal by Subject|0|||
25054996|NCT01358968|50158992|FG002|Continued Access Phase|Withdrawal by Subject|3|||
25054997|NCT01358968|50158993|FG003|Continued Access Phase|Withdrawal by Subject|0|||
25054998|NCT01358968|50158990|FG000|Continued Access Phase|Death|0|||
25054999|NCT01358968|50158991|FG001|Continued Access Phase|Death|0|||
25055000|NCT01358968|50158992|FG002|Continued Access Phase|Death|1|||
25055001|NCT01358968|50158993|FG003|Continued Access Phase|Death|1|||
25055002|NCT00701090|50159005|FG000|Overall Study|Adverse Event|11|||
25055003|NCT00701090|50159006|FG001|Overall Study|Adverse Event|2|||
25055004|NCT00701090|50159005|FG000|Overall Study|Death|0|||
25055005|NCT00701090|50159006|FG001|Overall Study|Death|1|||
25055006|NCT00701090|50159005|FG000|Overall Study|Lack of Efficacy|5|||
25055007|NCT00701090|50159006|FG001|Overall Study|Lack of Efficacy|4|||
25055008|NCT00701090|50159005|FG000|Overall Study|Lost to Follow-up|9|||
25055009|NCT00701090|50159006|FG001|Overall Study|Lost to Follow-up|9|||
25055010|NCT00701090|50159005|FG000|Overall Study|Physician Decision|3|||
25055011|NCT00701090|50159006|FG001|Overall Study|Physician Decision|4|||
25055012|NCT00701090|50159005|FG000|Overall Study|Protocol Violation|2|||
25055013|NCT00701090|50159006|FG001|Overall Study|Protocol Violation|3|||
25055014|NCT00701090|50159005|FG000|Overall Study|Withdrawal by Subject|11|||
25055015|NCT00701090|50159006|FG001|Overall Study|Withdrawal by Subject|16|||
25055016|NCT00701090|50159005|FG000|Overall Study|Other|7|||
25055017|NCT00701090|50159006|FG001|Overall Study|Other|12|||
25055018|NCT03057977|50159014|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
25055019|NCT03057977|50159015|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
25055020|NCT03057977|50159014|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
25055021|NCT03057977|50159015|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
25055022|NCT03057977|50159014|FG000|Discontinuation From Treatment|Protocol Violation|6|||
24962844|NCT00274742|50052919|FG002|Overall Study|Disease Progression|1|||
24962845|NCT00274742|50052920|FG003|Overall Study|Disease Progression|0|||
25055023|NCT03057977|50159015|FG001|Discontinuation From Treatment|Protocol Violation|5|||
25055024|NCT03057977|50159014|FG000|Discontinuation From Treatment|Not treated|4|||
25055025|NCT03057977|50159015|FG001|Discontinuation From Treatment|Not treated|0|||
25055026|NCT03057977|50159014|FG000|Discontinuation From Treatment|Adverse Event|343|||
25055027|NCT03057977|50159015|FG001|Discontinuation From Treatment|Adverse Event|337|||
25055028|NCT03057977|50159014|FG000|Discontinuation From Treatment|Reason Unknown|0|||
25055029|NCT03057977|50159015|FG001|Discontinuation From Treatment|Reason Unknown|1|||
25055030|NCT03057977|50159014|FG000|Discontinuation From Treatment|Personal Reasons|1|||
25162704|NCT01981187|50285039|FG000|Overall Study|Disease progression|2|||
25162705|NCT01981187|50285039|FG000|Overall Study|Adverse Event|7|||
25276613|NCT01061151|50590566|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
25276614|NCT01061151|50590563|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
25055031|NCT03057977|50159015|FG001|Discontinuation From Treatment|Personal Reasons|1|||
25055032|NCT03057977|50159014|FG000|Discontinuation From Treatment|Unblinded medication|1|||
25055033|NCT03057977|50159015|FG001|Discontinuation From Treatment|Unblinded medication|0|||
25055034|NCT03057977|50159014|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
25055035|NCT03057977|50159015|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
25055036|NCT03057977|50159014|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
25055037|NCT03057977|50159015|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
25055038|NCT03057977|50159014|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
25055039|NCT03057977|50159015|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
25055040|NCT03057977|50159014|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
25055041|NCT03057977|50159015|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
25055042|NCT03057977|50159014|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
25055043|NCT03057977|50159015|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
25055044|NCT03057977|50159014|FG000|Discontinuation From Treatment|Not attending study visit|3|||
24962846|NCT00274742|50052921|FG004|Overall Study|Disease Progression|1|||
24962847|NCT00274742|50052922|FG005|Overall Study|Disease Progression|0|||
24962848|NCT00274742|50052917|FG000|Overall Study|Other|0|||
24962849|NCT00274742|50052918|FG001|Overall Study|Other|3|||
24962850|NCT00274742|50052919|FG002|Overall Study|Other|0|||
24962851|NCT00274742|50052920|FG003|Overall Study|Other|0|||
24962852|NCT00274742|50052921|FG004|Overall Study|Other|2|||
24962853|NCT00274742|50052922|FG005|Overall Study|Other|0|||
24962854|NCT00262314|50052942|FG000|Overall Study|Changing physicians|38|||
24962855|NCT00262314|50052942|FG000|Overall Study|Death|12|||
24962856|NCT00262314|50052942|FG000|Overall Study|Patient's decision|92|||
24962857|NCT00262314|50052942|FG000|Overall Study|Other|95|||
24962858|NCT00262314|50052942|FG000|Overall Study|Lost to Follow-up|70|||
24962859|NCT00262314|50052942|FG000|Overall Study|Administrative withdrawal|30|||
24962860|NCT00283400|50052950|FG000|Overall Study|Withdrawal by Subject|1|||
24962861|NCT00283400|50052951|FG001|Overall Study|Withdrawal by Subject|1|||
24962862|NCT00283400|50052952|FG002|Overall Study|Withdrawal by Subject|0|||
24962863|NCT00283400|50052953|FG003|Overall Study|Withdrawal by Subject|0|||
24962864|NCT00283400|50052950|FG000|Overall Study|Death|1|||
24962865|NCT00283400|50052951|FG001|Overall Study|Death|0|||
24962866|NCT00283400|50052952|FG002|Overall Study|Death|1|||
25055045|NCT03057977|50159015|FG001|Discontinuation From Treatment|Not attending study visit|10|||
25055046|NCT03057977|50159014|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
25276615|NCT01061151|50590564|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
25276616|NCT01061151|50590565|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
25276617|NCT01061151|50590566|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
24962867|NCT00283400|50052953|FG003|Overall Study|Death|0|||
25276618|NCT01061151|50590563|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
25276619|NCT01061151|50590564|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
25276620|NCT01061151|50590565|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
25276621|NCT01061151|50590566|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
25276622|NCT01061151|50590563|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
25276623|NCT01061151|50590564|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
25276624|NCT01061151|50590565|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
25276625|NCT01061151|50590566|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
25276626|NCT01241552|50590590|FG000|Overall Study|Lack of Efficacy|1|||
24962868|NCT00444275|50052966|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
24962869|NCT00444275|50052967|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
24962870|NCT00444275|50052968|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
24962871|NCT00444275|50052969|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
24962872|NCT00444275|50052970|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
24962873|NCT00444275|50052966|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
24962874|NCT00444275|50052967|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
24962875|NCT00444275|50052968|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
24962876|NCT00444275|50052969|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
24962877|NCT00444275|50052970|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
25055047|NCT03057977|50159015|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
25276627|NCT01241552|50590591|FG001|Overall Study|Lack of Efficacy|0|||
25276628|NCT01241552|50590592|FG002|Overall Study|Lack of Efficacy|0|||
25276629|NCT01241552|50590593|FG003|Overall Study|Lack of Efficacy|0|||
24962878|NCT00444275|50052966|FG000|Maintenance Treatment Phase|Adverse Event|0|||
24962879|NCT00444275|50052967|FG001|Maintenance Treatment Phase|Adverse Event|0|||
24962880|NCT00444275|50052968|FG002|Maintenance Treatment Phase|Adverse Event|3|||
24962881|NCT00444275|50052969|FG003|Maintenance Treatment Phase|Adverse Event|2|||
24962882|NCT00444275|50052970|FG004|Maintenance Treatment Phase|Adverse Event|13|||
24962883|NCT00444275|50052966|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
24962884|NCT00444275|50052967|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
25055048|NCT03057977|50159014|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
25055049|NCT03057977|50159015|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
25055050|NCT03057977|50159014|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
25055051|NCT03057977|50159015|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
25055052|NCT03057977|50159014|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
25055053|NCT03057977|50159015|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
25055054|NCT03057977|50159014|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
25055055|NCT03057977|50159015|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
25055056|NCT03062891|50159027|FG000|Overall Study|Withdrawal by Subject|2|||
25055057|NCT03062891|50159028|FG001|Overall Study|Withdrawal by Subject|0|||
25055058|NCT03062891|50159027|FG000|Overall Study|Lost to Follow-up|50|||
25055059|NCT03062891|50159028|FG001|Overall Study|Lost to Follow-up|38|||
25055060|NCT02552212|50159037|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
25055061|NCT02552212|50159038|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
25055062|NCT02552212|50159039|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
25055063|NCT02552212|50159037|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
25055064|NCT02552212|50159038|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
25055065|NCT02552212|50159039|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
25055066|NCT02552212|50159037|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
25055067|NCT02552212|50159038|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
25055068|NCT02552212|50159039|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
25055069|NCT02552212|50159037|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
25055070|NCT02552212|50159038|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
25055071|NCT02552212|50159039|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
24962885|NCT00444275|50052968|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
24962886|NCT00444275|50052969|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
24962887|NCT00444275|50052970|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
25055072|NCT02552212|50159037|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
25055073|NCT02552212|50159038|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
25055074|NCT02552212|50159039|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
25055075|NCT02552212|50159037|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
25055076|NCT02552212|50159038|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
25055077|NCT02552212|50159039|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
25055078|NCT02552212|50159037|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
25055079|NCT02552212|50159038|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
25055080|NCT02552212|50159039|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
25055081|NCT02552212|50159037|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
25055082|NCT02552212|50159038|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
25055083|NCT02552212|50159039|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
25055084|NCT02552212|50159037|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
25055085|NCT02552212|50159038|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
25055086|NCT02552212|50159039|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
25055087|NCT02552212|50159037|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
24962888|NCT00444275|50052966|FG000|Maintenance Treatment Phase|Patient's wish|0|||
25055088|NCT02552212|50159038|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
25055089|NCT02552212|50159039|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
25055090|NCT02552212|50159037|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
25055091|NCT02552212|50159038|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
25055092|NCT02552212|50159039|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
25055093|NCT02552212|50159037|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
25055094|NCT02552212|50159038|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
25055095|NCT02552212|50159039|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
25055096|NCT02552212|50159037|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
25055097|NCT02552212|50159038|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
25055098|NCT02552212|50159039|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
25055099|NCT02552212|50159037|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
25055100|NCT02552212|50159038|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
25055101|NCT02552212|50159039|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
25055102|NCT02552212|50159037|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
25055103|NCT02552212|50159038|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
24962889|NCT00444275|50052967|FG001|Maintenance Treatment Phase|Patient's wish|0|||
25055104|NCT02552212|50159039|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
25055105|NCT02552212|50159037|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
24962890|NCT00444275|50052968|FG002|Maintenance Treatment Phase|Patient's wish|19|||
24962891|NCT00444275|50052969|FG003|Maintenance Treatment Phase|Patient's wish|9|||
24962892|NCT00444275|50052970|FG004|Maintenance Treatment Phase|Patient's wish|20|||
24962893|NCT00444275|50052966|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
25055106|NCT02552212|50159038|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
25055107|NCT02552212|50159039|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
25055108|NCT02552212|50159037|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
25055109|NCT02552212|50159038|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
25055110|NCT02552212|50159039|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
25055111|NCT02552212|50159037|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
25055112|NCT02552212|50159038|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
25055113|NCT02552212|50159039|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
25055114|NCT02552212|50159037|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
25055115|NCT02552212|50159038|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
24962894|NCT00444275|50052967|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
24962895|NCT00444275|50052968|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
24962896|NCT00444275|50052969|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
24962897|NCT00444275|50052970|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
24962898|NCT00444275|50052966|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
24962899|NCT00444275|50052967|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
24962900|NCT00444275|50052968|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
24962901|NCT00444275|50052969|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
24962902|NCT00444275|50052970|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
24962903|NCT00454805|50052987|FG000|Overall Study|Withdrawal by Subject|9|||
24962904|NCT00454805|50052988|FG001|Overall Study|Withdrawal by Subject|2|||
24962905|NCT00454805|50052987|FG000|Overall Study|Death|0|||
24962906|NCT00454805|50052988|FG001|Overall Study|Death|2|||
24962907|NCT00454805|50052987|FG000|Overall Study|Disease progression|16|||
24962908|NCT00454805|50052988|FG001|Overall Study|Disease progression|19|||
24962909|NCT00454805|50052987|FG000|Overall Study|In order to begin radiotherapy|1|||
24962910|NCT00454805|50052988|FG001|Overall Study|In order to begin radiotherapy|0|||
24962911|NCT00283244|50052997|FG000|Overall Study|Adverse Event|0|||
24962912|NCT00283244|50052998|FG001|Overall Study|Adverse Event|8|||
24962913|NCT00283244|50052999|FG002|Overall Study|Adverse Event|11|||
24962914|NCT00283244|50052997|FG000|Overall Study|Death|4|||
24962915|NCT00283244|50052998|FG001|Overall Study|Death|3|||
24962916|NCT00283244|50052999|FG002|Overall Study|Death|2|||
24962917|NCT00283244|50052997|FG000|Overall Study|Lack of Efficacy|8|||
24962918|NCT00283244|50052998|FG001|Overall Study|Lack of Efficacy|32|||
24962919|NCT00283244|50052999|FG002|Overall Study|Lack of Efficacy|26|||
24962920|NCT00283244|50052997|FG000|Overall Study|Withdrawal by Subject|1|||
24962921|NCT00283244|50052998|FG001|Overall Study|Withdrawal by Subject|2|||
24962922|NCT00283244|50052999|FG002|Overall Study|Withdrawal by Subject|2|||
24962923|NCT00283244|50052997|FG000|Overall Study|Physician Decision|0|||
24962924|NCT00283244|50052998|FG001|Overall Study|Physician Decision|0|||
24962925|NCT00283244|50052999|FG002|Overall Study|Physician Decision|1|||
24962926|NCT00283244|50052997|FG000|Overall Study|Medical illness (other complicating dz)|4|||
24962927|NCT00283244|50052998|FG001|Overall Study|Medical illness (other complicating dz)|3|||
24962928|NCT00283244|50052999|FG002|Overall Study|Medical illness (other complicating dz)|6|||
24962929|NCT00283244|50052997|FG000|Overall Study|Clinical deterioration|1|||
24962930|NCT00283244|50052998|FG001|Overall Study|Clinical deterioration|3|||
24962931|NCT00283244|50052999|FG002|Overall Study|Clinical deterioration|3|||
24962932|NCT00282464|50053010|FG000|Overall Study|Adverse Event|26|||
24962933|NCT00282464|50053011|FG001|Overall Study|Adverse Event|20|||
24962934|NCT00282464|50053010|FG000|Overall Study|Lack of Efficacy|8|||
24962935|NCT00282464|50053011|FG001|Overall Study|Lack of Efficacy|8|||
24962936|NCT00282464|50053010|FG000|Overall Study|Lost to Follow-up|10|||
24962937|NCT00282464|50053011|FG001|Overall Study|Lost to Follow-up|10|||
24962938|NCT00282464|50053010|FG000|Overall Study|Withdrawal by Subject|24|||
24962939|NCT00282464|50053011|FG001|Overall Study|Withdrawal by Subject|10|||
24962940|NCT00282464|50053010|FG000|Overall Study|laboratory abnormality|1|||
24962941|NCT00282464|50053011|FG001|Overall Study|laboratory abnormality|2|||
24962942|NCT00282464|50053010|FG000|Overall Study|Protocol Violation|0|||
24962943|NCT00282464|50053011|FG001|Overall Study|Protocol Violation|7|||
25055116|NCT02552212|50159039|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
25055117|NCT02552212|50159037|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
24962944|NCT00282464|50053010|FG000|Overall Study|Patient moved|1|||
24962945|NCT00282464|50053011|FG001|Overall Study|Patient moved|0|||
24962946|NCT00282464|50053010|FG000|Overall Study|patient non-compliant|3|||
25162706|NCT01278160|50285045|FG000|Overall Study|Adverse Event|1|||
24962947|NCT00282464|50053011|FG001|Overall Study|patient non-compliant|0|||
24962948|NCT00282464|50053010|FG000|Overall Study|patient no show|0|||
24962949|NCT00282464|50053011|FG001|Overall Study|patient no show|1|||
24962950|NCT00282464|50053010|FG000|Overall Study|patient incarcerated|0|||
24962951|NCT00282464|50053011|FG001|Overall Study|patient incarcerated|1|||
24962952|NCT00282464|50053010|FG000|Overall Study|family crisis|0|||
24962953|NCT00282464|50053011|FG001|Overall Study|family crisis|1|||
24962954|NCT00282464|50053010|FG000|Overall Study|dispensed wrong kit|0|||
24962955|NCT00282464|50053011|FG001|Overall Study|dispensed wrong kit|1|||
24962956|NCT00282464|50053010|FG000|Overall Study|dropped due to missed visits|0|||
24962957|NCT00282464|50053011|FG001|Overall Study|dropped due to missed visits|1|||
24962958|NCT00273182|50053017|FG000|Overall Study|Death|450|||
24962959|NCT00273182|50053017|FG000|Overall Study|Lost to Follow-up|88|||
24962960|NCT00273182|50053017|FG000|Overall Study|Withdrawal by Subject|257|||
24962961|NCT00273182|50053017|FG000|Overall Study|Device/System Explant|154|||
24962962|NCT00273182|50053017|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
24962963|NCT00209274|50053024|FG000|Overall Study|Missed visit|3|||
24962964|NCT00209274|50053025|FG001|Overall Study|Missed visit|2|||
24962965|NCT00209274|50053024|FG000|Overall Study|Death|32|||
24962966|NCT00209274|50053025|FG001|Overall Study|Death|15|||
24962967|NCT00209274|50053024|FG000|Overall Study|Withdrawal by Subject|30|||
24962968|NCT00209274|50053025|FG001|Overall Study|Withdrawal by Subject|15|||
24962969|NCT00209274|50053024|FG000|Overall Study|Randomized not treated (RNT)|6|||
24962970|NCT00209274|50053025|FG001|Overall Study|Randomized not treated (RNT)|15|||
24962971|NCT03841331|50053033|FG000|Overall Study|Withdrawal by Subject|4|||
24962972|NCT03841331|50053034|FG001|Overall Study|Withdrawal by Subject|9|||
24962973|NCT03841331|50053033|FG000|Overall Study|Lost to Follow-up|5|||
24962974|NCT03841331|50053034|FG001|Overall Study|Lost to Follow-up|1|||
24962975|NCT00262080|50053043|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
24962976|NCT00262080|50053044|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
24962977|NCT00262080|50053045|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
24962978|NCT00262080|50053043|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
24962979|NCT00262080|50053044|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
24962980|NCT00262080|50053045|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
24962981|NCT00262080|50053043|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
24962982|NCT00262080|50053044|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
24962983|NCT00262080|50053045|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
24962984|NCT00262080|50053043|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
24962985|NCT00262080|50053044|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
24962986|NCT00262080|50053045|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
24962987|NCT00262080|50053043|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
24962988|NCT00262080|50053044|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
24962989|NCT00262080|50053045|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
25055118|NCT02552212|50159038|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
25055119|NCT02552212|50159039|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
25055120|NCT02552212|50159037|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
25055121|NCT02552212|50159038|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
25055122|NCT02552212|50159039|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
25055123|NCT00685919|50159059|FG000|Overall Study|Withdrawal by Subject|0|||
25055124|NCT00685919|50159060|FG001|Overall Study|Withdrawal by Subject|0|||
25055125|NCT00685919|50159061|FG002|Overall Study|Withdrawal by Subject|1|||
25055126|NCT00685919|50159062|FG003|Overall Study|Withdrawal by Subject|0|||
25055127|NCT00685919|50159059|FG000|Overall Study|Physician Decision|1|||
25055128|NCT00685919|50159060|FG001|Overall Study|Physician Decision|0|||
25055129|NCT00685919|50159061|FG002|Overall Study|Physician Decision|0|||
25055130|NCT00685919|50159062|FG003|Overall Study|Physician Decision|0|||
25055131|NCT03061331|50159074|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
25055132|NCT03061331|50159075|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
25055133|NCT00700778|50159081|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
25055134|NCT03908476|50159087|FG000|Overall Study|Death|3|||
25055135|NCT03908476|50159088|FG001|Overall Study|Death|0|||
25055136|NCT03908476|50159087|FG000|Overall Study|Lost to Follow-up|3|||
25055137|NCT03908476|50159088|FG001|Overall Study|Lost to Follow-up|1|||
25055138|NCT03908476|50159087|FG000|Overall Study|Withdrawal by Subject|7|||
25055139|NCT03908476|50159088|FG001|Overall Study|Withdrawal by Subject|1|||
25055140|NCT03908476|50159087|FG000|Overall Study|Physician Decision|2|||
25055141|NCT03908476|50159088|FG001|Overall Study|Physician Decision|0|||
25055142|NCT03908476|50159087|FG000|Overall Study|System Explanted and not Replaced|4|||
25055143|NCT03908476|50159088|FG001|Overall Study|System Explanted and not Replaced|0|||
25055144|NCT03908476|50159087|FG000|Overall Study|Intrathecal Pump|1|||
25055145|NCT03908476|50159088|FG001|Overall Study|Intrathecal Pump|0|||
25055146|NCT03908476|50159087|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
25055147|NCT03908476|50159088|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
25055148|NCT02551666|50159096|FG000|Overall Study|Withdrawal by Subject|1|||
24962990|NCT00262080|50053043|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
24962991|NCT00262080|50053044|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
25055149|NCT02551666|50159097|FG001|Overall Study|Withdrawal by Subject|3|||
25055150|NCT03061175|50159109|FG000|Baseline|Participant was deemed ineligible|1|||
25055151|NCT03061175|50159110|FG001|Baseline|Participant was deemed ineligible|0|||
25055152|NCT03061175|50159109|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
25055153|NCT03061175|50159110|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
25055154|NCT03061175|50159109|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
25055155|NCT03061175|50159110|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
25055156|NCT03061175|50159109|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
25055157|NCT03061175|50159110|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
25055158|NCT02554474|50159127|FG000|Overall Study|Protocol Violation|1|||
25055159|NCT02554474|50159128|FG001|Overall Study|Protocol Violation|1|||
25055160|NCT02554474|50159127|FG000|Overall Study|Health issue not related to the study|1|||
25055161|NCT02554474|50159128|FG001|Overall Study|Health issue not related to the study|0|||
25055162|NCT02554474|50159127|FG000|Overall Study|Withdrawal by Subject|1|||
25055163|NCT02554474|50159128|FG001|Overall Study|Withdrawal by Subject|1|||
25055164|NCT03061097|50159136|FG000|Overall Study|Withdrawal by Subject|0|||
25055165|NCT03061097|50159137|FG001|Overall Study|Withdrawal by Subject|3|||
25055166|NCT02554318|50159145|FG000|Overall Study|Withdrawal by Subject|10|||
25055167|NCT02554318|50159146|FG001|Overall Study|Withdrawal by Subject|8|||
25055168|NCT02550106|50159152|FG000|Overall Study|Adverse Event|1|||
25055169|NCT02550106|50159152|FG000|Overall Study|Lack of Efficacy|3|||
25055170|NCT02550106|50159152|FG000|Overall Study|Protocol Violation|6|||
25055171|NCT02550106|50159152|FG000|Overall Study|Withdrawal by Subject|2|||
25055172|NCT03060551|50159158|FG000|Overall Study|Withdrawal by Subject|1|||
25055173|NCT03060551|50159158|FG000|Overall Study|Adverse Event|1|||
25055174|NCT01662310|50159162|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
25055175|NCT01662310|50159163|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
25055176|NCT01662310|50159164|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
25055177|NCT01662310|50159165|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
25055178|NCT01662310|50159166|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
25055179|NCT01662310|50159162|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
25055180|NCT01662310|50159163|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
25055181|NCT01662310|50159164|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
25055182|NCT01662310|50159165|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
25055183|NCT01662310|50159166|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
25055184|NCT01662310|50159162|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
25055185|NCT01662310|50159163|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
25055186|NCT01662310|50159164|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
25055187|NCT01662310|50159165|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
25055188|NCT01662310|50159166|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
25055189|NCT01662310|50159162|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
25055190|NCT01662310|50159163|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
25055191|NCT01662310|50159164|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
25055192|NCT01662310|50159165|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
25055193|NCT01662310|50159166|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
25055194|NCT01662310|50159162|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
25055195|NCT01662310|50159163|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
25055196|NCT01662310|50159164|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
25055197|NCT01662310|50159165|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
25055198|NCT01662310|50159166|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
25055199|NCT01662310|50159162|FG000|Run-In or Stabilization Phase|Other|1|||
25055200|NCT01662310|50159163|FG001|Run-In or Stabilization Phase|Other|0|||
25055201|NCT01662310|50159164|FG002|Run-In or Stabilization Phase|Other|0|||
25055202|NCT01662310|50159165|FG003|Run-In or Stabilization Phase|Other|0|||
25055203|NCT01662310|50159166|FG004|Run-In or Stabilization Phase|Other|0|||
25055204|NCT01662310|50159162|FG000|Double-Blind Phase|Adverse Event|0|||
25055205|NCT01662310|50159163|FG001|Double-Blind Phase|Adverse Event|0|||
25055206|NCT01662310|50159164|FG002|Double-Blind Phase|Adverse Event|1|||
25055207|NCT01662310|50159165|FG003|Double-Blind Phase|Adverse Event|0|||
25055208|NCT01662310|50159166|FG004|Double-Blind Phase|Adverse Event|0|||
25055209|NCT01662310|50159162|FG000|Double-Blind Phase|Lost to Follow-up|0|||
25055210|NCT01662310|50159163|FG001|Double-Blind Phase|Lost to Follow-up|3|||
25055211|NCT01662310|50159164|FG002|Double-Blind Phase|Lost to Follow-up|0|||
25055212|NCT01662310|50159165|FG003|Double-Blind Phase|Lost to Follow-up|0|||
25055213|NCT01662310|50159166|FG004|Double-Blind Phase|Lost to Follow-up|0|||
25055214|NCT01662310|50159162|FG000|Double-Blind Phase|Pregnancy|0|||
25055215|NCT01662310|50159163|FG001|Double-Blind Phase|Pregnancy|2|||
25055216|NCT01662310|50159164|FG002|Double-Blind Phase|Pregnancy|0|||
24962992|NCT00262080|50053045|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
25055217|NCT01662310|50159165|FG003|Double-Blind Phase|Pregnancy|0|||
25055218|NCT01662310|50159166|FG004|Double-Blind Phase|Pregnancy|0|||
25055219|NCT01662310|50159162|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
25055220|NCT01662310|50159163|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
25055221|NCT01662310|50159164|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
25055222|NCT01662310|50159165|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
25055223|NCT01662310|50159166|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
25055224|NCT01662310|50159162|FG000|Double-Blind Phase|Other|0|||
25055225|NCT01662310|50159163|FG001|Double-Blind Phase|Other|0|||
25055226|NCT01662310|50159164|FG002|Double-Blind Phase|Other|1|||
25055227|NCT01662310|50159165|FG003|Double-Blind Phase|Other|0|||
25055228|NCT01662310|50159166|FG004|Double-Blind Phase|Other|0|||
25055229|NCT01662310|50159162|FG000|Double-Blind Phase|Randomized but not treated|0|||
25055230|NCT01662310|50159163|FG001|Double-Blind Phase|Randomized but not treated|1|||
25055231|NCT01662310|50159164|FG002|Double-Blind Phase|Randomized but not treated|0|||
25055232|NCT01662310|50159165|FG003|Double-Blind Phase|Randomized but not treated|0|||
25055233|NCT01662310|50159166|FG004|Double-Blind Phase|Randomized but not treated|0|||
25055234|NCT01662310|50159162|FG000|Open-Label Extension Phase|Adverse Event|0|||
25055235|NCT01662310|50159163|FG001|Open-Label Extension Phase|Adverse Event|0|||
25055236|NCT01662310|50159164|FG002|Open-Label Extension Phase|Adverse Event|0|||
25055237|NCT01662310|50159165|FG003|Open-Label Extension Phase|Adverse Event|3|||
25055238|NCT01662310|50159166|FG004|Open-Label Extension Phase|Adverse Event|0|||
25055239|NCT01662310|50159162|FG000|Open-Label Extension Phase|Death|0|||
25055240|NCT01662310|50159163|FG001|Open-Label Extension Phase|Death|0|||
25055241|NCT01662310|50159164|FG002|Open-Label Extension Phase|Death|0|||
25055242|NCT01662310|50159165|FG003|Open-Label Extension Phase|Death|1|||
25055243|NCT01662310|50159166|FG004|Open-Label Extension Phase|Death|0|||
25055244|NCT01662310|50159162|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
25055245|NCT01662310|50159163|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
25055246|NCT01662310|50159164|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
25055247|NCT01662310|50159165|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
25055248|NCT01662310|50159166|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
25055249|NCT01662310|50159162|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
25055250|NCT01662310|50159163|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
25055251|NCT01662310|50159164|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
25055252|NCT01662310|50159165|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
25055253|NCT01662310|50159166|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
25055254|NCT01662310|50159162|FG000|Open-Label Extension Phase|Pregnancy|0|||
25055255|NCT01662310|50159163|FG001|Open-Label Extension Phase|Pregnancy|0|||
25055256|NCT01662310|50159164|FG002|Open-Label Extension Phase|Pregnancy|0|||
25055257|NCT01662310|50159165|FG003|Open-Label Extension Phase|Pregnancy|1|||
25055258|NCT01662310|50159166|FG004|Open-Label Extension Phase|Pregnancy|0|||
25055259|NCT01662310|50159162|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
25055260|NCT01662310|50159163|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
25055261|NCT01662310|50159164|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
25276630|NCT01241552|50590590|FG000|Overall Study|Death|26|||
24962993|NCT00282308|50053055|FG000|Treatment Period|Lost to Follow-up|1|||
24962994|NCT00282308|50053056|FG001|Treatment Period|Lost to Follow-up|0|||
24962995|NCT00282308|50053057|FG002|Treatment Period|Lost to Follow-up|0|||
24962996|NCT00282308|50053055|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
24962997|NCT00282308|50053056|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
24962998|NCT00282308|50053057|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
24962999|NCT00282308|50053055|FG000|Treatment Period|Adverse Event|0|||
24963000|NCT00282308|50053056|FG001|Treatment Period|Adverse Event|2|||
24963001|NCT00282308|50053057|FG002|Treatment Period|Adverse Event|0|||
24963002|NCT00282308|50053055|FG000|Treatment Period|Not Treated with Study Drug|1|||
24963003|NCT00282308|50053056|FG001|Treatment Period|Not Treated with Study Drug|0|||
24963004|NCT00282308|50053057|FG002|Treatment Period|Not Treated with Study Drug|0|||
24963005|NCT00282308|50053055|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
24963006|NCT00282308|50053056|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
24963007|NCT00282308|50053057|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
24963008|NCT00282308|50053055|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
24963009|NCT00282308|50053056|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
25055262|NCT01662310|50159165|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
25055263|NCT01662310|50159166|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
25055264|NCT00700622|50159180|FG000|Overall Study|Adverse Event|4|||
25055265|NCT00700622|50159181|FG001|Overall Study|Adverse Event|0|||
25055266|NCT00700622|50159180|FG000|Overall Study|Lost to Follow-up|0|||
25055267|NCT00700622|50159181|FG001|Overall Study|Lost to Follow-up|1|||
25055268|NCT00700622|50159180|FG000|Overall Study|Physician Decision|2|||
25055269|NCT00700622|50159181|FG001|Overall Study|Physician Decision|1|||
25055270|NCT00700622|50159180|FG000|Overall Study|Protocol Violation|0|||
25055271|NCT00700622|50159181|FG001|Overall Study|Protocol Violation|1|||
24963010|NCT00282308|50053057|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
24963011|NCT00282308|50053055|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
24963012|NCT00282308|50053056|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
25055272|NCT00700622|50159180|FG000|Overall Study|Withdrawal by Subject|4|||
25055273|NCT00700622|50159181|FG001|Overall Study|Withdrawal by Subject|1|||
25055274|NCT00700622|50159180|FG000|Overall Study|Other|3|||
25055275|NCT00700622|50159181|FG001|Overall Study|Other|1|||
25055276|NCT02553928|50159189|FG000|Overall Study|Adverse Event|2|||
25055277|NCT02553928|50159190|FG001|Overall Study|Adverse Event|1|||
25055278|NCT02553928|50159189|FG000|Overall Study|Lost to Follow-up|0|||
24963013|NCT00282308|50053057|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
24963014|NCT00282308|50053055|FG000|Safety Follow-up Period|Adverse Event|0|||
24963015|NCT00282308|50053056|FG001|Safety Follow-up Period|Adverse Event|0|||
24963016|NCT00282308|50053057|FG002|Safety Follow-up Period|Adverse Event|1|||
24963017|NCT00282308|50053055|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
24963018|NCT00282308|50053056|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
24963019|NCT00282308|50053057|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
24963020|NCT00282308|50053055|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
24963021|NCT00282308|50053056|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
24963022|NCT00282308|50053057|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
24963023|NCT00282308|50053055|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
24963024|NCT00282308|50053056|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
24963025|NCT00282308|50053057|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
24963026|NCT00282152|50053069|FG000|Overall Study|Withdrawal by Subject|1|||
24963027|NCT00282152|50053070|FG001|Overall Study|Withdrawal by Subject|0|||
24963028|NCT00281840|50053077|FG000|Overall Study|Adverse Event|12|||
24963029|NCT00281840|50053077|FG000|Overall Study|Physician Decision|6|||
24963030|NCT00281840|50053077|FG000|Overall Study|Withdrawal by Subject|3|||
24963031|NCT00281840|50053077|FG000|Overall Study|Disease Progression|2|||
24963032|NCT00281840|50053077|FG000|Overall Study|exceed maximum delay in treatment|1|||
24963033|NCT00281840|50053077|FG000|Overall Study|Complicating Disease|1|||
24963034|NCT00281684|50053086|FG000|Overall Study|Lost to Follow-up|0|||
24963035|NCT00281684|50053087|FG001|Overall Study|Lost to Follow-up|0|||
25055279|NCT02553928|50159190|FG001|Overall Study|Lost to Follow-up|1|||
25055280|NCT02553928|50159189|FG000|Overall Study|Administrative reason(s)|0|||
25055281|NCT02553928|50159190|FG001|Overall Study|Administrative reason(s)|1|||
25055282|NCT03076775|50159199|FG000|Overall Study|Lost to Follow-up|1|||
25055283|NCT03076775|50159200|FG001|Overall Study|Lost to Follow-up|0|||
25055284|NCT03058991|50159217|FG000|Overall Study|Lost to Follow-up|17|||
25055285|NCT03058991|50159218|FG001|Overall Study|Lost to Follow-up|12|||
25055286|NCT03058991|50159219|FG002|Overall Study|Lost to Follow-up|12|||
25055287|NCT03058991|50159217|FG000|Overall Study|Withdrawal by Subject|1|||
25055288|NCT03058991|50159218|FG001|Overall Study|Withdrawal by Subject|0|||
25055289|NCT03058991|50159219|FG002|Overall Study|Withdrawal by Subject|0|||
25055290|NCT00700310|50159231|FG000|Overall Study|Adverse Event|6|||
25055291|NCT00700310|50159232|FG001|Overall Study|Adverse Event|10|||
25055292|NCT00700310|50159233|FG002|Overall Study|Adverse Event|5|||
25055293|NCT00700310|50159234|FG003|Overall Study|Adverse Event|11|||
25055294|NCT00700310|50159231|FG000|Overall Study|Lost to Follow-up|4|||
25055295|NCT00700310|50159232|FG001|Overall Study|Lost to Follow-up|1|||
25055296|NCT00700310|50159233|FG002|Overall Study|Lost to Follow-up|0|||
25055297|NCT00700310|50159234|FG003|Overall Study|Lost to Follow-up|1|||
25055298|NCT00700310|50159231|FG000|Overall Study|Withdrawal by Subject|8|||
25055299|NCT00700310|50159232|FG001|Overall Study|Withdrawal by Subject|9|||
25055300|NCT00700310|50159233|FG002|Overall Study|Withdrawal by Subject|8|||
25055301|NCT00700310|50159234|FG003|Overall Study|Withdrawal by Subject|8|||
25055302|NCT00700310|50159231|FG000|Overall Study|Lack of Efficacy|0|||
25055303|NCT00700310|50159232|FG001|Overall Study|Lack of Efficacy|3|||
25055304|NCT00700310|50159233|FG002|Overall Study|Lack of Efficacy|0|||
24963036|NCT00281684|50053088|FG002|Overall Study|Lost to Follow-up|1|||
24963037|NCT00281684|50053089|FG003|Overall Study|Lost to Follow-up|0|||
24963038|NCT00281684|50053086|FG000|Overall Study|Withdrawal by Subject|1|||
24963039|NCT00281684|50053087|FG001|Overall Study|Withdrawal by Subject|0|||
25055305|NCT00700310|50159234|FG003|Overall Study|Lack of Efficacy|1|||
25055306|NCT00700310|50159231|FG000|Overall Study|Administrative/Other|1|||
25055307|NCT00700310|50159232|FG001|Overall Study|Administrative/Other|3|||
25055308|NCT00700310|50159233|FG002|Overall Study|Administrative/Other|1|||
24963040|NCT00281684|50053088|FG002|Overall Study|Withdrawal by Subject|0|||
24963041|NCT00281684|50053089|FG003|Overall Study|Withdrawal by Subject|0|||
25055309|NCT00700310|50159234|FG003|Overall Study|Administrative/Other|3|||
25055310|NCT00700310|50159231|FG000|Overall Study|Randomized, Not Treated|2|||
25055311|NCT00700310|50159232|FG001|Overall Study|Randomized, Not Treated|0|||
25055312|NCT00700310|50159233|FG002|Overall Study|Randomized, Not Treated|2|||
25055313|NCT00700310|50159234|FG003|Overall Study|Randomized, Not Treated|2|||
25055314|NCT01575548|50159264|FG000|Overall Study|Adverse Event|15|||
25055315|NCT01575548|50159265|FG001|Overall Study|Adverse Event|2|||
25055316|NCT01575548|50159264|FG000|Overall Study|Disease progression|12|||
25055317|NCT01575548|50159265|FG001|Overall Study|Disease progression|25|||
25055318|NCT01575548|50159264|FG000|Overall Study|Death|1|||
25055319|NCT01575548|50159265|FG001|Overall Study|Death|0|||
25055320|NCT01575548|50159264|FG000|Overall Study|Other complicating disease|1|||
25055321|NCT01575548|50159265|FG001|Overall Study|Other complicating disease|0|||
25055322|NCT01575548|50159264|FG000|Overall Study|Withdrawal by Subject|7|||
25055323|NCT01575548|50159265|FG001|Overall Study|Withdrawal by Subject|3|||
25055324|NCT01575548|50159264|FG000|Overall Study|Noncompliance|1|||
25055325|NCT01575548|50159265|FG001|Overall Study|Noncompliance|0|||
25055326|NCT01575548|50159264|FG000|Overall Study|Anticipated surgery|0|||
25055327|NCT01575548|50159265|FG001|Overall Study|Anticipated surgery|1|||
25055328|NCT01575548|50159264|FG000|Overall Study|Never started protocol therapy|3|||
25055329|NCT01575548|50159265|FG001|Overall Study|Never started protocol therapy|2|||
25055330|NCT01750281|50159274|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
25055331|NCT01750281|50159275|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
25055332|NCT01750281|50159276|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
25055333|NCT01750281|50159274|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
25055334|NCT01750281|50159275|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
25055335|NCT01750281|50159276|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
25055336|NCT01750281|50159274|FG000|Overall Study|Did not receive treatment|0|||
25055337|NCT01750281|50159275|FG001|Overall Study|Did not receive treatment|1|||
25055338|NCT01750281|50159276|FG002|Overall Study|Did not receive treatment|0|||
25055339|NCT03000569|50159303|FG000|Overall Study|Withdrawal by Subject|1|||
25055340|NCT03000569|50159304|FG001|Overall Study|Withdrawal by Subject|0|||
25055341|NCT02554786|50159323|FG000|Overall Study|Subject/guardian decision|29|||
25055342|NCT02554786|50159324|FG001|Overall Study|Subject/guardian decision|17|||
25055343|NCT02554786|50159325|FG002|Overall Study|Subject/guardian decision|18|||
25055344|NCT02554786|50159326|FG003|Overall Study|Subject/guardian decision|30|||
25055345|NCT02554786|50159327|FG004|Overall Study|Subject/guardian decision|20|||
25055346|NCT02554786|50159323|FG000|Overall Study|Lost to Follow-up|4|||
25055347|NCT02554786|50159324|FG001|Overall Study|Lost to Follow-up|3|||
25055348|NCT02554786|50159325|FG002|Overall Study|Lost to Follow-up|4|||
25055349|NCT02554786|50159326|FG003|Overall Study|Lost to Follow-up|2|||
25055350|NCT02554786|50159327|FG004|Overall Study|Lost to Follow-up|2|||
25055351|NCT02554786|50159323|FG000|Overall Study|Protocol deviation|1|||
25055352|NCT02554786|50159324|FG001|Overall Study|Protocol deviation|3|||
25055353|NCT02554786|50159325|FG002|Overall Study|Protocol deviation|3|||
25055354|NCT02554786|50159326|FG003|Overall Study|Protocol deviation|4|||
25055355|NCT02554786|50159327|FG004|Overall Study|Protocol deviation|2|||
25055356|NCT02554786|50159323|FG000|Overall Study|Technical problems|1|||
25055357|NCT02554786|50159324|FG001|Overall Study|Technical problems|1|||
25055358|NCT02554786|50159325|FG002|Overall Study|Technical problems|0|||
25055359|NCT02554786|50159326|FG003|Overall Study|Technical problems|2|||
25055360|NCT02554786|50159327|FG004|Overall Study|Technical problems|1|||
25055361|NCT02554786|50159323|FG000|Overall Study|Adverse Event|0|||
25055362|NCT02554786|50159324|FG001|Overall Study|Adverse Event|0|||
25055363|NCT02554786|50159325|FG002|Overall Study|Adverse Event|0|||
25055364|NCT02554786|50159326|FG003|Overall Study|Adverse Event|0|||
25055365|NCT02554786|50159327|FG004|Overall Study|Adverse Event|2|||
25276631|NCT01241552|50590591|FG001|Overall Study|Death|30|||
25055366|NCT02554786|50159323|FG000|Overall Study|Death|0|||
25055367|NCT02554786|50159324|FG001|Overall Study|Death|0|||
25055368|NCT02554786|50159325|FG002|Overall Study|Death|0|||
25276632|NCT01241552|50590592|FG002|Overall Study|Death|20|||
25276633|NCT01241552|50590593|FG003|Overall Study|Death|25|||
25055369|NCT02554786|50159326|FG003|Overall Study|Death|1|||
25055370|NCT02554786|50159327|FG004|Overall Study|Death|0|||
25055371|NCT02554786|50159323|FG000|Overall Study|Non-compliance with study treatment|0|||
25055372|NCT02554786|50159324|FG001|Overall Study|Non-compliance with study treatment|1|||
25055373|NCT02554786|50159325|FG002|Overall Study|Non-compliance with study treatment|1|||
25055374|NCT02554786|50159326|FG003|Overall Study|Non-compliance with study treatment|0|||
25055375|NCT02554786|50159327|FG004|Overall Study|Non-compliance with study treatment|1|||
24963042|NCT00272792|50053103|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
25055376|NCT02554786|50159323|FG000|Overall Study|Physician Decision|0|||
25055377|NCT02554786|50159324|FG001|Overall Study|Physician Decision|1|||
25055378|NCT02554786|50159325|FG002|Overall Study|Physician Decision|4|||
25055379|NCT02554786|50159326|FG003|Overall Study|Physician Decision|1|||
25055380|NCT02554786|50159327|FG004|Overall Study|Physician Decision|1|||
25055381|NCT02554786|50159323|FG000|Overall Study|Pregnancy|0|||
25055382|NCT02554786|50159324|FG001|Overall Study|Pregnancy|0|||
25055383|NCT02554786|50159325|FG002|Overall Study|Pregnancy|0|||
25055384|NCT02554786|50159326|FG003|Overall Study|Pregnancy|1|||
25055385|NCT02554786|50159327|FG004|Overall Study|Pregnancy|1|||
25055386|NCT02893930|50159343|FG000|Overall Study|Adverse Event|3|||
25055387|NCT02893930|50159343|FG000|Overall Study|Death|1|||
25055388|NCT02893930|50159343|FG000|Overall Study|Disease progression|5|||
25055389|NCT02893930|50159343|FG000|Overall Study|Withdrawal by Subject|2|||
25055390|NCT02893930|50159343|FG000|Overall Study|Physician Decision|1|||
25055391|NCT02893930|50159343|FG000|Overall Study|Ineligible|1|||
25055392|NCT01347645|50159352|FG000|Overall Study|Death|1|||
25055393|NCT01347645|50159353|FG001|Overall Study|Death|5|||
25055394|NCT01347645|50159354|FG002|Overall Study|Death|2|||
25055395|NCT01347645|50159355|FG003|Overall Study|Death|7|||
25055396|NCT01347645|50159356|FG004|Overall Study|Death|7|||
25055397|NCT01347645|50159352|FG000|Overall Study|Lost to Follow-up|1|||
25055398|NCT01347645|50159353|FG001|Overall Study|Lost to Follow-up|1|||
25055399|NCT01347645|50159354|FG002|Overall Study|Lost to Follow-up|0|||
25276634|NCT01241552|50590590|FG000|Overall Study|Adverse Event|1|||
25276635|NCT01241552|50590591|FG001|Overall Study|Adverse Event|1|||
24963043|NCT00272792|50053104|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
24963044|NCT00272792|50053103|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
24963045|NCT00272792|50053104|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
24963046|NCT00272792|50053103|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
24963047|NCT00272792|50053104|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
24963048|NCT00272792|50053103|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
24963049|NCT00272792|50053104|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
24963050|NCT00048568|50053112|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
24963051|NCT00048568|50053113|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
24963052|NCT00048568|50053114|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
24963053|NCT00048568|50053112|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
24963054|NCT00048568|50053113|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
24963055|NCT00048568|50053114|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
24963056|NCT00048568|50053112|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
24963057|NCT00048568|50053113|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
24963058|NCT00048568|50053114|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
24963059|NCT00048568|50053112|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
24963060|NCT00048568|50053113|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
24963061|NCT00048568|50053114|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
24963062|NCT00048568|50053112|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
24963063|NCT00048568|50053113|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
24963064|NCT00048568|50053114|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
24963065|NCT00048568|50053112|FG000|Double-Blind Period Days 170 to 365|Death|1|||
24963066|NCT00048568|50053113|FG001|Double-Blind Period Days 170 to 365|Death|1|||
24963067|NCT00048568|50053114|FG002|Double-Blind Period Days 170 to 365|Death|0|||
24963068|NCT00048568|50053112|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
24963069|NCT00048568|50053113|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
24963070|NCT00048568|50053114|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
24963071|NCT00048568|50053112|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
24963072|NCT00048568|50053113|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
24963073|NCT00048568|50053114|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
25055400|NCT01347645|50159355|FG003|Overall Study|Lost to Follow-up|1|||
25055401|NCT01347645|50159356|FG004|Overall Study|Lost to Follow-up|1|||
25055402|NCT01347645|50159352|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
25055403|NCT01347645|50159353|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
25055404|NCT01347645|50159354|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
25055405|NCT01347645|50159355|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
25162707|NCT01278160|50285046|FG001|Overall Study|Adverse Event|1|||
24963074|NCT00048568|50053112|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
24963075|NCT00048568|50053113|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
24963076|NCT00048568|50053114|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
24963077|NCT00048568|50053112|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
24963078|NCT00048568|50053113|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
24963079|NCT00048568|50053114|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
24963080|NCT00048568|50053112|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
24963081|NCT00048568|50053113|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
24963082|NCT00048568|50053114|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
24963083|NCT00048568|50053112|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
25055406|NCT01347645|50159356|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
25055407|NCT01347645|50159352|FG000|Overall Study|Other|1|||
25055408|NCT01347645|50159353|FG001|Overall Study|Other|0|||
25055409|NCT01347645|50159354|FG002|Overall Study|Other|0|||
25055410|NCT01347645|50159355|FG003|Overall Study|Other|0|||
25055411|NCT01347645|50159356|FG004|Overall Study|Other|1|||
25055412|NCT01347645|50159352|FG000|Overall Study|Withdrawal by Subject|0|||
25055413|NCT01347645|50159353|FG001|Overall Study|Withdrawal by Subject|0|||
24963084|NCT00048568|50053113|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
24963085|NCT00048568|50053114|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
24963086|NCT00048568|50053112|FG000|Open-Label Period|Death|0|||
24963087|NCT00048568|50053113|FG001|Open-Label Period|Death|0|||
24963088|NCT00048568|50053114|FG002|Open-Label Period|Death|13|||
24963089|NCT00048568|50053112|FG000|Open-Label Period|Adverse Event|0|||
24963090|NCT00048568|50053113|FG001|Open-Label Period|Adverse Event|0|||
24963091|NCT00048568|50053114|FG002|Open-Label Period|Adverse Event|49|||
24963092|NCT00048568|50053112|FG000|Open-Label Period|Lack of Efficacy|0|||
24963093|NCT00048568|50053113|FG001|Open-Label Period|Lack of Efficacy|0|||
24963094|NCT00048568|50053114|FG002|Open-Label Period|Lack of Efficacy|32|||
24963095|NCT00048568|50053112|FG000|Open-Label Period|Withdrawal by Subject|0|||
24963096|NCT00048568|50053113|FG001|Open-Label Period|Withdrawal by Subject|0|||
24963097|NCT00048568|50053114|FG002|Open-Label Period|Withdrawal by Subject|26|||
24963098|NCT00048568|50053112|FG000|Open-Label Period|Pregnancy|0|||
24963099|NCT00048568|50053113|FG001|Open-Label Period|Pregnancy|0|||
24963100|NCT00048568|50053114|FG002|Open-Label Period|Pregnancy|5|||
24963101|NCT00048568|50053112|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
24963102|NCT00048568|50053113|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
25055414|NCT01347645|50159354|FG002|Overall Study|Withdrawal by Subject|0|||
25162708|NCT01278160|50285045|FG000|Overall Study|Lost to Follow-up|0|||
25162709|NCT01278160|50285046|FG001|Overall Study|Lost to Follow-up|1|||
25162710|NCT01278160|50285045|FG000|Overall Study|Withdrawal by Subject|3|||
25162711|NCT01278160|50285046|FG001|Overall Study|Withdrawal by Subject|2|||
25055415|NCT01347645|50159355|FG003|Overall Study|Withdrawal by Subject|3|||
25055416|NCT01347645|50159356|FG004|Overall Study|Withdrawal by Subject|3|||
25055417|NCT01347645|50159352|FG000|Overall Study|Physician Decision|0|||
25055418|NCT01347645|50159353|FG001|Overall Study|Physician Decision|0|||
25055419|NCT01347645|50159354|FG002|Overall Study|Physician Decision|0|||
25055420|NCT01347645|50159355|FG003|Overall Study|Physician Decision|0|||
25055421|NCT01347645|50159356|FG004|Overall Study|Physician Decision|1|||
25055422|NCT01347645|50159352|FG000|Overall Study|Adverse Event|0|||
25055423|NCT01347645|50159353|FG001|Overall Study|Adverse Event|0|||
25055424|NCT01347645|50159354|FG002|Overall Study|Adverse Event|0|||
25055425|NCT01347645|50159355|FG003|Overall Study|Adverse Event|1|||
25055426|NCT01347645|50159356|FG004|Overall Study|Adverse Event|1|||
25055427|NCT00484419|50159394|FG000|Overall Study|Adverse Event|3|||
25055428|NCT00484419|50159395|FG001|Overall Study|Adverse Event|0|||
25055429|NCT00484419|50159396|FG002|Overall Study|Adverse Event|0|||
25055430|NCT00484419|50159394|FG000|Overall Study|Lost to Follow-up|1|||
25055431|NCT00484419|50159395|FG001|Overall Study|Lost to Follow-up|0|||
25055432|NCT00484419|50159396|FG002|Overall Study|Lost to Follow-up|2|||
25162712|NCT01278160|50285045|FG000|Overall Study|Unclassified|1|||
25162713|NCT01278160|50285046|FG001|Overall Study|Unclassified|2|||
25162714|NCT01996241|50285054|FG000|Overall Study|Lost to Follow-up|252|||
25162715|NCT01996241|50285055|FG001|Overall Study|Lost to Follow-up|235|||
24963103|NCT00048568|50053114|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
24963104|NCT00048568|50053112|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
24963105|NCT00048568|50053113|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
24963106|NCT00048568|50053114|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
24963107|NCT00048568|50053112|FG000|Open-Label Period|Unknown Reasons|0|||
24963108|NCT00048568|50053113|FG001|Open-Label Period|Unknown Reasons|0|||
24963109|NCT00048568|50053114|FG002|Open-Label Period|Unknown Reasons|25|||
24963110|NCT00048568|50053112|FG000|Open-Label Period|Lost to Follow-up|0|||
25055433|NCT00484419|50159394|FG000|Overall Study|Withdrawal by Subject|3|||
25055434|NCT00484419|50159395|FG001|Overall Study|Withdrawal by Subject|1|||
25162716|NCT02091869|50285065|FG000|Overall Study|Withdrawal by Subject|0|||
25162717|NCT02091869|50285066|FG001|Overall Study|Withdrawal by Subject|3|||
25055435|NCT00484419|50159396|FG002|Overall Study|Withdrawal by Subject|1|||
25055436|NCT00484419|50159394|FG000|Overall Study|subject met discontinuation criteria|2|||
25055437|NCT00484419|50159395|FG001|Overall Study|subject met discontinuation criteria|2|||
25055438|NCT00484419|50159396|FG002|Overall Study|subject met discontinuation criteria|4|||
25055439|NCT00484419|50159394|FG000|Overall Study|required restricted medication|1|||
25055440|NCT00484419|50159395|FG001|Overall Study|required restricted medication|0|||
25055441|NCT00484419|50159396|FG002|Overall Study|required restricted medication|1|||
25055442|NCT00484419|50159394|FG000|Overall Study|Physician Decision|1|||
25055443|NCT00484419|50159395|FG001|Overall Study|Physician Decision|1|||
25055444|NCT00484419|50159396|FG002|Overall Study|Physician Decision|1|||
25055445|NCT00484419|50159394|FG000|Overall Study|subject unable to receive medication|1|||
25055446|NCT00484419|50159395|FG001|Overall Study|subject unable to receive medication|0|||
24963111|NCT00048568|50053113|FG001|Open-Label Period|Lost to Follow-up|0|||
24963112|NCT00048568|50053114|FG002|Open-Label Period|Lost to Follow-up|7|||
24963113|NCT00262002|50053142|FG000|Overall Study|Adverse Event|2|||
24963114|NCT00262002|50053143|FG001|Overall Study|Adverse Event|1|||
24963115|NCT00262002|50053144|FG002|Overall Study|Adverse Event|0|||
24963116|NCT00262002|50053145|FG003|Overall Study|Adverse Event|0|||
24963117|NCT00262002|50053146|FG004|Overall Study|Adverse Event|0|||
24963118|NCT00262002|50053147|FG005|Overall Study|Adverse Event|1|||
24963119|NCT00262002|50053148|FG006|Overall Study|Adverse Event|0|||
24963120|NCT00262002|50053142|FG000|Overall Study|Withdrawal by Subject|4|||
24963121|NCT00262002|50053143|FG001|Overall Study|Withdrawal by Subject|2|||
24963122|NCT00262002|50053144|FG002|Overall Study|Withdrawal by Subject|0|||
24963123|NCT00262002|50053145|FG003|Overall Study|Withdrawal by Subject|1|||
24963124|NCT00262002|50053146|FG004|Overall Study|Withdrawal by Subject|2|||
24963125|NCT00262002|50053147|FG005|Overall Study|Withdrawal by Subject|2|||
24963126|NCT00262002|50053148|FG006|Overall Study|Withdrawal by Subject|2|||
24963127|NCT00262002|50053142|FG000|Overall Study|Lost to Follow-up|2|||
24963128|NCT00262002|50053143|FG001|Overall Study|Lost to Follow-up|0|||
24963129|NCT00262002|50053144|FG002|Overall Study|Lost to Follow-up|0|||
24963130|NCT00262002|50053145|FG003|Overall Study|Lost to Follow-up|2|||
24963131|NCT00262002|50053146|FG004|Overall Study|Lost to Follow-up|0|||
24963132|NCT00262002|50053147|FG005|Overall Study|Lost to Follow-up|1|||
24963133|NCT00262002|50053148|FG006|Overall Study|Lost to Follow-up|0|||
24963134|NCT00262002|50053142|FG000|Overall Study|Inapropriate enrollment|0|||
24963135|NCT00262002|50053143|FG001|Overall Study|Inapropriate enrollment|1|||
24963136|NCT00262002|50053144|FG002|Overall Study|Inapropriate enrollment|0|||
24963137|NCT00262002|50053145|FG003|Overall Study|Inapropriate enrollment|0|||
24963138|NCT00262002|50053146|FG004|Overall Study|Inapropriate enrollment|0|||
25055447|NCT00484419|50159396|FG002|Overall Study|subject unable to receive medication|0|||
25055448|NCT00484419|50159394|FG000|Overall Study|subject relocated|0|||
25055449|NCT00484419|50159395|FG001|Overall Study|subject relocated|1|||
25055450|NCT00484419|50159396|FG002|Overall Study|subject relocated|0|||
25055451|NCT00484419|50159394|FG000|Overall Study|sponsor decision, randomized in error|0|||
25055452|NCT00484419|50159395|FG001|Overall Study|sponsor decision, randomized in error|0|||
25055453|NCT00484419|50159396|FG002|Overall Study|sponsor decision, randomized in error|2|||
25055454|NCT03220724|50159405|FG000|Overall Study|Lost to Follow-up|2|||
25055455|NCT03220724|50159406|FG001|Overall Study|Lost to Follow-up|1|||
25055456|NCT03220724|50159407|FG002|Overall Study|Lost to Follow-up|0|||
25055457|NCT03220724|50159408|FG003|Overall Study|Lost to Follow-up|3|||
25055458|NCT03220724|50159405|FG000|Overall Study|Withdrawal by Subject|1|||
25055459|NCT03220724|50159406|FG001|Overall Study|Withdrawal by Subject|1|||
25055460|NCT03220724|50159407|FG002|Overall Study|Withdrawal by Subject|1|||
25055461|NCT03220724|50159408|FG003|Overall Study|Withdrawal by Subject|0|||
25055462|NCT02549092|50159420|FG000|Treatment Period|Adverse Event|2|||
25055463|NCT02549092|50159421|FG001|Treatment Period|Adverse Event|2|||
25055464|NCT02549092|50159420|FG000|Treatment Period|Withdrawal by Subject|1|||
25055465|NCT02549092|50159421|FG001|Treatment Period|Withdrawal by Subject|3|||
25276636|NCT01241552|50590592|FG002|Overall Study|Adverse Event|0|||
24963139|NCT00262002|50053147|FG005|Overall Study|Inapropriate enrollment|0|||
24963140|NCT00262002|50053148|FG006|Overall Study|Inapropriate enrollment|0|||
24963141|NCT00262002|50053142|FG000|Overall Study|Protocol Violation|3|||
24963142|NCT00262002|50053143|FG001|Overall Study|Protocol Violation|2|||
24963143|NCT00262002|50053144|FG002|Overall Study|Protocol Violation|0|||
24963144|NCT00262002|50053145|FG003|Overall Study|Protocol Violation|2|||
24963145|NCT00262002|50053146|FG004|Overall Study|Protocol Violation|5|||
24963146|NCT00262002|50053147|FG005|Overall Study|Protocol Violation|3|||
24963147|NCT00262002|50053148|FG006|Overall Study|Protocol Violation|2|||
24963148|NCT00262002|50053142|FG000|Overall Study|Unable to classify|0|||
24963149|NCT00262002|50053143|FG001|Overall Study|Unable to classify|0|||
24963150|NCT00262002|50053144|FG002|Overall Study|Unable to classify|0|||
25055466|NCT02549092|50159420|FG000|Treatment Period|Lack of Efficacy|0|||
25055467|NCT02549092|50159421|FG001|Treatment Period|Lack of Efficacy|2|||
25055468|NCT02549092|50159420|FG000|Extension/Transition Period|Still in Extension/Transition Period|4|||
24963151|NCT00262002|50053145|FG003|Overall Study|Unable to classify|0|||
24963152|NCT00262002|50053146|FG004|Overall Study|Unable to classify|0|||
24963153|NCT00262002|50053147|FG005|Overall Study|Unable to classify|0|||
24963154|NCT00262002|50053148|FG006|Overall Study|Unable to classify|2|||
24963155|NCT00281528|50053216|FG000|Overall Study|Progressive Disease|28|||
24963156|NCT00281528|50053217|FG001|Overall Study|Progressive Disease|18|||
24963157|NCT00281528|50053218|FG002|Overall Study|Progressive Disease|27|||
24963158|NCT00281528|50053216|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
24963159|NCT00281528|50053217|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
24963160|NCT00281528|50053218|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
24963161|NCT00281528|50053216|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
24963162|NCT00281528|50053217|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
24963163|NCT00281528|50053218|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
24963164|NCT00281528|50053216|FG000|Overall Study|Physician Decision|11|||
24963165|NCT00281528|50053217|FG001|Overall Study|Physician Decision|4|||
24963166|NCT00281528|50053218|FG002|Overall Study|Physician Decision|5|||
24963167|NCT00281528|50053216|FG000|Overall Study|Protocol Violation|1|||
24963168|NCT00281528|50053217|FG001|Overall Study|Protocol Violation|0|||
24963169|NCT00281528|50053218|FG002|Overall Study|Protocol Violation|1|||
24963170|NCT00281528|50053216|FG000|Overall Study|Withdrawal by Subject|5|||
24963171|NCT00281528|50053217|FG001|Overall Study|Withdrawal by Subject|5|||
24963172|NCT00281528|50053218|FG002|Overall Study|Withdrawal by Subject|7|||
24963173|NCT00281528|50053216|FG000|Overall Study|Other|6|||
24963174|NCT00281528|50053217|FG001|Overall Study|Other|3|||
24963175|NCT00281528|50053218|FG002|Overall Study|Other|5|||
24963176|NCT00280748|50053226|FG000|Overall Study|Decline in performance|3|||
24963177|NCT00280748|50053226|FG000|Overall Study|Extra-cranial disease progression|1|||
24963178|NCT00271856|50053232|FG000|Overall Study|Withdrawal by Subject|1|||
24963179|NCT00271856|50053233|FG001|Overall Study|Withdrawal by Subject|7|||
24963180|NCT00271856|50053232|FG000|Overall Study|Lost to Follow-up|10|||
24963181|NCT00271856|50053233|FG001|Overall Study|Lost to Follow-up|11|||
24963182|NCT00061048|50053239|FG000|Overall Study|Adverse Event|2|||
24963183|NCT00061048|50053239|FG000|Overall Study|disease progression|20|||
24963184|NCT00270998|50053246|FG000|3 Month Follow-up|Adverse Event|1|||
24963185|NCT00270998|50053247|FG001|3 Month Follow-up|Adverse Event|0|||
24963186|NCT00270998|50053248|FG002|3 Month Follow-up|Adverse Event|0|||
24963187|NCT00270998|50053246|FG000|3 Month Follow-up|Lack of Efficacy|1|||
24963188|NCT00270998|50053247|FG001|3 Month Follow-up|Lack of Efficacy|2|||
24963189|NCT00270998|50053248|FG002|3 Month Follow-up|Lack of Efficacy|1|||
24963190|NCT00270998|50053246|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
24963191|NCT00270998|50053247|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
24963192|NCT00270998|50053248|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
24963193|NCT00270998|50053246|FG000|3 Month Follow-up|Pessary did not fit|12|||
24963194|NCT00270998|50053247|FG001|3 Month Follow-up|Pessary did not fit|0|||
24963195|NCT00270998|50053248|FG002|3 Month Follow-up|Pessary did not fit|0|||
24963196|NCT00270998|50053246|FG000|3 Month Follow-up|Personal/family health|1|||
24963197|NCT00270998|50053247|FG001|3 Month Follow-up|Personal/family health|1|||
24963198|NCT00270998|50053248|FG002|3 Month Follow-up|Personal/family health|0|||
24963199|NCT00270998|50053246|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
24963200|NCT00270998|50053247|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
24963201|NCT00270998|50053248|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
24963202|NCT00270998|50053246|FG000|12 Month Follow-up|Lack of Efficacy|5|||
24963203|NCT00270998|50053247|FG001|12 Month Follow-up|Lack of Efficacy|4|||
24963204|NCT00270998|50053248|FG002|12 Month Follow-up|Lack of Efficacy|3|||
24963205|NCT00270998|50053246|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
24963206|NCT00270998|50053247|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
24963207|NCT00270998|50053248|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
24963208|NCT00270998|50053246|FG000|12 Month Follow-up|Pessary did not fit|1|||
24963209|NCT00270998|50053247|FG001|12 Month Follow-up|Pessary did not fit|0|||
24963210|NCT00270998|50053248|FG002|12 Month Follow-up|Pessary did not fit|0|||
24963211|NCT00270998|50053246|FG000|12 Month Follow-up|Personal/family health|0|||
24963212|NCT00270998|50053247|FG001|12 Month Follow-up|Personal/family health|5|||
24963213|NCT00270998|50053248|FG002|12 Month Follow-up|Personal/family health|1|||
24963214|NCT00270998|50053246|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
24963215|NCT00270998|50053247|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
24963216|NCT00270998|50053248|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
24963217|NCT00279812|50053264|FG000|Overall Study|Protocol Violation|1|||
24963218|NCT00279812|50053265|FG001|Overall Study|Protocol Violation|1|||
24963219|NCT00279812|50053266|FG002|Overall Study|Protocol Violation|0|||
24963220|NCT00279812|50053267|FG003|Overall Study|Protocol Violation|0|||
24963221|NCT00279812|50053268|FG004|Overall Study|Protocol Violation|1|||
24963222|NCT00279812|50053269|FG005|Overall Study|Protocol Violation|0|||
24963223|NCT00279812|50053264|FG000|Overall Study|Withdrawal by Subject|0|||
24963224|NCT00279812|50053265|FG001|Overall Study|Withdrawal by Subject|4|||
24963225|NCT00279812|50053266|FG002|Overall Study|Withdrawal by Subject|2|||
24963226|NCT00279812|50053267|FG003|Overall Study|Withdrawal by Subject|0|||
24963227|NCT00279812|50053268|FG004|Overall Study|Withdrawal by Subject|0|||
24963228|NCT00279812|50053269|FG005|Overall Study|Withdrawal by Subject|0|||
24963229|NCT00279812|50053264|FG000|Overall Study|Adverse Event|0|||
24963230|NCT00279812|50053265|FG001|Overall Study|Adverse Event|1|||
24963231|NCT00279812|50053266|FG002|Overall Study|Adverse Event|1|||
24963232|NCT00279812|50053267|FG003|Overall Study|Adverse Event|0|||
24963233|NCT00279812|50053268|FG004|Overall Study|Adverse Event|2|||
24963234|NCT00279812|50053269|FG005|Overall Study|Adverse Event|1|||
24963235|NCT00207714|50053288|FG000|Overall Study|Adverse Event|6|||
24963236|NCT00207714|50053289|FG001|Overall Study|Adverse Event|2|||
24963237|NCT00207714|50053290|FG002|Overall Study|Adverse Event|4|||
24963238|NCT00207714|50053291|FG003|Overall Study|Adverse Event|3|||
24963239|NCT00207714|50053292|FG004|Overall Study|Adverse Event|1|||
24963240|NCT00207714|50053288|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
25055469|NCT02549092|50159421|FG001|Extension/Transition Period|Still in Extension/Transition Period|8|||
25055470|NCT02549092|50159420|FG000|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1|||
25055471|NCT02549092|50159421|FG001|Extension/Transition Period|Premature Discontinuation for Unspecified Reason|1|||
25055472|NCT03056573|50159432|FG000|Overall Study|Death|2|||
25055473|NCT03056573|50159433|FG001|Overall Study|Death|4|||
25055474|NCT03056573|50159432|FG000|Overall Study|Withdrawal by Subject|2|||
25055475|NCT03056573|50159433|FG001|Overall Study|Withdrawal by Subject|0|||
25055476|NCT03056573|50159432|FG000|Overall Study|Lost to Follow-up|1|||
25055477|NCT03056573|50159433|FG001|Overall Study|Lost to Follow-up|1|||
25055478|NCT02553772|50159441|FG000|Overall Study|Adverse Event|2|||
25055479|NCT02553772|50159442|FG001|Overall Study|Adverse Event|3|||
25055480|NCT02553772|50159441|FG000|Overall Study|Lost to Follow-up|2|||
25055481|NCT02553772|50159442|FG001|Overall Study|Lost to Follow-up|1|||
25162718|NCT01981109|50285081|FG000|Overall Study|Death|36|||
25162719|NCT01981109|50285081|FG000|Overall Study|Withdrawal by Subject|40|||
24963241|NCT00207714|50053289|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
24963242|NCT00207714|50053290|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
24963243|NCT00207714|50053291|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
24963244|NCT00207714|50053292|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
24963245|NCT00207714|50053288|FG000|Overall Study|Other|3|||
24963246|NCT00207714|50053289|FG001|Overall Study|Other|2|||
24963247|NCT00207714|50053290|FG002|Overall Study|Other|5|||
24963248|NCT00207714|50053291|FG003|Overall Study|Other|1|||
24963249|NCT00207714|50053292|FG004|Overall Study|Other|0|||
24963250|NCT00207090|50053311|FG000|Overall Study|Study drug toxicity|3|||
24963251|NCT00207090|50053311|FG000|Overall Study|Chest wall mass larger|1|||
24963252|NCT00207090|50053311|FG000|Overall Study|Disease progression/relapse|2|||
24963253|NCT00207090|50053311|FG000|Overall Study|Physician Decision|1|||
24963254|NCT00059332|50053322|FG000|Overall Study|Withdrawal by Subject|2|||
24963255|NCT00059332|50053323|FG001|Overall Study|Withdrawal by Subject|1|||
24963256|NCT00059332|50053322|FG000|Overall Study|Lost to Follow-up|1|||
24963257|NCT00059332|50053323|FG001|Overall Study|Lost to Follow-up|1|||
24963258|NCT00233454|50053329|FG000|Overall Study|Death|6|||
24963259|NCT00047320|50053333|FG000|Overall Study|Lack of Efficacy|8|||
24963260|NCT00047320|50053333|FG000|Overall Study|Lost to Follow-up|1|||
24963261|NCT00047320|50053333|FG000|Overall Study|Physician Decision|8|||
24963262|NCT00047320|50053333|FG000|Overall Study|Withdrawal by Subject|9|||
24963263|NCT00047320|50053333|FG000|Overall Study|Ineligible|2|||
24963264|NCT00233064|50053339|FG000|Overall Study|Lost to Follow-up|7|||
24963265|NCT00233064|50053340|FG001|Overall Study|Lost to Follow-up|7|||
24963266|NCT00233064|50053339|FG000|Overall Study|Withdrawal by Subject|5|||
24963267|NCT00233064|50053340|FG001|Overall Study|Withdrawal by Subject|3|||
24963268|NCT00233064|50053339|FG000|Overall Study|Death|0|||
24963269|NCT00233064|50053340|FG001|Overall Study|Death|1|||
24963270|NCT00233064|50053339|FG000|Overall Study|Relocation|0|||
24963271|NCT00233064|50053340|FG001|Overall Study|Relocation|1|||
24963272|NCT00233064|50053339|FG000|Overall Study|Protocol Violation|1|||
24963273|NCT00233064|50053340|FG001|Overall Study|Protocol Violation|0|||
24963274|NCT00233064|50053339|FG000|Overall Study|Moved to Dom. Republic|1|||
24963275|NCT00233064|50053340|FG001|Overall Study|Moved to Dom. Republic|0|||
24963276|NCT00268892|50053350|FG000|Overall Study|Adverse Event|14|||
24963277|NCT00268892|50053351|FG001|Overall Study|Adverse Event|17|||
24963278|NCT00268892|50053352|FG002|Overall Study|Adverse Event|20|||
24963279|NCT00268892|50053350|FG000|Overall Study|Lack of Efficacy|1|||
24963280|NCT00268892|50053351|FG001|Overall Study|Lack of Efficacy|3|||
25055482|NCT02553772|50159441|FG000|Overall Study|Withdrawal of Consent|1|||
25162720|NCT01981109|50285081|FG000|Overall Study|Lost to Follow-up|9|||
25276637|NCT01241552|50590593|FG003|Overall Study|Adverse Event|0|||
24963281|NCT00268892|50053352|FG002|Overall Study|Lack of Efficacy|0|||
24963282|NCT00268892|50053350|FG000|Overall Study|Withdrawal by Subject|14|||
24963283|NCT00268892|50053351|FG001|Overall Study|Withdrawal by Subject|15|||
24963284|NCT00268892|50053352|FG002|Overall Study|Withdrawal by Subject|13|||
24963285|NCT00268892|50053350|FG000|Overall Study|Physician Decision|0|||
24963286|NCT00268892|50053351|FG001|Overall Study|Physician Decision|1|||
24963287|NCT00268892|50053352|FG002|Overall Study|Physician Decision|0|||
24963288|NCT00268892|50053350|FG000|Overall Study|Lost to Follow-up|5|||
25055483|NCT02553772|50159442|FG001|Overall Study|Withdrawal of Consent|1|||
25055484|NCT02553772|50159441|FG000|Overall Study|Lack of Efficacy|1|||
25055485|NCT02553772|50159442|FG001|Overall Study|Lack of Efficacy|0|||
25055486|NCT02553772|50159441|FG000|Overall Study|Other Miscellaneous Reasons|0|||
25055487|NCT02553772|50159442|FG001|Overall Study|Other Miscellaneous Reasons|1|||
25055488|NCT02553538|50159450|FG000|Overall Study|Could Not Reach by Telephone|133|||
25055489|NCT02553538|50159451|FG001|Overall Study|Could Not Reach by Telephone|0|||
25055490|NCT02553538|50159450|FG000|Overall Study|Died or Left Network|54|||
25055491|NCT02553538|50159451|FG001|Overall Study|Died or Left Network|56|||
25055492|NCT02548156|50159457|FG000|Washout Period 1|Lost to Follow-up|0|||
25055493|NCT02548156|50159458|FG001|Washout Period 1|Lost to Follow-up|0|||
25055494|NCT02548156|50159459|FG002|Washout Period 1|Lost to Follow-up|0|||
25055495|NCT02548156|50159460|FG003|Washout Period 1|Lost to Follow-up|0|||
25055496|NCT02548156|50159461|FG004|Washout Period 1|Lost to Follow-up|1|||
25055497|NCT02548156|50159462|FG005|Washout Period 1|Lost to Follow-up|0|||
25055498|NCT01503515|50159472|FG000|Overall Study|Adverse Event|4|||
25055499|NCT01503515|50159473|FG001|Overall Study|Adverse Event|5|||
25055500|NCT01503515|50159472|FG000|Overall Study|Death|0|||
25055501|NCT01503515|50159473|FG001|Overall Study|Death|1|||
25055502|NCT01503515|50159472|FG000|Overall Study|Physician Decision|14|||
25055503|NCT01503515|50159473|FG001|Overall Study|Physician Decision|23|||
25055504|NCT01503515|50159472|FG000|Overall Study|Withdrawal by Subject|0|||
25055505|NCT01503515|50159473|FG001|Overall Study|Withdrawal by Subject|1|||
25055506|NCT01503515|50159472|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
25055507|NCT01503515|50159473|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
25055508|NCT01503515|50159472|FG000|Overall Study|Ineligible|1|||
25055509|NCT01503515|50159473|FG001|Overall Study|Ineligible|1|||
25055510|NCT02742519|50159481|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
25055511|NCT02742519|50159482|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
25055512|NCT02742519|50159483|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
25055513|NCT02742519|50159481|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
25055514|NCT02742519|50159482|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
25055515|NCT02742519|50159483|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
25055516|NCT02742519|50159481|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
25055517|NCT02742519|50159482|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
25055518|NCT02742519|50159483|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
25055519|NCT01375010|50159493|FG000|Overall Study|Lost to Follow-up|8|||
25055520|NCT01375010|50159494|FG001|Overall Study|Lost to Follow-up|2|||
25055521|NCT01375010|50159493|FG000|Overall Study|Withdrawal by Subject|4|||
25055522|NCT01375010|50159494|FG001|Overall Study|Withdrawal by Subject|2|||
25055523|NCT00659061|50159518|FG000|Overall Study|Migration due to political unrest|21|||
25055524|NCT00659061|50159519|FG001|Overall Study|Migration due to political unrest|15|||
25055525|NCT02548078|50159536|FG000|Overall Study|Serious adverse event/Adverse event|1|||
25055526|NCT02548078|50159537|FG001|Overall Study|Serious adverse event/Adverse event|0|||
25055527|NCT02548078|50159536|FG000|Overall Study|Moved from study area|3|||
25055528|NCT02548078|50159537|FG001|Overall Study|Moved from study area|3|||
25055529|NCT02548078|50159536|FG000|Overall Study|Lost to Follow-up|1|||
25055530|NCT02548078|50159537|FG001|Overall Study|Lost to Follow-up|3|||
25055531|NCT02671435|50159565|FG000|Overall Study|Death|1|||
24963289|NCT00268892|50053351|FG001|Overall Study|Lost to Follow-up|2|||
24963290|NCT00268892|50053352|FG002|Overall Study|Lost to Follow-up|4|||
25055532|NCT02671435|50159566|FG001|Overall Study|Death|3|||
25055533|NCT02671435|50159567|FG002|Overall Study|Death|0|||
25055534|NCT02671435|50159568|FG003|Overall Study|Death|16|||
25055535|NCT02671435|50159569|FG004|Overall Study|Death|14|||
25055536|NCT02671435|50159570|FG005|Overall Study|Death|29|||
25055537|NCT02671435|50159571|FG006|Overall Study|Death|34|||
25055538|NCT02671435|50159572|FG007|Overall Study|Death|28|||
25055539|NCT02671435|50159573|FG008|Overall Study|Death|19|||
25055540|NCT02671435|50159574|FG009|Overall Study|Death|10|||
25055541|NCT02671435|50159575|FG010|Overall Study|Death|8|||
25055542|NCT02671435|50159576|FG011|Overall Study|Death|29|||
25055543|NCT02671435|50159577|FG012|Overall Study|Death|29|||
25055544|NCT02671435|50159578|FG013|Overall Study|Death|29|||
25055545|NCT02671435|50159579|FG014|Overall Study|Death|27|||
25055546|NCT02671435|50159565|FG000|Overall Study|Lost to Follow-up|0|||
25055547|NCT02671435|50159566|FG001|Overall Study|Lost to Follow-up|0|||
25055548|NCT02671435|50159567|FG002|Overall Study|Lost to Follow-up|1|||
25055549|NCT02671435|50159568|FG003|Overall Study|Lost to Follow-up|0|||
25055550|NCT02671435|50159569|FG004|Overall Study|Lost to Follow-up|1|||
25055551|NCT02671435|50159570|FG005|Overall Study|Lost to Follow-up|1|||
25055552|NCT02671435|50159571|FG006|Overall Study|Lost to Follow-up|2|||
25055553|NCT02671435|50159572|FG007|Overall Study|Lost to Follow-up|2|||
25055554|NCT02671435|50159573|FG008|Overall Study|Lost to Follow-up|0|||
25055555|NCT02671435|50159574|FG009|Overall Study|Lost to Follow-up|2|||
25055556|NCT02671435|50159575|FG010|Overall Study|Lost to Follow-up|0|||
25055557|NCT02671435|50159576|FG011|Overall Study|Lost to Follow-up|3|||
25055558|NCT02671435|50159577|FG012|Overall Study|Lost to Follow-up|3|||
25055559|NCT02671435|50159578|FG013|Overall Study|Lost to Follow-up|2|||
25055560|NCT02671435|50159579|FG014|Overall Study|Lost to Follow-up|0|||
25055561|NCT02671435|50159565|FG000|Overall Study|Withdrawal by Subject|2|||
25055562|NCT02671435|50159566|FG001|Overall Study|Withdrawal by Subject|0|||
25055563|NCT02671435|50159567|FG002|Overall Study|Withdrawal by Subject|2|||
25055564|NCT02671435|50159568|FG003|Overall Study|Withdrawal by Subject|2|||
25055565|NCT02671435|50159569|FG004|Overall Study|Withdrawal by Subject|2|||
25055566|NCT02671435|50159570|FG005|Overall Study|Withdrawal by Subject|7|||
25055567|NCT02671435|50159571|FG006|Overall Study|Withdrawal by Subject|2|||
25055568|NCT02671435|50159572|FG007|Overall Study|Withdrawal by Subject|7|||
25055569|NCT02671435|50159573|FG008|Overall Study|Withdrawal by Subject|1|||
25055570|NCT02671435|50159574|FG009|Overall Study|Withdrawal by Subject|1|||
25055571|NCT02671435|50159575|FG010|Overall Study|Withdrawal by Subject|2|||
25055572|NCT02671435|50159576|FG011|Overall Study|Withdrawal by Subject|4|||
25055573|NCT02671435|50159577|FG012|Overall Study|Withdrawal by Subject|4|||
25055574|NCT02671435|50159578|FG013|Overall Study|Withdrawal by Subject|4|||
25055575|NCT02671435|50159579|FG014|Overall Study|Withdrawal by Subject|2|||
25055576|NCT02671435|50159565|FG000|Overall Study|Un-specified|0|||
25055577|NCT02671435|50159566|FG001|Overall Study|Un-specified|0|||
25055578|NCT02671435|50159567|FG002|Overall Study|Un-specified|0|||
25055579|NCT02671435|50159568|FG003|Overall Study|Un-specified|0|||
25055580|NCT02671435|50159569|FG004|Overall Study|Un-specified|1|||
25055581|NCT02671435|50159570|FG005|Overall Study|Un-specified|3|||
25055582|NCT02671435|50159571|FG006|Overall Study|Un-specified|2|||
25055583|NCT02671435|50159572|FG007|Overall Study|Un-specified|3|||
25055584|NCT02671435|50159573|FG008|Overall Study|Un-specified|0|||
25055585|NCT02671435|50159574|FG009|Overall Study|Un-specified|5|||
25055586|NCT02671435|50159575|FG010|Overall Study|Un-specified|8|||
25055587|NCT02671435|50159576|FG011|Overall Study|Un-specified|4|||
25055588|NCT02671435|50159577|FG012|Overall Study|Un-specified|5|||
25055589|NCT02671435|50159578|FG013|Overall Study|Un-specified|9|||
25055590|NCT02671435|50159579|FG014|Overall Study|Un-specified|8|||
25055591|NCT02916433|50159634|FG000|Overall Study|Withdrawal by Subject|1|||
25055592|NCT02916433|50159635|FG001|Overall Study|Withdrawal by Subject|0|||
25055593|NCT02916433|50159634|FG000|Overall Study|Physician Decision|1|||
25055594|NCT02916433|50159635|FG001|Overall Study|Physician Decision|0|||
25055595|NCT00526227|50159644|FG000|Overall Study|Device not implanted|1|||
25055596|NCT00526227|50159644|FG000|Overall Study|Death|1|||
25055597|NCT02547922|50159652|FG000|Overall Study|Withdrawal by Subject|9|||
25055598|NCT02547922|50159653|FG001|Overall Study|Withdrawal by Subject|6|||
25055599|NCT02547922|50159654|FG002|Overall Study|Withdrawal by Subject|10|||
25055600|NCT02547922|50159652|FG000|Overall Study|Adverse Event|3|||
25055601|NCT02547922|50159653|FG001|Overall Study|Adverse Event|1|||
25055602|NCT02547922|50159654|FG002|Overall Study|Adverse Event|2|||
25055603|NCT02547922|50159652|FG000|Overall Study|Lost to Follow-up|1|||
25162721|NCT01981109|50285081|FG000|Overall Study|No Discontinuation Documentation|37|||
25162722|NCT01981109|50285081|FG000|Overall Study|Study Termination|100|||
25162723|NCT01981109|50285081|FG000|Overall Study|No data available|2|||
25055604|NCT02547922|50159653|FG001|Overall Study|Lost to Follow-up|0|||
25055605|NCT02547922|50159654|FG002|Overall Study|Lost to Follow-up|0|||
25055606|NCT02547922|50159652|FG000|Overall Study|Lack of Efficacy|5|||
25055607|NCT02547922|50159653|FG001|Overall Study|Lack of Efficacy|7|||
25055608|NCT02547922|50159654|FG002|Overall Study|Lack of Efficacy|4|||
25055609|NCT02547922|50159652|FG000|Overall Study|Death|1|||
25055610|NCT02547922|50159653|FG001|Overall Study|Death|0|||
25162724|NCT00248794|50285089|FG000|Overall Study|Lost to Follow-up|6|||
25055611|NCT02547922|50159654|FG002|Overall Study|Death|0|||
25055612|NCT02547922|50159652|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
25055613|NCT02547922|50159653|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
25055614|NCT02547922|50159654|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
25055615|NCT02547922|50159652|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
25055616|NCT02547922|50159653|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
25055617|NCT02547922|50159654|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
25055618|NCT02547922|50159652|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
25055619|NCT02547922|50159653|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
25055620|NCT02547922|50159654|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
25055621|NCT02547922|50159652|FG000|Overall Study|Physician Decision|2|||
25055622|NCT02547922|50159653|FG001|Overall Study|Physician Decision|1|||
25055623|NCT02547922|50159654|FG002|Overall Study|Physician Decision|2|||
25055624|NCT02547922|50159652|FG000|Overall Study|Patients did not receive IP|1|||
25055625|NCT02547922|50159653|FG001|Overall Study|Patients did not receive IP|1|||
25055626|NCT02547922|50159654|FG002|Overall Study|Patients did not receive IP|0|||
25055627|NCT02547766|50159668|FG000|Overall Study|Withdrawal by Subject|1|||
25055628|NCT02742441|50159681|FG000|Overall Study|Lost to Follow-up|4|||
25055629|NCT02742441|50159682|FG001|Overall Study|Lost to Follow-up|4|||
25055630|NCT02742441|50159681|FG000|Overall Study|Withdrawal by Subject|2|||
25055631|NCT02742441|50159682|FG001|Overall Study|Withdrawal by Subject|2|||
25055632|NCT02742441|50159681|FG000|Overall Study|Adverse Event|0|||
25055633|NCT02742441|50159682|FG001|Overall Study|Adverse Event|2|||
25055634|NCT02547220|50159690|FG000|Overall Study|Withdrawal by Subject|1|||
25055635|NCT02547220|50159691|FG001|Overall Study|Withdrawal by Subject|0|||
25055636|NCT02547220|50159690|FG000|Overall Study|Study terminated by sponsor|18|||
25055637|NCT02547220|50159691|FG001|Overall Study|Study terminated by sponsor|20|||
25055638|NCT02542072|50159699|FG000|First Intervention (1 Month)|Adverse Event|1|||
25055639|NCT02542072|50159700|FG001|First Intervention (1 Month)|Adverse Event|1|||
25055640|NCT02542072|50159699|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
25055641|NCT02542072|50159700|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
25055642|NCT02542072|50159699|FG000|First Intervention (1 Month)|Lens discomfort|1|||
25055643|NCT02542072|50159700|FG001|First Intervention (1 Month)|Lens discomfort|2|||
25055644|NCT02542072|50159699|FG000|First Intervention (1 Month)|Protocol Violation|1|||
25055645|NCT02542072|50159700|FG001|First Intervention (1 Month)|Protocol Violation|0|||
25055646|NCT02542072|50159699|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
25055647|NCT02542072|50159700|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
25055648|NCT02542072|50159699|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
25055649|NCT02542072|50159700|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
25055650|NCT02547454|50159726|FG000|Overall Study|Due to hemodialysis|53|||
25055651|NCT02547454|50159726|FG000|Overall Study|Due to transplantation|1|||
25055652|NCT02547454|50159726|FG000|Overall Study|Due to no further need to treat|4|||
25055653|NCT02547454|50159726|FG000|Overall Study|Death|38|||
25055654|NCT02547454|50159726|FG000|Overall Study|Lost to Follow-up|26|||
25055655|NCT02547454|50159726|FG000|Overall Study|Other|39|||
25055656|NCT02547454|50159726|FG000|Overall Study|No data|11|||
25055657|NCT00415623|50159757|FG000|Overall Study|Adverse Event|3|||
25055658|NCT00415623|50159758|FG001|Overall Study|Adverse Event|4|||
25055659|NCT00415623|50159757|FG000|Overall Study|Death|1|||
25055660|NCT00415623|50159758|FG001|Overall Study|Death|0|||
25055661|NCT00415623|50159757|FG000|Overall Study|Withdrawal by Subject|1|||
25055662|NCT00415623|50159758|FG001|Overall Study|Withdrawal by Subject|1|||
25055663|NCT01969409|50159767|FG000|Overall Study|Death|2|||
25276638|NCT01241552|50590590|FG000|Overall Study|Technical Problems|2|||
25276639|NCT01241552|50590591|FG001|Overall Study|Technical Problems|0|||
25055664|NCT01969409|50159768|FG001|Overall Study|Death|2|||
25055665|NCT01969409|50159767|FG000|Overall Study|Transplant|1|||
25055666|NCT01969409|50159768|FG001|Overall Study|Transplant|1|||
25055667|NCT01969409|50159767|FG000|Overall Study|Withdrawal by Subject|0|||
25055668|NCT01969409|50159768|FG001|Overall Study|Withdrawal by Subject|1|||
25055669|NCT00150813|50159774|FG000|Overall Study|Adverse Event|1|||
25055670|NCT00150813|50159774|FG000|Overall Study|Lack of Efficacy|1|||
25055671|NCT00150813|50159774|FG000|Overall Study|Lost to Follow-up|5|||
25055672|NCT00150813|50159774|FG000|Overall Study|Withdrawal by Subject|5|||
25055673|NCT00150813|50159774|FG000|Overall Study|Remission|3|||
25055674|NCT00150813|50159774|FG000|Overall Study|Planned pregancy|1|||
25055675|NCT00150813|50159774|FG000|Overall Study|Switch to commercially available LEV|2|||
25055676|NCT02712788|50159780|FG000|Overall Study|Physician Decision|1|||
25055677|NCT02712788|50159781|FG001|Overall Study|Physician Decision|0|||
25055678|NCT02712788|50159780|FG000|Overall Study|Protocol Violation|1|||
25055679|NCT02712788|50159781|FG001|Overall Study|Protocol Violation|0|||
25055680|NCT02308111|50159789|FG000|Overall Study|Adverse Event|31|||
25055681|NCT02308111|50159790|FG001|Overall Study|Adverse Event|19|||
25055682|NCT02308111|50159789|FG000|Overall Study|Death|9|||
25055683|NCT02308111|50159790|FG001|Overall Study|Death|6|||
25055684|NCT02308111|50159789|FG000|Overall Study|Lost to Follow-up|2|||
25055685|NCT02308111|50159790|FG001|Overall Study|Lost to Follow-up|7|||
25055686|NCT02308111|50159789|FG000|Overall Study|Physician Decision|6|||
25055687|NCT02308111|50159790|FG001|Overall Study|Physician Decision|17|||
25055688|NCT02308111|50159789|FG000|Overall Study|Protocol Violation|0|||
25055689|NCT02308111|50159790|FG001|Overall Study|Protocol Violation|1|||
25055690|NCT02308111|50159789|FG000|Overall Study|Withdrawal by Subject|28|||
25055691|NCT02308111|50159790|FG001|Overall Study|Withdrawal by Subject|38|||
25055692|NCT02308111|50159789|FG000|Overall Study|Study Terminated by Sponsor|72|||
25055693|NCT02308111|50159790|FG001|Overall Study|Study Terminated by Sponsor|61|||
25055694|NCT02308111|50159789|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
25055695|NCT02308111|50159790|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
25055696|NCT02308111|50159789|FG000|Overall Study|Site Closure|3|||
25055697|NCT02308111|50159790|FG001|Overall Study|Site Closure|3|||
25055698|NCT02308111|50159789|FG000|Overall Study|Non-compliance with Study Drug|3|||
25055699|NCT02308111|50159790|FG001|Overall Study|Non-compliance with Study Drug|1|||
25055700|NCT02308111|50159789|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
25055701|NCT02308111|50159790|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
25055702|NCT02308111|50159789|FG000|Overall Study|Liver Transplant|3|||
25055703|NCT02308111|50159790|FG001|Overall Study|Liver Transplant|3|||
25055704|NCT02308111|50159789|FG000|Overall Study|Liver Transplant Waitlist|2|||
25055705|NCT02308111|50159790|FG001|Overall Study|Liver Transplant Waitlist|2|||
25055706|NCT02308111|50159789|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
25055707|NCT02308111|50159790|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
25055708|NCT01346189|50159801|FG000|Overall Study|Withdrawal by Subject|7|||
25055709|NCT01346189|50159802|FG001|Overall Study|Withdrawal by Subject|5|||
25055710|NCT01346189|50159803|FG002|Overall Study|Withdrawal by Subject|3|||
25055711|NCT01346189|50159804|FG003|Overall Study|Withdrawal by Subject|5|||
25055712|NCT01346189|50159801|FG000|Overall Study|Physician Decision|4|||
25055713|NCT01346189|50159802|FG001|Overall Study|Physician Decision|0|||
25055714|NCT01346189|50159803|FG002|Overall Study|Physician Decision|0|||
25055715|NCT01346189|50159804|FG003|Overall Study|Physician Decision|0|||
25055716|NCT01346189|50159801|FG000|Overall Study|Moved|3|||
25055717|NCT01346189|50159802|FG001|Overall Study|Moved|0|||
25055718|NCT01346189|50159803|FG002|Overall Study|Moved|4|||
25055719|NCT01346189|50159804|FG003|Overall Study|Moved|0|||
25055720|NCT01346189|50159801|FG000|Overall Study|Other|2|||
25055721|NCT01346189|50159802|FG001|Overall Study|Other|4|||
25055722|NCT01346189|50159803|FG002|Overall Study|Other|7|||
25055723|NCT01346189|50159804|FG003|Overall Study|Other|3|||
25055724|NCT01346189|50159801|FG000|Overall Study|Death|0|||
25055725|NCT01346189|50159802|FG001|Overall Study|Death|3|||
25055726|NCT01346189|50159803|FG002|Overall Study|Death|0|||
25055727|NCT01346189|50159804|FG003|Overall Study|Death|0|||
25055728|NCT01346189|50159801|FG000|Overall Study|Non-health system primary care physician|0|||
25055729|NCT01346189|50159802|FG001|Overall Study|Non-health system primary care physician|5|||
25055730|NCT01346189|50159803|FG002|Overall Study|Non-health system primary care physician|0|||
25055731|NCT01346189|50159804|FG003|Overall Study|Non-health system primary care physician|0|||
25055732|NCT01346189|50159801|FG000|Overall Study|Travel|0|||
25055733|NCT01346189|50159802|FG001|Overall Study|Travel|0|||
25055734|NCT01346189|50159803|FG002|Overall Study|Travel|0|||
25055735|NCT01346189|50159804|FG003|Overall Study|Travel|3|||
25055736|NCT00369317|50159814|FG000|Overall Study|Adverse Event|3|||
25055737|NCT00369317|50159814|FG000|Overall Study|Death|1|||
25055738|NCT00369317|50159814|FG000|Overall Study|Lack of Efficacy|5|||
25055739|NCT00369317|50159814|FG000|Overall Study|Physician Decision|2|||
25055740|NCT00369317|50159814|FG000|Overall Study|Withdrawal by Subject|8|||
25055741|NCT00369317|50159814|FG000|Overall Study|Ineligible|1|||
25055742|NCT03193021|50159821|FG000|Overall Study|Lost to Follow-up|1|||
25055743|NCT03193021|50159822|FG001|Overall Study|Lost to Follow-up|1|||
25055744|NCT03913091|50159830|FG000|Overall Study|Lost to Follow-up|18|||
25055745|NCT03913091|50159831|FG001|Overall Study|Lost to Follow-up|11|||
25162725|NCT00248794|50285090|FG001|Overall Study|Lost to Follow-up|8|||
25162726|NCT00248794|50285091|FG002|Overall Study|Lost to Follow-up|3|||
25162727|NCT01995539|50285105|FG000|Overall Study|Screening Failure|1|||
25055746|NCT03913091|50159830|FG000|Overall Study|Required additional meds/surgery|1|||
25055747|NCT03913091|50159831|FG001|Overall Study|Required additional meds/surgery|2|||
25055748|NCT03913091|50159830|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
25055749|NCT03913091|50159831|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
25162728|NCT01995539|50285105|FG000|Overall Study|Withdrawal by Investigator|15|||
25055750|NCT01318499|50159855|FG000|Overall Study|Adverse Event|16|||
25055751|NCT01318499|50159856|FG001|Overall Study|Adverse Event|11|||
25055752|NCT01318499|50159857|FG002|Overall Study|Adverse Event|6|||
25055753|NCT01318499|50159855|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
25055754|NCT01318499|50159856|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
25055755|NCT01318499|50159857|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
25055756|NCT01318499|50159855|FG000|Overall Study|Noncompliance|2|||
25055757|NCT01318499|50159856|FG001|Overall Study|Noncompliance|3|||
25055758|NCT01318499|50159857|FG002|Overall Study|Noncompliance|0|||
25055759|NCT01318499|50159855|FG000|Overall Study|Treatment Failure|19|||
25055760|NCT01318499|50159856|FG001|Overall Study|Treatment Failure|19|||
25055761|NCT01318499|50159857|FG002|Overall Study|Treatment Failure|101|||
25055762|NCT01318499|50159855|FG000|Overall Study|Protocol Violation|2|||
25055763|NCT01318499|50159856|FG001|Overall Study|Protocol Violation|4|||
25055764|NCT01318499|50159857|FG002|Overall Study|Protocol Violation|2|||
25055765|NCT01318499|50159855|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
25055766|NCT01318499|50159856|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
25055767|NCT01318499|50159857|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
25055768|NCT01318499|50159855|FG000|Overall Study|Other|7|||
25055769|NCT01318499|50159856|FG001|Overall Study|Other|10|||
25055770|NCT01318499|50159857|FG002|Overall Study|Other|22|||
25055771|NCT02285595|50159891|FG000|Overall Study|Lost to Follow-up|14|||
25055772|NCT02285595|50159891|FG000|Overall Study|Withdrawal by Subject|1|||
25055773|NCT02712398|50159914|FG000|Overall Study|Withdrawal by Subject|6|||
25055774|NCT02712398|50159914|FG000|Overall Study|Lost to Follow-up|6|||
25055775|NCT02712398|50159914|FG000|Overall Study|Sponsor Decision|1|||
25055776|NCT02712398|50159914|FG000|Overall Study|Physician Decision|1|||
25055777|NCT02712398|50159914|FG000|Overall Study|Death|2|||
25055778|NCT02712398|50159914|FG000|Overall Study|Re-operation|21|||
25055779|NCT00282867|50159921|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
25055780|NCT00282867|50159922|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
25055781|NCT00282867|50159923|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
25055782|NCT00151281|50159928|FG000|Overall Study|Not evaluable|3|||
25055783|NCT01318109|50159943|FG000|Overall Study|Adverse Event|0|||
25055784|NCT01318109|50159944|FG001|Overall Study|Adverse Event|2|||
25055785|NCT01318109|50159945|FG002|Overall Study|Adverse Event|0|||
25055786|NCT01318109|50159943|FG000|Overall Study|Withdrawal by Subject|1|||
25055787|NCT01318109|50159944|FG001|Overall Study|Withdrawal by Subject|0|||
25055788|NCT01318109|50159945|FG002|Overall Study|Withdrawal by Subject|0|||
25055789|NCT01318109|50159943|FG000|Overall Study|Schedule Conflict|0|||
25055790|NCT01318109|50159944|FG001|Overall Study|Schedule Conflict|1|||
25055791|NCT01318109|50159945|FG002|Overall Study|Schedule Conflict|0|||
25055792|NCT02712554|50159955|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
25055793|NCT02712554|50159956|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
25055794|NCT02712554|50159955|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
25055795|NCT02712554|50159956|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
25055796|NCT02712554|50159955|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
25055797|NCT02712554|50159956|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
25055798|NCT02712554|50159955|FG000|Part B: Qualification Phase|Adverse Event|0|||
25055799|NCT02712554|50159956|FG001|Part B: Qualification Phase|Adverse Event|1|||
25055800|NCT02712554|50159955|FG000|Part B: Treatment Phase|Adverse Event|0|||
25055801|NCT02712554|50159956|FG001|Part B: Treatment Phase|Adverse Event|1|||
25055802|NCT02712554|50159955|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
25055803|NCT02712554|50159956|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
25055804|NCT02712554|50159955|FG000|Part B: Treatment Phase|Other|0|||
25055805|NCT02712554|50159956|FG001|Part B: Treatment Phase|Other|1|||
25055806|NCT02712320|50159979|FG000|Overall Study|Lost to Follow-up|1|||
25055807|NCT02712320|50159979|FG000|Overall Study|Withdrawal by Subject|1|||
25055808|NCT02712320|50159979|FG000|Overall Study|Transferred to another facility|1|||
25055809|NCT02712320|50159979|FG000|Overall Study|Treating with the prohibited medications|2|||
25055810|NCT03052751|50159985|FG000|Dosing Period 1|Adverse Event|0|||
25055811|NCT03052751|50159986|FG001|Dosing Period 1|Adverse Event|1|||
25055812|NCT03052751|50159987|FG002|Dosing Period 1|Adverse Event|0|||
25055813|NCT03052751|50159988|FG003|Dosing Period 1|Adverse Event|0|||
25055814|NCT03052751|50159989|FG004|Dosing Period 1|Adverse Event|0|||
25055815|NCT03052751|50159990|FG005|Dosing Period 1|Adverse Event|0|||
25055816|NCT03052751|50159985|FG000|Dosing Period 2|Adverse Event|0|||
25055817|NCT03052751|50159986|FG001|Dosing Period 2|Adverse Event|0|||
25055818|NCT03052751|50159987|FG002|Dosing Period 2|Adverse Event|3|||
25055819|NCT03052751|50159988|FG003|Dosing Period 2|Adverse Event|0|||
25055820|NCT03052751|50159989|FG004|Dosing Period 2|Adverse Event|0|||
25055821|NCT03052751|50159990|FG005|Dosing Period 2|Adverse Event|0|||
25055822|NCT03052751|50159985|FG000|Observation Period|Adverse Event|0|||
25055823|NCT03052751|50159986|FG001|Observation Period|Adverse Event|0|||
25055824|NCT03052751|50159987|FG002|Observation Period|Adverse Event|0|||
25055825|NCT03052751|50159988|FG003|Observation Period|Adverse Event|0|||
25055826|NCT03052751|50159989|FG004|Observation Period|Adverse Event|1|||
24963291|NCT00268892|50053350|FG000|Overall Study|Protocol Violation|0|||
24963292|NCT00268892|50053351|FG001|Overall Study|Protocol Violation|1|||
24963293|NCT00268892|50053352|FG002|Overall Study|Protocol Violation|0|||
24963294|NCT00268892|50053350|FG000|Overall Study|Disease Progression|1|||
24963295|NCT00268892|50053351|FG001|Overall Study|Disease Progression|1|||
24963296|NCT00268892|50053352|FG002|Overall Study|Disease Progression|0|||
24963297|NCT00268892|50053350|FG000|Overall Study|Trial Site Closed|4|||
24963298|NCT00268892|50053351|FG001|Overall Study|Trial Site Closed|2|||
24963299|NCT00268892|50053352|FG002|Overall Study|Trial Site Closed|2|||
24963300|NCT00206076|50053362|FG000|Overall Study|Physician Decision|2|||
24963301|NCT00206076|50053363|FG001|Overall Study|Physician Decision|0|||
24963302|NCT00206076|50053362|FG000|Overall Study|Withdrawal by Subject|1|||
24963303|NCT00206076|50053363|FG001|Overall Study|Withdrawal by Subject|1|||
24963304|NCT00278954|50053371|FG000|Overall Study|Adverse Event|3|||
24963305|NCT00278954|50053371|FG000|Overall Study|Lost to Follow-up|1|||
24963306|NCT00278954|50053371|FG000|Overall Study|Withdrawal by Subject|1|||
24963307|NCT00278564|50053375|FG000|Overall Study|Lack of Efficacy|4|||
24963308|NCT00268346|50053381|FG000|Overall Study|Adverse Event|0|||
24963309|NCT00268346|50053382|FG001|Overall Study|Adverse Event|1|||
24963310|NCT00268346|50053381|FG000|Overall Study|Death|0|||
24963311|NCT00268346|50053382|FG001|Overall Study|Death|1|||
24963312|NCT00268346|50053381|FG000|Overall Study|Withdrawal by Subject|0|||
24963313|NCT00268346|50053382|FG001|Overall Study|Withdrawal by Subject|1|||
24963314|NCT00203892|50053391|FG000|Overall Study|Physician Decision|1|||
24963315|NCT00203892|50053392|FG001|Overall Study|Physician Decision|2|||
24963316|NCT00203892|50053393|FG002|Overall Study|Physician Decision|0|||
24963317|NCT00203892|50053391|FG000|Overall Study|Death|1|||
24963318|NCT00203892|50053392|FG001|Overall Study|Death|0|||
24963319|NCT00203892|50053393|FG002|Overall Study|Death|0|||
24963320|NCT00250718|50053401|FG000|Overall Study|Death|1|||
24963321|NCT00250718|50053401|FG000|Overall Study|Adverse Event|1|||
24963322|NCT00250718|50053401|FG000|Overall Study|Withdrawal by Subject|1|||
24963323|NCT00276614|50053405|FG000|Overall Study|Progression of disease under study|3|||
24963324|NCT00276458|50053411|FG000|Overall Study|Adverse Event|0|||
24963325|NCT00276458|50053412|FG001|Overall Study|Adverse Event|2|||
24963326|NCT00276458|50053411|FG000|Overall Study|Lost to Follow-up|2|||
24963327|NCT00276458|50053412|FG001|Overall Study|Lost to Follow-up|2|||
24963328|NCT00276458|50053411|FG000|Overall Study|Protocol Violation|4|||
24963329|NCT00276458|50053412|FG001|Overall Study|Protocol Violation|3|||
24963330|NCT00276380|50053420|FG000|Overall Study|Adverse Event|5|||
24963331|NCT00276380|50053421|FG001|Overall Study|Adverse Event|3|||
24963332|NCT00276380|50053420|FG000|Overall Study|Lost to Follow-up|1|||
24963333|NCT00276380|50053421|FG001|Overall Study|Lost to Follow-up|1|||
24963334|NCT00276380|50053420|FG000|Overall Study|Withdrawal by Subject|3|||
24963335|NCT00276380|50053421|FG001|Overall Study|Withdrawal by Subject|6|||
24963336|NCT00276380|50053420|FG000|Overall Study|Death|5|||
24963337|NCT00276380|50053421|FG001|Overall Study|Death|3|||
24963338|NCT00276380|50053420|FG000|Overall Study|Abnormal aPPT Levels|0|||
24963339|NCT00276380|50053421|FG001|Overall Study|Abnormal aPPT Levels|1|||
24963340|NCT00267956|50053430|FG000|Controlled Period|Adverse Event|4|||
24963341|NCT00267956|50053431|FG001|Controlled Period|Adverse Event|1|||
24963342|NCT00267956|50053432|FG002|Controlled Period|Adverse Event|0|||
24963343|NCT00267956|50053433|FG003|Controlled Period|Adverse Event|0|||
24963344|NCT00267956|50053430|FG000|Controlled Period|Lack of Efficacy|4|||
25162729|NCT01995539|50285105|FG000|Overall Study|Withdrawal by Subject|11|||
25162730|NCT01995539|50285105|FG000|Overall Study|Lost to Follow-up|5|||
24963345|NCT00267956|50053431|FG001|Controlled Period|Lack of Efficacy|2|||
24963346|NCT00267956|50053432|FG002|Controlled Period|Lack of Efficacy|0|||
24963347|NCT00267956|50053433|FG003|Controlled Period|Lack of Efficacy|0|||
24963348|NCT00267956|50053430|FG000|Controlled Period|Lost to Follow-up|2|||
24963349|NCT00267956|50053431|FG001|Controlled Period|Lost to Follow-up|0|||
24963350|NCT00267956|50053432|FG002|Controlled Period|Lost to Follow-up|0|||
24963351|NCT00267956|50053433|FG003|Controlled Period|Lost to Follow-up|0|||
24963352|NCT00267956|50053430|FG000|Controlled Period|Withdrew consent|3|||
24963353|NCT00267956|50053431|FG001|Controlled Period|Withdrew consent|1|||
24963354|NCT00267956|50053432|FG002|Controlled Period|Withdrew consent|0|||
24963355|NCT00267956|50053433|FG003|Controlled Period|Withdrew consent|0|||
24963356|NCT00267956|50053430|FG000|After Controlled Period|Adverse Event|0|||
24963357|NCT00267956|50053431|FG001|After Controlled Period|Adverse Event|0|||
24963358|NCT00267956|50053432|FG002|After Controlled Period|Adverse Event|2|||
24963359|NCT00267956|50053433|FG003|After Controlled Period|Adverse Event|1|||
24963360|NCT00267956|50053430|FG000|After Controlled Period|Lack of Efficacy|0|||
24963361|NCT00267956|50053431|FG001|After Controlled Period|Lack of Efficacy|0|||
24963362|NCT00267956|50053432|FG002|After Controlled Period|Lack of Efficacy|1|||
24963363|NCT00267956|50053433|FG003|After Controlled Period|Lack of Efficacy|1|||
24963364|NCT00267956|50053430|FG000|After Controlled Period|Lost to Follow-up|0|||
24963365|NCT00267956|50053431|FG001|After Controlled Period|Lost to Follow-up|0|||
24963366|NCT00267956|50053432|FG002|After Controlled Period|Lost to Follow-up|1|||
24963367|NCT00267956|50053433|FG003|After Controlled Period|Lost to Follow-up|0|||
25055827|NCT03052751|50159990|FG005|Observation Period|Adverse Event|0|||
25055828|NCT01317797|50160003|FG000|Overall Study|Other|0|||
25055829|NCT01317797|50160004|FG001|Overall Study|Other|1|||
25055830|NCT01317797|50160005|FG002|Overall Study|Other|0|||
25055831|NCT01317797|50160003|FG000|Overall Study|Withdrawal of Patient|0|||
25055832|NCT01317797|50160004|FG001|Overall Study|Withdrawal of Patient|0|||
25055833|NCT01317797|50160005|FG002|Overall Study|Withdrawal of Patient|1|||
25055834|NCT01343693|50160013|FG000|Overall Study|Lost to Follow-up|9|||
25055835|NCT02712008|50160020|FG000|Baseline (Day 1) up to Week 12|Death|3|||
25055836|NCT02712008|50160021|FG001|Baseline (Day 1) up to Week 12|Death|0|||
25055837|NCT02712008|50160022|FG002|Baseline (Day 1) up to Week 12|Death|0|||
25055838|NCT02712008|50160023|FG003|Baseline (Day 1) up to Week 12|Death|0|||
25055839|NCT02712008|50160024|FG004|Baseline (Day 1) up to Week 12|Death|0|||
25055840|NCT02712008|50160025|FG005|Baseline (Day 1) up to Week 12|Death|0|||
25055841|NCT02712008|50160026|FG006|Baseline (Day 1) up to Week 12|Death|0|||
25055842|NCT02712008|50160027|FG007|Baseline (Day 1) up to Week 12|Death|0|||
25055843|NCT02712008|50160020|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
25055844|NCT02712008|50160021|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
25055845|NCT02712008|50160022|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
25055846|NCT02712008|50160023|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
25055847|NCT02712008|50160024|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
25055848|NCT02712008|50160025|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
25055849|NCT02712008|50160026|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
25055850|NCT02712008|50160027|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
25055851|NCT02712008|50160020|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
25055852|NCT02712008|50160021|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
25055853|NCT02712008|50160022|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
25055854|NCT02712008|50160023|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
25055855|NCT02712008|50160024|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
25055856|NCT02712008|50160025|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
25055857|NCT02712008|50160026|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
25055858|NCT02712008|50160027|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
25055859|NCT02712008|50160020|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
25055860|NCT02712008|50160021|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
25055861|NCT02712008|50160022|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
25055862|NCT02712008|50160023|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
25055863|NCT02712008|50160024|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
25055864|NCT02712008|50160025|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
25055865|NCT02712008|50160026|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
25055866|NCT02712008|50160027|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
25055867|NCT02712008|50160020|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
25055868|NCT02712008|50160021|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
25055869|NCT02712008|50160022|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
25055870|NCT02712008|50160023|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
25055871|NCT02712008|50160024|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
25055872|NCT02712008|50160025|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
25055873|NCT02712008|50160026|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
25055874|NCT02712008|50160027|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
25055875|NCT02712008|50160020|FG000|From Week 12 up to Week 36|Adverse Event|0|||
25055876|NCT02712008|50160021|FG001|From Week 12 up to Week 36|Adverse Event|0|||
25055877|NCT02712008|50160022|FG002|From Week 12 up to Week 36|Adverse Event|0|||
25055878|NCT02712008|50160023|FG003|From Week 12 up to Week 36|Adverse Event|0|||
25055879|NCT02712008|50160024|FG004|From Week 12 up to Week 36|Adverse Event|1|||
25055880|NCT02712008|50160025|FG005|From Week 12 up to Week 36|Adverse Event|0|||
25055881|NCT02712008|50160026|FG006|From Week 12 up to Week 36|Adverse Event|0|||
25055882|NCT02712008|50160027|FG007|From Week 12 up to Week 36|Adverse Event|2|||
25055883|NCT02712008|50160020|FG000|From Week 12 up to Week 36|Death|1|||
25055884|NCT02712008|50160021|FG001|From Week 12 up to Week 36|Death|0|||
25055885|NCT02712008|50160022|FG002|From Week 12 up to Week 36|Death|0|||
25055886|NCT02712008|50160023|FG003|From Week 12 up to Week 36|Death|0|||
25055887|NCT02712008|50160024|FG004|From Week 12 up to Week 36|Death|0|||
25055888|NCT02712008|50160025|FG005|From Week 12 up to Week 36|Death|0|||
25055889|NCT02712008|50160026|FG006|From Week 12 up to Week 36|Death|1|||
25055890|NCT02712008|50160027|FG007|From Week 12 up to Week 36|Death|0|||
25055891|NCT02712008|50160020|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
25055892|NCT02712008|50160021|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
25055893|NCT02712008|50160022|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
25055894|NCT02712008|50160023|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
25055895|NCT02712008|50160024|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
25055896|NCT02712008|50160025|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
25055897|NCT02712008|50160026|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
25055898|NCT02712008|50160027|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
25055899|NCT02712008|50160020|FG000|From Week 12 up to Week 36|Physician Decision|0|||
25055900|NCT02712008|50160021|FG001|From Week 12 up to Week 36|Physician Decision|0|||
25055901|NCT02712008|50160022|FG002|From Week 12 up to Week 36|Physician Decision|0|||
25055902|NCT02712008|50160023|FG003|From Week 12 up to Week 36|Physician Decision|1|||
25055903|NCT02712008|50160024|FG004|From Week 12 up to Week 36|Physician Decision|1|||
25055904|NCT02712008|50160025|FG005|From Week 12 up to Week 36|Physician Decision|0|||
25055905|NCT02712008|50160026|FG006|From Week 12 up to Week 36|Physician Decision|0|||
25055906|NCT02712008|50160027|FG007|From Week 12 up to Week 36|Physician Decision|0|||
25055907|NCT02712008|50160020|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
25055908|NCT02712008|50160021|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
25055909|NCT02712008|50160022|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
25055910|NCT02712008|50160023|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
25055911|NCT02712008|50160024|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
25055912|NCT02712008|50160025|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
25055913|NCT02712008|50160026|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
25055914|NCT02712008|50160027|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
25055915|NCT04238481|50160045|FG000|Overall Study|Miscellaneous|0|||
25055916|NCT04238481|50160046|FG001|Overall Study|Miscellaneous|1|||
25055917|NCT04238481|50160047|FG002|Overall Study|Miscellaneous|0|||
25055918|NCT04238481|50160048|FG003|Overall Study|Miscellaneous|0|||
25055919|NCT02711306|50160064|FG000|Overall Study|Withdrawal by Subject|2|||
25055920|NCT02711306|50160065|FG001|Overall Study|Withdrawal by Subject|2|||
25055921|NCT02710292|50160071|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
25055922|NCT02710292|50160072|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
25055923|NCT02710292|50160071|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
25055924|NCT02710292|50160072|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
25055925|NCT02710214|50160081|FG000|Overall Study|Lost to Follow-up|1|||
25055926|NCT02710214|50160082|FG001|Overall Study|Lost to Follow-up|0|||
25055927|NCT02710214|50160081|FG000|Overall Study|Lack of Efficacy|0|||
25055928|NCT02710214|50160082|FG001|Overall Study|Lack of Efficacy|1|||
25055929|NCT02710214|50160081|FG000|Overall Study|Death|0|||
25055930|NCT02710214|50160082|FG001|Overall Study|Death|1|||
25055931|NCT03052517|50160091|FG000|Overall Study|Study Terminated By Sponsor|928|||
25055932|NCT03052517|50160092|FG001|Overall Study|Study Terminated By Sponsor|938|||
25055933|NCT03052517|50160093|FG002|Overall Study|Study Terminated By Sponsor|296|||
25055934|NCT03052517|50160091|FG000|Overall Study|Subject/Guardian Decision|50|||
25055935|NCT03052517|50160092|FG001|Overall Study|Subject/Guardian Decision|45|||
25055936|NCT03052517|50160093|FG002|Overall Study|Subject/Guardian Decision|22|||
25055937|NCT03052517|50160091|FG000|Overall Study|Lack of Efficacy|23|||
25055938|NCT03052517|50160092|FG001|Overall Study|Lack of Efficacy|14|||
25055939|NCT03052517|50160093|FG002|Overall Study|Lack of Efficacy|7|||
25055940|NCT03052517|50160091|FG000|Overall Study|Adverse Event|6|||
25055941|NCT03052517|50160092|FG001|Overall Study|Adverse Event|5|||
25055942|NCT03052517|50160093|FG002|Overall Study|Adverse Event|0|||
25055943|NCT03052517|50160091|FG000|Overall Study|Physician Decision|4|||
25055944|NCT03052517|50160092|FG001|Overall Study|Physician Decision|5|||
25055945|NCT03052517|50160093|FG002|Overall Study|Physician Decision|1|||
25055946|NCT03052517|50160091|FG000|Overall Study|Death|3|||
25055947|NCT03052517|50160092|FG001|Overall Study|Death|0|||
25055948|NCT03052517|50160093|FG002|Overall Study|Death|1|||
25055949|NCT03052517|50160091|FG000|Overall Study|Lost to Follow-up|2|||
25055950|NCT03052517|50160092|FG001|Overall Study|Lost to Follow-up|4|||
25055951|NCT03052517|50160093|FG002|Overall Study|Lost to Follow-up|0|||
25055952|NCT03052517|50160091|FG000|Overall Study|Pregnancy|1|||
25055953|NCT03052517|50160092|FG001|Overall Study|Pregnancy|0|||
25055954|NCT03052517|50160093|FG002|Overall Study|Pregnancy|1|||
25055955|NCT03052517|50160091|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
25055956|NCT03052517|50160092|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
25055957|NCT03052517|50160093|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
25055958|NCT03052517|50160091|FG000|Overall Study|Technical Problems|0|||
25055959|NCT03052517|50160092|FG001|Overall Study|Technical Problems|1|||
25055960|NCT03052517|50160093|FG002|Overall Study|Technical Problems|0|||
25055961|NCT02708498|50160109|FG000|Overall Study|Death|20|||
25055962|NCT02708498|50160110|FG001|Overall Study|Death|19|||
25055963|NCT02708498|50160111|FG002|Overall Study|Death|0|||
25055964|NCT02708498|50160112|FG003|Overall Study|Death|0|||
25055965|NCT02708498|50160113|FG004|Overall Study|Death|1|||
25055966|NCT02708498|50160114|FG005|Overall Study|Death|0|||
25055967|NCT02708498|50160115|FG006|Overall Study|Death|0|||
25055968|NCT02708498|50160116|FG007|Overall Study|Death|0|||
25055969|NCT02708498|50160109|FG000|Overall Study|Unknown reason, missing data|0|||
25055970|NCT02708498|50160110|FG001|Overall Study|Unknown reason, missing data|0|||
25055971|NCT02708498|50160111|FG002|Overall Study|Unknown reason, missing data|62|||
25055972|NCT02708498|50160112|FG003|Overall Study|Unknown reason, missing data|51|||
25055973|NCT02708498|50160113|FG004|Overall Study|Unknown reason, missing data|195|||
25162731|NCT01995539|50285105|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
25055974|NCT02708498|50160114|FG005|Overall Study|Unknown reason, missing data|132|||
25055975|NCT02708498|50160115|FG006|Overall Study|Unknown reason, missing data|0|||
25055976|NCT02708498|50160116|FG007|Overall Study|Unknown reason, missing data|0|||
25055977|NCT02710136|50160134|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
25055978|NCT02710136|50160135|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
25055979|NCT03702231|50160145|FG000|Overall Study|Withdrawal by Subject|1|||
25055980|NCT03702231|50160146|FG001|Overall Study|Withdrawal by Subject|0|||
25055981|NCT03702231|50160147|FG002|Overall Study|Withdrawal by Subject|0|||
25055982|NCT03702231|50160145|FG000|Overall Study|Protocol Violation|0|||
25055983|NCT03702231|50160146|FG001|Overall Study|Protocol Violation|0|||
25055984|NCT03702231|50160147|FG002|Overall Study|Protocol Violation|1|||
25055985|NCT03702231|50160145|FG000|Overall Study|COVID Pandemic|3|||
25055986|NCT03702231|50160146|FG001|Overall Study|COVID Pandemic|4|||
25055987|NCT03702231|50160147|FG002|Overall Study|COVID Pandemic|1|||
25055988|NCT02741271|50160157|FG000|Overall Study|Lost to Follow-up|2|||
25055989|NCT02741271|50160158|FG001|Overall Study|Lost to Follow-up|0|||
25055990|NCT02741271|50160157|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
25055991|NCT02741271|50160158|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
25055992|NCT02709746|50160171|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
25055993|NCT02709746|50160172|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
25055994|NCT02709746|50160173|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
25055995|NCT02709746|50160174|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
25055996|NCT02709746|50160175|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
25055997|NCT02709746|50160171|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
25055998|NCT02709746|50160172|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
25055999|NCT02709746|50160173|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
25056000|NCT02709746|50160174|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
25056001|NCT02709746|50160175|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
25056002|NCT02709746|50160171|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
25056003|NCT02709746|50160172|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
25056004|NCT02709746|50160173|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
25056005|NCT02709746|50160174|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
25056006|NCT02709746|50160175|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
25056007|NCT02709746|50160171|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
25056008|NCT02709746|50160172|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
25056009|NCT02709746|50160173|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
25056010|NCT02709746|50160174|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
25056011|NCT02709746|50160175|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
25056012|NCT02709746|50160171|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
25056013|NCT02709746|50160172|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
25056014|NCT02709746|50160173|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
25056015|NCT02709746|50160174|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
25056016|NCT02709746|50160175|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
25056017|NCT02709746|50160171|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
25056018|NCT02709746|50160172|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
25056019|NCT02709746|50160173|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
25056020|NCT02709746|50160174|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
25056021|NCT02709746|50160175|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
25056022|NCT02709746|50160171|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
25056023|NCT02709746|50160172|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
25056024|NCT02709746|50160173|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
25056025|NCT02709746|50160174|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
25056026|NCT02709746|50160175|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
25056027|NCT02709746|50160171|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
25056028|NCT02709746|50160172|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
25056029|NCT02709746|50160173|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
25056030|NCT02709746|50160174|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
25056031|NCT02709746|50160175|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
25056032|NCT02709746|50160171|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
25056033|NCT02709746|50160172|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
25056034|NCT02709746|50160173|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
25056035|NCT02709746|50160174|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
25056036|NCT02709746|50160175|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
25162732|NCT01835587|50285113|FG000|Overall Study|Disease Recurrence or Relapse|0|||
25056037|NCT02709746|50160171|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
25056038|NCT02709746|50160172|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
25056039|NCT02709746|50160173|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
25056040|NCT02709746|50160174|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
25056041|NCT02709746|50160175|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
25056042|NCT02709746|50160171|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
25056043|NCT02709746|50160172|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
25056044|NCT02709746|50160173|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
25056045|NCT02709746|50160174|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
25056046|NCT02709746|50160175|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
25056047|NCT02709746|50160171|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
25056048|NCT02709746|50160172|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
25056049|NCT02709746|50160173|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
25056050|NCT02709746|50160174|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
25056051|NCT02709746|50160175|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
25056052|NCT02709746|50160171|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
25056053|NCT02709746|50160172|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
25056054|NCT02709746|50160173|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
25056055|NCT02709746|50160174|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
25056056|NCT02709746|50160175|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
25056057|NCT02709746|50160171|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
25056058|NCT02709746|50160172|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
25056059|NCT02709746|50160173|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
25056060|NCT02709746|50160174|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
25056061|NCT02709746|50160175|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
25056062|NCT02709746|50160171|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
25056063|NCT02709746|50160172|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
25056064|NCT02709746|50160173|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
25056065|NCT02709746|50160174|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
25056066|NCT02709746|50160175|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
25056067|NCT02709746|50160171|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
25056068|NCT02709746|50160172|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
25056069|NCT02709746|50160173|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
25056070|NCT02709746|50160174|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
25056071|NCT02709746|50160175|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
25056072|NCT02709746|50160171|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
25056073|NCT02709746|50160172|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
25056074|NCT02709746|50160173|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
25056075|NCT02709746|50160174|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
25056076|NCT02709746|50160175|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
25056077|NCT01317641|50160196|FG000|Overall Study|Not treated|0|||
25056078|NCT01317641|50160197|FG001|Overall Study|Not treated|0|||
25056079|NCT01317641|50160198|FG002|Overall Study|Not treated|0|||
25056080|NCT01317641|50160199|FG003|Overall Study|Not treated|0|||
25056081|NCT01317641|50160200|FG004|Overall Study|Not treated|0|||
25056082|NCT01317641|50160201|FG005|Overall Study|Not treated|0|||
25056083|NCT01317641|50160202|FG006|Overall Study|Not treated|0|||
25056084|NCT01317641|50160203|FG007|Overall Study|Not treated|1|||
25056085|NCT01317641|50160204|FG008|Overall Study|Not treated|1|||
25056086|NCT01317641|50160196|FG000|Overall Study|Adverse Event|0|||
25056087|NCT01317641|50160197|FG001|Overall Study|Adverse Event|1|||
25056088|NCT01317641|50160198|FG002|Overall Study|Adverse Event|0|||
25056089|NCT01317641|50160199|FG003|Overall Study|Adverse Event|1|||
25056090|NCT01317641|50160200|FG004|Overall Study|Adverse Event|0|||
25056091|NCT01317641|50160201|FG005|Overall Study|Adverse Event|0|||
25056092|NCT01317641|50160202|FG006|Overall Study|Adverse Event|2|||
25056093|NCT01317641|50160203|FG007|Overall Study|Adverse Event|1|||
25056094|NCT01317641|50160204|FG008|Overall Study|Adverse Event|0|||
25056095|NCT01317641|50160196|FG000|Overall Study|Protocol Violation|1|||
25056096|NCT01317641|50160197|FG001|Overall Study|Protocol Violation|0|||
25056097|NCT01317641|50160198|FG002|Overall Study|Protocol Violation|0|||
25056098|NCT01317641|50160199|FG003|Overall Study|Protocol Violation|0|||
25056099|NCT01317641|50160200|FG004|Overall Study|Protocol Violation|0|||
25056100|NCT01317641|50160201|FG005|Overall Study|Protocol Violation|0|||
25056101|NCT01317641|50160202|FG006|Overall Study|Protocol Violation|0|||
25056102|NCT01317641|50160203|FG007|Overall Study|Protocol Violation|0|||
25056103|NCT01317641|50160204|FG008|Overall Study|Protocol Violation|0|||
25056104|NCT01317641|50160196|FG000|Overall Study|Disease progression|0|||
25056105|NCT01317641|50160197|FG001|Overall Study|Disease progression|0|||
25056106|NCT01317641|50160198|FG002|Overall Study|Disease progression|0|||
25056107|NCT01317641|50160199|FG003|Overall Study|Disease progression|0|||
25056108|NCT01317641|50160200|FG004|Overall Study|Disease progression|0|||
25056109|NCT01317641|50160201|FG005|Overall Study|Disease progression|0|||
25056110|NCT01317641|50160202|FG006|Overall Study|Disease progression|0|||
25056111|NCT01317641|50160203|FG007|Overall Study|Disease progression|3|||
25056112|NCT01317641|50160204|FG008|Overall Study|Disease progression|4|||
25056113|NCT01317641|50160196|FG000|Overall Study|Withdrawal by Subject|0|||
25056114|NCT01317641|50160197|FG001|Overall Study|Withdrawal by Subject|0|||
25056115|NCT01317641|50160198|FG002|Overall Study|Withdrawal by Subject|0|||
25056116|NCT01317641|50160199|FG003|Overall Study|Withdrawal by Subject|0|||
25056117|NCT01317641|50160200|FG004|Overall Study|Withdrawal by Subject|0|||
25056118|NCT01317641|50160201|FG005|Overall Study|Withdrawal by Subject|0|||
25056119|NCT01317641|50160202|FG006|Overall Study|Withdrawal by Subject|1|||
25056120|NCT01317641|50160203|FG007|Overall Study|Withdrawal by Subject|0|||
25056121|NCT01317641|50160204|FG008|Overall Study|Withdrawal by Subject|0|||
25056122|NCT03186794|50160240|FG000|Overall Study|Physician Decision|2|||
25056123|NCT03186794|50160240|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
25056124|NCT02290431|50160245|FG000|Overall Study|Adverse Event|20|||
25056125|NCT02290431|50160245|FG000|Overall Study|Progressive disease|4|||
25056126|NCT02290431|50160245|FG000|Overall Study|Study terminated by Sponsor|1|||
25056127|NCT02290431|50160245|FG000|Overall Study|Physician Decision|2|||
25056128|NCT02707952|50160253|FG000|Overall Study|Adverse Event|1|||
25056129|NCT02707952|50160254|FG001|Overall Study|Adverse Event|0|||
25056130|NCT02707952|50160255|FG002|Overall Study|Adverse Event|0|||
25056131|NCT02707952|50160256|FG003|Overall Study|Adverse Event|0|||
25056132|NCT02707952|50160253|FG000|Overall Study|Lost to Follow-up|1|||
25056133|NCT02707952|50160254|FG001|Overall Study|Lost to Follow-up|0|||
25056134|NCT02707952|50160255|FG002|Overall Study|Lost to Follow-up|0|||
25056135|NCT02707952|50160256|FG003|Overall Study|Lost to Follow-up|0|||
25056136|NCT02707952|50160253|FG000|Overall Study|Withdrawal by Subject|0|||
25056137|NCT02707952|50160254|FG001|Overall Study|Withdrawal by Subject|1|||
25056138|NCT02707952|50160255|FG002|Overall Study|Withdrawal by Subject|2|||
25056139|NCT02707952|50160256|FG003|Overall Study|Withdrawal by Subject|0|||
25056140|NCT03050801|50160274|FG000|Experiment 1|Lost to Follow-up|0|||
25056141|NCT03050801|50160275|FG001|Experiment 1|Lost to Follow-up|1|||
25056142|NCT03050801|50160276|FG002|Experiment 1|Lost to Follow-up|0|||
25056143|NCT03050801|50160277|FG003|Experiment 1|Lost to Follow-up|0|||
25056144|NCT03050801|50160278|FG004|Experiment 1|Lost to Follow-up|0|||
25056145|NCT03050801|50160279|FG005|Experiment 1|Lost to Follow-up|0|||
25056146|NCT03050801|50160274|FG000|Experiment 1|Physician Decision|0|||
25056147|NCT03050801|50160275|FG001|Experiment 1|Physician Decision|3|||
25056148|NCT03050801|50160276|FG002|Experiment 1|Physician Decision|0|||
25056149|NCT03050801|50160277|FG003|Experiment 1|Physician Decision|0|||
25056150|NCT03050801|50160278|FG004|Experiment 1|Physician Decision|0|||
25056151|NCT03050801|50160279|FG005|Experiment 1|Physician Decision|0|||
25056152|NCT03050801|50160274|FG000|Experiment 1|Change of experimental design|0|||
25056153|NCT03050801|50160275|FG001|Experiment 1|Change of experimental design|3|||
25056154|NCT03050801|50160276|FG002|Experiment 1|Change of experimental design|0|||
25056155|NCT03050801|50160277|FG003|Experiment 1|Change of experimental design|0|||
25056156|NCT03050801|50160278|FG004|Experiment 1|Change of experimental design|0|||
25056157|NCT03050801|50160279|FG005|Experiment 1|Change of experimental design|0|||
25056158|NCT03050801|50160274|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
25056159|NCT03050801|50160275|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
25056160|NCT03050801|50160276|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
25056161|NCT03050801|50160277|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
25056162|NCT03050801|50160278|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
25056163|NCT03050801|50160279|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
25056164|NCT03050801|50160274|FG000|Experiment 2|Lost to Follow-up|0|||
25056165|NCT03050801|50160275|FG001|Experiment 2|Lost to Follow-up|0|||
25056166|NCT03050801|50160276|FG002|Experiment 2|Lost to Follow-up|0|||
25056167|NCT03050801|50160277|FG003|Experiment 2|Lost to Follow-up|1|||
25056168|NCT03050801|50160278|FG004|Experiment 2|Lost to Follow-up|1|||
25056169|NCT03050801|50160279|FG005|Experiment 2|Lost to Follow-up|0|||
25056170|NCT03050801|50160274|FG000|Experiment 2|Physician Decision|0|||
25056171|NCT03050801|50160275|FG001|Experiment 2|Physician Decision|0|||
25056172|NCT03050801|50160276|FG002|Experiment 2|Physician Decision|0|||
25056173|NCT03050801|50160277|FG003|Experiment 2|Physician Decision|0|||
25056174|NCT03050801|50160278|FG004|Experiment 2|Physician Decision|1|||
25056175|NCT03050801|50160279|FG005|Experiment 2|Physician Decision|0|||
25056176|NCT03050801|50160274|FG000|Experiment 2|Pregnancy|0|||
25056177|NCT03050801|50160275|FG001|Experiment 2|Pregnancy|0|||
25056178|NCT03050801|50160276|FG002|Experiment 2|Pregnancy|0|||
25056179|NCT03050801|50160277|FG003|Experiment 2|Pregnancy|0|||
25056180|NCT03050801|50160278|FG004|Experiment 2|Pregnancy|1|||
25056181|NCT03050801|50160279|FG005|Experiment 2|Pregnancy|0|||
25056182|NCT03050801|50160274|FG000|Experiment 2|Withdrawal by Subject|0|||
25056183|NCT03050801|50160275|FG001|Experiment 2|Withdrawal by Subject|0|||
24963368|NCT00267956|50053430|FG000|After Controlled Period|Withdrew consent|0|||
25056184|NCT03050801|50160276|FG002|Experiment 2|Withdrawal by Subject|0|||
25056185|NCT03050801|50160277|FG003|Experiment 2|Withdrawal by Subject|1|||
25276640|NCT01241552|50590592|FG002|Overall Study|Technical Problems|2|||
25056186|NCT03050801|50160278|FG004|Experiment 2|Withdrawal by Subject|0|||
25056187|NCT03050801|50160279|FG005|Experiment 2|Withdrawal by Subject|0|||
25056188|NCT03050801|50160274|FG000|Experiment 2|Poor data quality|0|||
25056189|NCT03050801|50160275|FG001|Experiment 2|Poor data quality|0|||
25056190|NCT03050801|50160276|FG002|Experiment 2|Poor data quality|0|||
25056191|NCT03050801|50160277|FG003|Experiment 2|Poor data quality|4|||
25056192|NCT03050801|50160278|FG004|Experiment 2|Poor data quality|1|||
25056193|NCT03050801|50160279|FG005|Experiment 2|Poor data quality|0|||
25056194|NCT03050801|50160274|FG000|Experiment 2|Discomfort during stimulation|0|||
25056195|NCT03050801|50160275|FG001|Experiment 2|Discomfort during stimulation|0|||
25056196|NCT03050801|50160276|FG002|Experiment 2|Discomfort during stimulation|0|||
25056197|NCT03050801|50160277|FG003|Experiment 2|Discomfort during stimulation|0|||
25056198|NCT03050801|50160278|FG004|Experiment 2|Discomfort during stimulation|0|||
25056199|NCT03050801|50160279|FG005|Experiment 2|Discomfort during stimulation|2|||
25056200|NCT02707640|50160298|FG000|Overall Study|Adverse Event|4|||
25056201|NCT02707640|50160299|FG001|Overall Study|Adverse Event|2|||
25056202|NCT02707640|50160298|FG000|Overall Study|Death|1|||
25056203|NCT02707640|50160299|FG001|Overall Study|Death|2|||
25056204|NCT02707640|50160298|FG000|Overall Study|Physician Decision|2|||
25056205|NCT02707640|50160299|FG001|Overall Study|Physician Decision|0|||
25056206|NCT02707640|50160298|FG000|Overall Study|Withdrawal by Subject|0|||
25056207|NCT02707640|50160299|FG001|Overall Study|Withdrawal by Subject|1|||
25056208|NCT02707640|50160298|FG000|Overall Study|Participant's Personal Decision|1|||
25056209|NCT02707640|50160299|FG001|Overall Study|Participant's Personal Decision|2|||
25056210|NCT02707640|50160298|FG000|Overall Study|Sponsor Discretion|1|||
25056211|NCT02707640|50160299|FG001|Overall Study|Sponsor Discretion|0|||
25056212|NCT02708966|50160307|FG000|Overall Study|Lost to Follow-up|2|||
25056213|NCT02708966|50160308|FG001|Overall Study|Lost to Follow-up|2|||
25056214|NCT02706938|50160316|FG000|First Period, 6 Weeks|Adverse Event|8|||
25056215|NCT02706938|50160317|FG001|First Period, 6 Weeks|Adverse Event|0|||
25056216|NCT02706938|50160316|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
25056217|NCT02706938|50160317|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
25056218|NCT02706938|50160316|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
25056219|NCT02706938|50160317|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
25056220|NCT02706938|50160316|FG000|Second Period, 6 Weeks|Adverse Event|0|||
25056221|NCT02706938|50160317|FG001|Second Period, 6 Weeks|Adverse Event|7|||
25056222|NCT02706938|50160316|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
25056223|NCT02706938|50160317|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
25056224|NCT03053063|50160327|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
25056225|NCT03053063|50160328|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
25056226|NCT03053063|50160329|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
25056227|NCT03053063|50160330|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
25056228|NCT03053063|50160327|FG000|Randomized Phase|Withdrew consent|8|||
25056229|NCT03053063|50160328|FG001|Randomized Phase|Withdrew consent|11|||
25056230|NCT03053063|50160329|FG002|Randomized Phase|Withdrew consent|5|||
25056231|NCT03053063|50160330|FG003|Randomized Phase|Withdrew consent|0|||
25056232|NCT03053063|50160327|FG000|Randomized Phase|Investigator's Discretion|8|||
25056233|NCT03053063|50160328|FG001|Randomized Phase|Investigator's Discretion|6|||
25056234|NCT03053063|50160329|FG002|Randomized Phase|Investigator's Discretion|2|||
25056235|NCT03053063|50160330|FG003|Randomized Phase|Investigator's Discretion|0|||
25056236|NCT03053063|50160327|FG000|Randomized Phase|Lost to Follow-up|3|||
25056237|NCT03053063|50160328|FG001|Randomized Phase|Lost to Follow-up|5|||
25056238|NCT03053063|50160329|FG002|Randomized Phase|Lost to Follow-up|1|||
25056239|NCT03053063|50160330|FG003|Randomized Phase|Lost to Follow-up|0|||
25056240|NCT03053063|50160327|FG000|Randomized Phase|Adverse Event|0|||
25056241|NCT03053063|50160328|FG001|Randomized Phase|Adverse Event|1|||
25056242|NCT03053063|50160329|FG002|Randomized Phase|Adverse Event|0|||
25056243|NCT03053063|50160330|FG003|Randomized Phase|Adverse Event|0|||
25056244|NCT03053063|50160327|FG000|Randomized Phase|Randomized but Never Treated|1|||
25056245|NCT03053063|50160328|FG001|Randomized Phase|Randomized but Never Treated|3|||
25056246|NCT03053063|50160329|FG002|Randomized Phase|Randomized but Never Treated|2|||
25056247|NCT03053063|50160330|FG003|Randomized Phase|Randomized but Never Treated|0|||
25056248|NCT03053063|50160327|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
25056249|NCT03053063|50160328|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
25056250|NCT03053063|50160329|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
25056251|NCT03053063|50160330|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
25056252|NCT03053063|50160327|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
25056253|NCT03053063|50160328|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
25056254|NCT03053063|50160329|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
25056255|NCT03053063|50160330|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
25056256|NCT03053063|50160327|FG000|Open-Label Phase|Death|0|||
25056257|NCT03053063|50160328|FG001|Open-Label Phase|Death|0|||
25056258|NCT03053063|50160329|FG002|Open-Label Phase|Death|0|||
25056259|NCT03053063|50160330|FG003|Open-Label Phase|Death|2|||
25056260|NCT03053063|50160327|FG000|Open-Label Phase|Investigator's discretion|0|||
25056261|NCT03053063|50160328|FG001|Open-Label Phase|Investigator's discretion|0|||
25056262|NCT03053063|50160329|FG002|Open-Label Phase|Investigator's discretion|0|||
25056263|NCT03053063|50160330|FG003|Open-Label Phase|Investigator's discretion|2|||
25056264|NCT01316939|50160352|FG000|Overall Study|Study closed/terminated|26|||
25056265|NCT01316939|50160353|FG001|Overall Study|Study closed/terminated|25|||
25056266|NCT01316939|50160354|FG002|Overall Study|Study closed/terminated|23|||
25056267|NCT01316939|50160352|FG000|Overall Study|Lack of Efficacy|24|||
25056268|NCT01316939|50160353|FG001|Overall Study|Lack of Efficacy|25|||
25056269|NCT01316939|50160354|FG002|Overall Study|Lack of Efficacy|25|||
25056270|NCT01316939|50160352|FG000|Overall Study|Adverse Event|9|||
25056271|NCT01316939|50160353|FG001|Overall Study|Adverse Event|12|||
25056272|NCT01316939|50160354|FG002|Overall Study|Adverse Event|11|||
25056273|NCT01316939|50160352|FG000|Overall Study|Withdrawal by Subject|1|||
25056274|NCT01316939|50160353|FG001|Overall Study|Withdrawal by Subject|3|||
25056275|NCT01316939|50160354|FG002|Overall Study|Withdrawal by Subject|6|||
25056276|NCT01316939|50160352|FG000|Overall Study|Physician Decision|2|||
25056277|NCT01316939|50160353|FG001|Overall Study|Physician Decision|2|||
25056278|NCT01316939|50160354|FG002|Overall Study|Physician Decision|1|||
25056279|NCT01316939|50160352|FG000|Overall Study|Lost to Follow-up|0|||
25056280|NCT01316939|50160353|FG001|Overall Study|Lost to Follow-up|0|||
25056281|NCT01316939|50160354|FG002|Overall Study|Lost to Follow-up|2|||
25056282|NCT01316939|50160352|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
25056283|NCT01316939|50160353|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
25056284|NCT01316939|50160354|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
25056285|NCT01316939|50160352|FG000|Overall Study|Protocol Violation|0|||
25056286|NCT01316939|50160353|FG001|Overall Study|Protocol Violation|1|||
25056287|NCT01316939|50160354|FG002|Overall Study|Protocol Violation|0|||
25056288|NCT03044249|50160364|FG000|Overall Study|Adverse Event|4|||
25056289|NCT03044249|50160365|FG001|Overall Study|Adverse Event|9|||
25056290|NCT03044249|50160364|FG000|Overall Study|Lost to Follow-up|1|||
25056291|NCT03044249|50160365|FG001|Overall Study|Lost to Follow-up|0|||
25056292|NCT03044249|50160364|FG000|Overall Study|Non-compliance with Study Drug|1|||
25056293|NCT03044249|50160365|FG001|Overall Study|Non-compliance with Study Drug|0|||
25056294|NCT03044249|50160364|FG000|Overall Study|Study Terminated by Sponsor|2|||
25056295|NCT03044249|50160365|FG001|Overall Study|Study Terminated by Sponsor|0|||
25056296|NCT03044249|50160364|FG000|Overall Study|Withdrawal by Subject|2|||
25056297|NCT03044249|50160365|FG001|Overall Study|Withdrawal by Subject|5|||
25056298|NCT02704130|50160378|FG000|Overall Study|Physician Decision|5|||
25056299|NCT02704130|50160379|FG001|Overall Study|Physician Decision|3|||
25056300|NCT03740009|50160385|FG000|Overall Study|Physician Decision|9|||
25056301|NCT03740009|50160385|FG000|Overall Study|Lost to Follow-up|1|||
25056302|NCT03649217|50160389|FG000|Overall Study|subject had severe ataxia not initially found|1|||
25056303|NCT03649217|50160389|FG000|Overall Study|subject had cognitive issues not initially found|1|||
25056304|NCT03138889|50160418|FG000|Overall Study|Withdrawal by Subject|5|||
25056305|NCT03138889|50160419|FG001|Overall Study|Withdrawal by Subject|5|||
25056306|NCT03138889|50160420|FG002|Overall Study|Withdrawal by Subject|0|||
25056307|NCT03138889|50160421|FG003|Overall Study|Withdrawal by Subject|2|||
25056308|NCT03138889|50160422|FG004|Overall Study|Withdrawal by Subject|1|||
25056309|NCT03138889|50160423|FG005|Overall Study|Withdrawal by Subject|3|||
25056310|NCT03138889|50160424|FG006|Overall Study|Withdrawal by Subject|0|||
25056311|NCT03138889|50160425|FG007|Overall Study|Withdrawal by Subject|1|||
25056312|NCT02706392|50160477|FG000|Overall Study|Death|1|||
25056313|NCT02706392|50160478|FG001|Overall Study|Death|0|||
25056314|NCT02706392|50160479|FG002|Overall Study|Death|2|||
25056315|NCT02706392|50160480|FG003|Overall Study|Death|2|||
25056316|NCT02706392|50160481|FG004|Overall Study|Death|5|||
25056317|NCT02706392|50160482|FG005|Overall Study|Death|2|||
25056318|NCT03042767|50160498|FG000|Overall Study|Lost to Follow-up|1|||
25056319|NCT03042767|50160499|FG001|Overall Study|Lost to Follow-up|2|||
25056320|NCT00703820|50160507|FG000|Overall Study|Adverse Event|12|||
25056321|NCT00703820|50160508|FG001|Overall Study|Adverse Event|17|||
25056322|NCT00703820|50160507|FG000|Overall Study|Death|5|||
25056323|NCT00703820|50160508|FG001|Overall Study|Death|0|||
25056324|NCT00703820|50160507|FG000|Overall Study|Lack of Efficacy|11|||
25056325|NCT00703820|50160508|FG001|Overall Study|Lack of Efficacy|11|||
25056326|NCT00703820|50160507|FG000|Overall Study|Received non-protocol therapy|1|||
25056327|NCT00703820|50160508|FG001|Overall Study|Received non-protocol therapy|0|||
25056328|NCT00703820|50160507|FG000|Overall Study|Physician Decision|4|||
25056329|NCT00703820|50160508|FG001|Overall Study|Physician Decision|5|||
25056330|NCT00703820|50160507|FG000|Overall Study|Withdrawal by Subject|2|||
25276641|NCT01241552|50590593|FG003|Overall Study|Technical Problems|2|||
25056331|NCT00703820|50160508|FG001|Overall Study|Withdrawal by Subject|1|||
25056332|NCT03045887|50160526|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
25056333|NCT03045887|50160527|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
25056334|NCT03045887|50160528|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
25056335|NCT03045887|50160529|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
25056336|NCT03045887|50160530|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
25056337|NCT03045887|50160531|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
25056338|NCT03045887|50160532|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
25056339|NCT03045887|50160533|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
25056340|NCT03045887|50160534|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
25056341|NCT03045887|50160535|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
25056342|NCT03045887|50160526|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
25056343|NCT03045887|50160527|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
25056344|NCT03045887|50160528|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
25056345|NCT03045887|50160529|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
25056346|NCT03045887|50160530|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
25056347|NCT03045887|50160531|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
25056348|NCT03045887|50160532|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
25056349|NCT03045887|50160533|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
25056350|NCT03045887|50160534|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
25056351|NCT03045887|50160535|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
25056352|NCT03045887|50160526|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
25056353|NCT03045887|50160527|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
25056354|NCT03045887|50160528|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
25056355|NCT03045887|50160529|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
25056356|NCT03045887|50160530|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
25056357|NCT03045887|50160531|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
25056358|NCT03045887|50160532|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
25056359|NCT03045887|50160533|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
25056360|NCT03045887|50160534|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
25056361|NCT03045887|50160535|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
25056362|NCT03045887|50160526|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
25056363|NCT03045887|50160527|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
25056364|NCT03045887|50160528|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
25056365|NCT03045887|50160529|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
25056366|NCT03045887|50160530|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
25056367|NCT03045887|50160531|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
25056368|NCT03045887|50160532|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
25056369|NCT03045887|50160533|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
25056370|NCT03045887|50160534|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
25056371|NCT03045887|50160535|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
25056372|NCT03045887|50160526|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
25056373|NCT03045887|50160527|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
25056374|NCT03045887|50160528|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
25056375|NCT03045887|50160529|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
25056376|NCT03045887|50160530|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
25056377|NCT03045887|50160531|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
25056378|NCT03045887|50160532|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
25056379|NCT03045887|50160533|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
25056380|NCT03045887|50160534|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
25056381|NCT03045887|50160535|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
25056382|NCT01564537|50160564|FG000|Overall Study|Site Terminated by Sponsor|1|||
25056383|NCT01564537|50160565|FG001|Overall Study|Site Terminated by Sponsor|0|||
25056384|NCT01564537|50160564|FG000|Overall Study|Withdrawal by Subject|12|||
25056385|NCT01564537|50160565|FG001|Overall Study|Withdrawal by Subject|14|||
25056386|NCT01564537|50160564|FG000|Overall Study|Lost to Follow-up|7|||
25056387|NCT01564537|50160565|FG001|Overall Study|Lost to Follow-up|3|||
25056388|NCT01564537|50160564|FG000|Overall Study|Reason not specified|81|||
25056389|NCT01564537|50160565|FG001|Overall Study|Reason not specified|82|||
25056390|NCT03042611|50160576|FG000|Core Phase|Withdrawal by Subject|13|||
25056391|NCT03042611|50160577|FG001|Core Phase|Withdrawal by Subject|4|||
25056392|NCT03042611|50160578|FG002|Core Phase|Withdrawal by Subject|0|||
25056393|NCT03042611|50160579|FG003|Core Phase|Withdrawal by Subject|0|||
25056394|NCT03042611|50160576|FG000|Core Phase|Death|232|||
25056395|NCT03042611|50160577|FG001|Core Phase|Death|110|||
25056396|NCT03042611|50160578|FG002|Core Phase|Death|0|||
25056397|NCT03042611|50160579|FG003|Core Phase|Death|0|||
25056398|NCT03042611|50160576|FG000|Core Phase|Lost to Follow-up|4|||
25056399|NCT03042611|50160577|FG001|Core Phase|Lost to Follow-up|7|||
25056400|NCT03042611|50160578|FG002|Core Phase|Lost to Follow-up|0|||
25056401|NCT03042611|50160579|FG003|Core Phase|Lost to Follow-up|0|||
25056402|NCT03042611|50160576|FG000|Core Phase|Physician Decision|7|||
25056403|NCT03042611|50160577|FG001|Core Phase|Physician Decision|2|||
25056404|NCT03042611|50160578|FG002|Core Phase|Physician Decision|0|||
25056405|NCT03042611|50160579|FG003|Core Phase|Physician Decision|0|||
25056406|NCT03042611|50160576|FG000|Core Phase|Study Closed|0|||
25056407|NCT03042611|50160577|FG001|Core Phase|Study Closed|1|||
25276642|NCT01241552|50590590|FG000|Overall Study|Progressive Disease|0|||
25056408|NCT03042611|50160578|FG002|Core Phase|Study Closed|0|||
25056409|NCT03042611|50160579|FG003|Core Phase|Study Closed|0|||
25056410|NCT03042611|50160576|FG000|Extension Phase|Death|0|||
25056411|NCT03042611|50160577|FG001|Extension Phase|Death|0|||
25056412|NCT03042611|50160578|FG002|Extension Phase|Death|34|||
25056413|NCT03042611|50160579|FG003|Extension Phase|Death|16|||
25056414|NCT03042611|50160576|FG000|Extension Phase|Lost to Follow-up|0|||
25056415|NCT03042611|50160577|FG001|Extension Phase|Lost to Follow-up|0|||
25056416|NCT03042611|50160578|FG002|Extension Phase|Lost to Follow-up|1|||
25056417|NCT03042611|50160579|FG003|Extension Phase|Lost to Follow-up|1|||
25056418|NCT03042611|50160576|FG000|Extension Phase|Study Closed|0|||
25056419|NCT03042611|50160577|FG001|Extension Phase|Study Closed|0|||
25056420|NCT03042611|50160578|FG002|Extension Phase|Study Closed|17|||
25056421|NCT03042611|50160579|FG003|Extension Phase|Study Closed|11|||
25056422|NCT02701634|50160587|FG000|Overall Study|Adverse Event|2|||
25056423|NCT02701634|50160588|FG001|Overall Study|Adverse Event|3|||
25056424|NCT02701634|50160587|FG000|Overall Study|Death|1|||
25056425|NCT02701634|50160588|FG001|Overall Study|Death|0|||
25056426|NCT02701634|50160587|FG000|Overall Study|Investigator's Discretion|7|||
25056427|NCT02701634|50160588|FG001|Overall Study|Investigator's Discretion|4|||
25056428|NCT02701634|50160587|FG000|Overall Study|Study terminated by Sponsor|15|||
25056429|NCT02701634|50160588|FG001|Overall Study|Study terminated by Sponsor|17|||
25056430|NCT02701634|50160587|FG000|Overall Study|Withdrew Consent|6|||
25056431|NCT02701634|50160588|FG001|Overall Study|Withdrew Consent|7|||
25056432|NCT02701634|50160587|FG000|Overall Study|Randomized but not treated|1|||
25056433|NCT02701634|50160588|FG001|Overall Study|Randomized but not treated|0|||
25056434|NCT02442765|50160598|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
25056435|NCT02442765|50160599|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
25056436|NCT02442765|50160600|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
25056437|NCT02442765|50160601|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
25056438|NCT02442765|50160602|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
25056439|NCT02442765|50160603|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
25056440|NCT02442765|50160604|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
25056441|NCT02442765|50160605|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
25056442|NCT02442765|50160598|FG000|Stage 2- (Days 43 to 85)|Death|0|||
25056443|NCT02442765|50160599|FG001|Stage 2- (Days 43 to 85)|Death|0|||
25056444|NCT02442765|50160600|FG002|Stage 2- (Days 43 to 85)|Death|0|||
25056445|NCT02442765|50160601|FG003|Stage 2- (Days 43 to 85)|Death|1|||
25056446|NCT02442765|50160602|FG004|Stage 2- (Days 43 to 85)|Death|1|||
25056447|NCT02442765|50160603|FG005|Stage 2- (Days 43 to 85)|Death|0|||
25056448|NCT02442765|50160604|FG006|Stage 2- (Days 43 to 85)|Death|2|||
25056449|NCT02442765|50160605|FG007|Stage 2- (Days 43 to 85)|Death|0|||
25056450|NCT02442765|50160598|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
25056451|NCT02442765|50160599|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
25056452|NCT02442765|50160600|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
25056453|NCT02442765|50160601|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
25056454|NCT02442765|50160602|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
25056455|NCT02442765|50160603|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
25056456|NCT02442765|50160604|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
25056457|NCT02442765|50160605|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
25056458|NCT02442765|50160598|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
25056459|NCT02442765|50160599|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
25056460|NCT02442765|50160600|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
25056461|NCT02442765|50160601|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
25056462|NCT02442765|50160602|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
25056463|NCT02442765|50160603|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
25056464|NCT02442765|50160604|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
25056465|NCT02442765|50160605|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
25056466|NCT02442765|50160598|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
25056467|NCT02442765|50160599|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
25056468|NCT02442765|50160600|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
25056469|NCT02442765|50160601|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
25056470|NCT02442765|50160602|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
25056471|NCT02442765|50160603|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
25056472|NCT02442765|50160604|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
25056473|NCT02442765|50160605|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
25056474|NCT02442765|50160598|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
25056475|NCT02442765|50160599|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
25056476|NCT02442765|50160600|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
25056477|NCT02442765|50160601|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
25056478|NCT02442765|50160602|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
25056479|NCT02442765|50160603|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
25056480|NCT02442765|50160604|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
25056481|NCT02442765|50160605|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
25056482|NCT02442765|50160598|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
25056483|NCT02442765|50160599|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
25056484|NCT02442765|50160600|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
25056485|NCT02442765|50160601|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
25056486|NCT02442765|50160602|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
25056487|NCT02442765|50160603|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
25056488|NCT02442765|50160604|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
25056489|NCT02442765|50160605|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
25056490|NCT02442765|50160598|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
25056491|NCT02442765|50160599|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
25056492|NCT02442765|50160600|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
25056493|NCT02442765|50160601|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
25056494|NCT02442765|50160602|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
25056495|NCT02442765|50160603|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
25056496|NCT02442765|50160604|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
25056497|NCT02442765|50160605|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
25056498|NCT03520413|50160638|FG000|Overall Study|Lost to Follow-up|1|||
25056499|NCT03520413|50160639|FG001|Overall Study|Lost to Follow-up|1|||
25056500|NCT03520413|50160638|FG000|Overall Study|Withdrawal by Subject|1|||
25056501|NCT03520413|50160639|FG001|Overall Study|Withdrawal by Subject|2|||
25056502|NCT03520413|50160638|FG000|Overall Study|Death|0|||
25056503|NCT03520413|50160639|FG001|Overall Study|Death|1|||
25056504|NCT03520413|50160638|FG000|Overall Study|Physician Decision|3|||
25056505|NCT03520413|50160639|FG001|Overall Study|Physician Decision|3|||
25056506|NCT03520413|50160638|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
25056507|NCT03520413|50160639|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
25056508|NCT02699684|50160646|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
25056509|NCT02699684|50160647|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
25056510|NCT02700698|50160656|FG000|Overall Study|Withdrawal by Subject|1|||
25056511|NCT02700698|50160657|FG001|Overall Study|Withdrawal by Subject|0|||
25056512|NCT01774721|50160665|FG000|Overall Study|Death|76|||
25056513|NCT01774721|50160666|FG001|Overall Study|Death|91|||
25056514|NCT01774721|50160665|FG000|Overall Study|Withdrawal by Subject|14|||
25056515|NCT01774721|50160666|FG001|Overall Study|Withdrawal by Subject|10|||
25056516|NCT01774721|50160665|FG000|Overall Study|Lost to Follow-up|1|||
25056517|NCT01774721|50160666|FG001|Overall Study|Lost to Follow-up|1|||
25056518|NCT01774721|50160665|FG000|Overall Study|Did not meet eligibility criteria|0|||
25056519|NCT01774721|50160666|FG001|Overall Study|Did not meet eligibility criteria|3|||
25056520|NCT01774721|50160665|FG000|Overall Study|Ongoing in study|136|||
25056521|NCT01774721|50160666|FG001|Overall Study|Ongoing in study|120|||
25056522|NCT02699450|50160677|FG000|Overall Study|Death|2|||
25056523|NCT02699450|50160678|FG001|Overall Study|Death|1|||
25056524|NCT02699450|50160679|FG002|Overall Study|Death|2|||
25056525|NCT02699450|50160677|FG000|Overall Study|Met Criteria for Study Exit|0|||
25056526|NCT02699450|50160678|FG001|Overall Study|Met Criteria for Study Exit|0|||
25056527|NCT02699450|50160679|FG002|Overall Study|Met Criteria for Study Exit|1|||
25056528|NCT02699450|50160677|FG000|Overall Study|Protocol Violation|4|||
25056529|NCT02699450|50160678|FG001|Overall Study|Protocol Violation|3|||
25056530|NCT02699450|50160679|FG002|Overall Study|Protocol Violation|5|||
25056531|NCT02699450|50160677|FG000|Overall Study|Lost to Follow-up|3|||
25056532|NCT02699450|50160678|FG001|Overall Study|Lost to Follow-up|0|||
25056533|NCT02699450|50160679|FG002|Overall Study|Lost to Follow-up|5|||
25056534|NCT02699450|50160677|FG000|Overall Study|Physician Decision|2|||
25056535|NCT02699450|50160678|FG001|Overall Study|Physician Decision|0|||
25056536|NCT02699450|50160679|FG002|Overall Study|Physician Decision|0|||
25056537|NCT02699450|50160677|FG000|Overall Study|Withdrawal by Subject|3|||
25056538|NCT02699450|50160678|FG001|Overall Study|Withdrawal by Subject|1|||
25056539|NCT02699450|50160679|FG002|Overall Study|Withdrawal by Subject|2|||
25056540|NCT02699450|50160677|FG000|Overall Study|Adverse Event|1|||
25056541|NCT02699450|50160678|FG001|Overall Study|Adverse Event|0|||
25056542|NCT02699450|50160679|FG002|Overall Study|Adverse Event|0|||
25056543|NCT02699996|50160690|FG000|Overall Study|Withdrawal by Subject|5|||
25056544|NCT02699996|50160691|FG001|Overall Study|Withdrawal by Subject|2|||
25056545|NCT02739321|50160700|FG000|Overall Study|Lack of Efficacy|1|||
25056546|NCT02739321|50160701|FG001|Overall Study|Lack of Efficacy|1|||
25056547|NCT02739321|50160700|FG000|Overall Study|Lost to Follow-up|1|||
25056548|NCT02739321|50160701|FG001|Overall Study|Lost to Follow-up|1|||
24963369|NCT00267956|50053431|FG001|After Controlled Period|Withdrew consent|0|||
25056549|NCT02739321|50160700|FG000|Overall Study|Withdrawal by Subject|1|||
25056550|NCT02739321|50160701|FG001|Overall Study|Withdrawal by Subject|2|||
25056551|NCT02696798|50160719|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
25056552|NCT02696798|50160720|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
25056553|NCT02696798|50160721|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
25056554|NCT02696798|50160719|FG000|Blinded Treatment Dosing Period|Death|0|||
25056555|NCT02696798|50160720|FG001|Blinded Treatment Dosing Period|Death|0|||
25056556|NCT02696798|50160721|FG002|Blinded Treatment Dosing Period|Death|1|||
25056557|NCT02696798|50160719|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
25056558|NCT02696798|50160720|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
25056559|NCT02696798|50160721|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
25056560|NCT02696798|50160719|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
25056561|NCT02696798|50160720|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
25056562|NCT02696798|50160721|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
25056563|NCT02696798|50160719|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
25056564|NCT02696798|50160720|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
25056565|NCT02696798|50160721|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
25056566|NCT02696798|50160719|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
25056567|NCT02696798|50160720|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
25056568|NCT02696798|50160721|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
25056569|NCT02696798|50160719|FG000|Extended Treatment Period|Adverse Event|1|||
25056570|NCT02696798|50160720|FG001|Extended Treatment Period|Adverse Event|4|||
25056571|NCT02696798|50160721|FG002|Extended Treatment Period|Adverse Event|5|||
25056572|NCT02696798|50160719|FG000|Extended Treatment Period|Lack of Efficacy|7|||
25056573|NCT02696798|50160720|FG001|Extended Treatment Period|Lack of Efficacy|2|||
25056574|NCT02696798|50160721|FG002|Extended Treatment Period|Lack of Efficacy|2|||
25056575|NCT02696798|50160719|FG000|Extended Treatment Period|Lost to Follow-up|1|||
25056576|NCT02696798|50160720|FG001|Extended Treatment Period|Lost to Follow-up|0|||
25056577|NCT02696798|50160721|FG002|Extended Treatment Period|Lost to Follow-up|0|||
25056578|NCT02696798|50160719|FG000|Extended Treatment Period|Physician Decision|0|||
25056579|NCT02696798|50160720|FG001|Extended Treatment Period|Physician Decision|1|||
25056580|NCT02696798|50160721|FG002|Extended Treatment Period|Physician Decision|0|||
25056581|NCT02696798|50160719|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
25056582|NCT02696798|50160720|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
25056583|NCT02696798|50160721|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
25056584|NCT02696798|50160719|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
25056585|NCT02696798|50160720|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
25056586|NCT02696798|50160721|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
25056587|NCT02696798|50160719|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
25056588|NCT02696798|50160720|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
25056589|NCT02696798|50160721|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
25056590|NCT02696798|50160719|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
25056591|NCT02696798|50160720|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
25056592|NCT02696798|50160721|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
25056593|NCT02696798|50160719|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
25056594|NCT02696798|50160720|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
25056595|NCT02696798|50160721|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
25056596|NCT02696798|50160719|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
25056597|NCT02696798|50160720|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
25056598|NCT02696798|50160721|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
25056599|NCT02696798|50160719|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
25056600|NCT02696798|50160720|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
25056601|NCT02696798|50160721|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
25056602|NCT02698826|50160743|FG000|Overall Study|Death|13|||
25056603|NCT02698826|50160743|FG000|Overall Study|Adverse Event|1|||
25056604|NCT02541604|50160761|FG000|Overall Study|Death|6|||
25056605|NCT02541604|50160762|FG001|Overall Study|Death|5|||
25056606|NCT02541604|50160763|FG002|Overall Study|Death|7|||
25056607|NCT02541604|50160764|FG003|Overall Study|Death|2|||
25056608|NCT02541604|50160765|FG004|Overall Study|Death|9|||
25056609|NCT02541604|50160766|FG005|Overall Study|Death|8|||
25056610|NCT02541604|50160767|FG006|Overall Study|Death|9|||
25056611|NCT02541604|50160768|FG007|Overall Study|Death|9|||
25056612|NCT02541604|50160769|FG008|Overall Study|Death|3|||
25056613|NCT02541604|50160770|FG009|Overall Study|Death|4|||
25056614|NCT02541604|50160771|FG010|Overall Study|Death|2|||
25056615|NCT02541604|50160772|FG011|Overall Study|Death|3|||
25056616|NCT02541604|50160761|FG000|Overall Study|Lost to Follow-up|2|||
25056617|NCT02541604|50160762|FG001|Overall Study|Lost to Follow-up|0|||
25056618|NCT02541604|50160763|FG002|Overall Study|Lost to Follow-up|1|||
25056619|NCT02541604|50160764|FG003|Overall Study|Lost to Follow-up|0|||
25056620|NCT02541604|50160765|FG004|Overall Study|Lost to Follow-up|0|||
25056621|NCT02541604|50160766|FG005|Overall Study|Lost to Follow-up|1|||
25056622|NCT02541604|50160767|FG006|Overall Study|Lost to Follow-up|1|||
25056623|NCT02541604|50160768|FG007|Overall Study|Lost to Follow-up|0|||
25056624|NCT02541604|50160769|FG008|Overall Study|Lost to Follow-up|0|||
25056625|NCT02541604|50160770|FG009|Overall Study|Lost to Follow-up|0|||
25056626|NCT02541604|50160771|FG010|Overall Study|Lost to Follow-up|0|||
25056627|NCT02541604|50160772|FG011|Overall Study|Lost to Follow-up|0|||
25056628|NCT02541604|50160761|FG000|Overall Study|Withdrawal by Subject|2|||
25056629|NCT02541604|50160762|FG001|Overall Study|Withdrawal by Subject|0|||
25056630|NCT02541604|50160763|FG002|Overall Study|Withdrawal by Subject|1|||
25056631|NCT02541604|50160764|FG003|Overall Study|Withdrawal by Subject|0|||
25056632|NCT02541604|50160765|FG004|Overall Study|Withdrawal by Subject|1|||
25056633|NCT02541604|50160766|FG005|Overall Study|Withdrawal by Subject|1|||
25056634|NCT02541604|50160767|FG006|Overall Study|Withdrawal by Subject|0|||
25056635|NCT02541604|50160768|FG007|Overall Study|Withdrawal by Subject|0|||
25056636|NCT02541604|50160769|FG008|Overall Study|Withdrawal by Subject|1|||
25056637|NCT02541604|50160770|FG009|Overall Study|Withdrawal by Subject|0|||
25056638|NCT02541604|50160771|FG010|Overall Study|Withdrawal by Subject|0|||
25056639|NCT02541604|50160772|FG011|Overall Study|Withdrawal by Subject|0|||
25056640|NCT02541604|50160761|FG000|Overall Study|Study Terminated by Sponsor|1|||
25056641|NCT02541604|50160762|FG001|Overall Study|Study Terminated by Sponsor|4|||
25056642|NCT02541604|50160763|FG002|Overall Study|Study Terminated by Sponsor|2|||
25056643|NCT02541604|50160764|FG003|Overall Study|Study Terminated by Sponsor|1|||
25056644|NCT02541604|50160765|FG004|Overall Study|Study Terminated by Sponsor|0|||
25056645|NCT02541604|50160766|FG005|Overall Study|Study Terminated by Sponsor|0|||
25056646|NCT02541604|50160767|FG006|Overall Study|Study Terminated by Sponsor|0|||
25056647|NCT02541604|50160768|FG007|Overall Study|Study Terminated by Sponsor|0|||
25056648|NCT02541604|50160769|FG008|Overall Study|Study Terminated by Sponsor|0|||
25056649|NCT02541604|50160770|FG009|Overall Study|Study Terminated by Sponsor|0|||
25056650|NCT02541604|50160771|FG010|Overall Study|Study Terminated by Sponsor|0|||
25056651|NCT02541604|50160772|FG011|Overall Study|Study Terminated by Sponsor|0|||
25056652|NCT02541604|50160761|FG000|Overall Study|Medical condition may jeopardize safety|0|||
25056653|NCT02541604|50160762|FG001|Overall Study|Medical condition may jeopardize safety|0|||
25056654|NCT02541604|50160763|FG002|Overall Study|Medical condition may jeopardize safety|0|||
25056655|NCT02541604|50160764|FG003|Overall Study|Medical condition may jeopardize safety|0|||
25056656|NCT02541604|50160765|FG004|Overall Study|Medical condition may jeopardize safety|0|||
25056657|NCT02541604|50160766|FG005|Overall Study|Medical condition may jeopardize safety|0|||
25056658|NCT02541604|50160767|FG006|Overall Study|Medical condition may jeopardize safety|0|||
25056659|NCT02541604|50160768|FG007|Overall Study|Medical condition may jeopardize safety|1|||
25056660|NCT02541604|50160769|FG008|Overall Study|Medical condition may jeopardize safety|0|||
25056661|NCT02541604|50160770|FG009|Overall Study|Medical condition may jeopardize safety|0|||
25056662|NCT02541604|50160771|FG010|Overall Study|Medical condition may jeopardize safety|0|||
25056663|NCT02541604|50160772|FG011|Overall Study|Medical condition may jeopardize safety|0|||
25056664|NCT02546674|50160821|FG000|Overall Study|Adverse Event|19|||
25056665|NCT02546674|50160821|FG000|Overall Study|Death|1|||
25056666|NCT02546674|50160821|FG000|Overall Study|Lost to Follow-up|1|||
25056667|NCT02546674|50160821|FG000|Overall Study|Physician Decision|13|||
25056668|NCT02546674|50160821|FG000|Overall Study|Pregnancy|1|||
25056669|NCT02546674|50160821|FG000|Overall Study|Progressive Disease|2|||
25056670|NCT02546674|50160821|FG000|Overall Study|Protocol Deviation|2|||
25056671|NCT02546674|50160821|FG000|Overall Study|Subject/Guardian Decision|6|||
25056672|NCT02546674|50160821|FG000|Overall Study|Withdrawal of Informed Consent|3|||
25056673|NCT02546362|50160826|FG000|4-week Treatment Period|Lost to Follow-up|1|||
25056674|NCT02546362|50160826|FG000|4-week Treatment Period|Change in medication|2|||
25056675|NCT02546362|50160826|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
25056676|NCT02546362|50160826|FG000|12-week Treatment Period|Lost to Follow-up|2|||
25056677|NCT02546362|50160826|FG000|12-week Treatment Period|Change in medication|1|||
25056678|NCT02698436|50160832|FG000|Overall Study|Adverse Event|1|||
25056679|NCT02698436|50160833|FG001|Overall Study|Adverse Event|0|||
25056680|NCT02698436|50160832|FG000|Overall Study|Withdrawal by Subject|3|||
25056681|NCT02698436|50160833|FG001|Overall Study|Withdrawal by Subject|3|||
25056682|NCT02698436|50160832|FG000|Overall Study|Lost to Follow-up|2|||
25056683|NCT02698436|50160833|FG001|Overall Study|Lost to Follow-up|4|||
25056684|NCT02698436|50160832|FG000|Overall Study|Non-compliance with study regimen|1|||
25056685|NCT02698436|50160833|FG001|Overall Study|Non-compliance with study regimen|0|||
25056686|NCT02694536|50160839|FG000|Overall Study|Progressive Disease|40|||
25056687|NCT02694536|50160839|FG000|Overall Study|Lost to Follow-up|1|||
25056688|NCT02694536|50160839|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
25056689|NCT02694536|50160839|FG000|Overall Study|Withdrawal by Subject|8|||
25056690|NCT02694536|50160839|FG000|Overall Study|Death|8|||
25056691|NCT02694536|50160839|FG000|Overall Study|Other|22|||
25056692|NCT01661686|50160845|FG000|Overall Study|Lost to Follow-up|2|||
25056693|NCT01661686|50160846|FG001|Overall Study|Lost to Follow-up|1|||
25056694|NCT01661686|50160845|FG000|Overall Study|did not receive allocated intervention|0|||
25056695|NCT01661686|50160846|FG001|Overall Study|did not receive allocated intervention|1|||
25056696|NCT02696096|50160852|FG000|Overall Study|ruled out at screening|1|||
25056697|NCT02696096|50160852|FG000|Overall Study|did not attend second fMRI|1|||
25056698|NCT02695628|50160860|FG000|Overall Study|Withdrawal by Subject|1|||
25056699|NCT02693834|50160864|FG000|Baseline Measurement|Withdrawal by Subject|1|||
25056700|NCT02693834|50160865|FG001|Baseline Measurement|Withdrawal by Subject|0|||
25056701|NCT02693834|50160864|FG000|Baseline Measurement|Adverse Event|1|||
25056702|NCT02693834|50160865|FG001|Baseline Measurement|Adverse Event|0|||
25056703|NCT02693834|50160864|FG000|Week 2 Practice|Adverse Event|0|||
25056704|NCT02693834|50160865|FG001|Week 2 Practice|Adverse Event|1|||
25056705|NCT02545504|50160873|FG000|Overall Study|Death|174|||
25056706|NCT02545504|50160874|FG001|Overall Study|Death|168|||
25056707|NCT02545504|50160873|FG000|Overall Study|Unknown reason|30|||
25056708|NCT02545504|50160874|FG001|Overall Study|Unknown reason|32|||
25056709|NCT02545504|50160873|FG000|Overall Study|Withdrew consent|9|||
25056710|NCT02545504|50160874|FG001|Overall Study|Withdrew consent|11|||
25056711|NCT02545504|50160873|FG000|Overall Study|Investigator's discretion|3|||
25056712|NCT02545504|50160874|FG001|Overall Study|Investigator's discretion|1|||
25056713|NCT02545504|50160873|FG000|Overall Study|Lost to Follow-up|2|||
25056714|NCT02545504|50160874|FG001|Overall Study|Lost to Follow-up|2|||
25056715|NCT02545270|50160887|FG000|Overall Study|technical difficulties|0|||
25056716|NCT02545270|50160888|FG001|Overall Study|technical difficulties|1|||
25056717|NCT02545270|50160889|FG002|Overall Study|technical difficulties|0|||
25056718|NCT02545270|50160887|FG000|Overall Study|Videos being too similar to other|0|||
25056719|NCT02545270|50160888|FG001|Overall Study|Videos being too similar to other|0|||
25056720|NCT02545270|50160889|FG002|Overall Study|Videos being too similar to other|2|||
25056721|NCT02540668|50160898|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
25056722|NCT02540668|50160899|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
25056723|NCT02339740|50160908|FG000|Overall Study|Death|1|||
25056724|NCT02339740|50160909|FG001|Overall Study|Death|0|||
25056725|NCT02339740|50160908|FG000|Overall Study|Physician Decision|0|||
25056726|NCT02339740|50160909|FG001|Overall Study|Physician Decision|2|||
25056727|NCT02339740|50160908|FG000|Overall Study|Withdrawal by Subject|5|||
25056728|NCT02339740|50160909|FG001|Overall Study|Withdrawal by Subject|1|||
25056729|NCT02339740|50160908|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
25056730|NCT02339740|50160909|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
25056731|NCT02535364|50160932|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
25056732|NCT02535364|50160932|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
25056733|NCT02535364|50160932|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
25056734|NCT02535364|50160932|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
25056735|NCT02535364|50160932|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
25056736|NCT02535364|50160932|FG000|Part B Screening|Death|2|||
25056737|NCT02535364|50160932|FG000|Part B Screening|Physician Decision|1|||
25056738|NCT02535364|50160932|FG000|Part B Screening|Withdrawal by Subject|1|||
25056739|NCT02535364|50160932|FG000|Part B Screening|Adverse Event|1|||
25056740|NCT02535364|50160932|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
25056741|NCT02535364|50160932|FG000|Study Treatment|Death|1|||
25056742|NCT02535364|50160932|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
25056743|NCT02535364|50160932|FG000|12-Month Follow-up Period|Disease progression|22|||
25056744|NCT02535364|50160932|FG000|12-Month Follow-up Period|Death|5|||
25056745|NCT02535364|50160932|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
25056746|NCT02535364|50160932|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
25056747|NCT02535364|50160932|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
25056748|NCT02540356|50160938|FG000|Overall Study|Terminated due to disease progression|1|||
25056749|NCT02540356|50160939|FG001|Overall Study|Terminated due to disease progression|0|||
25056750|NCT02534896|50160947|FG000|Overall Study|Adverse Event|2|||
25056751|NCT02534896|50160948|FG001|Overall Study|Adverse Event|1|||
25056752|NCT02534896|50160949|FG002|Overall Study|Adverse Event|1|||
25056753|NCT02534896|50160947|FG000|Overall Study|Insufficient therapeutic response|2|||
25056754|NCT02534896|50160948|FG001|Overall Study|Insufficient therapeutic response|0|||
25056755|NCT02534896|50160949|FG002|Overall Study|Insufficient therapeutic response|0|||
25056756|NCT02697734|50160959|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
25056757|NCT02697734|50160960|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
25056758|NCT02697734|50160959|FG000|Core Phase - up to Week 48|Adverse Event|1|||
25056759|NCT02697734|50160960|FG001|Core Phase - up to Week 48|Adverse Event|2|||
25056760|NCT02697734|50160959|FG000|Core Phase - up to Week 48|Physician Decision|1|||
25056761|NCT02697734|50160960|FG001|Core Phase - up to Week 48|Physician Decision|0|||
25056762|NCT02697734|50160959|FG000|Optional Extension Phase|Adverse Event|5|||
25056763|NCT02697734|50160960|FG001|Optional Extension Phase|Adverse Event|1|||
25056764|NCT02697734|50160959|FG000|Optional Extension Phase|Physician Decision|0|||
25056765|NCT02697734|50160960|FG001|Optional Extension Phase|Physician Decision|1|||
24963370|NCT00267956|50053432|FG002|After Controlled Period|Withdrew consent|1|||
25056766|NCT02692586|50160974|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
25056767|NCT02692586|50160974|FG000|Overall Study|Received adjunctive thrombolytics|2|||
25056768|NCT02534350|50160980|FG000|Overall Study|Randomized But Not Treated|1|||
25056769|NCT02534350|50160981|FG001|Overall Study|Randomized But Not Treated|0|||
25056770|NCT02534350|50160980|FG000|Overall Study|Protocol Violation|1|||
25056771|NCT02534350|50160981|FG001|Overall Study|Protocol Violation|0|||
25056772|NCT02534350|50160980|FG000|Overall Study|Withdrew Consent|2|||
25056773|NCT02534350|50160981|FG001|Overall Study|Withdrew Consent|0|||
25056774|NCT02689076|50160990|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
25056775|NCT02689076|50160991|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
25056776|NCT02689076|50160992|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
25056777|NCT02689076|50160990|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
25056778|NCT02689076|50160991|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
25056779|NCT02689076|50160992|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
25056780|NCT02689076|50160990|FG000|Overall Study|Did not have an HIE match|2|||
25056781|NCT02689076|50160991|FG001|Overall Study|Did not have an HIE match|0|||
25056782|NCT02689076|50160992|FG002|Overall Study|Did not have an HIE match|0|||
25056783|NCT02689076|50160990|FG000|Overall Study|Death during non-VA encounter|2|||
25056784|NCT02689076|50160991|FG001|Overall Study|Death during non-VA encounter|5|||
25056785|NCT02689076|50160992|FG002|Overall Study|Death during non-VA encounter|0|||
25056786|NCT02689076|50160990|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
25056787|NCT02689076|50160991|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
25056788|NCT02689076|50160992|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
25056789|NCT02689076|50160990|FG000|Overall Study|Participant no longer active in VA system|1|||
25056790|NCT02689076|50160991|FG001|Overall Study|Participant no longer active in VA system|0|||
25056791|NCT02689076|50160992|FG002|Overall Study|Participant no longer active in VA system|0|||
25056792|NCT02689076|50160990|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
25056793|NCT02689076|50160991|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
25056794|NCT02689076|50160992|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
25056795|NCT02688764|50161002|FG000|Overall Study|Adverse Event|3|||
25056796|NCT02688764|50161003|FG001|Overall Study|Adverse Event|3|||
25056797|NCT02688764|50161002|FG000|Overall Study|AE/Kidney transplant|1|||
25056798|NCT02688764|50161003|FG001|Overall Study|AE/Kidney transplant|0|||
25056799|NCT02688764|50161002|FG000|Overall Study|AE/Lack of efficacy|1|||
25056800|NCT02688764|50161003|FG001|Overall Study|AE/Lack of efficacy|0|||
25056801|NCT02688764|50161002|FG000|Overall Study|AE/Non-compl.|1|||
25056802|NCT02688764|50161003|FG001|Overall Study|AE/Non-compl.|0|||
25056803|NCT02688764|50161002|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
25056804|NCT02688764|50161003|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
25162733|NCT01835587|50285114|FG001|Overall Study|Disease Recurrence or Relapse|3|||
25162734|NCT01835587|50285115|FG002|Overall Study|Disease Recurrence or Relapse|0|||
25162735|NCT01835587|50285116|FG003|Overall Study|Disease Recurrence or Relapse|3|||
25162736|NCT01835587|50285113|FG000|Overall Study|Withdrawal by Subject|2|||
25056805|NCT02688764|50161002|FG000|Overall Study|AE/Other|0|||
25056806|NCT02688764|50161003|FG001|Overall Study|AE/Other|1|||
25056807|NCT02688764|50161002|FG000|Overall Study|AE/Physician decision|1|||
25162737|NCT01835587|50285114|FG001|Overall Study|Withdrawal by Subject|0|||
25162738|NCT01835587|50285115|FG002|Overall Study|Withdrawal by Subject|0|||
25162739|NCT01835587|50285116|FG003|Overall Study|Withdrawal by Subject|3|||
25162740|NCT01835587|50285113|FG000|Overall Study|Adverse Event|0|||
25162741|NCT01835587|50285114|FG001|Overall Study|Adverse Event|0|||
25162742|NCT01835587|50285115|FG002|Overall Study|Adverse Event|2|||
25162743|NCT01835587|50285116|FG003|Overall Study|Adverse Event|2|||
25056808|NCT02688764|50161003|FG001|Overall Study|AE/Physician decision|0|||
25056809|NCT02688764|50161002|FG000|Overall Study|AE/Withd. parent|3|||
25056810|NCT02688764|50161003|FG001|Overall Study|AE/Withd. parent|0|||
25056811|NCT02688764|50161002|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
25056812|NCT02688764|50161003|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
25056813|NCT02688764|50161002|FG000|Overall Study|AE/Withd. subject|1|||
25056814|NCT02688764|50161003|FG001|Overall Study|AE/Withd. subject|0|||
25056815|NCT02688764|50161002|FG000|Overall Study|Kidney transplant|10|||
25056816|NCT02688764|50161003|FG001|Overall Study|Kidney transplant|4|||
25056817|NCT02688764|50161002|FG000|Overall Study|Lack of Efficacy|3|||
25056818|NCT02688764|50161003|FG001|Overall Study|Lack of Efficacy|2|||
25056819|NCT02688764|50161002|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
25056820|NCT02688764|50161003|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
25056821|NCT02688764|50161002|FG000|Overall Study|Non-compliance with study drug|4|||
25056822|NCT02688764|50161003|FG001|Overall Study|Non-compliance with study drug|0|||
25056823|NCT02688764|50161002|FG000|Overall Study|Non-compl./Physician decision|2|||
25056824|NCT02688764|50161003|FG001|Overall Study|Non-compl./Physician decision|0|||
25056825|NCT02688764|50161002|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
25056826|NCT02688764|50161003|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
25056827|NCT02688764|50161002|FG000|Overall Study|Non-compl./Withd. subject|0|||
25056828|NCT02688764|50161003|FG001|Overall Study|Non-compl./Withd. subject|2|||
25162744|NCT01835587|50285113|FG000|Overall Study|Death|0|||
25162745|NCT01835587|50285114|FG001|Overall Study|Death|0|||
25276643|NCT01241552|50590591|FG001|Overall Study|Progressive Disease|0|||
25056829|NCT02688764|50161002|FG000|Overall Study|Phosphorus level outside safe range|0|||
25056830|NCT02688764|50161003|FG001|Overall Study|Phosphorus level outside safe range|1|||
25056831|NCT02688764|50161002|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
25056832|NCT02688764|50161003|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
25056833|NCT02688764|50161002|FG000|Overall Study|Study drug taste/Withd. parent|1|||
25056834|NCT02688764|50161003|FG001|Overall Study|Study drug taste/Withd. parent|0|||
25056835|NCT02688764|50161002|FG000|Overall Study|Subject moving out|2|||
25056836|NCT02688764|50161003|FG001|Overall Study|Subject moving out|0|||
25056837|NCT02688764|50161002|FG000|Overall Study|Subject taken off dialysis|1|||
25056838|NCT02688764|50161003|FG001|Overall Study|Subject taken off dialysis|0|||
25056839|NCT02688764|50161002|FG000|Overall Study|Withdrawal by parent|3|||
25056840|NCT02688764|50161003|FG001|Overall Study|Withdrawal by parent|0|||
25056841|NCT02688608|50161012|FG000|Overall Study|Lost to Follow-up|1|||
25056842|NCT02688530|50161020|FG000|Overall Study|Withdrawal by Subject|0|||
25056843|NCT02688530|50161021|FG001|Overall Study|Withdrawal by Subject|1|||
25056844|NCT02688530|50161022|FG002|Overall Study|Withdrawal by Subject|0|||
25056845|NCT02688530|50161023|FG003|Overall Study|Withdrawal by Subject|0|||
25056846|NCT02688530|50161020|FG000|Overall Study|Lost to Follow-up|0|||
25056847|NCT02688530|50161021|FG001|Overall Study|Lost to Follow-up|0|||
25056848|NCT02688530|50161022|FG002|Overall Study|Lost to Follow-up|2|||
25056849|NCT02688530|50161023|FG003|Overall Study|Lost to Follow-up|0|||
25056850|NCT02467270|50161040|FG000|Overall Study|Participants Never Treated|0|||
25056851|NCT02467270|50161041|FG001|Overall Study|Participants Never Treated|1|||
25056852|NCT02467270|50161042|FG002|Overall Study|Participants Never Treated|0|||
25056853|NCT02467270|50161040|FG000|Overall Study|Ongoing|50|||
25056854|NCT02467270|50161041|FG001|Overall Study|Ongoing|41|||
25056855|NCT02467270|50161042|FG002|Overall Study|Ongoing|43|||
25056856|NCT02467270|50161040|FG000|Overall Study|Adverse Event|16|||
25056857|NCT02467270|50161041|FG001|Overall Study|Adverse Event|15|||
25056858|NCT02467270|50161042|FG002|Overall Study|Adverse Event|14|||
25056859|NCT02467270|50161040|FG000|Overall Study|Progressive Disease|7|||
25056860|NCT02467270|50161041|FG001|Overall Study|Progressive Disease|7|||
25056861|NCT02467270|50161042|FG002|Overall Study|Progressive Disease|4|||
25056862|NCT02467270|50161040|FG000|Overall Study|Death|2|||
25056863|NCT02467270|50161041|FG001|Overall Study|Death|0|||
25056864|NCT02467270|50161042|FG002|Overall Study|Death|2|||
25056865|NCT02467270|50161040|FG000|Overall Study|Lack of Efficacy|12|||
25056866|NCT02467270|50161041|FG001|Overall Study|Lack of Efficacy|18|||
25056867|NCT02467270|50161042|FG002|Overall Study|Lack of Efficacy|23|||
25056868|NCT02467270|50161040|FG000|Overall Study|Non-compliance With Study Drug|0|||
25056869|NCT02467270|50161041|FG001|Overall Study|Non-compliance With Study Drug|2|||
25276644|NCT01241552|50590592|FG002|Overall Study|Progressive Disease|1|||
24963371|NCT00267956|50053433|FG003|After Controlled Period|Withdrew consent|0|||
24963372|NCT00267488|50053441|FG000|Overall Study|Sponsor Terminated Study|9|||
24963373|NCT00267488|50053441|FG000|Overall Study|Protocol Violation|1|||
24963374|NCT00267488|50053441|FG000|Overall Study|Other (Disease Progression)|1|||
24963375|NCT00046930|50053447|FG000|Overall Study|Ineligible|12|||
24963376|NCT00046930|50053448|FG001|Overall Study|Ineligible|4|||
24963377|NCT00058552|50053459|FG000|Overall Study|Died prior to receiving treatment|4|||
24963378|NCT00058552|50053460|FG001|Overall Study|Died prior to receiving treatment|2|||
24963379|NCT00058552|50053459|FG000|Overall Study|Disease progression|52|||
24963380|NCT00058552|50053460|FG001|Overall Study|Disease progression|44|||
24963381|NCT00058552|50053459|FG000|Overall Study|Adverse Event|4|||
24963382|NCT00058552|50053460|FG001|Overall Study|Adverse Event|2|||
24963383|NCT00058552|50053459|FG000|Overall Study|Withdrawal by Subject|3|||
24963384|NCT00058552|50053460|FG001|Overall Study|Withdrawal by Subject|5|||
24963385|NCT00058552|50053459|FG000|Overall Study|Physician Decision|2|||
24963386|NCT00058552|50053460|FG001|Overall Study|Physician Decision|5|||
24963387|NCT00058552|50053459|FG000|Overall Study|Clinical disease progression|0|||
24963388|NCT00058552|50053460|FG001|Overall Study|Clinical disease progression|4|||
24963389|NCT00044512|50053468|FG000|Follow Up|Lost to Follow-up|2|||
24963390|NCT03805438|50053472|FG000|Overall Study|Lack of Efficacy|1|||
24963391|NCT03805438|50053472|FG000|Overall Study|Protocol Violation|1|||
25056870|NCT02467270|50161042|FG002|Overall Study|Non-compliance With Study Drug|1|||
25056871|NCT02467270|50161040|FG000|Overall Study|Lost to Follow-up|2|||
25056872|NCT02467270|50161041|FG001|Overall Study|Lost to Follow-up|1|||
25056873|NCT02467270|50161042|FG002|Overall Study|Lost to Follow-up|0|||
25056874|NCT02467270|50161040|FG000|Overall Study|Pregnancy|0|||
25056875|NCT02467270|50161041|FG001|Overall Study|Pregnancy|1|||
25056876|NCT02467270|50161042|FG002|Overall Study|Pregnancy|0|||
24963392|NCT00147537|50053480|FG000|Phase 1b|Death|0|||
24963393|NCT00147537|50053481|FG001|Phase 1b|Death|1|||
24963394|NCT00147537|50053482|FG002|Phase 1b|Death|2|||
25056877|NCT02467270|50161040|FG000|Overall Study|Physician Decision|0|||
25056878|NCT02467270|50161041|FG001|Overall Study|Physician Decision|4|||
25056879|NCT02467270|50161042|FG002|Overall Study|Physician Decision|1|||
25056880|NCT02467270|50161040|FG000|Overall Study|Withdrawal by Subject|4|||
24963395|NCT00147537|50053483|FG003|Phase 1b|Death|1|||
24963396|NCT00147537|50053484|FG004|Phase 1b|Death|2|||
24963397|NCT00147537|50053485|FG005|Phase 1b|Death|2|||
24963398|NCT00147537|50053486|FG006|Phase 1b|Death|1|||
24963399|NCT00147537|50053487|FG007|Phase 1b|Death|3|||
24963400|NCT00147537|50053488|FG008|Phase 1b|Death|9|||
24963401|NCT00147537|50053489|FG009|Phase 1b|Death|0|||
24963402|NCT00147537|50053490|FG010|Phase 1b|Death|0|||
24963403|NCT00147537|50053480|FG000|Phase 1b|Lost to Follow-up|2|||
24963404|NCT00147537|50053481|FG001|Phase 1b|Lost to Follow-up|1|||
25056881|NCT02467270|50161041|FG001|Overall Study|Withdrawal by Subject|3|||
25056882|NCT02467270|50161042|FG002|Overall Study|Withdrawal by Subject|5|||
25056883|NCT02467270|50161040|FG000|Overall Study|Reason not Specified|1|||
25056884|NCT02467270|50161041|FG001|Overall Study|Reason not Specified|2|||
25056885|NCT02467270|50161042|FG002|Overall Study|Reason not Specified|1|||
25056886|NCT05083559|50161052|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
25056887|NCT05083559|50161053|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
25056888|NCT05083559|50161052|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
25056889|NCT05083559|50161053|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
25056890|NCT05083559|50161052|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
25056891|NCT05083559|50161053|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
25056892|NCT03037307|50161059|FG000|Period 1|Did Not Meet Study Criteria|0|||
25056893|NCT03037307|50161060|FG001|Period 1|Did Not Meet Study Criteria|0|||
25056894|NCT03037307|50161061|FG002|Period 1|Did Not Meet Study Criteria|0|||
25056895|NCT03037307|50161062|FG003|Period 1|Did Not Meet Study Criteria|1|||
25056896|NCT03037307|50161063|FG004|Period 1|Did Not Meet Study Criteria|0|||
25056897|NCT03037307|50161064|FG005|Period 1|Did Not Meet Study Criteria|0|||
25056898|NCT02538094|50161073|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
25056899|NCT02538094|50161074|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
25056900|NCT02538094|50161073|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
25056901|NCT02538094|50161074|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
25056902|NCT02686034|50161082|FG000|Run-In Period 1|Eligibility|12|||
25056903|NCT02686034|50161083|FG001|Run-In Period 1|Eligibility|10|||
25056904|NCT02686034|50161082|FG000|Run-In Period 1|Withdrawal by Subject|4|||
25056905|NCT02686034|50161083|FG001|Run-In Period 1|Withdrawal by Subject|3|||
25056906|NCT02686034|50161082|FG000|Run-In Period 1|Lost to Follow-up|4|||
25056907|NCT02686034|50161083|FG001|Run-In Period 1|Lost to Follow-up|4|||
25056908|NCT02686034|50161082|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
25056909|NCT02686034|50161083|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
25056910|NCT02686034|50161082|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
25056911|NCT02686034|50161083|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
25056912|NCT02686034|50161082|FG000|Randomized Controlled Period 2|Adverse Event|0|||
25056913|NCT02686034|50161083|FG001|Randomized Controlled Period 2|Adverse Event|2|||
25056914|NCT02686034|50161082|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
25056915|NCT02686034|50161083|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
25056916|NCT02686034|50161082|FG000|Open Label Period 3|Lost to Follow-up|0|||
25056917|NCT02686034|50161083|FG001|Open Label Period 3|Lost to Follow-up|1|||
25056918|NCT02685488|50161091|FG000|Overall Study|Withdrawal by Subject|0|||
24963405|NCT00147537|50053482|FG002|Phase 1b|Lost to Follow-up|0|||
24963406|NCT00147537|50053483|FG003|Phase 1b|Lost to Follow-up|0|||
24963407|NCT00147537|50053484|FG004|Phase 1b|Lost to Follow-up|0|||
24963408|NCT00147537|50053485|FG005|Phase 1b|Lost to Follow-up|0|||
24963409|NCT00147537|50053486|FG006|Phase 1b|Lost to Follow-up|2|||
24963410|NCT00147537|50053487|FG007|Phase 1b|Lost to Follow-up|0|||
24963411|NCT00147537|50053488|FG008|Phase 1b|Lost to Follow-up|1|||
24963412|NCT00147537|50053489|FG009|Phase 1b|Lost to Follow-up|0|||
25056919|NCT02685488|50161092|FG001|Overall Study|Withdrawal by Subject|1|||
25056920|NCT02533570|50161101|FG000|Overall Study|Adverse Event|0|||
25056921|NCT02533570|50161102|FG001|Overall Study|Adverse Event|1|||
25056922|NCT02533570|50161103|FG002|Overall Study|Adverse Event|1|||
25056923|NCT03036839|50161114|FG000|Overall Study|Adverse Event|0|||
25056924|NCT03036839|50161115|FG001|Overall Study|Adverse Event|0|||
25056925|NCT03036839|50161116|FG002|Overall Study|Adverse Event|1|||
25056926|NCT03036839|50161114|FG000|Overall Study|Death|3|||
25056927|NCT03036839|50161115|FG001|Overall Study|Death|0|||
24963413|NCT00147537|50053490|FG010|Phase 1b|Lost to Follow-up|0|||
24963414|NCT00147537|50053480|FG000|Phase 1b|Other|0|||
24963415|NCT00147537|50053481|FG001|Phase 1b|Other|0|||
25056928|NCT03036839|50161116|FG002|Overall Study|Death|3|||
25056929|NCT03036839|50161114|FG000|Overall Study|Withdrew Consent|0|||
25056930|NCT03036839|50161115|FG001|Overall Study|Withdrew Consent|0|||
25056931|NCT03036839|50161116|FG002|Overall Study|Withdrew Consent|1|||
24963416|NCT00147537|50053482|FG002|Phase 1b|Other|2|||
25056932|NCT01286207|50161127|FG000|Overall Study|Adverse Event|27|||
25056933|NCT01286207|50161128|FG001|Overall Study|Adverse Event|41|||
25056934|NCT01286207|50161129|FG002|Overall Study|Adverse Event|8|||
24963417|NCT00147537|50053483|FG003|Phase 1b|Other|1|||
24963418|NCT00147537|50053484|FG004|Phase 1b|Other|1|||
24963419|NCT00147537|50053485|FG005|Phase 1b|Other|1|||
25056935|NCT01286207|50161127|FG000|Overall Study|Lost to Follow-up|49|||
25056936|NCT01286207|50161128|FG001|Overall Study|Lost to Follow-up|43|||
25056937|NCT01286207|50161129|FG002|Overall Study|Lost to Follow-up|20|||
25056938|NCT01286207|50161127|FG000|Overall Study|Withdrawal by Subject|93|||
25056939|NCT01286207|50161128|FG001|Overall Study|Withdrawal by Subject|79|||
25056940|NCT01286207|50161129|FG002|Overall Study|Withdrawal by Subject|41|||
25056941|NCT01286207|50161127|FG000|Overall Study|Lack of Response|92|||
25056942|NCT01286207|50161128|FG001|Overall Study|Lack of Response|38|||
25056943|NCT01286207|50161129|FG002|Overall Study|Lack of Response|8|||
25056944|NCT01286207|50161127|FG000|Overall Study|Other|37|||
25056945|NCT01286207|50161128|FG001|Overall Study|Other|47|||
25056946|NCT01286207|50161129|FG002|Overall Study|Other|13|||
25056947|NCT00968201|50161166|FG000|Base Study - (Period II)|Adverse Event|8|||
25056948|NCT00968201|50161167|FG001|Base Study - (Period II)|Adverse Event|0|||
25056949|NCT00968201|50161168|FG002|Base Study - (Period II)|Adverse Event|16|||
25056950|NCT00968201|50161166|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
25056951|NCT00968201|50161167|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
25056952|NCT00968201|50161168|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
25056953|NCT00968201|50161166|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
25056954|NCT00968201|50161167|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
25056955|NCT00968201|50161168|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
25056956|NCT00968201|50161166|FG000|Base Study - (Period II)|Protocol Violation|12|||
25056957|NCT00968201|50161167|FG001|Base Study - (Period II)|Protocol Violation|0|||
25056958|NCT00968201|50161168|FG002|Base Study - (Period II)|Protocol Violation|12|||
25056959|NCT00968201|50161166|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
25056960|NCT00968201|50161167|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
25056961|NCT00968201|50161168|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
25056962|NCT00968201|50161166|FG000|Base Study - (Period II)|Site Error|0|||
25056963|NCT00968201|50161167|FG001|Base Study - (Period II)|Site Error|0|||
25056964|NCT00968201|50161168|FG002|Base Study - (Period II)|Site Error|1|||
25056965|NCT00968201|50161166|FG000|Extension Study - (Period III)|Adverse Event|0|||
25056966|NCT00968201|50161167|FG001|Extension Study - (Period III)|Adverse Event|5|||
25056967|NCT00968201|50161168|FG002|Extension Study - (Period III)|Adverse Event|22|||
25056968|NCT00968201|50161166|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
25056969|NCT00968201|50161167|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
25056970|NCT00968201|50161168|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
25056971|NCT00968201|50161166|FG000|Extension Study - (Period III)|Protocol Violation|0|||
25056972|NCT00968201|50161167|FG001|Extension Study - (Period III)|Protocol Violation|17|||
25056973|NCT00968201|50161168|FG002|Extension Study - (Period III)|Protocol Violation|14|||
25056974|NCT00968201|50161166|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
25056975|NCT00968201|50161167|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
25056976|NCT00968201|50161168|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
25056977|NCT00968201|50161166|FG000|Extension Study - (Period III)|Patient Relocated|0|||
25056978|NCT00968201|50161167|FG001|Extension Study - (Period III)|Patient Relocated|1|||
25056979|NCT00968201|50161168|FG002|Extension Study - (Period III)|Patient Relocated|1|||
25056980|NCT00968201|50161166|FG000|Extension Study - (Period III)|Noncompliance|0|||
25056981|NCT00968201|50161167|FG001|Extension Study - (Period III)|Noncompliance|0|||
25056982|NCT00968201|50161168|FG002|Extension Study - (Period III)|Noncompliance|3|||
25056983|NCT00968201|50161166|FG000|Extension Study - (Period III)|Other|0|||
25056984|NCT00968201|50161167|FG001|Extension Study - (Period III)|Other|0|||
25056985|NCT00968201|50161168|FG002|Extension Study - (Period III)|Other|2|||
25056986|NCT00968201|50161166|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
25056987|NCT00968201|50161167|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
25056988|NCT00968201|50161168|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
25056989|NCT00943397|50161179|FG000|Overall Study|Adverse Event|0|||
25056990|NCT00943397|50161180|FG001|Overall Study|Adverse Event|6|||
25056991|NCT00943397|50161179|FG000|Overall Study|Lost to Follow-up|0|||
25056992|NCT00943397|50161180|FG001|Overall Study|Lost to Follow-up|4|||
25056993|NCT00943397|50161179|FG000|Overall Study|Protocol Violation|2|||
25056994|NCT00943397|50161180|FG001|Overall Study|Protocol Violation|5|||
25056995|NCT00943397|50161179|FG000|Overall Study|Withdrawal by Subject|1|||
25056996|NCT00943397|50161180|FG001|Overall Study|Withdrawal by Subject|1|||
25056997|NCT00943397|50161179|FG000|Overall Study|Site terminated and other|12|||
25056998|NCT00943397|50161180|FG001|Overall Study|Site terminated and other|56|||
25056999|NCT00702845|50161188|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
25057000|NCT00702845|50161189|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
25057001|NCT00702845|50161188|FG000|Overall Study|Too high ovarian response|5|||
25057002|NCT00702845|50161189|FG001|Overall Study|Too high ovarian response|1|||
25162746|NCT01835587|50285115|FG002|Overall Study|Death|0|||
25162747|NCT01835587|50285116|FG003|Overall Study|Death|1|||
25057003|NCT00702845|50161188|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
25057004|NCT00702845|50161189|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
25162748|NCT01835587|50285113|FG000|Overall Study|Miscellaneous|0|||
25057005|NCT00702845|50161188|FG000|Overall Study|Insufficient ovarian response|1|||
25057006|NCT00702845|50161189|FG001|Overall Study|Insufficient ovarian response|0|||
25057007|NCT00702845|50161188|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
25057008|NCT00702845|50161189|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
25057009|NCT00702845|50161188|FG000|Overall Study|No or abnormal fertilization|4|||
25057010|NCT00702845|50161189|FG001|Overall Study|No or abnormal fertilization|2|||
25057011|NCT00702845|50161188|FG000|Overall Study|Patient's decision|2|||
25057012|NCT00702845|50161189|FG001|Overall Study|Patient's decision|1|||
25057013|NCT00702845|50161188|FG000|Overall Study|Not randomized|0|||
25057014|NCT00702845|50161189|FG001|Overall Study|Not randomized|1|||
25057015|NCT01302847|50161203|FG000|Overall Study|Ongoing|0|||
25057016|NCT01302847|50161204|FG001|Overall Study|Ongoing|0|||
25057017|NCT01302847|50161205|FG002|Overall Study|Ongoing|0|||
25057018|NCT01302847|50161206|FG003|Overall Study|Ongoing|0|||
25057019|NCT01302847|50161207|FG004|Overall Study|Ongoing|0|||
25057020|NCT01302847|50161208|FG005|Overall Study|Ongoing|27|||
25057021|NCT01302847|50161209|FG006|Overall Study|Ongoing|22|||
25057022|NCT01302847|50161210|FG007|Overall Study|Ongoing|17|||
25057023|NCT01302847|50161203|FG000|Overall Study|Death|0|||
25057024|NCT01302847|50161204|FG001|Overall Study|Death|1|||
25057025|NCT01302847|50161205|FG002|Overall Study|Death|0|||
25057026|NCT01302847|50161206|FG003|Overall Study|Death|0|||
25057027|NCT01302847|50161207|FG004|Overall Study|Death|0|||
25057028|NCT01302847|50161208|FG005|Overall Study|Death|1|||
25057029|NCT01302847|50161209|FG006|Overall Study|Death|1|||
25057030|NCT01302847|50161210|FG007|Overall Study|Death|0|||
25057031|NCT01302847|50161203|FG000|Overall Study|Pregnancy|2|||
25057032|NCT01302847|50161204|FG001|Overall Study|Pregnancy|0|||
25057033|NCT01302847|50161205|FG002|Overall Study|Pregnancy|0|||
25057034|NCT01302847|50161206|FG003|Overall Study|Pregnancy|0|||
25057035|NCT01302847|50161207|FG004|Overall Study|Pregnancy|0|||
25057036|NCT01302847|50161208|FG005|Overall Study|Pregnancy|0|||
25057037|NCT01302847|50161209|FG006|Overall Study|Pregnancy|0|||
25057038|NCT01302847|50161210|FG007|Overall Study|Pregnancy|0|||
25057039|NCT01302847|50161203|FG000|Overall Study|Virologic failure|0|||
25057040|NCT01302847|50161204|FG001|Overall Study|Virologic failure|2|||
25057041|NCT01302847|50161205|FG002|Overall Study|Virologic failure|2|||
25057042|NCT01302847|50161206|FG003|Overall Study|Virologic failure|0|||
25057043|NCT01302847|50161207|FG004|Overall Study|Virologic failure|1|||
25057044|NCT01302847|50161208|FG005|Overall Study|Virologic failure|1|||
25057045|NCT01302847|50161209|FG006|Overall Study|Virologic failure|0|||
25057046|NCT01302847|50161210|FG007|Overall Study|Virologic failure|2|||
25057047|NCT01302847|50161203|FG000|Overall Study|Severe debilitation, unable to continue|0|||
25057048|NCT01302847|50161204|FG001|Overall Study|Severe debilitation, unable to continue|0|||
25057049|NCT01302847|50161205|FG002|Overall Study|Severe debilitation, unable to continue|0|||
25057050|NCT01302847|50161206|FG003|Overall Study|Severe debilitation, unable to continue|0|||
25057051|NCT01302847|50161207|FG004|Overall Study|Severe debilitation, unable to continue|0|||
25057052|NCT01302847|50161208|FG005|Overall Study|Severe debilitation, unable to continue|1|||
25057053|NCT01302847|50161209|FG006|Overall Study|Severe debilitation, unable to continue|1|||
25276645|NCT01241552|50590593|FG003|Overall Study|Progressive Disease|2|||
25276646|NCT01241552|50590590|FG000|Overall Study|Protocol Violation|0|||
24963420|NCT00147537|50053486|FG006|Phase 1b|Other|14|||
24963421|NCT00147537|50053487|FG007|Phase 1b|Other|4|||
24963422|NCT00147537|50053488|FG008|Phase 1b|Other|4|||
24963423|NCT00147537|50053489|FG009|Phase 1b|Other|0|||
24963424|NCT00147537|50053490|FG010|Phase 1b|Other|0|||
24963425|NCT00147537|50053480|FG000|Phase 1b|Withdrawal by Subject|0|||
24963426|NCT00147537|50053481|FG001|Phase 1b|Withdrawal by Subject|0|||
24963427|NCT00147537|50053482|FG002|Phase 1b|Withdrawal by Subject|0|||
24963428|NCT00147537|50053483|FG003|Phase 1b|Withdrawal by Subject|0|||
24963429|NCT00147537|50053484|FG004|Phase 1b|Withdrawal by Subject|0|||
24963430|NCT00147537|50053485|FG005|Phase 1b|Withdrawal by Subject|0|||
24963431|NCT00147537|50053486|FG006|Phase 1b|Withdrawal by Subject|0|||
24963432|NCT00147537|50053487|FG007|Phase 1b|Withdrawal by Subject|0|||
24963433|NCT00147537|50053488|FG008|Phase 1b|Withdrawal by Subject|2|||
24963434|NCT00147537|50053489|FG009|Phase 1b|Withdrawal by Subject|0|||
24963435|NCT00147537|50053490|FG010|Phase 1b|Withdrawal by Subject|0|||
24963436|NCT00147537|50053480|FG000|Phase 1b|Randomized but not treated|0|||
24963437|NCT00147537|50053481|FG001|Phase 1b|Randomized but not treated|0|||
24963438|NCT00147537|50053482|FG002|Phase 1b|Randomized but not treated|0|||
24963439|NCT00147537|50053483|FG003|Phase 1b|Randomized but not treated|0|||
24963440|NCT00147537|50053484|FG004|Phase 1b|Randomized but not treated|0|||
24963441|NCT00147537|50053485|FG005|Phase 1b|Randomized but not treated|0|||
24963442|NCT00147537|50053486|FG006|Phase 1b|Randomized but not treated|1|||
24963443|NCT00147537|50053487|FG007|Phase 1b|Randomized but not treated|0|||
24963444|NCT00147537|50053488|FG008|Phase 1b|Randomized but not treated|1|||
24963445|NCT00147537|50053489|FG009|Phase 1b|Randomized but not treated|0|||
24963446|NCT00147537|50053490|FG010|Phase 1b|Randomized but not treated|0|||
24963447|NCT00147537|50053480|FG000|Phase 2|Death|0|||
25057054|NCT01302847|50161210|FG007|Overall Study|Severe debilitation, unable to continue|0|||
24963448|NCT00147537|50053481|FG001|Phase 2|Death|0|||
24963449|NCT00147537|50053482|FG002|Phase 2|Death|0|||
24963450|NCT00147537|50053483|FG003|Phase 2|Death|0|||
24963451|NCT00147537|50053484|FG004|Phase 2|Death|0|||
24963452|NCT00147537|50053485|FG005|Phase 2|Death|0|||
24963453|NCT00147537|50053486|FG006|Phase 2|Death|0|||
24963454|NCT00147537|50053487|FG007|Phase 2|Death|0|||
24963455|NCT00147537|50053488|FG008|Phase 2|Death|0|||
24963456|NCT00147537|50053489|FG009|Phase 2|Death|85|||
24963457|NCT00147537|50053490|FG010|Phase 2|Death|31|||
24963458|NCT00147537|50053480|FG000|Phase 2|Lost to Follow-up|0|||
24963459|NCT00147537|50053481|FG001|Phase 2|Lost to Follow-up|0|||
24963460|NCT00147537|50053482|FG002|Phase 2|Lost to Follow-up|0|||
24963461|NCT00147537|50053483|FG003|Phase 2|Lost to Follow-up|0|||
24963462|NCT00147537|50053484|FG004|Phase 2|Lost to Follow-up|0|||
24963463|NCT00147537|50053485|FG005|Phase 2|Lost to Follow-up|0|||
24963464|NCT00147537|50053486|FG006|Phase 2|Lost to Follow-up|0|||
24963465|NCT00147537|50053487|FG007|Phase 2|Lost to Follow-up|0|||
24963466|NCT00147537|50053488|FG008|Phase 2|Lost to Follow-up|0|||
24963467|NCT00147537|50053489|FG009|Phase 2|Lost to Follow-up|12|||
25057055|NCT01302847|50161203|FG000|Overall Study|Not able to get to clinic|1|||
24963468|NCT00147537|50053490|FG010|Phase 2|Lost to Follow-up|4|||
24963469|NCT00147537|50053480|FG000|Phase 2|Other|0|||
24963470|NCT00147537|50053481|FG001|Phase 2|Other|0|||
24963471|NCT00147537|50053482|FG002|Phase 2|Other|0|||
24963472|NCT00147537|50053483|FG003|Phase 2|Other|0|||
24963473|NCT00147537|50053484|FG004|Phase 2|Other|0|||
24963474|NCT00147537|50053485|FG005|Phase 2|Other|0|||
24963475|NCT00147537|50053486|FG006|Phase 2|Other|0|||
25057056|NCT01302847|50161204|FG001|Overall Study|Not able to get to clinic|1|||
25057057|NCT01302847|50161205|FG002|Overall Study|Not able to get to clinic|0|||
25057058|NCT01302847|50161206|FG003|Overall Study|Not able to get to clinic|0|||
25057059|NCT01302847|50161207|FG004|Overall Study|Not able to get to clinic|0|||
25057060|NCT01302847|50161208|FG005|Overall Study|Not able to get to clinic|0|||
25057061|NCT01302847|50161209|FG006|Overall Study|Not able to get to clinic|0|||
25057062|NCT01302847|50161210|FG007|Overall Study|Not able to get to clinic|0|||
25057063|NCT01302847|50161203|FG000|Overall Study|Site closing|2|||
25057064|NCT01302847|50161204|FG001|Overall Study|Site closing|2|||
25057065|NCT01302847|50161205|FG002|Overall Study|Site closing|0|||
25057066|NCT01302847|50161206|FG003|Overall Study|Site closing|0|||
25057067|NCT01302847|50161207|FG004|Overall Study|Site closing|0|||
25057068|NCT01302847|50161208|FG005|Overall Study|Site closing|0|||
25057069|NCT01302847|50161209|FG006|Overall Study|Site closing|0|||
25057070|NCT01302847|50161210|FG007|Overall Study|Site closing|0|||
25057071|NCT01302847|50161203|FG000|Overall Study|Withdrawal by Subject|1|||
25057072|NCT01302847|50161204|FG001|Overall Study|Withdrawal by Subject|0|||
25057073|NCT01302847|50161205|FG002|Overall Study|Withdrawal by Subject|0|||
25057074|NCT01302847|50161206|FG003|Overall Study|Withdrawal by Subject|0|||
25057075|NCT01302847|50161207|FG004|Overall Study|Withdrawal by Subject|1|||
25057076|NCT01302847|50161208|FG005|Overall Study|Withdrawal by Subject|0|||
25057077|NCT01302847|50161209|FG006|Overall Study|Withdrawal by Subject|0|||
25057078|NCT01302847|50161210|FG007|Overall Study|Withdrawal by Subject|1|||
25057079|NCT01302847|50161203|FG000|Overall Study|Not willing to adhere to requirements|5|||
25057080|NCT01302847|50161204|FG001|Overall Study|Not willing to adhere to requirements|0|||
25057081|NCT01302847|50161205|FG002|Overall Study|Not willing to adhere to requirements|0|||
25057082|NCT01302847|50161206|FG003|Overall Study|Not willing to adhere to requirements|1|||
25057083|NCT01302847|50161207|FG004|Overall Study|Not willing to adhere to requirements|0|||
25057084|NCT01302847|50161208|FG005|Overall Study|Not willing to adhere to requirements|0|||
25057085|NCT01302847|50161209|FG006|Overall Study|Not willing to adhere to requirements|0|||
25057086|NCT01302847|50161210|FG007|Overall Study|Not willing to adhere to requirements|2|||
25057087|NCT01302847|50161203|FG000|Overall Study|Site unable to contact participant|2|||
25057088|NCT01302847|50161204|FG001|Overall Study|Site unable to contact participant|1|||
25057089|NCT01302847|50161205|FG002|Overall Study|Site unable to contact participant|0|||
25057090|NCT01302847|50161206|FG003|Overall Study|Site unable to contact participant|0|||
25057091|NCT01302847|50161207|FG004|Overall Study|Site unable to contact participant|0|||
25057092|NCT01302847|50161208|FG005|Overall Study|Site unable to contact participant|0|||
25057093|NCT01302847|50161209|FG006|Overall Study|Site unable to contact participant|2|||
25162749|NCT01835587|50285114|FG001|Overall Study|Miscellaneous|1|||
24963476|NCT00147537|50053487|FG007|Phase 2|Other|0|||
24963477|NCT00147537|50053488|FG008|Phase 2|Other|0|||
25057094|NCT01302847|50161210|FG007|Overall Study|Site unable to contact participant|0|||
25162750|NCT01835587|50285115|FG002|Overall Study|Miscellaneous|0|||
25057095|NCT03039569|50161239|FG000|Overall Study|Lost to Follow-up|5|||
25057096|NCT03039569|50161240|FG001|Overall Study|Lost to Follow-up|4|||
25162751|NCT01835587|50285116|FG003|Overall Study|Miscellaneous|0|||
25057097|NCT01272037|50161249|FG000|Overall Study|Death|30|||
24963478|NCT00147537|50053489|FG009|Phase 2|Other|47|||
24963479|NCT00147537|50053490|FG010|Phase 2|Other|12|||
24963480|NCT00147537|50053480|FG000|Phase 2|Withdrawal by Subject|0|||
24963481|NCT00147537|50053481|FG001|Phase 2|Withdrawal by Subject|0|||
24963482|NCT00147537|50053482|FG002|Phase 2|Withdrawal by Subject|0|||
25057098|NCT01272037|50161250|FG001|Overall Study|Death|30|||
25057099|NCT01272037|50161249|FG000|Overall Study|Adverse Event|12|||
25057100|NCT01272037|50161250|FG001|Overall Study|Adverse Event|7|||
25057101|NCT01272037|50161249|FG000|Overall Study|Withdrawal by Subject|158|||
25057102|NCT01272037|50161250|FG001|Overall Study|Withdrawal by Subject|83|||
25057103|NCT01272037|50161249|FG000|Overall Study|Disease progression|85|||
25057104|NCT01272037|50161250|FG001|Overall Study|Disease progression|125|||
25057105|NCT01272037|50161249|FG000|Overall Study|Other reason|49|||
25057106|NCT01272037|50161250|FG001|Overall Study|Other reason|45|||
25057107|NCT01272037|50161249|FG000|Overall Study|Delinquent data|6|||
25057108|NCT01272037|50161250|FG001|Overall Study|Delinquent data|4|||
25057109|NCT01272037|50161249|FG000|Overall Study|Reason under review|107|||
25057110|NCT01272037|50161250|FG001|Overall Study|Reason under review|136|||
25057111|NCT01272037|50161249|FG000|Overall Study|On treatment|173|||
25057112|NCT01272037|50161250|FG001|Overall Study|On treatment|185|||
25057113|NCT02738775|50161262|FG000|Overall Study|Withdrawal by Subject|0|||
25057114|NCT02738775|50161263|FG001|Overall Study|Withdrawal by Subject|1|||
25057115|NCT02738775|50161264|FG002|Overall Study|Withdrawal by Subject|0|||
25057116|NCT02738775|50161265|FG003|Overall Study|Withdrawal by Subject|0|||
25057117|NCT02738775|50161266|FG004|Overall Study|Withdrawal by Subject|0|||
25057118|NCT02738775|50161267|FG005|Overall Study|Withdrawal by Subject|0|||
25057119|NCT02738775|50161262|FG000|Overall Study|Adverse Event|0|||
25057120|NCT02738775|50161263|FG001|Overall Study|Adverse Event|0|||
25057121|NCT02738775|50161264|FG002|Overall Study|Adverse Event|0|||
25057122|NCT02738775|50161265|FG003|Overall Study|Adverse Event|1|||
25057123|NCT02738775|50161266|FG004|Overall Study|Adverse Event|0|||
25057124|NCT02738775|50161267|FG005|Overall Study|Adverse Event|0|||
25057125|NCT02738775|50161262|FG000|Overall Study|Pregnancy|0|||
25057126|NCT02738775|50161263|FG001|Overall Study|Pregnancy|1|||
25057127|NCT02738775|50161264|FG002|Overall Study|Pregnancy|0|||
25057128|NCT02738775|50161265|FG003|Overall Study|Pregnancy|0|||
25057129|NCT02738775|50161266|FG004|Overall Study|Pregnancy|0|||
25057130|NCT02738775|50161267|FG005|Overall Study|Pregnancy|0|||
25057131|NCT02738775|50161262|FG000|Overall Study|Missing|0|||
25057132|NCT02738775|50161263|FG001|Overall Study|Missing|0|||
24963483|NCT00147537|50053483|FG003|Phase 2|Withdrawal by Subject|0|||
24963484|NCT00147537|50053484|FG004|Phase 2|Withdrawal by Subject|0|||
25057133|NCT02738775|50161264|FG002|Overall Study|Missing|0|||
25057134|NCT02738775|50161265|FG003|Overall Study|Missing|0|||
25057135|NCT02738775|50161266|FG004|Overall Study|Missing|0|||
25057136|NCT02738775|50161267|FG005|Overall Study|Missing|1|||
25276647|NCT01241552|50590591|FG001|Overall Study|Protocol Violation|2|||
24963485|NCT00147537|50053485|FG005|Phase 2|Withdrawal by Subject|0|||
24963486|NCT00147537|50053486|FG006|Phase 2|Withdrawal by Subject|0|||
24963487|NCT00147537|50053487|FG007|Phase 2|Withdrawal by Subject|0|||
24963488|NCT00147537|50053488|FG008|Phase 2|Withdrawal by Subject|0|||
24963489|NCT00147537|50053489|FG009|Phase 2|Withdrawal by Subject|16|||
24963490|NCT00147537|50053490|FG010|Phase 2|Withdrawal by Subject|4|||
24963491|NCT00147537|50053480|FG000|Phase 2|Randomized but not treated|0|||
24963492|NCT00147537|50053481|FG001|Phase 2|Randomized but not treated|0|||
24963493|NCT00147537|50053482|FG002|Phase 2|Randomized but not treated|0|||
24963494|NCT00147537|50053483|FG003|Phase 2|Randomized but not treated|0|||
24963495|NCT00147537|50053484|FG004|Phase 2|Randomized but not treated|0|||
24963496|NCT00147537|50053485|FG005|Phase 2|Randomized but not treated|0|||
24963497|NCT00147537|50053486|FG006|Phase 2|Randomized but not treated|0|||
24963498|NCT00147537|50053487|FG007|Phase 2|Randomized but not treated|0|||
24963499|NCT00147537|50053488|FG008|Phase 2|Randomized but not treated|0|||
24963500|NCT00147537|50053489|FG009|Phase 2|Randomized but not treated|1|||
24963501|NCT00147537|50053490|FG010|Phase 2|Randomized but not treated|1|||
24963502|NCT00222729|50053535|FG000|Overall Study|Adverse Event|3|||
24963503|NCT00147225|50053545|FG000|Overall Study|Withdrawal by Subject|1|||
24963504|NCT00147225|50053546|FG001|Overall Study|Withdrawal by Subject|0|||
24963505|NCT00147225|50053547|FG002|Overall Study|Withdrawal by Subject|1|||
24963506|NCT00147225|50053548|FG003|Overall Study|Withdrawal by Subject|0|||
25276648|NCT01241552|50590592|FG002|Overall Study|Protocol Violation|6|||
24963507|NCT00147225|50053549|FG004|Overall Study|Withdrawal by Subject|0|||
24963508|NCT00147225|50053550|FG005|Overall Study|Withdrawal by Subject|1|||
25162752|NCT01736917|50285133|FG000|Overall Study|Adverse Event|1|||
25276649|NCT01241552|50590593|FG003|Overall Study|Protocol Violation|1|||
24963509|NCT00147225|50053545|FG000|Overall Study|Adverse Event|0|||
24963510|NCT00147225|50053546|FG001|Overall Study|Adverse Event|0|||
24963511|NCT00147225|50053547|FG002|Overall Study|Adverse Event|1|||
25057137|NCT02314923|50161304|FG000|Overall Study|Death|0|||
25057138|NCT02314923|50161305|FG001|Overall Study|Death|0|||
25057139|NCT02314923|50161306|FG002|Overall Study|Death|0|||
25057140|NCT02314923|50161307|FG003|Overall Study|Death|1|||
25057141|NCT02314923|50161308|FG004|Overall Study|Death|0|||
25057142|NCT02314923|50161309|FG005|Overall Study|Death|0|||
25057143|NCT02314923|50161310|FG006|Overall Study|Death|0|||
25057144|NCT02314923|50161311|FG007|Overall Study|Death|0|||
25057145|NCT02314923|50161312|FG008|Overall Study|Death|0|||
25057146|NCT02314923|50161313|FG009|Overall Study|Death|0|||
25057147|NCT02314923|50161304|FG000|Overall Study|Lost to Follow-up|2|||
25057148|NCT02314923|50161305|FG001|Overall Study|Lost to Follow-up|3|||
25057149|NCT02314923|50161306|FG002|Overall Study|Lost to Follow-up|1|||
25057150|NCT02314923|50161307|FG003|Overall Study|Lost to Follow-up|0|||
25057151|NCT02314923|50161308|FG004|Overall Study|Lost to Follow-up|0|||
25057152|NCT02314923|50161309|FG005|Overall Study|Lost to Follow-up|0|||
25057153|NCT02314923|50161310|FG006|Overall Study|Lost to Follow-up|3|||
25057154|NCT02314923|50161311|FG007|Overall Study|Lost to Follow-up|4|||
25057155|NCT02314923|50161312|FG008|Overall Study|Lost to Follow-up|2|||
25057156|NCT02314923|50161313|FG009|Overall Study|Lost to Follow-up|0|||
25057157|NCT02314923|50161304|FG000|Overall Study|Withdrawal by Subject|0|||
25057158|NCT02314923|50161305|FG001|Overall Study|Withdrawal by Subject|0|||
25057159|NCT02314923|50161306|FG002|Overall Study|Withdrawal by Subject|1|||
25057160|NCT02314923|50161307|FG003|Overall Study|Withdrawal by Subject|0|||
25057161|NCT02314923|50161308|FG004|Overall Study|Withdrawal by Subject|1|||
25057162|NCT02314923|50161309|FG005|Overall Study|Withdrawal by Subject|0|||
25057163|NCT02314923|50161310|FG006|Overall Study|Withdrawal by Subject|1|||
25057164|NCT02314923|50161311|FG007|Overall Study|Withdrawal by Subject|0|||
25057165|NCT02314923|50161312|FG008|Overall Study|Withdrawal by Subject|0|||
25057166|NCT02314923|50161313|FG009|Overall Study|Withdrawal by Subject|0|||
25057167|NCT02314923|50161304|FG000|Overall Study|Physician Decision|0|||
25057168|NCT02314923|50161305|FG001|Overall Study|Physician Decision|1|||
25057169|NCT02314923|50161306|FG002|Overall Study|Physician Decision|0|||
25057170|NCT02314923|50161307|FG003|Overall Study|Physician Decision|0|||
25057171|NCT02314923|50161308|FG004|Overall Study|Physician Decision|0|||
25057172|NCT02314923|50161309|FG005|Overall Study|Physician Decision|0|||
25057173|NCT02314923|50161310|FG006|Overall Study|Physician Decision|0|||
25057174|NCT02314923|50161311|FG007|Overall Study|Physician Decision|0|||
25057175|NCT02314923|50161312|FG008|Overall Study|Physician Decision|0|||
25057176|NCT02314923|50161313|FG009|Overall Study|Physician Decision|0|||
25057177|NCT02314923|50161304|FG000|Overall Study|Participant unavailable|0|||
25057178|NCT02314923|50161305|FG001|Overall Study|Participant unavailable|0|||
25057179|NCT02314923|50161306|FG002|Overall Study|Participant unavailable|0|||
25057180|NCT02314923|50161307|FG003|Overall Study|Participant unavailable|0|||
25057181|NCT02314923|50161308|FG004|Overall Study|Participant unavailable|0|||
25057182|NCT02314923|50161309|FG005|Overall Study|Participant unavailable|1|||
25057183|NCT02314923|50161310|FG006|Overall Study|Participant unavailable|0|||
25057184|NCT02314923|50161311|FG007|Overall Study|Participant unavailable|0|||
25057185|NCT02314923|50161312|FG008|Overall Study|Participant unavailable|0|||
25057186|NCT02314923|50161313|FG009|Overall Study|Participant unavailable|0|||
25057187|NCT02314923|50161304|FG000|Overall Study|Screen failure|0|||
25057188|NCT02314923|50161305|FG001|Overall Study|Screen failure|0|||
25057189|NCT02314923|50161306|FG002|Overall Study|Screen failure|0|||
25057190|NCT02314923|50161307|FG003|Overall Study|Screen failure|0|||
25057191|NCT02314923|50161308|FG004|Overall Study|Screen failure|0|||
25057192|NCT02314923|50161309|FG005|Overall Study|Screen failure|0|||
25057193|NCT02314923|50161310|FG006|Overall Study|Screen failure|1|||
25057194|NCT02314923|50161311|FG007|Overall Study|Screen failure|0|||
25057195|NCT02314923|50161312|FG008|Overall Study|Screen failure|0|||
25057196|NCT02314923|50161313|FG009|Overall Study|Screen failure|0|||
25276650|NCT01241552|50590590|FG000|Overall Study|Withdrawal by Subject|7|||
25276651|NCT01241552|50590591|FG001|Overall Study|Withdrawal by Subject|15|||
25057197|NCT02314923|50161304|FG000|Overall Study|Participant relocation|1|||
25057198|NCT02314923|50161305|FG001|Overall Study|Participant relocation|0|||
25057199|NCT02314923|50161306|FG002|Overall Study|Participant relocation|0|||
25057200|NCT02314923|50161307|FG003|Overall Study|Participant relocation|0|||
25057201|NCT02314923|50161308|FG004|Overall Study|Participant relocation|0|||
25057202|NCT02314923|50161309|FG005|Overall Study|Participant relocation|0|||
25057203|NCT02314923|50161310|FG006|Overall Study|Participant relocation|0|||
25057204|NCT02314923|50161311|FG007|Overall Study|Participant relocation|1|||
25057205|NCT02314923|50161312|FG008|Overall Study|Participant relocation|0|||
25057206|NCT02314923|50161313|FG009|Overall Study|Participant relocation|0|||
25057207|NCT03023137|50161338|FG000|Overall Study|Multiple pregnancy|2|||
25057208|NCT03023137|50161339|FG001|Overall Study|Multiple pregnancy|4|||
25057209|NCT03023137|50161338|FG000|Overall Study|Lost to Follow-up|1|||
25162753|NCT01736917|50285133|FG000|Overall Study|Protocol Violation|10|||
25057210|NCT03023137|50161339|FG001|Overall Study|Lost to Follow-up|1|||
25057211|NCT03023137|50161338|FG000|Overall Study|Protocol Violation|0|||
25057212|NCT03023137|50161339|FG001|Overall Study|Protocol Violation|4|||
25057213|NCT03023137|50161338|FG000|Overall Study|Lost the baby in a car accident|1|||
25057214|NCT03023137|50161339|FG001|Overall Study|Lost the baby in a car accident|0|||
25057215|NCT03049813|50161350|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
25057216|NCT03049813|50161351|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
25057217|NCT03049813|50161352|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
25057218|NCT03049813|50161353|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
25057219|NCT03049813|50161350|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
25057220|NCT03049813|50161351|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
25057221|NCT03049813|50161352|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
25057222|NCT03049813|50161353|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
25057223|NCT03049813|50161350|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
25057224|NCT03049813|50161351|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
25057225|NCT03049813|50161352|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
25057226|NCT03049813|50161353|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
25057227|NCT03049813|50161350|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
25057228|NCT03049813|50161351|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
25057229|NCT03049813|50161352|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
25057230|NCT03049813|50161353|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
25057231|NCT03022981|50161364|FG000|Overall Study|Adverse Event|0|||
25057232|NCT03022981|50161365|FG001|Overall Study|Adverse Event|1|||
25057233|NCT03022981|50161366|FG002|Overall Study|Adverse Event|0|||
25057234|NCT03022981|50161364|FG000|Overall Study|Investigator's Discretion|0|||
25057235|NCT03022981|50161365|FG001|Overall Study|Investigator's Discretion|1|||
25057236|NCT03022981|50161366|FG002|Overall Study|Investigator's Discretion|2|||
25057237|NCT03022981|50161364|FG000|Overall Study|Lost to Follow-up|6|||
25057238|NCT03022981|50161365|FG001|Overall Study|Lost to Follow-up|2|||
25057239|NCT03022981|50161366|FG002|Overall Study|Lost to Follow-up|1|||
25057240|NCT03022981|50161364|FG000|Overall Study|Non-Compliance With Study Drug|0|||
25057241|NCT03022981|50161365|FG001|Overall Study|Non-Compliance With Study Drug|0|||
25057242|NCT03022981|50161366|FG002|Overall Study|Non-Compliance With Study Drug|2|||
25057243|NCT03022981|50161364|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
25057244|NCT03022981|50161365|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
25057245|NCT03022981|50161366|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
25057246|NCT03377699|50161386|FG000|Overall Study|Withdrawal by Subject|2|||
25057247|NCT03377699|50161387|FG001|Overall Study|Withdrawal by Subject|9|||
25057248|NCT03377699|50161386|FG000|Overall Study|Lost to Follow-up|1|||
25057249|NCT03377699|50161387|FG001|Overall Study|Lost to Follow-up|1|||
25057250|NCT03377699|50161386|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
25057251|NCT03377699|50161387|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
25057252|NCT03377699|50161386|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
25057253|NCT03377699|50161387|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
25057254|NCT03377699|50161386|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
25057255|NCT03377699|50161387|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
25057256|NCT03377699|50161386|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
25057257|NCT03377699|50161387|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
25057258|NCT01314443|50161399|FG000|Overall Study|Withdrawal by Subject|2|||
25057259|NCT01314443|50161400|FG001|Overall Study|Withdrawal by Subject|1|||
25057260|NCT01314443|50161401|FG002|Overall Study|Withdrawal by Subject|1|||
25057261|NCT01314443|50161402|FG003|Overall Study|Withdrawal by Subject|1|||
25057262|NCT01314443|50161399|FG000|Overall Study|Protocol Violation|2|||
25057263|NCT01314443|50161400|FG001|Overall Study|Protocol Violation|2|||
25057264|NCT01314443|50161401|FG002|Overall Study|Protocol Violation|1|||
25057265|NCT01314443|50161402|FG003|Overall Study|Protocol Violation|1|||
25057266|NCT02923921|50161414|FG000|Overall Study|Sponsor Decision|39|||
25057267|NCT02923921|50161415|FG001|Overall Study|Sponsor Decision|38|||
25057268|NCT02923921|50161414|FG000|Overall Study|Lost to Follow-up|1|||
25057269|NCT02923921|50161415|FG001|Overall Study|Lost to Follow-up|0|||
25057270|NCT02923921|50161414|FG000|Overall Study|Withdrawal by Subject|6|||
25057271|NCT02923921|50161415|FG001|Overall Study|Withdrawal by Subject|13|||
25057272|NCT02923921|50161414|FG000|Overall Study|Unknown, Not Collected|7|||
25057273|NCT02923921|50161415|FG001|Overall Study|Unknown, Not Collected|6|||
25057274|NCT03039023|50161426|FG000|Overall Study|Withdrawal by Subject|1|||
25057275|NCT03039023|50161427|FG001|Overall Study|Withdrawal by Subject|0|||
25057276|NCT03039023|50161428|FG002|Overall Study|Withdrawal by Subject|1|||
25057277|NCT03039023|50161429|FG003|Overall Study|Withdrawal by Subject|1|||
25057278|NCT03039023|50161430|FG004|Overall Study|Withdrawal by Subject|0|||
25057279|NCT03039023|50161426|FG000|Overall Study|Physician Decision|0|||
25057280|NCT03039023|50161427|FG001|Overall Study|Physician Decision|0|||
25057281|NCT03039023|50161428|FG002|Overall Study|Physician Decision|0|||
25057282|NCT03039023|50161429|FG003|Overall Study|Physician Decision|1|||
25057283|NCT03039023|50161430|FG004|Overall Study|Physician Decision|0|||
25057284|NCT03022045|50161444|FG000|Overall Study|Adverse Event|0|||
25057285|NCT03022045|50161445|FG001|Overall Study|Adverse Event|1|||
25057286|NCT03022045|50161444|FG000|Overall Study|Withdrawal by Subject|1|||
25057287|NCT03022045|50161445|FG001|Overall Study|Withdrawal by Subject|1|||
25186598|NCT02647320|50337193|FG000|Overall Study|Study terminated by sponsor|1|||
25057288|NCT03037619|50161457|FG000|Overall Study|Lost to Follow-up|0|||
25057289|NCT03037619|50161458|FG001|Overall Study|Lost to Follow-up|1|||
25057290|NCT04771013|50161466|FG000|Overall Study|Withdrawal by Subject|2|||
25057291|NCT04771013|50161467|FG001|Overall Study|Withdrawal by Subject|0|||
25057292|NCT04771013|50161466|FG000|Overall Study|Death|0|||
25057293|NCT04771013|50161467|FG001|Overall Study|Death|5|||
25057294|NCT04771013|50161466|FG000|Overall Study|Referred to another hospital before day 20|0|||
25057295|NCT04771013|50161467|FG001|Overall Study|Referred to another hospital before day 20|1|||
25057296|NCT03021265|50161473|FG000|Overall Study|Adverse Event|29|||
25057297|NCT03021265|50161473|FG000|Overall Study|Lack of Efficacy|3|||
25057298|NCT03021265|50161473|FG000|Overall Study|Improved|17|||
25057299|NCT03021265|50161473|FG000|Overall Study|Lost to Follow-up|67|||
25057300|NCT03021265|50161473|FG000|Overall Study|No reason given|2|||
25057301|NCT03021265|50161473|FG000|Overall Study|No visit since the first visit|4|||
25057302|NCT04611789|50161480|FG000|Overall Study|Lost to Follow-up|1|||
25057303|NCT04611789|50161481|FG001|Overall Study|Lost to Follow-up|0|||
25057304|NCT04611789|50161482|FG002|Overall Study|Lost to Follow-up|0|||
25057305|NCT03561597|50161498|FG000|Overall Study|Lost to Follow-up|20|||
25057306|NCT03034967|50161521|FG000|Overall Study|Withdrawal by Subject|9|||
25057307|NCT03034967|50161522|FG001|Overall Study|Withdrawal by Subject|2|||
25057308|NCT03034967|50161523|FG002|Overall Study|Withdrawal by Subject|6|||
25057309|NCT03034967|50161524|FG003|Overall Study|Withdrawal by Subject|6|||
25057310|NCT03034967|50161525|FG004|Overall Study|Withdrawal by Subject|9|||
25057311|NCT03034967|50161526|FG005|Overall Study|Withdrawal by Subject|2|||
25057312|NCT03034967|50161521|FG000|Overall Study|Physician Decision|1|||
25057313|NCT03034967|50161522|FG001|Overall Study|Physician Decision|0|||
25057314|NCT03034967|50161523|FG002|Overall Study|Physician Decision|1|||
25057315|NCT03034967|50161524|FG003|Overall Study|Physician Decision|1|||
25057316|NCT03034967|50161525|FG004|Overall Study|Physician Decision|1|||
25057317|NCT03034967|50161526|FG005|Overall Study|Physician Decision|0|||
25057318|NCT03034967|50161521|FG000|Overall Study|Lost to Follow-up|0|||
25057319|NCT03034967|50161522|FG001|Overall Study|Lost to Follow-up|0|||
25057320|NCT03034967|50161523|FG002|Overall Study|Lost to Follow-up|0|||
25057321|NCT03034967|50161524|FG003|Overall Study|Lost to Follow-up|1|||
25057322|NCT03034967|50161525|FG004|Overall Study|Lost to Follow-up|0|||
25057323|NCT03034967|50161526|FG005|Overall Study|Lost to Follow-up|2|||
25057324|NCT03034967|50161521|FG000|Overall Study|Liver function test abnormality|0|||
25057325|NCT03034967|50161522|FG001|Overall Study|Liver function test abnormality|0|||
25057326|NCT03034967|50161523|FG002|Overall Study|Liver function test abnormality|1|||
25057327|NCT03034967|50161524|FG003|Overall Study|Liver function test abnormality|0|||
25057328|NCT03034967|50161525|FG004|Overall Study|Liver function test abnormality|0|||
25057329|NCT03034967|50161526|FG005|Overall Study|Liver function test abnormality|0|||
25057330|NCT03034967|50161521|FG000|Overall Study|Protocol Violation|1|||
25057331|NCT03034967|50161522|FG001|Overall Study|Protocol Violation|0|||
25057332|NCT03034967|50161523|FG002|Overall Study|Protocol Violation|0|||
25057333|NCT03034967|50161524|FG003|Overall Study|Protocol Violation|0|||
25057334|NCT03034967|50161525|FG004|Overall Study|Protocol Violation|0|||
25057335|NCT03034967|50161526|FG005|Overall Study|Protocol Violation|2|||
25057336|NCT03034967|50161521|FG000|Overall Study|Lack of Efficacy|0|||
25057337|NCT03034967|50161522|FG001|Overall Study|Lack of Efficacy|1|||
25057338|NCT03034967|50161523|FG002|Overall Study|Lack of Efficacy|2|||
25057339|NCT03034967|50161524|FG003|Overall Study|Lack of Efficacy|1|||
25057340|NCT03034967|50161525|FG004|Overall Study|Lack of Efficacy|1|||
25057341|NCT03034967|50161526|FG005|Overall Study|Lack of Efficacy|0|||
25057342|NCT03034967|50161521|FG000|Overall Study|Adverse Event, non-fatal|3|||
25057343|NCT03034967|50161522|FG001|Overall Study|Adverse Event, non-fatal|1|||
25057344|NCT03034967|50161523|FG002|Overall Study|Adverse Event, non-fatal|2|||
25057345|NCT03034967|50161524|FG003|Overall Study|Adverse Event, non-fatal|0|||
25057346|NCT03034967|50161525|FG004|Overall Study|Adverse Event, non-fatal|2|||
25057347|NCT03034967|50161526|FG005|Overall Study|Adverse Event, non-fatal|8|||
25057348|NCT03034967|50161521|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
25057349|NCT03034967|50161522|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
25057350|NCT03034967|50161523|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
25057351|NCT03034967|50161524|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
25057352|NCT03034967|50161525|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
25057353|NCT03034967|50161526|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
25057354|NCT03021187|50161549|FG000|Overall Study|Death|0|||
25057355|NCT03021187|50161550|FG001|Overall Study|Death|0|||
25057356|NCT03021187|50161551|FG002|Overall Study|Death|3|||
25057357|NCT03021187|50161552|FG003|Overall Study|Death|0|||
25057358|NCT03021187|50161549|FG000|Overall Study|Withdrawal by Subject|0|||
25057359|NCT03021187|50161550|FG001|Overall Study|Withdrawal by Subject|6|||
25057360|NCT03021187|50161551|FG002|Overall Study|Withdrawal by Subject|2|||
25057361|NCT03021187|50161552|FG003|Overall Study|Withdrawal by Subject|5|||
25057362|NCT03021187|50161549|FG000|Overall Study|Lost to Follow-up|10|||
25057363|NCT03021187|50161550|FG001|Overall Study|Lost to Follow-up|3|||
25057364|NCT03021187|50161551|FG002|Overall Study|Lost to Follow-up|1|||
25057365|NCT03021187|50161552|FG003|Overall Study|Lost to Follow-up|4|||
25057366|NCT02143414|50161564|FG000|Induction|Adverse Event|1|||
25057367|NCT02143414|50161565|FG001|Induction|Adverse Event|2|||
25057368|NCT02143414|50161564|FG000|Induction|Death|1|||
25057369|NCT02143414|50161565|FG001|Induction|Death|2|||
25057370|NCT02143414|50161564|FG000|Induction|Patient refusal|1|||
25057371|NCT02143414|50161565|FG001|Induction|Patient refusal|1|||
25057372|NCT02143414|50161564|FG000|Induction|Refractory|1|||
25057373|NCT02143414|50161565|FG001|Induction|Refractory|0|||
25057374|NCT02143414|50161564|FG000|Induction|Began alternative treatment|1|||
25057375|NCT02143414|50161565|FG001|Induction|Began alternative treatment|0|||
25057376|NCT02143414|50161564|FG000|Induction|Ineligible for postremission|5|||
25057377|NCT02143414|50161565|FG001|Induction|Ineligible for postremission|1|||
25057378|NCT02143414|50161564|FG000|Post-remission|Adverse Event|0|||
25057379|NCT02143414|50161565|FG001|Post-remission|Adverse Event|2|||
25057380|NCT02143414|50161564|FG000|Post-remission|Disease progression/relapse|5|||
25057381|NCT02143414|50161565|FG001|Post-remission|Disease progression/relapse|0|||
25057382|NCT02143414|50161564|FG000|Maintenance|Adverse Event|4|||
25057383|NCT02143414|50161565|FG001|Maintenance|Adverse Event|6|||
25057384|NCT02143414|50161564|FG000|Maintenance|Disease progression/relapse|3|||
25057385|NCT02143414|50161565|FG001|Maintenance|Disease progression/relapse|2|||
25057386|NCT02143414|50161564|FG000|Maintenance|Patient refusal|2|||
25057387|NCT02143414|50161565|FG001|Maintenance|Patient refusal|1|||
25057388|NCT02143414|50161564|FG000|Maintenance|Physician Decision|1|||
25057389|NCT02143414|50161565|FG001|Maintenance|Physician Decision|0|||
25057390|NCT02143414|50161564|FG000|Maintenance|Death|0|||
25057391|NCT02143414|50161565|FG001|Maintenance|Death|1|||
25057392|NCT02143414|50161564|FG000|Maintenance|On protocol treatment|0|||
25057393|NCT02143414|50161565|FG001|Maintenance|On protocol treatment|6|||
25057394|NCT03014479|50161584|FG000|Overall Study|Adverse Event|0|||
25057395|NCT03014479|50161585|FG001|Overall Study|Adverse Event|1|||
25057396|NCT03014479|50161584|FG000|Overall Study|Voluntary Withdrawal|0|||
25057397|NCT03014479|50161585|FG001|Overall Study|Voluntary Withdrawal|2|||
25057398|NCT03014479|50161584|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
25057399|NCT03014479|50161585|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
25057400|NCT04766333|50161593|FG000|Overall Study|Lost to Follow-up|40|||
25057401|NCT04766333|50161594|FG001|Overall Study|Lost to Follow-up|826|||
25057402|NCT03020641|50161602|FG000|Overall Study|Lost to Follow-up|0|||
25057403|NCT03020641|50161603|FG001|Overall Study|Lost to Follow-up|1|||
25057404|NCT03020641|50161602|FG000|Overall Study|Converted to open surgery|2|||
25057405|NCT03020641|50161603|FG001|Overall Study|Converted to open surgery|1|||
25057406|NCT03020641|50161602|FG000|Overall Study|for surgery not performed|0|||
25057407|NCT03020641|50161603|FG001|Overall Study|for surgery not performed|1|||
25057408|NCT03020407|50161614|FG000|Overall Study|Withdrawal by Subject|2|||
25057409|NCT03020407|50161615|FG001|Overall Study|Withdrawal by Subject|1|||
25057410|NCT03020407|50161614|FG000|Overall Study|Lost to Follow-up|2|||
25057411|NCT03020407|50161615|FG001|Overall Study|Lost to Follow-up|3|||
25057412|NCT03020407|50161614|FG000|Overall Study|Protocol Violation|0|||
25057413|NCT03020407|50161615|FG001|Overall Study|Protocol Violation|1|||
25057414|NCT02536846|50161621|FG000|Overall Study|Withdrawal by Subject|1|||
25057415|NCT03014011|50161626|FG000|First Intervention|Withdrawal by Subject|1|||
25057416|NCT03014011|50161627|FG001|First Intervention|Withdrawal by Subject|0|||
25057417|NCT03014011|50161626|FG000|Washout|Withdrawal by Subject|1|||
25057418|NCT03014011|50161627|FG001|Washout|Withdrawal by Subject|0|||
25057419|NCT03012841|50161642|FG000|Overall Study|Protocol Violation|0|||
25057420|NCT03012841|50161643|FG001|Overall Study|Protocol Violation|10|||
25057421|NCT03012841|50161642|FG000|Overall Study|Lost to Follow-up|6|||
25057422|NCT03012841|50161643|FG001|Overall Study|Lost to Follow-up|1|||
25057423|NCT03012841|50161642|FG000|Overall Study|Withdrawal by Subject|6|||
25057424|NCT03012841|50161643|FG001|Overall Study|Withdrawal by Subject|0|||
25057425|NCT03012841|50161642|FG000|Overall Study|Unable to complete 12 month visit|6|||
25057426|NCT03012841|50161643|FG001|Overall Study|Unable to complete 12 month visit|0|||
25057427|NCT03012841|50161642|FG000|Overall Study|Subject relocation|1|||
25057428|NCT03012841|50161643|FG001|Overall Study|Subject relocation|0|||
25057429|NCT03012841|50161642|FG000|Overall Study|Seasonal winter travel|1|||
25057430|NCT03012841|50161643|FG001|Overall Study|Seasonal winter travel|0|||
25057431|NCT03012841|50161642|FG000|Overall Study|Physician Decision|0|||
25057432|NCT03012841|50161643|FG001|Overall Study|Physician Decision|2|||
25057433|NCT03012841|50161642|FG000|Overall Study|No ablation performed|0|||
25057434|NCT03012841|50161643|FG001|Overall Study|No ablation performed|2|||
25057435|NCT03012841|50161642|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
25057436|NCT03012841|50161643|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
25057437|NCT03012841|50161642|FG000|Overall Study|Insurance change|0|||
25057438|NCT03012841|50161643|FG001|Overall Study|Insurance change|1|||
25057439|NCT02359864|50161650|FG000|Overall Study|Withdrawal by Subject|1|||
25057440|NCT02359864|50161651|FG001|Overall Study|Withdrawal by Subject|0|||
25057441|NCT02533258|50161657|FG000|Overall Study|Adverse Event|1|||
25057442|NCT02533258|50161657|FG000|Overall Study|Death|2|||
25057443|NCT02533258|50161657|FG000|Overall Study|Other|1|||
25057444|NCT02533258|50161657|FG000|Overall Study|Economic factor|1|||
25057445|NCT02533258|50161657|FG000|Overall Study|Progression of pleural effusion|1|||
25057446|NCT02533258|50161657|FG000|Overall Study|Lack of Efficacy|2|||
25057447|NCT03019627|50161676|FG000|Overall Study|Adverse Event|8|||
25057448|NCT03019627|50161677|FG001|Overall Study|Adverse Event|0|||
25057449|NCT03019627|50161676|FG000|Overall Study|Unrelated to adverse event|1|||
25057450|NCT03019627|50161677|FG001|Overall Study|Unrelated to adverse event|3|||
25057451|NCT03019627|50161676|FG000|Overall Study|Lost to Follow-up|2|||
25057452|NCT03019627|50161677|FG001|Overall Study|Lost to Follow-up|1|||
25057453|NCT03019627|50161676|FG000|Overall Study|not compliance|2|||
25057454|NCT03019627|50161677|FG001|Overall Study|not compliance|2|||
25057455|NCT03019627|50161676|FG000|Overall Study|Other|2|||
25057456|NCT03019627|50161677|FG001|Overall Study|Other|2|||
25057457|NCT01661140|50161683|FG000|Open-Label Period|Adverse Event|44|||
25057458|NCT01661140|50161684|FG001|Open-Label Period|Adverse Event|0|||
25057459|NCT01661140|50161685|FG002|Open-Label Period|Adverse Event|0|||
25057460|NCT01661140|50161683|FG000|Open-Label Period|Protocol Violation|3|||
25057461|NCT01661140|50161684|FG001|Open-Label Period|Protocol Violation|0|||
25057462|NCT01661140|50161685|FG002|Open-Label Period|Protocol Violation|0|||
25057463|NCT01661140|50161683|FG000|Open-Label Period|Withdrawal by Subject|5|||
25057464|NCT01661140|50161684|FG001|Open-Label Period|Withdrawal by Subject|0|||
25057465|NCT01661140|50161685|FG002|Open-Label Period|Withdrawal by Subject|0|||
25057466|NCT01661140|50161683|FG000|Open-Label Period|Investigator Decision|3|||
25057467|NCT01661140|50161684|FG001|Open-Label Period|Investigator Decision|0|||
25057468|NCT01661140|50161685|FG002|Open-Label Period|Investigator Decision|0|||
25057469|NCT01661140|50161683|FG000|Open-Label Period|Death|1|||
25057470|NCT01661140|50161684|FG001|Open-Label Period|Death|0|||
25057471|NCT01661140|50161685|FG002|Open-Label Period|Death|0|||
25057472|NCT01661140|50161683|FG000|Open-Label Period|Administrative/Other|1|||
25057473|NCT01661140|50161684|FG001|Open-Label Period|Administrative/Other|0|||
25057474|NCT01661140|50161685|FG002|Open-Label Period|Administrative/Other|0|||
25057475|NCT01661140|50161683|FG000|Open-Label Period|Sponsor termination|16|||
25057476|NCT01661140|50161684|FG001|Open-Label Period|Sponsor termination|0|||
25057477|NCT01661140|50161685|FG002|Open-Label Period|Sponsor termination|0|||
25057478|NCT01661140|50161683|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
25057479|NCT01661140|50161684|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
25057480|NCT01661140|50161685|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
25057481|NCT01661140|50161683|FG000|Open-Label Period|Lost to Follow-up|2|||
25057482|NCT01661140|50161684|FG001|Open-Label Period|Lost to Follow-up|0|||
25057483|NCT01661140|50161685|FG002|Open-Label Period|Lost to Follow-up|0|||
25057484|NCT01661140|50161683|FG000|Double-Blind Period|Refused Treatment|0|||
25057485|NCT01661140|50161684|FG001|Double-Blind Period|Refused Treatment|0|||
25057486|NCT01661140|50161685|FG002|Double-Blind Period|Refused Treatment|1|||
25057487|NCT01661140|50161683|FG000|Double-Blind Period|Adverse Event|0|||
25057488|NCT01661140|50161684|FG001|Double-Blind Period|Adverse Event|16|||
25057489|NCT01661140|50161685|FG002|Double-Blind Period|Adverse Event|18|||
25057490|NCT01661140|50161683|FG000|Double-Blind Period|Protocol Violation|0|||
25057491|NCT01661140|50161684|FG001|Double-Blind Period|Protocol Violation|2|||
25057492|NCT01661140|50161685|FG002|Double-Blind Period|Protocol Violation|3|||
25057493|NCT01661140|50161683|FG000|Double-Blind Period|Withdrawal by Subject|0|||
25057494|NCT01661140|50161684|FG001|Double-Blind Period|Withdrawal by Subject|1|||
25057495|NCT01661140|50161685|FG002|Double-Blind Period|Withdrawal by Subject|3|||
25057496|NCT01661140|50161683|FG000|Double-Blind Period|Investigator's Decision|0|||
25057497|NCT01661140|50161684|FG001|Double-Blind Period|Investigator's Decision|1|||
25057498|NCT01661140|50161685|FG002|Double-Blind Period|Investigator's Decision|2|||
25057499|NCT01661140|50161683|FG000|Double-Blind Period|Sponsor Termination|0|||
25057500|NCT01661140|50161684|FG001|Double-Blind Period|Sponsor Termination|14|||
25057501|NCT01661140|50161685|FG002|Double-Blind Period|Sponsor Termination|17|||
25057502|NCT01661140|50161683|FG000|Double-Blind Period|Administrative/Other|0|||
25057503|NCT01661140|50161684|FG001|Double-Blind Period|Administrative/Other|7|||
25057504|NCT01661140|50161685|FG002|Double-Blind Period|Administrative/Other|6|||
25057505|NCT03019549|50161693|FG000|Washout|DId not meet genotype criteria|11|||
25057506|NCT03019549|50161693|FG000|Period 2|Adverse Event|2|||
25057507|NCT03019549|50161693|FG000|Period 2|Physician Decision|2|||
25057508|NCT03019549|50161693|FG000|Period 2|Withdrawal by Subject|1|||
25162754|NCT01277302|50285142|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
25276652|NCT01241552|50590592|FG002|Overall Study|Withdrawal by Subject|14|||
25057509|NCT01661062|50161702|FG000|Overall Study|Completed Treatment Off Study|3|||
25057510|NCT01661062|50161702|FG000|Overall Study|Withdrawal by Subject|2|||
25057511|NCT02536378|50161708|FG000|Overall Study|Physician Decision|0|||
25057512|NCT02536378|50161709|FG001|Overall Study|Physician Decision|2|||
25057513|NCT02536378|50161708|FG000|Overall Study|Withdrawal by Subject|0|||
25057514|NCT02536378|50161709|FG001|Overall Study|Withdrawal by Subject|1|||
25057515|NCT02536378|50161708|FG000|Overall Study|Death|1|||
25057516|NCT02536378|50161709|FG001|Overall Study|Death|2|||
25057517|NCT02536378|50161708|FG000|Overall Study|Patient refused further follow up|6|||
25057518|NCT02536378|50161709|FG001|Overall Study|Patient refused further follow up|2|||
25057519|NCT01373151|50161724|FG000|Period 1|Lack of Efficacy|3|||
25057520|NCT01373151|50161725|FG001|Period 1|Lack of Efficacy|0|||
25057521|NCT01373151|50161726|FG002|Period 1|Lack of Efficacy|0|||
25057522|NCT01373151|50161727|FG003|Period 1|Lack of Efficacy|0|||
25057523|NCT01373151|50161728|FG004|Period 1|Lack of Efficacy|1|||
25057524|NCT01373151|50161729|FG005|Period 1|Lack of Efficacy|0|||
25057525|NCT01373151|50161730|FG006|Period 1|Lack of Efficacy|0|||
25057526|NCT01373151|50161724|FG000|Period 1|Adverse Event|0|||
25057527|NCT01373151|50161725|FG001|Period 1|Adverse Event|0|||
25057528|NCT01373151|50161726|FG002|Period 1|Adverse Event|1|||
25057529|NCT01373151|50161727|FG003|Period 1|Adverse Event|0|||
25057530|NCT01373151|50161728|FG004|Period 1|Adverse Event|4|||
25057531|NCT01373151|50161729|FG005|Period 1|Adverse Event|3|||
25057532|NCT01373151|50161730|FG006|Period 1|Adverse Event|0|||
25057533|NCT01373151|50161724|FG000|Period 1|Withdrawal by Subject|2|||
25057534|NCT01373151|50161725|FG001|Period 1|Withdrawal by Subject|0|||
25057535|NCT01373151|50161726|FG002|Period 1|Withdrawal by Subject|3|||
25057536|NCT01373151|50161727|FG003|Period 1|Withdrawal by Subject|1|||
25057537|NCT01373151|50161728|FG004|Period 1|Withdrawal by Subject|0|||
25057538|NCT01373151|50161729|FG005|Period 1|Withdrawal by Subject|1|||
25057539|NCT01373151|50161730|FG006|Period 1|Withdrawal by Subject|0|||
25057540|NCT01373151|50161724|FG000|Period 2|Lack of Efficacy|9|||
25057541|NCT01373151|50161725|FG001|Period 2|Lack of Efficacy|0|||
25057542|NCT01373151|50161726|FG002|Period 2|Lack of Efficacy|0|||
25057543|NCT01373151|50161727|FG003|Period 2|Lack of Efficacy|1|||
25057544|NCT01373151|50161728|FG004|Period 2|Lack of Efficacy|2|||
25057545|NCT01373151|50161729|FG005|Period 2|Lack of Efficacy|0|||
25057546|NCT01373151|50161730|FG006|Period 2|Lack of Efficacy|3|||
25057547|NCT01373151|50161724|FG000|Period 2|Adverse Event|0|||
25057548|NCT01373151|50161725|FG001|Period 2|Adverse Event|0|||
25057549|NCT01373151|50161726|FG002|Period 2|Adverse Event|3|||
25057550|NCT01373151|50161727|FG003|Period 2|Adverse Event|3|||
25057551|NCT01373151|50161728|FG004|Period 2|Adverse Event|0|||
25057552|NCT01373151|50161729|FG005|Period 2|Adverse Event|0|||
25057553|NCT01373151|50161730|FG006|Period 2|Adverse Event|1|||
25057554|NCT01373151|50161724|FG000|Period 2|subject request to discontinue|0|||
25057555|NCT01373151|50161725|FG001|Period 2|subject request to discontinue|1|||
25057556|NCT01373151|50161726|FG002|Period 2|subject request to discontinue|0|||
25057557|NCT01373151|50161727|FG003|Period 2|subject request to discontinue|0|||
25057558|NCT01373151|50161728|FG004|Period 2|subject request to discontinue|0|||
25057559|NCT01373151|50161729|FG005|Period 2|subject request to discontinue|0|||
25057560|NCT01373151|50161730|FG006|Period 2|subject request to discontinue|0|||
25057561|NCT01373151|50161724|FG000|Period 2|Withdrawal by Subject|0|||
25057562|NCT01373151|50161725|FG001|Period 2|Withdrawal by Subject|0|||
25057563|NCT01373151|50161726|FG002|Period 2|Withdrawal by Subject|0|||
25057564|NCT01373151|50161727|FG003|Period 2|Withdrawal by Subject|1|||
25057565|NCT01373151|50161728|FG004|Period 2|Withdrawal by Subject|0|||
25057566|NCT01373151|50161729|FG005|Period 2|Withdrawal by Subject|0|||
25057567|NCT01373151|50161730|FG006|Period 2|Withdrawal by Subject|0|||
25057568|NCT01373151|50161724|FG000|Period 2|Other|0|||
25057569|NCT01373151|50161725|FG001|Period 2|Other|0|||
25057570|NCT01373151|50161726|FG002|Period 2|Other|1|||
25057571|NCT01373151|50161727|FG003|Period 2|Other|0|||
25057572|NCT01373151|50161728|FG004|Period 2|Other|0|||
25057573|NCT01373151|50161729|FG005|Period 2|Other|0|||
25057574|NCT01373151|50161730|FG006|Period 2|Other|1|||
25057575|NCT01660906|50161746|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
25057576|NCT03015181|50161766|FG000|Overall Study|Enrolled, but product never administered|1|||
25057577|NCT03015181|50161767|FG001|Overall Study|Enrolled, but product never administered|0|||
25057578|NCT03015181|50161768|FG002|Overall Study|Enrolled, but product never administered|0|||
25057579|NCT03015181|50161769|FG003|Overall Study|Enrolled, but product never administered|0|||
25162755|NCT01277302|50285143|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
25162756|NCT01277302|50285144|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
25057580|NCT03015181|50161770|FG004|Overall Study|Enrolled, but product never administered|0|||
25057581|NCT03015181|50161771|FG005|Overall Study|Enrolled, but product never administered|0|||
25057582|NCT03015181|50161772|FG006|Overall Study|Enrolled, but product never administered|0|||
25057583|NCT03015181|50161766|FG000|Overall Study|Withdrawal by Subject|0|||
25057584|NCT03015181|50161767|FG001|Overall Study|Withdrawal by Subject|0|||
25057585|NCT03015181|50161768|FG002|Overall Study|Withdrawal by Subject|0|||
25057586|NCT03015181|50161769|FG003|Overall Study|Withdrawal by Subject|0|||
25057587|NCT03015181|50161770|FG004|Overall Study|Withdrawal by Subject|0|||
25057588|NCT03015181|50161771|FG005|Overall Study|Withdrawal by Subject|1|||
25057589|NCT03015181|50161772|FG006|Overall Study|Withdrawal by Subject|0|||
25057590|NCT03015181|50161766|FG000|Overall Study|Physician Decision|0|||
25057591|NCT03015181|50161767|FG001|Overall Study|Physician Decision|0|||
25057592|NCT03015181|50161768|FG002|Overall Study|Physician Decision|0|||
25057593|NCT03015181|50161769|FG003|Overall Study|Physician Decision|0|||
25057594|NCT03015181|50161770|FG004|Overall Study|Physician Decision|0|||
25057595|NCT03015181|50161771|FG005|Overall Study|Physician Decision|0|||
25057596|NCT03015181|50161772|FG006|Overall Study|Physician Decision|1|||
25057597|NCT00960297|50161821|FG000|Overall Study|Physician Decision|1|||
25057598|NCT00960297|50161821|FG000|Overall Study|Venous port infection|1|||
25057599|NCT00960297|50161821|FG000|Overall Study|Disease progression|1|||
25057600|NCT03018691|50161828|FG000|Overall Study|Adverse Event|1|||
25057601|NCT03018691|50161829|FG001|Overall Study|Adverse Event|1|||
25057602|NCT03018691|50161830|FG002|Overall Study|Adverse Event|4|||
25057603|NCT03018691|50161828|FG000|Overall Study|Lack of Efficacy|0|||
25057604|NCT03018691|50161829|FG001|Overall Study|Lack of Efficacy|0|||
25057605|NCT03018691|50161830|FG002|Overall Study|Lack of Efficacy|1|||
25057606|NCT03018691|50161828|FG000|Overall Study|Withdrawal by Subject|0|||
25057607|NCT03018691|50161829|FG001|Overall Study|Withdrawal by Subject|0|||
25057608|NCT03018691|50161830|FG002|Overall Study|Withdrawal by Subject|1|||
25057609|NCT03018691|50161828|FG000|Overall Study|Withdrawal by parent/guardian|1|||
25057610|NCT03018691|50161829|FG001|Overall Study|Withdrawal by parent/guardian|0|||
25057611|NCT03018691|50161830|FG002|Overall Study|Withdrawal by parent/guardian|1|||
25057612|NCT03012061|50161843|FG000|Overall Study|Withdrawal by Subject|1|||
25057613|NCT03012061|50161844|FG001|Overall Study|Withdrawal by Subject|5|||
25057614|NCT03012061|50161845|FG002|Overall Study|Withdrawal by Subject|4|||
25057615|NCT03012061|50161843|FG000|Overall Study|Investigator Site Closed|1|||
25057616|NCT03012061|50161844|FG001|Overall Study|Investigator Site Closed|2|||
25057617|NCT03012061|50161845|FG002|Overall Study|Investigator Site Closed|0|||
25057618|NCT03012061|50161843|FG000|Overall Study|Lost to Follow-up|2|||
25057619|NCT03012061|50161844|FG001|Overall Study|Lost to Follow-up|1|||
25057620|NCT03012061|50161845|FG002|Overall Study|Lost to Follow-up|0|||
25057621|NCT03012061|50161843|FG000|Overall Study|Study closed/ Terminated|0|||
25057622|NCT03012061|50161844|FG001|Overall Study|Study closed/ Terminated|0|||
25057623|NCT03012061|50161845|FG002|Overall Study|Study closed/ Terminated|1|||
25057624|NCT03012061|50161843|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
25057625|NCT03012061|50161844|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
25057626|NCT03012061|50161845|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
25057627|NCT03012061|50161843|FG000|Overall Study|Protocol Violation|0|||
25057628|NCT03012061|50161844|FG001|Overall Study|Protocol Violation|0|||
25057629|NCT03012061|50161845|FG002|Overall Study|Protocol Violation|2|||
25057630|NCT03012061|50161843|FG000|Overall Study|Lack of Efficacy|0|||
25057631|NCT03012061|50161844|FG001|Overall Study|Lack of Efficacy|1|||
25057632|NCT03012061|50161845|FG002|Overall Study|Lack of Efficacy|0|||
25057633|NCT03012061|50161843|FG000|Overall Study|Adverse Event|2|||
25057634|NCT03012061|50161844|FG001|Overall Study|Adverse Event|0|||
25057635|NCT03012061|50161845|FG002|Overall Study|Adverse Event|0|||
25057636|NCT03010501|50161853|FG000|Study Week 1|Withdrawal by Subject|2|||
25057637|NCT03010501|50161854|FG001|Study Week 1|Withdrawal by Subject|1|||
25057638|NCT03010501|50161855|FG002|Study Week 1|Withdrawal by Subject|0|||
25057639|NCT03010501|50161856|FG003|Study Week 1|Withdrawal by Subject|2|||
25057640|NCT03010501|50161857|FG004|Study Week 1|Withdrawal by Subject|0|||
25057641|NCT03010501|50161858|FG005|Study Week 1|Withdrawal by Subject|0|||
25057642|NCT03010501|50161853|FG000|Study Week 3|Withdrawal by Subject|0|||
25057643|NCT03010501|50161854|FG001|Study Week 3|Withdrawal by Subject|0|||
25057644|NCT03010501|50161855|FG002|Study Week 3|Withdrawal by Subject|0|||
25057645|NCT03010501|50161856|FG003|Study Week 3|Withdrawal by Subject|1|||
25057646|NCT03010501|50161857|FG004|Study Week 3|Withdrawal by Subject|0|||
25057647|NCT03010501|50161858|FG005|Study Week 3|Withdrawal by Subject|0|||
25057648|NCT03002623|50161868|FG000|Overall Study|Lost to Follow-up|1|||
25057649|NCT03002623|50161869|FG001|Overall Study|Lost to Follow-up|0|||
25057650|NCT03002623|50161868|FG000|Overall Study|Physician Decision|1|||
25057651|NCT03002623|50161869|FG001|Overall Study|Physician Decision|1|||
25057652|NCT03010423|50161877|FG000|Overall Study|Study termination|8|||
25057653|NCT03002311|50161883|FG000|Overall Study|Lost to Follow-up|13|||
25057654|NCT03002311|50161884|FG001|Overall Study|Lost to Follow-up|26|||
25057655|NCT03002311|50161883|FG000|Overall Study|Referral provider called to schedule app|3|||
25057656|NCT03002311|50161884|FG001|Overall Study|Referral provider called to schedule app|3|||
25057657|NCT03002311|50161883|FG000|Overall Study|Physician Decision|3|||
25057658|NCT03002311|50161884|FG001|Overall Study|Physician Decision|1|||
25057659|NCT03002077|50161890|FG000|Overall Study|Non-compliance with Study Drug|4|||
25057660|NCT03002077|50161890|FG000|Overall Study|Non-compliance w/Background ADT|1|||
25057661|NCT03002077|50161890|FG000|Overall Study|Study Terminated by Sponsor|257|||
25057662|NCT03002077|50161890|FG000|Overall Study|Site Terminated by Sponsor|5|||
25057663|NCT03002077|50161890|FG000|Overall Study|Miscellaneous Reasons|10|||
25057664|NCT03002077|50161890|FG000|Overall Study|Adverse Event|23|||
25057665|NCT03002077|50161890|FG000|Overall Study|Lack of Efficacy|20|||
25057666|NCT03002077|50161890|FG000|Overall Study|Withdrawal by Subject|72|||
25057667|NCT03002077|50161890|FG000|Overall Study|Lost to Follow-up|21|||
25057668|NCT03002077|50161890|FG000|Overall Study|Pregnancy|4|||
25057669|NCT03002077|50161890|FG000|Overall Study|Protocol Violation|21|||
25057670|NCT03008005|50161897|FG000|Overall Study|Physician Decision|1|||
25057671|NCT03008005|50161898|FG001|Overall Study|Physician Decision|0|||
25057672|NCT03008005|50161899|FG002|Overall Study|Physician Decision|0|||
25057673|NCT03008005|50161897|FG000|Overall Study|Withdrawal by Subject|1|||
25057674|NCT03008005|50161898|FG001|Overall Study|Withdrawal by Subject|0|||
25057675|NCT03008005|50161899|FG002|Overall Study|Withdrawal by Subject|0|||
25057676|NCT03008005|50161897|FG000|Overall Study|Ineligible|0|||
25057677|NCT03008005|50161898|FG001|Overall Study|Ineligible|1|||
25057678|NCT03008005|50161899|FG002|Overall Study|Ineligible|0|||
25057679|NCT02440425|50161916|FG000|Overall Study|Death likely due to disease progression|1|||
25057680|NCT02440425|50161916|FG000|Overall Study|Withdrawal by Subject|2|||
25057681|NCT02440425|50161916|FG000|Overall Study|Adverse Event|1|||
25057682|NCT02440425|50161916|FG000|Overall Study|Adverse Event/Ineligible|1|||
25057683|NCT03001219|50161931|FG000|Proof of Concept|Study Termination by Sponsor|0|||
25057684|NCT03001219|50161932|FG001|Proof of Concept|Study Termination by Sponsor|1|||
25057685|NCT03001219|50161931|FG000|Proof of Concept|Withdrawal by Subject|0|||
25057686|NCT03001219|50161932|FG001|Proof of Concept|Withdrawal by Subject|4|||
25057687|NCT03001219|50161931|FG000|Proof of Concept|Protocol Deviation|0|||
25057688|NCT03001219|50161932|FG001|Proof of Concept|Protocol Deviation|1|||
25057689|NCT03001219|50161931|FG000|Proof of Concept|Adverse Event|1|||
25057690|NCT03001219|50161932|FG001|Proof of Concept|Adverse Event|1|||
25057691|NCT03001219|50161931|FG000|Proof of Concept|Physician Decision|1|||
25057692|NCT03001219|50161932|FG001|Proof of Concept|Physician Decision|0|||
25057693|NCT03001219|50161931|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
25057694|NCT03001219|50161932|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
25057695|NCT03001219|50161931|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
25057696|NCT03001219|50161932|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
25057697|NCT03001219|50161931|FG000|Extension Period Analysis|Physician Decision|0|||
25057698|NCT03001219|50161932|FG001|Extension Period Analysis|Physician Decision|1|||
25057699|NCT03001219|50161931|FG000|Extension Period Analysis|Adverse Event|1|||
25057700|NCT03001219|50161932|FG001|Extension Period Analysis|Adverse Event|1|||
25057701|NCT03001219|50161931|FG000|Extension Period Analysis|Protocol Deviation|0|||
25057702|NCT03001219|50161932|FG001|Extension Period Analysis|Protocol Deviation|1|||
25057703|NCT03001219|50161931|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
25057704|NCT03001219|50161932|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
25057705|NCT03000673|50161947|FG000|Overall Study|Withdrawal by Subject|1|||
25057706|NCT03000673|50161948|FG001|Overall Study|Withdrawal by Subject|0|||
25057707|NCT03000673|50161949|FG002|Overall Study|Withdrawal by Subject|0|||
25057708|NCT03000673|50161950|FG003|Overall Study|Withdrawal by Subject|0|||
25057709|NCT02912455|50161963|FG000|Overall Study|Withdrawal by Subject|0|||
25057710|NCT02912455|50161964|FG001|Overall Study|Withdrawal by Subject|1|||
25057711|NCT02912455|50161963|FG000|Overall Study|Lack of Efficacy|0|||
25057712|NCT02912455|50161964|FG001|Overall Study|Lack of Efficacy|1|||
25057713|NCT02912455|50161963|FG000|Overall Study|Lost to Follow-up|2|||
25057714|NCT02912455|50161964|FG001|Overall Study|Lost to Follow-up|1|||
25057715|NCT04524507|50161972|FG000|Overall Study|Lost to Follow-up|2|||
25057716|NCT04524507|50161973|FG001|Overall Study|Lost to Follow-up|4|||
25057717|NCT04524507|50161972|FG000|Overall Study|Withdrawal by Subject|2|||
25057718|NCT04524507|50161973|FG001|Overall Study|Withdrawal by Subject|9|||
25057719|NCT04524507|50161972|FG000|Overall Study|Death|2|||
25057720|NCT04524507|50161973|FG001|Overall Study|Death|10|||
25057721|NCT02999191|50161982|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
25057722|NCT02999191|50161983|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
25057723|NCT02999191|50161984|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
25057724|NCT02531698|50161994|FG000|Overall Study|Adverse Event|2|||
25057725|NCT02531698|50161995|FG001|Overall Study|Adverse Event|1|||
25057726|NCT02531698|50161994|FG000|Overall Study|Withdrawal by Subject|6|||
25057727|NCT02531698|50161995|FG001|Overall Study|Withdrawal by Subject|1|||
25057728|NCT02531698|50161994|FG000|Overall Study|Protocol Violation|2|||
25057729|NCT02531698|50161995|FG001|Overall Study|Protocol Violation|0|||
25057730|NCT02531698|50161994|FG000|Overall Study|Lost to Follow-up|1|||
25057731|NCT02531698|50161995|FG001|Overall Study|Lost to Follow-up|0|||
25057732|NCT02998021|50162012|FG000|Overall Study|Withdrawal by Subject|3|||
25057733|NCT02998021|50162013|FG001|Overall Study|Withdrawal by Subject|1|||
25057734|NCT02998021|50162012|FG000|Overall Study|unsafe home|0|||
25162757|NCT01277302|50285142|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
25162758|NCT01277302|50285143|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
25057735|NCT02998021|50162013|FG001|Overall Study|unsafe home|1|||
25057736|NCT01207492|50162025|FG000|Overall Study|Still on study|1|||
25057737|NCT01207492|50162025|FG000|Overall Study|Withdrawal by Subject|9|||
25057738|NCT01207492|50162025|FG000|Overall Study|Physician Decision|1|||
25057739|NCT01207492|50162025|FG000|Overall Study|Progressive disease|3|||
25057740|NCT01207492|50162025|FG000|Overall Study|Toxicity|1|||
25057741|NCT03034577|50162031|FG000|Overall Study|Withdrawal by Subject|6|||
25057742|NCT03034577|50162032|FG001|Overall Study|Withdrawal by Subject|9|||
25057743|NCT03034577|50162031|FG000|Overall Study|Lost to Follow-up|25|||
25057744|NCT03034577|50162032|FG001|Overall Study|Lost to Follow-up|26|||
25057745|NCT01659736|50162042|FG000|Treatment Period|Adverse Event|1|||
25057746|NCT01659736|50162043|FG001|Treatment Period|Adverse Event|1|||
25057747|NCT01659736|50162042|FG000|Treatment Period|Protocol Violation|3|||
25057748|NCT01659736|50162043|FG001|Treatment Period|Protocol Violation|1|||
25057749|NCT01659736|50162042|FG000|Treatment Period|Withdrawal by Subject|1|||
25057750|NCT01659736|50162043|FG001|Treatment Period|Withdrawal by Subject|0|||
25057751|NCT01659736|50162042|FG000|3-month Follow-up|Lost to Follow-up|0|||
25057752|NCT01659736|50162043|FG001|3-month Follow-up|Lost to Follow-up|1|||
25057753|NCT02997163|50162055|FG000|Overall Study|Adverse Event|1|||
25057754|NCT02997163|50162056|FG001|Overall Study|Adverse Event|0|||
25057755|NCT02997163|50162057|FG002|Overall Study|Adverse Event|0|||
25057756|NCT02997163|50162058|FG003|Overall Study|Adverse Event|1|||
25057757|NCT00458536|50162068|FG000|Overall Study|Disease progression prior to treatment|7|||
25057758|NCT00458536|50162068|FG000|Overall Study|Unable to make vaccine|3|||
25057759|NCT00458536|50162068|FG000|Overall Study|No measurable disease after surgery|2|||
25057760|NCT00458536|50162068|FG000|Overall Study|Did not have renal cell carcinoma|2|||
25057761|NCT00458536|50162068|FG000|Overall Study|Patient did not have surgery|1|||
25057762|NCT00458536|50162068|FG000|Overall Study|Ineligible due to toxicity|1|||
25057763|NCT00458536|50162068|FG000|Overall Study|Withdrawal by Subject|1|||
25057764|NCT00458536|50162068|FG000|Overall Study|Progressive disease during treatment|2|||
25057765|NCT02526550|50162072|FG000|Overall Study|Lost to Follow-up|1|||
25057766|NCT03030989|50162087|FG000|Overall Study|Fever|2|||
25057767|NCT03030989|50162088|FG001|Overall Study|Fever|2|||
25057768|NCT03030989|50162087|FG000|Overall Study|Rash|2|||
25057769|NCT03030989|50162088|FG001|Overall Study|Rash|1|||
25057770|NCT03030989|50162087|FG000|Overall Study|Fatigue/Overwhelmed|1|||
25057771|NCT03030989|50162088|FG001|Overall Study|Fatigue/Overwhelmed|5|||
25057772|NCT03030989|50162087|FG000|Overall Study|Positive Blood Cultures|2|||
25057773|NCT03030989|50162088|FG001|Overall Study|Positive Blood Cultures|1|||
25057774|NCT03030989|50162087|FG000|Overall Study|Line Removed|0|||
25057775|NCT03030989|50162088|FG001|Overall Study|Line Removed|2|||
25057776|NCT03030989|50162087|FG000|Overall Study|No longer interested|5|||
25057777|NCT03030989|50162088|FG001|Overall Study|No longer interested|3|||
25057778|NCT03030599|50162094|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
25057779|NCT03030599|50162095|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
25057780|NCT03030599|50162096|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
25057781|NCT03030599|50162094|FG000|Open Label Treatment and Titration|Other|1|||
25057782|NCT03030599|50162095|FG001|Open Label Treatment and Titration|Other|0|||
25057783|NCT03030599|50162096|FG002|Open Label Treatment and Titration|Other|0|||
25057784|NCT03030599|50162094|FG000|Open Label Treatment and Titration|Physician Decision|3|||
25057785|NCT03030599|50162095|FG001|Open Label Treatment and Titration|Physician Decision|0|||
25057786|NCT03030599|50162096|FG002|Open Label Treatment and Titration|Physician Decision|0|||
25057787|NCT03030599|50162094|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
25057788|NCT03030599|50162095|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
25057789|NCT03030599|50162096|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
25057790|NCT03030599|50162094|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
25057791|NCT03030599|50162095|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
25057792|NCT03030599|50162096|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
25057793|NCT03030599|50162094|FG000|Open Label Treatment and Titration|Adverse Event|18|||
25057794|NCT03030599|50162095|FG001|Open Label Treatment and Titration|Adverse Event|0|||
25057795|NCT03030599|50162096|FG002|Open Label Treatment and Titration|Adverse Event|0|||
25057796|NCT03030599|50162094|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
25057797|NCT03030599|50162095|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
25057798|NCT03030599|50162096|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
25057799|NCT03030599|50162094|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
25057800|NCT03030599|50162095|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
25057801|NCT03030599|50162096|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
25057802|NCT03030599|50162094|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
25057803|NCT03030599|50162095|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
25057804|NCT03030599|50162096|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
24963512|NCT00147225|50053548|FG003|Overall Study|Adverse Event|1|||
24963513|NCT00147225|50053549|FG004|Overall Study|Adverse Event|0|||
24963514|NCT00147225|50053550|FG005|Overall Study|Adverse Event|0|||
24963515|NCT00147225|50053545|FG000|Overall Study|Screen Failure|0|||
24963516|NCT00147225|50053546|FG001|Overall Study|Screen Failure|0|||
24963517|NCT00147225|50053547|FG002|Overall Study|Screen Failure|0|||
24963518|NCT00147225|50053548|FG003|Overall Study|Screen Failure|0|||
24963519|NCT00147225|50053549|FG004|Overall Study|Screen Failure|1|||
24963520|NCT00147225|50053550|FG005|Overall Study|Screen Failure|0|||
24963521|NCT00147225|50053545|FG000|Overall Study|Chemotherapy Changed|0|||
24963522|NCT00147225|50053546|FG001|Overall Study|Chemotherapy Changed|0|||
24963523|NCT00147225|50053547|FG002|Overall Study|Chemotherapy Changed|0|||
24963524|NCT00147225|50053548|FG003|Overall Study|Chemotherapy Changed|0|||
24963525|NCT00147225|50053549|FG004|Overall Study|Chemotherapy Changed|0|||
24963526|NCT00147225|50053550|FG005|Overall Study|Chemotherapy Changed|1|||
24963527|NCT00222105|50053564|FG000|Overall Study|Removed due to wrong diagnosis|1|||
24963528|NCT00222105|50053564|FG000|Overall Study|Withdrawal by Subject|1|||
25057805|NCT03030599|50162094|FG000|Stable Dose|Protocol deviation|3|||
25057806|NCT03030599|50162095|FG001|Stable Dose|Protocol deviation|0|||
25057807|NCT03030599|50162096|FG002|Stable Dose|Protocol deviation|0|||
25057808|NCT03030599|50162094|FG000|Stable Dose|Adverse Event|1|||
25057809|NCT03030599|50162095|FG001|Stable Dose|Adverse Event|0|||
25057810|NCT03030599|50162096|FG002|Stable Dose|Adverse Event|0|||
25057811|NCT03030599|50162094|FG000|Stable Dose|Lost to Follow-up|1|||
25057812|NCT03030599|50162095|FG001|Stable Dose|Lost to Follow-up|0|||
25057813|NCT03030599|50162096|FG002|Stable Dose|Lost to Follow-up|0|||
25057814|NCT03030599|50162094|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
25057815|NCT03030599|50162095|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
25057816|NCT03030599|50162096|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
25057817|NCT03030599|50162094|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
25057818|NCT03030599|50162095|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
25057819|NCT03030599|50162096|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
25057820|NCT03030599|50162094|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
25057821|NCT03030599|50162095|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
25057822|NCT03030599|50162096|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
25057823|NCT03030599|50162094|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
25057824|NCT03030599|50162095|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
25057825|NCT03030599|50162096|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
25057826|NCT03030599|50162094|FG000|Open-label Extension|Adverse Event|3|||
25057827|NCT03030599|50162095|FG001|Open-label Extension|Adverse Event|0|||
25057828|NCT03030599|50162096|FG002|Open-label Extension|Adverse Event|0|||
25057829|NCT03030599|50162094|FG000|Open-label Extension|Lost to Follow-up|2|||
25057830|NCT03030599|50162095|FG001|Open-label Extension|Lost to Follow-up|0|||
25057831|NCT03030599|50162096|FG002|Open-label Extension|Lost to Follow-up|0|||
25057832|NCT03030599|50162094|FG000|Open-label Extension|Lack of Efficacy|1|||
25057833|NCT03030599|50162095|FG001|Open-label Extension|Lack of Efficacy|0|||
25057834|NCT03030599|50162096|FG002|Open-label Extension|Lack of Efficacy|0|||
25057835|NCT03030599|50162094|FG000|Open-label Extension|Other Reason|1|||
25057836|NCT03030599|50162095|FG001|Open-label Extension|Other Reason|0|||
25057837|NCT03030599|50162096|FG002|Open-label Extension|Other Reason|0|||
25057838|NCT03031847|50162106|FG000|Overall Study|Death|1|||
25057839|NCT03031847|50162107|FG001|Overall Study|Death|1|||
25057840|NCT03031847|50162108|FG002|Overall Study|Death|2|||
25057841|NCT03031847|50162109|FG003|Overall Study|Death|3|||
25057842|NCT03031847|50162106|FG000|Overall Study|Lost to Follow-up|1|||
25057843|NCT03031847|50162107|FG001|Overall Study|Lost to Follow-up|1|||
25057844|NCT03031847|50162108|FG002|Overall Study|Lost to Follow-up|2|||
25057845|NCT03031847|50162109|FG003|Overall Study|Lost to Follow-up|3|||
25057846|NCT03028415|50162121|FG000|Overall Study|Lost to Follow-up|6|||
25057847|NCT03028415|50162122|FG001|Overall Study|Lost to Follow-up|3|||
25057848|NCT03028415|50162121|FG000|Overall Study|Withdrawal by Subject|1|||
25057849|NCT03028415|50162122|FG001|Overall Study|Withdrawal by Subject|0|||
25057850|NCT03028415|50162121|FG000|Overall Study|Discontinued due to COVID-19|1|||
25057851|NCT03028415|50162122|FG001|Overall Study|Discontinued due to COVID-19|0|||
25057852|NCT02692040|50162146|FG000|Overall Study|Protocol Violation|0|||
25057853|NCT02692040|50162147|FG001|Overall Study|Protocol Violation|0|||
25057854|NCT02692040|50162148|FG002|Overall Study|Protocol Violation|0|||
25057855|NCT02692040|50162149|FG003|Overall Study|Protocol Violation|0|||
25057856|NCT02692040|50162150|FG004|Overall Study|Protocol Violation|0|||
25057857|NCT02692040|50162151|FG005|Overall Study|Protocol Violation|0|||
25057858|NCT02692040|50162152|FG006|Overall Study|Protocol Violation|0|||
25057859|NCT02692040|50162153|FG007|Overall Study|Protocol Violation|0|||
25057860|NCT02692040|50162154|FG008|Overall Study|Protocol Violation|0|||
25057861|NCT02692040|50162155|FG009|Overall Study|Protocol Violation|0|||
25057862|NCT02692040|50162156|FG010|Overall Study|Protocol Violation|0|||
25162759|NCT01277302|50285144|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
25276653|NCT01241552|50590593|FG003|Overall Study|Withdrawal by Subject|15|||
25276654|NCT01241552|50590590|FG000|Overall Study|Physician Decision|2|||
25276655|NCT01241552|50590591|FG001|Overall Study|Physician Decision|4|||
25276656|NCT01241552|50590592|FG002|Overall Study|Physician Decision|2|||
25276657|NCT01241552|50590593|FG003|Overall Study|Physician Decision|3|||
25057863|NCT02692040|50162157|FG011|Overall Study|Protocol Violation|0|||
25057864|NCT02692040|50162158|FG012|Overall Study|Protocol Violation|1|||
25057865|NCT02692040|50162159|FG013|Overall Study|Protocol Violation|0|||
25057866|NCT02692040|50162160|FG014|Overall Study|Protocol Violation|0|||
25057867|NCT02692040|50162161|FG015|Overall Study|Protocol Violation|0|||
25057868|NCT02692040|50162162|FG016|Overall Study|Protocol Violation|0|||
25057869|NCT02692040|50162146|FG000|Overall Study|Adverse Event|0|||
25057870|NCT02692040|50162147|FG001|Overall Study|Adverse Event|0|||
25057871|NCT02692040|50162148|FG002|Overall Study|Adverse Event|0|||
25057872|NCT02692040|50162149|FG003|Overall Study|Adverse Event|0|||
25162760|NCT01277302|50285142|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
25057873|NCT02692040|50162150|FG004|Overall Study|Adverse Event|0|||
25276658|NCT01241552|50590590|FG000|Overall Study|Lost to Follow-up|2|||
25276659|NCT01241552|50590591|FG001|Overall Study|Lost to Follow-up|11|||
25276660|NCT01241552|50590592|FG002|Overall Study|Lost to Follow-up|15|||
25057874|NCT02692040|50162151|FG005|Overall Study|Adverse Event|0|||
25057875|NCT02692040|50162152|FG006|Overall Study|Adverse Event|0|||
25057876|NCT02692040|50162153|FG007|Overall Study|Adverse Event|0|||
25057877|NCT02692040|50162154|FG008|Overall Study|Adverse Event|0|||
25057878|NCT02692040|50162155|FG009|Overall Study|Adverse Event|0|||
25057879|NCT02692040|50162156|FG010|Overall Study|Adverse Event|0|||
25057880|NCT02692040|50162157|FG011|Overall Study|Adverse Event|0|||
25057881|NCT02692040|50162158|FG012|Overall Study|Adverse Event|0|||
25057882|NCT02692040|50162159|FG013|Overall Study|Adverse Event|3|||
25057883|NCT02692040|50162160|FG014|Overall Study|Adverse Event|1|||
25057884|NCT02692040|50162161|FG015|Overall Study|Adverse Event|1|||
25057885|NCT02692040|50162162|FG016|Overall Study|Adverse Event|0|||
25057886|NCT03029819|50162241|FG000|Overall Study|Lost to Follow-up|3|||
25057887|NCT03029819|50162242|FG001|Overall Study|Lost to Follow-up|5|||
25057888|NCT03029819|50162241|FG000|Overall Study|Removed due to disruptive behavior|0|||
25057889|NCT03029819|50162242|FG001|Overall Study|Removed due to disruptive behavior|1|||
25057890|NCT02678390|50162253|FG000|AE (1 Day)|Withdrawal by Subject|0|||
25057891|NCT02678390|50162254|FG001|AE (1 Day)|Withdrawal by Subject|1|||
25057892|NCT03027557|50162263|FG000|Overall Study|Adverse Event|1|||
25057893|NCT03027557|50162264|FG001|Overall Study|Adverse Event|0|||
25057894|NCT03027557|50162265|FG002|Overall Study|Adverse Event|0|||
25057895|NCT03029585|50162275|FG000|Overall Study|Death|1|||
25057896|NCT03029585|50162276|FG001|Overall Study|Death|1|||
25057897|NCT03029585|50162275|FG000|Overall Study|Withdrawal by Subject|1|||
25057898|NCT03029585|50162276|FG001|Overall Study|Withdrawal by Subject|0|||
25057899|NCT02678000|50162287|FG000|PART 2|Adverse Event|0|||
25057900|NCT02678000|50162288|FG001|PART 2|Adverse Event|0|||
25057901|NCT02678000|50162289|FG002|PART 2|Adverse Event|2|||
25057902|NCT02678000|50162290|FG003|PART 2|Adverse Event|1|||
25057903|NCT02678000|50162291|FG004|PART 2|Adverse Event|0|||
25057904|NCT02678000|50162287|FG000|PART 2|Withdrawal by Subject|0|||
25057905|NCT02678000|50162288|FG001|PART 2|Withdrawal by Subject|0|||
25057906|NCT02678000|50162289|FG002|PART 2|Withdrawal by Subject|1|||
25057907|NCT02678000|50162290|FG003|PART 2|Withdrawal by Subject|0|||
25057908|NCT02678000|50162291|FG004|PART 2|Withdrawal by Subject|0|||
25057909|NCT02691572|50162318|FG000|Overall Study|Withdrawal by Subject|1|||
25057910|NCT02691572|50162319|FG001|Overall Study|Withdrawal by Subject|0|||
25057911|NCT02691572|50162318|FG000|Overall Study|Protocol Violation|0|||
25057912|NCT02691572|50162319|FG001|Overall Study|Protocol Violation|1|||
25057913|NCT02677844|50162327|FG000|Period 3|Withdrawal by Subject|0|||
25057914|NCT02677844|50162328|FG001|Period 3|Withdrawal by Subject|0|||
25057915|NCT02677844|50162329|FG002|Period 3|Withdrawal by Subject|0|||
25057916|NCT02677844|50162330|FG003|Period 3|Withdrawal by Subject|1|||
25057917|NCT02677844|50162331|FG004|Period 3|Withdrawal by Subject|0|||
25057918|NCT02677844|50162332|FG005|Period 3|Withdrawal by Subject|0|||
25057919|NCT02677844|50162333|FG006|Period 3|Withdrawal by Subject|0|||
25057920|NCT02691494|50162355|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
25057921|NCT02691494|50162356|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
25057922|NCT02691494|50162357|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
25057923|NCT02691494|50162355|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
25057924|NCT02691494|50162356|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
25057925|NCT02691494|50162357|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
25057926|NCT02691494|50162355|FG000|Post-Treatment Follow-Up Period|Other|2|||
25057927|NCT02691494|50162356|FG001|Post-Treatment Follow-Up Period|Other|1|||
25057928|NCT02691494|50162357|FG002|Post-Treatment Follow-Up Period|Other|1|||
24963529|NCT00222105|50053564|FG000|Overall Study|Adverse Event|8|||
24963530|NCT00222105|50053564|FG000|Overall Study|Treatment delays|2|||
25057929|NCT02691494|50162355|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
25057930|NCT02691494|50162356|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
25057931|NCT02691494|50162357|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
25057932|NCT02691494|50162355|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
25057933|NCT02691494|50162356|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
25276661|NCT01241552|50590593|FG003|Overall Study|Lost to Follow-up|16|||
25057934|NCT02691494|50162357|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
25057935|NCT02677220|50162365|FG000|Overall Study|Adverse Event|1|||
25057936|NCT02682602|50162372|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
25057937|NCT02682602|50162373|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
25057938|NCT02682602|50162372|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
25057939|NCT02682602|50162373|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
25057940|NCT02681510|50162383|FG000|Overall Study|Withdrawal by Subject|1|||
25057941|NCT02681510|50162383|FG000|Overall Study|Lost to Follow-up|9|||
25057942|NCT02690714|50162387|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
25057943|NCT02690714|50162387|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
25057944|NCT01898793|50162402|FG000|Overall Study|Death|2|||
25057945|NCT01898793|50162403|FG001|Overall Study|Death|1|||
25057946|NCT01898793|50162404|FG002|Overall Study|Death|4|||
25057947|NCT01898793|50162405|FG003|Overall Study|Death|0|||
25057948|NCT01898793|50162406|FG004|Overall Study|Death|0|||
25057949|NCT01898793|50162407|FG005|Overall Study|Death|0|||
25057950|NCT01898793|50162408|FG006|Overall Study|Death|0|||
25057951|NCT01791543|50162427|FG000|Overall Study|Lost to Follow-up|1|||
25057952|NCT01791543|50162427|FG000|Overall Study|Adverse Event|1|||
25057953|NCT02925455|50162434|FG000|Overall Study|Withdrawal by Subject|2|||
25057954|NCT02925455|50162435|FG001|Overall Study|Withdrawal by Subject|0|||
25057955|NCT03033069|50162445|FG000|Overall Study|Adverse Event|6|||
25057956|NCT03033069|50162446|FG001|Overall Study|Adverse Event|7|||
25057957|NCT03033069|50162447|FG002|Overall Study|Adverse Event|4|||
25057958|NCT03033069|50162448|FG003|Overall Study|Adverse Event|6|||
25057959|NCT03033069|50162445|FG000|Overall Study|Lack of Efficacy|0|||
25057960|NCT03033069|50162446|FG001|Overall Study|Lack of Efficacy|0|||
25057961|NCT03033069|50162447|FG002|Overall Study|Lack of Efficacy|1|||
25057962|NCT03033069|50162448|FG003|Overall Study|Lack of Efficacy|0|||
25057963|NCT03033069|50162445|FG000|Overall Study|Lost to Follow-up|6|||
25057964|NCT03033069|50162446|FG001|Overall Study|Lost to Follow-up|5|||
25057965|NCT03033069|50162447|FG002|Overall Study|Lost to Follow-up|5|||
25057966|NCT03033069|50162448|FG003|Overall Study|Lost to Follow-up|6|||
25057967|NCT03033069|50162445|FG000|Overall Study|Non-Compliance With Study Drug|1|||
25057968|NCT03033069|50162446|FG001|Overall Study|Non-Compliance With Study Drug|1|||
25057969|NCT03033069|50162447|FG002|Overall Study|Non-Compliance With Study Drug|1|||
25057970|NCT03033069|50162448|FG003|Overall Study|Non-Compliance With Study Drug|0|||
25057971|NCT03033069|50162445|FG000|Overall Study|Protocol Deviation|0|||
25057972|NCT03033069|50162446|FG001|Overall Study|Protocol Deviation|1|||
25057973|NCT03033069|50162447|FG002|Overall Study|Protocol Deviation|0|||
25057974|NCT03033069|50162448|FG003|Overall Study|Protocol Deviation|0|||
25057975|NCT03033069|50162445|FG000|Overall Study|Withdrawal by Subject|10|||
25057976|NCT03033069|50162446|FG001|Overall Study|Withdrawal by Subject|10|||
25057977|NCT03033069|50162447|FG002|Overall Study|Withdrawal by Subject|11|||
25057978|NCT03033069|50162448|FG003|Overall Study|Withdrawal by Subject|6|||
25057979|NCT03033069|50162445|FG000|Overall Study|Withdrawal By Caregiver|1|||
25057980|NCT03033069|50162446|FG001|Overall Study|Withdrawal By Caregiver|0|||
25057981|NCT03033069|50162447|FG002|Overall Study|Withdrawal By Caregiver|0|||
25057982|NCT03033069|50162448|FG003|Overall Study|Withdrawal By Caregiver|0|||
25057983|NCT03033069|50162445|FG000|Overall Study|Reason not Specified|0|||
25057984|NCT03033069|50162446|FG001|Overall Study|Reason not Specified|1|||
25057985|NCT03033069|50162447|FG002|Overall Study|Reason not Specified|0|||
25057986|NCT03033069|50162448|FG003|Overall Study|Reason not Specified|1|||
25057987|NCT02917265|50162460|FG000|Overall Study|Physician Decision|1|||
25057988|NCT02917265|50162461|FG001|Overall Study|Physician Decision|0|||
25057989|NCT02917265|50162460|FG000|Overall Study|Withdrawal by Subject|1|||
25057990|NCT02917265|50162461|FG001|Overall Study|Withdrawal by Subject|0|||
25057991|NCT02136069|50162471|FG000|Overall Study|UC flare-up|1|||
25057992|NCT02136069|50162472|FG001|Overall Study|UC flare-up|0|||
24963531|NCT00222105|50053564|FG000|Overall Study|Death|2|||
24963532|NCT00146757|50053568|FG000|Overall Study|Death|1|||
24963533|NCT00146757|50053569|FG001|Overall Study|Death|0|||
24963534|NCT00146757|50053568|FG000|Overall Study|Adverse Event|1|||
24963535|NCT00146757|50053569|FG001|Overall Study|Adverse Event|0|||
24963536|NCT00267098|50053583|FG000|Overall Study|Death|0|||
24963537|NCT00267098|50053584|FG001|Overall Study|Death|0|||
24963538|NCT00267098|50053585|FG002|Overall Study|Death|57|||
24963539|NCT00267098|50053586|FG003|Overall Study|Death|66|||
24963540|NCT00267098|50053587|FG004|Overall Study|Death|14|||
25057993|NCT02136069|50162471|FG000|Overall Study|Adverse Event|6|||
25057994|NCT02136069|50162472|FG001|Overall Study|Adverse Event|8|||
24963541|NCT00267098|50053588|FG005|Overall Study|Death|23|||
24963542|NCT00267098|50053589|FG006|Overall Study|Death|28|||
25057995|NCT02136069|50162471|FG000|Overall Study|Death|0|||
25057996|NCT02136069|50162472|FG001|Overall Study|Death|1|||
25057997|NCT02136069|50162471|FG000|Overall Study|Lack of Efficacy|10|||
25057998|NCT02136069|50162472|FG001|Overall Study|Lack of Efficacy|4|||
25057999|NCT02136069|50162471|FG000|Overall Study|Lost to Follow-up|1|||
25058000|NCT02136069|50162472|FG001|Overall Study|Lost to Follow-up|0|||
25058001|NCT02136069|50162471|FG000|Overall Study|Non-Compliance|1|||
25058002|NCT02136069|50162472|FG001|Overall Study|Non-Compliance|0|||
25058003|NCT02136069|50162471|FG000|Overall Study|Physician Decision|5|||
25058004|NCT02136069|50162472|FG001|Overall Study|Physician Decision|4|||
25058005|NCT02136069|50162471|FG000|Overall Study|Withdrawal by Subject|10|||
25058006|NCT02136069|50162472|FG001|Overall Study|Withdrawal by Subject|11|||
25058007|NCT02917031|50162481|FG000|Overall Study|Reason not specified|7|||
25058008|NCT02917031|50162482|FG001|Overall Study|Reason not specified|5|||
25058009|NCT02917031|50162483|FG002|Overall Study|Reason not specified|6|||
25058010|NCT02917031|50162481|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
25058011|NCT02917031|50162482|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
25058012|NCT02917031|50162483|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
25058013|NCT02917031|50162481|FG000|Overall Study|Withdrawal by Subject|3|||
25058014|NCT02917031|50162482|FG001|Overall Study|Withdrawal by Subject|3|||
25058015|NCT02917031|50162483|FG002|Overall Study|Withdrawal by Subject|0|||
25058016|NCT02917031|50162481|FG000|Overall Study|Physician Decision|1|||
25058017|NCT02917031|50162482|FG001|Overall Study|Physician Decision|0|||
25058018|NCT02917031|50162483|FG002|Overall Study|Physician Decision|0|||
25058019|NCT02917031|50162481|FG000|Overall Study|Adverse Event|4|||
25058020|NCT02917031|50162482|FG001|Overall Study|Adverse Event|1|||
25058021|NCT02917031|50162483|FG002|Overall Study|Adverse Event|5|||
25058022|NCT02917031|50162481|FG000|Overall Study|Death|2|||
25058023|NCT02917031|50162482|FG001|Overall Study|Death|3|||
25058024|NCT02917031|50162483|FG002|Overall Study|Death|4|||
25058025|NCT01018563|50162492|FG000|Overall Study|Termination of the study by Sponsor|2|||
25058026|NCT01018563|50162493|FG001|Overall Study|Termination of the study by Sponsor|1|||
25058027|NCT02528188|50162506|FG000|Overall Study|Adverse Event|23|||
25058028|NCT02528188|50162507|FG001|Overall Study|Adverse Event|22|||
25058029|NCT02528188|50162508|FG002|Overall Study|Adverse Event|8|||
25058030|NCT02528188|50162506|FG000|Overall Study|Protocol Violation|4|||
25058031|NCT02528188|50162507|FG001|Overall Study|Protocol Violation|6|||
25058032|NCT02528188|50162508|FG002|Overall Study|Protocol Violation|4|||
25058033|NCT02528188|50162506|FG000|Overall Study|Lack of Efficacy|19|||
25058034|NCT02528188|50162507|FG001|Overall Study|Lack of Efficacy|21|||
25058035|NCT02528188|50162508|FG002|Overall Study|Lack of Efficacy|22|||
25058036|NCT02528188|50162506|FG000|Overall Study|Withdrawal by Subject|97|||
25058037|NCT02528188|50162507|FG001|Overall Study|Withdrawal by Subject|104|||
25058038|NCT02528188|50162508|FG002|Overall Study|Withdrawal by Subject|100|||
25058039|NCT02528188|50162506|FG000|Overall Study|Lost to Follow-up|25|||
25058040|NCT02528188|50162507|FG001|Overall Study|Lost to Follow-up|21|||
24963543|NCT00267098|50053590|FG007|Overall Study|Death|9|||
24963544|NCT00267098|50053583|FG000|Overall Study|Lost to Follow-up|0|||
24963545|NCT00267098|50053584|FG001|Overall Study|Lost to Follow-up|0|||
24963546|NCT00267098|50053585|FG002|Overall Study|Lost to Follow-up|6|||
24963547|NCT00267098|50053586|FG003|Overall Study|Lost to Follow-up|5|||
24963548|NCT00267098|50053587|FG004|Overall Study|Lost to Follow-up|2|||
24963549|NCT00267098|50053588|FG005|Overall Study|Lost to Follow-up|3|||
24963550|NCT00267098|50053589|FG006|Overall Study|Lost to Follow-up|1|||
24963551|NCT00267098|50053590|FG007|Overall Study|Lost to Follow-up|1|||
24963552|NCT00267098|50053583|FG000|Overall Study|Withdrawal by Subject|8|||
24963553|NCT00267098|50053584|FG001|Overall Study|Withdrawal by Subject|0|||
24963554|NCT00267098|50053585|FG002|Overall Study|Withdrawal by Subject|24|||
24963555|NCT00267098|50053586|FG003|Overall Study|Withdrawal by Subject|21|||
24963556|NCT00267098|50053587|FG004|Overall Study|Withdrawal by Subject|12|||
24963557|NCT00267098|50053588|FG005|Overall Study|Withdrawal by Subject|9|||
24963558|NCT00267098|50053589|FG006|Overall Study|Withdrawal by Subject|12|||
24963559|NCT00267098|50053590|FG007|Overall Study|Withdrawal by Subject|5|||
25058041|NCT02528188|50162508|FG002|Overall Study|Lost to Follow-up|31|||
25058042|NCT02528188|50162506|FG000|Overall Study|Death|4|||
25058043|NCT02528188|50162507|FG001|Overall Study|Death|4|||
25058044|NCT02528188|50162508|FG002|Overall Study|Death|0|||
25058045|NCT02528188|50162506|FG000|Overall Study|Other|89|||
25058046|NCT02528188|50162507|FG001|Overall Study|Other|91|||
25058047|NCT02528188|50162508|FG002|Overall Study|Other|74|||
25058048|NCT02528188|50162506|FG000|Overall Study|Randomized but not treated|6|||
25058049|NCT02528188|50162507|FG001|Overall Study|Randomized but not treated|7|||
25058050|NCT02528188|50162508|FG002|Overall Study|Randomized but not treated|12|||
25058051|NCT03896165|50162516|FG000|Overall Study|Withdrawal by Subject|2|||
25058052|NCT02269917|50162542|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
24963560|NCT00267098|50053583|FG000|Overall Study|Physician Decision|5|||
24963561|NCT00267098|50053584|FG001|Overall Study|Physician Decision|0|||
24963562|NCT00267098|50053585|FG002|Overall Study|Physician Decision|7|||
24963563|NCT00267098|50053586|FG003|Overall Study|Physician Decision|11|||
24963564|NCT00267098|50053587|FG004|Overall Study|Physician Decision|5|||
25058053|NCT02269917|50162543|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
25058054|NCT02269917|50162544|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
25058055|NCT02269917|50162542|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
24963565|NCT00267098|50053588|FG005|Overall Study|Physician Decision|4|||
25058056|NCT02269917|50162543|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
25058057|NCT02269917|50162544|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
25058058|NCT02269917|50162542|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
25058059|NCT02269917|50162543|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
25058060|NCT02269917|50162544|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
25058061|NCT02269917|50162542|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
25058062|NCT02269917|50162543|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
25058063|NCT02269917|50162544|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
25058064|NCT02269917|50162542|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
25058065|NCT02269917|50162543|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
25058066|NCT02269917|50162544|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
25058067|NCT02269917|50162542|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
25058068|NCT02269917|50162543|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
25058069|NCT02269917|50162544|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
25058070|NCT02269917|50162542|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
25058071|NCT02269917|50162543|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
25058072|NCT02269917|50162544|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
25058073|NCT02269917|50162542|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
25058074|NCT02269917|50162543|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
25058075|NCT02269917|50162544|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
25058076|NCT02269917|50162542|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
25058077|NCT02269917|50162543|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
25058078|NCT02269917|50162544|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
25058079|NCT02269917|50162542|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
25058080|NCT02269917|50162543|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
25058081|NCT02269917|50162544|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
25058082|NCT02269917|50162542|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
25058083|NCT02269917|50162543|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
25058084|NCT02269917|50162544|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
25058085|NCT02269917|50162542|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
25058086|NCT02269917|50162543|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
25058087|NCT02269917|50162544|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
25058088|NCT02269917|50162542|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
25058089|NCT02269917|50162543|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
25058090|NCT02269917|50162544|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
25058091|NCT02269917|50162542|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
25058092|NCT02269917|50162543|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
25058093|NCT02269917|50162544|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
25058094|NCT02269917|50162542|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
25058095|NCT02269917|50162543|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
25058096|NCT02269917|50162544|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
25058097|NCT02269917|50162542|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
25058098|NCT02269917|50162543|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
25058099|NCT02269917|50162544|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
25058100|NCT02522494|50162555|FG000|Overall Study|Lost to Follow-up|6|||
25058101|NCT02522494|50162556|FG001|Overall Study|Lost to Follow-up|2|||
25058102|NCT02522494|50162555|FG000|Overall Study|Withdrawal by Subject|1|||
25058103|NCT02522494|50162556|FG001|Overall Study|Withdrawal by Subject|0|||
25058104|NCT02522494|50162555|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
25058105|NCT02522494|50162556|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
25058106|NCT02522494|50162555|FG000|Overall Study|Participant did not watch the video|1|||
25058107|NCT02522494|50162556|FG001|Overall Study|Participant did not watch the video|0|||
25058108|NCT02522494|50162555|FG000|Overall Study|Death|0|||
25058109|NCT02522494|50162556|FG001|Overall Study|Death|1|||
25058110|NCT01658020|50162564|FG000|Overall Study|Adverse Event|3|||
25058111|NCT01658020|50162565|FG001|Overall Study|Adverse Event|3|||
25058112|NCT01658020|50162564|FG000|Overall Study|Lost to Follow-up|1|||
25058113|NCT01658020|50162565|FG001|Overall Study|Lost to Follow-up|0|||
25058114|NCT01658020|50162564|FG000|Overall Study|Withdrawal by Subject|4|||
25058115|NCT01658020|50162565|FG001|Overall Study|Withdrawal by Subject|5|||
25058116|NCT01658020|50162564|FG000|Overall Study|Protocol Violation|0|||
25058117|NCT01658020|50162565|FG001|Overall Study|Protocol Violation|1|||
25058118|NCT03389477|50162583|FG000|Step 1|Withdrawal by Subject|1|||
25058119|NCT03389477|50162584|FG001|Step 1|Withdrawal by Subject|0|||
25058120|NCT03389477|50162583|FG000|Step 2|Withdrawal by Subject|1|||
25058121|NCT03389477|50162584|FG001|Step 2|Withdrawal by Subject|2|||
25058122|NCT03389477|50162583|FG000|Step 2|Disease progression|1|||
25058123|NCT03389477|50162584|FG001|Step 2|Disease progression|0|||
25058124|NCT03389477|50162583|FG000|Step 2|Death|0|||
25058125|NCT03389477|50162584|FG001|Step 2|Death|1|||
25058126|NCT03389477|50162583|FG000|Step 2|Poor performance status and nutrition|0|||
25058127|NCT03389477|50162584|FG001|Step 2|Poor performance status and nutrition|1|||
25058128|NCT03389477|50162583|FG000|Step 3|Withdrawal after 3 cycles|0|||
25058129|NCT03389477|50162584|FG001|Step 3|Withdrawal after 3 cycles|1|||
25058130|NCT03389477|50162583|FG000|Step 3|Still receiving active treatment|4|||
25058131|NCT03389477|50162584|FG001|Step 3|Still receiving active treatment|0|||
25058132|NCT03389477|50162583|FG000|Step 3|Progressive disease after 2 cycles|1|||
25058133|NCT03389477|50162584|FG001|Step 3|Progressive disease after 2 cycles|0|||
25058134|NCT02680574|50162594|FG000|Overall Study|Death|137|||
25058135|NCT02680574|50162595|FG001|Overall Study|Death|137|||
25058136|NCT02680574|50162594|FG000|Overall Study|Withdrawal by Subject|17|||
25058137|NCT02680574|50162595|FG001|Overall Study|Withdrawal by Subject|9|||
25058138|NCT02680574|50162594|FG000|Overall Study|Lost to Follow-up|4|||
25058139|NCT02680574|50162595|FG001|Overall Study|Lost to Follow-up|6|||
25058140|NCT02522884|50162601|FG000|Overall Study|Withdrawal by Subject|6|||
25058141|NCT02522884|50162601|FG000|Overall Study|Death|3|||
25058142|NCT02522884|50162601|FG000|Overall Study|Missed 12-month Follow-up|9|||
25058143|NCT02674568|50162618|FG000|Overall Study|Withdrawal by Subject|5|||
25058144|NCT02674568|50162618|FG000|Overall Study|Death|303|||
25058145|NCT02674568|50162618|FG000|Overall Study|Physician Decision|2|||
25058146|NCT02674568|50162618|FG000|Overall Study|Lost to Follow-up|9|||
25058147|NCT02674568|50162618|FG000|Overall Study|Other, Not Specified|20|||
25058148|NCT03022799|50162647|FG000|Overall Study|Adverse Event|0|||
25058149|NCT03022799|50162648|FG001|Overall Study|Adverse Event|0|||
25058150|NCT03022799|50162649|FG002|Overall Study|Adverse Event|0|||
25058151|NCT03022799|50162650|FG003|Overall Study|Adverse Event|0|||
25058152|NCT03022799|50162651|FG004|Overall Study|Adverse Event|0|||
25058153|NCT03022799|50162652|FG005|Overall Study|Adverse Event|0|||
25058154|NCT03022799|50162653|FG006|Overall Study|Adverse Event|0|||
25058155|NCT03022799|50162654|FG007|Overall Study|Adverse Event|0|||
25058156|NCT03022799|50162655|FG008|Overall Study|Adverse Event|0|||
25058157|NCT03022799|50162656|FG009|Overall Study|Adverse Event|1|||
25058158|NCT03022799|50162657|FG010|Overall Study|Adverse Event|1|||
25058159|NCT03022799|50162658|FG011|Overall Study|Adverse Event|0|||
25058160|NCT03022799|50162659|FG012|Overall Study|Adverse Event|0|||
25058161|NCT02674334|50162706|FG000|Overall Study|Lost to Follow-up|5|||
25058162|NCT02674334|50162707|FG001|Overall Study|Lost to Follow-up|3|||
25058163|NCT02674334|50162706|FG000|Overall Study|participant difficulty breathing|1|||
25058164|NCT02674334|50162707|FG001|Overall Study|participant difficulty breathing|0|||
25058165|NCT02674334|50162706|FG000|Overall Study|NIRS not recording|1|||
25058166|NCT02674334|50162707|FG001|Overall Study|NIRS not recording|0|||
25058167|NCT03026075|50162713|FG000|Overall Study|Physician Decision|1|||
25058168|NCT01373918|50162719|FG000|Overall Study|Physician Decision|0|||
25058169|NCT01373918|50162720|FG001|Overall Study|Physician Decision|1|||
25058170|NCT02667626|50162728|FG000|Overall Study|Withdrawal by Subject|0|||
25058171|NCT02667626|50162729|FG001|Overall Study|Withdrawal by Subject|1|||
25058172|NCT02522728|50162740|FG000|Overall Study|Withdrawal by Subject|6|||
25058173|NCT02522728|50162741|FG001|Overall Study|Withdrawal by Subject|6|||
25058174|NCT02522728|50162740|FG000|Overall Study|Death|4|||
25058175|NCT02522728|50162741|FG001|Overall Study|Death|3|||
25058176|NCT02522728|50162740|FG000|Overall Study|Adverse Event|2|||
25058177|NCT02522728|50162741|FG001|Overall Study|Adverse Event|1|||
25058178|NCT02522728|50162740|FG000|Overall Study|Did not receive randomized study device|0|||
25058179|NCT02522728|50162741|FG001|Overall Study|Did not receive randomized study device|1|||
25058180|NCT02827877|50162747|FG000|Overall Study|Withdrawal by Subject|1|||
25058181|NCT03025217|50162760|FG000|Overall Study|Pregnancy|1|||
25058182|NCT03025217|50162760|FG000|Overall Study|Lost to Follow-up|1|||
25058183|NCT03025217|50162760|FG000|Overall Study|Not eligible, poor English|2|||
25058184|NCT03023813|50162767|FG000|Overall Study|Lost to Follow-up|1|||
25058185|NCT03023813|50162768|FG001|Overall Study|Lost to Follow-up|2|||
25058186|NCT03023813|50162769|FG002|Overall Study|Lost to Follow-up|0|||
25058187|NCT01365130|50162778|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
25058188|NCT01657162|50162784|FG000|Overall Study|Adverse Event|26|||
25058189|NCT01657162|50162785|FG001|Overall Study|Adverse Event|36|||
25058190|NCT01657162|50162784|FG000|Overall Study|Withdrawal by Subject|13|||
25058191|NCT01657162|50162785|FG001|Overall Study|Withdrawal by Subject|13|||
25058192|NCT01657162|50162784|FG000|Overall Study|Continuing Significant Deterioration|9|||
25058193|NCT01657162|50162785|FG001|Overall Study|Continuing Significant Deterioration|3|||
25058194|NCT01657162|50162784|FG000|Overall Study|Refusal of Treatment|4|||
25058195|NCT01657162|50162785|FG001|Overall Study|Refusal of Treatment|6|||
25058196|NCT01657162|50162784|FG000|Overall Study|Lost to Follow-up|3|||
25058197|NCT01657162|50162785|FG001|Overall Study|Lost to Follow-up|4|||
25058198|NCT01657162|50162784|FG000|Overall Study|Death|2|||
25058199|NCT01657162|50162785|FG001|Overall Study|Death|3|||
25058200|NCT01657162|50162784|FG000|Overall Study|Inability to Complete Study Procedures|1|||
25058201|NCT01657162|50162785|FG001|Overall Study|Inability to Complete Study Procedures|7|||
25058202|NCT01657162|50162784|FG000|Overall Study|Protocol Violation|1|||
25058203|NCT01657162|50162785|FG001|Overall Study|Protocol Violation|0|||
25058204|NCT01657162|50162784|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
25058205|NCT01657162|50162785|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
25058206|NCT01657162|50162784|FG000|Overall Study|Other than Specified|0|||
25058207|NCT01657162|50162785|FG001|Overall Study|Other than Specified|2|||
25058208|NCT01373294|50162819|FG000|Overall Study|Adverse Event|1|||
25058209|NCT01373294|50162820|FG001|Overall Study|Adverse Event|0|||
25058210|NCT01656304|50162826|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
25058211|NCT03023423|50162833|FG000|Overall Study|Death|5|||
25058212|NCT03023423|50162834|FG001|Overall Study|Death|12|||
25058213|NCT03023423|50162835|FG002|Overall Study|Death|20|||
25058214|NCT03023423|50162833|FG000|Overall Study|Other|0|||
25058215|NCT03023423|50162834|FG001|Overall Study|Other|2|||
25058216|NCT03023423|50162835|FG002|Overall Study|Other|2|||
25058217|NCT03023423|50162833|FG000|Overall Study|Ongoing|2|||
25058218|NCT03023423|50162834|FG001|Overall Study|Ongoing|32|||
25058219|NCT03023423|50162835|FG002|Overall Study|Ongoing|24|||
25058220|NCT03185741|50162850|FG000|Baseline|Withdrawal by Subject|1|||
25058221|NCT03185741|50162851|FG001|Baseline|Withdrawal by Subject|3|||
25058222|NCT03185741|50162852|FG002|Baseline|Withdrawal by Subject|2|||
25058223|NCT03185741|50162850|FG000|Baseline|Lost to Follow-up|1|||
25058224|NCT03185741|50162851|FG001|Baseline|Lost to Follow-up|2|||
25058225|NCT03185741|50162852|FG002|Baseline|Lost to Follow-up|3|||
25058226|NCT03185741|50162850|FG000|3Month|Death|1|||
25058227|NCT03185741|50162851|FG001|3Month|Death|1|||
25058228|NCT03185741|50162852|FG002|3Month|Death|2|||
25058229|NCT03185741|50162850|FG000|3Month|Withdrawal by Subject|1|||
25058230|NCT03185741|50162851|FG001|3Month|Withdrawal by Subject|5|||
25058231|NCT03185741|50162852|FG002|3Month|Withdrawal by Subject|1|||
25058232|NCT03185741|50162850|FG000|3Month|Lost to Follow-up|7|||
25058233|NCT03185741|50162851|FG001|3Month|Lost to Follow-up|9|||
25058234|NCT03185741|50162852|FG002|3Month|Lost to Follow-up|8|||
25058235|NCT03185741|50162850|FG000|3Month|Unavailable for 3Month|11|||
25058236|NCT03185741|50162851|FG001|3Month|Unavailable for 3Month|10|||
25058237|NCT03185741|50162852|FG002|3Month|Unavailable for 3Month|11|||
25058238|NCT03185741|50162850|FG000|3Month|Protocol Violation|0|||
25058239|NCT03185741|50162851|FG001|3Month|Protocol Violation|0|||
25058240|NCT03185741|50162852|FG002|3Month|Protocol Violation|3|||
25058241|NCT03185741|50162850|FG000|6Month|Death|1|||
25058242|NCT03185741|50162851|FG001|6Month|Death|1|||
25058243|NCT03185741|50162852|FG002|6Month|Death|2|||
25058244|NCT03185741|50162850|FG000|6Month|Withdrawal by Subject|2|||
25058245|NCT03185741|50162851|FG001|6Month|Withdrawal by Subject|3|||
25058246|NCT03185741|50162852|FG002|6Month|Withdrawal by Subject|1|||
25058247|NCT03185741|50162850|FG000|6Month|Lost to Follow-up|16|||
25058248|NCT03185741|50162851|FG001|6Month|Lost to Follow-up|15|||
25058249|NCT03185741|50162852|FG002|6Month|Lost to Follow-up|16|||
25058250|NCT02672852|50162862|FG000|Part A1|Disease Worsening|1|||
25058251|NCT02672852|50162863|FG001|Part A1|Disease Worsening|0|||
25058252|NCT02672852|50162864|FG002|Part A1|Disease Worsening|0|||
25058253|NCT02672852|50162865|FG003|Part A1|Disease Worsening|0|||
25058254|NCT02672852|50162866|FG004|Part A1|Disease Worsening|0|||
25058255|NCT02672852|50162867|FG005|Part A1|Disease Worsening|0|||
25058256|NCT02672852|50162868|FG006|Part A1|Disease Worsening|0|||
25058257|NCT02672852|50162862|FG000|Part A1|Adverse Event|0|||
25058258|NCT02672852|50162863|FG001|Part A1|Adverse Event|1|||
25058259|NCT02672852|50162864|FG002|Part A1|Adverse Event|0|||
25058260|NCT02672852|50162865|FG003|Part A1|Adverse Event|0|||
25058261|NCT02672852|50162866|FG004|Part A1|Adverse Event|0|||
25162761|NCT01277302|50285143|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
25058262|NCT02672852|50162867|FG005|Part A1|Adverse Event|0|||
25058263|NCT02672852|50162868|FG006|Part A1|Adverse Event|0|||
25058264|NCT02672852|50162862|FG000|Part A1|Lost to Follow-up|1|||
25058265|NCT02672852|50162863|FG001|Part A1|Lost to Follow-up|2|||
25058266|NCT02672852|50162864|FG002|Part A1|Lost to Follow-up|0|||
25058267|NCT02672852|50162865|FG003|Part A1|Lost to Follow-up|0|||
25058268|NCT02672852|50162866|FG004|Part A1|Lost to Follow-up|0|||
25058269|NCT02672852|50162867|FG005|Part A1|Lost to Follow-up|0|||
25058270|NCT02672852|50162868|FG006|Part A1|Lost to Follow-up|0|||
25058271|NCT02672852|50162862|FG000|Part A1|Withdrawal by Subject|1|||
25058272|NCT02672852|50162863|FG001|Part A1|Withdrawal by Subject|1|||
25058273|NCT02672852|50162864|FG002|Part A1|Withdrawal by Subject|0|||
24963566|NCT00267098|50053589|FG006|Overall Study|Physician Decision|3|||
25058274|NCT02672852|50162865|FG003|Part A1|Withdrawal by Subject|0|||
25058275|NCT02672852|50162866|FG004|Part A1|Withdrawal by Subject|0|||
25058276|NCT02672852|50162867|FG005|Part A1|Withdrawal by Subject|0|||
25058277|NCT02672852|50162868|FG006|Part A1|Withdrawal by Subject|0|||
25058278|NCT02672852|50162862|FG000|Part A2|Disease worsening|0|||
25058279|NCT02672852|50162863|FG001|Part A2|Disease worsening|0|||
25058280|NCT02672852|50162864|FG002|Part A2|Disease worsening|1|||
25058281|NCT02672852|50162865|FG003|Part A2|Disease worsening|0|||
24963567|NCT00267098|50053590|FG007|Overall Study|Physician Decision|0|||
25058282|NCT02672852|50162866|FG004|Part A2|Disease worsening|0|||
25058283|NCT02672852|50162867|FG005|Part A2|Disease worsening|0|||
25058284|NCT02672852|50162868|FG006|Part A2|Disease worsening|0|||
25058285|NCT02672852|50162862|FG000|Part A2|Adverse Event|0|||
25058286|NCT02672852|50162863|FG001|Part A2|Adverse Event|0|||
25058287|NCT02672852|50162864|FG002|Part A2|Adverse Event|3|||
25058288|NCT02672852|50162865|FG003|Part A2|Adverse Event|0|||
25058289|NCT02672852|50162866|FG004|Part A2|Adverse Event|0|||
25058290|NCT02672852|50162867|FG005|Part A2|Adverse Event|0|||
25058291|NCT02672852|50162868|FG006|Part A2|Adverse Event|0|||
25058292|NCT02672852|50162862|FG000|Part A2|Lost to Follow-up|0|||
25058293|NCT02672852|50162863|FG001|Part A2|Lost to Follow-up|0|||
25058294|NCT02672852|50162864|FG002|Part A2|Lost to Follow-up|2|||
25058295|NCT02672852|50162865|FG003|Part A2|Lost to Follow-up|0|||
25058296|NCT02672852|50162866|FG004|Part A2|Lost to Follow-up|0|||
25058297|NCT02672852|50162867|FG005|Part A2|Lost to Follow-up|0|||
25058298|NCT02672852|50162868|FG006|Part A2|Lost to Follow-up|0|||
25058299|NCT02672852|50162862|FG000|Part A2|Withdrawal by Subject|0|||
25058300|NCT02672852|50162863|FG001|Part A2|Withdrawal by Subject|0|||
25058301|NCT02672852|50162864|FG002|Part A2|Withdrawal by Subject|1|||
25058302|NCT02672852|50162865|FG003|Part A2|Withdrawal by Subject|0|||
25058303|NCT02672852|50162866|FG004|Part A2|Withdrawal by Subject|0|||
25058304|NCT02672852|50162867|FG005|Part A2|Withdrawal by Subject|0|||
25058305|NCT02672852|50162868|FG006|Part A2|Withdrawal by Subject|0|||
25058306|NCT02672852|50162862|FG000|Part A2|Other|0|||
25058307|NCT02672852|50162863|FG001|Part A2|Other|0|||
25058308|NCT02672852|50162864|FG002|Part A2|Other|3|||
25058309|NCT02672852|50162865|FG003|Part A2|Other|0|||
25058310|NCT02672852|50162866|FG004|Part A2|Other|0|||
25058311|NCT02672852|50162867|FG005|Part A2|Other|0|||
25058312|NCT02672852|50162868|FG006|Part A2|Other|0|||
25058313|NCT02672852|50162862|FG000|Part A2|Not entered in Part B|0|||
25058314|NCT02672852|50162863|FG001|Part A2|Not entered in Part B|0|||
25058315|NCT02672852|50162864|FG002|Part A2|Not entered in Part B|0|||
25058316|NCT02672852|50162865|FG003|Part A2|Not entered in Part B|4|||
25058317|NCT02672852|50162866|FG004|Part A2|Not entered in Part B|0|||
25058318|NCT02672852|50162867|FG005|Part A2|Not entered in Part B|0|||
25058319|NCT02672852|50162868|FG006|Part A2|Not entered in Part B|0|||
25058320|NCT02672852|50162862|FG000|Part B|Disease worsening|0|||
25058321|NCT02672852|50162863|FG001|Part B|Disease worsening|0|||
25058322|NCT02672852|50162864|FG002|Part B|Disease worsening|0|||
25058323|NCT02672852|50162865|FG003|Part B|Disease worsening|0|||
25058324|NCT02672852|50162866|FG004|Part B|Disease worsening|1|||
25058325|NCT02672852|50162867|FG005|Part B|Disease worsening|0|||
25058326|NCT02672852|50162868|FG006|Part B|Disease worsening|1|||
25058327|NCT02672852|50162862|FG000|Part B|Worsening pre-existing condition|0|||
25058328|NCT02672852|50162863|FG001|Part B|Worsening pre-existing condition|0|||
25058329|NCT02672852|50162864|FG002|Part B|Worsening pre-existing condition|0|||
25058330|NCT02672852|50162865|FG003|Part B|Worsening pre-existing condition|0|||
25058331|NCT02672852|50162866|FG004|Part B|Worsening pre-existing condition|0|||
25058332|NCT02672852|50162867|FG005|Part B|Worsening pre-existing condition|1|||
25058333|NCT02672852|50162868|FG006|Part B|Worsening pre-existing condition|0|||
25058334|NCT02672852|50162862|FG000|Part B|Other adverse event|0|||
25058335|NCT02672852|50162863|FG001|Part B|Other adverse event|0|||
25058336|NCT02672852|50162864|FG002|Part B|Other adverse event|0|||
25058337|NCT02672852|50162865|FG003|Part B|Other adverse event|0|||
25058338|NCT02672852|50162866|FG004|Part B|Other adverse event|3|||
25058339|NCT02672852|50162867|FG005|Part B|Other adverse event|5|||
25058340|NCT02672852|50162868|FG006|Part B|Other adverse event|1|||
25058341|NCT02672852|50162862|FG000|Part B|Lost to Follow-up|0|||
25058342|NCT02672852|50162863|FG001|Part B|Lost to Follow-up|0|||
25058343|NCT02672852|50162864|FG002|Part B|Lost to Follow-up|0|||
25058344|NCT02672852|50162865|FG003|Part B|Lost to Follow-up|0|||
25058345|NCT02672852|50162866|FG004|Part B|Lost to Follow-up|3|||
25058346|NCT02672852|50162867|FG005|Part B|Lost to Follow-up|4|||
25058347|NCT02672852|50162868|FG006|Part B|Lost to Follow-up|1|||
25058348|NCT02672852|50162862|FG000|Part B|Withdrawal by Subject|0|||
25058349|NCT02672852|50162863|FG001|Part B|Withdrawal by Subject|0|||
25058350|NCT02672852|50162864|FG002|Part B|Withdrawal by Subject|0|||
25058351|NCT02672852|50162865|FG003|Part B|Withdrawal by Subject|0|||
25058352|NCT02672852|50162866|FG004|Part B|Withdrawal by Subject|5|||
25058353|NCT02672852|50162867|FG005|Part B|Withdrawal by Subject|0|||
25058354|NCT02672852|50162868|FG006|Part B|Withdrawal by Subject|7|||
25058355|NCT02672852|50162862|FG000|Part B|Other|0|||
25058356|NCT02672852|50162863|FG001|Part B|Other|0|||
25058357|NCT02672852|50162864|FG002|Part B|Other|0|||
25058358|NCT02672852|50162865|FG003|Part B|Other|0|||
25058359|NCT02672852|50162866|FG004|Part B|Other|4|||
25058360|NCT02672852|50162867|FG005|Part B|Other|1|||
25058361|NCT02672852|50162868|FG006|Part B|Other|2|||
25058362|NCT02671760|50162879|FG000|Overall Study|Lost to Follow-up|0|||
25058363|NCT02671760|50162880|FG001|Overall Study|Lost to Follow-up|1|||
25058364|NCT02671760|50162881|FG002|Overall Study|Lost to Follow-up|0|||
25058365|NCT02667236|50162891|FG000|Overall Study|Adverse Event|1|||
25058366|NCT02667236|50162892|FG001|Overall Study|Adverse Event|1|||
25058367|NCT02667236|50162891|FG000|Overall Study|Withdrawal by Subject|2|||
25058368|NCT02667236|50162892|FG001|Overall Study|Withdrawal by Subject|0|||
25058369|NCT01126749|50162902|FG000|Phase 1b|Other|0|||
25058370|NCT01126749|50162903|FG001|Phase 1b|Other|1|||
25058371|NCT01126749|50162904|FG002|Phase 1b|Other|0|||
25058372|NCT01126749|50162905|FG003|Phase 1b|Other|0|||
25058373|NCT01126749|50162902|FG000|Phase 1b|Withdrawal by Subject|0|||
25058374|NCT01126749|50162903|FG001|Phase 1b|Withdrawal by Subject|1|||
25058375|NCT01126749|50162904|FG002|Phase 1b|Withdrawal by Subject|0|||
25058376|NCT01126749|50162905|FG003|Phase 1b|Withdrawal by Subject|0|||
25058377|NCT01126749|50162902|FG000|Phase 1b|Death|3|||
25058378|NCT01126749|50162903|FG001|Phase 1b|Death|4|||
25058379|NCT01126749|50162904|FG002|Phase 1b|Death|0|||
25058380|NCT01126749|50162905|FG003|Phase 1b|Death|0|||
25058381|NCT01126749|50162902|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
25058382|NCT01126749|50162903|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
25058383|NCT01126749|50162904|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
25058384|NCT01126749|50162905|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
25058385|NCT01126749|50162902|FG000|Phase 2|Study Termination by Sponsor|0|||
25058386|NCT01126749|50162903|FG001|Phase 2|Study Termination by Sponsor|0|||
25058387|NCT01126749|50162904|FG002|Phase 2|Study Termination by Sponsor|12|||
25058388|NCT01126749|50162905|FG003|Phase 2|Study Termination by Sponsor|6|||
25058389|NCT01126749|50162902|FG000|Phase 2|Other|0|||
25058390|NCT01126749|50162903|FG001|Phase 2|Other|0|||
25058391|NCT01126749|50162904|FG002|Phase 2|Other|4|||
25058392|NCT01126749|50162905|FG003|Phase 2|Other|2|||
25058393|NCT01126749|50162902|FG000|Phase 2|Withdrawal by Subject|0|||
25058394|NCT01126749|50162903|FG001|Phase 2|Withdrawal by Subject|0|||
25058395|NCT01126749|50162904|FG002|Phase 2|Withdrawal by Subject|0|||
25058396|NCT01126749|50162905|FG003|Phase 2|Withdrawal by Subject|2|||
25058397|NCT01126749|50162902|FG000|Phase 2|Lost to Follow-up|0|||
25058398|NCT01126749|50162903|FG001|Phase 2|Lost to Follow-up|0|||
25058399|NCT01126749|50162904|FG002|Phase 2|Lost to Follow-up|0|||
25058400|NCT01126749|50162905|FG003|Phase 2|Lost to Follow-up|1|||
25058401|NCT01126749|50162902|FG000|Phase 2|Death|0|||
25058402|NCT01126749|50162903|FG001|Phase 2|Death|0|||
25058403|NCT01126749|50162904|FG002|Phase 2|Death|22|||
25058404|NCT01126749|50162905|FG003|Phase 2|Death|22|||
25058405|NCT01126749|50162902|FG000|Phase 2|Adverse Event|0|||
25058406|NCT01126749|50162903|FG001|Phase 2|Adverse Event|0|||
25058407|NCT01126749|50162904|FG002|Phase 2|Adverse Event|0|||
25058408|NCT01126749|50162905|FG003|Phase 2|Adverse Event|1|||
25058409|NCT02521948|50162915|FG000|Overall Study|Adverse Event|2|||
25058410|NCT02521948|50162915|FG000|Overall Study|Death|4|||
25058411|NCT02521948|50162915|FG000|Overall Study|Lost to Follow-up|1|||
25058412|NCT02521948|50162915|FG000|Overall Study|Did not attend one or both follow-ups|6|||
25058413|NCT04446429|50162924|FG000|Overall Study|Lost to Follow-up|6|||
25058414|NCT04446429|50162925|FG001|Overall Study|Lost to Follow-up|0|||
25058415|NCT02832687|50162933|FG000|Overall Study|Adverse Event|0|||
25058416|NCT02832687|50162934|FG001|Overall Study|Adverse Event|2|||
25058417|NCT01656850|50162959|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
25058418|NCT01656850|50162960|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
25058419|NCT03116685|50162972|FG000|Overall Study|Physician Decision|0|||
25058420|NCT03116685|50162973|FG001|Overall Study|Physician Decision|1|||
25058421|NCT02666222|50162993|FG000|Overall Study|Death|2|||
25058422|NCT00739401|50162997|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
25058423|NCT00739401|50162997|FG000|Overall Study|Death|3|||
25058424|NCT00739401|50162997|FG000|Overall Study|Withdrawal by Subject|4|||
25058425|NCT01365052|50163003|FG000|Overall Study|Adverse Event|4|||
25058426|NCT01365052|50163004|FG001|Overall Study|Adverse Event|4|||
25058427|NCT01372748|50163012|FG000|Overall Study|Lost to Follow-up|16|||
25058428|NCT01372748|50163013|FG001|Overall Study|Lost to Follow-up|34|||
25058429|NCT01372748|50163012|FG000|Overall Study|Withdrawal by Subject|7|||
25058430|NCT01372748|50163013|FG001|Overall Study|Withdrawal by Subject|5|||
25058431|NCT02268851|50163025|FG000|Overall Study|Death|0|||
25058432|NCT02268851|50163026|FG001|Overall Study|Death|0|||
25058433|NCT02268851|50163027|FG002|Overall Study|Death|0|||
25058434|NCT02268851|50163028|FG003|Overall Study|Death|1|||
25058435|NCT02268851|50163029|FG004|Overall Study|Death|2|||
25058436|NCT02268851|50163030|FG005|Overall Study|Death|1|||
25058437|NCT02268851|50163025|FG000|Overall Study|Adverse Event|0|||
25058438|NCT02268851|50163026|FG001|Overall Study|Adverse Event|0|||
25058439|NCT02268851|50163027|FG002|Overall Study|Adverse Event|0|||
25058440|NCT02268851|50163028|FG003|Overall Study|Adverse Event|0|||
25058441|NCT02268851|50163029|FG004|Overall Study|Adverse Event|2|||
25058442|NCT02268851|50163030|FG005|Overall Study|Adverse Event|2|||
25058443|NCT02268851|50163025|FG000|Overall Study|Withdrawal by Subject|0|||
25058444|NCT02268851|50163026|FG001|Overall Study|Withdrawal by Subject|0|||
25058445|NCT02268851|50163027|FG002|Overall Study|Withdrawal by Subject|0|||
25058446|NCT02268851|50163028|FG003|Overall Study|Withdrawal by Subject|2|||
25058447|NCT02268851|50163029|FG004|Overall Study|Withdrawal by Subject|0|||
25058448|NCT02268851|50163030|FG005|Overall Study|Withdrawal by Subject|1|||
25058449|NCT02268851|50163025|FG000|Overall Study|Progressive Disease|1|||
25058450|NCT02268851|50163026|FG001|Overall Study|Progressive Disease|3|||
25058451|NCT02268851|50163027|FG002|Overall Study|Progressive Disease|0|||
25058452|NCT02268851|50163028|FG003|Overall Study|Progressive Disease|0|||
25058453|NCT02268851|50163029|FG004|Overall Study|Progressive Disease|1|||
25058454|NCT02268851|50163030|FG005|Overall Study|Progressive Disease|4|||
25058455|NCT02268851|50163025|FG000|Overall Study|Physician Decision|0|||
25058456|NCT02268851|50163026|FG001|Overall Study|Physician Decision|0|||
25058457|NCT02268851|50163027|FG002|Overall Study|Physician Decision|1|||
25058458|NCT02268851|50163028|FG003|Overall Study|Physician Decision|0|||
25058459|NCT02268851|50163029|FG004|Overall Study|Physician Decision|0|||
25058460|NCT02268851|50163030|FG005|Overall Study|Physician Decision|1|||
25058461|NCT02268851|50163025|FG000|Overall Study|Patient Compliance|0|||
25058462|NCT02268851|50163026|FG001|Overall Study|Patient Compliance|0|||
25058463|NCT02268851|50163027|FG002|Overall Study|Patient Compliance|0|||
25058464|NCT02268851|50163028|FG003|Overall Study|Patient Compliance|0|||
25058465|NCT02268851|50163029|FG004|Overall Study|Patient Compliance|1|||
25058466|NCT02268851|50163030|FG005|Overall Study|Patient Compliance|1|||
25058467|NCT02268851|50163025|FG000|Overall Study|Co-Morbid Condition|0|||
25058468|NCT02268851|50163026|FG001|Overall Study|Co-Morbid Condition|0|||
25058469|NCT02268851|50163027|FG002|Overall Study|Co-Morbid Condition|0|||
25058470|NCT02268851|50163028|FG003|Overall Study|Co-Morbid Condition|0|||
25058471|NCT02268851|50163029|FG004|Overall Study|Co-Morbid Condition|1|||
25058472|NCT02268851|50163030|FG005|Overall Study|Co-Morbid Condition|1|||
25058473|NCT02736825|50163046|FG000|Overall Study|Lost to Follow-up|10|||
25058474|NCT02736825|50163047|FG001|Overall Study|Lost to Follow-up|11|||
25058475|NCT02736825|50163046|FG000|Overall Study|Early Termination|0|||
25058476|NCT02736825|50163047|FG001|Overall Study|Early Termination|1|||
25058477|NCT02670122|50163054|FG000|Overall Study|Lost to Follow-up|4|||
25058478|NCT03283371|50163067|FG000|Placebo-controlled|Adverse Event|1|||
25058479|NCT03283371|50163068|FG001|Placebo-controlled|Adverse Event|1|||
25058480|NCT03283371|50163069|FG002|Placebo-controlled|Adverse Event|0|||
25058481|NCT03283371|50163070|FG003|Placebo-controlled|Adverse Event|0|||
25058482|NCT03283371|50163067|FG000|Placebo-controlled|Lack of Efficacy|1|||
25058483|NCT03283371|50163068|FG001|Placebo-controlled|Lack of Efficacy|0|||
25058484|NCT03283371|50163069|FG002|Placebo-controlled|Lack of Efficacy|0|||
25058485|NCT03283371|50163070|FG003|Placebo-controlled|Lack of Efficacy|0|||
25058486|NCT03283371|50163067|FG000|Placebo-controlled|Withdrawal by Subject|1|||
25058487|NCT03283371|50163068|FG001|Placebo-controlled|Withdrawal by Subject|1|||
25058488|NCT03283371|50163069|FG002|Placebo-controlled|Withdrawal by Subject|0|||
25058489|NCT03283371|50163070|FG003|Placebo-controlled|Withdrawal by Subject|0|||
25058490|NCT03283371|50163067|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
25058491|NCT03283371|50163068|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
25058492|NCT03283371|50163069|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
25058493|NCT03283371|50163070|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
25058494|NCT03283371|50163067|FG000|Open-label Phase|Adverse Event|0|||
25058495|NCT03283371|50163068|FG001|Open-label Phase|Adverse Event|0|||
25058496|NCT03283371|50163069|FG002|Open-label Phase|Adverse Event|2|||
25058497|NCT03283371|50163070|FG003|Open-label Phase|Adverse Event|0|||
25186599|NCT02647320|50337194|FG001|Overall Study|Study terminated by sponsor|1|||
25186600|NCT02647320|50337195|FG002|Overall Study|Study terminated by sponsor|1|||
25186601|NCT02647320|50337196|FG003|Overall Study|Study terminated by sponsor|1|||
25186602|NCT02647320|50337197|FG004|Overall Study|Study terminated by sponsor|2|||
25186603|NCT02647320|50337193|FG000|Overall Study|Reason not provided|0|||
25186604|NCT02647320|50337194|FG001|Overall Study|Reason not provided|0|||
25186605|NCT02647320|50337195|FG002|Overall Study|Reason not provided|1|||
25186606|NCT02647320|50337196|FG003|Overall Study|Reason not provided|0|||
25186607|NCT02647320|50337197|FG004|Overall Study|Reason not provided|2|||
25186608|NCT02647320|50337193|FG000|Overall Study|Lost to Follow-up|1|||
25186609|NCT02647320|50337194|FG001|Overall Study|Lost to Follow-up|1|||
25186610|NCT02647320|50337195|FG002|Overall Study|Lost to Follow-up|0|||
25186611|NCT02647320|50337196|FG003|Overall Study|Lost to Follow-up|0|||
25186612|NCT02647320|50337197|FG004|Overall Study|Lost to Follow-up|0|||
25186613|NCT02647320|50337193|FG000|Overall Study|Develop anemia|1|||
25186614|NCT02647320|50337194|FG001|Overall Study|Develop anemia|0|||
25186615|NCT02647320|50337195|FG002|Overall Study|Develop anemia|0|||
25186616|NCT02647320|50337196|FG003|Overall Study|Develop anemia|0|||
25186617|NCT02647320|50337197|FG004|Overall Study|Develop anemia|0|||
25186618|NCT02647320|50337193|FG000|Overall Study|Lack of Efficacy|0|||
24963568|NCT00267098|50053583|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
25058498|NCT03283371|50163067|FG000|Open-label Phase|Withdrawal by Subject|0|||
25058499|NCT03283371|50163068|FG001|Open-label Phase|Withdrawal by Subject|0|||
25058500|NCT03283371|50163069|FG002|Open-label Phase|Withdrawal by Subject|1|||
25058501|NCT03283371|50163070|FG003|Open-label Phase|Withdrawal by Subject|0|||
25186619|NCT02647320|50337194|FG001|Overall Study|Lack of Efficacy|0|||
25186620|NCT02647320|50337195|FG002|Overall Study|Lack of Efficacy|0|||
25058502|NCT03283371|50163067|FG000|Open-label Phase|Other|0|||
25058503|NCT03283371|50163068|FG001|Open-label Phase|Other|0|||
25058504|NCT03283371|50163069|FG002|Open-label Phase|Other|1|||
25058505|NCT03283371|50163070|FG003|Open-label Phase|Other|1|||
25058506|NCT03069417|50163082|FG000|Overall Study|Lost to Follow-up|2|||
25058507|NCT03069417|50163083|FG001|Overall Study|Lost to Follow-up|0|||
25058508|NCT03069417|50163082|FG000|Overall Study|Reason Unknown|4|||
25058509|NCT03069417|50163083|FG001|Overall Study|Reason Unknown|7|||
25058510|NCT04930263|50163092|FG000|Overall Study|Withdrawal by Subject|3|||
25058511|NCT04930263|50163093|FG001|Overall Study|Withdrawal by Subject|5|||
25058512|NCT02665286|50163102|FG000|Overall Study|Lost to Follow-up|3|||
25058513|NCT02665286|50163103|FG001|Overall Study|Lost to Follow-up|2|||
25058514|NCT02665286|50163104|FG002|Overall Study|Lost to Follow-up|1|||
25058515|NCT02134925|50163114|FG000|Overall Study|Withdrawal by Subject|1|||
25058516|NCT02134925|50163115|FG001|Overall Study|Withdrawal by Subject|0|||
25058517|NCT02134925|50163114|FG000|Overall Study|Cancel|1|||
25058518|NCT02134925|50163115|FG001|Overall Study|Cancel|6|||
25058519|NCT02911519|50163123|FG000|Overall Study|Lost to Follow-up|2|||
25058520|NCT02911519|50163124|FG001|Overall Study|Lost to Follow-up|2|||
25058521|NCT02911519|50163123|FG000|Overall Study|Death|0|||
25058522|NCT02911519|50163124|FG001|Overall Study|Death|2|||
25058523|NCT02911285|50163132|FG000|Overall Study|Lost to Follow-up|8|||
25058524|NCT02911285|50163133|FG001|Overall Study|Lost to Follow-up|5|||
25058525|NCT02911285|50163132|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
25058526|NCT02911285|50163133|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
25058527|NCT02910739|50163145|FG000|Overall Study|Adverse Event|1|||
25058528|NCT02910739|50163146|FG001|Overall Study|Adverse Event|0|||
25058529|NCT02910739|50163147|FG002|Overall Study|Adverse Event|0|||
25058530|NCT02910739|50163148|FG003|Overall Study|Adverse Event|0|||
25058531|NCT01069939|50163156|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
25058532|NCT01069939|50163157|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
25058533|NCT01069939|50163156|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
25058534|NCT01069939|50163157|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
25058535|NCT01069939|50163156|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
25058536|NCT01069939|50163157|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
25058537|NCT01069939|50163156|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
25058538|NCT01069939|50163157|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
25058539|NCT01069939|50163156|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
25058540|NCT01069939|50163157|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
25058541|NCT01069939|50163156|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
25058542|NCT01069939|50163157|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
25058543|NCT01069939|50163156|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
25058544|NCT01069939|50163157|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
25058545|NCT01069939|50163156|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
25058546|NCT01069939|50163157|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
25058547|NCT01069939|50163156|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
25058548|NCT01069939|50163157|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
25058549|NCT01069939|50163156|FG000|Randomised and Included in the Analyses|Removal|1|||
25058550|NCT01069939|50163157|FG001|Randomised and Included in the Analyses|Removal|0|||
25058551|NCT01069705|50163163|FG000|Overall Study|Adverse Event|1|||
25058552|NCT01069705|50163163|FG000|Overall Study|Withdrawal by Subject|2|||
25058553|NCT01069627|50163167|FG000|Overall Study|Disease progression|7|||
25058554|NCT01069627|50163167|FG000|Overall Study|Adverse Event|12|||
25058555|NCT01069627|50163167|FG000|Overall Study|Protocol Violation|1|||
25058556|NCT02422797|50163173|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
25058557|NCT02422797|50163174|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
25058558|NCT02422797|50163173|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
25058559|NCT02422797|50163174|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
25058560|NCT02422797|50163173|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
25058561|NCT02422797|50163174|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
25058562|NCT02422797|50163173|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
25058563|NCT02422797|50163174|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
25058564|NCT02422797|50163173|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
25058565|NCT02422797|50163174|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
25058566|NCT02422797|50163173|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
25058567|NCT02422797|50163174|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
25058568|NCT02422797|50163173|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
25058569|NCT02422797|50163174|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
25058570|NCT02422797|50163173|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
25058571|NCT02422797|50163174|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
25058572|NCT02422797|50163173|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
25058573|NCT02422797|50163174|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
25058574|NCT02422797|50163173|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
24963569|NCT00267098|50053584|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
25058575|NCT02422797|50163174|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
25058576|NCT02422797|50163173|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
25058577|NCT02422797|50163174|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
25058578|NCT02422797|50163173|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
25058579|NCT02422797|50163174|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
25058580|NCT02422797|50163173|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
25058581|NCT02422797|50163174|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
25058582|NCT02422797|50163173|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
25058583|NCT02422797|50163174|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
25058584|NCT03021551|50163190|FG000|Overall Study|Equipment Issues|2|||
25058585|NCT03021551|50163190|FG000|Overall Study|Protocol Violation|1|||
25067420|NCT02397460|50173044|FG007|Treatment Period 4|Physician Decision|0|||
25067421|NCT02834819|50173120|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
25067422|NCT02834819|50173121|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
25067423|NCT02454478|50173127|FG000|Overall Study|Incomplete DLT Evaluation|1|||
25067424|NCT01341587|50173133|FG000|Overall Study|Lost to Follow-up|2|||
25067425|NCT01341587|50173134|FG001|Overall Study|Lost to Follow-up|0|||
25067426|NCT01341587|50173133|FG000|Overall Study|stopped using the meters|2|||
25067427|NCT01341587|50173134|FG001|Overall Study|stopped using the meters|10|||
25067428|NCT01358825|50173142|FG000|Overall Study|Blood sample not drawn|0|||
25067429|NCT01358825|50173143|FG001|Overall Study|Blood sample not drawn|1|||
25067430|NCT02453386|50173152|FG000|Overall Study|Adverse Event|22|||
25067431|NCT02453386|50173153|FG001|Overall Study|Adverse Event|30|||
25067432|NCT02453386|50173154|FG002|Overall Study|Adverse Event|15|||
25067433|NCT02453386|50173152|FG000|Overall Study|Protocol Violation|1|||
25067434|NCT02453386|50173153|FG001|Overall Study|Protocol Violation|0|||
25067435|NCT02453386|50173154|FG002|Overall Study|Protocol Violation|1|||
25067436|NCT02453386|50173152|FG000|Overall Study|Withdrawal by Subject|10|||
25067437|NCT02453386|50173153|FG001|Overall Study|Withdrawal by Subject|9|||
25067438|NCT02453386|50173154|FG002|Overall Study|Withdrawal by Subject|9|||
25067439|NCT02453386|50173152|FG000|Overall Study|Sponsor Terminated Study|14|||
25067440|NCT02453386|50173153|FG001|Overall Study|Sponsor Terminated Study|8|||
25067441|NCT02453386|50173154|FG002|Overall Study|Sponsor Terminated Study|11|||
25067442|NCT02453386|50173152|FG000|Overall Study|Subject Terminated by Sponsor|1|||
25067443|NCT02453386|50173153|FG001|Overall Study|Subject Terminated by Sponsor|1|||
25067444|NCT02453386|50173154|FG002|Overall Study|Subject Terminated by Sponsor|1|||
25067445|NCT02453386|50173152|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
25067446|NCT02453386|50173153|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
25067447|NCT02453386|50173154|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
25067448|NCT02453386|50173152|FG000|Overall Study|Lost to Follow-up|0|||
25067449|NCT02453386|50173153|FG001|Overall Study|Lost to Follow-up|0|||
25067450|NCT02453386|50173154|FG002|Overall Study|Lost to Follow-up|1|||
25067451|NCT02453386|50173152|FG000|Overall Study|Other|1|||
25067452|NCT02453386|50173153|FG001|Overall Study|Other|0|||
25067453|NCT02453386|50173154|FG002|Overall Study|Other|1|||
25067454|NCT02431468|50173172|FG000|Overall Study|Adverse Event|2|||
25067455|NCT02431468|50173173|FG001|Overall Study|Adverse Event|4|||
25067456|NCT02431468|50173174|FG002|Overall Study|Adverse Event|5|||
25067457|NCT02431468|50173172|FG000|Overall Study|Withdrawal by Subject|4|||
25067458|NCT02431468|50173173|FG001|Overall Study|Withdrawal by Subject|12|||
25067459|NCT02431468|50173174|FG002|Overall Study|Withdrawal by Subject|2|||
25067460|NCT02431468|50173172|FG000|Overall Study|noncompliance, investigator termination,|2|||
25067461|NCT02431468|50173173|FG001|Overall Study|noncompliance, investigator termination,|2|||
25067462|NCT02431468|50173174|FG002|Overall Study|noncompliance, investigator termination,|2|||
25067463|NCT02452762|50173190|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
25067464|NCT02452762|50173191|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
25067465|NCT02452762|50173190|FG000|Overall Study|Withdrawal by Subject|1|||
25067466|NCT02452762|50173191|FG001|Overall Study|Withdrawal by Subject|0|||
25067467|NCT02631746|50173198|FG000|Overall Study|Lack of Efficacy|3|||
25067468|NCT02633306|50173202|FG000|Overall Study|Withdrawal by Subject|3|||
25067469|NCT02396758|50173211|FG000|Overall Study|Withdrawal by Subject|2|||
25067470|NCT02396758|50173212|FG001|Overall Study|Withdrawal by Subject|0|||
25067471|NCT02396758|50173213|FG002|Overall Study|Withdrawal by Subject|0|||
25067472|NCT02396758|50173214|FG003|Overall Study|Withdrawal by Subject|1|||
25067473|NCT02396758|50173211|FG000|Overall Study|Lost to Follow-up|8|||
25067474|NCT02396758|50173212|FG001|Overall Study|Lost to Follow-up|5|||
25067475|NCT02396758|50173213|FG002|Overall Study|Lost to Follow-up|3|||
25067476|NCT02396758|50173214|FG003|Overall Study|Lost to Follow-up|3|||
25067477|NCT02396758|50173211|FG000|Overall Study|Death|1|||
25067478|NCT02396758|50173212|FG001|Overall Study|Death|1|||
25067479|NCT02396758|50173213|FG002|Overall Study|Death|0|||
25067480|NCT02396758|50173214|FG003|Overall Study|Death|1|||
25067481|NCT02396758|50173211|FG000|Overall Study|Randomized but not treated|1|||
25067482|NCT02396758|50173212|FG001|Overall Study|Randomized but not treated|0|||
25058586|NCT01585025|50163197|FG000|Overall Study|Withdrawal by Subject|0|||
25058587|NCT01585025|50163198|FG001|Overall Study|Withdrawal by Subject|3|||
25058588|NCT01585025|50163199|FG002|Overall Study|Withdrawal by Subject|4|||
25058589|NCT01068769|50163207|FG000|Overall Study|Ineligible|1|||
25058590|NCT05114564|50163226|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
25058591|NCT05114564|50163227|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
25058592|NCT05114564|50163226|FG000|First Intervention|Adverse Event|0|||
25058593|NCT05114564|50163227|FG001|First Intervention|Adverse Event|1|||
25058594|NCT04706416|50163235|FG000|Overall Study|Lost to Follow-up|2|||
25058595|NCT04706416|50163236|FG001|Overall Study|Lost to Follow-up|0|||
25058596|NCT04683926|50163249|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
25058597|NCT04683926|50163250|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
25058598|NCT04683926|50163251|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
25058599|NCT04683926|50163252|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
25058600|NCT04285346|50163264|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
25058601|NCT04285346|50163265|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
25058602|NCT04285346|50163264|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
25058603|NCT04285346|50163265|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
25058604|NCT04285346|50163264|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
25058605|NCT04285346|50163265|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
25058606|NCT04148287|50163280|FG000|Overall Study|Death|2|||
25058607|NCT03772613|50163312|FG000|Overall Study|Lost to Follow-up|0|||
25058608|NCT03772613|50163313|FG001|Overall Study|Lost to Follow-up|1|||
25058609|NCT03772613|50163314|FG002|Overall Study|Lost to Follow-up|1|||
25058610|NCT03739437|50163324|FG000|Overall Study|Lost to Follow-up|2|||
25058611|NCT03739437|50163325|FG001|Overall Study|Lost to Follow-up|5|||
25058612|NCT03730194|50163333|FG000|First Stage Treatment|Withdrawal by Subject|1|||
25058613|NCT03730194|50163334|FG001|First Stage Treatment|Withdrawal by Subject|1|||
25058614|NCT03730194|50163335|FG002|First Stage Treatment|Withdrawal by Subject|0|||
25058615|NCT03730194|50163336|FG003|First Stage Treatment|Withdrawal by Subject|0|||
25058616|NCT03730194|50163337|FG004|First Stage Treatment|Withdrawal by Subject|0|||
25058617|NCT03730194|50163338|FG005|First Stage Treatment|Withdrawal by Subject|0|||
25058618|NCT03730194|50163333|FG000|First Stage Treatment|Protocol Violation|3|||
25058619|NCT03730194|50163334|FG001|First Stage Treatment|Protocol Violation|3|||
25058620|NCT03730194|50163335|FG002|First Stage Treatment|Protocol Violation|0|||
25058621|NCT03730194|50163336|FG003|First Stage Treatment|Protocol Violation|0|||
25058622|NCT03730194|50163337|FG004|First Stage Treatment|Protocol Violation|0|||
25058623|NCT03730194|50163338|FG005|First Stage Treatment|Protocol Violation|0|||
25058624|NCT03701555|50163381|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
25058625|NCT03701555|50163382|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
25058626|NCT03701555|50163383|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
25058627|NCT03701555|50163384|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
25058628|NCT03701555|50163385|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
25058629|NCT03701555|50163386|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
25058630|NCT03701555|50163387|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
25058631|NCT03701555|50163388|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
25058632|NCT03701555|50163389|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
25058633|NCT03701555|50163390|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
25058634|NCT03701555|50163391|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
25058635|NCT03701555|50163392|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
25058636|NCT03701555|50163393|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
25058637|NCT03701555|50163394|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
25058638|NCT03701555|50163395|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
25058639|NCT03701555|50163396|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
25058640|NCT03701555|50163397|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
25058641|NCT03701555|50163398|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
25058642|NCT03701555|50163399|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
25058643|NCT03701555|50163400|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
25058644|NCT03701555|50163401|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
25058645|NCT03701555|50163402|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
25058646|NCT03701555|50163403|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
25058647|NCT03701555|50163404|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
25058648|NCT03701555|50163405|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
25058649|NCT03701555|50163406|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
25058650|NCT03701555|50163407|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
25058651|NCT03701555|50163408|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
25058652|NCT03701555|50163409|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
25058653|NCT03701555|50163410|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
25058654|NCT03701555|50163411|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
25058655|NCT03701555|50163412|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
25058656|NCT03701555|50163413|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
25058657|NCT03701555|50163414|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
25058658|NCT03701555|50163415|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
25058659|NCT03701555|50163416|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
25058660|NCT03701555|50163381|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
25058661|NCT03701555|50163382|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
25058662|NCT03701555|50163383|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
25058663|NCT03701555|50163384|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
25058664|NCT03701555|50163385|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
25058665|NCT03701555|50163386|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
25058666|NCT03701555|50163387|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
25058667|NCT03701555|50163388|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
25058668|NCT03701555|50163389|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
25058669|NCT03701555|50163390|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
25058670|NCT03701555|50163391|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
25058671|NCT03701555|50163392|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
25058672|NCT03701555|50163393|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
25058673|NCT03701555|50163394|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
25058674|NCT03701555|50163395|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
25058675|NCT03701555|50163396|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
25058676|NCT03701555|50163397|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
25058677|NCT03701555|50163398|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
25058678|NCT03701555|50163399|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
25058679|NCT03701555|50163400|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
25058680|NCT03701555|50163401|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
25058681|NCT03701555|50163402|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
25058682|NCT03701555|50163403|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
25058683|NCT03701555|50163404|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
25058684|NCT03701555|50163405|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
25058685|NCT03701555|50163406|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
25058686|NCT03701555|50163407|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
25058687|NCT03701555|50163408|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
25058688|NCT03701555|50163409|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
25058689|NCT03701555|50163410|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
25058690|NCT03701555|50163411|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
25058691|NCT03701555|50163412|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
25058692|NCT03701555|50163413|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
25058693|NCT03701555|50163414|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
25058694|NCT03701555|50163415|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
25058695|NCT03701555|50163416|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
25058696|NCT03701555|50163381|FG000|Part 2 (Day 1)|Other|0|||
25058697|NCT03701555|50163382|FG001|Part 2 (Day 1)|Other|0|||
25058698|NCT03701555|50163383|FG002|Part 2 (Day 1)|Other|0|||
25058699|NCT03701555|50163384|FG003|Part 2 (Day 1)|Other|0|||
25058700|NCT03701555|50163385|FG004|Part 2 (Day 1)|Other|0|||
25058701|NCT03701555|50163386|FG005|Part 2 (Day 1)|Other|0|||
25058702|NCT03701555|50163387|FG006|Part 2 (Day 1)|Other|0|||
25058703|NCT03701555|50163388|FG007|Part 2 (Day 1)|Other|0|||
25058704|NCT03701555|50163389|FG008|Part 2 (Day 1)|Other|0|||
25162762|NCT01277302|50285144|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
25162763|NCT01277302|50285142|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
25058705|NCT03701555|50163390|FG009|Part 2 (Day 1)|Other|0|||
25058706|NCT03701555|50163391|FG010|Part 2 (Day 1)|Other|3|||
25058707|NCT03701555|50163392|FG011|Part 2 (Day 1)|Other|1|||
25058708|NCT03701555|50163393|FG012|Part 2 (Day 1)|Other|0|||
25162764|NCT01277302|50285143|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
25162765|NCT01277302|50285144|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
25058709|NCT03701555|50163394|FG013|Part 2 (Day 1)|Other|1|||
25058710|NCT03701555|50163395|FG014|Part 2 (Day 1)|Other|0|||
25058711|NCT03701555|50163396|FG015|Part 2 (Day 1)|Other|2|||
25058712|NCT03701555|50163397|FG016|Part 2 (Day 1)|Other|2|||
25058713|NCT03701555|50163398|FG017|Part 2 (Day 1)|Other|0|||
25058714|NCT03701555|50163399|FG018|Part 2 (Day 1)|Other|0|||
25058715|NCT03701555|50163400|FG019|Part 2 (Day 1)|Other|0|||
25058716|NCT03701555|50163401|FG020|Part 2 (Day 1)|Other|0|||
25058717|NCT03701555|50163402|FG021|Part 2 (Day 1)|Other|0|||
25058718|NCT03701555|50163403|FG022|Part 2 (Day 1)|Other|0|||
25058719|NCT03701555|50163404|FG023|Part 2 (Day 1)|Other|0|||
25058720|NCT03701555|50163405|FG024|Part 2 (Day 1)|Other|0|||
25058721|NCT03701555|50163406|FG025|Part 2 (Day 1)|Other|0|||
25058722|NCT03701555|50163407|FG026|Part 2 (Day 1)|Other|0|||
25058723|NCT03701555|50163408|FG027|Part 2 (Day 1)|Other|0|||
25058724|NCT03701555|50163409|FG028|Part 2 (Day 1)|Other|0|||
25058725|NCT03701555|50163410|FG029|Part 2 (Day 1)|Other|0|||
25058726|NCT03701555|50163411|FG030|Part 2 (Day 1)|Other|0|||
25058727|NCT03701555|50163412|FG031|Part 2 (Day 1)|Other|0|||
25058728|NCT03701555|50163413|FG032|Part 2 (Day 1)|Other|0|||
25058729|NCT03701555|50163414|FG033|Part 2 (Day 1)|Other|0|||
25058730|NCT03701555|50163415|FG034|Part 2 (Day 1)|Other|0|||
25058731|NCT03701555|50163416|FG035|Part 2 (Day 1)|Other|0|||
25058732|NCT03701555|50163381|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
25058733|NCT03701555|50163382|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
25058734|NCT03701555|50163383|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
25058735|NCT03701555|50163384|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
25058736|NCT03701555|50163385|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
25058737|NCT03701555|50163386|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
25058738|NCT03701555|50163387|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
25058739|NCT03701555|50163388|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
25058740|NCT03701555|50163389|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
25058741|NCT03701555|50163390|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
25058742|NCT03701555|50163391|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
25058743|NCT03701555|50163392|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
25058744|NCT03701555|50163393|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
25058745|NCT03701555|50163394|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
25058746|NCT03701555|50163395|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
25058747|NCT03701555|50163396|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
25058748|NCT03701555|50163397|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
25058749|NCT03701555|50163398|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
25058750|NCT03701555|50163399|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
25058751|NCT03701555|50163400|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
25058752|NCT03701555|50163401|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
25058753|NCT03701555|50163402|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
25058754|NCT03701555|50163403|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
25058755|NCT03701555|50163404|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
25058756|NCT03701555|50163405|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
25058757|NCT03701555|50163406|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
25058758|NCT03701555|50163407|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
25058759|NCT03701555|50163408|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
25058760|NCT03701555|50163409|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
25058761|NCT03701555|50163410|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
25058762|NCT03701555|50163411|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
25058763|NCT03701555|50163412|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
25058764|NCT03701555|50163413|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
25058765|NCT03701555|50163414|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
25058766|NCT03701555|50163415|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
25058767|NCT03701555|50163416|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
25058768|NCT03701555|50163381|FG000|Part 3 (Day 1)|Subject Decision|0|||
25058769|NCT03701555|50163382|FG001|Part 3 (Day 1)|Subject Decision|0|||
25058770|NCT03701555|50163383|FG002|Part 3 (Day 1)|Subject Decision|0|||
25058771|NCT03701555|50163384|FG003|Part 3 (Day 1)|Subject Decision|0|||
25058772|NCT03701555|50163385|FG004|Part 3 (Day 1)|Subject Decision|0|||
25058773|NCT03701555|50163386|FG005|Part 3 (Day 1)|Subject Decision|0|||
25058774|NCT03701555|50163387|FG006|Part 3 (Day 1)|Subject Decision|0|||
25058775|NCT03701555|50163388|FG007|Part 3 (Day 1)|Subject Decision|0|||
25058776|NCT03701555|50163389|FG008|Part 3 (Day 1)|Subject Decision|0|||
25058777|NCT03701555|50163390|FG009|Part 3 (Day 1)|Subject Decision|0|||
25058778|NCT03701555|50163391|FG010|Part 3 (Day 1)|Subject Decision|0|||
25058779|NCT03701555|50163392|FG011|Part 3 (Day 1)|Subject Decision|0|||
25058780|NCT03701555|50163393|FG012|Part 3 (Day 1)|Subject Decision|0|||
25058781|NCT03701555|50163394|FG013|Part 3 (Day 1)|Subject Decision|0|||
25058782|NCT03701555|50163395|FG014|Part 3 (Day 1)|Subject Decision|0|||
25058783|NCT03701555|50163396|FG015|Part 3 (Day 1)|Subject Decision|0|||
25058784|NCT03701555|50163397|FG016|Part 3 (Day 1)|Subject Decision|0|||
25058785|NCT03701555|50163398|FG017|Part 3 (Day 1)|Subject Decision|0|||
25058786|NCT03701555|50163399|FG018|Part 3 (Day 1)|Subject Decision|0|||
25058787|NCT03701555|50163400|FG019|Part 3 (Day 1)|Subject Decision|0|||
25058788|NCT03701555|50163401|FG020|Part 3 (Day 1)|Subject Decision|0|||
25058789|NCT03701555|50163402|FG021|Part 3 (Day 1)|Subject Decision|0|||
25058790|NCT03701555|50163403|FG022|Part 3 (Day 1)|Subject Decision|0|||
25058791|NCT03701555|50163404|FG023|Part 3 (Day 1)|Subject Decision|0|||
25058792|NCT03701555|50163405|FG024|Part 3 (Day 1)|Subject Decision|0|||
25058793|NCT03701555|50163406|FG025|Part 3 (Day 1)|Subject Decision|0|||
25058794|NCT03701555|50163407|FG026|Part 3 (Day 1)|Subject Decision|1|||
25058795|NCT03701555|50163408|FG027|Part 3 (Day 1)|Subject Decision|0|||
25058796|NCT03701555|50163409|FG028|Part 3 (Day 1)|Subject Decision|0|||
25058797|NCT03701555|50163410|FG029|Part 3 (Day 1)|Subject Decision|0|||
25058798|NCT03701555|50163411|FG030|Part 3 (Day 1)|Subject Decision|0|||
25058799|NCT03701555|50163412|FG031|Part 3 (Day 1)|Subject Decision|2|||
25058800|NCT03701555|50163413|FG032|Part 3 (Day 1)|Subject Decision|1|||
25058801|NCT03701555|50163414|FG033|Part 3 (Day 1)|Subject Decision|1|||
25058802|NCT03701555|50163415|FG034|Part 3 (Day 1)|Subject Decision|0|||
25058803|NCT03701555|50163416|FG035|Part 3 (Day 1)|Subject Decision|0|||
25058804|NCT03701555|50163381|FG000|Part 3 (Day 1)|Other|0|||
25058805|NCT03701555|50163382|FG001|Part 3 (Day 1)|Other|0|||
25058806|NCT03701555|50163383|FG002|Part 3 (Day 1)|Other|0|||
25058807|NCT03701555|50163384|FG003|Part 3 (Day 1)|Other|0|||
25058808|NCT03701555|50163385|FG004|Part 3 (Day 1)|Other|0|||
25058809|NCT03701555|50163386|FG005|Part 3 (Day 1)|Other|0|||
25058810|NCT03701555|50163387|FG006|Part 3 (Day 1)|Other|0|||
25058811|NCT03701555|50163388|FG007|Part 3 (Day 1)|Other|0|||
25058812|NCT03701555|50163389|FG008|Part 3 (Day 1)|Other|0|||
25058813|NCT03701555|50163390|FG009|Part 3 (Day 1)|Other|0|||
25058814|NCT03701555|50163391|FG010|Part 3 (Day 1)|Other|0|||
25058815|NCT03701555|50163392|FG011|Part 3 (Day 1)|Other|0|||
25058816|NCT03701555|50163393|FG012|Part 3 (Day 1)|Other|0|||
25058817|NCT03701555|50163394|FG013|Part 3 (Day 1)|Other|0|||
25058818|NCT03701555|50163395|FG014|Part 3 (Day 1)|Other|0|||
25058819|NCT03701555|50163396|FG015|Part 3 (Day 1)|Other|0|||
25058820|NCT03701555|50163397|FG016|Part 3 (Day 1)|Other|0|||
25058821|NCT03701555|50163398|FG017|Part 3 (Day 1)|Other|0|||
25058822|NCT03701555|50163399|FG018|Part 3 (Day 1)|Other|0|||
25058823|NCT03701555|50163400|FG019|Part 3 (Day 1)|Other|0|||
25058824|NCT03701555|50163401|FG020|Part 3 (Day 1)|Other|0|||
25058825|NCT03701555|50163402|FG021|Part 3 (Day 1)|Other|0|||
25058826|NCT03701555|50163403|FG022|Part 3 (Day 1)|Other|0|||
25058827|NCT03701555|50163404|FG023|Part 3 (Day 1)|Other|0|||
25058828|NCT03701555|50163405|FG024|Part 3 (Day 1)|Other|1|||
25058829|NCT03701555|50163406|FG025|Part 3 (Day 1)|Other|1|||
25058830|NCT03701555|50163407|FG026|Part 3 (Day 1)|Other|0|||
25058831|NCT03701555|50163408|FG027|Part 3 (Day 1)|Other|0|||
25058832|NCT03701555|50163409|FG028|Part 3 (Day 1)|Other|0|||
25058833|NCT03701555|50163410|FG029|Part 3 (Day 1)|Other|1|||
25058834|NCT03701555|50163411|FG030|Part 3 (Day 1)|Other|1|||
25058835|NCT03701555|50163412|FG031|Part 3 (Day 1)|Other|0|||
25058836|NCT03701555|50163413|FG032|Part 3 (Day 1)|Other|1|||
25058837|NCT03701555|50163414|FG033|Part 3 (Day 1)|Other|1|||
25058838|NCT03701555|50163415|FG034|Part 3 (Day 1)|Other|0|||
25058839|NCT03701555|50163416|FG035|Part 3 (Day 1)|Other|0|||
25058840|NCT03699007|50163531|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
25058841|NCT03699007|50163532|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
25058842|NCT03699007|50163531|FG000|6-month Follow Up|Lost to Follow-up|2|||
25058843|NCT03699007|50163532|FG001|6-month Follow Up|Lost to Follow-up|3|||
25058844|NCT02484443|50163561|FG000|Overall Study|Lack of Efficacy|28|||
25058845|NCT02484443|50163561|FG000|Overall Study|Physician Decision|2|||
25058846|NCT02484443|50163561|FG000|Overall Study|Ineligible|2|||
25058847|NCT02306161|50163567|FG000|Overall Study|Death|1|||
25058848|NCT02306161|50163568|FG001|Overall Study|Death|3|||
25058849|NCT02306161|50163567|FG000|Overall Study|Lack of Efficacy|20|||
25058850|NCT02306161|50163568|FG001|Overall Study|Lack of Efficacy|43|||
25058851|NCT02306161|50163567|FG000|Overall Study|Physician Decision|30|||
25058852|NCT02306161|50163568|FG001|Overall Study|Physician Decision|18|||
25058853|NCT02306161|50163567|FG000|Overall Study|Withdrawal by Subject|4|||
25058854|NCT02306161|50163568|FG001|Overall Study|Withdrawal by Subject|0|||
25058855|NCT02306161|50163567|FG000|Overall Study|Ineligible|9|||
25058856|NCT02306161|50163568|FG001|Overall Study|Ineligible|5|||
25058857|NCT02254278|50163576|FG000|Overall Study|Protocol Violation|1|||
25058858|NCT02254278|50163577|FG001|Overall Study|Protocol Violation|1|||
25058859|NCT02253316|50163586|FG000|Consolidation|Progression|4|||
25058860|NCT02253316|50163587|FG001|Consolidation|Progression|0|||
25058861|NCT02253316|50163588|FG002|Consolidation|Progression|0|||
25058862|NCT02253316|50163586|FG000|Consolidation|Non-Compliance|1|||
25058863|NCT02253316|50163587|FG001|Consolidation|Non-Compliance|0|||
25058864|NCT02253316|50163588|FG002|Consolidation|Non-Compliance|0|||
25058865|NCT02253316|50163586|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
25058866|NCT02253316|50163587|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
25058867|NCT02253316|50163588|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
25058868|NCT02253316|50163586|FG000|Consolidation|Secondary Malignancy|2|||
25058869|NCT02253316|50163587|FG001|Consolidation|Secondary Malignancy|0|||
25058870|NCT02253316|50163588|FG002|Consolidation|Secondary Malignancy|0|||
25058871|NCT02253316|50163586|FG000|Consolidation|Adverse Event|7|||
25058872|NCT02253316|50163587|FG001|Consolidation|Adverse Event|0|||
25058873|NCT02253316|50163588|FG002|Consolidation|Adverse Event|0|||
25058874|NCT02253316|50163586|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
25186621|NCT02647320|50337196|FG003|Overall Study|Lack of Efficacy|1|||
25058875|NCT02253316|50163587|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
25058876|NCT02253316|50163588|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
25058877|NCT02253316|50163586|FG000|Maintenance|Physician Decision|0|||
25058878|NCT02253316|50163587|FG001|Maintenance|Physician Decision|5|||
25058879|NCT02253316|50163588|FG002|Maintenance|Physician Decision|16|||
25058880|NCT02253316|50163586|FG000|Maintenance|Non-Compliance|0|||
25058881|NCT02253316|50163587|FG001|Maintenance|Non-Compliance|1|||
25058882|NCT02253316|50163588|FG002|Maintenance|Non-Compliance|0|||
25058883|NCT02253316|50163586|FG000|Maintenance|Secondary Malignancy|0|||
25058884|NCT02253316|50163587|FG001|Maintenance|Secondary Malignancy|1|||
25058885|NCT02253316|50163588|FG002|Maintenance|Secondary Malignancy|5|||
25058886|NCT02253316|50163586|FG000|Maintenance|Adverse Event|0|||
25058887|NCT02253316|50163587|FG001|Maintenance|Adverse Event|8|||
25058888|NCT02253316|50163588|FG002|Maintenance|Adverse Event|12|||
25058889|NCT02253316|50163586|FG000|Maintenance|Still receiving active treatment|0|||
25058890|NCT02253316|50163587|FG001|Maintenance|Still receiving active treatment|23|||
25058891|NCT02253316|50163588|FG002|Maintenance|Still receiving active treatment|26|||
25058892|NCT02178098|50163598|FG000|Overall Study|Withdrawal by Subject|0|||
25058893|NCT02178098|50163599|FG001|Overall Study|Withdrawal by Subject|6|||
25058894|NCT02178098|50163598|FG000|Overall Study|Adverse Event|1|||
25058895|NCT02178098|50163599|FG001|Overall Study|Adverse Event|2|||
25058896|NCT02178098|50163598|FG000|Overall Study|Protocol Violation|1|||
25058897|NCT02178098|50163599|FG001|Overall Study|Protocol Violation|1|||
25058898|NCT02178098|50163598|FG000|Overall Study|Lost to Follow-up|0|||
25058899|NCT02178098|50163599|FG001|Overall Study|Lost to Follow-up|1|||
25058900|NCT02178098|50163598|FG000|Overall Study|Sponsor Request|1|||
25058901|NCT02178098|50163599|FG001|Overall Study|Sponsor Request|0|||
25058902|NCT02178098|50163598|FG000|Overall Study|Other|2|||
25058903|NCT02178098|50163599|FG001|Overall Study|Other|2|||
25058904|NCT02101853|50163607|FG000|Block 1 Induction|Adverse Event|11|||
25058905|NCT02101853|50163608|FG001|Block 1 Induction|Adverse Event|0|||
25058906|NCT02101853|50163609|FG002|Block 1 Induction|Adverse Event|0|||
25058907|NCT02101853|50163610|FG003|Block 1 Induction|Adverse Event|0|||
25058908|NCT02101853|50163611|FG004|Block 1 Induction|Adverse Event|0|||
25058909|NCT02101853|50163612|FG005|Block 1 Induction|Adverse Event|0|||
25058910|NCT02101853|50163607|FG000|Block 1 Induction|Death|20|||
25058911|NCT02101853|50163608|FG001|Block 1 Induction|Death|0|||
25058912|NCT02101853|50163609|FG002|Block 1 Induction|Death|0|||
25058913|NCT02101853|50163610|FG003|Block 1 Induction|Death|0|||
25058914|NCT02101853|50163611|FG004|Block 1 Induction|Death|0|||
25058915|NCT02101853|50163612|FG005|Block 1 Induction|Death|0|||
25058916|NCT02101853|50163607|FG000|Block 1 Induction|Lack of Efficacy|6|||
25058917|NCT02101853|50163608|FG001|Block 1 Induction|Lack of Efficacy|0|||
25058918|NCT02101853|50163609|FG002|Block 1 Induction|Lack of Efficacy|0|||
25058919|NCT02101853|50163610|FG003|Block 1 Induction|Lack of Efficacy|0|||
25058920|NCT02101853|50163611|FG004|Block 1 Induction|Lack of Efficacy|0|||
25058921|NCT02101853|50163612|FG005|Block 1 Induction|Lack of Efficacy|0|||
25058922|NCT02101853|50163607|FG000|Block 1 Induction|Physician Decision|61|||
25058923|NCT02101853|50163608|FG001|Block 1 Induction|Physician Decision|0|||
25058924|NCT02101853|50163609|FG002|Block 1 Induction|Physician Decision|0|||
25058925|NCT02101853|50163610|FG003|Block 1 Induction|Physician Decision|0|||
25058926|NCT02101853|50163611|FG004|Block 1 Induction|Physician Decision|0|||
25058927|NCT02101853|50163612|FG005|Block 1 Induction|Physician Decision|0|||
25058928|NCT02101853|50163607|FG000|Block 1 Induction|Protocol Violation|2|||
25058929|NCT02101853|50163608|FG001|Block 1 Induction|Protocol Violation|0|||
25058930|NCT02101853|50163609|FG002|Block 1 Induction|Protocol Violation|0|||
25058931|NCT02101853|50163610|FG003|Block 1 Induction|Protocol Violation|0|||
25058932|NCT02101853|50163611|FG004|Block 1 Induction|Protocol Violation|0|||
25058933|NCT02101853|50163612|FG005|Block 1 Induction|Protocol Violation|0|||
25058934|NCT02101853|50163607|FG000|Block 1 Induction|Withdrawal by Subject|65|||
25058935|NCT02101853|50163608|FG001|Block 1 Induction|Withdrawal by Subject|0|||
25058936|NCT02101853|50163609|FG002|Block 1 Induction|Withdrawal by Subject|0|||
25058937|NCT02101853|50163610|FG003|Block 1 Induction|Withdrawal by Subject|0|||
25058938|NCT02101853|50163611|FG004|Block 1 Induction|Withdrawal by Subject|0|||
25058939|NCT02101853|50163612|FG005|Block 1 Induction|Withdrawal by Subject|0|||
25058940|NCT02101853|50163607|FG000|Block 1 Induction|Ineligible|8|||
25058941|NCT02101853|50163608|FG001|Block 1 Induction|Ineligible|0|||
25058942|NCT02101853|50163609|FG002|Block 1 Induction|Ineligible|0|||
25058943|NCT02101853|50163610|FG003|Block 1 Induction|Ineligible|0|||
25058944|NCT02101853|50163611|FG004|Block 1 Induction|Ineligible|0|||
25058945|NCT02101853|50163612|FG005|Block 1 Induction|Ineligible|0|||
25058946|NCT02101853|50163607|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
25058947|NCT02101853|50163608|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
25058948|NCT02101853|50163609|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
25058949|NCT02101853|50163610|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
25058950|NCT02101853|50163611|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
25058951|NCT02101853|50163612|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
25058952|NCT02101853|50163607|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
25058953|NCT02101853|50163608|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
25058954|NCT02101853|50163609|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
25058955|NCT02101853|50163610|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
25058956|NCT02101853|50163611|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
25058957|NCT02101853|50163612|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
25058958|NCT02101853|50163607|FG000|Post Induction Randomization|Adverse Event|0|||
25058959|NCT02101853|50163608|FG001|Post Induction Randomization|Adverse Event|3|||
25058960|NCT02101853|50163609|FG002|Post Induction Randomization|Adverse Event|8|||
25058961|NCT02101853|50163610|FG003|Post Induction Randomization|Adverse Event|4|||
25058962|NCT02101853|50163611|FG004|Post Induction Randomization|Adverse Event|4|||
25058963|NCT02101853|50163612|FG005|Post Induction Randomization|Adverse Event|0|||
25058964|NCT02101853|50163607|FG000|Post Induction Randomization|Death|0|||
25058965|NCT02101853|50163608|FG001|Post Induction Randomization|Death|9|||
25058966|NCT02101853|50163609|FG002|Post Induction Randomization|Death|2|||
25058967|NCT02101853|50163610|FG003|Post Induction Randomization|Death|2|||
25058968|NCT02101853|50163611|FG004|Post Induction Randomization|Death|0|||
25058969|NCT02101853|50163612|FG005|Post Induction Randomization|Death|0|||
25058970|NCT02101853|50163607|FG000|Post Induction Randomization|Lack of Efficacy|0|||
25058971|NCT02101853|50163608|FG001|Post Induction Randomization|Lack of Efficacy|14|||
25058972|NCT02101853|50163609|FG002|Post Induction Randomization|Lack of Efficacy|23|||
25058973|NCT02101853|50163610|FG003|Post Induction Randomization|Lack of Efficacy|18|||
25058974|NCT02101853|50163611|FG004|Post Induction Randomization|Lack of Efficacy|21|||
25058975|NCT02101853|50163612|FG005|Post Induction Randomization|Lack of Efficacy|0|||
25058976|NCT02101853|50163607|FG000|Post Induction Randomization|Physician Decision|0|||
25058977|NCT02101853|50163608|FG001|Post Induction Randomization|Physician Decision|43|||
25058978|NCT02101853|50163609|FG002|Post Induction Randomization|Physician Decision|23|||
25058979|NCT02101853|50163610|FG003|Post Induction Randomization|Physician Decision|14|||
25058980|NCT02101853|50163611|FG004|Post Induction Randomization|Physician Decision|14|||
25058981|NCT02101853|50163612|FG005|Post Induction Randomization|Physician Decision|0|||
25058982|NCT02101853|50163607|FG000|Post Induction Randomization|Protocol Violation|0|||
25058983|NCT02101853|50163608|FG001|Post Induction Randomization|Protocol Violation|3|||
25058984|NCT02101853|50163609|FG002|Post Induction Randomization|Protocol Violation|0|||
25058985|NCT02101853|50163610|FG003|Post Induction Randomization|Protocol Violation|0|||
25058986|NCT02101853|50163611|FG004|Post Induction Randomization|Protocol Violation|0|||
25058987|NCT02101853|50163612|FG005|Post Induction Randomization|Protocol Violation|0|||
25058988|NCT02101853|50163607|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
25058989|NCT02101853|50163608|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
25058990|NCT02101853|50163609|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
25058991|NCT02101853|50163610|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
25058992|NCT02101853|50163611|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
25058993|NCT02101853|50163612|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
25058994|NCT02101853|50163607|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
25058995|NCT02101853|50163608|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
25058996|NCT02101853|50163609|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
25058997|NCT02101853|50163610|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
25058998|NCT02101853|50163611|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
25058999|NCT02101853|50163612|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
25059000|NCT02101853|50163607|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
25059001|NCT02101853|50163608|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
25059002|NCT02101853|50163609|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
25059003|NCT02101853|50163610|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
25059004|NCT02101853|50163611|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
25059005|NCT02101853|50163612|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
25059006|NCT02101853|50163607|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
25059007|NCT02101853|50163608|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
25059008|NCT02101853|50163609|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
25059009|NCT02101853|50163610|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
25059010|NCT02101853|50163611|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
25059011|NCT02101853|50163612|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
25059012|NCT02101853|50163607|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
25059013|NCT02101853|50163608|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
25059014|NCT02101853|50163609|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
25059015|NCT02101853|50163610|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
25059016|NCT02101853|50163611|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
25059017|NCT02101853|50163612|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
25059018|NCT02101853|50163607|FG000|Blinatumomab Salvage Therapy|Death|0|||
25059019|NCT02101853|50163608|FG001|Blinatumomab Salvage Therapy|Death|0|||
25059020|NCT02101853|50163609|FG002|Blinatumomab Salvage Therapy|Death|0|||
25059021|NCT02101853|50163610|FG003|Blinatumomab Salvage Therapy|Death|0|||
25059022|NCT02101853|50163611|FG004|Blinatumomab Salvage Therapy|Death|0|||
25059023|NCT02101853|50163612|FG005|Blinatumomab Salvage Therapy|Death|2|||
25059024|NCT02101853|50163607|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
25059025|NCT02101853|50163608|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
25059026|NCT02101853|50163609|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
25059027|NCT02101853|50163610|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
25059028|NCT02101853|50163611|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
25059029|NCT02101853|50163612|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
25059030|NCT02101853|50163607|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
25059031|NCT02101853|50163608|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
25059032|NCT02101853|50163609|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
25059033|NCT02101853|50163610|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
25059034|NCT02101853|50163611|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
25059035|NCT02101853|50163612|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
25059036|NCT02101853|50163607|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
25059037|NCT02101853|50163608|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
25059038|NCT02101853|50163609|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
25059039|NCT02101853|50163610|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
25059040|NCT02101853|50163611|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
25059041|NCT02101853|50163612|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
25059042|NCT01915498|50163642|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
25059043|NCT01915498|50163643|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
25059044|NCT01915498|50163644|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
25059045|NCT01915498|50163645|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
25186622|NCT02647320|50337197|FG004|Overall Study|Lack of Efficacy|0|||
24963570|NCT00267098|50053585|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
25059046|NCT01915498|50163646|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
25059047|NCT01915498|50163647|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
25059048|NCT01915498|50163648|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
25059049|NCT01915498|50163649|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
25059050|NCT01915498|50163650|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
25059051|NCT01915498|50163651|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
25059052|NCT01915498|50163652|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
25059053|NCT01915498|50163653|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
25059054|NCT01915498|50163654|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
25059055|NCT01915498|50163655|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
25059056|NCT01915498|50163656|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
25059057|NCT01915498|50163657|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
25059058|NCT01915498|50163658|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
25059059|NCT01915498|50163659|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
25059060|NCT01915498|50163660|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
25059061|NCT01915498|50163642|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
25059062|NCT01915498|50163643|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
25059063|NCT01915498|50163644|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
25059064|NCT01915498|50163645|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
25059065|NCT01915498|50163646|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
25059066|NCT01915498|50163647|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
25059067|NCT01915498|50163648|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
25059068|NCT01915498|50163649|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
25059069|NCT01915498|50163650|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
25059070|NCT01915498|50163651|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
25059071|NCT01915498|50163652|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
25059072|NCT01915498|50163653|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
25059073|NCT01915498|50163654|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
25059074|NCT01915498|50163655|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
25059075|NCT01915498|50163656|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
25059076|NCT01915498|50163657|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
25059077|NCT01915498|50163658|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
25059078|NCT01915498|50163659|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
25059079|NCT01915498|50163660|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
25059080|NCT01915498|50163642|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
25059081|NCT01915498|50163643|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
25059082|NCT01915498|50163644|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
25059083|NCT01915498|50163645|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
25059084|NCT01915498|50163646|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
25059085|NCT01915498|50163647|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
25059086|NCT01915498|50163648|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
25059087|NCT01915498|50163649|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
25059088|NCT01915498|50163650|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
25059089|NCT01915498|50163651|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
25059090|NCT01915498|50163652|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
25059091|NCT01915498|50163653|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
25059092|NCT01915498|50163654|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
25059093|NCT01915498|50163655|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
25059094|NCT01915498|50163656|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
25059095|NCT01915498|50163657|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
25059096|NCT01915498|50163658|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
25059097|NCT01915498|50163659|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
25059098|NCT01915498|50163660|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
25059099|NCT01915498|50163642|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059100|NCT01915498|50163643|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059101|NCT01915498|50163644|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059102|NCT01915498|50163645|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059103|NCT01915498|50163646|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059104|NCT01915498|50163647|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059105|NCT01915498|50163648|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059106|NCT01915498|50163649|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059107|NCT01915498|50163650|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059108|NCT01915498|50163651|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059109|NCT01915498|50163652|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
25059110|NCT01915498|50163653|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059111|NCT01915498|50163654|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059112|NCT01915498|50163655|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059113|NCT01915498|50163656|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059114|NCT01915498|50163657|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059115|NCT01915498|50163658|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059116|NCT01915498|50163659|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059117|NCT01915498|50163660|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
25059118|NCT01915498|50163642|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
25059119|NCT01915498|50163643|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
25059120|NCT01915498|50163644|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
25059121|NCT01915498|50163645|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
25059122|NCT01915498|50163646|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
25059123|NCT01915498|50163647|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
25059124|NCT01915498|50163648|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
25059125|NCT01915498|50163649|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
25059126|NCT01915498|50163650|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
25059127|NCT01915498|50163651|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
25059128|NCT01915498|50163652|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
25059129|NCT01915498|50163653|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
25059130|NCT01915498|50163654|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
25059131|NCT01915498|50163655|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
25059132|NCT01915498|50163656|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
25059133|NCT01915498|50163657|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
25059134|NCT01915498|50163658|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
25059135|NCT01915498|50163659|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
25059136|NCT01915498|50163660|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
25059137|NCT01915498|50163642|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
25059138|NCT01915498|50163643|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
25059139|NCT01915498|50163644|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
25059140|NCT01915498|50163645|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
25059141|NCT01915498|50163646|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
25059142|NCT01915498|50163647|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
25059143|NCT01915498|50163648|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
25059144|NCT01915498|50163649|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
25059145|NCT01915498|50163650|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
25059146|NCT01915498|50163651|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
25059147|NCT01915498|50163652|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
25059148|NCT01915498|50163653|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
25059149|NCT01915498|50163654|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
25059150|NCT01915498|50163655|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
25059151|NCT01915498|50163656|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
25059152|NCT01915498|50163657|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
25059153|NCT01915498|50163658|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
25059154|NCT01915498|50163659|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
25059155|NCT01915498|50163660|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
25059156|NCT01915498|50163642|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
25059157|NCT01915498|50163643|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
25059158|NCT01915498|50163644|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
25059159|NCT01915498|50163645|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
25059160|NCT01915498|50163646|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
25059161|NCT01915498|50163647|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
25059162|NCT01915498|50163648|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
25059163|NCT01915498|50163649|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
25059164|NCT01915498|50163650|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
25059165|NCT01915498|50163651|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
25059166|NCT01915498|50163652|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
25059167|NCT01915498|50163653|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
25059168|NCT01915498|50163654|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
25059169|NCT01915498|50163655|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
25059170|NCT01915498|50163656|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
25059171|NCT01915498|50163657|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
25059172|NCT01915498|50163658|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
25059173|NCT01915498|50163659|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
25059174|NCT01915498|50163660|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
25067483|NCT02396758|50173213|FG002|Overall Study|Randomized but not treated|1|||
24963571|NCT00267098|50053586|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
25059175|NCT01915498|50163642|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
25059176|NCT01915498|50163643|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
25059177|NCT01915498|50163644|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
25059178|NCT01915498|50163645|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
25059179|NCT01915498|50163646|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
25059180|NCT01915498|50163647|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
25059181|NCT01915498|50163648|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
25059182|NCT01915498|50163649|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
25059183|NCT01915498|50163650|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
25059184|NCT01915498|50163651|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
25059185|NCT01915498|50163652|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
25059186|NCT01915498|50163653|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
25059187|NCT01915498|50163654|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
25059188|NCT01915498|50163655|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
25059189|NCT01915498|50163656|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
25059190|NCT01915498|50163657|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
25059191|NCT01915498|50163658|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
25059192|NCT01915498|50163659|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
25059193|NCT01915498|50163660|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
25059194|NCT01915498|50163642|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
25059195|NCT01915498|50163643|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
25059196|NCT01915498|50163644|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
25059197|NCT01915498|50163645|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
25059198|NCT01915498|50163646|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
25059199|NCT01915498|50163647|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
25059200|NCT01915498|50163648|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
25059201|NCT01915498|50163649|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
25059202|NCT01915498|50163650|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
25059203|NCT01915498|50163651|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
25059204|NCT01915498|50163652|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
25059205|NCT01915498|50163653|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
25059206|NCT01915498|50163654|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
25059207|NCT01915498|50163655|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
25059208|NCT01915498|50163656|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
25059209|NCT01915498|50163657|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
25059210|NCT01915498|50163658|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
25059211|NCT01915498|50163659|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
25059212|NCT01915498|50163660|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
25059213|NCT01915498|50163642|FG000|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
25059214|NCT01915498|50163643|FG001|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
25059215|NCT01915498|50163644|FG002|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
25059216|NCT01915498|50163645|FG003|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
25059217|NCT01915498|50163646|FG004|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
25059218|NCT01915498|50163647|FG005|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
25059219|NCT01915498|50163648|FG006|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
25059220|NCT01915498|50163649|FG007|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
25059221|NCT01915498|50163650|FG008|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
25059222|NCT01915498|50163651|FG009|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
25059223|NCT01915498|50163652|FG010|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
25059224|NCT01915498|50163653|FG011|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
25059225|NCT01915498|50163654|FG012|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
25059226|NCT01915498|50163655|FG013|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
25059227|NCT01915498|50163656|FG014|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
25059228|NCT01915498|50163657|FG015|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
25059229|NCT01915498|50163658|FG016|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
25059230|NCT01915498|50163659|FG017|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2|||
25059231|NCT01915498|50163660|FG018|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
25059232|NCT01915498|50163642|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
25059233|NCT01915498|50163643|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
25059234|NCT01915498|50163644|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
25059235|NCT01915498|50163645|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
25059236|NCT01915498|50163646|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
25059237|NCT01915498|50163647|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
25059238|NCT01915498|50163648|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
25059239|NCT01915498|50163649|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
25059240|NCT01915498|50163650|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
25059241|NCT01915498|50163651|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
25059242|NCT01915498|50163652|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
25059243|NCT01915498|50163653|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
25059244|NCT01915498|50163654|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
25059245|NCT01915498|50163655|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
25059246|NCT01915498|50163656|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
25059247|NCT01915498|50163657|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
25059248|NCT01915498|50163658|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
25059249|NCT01915498|50163659|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
25059250|NCT01915498|50163660|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
25059251|NCT01915498|50163642|FG000|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
25059252|NCT01915498|50163643|FG001|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
25059253|NCT01915498|50163644|FG002|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
25059254|NCT01915498|50163645|FG003|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
25059255|NCT01915498|50163646|FG004|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
25059256|NCT01915498|50163647|FG005|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
25059257|NCT01915498|50163648|FG006|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
25059258|NCT01915498|50163649|FG007|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
25059259|NCT01915498|50163650|FG008|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
25059260|NCT01915498|50163651|FG009|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
25059261|NCT01915498|50163652|FG010|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
25059262|NCT01915498|50163653|FG011|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
25059263|NCT01915498|50163654|FG012|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
25059264|NCT01915498|50163655|FG013|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
24963572|NCT00267098|50053587|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
24963573|NCT00267098|50053588|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
24963574|NCT00267098|50053589|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
24963575|NCT00267098|50053590|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
24963576|NCT00267098|50053583|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
24963577|NCT00267098|50053584|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
24963578|NCT00267098|50053585|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
24963579|NCT00267098|50053586|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
24963580|NCT00267098|50053587|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
24963581|NCT00267098|50053588|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
24963582|NCT00267098|50053589|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
24963583|NCT00267098|50053590|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
24963584|NCT00267098|50053583|FG000|Overall Study|Site closure|0|||
24963585|NCT00267098|50053584|FG001|Overall Study|Site closure|0|||
24963586|NCT00267098|50053585|FG002|Overall Study|Site closure|0|||
24963587|NCT00267098|50053586|FG003|Overall Study|Site closure|1|||
24963588|NCT00267098|50053587|FG004|Overall Study|Site closure|0|||
24963589|NCT00267098|50053588|FG005|Overall Study|Site closure|1|||
24963590|NCT00267098|50053589|FG006|Overall Study|Site closure|1|||
24963591|NCT00267098|50053590|FG007|Overall Study|Site closure|0|||
24963592|NCT00267098|50053583|FG000|Overall Study|Explanted Medtronic device|0|||
24963593|NCT00267098|50053584|FG001|Overall Study|Explanted Medtronic device|0|||
24963594|NCT00267098|50053585|FG002|Overall Study|Explanted Medtronic device|0|||
24963595|NCT00267098|50053586|FG003|Overall Study|Explanted Medtronic device|1|||
24963596|NCT00267098|50053587|FG004|Overall Study|Explanted Medtronic device|0|||
24963597|NCT00267098|50053588|FG005|Overall Study|Explanted Medtronic device|0|||
24963598|NCT00267098|50053589|FG006|Overall Study|Explanted Medtronic device|0|||
24963599|NCT00267098|50053590|FG007|Overall Study|Explanted Medtronic device|0|||
25059265|NCT01915498|50163656|FG014|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
25059266|NCT01915498|50163657|FG015|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
25059267|NCT01915498|50163658|FG016|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
25059268|NCT01915498|50163659|FG017|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
25059269|NCT01915498|50163660|FG018|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2|||
24963600|NCT00267098|50053583|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
24963601|NCT00267098|50053584|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
25059270|NCT01798004|50163752|FG000|Overall Study|Death|2|||
25059271|NCT01798004|50163752|FG000|Overall Study|Lack of Efficacy|8|||
25059272|NCT01798004|50163752|FG000|Overall Study|Physician Decision|25|||
25059273|NCT01798004|50163752|FG000|Overall Study|Withdrawal by Subject|4|||
25059274|NCT01798004|50163752|FG000|Overall Study|Ineligible|4|||
25059275|NCT01798004|50163752|FG000|Overall Study|Patient/parent refusal|7|||
25059276|NCT01798004|50163752|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
25059277|NCT01798004|50163752|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
25059278|NCT01630434|50163758|FG000|Overall Study|Donor lungs turned down|1|||
25059279|NCT01630434|50163759|FG001|Overall Study|Donor lungs turned down|0|||
25059280|NCT01630434|50163758|FG000|Overall Study|Protocol Violation|9|||
25059281|NCT01630434|50163759|FG001|Overall Study|Protocol Violation|4|||
25059282|NCT01630434|50163758|FG000|Overall Study|Death|20|||
25059283|NCT01630434|50163759|FG001|Overall Study|Death|26|||
25059284|NCT01256398|50163769|FG000|Overall Study|Withdrawal by Subject|1|||
25059285|NCT01175356|50163775|FG000|Overall Study|Death|1|||
25059286|NCT01175356|50163775|FG000|Overall Study|Lack of Efficacy|12|||
25059287|NCT01175356|50163775|FG000|Overall Study|Lost to Follow-up|1|||
25059288|NCT01175356|50163775|FG000|Overall Study|Physician Decision|23|||
25059289|NCT01175356|50163775|FG000|Overall Study|Ineligible|1|||
25059290|NCT01175356|50163775|FG000|Overall Study|Treatment Slot Not Available|18|||
25059291|NCT01175356|50163775|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
25059292|NCT01175356|50163775|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
25059293|NCT01175356|50163775|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
25059294|NCT01175356|50163775|FG000|Overall Study|Inadequate stem cell for transplant|1|||
25059295|NCT01175356|50163775|FG000|Overall Study|Initiation other tx prior to completion|9|||
25059296|NCT01151423|50163781|FG000|Overall Study|Study terminated by Sponsor|9|||
25059297|NCT01151423|50163782|FG001|Overall Study|Study terminated by Sponsor|10|||
25059298|NCT01151423|50163781|FG000|Overall Study|Protocol Violation|0|||
25059299|NCT01151423|50163782|FG001|Overall Study|Protocol Violation|1|||
25059300|NCT01151423|50163781|FG000|Overall Study|Physician Decision|1|||
25059301|NCT01151423|50163782|FG001|Overall Study|Physician Decision|1|||
25059302|NCT01151423|50163781|FG000|Overall Study|Pregnancy|0|||
25059303|NCT01151423|50163782|FG001|Overall Study|Pregnancy|1|||
25059304|NCT01151423|50163781|FG000|Overall Study|Death|0|||
25059305|NCT01151423|50163782|FG001|Overall Study|Death|1|||
25059306|NCT01151423|50163781|FG000|Overall Study|Adverse Event|3|||
25059307|NCT01151423|50163782|FG001|Overall Study|Adverse Event|0|||
25059308|NCT01151423|50163781|FG000|Overall Study|Withdrawal by Subject|1|||
25059309|NCT01151423|50163782|FG001|Overall Study|Withdrawal by Subject|3|||
25059310|NCT01151423|50163781|FG000|Overall Study|Lost to Follow-up|1|||
25059311|NCT01151423|50163782|FG001|Overall Study|Lost to Follow-up|0|||
25059312|NCT01151423|50163781|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
25059313|NCT01151423|50163782|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
25059314|NCT01151423|50163781|FG000|Overall Study|Participated in other clinical trial|1|||
25059315|NCT01151423|50163782|FG001|Overall Study|Participated in other clinical trial|0|||
25059316|NCT00977574|50163808|FG000|Overall Study|Never Treated|4|||
25059317|NCT00977574|50163809|FG001|Overall Study|Never Treated|2|||
25059318|NCT00977574|50163810|FG002|Overall Study|Never Treated|4|||
25059319|NCT00565617|50163827|FG000|Overall Study|Withdrawal by Subject|1|||
25059320|NCT00453154|50163834|FG000|Double BIind Maintenance|Adverse Event|0|||
25059321|NCT00453154|50163835|FG001|Double BIind Maintenance|Adverse Event|0|||
25059322|NCT00453154|50163836|FG002|Double BIind Maintenance|Adverse Event|3|||
25059323|NCT00453154|50163837|FG003|Double BIind Maintenance|Adverse Event|12|||
25059324|NCT00453154|50163834|FG000|Double BIind Maintenance|Death|0|||
25059325|NCT00453154|50163835|FG001|Double BIind Maintenance|Death|0|||
25059326|NCT00453154|50163836|FG002|Double BIind Maintenance|Death|2|||
25059327|NCT00453154|50163837|FG003|Double BIind Maintenance|Death|1|||
25059328|NCT00453154|50163834|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
25059329|NCT00453154|50163835|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
25059330|NCT00453154|50163836|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
25059331|NCT00453154|50163837|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
25059332|NCT00453154|50163834|FG000|Double BIind Maintenance|Progression|0|||
25059333|NCT00453154|50163835|FG001|Double BIind Maintenance|Progression|0|||
25059334|NCT00453154|50163836|FG002|Double BIind Maintenance|Progression|29|||
25059335|NCT00453154|50163837|FG003|Double BIind Maintenance|Progression|26|||
25059336|NCT00453154|50163834|FG000|Double BIind Maintenance|Medical Issues|0|||
25059337|NCT00453154|50163835|FG001|Double BIind Maintenance|Medical Issues|0|||
25059338|NCT00453154|50163836|FG002|Double BIind Maintenance|Medical Issues|3|||
25059339|NCT00453154|50163837|FG003|Double BIind Maintenance|Medical Issues|1|||
25059340|NCT00453154|50163834|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
25059341|NCT00453154|50163835|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
25059342|NCT00453154|50163836|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
25059343|NCT00453154|50163837|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
25059344|NCT00334815|50163848|FG000|Overall Study|Adverse Event|3|||
25059345|NCT00334815|50163849|FG001|Overall Study|Adverse Event|2|||
25059346|NCT00334815|50163848|FG000|Overall Study|Death|0|||
25059347|NCT00334815|50163849|FG001|Overall Study|Death|2|||
25059348|NCT00334815|50163848|FG000|Overall Study|Progression|1|||
25059349|NCT00334815|50163849|FG001|Overall Study|Progression|0|||
25059350|NCT00334815|50163848|FG000|Overall Study|ineligible|1|||
25059351|NCT00334815|50163849|FG001|Overall Study|ineligible|1|||
25059352|NCT00334815|50163848|FG000|Overall Study|patient refused treatment|0|||
25059353|NCT00334815|50163849|FG001|Overall Study|patient refused treatment|1|||
25059354|NCT00334815|50163848|FG000|Overall Study|Physician Decision|2|||
25059355|NCT00334815|50163849|FG001|Overall Study|Physician Decision|4|||
25059356|NCT00258960|50163857|FG000|Overall Study|Death|2|||
25059357|NCT00258960|50163857|FG000|Overall Study|Disease Progression|7|||
25059358|NCT00258960|50163857|FG000|Overall Study|Adverse Event|4|||
25059359|NCT00258960|50163857|FG000|Overall Study|Physician Decision|1|||
25059360|NCT00258960|50163857|FG000|Overall Study|Withdrawal by Subject|1|||
25059361|NCT00258960|50163857|FG000|Overall Study|Mistake|2|||
25059362|NCT00121992|50163863|FG000|Overall Study|Treatment not received|2|||
25059363|NCT00121992|50163864|FG001|Overall Study|Treatment not received|11|||
25059364|NCT00070564|50163876|FG000|Overall Study|Progression|2|||
25059365|NCT00070564|50163877|FG001|Overall Study|Progression|4|||
25059366|NCT00070564|50163878|FG002|Overall Study|Progression|7|||
25059367|NCT00070564|50163879|FG003|Overall Study|Progression|7|||
25059368|NCT00070564|50163880|FG004|Overall Study|Progression|1|||
25059369|NCT00070564|50163881|FG005|Overall Study|Progression|0|||
25059370|NCT00070564|50163876|FG000|Overall Study|Delinquent|1|||
25059371|NCT00070564|50163877|FG001|Overall Study|Delinquent|4|||
25059372|NCT00070564|50163878|FG002|Overall Study|Delinquent|2|||
25059373|NCT00070564|50163879|FG003|Overall Study|Delinquent|0|||
25059374|NCT00070564|50163880|FG004|Overall Study|Delinquent|0|||
25059375|NCT00070564|50163881|FG005|Overall Study|Delinquent|0|||
25059376|NCT00070564|50163876|FG000|Overall Study|Adverse Event|150|||
25059377|NCT00070564|50163877|FG001|Overall Study|Adverse Event|142|||
25059378|NCT00070564|50163878|FG002|Overall Study|Adverse Event|120|||
25059379|NCT00070564|50163879|FG003|Overall Study|Adverse Event|108|||
25059380|NCT00070564|50163880|FG004|Overall Study|Adverse Event|63|||
25059381|NCT00070564|50163881|FG005|Overall Study|Adverse Event|36|||
25059382|NCT00070564|50163876|FG000|Overall Study|Death|4|||
25059383|NCT00070564|50163877|FG001|Overall Study|Death|1|||
25059384|NCT00070564|50163878|FG002|Overall Study|Death|5|||
25059385|NCT00070564|50163879|FG003|Overall Study|Death|3|||
25059386|NCT00070564|50163880|FG004|Overall Study|Death|0|||
25059387|NCT00070564|50163881|FG005|Overall Study|Death|1|||
25059388|NCT00070564|50163876|FG000|Overall Study|Other, not protocol specified|17|||
25059389|NCT00070564|50163877|FG001|Overall Study|Other, not protocol specified|15|||
25059390|NCT00070564|50163878|FG002|Overall Study|Other, not protocol specified|14|||
25059391|NCT00070564|50163879|FG003|Overall Study|Other, not protocol specified|19|||
25059392|NCT00070564|50163880|FG004|Overall Study|Other, not protocol specified|6|||
25059393|NCT00070564|50163881|FG005|Overall Study|Other, not protocol specified|7|||
25059394|NCT00070564|50163876|FG000|Overall Study|Withdrawal by Subject|26|||
25059395|NCT00070564|50163877|FG001|Overall Study|Withdrawal by Subject|37|||
25059396|NCT00070564|50163878|FG002|Overall Study|Withdrawal by Subject|23|||
25059397|NCT00070564|50163879|FG003|Overall Study|Withdrawal by Subject|30|||
25059398|NCT00070564|50163880|FG004|Overall Study|Withdrawal by Subject|8|||
25059399|NCT00070564|50163881|FG005|Overall Study|Withdrawal by Subject|8|||
25059400|NCT00070564|50163876|FG000|Overall Study|Not reported|0|||
25059401|NCT00070564|50163877|FG001|Overall Study|Not reported|0|||
25059402|NCT00070564|50163878|FG002|Overall Study|Not reported|0|||
25162766|NCT01277302|50285142|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
25162767|NCT01277302|50285143|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
25162768|NCT01277302|50285144|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
24963602|NCT00267098|50053585|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
25059403|NCT00070564|50163879|FG003|Overall Study|Not reported|0|||
25059404|NCT00070564|50163880|FG004|Overall Study|Not reported|1|||
25059405|NCT00070564|50163881|FG005|Overall Study|Not reported|0|||
25059406|NCT02738151|50163907|FG000|Overall Study|Randomized but not treated|4|||
25059407|NCT02738151|50163908|FG001|Overall Study|Randomized but not treated|1|||
25059408|NCT02738151|50163907|FG000|Overall Study|Adverse Event|4|||
25059409|NCT02738151|50163908|FG001|Overall Study|Adverse Event|5|||
25059410|NCT02738151|50163907|FG000|Overall Study|Hypoglycemia|0|||
25059411|NCT02738151|50163908|FG001|Overall Study|Hypoglycemia|1|||
25059412|NCT02738151|50163907|FG000|Overall Study|Poor Compliance to Protocol|4|||
25059413|NCT02738151|50163908|FG001|Overall Study|Poor Compliance to Protocol|3|||
25059414|NCT02738151|50163907|FG000|Overall Study|Other than specified above|11|||
25059415|NCT02738151|50163908|FG001|Overall Study|Other than specified above|21|||
25059416|NCT02993731|50163916|FG000|Overall Study|Study Termination|101|||
25059417|NCT02993731|50163917|FG001|Overall Study|Study Termination|105|||
25059418|NCT02915159|50163935|FG000|Overall Study|Participant no longer meets criteria|2|||
25059419|NCT02915159|50163936|FG001|Overall Study|Participant no longer meets criteria|0|||
25059420|NCT02915159|50163935|FG000|Overall Study|poor/non-compliance|1|||
25059421|NCT02915159|50163936|FG001|Overall Study|poor/non-compliance|0|||
25059422|NCT02915159|50163935|FG000|Overall Study|Participant withdrew consent|5|||
25059423|NCT02915159|50163936|FG001|Overall Study|Participant withdrew consent|1|||
25059424|NCT02915159|50163935|FG000|Overall Study|Request to discontinue treatment|1|||
25059425|NCT02915159|50163936|FG001|Overall Study|Request to discontinue treatment|2|||
25059426|NCT02915159|50163935|FG000|Overall Study|Adverse Event|2|||
25059427|NCT02915159|50163936|FG001|Overall Study|Adverse Event|2|||
25059428|NCT02915159|50163935|FG000|Overall Study|Lack of Efficacy|0|||
25059429|NCT02915159|50163936|FG001|Overall Study|Lack of Efficacy|3|||
25059430|NCT02924051|50163948|FG000|Overall Study|Withdrawal by Subject|1|||
25059431|NCT02924051|50163949|FG001|Overall Study|Withdrawal by Subject|9|||
25059432|NCT02923427|50163959|FG000|Overall Study|convert to laparatomy|2|||
25059433|NCT02923427|50163960|FG001|Overall Study|convert to laparatomy|2|||
25059434|NCT02923427|50163959|FG000|Overall Study|destaturation|1|||
25059435|NCT02923427|50163960|FG001|Overall Study|destaturation|0|||
25059436|NCT02923427|50163959|FG000|Overall Study|can not replace LMA|1|||
25059437|NCT02923427|50163960|FG001|Overall Study|can not replace LMA|0|||
25059438|NCT02669264|50163973|FG000|Overall Study|Death|5|||
25059439|NCT02669264|50163974|FG001|Overall Study|Death|5|||
25059440|NCT02669264|50163975|FG002|Overall Study|Death|3|||
25059441|NCT02669264|50163976|FG003|Overall Study|Death|3|||
25059442|NCT02669264|50163977|FG004|Overall Study|Death|3|||
25059443|NCT02669264|50163978|FG005|Overall Study|Death|6|||
25059444|NCT02669264|50163979|FG006|Overall Study|Death|3|||
25059445|NCT02669264|50163973|FG000|Overall Study|Withdrawal by Subject|0|||
25059446|NCT02669264|50163974|FG001|Overall Study|Withdrawal by Subject|1|||
25059447|NCT02669264|50163975|FG002|Overall Study|Withdrawal by Subject|0|||
25059448|NCT02669264|50163976|FG003|Overall Study|Withdrawal by Subject|0|||
25059449|NCT02669264|50163977|FG004|Overall Study|Withdrawal by Subject|1|||
25059450|NCT02669264|50163978|FG005|Overall Study|Withdrawal by Subject|0|||
25059451|NCT02669264|50163979|FG006|Overall Study|Withdrawal by Subject|0|||
25059452|NCT02669264|50163973|FG000|Overall Study|Lost to Follow-up|0|||
25059453|NCT02669264|50163974|FG001|Overall Study|Lost to Follow-up|0|||
25059454|NCT02669264|50163975|FG002|Overall Study|Lost to Follow-up|0|||
25059455|NCT02669264|50163976|FG003|Overall Study|Lost to Follow-up|0|||
25059456|NCT02669264|50163977|FG004|Overall Study|Lost to Follow-up|1|||
25059457|NCT02669264|50163978|FG005|Overall Study|Lost to Follow-up|0|||
25059458|NCT02669264|50163979|FG006|Overall Study|Lost to Follow-up|0|||
25059459|NCT02669264|50163973|FG000|Overall Study|Miscellaneous|0|||
25059460|NCT02669264|50163974|FG001|Overall Study|Miscellaneous|0|||
25059461|NCT02669264|50163975|FG002|Overall Study|Miscellaneous|0|||
25059462|NCT02669264|50163976|FG003|Overall Study|Miscellaneous|0|||
25059463|NCT02669264|50163977|FG004|Overall Study|Miscellaneous|0|||
25059464|NCT02669264|50163978|FG005|Overall Study|Miscellaneous|0|||
25059465|NCT02669264|50163979|FG006|Overall Study|Miscellaneous|2|||
25059466|NCT02521870|50164005|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
25059467|NCT02521870|50164006|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
25059468|NCT02521870|50164007|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
25059469|NCT02521870|50164008|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
25059470|NCT02521870|50164009|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
25059471|NCT02521870|50164010|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
25059472|NCT02521870|50164011|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
25059473|NCT02521870|50164012|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
25059474|NCT02521870|50164013|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
25059475|NCT02521870|50164014|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
25059476|NCT02521870|50164015|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
25059477|NCT02521870|50164016|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
25059478|NCT02521870|50164005|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
25059479|NCT02521870|50164006|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
25059480|NCT02521870|50164007|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
25059481|NCT02521870|50164008|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
25059482|NCT02521870|50164009|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
25059483|NCT02521870|50164010|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
25059484|NCT02521870|50164011|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
25059485|NCT02521870|50164012|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
25059486|NCT02521870|50164013|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
25059487|NCT02521870|50164014|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
25059488|NCT02521870|50164015|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
25059489|NCT02521870|50164016|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
25059490|NCT02521870|50164005|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
25059491|NCT02521870|50164006|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
25059492|NCT02521870|50164007|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
25059493|NCT02521870|50164008|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
25059494|NCT02521870|50164009|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
25059495|NCT02521870|50164010|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
25059496|NCT02521870|50164011|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
25059497|NCT02521870|50164012|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
25059498|NCT02521870|50164013|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
25059499|NCT02521870|50164014|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
25059500|NCT02521870|50164015|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
25059501|NCT02521870|50164016|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
25059502|NCT02521870|50164005|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
25059503|NCT02521870|50164006|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
25059504|NCT02521870|50164007|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
25059505|NCT02521870|50164008|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
25059506|NCT02521870|50164009|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
25059507|NCT02521870|50164010|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
25059508|NCT02521870|50164011|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
25059509|NCT02521870|50164012|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
25059510|NCT02521870|50164013|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
25059511|NCT02521870|50164014|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
25059512|NCT02521870|50164015|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
25059513|NCT02521870|50164016|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
25059514|NCT02521870|50164005|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
25059515|NCT02521870|50164006|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
25059516|NCT02521870|50164007|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
25059517|NCT02521870|50164008|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
25059518|NCT02521870|50164009|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
25059519|NCT02521870|50164010|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
25059520|NCT02521870|50164011|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
25059521|NCT02521870|50164012|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
25059522|NCT02521870|50164013|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
25059523|NCT02521870|50164014|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
25059524|NCT02521870|50164015|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
25059525|NCT02521870|50164016|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
25059526|NCT02521870|50164005|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
25059527|NCT02521870|50164006|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
25059528|NCT02521870|50164007|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
25059529|NCT02521870|50164008|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
25059530|NCT02521870|50164009|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
25059531|NCT02521870|50164010|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
25059532|NCT02521870|50164011|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
25059533|NCT02521870|50164012|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
25059534|NCT02521870|50164013|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
25059535|NCT02521870|50164014|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
25059536|NCT02521870|50164015|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
25059537|NCT02521870|50164016|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
25059538|NCT02521870|50164005|FG000|Phase 2: Dose Expansion|Death|0|||
25059539|NCT02521870|50164006|FG001|Phase 2: Dose Expansion|Death|0|||
25059540|NCT02521870|50164007|FG002|Phase 2: Dose Expansion|Death|0|||
25059541|NCT02521870|50164008|FG003|Phase 2: Dose Expansion|Death|0|||
25059542|NCT02521870|50164009|FG004|Phase 2: Dose Expansion|Death|1|||
25059543|NCT02521870|50164010|FG005|Phase 2: Dose Expansion|Death|1|||
25059544|NCT02521870|50164011|FG006|Phase 2: Dose Expansion|Death|3|||
25059545|NCT02521870|50164012|FG007|Phase 2: Dose Expansion|Death|1|||
25059546|NCT02521870|50164013|FG008|Phase 2: Dose Expansion|Death|1|||
25059547|NCT02521870|50164014|FG009|Phase 2: Dose Expansion|Death|5|||
25059548|NCT02521870|50164015|FG010|Phase 2: Dose Expansion|Death|2|||
25059549|NCT02521870|50164016|FG011|Phase 2: Dose Expansion|Death|2|||
25059550|NCT02521870|50164005|FG000|Phase 2: Dose Expansion|Other|0|||
25059551|NCT02521870|50164006|FG001|Phase 2: Dose Expansion|Other|0|||
25059552|NCT02521870|50164007|FG002|Phase 2: Dose Expansion|Other|0|||
25059553|NCT02521870|50164008|FG003|Phase 2: Dose Expansion|Other|0|||
25059554|NCT02521870|50164009|FG004|Phase 2: Dose Expansion|Other|10|||
25059555|NCT02521870|50164010|FG005|Phase 2: Dose Expansion|Other|3|||
25059556|NCT02521870|50164011|FG006|Phase 2: Dose Expansion|Other|2|||
25059557|NCT02521870|50164012|FG007|Phase 2: Dose Expansion|Other|0|||
25059558|NCT02521870|50164013|FG008|Phase 2: Dose Expansion|Other|10|||
25059559|NCT02521870|50164014|FG009|Phase 2: Dose Expansion|Other|5|||
25059560|NCT02521870|50164015|FG010|Phase 2: Dose Expansion|Other|1|||
25059561|NCT02521870|50164016|FG011|Phase 2: Dose Expansion|Other|7|||
25059562|NCT02521870|50164005|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
25059563|NCT02521870|50164006|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
25059564|NCT02521870|50164007|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
25059565|NCT02521870|50164008|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
25059566|NCT02521870|50164009|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
25059567|NCT02521870|50164010|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
25059568|NCT02521870|50164011|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
25059569|NCT02521870|50164012|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
25059570|NCT02521870|50164013|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
25059571|NCT02521870|50164014|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
25059572|NCT02521870|50164015|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
25059573|NCT02521870|50164016|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
25059574|NCT02521870|50164005|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
25059575|NCT02521870|50164006|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
25059576|NCT02521870|50164007|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
25059577|NCT02521870|50164008|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
25059578|NCT02521870|50164009|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
25059579|NCT02521870|50164010|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
25059580|NCT02521870|50164011|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
25059581|NCT02521870|50164012|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
25059582|NCT02521870|50164013|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
25059583|NCT02521870|50164014|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
25059584|NCT02521870|50164015|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
25059585|NCT02521870|50164016|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
25059586|NCT02923349|50164053|FG000|Overall Study|Other|1|||
25059587|NCT02923349|50164054|FG001|Overall Study|Other|2|||
25059588|NCT02923349|50164055|FG002|Overall Study|Other|4|||
25059589|NCT02923349|50164056|FG003|Overall Study|Other|1|||
25059590|NCT02923349|50164057|FG004|Overall Study|Other|3|||
25059591|NCT02923349|50164058|FG005|Overall Study|Other|0|||
25059592|NCT02923349|50164059|FG006|Overall Study|Other|1|||
25059593|NCT02923349|50164053|FG000|Overall Study|Withdrawal by Subject|2|||
25059594|NCT02923349|50164054|FG001|Overall Study|Withdrawal by Subject|2|||
25059595|NCT02923349|50164055|FG002|Overall Study|Withdrawal by Subject|8|||
25059596|NCT02923349|50164056|FG003|Overall Study|Withdrawal by Subject|10|||
25059597|NCT02923349|50164057|FG004|Overall Study|Withdrawal by Subject|12|||
25059598|NCT02923349|50164058|FG005|Overall Study|Withdrawal by Subject|3|||
25059599|NCT02923349|50164059|FG006|Overall Study|Withdrawal by Subject|0|||
25059600|NCT02923349|50164053|FG000|Overall Study|Physician Decision|0|||
25059601|NCT02923349|50164054|FG001|Overall Study|Physician Decision|0|||
25059602|NCT02923349|50164055|FG002|Overall Study|Physician Decision|0|||
25059603|NCT02923349|50164056|FG003|Overall Study|Physician Decision|1|||
25059604|NCT02923349|50164057|FG004|Overall Study|Physician Decision|1|||
25059605|NCT02923349|50164058|FG005|Overall Study|Physician Decision|0|||
25059606|NCT02923349|50164059|FG006|Overall Study|Physician Decision|2|||
25059607|NCT02923349|50164053|FG000|Overall Study|Lost to Follow-up|0|||
25059608|NCT02923349|50164054|FG001|Overall Study|Lost to Follow-up|0|||
25059609|NCT02923349|50164055|FG002|Overall Study|Lost to Follow-up|3|||
25059610|NCT02923349|50164056|FG003|Overall Study|Lost to Follow-up|0|||
25059611|NCT02923349|50164057|FG004|Overall Study|Lost to Follow-up|1|||
25059612|NCT02923349|50164058|FG005|Overall Study|Lost to Follow-up|1|||
25059613|NCT02923349|50164059|FG006|Overall Study|Lost to Follow-up|0|||
25059614|NCT02923349|50164053|FG000|Overall Study|Death|1|||
25059615|NCT02923349|50164054|FG001|Overall Study|Death|0|||
25059616|NCT02923349|50164055|FG002|Overall Study|Death|2|||
25059617|NCT02923349|50164056|FG003|Overall Study|Death|4|||
25059618|NCT02923349|50164057|FG004|Overall Study|Death|2|||
25059619|NCT02923349|50164058|FG005|Overall Study|Death|3|||
25059620|NCT02923349|50164059|FG006|Overall Study|Death|0|||
25059621|NCT02521792|50164075|FG000|Overall Study|Study Terminated|6|||
25059622|NCT03020615|50164082|FG000|Overall Study|Physician Decision|3|||
25059623|NCT03020615|50164083|FG001|Overall Study|Physician Decision|1|||
25059624|NCT03020615|50164084|FG002|Overall Study|Physician Decision|2|||
25059625|NCT03020615|50164082|FG000|Overall Study|Parent/guardian/patient choice|3|||
25059626|NCT03020615|50164083|FG001|Overall Study|Parent/guardian/patient choice|0|||
25059627|NCT03020615|50164084|FG002|Overall Study|Parent/guardian/patient choice|4|||
25059628|NCT03020615|50164082|FG000|Overall Study|Screen failure|0|||
25059629|NCT03020615|50164083|FG001|Overall Study|Screen failure|0|||
25059630|NCT03020615|50164084|FG002|Overall Study|Screen failure|1|||
25059631|NCT03020615|50164082|FG000|Overall Study|Death|1|||
25059632|NCT03020615|50164083|FG001|Overall Study|Death|0|||
25059633|NCT03020615|50164084|FG002|Overall Study|Death|0|||
25059634|NCT03020615|50164082|FG000|Overall Study|Lost to Follow-up|0|||
25059635|NCT03020615|50164083|FG001|Overall Study|Lost to Follow-up|1|||
25059636|NCT03020615|50164084|FG002|Overall Study|Lost to Follow-up|0|||
25059637|NCT03020069|50164097|FG000|Overall Study|Lost to Follow-up|0|||
25059638|NCT03020069|50164098|FG001|Overall Study|Lost to Follow-up|1|||
25059639|NCT03693170|50164104|FG000|Overall Study|Disease Progression|48|||
25059640|NCT03693170|50164104|FG000|Overall Study|Adverse Event|16|||
25059641|NCT03693170|50164104|FG000|Overall Study|Physician Decision|6|||
25059642|NCT03693170|50164104|FG000|Overall Study|Protocol Violation|2|||
25059643|NCT03693170|50164104|FG000|Overall Study|Death|1|||
25059644|NCT03693170|50164104|FG000|Overall Study|Non compliance with study drug|1|||
25059645|NCT03693170|50164104|FG000|Overall Study|Withdrawal by Subject|1|||
25059646|NCT03021005|50164111|FG000|Overall Study|Lost to Follow-up|39|||
25059647|NCT03021005|50164112|FG001|Overall Study|Lost to Follow-up|26|||
25059648|NCT02914457|50164118|FG000|Overall Study|Withdrawal by Subject|1|||
25059649|NCT02914457|50164118|FG000|Overall Study|Physician Decision|1|||
25059650|NCT02914457|50164118|FG000|Overall Study|No veins available for lead placement|1|||
25059651|NCT02914457|50164118|FG000|Overall Study|Electrical instability of patient|1|||
25059652|NCT02914457|50164118|FG000|Overall Study|ECG acquisition error due to sweating|1|||
25059653|NCT02914457|50164118|FG000|Overall Study|Protocol Violation|1|||
25059654|NCT02665052|50164126|FG000|Overall Study|Lost to Follow-up|1|||
25059655|NCT02665052|50164127|FG001|Overall Study|Lost to Follow-up|0|||
25059656|NCT02665052|50164128|FG002|Overall Study|Lost to Follow-up|0|||
25059657|NCT02665052|50164129|FG003|Overall Study|Lost to Follow-up|0|||
25059658|NCT02665052|50164126|FG000|Overall Study|Withdrawal by Subject|1|||
25059659|NCT02665052|50164127|FG001|Overall Study|Withdrawal by Subject|1|||
25059660|NCT02665052|50164128|FG002|Overall Study|Withdrawal by Subject|0|||
25059661|NCT02665052|50164129|FG003|Overall Study|Withdrawal by Subject|5|||
25059662|NCT02665052|50164126|FG000|Overall Study|Adverse Event|1|||
25059663|NCT02665052|50164127|FG001|Overall Study|Adverse Event|1|||
25059664|NCT02665052|50164128|FG002|Overall Study|Adverse Event|0|||
25059665|NCT02665052|50164129|FG003|Overall Study|Adverse Event|0|||
25059666|NCT03019289|50164149|FG000|Overall Study|Adverse Event|1|||
25059667|NCT03019289|50164150|FG001|Overall Study|Adverse Event|0|||
25059668|NCT03019289|50164151|FG002|Overall Study|Adverse Event|0|||
25059669|NCT03019289|50164152|FG003|Overall Study|Adverse Event|0|||
25059670|NCT03019289|50164153|FG004|Overall Study|Adverse Event|0|||
25059671|NCT03019289|50164154|FG005|Overall Study|Adverse Event|0|||
25059672|NCT03019289|50164155|FG006|Overall Study|Adverse Event|0|||
25059673|NCT03019289|50164156|FG007|Overall Study|Adverse Event|0|||
25059674|NCT03019289|50164157|FG008|Overall Study|Adverse Event|1|||
25059675|NCT03019289|50164149|FG000|Overall Study|Other|1|||
25059676|NCT03019289|50164150|FG001|Overall Study|Other|0|||
25059677|NCT03019289|50164151|FG002|Overall Study|Other|0|||
25059678|NCT03019289|50164152|FG003|Overall Study|Other|0|||
25059679|NCT03019289|50164153|FG004|Overall Study|Other|0|||
25059680|NCT03019289|50164154|FG005|Overall Study|Other|0|||
25059681|NCT03019289|50164155|FG006|Overall Study|Other|0|||
25059682|NCT03019289|50164156|FG007|Overall Study|Other|0|||
25059683|NCT03019289|50164157|FG008|Overall Study|Other|0|||
25059684|NCT02520388|50164180|FG000|Overall Study|Physician Decision|1|||
25059685|NCT02520388|50164181|FG001|Overall Study|Physician Decision|0|||
25059686|NCT02520388|50164180|FG000|Overall Study|Subject or parent/guardian request|0|||
25059687|NCT02520388|50164181|FG001|Overall Study|Subject or parent/guardian request|6|||
25059688|NCT02520388|50164180|FG000|Overall Study|Adverse Event|1|||
25059689|NCT02520388|50164181|FG001|Overall Study|Adverse Event|4|||
25059690|NCT02520388|50164180|FG000|Overall Study|Lost to Follow-up|3|||
25059691|NCT02520388|50164181|FG001|Overall Study|Lost to Follow-up|2|||
25059692|NCT02520388|50164180|FG000|Overall Study|Other (reason not defined)|4|||
25059693|NCT02520388|50164181|FG001|Overall Study|Other (reason not defined)|4|||
25059694|NCT02924129|50164189|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
25059695|NCT02924129|50164190|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
25059696|NCT02924129|50164189|FG000|Overall Study|Withdrawal by Subject|2|||
25059697|NCT02924129|50164190|FG001|Overall Study|Withdrawal by Subject|2|||
25059698|NCT02924129|50164189|FG000|Overall Study|Physician Decision|1|||
25059699|NCT02924129|50164190|FG001|Overall Study|Physician Decision|0|||
25059700|NCT02924129|50164189|FG000|Overall Study|Missed Visit|0|||
25059701|NCT02924129|50164190|FG001|Overall Study|Missed Visit|1|||
25059702|NCT02668640|50164196|FG000|Overall Study|Lost to Follow-up|13|||
25059703|NCT02668640|50164196|FG000|Overall Study|Other, not specified|1|||
25059704|NCT03014453|50164200|FG000|Overall Study|Lost to Follow-up|12|||
25059705|NCT03014453|50164200|FG000|Overall Study|Discontinued GER|3|||
25059706|NCT03014453|50164200|FG000|Overall Study|Excluded|19|||
25059707|NCT03014453|50164200|FG000|Overall Study|Refused to take part in|37|||
25059708|NCT02664272|50164204|FG000|Overall Study|Fluoroscopic images not made available|2|||
25059709|NCT02663882|50164210|FG000|Overall Study|Lost to Follow-up|4|||
25059710|NCT02663882|50164211|FG001|Overall Study|Lost to Follow-up|2|||
25059711|NCT03011333|50164224|FG000|Overall Study|Lost to Follow-up|0|||
25059712|NCT03011333|50164225|FG001|Overall Study|Lost to Follow-up|1|||
25059713|NCT03011333|50164226|FG002|Overall Study|Lost to Follow-up|0|||
25059714|NCT03011333|50164227|FG003|Overall Study|Lost to Follow-up|1|||
25059715|NCT03011333|50164228|FG004|Overall Study|Lost to Follow-up|4|||
25059716|NCT03011333|50164229|FG005|Overall Study|Lost to Follow-up|4|||
25059717|NCT03011333|50164230|FG006|Overall Study|Lost to Follow-up|5|||
25059718|NCT03011099|50164248|FG000|Overall Study|Withdrawal by Subject|0|||
25162769|NCT01277302|50285142|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
25059719|NCT03011099|50164249|FG001|Overall Study|Withdrawal by Subject|2|||
25059720|NCT03013985|50164259|FG000|Overall Study|Protocol Violation|2|||
25059721|NCT03013985|50164260|FG001|Overall Study|Protocol Violation|2|||
25059722|NCT03013985|50164259|FG000|Overall Study|Withdrawal by Subject|14|||
25059723|NCT03013985|50164260|FG001|Overall Study|Withdrawal by Subject|17|||
25059724|NCT03016403|50164270|FG000|Baseline|Death|5|||
25059725|NCT03016403|50164271|FG001|Baseline|Death|8|||
25059726|NCT03016403|50164272|FG002|Baseline|Death|1|||
25059727|NCT03016403|50164273|FG003|Baseline|Death|0|||
25059728|NCT03016403|50164270|FG000|Baseline|Withdrawal by Subject|2|||
25059729|NCT03016403|50164271|FG001|Baseline|Withdrawal by Subject|8|||
25059730|NCT03016403|50164272|FG002|Baseline|Withdrawal by Subject|4|||
25059731|NCT03016403|50164273|FG003|Baseline|Withdrawal by Subject|10|||
25059732|NCT03016403|50164270|FG000|Baseline|Lost to Follow-up|9|||
25059733|NCT03016403|50164271|FG001|Baseline|Lost to Follow-up|11|||
25059734|NCT03016403|50164272|FG002|Baseline|Lost to Follow-up|6|||
25059735|NCT03016403|50164273|FG003|Baseline|Lost to Follow-up|24|||
25059736|NCT03016403|50164270|FG000|6-week Follow-up|Death|1|||
25059737|NCT03016403|50164271|FG001|6-week Follow-up|Death|4|||
25059738|NCT03016403|50164272|FG002|6-week Follow-up|Death|0|||
25059739|NCT03016403|50164273|FG003|6-week Follow-up|Death|0|||
25059740|NCT03016403|50164270|FG000|6-week Follow-up|Lost to Follow-up|2|||
25059741|NCT03016403|50164271|FG001|6-week Follow-up|Lost to Follow-up|7|||
25059742|NCT03016403|50164272|FG002|6-week Follow-up|Lost to Follow-up|4|||
25059743|NCT03016403|50164273|FG003|6-week Follow-up|Lost to Follow-up|8|||
25059744|NCT03016403|50164270|FG000|6-week Follow-up|Withdrawal by Subject|0|||
25059745|NCT03016403|50164271|FG001|6-week Follow-up|Withdrawal by Subject|2|||
25059746|NCT03016403|50164272|FG002|6-week Follow-up|Withdrawal by Subject|0|||
25059747|NCT03016403|50164273|FG003|6-week Follow-up|Withdrawal by Subject|1|||
25059748|NCT03016403|50164270|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
25059749|NCT03016403|50164271|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
25059750|NCT03016403|50164272|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
25059751|NCT03016403|50164273|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
25059752|NCT03016403|50164270|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
25059753|NCT03016403|50164271|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
25059754|NCT03016403|50164272|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
25059755|NCT03016403|50164273|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
25059756|NCT03016403|50164270|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
25059757|NCT03016403|50164271|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
25059758|NCT03016403|50164272|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
25059759|NCT03016403|50164273|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
25059760|NCT02520310|50164285|FG000|At 6 Months Clinical Follow-up|Death|1|||
25059761|NCT02520310|50164285|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
25059762|NCT02520310|50164285|FG000|AT 3 Year Clinical Follow-up|Death|2|||
25059763|NCT02520310|50164285|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
25059764|NCT02520310|50164285|FG000|AT 4 Year Clinical Follow-up|Death|1|||
25162770|NCT01277302|50285143|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
25162771|NCT01277302|50285144|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
24963603|NCT00267098|50053586|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
24963604|NCT00267098|50053587|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
24963605|NCT00267098|50053588|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
24963606|NCT00267098|50053589|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
24963607|NCT00267098|50053590|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
24963608|NCT00267098|50053583|FG000|Overall Study|Subject listed for heart transplant|0|||
24963609|NCT00267098|50053584|FG001|Overall Study|Subject listed for heart transplant|0|||
24963610|NCT00267098|50053585|FG002|Overall Study|Subject listed for heart transplant|0|||
24963611|NCT00267098|50053586|FG003|Overall Study|Subject listed for heart transplant|0|||
24963612|NCT00267098|50053587|FG004|Overall Study|Subject listed for heart transplant|0|||
24963613|NCT00267098|50053588|FG005|Overall Study|Subject listed for heart transplant|0|||
24963614|NCT00267098|50053589|FG006|Overall Study|Subject listed for heart transplant|1|||
24963615|NCT00267098|50053590|FG007|Overall Study|Subject listed for heart transplant|0|||
24963616|NCT00267098|50053583|FG000|Overall Study|Sponsor withdrew subject|0|||
24963617|NCT00267098|50053584|FG001|Overall Study|Sponsor withdrew subject|0|||
24963618|NCT00267098|50053585|FG002|Overall Study|Sponsor withdrew subject|0|||
24963619|NCT00267098|50053586|FG003|Overall Study|Sponsor withdrew subject|1|||
24963620|NCT00267098|50053587|FG004|Overall Study|Sponsor withdrew subject|0|||
24963621|NCT00267098|50053588|FG005|Overall Study|Sponsor withdrew subject|0|||
24963622|NCT00267098|50053589|FG006|Overall Study|Sponsor withdrew subject|0|||
24963623|NCT00267098|50053590|FG007|Overall Study|Sponsor withdrew subject|0|||
25059765|NCT02520310|50164285|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
25059766|NCT02662556|50164291|FG000|Overall Study|Adverse Event|4|||
25059767|NCT02662556|50164291|FG000|Overall Study|Lack of Efficacy|4|||
25059768|NCT02516098|50164298|FG000|Period 1|Protocol Violation|1|||
25059769|NCT02516098|50164299|FG001|Period 1|Protocol Violation|0|||
25059770|NCT02516098|50164298|FG000|Washout After Period 1|Adverse Event|0|||
25059771|NCT02516098|50164299|FG001|Washout After Period 1|Adverse Event|1|||
25059772|NCT02516098|50164298|FG000|Period 2|Withdrawal by Subject|0|||
25059773|NCT02516098|50164299|FG001|Period 2|Withdrawal by Subject|1|||
25059774|NCT01364428|50164307|FG000|Overall Study|Adverse Event|1|||
25059775|NCT01364428|50164308|FG001|Overall Study|Adverse Event|2|||
25059776|NCT01364428|50164307|FG000|Overall Study|Protocol Violation|2|||
25059777|NCT01364428|50164308|FG001|Overall Study|Protocol Violation|0|||
25059778|NCT01364428|50164307|FG000|Overall Study|Withdrawal Criteria|14|||
25059779|NCT01364428|50164308|FG001|Overall Study|Withdrawal Criteria|10|||
25059780|NCT01364428|50164307|FG000|Overall Study|Other|3|||
25059781|NCT01364428|50164308|FG001|Overall Study|Other|3|||
25059782|NCT02515942|50164317|FG000|Overall Study|Adverse Event|5|||
25059783|NCT02515942|50164318|FG001|Overall Study|Adverse Event|0|||
25059784|NCT02515942|50164319|FG002|Overall Study|Adverse Event|0|||
25059785|NCT02515942|50164317|FG000|Overall Study|Death|0|||
25059786|NCT02515942|50164318|FG001|Overall Study|Death|0|||
25059787|NCT02515942|50164319|FG002|Overall Study|Death|1|||
25059788|NCT02515942|50164317|FG000|Overall Study|Lack of Efficacy|0|||
25059789|NCT02515942|50164318|FG001|Overall Study|Lack of Efficacy|0|||
25059790|NCT02515942|50164319|FG002|Overall Study|Lack of Efficacy|1|||
25059791|NCT02515942|50164317|FG000|Overall Study|Lost to Follow-up|2|||
25059792|NCT02515942|50164318|FG001|Overall Study|Lost to Follow-up|0|||
25059793|NCT02515942|50164319|FG002|Overall Study|Lost to Follow-up|0|||
25059794|NCT02515942|50164317|FG000|Overall Study|Withdrawal by Subject|0|||
25059795|NCT02515942|50164318|FG001|Overall Study|Withdrawal by Subject|3|||
25059796|NCT02515942|50164319|FG002|Overall Study|Withdrawal by Subject|2|||
25059797|NCT02991859|50164346|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
25059798|NCT02991859|50164347|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
25059799|NCT02991859|50164348|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
25059800|NCT02991859|50164349|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
25059801|NCT02991859|50164350|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
25059802|NCT02991859|50164351|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
25059803|NCT02991859|50164352|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
25059804|NCT02991859|50164353|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
25059805|NCT02991859|50164354|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
25059806|NCT02991859|50164355|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
25059807|NCT02991859|50164356|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
25059808|NCT02991859|50164357|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
25059809|NCT02991859|50164358|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
25059810|NCT02991859|50164359|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
25059811|NCT02991859|50164360|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
25059812|NCT02991859|50164361|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
25059813|NCT02991859|50164362|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
25059814|NCT02991859|50164346|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
25059815|NCT02991859|50164347|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
25059816|NCT02991859|50164348|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
25059817|NCT02991859|50164349|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
25059818|NCT02991859|50164350|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
25059819|NCT02991859|50164351|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
25059820|NCT02991859|50164352|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
25059821|NCT02991859|50164353|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
25059822|NCT02991859|50164354|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
25059823|NCT02991859|50164355|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
25059824|NCT02991859|50164356|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
25059825|NCT02991859|50164357|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
25059826|NCT02991859|50164358|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
25059827|NCT02991859|50164359|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
25059828|NCT02991859|50164360|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
25059829|NCT02991859|50164361|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
25059830|NCT02991859|50164362|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
25059831|NCT02991859|50164346|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
25059832|NCT02991859|50164347|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
25059833|NCT02991859|50164348|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
25059834|NCT02991859|50164349|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
25059835|NCT02991859|50164350|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
24963624|NCT00247676|50053613|FG000|Overall Study|Death|5|||
25059836|NCT02991859|50164351|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
25059837|NCT02991859|50164352|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
25059838|NCT02991859|50164353|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
25059839|NCT02991859|50164354|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
25059840|NCT02991859|50164355|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
25059841|NCT02991859|50164356|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
25059842|NCT02991859|50164357|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
25059843|NCT02991859|50164358|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
25059844|NCT02991859|50164359|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
25059845|NCT02991859|50164360|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
25059846|NCT02991859|50164361|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
25059847|NCT02991859|50164362|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
25059848|NCT02991859|50164346|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
25059849|NCT02991859|50164347|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
25059850|NCT02991859|50164348|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
25059851|NCT02991859|50164349|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
25059852|NCT02991859|50164350|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
25059853|NCT02991859|50164351|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
25059854|NCT02991859|50164352|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
25059855|NCT02991859|50164353|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
25059856|NCT02991859|50164354|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
25059857|NCT02991859|50164355|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
25059858|NCT02991859|50164356|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
25059859|NCT02991859|50164357|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
24963625|NCT00247676|50053613|FG000|Overall Study|Adverse Event|11|||
24963626|NCT00247676|50053613|FG000|Overall Study|Lack of Efficacy|15|||
24963627|NCT00247676|50053613|FG000|Overall Study|Other|3|||
24963628|NCT00247676|50053613|FG000|Overall Study|Withdrawal by Subject|2|||
24963629|NCT00267020|50053619|FG000|Overall Study|Adverse Event|22|||
24963630|NCT00267020|50053620|FG001|Overall Study|Adverse Event|5|||
24963631|NCT00267020|50053619|FG000|Overall Study|Death|2|||
24963632|NCT00267020|50053620|FG001|Overall Study|Death|1|||
24963633|NCT00267020|50053619|FG000|Overall Study|Withdrawal by Subject|17|||
24963634|NCT00267020|50053620|FG001|Overall Study|Withdrawal by Subject|7|||
24963635|NCT00267020|50053619|FG000|Overall Study|Physician Decision|3|||
24963636|NCT00267020|50053620|FG001|Overall Study|Physician Decision|2|||
24963637|NCT00267020|50053619|FG000|Overall Study|Disease Progression|39|||
24963638|NCT00267020|50053620|FG001|Overall Study|Disease Progression|25|||
24963639|NCT00267020|50053619|FG000|Overall Study|Unrelated Complication|1|||
24963640|NCT00267020|50053620|FG001|Overall Study|Unrelated Complication|1|||
24963641|NCT00267020|50053619|FG000|Overall Study|Sponsor Request|1|||
25059860|NCT02991859|50164358|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
25059861|NCT02991859|50164359|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
25059862|NCT02991859|50164360|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
24963642|NCT00267020|50053620|FG001|Overall Study|Sponsor Request|0|||
24963643|NCT00267020|50053619|FG000|Overall Study|Other|1|||
24963644|NCT00267020|50053620|FG001|Overall Study|Other|2|||
24963645|NCT00242216|50053628|FG000|Overall Study|Lost to Follow-up|12|||
24963646|NCT00242216|50053629|FG001|Overall Study|Lost to Follow-up|17|||
24963647|NCT00242216|50053628|FG000|Overall Study|Death|4|||
24963648|NCT00242216|50053629|FG001|Overall Study|Death|2|||
25059863|NCT02991859|50164361|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
25059864|NCT02991859|50164362|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
25059865|NCT02991859|50164346|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
25059866|NCT02991859|50164347|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
25059867|NCT02991859|50164348|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
25059868|NCT02991859|50164349|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
25059869|NCT02991859|50164350|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
25059870|NCT02991859|50164351|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
25059871|NCT02991859|50164352|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
25059872|NCT02991859|50164353|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
25059873|NCT02991859|50164354|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
25059874|NCT02991859|50164355|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
25059875|NCT02991859|50164356|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
25059876|NCT02991859|50164357|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
25059877|NCT02991859|50164358|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
25059878|NCT02991859|50164359|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
25059879|NCT02991859|50164360|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
25059880|NCT02991859|50164361|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
25059881|NCT02991859|50164362|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
25059882|NCT03016325|50164445|FG000|Treatment Period|Participant withdrew consent|0|||
25059883|NCT03016325|50164446|FG001|Treatment Period|Participant withdrew consent|1|||
25059884|NCT03016325|50164447|FG002|Treatment Period|Participant withdrew consent|0|||
25059885|NCT03016325|50164448|FG003|Treatment Period|Participant withdrew consent|0|||
25059886|NCT03016325|50164449|FG004|Treatment Period|Participant withdrew consent|0|||
25059887|NCT03016325|50164450|FG005|Treatment Period|Participant withdrew consent|0|||
25059888|NCT03016325|50164451|FG006|Treatment Period|Participant withdrew consent|0|||
25059889|NCT03016325|50164452|FG007|Treatment Period|Participant withdrew consent|0|||
25059890|NCT03016325|50164445|FG000|Treatment Period|Death|0|||
25059891|NCT03016325|50164446|FG001|Treatment Period|Death|0|||
25059892|NCT03016325|50164447|FG002|Treatment Period|Death|0|||
25059893|NCT03016325|50164448|FG003|Treatment Period|Death|0|||
25059894|NCT03016325|50164449|FG004|Treatment Period|Death|2|||
25059895|NCT03016325|50164450|FG005|Treatment Period|Death|0|||
25059896|NCT03016325|50164451|FG006|Treatment Period|Death|0|||
25059897|NCT03016325|50164452|FG007|Treatment Period|Death|0|||
25059898|NCT03016325|50164445|FG000|Treatment Period|Participant refuses assessments|0|||
25059899|NCT03016325|50164446|FG001|Treatment Period|Participant refuses assessments|0|||
25059900|NCT03016325|50164447|FG002|Treatment Period|Participant refuses assessments|1|||
25059901|NCT03016325|50164448|FG003|Treatment Period|Participant refuses assessments|0|||
25059902|NCT03016325|50164449|FG004|Treatment Period|Participant refuses assessments|0|||
25059903|NCT03016325|50164450|FG005|Treatment Period|Participant refuses assessments|0|||
25059904|NCT03016325|50164451|FG006|Treatment Period|Participant refuses assessments|0|||
25059905|NCT03016325|50164452|FG007|Treatment Period|Participant refuses assessments|0|||
25059906|NCT03016325|50164445|FG000|32-Day Follow-Up Period|Death|2|||
25059907|NCT03016325|50164446|FG001|32-Day Follow-Up Period|Death|0|||
25059908|NCT03016325|50164447|FG002|32-Day Follow-Up Period|Death|5|||
25059909|NCT03016325|50164448|FG003|32-Day Follow-Up Period|Death|6|||
25059910|NCT03016325|50164449|FG004|32-Day Follow-Up Period|Death|3|||
25059911|NCT03016325|50164450|FG005|32-Day Follow-Up Period|Death|0|||
25059912|NCT03016325|50164451|FG006|32-Day Follow-Up Period|Death|0|||
25059913|NCT03016325|50164452|FG007|32-Day Follow-Up Period|Death|0|||
25059914|NCT03016325|50164445|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
25059915|NCT03016325|50164446|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
25059916|NCT03016325|50164447|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
24963649|NCT00242216|50053628|FG000|Overall Study|Lack of Efficacy|1|||
24963650|NCT00242216|50053629|FG001|Overall Study|Lack of Efficacy|2|||
24963651|NCT00242216|50053628|FG000|Overall Study|no medicaiton dispensed|1|||
24963652|NCT00242216|50053629|FG001|Overall Study|no medicaiton dispensed|1|||
24963653|NCT00240110|50053637|FG000|Overall Study|Lost to Follow-up|6|||
24963654|NCT00240110|50053638|FG001|Overall Study|Lost to Follow-up|7|||
24963655|NCT00239720|50053648|FG000|Overall Study|Adverse Event|1|||
24963656|NCT00239720|50053649|FG001|Overall Study|Adverse Event|0|||
25059917|NCT03016325|50164448|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
25059918|NCT03016325|50164449|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
25059919|NCT03016325|50164450|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
25059920|NCT03016325|50164451|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
25059921|NCT03016325|50164452|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
25059922|NCT03016325|50164445|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
25059923|NCT03016325|50164446|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
25059924|NCT03016325|50164447|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
24963657|NCT00239720|50053648|FG000|Overall Study|Lost to Follow-up|0|||
24963658|NCT00239720|50053649|FG001|Overall Study|Lost to Follow-up|1|||
25059925|NCT03016325|50164448|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
25059926|NCT03016325|50164449|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
25059927|NCT03016325|50164450|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
25059928|NCT03016325|50164451|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
25059929|NCT03016325|50164452|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
25059930|NCT03016325|50164445|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
25059931|NCT03016325|50164446|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
25059932|NCT03016325|50164447|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
25059933|NCT03016325|50164448|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
25059934|NCT03016325|50164449|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
25059935|NCT03016325|50164450|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
25059936|NCT03016325|50164451|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
25059937|NCT03016325|50164452|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
25059938|NCT03016325|50164445|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
25059939|NCT03016325|50164446|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
25059940|NCT03016325|50164447|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
25059941|NCT03016325|50164448|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
25059942|NCT03016325|50164449|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
25059943|NCT03016325|50164450|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
25059944|NCT03016325|50164451|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
25059945|NCT03016325|50164452|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
25059946|NCT03016325|50164445|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
25059947|NCT03016325|50164446|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
25059948|NCT03016325|50164447|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
25059949|NCT03016325|50164448|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
25059950|NCT03016325|50164449|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
25059951|NCT03016325|50164450|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
25059952|NCT03016325|50164451|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
25059953|NCT03016325|50164452|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
25059954|NCT03016325|50164445|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
25059955|NCT03016325|50164446|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
25059956|NCT03016325|50164447|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
25059957|NCT03016325|50164448|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
25059958|NCT03016325|50164449|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
25059959|NCT03016325|50164450|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
25059960|NCT03016325|50164451|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
25059961|NCT03016325|50164452|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
25059962|NCT03016325|50164445|FG000|182-Day Follow-Up Period|Death|3|||
25059963|NCT03016325|50164446|FG001|182-Day Follow-Up Period|Death|3|||
25059964|NCT03016325|50164447|FG002|182-Day Follow-Up Period|Death|11|||
25059965|NCT03016325|50164448|FG003|182-Day Follow-Up Period|Death|12|||
25059966|NCT03016325|50164449|FG004|182-Day Follow-Up Period|Death|9|||
25059967|NCT03016325|50164450|FG005|182-Day Follow-Up Period|Death|0|||
25059968|NCT03016325|50164451|FG006|182-Day Follow-Up Period|Death|0|||
25059969|NCT03016325|50164452|FG007|182-Day Follow-Up Period|Death|1|||
25059970|NCT03016325|50164445|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
25059971|NCT03016325|50164446|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
25059972|NCT03016325|50164447|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
25059973|NCT03016325|50164448|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
25059974|NCT03016325|50164449|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
25059975|NCT03016325|50164450|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
25059976|NCT03016325|50164451|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
25059977|NCT03016325|50164452|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
25059978|NCT03016325|50164445|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
25059979|NCT03016325|50164446|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
25059980|NCT03016325|50164447|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
25059981|NCT03016325|50164448|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
25059982|NCT03016325|50164449|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
25059983|NCT03016325|50164450|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
25059984|NCT03016325|50164451|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
25059985|NCT03016325|50164452|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
25059986|NCT03016325|50164445|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
25059987|NCT03016325|50164446|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
25059988|NCT03016325|50164447|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
25059989|NCT03016325|50164448|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
25162772|NCT01277302|50285142|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
25162773|NCT01277302|50285143|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
25162774|NCT01277302|50285144|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
25162775|NCT01277302|50285142|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
25162776|NCT01277302|50285143|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
25162777|NCT01277302|50285144|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
25162778|NCT01277302|50285142|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
25162779|NCT01277302|50285143|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
25162780|NCT01277302|50285144|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
25162781|NCT01980875|50285155|FG000|Overall Study|Withdrew Consent|1|||
25162782|NCT01980875|50285156|FG001|Overall Study|Withdrew Consent|1|||
25162783|NCT01980875|50285157|FG002|Overall Study|Withdrew Consent|1|||
25162784|NCT01980875|50285155|FG000|Overall Study|Study Terminated by Sponsor|7|||
25162785|NCT01980875|50285156|FG001|Overall Study|Study Terminated by Sponsor|24|||
25162786|NCT01980875|50285157|FG002|Overall Study|Study Terminated by Sponsor|22|||
25162787|NCT01980875|50285155|FG000|Overall Study|Lost to Follow-up|0|||
25162788|NCT01980875|50285156|FG001|Overall Study|Lost to Follow-up|0|||
25162789|NCT01980875|50285157|FG002|Overall Study|Lost to Follow-up|1|||
25162790|NCT01995461|50285165|FG000|Overall Study|Death|1|||
25162791|NCT01995461|50285165|FG000|Overall Study|Lost to Follow-up|2|||
25162792|NCT01995461|50285165|FG000|Overall Study|Withdrawal by Subject|2|||
25162793|NCT01980095|50285171|FG000|Overall Study|Lost to Follow-up|6|||
25162794|NCT01980095|50285172|FG001|Overall Study|Lost to Follow-up|7|||
25162795|NCT01980095|50285171|FG000|Overall Study|Withdrawal by Subject|2|||
25162796|NCT01980095|50285172|FG001|Overall Study|Withdrawal by Subject|3|||
25162797|NCT01980095|50285171|FG000|Overall Study|Poor compliance|5|||
25162798|NCT01980095|50285172|FG001|Overall Study|Poor compliance|0|||
25059990|NCT03016325|50164449|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
25059991|NCT03016325|50164450|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
25059992|NCT03016325|50164451|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
25059993|NCT03016325|50164452|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
25059994|NCT03016325|50164445|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
25059995|NCT03016325|50164446|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
25059996|NCT03016325|50164447|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
25059997|NCT03016325|50164448|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
25059998|NCT03016325|50164449|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
24963659|NCT00266864|50053657|FG000|Overall Study|Lost to Follow-up|4|||
24963660|NCT00266864|50053658|FG001|Overall Study|Lost to Follow-up|1|||
24963661|NCT00266864|50053657|FG000|Overall Study|Withdrawal by Subject|1|||
24963662|NCT00266864|50053658|FG001|Overall Study|Withdrawal by Subject|1|||
24963663|NCT00266708|50053666|FG000|Overall Study|No renal function|1|||
24963664|NCT00266708|50053667|FG001|Overall Study|No renal function|1|||
24963665|NCT00266708|50053666|FG000|Overall Study|Refused biopsy|3|||
24963666|NCT00266708|50053667|FG001|Overall Study|Refused biopsy|6|||
24963667|NCT00266708|50053666|FG000|Overall Study|Asthma|0|||
24963668|NCT00266708|50053667|FG001|Overall Study|Asthma|2|||
24963669|NCT00266630|50053675|FG000|Overall Study|Adverse Event|8|||
24963670|NCT00266630|50053676|FG001|Overall Study|Adverse Event|6|||
24963671|NCT00266630|50053675|FG000|Overall Study|Lack of Efficacy|1|||
24963672|NCT00266630|50053676|FG001|Overall Study|Lack of Efficacy|4|||
24963673|NCT00266630|50053675|FG000|Overall Study|Entry Criteria not met|1|||
24963674|NCT00266630|50053676|FG001|Overall Study|Entry Criteria not met|0|||
24963675|NCT00266630|50053675|FG000|Overall Study|Protocol Violation|1|||
24963676|NCT00266630|50053676|FG001|Overall Study|Protocol Violation|3|||
24963677|NCT00266630|50053675|FG000|Overall Study|Physician Decision|1|||
24963678|NCT00266630|50053676|FG001|Overall Study|Physician Decision|2|||
24963679|NCT00266630|50053675|FG000|Overall Study|Withdrawal by Subject|10|||
24963680|NCT00266630|50053676|FG001|Overall Study|Withdrawal by Subject|2|||
24963681|NCT00266630|50053675|FG000|Overall Study|Lost to Follow-up|1|||
24963682|NCT00266630|50053676|FG001|Overall Study|Lost to Follow-up|0|||
24963683|NCT00266630|50053675|FG000|Overall Study|Other|19|||
24963684|NCT00266630|50053676|FG001|Overall Study|Other|11|||
24963685|NCT00129129|50053687|FG000|Primary Phase|Adverse Event|2|||
24963686|NCT00129129|50053688|FG001|Primary Phase|Adverse Event|1|||
24963687|NCT00129129|50053689|FG002|Primary Phase|Adverse Event|0|||
24963688|NCT00129129|50053690|FG003|Primary Phase|Adverse Event|0|||
24963689|NCT00129129|50053691|FG004|Primary Phase|Adverse Event|0|||
24963690|NCT00129129|50053687|FG000|Primary Phase|Withdrawal by Subject|12|||
25059999|NCT03016325|50164450|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
24963691|NCT00129129|50053688|FG001|Primary Phase|Withdrawal by Subject|10|||
24963692|NCT00129129|50053689|FG002|Primary Phase|Withdrawal by Subject|0|||
24963693|NCT00129129|50053690|FG003|Primary Phase|Withdrawal by Subject|0|||
24963694|NCT00129129|50053691|FG004|Primary Phase|Withdrawal by Subject|0|||
24963695|NCT00129129|50053687|FG000|Primary Phase|Migration from study area|1|||
24963696|NCT00129129|50053688|FG001|Primary Phase|Migration from study area|3|||
25162799|NCT01980095|50285171|FG000|Overall Study|Safety issue|0|||
25162800|NCT01980095|50285172|FG001|Overall Study|Safety issue|1|||
24963697|NCT00129129|50053689|FG002|Primary Phase|Migration from study area|0|||
24963698|NCT00129129|50053690|FG003|Primary Phase|Migration from study area|0|||
25162801|NCT01980095|50285171|FG000|Overall Study|Study drug discontinued|1|||
24963699|NCT00129129|50053691|FG004|Primary Phase|Migration from study area|0|||
24963700|NCT00129129|50053687|FG000|Primary Phase|Lost to Follow-up|8|||
25060000|NCT03016325|50164451|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
25060001|NCT03016325|50164452|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
25060002|NCT03016325|50164445|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
25060003|NCT03016325|50164446|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
25060004|NCT03016325|50164447|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
25060005|NCT03016325|50164448|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
25060006|NCT03016325|50164449|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
25060007|NCT03016325|50164450|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
25060008|NCT03016325|50164451|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
25060009|NCT03016325|50164452|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
25060010|NCT03016325|50164445|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
25060011|NCT03016325|50164446|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
25060012|NCT03016325|50164447|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
25060013|NCT03016325|50164448|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
25060014|NCT03016325|50164449|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
25060015|NCT03016325|50164450|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
25060016|NCT03016325|50164451|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
25060017|NCT03016325|50164452|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
25060018|NCT03016325|50164445|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
25060019|NCT03016325|50164446|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
25060020|NCT03016325|50164447|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
25060021|NCT03016325|50164448|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
25060022|NCT03016325|50164449|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
25060023|NCT03016325|50164450|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
25060024|NCT03016325|50164451|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
25060025|NCT03016325|50164452|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
25060026|NCT02988115|50164475|FG000|Overall Study|Adverse Event|6|||
25060027|NCT02988115|50164476|FG001|Overall Study|Adverse Event|1|||
25060028|NCT02988115|50164475|FG000|Overall Study|Sponsor Decision|5|||
25060029|NCT02988115|50164476|FG001|Overall Study|Sponsor Decision|2|||
25060030|NCT02988115|50164475|FG000|Overall Study|Withdrawal by Subject|1|||
25060031|NCT02988115|50164476|FG001|Overall Study|Withdrawal by Subject|1|||
25060032|NCT02988115|50164475|FG000|Overall Study|Withdrawn by Mistake|1|||
25060033|NCT02988115|50164476|FG001|Overall Study|Withdrawn by Mistake|0|||
25060034|NCT02988115|50164475|FG000|Overall Study|Lost to Follow-up|1|||
25060035|NCT02988115|50164476|FG001|Overall Study|Lost to Follow-up|0|||
25060036|NCT02921425|50164482|FG000|Overall Study|Protocol Violation|9|||
25060037|NCT03008915|50164486|FG000|Treatment 1|Withdrawal by Subject|0|||
25060038|NCT03008915|50164487|FG001|Treatment 1|Withdrawal by Subject|1|||
25060039|NCT02920957|50164498|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
25060040|NCT02920957|50164499|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
25060041|NCT02920957|50164498|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
25060042|NCT02920957|50164499|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
25060043|NCT02920957|50164498|FG000|First Intervention : 1 Month|Adverse Event|1|||
25060044|NCT02920957|50164499|FG001|First Intervention : 1 Month|Adverse Event|0|||
25060045|NCT02920957|50164498|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
25060046|NCT02920957|50164499|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
25060047|NCT03006887|50164516|FG000|Overall Study|Adverse Event|1|||
25060048|NCT02514772|50164522|FG000|Overall Study|Adverse Event|1|||
25060049|NCT02514772|50164523|FG001|Overall Study|Adverse Event|0|||
25060050|NCT02514772|50164522|FG000|Overall Study|Death|0|||
25060051|NCT02514772|50164523|FG001|Overall Study|Death|1|||
25060052|NCT02514772|50164522|FG000|Overall Study|Withdrawal by Subject|2|||
25060053|NCT02514772|50164523|FG001|Overall Study|Withdrawal by Subject|1|||
25060054|NCT03000179|50164531|FG000|Overall Study|Lost to Follow-up|2|||
25060055|NCT02920177|50164537|FG000|Overall Study|Withdrawal by Subject|1|||
25060056|NCT02920177|50164538|FG001|Overall Study|Withdrawal by Subject|1|||
25060057|NCT02920177|50164537|FG000|Overall Study|Physician Decision|1|||
25060058|NCT02920177|50164538|FG001|Overall Study|Physician Decision|0|||
25060059|NCT02920177|50164537|FG000|Overall Study|Lost to Follow-up|0|||
25162802|NCT01980095|50285172|FG001|Overall Study|Study drug discontinued|0|||
24963701|NCT00129129|50053688|FG001|Primary Phase|Lost to Follow-up|6|||
24963702|NCT00129129|50053689|FG002|Primary Phase|Lost to Follow-up|0|||
24963703|NCT00129129|50053690|FG003|Primary Phase|Lost to Follow-up|0|||
24963704|NCT00129129|50053691|FG004|Primary Phase|Lost to Follow-up|0|||
25060060|NCT02920177|50164538|FG001|Overall Study|Lost to Follow-up|1|||
25060061|NCT03006341|50164548|FG000|Overall Study|Not linked in the EMR|25069|||
25060062|NCT03006341|50164549|FG001|Overall Study|Not linked in the EMR|67505|||
25060063|NCT03006341|50164550|FG002|Overall Study|Not linked in the EMR|30993|||
25060064|NCT03006341|50164551|FG003|Overall Study|Not linked in the EMR|10685|||
25060065|NCT03935594|50164559|FG000|Overall Study|Physician Decision|3|||
25060066|NCT02512042|50164567|FG000|Overall Study|Adverse Event|0|||
25060067|NCT02512042|50164568|FG001|Overall Study|Adverse Event|4|||
25060068|NCT02512042|50164567|FG000|Overall Study|Withdrawal by Subject|6|||
25060069|NCT02512042|50164568|FG001|Overall Study|Withdrawal by Subject|6|||
25060070|NCT02512042|50164567|FG000|Overall Study|Non-compliance with study drug|1|||
25060071|NCT02512042|50164568|FG001|Overall Study|Non-compliance with study drug|2|||
25060072|NCT02512042|50164567|FG000|Overall Study|Lost to Follow-up|5|||
25060073|NCT02512042|50164568|FG001|Overall Study|Lost to Follow-up|2|||
25060074|NCT02512042|50164567|FG000|Overall Study|Other|11|||
25060075|NCT02512042|50164568|FG001|Overall Study|Other|11|||
25060076|NCT02911025|50164574|FG000|Overall Study|Lost to Follow-up|3|||
25060077|NCT02919475|50164583|FG000|Overall Study|Adverse Event|3|||
25060078|NCT02919475|50164584|FG001|Overall Study|Adverse Event|3|||
25060079|NCT02919475|50164585|FG002|Overall Study|Adverse Event|3|||
25060080|NCT02919475|50164586|FG003|Overall Study|Adverse Event|9|||
25060081|NCT02919475|50164587|FG004|Overall Study|Adverse Event|2|||
25060082|NCT02919475|50164583|FG000|Overall Study|Death|0|||
25060083|NCT02919475|50164584|FG001|Overall Study|Death|1|||
25060084|NCT02919475|50164585|FG002|Overall Study|Death|0|||
25060085|NCT02919475|50164586|FG003|Overall Study|Death|0|||
25060086|NCT02919475|50164587|FG004|Overall Study|Death|0|||
25060087|NCT02919475|50164583|FG000|Overall Study|Lost to Follow-up|0|||
25060088|NCT02919475|50164584|FG001|Overall Study|Lost to Follow-up|0|||
25060089|NCT02919475|50164585|FG002|Overall Study|Lost to Follow-up|0|||
25060090|NCT02919475|50164586|FG003|Overall Study|Lost to Follow-up|1|||
25060091|NCT02919475|50164587|FG004|Overall Study|Lost to Follow-up|0|||
25060092|NCT02919475|50164583|FG000|Overall Study|Withdrawal by Subject|2|||
25060093|NCT02919475|50164584|FG001|Overall Study|Withdrawal by Subject|3|||
25060094|NCT02919475|50164585|FG002|Overall Study|Withdrawal by Subject|1|||
25060095|NCT02919475|50164586|FG003|Overall Study|Withdrawal by Subject|2|||
25060096|NCT02919475|50164587|FG004|Overall Study|Withdrawal by Subject|2|||
25060097|NCT02919475|50164583|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
25060098|NCT02919475|50164584|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
25060099|NCT02919475|50164585|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
25060100|NCT02919475|50164586|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
25060101|NCT02919475|50164587|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
25060102|NCT01066897|50164601|FG000|Overall Study|Withdrawal by Subject|1|||
25060103|NCT01066897|50164602|FG001|Overall Study|Withdrawal by Subject|0|||
25060104|NCT01066897|50164601|FG000|Overall Study|stopped study after developing the flu.|1|||
25060105|NCT01066897|50164602|FG001|Overall Study|stopped study after developing the flu.|0|||
25060106|NCT02985541|50164609|FG000|Overall Study|Withdrawal by Subject|33|||
25060107|NCT02985541|50164609|FG000|Overall Study|Lost to Follow-up|26|||
25060108|NCT02985541|50164609|FG000|Overall Study|Adverse Event|27|||
25060109|NCT02985541|50164609|FG000|Overall Study|Physician Decision|2|||
25060110|NCT02985541|50164609|FG000|Overall Study|Pregnancy|2|||
25060111|NCT02985541|50164609|FG000|Overall Study|Wish for pregnancy|44|||
25060112|NCT02985541|50164609|FG000|Overall Study|Other reason|5|||
25060113|NCT02985541|50164609|FG000|Overall Study|Not valid for analysis|2|||
25060114|NCT02910037|50164622|FG000|Overall Study|Withdrawal by Subject|4|||
25060115|NCT02910037|50164622|FG000|Overall Study|Lost to Follow-up|6|||
25060116|NCT02511184|50164657|FG000|Overall Study|Death|1|||
25060117|NCT02511184|50164658|FG001|Overall Study|Death|0|||
25060118|NCT02511184|50164657|FG000|Overall Study|Lost to Follow-up|0|||
25060119|NCT02511184|50164658|FG001|Overall Study|Lost to Follow-up|1|||
25060120|NCT02511184|50164657|FG000|Overall Study|Study terminated by sponsor|1|||
25060121|NCT02511184|50164658|FG001|Overall Study|Study terminated by sponsor|5|||
25060122|NCT02511184|50164657|FG000|Overall Study|Withdrawal by Subject|0|||
25060123|NCT02511184|50164658|FG001|Overall Study|Withdrawal by Subject|1|||
25060124|NCT02984995|50164667|FG000|Overall Study|Required stem cell transplant|13|||
25060125|NCT02984995|50164668|FG001|Overall Study|Required stem cell transplant|2|||
25060126|NCT02984995|50164667|FG000|Overall Study|Progressive disease|11|||
25060127|NCT02984995|50164668|FG001|Overall Study|Progressive disease|1|||
25060128|NCT02984995|50164667|FG000|Overall Study|Adverse Event|1|||
25060129|NCT02984995|50164668|FG001|Overall Study|Adverse Event|0|||
25060130|NCT02984683|50164692|FG000|Overall Study|Adverse Event|3|||
25060131|NCT02984683|50164693|FG001|Overall Study|Adverse Event|3|||
25060132|NCT02984683|50164692|FG000|Overall Study|Withdrawal by Subject|1|||
25060133|NCT02984683|50164693|FG001|Overall Study|Withdrawal by Subject|0|||
25060134|NCT02984683|50164692|FG000|Overall Study|Disease progression|7|||
25060135|NCT02984683|50164693|FG001|Overall Study|Disease progression|9|||
25060136|NCT02909101|50164701|FG000|Overall Study|Lost to Follow-up|1|||
25060137|NCT02909101|50164702|FG001|Overall Study|Lost to Follow-up|1|||
25060138|NCT03004469|50164711|FG000|Overall Study|Adverse Event|6|||
25060139|NCT03004469|50164712|FG001|Overall Study|Adverse Event|4|||
25060140|NCT03004469|50164713|FG002|Overall Study|Adverse Event|6|||
25060141|NCT03004469|50164711|FG000|Overall Study|Lack of Efficacy|1|||
25060142|NCT03004469|50164712|FG001|Overall Study|Lack of Efficacy|0|||
25060143|NCT03004469|50164713|FG002|Overall Study|Lack of Efficacy|1|||
25060144|NCT03004469|50164711|FG000|Overall Study|Lost to Follow-up|23|||
25060145|NCT03004469|50164712|FG001|Overall Study|Lost to Follow-up|14|||
25060146|NCT03004469|50164713|FG002|Overall Study|Lost to Follow-up|6|||
25060147|NCT03004469|50164711|FG000|Overall Study|Non-Compliance with Study Drug|2|||
25060148|NCT03004469|50164712|FG001|Overall Study|Non-Compliance with Study Drug|0|||
25060149|NCT03004469|50164713|FG002|Overall Study|Non-Compliance with Study Drug|0|||
25060150|NCT03004469|50164711|FG000|Overall Study|Protocol Violation|0|||
25060151|NCT03004469|50164712|FG001|Overall Study|Protocol Violation|0|||
25060152|NCT03004469|50164713|FG002|Overall Study|Protocol Violation|1|||
25060153|NCT03004469|50164711|FG000|Overall Study|Withdrawal by Subject|29|||
25060154|NCT03004469|50164712|FG001|Overall Study|Withdrawal by Subject|27|||
25060155|NCT03004469|50164713|FG002|Overall Study|Withdrawal by Subject|10|||
25060156|NCT03004469|50164711|FG000|Overall Study|Other unspecified reason|0|||
25060157|NCT03004469|50164712|FG001|Overall Study|Other unspecified reason|4|||
25060158|NCT03004469|50164713|FG002|Overall Study|Other unspecified reason|1|||
25060159|NCT02910713|50164722|FG000|Overall Study|Protocol Violation|2|||
25060160|NCT02910713|50164722|FG000|Overall Study|Subject Choice|4|||
25060161|NCT02910713|50164722|FG000|Overall Study|Received One Application|10|||
25060162|NCT02910713|50164722|FG000|Overall Study|Received Neither Application|18|||
25060163|NCT02910713|50164722|FG000|Overall Study|Enrollment cap|7|||
25060164|NCT02910713|50164722|FG000|Overall Study|Investigator Discretion|1|||
25060165|NCT02998541|50164730|FG000|Overall Study|Adverse Event|4|||
25060166|NCT02998541|50164731|FG001|Overall Study|Adverse Event|5|||
25060167|NCT02998541|50164732|FG002|Overall Study|Adverse Event|1|||
25060168|NCT02998541|50164730|FG000|Overall Study|Protocol Violation|1|||
25060169|NCT02998541|50164731|FG001|Overall Study|Protocol Violation|0|||
25060170|NCT02998541|50164732|FG002|Overall Study|Protocol Violation|0|||
25060171|NCT02998541|50164730|FG000|Overall Study|Withdrawal by Subject|3|||
25060172|NCT02998541|50164731|FG001|Overall Study|Withdrawal by Subject|1|||
25060173|NCT02998541|50164732|FG002|Overall Study|Withdrawal by Subject|0|||
25060174|NCT02998541|50164730|FG000|Overall Study|Lost to Follow-up|0|||
25060175|NCT02998541|50164731|FG001|Overall Study|Lost to Follow-up|3|||
25060176|NCT02998541|50164732|FG002|Overall Study|Lost to Follow-up|1|||
25060177|NCT02998541|50164730|FG000|Overall Study|Physician Decision|0|||
25060178|NCT02998541|50164731|FG001|Overall Study|Physician Decision|0|||
25060179|NCT02998541|50164732|FG002|Overall Study|Physician Decision|3|||
25060180|NCT02998541|50164730|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
25060181|NCT02998541|50164731|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
25060182|NCT02998541|50164732|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
25060183|NCT02998151|50164740|FG000|Overall Study|Withdrawal by Subject|3|||
25060184|NCT02998151|50164740|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
25060185|NCT02998151|50164740|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
25060186|NCT01066819|50164771|FG000|Overall Study|Adverse Event|18|||
25060187|NCT01066819|50164772|FG001|Overall Study|Adverse Event|1|||
25060188|NCT01066819|50164773|FG002|Overall Study|Adverse Event|6|||
25060189|NCT01066819|50164774|FG003|Overall Study|Adverse Event|0|||
25060190|NCT01066819|50164775|FG004|Overall Study|Adverse Event|0|||
25060191|NCT01066819|50164776|FG005|Overall Study|Adverse Event|0|||
25060192|NCT01066819|50164771|FG000|Overall Study|Death|5|||
25060193|NCT01066819|50164772|FG001|Overall Study|Death|0|||
25060194|NCT01066819|50164773|FG002|Overall Study|Death|1|||
25060195|NCT01066819|50164774|FG003|Overall Study|Death|0|||
25060196|NCT01066819|50164775|FG004|Overall Study|Death|0|||
25060197|NCT01066819|50164776|FG005|Overall Study|Death|0|||
25060198|NCT01066819|50164771|FG000|Overall Study|Lack of Efficacy|22|||
25060199|NCT01066819|50164772|FG001|Overall Study|Lack of Efficacy|1|||
25060200|NCT01066819|50164773|FG002|Overall Study|Lack of Efficacy|2|||
25060201|NCT01066819|50164774|FG003|Overall Study|Lack of Efficacy|1|||
25060202|NCT01066819|50164775|FG004|Overall Study|Lack of Efficacy|0|||
25060203|NCT01066819|50164776|FG005|Overall Study|Lack of Efficacy|0|||
25060204|NCT01066819|50164771|FG000|Overall Study|Physician Decision|6|||
25060205|NCT01066819|50164772|FG001|Overall Study|Physician Decision|2|||
25060206|NCT01066819|50164773|FG002|Overall Study|Physician Decision|3|||
25060207|NCT01066819|50164774|FG003|Overall Study|Physician Decision|0|||
25060208|NCT01066819|50164775|FG004|Overall Study|Physician Decision|0|||
25060209|NCT01066819|50164776|FG005|Overall Study|Physician Decision|0|||
25060210|NCT01066819|50164771|FG000|Overall Study|Protocol Violation|12|||
25060211|NCT01066819|50164772|FG001|Overall Study|Protocol Violation|6|||
25060212|NCT01066819|50164773|FG002|Overall Study|Protocol Violation|0|||
25060213|NCT01066819|50164774|FG003|Overall Study|Protocol Violation|0|||
24963705|NCT00129129|50053687|FG000|Primary Phase|Other|2|||
25060214|NCT01066819|50164775|FG004|Overall Study|Protocol Violation|0|||
25060215|NCT01066819|50164776|FG005|Overall Study|Protocol Violation|0|||
25060216|NCT01066819|50164771|FG000|Overall Study|Withdrawal by Subject|29|||
25060217|NCT01066819|50164772|FG001|Overall Study|Withdrawal by Subject|11|||
25060218|NCT01066819|50164773|FG002|Overall Study|Withdrawal by Subject|6|||
25060219|NCT01066819|50164774|FG003|Overall Study|Withdrawal by Subject|0|||
25060220|NCT01066819|50164775|FG004|Overall Study|Withdrawal by Subject|0|||
25060221|NCT01066819|50164776|FG005|Overall Study|Withdrawal by Subject|0|||
25060222|NCT01066819|50164771|FG000|Overall Study|Administrative|6|||
25060223|NCT01066819|50164772|FG001|Overall Study|Administrative|4|||
25060224|NCT01066819|50164773|FG002|Overall Study|Administrative|2|||
25060225|NCT01066819|50164774|FG003|Overall Study|Administrative|0|||
25060226|NCT01066819|50164775|FG004|Overall Study|Administrative|0|||
25060227|NCT01066819|50164776|FG005|Overall Study|Administrative|0|||
25060228|NCT01066819|50164771|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
25060229|NCT01066819|50164772|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
25060230|NCT01066819|50164773|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
25060231|NCT01066819|50164774|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
25060232|NCT01066819|50164775|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
25060233|NCT01066819|50164776|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
25060234|NCT01066819|50164771|FG000|Overall Study|Early termination|2|||
25060235|NCT01066819|50164772|FG001|Overall Study|Early termination|0|||
25060236|NCT01066819|50164773|FG002|Overall Study|Early termination|0|||
25060237|NCT01066819|50164774|FG003|Overall Study|Early termination|0|||
25060238|NCT01066819|50164775|FG004|Overall Study|Early termination|0|||
25060239|NCT01066819|50164776|FG005|Overall Study|Early termination|0|||
25060240|NCT01066819|50164771|FG000|Overall Study|Failed to return|298|||
25060241|NCT01066819|50164772|FG001|Overall Study|Failed to return|107|||
25060242|NCT01066819|50164773|FG002|Overall Study|Failed to return|68|||
25060243|NCT01066819|50164774|FG003|Overall Study|Failed to return|7|||
25060244|NCT01066819|50164775|FG004|Overall Study|Failed to return|2|||
25060245|NCT01066819|50164776|FG005|Overall Study|Failed to return|3|||
25060246|NCT01066819|50164771|FG000|Overall Study|Lab test not done|9|||
25060247|NCT01066819|50164772|FG001|Overall Study|Lab test not done|0|||
25060248|NCT01066819|50164773|FG002|Overall Study|Lab test not done|2|||
25060249|NCT01066819|50164774|FG003|Overall Study|Lab test not done|1|||
25060250|NCT01066819|50164775|FG004|Overall Study|Lab test not done|0|||
25060251|NCT01066819|50164776|FG005|Overall Study|Lab test not done|0|||
25060252|NCT01066819|50164771|FG000|Overall Study|Miscellaneous|28|||
25060253|NCT01066819|50164772|FG001|Overall Study|Miscellaneous|10|||
25060254|NCT01066819|50164773|FG002|Overall Study|Miscellaneous|18|||
25060255|NCT01066819|50164774|FG003|Overall Study|Miscellaneous|1|||
25060256|NCT01066819|50164775|FG004|Overall Study|Miscellaneous|0|||
25060257|NCT01066819|50164776|FG005|Overall Study|Miscellaneous|0|||
25060258|NCT01066819|50164771|FG000|Overall Study|Non responders|123|||
25060259|NCT01066819|50164772|FG001|Overall Study|Non responders|2|||
25060260|NCT01066819|50164773|FG002|Overall Study|Non responders|7|||
25060261|NCT01066819|50164774|FG003|Overall Study|Non responders|2|||
25060262|NCT01066819|50164775|FG004|Overall Study|Non responders|0|||
25060263|NCT01066819|50164776|FG005|Overall Study|Non responders|1|||
25060264|NCT01066819|50164771|FG000|Overall Study|Not categorised|9|||
25060265|NCT01066819|50164772|FG001|Overall Study|Not categorised|2|||
25060266|NCT01066819|50164773|FG002|Overall Study|Not categorised|6|||
25060267|NCT01066819|50164774|FG003|Overall Study|Not categorised|1|||
25060268|NCT01066819|50164775|FG004|Overall Study|Not categorised|0|||
25060269|NCT01066819|50164776|FG005|Overall Study|Not categorised|0|||
25060270|NCT01066819|50164771|FG000|Overall Study|Relapse|16|||
25060271|NCT01066819|50164772|FG001|Overall Study|Relapse|4|||
25060272|NCT01066819|50164773|FG002|Overall Study|Relapse|3|||
25060273|NCT01066819|50164774|FG003|Overall Study|Relapse|0|||
25060274|NCT01066819|50164775|FG004|Overall Study|Relapse|0|||
25060275|NCT01066819|50164776|FG005|Overall Study|Relapse|0|||
25060276|NCT01066819|50164771|FG000|Overall Study|Results not available|1|||
25060277|NCT01066819|50164772|FG001|Overall Study|Results not available|0|||
25060278|NCT01066819|50164773|FG002|Overall Study|Results not available|0|||
25060279|NCT01066819|50164774|FG003|Overall Study|Results not available|0|||
25162803|NCT01980095|50285171|FG000|Overall Study|Randomized by mistake|1|||
25060280|NCT01066819|50164775|FG004|Overall Study|Results not available|0|||
25060281|NCT01066819|50164776|FG005|Overall Study|Results not available|0|||
25060282|NCT01066819|50164771|FG000|Overall Study|Screen failure|1|||
25060283|NCT01066819|50164772|FG001|Overall Study|Screen failure|0|||
25060284|NCT01066819|50164773|FG002|Overall Study|Screen failure|0|||
25060285|NCT01066819|50164774|FG003|Overall Study|Screen failure|0|||
25060286|NCT01066819|50164775|FG004|Overall Study|Screen failure|0|||
25060287|NCT01066819|50164776|FG005|Overall Study|Screen failure|0|||
25060288|NCT01066819|50164771|FG000|Overall Study|Spontaneous cure|1|||
25060289|NCT01066819|50164772|FG001|Overall Study|Spontaneous cure|0|||
25060290|NCT01066819|50164773|FG002|Overall Study|Spontaneous cure|0|||
25060291|NCT01066819|50164774|FG003|Overall Study|Spontaneous cure|0|||
25060292|NCT01066819|50164775|FG004|Overall Study|Spontaneous cure|0|||
25060293|NCT01066819|50164776|FG005|Overall Study|Spontaneous cure|0|||
25060294|NCT01066819|50164771|FG000|Overall Study|Treatment never started|85|||
25060295|NCT01066819|50164772|FG001|Overall Study|Treatment never started|19|||
25060296|NCT01066819|50164773|FG002|Overall Study|Treatment never started|19|||
25060297|NCT01066819|50164774|FG003|Overall Study|Treatment never started|3|||
25060298|NCT01066819|50164775|FG004|Overall Study|Treatment never started|2|||
25060299|NCT01066819|50164776|FG005|Overall Study|Treatment never started|2|||
25060300|NCT01066819|50164771|FG000|Overall Study|Treatment stopped|12|||
25060301|NCT01066819|50164772|FG001|Overall Study|Treatment stopped|1|||
25060302|NCT01066819|50164773|FG002|Overall Study|Treatment stopped|2|||
25060303|NCT01066819|50164774|FG003|Overall Study|Treatment stopped|1|||
25060304|NCT01066819|50164775|FG004|Overall Study|Treatment stopped|0|||
25060305|NCT01066819|50164776|FG005|Overall Study|Treatment stopped|0|||
25060306|NCT01066819|50164771|FG000|Overall Study|Other|5|||
25060307|NCT01066819|50164772|FG001|Overall Study|Other|1|||
25060308|NCT01066819|50164773|FG002|Overall Study|Other|1|||
25060309|NCT01066819|50164774|FG003|Overall Study|Other|0|||
25060310|NCT01066819|50164775|FG004|Overall Study|Other|0|||
25060311|NCT01066819|50164776|FG005|Overall Study|Other|0|||
25060312|NCT04056299|50164790|FG000|Overall Study|Sponsor discontinued study|3|||
25060313|NCT04056299|50164791|FG001|Overall Study|Sponsor discontinued study|3|||
25060314|NCT04057937|50164799|FG000|Placebo-controlled Phase|Adverse Event|3|||
25060315|NCT04057937|50164800|FG001|Placebo-controlled Phase|Adverse Event|0|||
25060316|NCT04057937|50164799|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
25060317|NCT04057937|50164800|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
25060318|NCT04057937|50164799|FG000|Active-treatment Phase|Pregnancy|0|||
25060319|NCT04057937|50164800|FG001|Active-treatment Phase|Pregnancy|1|||
25060320|NCT04057937|50164799|FG000|Active-treatment Phase|Physician Decision|0|||
25060321|NCT04057937|50164800|FG001|Active-treatment Phase|Physician Decision|1|||
25060322|NCT01069523|50164809|FG000|Overall Study|Withdrawal by Subject|4|||
25060323|NCT01069523|50164810|FG001|Overall Study|Withdrawal by Subject|7|||
25060324|NCT01069289|50164820|FG000|Overall Study|Withdrawal by Subject|15|||
25060325|NCT01069289|50164821|FG001|Overall Study|Withdrawal by Subject|26|||
25060326|NCT01069289|50164820|FG000|Overall Study|Adverse Event|21|||
25060327|NCT01069289|50164821|FG001|Overall Study|Adverse Event|28|||
25060328|NCT01069289|50164820|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
25060329|NCT01069289|50164821|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
25060330|NCT01069289|50164820|FG000|Overall Study|Severe non-compliance to protocol|3|||
25060331|NCT01069289|50164821|FG001|Overall Study|Severe non-compliance to protocol|2|||
25060332|NCT01069289|50164820|FG000|Overall Study|Due to deteriorating health condition|1|||
25060333|NCT01069289|50164821|FG001|Overall Study|Due to deteriorating health condition|0|||
25060334|NCT02510794|50164840|FG000|Overall Study|Adverse Event|0|||
25060335|NCT02510794|50164841|FG001|Overall Study|Adverse Event|1|||
25060336|NCT02510794|50164842|FG002|Overall Study|Adverse Event|0|||
25060337|NCT02510794|50164843|FG003|Overall Study|Adverse Event|0|||
25060338|NCT02510794|50164840|FG000|Overall Study|Death|1|||
25060339|NCT02510794|50164841|FG001|Overall Study|Death|2|||
25060340|NCT02510794|50164842|FG002|Overall Study|Death|1|||
25060341|NCT02510794|50164843|FG003|Overall Study|Death|1|||
25060342|NCT02510794|50164840|FG000|Overall Study|Lack of Efficacy|3|||
25060343|NCT02510794|50164841|FG001|Overall Study|Lack of Efficacy|1|||
25060344|NCT02510794|50164842|FG002|Overall Study|Lack of Efficacy|1|||
25060345|NCT02510794|50164843|FG003|Overall Study|Lack of Efficacy|0|||
25060346|NCT02510794|50164840|FG000|Overall Study|Participant moved out of the area|0|||
25060347|NCT02510794|50164841|FG001|Overall Study|Participant moved out of the area|0|||
25060348|NCT02510794|50164842|FG002|Overall Study|Participant moved out of the area|0|||
25060349|NCT02510794|50164843|FG003|Overall Study|Participant moved out of the area|1|||
25060350|NCT02510794|50164840|FG000|Overall Study|Physician Decision|3|||
25060351|NCT02510794|50164841|FG001|Overall Study|Physician Decision|0|||
25060352|NCT02510794|50164842|FG002|Overall Study|Physician Decision|0|||
25060353|NCT02510794|50164843|FG003|Overall Study|Physician Decision|0|||
25060354|NCT02510794|50164840|FG000|Overall Study|Protocol Violation|0|||
25060355|NCT02510794|50164841|FG001|Overall Study|Protocol Violation|0|||
25060356|NCT02510794|50164842|FG002|Overall Study|Protocol Violation|1|||
25060357|NCT02510794|50164843|FG003|Overall Study|Protocol Violation|0|||
25060358|NCT02510794|50164840|FG000|Overall Study|Withdrawal by Subject|1|||
25060359|NCT02510794|50164841|FG001|Overall Study|Withdrawal by Subject|2|||
25060360|NCT02510794|50164842|FG002|Overall Study|Withdrawal by Subject|4|||
25060361|NCT02510794|50164843|FG003|Overall Study|Withdrawal by Subject|3|||
25060362|NCT02510014|50164868|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
25060363|NCT02510014|50164869|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
25060364|NCT02510014|50164868|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
25060365|NCT02510014|50164869|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
25060366|NCT02510014|50164868|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
25060367|NCT02510014|50164869|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
24963706|NCT00129129|50053688|FG001|Primary Phase|Other|5|||
25060368|NCT02510014|50164868|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
25060369|NCT02510014|50164869|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
25060370|NCT02510014|50164868|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
25060371|NCT02510014|50164869|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
25060372|NCT02510014|50164868|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
25060373|NCT02510014|50164869|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
25060374|NCT02510014|50164868|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
25060375|NCT02510014|50164869|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
25060376|NCT02510014|50164868|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
25060377|NCT02510014|50164869|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
25060378|NCT02510014|50164868|FG000|Treatment Period|Adverse Event|11|||
25060379|NCT02510014|50164869|FG001|Treatment Period|Adverse Event|4|||
25060380|NCT02510014|50164868|FG000|Treatment Period|Withdrawal symptoms|3|||
25060381|NCT02510014|50164869|FG001|Treatment Period|Withdrawal symptoms|0|||
25060382|NCT02510014|50164868|FG000|Treatment Period|Lost to Follow-up|80|||
25060383|NCT02510014|50164869|FG001|Treatment Period|Lost to Follow-up|19|||
25060384|NCT02510014|50164868|FG000|Treatment Period|Physician Decision|5|||
25060385|NCT02510014|50164869|FG001|Treatment Period|Physician Decision|0|||
25060386|NCT02510014|50164868|FG000|Treatment Period|Withdrawal by Subject|67|||
25060387|NCT02510014|50164869|FG001|Treatment Period|Withdrawal by Subject|24|||
25060388|NCT02510014|50164868|FG000|Treatment Period|Withdrawn by the investigator|7|||
25060389|NCT02510014|50164869|FG001|Treatment Period|Withdrawn by the investigator|1|||
25060390|NCT02510014|50164868|FG000|Treatment Period|Protocol Violation|4|||
25060391|NCT02510014|50164869|FG001|Treatment Period|Protocol Violation|4|||
25060392|NCT02510014|50164868|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
25060393|NCT02510014|50164869|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
25060394|NCT02509312|50164877|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
25060395|NCT02509312|50164878|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
25060396|NCT02509312|50164877|FG000|Overall Study|Obstetrician refusal|0|||
25060397|NCT02509312|50164878|FG001|Overall Study|Obstetrician refusal|1|||
25060398|NCT02509312|50164877|FG000|Overall Study|Patient elected for TOLAC|1|||
25060399|NCT02509312|50164878|FG001|Overall Study|Patient elected for TOLAC|0|||
25162804|NCT01980095|50285172|FG001|Overall Study|Randomized by mistake|0|||
24963707|NCT00129129|50053689|FG002|Primary Phase|Other|0|||
24963708|NCT00129129|50053690|FG003|Primary Phase|Other|0|||
24963709|NCT00129129|50053691|FG004|Primary Phase|Other|0|||
24963710|NCT00129129|50053687|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
24963711|NCT00129129|50053688|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
24963712|NCT00129129|50053689|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
24963713|NCT00129129|50053690|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
24963714|NCT00129129|50053691|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
24963715|NCT00129129|50053687|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
24963716|NCT00129129|50053688|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
24963717|NCT00129129|50053689|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
24963718|NCT00129129|50053690|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
24963719|NCT00129129|50053691|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
24963720|NCT00129129|50053687|FG000|Fourth Dose Phase|Migration from study area|0|||
24963721|NCT00129129|50053688|FG001|Fourth Dose Phase|Migration from study area|0|||
24963722|NCT00129129|50053689|FG002|Fourth Dose Phase|Migration from study area|0|||
24963723|NCT00129129|50053690|FG003|Fourth Dose Phase|Migration from study area|0|||
24963724|NCT00129129|50053691|FG004|Fourth Dose Phase|Migration from study area|2|||
24963725|NCT00129129|50053687|FG000|Fourth Dose Phase|Other|0|||
24963726|NCT00129129|50053688|FG001|Fourth Dose Phase|Other|0|||
24963727|NCT00129129|50053689|FG002|Fourth Dose Phase|Other|0|||
24963728|NCT00129129|50053690|FG003|Fourth Dose Phase|Other|1|||
24963729|NCT00129129|50053691|FG004|Fourth Dose Phase|Other|1|||
24963730|NCT00129129|50053687|FG000|Fourth Dose Phase|Protocol Violation|0|||
24963731|NCT00129129|50053688|FG001|Fourth Dose Phase|Protocol Violation|0|||
24963732|NCT00129129|50053689|FG002|Fourth Dose Phase|Protocol Violation|0|||
25060400|NCT02509312|50164877|FG000|Overall Study|Cesarean deemed stat|1|||
24963733|NCT00129129|50053690|FG003|Fourth Dose Phase|Protocol Violation|1|||
25060401|NCT02509312|50164878|FG001|Overall Study|Cesarean deemed stat|0|||
25060402|NCT02509312|50164877|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
25060403|NCT02509312|50164878|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
25060404|NCT02509156|50164888|FG000|Randomized Phase|Death|1|||
25060405|NCT02509156|50164889|FG001|Randomized Phase|Death|0|||
25060406|NCT02509156|50164888|FG000|Randomized Phase|Withdrawal by Subject|1|||
25060407|NCT02509156|50164889|FG001|Randomized Phase|Withdrawal by Subject|1|||
25060408|NCT01654666|50164898|FG000|Overall Study|Protocol Violation|7|||
25060409|NCT01654666|50164899|FG001|Overall Study|Protocol Violation|4|||
25060410|NCT01654666|50164900|FG002|Overall Study|Protocol Violation|8|||
25060411|NCT01654666|50164898|FG000|Overall Study|Lost to Follow-up|4|||
25060412|NCT01654666|50164899|FG001|Overall Study|Lost to Follow-up|5|||
25060413|NCT01654666|50164900|FG002|Overall Study|Lost to Follow-up|5|||
25060414|NCT01654666|50164898|FG000|Overall Study|Withdrawal by Subject|4|||
25060415|NCT01654666|50164899|FG001|Overall Study|Withdrawal by Subject|4|||
25060416|NCT01654666|50164900|FG002|Overall Study|Withdrawal by Subject|1|||
25060417|NCT02519842|50164910|FG000|Base Study: Cycle 1|Screening Failure|1|||
25060418|NCT02519842|50164911|FG001|Base Study: Cycle 1|Screening Failure|1|||
25060419|NCT02519842|50164912|FG002|Base Study: Cycle 1|Screening Failure|0|||
25060420|NCT02519842|50164910|FG000|Base Study: Cycle 1|Adverse Event|1|||
25060421|NCT02519842|50164911|FG001|Base Study: Cycle 1|Adverse Event|0|||
25060422|NCT02519842|50164912|FG002|Base Study: Cycle 1|Adverse Event|0|||
25060423|NCT02519842|50164910|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
25060424|NCT02519842|50164911|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
25060425|NCT02519842|50164912|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
25060426|NCT02519842|50164910|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
25060427|NCT02519842|50164911|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
25060428|NCT02519842|50164912|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
25060429|NCT02519842|50164910|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
25060430|NCT02519842|50164911|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
25060431|NCT02519842|50164912|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
25060432|NCT02519842|50164910|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
25060433|NCT02519842|50164911|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
25060434|NCT02519842|50164912|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
25060435|NCT02519842|50164910|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
25060436|NCT02519842|50164911|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
25060437|NCT02519842|50164912|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
25060438|NCT02519842|50164910|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
25060439|NCT02519842|50164911|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
25060440|NCT02519842|50164912|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
25060441|NCT02519842|50164910|FG000|Optional Extension: Cycles 2-6|Death|0|||
25060442|NCT02519842|50164911|FG001|Optional Extension: Cycles 2-6|Death|0|||
25060443|NCT02519842|50164912|FG002|Optional Extension: Cycles 2-6|Death|1|||
25060444|NCT02519842|50164910|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
25060445|NCT02519842|50164911|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
25060446|NCT02519842|50164912|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
25060447|NCT02519842|50164910|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
25060448|NCT02519842|50164911|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
25060449|NCT02519842|50164912|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
25060450|NCT02519842|50164910|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
25060451|NCT02519842|50164911|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
25060452|NCT02519842|50164912|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
25060453|NCT02519842|50164910|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
25060454|NCT02519842|50164911|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
25060455|NCT02519842|50164912|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
25060456|NCT02509078|50164922|FG000|Overall Study|Protocol Violation|1|||
25060457|NCT02509078|50164923|FG001|Overall Study|Protocol Violation|1|||
25060458|NCT02993783|50164933|FG000|Overall Study|Reason not Specified|6|||
24963734|NCT00129129|50053691|FG004|Fourth Dose Phase|Protocol Violation|0|||
24963735|NCT00221403|50053714|FG000|Overall Study|Protocol Violation|1|||
24963736|NCT00221403|50053715|FG001|Overall Study|Protocol Violation|0|||
24963737|NCT00221403|50053716|FG002|Overall Study|Protocol Violation|0|||
24963738|NCT00221403|50053714|FG000|Overall Study|Physician Decision|1|||
24963739|NCT00221403|50053715|FG001|Overall Study|Physician Decision|0|||
24963740|NCT00221403|50053716|FG002|Overall Study|Physician Decision|0|||
24963741|NCT00221403|50053714|FG000|Overall Study|Withdrawal by Subject|0|||
24963742|NCT00221403|50053715|FG001|Overall Study|Withdrawal by Subject|3|||
24963743|NCT00221403|50053716|FG002|Overall Study|Withdrawal by Subject|0|||
25060459|NCT02993783|50164934|FG001|Overall Study|Reason not Specified|9|||
25060460|NCT02993471|50164940|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
25060461|NCT02993471|50164940|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
25060462|NCT02988713|50164962|FG000|Overall Study|Withdrawal by Subject|1|||
25060463|NCT02988713|50164962|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
25060464|NCT01068743|50164966|FG000|Period 3|Adverse Event|0|||
25060465|NCT01068743|50164967|FG001|Period 3|Adverse Event|1|||
25060466|NCT01068743|50164968|FG002|Period 3|Adverse Event|0|||
25060467|NCT01068743|50164969|FG003|Period 3|Adverse Event|0|||
25060468|NCT02992691|50164982|FG000|Overall Study|Adverse Event|2|||
25060469|NCT02992691|50164982|FG000|Overall Study|Withdrawal by Subject|1|||
25060470|NCT02921087|50164999|FG000|Overall Study|Withdrawal by Subject|0|||
25060471|NCT02921087|50165000|FG001|Overall Study|Withdrawal by Subject|1|||
25060472|NCT02907619|50165019|FG000|Overall Study|Study terminated by sponsor|18|||
25060473|NCT02907619|50165020|FG001|Overall Study|Study terminated by sponsor|18|||
25060474|NCT02907619|50165021|FG002|Overall Study|Study terminated by sponsor|19|||
25060475|NCT02907619|50165019|FG000|Overall Study|Death|0|||
25060476|NCT02907619|50165020|FG001|Overall Study|Death|0|||
25060477|NCT02907619|50165021|FG002|Overall Study|Death|1|||
25060478|NCT02907619|50165019|FG000|Overall Study|Withdrawal by Subject|1|||
25060479|NCT02907619|50165020|FG001|Overall Study|Withdrawal by Subject|1|||
25060480|NCT02907619|50165021|FG002|Overall Study|Withdrawal by Subject|0|||
25060481|NCT02907619|50165019|FG000|Overall Study|Other|0|||
25060482|NCT02907619|50165020|FG001|Overall Study|Other|1|||
25060483|NCT02907619|50165021|FG002|Overall Study|Other|0|||
25060484|NCT02986373|50165031|FG000|Overall Study|Adverse Event|4|||
25060485|NCT02986373|50165031|FG000|Overall Study|Lost to Follow-up|1|||
25060486|NCT02986373|50165031|FG000|Overall Study|Withdrawal by Subject|10|||
25060487|NCT02986373|50165031|FG000|Overall Study|Other|24|||
25060488|NCT02986139|50165037|FG000|Overall Study|Sponsor Decision|1|||
25060489|NCT02986139|50165038|FG001|Overall Study|Sponsor Decision|2|||
25060490|NCT02986139|50165037|FG000|Overall Study|Withdrawal by Subject|0|||
25060491|NCT02986139|50165038|FG001|Overall Study|Withdrawal by Subject|1|||
25060492|NCT02986139|50165037|FG000|Overall Study|Lost to Follow-up|0|||
25060493|NCT02986139|50165038|FG001|Overall Study|Lost to Follow-up|1|||
25060494|NCT02989805|50165050|FG000|Overall Study|invalid consent|6|||
25060495|NCT02989805|50165051|FG001|Overall Study|invalid consent|4|||
25060496|NCT02907463|50165057|FG000|Overall Study|Lost to Follow-up|17|||
25060497|NCT02907463|50165057|FG000|Overall Study|Death|10|||
25060498|NCT02907463|50165057|FG000|Overall Study|Withdrawal by Subject|4|||
25060499|NCT02907463|50165057|FG000|Overall Study|MIS Approach was not used|2|||
25060500|NCT02907463|50165057|FG000|Overall Study|Not Implanted with Study Device|2|||
25060501|NCT02907463|50165057|FG000|Overall Study|Device Explanted|1|||
25060502|NCT02907463|50165057|FG000|Overall Study|Missing Exit Form|1|||
25060503|NCT02906917|50165071|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
25060504|NCT02906917|50165072|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
25060505|NCT02906917|50165071|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
25060506|NCT02906917|50165072|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
25060507|NCT02906917|50165071|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
25060508|NCT02906917|50165072|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
25060509|NCT02906917|50165071|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
25060510|NCT02906917|50165072|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
25060511|NCT02906917|50165071|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
25060512|NCT02906917|50165072|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
25060513|NCT02906917|50165071|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
25060514|NCT02906917|50165072|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
25060515|NCT02906917|50165071|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
25060516|NCT02906917|50165072|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
25060517|NCT02906917|50165071|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
25060518|NCT02906917|50165072|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
25060519|NCT02982187|50165080|FG000|Overall Study|Withdrawal by Subject|0|||
25060520|NCT02982187|50165081|FG001|Overall Study|Withdrawal by Subject|0|||
25060521|NCT02982187|50165082|FG002|Overall Study|Withdrawal by Subject|0|||
24963744|NCT00221403|50053714|FG000|Overall Study|Lack of Efficacy|0|||
24963745|NCT00221403|50053715|FG001|Overall Study|Lack of Efficacy|1|||
24963746|NCT00221403|50053716|FG002|Overall Study|Lack of Efficacy|0|||
24963747|NCT00221403|50053714|FG000|Overall Study|Adverse Event|0|||
24963748|NCT00221403|50053715|FG001|Overall Study|Adverse Event|1|||
24963749|NCT00221403|50053716|FG002|Overall Study|Adverse Event|0|||
24963750|NCT00145977|50053726|FG000|Overall Study|Lack of Efficacy|0|||
24963751|NCT00145977|50053727|FG001|Overall Study|Lack of Efficacy|4|||
24963752|NCT00145977|50053726|FG000|Overall Study|Lost to Follow-up|1|||
25060522|NCT02982187|50165083|FG003|Overall Study|Withdrawal by Subject|0|||
25060523|NCT02982187|50165084|FG004|Overall Study|Withdrawal by Subject|0|||
25162805|NCT01980017|50285182|FG000|Overall Study|Lost to Follow-up|30|||
24963753|NCT00145977|50053727|FG001|Overall Study|Lost to Follow-up|0|||
25060524|NCT02982187|50165085|FG005|Overall Study|Withdrawal by Subject|0|||
25060525|NCT02982187|50165086|FG006|Overall Study|Withdrawal by Subject|1|||
25060526|NCT02982187|50165087|FG007|Overall Study|Withdrawal by Subject|0|||
25060527|NCT02981953|50165097|FG000|Overall Study|Death|9|||
25060528|NCT02981953|50165097|FG000|Overall Study|Withdrawal by Subject|1|||
25060529|NCT02981953|50165097|FG000|Overall Study|Withdrawal to non-compliance|1|||
25060530|NCT01066585|50165113|FG000|Overall Study|Protocol Violation|1|||
25060531|NCT01066585|50165114|FG001|Overall Study|Protocol Violation|0|||
25060532|NCT01066585|50165113|FG000|Overall Study|Withdrawal by Subject|0|||
25060533|NCT01066585|50165114|FG001|Overall Study|Withdrawal by Subject|3|||
25060534|NCT02980783|50165120|FG000|Overall Study|Lost to Follow-up|1|||
25060535|NCT02980705|50165126|FG000|Overall Study|Adverse Event|0|||
25060536|NCT02980705|50165127|FG001|Overall Study|Adverse Event|1|||
25060537|NCT02980705|50165126|FG000|Overall Study|Withdrawal by Subject|6|||
25060538|NCT02980705|50165127|FG001|Overall Study|Withdrawal by Subject|9|||
25060539|NCT02980705|50165126|FG000|Overall Study|withdrew participation|0|||
25060540|NCT02980705|50165127|FG001|Overall Study|withdrew participation|1|||
25060541|NCT02980705|50165126|FG000|Overall Study|Lost to Follow-up|2|||
25060542|NCT02980705|50165127|FG001|Overall Study|Lost to Follow-up|0|||
25060543|NCT02989649|50165134|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
25060544|NCT02989649|50165134|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
25060545|NCT02989649|50165134|FG000|Overall Study|Lost For Observation During Study|3|||
25060546|NCT02989649|50165134|FG000|Overall Study|Reason Not Specified|13|||
25060547|NCT02905435|50165138|FG000|Overall Study|Death|2|||
25060548|NCT02905435|50165138|FG000|Overall Study|Physician Decision|1|||
25060549|NCT02905435|50165138|FG000|Overall Study|Lost to Follow-up|4|||
25060550|NCT02978833|50165145|FG000|Overall Study|Study terminated|1|||
25060551|NCT02978833|50165146|FG001|Overall Study|Study terminated|1|||
25060552|NCT01067339|50165155|FG000|Overall Study|Withdrawal by Subject|6|||
25060553|NCT01067339|50165156|FG001|Overall Study|Withdrawal by Subject|5|||
25060554|NCT02573259|50165169|FG000|Overall Study|Death|1|||
25060555|NCT02573259|50165170|FG001|Overall Study|Death|6|||
25060556|NCT02573259|50165171|FG002|Overall Study|Death|5|||
25060557|NCT02573259|50165172|FG003|Overall Study|Death|6|||
25060558|NCT02573259|50165173|FG004|Overall Study|Death|9|||
25060559|NCT02573259|50165174|FG005|Overall Study|Death|32|||
25060560|NCT02573259|50165175|FG006|Overall Study|Death|21|||
25060561|NCT02573259|50165169|FG000|Overall Study|Lost to Follow-up|0|||
25060562|NCT02573259|50165170|FG001|Overall Study|Lost to Follow-up|0|||
25060563|NCT02573259|50165171|FG002|Overall Study|Lost to Follow-up|0|||
25060564|NCT02573259|50165172|FG003|Overall Study|Lost to Follow-up|0|||
25060565|NCT02573259|50165173|FG004|Overall Study|Lost to Follow-up|0|||
25060566|NCT02573259|50165174|FG005|Overall Study|Lost to Follow-up|2|||
25060567|NCT02573259|50165175|FG006|Overall Study|Lost to Follow-up|1|||
25060568|NCT02573259|50165169|FG000|Overall Study|Participant refused further follow-up|0|||
25060569|NCT02573259|50165170|FG001|Overall Study|Participant refused further follow-up|2|||
25060570|NCT02573259|50165171|FG002|Overall Study|Participant refused further follow-up|1|||
25060571|NCT02573259|50165172|FG003|Overall Study|Participant refused further follow-up|0|||
25060572|NCT02573259|50165173|FG004|Overall Study|Participant refused further follow-up|3|||
25060573|NCT02573259|50165174|FG005|Overall Study|Participant refused further follow-up|20|||
25060574|NCT02573259|50165175|FG006|Overall Study|Participant refused further follow-up|7|||
25060575|NCT02573259|50165169|FG000|Overall Study|Other|0|||
25060576|NCT02573259|50165170|FG001|Overall Study|Other|0|||
25060577|NCT02573259|50165171|FG002|Overall Study|Other|0|||
25060578|NCT02573259|50165172|FG003|Overall Study|Other|0|||
25060579|NCT02573259|50165173|FG004|Overall Study|Other|1|||
25060580|NCT02573259|50165174|FG005|Overall Study|Other|4|||
25060581|NCT02573259|50165175|FG006|Overall Study|Other|5|||
25060582|NCT02977507|50165212|FG000|Overall Study|Protocol Deviation|1|||
25060583|NCT02977507|50165213|FG001|Overall Study|Protocol Deviation|0|||
25060584|NCT02977507|50165212|FG000|Overall Study|Lost to Follow-up|1|||
25060585|NCT02977507|50165213|FG001|Overall Study|Lost to Follow-up|0|||
25060586|NCT02976103|50165222|FG000|Overall Study|Withdrawal by Subject|1|||
25060587|NCT02976103|50165223|FG001|Overall Study|Withdrawal by Subject|0|||
25060588|NCT02976103|50165222|FG000|Overall Study|Lost to Follow-up|12|||
25060589|NCT02976103|50165223|FG001|Overall Study|Lost to Follow-up|8|||
25060590|NCT01066039|50165230|FG000|Overall Study|Adverse Event|6|||
25060591|NCT01066039|50165230|FG000|Overall Study|Withdrawal by Subject|17|||
25060592|NCT01066039|50165230|FG000|Overall Study|Protocol Violation|2|||
25060593|NCT01066039|50165230|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
25060594|NCT01066039|50165230|FG000|Overall Study|Investigator's Request|1|||
25060595|NCT01066039|50165230|FG000|Overall Study|Dropout due to Insulin Administration|1|||
25060596|NCT01066039|50165230|FG000|Overall Study|Additional Antihypertensive Required|4|||
25162806|NCT01980017|50285183|FG001|Overall Study|Lost to Follow-up|21|||
25060597|NCT01066039|50165230|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
25060598|NCT01066039|50165230|FG000|Overall Study|Failure to Control Blood Pressure|1|||
25060599|NCT01066039|50165230|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
25060600|NCT02919995|50165240|FG000|Overall Study|Adverse Event|0|||
25162807|NCT01980017|50285182|FG000|Overall Study|Death|0|||
25162808|NCT01980017|50285183|FG001|Overall Study|Death|1|||
25060601|NCT02919995|50165241|FG001|Overall Study|Adverse Event|0|||
25060602|NCT02919995|50165242|FG002|Overall Study|Adverse Event|0|||
25060603|NCT02919995|50165243|FG003|Overall Study|Adverse Event|0|||
25060604|NCT02919995|50165244|FG004|Overall Study|Adverse Event|0|||
25060605|NCT02919995|50165245|FG005|Overall Study|Adverse Event|1|||
25060606|NCT02919761|50165253|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
25060607|NCT02919761|50165254|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
25060608|NCT02919761|50165255|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
25060609|NCT02919761|50165253|FG000|Part 1: Open Label|Adverse Event|1|||
25060610|NCT02919761|50165254|FG001|Part 1: Open Label|Adverse Event|0|||
25060611|NCT02919761|50165255|FG002|Part 1: Open Label|Adverse Event|0|||
25060612|NCT02919761|50165253|FG000|Part 1: Open Label|Lost to Follow-up|1|||
25060613|NCT02919761|50165254|FG001|Part 1: Open Label|Lost to Follow-up|0|||
25060614|NCT02919761|50165255|FG002|Part 1: Open Label|Lost to Follow-up|0|||
25060615|NCT02919761|50165253|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
25060616|NCT02919761|50165254|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
25060617|NCT02919761|50165255|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
25060618|NCT02919761|50165253|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
25060619|NCT02919761|50165254|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
25060620|NCT02919761|50165255|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
25060621|NCT02919761|50165253|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
25060622|NCT02919761|50165254|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
25060623|NCT02919761|50165255|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
25060624|NCT02919761|50165253|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
25060625|NCT02919761|50165254|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
25060626|NCT02919761|50165255|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
25060627|NCT02919761|50165253|FG000|Part 1: Open Label|Termination by Sponsor|1|||
25060628|NCT02919761|50165254|FG001|Part 1: Open Label|Termination by Sponsor|0|||
25060629|NCT02919761|50165255|FG002|Part 1: Open Label|Termination by Sponsor|0|||
25060630|NCT02919761|50165253|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
25060631|NCT02919761|50165254|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
25060632|NCT02919761|50165255|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
25060633|NCT02919761|50165253|FG000|Part 2: Double-blind|Adverse Event|0|||
25060634|NCT02919761|50165254|FG001|Part 2: Double-blind|Adverse Event|1|||
25060635|NCT02919761|50165255|FG002|Part 2: Double-blind|Adverse Event|0|||
25060636|NCT02919761|50165253|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
25060637|NCT02919761|50165254|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
25060638|NCT02919761|50165255|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
25060639|NCT02919761|50165253|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
25060640|NCT02919761|50165254|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
25060641|NCT02919761|50165255|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
25060642|NCT02919761|50165253|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
25060643|NCT02919761|50165254|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
25060644|NCT02919761|50165255|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
25060645|NCT02919761|50165253|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
25060646|NCT02919761|50165254|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
25060647|NCT02919761|50165255|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
25060648|NCT02919761|50165253|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
25060649|NCT02919761|50165254|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
25060650|NCT02919761|50165255|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
25060651|NCT02919761|50165253|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
25060652|NCT02919761|50165254|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
25060653|NCT02919761|50165255|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
25060654|NCT02910167|50165266|FG000|Overall Study|Adverse Event|1|||
25060655|NCT02910167|50165266|FG000|Overall Study|Lost to Follow-up|18|||
25060656|NCT01067105|50165270|FG000|Overall Study|Adverse Event|14|||
25060657|NCT01067105|50165270|FG000|Overall Study|Protocol Violation|48|||
25060658|NCT01067105|50165270|FG000|Overall Study|Withdrawal by Subject|36|||
25060659|NCT01067105|50165270|FG000|Overall Study|Lost to Follow-up|6|||
25060660|NCT01067105|50165270|FG000|Overall Study|Physician Decision|6|||
25060661|NCT01067105|50165270|FG000|Overall Study|Other|31|||
25060662|NCT02910089|50165280|FG000|Overall Study|Lost insurance eligibility|22|||
25060663|NCT02910089|50165281|FG001|Overall Study|Lost insurance eligibility|16|||
25060664|NCT02985515|50165289|FG000|Olfaction Testing|Lost to Follow-up|0|||
25060665|NCT02985515|50165290|FG001|Olfaction Testing|Lost to Follow-up|5|||
25060666|NCT02985515|50165289|FG000|Olfaction Testing|Protocol Violation|0|||
25060667|NCT02985515|50165290|FG001|Olfaction Testing|Protocol Violation|3|||
25060668|NCT02910011|50165303|FG000|Overall Study|Physician Decision|2|||
25060669|NCT02908841|50165311|FG000|Overall Study|Physician Decision|4|||
25060670|NCT02908841|50165312|FG001|Overall Study|Physician Decision|0|||
25060671|NCT02909153|50165323|FG000|Overall Study|Withdrawal by Subject|0|||
25060672|NCT02909153|50165324|FG001|Overall Study|Withdrawal by Subject|1|||
25060673|NCT02909153|50165325|FG002|Overall Study|Withdrawal by Subject|0|||
25060674|NCT02909153|50165326|FG003|Overall Study|Withdrawal by Subject|0|||
25060675|NCT02909153|50165327|FG004|Overall Study|Withdrawal by Subject|0|||
25060676|NCT02908529|50165339|FG000|Overall Study|Lost to Follow-up|0|||
25060677|NCT02908529|50165340|FG001|Overall Study|Lost to Follow-up|2|||
25060678|NCT02984267|50165350|FG000|Overall Study|Protocol Violation|1|||
24963754|NCT00145977|50053726|FG000|Overall Study|Withdrawal by Subject|1|||
24963755|NCT00145977|50053727|FG001|Overall Study|Withdrawal by Subject|0|||
24963756|NCT00238238|50053736|FG000|Overall Study|Withdrawal by Subject|0|||
24963757|NCT00238238|50053737|FG001|Overall Study|Withdrawal by Subject|3|||
25060679|NCT02984267|50165351|FG001|Overall Study|Protocol Violation|0|||
25060680|NCT02984267|50165350|FG000|Overall Study|Withdrawal by Subject|0|||
25060681|NCT02984267|50165351|FG001|Overall Study|Withdrawal by Subject|1|||
25060682|NCT02675751|50165357|FG000|Overall Study|Lost to Follow-up|16|||
25060683|NCT02974855|50165374|FG000|Overall Study|Adverse Event|0|||
25060684|NCT02974855|50165375|FG001|Overall Study|Adverse Event|1|||
25060685|NCT02974855|50165376|FG002|Overall Study|Adverse Event|0|||
25060686|NCT02974855|50165377|FG003|Overall Study|Adverse Event|1|||
25060687|NCT00455403|50165402|FG000|Overall Study|Lost to Follow-up|2|||
25060688|NCT00455403|50165403|FG001|Overall Study|Lost to Follow-up|1|||
25060689|NCT00455403|50165402|FG000|Overall Study|Withdrawal by Subject|1|||
25060690|NCT00455403|50165403|FG001|Overall Study|Withdrawal by Subject|3|||
25060691|NCT00455403|50165402|FG000|Overall Study|Protocol Violation|0|||
25060692|NCT00455403|50165403|FG001|Overall Study|Protocol Violation|2|||
25060693|NCT02979613|50165411|FG000|Double-Blind Phase|Withdrew Consent|2|||
25060694|NCT02979613|50165412|FG001|Double-Blind Phase|Withdrew Consent|4|||
25060695|NCT02979613|50165411|FG000|Double-Blind Phase|Pregnancy|2|||
25060696|NCT02979613|50165412|FG001|Double-Blind Phase|Pregnancy|2|||
25060697|NCT02979613|50165411|FG000|Double-Blind Phase|Adverse Event|2|||
25060698|NCT02979613|50165412|FG001|Double-Blind Phase|Adverse Event|0|||
25060699|NCT02979613|50165411|FG000|Double-Blind Phase|Lost to Follow-up|1|||
25060700|NCT02979613|50165412|FG001|Double-Blind Phase|Lost to Follow-up|1|||
25060701|NCT02979613|50165411|FG000|Double-Blind Phase|Protocol Violation|1|||
25060702|NCT02979613|50165412|FG001|Double-Blind Phase|Protocol Violation|1|||
25060703|NCT02979613|50165411|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
25060704|NCT02979613|50165412|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
25060705|NCT02979613|50165411|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
25060706|NCT02979613|50165412|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
25060707|NCT02979613|50165411|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
25060708|NCT02979613|50165412|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
25060709|NCT02979613|50165411|FG000|Open-Label Extension (OLE) Phase|Death|0|||
25060710|NCT02979613|50165412|FG001|Open-Label Extension (OLE) Phase|Death|1|||
25060711|NCT02979613|50165411|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
25060712|NCT02979613|50165412|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
25060713|NCT01064167|50165422|FG000|Overall Study|Protocol Violation|14|||
25060714|NCT01064167|50165423|FG001|Overall Study|Protocol Violation|15|||
25060715|NCT02974543|50165431|FG000|Overall Study|Withdrawal by Subject|1|||
25060716|NCT02974543|50165432|FG001|Overall Study|Withdrawal by Subject|0|||
25060717|NCT01064947|50165446|FG000|Overall Study|negative culture|41|||
25060718|NCT02974153|50165457|FG000|Overall Study|Adverse Event|6|||
25060719|NCT02974153|50165458|FG001|Overall Study|Adverse Event|0|||
25060720|NCT02974153|50165459|FG002|Overall Study|Adverse Event|1|||
25060721|NCT02974153|50165457|FG000|Overall Study|Lack of Efficacy|6|||
25060722|NCT02974153|50165458|FG001|Overall Study|Lack of Efficacy|5|||
25060723|NCT02974153|50165459|FG002|Overall Study|Lack of Efficacy|10|||
25060724|NCT02974153|50165457|FG000|Overall Study|Lost to Follow-up|9|||
25060725|NCT02974153|50165458|FG001|Overall Study|Lost to Follow-up|10|||
25060726|NCT02974153|50165459|FG002|Overall Study|Lost to Follow-up|17|||
25060727|NCT02974153|50165457|FG000|Overall Study|Physician Decision|0|||
25060728|NCT02974153|50165458|FG001|Overall Study|Physician Decision|2|||
25060729|NCT02974153|50165459|FG002|Overall Study|Physician Decision|1|||
25060730|NCT02974153|50165457|FG000|Overall Study|Withdrawal by Subject|9|||
25060731|NCT02974153|50165458|FG001|Overall Study|Withdrawal by Subject|16|||
25060732|NCT02974153|50165459|FG002|Overall Study|Withdrawal by Subject|11|||
25060733|NCT02974153|50165457|FG000|Overall Study|Study Burden|8|||
25060734|NCT02974153|50165458|FG001|Overall Study|Study Burden|7|||
25060735|NCT02974153|50165459|FG002|Overall Study|Study Burden|3|||
25060736|NCT02974153|50165457|FG000|Overall Study|Other|14|||
25060737|NCT02974153|50165458|FG001|Overall Study|Other|8|||
25060738|NCT02974153|50165459|FG002|Overall Study|Other|7|||
25060739|NCT02508532|50165474|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
25060740|NCT02508532|50165475|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
25060741|NCT02508532|50165476|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
25060742|NCT02508532|50165477|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
24963758|NCT00238238|50053738|FG002|Overall Study|Withdrawal by Subject|0|||
25060743|NCT02508532|50165478|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
25060744|NCT02508532|50165479|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
25060745|NCT02508532|50165480|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
25060746|NCT02508532|50165481|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
25060747|NCT02508532|50165482|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
25060748|NCT02508532|50165474|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
25060749|NCT02508532|50165475|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
25060750|NCT02508532|50165476|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
25060751|NCT02508532|50165477|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
25060752|NCT02508532|50165478|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
25060753|NCT02508532|50165479|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
25060754|NCT02508532|50165480|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
25060755|NCT02508532|50165481|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
25060756|NCT02508532|50165482|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
25060757|NCT02508532|50165474|FG000|Part 2 - Treatment|Disease Progression|0|||
25060758|NCT02508532|50165475|FG001|Part 2 - Treatment|Disease Progression|0|||
25060759|NCT02508532|50165476|FG002|Part 2 - Treatment|Disease Progression|0|||
25060760|NCT02508532|50165477|FG003|Part 2 - Treatment|Disease Progression|0|||
25060761|NCT02508532|50165478|FG004|Part 2 - Treatment|Disease Progression|0|||
25060762|NCT02508532|50165479|FG005|Part 2 - Treatment|Disease Progression|0|||
25060763|NCT02508532|50165480|FG006|Part 2 - Treatment|Disease Progression|0|||
25060764|NCT02508532|50165481|FG007|Part 2 - Treatment|Disease Progression|0|||
25060765|NCT02508532|50165482|FG008|Part 2 - Treatment|Disease Progression|118|||
25060766|NCT02508532|50165474|FG000|Part 2 - Treatment|Adverse Event|0|||
25060767|NCT02508532|50165475|FG001|Part 2 - Treatment|Adverse Event|0|||
25060768|NCT02508532|50165476|FG002|Part 2 - Treatment|Adverse Event|0|||
25060769|NCT02508532|50165477|FG003|Part 2 - Treatment|Adverse Event|0|||
25060770|NCT02508532|50165478|FG004|Part 2 - Treatment|Adverse Event|0|||
25060771|NCT02508532|50165479|FG005|Part 2 - Treatment|Adverse Event|0|||
25060772|NCT02508532|50165480|FG006|Part 2 - Treatment|Adverse Event|0|||
25060773|NCT02508532|50165481|FG007|Part 2 - Treatment|Adverse Event|0|||
25060774|NCT02508532|50165482|FG008|Part 2 - Treatment|Adverse Event|49|||
25060775|NCT02508532|50165474|FG000|Part 2 - Treatment|Physician Decision|0|||
25060776|NCT02508532|50165475|FG001|Part 2 - Treatment|Physician Decision|0|||
25060777|NCT02508532|50165476|FG002|Part 2 - Treatment|Physician Decision|0|||
25060778|NCT02508532|50165477|FG003|Part 2 - Treatment|Physician Decision|0|||
25060779|NCT02508532|50165478|FG004|Part 2 - Treatment|Physician Decision|0|||
25060780|NCT02508532|50165479|FG005|Part 2 - Treatment|Physician Decision|0|||
25060781|NCT02508532|50165480|FG006|Part 2 - Treatment|Physician Decision|0|||
25060782|NCT02508532|50165481|FG007|Part 2 - Treatment|Physician Decision|0|||
25060783|NCT02508532|50165482|FG008|Part 2 - Treatment|Physician Decision|12|||
25060784|NCT02508532|50165474|FG000|Part 2 - Treatment|Administrative|0|||
25060785|NCT02508532|50165475|FG001|Part 2 - Treatment|Administrative|0|||
25060786|NCT02508532|50165476|FG002|Part 2 - Treatment|Administrative|0|||
25060787|NCT02508532|50165477|FG003|Part 2 - Treatment|Administrative|0|||
25060788|NCT02508532|50165478|FG004|Part 2 - Treatment|Administrative|0|||
25060789|NCT02508532|50165479|FG005|Part 2 - Treatment|Administrative|0|||
25060790|NCT02508532|50165480|FG006|Part 2 - Treatment|Administrative|0|||
25060791|NCT02508532|50165481|FG007|Part 2 - Treatment|Administrative|0|||
25060792|NCT02508532|50165482|FG008|Part 2 - Treatment|Administrative|3|||
25060793|NCT02508532|50165474|FG000|Part 2 - Treatment|Sponsor Decision|0|||
25060794|NCT02508532|50165475|FG001|Part 2 - Treatment|Sponsor Decision|0|||
25060795|NCT02508532|50165476|FG002|Part 2 - Treatment|Sponsor Decision|0|||
25060796|NCT02508532|50165477|FG003|Part 2 - Treatment|Sponsor Decision|0|||
25060797|NCT02508532|50165478|FG004|Part 2 - Treatment|Sponsor Decision|0|||
25060798|NCT02508532|50165479|FG005|Part 2 - Treatment|Sponsor Decision|0|||
25060799|NCT02508532|50165480|FG006|Part 2 - Treatment|Sponsor Decision|0|||
25060800|NCT02508532|50165481|FG007|Part 2 - Treatment|Sponsor Decision|0|||
25060801|NCT02508532|50165482|FG008|Part 2 - Treatment|Sponsor Decision|28|||
25060802|NCT02508532|50165474|FG000|Part 2 - Treatment|Death|0|||
25060803|NCT02508532|50165475|FG001|Part 2 - Treatment|Death|0|||
24963759|NCT00128661|50053748|FG000|Overall Study|Adverse Event|14|||
24963760|NCT00128661|50053749|FG001|Overall Study|Adverse Event|11|||
24963761|NCT00128661|50053748|FG000|Overall Study|Lost to Follow-up|10|||
25060804|NCT02508532|50165476|FG002|Part 2 - Treatment|Death|0|||
25060805|NCT02508532|50165477|FG003|Part 2 - Treatment|Death|0|||
25060806|NCT02508532|50165478|FG004|Part 2 - Treatment|Death|0|||
25060807|NCT02508532|50165479|FG005|Part 2 - Treatment|Death|0|||
25060808|NCT02508532|50165480|FG006|Part 2 - Treatment|Death|0|||
25060809|NCT02508532|50165481|FG007|Part 2 - Treatment|Death|0|||
24963762|NCT00128661|50053749|FG001|Overall Study|Lost to Follow-up|7|||
25060810|NCT02508532|50165482|FG008|Part 2 - Treatment|Death|1|||
25060811|NCT02508532|50165474|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
25060812|NCT02508532|50165475|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
25060813|NCT02508532|50165476|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
25060814|NCT02508532|50165477|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
25060815|NCT02508532|50165478|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
25060816|NCT02508532|50165479|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
25060817|NCT02508532|50165480|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
25060818|NCT02508532|50165481|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
25060819|NCT02508532|50165482|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
25060820|NCT02508532|50165474|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
25060821|NCT02508532|50165475|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
25060822|NCT02508532|50165476|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
25060823|NCT02508532|50165477|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
25060824|NCT02508532|50165478|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
25186623|NCT02647320|50337193|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
25186624|NCT02647320|50337194|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
25060825|NCT02508532|50165479|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
25060826|NCT02508532|50165480|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
25060827|NCT02508532|50165481|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
25060828|NCT02508532|50165482|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
25060829|NCT02508532|50165474|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
25060830|NCT02508532|50165475|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
25060831|NCT02508532|50165476|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
25060832|NCT02508532|50165477|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
25060833|NCT02508532|50165478|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
25060834|NCT02508532|50165479|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
25060835|NCT02508532|50165480|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
25060836|NCT02508532|50165481|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
25060837|NCT02508532|50165482|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
25060838|NCT02508532|50165474|FG000|Part 1 and Part 2 End of Study|Death|0|||
25060839|NCT02508532|50165475|FG001|Part 1 and Part 2 End of Study|Death|4|||
25060840|NCT02508532|50165476|FG002|Part 1 and Part 2 End of Study|Death|2|||
25060841|NCT02508532|50165477|FG003|Part 1 and Part 2 End of Study|Death|4|||
25060842|NCT02508532|50165478|FG004|Part 1 and Part 2 End of Study|Death|3|||
25060843|NCT02508532|50165479|FG005|Part 1 and Part 2 End of Study|Death|0|||
25060844|NCT02508532|50165480|FG006|Part 1 and Part 2 End of Study|Death|0|||
25060845|NCT02508532|50165481|FG007|Part 1 and Part 2 End of Study|Death|1|||
25060846|NCT02508532|50165482|FG008|Part 1 and Part 2 End of Study|Death|111|||
25060847|NCT02508532|50165474|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
25060848|NCT02508532|50165475|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
25060849|NCT02508532|50165476|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
25060850|NCT02508532|50165477|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
25060851|NCT02508532|50165478|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
25060852|NCT02508532|50165479|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
25060853|NCT02508532|50165480|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
25060854|NCT02508532|50165481|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
25060855|NCT02508532|50165482|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
25060856|NCT02508532|50165474|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
25060857|NCT02508532|50165475|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
25060858|NCT02508532|50165476|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
25060859|NCT02508532|50165477|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
25060860|NCT02508532|50165478|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
25060861|NCT02508532|50165479|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
25060862|NCT02508532|50165480|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
25060863|NCT02508532|50165481|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
25060864|NCT02508532|50165482|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
25060865|NCT02508532|50165474|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
25060866|NCT02508532|50165475|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
25060867|NCT02508532|50165476|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
25060868|NCT02508532|50165477|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
25060869|NCT02508532|50165478|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
25060870|NCT02508532|50165479|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
25060871|NCT02508532|50165480|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
25060872|NCT02508532|50165481|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
25060873|NCT02508532|50165482|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
25060874|NCT02508532|50165474|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
25060875|NCT02508532|50165475|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
25060876|NCT02508532|50165476|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
25060877|NCT02508532|50165477|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
25060878|NCT02508532|50165478|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
25060879|NCT02508532|50165479|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
25060880|NCT02508532|50165480|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
25060881|NCT02508532|50165481|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
25060882|NCT02508532|50165482|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
25162809|NCT01978145|50285192|FG000|Treatment Period 1|Adverse Event|1|||
25060883|NCT02508532|50165474|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
25060884|NCT02508532|50165475|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
25060885|NCT02508532|50165476|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
25060886|NCT02508532|50165477|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
25060887|NCT02508532|50165478|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
25060888|NCT02508532|50165479|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
25060889|NCT02508532|50165480|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
25060890|NCT02508532|50165481|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
25060891|NCT02508532|50165482|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
25060892|NCT02918071|50165511|FG000|Overall Study|Withdrawal by Subject|2|||
25060893|NCT02918071|50165511|FG000|Overall Study|Lost to Follow-up|1|||
25060894|NCT02507752|50165515|FG000|Overall Study|Adverse Event|1|||
25060895|NCT02507752|50165515|FG000|Overall Study|Protocol Violation|6|||
25060896|NCT02507752|50165515|FG000|Overall Study|Lost to Follow-up|7|||
25060897|NCT02507752|50165515|FG000|Overall Study|Infusion reaction at first infusion|1|||
25060898|NCT02507752|50165515|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
25060899|NCT02507752|50165515|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
25060900|NCT02506816|50165519|FG000|Overall Study|Adverse Event|3|||
25060901|NCT02506036|50165525|FG000|First Intervention (4-6 Weeks)|Death|1|||
25060902|NCT02506036|50165526|FG001|First Intervention (4-6 Weeks)|Death|0|||
25060903|NCT02506036|50165525|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
25060904|NCT02506036|50165526|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
25060905|NCT02506036|50165525|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
25060906|NCT02506036|50165526|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
25060907|NCT01063855|50165534|FG000|Overall Study|Adverse Event|4|||
25060908|NCT01063855|50165535|FG001|Overall Study|Adverse Event|4|||
25060909|NCT01063855|50165534|FG000|Overall Study|Death|0|||
25060910|NCT01063855|50165535|FG001|Overall Study|Death|1|||
25060911|NCT01063855|50165534|FG000|Overall Study|Lost to Follow-up|8|||
25060912|NCT01063855|50165535|FG001|Overall Study|Lost to Follow-up|4|||
25060913|NCT01063855|50165534|FG000|Overall Study|Pregnancy|1|||
25060914|NCT01063855|50165535|FG001|Overall Study|Pregnancy|0|||
25060915|NCT01063855|50165534|FG000|Overall Study|Lack of Efficacy|0|||
25060916|NCT01063855|50165535|FG001|Overall Study|Lack of Efficacy|1|||
25060917|NCT01063855|50165534|FG000|Overall Study|Withdrawal by Subject|11|||
25060918|NCT01063855|50165535|FG001|Overall Study|Withdrawal by Subject|8|||
25060919|NCT01063855|50165534|FG000|Overall Study|Reason not specified|13|||
25060920|NCT01063855|50165535|FG001|Overall Study|Reason not specified|11|||
25060921|NCT01063153|50165547|FG000|Overall Study|Found Ineligible During Screening|2|||
25060922|NCT01063153|50165548|FG001|Overall Study|Found Ineligible During Screening|0|||
25060923|NCT01063153|50165547|FG000|Overall Study|Lost to Follow-up|0|||
25060924|NCT01063153|50165548|FG001|Overall Study|Lost to Follow-up|7|||
25060925|NCT01063153|50165547|FG000|Overall Study|Withdrawal by Subject|0|||
25060926|NCT01063153|50165548|FG001|Overall Study|Withdrawal by Subject|1|||
25060927|NCT01063153|50165547|FG000|Overall Study|Physician Decision|0|||
25060928|NCT01063153|50165548|FG001|Overall Study|Physician Decision|4|||
25060929|NCT01062841|50165560|FG000|Overall Study|Indwelling Device Removed|41|||
25060930|NCT01062841|50165561|FG001|Overall Study|Indwelling Device Removed|48|||
25060931|NCT01062841|50165560|FG000|Overall Study|Death|3|||
25060932|NCT01062841|50165561|FG001|Overall Study|Death|5|||
25060933|NCT01062841|50165560|FG000|Overall Study|Withdrawal by Subject|2|||
25060934|NCT01062841|50165561|FG001|Overall Study|Withdrawal by Subject|0|||
25060935|NCT01062841|50165560|FG000|Overall Study|Withdrawal by Study|3|||
25060936|NCT01062841|50165561|FG001|Overall Study|Withdrawal by Study|0|||
25060937|NCT02505334|50165569|FG000|Main Treatment Period|Adverse Event|3|||
25060938|NCT02505334|50165570|FG001|Main Treatment Period|Adverse Event|3|||
25060939|NCT02505334|50165569|FG000|Main Treatment Period|Lack of Efficacy|7|||
25060940|NCT02505334|50165570|FG001|Main Treatment Period|Lack of Efficacy|17|||
25060941|NCT02505334|50165569|FG000|Main Treatment Period|Protocol Violation|0|||
25060942|NCT02505334|50165570|FG001|Main Treatment Period|Protocol Violation|1|||
25060943|NCT02505334|50165569|FG000|Main Treatment Period|Withdrawal by Subject|1|||
25060944|NCT02505334|50165570|FG001|Main Treatment Period|Withdrawal by Subject|8|||
25060945|NCT02505334|50165569|FG000|Main Treatment Period|Unclassified|4|||
25060946|NCT02505334|50165570|FG001|Main Treatment Period|Unclassified|10|||
25060947|NCT02505334|50165569|FG000|Extension Treatment Period|Adverse Event|5|||
25060948|NCT02505334|50165570|FG001|Extension Treatment Period|Adverse Event|0|||
25060949|NCT02505334|50165569|FG000|Extension Treatment Period|Lack of Efficacy|4|||
25060950|NCT02505334|50165570|FG001|Extension Treatment Period|Lack of Efficacy|0|||
25060951|NCT02505334|50165569|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
25060952|NCT02505334|50165570|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
25060953|NCT02505334|50165569|FG000|Extension Treatment Period|Unclassified|3|||
25060954|NCT02505334|50165570|FG001|Extension Treatment Period|Unclassified|0|||
25060955|NCT01062061|50165576|FG000|Overall Study|Enrolled more than once|2|||
25060956|NCT01062061|50165576|FG000|Overall Study|Investigated before study start|13|||
25186625|NCT02647320|50337195|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
25060957|NCT01062061|50165576|FG000|Overall Study|Outside chief indications|10|||
25060958|NCT01062061|50165576|FG000|Overall Study|Failed to meet inclusion criteria|2|||
25060959|NCT02504320|50165588|FG000|Treatment Period 1|Positive Drug Screen|0|||
25060960|NCT02504320|50165589|FG001|Treatment Period 1|Positive Drug Screen|0|||
25060961|NCT02504320|50165590|FG002|Treatment Period 1|Positive Drug Screen|1|||
25060962|NCT02504320|50165591|FG003|Treatment Period 1|Positive Drug Screen|0|||
25060963|NCT02504320|50165588|FG000|Treatment Period 2|Positive Drug Screen|0|||
25060964|NCT02504320|50165589|FG001|Treatment Period 2|Positive Drug Screen|1|||
25060965|NCT02504320|50165590|FG002|Treatment Period 2|Positive Drug Screen|0|||
25060966|NCT02504320|50165591|FG003|Treatment Period 2|Positive Drug Screen|0|||
25060967|NCT02504320|50165588|FG000|Treatment Period 3|Positive Drug Screen|0|||
25060968|NCT02504320|50165589|FG001|Treatment Period 3|Positive Drug Screen|0|||
25060969|NCT02504320|50165590|FG002|Treatment Period 3|Positive Drug Screen|0|||
25060970|NCT02504320|50165591|FG003|Treatment Period 3|Positive Drug Screen|1|||
25060971|NCT02504320|50165588|FG000|Treatment Period 3|Adverse Event|0|||
25060972|NCT02504320|50165589|FG001|Treatment Period 3|Adverse Event|0|||
25060973|NCT02504320|50165590|FG002|Treatment Period 3|Adverse Event|1|||
25060974|NCT02504320|50165591|FG003|Treatment Period 3|Adverse Event|0|||
25060975|NCT01061671|50165603|FG000|Overall Study|Withdrawal by Subject|16|||
25060976|NCT01061671|50165604|FG001|Overall Study|Withdrawal by Subject|20|||
25060977|NCT01061671|50165603|FG000|Overall Study|Lost to Follow-up|3|||
25060978|NCT01061671|50165604|FG001|Overall Study|Lost to Follow-up|5|||
25060979|NCT01061671|50165603|FG000|Overall Study|Death|28|||
25060980|NCT01061671|50165604|FG001|Overall Study|Death|30|||
25060981|NCT00709995|50165612|FG000|Overall Study|Adverse Event|4|||
25060982|NCT00709995|50165613|FG001|Overall Study|Adverse Event|2|||
25060983|NCT00709995|50165612|FG000|Overall Study|Withdrawal by Subject|1|||
25060984|NCT00709995|50165613|FG001|Overall Study|Withdrawal by Subject|3|||
25060985|NCT02503540|50165622|FG000|Overall Study|Death|2|||
25060986|NCT02503540|50165622|FG000|Overall Study|Withdrawal by Subject|1|||
25060987|NCT02502526|50165629|FG000|Overall Study|Lost to Follow-up|2|||
25060988|NCT02502526|50165630|FG001|Overall Study|Lost to Follow-up|2|||
25060989|NCT02502526|50165631|FG002|Overall Study|Lost to Follow-up|3|||
25060990|NCT02502526|50165629|FG000|Overall Study|Withdrawal by Subject|0|||
25060991|NCT02502526|50165630|FG001|Overall Study|Withdrawal by Subject|1|||
25060992|NCT02502526|50165631|FG002|Overall Study|Withdrawal by Subject|1|||
25060993|NCT02502526|50165629|FG000|Overall Study|Disqualified due to cataract grading|0|||
25060994|NCT02502526|50165630|FG001|Overall Study|Disqualified due to cataract grading|0|||
25060995|NCT02502526|50165631|FG002|Overall Study|Disqualified due to cataract grading|1|||
25060996|NCT02502526|50165629|FG000|Overall Study|Enrollment suspension|4|||
25060997|NCT02502526|50165630|FG001|Overall Study|Enrollment suspension|1|||
25060998|NCT02502526|50165631|FG002|Overall Study|Enrollment suspension|1|||
25060999|NCT02972515|50165640|FG000|Overall Study|Lost to Follow-up|78|||
25061000|NCT02972359|50165644|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
25061001|NCT02972359|50165644|FG000|Overall Study|Lack of Efficacy|1|||
25061002|NCT02972359|50165644|FG000|Overall Study|Adverse Event|4|||
25061003|NCT02972359|50165644|FG000|Overall Study|Death|1|||
25061004|NCT02972359|50165644|FG000|Overall Study|Withdrawal by Subject|30|||
25061005|NCT02972359|50165644|FG000|Overall Study|Protocol Violation|1|||
25061006|NCT02972359|50165644|FG000|Overall Study|Lost to Follow-up|26|||
25061007|NCT02972359|50165644|FG000|Overall Study|Other reasons|5|||
25061008|NCT02972359|50165644|FG000|Overall Study|Missing|1|||
25061009|NCT01060111|50165651|FG000|Overall Study|Adverse Event|9|||
25061010|NCT01060111|50165652|FG001|Overall Study|Adverse Event|5|||
25061011|NCT01060111|50165653|FG002|Overall Study|Adverse Event|18|||
25061012|NCT01060111|50165651|FG000|Overall Study|Lack of Efficacy|2|||
25061013|NCT01060111|50165652|FG001|Overall Study|Lack of Efficacy|1|||
25061014|NCT01060111|50165653|FG002|Overall Study|Lack of Efficacy|0|||
25061015|NCT01060111|50165651|FG000|Overall Study|Inappropriate participant|5|||
25061016|NCT01060111|50165652|FG001|Overall Study|Inappropriate participant|4|||
25061017|NCT01060111|50165653|FG002|Overall Study|Inappropriate participant|5|||
25061018|NCT01060111|50165651|FG000|Overall Study|Participants' evasion for hospital visit|0|||
25061019|NCT01060111|50165652|FG001|Overall Study|Participants' evasion for hospital visit|3|||
25061020|NCT01060111|50165653|FG002|Overall Study|Participants' evasion for hospital visit|2|||
25061021|NCT01060111|50165651|FG000|Overall Study|Participants' non-cooperation|8|||
25162810|NCT01978145|50285193|FG001|Treatment Period 1|Adverse Event|9|||
25061022|NCT01060111|50165652|FG001|Overall Study|Participants' non-cooperation|6|||
25061023|NCT01060111|50165653|FG002|Overall Study|Participants' non-cooperation|6|||
25061024|NCT01060111|50165651|FG000|Overall Study|Adverse event and insufficient effect|0|||
25061025|NCT01060111|50165652|FG001|Overall Study|Adverse event and insufficient effect|1|||
25061026|NCT01060111|50165653|FG002|Overall Study|Adverse event and insufficient effect|0|||
25061027|NCT01060111|50165651|FG000|Overall Study|Participants' non-cooperation|1|||
25061028|NCT01060111|50165652|FG001|Overall Study|Participants' non-cooperation|0|||
25061029|NCT01060111|50165653|FG002|Overall Study|Participants' non-cooperation|0|||
25061030|NCT01060111|50165651|FG000|Overall Study|Other|2|||
25061031|NCT01060111|50165652|FG001|Overall Study|Other|3|||
25061032|NCT01060111|50165653|FG002|Overall Study|Other|4|||
25061033|NCT02969863|50165664|FG000|Overall Study|Physician Decision|1|||
25061034|NCT02969863|50165665|FG001|Overall Study|Physician Decision|0|||
25061035|NCT02969863|50165666|FG002|Overall Study|Physician Decision|0|||
25061036|NCT02969863|50165667|FG003|Overall Study|Physician Decision|0|||
25061037|NCT02969863|50165668|FG004|Overall Study|Physician Decision|0|||
25061038|NCT02969863|50165669|FG005|Overall Study|Physician Decision|0|||
25061039|NCT02969707|50165685|FG000|Overall Study|Adverse Event|1|||
25061040|NCT02969707|50165686|FG001|Overall Study|Adverse Event|2|||
25061041|NCT02969707|50165685|FG000|Overall Study|Lost to Follow-up|3|||
25061042|NCT02969707|50165686|FG001|Overall Study|Lost to Follow-up|0|||
25061043|NCT02969707|50165685|FG000|Overall Study|Physician Decision|0|||
25061044|NCT02969707|50165686|FG001|Overall Study|Physician Decision|1|||
25061045|NCT02969707|50165685|FG000|Overall Study|Protocol Violation|1|||
25061046|NCT02969707|50165686|FG001|Overall Study|Protocol Violation|1|||
25061047|NCT02969707|50165685|FG000|Overall Study|Withdrawal by Subject|3|||
25061048|NCT02969707|50165686|FG001|Overall Study|Withdrawal by Subject|4|||
25061049|NCT02967055|50165697|FG000|Overall Study|Excluded|40|||
25061050|NCT02967055|50165697|FG000|Overall Study|Screen fail|3|||
25061051|NCT02967055|50165697|FG000|Overall Study|Lost to Follow-up|2|||
25061052|NCT02967055|50165697|FG000|Overall Study|Stopped due to side effects|3|||
25061053|NCT02967055|50165697|FG000|Overall Study|Stopped due to drug cost|1|||
25061054|NCT02904265|50165703|FG000|Overall Study|Physician Decision|1|||
25061055|NCT02904265|50165704|FG001|Overall Study|Physician Decision|2|||
25061056|NCT03461211|50165712|FG000|Overall Study|Adverse Event|1|||
25061057|NCT03461211|50165713|FG001|Overall Study|Adverse Event|1|||
25061058|NCT03461211|50165712|FG000|Overall Study|Lack of Efficacy|0|||
25162811|NCT01978145|50285192|FG000|Treatment Period 1|Physician Decision|1|||
25162812|NCT01978145|50285193|FG001|Treatment Period 1|Physician Decision|0|||
25162813|NCT01978145|50285192|FG000|Treatment Period 1|Withdrawal by Subject|5|||
25162814|NCT01978145|50285193|FG001|Treatment Period 1|Withdrawal by Subject|4|||
25162815|NCT01978145|50285192|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
25162816|NCT01978145|50285193|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
25061059|NCT03461211|50165713|FG001|Overall Study|Lack of Efficacy|1|||
25061060|NCT02967679|50165721|FG000|Overall Study|Adverse Event|1|||
25061061|NCT02966509|50165731|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
25061062|NCT02966509|50165732|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
25061063|NCT02966509|50165731|FG000|Baseline Satisfaction Survey|Death|0|||
25061064|NCT02966509|50165732|FG001|Baseline Satisfaction Survey|Death|1|||
25061065|NCT02966509|50165731|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
25061066|NCT02966509|50165732|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
25061067|NCT02966509|50165731|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
25061068|NCT02966509|50165732|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
25061069|NCT02966509|50165731|FG000|6 Month Satisfaction Decision Survey|Death|22|||
25061070|NCT02966509|50165732|FG001|6 Month Satisfaction Decision Survey|Death|25|||
25061071|NCT02966509|50165731|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
25061072|NCT02966509|50165732|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
25061073|NCT02966509|50165731|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
25061074|NCT02966509|50165732|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
25061075|NCT02966509|50165731|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
25061076|NCT02966509|50165732|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
25061077|NCT02966509|50165731|FG000|6 Month Satisfaction Survey|Death|36|||
25061078|NCT02966509|50165732|FG001|6 Month Satisfaction Survey|Death|33|||
25061079|NCT02966509|50165731|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
25061080|NCT02966509|50165732|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
25061081|NCT02966509|50165731|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
25061082|NCT02966509|50165732|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
25061083|NCT02966509|50165731|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
25061084|NCT02966509|50165732|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
25061085|NCT02966509|50165731|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
25061086|NCT02966509|50165732|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
25061087|NCT02966509|50165731|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
25061088|NCT02966509|50165732|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
25061089|NCT02966353|50165738|FG000|Overall Study|Withdrawal by Subject|7|||
25061090|NCT02966353|50165738|FG000|Overall Study|Adverse Event|4|||
25061091|NCT02966353|50165738|FG000|Overall Study|Death|4|||
25061092|NCT02966353|50165738|FG000|Overall Study|Physician Decision|3|||
25061093|NCT02966353|50165738|FG000|Overall Study|Progressive disease|2|||
25061094|NCT02966353|50165738|FG000|Overall Study|Protocol deviation|2|||
25061095|NCT02965573|50165771|FG000|Overall Study|Lack of Efficacy|1|||
25061096|NCT02965573|50165772|FG001|Overall Study|Lack of Efficacy|0|||
25061097|NCT02964325|50165780|FG000|Overall Study|Lost to Follow-up|3|||
25061098|NCT02964325|50165781|FG001|Overall Study|Lost to Follow-up|3|||
25061099|NCT02964325|50165780|FG000|Overall Study|Physician Decision|5|||
25061100|NCT02964325|50165781|FG001|Overall Study|Physician Decision|4|||
25061101|NCT02964325|50165780|FG000|Overall Study|Death|1|||
25061102|NCT02964325|50165781|FG001|Overall Study|Death|3|||
25061103|NCT02964325|50165780|FG000|Overall Study|Withdrawal by Subject|2|||
25061104|NCT02964325|50165781|FG001|Overall Study|Withdrawal by Subject|1|||
25061105|NCT02964325|50165780|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
25061106|NCT02964325|50165781|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
25061107|NCT02964247|50165789|FG000|Overall Study|Lost to Follow-up|2|||
25061108|NCT02964247|50165790|FG001|Overall Study|Lost to Follow-up|0|||
25061109|NCT02964247|50165789|FG000|Overall Study|Withdrawal by Subject|1|||
25061110|NCT02964247|50165790|FG001|Overall Study|Withdrawal by Subject|2|||
25061111|NCT03654729|50165799|FG000|Overall Study|Death|9|||
25061112|NCT03654729|50165800|FG001|Overall Study|Death|9|||
25061113|NCT03654729|50165801|FG002|Overall Study|Death|16|||
25061114|NCT03654729|50165799|FG000|Overall Study|Withdrawal by Subject|8|||
25061115|NCT03654729|50165800|FG001|Overall Study|Withdrawal by Subject|6|||
25061116|NCT03654729|50165801|FG002|Overall Study|Withdrawal by Subject|4|||
25061117|NCT03654729|50165799|FG000|Overall Study|Study terminated by Sponsor|3|||
25061118|NCT03654729|50165800|FG001|Overall Study|Study terminated by Sponsor|5|||
25061119|NCT03654729|50165801|FG002|Overall Study|Study terminated by Sponsor|4|||
25061120|NCT03654729|50165799|FG000|Overall Study|Not reported|2|||
25061121|NCT03654729|50165800|FG001|Overall Study|Not reported|4|||
25061122|NCT03654729|50165801|FG002|Overall Study|Not reported|5|||
25061123|NCT03654729|50165799|FG000|Overall Study|Progressive disease|3|||
25061124|NCT03654729|50165800|FG001|Overall Study|Progressive disease|0|||
25061125|NCT03654729|50165801|FG002|Overall Study|Progressive disease|0|||
25061126|NCT03654729|50165799|FG000|Overall Study|Lost to Follow-up|2|||
25061127|NCT03654729|50165800|FG001|Overall Study|Lost to Follow-up|0|||
25061128|NCT03654729|50165801|FG002|Overall Study|Lost to Follow-up|0|||
25061129|NCT03654729|50165799|FG000|Overall Study|Physician Decision|2|||
25061130|NCT03654729|50165800|FG001|Overall Study|Physician Decision|0|||
25061131|NCT03654729|50165801|FG002|Overall Study|Physician Decision|0|||
25061132|NCT03654729|50165799|FG000|Overall Study|Protocol Violation|1|||
25186626|NCT02647320|50337196|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
25061133|NCT03654729|50165800|FG001|Overall Study|Protocol Violation|1|||
25061134|NCT03654729|50165801|FG002|Overall Study|Protocol Violation|0|||
25061135|NCT03654729|50165799|FG000|Overall Study|Non-compliance with study drug|0|||
25061136|NCT03654729|50165800|FG001|Overall Study|Non-compliance with study drug|1|||
25061137|NCT03654729|50165801|FG002|Overall Study|Non-compliance with study drug|0|||
25061138|NCT03654729|50165799|FG000|Overall Study|Site terminated by Sponsor|1|||
25061139|NCT03654729|50165800|FG001|Overall Study|Site terminated by Sponsor|0|||
25061140|NCT03654729|50165801|FG002|Overall Study|Site terminated by Sponsor|0|||
25061141|NCT01377987|50165809|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
25061142|NCT01377987|50165810|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
25061143|NCT02898259|50165821|FG000|Overall Study|Adverse Event|0|||
25061144|NCT02898259|50165822|FG001|Overall Study|Adverse Event|0|||
25061145|NCT02898259|50165823|FG002|Overall Study|Adverse Event|1|||
25061146|NCT02898259|50165824|FG003|Overall Study|Adverse Event|0|||
25061147|NCT02898259|50165825|FG004|Overall Study|Adverse Event|0|||
25061148|NCT02898259|50165821|FG000|Overall Study|Lack of Efficacy|1|||
25061149|NCT02898259|50165822|FG001|Overall Study|Lack of Efficacy|1|||
25061150|NCT02898259|50165823|FG002|Overall Study|Lack of Efficacy|3|||
25061151|NCT02898259|50165824|FG003|Overall Study|Lack of Efficacy|0|||
25061152|NCT02898259|50165825|FG004|Overall Study|Lack of Efficacy|0|||
25061153|NCT02898259|50165821|FG000|Overall Study|Lost to Follow-up|0|||
25061154|NCT02898259|50165822|FG001|Overall Study|Lost to Follow-up|0|||
25061155|NCT02898259|50165823|FG002|Overall Study|Lost to Follow-up|1|||
25061156|NCT02898259|50165824|FG003|Overall Study|Lost to Follow-up|0|||
25061157|NCT02898259|50165825|FG004|Overall Study|Lost to Follow-up|0|||
25061158|NCT02898259|50165821|FG000|Overall Study|Transformation before study began|0|||
25061159|NCT02898259|50165822|FG001|Overall Study|Transformation before study began|0|||
25061160|NCT02898259|50165823|FG002|Overall Study|Transformation before study began|0|||
25061161|NCT02898259|50165824|FG003|Overall Study|Transformation before study began|1|||
25061162|NCT02898259|50165825|FG004|Overall Study|Transformation before study began|0|||
25061163|NCT02963935|50165840|FG000|Overall Study|Adverse Event|12|||
25061164|NCT02963935|50165841|FG001|Overall Study|Adverse Event|6|||
25061165|NCT02963935|50165840|FG000|Overall Study|Protocol Violation|2|||
25061166|NCT02963935|50165841|FG001|Overall Study|Protocol Violation|1|||
25061167|NCT02963935|50165840|FG000|Overall Study|Lack of Efficacy|0|||
25061168|NCT02963935|50165841|FG001|Overall Study|Lack of Efficacy|2|||
25061169|NCT02963935|50165840|FG000|Overall Study|Lost to Follow-up|1|||
25061170|NCT02963935|50165841|FG001|Overall Study|Lost to Follow-up|6|||
25061171|NCT02963935|50165840|FG000|Overall Study|Unclassified|13|||
25061172|NCT02963935|50165841|FG001|Overall Study|Unclassified|22|||
25061173|NCT02899195|50165847|FG000|Concurrent Durvalumab|Adverse Event|4|||
25061174|NCT02899195|50165847|FG000|Concurrent Durvalumab|Physician Decision|1|||
25061175|NCT02899195|50165847|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
25061176|NCT02899195|50165847|FG000|Concurrent Durvalumab|Progressive Disease|5|||
25061177|NCT02899195|50165847|FG000|Maintenance Durvalumab|Adverse Event|1|||
25061178|NCT02899195|50165847|FG000|Maintenance Durvalumab|Physician Decision|1|||
25061179|NCT02899195|50165847|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
25061180|NCT02899195|50165847|FG000|Maintenance Durvalumab|Progressive Disease|31|||
25061181|NCT02963701|50165853|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
25061182|NCT02963701|50165854|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
25061183|NCT01345591|50165860|FG000|Overall Study|Lost to Follow-up|1|||
25061184|NCT02961751|50165869|FG000|Overall Study|Lost to Follow-up|11|||
25061185|NCT02961751|50165869|FG000|Overall Study|Physician Decision|2|||
25061186|NCT02961751|50165869|FG000|Overall Study|Not Eligible at Enrollment|1|||
25061187|NCT02961751|50165869|FG000|Overall Study|Protocol Violation|1|||
25061188|NCT02963311|50165873|FG000|Overall Study|Withdrawal by Subject|1|||
25061189|NCT02963311|50165873|FG000|Overall Study|Screen Failure|4|||
25061190|NCT02962765|50165877|FG000|Overall Study|Protocol Violation|9|||
25061191|NCT02962765|50165877|FG000|Overall Study|Withdrawal by Subject|3|||
25061192|NCT02962765|50165877|FG000|Overall Study|Lost to Follow-up|1|||
25061193|NCT02962765|50165877|FG000|Overall Study|Death|1|||
25061194|NCT02962765|50165877|FG000|Overall Study|Limited access to study medication|3|||
25061195|NCT00965757|50165890|FG000|Double-blind Phase|Progression of concomitant disease|1|||
25061196|NCT00965757|50165891|FG001|Double-blind Phase|Progression of concomitant disease|2|||
25061197|NCT00965757|50165892|FG002|Double-blind Phase|Progression of concomitant disease|0|||
25061198|NCT00965757|50165893|FG003|Double-blind Phase|Progression of concomitant disease|0|||
25061199|NCT00965757|50165890|FG000|Double-blind Phase|Adverse drug reaction|2|||
25061200|NCT00965757|50165891|FG001|Double-blind Phase|Adverse drug reaction|1|||
25061201|NCT00965757|50165892|FG002|Double-blind Phase|Adverse drug reaction|0|||
25061202|NCT00965757|50165893|FG003|Double-blind Phase|Adverse drug reaction|0|||
25061203|NCT00965757|50165890|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
25061204|NCT00965757|50165891|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
25061205|NCT00965757|50165892|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
25061206|NCT00965757|50165893|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
25061207|NCT00965757|50165890|FG000|Double-blind Phase|Lack of Efficacy|7|||
25162817|NCT01978145|50285192|FG000|Washout Period 1|Adverse Event|0|||
25162818|NCT01978145|50285193|FG001|Washout Period 1|Adverse Event|1|||
25162819|NCT01978145|50285192|FG000|Washout Period 1|Withdrawal by Subject|1|||
25162820|NCT01978145|50285193|FG001|Washout Period 1|Withdrawal by Subject|1|||
25186627|NCT02647320|50337197|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
25061208|NCT00965757|50165891|FG001|Double-blind Phase|Lack of Efficacy|11|||
25061209|NCT00965757|50165892|FG002|Double-blind Phase|Lack of Efficacy|0|||
25061210|NCT00965757|50165893|FG003|Double-blind Phase|Lack of Efficacy|0|||
25061211|NCT00965757|50165890|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
25061212|NCT00965757|50165891|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
25162821|NCT01978145|50285192|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
25061213|NCT00965757|50165892|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
25061214|NCT00965757|50165893|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
25061215|NCT00965757|50165890|FG000|Double-blind Phase|Lost to Follow-up|0|||
25061216|NCT00965757|50165891|FG001|Double-blind Phase|Lost to Follow-up|1|||
25061217|NCT00965757|50165892|FG002|Double-blind Phase|Lost to Follow-up|0|||
25061218|NCT00965757|50165893|FG003|Double-blind Phase|Lost to Follow-up|0|||
25061219|NCT00965757|50165890|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
25061220|NCT00965757|50165891|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
25061221|NCT00965757|50165892|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
25061222|NCT00965757|50165893|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
25061223|NCT00965757|50165890|FG000|Double-blind Phase|Other|1|||
25061224|NCT00965757|50165891|FG001|Double-blind Phase|Other|0|||
25061225|NCT00965757|50165892|FG002|Double-blind Phase|Other|0|||
25061226|NCT00965757|50165893|FG003|Double-blind Phase|Other|0|||
25061227|NCT00965757|50165890|FG000|Extension Phase|Progression of concomitant disease|0|||
25061228|NCT00965757|50165891|FG001|Extension Phase|Progression of concomitant disease|0|||
25061229|NCT00965757|50165892|FG002|Extension Phase|Progression of concomitant disease|4|||
25061230|NCT00965757|50165893|FG003|Extension Phase|Progression of concomitant disease|2|||
25061231|NCT00965757|50165890|FG000|Extension Phase|Adverse drug reaction|0|||
25061232|NCT00965757|50165891|FG001|Extension Phase|Adverse drug reaction|0|||
25061233|NCT00965757|50165892|FG002|Extension Phase|Adverse drug reaction|6|||
25061234|NCT00965757|50165893|FG003|Extension Phase|Adverse drug reaction|3|||
25061235|NCT00965757|50165890|FG000|Extension Phase|Abnormal Laboratory Value|0|||
25061236|NCT00965757|50165891|FG001|Extension Phase|Abnormal Laboratory Value|0|||
25061237|NCT00965757|50165892|FG002|Extension Phase|Abnormal Laboratory Value|6|||
25061238|NCT00965757|50165893|FG003|Extension Phase|Abnormal Laboratory Value|1|||
25061239|NCT00965757|50165890|FG000|Extension Phase|Lack of Efficacy|0|||
25061240|NCT00965757|50165891|FG001|Extension Phase|Lack of Efficacy|0|||
25061241|NCT00965757|50165892|FG002|Extension Phase|Lack of Efficacy|8|||
25061242|NCT00965757|50165893|FG003|Extension Phase|Lack of Efficacy|12|||
25061243|NCT00965757|50165890|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
25061244|NCT00965757|50165891|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
25061245|NCT00965757|50165892|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
25061246|NCT00965757|50165893|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
25061247|NCT00965757|50165890|FG000|Extension Phase|Lost to Follow-up|0|||
25061248|NCT00965757|50165891|FG001|Extension Phase|Lost to Follow-up|0|||
25061249|NCT00965757|50165892|FG002|Extension Phase|Lost to Follow-up|0|||
25061250|NCT00965757|50165893|FG003|Extension Phase|Lost to Follow-up|1|||
25061251|NCT00965757|50165890|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
25061252|NCT00965757|50165891|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
25061253|NCT00965757|50165892|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
25061254|NCT00965757|50165893|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
25061255|NCT00965757|50165890|FG000|Extension Phase|Protocol Violation|0|||
25061256|NCT00965757|50165891|FG001|Extension Phase|Protocol Violation|0|||
25061257|NCT00965757|50165892|FG002|Extension Phase|Protocol Violation|0|||
25061258|NCT00965757|50165893|FG003|Extension Phase|Protocol Violation|1|||
25061259|NCT00965757|50165890|FG000|Extension Phase|Other|0|||
25061260|NCT00965757|50165891|FG001|Extension Phase|Other|0|||
25061261|NCT00965757|50165892|FG002|Extension Phase|Other|2|||
25061262|NCT00965757|50165893|FG003|Extension Phase|Other|1|||
25061263|NCT03072459|50165901|FG000|Overall Study|Device revised/removed|1|||
25061264|NCT03072459|50165901|FG000|Overall Study|Subject not able to return|1|||
25061265|NCT01067521|50165907|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
25061266|NCT01067521|50165908|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
25061267|NCT01067521|50165907|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
25061268|NCT01067521|50165908|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
25061269|NCT01067521|50165907|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
25061270|NCT01067521|50165908|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
25061271|NCT01067521|50165907|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
25061272|NCT01067521|50165908|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
25061273|NCT01067521|50165907|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
25061274|NCT01067521|50165908|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
25061275|NCT01067521|50165907|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
25061276|NCT01067521|50165908|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
25061277|NCT01067521|50165907|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
25061278|NCT01067521|50165908|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
25061279|NCT01067521|50165907|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
25061280|NCT01067521|50165908|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
25061281|NCT01067521|50165907|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
25061282|NCT01067521|50165908|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
25061283|NCT01067521|50165907|FG000|Open-Label Period|Death|3|||
25061284|NCT01067521|50165908|FG001|Open-Label Period|Death|1|||
25061285|NCT01067521|50165907|FG000|Open-Label Period|Adverse Event|30|||
25061286|NCT01067521|50165908|FG001|Open-Label Period|Adverse Event|28|||
25061287|NCT01067521|50165907|FG000|Open-Label Period|Withdrawal by Subject|160|||
25061288|NCT01067521|50165908|FG001|Open-Label Period|Withdrawal by Subject|88|||
25061289|NCT01067521|50165907|FG000|Open-Label Period|Physician Decision|13|||
25061290|NCT01067521|50165908|FG001|Open-Label Period|Physician Decision|11|||
25061291|NCT01067521|50165907|FG000|Open-Label Period|Non-compliance with study drug|5|||
25061292|NCT01067521|50165908|FG001|Open-Label Period|Non-compliance with study drug|0|||
25061293|NCT01067521|50165907|FG000|Open-Label Period|Protocol Violation|3|||
25061294|NCT01067521|50165908|FG001|Open-Label Period|Protocol Violation|0|||
25061295|NCT01067521|50165907|FG000|Open-Label Period|Pregnancy|14|||
25061296|NCT01067521|50165908|FG001|Open-Label Period|Pregnancy|8|||
25061297|NCT01067521|50165907|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
25061298|NCT01067521|50165908|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
25061299|NCT01067521|50165907|FG000|Open-Label Period|Lost to Follow-up|21|||
25061300|NCT01067521|50165908|FG001|Open-Label Period|Lost to Follow-up|20|||
25061301|NCT02735577|50165919|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
25061302|NCT02735577|50165919|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
25061303|NCT01345123|50165926|FG000|Overall Study|participants no longer with health plan|79|||
25061304|NCT01345123|50165927|FG001|Overall Study|participants no longer with health plan|85|||
25061305|NCT01345123|50165928|FG002|Overall Study|participants no longer with health plan|88|||
25061306|NCT02735421|50165937|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
25061307|NCT02735421|50165937|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
25061308|NCT02735421|50165937|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
25061309|NCT02735421|50165937|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
25061310|NCT02735421|50165937|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
25061311|NCT02735421|50165937|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
25061312|NCT02735421|50165937|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
25061313|NCT02983799|50165954|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
25061314|NCT02983799|50165955|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
25061315|NCT02983799|50165956|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
25061316|NCT02983799|50165957|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
25061317|NCT02983799|50165958|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
25061318|NCT02983799|50165954|FG000|Overall Study|Death|20|||
25061319|NCT02983799|50165955|FG001|Overall Study|Death|5|||
25061320|NCT02983799|50165956|FG002|Overall Study|Death|23|||
25061321|NCT02983799|50165957|FG003|Overall Study|Death|47|||
25061322|NCT02983799|50165958|FG004|Overall Study|Death|7|||
25061323|NCT02983799|50165954|FG000|Overall Study|Withdrawal by Subject|1|||
25061324|NCT02983799|50165955|FG001|Overall Study|Withdrawal by Subject|0|||
25061325|NCT02983799|50165956|FG002|Overall Study|Withdrawal by Subject|3|||
25061326|NCT02983799|50165957|FG003|Overall Study|Withdrawal by Subject|4|||
25061327|NCT02983799|50165958|FG004|Overall Study|Withdrawal by Subject|1|||
25061328|NCT02983799|50165954|FG000|Overall Study|Protocol Violation|0|||
25061329|NCT02983799|50165955|FG001|Overall Study|Protocol Violation|1|||
25061330|NCT02983799|50165956|FG002|Overall Study|Protocol Violation|0|||
25061331|NCT02983799|50165957|FG003|Overall Study|Protocol Violation|0|||
25061332|NCT02983799|50165958|FG004|Overall Study|Protocol Violation|1|||
25061333|NCT02983799|50165954|FG000|Overall Study|Lost to Follow-up|1|||
25061334|NCT02983799|50165955|FG001|Overall Study|Lost to Follow-up|0|||
25061335|NCT02983799|50165956|FG002|Overall Study|Lost to Follow-up|1|||
25061336|NCT02983799|50165957|FG003|Overall Study|Lost to Follow-up|0|||
25061337|NCT02983799|50165958|FG004|Overall Study|Lost to Follow-up|0|||
25061338|NCT02186847|50165976|FG000|Overall Study|Protocol Violation|3|||
25061339|NCT02186847|50165977|FG001|Overall Study|Protocol Violation|0|||
25061340|NCT01066871|50165987|FG000|Overall Study|Lost to Follow-up|0|||
25061341|NCT01066871|50165988|FG001|Overall Study|Lost to Follow-up|2|||
25061342|NCT01066871|50165989|FG002|Overall Study|Lost to Follow-up|2|||
25061343|NCT01066871|50165990|FG003|Overall Study|Lost to Follow-up|0|||
25061344|NCT01066871|50165987|FG000|Overall Study|Protocol Violation|1|||
25061345|NCT01066871|50165988|FG001|Overall Study|Protocol Violation|0|||
25061346|NCT01066871|50165989|FG002|Overall Study|Protocol Violation|3|||
25061347|NCT01066871|50165990|FG003|Overall Study|Protocol Violation|2|||
25061348|NCT01066871|50165987|FG000|Overall Study|Lack of Efficacy|0|||
25061349|NCT01066871|50165988|FG001|Overall Study|Lack of Efficacy|0|||
25061350|NCT01066871|50165989|FG002|Overall Study|Lack of Efficacy|0|||
25061351|NCT01066871|50165990|FG003|Overall Study|Lack of Efficacy|1|||
25061352|NCT01066871|50165987|FG000|Overall Study|Withdrawal by Subject|3|||
25061353|NCT01066871|50165988|FG001|Overall Study|Withdrawal by Subject|1|||
25061354|NCT01066871|50165989|FG002|Overall Study|Withdrawal by Subject|0|||
25061355|NCT01066871|50165990|FG003|Overall Study|Withdrawal by Subject|0|||
25061356|NCT01066871|50165987|FG000|Overall Study|Other|0|||
25061357|NCT01066871|50165988|FG001|Overall Study|Other|2|||
25061358|NCT01066871|50165989|FG002|Overall Study|Other|1|||
25061359|NCT01066871|50165990|FG003|Overall Study|Other|2|||
25061360|NCT02982863|50166010|FG000|Overall Study|Not eligible patients|809|||
25061361|NCT02982863|50166011|FG001|Overall Study|Not eligible patients|4261|||
25061362|NCT02982863|50166012|FG002|Overall Study|Not eligible patients|1852|||
25061363|NCT02982863|50166013|FG003|Overall Study|Not eligible patients|1400|||
25061364|NCT02982863|50166014|FG004|Overall Study|Not eligible patients|492|||
25061365|NCT04343651|50166057|FG000|Overall Study|Physician Decision|2|||
25061366|NCT04343651|50166058|FG001|Overall Study|Physician Decision|1|||
25061367|NCT04343651|50166057|FG000|Overall Study|Lost to Follow-up|2|||
25061368|NCT04343651|50166058|FG001|Overall Study|Lost to Follow-up|1|||
25061369|NCT04343651|50166057|FG000|Overall Study|Protocol Violation|4|||
25061370|NCT04343651|50166058|FG001|Overall Study|Protocol Violation|6|||
25061371|NCT04343651|50166057|FG000|Overall Study|Missing|3|||
25061372|NCT04343651|50166058|FG001|Overall Study|Missing|9|||
25061373|NCT04343651|50166057|FG000|Overall Study|Withdrawal by Subject|0|||
25061374|NCT04343651|50166058|FG001|Overall Study|Withdrawal by Subject|4|||
25061375|NCT04343651|50166057|FG000|Overall Study|Death|0|||
25061376|NCT04343651|50166058|FG001|Overall Study|Death|1|||
25061377|NCT04343651|50166057|FG000|Overall Study|Did not start treatment|1|||
25061378|NCT04343651|50166058|FG001|Overall Study|Did not start treatment|1|||
25061379|NCT04343651|50166057|FG000|Overall Study|Patient did not complete visits 3-6|0|||
25061380|NCT04343651|50166058|FG001|Overall Study|Patient did not complete visits 3-6|1|||
25061381|NCT02906579|50166066|FG000|Overall Study|Adverse Event|1|||
25061382|NCT02906579|50166066|FG000|Overall Study|Physician Decision|1|||
25061383|NCT01328535|50166086|FG000|Overall Study|Ineligible|1|||
25061384|NCT02905331|50166094|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
25061385|NCT02905331|50166095|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
25061386|NCT02905331|50166096|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
25061387|NCT02905331|50166094|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
25061388|NCT02905331|50166095|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
25061389|NCT02905331|50166096|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
25061390|NCT02905331|50166094|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
25061391|NCT02905331|50166095|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
25061392|NCT02905331|50166096|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
25061393|NCT02905331|50166094|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
25061394|NCT02905331|50166095|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
25061395|NCT02905331|50166096|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
25061396|NCT02905331|50166094|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
25061397|NCT02905331|50166095|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
25061398|NCT02905331|50166096|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
25061399|NCT02979197|50166107|FG000|Overall Study|Adverse Event|4|||
25061400|NCT02979197|50166108|FG001|Overall Study|Adverse Event|2|||
25061401|NCT02979197|50166109|FG002|Overall Study|Adverse Event|0|||
25061402|NCT02979197|50166107|FG000|Overall Study|Protocol Violation|0|||
25061403|NCT02979197|50166108|FG001|Overall Study|Protocol Violation|1|||
25061404|NCT02979197|50166109|FG002|Overall Study|Protocol Violation|0|||
25061405|NCT02979197|50166107|FG000|Overall Study|Subject unable to commit to study dates|0|||
25061406|NCT02979197|50166108|FG001|Overall Study|Subject unable to commit to study dates|1|||
25061407|NCT02979197|50166109|FG002|Overall Study|Subject unable to commit to study dates|0|||
25061408|NCT02982239|50166119|FG000|Overall Study|Lost to Follow-up|3|||
25061409|NCT02982239|50166120|FG001|Overall Study|Lost to Follow-up|2|||
25061410|NCT01066793|50166133|FG000|Overall Study|Death|4|||
25061411|NCT01066793|50166134|FG001|Overall Study|Death|1|||
25061412|NCT01066793|50166135|FG002|Overall Study|Death|1|||
25061413|NCT01066793|50166136|FG003|Overall Study|Death|0|||
25061414|NCT01066793|50166137|FG004|Overall Study|Death|0|||
25061415|NCT01066793|50166138|FG005|Overall Study|Death|0|||
25061416|NCT01066793|50166133|FG000|Overall Study|Lack of Efficacy|2|||
25061417|NCT01066793|50166134|FG001|Overall Study|Lack of Efficacy|1|||
25061418|NCT01066793|50166135|FG002|Overall Study|Lack of Efficacy|0|||
25061419|NCT01066793|50166136|FG003|Overall Study|Lack of Efficacy|0|||
25061420|NCT01066793|50166137|FG004|Overall Study|Lack of Efficacy|0|||
25061421|NCT01066793|50166138|FG005|Overall Study|Lack of Efficacy|0|||
25061422|NCT01066793|50166133|FG000|Overall Study|Lost to Follow-up|180|||
25061423|NCT01066793|50166134|FG001|Overall Study|Lost to Follow-up|39|||
25061424|NCT01066793|50166135|FG002|Overall Study|Lost to Follow-up|82|||
25061425|NCT01066793|50166136|FG003|Overall Study|Lost to Follow-up|16|||
25061426|NCT01066793|50166137|FG004|Overall Study|Lost to Follow-up|0|||
25061427|NCT01066793|50166138|FG005|Overall Study|Lost to Follow-up|1|||
25061428|NCT01066793|50166133|FG000|Overall Study|Physician Decision|3|||
25061429|NCT01066793|50166134|FG001|Overall Study|Physician Decision|0|||
25061430|NCT01066793|50166135|FG002|Overall Study|Physician Decision|0|||
25061431|NCT01066793|50166136|FG003|Overall Study|Physician Decision|0|||
25061432|NCT01066793|50166137|FG004|Overall Study|Physician Decision|0|||
25061433|NCT01066793|50166138|FG005|Overall Study|Physician Decision|0|||
25061434|NCT01066793|50166133|FG000|Overall Study|Protocol Violation|3|||
24963763|NCT00128661|50053748|FG000|Overall Study|Withdrawal by Subject|243|||
24963764|NCT00128661|50053749|FG001|Overall Study|Withdrawal by Subject|232|||
24963765|NCT00128661|50053748|FG000|Overall Study|Other|7|||
24963766|NCT00128661|50053749|FG001|Overall Study|Other|8|||
24963767|NCT00145509|50053757|FG000|Overall Study|Adverse Event|10|||
24963768|NCT00145509|50053758|FG001|Overall Study|Adverse Event|3|||
24963769|NCT00145509|50053757|FG000|Overall Study|Lack of Efficacy|3|||
24963770|NCT00145509|50053758|FG001|Overall Study|Lack of Efficacy|1|||
24963771|NCT00145509|50053757|FG000|Overall Study|Lost to Follow-up|5|||
24963772|NCT00145509|50053758|FG001|Overall Study|Lost to Follow-up|9|||
24963773|NCT00145509|50053757|FG000|Overall Study|Withdrew Consent|2|||
24963774|NCT00145509|50053758|FG001|Overall Study|Withdrew Consent|7|||
24963775|NCT00145509|50053757|FG000|Overall Study|Reason not provided|2|||
24963776|NCT00145509|50053758|FG001|Overall Study|Reason not provided|1|||
24963777|NCT00145119|50053764|FG000|Overall Study|Death|45|||
24963778|NCT00220779|50053771|FG000|Overall Study|Adverse Event|1|||
24963779|NCT00220779|50053772|FG001|Overall Study|Adverse Event|0|||
24963780|NCT00220779|50053773|FG002|Overall Study|Adverse Event|0|||
24963781|NCT00220779|50053771|FG000|Overall Study|Withdrawal by Subject|1|||
24963782|NCT00220779|50053772|FG001|Overall Study|Withdrawal by Subject|4|||
24963783|NCT00220779|50053773|FG002|Overall Study|Withdrawal by Subject|1|||
24963784|NCT00220779|50053771|FG000|Overall Study|Non-compliance|1|||
24963785|NCT00220779|50053772|FG001|Overall Study|Non-compliance|0|||
24963786|NCT00220779|50053773|FG002|Overall Study|Non-compliance|0|||
24963787|NCT00220779|50053771|FG000|Overall Study|Too time consuming|1|||
24963788|NCT00220779|50053772|FG001|Overall Study|Too time consuming|0|||
24963789|NCT00220779|50053773|FG002|Overall Study|Too time consuming|0|||
24963790|NCT00220779|50053771|FG000|Overall Study|Pregnancy|0|||
24963791|NCT00220779|50053772|FG001|Overall Study|Pregnancy|0|||
24963792|NCT00220779|50053773|FG002|Overall Study|Pregnancy|2|||
24963793|NCT00220779|50053771|FG000|Overall Study|Lack of Efficacy|3|||
24963794|NCT00220779|50053772|FG001|Overall Study|Lack of Efficacy|0|||
24963795|NCT00220779|50053773|FG002|Overall Study|Lack of Efficacy|1|||
24963796|NCT00207740|50053785|FG000|Overall Study|Adverse Event|4|||
24963797|NCT00207740|50053786|FG001|Overall Study|Adverse Event|14|||
24963798|NCT00207740|50053787|FG002|Overall Study|Adverse Event|14|||
24963799|NCT00207740|50053788|FG003|Overall Study|Adverse Event|11|||
24963800|NCT00207740|50053785|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25061435|NCT01066793|50166134|FG001|Overall Study|Protocol Violation|2|||
25061436|NCT01066793|50166135|FG002|Overall Study|Protocol Violation|2|||
24963801|NCT00207740|50053786|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
24963802|NCT00207740|50053787|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
24963803|NCT00207740|50053788|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
24963804|NCT00207740|50053785|FG000|Overall Study|Lost to Follow-up|0|||
24963805|NCT00207740|50053786|FG001|Overall Study|Lost to Follow-up|2|||
24963806|NCT00207740|50053787|FG002|Overall Study|Lost to Follow-up|1|||
24963807|NCT00207740|50053788|FG003|Overall Study|Lost to Follow-up|1|||
24963808|NCT00207740|50053785|FG000|Overall Study|Death|0|||
24963809|NCT00207740|50053786|FG001|Overall Study|Death|0|||
25061437|NCT01066793|50166136|FG003|Overall Study|Protocol Violation|0|||
25061438|NCT01066793|50166137|FG004|Overall Study|Protocol Violation|0|||
25061439|NCT01066793|50166138|FG005|Overall Study|Protocol Violation|0|||
25061440|NCT01066793|50166133|FG000|Overall Study|Withdrawal by Subject|7|||
25061441|NCT01066793|50166134|FG001|Overall Study|Withdrawal by Subject|4|||
25061442|NCT01066793|50166135|FG002|Overall Study|Withdrawal by Subject|1|||
25061443|NCT01066793|50166136|FG003|Overall Study|Withdrawal by Subject|0|||
25061444|NCT01066793|50166137|FG004|Overall Study|Withdrawal by Subject|0|||
25061445|NCT01066793|50166138|FG005|Overall Study|Withdrawal by Subject|0|||
25061446|NCT01066793|50166133|FG000|Overall Study|Early Termination|3|||
25061447|NCT01066793|50166134|FG001|Overall Study|Early Termination|0|||
25061448|NCT01066793|50166135|FG002|Overall Study|Early Termination|0|||
25061449|NCT01066793|50166136|FG003|Overall Study|Early Termination|0|||
25061450|NCT01066793|50166137|FG004|Overall Study|Early Termination|0|||
25061451|NCT01066793|50166138|FG005|Overall Study|Early Termination|0|||
25061452|NCT01066793|50166133|FG000|Overall Study|Lab test not done|7|||
25061453|NCT01066793|50166134|FG001|Overall Study|Lab test not done|0|||
25061454|NCT01066793|50166135|FG002|Overall Study|Lab test not done|0|||
25061455|NCT01066793|50166136|FG003|Overall Study|Lab test not done|1|||
25061456|NCT01066793|50166137|FG004|Overall Study|Lab test not done|0|||
25061457|NCT01066793|50166138|FG005|Overall Study|Lab test not done|0|||
25061458|NCT01066793|50166133|FG000|Overall Study|Miscellaneous|4|||
25061459|NCT01066793|50166134|FG001|Overall Study|Miscellaneous|5|||
25061460|NCT01066793|50166135|FG002|Overall Study|Miscellaneous|6|||
25061461|NCT01066793|50166136|FG003|Overall Study|Miscellaneous|0|||
25061462|NCT01066793|50166137|FG004|Overall Study|Miscellaneous|0|||
25061463|NCT01066793|50166138|FG005|Overall Study|Miscellaneous|0|||
25061464|NCT01066793|50166133|FG000|Overall Study|Non-responders|104|||
25061465|NCT01066793|50166134|FG001|Overall Study|Non-responders|5|||
25061466|NCT01066793|50166135|FG002|Overall Study|Non-responders|11|||
25061467|NCT01066793|50166136|FG003|Overall Study|Non-responders|25|||
25061468|NCT01066793|50166137|FG004|Overall Study|Non-responders|0|||
25061469|NCT01066793|50166138|FG005|Overall Study|Non-responders|0|||
25061470|NCT01066793|50166133|FG000|Overall Study|Other|15|||
25061471|NCT01066793|50166134|FG001|Overall Study|Other|5|||
25061472|NCT01066793|50166135|FG002|Overall Study|Other|6|||
25061473|NCT01066793|50166136|FG003|Overall Study|Other|2|||
25061474|NCT01066793|50166137|FG004|Overall Study|Other|0|||
25061475|NCT01066793|50166138|FG005|Overall Study|Other|0|||
25061476|NCT01066793|50166133|FG000|Overall Study|Relapse|20|||
25061477|NCT01066793|50166134|FG001|Overall Study|Relapse|8|||
25061478|NCT01066793|50166135|FG002|Overall Study|Relapse|2|||
25061479|NCT01066793|50166136|FG003|Overall Study|Relapse|3|||
25061480|NCT01066793|50166137|FG004|Overall Study|Relapse|0|||
25061481|NCT01066793|50166138|FG005|Overall Study|Relapse|0|||
25061482|NCT01066793|50166133|FG000|Overall Study|Result Not Available|1|||
25061483|NCT01066793|50166134|FG001|Overall Study|Result Not Available|0|||
25061484|NCT01066793|50166135|FG002|Overall Study|Result Not Available|0|||
25061485|NCT01066793|50166136|FG003|Overall Study|Result Not Available|0|||
25061486|NCT01066793|50166137|FG004|Overall Study|Result Not Available|0|||
25061487|NCT01066793|50166138|FG005|Overall Study|Result Not Available|0|||
25061488|NCT01066793|50166133|FG000|Overall Study|Treatment Interrupted|1|||
25061489|NCT01066793|50166134|FG001|Overall Study|Treatment Interrupted|1|||
25061490|NCT01066793|50166135|FG002|Overall Study|Treatment Interrupted|0|||
25061491|NCT01066793|50166136|FG003|Overall Study|Treatment Interrupted|0|||
25061492|NCT01066793|50166137|FG004|Overall Study|Treatment Interrupted|0|||
25061493|NCT01066793|50166138|FG005|Overall Study|Treatment Interrupted|0|||
25061494|NCT01066793|50166133|FG000|Overall Study|Treatment Never Started|18|||
25061495|NCT01066793|50166134|FG001|Overall Study|Treatment Never Started|5|||
25061496|NCT01066793|50166135|FG002|Overall Study|Treatment Never Started|4|||
25061497|NCT01066793|50166136|FG003|Overall Study|Treatment Never Started|1|||
25061498|NCT01066793|50166137|FG004|Overall Study|Treatment Never Started|0|||
25061499|NCT01066793|50166138|FG005|Overall Study|Treatment Never Started|0|||
25061500|NCT01066793|50166133|FG000|Overall Study|Treatment Stopped|2|||
25061501|NCT01066793|50166134|FG001|Overall Study|Treatment Stopped|1|||
25061502|NCT01066793|50166135|FG002|Overall Study|Treatment Stopped|0|||
25061503|NCT01066793|50166136|FG003|Overall Study|Treatment Stopped|1|||
25061504|NCT01066793|50166137|FG004|Overall Study|Treatment Stopped|0|||
25061505|NCT01066793|50166138|FG005|Overall Study|Treatment Stopped|0|||
25061506|NCT03985293|50166159|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
24963810|NCT00207740|50053787|FG002|Overall Study|Death|0|||
25061507|NCT03985293|50166160|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
25061508|NCT03985293|50166161|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
25061509|NCT03985293|50166162|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
25061510|NCT03985293|50166163|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
25061511|NCT03985293|50166164|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
25061512|NCT03985293|50166159|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
25061513|NCT03985293|50166160|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
25061514|NCT03985293|50166161|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
25061515|NCT03985293|50166162|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
25061516|NCT03985293|50166163|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
25061517|NCT03985293|50166164|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
25061518|NCT03985293|50166159|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
25061519|NCT03985293|50166160|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
25061520|NCT03985293|50166161|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
25061521|NCT03985293|50166162|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
25061522|NCT03985293|50166163|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
25061523|NCT03985293|50166164|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
25061524|NCT03985293|50166159|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
25061525|NCT03985293|50166160|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
25061526|NCT03985293|50166161|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
25061527|NCT03985293|50166162|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
25061528|NCT03985293|50166163|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
25061529|NCT03985293|50166164|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
25061530|NCT03985293|50166159|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
25061531|NCT03985293|50166160|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
25061532|NCT03985293|50166161|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
25061533|NCT03985293|50166162|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
25061534|NCT03985293|50166163|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
25061535|NCT03985293|50166164|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
25061536|NCT03985293|50166159|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
25061537|NCT03985293|50166160|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
25061538|NCT03985293|50166161|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
25061539|NCT03985293|50166162|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
25061540|NCT03985293|50166163|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
25061541|NCT03985293|50166164|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
25061542|NCT03985293|50166159|FG000|FOLLOW-UP|Lost to Follow-up|0|||
25061543|NCT03985293|50166160|FG001|FOLLOW-UP|Lost to Follow-up|0|||
25061544|NCT03985293|50166161|FG002|FOLLOW-UP|Lost to Follow-up|1|||
25061545|NCT03985293|50166162|FG003|FOLLOW-UP|Lost to Follow-up|0|||
25061546|NCT03985293|50166163|FG004|FOLLOW-UP|Lost to Follow-up|0|||
25061547|NCT03985293|50166164|FG005|FOLLOW-UP|Lost to Follow-up|0|||
25061548|NCT02980601|50166180|FG000|Overall Study|Lost to Follow-up|2|||
25061549|NCT02980601|50166181|FG001|Overall Study|Lost to Follow-up|2|||
25061550|NCT02980601|50166180|FG000|Overall Study|Death|0|||
25061551|NCT02980601|50166181|FG001|Overall Study|Death|1|||
25061552|NCT02980601|50166180|FG000|Overall Study|Graft loss|1|||
25061553|NCT02980601|50166181|FG001|Overall Study|Graft loss|0|||
25061554|NCT02980601|50166180|FG000|Overall Study|Failed to sign consent|2|||
25061555|NCT02980601|50166181|FG001|Overall Study|Failed to sign consent|0|||
25061556|NCT02980523|50166192|FG000|Overall Study|Lost to Follow-up|1|||
25061557|NCT02980523|50166193|FG001|Overall Study|Lost to Follow-up|4|||
25061558|NCT02980523|50166194|FG002|Overall Study|Lost to Follow-up|1|||
25061559|NCT02980523|50166195|FG003|Overall Study|Lost to Follow-up|2|||
25061560|NCT02980523|50166196|FG004|Overall Study|Lost to Follow-up|1|||
25061561|NCT02980523|50166192|FG000|Overall Study|Excluded from analysis|1|||
25061562|NCT02980523|50166193|FG001|Overall Study|Excluded from analysis|3|||
25061563|NCT02980523|50166194|FG002|Overall Study|Excluded from analysis|1|||
25061564|NCT02980523|50166195|FG003|Overall Study|Excluded from analysis|1|||
25061565|NCT02980523|50166196|FG004|Overall Study|Excluded from analysis|1|||
25061566|NCT02980523|50166192|FG000|Overall Study|Lack of Efficacy|1|||
25061567|NCT02980523|50166193|FG001|Overall Study|Lack of Efficacy|4|||
24963811|NCT00207740|50053788|FG003|Overall Study|Death|1|||
24963812|NCT00207740|50053785|FG000|Overall Study|Sponsor Directive|22|||
24963813|NCT00207740|50053786|FG001|Overall Study|Sponsor Directive|15|||
24963814|NCT00207740|50053787|FG002|Overall Study|Sponsor Directive|16|||
24963815|NCT00207740|50053788|FG003|Overall Study|Sponsor Directive|21|||
24963816|NCT00207740|50053785|FG000|Overall Study|Other|2|||
24963817|NCT00207740|50053786|FG001|Overall Study|Other|10|||
24963818|NCT00207740|50053787|FG002|Overall Study|Other|7|||
25061568|NCT02980523|50166194|FG002|Overall Study|Lack of Efficacy|4|||
25061569|NCT02980523|50166195|FG003|Overall Study|Lack of Efficacy|5|||
25061570|NCT02980523|50166196|FG004|Overall Study|Lack of Efficacy|8|||
24963819|NCT00207740|50053788|FG003|Overall Study|Other|5|||
24963820|NCT00265382|50053802|FG000|Overall Study|Adverse Event|21|||
24963821|NCT00265382|50053802|FG000|Overall Study|Laboratory Abnormality|1|||
25061571|NCT02980523|50166192|FG000|Overall Study|Did not receive intervention|0|||
25061572|NCT02980523|50166193|FG001|Overall Study|Did not receive intervention|0|||
25061573|NCT02980523|50166194|FG002|Overall Study|Did not receive intervention|0|||
25061574|NCT02980523|50166195|FG003|Overall Study|Did not receive intervention|1|||
25061575|NCT02980523|50166196|FG004|Overall Study|Did not receive intervention|0|||
25061576|NCT02980133|50166215|FG000|Overall Study|Other than specified|1|||
24963822|NCT00265382|50053802|FG000|Overall Study|Lost to Follow-up|3|||
24963823|NCT00265382|50053802|FG000|Overall Study|Lack of Efficacy|6|||
25061577|NCT02980133|50166216|FG001|Overall Study|Other than specified|1|||
25061578|NCT02980133|50166217|FG002|Overall Study|Other than specified|2|||
25061579|NCT02980133|50166218|FG003|Overall Study|Other than specified|2|||
25061580|NCT02980133|50166215|FG000|Overall Study|Lost to Follow-up|0|||
25061581|NCT02980133|50166216|FG001|Overall Study|Lost to Follow-up|0|||
25061582|NCT02980133|50166217|FG002|Overall Study|Lost to Follow-up|1|||
25061583|NCT02980133|50166218|FG003|Overall Study|Lost to Follow-up|3|||
25061584|NCT02980133|50166215|FG000|Overall Study|Protocol Violation|0|||
25061585|NCT02980133|50166216|FG001|Overall Study|Protocol Violation|1|||
25061586|NCT02980133|50166217|FG002|Overall Study|Protocol Violation|0|||
25061587|NCT02980133|50166218|FG003|Overall Study|Protocol Violation|0|||
25061588|NCT02980133|50166215|FG000|Overall Study|Withdrawal by parent/guardian|6|||
25061589|NCT02980133|50166216|FG001|Overall Study|Withdrawal by parent/guardian|3|||
25061590|NCT02980133|50166217|FG002|Overall Study|Withdrawal by parent/guardian|3|||
25061591|NCT02980133|50166218|FG003|Overall Study|Withdrawal by parent/guardian|1|||
25061592|NCT02980133|50166215|FG000|Overall Study|Withdrawal by Subject|0|||
25061593|NCT02980133|50166216|FG001|Overall Study|Withdrawal by Subject|0|||
25061594|NCT02980133|50166217|FG002|Overall Study|Withdrawal by Subject|1|||
25061595|NCT02980133|50166218|FG003|Overall Study|Withdrawal by Subject|0|||
25061596|NCT02979431|50166235|FG000|Overall Study|Parent/guardian withdrew consent|2|||
25061597|NCT02979431|50166236|FG001|Overall Study|Parent/guardian withdrew consent|1|||
25061598|NCT02979431|50166237|FG002|Overall Study|Parent/guardian withdrew consent|1|||
25061599|NCT02979431|50166238|FG003|Overall Study|Parent/guardian withdrew consent|1|||
25061600|NCT02979431|50166235|FG000|Overall Study|Randomized but received no study drug|1|||
25061601|NCT02979431|50166236|FG001|Overall Study|Randomized but received no study drug|1|||
25061602|NCT02979431|50166237|FG002|Overall Study|Randomized but received no study drug|0|||
25061603|NCT02979431|50166238|FG003|Overall Study|Randomized but received no study drug|0|||
25061604|NCT02979431|50166235|FG000|Overall Study|Adverse Event|0|||
25061605|NCT02979431|50166236|FG001|Overall Study|Adverse Event|0|||
25061606|NCT02979431|50166237|FG002|Overall Study|Adverse Event|1|||
25061607|NCT02979431|50166238|FG003|Overall Study|Adverse Event|0|||
25061608|NCT02979431|50166235|FG000|Overall Study|Subject left country after Day14|1|||
25061609|NCT02979431|50166236|FG001|Overall Study|Subject left country after Day14|0|||
25061610|NCT02979431|50166237|FG002|Overall Study|Subject left country after Day14|0|||
25061611|NCT02979431|50166238|FG003|Overall Study|Subject left country after Day14|0|||
25061612|NCT02978417|50166250|FG000|Overall Study|Lost to Follow-up|2|||
25061613|NCT02978417|50166251|FG001|Overall Study|Lost to Follow-up|2|||
25061614|NCT04368429|50166259|FG000|Overall Study|Adverse Event|1|||
25061615|NCT04368429|50166260|FG001|Overall Study|Adverse Event|0|||
25061616|NCT02733627|50166283|FG000|Overall Study|Adverse Event|0|||
25061617|NCT02733627|50166284|FG001|Overall Study|Adverse Event|1|||
25061618|NCT02733627|50166285|FG002|Overall Study|Adverse Event|1|||
25061619|NCT02733627|50166286|FG003|Overall Study|Adverse Event|0|||
25061620|NCT02733627|50166283|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
25061621|NCT02733627|50166284|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
25061622|NCT02733627|50166285|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
25061623|NCT02733627|50166286|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
25061624|NCT02958865|50166303|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
25061625|NCT02958865|50166304|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
25061626|NCT02958865|50166305|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
25061627|NCT02958865|50166306|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
25061628|NCT02958865|50166307|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
25061629|NCT02958865|50166308|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
25061630|NCT02958865|50166309|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
25061631|NCT02958865|50166310|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
25061632|NCT02958865|50166311|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
25061633|NCT02958865|50166312|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
25061634|NCT02958865|50166313|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
25061635|NCT02958865|50166314|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
25061636|NCT02958865|50166315|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
25061637|NCT02958865|50166316|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
25061638|NCT02958865|50166317|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
25061639|NCT02958865|50166318|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
25061640|NCT02958865|50166303|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
25061641|NCT02958865|50166304|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
25061642|NCT02958865|50166305|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
25061643|NCT02958865|50166306|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
25061644|NCT02958865|50166307|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
25061645|NCT02958865|50166308|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
25061646|NCT02958865|50166309|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
25061647|NCT02958865|50166310|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
25061648|NCT02958865|50166311|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
25061649|NCT02958865|50166312|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
25061650|NCT02958865|50166313|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
25061651|NCT02958865|50166314|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
25061652|NCT02958865|50166315|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
25061653|NCT02958865|50166316|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
25061654|NCT02958865|50166317|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
25061655|NCT02958865|50166318|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
25061656|NCT02958865|50166303|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
25061657|NCT02958865|50166304|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
25061658|NCT02958865|50166305|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
25061659|NCT02958865|50166306|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
25061660|NCT02958865|50166307|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
25061661|NCT02958865|50166308|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
25061662|NCT02958865|50166309|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
25061663|NCT02958865|50166310|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
25061664|NCT02958865|50166311|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
25061665|NCT02958865|50166312|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
25061666|NCT02958865|50166313|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
25061667|NCT02958865|50166314|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
25061668|NCT02958865|50166315|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
25061669|NCT02958865|50166316|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
25061670|NCT02958865|50166317|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
25061671|NCT02958865|50166318|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
25061672|NCT02958865|50166303|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
25061673|NCT02958865|50166304|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
25061674|NCT02958865|50166305|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
25061675|NCT02958865|50166306|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
25061676|NCT02958865|50166307|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
25061677|NCT02958865|50166308|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
25061678|NCT02958865|50166309|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
25061679|NCT02958865|50166310|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
25061680|NCT02958865|50166311|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
25061681|NCT02958865|50166312|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
25061682|NCT02958865|50166313|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
25061683|NCT02958865|50166314|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
25061684|NCT02958865|50166315|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
25061685|NCT02958865|50166316|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
25061686|NCT02958865|50166317|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
25061687|NCT02958865|50166318|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
25061688|NCT02958865|50166303|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
25061689|NCT02958865|50166304|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
25061690|NCT02958865|50166305|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
25061691|NCT02958865|50166306|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
25061692|NCT02958865|50166307|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
25061693|NCT02958865|50166308|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
25061694|NCT02958865|50166309|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
25061695|NCT02958865|50166310|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
25061696|NCT02958865|50166311|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
25061697|NCT02958865|50166312|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
25061698|NCT02958865|50166313|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
25061699|NCT02958865|50166314|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
25061700|NCT02958865|50166315|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
25061701|NCT02958865|50166316|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
25061702|NCT02958865|50166317|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
25061703|NCT02958865|50166318|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
25061704|NCT02958865|50166303|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
25061705|NCT02958865|50166304|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
25061706|NCT02958865|50166305|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
25061707|NCT02958865|50166306|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
25061708|NCT02958865|50166307|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
25061709|NCT02958865|50166308|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
25061710|NCT02958865|50166309|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
25276662|NCT00948922|50590606|FG000|Overall Study|Did not start study treatment|2|||
25276663|NCT00948922|50590607|FG001|Overall Study|Did not start study treatment|5|||
25276664|NCT00948922|50590608|FG002|Overall Study|Did not start study treatment|0|||
25276665|NCT00948922|50590606|FG000|Overall Study|Withdrawal by Subject|0|||
25276666|NCT00948922|50590607|FG001|Overall Study|Withdrawal by Subject|2|||
25061711|NCT02958865|50166310|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
25061712|NCT02958865|50166311|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
25061713|NCT02958865|50166312|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
25061714|NCT02958865|50166313|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
25061715|NCT02958865|50166314|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
25061716|NCT02958865|50166315|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
25061717|NCT02958865|50166316|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
25061718|NCT02958865|50166317|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
25061719|NCT02958865|50166318|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
25061720|NCT02958865|50166303|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
25061721|NCT02958865|50166304|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
25061722|NCT02958865|50166305|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
25061723|NCT02958865|50166306|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25061724|NCT02958865|50166307|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25061725|NCT02958865|50166308|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25061726|NCT02958865|50166309|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25061727|NCT02958865|50166310|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25061728|NCT02958865|50166311|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25061729|NCT02958865|50166312|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25061730|NCT02958865|50166313|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25061731|NCT02958865|50166314|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25061732|NCT02958865|50166315|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25061733|NCT02958865|50166316|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25061734|NCT02958865|50166317|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25061735|NCT02958865|50166318|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
25061736|NCT02958865|50166303|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
25061737|NCT02958865|50166304|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
25061738|NCT02958865|50166305|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
25061739|NCT02958865|50166306|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
25061740|NCT02958865|50166307|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
25061741|NCT02958865|50166308|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
25061742|NCT02958865|50166309|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
25061743|NCT02958865|50166310|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
25061744|NCT02958865|50166311|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
25061745|NCT02958865|50166312|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
25061746|NCT02958865|50166313|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
25061747|NCT02958865|50166314|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
25061748|NCT02958865|50166315|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
25061749|NCT02958865|50166316|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
25061750|NCT02958865|50166317|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
25061751|NCT02958865|50166318|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
25061752|NCT02958865|50166303|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25061753|NCT02958865|50166304|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25061754|NCT02958865|50166305|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25061755|NCT02958865|50166306|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25061756|NCT02958865|50166307|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
25061757|NCT02958865|50166308|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25061758|NCT02958865|50166309|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25061759|NCT02958865|50166310|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25061760|NCT02958865|50166311|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25061761|NCT02958865|50166312|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25061762|NCT02958865|50166313|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25061763|NCT02958865|50166314|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25061764|NCT02958865|50166315|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25061765|NCT02958865|50166316|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25061766|NCT02958865|50166317|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25061767|NCT02958865|50166318|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25061768|NCT02958865|50166303|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
25061769|NCT02958865|50166304|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
25061770|NCT02958865|50166305|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
25061771|NCT02958865|50166306|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
25061772|NCT02958865|50166307|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
25061773|NCT02958865|50166308|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
25061774|NCT02958865|50166309|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
25061775|NCT02958865|50166310|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
25061776|NCT02958865|50166311|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
25061777|NCT02958865|50166312|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
25061778|NCT02958865|50166313|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
25061779|NCT02958865|50166314|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
25061780|NCT02958865|50166315|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
25061781|NCT02958865|50166316|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
25061782|NCT02958865|50166317|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
25061783|NCT02958865|50166318|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
25061784|NCT02958865|50166303|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
25061785|NCT02958865|50166304|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
25061786|NCT02958865|50166305|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
25061787|NCT02958865|50166306|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
25061788|NCT02958865|50166307|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
25061789|NCT02958865|50166308|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
25061790|NCT02958865|50166309|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
25061791|NCT02958865|50166310|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
25061792|NCT02958865|50166311|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
25061793|NCT02958865|50166312|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
25061794|NCT02958865|50166313|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
25162822|NCT01978145|50285193|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
24963824|NCT00265382|50053802|FG000|Overall Study|Miscellaneous|6|||
24963825|NCT00265382|50053802|FG000|Overall Study|Withdrawal by Subject|13|||
24963826|NCT00265382|50053802|FG000|Overall Study|Study terminated by sponsor|94|||
24963827|NCT00265382|50053802|FG000|Overall Study|Death|1|||
24963828|NCT00206726|50053806|FG000|Overall Study|Delayed recovery of blood counts|1|||
24963829|NCT00206726|50053806|FG000|Overall Study|Progressive disease or relapsed disease|18|||
24963830|NCT00206726|50053806|FG000|Overall Study|Placed on new protocol|1|||
24963831|NCT00206726|50053806|FG000|Overall Study|Bone marrow transplant|1|||
24963832|NCT00206726|50053806|FG000|Overall Study|Adverse Event|17|||
24963833|NCT00206726|50053806|FG000|Overall Study|Death|4|||
24963834|NCT00206726|50053806|FG000|Overall Study|Protocol Violation|1|||
24963835|NCT00206726|50053806|FG000|Overall Study|Withdrawal by Subject|8|||
24963836|NCT00237692|50053814|FG000|Overall Study|Lost to Follow-up|9|||
24963837|NCT00237692|50053815|FG001|Overall Study|Lost to Follow-up|3|||
24963838|NCT00237692|50053816|FG002|Overall Study|Lost to Follow-up|5|||
24963839|NCT00237692|50053817|FG003|Overall Study|Lost to Follow-up|3|||
24963840|NCT00237692|50053814|FG000|Overall Study|Death|1|||
24963841|NCT00237692|50053815|FG001|Overall Study|Death|2|||
25061795|NCT02958865|50166314|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
25061796|NCT02958865|50166315|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
25061797|NCT02958865|50166316|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
24963842|NCT00237692|50053816|FG002|Overall Study|Death|2|||
25162823|NCT01978145|50285192|FG000|Treatment Period 2|Adverse Event|3|||
25061798|NCT02958865|50166317|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
25061799|NCT02958865|50166318|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
25061800|NCT02958865|50166303|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
25061801|NCT02958865|50166304|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
25061802|NCT02958865|50166305|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
25061803|NCT02958865|50166306|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
25061804|NCT02958865|50166307|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
25061805|NCT02958865|50166308|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
25061806|NCT02958865|50166309|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
25061807|NCT02958865|50166310|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
25061808|NCT02958865|50166311|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
25061809|NCT02958865|50166312|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
25061810|NCT02958865|50166313|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
25061811|NCT02958865|50166314|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
25061812|NCT02958865|50166315|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
25061813|NCT02958865|50166316|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
25061814|NCT02958865|50166317|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
25061815|NCT02958865|50166318|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
25061816|NCT02958865|50166303|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
25061817|NCT02958865|50166304|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
25061818|NCT02958865|50166305|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
25061819|NCT02958865|50166306|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
25061820|NCT02958865|50166307|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
25061821|NCT02958865|50166308|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
25061822|NCT02958865|50166309|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
25061823|NCT02958865|50166310|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
25061824|NCT02958865|50166311|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
25061825|NCT02958865|50166312|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
25061826|NCT02958865|50166313|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
25061827|NCT02958865|50166314|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
25061828|NCT02958865|50166315|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
25061829|NCT02958865|50166316|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
25061830|NCT02958865|50166317|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
25061831|NCT02958865|50166318|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
25061832|NCT02958865|50166303|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
25061833|NCT02958865|50166304|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
25061834|NCT02958865|50166305|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
25061835|NCT02958865|50166306|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
25061836|NCT02958865|50166307|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
25061837|NCT02958865|50166308|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
25061838|NCT02958865|50166309|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
25061839|NCT02958865|50166310|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
25061840|NCT02958865|50166311|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
25061841|NCT02958865|50166312|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
25061842|NCT02958865|50166313|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
25061843|NCT02958865|50166314|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
25061844|NCT02958865|50166315|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
25061845|NCT02958865|50166316|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
25061846|NCT02958865|50166317|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
25061847|NCT02958865|50166318|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
25061848|NCT02958865|50166303|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
25061849|NCT02958865|50166304|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
25061850|NCT02958865|50166305|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
25061851|NCT02958865|50166306|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
25061852|NCT02958865|50166307|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
25061853|NCT02958865|50166308|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
25061854|NCT02958865|50166309|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
25061855|NCT02958865|50166310|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
25061856|NCT02958865|50166311|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
25061857|NCT02958865|50166312|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
25061858|NCT02958865|50166313|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
25061859|NCT02958865|50166314|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
25061860|NCT02958865|50166315|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
25061861|NCT02958865|50166316|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
25061862|NCT02958865|50166317|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
25061863|NCT02958865|50166318|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
25061864|NCT02958865|50166303|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
25061865|NCT02958865|50166304|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
25061866|NCT02958865|50166305|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
25061867|NCT02958865|50166306|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
25061868|NCT02958865|50166307|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
25061869|NCT02958865|50166308|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
25061870|NCT02958865|50166309|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
25061871|NCT02958865|50166310|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
25061872|NCT02958865|50166311|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
25061873|NCT02958865|50166312|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
25061874|NCT02958865|50166313|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
25061875|NCT02958865|50166314|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
25061876|NCT02958865|50166315|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
25061877|NCT02958865|50166316|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
25061878|NCT02958865|50166317|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
25061879|NCT02958865|50166318|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
25061880|NCT02958865|50166303|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
25061881|NCT02958865|50166304|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
25061882|NCT02958865|50166305|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
25061883|NCT02958865|50166306|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
25061884|NCT02958865|50166307|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
25061885|NCT02958865|50166308|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
25061886|NCT02958865|50166309|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
25061887|NCT02958865|50166310|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
25061888|NCT02958865|50166311|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
25061889|NCT02958865|50166312|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
25061890|NCT02958865|50166313|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
25061891|NCT02958865|50166314|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
25061892|NCT02958865|50166315|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
25061893|NCT02958865|50166316|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
25061894|NCT02958865|50166317|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
25061895|NCT02958865|50166318|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
25061896|NCT02958553|50166370|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
25061897|NCT02958553|50166370|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
25061898|NCT02501902|50166383|FG000|Overall Study|Subject Refused Further Follow-up|0|||
25061899|NCT02501902|50166384|FG001|Overall Study|Subject Refused Further Follow-up|0|||
25061900|NCT02501902|50166385|FG002|Overall Study|Subject Refused Further Follow-up|0|||
25276667|NCT00948922|50590608|FG002|Overall Study|Withdrawal by Subject|1|||
25276668|NCT00948922|50590606|FG000|Overall Study|Death|3|||
25061901|NCT02501902|50166386|FG003|Overall Study|Subject Refused Further Follow-up|0|||
25061902|NCT02501902|50166387|FG004|Overall Study|Subject Refused Further Follow-up|0|||
25061903|NCT02501902|50166388|FG005|Overall Study|Subject Refused Further Follow-up|0|||
25061904|NCT02501902|50166389|FG006|Overall Study|Subject Refused Further Follow-up|0|||
25061905|NCT02501902|50166390|FG007|Overall Study|Subject Refused Further Follow-up|1|||
25061906|NCT02501902|50166383|FG000|Overall Study|Study Terminated by Sponsor|0|||
25061907|NCT02501902|50166384|FG001|Overall Study|Study Terminated by Sponsor|3|||
25061908|NCT02501902|50166385|FG002|Overall Study|Study Terminated by Sponsor|0|||
25061909|NCT02501902|50166386|FG003|Overall Study|Study Terminated by Sponsor|1|||
25061910|NCT02501902|50166387|FG004|Overall Study|Study Terminated by Sponsor|1|||
25061911|NCT02501902|50166388|FG005|Overall Study|Study Terminated by Sponsor|0|||
25061912|NCT02501902|50166389|FG006|Overall Study|Study Terminated by Sponsor|2|||
25061913|NCT02501902|50166390|FG007|Overall Study|Study Terminated by Sponsor|4|||
25061914|NCT02501902|50166383|FG000|Overall Study|Death|3|||
25061915|NCT02501902|50166384|FG001|Overall Study|Death|4|||
25061916|NCT02501902|50166385|FG002|Overall Study|Death|4|||
25061917|NCT02501902|50166386|FG003|Overall Study|Death|10|||
25061918|NCT02501902|50166387|FG004|Overall Study|Death|10|||
25061919|NCT02501902|50166388|FG005|Overall Study|Death|11|||
25061920|NCT02501902|50166389|FG006|Overall Study|Death|7|||
25061921|NCT02501902|50166390|FG007|Overall Study|Death|15|||
25061922|NCT01955109|50166415|FG000|Overall Study|Adverse Event|2|||
25061923|NCT01955109|50166416|FG001|Overall Study|Adverse Event|0|||
25061924|NCT01955109|50166415|FG000|Overall Study|Participant unwilling to continue|35|||
25061925|NCT01955109|50166416|FG001|Overall Study|Participant unwilling to continue|7|||
25061926|NCT01955109|50166415|FG000|Overall Study|Physician Decision|2|||
25061927|NCT01955109|50166416|FG001|Overall Study|Physician Decision|0|||
25061928|NCT01955109|50166415|FG000|Overall Study|Lost to Follow-up|3|||
25061929|NCT01955109|50166416|FG001|Overall Study|Lost to Follow-up|1|||
25061930|NCT01955109|50166415|FG000|Overall Study|Non-compliance|3|||
25162824|NCT01978145|50285193|FG001|Treatment Period 2|Adverse Event|3|||
25061931|NCT01955109|50166416|FG001|Overall Study|Non-compliance|1|||
25061932|NCT02500732|50166424|FG000|Overall Study|Physician Decision|0|||
25061933|NCT02500732|50166425|FG001|Overall Study|Physician Decision|1|||
25061934|NCT02518048|50166431|FG000|Overall Study|Withdrawal by Subject|1|||
25061935|NCT02499952|50166436|FG000|Overall Study|Lost to Follow-up|1|||
25061936|NCT02499952|50166436|FG000|Overall Study|Death|9|||
25061937|NCT02499406|50166440|FG000|Overall Study|missed 3 treatment sessions|4|||
25061938|NCT02499172|50166448|FG000|Overall Study|Financial reason|0|||
25061939|NCT02499172|50166449|FG001|Overall Study|Financial reason|0|||
25061940|NCT02499172|50166450|FG002|Overall Study|Financial reason|523|||
25061941|NCT02499172|50166451|FG003|Overall Study|Financial reason|436|||
25061942|NCT02499172|50166448|FG000|Overall Study|Lost to Follow-up|65|||
25061943|NCT02499172|50166449|FG001|Overall Study|Lost to Follow-up|64|||
25061944|NCT02499172|50166450|FG002|Overall Study|Lost to Follow-up|0|||
25061945|NCT02499172|50166451|FG003|Overall Study|Lost to Follow-up|0|||
25061946|NCT02498392|50166463|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
25061947|NCT02498392|50166464|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
25061948|NCT02498392|50166463|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
25061949|NCT02498392|50166464|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
25061950|NCT02498392|50166463|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
25061951|NCT02498392|50166464|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
25061952|NCT02498392|50166463|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
25061953|NCT02498392|50166464|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
25061954|NCT02498392|50166463|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
25061955|NCT02498392|50166464|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
25061956|NCT02498392|50166463|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
25061957|NCT02498392|50166464|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
25061958|NCT03205605|50166472|FG000|Overall Study|Withdrawal by Subject|1|||
25061959|NCT02498236|50166490|FG000|Overall Study|Did not show for testing|1|||
25061960|NCT02498236|50166491|FG001|Overall Study|Did not show for testing|0|||
25061961|NCT02498236|50166492|FG002|Overall Study|Did not show for testing|0|||
25061962|NCT02498236|50166493|FG003|Overall Study|Did not show for testing|0|||
25061963|NCT02498236|50166494|FG004|Overall Study|Did not show for testing|0|||
25061964|NCT02498236|50166495|FG005|Overall Study|Did not show for testing|0|||
25061965|NCT02498236|50166496|FG006|Overall Study|Did not show for testing|0|||
25061966|NCT02498236|50166497|FG007|Overall Study|Did not show for testing|1|||
25061967|NCT02498236|50166490|FG000|Overall Study|Equipment failure|0|||
25061968|NCT02498236|50166491|FG001|Overall Study|Equipment failure|0|||
25061969|NCT02498236|50166492|FG002|Overall Study|Equipment failure|0|||
25061970|NCT02498236|50166493|FG003|Overall Study|Equipment failure|0|||
25061971|NCT02498236|50166494|FG004|Overall Study|Equipment failure|0|||
25061972|NCT02498236|50166495|FG005|Overall Study|Equipment failure|0|||
25061973|NCT02498236|50166496|FG006|Overall Study|Equipment failure|1|||
25061974|NCT02498236|50166497|FG007|Overall Study|Equipment failure|0|||
25061975|NCT02498236|50166490|FG000|Overall Study|Withdrawal by Subject|0|||
25061976|NCT02498236|50166491|FG001|Overall Study|Withdrawal by Subject|0|||
25061977|NCT02498236|50166492|FG002|Overall Study|Withdrawal by Subject|0|||
25061978|NCT02498236|50166493|FG003|Overall Study|Withdrawal by Subject|0|||
25061979|NCT02498236|50166494|FG004|Overall Study|Withdrawal by Subject|1|||
25061980|NCT02498236|50166495|FG005|Overall Study|Withdrawal by Subject|0|||
25061981|NCT02498236|50166496|FG006|Overall Study|Withdrawal by Subject|0|||
25061982|NCT02498236|50166497|FG007|Overall Study|Withdrawal by Subject|0|||
25061983|NCT02496676|50166520|FG000|Phase 1 - Period 1|Adverse Event|0|||
25061984|NCT02496676|50166521|FG001|Phase 1 - Period 1|Adverse Event|1|||
25061985|NCT02496676|50166520|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
25061986|NCT02496676|50166521|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
25061987|NCT02517268|50166537|FG000|Overall Study|Withdrawal by Subject|1|||
25061988|NCT02517268|50166538|FG001|Overall Study|Withdrawal by Subject|0|||
25061989|NCT01160211|50166547|FG000|Overall Study|ongoing|90|||
25061990|NCT01160211|50166548|FG001|Overall Study|ongoing|75|||
25061991|NCT01160211|50166549|FG002|Overall Study|ongoing|79|||
25061992|NCT01160211|50166547|FG000|Overall Study|Withdrawal by Subject|3|||
25061993|NCT01160211|50166548|FG001|Overall Study|Withdrawal by Subject|5|||
25061994|NCT01160211|50166549|FG002|Overall Study|Withdrawal by Subject|3|||
25061995|NCT01160211|50166547|FG000|Overall Study|Physician Decision|2|||
25061996|NCT01160211|50166548|FG001|Overall Study|Physician Decision|0|||
25061997|NCT01160211|50166549|FG002|Overall Study|Physician Decision|0|||
25061998|NCT01160211|50166547|FG000|Overall Study|Lost to Follow-up|4|||
25061999|NCT01160211|50166548|FG001|Overall Study|Lost to Follow-up|7|||
25062000|NCT01160211|50166549|FG002|Overall Study|Lost to Follow-up|5|||
25062001|NCT01064687|50166562|FG000|Overall Study|Adverse Event|9|||
25062002|NCT01064687|50166563|FG001|Overall Study|Adverse Event|4|||
25062003|NCT01064687|50166564|FG002|Overall Study|Adverse Event|10|||
25062004|NCT01064687|50166565|FG003|Overall Study|Adverse Event|3|||
25062005|NCT01064687|50166562|FG000|Overall Study|Death|1|||
25062006|NCT01064687|50166563|FG001|Overall Study|Death|1|||
25062007|NCT01064687|50166564|FG002|Overall Study|Death|0|||
25062008|NCT01064687|50166565|FG003|Overall Study|Death|0|||
25062009|NCT01064687|50166562|FG000|Overall Study|Entry Criteria Not Met|3|||
25062010|NCT01064687|50166563|FG001|Overall Study|Entry Criteria Not Met|0|||
25062011|NCT01064687|50166564|FG002|Overall Study|Entry Criteria Not Met|0|||
25062012|NCT01064687|50166565|FG003|Overall Study|Entry Criteria Not Met|0|||
25062013|NCT01064687|50166562|FG000|Overall Study|Lack of Efficacy|1|||
25062014|NCT01064687|50166563|FG001|Overall Study|Lack of Efficacy|0|||
25062015|NCT01064687|50166564|FG002|Overall Study|Lack of Efficacy|2|||
25062016|NCT01064687|50166565|FG003|Overall Study|Lack of Efficacy|3|||
25062017|NCT01064687|50166562|FG000|Overall Study|Lost to Follow-up|7|||
25062018|NCT01064687|50166563|FG001|Overall Study|Lost to Follow-up|10|||
25062019|NCT01064687|50166564|FG002|Overall Study|Lost to Follow-up|13|||
25062020|NCT01064687|50166565|FG003|Overall Study|Lost to Follow-up|5|||
25062021|NCT01064687|50166562|FG000|Overall Study|Physician Decision|2|||
25062022|NCT01064687|50166563|FG001|Overall Study|Physician Decision|2|||
25062023|NCT01064687|50166564|FG002|Overall Study|Physician Decision|0|||
25062024|NCT01064687|50166565|FG003|Overall Study|Physician Decision|0|||
25062025|NCT01064687|50166562|FG000|Overall Study|Protocol Violation|1|||
25062026|NCT01064687|50166563|FG001|Overall Study|Protocol Violation|1|||
25062027|NCT01064687|50166564|FG002|Overall Study|Protocol Violation|0|||
25062028|NCT01064687|50166565|FG003|Overall Study|Protocol Violation|1|||
25062029|NCT01064687|50166562|FG000|Overall Study|Sponsor Decision|0|||
25062030|NCT01064687|50166563|FG001|Overall Study|Sponsor Decision|0|||
25062031|NCT01064687|50166564|FG002|Overall Study|Sponsor Decision|3|||
25062032|NCT01064687|50166565|FG003|Overall Study|Sponsor Decision|0|||
25062033|NCT01064687|50166562|FG000|Overall Study|Withdrawal by Subject|9|||
25062034|NCT01064687|50166563|FG001|Overall Study|Withdrawal by Subject|7|||
25062035|NCT01064687|50166564|FG002|Overall Study|Withdrawal by Subject|12|||
25062036|NCT01064687|50166565|FG003|Overall Study|Withdrawal by Subject|5|||
25062037|NCT01064687|50166562|FG000|Overall Study|Treatment Noncompliance|1|||
25062038|NCT01064687|50166563|FG001|Overall Study|Treatment Noncompliance|1|||
25062039|NCT01064687|50166564|FG002|Overall Study|Treatment Noncompliance|1|||
25062040|NCT01064687|50166565|FG003|Overall Study|Treatment Noncompliance|0|||
25062041|NCT02493946|50166589|FG000|DB Period|Withdrawal by Subject|8|||
25062042|NCT02493946|50166590|FG001|DB Period|Withdrawal by Subject|5|||
25062043|NCT02493946|50166591|FG002|DB Period|Withdrawal by Subject|0|||
25062044|NCT02493946|50166589|FG000|Open Label Period|Withdrawal by Subject|0|||
25062045|NCT02493946|50166590|FG001|Open Label Period|Withdrawal by Subject|0|||
25062046|NCT02493946|50166591|FG002|Open Label Period|Withdrawal by Subject|74|||
25062047|NCT02493946|50166589|FG000|Open Label Period|Adverse Event|0|||
25062048|NCT02493946|50166590|FG001|Open Label Period|Adverse Event|0|||
25062049|NCT02493946|50166591|FG002|Open Label Period|Adverse Event|4|||
25062050|NCT02493946|50166589|FG000|Open Label Period|Lost to Follow-up|0|||
25062051|NCT02493946|50166590|FG001|Open Label Period|Lost to Follow-up|0|||
25062052|NCT02493946|50166591|FG002|Open Label Period|Lost to Follow-up|1|||
25062053|NCT02493946|50166589|FG000|Open Label Period|Investigator decision, non-compliance|0|||
25062054|NCT02493946|50166590|FG001|Open Label Period|Investigator decision, non-compliance|0|||
25062055|NCT02493946|50166591|FG002|Open Label Period|Investigator decision, non-compliance|2|||
25062056|NCT02493946|50166589|FG000|Open Label Period|Investigator decision, non-availability|0|||
25062057|NCT02493946|50166590|FG001|Open Label Period|Investigator decision, non-availability|0|||
25062058|NCT02493946|50166591|FG002|Open Label Period|Investigator decision, non-availability|1|||
25062059|NCT02493946|50166589|FG000|Open Label Period|Pregnancy|0|||
25062060|NCT02493946|50166590|FG001|Open Label Period|Pregnancy|0|||
25062061|NCT02493946|50166591|FG002|Open Label Period|Pregnancy|3|||
25062062|NCT02493946|50166589|FG000|Open Label Period|Site error|0|||
25062063|NCT02493946|50166590|FG001|Open Label Period|Site error|0|||
25062064|NCT02493946|50166591|FG002|Open Label Period|Site error|1|||
25062065|NCT01064531|50166601|FG000|Overall Study|Lost to Follow-up|0|||
25062066|NCT01064531|50166602|FG001|Overall Study|Lost to Follow-up|2|||
25062067|NCT01064531|50166601|FG000|Overall Study|Physician Decision|0|||
25062068|NCT01064531|50166602|FG001|Overall Study|Physician Decision|1|||
25062069|NCT01064531|50166601|FG000|Overall Study|Withdrawal by Subject|2|||
25062070|NCT01064531|50166602|FG001|Overall Study|Withdrawal by Subject|2|||
25062071|NCT01064531|50166601|FG000|Overall Study|Revision due to femoral stem loosening|1|||
25062072|NCT01064531|50166602|FG001|Overall Study|Revision due to femoral stem loosening|0|||
25062073|NCT01064531|50166601|FG000|Overall Study|Revision due to dislocation|0|||
25062074|NCT01064531|50166602|FG001|Overall Study|Revision due to dislocation|1|||
25062075|NCT01064531|50166601|FG000|Overall Study|Death|0|||
25062076|NCT01064531|50166602|FG001|Overall Study|Death|1|||
25162825|NCT01978145|50285192|FG000|Treatment Period 2|Protocol Violation|0|||
25062077|NCT02220855|50166608|FG000|Overall Study|Adverse Event|8|||
25062078|NCT02220855|50166608|FG000|Overall Study|Disease Progression|5|||
25062079|NCT02220855|50166608|FG000|Overall Study|Withdrawal by Subject|1|||
25062080|NCT02918279|50166614|FG000|Overall Study|Lost to Follow-up|3|||
25062081|NCT02918279|50166615|FG001|Overall Study|Lost to Follow-up|6|||
25062082|NCT02918279|50166614|FG000|Overall Study|Withdrawal by Subject|5|||
25062083|NCT02918279|50166615|FG001|Overall Study|Withdrawal by Subject|15|||
25062084|NCT02918279|50166614|FG000|Overall Study|Withdrawal by parent/guardian|2|||
25062085|NCT02918279|50166615|FG001|Overall Study|Withdrawal by parent/guardian|1|||
25062086|NCT02918279|50166614|FG000|Overall Study|Other|3|||
25062087|NCT02918279|50166615|FG001|Overall Study|Other|1|||
25062088|NCT02956837|50166625|FG000|Overall Study|Serious Adverse Events|0|||
25062089|NCT02956837|50166626|FG001|Overall Study|Serious Adverse Events|1|||
25062090|NCT02956837|50166627|FG002|Overall Study|Serious Adverse Events|0|||
25062091|NCT02956837|50166628|FG003|Overall Study|Serious Adverse Events|0|||
25062092|NCT02956837|50166625|FG000|Overall Study|Withdrawal by Subject|0|||
25062093|NCT02956837|50166626|FG001|Overall Study|Withdrawal by Subject|1|||
25062094|NCT02956837|50166627|FG002|Overall Study|Withdrawal by Subject|0|||
25062095|NCT02956837|50166628|FG003|Overall Study|Withdrawal by Subject|3|||
25062096|NCT02956837|50166625|FG000|Overall Study|Lost to Follow-up|0|||
25062097|NCT02956837|50166626|FG001|Overall Study|Lost to Follow-up|1|||
25062098|NCT02956837|50166627|FG002|Overall Study|Lost to Follow-up|2|||
25062099|NCT02956837|50166628|FG003|Overall Study|Lost to Follow-up|0|||
25062100|NCT01063595|50166641|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
25062101|NCT01063595|50166642|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
25062102|NCT01063595|50166641|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
25062103|NCT01063595|50166642|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
25062104|NCT01063595|50166641|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
25062105|NCT01063595|50166642|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
25062106|NCT01063595|50166641|FG000|First Intervention|Adverse Event|1|||
25062107|NCT01063595|50166642|FG001|First Intervention|Adverse Event|4|||
25062108|NCT01063595|50166641|FG000|First Intervention|Withdrawal by Subject|1|||
25062109|NCT01063595|50166642|FG001|First Intervention|Withdrawal by Subject|0|||
25062110|NCT01063595|50166641|FG000|First Intervention|Reason not Specified|0|||
25062111|NCT01063595|50166642|FG001|First Intervention|Reason not Specified|1|||
25062112|NCT01063283|50166650|FG000|Cycle 1|Adverse Event|2|||
25062113|NCT01063283|50166651|FG001|Cycle 1|Adverse Event|0|||
25062114|NCT01063283|50166652|FG002|Cycle 1|Adverse Event|0|||
25062115|NCT01063283|50166650|FG000|Cycle 1|Technical failure in data collection|1|||
25062116|NCT01063283|50166651|FG001|Cycle 1|Technical failure in data collection|0|||
25062117|NCT01063283|50166652|FG002|Cycle 1|Technical failure in data collection|0|||
25062118|NCT01062971|50166660|FG000|Overall Study|Protocol Violation|1|||
25062119|NCT01062971|50166661|FG001|Overall Study|Protocol Violation|3|||
25062120|NCT01062971|50166660|FG000|Overall Study|Lost to Follow-up|3|||
25062121|NCT01062971|50166661|FG001|Overall Study|Lost to Follow-up|4|||
25062122|NCT01348165|50166674|FG000|Overall Study|Adverse Event|0|||
25062123|NCT01348165|50166675|FG001|Overall Study|Adverse Event|0|||
25062124|NCT01348165|50166676|FG002|Overall Study|Adverse Event|0|||
25062125|NCT01348165|50166677|FG003|Overall Study|Adverse Event|0|||
25062126|NCT01348165|50166678|FG004|Overall Study|Adverse Event|0|||
25062127|NCT01348165|50166679|FG005|Overall Study|Adverse Event|0|||
25062128|NCT01348165|50166680|FG006|Overall Study|Adverse Event|1|||
25062129|NCT02493868|50166700|FG000|Induction Phase: DE Participants|Adverse Event|22|||
25062130|NCT02493868|50166701|FG001|Induction Phase: DE Participants|Adverse Event|0|||
25062131|NCT02493868|50166700|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
25062132|NCT02493868|50166701|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
25062133|NCT02493868|50166700|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
25062134|NCT02493868|50166701|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
25062135|NCT02493868|50166700|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
24963843|NCT00237692|50053817|FG003|Overall Study|Death|3|||
25062136|NCT02493868|50166701|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
25062137|NCT02493868|50166700|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
25062138|NCT02493868|50166701|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
25062139|NCT02493868|50166700|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
25062140|NCT02493868|50166701|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
25062141|NCT02493868|50166700|FG000|Induction Phase: DE Participants|Other|8|||
25062142|NCT02493868|50166701|FG001|Induction Phase: DE Participants|Other|0|||
25062143|NCT02493868|50166700|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
25062144|NCT02493868|50166701|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
25062145|NCT02493868|50166700|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
25062146|NCT02493868|50166701|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
25062147|NCT02493868|50166700|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
25062148|NCT02493868|50166701|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
25062149|NCT02493868|50166700|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
25062150|NCT02493868|50166701|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
25062151|NCT02493868|50166700|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
25062152|NCT02493868|50166701|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
25062153|NCT02493868|50166700|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
25062154|NCT02493868|50166701|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
25062155|NCT02493868|50166700|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
25062156|NCT02493868|50166701|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
25062157|NCT02493868|50166700|FG000|Optimization Phase: DE+TE Participants|Other|10|||
25062158|NCT02493868|50166701|FG001|Optimization Phase: DE+TE Participants|Other|2|||
25062159|NCT02493868|50166700|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
25062160|NCT02493868|50166701|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
25062161|NCT02493868|50166700|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
25062162|NCT02493868|50166701|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
25062163|NCT02493868|50166700|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
25062164|NCT02493868|50166701|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
25062165|NCT02493868|50166700|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
25062166|NCT02493868|50166701|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
25062167|NCT02493868|50166700|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
25062168|NCT02493868|50166701|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
25062169|NCT02493868|50166700|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
25062170|NCT02493868|50166701|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
25062171|NCT02493868|50166700|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
25062172|NCT02493868|50166701|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
25062173|NCT02493868|50166700|FG000|Follow-up Phase|Lost to Follow-up|1|||
25062174|NCT02493868|50166701|FG001|Follow-up Phase|Lost to Follow-up|0|||
25062175|NCT02493868|50166700|FG000|Follow-up Phase|Withdrawal by Subject|3|||
25062176|NCT02493868|50166701|FG001|Follow-up Phase|Withdrawal by Subject|0|||
25062177|NCT02493868|50166700|FG000|Follow-up Phase|Investigator Decision|5|||
25062178|NCT02493868|50166701|FG001|Follow-up Phase|Investigator Decision|1|||
25062179|NCT02493868|50166700|FG000|Follow-up Phase|Other|2|||
25062180|NCT02493868|50166701|FG001|Follow-up Phase|Other|1|||
25062181|NCT02516410|50166715|FG000|Overall Study|Adverse Event|0|||
25062182|NCT02516410|50166716|FG001|Overall Study|Adverse Event|1|||
25062183|NCT02516410|50166715|FG000|Overall Study|Withdrawal by Subject|0|||
25062184|NCT02516410|50166716|FG001|Overall Study|Withdrawal by Subject|1|||
25062185|NCT02493712|50166726|FG000|Overall Study|Withdrawal by Subject|1|||
25062186|NCT02493712|50166727|FG001|Overall Study|Withdrawal by Subject|0|||
25062187|NCT02493712|50166728|FG002|Overall Study|Withdrawal by Subject|2|||
25062188|NCT02493712|50166726|FG000|Overall Study|Protocol Violation|0|||
25062189|NCT02493712|50166727|FG001|Overall Study|Protocol Violation|0|||
25062190|NCT02493712|50166728|FG002|Overall Study|Protocol Violation|1|||
25062191|NCT02493712|50166726|FG000|Overall Study|Lost to Follow-up|1|||
25062192|NCT02493712|50166727|FG001|Overall Study|Lost to Follow-up|0|||
25062193|NCT02493712|50166728|FG002|Overall Study|Lost to Follow-up|0|||
25062194|NCT02493712|50166726|FG000|Overall Study|Physician Decision|0|||
25062195|NCT02493712|50166727|FG001|Overall Study|Physician Decision|1|||
25062196|NCT02493712|50166728|FG002|Overall Study|Physician Decision|0|||
25062197|NCT02493712|50166726|FG000|Overall Study|Lack of Efficacy|0|||
25062198|NCT02493712|50166727|FG001|Overall Study|Lack of Efficacy|5|||
25062199|NCT02493712|50166728|FG002|Overall Study|Lack of Efficacy|3|||
25062200|NCT02516332|50166739|FG000|Overall Study|Withdrawal by Subject|2|||
25062201|NCT02516332|50166740|FG001|Overall Study|Withdrawal by Subject|1|||
25062202|NCT02516332|50166741|FG002|Overall Study|Withdrawal by Subject|2|||
25062203|NCT02483572|50166751|FG000|Overall Study|Withdrawal by Subject|1|||
25062204|NCT02483572|50166752|FG001|Overall Study|Withdrawal by Subject|0|||
25062205|NCT02483572|50166751|FG000|Overall Study|Lost to Follow-up|1|||
25062206|NCT02483572|50166752|FG001|Overall Study|Lost to Follow-up|0|||
25062207|NCT02483572|50166751|FG000|Overall Study|Physician Decision|0|||
25062208|NCT02483572|50166752|FG001|Overall Study|Physician Decision|1|||
25062209|NCT01062425|50166760|FG000|Overall Study|Protocol Violation|3|||
25062210|NCT01062425|50166761|FG001|Overall Study|Protocol Violation|6|||
25062211|NCT01060553|50166767|FG000|Overall Study|Lost to Follow-up|3|||
25062212|NCT01060553|50166768|FG001|Overall Study|Lost to Follow-up|5|||
25062213|NCT01060553|50166767|FG000|Overall Study|Withdrawal by Subject|5|||
25062214|NCT01060553|50166768|FG001|Overall Study|Withdrawal by Subject|5|||
25062215|NCT01060553|50166767|FG000|Overall Study|Lack of Efficacy|1|||
25062216|NCT01060553|50166768|FG001|Overall Study|Lack of Efficacy|0|||
25062217|NCT02491684|50166775|FG000|Treatment Phase|Adverse Event|2|||
25062218|NCT02491684|50166776|FG001|Treatment Phase|Adverse Event|2|||
25062219|NCT02491684|50166775|FG000|Treatment Phase|Incorrect randomisation|1|||
25062220|NCT02491684|50166776|FG001|Treatment Phase|Incorrect randomisation|0|||
25062221|NCT02491684|50166775|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
25062222|NCT02491684|50166776|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
25062223|NCT01061723|50166788|FG000|Overall Study|Adverse Event|0|||
25062224|NCT01061723|50166789|FG001|Overall Study|Adverse Event|2|||
25062225|NCT01061723|50166790|FG002|Overall Study|Adverse Event|5|||
25062226|NCT01061723|50166791|FG003|Overall Study|Adverse Event|5|||
25062227|NCT01061723|50166792|FG004|Overall Study|Adverse Event|2|||
25062228|NCT01061723|50166793|FG005|Overall Study|Adverse Event|6|||
25062229|NCT01061723|50166788|FG000|Overall Study|Lack of Efficacy|2|||
25062230|NCT01061723|50166789|FG001|Overall Study|Lack of Efficacy|3|||
25062231|NCT01061723|50166790|FG002|Overall Study|Lack of Efficacy|4|||
25062232|NCT01061723|50166791|FG003|Overall Study|Lack of Efficacy|2|||
25062233|NCT01061723|50166792|FG004|Overall Study|Lack of Efficacy|1|||
25062234|NCT01061723|50166793|FG005|Overall Study|Lack of Efficacy|1|||
25062235|NCT01061723|50166788|FG000|Overall Study|Randomized but not treated|0|||
25062236|NCT01061723|50166789|FG001|Overall Study|Randomized but not treated|0|||
25062237|NCT01061723|50166790|FG002|Overall Study|Randomized but not treated|0|||
25062238|NCT01061723|50166791|FG003|Overall Study|Randomized but not treated|0|||
25062239|NCT01061723|50166792|FG004|Overall Study|Randomized but not treated|0|||
25062240|NCT01061723|50166793|FG005|Overall Study|Randomized but not treated|1|||
25062241|NCT01061723|50166788|FG000|Overall Study|Other than specified above|2|||
25062242|NCT01061723|50166789|FG001|Overall Study|Other than specified above|1|||
25062243|NCT01061723|50166790|FG002|Overall Study|Other than specified above|1|||
25062244|NCT01061723|50166791|FG003|Overall Study|Other than specified above|1|||
25062245|NCT01061723|50166792|FG004|Overall Study|Other than specified above|0|||
25062246|NCT01061723|50166793|FG005|Overall Study|Other than specified above|1|||
25062247|NCT01061567|50166812|FG000|Overall Study|Adverse Event|32|||
25062248|NCT01061567|50166812|FG000|Overall Study|Death|2|||
25062249|NCT01061567|50166812|FG000|Overall Study|Lack of Efficacy|3|||
25062250|NCT01061567|50166812|FG000|Overall Study|Lost to Follow-up|24|||
25062251|NCT01061567|50166812|FG000|Overall Study|Protocol Violation|1|||
25062252|NCT01061567|50166812|FG000|Overall Study|Withdrawal by Subject|11|||
25062253|NCT01061567|50166812|FG000|Overall Study|Other reason than stated above|3|||
25062254|NCT01061333|50166816|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
25062255|NCT01061333|50166817|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
25062256|NCT02489968|50166830|FG000|Open-label Treatment Period|Adverse Event|14|||
25062257|NCT02489968|50166831|FG001|Open-label Treatment Period|Adverse Event|7|||
25062258|NCT02489968|50166832|FG002|Open-label Treatment Period|Adverse Event|0|||
25062259|NCT02489968|50166833|FG003|Open-label Treatment Period|Adverse Event|0|||
25062260|NCT02489968|50166834|FG004|Open-label Treatment Period|Adverse Event|0|||
25062261|NCT02489968|50166835|FG005|Open-label Treatment Period|Adverse Event|0|||
25062262|NCT02489968|50166830|FG000|Open-label Treatment Period|Protocol Violation|2|||
25062263|NCT02489968|50166831|FG001|Open-label Treatment Period|Protocol Violation|2|||
25062264|NCT02489968|50166832|FG002|Open-label Treatment Period|Protocol Violation|0|||
25062265|NCT02489968|50166833|FG003|Open-label Treatment Period|Protocol Violation|0|||
25062266|NCT02489968|50166834|FG004|Open-label Treatment Period|Protocol Violation|0|||
25062267|NCT02489968|50166835|FG005|Open-label Treatment Period|Protocol Violation|0|||
25062268|NCT02489968|50166830|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
25062269|NCT02489968|50166831|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
25062270|NCT02489968|50166832|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
25062271|NCT02489968|50166833|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
25062272|NCT02489968|50166834|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
25062273|NCT02489968|50166835|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
25062274|NCT02489968|50166830|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
25062275|NCT02489968|50166831|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
25062276|NCT02489968|50166832|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
25062277|NCT02489968|50166833|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
25062278|NCT02489968|50166834|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
25062279|NCT02489968|50166835|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
25062280|NCT02489968|50166830|FG000|Open-label Treatment Period|Other than specified above|204|||
25062281|NCT02489968|50166831|FG001|Open-label Treatment Period|Other than specified above|189|||
25062282|NCT02489968|50166832|FG002|Open-label Treatment Period|Other than specified above|0|||
25062283|NCT02489968|50166833|FG003|Open-label Treatment Period|Other than specified above|0|||
25062284|NCT02489968|50166834|FG004|Open-label Treatment Period|Other than specified above|0|||
25062285|NCT02489968|50166835|FG005|Open-label Treatment Period|Other than specified above|0|||
25062286|NCT02489968|50166830|FG000|Double-blind Treatment Period|Adverse Event|0|||
25276669|NCT00948922|50590607|FG001|Overall Study|Death|0|||
25162826|NCT01978145|50285193|FG001|Treatment Period 2|Protocol Violation|1|||
25062287|NCT02489968|50166831|FG001|Double-blind Treatment Period|Adverse Event|0|||
25162827|NCT01978145|50285192|FG000|Treatment Period 2|Lost to Follow-up|1|||
25162828|NCT01978145|50285193|FG001|Treatment Period 2|Lost to Follow-up|1|||
25062288|NCT02489968|50166832|FG002|Double-blind Treatment Period|Adverse Event|2|||
25062289|NCT02489968|50166833|FG003|Double-blind Treatment Period|Adverse Event|6|||
25062290|NCT02489968|50166834|FG004|Double-blind Treatment Period|Adverse Event|4|||
25062291|NCT02489968|50166835|FG005|Double-blind Treatment Period|Adverse Event|5|||
25062292|NCT02489968|50166830|FG000|Double-blind Treatment Period|Protocol Violation|0|||
25062293|NCT02489968|50166831|FG001|Double-blind Treatment Period|Protocol Violation|0|||
25062294|NCT02489968|50166832|FG002|Double-blind Treatment Period|Protocol Violation|0|||
25062295|NCT02489968|50166833|FG003|Double-blind Treatment Period|Protocol Violation|0|||
25062296|NCT02489968|50166834|FG004|Double-blind Treatment Period|Protocol Violation|1|||
25062297|NCT02489968|50166835|FG005|Double-blind Treatment Period|Protocol Violation|1|||
25062298|NCT02489968|50166830|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
25062299|NCT02489968|50166831|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
25062300|NCT02489968|50166832|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
25062301|NCT02489968|50166833|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
25062302|NCT02489968|50166834|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
25062303|NCT02489968|50166835|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
25062304|NCT02489968|50166830|FG000|Double-blind Treatment Period|Other than specified above|0|||
25062305|NCT02489968|50166831|FG001|Double-blind Treatment Period|Other than specified above|0|||
25062306|NCT02489968|50166832|FG002|Double-blind Treatment Period|Other than specified above|0|||
25062307|NCT02489968|50166833|FG003|Double-blind Treatment Period|Other than specified above|0|||
25062308|NCT02489968|50166834|FG004|Double-blind Treatment Period|Other than specified above|1|||
25062309|NCT02489968|50166835|FG005|Double-blind Treatment Period|Other than specified above|0|||
25062310|NCT02483416|50166849|FG000|Overall Study|Other reason|0|||
25062311|NCT02483416|50166850|FG001|Overall Study|Other reason|1|||
25062312|NCT02483416|50166849|FG000|Overall Study|Treatment stop|3|||
25062313|NCT02483416|50166850|FG001|Overall Study|Treatment stop|0|||
25062314|NCT01061177|50166857|FG000|Overall Study|Adverse Event|117|||
25062315|NCT01061177|50166857|FG000|Overall Study|Withdrawal by Subject|27|||
25062316|NCT01061177|50166857|FG000|Overall Study|Disease progression|17|||
25062317|NCT01061177|50166857|FG000|Overall Study|Protocol Violation|11|||
25062318|NCT01061177|50166857|FG000|Overall Study|Lost to Follow-up|9|||
25062319|NCT01061177|50166857|FG000|Overall Study|New cancer therapy|9|||
25062320|NCT01061177|50166857|FG000|Overall Study|Abnormal laboratory values|6|||
25062321|NCT01061177|50166857|FG000|Overall Study|Abnormal test procedure results|4|||
25062322|NCT01061177|50166857|FG000|Overall Study|Administratie problems|4|||
25062323|NCT01061177|50166857|FG000|Overall Study|Death|4|||
25062324|NCT02481934|50166861|FG000|Overall Study|Death|2|||
25062325|NCT02973425|50166867|FG000|Overall Study|Lost to Follow-up|49|||
25062326|NCT02973425|50166868|FG001|Overall Study|Lost to Follow-up|53|||
25062327|NCT02489500|50166877|FG000|Overall Study|Death|1|||
25062328|NCT02489500|50166878|FG001|Overall Study|Death|1|||
25062329|NCT02732847|50166886|FG000|Overall Study|some filled early|42|||
25062330|NCT02732847|50166887|FG001|Overall Study|some filled early|42|||
25062331|NCT02489344|50166893|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
25062332|NCT02489344|50166893|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
25062333|NCT02489344|50166893|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
25062334|NCT02489344|50166893|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
25062335|NCT02488330|50166897|FG000|Overall Study|Adverse Event|1|||
25062336|NCT02488330|50166897|FG000|Overall Study|Physician Decision|2|||
25062337|NCT02488330|50166897|FG000|Overall Study|Death|2|||
25062338|NCT02488330|50166897|FG000|Overall Study|Disease Progression|3|||
25062339|NCT02488330|50166897|FG000|Overall Study|Study Termination by Sponsor|4|||
25062340|NCT02481310|50166904|FG000|Follow up|Still in follow up|0|||
25062341|NCT02481310|50166905|FG001|Follow up|Still in follow up|3|||
25062342|NCT02481310|50166906|FG002|Follow up|Still in follow up|0|||
25062343|NCT02480764|50166913|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
25062344|NCT02480764|50166914|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
25062345|NCT02480764|50166915|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
25062346|NCT02480764|50166913|FG000|Overall Study|Major Protocol Deviation|1|||
25062347|NCT02480764|50166914|FG001|Overall Study|Major Protocol Deviation|4|||
25062348|NCT02480764|50166915|FG002|Overall Study|Major Protocol Deviation|3|||
25062349|NCT02480764|50166913|FG000|Overall Study|Lost to Follow-up|0|||
25062350|NCT02480764|50166914|FG001|Overall Study|Lost to Follow-up|1|||
25062351|NCT02480764|50166915|FG002|Overall Study|Lost to Follow-up|2|||
25062352|NCT02480764|50166913|FG000|Overall Study|Voluntary Withdrawal|6|||
25062353|NCT02480764|50166914|FG001|Overall Study|Voluntary Withdrawal|5|||
25062354|NCT02480764|50166915|FG002|Overall Study|Voluntary Withdrawal|10|||
25062355|NCT02480764|50166913|FG000|Overall Study|Lack of Efficacy|0|||
25062356|NCT02480764|50166914|FG001|Overall Study|Lack of Efficacy|3|||
25062357|NCT02480764|50166915|FG002|Overall Study|Lack of Efficacy|3|||
25062358|NCT02480764|50166913|FG000|Overall Study|Reason not Specified|0|||
25062359|NCT02480764|50166914|FG001|Overall Study|Reason not Specified|1|||
25062360|NCT02480764|50166915|FG002|Overall Study|Reason not Specified|0|||
25062361|NCT02487472|50166923|FG000|Overall Study|Did not complete telephonic interviews|9|||
25062362|NCT02487472|50166923|FG000|Overall Study|Other|2|||
25062363|NCT02451670|50166931|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
25062364|NCT02451670|50166932|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
25062365|NCT02486692|50166940|FG000|Overall Study|did not login for randomization|4|||
25062366|NCT02486692|50166941|FG001|Overall Study|did not login for randomization|7|||
25062367|NCT01060007|50166958|FG000|Overall Study|Withdrawal by Subject|1|||
25062368|NCT01060007|50166958|FG000|Overall Study|Inevaluable for response at surgery|3|||
25062369|NCT02971163|50166967|FG000|Overall Study|Lost to Follow-up|4|||
25062370|NCT02971163|50166968|FG001|Overall Study|Lost to Follow-up|2|||
25062371|NCT02971007|50166977|FG000|Overall Study|Adverse Event|1|||
25062372|NCT02971007|50166978|FG001|Overall Study|Adverse Event|0|||
25062373|NCT02971007|50166979|FG002|Overall Study|Adverse Event|0|||
25062374|NCT02971007|50166977|FG000|Overall Study|Lost to Follow-up|0|||
25062375|NCT02971007|50166978|FG001|Overall Study|Lost to Follow-up|1|||
25062376|NCT02971007|50166979|FG002|Overall Study|Lost to Follow-up|1|||
25062377|NCT02971007|50166977|FG000|Overall Study|Withdrawal by Subject|0|||
25062378|NCT02971007|50166978|FG001|Overall Study|Withdrawal by Subject|1|||
25062379|NCT02971007|50166979|FG002|Overall Study|Withdrawal by Subject|0|||
25062380|NCT02971007|50166977|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
25062381|NCT02971007|50166978|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
25062382|NCT02971007|50166979|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
25062383|NCT02971007|50166977|FG000|Overall Study|Patient discontinued study drug|0|||
25062384|NCT02971007|50166978|FG001|Overall Study|Patient discontinued study drug|1|||
25062385|NCT02971007|50166979|FG002|Overall Study|Patient discontinued study drug|0|||
25062386|NCT03881553|50166990|FG000|Overall Study|Discharged prior to participation|1|||
25062387|NCT03881553|50166991|FG001|Overall Study|Discharged prior to participation|1|||
24963844|NCT00237692|50053814|FG000|Overall Study|Excluded - did not meet criteria|4|||
24963845|NCT00237692|50053815|FG001|Overall Study|Excluded - did not meet criteria|3|||
24963846|NCT00237692|50053816|FG002|Overall Study|Excluded - did not meet criteria|5|||
24963847|NCT00237692|50053817|FG003|Overall Study|Excluded - did not meet criteria|9|||
24963848|NCT00237692|50053814|FG000|Overall Study|Withdrawal by Subject|4|||
24963849|NCT00237692|50053815|FG001|Overall Study|Withdrawal by Subject|6|||
24963850|NCT00237692|50053816|FG002|Overall Study|Withdrawal by Subject|10|||
24963851|NCT00237692|50053817|FG003|Overall Study|Withdrawal by Subject|4|||
24963852|NCT00237458|50053827|FG000|Overall Study|Lack of Efficacy|1|||
24963853|NCT00237458|50053827|FG000|Overall Study|Adverse Event|1|||
24963854|NCT00237458|50053827|FG000|Overall Study|Withdrawal by Subject|1|||
24963855|NCT00265148|50053833|FG000|Overall Study|Adverse Event|2|||
24963856|NCT00265148|50053834|FG001|Overall Study|Adverse Event|2|||
24963857|NCT00265148|50053833|FG000|Overall Study|Lack of Efficacy|0|||
24963858|NCT00265148|50053834|FG001|Overall Study|Lack of Efficacy|2|||
24963859|NCT00265148|50053833|FG000|Overall Study|Protocol Violation|3|||
24963860|NCT00265148|50053834|FG001|Overall Study|Protocol Violation|2|||
24963861|NCT00265148|50053833|FG000|Overall Study|Lost to Follow-up|0|||
24963862|NCT00265148|50053834|FG001|Overall Study|Lost to Follow-up|1|||
24963863|NCT00265148|50053833|FG000|Overall Study|Withdrawal by Subject|2|||
24963864|NCT00265148|50053834|FG001|Overall Study|Withdrawal by Subject|1|||
24963865|NCT00265148|50053833|FG000|Overall Study|Physician Decision|1|||
25062388|NCT03881553|50166992|FG002|Overall Study|Discharged prior to participation|0|||
25162829|NCT01978145|50285192|FG000|Treatment Period 2|Withdrawal by Subject|7|||
25162830|NCT01978145|50285193|FG001|Treatment Period 2|Withdrawal by Subject|4|||
24963866|NCT00265148|50053834|FG001|Overall Study|Physician Decision|0|||
24963867|NCT00265148|50053833|FG000|Overall Study|Increasing frailty|0|||
24963868|NCT00265148|50053834|FG001|Overall Study|Increasing frailty|1|||
25162831|NCT01978145|50285192|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
25062389|NCT03881553|50166990|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
25062390|NCT03881553|50166991|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
25062391|NCT03881553|50166992|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
24963869|NCT00265148|50053833|FG000|Overall Study|Subject chose to change of the dose|1|||
24963870|NCT00265148|50053834|FG001|Overall Study|Subject chose to change of the dose|0|||
24963871|NCT00043186|50053850|FG000|Overall Study|Physician Decision|0|||
24963872|NCT00043186|50053851|FG001|Overall Study|Physician Decision|0|||
24963873|NCT00043186|50053852|FG002|Overall Study|Physician Decision|3|||
24963874|NCT00043186|50053853|FG003|Overall Study|Physician Decision|0|||
24963875|NCT00043186|50053854|FG004|Overall Study|Physician Decision|1|||
24963876|NCT00043186|50053855|FG005|Overall Study|Physician Decision|0|||
24963877|NCT00043186|50053856|FG006|Overall Study|Physician Decision|0|||
24963878|NCT00043186|50053857|FG007|Overall Study|Physician Decision|1|||
24963879|NCT00043186|50053858|FG008|Overall Study|Physician Decision|1|||
24963880|NCT00043186|50053850|FG000|Overall Study|Adverse Event|2|||
24963881|NCT00043186|50053851|FG001|Overall Study|Adverse Event|2|||
24963882|NCT00043186|50053852|FG002|Overall Study|Adverse Event|2|||
24963883|NCT00043186|50053853|FG003|Overall Study|Adverse Event|3|||
24963884|NCT00043186|50053854|FG004|Overall Study|Adverse Event|2|||
24963885|NCT00043186|50053855|FG005|Overall Study|Adverse Event|1|||
24963886|NCT00043186|50053856|FG006|Overall Study|Adverse Event|2|||
24963887|NCT00043186|50053857|FG007|Overall Study|Adverse Event|1|||
24963888|NCT00043186|50053858|FG008|Overall Study|Adverse Event|3|||
24963889|NCT00043186|50053850|FG000|Overall Study|Withdrawal by Subject|11|||
24963890|NCT00043186|50053851|FG001|Overall Study|Withdrawal by Subject|8|||
24963891|NCT00043186|50053852|FG002|Overall Study|Withdrawal by Subject|11|||
24963892|NCT00043186|50053853|FG003|Overall Study|Withdrawal by Subject|13|||
24963893|NCT00043186|50053854|FG004|Overall Study|Withdrawal by Subject|14|||
24963894|NCT00043186|50053855|FG005|Overall Study|Withdrawal by Subject|6|||
24963895|NCT00043186|50053856|FG006|Overall Study|Withdrawal by Subject|12|||
24963896|NCT00043186|50053857|FG007|Overall Study|Withdrawal by Subject|9|||
24963897|NCT00043186|50053858|FG008|Overall Study|Withdrawal by Subject|10|||
24963898|NCT00043186|50053850|FG000|Overall Study|Death|0|||
24963899|NCT00043186|50053851|FG001|Overall Study|Death|0|||
25276670|NCT00948922|50590608|FG002|Overall Study|Death|0|||
25276671|NCT00948922|50590606|FG000|Overall Study|Disease progression|0|||
24963900|NCT00043186|50053852|FG002|Overall Study|Death|1|||
24963901|NCT00043186|50053853|FG003|Overall Study|Death|0|||
24963902|NCT00043186|50053854|FG004|Overall Study|Death|0|||
24963903|NCT00043186|50053855|FG005|Overall Study|Death|0|||
24963904|NCT00043186|50053856|FG006|Overall Study|Death|2|||
24963905|NCT00043186|50053857|FG007|Overall Study|Death|0|||
25276672|NCT00948922|50590607|FG001|Overall Study|Disease progression|1|||
25276673|NCT00948922|50590608|FG002|Overall Study|Disease progression|0|||
25276674|NCT00948922|50590606|FG000|Overall Study|Insurance issues|1|||
25276675|NCT00948922|50590607|FG001|Overall Study|Insurance issues|0|||
25276676|NCT00948922|50590608|FG002|Overall Study|Insurance issues|0|||
25276677|NCT00948922|50590606|FG000|Overall Study|Transplant eligibility issues|2|||
25162832|NCT01978145|50285193|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
25276678|NCT00948922|50590607|FG001|Overall Study|Transplant eligibility issues|3|||
24963906|NCT00043186|50053858|FG008|Overall Study|Death|0|||
24963907|NCT00043186|50053850|FG000|Overall Study|Disease progression|1|||
24963908|NCT00043186|50053851|FG001|Overall Study|Disease progression|0|||
24963909|NCT00043186|50053852|FG002|Overall Study|Disease progression|0|||
24963910|NCT00043186|50053853|FG003|Overall Study|Disease progression|3|||
24963911|NCT00043186|50053854|FG004|Overall Study|Disease progression|0|||
24963912|NCT00043186|50053855|FG005|Overall Study|Disease progression|0|||
25276679|NCT00948922|50590608|FG002|Overall Study|Transplant eligibility issues|0|||
25062392|NCT02970929|50167000|FG000|Overall Study|Adverse Event|18|||
25062393|NCT02970929|50167000|FG000|Overall Study|Lack of Efficacy|8|||
25062394|NCT02970929|50167000|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
25062395|NCT02970929|50167000|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
25062396|NCT02970929|50167000|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
25062397|NCT02970929|50167000|FG000|Overall Study|LOST TO FOLLOWUP|6|||
25062398|NCT02970929|50167000|FG000|Overall Study|MOVED OUT OF STATE|1|||
25062399|NCT02970929|50167000|FG000|Overall Study|Withdrawal by Subject|16|||
25062400|NCT02970305|50167017|FG000|Overall Study|Adverse Event|10|||
25062401|NCT02970305|50167018|FG001|Overall Study|Adverse Event|6|||
25062402|NCT02970305|50167017|FG000|Overall Study|Lack of Efficacy|1|||
25062403|NCT02970305|50167018|FG001|Overall Study|Lack of Efficacy|1|||
25062404|NCT02970305|50167017|FG000|Overall Study|Noncompliance with study drug|2|||
25062405|NCT02970305|50167018|FG001|Overall Study|Noncompliance with study drug|4|||
25062406|NCT02970305|50167017|FG000|Overall Study|Protocol Violation|2|||
25062407|NCT02970305|50167018|FG001|Overall Study|Protocol Violation|2|||
25062408|NCT02970305|50167017|FG000|Overall Study|Withdrawal by Subject|12|||
25062409|NCT02970305|50167018|FG001|Overall Study|Withdrawal by Subject|11|||
25062410|NCT02970305|50167017|FG000|Overall Study|Not further specified|1|||
25062411|NCT02970305|50167018|FG001|Overall Study|Not further specified|2|||
25062412|NCT02970305|50167017|FG000|Overall Study|Lost to Follow-up|1|||
25062413|NCT02970305|50167018|FG001|Overall Study|Lost to Follow-up|2|||
25062414|NCT03654651|50167035|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
25062415|NCT03654651|50167036|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
25062416|NCT02022033|50167047|FG000|Overall Study|Physician Decision|1|||
25062417|NCT03505671|50167053|FG000|Overall Study|Withdrawal by Subject|2|||
25062418|NCT03505671|50167054|FG001|Overall Study|Withdrawal by Subject|1|||
25062419|NCT03505671|50167053|FG000|Overall Study|Lost to Follow-up|1|||
25062420|NCT03505671|50167054|FG001|Overall Study|Lost to Follow-up|0|||
25062421|NCT01103349|50167075|FG000|Overall Study|Adverse Event|8|||
25062422|NCT01103349|50167076|FG001|Overall Study|Adverse Event|5|||
25062423|NCT01103349|50167077|FG002|Overall Study|Adverse Event|3|||
25062424|NCT01103349|50167075|FG000|Overall Study|Consent withdrawn|1|||
25062425|NCT01103349|50167076|FG001|Overall Study|Consent withdrawn|0|||
25062426|NCT01103349|50167077|FG002|Overall Study|Consent withdrawn|0|||
25062427|NCT01103349|50167075|FG000|Overall Study|Incorrectly included in the trial|1|||
25062428|NCT01103349|50167076|FG001|Overall Study|Incorrectly included in the trial|0|||
25062429|NCT01103349|50167077|FG002|Overall Study|Incorrectly included in the trial|0|||
25062430|NCT01103349|50167075|FG000|Overall Study|Withdrawal by Subject|1|||
25062431|NCT01103349|50167076|FG001|Overall Study|Withdrawal by Subject|1|||
25062432|NCT01103349|50167077|FG002|Overall Study|Withdrawal by Subject|0|||
25062433|NCT01103349|50167075|FG000|Overall Study|did not want to take trial medication|0|||
25062434|NCT01103349|50167076|FG001|Overall Study|did not want to take trial medication|1|||
25062435|NCT01103349|50167077|FG002|Overall Study|did not want to take trial medication|0|||
25062436|NCT01103349|50167075|FG000|Overall Study|forgot to take medication|0|||
25062437|NCT01103349|50167076|FG001|Overall Study|forgot to take medication|0|||
25062438|NCT01103349|50167077|FG002|Overall Study|forgot to take medication|1|||
25062439|NCT02959177|50167088|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
25062440|NCT02959177|50167089|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
25062441|NCT02959177|50167090|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
25062442|NCT02959177|50167088|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
25062443|NCT02959177|50167089|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
25062444|NCT02959177|50167090|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
25062445|NCT02959177|50167088|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
25062446|NCT02959177|50167089|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
25062447|NCT02959177|50167090|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
25062448|NCT02959177|50167088|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
25062449|NCT02959177|50167089|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
25062450|NCT02959177|50167090|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
25062451|NCT02959177|50167088|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
25186628|NCT03458325|50337220|FG000|Overall Study|Withdrawal by Subject|1|||
25186629|NCT02646618|50337229|FG000|Overall Study|Lost to Follow-up|10|||
25186630|NCT02646618|50337230|FG001|Overall Study|Lost to Follow-up|14|||
25062452|NCT02959177|50167089|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
25062453|NCT02959177|50167090|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
25062454|NCT02959177|50167088|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
25062455|NCT02959177|50167089|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
25062456|NCT02959177|50167090|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
25062457|NCT02959177|50167088|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
25062458|NCT02959177|50167089|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
25062459|NCT02959177|50167090|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
25062460|NCT04706403|50167107|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
25062461|NCT04706403|50167108|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
25062462|NCT04706403|50167109|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
25062463|NCT04706403|50167110|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
25062464|NCT04706403|50167111|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
25062465|NCT02983617|50167125|FG000|Overall Study|Adverse Event|0|||
25062466|NCT02983617|50167126|FG001|Overall Study|Adverse Event|7|||
25062467|NCT02983617|50167125|FG000|Overall Study|Death|0|||
25062468|NCT02983617|50167126|FG001|Overall Study|Death|1|||
25062469|NCT02983617|50167125|FG000|Overall Study|Investigator's Discretion|0|||
25062470|NCT02983617|50167126|FG001|Overall Study|Investigator's Discretion|1|||
25062471|NCT02873689|50167134|FG000|Overall Study|Lack of Efficacy|1|||
25062472|NCT02873689|50167135|FG001|Overall Study|Lack of Efficacy|0|||
25062473|NCT02873689|50167134|FG000|Overall Study|Withdrawal by Subject|2|||
25062474|NCT02873689|50167135|FG001|Overall Study|Withdrawal by Subject|2|||
24963913|NCT00043186|50053856|FG006|Overall Study|Disease progression|0|||
24963914|NCT00043186|50053857|FG007|Overall Study|Disease progression|4|||
25062475|NCT02873689|50167134|FG000|Overall Study|Protocol Violation|1|||
25062476|NCT02873689|50167135|FG001|Overall Study|Protocol Violation|0|||
25062477|NCT02873689|50167134|FG000|Overall Study|Adverse Event|2|||
25062478|NCT02873689|50167135|FG001|Overall Study|Adverse Event|2|||
25062479|NCT02873689|50167134|FG000|Overall Study|Randomized but not Treated|1|||
25062480|NCT02873689|50167135|FG001|Overall Study|Randomized but not Treated|1|||
25062481|NCT02901431|50167149|FG000|PK Part|Adverse Event|0|||
25062482|NCT02901431|50167150|FG001|PK Part|Adverse Event|1|||
25062483|NCT02901431|50167151|FG002|PK Part|Adverse Event|0|||
25062484|NCT02901431|50167152|FG003|PK Part|Adverse Event|0|||
25062485|NCT02901431|50167153|FG004|PK Part|Adverse Event|0|||
25062486|NCT02901431|50167154|FG005|PK Part|Adverse Event|0|||
25062487|NCT02901431|50167155|FG006|PK Part|Adverse Event|0|||
25062488|NCT02901431|50167156|FG007|PK Part|Adverse Event|0|||
25062489|NCT02901431|50167157|FG008|PK Part|Adverse Event|0|||
25062490|NCT02901431|50167158|FG009|PK Part|Adverse Event|0|||
24963915|NCT00043186|50053858|FG008|Overall Study|Disease progression|0|||
24963916|NCT00043186|50053850|FG000|Overall Study|Ineligibility determined|0|||
24963917|NCT00043186|50053851|FG001|Overall Study|Ineligibility determined|0|||
24963918|NCT00043186|50053852|FG002|Overall Study|Ineligibility determined|0|||
24963919|NCT00043186|50053853|FG003|Overall Study|Ineligibility determined|0|||
24963920|NCT00043186|50053854|FG004|Overall Study|Ineligibility determined|0|||
24963921|NCT00043186|50053855|FG005|Overall Study|Ineligibility determined|0|||
24963922|NCT00043186|50053856|FG006|Overall Study|Ineligibility determined|0|||
24963923|NCT00043186|50053857|FG007|Overall Study|Ineligibility determined|0|||
24963924|NCT00043186|50053858|FG008|Overall Study|Ineligibility determined|1|||
24963925|NCT00043186|50053850|FG000|Overall Study|Lost to Follow-up|3|||
24963926|NCT00043186|50053851|FG001|Overall Study|Lost to Follow-up|5|||
24963927|NCT00043186|50053852|FG002|Overall Study|Lost to Follow-up|1|||
24963928|NCT00043186|50053853|FG003|Overall Study|Lost to Follow-up|1|||
24963929|NCT00043186|50053854|FG004|Overall Study|Lost to Follow-up|1|||
24963930|NCT00043186|50053855|FG005|Overall Study|Lost to Follow-up|1|||
24963931|NCT00043186|50053856|FG006|Overall Study|Lost to Follow-up|1|||
24963932|NCT00043186|50053857|FG007|Overall Study|Lost to Follow-up|1|||
24963933|NCT00043186|50053858|FG008|Overall Study|Lost to Follow-up|2|||
24963934|NCT00043186|50053850|FG000|Overall Study|Noncompliance|0|||
24963935|NCT00043186|50053851|FG001|Overall Study|Noncompliance|0|||
24963936|NCT00043186|50053852|FG002|Overall Study|Noncompliance|1|||
24963937|NCT00043186|50053853|FG003|Overall Study|Noncompliance|1|||
24963938|NCT00043186|50053854|FG004|Overall Study|Noncompliance|0|||
24963939|NCT00043186|50053855|FG005|Overall Study|Noncompliance|0|||
24963940|NCT00043186|50053856|FG006|Overall Study|Noncompliance|0|||
24963941|NCT00043186|50053857|FG007|Overall Study|Noncompliance|0|||
24963942|NCT00043186|50053858|FG008|Overall Study|Noncompliance|0|||
24963943|NCT00043186|50053850|FG000|Overall Study|Other|0|||
24963944|NCT00043186|50053851|FG001|Overall Study|Other|0|||
25062491|NCT02901431|50167159|FG010|PK Part|Adverse Event|0|||
25062492|NCT02901431|50167160|FG011|PK Part|Adverse Event|0|||
25062493|NCT02901431|50167161|FG012|PK Part|Adverse Event|0|||
25062494|NCT02901431|50167149|FG000|PK Part|Lost to Follow-up|0|||
24963945|NCT00043186|50053852|FG002|Overall Study|Other|1|||
24963946|NCT00043186|50053853|FG003|Overall Study|Other|1|||
24963947|NCT00043186|50053854|FG004|Overall Study|Other|0|||
24963948|NCT00043186|50053855|FG005|Overall Study|Other|0|||
25062495|NCT02901431|50167150|FG001|PK Part|Lost to Follow-up|0|||
25062496|NCT02901431|50167151|FG002|PK Part|Lost to Follow-up|1|||
25062497|NCT02901431|50167152|FG003|PK Part|Lost to Follow-up|0|||
25062498|NCT02901431|50167153|FG004|PK Part|Lost to Follow-up|0|||
25062499|NCT02901431|50167154|FG005|PK Part|Lost to Follow-up|0|||
25062500|NCT02901431|50167155|FG006|PK Part|Lost to Follow-up|0|||
25062501|NCT02901431|50167156|FG007|PK Part|Lost to Follow-up|0|||
25062502|NCT02901431|50167157|FG008|PK Part|Lost to Follow-up|0|||
25062503|NCT02901431|50167158|FG009|PK Part|Lost to Follow-up|0|||
25062504|NCT02901431|50167159|FG010|PK Part|Lost to Follow-up|0|||
25062505|NCT02901431|50167160|FG011|PK Part|Lost to Follow-up|0|||
25062506|NCT02901431|50167161|FG012|PK Part|Lost to Follow-up|0|||
25062507|NCT02901431|50167149|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
25062508|NCT02901431|50167150|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
25062509|NCT02901431|50167151|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
25062510|NCT02901431|50167152|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
25062511|NCT02901431|50167153|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
25062512|NCT02901431|50167154|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
25062513|NCT02901431|50167155|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
25062514|NCT02901431|50167156|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
25062515|NCT02901431|50167157|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
25062516|NCT02901431|50167158|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
25062517|NCT02901431|50167159|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
25062518|NCT02901431|50167160|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
25062519|NCT02901431|50167161|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
25062520|NCT02901431|50167149|FG000|PK Part|Pending dose confirmation|0|||
25062521|NCT02901431|50167150|FG001|PK Part|Pending dose confirmation|1|||
25062522|NCT02901431|50167151|FG002|PK Part|Pending dose confirmation|0|||
25062523|NCT02901431|50167152|FG003|PK Part|Pending dose confirmation|0|||
25062524|NCT02901431|50167153|FG004|PK Part|Pending dose confirmation|0|||
25062525|NCT02901431|50167154|FG005|PK Part|Pending dose confirmation|0|||
25062526|NCT02901431|50167155|FG006|PK Part|Pending dose confirmation|0|||
25062527|NCT02901431|50167156|FG007|PK Part|Pending dose confirmation|0|||
25062528|NCT02901431|50167157|FG008|PK Part|Pending dose confirmation|0|||
25062529|NCT02901431|50167158|FG009|PK Part|Pending dose confirmation|0|||
25062530|NCT02901431|50167159|FG010|PK Part|Pending dose confirmation|0|||
25062531|NCT02901431|50167160|FG011|PK Part|Pending dose confirmation|0|||
25062532|NCT02901431|50167161|FG012|PK Part|Pending dose confirmation|0|||
25062533|NCT02901431|50167149|FG000|PK Part|8 weeks of treatment ran out|2|||
25062534|NCT02901431|50167150|FG001|PK Part|8 weeks of treatment ran out|0|||
25062535|NCT02901431|50167151|FG002|PK Part|8 weeks of treatment ran out|0|||
25062536|NCT02901431|50167152|FG003|PK Part|8 weeks of treatment ran out|0|||
25062537|NCT02901431|50167153|FG004|PK Part|8 weeks of treatment ran out|0|||
25062538|NCT02901431|50167154|FG005|PK Part|8 weeks of treatment ran out|0|||
25062539|NCT02901431|50167155|FG006|PK Part|8 weeks of treatment ran out|0|||
25062540|NCT02901431|50167156|FG007|PK Part|8 weeks of treatment ran out|0|||
25062541|NCT02901431|50167157|FG008|PK Part|8 weeks of treatment ran out|0|||
25062542|NCT02901431|50167158|FG009|PK Part|8 weeks of treatment ran out|0|||
25062543|NCT02901431|50167159|FG010|PK Part|8 weeks of treatment ran out|0|||
25062544|NCT02901431|50167160|FG011|PK Part|8 weeks of treatment ran out|0|||
25062545|NCT02901431|50167161|FG012|PK Part|8 weeks of treatment ran out|0|||
25062546|NCT02901431|50167149|FG000|PK Part|Stopped treatment after 8 weeks|1|||
25062547|NCT02901431|50167150|FG001|PK Part|Stopped treatment after 8 weeks|0|||
25062548|NCT02901431|50167151|FG002|PK Part|Stopped treatment after 8 weeks|1|||
25062549|NCT02901431|50167152|FG003|PK Part|Stopped treatment after 8 weeks|0|||
25062550|NCT02901431|50167153|FG004|PK Part|Stopped treatment after 8 weeks|0|||
25062551|NCT02901431|50167154|FG005|PK Part|Stopped treatment after 8 weeks|0|||
25062552|NCT02901431|50167155|FG006|PK Part|Stopped treatment after 8 weeks|0|||
25062553|NCT02901431|50167156|FG007|PK Part|Stopped treatment after 8 weeks|0|||
25062554|NCT02901431|50167157|FG008|PK Part|Stopped treatment after 8 weeks|0|||
25062555|NCT02901431|50167158|FG009|PK Part|Stopped treatment after 8 weeks|0|||
25062556|NCT02901431|50167159|FG010|PK Part|Stopped treatment after 8 weeks|0|||
25062557|NCT02901431|50167160|FG011|PK Part|Stopped treatment after 8 weeks|0|||
25062558|NCT02901431|50167161|FG012|PK Part|Stopped treatment after 8 weeks|0|||
25062559|NCT02901431|50167149|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
25062560|NCT02901431|50167150|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
25062561|NCT02901431|50167151|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
25062562|NCT02901431|50167152|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
25062563|NCT02901431|50167153|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
25062564|NCT02901431|50167154|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
25276680|NCT00948922|50590606|FG000|Overall Study|Not evaluable at time of analysis|0|||
25276681|NCT00948922|50590607|FG001|Overall Study|Not evaluable at time of analysis|3|||
25062565|NCT02901431|50167155|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
25062566|NCT02901431|50167156|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
25062567|NCT02901431|50167157|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
25062568|NCT02901431|50167158|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
25062569|NCT02901431|50167159|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
25062570|NCT02901431|50167160|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
25276682|NCT00948922|50590608|FG002|Overall Study|Not evaluable at time of analysis|0|||
25062571|NCT02901431|50167161|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
25062572|NCT02901431|50167149|FG000|PK Part|Discontinued per Sponsor|0|||
25062573|NCT02901431|50167150|FG001|PK Part|Discontinued per Sponsor|3|||
25062574|NCT02901431|50167151|FG002|PK Part|Discontinued per Sponsor|0|||
25062575|NCT02901431|50167152|FG003|PK Part|Discontinued per Sponsor|0|||
25062576|NCT02901431|50167153|FG004|PK Part|Discontinued per Sponsor|0|||
25062577|NCT02901431|50167154|FG005|PK Part|Discontinued per Sponsor|0|||
25062578|NCT02901431|50167155|FG006|PK Part|Discontinued per Sponsor|0|||
25062579|NCT02901431|50167156|FG007|PK Part|Discontinued per Sponsor|0|||
25062580|NCT02901431|50167157|FG008|PK Part|Discontinued per Sponsor|0|||
25062581|NCT02901431|50167158|FG009|PK Part|Discontinued per Sponsor|0|||
25062582|NCT02901431|50167159|FG010|PK Part|Discontinued per Sponsor|0|||
25062583|NCT02901431|50167160|FG011|PK Part|Discontinued per Sponsor|0|||
25062584|NCT02901431|50167161|FG012|PK Part|Discontinued per Sponsor|0|||
25062585|NCT02901431|50167149|FG000|PK Part|Withdrawal by Subject|1|||
25062586|NCT02901431|50167150|FG001|PK Part|Withdrawal by Subject|1|||
25062587|NCT02901431|50167151|FG002|PK Part|Withdrawal by Subject|3|||
25062588|NCT02901431|50167152|FG003|PK Part|Withdrawal by Subject|0|||
25062589|NCT02901431|50167153|FG004|PK Part|Withdrawal by Subject|0|||
25062590|NCT02901431|50167154|FG005|PK Part|Withdrawal by Subject|0|||
25062591|NCT02901431|50167155|FG006|PK Part|Withdrawal by Subject|0|||
25062592|NCT02901431|50167156|FG007|PK Part|Withdrawal by Subject|0|||
25186631|NCT02644122|50337266|FG000|Overall Study|Withdrawal by Subject|1|||
25062593|NCT02901431|50167157|FG008|PK Part|Withdrawal by Subject|0|||
25186632|NCT01394939|50337292|FG000|Overall Study|Adverse Event|1|||
25186633|NCT01394939|50337293|FG001|Overall Study|Adverse Event|3|||
25162833|NCT01967537|50285199|FG000|Overall Study|Withdrawal by Subject|52|||
25162834|NCT01967537|50285199|FG000|Overall Study|Refuse treatment|2|||
25162835|NCT01967537|50285199|FG000|Overall Study|Lost to Follow-up|6|||
25162836|NCT01967225|50285207|FG000|Overall Study|Adverse Event|3|||
25062594|NCT02901431|50167158|FG009|PK Part|Withdrawal by Subject|0|||
25062595|NCT02901431|50167159|FG010|PK Part|Withdrawal by Subject|0|||
25062596|NCT02901431|50167160|FG011|PK Part|Withdrawal by Subject|0|||
25062597|NCT02901431|50167161|FG012|PK Part|Withdrawal by Subject|0|||
25062598|NCT02901431|50167149|FG000|Main Treatment Part|Adverse Event|0|||
25062599|NCT02901431|50167150|FG001|Main Treatment Part|Adverse Event|0|||
25062600|NCT02901431|50167151|FG002|Main Treatment Part|Adverse Event|0|||
25062601|NCT02901431|50167152|FG003|Main Treatment Part|Adverse Event|3|||
25062602|NCT02901431|50167153|FG004|Main Treatment Part|Adverse Event|3|||
25062603|NCT02901431|50167154|FG005|Main Treatment Part|Adverse Event|4|||
25062604|NCT02901431|50167155|FG006|Main Treatment Part|Adverse Event|1|||
25062605|NCT02901431|50167156|FG007|Main Treatment Part|Adverse Event|0|||
25062606|NCT02901431|50167157|FG008|Main Treatment Part|Adverse Event|0|||
25062607|NCT02901431|50167158|FG009|Main Treatment Part|Adverse Event|0|||
25062608|NCT02901431|50167159|FG010|Main Treatment Part|Adverse Event|0|||
25062609|NCT02901431|50167160|FG011|Main Treatment Part|Adverse Event|0|||
25062610|NCT02901431|50167161|FG012|Main Treatment Part|Adverse Event|0|||
25062611|NCT02901431|50167149|FG000|Main Treatment Part|Lack of Efficacy|0|||
25062612|NCT02901431|50167150|FG001|Main Treatment Part|Lack of Efficacy|0|||
25062613|NCT02901431|50167151|FG002|Main Treatment Part|Lack of Efficacy|0|||
25062614|NCT02901431|50167152|FG003|Main Treatment Part|Lack of Efficacy|1|||
25062615|NCT02901431|50167153|FG004|Main Treatment Part|Lack of Efficacy|0|||
25062616|NCT02901431|50167154|FG005|Main Treatment Part|Lack of Efficacy|0|||
25062617|NCT02901431|50167155|FG006|Main Treatment Part|Lack of Efficacy|0|||
25062618|NCT02901431|50167156|FG007|Main Treatment Part|Lack of Efficacy|0|||
25062619|NCT02901431|50167157|FG008|Main Treatment Part|Lack of Efficacy|0|||
25062620|NCT02901431|50167158|FG009|Main Treatment Part|Lack of Efficacy|0|||
25062621|NCT02901431|50167159|FG010|Main Treatment Part|Lack of Efficacy|0|||
25062622|NCT02901431|50167160|FG011|Main Treatment Part|Lack of Efficacy|0|||
25062623|NCT02901431|50167161|FG012|Main Treatment Part|Lack of Efficacy|0|||
25062624|NCT02901431|50167149|FG000|Main Treatment Part|Lost to Follow-up|0|||
25062625|NCT02901431|50167150|FG001|Main Treatment Part|Lost to Follow-up|0|||
25062626|NCT02901431|50167151|FG002|Main Treatment Part|Lost to Follow-up|0|||
25062627|NCT02901431|50167152|FG003|Main Treatment Part|Lost to Follow-up|3|||
25062628|NCT02901431|50167153|FG004|Main Treatment Part|Lost to Follow-up|1|||
25062629|NCT02901431|50167154|FG005|Main Treatment Part|Lost to Follow-up|2|||
25062630|NCT02901431|50167155|FG006|Main Treatment Part|Lost to Follow-up|3|||
25062631|NCT02901431|50167156|FG007|Main Treatment Part|Lost to Follow-up|0|||
25062632|NCT02901431|50167157|FG008|Main Treatment Part|Lost to Follow-up|0|||
25062633|NCT02901431|50167158|FG009|Main Treatment Part|Lost to Follow-up|0|||
25062634|NCT02901431|50167159|FG010|Main Treatment Part|Lost to Follow-up|0|||
25062635|NCT02901431|50167160|FG011|Main Treatment Part|Lost to Follow-up|0|||
25062636|NCT02901431|50167161|FG012|Main Treatment Part|Lost to Follow-up|0|||
25062637|NCT02901431|50167149|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
25062638|NCT02901431|50167150|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
25062639|NCT02901431|50167151|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
25062640|NCT02901431|50167152|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
25062641|NCT02901431|50167153|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
25062642|NCT02901431|50167154|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
25062643|NCT02901431|50167155|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
25062644|NCT02901431|50167156|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
25062645|NCT02901431|50167157|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
25062646|NCT02901431|50167158|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
25062647|NCT02901431|50167159|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
25062648|NCT02901431|50167160|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
25062649|NCT02901431|50167161|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
25062650|NCT02901431|50167149|FG000|Main Treatment Part|Physician Decision|0|||
25062651|NCT02901431|50167150|FG001|Main Treatment Part|Physician Decision|0|||
25062652|NCT02901431|50167151|FG002|Main Treatment Part|Physician Decision|0|||
25062653|NCT02901431|50167152|FG003|Main Treatment Part|Physician Decision|1|||
25062654|NCT02901431|50167153|FG004|Main Treatment Part|Physician Decision|0|||
25162837|NCT01967225|50285208|FG001|Overall Study|Adverse Event|1|||
25162838|NCT01967225|50285207|FG000|Overall Study|Withdrawal by Subject|2|||
25062655|NCT02901431|50167154|FG005|Main Treatment Part|Physician Decision|0|||
25062656|NCT02901431|50167155|FG006|Main Treatment Part|Physician Decision|1|||
25062657|NCT02901431|50167156|FG007|Main Treatment Part|Physician Decision|0|||
25062658|NCT02901431|50167157|FG008|Main Treatment Part|Physician Decision|0|||
25062659|NCT02901431|50167158|FG009|Main Treatment Part|Physician Decision|0|||
25062660|NCT02901431|50167159|FG010|Main Treatment Part|Physician Decision|0|||
25062661|NCT02901431|50167160|FG011|Main Treatment Part|Physician Decision|0|||
25062662|NCT02901431|50167161|FG012|Main Treatment Part|Physician Decision|0|||
25162839|NCT01967225|50285208|FG001|Overall Study|Withdrawal by Subject|1|||
25062663|NCT02901431|50167149|FG000|Main Treatment Part|Withdrawal by Subject|0|||
25062664|NCT02901431|50167150|FG001|Main Treatment Part|Withdrawal by Subject|0|||
25062665|NCT02901431|50167151|FG002|Main Treatment Part|Withdrawal by Subject|0|||
25062666|NCT02901431|50167152|FG003|Main Treatment Part|Withdrawal by Subject|18|||
25062667|NCT02901431|50167153|FG004|Main Treatment Part|Withdrawal by Subject|3|||
25062668|NCT02901431|50167154|FG005|Main Treatment Part|Withdrawal by Subject|5|||
25062669|NCT02901431|50167155|FG006|Main Treatment Part|Withdrawal by Subject|6|||
25062670|NCT02901431|50167156|FG007|Main Treatment Part|Withdrawal by Subject|0|||
25062671|NCT02901431|50167157|FG008|Main Treatment Part|Withdrawal by Subject|0|||
25062672|NCT02901431|50167158|FG009|Main Treatment Part|Withdrawal by Subject|0|||
25062673|NCT02901431|50167159|FG010|Main Treatment Part|Withdrawal by Subject|0|||
25062674|NCT02901431|50167160|FG011|Main Treatment Part|Withdrawal by Subject|0|||
25062675|NCT02901431|50167161|FG012|Main Treatment Part|Withdrawal by Subject|0|||
25062676|NCT02901431|50167149|FG000|Open Label Part|Adverse Event|0|||
25062677|NCT02901431|50167150|FG001|Open Label Part|Adverse Event|0|||
25062678|NCT02901431|50167151|FG002|Open Label Part|Adverse Event|0|||
25062679|NCT02901431|50167152|FG003|Open Label Part|Adverse Event|0|||
25062680|NCT02901431|50167153|FG004|Open Label Part|Adverse Event|0|||
25062681|NCT02901431|50167154|FG005|Open Label Part|Adverse Event|0|||
25062682|NCT02901431|50167155|FG006|Open Label Part|Adverse Event|0|||
25062683|NCT02901431|50167156|FG007|Open Label Part|Adverse Event|0|||
25062684|NCT02901431|50167157|FG008|Open Label Part|Adverse Event|4|||
25062685|NCT02901431|50167158|FG009|Open Label Part|Adverse Event|4|||
25062686|NCT02901431|50167159|FG010|Open Label Part|Adverse Event|0|||
25062687|NCT02901431|50167160|FG011|Open Label Part|Adverse Event|4|||
25062688|NCT02901431|50167161|FG012|Open Label Part|Adverse Event|1|||
25062689|NCT02901431|50167149|FG000|Open Label Part|Lost to Follow-up|0|||
25062690|NCT02901431|50167150|FG001|Open Label Part|Lost to Follow-up|0|||
25062691|NCT02901431|50167151|FG002|Open Label Part|Lost to Follow-up|0|||
25062692|NCT02901431|50167152|FG003|Open Label Part|Lost to Follow-up|0|||
25062693|NCT02901431|50167153|FG004|Open Label Part|Lost to Follow-up|0|||
25062694|NCT02901431|50167154|FG005|Open Label Part|Lost to Follow-up|0|||
25062695|NCT02901431|50167155|FG006|Open Label Part|Lost to Follow-up|0|||
25062696|NCT02901431|50167156|FG007|Open Label Part|Lost to Follow-up|0|||
25062697|NCT02901431|50167157|FG008|Open Label Part|Lost to Follow-up|2|||
25062698|NCT02901431|50167158|FG009|Open Label Part|Lost to Follow-up|2|||
25062699|NCT02901431|50167159|FG010|Open Label Part|Lost to Follow-up|1|||
25062700|NCT02901431|50167160|FG011|Open Label Part|Lost to Follow-up|1|||
25062701|NCT02901431|50167161|FG012|Open Label Part|Lost to Follow-up|1|||
25062702|NCT02901431|50167149|FG000|Open Label Part|Physician Decision|0|||
25062703|NCT02901431|50167150|FG001|Open Label Part|Physician Decision|0|||
25062704|NCT02901431|50167151|FG002|Open Label Part|Physician Decision|0|||
25062705|NCT02901431|50167152|FG003|Open Label Part|Physician Decision|0|||
25062706|NCT02901431|50167153|FG004|Open Label Part|Physician Decision|0|||
25062707|NCT02901431|50167154|FG005|Open Label Part|Physician Decision|0|||
25062708|NCT02901431|50167155|FG006|Open Label Part|Physician Decision|0|||
25062709|NCT02901431|50167156|FG007|Open Label Part|Physician Decision|0|||
25062710|NCT02901431|50167157|FG008|Open Label Part|Physician Decision|1|||
25062711|NCT02901431|50167158|FG009|Open Label Part|Physician Decision|1|||
25062712|NCT02901431|50167159|FG010|Open Label Part|Physician Decision|0|||
25062713|NCT02901431|50167160|FG011|Open Label Part|Physician Decision|0|||
25062714|NCT02901431|50167161|FG012|Open Label Part|Physician Decision|0|||
25062715|NCT02901431|50167149|FG000|Open Label Part|Study Terminated By Sponsor|0|||
25062716|NCT02901431|50167150|FG001|Open Label Part|Study Terminated By Sponsor|0|||
25062717|NCT02901431|50167151|FG002|Open Label Part|Study Terminated By Sponsor|0|||
24963949|NCT00043186|50053856|FG006|Overall Study|Other|0|||
24963950|NCT00043186|50053857|FG007|Overall Study|Other|0|||
24963951|NCT00043186|50053858|FG008|Overall Study|Other|0|||
24963952|NCT00041470|50053879|FG000|Overall Study|Loss of Funding|38|||
24963953|NCT00206102|50053885|FG000|Overall Study|Adverse Event|119|||
24963954|NCT00206102|50053886|FG001|Overall Study|Adverse Event|82|||
24963955|NCT00206102|50053885|FG000|Overall Study|Protocol Violation|0|||
24963956|NCT00206102|50053886|FG001|Overall Study|Protocol Violation|2|||
24963957|NCT00206102|50053885|FG000|Overall Study|Lack of therapeutic response|16|||
24963958|NCT00206102|50053886|FG001|Overall Study|Lack of therapeutic response|11|||
24963959|NCT00206102|50053885|FG000|Overall Study|Lost to Follow-up|95|||
24963960|NCT00206102|50053886|FG001|Overall Study|Lost to Follow-up|66|||
25062718|NCT02901431|50167152|FG003|Open Label Part|Study Terminated By Sponsor|0|||
25062719|NCT02901431|50167153|FG004|Open Label Part|Study Terminated By Sponsor|0|||
25062720|NCT02901431|50167154|FG005|Open Label Part|Study Terminated By Sponsor|0|||
25062721|NCT02901431|50167155|FG006|Open Label Part|Study Terminated By Sponsor|0|||
25062722|NCT02901431|50167156|FG007|Open Label Part|Study Terminated By Sponsor|0|||
25062723|NCT02901431|50167157|FG008|Open Label Part|Study Terminated By Sponsor|35|||
25062724|NCT02901431|50167158|FG009|Open Label Part|Study Terminated By Sponsor|12|||
25062725|NCT02901431|50167159|FG010|Open Label Part|Study Terminated By Sponsor|21|||
25062726|NCT02901431|50167160|FG011|Open Label Part|Study Terminated By Sponsor|31|||
25062727|NCT02901431|50167161|FG012|Open Label Part|Study Terminated By Sponsor|0|||
25062728|NCT02901431|50167149|FG000|Open Label Part|Withdrawal by Subject|0|||
25062729|NCT02901431|50167150|FG001|Open Label Part|Withdrawal by Subject|0|||
25062730|NCT02901431|50167151|FG002|Open Label Part|Withdrawal by Subject|0|||
25062731|NCT02901431|50167152|FG003|Open Label Part|Withdrawal by Subject|0|||
25062732|NCT02901431|50167153|FG004|Open Label Part|Withdrawal by Subject|0|||
25062733|NCT02901431|50167154|FG005|Open Label Part|Withdrawal by Subject|0|||
25062734|NCT02901431|50167155|FG006|Open Label Part|Withdrawal by Subject|0|||
25062735|NCT02901431|50167156|FG007|Open Label Part|Withdrawal by Subject|0|||
25062736|NCT02901431|50167157|FG008|Open Label Part|Withdrawal by Subject|6|||
25062737|NCT02901431|50167158|FG009|Open Label Part|Withdrawal by Subject|5|||
25062738|NCT02901431|50167159|FG010|Open Label Part|Withdrawal by Subject|7|||
25062739|NCT02901431|50167160|FG011|Open Label Part|Withdrawal by Subject|3|||
25062740|NCT02901431|50167161|FG012|Open Label Part|Withdrawal by Subject|1|||
25062741|NCT02873377|50167188|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
25062742|NCT02873377|50167189|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
25062743|NCT02873377|50167188|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
25062744|NCT02873377|50167189|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
25062745|NCT02966795|50167198|FG000|Overall Study|Patient Left the Country|0|||
25062746|NCT02966795|50167199|FG001|Overall Study|Patient Left the Country|1|||
25062747|NCT02873221|50167207|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
25062748|NCT02873221|50167208|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
25062749|NCT02873221|50167209|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
25062750|NCT02873221|50167207|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
25062751|NCT02873221|50167208|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
25062752|NCT02873221|50167209|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
25062753|NCT02873221|50167207|FG000|Treatment Period|Protocol Violation|2|||
25062754|NCT02873221|50167208|FG001|Treatment Period|Protocol Violation|5|||
25062755|NCT02873221|50167209|FG002|Treatment Period|Protocol Violation|8|||
25062756|NCT02873221|50167207|FG000|Treatment Period|Pregnancy|4|||
25062757|NCT02873221|50167208|FG001|Treatment Period|Pregnancy|6|||
25062758|NCT02873221|50167209|FG002|Treatment Period|Pregnancy|3|||
25062759|NCT02873221|50167207|FG000|Treatment Period|Lack of Qualifying Event|0|||
25062760|NCT02873221|50167208|FG001|Treatment Period|Lack of Qualifying Event|3|||
25062761|NCT02873221|50167209|FG002|Treatment Period|Lack of Qualifying Event|1|||
25062762|NCT02873221|50167207|FG000|Treatment Period|Withdrawal of Consent|52|||
25062763|NCT02873221|50167208|FG001|Treatment Period|Withdrawal of Consent|51|||
25062764|NCT02873221|50167209|FG002|Treatment Period|Withdrawal of Consent|41|||
25062765|NCT02873221|50167207|FG000|Treatment Period|Lack of Efficacy|0|||
25062766|NCT02873221|50167208|FG001|Treatment Period|Lack of Efficacy|17|||
25062767|NCT02873221|50167209|FG002|Treatment Period|Lack of Efficacy|12|||
25062768|NCT02873221|50167207|FG000|Treatment Period|Adverse Event|4|||
25062769|NCT02873221|50167208|FG001|Treatment Period|Adverse Event|9|||
25062770|NCT02873221|50167209|FG002|Treatment Period|Adverse Event|11|||
25062771|NCT02873221|50167207|FG000|Treatment Period|Lost to Follow-up|26|||
25062772|NCT02873221|50167208|FG001|Treatment Period|Lost to Follow-up|30|||
25062773|NCT02873221|50167209|FG002|Treatment Period|Lost to Follow-up|26|||
25062774|NCT02873221|50167207|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
25062775|NCT02873221|50167208|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
25062776|NCT02873221|50167209|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
25062777|NCT02873221|50167207|FG000|Safety Follow-up Period|Protocol Violation|0|||
25062778|NCT02873221|50167208|FG001|Safety Follow-up Period|Protocol Violation|0|||
25062779|NCT02873221|50167209|FG002|Safety Follow-up Period|Protocol Violation|1|||
25062780|NCT02873221|50167207|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
25062781|NCT02873221|50167208|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
25062782|NCT02873221|50167209|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
25062783|NCT02873221|50167207|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
25062784|NCT02873221|50167208|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
25062785|NCT02873221|50167209|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
25062786|NCT02968979|50167217|FG000|Overall Study|Protocol Violation|7|||
25062787|NCT02968979|50167217|FG000|Overall Study|Withdrawal by Subject|1|||
25062788|NCT02966015|50167269|FG000|Inclusion Visit|did not answer questionnaire|8|||
25062789|NCT02966015|50167270|FG001|Inclusion Visit|did not answer questionnaire|3|||
25062790|NCT02968433|50167276|FG000|Overall Study|Withdrawal by Subject|1|||
25062791|NCT02872285|50167288|FG000|Overall Study|Withdrawal by Subject|2|||
25062792|NCT02872285|50167289|FG001|Overall Study|Withdrawal by Subject|0|||
25062793|NCT02872285|50167288|FG000|Overall Study|Lost to Follow-up|2|||
25062794|NCT02872285|50167289|FG001|Overall Study|Lost to Follow-up|2|||
25162840|NCT01967225|50285207|FG000|Overall Study|Lack of Efficacy|1|||
25276683|NCT01239992|50590620|FG000|Overall Study|Withdrawal by Subject|2|||
25062795|NCT02872285|50167288|FG000|Overall Study|Discontinued due to back surgery|1|||
25062796|NCT02872285|50167289|FG001|Overall Study|Discontinued due to back surgery|0|||
25062797|NCT02871739|50167299|FG000|Overall Study|Lost to Follow-up|3|||
25062798|NCT02871739|50167300|FG001|Overall Study|Lost to Follow-up|2|||
25062799|NCT02871739|50167301|FG002|Overall Study|Lost to Follow-up|0|||
25062800|NCT02871739|50167302|FG003|Overall Study|Lost to Follow-up|2|||
25062801|NCT02896361|50167312|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
25062802|NCT02896361|50167313|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
25062803|NCT02896361|50167314|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
25062804|NCT02896361|50167312|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
25062805|NCT02896361|50167313|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
25062806|NCT02896361|50167314|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
25062807|NCT02962739|50167337|FG000|Overall Study|Withdrawal by Subject|0|||
25062808|NCT02962739|50167338|FG001|Overall Study|Withdrawal by Subject|1|||
25062809|NCT02962739|50167339|FG002|Overall Study|Withdrawal by Subject|0|||
25062810|NCT02962739|50167340|FG003|Overall Study|Withdrawal by Subject|0|||
25062811|NCT02962739|50167341|FG004|Overall Study|Withdrawal by Subject|0|||
25062812|NCT02962739|50167342|FG005|Overall Study|Withdrawal by Subject|0|||
25062813|NCT02962739|50167337|FG000|Overall Study|Protocol Violation|0|||
25062814|NCT02962739|50167338|FG001|Overall Study|Protocol Violation|0|||
25062815|NCT02962739|50167339|FG002|Overall Study|Protocol Violation|1|||
25062816|NCT02962739|50167340|FG003|Overall Study|Protocol Violation|0|||
25062817|NCT02962739|50167341|FG004|Overall Study|Protocol Violation|1|||
25062818|NCT02962739|50167342|FG005|Overall Study|Protocol Violation|0|||
25062819|NCT01344629|50167350|FG000|Crossover Period 2|Withdrawal by Subject|0|||
25062820|NCT01344629|50167351|FG001|Crossover Period 2|Withdrawal by Subject|1|||
25062821|NCT01092117|50167357|FG000|Index Procedure to 1 Month|Death|1|||
25062822|NCT01092117|50167357|FG000|1 Month|Death|1|||
25062823|NCT01092117|50167357|FG000|1 Month|Withdrawal by Subject|1|||
25062824|NCT01092117|50167357|FG000|1 Month|Lost to Follow-up|1|||
25062825|NCT01092117|50167357|FG000|6 Months|Death|2|||
25062826|NCT01092117|50167357|FG000|6 Months|Withdrawal by Subject|3|||
25062827|NCT01092117|50167357|FG000|12 Month|Death|11|||
25062828|NCT01092117|50167357|FG000|12 Month|Withdrawal by Subject|2|||
25062829|NCT01092117|50167357|FG000|12 Month|Lost to Follow-up|1|||
25062830|NCT01092117|50167357|FG000|Year 2|Death|5|||
25062831|NCT01092117|50167357|FG000|Year 2|Withdrawal by Subject|4|||
25062832|NCT01092117|50167357|FG000|Year 2|Lost to Follow-up|1|||
25062833|NCT01092117|50167357|FG000|Year 3|Death|7|||
25062834|NCT01092117|50167357|FG000|Year 3|Withdrawal by Subject|9|||
25062835|NCT01092117|50167357|FG000|Year 3|Lost to Follow-up|3|||
25062836|NCT01092117|50167357|FG000|Year 4|Death|8|||
25062837|NCT01092117|50167357|FG000|Year 4|Withdrawal by Subject|4|||
25062838|NCT01092117|50167357|FG000|Year 4|Lost to Follow-up|4|||
25062839|NCT01065779|50167370|FG000|Overall Study|Duplicate Investigation|1|||
25062840|NCT01065779|50167370|FG000|Overall Study|Investigation Before Contract Date|37|||
25062841|NCT01065779|50167370|FG000|Overall Study|Non-enrollment Period Administration|10|||
25062842|NCT01065779|50167370|FG000|Overall Study|Not Administered With Study Drug|17|||
25062843|NCT01065779|50167370|FG000|Overall Study|Failed to Follow-up|10|||
25062844|NCT01065779|50167370|FG000|Overall Study|Inclusion Criteria Violation|7|||
25062845|NCT02963441|50167374|FG000|Overall Study|Protocol violation or withdrawn|8|||
25062846|NCT02963441|50167374|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
25062847|NCT02963441|50167374|FG000|Overall Study|IDx-DR insufficient quality|33|||
25062848|NCT01345253|50167381|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
25062849|NCT01345253|50167382|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
25062850|NCT01345253|50167381|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
25062851|NCT01345253|50167382|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
25062852|NCT01345253|50167381|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
25062853|NCT01345253|50167382|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
25062854|NCT01345253|50167381|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
25062855|NCT01345253|50167382|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
25062856|NCT01345253|50167381|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
25062857|NCT01345253|50167382|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
25062858|NCT01345253|50167381|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
25062859|NCT01345253|50167382|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
25062860|NCT01345253|50167381|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
25162841|NCT01967225|50285208|FG001|Overall Study|Lack of Efficacy|1|||
25162842|NCT01967225|50285207|FG000|Overall Study|Switching to other therapy|2|||
25062861|NCT01345253|50167382|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
25062862|NCT01345253|50167381|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
25062863|NCT01345253|50167382|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
25062864|NCT01345253|50167381|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
25062865|NCT01345253|50167382|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
25062866|NCT01345253|50167381|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
25062867|NCT01345253|50167382|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
25062868|NCT01345253|50167381|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
25162843|NCT01967225|50285208|FG001|Overall Study|Switching to other therapy|0|||
25162844|NCT01967225|50285207|FG000|Overall Study|Protocol driven decision point|1|||
25186634|NCT01394939|50337294|FG002|Overall Study|Adverse Event|0|||
25062869|NCT01345253|50167382|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
25062870|NCT01345253|50167381|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
25062871|NCT01345253|50167382|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
25062872|NCT01345253|50167381|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
25062873|NCT01345253|50167382|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
25062874|NCT01345253|50167381|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
25062875|NCT01345253|50167382|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
25062876|NCT01345253|50167381|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
25062877|NCT01345253|50167382|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
25062878|NCT02477800|50167393|FG000|Placebo-Controlled Period|Adverse Event|16|||
25062879|NCT02477800|50167394|FG001|Placebo-Controlled Period|Adverse Event|25|||
25062880|NCT02477800|50167395|FG002|Placebo-Controlled Period|Adverse Event|28|||
25062881|NCT02477800|50167396|FG003|Placebo-Controlled Period|Adverse Event|0|||
25062882|NCT02477800|50167397|FG004|Placebo-Controlled Period|Adverse Event|0|||
25062883|NCT02477800|50167398|FG005|Placebo-Controlled Period|Adverse Event|0|||
25062884|NCT02477800|50167399|FG006|Placebo-Controlled Period|Adverse Event|0|||
25062885|NCT02477800|50167393|FG000|Placebo-Controlled Period|Change of Treatment|1|||
25062886|NCT02477800|50167394|FG001|Placebo-Controlled Period|Change of Treatment|2|||
25062887|NCT02477800|50167395|FG002|Placebo-Controlled Period|Change of Treatment|1|||
25062888|NCT02477800|50167396|FG003|Placebo-Controlled Period|Change of Treatment|0|||
25062889|NCT02477800|50167397|FG004|Placebo-Controlled Period|Change of Treatment|0|||
25062890|NCT02477800|50167398|FG005|Placebo-Controlled Period|Change of Treatment|0|||
25062891|NCT02477800|50167399|FG006|Placebo-Controlled Period|Change of Treatment|0|||
25062892|NCT02477800|50167393|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
25062893|NCT02477800|50167394|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
25062894|NCT02477800|50167395|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
25062895|NCT02477800|50167396|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
25062896|NCT02477800|50167397|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
25062897|NCT02477800|50167398|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
25062898|NCT02477800|50167399|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
25062899|NCT02477800|50167393|FG000|Placebo-Controlled Period|Death|0|||
25062900|NCT02477800|50167394|FG001|Placebo-Controlled Period|Death|3|||
25062901|NCT02477800|50167395|FG002|Placebo-Controlled Period|Death|2|||
25062902|NCT02477800|50167396|FG003|Placebo-Controlled Period|Death|0|||
25062903|NCT02477800|50167397|FG004|Placebo-Controlled Period|Death|0|||
25062904|NCT02477800|50167398|FG005|Placebo-Controlled Period|Death|0|||
25062905|NCT02477800|50167399|FG006|Placebo-Controlled Period|Death|0|||
25062906|NCT02477800|50167393|FG000|Placebo-Controlled Period|Disease Progression|1|||
25062907|NCT02477800|50167394|FG001|Placebo-Controlled Period|Disease Progression|0|||
25062908|NCT02477800|50167395|FG002|Placebo-Controlled Period|Disease Progression|1|||
25062909|NCT02477800|50167396|FG003|Placebo-Controlled Period|Disease Progression|0|||
25062910|NCT02477800|50167397|FG004|Placebo-Controlled Period|Disease Progression|0|||
25062911|NCT02477800|50167398|FG005|Placebo-Controlled Period|Disease Progression|0|||
25062912|NCT02477800|50167399|FG006|Placebo-Controlled Period|Disease Progression|0|||
25062913|NCT02477800|50167393|FG000|Placebo-Controlled Period|Investigator Decision|3|||
25062914|NCT02477800|50167394|FG001|Placebo-Controlled Period|Investigator Decision|2|||
25062915|NCT02477800|50167395|FG002|Placebo-Controlled Period|Investigator Decision|1|||
25062916|NCT02477800|50167396|FG003|Placebo-Controlled Period|Investigator Decision|0|||
25062917|NCT02477800|50167397|FG004|Placebo-Controlled Period|Investigator Decision|0|||
25062918|NCT02477800|50167398|FG005|Placebo-Controlled Period|Investigator Decision|0|||
25062919|NCT02477800|50167399|FG006|Placebo-Controlled Period|Investigator Decision|0|||
25062920|NCT02477800|50167393|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
25062921|NCT02477800|50167394|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
25062922|NCT02477800|50167395|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
25062923|NCT02477800|50167396|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
25062924|NCT02477800|50167397|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
25062925|NCT02477800|50167398|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
25062926|NCT02477800|50167399|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
25062927|NCT02477800|50167393|FG000|Placebo-Controlled Period|Relocation|2|||
25062928|NCT02477800|50167394|FG001|Placebo-Controlled Period|Relocation|0|||
25062929|NCT02477800|50167395|FG002|Placebo-Controlled Period|Relocation|0|||
25062930|NCT02477800|50167396|FG003|Placebo-Controlled Period|Relocation|0|||
25062931|NCT02477800|50167397|FG004|Placebo-Controlled Period|Relocation|0|||
25062932|NCT02477800|50167398|FG005|Placebo-Controlled Period|Relocation|0|||
25062933|NCT02477800|50167399|FG006|Placebo-Controlled Period|Relocation|0|||
25062934|NCT02477800|50167393|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
25062935|NCT02477800|50167394|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
25062936|NCT02477800|50167395|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
25062937|NCT02477800|50167396|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
25062938|NCT02477800|50167397|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
25186635|NCT01394939|50337295|FG003|Overall Study|Adverse Event|2|||
25062939|NCT02477800|50167398|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
25062940|NCT02477800|50167399|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
25062941|NCT02477800|50167393|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
25062942|NCT02477800|50167394|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
25062943|NCT02477800|50167395|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
25062944|NCT02477800|50167396|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
25062945|NCT02477800|50167397|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
25062946|NCT02477800|50167398|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
25062947|NCT02477800|50167399|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
25062948|NCT02477800|50167393|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
25062949|NCT02477800|50167394|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
25062950|NCT02477800|50167395|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
25062951|NCT02477800|50167396|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
25062952|NCT02477800|50167397|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
25062953|NCT02477800|50167398|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
25062954|NCT02477800|50167399|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
25062955|NCT02477800|50167393|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
25062956|NCT02477800|50167394|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
25062957|NCT02477800|50167395|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
25062958|NCT02477800|50167396|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
25062959|NCT02477800|50167397|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
25062960|NCT02477800|50167398|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
25062961|NCT02477800|50167399|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
25062962|NCT02477800|50167393|FG000|Placebo-Controlled Period|Reason not Specified|161|||
25062963|NCT02477800|50167394|FG001|Placebo-Controlled Period|Reason not Specified|161|||
25062964|NCT02477800|50167395|FG002|Placebo-Controlled Period|Reason not Specified|189|||
24963961|NCT00206102|50053885|FG000|Overall Study|Withdrawal by Subject|118|||
24963962|NCT00206102|50053886|FG001|Overall Study|Withdrawal by Subject|101|||
24963963|NCT00206102|50053885|FG000|Overall Study|Study-specific discontinuation criteria|18|||
24963964|NCT00206102|50053886|FG001|Overall Study|Study-specific discontinuation criteria|17|||
24963965|NCT00206102|50053885|FG000|Overall Study|None of those categories|42|||
24963966|NCT00206102|50053886|FG001|Overall Study|None of those categories|36|||
24963967|NCT00041080|50053894|FG000|Overall Study|Adverse Event|21|||
24963968|NCT00041080|50053895|FG001|Overall Study|Adverse Event|1|||
24963969|NCT00041080|50053894|FG000|Overall Study|Withdrawal by Subject|6|||
24963970|NCT00041080|50053895|FG001|Overall Study|Withdrawal by Subject|6|||
24963971|NCT00041080|50053894|FG000|Overall Study|Concommitant Illness/Other|1|||
24963972|NCT00041080|50053895|FG001|Overall Study|Concommitant Illness/Other|2|||
24963973|NCT00041080|50053894|FG000|Overall Study|Did not start therapy|1|||
24963974|NCT00041080|50053895|FG001|Overall Study|Did not start therapy|1|||
24963975|NCT00041080|50053894|FG000|Overall Study|Ineligible|1|||
24963976|NCT00041080|50053895|FG001|Overall Study|Ineligible|0|||
24963977|NCT00205712|50053903|FG000|Overall Study|Lost to Follow-up|0|||
24963978|NCT00205712|50053904|FG001|Overall Study|Lost to Follow-up|1|||
24963979|NCT00203294|50053914|FG000|Overall Study|Withdrawal by Subject|8|||
24963980|NCT00203294|50053915|FG001|Overall Study|Withdrawal by Subject|13|||
25062965|NCT02477800|50167396|FG003|Placebo-Controlled Period|Reason not Specified|0|||
25062966|NCT02477800|50167397|FG004|Placebo-Controlled Period|Reason not Specified|0|||
24963981|NCT00264290|50053923|FG000|Intervention (8 Weeks)|Adverse Event|1|||
24963982|NCT00264290|50053924|FG001|Intervention (8 Weeks)|Adverse Event|0|||
24963983|NCT00234494|50053934|FG000|Overall Study|Protocol Violation|2|||
24963984|NCT00234104|50053942|FG000|Overall Study|Adverse Event|4|||
24963985|NCT00234104|50053943|FG001|Overall Study|Adverse Event|0|||
25062967|NCT02477800|50167398|FG005|Placebo-Controlled Period|Reason not Specified|0|||
25062968|NCT02477800|50167399|FG006|Placebo-Controlled Period|Reason not Specified|0|||
25062969|NCT02477800|50167393|FG000|Long Term Extension Period|Adverse Event|0|||
25062970|NCT02477800|50167394|FG001|Long Term Extension Period|Adverse Event|0|||
25062971|NCT02477800|50167395|FG002|Long Term Extension Period|Adverse Event|0|||
25062972|NCT02477800|50167396|FG003|Long Term Extension Period|Adverse Event|6|||
25062973|NCT02477800|50167397|FG004|Long Term Extension Period|Adverse Event|2|||
25062974|NCT02477800|50167398|FG005|Long Term Extension Period|Adverse Event|4|||
25062975|NCT02477800|50167399|FG006|Long Term Extension Period|Adverse Event|3|||
25062976|NCT02477800|50167393|FG000|Long Term Extension Period|Death|0|||
25062977|NCT02477800|50167394|FG001|Long Term Extension Period|Death|0|||
25062978|NCT02477800|50167395|FG002|Long Term Extension Period|Death|0|||
24963986|NCT00234104|50053944|FG002|Overall Study|Adverse Event|3|||
24963987|NCT00234104|50053945|FG003|Overall Study|Adverse Event|5|||
24963988|NCT00234104|50053942|FG000|Overall Study|Protocol Violation|0|||
24963989|NCT00234104|50053943|FG001|Overall Study|Protocol Violation|0|||
24963990|NCT00234104|50053944|FG002|Overall Study|Protocol Violation|0|||
24963991|NCT00234104|50053945|FG003|Overall Study|Protocol Violation|1|||
24963992|NCT00234104|50053942|FG000|Overall Study|Physician Decision|0|||
24963993|NCT00234104|50053943|FG001|Overall Study|Physician Decision|1|||
24963994|NCT00234104|50053944|FG002|Overall Study|Physician Decision|2|||
24963995|NCT00234104|50053945|FG003|Overall Study|Physician Decision|2|||
24963996|NCT00263666|50053957|FG000|Overall Study|Adverse Event|6|||
24963997|NCT00263666|50053958|FG001|Overall Study|Adverse Event|8|||
24963998|NCT00263666|50053957|FG000|Overall Study|Lost to Follow-up|1|||
24963999|NCT00263666|50053958|FG001|Overall Study|Lost to Follow-up|2|||
24964000|NCT00263666|50053957|FG000|Overall Study|Withdrawal by Subject|0|||
24964001|NCT00263666|50053958|FG001|Overall Study|Withdrawal by Subject|1|||
24964002|NCT00195338|50053964|FG000|Overall Study|Lost to Follow-up|2|||
24964003|NCT00195338|50053964|FG000|Overall Study|Adverse Event|5|||
24964004|NCT00195338|50053964|FG000|Overall Study|Lack of Efficacy|1|||
24964005|NCT00195338|50053964|FG000|Overall Study|Early closure of the site|4|||
24964006|NCT00039130|50053968|FG000|Overall Study|Adverse Event|11|||
24964007|NCT00039130|50053968|FG000|Overall Study|Death|9|||
24964008|NCT00039130|50053968|FG000|Overall Study|Withdrawal by Subject|3|||
24964009|NCT00039130|50053968|FG000|Overall Study|Progression|2|||
24964010|NCT00039130|50053968|FG000|Overall Study|Subsequent treatment|2|||
24964011|NCT00039130|50053968|FG000|Overall Study|Physician Decision|3|||
24964012|NCT00035932|50053975|FG000|Overall Study|Adverse Event|10|||
24964013|NCT00035932|50053976|FG001|Overall Study|Adverse Event|9|||
24964014|NCT00035932|50053977|FG002|Overall Study|Adverse Event|9|||
24964015|NCT00035932|50053975|FG000|Overall Study|Death|0|||
24964016|NCT00035932|50053976|FG001|Overall Study|Death|0|||
24964017|NCT00035932|50053977|FG002|Overall Study|Death|1|||
25062979|NCT02477800|50167396|FG003|Long Term Extension Period|Death|1|||
25062980|NCT02477800|50167397|FG004|Long Term Extension Period|Death|1|||
25062981|NCT02477800|50167398|FG005|Long Term Extension Period|Death|1|||
24964018|NCT00035932|50053975|FG000|Overall Study|Disease Progression / Relapse|1|||
24964019|NCT00035932|50053976|FG001|Overall Study|Disease Progression / Relapse|1|||
24964020|NCT00035932|50053977|FG002|Overall Study|Disease Progression / Relapse|0|||
25062982|NCT02477800|50167399|FG006|Long Term Extension Period|Death|2|||
25062983|NCT02477800|50167393|FG000|Long Term Extension Period|Consent Withdrawn|0|||
25062984|NCT02477800|50167394|FG001|Long Term Extension Period|Consent Withdrawn|0|||
25062985|NCT02477800|50167395|FG002|Long Term Extension Period|Consent Withdrawn|0|||
25062986|NCT02477800|50167396|FG003|Long Term Extension Period|Consent Withdrawn|10|||
25062987|NCT02477800|50167397|FG004|Long Term Extension Period|Consent Withdrawn|4|||
25062988|NCT02477800|50167398|FG005|Long Term Extension Period|Consent Withdrawn|13|||
25062989|NCT02477800|50167399|FG006|Long Term Extension Period|Consent Withdrawn|16|||
25062990|NCT02477800|50167393|FG000|Long Term Extension Period|Disease Progression|0|||
25062991|NCT02477800|50167394|FG001|Long Term Extension Period|Disease Progression|0|||
25062992|NCT02477800|50167395|FG002|Long Term Extension Period|Disease Progression|0|||
25062993|NCT02477800|50167396|FG003|Long Term Extension Period|Disease Progression|3|||
25062994|NCT02477800|50167397|FG004|Long Term Extension Period|Disease Progression|1|||
25062995|NCT02477800|50167398|FG005|Long Term Extension Period|Disease Progression|1|||
25062996|NCT02477800|50167399|FG006|Long Term Extension Period|Disease Progression|0|||
25062997|NCT02477800|50167393|FG000|Long Term Extension Period|Investigator Decision|0|||
25062998|NCT02477800|50167394|FG001|Long Term Extension Period|Investigator Decision|0|||
25062999|NCT02477800|50167395|FG002|Long Term Extension Period|Investigator Decision|0|||
24964021|NCT00035932|50053975|FG000|Overall Study|Lost to Follow-up|4|||
24964022|NCT00035932|50053976|FG001|Overall Study|Lost to Follow-up|4|||
24964023|NCT00035932|50053977|FG002|Overall Study|Lost to Follow-up|3|||
24964024|NCT00035932|50053975|FG000|Overall Study|Noncompliance|6|||
24964025|NCT00035932|50053976|FG001|Overall Study|Noncompliance|7|||
24964026|NCT00035932|50053977|FG002|Overall Study|Noncompliance|6|||
24964027|NCT00035932|50053975|FG000|Overall Study|Protocol Violation While on Study|0|||
24964028|NCT00035932|50053976|FG001|Overall Study|Protocol Violation While on Study|1|||
24964029|NCT00035932|50053977|FG002|Overall Study|Protocol Violation While on Study|2|||
24964030|NCT00035932|50053975|FG000|Overall Study|Withdrawal by Subject|1|||
24964031|NCT00035932|50053976|FG001|Overall Study|Withdrawal by Subject|5|||
24964032|NCT00035932|50053977|FG002|Overall Study|Withdrawal by Subject|0|||
24964033|NCT00035932|50053975|FG000|Overall Study|Study Termination by Sponsor|1|||
25063000|NCT02477800|50167396|FG003|Long Term Extension Period|Investigator Decision|0|||
25063001|NCT02477800|50167397|FG004|Long Term Extension Period|Investigator Decision|0|||
25063002|NCT02477800|50167398|FG005|Long Term Extension Period|Investigator Decision|0|||
25063003|NCT02477800|50167399|FG006|Long Term Extension Period|Investigator Decision|2|||
25063004|NCT02477800|50167393|FG000|Long Term Extension Period|Lost to Follow-up|0|||
25063005|NCT02477800|50167394|FG001|Long Term Extension Period|Lost to Follow-up|0|||
25063006|NCT02477800|50167395|FG002|Long Term Extension Period|Lost to Follow-up|0|||
25063007|NCT02477800|50167396|FG003|Long Term Extension Period|Lost to Follow-up|0|||
25063008|NCT02477800|50167397|FG004|Long Term Extension Period|Lost to Follow-up|1|||
25063009|NCT02477800|50167398|FG005|Long Term Extension Period|Lost to Follow-up|3|||
25063010|NCT02477800|50167399|FG006|Long Term Extension Period|Lost to Follow-up|0|||
25063011|NCT02477800|50167393|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
25063012|NCT02477800|50167394|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
25063013|NCT02477800|50167395|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
25063014|NCT02477800|50167396|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
25063015|NCT02477800|50167397|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
25063016|NCT02477800|50167398|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
25063017|NCT02477800|50167399|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
25063018|NCT02477800|50167393|FG000|Long Term Extension Period|Study Visit Burden|0|||
25063019|NCT02477800|50167394|FG001|Long Term Extension Period|Study Visit Burden|0|||
25063020|NCT02477800|50167395|FG002|Long Term Extension Period|Study Visit Burden|0|||
24964034|NCT00035932|50053976|FG001|Overall Study|Study Termination by Sponsor|0|||
24964035|NCT00035932|50053977|FG002|Overall Study|Study Termination by Sponsor|0|||
24964036|NCT00035932|50053975|FG000|Overall Study|Lack of Efficacy|33|||
24964037|NCT00035932|50053976|FG001|Overall Study|Lack of Efficacy|33|||
24964038|NCT00035932|50053977|FG002|Overall Study|Lack of Efficacy|28|||
25063021|NCT02477800|50167396|FG003|Long Term Extension Period|Study Visit Burden|3|||
25063022|NCT02477800|50167397|FG004|Long Term Extension Period|Study Visit Burden|0|||
25063023|NCT02477800|50167398|FG005|Long Term Extension Period|Study Visit Burden|2|||
25063024|NCT02477800|50167399|FG006|Long Term Extension Period|Study Visit Burden|2|||
25063025|NCT02477800|50167393|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
25063026|NCT02477800|50167394|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
25063027|NCT02477800|50167395|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
25063028|NCT02477800|50167396|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
25186636|NCT01394939|50337292|FG000|Overall Study|Death|0|||
25186637|NCT01394939|50337293|FG001|Overall Study|Death|2|||
24964039|NCT00022516|50053992|FG000|Overall Study|Adverse Event|0|||
24964040|NCT00022516|50053993|FG001|Overall Study|Adverse Event|59|||
24964041|NCT00022516|50053992|FG000|Overall Study|Lack of Efficacy|0|||
24964042|NCT00022516|50053993|FG001|Overall Study|Lack of Efficacy|27|||
24964043|NCT00022516|50053992|FG000|Overall Study|Physician Decision|0|||
24964044|NCT00022516|50053993|FG001|Overall Study|Physician Decision|1|||
24964045|NCT00022516|50053992|FG000|Overall Study|Protocol Violation|1|||
24964046|NCT00022516|50053993|FG001|Overall Study|Protocol Violation|3|||
24964047|NCT00022516|50053992|FG000|Overall Study|Withdrawal by Subject|2|||
24964048|NCT00022516|50053993|FG001|Overall Study|Withdrawal by Subject|113|||
24964049|NCT00022516|50053992|FG000|Overall Study|Incomplete documentation|0|||
24964050|NCT00022516|50053993|FG001|Overall Study|Incomplete documentation|27|||
24964051|NCT00033514|50054001|FG000|Overall Study|Lost to Follow-up|1|||
25063029|NCT02477800|50167397|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
25063030|NCT02477800|50167398|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
25063031|NCT02477800|50167399|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
25063032|NCT02477800|50167393|FG000|Long Term Extension Period|Reason not Specified|0|||
25063033|NCT02477800|50167394|FG001|Long Term Extension Period|Reason not Specified|0|||
25063034|NCT02477800|50167395|FG002|Long Term Extension Period|Reason not Specified|0|||
25063035|NCT02477800|50167396|FG003|Long Term Extension Period|Reason not Specified|126|||
24964052|NCT00033514|50054002|FG001|Overall Study|Lost to Follow-up|1|||
24964053|NCT00033514|50054001|FG000|Overall Study|Withdrawal by Subject|0|||
24964054|NCT00033514|50054002|FG001|Overall Study|Withdrawal by Subject|3|||
25063036|NCT02477800|50167397|FG004|Long Term Extension Period|Reason not Specified|140|||
25063037|NCT02477800|50167398|FG005|Long Term Extension Period|Reason not Specified|270|||
25063038|NCT02477800|50167399|FG006|Long Term Extension Period|Reason not Specified|224|||
25063039|NCT02957747|50167413|FG000|Overall Study|Withdrawal by Subject|0|||
25063040|NCT02957747|50167414|FG001|Overall Study|Withdrawal by Subject|3|||
25063041|NCT02957747|50167413|FG000|Overall Study|Lost to Follow-up|10|||
25063042|NCT02957747|50167414|FG001|Overall Study|Lost to Follow-up|5|||
25063043|NCT01344161|50167423|FG000|Overall Study|Lost to Follow-up|4|||
25162845|NCT01967225|50285208|FG001|Overall Study|Protocol driven decision point|0|||
25063044|NCT01344161|50167424|FG001|Overall Study|Lost to Follow-up|1|||
25063045|NCT01344161|50167423|FG000|Overall Study|Pregnancy|0|||
25063046|NCT01344161|50167424|FG001|Overall Study|Pregnancy|1|||
24964055|NCT00006916|50054009|FG000|Overall Study|Device not inserted|4|||
25063047|NCT01344161|50167423|FG000|Overall Study|Protocol Violation|1|||
25063048|NCT01344161|50167424|FG001|Overall Study|Protocol Violation|1|||
25063049|NCT02451358|50167434|FG000|Overall Study|Withdrawal by Subject|1|||
25063050|NCT02451358|50167435|FG001|Overall Study|Withdrawal by Subject|1|||
25063051|NCT02451358|50167436|FG002|Overall Study|Withdrawal by Subject|0|||
25063052|NCT02451358|50167437|FG003|Overall Study|Withdrawal by Subject|0|||
25063053|NCT02451358|50167434|FG000|Overall Study|Protocol Violation|0|||
25063054|NCT02451358|50167435|FG001|Overall Study|Protocol Violation|1|||
25063055|NCT02451358|50167436|FG002|Overall Study|Protocol Violation|1|||
25063056|NCT02451358|50167437|FG003|Overall Study|Protocol Violation|0|||
25063057|NCT02749721|50167447|FG000|Screening|Withdrawal by Subject|1|||
25063058|NCT02749721|50167447|FG000|Screening|Lost to Follow-up|2|||
25063059|NCT02749721|50167447|FG000|Screening|Protocol Violation|3|||
25063060|NCT02749721|50167447|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
25063061|NCT02749721|50167447|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
25063062|NCT01348139|50167453|FG000|Period 1|Adverse Event|1|||
25063063|NCT01348139|50167454|FG001|Period 1|Adverse Event|0|||
25063064|NCT01348139|50167455|FG002|Period 1|Adverse Event|0|||
25063065|NCT01348139|50167456|FG003|Period 1|Adverse Event|0|||
25063066|NCT01348139|50167457|FG004|Period 1|Adverse Event|0|||
25063067|NCT01348139|50167458|FG005|Period 1|Adverse Event|0|||
25063068|NCT02868229|50167476|FG000|Overall Study|Adverse Event|1|||
25063069|NCT02868229|50167477|FG001|Overall Study|Adverse Event|0|||
25063070|NCT02868229|50167478|FG002|Overall Study|Adverse Event|0|||
25063071|NCT02868229|50167479|FG003|Overall Study|Adverse Event|1|||
25063072|NCT02868229|50167476|FG000|Overall Study|Death|0|||
25063073|NCT02868229|50167477|FG001|Overall Study|Death|0|||
25063074|NCT02868229|50167478|FG002|Overall Study|Death|1|||
25063075|NCT02868229|50167479|FG003|Overall Study|Death|1|||
25063076|NCT02868229|50167476|FG000|Overall Study|Missed dose|0|||
25063077|NCT02868229|50167477|FG001|Overall Study|Missed dose|0|||
25063078|NCT02868229|50167478|FG002|Overall Study|Missed dose|0|||
25063079|NCT02868229|50167479|FG003|Overall Study|Missed dose|3|||
25063080|NCT02956967|50167494|FG000|Overall Study|Adverse Event|3|||
25063081|NCT02956967|50167494|FG000|Overall Study|Reason non-related to neutropenia|10|||
25063082|NCT02956967|50167494|FG000|Overall Study|Lost to Follow-up|5|||
25063083|NCT02956967|50167494|FG000|Overall Study|Missing|1|||
25063084|NCT02956967|50167494|FG000|Overall Study|Termination of Nivestim administration|29|||
25063085|NCT02867995|50167518|FG000|Overall Study|Withdrawal by Subject|0|||
25063086|NCT02867995|50167519|FG001|Overall Study|Withdrawal by Subject|1|||
25063087|NCT02867995|50167518|FG000|Overall Study|Lost to Follow-up|0|||
25063088|NCT02867995|50167519|FG001|Overall Study|Lost to Follow-up|2|||
25063089|NCT03392883|50167532|FG000|Overall Study|Lost to Follow-up|122|||
25063090|NCT03392883|50167533|FG001|Overall Study|Lost to Follow-up|13|||
25063091|NCT03392883|50167534|FG002|Overall Study|Lost to Follow-up|9|||
25063092|NCT03392883|50167532|FG000|Overall Study|Death|4|||
25063093|NCT03392883|50167533|FG001|Overall Study|Death|0|||
25063094|NCT03392883|50167534|FG002|Overall Study|Death|0|||
25063095|NCT03392883|50167532|FG000|Overall Study|Lack of Efficacy|29|||
25063096|NCT03392883|50167533|FG001|Overall Study|Lack of Efficacy|0|||
25063097|NCT03392883|50167534|FG002|Overall Study|Lack of Efficacy|0|||
25063098|NCT03392883|50167532|FG000|Overall Study|Withdrawal by Subject|180|||
25063099|NCT03392883|50167533|FG001|Overall Study|Withdrawal by Subject|0|||
25063100|NCT03392883|50167534|FG002|Overall Study|Withdrawal by Subject|0|||
25063101|NCT03392883|50167532|FG000|Overall Study|Adverse Event|1|||
25063102|NCT03392883|50167533|FG001|Overall Study|Adverse Event|0|||
25063103|NCT03392883|50167534|FG002|Overall Study|Adverse Event|0|||
25063104|NCT02748863|50167545|FG000|Treatment Period 1|Adverse Event|0|||
25063105|NCT02748863|50167546|FG001|Treatment Period 1|Adverse Event|1|||
25063106|NCT02748863|50167547|FG002|Treatment Period 1|Adverse Event|0|||
25063107|NCT02748863|50167548|FG003|Treatment Period 1|Adverse Event|0|||
25063108|NCT02748863|50167549|FG004|Treatment Period 1|Adverse Event|0|||
25063109|NCT02748863|50167545|FG000|Treatment Period 1|Lack of Efficacy|0|||
25063110|NCT02748863|50167546|FG001|Treatment Period 1|Lack of Efficacy|0|||
25063111|NCT02748863|50167547|FG002|Treatment Period 1|Lack of Efficacy|1|||
25063112|NCT02748863|50167548|FG003|Treatment Period 1|Lack of Efficacy|0|||
25063113|NCT02748863|50167549|FG004|Treatment Period 1|Lack of Efficacy|0|||
25063114|NCT02748863|50167545|FG000|Treatment Period 1|Withdrawal by Subject|0|||
25063115|NCT02748863|50167546|FG001|Treatment Period 1|Withdrawal by Subject|1|||
25162846|NCT01967225|50285207|FG000|Overall Study|Logistical difficulties|1|||
25162847|NCT01967225|50285208|FG001|Overall Study|Logistical difficulties|0|||
25063116|NCT02748863|50167547|FG002|Treatment Period 1|Withdrawal by Subject|1|||
25063117|NCT02748863|50167548|FG003|Treatment Period 1|Withdrawal by Subject|0|||
25063118|NCT02748863|50167549|FG004|Treatment Period 1|Withdrawal by Subject|0|||
25063119|NCT02748863|50167545|FG000|Treatment Period 2|Lost to Follow-up|2|||
25063120|NCT02748863|50167546|FG001|Treatment Period 2|Lost to Follow-up|0|||
25063121|NCT02748863|50167547|FG002|Treatment Period 2|Lost to Follow-up|0|||
25063122|NCT02748863|50167548|FG003|Treatment Period 2|Lost to Follow-up|0|||
25063123|NCT02748863|50167549|FG004|Treatment Period 2|Lost to Follow-up|0|||
25162848|NCT01967225|50285207|FG000|Overall Study|Protocol Violation|2|||
25063124|NCT02748863|50167545|FG000|Treatment Period 2|Adverse Event|3|||
25063125|NCT02748863|50167546|FG001|Treatment Period 2|Adverse Event|2|||
25063126|NCT02748863|50167547|FG002|Treatment Period 2|Adverse Event|0|||
25063127|NCT02748863|50167548|FG003|Treatment Period 2|Adverse Event|2|||
25063128|NCT02748863|50167549|FG004|Treatment Period 2|Adverse Event|0|||
25063129|NCT02748863|50167545|FG000|Treatment Period 2|Lack of Efficacy|0|||
25063130|NCT02748863|50167546|FG001|Treatment Period 2|Lack of Efficacy|1|||
25063131|NCT02748863|50167547|FG002|Treatment Period 2|Lack of Efficacy|0|||
25063132|NCT02748863|50167548|FG003|Treatment Period 2|Lack of Efficacy|0|||
25063133|NCT02748863|50167549|FG004|Treatment Period 2|Lack of Efficacy|0|||
25063134|NCT02748863|50167545|FG000|Treatment Period 2|Pregnancy|0|||
25063135|NCT02748863|50167546|FG001|Treatment Period 2|Pregnancy|0|||
25063136|NCT02748863|50167547|FG002|Treatment Period 2|Pregnancy|0|||
25063137|NCT02748863|50167548|FG003|Treatment Period 2|Pregnancy|0|||
25063138|NCT02748863|50167549|FG004|Treatment Period 2|Pregnancy|1|||
25063139|NCT02865499|50167570|FG000|Baseline|Adverse Event|1|||
25063140|NCT02865499|50167570|FG000|Baseline|Withdrawal by Subject|1|||
25063141|NCT02870933|50167576|FG000|Overall Study|Death|2|||
25063142|NCT02870933|50167577|FG001|Overall Study|Death|1|||
25063143|NCT02870933|50167576|FG000|Overall Study|Withdrawal by Subject|0|||
25063144|NCT02870933|50167577|FG001|Overall Study|Withdrawal by Subject|1|||
25063145|NCT02864407|50167584|FG000|Overall Study|Protocol Violation|3|||
25063146|NCT02864407|50167584|FG000|Overall Study|Lost to Follow-up|115|||
25063147|NCT02864407|50167584|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
25063148|NCT02864407|50167584|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
25063149|NCT02864407|50167584|FG000|Overall Study|Consent prior to the contract date|1|||
25063150|NCT02873429|50167590|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
25063151|NCT02873429|50167591|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
25063152|NCT02873429|50167590|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
25063153|NCT02873429|50167591|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
25063154|NCT02873429|50167590|FG000|16 Weeks|Lost to Follow-up|3|||
25276684|NCT01072539|50590624|FG000|Overall Study|Treated prior to the Site Initiation|1|||
25276685|NCT01072539|50590624|FG000|Overall Study|Protocol Violation|2|||
25276686|NCT01239680|50590630|FG000|Overall Study|Withdrawal by Subject|2|||
25276687|NCT01239680|50590631|FG001|Overall Study|Withdrawal by Subject|0|||
25276688|NCT01238900|50590637|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
25276689|NCT01238900|50590637|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
25276690|NCT01238822|50590642|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
25276691|NCT01238588|50590652|FG000|Overall Study|Withdrawal by Subject|1|||
25276692|NCT01238588|50590652|FG000|Overall Study|Physician Decision|2|||
25276693|NCT01047501|50590659|FG000|Overall Study|Adverse Event|7|||
25276694|NCT01047501|50590660|FG001|Overall Study|Adverse Event|8|||
25276695|NCT01047501|50590661|FG002|Overall Study|Adverse Event|5|||
25276696|NCT01047501|50590659|FG000|Overall Study|Withdrew Consent|6|||
25276697|NCT01047501|50590660|FG001|Overall Study|Withdrew Consent|2|||
25276698|NCT01047501|50590661|FG002|Overall Study|Withdrew Consent|4|||
25276699|NCT01047501|50590659|FG000|Overall Study|Lost to Follow-up|0|||
25276700|NCT01047501|50590660|FG001|Overall Study|Lost to Follow-up|1|||
25276701|NCT01047501|50590661|FG002|Overall Study|Lost to Follow-up|1|||
25276702|NCT01047501|50590659|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
25276703|NCT01047501|50590660|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
25276704|NCT01047501|50590661|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
25276705|NCT01047501|50590659|FG000|Overall Study|Death|1|||
25276706|NCT01047501|50590660|FG001|Overall Study|Death|0|||
25276707|NCT01047501|50590661|FG002|Overall Study|Death|0|||
25276708|NCT01047501|50590659|FG000|Overall Study|Other discontinuation|1|||
25276709|NCT01047501|50590660|FG001|Overall Study|Other discontinuation|0|||
25276710|NCT01047501|50590661|FG002|Overall Study|Other discontinuation|1|||
25276711|NCT01047501|50590659|FG000|Overall Study|Investigator judgement|0|||
25063155|NCT02873429|50167591|FG001|16 Weeks|Lost to Follow-up|0|||
25063156|NCT02486302|50167597|FG000|Overall Study|Discontinued prematurely|410|||
25063157|NCT02486302|50167597|FG000|Overall Study|Documentation not completed|255|||
25063158|NCT02486302|50167597|FG000|Overall Study|Excluded due to legal reasons|8|||
25063159|NCT02486302|50167597|FG000|Overall Study|Not treated|3|||
25162849|NCT01967225|50285208|FG001|Overall Study|Protocol Violation|0|||
25276712|NCT01047501|50590660|FG001|Overall Study|Investigator judgement|0|||
25276713|NCT01047501|50590661|FG002|Overall Study|Investigator judgement|1|||
25276714|NCT01238120|50590673|FG000|Overall Study|Withdrawal by Subject|4|||
25063160|NCT02747875|50167612|FG000|Overall Study|Physician Decision|1|||
25063161|NCT02747875|50167613|FG001|Overall Study|Physician Decision|0|||
25063162|NCT02747875|50167612|FG000|Overall Study|Adverse Event|0|||
25063163|NCT02747875|50167613|FG001|Overall Study|Adverse Event|1|||
25063164|NCT02451124|50167639|FG000|Overall Study|Withdrawal by Subject|1|||
25063165|NCT02450578|50167651|FG000|Overall Study|ECG abnormality so not treated|1|||
25063166|NCT02450578|50167652|FG001|Overall Study|ECG abnormality so not treated|0|||
25063167|NCT02450578|50167653|FG002|Overall Study|ECG abnormality so not treated|0|||
25276715|NCT01238120|50590674|FG001|Overall Study|Withdrawal by Subject|1|||
25063168|NCT02450578|50167654|FG003|Overall Study|ECG abnormality so not treated|0|||
25063169|NCT02449018|50167681|FG000|Overall Study|Abnormal laboratory value|0|||
25063170|NCT02449018|50167682|FG001|Overall Study|Abnormal laboratory value|1|||
25063171|NCT02449018|50167681|FG000|Overall Study|Administrative problems|1|||
25063172|NCT02449018|50167682|FG001|Overall Study|Administrative problems|0|||
25063173|NCT02449018|50167681|FG000|Overall Study|Adverse Event|5|||
25063174|NCT02449018|50167682|FG001|Overall Study|Adverse Event|1|||
25063175|NCT02449018|50167681|FG000|Overall Study|Protocol deviation|4|||
25063176|NCT02449018|50167682|FG001|Overall Study|Protocol deviation|0|||
25063177|NCT02449018|50167681|FG000|Overall Study|Patient decision|2|||
25063178|NCT02449018|50167682|FG001|Overall Study|Patient decision|0|||
25063179|NCT02859415|50167690|FG000|Overall Study|Physician Decision|1|||
25063180|NCT02859415|50167691|FG001|Overall Study|Physician Decision|0|||
25063181|NCT02859415|50167690|FG000|Overall Study|Off treatment due to cardiac event|0|||
25063182|NCT02859415|50167691|FG001|Overall Study|Off treatment due to cardiac event|1|||
25063183|NCT02871791|50167701|FG000|Phase 1b|Death|0|||
25063184|NCT02871791|50167702|FG001|Phase 1b|Death|1|||
25063185|NCT02871791|50167701|FG000|Phase 1b|progressive disease|6|||
25063186|NCT02871791|50167702|FG001|Phase 1b|progressive disease|2|||
25063187|NCT02871791|50167701|FG000|Phase 2|Death|1|||
25063188|NCT02871791|50167702|FG001|Phase 2|Death|0|||
25063189|NCT02871791|50167701|FG000|Phase 2|Lost to Follow-up|2|||
25063190|NCT02871791|50167702|FG001|Phase 2|Lost to Follow-up|0|||
25063191|NCT02871635|50167710|FG000|Overall Study|Primary lack of efficacy|4|||
25063192|NCT02871635|50167711|FG001|Overall Study|Primary lack of efficacy|4|||
25063193|NCT02871635|50167710|FG000|Overall Study|Protocol Violation|3|||
25063194|NCT02871635|50167711|FG001|Overall Study|Protocol Violation|1|||
25063195|NCT02871635|50167710|FG000|Overall Study|Lost to Follow-up|1|||
25063196|NCT02871635|50167711|FG001|Overall Study|Lost to Follow-up|2|||
25063197|NCT02871635|50167710|FG000|Overall Study|Pregnancy|0|||
25063198|NCT02871635|50167711|FG001|Overall Study|Pregnancy|2|||
25063199|NCT02871635|50167710|FG000|Overall Study|Physician Decision|1|||
25063200|NCT02871635|50167711|FG001|Overall Study|Physician Decision|1|||
25063201|NCT02871635|50167710|FG000|Overall Study|Withdrawal by Subject|3|||
25063202|NCT02871635|50167711|FG001|Overall Study|Withdrawal by Subject|4|||
25063203|NCT02871635|50167710|FG000|Overall Study|Adverse Event|4|||
25063204|NCT02871635|50167711|FG001|Overall Study|Adverse Event|4|||
25063205|NCT02871635|50167710|FG000|Overall Study|Secondary lack of efficacy|2|||
25063206|NCT02871635|50167711|FG001|Overall Study|Secondary lack of efficacy|1|||
25063207|NCT02477332|50167725|FG000|Overall Study|Adverse Event|0|||
25063208|NCT02477332|50167726|FG001|Overall Study|Adverse Event|1|||
25063209|NCT02477332|50167727|FG002|Overall Study|Adverse Event|1|||
25063210|NCT02477332|50167728|FG003|Overall Study|Adverse Event|2|||
25063211|NCT02477332|50167729|FG004|Overall Study|Adverse Event|1|||
25063212|NCT02477332|50167730|FG005|Overall Study|Adverse Event|2|||
25063213|NCT02477332|50167725|FG000|Overall Study|Lack of Efficacy|1|||
25063214|NCT02477332|50167726|FG001|Overall Study|Lack of Efficacy|2|||
25063215|NCT02477332|50167727|FG002|Overall Study|Lack of Efficacy|1|||
25063216|NCT02477332|50167728|FG003|Overall Study|Lack of Efficacy|2|||
25063217|NCT02477332|50167729|FG004|Overall Study|Lack of Efficacy|1|||
25063218|NCT02477332|50167730|FG005|Overall Study|Lack of Efficacy|1|||
25063219|NCT02477332|50167725|FG000|Overall Study|Non-compliance with study treatment|0|||
25063220|NCT02477332|50167726|FG001|Overall Study|Non-compliance with study treatment|1|||
25063221|NCT02477332|50167727|FG002|Overall Study|Non-compliance with study treatment|2|||
25063222|NCT02477332|50167728|FG003|Overall Study|Non-compliance with study treatment|0|||
25063223|NCT02477332|50167729|FG004|Overall Study|Non-compliance with study treatment|0|||
25063224|NCT02477332|50167730|FG005|Overall Study|Non-compliance with study treatment|0|||
25063225|NCT02477332|50167725|FG000|Overall Study|Pregnancy|0|||
25063226|NCT02477332|50167726|FG001|Overall Study|Pregnancy|0|||
25063227|NCT02477332|50167727|FG002|Overall Study|Pregnancy|0|||
25063228|NCT02477332|50167728|FG003|Overall Study|Pregnancy|1|||
25063229|NCT02477332|50167729|FG004|Overall Study|Pregnancy|0|||
25063230|NCT02477332|50167730|FG005|Overall Study|Pregnancy|0|||
25276716|NCT01238120|50590675|FG002|Overall Study|Withdrawal by Subject|2|||
25276717|NCT01238120|50590676|FG003|Overall Study|Withdrawal by Subject|5|||
25063231|NCT02477332|50167725|FG000|Overall Study|Protocol Violation|2|||
25063232|NCT02477332|50167726|FG001|Overall Study|Protocol Violation|0|||
25063233|NCT02477332|50167727|FG002|Overall Study|Protocol Violation|3|||
25063234|NCT02477332|50167728|FG003|Overall Study|Protocol Violation|3|||
25276718|NCT01238120|50590673|FG000|Overall Study|Lost to Follow-up|2|||
25063235|NCT02477332|50167729|FG004|Overall Study|Protocol Violation|1|||
25063236|NCT02477332|50167730|FG005|Overall Study|Protocol Violation|1|||
25063237|NCT02477332|50167725|FG000|Overall Study|Technical problems|0|||
25063238|NCT02477332|50167726|FG001|Overall Study|Technical problems|0|||
25063239|NCT02477332|50167727|FG002|Overall Study|Technical problems|1|||
25063240|NCT02477332|50167728|FG003|Overall Study|Technical problems|0|||
25063241|NCT02477332|50167729|FG004|Overall Study|Technical problems|0|||
25063242|NCT02477332|50167730|FG005|Overall Study|Technical problems|0|||
25063243|NCT02477332|50167725|FG000|Overall Study|Lost to Follow-up|0|||
25063244|NCT02477332|50167726|FG001|Overall Study|Lost to Follow-up|0|||
25063245|NCT02477332|50167727|FG002|Overall Study|Lost to Follow-up|2|||
24964056|NCT00006916|50054009|FG000|Overall Study|Complication of device insertion|1|||
24964057|NCT00454649|50054023|FG000|Overall Study|Lack of Efficacy|2|||
24964058|NCT00454649|50054024|FG001|Overall Study|Lack of Efficacy|2|||
24964059|NCT00454649|50054025|FG002|Overall Study|Lack of Efficacy|10|||
24964060|NCT00454649|50054026|FG003|Overall Study|Lack of Efficacy|3|||
24964061|NCT00454649|50054027|FG004|Overall Study|Lack of Efficacy|0|||
24964062|NCT00454649|50054028|FG005|Overall Study|Lack of Efficacy|4|||
24964063|NCT00454649|50054029|FG006|Overall Study|Lack of Efficacy|5|||
24964064|NCT00454649|50054030|FG007|Overall Study|Lack of Efficacy|13|||
24964065|NCT00454649|50054031|FG008|Overall Study|Lack of Efficacy|10|||
24964066|NCT00454649|50054032|FG009|Overall Study|Lack of Efficacy|2|||
24964067|NCT00454649|50054023|FG000|Overall Study|Adverse Event|0|||
24964068|NCT00454649|50054024|FG001|Overall Study|Adverse Event|1|||
24964069|NCT00454649|50054025|FG002|Overall Study|Adverse Event|3|||
24964070|NCT00454649|50054026|FG003|Overall Study|Adverse Event|0|||
24964071|NCT00454649|50054027|FG004|Overall Study|Adverse Event|1|||
24964072|NCT00454649|50054028|FG005|Overall Study|Adverse Event|2|||
24964073|NCT00454649|50054029|FG006|Overall Study|Adverse Event|3|||
24964074|NCT00454649|50054030|FG007|Overall Study|Adverse Event|4|||
24964075|NCT00454649|50054031|FG008|Overall Study|Adverse Event|6|||
24964076|NCT00454649|50054032|FG009|Overall Study|Adverse Event|2|||
24964077|NCT00454649|50054023|FG000|Overall Study|Lost to Follow-up|0|||
24964078|NCT00454649|50054024|FG001|Overall Study|Lost to Follow-up|0|||
24964079|NCT00454649|50054025|FG002|Overall Study|Lost to Follow-up|1|||
24964080|NCT00454649|50054026|FG003|Overall Study|Lost to Follow-up|0|||
24964081|NCT00454649|50054027|FG004|Overall Study|Lost to Follow-up|0|||
24964082|NCT00454649|50054028|FG005|Overall Study|Lost to Follow-up|0|||
24964083|NCT00454649|50054029|FG006|Overall Study|Lost to Follow-up|1|||
24964084|NCT00454649|50054030|FG007|Overall Study|Lost to Follow-up|0|||
24964085|NCT00454649|50054031|FG008|Overall Study|Lost to Follow-up|0|||
24964086|NCT00454649|50054032|FG009|Overall Study|Lost to Follow-up|0|||
24964087|NCT00454649|50054023|FG000|Overall Study|Other|1|||
24964088|NCT00454649|50054024|FG001|Overall Study|Other|1|||
24964089|NCT00454649|50054025|FG002|Overall Study|Other|5|||
24964090|NCT00454649|50054026|FG003|Overall Study|Other|3|||
24964091|NCT00454649|50054027|FG004|Overall Study|Other|0|||
24964092|NCT00454649|50054028|FG005|Overall Study|Other|0|||
24964093|NCT00454649|50054029|FG006|Overall Study|Other|0|||
24964094|NCT00454649|50054030|FG007|Overall Study|Other|0|||
24964095|NCT00454649|50054031|FG008|Overall Study|Other|3|||
24964096|NCT00454649|50054032|FG009|Overall Study|Other|1|||
24964097|NCT00454649|50054023|FG000|Overall Study|Withdrawal by Subject|0|||
24964098|NCT00454649|50054024|FG001|Overall Study|Withdrawal by Subject|0|||
24964099|NCT00454649|50054025|FG002|Overall Study|Withdrawal by Subject|0|||
24964100|NCT00454649|50054026|FG003|Overall Study|Withdrawal by Subject|0|||
24964101|NCT00454649|50054027|FG004|Overall Study|Withdrawal by Subject|0|||
24964102|NCT00454649|50054028|FG005|Overall Study|Withdrawal by Subject|1|||
24964103|NCT00454649|50054029|FG006|Overall Study|Withdrawal by Subject|0|||
24964104|NCT00454649|50054030|FG007|Overall Study|Withdrawal by Subject|2|||
24964105|NCT00454649|50054031|FG008|Overall Study|Withdrawal by Subject|1|||
24964106|NCT00454649|50054032|FG009|Overall Study|Withdrawal by Subject|0|||
24964107|NCT00454571|50054075|FG000|Overall Study|Adverse Event|2|||
24964108|NCT00454571|50054076|FG001|Overall Study|Adverse Event|0|||
24964109|NCT00454571|50054075|FG000|Overall Study|Physician Decision|0|||
24964110|NCT00454571|50054076|FG001|Overall Study|Physician Decision|1|||
24964111|NCT00454571|50054075|FG000|Overall Study|Protocol Violation|1|||
25063246|NCT02477332|50167728|FG003|Overall Study|Lost to Follow-up|0|||
25276719|NCT01238120|50590674|FG001|Overall Study|Lost to Follow-up|0|||
24964112|NCT00454571|50054076|FG001|Overall Study|Protocol Violation|0|||
24964113|NCT00454571|50054075|FG000|Overall Study|Withdrawal by Subject|10|||
24964114|NCT00454571|50054076|FG001|Overall Study|Withdrawal by Subject|5|||
24964115|NCT03837743|50054082|FG000|Overall Study|Adverse Event|1|||
24964116|NCT03837743|50054082|FG000|Overall Study|Withdrawal by Subject|2|||
24964117|NCT03836729|50054090|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
24964118|NCT00443729|50054100|FG000|Overall Study|Never Treated|0|||
24964119|NCT00443729|50054101|FG001|Overall Study|Never Treated|1|||
25063247|NCT02477332|50167729|FG004|Overall Study|Lost to Follow-up|0|||
24964120|NCT00443729|50054100|FG000|Overall Study|Lack of Efficacy|4|||
25063248|NCT02477332|50167730|FG005|Overall Study|Lost to Follow-up|0|||
25063249|NCT02477332|50167725|FG000|Overall Study|Physician Decision|0|||
25063250|NCT02477332|50167726|FG001|Overall Study|Physician Decision|0|||
25063251|NCT02477332|50167727|FG002|Overall Study|Physician Decision|1|||
25063252|NCT02477332|50167728|FG003|Overall Study|Physician Decision|3|||
25063253|NCT02477332|50167729|FG004|Overall Study|Physician Decision|0|||
25063254|NCT02477332|50167730|FG005|Overall Study|Physician Decision|1|||
25063255|NCT02477332|50167725|FG000|Overall Study|Withdrawal by Subject|0|||
25063256|NCT02477332|50167726|FG001|Overall Study|Withdrawal by Subject|3|||
25063257|NCT02477332|50167727|FG002|Overall Study|Withdrawal by Subject|1|||
25063258|NCT02477332|50167728|FG003|Overall Study|Withdrawal by Subject|2|||
25063259|NCT02477332|50167729|FG004|Overall Study|Withdrawal by Subject|1|||
25063260|NCT02477332|50167730|FG005|Overall Study|Withdrawal by Subject|0|||
25063261|NCT02477020|50167748|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
25063262|NCT02477020|50167749|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
25063263|NCT02477020|50167748|FG000|Overall Study|Voluntary Withdrawal|7|||
25063264|NCT02477020|50167749|FG001|Overall Study|Voluntary Withdrawal|16|||
25063265|NCT02477020|50167748|FG000|Overall Study|Reason not Specified|3|||
25063266|NCT02477020|50167749|FG001|Overall Study|Reason not Specified|1|||
25063267|NCT02477020|50167748|FG000|Overall Study|Lack of Efficacy|14|||
25063268|NCT02477020|50167749|FG001|Overall Study|Lack of Efficacy|5|||
25063269|NCT02862535|50167759|FG000|Overall Study|Death|7|||
25063270|NCT02862535|50167760|FG001|Overall Study|Death|3|||
25063271|NCT02862535|50167761|FG002|Overall Study|Death|2|||
25063272|NCT02862535|50167762|FG003|Overall Study|Death|5|||
25063273|NCT02862535|50167759|FG000|Overall Study|Study Terminated by Sponsor|1|||
25063274|NCT02862535|50167760|FG001|Overall Study|Study Terminated by Sponsor|3|||
25063275|NCT02862535|50167761|FG002|Overall Study|Study Terminated by Sponsor|8|||
25063276|NCT02862535|50167762|FG003|Overall Study|Study Terminated by Sponsor|5|||
25063277|NCT02862535|50167759|FG000|Overall Study|Enrolled, not Treated|1|||
25063278|NCT02862535|50167760|FG001|Overall Study|Enrolled, not Treated|0|||
25063279|NCT02862535|50167761|FG002|Overall Study|Enrolled, not Treated|0|||
25063280|NCT02862535|50167762|FG003|Overall Study|Enrolled, not Treated|1|||
25063281|NCT02448706|50167772|FG000|Overall Study|Withdrawal by Subject|4|||
25063282|NCT02448706|50167773|FG001|Overall Study|Withdrawal by Subject|3|||
25063283|NCT02448706|50167772|FG000|Overall Study|Protocol Violation|1|||
25063284|NCT02448706|50167773|FG001|Overall Study|Protocol Violation|1|||
25063285|NCT02868281|50167783|FG000|Overall Study|Adverse Event|2|||
25063286|NCT02868281|50167784|FG001|Overall Study|Adverse Event|2|||
25063287|NCT02868281|50167783|FG000|Overall Study|Protocol Violation|13|||
25063288|NCT02868281|50167784|FG001|Overall Study|Protocol Violation|10|||
25063289|NCT02868281|50167783|FG000|Overall Study|Lost to Follow-up|3|||
25063290|NCT02868281|50167784|FG001|Overall Study|Lost to Follow-up|6|||
25063291|NCT02868281|50167783|FG000|Overall Study|Withdrawal by Subject|11|||
25063292|NCT02868281|50167784|FG001|Overall Study|Withdrawal by Subject|15|||
25063293|NCT02868281|50167783|FG000|Overall Study|Physician Decision|2|||
25063294|NCT02868281|50167784|FG001|Overall Study|Physician Decision|0|||
25063295|NCT02868281|50167783|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
25063296|NCT02868281|50167784|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
25063297|NCT02868281|50167783|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
25063298|NCT02868281|50167784|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
25063299|NCT02868281|50167783|FG000|Overall Study|Long journey/moving away|1|||
25063300|NCT02868281|50167784|FG001|Overall Study|Long journey/moving away|1|||
25063301|NCT02476006|50167790|FG000|Overall Study|Death|4|||
25063302|NCT02476006|50167790|FG000|Overall Study|Lack of treatment efficacy|2|||
25063303|NCT02476006|50167790|FG000|Overall Study|Pregnancy|1|||
25063304|NCT02476006|50167790|FG000|Overall Study|Participant did not wish to continue|39|||
25063305|NCT02476006|50167790|FG000|Overall Study|Adverse Event|41|||
25063306|NCT02476006|50167790|FG000|Overall Study|Poor compliance to study protocol|3|||
25063307|NCT02476006|50167790|FG000|Overall Study|Sponsor decision|6|||
25063308|NCT02476006|50167790|FG000|Overall Study|Lost to Follow-up|5|||
25063309|NCT02476006|50167790|FG000|Overall Study|Physician Decision|5|||
25063310|NCT02476006|50167790|FG000|Overall Study|Study ended treatment not available|4|||
25063311|NCT02476006|50167790|FG000|Overall Study|Switched to commercial drug|4|||
25063312|NCT02476006|50167790|FG000|Overall Study|Excluded from study|1|||
25063313|NCT02476006|50167790|FG000|Overall Study|Protocol Violation|1|||
25063314|NCT02476006|50167790|FG000|Overall Study|Enrolled but not treated|4|||
25063315|NCT02475850|50167796|FG000|Overall Study|Death|155|||
25063316|NCT02475850|50167797|FG001|Overall Study|Death|141|||
25063317|NCT02475850|50167796|FG000|Overall Study|Lost to Follow-up|217|||
25063318|NCT02475850|50167797|FG001|Overall Study|Lost to Follow-up|188|||
25063319|NCT02475850|50167796|FG000|Overall Study|Withdrawal by Subject|221|||
25063320|NCT02475850|50167797|FG001|Overall Study|Withdrawal by Subject|155|||
25063321|NCT02419612|50167806|FG000|Short-term Treatment Period|Adverse Event|1|||
25063322|NCT02419612|50167807|FG001|Short-term Treatment Period|Adverse Event|1|||
25186638|NCT01394939|50337294|FG002|Overall Study|Death|0|||
25063323|NCT02419612|50167806|FG000|Short-term Treatment Period|Death|0|||
25186639|NCT01394939|50337295|FG003|Overall Study|Death|0|||
25063324|NCT02419612|50167807|FG001|Short-term Treatment Period|Death|2|||
25063325|NCT02419612|50167806|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
25063326|NCT02419612|50167807|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
25063327|NCT02419612|50167806|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
25063328|NCT02419612|50167807|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
25063329|NCT02419612|50167806|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
25063330|NCT02419612|50167807|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
25063331|NCT02419612|50167806|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
25063332|NCT02419612|50167807|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
25063333|NCT02419612|50167806|FG000|Short-term Treatment Period|Worsening of liver function|0|||
25063334|NCT02419612|50167807|FG001|Short-term Treatment Period|Worsening of liver function|1|||
25063335|NCT02419612|50167806|FG000|Short-term Treatment Period|Subject moved out of state|0|||
25063336|NCT02419612|50167807|FG001|Short-term Treatment Period|Subject moved out of state|1|||
25063337|NCT02419612|50167806|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
25063338|NCT02419612|50167807|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
25063339|NCT02419612|50167806|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
25063340|NCT02419612|50167807|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
25063341|NCT02419612|50167806|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
25063342|NCT02419612|50167807|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
25063343|NCT02419612|50167806|FG000|Long-term Treatment Period|Death|0|||
25063344|NCT02419612|50167807|FG001|Long-term Treatment Period|Death|1|||
25063345|NCT02419612|50167806|FG000|Long-term Treatment Period|Adverse Event|0|||
25063346|NCT02419612|50167807|FG001|Long-term Treatment Period|Adverse Event|5|||
25063347|NCT02419612|50167806|FG000|Long-term Treatment Period|Other|4|||
25063348|NCT02419612|50167807|FG001|Long-term Treatment Period|Other|4|||
25063349|NCT02419612|50167806|FG000|Long-term Treatment Period|Subject Decision|2|||
25063350|NCT02419612|50167807|FG001|Long-term Treatment Period|Subject Decision|4|||
25063351|NCT02419612|50167806|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
25063352|NCT02419612|50167807|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
25063353|NCT02447848|50167813|FG000|Overall Study|Patient discharged|3|||
25063354|NCT02447848|50167813|FG000|Overall Study|Lack of Efficacy|4|||
25063355|NCT02447848|50167813|FG000|Overall Study|Withdrawal by Subject|4|||
25063356|NCT02418910|50167817|FG000|Overall Study|Lost to Follow-up|3|||
25063357|NCT02418910|50167817|FG000|Overall Study|Withdrawal by Subject|4|||
25063358|NCT02418754|50167833|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
25063359|NCT02418754|50167834|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
25063360|NCT02418754|50167835|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
25063361|NCT02418754|50167836|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
25063362|NCT02418754|50167837|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
25063363|NCT02418754|50167833|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
25063364|NCT02418754|50167834|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
25063365|NCT02418754|50167835|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
25063366|NCT02418754|50167836|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
25063367|NCT02418754|50167837|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
25063368|NCT02418754|50167833|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
25063369|NCT02418754|50167834|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
25063370|NCT02418754|50167835|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
25063371|NCT02418754|50167836|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
25063372|NCT02418754|50167837|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
25063373|NCT02418754|50167833|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
25063374|NCT02418754|50167834|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
25063375|NCT02418754|50167835|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
25063376|NCT02418754|50167836|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
25063377|NCT02418754|50167837|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
25063378|NCT02418754|50167833|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
25063379|NCT02418754|50167834|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
25063380|NCT02418754|50167835|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
25063381|NCT02418754|50167836|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
25063382|NCT02418754|50167837|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
25063383|NCT02418754|50167833|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
25063384|NCT02418754|50167834|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
25063385|NCT02418754|50167835|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
25063386|NCT02418754|50167836|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
25063387|NCT02418754|50167837|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
25063388|NCT02418754|50167833|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
25063389|NCT02418754|50167834|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
25063390|NCT02418754|50167835|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
25063391|NCT02418754|50167836|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
25063392|NCT02418754|50167837|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
25063393|NCT02418754|50167833|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
25063394|NCT02418754|50167834|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
25063395|NCT02418754|50167835|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
25063396|NCT02418754|50167836|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
25063397|NCT02418754|50167837|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
25063398|NCT02418754|50167833|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
25063399|NCT02418754|50167834|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
25063400|NCT02418754|50167835|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
25063401|NCT02418754|50167836|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
25063402|NCT02418754|50167837|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
25063403|NCT02418754|50167833|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
25063404|NCT02418754|50167834|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
25063405|NCT02418754|50167835|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
25063406|NCT02418754|50167836|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
25063407|NCT02418754|50167837|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
25063408|NCT02418754|50167833|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
25063409|NCT02418754|50167834|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
25063410|NCT02418754|50167835|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
25063411|NCT02418754|50167836|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
25063412|NCT02418754|50167837|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
25063413|NCT02447458|50167853|FG000|Overall Study|Other|0|||
25063414|NCT02447458|50167854|FG001|Overall Study|Other|0|||
25063415|NCT02447458|50167855|FG002|Overall Study|Other|1|||
25063416|NCT02447458|50167856|FG003|Overall Study|Other|0|||
25063417|NCT02447458|50167857|FG004|Overall Study|Other|0|||
25063418|NCT02447458|50167858|FG005|Overall Study|Other|0|||
25063419|NCT02862457|50167884|FG000|Overall Study|Death|1|||
25063420|NCT02862457|50167885|FG001|Overall Study|Death|3|||
25063421|NCT02862457|50167886|FG002|Overall Study|Death|2|||
25063422|NCT02862457|50167887|FG003|Overall Study|Death|3|||
25063423|NCT02862457|50167888|FG004|Overall Study|Death|0|||
25063424|NCT02862457|50167889|FG005|Overall Study|Death|2|||
25063425|NCT02862457|50167890|FG006|Overall Study|Death|1|||
25063426|NCT02862457|50167884|FG000|Overall Study|Lost to Follow-up|1|||
25063427|NCT02862457|50167885|FG001|Overall Study|Lost to Follow-up|0|||
25063428|NCT02862457|50167886|FG002|Overall Study|Lost to Follow-up|0|||
25063429|NCT02862457|50167887|FG003|Overall Study|Lost to Follow-up|1|||
25063430|NCT02862457|50167888|FG004|Overall Study|Lost to Follow-up|0|||
25063431|NCT02862457|50167889|FG005|Overall Study|Lost to Follow-up|0|||
25063432|NCT02862457|50167890|FG006|Overall Study|Lost to Follow-up|0|||
25063433|NCT02862457|50167884|FG000|Overall Study|Withdrawal by Subject|0|||
25063434|NCT02862457|50167885|FG001|Overall Study|Withdrawal by Subject|0|||
25063435|NCT02862457|50167886|FG002|Overall Study|Withdrawal by Subject|1|||
25063436|NCT02862457|50167887|FG003|Overall Study|Withdrawal by Subject|0|||
25063437|NCT02862457|50167888|FG004|Overall Study|Withdrawal by Subject|0|||
25063438|NCT02862457|50167889|FG005|Overall Study|Withdrawal by Subject|1|||
25063439|NCT02862457|50167890|FG006|Overall Study|Withdrawal by Subject|0|||
25063440|NCT02447302|50167917|FG000|Overall Study|Physician Decision|1|||
25063441|NCT02447302|50167918|FG001|Overall Study|Physician Decision|0|||
25063442|NCT02447302|50167919|FG002|Overall Study|Physician Decision|0|||
25063443|NCT02447302|50167917|FG000|Overall Study|Adverse Event|4|||
25063444|NCT02447302|50167918|FG001|Overall Study|Adverse Event|3|||
25063445|NCT02447302|50167919|FG002|Overall Study|Adverse Event|0|||
25063446|NCT02447302|50167917|FG000|Overall Study|Withdrawal by Subject|0|||
25063447|NCT02447302|50167918|FG001|Overall Study|Withdrawal by Subject|1|||
25063448|NCT02447302|50167919|FG002|Overall Study|Withdrawal by Subject|5|||
25063449|NCT02447302|50167917|FG000|Overall Study|Sponsor Decision|0|||
25063450|NCT02447302|50167918|FG001|Overall Study|Sponsor Decision|0|||
25063451|NCT02447302|50167919|FG002|Overall Study|Sponsor Decision|1|||
25063452|NCT02454517|50167929|FG000|Overall Study|Withdrawal by Subject|3|||
25063453|NCT02454517|50167930|FG001|Overall Study|Withdrawal by Subject|0|||
25063454|NCT02454517|50167929|FG000|Overall Study|Lost to Follow-up|4|||
25063455|NCT02454517|50167930|FG001|Overall Study|Lost to Follow-up|7|||
25063456|NCT02454517|50167929|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
25063457|NCT02454517|50167930|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
25063458|NCT03861039|50167941|FG000|Overall Study|Adverse Event|2|||
25063459|NCT03861039|50167942|FG001|Overall Study|Adverse Event|5|||
25063460|NCT03861039|50167943|FG002|Overall Study|Adverse Event|11|||
25063461|NCT03861039|50167941|FG000|Overall Study|Withdrawal by Subject|1|||
25063462|NCT03861039|50167942|FG001|Overall Study|Withdrawal by Subject|3|||
25063463|NCT03861039|50167943|FG002|Overall Study|Withdrawal by Subject|4|||
25063464|NCT02731755|50167953|FG000|First Intervention|Withdrawal by Subject|0|||
25063465|NCT02731755|50167954|FG001|First Intervention|Withdrawal by Subject|2|||
25063466|NCT02866175|50167983|FG000|Overall Study|Adverse Event|56|||
25063467|NCT02866175|50167984|FG001|Overall Study|Adverse Event|54|||
25063468|NCT02866175|50167983|FG000|Overall Study|Withdrawal by Subject|31|||
25063469|NCT02866175|50167984|FG001|Overall Study|Withdrawal by Subject|52|||
25063470|NCT02866175|50167983|FG000|Overall Study|Death|30|||
25063471|NCT02866175|50167984|FG001|Overall Study|Death|23|||
25063472|NCT02866175|50167983|FG000|Overall Study|Other|7|||
25063473|NCT02866175|50167984|FG001|Overall Study|Other|14|||
25063474|NCT02866175|50167983|FG000|Overall Study|Progressive disease|1|||
25063475|NCT02866175|50167984|FG001|Overall Study|Progressive disease|1|||
25063476|NCT02866175|50167983|FG000|Overall Study|Lost to Follow-up|2|||
25063477|NCT02866175|50167984|FG001|Overall Study|Lost to Follow-up|0|||
25063478|NCT02866175|50167983|FG000|Overall Study|Lack of Efficacy|0|||
25063479|NCT02866175|50167984|FG001|Overall Study|Lack of Efficacy|1|||
25063480|NCT02866175|50167983|FG000|Overall Study|Physician Decision|3|||
25063481|NCT02866175|50167984|FG001|Overall Study|Physician Decision|15|||
25063482|NCT02866175|50167983|FG000|Overall Study|Did not receive treatment|5|||
25063483|NCT02866175|50167984|FG001|Overall Study|Did not receive treatment|15|||
25063484|NCT01336205|50167997|FG000|Overall Study|Other|22|||
25063485|NCT01336205|50167998|FG001|Overall Study|Other|9|||
25063486|NCT01336205|50167997|FG000|Overall Study|Lost to Follow-up|40|||
25063487|NCT01336205|50167998|FG001|Overall Study|Lost to Follow-up|20|||
25063488|NCT01336205|50167997|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
25063489|NCT01336205|50167998|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
25063490|NCT01336205|50167997|FG000|Overall Study|Lack of Efficacy|4|||
25063491|NCT01336205|50167998|FG001|Overall Study|Lack of Efficacy|0|||
25063492|NCT01336205|50167997|FG000|Overall Study|Severe noncompliance with protocol|9|||
25063493|NCT01336205|50167998|FG001|Overall Study|Severe noncompliance with protocol|2|||
25063494|NCT01336205|50167997|FG000|Overall Study|Adverse Event|56|||
25063495|NCT01336205|50167998|FG001|Overall Study|Adverse Event|6|||
25063496|NCT01336205|50167997|FG000|Overall Study|Death|1|||
25063497|NCT01336205|50167998|FG001|Overall Study|Death|1|||
25063498|NCT01336205|50167997|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
25063499|NCT01336205|50167998|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
25063500|NCT01336205|50167997|FG000|Overall Study|Withdrawal by Subject|72|||
25063501|NCT01336205|50167998|FG001|Overall Study|Withdrawal by Subject|38|||
25063502|NCT01336205|50167997|FG000|Overall Study|Did not receive treatment|4|||
25063503|NCT01336205|50167998|FG001|Overall Study|Did not receive treatment|0|||
25063504|NCT02865395|50168007|FG000|Overall Study|Physician Decision|6|||
25063505|NCT02865395|50168008|FG001|Overall Study|Physician Decision|10|||
25063506|NCT02865395|50168009|FG002|Overall Study|Physician Decision|7|||
25063507|NCT01123707|50168021|FG000|Overall Study|Lost to Follow-up|3|||
25063508|NCT01123707|50168022|FG001|Overall Study|Lost to Follow-up|1|||
25063509|NCT01123707|50168023|FG002|Overall Study|Lost to Follow-up|3|||
25063510|NCT01123707|50168024|FG003|Overall Study|Lost to Follow-up|2|||
25063511|NCT01123707|50168021|FG000|Overall Study|Adverse Event|5|||
25063512|NCT01123707|50168022|FG001|Overall Study|Adverse Event|7|||
25063513|NCT01123707|50168023|FG002|Overall Study|Adverse Event|5|||
25063514|NCT01123707|50168024|FG003|Overall Study|Adverse Event|3|||
25063515|NCT01123707|50168021|FG000|Overall Study|Sponsor Discontinued Study|30|||
25063516|NCT01123707|50168022|FG001|Overall Study|Sponsor Discontinued Study|24|||
25063517|NCT01123707|50168023|FG002|Overall Study|Sponsor Discontinued Study|25|||
25063518|NCT01123707|50168024|FG003|Overall Study|Sponsor Discontinued Study|40|||
25063519|NCT01123707|50168021|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
25063520|NCT01123707|50168022|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
25063521|NCT01123707|50168023|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
25063522|NCT01123707|50168024|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
25063523|NCT01123707|50168021|FG000|Overall Study|Investigator Withdrew Participant|0|||
25063524|NCT01123707|50168022|FG001|Overall Study|Investigator Withdrew Participant|1|||
25063525|NCT01123707|50168023|FG002|Overall Study|Investigator Withdrew Participant|1|||
25063526|NCT01123707|50168024|FG003|Overall Study|Investigator Withdrew Participant|1|||
25063527|NCT01123707|50168021|FG000|Overall Study|Subject Withdrew Consent|4|||
25063528|NCT01123707|50168022|FG001|Overall Study|Subject Withdrew Consent|5|||
25063529|NCT01123707|50168023|FG002|Overall Study|Subject Withdrew Consent|1|||
25063530|NCT01123707|50168024|FG003|Overall Study|Subject Withdrew Consent|2|||
25063531|NCT01123707|50168021|FG000|Overall Study|Lack of Efficacy|1|||
25063532|NCT01123707|50168022|FG001|Overall Study|Lack of Efficacy|2|||
25063533|NCT01123707|50168023|FG002|Overall Study|Lack of Efficacy|1|||
25063534|NCT01123707|50168024|FG003|Overall Study|Lack of Efficacy|0|||
25063535|NCT01123707|50168021|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
25063536|NCT01123707|50168022|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
25063537|NCT01123707|50168023|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
25063538|NCT01123707|50168024|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
25063539|NCT02755103|50168036|FG000|Overall Study|Lost to Follow-up|17|||
25063540|NCT02755103|50168037|FG001|Overall Study|Lost to Follow-up|15|||
25063541|NCT02755103|50168036|FG000|Overall Study|Death|0|||
25063542|NCT02755103|50168037|FG001|Overall Study|Death|1|||
25063543|NCT02755103|50168036|FG000|Overall Study|Physician Decision|0|||
25063544|NCT02755103|50168037|FG001|Overall Study|Physician Decision|1|||
25063545|NCT02755103|50168036|FG000|Overall Study|Pregnancy|0|||
25063546|NCT02755103|50168037|FG001|Overall Study|Pregnancy|1|||
25063547|NCT02755103|50168036|FG000|Overall Study|Withdrawal by Subject|3|||
25063548|NCT02755103|50168037|FG001|Overall Study|Withdrawal by Subject|0|||
25063549|NCT01258803|50168047|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
25063550|NCT01258803|50168048|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
25063551|NCT01258803|50168049|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
25063552|NCT01258803|50168050|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
25063553|NCT01258803|50168051|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
25063554|NCT01258803|50168052|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
25063555|NCT01258803|50168047|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
25063556|NCT01258803|50168048|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
25063557|NCT01258803|50168049|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
25063558|NCT01258803|50168050|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
25063559|NCT01258803|50168051|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
25063560|NCT01258803|50168052|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
25063561|NCT01258803|50168047|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
25063562|NCT01258803|50168048|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
25063563|NCT01258803|50168049|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
25063564|NCT01258803|50168050|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
25063565|NCT01258803|50168051|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
25063566|NCT01258803|50168052|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
25063567|NCT02865083|50168068|FG000|Overall Study|Early Termination|3|||
25063568|NCT02865083|50168069|FG001|Overall Study|Early Termination|1|||
25063569|NCT00862251|50168078|FG000|Overall Study|Adverse Event|8|||
25063570|NCT00862251|50168079|FG001|Overall Study|Adverse Event|3|||
25063571|NCT00862251|50168080|FG002|Overall Study|Adverse Event|1|||
25063572|NCT00862251|50168078|FG000|Overall Study|Lost to Follow-up|0|||
25063573|NCT00862251|50168079|FG001|Overall Study|Lost to Follow-up|0|||
25063574|NCT00862251|50168080|FG002|Overall Study|Lost to Follow-up|1|||
25063575|NCT00862251|50168078|FG000|Overall Study|Protocol Violation|2|||
25063576|NCT00862251|50168079|FG001|Overall Study|Protocol Violation|0|||
25063577|NCT00862251|50168080|FG002|Overall Study|Protocol Violation|1|||
25063578|NCT00862251|50168078|FG000|Overall Study|Withdrawal by Subject|9|||
25063579|NCT00862251|50168079|FG001|Overall Study|Withdrawal by Subject|2|||
25063580|NCT00862251|50168080|FG002|Overall Study|Withdrawal by Subject|6|||
25063581|NCT02864381|50168109|FG000|Overall Study|Death|58|||
25063582|NCT02864381|50168110|FG001|Overall Study|Death|61|||
25063583|NCT02864381|50168109|FG000|Overall Study|Withdrew Consent|5|||
25063584|NCT02864381|50168110|FG001|Overall Study|Withdrew Consent|6|||
25063585|NCT02864381|50168109|FG000|Overall Study|Reason Unknown|7|||
25063586|NCT02864381|50168110|FG001|Overall Study|Reason Unknown|3|||
25063587|NCT02864381|50168109|FG000|Overall Study|Lost to Follow-up|1|||
25063588|NCT02864381|50168110|FG001|Overall Study|Lost to Follow-up|1|||
25063589|NCT02864381|50168109|FG000|Overall Study|Investigator's Discretion|1|||
25063590|NCT02864381|50168110|FG001|Overall Study|Investigator's Discretion|0|||
25063591|NCT02864381|50168109|FG000|Overall Study|Protocol Violation|0|||
25063592|NCT02864381|50168110|FG001|Overall Study|Protocol Violation|1|||
25063593|NCT02860169|50168118|FG000|Part A|Withdrawal by Subject|1|||
25063594|NCT02860169|50168118|FG000|Part A|Other (Screening failure)|6|||
25063595|NCT02860169|50168118|FG000|Part A|Other (Survey not completed)|3|||
25063596|NCT02860169|50168118|FG000|Part A|Other (did not completed consent)|1|||
25063597|NCT02860169|50168118|FG000|Part B|Other (Screening failure)|10|||
25063598|NCT02860169|50168118|FG000|Part B|Withdrawal by Subject|1|||
25063599|NCT02860169|50168118|FG000|Part C|Other (Screening failure)|1|||
25063600|NCT00409773|50168129|FG000|Overall Study|Adverse Event|3|||
25063601|NCT00409773|50168130|FG001|Overall Study|Adverse Event|4|||
25063602|NCT00409773|50168131|FG002|Overall Study|Adverse Event|4|||
25063603|NCT00409773|50168132|FG003|Overall Study|Adverse Event|2|||
25063604|NCT00409773|50168133|FG004|Overall Study|Adverse Event|6|||
25063605|NCT00409773|50168129|FG000|Overall Study|Lost to Follow-up|6|||
25063606|NCT00409773|50168130|FG001|Overall Study|Lost to Follow-up|1|||
25063607|NCT00409773|50168131|FG002|Overall Study|Lost to Follow-up|2|||
25063608|NCT00409773|50168132|FG003|Overall Study|Lost to Follow-up|3|||
25063609|NCT00409773|50168133|FG004|Overall Study|Lost to Follow-up|1|||
25063610|NCT00409773|50168129|FG000|Overall Study|Physician Decision|0|||
25186640|NCT01394939|50337292|FG000|Overall Study|Physician Decision|0|||
25186641|NCT01394939|50337293|FG001|Overall Study|Physician Decision|1|||
25186642|NCT01394939|50337294|FG002|Overall Study|Physician Decision|0|||
25186643|NCT01394939|50337295|FG003|Overall Study|Physician Decision|0|||
25186644|NCT01394939|50337292|FG000|Overall Study|Withdrawal by Subject|0|||
25186645|NCT01394939|50337293|FG001|Overall Study|Withdrawal by Subject|2|||
25186646|NCT01394939|50337294|FG002|Overall Study|Withdrawal by Subject|0|||
25186647|NCT01394939|50337295|FG003|Overall Study|Withdrawal by Subject|2|||
25186648|NCT01394939|50337292|FG000|Overall Study|Others|0|||
25063611|NCT00409773|50168130|FG001|Overall Study|Physician Decision|0|||
25063612|NCT00409773|50168131|FG002|Overall Study|Physician Decision|0|||
25063613|NCT00409773|50168132|FG003|Overall Study|Physician Decision|2|||
25186649|NCT01394939|50337293|FG001|Overall Study|Others|2|||
25186650|NCT01394939|50337294|FG002|Overall Study|Others|0|||
25186651|NCT01394939|50337295|FG003|Overall Study|Others|3|||
25186652|NCT01394627|50337313|FG000|First Intervention (1 Day)|poor intravenous access|0|||
25186653|NCT01394627|50337314|FG001|First Intervention (1 Day)|poor intravenous access|1|||
25186654|NCT01394627|50337313|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
25063614|NCT00409773|50168133|FG004|Overall Study|Physician Decision|0|||
25063615|NCT00409773|50168129|FG000|Overall Study|Protocol Violation|0|||
25063616|NCT00409773|50168130|FG001|Overall Study|Protocol Violation|2|||
25063617|NCT00409773|50168131|FG002|Overall Study|Protocol Violation|3|||
25063618|NCT00409773|50168132|FG003|Overall Study|Protocol Violation|3|||
25063619|NCT00409773|50168133|FG004|Overall Study|Protocol Violation|1|||
25063620|NCT00409773|50168129|FG000|Overall Study|Withdrawal by Subject|0|||
25063621|NCT00409773|50168130|FG001|Overall Study|Withdrawal by Subject|0|||
25063622|NCT00409773|50168131|FG002|Overall Study|Withdrawal by Subject|0|||
25063623|NCT00409773|50168132|FG003|Overall Study|Withdrawal by Subject|2|||
25063624|NCT00409773|50168133|FG004|Overall Study|Withdrawal by Subject|1|||
25063625|NCT00409773|50168129|FG000|Overall Study|Lack of Eligibility|0|||
25063626|NCT00409773|50168130|FG001|Overall Study|Lack of Eligibility|0|||
25063627|NCT00409773|50168131|FG002|Overall Study|Lack of Eligibility|0|||
25063628|NCT00409773|50168132|FG003|Overall Study|Lack of Eligibility|0|||
25063629|NCT00409773|50168133|FG004|Overall Study|Lack of Eligibility|1|||
25063630|NCT02861807|50168147|FG000|Overall Study|Lost to Follow-up|7|||
25063631|NCT02861807|50168148|FG001|Overall Study|Lost to Follow-up|6|||
25063632|NCT02861807|50168147|FG000|Overall Study|Withdrawal by Subject|5|||
25063633|NCT02861807|50168148|FG001|Overall Study|Withdrawal by Subject|8|||
25063634|NCT02858401|50168161|FG000|Overall Study|Withdrew Consent|0|||
25063635|NCT02858401|50168162|FG001|Overall Study|Withdrew Consent|0|||
25063636|NCT02858401|50168163|FG002|Overall Study|Withdrew Consent|0|||
25063637|NCT02858401|50168164|FG003|Overall Study|Withdrew Consent|0|||
25063638|NCT02858401|50168165|FG004|Overall Study|Withdrew Consent|0|||
25063639|NCT02858401|50168166|FG005|Overall Study|Withdrew Consent|1|||
25063640|NCT02858401|50168167|FG006|Overall Study|Withdrew Consent|0|||
25063641|NCT02858401|50168161|FG000|Overall Study|Lost to Follow-up|0|||
25063642|NCT02858401|50168162|FG001|Overall Study|Lost to Follow-up|1|||
25063643|NCT02858401|50168163|FG002|Overall Study|Lost to Follow-up|0|||
25063644|NCT02858401|50168164|FG003|Overall Study|Lost to Follow-up|0|||
25063645|NCT02858401|50168165|FG004|Overall Study|Lost to Follow-up|0|||
25063646|NCT02858401|50168166|FG005|Overall Study|Lost to Follow-up|0|||
25063647|NCT02858401|50168167|FG006|Overall Study|Lost to Follow-up|0|||
25063648|NCT02857283|50168194|FG000|First Exposure|Withdrawal by Subject|1|||
25063649|NCT02857283|50168195|FG001|First Exposure|Withdrawal by Subject|0|||
25063650|NCT02747927|50168213|FG000|Overall Study|Adverse Event|5|||
25063651|NCT02747927|50168214|FG001|Overall Study|Adverse Event|14|||
25063652|NCT02747927|50168213|FG000|Overall Study|Lost to Follow-up|22|||
25063653|NCT02747927|50168214|FG001|Overall Study|Lost to Follow-up|43|||
25063654|NCT02747927|50168213|FG000|Overall Study|Pregnancy|34|||
25063655|NCT02747927|50168214|FG001|Overall Study|Pregnancy|66|||
25063656|NCT02747927|50168213|FG000|Overall Study|Protocol Violation|2|||
25063657|NCT02747927|50168214|FG001|Overall Study|Protocol Violation|4|||
25063658|NCT02747927|50168213|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
25063659|NCT02747927|50168214|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
25063660|NCT02747927|50168213|FG000|Overall Study|Reason not Specified|11|||
25063661|NCT02747927|50168214|FG001|Overall Study|Reason not Specified|27|||
25063662|NCT02746679|50168222|FG000|Overall Study|Lost to Follow-up|4|||
25063663|NCT02746679|50168223|FG001|Overall Study|Lost to Follow-up|6|||
25063664|NCT02731131|50168231|FG000|Overall Study|Psychiatric Disorder|0|||
25063665|NCT02731131|50168232|FG001|Overall Study|Psychiatric Disorder|1|||
25063666|NCT02731131|50168231|FG000|Overall Study|Refused Therapy|0|||
25063667|NCT02731131|50168232|FG001|Overall Study|Refused Therapy|1|||
25063668|NCT02746705|50168240|FG000|Overall Study|Physician Decision|1|||
25063669|NCT02746705|50168241|FG001|Overall Study|Physician Decision|1|||
25063670|NCT02746705|50168240|FG000|Overall Study|Lost to Follow-up|1|||
25063671|NCT02746705|50168241|FG001|Overall Study|Lost to Follow-up|0|||
25063672|NCT02746705|50168240|FG000|Overall Study|outlier scores deemed not valid|0|||
25063673|NCT02746705|50168241|FG001|Overall Study|outlier scores deemed not valid|1|||
25063674|NCT02746627|50168250|FG000|Overall Study|Withdrawal by Subject|1|||
25063675|NCT02746627|50168251|FG001|Overall Study|Withdrawal by Subject|1|||
25063676|NCT02746627|50168252|FG002|Overall Study|Withdrawal by Subject|1|||
25063677|NCT02856113|50168262|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
25063678|NCT02856113|50168263|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
25063679|NCT02856113|50168262|FG000|Overall Study|Significant Protocol Deviation|1|||
25162850|NCT01967147|50285218|FG000|Overall Study|Adverse Event|5|||
25162851|NCT01967147|50285219|FG001|Overall Study|Adverse Event|2|||
25162852|NCT01967147|50285218|FG000|Overall Study|Lack of Efficacy|1|||
25162853|NCT01967147|50285219|FG001|Overall Study|Lack of Efficacy|4|||
25162854|NCT01967147|50285218|FG000|Overall Study|Lost to Follow-up|1|||
25162855|NCT01967147|50285219|FG001|Overall Study|Lost to Follow-up|2|||
25162856|NCT01967147|50285218|FG000|Overall Study|Withdrawal by Subject|2|||
25063680|NCT02856113|50168263|FG001|Overall Study|Significant Protocol Deviation|0|||
25063681|NCT02856113|50168262|FG000|Overall Study|Lost to Follow-up|3|||
25063682|NCT02856113|50168263|FG001|Overall Study|Lost to Follow-up|5|||
25063683|NCT02856113|50168262|FG000|Overall Study|Voluntary Withdrawal|3|||
25063684|NCT02856113|50168263|FG001|Overall Study|Voluntary Withdrawal|5|||
25063685|NCT02856113|50168262|FG000|Overall Study|Pregnancy|0|||
25063686|NCT02856113|50168263|FG001|Overall Study|Pregnancy|1|||
25063687|NCT02856113|50168262|FG000|Overall Study|Principal Investigator Discretion|2|||
25063688|NCT02856113|50168263|FG001|Overall Study|Principal Investigator Discretion|1|||
25063689|NCT02856113|50168262|FG000|Overall Study|Randomized but not Treated|1|||
25063690|NCT02856113|50168263|FG001|Overall Study|Randomized but not Treated|0|||
25063691|NCT02856113|50168262|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
25063692|NCT02856113|50168263|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
25063693|NCT02855411|50168270|FG000|Overall Study|Study terminated by sponsor|21|||
25063694|NCT02855411|50168270|FG000|Overall Study|Does not meet entrance criteria|14|||
25063695|NCT02745145|50168277|FG000|Overall Study|Adverse Event|1|||
25063696|NCT02745145|50168278|FG001|Overall Study|Adverse Event|0|||
25063697|NCT02745145|50168279|FG002|Overall Study|Adverse Event|0|||
25063698|NCT02745145|50168277|FG000|Overall Study|Death|0|||
25063699|NCT02745145|50168278|FG001|Overall Study|Death|1|||
25063700|NCT02745145|50168279|FG002|Overall Study|Death|0|||
25063701|NCT02745145|50168277|FG000|Overall Study|Progressive disease|0|||
25063702|NCT02745145|50168278|FG001|Overall Study|Progressive disease|0|||
25063703|NCT02745145|50168279|FG002|Overall Study|Progressive disease|1|||
25063704|NCT02745145|50168277|FG000|Overall Study|Withdrew consent|1|||
25063705|NCT02745145|50168278|FG001|Overall Study|Withdrew consent|1|||
25063706|NCT02745145|50168279|FG002|Overall Study|Withdrew consent|1|||
25063707|NCT02745145|50168277|FG000|Overall Study|Study Termination|8|||
25063708|NCT02745145|50168278|FG001|Overall Study|Study Termination|3|||
25063709|NCT02745145|50168279|FG002|Overall Study|Study Termination|7|||
25063710|NCT02854631|50168298|FG000|Overall Study|Adverse Event|1|||
25063711|NCT02854631|50168299|FG001|Overall Study|Adverse Event|2|||
25063712|NCT02854631|50168298|FG000|Overall Study|Withdrew Consent|3|||
25063713|NCT02854631|50168299|FG001|Overall Study|Withdrew Consent|2|||
25063714|NCT02854631|50168298|FG000|Overall Study|Investigator's Discretion|2|||
25063715|NCT02854631|50168299|FG001|Overall Study|Investigator's Discretion|0|||
25063716|NCT02854631|50168298|FG000|Overall Study|Death|12|||
25063717|NCT02854631|50168299|FG001|Overall Study|Death|8|||
25063718|NCT02854631|50168298|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
25063719|NCT02854631|50168299|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
25063720|NCT02854631|50168298|FG000|Overall Study|Protocol Violation|0|||
25063721|NCT02854631|50168299|FG001|Overall Study|Protocol Violation|1|||
25063722|NCT02854631|50168298|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
25063723|NCT02854631|50168299|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
25063724|NCT02854631|50168298|FG000|Overall Study|Lost to Follow-up|4|||
25063725|NCT02854631|50168299|FG001|Overall Study|Lost to Follow-up|2|||
25063726|NCT02855359|50168307|FG000|Overall Study|Death|2|||
25063727|NCT02855359|50168308|FG001|Overall Study|Death|2|||
25063728|NCT02855359|50168309|FG002|Overall Study|Death|0|||
25063729|NCT02855359|50168310|FG003|Overall Study|Death|0|||
25063730|NCT02855359|50168307|FG000|Overall Study|Study Termination by Sponsor|9|||
25063731|NCT02855359|50168308|FG001|Overall Study|Study Termination by Sponsor|11|||
25063732|NCT02855359|50168309|FG002|Overall Study|Study Termination by Sponsor|0|||
25063733|NCT02855359|50168310|FG003|Overall Study|Study Termination by Sponsor|0|||
25063734|NCT02853929|50168324|FG000|Overall Study|Lost to Follow-up|3|||
25063735|NCT02853929|50168325|FG001|Overall Study|Lost to Follow-up|0|||
25063736|NCT02853929|50168324|FG000|Overall Study|Withdrawal by Subject|1|||
25063737|NCT02853929|50168325|FG001|Overall Study|Withdrawal by Subject|0|||
25063738|NCT02853929|50168324|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
25063739|NCT02853929|50168325|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
25063740|NCT02730819|50168361|FG000|Overall Study|Lost to Follow-up|9|||
25063741|NCT02038946|50168365|FG000|Overall Study|Death|5|||
25063742|NCT02038946|50168365|FG000|Overall Study|Withdrawal by Subject|3|||
25063743|NCT02038946|50168365|FG000|Overall Study|Lost to Follow-up|2|||
25063744|NCT02038946|50168365|FG000|Overall Study|Other reasons|2|||
25063745|NCT03143829|50168371|FG000|Overall Study|Withdrawal by Subject|2|||
25063746|NCT03143829|50168372|FG001|Overall Study|Withdrawal by Subject|5|||
25063747|NCT03143829|50168371|FG000|Overall Study|Lost to Follow-up|0|||
25063748|NCT03143829|50168372|FG001|Overall Study|Lost to Follow-up|2|||
25063749|NCT03143829|50168371|FG000|Overall Study|Death|1|||
25063750|NCT03143829|50168372|FG001|Overall Study|Death|1|||
25063751|NCT03143829|50168371|FG000|Overall Study|changed treatment, no longer eligible|2|||
25063752|NCT03143829|50168372|FG001|Overall Study|changed treatment, no longer eligible|2|||
25063753|NCT02853331|50168380|FG000|Overall Study|Death|59|||
25063754|NCT02853331|50168381|FG001|Overall Study|Death|95|||
25063755|NCT02853331|50168380|FG000|Overall Study|Withdrawal by Subject|5|||
25063756|NCT02853331|50168381|FG001|Overall Study|Withdrawal by Subject|9|||
25063757|NCT02853331|50168380|FG000|Overall Study|Ongoing in study|368|||
25063758|NCT02853331|50168381|FG001|Overall Study|Ongoing in study|325|||
25063759|NCT05288673|50168390|FG000|Overall Study|Consent withdrawn by subject|0|||
25063760|NCT05288673|50168391|FG001|Overall Study|Consent withdrawn by subject|0|||
25063761|NCT05288673|50168392|FG002|Overall Study|Consent withdrawn by subject|1|||
25063762|NCT04604795|50168438|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
25063763|NCT04604795|50168439|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
25063764|NCT04604795|50168440|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
25063765|NCT04604795|50168441|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
25063766|NCT04604795|50168442|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
25063767|NCT04604795|50168443|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
25063768|NCT04604795|50168444|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
25063769|NCT04604795|50168445|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
25063770|NCT04604795|50168446|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
25063771|NCT04604795|50168447|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
25063772|NCT04604795|50168438|FG000|Part B: Up to Day 14|Adverse Event|0|||
25063773|NCT04604795|50168439|FG001|Part B: Up to Day 14|Adverse Event|0|||
25063774|NCT04604795|50168440|FG002|Part B: Up to Day 14|Adverse Event|0|||
25063775|NCT04604795|50168441|FG003|Part B: Up to Day 14|Adverse Event|0|||
25063776|NCT04604795|50168442|FG004|Part B: Up to Day 14|Adverse Event|2|||
25063777|NCT04604795|50168443|FG005|Part B: Up to Day 14|Adverse Event|1|||
25063778|NCT04604795|50168444|FG006|Part B: Up to Day 14|Adverse Event|0|||
25063779|NCT04604795|50168445|FG007|Part B: Up to Day 14|Adverse Event|0|||
25063780|NCT04604795|50168446|FG008|Part B: Up to Day 14|Adverse Event|0|||
25063781|NCT04604795|50168447|FG009|Part B: Up to Day 14|Adverse Event|0|||
25063782|NCT04604795|50168438|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
25063783|NCT04604795|50168439|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
25063784|NCT04604795|50168440|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
25063785|NCT04604795|50168441|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
25063786|NCT04604795|50168442|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
25063787|NCT04604795|50168443|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
25063788|NCT04604795|50168444|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
25063789|NCT04604795|50168445|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
25063790|NCT04604795|50168446|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
25063791|NCT04604795|50168447|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
25063792|NCT04604795|50168438|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
25063793|NCT04604795|50168439|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
25063794|NCT04604795|50168440|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
25063795|NCT04604795|50168441|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
25063796|NCT04604795|50168442|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
25063797|NCT04604795|50168443|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
25063798|NCT04604795|50168444|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
25063799|NCT04604795|50168445|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
25063800|NCT04604795|50168446|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
25063801|NCT04604795|50168447|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
25063802|NCT04604795|50168438|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
25063803|NCT04604795|50168439|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
25063804|NCT04604795|50168440|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
25063805|NCT04604795|50168441|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
25063806|NCT04604795|50168442|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
25063807|NCT04604795|50168443|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
25063808|NCT04604795|50168444|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
25063809|NCT04604795|50168445|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
25063810|NCT04604795|50168446|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
25063811|NCT04604795|50168447|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
25063812|NCT04604795|50168438|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
25063813|NCT04604795|50168439|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
25063814|NCT04604795|50168440|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
25063815|NCT04604795|50168441|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
25063816|NCT04604795|50168442|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
25063817|NCT04604795|50168443|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
25063818|NCT04604795|50168444|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
25063819|NCT04604795|50168445|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
25063820|NCT04604795|50168446|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
25063821|NCT04604795|50168447|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
25063822|NCT04314284|50168543|FG000|Overall Study|Withdrawal by Subject|4|||
25063823|NCT04314284|50168544|FG001|Overall Study|Withdrawal by Subject|7|||
25063824|NCT04314284|50168543|FG000|Overall Study|Consented but did not complete survey|0|||
25063825|NCT04314284|50168544|FG001|Overall Study|Consented but did not complete survey|6|||
25063826|NCT04246489|50168550|FG000|Overall Study|Ongoing at cut-off date|6|||
25063827|NCT04203823|50168556|FG000|Overall Study|Withdrawal by Subject|2|||
25063828|NCT04203823|50168557|FG001|Overall Study|Withdrawal by Subject|2|||
25063829|NCT04203823|50168556|FG000|Overall Study|Adverse Event|1|||
25063830|NCT04203823|50168557|FG001|Overall Study|Adverse Event|1|||
25063831|NCT04203823|50168556|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
25063832|NCT04203823|50168557|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
25063833|NCT03703466|50168610|FG000|Overall Study|Death|2|||
25063834|NCT03703466|50168611|FG001|Overall Study|Death|1|||
25063835|NCT03703466|50168612|FG002|Overall Study|Death|0|||
25063836|NCT03703466|50168610|FG000|Overall Study|Protocol Violation|1|||
25063837|NCT03703466|50168611|FG001|Overall Study|Protocol Violation|0|||
25063838|NCT03703466|50168612|FG002|Overall Study|Protocol Violation|0|||
25063839|NCT03703466|50168610|FG000|Overall Study|Withdrawal by Subject|0|||
25063840|NCT03703466|50168611|FG001|Overall Study|Withdrawal by Subject|3|||
25063841|NCT03703466|50168612|FG002|Overall Study|Withdrawal by Subject|0|||
25063842|NCT03703466|50168610|FG000|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1|||
25063843|NCT03703466|50168611|FG001|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
25063844|NCT03703466|50168612|FG002|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
25063845|NCT03248128|50168680|FG000|Overall Study|Lost to Follow-up|1|||
25063846|NCT03248128|50168681|FG001|Overall Study|Lost to Follow-up|0|||
25063847|NCT03248128|50168680|FG000|Overall Study|Withdrawal by Subject|16|||
25063848|NCT03248128|50168681|FG001|Overall Study|Withdrawal by Subject|14|||
25063849|NCT03248128|50168680|FG000|Overall Study|Site Closed|4|||
25063850|NCT03248128|50168681|FG001|Overall Study|Site Closed|3|||
25063851|NCT03248128|50168680|FG000|Overall Study|Randomized, but did not receive treatment|1|||
25063852|NCT03248128|50168681|FG001|Overall Study|Randomized, but did not receive treatment|3|||
25063853|NCT03193853|50168690|FG000|Overall Study|Death|6|||
25063854|NCT03143153|50168697|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
25063855|NCT03143153|50168698|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
25063856|NCT03143153|50168699|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
25063857|NCT03143153|50168697|FG000|Pre-Treatment|Participant withdrew consent|0|||
25063858|NCT03143153|50168698|FG001|Pre-Treatment|Participant withdrew consent|1|||
25063859|NCT03143153|50168699|FG002|Pre-Treatment|Participant withdrew consent|12|||
25063860|NCT03143153|50168697|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
25063861|NCT03143153|50168698|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
25063862|NCT03143153|50168699|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
25063863|NCT03143153|50168697|FG000|Pre-Treatment|Other Reasons|1|||
25063864|NCT03143153|50168698|FG001|Pre-Treatment|Other Reasons|2|||
25063865|NCT03143153|50168699|FG002|Pre-Treatment|Other Reasons|1|||
25063866|NCT03143153|50168697|FG000|Pre-Treatment|Disease Progression|1|||
25063867|NCT03143153|50168698|FG001|Pre-Treatment|Disease Progression|1|||
25063868|NCT03143153|50168699|FG002|Pre-Treatment|Disease Progression|2|||
25063869|NCT03143153|50168697|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
25063870|NCT03143153|50168698|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
25063871|NCT03143153|50168699|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
25063872|NCT03143153|50168697|FG000|Treatment|Disease progression|174|||
25063873|NCT03143153|50168698|FG001|Treatment|Disease progression|184|||
25063874|NCT03143153|50168699|FG002|Treatment|Disease progression|193|||
25063875|NCT03143153|50168697|FG000|Treatment|Study drug toxicity|59|||
25063876|NCT03143153|50168698|FG001|Treatment|Study drug toxicity|33|||
25063877|NCT03143153|50168699|FG002|Treatment|Study drug toxicity|40|||
25063878|NCT03143153|50168697|FG000|Treatment|Death|5|||
25063879|NCT03143153|50168698|FG001|Treatment|Death|3|||
25063880|NCT03143153|50168699|FG002|Treatment|Death|4|||
25063881|NCT03143153|50168697|FG000|Treatment|Adverse event unrelated to study drug|19|||
25063882|NCT03143153|50168698|FG001|Treatment|Adverse event unrelated to study drug|28|||
25063883|NCT03143153|50168699|FG002|Treatment|Adverse event unrelated to study drug|12|||
25063884|NCT03143153|50168697|FG000|Treatment|Participant request to discontinue study treatment|13|||
25063885|NCT03143153|50168698|FG001|Treatment|Participant request to discontinue study treatment|15|||
25063886|NCT03143153|50168699|FG002|Treatment|Participant request to discontinue study treatment|20|||
25063887|NCT03143153|50168697|FG000|Treatment|Participant withdrew consent|3|||
25063888|NCT03143153|50168698|FG001|Treatment|Participant withdrew consent|4|||
25063889|NCT03143153|50168699|FG002|Treatment|Participant withdrew consent|12|||
25063890|NCT03143153|50168697|FG000|Treatment|Pregnancy|1|||
25063891|NCT03143153|50168698|FG001|Treatment|Pregnancy|0|||
25063892|NCT03143153|50168699|FG002|Treatment|Pregnancy|0|||
25063893|NCT03143153|50168697|FG000|Treatment|Maximum clinical benefit|1|||
25063894|NCT03143153|50168698|FG001|Treatment|Maximum clinical benefit|3|||
25063895|NCT03143153|50168699|FG002|Treatment|Maximum clinical benefit|4|||
25186655|NCT01394627|50337314|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
25276720|NCT01238120|50590675|FG002|Overall Study|Lost to Follow-up|1|||
25063896|NCT03143153|50168697|FG000|Treatment|Completed treatment as per Protocol|13|||
25063897|NCT03143153|50168698|FG001|Treatment|Completed treatment as per Protocol|8|||
25063898|NCT03143153|50168699|FG002|Treatment|Completed treatment as per Protocol|0|||
25063899|NCT03143153|50168697|FG000|Treatment|Other reasons|12|||
25063900|NCT03143153|50168698|FG001|Treatment|Other reasons|7|||
25063901|NCT03143153|50168699|FG002|Treatment|Other reasons|15|||
25063902|NCT03143153|50168697|FG000|Treatment|Not reported|1|||
25063903|NCT03143153|50168698|FG001|Treatment|Not reported|0|||
25063904|NCT03143153|50168699|FG002|Treatment|Not reported|0|||
25063905|NCT02802631|50168751|FG000|Overall Study|Withdrawal by Subject|1|||
25063906|NCT02802631|50168752|FG001|Overall Study|Withdrawal by Subject|0|||
25063907|NCT02802631|50168753|FG002|Overall Study|Withdrawal by Subject|0|||
25063908|NCT02802631|50168754|FG003|Overall Study|Withdrawal by Subject|0|||
25063909|NCT02802631|50168755|FG004|Overall Study|Withdrawal by Subject|0|||
25063910|NCT02802631|50168756|FG005|Overall Study|Withdrawal by Subject|0|||
25063911|NCT02802631|50168757|FG006|Overall Study|Withdrawal by Subject|0|||
25063912|NCT02802631|50168758|FG007|Overall Study|Withdrawal by Subject|0|||
25063913|NCT02802631|50168751|FG000|Overall Study|Physician Decision|1|||
25063914|NCT02802631|50168752|FG001|Overall Study|Physician Decision|0|||
25063915|NCT02802631|50168753|FG002|Overall Study|Physician Decision|0|||
25063916|NCT02802631|50168754|FG003|Overall Study|Physician Decision|0|||
25063917|NCT02802631|50168755|FG004|Overall Study|Physician Decision|0|||
25063918|NCT02802631|50168756|FG005|Overall Study|Physician Decision|0|||
25063919|NCT02802631|50168757|FG006|Overall Study|Physician Decision|1|||
25063920|NCT02802631|50168758|FG007|Overall Study|Physician Decision|0|||
25063921|NCT02802631|50168751|FG000|Overall Study|Adverse Event|0|||
25063922|NCT02802631|50168752|FG001|Overall Study|Adverse Event|2|||
25063923|NCT02802631|50168753|FG002|Overall Study|Adverse Event|0|||
25063924|NCT02802631|50168754|FG003|Overall Study|Adverse Event|1|||
25063925|NCT02802631|50168755|FG004|Overall Study|Adverse Event|6|||
25063926|NCT02802631|50168756|FG005|Overall Study|Adverse Event|1|||
25063927|NCT02802631|50168757|FG006|Overall Study|Adverse Event|4|||
25063928|NCT02802631|50168758|FG007|Overall Study|Adverse Event|0|||
25063929|NCT02802631|50168751|FG000|Overall Study|Sponsor Decision|0|||
25063930|NCT02802631|50168752|FG001|Overall Study|Sponsor Decision|0|||
25063931|NCT02802631|50168753|FG002|Overall Study|Sponsor Decision|6|||
25063932|NCT02802631|50168754|FG003|Overall Study|Sponsor Decision|0|||
25063933|NCT02802631|50168755|FG004|Overall Study|Sponsor Decision|2|||
25063934|NCT02802631|50168756|FG005|Overall Study|Sponsor Decision|0|||
25063935|NCT02802631|50168757|FG006|Overall Study|Sponsor Decision|0|||
25063936|NCT02802631|50168758|FG007|Overall Study|Sponsor Decision|4|||
25063937|NCT02759185|50168789|FG000|Stage 1|Adverse Event|0|||
25063938|NCT02759185|50168790|FG001|Stage 1|Adverse Event|1|||
25063939|NCT02759185|50168791|FG002|Stage 1|Adverse Event|3|||
25063940|NCT02759185|50168792|FG003|Stage 1|Adverse Event|0|||
25063941|NCT02759185|50168793|FG004|Stage 1|Adverse Event|0|||
25063942|NCT02759185|50168794|FG005|Stage 1|Adverse Event|0|||
25063943|NCT02759185|50168795|FG006|Stage 1|Adverse Event|0|||
25063944|NCT02759185|50168789|FG000|Stage 1|Withdrawal by Subject|1|||
25063945|NCT02759185|50168790|FG001|Stage 1|Withdrawal by Subject|0|||
25063946|NCT02759185|50168791|FG002|Stage 1|Withdrawal by Subject|0|||
25063947|NCT02759185|50168792|FG003|Stage 1|Withdrawal by Subject|0|||
25063948|NCT02759185|50168793|FG004|Stage 1|Withdrawal by Subject|0|||
25063949|NCT02759185|50168794|FG005|Stage 1|Withdrawal by Subject|0|||
25063950|NCT02759185|50168795|FG006|Stage 1|Withdrawal by Subject|0|||
25063951|NCT02759185|50168789|FG000|Stage 2|Adverse Event|0|||
25063952|NCT02759185|50168790|FG001|Stage 2|Adverse Event|0|||
25063953|NCT02759185|50168791|FG002|Stage 2|Adverse Event|0|||
25063954|NCT02759185|50168792|FG003|Stage 2|Adverse Event|0|||
25063955|NCT02759185|50168793|FG004|Stage 2|Adverse Event|1|||
25063956|NCT02759185|50168794|FG005|Stage 2|Adverse Event|2|||
25063957|NCT02759185|50168795|FG006|Stage 2|Adverse Event|0|||
25063958|NCT02759185|50168789|FG000|Stage 2|Withdrawal by Subject|0|||
25063959|NCT02759185|50168790|FG001|Stage 2|Withdrawal by Subject|0|||
25063960|NCT02759185|50168791|FG002|Stage 2|Withdrawal by Subject|0|||
25063961|NCT02759185|50168792|FG003|Stage 2|Withdrawal by Subject|0|||
25063962|NCT02759185|50168793|FG004|Stage 2|Withdrawal by Subject|1|||
25063963|NCT02759185|50168794|FG005|Stage 2|Withdrawal by Subject|1|||
25063964|NCT02759185|50168795|FG006|Stage 2|Withdrawal by Subject|1|||
25063965|NCT02754479|50168822|FG000|Overall Study|Lost to Follow-up|1|||
25063966|NCT02036476|50168848|FG000|Overall Study|Withdrawal by Subject|2|||
25186656|NCT01391663|50337333|FG000|Overall Study|Withdrawal by Subject|0|||
25063967|NCT02036476|50168848|FG000|Overall Study|Progressive Disease|4|||
25063968|NCT02036476|50168848|FG000|Overall Study|Unacceptable Toxicity|2|||
25063969|NCT01802632|50168869|FG000|Overall Study|Death|28|||
25063970|NCT01802632|50168870|FG001|Overall Study|Death|1|||
25063971|NCT01802632|50168871|FG002|Overall Study|Death|38|||
25063972|NCT01802632|50168872|FG003|Overall Study|Death|0|||
25063973|NCT01802632|50168873|FG004|Overall Study|Death|2|||
25063974|NCT01802632|50168874|FG005|Overall Study|Death|0|||
25063975|NCT01802632|50168869|FG000|Overall Study|Withdrawal by Subject|4|||
25063976|NCT01802632|50168870|FG001|Overall Study|Withdrawal by Subject|2|||
25063977|NCT01802632|50168871|FG002|Overall Study|Withdrawal by Subject|7|||
25063978|NCT01802632|50168872|FG003|Overall Study|Withdrawal by Subject|3|||
25063979|NCT01802632|50168873|FG004|Overall Study|Withdrawal by Subject|0|||
25063980|NCT01802632|50168874|FG005|Overall Study|Withdrawal by Subject|1|||
25063981|NCT01802632|50168869|FG000|Overall Study|Objective Disease Progression|1|||
25063982|NCT01802632|50168870|FG001|Overall Study|Objective Disease Progression|12|||
25063983|NCT01802632|50168871|FG002|Overall Study|Objective Disease Progression|104|||
25063984|NCT01802632|50168872|FG003|Overall Study|Objective Disease Progression|6|||
25063985|NCT01802632|50168873|FG004|Overall Study|Objective Disease Progression|4|||
25063986|NCT01802632|50168874|FG005|Overall Study|Objective Disease Progression|4|||
25063987|NCT01802632|50168869|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
25063988|NCT01802632|50168870|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
25063989|NCT01802632|50168871|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
25063990|NCT01802632|50168872|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
25063991|NCT01802632|50168873|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
25063992|NCT01802632|50168874|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
25063993|NCT01802632|50168869|FG000|Overall Study|Other (not specified)|0|||
25063994|NCT01802632|50168870|FG001|Overall Study|Other (not specified)|0|||
25063995|NCT01802632|50168871|FG002|Overall Study|Other (not specified)|7|||
25063996|NCT01802632|50168872|FG003|Overall Study|Other (not specified)|1|||
25063997|NCT01802632|50168873|FG004|Overall Study|Other (not specified)|0|||
25063998|NCT01802632|50168874|FG005|Overall Study|Other (not specified)|1|||
25063999|NCT01793610|50168889|FG000|Overall Study|Withdrawal by Subject|1|||
25064000|NCT01793610|50168890|FG001|Overall Study|Withdrawal by Subject|0|||
25064001|NCT01793610|50168891|FG002|Overall Study|Withdrawal by Subject|1|||
25064002|NCT00643994|50168951|FG000|Overall Study|Death|24|||
25064003|NCT00643994|50168951|FG000|Overall Study|Lost to Follow-up|72|||
25064004|NCT00643617|50168957|FG000|Overall Study|Death|6|||
25064005|NCT00643617|50168958|FG001|Overall Study|Death|9|||
25064006|NCT00643617|50168957|FG000|Overall Study|Lost to Follow-up|42|||
25064007|NCT00643617|50168958|FG001|Overall Study|Lost to Follow-up|51|||
25064008|NCT00504582|50168985|FG000|Overall Study|Lost to Follow-up|1|||
25064009|NCT00504582|50168986|FG001|Overall Study|Lost to Follow-up|0|||
25064010|NCT00504582|50168987|FG002|Overall Study|Lost to Follow-up|0|||
25064011|NCT00314366|50169010|FG000|Overall Study|not treated due to patient medical condi|1|||
25064012|NCT00314366|50169011|FG001|Overall Study|not treated due to patient medical condi|0|||
25064013|NCT01595061|50169032|FG000|Overall Study|Never Treated|3|||
25064014|NCT01595061|50169032|FG000|Overall Study|Inadequate Pathology|1|||
25064015|NCT02852005|50169053|FG000|Overall Study|Lost to Follow-up|0|||
25064016|NCT02852005|50169054|FG001|Overall Study|Lost to Follow-up|0|||
25064017|NCT02852005|50169055|FG002|Overall Study|Lost to Follow-up|0|||
25064018|NCT02852005|50169056|FG003|Overall Study|Lost to Follow-up|0|||
25064019|NCT02852005|50169057|FG004|Overall Study|Lost to Follow-up|1|||
25064020|NCT02852005|50169053|FG000|Overall Study|Withdrawal by Subject|1|||
25064021|NCT02852005|50169054|FG001|Overall Study|Withdrawal by Subject|0|||
25064022|NCT02852005|50169055|FG002|Overall Study|Withdrawal by Subject|0|||
25064023|NCT02852005|50169056|FG003|Overall Study|Withdrawal by Subject|0|||
25064024|NCT02852005|50169057|FG004|Overall Study|Withdrawal by Subject|0|||
25064025|NCT02851615|50169073|FG000|Overall Study|Cognitive Issue|1|||
25064026|NCT02851615|50169074|FG001|Overall Study|Cognitive Issue|0|||
25064027|NCT02851615|50169073|FG000|Overall Study|Lost to Follow-up|0|||
25064028|NCT02851615|50169074|FG001|Overall Study|Lost to Follow-up|4|||
25064029|NCT02849743|50169092|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
25064030|NCT02849743|50169093|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
25064031|NCT02849743|50169092|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
25064032|NCT02849743|50169093|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
25064033|NCT02851069|50169128|FG000|Overall Study|Failure to Return|3|||
25064034|NCT02851069|50169128|FG000|Overall Study|Other|3|||
25064035|NCT02849509|50169140|FG000|Overall Study|Worsening of disease under study|1|||
25064036|NCT02849509|50169141|FG001|Overall Study|Worsening of disease under study|1|||
25064037|NCT02849509|50169142|FG002|Overall Study|Worsening of disease under study|1|||
25064038|NCT02849509|50169140|FG000|Overall Study|Worsening of other pre-existing disease|0|||
25276721|NCT01238120|50590676|FG003|Overall Study|Lost to Follow-up|1|||
25276722|NCT01238120|50590673|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
25064039|NCT02849509|50169141|FG001|Overall Study|Worsening of other pre-existing disease|1|||
25064040|NCT02849509|50169142|FG002|Overall Study|Worsening of other pre-existing disease|2|||
25064041|NCT02849509|50169140|FG000|Overall Study|Other adverse event|36|||
25064042|NCT02849509|50169141|FG001|Overall Study|Other adverse event|41|||
25064043|NCT02849509|50169142|FG002|Overall Study|Other adverse event|8|||
25064044|NCT02849509|50169140|FG000|Overall Study|Withdrawal by Subject|6|||
25064045|NCT02849509|50169141|FG001|Overall Study|Withdrawal by Subject|17|||
25064046|NCT02849509|50169142|FG002|Overall Study|Withdrawal by Subject|12|||
25064047|NCT02849509|50169140|FG000|Overall Study|Lost to Follow-up|27|||
25064048|NCT02849509|50169141|FG001|Overall Study|Lost to Follow-up|67|||
25064049|NCT02849509|50169142|FG002|Overall Study|Lost to Follow-up|36|||
25064050|NCT02849509|50169140|FG000|Overall Study|Other, reason not specified|14|||
25064051|NCT02849509|50169141|FG001|Overall Study|Other, reason not specified|29|||
25064052|NCT02849509|50169142|FG002|Overall Study|Other, reason not specified|25|||
25064053|NCT02849509|50169140|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
25064054|NCT02849509|50169141|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
25064055|NCT02849509|50169142|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
25064056|NCT02853305|50169155|FG000|Overall Study|Death|244|||
25064057|NCT02853305|50169156|FG001|Overall Study|Death|207|||
25064058|NCT02853305|50169157|FG002|Overall Study|Death|263|||
25064059|NCT02853305|50169155|FG000|Overall Study|Withdrawal by Subject|2|||
25064060|NCT02853305|50169156|FG001|Overall Study|Withdrawal by Subject|4|||
25064061|NCT02853305|50169157|FG002|Overall Study|Withdrawal by Subject|2|||
25064062|NCT02853305|50169155|FG000|Overall Study|Ongoing in Trial|105|||
25064063|NCT02853305|50169156|FG001|Overall Study|Ongoing in Trial|96|||
25064064|NCT02853305|50169157|FG002|Overall Study|Ongoing in Trial|87|||
25064065|NCT02848729|50169167|FG000|Overall Study|Withdrawal by Subject|1|||
25064066|NCT02848729|50169168|FG001|Overall Study|Withdrawal by Subject|0|||
25064067|NCT02848729|50169167|FG000|Overall Study|Emesis|15|||
25064068|NCT02848729|50169168|FG001|Overall Study|Emesis|11|||
25064069|NCT00158756|50169186|FG000|Overall Study|Withdrawal by Subject|5|||
25064070|NCT00158756|50169187|FG001|Overall Study|Withdrawal by Subject|0|||
25064071|NCT00158756|50169188|FG002|Overall Study|Withdrawal by Subject|6|||
25064072|NCT00158756|50169189|FG003|Overall Study|Withdrawal by Subject|1|||
25064073|NCT00158756|50169190|FG004|Overall Study|Withdrawal by Subject|3|||
25064074|NCT00158756|50169186|FG000|Overall Study|Adverse Event|0|||
25064075|NCT00158756|50169187|FG001|Overall Study|Adverse Event|0|||
25064076|NCT00158756|50169188|FG002|Overall Study|Adverse Event|1|||
25064077|NCT00158756|50169189|FG003|Overall Study|Adverse Event|0|||
25064078|NCT00158756|50169190|FG004|Overall Study|Adverse Event|0|||
25064079|NCT00158756|50169186|FG000|Overall Study|Serious adverse event|0|||
25064080|NCT00158756|50169187|FG001|Overall Study|Serious adverse event|0|||
25064081|NCT00158756|50169188|FG002|Overall Study|Serious adverse event|1|||
25064082|NCT00158756|50169189|FG003|Overall Study|Serious adverse event|0|||
25064083|NCT00158756|50169190|FG004|Overall Study|Serious adverse event|0|||
25064084|NCT02730195|50169202|FG000|Overall Study|Withdrawal by Subject|1|||
25064085|NCT02730351|50169210|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
25064086|NCT02730351|50169211|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
25064087|NCT02730351|50169210|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
25064088|NCT02730351|50169211|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
25064089|NCT02730351|50169210|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
25064090|NCT02730351|50169211|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
25064091|NCT02730351|50169210|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
25064092|NCT02730351|50169211|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
25064093|NCT02730351|50169210|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
25064094|NCT02730351|50169211|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
25064095|NCT01376349|50169220|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
25064096|NCT01376349|50169221|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
25064097|NCT01376349|50169222|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
25064098|NCT01376349|50169220|FG000|Raondomized Treatment|Adverse Event|13|||
25064099|NCT01376349|50169221|FG001|Raondomized Treatment|Adverse Event|17|||
25064100|NCT01376349|50169222|FG002|Raondomized Treatment|Adverse Event|14|||
25064101|NCT01376349|50169220|FG000|Raondomized Treatment|Unkown|1|||
25064102|NCT01376349|50169221|FG001|Raondomized Treatment|Unkown|2|||
25064103|NCT01376349|50169222|FG002|Raondomized Treatment|Unkown|1|||
25064104|NCT01376349|50169220|FG000|Raondomized Treatment|Alternative Treatment|0|||
25064105|NCT01376349|50169221|FG001|Raondomized Treatment|Alternative Treatment|0|||
25064106|NCT01376349|50169222|FG002|Raondomized Treatment|Alternative Treatment|1|||
25064107|NCT00158600|50169260|FG000|Overall Study|unable to commit time to study|0|||
25064108|NCT00158600|50169261|FG001|Overall Study|unable to commit time to study|1|||
25064109|NCT00158600|50169260|FG000|Overall Study|Adverse Event|2|||
25064110|NCT00158600|50169261|FG001|Overall Study|Adverse Event|1|||
25064111|NCT00158600|50169260|FG000|Overall Study|Death|1|||
25064112|NCT00158600|50169261|FG001|Overall Study|Death|0|||
25064113|NCT00158600|50169260|FG000|Overall Study|Withdrawal by Subject|2|||
25064114|NCT00158600|50169261|FG001|Overall Study|Withdrawal by Subject|2|||
25064115|NCT01680458|50169268|FG000|Overall Study|Protocol Violation|3|||
25064116|NCT00709761|50169272|FG000|Overall Study|Withdrawal by Subject|8|||
25064117|NCT00709761|50169272|FG000|Overall Study|study closed/terminated|17|||
25064118|NCT00709761|50169272|FG000|Overall Study|Lost to Follow-up|2|||
25064119|NCT02358031|50169285|FG000|Overall Study|Death|226|||
25064120|NCT02358031|50169286|FG001|Overall Study|Death|204|||
25064121|NCT02358031|50169287|FG002|Overall Study|Death|249|||
25064122|NCT02358031|50169285|FG000|Overall Study|Lost to Follow-up|0|||
25064123|NCT02358031|50169286|FG001|Overall Study|Lost to Follow-up|1|||
25064124|NCT02358031|50169287|FG002|Overall Study|Lost to Follow-up|1|||
25064125|NCT02358031|50169285|FG000|Overall Study|Withdrawal by Subject|14|||
25064126|NCT02358031|50169286|FG001|Overall Study|Withdrawal by Subject|12|||
25064127|NCT02358031|50169287|FG002|Overall Study|Withdrawal by Subject|17|||
25064128|NCT02358031|50169285|FG000|Overall Study|Ongoing in Study|61|||
25064129|NCT02358031|50169286|FG001|Overall Study|Ongoing in Study|64|||
25064130|NCT02358031|50169287|FG002|Overall Study|Ongoing in Study|33|||
25064131|NCT02848651|50169295|FG000|Overall Study|Death|85|||
25064132|NCT02848651|50169295|FG000|Overall Study|Lost to Follow-up|1|||
25064133|NCT02848651|50169295|FG000|Overall Study|Non-Compliance|1|||
25064134|NCT02848651|50169295|FG000|Overall Study|Symptomatic Deterioration|1|||
25064135|NCT02848651|50169295|FG000|Overall Study|Physician Decision|4|||
25064136|NCT02848651|50169295|FG000|Overall Study|Withdrawal by Subject|14|||
25064137|NCT00709059|50169315|FG000|Overall Study|Lost to Follow-up|34|||
25064138|NCT00709059|50169315|FG000|Overall Study|Withdrawal by Subject|19|||
25064139|NCT00709059|50169315|FG000|Overall Study|Physician Decision|7|||
25064140|NCT00709059|50169315|FG000|Overall Study|Disease complication|3|||
25064141|NCT00709059|50169315|FG000|Overall Study|Side effects|20|||
25064142|NCT00709059|50169315|FG000|Overall Study|Serious side effects|11|||
25064143|NCT01678898|50169322|FG000|PB-102-F01|Adverse Event|0|||
25064144|NCT01678898|50169323|FG001|PB-102-F01|Adverse Event|1|||
25064145|NCT01678898|50169324|FG002|PB-102-F01|Adverse Event|0|||
25064146|NCT01678898|50169322|FG000|PB-102-F01|Physician Decision|0|||
25064147|NCT01678898|50169323|FG001|PB-102-F01|Physician Decision|1|||
25064148|NCT01678898|50169324|FG002|PB-102-F01|Physician Decision|0|||
25064149|NCT01678820|50169344|FG000|Overall Study|Study Terminated by Sponsor|45|||
25064150|NCT01678820|50169345|FG001|Overall Study|Study Terminated by Sponsor|43|||
25064151|NCT01678820|50169346|FG002|Overall Study|Study Terminated by Sponsor|43|||
25064152|NCT01678820|50169344|FG000|Overall Study|Withdrawal by Subject|2|||
25064153|NCT01678820|50169345|FG001|Overall Study|Withdrawal by Subject|5|||
25064154|NCT01678820|50169346|FG002|Overall Study|Withdrawal by Subject|2|||
25064155|NCT01678820|50169344|FG000|Overall Study|Protocol Specified Criteria|2|||
25064156|NCT01678820|50169345|FG001|Overall Study|Protocol Specified Criteria|3|||
25064157|NCT01678820|50169346|FG002|Overall Study|Protocol Specified Criteria|1|||
25064158|NCT01678820|50169344|FG000|Overall Study|Adverse Event|2|||
25064159|NCT01678820|50169345|FG001|Overall Study|Adverse Event|2|||
25064160|NCT01678820|50169346|FG002|Overall Study|Adverse Event|2|||
25064161|NCT01678820|50169344|FG000|Overall Study|Lost to Follow-up|7|||
25064162|NCT01678820|50169345|FG001|Overall Study|Lost to Follow-up|2|||
25064163|NCT01678820|50169346|FG002|Overall Study|Lost to Follow-up|2|||
25064164|NCT01678820|50169344|FG000|Overall Study|Non-compliance with study drug|0|||
24964121|NCT00443729|50054101|FG001|Overall Study|Lack of Efficacy|2|||
24964122|NCT00443729|50054100|FG000|Overall Study|Lost to Follow-up|0|||
24964123|NCT00443729|50054101|FG001|Overall Study|Lost to Follow-up|1|||
24964124|NCT00443729|50054100|FG000|Overall Study|Physician Decision|2|||
24964125|NCT00443729|50054101|FG001|Overall Study|Physician Decision|1|||
24964126|NCT00443729|50054100|FG000|Overall Study|Protocol Violation|1|||
24964127|NCT00443729|50054101|FG001|Overall Study|Protocol Violation|1|||
24964128|NCT00443729|50054100|FG000|Overall Study|Withdrawal by Subject|3|||
24964129|NCT00443729|50054101|FG001|Overall Study|Withdrawal by Subject|1|||
24964130|NCT00443651|50054109|FG000|Overall Study|Death|1|||
24964131|NCT00443651|50054110|FG001|Overall Study|Death|5|||
24964132|NCT00443651|50054109|FG000|Overall Study|Adverse Event|5|||
24964133|NCT00443651|50054110|FG001|Overall Study|Adverse Event|6|||
24964134|NCT00443651|50054109|FG000|Overall Study|Lost to Follow-up|18|||
24964135|NCT00443651|50054110|FG001|Overall Study|Lost to Follow-up|12|||
24964136|NCT00443651|50054109|FG000|Overall Study|Patient's/Guardian's Decision|58|||
24964137|NCT00443651|50054110|FG001|Overall Study|Patient's/Guardian's Decision|30|||
24964138|NCT00443651|50054109|FG000|Overall Study|Physician Decision|13|||
24964139|NCT00443651|50054110|FG001|Overall Study|Physician Decision|4|||
24964140|NCT00443651|50054109|FG000|Overall Study|Pregnancy|0|||
24964141|NCT00443651|50054110|FG001|Overall Study|Pregnancy|1|||
24964142|NCT00443261|50054116|FG000|Overall Study|Death|1|||
24964143|NCT00439517|50054122|FG000|Overall Study|Subject on treatment|1|||
24964144|NCT00439517|50054123|FG001|Overall Study|Subject on treatment|0|||
24964145|NCT00439517|50054122|FG000|Overall Study|Subject in survival follow-up|1|||
24964146|NCT00439517|50054123|FG001|Overall Study|Subject in survival follow-up|0|||
24964147|NCT00438815|50054129|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
24964148|NCT00438815|50054129|FG000|Overall Study|3-month follow-up no longer required|12|||
24964149|NCT00438815|50054129|FG000|Overall Study|Noncompliance with protocol requirements|9|||
25064165|NCT01678820|50169345|FG001|Overall Study|Non-compliance with study drug|1|||
25064166|NCT01678820|50169346|FG002|Overall Study|Non-compliance with study drug|0|||
25064167|NCT01678820|50169344|FG000|Overall Study|Physician Decision|0|||
25064168|NCT01678820|50169345|FG001|Overall Study|Physician Decision|0|||
25064169|NCT01678820|50169346|FG002|Overall Study|Physician Decision|1|||
25064170|NCT01678820|50169344|FG000|Overall Study|Protocol Violation|4|||
25064171|NCT01678820|50169345|FG001|Overall Study|Protocol Violation|5|||
25064172|NCT01678820|50169346|FG002|Overall Study|Protocol Violation|4|||
25064173|NCT01678820|50169344|FG000|Overall Study|Not treated with double-blind study drug|0|||
25064174|NCT01678820|50169345|FG001|Overall Study|Not treated with double-blind study drug|2|||
25064175|NCT01678820|50169346|FG002|Overall Study|Not treated with double-blind study drug|2|||
25064176|NCT00770809|50169358|FG000|Overall Study|Adverse Event|9|||
25064177|NCT00770809|50169359|FG001|Overall Study|Adverse Event|1|||
25064178|NCT00770809|50169360|FG002|Overall Study|Adverse Event|12|||
25064179|NCT00770809|50169358|FG000|Overall Study|Death|1|||
25064180|NCT00770809|50169359|FG001|Overall Study|Death|0|||
25064181|NCT00770809|50169360|FG002|Overall Study|Death|0|||
25064182|NCT00770809|50169358|FG000|Overall Study|Withdrawal by Subject|3|||
25064183|NCT00770809|50169359|FG001|Overall Study|Withdrawal by Subject|3|||
25064184|NCT00770809|50169360|FG002|Overall Study|Withdrawal by Subject|7|||
25064185|NCT00770809|50169358|FG000|Overall Study|Progression|2|||
25064186|NCT00770809|50169359|FG001|Overall Study|Progression|2|||
25064187|NCT00770809|50169360|FG002|Overall Study|Progression|0|||
25064188|NCT00770809|50169358|FG000|Overall Study|Complicating illness|0|||
25064189|NCT00770809|50169359|FG001|Overall Study|Complicating illness|0|||
25064190|NCT00770809|50169360|FG002|Overall Study|Complicating illness|1|||
25064191|NCT00770809|50169358|FG000|Overall Study|Other Medical Reasons|2|||
25064192|NCT00770809|50169359|FG001|Overall Study|Other Medical Reasons|4|||
25064193|NCT00770809|50169360|FG002|Overall Study|Other Medical Reasons|3|||
25064194|NCT02660138|50169371|FG000|Overall Study|Adverse Event|0|||
25064195|NCT02660138|50169372|FG001|Overall Study|Adverse Event|3|||
25064196|NCT02660138|50169373|FG002|Overall Study|Adverse Event|2|||
25064197|NCT02660138|50169371|FG000|Overall Study|Lack of Efficacy|1|||
25064198|NCT02660138|50169372|FG001|Overall Study|Lack of Efficacy|2|||
25064199|NCT02660138|50169373|FG002|Overall Study|Lack of Efficacy|1|||
25064200|NCT02660138|50169371|FG000|Overall Study|Withdrawal by Subject|7|||
25064201|NCT02660138|50169372|FG001|Overall Study|Withdrawal by Subject|6|||
25064202|NCT02660138|50169373|FG002|Overall Study|Withdrawal by Subject|6|||
25064203|NCT02660138|50169371|FG000|Overall Study|Lost to Follow-up|4|||
25064204|NCT02660138|50169372|FG001|Overall Study|Lost to Follow-up|4|||
25064205|NCT02660138|50169373|FG002|Overall Study|Lost to Follow-up|1|||
25064206|NCT02660138|50169371|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
25064207|NCT02660138|50169372|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
25064208|NCT02660138|50169373|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
25064209|NCT02660138|50169371|FG000|Overall Study|Other|1|||
25064210|NCT02660138|50169372|FG001|Overall Study|Other|1|||
25064211|NCT02660138|50169373|FG002|Overall Study|Other|0|||
25064212|NCT02660138|50169371|FG000|Overall Study|Not treated|0|||
25064213|NCT02660138|50169372|FG001|Overall Study|Not treated|1|||
25064214|NCT02660138|50169373|FG002|Overall Study|Not treated|0|||
25064215|NCT01603394|50169384|FG000|Overall Study|Adverse Event|1|||
25064216|NCT02729025|50169390|FG000|Overall Study|Sponsor Decision|0|||
25064217|NCT02729025|50169391|FG001|Overall Study|Sponsor Decision|1|||
25064218|NCT01603082|50169399|FG000|Overall Study|Adverse Event|0|||
25064219|NCT01603082|50169400|FG001|Overall Study|Adverse Event|1|||
25064220|NCT01603082|50169399|FG000|Overall Study|Withdrawal by Subject|1|||
25064221|NCT01603082|50169400|FG001|Overall Study|Withdrawal by Subject|0|||
25064222|NCT01603082|50169399|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
25064223|NCT01603082|50169400|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
25064224|NCT02499835|50169410|FG000|Overall Study|Withdrawal by Subject|1|||
25064225|NCT02499835|50169411|FG001|Overall Study|Withdrawal by Subject|0|||
25064226|NCT02499835|50169412|FG002|Overall Study|Withdrawal by Subject|0|||
25064227|NCT02499835|50169413|FG003|Overall Study|Withdrawal by Subject|1|||
25064228|NCT02499835|50169410|FG000|Overall Study|Physician Decision|0|||
25064229|NCT02499835|50169411|FG001|Overall Study|Physician Decision|3|||
25064230|NCT02499835|50169412|FG002|Overall Study|Physician Decision|18|||
25064231|NCT02499835|50169413|FG003|Overall Study|Physician Decision|7|||
25064232|NCT02499835|50169410|FG000|Overall Study|Adverse Event|0|||
25064233|NCT02499835|50169411|FG001|Overall Study|Adverse Event|0|||
25064234|NCT02499835|50169412|FG002|Overall Study|Adverse Event|0|||
25064235|NCT02499835|50169413|FG003|Overall Study|Adverse Event|1|||
25064236|NCT02499835|50169410|FG000|Overall Study|Disease progression|2|||
25064237|NCT02499835|50169411|FG001|Overall Study|Disease progression|1|||
25064238|NCT02499835|50169412|FG002|Overall Study|Disease progression|0|||
25064239|NCT02499835|50169413|FG003|Overall Study|Disease progression|7|||
25064240|NCT02846779|50169432|FG000|Overall Study|Lost Enrollment|83|||
25064241|NCT02846779|50169433|FG001|Overall Study|Lost Enrollment|82|||
25064242|NCT02846779|50169434|FG002|Overall Study|Lost Enrollment|86|||
25064243|NCT02846779|50169432|FG000|Overall Study|Less than 31 days of follow-up|56|||
25064244|NCT02846779|50169433|FG001|Overall Study|Less than 31 days of follow-up|45|||
25064245|NCT02846779|50169434|FG002|Overall Study|Less than 31 days of follow-up|52|||
25064246|NCT00406393|50169444|FG000|Overall Study|Did not undergo transplantation|2|||
25064247|NCT00406393|50169445|FG001|Overall Study|Did not undergo transplantation|1|||
25064248|NCT02845375|50169454|FG000|Overall Study|upper airway obstruction|1|||
25064249|NCT02845375|50169455|FG001|Overall Study|upper airway obstruction|2|||
25064250|NCT02845375|50169456|FG002|Overall Study|upper airway obstruction|1|||
25064251|NCT02658734|50169464|FG000|Overall Study|Adverse Event|2|||
25064252|NCT02658734|50169464|FG000|Overall Study|Death|4|||
25064253|NCT02658734|50169464|FG000|Overall Study|Lost to Follow-up|7|||
25064254|NCT02658734|50169464|FG000|Overall Study|Withdrawal of Consent|16|||
25064255|NCT02658734|50169464|FG000|Overall Study|Disease Progression|28|||
25064256|NCT02844439|50169468|FG000|Overall Study|Withdrawal by Subject|1|||
25064257|NCT02844439|50169468|FG000|Overall Study|Lost to Follow-up|2|||
25064258|NCT02844439|50169468|FG000|Overall Study|Termination by Sponsor|4|||
25064259|NCT02844439|50169468|FG000|Overall Study|Death|28|||
25064260|NCT02844439|50169468|FG000|Overall Study|Other|5|||
25064261|NCT01677182|50169482|FG000|Overall Study|Adverse Event|2|||
25064262|NCT01677182|50169483|FG001|Overall Study|Adverse Event|1|||
25064263|NCT01677182|50169484|FG002|Overall Study|Adverse Event|8|||
25064264|NCT01677182|50169482|FG000|Overall Study|Protocol Violation|5|||
25064265|NCT01677182|50169483|FG001|Overall Study|Protocol Violation|1|||
25064266|NCT01677182|50169484|FG002|Overall Study|Protocol Violation|4|||
25064267|NCT01677182|50169482|FG000|Overall Study|Lost to Follow-up|4|||
25064268|NCT01677182|50169483|FG001|Overall Study|Lost to Follow-up|0|||
25064269|NCT01677182|50169484|FG002|Overall Study|Lost to Follow-up|3|||
25064270|NCT01677182|50169482|FG000|Overall Study|Withdrawal by Subject|7|||
25064271|NCT01677182|50169483|FG001|Overall Study|Withdrawal by Subject|12|||
25064272|NCT01677182|50169484|FG002|Overall Study|Withdrawal by Subject|10|||
25064273|NCT01677182|50169482|FG000|Overall Study|Study termination|12|||
25064274|NCT01677182|50169483|FG001|Overall Study|Study termination|9|||
25064275|NCT01677182|50169484|FG002|Overall Study|Study termination|11|||
25064276|NCT01677182|50169482|FG000|Overall Study|Lack of Efficacy|3|||
25064277|NCT01677182|50169483|FG001|Overall Study|Lack of Efficacy|0|||
25064278|NCT01677182|50169484|FG002|Overall Study|Lack of Efficacy|1|||
25064279|NCT01677182|50169482|FG000|Overall Study|Other reasons|1|||
25064280|NCT01677182|50169483|FG001|Overall Study|Other reasons|5|||
25064281|NCT01677182|50169484|FG002|Overall Study|Other reasons|2|||
25064282|NCT02843659|50169495|FG000|Overall Study|Subject Withdrew Consent|0|||
25064283|NCT02843659|50169496|FG001|Overall Study|Subject Withdrew Consent|0|||
25064284|NCT02843659|50169497|FG002|Overall Study|Subject Withdrew Consent|1|||
25064285|NCT02843659|50169495|FG000|Overall Study|Administrative Reason by Sponsor|4|||
25064286|NCT02843659|50169496|FG001|Overall Study|Administrative Reason by Sponsor|5|||
25064287|NCT02843659|50169497|FG002|Overall Study|Administrative Reason by Sponsor|4|||
25064288|NCT02843659|50169495|FG000|Overall Study|Adverse Event|0|||
25064289|NCT02843659|50169496|FG001|Overall Study|Adverse Event|1|||
25064290|NCT02843659|50169497|FG002|Overall Study|Adverse Event|0|||
25064291|NCT00708435|50169507|FG000|Overall Study|Death / Serious Adverse Event|10|||
25064292|NCT00708435|50169508|FG001|Overall Study|Death / Serious Adverse Event|5|||
25064293|NCT00708435|50169507|FG000|Overall Study|Lost to Follow-up|9|||
25064294|NCT00708435|50169508|FG001|Overall Study|Lost to Follow-up|4|||
25064295|NCT00708435|50169507|FG000|Overall Study|Withdrawal by Subject|3|||
25064296|NCT00708435|50169508|FG001|Overall Study|Withdrawal by Subject|7|||
25064297|NCT00708435|50169507|FG000|Overall Study|Adverse Event|1|||
25064298|NCT00708435|50169508|FG001|Overall Study|Adverse Event|0|||
25064299|NCT00708435|50169507|FG000|Overall Study|Protocol Violation|0|||
25064300|NCT00708435|50169508|FG001|Overall Study|Protocol Violation|1|||
25064301|NCT00708435|50169507|FG000|Overall Study|Intervention by primary care physician|1|||
25064302|NCT00708435|50169508|FG001|Overall Study|Intervention by primary care physician|0|||
25064303|NCT00708435|50169507|FG000|Overall Study|Refused hospitalization|1|||
25064304|NCT00708435|50169508|FG001|Overall Study|Refused hospitalization|0|||
25064305|NCT02841787|50169519|FG000|Overall Study|Lost to Follow-up|1|||
25064306|NCT02841787|50169520|FG001|Overall Study|Lost to Follow-up|0|||
25064307|NCT02841787|50169521|FG002|Overall Study|Lost to Follow-up|0|||
25064308|NCT02841787|50169519|FG000|Overall Study|Symptoms dropped below threshold|1|||
25064309|NCT02841787|50169520|FG001|Overall Study|Symptoms dropped below threshold|0|||
25064310|NCT02841787|50169521|FG002|Overall Study|Symptoms dropped below threshold|0|||
25064311|NCT02841787|50169519|FG000|Overall Study|Withdrawal by Subject|1|||
25064312|NCT02841787|50169520|FG001|Overall Study|Withdrawal by Subject|4|||
25064313|NCT02841787|50169521|FG002|Overall Study|Withdrawal by Subject|0|||
25064314|NCT01376037|50169531|FG000|Overall Study|Lost to Follow-up|0|||
25064315|NCT01376037|50169532|FG001|Overall Study|Lost to Follow-up|2|||
25064316|NCT02657408|50169540|FG000|Overall Study|Adverse Event|3|||
25064317|NCT02657408|50169541|FG001|Overall Study|Adverse Event|7|||
25064318|NCT02841709|50169547|FG000|5th Intervention|Adverse Event|2|||
25064319|NCT02841709|50169548|FG001|5th Intervention|Adverse Event|0|||
25064320|NCT02841709|50169549|FG002|5th Intervention|Adverse Event|0|||
25064321|NCT02841709|50169550|FG003|5th Intervention|Adverse Event|0|||
25064322|NCT02841709|50169551|FG004|5th Intervention|Adverse Event|2|||
25064323|NCT01353859|50169564|FG000|Overall Study|Adverse Event|3|||
25064324|NCT01353859|50169564|FG000|Overall Study|Lack of Efficacy|1|||
25064325|NCT02850965|50169570|FG000|Overall Study|Other than listed|3|||
25064326|NCT02850965|50169571|FG001|Overall Study|Other than listed|4|||
25064327|NCT02850965|50169570|FG000|Overall Study|Protocol Violation|0|||
25064328|NCT02850965|50169571|FG001|Overall Study|Protocol Violation|2|||
25064329|NCT02850965|50169570|FG000|Overall Study|Lost to Follow-up|5|||
25064330|NCT02850965|50169571|FG001|Overall Study|Lost to Follow-up|3|||
25064331|NCT02850965|50169570|FG000|Overall Study|Lack of Efficacy|4|||
25064332|NCT02850965|50169571|FG001|Overall Study|Lack of Efficacy|8|||
25064333|NCT02850965|50169570|FG000|Overall Study|Adverse Event|3|||
25064334|NCT02850965|50169571|FG001|Overall Study|Adverse Event|2|||
25064335|NCT02850965|50169570|FG000|Overall Study|Withdrawal by Subject|3|||
25064336|NCT02850965|50169571|FG001|Overall Study|Withdrawal by Subject|4|||
25064337|NCT02850965|50169570|FG000|Overall Study|Physician Decision|0|||
25064338|NCT02850965|50169571|FG001|Overall Study|Physician Decision|1|||
25064339|NCT02850965|50169570|FG000|Overall Study|Randomized but not treated|0|||
25064340|NCT02850965|50169571|FG001|Overall Study|Randomized but not treated|1|||
25064341|NCT01375959|50169579|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
25064342|NCT01375959|50169580|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
25064343|NCT01375959|50169579|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
25064344|NCT01375959|50169580|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
25064345|NCT01375959|50169579|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
25064346|NCT01375959|50169580|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
25064347|NCT00708201|50169590|FG000|Overall Study|Adverse Event|4|||
25064348|NCT00708201|50169591|FG001|Overall Study|Adverse Event|4|||
25064349|NCT00708201|50169590|FG000|Overall Study|Withdrawal by Subject|1|||
25064350|NCT00708201|50169591|FG001|Overall Study|Withdrawal by Subject|1|||
25064351|NCT00708201|50169590|FG000|Overall Study|Lost to Follow-up|2|||
25064352|NCT00708201|50169591|FG001|Overall Study|Lost to Follow-up|0|||
25064353|NCT00708201|50169590|FG000|Overall Study|Protocol Violation|0|||
25064354|NCT00708201|50169591|FG001|Overall Study|Protocol Violation|1|||
25064355|NCT02848313|50169599|FG000|Overall Study|Adverse Event|1|||
25064356|NCT02848313|50169600|FG001|Overall Study|Adverse Event|2|||
25064357|NCT02848313|50169599|FG000|Overall Study|Lack of Efficacy|0|||
25064358|NCT02848313|50169600|FG001|Overall Study|Lack of Efficacy|1|||
25064359|NCT02848313|50169599|FG000|Overall Study|Withdrawal by Subject|1|||
25064360|NCT02848313|50169600|FG001|Overall Study|Withdrawal by Subject|1|||
25064361|NCT02848313|50169599|FG000|Overall Study|Lost to follow up|1|||
25064362|NCT02848313|50169600|FG001|Overall Study|Lost to follow up|0|||
25064363|NCT02728089|50169606|FG000|Overall Study|Physician Decision|2|||
25064364|NCT02728089|50169606|FG000|Overall Study|Withdrawal by Subject|1|||
25064365|NCT02840461|50169613|FG000|Overall Study|Adverse Event|1|||
25064366|NCT02840461|50169614|FG001|Overall Study|Adverse Event|5|||
25064367|NCT02840461|50169615|FG002|Overall Study|Adverse Event|3|||
25064368|NCT02840461|50169613|FG000|Overall Study|Lost to Follow-up|10|||
25064369|NCT02840461|50169614|FG001|Overall Study|Lost to Follow-up|7|||
25064370|NCT02840461|50169615|FG002|Overall Study|Lost to Follow-up|6|||
25064371|NCT02840461|50169613|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
25064372|NCT02840461|50169614|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
25064373|NCT02840461|50169615|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
25064374|NCT02840461|50169613|FG000|Overall Study|Protocol Violation|2|||
25064375|NCT02840461|50169614|FG001|Overall Study|Protocol Violation|3|||
25064376|NCT02840461|50169615|FG002|Overall Study|Protocol Violation|1|||
25064377|NCT02840461|50169613|FG000|Overall Study|Withdrawal by Subject|10|||
25064378|NCT02840461|50169614|FG001|Overall Study|Withdrawal by Subject|6|||
25064379|NCT02840461|50169615|FG002|Overall Study|Withdrawal by Subject|2|||
25064380|NCT02840461|50169613|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
25064381|NCT02840461|50169614|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
25064382|NCT02840461|50169615|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
25064383|NCT02839681|50169624|FG000|Overall Study|Death|2|||
25064384|NCT01676012|50169628|FG000|Overall Study|Adverse Event|2|||
25064385|NCT01676012|50169628|FG000|Overall Study|incomplete set of videos|1|||
25064386|NCT02727777|50169644|FG000|Overall Study|Screen Failure|2|||
25162857|NCT01967147|50285219|FG001|Overall Study|Withdrawal by Subject|4|||
25162858|NCT01967147|50285218|FG000|Overall Study|Non-compliance with Study Drug|0|||
25276723|NCT01238120|50590674|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
25276724|NCT01238120|50590675|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
25064387|NCT02727777|50169645|FG001|Overall Study|Screen Failure|0|||
25064388|NCT02727777|50169646|FG002|Overall Study|Screen Failure|0|||
25064389|NCT02727777|50169644|FG000|Overall Study|Progressive disease|2|||
25064390|NCT02727777|50169645|FG001|Overall Study|Progressive disease|0|||
25064391|NCT02727777|50169646|FG002|Overall Study|Progressive disease|0|||
25276725|NCT01238120|50590676|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
25064392|NCT00707577|50169656|FG000|Overall Study|Withdrawal by Subject|3|||
25064393|NCT00707577|50169657|FG001|Overall Study|Withdrawal by Subject|2|||
25064394|NCT00707577|50169656|FG000|Overall Study|Lost to Follow-up|34|||
25064395|NCT00707577|50169657|FG001|Overall Study|Lost to Follow-up|25|||
25064396|NCT00707577|50169656|FG000|Overall Study|Left employment|13|||
25064397|NCT00707577|50169657|FG001|Overall Study|Left employment|10|||
25064398|NCT00707577|50169656|FG000|Overall Study|Pregnancy|4|||
25064399|NCT00707577|50169657|FG001|Overall Study|Pregnancy|1|||
25064400|NCT01675622|50169665|FG000|Overall Study|Withdrawal by Subject|2|||
25064401|NCT01675622|50169666|FG001|Overall Study|Withdrawal by Subject|2|||
25064402|NCT01675622|50169665|FG000|Overall Study|Adverse Event|12|||
25064403|NCT01675622|50169666|FG001|Overall Study|Adverse Event|10|||
25064404|NCT01675622|50169665|FG000|Overall Study|Protocol Violation|4|||
25064405|NCT01675622|50169666|FG001|Overall Study|Protocol Violation|1|||
25064406|NCT01675622|50169665|FG000|Overall Study|Lack of Efficacy|2|||
25064407|NCT01675622|50169666|FG001|Overall Study|Lack of Efficacy|4|||
25064408|NCT01675622|50169665|FG000|Overall Study|Lost to Follow-up|1|||
25064409|NCT01675622|50169666|FG001|Overall Study|Lost to Follow-up|3|||
25064410|NCT01675622|50169665|FG000|Overall Study|Other|5|||
25064411|NCT01675622|50169666|FG001|Overall Study|Other|4|||
25064412|NCT02655224|50169674|FG000|Overall Study|Adverse Event|1|||
25064413|NCT02655224|50169675|FG001|Overall Study|Adverse Event|1|||
25064414|NCT01675544|50169681|FG000|Overall Study|Withdrawal by Subject|2|||
25064415|NCT02838901|50169724|FG000|Overall Study|Withdrawal by Subject|1|||
25064416|NCT02838901|50169725|FG001|Overall Study|Withdrawal by Subject|1|||
25064417|NCT02838901|50169724|FG000|Overall Study|Lost to Follow-up|1|||
25064418|NCT02838901|50169725|FG001|Overall Study|Lost to Follow-up|1|||
25064419|NCT00706797|50169753|FG000|Overall Study|Lack of Efficacy|3|||
25064420|NCT00706797|50169754|FG001|Overall Study|Lack of Efficacy|0|||
25064421|NCT00706797|50169753|FG000|Overall Study|Adverse Event|0|||
25064422|NCT00706797|50169754|FG001|Overall Study|Adverse Event|3|||
25064423|NCT00706797|50169753|FG000|Overall Study|Withdrawal by Subject|8|||
25064424|NCT00706797|50169754|FG001|Overall Study|Withdrawal by Subject|1|||
25064425|NCT00706797|50169753|FG000|Overall Study|Death|1|||
25064426|NCT00706797|50169754|FG001|Overall Study|Death|0|||
25064427|NCT00706797|50169753|FG000|Overall Study|Discontinuation of study by sponsor|52|||
25064428|NCT00706797|50169754|FG001|Overall Study|Discontinuation of study by sponsor|63|||
25064429|NCT00706797|50169753|FG000|Overall Study|Protocol Violation|3|||
25064430|NCT00706797|50169754|FG001|Overall Study|Protocol Violation|2|||
25064431|NCT00706797|50169753|FG000|Overall Study|Lost to Follow-up|1|||
25064432|NCT00706797|50169754|FG001|Overall Study|Lost to Follow-up|2|||
25064433|NCT00706797|50169753|FG000|Overall Study|Other|1|||
25064434|NCT00706797|50169754|FG001|Overall Study|Other|0|||
25064435|NCT00706641|50169760|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
25064436|NCT00706641|50169760|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
25064437|NCT00706641|50169760|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
25064438|NCT01362530|50169766|FG000|Base Study (Cycle 1)|Adverse Event|2|||
25064439|NCT01362530|50169767|FG001|Base Study (Cycle 1)|Adverse Event|0|||
25064440|NCT01362530|50169766|FG000|Base Study (Cycle 1)|Physician Decision|0|||
25064441|NCT01362530|50169767|FG001|Base Study (Cycle 1)|Physician Decision|1|||
25064442|NCT01362530|50169766|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
24964150|NCT00438815|50054129|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
24964151|NCT00438815|50054129|FG000|Overall Study|Lost to Follow-up|6|||
24964152|NCT00438815|50054129|FG000|Overall Study|Withdrawal by Subject|6|||
24964153|NCT00438815|50054129|FG000|Overall Study|Death|1|||
24964154|NCT00438659|50054135|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
24964155|NCT00438659|50054136|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
24964156|NCT00438659|50054135|FG000|Overall Study|Cancel|5|||
24964157|NCT00438659|50054136|FG001|Overall Study|Cancel|2|||
24964158|NCT00437645|50054145|FG000|Overall Study|Adverse Event|15|||
25064443|NCT01362530|50169767|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
25064444|NCT01362530|50169766|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
25064445|NCT01362530|50169767|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
25162859|NCT01967147|50285219|FG001|Overall Study|Non-compliance with Study Drug|3|||
25162860|NCT01967147|50285218|FG000|Overall Study|Other|4|||
25162861|NCT01967147|50285219|FG001|Overall Study|Other|5|||
25162862|NCT01967069|50285228|FG000|Overall Study|Adverse Event|2|||
25064446|NCT01362530|50169766|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
25064447|NCT01362530|50169767|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
24964159|NCT00437645|50054146|FG001|Overall Study|Adverse Event|84|||
24964160|NCT00437645|50054145|FG000|Overall Study|Withdrawal by Subject|10|||
25064448|NCT01362530|50169766|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
25064449|NCT01362530|50169767|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
25064450|NCT01362530|50169766|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
25064451|NCT01362530|50169767|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
25064452|NCT01362530|50169766|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
25162863|NCT01967069|50285229|FG001|Overall Study|Adverse Event|2|||
25162864|NCT01967069|50285228|FG000|Overall Study|Lost to Follow-up|5|||
25064453|NCT01362530|50169767|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
25064454|NCT01362530|50169766|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
25064455|NCT01362530|50169767|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
25064456|NCT01362530|50169766|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
25064457|NCT01362530|50169767|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
25064458|NCT01362530|50169766|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
25064459|NCT01362530|50169767|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
25064460|NCT01362530|50169766|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
25064461|NCT01362530|50169767|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
25064462|NCT01362530|50169766|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
25064463|NCT01362530|50169767|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
25064464|NCT02654054|50169777|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
25064465|NCT02654054|50169778|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
25064466|NCT02654054|50169779|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
25064467|NCT02654054|50169777|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
25064468|NCT02654054|50169778|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
25064469|NCT02654054|50169779|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
25064470|NCT02654054|50169777|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
25064471|NCT02654054|50169778|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
25064472|NCT02654054|50169779|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
25064473|NCT02654054|50169777|FG000|Post-Treatment Follow-Up Period|Other|1|||
25064474|NCT02654054|50169778|FG001|Post-Treatment Follow-Up Period|Other|0|||
25064475|NCT02654054|50169779|FG002|Post-Treatment Follow-Up Period|Other|4|||
25064476|NCT02654054|50169777|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
25064477|NCT02654054|50169778|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
25064478|NCT02654054|50169779|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
25064479|NCT02653664|50169800|FG000|Post-Treatment|Withdrawal by Subject|6|||
25064480|NCT02653664|50169801|FG001|Post-Treatment|Withdrawal by Subject|5|||
25064481|NCT02653664|50169802|FG002|Post-Treatment|Withdrawal by Subject|7|||
25064482|NCT02653664|50169800|FG000|Post-Treatment|Lost to Follow-up|8|||
25064483|NCT02653664|50169801|FG001|Post-Treatment|Lost to Follow-up|1|||
25064484|NCT02653664|50169802|FG002|Post-Treatment|Lost to Follow-up|7|||
25064485|NCT02653664|50169800|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
25064486|NCT02653664|50169801|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
25064487|NCT02653664|50169802|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
25064488|NCT02653664|50169800|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
25064489|NCT02653664|50169801|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
25064490|NCT02653664|50169802|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
25064491|NCT02653664|50169800|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
25064492|NCT02653664|50169801|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
25064493|NCT02653664|50169802|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
25064494|NCT02653664|50169800|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
25064495|NCT02653664|50169801|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
25064496|NCT02653664|50169802|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
25064497|NCT02653664|50169800|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
25064498|NCT02653664|50169801|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
25064499|NCT02653664|50169802|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
25064500|NCT02653664|50169800|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
25064501|NCT02653664|50169801|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
25064502|NCT02653664|50169802|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
25064503|NCT02653664|50169800|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
25064504|NCT02653664|50169801|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
25064505|NCT02653664|50169802|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
25064506|NCT02653664|50169800|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
25064507|NCT02653664|50169801|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
25064508|NCT02653664|50169802|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
25064509|NCT02488629|50169820|FG000|Overall Study|Lack of Efficacy|3|||
25064510|NCT02488629|50169821|FG001|Overall Study|Lack of Efficacy|1|||
25064511|NCT02488629|50169822|FG002|Overall Study|Lack of Efficacy|0|||
25064512|NCT02488629|50169823|FG003|Overall Study|Lack of Efficacy|0|||
25064513|NCT02488629|50169820|FG000|Overall Study|Withdrawal by Subject|0|||
25064514|NCT02488629|50169821|FG001|Overall Study|Withdrawal by Subject|1|||
25064515|NCT02488629|50169822|FG002|Overall Study|Withdrawal by Subject|0|||
25064516|NCT02488629|50169823|FG003|Overall Study|Withdrawal by Subject|0|||
25064517|NCT02727699|50169834|FG000|Overall Study|Adverse Event|2|||
25064518|NCT02727699|50169835|FG001|Overall Study|Adverse Event|0|||
25064519|NCT02727699|50169834|FG000|Overall Study|Withdrawal by Subject|5|||
25064520|NCT02727699|50169835|FG001|Overall Study|Withdrawal by Subject|3|||
24964161|NCT00437645|50054146|FG001|Overall Study|Withdrawal by Subject|22|||
25064521|NCT02727699|50169834|FG000|Overall Study|Protocol Violation|0|||
25064522|NCT02727699|50169835|FG001|Overall Study|Protocol Violation|1|||
25064523|NCT02727699|50169834|FG000|Overall Study|Physician Decision|0|||
25064524|NCT02727699|50169835|FG001|Overall Study|Physician Decision|1|||
25064525|NCT02727699|50169834|FG000|Overall Study|Lost to Follow-up|1|||
25064526|NCT02727699|50169835|FG001|Overall Study|Lost to Follow-up|0|||
25064527|NCT02727699|50169834|FG000|Overall Study|Sponsor Decision|1|||
25064528|NCT02727699|50169835|FG001|Overall Study|Sponsor Decision|0|||
25064529|NCT03576716|50169843|FG000|Overall Study|Withdrawal by Subject|0|||
25064530|NCT03576716|50169844|FG001|Overall Study|Withdrawal by Subject|1|||
25064531|NCT02847637|50169863|FG000|Overall Study|Withdrawal by Subject|0|||
25064532|NCT02847637|50169864|FG001|Overall Study|Withdrawal by Subject|1|||
25064533|NCT02847637|50169865|FG002|Overall Study|Withdrawal by Subject|1|||
25064534|NCT02847637|50169866|FG003|Overall Study|Withdrawal by Subject|0|||
25064535|NCT02847637|50169863|FG000|Overall Study|Lost to Follow-up|1|||
25064536|NCT02847637|50169864|FG001|Overall Study|Lost to Follow-up|1|||
25064537|NCT02847637|50169865|FG002|Overall Study|Lost to Follow-up|0|||
25064538|NCT02847637|50169866|FG003|Overall Study|Lost to Follow-up|0|||
25064539|NCT02652260|50169892|FG000|Overall Study|Pregnancy|0|||
25064540|NCT02652260|50169893|FG001|Overall Study|Pregnancy|1|||
25064541|NCT02652260|50169892|FG000|Overall Study|Withdrawal by Subject|0|||
25064542|NCT02652260|50169893|FG001|Overall Study|Withdrawal by Subject|1|||
25064543|NCT00706095|50169905|FG000|Overall Study|Progressive Disease|4|||
25064544|NCT00706095|50169906|FG001|Overall Study|Progressive Disease|5|||
25064545|NCT00706095|50169907|FG002|Overall Study|Progressive Disease|3|||
25064546|NCT00706095|50169905|FG000|Overall Study|Clinical Progression|1|||
25064547|NCT00706095|50169906|FG001|Overall Study|Clinical Progression|2|||
25064548|NCT00706095|50169907|FG002|Overall Study|Clinical Progression|2|||
25064549|NCT00706095|50169905|FG000|Overall Study|Withdrawal by Subject|1|||
25064550|NCT00706095|50169906|FG001|Overall Study|Withdrawal by Subject|0|||
25064551|NCT00706095|50169907|FG002|Overall Study|Withdrawal by Subject|0|||
25064552|NCT02837731|50169917|FG000|Allocation|Admitted to General Floor|3|||
25064553|NCT02837731|50169918|FG001|Allocation|Admitted to General Floor|4|||
25064554|NCT02837731|50169917|FG000|Allocation|Immediate surgery/withdrew|2|||
25064555|NCT02837731|50169918|FG001|Allocation|Immediate surgery/withdrew|0|||
25064556|NCT02837731|50169917|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
25162865|NCT01967069|50285229|FG001|Overall Study|Lost to Follow-up|2|||
25162866|NCT01967069|50285228|FG000|Overall Study|Withdrawal by Subject|1|||
24964162|NCT00437645|50054145|FG000|Overall Study|Protocol Violation|3|||
24964163|NCT00437645|50054146|FG001|Overall Study|Protocol Violation|3|||
24964164|NCT00437645|50054145|FG000|Overall Study|Lost to Follow-up|2|||
24964165|NCT00437645|50054146|FG001|Overall Study|Lost to Follow-up|3|||
24964166|NCT00437645|50054145|FG000|Overall Study|Administrative problems|2|||
24964167|NCT00437645|50054146|FG001|Overall Study|Administrative problems|1|||
24964168|NCT00437645|50054145|FG000|Overall Study|Lack of Efficacy|2|||
24964169|NCT00437645|50054146|FG001|Overall Study|Lack of Efficacy|1|||
24964170|NCT00437645|50054145|FG000|Overall Study|Condition no longer requires study drug|1|||
24964171|NCT00437645|50054146|FG001|Overall Study|Condition no longer requires study drug|1|||
24964172|NCT00437489|50054154|FG000|Overall Study|Study terminated by sponsor|23|||
24964173|NCT00437489|50054155|FG001|Overall Study|Study terminated by sponsor|21|||
25064557|NCT02837731|50169918|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
25064558|NCT02837731|50169917|FG000|Allocation|Withdrawal by Subject|2|||
25064559|NCT02837731|50169918|FG001|Allocation|Withdrawal by Subject|0|||
25064560|NCT02837731|50169917|FG000|Allocation|Device not available|1|||
24964174|NCT00437489|50054154|FG000|Overall Study|Lost to Follow-up|0|||
25064561|NCT02837731|50169918|FG001|Allocation|Device not available|0|||
25064562|NCT02837731|50169917|FG000|Allocation|Protocol not implemented|7|||
25064563|NCT02837731|50169918|FG001|Allocation|Protocol not implemented|0|||
25162867|NCT01967069|50285229|FG001|Overall Study|Withdrawal by Subject|3|||
25064564|NCT02837731|50169917|FG000|Allocation|Moribund/Do not resuscitate|2|||
25064565|NCT02837731|50169918|FG001|Allocation|Moribund/Do not resuscitate|0|||
25064566|NCT02837731|50169917|FG000|Allocation|Did not meet sepsis criteria|1|||
25064567|NCT02837731|50169918|FG001|Allocation|Did not meet sepsis criteria|2|||
25064568|NCT02837731|50169917|FG000|Allocation|Known aortic abnormalities|0|||
25064569|NCT02837731|50169918|FG001|Allocation|Known aortic abnormalities|1|||
25064570|NCT02836873|50169926|FG000|Overall Study|Protocol Violation|0|||
25064571|NCT02836873|50169927|FG001|Overall Study|Protocol Violation|1|||
25064572|NCT02836873|50169926|FG000|Overall Study|Adverse Event|1|||
25064573|NCT02836873|50169927|FG001|Overall Study|Adverse Event|4|||
25064574|NCT02836873|50169926|FG000|Overall Study|Withdrawal by Subject|2|||
25064575|NCT02836873|50169927|FG001|Overall Study|Withdrawal by Subject|2|||
25064576|NCT02836873|50169926|FG000|Overall Study|Lost to Follow-up|1|||
25064577|NCT02836873|50169927|FG001|Overall Study|Lost to Follow-up|3|||
25064578|NCT02836873|50169926|FG000|Overall Study|Physician Decision|0|||
25064579|NCT02836873|50169927|FG001|Overall Study|Physician Decision|1|||
25064580|NCT02836873|50169926|FG000|Overall Study|Other|1|||
25064581|NCT02836873|50169927|FG001|Overall Study|Other|0|||
25064582|NCT02836249|50169935|FG000|Overall Study|Randomized but Never Treated|0|||
25064583|NCT02836249|50169936|FG001|Overall Study|Randomized but Never Treated|1|||
25064584|NCT02836249|50169935|FG000|Overall Study|Pregnancy|2|||
25064585|NCT02836249|50169936|FG001|Overall Study|Pregnancy|0|||
25064586|NCT02836249|50169935|FG000|Overall Study|Withdrew Consent|0|||
25064587|NCT02836249|50169936|FG001|Overall Study|Withdrew Consent|1|||
25064588|NCT02836249|50169935|FG000|Overall Study|Lost to Follow-up|0|||
25064589|NCT02836249|50169936|FG001|Overall Study|Lost to Follow-up|1|||
25064590|NCT02836249|50169935|FG000|Overall Study|Still on Study|121|||
25064591|NCT02836249|50169936|FG001|Overall Study|Still on Study|55|||
25064592|NCT01342081|50169954|FG000|Overall Study|Did not receive allocated intervention|0|||
25064593|NCT01342081|50169955|FG001|Overall Study|Did not receive allocated intervention|0|||
25064594|NCT01342081|50169956|FG002|Overall Study|Did not receive allocated intervention|1|||
25064595|NCT01342081|50169954|FG000|Overall Study|Adverse Event|1|||
25064596|NCT01342081|50169955|FG001|Overall Study|Adverse Event|0|||
25064597|NCT01342081|50169956|FG002|Overall Study|Adverse Event|0|||
25064598|NCT01342081|50169954|FG000|Overall Study|Physician Decision|0|||
25064599|NCT01342081|50169955|FG001|Overall Study|Physician Decision|1|||
25064600|NCT01342081|50169956|FG002|Overall Study|Physician Decision|0|||
25064601|NCT01342081|50169954|FG000|Overall Study|Withdrawal by Subject|1|||
25064602|NCT01342081|50169955|FG001|Overall Study|Withdrawal by Subject|1|||
25064603|NCT01342081|50169956|FG002|Overall Study|Withdrawal by Subject|0|||
25064604|NCT01341457|50169966|FG000|Overall Study|Adverse Event|2|||
25064605|NCT01341457|50169967|FG001|Overall Study|Adverse Event|0|||
25064606|NCT02832037|50169979|FG000|Overall Study|Administrative reasons|0|||
25064607|NCT02832037|50169980|FG001|Overall Study|Administrative reasons|0|||
25064608|NCT02832037|50169981|FG002|Overall Study|Administrative reasons|1|||
25064609|NCT02832037|50169982|FG003|Overall Study|Administrative reasons|0|||
25064610|NCT02832037|50169983|FG004|Overall Study|Administrative reasons|0|||
25064611|NCT02832037|50169979|FG000|Overall Study|Protocol Violation|3|||
25064612|NCT02832037|50169980|FG001|Overall Study|Protocol Violation|0|||
25064613|NCT02832037|50169981|FG002|Overall Study|Protocol Violation|4|||
25064614|NCT02832037|50169982|FG003|Overall Study|Protocol Violation|1|||
25064615|NCT02832037|50169983|FG004|Overall Study|Protocol Violation|2|||
25064616|NCT02832037|50169979|FG000|Overall Study|Lost to Follow-up|2|||
25064617|NCT02832037|50169980|FG001|Overall Study|Lost to Follow-up|0|||
25064618|NCT02832037|50169981|FG002|Overall Study|Lost to Follow-up|3|||
25064619|NCT02832037|50169982|FG003|Overall Study|Lost to Follow-up|0|||
25064620|NCT02832037|50169983|FG004|Overall Study|Lost to Follow-up|5|||
25064621|NCT02832037|50169979|FG000|Overall Study|Withdrawal by Subject|9|||
25064622|NCT02832037|50169980|FG001|Overall Study|Withdrawal by Subject|8|||
25064623|NCT02832037|50169981|FG002|Overall Study|Withdrawal by Subject|0|||
25064624|NCT02832037|50169982|FG003|Overall Study|Withdrawal by Subject|4|||
25064625|NCT02832037|50169983|FG004|Overall Study|Withdrawal by Subject|8|||
25064626|NCT02832037|50169979|FG000|Overall Study|Adverse Event|5|||
25064627|NCT02832037|50169980|FG001|Overall Study|Adverse Event|4|||
25064628|NCT02832037|50169981|FG002|Overall Study|Adverse Event|0|||
25064629|NCT02832037|50169982|FG003|Overall Study|Adverse Event|2|||
25064630|NCT02832037|50169983|FG004|Overall Study|Adverse Event|4|||
25064631|NCT01675154|50169999|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
25186657|NCT01391663|50337334|FG001|Overall Study|Withdrawal by Subject|0|||
25064632|NCT01675154|50170000|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
25064633|NCT01675154|50170001|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
25064634|NCT01675154|50170002|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
25064635|NCT02744755|50170026|FG000|Study Period 1|Protocol Violation|2|||
25064636|NCT02744755|50170027|FG001|Study Period 1|Protocol Violation|1|||
25064637|NCT02744755|50170026|FG000|Study Period 1|not defined|0|||
25064638|NCT02744755|50170027|FG001|Study Period 1|not defined|1|||
25064639|NCT02744755|50170026|FG000|Study Period 1|Pregnancy|1|||
25064640|NCT02744755|50170027|FG001|Study Period 1|Pregnancy|0|||
25064641|NCT02744755|50170026|FG000|Study Period 1|Adverse Event|1|||
25064642|NCT02744755|50170027|FG001|Study Period 1|Adverse Event|1|||
25064643|NCT02744755|50170026|FG000|Study Period 1|Lost to Follow-up|1|||
25064644|NCT02744755|50170027|FG001|Study Period 1|Lost to Follow-up|1|||
25064645|NCT02744755|50170026|FG000|Study Period 1|Lack of Efficacy|1|||
25064646|NCT02744755|50170027|FG001|Study Period 1|Lack of Efficacy|0|||
25064647|NCT02744755|50170026|FG000|Study Period 1|Withdrawal by Subject|8|||
25064648|NCT02744755|50170027|FG001|Study Period 1|Withdrawal by Subject|4|||
25064649|NCT02744755|50170026|FG000|Study Period 2|Adverse Event|5|||
25064650|NCT02744755|50170027|FG001|Study Period 2|Adverse Event|0|||
25064651|NCT02744755|50170026|FG000|Study Period 2|Protocol Violation|1|||
25064652|NCT02744755|50170027|FG001|Study Period 2|Protocol Violation|0|||
25064653|NCT02744755|50170026|FG000|Study Period 2|not defined|3|||
25064654|NCT02744755|50170027|FG001|Study Period 2|not defined|2|||
25064655|NCT02744755|50170026|FG000|Study Period 2|Lost to Follow-up|0|||
25064656|NCT02744755|50170027|FG001|Study Period 2|Lost to Follow-up|2|||
25064657|NCT02744755|50170026|FG000|Study Period 2|Withdrawal by Subject|2|||
25064658|NCT02744755|50170027|FG001|Study Period 2|Withdrawal by Subject|2|||
25064659|NCT02744755|50170026|FG000|Study Period 2|Lack of Efficacy|3|||
25064660|NCT02744755|50170027|FG001|Study Period 2|Lack of Efficacy|2|||
25064661|NCT01356589|50170045|FG000|Overall Study|Enrolled, but not treated|3|||
25064662|NCT01356589|50170045|FG000|Overall Study|Dose data not recorded|2|||
25064663|NCT02830087|50170055|FG000|Overall Study|No study staff to follow-up patients|4|||
25064664|NCT02830087|50170056|FG001|Overall Study|No study staff to follow-up patients|4|||
25064665|NCT02830087|50170057|FG002|Overall Study|No study staff to follow-up patients|4|||
25064666|NCT02830087|50170058|FG003|Overall Study|No study staff to follow-up patients|3|||
25064667|NCT02830087|50170059|FG004|Overall Study|No study staff to follow-up patients|3|||
25064668|NCT02830087|50170060|FG005|Overall Study|No study staff to follow-up patients|3|||
25064669|NCT02829775|50170074|FG000|Overall Study|Death|1|||
25064670|NCT02829775|50170074|FG000|Overall Study|Withdrawal by Subject|3|||
25186658|NCT01391663|50337335|FG002|Overall Study|Withdrawal by Subject|1|||
24964175|NCT00437489|50054155|FG001|Overall Study|Lost to Follow-up|1|||
24964176|NCT00442559|50054163|FG000|Overall Study|Lost to Follow-up|32|||
24964177|NCT00442559|50054164|FG001|Overall Study|Lost to Follow-up|34|||
24964178|NCT00442559|50054163|FG000|Overall Study|Protocol Violation|1|||
24964179|NCT00442559|50054164|FG001|Overall Study|Protocol Violation|1|||
24964180|NCT00442559|50054163|FG000|Overall Study|Withdrawal by Subject|1|||
24964181|NCT00442559|50054164|FG001|Overall Study|Withdrawal by Subject|0|||
24964182|NCT00441701|50054186|FG000|Overall Study|Adverse Event|3|||
24964183|NCT00441701|50054187|FG001|Overall Study|Adverse Event|2|||
24964184|NCT00441701|50054188|FG002|Overall Study|Adverse Event|1|||
25064671|NCT02829775|50170074|FG000|Overall Study|Disease remission|1|||
25186659|NCT01391663|50337336|FG003|Overall Study|Withdrawal by Subject|0|||
25064672|NCT01355497|50170095|FG000|Overall Study|Death|19|||
25064673|NCT01355497|50170096|FG001|Overall Study|Death|18|||
25064674|NCT01355497|50170095|FG000|Overall Study|Lost to Follow-up|3|||
25064675|NCT01355497|50170096|FG001|Overall Study|Lost to Follow-up|0|||
25064676|NCT01355497|50170095|FG000|Overall Study|Protocol Violation|0|||
25064677|NCT01355497|50170096|FG001|Overall Study|Protocol Violation|1|||
25064678|NCT01355497|50170095|FG000|Overall Study|other-not provided|9|||
25064679|NCT01355497|50170096|FG001|Overall Study|other-not provided|4|||
25064680|NCT01355497|50170095|FG000|Overall Study|Withdrawal by Subject|12|||
25064681|NCT01355497|50170096|FG001|Overall Study|Withdrawal by Subject|20|||
25064682|NCT01355497|50170095|FG000|Overall Study|noncompliance|1|||
25064683|NCT01355497|50170096|FG001|Overall Study|noncompliance|2|||
25064684|NCT01355497|50170095|FG000|Overall Study|progressive disease|11|||
25064685|NCT01355497|50170096|FG001|Overall Study|progressive disease|8|||
25064686|NCT01355497|50170095|FG000|Overall Study|Adverse Event|11|||
25064687|NCT01355497|50170096|FG001|Overall Study|Adverse Event|10|||
25064688|NCT01355575|50170102|FG000|Overall Study|Withdrawal by Subject|2|||
25064689|NCT02826421|50170114|FG000|Overall Study|Adverse Event|1|||
25064690|NCT02826421|50170115|FG001|Overall Study|Adverse Event|0|||
25064691|NCT02826421|50170116|FG002|Overall Study|Adverse Event|0|||
25064692|NCT02826421|50170117|FG003|Overall Study|Adverse Event|1|||
25064693|NCT02826421|50170114|FG000|Overall Study|Withdrawal by Subject|1|||
25064694|NCT02826421|50170115|FG001|Overall Study|Withdrawal by Subject|3|||
25064695|NCT02826421|50170116|FG002|Overall Study|Withdrawal by Subject|1|||
25064696|NCT02826421|50170117|FG003|Overall Study|Withdrawal by Subject|1|||
25064697|NCT02826421|50170114|FG000|Overall Study|Reason not given|1|||
25064698|NCT02826421|50170115|FG001|Overall Study|Reason not given|0|||
25064699|NCT02826421|50170116|FG002|Overall Study|Reason not given|1|||
25064700|NCT02826421|50170117|FG003|Overall Study|Reason not given|0|||
25064701|NCT02825251|50170130|FG000|Overall Study|Adverse Event|0|||
25064702|NCT02825251|50170131|FG001|Overall Study|Adverse Event|1|||
25064703|NCT02825251|50170130|FG000|Overall Study|Lost to Follow-up|0|||
25064704|NCT02825251|50170131|FG001|Overall Study|Lost to Follow-up|1|||
25064705|NCT02825251|50170130|FG000|Overall Study|Withdrawal by Subject|1|||
25064706|NCT02825251|50170131|FG001|Overall Study|Withdrawal by Subject|4|||
25064707|NCT02825251|50170130|FG000|Overall Study|Unclassified|2|||
25064708|NCT02825251|50170131|FG001|Overall Study|Unclassified|0|||
25064709|NCT02824627|50170139|FG000|Overall Study|Adverse Event|1|||
25064710|NCT02824627|50170140|FG001|Overall Study|Adverse Event|2|||
25064711|NCT02824627|50170139|FG000|Overall Study|Lost to Follow-up|2|||
25064712|NCT02824627|50170140|FG001|Overall Study|Lost to Follow-up|1|||
25064713|NCT04860505|50170146|FG000|Overall Study|Lost to Follow-up|2|||
25064714|NCT04063865|50170152|FG000|Overall Study|Physician Decision|1|||
25064715|NCT04063865|50170153|FG001|Overall Study|Physician Decision|3|||
25064716|NCT04063865|50170152|FG000|Overall Study|Study Closed Prior to Completion|4|||
25064717|NCT04063865|50170153|FG001|Overall Study|Study Closed Prior to Completion|4|||
25064718|NCT04063865|50170152|FG000|Overall Study|Withdrawal by Subject|1|||
25064719|NCT04063865|50170153|FG001|Overall Study|Withdrawal by Subject|1|||
25064720|NCT03994211|50170161|FG000|Core Phase|Adverse Event|0|||
25064721|NCT03994211|50170162|FG001|Core Phase|Adverse Event|1|||
25064722|NCT03994211|50170163|FG002|Core Phase|Adverse Event|0|||
25064723|NCT03994211|50170161|FG000|Extension Phase|Adverse Event|0|||
25064724|NCT03994211|50170162|FG001|Extension Phase|Adverse Event|0|||
25064725|NCT03994211|50170163|FG002|Extension Phase|Adverse Event|1|||
25064726|NCT03994211|50170161|FG000|Extension Phase|Physician Decision|0|||
25064727|NCT03994211|50170162|FG001|Extension Phase|Physician Decision|0|||
25064728|NCT03994211|50170163|FG002|Extension Phase|Physician Decision|1|||
25064729|NCT03994211|50170161|FG000|Extension Phase|Progressive Disease|0|||
25064730|NCT03994211|50170162|FG001|Extension Phase|Progressive Disease|0|||
25064731|NCT03994211|50170163|FG002|Extension Phase|Progressive Disease|20|||
25064732|NCT03994211|50170161|FG000|Extension Phase|Withdrawal by Subject|0|||
25064733|NCT03994211|50170162|FG001|Extension Phase|Withdrawal by Subject|0|||
25064734|NCT03994211|50170163|FG002|Extension Phase|Withdrawal by Subject|2|||
25064735|NCT03818607|50170178|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
25064736|NCT03818607|50170179|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
25064737|NCT03818607|50170178|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
25064738|NCT03818607|50170179|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
25064739|NCT03818607|50170178|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
25064740|NCT03818607|50170179|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
25064741|NCT03300817|50170217|FG000|Overall Study|Withdrawal by Subject|1|||
25064742|NCT03300817|50170217|FG000|Overall Study|Adverse Event|1|||
25064743|NCT03300817|50170217|FG000|Overall Study|Subject Found to be Ineligible|2|||
25064744|NCT03144674|50170229|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
25064745|NCT03144674|50170230|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
25064746|NCT03144674|50170231|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
25064747|NCT03144674|50170232|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
25064748|NCT03144674|50170229|FG000|Overall Study|Death|3|||
25064749|NCT03144674|50170230|FG001|Overall Study|Death|1|||
25064750|NCT03144674|50170231|FG002|Overall Study|Death|1|||
25064751|NCT03144674|50170232|FG003|Overall Study|Death|10|||
25064752|NCT03144674|50170229|FG000|Overall Study|Lost to Follow-up|0|||
25064753|NCT03144674|50170230|FG001|Overall Study|Lost to Follow-up|1|||
25064754|NCT03144674|50170231|FG002|Overall Study|Lost to Follow-up|1|||
25064755|NCT03144674|50170232|FG003|Overall Study|Lost to Follow-up|1|||
25064756|NCT03144674|50170229|FG000|Overall Study|Withdrawal by Participant|0|||
25064757|NCT03144674|50170230|FG001|Overall Study|Withdrawal by Participant|0|||
25064758|NCT03144674|50170231|FG002|Overall Study|Withdrawal by Participant|0|||
25064759|NCT03144674|50170232|FG003|Overall Study|Withdrawal by Participant|3|||
25064760|NCT03144674|50170229|FG000|Overall Study|Reason not Specified|0|||
25064761|NCT03144674|50170230|FG001|Overall Study|Reason not Specified|0|||
25064762|NCT03144674|50170231|FG002|Overall Study|Reason not Specified|2|||
25064763|NCT03144674|50170232|FG003|Overall Study|Reason not Specified|4|||
25064764|NCT02521285|50170249|FG000|Overall Study|Lost to Follow-up|1|||
25064765|NCT02521285|50170250|FG001|Overall Study|Lost to Follow-up|1|||
25064766|NCT02521285|50170249|FG000|Overall Study|Withdrawal by Subject|1|||
25064767|NCT02521285|50170250|FG001|Overall Study|Withdrawal by Subject|1|||
25064768|NCT02521285|50170249|FG000|Overall Study|Adverse Event|0|||
25064769|NCT02521285|50170250|FG001|Overall Study|Adverse Event|1|||
25064770|NCT02422615|50170258|FG000|Overall Study|Progressive disease|193|||
25064771|NCT02422615|50170259|FG001|Overall Study|Progressive disease|142|||
25064772|NCT02422615|50170258|FG000|Overall Study|Adverse Event|41|||
25064773|NCT02422615|50170259|FG001|Overall Study|Adverse Event|10|||
25064774|NCT02422615|50170258|FG000|Overall Study|Physician Decision|22|||
25064775|NCT02422615|50170259|FG001|Overall Study|Physician Decision|7|||
25064776|NCT02422615|50170258|FG000|Overall Study|Subject/guardian decision|21|||
25064777|NCT02422615|50170259|FG001|Overall Study|Subject/guardian decision|5|||
25064778|NCT02422615|50170258|FG000|Overall Study|Death|2|||
25064779|NCT02422615|50170259|FG001|Overall Study|Death|0|||
25064780|NCT02422615|50170258|FG000|Overall Study|Protocol Violation|1|||
25064781|NCT02422615|50170259|FG001|Overall Study|Protocol Violation|1|||
25064782|NCT02422615|50170258|FG000|Overall Study|Technical problems|0|||
25064783|NCT02422615|50170259|FG001|Overall Study|Technical problems|1|||
25064784|NCT02382406|50170268|FG000|Study Treatment|Disease Progression|8|||
25064785|NCT02382406|50170269|FG001|Study Treatment|Disease Progression|0|||
25064786|NCT02382406|50170270|FG002|Study Treatment|Disease Progression|20|||
25064787|NCT02382406|50170268|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
25064788|NCT02382406|50170269|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
25064789|NCT02382406|50170270|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
25064790|NCT02382406|50170268|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
25064791|NCT02382406|50170269|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
25064792|NCT02382406|50170270|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
25064793|NCT02382406|50170268|FG000|Study Treatment|symptomatic deterioration|1|||
25064794|NCT02382406|50170269|FG001|Study Treatment|symptomatic deterioration|0|||
25064795|NCT02382406|50170270|FG002|Study Treatment|symptomatic deterioration|1|||
25064796|NCT02382406|50170268|FG000|Study Treatment|Death|0|||
25064797|NCT02382406|50170269|FG001|Study Treatment|Death|0|||
25064798|NCT02382406|50170270|FG002|Study Treatment|Death|2|||
25064799|NCT02382406|50170268|FG000|Follow up|Death|11|||
25064800|NCT02382406|50170269|FG001|Follow up|Death|0|||
25064801|NCT02382406|50170270|FG002|Follow up|Death|19|||
25064802|NCT02382406|50170268|FG000|Follow up|Symptomatic deterioration|1|||
25064803|NCT02382406|50170269|FG001|Follow up|Symptomatic deterioration|0|||
25064804|NCT02382406|50170270|FG002|Follow up|Symptomatic deterioration|1|||
25064805|NCT02382406|50170268|FG000|Follow up|Patient Refused Follow-up|1|||
25064806|NCT02382406|50170269|FG001|Follow up|Patient Refused Follow-up|0|||
25064807|NCT02382406|50170270|FG002|Follow up|Patient Refused Follow-up|0|||
25064808|NCT02382406|50170268|FG000|Follow up|Study Terminated|1|||
25064809|NCT02382406|50170269|FG001|Follow up|Study Terminated|0|||
25064810|NCT02382406|50170270|FG002|Follow up|Study Terminated|8|||
24964185|NCT00441701|50054189|FG003|Overall Study|Adverse Event|0|||
25064811|NCT02382406|50170268|FG000|Follow up|Withdrawal by Subject|0|||
25064812|NCT02382406|50170269|FG001|Follow up|Withdrawal by Subject|0|||
25186660|NCT02641392|50337357|FG000|Overall Study|Lost to Follow-up|0|||
25064813|NCT02382406|50170270|FG002|Follow up|Withdrawal by Subject|2|||
25064814|NCT02112916|50170292|FG000|Overall Study|Adverse Event|6|||
25064815|NCT02112916|50170293|FG001|Overall Study|Adverse Event|9|||
25064816|NCT02112916|50170294|FG002|Overall Study|Adverse Event|3|||
25064817|NCT02112916|50170295|FG003|Overall Study|Adverse Event|2|||
25064818|NCT02112916|50170292|FG000|Overall Study|Death|9|||
25064819|NCT02112916|50170293|FG001|Overall Study|Death|9|||
25064820|NCT02112916|50170294|FG002|Overall Study|Death|3|||
25064821|NCT02112916|50170295|FG003|Overall Study|Death|4|||
25064822|NCT02112916|50170292|FG000|Overall Study|Lost to Follow-up|1|||
25064823|NCT02112916|50170293|FG001|Overall Study|Lost to Follow-up|0|||
25064824|NCT02112916|50170294|FG002|Overall Study|Lost to Follow-up|0|||
25064825|NCT02112916|50170295|FG003|Overall Study|Lost to Follow-up|0|||
25064826|NCT02112916|50170292|FG000|Overall Study|Physician Decision|94|||
25064827|NCT02112916|50170293|FG001|Overall Study|Physician Decision|72|||
25064828|NCT02112916|50170294|FG002|Overall Study|Physician Decision|24|||
25064829|NCT02112916|50170295|FG003|Overall Study|Physician Decision|15|||
25064830|NCT02112916|50170292|FG000|Overall Study|Withdrawal by Subject|5|||
25064831|NCT02112916|50170293|FG001|Overall Study|Withdrawal by Subject|3|||
25064832|NCT02112916|50170294|FG002|Overall Study|Withdrawal by Subject|1|||
25064833|NCT02112916|50170295|FG003|Overall Study|Withdrawal by Subject|1|||
25064834|NCT02112916|50170292|FG000|Overall Study|Ineligible|4|||
25064835|NCT02112916|50170293|FG001|Overall Study|Ineligible|8|||
25064836|NCT02112916|50170294|FG002|Overall Study|Ineligible|3|||
25064837|NCT02112916|50170295|FG003|Overall Study|Ineligible|8|||
25064838|NCT02112916|50170292|FG000|Overall Study|Inevaluable|6|||
25064839|NCT02112916|50170293|FG001|Overall Study|Inevaluable|4|||
25064840|NCT02112916|50170294|FG002|Overall Study|Inevaluable|5|||
25064841|NCT02112916|50170295|FG003|Overall Study|Inevaluable|5|||
25064842|NCT02112916|50170292|FG000|Overall Study|Refusal of further protocol therapy|19|||
25064843|NCT02112916|50170293|FG001|Overall Study|Refusal of further protocol therapy|16|||
25064844|NCT02112916|50170294|FG002|Overall Study|Refusal of further protocol therapy|1|||
25064845|NCT02112916|50170295|FG003|Overall Study|Refusal of further protocol therapy|7|||
25064846|NCT02112916|50170292|FG000|Overall Study|Development of SMN|1|||
25064847|NCT02112916|50170293|FG001|Overall Study|Development of SMN|0|||
25064848|NCT02112916|50170294|FG002|Overall Study|Development of SMN|0|||
25064849|NCT02112916|50170295|FG003|Overall Study|Development of SMN|1|||
25064850|NCT02112916|50170292|FG000|Overall Study|Relapse/Progression|10|||
25064851|NCT02112916|50170293|FG001|Overall Study|Relapse/Progression|18|||
25064852|NCT02112916|50170294|FG002|Overall Study|Relapse/Progression|15|||
25064853|NCT02112916|50170295|FG003|Overall Study|Relapse/Progression|2|||
25064854|NCT02112916|50170292|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
25064855|NCT02112916|50170293|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
25064856|NCT02112916|50170294|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
25064857|NCT02112916|50170295|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
25064858|NCT02112916|50170292|FG000|Overall Study|Still on Therapy|44|||
25064859|NCT02112916|50170293|FG001|Overall Study|Still on Therapy|47|||
25064860|NCT02112916|50170294|FG002|Overall Study|Still on Therapy|3|||
25064861|NCT02112916|50170295|FG003|Overall Study|Still on Therapy|2|||
25064862|NCT02112916|50170292|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
25064863|NCT02112916|50170293|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
25064864|NCT02112916|50170294|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
25064865|NCT02112916|50170295|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
25064866|NCT02112916|50170292|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
25064867|NCT02112916|50170293|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
25064868|NCT02112916|50170294|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
25064869|NCT02112916|50170295|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
25064870|NCT02101268|50170312|FG000|Randomized Treatment Phase|Subject Decision|8|||
25064871|NCT02101268|50170313|FG001|Randomized Treatment Phase|Subject Decision|4|||
25064872|NCT02101268|50170314|FG002|Randomized Treatment Phase|Subject Decision|0|||
25064873|NCT02101268|50170315|FG003|Randomized Treatment Phase|Subject Decision|0|||
25064874|NCT02101268|50170312|FG000|Randomized Treatment Phase|Physician Decision|4|||
25064875|NCT02101268|50170313|FG001|Randomized Treatment Phase|Physician Decision|1|||
25064876|NCT02101268|50170314|FG002|Randomized Treatment Phase|Physician Decision|0|||
25064877|NCT02101268|50170315|FG003|Randomized Treatment Phase|Physician Decision|0|||
25064878|NCT02101268|50170312|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
25064879|NCT02101268|50170313|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
25064880|NCT02101268|50170314|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
25064881|NCT02101268|50170315|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
25064882|NCT02101268|50170312|FG000|Randomized Treatment Phase|Adverse Event|6|||
25064883|NCT02101268|50170313|FG001|Randomized Treatment Phase|Adverse Event|0|||
25064884|NCT02101268|50170314|FG002|Randomized Treatment Phase|Adverse Event|0|||
25064885|NCT02101268|50170315|FG003|Randomized Treatment Phase|Adverse Event|0|||
25064886|NCT02101268|50170312|FG000|Randomized Treatment Phase|Death|5|||
25162868|NCT01967069|50285228|FG000|Overall Study|Lack of Efficacy|0|||
25064887|NCT02101268|50170313|FG001|Randomized Treatment Phase|Death|4|||
25064888|NCT02101268|50170314|FG002|Randomized Treatment Phase|Death|0|||
25064889|NCT02101268|50170315|FG003|Randomized Treatment Phase|Death|0|||
25064890|NCT02101268|50170312|FG000|Randomized Treatment Phase|Disease Progression|4|||
25064891|NCT02101268|50170313|FG001|Randomized Treatment Phase|Disease Progression|1|||
25064892|NCT02101268|50170314|FG002|Randomized Treatment Phase|Disease Progression|0|||
25064893|NCT02101268|50170315|FG003|Randomized Treatment Phase|Disease Progression|0|||
25064894|NCT02101268|50170312|FG000|Extended Treatment Phase|Subject Decision|0|||
25064895|NCT02101268|50170313|FG001|Extended Treatment Phase|Subject Decision|0|||
25064896|NCT02101268|50170314|FG002|Extended Treatment Phase|Subject Decision|3|||
25064897|NCT02101268|50170315|FG003|Extended Treatment Phase|Subject Decision|2|||
25064898|NCT02101268|50170312|FG000|Extended Treatment Phase|Physician Decision|0|||
25064899|NCT02101268|50170313|FG001|Extended Treatment Phase|Physician Decision|0|||
25064900|NCT02101268|50170314|FG002|Extended Treatment Phase|Physician Decision|5|||
25064901|NCT02101268|50170315|FG003|Extended Treatment Phase|Physician Decision|2|||
25064902|NCT02101268|50170312|FG000|Extended Treatment Phase|Adverse Event|0|||
25064903|NCT02101268|50170313|FG001|Extended Treatment Phase|Adverse Event|0|||
25064904|NCT02101268|50170314|FG002|Extended Treatment Phase|Adverse Event|14|||
25064905|NCT02101268|50170315|FG003|Extended Treatment Phase|Adverse Event|18|||
25064906|NCT02101268|50170312|FG000|Extended Treatment Phase|Death|0|||
25064907|NCT02101268|50170313|FG001|Extended Treatment Phase|Death|0|||
25064908|NCT02101268|50170314|FG002|Extended Treatment Phase|Death|5|||
25064909|NCT02101268|50170315|FG003|Extended Treatment Phase|Death|1|||
25064910|NCT02101268|50170312|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
25064911|NCT02101268|50170313|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
25064912|NCT02101268|50170314|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
25064913|NCT02101268|50170315|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
25064914|NCT02101268|50170312|FG000|Extended Treatment Phase|Disease Progression|0|||
25064915|NCT02101268|50170313|FG001|Extended Treatment Phase|Disease Progression|0|||
25064916|NCT02101268|50170314|FG002|Extended Treatment Phase|Disease Progression|13|||
25064917|NCT02101268|50170315|FG003|Extended Treatment Phase|Disease Progression|6|||
25064918|NCT02101268|50170312|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
25064919|NCT02101268|50170313|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
25064920|NCT02101268|50170314|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
25064921|NCT02101268|50170315|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
25064922|NCT01898650|50170332|FG000|Overall Study|the subject would not lie still for imaging|1|||
25064923|NCT01880515|50170338|FG000|Overall Study|Lost to Follow-up|3|||
25064924|NCT01880515|50170339|FG001|Overall Study|Lost to Follow-up|2|||
25064925|NCT01880515|50170338|FG000|Overall Study|Disease Progression|5|||
25064926|NCT01880515|50170339|FG001|Overall Study|Disease Progression|7|||
25064927|NCT01668719|50170349|FG000|Phase I|On treatment|1|||
25064928|NCT01668719|50170350|FG001|Phase I|On treatment|0|||
25064929|NCT01668719|50170351|FG002|Phase I|On treatment|0|||
25064930|NCT01668719|50170349|FG000|Phase I|Adverse Event|2|||
25064931|NCT01668719|50170350|FG001|Phase I|Adverse Event|0|||
25064932|NCT01668719|50170351|FG002|Phase I|Adverse Event|0|||
25064933|NCT01668719|50170349|FG000|Phase I|Progression/relapse|1|||
25064934|NCT01668719|50170350|FG001|Phase I|Progression/relapse|0|||
25064935|NCT01668719|50170351|FG002|Phase I|Progression/relapse|0|||
25064936|NCT01668719|50170349|FG000|Phase I|not protocol specified|2|||
25064937|NCT01668719|50170350|FG001|Phase I|not protocol specified|0|||
25064938|NCT01668719|50170351|FG002|Phase I|not protocol specified|0|||
25064939|NCT01668719|50170349|FG000|Phase II|On treatment|0|||
25064940|NCT01668719|50170350|FG001|Phase II|On treatment|4|||
25064941|NCT01668719|50170351|FG002|Phase II|On treatment|3|||
25064942|NCT01668719|50170349|FG000|Phase II|Adverse Event|0|||
25064943|NCT01668719|50170350|FG001|Phase II|Adverse Event|18|||
25064944|NCT01668719|50170351|FG002|Phase II|Adverse Event|18|||
25064945|NCT01668719|50170349|FG000|Phase II|Refusal unrelated to adverse event|0|||
25064946|NCT01668719|50170350|FG001|Phase II|Refusal unrelated to adverse event|4|||
25064947|NCT01668719|50170351|FG002|Phase II|Refusal unrelated to adverse event|1|||
25064948|NCT01668719|50170349|FG000|Phase II|Progression/relapse|0|||
25064949|NCT01668719|50170350|FG001|Phase II|Progression/relapse|13|||
25064950|NCT01668719|50170351|FG002|Phase II|Progression/relapse|17|||
25064951|NCT01668719|50170349|FG000|Phase II|Death|0|||
25064952|NCT01668719|50170350|FG001|Phase II|Death|0|||
25064953|NCT01668719|50170351|FG002|Phase II|Death|2|||
25064954|NCT01668719|50170349|FG000|Phase II|not protocol specified|0|||
25064955|NCT01668719|50170350|FG001|Phase II|not protocol specified|13|||
25064956|NCT01668719|50170351|FG002|Phase II|not protocol specified|7|||
25064957|NCT01642901|50170363|FG000|12-month Follow-up|Withdrawal by Subject|1|||
25064958|NCT01642901|50170364|FG001|12-month Follow-up|Withdrawal by Subject|0|||
25186661|NCT02641392|50337358|FG001|Overall Study|Lost to Follow-up|0|||
25064959|NCT01488045|50170372|FG000|Overall Study|Withdrawal by Subject|6|||
25064960|NCT01488045|50170373|FG001|Overall Study|Withdrawal by Subject|11|||
25064961|NCT01488045|50170372|FG000|Overall Study|Failure to present for colonoscopy|3|||
25064962|NCT01488045|50170373|FG001|Overall Study|Failure to present for colonoscopy|6|||
25064963|NCT01488045|50170372|FG000|Overall Study|Failure to report exclusion criteria|0|||
25064964|NCT01488045|50170373|FG001|Overall Study|Failure to report exclusion criteria|1|||
25064965|NCT00946712|50170392|FG000|Overall Study|Adverse Event|118|||
25064966|NCT00946712|50170393|FG001|Overall Study|Adverse Event|124|||
25064967|NCT00946712|50170392|FG000|Overall Study|Disease progression|308|||
25064968|NCT00946712|50170393|FG001|Overall Study|Disease progression|404|||
25064969|NCT00946712|50170392|FG000|Overall Study|Death|21|||
25064970|NCT00946712|50170393|FG001|Overall Study|Death|22|||
25064971|NCT00946712|50170392|FG000|Overall Study|No treatment given|25|||
25064972|NCT00946712|50170393|FG001|Overall Study|No treatment given|29|||
25064973|NCT00946712|50170392|FG000|Overall Study|Other reasons|61|||
25064974|NCT00946712|50170393|FG001|Overall Study|Other reasons|73|||
25064975|NCT00946712|50170392|FG000|Overall Study|On Treatment|0|||
25064976|NCT00946712|50170393|FG001|Overall Study|On Treatment|4|||
25064977|NCT00946712|50170392|FG000|Overall Study|Ineligible|14|||
25064978|NCT00946712|50170393|FG001|Overall Study|Ineligible|6|||
25064979|NCT00656669|50170400|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
25064980|NCT00656669|50170400|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
25064981|NCT00656669|50170400|FG000|AC (Cycles 6-9)|Adverse Event|1|||
25064982|NCT00656669|50170400|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
25064983|NCT00470704|50170411|FG000|Overall Study|Withdrawal by Subject|4|||
25064984|NCT00470704|50170412|FG001|Overall Study|Withdrawal by Subject|3|||
25064985|NCT00470704|50170411|FG000|Overall Study|Relapse/Progression|37|||
25064986|NCT00470704|50170412|FG001|Overall Study|Relapse/Progression|42|||
25064987|NCT00470704|50170411|FG000|Overall Study|toxicity|0|||
25064988|NCT00470704|50170412|FG001|Overall Study|toxicity|1|||
25064989|NCT01338493|50170418|FG000|Enrolled|Withdrawal by Subject|1|||
25064990|NCT01338493|50170418|FG000|Enrolled|Patient not implanted|4|||
25064991|NCT01338493|50170418|FG000|Discharge|Death|1|||
25064992|NCT01338493|50170418|FG000|Discharge|Missed visit|1|||
25064993|NCT01338493|50170418|FG000|6 Months Follow up|Lost to Follow-up|11|||
25064994|NCT01338493|50170418|FG000|6 Months Follow up|Missed visit|8|||
25064995|NCT01338493|50170418|FG000|12 Months Follow up|Lost to Follow-up|9|||
25064996|NCT01362296|50170424|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
25064997|NCT01362296|50170425|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
25064998|NCT01362296|50170426|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
25064999|NCT01362296|50170427|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
25065000|NCT01362296|50170424|FG000|Randomized Phase (RP)|Physician Decision|1|||
25065001|NCT01362296|50170425|FG001|Randomized Phase (RP)|Physician Decision|9|||
25065002|NCT01362296|50170426|FG002|Randomized Phase (RP)|Physician Decision|0|||
25065003|NCT01362296|50170427|FG003|Randomized Phase (RP)|Physician Decision|0|||
25065004|NCT01362296|50170424|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
25065005|NCT01362296|50170425|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
25065006|NCT01362296|50170426|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
25065007|NCT01362296|50170427|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
25065008|NCT01362296|50170424|FG000|Randomized Phase (RP)|Adverse Event|20|||
25065009|NCT01362296|50170425|FG001|Randomized Phase (RP)|Adverse Event|4|||
25065010|NCT01362296|50170426|FG002|Randomized Phase (RP)|Adverse Event|0|||
25065011|NCT01362296|50170427|FG003|Randomized Phase (RP)|Adverse Event|0|||
25065012|NCT01362296|50170424|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
25065013|NCT01362296|50170425|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
25065014|NCT01362296|50170426|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
25065015|NCT01362296|50170427|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
25065016|NCT01362296|50170424|FG000|Crossover Phase|PD including Death due to PD|0|||
25065017|NCT01362296|50170425|FG001|Crossover Phase|PD including Death due to PD|0|||
25065018|NCT01362296|50170426|FG002|Crossover Phase|PD including Death due to PD|16|||
25065019|NCT01362296|50170427|FG003|Crossover Phase|PD including Death due to PD|1|||
25065020|NCT01362296|50170424|FG000|Crossover Phase|Withdrawal by Subject|0|||
25065021|NCT01362296|50170425|FG001|Crossover Phase|Withdrawal by Subject|0|||
25065022|NCT01362296|50170426|FG002|Crossover Phase|Withdrawal by Subject|2|||
25065023|NCT01362296|50170427|FG003|Crossover Phase|Withdrawal by Subject|1|||
25065024|NCT01362296|50170424|FG000|Crossover Phase|Adverse Event|0|||
25065025|NCT01362296|50170425|FG001|Crossover Phase|Adverse Event|0|||
25065026|NCT01362296|50170426|FG002|Crossover Phase|Adverse Event|4|||
25065027|NCT01362296|50170427|FG003|Crossover Phase|Adverse Event|0|||
25065028|NCT01362296|50170424|FG000|Crossover Phase|Study Closed/Terminated|0|||
25065029|NCT01362296|50170425|FG001|Crossover Phase|Study Closed/Terminated|0|||
25065030|NCT01362296|50170426|FG002|Crossover Phase|Study Closed/Terminated|1|||
25065031|NCT01362296|50170427|FG003|Crossover Phase|Study Closed/Terminated|0|||
25065032|NCT01338415|50170439|FG000|Core + Extension|Adverse Event|8|||
25065033|NCT01338415|50170440|FG001|Core + Extension|Adverse Event|6|||
25065034|NCT01338415|50170441|FG002|Core + Extension|Adverse Event|0|||
25065035|NCT01338415|50170439|FG000|Core + Extension|Withdrawal by Subject|1|||
25065036|NCT01338415|50170440|FG001|Core + Extension|Withdrawal by Subject|1|||
25065037|NCT01338415|50170441|FG002|Core + Extension|Withdrawal by Subject|0|||
25065038|NCT01338415|50170439|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
25065039|NCT01338415|50170440|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
25065040|NCT01338415|50170441|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
25065041|NCT01338415|50170439|FG000|Core + Extension|Other (administrative reason)|1|||
25065042|NCT01338415|50170440|FG001|Core + Extension|Other (administrative reason)|0|||
25065043|NCT01338415|50170441|FG002|Core + Extension|Other (administrative reason)|0|||
25162869|NCT01967069|50285229|FG001|Overall Study|Lack of Efficacy|1|||
25065044|NCT01338415|50170439|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
25065045|NCT01338415|50170440|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
25065046|NCT01338415|50170441|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
25065047|NCT01338415|50170439|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
25065048|NCT01338415|50170440|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
25065049|NCT01338415|50170441|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
25065050|NCT01338415|50170439|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
25065051|NCT01338415|50170440|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
25065052|NCT01338415|50170441|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
25065053|NCT01338415|50170439|FG000|Exceptional Use Treatment Period|Death|0|||
25065054|NCT01338415|50170440|FG001|Exceptional Use Treatment Period|Death|0|||
25065055|NCT01338415|50170441|FG002|Exceptional Use Treatment Period|Death|1|||
25065056|NCT05258149|50170451|FG000|Period 1|Protocol Deviation|1|||
25065057|NCT05258149|50170452|FG001|Period 1|Protocol Deviation|0|||
25065058|NCT05258149|50170451|FG000|Period 1|Adverse Event|0|||
25065059|NCT05258149|50170452|FG001|Period 1|Adverse Event|1|||
25065060|NCT05258149|50170451|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
25065061|NCT05258149|50170452|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
25065062|NCT05258149|50170451|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
25065063|NCT05258149|50170452|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
25065064|NCT05258149|50170451|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
25065065|NCT05258149|50170452|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
25065066|NCT01371643|50170460|FG000|Overall Study|Withdrawal by Subject|3|||
25065067|NCT01371643|50170461|FG001|Overall Study|Withdrawal by Subject|0|||
25065068|NCT01371565|50170467|FG000|Overall Study|Withdrawal by Subject|1|||
25065069|NCT01371565|50170467|FG000|Overall Study|Death|1|||
25065070|NCT01371565|50170467|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
25065071|NCT02821819|50170475|FG000|Overall Study|Protocol Violation|1|||
25065072|NCT03926611|50170486|FG000|Overall Study|Adverse Event|0|||
25065073|NCT03926611|50170487|FG001|Overall Study|Adverse Event|0|||
25065074|NCT03926611|50170488|FG002|Overall Study|Adverse Event|0|||
25065075|NCT03926611|50170489|FG003|Overall Study|Adverse Event|3|||
25065076|NCT03926611|50170490|FG004|Overall Study|Adverse Event|1|||
25065077|NCT03926611|50170491|FG005|Overall Study|Adverse Event|3|||
25065078|NCT03926611|50170492|FG006|Overall Study|Adverse Event|0|||
25065079|NCT03926611|50170486|FG000|Overall Study|Lack of Efficacy|1|||
25065080|NCT03926611|50170487|FG001|Overall Study|Lack of Efficacy|2|||
25065081|NCT03926611|50170488|FG002|Overall Study|Lack of Efficacy|0|||
25065082|NCT03926611|50170489|FG003|Overall Study|Lack of Efficacy|0|||
25065083|NCT03926611|50170490|FG004|Overall Study|Lack of Efficacy|1|||
25065084|NCT03926611|50170491|FG005|Overall Study|Lack of Efficacy|0|||
25065085|NCT03926611|50170492|FG006|Overall Study|Lack of Efficacy|1|||
25065086|NCT03926611|50170486|FG000|Overall Study|Physician Decision|0|||
25065087|NCT03926611|50170487|FG001|Overall Study|Physician Decision|0|||
25065088|NCT03926611|50170488|FG002|Overall Study|Physician Decision|0|||
25065089|NCT03926611|50170489|FG003|Overall Study|Physician Decision|0|||
25065090|NCT03926611|50170490|FG004|Overall Study|Physician Decision|0|||
25065091|NCT03926611|50170491|FG005|Overall Study|Physician Decision|1|||
25065092|NCT03926611|50170492|FG006|Overall Study|Physician Decision|0|||
25065093|NCT03926611|50170486|FG000|Overall Study|Protocol Violation|1|||
25065094|NCT03926611|50170487|FG001|Overall Study|Protocol Violation|0|||
25065095|NCT03926611|50170488|FG002|Overall Study|Protocol Violation|0|||
25065096|NCT03926611|50170489|FG003|Overall Study|Protocol Violation|1|||
25065097|NCT03926611|50170490|FG004|Overall Study|Protocol Violation|1|||
25065098|NCT03926611|50170491|FG005|Overall Study|Protocol Violation|1|||
25065099|NCT03926611|50170492|FG006|Overall Study|Protocol Violation|1|||
25065100|NCT03926611|50170486|FG000|Overall Study|Technical problems|0|||
25065101|NCT03926611|50170487|FG001|Overall Study|Technical problems|0|||
25065102|NCT03926611|50170488|FG002|Overall Study|Technical problems|0|||
25065103|NCT03926611|50170489|FG003|Overall Study|Technical problems|0|||
25065104|NCT03926611|50170490|FG004|Overall Study|Technical problems|0|||
25065105|NCT03926611|50170491|FG005|Overall Study|Technical problems|1|||
25065106|NCT03926611|50170492|FG006|Overall Study|Technical problems|0|||
25065107|NCT03926611|50170486|FG000|Overall Study|Withdrawal by Subject|1|||
25065108|NCT03926611|50170487|FG001|Overall Study|Withdrawal by Subject|1|||
25065109|NCT03926611|50170488|FG002|Overall Study|Withdrawal by Subject|1|||
25065110|NCT03926611|50170489|FG003|Overall Study|Withdrawal by Subject|0|||
25065111|NCT03926611|50170490|FG004|Overall Study|Withdrawal by Subject|0|||
25065112|NCT03926611|50170491|FG005|Overall Study|Withdrawal by Subject|1|||
25065113|NCT03926611|50170492|FG006|Overall Study|Withdrawal by Subject|3|||
25065114|NCT03926611|50170486|FG000|Overall Study|Covid-19 pandemic|0|||
25162870|NCT01790503|50285246|FG000|Overall Study|Adverse Event|1|||
25065115|NCT03926611|50170487|FG001|Overall Study|Covid-19 pandemic|0|||
25065116|NCT03926611|50170488|FG002|Overall Study|Covid-19 pandemic|1|||
25065117|NCT03926611|50170489|FG003|Overall Study|Covid-19 pandemic|0|||
25162871|NCT01790503|50285247|FG001|Overall Study|Adverse Event|0|||
25065118|NCT03926611|50170490|FG004|Overall Study|Covid-19 pandemic|1|||
25065119|NCT03926611|50170491|FG005|Overall Study|Covid-19 pandemic|2|||
25065120|NCT03926611|50170492|FG006|Overall Study|Covid-19 pandemic|0|||
25065121|NCT02818777|50170521|FG000|Overall Study|Adverse Event|3|||
25065122|NCT02817841|50170535|FG000|Overall Study|Lost to Follow-up|287|||
25065123|NCT02817841|50170535|FG000|Overall Study|Withdrawal by Subject|183|||
25065124|NCT02817841|50170535|FG000|Overall Study|Adverse event not related to bleeding|131|||
25065125|NCT02817841|50170535|FG000|Overall Study|Adverse event related to bleeding|51|||
25065126|NCT02817841|50170535|FG000|Overall Study|Pregnancy|32|||
25065127|NCT02817841|50170535|FG000|Overall Study|Pregnancy wish|17|||
25065128|NCT02817841|50170535|FG000|Overall Study|Other reasons|53|||
25065129|NCT02817841|50170535|FG000|Overall Study|Protocol Violation|94|||
25065130|NCT02814565|50170545|FG000|Overall Study|Lack of Efficacy|0|||
25065131|NCT02814565|50170546|FG001|Overall Study|Lack of Efficacy|1|||
25065132|NCT02814565|50170545|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
25065133|NCT02814565|50170546|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
25065134|NCT02650466|50170552|FG000|Overall Study|Physician Decision|1|||
25065135|NCT02650466|50170552|FG000|Overall Study|Withdrawal by Subject|5|||
25065136|NCT02650466|50170552|FG000|Overall Study|Lost to Follow-up|1|||
25065137|NCT02815735|50170558|FG000|First Intervention (4 Weeks)|Discomfort|1|||
25065138|NCT02815735|50170559|FG001|First Intervention (4 Weeks)|Discomfort|0|||
25065139|NCT02815735|50170558|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
25065140|NCT02815735|50170559|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
25065141|NCT02815735|50170558|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
25065142|NCT02815735|50170559|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
25065143|NCT02815735|50170558|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
25065144|NCT02815735|50170559|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
25065145|NCT02814643|50170576|FG000|Overall Study|Lost to Follow-up|0|||
25065146|NCT02814643|50170577|FG001|Overall Study|Lost to Follow-up|1|||
25065147|NCT02814643|50170576|FG000|Overall Study|Withdrawal by Subject|1|||
25065148|NCT02814643|50170577|FG001|Overall Study|Withdrawal by Subject|2|||
25065149|NCT02724111|50170585|FG000|Overall Study|Protocol Violation|2|||
25065150|NCT02724111|50170586|FG001|Overall Study|Protocol Violation|5|||
25065151|NCT02649218|50170592|FG000|Overall Study|Adverse Event|8|||
25065152|NCT02649218|50170592|FG000|Overall Study|Lack of Efficacy|8|||
25065153|NCT02649218|50170592|FG000|Overall Study|Pregnancy|3|||
25065154|NCT02649218|50170592|FG000|Overall Study|Protocol Violation|3|||
25065155|NCT02649218|50170592|FG000|Overall Study|Physician Decision|1|||
25065156|NCT02649218|50170592|FG000|Overall Study|Withdrawal by Subject|2|||
25065157|NCT02814175|50170599|FG000|Part 1|Adverse Event|2|||
25065158|NCT02814175|50170600|FG001|Part 1|Adverse Event|3|||
25065159|NCT02814175|50170601|FG002|Part 1|Adverse Event|0|||
25065160|NCT02814175|50170602|FG003|Part 1|Adverse Event|0|||
25065161|NCT02814175|50170603|FG004|Part 1|Adverse Event|0|||
25065162|NCT02814175|50170604|FG005|Part 1|Adverse Event|0|||
25065163|NCT02814175|50170599|FG000|Part 1|Withdrawal Consent|8|||
25065164|NCT02814175|50170600|FG001|Part 1|Withdrawal Consent|1|||
25065165|NCT02814175|50170601|FG002|Part 1|Withdrawal Consent|0|||
25065166|NCT02814175|50170602|FG003|Part 1|Withdrawal Consent|0|||
25065167|NCT02814175|50170603|FG004|Part 1|Withdrawal Consent|0|||
25065168|NCT02814175|50170604|FG005|Part 1|Withdrawal Consent|0|||
25065169|NCT02814175|50170599|FG000|Part 1|Lost to Follow-up|1|||
25065170|NCT02814175|50170600|FG001|Part 1|Lost to Follow-up|0|||
25065171|NCT02814175|50170601|FG002|Part 1|Lost to Follow-up|0|||
25065172|NCT02814175|50170602|FG003|Part 1|Lost to Follow-up|0|||
25065173|NCT02814175|50170603|FG004|Part 1|Lost to Follow-up|0|||
25065174|NCT02814175|50170604|FG005|Part 1|Lost to Follow-up|0|||
25065175|NCT02814175|50170599|FG000|Part 1|Lack of Efficacy|1|||
25065176|NCT02814175|50170600|FG001|Part 1|Lack of Efficacy|2|||
25065177|NCT02814175|50170601|FG002|Part 1|Lack of Efficacy|0|||
25065178|NCT02814175|50170602|FG003|Part 1|Lack of Efficacy|0|||
25065179|NCT02814175|50170603|FG004|Part 1|Lack of Efficacy|0|||
25065180|NCT02814175|50170604|FG005|Part 1|Lack of Efficacy|0|||
25065181|NCT02814175|50170599|FG000|Part 2|Adverse Event|0|||
25065182|NCT02814175|50170600|FG001|Part 2|Adverse Event|0|||
25065183|NCT02814175|50170601|FG002|Part 2|Adverse Event|0|||
25065184|NCT02814175|50170602|FG003|Part 2|Adverse Event|1|||
25065185|NCT02814175|50170603|FG004|Part 2|Adverse Event|1|||
25065186|NCT02814175|50170604|FG005|Part 2|Adverse Event|2|||
25065187|NCT02814175|50170599|FG000|Part 2|Withdrawal Consent|0|||
25065188|NCT02814175|50170600|FG001|Part 2|Withdrawal Consent|0|||
25065189|NCT02814175|50170601|FG002|Part 2|Withdrawal Consent|0|||
25065190|NCT02814175|50170602|FG003|Part 2|Withdrawal Consent|2|||
25065191|NCT02814175|50170603|FG004|Part 2|Withdrawal Consent|1|||
25065192|NCT02814175|50170604|FG005|Part 2|Withdrawal Consent|1|||
25065193|NCT02814175|50170599|FG000|Part 2|Lost to Follow-up|0|||
25065194|NCT02814175|50170600|FG001|Part 2|Lost to Follow-up|0|||
25065195|NCT02814175|50170601|FG002|Part 2|Lost to Follow-up|0|||
25065196|NCT02814175|50170602|FG003|Part 2|Lost to Follow-up|1|||
25065197|NCT02814175|50170603|FG004|Part 2|Lost to Follow-up|0|||
25065198|NCT02814175|50170604|FG005|Part 2|Lost to Follow-up|0|||
25065199|NCT02814175|50170599|FG000|Part 2|Lack of Efficacy|0|||
25065200|NCT02814175|50170600|FG001|Part 2|Lack of Efficacy|0|||
25065201|NCT02814175|50170601|FG002|Part 2|Lack of Efficacy|0|||
25065202|NCT02814175|50170602|FG003|Part 2|Lack of Efficacy|0|||
25065203|NCT02814175|50170603|FG004|Part 2|Lack of Efficacy|0|||
25065204|NCT02814175|50170604|FG005|Part 2|Lack of Efficacy|3|||
25065205|NCT01335997|50170620|FG000|Period I and II|Adverse Event|63|||
25065206|NCT01335997|50170621|FG001|Period I and II|Adverse Event|43|||
25065207|NCT01335997|50170620|FG000|Period I and II|Noncompliance with Study Drug|1|||
25065208|NCT01335997|50170621|FG001|Period I and II|Noncompliance with Study Drug|1|||
25065209|NCT01335997|50170620|FG000|Period I and II|Lost to Follow-up|3|||
25065210|NCT01335997|50170621|FG001|Period I and II|Lost to Follow-up|5|||
25065211|NCT01335997|50170620|FG000|Period I and II|Withdrawal by Subject|9|||
25065212|NCT01335997|50170621|FG001|Period I and II|Withdrawal by Subject|4|||
25065213|NCT01335997|50170620|FG000|Period I and II|Study Terminated by Sponsor|406|||
25065214|NCT01335997|50170621|FG001|Period I and II|Study Terminated by Sponsor|415|||
25065215|NCT01335997|50170620|FG000|Period I and II|Protocol Violation|9|||
25065216|NCT01335997|50170621|FG001|Period I and II|Protocol Violation|10|||
25065217|NCT01335997|50170620|FG000|Period I and II|Physician Decision|2|||
25065218|NCT01335997|50170621|FG001|Period I and II|Physician Decision|1|||
25065219|NCT01335997|50170620|FG000|Period III|Adverse Event|0|||
25065220|NCT01335997|50170621|FG001|Period III|Adverse Event|2|||
25065221|NCT01335997|50170620|FG000|Period III|Study Terminated by Sponsor|77|||
25065222|NCT01335997|50170621|FG001|Period III|Study Terminated by Sponsor|76|||
25065223|NCT01335997|50170620|FG000|Period III|Protocol Violation|0|||
25065224|NCT01335997|50170621|FG001|Period III|Protocol Violation|1|||
25065225|NCT01335997|50170620|FG000|Period III|Lost to Follow-up|1|||
25065226|NCT01335997|50170621|FG001|Period III|Lost to Follow-up|0|||
25065227|NCT02725671|50170629|FG000|Overall Study|Lost to Follow-up|1|||
25065228|NCT02446990|50170637|FG000|Overall Study|Death|485|||
25065229|NCT02446990|50170638|FG001|Overall Study|Death|458|||
25065230|NCT02446990|50170637|FG000|Overall Study|Lost to Follow-up|3|||
25065231|NCT02446990|50170638|FG001|Overall Study|Lost to Follow-up|1|||
25065232|NCT02446990|50170637|FG000|Overall Study|Physician Decision|1|||
25065233|NCT02446990|50170638|FG001|Overall Study|Physician Decision|0|||
25065234|NCT02446990|50170637|FG000|Overall Study|Withdrawal by Subject|231|||
25065235|NCT02446990|50170638|FG001|Overall Study|Withdrawal by Subject|199|||
25065236|NCT02725515|50170646|FG000|Overall Study|Refused infusion (no study treatment)|1|||
25065237|NCT02725515|50170647|FG001|Overall Study|Refused infusion (no study treatment)|0|||
25065238|NCT02725515|50170646|FG000|Overall Study|Loss of Improvement per Protocol|14|||
25065239|NCT02725515|50170647|FG001|Overall Study|Loss of Improvement per Protocol|25|||
25065240|NCT02725515|50170646|FG000|Overall Study|Withdrawal by Subject|2|||
25065241|NCT02725515|50170647|FG001|Overall Study|Withdrawal by Subject|1|||
25065242|NCT02725515|50170646|FG000|Overall Study|Non-Compliance With Study Drug|0|||
25065243|NCT02725515|50170647|FG001|Overall Study|Non-Compliance With Study Drug|3|||
25065244|NCT02725515|50170646|FG000|Overall Study|Lost to Follow-up|1|||
25065245|NCT02725515|50170647|FG001|Overall Study|Lost to Follow-up|1|||
25065246|NCT02725515|50170646|FG000|Overall Study|Adverse Event|7|||
25065247|NCT02725515|50170647|FG001|Overall Study|Adverse Event|2|||
25065248|NCT02725515|50170646|FG000|Overall Study|No Documented Disease Improvement|0|||
25065249|NCT02725515|50170647|FG001|Overall Study|No Documented Disease Improvement|1|||
25065250|NCT02725515|50170646|FG000|Overall Study|Completed Study Under Original Protocol|0|||
25065251|NCT02725515|50170647|FG001|Overall Study|Completed Study Under Original Protocol|1|||
25065252|NCT02725515|50170646|FG000|Overall Study|Lack of Response|0|||
25065253|NCT02725515|50170647|FG001|Overall Study|Lack of Response|1|||
25065254|NCT02416180|50170653|FG000|Overall Study|Withdrawal by Subject|1|||
25065255|NCT02473510|50170659|FG000|Overall Study|Lost to Follow-up|1|||
25065256|NCT02473510|50170660|FG001|Overall Study|Lost to Follow-up|2|||
25065257|NCT02445586|50170666|FG000|Overall Study|Death|14|||
25065258|NCT02445586|50170666|FG000|Overall Study|Withdrawal by Subject|13|||
25065259|NCT02445586|50170666|FG000|Overall Study|Disease Progression|10|||
25065260|NCT02445586|50170666|FG000|Overall Study|Protocol Violation|1|||
25065261|NCT02445586|50170666|FG000|Overall Study|Medical Condition|1|||
25065262|NCT01674062|50170672|FG000|Overall Study|Insufficient Therapeutic Response|56|||
25065263|NCT01674062|50170673|FG001|Overall Study|Insufficient Therapeutic Response|26|||
25186662|NCT02641392|50337359|FG002|Overall Study|Lost to Follow-up|2|||
25065264|NCT01674062|50170672|FG000|Overall Study|Other|8|||
25065265|NCT01674062|50170673|FG001|Overall Study|Other|1|||
25065266|NCT01674062|50170672|FG000|Overall Study|Adverse Event|1|||
25065267|NCT01674062|50170673|FG001|Overall Study|Adverse Event|1|||
25065268|NCT01674062|50170672|FG000|Overall Study|Death|0|||
25065269|NCT01674062|50170673|FG001|Overall Study|Death|1|||
25065270|NCT01674062|50170672|FG000|Overall Study|Programming Error|1|||
25065271|NCT01674062|50170673|FG001|Overall Study|Programming Error|0|||
25065272|NCT02472886|50170682|FG000|Overall Study|Lack of Efficacy|0|||
25065273|NCT02472886|50170683|FG001|Overall Study|Lack of Efficacy|2|||
25065274|NCT02472886|50170684|FG002|Overall Study|Lack of Efficacy|1|||
25065275|NCT02472652|50170697|FG000|Overall Study|Lost to Follow-up|1|||
25065276|NCT02807857|50170701|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
25065277|NCT02807857|50170701|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
25065278|NCT02807857|50170701|FG000|Follow-Up Set|Withdrawal by Subject|8|||
25065279|NCT02807857|50170701|FG000|Follow-Up Set|Lost to Follow-up|7|||
25065280|NCT02807857|50170701|FG000|Follow-Up Set|Physician Decision|6|||
25065281|NCT02807857|50170701|FG000|Follow-Up Set|Adverse Event|3|||
25065282|NCT02807857|50170701|FG000|Follow-Up Set|Death|27|||
25065283|NCT02807857|50170701|FG000|Follow-Up Set|Relocation|2|||
25065284|NCT02648438|50170714|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
25065285|NCT02648438|50170715|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
25065286|NCT02648438|50170716|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
25065287|NCT02648438|50170714|FG000|Overall Study|Protocol Violation|2|||
25065288|NCT02648438|50170715|FG001|Overall Study|Protocol Violation|0|||
25065289|NCT02648438|50170716|FG002|Overall Study|Protocol Violation|0|||
25065290|NCT02648438|50170714|FG000|Overall Study|Withdrawal by Subject|1|||
25065291|NCT02648438|50170715|FG001|Overall Study|Withdrawal by Subject|1|||
25065292|NCT02648438|50170716|FG002|Overall Study|Withdrawal by Subject|0|||
25065293|NCT02415556|50170736|FG000|Overall Study|Adverse Event|3|||
25065294|NCT02415556|50170737|FG001|Overall Study|Adverse Event|4|||
25065295|NCT02415556|50170738|FG002|Overall Study|Adverse Event|2|||
25065296|NCT02415556|50170739|FG003|Overall Study|Adverse Event|4|||
25065297|NCT02415556|50170736|FG000|Overall Study|Lost to Follow-up|4|||
25065298|NCT02415556|50170737|FG001|Overall Study|Lost to Follow-up|5|||
25065299|NCT02415556|50170738|FG002|Overall Study|Lost to Follow-up|4|||
25065300|NCT02415556|50170739|FG003|Overall Study|Lost to Follow-up|1|||
25065301|NCT02415556|50170736|FG000|Overall Study|Withdrawal by Subject|13|||
25065302|NCT02415556|50170737|FG001|Overall Study|Withdrawal by Subject|4|||
25065303|NCT02415556|50170738|FG002|Overall Study|Withdrawal by Subject|14|||
25065304|NCT02415556|50170739|FG003|Overall Study|Withdrawal by Subject|12|||
25065305|NCT02415556|50170736|FG000|Overall Study|Physician Decision|1|||
25065306|NCT02415556|50170737|FG001|Overall Study|Physician Decision|3|||
25065307|NCT02415556|50170738|FG002|Overall Study|Physician Decision|1|||
25065308|NCT02415556|50170739|FG003|Overall Study|Physician Decision|2|||
25065309|NCT02415556|50170736|FG000|Overall Study|Censored - study completion|4|||
25065310|NCT02415556|50170737|FG001|Overall Study|Censored - study completion|5|||
25065311|NCT02415556|50170738|FG002|Overall Study|Censored - study completion|1|||
25065312|NCT02415556|50170739|FG003|Overall Study|Censored - study completion|0|||
25065313|NCT02415556|50170736|FG000|Overall Study|Family-related issues|0|||
25065314|NCT02415556|50170737|FG001|Overall Study|Family-related issues|0|||
25065315|NCT02415556|50170738|FG002|Overall Study|Family-related issues|0|||
25065316|NCT02415556|50170739|FG003|Overall Study|Family-related issues|1|||
25065317|NCT02807623|50170752|FG000|Overall Study|Lost to Follow-up|23|||
25065318|NCT02807623|50170753|FG001|Overall Study|Lost to Follow-up|18|||
25065319|NCT02807623|50170754|FG002|Overall Study|Lost to Follow-up|22|||
25065320|NCT02807623|50170752|FG000|Overall Study|Drug intolerance|0|||
25065321|NCT02807623|50170753|FG001|Overall Study|Drug intolerance|1|||
25065322|NCT02807623|50170754|FG002|Overall Study|Drug intolerance|0|||
25065323|NCT02807623|50170752|FG000|Overall Study|incomplete blood draw|0|||
25065324|NCT02807623|50170753|FG001|Overall Study|incomplete blood draw|2|||
25065325|NCT02807623|50170754|FG002|Overall Study|incomplete blood draw|1|||
25065326|NCT02805907|50170773|FG000|Overall Study|Lost to Follow-up|3|||
25065327|NCT02805907|50170774|FG001|Overall Study|Lost to Follow-up|3|||
25065328|NCT02723175|50170782|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
25065329|NCT02723175|50170783|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
25065330|NCT02723175|50170782|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
25065331|NCT02723175|50170783|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
25065332|NCT02801617|50170791|FG000|Overall Study|Protocol Violation|2|||
25065333|NCT02801617|50170792|FG001|Overall Study|Protocol Violation|6|||
25065334|NCT01334515|50170804|FG000|Overall Study|Adverse Event|1|||
25065335|NCT01334515|50170805|FG001|Overall Study|Adverse Event|6|||
25065336|NCT01334515|50170804|FG000|Overall Study|Death|1|||
25065337|NCT01334515|50170805|FG001|Overall Study|Death|0|||
25065338|NCT01334515|50170804|FG000|Overall Study|Lack of Efficacy|8|||
25065339|NCT01334515|50170805|FG001|Overall Study|Lack of Efficacy|21|||
25065340|NCT01334515|50170804|FG000|Overall Study|Physician Decision|1|||
25065341|NCT01334515|50170805|FG001|Overall Study|Physician Decision|1|||
25065342|NCT01334515|50170804|FG000|Overall Study|Withdrawal by Subject|1|||
25065343|NCT01334515|50170805|FG001|Overall Study|Withdrawal by Subject|1|||
25065344|NCT02802319|50170813|FG000|Overall Study|Physician Decision|2|||
25065345|NCT02802319|50170814|FG001|Overall Study|Physician Decision|1|||
25065346|NCT02802319|50170813|FG000|Overall Study|Lost to Follow-up|0|||
25065347|NCT02802319|50170814|FG001|Overall Study|Lost to Follow-up|4|||
25065348|NCT02415400|50170824|FG000|Overall Study|Adverse Event|0|||
25065349|NCT02415400|50170825|FG001|Overall Study|Adverse Event|1|||
25065350|NCT02415400|50170826|FG002|Overall Study|Adverse Event|1|||
25065351|NCT02415400|50170827|FG003|Overall Study|Adverse Event|2|||
25065352|NCT02415400|50170824|FG000|Overall Study|Participant request to stop therapy|4|||
25162872|NCT01790503|50285248|FG002|Overall Study|Adverse Event|0|||
25065353|NCT02415400|50170825|FG001|Overall Study|Participant request to stop therapy|3|||
25065354|NCT02415400|50170826|FG002|Overall Study|Participant request to stop therapy|8|||
25065355|NCT02415400|50170827|FG003|Overall Study|Participant request to stop therapy|6|||
25065356|NCT02415400|50170824|FG000|Overall Study|Participant withdrew consent|14|||
25065357|NCT02415400|50170825|FG001|Overall Study|Participant withdrew consent|12|||
25065358|NCT02415400|50170826|FG002|Overall Study|Participant withdrew consent|30|||
25065359|NCT02415400|50170827|FG003|Overall Study|Participant withdrew consent|21|||
25065360|NCT02415400|50170824|FG000|Overall Study|Death|39|||
25065361|NCT02415400|50170825|FG001|Overall Study|Death|41|||
25065362|NCT02415400|50170826|FG002|Overall Study|Death|35|||
25065363|NCT02415400|50170827|FG003|Overall Study|Death|42|||
25065364|NCT02415400|50170824|FG000|Overall Study|Lost to Follow-up|3|||
25065365|NCT02415400|50170825|FG001|Overall Study|Lost to Follow-up|3|||
25065366|NCT02415400|50170826|FG002|Overall Study|Lost to Follow-up|2|||
25065367|NCT02415400|50170827|FG003|Overall Study|Lost to Follow-up|5|||
25065368|NCT02415400|50170824|FG000|Overall Study|Poor/Non-Compliance|0|||
25065369|NCT02415400|50170825|FG001|Overall Study|Poor/Non-Compliance|1|||
25065370|NCT02415400|50170826|FG002|Overall Study|Poor/Non-Compliance|3|||
25065371|NCT02415400|50170827|FG003|Overall Study|Poor/Non-Compliance|4|||
25065372|NCT02415400|50170824|FG000|Overall Study|Participant no longer meets criteria|2|||
25065373|NCT02415400|50170825|FG001|Overall Study|Participant no longer meets criteria|0|||
25065374|NCT02415400|50170826|FG002|Overall Study|Participant no longer meets criteria|0|||
25065375|NCT02415400|50170827|FG003|Overall Study|Participant no longer meets criteria|1|||
25065376|NCT02415400|50170824|FG000|Overall Study|Participant doesn't answer phone|1|||
25065377|NCT02415400|50170825|FG001|Overall Study|Participant doesn't answer phone|0|||
25065378|NCT02415400|50170826|FG002|Overall Study|Participant doesn't answer phone|0|||
25065379|NCT02415400|50170827|FG003|Overall Study|Participant doesn't answer phone|0|||
25065380|NCT02415400|50170824|FG000|Overall Study|Participant wanted home visits|1|||
25065381|NCT02415400|50170825|FG001|Overall Study|Participant wanted home visits|0|||
25065382|NCT02415400|50170826|FG002|Overall Study|Participant wanted home visits|0|||
25065383|NCT02415400|50170827|FG003|Overall Study|Participant wanted home visits|0|||
25065384|NCT02415400|50170824|FG000|Overall Study|Randomized in error|2|||
25065385|NCT02415400|50170825|FG001|Overall Study|Randomized in error|0|||
25065386|NCT02415400|50170826|FG002|Overall Study|Randomized in error|0|||
25065387|NCT02415400|50170827|FG003|Overall Study|Randomized in error|0|||
25065388|NCT02415400|50170824|FG000|Overall Study|No study drug on site|0|||
25065389|NCT02415400|50170825|FG001|Overall Study|No study drug on site|1|||
25065390|NCT02415400|50170826|FG002|Overall Study|No study drug on site|0|||
25065391|NCT02415400|50170827|FG003|Overall Study|No study drug on site|0|||
25065392|NCT02415400|50170824|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
25065393|NCT02415400|50170825|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
25065394|NCT02415400|50170826|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
25065395|NCT02415400|50170827|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
25065396|NCT02415400|50170824|FG000|Overall Study|Coagulation values cannot be set|0|||
25065397|NCT02415400|50170825|FG001|Overall Study|Coagulation values cannot be set|0|||
25065398|NCT02415400|50170826|FG002|Overall Study|Coagulation values cannot be set|1|||
25065399|NCT02415400|50170827|FG003|Overall Study|Coagulation values cannot be set|0|||
25065400|NCT02415400|50170824|FG000|Overall Study|State regulations prevent participation|0|||
25065401|NCT02415400|50170825|FG001|Overall Study|State regulations prevent participation|0|||
25065402|NCT02415400|50170826|FG002|Overall Study|State regulations prevent participation|1|||
25065403|NCT02415400|50170827|FG003|Overall Study|State regulations prevent participation|0|||
25065404|NCT02415400|50170824|FG000|Overall Study|Poor treatment monitoring|0|||
25065405|NCT02415400|50170825|FG001|Overall Study|Poor treatment monitoring|0|||
25065406|NCT02415400|50170826|FG002|Overall Study|Poor treatment monitoring|1|||
25065407|NCT02415400|50170827|FG003|Overall Study|Poor treatment monitoring|0|||
25065408|NCT02415400|50170824|FG000|Overall Study|Participant in jail|0|||
25065409|NCT02415400|50170825|FG001|Overall Study|Participant in jail|0|||
25065410|NCT02415400|50170826|FG002|Overall Study|Participant in jail|1|||
25065411|NCT02415400|50170827|FG003|Overall Study|Participant in jail|0|||
25065412|NCT02415400|50170824|FG000|Overall Study|Investigator decision|0|||
25065413|NCT02415400|50170825|FG001|Overall Study|Investigator decision|0|||
25065414|NCT02415400|50170826|FG002|Overall Study|Investigator decision|1|||
25065415|NCT02415400|50170827|FG003|Overall Study|Investigator decision|1|||
25065416|NCT02415400|50170824|FG000|Overall Study|Site closure; participant won't transfer|0|||
25065417|NCT02415400|50170825|FG001|Overall Study|Site closure; participant won't transfer|0|||
25065418|NCT02415400|50170826|FG002|Overall Study|Site closure; participant won't transfer|0|||
25065419|NCT02415400|50170827|FG003|Overall Study|Site closure; participant won't transfer|1|||
25065420|NCT04194801|50170844|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
25065421|NCT04194801|50170845|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
25065422|NCT04194801|50170846|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
25065423|NCT04194801|50170844|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
25186663|NCT02641392|50337357|FG000|Overall Study|Withdrawal by Subject|0|||
25186664|NCT02641392|50337358|FG001|Overall Study|Withdrawal by Subject|0|||
25065424|NCT04194801|50170845|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
25065425|NCT04194801|50170846|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
25065426|NCT04194801|50170844|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
25065427|NCT04194801|50170845|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
25065428|NCT04194801|50170846|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
25065429|NCT04194801|50170844|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
25065430|NCT04194801|50170845|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
25065431|NCT04194801|50170846|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
25065432|NCT04194801|50170844|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
25065433|NCT04194801|50170845|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
25065434|NCT04194801|50170846|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
25065435|NCT04194801|50170844|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
25065436|NCT04194801|50170845|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
25065437|NCT04194801|50170846|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
25065438|NCT04194801|50170844|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
25065439|NCT04194801|50170845|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
25065440|NCT04194801|50170846|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
25065441|NCT04194801|50170844|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
25065442|NCT04194801|50170845|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
25065443|NCT04194801|50170846|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
25065444|NCT04194801|50170844|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
25065445|NCT04194801|50170845|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
25065446|NCT04194801|50170846|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
25065447|NCT04194801|50170844|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
25065448|NCT04194801|50170845|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
25065449|NCT04194801|50170846|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
25065450|NCT04194801|50170844|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
25065451|NCT04194801|50170845|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
25065452|NCT04194801|50170846|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
25065453|NCT04194801|50170844|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
25065454|NCT04194801|50170845|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
25065455|NCT04194801|50170846|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
25065456|NCT04194801|50170844|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
25065457|NCT04194801|50170845|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
25065458|NCT04194801|50170846|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
25065459|NCT04194801|50170844|FG000|Part Ib/II End of Study|Death|2|||
25065460|NCT04194801|50170845|FG001|Part Ib/II End of Study|Death|3|||
25065461|NCT04194801|50170846|FG002|Part Ib/II End of Study|Death|3|||
25065462|NCT04194801|50170844|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
25065463|NCT04194801|50170845|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
25065464|NCT04194801|50170846|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
25065465|NCT04194801|50170844|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
25065466|NCT04194801|50170845|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
25065467|NCT04194801|50170846|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
25065468|NCT04194801|50170844|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
25065469|NCT04194801|50170845|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
25065470|NCT04194801|50170846|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
25065471|NCT04194801|50170844|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
25065472|NCT04194801|50170845|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
25065473|NCT04194801|50170846|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
25065474|NCT02802865|50170870|FG000|Overall Study|Pregnancy|1|||
25065475|NCT02802865|50170871|FG001|Overall Study|Pregnancy|1|||
25065476|NCT02802865|50170870|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
25065477|NCT02802865|50170871|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
25065478|NCT02414932|50170879|FG000|Overall Study|Withdrawal by Subject|2|||
25065479|NCT02414932|50170880|FG001|Overall Study|Withdrawal by Subject|3|||
25065480|NCT02414932|50170879|FG000|Overall Study|Adverse Event|1|||
25065481|NCT02414932|50170880|FG001|Overall Study|Adverse Event|0|||
25065482|NCT00704535|50170886|FG000|Overall Study|Adverse Event|2|||
25065483|NCT00704535|50170886|FG000|Overall Study|Death|2|||
25065484|NCT00704535|50170886|FG000|Overall Study|Lost to Follow-up|8|||
25065485|NCT00704535|50170886|FG000|Overall Study|Protocol Violation|10|||
25065486|NCT00704535|50170886|FG000|Overall Study|Completed status not on Case Report Form|124|||
25065487|NCT01740687|50170890|FG000|Overall Study|Lost to Follow-up|11|||
25065488|NCT01740687|50170890|FG000|Overall Study|Withdrawal by Subject|2|||
25065489|NCT01740687|50170890|FG000|Overall Study|other reason|22|||
25065490|NCT01740687|50170890|FG000|Overall Study|treatment not received|2|||
25065491|NCT02648204|50170898|FG000|Overall Study|Withdrawal by Subject|12|||
25065492|NCT02648204|50170899|FG001|Overall Study|Withdrawal by Subject|8|||
25065493|NCT02648204|50170900|FG002|Overall Study|Withdrawal by Subject|2|||
25065494|NCT02648204|50170901|FG003|Overall Study|Withdrawal by Subject|6|||
25065495|NCT02648204|50170898|FG000|Overall Study|Lost to Follow-up|5|||
25065496|NCT02648204|50170899|FG001|Overall Study|Lost to Follow-up|8|||
25065497|NCT02648204|50170900|FG002|Overall Study|Lost to Follow-up|4|||
25065498|NCT02648204|50170901|FG003|Overall Study|Lost to Follow-up|6|||
25065499|NCT02648204|50170898|FG000|Overall Study|Missing follow-up information|4|||
25065500|NCT02648204|50170899|FG001|Overall Study|Missing follow-up information|4|||
25065501|NCT02648204|50170900|FG002|Overall Study|Missing follow-up information|4|||
25065502|NCT02648204|50170901|FG003|Overall Study|Missing follow-up information|2|||
25065503|NCT02648204|50170898|FG000|Overall Study|Death|1|||
25065504|NCT02648204|50170899|FG001|Overall Study|Death|1|||
24964186|NCT00441701|50054190|FG004|Overall Study|Adverse Event|2|||
24964187|NCT00441701|50054191|FG005|Overall Study|Adverse Event|2|||
25065505|NCT02648204|50170900|FG002|Overall Study|Death|2|||
25065506|NCT02648204|50170901|FG003|Overall Study|Death|2|||
25065507|NCT02648204|50170898|FG000|Overall Study|Adverse Event|0|||
25065508|NCT02648204|50170899|FG001|Overall Study|Adverse Event|0|||
25065509|NCT02648204|50170900|FG002|Overall Study|Adverse Event|1|||
25065510|NCT02648204|50170901|FG003|Overall Study|Adverse Event|0|||
25065511|NCT02799745|50170913|FG000|Overall Study|Participant moved out of state|1|||
25065512|NCT02799745|50170914|FG001|Overall Study|Participant moved out of state|0|||
25065513|NCT02799745|50170913|FG000|Overall Study|Discontinued due to planned surgery|1|||
25065514|NCT02799745|50170914|FG001|Overall Study|Discontinued due to planned surgery|0|||
25065515|NCT02799745|50170913|FG000|Overall Study|Withdrawal by Subject|16|||
25065516|NCT02799745|50170914|FG001|Overall Study|Withdrawal by Subject|25|||
25065517|NCT02799745|50170913|FG000|Overall Study|Protocol Deviation|4|||
25065518|NCT02799745|50170914|FG001|Overall Study|Protocol Deviation|5|||
25065519|NCT02799745|50170913|FG000|Overall Study|Progressive Disease|28|||
25065520|NCT02799745|50170914|FG001|Overall Study|Progressive Disease|38|||
25065521|NCT02799745|50170913|FG000|Overall Study|Lost to Follow-up|3|||
25065522|NCT02799745|50170914|FG001|Overall Study|Lost to Follow-up|2|||
25065523|NCT02799745|50170913|FG000|Overall Study|Death|3|||
25065524|NCT02799745|50170914|FG001|Overall Study|Death|0|||
25065525|NCT02799745|50170913|FG000|Overall Study|Adverse Event|0|||
25065526|NCT02799745|50170914|FG001|Overall Study|Adverse Event|1|||
25065527|NCT00705159|50170924|FG000|Overall Study|Withdrawal by Subject|0|||
25065528|NCT00705159|50170925|FG001|Overall Study|Withdrawal by Subject|1|||
25065529|NCT00705159|50170926|FG002|Overall Study|Withdrawal by Subject|1|||
25065530|NCT00705159|50170927|FG003|Overall Study|Withdrawal by Subject|1|||
25065531|NCT00705159|50170924|FG000|Overall Study|Protocol Violation|0|||
25065532|NCT00705159|50170925|FG001|Overall Study|Protocol Violation|1|||
25065533|NCT00705159|50170926|FG002|Overall Study|Protocol Violation|0|||
25065534|NCT00705159|50170927|FG003|Overall Study|Protocol Violation|0|||
25065535|NCT00705159|50170924|FG000|Overall Study|Adverse Event|0|||
25065536|NCT00705159|50170925|FG001|Overall Study|Adverse Event|0|||
25065537|NCT00705159|50170926|FG002|Overall Study|Adverse Event|1|||
25065538|NCT00705159|50170927|FG003|Overall Study|Adverse Event|0|||
25065539|NCT00705159|50170924|FG000|Overall Study|Lost to Follow-up|0|||
25065540|NCT00705159|50170925|FG001|Overall Study|Lost to Follow-up|0|||
25065541|NCT00705159|50170926|FG002|Overall Study|Lost to Follow-up|3|||
25065542|NCT00705159|50170927|FG003|Overall Study|Lost to Follow-up|2|||
25065543|NCT00705159|50170924|FG000|Overall Study|Screen Failure|0|||
25065544|NCT00705159|50170925|FG001|Overall Study|Screen Failure|0|||
25065545|NCT00705159|50170926|FG002|Overall Study|Screen Failure|0|||
25065546|NCT00705159|50170927|FG003|Overall Study|Screen Failure|1|||
25065547|NCT01673984|50170939|FG000|Overall Study|Adverse Event|1|||
25065548|NCT01673984|50170940|FG001|Overall Study|Adverse Event|0|||
25065549|NCT01673984|50170939|FG000|Overall Study|Study termination|9|||
25065550|NCT01673984|50170940|FG001|Overall Study|Study termination|6|||
25065551|NCT02332928|50170959|FG000|Overall Study|Withdrawal by Subject|0|||
25065552|NCT02332928|50170960|FG001|Overall Study|Withdrawal by Subject|2|||
25065553|NCT02332928|50170959|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
25065554|NCT02332928|50170960|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
25065555|NCT02647658|50170968|FG000|Overall Study|Consent refusal|15|||
25065556|NCT02647658|50170969|FG001|Overall Study|Consent refusal|24|||
25065557|NCT00703677|50170975|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
25065558|NCT00703911|50170983|FG000|Overall Study|Death|1|||
25065559|NCT00703911|50170983|FG000|Overall Study|Physician Decision|6|||
25065560|NCT00703911|50170983|FG000|Overall Study|Lost to Follow-up|1|||
25065561|NCT00703911|50170983|FG000|Overall Study|Withdrawal by Subject|2|||
25065562|NCT02055547|50170987|FG000|Overall Study|Protocol Violation|0|||
25065563|NCT02055547|50170988|FG001|Overall Study|Protocol Violation|0|||
25065564|NCT02055547|50170989|FG002|Overall Study|Protocol Violation|1|||
25065565|NCT02055547|50170990|FG003|Overall Study|Protocol Violation|0|||
25065566|NCT02055547|50170991|FG004|Overall Study|Protocol Violation|0|||
25065567|NCT02055547|50170992|FG005|Overall Study|Protocol Violation|0|||
25065568|NCT02055547|50170993|FG006|Overall Study|Protocol Violation|1|||
25065569|NCT02055547|50170994|FG007|Overall Study|Protocol Violation|0|||
25065570|NCT02055547|50170995|FG008|Overall Study|Protocol Violation|0|||
25065571|NCT02055547|50170996|FG009|Overall Study|Protocol Violation|0|||
25065572|NCT02055547|50170997|FG010|Overall Study|Protocol Violation|0|||
25065573|NCT02055547|50170998|FG011|Overall Study|Protocol Violation|0|||
25065574|NCT02055547|50170999|FG012|Overall Study|Protocol Violation|0|||
25065575|NCT02055547|50171000|FG013|Overall Study|Protocol Violation|0|||
25065576|NCT02055547|50171001|FG014|Overall Study|Protocol Violation|0|||
25065577|NCT02055547|50171002|FG015|Overall Study|Protocol Violation|0|||
25065578|NCT02055547|50171003|FG016|Overall Study|Protocol Violation|0|||
25065579|NCT02055547|50171004|FG017|Overall Study|Protocol Violation|0|||
25065580|NCT02055547|50171005|FG018|Overall Study|Protocol Violation|0|||
25065581|NCT02055547|50170987|FG000|Overall Study|Physician Decision|0|||
25065582|NCT02055547|50170988|FG001|Overall Study|Physician Decision|1|||
25065583|NCT02055547|50170989|FG002|Overall Study|Physician Decision|1|||
25065584|NCT02055547|50170990|FG003|Overall Study|Physician Decision|0|||
25065585|NCT02055547|50170991|FG004|Overall Study|Physician Decision|1|||
25065586|NCT02055547|50170992|FG005|Overall Study|Physician Decision|0|||
25065587|NCT02055547|50170993|FG006|Overall Study|Physician Decision|0|||
25065588|NCT02055547|50170994|FG007|Overall Study|Physician Decision|0|||
25065589|NCT02055547|50170995|FG008|Overall Study|Physician Decision|0|||
25065590|NCT02055547|50170996|FG009|Overall Study|Physician Decision|1|||
25065591|NCT02055547|50170997|FG010|Overall Study|Physician Decision|1|||
25065592|NCT02055547|50170998|FG011|Overall Study|Physician Decision|0|||
25065593|NCT02055547|50170999|FG012|Overall Study|Physician Decision|0|||
25065594|NCT02055547|50171000|FG013|Overall Study|Physician Decision|0|||
25065595|NCT02055547|50171001|FG014|Overall Study|Physician Decision|0|||
25065596|NCT02055547|50171002|FG015|Overall Study|Physician Decision|0|||
25065597|NCT02055547|50171003|FG016|Overall Study|Physician Decision|0|||
25065598|NCT02055547|50171004|FG017|Overall Study|Physician Decision|0|||
25065599|NCT02055547|50171005|FG018|Overall Study|Physician Decision|0|||
25065600|NCT02055547|50170987|FG000|Overall Study|Adverse Event|0|||
25065601|NCT02055547|50170988|FG001|Overall Study|Adverse Event|0|||
25065602|NCT02055547|50170989|FG002|Overall Study|Adverse Event|0|||
25065603|NCT02055547|50170990|FG003|Overall Study|Adverse Event|0|||
25065604|NCT02055547|50170991|FG004|Overall Study|Adverse Event|0|||
25065605|NCT02055547|50170992|FG005|Overall Study|Adverse Event|0|||
25065606|NCT02055547|50170993|FG006|Overall Study|Adverse Event|1|||
25065607|NCT02055547|50170994|FG007|Overall Study|Adverse Event|0|||
25065608|NCT02055547|50170995|FG008|Overall Study|Adverse Event|1|||
25065609|NCT02055547|50170996|FG009|Overall Study|Adverse Event|0|||
25065610|NCT02055547|50170997|FG010|Overall Study|Adverse Event|0|||
25065611|NCT02055547|50170998|FG011|Overall Study|Adverse Event|0|||
25065612|NCT02055547|50170999|FG012|Overall Study|Adverse Event|0|||
25065613|NCT02055547|50171000|FG013|Overall Study|Adverse Event|0|||
25065614|NCT02055547|50171001|FG014|Overall Study|Adverse Event|0|||
25065615|NCT02055547|50171002|FG015|Overall Study|Adverse Event|0|||
25065616|NCT02055547|50171003|FG016|Overall Study|Adverse Event|0|||
25065617|NCT02055547|50171004|FG017|Overall Study|Adverse Event|0|||
25276726|NCT01237340|50590686|FG000|Overall Study|Adverse Event|3|||
25065618|NCT02055547|50171005|FG018|Overall Study|Adverse Event|0|||
25065619|NCT02055547|50170987|FG000|Overall Study|Withdrawal by Subject|0|||
25065620|NCT02055547|50170988|FG001|Overall Study|Withdrawal by Subject|0|||
25065621|NCT02055547|50170989|FG002|Overall Study|Withdrawal by Subject|0|||
25065622|NCT02055547|50170990|FG003|Overall Study|Withdrawal by Subject|0|||
25065623|NCT02055547|50170991|FG004|Overall Study|Withdrawal by Subject|0|||
25065624|NCT02055547|50170992|FG005|Overall Study|Withdrawal by Subject|1|||
25065625|NCT02055547|50170993|FG006|Overall Study|Withdrawal by Subject|0|||
25065626|NCT02055547|50170994|FG007|Overall Study|Withdrawal by Subject|0|||
25065627|NCT02055547|50170995|FG008|Overall Study|Withdrawal by Subject|1|||
25065628|NCT02055547|50170996|FG009|Overall Study|Withdrawal by Subject|0|||
25065629|NCT02055547|50170997|FG010|Overall Study|Withdrawal by Subject|0|||
25065630|NCT02055547|50170998|FG011|Overall Study|Withdrawal by Subject|0|||
25065631|NCT02055547|50170999|FG012|Overall Study|Withdrawal by Subject|0|||
25065632|NCT02055547|50171000|FG013|Overall Study|Withdrawal by Subject|1|||
25065633|NCT02055547|50171001|FG014|Overall Study|Withdrawal by Subject|0|||
25065634|NCT02055547|50171002|FG015|Overall Study|Withdrawal by Subject|1|||
25065635|NCT02055547|50171003|FG016|Overall Study|Withdrawal by Subject|0|||
25065636|NCT02055547|50171004|FG017|Overall Study|Withdrawal by Subject|0|||
25065637|NCT02055547|50171005|FG018|Overall Study|Withdrawal by Subject|0|||
25065638|NCT02055547|50170987|FG000|Overall Study|Lost to Follow-up|0|||
25065639|NCT02055547|50170988|FG001|Overall Study|Lost to Follow-up|0|||
25065640|NCT02055547|50170989|FG002|Overall Study|Lost to Follow-up|1|||
25065641|NCT02055547|50170990|FG003|Overall Study|Lost to Follow-up|0|||
25065642|NCT02055547|50170991|FG004|Overall Study|Lost to Follow-up|0|||
25065643|NCT02055547|50170992|FG005|Overall Study|Lost to Follow-up|0|||
25065644|NCT02055547|50170993|FG006|Overall Study|Lost to Follow-up|0|||
25065645|NCT02055547|50170994|FG007|Overall Study|Lost to Follow-up|0|||
25065646|NCT02055547|50170995|FG008|Overall Study|Lost to Follow-up|0|||
25065647|NCT02055547|50170996|FG009|Overall Study|Lost to Follow-up|0|||
25065648|NCT02055547|50170997|FG010|Overall Study|Lost to Follow-up|0|||
25065649|NCT02055547|50170998|FG011|Overall Study|Lost to Follow-up|0|||
25065650|NCT02055547|50170999|FG012|Overall Study|Lost to Follow-up|0|||
25065651|NCT02055547|50171000|FG013|Overall Study|Lost to Follow-up|0|||
25065652|NCT02055547|50171001|FG014|Overall Study|Lost to Follow-up|0|||
25065653|NCT02055547|50171002|FG015|Overall Study|Lost to Follow-up|0|||
25065654|NCT02055547|50171003|FG016|Overall Study|Lost to Follow-up|0|||
25065655|NCT02055547|50171004|FG017|Overall Study|Lost to Follow-up|0|||
25065656|NCT02055547|50171005|FG018|Overall Study|Lost to Follow-up|0|||
25065657|NCT02414854|50171043|FG000|Overall Study|Adverse Event|9|||
25065658|NCT02414854|50171044|FG001|Overall Study|Adverse Event|7|||
25065659|NCT02414854|50171045|FG002|Overall Study|Adverse Event|1|||
25065660|NCT02414854|50171046|FG003|Overall Study|Adverse Event|12|||
25065661|NCT02414854|50171043|FG000|Overall Study|Poor compliance to protocol|1|||
25065662|NCT02414854|50171044|FG001|Overall Study|Poor compliance to protocol|1|||
25065663|NCT02414854|50171045|FG002|Overall Study|Poor compliance to protocol|2|||
25065664|NCT02414854|50171046|FG003|Overall Study|Poor compliance to protocol|2|||
25065665|NCT02414854|50171043|FG000|Overall Study|Other than specified above|12|||
25065666|NCT02414854|50171044|FG001|Overall Study|Other than specified above|37|||
25065667|NCT02414854|50171045|FG002|Overall Study|Other than specified above|17|||
25065668|NCT02414854|50171046|FG003|Overall Study|Other than specified above|37|||
25065669|NCT03332498|50171059|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
25065670|NCT03332498|50171060|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
25065671|NCT03332498|50171061|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
25065672|NCT01334125|50171070|FG000|Overall Study|Lost to Follow-up|3|||
25065673|NCT01334125|50171071|FG001|Overall Study|Lost to Follow-up|3|||
25065674|NCT02414152|50171078|FG000|Overall Study|Withdrawal by Subject|1|||
25065675|NCT02414152|50171078|FG000|Overall Study|Lack of Efficacy|1|||
25065676|NCT02413996|50171084|FG000|Overall Study|not comfortable with the intervention|9|||
25065677|NCT02413996|50171085|FG001|Overall Study|not comfortable with the intervention|2|||
25065678|NCT01333501|50171093|FG000|Overall Study|Adverse Event|3|||
25065679|NCT01333501|50171094|FG001|Overall Study|Adverse Event|1|||
25065680|NCT01333501|50171093|FG000|Overall Study|Abnormal laboratory value|2|||
25065681|NCT01333501|50171094|FG001|Overall Study|Abnormal laboratory value|1|||
25065682|NCT01333501|50171093|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25065683|NCT01333501|50171094|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
25065684|NCT01333501|50171093|FG000|Overall Study|Withdrawn consent|3|||
25065685|NCT01333501|50171094|FG001|Overall Study|Withdrawn consent|12|||
25065686|NCT01362140|50171102|FG000|Overall Study|Noncompliance|1|||
25065687|NCT01362140|50171103|FG001|Overall Study|Noncompliance|0|||
25065688|NCT01362140|50171102|FG000|Overall Study|Adverse Event|2|||
25065689|NCT01362140|50171103|FG001|Overall Study|Adverse Event|2|||
25065690|NCT01362140|50171102|FG000|Overall Study|Withdrawal by Subject|3|||
25065691|NCT01362140|50171103|FG001|Overall Study|Withdrawal by Subject|3|||
25065692|NCT01362140|50171102|FG000|Overall Study|Administrative Decision|0|||
25065693|NCT01362140|50171103|FG001|Overall Study|Administrative Decision|1|||
25065694|NCT01362140|50171102|FG000|Overall Study|Death|2|||
25065695|NCT01362140|50171103|FG001|Overall Study|Death|1|||
25065696|NCT01362140|50171102|FG000|Overall Study|Other|1|||
25065697|NCT01362140|50171103|FG001|Overall Study|Other|1|||
25065698|NCT01362140|50171102|FG000|Overall Study|Protocol-specified Criteria|1|||
25065699|NCT01362140|50171103|FG001|Overall Study|Protocol-specified Criteria|2|||
25065700|NCT01362140|50171102|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
25065701|NCT01362140|50171103|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
25065702|NCT01333189|50171111|FG000|Overall Study|Time constraints|1|||
25065703|NCT01333189|50171112|FG001|Overall Study|Time constraints|0|||
25065704|NCT01333189|50171111|FG000|Overall Study|Adverse Event|1|||
25065705|NCT01333189|50171112|FG001|Overall Study|Adverse Event|0|||
25065706|NCT01333189|50171111|FG000|Overall Study|Transportation difficulties|0|||
25065707|NCT01333189|50171112|FG001|Overall Study|Transportation difficulties|1|||
25065708|NCT01333189|50171111|FG000|Overall Study|Moved from region|0|||
25065709|NCT01333189|50171112|FG001|Overall Study|Moved from region|1|||
25065710|NCT01333111|50171121|FG000|Overall Study|patient undergoing major surgery|0|||
25162873|NCT01790503|50285249|FG003|Overall Study|Adverse Event|0|||
25065711|NCT01333111|50171122|FG001|Overall Study|patient undergoing major surgery|2|||
25065712|NCT01333111|50171123|FG002|Overall Study|patient undergoing major surgery|0|||
25065713|NCT01333111|50171121|FG000|Overall Study|personal reasons|0|||
25065714|NCT01333111|50171122|FG001|Overall Study|personal reasons|0|||
25065715|NCT01333111|50171123|FG002|Overall Study|personal reasons|1|||
25065716|NCT01333111|50171121|FG000|Overall Study|unclassified|1|||
25065717|NCT01333111|50171122|FG001|Overall Study|unclassified|0|||
25065718|NCT01333111|50171123|FG002|Overall Study|unclassified|0|||
25065719|NCT01333111|50171121|FG000|Overall Study|withdrawal criteria|0|||
25065720|NCT01333111|50171122|FG001|Overall Study|withdrawal criteria|1|||
25065721|NCT01333111|50171123|FG002|Overall Study|withdrawal criteria|0|||
25065722|NCT01333111|50171121|FG000|Overall Study|Non-compliance|1|||
25065723|NCT01333111|50171122|FG001|Overall Study|Non-compliance|0|||
25065724|NCT01333111|50171123|FG002|Overall Study|Non-compliance|0|||
25065725|NCT01333111|50171121|FG000|Overall Study|Ineffective therapy|0|||
25065726|NCT01333111|50171122|FG001|Overall Study|Ineffective therapy|0|||
25065727|NCT01333111|50171123|FG002|Overall Study|Ineffective therapy|1|||
25065728|NCT00702507|50171131|FG000|Initial Treatment Phase|Adverse Event|2|||
25065729|NCT00702507|50171131|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
25162874|NCT01790503|50285250|FG004|Overall Study|Adverse Event|0|||
25162875|NCT01790503|50285251|FG005|Overall Study|Adverse Event|2|||
25162876|NCT01790503|50285252|FG006|Overall Study|Adverse Event|0|||
25162877|NCT01790503|50285253|FG007|Overall Study|Adverse Event|0|||
25162878|NCT01790503|50285254|FG008|Overall Study|Adverse Event|2|||
25162879|NCT01790503|50285255|FG009|Overall Study|Adverse Event|4|||
25162880|NCT01790503|50285256|FG010|Overall Study|Adverse Event|7|||
25162881|NCT01790503|50285246|FG000|Overall Study|Withdrawal by Subject|0|||
25162882|NCT01790503|50285247|FG001|Overall Study|Withdrawal by Subject|0|||
25162883|NCT01790503|50285248|FG002|Overall Study|Withdrawal by Subject|1|||
25162884|NCT01790503|50285249|FG003|Overall Study|Withdrawal by Subject|1|||
25162885|NCT01790503|50285250|FG004|Overall Study|Withdrawal by Subject|1|||
25162886|NCT01790503|50285251|FG005|Overall Study|Withdrawal by Subject|2|||
25162887|NCT01790503|50285252|FG006|Overall Study|Withdrawal by Subject|1|||
25162888|NCT01790503|50285253|FG007|Overall Study|Withdrawal by Subject|0|||
25065730|NCT00702507|50171131|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
25065731|NCT00702507|50171131|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
25065732|NCT00702507|50171131|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
25065733|NCT00702507|50171131|FG000|Follow-up Phase|Protocol Violation|2|||
25065734|NCT00702507|50171131|FG000|Follow-up Phase|Lost to Follow-up|23|||
25162889|NCT01790503|50285254|FG008|Overall Study|Withdrawal by Subject|0|||
25065735|NCT00702507|50171131|FG000|Follow-up Phase|Late Enrollment|1|||
25065736|NCT01673594|50171147|FG000|Overall Study|Adverse Event|3|||
25065737|NCT01673594|50171148|FG001|Overall Study|Adverse Event|1|||
25065738|NCT01673594|50171147|FG000|Overall Study|Lost to Follow-up|1|||
25065739|NCT01673594|50171148|FG001|Overall Study|Lost to Follow-up|0|||
25065740|NCT01673594|50171147|FG000|Overall Study|Physician Decision|2|||
25065741|NCT01673594|50171148|FG001|Overall Study|Physician Decision|4|||
25065742|NCT01673594|50171147|FG000|Overall Study|Withdrawal by Subject|0|||
25065743|NCT01673594|50171148|FG001|Overall Study|Withdrawal by Subject|1|||
25065744|NCT02721147|50171157|FG000|Overall Study|Lost to Follow-up|2|||
25065745|NCT02721147|50171158|FG001|Overall Study|Lost to Follow-up|0|||
25065746|NCT02721147|50171159|FG002|Overall Study|Lost to Follow-up|0|||
25065747|NCT02720757|50171167|FG000|Overall Study|Other reason|5|||
25065748|NCT02720757|50171167|FG000|Overall Study|Loss of contact|4|||
25065749|NCT02720757|50171167|FG000|Overall Study|Informed consent withdrawal|1|||
25065750|NCT02720757|50171167|FG000|Overall Study|Patients wish to withdraw|2|||
25065751|NCT02720757|50171167|FG000|Overall Study|Missing|3|||
25065752|NCT02720757|50171167|FG000|Overall Study|General exclusion|3|||
25065753|NCT02646566|50171197|FG000|Overall Study|Lost to Follow-up|5|||
25065754|NCT02646566|50171198|FG001|Overall Study|Lost to Follow-up|4|||
25065755|NCT02646566|50171199|FG002|Overall Study|Lost to Follow-up|5|||
25065756|NCT02646566|50171197|FG000|Overall Study|Treatment failure|1|||
25065757|NCT02646566|50171198|FG001|Overall Study|Treatment failure|0|||
25065758|NCT02646566|50171199|FG002|Overall Study|Treatment failure|0|||
25065759|NCT02720523|50171215|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
25065760|NCT02720523|50171216|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
25065761|NCT02720523|50171217|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
25065762|NCT02720523|50171218|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
25065763|NCT02720523|50171219|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
25065764|NCT02720523|50171220|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
25065765|NCT02720523|50171221|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
25065766|NCT02720523|50171215|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
25065767|NCT02720523|50171216|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
25065768|NCT02720523|50171217|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
25065769|NCT02720523|50171218|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
25065770|NCT02720523|50171219|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
25065771|NCT02720523|50171220|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
25065772|NCT02720523|50171221|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
25065773|NCT02720523|50171215|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
25065774|NCT02720523|50171216|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
25065775|NCT02720523|50171217|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
25065776|NCT02720523|50171218|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
25065777|NCT02720523|50171219|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
25065778|NCT02720523|50171220|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
25065779|NCT02720523|50171221|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
25065780|NCT02720523|50171215|FG000|Period 1: Placebo-controlled Period|Other|0|||
25065781|NCT02720523|50171216|FG001|Period 1: Placebo-controlled Period|Other|0|||
25065782|NCT02720523|50171217|FG002|Period 1: Placebo-controlled Period|Other|1|||
25065783|NCT02720523|50171218|FG003|Period 1: Placebo-controlled Period|Other|1|||
25065784|NCT02720523|50171219|FG004|Period 1: Placebo-controlled Period|Other|0|||
25065785|NCT02720523|50171220|FG005|Period 1: Placebo-controlled Period|Other|0|||
25065786|NCT02720523|50171221|FG006|Period 1: Placebo-controlled Period|Other|0|||
25065787|NCT02720523|50171215|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
25065788|NCT02720523|50171216|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
25065789|NCT02720523|50171217|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
25065790|NCT02720523|50171218|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
25065791|NCT02720523|50171219|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
25065792|NCT02720523|50171220|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
25065793|NCT02720523|50171221|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
25065794|NCT02720523|50171215|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
25065795|NCT02720523|50171216|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
25065796|NCT02720523|50171217|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
25065797|NCT02720523|50171218|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
25065798|NCT02720523|50171219|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
25065799|NCT02720523|50171220|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
25065800|NCT02720523|50171221|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
25065801|NCT02720523|50171215|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
24964188|NCT00441701|50054192|FG006|Overall Study|Adverse Event|0|||
25065802|NCT02720523|50171216|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
25065803|NCT02720523|50171217|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
25065804|NCT02720523|50171218|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
25065805|NCT02720523|50171219|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
25065806|NCT02720523|50171220|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
25065807|NCT02720523|50171221|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
25065808|NCT02720523|50171215|FG000|Period 2: Long-term Extension Period|Other|0|||
25065809|NCT02720523|50171216|FG001|Period 2: Long-term Extension Period|Other|0|||
25065810|NCT02720523|50171217|FG002|Period 2: Long-term Extension Period|Other|0|||
25065811|NCT02720523|50171218|FG003|Period 2: Long-term Extension Period|Other|0|||
25065812|NCT02720523|50171219|FG004|Period 2: Long-term Extension Period|Other|2|||
25065813|NCT02720523|50171220|FG005|Period 2: Long-term Extension Period|Other|0|||
25065814|NCT02720523|50171221|FG006|Period 2: Long-term Extension Period|Other|3|||
25065815|NCT02646332|50171236|FG000|Overall Study|Lost to Follow-up|0|||
25065816|NCT02646332|50171237|FG001|Overall Study|Lost to Follow-up|3|||
25065817|NCT02471716|50171248|FG000|Overall Study|Withdrawal by Subject|0|||
25065818|NCT02471716|50171249|FG001|Overall Study|Withdrawal by Subject|1|||
25065819|NCT02471716|50171250|FG002|Overall Study|Withdrawal by Subject|0|||
25065820|NCT02471716|50171251|FG003|Overall Study|Withdrawal by Subject|2|||
25065821|NCT02471716|50171252|FG004|Overall Study|Withdrawal by Subject|5|||
25065822|NCT02471716|50171248|FG000|Overall Study|Study Terminiated by sponsor|0|||
25065823|NCT02471716|50171249|FG001|Overall Study|Study Terminiated by sponsor|0|||
25065824|NCT02471716|50171250|FG002|Overall Study|Study Terminiated by sponsor|0|||
25065825|NCT02471716|50171251|FG003|Overall Study|Study Terminiated by sponsor|1|||
25065826|NCT02471716|50171252|FG004|Overall Study|Study Terminiated by sponsor|0|||
25065827|NCT02471716|50171248|FG000|Overall Study|Lost to Follow-up|0|||
25065828|NCT02471716|50171249|FG001|Overall Study|Lost to Follow-up|0|||
25065829|NCT02471716|50171250|FG002|Overall Study|Lost to Follow-up|0|||
25065830|NCT02471716|50171251|FG003|Overall Study|Lost to Follow-up|3|||
25065831|NCT02471716|50171252|FG004|Overall Study|Lost to Follow-up|2|||
25065832|NCT02471716|50171248|FG000|Overall Study|Death|0|||
25065833|NCT02471716|50171249|FG001|Overall Study|Death|0|||
25065834|NCT02471716|50171250|FG002|Overall Study|Death|0|||
25065835|NCT02471716|50171251|FG003|Overall Study|Death|1|||
25065836|NCT02471716|50171252|FG004|Overall Study|Death|0|||
25065837|NCT02471716|50171248|FG000|Overall Study|Other|0|||
25065838|NCT02471716|50171249|FG001|Overall Study|Other|0|||
25065839|NCT02471716|50171250|FG002|Overall Study|Other|0|||
25065840|NCT02471716|50171251|FG003|Overall Study|Other|8|||
25065841|NCT02471716|50171252|FG004|Overall Study|Other|9|||
25065842|NCT01370863|50171268|FG000|Overall Study|Adverse Event|1|||
25065843|NCT01370863|50171269|FG001|Overall Study|Adverse Event|1|||
25065844|NCT01370863|50171268|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
25065845|NCT01370863|50171269|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
25065846|NCT01370863|50171268|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
25065847|NCT01370863|50171269|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
25065848|NCT02444182|50171277|FG000|Overall Study|non-compliance|2|||
25065849|NCT02444182|50171278|FG001|Overall Study|non-compliance|1|||
25065850|NCT02444182|50171277|FG000|Overall Study|Lost to Follow-up|0|||
25065851|NCT02444182|50171278|FG001|Overall Study|Lost to Follow-up|4|||
25065852|NCT02471404|50171287|FG000|Overall Study|Adverse Event|7|||
25065853|NCT02471404|50171288|FG001|Overall Study|Adverse Event|1|||
25065854|NCT02471404|50171289|FG002|Overall Study|Adverse Event|2|||
25065855|NCT02471404|50171287|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
25065856|NCT02471404|50171288|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
25065857|NCT02471404|50171289|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
25065858|NCT02471404|50171287|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
25065859|NCT02471404|50171288|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
25065860|NCT02471404|50171289|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
25065861|NCT02471404|50171287|FG000|Overall Study|Lost to Follow-up|1|||
25065862|NCT02471404|50171288|FG001|Overall Study|Lost to Follow-up|1|||
25065863|NCT02471404|50171289|FG002|Overall Study|Lost to Follow-up|3|||
25065864|NCT02471404|50171287|FG000|Overall Study|Protocol Violation|1|||
25065865|NCT02471404|50171288|FG001|Overall Study|Protocol Violation|0|||
25065866|NCT02471404|50171289|FG002|Overall Study|Protocol Violation|0|||
25065867|NCT02471404|50171287|FG000|Overall Study|Withdrawal by Subject|8|||
25065868|NCT02471404|50171288|FG001|Overall Study|Withdrawal by Subject|4|||
25065869|NCT02471404|50171289|FG002|Overall Study|Withdrawal by Subject|5|||
25065870|NCT02471404|50171287|FG000|Overall Study|Other reasons not specified|10|||
25065871|NCT02471404|50171288|FG001|Overall Study|Other reasons not specified|7|||
25162890|NCT01790503|50285255|FG009|Overall Study|Withdrawal by Subject|0|||
25065872|NCT02471404|50171289|FG002|Overall Study|Other reasons not specified|12|||
25065873|NCT02471014|50171299|FG000|Overall Study|Lost to Follow-up|2|||
25065874|NCT02471014|50171300|FG001|Overall Study|Lost to Follow-up|2|||
25065875|NCT02413372|50171309|FG000|Treatment|Lost to Follow-up|0|||
25065876|NCT02413372|50171310|FG001|Treatment|Lost to Follow-up|2|||
25065877|NCT02413372|50171311|FG002|Treatment|Lost to Follow-up|1|||
25065878|NCT02413372|50171309|FG000|Treatment|Withdrawal by Subject|1|||
25065879|NCT02413372|50171310|FG001|Treatment|Withdrawal by Subject|0|||
25065880|NCT02413372|50171311|FG002|Treatment|Withdrawal by Subject|0|||
25065881|NCT02413372|50171309|FG000|Follow-up|Lost to Follow-up|1|||
25065882|NCT02413372|50171310|FG001|Follow-up|Lost to Follow-up|1|||
25065883|NCT02413372|50171311|FG002|Follow-up|Lost to Follow-up|0|||
25065884|NCT02413372|50171309|FG000|Follow-up|Subject Withdrew Consent|1|||
25065885|NCT02413372|50171310|FG001|Follow-up|Subject Withdrew Consent|0|||
25065886|NCT02413372|50171311|FG002|Follow-up|Subject Withdrew Consent|1|||
25065887|NCT02413372|50171309|FG000|Follow-up|Subject unable to return for visit|0|||
25065888|NCT02413372|50171310|FG001|Follow-up|Subject unable to return for visit|0|||
25065889|NCT02413372|50171311|FG002|Follow-up|Subject unable to return for visit|1|||
25065890|NCT02413294|50171319|FG000|Overall Study|Withdrawal by Subject|1|||
25065891|NCT02719353|50171332|FG000|First Intervention|Physician Decision|0|||
25065892|NCT02719353|50171333|FG001|First Intervention|Physician Decision|1|||
25065893|NCT01362062|50171342|FG000|Overall Study|Adverse Event|1|||
25065894|NCT01362062|50171343|FG001|Overall Study|Adverse Event|0|||
25065895|NCT01362062|50171342|FG000|Overall Study|Lost to Follow-up|11|||
25065896|NCT01362062|50171343|FG001|Overall Study|Lost to Follow-up|0|||
25065897|NCT01362062|50171342|FG000|Overall Study|Withdrawal by Subject|2|||
25065898|NCT01362062|50171343|FG001|Overall Study|Withdrawal by Subject|0|||
25065899|NCT01362062|50171342|FG000|Overall Study|Non-compliant participant|2|||
25065900|NCT01362062|50171343|FG001|Overall Study|Non-compliant participant|0|||
25065901|NCT01362062|50171342|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
25065902|NCT01362062|50171343|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
25065903|NCT01362062|50171342|FG000|Overall Study|Had significant improvement|9|||
25065904|NCT01362062|50171343|FG001|Overall Study|Had significant improvement|0|||
25065905|NCT01361594|50171350|FG000|Overall Study|Withdrawal by Subject|1|||
25065906|NCT01361594|50171351|FG001|Overall Study|Withdrawal by Subject|2|||
25065907|NCT02642432|50171357|FG000|Overall Study|Adverse Event|2|||
25065908|NCT02642432|50171357|FG000|Overall Study|Withdrew Consent|1|||
25065909|NCT02642432|50171357|FG000|Overall Study|Lost to Follow-up|2|||
25065910|NCT02642432|50171357|FG000|Overall Study|Other|3|||
25065911|NCT02640482|50171363|FG000|Overall Study|Lost to Follow-up|3|||
25065912|NCT02640482|50171364|FG001|Overall Study|Lost to Follow-up|0|||
25065913|NCT02719743|50171375|FG000|Overall Study|Consent withdrawal|0|||
25065914|NCT02719743|50171376|FG001|Overall Study|Consent withdrawal|2|||
25065915|NCT02719743|50171377|FG002|Overall Study|Consent withdrawal|0|||
25065916|NCT02719743|50171378|FG003|Overall Study|Consent withdrawal|1|||
25065917|NCT02719743|50171379|FG004|Overall Study|Consent withdrawal|0|||
25065918|NCT02719743|50171375|FG000|Overall Study|Migrated/moved from study area|0|||
25065919|NCT02719743|50171376|FG001|Overall Study|Migrated/moved from study area|0|||
25065920|NCT02719743|50171377|FG002|Overall Study|Migrated/moved from study area|0|||
25065921|NCT02719743|50171378|FG003|Overall Study|Migrated/moved from study area|0|||
25065922|NCT02719743|50171379|FG004|Overall Study|Migrated/moved from study area|2|||
25065923|NCT02719743|50171375|FG000|Overall Study|Lost to Follow-up|1|||
25065924|NCT02719743|50171376|FG001|Overall Study|Lost to Follow-up|1|||
25065925|NCT02719743|50171377|FG002|Overall Study|Lost to Follow-up|0|||
25065926|NCT02719743|50171378|FG003|Overall Study|Lost to Follow-up|0|||
25065927|NCT02719743|50171379|FG004|Overall Study|Lost to Follow-up|0|||
25065928|NCT02641730|50171394|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
25065929|NCT02641730|50171395|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
25065930|NCT02641730|50171396|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
25065931|NCT02641730|50171397|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
25065932|NCT02641730|50171398|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
25065933|NCT02641730|50171394|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
25065934|NCT02641730|50171395|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
25065935|NCT02641730|50171396|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
25065936|NCT02641730|50171397|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
25276727|NCT01237340|50590686|FG000|Overall Study|Withdrawal by Subject|1|||
25276728|NCT01237340|50590686|FG000|Overall Study|Early termination of the trial|36|||
25276729|NCT01045707|50590695|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
25276730|NCT01045707|50590696|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
25276731|NCT01045707|50590695|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
25276732|NCT01045707|50590696|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
25276733|NCT01045707|50590695|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
25276734|NCT01045707|50590696|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
25276735|NCT01045707|50590695|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
25276736|NCT01045707|50590696|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
25276737|NCT01045707|50590695|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
25276738|NCT01045707|50590696|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
25276739|NCT01045707|50590695|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
25276740|NCT01045707|50590696|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
25276741|NCT01045707|50590695|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
25276742|NCT01045707|50590696|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
25276743|NCT01045707|50590695|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
25276744|NCT01045707|50590696|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
24964189|NCT00441701|50054193|FG007|Overall Study|Adverse Event|0|||
24964190|NCT00441701|50054194|FG008|Overall Study|Adverse Event|0|||
24964191|NCT00441701|50054195|FG009|Overall Study|Adverse Event|0|||
25276745|NCT01045707|50590695|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
25276746|NCT01045707|50590696|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
25276747|NCT01054599|50590704|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
25276748|NCT01054599|50590705|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
25276749|NCT01054599|50590704|FG000|Overall Study|Protocol Violation|1|||
25276750|NCT01054599|50590705|FG001|Overall Study|Protocol Violation|0|||
25276751|NCT01054599|50590704|FG000|Overall Study|Spells/seizure-like episodes|1|||
25276752|NCT01054599|50590705|FG001|Overall Study|Spells/seizure-like episodes|1|||
25276753|NCT01054599|50590704|FG000|Overall Study|Timing/scheduling difficulties|1|||
25276754|NCT01054599|50590705|FG001|Overall Study|Timing/scheduling difficulties|1|||
25065937|NCT02641730|50171398|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
25065938|NCT02641730|50171394|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
25065939|NCT02641730|50171395|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
25065940|NCT02641730|50171396|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
25065941|NCT02641730|50171397|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
25065942|NCT02641730|50171398|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
25065943|NCT02641730|50171394|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
25065944|NCT02641730|50171395|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
25065945|NCT02641730|50171396|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
25065946|NCT02641730|50171397|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
25065947|NCT02641730|50171398|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
25065948|NCT02641730|50171394|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
25065949|NCT02641730|50171395|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
25065950|NCT02641730|50171396|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
25065951|NCT02641730|50171397|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
25065952|NCT02641730|50171398|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
25065953|NCT02641730|50171394|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
25065954|NCT02641730|50171395|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
25065955|NCT02641730|50171396|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
25065956|NCT02641730|50171397|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
24964192|NCT00441701|50054186|FG000|Overall Study|Lack of Efficacy|2|||
24964193|NCT00441701|50054187|FG001|Overall Study|Lack of Efficacy|0|||
24964194|NCT00441701|50054188|FG002|Overall Study|Lack of Efficacy|2|||
24964195|NCT00441701|50054189|FG003|Overall Study|Lack of Efficacy|2|||
25065957|NCT02641730|50171398|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
25065958|NCT02797171|50171418|FG000|Overall Study|Lost to Follow-up|2|||
25065959|NCT02797171|50171419|FG001|Overall Study|Lost to Follow-up|0|||
25065960|NCT02797171|50171420|FG002|Overall Study|Lost to Follow-up|2|||
25065961|NCT02797171|50171421|FG003|Overall Study|Lost to Follow-up|1|||
25065962|NCT02797171|50171422|FG004|Overall Study|Lost to Follow-up|2|||
25065963|NCT02797171|50171423|FG005|Overall Study|Lost to Follow-up|0|||
25065964|NCT02797171|50171418|FG000|Overall Study|Withdrawal by Subject|1|||
25065965|NCT02797171|50171419|FG001|Overall Study|Withdrawal by Subject|1|||
25065966|NCT02797171|50171420|FG002|Overall Study|Withdrawal by Subject|0|||
25065967|NCT02797171|50171421|FG003|Overall Study|Withdrawal by Subject|0|||
25065968|NCT02797171|50171422|FG004|Overall Study|Withdrawal by Subject|0|||
25065969|NCT02797171|50171423|FG005|Overall Study|Withdrawal by Subject|0|||
25065970|NCT02797171|50171418|FG000|Overall Study|Protocol Violation|1|||
25065971|NCT02797171|50171419|FG001|Overall Study|Protocol Violation|0|||
25065972|NCT02797171|50171420|FG002|Overall Study|Protocol Violation|0|||
25065973|NCT02797171|50171421|FG003|Overall Study|Protocol Violation|0|||
25065974|NCT02797171|50171422|FG004|Overall Study|Protocol Violation|0|||
25065975|NCT02797171|50171423|FG005|Overall Study|Protocol Violation|0|||
25065976|NCT02797171|50171418|FG000|Overall Study|Participant unable to adhere|0|||
25065977|NCT02797171|50171419|FG001|Overall Study|Participant unable to adhere|1|||
25065978|NCT02797171|50171420|FG002|Overall Study|Participant unable to adhere|0|||
25186665|NCT02641392|50337359|FG002|Overall Study|Withdrawal by Subject|17|||
25276755|NCT01054599|50590704|FG000|Overall Study|Visual impairment, WTAR <80|0|||
24964196|NCT00441701|50054190|FG004|Overall Study|Lack of Efficacy|0|||
24964197|NCT00441701|50054191|FG005|Overall Study|Lack of Efficacy|1|||
25065979|NCT02797171|50171421|FG003|Overall Study|Participant unable to adhere|0|||
25065980|NCT02797171|50171422|FG004|Overall Study|Participant unable to adhere|0|||
25065981|NCT02797171|50171423|FG005|Overall Study|Participant unable to adhere|0|||
25065982|NCT02797171|50171418|FG000|Overall Study|Not Randomized|0|||
25065983|NCT02797171|50171419|FG001|Overall Study|Not Randomized|0|||
25065984|NCT02797171|50171420|FG002|Overall Study|Not Randomized|0|||
25065985|NCT02797171|50171421|FG003|Overall Study|Not Randomized|0|||
25065986|NCT02797171|50171422|FG004|Overall Study|Not Randomized|0|||
25065987|NCT02797171|50171423|FG005|Overall Study|Not Randomized|1|||
25065988|NCT02797951|50171437|FG000|Overall Study|Adverse Event|4|||
25065989|NCT02797951|50171437|FG000|Overall Study|Death|1|||
25065990|NCT02797951|50171437|FG000|Overall Study|Lack of Efficacy|19|||
25065991|NCT02797951|50171437|FG000|Overall Study|Lost to Follow-up|4|||
25065992|NCT02797951|50171437|FG000|Overall Study|Physician Decision|6|||
25065993|NCT02797951|50171437|FG000|Overall Study|Withdrawal by Subject|15|||
25065994|NCT00701805|50171445|FG000|Overall Study|Withdrawal by Subject|3|||
25065995|NCT00701805|50171446|FG001|Overall Study|Withdrawal by Subject|1|||
25065996|NCT00701805|50171447|FG002|Overall Study|Withdrawal by Subject|4|||
25065997|NCT00701805|50171448|FG003|Overall Study|Withdrawal by Subject|3|||
25065998|NCT00701805|50171445|FG000|Overall Study|Adverse Event|0|||
25065999|NCT00701805|50171446|FG001|Overall Study|Adverse Event|1|||
25066000|NCT00701805|50171447|FG002|Overall Study|Adverse Event|1|||
25066001|NCT00701805|50171448|FG003|Overall Study|Adverse Event|0|||
25066002|NCT00701805|50171445|FG000|Overall Study|Missed 7 consecutive doses|0|||
25066003|NCT00701805|50171446|FG001|Overall Study|Missed 7 consecutive doses|1|||
25066004|NCT00701805|50171447|FG002|Overall Study|Missed 7 consecutive doses|0|||
25066005|NCT00701805|50171448|FG003|Overall Study|Missed 7 consecutive doses|0|||
25066006|NCT00701805|50171445|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
25066007|NCT00701805|50171446|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
25066008|NCT00701805|50171447|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
25066009|NCT00701805|50171448|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
25066010|NCT00701805|50171445|FG000|Overall Study|Physician decision, change of therapy|0|||
25066011|NCT00701805|50171446|FG001|Overall Study|Physician decision, change of therapy|0|||
25066012|NCT00701805|50171447|FG002|Overall Study|Physician decision, change of therapy|0|||
25066013|NCT00701805|50171448|FG003|Overall Study|Physician decision, change of therapy|1|||
25066014|NCT00701805|50171445|FG000|Overall Study|Difficult to travel to dialysis site|0|||
25066015|NCT00701805|50171446|FG001|Overall Study|Difficult to travel to dialysis site|0|||
25066016|NCT00701805|50171447|FG002|Overall Study|Difficult to travel to dialysis site|1|||
25066017|NCT00701805|50171448|FG003|Overall Study|Difficult to travel to dialysis site|0|||
25066018|NCT00701805|50171445|FG000|Overall Study|Resumption criteria were not met|0|||
25066019|NCT00701805|50171446|FG001|Overall Study|Resumption criteria were not met|1|||
25066020|NCT00701805|50171447|FG002|Overall Study|Resumption criteria were not met|0|||
25066021|NCT00701805|50171448|FG003|Overall Study|Resumption criteria were not met|0|||
25066022|NCT02715765|50171461|FG000|Overall Study|Study Termination|3|||
25066023|NCT02715765|50171462|FG001|Overall Study|Study Termination|0|||
25066024|NCT02715765|50171463|FG002|Overall Study|Study Termination|0|||
25066025|NCT04542291|50171471|FG000|Overall Study|Adverse Event|1|||
25066026|NCT04542291|50171471|FG000|Overall Study|Physician Decision|2|||
25066027|NCT02795767|50171478|FG000|Overall Study|Received Commercial Emicizumab|1|||
25066028|NCT02795767|50171479|FG001|Overall Study|Received Commercial Emicizumab|0|||
25066029|NCT02795767|50171480|FG002|Overall Study|Received Commercial Emicizumab|0|||
25066030|NCT02639559|50171494|FG000|Overall Study|Mobilization failure|0|||
25066031|NCT02639559|50171495|FG001|Overall Study|Mobilization failure|3|||
25066032|NCT02639559|50171494|FG000|Overall Study|Issues with vascular acess|1|||
25066033|NCT02639559|50171495|FG001|Overall Study|Issues with vascular acess|0|||
25066034|NCT02796391|50171516|FG000|Overall Study|Lost to Follow-up|2|||
25066035|NCT02796391|50171517|FG001|Overall Study|Lost to Follow-up|2|||
25066036|NCT02796391|50171518|FG002|Overall Study|Lost to Follow-up|13|||
25066037|NCT02796391|50171519|FG003|Overall Study|Lost to Follow-up|8|||
25066038|NCT02796391|50171520|FG004|Overall Study|Lost to Follow-up|14|||
25066039|NCT02796391|50171521|FG005|Overall Study|Lost to Follow-up|13|||
25066040|NCT02796391|50171516|FG000|Overall Study|COVID|0|||
25066041|NCT02796391|50171517|FG001|Overall Study|COVID|0|||
25066042|NCT02796391|50171518|FG002|Overall Study|COVID|5|||
25066043|NCT02796391|50171519|FG003|Overall Study|COVID|5|||
25066044|NCT02796391|50171520|FG004|Overall Study|COVID|2|||
25066045|NCT02796391|50171521|FG005|Overall Study|COVID|4|||
25066046|NCT02796391|50171516|FG000|Overall Study|Participant did not like study cigarettes|0|||
25066047|NCT02796391|50171517|FG001|Overall Study|Participant did not like study cigarettes|0|||
25066048|NCT02796391|50171518|FG002|Overall Study|Participant did not like study cigarettes|3|||
25066049|NCT02796391|50171519|FG003|Overall Study|Participant did not like study cigarettes|0|||
25066050|NCT02796391|50171520|FG004|Overall Study|Participant did not like study cigarettes|0|||
25066051|NCT02796391|50171521|FG005|Overall Study|Participant did not like study cigarettes|0|||
25066052|NCT02796391|50171516|FG000|Overall Study|Withdrawal by Subject|1|||
25066053|NCT02796391|50171517|FG001|Overall Study|Withdrawal by Subject|1|||
25066054|NCT02796391|50171518|FG002|Overall Study|Withdrawal by Subject|4|||
25066055|NCT02796391|50171519|FG003|Overall Study|Withdrawal by Subject|3|||
25066056|NCT02796391|50171520|FG004|Overall Study|Withdrawal by Subject|4|||
25066057|NCT02796391|50171521|FG005|Overall Study|Withdrawal by Subject|3|||
25066058|NCT02796391|50171516|FG000|Overall Study|Adverse Event|0|||
25066059|NCT02796391|50171517|FG001|Overall Study|Adverse Event|0|||
25066060|NCT02796391|50171518|FG002|Overall Study|Adverse Event|0|||
25066061|NCT02796391|50171519|FG003|Overall Study|Adverse Event|1|||
25066062|NCT02796391|50171520|FG004|Overall Study|Adverse Event|0|||
25066063|NCT02796391|50171521|FG005|Overall Study|Adverse Event|0|||
25066064|NCT02796391|50171516|FG000|Overall Study|Protocol Violation|0|||
25066065|NCT02796391|50171517|FG001|Overall Study|Protocol Violation|0|||
25066066|NCT02796391|50171518|FG002|Overall Study|Protocol Violation|0|||
25066067|NCT02796391|50171519|FG003|Overall Study|Protocol Violation|1|||
25066068|NCT02796391|50171520|FG004|Overall Study|Protocol Violation|0|||
25066069|NCT02796391|50171521|FG005|Overall Study|Protocol Violation|0|||
25066070|NCT01370317|50171537|FG000|Overall Study|Participant withdrew consent|1|||
25066071|NCT01370317|50171538|FG001|Overall Study|Participant withdrew consent|0|||
25066072|NCT01370317|50171537|FG000|Overall Study|Protocol deviation|0|||
25066073|NCT01370317|50171538|FG001|Overall Study|Protocol deviation|1|||
25066074|NCT01370083|50171546|FG000|Overall Study|Lost to Follow-up|2|||
25066075|NCT01370083|50171547|FG001|Overall Study|Lost to Follow-up|0|||
25066076|NCT01370083|50171546|FG000|Overall Study|Adverse Event|0|||
25066077|NCT01370083|50171547|FG001|Overall Study|Adverse Event|1|||
25066078|NCT03350815|50171553|FG000|Period 1|Adverse Event|10|||
25066079|NCT03350815|50171554|FG001|Period 1|Adverse Event|0|||
25066080|NCT03350815|50171555|FG002|Period 1|Adverse Event|0|||
25066081|NCT03350815|50171556|FG003|Period 1|Adverse Event|0|||
25066082|NCT03350815|50171553|FG000|Period 1|Technical problems|1|||
25066083|NCT03350815|50171554|FG001|Period 1|Technical problems|0|||
25066084|NCT03350815|50171555|FG002|Period 1|Technical problems|0|||
25066085|NCT03350815|50171556|FG003|Period 1|Technical problems|0|||
25066086|NCT03350815|50171553|FG000|Period 1|Lost to Follow-up|3|||
25066087|NCT03350815|50171554|FG001|Period 1|Lost to Follow-up|0|||
25066088|NCT03350815|50171555|FG002|Period 1|Lost to Follow-up|0|||
25066089|NCT03350815|50171556|FG003|Period 1|Lost to Follow-up|0|||
25066090|NCT03350815|50171553|FG000|Period 1|Physician Decision|1|||
25066091|NCT03350815|50171554|FG001|Period 1|Physician Decision|0|||
25066092|NCT03350815|50171555|FG002|Period 1|Physician Decision|0|||
25066093|NCT03350815|50171556|FG003|Period 1|Physician Decision|0|||
25066094|NCT03350815|50171553|FG000|Period 1|Withdrawal by Subject|8|||
25066095|NCT03350815|50171554|FG001|Period 1|Withdrawal by Subject|0|||
25066096|NCT03350815|50171555|FG002|Period 1|Withdrawal by Subject|0|||
25066097|NCT03350815|50171556|FG003|Period 1|Withdrawal by Subject|0|||
25066098|NCT03350815|50171553|FG000|Period 1|Lack of Efficacy|15|||
25066099|NCT03350815|50171554|FG001|Period 1|Lack of Efficacy|0|||
25066100|NCT03350815|50171555|FG002|Period 1|Lack of Efficacy|0|||
25066101|NCT03350815|50171556|FG003|Period 1|Lack of Efficacy|0|||
25066102|NCT03350815|50171553|FG000|Period 1|Non-compliance with study treatment|2|||
25066103|NCT03350815|50171554|FG001|Period 1|Non-compliance with study treatment|0|||
25066104|NCT03350815|50171555|FG002|Period 1|Non-compliance with study treatment|0|||
25066105|NCT03350815|50171556|FG003|Period 1|Non-compliance with study treatment|0|||
25066106|NCT03350815|50171553|FG000|Period 1|Protocol Violation|3|||
25066107|NCT03350815|50171554|FG001|Period 1|Protocol Violation|0|||
25066108|NCT03350815|50171555|FG002|Period 1|Protocol Violation|0|||
25066109|NCT03350815|50171556|FG003|Period 1|Protocol Violation|0|||
25066110|NCT03350815|50171553|FG000|Period 2|Adverse Event|0|||
24964198|NCT00441701|50054192|FG006|Overall Study|Lack of Efficacy|0|||
24964199|NCT00441701|50054193|FG007|Overall Study|Lack of Efficacy|0|||
24964200|NCT00441701|50054194|FG008|Overall Study|Lack of Efficacy|0|||
24964201|NCT00441701|50054195|FG009|Overall Study|Lack of Efficacy|0|||
24964202|NCT00441701|50054186|FG000|Overall Study|Withdrawal by Subject|0|||
24964203|NCT00441701|50054187|FG001|Overall Study|Withdrawal by Subject|2|||
25066111|NCT03350815|50171554|FG001|Period 2|Adverse Event|3|||
25066112|NCT03350815|50171555|FG002|Period 2|Adverse Event|5|||
25066113|NCT03350815|50171556|FG003|Period 2|Adverse Event|0|||
25066114|NCT03350815|50171553|FG000|Period 2|Technical problem|0|||
25066115|NCT03350815|50171554|FG001|Period 2|Technical problem|1|||
25066116|NCT03350815|50171555|FG002|Period 2|Technical problem|0|||
25066117|NCT03350815|50171556|FG003|Period 2|Technical problem|0|||
25066118|NCT03350815|50171553|FG000|Period 2|Lost to Follow-up|0|||
24964204|NCT00441701|50054188|FG002|Overall Study|Withdrawal by Subject|1|||
24964205|NCT00441701|50054189|FG003|Overall Study|Withdrawal by Subject|1|||
24964206|NCT00441701|50054190|FG004|Overall Study|Withdrawal by Subject|0|||
25066119|NCT03350815|50171554|FG001|Period 2|Lost to Follow-up|3|||
25066120|NCT03350815|50171555|FG002|Period 2|Lost to Follow-up|3|||
25066121|NCT03350815|50171556|FG003|Period 2|Lost to Follow-up|0|||
25066122|NCT03350815|50171553|FG000|Period 2|Physician Decision|0|||
25066123|NCT03350815|50171554|FG001|Period 2|Physician Decision|0|||
25066124|NCT03350815|50171555|FG002|Period 2|Physician Decision|1|||
25066125|NCT03350815|50171556|FG003|Period 2|Physician Decision|0|||
25066126|NCT03350815|50171553|FG000|Period 2|Withdrawal by Subject|0|||
25066127|NCT03350815|50171554|FG001|Period 2|Withdrawal by Subject|3|||
25066128|NCT03350815|50171555|FG002|Period 2|Withdrawal by Subject|4|||
25066129|NCT03350815|50171556|FG003|Period 2|Withdrawal by Subject|0|||
25066130|NCT03350815|50171553|FG000|Period 2|Lack of Efficacy|0|||
25066131|NCT03350815|50171554|FG001|Period 2|Lack of Efficacy|6|||
25066132|NCT03350815|50171555|FG002|Period 2|Lack of Efficacy|2|||
25066133|NCT03350815|50171556|FG003|Period 2|Lack of Efficacy|0|||
25066134|NCT03350815|50171553|FG000|Period 2|Protocol Violation|0|||
25066135|NCT03350815|50171554|FG001|Period 2|Protocol Violation|0|||
25066136|NCT03350815|50171555|FG002|Period 2|Protocol Violation|1|||
25066137|NCT03350815|50171556|FG003|Period 2|Protocol Violation|0|||
25066138|NCT03350815|50171553|FG000|Period 2|New therapy for study indication|0|||
25066139|NCT03350815|50171554|FG001|Period 2|New therapy for study indication|0|||
25066140|NCT03350815|50171555|FG002|Period 2|New therapy for study indication|1|||
25066141|NCT03350815|50171556|FG003|Period 2|New therapy for study indication|0|||
25066142|NCT00854295|50171571|FG000|Overall Study|Death|7|||
25066143|NCT00854295|50171572|FG001|Overall Study|Death|0|||
25066144|NCT00854295|50171573|FG002|Overall Study|Death|1|||
25066145|NCT00854295|50171574|FG003|Overall Study|Death|1|||
25066146|NCT00854295|50171571|FG000|Overall Study|Adverse Event|6|||
25066147|NCT00854295|50171572|FG001|Overall Study|Adverse Event|1|||
25066148|NCT00854295|50171573|FG002|Overall Study|Adverse Event|1|||
25066149|NCT00854295|50171574|FG003|Overall Study|Adverse Event|3|||
25066150|NCT00854295|50171571|FG000|Overall Study|Lost to Follow-up|18|||
25066151|NCT00854295|50171572|FG001|Overall Study|Lost to Follow-up|5|||
25066152|NCT00854295|50171573|FG002|Overall Study|Lost to Follow-up|21|||
25066153|NCT00854295|50171574|FG003|Overall Study|Lost to Follow-up|21|||
25066154|NCT00854295|50171571|FG000|Overall Study|Physician Decision|10|||
25066155|NCT00854295|50171572|FG001|Overall Study|Physician Decision|0|||
25066156|NCT00854295|50171573|FG002|Overall Study|Physician Decision|0|||
25066157|NCT00854295|50171574|FG003|Overall Study|Physician Decision|0|||
25066158|NCT02792959|50171585|FG000|Overall Study|Protocol Violation|1|||
25066159|NCT01652872|50171591|FG000|Overall Study|Death|36|||
25066160|NCT01652872|50171592|FG001|Overall Study|Death|39|||
25066161|NCT01652872|50171591|FG000|Overall Study|Lost to Follow-up|28|||
25066162|NCT01652872|50171592|FG001|Overall Study|Lost to Follow-up|23|||
25066163|NCT01652872|50171591|FG000|Overall Study|Decision by sponsor|5|||
25066164|NCT01652872|50171592|FG001|Overall Study|Decision by sponsor|7|||
25066165|NCT01652872|50171591|FG000|Overall Study|Withdrawal by Subject|76|||
25066166|NCT01652872|50171592|FG001|Overall Study|Withdrawal by Subject|84|||
25066167|NCT04251273|50171600|FG000|Overall Study|Lost to Follow-up|331|||
25066168|NCT04251273|50171601|FG001|Overall Study|Lost to Follow-up|290|||
25066169|NCT02443402|50171609|FG000|Overall Study|Withdrawal by Subject|3|||
25066170|NCT02443402|50171610|FG001|Overall Study|Withdrawal by Subject|1|||
25066171|NCT02443402|50171609|FG000|Overall Study|Screen Failure|1|||
25066172|NCT02443402|50171610|FG001|Overall Study|Screen Failure|2|||
25066173|NCT02412670|50171618|FG000|Overall Study|Adverse Event|4|||
25066174|NCT02412670|50171619|FG001|Overall Study|Adverse Event|1|||
25066175|NCT02412670|50171618|FG000|Overall Study|Physician Decision|1|||
25066176|NCT02412670|50171619|FG001|Overall Study|Physician Decision|0|||
25066177|NCT02412670|50171618|FG000|Overall Study|Withdrawal by Subject|1|||
25066178|NCT02412670|50171619|FG001|Overall Study|Withdrawal by Subject|0|||
25066179|NCT02412670|50171618|FG000|Overall Study|Ineligible|1|||
25066180|NCT02412670|50171619|FG001|Overall Study|Ineligible|0|||
25066181|NCT01370005|50171628|FG000|Overall Study|Not treated|1|||
25066182|NCT01370005|50171629|FG001|Overall Study|Not treated|0|||
25066183|NCT01370005|50171630|FG002|Overall Study|Not treated|0|||
25066184|NCT01370005|50171628|FG000|Overall Study|Adverse Event|5|||
25066185|NCT01370005|50171629|FG001|Overall Study|Adverse Event|5|||
25066186|NCT01370005|50171630|FG002|Overall Study|Adverse Event|6|||
25066187|NCT01370005|50171628|FG000|Overall Study|Lack of Efficacy|1|||
25066188|NCT01370005|50171629|FG001|Overall Study|Lack of Efficacy|0|||
25066189|NCT01370005|50171630|FG002|Overall Study|Lack of Efficacy|0|||
25066190|NCT01370005|50171628|FG000|Overall Study|Non compliant with protocol|0|||
25066191|NCT01370005|50171629|FG001|Overall Study|Non compliant with protocol|1|||
25066192|NCT01370005|50171630|FG002|Overall Study|Non compliant with protocol|2|||
25066193|NCT01370005|50171628|FG000|Overall Study|Lost to Follow-up|1|||
25066194|NCT01370005|50171629|FG001|Overall Study|Lost to Follow-up|1|||
25066195|NCT01370005|50171630|FG002|Overall Study|Lost to Follow-up|1|||
25066196|NCT01370005|50171628|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
25066197|NCT01370005|50171629|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
25066198|NCT01370005|50171630|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
25066199|NCT01370005|50171628|FG000|Overall Study|Other reason not defined above|3|||
25066200|NCT01370005|50171629|FG001|Overall Study|Other reason not defined above|0|||
25066201|NCT01370005|50171630|FG002|Overall Study|Other reason not defined above|2|||
25066202|NCT02442778|50171641|FG000|Overall Study|Adverse Event|2|||
25066203|NCT02442778|50171642|FG001|Overall Study|Adverse Event|6|||
25066204|NCT02442778|50171643|FG002|Overall Study|Adverse Event|6|||
25066205|NCT02442778|50171641|FG000|Overall Study|Death|0|||
25066206|NCT02442778|50171642|FG001|Overall Study|Death|2|||
25066207|NCT02442778|50171643|FG002|Overall Study|Death|0|||
25066208|NCT02442778|50171641|FG000|Overall Study|Lack of Efficacy|1|||
25066209|NCT02442778|50171642|FG001|Overall Study|Lack of Efficacy|0|||
25066210|NCT02442778|50171643|FG002|Overall Study|Lack of Efficacy|0|||
25066211|NCT02442778|50171641|FG000|Overall Study|Lost to Follow-up|1|||
25066212|NCT02442778|50171642|FG001|Overall Study|Lost to Follow-up|1|||
25066213|NCT02442778|50171643|FG002|Overall Study|Lost to Follow-up|1|||
25066214|NCT02442778|50171641|FG000|Overall Study|Non-compliance with study drug|2|||
25066215|NCT02442778|50171642|FG001|Overall Study|Non-compliance with study drug|0|||
25066216|NCT02442778|50171643|FG002|Overall Study|Non-compliance with study drug|1|||
25066217|NCT02442778|50171641|FG000|Overall Study|Physician Decision|1|||
25066218|NCT02442778|50171642|FG001|Overall Study|Physician Decision|1|||
25066219|NCT02442778|50171643|FG002|Overall Study|Physician Decision|1|||
25066220|NCT02442778|50171641|FG000|Overall Study|Protocol Deviation|3|||
25066221|NCT02442778|50171642|FG001|Overall Study|Protocol Deviation|0|||
25066222|NCT02442778|50171643|FG002|Overall Study|Protocol Deviation|1|||
25066223|NCT02442778|50171641|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
25066224|NCT02442778|50171642|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
25066225|NCT02442778|50171643|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
25066226|NCT02442778|50171641|FG000|Overall Study|Withdrawal by Subject|4|||
25066227|NCT02442778|50171642|FG001|Overall Study|Withdrawal by Subject|4|||
25066228|NCT02442778|50171643|FG002|Overall Study|Withdrawal by Subject|3|||
25066229|NCT02442778|50171641|FG000|Overall Study|Reason not specified|1|||
25066230|NCT02442778|50171642|FG001|Overall Study|Reason not specified|4|||
25066231|NCT02442778|50171643|FG002|Overall Study|Reason not specified|0|||
25066232|NCT02412436|50171651|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
25066233|NCT02412436|50171651|FG000|Overall Study|Lost to Follow-up|6|||
25066234|NCT02412436|50171651|FG000|Overall Study|Unable to get to clinic|3|||
25066235|NCT02412436|50171651|FG000|Overall Study|Death|1|||
25066236|NCT02412436|50171651|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
25066237|NCT01651000|50171657|FG000|Overall Study|Adverse Event|2|||
25066238|NCT01651000|50171658|FG001|Overall Study|Adverse Event|8|||
25066239|NCT01651000|50171657|FG000|Overall Study|Lost to Follow-up|3|||
25066240|NCT01651000|50171658|FG001|Overall Study|Lost to Follow-up|2|||
25066241|NCT01651000|50171657|FG000|Overall Study|Protocol Violation|0|||
25066242|NCT01651000|50171658|FG001|Overall Study|Protocol Violation|3|||
25066243|NCT01651000|50171657|FG000|Overall Study|Withdrawal by Subject|2|||
25066244|NCT01651000|50171658|FG001|Overall Study|Withdrawal by Subject|10|||
25066245|NCT01651000|50171657|FG000|Overall Study|Subject noncompliance|0|||
25066246|NCT01651000|50171658|FG001|Overall Study|Subject noncompliance|3|||
25066247|NCT01651000|50171657|FG000|Overall Study|Lack of Efficacy|1|||
25066248|NCT01651000|50171658|FG001|Overall Study|Lack of Efficacy|1|||
25066249|NCT01651000|50171657|FG000|Overall Study|Physician Decision|1|||
25066250|NCT01651000|50171658|FG001|Overall Study|Physician Decision|0|||
25066251|NCT01651000|50171657|FG000|Overall Study|Administrative reason|1|||
25066252|NCT01651000|50171658|FG001|Overall Study|Administrative reason|0|||
25066253|NCT01651000|50171657|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
25066254|NCT01651000|50171658|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
25066255|NCT02469610|50171666|FG000|Overall Study|Death|1|||
25066256|NCT02469610|50171667|FG001|Overall Study|Death|0|||
25066257|NCT02469610|50171666|FG000|Overall Study|Lost to Follow-up|1|||
25066258|NCT02469610|50171667|FG001|Overall Study|Lost to Follow-up|0|||
25066259|NCT02469610|50171666|FG000|Overall Study|exclusion criteria|2|||
25066260|NCT02469610|50171667|FG001|Overall Study|exclusion criteria|1|||
25066261|NCT02469298|50171677|FG000|Overall Study|Protocol Violation|0|||
25066262|NCT02469298|50171678|FG001|Overall Study|Protocol Violation|1|||
25066263|NCT02469298|50171679|FG002|Overall Study|Protocol Violation|1|||
25066264|NCT02469298|50171680|FG003|Overall Study|Protocol Violation|0|||
25066265|NCT02469298|50171677|FG000|Overall Study|Lost to Follow-up|1|||
25066266|NCT02469298|50171678|FG001|Overall Study|Lost to Follow-up|0|||
25066267|NCT02469298|50171679|FG002|Overall Study|Lost to Follow-up|1|||
25066268|NCT02469298|50171680|FG003|Overall Study|Lost to Follow-up|0|||
25066269|NCT02469298|50171677|FG000|Overall Study|Physician Decision|0|||
25066270|NCT02469298|50171678|FG001|Overall Study|Physician Decision|0|||
25066271|NCT02469298|50171679|FG002|Overall Study|Physician Decision|0|||
25066272|NCT02469298|50171680|FG003|Overall Study|Physician Decision|1|||
25066273|NCT02469298|50171677|FG000|Overall Study|Withdrawal by Subject|0|||
25066274|NCT02469298|50171678|FG001|Overall Study|Withdrawal by Subject|0|||
25066275|NCT02469298|50171679|FG002|Overall Study|Withdrawal by Subject|0|||
25066276|NCT02469298|50171680|FG003|Overall Study|Withdrawal by Subject|1|||
25066277|NCT04163991|50171702|FG000|Overall Study|Adverse Event|0|||
25066278|NCT04163991|50171703|FG001|Overall Study|Adverse Event|0|||
25066279|NCT04163991|50171704|FG002|Overall Study|Adverse Event|0|||
25276756|NCT01054599|50590705|FG001|Overall Study|Visual impairment, WTAR <80|1|||
25066280|NCT04163991|50171705|FG003|Overall Study|Adverse Event|1|||
25066281|NCT04163991|50171706|FG004|Overall Study|Adverse Event|0|||
25066282|NCT04163991|50171702|FG000|Overall Study|Death|0|||
25066283|NCT04163991|50171703|FG001|Overall Study|Death|0|||
25066284|NCT04163991|50171704|FG002|Overall Study|Death|1|||
25066285|NCT04163991|50171705|FG003|Overall Study|Death|0|||
25066286|NCT04163991|50171706|FG004|Overall Study|Death|0|||
25066287|NCT04163991|50171702|FG000|Overall Study|Lost to Follow-up|0|||
25066288|NCT04163991|50171703|FG001|Overall Study|Lost to Follow-up|1|||
25066289|NCT04163991|50171704|FG002|Overall Study|Lost to Follow-up|0|||
25066290|NCT04163991|50171705|FG003|Overall Study|Lost to Follow-up|0|||
25066291|NCT04163991|50171706|FG004|Overall Study|Lost to Follow-up|0|||
25066292|NCT04163991|50171702|FG000|Overall Study|Withdrawal by Subject|1|||
25066293|NCT04163991|50171703|FG001|Overall Study|Withdrawal by Subject|1|||
25066294|NCT04163991|50171704|FG002|Overall Study|Withdrawal by Subject|3|||
25066295|NCT04163991|50171705|FG003|Overall Study|Withdrawal by Subject|1|||
25066296|NCT04163991|50171706|FG004|Overall Study|Withdrawal by Subject|1|||
25066297|NCT04163991|50171702|FG000|Overall Study|Other, Not Specified|0|||
25066298|NCT04163991|50171703|FG001|Overall Study|Other, Not Specified|1|||
25066299|NCT04163991|50171704|FG002|Overall Study|Other, Not Specified|1|||
25066300|NCT04163991|50171705|FG003|Overall Study|Other, Not Specified|1|||
25066301|NCT04163991|50171706|FG004|Overall Study|Other, Not Specified|0|||
25066302|NCT02442622|50171724|FG000|Overall Study|Withdrawal by Subject|3|||
25066303|NCT02442622|50171725|FG001|Overall Study|Withdrawal by Subject|1|||
25066304|NCT02411578|50171733|FG000|Crossover Trial Phase|Pregnancy|0|||
25066305|NCT02411578|50171734|FG001|Crossover Trial Phase|Pregnancy|1|||
25066306|NCT02442310|50171742|FG000|Overall Study|Adverse Event|2|||
25066307|NCT02442310|50171742|FG000|Overall Study|Withdrawal by Subject|1|||
25066308|NCT02411110|50171754|FG000|Treatment Period 1|Adverse Event|4|||
25066309|NCT02411110|50171755|FG001|Treatment Period 1|Adverse Event|2|||
25066310|NCT02411110|50171754|FG000|Treatment Period 1|Lost to Follow-up|1|||
25066311|NCT02411110|50171755|FG001|Treatment Period 1|Lost to Follow-up|0|||
25066312|NCT02411110|50171754|FG000|Treatment Period 1|Personal Reasons|2|||
25066313|NCT02411110|50171755|FG001|Treatment Period 1|Personal Reasons|5|||
25066314|NCT02411110|50171754|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
25066315|NCT02411110|50171755|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
25066316|NCT02411110|50171754|FG000|Treatment Period 2|Adverse Event|1|||
25066317|NCT02411110|50171755|FG001|Treatment Period 2|Adverse Event|0|||
25066318|NCT02411110|50171754|FG000|Treatment Period 2|Lost to Follow-up|0|||
25066319|NCT02411110|50171755|FG001|Treatment Period 2|Lost to Follow-up|2|||
25066320|NCT02411110|50171754|FG000|Treatment Period 2|Personal Reasons|0|||
25066321|NCT02411110|50171755|FG001|Treatment Period 2|Personal Reasons|2|||
25066322|NCT01369849|50171766|FG000|Overall Study|Ineligible prior to treatment|0|||
25066323|NCT01369849|50171767|FG001|Overall Study|Ineligible prior to treatment|0|||
25066324|NCT01369849|50171768|FG002|Overall Study|Ineligible prior to treatment|1|||
25066325|NCT01369849|50171766|FG000|Overall Study|Ineligible after receiving treatment|0|||
25066326|NCT01369849|50171767|FG001|Overall Study|Ineligible after receiving treatment|1|||
25066327|NCT01369849|50171768|FG002|Overall Study|Ineligible after receiving treatment|0|||
25066328|NCT02716779|50171781|FG000|Monotherapy|Adverse Event|0|||
25066329|NCT02716779|50171782|FG001|Monotherapy|Adverse Event|1|||
25066330|NCT02716779|50171783|FG002|Monotherapy|Adverse Event|1|||
25066331|NCT02716779|50171781|FG000|Combination Therapy|Adverse Event|0|||
25066332|NCT02716779|50171782|FG001|Combination Therapy|Adverse Event|2|||
25066333|NCT02716779|50171783|FG002|Combination Therapy|Adverse Event|1|||
25066334|NCT01369615|50171799|FG000|Overall Study|Withdrawal by Subject|0|||
25066335|NCT01369615|50171800|FG001|Overall Study|Withdrawal by Subject|1|||
25066336|NCT01369615|50171799|FG000|Overall Study|Lost to Follow-up|0|||
25066337|NCT01369615|50171800|FG001|Overall Study|Lost to Follow-up|1|||
25066338|NCT02468674|50171824|FG000|Overall Study|Adverse Event|0|||
25066339|NCT02468674|50171825|FG001|Overall Study|Adverse Event|0|||
25066340|NCT02468674|50171826|FG002|Overall Study|Adverse Event|0|||
25066341|NCT02468674|50171827|FG003|Overall Study|Adverse Event|1|||
25066342|NCT02468674|50171828|FG004|Overall Study|Adverse Event|0|||
25066343|NCT02468674|50171829|FG005|Overall Study|Adverse Event|1|||
25066344|NCT02468674|50171830|FG006|Overall Study|Adverse Event|0|||
25186666|NCT02641392|50337357|FG000|Overall Study|Adverse Event|0|||
25066345|NCT02468674|50171831|FG007|Overall Study|Adverse Event|0|||
25066346|NCT02468674|50171832|FG008|Overall Study|Adverse Event|0|||
25066347|NCT02468674|50171824|FG000|Overall Study|Lost to Follow-up|1|||
25066348|NCT02468674|50171825|FG001|Overall Study|Lost to Follow-up|0|||
25066349|NCT02468674|50171826|FG002|Overall Study|Lost to Follow-up|0|||
25066350|NCT02468674|50171827|FG003|Overall Study|Lost to Follow-up|0|||
25066351|NCT02468674|50171828|FG004|Overall Study|Lost to Follow-up|0|||
25066352|NCT02468674|50171829|FG005|Overall Study|Lost to Follow-up|0|||
25066353|NCT02468674|50171830|FG006|Overall Study|Lost to Follow-up|0|||
25066354|NCT02468674|50171831|FG007|Overall Study|Lost to Follow-up|1|||
25066355|NCT02468674|50171832|FG008|Overall Study|Lost to Follow-up|1|||
25066356|NCT02468674|50171824|FG000|Overall Study|Physician Decision|0|||
25066357|NCT02468674|50171825|FG001|Overall Study|Physician Decision|0|||
25066358|NCT02468674|50171826|FG002|Overall Study|Physician Decision|0|||
25066359|NCT02468674|50171827|FG003|Overall Study|Physician Decision|0|||
25066360|NCT02468674|50171828|FG004|Overall Study|Physician Decision|0|||
25066361|NCT02468674|50171829|FG005|Overall Study|Physician Decision|0|||
25066362|NCT02468674|50171830|FG006|Overall Study|Physician Decision|1|||
25066363|NCT02468674|50171831|FG007|Overall Study|Physician Decision|0|||
25066364|NCT02468674|50171832|FG008|Overall Study|Physician Decision|0|||
25066365|NCT02468674|50171824|FG000|Overall Study|Patient/Guardian Decision|0|||
25066366|NCT02468674|50171825|FG001|Overall Study|Patient/Guardian Decision|0|||
25066367|NCT02468674|50171826|FG002|Overall Study|Patient/Guardian Decision|0|||
25066368|NCT02468674|50171827|FG003|Overall Study|Patient/Guardian Decision|0|||
25066369|NCT02468674|50171828|FG004|Overall Study|Patient/Guardian Decision|1|||
25066370|NCT02468674|50171829|FG005|Overall Study|Patient/Guardian Decision|0|||
25066371|NCT02468674|50171830|FG006|Overall Study|Patient/Guardian Decision|0|||
25066372|NCT02468674|50171831|FG007|Overall Study|Patient/Guardian Decision|2|||
25066373|NCT02468674|50171832|FG008|Overall Study|Patient/Guardian Decision|1|||
25066374|NCT02468674|50171824|FG000|Overall Study|Protocol Deviation|0|||
25066375|NCT02468674|50171825|FG001|Overall Study|Protocol Deviation|0|||
25066376|NCT02468674|50171826|FG002|Overall Study|Protocol Deviation|0|||
25066377|NCT02468674|50171827|FG003|Overall Study|Protocol Deviation|0|||
25066378|NCT02468674|50171828|FG004|Overall Study|Protocol Deviation|0|||
25066379|NCT02468674|50171829|FG005|Overall Study|Protocol Deviation|0|||
25066380|NCT02468674|50171830|FG006|Overall Study|Protocol Deviation|0|||
25066381|NCT02468674|50171831|FG007|Overall Study|Protocol Deviation|1|||
25066382|NCT02468674|50171832|FG008|Overall Study|Protocol Deviation|1|||
25066383|NCT02467192|50171852|FG000|Overall Study|Death|1|||
25066384|NCT02467192|50171852|FG000|Overall Study|revealed to have pneumonia before|2|||
25066385|NCT02410954|50171862|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
25066386|NCT02410954|50171863|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
25066387|NCT02410954|50171862|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
25066388|NCT02410954|50171863|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
25066389|NCT02689453|50171872|FG000|Overall Study|Progressive disease|0|||
25066390|NCT02689453|50171873|FG001|Overall Study|Progressive disease|1|||
25066391|NCT02689453|50171874|FG002|Overall Study|Progressive disease|1|||
25066392|NCT00701103|50171905|FG000|Overall Study|Adverse Event|0|||
25066393|NCT00701103|50171906|FG001|Overall Study|Adverse Event|0|||
25066394|NCT00701103|50171907|FG002|Overall Study|Adverse Event|1|||
25066395|NCT00701103|50171908|FG003|Overall Study|Adverse Event|1|||
25066396|NCT00701103|50171909|FG004|Overall Study|Adverse Event|0|||
25066397|NCT00701103|50171910|FG005|Overall Study|Adverse Event|1|||
25066398|NCT00701103|50171911|FG006|Overall Study|Adverse Event|1|||
25066399|NCT00701103|50171912|FG007|Overall Study|Adverse Event|0|||
25066400|NCT00701103|50171913|FG008|Overall Study|Adverse Event|0|||
25066401|NCT00701103|50171914|FG009|Overall Study|Adverse Event|2|||
25066402|NCT00701103|50171915|FG010|Overall Study|Adverse Event|0|||
25066403|NCT00701103|50171905|FG000|Overall Study|Progressive Disease|5|||
25066404|NCT00701103|50171906|FG001|Overall Study|Progressive Disease|2|||
25066405|NCT00701103|50171907|FG002|Overall Study|Progressive Disease|6|||
25066406|NCT00701103|50171908|FG003|Overall Study|Progressive Disease|5|||
25066407|NCT00701103|50171909|FG004|Overall Study|Progressive Disease|6|||
25066408|NCT00701103|50171910|FG005|Overall Study|Progressive Disease|5|||
25066409|NCT00701103|50171911|FG006|Overall Study|Progressive Disease|7|||
25066410|NCT00701103|50171912|FG007|Overall Study|Progressive Disease|7|||
25066411|NCT00701103|50171913|FG008|Overall Study|Progressive Disease|8|||
25066412|NCT00701103|50171914|FG009|Overall Study|Progressive Disease|8|||
25066413|NCT00701103|50171915|FG010|Overall Study|Progressive Disease|11|||
25066414|NCT00701103|50171905|FG000|Overall Study|Withdrawal by Subject|0|||
25066415|NCT00701103|50171906|FG001|Overall Study|Withdrawal by Subject|1|||
25066416|NCT00701103|50171907|FG002|Overall Study|Withdrawal by Subject|1|||
25066417|NCT00701103|50171908|FG003|Overall Study|Withdrawal by Subject|0|||
25066418|NCT00701103|50171909|FG004|Overall Study|Withdrawal by Subject|0|||
25066419|NCT00701103|50171910|FG005|Overall Study|Withdrawal by Subject|0|||
25066420|NCT00701103|50171911|FG006|Overall Study|Withdrawal by Subject|0|||
25066421|NCT00701103|50171912|FG007|Overall Study|Withdrawal by Subject|0|||
25066422|NCT00701103|50171913|FG008|Overall Study|Withdrawal by Subject|0|||
25066423|NCT00701103|50171914|FG009|Overall Study|Withdrawal by Subject|0|||
25066424|NCT00701103|50171915|FG010|Overall Study|Withdrawal by Subject|0|||
25066425|NCT00701103|50171905|FG000|Overall Study|Other|0|||
25066426|NCT00701103|50171906|FG001|Overall Study|Other|0|||
25066427|NCT00701103|50171907|FG002|Overall Study|Other|0|||
25066428|NCT00701103|50171908|FG003|Overall Study|Other|0|||
25066429|NCT00701103|50171909|FG004|Overall Study|Other|0|||
25066430|NCT00701103|50171910|FG005|Overall Study|Other|0|||
25066431|NCT00701103|50171911|FG006|Overall Study|Other|0|||
25066432|NCT00701103|50171912|FG007|Overall Study|Other|0|||
25066433|NCT00701103|50171913|FG008|Overall Study|Other|1|||
25066434|NCT00701103|50171914|FG009|Overall Study|Other|1|||
25066435|NCT00701103|50171915|FG010|Overall Study|Other|0|||
25186667|NCT02641392|50337358|FG001|Overall Study|Adverse Event|1|||
25066436|NCT01369225|50171949|FG000|Overall Study|Withdrawal by Subject|1|||
25066437|NCT01369225|50171950|FG001|Overall Study|Withdrawal by Subject|0|||
25066438|NCT01369225|50171951|FG002|Overall Study|Withdrawal by Subject|2|||
25066439|NCT01369225|50171952|FG003|Overall Study|Withdrawal by Subject|1|||
25066440|NCT01369225|50171953|FG004|Overall Study|Withdrawal by Subject|0|||
25066441|NCT01369225|50171954|FG005|Overall Study|Withdrawal by Subject|0|||
25066442|NCT01369225|50171949|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
25066443|NCT01369225|50171950|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
25066444|NCT01369225|50171951|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
25066445|NCT01369225|50171952|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
25066446|NCT01369225|50171953|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
25066447|NCT01369225|50171954|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
25066448|NCT01369225|50171949|FG000|Overall Study|Other|1|||
25066449|NCT01369225|50171950|FG001|Overall Study|Other|0|||
25066450|NCT01369225|50171951|FG002|Overall Study|Other|0|||
25066451|NCT01369225|50171952|FG003|Overall Study|Other|0|||
25066452|NCT01369225|50171953|FG004|Overall Study|Other|1|||
25066453|NCT01369225|50171954|FG005|Overall Study|Other|0|||
25066454|NCT01369225|50171949|FG000|Overall Study|Adverse Event|0|||
25066455|NCT01369225|50171950|FG001|Overall Study|Adverse Event|0|||
25066456|NCT01369225|50171951|FG002|Overall Study|Adverse Event|0|||
25066457|NCT01369225|50171952|FG003|Overall Study|Adverse Event|1|||
25066458|NCT01369225|50171953|FG004|Overall Study|Adverse Event|1|||
25066459|NCT01369225|50171954|FG005|Overall Study|Adverse Event|0|||
25066460|NCT02639546|50171976|FG000|Overall Study|Death|2|||
25066461|NCT02639546|50171977|FG001|Overall Study|Death|2|||
25066462|NCT02639546|50171978|FG002|Overall Study|Death|1|||
25066463|NCT02639546|50171979|FG003|Overall Study|Death|2|||
25066464|NCT02639546|50171980|FG004|Overall Study|Death|2|||
25066465|NCT02639546|50171981|FG005|Overall Study|Death|2|||
25066466|NCT02639546|50171982|FG006|Overall Study|Death|0|||
25066467|NCT02639546|50171983|FG007|Overall Study|Death|0|||
25066468|NCT02639546|50171976|FG000|Overall Study|Lost to Follow-up|0|||
25066469|NCT02639546|50171977|FG001|Overall Study|Lost to Follow-up|0|||
25066470|NCT02639546|50171978|FG002|Overall Study|Lost to Follow-up|1|||
25066471|NCT02639546|50171979|FG003|Overall Study|Lost to Follow-up|0|||
25066472|NCT02639546|50171980|FG004|Overall Study|Lost to Follow-up|1|||
25066473|NCT02639546|50171981|FG005|Overall Study|Lost to Follow-up|1|||
25066474|NCT02639546|50171982|FG006|Overall Study|Lost to Follow-up|0|||
25066475|NCT02639546|50171983|FG007|Overall Study|Lost to Follow-up|1|||
25066476|NCT02639546|50171976|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
25066477|NCT02639546|50171977|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
25066478|NCT02639546|50171978|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
25066479|NCT02639546|50171979|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
25066480|NCT02639546|50171980|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
25066481|NCT02639546|50171981|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
25066482|NCT02639546|50171982|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
25066483|NCT02639546|50171983|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
25066484|NCT02639546|50171976|FG000|Overall Study|Study Terminated By Sponsor|0|||
25066485|NCT02639546|50171977|FG001|Overall Study|Study Terminated By Sponsor|2|||
25066486|NCT02639546|50171978|FG002|Overall Study|Study Terminated By Sponsor|3|||
25066487|NCT02639546|50171979|FG003|Overall Study|Study Terminated By Sponsor|4|||
25066488|NCT02639546|50171980|FG004|Overall Study|Study Terminated By Sponsor|4|||
25066489|NCT02639546|50171981|FG005|Overall Study|Study Terminated By Sponsor|3|||
25066490|NCT02639546|50171982|FG006|Overall Study|Study Terminated By Sponsor|3|||
25066491|NCT02639546|50171983|FG007|Overall Study|Study Terminated By Sponsor|9|||
25066492|NCT02639546|50171976|FG000|Overall Study|Withdrawal by Subject|2|||
25066493|NCT02639546|50171977|FG001|Overall Study|Withdrawal by Subject|2|||
25066494|NCT02639546|50171978|FG002|Overall Study|Withdrawal by Subject|1|||
25066495|NCT02639546|50171979|FG003|Overall Study|Withdrawal by Subject|0|||
25066496|NCT02639546|50171980|FG004|Overall Study|Withdrawal by Subject|0|||
25066497|NCT02639546|50171981|FG005|Overall Study|Withdrawal by Subject|1|||
25066498|NCT02639546|50171982|FG006|Overall Study|Withdrawal by Subject|2|||
25066499|NCT02639546|50171983|FG007|Overall Study|Withdrawal by Subject|1|||
25066500|NCT02639390|50172017|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
25066501|NCT02639390|50172018|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
25066502|NCT02718417|50172027|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
25066503|NCT02718417|50172028|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
25066504|NCT02718417|50172029|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
25066505|NCT02718417|50172027|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
25066506|NCT02718417|50172028|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
25066507|NCT02718417|50172029|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
25066508|NCT02718417|50172027|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
25066509|NCT02718417|50172028|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
25066510|NCT02718417|50172029|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
25066511|NCT02718417|50172027|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
25066512|NCT02718417|50172028|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
25066513|NCT02718417|50172029|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
25066514|NCT02718417|50172027|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
25066515|NCT02718417|50172028|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
25066516|NCT02718417|50172029|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
25066517|NCT02718417|50172027|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
25066518|NCT02718417|50172028|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
25066519|NCT02718417|50172029|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
25066520|NCT02718417|50172027|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
25066521|NCT02718417|50172028|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
25066522|NCT02718417|50172029|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
25066523|NCT02718417|50172027|FG000|Chemotherapy Phase (CP)|Other|2|||
25066524|NCT02718417|50172028|FG001|Chemotherapy Phase (CP)|Other|0|||
25066525|NCT02718417|50172029|FG002|Chemotherapy Phase (CP)|Other|1|||
25066526|NCT02718417|50172027|FG000|Maintenance Phase (MP)|Adverse Event|21|||
25066527|NCT02718417|50172028|FG001|Maintenance Phase (MP)|Adverse Event|26|||
25066528|NCT02718417|50172029|FG002|Maintenance Phase (MP)|Adverse Event|0|||
25066529|NCT02718417|50172027|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
25066530|NCT02718417|50172028|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
25066531|NCT02718417|50172029|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
25066532|NCT02718417|50172027|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
25066533|NCT02718417|50172028|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
25066534|NCT02718417|50172029|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
25066535|NCT02718417|50172027|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
25066536|NCT02718417|50172028|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
25066537|NCT02718417|50172029|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
25066538|NCT02718417|50172027|FG000|Maintenance Phase (MP)|Physician's decision|6|||
25066539|NCT02718417|50172028|FG001|Maintenance Phase (MP)|Physician's decision|7|||
25066540|NCT02718417|50172029|FG002|Maintenance Phase (MP)|Physician's decision|0|||
25066541|NCT02718417|50172027|FG000|Maintenance Phase (MP)|Progressive disease|100|||
25066542|NCT02718417|50172028|FG001|Maintenance Phase (MP)|Progressive disease|88|||
25066543|NCT02718417|50172029|FG002|Maintenance Phase (MP)|Progressive disease|0|||
25066544|NCT02718417|50172027|FG000|Maintenance Phase (MP)|Other|2|||
25066545|NCT02718417|50172028|FG001|Maintenance Phase (MP)|Other|1|||
25066546|NCT02718417|50172029|FG002|Maintenance Phase (MP)|Other|0|||
25066547|NCT02718417|50172027|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
25066548|NCT02718417|50172028|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
25066549|NCT02718417|50172029|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
25066550|NCT02718417|50172027|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
25066551|NCT02718417|50172028|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
25066552|NCT02718417|50172029|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
25066553|NCT02718417|50172027|FG000|Observation Phase (OP)|Adverse Event|0|||
25066554|NCT02718417|50172028|FG001|Observation Phase (OP)|Adverse Event|0|||
25066555|NCT02718417|50172029|FG002|Observation Phase (OP)|Adverse Event|1|||
25066556|NCT02718417|50172027|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
25066557|NCT02718417|50172028|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
25066558|NCT02718417|50172029|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
25066559|NCT02718417|50172027|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
25066560|NCT02718417|50172028|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
25066561|NCT02718417|50172029|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
25066562|NCT02718417|50172027|FG000|Observation Phase (OP)|Physician Decision|0|||
25066563|NCT02718417|50172028|FG001|Observation Phase (OP)|Physician Decision|0|||
25066564|NCT02718417|50172029|FG002|Observation Phase (OP)|Physician Decision|9|||
25066565|NCT02718417|50172027|FG000|Observation Phase (OP)|Progressive disease|0|||
25066566|NCT02718417|50172028|FG001|Observation Phase (OP)|Progressive disease|0|||
25186668|NCT02641392|50337359|FG002|Overall Study|Adverse Event|25|||
25276757|NCT01054599|50590704|FG000|Overall Study|Lost to Follow-up|0|||
25066567|NCT02718417|50172029|FG002|Observation Phase (OP)|Progressive disease|92|||
25066568|NCT02718417|50172027|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
25066569|NCT02718417|50172028|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
25066570|NCT02718417|50172029|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
25066571|NCT02718417|50172027|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
25066572|NCT02718417|50172028|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
25066573|NCT02718417|50172029|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
25066574|NCT02718417|50172027|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
25066575|NCT02718417|50172028|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
25066576|NCT02718417|50172029|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
25066577|NCT02718417|50172027|FG000|Observation Phase (OP)|Other|0|||
25066578|NCT02718417|50172028|FG001|Observation Phase (OP)|Other|0|||
25066579|NCT02718417|50172029|FG002|Observation Phase (OP)|Other|7|||
25066580|NCT02718417|50172027|FG000|Follow-up Phase|Adverse Event|3|||
25066581|NCT02718417|50172028|FG001|Follow-up Phase|Adverse Event|1|||
25066582|NCT02718417|50172029|FG002|Follow-up Phase|Adverse Event|1|||
25066583|NCT02718417|50172027|FG000|Follow-up Phase|Other|4|||
25066584|NCT02718417|50172028|FG001|Follow-up Phase|Other|6|||
25066585|NCT02718417|50172029|FG002|Follow-up Phase|Other|4|||
25066586|NCT02718417|50172027|FG000|Follow-up Phase|Withdrawal by Subject|19|||
25066587|NCT02718417|50172028|FG001|Follow-up Phase|Withdrawal by Subject|17|||
25066588|NCT02718417|50172029|FG002|Follow-up Phase|Withdrawal by Subject|5|||
25066589|NCT02718417|50172027|FG000|Follow-up Phase|Study terminated by sponsor|100|||
25066590|NCT02718417|50172028|FG001|Follow-up Phase|Study terminated by sponsor|138|||
25066591|NCT02718417|50172029|FG002|Follow-up Phase|Study terminated by sponsor|6|||
25066592|NCT02718417|50172027|FG000|Follow-up Phase|Lost to Follow-up|2|||
25066593|NCT02718417|50172028|FG001|Follow-up Phase|Lost to Follow-up|3|||
25066594|NCT02718417|50172029|FG002|Follow-up Phase|Lost to Follow-up|0|||
25066595|NCT02718417|50172027|FG000|Follow-up Phase|Death leading to discontinuation|7|||
25066596|NCT02718417|50172028|FG001|Follow-up Phase|Death leading to discontinuation|7|||
25066597|NCT02718417|50172029|FG002|Follow-up Phase|Death leading to discontinuation|3|||
25066598|NCT02718417|50172027|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
25066599|NCT02718417|50172028|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
25066600|NCT02718417|50172029|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
25066601|NCT02718417|50172027|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
25066602|NCT02718417|50172028|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
25066603|NCT02718417|50172029|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
25066604|NCT02718417|50172027|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
25066605|NCT02718417|50172028|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
25066606|NCT02718417|50172029|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
25066607|NCT02718417|50172027|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
25066608|NCT02718417|50172028|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
25066609|NCT02718417|50172029|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
25066610|NCT02718417|50172027|FG000|Long-term Follow-up Phase|Other|0|||
25066611|NCT02718417|50172028|FG001|Long-term Follow-up Phase|Other|2|||
25066612|NCT02718417|50172029|FG002|Long-term Follow-up Phase|Other|0|||
25066613|NCT02640404|50172046|FG000|Overall Study|Protocol Violation|1|||
25066614|NCT02640404|50172047|FG001|Overall Study|Protocol Violation|0|||
25066615|NCT02640404|50172046|FG000|Overall Study|Withdrawal by Subject|1|||
25066616|NCT02640404|50172047|FG001|Overall Study|Withdrawal by Subject|0|||
25066617|NCT00701727|50172053|FG000|First Treatment Period|Adverse Event|0|||
25066618|NCT00701727|50172054|FG001|First Treatment Period|Adverse Event|0|||
25066619|NCT00701727|50172053|FG000|First Treatment Period|Withdrawal by Subject|1|||
25066620|NCT00701727|50172054|FG001|First Treatment Period|Withdrawal by Subject|0|||
25066621|NCT00701727|50172053|FG000|First Treatment Period|sponsor decision|0|||
25066622|NCT00701727|50172054|FG001|First Treatment Period|sponsor decision|1|||
25066623|NCT00701727|50172053|FG000|First Treatment Period|Lost to Follow-up|0|||
25066624|NCT00701727|50172054|FG001|First Treatment Period|Lost to Follow-up|1|||
25066625|NCT00701727|50172053|FG000|Second Treatment Period|Withdrawal by Subject|2|||
25066626|NCT00701727|50172054|FG001|Second Treatment Period|Withdrawal by Subject|0|||
25066627|NCT01369069|50172071|FG000|Overall Study|Lost to Follow-up|8|||
25066628|NCT01369069|50172072|FG001|Overall Study|Lost to Follow-up|9|||
25066629|NCT01369069|50172071|FG000|Overall Study|Withdrawal by Subject|9|||
25066630|NCT01369069|50172072|FG001|Overall Study|Withdrawal by Subject|7|||
25066631|NCT02441218|50172080|FG000|Overall Study|Death|503|||
25066632|NCT02441218|50172081|FG001|Overall Study|Death|553|||
25066633|NCT02441218|50172080|FG000|Overall Study|Withdrawal by Subject|73|||
25066634|NCT02441218|50172081|FG001|Overall Study|Withdrawal by Subject|58|||
25066635|NCT02441218|50172080|FG000|Overall Study|Lost to Follow-up|2|||
25066636|NCT02441218|50172081|FG001|Overall Study|Lost to Follow-up|1|||
25066637|NCT02410252|50172087|FG000|Overall Study|Withdrawal by Subject|4|||
25066638|NCT02410252|50172087|FG000|Overall Study|Physician Decision|2|||
25066639|NCT02440594|50172101|FG000|Overall Study|Lost to Follow-up|34|||
25066640|NCT02440594|50172102|FG001|Overall Study|Lost to Follow-up|33|||
25066641|NCT02440594|50172103|FG002|Overall Study|Lost to Follow-up|54|||
25066642|NCT02440594|50172104|FG003|Overall Study|Lost to Follow-up|47|||
25066643|NCT02440594|50172105|FG004|Overall Study|Lost to Follow-up|5|||
25066644|NCT02440594|50172106|FG005|Overall Study|Lost to Follow-up|4|||
25066645|NCT02440594|50172107|FG006|Overall Study|Lost to Follow-up|28|||
25066646|NCT02440594|50172108|FG007|Overall Study|Lost to Follow-up|48|||
25066647|NCT02440594|50172101|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
25066648|NCT02440594|50172102|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
25066649|NCT02440594|50172103|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
25066650|NCT02440594|50172104|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
25066651|NCT02440594|50172105|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
25066652|NCT02440594|50172106|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
25276758|NCT01054599|50590705|FG001|Overall Study|Lost to Follow-up|2|||
25066653|NCT02440594|50172107|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
25066654|NCT02440594|50172108|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
25066655|NCT02440594|50172101|FG000|Overall Study|Withdrawal by Subject|81|||
25066656|NCT02440594|50172102|FG001|Overall Study|Withdrawal by Subject|67|||
25066657|NCT02440594|50172103|FG002|Overall Study|Withdrawal by Subject|59|||
25066658|NCT02440594|50172104|FG003|Overall Study|Withdrawal by Subject|38|||
25066659|NCT02440594|50172105|FG004|Overall Study|Withdrawal by Subject|2|||
25066660|NCT02440594|50172106|FG005|Overall Study|Withdrawal by Subject|2|||
25066661|NCT02440594|50172107|FG006|Overall Study|Withdrawal by Subject|7|||
25066662|NCT02440594|50172108|FG007|Overall Study|Withdrawal by Subject|7|||
25066663|NCT02440594|50172101|FG000|Overall Study|Administratively w/drawn|3|||
25066664|NCT02440594|50172102|FG001|Overall Study|Administratively w/drawn|2|||
25066665|NCT02440594|50172103|FG002|Overall Study|Administratively w/drawn|0|||
25066666|NCT02440594|50172104|FG003|Overall Study|Administratively w/drawn|0|||
25066667|NCT02440594|50172105|FG004|Overall Study|Administratively w/drawn|0|||
25066668|NCT02440594|50172106|FG005|Overall Study|Administratively w/drawn|0|||
25066669|NCT02440594|50172107|FG006|Overall Study|Administratively w/drawn|2|||
25066670|NCT02440594|50172108|FG007|Overall Study|Administratively w/drawn|1|||
25066671|NCT03836001|50172135|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
25066672|NCT03836001|50172136|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
25066673|NCT03836001|50172137|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
25066674|NCT03836001|50172135|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
25066675|NCT03836001|50172136|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
25066676|NCT03836001|50172137|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
25066677|NCT03836001|50172135|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
25066678|NCT03836001|50172136|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
25066679|NCT03836001|50172137|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
25066680|NCT03836001|50172135|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
25066681|NCT03836001|50172136|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
25066682|NCT03836001|50172137|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
25066683|NCT02465866|50172144|FG000|Period 3|Withdrawal by Subject|0|||
25066684|NCT02465866|50172145|FG001|Period 3|Withdrawal by Subject|1|||
25066685|NCT02465866|50172146|FG002|Period 3|Withdrawal by Subject|0|||
25066686|NCT02465866|50172147|FG003|Period 3|Withdrawal by Subject|0|||
25066687|NCT02439970|50172159|FG000|Overall Study|Study Terminated|2|||
25066688|NCT02439970|50172160|FG001|Overall Study|Study Terminated|3|||
24964207|NCT00441701|50054191|FG005|Overall Study|Withdrawal by Subject|0|||
24964208|NCT00441701|50054192|FG006|Overall Study|Withdrawal by Subject|0|||
24964209|NCT00441701|50054193|FG007|Overall Study|Withdrawal by Subject|0|||
24964210|NCT00441701|50054194|FG008|Overall Study|Withdrawal by Subject|0|||
24964211|NCT00441701|50054195|FG009|Overall Study|Withdrawal by Subject|0|||
24964212|NCT00441545|50054213|FG000|First Intervention|Adverse Event|6|||
24964213|NCT00441545|50054214|FG001|First Intervention|Adverse Event|5|||
24964214|NCT00441545|50054213|FG000|First Intervention|Protocol Violation|2|||
24964215|NCT00441545|50054214|FG001|First Intervention|Protocol Violation|2|||
24964216|NCT00441545|50054213|FG000|First Intervention|Withdrawal by Subject|3|||
24964217|NCT00441545|50054214|FG001|First Intervention|Withdrawal by Subject|3|||
25066689|NCT02437864|50172168|FG000|Overall Study|Protocol Violation|4|||
25066690|NCT02437864|50172169|FG001|Overall Study|Protocol Violation|0|||
24964218|NCT00441545|50054213|FG000|First Intervention|Kidney transplant|1|||
25066691|NCT02408068|50172175|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
24964219|NCT00441545|50054214|FG001|First Intervention|Kidney transplant|1|||
25066692|NCT02408068|50172176|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
25066693|NCT02408068|50172177|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
25066694|NCT02408068|50172178|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
25066695|NCT02408068|50172179|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
25066696|NCT02408068|50172180|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
25066697|NCT01361126|50172193|FG000|Overall Study|Sponsor decision|0|||
25066698|NCT01361126|50172194|FG001|Overall Study|Sponsor decision|2|||
25066699|NCT04428645|50172201|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
25066700|NCT01368835|50172205|FG000|Overall Study|Inclusion criteria/photography quality|22|||
25066701|NCT01368835|50172205|FG000|Overall Study|Lost to Follow-up|11|||
25066702|NCT02407990|50172224|FG000|Overall Study|Death|2|||
25066703|NCT02407990|50172225|FG001|Overall Study|Death|22|||
25066704|NCT02407990|50172226|FG002|Overall Study|Death|23|||
25066705|NCT02407990|50172227|FG003|Overall Study|Death|7|||
25066706|NCT02407990|50172228|FG004|Overall Study|Death|17|||
25066707|NCT02407990|50172229|FG005|Overall Study|Death|16|||
25066708|NCT02407990|50172230|FG006|Overall Study|Death|10|||
25066709|NCT02407990|50172231|FG007|Overall Study|Death|248|||
25066710|NCT02407990|50172224|FG000|Overall Study|Lost to Follow-up|0|||
25066711|NCT02407990|50172225|FG001|Overall Study|Lost to Follow-up|1|||
25066712|NCT02407990|50172226|FG002|Overall Study|Lost to Follow-up|0|||
25066713|NCT02407990|50172227|FG003|Overall Study|Lost to Follow-up|0|||
25066714|NCT02407990|50172228|FG004|Overall Study|Lost to Follow-up|0|||
25066715|NCT02407990|50172229|FG005|Overall Study|Lost to Follow-up|0|||
25066716|NCT02407990|50172230|FG006|Overall Study|Lost to Follow-up|0|||
25066717|NCT02407990|50172231|FG007|Overall Study|Lost to Follow-up|17|||
25066718|NCT02407990|50172224|FG000|Overall Study|Progressive Disease|0|||
25066719|NCT02407990|50172225|FG001|Overall Study|Progressive Disease|0|||
25066720|NCT02407990|50172226|FG002|Overall Study|Progressive Disease|0|||
25066721|NCT02407990|50172227|FG003|Overall Study|Progressive Disease|0|||
25066722|NCT02407990|50172228|FG004|Overall Study|Progressive Disease|0|||
25066723|NCT02407990|50172229|FG005|Overall Study|Progressive Disease|0|||
25066724|NCT02407990|50172230|FG006|Overall Study|Progressive Disease|0|||
25066725|NCT02407990|50172231|FG007|Overall Study|Progressive Disease|1|||
25066726|NCT02407990|50172224|FG000|Overall Study|Withdrawal by Subject|0|||
25066727|NCT02407990|50172225|FG001|Overall Study|Withdrawal by Subject|0|||
25066728|NCT02407990|50172226|FG002|Overall Study|Withdrawal by Subject|0|||
25066729|NCT02407990|50172227|FG003|Overall Study|Withdrawal by Subject|0|||
25066730|NCT02407990|50172228|FG004|Overall Study|Withdrawal by Subject|1|||
25066731|NCT02407990|50172229|FG005|Overall Study|Withdrawal by Subject|0|||
25066732|NCT02407990|50172230|FG006|Overall Study|Withdrawal by Subject|0|||
25066733|NCT02407990|50172231|FG007|Overall Study|Withdrawal by Subject|30|||
25066734|NCT02407990|50172224|FG000|Overall Study|Study Terminated by Sponsor|1|||
25066735|NCT02407990|50172225|FG001|Overall Study|Study Terminated by Sponsor|3|||
25066736|NCT02407990|50172226|FG002|Overall Study|Study Terminated by Sponsor|3|||
25066737|NCT02407990|50172227|FG003|Overall Study|Study Terminated by Sponsor|0|||
25066738|NCT02407990|50172228|FG004|Overall Study|Study Terminated by Sponsor|3|||
25066739|NCT02407990|50172229|FG005|Overall Study|Study Terminated by Sponsor|4|||
25066740|NCT02407990|50172230|FG006|Overall Study|Study Terminated by Sponsor|3|||
25066741|NCT02407990|50172231|FG007|Overall Study|Study Terminated by Sponsor|37|||
25066742|NCT02407990|50172224|FG000|Overall Study|Logistics|0|||
25066743|NCT02407990|50172225|FG001|Overall Study|Logistics|0|||
25066744|NCT02407990|50172226|FG002|Overall Study|Logistics|0|||
25066745|NCT02407990|50172227|FG003|Overall Study|Logistics|0|||
25066746|NCT02407990|50172228|FG004|Overall Study|Logistics|0|||
25066747|NCT02407990|50172229|FG005|Overall Study|Logistics|0|||
24964220|NCT00441545|50054213|FG000|First Intervention|Lack of Efficacy|2|||
24964221|NCT00441545|50054214|FG001|First Intervention|Lack of Efficacy|0|||
24964222|NCT00441545|50054213|FG000|First Intervention|Subject exceeded safety criteria|0|||
24964223|NCT00441545|50054214|FG001|First Intervention|Subject exceeded safety criteria|1|||
25066748|NCT02407990|50172230|FG006|Overall Study|Logistics|0|||
25066749|NCT02407990|50172231|FG007|Overall Study|Logistics|1|||
25066750|NCT02407990|50172224|FG000|Overall Study|Rolled into long-term extension study|0|||
25066751|NCT02407990|50172225|FG001|Overall Study|Rolled into long-term extension study|0|||
25066752|NCT02407990|50172226|FG002|Overall Study|Rolled into long-term extension study|0|||
25066753|NCT02407990|50172227|FG003|Overall Study|Rolled into long-term extension study|0|||
25066754|NCT02407990|50172228|FG004|Overall Study|Rolled into long-term extension study|0|||
25066755|NCT02407990|50172229|FG005|Overall Study|Rolled into long-term extension study|0|||
25066756|NCT02407990|50172230|FG006|Overall Study|Rolled into long-term extension study|0|||
25066757|NCT02407990|50172231|FG007|Overall Study|Rolled into long-term extension study|1|||
24964224|NCT00441545|50054213|FG000|First Intervention|Subject met an exclusionary criteria|1|||
25066758|NCT03288129|50172255|FG000|Overall Study|Adverse Event|10|||
25066759|NCT03288129|50172255|FG000|Overall Study|Lost to Follow-up|3|||
25066760|NCT03288129|50172255|FG000|Overall Study|Withdrawal by Subject|3|||
25066761|NCT03288129|50172255|FG000|Overall Study|Withdrawal of consent/assent|1|||
25066762|NCT03288129|50172255|FG000|Overall Study|Other|5|||
25066763|NCT01673282|50172261|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
25066764|NCT01673282|50172262|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
25066765|NCT01673282|50172261|FG000|Overall Study|Lack of Efficacy|9|||
25066766|NCT01673282|50172262|FG001|Overall Study|Lack of Efficacy|2|||
25066767|NCT01673282|50172261|FG000|Overall Study|Lost to Follow-up|11|||
25066768|NCT01673282|50172262|FG001|Overall Study|Lost to Follow-up|10|||
25066769|NCT01673282|50172261|FG000|Overall Study|Withdrawal by Subject|3|||
25066770|NCT01673282|50172262|FG001|Overall Study|Withdrawal by Subject|3|||
25066771|NCT01673282|50172261|FG000|Overall Study|Other|1|||
25066772|NCT01673282|50172262|FG001|Overall Study|Other|6|||
25066773|NCT04157751|50172270|FG000|Overall Study|Withdrawal by Subject|12|||
25066774|NCT04157751|50172271|FG001|Overall Study|Withdrawal by Subject|17|||
25066775|NCT04157751|50172270|FG000|Overall Study|Lost to Follow-up|6|||
25066776|NCT04157751|50172271|FG001|Overall Study|Lost to Follow-up|2|||
25066777|NCT04157751|50172270|FG000|Overall Study|Adverse Event|34|||
25066778|NCT04157751|50172271|FG001|Overall Study|Adverse Event|23|||
25066779|NCT04157751|50172270|FG000|Overall Study|Not treated|1|||
25066780|NCT04157751|50172271|FG001|Overall Study|Not treated|5|||
25066781|NCT04157751|50172270|FG000|Overall Study|Other reason not stated above|10|||
25066782|NCT04157751|50172271|FG001|Overall Study|Other reason not stated above|10|||
25066783|NCT01673126|50172279|FG000|Overall Study|change of diagnosis|4|||
25066784|NCT01673126|50172280|FG001|Overall Study|change of diagnosis|3|||
25066785|NCT02407054|50172289|FG000|Overall Study|Adverse Event|1|||
25066786|NCT02407054|50172290|FG001|Overall Study|Adverse Event|4|||
25066787|NCT02407054|50172291|FG002|Overall Study|Adverse Event|1|||
25066788|NCT02407054|50172289|FG000|Overall Study|Non-compliance with Study|0|||
25066789|NCT02407054|50172290|FG001|Overall Study|Non-compliance with Study|2|||
25066790|NCT02407054|50172291|FG002|Overall Study|Non-compliance with Study|1|||
25066791|NCT02407054|50172289|FG000|Overall Study|Physician Decision|1|||
25066792|NCT02407054|50172290|FG001|Overall Study|Physician Decision|3|||
25066793|NCT02407054|50172291|FG002|Overall Study|Physician Decision|3|||
25066794|NCT02407054|50172289|FG000|Overall Study|Withdrawal by Subject|5|||
25066795|NCT02407054|50172290|FG001|Overall Study|Withdrawal by Subject|9|||
25066796|NCT02407054|50172291|FG002|Overall Study|Withdrawal by Subject|2|||
25066797|NCT01652716|50172302|FG000|Overall Study|Loss of glucose control|1|||
25066798|NCT01652716|50172303|FG001|Overall Study|Loss of glucose control|0|||
25066799|NCT01652716|50172302|FG000|Overall Study|Administrative|0|||
25066800|NCT01652716|50172303|FG001|Overall Study|Administrative|2|||
25066801|NCT01652716|50172302|FG000|Overall Study|Investigator decision|1|||
25066802|NCT01652716|50172303|FG001|Overall Study|Investigator decision|4|||
25066803|NCT01652716|50172302|FG000|Overall Study|Lost to Follow-up|12|||
25066804|NCT01652716|50172303|FG001|Overall Study|Lost to Follow-up|11|||
25066805|NCT01652716|50172302|FG000|Overall Study|Protocol Violation|2|||
25066806|NCT01652716|50172303|FG001|Overall Study|Protocol Violation|1|||
25066807|NCT01652716|50172302|FG000|Overall Study|Adverse Event|7|||
25066808|NCT01652716|50172303|FG001|Overall Study|Adverse Event|10|||
25066809|NCT01652716|50172302|FG000|Overall Study|Withdrawal by Subject|33|||
25066810|NCT01652716|50172303|FG001|Overall Study|Withdrawal by Subject|18|||
25066811|NCT02790073|50172309|FG000|Overall Study|Death|1|||
25066812|NCT02790073|50172309|FG000|Overall Study|Withdrawal from HD|1|||
25066813|NCT02790073|50172309|FG000|Overall Study|Withdrawal by Subject|1|||
25066814|NCT02789137|50172313|FG000|Overall Study|Dropped out/Died|58|||
25066815|NCT01672970|50172318|FG000|Overall Study|Lack of Efficacy|12|||
25066816|NCT01672970|50172318|FG000|Overall Study|Adverse Event|18|||
25066817|NCT01672970|50172318|FG000|Overall Study|Withdrawal by Subject|2|||
25066818|NCT01672970|50172318|FG000|Overall Study|Lost to Follow-up|5|||
25066819|NCT01672970|50172318|FG000|Overall Study|Other|9|||
25066820|NCT01672970|50172318|FG000|Overall Study|Enrolled but not treated|1|||
25066821|NCT02788747|50172342|FG000|Overall Study|Adverse Event|1|||
25066822|NCT02788747|50172343|FG001|Overall Study|Adverse Event|0|||
25066823|NCT02788747|50172344|FG002|Overall Study|Adverse Event|0|||
25066824|NCT02406742|50172358|FG000|Overall Study|Progression of Disease|5|||
25066825|NCT02406742|50172359|FG001|Overall Study|Progression of Disease|1|||
25066826|NCT02406742|50172360|FG002|Overall Study|Progression of Disease|6|||
25066827|NCT02406742|50172358|FG000|Overall Study|Adverse Event|3|||
25066828|NCT02406742|50172359|FG001|Overall Study|Adverse Event|0|||
25066829|NCT02406742|50172360|FG002|Overall Study|Adverse Event|2|||
25066830|NCT02406742|50172358|FG000|Overall Study|Death|1|||
25066831|NCT02406742|50172359|FG001|Overall Study|Death|0|||
25066832|NCT02406742|50172360|FG002|Overall Study|Death|0|||
25066833|NCT02406742|50172358|FG000|Overall Study|Lack of Efficacy|0|||
25066834|NCT02406742|50172359|FG001|Overall Study|Lack of Efficacy|0|||
25066835|NCT02406742|50172360|FG002|Overall Study|Lack of Efficacy|1|||
25066836|NCT02406742|50172358|FG000|Overall Study|Withdrawal by Participant|1|||
25066837|NCT02406742|50172359|FG001|Overall Study|Withdrawal by Participant|2|||
25066838|NCT02406742|50172360|FG002|Overall Study|Withdrawal by Participant|0|||
25066839|NCT02406742|50172358|FG000|Overall Study|Physician Decision|1|||
25066840|NCT02406742|50172359|FG001|Overall Study|Physician Decision|2|||
25066841|NCT02406742|50172360|FG002|Overall Study|Physician Decision|1|||
25276759|NCT01054599|50590704|FG000|Overall Study|Adverse Event|0|||
25066842|NCT02406742|50172358|FG000|Overall Study|Transition to other treatment|2|||
25066843|NCT02406742|50172359|FG001|Overall Study|Transition to other treatment|0|||
25066844|NCT02406742|50172360|FG002|Overall Study|Transition to other treatment|1|||
25066845|NCT02406742|50172358|FG000|Overall Study|Other Reasons|1|||
25066846|NCT02406742|50172359|FG001|Overall Study|Other Reasons|11|||
25066847|NCT02406742|50172360|FG002|Overall Study|Other Reasons|5|||
25066848|NCT02714595|50172370|FG000|Overall Study|Lost to Follow-up|1|||
25066849|NCT02714595|50172371|FG001|Overall Study|Lost to Follow-up|0|||
25066850|NCT02714595|50172370|FG000|Overall Study|Withdrawal by Subject|1|||
25066851|NCT02714595|50172371|FG001|Overall Study|Withdrawal by Subject|2|||
25066852|NCT02714595|50172370|FG000|Overall Study|Lack of Efficacy|0|||
25066853|NCT02714595|50172371|FG001|Overall Study|Lack of Efficacy|1|||
25066854|NCT02714595|50172370|FG000|Overall Study|Death|30|||
25066855|NCT02714595|50172371|FG001|Overall Study|Death|9|||
25066856|NCT02714595|50172370|FG000|Overall Study|Other-Miscellaneous|0|||
25066857|NCT02714595|50172371|FG001|Overall Study|Other-Miscellaneous|1|||
25066858|NCT02437162|50172398|FG000|Overall Study|Protocol Violation|0|||
25066859|NCT02437162|50172399|FG001|Overall Study|Protocol Violation|1|||
25066860|NCT02437162|50172400|FG002|Overall Study|Protocol Violation|0|||
25066861|NCT02437162|50172398|FG000|Overall Study|Randomized but not treated|0|||
25066862|NCT02437162|50172399|FG001|Overall Study|Randomized but not treated|0|||
25066863|NCT02437162|50172400|FG002|Overall Study|Randomized but not treated|1|||
25066864|NCT02437162|50172398|FG000|Overall Study|Study discontinued by Sponsor|93|||
25066865|NCT02437162|50172399|FG001|Overall Study|Study discontinued by Sponsor|98|||
25066866|NCT02437162|50172400|FG002|Overall Study|Study discontinued by Sponsor|97|||
25066867|NCT02437162|50172398|FG000|Overall Study|Withdrawal by Subject|13|||
25066868|NCT02437162|50172399|FG001|Overall Study|Withdrawal by Subject|7|||
25066869|NCT02437162|50172400|FG002|Overall Study|Withdrawal by Subject|9|||
25066870|NCT02437162|50172398|FG000|Overall Study|Adverse Event|0|||
25066871|NCT02437162|50172399|FG001|Overall Study|Adverse Event|1|||
25066872|NCT02437162|50172400|FG002|Overall Study|Adverse Event|0|||
25066873|NCT02437162|50172398|FG000|Overall Study|Lost to Follow-up|1|||
25066874|NCT02437162|50172399|FG001|Overall Study|Lost to Follow-up|0|||
25066875|NCT02437162|50172400|FG002|Overall Study|Lost to Follow-up|1|||
25066876|NCT02437162|50172398|FG000|Overall Study|Death|0|||
25066877|NCT02437162|50172399|FG001|Overall Study|Death|1|||
25066878|NCT02437162|50172400|FG002|Overall Study|Death|0|||
25066879|NCT02437162|50172398|FG000|Overall Study|Other|0|||
25066880|NCT02437162|50172399|FG001|Overall Study|Other|0|||
25066881|NCT02437162|50172400|FG002|Overall Study|Other|1|||
25066882|NCT01368211|50172415|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
25066883|NCT01368211|50172416|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
25066884|NCT02437084|50172422|FG000|Overall Study|Withdrawal by Subject|2|||
25066885|NCT02437084|50172422|FG000|Overall Study|Physician Decision|1|||
25066886|NCT02406586|50172429|FG000|Overall Study|Lost to Follow-up|0|||
25066887|NCT02406586|50172430|FG001|Overall Study|Lost to Follow-up|4|||
25066888|NCT02406586|50172431|FG002|Overall Study|Lost to Follow-up|2|||
25162891|NCT01790503|50285256|FG010|Overall Study|Withdrawal by Subject|1|||
25162892|NCT01790503|50285246|FG000|Overall Study|Disease progression|2|||
25162893|NCT01790503|50285247|FG001|Overall Study|Disease progression|1|||
25162894|NCT01790503|50285248|FG002|Overall Study|Disease progression|0|||
24964225|NCT00441545|50054214|FG001|First Intervention|Subject met an exclusionary criteria|0|||
24964226|NCT00441545|50054213|FG000|First Intervention|Extended hospitalization|1|||
24964227|NCT00441545|50054214|FG001|First Intervention|Extended hospitalization|0|||
24964228|NCT00441545|50054213|FG000|First Intervention|Site error|1|||
24964229|NCT00441545|50054214|FG001|First Intervention|Site error|0|||
24964230|NCT00441545|50054213|FG000|First Intervention|Sponsor's request|1|||
24964231|NCT00441545|50054214|FG001|First Intervention|Sponsor's request|0|||
24964232|NCT00441545|50054213|FG000|Second Intervention|Adverse Event|5|||
24964233|NCT00441545|50054214|FG001|Second Intervention|Adverse Event|2|||
24964234|NCT00441545|50054213|FG000|Second Intervention|Protocol Violation|4|||
24964235|NCT00441545|50054214|FG001|Second Intervention|Protocol Violation|1|||
24964236|NCT00441545|50054213|FG000|Second Intervention|Withdrawal by Subject|1|||
24964237|NCT00441545|50054214|FG001|Second Intervention|Withdrawal by Subject|1|||
24964238|NCT00441545|50054213|FG000|Second Intervention|Kidney Transplant|1|||
24964239|NCT00441545|50054214|FG001|Second Intervention|Kidney Transplant|1|||
24964240|NCT00441545|50054213|FG000|Second Intervention|Lack of Efficacy|0|||
24964241|NCT00441545|50054214|FG001|Second Intervention|Lack of Efficacy|1|||
25066889|NCT02406586|50172429|FG000|Overall Study|Withdrawal by Subject|1|||
25066890|NCT02406586|50172430|FG001|Overall Study|Withdrawal by Subject|0|||
25066891|NCT02406586|50172431|FG002|Overall Study|Withdrawal by Subject|0|||
25066892|NCT02460562|50172444|FG000|Overall Study|Lost to Follow-up|15|||
25066893|NCT02460562|50172445|FG001|Overall Study|Lost to Follow-up|16|||
25066894|NCT02788357|50172453|FG000|Overall Study|Lost to Follow-up|3|||
25162895|NCT01790503|50285249|FG003|Overall Study|Disease progression|1|||
25066895|NCT02788357|50172454|FG001|Overall Study|Lost to Follow-up|0|||
25066896|NCT02457910|50172466|FG000|Overall Study|Withdrawal by Subject|0|||
25066897|NCT02457910|50172467|FG001|Overall Study|Withdrawal by Subject|0|||
25066898|NCT02457910|50172468|FG002|Overall Study|Withdrawal by Subject|0|||
25066899|NCT02457910|50172469|FG003|Overall Study|Withdrawal by Subject|0|||
25066900|NCT02457910|50172470|FG004|Overall Study|Withdrawal by Subject|0|||
25066901|NCT02457910|50172471|FG005|Overall Study|Withdrawal by Subject|1|||
25066902|NCT02457910|50172466|FG000|Overall Study|Adverse Event|0|||
25066903|NCT02457910|50172467|FG001|Overall Study|Adverse Event|2|||
25066904|NCT02457910|50172468|FG002|Overall Study|Adverse Event|1|||
25066905|NCT02457910|50172469|FG003|Overall Study|Adverse Event|1|||
25066906|NCT02457910|50172470|FG004|Overall Study|Adverse Event|1|||
25066907|NCT02457910|50172471|FG005|Overall Study|Adverse Event|3|||
25066908|NCT02457910|50172466|FG000|Overall Study|Disease progression|3|||
25066909|NCT02457910|50172467|FG001|Overall Study|Disease progression|3|||
25066910|NCT02457910|50172468|FG002|Overall Study|Disease progression|1|||
25066911|NCT02457910|50172469|FG003|Overall Study|Disease progression|1|||
25066912|NCT02457910|50172470|FG004|Overall Study|Disease progression|4|||
25066913|NCT02457910|50172471|FG005|Overall Study|Disease progression|6|||
25066914|NCT02457910|50172466|FG000|Overall Study|Other complicating illness|0|||
25066915|NCT02457910|50172467|FG001|Overall Study|Other complicating illness|0|||
25066916|NCT02457910|50172468|FG002|Overall Study|Other complicating illness|0|||
25066917|NCT02457910|50172469|FG003|Overall Study|Other complicating illness|0|||
25066918|NCT02457910|50172470|FG004|Overall Study|Other complicating illness|0|||
25066919|NCT02457910|50172471|FG005|Overall Study|Other complicating illness|1|||
25066920|NCT02457910|50172466|FG000|Overall Study|Death|0|||
25066921|NCT02457910|50172467|FG001|Overall Study|Death|0|||
25066922|NCT02457910|50172468|FG002|Overall Study|Death|1|||
25066923|NCT02457910|50172469|FG003|Overall Study|Death|0|||
25066924|NCT02457910|50172470|FG004|Overall Study|Death|0|||
25066925|NCT02457910|50172471|FG005|Overall Study|Death|0|||
25066926|NCT02405962|50172490|FG000|Overall Study|Lost to Follow-up|1|||
25066927|NCT02405962|50172491|FG001|Overall Study|Lost to Follow-up|4|||
25066928|NCT02405962|50172490|FG000|Overall Study|A participant has moved to another place|0|||
25066929|NCT02405962|50172491|FG001|Overall Study|A participant has moved to another place|1|||
25066930|NCT02436304|50172500|FG000|Overall Study|Lost to Follow-up|0|||
25066931|NCT02436304|50172501|FG001|Overall Study|Lost to Follow-up|1|||
25066932|NCT02436304|50172502|FG002|Overall Study|Lost to Follow-up|0|||
25066933|NCT02436304|50172500|FG000|Overall Study|Withdrawal by Subject|0|||
25066934|NCT02436304|50172501|FG001|Overall Study|Withdrawal by Subject|1|||
25066935|NCT02436304|50172502|FG002|Overall Study|Withdrawal by Subject|0|||
25066936|NCT02436304|50172500|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
25066937|NCT02436304|50172501|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
25066938|NCT02436304|50172502|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
25066939|NCT02402218|50172514|FG000|Overall Study|Did not pickup study medication|12|||
25066940|NCT02402218|50172515|FG001|Overall Study|Did not pickup study medication|9|||
25066941|NCT02402218|50172516|FG002|Overall Study|Did not pickup study medication|13|||
25066942|NCT02402218|50172514|FG000|Overall Study|Lack of Efficacy|0|||
25066943|NCT02402218|50172515|FG001|Overall Study|Lack of Efficacy|1|||
25066944|NCT02402218|50172516|FG002|Overall Study|Lack of Efficacy|1|||
25066945|NCT02402218|50172514|FG000|Overall Study|Death|1|||
25066946|NCT02402218|50172515|FG001|Overall Study|Death|0|||
25066947|NCT02402218|50172516|FG002|Overall Study|Death|0|||
25066948|NCT02402218|50172514|FG000|Overall Study|Reinfection|0|||
25066949|NCT02402218|50172515|FG001|Overall Study|Reinfection|0|||
25066950|NCT02402218|50172516|FG002|Overall Study|Reinfection|1|||
25066951|NCT02402218|50172514|FG000|Overall Study|Adverse Event|0|||
25066952|NCT02402218|50172515|FG001|Overall Study|Adverse Event|2|||
25066953|NCT02402218|50172516|FG002|Overall Study|Adverse Event|1|||
25066954|NCT02402218|50172514|FG000|Overall Study|Withdrawal by Subject|1|||
25066955|NCT02402218|50172515|FG001|Overall Study|Withdrawal by Subject|1|||
25066956|NCT02402218|50172516|FG002|Overall Study|Withdrawal by Subject|1|||
25066957|NCT02457520|50172524|FG000|Active Treatment Phase|Adverse Event|10|||
25066958|NCT02457520|50172524|FG000|Active Treatment Phase|Lost to Follow-up|8|||
25066959|NCT02457520|50172524|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
25066960|NCT02457520|50172524|FG000|Active Treatment Phase|other|4|||
25066961|NCT02457520|50172524|FG000|Active Treatment Phase|Physician Decision|1|||
25066962|NCT02457520|50172524|FG000|Active Treatment Phase|Protocol Violation|1|||
25066963|NCT02457520|50172524|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
25066964|NCT02457520|50172524|FG000|Post-treatment Period|Other: Retreatment Required|7|||
25066965|NCT02457520|50172524|FG000|Post-treatment Period|Lost to Follow-up|23|||
25066966|NCT02457520|50172524|FG000|Post-treatment Period|Other|3|||
25066967|NCT02457520|50172524|FG000|Post-treatment Period|Physician Decision|1|||
25066968|NCT02457520|50172524|FG000|Post-treatment Period|Withdrawal by Subject|14|||
25066969|NCT02788279|50172557|FG000|Overall Study|Death|62|||
25066970|NCT02788279|50172558|FG001|Overall Study|Death|136|||
25066971|NCT02788279|50172559|FG002|Overall Study|Death|72|||
25066972|NCT02788279|50172557|FG000|Overall Study|Withdrawal by Subject|10|||
25066973|NCT02788279|50172558|FG001|Overall Study|Withdrawal by Subject|15|||
25066974|NCT02788279|50172559|FG002|Overall Study|Withdrawal by Subject|5|||
25066975|NCT02788279|50172557|FG000|Overall Study|Lost to Follow-up|0|||
25066976|NCT02788279|50172558|FG001|Overall Study|Lost to Follow-up|3|||
25066977|NCT02788279|50172559|FG002|Overall Study|Lost to Follow-up|2|||
25066978|NCT02788279|50172557|FG000|Overall Study|Sponsor decision|18|||
25066979|NCT02788279|50172558|FG001|Overall Study|Sponsor decision|29|||
25066980|NCT02788279|50172559|FG002|Overall Study|Sponsor decision|11|||
25066981|NCT02435992|50172575|FG000|Overall Study|non compliance with protocol|2|||
25066982|NCT02435992|50172576|FG001|Overall Study|non compliance with protocol|0|||
25066983|NCT02435992|50172577|FG002|Overall Study|non compliance with protocol|1|||
25066984|NCT02435992|50172578|FG003|Overall Study|non compliance with protocol|0|||
25066985|NCT02435992|50172579|FG004|Overall Study|non compliance with protocol|0|||
25066986|NCT02435992|50172575|FG000|Overall Study|Adverse Event|11|||
25066987|NCT02435992|50172576|FG001|Overall Study|Adverse Event|6|||
25066988|NCT02435992|50172577|FG002|Overall Study|Adverse Event|12|||
24964242|NCT00441545|50054213|FG000|Second Intervention|Subject exceeded safety criteria|1|||
24964243|NCT00441545|50054214|FG001|Second Intervention|Subject exceeded safety criteria|0|||
24964244|NCT00441545|50054213|FG000|Second Intervention|Subject moved|0|||
24964245|NCT00441545|50054214|FG001|Second Intervention|Subject moved|1|||
24964246|NCT00436553|50054223|FG000|Overall Study|Adverse Event|4|||
24964247|NCT00436553|50054224|FG001|Overall Study|Adverse Event|3|||
24964248|NCT00436553|50054225|FG002|Overall Study|Adverse Event|4|||
24964249|NCT00436553|50054223|FG000|Overall Study|Death|3|||
24964250|NCT00436553|50054224|FG001|Overall Study|Death|1|||
24964251|NCT00436553|50054225|FG002|Overall Study|Death|3|||
24964252|NCT00436553|50054223|FG000|Overall Study|Lost to Follow-up|0|||
24964253|NCT00436553|50054224|FG001|Overall Study|Lost to Follow-up|2|||
24964254|NCT00436553|50054225|FG002|Overall Study|Lost to Follow-up|0|||
25066989|NCT02435992|50172578|FG003|Overall Study|Adverse Event|0|||
25186669|NCT02641392|50337357|FG000|Overall Study|Study Terminated by Sponsor|4|||
25186670|NCT02641392|50337358|FG001|Overall Study|Study Terminated by Sponsor|12|||
25066990|NCT02435992|50172579|FG004|Overall Study|Adverse Event|0|||
24964255|NCT00436553|50054223|FG000|Overall Study|Protocol Violation|1|||
24964256|NCT00436553|50054224|FG001|Overall Study|Protocol Violation|0|||
24964257|NCT00436553|50054225|FG002|Overall Study|Protocol Violation|0|||
24964258|NCT00436553|50054223|FG000|Overall Study|Withdrawal by Subject|5|||
24964259|NCT00436553|50054224|FG001|Overall Study|Withdrawal by Subject|6|||
25066991|NCT02435992|50172575|FG000|Overall Study|Lack of Efficacy|4|||
25066992|NCT02435992|50172576|FG001|Overall Study|Lack of Efficacy|10|||
25066993|NCT02435992|50172577|FG002|Overall Study|Lack of Efficacy|9|||
25066994|NCT02435992|50172578|FG003|Overall Study|Lack of Efficacy|0|||
25066995|NCT02435992|50172579|FG004|Overall Study|Lack of Efficacy|0|||
25066996|NCT02435992|50172575|FG000|Overall Study|Withdrawal by Subject|10|||
25066997|NCT02435992|50172576|FG001|Overall Study|Withdrawal by Subject|8|||
25066998|NCT02435992|50172577|FG002|Overall Study|Withdrawal by Subject|20|||
25066999|NCT02435992|50172578|FG003|Overall Study|Withdrawal by Subject|0|||
25067000|NCT02435992|50172579|FG004|Overall Study|Withdrawal by Subject|0|||
25067001|NCT02435992|50172575|FG000|Overall Study|Other Reason|1|||
25067002|NCT02435992|50172576|FG001|Overall Study|Other Reason|0|||
25067003|NCT02435992|50172577|FG002|Overall Study|Other Reason|0|||
25067004|NCT02435992|50172578|FG003|Overall Study|Other Reason|0|||
25067005|NCT02435992|50172579|FG004|Overall Study|Other Reason|0|||
25067006|NCT02435992|50172575|FG000|Overall Study|Physician Decision|0|||
25067007|NCT02435992|50172576|FG001|Overall Study|Physician Decision|0|||
25067008|NCT02435992|50172577|FG002|Overall Study|Physician Decision|1|||
25067009|NCT02435992|50172578|FG003|Overall Study|Physician Decision|0|||
25067010|NCT02435992|50172579|FG004|Overall Study|Physician Decision|0|||
25067011|NCT02788513|50172596|FG000|Overall Study|Withdrawal by Subject|3|||
25067012|NCT02788513|50172597|FG001|Overall Study|Withdrawal by Subject|0|||
25067013|NCT02788513|50172598|FG002|Overall Study|Withdrawal by Subject|2|||
25067014|NCT02788513|50172599|FG003|Overall Study|Withdrawal by Subject|3|||
25067015|NCT02788513|50172600|FG004|Overall Study|Withdrawal by Subject|1|||
25067016|NCT02788513|50172596|FG000|Overall Study|Lost to Follow-up|1|||
25067017|NCT02788513|50172597|FG001|Overall Study|Lost to Follow-up|0|||
25067018|NCT02788513|50172598|FG002|Overall Study|Lost to Follow-up|0|||
25067019|NCT02788513|50172599|FG003|Overall Study|Lost to Follow-up|0|||
25067020|NCT02788513|50172600|FG004|Overall Study|Lost to Follow-up|1|||
25067021|NCT02788513|50172596|FG000|Overall Study|Adverse Event|5|||
25067022|NCT02788513|50172597|FG001|Overall Study|Adverse Event|8|||
25067023|NCT02788513|50172598|FG002|Overall Study|Adverse Event|4|||
25067024|NCT02788513|50172599|FG003|Overall Study|Adverse Event|2|||
25067025|NCT02788513|50172600|FG004|Overall Study|Adverse Event|2|||
25067026|NCT02788513|50172596|FG000|Overall Study|Protocol Violation|0|||
25067027|NCT02788513|50172597|FG001|Overall Study|Protocol Violation|0|||
25067028|NCT02788513|50172598|FG002|Overall Study|Protocol Violation|1|||
25067029|NCT02788513|50172599|FG003|Overall Study|Protocol Violation|1|||
25067030|NCT02788513|50172600|FG004|Overall Study|Protocol Violation|0|||
25067031|NCT02788513|50172596|FG000|Overall Study|Subject decided to stop taking treatment|0|||
25067032|NCT02788513|50172597|FG001|Overall Study|Subject decided to stop taking treatment|0|||
25067033|NCT02788513|50172598|FG002|Overall Study|Subject decided to stop taking treatment|1|||
25067034|NCT02788513|50172599|FG003|Overall Study|Subject decided to stop taking treatment|0|||
25067035|NCT02788513|50172600|FG004|Overall Study|Subject decided to stop taking treatment|0|||
25067036|NCT02788513|50172596|FG000|Overall Study|Decision by the study team|0|||
25067037|NCT02788513|50172597|FG001|Overall Study|Decision by the study team|0|||
25067038|NCT02788513|50172598|FG002|Overall Study|Decision by the study team|0|||
25067039|NCT02788513|50172599|FG003|Overall Study|Decision by the study team|0|||
25067040|NCT02788513|50172600|FG004|Overall Study|Decision by the study team|1|||
25067041|NCT03077828|50172612|FG000|Treatment Cycles|Death|1|||
25067042|NCT03077828|50172612|FG000|Treatment Cycles|Withdrawal by Subject|1|||
25067043|NCT03077828|50172612|FG000|Treatment Cycles|Screen Fail|2|||
25067044|NCT03077828|50172612|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
25162896|NCT01790503|50285250|FG004|Overall Study|Disease progression|2|||
25162897|NCT01790503|50285251|FG005|Overall Study|Disease progression|1|||
25162898|NCT01790503|50285252|FG006|Overall Study|Disease progression|0|||
25162899|NCT01790503|50285253|FG007|Overall Study|Disease progression|1|||
25162900|NCT01790503|50285254|FG008|Overall Study|Disease progression|0|||
25162901|NCT01790503|50285255|FG009|Overall Study|Disease progression|17|||
25162902|NCT01790503|50285256|FG010|Overall Study|Disease progression|7|||
25162903|NCT01790503|50285246|FG000|Overall Study|Protocol Violation|0|||
25162904|NCT01790503|50285247|FG001|Overall Study|Protocol Violation|0|||
25162905|NCT01790503|50285248|FG002|Overall Study|Protocol Violation|0|||
25162906|NCT01790503|50285249|FG003|Overall Study|Protocol Violation|0|||
25162907|NCT01790503|50285250|FG004|Overall Study|Protocol Violation|0|||
25162908|NCT01790503|50285251|FG005|Overall Study|Protocol Violation|0|||
25162909|NCT01790503|50285252|FG006|Overall Study|Protocol Violation|0|||
25162910|NCT01790503|50285253|FG007|Overall Study|Protocol Violation|0|||
25067045|NCT03077828|50172612|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
25067046|NCT03077828|50172612|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
25067047|NCT03077828|50172612|FG000|Follow-up|Patients still in follow-up|15|||
25162911|NCT01790503|50285254|FG008|Overall Study|Protocol Violation|0|||
25162912|NCT01790503|50285255|FG009|Overall Study|Protocol Violation|1|||
25067048|NCT02401672|50172618|FG000|Overall Study|Withdrawal by Subject|1|||
25067049|NCT02401672|50172619|FG001|Overall Study|Withdrawal by Subject|3|||
25067050|NCT02435914|50172629|FG000|Overall Study|Ocular Adverse Event|1|||
25162913|NCT01790503|50285256|FG010|Overall Study|Protocol Violation|0|||
25162914|NCT01790503|50285246|FG000|Overall Study|Physician Decision|0|||
25162915|NCT01790503|50285247|FG001|Overall Study|Physician Decision|0|||
25162916|NCT01790503|50285248|FG002|Overall Study|Physician Decision|0|||
25162917|NCT01790503|50285249|FG003|Overall Study|Physician Decision|0|||
25162918|NCT01790503|50285250|FG004|Overall Study|Physician Decision|0|||
25162919|NCT01790503|50285251|FG005|Overall Study|Physician Decision|0|||
25162920|NCT01790503|50285252|FG006|Overall Study|Physician Decision|0|||
25162921|NCT01790503|50285253|FG007|Overall Study|Physician Decision|0|||
25162922|NCT01790503|50285254|FG008|Overall Study|Physician Decision|0|||
25162923|NCT01790503|50285255|FG009|Overall Study|Physician Decision|1|||
25162924|NCT01790503|50285256|FG010|Overall Study|Physician Decision|1|||
25162925|NCT01790503|50285246|FG000|Overall Study|Death|0|||
25162926|NCT01790503|50285247|FG001|Overall Study|Death|0|||
25162927|NCT01790503|50285248|FG002|Overall Study|Death|0|||
25162928|NCT01790503|50285249|FG003|Overall Study|Death|0|||
25162929|NCT01790503|50285250|FG004|Overall Study|Death|0|||
25162930|NCT01790503|50285251|FG005|Overall Study|Death|0|||
25162931|NCT01790503|50285252|FG006|Overall Study|Death|0|||
25162932|NCT01790503|50285253|FG007|Overall Study|Death|0|||
25162933|NCT01790503|50285254|FG008|Overall Study|Death|0|||
25162934|NCT01790503|50285255|FG009|Overall Study|Death|1|||
25162935|NCT01790503|50285256|FG010|Overall Study|Death|0|||
25162936|NCT01790503|50285246|FG000|Overall Study|Non Compliance|0|||
25162937|NCT01790503|50285247|FG001|Overall Study|Non Compliance|0|||
25162938|NCT01790503|50285248|FG002|Overall Study|Non Compliance|0|||
25162939|NCT01790503|50285249|FG003|Overall Study|Non Compliance|0|||
25162940|NCT01790503|50285250|FG004|Overall Study|Non Compliance|1|||
25162941|NCT01790503|50285251|FG005|Overall Study|Non Compliance|0|||
25162942|NCT01790503|50285252|FG006|Overall Study|Non Compliance|0|||
25162943|NCT01790503|50285253|FG007|Overall Study|Non Compliance|0|||
25162944|NCT01790503|50285254|FG008|Overall Study|Non Compliance|0|||
25162945|NCT01790503|50285255|FG009|Overall Study|Non Compliance|0|||
25162946|NCT01790503|50285256|FG010|Overall Study|Non Compliance|0|||
25162947|NCT01790503|50285246|FG000|Overall Study|Other|0|||
25162948|NCT01790503|50285247|FG001|Overall Study|Other|0|||
25162949|NCT01790503|50285248|FG002|Overall Study|Other|0|||
25162950|NCT01790503|50285249|FG003|Overall Study|Other|0|||
25162951|NCT01790503|50285250|FG004|Overall Study|Other|1|||
25162952|NCT01790503|50285251|FG005|Overall Study|Other|0|||
25162953|NCT01790503|50285252|FG006|Overall Study|Other|0|||
25162954|NCT01790503|50285253|FG007|Overall Study|Other|0|||
25162955|NCT01790503|50285254|FG008|Overall Study|Other|1|||
25162956|NCT01790503|50285255|FG009|Overall Study|Other|2|||
25162957|NCT01790503|50285256|FG010|Overall Study|Other|0|||
25162958|NCT01790113|50285295|FG000|Overall Study|Adverse Event|2|||
25162959|NCT01790113|50285296|FG001|Overall Study|Adverse Event|7|||
25162960|NCT01790113|50285295|FG000|Overall Study|Study ended due to FDA clearance|1|||
25162961|NCT01790113|50285296|FG001|Overall Study|Study ended due to FDA clearance|68|||
25162962|NCT01789567|50285302|FG000|Overall Study|Death|6|||
25162963|NCT01765543|50285306|FG000|Overall Study|Death|1|||
25162964|NCT01765543|50285306|FG000|Overall Study|Withdrawal by Subject|2|||
25162965|NCT01765153|50285316|FG000|Training Phase 1|Format of intervention differed|1|||
25162966|NCT01765153|50285317|FG001|Training Phase 1|Format of intervention differed|0|||
25162967|NCT01765153|50285316|FG000|Training Phase 1|Poor participation in intervention|0|||
25162968|NCT01765153|50285317|FG001|Training Phase 1|Poor participation in intervention|1|||
25162969|NCT01765153|50285316|FG000|Rest Phase 1|Withdrawal by Subject|0|||
25162970|NCT01765153|50285317|FG001|Rest Phase 1|Withdrawal by Subject|1|||
25162971|NCT01765153|50285316|FG000|Training Phase 2|Withdrawal by Subject|0|||
25162972|NCT01765153|50285317|FG001|Training Phase 2|Withdrawal by Subject|1|||
25162973|NCT01765153|50285316|FG000|Rest Phase 2|Lost to Follow-up|2|||
25162974|NCT01765153|50285317|FG001|Rest Phase 2|Lost to Follow-up|1|||
25162975|NCT00248170|50285329|FG000|Overall Study|Withdrawal by Subject|71|||
25162976|NCT00248170|50285330|FG001|Overall Study|Withdrawal by Subject|79|||
25162977|NCT00248170|50285329|FG000|Overall Study|Protocol Violation|35|||
25162978|NCT00248170|50285330|FG001|Overall Study|Protocol Violation|30|||
25162979|NCT00248170|50285329|FG000|Overall Study|Lost to Follow-up|28|||
25162980|NCT00248170|50285330|FG001|Overall Study|Lost to Follow-up|35|||
25162981|NCT00248170|50285329|FG000|Overall Study|Disease progression|196|||
25162982|NCT00248170|50285330|FG001|Overall Study|Disease progression|216|||
25162983|NCT00248170|50285329|FG000|Overall Study|Death|28|||
25162984|NCT00248170|50285330|FG001|Overall Study|Death|47|||
25162985|NCT00248170|50285329|FG000|Overall Study|Adverse Event|311|||
25162986|NCT00248170|50285330|FG001|Overall Study|Adverse Event|296|||
25162987|NCT00248170|50285329|FG000|Overall Study|Administrative problems|22|||
25162988|NCT00248170|50285330|FG001|Overall Study|Administrative problems|25|||
25162989|NCT00248170|50285329|FG000|Overall Study|Abnormal test procedure(s) result|49|||
25162990|NCT00248170|50285330|FG001|Overall Study|Abnormal test procedure(s) result|61|||
25162991|NCT00248170|50285329|FG000|Overall Study|Abnormal laboratory values|4|||
25162992|NCT00248170|50285330|FG001|Overall Study|Abnormal laboratory values|0|||
25162993|NCT00248170|50285329|FG000|Overall Study|Protocol deviation|17|||
25162994|NCT00248170|50285330|FG001|Overall Study|Protocol deviation|19|||
25162995|NCT01764997|50285341|FG000|Run-in Period|Adverse Event|15|||
25162996|NCT01764997|50285342|FG001|Run-in Period|Adverse Event|0|||
25162997|NCT01764997|50285343|FG002|Run-in Period|Adverse Event|0|||
25162998|NCT01764997|50285344|FG003|Run-in Period|Adverse Event|0|||
25162999|NCT01764997|50285345|FG004|Run-in Period|Adverse Event|0|||
25163000|NCT01764997|50285341|FG000|Run-in Period|Lack of Efficacy|5|||
25163001|NCT01764997|50285342|FG001|Run-in Period|Lack of Efficacy|0|||
25163002|NCT01764997|50285343|FG002|Run-in Period|Lack of Efficacy|0|||
25163003|NCT01764997|50285344|FG003|Run-in Period|Lack of Efficacy|0|||
25163004|NCT01764997|50285345|FG004|Run-in Period|Lack of Efficacy|0|||
25163005|NCT01764997|50285341|FG000|Run-in Period|Poor compliance to protocol|1|||
25163006|NCT01764997|50285342|FG001|Run-in Period|Poor compliance to protocol|0|||
25163007|NCT01764997|50285343|FG002|Run-in Period|Poor compliance to protocol|0|||
25163008|NCT01764997|50285344|FG003|Run-in Period|Poor compliance to protocol|0|||
25163009|NCT01764997|50285345|FG004|Run-in Period|Poor compliance to protocol|0|||
25163010|NCT01764997|50285341|FG000|Run-in Period|Other than specified above|17|||
25163011|NCT01764997|50285342|FG001|Run-in Period|Other than specified above|0|||
25163012|NCT01764997|50285343|FG002|Run-in Period|Other than specified above|0|||
25163013|NCT01764997|50285344|FG003|Run-in Period|Other than specified above|0|||
25163014|NCT01764997|50285345|FG004|Run-in Period|Other than specified above|0|||
25163015|NCT01764997|50285341|FG000|Study Drug Treatment Period|Adverse Event|0|||
25163016|NCT01764997|50285342|FG001|Study Drug Treatment Period|Adverse Event|1|||
25163017|NCT01764997|50285343|FG002|Study Drug Treatment Period|Adverse Event|0|||
25163018|NCT01764997|50285344|FG003|Study Drug Treatment Period|Adverse Event|0|||
25163019|NCT01764997|50285345|FG004|Study Drug Treatment Period|Adverse Event|24|||
25163020|NCT01764997|50285341|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
25163021|NCT01764997|50285342|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
25163022|NCT01764997|50285343|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
25163023|NCT01764997|50285344|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
25163024|NCT01764997|50285345|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
25163025|NCT01764997|50285341|FG000|Study Drug Treatment Period|Other than specified above|0|||
25163026|NCT01764997|50285342|FG001|Study Drug Treatment Period|Other than specified above|0|||
25163027|NCT01764997|50285343|FG002|Study Drug Treatment Period|Other than specified above|0|||
25163028|NCT01764997|50285344|FG003|Study Drug Treatment Period|Other than specified above|0|||
25163029|NCT01764997|50285345|FG004|Study Drug Treatment Period|Other than specified above|10|||
25163030|NCT01276756|50285357|FG000|Overall Study|Lost to Follow-up|2|||
25163031|NCT01276756|50285358|FG001|Overall Study|Lost to Follow-up|0|||
25163032|NCT01276756|50285357|FG000|Overall Study|Adverse Event|3|||
25163033|NCT01276756|50285358|FG001|Overall Study|Adverse Event|2|||
25163034|NCT00246376|50285369|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
25163035|NCT00246376|50285370|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
25163036|NCT00246376|50285371|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
25163037|NCT00246376|50285372|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
25163038|NCT00246376|50285373|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
25163039|NCT00246376|50285369|FG000|Overall Study|Adverse Event|2|||
25163040|NCT00246376|50285370|FG001|Overall Study|Adverse Event|3|||
25163041|NCT00246376|50285371|FG002|Overall Study|Adverse Event|1|||
25163042|NCT00246376|50285372|FG003|Overall Study|Adverse Event|3|||
25163043|NCT00246376|50285373|FG004|Overall Study|Adverse Event|1|||
25163044|NCT00246376|50285369|FG000|Overall Study|Lost to Follow-up|2|||
25163045|NCT00246376|50285370|FG001|Overall Study|Lost to Follow-up|11|||
25163046|NCT00246376|50285371|FG002|Overall Study|Lost to Follow-up|11|||
25163047|NCT00246376|50285372|FG003|Overall Study|Lost to Follow-up|16|||
25163048|NCT00246376|50285373|FG004|Overall Study|Lost to Follow-up|13|||
25163049|NCT01764841|50285431|FG000|Overall Study|Logistical Difficulties|0|||
25163050|NCT01764841|50285432|FG001|Overall Study|Logistical Difficulties|1|||
25163051|NCT01764841|50285433|FG002|Overall Study|Logistical Difficulties|0|||
25163052|NCT01764841|50285434|FG003|Overall Study|Logistical Difficulties|0|||
25163053|NCT01764841|50285431|FG000|Overall Study|Death|3|||
25163054|NCT01764841|50285432|FG001|Overall Study|Death|0|||
25163055|NCT01764841|50285433|FG002|Overall Study|Death|1|||
25163056|NCT01764841|50285434|FG003|Overall Study|Death|4|||
25163057|NCT01764841|50285431|FG000|Overall Study|No Follow Up|1|||
25163058|NCT01764841|50285432|FG001|Overall Study|No Follow Up|0|||
25163059|NCT01764841|50285433|FG002|Overall Study|No Follow Up|1|||
25163060|NCT01764841|50285434|FG003|Overall Study|No Follow Up|0|||
25163061|NCT01764841|50285431|FG000|Overall Study|Protocol Violation|0|||
25163062|NCT01764841|50285432|FG001|Overall Study|Protocol Violation|1|||
25163063|NCT01764841|50285433|FG002|Overall Study|Protocol Violation|0|||
25163064|NCT01764841|50285434|FG003|Overall Study|Protocol Violation|0|||
25163065|NCT01764841|50285431|FG000|Overall Study|Withdrawal by Subject|16|||
25163066|NCT01764841|50285432|FG001|Overall Study|Withdrawal by Subject|24|||
25163067|NCT01764841|50285433|FG002|Overall Study|Withdrawal by Subject|11|||
25163068|NCT01764841|50285434|FG003|Overall Study|Withdrawal by Subject|15|||
25163069|NCT01764841|50285431|FG000|Overall Study|Lost to Follow-up|3|||
25186671|NCT02641392|50337359|FG002|Overall Study|Study Terminated by Sponsor|144|||
25163070|NCT01764841|50285432|FG001|Overall Study|Lost to Follow-up|0|||
25186672|NCT02641392|50337357|FG000|Overall Study|Lack of Efficacy|0|||
25163071|NCT01764841|50285433|FG002|Overall Study|Lost to Follow-up|1|||
25163072|NCT01764841|50285434|FG003|Overall Study|Lost to Follow-up|0|||
25163073|NCT00245050|50285446|FG000|Overall Study|Adverse Event|3|||
25163074|NCT00245050|50285447|FG001|Overall Study|Adverse Event|2|||
25163075|NCT00243412|50285485|FG000|Overall Study|Death|0|||
25163076|NCT00243412|50285486|FG001|Overall Study|Death|1|||
25163077|NCT00243412|50285485|FG000|Overall Study|Adverse Event|4|||
25163078|NCT00243412|50285486|FG001|Overall Study|Adverse Event|2|||
25163079|NCT00243412|50285485|FG000|Overall Study|Lost to Follow-up|0|||
25163080|NCT00243412|50285486|FG001|Overall Study|Lost to Follow-up|1|||
25163081|NCT00243412|50285485|FG000|Overall Study|Physician Decision|1|||
25163082|NCT00243412|50285486|FG001|Overall Study|Physician Decision|1|||
25163083|NCT00243412|50285485|FG000|Overall Study|Withdrawal by Subject|4|||
25163084|NCT00243412|50285486|FG001|Overall Study|Withdrawal by Subject|5|||
25163085|NCT00243412|50285485|FG000|Overall Study|Other|1|||
25163086|NCT00243412|50285486|FG001|Overall Study|Other|1|||
25163087|NCT03805750|50285501|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
25163088|NCT03805750|50285502|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
25163089|NCT03804268|50285510|FG000|Overall Study|Adverse Event|2|||
25163090|NCT03804268|50285511|FG001|Overall Study|Adverse Event|2|||
25163091|NCT03804268|50285510|FG000|Overall Study|Withdrawal by Subject|2|||
25163092|NCT03804268|50285511|FG001|Overall Study|Withdrawal by Subject|0|||
25163093|NCT03804268|50285510|FG000|Overall Study|Lost to Follow-up|1|||
25163094|NCT03804268|50285511|FG001|Overall Study|Lost to Follow-up|0|||
25163095|NCT03804268|50285510|FG000|Overall Study|Physician Decision|2|||
25163096|NCT03804268|50285511|FG001|Overall Study|Physician Decision|0|||
25163097|NCT00243022|50285536|FG000|Overall Study|Withdrawal by Subject|1|||
25163098|NCT00243022|50285537|FG001|Overall Study|Withdrawal by Subject|0|||
25163099|NCT00243022|50285536|FG000|Overall Study|Death|1|||
25163100|NCT00243022|50285537|FG001|Overall Study|Death|0|||
25163101|NCT00243022|50285536|FG000|Overall Study|Difficult Travel Distance|0|||
25163102|NCT00243022|50285537|FG001|Overall Study|Difficult Travel Distance|1|||
25163103|NCT01736683|50285622|FG000|Overall Study|Disease Relapse|0|||
25163104|NCT01736683|50285623|FG001|Overall Study|Disease Relapse|0|||
25163105|NCT01736683|50285624|FG002|Overall Study|Disease Relapse|2|||
25163106|NCT01736683|50285625|FG003|Overall Study|Disease Relapse|1|||
25163107|NCT01736683|50285626|FG004|Overall Study|Disease Relapse|0|||
25163108|NCT01736683|50285622|FG000|Overall Study|Adverse Event|0|||
25163109|NCT01736683|50285623|FG001|Overall Study|Adverse Event|2|||
25163110|NCT01736683|50285624|FG002|Overall Study|Adverse Event|2|||
25163111|NCT01736683|50285625|FG003|Overall Study|Adverse Event|3|||
25163112|NCT01736683|50285626|FG004|Overall Study|Adverse Event|2|||
25163113|NCT01736683|50285622|FG000|Overall Study|Withdrawal by Subject|0|||
25163114|NCT01736683|50285623|FG001|Overall Study|Withdrawal by Subject|0|||
25163115|NCT01736683|50285624|FG002|Overall Study|Withdrawal by Subject|3|||
25163116|NCT01736683|50285625|FG003|Overall Study|Withdrawal by Subject|1|||
25163117|NCT01736683|50285626|FG004|Overall Study|Withdrawal by Subject|1|||
25163118|NCT01736683|50285622|FG000|Overall Study|Lack of Therapeutic Effect|7|||
25163119|NCT01736683|50285623|FG001|Overall Study|Lack of Therapeutic Effect|4|||
25163120|NCT01736683|50285624|FG002|Overall Study|Lack of Therapeutic Effect|13|||
25163121|NCT01736683|50285625|FG003|Overall Study|Lack of Therapeutic Effect|20|||
25163122|NCT01736683|50285626|FG004|Overall Study|Lack of Therapeutic Effect|1|||
25163123|NCT01736683|50285622|FG000|Overall Study|Progressive Disease|0|||
25163124|NCT01736683|50285623|FG001|Overall Study|Progressive Disease|0|||
25163125|NCT01736683|50285624|FG002|Overall Study|Progressive Disease|0|||
25163126|NCT01736683|50285625|FG003|Overall Study|Progressive Disease|1|||
25163127|NCT01736683|50285626|FG004|Overall Study|Progressive Disease|0|||
25163128|NCT01736683|50285622|FG000|Overall Study|Other|0|||
25163129|NCT01736683|50285623|FG001|Overall Study|Other|0|||
25163130|NCT01736683|50285624|FG002|Overall Study|Other|1|||
25163131|NCT01736683|50285625|FG003|Overall Study|Other|9|||
25163132|NCT01736683|50285626|FG004|Overall Study|Other|1|||
25163133|NCT01788943|50285642|FG000|Overall Study|Withdrawal by Subject|1|||
25163134|NCT01788943|50285643|FG001|Overall Study|Withdrawal by Subject|0|||
25163135|NCT01788163|50285670|FG000|Overall Study|Other|53|||
25163136|NCT01788163|50285671|FG001|Overall Study|Other|0|||
25163137|NCT01788163|50285672|FG002|Overall Study|Other|0|||
25163138|NCT01788163|50285673|FG003|Overall Study|Other|0|||
25163139|NCT01788163|50285674|FG004|Overall Study|Other|0|||
25163140|NCT01788163|50285675|FG005|Overall Study|Other|7|||
25163141|NCT01788163|50285676|FG006|Overall Study|Other|1|||
25163142|NCT01788163|50285677|FG007|Overall Study|Other|48|||
25163143|NCT01788163|50285678|FG008|Overall Study|Other|15|||
25163144|NCT01788163|50285670|FG000|Overall Study|Withdrawal by Subject|2|||
25163145|NCT01788163|50285671|FG001|Overall Study|Withdrawal by Subject|0|||
25163146|NCT01788163|50285672|FG002|Overall Study|Withdrawal by Subject|0|||
25163147|NCT01788163|50285673|FG003|Overall Study|Withdrawal by Subject|0|||
25163148|NCT01788163|50285674|FG004|Overall Study|Withdrawal by Subject|0|||
25163149|NCT01788163|50285675|FG005|Overall Study|Withdrawal by Subject|0|||
25163150|NCT01788163|50285676|FG006|Overall Study|Withdrawal by Subject|0|||
25163151|NCT01788163|50285677|FG007|Overall Study|Withdrawal by Subject|0|||
25163152|NCT01788163|50285678|FG008|Overall Study|Withdrawal by Subject|1|||
25163153|NCT01787461|50285814|FG000|Overall Study|Adverse Event|4|||
25163154|NCT01787461|50285815|FG001|Overall Study|Adverse Event|3|||
25163155|NCT01787461|50285814|FG000|Overall Study|Lost to Follow-up|3|||
25163156|NCT01787461|50285815|FG001|Overall Study|Lost to Follow-up|2|||
25163157|NCT01787461|50285814|FG000|Overall Study|No longer met eligibility criteria|1|||
25163158|NCT01787461|50285815|FG001|Overall Study|No longer met eligibility criteria|0|||
25163159|NCT01787461|50285814|FG000|Overall Study|Withdrawal by Subject|3|||
25163160|NCT01787461|50285815|FG001|Overall Study|Withdrawal by Subject|4|||
25163161|NCT01787461|50285814|FG000|Overall Study|Protocol Violation|3|||
25163162|NCT01787461|50285815|FG001|Overall Study|Protocol Violation|0|||
25163163|NCT01786993|50285840|FG000|Overall Study|Death|6|||
25163164|NCT01786993|50285841|FG001|Overall Study|Death|7|||
25163165|NCT01786993|50285840|FG000|Overall Study|Withdrawal by Subject|3|||
25163166|NCT01786993|50285841|FG001|Overall Study|Withdrawal by Subject|2|||
25163167|NCT01786993|50285840|FG000|Overall Study|Lost to Follow-up|0|||
25163168|NCT01786993|50285841|FG001|Overall Study|Lost to Follow-up|1|||
25163169|NCT01786993|50285840|FG000|Overall Study|Subject Non-Compliance|1|||
25163170|NCT01786993|50285841|FG001|Overall Study|Subject Non-Compliance|0|||
25163171|NCT01786993|50285840|FG000|Overall Study|System Explant|1|||
25163172|NCT01786993|50285841|FG001|Overall Study|System Explant|0|||
25163173|NCT01786993|50285840|FG000|Overall Study|Hospice Admission|1|||
25163174|NCT01786993|50285841|FG001|Overall Study|Hospice Admission|0|||
25163175|NCT01966445|50285866|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
25163176|NCT01966445|50285867|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
25163177|NCT01966445|50285868|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
25163178|NCT01966445|50285869|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
25163179|NCT01966445|50285870|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
25163180|NCT01966445|50285871|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
25163181|NCT01966445|50285872|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
25163182|NCT01966445|50285866|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
25163183|NCT01966445|50285867|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
25163184|NCT01966445|50285868|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
25163185|NCT01966445|50285869|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
25163186|NCT01966445|50285870|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
25163187|NCT01966445|50285871|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
25163188|NCT01966445|50285872|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
25163189|NCT01966445|50285866|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
25163190|NCT01966445|50285867|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
25163191|NCT01966445|50285868|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
25163192|NCT01966445|50285869|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
25163193|NCT01966445|50285870|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
25163194|NCT01966445|50285871|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
25163195|NCT01966445|50285872|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
25163196|NCT01966445|50285866|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
25163197|NCT01966445|50285867|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
25163198|NCT01966445|50285868|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
25163199|NCT01966445|50285869|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
25163200|NCT01966445|50285870|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
25163201|NCT01966445|50285871|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
25163202|NCT01966445|50285872|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
25163203|NCT01966445|50285866|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
25163204|NCT01966445|50285867|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
25163205|NCT01966445|50285868|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
25163206|NCT01966445|50285869|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
25163207|NCT01966445|50285870|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
25163208|NCT01966445|50285871|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
25163209|NCT01966445|50285872|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
25163210|NCT01763905|50285892|FG000|Overall Study|Withdrawal by Subject|1|||
25163211|NCT01763905|50285893|FG001|Overall Study|Withdrawal by Subject|1|||
25163212|NCT01763905|50285894|FG002|Overall Study|Withdrawal by Subject|0|||
25163213|NCT01763905|50285895|FG003|Overall Study|Withdrawal by Subject|1|||
25163214|NCT01763905|50285892|FG000|Overall Study|Decision by sponsor|5|||
25163215|NCT01763905|50285893|FG001|Overall Study|Decision by sponsor|0|||
25163216|NCT01763905|50285894|FG002|Overall Study|Decision by sponsor|8|||
25163217|NCT01763905|50285895|FG003|Overall Study|Decision by sponsor|0|||
25163218|NCT01763905|50285892|FG000|Overall Study|Lost to Follow-up|0|||
25163219|NCT01763905|50285893|FG001|Overall Study|Lost to Follow-up|0|||
25163220|NCT01763905|50285894|FG002|Overall Study|Lost to Follow-up|1|||
25276760|NCT01054599|50590705|FG001|Overall Study|Adverse Event|1|||
25276761|NCT01054599|50590704|FG000|Overall Study|Withdrawal by Subject|0|||
25163221|NCT01763905|50285895|FG003|Overall Study|Lost to Follow-up|0|||
25163222|NCT02091167|50285907|FG000|Overall Study|Lost to Follow-up|0|||
25163223|NCT02091167|50285908|FG001|Overall Study|Lost to Follow-up|2|||
25163224|NCT02091089|50285914|FG000|Overall Study|Lost to Follow-up|2|||
25163225|NCT01763203|50285929|FG000|Overall Study|Death|4|||
25163226|NCT01763203|50285930|FG001|Overall Study|Death|7|||
25163227|NCT01763203|50285929|FG000|Overall Study|Lost to Follow-up|12|||
25163228|NCT01763203|50285930|FG001|Overall Study|Lost to Follow-up|12|||
25163229|NCT01763203|50285929|FG000|Overall Study|Withdrawal by Subject|8|||
25163230|NCT01763203|50285930|FG001|Overall Study|Withdrawal by Subject|12|||
25163231|NCT01763203|50285929|FG000|Overall Study|Moved out of study region|7|||
25163232|NCT01763203|50285930|FG001|Overall Study|Moved out of study region|10|||
25163233|NCT01763203|50285929|FG000|Overall Study|Physician Decision|2|||
25163234|NCT01763203|50285930|FG001|Overall Study|Physician Decision|1|||
25163235|NCT01763047|50285947|FG000|Period 1|Test Article Not Available|4|||
25163236|NCT01763047|50285948|FG001|Period 1|Test Article Not Available|1|||
25163237|NCT01763047|50285947|FG000|Period 1|Protocol Violation|4|||
25163238|NCT01763047|50285948|FG001|Period 1|Protocol Violation|4|||
25163239|NCT01763047|50285947|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
25163240|NCT01763047|50285948|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
25163241|NCT01763047|50285947|FG000|Period 1|Adverse Event|0|||
25163242|NCT01763047|50285948|FG001|Period 1|Adverse Event|1|||
25163243|NCT01763047|50285947|FG000|Period 1|Unsatisfactory Visual Response|0|||
25163244|NCT01763047|50285948|FG001|Period 1|Unsatisfactory Visual Response|3|||
25163245|NCT01763047|50285947|FG000|Period 1|Lens Power Not Available|0|||
25163246|NCT01763047|50285948|FG001|Period 1|Lens Power Not Available|1|||
25163247|NCT01763047|50285947|FG000|Period 1|Study Site office Closed|0|||
25163248|NCT01763047|50285948|FG001|Period 1|Study Site office Closed|1|||
25163249|NCT01763047|50285947|FG000|Period 2|Lens Discomfort|1|||
25163250|NCT01763047|50285948|FG001|Period 2|Lens Discomfort|0|||
25163251|NCT01763047|50285947|FG000|Period 2|No longer meets Eligibility Criteria|1|||
25163252|NCT01763047|50285948|FG001|Period 2|No longer meets Eligibility Criteria|0|||
25163253|NCT01763047|50285947|FG000|Period 2|Study Site office Closed|1|||
25163254|NCT01763047|50285948|FG001|Period 2|Study Site office Closed|1|||
25163255|NCT01763047|50285947|FG000|Period 2|Unsatisfactory Visual Response|1|||
25163256|NCT01763047|50285948|FG001|Period 2|Unsatisfactory Visual Response|1|||
25163257|NCT01763047|50285947|FG000|Period 2|Protocol Violation|0|||
25163258|NCT01763047|50285948|FG001|Period 2|Protocol Violation|2|||
25163259|NCT01763047|50285947|FG000|Period 2|Unsatisfactory lens Fitting|0|||
25163260|NCT01763047|50285948|FG001|Period 2|Unsatisfactory lens Fitting|1|||
25163261|NCT01977677|50285960|FG000|Overall Study|Unrelated Adverse Event|0|||
25163262|NCT01977677|50285961|FG001|Overall Study|Unrelated Adverse Event|0|||
25163263|NCT01977677|50285962|FG002|Overall Study|Unrelated Adverse Event|1|||
25163264|NCT01762345|50285970|FG000|Overall Study|Adverse Event|5|||
25163265|NCT01762345|50285970|FG000|Overall Study|Protocol Violation|2|||
25163266|NCT02090855|50285975|FG000|Overall Study|no evaluable Standard of Truth results|2|||
25163267|NCT01761565|50285982|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
25163268|NCT01619579|50285992|FG000|Overall Study|Withdrawal by Subject|0|||
25163269|NCT01619579|50285993|FG001|Overall Study|Withdrawal by Subject|3|||
25163270|NCT01736215|50285999|FG000|Overall Study|Early termination of erythropoietin use|1|||
25163271|NCT01736215|50285999|FG000|Overall Study|Adverse Event|4|||
25163272|NCT01736215|50285999|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
25163273|NCT01736215|50285999|FG000|Overall Study|Insufficient data to perform analysis|8|||
25163274|NCT01786603|50286005|FG000|Overall Study|Death|5|||
25163275|NCT01786603|50286006|FG001|Overall Study|Death|1|||
25163276|NCT01786603|50286005|FG000|Overall Study|Adverse Event|6|||
25163277|NCT01786603|50286006|FG001|Overall Study|Adverse Event|2|||
25163278|NCT01786603|50286005|FG000|Overall Study|Physician decision to withdraw|6|||
25163279|NCT01786603|50286006|FG001|Overall Study|Physician decision to withdraw|7|||
25163280|NCT01786603|50286005|FG000|Overall Study|Lost to Follow-up|1|||
25163281|NCT01786603|50286006|FG001|Overall Study|Lost to Follow-up|2|||
25163282|NCT01619423|50286029|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
25163283|NCT01619423|50286030|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
25163284|NCT01619423|50286031|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
25163285|NCT01619423|50286032|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
25163286|NCT01735279|50286045|FG000|Overall Study|Lost to Follow-up|11|||
25163287|NCT01735279|50286046|FG001|Overall Study|Lost to Follow-up|8|||
25163288|NCT01759381|50286054|FG000|Overall Study|Death|1|||
25163289|NCT01759381|50286055|FG001|Overall Study|Death|0|||
25163290|NCT01758523|50286074|FG000|Overall Study|Adverse Event|2|||
25163291|NCT01758523|50286075|FG001|Overall Study|Adverse Event|1|||
25163292|NCT01758523|50286074|FG000|Overall Study|Lack of Efficacy|4|||
25163293|NCT01758523|50286075|FG001|Overall Study|Lack of Efficacy|2|||
25163294|NCT01758523|50286074|FG000|Overall Study|Lost to Follow-up|3|||
25163295|NCT01758523|50286075|FG001|Overall Study|Lost to Follow-up|4|||
24964260|NCT00436553|50054225|FG002|Overall Study|Withdrawal by Subject|3|||
25163296|NCT01758523|50286074|FG000|Overall Study|Withdrawal by Subject|12|||
25163297|NCT01758523|50286075|FG001|Overall Study|Withdrawal by Subject|7|||
25163298|NCT01758289|50286098|FG000|Overall Study|Premature Study Termination|44|||
25163299|NCT01758289|50286098|FG000|Overall Study|Adverse Event|9|||
25163300|NCT01757821|50286122|FG000|Overall Study|Adverse Event|1|||
25163301|NCT01735201|50286151|FG000|Overall Study|Adverse Event|1|||
25163302|NCT01735201|50286152|FG001|Overall Study|Adverse Event|1|||
25163303|NCT01735201|50286153|FG002|Overall Study|Adverse Event|0|||
25163304|NCT01735201|50286154|FG003|Overall Study|Adverse Event|1|||
25163305|NCT01735201|50286155|FG004|Overall Study|Adverse Event|1|||
25163306|NCT01735201|50286156|FG005|Overall Study|Adverse Event|3|||
25163307|NCT01735201|50286157|FG006|Overall Study|Adverse Event|2|||
25163308|NCT01735201|50286158|FG007|Overall Study|Adverse Event|1|||
25163309|NCT01735201|50286151|FG000|Overall Study|Personal Reasons|1|||
25163310|NCT01735201|50286152|FG001|Overall Study|Personal Reasons|0|||
25163311|NCT01735201|50286153|FG002|Overall Study|Personal Reasons|0|||
25163312|NCT01735201|50286154|FG003|Overall Study|Personal Reasons|0|||
25163313|NCT01735201|50286155|FG004|Overall Study|Personal Reasons|0|||
25163314|NCT01735201|50286156|FG005|Overall Study|Personal Reasons|0|||
25163315|NCT01735201|50286157|FG006|Overall Study|Personal Reasons|0|||
25163316|NCT01735201|50286158|FG007|Overall Study|Personal Reasons|0|||
25163317|NCT01735201|50286151|FG000|Overall Study|Protocol Violation|1|||
25163318|NCT01735201|50286152|FG001|Overall Study|Protocol Violation|0|||
25163319|NCT01735201|50286153|FG002|Overall Study|Protocol Violation|0|||
25163320|NCT01735201|50286154|FG003|Overall Study|Protocol Violation|0|||
25163321|NCT01735201|50286155|FG004|Overall Study|Protocol Violation|0|||
25163322|NCT01735201|50286156|FG005|Overall Study|Protocol Violation|0|||
25163323|NCT01735201|50286157|FG006|Overall Study|Protocol Violation|0|||
25163324|NCT01735201|50286158|FG007|Overall Study|Protocol Violation|0|||
25163325|NCT01735201|50286151|FG000|Overall Study|Other Miscellaneous Reasons|0|||
25163326|NCT01735201|50286152|FG001|Overall Study|Other Miscellaneous Reasons|0|||
25163327|NCT01735201|50286153|FG002|Overall Study|Other Miscellaneous Reasons|0|||
25163328|NCT01735201|50286154|FG003|Overall Study|Other Miscellaneous Reasons|1|||
25163329|NCT01735201|50286155|FG004|Overall Study|Other Miscellaneous Reasons|0|||
25163330|NCT01735201|50286156|FG005|Overall Study|Other Miscellaneous Reasons|2|||
25163331|NCT01735201|50286157|FG006|Overall Study|Other Miscellaneous Reasons|1|||
25163332|NCT01735201|50286158|FG007|Overall Study|Other Miscellaneous Reasons|1|||
25163333|NCT01734811|50286178|FG000|Overall Study|Lost to Follow-up|2|||
25163334|NCT01734811|50286179|FG001|Overall Study|Lost to Follow-up|3|||
25163335|NCT01734811|50286178|FG000|Overall Study|Withdrawal by Subject|2|||
25163336|NCT01734811|50286179|FG001|Overall Study|Withdrawal by Subject|0|||
25163337|NCT01757275|50286187|FG000|Overall Study|Lost to Follow-up|1|||
25163338|NCT01757275|50286188|FG001|Overall Study|Lost to Follow-up|2|||
25163339|NCT01757275|50286187|FG000|Overall Study|Adverse Event|3|||
25163340|NCT01757275|50286188|FG001|Overall Study|Adverse Event|3|||
25163341|NCT01757275|50286187|FG000|Overall Study|Withdrawal by Subject|2|||
25163342|NCT01757275|50286188|FG001|Overall Study|Withdrawal by Subject|4|||
25163343|NCT01757275|50286187|FG000|Overall Study|Not treated|3|||
25163344|NCT01757275|50286188|FG001|Overall Study|Not treated|4|||
25163345|NCT01757197|50286203|FG000|Overall Study|Death|2|||
25163346|NCT01784965|50286227|FG000|Overall Study|Withdrawal by Subject|6|||
25163347|NCT01784965|50286228|FG001|Overall Study|Withdrawal by Subject|3|||
25163348|NCT01784965|50286227|FG000|Overall Study|Adverse Event|0|||
25163349|NCT01784965|50286228|FG001|Overall Study|Adverse Event|8|||
24964261|NCT00441467|50054233|FG000|Overall Study|Adverse Event|6|||
24964262|NCT00441467|50054233|FG000|Overall Study|Withdrawal by Subject|3|||
24964263|NCT00441467|50054233|FG000|Overall Study|Progressive disease|9|||
24964264|NCT00436163|50054237|FG000|Overall Study|Lost to Follow-up|2|||
24964265|NCT00436163|50054237|FG000|Overall Study|Adverse Event|1|||
24964266|NCT00006604|50054249|FG000|Overall Study|Met study objective - no further FU|1|||
24964267|NCT00006604|50054250|FG001|Overall Study|Met study objective - no further FU|0|||
24964268|NCT00006604|50054251|FG002|Overall Study|Met study objective - no further FU|0|||
24964269|NCT00006604|50054252|FG003|Overall Study|Met study objective - no further FU|0|||
24964270|NCT00006604|50054253|FG004|Overall Study|Met study objective - no further FU|0|||
24964271|NCT00006604|50054254|FG005|Overall Study|Met study objective - no further FU|0|||
24964272|NCT00006604|50054255|FG006|Overall Study|Met study objective - no further FU|0|||
24964273|NCT00006604|50054256|FG007|Overall Study|Met study objective - no further FU|0|||
24964274|NCT00006604|50054257|FG008|Overall Study|Met study objective - no further FU|0|||
24964275|NCT00006604|50054258|FG009|Overall Study|Met study objective - no further FU|0|||
24964276|NCT00006604|50054259|FG010|Overall Study|Met study objective - no further FU|0|||
24964277|NCT00006604|50054260|FG011|Overall Study|Met study objective - no further FU|0|||
25163350|NCT01784419|50286236|FG000|Overall Study|Adverse Event|3|||
25163351|NCT01784029|50286243|FG000|Overall Study|Lost to Follow-up|19|||
25163352|NCT01784029|50286244|FG001|Overall Study|Lost to Follow-up|20|||
24964278|NCT00006604|50054261|FG012|Overall Study|Met study objective - no further FU|0|||
25067051|NCT02435914|50172630|FG001|Overall Study|Ocular Adverse Event|0|||
25163353|NCT01784029|50286245|FG002|Overall Study|Lost to Follow-up|22|||
25163354|NCT01733329|50286267|FG000|Overall Study|Protocol Violation|1|||
25163355|NCT01733329|50286268|FG001|Overall Study|Protocol Violation|1|||
25163356|NCT01733329|50286267|FG000|Overall Study|Uterine artery injury|1|||
25163357|NCT01733329|50286268|FG001|Overall Study|Uterine artery injury|0|||
25163358|NCT01783483|50286276|FG000|Overall Study|Death|3|||
25163359|NCT01783483|50286277|FG001|Overall Study|Death|3|||
25163360|NCT01783483|50286276|FG000|Overall Study|Lost to Follow-up|14|||
25163361|NCT01783483|50286277|FG001|Overall Study|Lost to Follow-up|10|||
25163362|NCT01783483|50286276|FG000|Overall Study|Withdrawal by Subject|2|||
25163363|NCT01783483|50286277|FG001|Overall Study|Withdrawal by Subject|1|||
25163364|NCT01783483|50286276|FG000|Overall Study|Physician Decision|1|||
25163365|NCT01783483|50286277|FG001|Overall Study|Physician Decision|1|||
25163366|NCT01607593|50286296|FG000|Overall Study|Adverse Event|15|||
25163367|NCT01607593|50286296|FG000|Overall Study|Lack of Efficacy|16|||
25163368|NCT01607593|50286296|FG000|Overall Study|Lost to Follow-up|25|||
25163369|NCT01607593|50286296|FG000|Overall Study|Continuation|33|||
25163370|NCT01607593|50286296|FG000|Overall Study|Other|4|||
25163371|NCT01755637|50286309|FG000|Period 1|Adverse Event|0|||
25163372|NCT01755637|50286310|FG001|Period 1|Adverse Event|1|||
25163373|NCT01732549|50286328|FG000|Overall Study|Adverse Event|13|||
25163374|NCT01732549|50286329|FG001|Overall Study|Adverse Event|3|||
25163375|NCT01732549|50286328|FG000|Overall Study|Consent withdrawn|13|||
25163376|NCT01732549|50286329|FG001|Overall Study|Consent withdrawn|6|||
25163377|NCT01732549|50286328|FG000|Overall Study|Disease progression|37|||
25163378|NCT01732549|50286329|FG001|Overall Study|Disease progression|50|||
25163379|NCT01732549|50286328|FG000|Overall Study|Other|8|||
25163380|NCT01732549|50286329|FG001|Overall Study|Other|14|||
25163381|NCT01755091|50286348|FG000|Overall Study|Withdrawal by Subject|6|||
25163382|NCT01755091|50286349|FG001|Overall Study|Withdrawal by Subject|1|||
25163383|NCT01755091|50286350|FG002|Overall Study|Withdrawal by Subject|3|||
25163384|NCT01755091|50286348|FG000|Overall Study|Adverse Event|1|||
25163385|NCT01755091|50286349|FG001|Overall Study|Adverse Event|1|||
25163386|NCT01755091|50286350|FG002|Overall Study|Adverse Event|1|||
25163387|NCT01755091|50286348|FG000|Overall Study|Lost to Follow-up|1|||
25163388|NCT01755091|50286349|FG001|Overall Study|Lost to Follow-up|0|||
25163389|NCT01755091|50286350|FG002|Overall Study|Lost to Follow-up|1|||
25163390|NCT01755091|50286348|FG000|Overall Study|Physician Decision|1|||
25163391|NCT01755091|50286349|FG001|Overall Study|Physician Decision|1|||
25163392|NCT01755091|50286350|FG002|Overall Study|Physician Decision|2|||
25163393|NCT01754467|50286383|FG000|Overall Study|Lost to Follow-up|1|||
25163394|NCT01753999|50286387|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
25163395|NCT01753999|50286388|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
25163396|NCT01753999|50286387|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
25163397|NCT01753999|50286388|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
25163398|NCT01753999|50286387|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
25163399|NCT01753999|50286388|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
25163400|NCT01753999|50286387|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
25163401|NCT01753999|50286388|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
25163402|NCT01753999|50286387|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
25163403|NCT01753999|50286388|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
25163404|NCT01753999|50286387|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
25163405|NCT01753999|50286388|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
25163406|NCT01783015|50286408|FG000|Blinded Treatment|Adverse Event|0|||
25163407|NCT01783015|50286409|FG001|Blinded Treatment|Adverse Event|1|||
25163408|NCT01783015|50286410|FG002|Blinded Treatment|Adverse Event|0|||
25163409|NCT01783015|50286408|FG000|Blinded Treatment|Protocol Violation|0|||
25163410|NCT01783015|50286409|FG001|Blinded Treatment|Protocol Violation|1|||
25163411|NCT01783015|50286410|FG002|Blinded Treatment|Protocol Violation|0|||
25163412|NCT01783015|50286408|FG000|Blinded Treatment|Withdrawal by Subject|0|||
25163413|NCT01783015|50286409|FG001|Blinded Treatment|Withdrawal by Subject|1|||
25163414|NCT01783015|50286410|FG002|Blinded Treatment|Withdrawal by Subject|0|||
25163415|NCT01783015|50286408|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
25163416|NCT01783015|50286409|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
25163417|NCT01783015|50286410|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
25163418|NCT01783015|50286408|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
25163419|NCT01783015|50286409|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
25163420|NCT01783015|50286410|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
25163421|NCT01782859|50286420|FG000|Overall Study|Protocol Violation|6|||
25163422|NCT01782859|50286421|FG001|Overall Study|Protocol Violation|6|||
25163423|NCT01782859|50286420|FG000|Overall Study|Withdrawal by Subject|0|||
25163424|NCT01782859|50286421|FG001|Overall Study|Withdrawal by Subject|1|||
25163425|NCT01782469|50286428|FG000|Overall Study|Lost to Follow-up|1|||
25163426|NCT01782313|50286432|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
25163427|NCT01782313|50286432|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
25163428|NCT01782313|50286432|FG000|Treated Cycle 3|Progressive Disease|21|||
25163429|NCT01782313|50286432|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
25163430|NCT01782313|50286432|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
25163431|NCT01782313|50286432|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
25163432|NCT01782313|50286432|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
25163433|NCT01782313|50286432|FG000|Survival Follow up|Lost to Follow-up|1|||
25163434|NCT01781611|50286455|FG000|Overall Study|Adverse Event|4|||
25163435|NCT01781611|50286456|FG001|Overall Study|Adverse Event|0|||
25163436|NCT01781299|50286473|FG000|Overall Study|Withdrawal by Subject|0|||
25163437|NCT01781299|50286474|FG001|Overall Study|Withdrawal by Subject|1|||
25163438|NCT01732471|50286480|FG000|Overall Study|Withdrawal by Subject|1|||
25163439|NCT01780987|50286499|FG000|Overall Study|Adverse Event|0|||
25163440|NCT01780987|50286500|FG001|Overall Study|Adverse Event|4|||
25163441|NCT01780987|50286499|FG000|Overall Study|Withdrawal by Subject|2|||
25163442|NCT01780987|50286500|FG001|Overall Study|Withdrawal by Subject|0|||
25163443|NCT01780987|50286499|FG000|Overall Study|Request of Changing Hospital|0|||
25163444|NCT01780987|50286500|FG001|Overall Study|Request of Changing Hospital|1|||
25163445|NCT01780987|50286499|FG000|Overall Study|Changing Residence|1|||
25163446|NCT01780987|50286500|FG001|Overall Study|Changing Residence|0|||
25163447|NCT01780987|50286499|FG000|Overall Study|Not Receiving any Study Medication|0|||
25163448|NCT01780987|50286500|FG001|Overall Study|Not Receiving any Study Medication|1|||
25163449|NCT01730053|50286589|FG000|Overall Study|Participant moved|0|||
25163450|NCT01730053|50286590|FG001|Overall Study|Participant moved|0|||
25163451|NCT01730053|50286591|FG002|Overall Study|Participant moved|1|||
25163452|NCT01730053|50286592|FG003|Overall Study|Participant moved|0|||
25163453|NCT01730053|50286593|FG004|Overall Study|Participant moved|0|||
25163454|NCT01730053|50286594|FG005|Overall Study|Participant moved|0|||
25163455|NCT01730053|50286589|FG000|Overall Study|Physician Decision|0|||
25163456|NCT01730053|50286590|FG001|Overall Study|Physician Decision|0|||
25163457|NCT01730053|50286591|FG002|Overall Study|Physician Decision|0|||
25163458|NCT01730053|50286592|FG003|Overall Study|Physician Decision|1|||
25163459|NCT01730053|50286593|FG004|Overall Study|Physician Decision|0|||
25163460|NCT01730053|50286594|FG005|Overall Study|Physician Decision|0|||
25163461|NCT01730053|50286589|FG000|Overall Study|Adverse Event|2|||
25163462|NCT01730053|50286590|FG001|Overall Study|Adverse Event|6|||
25163463|NCT01730053|50286591|FG002|Overall Study|Adverse Event|3|||
25163464|NCT01730053|50286592|FG003|Overall Study|Adverse Event|3|||
25163465|NCT01730053|50286593|FG004|Overall Study|Adverse Event|2|||
25163466|NCT01730053|50286594|FG005|Overall Study|Adverse Event|2|||
25163467|NCT01730053|50286589|FG000|Overall Study|Poor compliance to protocol|1|||
25163468|NCT01730053|50286590|FG001|Overall Study|Poor compliance to protocol|2|||
25163469|NCT01730053|50286591|FG002|Overall Study|Poor compliance to protocol|2|||
25163470|NCT01730053|50286592|FG003|Overall Study|Poor compliance to protocol|0|||
25163471|NCT01730053|50286593|FG004|Overall Study|Poor compliance to protocol|0|||
25163472|NCT01730053|50286594|FG005|Overall Study|Poor compliance to protocol|2|||
25163473|NCT01730053|50286589|FG000|Overall Study|Other than specified|2|||
25163474|NCT01730053|50286590|FG001|Overall Study|Other than specified|6|||
25163475|NCT01730053|50286591|FG002|Overall Study|Other than specified|5|||
25163476|NCT01730053|50286592|FG003|Overall Study|Other than specified|4|||
25163477|NCT01730053|50286593|FG004|Overall Study|Other than specified|7|||
25163478|NCT01730053|50286594|FG005|Overall Study|Other than specified|9|||
25163479|NCT01752985|50286629|FG000|Treatment Period|Subject request to discontinue treatment|1|||
25163480|NCT01752985|50286630|FG001|Treatment Period|Subject request to discontinue treatment|0|||
25163481|NCT01752985|50286631|FG002|Treatment Period|Subject request to discontinue treatment|1|||
25163482|NCT01752985|50286629|FG000|Treatment Period|Subject no longer meets study criteria|0|||
25163483|NCT01752985|50286630|FG001|Treatment Period|Subject no longer meets study criteria|1|||
25163484|NCT01752985|50286631|FG002|Treatment Period|Subject no longer meets study criteria|1|||
25163485|NCT01752985|50286629|FG000|Treatment Period|Adverse Event|2|||
25163486|NCT01752985|50286630|FG001|Treatment Period|Adverse Event|1|||
25163487|NCT01752985|50286631|FG002|Treatment Period|Adverse Event|2|||
25163488|NCT01752985|50286629|FG000|Treatment Period|Withdrawal by Subject|1|||
25163489|NCT01752985|50286630|FG001|Treatment Period|Withdrawal by Subject|1|||
25163490|NCT01752985|50286631|FG002|Treatment Period|Withdrawal by Subject|0|||
25163491|NCT01752985|50286629|FG000|Treatment Period|Lost to Follow-up|0|||
25163492|NCT01752985|50286630|FG001|Treatment Period|Lost to Follow-up|0|||
25163493|NCT01752985|50286631|FG002|Treatment Period|Lost to Follow-up|1|||
25163494|NCT01751113|50286639|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
25067052|NCT02435914|50172631|FG002|Overall Study|Ocular Adverse Event|0|||
25163495|NCT01751113|50286640|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
25163496|NCT01751113|50286641|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
25163497|NCT01751113|50286642|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
25163498|NCT01751113|50286643|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
25163499|NCT01751113|50286644|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
25163500|NCT01751113|50286639|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
25163501|NCT01751113|50286640|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
25163502|NCT01751113|50286641|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
25163503|NCT01751113|50286642|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
25163504|NCT01751113|50286643|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
25163505|NCT01751113|50286644|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
25163506|NCT01750879|50286664|FG000|Overall Study|Adverse Event|8|||
25163507|NCT01750879|50286665|FG001|Overall Study|Adverse Event|0|||
25163508|NCT01750879|50286664|FG000|Overall Study|Lack of Efficacy|1|||
25163509|NCT01750879|50286665|FG001|Overall Study|Lack of Efficacy|0|||
25163510|NCT01750879|50286664|FG000|Overall Study|Withdrawal by Subject|1|||
25163511|NCT01750879|50286665|FG001|Overall Study|Withdrawal by Subject|0|||
25163512|NCT01750879|50286664|FG000|Overall Study|Did not complete per protocol|0|||
25163513|NCT01750879|50286665|FG001|Overall Study|Did not complete per protocol|3|||
25163514|NCT01719380|50286691|FG000|Overall Study|Adverse Event|0|||
25163515|NCT01719380|50286692|FG001|Overall Study|Adverse Event|0|||
25163516|NCT01719380|50286693|FG002|Overall Study|Adverse Event|1|||
25163517|NCT01719380|50286694|FG003|Overall Study|Adverse Event|2|||
25163518|NCT01719380|50286695|FG004|Overall Study|Adverse Event|0|||
25163519|NCT01719380|50286696|FG005|Overall Study|Adverse Event|1|||
25163520|NCT01719380|50286697|FG006|Overall Study|Adverse Event|0|||
25163521|NCT01719380|50286698|FG007|Overall Study|Adverse Event|1|||
25163522|NCT01719380|50286699|FG008|Overall Study|Adverse Event|4|||
25163523|NCT01719380|50286700|FG009|Overall Study|Adverse Event|3|||
25163524|NCT01719380|50286691|FG000|Overall Study|Death|0|||
25163525|NCT01719380|50286692|FG001|Overall Study|Death|1|||
25163526|NCT01719380|50286693|FG002|Overall Study|Death|0|||
25163527|NCT01719380|50286694|FG003|Overall Study|Death|0|||
25163528|NCT01719380|50286695|FG004|Overall Study|Death|0|||
25163529|NCT01719380|50286696|FG005|Overall Study|Death|0|||
25163530|NCT01719380|50286697|FG006|Overall Study|Death|0|||
25163531|NCT01719380|50286698|FG007|Overall Study|Death|0|||
25163532|NCT01719380|50286699|FG008|Overall Study|Death|3|||
25163533|NCT01719380|50286700|FG009|Overall Study|Death|3|||
25163534|NCT01719380|50286691|FG000|Overall Study|Participant/Guardian Decision|0|||
25163535|NCT01719380|50286692|FG001|Overall Study|Participant/Guardian Decision|0|||
25163536|NCT01719380|50286693|FG002|Overall Study|Participant/Guardian Decision|1|||
25163537|NCT01719380|50286694|FG003|Overall Study|Participant/Guardian Decision|0|||
25163538|NCT01719380|50286695|FG004|Overall Study|Participant/Guardian Decision|0|||
25163539|NCT01719380|50286696|FG005|Overall Study|Participant/Guardian Decision|0|||
25163540|NCT01719380|50286697|FG006|Overall Study|Participant/Guardian Decision|0|||
25163541|NCT01719380|50286698|FG007|Overall Study|Participant/Guardian Decision|0|||
25163542|NCT01719380|50286699|FG008|Overall Study|Participant/Guardian Decision|2|||
25163543|NCT01719380|50286700|FG009|Overall Study|Participant/Guardian Decision|2|||
25163544|NCT01719380|50286691|FG000|Overall Study|Physician Decision|0|||
25163545|NCT01719380|50286692|FG001|Overall Study|Physician Decision|0|||
25163546|NCT01719380|50286693|FG002|Overall Study|Physician Decision|2|||
25163547|NCT01719380|50286694|FG003|Overall Study|Physician Decision|0|||
25163548|NCT01719380|50286695|FG004|Overall Study|Physician Decision|0|||
25163549|NCT01719380|50286696|FG005|Overall Study|Physician Decision|0|||
25163550|NCT01719380|50286697|FG006|Overall Study|Physician Decision|0|||
25163551|NCT01719380|50286698|FG007|Overall Study|Physician Decision|0|||
25163552|NCT01719380|50286699|FG008|Overall Study|Physician Decision|1|||
25163553|NCT01719380|50286700|FG009|Overall Study|Physician Decision|1|||
25163554|NCT01719380|50286691|FG000|Overall Study|Lack of Efficacy|2|||
25163555|NCT01719380|50286692|FG001|Overall Study|Lack of Efficacy|6|||
25163556|NCT01719380|50286693|FG002|Overall Study|Lack of Efficacy|5|||
25163557|NCT01719380|50286694|FG003|Overall Study|Lack of Efficacy|6|||
25163558|NCT01719380|50286695|FG004|Overall Study|Lack of Efficacy|3|||
25163559|NCT01719380|50286696|FG005|Overall Study|Lack of Efficacy|7|||
25163560|NCT01719380|50286697|FG006|Overall Study|Lack of Efficacy|10|||
25163561|NCT01719380|50286698|FG007|Overall Study|Lack of Efficacy|6|||
25163562|NCT01719380|50286699|FG008|Overall Study|Lack of Efficacy|39|||
25163563|NCT01719380|50286700|FG009|Overall Study|Lack of Efficacy|42|||
25163564|NCT01719380|50286691|FG000|Overall Study|Progressive Disease|0|||
25163565|NCT01719380|50286692|FG001|Overall Study|Progressive Disease|0|||
25163566|NCT01719380|50286693|FG002|Overall Study|Progressive Disease|0|||
25163567|NCT01719380|50286694|FG003|Overall Study|Progressive Disease|0|||
25163568|NCT01719380|50286695|FG004|Overall Study|Progressive Disease|0|||
25163569|NCT01719380|50286696|FG005|Overall Study|Progressive Disease|0|||
25163570|NCT01719380|50286697|FG006|Overall Study|Progressive Disease|0|||
25163571|NCT01719380|50286698|FG007|Overall Study|Progressive Disease|0|||
25163572|NCT01719380|50286699|FG008|Overall Study|Progressive Disease|1|||
25163573|NCT01719380|50286700|FG009|Overall Study|Progressive Disease|0|||
25163574|NCT01743560|50286750|FG000|Overall Study|Disease progression|26|||
25163575|NCT01743560|50286750|FG000|Overall Study|Adverse Event|8|||
25163576|NCT01743560|50286750|FG000|Overall Study|Death|3|||
25163577|NCT01743560|50286750|FG000|Overall Study|Withdrawal by Subject|2|||
25163578|NCT01743560|50286750|FG000|Overall Study|Protocol Violation|1|||
25163579|NCT01743560|50286750|FG000|Overall Study|>1 dose of study drug|3|||
25163580|NCT01743092|50286780|FG000|Overall Study|Lost to Follow-up|14|||
25163581|NCT01743092|50286781|FG001|Overall Study|Lost to Follow-up|15|||
25163582|NCT01780831|50286814|FG000|Overall Study|Withdrawal by Subject|0|||
25163583|NCT01780831|50286815|FG001|Overall Study|Withdrawal by Subject|0|||
25163584|NCT01780831|50286816|FG002|Overall Study|Withdrawal by Subject|4|||
25163585|NCT01780831|50286817|FG003|Overall Study|Withdrawal by Subject|0|||
25163586|NCT01780831|50286814|FG000|Overall Study|Lost to Follow-up|0|||
25163587|NCT01780831|50286815|FG001|Overall Study|Lost to Follow-up|0|||
25163588|NCT01780831|50286816|FG002|Overall Study|Lost to Follow-up|0|||
25163589|NCT01780831|50286817|FG003|Overall Study|Lost to Follow-up|1|||
25163590|NCT01778023|50286876|FG000|Overall Study|Withdrawal by Subject|0|||
25163591|NCT01778023|50286877|FG001|Overall Study|Withdrawal by Subject|3|||
25163592|NCT01753297|50286885|FG000|Overall Study|Lost to Follow-up|7|||
25163593|NCT01753297|50286886|FG001|Overall Study|Lost to Follow-up|2|||
25163594|NCT01753297|50286885|FG000|Overall Study|Withdrawal by Subject|26|||
25163595|NCT01753297|50286886|FG001|Overall Study|Withdrawal by Subject|23|||
25163596|NCT01753297|50286885|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
25163597|NCT01753297|50286886|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
25163598|NCT01753297|50286885|FG000|Overall Study|Death|0|||
25163599|NCT01753297|50286886|FG001|Overall Study|Death|2|||
25163600|NCT01753297|50286885|FG000|Overall Study|Did not attend end of study visit|7|||
25163601|NCT01753297|50286886|FG001|Overall Study|Did not attend end of study visit|8|||
25163602|NCT01777321|50286896|FG000|Overall Study|Withdrawal by Subject|0|||
25163603|NCT01777321|50286897|FG001|Overall Study|Withdrawal by Subject|1|||
25163604|NCT01729819|50286905|FG000|Overall Study|Adverse Event|2|||
25163605|NCT01729819|50286906|FG001|Overall Study|Adverse Event|4|||
25163606|NCT01729819|50286905|FG000|Overall Study|Lack of Efficacy|1|||
25163607|NCT01729819|50286906|FG001|Overall Study|Lack of Efficacy|0|||
25163608|NCT01729819|50286905|FG000|Overall Study|Lost to Follow-up|2|||
25163609|NCT01729819|50286906|FG001|Overall Study|Lost to Follow-up|0|||
25163610|NCT01729819|50286905|FG000|Overall Study|Other reason|1|||
25163611|NCT01729819|50286906|FG001|Overall Study|Other reason|0|||
25163612|NCT01729819|50286905|FG000|Overall Study|Protocol Violation|0|||
25163613|NCT01729819|50286906|FG001|Overall Study|Protocol Violation|1|||
25163614|NCT01729819|50286905|FG000|Overall Study|Withdrawal by Subject|0|||
25163615|NCT01729819|50286906|FG001|Overall Study|Withdrawal by Subject|2|||
25163616|NCT01776541|50286917|FG000|Overall Study|Administrative Reason|6|||
25163617|NCT01776541|50286918|FG001|Overall Study|Administrative Reason|2|||
25163618|NCT01776541|50286917|FG000|Overall Study|Death|4|||
25163619|NCT01776541|50286918|FG001|Overall Study|Death|0|||
25163620|NCT01776541|50286917|FG000|Overall Study|Lost to Follow-up|27|||
24964279|NCT00006604|50054262|FG013|Overall Study|Met study objective - no further FU|0|||
24964280|NCT00006604|50054263|FG014|Overall Study|Met study objective - no further FU|1|||
24964281|NCT00006604|50054264|FG015|Overall Study|Met study objective - no further FU|1|||
24964282|NCT00006604|50054265|FG016|Overall Study|Met study objective - no further FU|0|||
24964283|NCT00006604|50054249|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
24964284|NCT00006604|50054250|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
24964285|NCT00006604|50054251|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
24964286|NCT00006604|50054252|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
24964287|NCT00006604|50054253|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
24964288|NCT00006604|50054254|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
24964289|NCT00006604|50054255|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
24964290|NCT00006604|50054256|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
24964291|NCT00006604|50054257|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
24964292|NCT00006604|50054258|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
24964293|NCT00006604|50054259|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
24964294|NCT00006604|50054260|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
24964295|NCT00006604|50054261|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
24964296|NCT00006604|50054262|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
24964297|NCT00006604|50054263|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
24964298|NCT00006604|50054264|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
24964299|NCT00006604|50054265|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
24964300|NCT00006604|50054249|FG000|Overall Study|Death|0|||
24964301|NCT00006604|50054250|FG001|Overall Study|Death|0|||
24964302|NCT00006604|50054251|FG002|Overall Study|Death|0|||
24964303|NCT00006604|50054252|FG003|Overall Study|Death|0|||
24964304|NCT00006604|50054253|FG004|Overall Study|Death|0|||
24964305|NCT00006604|50054254|FG005|Overall Study|Death|0|||
24964306|NCT00006604|50054255|FG006|Overall Study|Death|0|||
24964307|NCT00006604|50054256|FG007|Overall Study|Death|0|||
24964308|NCT00006604|50054257|FG008|Overall Study|Death|0|||
24964309|NCT00006604|50054258|FG009|Overall Study|Death|1|||
24964310|NCT00006604|50054259|FG010|Overall Study|Death|1|||
25163621|NCT01776541|50286918|FG001|Overall Study|Lost to Follow-up|48|||
25163622|NCT01776541|50286917|FG000|Overall Study|Unclassified|5|||
25163623|NCT01776541|50286918|FG001|Overall Study|Unclassified|4|||
25163624|NCT01776541|50286917|FG000|Overall Study|Protocol Violation|2|||
25163625|NCT01776541|50286918|FG001|Overall Study|Protocol Violation|1|||
24964311|NCT00006604|50054260|FG011|Overall Study|Death|1|||
25163626|NCT01776541|50286917|FG000|Overall Study|Withdrawal by Subject|12|||
25163627|NCT01776541|50286918|FG001|Overall Study|Withdrawal by Subject|20|||
25163628|NCT01742078|50286947|FG000|Overall Study|Withdrawal by Subject|0|||
25163629|NCT01742078|50286948|FG001|Overall Study|Withdrawal by Subject|0|||
25163630|NCT01742078|50286949|FG002|Overall Study|Withdrawal by Subject|0|||
25163631|NCT01742078|50286950|FG003|Overall Study|Withdrawal by Subject|1|||
25163632|NCT01742078|50286951|FG004|Overall Study|Withdrawal by Subject|0|||
25163633|NCT01742078|50286952|FG005|Overall Study|Withdrawal by Subject|0|||
25163634|NCT01742078|50286953|FG006|Overall Study|Withdrawal by Subject|0|||
25163635|NCT01742078|50286954|FG007|Overall Study|Withdrawal by Subject|0|||
25163636|NCT01742078|50286955|FG008|Overall Study|Withdrawal by Subject|0|||
25163637|NCT01741688|50286977|FG000|Overall Study|Lack of insurance coverage|2|||
25163638|NCT01741688|50286977|FG000|Overall Study|Withdrawal by Subject|1|||
25163639|NCT01709084|50286984|FG000|Overall Study|Lost to Follow-up|4|||
25163640|NCT01709084|50286985|FG001|Overall Study|Lost to Follow-up|7|||
25163641|NCT01709084|50286984|FG000|Overall Study|Withdrawal by Subject|2|||
25163642|NCT01709084|50286985|FG001|Overall Study|Withdrawal by Subject|2|||
25163643|NCT01709084|50286984|FG000|Overall Study|Adverse Event|5|||
25163644|NCT01709084|50286985|FG001|Overall Study|Adverse Event|0|||
25163645|NCT01709084|50286984|FG000|Overall Study|Other|5|||
25163646|NCT01709084|50286985|FG001|Overall Study|Other|3|||
25163647|NCT01709084|50286984|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
25163648|NCT01709084|50286985|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
25163649|NCT01709084|50286984|FG000|Overall Study|Not Treated|0|||
25163650|NCT01709084|50286985|FG001|Overall Study|Not Treated|2|||
25163651|NCT01776307|50286994|FG000|Overall Study|Not dosed|0|||
25163652|NCT01776307|50286995|FG001|Overall Study|Not dosed|0|||
25163653|NCT01776307|50286996|FG002|Overall Study|Not dosed|1|||
25163654|NCT01729039|50287027|FG000|Overall Study|disqualified|2|||
25163655|NCT01729039|50287028|FG001|Overall Study|disqualified|5|||
25163656|NCT01729039|50287027|FG000|Overall Study|Withdrawal by Subject|8|||
25163657|NCT01729039|50287028|FG001|Overall Study|Withdrawal by Subject|7|||
25163658|NCT01775995|50287039|FG000|Overall Study|Lost to Follow-up|1|||
25163659|NCT01775995|50287040|FG001|Overall Study|Lost to Follow-up|1|||
25163660|NCT01741532|50287048|FG000|Overall Study|Adverse Event|4|||
25163661|NCT01741532|50287049|FG001|Overall Study|Adverse Event|0|||
25163662|NCT01741532|50287048|FG000|Overall Study|Withdrawal by Subject|1|||
25163663|NCT01741532|50287049|FG001|Overall Study|Withdrawal by Subject|1|||
25163664|NCT01741532|50287048|FG000|Overall Study|Protocol Violation|0|||
25163665|NCT01741532|50287049|FG001|Overall Study|Protocol Violation|1|||
25163666|NCT01741532|50287048|FG000|Overall Study|Worsening of the disease|3|||
25163667|NCT01741532|50287049|FG001|Overall Study|Worsening of the disease|1|||
25163668|NCT01741532|50287048|FG000|Overall Study|Sponsor decision|1|||
25163669|NCT01741532|50287049|FG001|Overall Study|Sponsor decision|0|||
25163670|NCT01741532|50287048|FG000|Overall Study|Medical event|1|||
25163671|NCT01741532|50287049|FG001|Overall Study|Medical event|0|||
25163672|NCT01719224|50287059|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
25163673|NCT01719224|50287060|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
25163674|NCT01717976|50287071|FG000|Overall Study|Protocol Violation|0|||
25163675|NCT01717976|50287072|FG001|Overall Study|Protocol Violation|1|||
25163676|NCT01740440|50287078|FG000|Overall Study|Lost to Follow-up|3|||
25163677|NCT01740128|50287085|FG000|Overall Study|Pregnancy|0|||
25163678|NCT01740128|50287086|FG001|Overall Study|Pregnancy|1|||
25163679|NCT01740128|50287085|FG000|Overall Study|Protocol Violation|1|||
25163680|NCT01740128|50287086|FG001|Overall Study|Protocol Violation|2|||
25163681|NCT01740128|50287085|FG000|Overall Study|Lost to Follow-up|2|||
25163682|NCT01740128|50287086|FG001|Overall Study|Lost to Follow-up|2|||
25163683|NCT01740128|50287085|FG000|Overall Study|Withdrawal by Subject|1|||
25163684|NCT01740128|50287086|FG001|Overall Study|Withdrawal by Subject|0|||
25163685|NCT01740128|50287085|FG000|Overall Study|Insufficient protocol compliance|2|||
25163686|NCT01740128|50287086|FG001|Overall Study|Insufficient protocol compliance|2|||
25163687|NCT01976741|50287102|FG000|Overall Study|Withdrawal by Subject|1|||
25163688|NCT01976741|50287103|FG001|Overall Study|Withdrawal by Subject|0|||
25163689|NCT01976741|50287104|FG002|Overall Study|Withdrawal by Subject|1|||
25163690|NCT01976741|50287105|FG003|Overall Study|Withdrawal by Subject|1|||
25163691|NCT01976741|50287106|FG004|Overall Study|Withdrawal by Subject|0|||
25163692|NCT01976741|50287107|FG005|Overall Study|Withdrawal by Subject|0|||
25163693|NCT01976741|50287108|FG006|Overall Study|Withdrawal by Subject|1|||
25163694|NCT01976741|50287109|FG007|Overall Study|Withdrawal by Subject|4|||
25163695|NCT01976741|50287110|FG008|Overall Study|Withdrawal by Subject|0|||
25163696|NCT01976741|50287111|FG009|Overall Study|Withdrawal by Subject|0|||
25163697|NCT01976741|50287102|FG000|Overall Study|Adverse Event|0|||
25163698|NCT01976741|50287103|FG001|Overall Study|Adverse Event|0|||
25163699|NCT01976741|50287104|FG002|Overall Study|Adverse Event|2|||
25163700|NCT01976741|50287105|FG003|Overall Study|Adverse Event|0|||
25163701|NCT01976741|50287106|FG004|Overall Study|Adverse Event|0|||
25163702|NCT01976741|50287107|FG005|Overall Study|Adverse Event|0|||
25163703|NCT01976741|50287108|FG006|Overall Study|Adverse Event|3|||
25163704|NCT01976741|50287109|FG007|Overall Study|Adverse Event|8|||
25163705|NCT01976741|50287110|FG008|Overall Study|Adverse Event|1|||
25163706|NCT01976741|50287111|FG009|Overall Study|Adverse Event|4|||
25163707|NCT01727713|50287145|FG000|Overall Study|Lost to Follow-up|5|||
25163708|NCT01727713|50287145|FG000|Overall Study|Adverse Event|10|||
25163709|NCT01727713|50287145|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
25163710|NCT01727713|50287145|FG000|Overall Study|Withdrawal by Subject|13|||
25163711|NCT01727713|50287145|FG000|Overall Study|Protocol Deviation|2|||
25163712|NCT01965431|50287149|FG000|Overall Study|Adverse Event|0|||
25163713|NCT01965431|50287150|FG001|Overall Study|Adverse Event|1|||
25163714|NCT01965431|50287151|FG002|Overall Study|Adverse Event|0|||
25163715|NCT01965431|50287152|FG003|Overall Study|Adverse Event|0|||
25163716|NCT01965431|50287153|FG004|Overall Study|Adverse Event|0|||
25163717|NCT01965431|50287154|FG005|Overall Study|Adverse Event|0|||
25163718|NCT01965431|50287149|FG000|Overall Study|Other than stated above|6|||
25163719|NCT01965431|50287150|FG001|Overall Study|Other than stated above|5|||
25163720|NCT01965431|50287151|FG002|Overall Study|Other than stated above|6|||
25163721|NCT01965431|50287152|FG003|Overall Study|Other than stated above|6|||
25163722|NCT01965431|50287153|FG004|Overall Study|Other than stated above|6|||
25163723|NCT01965431|50287154|FG005|Overall Study|Other than stated above|6|||
25163724|NCT01976663|50287164|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
25163725|NCT01976663|50287164|FG000|Overall Study|Personal Reasons|6|||
25163726|NCT01976663|50287164|FG000|Overall Study|Withdrawal by Subject|4|||
25163727|NCT01976663|50287164|FG000|Overall Study|Screen Failure|3|||
25163728|NCT01976663|50287164|FG000|Overall Study|Adverse Event|2|||
25163729|NCT01976663|50287164|FG000|Overall Study|Lost to Follow-up|3|||
25163730|NCT01775137|50287172|FG000|Overall Study|Death|1|||
25163731|NCT01775137|50287172|FG000|Overall Study|Protocol deviation|2|||
25163732|NCT01775137|50287172|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
25163733|NCT01775137|50287172|FG000|Overall Study|Adverse Event|1|||
25163734|NCT01775137|50287172|FG000|Overall Study|Withdrawal by participants|5|||
25163735|NCT01976507|50287179|FG000|Overall Study|Adverse Event|6|||
25163736|NCT01976507|50287179|FG000|Overall Study|ablation not done, drug not given|1|||
25163737|NCT01964963|50287183|FG000|Overall Study|Case Report Forms Uncollected|888|||
25163738|NCT01964963|50287183|FG000|Overall Study|Protocol Deviation|50|||
25163739|NCT01964963|50287183|FG000|Overall Study|Data Reliability was not Assured|5|||
25163740|NCT01964105|50287190|FG000|Overall Study|Lost to Follow-up|2|||
25163741|NCT01964105|50287191|FG001|Overall Study|Lost to Follow-up|13|||
25163742|NCT01964105|50287192|FG002|Overall Study|Lost to Follow-up|0|||
25163743|NCT01974323|50287202|FG000|Overall Study|Other Reasons|25|||
25163744|NCT01974323|50287203|FG001|Overall Study|Other Reasons|28|||
25163745|NCT01974323|50287202|FG000|Overall Study|Protocol Violation|2|||
25163746|NCT01974323|50287203|FG001|Overall Study|Protocol Violation|2|||
25163747|NCT01974323|50287202|FG000|Overall Study|Personal Reasons|15|||
25163748|NCT01974323|50287203|FG001|Overall Study|Personal Reasons|19|||
25163749|NCT01974323|50287202|FG000|Overall Study|Lost to Follow-up|45|||
25163750|NCT01974323|50287203|FG001|Overall Study|Lost to Follow-up|40|||
25163751|NCT01974323|50287202|FG000|Overall Study|Pregnancy|2|||
25163752|NCT01974323|50287203|FG001|Overall Study|Pregnancy|1|||
25163753|NCT01974323|50287202|FG000|Overall Study|Lack of Efficacy|1|||
25163754|NCT01974323|50287203|FG001|Overall Study|Lack of Efficacy|1|||
25163755|NCT01974323|50287202|FG000|Overall Study|Adverse Event|2|||
25163756|NCT01974323|50287203|FG001|Overall Study|Adverse Event|2|||
25163757|NCT01963403|50287211|FG000|Overall Study|Lost to Follow-up|2|||
25163758|NCT01963403|50287212|FG001|Overall Study|Lost to Follow-up|3|||
25163759|NCT01963403|50287211|FG000|Overall Study|Implant removal|0|||
25163760|NCT01963403|50287212|FG001|Overall Study|Implant removal|1|||
25163761|NCT01973387|50287222|FG000|Overall Study|Adverse Event|14|||
25163762|NCT01973387|50287223|FG001|Overall Study|Adverse Event|4|||
25163763|NCT01973387|50287222|FG000|Overall Study|Withdrawal by Subject|7|||
25163764|NCT01973387|50287223|FG001|Overall Study|Withdrawal by Subject|4|||
25163765|NCT01973387|50287222|FG000|Overall Study|Study terminated by sponsor|63|||
25163766|NCT01973387|50287223|FG001|Overall Study|Study terminated by sponsor|0|||
25163767|NCT01973387|50287222|FG000|Overall Study|Progressive disease or relapse|16|||
25163768|NCT01973387|50287223|FG001|Overall Study|Progressive disease or relapse|5|||
25163769|NCT01973387|50287222|FG000|Overall Study|Death|4|||
25163770|NCT01973387|50287223|FG001|Overall Study|Death|3|||
25163771|NCT01973387|50287222|FG000|Overall Study|Randomized, not treated|2|||
25163772|NCT01973387|50287223|FG001|Overall Study|Randomized, not treated|2|||
25163773|NCT01973231|50287231|FG000|Overall Study|Protocol Violation|1|||
25163774|NCT01973231|50287232|FG001|Overall Study|Protocol Violation|1|||
25163775|NCT01973231|50287231|FG000|Overall Study|Lost to Follow-up|1|||
25163776|NCT01973231|50287232|FG001|Overall Study|Lost to Follow-up|1|||
25163777|NCT01973231|50287231|FG000|Overall Study|unclassified|2|||
25163778|NCT01973231|50287232|FG001|Overall Study|unclassified|1|||
25163779|NCT01973231|50287231|FG000|Overall Study|Withdrawal by Subject|7|||
25163780|NCT01973231|50287232|FG001|Overall Study|Withdrawal by Subject|9|||
25163781|NCT01961687|50287238|FG000|Overall Study|Lost to Follow-up|19|||
25163782|NCT01961687|50287238|FG000|Overall Study|Re-operation|17|||
25163783|NCT01961687|50287238|FG000|Overall Study|Death|7|||
25163784|NCT01961687|50287238|FG000|Overall Study|Withdrawal by Subject|6|||
25163785|NCT01961687|50287238|FG000|Overall Study|Adverse Event|6|||
25163786|NCT01961687|50287238|FG000|Overall Study|Moved to area without study site|2|||
25163787|NCT01961687|50287238|FG000|Overall Study|Sponsor decision|2|||
25163788|NCT01961687|50287238|FG000|Overall Study|Physician Decision|1|||
25163789|NCT01961687|50287238|FG000|Overall Study|Unable to meet follow-up requirements|1|||
25163790|NCT01961609|50287300|FG000|Initiation|Missing|3|||
25163791|NCT01961609|50287301|FG001|Initiation|Missing|2|||
25163792|NCT01961609|50287302|FG002|Initiation|Missing|0|||
25163793|NCT01961609|50287303|FG003|Initiation|Missing|0|||
25163794|NCT01961609|50287300|FG000|Initiation|Protocol deviation|1|||
25163795|NCT01961609|50287301|FG001|Initiation|Protocol deviation|0|||
25163796|NCT01961609|50287302|FG002|Initiation|Protocol deviation|0|||
25163797|NCT01961609|50287303|FG003|Initiation|Protocol deviation|0|||
25163798|NCT01961609|50287300|FG000|Initiation|Death|0|||
25163799|NCT01961609|50287301|FG001|Initiation|Death|1|||
25163800|NCT01961609|50287302|FG002|Initiation|Death|0|||
25163801|NCT01961609|50287303|FG003|Initiation|Death|0|||
25163802|NCT01961609|50287300|FG000|Initiation|Administrative problems|1|||
25163803|NCT01961609|50287301|FG001|Initiation|Administrative problems|0|||
25163804|NCT01961609|50287302|FG002|Initiation|Administrative problems|0|||
25163805|NCT01961609|50287303|FG003|Initiation|Administrative problems|0|||
25163806|NCT01961609|50287300|FG000|Initiation|Withdrawal by Subject|1|||
25163807|NCT01961609|50287301|FG001|Initiation|Withdrawal by Subject|2|||
25163808|NCT01961609|50287302|FG002|Initiation|Withdrawal by Subject|0|||
25163809|NCT01961609|50287303|FG003|Initiation|Withdrawal by Subject|0|||
25163810|NCT01961609|50287300|FG000|Initiation|Lack of Efficacy|2|||
25163811|NCT01961609|50287301|FG001|Initiation|Lack of Efficacy|1|||
25163812|NCT01961609|50287302|FG002|Initiation|Lack of Efficacy|0|||
25163813|NCT01961609|50287303|FG003|Initiation|Lack of Efficacy|0|||
25163814|NCT01961609|50287300|FG000|Initiation|Abnormal lab values|0|||
25163815|NCT01961609|50287301|FG001|Initiation|Abnormal lab values|1|||
25163816|NCT01961609|50287302|FG002|Initiation|Abnormal lab values|0|||
25163817|NCT01961609|50287303|FG003|Initiation|Abnormal lab values|0|||
25163818|NCT01961609|50287300|FG000|Initiation|Adverse Event|3|||
25163819|NCT01961609|50287301|FG001|Initiation|Adverse Event|5|||
25163820|NCT01961609|50287302|FG002|Initiation|Adverse Event|0|||
25163821|NCT01961609|50287303|FG003|Initiation|Adverse Event|0|||
25163822|NCT01961609|50287300|FG000|Initiation|Randomized but not treated|1|||
25163823|NCT01961609|50287301|FG001|Initiation|Randomized but not treated|1|||
25163824|NCT01961609|50287302|FG002|Initiation|Randomized but not treated|0|||
25163825|NCT01961609|50287303|FG003|Initiation|Randomized but not treated|0|||
25163826|NCT01961609|50287300|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
25163827|NCT01961609|50287301|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
25163828|NCT01961609|50287302|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
25163829|NCT01961609|50287303|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
25163830|NCT01961609|50287300|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
25163831|NCT01961609|50287301|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
25163832|NCT01961609|50287302|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
25163833|NCT01961609|50287303|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
25163834|NCT01961609|50287300|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
25163835|NCT01961609|50287301|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
25163836|NCT01961609|50287302|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
25163837|NCT01961609|50287303|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
25163838|NCT01961609|50287300|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
25163839|NCT01961609|50287301|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
25163840|NCT01961609|50287302|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
25163841|NCT01961609|50287303|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
25163842|NCT01961609|50287300|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
25163843|NCT01961609|50287301|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
25163844|NCT01961609|50287302|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
25163845|NCT01961609|50287303|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
25163846|NCT01961609|50287300|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
25163847|NCT01961609|50287301|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
25163848|NCT01961609|50287302|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
25163849|NCT01961609|50287303|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
24964312|NCT00006604|50054261|FG012|Overall Study|Death|0|||
25163850|NCT01961609|50287300|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
25163851|NCT01961609|50287301|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
25163852|NCT01961609|50287302|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
24964313|NCT00006604|50054262|FG013|Overall Study|Death|0|||
25163853|NCT01961609|50287303|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
24964314|NCT00006604|50054263|FG014|Overall Study|Death|0|||
25163854|NCT01961609|50287300|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
25163855|NCT01961609|50287301|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
25163856|NCT01961609|50287302|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
25163857|NCT01961609|50287303|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
25163858|NCT01961609|50287300|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
25163859|NCT01961609|50287301|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
25163860|NCT01961609|50287302|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
25163861|NCT01961609|50287303|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
25163862|NCT01961609|50287300|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
25163863|NCT01961609|50287301|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
25163864|NCT01961609|50287302|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
25163865|NCT01961609|50287303|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
25163866|NCT01961609|50287300|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
25163867|NCT01961609|50287301|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
25163868|NCT01961609|50287302|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
25163869|NCT01961609|50287303|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
25163870|NCT01961609|50287300|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
25163871|NCT01961609|50287301|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
25163872|NCT01961609|50287302|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
25163873|NCT01961609|50287303|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
25163874|NCT01774981|50287412|FG000|Overall Study|Adverse Event|0|||
25163875|NCT01774981|50287413|FG001|Overall Study|Adverse Event|0|||
25163876|NCT01774981|50287414|FG002|Overall Study|Adverse Event|0|||
25163877|NCT01774981|50287415|FG003|Overall Study|Adverse Event|0|||
25163878|NCT01774981|50287416|FG004|Overall Study|Adverse Event|0|||
25163879|NCT01774981|50287417|FG005|Overall Study|Adverse Event|1|||
25163880|NCT01774981|50287418|FG006|Overall Study|Adverse Event|0|||
25163881|NCT01774981|50287419|FG007|Overall Study|Adverse Event|0|||
25163882|NCT01774981|50287412|FG000|Overall Study|Withdrawal by Subject|0|||
25163883|NCT01774981|50287413|FG001|Overall Study|Withdrawal by Subject|0|||
25163884|NCT01774981|50287414|FG002|Overall Study|Withdrawal by Subject|0|||
25163885|NCT01774981|50287415|FG003|Overall Study|Withdrawal by Subject|0|||
25163886|NCT01774981|50287416|FG004|Overall Study|Withdrawal by Subject|0|||
25163887|NCT01774981|50287417|FG005|Overall Study|Withdrawal by Subject|0|||
25163888|NCT01774981|50287418|FG006|Overall Study|Withdrawal by Subject|0|||
25163889|NCT01774981|50287419|FG007|Overall Study|Withdrawal by Subject|1|||
25163890|NCT01774981|50287412|FG000|Overall Study|Death|0|||
25163891|NCT01774981|50287413|FG001|Overall Study|Death|0|||
25163892|NCT01774981|50287414|FG002|Overall Study|Death|0|||
25163893|NCT01774981|50287415|FG003|Overall Study|Death|0|||
25163894|NCT01774981|50287416|FG004|Overall Study|Death|1|||
25163895|NCT01774981|50287417|FG005|Overall Study|Death|0|||
25163896|NCT01774981|50287418|FG006|Overall Study|Death|0|||
25163897|NCT01774981|50287419|FG007|Overall Study|Death|0|||
25163898|NCT01972841|50287448|FG000|Overall Study|Randomized but Never Received Treatment|2|||
25163899|NCT01972841|50287449|FG001|Overall Study|Randomized but Never Received Treatment|5|||
25163900|NCT01972841|50287450|FG002|Overall Study|Randomized but Never Received Treatment|4|||
25163901|NCT01972841|50287451|FG003|Overall Study|Randomized but Never Received Treatment|2|||
25163902|NCT01972841|50287452|FG004|Overall Study|Randomized but Never Received Treatment|6|||
25163903|NCT01972841|50287453|FG005|Overall Study|Randomized but Never Received Treatment|13|||
25163904|NCT01972841|50287448|FG000|Overall Study|Adverse Event|13|||
25163905|NCT01972841|50287449|FG001|Overall Study|Adverse Event|8|||
25163906|NCT01972841|50287450|FG002|Overall Study|Adverse Event|12|||
25163907|NCT01972841|50287451|FG003|Overall Study|Adverse Event|9|||
25163908|NCT01972841|50287452|FG004|Overall Study|Adverse Event|21|||
25163909|NCT01972841|50287453|FG005|Overall Study|Adverse Event|26|||
25163910|NCT01972841|50287448|FG000|Overall Study|Lack of Efficacy|1|||
25163911|NCT01972841|50287449|FG001|Overall Study|Lack of Efficacy|0|||
25163912|NCT01972841|50287450|FG002|Overall Study|Lack of Efficacy|0|||
25163913|NCT01972841|50287451|FG003|Overall Study|Lack of Efficacy|2|||
25163914|NCT01972841|50287452|FG004|Overall Study|Lack of Efficacy|4|||
25163915|NCT01972841|50287453|FG005|Overall Study|Lack of Efficacy|1|||
25163916|NCT01972841|50287448|FG000|Overall Study|Lost to Follow-up|4|||
25163917|NCT01972841|50287449|FG001|Overall Study|Lost to Follow-up|2|||
25163918|NCT01972841|50287450|FG002|Overall Study|Lost to Follow-up|4|||
25163919|NCT01972841|50287451|FG003|Overall Study|Lost to Follow-up|2|||
25163920|NCT01972841|50287452|FG004|Overall Study|Lost to Follow-up|9|||
25163921|NCT01972841|50287453|FG005|Overall Study|Lost to Follow-up|3|||
25163922|NCT01972841|50287448|FG000|Overall Study|Protocol Violation|2|||
25163923|NCT01972841|50287449|FG001|Overall Study|Protocol Violation|2|||
25163924|NCT01972841|50287450|FG002|Overall Study|Protocol Violation|3|||
25163925|NCT01972841|50287451|FG003|Overall Study|Protocol Violation|5|||
25163926|NCT01972841|50287452|FG004|Overall Study|Protocol Violation|9|||
25163927|NCT01972841|50287453|FG005|Overall Study|Protocol Violation|4|||
25163928|NCT01972841|50287448|FG000|Overall Study|Withdrawal by participants|21|||
25163929|NCT01972841|50287449|FG001|Overall Study|Withdrawal by participants|27|||
25163930|NCT01972841|50287450|FG002|Overall Study|Withdrawal by participants|23|||
25163931|NCT01972841|50287451|FG003|Overall Study|Withdrawal by participants|16|||
25163932|NCT01972841|50287452|FG004|Overall Study|Withdrawal by participants|33|||
25163933|NCT01972841|50287453|FG005|Overall Study|Withdrawal by participants|34|||
25163934|NCT01972841|50287448|FG000|Overall Study|Miscellaneous|0|||
25163935|NCT01972841|50287449|FG001|Overall Study|Miscellaneous|0|||
25163936|NCT01972841|50287450|FG002|Overall Study|Miscellaneous|4|||
25163937|NCT01972841|50287451|FG003|Overall Study|Miscellaneous|1|||
25163938|NCT01972841|50287452|FG004|Overall Study|Miscellaneous|0|||
25163939|NCT01972841|50287453|FG005|Overall Study|Miscellaneous|4|||
25163940|NCT01972841|50287448|FG000|Overall Study|Did not have end of treatment page|0|||
25163941|NCT01972841|50287449|FG001|Overall Study|Did not have end of treatment page|0|||
25163942|NCT01972841|50287450|FG002|Overall Study|Did not have end of treatment page|0|||
25163943|NCT01972841|50287451|FG003|Overall Study|Did not have end of treatment page|0|||
25163944|NCT01972841|50287452|FG004|Overall Study|Did not have end of treatment page|1|||
25163945|NCT01972841|50287453|FG005|Overall Study|Did not have end of treatment page|0|||
25163946|NCT01774903|50287467|FG000|Overall Study|Adverse Event|7|||
25163947|NCT01774903|50287467|FG000|Overall Study|Withdrawal by Subject|2|||
25163948|NCT01774903|50287467|FG000|Overall Study|Lack of Efficacy|1|||
25163949|NCT01774903|50287467|FG000|Overall Study|Ineligible to continue the trial|1|||
25163950|NCT01774591|50287474|FG000|Overall Study|Physician Decision|1|||
25163951|NCT01774591|50287475|FG001|Overall Study|Physician Decision|1|||
25163952|NCT01774591|50287474|FG000|Overall Study|Withdrawal by Subject|0|||
25163953|NCT01774591|50287475|FG001|Overall Study|Withdrawal by Subject|1|||
25163954|NCT01774591|50287474|FG000|Overall Study|Adverse Event|0|||
25163955|NCT01774591|50287475|FG001|Overall Study|Adverse Event|2|||
25163956|NCT01708915|50287485|FG000|Overall Study|Adverse Event|1|||
25067053|NCT02435914|50172632|FG003|Overall Study|Ocular Adverse Event|0|||
25067054|NCT02435914|50172629|FG000|Overall Study|Withdrawal by Subject|0|||
25067055|NCT02435914|50172630|FG001|Overall Study|Withdrawal by Subject|1|||
25067056|NCT02435914|50172631|FG002|Overall Study|Withdrawal by Subject|0|||
25067057|NCT02435914|50172632|FG003|Overall Study|Withdrawal by Subject|0|||
25067058|NCT02435914|50172629|FG000|Overall Study|Other Miscellaneous Reason|0|||
25067059|NCT02435914|50172630|FG001|Overall Study|Other Miscellaneous Reason|0|||
25067060|NCT02435914|50172631|FG002|Overall Study|Other Miscellaneous Reason|1|||
25067061|NCT02435914|50172632|FG003|Overall Study|Other Miscellaneous Reason|0|||
25067062|NCT02786953|50172644|FG000|Overall Study|Withdrawal by Subject|3|||
25067063|NCT02786953|50172645|FG001|Overall Study|Withdrawal by Subject|0|||
25067064|NCT02786953|50172644|FG000|Overall Study|Physician Decision|0|||
25067065|NCT02786953|50172645|FG001|Overall Study|Physician Decision|1|||
25067066|NCT02435836|50172651|FG000|Overall Study|Lost to Follow-up|21|||
25067067|NCT02435836|50172651|FG000|Overall Study|Lack of Efficacy|1|||
25067068|NCT02435836|50172651|FG000|Overall Study|Withdrawal by Subject|236|||
25067069|NCT02435836|50172651|FG000|Overall Study|Insufficient Clinical Response|26|||
25067070|NCT02435836|50172651|FG000|Overall Study|Adverse Event|44|||
25067071|NCT02435836|50172651|FG000|Overall Study|Sponsor discontinued trial|167|||
25067072|NCT02435836|50172651|FG000|Overall Study|Noncompliance|27|||
25067073|NCT02435836|50172651|FG000|Overall Study|Protocol Violation|6|||
25067074|NCT02435836|50172651|FG000|Overall Study|Met Withdrawal Criteria|7|||
25067075|NCT02435836|50172651|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
25067076|NCT02788201|50172661|FG000|Overall Study|Death|1|||
24964315|NCT00006604|50054264|FG015|Overall Study|Death|0|||
25067077|NCT02788201|50172662|FG001|Overall Study|Death|1|||
25067078|NCT02788201|50172663|FG002|Overall Study|Death|1|||
25067079|NCT02788201|50172664|FG003|Overall Study|Death|1|||
25067080|NCT02788201|50172665|FG004|Overall Study|Death|0|||
25067081|NCT02788201|50172666|FG005|Overall Study|Death|1|||
25163957|NCT01708915|50287486|FG001|Overall Study|Adverse Event|0|||
25067082|NCT02788201|50172661|FG000|Overall Study|Ineligible|0|||
25067083|NCT02788201|50172662|FG001|Overall Study|Ineligible|0|||
25163958|NCT01708915|50287487|FG002|Overall Study|Adverse Event|9|||
25163959|NCT01708915|50287488|FG003|Overall Study|Adverse Event|13|||
25067084|NCT02788201|50172663|FG002|Overall Study|Ineligible|0|||
25067085|NCT02788201|50172664|FG003|Overall Study|Ineligible|0|||
25163960|NCT01708915|50287485|FG000|Overall Study|Lack of Efficacy|84|||
25163961|NCT01708915|50287486|FG001|Overall Study|Lack of Efficacy|60|||
25163962|NCT01708915|50287487|FG002|Overall Study|Lack of Efficacy|35|||
25163963|NCT01708915|50287488|FG003|Overall Study|Lack of Efficacy|15|||
25163964|NCT01708915|50287485|FG000|Overall Study|Protocol Violation|0|||
25163965|NCT01708915|50287486|FG001|Overall Study|Protocol Violation|0|||
25163966|NCT01708915|50287487|FG002|Overall Study|Protocol Violation|0|||
25163967|NCT01708915|50287488|FG003|Overall Study|Protocol Violation|1|||
25163968|NCT01708915|50287485|FG000|Overall Study|Withdrawal by Subject|0|||
25163969|NCT01708915|50287486|FG001|Overall Study|Withdrawal by Subject|1|||
25163970|NCT01708915|50287487|FG002|Overall Study|Withdrawal by Subject|2|||
25163971|NCT01708915|50287488|FG003|Overall Study|Withdrawal by Subject|2|||
25163972|NCT01708915|50287485|FG000|Overall Study|Other reasons than stated above|1|||
25163973|NCT01708915|50287486|FG001|Overall Study|Other reasons than stated above|1|||
25163974|NCT01708915|50287487|FG002|Overall Study|Other reasons than stated above|0|||
25163975|NCT01708915|50287488|FG003|Overall Study|Other reasons than stated above|2|||
25163976|NCT01708291|50287500|FG000|Overall Study|fighting|2|||
25163977|NCT01708291|50287501|FG001|Overall Study|fighting|1|||
25163978|NCT01708057|50287507|FG000|Overall Study|Withdrawal due to study termination.|1|||
25163979|NCT01708057|50287508|FG001|Overall Study|Withdrawal due to study termination.|1|||
25163980|NCT01708057|50287509|FG002|Overall Study|Withdrawal due to study termination.|1|||
25163981|NCT01748071|50287526|FG000|Overall Study|Adverse Event|2|||
25163982|NCT01748071|50287527|FG001|Overall Study|Adverse Event|2|||
25163983|NCT01748071|50287528|FG002|Overall Study|Adverse Event|0|||
25163984|NCT01972529|50287540|FG000|Overall Study|Adverse Event|0|||
25163985|NCT01972529|50287541|FG001|Overall Study|Adverse Event|1|||
25163986|NCT01972529|50287542|FG002|Overall Study|Adverse Event|0|||
25163987|NCT01972529|50287543|FG003|Overall Study|Adverse Event|0|||
25163988|NCT01972529|50287540|FG000|Overall Study|Lost to Follow-up|1|||
25163989|NCT01972529|50287541|FG001|Overall Study|Lost to Follow-up|0|||
25163990|NCT01972529|50287542|FG002|Overall Study|Lost to Follow-up|0|||
25163991|NCT01972529|50287543|FG003|Overall Study|Lost to Follow-up|0|||
25163992|NCT01972529|50287540|FG000|Overall Study|Participant Choice|0|||
25163993|NCT01972529|50287541|FG001|Overall Study|Participant Choice|1|||
25163994|NCT01972529|50287542|FG002|Overall Study|Participant Choice|0|||
25163995|NCT01972529|50287543|FG003|Overall Study|Participant Choice|0|||
25163996|NCT01972529|50287540|FG000|Overall Study|Withdrawl of Consent|1|||
25163997|NCT01972529|50287541|FG001|Overall Study|Withdrawl of Consent|2|||
25163998|NCT01972529|50287542|FG002|Overall Study|Withdrawl of Consent|0|||
25163999|NCT01972529|50287543|FG003|Overall Study|Withdrawl of Consent|1|||
25164000|NCT01972529|50287540|FG000|Overall Study|Other|0|||
25164001|NCT01972529|50287541|FG001|Overall Study|Other|0|||
25164002|NCT01972529|50287542|FG002|Overall Study|Other|0|||
25164003|NCT01972529|50287543|FG003|Overall Study|Other|2|||
25164004|NCT01972529|50287540|FG000|Overall Study|Not treated|0|||
25164005|NCT01972529|50287541|FG001|Overall Study|Not treated|1|||
25164006|NCT01972529|50287542|FG002|Overall Study|Not treated|2|||
25164007|NCT01972529|50287543|FG003|Overall Study|Not treated|1|||
25164008|NCT01747915|50287557|FG000|Overall Study|Other|1|||
25164009|NCT01747915|50287558|FG001|Overall Study|Other|1|||
25164010|NCT01747915|50287559|FG002|Overall Study|Other|1|||
25164011|NCT01747915|50287557|FG000|Overall Study|Adverse Event|8|||
25164012|NCT01747915|50287558|FG001|Overall Study|Adverse Event|5|||
25164013|NCT01747915|50287559|FG002|Overall Study|Adverse Event|2|||
25164014|NCT01747915|50287557|FG000|Overall Study|Death|0|||
25164015|NCT01747915|50287558|FG001|Overall Study|Death|0|||
25164016|NCT01747915|50287559|FG002|Overall Study|Death|1|||
25164017|NCT01747915|50287557|FG000|Overall Study|Lack of Efficacy|0|||
25164018|NCT01747915|50287558|FG001|Overall Study|Lack of Efficacy|1|||
25164019|NCT01747915|50287559|FG002|Overall Study|Lack of Efficacy|0|||
25164020|NCT01747915|50287557|FG000|Overall Study|Lost to Follow-up|1|||
25164021|NCT01747915|50287558|FG001|Overall Study|Lost to Follow-up|0|||
25164022|NCT01747915|50287559|FG002|Overall Study|Lost to Follow-up|0|||
25164023|NCT01747915|50287557|FG000|Overall Study|Withdrawal by Subject|4|||
25164024|NCT01747915|50287558|FG001|Overall Study|Withdrawal by Subject|4|||
25164025|NCT01747915|50287559|FG002|Overall Study|Withdrawal by Subject|1|||
25164026|NCT01747915|50287557|FG000|Overall Study|Protocol Violation|1|||
25164027|NCT01747915|50287558|FG001|Overall Study|Protocol Violation|0|||
25164028|NCT01747915|50287559|FG002|Overall Study|Protocol Violation|0|||
25164029|NCT01747915|50287557|FG000|Overall Study|Pregnancy|0|||
25164030|NCT01747915|50287558|FG001|Overall Study|Pregnancy|0|||
25164031|NCT01747915|50287559|FG002|Overall Study|Pregnancy|1|||
25164032|NCT01961297|50287569|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
25164033|NCT01961297|50287570|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
25164034|NCT01960907|50287578|FG000|Overall Study|Death|4|||
25164035|NCT01960907|50287579|FG001|Overall Study|Death|3|||
25164036|NCT01960907|50287578|FG000|Overall Study|Withdrawal by Subject|32|||
25164037|NCT01960907|50287579|FG001|Overall Study|Withdrawal by Subject|42|||
25164038|NCT01747837|50287590|FG000|Overall Study|Lost to Follow-up|5|||
25164039|NCT01747837|50287591|FG001|Overall Study|Lost to Follow-up|2|||
25164040|NCT01747837|50287590|FG000|Overall Study|Death|4|||
25164041|NCT01747837|50287591|FG001|Overall Study|Death|4|||
25164042|NCT01971203|50287599|FG000|Overall Study|Protocol Violation|3|||
25164043|NCT01971203|50287600|FG001|Overall Study|Protocol Violation|2|||
25164044|NCT01971203|50287599|FG000|Overall Study|Withdrawal by Subject|5|||
25164045|NCT01971203|50287600|FG001|Overall Study|Withdrawal by Subject|6|||
25164046|NCT01971203|50287599|FG000|Overall Study|Adverse Event|1|||
25164047|NCT01971203|50287600|FG001|Overall Study|Adverse Event|0|||
25164048|NCT01605877|50287606|FG000|Overall Study|Withdrawal by Subject|1|||
25164049|NCT01970501|50287630|FG000|Overall Study|Discontinuation of study by sponsor|16|||
25164050|NCT01970501|50287631|FG001|Overall Study|Discontinuation of study by sponsor|14|||
25164051|NCT01970501|50287630|FG000|Overall Study|Withdrawal by Subject|6|||
25164052|NCT01970501|50287631|FG001|Overall Study|Withdrawal by Subject|7|||
25164053|NCT01970501|50287630|FG000|Overall Study|Adverse Event|2|||
25164054|NCT01970501|50287631|FG001|Overall Study|Adverse Event|4|||
25164055|NCT01970501|50287630|FG000|Overall Study|Death|1|||
25164056|NCT01970501|50287631|FG001|Overall Study|Death|3|||
25164057|NCT01970501|50287630|FG000|Overall Study|Physician Decision|2|||
25164058|NCT01970501|50287631|FG001|Overall Study|Physician Decision|0|||
25164059|NCT01969799|50287639|FG000|Overall Study|Adverse Event|0|||
25164060|NCT01969799|50287640|FG001|Overall Study|Adverse Event|1|||
25164061|NCT01969799|50287639|FG000|Overall Study|Death|16|||
25164062|NCT01969799|50287640|FG001|Overall Study|Death|11|||
25164063|NCT01969799|50287639|FG000|Overall Study|Lost to Follow-up|0|||
25164064|NCT01969799|50287640|FG001|Overall Study|Lost to Follow-up|2|||
25164065|NCT01969799|50287639|FG000|Overall Study|Physician Decision|1|||
25164066|NCT01969799|50287640|FG001|Overall Study|Physician Decision|0|||
25164067|NCT01969721|50287646|FG000|Overall Study|Adverse Event|3|||
25164068|NCT01969721|50287647|FG001|Overall Study|Adverse Event|8|||
25164069|NCT01969721|50287648|FG002|Overall Study|Adverse Event|3|||
25164070|NCT01969721|50287649|FG003|Overall Study|Adverse Event|2|||
25164071|NCT01969721|50287646|FG000|Overall Study|Lack of Efficacy|0|||
25164072|NCT01969721|50287647|FG001|Overall Study|Lack of Efficacy|0|||
25164073|NCT01969721|50287648|FG002|Overall Study|Lack of Efficacy|1|||
25164074|NCT01969721|50287649|FG003|Overall Study|Lack of Efficacy|0|||
25164075|NCT01969721|50287646|FG000|Overall Study|Non compliant with protocol|1|||
25164076|NCT01969721|50287647|FG001|Overall Study|Non compliant with protocol|1|||
25164077|NCT01969721|50287648|FG002|Overall Study|Non compliant with protocol|0|||
25164078|NCT01969721|50287649|FG003|Overall Study|Non compliant with protocol|2|||
25164079|NCT01969721|50287646|FG000|Overall Study|Other not defined above|0|||
25164080|NCT01969721|50287647|FG001|Overall Study|Other not defined above|2|||
25164081|NCT01969721|50287648|FG002|Overall Study|Other not defined above|0|||
25164082|NCT01969721|50287649|FG003|Overall Study|Other not defined above|0|||
25164083|NCT01969721|50287646|FG000|Overall Study|Discontinued during washout periods.|0|||
25164084|NCT01969721|50287647|FG001|Overall Study|Discontinued during washout periods.|1|||
25164085|NCT01969721|50287648|FG002|Overall Study|Discontinued during washout periods.|1|||
24964316|NCT00006604|50054265|FG016|Overall Study|Death|0|||
24964317|NCT00006604|50054249|FG000|Overall Study|Severe debilitation, unable to continue|0|||
24964318|NCT00006604|50054250|FG001|Overall Study|Severe debilitation, unable to continue|0|||
24964319|NCT00006604|50054251|FG002|Overall Study|Severe debilitation, unable to continue|0|||
24964320|NCT00006604|50054252|FG003|Overall Study|Severe debilitation, unable to continue|0|||
24964321|NCT00006604|50054253|FG004|Overall Study|Severe debilitation, unable to continue|0|||
24964322|NCT00006604|50054254|FG005|Overall Study|Severe debilitation, unable to continue|0|||
24964323|NCT00006604|50054255|FG006|Overall Study|Severe debilitation, unable to continue|3|||
25164086|NCT01969721|50287649|FG003|Overall Study|Discontinued during washout periods.|2|||
25164087|NCT01969565|50287659|FG000|Overall Study|Withdrawal by Subject|1|||
25164088|NCT01968707|50287672|FG000|Overall Study|Did not meet treatment day baseline|49|||
25164089|NCT01968707|50287673|FG001|Overall Study|Did not meet treatment day baseline|12|||
25164090|NCT01968707|50287674|FG002|Overall Study|Did not meet treatment day baseline|41|||
24964324|NCT00006604|50054256|FG007|Overall Study|Severe debilitation, unable to continue|0|||
24964325|NCT00006604|50054257|FG008|Overall Study|Severe debilitation, unable to continue|0|||
24964326|NCT00006604|50054258|FG009|Overall Study|Severe debilitation, unable to continue|5|||
24964327|NCT00006604|50054259|FG010|Overall Study|Severe debilitation, unable to continue|0|||
24964328|NCT00006604|50054260|FG011|Overall Study|Severe debilitation, unable to continue|2|||
24964329|NCT00006604|50054261|FG012|Overall Study|Severe debilitation, unable to continue|1|||
24964330|NCT00006604|50054262|FG013|Overall Study|Severe debilitation, unable to continue|0|||
24964331|NCT00006604|50054263|FG014|Overall Study|Severe debilitation, unable to continue|2|||
24964332|NCT00006604|50054264|FG015|Overall Study|Severe debilitation, unable to continue|0|||
24964333|NCT00006604|50054265|FG016|Overall Study|Severe debilitation, unable to continue|0|||
24964334|NCT00006604|50054249|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
24964335|NCT00006604|50054250|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
24964336|NCT00006604|50054251|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
24964337|NCT00006604|50054252|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
24964338|NCT00006604|50054253|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
24964339|NCT00006604|50054254|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
24964340|NCT00006604|50054255|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
24964341|NCT00006604|50054256|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
24964342|NCT00006604|50054257|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
24964343|NCT00006604|50054258|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
24964344|NCT00006604|50054259|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
24964345|NCT00006604|50054260|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
24964346|NCT00006604|50054261|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
24964347|NCT00006604|50054262|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
24964348|NCT00006604|50054263|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
25164091|NCT01968707|50287675|FG003|Overall Study|Did not meet treatment day baseline|44|||
25164092|NCT01968707|50287676|FG004|Overall Study|Did not meet treatment day baseline|36|||
25164093|NCT01968707|50287677|FG005|Overall Study|Did not meet treatment day baseline|11|||
25164094|NCT01968707|50287678|FG006|Overall Study|Did not meet treatment day baseline|34|||
25164095|NCT01968707|50287679|FG007|Overall Study|Did not meet treatment day baseline|35|||
25164096|NCT01959581|50287712|FG000|Overall Study|Lost to Follow-up|5|||
25164097|NCT01746901|50287716|FG000|Naloxone Challenge Phase|Adverse Event|2|||
25164098|NCT01746901|50287717|FG001|Naloxone Challenge Phase|Adverse Event|0|||
25164099|NCT01746901|50287718|FG002|Naloxone Challenge Phase|Adverse Event|0|||
25164100|NCT01746901|50287719|FG003|Naloxone Challenge Phase|Adverse Event|0|||
25164101|NCT01746901|50287720|FG004|Naloxone Challenge Phase|Adverse Event|0|||
25164102|NCT01746901|50287721|FG005|Naloxone Challenge Phase|Adverse Event|0|||
25164103|NCT01746901|50287722|FG006|Naloxone Challenge Phase|Adverse Event|0|||
25164104|NCT01746901|50287723|FG007|Naloxone Challenge Phase|Adverse Event|0|||
25164105|NCT01746901|50287724|FG008|Naloxone Challenge Phase|Adverse Event|0|||
25164106|NCT01746901|50287716|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
25164107|NCT01746901|50287717|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
25164108|NCT01746901|50287718|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
25164109|NCT01746901|50287719|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
25164110|NCT01746901|50287720|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
25164111|NCT01746901|50287721|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
25164112|NCT01746901|50287722|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
25164113|NCT01746901|50287723|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
25164114|NCT01746901|50287724|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
25164115|NCT01746901|50287716|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
25164116|NCT01746901|50287717|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
25164117|NCT01746901|50287718|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
25164118|NCT01746901|50287719|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
25164119|NCT01746901|50287720|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
25164120|NCT01746901|50287721|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
25164121|NCT01746901|50287722|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
25164122|NCT01746901|50287723|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
25164123|NCT01746901|50287724|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
25164124|NCT01746901|50287716|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
25164125|NCT01746901|50287717|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
25164126|NCT01746901|50287718|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
25164127|NCT01746901|50287719|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
25164128|NCT01746901|50287720|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
25164129|NCT01746901|50287721|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
25164130|NCT01746901|50287722|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
25164131|NCT01746901|50287723|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
25164132|NCT01746901|50287724|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
25164133|NCT01746901|50287716|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
25276762|NCT01054599|50590705|FG001|Overall Study|Withdrawal by Subject|1|||
25276763|NCT00948766|50590713|FG000|Core Study|Adverse Event|73|||
25164134|NCT01746901|50287717|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
25164135|NCT01746901|50287718|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
25164136|NCT01746901|50287719|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
25164137|NCT01746901|50287720|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
25164138|NCT01746901|50287721|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
25164139|NCT01746901|50287722|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
25164140|NCT01746901|50287723|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
25164141|NCT01746901|50287724|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
25164142|NCT01746901|50287716|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
25164143|NCT01746901|50287717|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
25164144|NCT01746901|50287718|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
25164145|NCT01746901|50287719|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
25164146|NCT01746901|50287720|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
25164147|NCT01746901|50287721|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
25164148|NCT01746901|50287722|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
25164149|NCT01746901|50287723|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
25164150|NCT01746901|50287724|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
25164151|NCT01746901|50287716|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
25164152|NCT01746901|50287717|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
25164153|NCT01746901|50287718|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
25164154|NCT01746901|50287719|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
25164155|NCT01746901|50287720|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
25164156|NCT01746901|50287721|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
25164157|NCT01746901|50287722|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
25164158|NCT01746901|50287723|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
25164159|NCT01746901|50287724|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
25164160|NCT01746901|50287716|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
25164161|NCT01746901|50287717|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
25164162|NCT01746901|50287718|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
25164163|NCT01746901|50287719|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
25164164|NCT01746901|50287720|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
25164165|NCT01746901|50287721|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
25164166|NCT01746901|50287722|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
25164167|NCT01746901|50287723|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
25164168|NCT01746901|50287724|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
25164169|NCT01746901|50287716|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
25164170|NCT01746901|50287717|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
25164171|NCT01746901|50287718|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
25164172|NCT01746901|50287719|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
25164173|NCT01746901|50287720|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
25164174|NCT01746901|50287721|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
25164175|NCT01746901|50287722|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
25164176|NCT01746901|50287723|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
25164177|NCT01746901|50287724|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
25164178|NCT01746901|50287716|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
25164179|NCT01746901|50287717|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
25164180|NCT01746901|50287718|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
25164181|NCT01746901|50287719|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
25164182|NCT01746901|50287720|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
25164183|NCT01746901|50287721|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
25164184|NCT01746901|50287722|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
25164185|NCT01746901|50287723|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
25164186|NCT01746901|50287724|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
25164187|NCT01746901|50287716|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
25164188|NCT01746901|50287717|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
25164189|NCT01746901|50287718|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
25164190|NCT01746901|50287719|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
25164191|NCT01746901|50287720|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
25164192|NCT01746901|50287721|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
25164193|NCT01746901|50287722|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
25164194|NCT01746901|50287723|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
25164195|NCT01746901|50287724|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
25164196|NCT01746901|50287716|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
25164197|NCT01746901|50287717|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
25164198|NCT01746901|50287718|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
25164199|NCT01746901|50287719|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
25164200|NCT01746901|50287720|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
25164201|NCT01746901|50287721|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
25164202|NCT01746901|50287722|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
25067086|NCT02788201|50172665|FG004|Overall Study|Ineligible|0|||
25067087|NCT02788201|50172666|FG005|Overall Study|Ineligible|1|||
25067088|NCT02788201|50172661|FG000|Overall Study|Withdrawal by Subject|0|||
25067089|NCT02788201|50172662|FG001|Overall Study|Withdrawal by Subject|0|||
25067090|NCT02788201|50172663|FG002|Overall Study|Withdrawal by Subject|0|||
25067091|NCT02788201|50172664|FG003|Overall Study|Withdrawal by Subject|0|||
25067092|NCT02788201|50172665|FG004|Overall Study|Withdrawal by Subject|0|||
25067093|NCT02788201|50172666|FG005|Overall Study|Withdrawal by Subject|1|||
25067094|NCT02456740|50172685|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
25067095|NCT02456740|50172686|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
25067096|NCT02456740|50172687|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
25067097|NCT02456740|50172688|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
25067098|NCT02456740|50172689|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
25067099|NCT02456740|50172690|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
25067100|NCT02456740|50172691|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
25067101|NCT02456740|50172692|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
25164203|NCT01746901|50287723|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
25164204|NCT01746901|50287724|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
25164205|NCT01968551|50287763|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
25164206|NCT01968551|50287764|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
25164207|NCT01968551|50287765|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
25164208|NCT01968551|50287763|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
25164209|NCT01968551|50287764|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
25164210|NCT01968551|50287765|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
24964349|NCT00006604|50054264|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
24964350|NCT00006604|50054265|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
24964351|NCT00006604|50054249|FG000|Overall Study|Site closing|0|||
24964352|NCT00006604|50054250|FG001|Overall Study|Site closing|0|||
24964353|NCT00006604|50054251|FG002|Overall Study|Site closing|1|||
24964354|NCT00006604|50054252|FG003|Overall Study|Site closing|1|||
24964355|NCT00006604|50054253|FG004|Overall Study|Site closing|0|||
24964356|NCT00006604|50054254|FG005|Overall Study|Site closing|0|||
24964357|NCT00006604|50054255|FG006|Overall Study|Site closing|0|||
24964358|NCT00006604|50054256|FG007|Overall Study|Site closing|1|||
24964359|NCT00006604|50054257|FG008|Overall Study|Site closing|0|||
24964360|NCT00006604|50054258|FG009|Overall Study|Site closing|0|||
24964361|NCT00006604|50054259|FG010|Overall Study|Site closing|0|||
24964362|NCT00006604|50054260|FG011|Overall Study|Site closing|1|||
24964363|NCT00006604|50054261|FG012|Overall Study|Site closing|1|||
24964364|NCT00006604|50054262|FG013|Overall Study|Site closing|1|||
24964365|NCT00006604|50054263|FG014|Overall Study|Site closing|0|||
24964366|NCT00006604|50054264|FG015|Overall Study|Site closing|0|||
24964367|NCT00006604|50054265|FG016|Overall Study|Site closing|1|||
24964368|NCT00006604|50054249|FG000|Overall Study|Withdrawal by Subject|1|||
24964369|NCT00006604|50054250|FG001|Overall Study|Withdrawal by Subject|0|||
24964370|NCT00006604|50054251|FG002|Overall Study|Withdrawal by Subject|2|||
25164211|NCT01968551|50287763|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
25164212|NCT01968551|50287764|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
25164213|NCT01968551|50287765|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
25164214|NCT01968551|50287763|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
25164215|NCT01968551|50287764|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
25164216|NCT01968551|50287765|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
25164217|NCT01968551|50287763|FG000|Extension Phase|Adverse Event|0|||
25164218|NCT01968551|50287764|FG001|Extension Phase|Adverse Event|0|||
25164219|NCT01968551|50287765|FG002|Extension Phase|Adverse Event|2|||
25164220|NCT01968551|50287763|FG000|Extension Phase|Death|0|||
25164221|NCT01968551|50287764|FG001|Extension Phase|Death|1|||
25164222|NCT01968551|50287765|FG002|Extension Phase|Death|0|||
25164223|NCT01968551|50287763|FG000|Extension Phase|Withdrew Consent|0|||
25164224|NCT01968551|50287764|FG001|Extension Phase|Withdrew Consent|0|||
25164225|NCT01968551|50287765|FG002|Extension Phase|Withdrew Consent|1|||
25164226|NCT01968551|50287763|FG000|Extension Phase|Lost to Follow-up|1|||
25164227|NCT01968551|50287764|FG001|Extension Phase|Lost to Follow-up|0|||
24964371|NCT00006604|50054252|FG003|Overall Study|Withdrawal by Subject|0|||
25164228|NCT01968551|50287765|FG002|Extension Phase|Lost to Follow-up|1|||
25164229|NCT01707992|50287780|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
25164230|NCT01707992|50287781|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
24964372|NCT00006604|50054253|FG004|Overall Study|Withdrawal by Subject|1|||
24964373|NCT00006604|50054254|FG005|Overall Study|Withdrawal by Subject|2|||
24964374|NCT00006604|50054255|FG006|Overall Study|Withdrawal by Subject|2|||
24964375|NCT00006604|50054256|FG007|Overall Study|Withdrawal by Subject|0|||
24964376|NCT00006604|50054257|FG008|Overall Study|Withdrawal by Subject|1|||
25164231|NCT01707992|50287782|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
25164232|NCT01707992|50287783|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
25164233|NCT01707992|50287784|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
25164234|NCT01707992|50287785|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
25164235|NCT01707992|50287780|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
25164236|NCT01707992|50287781|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
25164237|NCT01707992|50287782|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
25164238|NCT01707992|50287783|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
25164239|NCT01707992|50287784|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
25164240|NCT01707992|50287785|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
25164241|NCT01707992|50287780|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
25164242|NCT01707992|50287781|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
25164243|NCT01707992|50287782|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
25164244|NCT01707992|50287783|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
25164245|NCT01707992|50287784|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
25164246|NCT01707992|50287785|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
25164247|NCT01707992|50287780|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
25164248|NCT01707992|50287781|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
25164249|NCT01707992|50287782|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
25164250|NCT01707992|50287783|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
25164251|NCT01707992|50287784|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
25164252|NCT01707992|50287785|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
25164253|NCT01707992|50287780|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
25164254|NCT01707992|50287781|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
25164255|NCT01707992|50287782|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
25164256|NCT01707992|50287783|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
25164257|NCT01707992|50287784|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
25164258|NCT01707992|50287785|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
25164259|NCT01707992|50287780|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
25164260|NCT01707992|50287781|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
25164261|NCT01707992|50287782|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
25164262|NCT01707992|50287783|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
25164263|NCT01707992|50287784|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
25164264|NCT01707992|50287785|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
25164265|NCT01707992|50287780|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
25164266|NCT01707992|50287781|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
25164267|NCT01707992|50287782|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
25164268|NCT01707992|50287783|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
25164269|NCT01707992|50287784|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
25164270|NCT01707992|50287785|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
25164271|NCT01707992|50287780|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
25164272|NCT01707992|50287781|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
25164273|NCT01707992|50287782|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
25164274|NCT01707992|50287783|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
25164275|NCT01707992|50287784|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
25164276|NCT01707992|50287785|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
25164277|NCT01707992|50287780|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
25164278|NCT01707992|50287781|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
25164279|NCT01707992|50287782|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
25164280|NCT01707992|50287783|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
25164281|NCT01707992|50287784|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
25164282|NCT01707992|50287785|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
25164283|NCT01707992|50287780|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
25164284|NCT01707992|50287781|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
25164285|NCT01707992|50287782|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
25164286|NCT01707992|50287783|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
25164287|NCT01707992|50287784|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
25164288|NCT01707992|50287785|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
25164289|NCT01707992|50287780|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
25164290|NCT01707992|50287781|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
25164291|NCT01707992|50287782|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
25164292|NCT01707992|50287783|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
25164293|NCT01707992|50287784|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
25164294|NCT01707992|50287785|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
25164295|NCT01707992|50287780|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
25164296|NCT01707992|50287781|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
25164297|NCT01707992|50287782|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
25164298|NCT01707992|50287783|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
25164299|NCT01707992|50287784|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
25164300|NCT01707992|50287785|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
25164301|NCT01707992|50287780|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
25164302|NCT01707992|50287781|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
24964377|NCT00006604|50054258|FG009|Overall Study|Withdrawal by Subject|3|||
24964378|NCT00006604|50054259|FG010|Overall Study|Withdrawal by Subject|2|||
24964379|NCT00006604|50054260|FG011|Overall Study|Withdrawal by Subject|0|||
24964380|NCT00006604|50054261|FG012|Overall Study|Withdrawal by Subject|1|||
24964381|NCT00006604|50054262|FG013|Overall Study|Withdrawal by Subject|2|||
24964382|NCT00006604|50054263|FG014|Overall Study|Withdrawal by Subject|1|||
24964383|NCT00006604|50054264|FG015|Overall Study|Withdrawal by Subject|0|||
24964384|NCT00006604|50054265|FG016|Overall Study|Withdrawal by Subject|1|||
24964385|NCT00006604|50054249|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
24964386|NCT00006604|50054250|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
24964387|NCT00006604|50054251|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
24964388|NCT00006604|50054252|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
24964389|NCT00006604|50054253|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
24964390|NCT00006604|50054254|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
24964391|NCT00006604|50054255|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
24964392|NCT00006604|50054256|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
25067102|NCT02456740|50172693|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
25067103|NCT02456740|50172685|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
25067104|NCT02456740|50172686|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
25067105|NCT02456740|50172687|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
25067106|NCT02456740|50172688|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
25067107|NCT02456740|50172689|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
25067108|NCT02456740|50172690|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
25067109|NCT02456740|50172691|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
25067110|NCT02456740|50172692|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
25067111|NCT02456740|50172693|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
25067112|NCT02456740|50172685|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
25067113|NCT02456740|50172686|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
25067114|NCT02456740|50172687|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
25067115|NCT02456740|50172688|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
25067116|NCT02456740|50172689|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
25067117|NCT02456740|50172690|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
25067118|NCT02456740|50172691|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
25067119|NCT02456740|50172692|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
25067120|NCT02456740|50172693|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
25067121|NCT02456740|50172685|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
25067122|NCT02456740|50172686|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
25067123|NCT02456740|50172687|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
25067124|NCT02456740|50172688|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
25067125|NCT02456740|50172689|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
25067126|NCT02456740|50172690|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
25067127|NCT02456740|50172691|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
25067128|NCT02456740|50172692|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
24964393|NCT00006604|50054257|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
24964394|NCT00006604|50054258|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
25164303|NCT01707992|50287782|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
25164304|NCT01707992|50287783|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
25164305|NCT01707992|50287784|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
25164306|NCT01707992|50287785|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
25164307|NCT01707992|50287780|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
25164308|NCT01707992|50287781|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
25164309|NCT01707992|50287782|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
25164310|NCT01707992|50287783|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
25164311|NCT01707992|50287784|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
25164312|NCT01707992|50287785|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
25164313|NCT01707992|50287780|FG000|Active Treatment Phase (24 Months)|Death|0|||
25164314|NCT01707992|50287781|FG001|Active Treatment Phase (24 Months)|Death|0|||
25164315|NCT01707992|50287782|FG002|Active Treatment Phase (24 Months)|Death|0|||
25164316|NCT01707992|50287783|FG003|Active Treatment Phase (24 Months)|Death|2|||
25164317|NCT01707992|50287784|FG004|Active Treatment Phase (24 Months)|Death|0|||
25164318|NCT01707992|50287785|FG005|Active Treatment Phase (24 Months)|Death|0|||
25164319|NCT01707992|50287780|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
25164320|NCT01707992|50287781|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
25164321|NCT01707992|50287782|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
25164322|NCT01707992|50287783|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
25164323|NCT01707992|50287784|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
25164324|NCT01707992|50287785|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
25164325|NCT01707992|50287780|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
25164326|NCT01707992|50287781|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
25164327|NCT01707992|50287782|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
25164328|NCT01707992|50287783|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
25164329|NCT01707992|50287784|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
25164330|NCT01707992|50287785|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
25164331|NCT01707992|50287780|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
25164332|NCT01707992|50287781|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
25164333|NCT01707992|50287782|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
25164334|NCT01707992|50287783|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
25164335|NCT01707992|50287784|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
25164336|NCT01707992|50287785|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
25164337|NCT01707992|50287780|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
25164338|NCT01707992|50287781|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
25164339|NCT01707992|50287782|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
25164340|NCT01707992|50287783|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
25164341|NCT01707992|50287784|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
25164342|NCT01707992|50287785|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
25164343|NCT01946165|50287802|FG000|Overall Study|Physician Decision|2|||
25164344|NCT01946165|50287803|FG001|Overall Study|Physician Decision|0|||
25164345|NCT01946165|50287802|FG000|Overall Study|Withdrawal by Subject|0|||
25164346|NCT01946165|50287803|FG001|Overall Study|Withdrawal by Subject|2|||
25164347|NCT01707667|50287812|FG000|Period 1|expulsion of colonic sensor catheter|1|||
25164348|NCT01707667|50287813|FG001|Period 1|expulsion of colonic sensor catheter|0|||
25164349|NCT01959503|50287821|FG000|Overall Study|Death|2|||
25164350|NCT01959503|50287822|FG001|Overall Study|Death|1|||
25164351|NCT01959503|50287821|FG000|Overall Study|Randomized but not treated|1|||
25164352|NCT01959503|50287822|FG001|Overall Study|Randomized but not treated|1|||
25164353|NCT01605799|50287830|FG000|Overall Study|Withdrawal by Subject|2|||
25164354|NCT01605799|50287831|FG001|Overall Study|Withdrawal by Subject|1|||
25164355|NCT01706575|50287837|FG000|Overall Study|Participant Withdrew Consent|4|||
25164356|NCT01706575|50287837|FG000|Overall Study|Lost to Follow-up|2|||
25164357|NCT01706575|50287837|FG000|Overall Study|Started but not Treated|6|||
25164358|NCT01959425|50287843|FG000|Overall Study|Withdrawal by Subject|5|||
25164359|NCT01959425|50287844|FG001|Overall Study|Withdrawal by Subject|4|||
25164360|NCT01959425|50287843|FG000|Overall Study|Lost to Follow-up|1|||
25164361|NCT01959425|50287844|FG001|Overall Study|Lost to Follow-up|0|||
25164362|NCT01959425|50287843|FG000|Overall Study|Discontinued Subjects|6|||
25164363|NCT01959425|50287844|FG001|Overall Study|Discontinued Subjects|4|||
25164364|NCT01725529|50287853|FG000|Overall Study|Adverse Event|1|||
25164365|NCT01725529|50287854|FG001|Overall Study|Adverse Event|0|||
25164366|NCT01725529|50287855|FG002|Overall Study|Adverse Event|0|||
25164367|NCT01725529|50287853|FG000|Overall Study|Lost to Follow-up|2|||
25164368|NCT01725529|50287854|FG001|Overall Study|Lost to Follow-up|1|||
25164369|NCT01725529|50287855|FG002|Overall Study|Lost to Follow-up|1|||
25164370|NCT01725529|50287853|FG000|Overall Study|Protocol Violation|0|||
25164371|NCT01725529|50287854|FG001|Overall Study|Protocol Violation|1|||
25164372|NCT01725529|50287855|FG002|Overall Study|Protocol Violation|1|||
25164373|NCT01725529|50287853|FG000|Overall Study|Withdrawal by Subject|12|||
25164374|NCT01725529|50287854|FG001|Overall Study|Withdrawal by Subject|14|||
25164375|NCT01725529|50287855|FG002|Overall Study|Withdrawal by Subject|8|||
25164376|NCT01605097|50287863|FG000|Overall Study|Protocol Violation|1|||
25164377|NCT01605019|50287870|FG000|Overall Study|pt did not meet transplant endpoint|3|||
25164378|NCT01605019|50287871|FG001|Overall Study|pt did not meet transplant endpoint|0|||
25164379|NCT01705717|50287879|FG000|Overall Study|Adverse Event|2|||
25164380|NCT01705717|50287880|FG001|Overall Study|Adverse Event|2|||
25164381|NCT01705717|50287879|FG000|Overall Study|Lack of Efficacy|0|||
25164382|NCT01705717|50287880|FG001|Overall Study|Lack of Efficacy|1|||
25164383|NCT01705717|50287879|FG000|Overall Study|Other|0|||
25164384|NCT01705717|50287880|FG001|Overall Study|Other|2|||
25164385|NCT01744483|50287888|FG000|Overall Study|Death|9|||
25164386|NCT01744483|50287889|FG001|Overall Study|Death|4|||
25164387|NCT01744483|50287890|FG002|Overall Study|Death|11|||
25164388|NCT01744483|50287888|FG000|Overall Study|Lost to Follow-up|8|||
25164389|NCT01744483|50287889|FG001|Overall Study|Lost to Follow-up|9|||
25164390|NCT01744483|50287890|FG002|Overall Study|Lost to Follow-up|11|||
25164391|NCT01744483|50287888|FG000|Overall Study|Protocol Violation|1|||
25164392|NCT01744483|50287889|FG001|Overall Study|Protocol Violation|2|||
25164393|NCT01744483|50287890|FG002|Overall Study|Protocol Violation|1|||
25164394|NCT01744483|50287888|FG000|Overall Study|Withdrawal by Subject|4|||
25164395|NCT01744483|50287889|FG001|Overall Study|Withdrawal by Subject|6|||
25164396|NCT01744483|50287890|FG002|Overall Study|Withdrawal by Subject|2|||
25164397|NCT01744483|50287888|FG000|Overall Study|No ICU Admit|5|||
25164398|NCT01744483|50287889|FG001|Overall Study|No ICU Admit|1|||
25164399|NCT01744483|50287890|FG002|Overall Study|No ICU Admit|2|||
25164400|NCT01744483|50287888|FG000|Overall Study|Routed to OSH|2|||
25164401|NCT01744483|50287889|FG001|Overall Study|Routed to OSH|0|||
25164402|NCT01744483|50287890|FG002|Overall Study|Routed to OSH|1|||
25164403|NCT01744093|50287900|FG000|Overall Study|Withdrawal by Subject|6|||
25164404|NCT01744093|50287901|FG001|Overall Study|Withdrawal by Subject|1|||
25164405|NCT01725451|50287915|FG000|Period 1|Withdrawal by Subject|1|||
25164406|NCT01725451|50287916|FG001|Period 1|Withdrawal by Subject|0|||
25164407|NCT01725451|50287917|FG002|Period 1|Withdrawal by Subject|0|||
25164408|NCT01725451|50287918|FG003|Period 1|Withdrawal by Subject|0|||
25164409|NCT01725451|50287915|FG000|Washout From Period 3|Protocol Violation|0|||
25164410|NCT01725451|50287916|FG001|Washout From Period 3|Protocol Violation|0|||
25164411|NCT01725451|50287917|FG002|Washout From Period 3|Protocol Violation|1|||
25164412|NCT01725451|50287918|FG003|Washout From Period 3|Protocol Violation|0|||
25164413|NCT01725451|50287915|FG000|Washout From Period 3|Adverse Event|0|||
25164414|NCT01725451|50287916|FG001|Washout From Period 3|Adverse Event|1|||
25164415|NCT01725451|50287917|FG002|Washout From Period 3|Adverse Event|0|||
25164416|NCT01725451|50287918|FG003|Washout From Period 3|Adverse Event|0|||
25164417|NCT01725451|50287915|FG000|Period 4|Adverse Event|0|||
25164418|NCT01725451|50287916|FG001|Period 4|Adverse Event|0|||
25164419|NCT01725451|50287917|FG002|Period 4|Adverse Event|1|||
25186673|NCT02641392|50337358|FG001|Overall Study|Lack of Efficacy|0|||
25186674|NCT02641392|50337359|FG002|Overall Study|Lack of Efficacy|101|||
25276764|NCT00948766|50590714|FG001|Core Study|Adverse Event|51|||
25164420|NCT01725451|50287918|FG003|Period 4|Adverse Event|0|||
24964395|NCT00006604|50054259|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
25164421|NCT01707290|50287935|FG000|Overall Study|Adverse event (AE)|1|||
25164422|NCT01707290|50287936|FG001|Overall Study|Adverse event (AE)|0|||
25164423|NCT01707290|50287935|FG000|Overall Study|Physician Decision|1|||
25164424|NCT01707290|50287936|FG001|Overall Study|Physician Decision|0|||
25186675|NCT02641392|50337357|FG000|Overall Study|Miscellaneous|0|||
25164425|NCT01707290|50287935|FG000|Overall Study|Lost to Follow-up|3|||
25164426|NCT01707290|50287936|FG001|Overall Study|Lost to Follow-up|0|||
25164427|NCT01707290|50287935|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
25186676|NCT02641392|50337358|FG001|Overall Study|Miscellaneous|0|||
25164428|NCT01707290|50287936|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
25164429|NCT01707290|50287935|FG000|Overall Study|Commercial drug available|60|||
25164430|NCT01707290|50287936|FG001|Overall Study|Commercial drug available|1|||
25164431|NCT01707290|50287935|FG000|Overall Study|Other unspecified|17|||
25164432|NCT01707290|50287936|FG001|Overall Study|Other unspecified|0|||
25164433|NCT01717040|50287947|FG000|Overall Study|Lost to Follow-up|2|||
25164434|NCT01717040|50287948|FG001|Overall Study|Lost to Follow-up|3|||
25164435|NCT01717040|50287947|FG000|Overall Study|Lack of Efficacy|1|||
25164436|NCT01717040|50287948|FG001|Overall Study|Lack of Efficacy|1|||
25164437|NCT01717040|50287947|FG000|Overall Study|Adverse Event|1|||
25164438|NCT01717040|50287948|FG001|Overall Study|Adverse Event|0|||
25164439|NCT01717040|50287947|FG000|Overall Study|Required Medication Change|0|||
25164440|NCT01717040|50287948|FG001|Overall Study|Required Medication Change|1|||
25164441|NCT01717040|50287947|FG000|Overall Study|New Substance Use Disorder|1|||
25164442|NCT01717040|50287948|FG001|Overall Study|New Substance Use Disorder|0|||
25164443|NCT01743469|50287975|FG000|Active Treatment Phase|Adverse Event|10|||
25164444|NCT01743469|50287976|FG001|Active Treatment Phase|Adverse Event|5|||
25164445|NCT01743469|50287977|FG002|Active Treatment Phase|Adverse Event|8|||
25164446|NCT01743469|50287978|FG003|Active Treatment Phase|Adverse Event|1|||
25164447|NCT01743469|50287975|FG000|Active Treatment Phase|Disease Progression|40|||
25164448|NCT01743469|50287976|FG001|Active Treatment Phase|Disease Progression|47|||
25164449|NCT01743469|50287977|FG002|Active Treatment Phase|Disease Progression|30|||
25164450|NCT01743469|50287978|FG003|Active Treatment Phase|Disease Progression|20|||
25164451|NCT01743469|50287975|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
25164452|NCT01743469|50287976|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
25164453|NCT01743469|50287977|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
25164454|NCT01743469|50287978|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
25164455|NCT01743469|50287975|FG000|Active Treatment Phase|Missing|1|||
25164456|NCT01743469|50287976|FG001|Active Treatment Phase|Missing|0|||
25164457|NCT01743469|50287977|FG002|Active Treatment Phase|Missing|0|||
25164458|NCT01743469|50287978|FG003|Active Treatment Phase|Missing|0|||
25164459|NCT01743469|50287975|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
25164460|NCT01743469|50287976|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
25164461|NCT01743469|50287977|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
25164462|NCT01743469|50287978|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
25164463|NCT01743469|50287975|FG000|Follow-up Period - Post-Treatment|Death|43|||
25164464|NCT01743469|50287976|FG001|Follow-up Period - Post-Treatment|Death|47|||
25164465|NCT01743469|50287977|FG002|Follow-up Period - Post-Treatment|Death|22|||
25164466|NCT01743469|50287978|FG003|Follow-up Period - Post-Treatment|Death|16|||
25164467|NCT01743469|50287975|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
25164468|NCT01743469|50287976|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
25164469|NCT01743469|50287977|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
25164470|NCT01743469|50287978|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
25164471|NCT01743001|50287990|FG000|Overall Study|Physician Decision|1|||
25164472|NCT01743001|50287991|FG001|Overall Study|Physician Decision|0|||
25164473|NCT01743001|50287990|FG000|Overall Study|Pregnancy|1|||
25164474|NCT01743001|50287991|FG001|Overall Study|Pregnancy|0|||
25164475|NCT01743001|50287990|FG000|Overall Study|Death|1|||
25164476|NCT01743001|50287991|FG001|Overall Study|Death|0|||
25164477|NCT01704079|50288010|FG000|Overall Study|Withdrawal by Subject|5|||
25164478|NCT01704079|50288011|FG001|Overall Study|Withdrawal by Subject|7|||
25164479|NCT01704079|50288010|FG000|Overall Study|Lost to Follow-up|2|||
25164480|NCT01704079|50288011|FG001|Overall Study|Lost to Follow-up|5|||
25164481|NCT01704079|50288010|FG000|Overall Study|Adverse Event|4|||
25164482|NCT01704079|50288011|FG001|Overall Study|Adverse Event|7|||
25164483|NCT01704079|50288010|FG000|Overall Study|Protocol Violation|1|||
25164484|NCT01704079|50288011|FG001|Overall Study|Protocol Violation|0|||
25164485|NCT01704079|50288010|FG000|Overall Study|Subject noncompliance|2|||
25164486|NCT01704079|50288011|FG001|Overall Study|Subject noncompliance|3|||
25164487|NCT01704079|50288010|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
25164488|NCT01704079|50288011|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
25164489|NCT01703845|50288019|FG000|Overall Study|Adverse Event|1|||
25164490|NCT01703845|50288020|FG001|Overall Study|Adverse Event|0|||
25164491|NCT01703845|50288019|FG000|Overall Study|Protocol Violation|1|||
25164492|NCT01703845|50288020|FG001|Overall Study|Protocol Violation|0|||
25164493|NCT01703845|50288019|FG000|Overall Study|other than stated above|1|||
25276765|NCT00948766|50590713|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
25164494|NCT01703845|50288020|FG001|Overall Study|other than stated above|0|||
25164495|NCT01724359|50288028|FG000|Overall Study|Adverse Event|10|||
25164496|NCT01724359|50288028|FG000|Overall Study|Death|1|||
25164497|NCT01724359|50288028|FG000|Overall Study|Other|20|||
25276766|NCT00948766|50590714|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
25164498|NCT01703221|50288037|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
25164499|NCT01703221|50288038|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
25164500|NCT01703221|50288039|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
25164501|NCT01703221|50288037|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
25164502|NCT01703221|50288038|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
25164503|NCT01703221|50288039|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
25164504|NCT01703221|50288037|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
25164505|NCT01703221|50288038|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
25164506|NCT01703221|50288039|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
25164507|NCT01703221|50288037|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
25164508|NCT01703221|50288038|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
25164509|NCT01703221|50288039|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
25164510|NCT01703221|50288037|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
25164511|NCT01703221|50288038|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
25164512|NCT01703221|50288039|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
25164513|NCT01703221|50288037|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
25164514|NCT01703221|50288038|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
25164515|NCT01703221|50288039|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
25164516|NCT01703221|50288037|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
25164517|NCT01703221|50288038|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
25164518|NCT01703221|50288039|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
25164519|NCT01703221|50288037|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
25164520|NCT01703221|50288038|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
25164521|NCT01703221|50288039|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
25164522|NCT01722877|50288053|FG000|Overall Study|Death|1|||
25164523|NCT01722877|50288053|FG000|Overall Study|Lost to Follow-up|1|||
25164524|NCT01703065|50288098|FG000|Overall Study|Lack of Efficacy|1|||
25164525|NCT01703065|50288099|FG001|Overall Study|Lack of Efficacy|0|||
25164526|NCT01702987|50288112|FG000|Overall Study|Withdrawal by Subject|1|||
25164527|NCT01702987|50288113|FG001|Overall Study|Withdrawal by Subject|0|||
25164528|NCT01702519|50288134|FG000|Washout Period|Lost to Follow-up|1|||
25164529|NCT01702519|50288135|FG001|Washout Period|Lost to Follow-up|0|||
25164530|NCT01702519|50288134|FG000|Washout Period|Withdrawal by Subject|0|||
25164531|NCT01702519|50288135|FG001|Washout Period|Withdrawal by Subject|2|||
25164532|NCT01739803|50288147|FG000|Overall Study|Lost to Follow-up|9|||
25164533|NCT01739803|50288148|FG001|Overall Study|Lost to Follow-up|6|||
25164534|NCT01739335|50288160|FG000|Overall Study|Lost to Follow-up|7|||
25164535|NCT01739335|50288161|FG001|Overall Study|Lost to Follow-up|4|||
25164536|NCT01739335|50288160|FG000|Overall Study|Ineligible patient randomized|0|||
25164537|NCT01739335|50288161|FG001|Overall Study|Ineligible patient randomized|1|||
25164538|NCT01702363|50288186|FG000|Overall Study|Adverse Event|14|||
25164539|NCT01702363|50288186|FG000|Overall Study|Lack of Efficacy|4|||
25164540|NCT01702363|50288186|FG000|Overall Study|Withdrawal by Subject|2|||
25164541|NCT01722097|50288193|FG000|Overall Study|Patient sheets not returned|6|||
25164542|NCT01722097|50288194|FG001|Overall Study|Patient sheets not returned|5|||
25164543|NCT01701973|50288209|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
25164544|NCT01701973|50288210|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
25164545|NCT01701973|50288211|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
25164546|NCT01701973|50288212|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
25164547|NCT01701973|50288213|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
25164548|NCT01701973|50288214|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
25164549|NCT01701973|50288215|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
25164550|NCT01701973|50288216|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
25164551|NCT01721317|50288267|FG000|Overall Study|Study Closed / Terminated|2|||
25164552|NCT01721317|50288268|FG001|Overall Study|Study Closed / Terminated|2|||
25164553|NCT01721317|50288267|FG000|Overall Study|Physician Decision|0|||
25164554|NCT01721317|50288268|FG001|Overall Study|Physician Decision|1|||
25164555|NCT01721317|50288267|FG000|Overall Study|Withdrawal by Subject|0|||
25164556|NCT01721317|50288268|FG001|Overall Study|Withdrawal by Subject|1|||
25164557|NCT01701193|50288278|FG000|Overall Study|Withdrawal by Subject|2|||
25164558|NCT01701193|50288279|FG001|Overall Study|Withdrawal by Subject|2|||
25164559|NCT01701193|50288280|FG002|Overall Study|Withdrawal by Subject|1|||
25164560|NCT01701193|50288281|FG003|Overall Study|Withdrawal by Subject|2|||
25164561|NCT01701193|50288278|FG000|Overall Study|Adverse Event|1|||
25164562|NCT01701193|50288279|FG001|Overall Study|Adverse Event|0|||
25164563|NCT01701193|50288280|FG002|Overall Study|Adverse Event|0|||
25164564|NCT01701193|50288281|FG003|Overall Study|Adverse Event|0|||
25164565|NCT01959347|50288329|FG000|Overall Study|Protocol Violation|9|||
25164566|NCT01959347|50288330|FG001|Overall Study|Protocol Violation|7|||
25164567|NCT01959035|50288356|FG000|Overall Study|Adverse Event|5|||
25164568|NCT01959035|50288356|FG000|Overall Study|Withdrawal by Subject|4|||
25164569|NCT01959035|50288356|FG000|Overall Study|Lost to Follow-up|1|||
25164570|NCT01959035|50288356|FG000|Overall Study|Other (no primary reason given)|1|||
25164571|NCT01700959|50288366|FG000|Overall Study|Adverse Event|0|||
25164572|NCT01700959|50288367|FG001|Overall Study|Adverse Event|1|||
25164573|NCT01700959|50288368|FG002|Overall Study|Adverse Event|1|||
25164574|NCT01700959|50288369|FG003|Overall Study|Adverse Event|2|||
25164575|NCT01700959|50288370|FG004|Overall Study|Adverse Event|0|||
25164576|NCT01700959|50288371|FG005|Overall Study|Adverse Event|2|||
25164577|NCT01700959|50288366|FG000|Overall Study|Withdrawal by Subject|15|||
25164578|NCT01700959|50288367|FG001|Overall Study|Withdrawal by Subject|9|||
25164579|NCT01700959|50288368|FG002|Overall Study|Withdrawal by Subject|12|||
25164580|NCT01700959|50288369|FG003|Overall Study|Withdrawal by Subject|11|||
25164581|NCT01700959|50288370|FG004|Overall Study|Withdrawal by Subject|8|||
25164582|NCT01700959|50288371|FG005|Overall Study|Withdrawal by Subject|12|||
25164583|NCT01700959|50288366|FG000|Overall Study|Ineligible|2|||
25164584|NCT01700959|50288367|FG001|Overall Study|Ineligible|1|||
25164585|NCT01700959|50288368|FG002|Overall Study|Ineligible|2|||
25164586|NCT01700959|50288369|FG003|Overall Study|Ineligible|0|||
25164587|NCT01700959|50288370|FG004|Overall Study|Ineligible|0|||
25164588|NCT01700959|50288371|FG005|Overall Study|Ineligible|1|||
25164589|NCT01700959|50288366|FG000|Overall Study|Noncompliant|9|||
25164590|NCT01700959|50288367|FG001|Overall Study|Noncompliant|9|||
25164591|NCT01700959|50288368|FG002|Overall Study|Noncompliant|17|||
25164592|NCT01700959|50288369|FG003|Overall Study|Noncompliant|18|||
25164593|NCT01700959|50288370|FG004|Overall Study|Noncompliant|15|||
25164594|NCT01700959|50288371|FG005|Overall Study|Noncompliant|9|||
25164595|NCT01700959|50288366|FG000|Overall Study|Side effects|1|||
25164596|NCT01700959|50288367|FG001|Overall Study|Side effects|4|||
25164597|NCT01700959|50288368|FG002|Overall Study|Side effects|8|||
25164598|NCT01700959|50288369|FG003|Overall Study|Side effects|4|||
25164599|NCT01700959|50288370|FG004|Overall Study|Side effects|4|||
25164600|NCT01700959|50288371|FG005|Overall Study|Side effects|1|||
25164601|NCT01738477|50288393|FG000|Overall Study|Lost to Follow-up|1|||
25164602|NCT01738477|50288394|FG001|Overall Study|Lost to Follow-up|4|||
25164603|NCT01737931|50288410|FG000|Overall Study|Withdrawal by Subject|0|||
25164604|NCT01737931|50288411|FG001|Overall Study|Withdrawal by Subject|1|||
25164605|NCT01737931|50288412|FG002|Overall Study|Withdrawal by Subject|1|||
25164606|NCT01737931|50288410|FG000|Overall Study|Physician Decision|0|||
25164607|NCT01737931|50288411|FG001|Overall Study|Physician Decision|1|||
25164608|NCT01737931|50288412|FG002|Overall Study|Physician Decision|0|||
25164609|NCT01958489|50288418|FG000|Period 2|Adverse Event|0|||
25164610|NCT01958489|50288419|FG001|Period 2|Adverse Event|1|||
25164611|NCT01721161|50288432|FG000|Overall Study|Adverse Event|2|||
25164612|NCT01721161|50288433|FG001|Overall Study|Adverse Event|3|||
25164613|NCT01721161|50288432|FG000|Overall Study|Lost to Follow-up|1|||
25164614|NCT01721161|50288433|FG001|Overall Study|Lost to Follow-up|2|||
25164615|NCT01721161|50288432|FG000|Overall Study|Withdrawal by Subject|1|||
25164616|NCT01721161|50288433|FG001|Overall Study|Withdrawal by Subject|1|||
25164617|NCT01721161|50288432|FG000|Overall Study|Other|0|||
25164618|NCT01721161|50288433|FG001|Overall Study|Other|1|||
25164619|NCT01700179|50288440|FG000|Overall Study|Physician Decision|2|||
25164620|NCT01699867|50288444|FG000|Overall Study|Screening Failure|3|||
25164621|NCT01699789|50288463|FG000|Overall Study|Withdrawal by Subject|18|||
25164622|NCT01699789|50288464|FG001|Overall Study|Withdrawal by Subject|23|||
25164623|NCT01699789|50288463|FG000|Overall Study|Death|1|||
25164624|NCT01699789|50288464|FG001|Overall Study|Death|2|||
25164625|NCT01699789|50288463|FG000|Overall Study|Lost to Follow-up|83|||
25164626|NCT01699789|50288464|FG001|Overall Study|Lost to Follow-up|101|||
25164627|NCT01944839|50288487|FG000|Overall Study|Physician Decision|2|||
25164628|NCT01944839|50288488|FG001|Overall Study|Physician Decision|2|||
25164629|NCT01944839|50288487|FG000|Overall Study|Protocol Violation|0|||
25164630|NCT01944839|50288488|FG001|Overall Study|Protocol Violation|1|||
25164631|NCT01944839|50288487|FG000|Overall Study|Adverse Event|10|||
25164632|NCT01944839|50288488|FG001|Overall Study|Adverse Event|5|||
25164633|NCT01944839|50288487|FG000|Overall Study|Withdrawal by Subject|9|||
25164634|NCT01944839|50288488|FG001|Overall Study|Withdrawal by Subject|17|||
25164635|NCT01944839|50288487|FG000|Overall Study|Lost to Follow-up|1|||
25164636|NCT01944839|50288488|FG001|Overall Study|Lost to Follow-up|0|||
25164637|NCT01944839|50288487|FG000|Overall Study|Subject non-compliance|0|||
25164638|NCT01944839|50288488|FG001|Overall Study|Subject non-compliance|3|||
25164639|NCT01944059|50288503|FG000|Overall Study|Lost to Follow-up|1|||
25164640|NCT01944059|50288503|FG000|Overall Study|Physician Decision|3|||
25164641|NCT01944059|50288503|FG000|Overall Study|Withdrawal by Subject|1|||
25164642|NCT01944059|50288503|FG000|Overall Study|Adverse Event|2|||
25164643|NCT01720225|50288510|FG000|Overall Study|Withdrawal by Subject|0|||
25164644|NCT01720225|50288511|FG001|Overall Study|Withdrawal by Subject|1|||
25164645|NCT01720225|50288510|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
25164646|NCT01720225|50288511|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
25164647|NCT01943591|50288519|FG000|Overall Study|Lost to Follow-up|3|||
25164648|NCT01943591|50288520|FG001|Overall Study|Lost to Follow-up|4|||
25164649|NCT01943591|50288519|FG000|Overall Study|Death|2|||
25164650|NCT01943591|50288520|FG001|Overall Study|Death|7|||
25164651|NCT01699087|50288526|FG000|Overall Study|Lost to Follow-up|7|||
25164652|NCT01699087|50288526|FG000|Overall Study|Screen failure (prior to treatment)|15|||
25164653|NCT01699087|50288526|FG000|Overall Study|Unable to make future visits|2|||
25164654|NCT01943435|50288534|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
25164655|NCT01943435|50288535|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
25164656|NCT01943435|50288536|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
25164657|NCT01943435|50288534|FG000|Intervention Period|Withdrawal by Subject|3|||
25164658|NCT01943435|50288535|FG001|Intervention Period|Withdrawal by Subject|3|||
25164659|NCT01943435|50288536|FG002|Intervention Period|Withdrawal by Subject|4|||
25164660|NCT01943435|50288534|FG000|2 Month Follow up|Lost to Follow-up|2|||
25164661|NCT01943435|50288535|FG001|2 Month Follow up|Lost to Follow-up|3|||
25164662|NCT01943435|50288536|FG002|2 Month Follow up|Lost to Follow-up|0|||
25164663|NCT01943435|50288534|FG000|6 Month Follow up|Lost to Follow-up|12|||
25164664|NCT01943435|50288535|FG001|6 Month Follow up|Lost to Follow-up|7|||
25164665|NCT01943435|50288536|FG002|6 Month Follow up|Lost to Follow-up|15|||
25164666|NCT01942733|50288554|FG000|Overall Study|Lost to Follow-up|1|||
25164667|NCT01942733|50288554|FG000|Overall Study|Non-compliance with IMP|1|||
25164668|NCT01942733|50288554|FG000|Overall Study|Administrative|1|||
25164669|NCT01957865|50288570|FG000|Overall Study|Found HIV negative|0|||
25164670|NCT01957865|50288571|FG001|Overall Study|Found HIV negative|0|||
25164671|NCT01957865|50288572|FG002|Overall Study|Found HIV negative|1|||
25164672|NCT01957865|50288570|FG000|Overall Study|Lost to Follow-up|0|||
25164673|NCT01957865|50288571|FG001|Overall Study|Lost to Follow-up|2|||
25164674|NCT01957865|50288572|FG002|Overall Study|Lost to Follow-up|2|||
25164675|NCT01957787|50288581|FG000|Overall Study|Death|18|||
25164676|NCT01957787|50288581|FG000|Overall Study|Lost to Follow-up|3|||
25164677|NCT01957787|50288581|FG000|Overall Study|Withdrawal by Subject|3|||
25164678|NCT01957787|50288581|FG000|Overall Study|Entered Hospice or Similar Program|2|||
25164679|NCT01957787|50288581|FG000|Overall Study|Index Tumor(s) Resected|2|||
25164680|NCT01957787|50288581|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
25164681|NCT01957787|50288581|FG000|Overall Study|Local therapy, not cryoablation|6|||
25164682|NCT01698775|50288587|FG000|Phase A|Adverse Event|2|||
25164683|NCT01698775|50288588|FG001|Phase A|Adverse Event|1|||
25164684|NCT01698775|50288587|FG000|Phase A|Death|1|||
25164685|NCT01698775|50288588|FG001|Phase A|Death|1|||
25164686|NCT01698775|50288587|FG000|Phase A|Lack of Efficacy|1|||
25164687|NCT01698775|50288588|FG001|Phase A|Lack of Efficacy|0|||
25164688|NCT01698775|50288587|FG000|Phase A|Lost to Follow-up|1|||
25164689|NCT01698775|50288588|FG001|Phase A|Lost to Follow-up|2|||
25164690|NCT01698775|50288587|FG000|Phase A|Protocol Violation|1|||
25164691|NCT01698775|50288588|FG001|Phase A|Protocol Violation|0|||
25164692|NCT01698775|50288587|FG000|Phase A|Withdrawal by Subject|3|||
25164693|NCT01698775|50288588|FG001|Phase A|Withdrawal by Subject|4|||
25164694|NCT01698775|50288587|FG000|Phase A|Kidney [transplant]|0|||
25164695|NCT01698775|50288588|FG001|Phase A|Kidney [transplant]|1|||
25164696|NCT01698775|50288587|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
25164697|NCT01698775|50288588|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
25164698|NCT01698775|50288587|FG000|Phase B|Adverse Event|6|||
25164699|NCT01698775|50288588|FG001|Phase B|Adverse Event|3|||
25164700|NCT01698775|50288587|FG000|Phase B|Death|0|||
25164701|NCT01698775|50288588|FG001|Phase B|Death|1|||
25164702|NCT01698775|50288587|FG000|Phase B|Lack of Efficacy|0|||
25164703|NCT01698775|50288588|FG001|Phase B|Lack of Efficacy|1|||
25164704|NCT01698775|50288587|FG000|Phase B|Lost to Follow-up|0|||
25164705|NCT01698775|50288588|FG001|Phase B|Lost to Follow-up|1|||
25164706|NCT01698775|50288587|FG000|Phase B|Physician Decision|1|||
25164707|NCT01698775|50288588|FG001|Phase B|Physician Decision|1|||
25164708|NCT01698775|50288587|FG000|Phase B|Protocol Violation|1|||
25164709|NCT01698775|50288588|FG001|Phase B|Protocol Violation|1|||
25164710|NCT01698775|50288587|FG000|Phase B|Withdrawal by Subject|6|||
25276767|NCT00948766|50590713|FG000|Core Study|Patient Withdrew Consent|27|||
25276768|NCT00948766|50590714|FG001|Core Study|Patient Withdrew Consent|46|||
25276769|NCT00948766|50590713|FG000|Core Study|Lost to Follow-up|3|||
25164711|NCT01698775|50288588|FG001|Phase B|Withdrawal by Subject|2|||
25164712|NCT01941095|50288598|FG000|Overall Study|Insufficient therapeutic response|13|||
25164713|NCT01941095|50288598|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
25164714|NCT01941095|50288598|FG000|Overall Study|Adverse Event|11|||
25164715|NCT01941095|50288598|FG000|Overall Study|Physician Decision|3|||
25164716|NCT01941095|50288598|FG000|Overall Study|Withdrawal by Subject|17|||
25164717|NCT01941095|50288598|FG000|Overall Study|Lost to Follow-up|10|||
25164718|NCT01957709|50288613|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
25164719|NCT01957553|50288630|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
25164720|NCT01957553|50288631|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
25164721|NCT01957553|50288630|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
25164722|NCT01957553|50288631|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
25164723|NCT01957553|50288630|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
25164724|NCT01957553|50288631|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
25164725|NCT01957553|50288630|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
25164726|NCT01957553|50288631|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
25186677|NCT02641392|50337359|FG002|Overall Study|Miscellaneous|3|||
25164727|NCT01957553|50288630|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
25164728|NCT01957553|50288631|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
25164729|NCT01957553|50288630|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
25164730|NCT01957553|50288631|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
25164731|NCT01957553|50288630|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
25164732|NCT01957553|50288631|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
25164733|NCT01957553|50288630|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
25164734|NCT01957553|50288631|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
25164735|NCT01957553|50288630|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
25164736|NCT01957553|50288631|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
25164737|NCT01957475|50288656|FG000|Test Period 1|Withdrawal by Subject|1|||
25164738|NCT01957475|50288657|FG001|Test Period 1|Withdrawal by Subject|0|||
25164739|NCT01957475|50288656|FG000|Test Period 1|Other|1|||
25164740|NCT01957475|50288657|FG001|Test Period 1|Other|0|||
25164741|NCT01957475|50288656|FG000|Test Period 1|Lack of Efficacy|0|||
25164742|NCT01957475|50288657|FG001|Test Period 1|Lack of Efficacy|1|||
25164743|NCT01957475|50288656|FG000|Test Period 2|Adverse Event|1|||
25164744|NCT01957475|50288657|FG001|Test Period 2|Adverse Event|0|||
25164745|NCT01940939|50288665|FG000|Overall Study|Withdrawal by Subject|2|||
25164746|NCT01940939|50288666|FG001|Overall Study|Withdrawal by Subject|8|||
25164747|NCT01957397|50288672|FG000|Test Period 1|sudden leakage/small bag|1|||
25164748|NCT01957397|50288673|FG001|Test Period 1|sudden leakage/small bag|1|||
25164749|NCT01957397|50288672|FG000|Test Period 1|Withdrawal by Subject|1|||
25164750|NCT01957397|50288673|FG001|Test Period 1|Withdrawal by Subject|0|||
25164751|NCT01957397|50288672|FG000|Test Period 2|Adverse Event|0|||
25164752|NCT01957397|50288673|FG001|Test Period 2|Adverse Event|1|||
25164753|NCT01957397|50288672|FG000|Test Period 3|Adverse Event|1|||
25164754|NCT01957397|50288673|FG001|Test Period 3|Adverse Event|2|||
25164755|NCT01957397|50288672|FG000|Test Period 3|the adhesive did not work|1|||
25164756|NCT01957397|50288673|FG001|Test Period 3|the adhesive did not work|0|||
25164757|NCT01940705|50288687|FG000|Overall Study|Lost to Follow-up|1|||
25164758|NCT01940705|50288688|FG001|Overall Study|Lost to Follow-up|3|||
25186678|NCT02641392|50337357|FG000|Overall Study|Death|0|||
25186679|NCT02641392|50337358|FG001|Overall Study|Death|0|||
25186680|NCT02641392|50337359|FG002|Overall Study|Death|1|||
25186681|NCT04440007|50337369|FG000|Overall Study|Adverse Event|0|||
25186682|NCT04440007|50337370|FG001|Overall Study|Adverse Event|1|||
25186683|NCT04440007|50337369|FG000|Overall Study|Lost to Follow-up|1|||
25186684|NCT04440007|50337370|FG001|Overall Study|Lost to Follow-up|3|||
25186685|NCT04440007|50337369|FG000|Overall Study|Death|7|||
25186686|NCT04440007|50337370|FG001|Overall Study|Death|2|||
25186687|NCT04440007|50337369|FG000|Overall Study|Physician Decision|1|||
25186688|NCT04440007|50337370|FG001|Overall Study|Physician Decision|1|||
25186689|NCT04440007|50337369|FG000|Overall Study|Withdrawal by Subject|2|||
25186690|NCT04440007|50337370|FG001|Overall Study|Withdrawal by Subject|1|||
25186691|NCT04440007|50337369|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
25186692|NCT04440007|50337370|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
25186693|NCT04440007|50337369|FG000|Overall Study|Discontinued prior to dosing|0|||
25186694|NCT04440007|50337370|FG001|Overall Study|Discontinued prior to dosing|2|||
25164759|NCT01940705|50288689|FG002|Overall Study|Lost to Follow-up|2|||
25164760|NCT01940705|50288690|FG003|Overall Study|Lost to Follow-up|2|||
25164761|NCT01940705|50288687|FG000|Overall Study|Withdrawal by Subject|2|||
25164762|NCT01940705|50288688|FG001|Overall Study|Withdrawal by Subject|2|||
25164763|NCT01940705|50288689|FG002|Overall Study|Withdrawal by Subject|3|||
25164764|NCT01940705|50288690|FG003|Overall Study|Withdrawal by Subject|2|||
25164765|NCT01940705|50288687|FG000|Overall Study|Intervention not given|0|||
25164766|NCT01940705|50288688|FG001|Overall Study|Intervention not given|3|||
25164767|NCT01940705|50288689|FG002|Overall Study|Intervention not given|3|||
25164768|NCT01940705|50288690|FG003|Overall Study|Intervention not given|0|||
25164769|NCT01940705|50288687|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
25164770|NCT01940705|50288688|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
25164771|NCT01940705|50288689|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
25164772|NCT01940705|50288690|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
25164773|NCT01957163|50288715|FG000|Overall Study|Adverse Event|5|||
25164774|NCT01957163|50288716|FG001|Overall Study|Adverse Event|2|||
25164775|NCT01957163|50288717|FG002|Overall Study|Adverse Event|4|||
25164776|NCT01957163|50288715|FG000|Overall Study|Lack of Efficacy|5|||
25164777|NCT01957163|50288716|FG001|Overall Study|Lack of Efficacy|4|||
25164778|NCT01957163|50288717|FG002|Overall Study|Lack of Efficacy|9|||
25186695|NCT01391507|50337389|FG000|Overall Study|Death|0|||
25186696|NCT01391507|50337390|FG001|Overall Study|Death|0|||
25186697|NCT01391507|50337391|FG002|Overall Study|Death|0|||
25186698|NCT01391507|50337392|FG003|Overall Study|Death|1|||
25186699|NCT01391507|50337389|FG000|Overall Study|Adverse Event|1|||
25186700|NCT01391507|50337390|FG001|Overall Study|Adverse Event|1|||
25186701|NCT01391507|50337391|FG002|Overall Study|Adverse Event|2|||
25186702|NCT01391507|50337392|FG003|Overall Study|Adverse Event|2|||
25186703|NCT01391507|50337389|FG000|Overall Study|Withdrawal by Subject|1|||
25186704|NCT01391507|50337390|FG001|Overall Study|Withdrawal by Subject|2|||
25186705|NCT01391507|50337391|FG002|Overall Study|Withdrawal by Subject|1|||
25186706|NCT01391507|50337392|FG003|Overall Study|Withdrawal by Subject|1|||
25186707|NCT01391507|50337389|FG000|Overall Study|Lack of Efficacy|0|||
25186708|NCT01391507|50337390|FG001|Overall Study|Lack of Efficacy|0|||
25186709|NCT01391507|50337391|FG002|Overall Study|Lack of Efficacy|0|||
25186710|NCT01391507|50337392|FG003|Overall Study|Lack of Efficacy|1|||
25186711|NCT01391507|50337389|FG000|Overall Study|Protocol Violation|2|||
25186712|NCT01391507|50337390|FG001|Overall Study|Protocol Violation|1|||
25186713|NCT01391507|50337391|FG002|Overall Study|Protocol Violation|1|||
25186714|NCT01391507|50337392|FG003|Overall Study|Protocol Violation|2|||
25186715|NCT01473524|50337414|FG000|DB Phase|Adverse Event|4|||
25186716|NCT01473524|50337415|FG001|DB Phase|Adverse Event|8|||
25186717|NCT01473524|50337416|FG002|DB Phase|Adverse Event|2|||
25186718|NCT01473524|50337417|FG003|DB Phase|Adverse Event|0|||
25186719|NCT01473524|50337418|FG004|DB Phase|Adverse Event|0|||
25186720|NCT01473524|50337419|FG005|DB Phase|Adverse Event|0|||
25186721|NCT01473524|50337414|FG000|DB Phase|Death|1|||
25186722|NCT01473524|50337415|FG001|DB Phase|Death|0|||
25186723|NCT01473524|50337416|FG002|DB Phase|Death|0|||
25186724|NCT01473524|50337417|FG003|DB Phase|Death|0|||
25186725|NCT01473524|50337418|FG004|DB Phase|Death|0|||
25186726|NCT01473524|50337419|FG005|DB Phase|Death|0|||
25164779|NCT01957163|50288715|FG000|Overall Study|Protocol Violation|1|||
25164780|NCT01957163|50288716|FG001|Overall Study|Protocol Violation|2|||
25164781|NCT01957163|50288717|FG002|Overall Study|Protocol Violation|0|||
25164782|NCT01957163|50288715|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
25164783|NCT01957163|50288716|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
25164784|NCT01957163|50288717|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
25164785|NCT01957163|50288715|FG000|Overall Study|Lost to Follow-up|0|||
25164786|NCT01957163|50288716|FG001|Overall Study|Lost to Follow-up|1|||
25164787|NCT01957163|50288717|FG002|Overall Study|Lost to Follow-up|0|||
25164788|NCT01957163|50288715|FG000|Overall Study|Withdrawal by Subject|4|||
25164789|NCT01957163|50288716|FG001|Overall Study|Withdrawal by Subject|2|||
25164790|NCT01957163|50288717|FG002|Overall Study|Withdrawal by Subject|4|||
25164791|NCT01956773|50288740|FG000|Overall Study|Lost to Follow-up|628|||
25164792|NCT01956773|50288741|FG001|Overall Study|Lost to Follow-up|1|||
25164793|NCT01939223|50288780|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
25164794|NCT01939223|50288781|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
25164795|NCT01939223|50288780|FG000|Overall Study|Disease recurrence (radiological)|1|||
25164796|NCT01939223|50288781|FG001|Overall Study|Disease recurrence (radiological)|3|||
25164797|NCT01939223|50288780|FG000|Overall Study|Study stopped by Sponsor|5|||
25164798|NCT01939223|50288781|FG001|Overall Study|Study stopped by Sponsor|7|||
25164799|NCT01939223|50288780|FG000|Overall Study|Withdrawal by Subject|6|||
25186727|NCT01473524|50337414|FG000|DB Phase|Withdrawal by Subject|2|||
25186728|NCT01473524|50337415|FG001|DB Phase|Withdrawal by Subject|1|||
25186729|NCT01473524|50337416|FG002|DB Phase|Withdrawal by Subject|1|||
25186730|NCT01473524|50337417|FG003|DB Phase|Withdrawal by Subject|0|||
25276770|NCT00948766|50590714|FG001|Core Study|Lost to Follow-up|2|||
25164800|NCT01939223|50288781|FG001|Overall Study|Withdrawal by Subject|0|||
25164801|NCT01954745|50288826|FG000|Overall Study|Radiological Progression|11|||
25164802|NCT01954745|50288826|FG000|Overall Study|Clinical Progression|5|||
25164803|NCT01954745|50288826|FG000|Overall Study|Adverse Event|2|||
25164804|NCT01954745|50288826|FG000|Overall Study|Death|1|||
25164805|NCT01954121|50288841|FG000|Overall Study|Lack of Efficacy|94|||
25164806|NCT01954121|50288842|FG001|Overall Study|Lack of Efficacy|41|||
25164807|NCT01954121|50288841|FG000|Overall Study|Protocol Violation|0|||
25164808|NCT01954121|50288842|FG001|Overall Study|Protocol Violation|2|||
25164809|NCT01954121|50288841|FG000|Overall Study|Lost to Follow-up|5|||
25164810|NCT01954121|50288842|FG001|Overall Study|Lost to Follow-up|6|||
25164811|NCT01954121|50288841|FG000|Overall Study|Withdrawal by Subject|18|||
25164812|NCT01954121|50288842|FG001|Overall Study|Withdrawal by Subject|12|||
25164813|NCT01954121|50288841|FG000|Overall Study|Pregnancy|1|||
25164814|NCT01954121|50288842|FG001|Overall Study|Pregnancy|1|||
25186731|NCT01473524|50337418|FG004|DB Phase|Withdrawal by Subject|0|||
25186732|NCT01473524|50337419|FG005|DB Phase|Withdrawal by Subject|0|||
25186733|NCT01473524|50337414|FG000|LTSE Phase|Withdrawal by Subject|0|||
25186734|NCT01473524|50337415|FG001|LTSE Phase|Withdrawal by Subject|0|||
25186735|NCT01473524|50337416|FG002|LTSE Phase|Withdrawal by Subject|0|||
25186736|NCT01473524|50337417|FG003|LTSE Phase|Withdrawal by Subject|3|||
25186737|NCT01473524|50337418|FG004|LTSE Phase|Withdrawal by Subject|3|||
25186738|NCT01473524|50337419|FG005|LTSE Phase|Withdrawal by Subject|6|||
25186739|NCT01473524|50337414|FG000|LTSE Phase|Death|0|||
25186740|NCT01473524|50337415|FG001|LTSE Phase|Death|0|||
25186741|NCT01473524|50337416|FG002|LTSE Phase|Death|0|||
25164815|NCT01954121|50288841|FG000|Overall Study|AE, serious fatal|1|||
25164816|NCT01954121|50288842|FG001|Overall Study|AE, serious fatal|0|||
25186742|NCT01473524|50337417|FG003|LTSE Phase|Death|0|||
25186743|NCT01473524|50337418|FG004|LTSE Phase|Death|1|||
25186744|NCT01473524|50337419|FG005|LTSE Phase|Death|0|||
25186745|NCT01473524|50337414|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
25186746|NCT01473524|50337415|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
25186747|NCT01473524|50337416|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
25186748|NCT01473524|50337417|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
25186749|NCT01473524|50337418|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
25186750|NCT01473524|50337419|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
25186751|NCT01473524|50337414|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
25186752|NCT01473524|50337415|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
25186753|NCT01473524|50337416|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
25186754|NCT01473524|50337417|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
25186755|NCT01473524|50337418|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
25186756|NCT01473524|50337419|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
25186757|NCT01473524|50337414|FG000|LTSE Phase|Lost to Follow-up|0|||
25186758|NCT01473524|50337415|FG001|LTSE Phase|Lost to Follow-up|0|||
25186759|NCT01473524|50337416|FG002|LTSE Phase|Lost to Follow-up|0|||
25186760|NCT01473524|50337417|FG003|LTSE Phase|Lost to Follow-up|1|||
25186761|NCT01473524|50337418|FG004|LTSE Phase|Lost to Follow-up|3|||
25186762|NCT01473524|50337419|FG005|LTSE Phase|Lost to Follow-up|2|||
25186763|NCT01473524|50337414|FG000|LTSE Phase|Principal Investigator Decision|0|||
25186764|NCT01473524|50337415|FG001|LTSE Phase|Principal Investigator Decision|0|||
25186765|NCT01473524|50337416|FG002|LTSE Phase|Principal Investigator Decision|0|||
25186766|NCT01473524|50337417|FG003|LTSE Phase|Principal Investigator Decision|1|||
25186767|NCT01473524|50337418|FG004|LTSE Phase|Principal Investigator Decision|1|||
25186768|NCT01473524|50337419|FG005|LTSE Phase|Principal Investigator Decision|3|||
25186769|NCT01473524|50337414|FG000|LTSE Phase|Liver Transplantation|0|||
25186770|NCT01473524|50337415|FG001|LTSE Phase|Liver Transplantation|0|||
25186771|NCT01473524|50337416|FG002|LTSE Phase|Liver Transplantation|0|||
25186772|NCT01473524|50337417|FG003|LTSE Phase|Liver Transplantation|0|||
25186773|NCT01473524|50337418|FG004|LTSE Phase|Liver Transplantation|0|||
25186774|NCT01473524|50337419|FG005|LTSE Phase|Liver Transplantation|1|||
25186775|NCT01473524|50337414|FG000|LTSE Phase|Pregnancy|0|||
25186776|NCT01473524|50337415|FG001|LTSE Phase|Pregnancy|0|||
25186777|NCT01473524|50337416|FG002|LTSE Phase|Pregnancy|0|||
25186778|NCT01473524|50337417|FG003|LTSE Phase|Pregnancy|1|||
25164817|NCT01954121|50288841|FG000|Overall Study|AE, non-serious non-fatal|5|||
25164818|NCT01954121|50288842|FG001|Overall Study|AE, non-serious non-fatal|22|||
25164819|NCT01954121|50288841|FG000|Overall Study|SAE, non-fatal|1|||
25164820|NCT01954121|50288842|FG001|Overall Study|SAE, non-fatal|4|||
25164821|NCT01954121|50288841|FG000|Overall Study|Non-compliant with study procedures|1|||
25186779|NCT01473524|50337418|FG004|LTSE Phase|Pregnancy|0|||
25186780|NCT01473524|50337419|FG005|LTSE Phase|Pregnancy|0|||
25186781|NCT01473524|50337414|FG000|LTSE Phase|Protocol Violation|0|||
25186782|NCT01473524|50337415|FG001|LTSE Phase|Protocol Violation|0|||
25186783|NCT01473524|50337416|FG002|LTSE Phase|Protocol Violation|0|||
25186784|NCT01473524|50337417|FG003|LTSE Phase|Protocol Violation|0|||
25186785|NCT01473524|50337418|FG004|LTSE Phase|Protocol Violation|0|||
25186786|NCT01473524|50337419|FG005|LTSE Phase|Protocol Violation|1|||
25186787|NCT01390649|50337450|FG000|Overall Study|Physician Decision|1|||
25186788|NCT01390181|50337454|FG000|Overall Study|Lost to Follow-up|1|||
25186789|NCT01390181|50337454|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
25186790|NCT02641080|50337460|FG000|Overall Study|Physician Decision|2|||
25186791|NCT02641080|50337461|FG001|Overall Study|Physician Decision|0|||
25186792|NCT02641080|50337460|FG000|Overall Study|Withdrawal by Subject|0|||
25164822|NCT01954121|50288842|FG001|Overall Study|Non-compliant with study procedures|0|||
25164823|NCT01954121|50288841|FG000|Overall Study|Non-compliant patient|1|||
25164824|NCT01954121|50288842|FG001|Overall Study|Non-compliant patient|1|||
25186793|NCT02641080|50337461|FG001|Overall Study|Withdrawal by Subject|1|||
25186794|NCT02641080|50337460|FG000|Overall Study|Rehab Center denied use of pumps|0|||
25186795|NCT02641080|50337461|FG001|Overall Study|Rehab Center denied use of pumps|3|||
25186796|NCT02641080|50337460|FG000|Overall Study|Lost to Follow-up|0|||
25186797|NCT02641080|50337461|FG001|Overall Study|Lost to Follow-up|3|||
25186798|NCT01457846|50337469|FG000|Overall Study|Death before treatment|1|||
25186799|NCT01457846|50337470|FG001|Overall Study|Death before treatment|2|||
25186800|NCT01457846|50337469|FG000|Overall Study|Did not receive treatment|0|||
25164825|NCT01954121|50288841|FG000|Overall Study|Subject did not follow instructions|0|||
25186801|NCT01457846|50337470|FG001|Overall Study|Did not receive treatment|1|||
25186802|NCT01457846|50337469|FG000|Overall Study|Death|27|||
25186803|NCT01457846|50337470|FG001|Overall Study|Death|16|||
25186804|NCT01457846|50337469|FG000|Overall Study|Unclassified reason for not completed|11|||
25186805|NCT01457846|50337470|FG001|Overall Study|Unclassified reason for not completed|10|||
25164826|NCT01954121|50288842|FG001|Overall Study|Subject did not follow instructions|2|||
25164827|NCT01952015|50288877|FG000|Induction|Protocol Violation|1|||
25164828|NCT01952015|50288877|FG000|Maintenance|Adverse Event|2|||
25164829|NCT01952015|50288877|FG000|Treatment Period 3|Physician Decision|9|||
25164830|NCT01951703|50288910|FG000|First Intervention|Withdrawal by Subject|1|||
25164831|NCT01951703|50288911|FG001|First Intervention|Withdrawal by Subject|0|||
25164832|NCT01951703|50288910|FG000|First Intervention|Subject was not compliant|1|||
25164833|NCT01951703|50288911|FG001|First Intervention|Subject was not compliant|1|||
25164834|NCT01951703|50288910|FG000|First Intervention|Physician Decision|1|||
25186806|NCT01457846|50337469|FG000|Overall Study|Withdrawal by Subject|1|||
25186807|NCT01457846|50337470|FG001|Overall Study|Withdrawal by Subject|1|||
25186808|NCT01457846|50337469|FG000|Overall Study|Lost to Follow-up|1|||
25186809|NCT01457846|50337470|FG001|Overall Study|Lost to Follow-up|0|||
25186810|NCT01496066|50337482|FG000|Overall Study|Lost to Follow-up|8|||
25186811|NCT01496066|50337483|FG001|Overall Study|Lost to Follow-up|5|||
25186812|NCT01496066|50337482|FG000|Overall Study|Explant|3|||
25186813|NCT01496066|50337483|FG001|Overall Study|Explant|0|||
25186814|NCT01496066|50337482|FG000|Overall Study|Death|1|||
25186815|NCT01496066|50337483|FG001|Overall Study|Death|4|||
25186816|NCT01389323|50337496|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
25186817|NCT01389323|50337496|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
25186818|NCT01389323|50337496|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
25186819|NCT01389323|50337496|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
25186820|NCT01389323|50337496|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
25186821|NCT01389323|50337496|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
25186822|NCT01389323|50337496|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
25186823|NCT01389323|50337496|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
25186824|NCT01389323|50337496|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
25186825|NCT01389323|50337496|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
25186826|NCT01389323|50337496|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
25186827|NCT01389245|50337507|FG000|Overall Study|Protocol Violation|10|||
25186828|NCT01389245|50337507|FG000|Overall Study|Lost to Follow-up|3|||
25186829|NCT01389245|50337507|FG000|Overall Study|Withdrawal by Subject|2|||
25186830|NCT01494818|50337513|FG000|Overall Study|Relocation|1|||
25186831|NCT01494818|50337514|FG001|Overall Study|Relocation|2|||
25186832|NCT01494818|50337513|FG000|Overall Study|Lost to Follow-up|1|||
25186833|NCT01494818|50337514|FG001|Overall Study|Lost to Follow-up|0|||
25186834|NCT01494584|50337520|FG000|Overall Study|Study Closed/Terminated|1|||
25186835|NCT01388543|50337545|FG000|Day 14|Adverse Event|1|||
25186836|NCT01388543|50337546|FG001|Day 14|Adverse Event|4|||
25186837|NCT00512317|50337565|FG000|Overall Study|Insufficient clinical response|36|||
25186838|NCT00512317|50337565|FG000|Overall Study|Withdrawal by Subject|23|||
25164835|NCT01951703|50288911|FG001|First Intervention|Physician Decision|0|||
25164836|NCT01951703|50288910|FG000|Second Intervention|Protocol Violation|0|||
25164837|NCT01951703|50288911|FG001|Second Intervention|Protocol Violation|1|||
25164838|NCT01951703|50288910|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
25164839|NCT01951703|50288911|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
25164840|NCT01937351|50288937|FG000|Overall Study|Withdrawal by Subject|4|||
25164841|NCT01937351|50288938|FG001|Overall Study|Withdrawal by Subject|2|||
25164842|NCT01937351|50288937|FG000|Overall Study|Death|1|||
25164843|NCT01937351|50288938|FG001|Overall Study|Death|0|||
25164844|NCT01937351|50288937|FG000|Overall Study|Not treated w device, per protocol fail|4|||
25186839|NCT00512317|50337565|FG000|Overall Study|Sponsor closure of study|21|||
25186840|NCT00512317|50337565|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
25186841|NCT00512317|50337565|FG000|Overall Study|Adverse Event|13|||
25186842|NCT00512317|50337565|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
25186843|NCT00512317|50337565|FG000|Overall Study|Lost to Follow-up|2|||
25186844|NCT00512317|50337565|FG000|Overall Study|Other|2|||
25186845|NCT01494506|50337581|FG000|Overall Study|Lack of Efficacy|77|||
25186846|NCT01494506|50337582|FG001|Overall Study|Lack of Efficacy|83|||
25186847|NCT01494506|50337583|FG002|Overall Study|Lack of Efficacy|57|||
25186848|NCT01494506|50337581|FG000|Overall Study|Adverse Event|17|||
25186849|NCT01494506|50337582|FG001|Overall Study|Adverse Event|10|||
25186850|NCT01494506|50337583|FG002|Overall Study|Adverse Event|11|||
25186851|NCT01494506|50337581|FG000|Overall Study|Death|9|||
25186852|NCT01494506|50337582|FG001|Overall Study|Death|5|||
25164845|NCT01937351|50288938|FG001|Overall Study|Not treated w device, per protocol fail|0|||
25164846|NCT01737697|50288971|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
25164847|NCT01737697|50288972|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
25164848|NCT01737697|50288973|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
25186853|NCT01494506|50337583|FG002|Overall Study|Death|2|||
25186854|NCT01494506|50337581|FG000|Overall Study|Physician Decision|7|||
25186855|NCT01494506|50337582|FG001|Overall Study|Physician Decision|5|||
25186856|NCT01494506|50337583|FG002|Overall Study|Physician Decision|4|||
25186857|NCT01494506|50337581|FG000|Overall Study|Withdrawal by Subject|17|||
25186858|NCT01494506|50337582|FG001|Overall Study|Withdrawal by Subject|20|||
25164849|NCT01737697|50288974|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
25164850|NCT01737697|50288975|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
25164851|NCT01737697|50288976|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
25164852|NCT01737697|50288977|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
25164853|NCT01737697|50288978|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
25164854|NCT01737697|50288979|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
25164855|NCT01737697|50288980|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
25164856|NCT01737697|50288981|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
25164857|NCT01737697|50288982|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
25186859|NCT01494506|50337583|FG002|Overall Study|Withdrawal by Subject|14|||
25186860|NCT01494506|50337581|FG000|Overall Study|Clinical Deterioration|21|||
25186861|NCT01494506|50337582|FG001|Overall Study|Clinical Deterioration|17|||
25186862|NCT01494506|50337583|FG002|Overall Study|Clinical Deterioration|13|||
25186863|NCT01494506|50337581|FG000|Overall Study|Sponsor Decision|0|||
25186864|NCT01494506|50337582|FG001|Overall Study|Sponsor Decision|0|||
25186865|NCT01494506|50337583|FG002|Overall Study|Sponsor Decision|1|||
25186866|NCT01494506|50337581|FG000|Overall Study|Other|0|||
25186867|NCT01494506|50337582|FG001|Overall Study|Other|3|||
25186868|NCT01494506|50337583|FG002|Overall Study|Other|1|||
25186869|NCT02643420|50337595|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
25186870|NCT02643420|50337596|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
25186871|NCT02643420|50337595|FG000|Overall Study|Withdrawal by Subject|25|||
25186872|NCT02643420|50337596|FG001|Overall Study|Withdrawal by Subject|19|||
25186873|NCT02643420|50337595|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
25186874|NCT02643420|50337596|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
25186875|NCT02643420|50337595|FG000|Overall Study|Lost to Follow-up|6|||
25186876|NCT02643420|50337596|FG001|Overall Study|Lost to Follow-up|10|||
25186877|NCT02643420|50337595|FG000|Overall Study|Investigator Decision|2|||
25186878|NCT02643420|50337596|FG001|Overall Study|Investigator Decision|4|||
25186879|NCT02643420|50337595|FG000|Overall Study|Sponsor decision|1|||
25164858|NCT01737697|50288983|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
25164859|NCT01737697|50288984|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
25164860|NCT01737697|50288985|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
25186880|NCT02643420|50337596|FG001|Overall Study|Sponsor decision|1|||
25186881|NCT02643420|50337595|FG000|Overall Study|Death|0|||
25186882|NCT02643420|50337596|FG001|Overall Study|Death|2|||
25186883|NCT02643420|50337595|FG000|Overall Study|Reason not Specified|8|||
25186884|NCT02643420|50337596|FG001|Overall Study|Reason not Specified|7|||
25186885|NCT01456130|50337619|FG000|Overall Study|Adverse Event|4|||
25186886|NCT01456130|50337619|FG000|Overall Study|Voluntary Withdrawal|1|||
25186887|NCT01456130|50337619|FG000|Overall Study|Lack of Efficacy|4|||
25186888|NCT01456130|50337619|FG000|Overall Study|Other|1|||
25186889|NCT01456052|50337626|FG000|Overall Study|Adverse Event|1|||
25186890|NCT01456052|50337627|FG001|Overall Study|Adverse Event|1|||
25276771|NCT00948766|50590713|FG000|Core Study|Administrative Problems|2|||
25276772|NCT00948766|50590714|FG001|Core Study|Administrative Problems|2|||
25276773|NCT00948766|50590713|FG000|Core Study|Death|1|||
25276774|NCT00948766|50590714|FG001|Core Study|Death|1|||
25276775|NCT00948766|50590713|FG000|Core Study|Protocol Deviation|8|||
25276776|NCT00948766|50590714|FG001|Core Study|Protocol Deviation|10|||
25164861|NCT01737697|50288971|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
25164862|NCT01737697|50288972|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
25164863|NCT01737697|50288973|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
25164864|NCT01737697|50288974|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
25164865|NCT01737697|50288975|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
25164866|NCT01737697|50288976|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
25276777|NCT00948766|50590713|FG000|Extension Study|Adverse Event|43|||
25276778|NCT00948766|50590714|FG001|Extension Study|Adverse Event|0|||
25276779|NCT00948766|50590713|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
25276780|NCT00948766|50590714|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
25067129|NCT02456740|50172693|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
25164867|NCT01737697|50288977|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
25186891|NCT01456052|50337628|FG002|Overall Study|Adverse Event|2|||
25186892|NCT01456052|50337626|FG000|Overall Study|Consent withdrawn|0|||
25186893|NCT01456052|50337627|FG001|Overall Study|Consent withdrawn|2|||
25186894|NCT01456052|50337628|FG002|Overall Study|Consent withdrawn|1|||
25186895|NCT01456052|50337626|FG000|Overall Study|Protocol Violation|0|||
25186896|NCT01456052|50337627|FG001|Overall Study|Protocol Violation|1|||
25186897|NCT01456052|50337628|FG002|Overall Study|Protocol Violation|0|||
25186898|NCT01456052|50337626|FG000|Overall Study|Physician Decision|1|||
25276781|NCT00948766|50590713|FG000|Extension Study|Study Drug No Longer Required|1|||
25276782|NCT00948766|50590714|FG001|Extension Study|Study Drug No Longer Required|0|||
25164868|NCT01737697|50288978|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
25164869|NCT01737697|50288979|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
25164870|NCT01737697|50288980|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
25164871|NCT01737697|50288981|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
25164872|NCT01737697|50288982|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
25164873|NCT01737697|50288983|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
25164874|NCT01737697|50288984|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
25164875|NCT01737697|50288985|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
25164876|NCT01737697|50288971|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
25164877|NCT01737697|50288972|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
25164878|NCT01737697|50288973|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
25164879|NCT01737697|50288974|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
25164880|NCT01737697|50288975|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
25164881|NCT01737697|50288976|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
25164882|NCT01737697|50288977|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
25164883|NCT01737697|50288978|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
25164884|NCT01737697|50288979|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
25164885|NCT01737697|50288980|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
25164886|NCT01737697|50288981|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
25164887|NCT01737697|50288982|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
25164888|NCT01737697|50288983|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
25164889|NCT01737697|50288984|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
25164890|NCT01737697|50288985|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
25164891|NCT01737697|50288971|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
25164892|NCT01737697|50288972|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
25164893|NCT01737697|50288973|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
25164894|NCT01737697|50288974|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
25164895|NCT01737697|50288975|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
25164896|NCT01737697|50288976|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
25164897|NCT01737697|50288977|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
25164898|NCT01737697|50288978|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
25164899|NCT01737697|50288979|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
25164900|NCT01737697|50288980|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
25164901|NCT01737697|50288981|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
25164902|NCT01737697|50288982|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
25164903|NCT01737697|50288983|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
25164904|NCT01737697|50288984|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
25164905|NCT01737697|50288985|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
25164906|NCT01737697|50288971|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
25164907|NCT01737697|50288972|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
25164908|NCT01737697|50288973|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
25164909|NCT01737697|50288974|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
25164910|NCT01737697|50288975|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
25164911|NCT01737697|50288976|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
25164912|NCT01737697|50288977|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
25164913|NCT01737697|50288978|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
25164914|NCT01737697|50288979|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
25164915|NCT01737697|50288980|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
25164916|NCT01737697|50288981|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
25164917|NCT01737697|50288982|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
25164918|NCT01737697|50288983|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
25164919|NCT01737697|50288984|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
25164920|NCT01737697|50288985|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
25164921|NCT01737697|50288971|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
25164922|NCT01737697|50288972|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
25164923|NCT01737697|50288973|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
25164924|NCT01737697|50288974|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
25164925|NCT01737697|50288975|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
25164926|NCT01737697|50288976|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
25164927|NCT01737697|50288977|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
25164928|NCT01737697|50288978|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
25164929|NCT01737697|50288979|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
25164930|NCT01737697|50288980|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
25164931|NCT01737697|50288981|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
25164932|NCT01737697|50288982|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
25164933|NCT01737697|50288983|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
25164934|NCT01737697|50288984|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
25164935|NCT01737697|50288985|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
25164936|NCT01737697|50288971|FG000|Subacute Phase|Adverse Event|0|||
25164937|NCT01737697|50288972|FG001|Subacute Phase|Adverse Event|0|||
25164938|NCT01737697|50288973|FG002|Subacute Phase|Adverse Event|0|||
25164939|NCT01737697|50288974|FG003|Subacute Phase|Adverse Event|0|||
25164940|NCT01737697|50288975|FG004|Subacute Phase|Adverse Event|0|||
25164941|NCT01737697|50288976|FG005|Subacute Phase|Adverse Event|1|||
25164942|NCT01737697|50288977|FG006|Subacute Phase|Adverse Event|1|||
25164943|NCT01737697|50288978|FG007|Subacute Phase|Adverse Event|1|||
25164944|NCT01737697|50288979|FG008|Subacute Phase|Adverse Event|1|||
25164945|NCT01737697|50288980|FG009|Subacute Phase|Adverse Event|1|||
25164946|NCT01737697|50288981|FG010|Subacute Phase|Adverse Event|4|||
25164947|NCT01737697|50288982|FG011|Subacute Phase|Adverse Event|1|||
25164948|NCT01737697|50288983|FG012|Subacute Phase|Adverse Event|1|||
25164949|NCT01737697|50288984|FG013|Subacute Phase|Adverse Event|0|||
25164950|NCT01737697|50288985|FG014|Subacute Phase|Adverse Event|0|||
25164951|NCT01737697|50288971|FG000|Subacute Phase|Withdrawal by Subject|0|||
25164952|NCT01737697|50288972|FG001|Subacute Phase|Withdrawal by Subject|0|||
25164953|NCT01737697|50288973|FG002|Subacute Phase|Withdrawal by Subject|0|||
25164954|NCT01737697|50288974|FG003|Subacute Phase|Withdrawal by Subject|0|||
25164955|NCT01737697|50288975|FG004|Subacute Phase|Withdrawal by Subject|0|||
25164956|NCT01737697|50288976|FG005|Subacute Phase|Withdrawal by Subject|1|||
25164957|NCT01737697|50288977|FG006|Subacute Phase|Withdrawal by Subject|0|||
25164958|NCT01737697|50288978|FG007|Subacute Phase|Withdrawal by Subject|2|||
25164959|NCT01737697|50288979|FG008|Subacute Phase|Withdrawal by Subject|0|||
25164960|NCT01737697|50288980|FG009|Subacute Phase|Withdrawal by Subject|1|||
25164961|NCT01737697|50288981|FG010|Subacute Phase|Withdrawal by Subject|0|||
25164962|NCT01737697|50288982|FG011|Subacute Phase|Withdrawal by Subject|1|||
25164963|NCT01737697|50288983|FG012|Subacute Phase|Withdrawal by Subject|1|||
25164964|NCT01737697|50288984|FG013|Subacute Phase|Withdrawal by Subject|1|||
25164965|NCT01737697|50288985|FG014|Subacute Phase|Withdrawal by Subject|0|||
25164966|NCT01737697|50288971|FG000|Subacute Phase|Lost to Follow-up|0|||
25164967|NCT01737697|50288972|FG001|Subacute Phase|Lost to Follow-up|0|||
25164968|NCT01737697|50288973|FG002|Subacute Phase|Lost to Follow-up|0|||
25164969|NCT01737697|50288974|FG003|Subacute Phase|Lost to Follow-up|0|||
25164970|NCT01737697|50288975|FG004|Subacute Phase|Lost to Follow-up|0|||
25164971|NCT01737697|50288976|FG005|Subacute Phase|Lost to Follow-up|0|||
25164972|NCT01737697|50288977|FG006|Subacute Phase|Lost to Follow-up|0|||
25164973|NCT01737697|50288978|FG007|Subacute Phase|Lost to Follow-up|0|||
25164974|NCT01737697|50288979|FG008|Subacute Phase|Lost to Follow-up|0|||
25164975|NCT01737697|50288980|FG009|Subacute Phase|Lost to Follow-up|0|||
25164976|NCT01737697|50288981|FG010|Subacute Phase|Lost to Follow-up|0|||
25164977|NCT01737697|50288982|FG011|Subacute Phase|Lost to Follow-up|0|||
25164978|NCT01737697|50288983|FG012|Subacute Phase|Lost to Follow-up|0|||
25164979|NCT01737697|50288984|FG013|Subacute Phase|Lost to Follow-up|0|||
25164980|NCT01737697|50288985|FG014|Subacute Phase|Lost to Follow-up|1|||
25164981|NCT01737697|50288971|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
25164982|NCT01737697|50288972|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
25164983|NCT01737697|50288973|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
25164984|NCT01737697|50288974|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
25164985|NCT01737697|50288975|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
25164986|NCT01737697|50288976|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
25164987|NCT01737697|50288977|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
25164988|NCT01737697|50288978|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
25164989|NCT01737697|50288979|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
25164990|NCT01737697|50288980|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
25164991|NCT01737697|50288981|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
25164992|NCT01737697|50288982|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
25164993|NCT01737697|50288983|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
25164994|NCT01737697|50288984|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
25164995|NCT01737697|50288985|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
25164996|NCT01737697|50288971|FG000|Subacute Phase|Protocol Violation|0|||
25164997|NCT01737697|50288972|FG001|Subacute Phase|Protocol Violation|0|||
25164998|NCT01737697|50288973|FG002|Subacute Phase|Protocol Violation|0|||
25164999|NCT01737697|50288974|FG003|Subacute Phase|Protocol Violation|0|||
25165000|NCT01737697|50288975|FG004|Subacute Phase|Protocol Violation|0|||
25165001|NCT01737697|50288976|FG005|Subacute Phase|Protocol Violation|1|||
25165002|NCT01737697|50288977|FG006|Subacute Phase|Protocol Violation|0|||
25165003|NCT01737697|50288978|FG007|Subacute Phase|Protocol Violation|0|||
25165004|NCT01737697|50288979|FG008|Subacute Phase|Protocol Violation|0|||
25165005|NCT01737697|50288980|FG009|Subacute Phase|Protocol Violation|0|||
25165006|NCT01737697|50288981|FG010|Subacute Phase|Protocol Violation|1|||
25165007|NCT01737697|50288982|FG011|Subacute Phase|Protocol Violation|0|||
25165008|NCT01737697|50288983|FG012|Subacute Phase|Protocol Violation|0|||
25165009|NCT01737697|50288984|FG013|Subacute Phase|Protocol Violation|0|||
25165010|NCT01737697|50288985|FG014|Subacute Phase|Protocol Violation|0|||
25165011|NCT01737697|50288971|FG000|Subacute Phase|Physician Decision|0|||
25165012|NCT01737697|50288972|FG001|Subacute Phase|Physician Decision|0|||
25165013|NCT01737697|50288973|FG002|Subacute Phase|Physician Decision|0|||
25165014|NCT01737697|50288974|FG003|Subacute Phase|Physician Decision|0|||
25165015|NCT01737697|50288975|FG004|Subacute Phase|Physician Decision|0|||
25165016|NCT01737697|50288976|FG005|Subacute Phase|Physician Decision|0|||
25165017|NCT01737697|50288977|FG006|Subacute Phase|Physician Decision|0|||
25165018|NCT01737697|50288978|FG007|Subacute Phase|Physician Decision|0|||
25165019|NCT01737697|50288979|FG008|Subacute Phase|Physician Decision|1|||
25165020|NCT01737697|50288980|FG009|Subacute Phase|Physician Decision|0|||
25165021|NCT01737697|50288981|FG010|Subacute Phase|Physician Decision|0|||
25165022|NCT01737697|50288982|FG011|Subacute Phase|Physician Decision|0|||
25165023|NCT01737697|50288983|FG012|Subacute Phase|Physician Decision|0|||
25165024|NCT01737697|50288984|FG013|Subacute Phase|Physician Decision|0|||
25165025|NCT01737697|50288985|FG014|Subacute Phase|Physician Decision|0|||
25165026|NCT01737697|50288971|FG000|Subacute Phase|Death|0|||
25165027|NCT01737697|50288972|FG001|Subacute Phase|Death|0|||
25165028|NCT01737697|50288973|FG002|Subacute Phase|Death|0|||
25165029|NCT01737697|50288974|FG003|Subacute Phase|Death|0|||
25165030|NCT01737697|50288975|FG004|Subacute Phase|Death|0|||
25165031|NCT01737697|50288976|FG005|Subacute Phase|Death|0|||
25165032|NCT01737697|50288977|FG006|Subacute Phase|Death|0|||
25165033|NCT01737697|50288978|FG007|Subacute Phase|Death|0|||
25165034|NCT01737697|50288979|FG008|Subacute Phase|Death|0|||
25165035|NCT01737697|50288980|FG009|Subacute Phase|Death|0|||
25165036|NCT01737697|50288981|FG010|Subacute Phase|Death|1|||
25165037|NCT01737697|50288982|FG011|Subacute Phase|Death|0|||
25165038|NCT01737697|50288983|FG012|Subacute Phase|Death|0|||
25165039|NCT01737697|50288984|FG013|Subacute Phase|Death|0|||
25165040|NCT01737697|50288985|FG014|Subacute Phase|Death|0|||
25165041|NCT01682863|50289141|FG000|Overall Study|Subject/guardian decision|19|||
25165042|NCT01682863|50289142|FG001|Overall Study|Subject/guardian decision|12|||
25165043|NCT01682863|50289143|FG002|Overall Study|Subject/guardian decision|10|||
25165044|NCT01682863|50289141|FG000|Overall Study|Lost to Follow-up|5|||
25165045|NCT01682863|50289142|FG001|Overall Study|Lost to Follow-up|1|||
25165046|NCT01682863|50289143|FG002|Overall Study|Lost to Follow-up|6|||
25165047|NCT01682863|50289141|FG000|Overall Study|Death|1|||
25165048|NCT01682863|50289142|FG001|Overall Study|Death|3|||
25165049|NCT01682863|50289143|FG002|Overall Study|Death|4|||
25165050|NCT01682863|50289141|FG000|Overall Study|Protocol deviation|1|||
25165051|NCT01682863|50289142|FG001|Overall Study|Protocol deviation|0|||
25165052|NCT01682863|50289143|FG002|Overall Study|Protocol deviation|1|||
25165053|NCT01682863|50289141|FG000|Overall Study|Technical problems|1|||
25165054|NCT01682863|50289142|FG001|Overall Study|Technical problems|0|||
25165055|NCT01682863|50289143|FG002|Overall Study|Technical problems|0|||
25165056|NCT01682863|50289141|FG000|Overall Study|Adverse Event|0|||
25165057|NCT01682863|50289142|FG001|Overall Study|Adverse Event|1|||
25165058|NCT01682863|50289143|FG002|Overall Study|Adverse Event|2|||
25165059|NCT01682863|50289141|FG000|Overall Study|Physician Decision|0|||
24964396|NCT00006604|50054260|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
24964397|NCT00006604|50054261|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
24964398|NCT00006604|50054262|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
25165060|NCT01682863|50289142|FG001|Overall Study|Physician Decision|0|||
25165061|NCT01682863|50289143|FG002|Overall Study|Physician Decision|1|||
25165062|NCT01951625|50289156|FG000|Treatment Period|Protocol Violation|2|||
25165063|NCT01951625|50289157|FG001|Treatment Period|Protocol Violation|0|||
25165064|NCT01951625|50289158|FG002|Treatment Period|Protocol Violation|1|||
25186899|NCT01456052|50337627|FG001|Overall Study|Physician Decision|0|||
25165065|NCT01951625|50289159|FG003|Treatment Period|Protocol Violation|3|||
25165066|NCT01951625|50289160|FG004|Treatment Period|Protocol Violation|2|||
25165067|NCT01951625|50289156|FG000|Treatment Period|Physician Decision|0|||
25186900|NCT01456052|50337628|FG002|Overall Study|Physician Decision|1|||
25165068|NCT01951625|50289157|FG001|Treatment Period|Physician Decision|0|||
25165069|NCT01951625|50289158|FG002|Treatment Period|Physician Decision|0|||
25165070|NCT01951625|50289159|FG003|Treatment Period|Physician Decision|0|||
25165071|NCT01951625|50289160|FG004|Treatment Period|Physician Decision|1|||
25165072|NCT01951625|50289156|FG000|Treatment Period|Protocol driven decision point|0|||
25165073|NCT01951625|50289157|FG001|Treatment Period|Protocol driven decision point|5|||
25165074|NCT01951625|50289158|FG002|Treatment Period|Protocol driven decision point|0|||
25165075|NCT01951625|50289159|FG003|Treatment Period|Protocol driven decision point|2|||
25165076|NCT01951625|50289160|FG004|Treatment Period|Protocol driven decision point|1|||
25165077|NCT01951625|50289156|FG000|Treatment Period|Non compliance with study drug|1|||
25165078|NCT01951625|50289157|FG001|Treatment Period|Non compliance with study drug|2|||
25165079|NCT01951625|50289158|FG002|Treatment Period|Non compliance with study drug|2|||
25186901|NCT01456052|50337626|FG000|Overall Study|Treatment Failure|0|||
25165080|NCT01951625|50289159|FG003|Treatment Period|Non compliance with study drug|0|||
25165081|NCT01951625|50289160|FG004|Treatment Period|Non compliance with study drug|0|||
25165082|NCT01951625|50289156|FG000|Treatment Period|Death|3|||
25165083|NCT01951625|50289157|FG001|Treatment Period|Death|2|||
25165084|NCT01951625|50289158|FG002|Treatment Period|Death|2|||
25165085|NCT01951625|50289159|FG003|Treatment Period|Death|1|||
25165086|NCT01951625|50289160|FG004|Treatment Period|Death|2|||
25165087|NCT01951625|50289156|FG000|Treatment Period|Adverse Event|7|||
25165088|NCT01951625|50289157|FG001|Treatment Period|Adverse Event|10|||
25165089|NCT01951625|50289158|FG002|Treatment Period|Adverse Event|9|||
25165090|NCT01951625|50289159|FG003|Treatment Period|Adverse Event|8|||
25165091|NCT01951625|50289160|FG004|Treatment Period|Adverse Event|8|||
25165092|NCT01951625|50289156|FG000|Treatment Period|Withdrawal by Subject|5|||
25165093|NCT01951625|50289157|FG001|Treatment Period|Withdrawal by Subject|2|||
25165094|NCT01951625|50289158|FG002|Treatment Period|Withdrawal by Subject|1|||
25165095|NCT01951625|50289159|FG003|Treatment Period|Withdrawal by Subject|7|||
25165096|NCT01951625|50289160|FG004|Treatment Period|Withdrawal by Subject|3|||
25165097|NCT01951625|50289156|FG000|Treatment Period|Lost to Follow-up|1|||
25165098|NCT01951625|50289157|FG001|Treatment Period|Lost to Follow-up|0|||
25165099|NCT01951625|50289158|FG002|Treatment Period|Lost to Follow-up|0|||
25165100|NCT01951625|50289159|FG003|Treatment Period|Lost to Follow-up|1|||
25165101|NCT01951625|50289160|FG004|Treatment Period|Lost to Follow-up|0|||
25165102|NCT01951625|50289156|FG000|Follow Up Period|Non-compliance with study drug|1|||
25165103|NCT01951625|50289157|FG001|Follow Up Period|Non-compliance with study drug|0|||
25165104|NCT01951625|50289158|FG002|Follow Up Period|Non-compliance with study drug|0|||
25165105|NCT01951625|50289159|FG003|Follow Up Period|Non-compliance with study drug|0|||
25165106|NCT01951625|50289160|FG004|Follow Up Period|Non-compliance with study drug|0|||
25165107|NCT01951625|50289156|FG000|Follow Up Period|Death|1|||
25165108|NCT01951625|50289157|FG001|Follow Up Period|Death|3|||
25165109|NCT01951625|50289158|FG002|Follow Up Period|Death|2|||
25165110|NCT01951625|50289159|FG003|Follow Up Period|Death|2|||
25165111|NCT01951625|50289160|FG004|Follow Up Period|Death|1|||
25165112|NCT01951625|50289156|FG000|Follow Up Period|Logistical difficulties|1|||
25165113|NCT01951625|50289157|FG001|Follow Up Period|Logistical difficulties|2|||
25165114|NCT01951625|50289158|FG002|Follow Up Period|Logistical difficulties|0|||
25165115|NCT01951625|50289159|FG003|Follow Up Period|Logistical difficulties|0|||
25165116|NCT01951625|50289160|FG004|Follow Up Period|Logistical difficulties|0|||
25165117|NCT01951625|50289156|FG000|Follow Up Period|Adverse Event|0|||
25165118|NCT01951625|50289157|FG001|Follow Up Period|Adverse Event|3|||
25165119|NCT01951625|50289158|FG002|Follow Up Period|Adverse Event|2|||
25165120|NCT01951625|50289159|FG003|Follow Up Period|Adverse Event|3|||
25165121|NCT01951625|50289160|FG004|Follow Up Period|Adverse Event|5|||
25165122|NCT01951625|50289156|FG000|Follow Up Period|Withdrawal by Subject|4|||
25165123|NCT01951625|50289157|FG001|Follow Up Period|Withdrawal by Subject|1|||
25165124|NCT01951625|50289158|FG002|Follow Up Period|Withdrawal by Subject|0|||
25165125|NCT01951625|50289159|FG003|Follow Up Period|Withdrawal by Subject|5|||
25165126|NCT01951625|50289160|FG004|Follow Up Period|Withdrawal by Subject|3|||
25165127|NCT01951625|50289156|FG000|Follow Up Period|Lost to Follow-up|1|||
25165128|NCT01951625|50289157|FG001|Follow Up Period|Lost to Follow-up|0|||
25165129|NCT01951625|50289158|FG002|Follow Up Period|Lost to Follow-up|0|||
25165130|NCT01951625|50289159|FG003|Follow Up Period|Lost to Follow-up|1|||
25165131|NCT01951625|50289160|FG004|Follow Up Period|Lost to Follow-up|1|||
25165132|NCT04400890|50289175|FG000|Overall Study|Withdrawal by Subject|3|||
25165133|NCT04400890|50289176|FG001|Overall Study|Withdrawal by Subject|2|||
25165134|NCT01936649|50289182|FG000|Overall Study|Withdrawal by Subject|4|||
25165135|NCT01936649|50289182|FG000|Overall Study|Physician Decision|2|||
25165136|NCT01936649|50289182|FG000|Overall Study|Protocol Violation|2|||
24964399|NCT00006604|50054263|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
24964400|NCT00006604|50054264|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
24964401|NCT00006604|50054265|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
25165137|NCT01936649|50289182|FG000|Overall Study|Other than specified above|5|||
25165138|NCT01720069|50289189|FG000|Overall Study|Could not use e-diary correctly|0|||
25165139|NCT01720069|50289190|FG001|Overall Study|Could not use e-diary correctly|1|||
25165140|NCT01720069|50289191|FG002|Overall Study|Could not use e-diary correctly|1|||
25165141|NCT01720069|50289189|FG000|Overall Study|Randomised without baseline values|0|||
25165142|NCT01720069|50289190|FG001|Overall Study|Randomised without baseline values|0|||
25165143|NCT01720069|50289191|FG002|Overall Study|Randomised without baseline values|1|||
25165144|NCT01720069|50289189|FG000|Overall Study|Adverse Event|0|||
25165145|NCT01720069|50289190|FG001|Overall Study|Adverse Event|0|||
25165146|NCT01720069|50289191|FG002|Overall Study|Adverse Event|1|||
25165147|NCT01720069|50289189|FG000|Overall Study|Lack of Efficacy|0|||
25165148|NCT01720069|50289190|FG001|Overall Study|Lack of Efficacy|4|||
25165149|NCT01720069|50289191|FG002|Overall Study|Lack of Efficacy|0|||
25165150|NCT01720069|50289189|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
25165151|NCT01720069|50289190|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
25165152|NCT01720069|50289191|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
25165153|NCT01720069|50289189|FG000|Overall Study|Withdrawal by Subject|0|||
25165154|NCT01720069|50289190|FG001|Overall Study|Withdrawal by Subject|2|||
25165155|NCT01720069|50289191|FG002|Overall Study|Withdrawal by Subject|1|||
25165156|NCT01720069|50289189|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
25165157|NCT01720069|50289190|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
25165158|NCT01720069|50289191|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
25165159|NCT01720069|50289189|FG000|Overall Study|Non-compliance on using e-diary|0|||
25165160|NCT01720069|50289190|FG001|Overall Study|Non-compliance on using e-diary|0|||
25165161|NCT01720069|50289191|FG002|Overall Study|Non-compliance on using e-diary|1|||
25165162|NCT01720069|50289189|FG000|Overall Study|Lost to Follow-up|0|||
25165163|NCT01720069|50289190|FG001|Overall Study|Lost to Follow-up|0|||
25165164|NCT01720069|50289191|FG002|Overall Study|Lost to Follow-up|1|||
25165165|NCT01719757|50289237|FG000|Overall Study|Adverse Event|38|||
25165166|NCT01719757|50289237|FG000|Overall Study|Withdrawal by Subject|15|||
25165167|NCT01719757|50289237|FG000|Overall Study|Lost to Follow-up|20|||
25165168|NCT01719757|50289237|FG000|Overall Study|Protocol Violation|1|||
24964402|NCT00006604|50054249|FG000|Overall Study|Lost to Follow-up|0|||
24964403|NCT00006604|50054250|FG001|Overall Study|Lost to Follow-up|0|||
24964404|NCT00006604|50054251|FG002|Overall Study|Lost to Follow-up|0|||
24964405|NCT00006604|50054252|FG003|Overall Study|Lost to Follow-up|0|||
24964406|NCT00006604|50054253|FG004|Overall Study|Lost to Follow-up|0|||
24964407|NCT00006604|50054254|FG005|Overall Study|Lost to Follow-up|0|||
24964408|NCT00006604|50054255|FG006|Overall Study|Lost to Follow-up|0|||
24964409|NCT00006604|50054256|FG007|Overall Study|Lost to Follow-up|1|||
24964410|NCT00006604|50054257|FG008|Overall Study|Lost to Follow-up|0|||
25067130|NCT02456740|50172685|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
25067131|NCT02456740|50172686|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
25067132|NCT02456740|50172687|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
25067133|NCT02456740|50172688|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
25067134|NCT02456740|50172689|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
25067135|NCT02456740|50172690|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
25067136|NCT02456740|50172691|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
25067137|NCT02456740|50172692|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
25067138|NCT02456740|50172693|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
25165169|NCT01719757|50289237|FG000|Overall Study|well controlled pain|27|||
25165170|NCT01718509|50289245|FG000|Overall Study|Lost to Follow-up|18|||
25165171|NCT01718509|50289246|FG001|Overall Study|Lost to Follow-up|15|||
25165172|NCT01718509|50289245|FG000|Overall Study|Withdrawal by Subject|7|||
25165173|NCT01718509|50289246|FG001|Overall Study|Withdrawal by Subject|13|||
25165174|NCT01718509|50289245|FG000|Overall Study|Adverse Event|5|||
25165175|NCT01718509|50289246|FG001|Overall Study|Adverse Event|7|||
25165176|NCT01718509|50289245|FG000|Overall Study|Other|13|||
25165177|NCT01718509|50289246|FG001|Overall Study|Other|11|||
25186902|NCT01456052|50337627|FG001|Overall Study|Treatment Failure|1|||
25165178|NCT01718509|50289245|FG000|Overall Study|Protocol Violation|4|||
25165179|NCT01718509|50289246|FG001|Overall Study|Protocol Violation|2|||
25186903|NCT01456052|50337628|FG002|Overall Study|Treatment Failure|1|||
24964411|NCT00006604|50054258|FG009|Overall Study|Lost to Follow-up|2|||
24964412|NCT00006604|50054259|FG010|Overall Study|Lost to Follow-up|0|||
24964413|NCT00006604|50054260|FG011|Overall Study|Lost to Follow-up|0|||
25165180|NCT01718509|50289245|FG000|Overall Study|Lack of Efficacy|1|||
25165181|NCT01718509|50289246|FG001|Overall Study|Lack of Efficacy|0|||
25165182|NCT01857934|50289252|FG000|Overall Study|Relapse or progression|2|||
25165183|NCT01857934|50289252|FG000|Overall Study|Unacceptable toxicity|3|||
25165184|NCT01857934|50289252|FG000|Overall Study|Unwillingness or inability to comply|2|||
25165185|NCT01857934|50289252|FG000|Overall Study|Physician Decision|3|||
25165186|NCT01604941|50289293|FG000|Overall Study|Adverse Event|1|||
25165187|NCT01604941|50289294|FG001|Overall Study|Adverse Event|2|||
25165188|NCT01604941|50289295|FG002|Overall Study|Adverse Event|0|||
25165189|NCT01604941|50289296|FG003|Overall Study|Adverse Event|0|||
25165190|NCT01604941|50289297|FG004|Overall Study|Adverse Event|1|||
25165191|NCT01604941|50289298|FG005|Overall Study|Adverse Event|5|||
25165192|NCT01604941|50289293|FG000|Overall Study|Non-compliance|1|||
25165193|NCT01604941|50289294|FG001|Overall Study|Non-compliance|0|||
25165194|NCT01604941|50289295|FG002|Overall Study|Non-compliance|0|||
25165195|NCT01604941|50289296|FG003|Overall Study|Non-compliance|0|||
25165196|NCT01604941|50289297|FG004|Overall Study|Non-compliance|0|||
25165197|NCT01604941|50289298|FG005|Overall Study|Non-compliance|0|||
25165198|NCT01604941|50289293|FG000|Overall Study|Participant Decision|0|||
25165199|NCT01604941|50289294|FG001|Overall Study|Participant Decision|0|||
25165200|NCT01604941|50289295|FG002|Overall Study|Participant Decision|0|||
25165201|NCT01604941|50289296|FG003|Overall Study|Participant Decision|0|||
25165202|NCT01604941|50289297|FG004|Overall Study|Participant Decision|0|||
25165203|NCT01604941|50289298|FG005|Overall Study|Participant Decision|2|||
25165204|NCT01604941|50289293|FG000|Overall Study|Early Study Termination|9|||
25165205|NCT01604941|50289294|FG001|Overall Study|Early Study Termination|2|||
25165206|NCT01604941|50289295|FG002|Overall Study|Early Study Termination|3|||
25165207|NCT01604941|50289296|FG003|Overall Study|Early Study Termination|3|||
25165208|NCT01604941|50289297|FG004|Overall Study|Early Study Termination|0|||
25165209|NCT01604941|50289298|FG005|Overall Study|Early Study Termination|0|||
25165210|NCT01604785|50289306|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
25165211|NCT01604785|50289307|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
25165212|NCT01681849|50289316|FG000|Overall Study|Protocol Violation|2|||
25165213|NCT01681849|50289317|FG001|Overall Study|Protocol Violation|0|||
25165214|NCT01681849|50289318|FG002|Overall Study|Protocol Violation|0|||
25165215|NCT01681849|50289316|FG000|Overall Study|Withdrawal by Subject|3|||
25165216|NCT01681849|50289317|FG001|Overall Study|Withdrawal by Subject|5|||
25165217|NCT01681849|50289318|FG002|Overall Study|Withdrawal by Subject|33|||
25165218|NCT01681849|50289316|FG000|Overall Study|Lost to Follow-up|3|||
25165219|NCT01681849|50289317|FG001|Overall Study|Lost to Follow-up|2|||
25165220|NCT01681849|50289318|FG002|Overall Study|Lost to Follow-up|6|||
25165221|NCT01681771|50289327|FG000|Overall Study|Lost to Follow-up|4|||
25165222|NCT01681771|50289328|FG001|Overall Study|Lost to Follow-up|2|||
25165223|NCT04250350|50289334|FG000|Overall Study|Withdrawal by Subject|13|||
25165224|NCT04250350|50289334|FG000|Overall Study|Lost to Follow-up|8|||
25165225|NCT04250350|50289334|FG000|Overall Study|Adverse Event|5|||
25165226|NCT04250350|50289334|FG000|Overall Study|Lack of Efficacy|4|||
25165227|NCT04250350|50289334|FG000|Overall Study|Physician Decision|1|||
25165228|NCT04250350|50289334|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
25165229|NCT01718353|50289365|FG000|Overall Study|Lost to Follow-up|0|||
25165230|NCT01718353|50289366|FG001|Overall Study|Lost to Follow-up|1|||
25165231|NCT01718353|50289365|FG000|Overall Study|Principal Investigator's Decision|10|||
25165232|NCT01718353|50289366|FG001|Overall Study|Principal Investigator's Decision|4|||
25165233|NCT01718353|50289365|FG000|Overall Study|Randomized but not treated|2|||
25165234|NCT01718353|50289366|FG001|Overall Study|Randomized but not treated|0|||
25165235|NCT01716715|50289376|FG000|Overall Study|Never Treated|2|||
25165236|NCT01716715|50289377|FG001|Overall Study|Never Treated|4|||
25165237|NCT01697449|50289385|FG000|Overall Study|Disease progression|47|||
25165238|NCT01697449|50289385|FG000|Overall Study|Adverse Event|7|||
25165239|NCT01697449|50289385|FG000|Overall Study|Lost to Follow-up|5|||
25165240|NCT01697449|50289385|FG000|Overall Study|Withdrawal by Subject|2|||
25165241|NCT01697449|50289385|FG000|Overall Study|Physician Decision|1|||
25165242|NCT01697449|50289385|FG000|Overall Study|Death|2|||
25165243|NCT01697449|50289385|FG000|Overall Study|Other|1|||
25165244|NCT01697449|50289385|FG000|Overall Study|Missing|25|||
25165245|NCT01696981|50289394|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
25165246|NCT01696981|50289395|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
25165247|NCT01696981|50289394|FG000|Overall Study|Died Before Randomization|3|||
25165248|NCT01696981|50289395|FG001|Overall Study|Died Before Randomization|8|||
25165249|NCT01696981|50289394|FG000|Overall Study|Died Before ASU (Control)|278|||
25165250|NCT01696981|50289395|FG001|Overall Study|Died Before ASU (Control)|0|||
25165251|NCT01696981|50289394|FG000|Overall Study|Refused ASU (Control)|920|||
25165252|NCT01696981|50289395|FG001|Overall Study|Refused ASU (Control)|0|||
25165253|NCT01696981|50289394|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
25165254|NCT01696981|50289395|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
25165255|NCT01696279|50289401|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
25186904|NCT01387607|50337639|FG000|Overall Study|Adverse Event|23|||
25165256|NCT01696279|50289402|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
25165257|NCT01696279|50289403|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
25165258|NCT01696279|50289404|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
25165259|NCT01696279|50289401|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
25165260|NCT01696279|50289402|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
25165261|NCT01696279|50289403|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
25165262|NCT01696279|50289404|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
25165263|NCT01696279|50289401|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
25165264|NCT01696279|50289402|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
25165265|NCT01696279|50289403|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
25165266|NCT01696279|50289404|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
25165267|NCT01696279|50289401|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
25165268|NCT01696279|50289402|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
25165269|NCT01696279|50289403|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
25165270|NCT01696279|50289404|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
25165271|NCT01696279|50289401|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
25165272|NCT01696279|50289402|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
25165273|NCT01696279|50289403|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
25165274|NCT01696279|50289404|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
25165275|NCT01696279|50289401|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
25165276|NCT01696279|50289402|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
25165277|NCT01696279|50289403|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
25165278|NCT01696279|50289404|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
25165279|NCT01696279|50289401|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
25165280|NCT01696279|50289402|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
25165281|NCT01696279|50289403|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
25165282|NCT01696279|50289404|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
25165283|NCT01696279|50289401|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
25165284|NCT01696279|50289402|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
25165285|NCT01696279|50289403|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
25165286|NCT01696279|50289404|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
25165287|NCT01696279|50289401|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
25165288|NCT01696279|50289402|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
25165289|NCT01696279|50289403|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
25165290|NCT01696279|50289404|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
25165291|NCT01696279|50289401|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
25165292|NCT01696279|50289402|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
25165293|NCT01696279|50289403|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
25165294|NCT01696279|50289404|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
25165295|NCT01696279|50289401|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
25165296|NCT01696279|50289402|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
25165297|NCT01696279|50289403|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
25165298|NCT01696279|50289404|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
25165299|NCT01681069|50289415|FG000|Overall Study|Withdrawal by Subject|4|||
25165300|NCT01681069|50289416|FG001|Overall Study|Withdrawal by Subject|5|||
25165301|NCT01681069|50289415|FG000|Overall Study|Protocol Violation|1|||
25165302|NCT01681069|50289416|FG001|Overall Study|Protocol Violation|1|||
25165303|NCT01681069|50289415|FG000|Overall Study|Adverse Event|0|||
25165304|NCT01681069|50289416|FG001|Overall Study|Adverse Event|1|||
25165305|NCT01716559|50289422|FG000|Overall Study|Adverse Event|11|||
25165306|NCT01716559|50289422|FG000|Overall Study|Death|21|||
25165307|NCT01716559|50289422|FG000|Overall Study|Withdrawal by Subject|4|||
25165308|NCT01716559|50289422|FG000|Overall Study|Other withdrawal reason|75|||
25165309|NCT01936181|50289428|FG000|Randomised, Double-blind|Adverse Event|27|||
25165310|NCT01936181|50289429|FG001|Randomised, Double-blind|Adverse Event|21|||
25165311|NCT01936181|50289430|FG002|Randomised, Double-blind|Adverse Event|0|||
25165312|NCT01936181|50289431|FG003|Randomised, Double-blind|Adverse Event|0|||
25165313|NCT01936181|50289428|FG000|Randomised, Double-blind|Protocol Violation|1|||
25165314|NCT01936181|50289429|FG001|Randomised, Double-blind|Protocol Violation|5|||
25165315|NCT01936181|50289430|FG002|Randomised, Double-blind|Protocol Violation|0|||
25165316|NCT01936181|50289431|FG003|Randomised, Double-blind|Protocol Violation|0|||
25165317|NCT01936181|50289428|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
25165318|NCT01936181|50289429|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
25165319|NCT01936181|50289430|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
25165320|NCT01936181|50289431|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
25165321|NCT01936181|50289428|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
25186905|NCT01387607|50337640|FG001|Overall Study|Adverse Event|11|||
25276783|NCT00948766|50590713|FG000|Extension Study|Patient Withdrew Consent|32|||
25165322|NCT01936181|50289429|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
25165323|NCT01936181|50289430|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
25165324|NCT01936181|50289431|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
25165325|NCT01936181|50289428|FG000|Randomised, Double-blind|Pregnancy|0|||
25165326|NCT01936181|50289429|FG001|Randomised, Double-blind|Pregnancy|1|||
25165327|NCT01936181|50289430|FG002|Randomised, Double-blind|Pregnancy|0|||
25165328|NCT01936181|50289431|FG003|Randomised, Double-blind|Pregnancy|0|||
25165329|NCT01936181|50289428|FG000|Randomised, Double-blind|Physician Decision|4|||
25165330|NCT01936181|50289429|FG001|Randomised, Double-blind|Physician Decision|4|||
25165331|NCT01936181|50289430|FG002|Randomised, Double-blind|Physician Decision|0|||
25165332|NCT01936181|50289431|FG003|Randomised, Double-blind|Physician Decision|0|||
25165333|NCT01936181|50289428|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
25165334|NCT01936181|50289429|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
25165335|NCT01936181|50289430|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
25165336|NCT01936181|50289431|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
25165337|NCT01936181|50289428|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
25165338|NCT01936181|50289429|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
25165339|NCT01936181|50289430|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
25165340|NCT01936181|50289431|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
25165341|NCT01936181|50289428|FG000|Transition-extension|Adverse Event|3|||
25165342|NCT01936181|50289429|FG001|Transition-extension|Adverse Event|0|||
25165343|NCT01936181|50289430|FG002|Transition-extension|Adverse Event|3|||
25165344|NCT01936181|50289431|FG003|Transition-extension|Adverse Event|1|||
25165345|NCT01936181|50289428|FG000|Transition-extension|Lost to Follow-up|3|||
25165346|NCT01936181|50289429|FG001|Transition-extension|Lost to Follow-up|0|||
25165347|NCT01936181|50289430|FG002|Transition-extension|Lost to Follow-up|1|||
25165348|NCT01936181|50289431|FG003|Transition-extension|Lost to Follow-up|2|||
25165349|NCT01936181|50289428|FG000|Transition-extension|Physician Decision|2|||
25165350|NCT01936181|50289429|FG001|Transition-extension|Physician Decision|0|||
25165351|NCT01936181|50289430|FG002|Transition-extension|Physician Decision|0|||
25165352|NCT01936181|50289431|FG003|Transition-extension|Physician Decision|1|||
25165353|NCT01936181|50289428|FG000|Transition-extension|Withdrawal by Subject|7|||
25165354|NCT01936181|50289429|FG001|Transition-extension|Withdrawal by Subject|0|||
25165355|NCT01936181|50289430|FG002|Transition-extension|Withdrawal by Subject|2|||
25165356|NCT01936181|50289431|FG003|Transition-extension|Withdrawal by Subject|1|||
25165357|NCT01696045|50289444|FG000|Overall Study|Study drug toxicity|1|||
25165358|NCT01696045|50289445|FG001|Overall Study|Study drug toxicity|5|||
25165359|NCT01696045|50289444|FG000|Overall Study|Disease progression|2|||
25165360|NCT01696045|50289445|FG001|Overall Study|Disease progression|2|||
25165361|NCT01716169|50289451|FG000|Overall Study|Adverse Event|1|||
25165362|NCT01716169|50289451|FG000|Overall Study|Lost to Follow-up|1|||
25165363|NCT01716169|50289451|FG000|Overall Study|Withdrawal by Subject|1|||
25165364|NCT01716169|50289451|FG000|Overall Study|inconsistent dressing application|1|||
25165365|NCT01935947|50289460|FG000|Overall Study|Adverse Event|0|||
25165366|NCT01935947|50289461|FG001|Overall Study|Adverse Event|2|||
25165367|NCT01935947|50289462|FG002|Overall Study|Adverse Event|0|||
25165368|NCT01935947|50289460|FG000|Overall Study|Diease Progression|2|||
25165369|NCT01935947|50289461|FG001|Overall Study|Diease Progression|2|||
25165370|NCT01935947|50289462|FG002|Overall Study|Diease Progression|2|||
25165371|NCT01935947|50289460|FG000|Overall Study|Death|1|||
25165372|NCT01935947|50289461|FG001|Overall Study|Death|0|||
25165373|NCT01935947|50289462|FG002|Overall Study|Death|0|||
25165374|NCT01618019|50289475|FG000|Overall Study|Withdrawal by Subject|14|||
25165375|NCT01618019|50289476|FG001|Overall Study|Withdrawal by Subject|14|||
25165376|NCT01593787|50289485|FG000|Overall Study|Adverse Event|1|||
25165377|NCT01593787|50289486|FG001|Overall Study|Adverse Event|0|||
25165378|NCT01593787|50289487|FG002|Overall Study|Adverse Event|0|||
25165379|NCT01951157|50289500|FG000|Overall Study|Progressive Disease|12|||
25165380|NCT01951157|50289501|FG001|Overall Study|Progressive Disease|13|||
25165381|NCT01951157|50289502|FG002|Overall Study|Progressive Disease|10|||
25165382|NCT01951157|50289500|FG000|Overall Study|Treatment-unrelated AE|1|||
25165383|NCT01951157|50289501|FG001|Overall Study|Treatment-unrelated AE|0|||
25165384|NCT01951157|50289502|FG002|Overall Study|Treatment-unrelated AE|3|||
25165385|NCT01951157|50289500|FG000|Overall Study|Study Termination|0|||
25165386|NCT01951157|50289501|FG001|Overall Study|Study Termination|0|||
25165387|NCT01951157|50289502|FG002|Overall Study|Study Termination|1|||
25165388|NCT01951157|50289500|FG000|Overall Study|Physician Decision|5|||
25165389|NCT01951157|50289501|FG001|Overall Study|Physician Decision|3|||
25165390|NCT01951157|50289502|FG002|Overall Study|Physician Decision|2|||
25165391|NCT01951157|50289500|FG000|Overall Study|Non-treatmentrelated death|2|||
25165392|NCT01951157|50289501|FG001|Overall Study|Non-treatmentrelated death|2|||
25186906|NCT01387607|50337639|FG000|Overall Study|Lack of Efficacy|8|||
25165393|NCT01951157|50289502|FG002|Overall Study|Non-treatmentrelated death|2|||
25165394|NCT01951157|50289500|FG000|Overall Study|No treated|0|||
25165395|NCT01951157|50289501|FG001|Overall Study|No treated|1|||
25165396|NCT01951157|50289502|FG002|Overall Study|No treated|0|||
25165397|NCT01951157|50289500|FG000|Overall Study|Treatment-related AE|2|||
25165398|NCT01951157|50289501|FG001|Overall Study|Treatment-related AE|0|||
25165399|NCT01951157|50289502|FG002|Overall Study|Treatment-related AE|4|||
25165400|NCT01951157|50289500|FG000|Overall Study|Consent withdrawn by subject|0|||
25165401|NCT01951157|50289501|FG001|Overall Study|Consent withdrawn by subject|1|||
25165402|NCT01951157|50289502|FG002|Overall Study|Consent withdrawn by subject|3|||
25165403|NCT01951157|50289500|FG000|Overall Study|Treatment-related death|0|||
25165404|NCT01951157|50289501|FG001|Overall Study|Treatment-related death|2|||
25165405|NCT01951157|50289502|FG002|Overall Study|Treatment-related death|0|||
25165406|NCT01363349|50289513|FG000|Overall Study|Adverse Event|6|||
25165407|NCT01363349|50289514|FG001|Overall Study|Adverse Event|7|||
25165408|NCT01363349|50289513|FG000|Overall Study|Lack of Efficacy|3|||
25165409|NCT01363349|50289514|FG001|Overall Study|Lack of Efficacy|10|||
25165410|NCT01363349|50289513|FG000|Overall Study|Non compliance/Protocol deviations|2|||
25165411|NCT01363349|50289514|FG001|Overall Study|Non compliance/Protocol deviations|2|||
25165412|NCT01363349|50289513|FG000|Overall Study|Withdrawal by Subject|14|||
25165413|NCT01363349|50289514|FG001|Overall Study|Withdrawal by Subject|6|||
25165414|NCT01363349|50289513|FG000|Overall Study|Lost to Follow-up|5|||
25165415|NCT01363349|50289514|FG001|Overall Study|Lost to Follow-up|6|||
25165416|NCT01363349|50289513|FG000|Overall Study|Not reported|36|||
25165417|NCT01363349|50289514|FG001|Overall Study|Not reported|37|||
25165418|NCT01363349|50289513|FG000|Overall Study|missing|1|||
25165419|NCT01363349|50289514|FG001|Overall Study|missing|2|||
25165420|NCT01933919|50289605|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
25165421|NCT01933919|50289606|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
25165422|NCT01933919|50289605|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
25165423|NCT01933919|50289606|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
25165424|NCT01933919|50289605|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
25165425|NCT01933919|50289606|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
25165426|NCT01933919|50289605|FG000|Open-label Long-term Phase|Adverse Event|2|||
25165427|NCT01933919|50289606|FG001|Open-label Long-term Phase|Adverse Event|0|||
25165428|NCT01933919|50289605|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
25165429|NCT01933919|50289606|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
25165430|NCT01933919|50289605|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
25165431|NCT01933919|50289606|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
25165432|NCT01933919|50289605|FG000|Open-label Long-term Phase|Other|1|||
25165433|NCT01933919|50289606|FG001|Open-label Long-term Phase|Other|2|||
25165434|NCT01933217|50289635|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
25165435|NCT01933217|50289636|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
25165436|NCT01933217|50289635|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
25165437|NCT01933217|50289636|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
25165438|NCT01932437|50289646|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
25165439|NCT01932437|50289647|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
25165440|NCT01932437|50289648|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
25165441|NCT01932437|50289649|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
25165442|NCT01932437|50289650|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
25165443|NCT01932437|50289651|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
25165444|NCT01949051|50289672|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
25165445|NCT01949051|50289673|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
25165446|NCT01949051|50289674|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
25165447|NCT01949051|50289675|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
25165448|NCT01949051|50289676|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
25165449|NCT01949051|50289677|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
25165450|NCT01949051|50289672|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
25165451|NCT01949051|50289673|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
25165452|NCT01949051|50289674|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
25165453|NCT01949051|50289675|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
25165454|NCT01949051|50289676|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
25165455|NCT01949051|50289677|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
25165456|NCT01949051|50289672|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
25165457|NCT01949051|50289673|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
25165458|NCT01949051|50289674|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
25165459|NCT01949051|50289675|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
25165460|NCT01949051|50289676|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
25165461|NCT01949051|50289677|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
25165462|NCT01949051|50289672|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
25165463|NCT01949051|50289673|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
25165464|NCT01949051|50289674|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
25165465|NCT01949051|50289675|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
25165466|NCT01949051|50289676|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
25165467|NCT01949051|50289677|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
25165468|NCT01949051|50289672|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
25165469|NCT01949051|50289673|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
25165470|NCT01949051|50289674|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
25165471|NCT01949051|50289675|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
25165472|NCT01949051|50289676|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
25165473|NCT01949051|50289677|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
25165474|NCT01948427|50289690|FG000|Overall Study|Serious Adverse Event|3|||
25165475|NCT01948427|50289691|FG001|Overall Study|Serious Adverse Event|0|||
25165476|NCT01948427|50289692|FG002|Overall Study|Serious Adverse Event|0|||
25165477|NCT01948427|50289693|FG003|Overall Study|Serious Adverse Event|0|||
25165478|NCT01948427|50289694|FG004|Overall Study|Serious Adverse Event|1|||
25165479|NCT01948427|50289690|FG000|Overall Study|Investigator Request|0|||
25165480|NCT01948427|50289691|FG001|Overall Study|Investigator Request|8|||
25165481|NCT01948427|50289692|FG002|Overall Study|Investigator Request|0|||
25165482|NCT01948427|50289693|FG003|Overall Study|Investigator Request|0|||
25165483|NCT01948427|50289694|FG004|Overall Study|Investigator Request|6|||
25165484|NCT01948427|50289690|FG000|Overall Study|Lost to Follow-up|1|||
25165485|NCT01948427|50289691|FG001|Overall Study|Lost to Follow-up|0|||
25165486|NCT01948427|50289692|FG002|Overall Study|Lost to Follow-up|0|||
25165487|NCT01948427|50289693|FG003|Overall Study|Lost to Follow-up|0|||
25165488|NCT01948427|50289694|FG004|Overall Study|Lost to Follow-up|4|||
25165489|NCT01948427|50289690|FG000|Overall Study|Withdrawal by Subject|2|||
25165490|NCT01948427|50289691|FG001|Overall Study|Withdrawal by Subject|0|||
25165491|NCT01948427|50289692|FG002|Overall Study|Withdrawal by Subject|0|||
25165492|NCT01948427|50289693|FG003|Overall Study|Withdrawal by Subject|0|||
25165493|NCT01948427|50289694|FG004|Overall Study|Withdrawal by Subject|1|||
25165494|NCT01948427|50289690|FG000|Overall Study|Other, Not Specified|1|||
25165495|NCT01948427|50289691|FG001|Overall Study|Other, Not Specified|9|||
25165496|NCT01948427|50289692|FG002|Overall Study|Other, Not Specified|0|||
25165497|NCT01948427|50289693|FG003|Overall Study|Other, Not Specified|0|||
25165498|NCT01948427|50289694|FG004|Overall Study|Other, Not Specified|2|||
25165499|NCT01948193|50289711|FG000|Overall Study|Serious event|2|||
25165500|NCT01948193|50289711|FG000|Overall Study|Lost to Follow-up|7|||
25165501|NCT01694485|50289721|FG000|Overall Study|Withdrawal by Subject|20|||
25165502|NCT01694485|50289722|FG001|Overall Study|Withdrawal by Subject|6|||
25165503|NCT01694485|50289723|FG002|Overall Study|Withdrawal by Subject|7|||
25165504|NCT01694485|50289724|FG003|Overall Study|Withdrawal by Subject|25|||
25165505|NCT01694485|50289725|FG004|Overall Study|Withdrawal by Subject|18|||
25165506|NCT01694485|50289721|FG000|Overall Study|Sponsor Decision|3|||
25165507|NCT01694485|50289722|FG001|Overall Study|Sponsor Decision|0|||
25165508|NCT01694485|50289723|FG002|Overall Study|Sponsor Decision|0|||
25165509|NCT01694485|50289724|FG003|Overall Study|Sponsor Decision|2|||
25165510|NCT01694485|50289725|FG004|Overall Study|Sponsor Decision|0|||
25165511|NCT01694485|50289721|FG000|Overall Study|Lost to Follow-up|9|||
25165512|NCT01694485|50289722|FG001|Overall Study|Lost to Follow-up|1|||
25165513|NCT01694485|50289723|FG002|Overall Study|Lost to Follow-up|6|||
25165514|NCT01694485|50289724|FG003|Overall Study|Lost to Follow-up|10|||
25165515|NCT01694485|50289725|FG004|Overall Study|Lost to Follow-up|7|||
25165516|NCT01694485|50289721|FG000|Overall Study|Death|1|||
25165517|NCT01694485|50289722|FG001|Overall Study|Death|0|||
25165518|NCT01694485|50289723|FG002|Overall Study|Death|0|||
25165519|NCT01694485|50289724|FG003|Overall Study|Death|1|||
25165520|NCT01694485|50289725|FG004|Overall Study|Death|0|||
25165521|NCT01931735|50289746|FG000|Randomized Phase|Lost to Follow-up|2|||
25165522|NCT01931735|50289747|FG001|Randomized Phase|Lost to Follow-up|2|||
25165523|NCT01931735|50289748|FG002|Randomized Phase|Lost to Follow-up|5|||
25165524|NCT01931735|50289749|FG003|Randomized Phase|Lost to Follow-up|0|||
25165525|NCT01931735|50289746|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
25165526|NCT01931735|50289747|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
25165527|NCT01931735|50289748|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
25165528|NCT01931735|50289749|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
25165529|NCT01931735|50289746|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
25165530|NCT01931735|50289747|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
25165531|NCT01931735|50289748|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
25165532|NCT01931735|50289749|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
25165533|NCT01930799|50289759|FG000|Overall Study|Withdrawal by Subject|3|||
25165534|NCT01930799|50289759|FG000|Overall Study|Lost to Follow-up|5|||
25165535|NCT01947491|50289767|FG000|Overall Study|Lost to Follow-up|5|||
25165536|NCT01947491|50289768|FG001|Overall Study|Lost to Follow-up|3|||
25165537|NCT01947491|50289769|FG002|Overall Study|Lost to Follow-up|1|||
25276784|NCT00948766|50590714|FG001|Extension Study|Patient Withdrew Consent|0|||
25165538|NCT01947491|50289770|FG003|Overall Study|Lost to Follow-up|2|||
25165539|NCT01947491|50289767|FG000|Overall Study|Lack of Efficacy|1|||
25165540|NCT01947491|50289768|FG001|Overall Study|Lack of Efficacy|0|||
25165541|NCT01947491|50289769|FG002|Overall Study|Lack of Efficacy|0|||
25165542|NCT01947491|50289770|FG003|Overall Study|Lack of Efficacy|1|||
25165543|NCT01947491|50289767|FG000|Overall Study|Protocol Violation|1|||
25165544|NCT01947491|50289768|FG001|Overall Study|Protocol Violation|0|||
25165545|NCT01947491|50289769|FG002|Overall Study|Protocol Violation|0|||
25165546|NCT01947491|50289770|FG003|Overall Study|Protocol Violation|0|||
25165547|NCT01947491|50289767|FG000|Overall Study|Withdrawal by Subject|1|||
25165548|NCT01947491|50289768|FG001|Overall Study|Withdrawal by Subject|1|||
25165549|NCT01947491|50289769|FG002|Overall Study|Withdrawal by Subject|1|||
25165550|NCT01947491|50289770|FG003|Overall Study|Withdrawal by Subject|0|||
25165551|NCT01947491|50289767|FG000|Overall Study|Worsening of condition|0|||
25165552|NCT01947491|50289768|FG001|Overall Study|Worsening of condition|1|||
25165553|NCT01947491|50289769|FG002|Overall Study|Worsening of condition|0|||
25165554|NCT01947491|50289770|FG003|Overall Study|Worsening of condition|0|||
25165555|NCT01947491|50289767|FG000|Overall Study|Adverse Event|0|||
25165556|NCT01947491|50289768|FG001|Overall Study|Adverse Event|1|||
25165557|NCT01947491|50289769|FG002|Overall Study|Adverse Event|0|||
25165558|NCT01947491|50289770|FG003|Overall Study|Adverse Event|2|||
25165559|NCT01715857|50289780|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
25165560|NCT01692301|50289786|FG000|Overall Study|Adverse Event|15|||
25165561|NCT01692301|50289787|FG001|Overall Study|Adverse Event|12|||
25165562|NCT01692301|50289786|FG000|Overall Study|Death|1|||
25165563|NCT01692301|50289787|FG001|Overall Study|Death|2|||
25165564|NCT01692301|50289786|FG000|Overall Study|Lack of Efficacy|0|||
25165565|NCT01692301|50289787|FG001|Overall Study|Lack of Efficacy|5|||
25165566|NCT01692301|50289786|FG000|Overall Study|Non-compliance with study treatment|1|||
25165567|NCT01692301|50289787|FG001|Overall Study|Non-compliance with study treatment|2|||
25165568|NCT01692301|50289786|FG000|Overall Study|Protocol deviation|9|||
25165569|NCT01692301|50289787|FG001|Overall Study|Protocol deviation|2|||
25165570|NCT01692301|50289786|FG000|Overall Study|Patient/guardian decision|16|||
25165571|NCT01692301|50289787|FG001|Overall Study|Patient/guardian decision|15|||
25165572|NCT01692301|50289786|FG000|Overall Study|Technical problems|0|||
25165573|NCT01692301|50289787|FG001|Overall Study|Technical problems|1|||
25165574|NCT01692301|50289786|FG000|Overall Study|Physician Decision|2|||
25165575|NCT01692301|50289787|FG001|Overall Study|Physician Decision|2|||
25165576|NCT01692301|50289786|FG000|Overall Study|Lost to Follow-up|1|||
25165577|NCT01692301|50289787|FG001|Overall Study|Lost to Follow-up|1|||
25165578|NCT01592773|50289793|FG000|Overall Study|Study Terminated by Sponsor|582|||
25165579|NCT01592773|50289793|FG000|Overall Study|Withdrawal by Subject|35|||
25165580|NCT01592773|50289793|FG000|Overall Study|Lost to Follow-up|19|||
25165581|NCT01592773|50289793|FG000|Overall Study|Adverse Event|17|||
25165582|NCT01592773|50289793|FG000|Overall Study|Lack of Efficacy|9|||
25165583|NCT01592773|50289793|FG000|Overall Study|Protocol Violation|2|||
25165584|NCT01592773|50289793|FG000|Overall Study|Inclusion/exclusion not meet|1|||
25165585|NCT01592773|50289793|FG000|Overall Study|Other Reason|1|||
25165586|NCT01930175|50289800|FG000|Core Study|Lost to Follow-up|0|||
25165587|NCT01930175|50289801|FG001|Core Study|Lost to Follow-up|1|||
25165588|NCT01930175|50289802|FG002|Core Study|Lost to Follow-up|0|||
25165589|NCT01930175|50289800|FG000|Core Study|Adverse Event|0|||
25165590|NCT01930175|50289801|FG001|Core Study|Adverse Event|0|||
25165591|NCT01930175|50289802|FG002|Core Study|Adverse Event|1|||
25165592|NCT01592695|50289813|FG000|Overall Study|Lost to Follow-up|8|||
25165593|NCT01592695|50289814|FG001|Overall Study|Lost to Follow-up|4|||
25165594|NCT01929863|50289820|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
25165595|NCT01929863|50289821|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
25165596|NCT01929863|50289820|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
25165597|NCT01929863|50289821|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
25165598|NCT01929863|50289820|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
25165599|NCT01929863|50289821|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
25165600|NCT01918085|50289834|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
25165601|NCT01918085|50289835|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
25165602|NCT01714687|50289845|FG000|Overall Study|Withdrawal by Subject|1|||
25165603|NCT01714687|50289846|FG001|Overall Study|Withdrawal by Subject|0|||
25165604|NCT01714687|50289845|FG000|Overall Study|Lost to Follow-up|2|||
25165605|NCT01714687|50289846|FG001|Overall Study|Lost to Follow-up|4|||
25165606|NCT01714609|50289856|FG000|Overall Study|Protocol Violation|1|||
25165607|NCT01714609|50289857|FG001|Overall Study|Protocol Violation|0|||
25165608|NCT01929707|50289863|FG000|Intervention Period 1|Lost to Follow-up|0|||
25165609|NCT01929707|50289864|FG001|Intervention Period 1|Lost to Follow-up|0|||
25165610|NCT01929707|50289865|FG002|Intervention Period 1|Lost to Follow-up|0|||
25165611|NCT01929707|50289866|FG003|Intervention Period 1|Lost to Follow-up|1|||
25165612|NCT01929707|50289867|FG004|Intervention Period 1|Lost to Follow-up|0|||
25165613|NCT01929707|50289868|FG005|Intervention Period 1|Lost to Follow-up|0|||
25165614|NCT01929707|50289869|FG006|Intervention Period 1|Lost to Follow-up|0|||
25186907|NCT01387607|50337640|FG001|Overall Study|Lack of Efficacy|6|||
25276785|NCT00948766|50590713|FG000|Extension Study|Lost to Follow-up|8|||
25276786|NCT00948766|50590714|FG001|Extension Study|Lost to Follow-up|0|||
25165615|NCT01929707|50289870|FG007|Intervention Period 1|Lost to Follow-up|0|||
25165616|NCT01929707|50289863|FG000|Intervention Period 1|Withdrawal by Subject|0|||
25165617|NCT01929707|50289864|FG001|Intervention Period 1|Withdrawal by Subject|0|||
25165618|NCT01929707|50289865|FG002|Intervention Period 1|Withdrawal by Subject|0|||
25165619|NCT01929707|50289866|FG003|Intervention Period 1|Withdrawal by Subject|2|||
25165620|NCT01929707|50289867|FG004|Intervention Period 1|Withdrawal by Subject|0|||
25165621|NCT01929707|50289868|FG005|Intervention Period 1|Withdrawal by Subject|0|||
25165622|NCT01929707|50289869|FG006|Intervention Period 1|Withdrawal by Subject|0|||
25165623|NCT01929707|50289870|FG007|Intervention Period 1|Withdrawal by Subject|0|||
25165624|NCT01929707|50289863|FG000|Intervention Period 2|Withdrawal by Subject|0|||
25165625|NCT01929707|50289864|FG001|Intervention Period 2|Withdrawal by Subject|0|||
25165626|NCT01929707|50289865|FG002|Intervention Period 2|Withdrawal by Subject|0|||
25165627|NCT01929707|50289866|FG003|Intervention Period 2|Withdrawal by Subject|0|||
25165628|NCT01929707|50289867|FG004|Intervention Period 2|Withdrawal by Subject|0|||
25165629|NCT01929707|50289868|FG005|Intervention Period 2|Withdrawal by Subject|2|||
25165630|NCT01929707|50289869|FG006|Intervention Period 2|Withdrawal by Subject|0|||
25165631|NCT01929707|50289870|FG007|Intervention Period 2|Withdrawal by Subject|0|||
25165632|NCT01714063|50289891|FG000|Overall Study|Equipment malfunction|2|||
25165633|NCT01929395|50289902|FG000|Overall Study|Did not complete - non-related toxicity|1|||
25165634|NCT01929395|50289903|FG001|Overall Study|Did not complete - non-related toxicity|0|||
25165635|NCT01929395|50289904|FG002|Overall Study|Did not complete - non-related toxicity|0|||
25165636|NCT01929395|50289902|FG000|Overall Study|Withdrawal by Subject|0|||
25165637|NCT01929395|50289903|FG001|Overall Study|Withdrawal by Subject|1|||
25165638|NCT01929395|50289904|FG002|Overall Study|Withdrawal by Subject|0|||
25165639|NCT01929395|50289902|FG000|Overall Study|Screen Fail|0|||
25165640|NCT01929395|50289903|FG001|Overall Study|Screen Fail|0|||
25165641|NCT01929395|50289904|FG002|Overall Study|Screen Fail|1|||
25165642|NCT01713283|50289916|FG000|Overall Study|Lack of Efficacy|10|||
25165643|NCT01713283|50289917|FG001|Overall Study|Lack of Efficacy|2|||
25165644|NCT01713283|50289916|FG000|Overall Study|Lost to Follow-up|1|||
25165645|NCT01713283|50289917|FG001|Overall Study|Lost to Follow-up|1|||
25165646|NCT01592383|50289927|FG000|Overall Study|Adverse Event|1|||
25165647|NCT01691521|50289935|FG000|Overall Study|Adverse Event|4|||
25165648|NCT01691521|50289936|FG001|Overall Study|Adverse Event|0|||
25165649|NCT01691521|50289937|FG002|Overall Study|Adverse Event|1|||
25165650|NCT01691521|50289935|FG000|Overall Study|Lack of Efficacy|1|||
25165651|NCT01691521|50289936|FG001|Overall Study|Lack of Efficacy|1|||
25165652|NCT01691521|50289937|FG002|Overall Study|Lack of Efficacy|2|||
25165653|NCT01691521|50289935|FG000|Overall Study|Protocol Violation|0|||
25165654|NCT01691521|50289936|FG001|Overall Study|Protocol Violation|3|||
25165655|NCT01691521|50289937|FG002|Overall Study|Protocol Violation|0|||
25165656|NCT01691521|50289935|FG000|Overall Study|Lost to Follow-up|0|||
25165657|NCT01691521|50289936|FG001|Overall Study|Lost to Follow-up|2|||
25165658|NCT01691521|50289937|FG002|Overall Study|Lost to Follow-up|2|||
25165659|NCT01691521|50289935|FG000|Overall Study|Physician Decision|2|||
25165660|NCT01691521|50289936|FG001|Overall Study|Physician Decision|1|||
25165661|NCT01691521|50289937|FG002|Overall Study|Physician Decision|0|||
25165662|NCT01691521|50289935|FG000|Overall Study|Withdrawal by Subject|5|||
25165663|NCT01691521|50289936|FG001|Overall Study|Withdrawal by Subject|9|||
25165664|NCT01691521|50289937|FG002|Overall Study|Withdrawal by Subject|4|||
25165665|NCT01929317|50289948|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
25165666|NCT01929317|50289949|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
25165667|NCT01929317|50289948|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
25165668|NCT01929317|50289949|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
25165669|NCT01929317|50289948|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
25165670|NCT01929317|50289949|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
25165671|NCT01929317|50289948|FG000|Long-term Phase|Adverse Event|5|||
25165672|NCT01929317|50289949|FG001|Long-term Phase|Adverse Event|1|||
25165673|NCT01929317|50289948|FG000|Long-term Phase|Physician Decision|3|||
25165674|NCT01929317|50289949|FG001|Long-term Phase|Physician Decision|0|||
25165675|NCT01929317|50289948|FG000|Long-term Phase|Withdrawal by Subject|4|||
25165676|NCT01929317|50289949|FG001|Long-term Phase|Withdrawal by Subject|0|||
25165677|NCT01929317|50289948|FG000|Long-term Phase|Protocol Violation|1|||
25165678|NCT01929317|50289949|FG001|Long-term Phase|Protocol Violation|0|||
25165679|NCT01929317|50289948|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
25165680|NCT01929317|50289949|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
25165681|NCT01929317|50289948|FG000|Long-term Phase|Study Closed/Terminated|5|||
25186908|NCT01387607|50337639|FG000|Overall Study|Lost to Follow-up|2|||
25165682|NCT01929317|50289949|FG001|Long-term Phase|Study Closed/Terminated|3|||
25165683|NCT01711879|50289963|FG000|Overall Study|Death|1|||
25165684|NCT01711879|50289964|FG001|Overall Study|Death|0|||
25165685|NCT01689649|50289987|FG000|Overall Study|Lack of Efficacy|3|||
25165686|NCT01689649|50289987|FG000|Overall Study|Non-compliance|11|||
25165687|NCT01689649|50289987|FG000|Overall Study|Protocol Violation|3|||
25165688|NCT01689649|50289987|FG000|Overall Study|Lost to Follow-up|5|||
25165689|NCT01929083|50289991|FG000|Intervention 1|Lost to Follow-up|2|||
25165690|NCT01929083|50289992|FG001|Intervention 1|Lost to Follow-up|0|||
25165691|NCT01929083|50289991|FG000|Intervention 1|Nonadherent to study medications|1|||
25165692|NCT01929083|50289992|FG001|Intervention 1|Nonadherent to study medications|0|||
25165693|NCT01929083|50289991|FG000|Intervention 2|Adverse Event|0|||
25165694|NCT01929083|50289992|FG001|Intervention 2|Adverse Event|1|||
25165695|NCT01689337|50289998|FG000|Overall Study|Study Discontinuation|1|||
25165696|NCT01688635|50290004|FG000|Washout 1|Withdrawal by Subject|1|||
25165697|NCT01688635|50290005|FG001|Washout 1|Withdrawal by Subject|0|||
25165698|NCT01688635|50290004|FG000|Washout 1|Adverse Event|0|||
25165699|NCT01688635|50290005|FG001|Washout 1|Adverse Event|1|||
25165700|NCT01688635|50290004|FG000|Washout 1|Physician Decision|0|||
25165701|NCT01688635|50290005|FG001|Washout 1|Physician Decision|1|||
25165702|NCT01688635|50290004|FG000|Washout 2|Physician Decision|1|||
25165703|NCT01688635|50290005|FG001|Washout 2|Physician Decision|0|||
25165704|NCT01688635|50290004|FG000|Washout 2|Withdrawal by Subject|1|||
25165705|NCT01688635|50290005|FG001|Washout 2|Withdrawal by Subject|0|||
25165706|NCT01688635|50290004|FG000|Washout 2|Sponsor Decision|1|||
25165707|NCT01688635|50290005|FG001|Washout 2|Sponsor Decision|2|||
25165708|NCT01688635|50290004|FG000|Washout 3|Withdrawal by Subject|1|||
25165709|NCT01688635|50290005|FG001|Washout 3|Withdrawal by Subject|0|||
25165710|NCT01591681|50290012|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
25165711|NCT01591681|50290012|FG000|Overall Study|Failed to use system during run-in|1|||
25165712|NCT01711645|50290027|FG000|Overall Study|Withdrawal by Subject|8|||
25165713|NCT01711645|50290027|FG000|Overall Study|Lost to Follow-up|6|||
25165714|NCT01711645|50290027|FG000|Overall Study|Physician Decision|5|||
25165715|NCT01590433|50290042|FG000|Overall Study|Lost to Follow-up|20|||
25165716|NCT01590433|50290043|FG001|Overall Study|Lost to Follow-up|8|||
25165717|NCT01590433|50290042|FG000|Overall Study|Withdrawal by Subject|21|||
25165718|NCT01590433|50290043|FG001|Overall Study|Withdrawal by Subject|11|||
25165719|NCT01590433|50290042|FG000|Overall Study|Adverse Event|11|||
25165720|NCT01590433|50290043|FG001|Overall Study|Adverse Event|3|||
25165721|NCT01928927|50290060|FG000|Overall Study|Lost to Follow-up|1|||
25165722|NCT01928927|50290061|FG001|Overall Study|Lost to Follow-up|0|||
25165723|NCT01928927|50290060|FG000|Overall Study|Withdrawal by Subject|1|||
25165724|NCT01928927|50290061|FG001|Overall Study|Withdrawal by Subject|1|||
25165725|NCT01710709|50290082|FG000|Overall Study|Lost to Follow-up|29|||
25165726|NCT01710709|50290082|FG000|Overall Study|Adverse Event|48|||
25165727|NCT01710709|50290082|FG000|Overall Study|Participant met withdrawal criteria|33|||
25165728|NCT01710709|50290082|FG000|Overall Study|Participant withdrawn by investigator|2|||
25165729|NCT01710709|50290082|FG000|Overall Study|Withdrawal by Subject|53|||
25165730|NCT01710709|50290082|FG000|Overall Study|Protocol Violation|5|||
25165731|NCT01710709|50290082|FG000|Overall Study|Lack of Efficacy|3|||
25165732|NCT01617629|50290087|FG000|Overall Study|Death|2|||
25165733|NCT01617629|50290087|FG000|Overall Study|Investigator's Clinical Judgement|1|||
25165734|NCT01617629|50290087|FG000|Overall Study|Reason Not Specified|1|||
25165735|NCT01617629|50290087|FG000|Overall Study|Participant Withdrew Consent|2|||
25165736|NCT01686373|50290102|FG000|Overall Study|Lost to Follow-up|3|||
25165737|NCT01686373|50290103|FG001|Overall Study|Lost to Follow-up|0|||
25165738|NCT01686373|50290102|FG000|Overall Study|Withdrawal by Subject|0|||
25165739|NCT01686373|50290103|FG001|Overall Study|Withdrawal by Subject|1|||
25165740|NCT01686373|50290102|FG000|Overall Study|Adverse Event|0|||
25165741|NCT01686373|50290103|FG001|Overall Study|Adverse Event|1|||
25165742|NCT01709695|50290111|FG000|Overall Study|Withdrawal by Subject|1|||
25165743|NCT01709695|50290112|FG001|Overall Study|Withdrawal by Subject|1|||
25165744|NCT01685983|50290122|FG000|Overall Study|Adverse Event|7|||
25165745|NCT01685983|50290122|FG000|Overall Study|Death|1|||
25165746|NCT01685983|50290122|FG000|Overall Study|Withdrawal by Subject|19|||
25165747|NCT01685983|50290122|FG000|Overall Study|Protocol Violation|2|||
25165748|NCT01685983|50290122|FG000|Overall Study|Physician Decision|13|||
25165749|NCT01685983|50290122|FG000|Overall Study|Other|7|||
25165750|NCT01685983|50290122|FG000|Overall Study|Progressive Disease|32|||
25165751|NCT01685983|50290122|FG000|Overall Study|Noncompliance with Study Drug|1|||
25165752|NCT01685437|50290134|FG000|Overall Study|Withdrawal by Subject|22|||
25165753|NCT01685437|50290134|FG000|Overall Study|Lost to Follow-up|3|||
25165754|NCT01685437|50290134|FG000|Overall Study|Adverse Event|1|||
25165755|NCT01685437|50290134|FG000|Overall Study|Protocol Violation|4|||
25165756|NCT01685437|50290134|FG000|Overall Study|Unable to make visits due to work|1|||
25165757|NCT01685203|50290174|FG000|Overall Study|Lost to Follow-up|3|||
25165758|NCT01685203|50290175|FG001|Overall Study|Lost to Follow-up|3|||
25165759|NCT01685203|50290176|FG002|Overall Study|Lost to Follow-up|0|||
25165760|NCT01685203|50290177|FG003|Overall Study|Lost to Follow-up|1|||
25165761|NCT01685203|50290178|FG004|Overall Study|Lost to Follow-up|0|||
25165762|NCT01685203|50290179|FG005|Overall Study|Lost to Follow-up|0|||
25165763|NCT01685203|50290180|FG006|Overall Study|Lost to Follow-up|0|||
25165764|NCT01685203|50290174|FG000|Overall Study|Adverse Event|0|||
25165765|NCT01685203|50290175|FG001|Overall Study|Adverse Event|0|||
25165766|NCT01685203|50290176|FG002|Overall Study|Adverse Event|0|||
25165767|NCT01685203|50290177|FG003|Overall Study|Adverse Event|0|||
25165768|NCT01685203|50290178|FG004|Overall Study|Adverse Event|0|||
25165769|NCT01685203|50290179|FG005|Overall Study|Adverse Event|2|||
25165770|NCT01685203|50290180|FG006|Overall Study|Adverse Event|0|||
25165771|NCT01685203|50290174|FG000|Overall Study|Adverse event and withdrew consent|1|||
25165772|NCT01685203|50290175|FG001|Overall Study|Adverse event and withdrew consent|0|||
25165773|NCT01685203|50290176|FG002|Overall Study|Adverse event and withdrew consent|0|||
25165774|NCT01685203|50290177|FG003|Overall Study|Adverse event and withdrew consent|0|||
25165775|NCT01685203|50290178|FG004|Overall Study|Adverse event and withdrew consent|0|||
25165776|NCT01685203|50290179|FG005|Overall Study|Adverse event and withdrew consent|0|||
25165777|NCT01685203|50290180|FG006|Overall Study|Adverse event and withdrew consent|0|||
25165778|NCT01685203|50290174|FG000|Overall Study|Patient's decision|0|||
25165779|NCT01685203|50290175|FG001|Overall Study|Patient's decision|0|||
25165780|NCT01685203|50290176|FG002|Overall Study|Patient's decision|0|||
25165781|NCT01685203|50290177|FG003|Overall Study|Patient's decision|0|||
25165782|NCT01685203|50290178|FG004|Overall Study|Patient's decision|0|||
25165783|NCT01685203|50290179|FG005|Overall Study|Patient's decision|1|||
25165784|NCT01685203|50290180|FG006|Overall Study|Patient's decision|0|||
25165785|NCT01928771|50290199|FG000|Overall Study|Adverse Event|6|||
25165786|NCT01928771|50290200|FG001|Overall Study|Adverse Event|5|||
25165787|NCT01928771|50290201|FG002|Overall Study|Adverse Event|1|||
25165788|NCT01928771|50290199|FG000|Overall Study|Death|2|||
25165789|NCT01928771|50290200|FG001|Overall Study|Death|2|||
25165790|NCT01928771|50290201|FG002|Overall Study|Death|2|||
25165791|NCT01928771|50290199|FG000|Overall Study|Lost to Follow-up|5|||
25165792|NCT01928771|50290200|FG001|Overall Study|Lost to Follow-up|6|||
25165793|NCT01928771|50290201|FG002|Overall Study|Lost to Follow-up|3|||
25165794|NCT01928771|50290199|FG000|Overall Study|Withdrawal by Subject|20|||
25165795|NCT01928771|50290200|FG001|Overall Study|Withdrawal by Subject|15|||
25165796|NCT01928771|50290201|FG002|Overall Study|Withdrawal by Subject|17|||
25165797|NCT01928771|50290199|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
25165798|NCT01928771|50290200|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
25165799|NCT01928771|50290201|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
25165800|NCT01928771|50290199|FG000|Overall Study|Other Reasons|9|||
25165801|NCT01928771|50290200|FG001|Overall Study|Other Reasons|9|||
25165802|NCT01928771|50290201|FG002|Overall Study|Other Reasons|14|||
25165803|NCT01928771|50290199|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
25165804|NCT01928771|50290200|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
25165805|NCT01928771|50290201|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
25165806|NCT01589653|50290211|FG000|Overall Study|Protocol Violation|3|||
25165807|NCT01589653|50290212|FG001|Overall Study|Protocol Violation|1|||
25165808|NCT01589653|50290211|FG000|Overall Study|Withdrawal criteria|4|||
25165809|NCT01589653|50290212|FG001|Overall Study|Withdrawal criteria|7|||
25165810|NCT01589653|50290211|FG000|Overall Study|Unclassified|0|||
25165811|NCT01589653|50290212|FG001|Overall Study|Unclassified|3|||
25165812|NCT01928615|50290218|FG000|Overall Study|Study Terminated by Sponsor|2|||
25165813|NCT01589497|50290227|FG000|Overall Study|Withdrawal by Subject|0|||
25165814|NCT01589497|50290228|FG001|Overall Study|Withdrawal by Subject|1|||
25165815|NCT01589497|50290229|FG002|Overall Study|Withdrawal by Subject|0|||
25165816|NCT01589497|50290230|FG003|Overall Study|Withdrawal by Subject|1|||
25165817|NCT01589497|50290227|FG000|Overall Study|Death|1|||
25165818|NCT01589497|50290228|FG001|Overall Study|Death|0|||
25165819|NCT01589497|50290229|FG002|Overall Study|Death|0|||
25165820|NCT01589497|50290230|FG003|Overall Study|Death|0|||
25165821|NCT01589497|50290227|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
25165822|NCT01589497|50290228|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
25165823|NCT01589497|50290229|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
25165824|NCT01589497|50290230|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
25165825|NCT01928381|50290245|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
25165826|NCT01928381|50290246|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
25165827|NCT01928381|50290247|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
25165828|NCT01928381|50290248|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
25165829|NCT01928381|50290249|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
25165830|NCT01928381|50290250|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
25165831|NCT01928381|50290251|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
25165832|NCT01928381|50290245|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
25165833|NCT01928381|50290246|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
25186909|NCT01387607|50337640|FG001|Overall Study|Lost to Follow-up|1|||
24964414|NCT00006604|50054261|FG012|Overall Study|Lost to Follow-up|0|||
25165834|NCT01928381|50290247|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
25165835|NCT01928381|50290248|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
25165836|NCT01928381|50290249|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
25165837|NCT01928381|50290250|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
25165838|NCT01928381|50290251|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
24964415|NCT00006604|50054262|FG013|Overall Study|Lost to Follow-up|0|||
25165839|NCT01928381|50290245|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
25165840|NCT01928381|50290246|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
25165841|NCT01928381|50290247|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
25165842|NCT01928381|50290248|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
25165843|NCT01928381|50290249|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
25165844|NCT01928381|50290250|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
25165845|NCT01928381|50290251|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
25165846|NCT01928381|50290245|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
25165847|NCT01928381|50290246|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
25165848|NCT01928381|50290247|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
25165849|NCT01928381|50290248|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
25165850|NCT01928381|50290249|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
25165851|NCT01928381|50290250|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
25165852|NCT01928381|50290251|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
25165853|NCT01928381|50290245|FG000|Part 1 - Pain Training|Protocol Violation|1|||
25165854|NCT01928381|50290246|FG001|Part 1 - Pain Training|Protocol Violation|0|||
25165855|NCT01928381|50290247|FG002|Part 1 - Pain Training|Protocol Violation|0|||
25165856|NCT01928381|50290248|FG003|Part 1 - Pain Training|Protocol Violation|0|||
25165857|NCT01928381|50290249|FG004|Part 1 - Pain Training|Protocol Violation|0|||
25165858|NCT01928381|50290250|FG005|Part 1 - Pain Training|Protocol Violation|0|||
25165859|NCT01928381|50290251|FG006|Part 1 - Pain Training|Protocol Violation|0|||
24964416|NCT00006604|50054263|FG014|Overall Study|Lost to Follow-up|0|||
25165860|NCT01928381|50290245|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
25165861|NCT01928381|50290246|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
25165862|NCT01928381|50290247|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
25165863|NCT01928381|50290248|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
25165864|NCT01928381|50290249|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
25165865|NCT01928381|50290250|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
25165866|NCT01928381|50290251|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
25165867|NCT01928381|50290245|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
25165868|NCT01928381|50290246|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
25165869|NCT01928381|50290247|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
25165870|NCT01928381|50290248|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
25165871|NCT01928381|50290249|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
25165872|NCT01928381|50290250|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
25165873|NCT01928381|50290251|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
25165874|NCT01928381|50290245|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
25165875|NCT01928381|50290246|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
25165876|NCT01928381|50290247|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
25165877|NCT01928381|50290248|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
25165878|NCT01928381|50290249|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
25165879|NCT01928381|50290250|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
25165880|NCT01928381|50290251|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
25165881|NCT01928381|50290245|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
25165882|NCT01928381|50290246|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
25165883|NCT01928381|50290247|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
25165884|NCT01928381|50290248|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
25165885|NCT01928381|50290249|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
25165886|NCT01928381|50290250|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
25165887|NCT01928381|50290251|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
25165888|NCT01928381|50290245|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
25165889|NCT01928381|50290246|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
25165890|NCT01928381|50290247|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
25165891|NCT01928381|50290248|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
25165892|NCT01928381|50290249|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
25165893|NCT01928381|50290250|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
25165894|NCT01928381|50290251|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
25165895|NCT01928381|50290245|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
25165896|NCT01928381|50290246|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
25165897|NCT01928381|50290247|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
25165898|NCT01928381|50290248|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
25165899|NCT01928381|50290249|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
25165900|NCT01928381|50290250|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
25165901|NCT01928381|50290251|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
25165902|NCT01928381|50290245|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
25165903|NCT01928381|50290246|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
25165904|NCT01928381|50290247|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
25165905|NCT01928381|50290248|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
25165906|NCT01928381|50290249|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
25165907|NCT01928381|50290250|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
25165908|NCT01928381|50290251|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
25165909|NCT01928381|50290245|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
25165910|NCT01928381|50290246|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
25165911|NCT01928381|50290247|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
25165912|NCT01928381|50290248|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
25165913|NCT01928381|50290249|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
25165914|NCT01928381|50290250|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
25165915|NCT01928381|50290251|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
25165916|NCT01928381|50290245|FG000|Washout First Intervention|Protocol Violation|0|||
25165917|NCT01928381|50290246|FG001|Washout First Intervention|Protocol Violation|0|||
25165918|NCT01928381|50290247|FG002|Washout First Intervention|Protocol Violation|0|||
25165919|NCT01928381|50290248|FG003|Washout First Intervention|Protocol Violation|0|||
25165920|NCT01928381|50290249|FG004|Washout First Intervention|Protocol Violation|1|||
25165921|NCT01928381|50290250|FG005|Washout First Intervention|Protocol Violation|0|||
25165922|NCT01928381|50290251|FG006|Washout First Intervention|Protocol Violation|0|||
25165923|NCT01928381|50290245|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
25165924|NCT01928381|50290246|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
25165925|NCT01928381|50290247|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
25165926|NCT01928381|50290248|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
25165927|NCT01928381|50290249|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
25165928|NCT01928381|50290250|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
25165929|NCT01928381|50290251|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
25165930|NCT01928381|50290245|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
25165931|NCT01928381|50290246|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
25165932|NCT01928381|50290247|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
25165933|NCT01928381|50290248|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
25165934|NCT01928381|50290249|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
25165935|NCT01928381|50290250|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
25165936|NCT01928381|50290251|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
25165937|NCT01928225|50290263|FG000|Overall Study|Pregnancy|1|||
25165938|NCT01928225|50290264|FG001|Overall Study|Pregnancy|0|||
25165939|NCT01928225|50290263|FG000|Overall Study|basaloid cervical cancer|1|||
25165940|NCT01928225|50290264|FG001|Overall Study|basaloid cervical cancer|0|||
25165941|NCT01928225|50290263|FG000|Overall Study|Lost to Follow-up|1|||
25165942|NCT01928225|50290264|FG001|Overall Study|Lost to Follow-up|3|||
25165943|NCT01927757|50290271|FG000|Overall Study|Withdrawal by Subject|14|||
25165944|NCT01927757|50290271|FG000|Overall Study|Lost to Follow-up|2|||
25165945|NCT01927757|50290271|FG000|Overall Study|Decision by Sponsor|2|||
25165946|NCT01927757|50290271|FG000|Overall Study|Other|1|||
25165947|NCT01927757|50290271|FG000|Overall Study|Ethical Reasons|4|||
25165948|NCT01927367|50290281|FG000|Overall Study|Withdrawal by Subject|7|||
25165949|NCT01927367|50290282|FG001|Overall Study|Withdrawal by Subject|4|||
25165950|NCT01927367|50290281|FG000|Overall Study|No baseline data|0|||
25165951|NCT01927367|50290282|FG001|Overall Study|No baseline data|1|||
25165952|NCT01913639|50290288|FG000|Overall Study|Not Eligible|3|||
25165953|NCT01913483|50290294|FG000|Overall Study|Withdrawal by Subject|1|||
25165954|NCT01913483|50290295|FG001|Overall Study|Withdrawal by Subject|2|||
25165955|NCT01913483|50290294|FG000|Overall Study|Lost to Follow-up|6|||
25165956|NCT01913483|50290295|FG001|Overall Study|Lost to Follow-up|3|||
25165957|NCT01913483|50290294|FG000|Overall Study|Death|14|||
25165958|NCT01913483|50290295|FG001|Overall Study|Death|17|||
25165959|NCT01913405|50290301|FG000|Overall Study|Withdrawal by Subject|1|||
25165960|NCT01913405|50290301|FG000|Overall Study|Adverse Event|1|||
25165961|NCT01927055|50290321|FG000|Open-label|Adverse Event|6|||
25165962|NCT01927055|50290322|FG001|Open-label|Adverse Event|0|||
25165963|NCT01927055|50290323|FG002|Open-label|Adverse Event|0|||
25165964|NCT01927055|50290321|FG000|Open-label|Withdrawal by Subject|1|||
25165965|NCT01927055|50290322|FG001|Open-label|Withdrawal by Subject|0|||
25165966|NCT01927055|50290323|FG002|Open-label|Withdrawal by Subject|0|||
25165967|NCT01927055|50290321|FG000|Open-label|Study Stopped|4|||
25165968|NCT01927055|50290322|FG001|Open-label|Study Stopped|0|||
24964417|NCT00006604|50054264|FG015|Overall Study|Lost to Follow-up|1|||
24964418|NCT00006604|50054265|FG016|Overall Study|Lost to Follow-up|3|||
25165969|NCT01927055|50290323|FG002|Open-label|Study Stopped|0|||
25165970|NCT01927055|50290321|FG000|Open-label|Supine Hypertension|4|||
25165971|NCT01927055|50290322|FG001|Open-label|Supine Hypertension|0|||
25165972|NCT01927055|50290323|FG002|Open-label|Supine Hypertension|0|||
25165973|NCT01927055|50290321|FG000|Open-label|Difficulty attending study visits|1|||
25165974|NCT01927055|50290322|FG001|Open-label|Difficulty attending study visits|0|||
25165975|NCT01927055|50290323|FG002|Open-label|Difficulty attending study visits|0|||
25165976|NCT01927055|50290321|FG000|Double-Blind|Adverse Event|0|||
25165977|NCT01927055|50290322|FG001|Double-Blind|Adverse Event|1|||
25165978|NCT01927055|50290323|FG002|Double-Blind|Adverse Event|1|||
25165979|NCT01927055|50290321|FG000|Double-Blind|Protocol Violation|0|||
25165980|NCT01927055|50290322|FG001|Double-Blind|Protocol Violation|0|||
25165981|NCT01927055|50290323|FG002|Double-Blind|Protocol Violation|1|||
25165982|NCT01927055|50290321|FG000|Double-Blind|Withdrawal by Subject|0|||
25165983|NCT01927055|50290322|FG001|Double-Blind|Withdrawal by Subject|2|||
25165984|NCT01927055|50290323|FG002|Double-Blind|Withdrawal by Subject|3|||
25165985|NCT01927055|50290321|FG000|Double-Blind|Study Stopped|0|||
25165986|NCT01927055|50290322|FG001|Double-Blind|Study Stopped|7|||
25165987|NCT01927055|50290323|FG002|Double-Blind|Study Stopped|7|||
25165988|NCT01927055|50290321|FG000|Double-Blind|Supine Hypertension|0|||
25165989|NCT01927055|50290322|FG001|Double-Blind|Supine Hypertension|0|||
25165990|NCT01927055|50290323|FG002|Double-Blind|Supine Hypertension|1|||
25165991|NCT01927055|50290321|FG000|Double-Blind|Extended Vacation|0|||
25165992|NCT01927055|50290322|FG001|Double-Blind|Extended Vacation|1|||
25165993|NCT01927055|50290323|FG002|Double-Blind|Extended Vacation|0|||
25165994|NCT01913327|50290332|FG000|Overall Study|Withdrawal by Subject|0|||
25165995|NCT01913327|50290333|FG001|Overall Study|Withdrawal by Subject|1|||
25165996|NCT01926509|50290343|FG000|Overall Study|vital sign met discontinuation criteria|1|||
25165997|NCT01926509|50290344|FG001|Overall Study|vital sign met discontinuation criteria|0|||
25165998|NCT01926509|50290345|FG002|Overall Study|vital sign met discontinuation criteria|0|||
25165999|NCT01926509|50290346|FG003|Overall Study|vital sign met discontinuation criteria|0|||
25166000|NCT01926119|50290356|FG000|Overall Study|Withdrawal by Subject|1|||
25166001|NCT01912781|50290362|FG000|Overall Study|Withdrawal by Subject|2|||
25166002|NCT01912781|50290363|FG001|Overall Study|Withdrawal by Subject|0|||
25166003|NCT01925417|50290370|FG000|Overall Study|Withdrawal by Subject|2|||
25166004|NCT01925417|50290370|FG000|Overall Study|Death|1|||
25166005|NCT01911845|50290375|FG000|Overall Study|Adverse Event|2|||
25166006|NCT01911845|50290375|FG000|Overall Study|Lost to Follow-up|1|||
25166007|NCT01911845|50290375|FG000|Overall Study|Other (not specified)|3|||
25166008|NCT01925183|50290383|FG000|Overall Study|Adverse Event|1|||
25166009|NCT01925183|50290384|FG001|Overall Study|Adverse Event|0|||
25166010|NCT01910519|50290392|FG000|Overall Study|Withdrawal by Subject|2|||
25166011|NCT01910519|50290393|FG001|Overall Study|Withdrawal by Subject|0|||
25166012|NCT01910519|50290392|FG000|Overall Study|Adverse Event|2|||
25166013|NCT01910519|50290393|FG001|Overall Study|Adverse Event|0|||
25166014|NCT01910441|50290401|FG000|Overall Study|Sponsor decision|0|||
25166015|NCT01910441|50290402|FG001|Overall Study|Sponsor decision|2|||
25166016|NCT01910441|50290401|FG000|Overall Study|Lost to Follow-up|6|||
25166017|NCT01910441|50290402|FG001|Overall Study|Lost to Follow-up|5|||
25166018|NCT01910441|50290401|FG000|Overall Study|Withdrawal by Subject|0|||
25166019|NCT01910441|50290402|FG001|Overall Study|Withdrawal by Subject|1|||
25166020|NCT01910441|50290401|FG000|Overall Study|Non-compliance|0|||
25166021|NCT01910441|50290402|FG001|Overall Study|Non-compliance|1|||
25166022|NCT01910441|50290401|FG000|Overall Study|Adverse Event|1|||
25166023|NCT01910441|50290402|FG001|Overall Study|Adverse Event|0|||
25166024|NCT01910441|50290401|FG000|Overall Study|Physician Decision|0|||
25166025|NCT01910441|50290402|FG001|Overall Study|Physician Decision|1|||
25166026|NCT01923467|50290408|FG000|Overall Study|Lost to Follow-up|62|||
25166027|NCT01923467|50290408|FG000|Overall Study|Subject non-interest|479|||
25166028|NCT01910129|50290414|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
25166029|NCT01910129|50290415|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
25166030|NCT01910129|50290416|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
25166031|NCT01910129|50290414|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
25166032|NCT01910129|50290415|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
25166033|NCT01910129|50290416|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
25166034|NCT01909973|50290436|FG000|Overall Study|Lost to Follow-up|1|||
25166035|NCT01909973|50290437|FG001|Overall Study|Lost to Follow-up|0|||
25166036|NCT01617005|50290443|FG000|Overall Study|Pregnancy|1|||
25166037|NCT01617005|50290443|FG000|Overall Study|Lack of motivation for treatment|1|||
25166038|NCT01925339|50290449|FG000|Overall Study|Adverse Event|2|||
25166039|NCT01925339|50290450|FG001|Overall Study|Adverse Event|0|||
25186910|NCT01387607|50337639|FG000|Overall Study|No longer meets eligibility criteria|0|||
25166040|NCT01908803|50290458|FG000|Overall Study|Adverse Event|1|||
25166041|NCT01908803|50290459|FG001|Overall Study|Adverse Event|0|||
25166042|NCT01908803|50290458|FG000|Overall Study|Physician Decision|0|||
25166043|NCT01908803|50290459|FG001|Overall Study|Physician Decision|1|||
25166044|NCT01908803|50290458|FG000|Overall Study|Withdrawal by Subject|1|||
25166045|NCT01908803|50290459|FG001|Overall Study|Withdrawal by Subject|0|||
25166046|NCT01908803|50290458|FG000|Overall Study|Randomization Error|1|||
25166047|NCT01908803|50290459|FG001|Overall Study|Randomization Error|0|||
25166048|NCT01908803|50290458|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
25166049|NCT01908803|50290459|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
25166050|NCT01908101|50290466|FG000|Overall Study|Physician Decision|1|||
25166051|NCT01908101|50290466|FG000|Overall Study|Withdrawal by Subject|1|||
25166052|NCT01908101|50290466|FG000|Overall Study|Incorrect Diagnosis|2|||
25166053|NCT01908101|50290466|FG000|Overall Study|Incorrect Starting Dose|1|||
25166054|NCT01908101|50290466|FG000|Overall Study|Did not complete the first cycle|4|||
25166055|NCT01923389|50290472|FG000|Overall Study|Protocol Violation|1|||
25166056|NCT01923389|50290473|FG001|Overall Study|Protocol Violation|0|||
25166057|NCT01907087|50290480|FG000|Overall Study|Withdrawal by Subject|1|||
25166058|NCT01616771|50290484|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
25166059|NCT01589185|50290498|FG000|Overall Study|Death|1|||
25166060|NCT01589185|50290499|FG001|Overall Study|Death|2|||
25166061|NCT01589185|50290500|FG002|Overall Study|Death|2|||
25166062|NCT01589185|50290501|FG003|Overall Study|Death|0|||
25166063|NCT01589185|50290502|FG004|Overall Study|Death|1|||
25166064|NCT01589185|50290498|FG000|Overall Study|Lost to Follow-up|1|||
25166065|NCT01589185|50290499|FG001|Overall Study|Lost to Follow-up|0|||
25166066|NCT01589185|50290500|FG002|Overall Study|Lost to Follow-up|2|||
25166067|NCT01589185|50290501|FG003|Overall Study|Lost to Follow-up|3|||
25166068|NCT01589185|50290502|FG004|Overall Study|Lost to Follow-up|0|||
25166069|NCT01588951|50290518|FG000|Overall Study|Ineligible in retrospect|0|||
25166070|NCT01588951|50290519|FG001|Overall Study|Ineligible in retrospect|0|||
25166071|NCT01588951|50290520|FG002|Overall Study|Ineligible in retrospect|1|||
25166072|NCT01709383|50290530|FG000|Overall Study|Lost to Follow-up|1|||
25166073|NCT01709383|50290531|FG001|Overall Study|Lost to Follow-up|0|||
25166074|NCT01588405|50290539|FG000|Overall Study|Adverse Event|1|||
25166075|NCT01588405|50290539|FG000|Overall Study|Clinical Worsening|1|||
25166076|NCT01923311|50290548|FG000|Overall Study|Pregnancy|1|||
25166077|NCT01923311|50290549|FG001|Overall Study|Pregnancy|0|||
25166078|NCT01923311|50290548|FG000|Overall Study|Investigator's Discretion|1|||
25166079|NCT01923311|50290549|FG001|Overall Study|Investigator's Discretion|0|||
25186911|NCT01387607|50337640|FG001|Overall Study|No longer meets eligibility criteria|1|||
25186912|NCT01387607|50337639|FG000|Overall Study|Protocol Violation|1|||
25186913|NCT01387607|50337640|FG001|Overall Study|Protocol Violation|5|||
25186914|NCT01387607|50337639|FG000|Overall Study|Withdrawal by Subject|13|||
25276787|NCT00948766|50590713|FG000|Extension Study|Administrative Problems|1|||
25276788|NCT00948766|50590714|FG001|Extension Study|Administrative Problems|0|||
25276789|NCT00948766|50590713|FG000|Extension Study|Death|4|||
25276790|NCT00948766|50590714|FG001|Extension Study|Death|0|||
25276791|NCT01053663|50590724|FG000|Overall Study|Death|2|||
25276792|NCT01053663|50590724|FG000|Overall Study|Lost to Follow-up|1|||
25276793|NCT01053663|50590724|FG000|Overall Study|Poor IV Access|1|||
25276794|NCT01053663|50590724|FG000|Overall Study|Transferred to Another Hospital|1|||
25276795|NCT01053663|50590724|FG000|Overall Study|Negative Influenza Diagnosis|1|||
25276796|NCT01235546|50590736|FG000|Overall Study|Staff error, medication not administered|1|||
25276797|NCT01235546|50590737|FG001|Overall Study|Staff error, medication not administered|0|||
25276798|NCT01235546|50590736|FG000|Overall Study|Protocol Violation|1|||
25276799|NCT01235546|50590737|FG001|Overall Study|Protocol Violation|1|||
25276800|NCT01053429|50590752|FG000|Overall Study|Adverse Event|64|||
25276801|NCT01053429|50590752|FG000|Overall Study|Other|309|||
25276802|NCT01233284|50590756|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
25186915|NCT01387607|50337640|FG001|Overall Study|Withdrawal by Subject|14|||
25186916|NCT01387607|50337639|FG000|Overall Study|Other|1|||
25186917|NCT01387607|50337640|FG001|Overall Study|Other|1|||
25186918|NCT01387607|50337639|FG000|Overall Study|Randomized, not treated|3|||
25186919|NCT01387607|50337640|FG001|Overall Study|Randomized, not treated|6|||
25186920|NCT03451045|50337649|FG000|Overall Study|Lack of Efficacy|3|||
25186921|NCT03451045|50337650|FG001|Overall Study|Lack of Efficacy|2|||
25186922|NCT03451045|50337651|FG002|Overall Study|Lack of Efficacy|2|||
25186923|NCT03451045|50337649|FG000|Overall Study|Physician Decision|1|||
25186924|NCT03451045|50337650|FG001|Overall Study|Physician Decision|1|||
25186925|NCT03451045|50337651|FG002|Overall Study|Physician Decision|1|||
25186926|NCT03451045|50337649|FG000|Overall Study|Withdrawal by Subject|4|||
25186927|NCT03451045|50337650|FG001|Overall Study|Withdrawal by Subject|0|||
25186928|NCT03451045|50337651|FG002|Overall Study|Withdrawal by Subject|5|||
25186929|NCT03451045|50337649|FG000|Overall Study|Pregnancy|0|||
25186930|NCT03451045|50337650|FG001|Overall Study|Pregnancy|0|||
25186931|NCT03451045|50337651|FG002|Overall Study|Pregnancy|2|||
25276803|NCT01233284|50590757|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
25276804|NCT01233284|50590758|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
25166080|NCT01923311|50290548|FG000|Overall Study|Non-Compliance with Study Drug|2|||
25166081|NCT01923311|50290549|FG001|Overall Study|Non-Compliance with Study Drug|1|||
25166082|NCT01923311|50290548|FG000|Overall Study|Withdrew Consent|1|||
25166083|NCT01923311|50290549|FG001|Overall Study|Withdrew Consent|0|||
25166084|NCT01923311|50290548|FG000|Overall Study|Study Terminated by Sponsor|12|||
25166085|NCT01923311|50290549|FG001|Overall Study|Study Terminated by Sponsor|0|||
25166086|NCT01603615|50290556|FG000|Overall Study|Did not Receive Treatment|7|||
25186932|NCT03451045|50337649|FG000|Overall Study|Adverse Event|7|||
25276805|NCT01233284|50590759|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
25276806|NCT01233284|50590760|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
25276807|NCT01233284|50590756|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
25276808|NCT01233284|50590757|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
25276809|NCT01233284|50590758|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
25276810|NCT01233284|50590759|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
25276811|NCT01233284|50590760|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
25276812|NCT01233284|50590756|FG000|Period 1 (4 Weeks)|Other|0|||
25276813|NCT01233284|50590757|FG001|Period 1 (4 Weeks)|Other|0|||
25276814|NCT01233284|50590758|FG002|Period 1 (4 Weeks)|Other|1|||
25276815|NCT01233284|50590759|FG003|Period 1 (4 Weeks)|Other|0|||
25276816|NCT01233284|50590760|FG004|Period 1 (4 Weeks)|Other|0|||
25276817|NCT01233284|50590756|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
25276818|NCT01233284|50590757|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
25276819|NCT01233284|50590758|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
25276820|NCT01233284|50590759|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
25276821|NCT01233284|50590760|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
25276822|NCT01233284|50590756|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
25276823|NCT01233284|50590757|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
25276824|NCT01233284|50590758|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
25276825|NCT01233284|50590759|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
25276826|NCT01233284|50590760|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
25276827|NCT01233284|50590756|FG000|Period 3 (4 Weeks)|Other|0|||
25276828|NCT01233284|50590757|FG001|Period 3 (4 Weeks)|Other|0|||
25276829|NCT01233284|50590758|FG002|Period 3 (4 Weeks)|Other|0|||
25276830|NCT01233284|50590759|FG003|Period 3 (4 Weeks)|Other|1|||
25276831|NCT01233284|50590760|FG004|Period 3 (4 Weeks)|Other|0|||
25276832|NCT01233284|50590756|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
25276833|NCT01233284|50590757|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
25276834|NCT01233284|50590758|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
25276835|NCT01233284|50590759|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
25276836|NCT01233284|50590760|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
25276837|NCT01233284|50590756|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
25276838|NCT01233284|50590757|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
25276839|NCT01233284|50590758|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
25276840|NCT01233284|50590759|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
25276841|NCT01233284|50590760|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
25276842|NCT00948688|50590770|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
25276843|NCT00948688|50590771|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
25276844|NCT00948688|50590770|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
25276845|NCT00948688|50590771|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
25276846|NCT00948688|50590770|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
25276847|NCT00948688|50590771|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
25276848|NCT01233050|50590780|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
25276849|NCT01233050|50590781|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
25276850|NCT01232894|50590789|FG000|Overall Study|Lost to Follow-up|0|||
25276851|NCT01232894|50590790|FG001|Overall Study|Lost to Follow-up|1|||
25276852|NCT01232894|50590789|FG000|Overall Study|Death|1|||
25276853|NCT01232894|50590790|FG001|Overall Study|Death|0|||
25276854|NCT01232894|50590789|FG000|Overall Study|Protocol Violation|1|||
25276855|NCT01232894|50590790|FG001|Overall Study|Protocol Violation|1|||
25276856|NCT01232894|50590789|FG000|Overall Study|Withdrawal by Subject|8|||
25276857|NCT01232894|50590790|FG001|Overall Study|Withdrawal by Subject|5|||
25276858|NCT01232894|50590789|FG000|Overall Study|Physician Decision|2|||
25276859|NCT01232894|50590790|FG001|Overall Study|Physician Decision|1|||
25067139|NCT02456740|50172685|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
25166087|NCT01603615|50290556|FG000|Overall Study|Lost to Follow-up|9|||
25166088|NCT01603615|50290556|FG000|Overall Study|Personal Reasons|17|||
25166089|NCT01603615|50290556|FG000|Overall Study|Other Miscellaneous|1|||
25166090|NCT01685047|50290560|FG000|Overall Study|Withdrawal by Subject|20|||
25166091|NCT01685047|50290560|FG000|Overall Study|Death|26|||
25166092|NCT01685047|50290560|FG000|Overall Study|Lost to Follow-up|8|||
25166093|NCT01685047|50290560|FG000|Overall Study|Physician Decision|25|||
25166094|NCT01685047|50290560|FG000|Overall Study|Adverse Event|5|||
25166095|NCT01685047|50290560|FG000|Overall Study|patient withdrawn by sponsor|1|||
25166096|NCT01905683|50290564|FG000|Overall Study|Protocol Violation|1|||
25276860|NCT01049217|50590798|FG000|Overall Study|Adverse Event|2|||
25276861|NCT01049217|50590799|FG001|Overall Study|Adverse Event|1|||
25276862|NCT01049217|50590798|FG000|Overall Study|Lack of Efficacy|1|||
25276863|NCT01049217|50590799|FG001|Overall Study|Lack of Efficacy|1|||
25276864|NCT01049217|50590798|FG000|Overall Study|Lost to Follow-up|3|||
25276865|NCT01049217|50590799|FG001|Overall Study|Lost to Follow-up|8|||
25276866|NCT01049217|50590798|FG000|Overall Study|Withdrawal by Subject|4|||
25276867|NCT01049217|50590799|FG001|Overall Study|Withdrawal by Subject|3|||
25276868|NCT01049217|50590798|FG000|Overall Study|Protocol Violation|1|||
25166097|NCT01905683|50290564|FG000|Overall Study|Re-injection criteria not met; others|13|||
25166098|NCT01905683|50290564|FG000|Overall Study|Physician Decision|1|||
25276869|NCT01049217|50590799|FG001|Overall Study|Protocol Violation|3|||
25166099|NCT01905683|50290564|FG000|Overall Study|Lack of Efficacy|8|||
25186933|NCT03451045|50337650|FG001|Overall Study|Adverse Event|1|||
25067140|NCT02456740|50172686|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
25067141|NCT02456740|50172687|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
25067142|NCT02456740|50172688|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
25067143|NCT02456740|50172689|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
25067144|NCT02456740|50172690|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
25067145|NCT02456740|50172691|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
25067146|NCT02456740|50172692|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
25067147|NCT02456740|50172693|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
25067148|NCT02456740|50172685|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
25067149|NCT02456740|50172686|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
25067150|NCT02456740|50172687|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
25067151|NCT02456740|50172688|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
25067152|NCT02456740|50172689|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
25067153|NCT02456740|50172690|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
25067154|NCT02456740|50172691|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
24964419|NCT00006604|50054249|FG000|Overall Study|Other Reason|0|||
24964420|NCT00006604|50054250|FG001|Overall Study|Other Reason|0|||
24964421|NCT00006604|50054251|FG002|Overall Study|Other Reason|0|||
24964422|NCT00006604|50054252|FG003|Overall Study|Other Reason|0|||
24964423|NCT00006604|50054253|FG004|Overall Study|Other Reason|0|||
24964424|NCT00006604|50054254|FG005|Overall Study|Other Reason|1|||
24964425|NCT00006604|50054255|FG006|Overall Study|Other Reason|0|||
24964426|NCT00006604|50054256|FG007|Overall Study|Other Reason|0|||
24964427|NCT00006604|50054257|FG008|Overall Study|Other Reason|0|||
24964428|NCT00006604|50054258|FG009|Overall Study|Other Reason|1|||
24964429|NCT00006604|50054259|FG010|Overall Study|Other Reason|0|||
24964430|NCT00006604|50054260|FG011|Overall Study|Other Reason|0|||
24964431|NCT00006604|50054261|FG012|Overall Study|Other Reason|0|||
24964432|NCT00006604|50054262|FG013|Overall Study|Other Reason|0|||
24964433|NCT00006604|50054263|FG014|Overall Study|Other Reason|0|||
24964434|NCT00006604|50054264|FG015|Overall Study|Other Reason|0|||
24964435|NCT00006604|50054265|FG016|Overall Study|Other Reason|0|||
24964436|NCT00006478|50054288|FG000|Overall Study|Vaccine could not be produced|1|||
24964437|NCT00006478|50054288|FG000|Overall Study|Physician Decision|6|||
24964438|NCT00436007|50054295|FG000|Overall Study|Withdrawal by Subject|5|||
24964439|NCT00436007|50054296|FG001|Overall Study|Withdrawal by Subject|3|||
24964440|NCT00436007|50054297|FG002|Overall Study|Withdrawal by Subject|4|||
24964441|NCT00436007|50054295|FG000|Overall Study|Lost to Follow-up|14|||
24964442|NCT00436007|50054296|FG001|Overall Study|Lost to Follow-up|10|||
24964443|NCT00436007|50054297|FG002|Overall Study|Lost to Follow-up|13|||
24964444|NCT00436007|50054295|FG000|Overall Study|Physician Decision|0|||
24964445|NCT00436007|50054296|FG001|Overall Study|Physician Decision|0|||
24964446|NCT00436007|50054297|FG002|Overall Study|Physician Decision|2|||
24964447|NCT00436007|50054295|FG000|Overall Study|Death|0|||
24964448|NCT00436007|50054296|FG001|Overall Study|Death|1|||
24964449|NCT00436007|50054297|FG002|Overall Study|Death|3|||
24964450|NCT00436007|50054295|FG000|Overall Study|Other|0|||
25067155|NCT02456740|50172692|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
25186934|NCT03451045|50337651|FG002|Overall Study|Adverse Event|3|||
24964451|NCT00436007|50054296|FG001|Overall Study|Other|0|||
24964452|NCT00436007|50054297|FG002|Overall Study|Other|1|||
24964453|NCT00435461|50054313|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
24964454|NCT00435461|50054314|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
25166100|NCT01905683|50290564|FG000|Overall Study|Withdrawal by Subject|20|||
25166101|NCT01905683|50290564|FG000|Overall Study|Adverse Event|4|||
25166102|NCT01905683|50290564|FG000|Overall Study|Lost to Follow-up|4|||
25166103|NCT01921829|50290570|FG000|Overall Study|Withdrawal by Subject|0|||
25166104|NCT01921829|50290571|FG001|Overall Study|Withdrawal by Subject|1|||
25166105|NCT01904903|50290577|FG000|Overall Study|Withdrawal by Subject|1|||
25166106|NCT01921517|50290583|FG000|Overall Study|Lost to Follow-up|5|||
25166107|NCT01921517|50290584|FG001|Overall Study|Lost to Follow-up|0|||
25166108|NCT01921517|50290583|FG000|Overall Study|Newly diagnosed health concern|2|||
25166109|NCT01921517|50290584|FG001|Overall Study|Newly diagnosed health concern|0|||
25166110|NCT01921517|50290583|FG000|Overall Study|Physician Decision|0|||
25166111|NCT01921517|50290584|FG001|Overall Study|Physician Decision|2|||
25166112|NCT01921517|50290583|FG000|Overall Study|Withdrawal by Subject|7|||
25166113|NCT01921517|50290584|FG001|Overall Study|Withdrawal by Subject|3|||
25166114|NCT01921517|50290583|FG000|Overall Study|Subject missed final imaging|1|||
25166115|NCT01921517|50290584|FG001|Overall Study|Subject missed final imaging|4|||
25166116|NCT01921205|50290592|FG000|Overall Study|Adverse Event|12|||
25166117|NCT01921205|50290593|FG001|Overall Study|Adverse Event|7|||
25166118|NCT01921205|50290592|FG000|Overall Study|Lack of Efficacy|1|||
25166119|NCT01921205|50290593|FG001|Overall Study|Lack of Efficacy|0|||
25166120|NCT01921205|50290592|FG000|Overall Study|Protocol Violation|1|||
25166121|NCT01921205|50290593|FG001|Overall Study|Protocol Violation|3|||
25166122|NCT01921205|50290592|FG000|Overall Study|Lost to Follow-up|1|||
25166123|NCT01921205|50290593|FG001|Overall Study|Lost to Follow-up|1|||
25166124|NCT01921205|50290592|FG000|Overall Study|Withdrawal by Subject|6|||
25166125|NCT01921205|50290593|FG001|Overall Study|Withdrawal by Subject|5|||
25166126|NCT01921205|50290592|FG000|Overall Study|Use Of Prohibited Medication|0|||
25166127|NCT01921205|50290593|FG001|Overall Study|Use Of Prohibited Medication|1|||
25166128|NCT01921205|50290592|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
25166129|NCT01921205|50290593|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
25166130|NCT01921205|50290592|FG000|Overall Study|Non Compliance Of The Parent|0|||
25166131|NCT01921205|50290593|FG001|Overall Study|Non Compliance Of The Parent|1|||
25166132|NCT01921205|50290592|FG000|Overall Study|Non Compliance Of Child|0|||
25166133|NCT01921205|50290593|FG001|Overall Study|Non Compliance Of Child|1|||
25166134|NCT01920893|50290601|FG000|Overall Study|Adverse Event|5|||
25166135|NCT01920893|50290602|FG001|Overall Study|Adverse Event|2|||
25166136|NCT01920893|50290601|FG000|Overall Study|Lack of Efficacy|2|||
25166137|NCT01920893|50290602|FG001|Overall Study|Lack of Efficacy|0|||
25166138|NCT01709305|50290609|FG000|Phase 1|Clinical Adverse Event|80|||
25166139|NCT01709305|50290610|FG001|Phase 1|Clinical Adverse Event|0|||
25166140|NCT01709305|50290611|FG002|Phase 1|Clinical Adverse Event|0|||
25166141|NCT01709305|50290612|FG003|Phase 1|Clinical Adverse Event|0|||
25166142|NCT01709305|50290613|FG004|Phase 1|Clinical Adverse Event|0|||
25166143|NCT01709305|50290609|FG000|Phase 1|Death|2|||
25166144|NCT01709305|50290610|FG001|Phase 1|Death|0|||
25166145|NCT01709305|50290611|FG002|Phase 1|Death|0|||
25166146|NCT01709305|50290612|FG003|Phase 1|Death|0|||
25166147|NCT01709305|50290613|FG004|Phase 1|Death|0|||
25166148|NCT01709305|50290609|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
25166149|NCT01709305|50290610|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
25166150|NCT01709305|50290611|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
25166151|NCT01709305|50290612|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
25166152|NCT01709305|50290613|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
25166153|NCT01709305|50290609|FG000|Phase 1|Laboratory Adverse Event|16|||
25166154|NCT01709305|50290610|FG001|Phase 1|Laboratory Adverse Event|0|||
25166155|NCT01709305|50290611|FG002|Phase 1|Laboratory Adverse Event|0|||
25166156|NCT01709305|50290612|FG003|Phase 1|Laboratory Adverse Event|0|||
25166157|NCT01709305|50290613|FG004|Phase 1|Laboratory Adverse Event|0|||
25166158|NCT01709305|50290609|FG000|Phase 1|Lost to Follow-up|147|||
25186935|NCT03451045|50337649|FG000|Overall Study|Non-compliance with study|2|||
25166159|NCT01709305|50290610|FG001|Phase 1|Lost to Follow-up|0|||
25166160|NCT01709305|50290611|FG002|Phase 1|Lost to Follow-up|0|||
25166161|NCT01709305|50290612|FG003|Phase 1|Lost to Follow-up|0|||
25166162|NCT01709305|50290613|FG004|Phase 1|Lost to Follow-up|0|||
25166163|NCT01709305|50290609|FG000|Phase 1|Travel, moving, etc.|30|||
25166164|NCT01709305|50290610|FG001|Phase 1|Travel, moving, etc.|0|||
25166165|NCT01709305|50290611|FG002|Phase 1|Travel, moving, etc.|0|||
25166166|NCT01709305|50290612|FG003|Phase 1|Travel, moving, etc.|0|||
25166167|NCT01709305|50290613|FG004|Phase 1|Travel, moving, etc.|0|||
25166168|NCT01709305|50290609|FG000|Phase 1|Physician Decision|13|||
25166169|NCT01709305|50290610|FG001|Phase 1|Physician Decision|0|||
25166170|NCT01709305|50290611|FG002|Phase 1|Physician Decision|0|||
25166171|NCT01709305|50290612|FG003|Phase 1|Physician Decision|0|||
25166172|NCT01709305|50290613|FG004|Phase 1|Physician Decision|0|||
25166173|NCT01709305|50290609|FG000|Phase 1|Protocol Violation|118|||
25166174|NCT01709305|50290610|FG001|Phase 1|Protocol Violation|0|||
25166175|NCT01709305|50290611|FG002|Phase 1|Protocol Violation|0|||
25166176|NCT01709305|50290612|FG003|Phase 1|Protocol Violation|0|||
25166177|NCT01709305|50290613|FG004|Phase 1|Protocol Violation|0|||
25166178|NCT01709305|50290609|FG000|Phase 1|Withdrawal by Subject|218|||
25166179|NCT01709305|50290610|FG001|Phase 1|Withdrawal by Subject|0|||
25166180|NCT01709305|50290611|FG002|Phase 1|Withdrawal by Subject|0|||
25166181|NCT01709305|50290612|FG003|Phase 1|Withdrawal by Subject|0|||
25166182|NCT01709305|50290613|FG004|Phase 1|Withdrawal by Subject|0|||
25166183|NCT01709305|50290609|FG000|Phase 2|Clinical Adverse Event|0|||
25166184|NCT01709305|50290610|FG001|Phase 2|Clinical Adverse Event|10|||
25166185|NCT01709305|50290611|FG002|Phase 2|Clinical Adverse Event|10|||
25166186|NCT01709305|50290612|FG003|Phase 2|Clinical Adverse Event|6|||
25166187|NCT01709305|50290613|FG004|Phase 2|Clinical Adverse Event|11|||
25166188|NCT01709305|50290609|FG000|Phase 2|Death|0|||
25166189|NCT01709305|50290610|FG001|Phase 2|Death|0|||
25166190|NCT01709305|50290611|FG002|Phase 2|Death|1|||
25166191|NCT01709305|50290612|FG003|Phase 2|Death|0|||
25166192|NCT01709305|50290613|FG004|Phase 2|Death|0|||
25166193|NCT01709305|50290609|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
25166194|NCT01709305|50290610|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
25166195|NCT01709305|50290611|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
25166196|NCT01709305|50290612|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
25166197|NCT01709305|50290613|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
25166198|NCT01709305|50290609|FG000|Phase 2|Laboratory Adverse Event|0|||
25166199|NCT01709305|50290610|FG001|Phase 2|Laboratory Adverse Event|1|||
25166200|NCT01709305|50290611|FG002|Phase 2|Laboratory Adverse Event|0|||
25166201|NCT01709305|50290612|FG003|Phase 2|Laboratory Adverse Event|1|||
25166202|NCT01709305|50290613|FG004|Phase 2|Laboratory Adverse Event|1|||
25166203|NCT01709305|50290609|FG000|Phase 2|Lost to Follow-up|0|||
25166204|NCT01709305|50290610|FG001|Phase 2|Lost to Follow-up|10|||
25166205|NCT01709305|50290611|FG002|Phase 2|Lost to Follow-up|6|||
25166206|NCT01709305|50290612|FG003|Phase 2|Lost to Follow-up|9|||
25166207|NCT01709305|50290613|FG004|Phase 2|Lost to Follow-up|5|||
25166208|NCT01709305|50290609|FG000|Phase 2|Travel, moving, etc.|0|||
25166209|NCT01709305|50290610|FG001|Phase 2|Travel, moving, etc.|2|||
25166210|NCT01709305|50290611|FG002|Phase 2|Travel, moving, etc.|3|||
25166211|NCT01709305|50290612|FG003|Phase 2|Travel, moving, etc.|3|||
25166212|NCT01709305|50290613|FG004|Phase 2|Travel, moving, etc.|5|||
25166213|NCT01709305|50290609|FG000|Phase 2|Physician Decision|0|||
25166214|NCT01709305|50290610|FG001|Phase 2|Physician Decision|2|||
25166215|NCT01709305|50290611|FG002|Phase 2|Physician Decision|0|||
25166216|NCT01709305|50290612|FG003|Phase 2|Physician Decision|1|||
25166217|NCT01709305|50290613|FG004|Phase 2|Physician Decision|2|||
25166218|NCT01709305|50290609|FG000|Phase 2|Protocol Violation|0|||
25166219|NCT01709305|50290610|FG001|Phase 2|Protocol Violation|19|||
25166220|NCT01709305|50290611|FG002|Phase 2|Protocol Violation|19|||
25166221|NCT01709305|50290612|FG003|Phase 2|Protocol Violation|13|||
25166222|NCT01709305|50290613|FG004|Phase 2|Protocol Violation|9|||
25166223|NCT01709305|50290609|FG000|Phase 2|Withdrawal by Subject|0|||
25166224|NCT01709305|50290610|FG001|Phase 2|Withdrawal by Subject|8|||
25166225|NCT01709305|50290611|FG002|Phase 2|Withdrawal by Subject|6|||
25166226|NCT01709305|50290612|FG003|Phase 2|Withdrawal by Subject|15|||
25166227|NCT01709305|50290613|FG004|Phase 2|Withdrawal by Subject|12|||
25166228|NCT01684423|50290633|FG000|Overall Study|Withdrawal by Subject|0|||
25166229|NCT01684423|50290634|FG001|Overall Study|Withdrawal by Subject|0|||
25166230|NCT01684423|50290635|FG002|Overall Study|Withdrawal by Subject|1|||
25186936|NCT03451045|50337650|FG001|Overall Study|Non-compliance with study|0|||
25186937|NCT03451045|50337651|FG002|Overall Study|Non-compliance with study|1|||
25186938|NCT03451045|50337649|FG000|Overall Study|any other reason|10|||
25186939|NCT03451045|50337650|FG001|Overall Study|any other reason|2|||
25186940|NCT03451045|50337651|FG002|Overall Study|any other reason|13|||
24964455|NCT00435461|50054315|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
25166231|NCT01684423|50290636|FG003|Overall Study|Withdrawal by Subject|0|||
25166232|NCT01684423|50290637|FG004|Overall Study|Withdrawal by Subject|0|||
25166233|NCT01709227|50290653|FG000|Overall Study|Physician Decision|1|||
25166234|NCT01709227|50290654|FG001|Overall Study|Physician Decision|0|||
25166235|NCT01709227|50290653|FG000|Overall Study|Pleural Peritoneal communication|0|||
25166236|NCT01709227|50290654|FG001|Overall Study|Pleural Peritoneal communication|9|||
25166237|NCT01684033|50290661|FG000|Period 1, First 30 Days|Adverse Event|1|||
25166238|NCT01684033|50290662|FG001|Period 1, First 30 Days|Adverse Event|1|||
25166239|NCT01684033|50290661|FG000|Period 1, First 30 Days|Noncompliance|1|||
25186941|NCT03219567|50337662|FG000|Overall Study|Withdrawal by Subject|0|||
25186942|NCT03219567|50337663|FG001|Overall Study|Withdrawal by Subject|1|||
25166240|NCT01684033|50290662|FG001|Period 1, First 30 Days|Noncompliance|0|||
25166241|NCT01684033|50290661|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
25166242|NCT01684033|50290662|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
25166243|NCT01684033|50290661|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
25166244|NCT01684033|50290662|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
25166245|NCT01684033|50290661|FG000|Period 2, Second 30 Days|Adverse Event|1|||
25166246|NCT01684033|50290662|FG001|Period 2, Second 30 Days|Adverse Event|0|||
25276870|NCT01049217|50590798|FG000|Overall Study|Pregnancy|1|||
25276871|NCT01049217|50590799|FG001|Overall Study|Pregnancy|0|||
25276872|NCT01049217|50590798|FG000|Overall Study|Study Terminated by Sponsor|43|||
25276873|NCT01049217|50590799|FG001|Overall Study|Study Terminated by Sponsor|43|||
25276874|NCT01049217|50590798|FG000|Overall Study|Other|1|||
25276875|NCT01049217|50590799|FG001|Overall Study|Other|2|||
25276876|NCT01049217|50590798|FG000|Overall Study|Randomized but not Treated|0|||
25166247|NCT01903811|50290703|FG000|Overall Study|No measurable disease|1|||
25166248|NCT01903811|50290704|FG001|Overall Study|No measurable disease|1|||
25166249|NCT01903811|50290703|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
25166250|NCT01903811|50290704|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
25166251|NCT01903811|50290703|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
25166252|NCT01903811|50290704|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
25166253|NCT01903811|50290703|FG000|Overall Study|Withdrawal by Subject|0|||
25166254|NCT01903811|50290704|FG001|Overall Study|Withdrawal by Subject|1|||
25166255|NCT01709149|50290721|FG000|Open-label Lead-in Phase|Adverse Event|109|||
25166256|NCT01709149|50290722|FG001|Open-label Lead-in Phase|Adverse Event|0|||
25166257|NCT01709149|50290723|FG002|Open-label Lead-in Phase|Adverse Event|0|||
25166258|NCT01709149|50290721|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
25166259|NCT01709149|50290722|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
25166260|NCT01709149|50290723|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
25166261|NCT01709149|50290721|FG000|Open-label Lead-in Phase|Death|1|||
25166262|NCT01709149|50290722|FG001|Open-label Lead-in Phase|Death|0|||
25166263|NCT01709149|50290723|FG002|Open-label Lead-in Phase|Death|0|||
25166264|NCT01709149|50290721|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
25166265|NCT01709149|50290722|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
25166266|NCT01709149|50290723|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
25166267|NCT01709149|50290721|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
25166268|NCT01709149|50290722|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
25166269|NCT01709149|50290723|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
25166270|NCT01709149|50290721|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
25166271|NCT01709149|50290722|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
25166272|NCT01709149|50290723|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
25166273|NCT01709149|50290721|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
25166274|NCT01709149|50290722|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
25166275|NCT01709149|50290723|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
25166276|NCT01709149|50290721|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
25166277|NCT01709149|50290722|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
25166278|NCT01709149|50290723|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
25166279|NCT01709149|50290721|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
25166280|NCT01709149|50290722|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
25166281|NCT01709149|50290723|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
25166282|NCT01709149|50290721|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
25166283|NCT01709149|50290722|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
25166284|NCT01709149|50290723|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
25166285|NCT01568593|50290732|FG000|Overall Study|Lack of Efficacy|4|||
25166286|NCT01568593|50290733|FG001|Overall Study|Lack of Efficacy|1|||
25166287|NCT01568593|50290732|FG000|Overall Study|Adverse Event|3|||
25166288|NCT01568593|50290733|FG001|Overall Study|Adverse Event|2|||
25166289|NCT01683565|50290741|FG000|Overall Study|Lost to Follow-up|2|||
25186943|NCT01386125|50337672|FG000|Overall Study|Lost to Follow-up|3|||
25186944|NCT01386125|50337673|FG001|Overall Study|Lost to Follow-up|9|||
25186945|NCT01386125|50337672|FG000|Overall Study|Physician Decision|0|||
25186946|NCT01386125|50337673|FG001|Overall Study|Physician Decision|1|||
25186947|NCT01386125|50337672|FG000|Overall Study|Protocol Violation|5|||
25186948|NCT01386125|50337673|FG001|Overall Study|Protocol Violation|7|||
25186949|NCT01386125|50337672|FG000|Overall Study|Disease Progress|1|||
25186950|NCT01386125|50337673|FG001|Overall Study|Disease Progress|2|||
25186951|NCT01386125|50337672|FG000|Overall Study|Withdrawal by Subject|13|||
25186952|NCT01386125|50337673|FG001|Overall Study|Withdrawal by Subject|12|||
25186953|NCT01386125|50337672|FG000|Overall Study|Adverse Event|2|||
25186954|NCT01386125|50337673|FG001|Overall Study|Adverse Event|5|||
25276877|NCT01049217|50590799|FG001|Overall Study|Randomized but not Treated|2|||
25276878|NCT01232738|50590805|FG000|Overall Study|Death|3|||
25276879|NCT01232738|50590805|FG000|Overall Study|Physician Decision|2|||
25166290|NCT01683565|50290742|FG001|Overall Study|Lost to Follow-up|0|||
25166291|NCT01683565|50290741|FG000|Overall Study|Discontinued Intervention|1|||
25166292|NCT01683565|50290742|FG001|Overall Study|Discontinued Intervention|1|||
25166293|NCT01903031|50290766|FG000|Overall Study|Not Able to Attend Clinic|1|||
25166294|NCT01903031|50290767|FG001|Overall Study|Not Able to Attend Clinic|1|||
25166295|NCT01903031|50290768|FG002|Overall Study|Not Able to Attend Clinic|0|||
25186955|NCT01386125|50337672|FG000|Overall Study|Lack of Efficacy|0|||
25276880|NCT01232738|50590805|FG000|Overall Study|Lost to Follow-up|1|||
25276881|NCT01232738|50590805|FG000|Overall Study|Withdrawal by Subject|2|||
25166296|NCT01903031|50290766|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
25166297|NCT01903031|50290767|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
25166298|NCT01903031|50290768|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
25166299|NCT01903031|50290766|FG000|Overall Study|Adverse Event|0|||
25166300|NCT01903031|50290767|FG001|Overall Study|Adverse Event|1|||
25166301|NCT01903031|50290768|FG002|Overall Study|Adverse Event|0|||
25166302|NCT01903031|50290766|FG000|Overall Study|Withdrawal by Subject|0|||
25166303|NCT01903031|50290767|FG001|Overall Study|Withdrawal by Subject|1|||
25166304|NCT01903031|50290768|FG002|Overall Study|Withdrawal by Subject|1|||
25166305|NCT01903031|50290766|FG000|Overall Study|Protocol Violation|0|||
25166306|NCT01903031|50290767|FG001|Overall Study|Protocol Violation|0|||
25166307|NCT01903031|50290768|FG002|Overall Study|Protocol Violation|2|||
25166308|NCT01903031|50290766|FG000|Overall Study|Lost to Follow-up|0|||
25166309|NCT01903031|50290767|FG001|Overall Study|Lost to Follow-up|0|||
25166310|NCT01903031|50290768|FG002|Overall Study|Lost to Follow-up|1|||
25166311|NCT01903031|50290766|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
25166312|NCT01903031|50290767|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
25166313|NCT01903031|50290768|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
25166314|NCT01616693|50290800|FG000|Evaluated for Safety|Physician Decision|1|||
25166315|NCT01616693|50290801|FG001|Evaluated for Safety|Physician Decision|0|||
25166316|NCT01616693|50290802|FG002|Evaluated for Safety|Physician Decision|1|||
25166317|NCT01616693|50290803|FG003|Evaluated for Safety|Physician Decision|0|||
25166318|NCT01616693|50290800|FG000|Received Both Vaccines|Adverse Event|2|||
25166319|NCT01616693|50290801|FG001|Received Both Vaccines|Adverse Event|0|||
25166320|NCT01616693|50290802|FG002|Received Both Vaccines|Adverse Event|0|||
25166321|NCT01616693|50290803|FG003|Received Both Vaccines|Adverse Event|0|||
25166322|NCT01616693|50290800|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
25166323|NCT01616693|50290801|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
25166324|NCT01616693|50290802|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
25166325|NCT01616693|50290803|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
25166326|NCT01616693|50290800|FG000|Received Both Vaccines|Lost to Follow-up|4|||
25166327|NCT01616693|50290801|FG001|Received Both Vaccines|Lost to Follow-up|3|||
25166328|NCT01616693|50290802|FG002|Received Both Vaccines|Lost to Follow-up|4|||
25166329|NCT01616693|50290803|FG003|Received Both Vaccines|Lost to Follow-up|4|||
25166330|NCT01616693|50290800|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
25166331|NCT01616693|50290801|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
25166332|NCT01616693|50290802|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
25166333|NCT01616693|50290803|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
25166334|NCT01616459|50290910|FG000|Overall Study|Adverse Event|1|||
25166335|NCT01616459|50290911|FG001|Overall Study|Adverse Event|1|||
25166336|NCT01616459|50290912|FG002|Overall Study|Adverse Event|2|||
25166337|NCT01616459|50290913|FG003|Overall Study|Adverse Event|0|||
25166338|NCT01616459|50290910|FG000|Overall Study|Lost to Follow-up|1|||
25166339|NCT01616459|50290911|FG001|Overall Study|Lost to Follow-up|11|||
25166340|NCT01616459|50290912|FG002|Overall Study|Lost to Follow-up|3|||
25166341|NCT01616459|50290913|FG003|Overall Study|Lost to Follow-up|2|||
25166342|NCT01616459|50290910|FG000|Overall Study|Protocol Violation|0|||
25166343|NCT01616459|50290911|FG001|Overall Study|Protocol Violation|0|||
25166344|NCT01616459|50290912|FG002|Overall Study|Protocol Violation|0|||
25166345|NCT01616459|50290913|FG003|Overall Study|Protocol Violation|2|||
25166346|NCT01616459|50290910|FG000|Overall Study|Withdrawal by Subject|2|||
25166347|NCT01616459|50290911|FG001|Overall Study|Withdrawal by Subject|4|||
25166348|NCT01616459|50290912|FG002|Overall Study|Withdrawal by Subject|4|||
25166349|NCT01616459|50290913|FG003|Overall Study|Withdrawal by Subject|4|||
25166350|NCT01616459|50290910|FG000|Overall Study|Other reason|0|||
25166351|NCT01616459|50290911|FG001|Overall Study|Other reason|1|||
25166352|NCT01616459|50290912|FG002|Overall Study|Other reason|1|||
25276882|NCT01232738|50590805|FG000|Overall Study|Adverse Event|5|||
25166353|NCT01616459|50290913|FG003|Overall Study|Other reason|0|||
25166354|NCT01919801|50290930|FG000|Overall Study|Withdrawal by Subject|1|||
25166355|NCT01919801|50290931|FG001|Overall Study|Withdrawal by Subject|0|||
25166356|NCT01919801|50290930|FG000|Overall Study|Physician Decision|0|||
25166357|NCT01919801|50290931|FG001|Overall Study|Physician Decision|1|||
25166358|NCT01919801|50290930|FG000|Overall Study|Lost to Follow-up|0|||
25166359|NCT01919801|50290931|FG001|Overall Study|Lost to Follow-up|1|||
25166360|NCT01919801|50290930|FG000|Overall Study|Other|0|||
25166361|NCT01919801|50290931|FG001|Overall Study|Other|1|||
25166362|NCT01919723|50290939|FG000|Overall Study|Blood Samples Hemolyzed|2|||
25166363|NCT01919723|50290940|FG001|Overall Study|Blood Samples Hemolyzed|2|||
25166364|NCT01919489|50290948|FG000|Overall Study|Rejected the need of injections|4|||
25166365|NCT01919489|50290949|FG001|Overall Study|Rejected the need of injections|7|||
25166366|NCT01919489|50290948|FG000|Overall Study|Adverse Event|10|||
25166367|NCT01919489|50290949|FG001|Overall Study|Adverse Event|0|||
25166368|NCT01919489|50290948|FG000|Overall Study|Hospital readmission|2|||
25166369|NCT01919489|50290949|FG001|Overall Study|Hospital readmission|9|||
25166370|NCT01919489|50290948|FG000|Overall Study|Death|2|||
25166371|NCT01919489|50290949|FG001|Overall Study|Death|1|||
25166372|NCT01919489|50290948|FG000|Overall Study|Lost to Follow-up|38|||
25166373|NCT01919489|50290949|FG001|Overall Study|Lost to Follow-up|27|||
25166374|NCT01919411|50290957|FG000|Overall Study|Lost to Follow-up|2|||
25166375|NCT01919411|50290958|FG001|Overall Study|Lost to Follow-up|4|||
25166376|NCT01919411|50290957|FG000|Overall Study|Physician Decision|1|||
25166377|NCT01919411|50290958|FG001|Overall Study|Physician Decision|0|||
25166378|NCT01919411|50290957|FG000|Overall Study|Protocol Violation|2|||
25166379|NCT01919411|50290958|FG001|Overall Study|Protocol Violation|1|||
25166380|NCT01901393|50290966|FG000|Overall Study|Adverse Event|1|||
25166381|NCT01901393|50290967|FG001|Overall Study|Adverse Event|0|||
25166382|NCT01890707|50290975|FG000|Overall Study|Lost to Follow-up|1|||
25166383|NCT01890707|50290976|FG001|Overall Study|Lost to Follow-up|1|||
25166384|NCT01900691|50290982|FG000|Overall Study|Death|7|||
25166385|NCT01900691|50290982|FG000|Overall Study|Lost to Follow-up|4|||
25166386|NCT01900691|50290982|FG000|Overall Study|Study Device Not Placed|3|||
25166387|NCT01900691|50290982|FG000|Overall Study|Non study stent placed|2|||
25166388|NCT01900691|50290982|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
25166389|NCT01900691|50290982|FG000|Overall Study|Complete stent migration through digestive tract|1|||
25166390|NCT01890473|50290989|FG000|Overall Study|Lost to Follow-up|1|||
25166391|NCT01890473|50290990|FG001|Overall Study|Lost to Follow-up|0|||
25166392|NCT01890473|50290989|FG000|Overall Study|Poor/non-compliance|1|||
25166393|NCT01890473|50290990|FG001|Overall Study|Poor/non-compliance|0|||
25166394|NCT01889069|50291000|FG000|Overall Study|Death|18|||
25166395|NCT01889069|50291000|FG000|Overall Study|Progression of Disease|14|||
25166396|NCT01889069|50291000|FG000|Overall Study|Lost to Follow-up|6|||
25166397|NCT01889069|50291000|FG000|Overall Study|Other|4|||
25166398|NCT01889069|50291000|FG000|Overall Study|Consent Withdrawal|3|||
25166399|NCT02533180|50291012|FG000|Overall Study|Death|0|||
25166400|NCT02533180|50291013|FG001|Overall Study|Death|1|||
25166401|NCT02533180|50291012|FG000|Overall Study|Lost to Follow-up|0|||
25166402|NCT02533180|50291013|FG001|Overall Study|Lost to Follow-up|1|||
25166403|NCT02533180|50291012|FG000|Overall Study|Physician Decision|0|||
25166404|NCT02533180|50291013|FG001|Overall Study|Physician Decision|1|||
25166405|NCT02533180|50291012|FG000|Overall Study|Withdrawal by Subject|2|||
25166406|NCT02533180|50291013|FG001|Overall Study|Withdrawal by Subject|4|||
25166407|NCT02533180|50291012|FG000|Overall Study|Screen Failure|37|||
25166408|NCT02533180|50291013|FG001|Overall Study|Screen Failure|0|||
25166409|NCT02533180|50291012|FG000|Overall Study|Protocol Deviation|0|||
25166410|NCT02533180|50291013|FG001|Overall Study|Protocol Deviation|1|||
25166411|NCT02533180|50291012|FG000|Overall Study|On Study|0|||
25166412|NCT02533180|50291013|FG001|Overall Study|On Study|39|||
25166413|NCT01739348|50291044|FG000|Part I (Base Study)|Adverse Event|41|||
25166414|NCT01739348|50291045|FG001|Part I (Base Study)|Adverse Event|52|||
25166415|NCT01739348|50291046|FG002|Part I (Base Study)|Adverse Event|8|||
25166416|NCT01739348|50291047|FG003|Part I (Base Study)|Adverse Event|33|||
25166417|NCT01739348|50291044|FG000|Part I (Base Study)|Death|10|||
25166418|NCT01739348|50291045|FG001|Part I (Base Study)|Death|7|||
25166419|NCT01739348|50291046|FG002|Part I (Base Study)|Death|2|||
25166420|NCT01739348|50291047|FG003|Part I (Base Study)|Death|8|||
25166421|NCT01739348|50291044|FG000|Part I (Base Study)|Lack of Efficacy|3|||
25166422|NCT01739348|50291045|FG001|Part I (Base Study)|Lack of Efficacy|8|||
25186956|NCT01386125|50337673|FG001|Overall Study|Lack of Efficacy|1|||
24964456|NCT00435461|50054313|FG000|Overall Study|Protocol Violation|6|||
24964457|NCT00435461|50054314|FG001|Overall Study|Protocol Violation|9|||
24964458|NCT00435461|50054315|FG002|Overall Study|Protocol Violation|10|||
24964459|NCT00435461|50054313|FG000|Overall Study|Participant randomized(inadequate score)|1|||
25067156|NCT02456740|50172693|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
25067157|NCT02400580|50172705|FG000|Overall Study|Withdrawal by Subject|1|||
25067158|NCT02400580|50172706|FG001|Overall Study|Withdrawal by Subject|1|||
25067159|NCT02400580|50172705|FG000|Overall Study|Adverse Event|1|||
25067160|NCT02400580|50172706|FG001|Overall Study|Adverse Event|0|||
25067161|NCT01367119|50172714|FG000|Overall Study|Adverse Event|1|||
25166423|NCT01739348|50291046|FG002|Part I (Base Study)|Lack of Efficacy|0|||
25166424|NCT01739348|50291047|FG003|Part I (Base Study)|Lack of Efficacy|7|||
25166425|NCT01739348|50291044|FG000|Part I (Base Study)|Lost to Follow-up|4|||
25166426|NCT01739348|50291045|FG001|Part I (Base Study)|Lost to Follow-up|2|||
25166427|NCT01739348|50291046|FG002|Part I (Base Study)|Lost to Follow-up|4|||
25166428|NCT01739348|50291047|FG003|Part I (Base Study)|Lost to Follow-up|4|||
25166429|NCT01739348|50291044|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
25166430|NCT01739348|50291045|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
25166431|NCT01739348|50291046|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
25166432|NCT01739348|50291047|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
25166433|NCT01739348|50291044|FG000|Part I (Base Study)|Physician Decision|10|||
25166434|NCT01739348|50291045|FG001|Part I (Base Study)|Physician Decision|7|||
25166435|NCT01739348|50291046|FG002|Part I (Base Study)|Physician Decision|1|||
25166436|NCT01739348|50291047|FG003|Part I (Base Study)|Physician Decision|4|||
24964460|NCT00435461|50054314|FG001|Overall Study|Participant randomized(inadequate score)|0|||
24964461|NCT00435461|50054315|FG002|Overall Study|Participant randomized(inadequate score)|0|||
24964462|NCT00435461|50054313|FG000|Overall Study|Compliance less than 80 percent|1|||
25166437|NCT01739348|50291044|FG000|Part I (Base Study)|Protocol Violation|2|||
25166438|NCT01739348|50291045|FG001|Part I (Base Study)|Protocol Violation|0|||
25166439|NCT01739348|50291046|FG002|Part I (Base Study)|Protocol Violation|1|||
25166440|NCT01739348|50291047|FG003|Part I (Base Study)|Protocol Violation|2|||
25166441|NCT01739348|50291044|FG000|Part I (Base Study)|Screen Failure|2|||
25166442|NCT01739348|50291045|FG001|Part I (Base Study)|Screen Failure|0|||
25166443|NCT01739348|50291046|FG002|Part I (Base Study)|Screen Failure|0|||
25166444|NCT01739348|50291047|FG003|Part I (Base Study)|Screen Failure|0|||
25166445|NCT01739348|50291044|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
25166446|NCT01739348|50291045|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
25166447|NCT01739348|50291046|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
25166448|NCT01739348|50291047|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
25166449|NCT01739348|50291044|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
25166450|NCT01739348|50291045|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
25166451|NCT01739348|50291046|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
25166452|NCT01739348|50291047|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
25166453|NCT01739348|50291044|FG000|Part I (Base Study)|Participant Moved|4|||
25166454|NCT01739348|50291045|FG001|Part I (Base Study)|Participant Moved|3|||
25166455|NCT01739348|50291046|FG002|Part I (Base Study)|Participant Moved|1|||
25166456|NCT01739348|50291047|FG003|Part I (Base Study)|Participant Moved|7|||
25166457|NCT01739348|50291044|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
25166458|NCT01739348|50291045|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
25166459|NCT01739348|50291046|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
25166460|NCT01739348|50291047|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
25166461|NCT01739348|50291044|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
25166462|NCT01739348|50291045|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
25166463|NCT01739348|50291046|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
25166464|NCT01739348|50291047|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
25166465|NCT01739348|50291044|FG000|Part II (Extension Study)|Adverse Event|10|||
25166466|NCT01739348|50291045|FG001|Part II (Extension Study)|Adverse Event|11|||
25166467|NCT01739348|50291046|FG002|Part II (Extension Study)|Adverse Event|7|||
25166468|NCT01739348|50291047|FG003|Part II (Extension Study)|Adverse Event|26|||
25166469|NCT01739348|50291044|FG000|Part II (Extension Study)|Death|3|||
25166470|NCT01739348|50291045|FG001|Part II (Extension Study)|Death|3|||
25166471|NCT01739348|50291046|FG002|Part II (Extension Study)|Death|2|||
25166472|NCT01739348|50291047|FG003|Part II (Extension Study)|Death|6|||
25166473|NCT01739348|50291044|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
25166474|NCT01739348|50291045|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
25166475|NCT01739348|50291046|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
25166476|NCT01739348|50291047|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
25166477|NCT01739348|50291044|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
25166478|NCT01739348|50291045|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
25166479|NCT01739348|50291046|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
25166480|NCT01739348|50291047|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
25166481|NCT01739348|50291044|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
25166482|NCT01739348|50291045|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
25166483|NCT01739348|50291046|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
25166484|NCT01739348|50291047|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
25166485|NCT01739348|50291044|FG000|Part II (Extension Study)|Physician Decision|7|||
25166486|NCT01739348|50291045|FG001|Part II (Extension Study)|Physician Decision|11|||
25166487|NCT01739348|50291046|FG002|Part II (Extension Study)|Physician Decision|6|||
24964463|NCT00435461|50054314|FG001|Overall Study|Compliance less than 80 percent|0|||
24964464|NCT00435461|50054315|FG002|Overall Study|Compliance less than 80 percent|0|||
24964465|NCT00435461|50054313|FG000|Overall Study|In error, two study medications switched|1|||
24964466|NCT00435461|50054314|FG001|Overall Study|In error, two study medications switched|0|||
24964467|NCT00435461|50054315|FG002|Overall Study|In error, two study medications switched|0|||
24964468|NCT00435461|50054313|FG000|Overall Study|Lack of Efficacy|2|||
24964469|NCT00435461|50054314|FG001|Overall Study|Lack of Efficacy|1|||
24964470|NCT00435461|50054315|FG002|Overall Study|Lack of Efficacy|0|||
24964471|NCT00435461|50054313|FG000|Overall Study|Withdrawal by Subject|1|||
24964472|NCT00435461|50054314|FG001|Overall Study|Withdrawal by Subject|0|||
24964473|NCT00435461|50054315|FG002|Overall Study|Withdrawal by Subject|2|||
24964474|NCT00435461|50054313|FG000|Overall Study|Randomized in error|1|||
24964475|NCT00435461|50054314|FG001|Overall Study|Randomized in error|0|||
24964476|NCT00435461|50054315|FG002|Overall Study|Randomized in error|0|||
25166488|NCT01739348|50291047|FG003|Part II (Extension Study)|Physician Decision|12|||
25166489|NCT01739348|50291044|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
25067162|NCT01367119|50172715|FG001|Overall Study|Adverse Event|0|||
25166490|NCT01739348|50291045|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
25166491|NCT01739348|50291046|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
25166492|NCT01739348|50291047|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
25166493|NCT01739348|50291044|FG000|Part II (Extension Study)|Participant Moved|3|||
25166494|NCT01739348|50291045|FG001|Part II (Extension Study)|Participant Moved|3|||
25166495|NCT01739348|50291046|FG002|Part II (Extension Study)|Participant Moved|0|||
25166496|NCT01739348|50291047|FG003|Part II (Extension Study)|Participant Moved|3|||
25166497|NCT01739348|50291044|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
25166498|NCT01739348|50291045|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
25166499|NCT01739348|50291046|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
25166500|NCT01739348|50291047|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
25166501|NCT01739348|50291044|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
25166502|NCT01739348|50291045|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
25166503|NCT01739348|50291046|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
25166504|NCT01739348|50291047|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
25166505|NCT01738646|50291079|FG000|Overall Study|Still Receiving Treatment|2|||
25166506|NCT01716104|50291086|FG000|Overall Study|Do not meet inclusion criteria|6|||
25166507|NCT01716104|50291087|FG001|Overall Study|Do not meet inclusion criteria|7|||
25166508|NCT04426695|50291167|FG000|Overall Study|Death|2|||
25166509|NCT04426695|50291168|FG001|Overall Study|Death|0|||
25166510|NCT04426695|50291169|FG002|Overall Study|Death|1|||
25166511|NCT04426695|50291170|FG003|Overall Study|Death|27|||
25166512|NCT04426695|50291171|FG004|Overall Study|Death|25|||
25166513|NCT04426695|50291172|FG005|Overall Study|Death|21|||
25166514|NCT04426695|50291173|FG006|Overall Study|Death|42|||
25166515|NCT04426695|50291174|FG007|Overall Study|Death|23|||
25166516|NCT04426695|50291175|FG008|Overall Study|Death|37|||
25166517|NCT04426695|50291176|FG009|Overall Study|Death|14|||
25166518|NCT04426695|50291177|FG010|Overall Study|Death|8|||
25166519|NCT04426695|50291178|FG011|Overall Study|Death|7|||
25166520|NCT04426695|50291179|FG012|Overall Study|Death|13|||
25166521|NCT04426695|50291180|FG013|Overall Study|Death|25|||
25166522|NCT04426695|50291181|FG014|Overall Study|Death|19|||
25166523|NCT04426695|50291182|FG015|Overall Study|Death|7|||
25166524|NCT04426695|50291183|FG016|Overall Study|Death|8|||
25166525|NCT04426695|50291184|FG017|Overall Study|Death|4|||
25166526|NCT04426695|50291167|FG000|Overall Study|Lost to Follow-up|2|||
25166527|NCT04426695|50291168|FG001|Overall Study|Lost to Follow-up|4|||
25166528|NCT04426695|50291169|FG002|Overall Study|Lost to Follow-up|1|||
25166529|NCT04426695|50291170|FG003|Overall Study|Lost to Follow-up|19|||
25166530|NCT04426695|50291171|FG004|Overall Study|Lost to Follow-up|10|||
25166531|NCT04426695|50291172|FG005|Overall Study|Lost to Follow-up|14|||
25166532|NCT04426695|50291173|FG006|Overall Study|Lost to Follow-up|5|||
25166533|NCT04426695|50291174|FG007|Overall Study|Lost to Follow-up|14|||
25166534|NCT04426695|50291175|FG008|Overall Study|Lost to Follow-up|10|||
25166535|NCT04426695|50291176|FG009|Overall Study|Lost to Follow-up|11|||
25166536|NCT04426695|50291177|FG010|Overall Study|Lost to Follow-up|12|||
25166537|NCT04426695|50291178|FG011|Overall Study|Lost to Follow-up|6|||
25166538|NCT04426695|50291179|FG012|Overall Study|Lost to Follow-up|2|||
25166539|NCT04426695|50291180|FG013|Overall Study|Lost to Follow-up|2|||
25166540|NCT04426695|50291181|FG014|Overall Study|Lost to Follow-up|2|||
25166541|NCT04426695|50291182|FG015|Overall Study|Lost to Follow-up|0|||
25166542|NCT04426695|50291183|FG016|Overall Study|Lost to Follow-up|0|||
25166543|NCT04426695|50291184|FG017|Overall Study|Lost to Follow-up|0|||
25166544|NCT04426695|50291167|FG000|Overall Study|Participant Decision|1|||
25166545|NCT04426695|50291168|FG001|Overall Study|Participant Decision|2|||
25166546|NCT04426695|50291169|FG002|Overall Study|Participant Decision|2|||
25166547|NCT04426695|50291170|FG003|Overall Study|Participant Decision|12|||
25166548|NCT04426695|50291171|FG004|Overall Study|Participant Decision|18|||
25166549|NCT04426695|50291172|FG005|Overall Study|Participant Decision|22|||
25166550|NCT04426695|50291173|FG006|Overall Study|Participant Decision|13|||
25166551|NCT04426695|50291174|FG007|Overall Study|Participant Decision|13|||
25166552|NCT04426695|50291175|FG008|Overall Study|Participant Decision|10|||
25166553|NCT04426695|50291176|FG009|Overall Study|Participant Decision|15|||
25276883|NCT00957268|50590818|FG000|Overall Study|Voluntary Withdrawal|0|||
25166554|NCT04426695|50291177|FG010|Overall Study|Participant Decision|16|||
25166555|NCT04426695|50291178|FG011|Overall Study|Participant Decision|17|||
25166556|NCT04426695|50291179|FG012|Overall Study|Participant Decision|2|||
25166557|NCT04426695|50291180|FG013|Overall Study|Participant Decision|1|||
25166558|NCT04426695|50291181|FG014|Overall Study|Participant Decision|2|||
25276884|NCT00957268|50590819|FG001|Overall Study|Voluntary Withdrawal|0|||
25166559|NCT04426695|50291182|FG015|Overall Study|Participant Decision|0|||
25166560|NCT04426695|50291183|FG016|Overall Study|Participant Decision|0|||
25166561|NCT04426695|50291184|FG017|Overall Study|Participant Decision|0|||
25166562|NCT04426695|50291167|FG000|Overall Study|Adverse Event|0|||
25166563|NCT04426695|50291168|FG001|Overall Study|Adverse Event|0|||
25166564|NCT04426695|50291169|FG002|Overall Study|Adverse Event|0|||
25166565|NCT04426695|50291170|FG003|Overall Study|Adverse Event|0|||
25166566|NCT04426695|50291171|FG004|Overall Study|Adverse Event|0|||
25166567|NCT04426695|50291172|FG005|Overall Study|Adverse Event|0|||
25166568|NCT04426695|50291173|FG006|Overall Study|Adverse Event|0|||
25166569|NCT04426695|50291174|FG007|Overall Study|Adverse Event|1|||
25166570|NCT04426695|50291175|FG008|Overall Study|Adverse Event|0|||
25166571|NCT04426695|50291176|FG009|Overall Study|Adverse Event|0|||
25166572|NCT04426695|50291177|FG010|Overall Study|Adverse Event|1|||
25166573|NCT04426695|50291178|FG011|Overall Study|Adverse Event|1|||
25166574|NCT04426695|50291179|FG012|Overall Study|Adverse Event|0|||
25166575|NCT04426695|50291180|FG013|Overall Study|Adverse Event|0|||
25166576|NCT04426695|50291181|FG014|Overall Study|Adverse Event|0|||
25166577|NCT04426695|50291182|FG015|Overall Study|Adverse Event|0|||
25166578|NCT04426695|50291183|FG016|Overall Study|Adverse Event|0|||
25166579|NCT04426695|50291184|FG017|Overall Study|Adverse Event|0|||
25166580|NCT04426695|50291167|FG000|Overall Study|Sponsor Request|0|||
25166581|NCT04426695|50291168|FG001|Overall Study|Sponsor Request|0|||
25166582|NCT04426695|50291169|FG002|Overall Study|Sponsor Request|0|||
25166583|NCT04426695|50291170|FG003|Overall Study|Sponsor Request|0|||
25166584|NCT04426695|50291171|FG004|Overall Study|Sponsor Request|0|||
25166585|NCT04426695|50291172|FG005|Overall Study|Sponsor Request|0|||
25166586|NCT04426695|50291173|FG006|Overall Study|Sponsor Request|1|||
25186957|NCT01386125|50337672|FG000|Overall Study|Participant Leaving Country|1|||
25186958|NCT01386125|50337673|FG001|Overall Study|Participant Leaving Country|0|||
25186959|NCT01384877|50337681|FG000|Treatment 2|Lost to Follow-up|2|||
25186960|NCT01384877|50337682|FG001|Treatment 2|Lost to Follow-up|2|||
25186961|NCT00114517|50337692|FG000|Overall Study|Adverse Event|6|||
25186962|NCT00114517|50337693|FG001|Overall Study|Adverse Event|1|||
25186963|NCT00114517|50337694|FG002|Overall Study|Adverse Event|6|||
25186964|NCT00114517|50337695|FG003|Overall Study|Adverse Event|3|||
25186965|NCT00114517|50337692|FG000|Overall Study|Lost to Follow-up|2|||
25186966|NCT00114517|50337693|FG001|Overall Study|Lost to Follow-up|2|||
25186967|NCT00114517|50337694|FG002|Overall Study|Lost to Follow-up|2|||
25186968|NCT00114517|50337695|FG003|Overall Study|Lost to Follow-up|1|||
25186969|NCT00114517|50337692|FG000|Overall Study|Too busy|3|||
25186970|NCT00114517|50337693|FG001|Overall Study|Too busy|1|||
25186971|NCT00114517|50337694|FG002|Overall Study|Too busy|1|||
25186972|NCT00114517|50337695|FG003|Overall Study|Too busy|2|||
25186973|NCT00114517|50337692|FG000|Overall Study|Moved from area|0|||
25186974|NCT00114517|50337693|FG001|Overall Study|Moved from area|3|||
25186975|NCT00114517|50337694|FG002|Overall Study|Moved from area|2|||
25186976|NCT00114517|50337695|FG003|Overall Study|Moved from area|1|||
25186977|NCT00114517|50337692|FG000|Overall Study|Did not want estradiol|1|||
25186978|NCT00114517|50337693|FG001|Overall Study|Did not want estradiol|1|||
25186979|NCT00114517|50337694|FG002|Overall Study|Did not want estradiol|0|||
25166587|NCT04426695|50291174|FG007|Overall Study|Sponsor Request|0|||
25166588|NCT04426695|50291175|FG008|Overall Study|Sponsor Request|0|||
25166589|NCT04426695|50291176|FG009|Overall Study|Sponsor Request|0|||
25166590|NCT04426695|50291177|FG010|Overall Study|Sponsor Request|0|||
25186980|NCT00114517|50337695|FG003|Overall Study|Did not want estradiol|0|||
25186981|NCT00114517|50337692|FG000|Overall Study|Armed-services duty|0|||
25186982|NCT00114517|50337693|FG001|Overall Study|Armed-services duty|1|||
25186983|NCT00114517|50337694|FG002|Overall Study|Armed-services duty|0|||
25186984|NCT00114517|50337695|FG003|Overall Study|Armed-services duty|1|||
25166591|NCT04426695|50291178|FG011|Overall Study|Sponsor Request|0|||
25166592|NCT04426695|50291179|FG012|Overall Study|Sponsor Request|0|||
25166593|NCT04426695|50291180|FG013|Overall Study|Sponsor Request|0|||
25166594|NCT04426695|50291181|FG014|Overall Study|Sponsor Request|0|||
25166595|NCT04426695|50291182|FG015|Overall Study|Sponsor Request|0|||
25166596|NCT04426695|50291183|FG016|Overall Study|Sponsor Request|0|||
25166597|NCT04426695|50291184|FG017|Overall Study|Sponsor Request|0|||
25166598|NCT04426695|50291167|FG000|Overall Study|Physician Decision|0|||
25166599|NCT04426695|50291168|FG001|Overall Study|Physician Decision|0|||
25166600|NCT04426695|50291169|FG002|Overall Study|Physician Decision|0|||
25166601|NCT04426695|50291170|FG003|Overall Study|Physician Decision|0|||
25166602|NCT04426695|50291171|FG004|Overall Study|Physician Decision|0|||
25186985|NCT00114517|50337692|FG000|Overall Study|Competing family issue|0|||
25186986|NCT00114517|50337693|FG001|Overall Study|Competing family issue|1|||
25186987|NCT00114517|50337694|FG002|Overall Study|Competing family issue|0|||
25166603|NCT04426695|50291172|FG005|Overall Study|Physician Decision|0|||
25166604|NCT04426695|50291173|FG006|Overall Study|Physician Decision|0|||
25166605|NCT04426695|50291174|FG007|Overall Study|Physician Decision|0|||
25166606|NCT04426695|50291175|FG008|Overall Study|Physician Decision|0|||
25166607|NCT04426695|50291176|FG009|Overall Study|Physician Decision|1|||
25166608|NCT04426695|50291177|FG010|Overall Study|Physician Decision|0|||
25166609|NCT04426695|50291178|FG011|Overall Study|Physician Decision|0|||
25186988|NCT00114517|50337695|FG003|Overall Study|Competing family issue|1|||
25186989|NCT00114517|50337692|FG000|Overall Study|Physician Decision|0|||
25186990|NCT00114517|50337693|FG001|Overall Study|Physician Decision|1|||
25166610|NCT04426695|50291179|FG012|Overall Study|Physician Decision|1|||
25166611|NCT04426695|50291180|FG013|Overall Study|Physician Decision|0|||
25166612|NCT04426695|50291181|FG014|Overall Study|Physician Decision|0|||
25166613|NCT04426695|50291182|FG015|Overall Study|Physician Decision|0|||
25166614|NCT04426695|50291183|FG016|Overall Study|Physician Decision|0|||
25166615|NCT04426695|50291184|FG017|Overall Study|Physician Decision|0|||
25166616|NCT04426695|50291167|FG000|Overall Study|Randomized but Never Treated|3|||
25166617|NCT04426695|50291168|FG001|Overall Study|Randomized but Never Treated|1|||
25166618|NCT04426695|50291169|FG002|Overall Study|Randomized but Never Treated|0|||
25166619|NCT04426695|50291170|FG003|Overall Study|Randomized but Never Treated|4|||
25166620|NCT04426695|50291171|FG004|Overall Study|Randomized but Never Treated|5|||
25166621|NCT04426695|50291172|FG005|Overall Study|Randomized but Never Treated|5|||
25166622|NCT04426695|50291173|FG006|Overall Study|Randomized but Never Treated|4|||
25166623|NCT04426695|50291174|FG007|Overall Study|Randomized but Never Treated|6|||
25166624|NCT04426695|50291175|FG008|Overall Study|Randomized but Never Treated|6|||
25166625|NCT04426695|50291176|FG009|Overall Study|Randomized but Never Treated|3|||
25166626|NCT04426695|50291177|FG010|Overall Study|Randomized but Never Treated|3|||
25166627|NCT04426695|50291178|FG011|Overall Study|Randomized but Never Treated|6|||
25166628|NCT04426695|50291179|FG012|Overall Study|Randomized but Never Treated|1|||
25166629|NCT04426695|50291180|FG013|Overall Study|Randomized but Never Treated|2|||
25166630|NCT04426695|50291181|FG014|Overall Study|Randomized but Never Treated|0|||
25166631|NCT04426695|50291182|FG015|Overall Study|Randomized but Never Treated|0|||
25166632|NCT04426695|50291183|FG016|Overall Study|Randomized but Never Treated|0|||
25166633|NCT04426695|50291184|FG017|Overall Study|Randomized but Never Treated|0|||
25166634|NCT01838200|50291261|FG000|Overall Study|Adverse Event|0|||
25166635|NCT01838200|50291262|FG001|Overall Study|Adverse Event|2|||
25166636|NCT01838200|50291261|FG000|Overall Study|Progressive disease|3|||
25166637|NCT01838200|50291262|FG001|Overall Study|Progressive disease|0|||
25166638|NCT03219034|50291305|FG000|Overall Study|Lost to Follow-up|9|||
25166639|NCT03219034|50291306|FG001|Overall Study|Lost to Follow-up|13|||
25166640|NCT03219034|50291305|FG000|Overall Study|Additional dental work needed|1|||
25166641|NCT03219034|50291306|FG001|Overall Study|Additional dental work needed|0|||
25166642|NCT03219034|50291305|FG000|Overall Study|UPPP Surgery|1|||
25166643|NCT03219034|50291306|FG001|Overall Study|UPPP Surgery|0|||
25166644|NCT03219034|50291305|FG000|Overall Study|Dental sensitivity|0|||
25166645|NCT03219034|50291306|FG001|Overall Study|Dental sensitivity|1|||
25166646|NCT03219034|50291305|FG000|Overall Study|Death in family|0|||
25166647|NCT03219034|50291306|FG001|Overall Study|Death in family|1|||
25166648|NCT01706198|50291330|FG000|Overall Study|Adverse Event|12|||
25166649|NCT01706198|50291331|FG001|Overall Study|Adverse Event|15|||
25166650|NCT01706198|50291330|FG000|Overall Study|Protocol Violation|7|||
25166651|NCT01706198|50291331|FG001|Overall Study|Protocol Violation|5|||
25166652|NCT01706198|50291330|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
25166653|NCT01706198|50291331|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
25166654|NCT01706198|50291330|FG000|Overall Study|Lost to Follow-up|97|||
25166655|NCT01706198|50291331|FG001|Overall Study|Lost to Follow-up|93|||
25166656|NCT01706198|50291330|FG000|Overall Study|Physician Decision|23|||
25166657|NCT01706198|50291331|FG001|Overall Study|Physician Decision|37|||
25166658|NCT01706198|50291330|FG000|Overall Study|Withdrawal by Subject|23|||
25166659|NCT01706198|50291331|FG001|Overall Study|Withdrawal by Subject|31|||
25166660|NCT01705730|50291337|FG000|Overall Study|Lack of Efficacy|1|||
25166661|NCT01705730|50291337|FG000|Overall Study|Adverse Event|3|||
25166662|NCT01705730|50291337|FG000|Overall Study|Lost to Follow-up|1|||
25166663|NCT01705730|50291337|FG000|Overall Study|Reason not Specified|4|||
25166664|NCT01705652|50291343|FG000|Overall Study|Adverse Event|1|||
25166665|NCT01705652|50291344|FG001|Overall Study|Adverse Event|0|||
25166666|NCT01705652|50291343|FG000|Overall Study|Withdrawal by Subject|1|||
25166667|NCT01705652|50291344|FG001|Overall Study|Withdrawal by Subject|2|||
25166668|NCT01705652|50291343|FG000|Overall Study|non-compliance|1|||
25166669|NCT01705652|50291344|FG001|Overall Study|non-compliance|1|||
25166670|NCT01705574|50291372|FG000|Double-Blind Phase|Lost to Follow-up|12|||
25166671|NCT01705574|50291373|FG001|Double-Blind Phase|Lost to Follow-up|16|||
25166672|NCT01705574|50291374|FG002|Double-Blind Phase|Lost to Follow-up|0|||
25276885|NCT00957268|50590820|FG002|Overall Study|Voluntary Withdrawal|1|||
24964477|NCT00435461|50054313|FG000|Overall Study|Participant could not tolerate symptoms|0|||
25166673|NCT01705574|50291375|FG003|Double-Blind Phase|Lost to Follow-up|0|||
25166674|NCT01705574|50291372|FG000|Double-Blind Phase|Adverse Event|3|||
25166675|NCT01705574|50291373|FG001|Double-Blind Phase|Adverse Event|10|||
25166676|NCT01705574|50291374|FG002|Double-Blind Phase|Adverse Event|0|||
25166677|NCT01705574|50291375|FG003|Double-Blind Phase|Adverse Event|0|||
25166678|NCT01705574|50291372|FG000|Double-Blind Phase|Withdrew Consent|8|||
25166679|NCT01705574|50291373|FG001|Double-Blind Phase|Withdrew Consent|5|||
25166680|NCT01705574|50291374|FG002|Double-Blind Phase|Withdrew Consent|0|||
25166681|NCT01705574|50291375|FG003|Double-Blind Phase|Withdrew Consent|0|||
25166682|NCT01705574|50291372|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
25166683|NCT01705574|50291373|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
25166684|NCT01705574|50291374|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
25166685|NCT01705574|50291375|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
25166686|NCT01705574|50291372|FG000|Double-Blind Phase|Pregnancy|1|||
25166687|NCT01705574|50291373|FG001|Double-Blind Phase|Pregnancy|1|||
25166688|NCT01705574|50291374|FG002|Double-Blind Phase|Pregnancy|0|||
25166689|NCT01705574|50291375|FG003|Double-Blind Phase|Pregnancy|0|||
25166690|NCT01705574|50291372|FG000|Double-Blind Phase|Protocol Violation|1|||
25166691|NCT01705574|50291373|FG001|Double-Blind Phase|Protocol Violation|0|||
25166692|NCT01705574|50291374|FG002|Double-Blind Phase|Protocol Violation|0|||
25166693|NCT01705574|50291375|FG003|Double-Blind Phase|Protocol Violation|0|||
25166694|NCT01705574|50291372|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
25166695|NCT01705574|50291373|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
25166696|NCT01705574|50291374|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
25166697|NCT01705574|50291375|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
25166698|NCT01705574|50291372|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
25166699|NCT01705574|50291373|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
25166700|NCT01705574|50291374|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
25166701|NCT01705574|50291375|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
25166702|NCT01705574|50291372|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
25166703|NCT01705574|50291373|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
25166704|NCT01705574|50291374|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
25166705|NCT01705574|50291375|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
25166706|NCT01705574|50291372|FG000|Open-Label Extension Phase|Adverse Event|3|||
25166707|NCT01705574|50291373|FG001|Open-Label Extension Phase|Adverse Event|0|||
25166708|NCT01705574|50291374|FG002|Open-Label Extension Phase|Adverse Event|0|||
25166709|NCT01705574|50291375|FG003|Open-Label Extension Phase|Adverse Event|1|||
25166710|NCT01705574|50291372|FG000|Open-Label Extension Phase|Death|2|||
25166711|NCT01705574|50291373|FG001|Open-Label Extension Phase|Death|0|||
25166712|NCT01705574|50291374|FG002|Open-Label Extension Phase|Death|1|||
25166713|NCT01705574|50291375|FG003|Open-Label Extension Phase|Death|0|||
25166714|NCT01705574|50291372|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
25166715|NCT01705574|50291373|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
25166716|NCT01705574|50291374|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
25166717|NCT01705574|50291375|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
25166718|NCT01705574|50291372|FG000|Open-Label Extension Phase|Physician Decision|0|||
25166719|NCT01705574|50291373|FG001|Open-Label Extension Phase|Physician Decision|0|||
25166720|NCT01705574|50291374|FG002|Open-Label Extension Phase|Physician Decision|2|||
25166721|NCT01705574|50291375|FG003|Open-Label Extension Phase|Physician Decision|0|||
25166722|NCT01705574|50291372|FG000|Open-Label Extension Phase|Pregnancy|0|||
25166723|NCT01705574|50291373|FG001|Open-Label Extension Phase|Pregnancy|0|||
25166724|NCT01705574|50291374|FG002|Open-Label Extension Phase|Pregnancy|1|||
25166725|NCT01705574|50291375|FG003|Open-Label Extension Phase|Pregnancy|1|||
25166726|NCT01737710|50291396|FG000|Overall Study|Lost to Follow-up|0|||
25166727|NCT01737710|50291397|FG001|Overall Study|Lost to Follow-up|2|||
25166728|NCT01737710|50291398|FG002|Overall Study|Lost to Follow-up|2|||
25166729|NCT01737710|50291399|FG003|Overall Study|Lost to Follow-up|0|||
25166730|NCT01737710|50291400|FG004|Overall Study|Lost to Follow-up|0|||
25166731|NCT01737710|50291396|FG000|Overall Study|Withdrawal by Subject|1|||
25166732|NCT01737710|50291397|FG001|Overall Study|Withdrawal by Subject|1|||
25166733|NCT01737710|50291398|FG002|Overall Study|Withdrawal by Subject|1|||
25166734|NCT01737710|50291399|FG003|Overall Study|Withdrawal by Subject|0|||
25166735|NCT01737710|50291400|FG004|Overall Study|Withdrawal by Subject|0|||
25166736|NCT01737710|50291396|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
25166737|NCT01737710|50291397|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
25166738|NCT01737710|50291398|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
25166739|NCT01737710|50291399|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
25166740|NCT01737710|50291400|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
25166741|NCT01682876|50291415|FG000|Overall Study|Administrative reason|4|||
25166742|NCT01682876|50291416|FG001|Overall Study|Administrative reason|4|||
25166743|NCT01682876|50291417|FG002|Overall Study|Administrative reason|0|||
25166744|NCT01682876|50291418|FG003|Overall Study|Administrative reason|3|||
25166745|NCT01682876|50291415|FG000|Overall Study|Adverse Event|0|||
25166746|NCT01682876|50291416|FG001|Overall Study|Adverse Event|0|||
25166747|NCT01682876|50291417|FG002|Overall Study|Adverse Event|0|||
25166748|NCT01682876|50291418|FG003|Overall Study|Adverse Event|1|||
25166749|NCT01682876|50291415|FG000|Overall Study|Lost to Follow-up|11|||
25166750|NCT01682876|50291416|FG001|Overall Study|Lost to Follow-up|15|||
25166751|NCT01682876|50291417|FG002|Overall Study|Lost to Follow-up|9|||
25166752|NCT01682876|50291418|FG003|Overall Study|Lost to Follow-up|11|||
25166753|NCT01682876|50291415|FG000|Overall Study|Protocol Violation|1|||
25166754|NCT01682876|50291416|FG001|Overall Study|Protocol Violation|1|||
25166755|NCT01682876|50291417|FG002|Overall Study|Protocol Violation|1|||
25166756|NCT01682876|50291418|FG003|Overall Study|Protocol Violation|1|||
25166757|NCT01682876|50291415|FG000|Overall Study|Withdrawal by Subject|4|||
25166758|NCT01682876|50291416|FG001|Overall Study|Withdrawal by Subject|0|||
25166759|NCT01682876|50291417|FG002|Overall Study|Withdrawal by Subject|0|||
25166760|NCT01682876|50291418|FG003|Overall Study|Withdrawal by Subject|2|||
25166761|NCT01682876|50291415|FG000|Overall Study|Other|1|||
25166762|NCT01682876|50291416|FG001|Overall Study|Other|0|||
25166763|NCT01682876|50291417|FG002|Overall Study|Other|1|||
25166764|NCT01682876|50291418|FG003|Overall Study|Other|1|||
25166765|NCT01682720|50291435|FG000|Overall Study|Randomized but Not Treated|0|||
25166766|NCT01682720|50291436|FG001|Overall Study|Randomized but Not Treated|1|||
25166767|NCT01682720|50291437|FG002|Overall Study|Randomized but Not Treated|1|||
25166768|NCT01682720|50291438|FG003|Overall Study|Randomized but Not Treated|0|||
25166769|NCT01682720|50291435|FG000|Overall Study|Terminated by Sponsor|83|||
25166770|NCT01682720|50291436|FG001|Overall Study|Terminated by Sponsor|0|||
25166771|NCT01682720|50291437|FG002|Overall Study|Terminated by Sponsor|0|||
25166772|NCT01682720|50291438|FG003|Overall Study|Terminated by Sponsor|0|||
25166773|NCT01682720|50291435|FG000|Overall Study|Efficacy Failure|0|||
25166774|NCT01682720|50291436|FG001|Overall Study|Efficacy Failure|3|||
25166775|NCT01682720|50291437|FG002|Overall Study|Efficacy Failure|3|||
25166776|NCT01682720|50291438|FG003|Overall Study|Efficacy Failure|30|||
25166777|NCT01682720|50291435|FG000|Overall Study|Lost to Follow-up|1|||
25166778|NCT01682720|50291436|FG001|Overall Study|Lost to Follow-up|1|||
25166779|NCT01682720|50291437|FG002|Overall Study|Lost to Follow-up|0|||
25166780|NCT01682720|50291438|FG003|Overall Study|Lost to Follow-up|6|||
25166781|NCT01682720|50291435|FG000|Overall Study|Subject Withdrew Consent|0|||
25166782|NCT01682720|50291436|FG001|Overall Study|Subject Withdrew Consent|0|||
25166783|NCT01682720|50291437|FG002|Overall Study|Subject Withdrew Consent|2|||
25166784|NCT01682720|50291438|FG003|Overall Study|Subject Withdrew Consent|2|||
25166785|NCT01682720|50291435|FG000|Overall Study|Adverse Event|1|||
25166786|NCT01682720|50291436|FG001|Overall Study|Adverse Event|0|||
25166787|NCT01682720|50291437|FG002|Overall Study|Adverse Event|1|||
25166788|NCT01682720|50291438|FG003|Overall Study|Adverse Event|1|||
25166789|NCT01714544|50291457|FG000|Overall Study|Lost to Follow-up|1|||
25166790|NCT01714544|50291457|FG000|Overall Study|Physician Decision|1|||
25166791|NCT01714544|50291457|FG000|Overall Study|Withdrawal by Subject|1|||
25166792|NCT01703858|50291464|FG000|Overall Study|Withdrawal by Subject|0|||
25166793|NCT01703858|50291465|FG001|Overall Study|Withdrawal by Subject|1|||
25166794|NCT01703858|50291466|FG002|Overall Study|Withdrawal by Subject|0|||
25166795|NCT01714310|50291482|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
25166796|NCT01714310|50291483|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
25166797|NCT01714310|50291484|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
25166798|NCT01714310|50291482|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
25166799|NCT01714310|50291483|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
25166800|NCT01714310|50291484|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
25166801|NCT01714310|50291482|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
25166802|NCT01714310|50291483|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
25166803|NCT01714310|50291484|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
25166804|NCT01714310|50291482|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
25166805|NCT01714310|50291483|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
25166806|NCT01714310|50291484|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
25166807|NCT01713998|50291505|FG000|Overall Study|Lost to Follow-up|2|||
25166808|NCT01713998|50291506|FG001|Overall Study|Lost to Follow-up|0|||
25166809|NCT01713998|50291507|FG002|Overall Study|Lost to Follow-up|2|||
25166810|NCT01713998|50291505|FG000|Overall Study|Withdrawal by Subject|1|||
25166811|NCT01713998|50291506|FG001|Overall Study|Withdrawal by Subject|0|||
25166812|NCT01713998|50291507|FG002|Overall Study|Withdrawal by Subject|0|||
25166813|NCT01681628|50291517|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
25166814|NCT01681628|50291518|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
25166815|NCT01681628|50291517|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
25166816|NCT01681628|50291518|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
25166817|NCT01681628|50291517|FG000|19 Months Follow-up|Death|1|||
25166818|NCT01681628|50291518|FG001|19 Months Follow-up|Death|0|||
25166819|NCT01681628|50291517|FG000|19 Months Follow-up|Lost to Follow-up|61|||
25166820|NCT01681628|50291518|FG001|19 Months Follow-up|Lost to Follow-up|43|||
25166821|NCT00016354|50291540|FG000|Overall Study|Lack of Efficacy|0|||
25166822|NCT00016354|50291541|FG001|Overall Study|Lack of Efficacy|0|||
25166823|NCT00016354|50291542|FG002|Overall Study|Lack of Efficacy|0|||
25166824|NCT00016354|50291543|FG003|Overall Study|Lack of Efficacy|0|||
25166825|NCT00016354|50291544|FG004|Overall Study|Lack of Efficacy|0|||
25166826|NCT00016354|50291545|FG005|Overall Study|Lack of Efficacy|0|||
25166827|NCT00016354|50291546|FG006|Overall Study|Lack of Efficacy|0|||
24964478|NCT00435461|50054314|FG001|Overall Study|Participant could not tolerate symptoms|0|||
25166828|NCT00016354|50291547|FG007|Overall Study|Lack of Efficacy|1|||
25166829|NCT01681472|50291555|FG000|Overall Study|Adverse Event|0|||
25166830|NCT01681472|50291556|FG001|Overall Study|Adverse Event|1|||
25166831|NCT01681472|50291557|FG002|Overall Study|Adverse Event|0|||
25166832|NCT01681472|50291558|FG003|Overall Study|Adverse Event|0|||
25166833|NCT01049308|50291587|FG000|Pill Counts|Withdrawal by Subject|83|||
25166834|NCT01713686|50291594|FG000|Overall Study|Lost to Follow-up|9|||
25166835|NCT01713686|50291594|FG000|Overall Study|Withdrawal by Subject|6|||
25166836|NCT01047436|50291600|FG000|Overall Study|Protocol Violation|1|||
25166837|NCT01047436|50291601|FG001|Overall Study|Protocol Violation|0|||
25166838|NCT01681004|50291609|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
25166839|NCT01681004|50291610|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
25166840|NCT01681004|50291609|FG000|Study Completion|Lost to Follow-up|8|||
25166841|NCT01681004|50291610|FG001|Study Completion|Lost to Follow-up|3|||
25166842|NCT01681004|50291609|FG000|Study Completion|Physician Decision|1|||
25166843|NCT01681004|50291610|FG001|Study Completion|Physician Decision|3|||
25166844|NCT01681004|50291609|FG000|Study Completion|Site Termination|2|||
25166845|NCT01681004|50291610|FG001|Study Completion|Site Termination|1|||
25166846|NCT01681004|50291609|FG000|Study Completion|Death|1|||
25166847|NCT01681004|50291610|FG001|Study Completion|Death|1|||
25166848|NCT01046110|50291622|FG000|Overall Study|Adverse Event|9|||
25166849|NCT01046110|50291623|FG001|Overall Study|Adverse Event|2|||
25166850|NCT01046110|50291622|FG000|Overall Study|Lack of Efficacy|0|||
25166851|NCT01046110|50291623|FG001|Overall Study|Lack of Efficacy|1|||
25166852|NCT01046110|50291622|FG000|Overall Study|Protocol Violation|7|||
25166853|NCT01046110|50291623|FG001|Overall Study|Protocol Violation|12|||
25166854|NCT01046110|50291622|FG000|Overall Study|Withdrawal Criteria|3|||
25166855|NCT01046110|50291623|FG001|Overall Study|Withdrawal Criteria|5|||
25166856|NCT01046110|50291622|FG000|Overall Study|Unclassified|36|||
25166857|NCT01046110|50291623|FG001|Overall Study|Unclassified|35|||
25166858|NCT01713530|50291631|FG000|Overall Study|Adverse Event|0|||
25166859|NCT01713530|50291632|FG001|Overall Study|Adverse Event|5|||
25166860|NCT01713530|50291631|FG000|Overall Study|Withdrawal criteria|21|||
25166861|NCT01713530|50291632|FG001|Overall Study|Withdrawal criteria|12|||
25166862|NCT01713530|50291631|FG000|Overall Study|Unclassified|4|||
25166863|NCT01713530|50291632|FG001|Overall Study|Unclassified|2|||
25166864|NCT01045798|50291640|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
25166865|NCT01045798|50291641|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
25166866|NCT01045798|50291640|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
25166867|NCT01045798|50291641|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
25166868|NCT01045798|50291640|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
25166869|NCT01045798|50291641|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
25166870|NCT01045798|50291640|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
25166871|NCT01045798|50291641|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
25166872|NCT01712984|50291654|FG000|Overall Study|Adverse Event|0|||
25166873|NCT01712984|50291655|FG001|Overall Study|Adverse Event|0|||
25166874|NCT01712984|50291656|FG002|Overall Study|Adverse Event|1|||
25166875|NCT01712984|50291654|FG000|Overall Study|Protocol Violation|2|||
25166876|NCT01712984|50291655|FG001|Overall Study|Protocol Violation|0|||
25166877|NCT01712984|50291656|FG002|Overall Study|Protocol Violation|1|||
25166878|NCT01712984|50291654|FG000|Overall Study|Lost to Follow-up|8|||
25166879|NCT01712984|50291655|FG001|Overall Study|Lost to Follow-up|10|||
25166880|NCT01712984|50291656|FG002|Overall Study|Lost to Follow-up|1|||
25166881|NCT01712984|50291654|FG000|Overall Study|Withdrawal by Subject|6|||
25166882|NCT01712984|50291655|FG001|Overall Study|Withdrawal by Subject|6|||
25166883|NCT01712984|50291656|FG002|Overall Study|Withdrawal by Subject|7|||
25166884|NCT01042678|50291667|FG000|Overall Study|Physician Decision|1|||
25166885|NCT01042678|50291668|FG001|Overall Study|Physician Decision|0|||
25166886|NCT01042678|50291669|FG002|Overall Study|Physician Decision|0|||
25166887|NCT01042678|50291670|FG003|Overall Study|Physician Decision|0|||
25166888|NCT01042678|50291671|FG004|Overall Study|Physician Decision|0|||
25166889|NCT01042678|50291672|FG005|Overall Study|Physician Decision|0|||
25166890|NCT01042600|50291682|FG000|Overall Study|Ineligible|1|||
25166891|NCT01042600|50291683|FG001|Overall Study|Ineligible|0|||
25166892|NCT01041976|50291692|FG000|Overall Study|Withdrawal by Subject|3|||
25166893|NCT01041976|50291693|FG001|Overall Study|Withdrawal by Subject|0|||
25166894|NCT01041976|50291692|FG000|Overall Study|Incarceration|2|||
25166895|NCT01041976|50291693|FG001|Overall Study|Incarceration|0|||
25166896|NCT01041976|50291692|FG000|Overall Study|Death|0|||
25166897|NCT01041976|50291693|FG001|Overall Study|Death|4|||
25166898|NCT01712516|50291719|FG000|Overall Study|Technical problems|0|||
25166899|NCT01712516|50291720|FG001|Overall Study|Technical problems|0|||
25166900|NCT01712516|50291721|FG002|Overall Study|Technical problems|0|||
25166901|NCT01712516|50291722|FG003|Overall Study|Technical problems|2|||
25166902|NCT01712516|50291719|FG000|Overall Study|Lost to Follow-up|0|||
25166903|NCT01712516|50291720|FG001|Overall Study|Lost to Follow-up|0|||
25166904|NCT01712516|50291721|FG002|Overall Study|Lost to Follow-up|2|||
25166905|NCT01712516|50291722|FG003|Overall Study|Lost to Follow-up|1|||
25166906|NCT01712516|50291719|FG000|Overall Study|Death|0|||
25166907|NCT01712516|50291720|FG001|Overall Study|Death|1|||
25166908|NCT01712516|50291721|FG002|Overall Study|Death|0|||
25166909|NCT01712516|50291722|FG003|Overall Study|Death|0|||
25166910|NCT01712516|50291719|FG000|Overall Study|Protocol deviation|1|||
25166911|NCT01712516|50291720|FG001|Overall Study|Protocol deviation|0|||
25166912|NCT01712516|50291721|FG002|Overall Study|Protocol deviation|1|||
25166913|NCT01712516|50291722|FG003|Overall Study|Protocol deviation|0|||
25166914|NCT01712516|50291719|FG000|Overall Study|Physician Decision|2|||
25166915|NCT01712516|50291720|FG001|Overall Study|Physician Decision|0|||
25166916|NCT01712516|50291721|FG002|Overall Study|Physician Decision|0|||
25166917|NCT01712516|50291722|FG003|Overall Study|Physician Decision|1|||
25166918|NCT01712516|50291719|FG000|Overall Study|Withdrawal by Subject|3|||
25166919|NCT01712516|50291720|FG001|Overall Study|Withdrawal by Subject|9|||
25166920|NCT01712516|50291721|FG002|Overall Study|Withdrawal by Subject|3|||
25166921|NCT01712516|50291722|FG003|Overall Study|Withdrawal by Subject|9|||
25166922|NCT01703000|50291732|FG000|Overall Study|Death|1|||
25166923|NCT01040728|50291736|FG000|Overall Study|Adverse Event|4|||
25166924|NCT01040728|50291737|FG001|Overall Study|Adverse Event|8|||
25166925|NCT01040728|50291738|FG002|Overall Study|Adverse Event|0|||
25166926|NCT01040728|50291739|FG003|Overall Study|Adverse Event|4|||
25166927|NCT01040728|50291736|FG000|Overall Study|Withdrawal by Subject|0|||
25166928|NCT01040728|50291737|FG001|Overall Study|Withdrawal by Subject|1|||
25166929|NCT01040728|50291738|FG002|Overall Study|Withdrawal by Subject|1|||
25166930|NCT01040728|50291739|FG003|Overall Study|Withdrawal by Subject|0|||
25166931|NCT01040728|50291736|FG000|Overall Study|Protocol Violation|0|||
25166932|NCT01040728|50291737|FG001|Overall Study|Protocol Violation|0|||
25166933|NCT01040728|50291738|FG002|Overall Study|Protocol Violation|0|||
25166934|NCT01040728|50291739|FG003|Overall Study|Protocol Violation|1|||
25166935|NCT01040728|50291736|FG000|Overall Study|Lack of Efficacy|0|||
25166936|NCT01040728|50291737|FG001|Overall Study|Lack of Efficacy|1|||
25166937|NCT01040728|50291738|FG002|Overall Study|Lack of Efficacy|0|||
25166938|NCT01040728|50291739|FG003|Overall Study|Lack of Efficacy|1|||
25166939|NCT01040728|50291736|FG000|Overall Study|Other reasons not listed above|0|||
25166940|NCT01040728|50291737|FG001|Overall Study|Other reasons not listed above|1|||
25166941|NCT01040728|50291738|FG002|Overall Study|Other reasons not listed above|0|||
25166942|NCT01040728|50291739|FG003|Overall Study|Other reasons not listed above|0|||
25166943|NCT01593020|50291757|FG000|Overall Study|Adverse Event|1|||
25166944|NCT01593020|50291758|FG001|Overall Study|Adverse Event|1|||
25166945|NCT01593020|50291757|FG000|Overall Study|Death|0|||
25166946|NCT01593020|50291758|FG001|Overall Study|Death|1|||
25166947|NCT01593020|50291757|FG000|Overall Study|Ineligible|1|||
25166948|NCT01593020|50291758|FG001|Overall Study|Ineligible|0|||
25166949|NCT01040260|50291766|FG000|Overall Study|Withdrawal by Subject|12|||
25166950|NCT01040260|50291767|FG001|Overall Study|Withdrawal by Subject|6|||
25166951|NCT01040260|50291766|FG000|Overall Study|Lost to Follow-up|3|||
25166952|NCT01040260|50291767|FG001|Overall Study|Lost to Follow-up|5|||
25166953|NCT01712438|50291773|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
25166954|NCT01712438|50291773|FG000|Overall Study|Ongoing ITI treatment|6|||
25166955|NCT01712438|50291773|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
25166956|NCT01712438|50291773|FG000|Overall Study|Prematurely Discontinued|25|||
25166957|NCT01712204|50291784|FG000|Overall Study|Adverse Event|3|||
25166958|NCT01712204|50291785|FG001|Overall Study|Adverse Event|1|||
25166959|NCT01712204|50291784|FG000|Overall Study|Withdrawal by Subject|3|||
25166960|NCT01712204|50291785|FG001|Overall Study|Withdrawal by Subject|3|||
25166961|NCT01712204|50291784|FG000|Overall Study|Lost to Follow-up|1|||
25166962|NCT01712204|50291785|FG001|Overall Study|Lost to Follow-up|0|||
25166963|NCT01712204|50291784|FG000|Overall Study|Protocol Violation|1|||
25166964|NCT01712204|50291785|FG001|Overall Study|Protocol Violation|1|||
25166965|NCT01592864|50291793|FG000|Overall Study|Withdrawal by Subject|0|||
25166966|NCT01592864|50291794|FG001|Overall Study|Withdrawal by Subject|1|||
25166967|NCT01592786|50291800|FG000|Overall Study|Adverse Event|60|||
24964479|NCT00435461|50054315|FG002|Overall Study|Participant could not tolerate symptoms|1|||
24964480|NCT00435461|50054313|FG000|Overall Study|Participant could not swallow capsule|0|||
24964481|NCT00435461|50054314|FG001|Overall Study|Participant could not swallow capsule|0|||
24964482|NCT00435461|50054315|FG002|Overall Study|Participant could not swallow capsule|1|||
24964483|NCT00435461|50054313|FG000|Overall Study|Pregnancy|2|||
24964484|NCT00435461|50054314|FG001|Overall Study|Pregnancy|0|||
24964485|NCT00435461|50054315|FG002|Overall Study|Pregnancy|0|||
24964486|NCT00435461|50054313|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
25166968|NCT01592786|50291800|FG000|Overall Study|Lack of Efficacy|19|||
25166969|NCT01592786|50291800|FG000|Overall Study|Protocol Violation|14|||
25166970|NCT01592786|50291800|FG000|Overall Study|Withdrawal by Subject|23|||
25166971|NCT01592786|50291800|FG000|Overall Study|Lost to Follow-up|19|||
25166972|NCT01592786|50291800|FG000|Overall Study|Other|3|||
25166973|NCT01711736|50291806|FG000|Overall Study|Lost to Follow-up|4|||
25166974|NCT01711736|50291807|FG001|Overall Study|Lost to Follow-up|1|||
25166975|NCT01711736|50291806|FG000|Overall Study|Withdrawal by Subject|6|||
25166976|NCT01711736|50291807|FG001|Overall Study|Withdrawal by Subject|6|||
25166977|NCT01711736|50291806|FG000|Overall Study|Migrated/moved from study area|2|||
25166978|NCT01711736|50291807|FG001|Overall Study|Migrated/moved from study area|1|||
25166979|NCT01592708|50291816|FG000|Overall Study|Protocol Violation|3|||
25166980|NCT01592708|50291817|FG001|Overall Study|Protocol Violation|0|||
25166981|NCT01042522|50291828|FG000|Overall Study|Adverse Event|1|||
25166982|NCT01042522|50291829|FG001|Overall Study|Adverse Event|2|||
25166983|NCT01042522|50291828|FG000|Overall Study|Disease Progression|5|||
25166984|NCT01042522|50291829|FG001|Overall Study|Disease Progression|0|||
25166985|NCT01042522|50291828|FG000|Overall Study|Death|1|||
25166986|NCT01042522|50291829|FG001|Overall Study|Death|0|||
25166987|NCT01042522|50291828|FG000|Overall Study|Patient Refused|0|||
25166988|NCT01042522|50291829|FG001|Overall Study|Patient Refused|3|||
25166989|NCT01042522|50291828|FG000|Overall Study|Withdrawal by Subject|1|||
25166990|NCT01042522|50291829|FG001|Overall Study|Withdrawal by Subject|1|||
25166991|NCT01702844|50291835|FG000|Overall Study|Adverse Event|9|||
25166992|NCT01702844|50291835|FG000|Overall Study|Death|1|||
25166993|NCT01702844|50291835|FG000|Overall Study|Withdrawal by Subject|3|||
25166994|NCT01702844|50291835|FG000|Overall Study|Physician Decision|6|||
25166995|NCT01702532|50291841|FG000|Overall Study|Adverse Event|0|||
25166996|NCT01702532|50291842|FG001|Overall Study|Adverse Event|1|||
25166997|NCT01702454|50291851|FG000|Overall Study|Consent withdrawal|0|||
25166998|NCT01702454|50291852|FG001|Overall Study|Consent withdrawal|1|||
25166999|NCT01702454|50291851|FG000|Overall Study|Migrated/moved from study area|0|||
25167000|NCT01702454|50291852|FG001|Overall Study|Migrated/moved from study area|1|||
25167001|NCT01702454|50291851|FG000|Overall Study|Lost to Follow-up|3|||
25167002|NCT01702454|50291852|FG001|Overall Study|Lost to Follow-up|6|||
25167003|NCT01702298|50291865|FG000|Overall Study|Withdrawal by Subject|1|||
25167004|NCT02993523|50291874|FG000|Overall Study|Withdrew Consent|0|||
25167005|NCT02993523|50291875|FG001|Overall Study|Withdrew Consent|0|||
25167006|NCT02993523|50291876|FG002|Overall Study|Withdrew Consent|2|||
25167007|NCT02993523|50291877|FG003|Overall Study|Withdrew Consent|9|||
25167008|NCT02993523|50291878|FG004|Overall Study|Withdrew Consent|0|||
25167009|NCT02993523|50291874|FG000|Overall Study|Lost to Follow-up|0|||
25167010|NCT02993523|50291875|FG001|Overall Study|Lost to Follow-up|0|||
25167011|NCT02993523|50291876|FG002|Overall Study|Lost to Follow-up|3|||
25167012|NCT02993523|50291877|FG003|Overall Study|Lost to Follow-up|6|||
25167013|NCT02993523|50291878|FG004|Overall Study|Lost to Follow-up|0|||
25167014|NCT02993523|50291874|FG000|Overall Study|Death|1|||
25167015|NCT02993523|50291875|FG001|Overall Study|Death|1|||
25167016|NCT02993523|50291876|FG002|Overall Study|Death|138|||
25167017|NCT02993523|50291877|FG003|Overall Study|Death|222|||
25167018|NCT02993523|50291878|FG004|Overall Study|Death|6|||
25167019|NCT02993523|50291874|FG000|Overall Study|Reason not Specified|0|||
25167020|NCT02993523|50291875|FG001|Overall Study|Reason not Specified|0|||
25167021|NCT02993523|50291876|FG002|Overall Study|Reason not Specified|1|||
25167022|NCT02993523|50291877|FG003|Overall Study|Reason not Specified|1|||
25167023|NCT02993523|50291878|FG004|Overall Study|Reason not Specified|0|||
25167024|NCT01701362|50291888|FG000|Overall Study|Adverse events not related to study drug|1|||
25167025|NCT01701362|50291889|FG001|Overall Study|Adverse events not related to study drug|6|||
25167026|NCT01701362|50291888|FG000|Overall Study|Adverse events related to study drug|12|||
25167027|NCT01701362|50291889|FG001|Overall Study|Adverse events related to study drug|10|||
25167028|NCT01701362|50291888|FG000|Overall Study|Protocol Violation|5|||
25167029|NCT01701362|50291889|FG001|Overall Study|Protocol Violation|3|||
25167030|NCT01701362|50291888|FG000|Overall Study|No longer willing to participate|8|||
25167031|NCT01701362|50291889|FG001|Overall Study|No longer willing to participate|14|||
25167032|NCT01701362|50291888|FG000|Overall Study|Lost to Follow-up|6|||
25167033|NCT01701362|50291889|FG001|Overall Study|Lost to Follow-up|9|||
25167034|NCT01701362|50291888|FG000|Overall Study|Insufficient clinical response|6|||
25167035|NCT01701362|50291889|FG001|Overall Study|Insufficient clinical response|6|||
25167036|NCT01701362|50291888|FG000|Overall Study|Death|0|||
25167037|NCT01701362|50291889|FG001|Overall Study|Death|1|||
25167038|NCT01701362|50291888|FG000|Overall Study|Randomized but not treated|1|||
25167039|NCT01701362|50291889|FG001|Overall Study|Randomized but not treated|2|||
25167040|NCT01701362|50291888|FG000|Overall Study|Reasons other than those mentioned above|3|||
25167041|NCT01701362|50291889|FG001|Overall Study|Reasons other than those mentioned above|5|||
25167042|NCT01710800|50291918|FG000|Overall Study|Withdrawal by Subject|21|||
25167043|NCT01710800|50291918|FG000|Overall Study|Protocol Violation|1|||
25167044|NCT01710020|50291924|FG000|Period 1|Protocol Violation|1|||
25167045|NCT01700348|50291930|FG000|Overall Study|Withdrawal by Subject|22|||
25167046|NCT01700348|50291930|FG000|Overall Study|Lost to Follow-up|1|||
25167047|NCT01700192|50291938|FG000|Overall Study|Adverse Event|73|||
25167048|NCT01700192|50291939|FG001|Overall Study|Adverse Event|18|||
25167049|NCT01700192|50291938|FG000|Overall Study|Lack of Efficacy|1|||
25167050|NCT01700192|50291939|FG001|Overall Study|Lack of Efficacy|0|||
25167051|NCT01700192|50291938|FG000|Overall Study|Lost to Follow-up|42|||
25167052|NCT01700192|50291939|FG001|Overall Study|Lost to Follow-up|29|||
25167053|NCT01700192|50291938|FG000|Overall Study|Noncompliance with study drug|0|||
25167054|NCT01700192|50291939|FG001|Overall Study|Noncompliance with study drug|5|||
25167055|NCT01700192|50291938|FG000|Overall Study|Physician Decision|2|||
25167056|NCT01700192|50291939|FG001|Overall Study|Physician Decision|3|||
25167057|NCT01700192|50291938|FG000|Overall Study|Pregnancy|1|||
25167058|NCT01700192|50291939|FG001|Overall Study|Pregnancy|4|||
25167059|NCT01700192|50291938|FG000|Overall Study|Progressive disease|1|||
25167060|NCT01700192|50291939|FG001|Overall Study|Progressive disease|0|||
25167061|NCT01700192|50291938|FG000|Overall Study|Protocol Violation|3|||
25167062|NCT01700192|50291939|FG001|Overall Study|Protocol Violation|4|||
25167063|NCT01700192|50291938|FG000|Overall Study|Technical problems|0|||
25167064|NCT01700192|50291939|FG001|Overall Study|Technical problems|1|||
25167065|NCT01700192|50291938|FG000|Overall Study|Withdrawal by Subject|56|||
25167066|NCT01700192|50291939|FG001|Overall Study|Withdrawal by Subject|64|||
25167067|NCT01700192|50291938|FG000|Overall Study|Never received study drug|1|||
25167068|NCT01700192|50291939|FG001|Overall Study|Never received study drug|0|||
25167069|NCT01709864|50291956|FG000|Overall Study|Physician Decision|0|||
25167070|NCT01709864|50291957|FG001|Overall Study|Physician Decision|1|||
25167071|NCT01709864|50291956|FG000|Overall Study|subject/guardian decision|5|||
25167072|NCT01709864|50291957|FG001|Overall Study|subject/guardian decision|6|||
25167073|NCT01709864|50291956|FG000|Overall Study|Lost to Follow-up|1|||
25167074|NCT01709864|50291957|FG001|Overall Study|Lost to Follow-up|0|||
25167075|NCT01709864|50291956|FG000|Overall Study|non-compliance with study treatment|1|||
25167076|NCT01709864|50291957|FG001|Overall Study|non-compliance with study treatment|1|||
25167077|NCT01709864|50291956|FG000|Overall Study|Adverse Event|0|||
25167078|NCT01709864|50291957|FG001|Overall Study|Adverse Event|2|||
25167079|NCT01709864|50291956|FG000|Overall Study|Death|0|||
25167080|NCT01709864|50291957|FG001|Overall Study|Death|1|||
25167081|NCT01709708|50291965|FG000|Overall Study|Protocol Violation|1|||
25167082|NCT01709708|50291966|FG001|Overall Study|Protocol Violation|2|||
25167083|NCT01709318|50291989|FG000|Overall Study|Adverse Event|3|||
25167084|NCT01709318|50291990|FG001|Overall Study|Adverse Event|4|||
25167085|NCT01709318|50291991|FG002|Overall Study|Adverse Event|2|||
25167086|NCT01709318|50291992|FG003|Overall Study|Adverse Event|2|||
25167087|NCT01709318|50291993|FG004|Overall Study|Adverse Event|0|||
25167088|NCT01709318|50291994|FG005|Overall Study|Adverse Event|1|||
25167089|NCT01709318|50291995|FG006|Overall Study|Adverse Event|2|||
25167090|NCT01709318|50291989|FG000|Overall Study|Lost to Follow-up|2|||
25167091|NCT01709318|50291990|FG001|Overall Study|Lost to Follow-up|0|||
25167092|NCT01709318|50291991|FG002|Overall Study|Lost to Follow-up|0|||
25167093|NCT01709318|50291992|FG003|Overall Study|Lost to Follow-up|0|||
25167094|NCT01709318|50291993|FG004|Overall Study|Lost to Follow-up|1|||
25167095|NCT01709318|50291994|FG005|Overall Study|Lost to Follow-up|1|||
25167096|NCT01709318|50291995|FG006|Overall Study|Lost to Follow-up|1|||
25167097|NCT01709318|50291989|FG000|Overall Study|Non-compliance with Study Drug|0|||
25167098|NCT01709318|50291990|FG001|Overall Study|Non-compliance with Study Drug|2|||
25167099|NCT01709318|50291991|FG002|Overall Study|Non-compliance with Study Drug|1|||
25167100|NCT01709318|50291992|FG003|Overall Study|Non-compliance with Study Drug|1|||
25167101|NCT01709318|50291993|FG004|Overall Study|Non-compliance with Study Drug|0|||
25167102|NCT01709318|50291994|FG005|Overall Study|Non-compliance with Study Drug|0|||
25167103|NCT01709318|50291995|FG006|Overall Study|Non-compliance with Study Drug|2|||
25167104|NCT01709318|50291989|FG000|Overall Study|Physician Decision|0|||
25167105|NCT01709318|50291990|FG001|Overall Study|Physician Decision|0|||
25167106|NCT01709318|50291991|FG002|Overall Study|Physician Decision|0|||
25167107|NCT01709318|50291992|FG003|Overall Study|Physician Decision|0|||
25167108|NCT01709318|50291993|FG004|Overall Study|Physician Decision|0|||
25167109|NCT01709318|50291994|FG005|Overall Study|Physician Decision|0|||
25167110|NCT01709318|50291995|FG006|Overall Study|Physician Decision|1|||
25167111|NCT01709318|50291989|FG000|Overall Study|Pregnancy|0|||
25167112|NCT01709318|50291990|FG001|Overall Study|Pregnancy|0|||
25167113|NCT01709318|50291991|FG002|Overall Study|Pregnancy|0|||
25167114|NCT01709318|50291992|FG003|Overall Study|Pregnancy|0|||
25167115|NCT01709318|50291993|FG004|Overall Study|Pregnancy|1|||
25167116|NCT01709318|50291994|FG005|Overall Study|Pregnancy|0|||
25167117|NCT01709318|50291995|FG006|Overall Study|Pregnancy|0|||
25167118|NCT01709318|50291989|FG000|Overall Study|Protocol Violation|0|||
25167119|NCT01709318|50291990|FG001|Overall Study|Protocol Violation|0|||
25167120|NCT01709318|50291991|FG002|Overall Study|Protocol Violation|0|||
25167121|NCT01709318|50291992|FG003|Overall Study|Protocol Violation|0|||
25167122|NCT01709318|50291993|FG004|Overall Study|Protocol Violation|2|||
25167123|NCT01709318|50291994|FG005|Overall Study|Protocol Violation|0|||
25167124|NCT01709318|50291995|FG006|Overall Study|Protocol Violation|1|||
25167125|NCT01709318|50291989|FG000|Overall Study|Technical Problems|1|||
25167126|NCT01709318|50291990|FG001|Overall Study|Technical Problems|0|||
25167127|NCT01709318|50291991|FG002|Overall Study|Technical Problems|0|||
25167128|NCT01709318|50291992|FG003|Overall Study|Technical Problems|0|||
25167129|NCT01709318|50291993|FG004|Overall Study|Technical Problems|0|||
25167130|NCT01709318|50291994|FG005|Overall Study|Technical Problems|0|||
25167131|NCT01709318|50291995|FG006|Overall Study|Technical Problems|0|||
25167132|NCT01709318|50291989|FG000|Overall Study|Withdrawal by Subject|3|||
25167133|NCT01709318|50291990|FG001|Overall Study|Withdrawal by Subject|0|||
25167134|NCT01709318|50291991|FG002|Overall Study|Withdrawal by Subject|3|||
25167135|NCT01709318|50291992|FG003|Overall Study|Withdrawal by Subject|3|||
25167136|NCT01709318|50291993|FG004|Overall Study|Withdrawal by Subject|0|||
25167137|NCT01709318|50291994|FG005|Overall Study|Withdrawal by Subject|2|||
25186991|NCT00114517|50337694|FG002|Overall Study|Physician Decision|0|||
25167138|NCT01709318|50291995|FG006|Overall Study|Withdrawal by Subject|4|||
25167139|NCT01709318|50291989|FG000|Overall Study|Other Protocol Specified Criteria|0|||
25167140|NCT01709318|50291990|FG001|Overall Study|Other Protocol Specified Criteria|1|||
25167141|NCT01709318|50291991|FG002|Overall Study|Other Protocol Specified Criteria|0|||
25167142|NCT01709318|50291992|FG003|Overall Study|Other Protocol Specified Criteria|0|||
25167143|NCT01709318|50291993|FG004|Overall Study|Other Protocol Specified Criteria|0|||
25167144|NCT01709318|50291994|FG005|Overall Study|Other Protocol Specified Criteria|0|||
25167145|NCT01709318|50291995|FG006|Overall Study|Other Protocol Specified Criteria|0|||
25167146|NCT01699178|50292013|FG000|Overall Study|Adverse Event|1|||
25167147|NCT01699178|50292014|FG001|Overall Study|Adverse Event|5|||
25167148|NCT01699178|50292013|FG000|Overall Study|Lost to Follow-up|1|||
25167149|NCT01699178|50292014|FG001|Overall Study|Lost to Follow-up|6|||
25167150|NCT01699178|50292013|FG000|Overall Study|Non-compliance with Study Drug|3|||
25167151|NCT01699178|50292014|FG001|Overall Study|Non-compliance with Study Drug|1|||
25167152|NCT01699178|50292013|FG000|Overall Study|Physician Decision|1|||
25167153|NCT01699178|50292014|FG001|Overall Study|Physician Decision|0|||
25167154|NCT01699178|50292013|FG000|Overall Study|Withdrawal by Subject|4|||
25167155|NCT01699178|50292014|FG001|Overall Study|Withdrawal by Subject|12|||
25167156|NCT01699178|50292013|FG000|Overall Study|Hematocrit >54%|1|||
25167157|NCT01699178|50292014|FG001|Overall Study|Hematocrit >54%|1|||
25167158|NCT01699178|50292013|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
25167159|NCT01699178|50292014|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
25167160|NCT01699178|50292013|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
25167161|NCT01699178|50292014|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
25167162|NCT01683409|50292025|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
25167163|NCT01683409|50292026|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
25167164|NCT01683409|50292027|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
25167165|NCT01683409|50292028|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
25167166|NCT01683409|50292029|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
25167167|NCT01683409|50292025|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
25167168|NCT01683409|50292026|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
25167169|NCT01683409|50292027|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
25167170|NCT01683409|50292028|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
25167171|NCT01683409|50292029|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
25167172|NCT01683409|50292025|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
25167173|NCT01683409|50292026|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
25167174|NCT01683409|50292027|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
25167175|NCT01683409|50292028|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
25167176|NCT01683409|50292029|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
25167177|NCT01683409|50292025|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
25167178|NCT01683409|50292026|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
25167179|NCT01683409|50292027|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
25167180|NCT01683409|50292028|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
25167181|NCT01683409|50292029|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
25167182|NCT01683409|50292025|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
25167183|NCT01683409|50292026|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
25167184|NCT01683409|50292027|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
25167185|NCT01683409|50292028|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
25167186|NCT01683409|50292029|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
25167187|NCT01683409|50292025|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
25167188|NCT01683409|50292026|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
25167189|NCT01683409|50292027|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
25167190|NCT01683409|50292028|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
25167191|NCT01683409|50292029|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
25167192|NCT01683409|50292025|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
25167193|NCT01683409|50292026|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
25167194|NCT01683409|50292027|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
25167195|NCT01683409|50292028|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
25167196|NCT01683409|50292029|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
25167197|NCT01683409|50292025|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
25067163|NCT01367119|50172714|FG000|Overall Study|Withdrawal by Subject|1|||
25067164|NCT01367119|50172715|FG001|Overall Study|Withdrawal by Subject|1|||
25067165|NCT02635724|50172724|FG000|Overall Study|Withdrawal by Subject|0|||
25067166|NCT02635724|50172725|FG001|Overall Study|Withdrawal by Subject|1|||
25067167|NCT02635724|50172726|FG002|Overall Study|Withdrawal by Subject|0|||
25167198|NCT01683409|50292026|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
25167199|NCT01683409|50292027|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
25167200|NCT01683409|50292028|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
25167201|NCT01683409|50292029|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
25167202|NCT01683409|50292025|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
25167203|NCT01683409|50292026|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
25167204|NCT01683409|50292027|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
25167205|NCT01683409|50292028|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
25167206|NCT01683409|50292029|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
25167207|NCT01683409|50292025|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
25167208|NCT01683409|50292026|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
25167209|NCT01683409|50292027|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
25167210|NCT01683409|50292028|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
25167211|NCT01683409|50292029|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
25167212|NCT01683409|50292025|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
25167213|NCT01683409|50292026|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
25167214|NCT01683409|50292027|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
25167215|NCT01683409|50292028|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
25167216|NCT01683409|50292029|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
25167217|NCT01699022|50292055|FG000|Overall Study|Early discontinuation from the study|3|||
25167218|NCT01683019|50292063|FG000|Overall Study|Withdrawal by Subject|2|||
25167219|NCT01683019|50292064|FG001|Overall Study|Withdrawal by Subject|1|||
25167220|NCT01683019|50292065|FG002|Overall Study|Withdrawal by Subject|4|||
25167221|NCT01709162|50292075|FG000|Overall Study|Disease progression|3|||
25167222|NCT01709162|50292076|FG001|Overall Study|Disease progression|3|||
25167223|NCT01709162|50292075|FG000|Overall Study|Study drug toxicity|2|||
25167224|NCT01709162|50292076|FG001|Overall Study|Study drug toxicity|0|||
25167225|NCT01709162|50292075|FG000|Overall Study|Administrative reason by sponsor|0|||
25167226|NCT01709162|50292076|FG001|Overall Study|Administrative reason by sponsor|1|||
25167227|NCT01709162|50292075|FG000|Overall Study|Other|1|||
25167228|NCT01709162|50292076|FG001|Overall Study|Other|0|||
25167229|NCT01709162|50292075|FG000|Overall Study|Withdrawal by Subject|0|||
25167230|NCT01709162|50292076|FG001|Overall Study|Withdrawal by Subject|1|||
25167231|NCT01698554|50292086|FG000|Overall Study|Adverse Event|2|||
25167232|NCT01698554|50292087|FG001|Overall Study|Adverse Event|5|||
25167233|NCT01698554|50292088|FG002|Overall Study|Adverse Event|0|||
25167234|NCT01698554|50292089|FG003|Overall Study|Adverse Event|1|||
25167235|NCT01698554|50292086|FG000|Overall Study|Lost to Follow-up|1|||
25167236|NCT01698554|50292087|FG001|Overall Study|Lost to Follow-up|0|||
25167237|NCT01698554|50292088|FG002|Overall Study|Lost to Follow-up|0|||
25167238|NCT01698554|50292089|FG003|Overall Study|Lost to Follow-up|0|||
25167239|NCT01698554|50292086|FG000|Overall Study|Personal Reasons|0|||
25167240|NCT01698554|50292087|FG001|Overall Study|Personal Reasons|5|||
25167241|NCT01698554|50292088|FG002|Overall Study|Personal Reasons|1|||
25167242|NCT01698554|50292089|FG003|Overall Study|Personal Reasons|1|||
25167243|NCT01698554|50292086|FG000|Overall Study|Protocol Violation|2|||
25167244|NCT01698554|50292087|FG001|Overall Study|Protocol Violation|0|||
25167245|NCT01698554|50292088|FG002|Overall Study|Protocol Violation|1|||
25167246|NCT01698554|50292089|FG003|Overall Study|Protocol Violation|0|||
25167247|NCT01698554|50292086|FG000|Overall Study|Other Miscellaneous Reasons|1|||
25167248|NCT01698554|50292087|FG001|Overall Study|Other Miscellaneous Reasons|0|||
25167249|NCT01698554|50292088|FG002|Overall Study|Other Miscellaneous Reasons|0|||
25167250|NCT01698554|50292089|FG003|Overall Study|Other Miscellaneous Reasons|0|||
25167251|NCT01698320|50292101|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
25167252|NCT01698320|50292102|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
25167253|NCT01698320|50292103|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
25167254|NCT01698320|50292101|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
25167255|NCT01698320|50292102|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
25167256|NCT01698320|50292103|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
25167257|NCT01698320|50292101|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
25167258|NCT01698320|50292102|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
25167259|NCT01698320|50292103|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
25167260|NCT01698320|50292101|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
25167261|NCT01698320|50292102|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
25167262|NCT01698320|50292103|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
25167263|NCT01698320|50292101|FG000|12-Week Double-Blind Period|Adverse Event|0|||
25167264|NCT01698320|50292102|FG001|12-Week Double-Blind Period|Adverse Event|1|||
25167265|NCT01698320|50292103|FG002|12-Week Double-Blind Period|Adverse Event|1|||
25167266|NCT01698320|50292101|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
25167267|NCT01698320|50292102|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
25167268|NCT01698320|50292103|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
25167269|NCT01698320|50292101|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
25167270|NCT01698320|50292102|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
25167271|NCT01698320|50292103|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
25167272|NCT01698320|50292101|FG000|12-Week Double-Blind Period|Pregnancy|0|||
25167273|NCT01698320|50292102|FG001|12-Week Double-Blind Period|Pregnancy|1|||
25167274|NCT01698320|50292103|FG002|12-Week Double-Blind Period|Pregnancy|1|||
25167275|NCT01698320|50292101|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
25067168|NCT02635646|50172736|FG000|Overall Study|Lost to Follow-up|24|||
25167276|NCT01698320|50292102|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
25167277|NCT01698320|50292103|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
25167278|NCT01698320|50292101|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
25167279|NCT01698320|50292102|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
25167280|NCT01698320|50292103|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
25167281|NCT01698320|50292101|FG000|40-Week Open-Label Period|Adverse Event|0|||
25167282|NCT01698320|50292102|FG001|40-Week Open-Label Period|Adverse Event|3|||
25167283|NCT01698320|50292103|FG002|40-Week Open-Label Period|Adverse Event|2|||
25167284|NCT01698320|50292101|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
25167285|NCT01698320|50292102|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
25167286|NCT01698320|50292103|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
25167287|NCT01698320|50292101|FG000|40-Week Open-Label Period|Pregnancy|0|||
25167288|NCT01698320|50292102|FG001|40-Week Open-Label Period|Pregnancy|2|||
25167289|NCT01698320|50292103|FG002|40-Week Open-Label Period|Pregnancy|1|||
25167290|NCT01698320|50292101|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
25167291|NCT01698320|50292102|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
25167292|NCT01698320|50292103|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
25167293|NCT01698320|50292101|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
25167294|NCT01698320|50292102|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
25167295|NCT01698320|50292103|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
25167296|NCT01698008|50292113|FG000|Overall Study|Withdrawal by Subject|1|||
25167297|NCT01698008|50292114|FG001|Overall Study|Withdrawal by Subject|2|||
25167298|NCT01697696|50292130|FG000|Overall Study|Study terminated by sponsor|0|||
25167299|NCT01697696|50292131|FG001|Overall Study|Study terminated by sponsor|3|||
25167300|NCT01697696|50292130|FG000|Overall Study|Protocol deviation|1|||
25167301|NCT01697696|50292131|FG001|Overall Study|Protocol deviation|0|||
25167302|NCT01697696|50292130|FG000|Overall Study|Physician Decision|1|||
25167303|NCT01697696|50292131|FG001|Overall Study|Physician Decision|0|||
25167304|NCT01697696|50292130|FG000|Overall Study|Death|4|||
25167305|NCT01697696|50292131|FG001|Overall Study|Death|2|||
25167306|NCT01697696|50292130|FG000|Overall Study|Lost to Follow-up|10|||
25167307|NCT01697696|50292131|FG001|Overall Study|Lost to Follow-up|7|||
25167308|NCT01697696|50292130|FG000|Overall Study|Subject/guardian decision|31|||
25167309|NCT01697696|50292131|FG001|Overall Study|Subject/guardian decision|35|||
25167310|NCT01569152|50292139|FG000|Phase IIa, Period 1|Early Escape|5|||
25167311|NCT01569152|50292140|FG001|Phase IIa, Period 1|Early Escape|22|||
25167312|NCT01569152|50292141|FG002|Phase IIa, Period 1|Early Escape|0|||
25167313|NCT01569152|50292139|FG000|Phase IIa, Period 1|Adverse Event|4|||
25167314|NCT01569152|50292140|FG001|Phase IIa, Period 1|Adverse Event|0|||
25167315|NCT01569152|50292141|FG002|Phase IIa, Period 1|Adverse Event|0|||
25167316|NCT01569152|50292139|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
25167317|NCT01569152|50292140|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
25167318|NCT01569152|50292141|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
25167319|NCT01569152|50292139|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
25167320|NCT01569152|50292140|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
25167321|NCT01569152|50292141|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
25167322|NCT01569152|50292139|FG000|Phase IIa, Period 1|Protocol Violation|0|||
25167323|NCT01569152|50292140|FG001|Phase IIa, Period 1|Protocol Violation|1|||
25167324|NCT01569152|50292141|FG002|Phase IIa, Period 1|Protocol Violation|0|||
25167325|NCT01569152|50292139|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
25167326|NCT01569152|50292140|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
25167327|NCT01569152|50292141|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
25167328|NCT01569152|50292139|FG000|Safety Extension, Period 3|Adverse Event|0|||
25167329|NCT01569152|50292140|FG001|Safety Extension, Period 3|Adverse Event|0|||
25167330|NCT01569152|50292141|FG002|Safety Extension, Period 3|Adverse Event|4|||
25167331|NCT01569152|50292139|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
25167332|NCT01569152|50292140|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
25167333|NCT01569152|50292141|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
25167334|NCT01569152|50292139|FG000|Safety Extension, Period 3|Physician Decision|0|||
25167335|NCT01569152|50292140|FG001|Safety Extension, Period 3|Physician Decision|0|||
25167336|NCT01569152|50292141|FG002|Safety Extension, Period 3|Physician Decision|2|||
25167337|NCT01569152|50292139|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
25167338|NCT01569152|50292140|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
25276886|NCT00957268|50590821|FG003|Overall Study|Voluntary Withdrawal|0|||
24964487|NCT00435461|50054314|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
25167339|NCT01569152|50292141|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
25167340|NCT01569074|50292166|FG000|Overall Study|Study stopped|6|||
25167341|NCT01569074|50292167|FG001|Overall Study|Study stopped|6|||
25167342|NCT01569074|50292168|FG002|Overall Study|Study stopped|8|||
25167343|NCT01569074|50292169|FG003|Overall Study|Study stopped|7|||
25167344|NCT01569074|50292170|FG004|Overall Study|Study stopped|7|||
25167345|NCT01569074|50292166|FG000|Overall Study|Study-specific discontinuation criteria|0|||
25167346|NCT01569074|50292167|FG001|Overall Study|Study-specific discontinuation criteria|1|||
25167347|NCT01569074|50292168|FG002|Overall Study|Study-specific discontinuation criteria|0|||
25167348|NCT01569074|50292169|FG003|Overall Study|Study-specific discontinuation criteria|0|||
25167349|NCT01569074|50292170|FG004|Overall Study|Study-specific discontinuation criteria|0|||
25167350|NCT01569074|50292166|FG000|Overall Study|Severe non-compliance to protocol|0|||
25167351|NCT01569074|50292167|FG001|Overall Study|Severe non-compliance to protocol|0|||
25167352|NCT01569074|50292168|FG002|Overall Study|Severe non-compliance to protocol|1|||
25167353|NCT01569074|50292169|FG003|Overall Study|Severe non-compliance to protocol|0|||
25167354|NCT01569074|50292170|FG004|Overall Study|Severe non-compliance to protocol|0|||
25167355|NCT01569074|50292166|FG000|Overall Study|eg change in circumstances|0|||
25167356|NCT01569074|50292167|FG001|Overall Study|eg change in circumstances|2|||
25167357|NCT01569074|50292168|FG002|Overall Study|eg change in circumstances|0|||
25167358|NCT01569074|50292169|FG003|Overall Study|eg change in circumstances|1|||
25167359|NCT01569074|50292170|FG004|Overall Study|eg change in circumstances|1|||
25167360|NCT01569074|50292166|FG000|Overall Study|Adverse Event|1|||
25167361|NCT01569074|50292167|FG001|Overall Study|Adverse Event|0|||
25167362|NCT01569074|50292168|FG002|Overall Study|Adverse Event|3|||
25167363|NCT01569074|50292169|FG003|Overall Study|Adverse Event|0|||
25167364|NCT01569074|50292170|FG004|Overall Study|Adverse Event|0|||
25167365|NCT01604408|50292188|FG000|Treatment Period 1|Protocol Violation|0|||
25167366|NCT01604408|50292189|FG001|Treatment Period 1|Protocol Violation|1|||
25167367|NCT01604408|50292188|FG000|Treatment Period 2|Withdrawal by Subject|1|||
25167368|NCT01604408|50292189|FG001|Treatment Period 2|Withdrawal by Subject|1|||
25167369|NCT01604408|50292188|FG000|Treatment Period 2|Protocol Violation|1|||
25167370|NCT01604408|50292189|FG001|Treatment Period 2|Protocol Violation|0|||
25167371|NCT01604408|50292188|FG000|Treatment Period 2|Adverse Event|0|||
25167372|NCT01604408|50292189|FG001|Treatment Period 2|Adverse Event|1|||
25167373|NCT01604408|50292188|FG000|Treatment Period 3|Protocol Violation|1|||
25167374|NCT01604408|50292189|FG001|Treatment Period 3|Protocol Violation|1|||
25167375|NCT01604408|50292188|FG000|Treatment Period 3|Adverse Event|0|||
25167376|NCT01604408|50292189|FG001|Treatment Period 3|Adverse Event|3|||
25167377|NCT01604408|50292188|FG000|Treatment Period 3|Withdrawal by Subject|3|||
24964488|NCT00435461|50054315|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
25167378|NCT01604408|50292189|FG001|Treatment Period 3|Withdrawal by Subject|1|||
25167379|NCT01604408|50292188|FG000|Treatment Period 3|Sponsor Decision|1|||
25167380|NCT01604408|50292189|FG001|Treatment Period 3|Sponsor Decision|0|||
25167381|NCT01604408|50292188|FG000|Treatment Period 4|Death|1|||
25186992|NCT00114517|50337695|FG003|Overall Study|Physician Decision|0|||
25167382|NCT01604408|50292189|FG001|Treatment Period 4|Death|0|||
25167383|NCT01604408|50292188|FG000|Treatment Period 4|Withdrawal by Subject|2|||
25167384|NCT01604408|50292189|FG001|Treatment Period 4|Withdrawal by Subject|1|||
25167385|NCT01604408|50292188|FG000|Treatment Period 4|Adverse Event|0|||
25167386|NCT01604408|50292189|FG001|Treatment Period 4|Adverse Event|1|||
25167387|NCT01604408|50292188|FG000|Treatment Period 5|Adverse Event|4|||
25167388|NCT01604408|50292189|FG001|Treatment Period 5|Adverse Event|0|||
25167389|NCT01604408|50292188|FG000|Treatment Period 6|Lost to Follow-up|0|||
25167390|NCT01604408|50292189|FG001|Treatment Period 6|Lost to Follow-up|1|||
25167391|NCT01604408|50292188|FG000|Treatment Period 6|Adverse Event|2|||
25167392|NCT01604408|50292189|FG001|Treatment Period 6|Adverse Event|0|||
25167393|NCT01604408|50292188|FG000|Treatment Period 6|Sponsor decision|0|||
25167394|NCT01604408|50292189|FG001|Treatment Period 6|Sponsor decision|1|||
25167395|NCT01604408|50292188|FG000|Observation Period|Adverse Event|1|||
25167396|NCT01604408|50292189|FG001|Observation Period|Adverse Event|1|||
25167397|NCT01604408|50292188|FG000|Observation Period|Withdrawal by Subject|0|||
25167398|NCT01604408|50292189|FG001|Observation Period|Withdrawal by Subject|2|||
25167399|NCT01567826|50292197|FG000|Overall Study|Lost to Follow-up|3|||
25167400|NCT01567826|50292198|FG001|Overall Study|Lost to Follow-up|2|||
25167401|NCT01697462|50292206|FG000|Overall Study|Disease Progression|1|||
25167402|NCT01697462|50292206|FG000|Overall Study|Adverse Event|6|||
25167403|NCT01697462|50292206|FG000|Overall Study|Lost to Follow-up|21|||
25167404|NCT01697462|50292206|FG000|Overall Study|Withdrawal by Subject|12|||
25167405|NCT01697462|50292206|FG000|Overall Study|Investigator Decision|21|||
25167406|NCT01697462|50292206|FG000|Overall Study|Death|1|||
25167407|NCT01697462|50292206|FG000|Overall Study|Other|10|||
25167408|NCT01697462|50292206|FG000|Overall Study|Missing|5|||
25167409|NCT01696994|50292212|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
25167410|NCT01696994|50292213|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
25167411|NCT01696994|50292212|FG000|Overall Study|Died Before Randomization|1|||
25167412|NCT01696994|50292213|FG001|Overall Study|Died Before Randomization|2|||
25167413|NCT01696994|50292212|FG000|Overall Study|Died Before ASU (Control)|73|||
25167414|NCT01696994|50292213|FG001|Overall Study|Died Before ASU (Control)|0|||
25167415|NCT01696994|50292212|FG000|Overall Study|No Ovaries at Baseline|4807|||
25167416|NCT01696994|50292213|FG001|Overall Study|No Ovaries at Baseline|4851|||
25167417|NCT01696994|50292212|FG000|Overall Study|Refused ASU (Control)|311|||
25167418|NCT01696994|50292213|FG001|Overall Study|Refused ASU (Control)|0|||
25167419|NCT01696994|50292212|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
25167420|NCT01696994|50292213|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
25167421|NCT01592240|50292392|FG000|Overall Study|Adverse Event|1|||
25167422|NCT01592240|50292393|FG001|Overall Study|Adverse Event|0|||
25167423|NCT01592240|50292394|FG002|Overall Study|Adverse Event|0|||
25167424|NCT01592240|50292395|FG003|Overall Study|Adverse Event|1|||
25167425|NCT01592240|50292396|FG004|Overall Study|Adverse Event|1|||
25167426|NCT01592240|50292397|FG005|Overall Study|Adverse Event|0|||
25167427|NCT01592240|50292398|FG006|Overall Study|Adverse Event|0|||
25167428|NCT01592240|50292392|FG000|Overall Study|Death|0|||
25167429|NCT01592240|50292393|FG001|Overall Study|Death|1|||
25167430|NCT01592240|50292394|FG002|Overall Study|Death|0|||
25167431|NCT01592240|50292395|FG003|Overall Study|Death|0|||
25167432|NCT01592240|50292396|FG004|Overall Study|Death|0|||
25167433|NCT01592240|50292397|FG005|Overall Study|Death|0|||
25167434|NCT01592240|50292398|FG006|Overall Study|Death|0|||
25167435|NCT01592240|50292392|FG000|Overall Study|Lost to Follow-up|1|||
25167436|NCT01592240|50292393|FG001|Overall Study|Lost to Follow-up|3|||
25167437|NCT01592240|50292394|FG002|Overall Study|Lost to Follow-up|1|||
25167438|NCT01592240|50292395|FG003|Overall Study|Lost to Follow-up|0|||
25167439|NCT01592240|50292396|FG004|Overall Study|Lost to Follow-up|3|||
25167440|NCT01592240|50292397|FG005|Overall Study|Lost to Follow-up|2|||
25167441|NCT01592240|50292398|FG006|Overall Study|Lost to Follow-up|0|||
25167442|NCT01592240|50292392|FG000|Overall Study|Protocol Violation|0|||
25167443|NCT01592240|50292393|FG001|Overall Study|Protocol Violation|0|||
25167444|NCT01592240|50292394|FG002|Overall Study|Protocol Violation|0|||
25167445|NCT01592240|50292395|FG003|Overall Study|Protocol Violation|0|||
25167446|NCT01592240|50292396|FG004|Overall Study|Protocol Violation|0|||
25167447|NCT01592240|50292397|FG005|Overall Study|Protocol Violation|1|||
25167448|NCT01592240|50292398|FG006|Overall Study|Protocol Violation|0|||
25167449|NCT01592240|50292392|FG000|Overall Study|Withdrawal by Subject|0|||
25167450|NCT01592240|50292393|FG001|Overall Study|Withdrawal by Subject|4|||
25167451|NCT01592240|50292394|FG002|Overall Study|Withdrawal by Subject|4|||
25167452|NCT01592240|50292395|FG003|Overall Study|Withdrawal by Subject|1|||
25167453|NCT01592240|50292396|FG004|Overall Study|Withdrawal by Subject|3|||
25167454|NCT01592240|50292397|FG005|Overall Study|Withdrawal by Subject|0|||
25167455|NCT01592240|50292398|FG006|Overall Study|Withdrawal by Subject|2|||
25186993|NCT00114517|50337692|FG000|Overall Study|Lost interest|0|||
25167456|NCT01592240|50292392|FG000|Overall Study|Other|0|||
25167457|NCT01592240|50292393|FG001|Overall Study|Other|3|||
25167458|NCT01592240|50292394|FG002|Overall Study|Other|1|||
25167459|NCT01592240|50292395|FG003|Overall Study|Other|1|||
25167460|NCT01592240|50292396|FG004|Overall Study|Other|0|||
25167461|NCT01592240|50292397|FG005|Overall Study|Other|0|||
25167462|NCT01592240|50292398|FG006|Overall Study|Other|1|||
25167463|NCT01592240|50292392|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
25167464|NCT01592240|50292393|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
25167465|NCT01592240|50292394|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
25167466|NCT01592240|50292395|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
25167467|NCT01592240|50292396|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
25167468|NCT01592240|50292397|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
25167469|NCT01592240|50292398|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
25167470|NCT01591616|50292441|FG000|Overall Study|Withdrawal by Subject|1|||
25167471|NCT01591460|50292597|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
25167472|NCT01591460|50292597|FG000|Overall Study|Futility Rule (Week 12)|7|||
25167473|NCT01591460|50292597|FG000|Overall Study|Futility Rule (Week 24)|3|||
25167474|NCT01591460|50292597|FG000|Overall Study|Rebound or Breakthrough|3|||
25167475|NCT01591460|50292597|FG000|Overall Study|Treatment Discontinued by Error|1|||
25167476|NCT01591460|50292597|FG000|Overall Study|Lost to Follow-up|1|||
25167477|NCT01591460|50292597|FG000|Overall Study|Noncompliance|1|||
25167478|NCT01591460|50292597|FG000|Overall Study|Participant Refusal|3|||
25167479|NCT01591460|50292597|FG000|Overall Study|Withdrawal by Subject|1|||
25167480|NCT01591460|50292597|FG000|Overall Study|Protocol Violation|1|||
25167481|NCT01591382|50292620|FG000|Overall Study|Discharged Prior to Study Completion|2|||
25167482|NCT01591382|50292621|FG001|Overall Study|Discharged Prior to Study Completion|1|||
25167483|NCT01591382|50292620|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
25167484|NCT01591382|50292621|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
25167485|NCT01696214|50292639|FG000|Overall Study|Lost to Follow-up|1|||
25167486|NCT01696214|50292640|FG001|Overall Study|Lost to Follow-up|0|||
25167487|NCT01696214|50292641|FG002|Overall Study|Lost to Follow-up|0|||
25167488|NCT01696214|50292642|FG003|Overall Study|Lost to Follow-up|0|||
25167489|NCT01543087|50292675|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
25167490|NCT01543087|50292676|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
25167491|NCT01543087|50292677|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
25167492|NCT01543087|50292678|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
25167493|NCT01543087|50292679|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
25167494|NCT01543087|50292680|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
25167495|NCT01543087|50292675|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
25167496|NCT01543087|50292676|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
25167497|NCT01543087|50292677|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
25167498|NCT01543087|50292678|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
25167499|NCT01543087|50292679|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
25167500|NCT01543087|50292680|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
25167501|NCT01543087|50292675|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
25167502|NCT01543087|50292676|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
25167503|NCT01543087|50292677|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
25167504|NCT01543087|50292678|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
25167505|NCT01543087|50292679|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
25167506|NCT01543087|50292680|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
25167507|NCT01543087|50292675|FG000|Stage 1 (48 Months)|Other than specified|5|||
25167508|NCT01543087|50292676|FG001|Stage 1 (48 Months)|Other than specified|0|||
25167509|NCT01543087|50292677|FG002|Stage 1 (48 Months)|Other than specified|9|||
25167510|NCT01543087|50292678|FG003|Stage 1 (48 Months)|Other than specified|0|||
25167511|NCT01543087|50292679|FG004|Stage 1 (48 Months)|Other than specified|0|||
25067169|NCT02635646|50172737|FG001|Overall Study|Lost to Follow-up|25|||
25167512|NCT01543087|50292680|FG005|Stage 1 (48 Months)|Other than specified|0|||
25167513|NCT01543087|50292675|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
25167514|NCT01543087|50292676|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
25167515|NCT01543087|50292677|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
25167516|NCT01543087|50292678|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
25167517|NCT01543087|50292679|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
25167518|NCT01543087|50292680|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
25167519|NCT01543087|50292675|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
25167520|NCT01543087|50292676|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
25167521|NCT01543087|50292677|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
25167522|NCT01543087|50292678|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
25167523|NCT01543087|50292679|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
25167524|NCT01543087|50292680|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
25276887|NCT00957268|50590822|FG004|Overall Study|Voluntary Withdrawal|0|||
25167525|NCT01543087|50292675|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
25167526|NCT01543087|50292676|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
25167527|NCT01543087|50292677|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
25167528|NCT01543087|50292678|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
25167529|NCT01543087|50292679|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
25167530|NCT01543087|50292680|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
25167531|NCT01696058|50292718|FG000|Overall Study|Adverse Event|21|||
25167532|NCT01696058|50292719|FG001|Overall Study|Adverse Event|11|||
25167533|NCT01696058|50292718|FG000|Overall Study|Lack of Efficacy|2|||
25167534|NCT01696058|50292719|FG001|Overall Study|Lack of Efficacy|3|||
25167535|NCT01696058|50292718|FG000|Overall Study|Protocol Violation|9|||
25167536|NCT01696058|50292719|FG001|Overall Study|Protocol Violation|3|||
25167537|NCT01696058|50292718|FG000|Overall Study|Lost to Follow-up|2|||
25167538|NCT01696058|50292719|FG001|Overall Study|Lost to Follow-up|5|||
25167539|NCT01696058|50292718|FG000|Overall Study|Withdrawal by Subject|4|||
25167540|NCT01696058|50292719|FG001|Overall Study|Withdrawal by Subject|6|||
25167541|NCT01696058|50292718|FG000|Overall Study|Other reason prematurely discontinued|5|||
25167542|NCT01696058|50292719|FG001|Overall Study|Other reason prematurely discontinued|3|||
25167543|NCT01695746|50292725|FG000|Overall Study|Adverse Event|1|||
25167544|NCT01695746|50292725|FG000|Overall Study|Non-compliance by the participant|3|||
25167545|NCT01695746|50292725|FG000|Overall Study|Protocol Violation|5|||
25167546|NCT01695746|50292725|FG000|Overall Study|Participant not willing to participate|3|||
25167547|NCT01694420|50292736|FG000|Overall Study|Lost to Follow-up|3|||
25167548|NCT01675479|50292907|FG000|Overall Study|Lost to Follow-up|11|||
25167549|NCT00089973|50293029|FG000|Overall Study|Adverse Event|3|||
25167550|NCT00089973|50293029|FG000|Overall Study|Withdrawal by Subject|1|||
25167551|NCT00089973|50293029|FG000|Overall Study|Disease progression|45|||
25167552|NCT00089973|50293029|FG000|Overall Study|Death|1|||
25167553|NCT00089661|50293047|FG000|Overall Study|Adverse Event|0|||
25167554|NCT00089661|50293048|FG001|Overall Study|Adverse Event|2|||
25167555|NCT00089661|50293047|FG000|Overall Study|Death|1|||
25167556|NCT00089661|50293048|FG001|Overall Study|Death|0|||
25167557|NCT00089661|50293047|FG000|Overall Study|Lost to Follow-up|0|||
25167558|NCT00089661|50293048|FG001|Overall Study|Lost to Follow-up|3|||
25167559|NCT00089661|50293047|FG000|Overall Study|Withdrawal by Subject|11|||
25167560|NCT00089661|50293048|FG001|Overall Study|Withdrawal by Subject|9|||
25167561|NCT00089661|50293047|FG000|Overall Study|Disease progression|1|||
25167562|NCT00089661|50293048|FG001|Overall Study|Disease progression|3|||
25167563|NCT00089661|50293047|FG000|Overall Study|Ineligibility determined|4|||
25167564|NCT00089661|50293048|FG001|Overall Study|Ineligibility determined|4|||
25167565|NCT00089661|50293047|FG000|Overall Study|Noncompliance|2|||
25167566|NCT00089661|50293048|FG001|Overall Study|Noncompliance|4|||
25167567|NCT00089661|50293047|FG000|Overall Study|Other|2|||
25167568|NCT00089661|50293048|FG001|Overall Study|Other|1|||
25167569|NCT00089583|50293069|FG000|Overall Study|Adverse Event|0|||
25167570|NCT00089583|50293070|FG001|Overall Study|Adverse Event|3|||
25167571|NCT00089583|50293069|FG000|Overall Study|Insufficient Viral Load Response|5|||
25167572|NCT00089583|50293070|FG001|Overall Study|Insufficient Viral Load Response|5|||
25167573|NCT00089583|50293069|FG000|Overall Study|Withdrawal by Subject|0|||
25167574|NCT00089583|50293070|FG001|Overall Study|Withdrawal by Subject|4|||
25167575|NCT00089583|50293069|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
25167576|NCT00089583|50293070|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
25167577|NCT00089583|50293069|FG000|Overall Study|Participant Refused Study Medication|0|||
25167578|NCT00089583|50293070|FG001|Overall Study|Participant Refused Study Medication|2|||
25167579|NCT00089583|50293069|FG000|Overall Study|Non-Compliance|0|||
25167580|NCT00089583|50293070|FG001|Overall Study|Non-Compliance|4|||
25167581|NCT00089583|50293069|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
25167582|NCT00089583|50293070|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
25167583|NCT00089583|50293069|FG000|Overall Study|Participant Management Criteria Met|0|||
25167584|NCT00089583|50293070|FG001|Overall Study|Participant Management Criteria Met|1|||
25167585|NCT00089583|50293069|FG000|Overall Study|Reason Not Provided|0|||
25167586|NCT00089583|50293070|FG001|Overall Study|Reason Not Provided|1|||
25167587|NCT00089583|50293069|FG000|Overall Study|Protocol Violation|0|||
25167588|NCT00089583|50293070|FG001|Overall Study|Protocol Violation|3|||
25167589|NCT00089583|50293069|FG000|Overall Study|Principal Investigator Decision|0|||
25167590|NCT00089583|50293070|FG001|Overall Study|Principal Investigator Decision|10|||
25167591|NCT00089583|50293069|FG000|Overall Study|Start of Disallowed Medication|0|||
25167592|NCT00089583|50293070|FG001|Overall Study|Start of Disallowed Medication|1|||
25167593|NCT00089583|50293069|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
24964489|NCT00435461|50054313|FG000|Overall Study|Participant ended study one day early|1|||
25067170|NCT02635646|50172736|FG000|Overall Study|Pregnancy|1|||
25167594|NCT00089583|50293070|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
25167595|NCT00089583|50293069|FG000|Overall Study|Participant Incarcerated|0|||
25167596|NCT00089583|50293070|FG001|Overall Study|Participant Incarcerated|1|||
25167597|NCT00088881|50293082|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
25167598|NCT00088881|50293082|FG000|Step 1 - R-CHOP|Adverse Event|1|||
25167599|NCT00088881|50293082|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
25167600|NCT00088881|50293082|FG000|Step 1 - R-CHOP|Physician Decision|1|||
25167601|NCT00088881|50293082|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
25186994|NCT00114517|50337693|FG001|Overall Study|Lost interest|0|||
25167602|NCT00088881|50293082|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
25167603|NCT00088881|50293082|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
25167604|NCT00087555|50293130|FG000|Overall Study|Adverse Event|3|||
25167605|NCT00087555|50293131|FG001|Overall Study|Adverse Event|6|||
25276888|NCT01230788|50590834|FG000|Overall Study|Prescribed exclusion drug|1|||
25276889|NCT01230710|50590838|FG000|Overall Study|Disease Progression|41|||
25276890|NCT01230710|50590838|FG000|Overall Study|Lost to Follow-up|3|||
25276891|NCT01230710|50590838|FG000|Overall Study|Death|4|||
25276892|NCT01230710|50590838|FG000|Overall Study|Withdrawal of Consent|1|||
25276893|NCT01230554|50590842|FG000|Overall Study|Lost to Follow-up|2|||
25276894|NCT01230554|50590842|FG000|Overall Study|Inability to maintain visit schedule|1|||
25276895|NCT01040793|50590846|FG000|Overall Study|Adverse Event|5|||
25276896|NCT01040793|50590847|FG001|Overall Study|Adverse Event|3|||
25276897|NCT01040793|50590848|FG002|Overall Study|Adverse Event|0|||
24964490|NCT00435461|50054314|FG001|Overall Study|Participant ended study one day early|0|||
25167606|NCT00087555|50293132|FG002|Overall Study|Adverse Event|14|||
25167607|NCT00087555|50293130|FG000|Overall Study|Lost to Follow-up|0|||
25167608|NCT00087555|50293131|FG001|Overall Study|Lost to Follow-up|1|||
25167609|NCT00087555|50293132|FG002|Overall Study|Lost to Follow-up|1|||
25167610|NCT00087555|50293130|FG000|Overall Study|Non - Compliance|1|||
25167611|NCT00087555|50293131|FG001|Overall Study|Non - Compliance|0|||
25167612|NCT00087555|50293132|FG002|Overall Study|Non - Compliance|0|||
25167613|NCT00087555|50293130|FG000|Overall Study|Protocol Violation|0|||
25167614|NCT00087555|50293131|FG001|Overall Study|Protocol Violation|0|||
25167615|NCT00087555|50293132|FG002|Overall Study|Protocol Violation|2|||
25167616|NCT00087555|50293130|FG000|Overall Study|Screen Failure|1|||
25167617|NCT00087555|50293131|FG001|Overall Study|Screen Failure|1|||
25167618|NCT00087555|50293132|FG002|Overall Study|Screen Failure|0|||
25167619|NCT00087555|50293130|FG000|Overall Study|Pregnancy|0|||
25167620|NCT00087555|50293131|FG001|Overall Study|Pregnancy|1|||
25167621|NCT00087555|50293132|FG002|Overall Study|Pregnancy|1|||
25167622|NCT00087555|50293130|FG000|Overall Study|Withdrawal by Subject|3|||
25167623|NCT00087555|50293131|FG001|Overall Study|Withdrawal by Subject|2|||
25167624|NCT00087555|50293132|FG002|Overall Study|Withdrawal by Subject|1|||
25167625|NCT00087555|50293130|FG000|Overall Study|Lack of Efficacy|2|||
25167626|NCT00087555|50293131|FG001|Overall Study|Lack of Efficacy|0|||
25167627|NCT00087555|50293132|FG002|Overall Study|Lack of Efficacy|1|||
25167628|NCT00087555|50293130|FG000|Overall Study|Non Compliance|0|||
25167629|NCT00087555|50293131|FG001|Overall Study|Non Compliance|0|||
25167630|NCT00087555|50293132|FG002|Overall Study|Non Compliance|1|||
25167631|NCT00087555|50293130|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
25167632|NCT00087555|50293131|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
25167633|NCT00087555|50293132|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
25167634|NCT00087555|50293130|FG000|Overall Study|Patient wanted to go back on Med|1|||
25167635|NCT00087555|50293131|FG001|Overall Study|Patient wanted to go back on Med|0|||
25167636|NCT00087555|50293132|FG002|Overall Study|Patient wanted to go back on Med|0|||
25167637|NCT00086619|50293155|FG000|Overall Study|Withdrawal by Subject|6|||
25167638|NCT00086619|50293156|FG001|Overall Study|Withdrawal by Subject|6|||
25167639|NCT00086619|50293155|FG000|Overall Study|Adverse Event|8|||
25167640|NCT00086619|50293156|FG001|Overall Study|Adverse Event|10|||
25167641|NCT00086619|50293155|FG000|Overall Study|Protocol Violation|1|||
25186995|NCT00114517|50337694|FG002|Overall Study|Lost interest|1|||
25186996|NCT00114517|50337695|FG003|Overall Study|Lost interest|0|||
25167642|NCT00086619|50293156|FG001|Overall Study|Protocol Violation|1|||
25167643|NCT00085917|50293169|FG000|Overall Study|Adverse Event|4|||
25167644|NCT00085917|50293170|FG001|Overall Study|Adverse Event|3|||
25167645|NCT00084747|50293176|FG000|Overall Study|Relapsed|8|||
25167646|NCT00084747|50293176|FG000|Overall Study|Death|3|||
25167647|NCT00084747|50293176|FG000|Overall Study|Withdrawal by Subject|2|||
25167648|NCT00081159|50293211|FG000|Overall Study|Withdrawal by Subject|0|||
25186997|NCT00114517|50337692|FG000|Overall Study|Weight increase|0|||
24964491|NCT00435461|50054315|FG002|Overall Study|Participant ended study one day early|0|||
25167649|NCT00081159|50293212|FG001|Overall Study|Withdrawal by Subject|3|||
25167650|NCT00081159|50293211|FG000|Overall Study|Myelosuppression prior to treatment|0|||
25167651|NCT00081159|50293212|FG001|Overall Study|Myelosuppression prior to treatment|1|||
25167652|NCT00081159|50293211|FG000|Overall Study|Lost to Follow-up|2|||
25167653|NCT00081159|50293212|FG001|Overall Study|Lost to Follow-up|1|||
25167654|NCT00080223|50293227|FG000|Overall Study|Adverse Event|23|||
25167655|NCT00080223|50293227|FG000|Overall Study|Death|21|||
25167656|NCT00080223|50293227|FG000|Overall Study|Withdrawal by Subject|13|||
25167657|NCT00080223|50293227|FG000|Overall Study|Lung Transplantation|9|||
25167658|NCT00080223|50293227|FG000|Overall Study|Non-compliance With Study Treatment|7|||
25167659|NCT00080223|50293227|FG000|Overall Study|Participant unwilling to continue|2|||
25167660|NCT00080223|50293227|FG000|Overall Study|Physician Decision|1|||
25167661|NCT01899053|50293847|FG000|Overall Study|Progressive Disease|4|||
25167662|NCT01899053|50293848|FG001|Overall Study|Progressive Disease|0|||
25167663|NCT01899053|50293849|FG002|Overall Study|Progressive Disease|3|||
25167664|NCT01899053|50293850|FG003|Overall Study|Progressive Disease|0|||
25167665|NCT01899053|50293851|FG004|Overall Study|Progressive Disease|3|||
25167666|NCT01899053|50293852|FG005|Overall Study|Progressive Disease|1|||
25167667|NCT01899053|50293853|FG006|Overall Study|Progressive Disease|1|||
25167668|NCT01899053|50293854|FG007|Overall Study|Progressive Disease|1|||
25167669|NCT01899053|50293855|FG008|Overall Study|Progressive Disease|4|||
25167670|NCT01899053|50293856|FG009|Overall Study|Progressive Disease|3|||
25167671|NCT01899053|50293857|FG010|Overall Study|Progressive Disease|12|||
25167672|NCT01899053|50293858|FG011|Overall Study|Progressive Disease|5|||
25167673|NCT01899053|50293859|FG012|Overall Study|Progressive Disease|8|||
25167674|NCT01899053|50293860|FG013|Overall Study|Progressive Disease|17|||
25167675|NCT01899053|50293847|FG000|Overall Study|Adverse Event|1|||
25167676|NCT01899053|50293848|FG001|Overall Study|Adverse Event|1|||
25167677|NCT01899053|50293849|FG002|Overall Study|Adverse Event|1|||
25167678|NCT01899053|50293850|FG003|Overall Study|Adverse Event|3|||
25167679|NCT01899053|50293851|FG004|Overall Study|Adverse Event|1|||
25167680|NCT01899053|50293852|FG005|Overall Study|Adverse Event|1|||
25167681|NCT01899053|50293853|FG006|Overall Study|Adverse Event|1|||
25167682|NCT01899053|50293854|FG007|Overall Study|Adverse Event|0|||
25167683|NCT01899053|50293855|FG008|Overall Study|Adverse Event|2|||
25167684|NCT01899053|50293856|FG009|Overall Study|Adverse Event|0|||
25167685|NCT01899053|50293857|FG010|Overall Study|Adverse Event|3|||
25167686|NCT01899053|50293858|FG011|Overall Study|Adverse Event|1|||
25167687|NCT01899053|50293859|FG012|Overall Study|Adverse Event|2|||
25167688|NCT01899053|50293860|FG013|Overall Study|Adverse Event|2|||
25167689|NCT01899053|50293847|FG000|Overall Study|Reason Not Specified|0|||
25167690|NCT01899053|50293848|FG001|Overall Study|Reason Not Specified|0|||
25167691|NCT01899053|50293849|FG002|Overall Study|Reason Not Specified|0|||
25167692|NCT01899053|50293850|FG003|Overall Study|Reason Not Specified|0|||
25167693|NCT01899053|50293851|FG004|Overall Study|Reason Not Specified|0|||
25167694|NCT01899053|50293852|FG005|Overall Study|Reason Not Specified|0|||
25167695|NCT01899053|50293853|FG006|Overall Study|Reason Not Specified|1|||
25167696|NCT01899053|50293854|FG007|Overall Study|Reason Not Specified|0|||
25167697|NCT01899053|50293855|FG008|Overall Study|Reason Not Specified|0|||
25167698|NCT01899053|50293856|FG009|Overall Study|Reason Not Specified|0|||
25167699|NCT01899053|50293857|FG010|Overall Study|Reason Not Specified|0|||
25167700|NCT01899053|50293858|FG011|Overall Study|Reason Not Specified|0|||
25167701|NCT01899053|50293859|FG012|Overall Study|Reason Not Specified|1|||
25167702|NCT01899053|50293860|FG013|Overall Study|Reason Not Specified|0|||
25167703|NCT01899053|50293847|FG000|Overall Study|Withdrawal by Subject|1|||
25167704|NCT01899053|50293848|FG001|Overall Study|Withdrawal by Subject|1|||
25167705|NCT01899053|50293849|FG002|Overall Study|Withdrawal by Subject|2|||
25167706|NCT01899053|50293850|FG003|Overall Study|Withdrawal by Subject|0|||
25167707|NCT01899053|50293851|FG004|Overall Study|Withdrawal by Subject|2|||
25167708|NCT01899053|50293852|FG005|Overall Study|Withdrawal by Subject|0|||
25167709|NCT01899053|50293853|FG006|Overall Study|Withdrawal by Subject|0|||
25167710|NCT01899053|50293854|FG007|Overall Study|Withdrawal by Subject|1|||
25167711|NCT01899053|50293855|FG008|Overall Study|Withdrawal by Subject|0|||
25167712|NCT01899053|50293856|FG009|Overall Study|Withdrawal by Subject|0|||
25167713|NCT01899053|50293857|FG010|Overall Study|Withdrawal by Subject|0|||
25167714|NCT01899053|50293858|FG011|Overall Study|Withdrawal by Subject|0|||
25167715|NCT01899053|50293859|FG012|Overall Study|Withdrawal by Subject|1|||
25167716|NCT01899053|50293860|FG013|Overall Study|Withdrawal by Subject|1|||
25167717|NCT01899053|50293847|FG000|Overall Study|Protocol Violation|0|||
25167718|NCT01899053|50293848|FG001|Overall Study|Protocol Violation|0|||
25167719|NCT01899053|50293849|FG002|Overall Study|Protocol Violation|1|||
25167720|NCT01899053|50293850|FG003|Overall Study|Protocol Violation|0|||
25167721|NCT01899053|50293851|FG004|Overall Study|Protocol Violation|0|||
25167722|NCT01899053|50293852|FG005|Overall Study|Protocol Violation|0|||
25167723|NCT01899053|50293853|FG006|Overall Study|Protocol Violation|0|||
25167724|NCT01899053|50293854|FG007|Overall Study|Protocol Violation|0|||
25167725|NCT01899053|50293855|FG008|Overall Study|Protocol Violation|0|||
25167726|NCT01899053|50293856|FG009|Overall Study|Protocol Violation|0|||
25167727|NCT01899053|50293857|FG010|Overall Study|Protocol Violation|0|||
25167728|NCT01899053|50293858|FG011|Overall Study|Protocol Violation|0|||
25167729|NCT01899053|50293859|FG012|Overall Study|Protocol Violation|0|||
25167730|NCT01899053|50293860|FG013|Overall Study|Protocol Violation|0|||
25186998|NCT00114517|50337693|FG001|Overall Study|Weight increase|0|||
25167731|NCT01899053|50293847|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
25167732|NCT01899053|50293848|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
25167733|NCT01899053|50293849|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
25167734|NCT01899053|50293850|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
25167735|NCT01899053|50293851|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
25167736|NCT01899053|50293852|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
25167737|NCT01899053|50293853|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
25167738|NCT01899053|50293854|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
25167739|NCT01899053|50293855|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
25167740|NCT01899053|50293856|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
25167741|NCT01899053|50293857|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
25167742|NCT01899053|50293858|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
25167743|NCT01899053|50293859|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
25167744|NCT01899053|50293860|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
25167745|NCT01899053|50293847|FG000|Overall Study|Symptomatic Deterioration|0|||
25167746|NCT01899053|50293848|FG001|Overall Study|Symptomatic Deterioration|0|||
25167747|NCT01899053|50293849|FG002|Overall Study|Symptomatic Deterioration|0|||
25167748|NCT01899053|50293850|FG003|Overall Study|Symptomatic Deterioration|0|||
25167749|NCT01899053|50293851|FG004|Overall Study|Symptomatic Deterioration|0|||
25167750|NCT01899053|50293852|FG005|Overall Study|Symptomatic Deterioration|1|||
25167751|NCT01899053|50293853|FG006|Overall Study|Symptomatic Deterioration|0|||
25167752|NCT01899053|50293854|FG007|Overall Study|Symptomatic Deterioration|1|||
25167753|NCT01899053|50293855|FG008|Overall Study|Symptomatic Deterioration|0|||
25167754|NCT01899053|50293856|FG009|Overall Study|Symptomatic Deterioration|0|||
25167755|NCT01899053|50293857|FG010|Overall Study|Symptomatic Deterioration|0|||
25167756|NCT01899053|50293858|FG011|Overall Study|Symptomatic Deterioration|1|||
25167757|NCT01899053|50293859|FG012|Overall Study|Symptomatic Deterioration|2|||
25167758|NCT01899053|50293860|FG013|Overall Study|Symptomatic Deterioration|0|||
25167759|NCT01888367|50293965|FG000|Overall Study|Physician Decision|3|||
25167760|NCT01888367|50293966|FG001|Overall Study|Physician Decision|4|||
25167761|NCT01888367|50293967|FG002|Overall Study|Physician Decision|2|||
25167762|NCT01888367|50293965|FG000|Overall Study|Death|2|||
25167763|NCT01888367|50293966|FG001|Overall Study|Death|0|||
25167764|NCT01888367|50293967|FG002|Overall Study|Death|1|||
25167765|NCT01888367|50293965|FG000|Overall Study|Withdrawal by Subject|1|||
25167766|NCT01888367|50293966|FG001|Overall Study|Withdrawal by Subject|0|||
25167767|NCT01888367|50293967|FG002|Overall Study|Withdrawal by Subject|1|||
25167768|NCT01888367|50293965|FG000|Overall Study|Lost to Follow-up|1|||
25167769|NCT01888367|50293966|FG001|Overall Study|Lost to Follow-up|1|||
25167770|NCT01888367|50293967|FG002|Overall Study|Lost to Follow-up|0|||
25167771|NCT01888367|50293965|FG000|Overall Study|Protocol Violation|0|||
25167772|NCT01888367|50293966|FG001|Overall Study|Protocol Violation|0|||
25167773|NCT01888367|50293967|FG002|Overall Study|Protocol Violation|1|||
25167774|NCT01888367|50293965|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
25167775|NCT01888367|50293966|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
25167776|NCT01888367|50293967|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
25167777|NCT01898195|50293993|FG000|Smoking Abstinence|Did not have good measurements|35|||
25167778|NCT01898195|50293994|FG001|Smoking Abstinence|Did not have good measurements|38|||
25167779|NCT01898195|50293995|FG002|Smoking Abstinence|Did not have good measurements|36|||
25167780|NCT01897727|50294009|FG000|Overall Study|Exclusion: central sleep apnea|0|||
25167781|NCT01897727|50294010|FG001|Overall Study|Exclusion: central sleep apnea|1|||
25167782|NCT01897493|50294016|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
25167783|NCT01887353|50294025|FG000|Overall Study|Study stopped early|4|||
25167784|NCT01887353|50294026|FG001|Overall Study|Study stopped early|3|||
25167785|NCT01896869|50294048|FG000|Overall Study|Withdrawal by Subject|0|||
25167786|NCT01896869|50294049|FG001|Overall Study|Withdrawal by Subject|6|||
25167787|NCT01896869|50294048|FG000|Overall Study|Lost to Follow-up|1|||
25167788|NCT01896869|50294049|FG001|Overall Study|Lost to Follow-up|0|||
25167789|NCT01896557|50294059|FG000|Clopidogrel Alone|Adverse Event|1|||
25167790|NCT01896557|50294060|FG001|Clopidogrel Alone|Adverse Event|0|||
25167791|NCT01896557|50294059|FG000|Clopidogrel + GI Protector|low adherence|1|||
25167792|NCT01896557|50294060|FG001|Clopidogrel + GI Protector|low adherence|1|||
25167793|NCT01896557|50294059|FG000|Clopidogrel + GI Protector|Reading error|1|||
25167794|NCT01896557|50294060|FG001|Clopidogrel + GI Protector|Reading error|3|||
25167795|NCT01886105|50294075|FG000|Overall Study|Lack of Efficacy|3|||
25167796|NCT01895777|50294104|FG000|Overall Study|Adverse Event|1|||
25167797|NCT01895777|50294105|FG001|Overall Study|Adverse Event|2|||
25167798|NCT01895777|50294104|FG000|Overall Study|Lost to Follow-up|2|||
25167799|NCT01895777|50294105|FG001|Overall Study|Lost to Follow-up|0|||
25167800|NCT01895777|50294104|FG000|Overall Study|Not treated|1|||
25167801|NCT01895777|50294105|FG001|Overall Study|Not treated|0|||
25167802|NCT01895777|50294104|FG000|Overall Study|Other reasons|3|||
25167803|NCT01895777|50294105|FG001|Overall Study|Other reasons|2|||
25167804|NCT01895777|50294104|FG000|Overall Study|Non-compliance with the CTP|2|||
25167805|NCT01895777|50294105|FG001|Overall Study|Non-compliance with the CTP|1|||
25167806|NCT01885559|50294133|FG000|Overall Study|Lost to Follow-up|15|||
25167807|NCT01885559|50294134|FG001|Overall Study|Lost to Follow-up|16|||
25167808|NCT01885559|50294133|FG000|Overall Study|Less than full participation|9|||
25167809|NCT01885559|50294134|FG001|Overall Study|Less than full participation|19|||
25167810|NCT01885559|50294133|FG000|Overall Study|Protocol Violation|0|||
25167811|NCT01885559|50294134|FG001|Overall Study|Protocol Violation|1|||
25167812|NCT01884545|50294144|FG000|Overall Study|Lost to Follow-up|6|||
25167813|NCT01884545|50294145|FG001|Overall Study|Lost to Follow-up|4|||
25167814|NCT01884545|50294146|FG002|Overall Study|Lost to Follow-up|9|||
25167815|NCT01884545|50294147|FG003|Overall Study|Lost to Follow-up|4|||
25167816|NCT01884545|50294144|FG000|Overall Study|Patient withdrawn|7|||
25167817|NCT01884545|50294145|FG001|Overall Study|Patient withdrawn|12|||
25167818|NCT01884545|50294146|FG002|Overall Study|Patient withdrawn|5|||
25167819|NCT01884545|50294147|FG003|Overall Study|Patient withdrawn|5|||
25167820|NCT01884545|50294144|FG000|Overall Study|Non-adherence|0|||
25167821|NCT01884545|50294145|FG001|Overall Study|Non-adherence|2|||
25167822|NCT01884545|50294146|FG002|Overall Study|Non-adherence|0|||
25167823|NCT01884545|50294147|FG003|Overall Study|Non-adherence|0|||
25167824|NCT01895543|50294157|FG000|Overall Study|Withdrawal by Subject|43|||
25167825|NCT01895543|50294157|FG000|Overall Study|Lost to Follow-up|25|||
25167826|NCT01895543|50294157|FG000|Overall Study|Adverse Event|28|||
25167827|NCT01895543|50294157|FG000|Overall Study|Subject's substantial non-compliance|6|||
25167828|NCT01895543|50294157|FG000|Overall Study|Protocol Violation|1|||
25167829|NCT01895543|50294157|FG000|Overall Study|Physician Decision|2|||
25167830|NCT01895543|50294157|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
25167831|NCT04828161|50294254|FG000|Overall Study|Withdrawal by Subject|0|||
25167832|NCT04828161|50294255|FG001|Overall Study|Withdrawal by Subject|3|||
25167833|NCT04828161|50294256|FG002|Overall Study|Withdrawal by Subject|3|||
25167834|NCT04828161|50294257|FG003|Overall Study|Withdrawal by Subject|4|||
25167835|NCT04828161|50294254|FG000|Overall Study|Lost to Follow-up|1|||
25167836|NCT04828161|50294255|FG001|Overall Study|Lost to Follow-up|4|||
25167837|NCT04828161|50294256|FG002|Overall Study|Lost to Follow-up|2|||
25167838|NCT04828161|50294257|FG003|Overall Study|Lost to Follow-up|2|||
25167839|NCT04828161|50294254|FG000|Overall Study|Other|2|||
25167840|NCT04828161|50294255|FG001|Overall Study|Other|0|||
25167841|NCT04828161|50294256|FG002|Overall Study|Other|2|||
25167842|NCT04828161|50294257|FG003|Overall Study|Other|0|||
25167843|NCT04828161|50294254|FG000|Overall Study|Death|0|||
25167844|NCT04828161|50294255|FG001|Overall Study|Death|0|||
25167845|NCT04828161|50294256|FG002|Overall Study|Death|0|||
25167846|NCT04828161|50294257|FG003|Overall Study|Death|2|||
25167847|NCT01895309|50294355|FG000|Overall Study|Adverse Event|13|||
25167848|NCT01895309|50294356|FG001|Overall Study|Adverse Event|17|||
25167849|NCT01895309|50294355|FG000|Overall Study|Protocol Violation|1|||
25167850|NCT01895309|50294356|FG001|Overall Study|Protocol Violation|0|||
25167851|NCT01895309|50294355|FG000|Overall Study|Lack of Efficacy|1|||
25167852|NCT01895309|50294356|FG001|Overall Study|Lack of Efficacy|3|||
25167853|NCT01895309|50294355|FG000|Overall Study|Lost to Follow-up|1|||
25167854|NCT01895309|50294356|FG001|Overall Study|Lost to Follow-up|3|||
25167855|NCT01895309|50294355|FG000|Overall Study|Physician Decision|15|||
25167856|NCT01895309|50294356|FG001|Overall Study|Physician Decision|10|||
25167857|NCT01895309|50294355|FG000|Overall Study|Withdrawal by Subject|9|||
25167858|NCT01895309|50294356|FG001|Overall Study|Withdrawal by Subject|18|||
25167859|NCT01884311|50294366|FG000|Overall Study|Withdrawal by Subject|3|||
25186999|NCT00114517|50337694|FG002|Overall Study|Weight increase|1|||
25187000|NCT00114517|50337695|FG003|Overall Study|Weight increase|0|||
25187001|NCT00114517|50337692|FG000|Overall Study|Concern about blood clots|0|||
25187002|NCT00114517|50337693|FG001|Overall Study|Concern about blood clots|0|||
25187003|NCT00114517|50337694|FG002|Overall Study|Concern about blood clots|1|||
25187004|NCT00114517|50337695|FG003|Overall Study|Concern about blood clots|0|||
25187005|NCT00114517|50337692|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
25187006|NCT00114517|50337693|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
25187007|NCT00114517|50337694|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
24964492|NCT00435461|50054313|FG000|Overall Study|Noncompliance with study requirements|1|||
25167860|NCT01884311|50294366|FG000|Overall Study|withdrew consent due to AEs|1|||
25167861|NCT01884311|50294366|FG000|Overall Study|Precautionary measure|1|||
25167862|NCT01884077|50294406|FG000|Overall Study|screen fail|0|||
25167863|NCT01884077|50294407|FG001|Overall Study|screen fail|2|||
25167864|NCT01884077|50294406|FG000|Overall Study|canceled surgery|2|||
24964493|NCT00435461|50054314|FG001|Overall Study|Noncompliance with study requirements|1|||
25187008|NCT00114517|50337695|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
25187009|NCT01384019|50337748|FG000|Overall Study|Withdrawal by Subject|3|||
25167865|NCT01884077|50294407|FG001|Overall Study|canceled surgery|0|||
25167866|NCT01884077|50294406|FG000|Overall Study|Lost to Follow-up|0|||
25167867|NCT01884077|50294407|FG001|Overall Study|Lost to Follow-up|4|||
25167868|NCT01884077|50294406|FG000|Overall Study|study closed|6|||
25167869|NCT01884077|50294407|FG001|Overall Study|study closed|4|||
25167870|NCT01894919|50294426|FG000|Overall Study|Withdrawal by Subject|1|||
25167871|NCT01894919|50294427|FG001|Overall Study|Withdrawal by Subject|0|||
25167872|NCT01894919|50294428|FG002|Overall Study|Withdrawal by Subject|0|||
25167873|NCT01894919|50294429|FG003|Overall Study|Withdrawal by Subject|0|||
25167874|NCT01894919|50294430|FG004|Overall Study|Withdrawal by Subject|1|||
25167875|NCT01894919|50294431|FG005|Overall Study|Withdrawal by Subject|0|||
25167876|NCT01894919|50294432|FG006|Overall Study|Withdrawal by Subject|0|||
25167877|NCT01894919|50294433|FG007|Overall Study|Withdrawal by Subject|0|||
25167878|NCT01894919|50294434|FG008|Overall Study|Withdrawal by Subject|0|||
25167879|NCT01894919|50294435|FG009|Overall Study|Withdrawal by Subject|1|||
25167880|NCT01894919|50294436|FG010|Overall Study|Withdrawal by Subject|1|||
25167881|NCT01894919|50294437|FG011|Overall Study|Withdrawal by Subject|0|||
25167882|NCT01894919|50294438|FG012|Overall Study|Withdrawal by Subject|0|||
25167883|NCT01894919|50294426|FG000|Overall Study|Adverse Event|0|||
25167884|NCT01894919|50294427|FG001|Overall Study|Adverse Event|0|||
25167885|NCT01894919|50294428|FG002|Overall Study|Adverse Event|0|||
25167886|NCT01894919|50294429|FG003|Overall Study|Adverse Event|0|||
25167887|NCT01894919|50294430|FG004|Overall Study|Adverse Event|0|||
25167888|NCT01894919|50294431|FG005|Overall Study|Adverse Event|0|||
25167889|NCT01894919|50294432|FG006|Overall Study|Adverse Event|0|||
25167890|NCT01894919|50294433|FG007|Overall Study|Adverse Event|0|||
25167891|NCT01894919|50294434|FG008|Overall Study|Adverse Event|0|||
25167892|NCT01894919|50294435|FG009|Overall Study|Adverse Event|0|||
25167893|NCT01894919|50294436|FG010|Overall Study|Adverse Event|1|||
25167894|NCT01894919|50294437|FG011|Overall Study|Adverse Event|0|||
25167895|NCT01894919|50294438|FG012|Overall Study|Adverse Event|0|||
25167896|NCT01894919|50294426|FG000|Overall Study|Other-Unspecified|1|||
25167897|NCT01894919|50294427|FG001|Overall Study|Other-Unspecified|0|||
25167898|NCT01894919|50294428|FG002|Overall Study|Other-Unspecified|0|||
25167899|NCT01894919|50294429|FG003|Overall Study|Other-Unspecified|0|||
25167900|NCT01894919|50294430|FG004|Overall Study|Other-Unspecified|0|||
25167901|NCT01894919|50294431|FG005|Overall Study|Other-Unspecified|0|||
25167902|NCT01894919|50294432|FG006|Overall Study|Other-Unspecified|0|||
25167903|NCT01894919|50294433|FG007|Overall Study|Other-Unspecified|0|||
25167904|NCT01894919|50294434|FG008|Overall Study|Other-Unspecified|0|||
25167905|NCT01894919|50294435|FG009|Overall Study|Other-Unspecified|0|||
25167906|NCT01894919|50294436|FG010|Overall Study|Other-Unspecified|0|||
25167907|NCT01894919|50294437|FG011|Overall Study|Other-Unspecified|0|||
25167908|NCT01894919|50294438|FG012|Overall Study|Other-Unspecified|0|||
25167909|NCT01894919|50294426|FG000|Overall Study|Lost to Follow-up|0|||
25167910|NCT01894919|50294427|FG001|Overall Study|Lost to Follow-up|0|||
25167911|NCT01894919|50294428|FG002|Overall Study|Lost to Follow-up|0|||
25167912|NCT01894919|50294429|FG003|Overall Study|Lost to Follow-up|0|||
25167913|NCT01894919|50294430|FG004|Overall Study|Lost to Follow-up|2|||
25167914|NCT01894919|50294431|FG005|Overall Study|Lost to Follow-up|0|||
25167915|NCT01894919|50294432|FG006|Overall Study|Lost to Follow-up|0|||
25167916|NCT01894919|50294433|FG007|Overall Study|Lost to Follow-up|0|||
25167917|NCT01894919|50294434|FG008|Overall Study|Lost to Follow-up|0|||
25167918|NCT01894919|50294435|FG009|Overall Study|Lost to Follow-up|0|||
25167919|NCT01894919|50294436|FG010|Overall Study|Lost to Follow-up|0|||
25167920|NCT01894919|50294437|FG011|Overall Study|Lost to Follow-up|0|||
25167921|NCT01894919|50294438|FG012|Overall Study|Lost to Follow-up|0|||
25167922|NCT01894841|50294482|FG000|Overall Study|Withdrawal by Subject|9|||
25167923|NCT01894841|50294483|FG001|Overall Study|Withdrawal by Subject|4|||
25167924|NCT01894841|50294482|FG000|Overall Study|Withdrawn by investigator|2|||
25167925|NCT01894841|50294483|FG001|Overall Study|Withdrawn by investigator|2|||
25167926|NCT01894841|50294482|FG000|Overall Study|Lost to Follow-up|7|||
25067171|NCT02635646|50172737|FG001|Overall Study|Pregnancy|1|||
25067172|NCT02634788|50172753|FG000|Overall Study|Adverse Event|0|||
25067173|NCT02634788|50172754|FG001|Overall Study|Adverse Event|8|||
25067174|NCT02634788|50172755|FG002|Overall Study|Adverse Event|3|||
25067175|NCT02634788|50172756|FG003|Overall Study|Adverse Event|1|||
25067176|NCT02634788|50172753|FG000|Overall Study|Lack of Efficacy|4|||
25067177|NCT02634788|50172754|FG001|Overall Study|Lack of Efficacy|0|||
25067178|NCT02634788|50172755|FG002|Overall Study|Lack of Efficacy|1|||
25067179|NCT02634788|50172756|FG003|Overall Study|Lack of Efficacy|4|||
25167927|NCT01894841|50294483|FG001|Overall Study|Lost to Follow-up|3|||
25167928|NCT01894607|50294493|FG000|Overall Study|Ineligible|1|||
25167929|NCT01883453|50294499|FG000|Overall Study|No episode of common cold|25|||
25167930|NCT01883453|50294500|FG001|Overall Study|No episode of common cold|23|||
25167931|NCT01882985|50294534|FG000|Overall Study|Lost to Follow-up|1|||
25067180|NCT02634788|50172753|FG000|Overall Study|Lost to Follow-up|0|||
25067181|NCT02634788|50172754|FG001|Overall Study|Lost to Follow-up|1|||
25067182|NCT02634788|50172755|FG002|Overall Study|Lost to Follow-up|0|||
25167932|NCT01882985|50294534|FG000|Overall Study|Withdrawal by Subject|1|||
25167933|NCT01893905|50294547|FG000|Overall Study|Withdrawal by Subject|1|||
25167934|NCT01893905|50294548|FG001|Overall Study|Withdrawal by Subject|0|||
25167935|NCT01893905|50294547|FG000|Overall Study|Adverse Event|9|||
25167936|NCT01893905|50294548|FG001|Overall Study|Adverse Event|3|||
25167937|NCT01893905|50294547|FG000|Overall Study|Lack of Efficacy|5|||
25167938|NCT01893905|50294548|FG001|Overall Study|Lack of Efficacy|7|||
25167939|NCT01893905|50294547|FG000|Overall Study|Lost to Follow-up|1|||
25167940|NCT01893905|50294548|FG001|Overall Study|Lost to Follow-up|0|||
25167941|NCT01893905|50294547|FG000|Overall Study|Protocol Violation|6|||
25167942|NCT01893905|50294548|FG001|Overall Study|Protocol Violation|1|||
25167943|NCT01893905|50294547|FG000|Overall Study|Lack of adherence to treatment|2|||
25167944|NCT01893905|50294548|FG001|Overall Study|Lack of adherence to treatment|0|||
25167945|NCT01893905|50294547|FG000|Overall Study|Other reason|1|||
25167946|NCT01893905|50294548|FG001|Overall Study|Other reason|3|||
25167947|NCT01893827|50294561|FG000|Overall Study|Lost to Follow-up|19|||
25167948|NCT01893827|50294562|FG001|Overall Study|Lost to Follow-up|26|||
25167949|NCT01882907|50294570|FG000|Overall Study|Adverse Event|3|||
25167950|NCT01882907|50294571|FG001|Overall Study|Adverse Event|1|||
25167951|NCT01882907|50294570|FG000|Overall Study|Lack of Efficacy|0|||
25167952|NCT01882907|50294571|FG001|Overall Study|Lack of Efficacy|3|||
25167953|NCT01882907|50294570|FG000|Overall Study|Lost to Follow-up|1|||
24964494|NCT00435461|50054315|FG002|Overall Study|Noncompliance with study requirements|1|||
24964495|NCT00435461|50054313|FG000|Overall Study|Adverse Event|1|||
24964496|NCT00435461|50054314|FG001|Overall Study|Adverse Event|2|||
24964497|NCT00435461|50054315|FG002|Overall Study|Adverse Event|6|||
24964498|NCT00435461|50054313|FG000|Overall Study|Non-Compliance of diary|2|||
24964499|NCT00435461|50054314|FG001|Overall Study|Non-Compliance of diary|0|||
24964500|NCT00435461|50054315|FG002|Overall Study|Non-Compliance of diary|1|||
24964501|NCT00435461|50054313|FG000|Overall Study|Lost to Follow-up|1|||
25167954|NCT01882907|50294571|FG001|Overall Study|Lost to Follow-up|4|||
25167955|NCT01882907|50294570|FG000|Overall Study|Protocol Violation|10|||
25167956|NCT01882907|50294571|FG001|Overall Study|Protocol Violation|14|||
25167957|NCT01882907|50294570|FG000|Overall Study|Withdrawal by Subject|0|||
25167958|NCT01882907|50294571|FG001|Overall Study|Withdrawal by Subject|6|||
25167959|NCT01893281|50294593|FG000|Overall Study|Adverse Event|1|||
25167960|NCT01893281|50294593|FG000|Overall Study|Protocol Violation|1|||
25167961|NCT01893281|50294593|FG000|Overall Study|Withdrawal by Subject|1|||
25167962|NCT01893203|50294597|FG000|Overall Study|Withdrawal by Subject|1|||
25167963|NCT01882829|50294601|FG000|Overall Study|Adverse Event|4|||
25167964|NCT01882829|50294601|FG000|Overall Study|Protocol Violation|1|||
25167965|NCT01882829|50294601|FG000|Overall Study|Withdrawal by Subject|1|||
25167966|NCT01882439|50294685|FG000|Overall Study|Adverse event related to study drug|3|||
25167967|NCT01882439|50294686|FG001|Overall Study|Adverse event related to study drug|8|||
25167968|NCT01882439|50294687|FG002|Overall Study|Adverse event related to study drug|1|||
25167969|NCT01882439|50294688|FG003|Overall Study|Adverse event related to study drug|2|||
25167970|NCT01882439|50294685|FG000|Overall Study|Pregnancy|0|||
25167971|NCT01882439|50294686|FG001|Overall Study|Pregnancy|1|||
25167972|NCT01882439|50294687|FG002|Overall Study|Pregnancy|0|||
25167973|NCT01882439|50294688|FG003|Overall Study|Pregnancy|0|||
25167974|NCT01882439|50294685|FG000|Overall Study|Protocol Violation|2|||
25167975|NCT01882439|50294686|FG001|Overall Study|Protocol Violation|2|||
25167976|NCT01882439|50294687|FG002|Overall Study|Protocol Violation|0|||
25167977|NCT01882439|50294688|FG003|Overall Study|Protocol Violation|1|||
25167978|NCT01882439|50294685|FG000|Overall Study|No longer willing to participate|1|||
25167979|NCT01882439|50294686|FG001|Overall Study|No longer willing to participate|4|||
25167980|NCT01882439|50294687|FG002|Overall Study|No longer willing to participate|2|||
25167981|NCT01882439|50294688|FG003|Overall Study|No longer willing to participate|3|||
25167982|NCT01882439|50294685|FG000|Overall Study|Medication error with no associated AE|0|||
25167983|NCT01882439|50294686|FG001|Overall Study|Medication error with no associated AE|0|||
25167984|NCT01882439|50294687|FG002|Overall Study|Medication error with no associated AE|2|||
25167985|NCT01882439|50294688|FG003|Overall Study|Medication error with no associated AE|0|||
25167986|NCT01882439|50294685|FG000|Overall Study|Insufficient clinical response|1|||
25167987|NCT01882439|50294686|FG001|Overall Study|Insufficient clinical response|4|||
25167988|NCT01882439|50294687|FG002|Overall Study|Insufficient clinical response|4|||
25167989|NCT01882439|50294688|FG003|Overall Study|Insufficient clinical response|2|||
25167990|NCT01882439|50294685|FG000|Overall Study|Adverse event unrelated to study drug|2|||
25167991|NCT01882439|50294686|FG001|Overall Study|Adverse event unrelated to study drug|2|||
25167992|NCT01882439|50294687|FG002|Overall Study|Adverse event unrelated to study drug|1|||
25276898|NCT01040793|50590849|FG003|Overall Study|Adverse Event|2|||
25276899|NCT01040793|50590850|FG004|Overall Study|Adverse Event|2|||
25276900|NCT01040793|50590851|FG005|Overall Study|Adverse Event|1|||
24964502|NCT00435461|50054314|FG001|Overall Study|Lost to Follow-up|1|||
24964503|NCT00435461|50054315|FG002|Overall Study|Lost to Follow-up|2|||
24964504|NCT00006436|50054323|FG000|Overall Study|Refused further treatment|2|||
24964505|NCT00006436|50054323|FG000|Overall Study|Declined to participate (before treatment started)|1|||
24964506|NCT00434759|50054332|FG000|Overall Study|Lack of Efficacy|5|||
24964507|NCT00434759|50054333|FG001|Overall Study|Lack of Efficacy|4|||
24964508|NCT00434759|50054332|FG000|Overall Study|Withdrawal by Subject|17|||
24964509|NCT00434759|50054333|FG001|Overall Study|Withdrawal by Subject|1|||
25067183|NCT02634788|50172756|FG003|Overall Study|Lost to Follow-up|0|||
25067184|NCT02634788|50172753|FG000|Overall Study|Withdrawal by Subject|0|||
25167993|NCT01882439|50294688|FG003|Overall Study|Adverse event unrelated to study drug|1|||
25276901|NCT01040793|50590846|FG000|Overall Study|Protocol Violation|1|||
25167994|NCT01892657|50294735|FG000|Overall Study|Withdrawal by Subject|6|||
25167995|NCT01892657|50294735|FG000|Overall Study|Protocol Violation|12|||
25167996|NCT01881737|50294762|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
25167997|NCT01881737|50294762|FG000|Overall Study|Withdrawal by Subject|1|||
25167998|NCT01881737|50294762|FG000|Overall Study|Worsening of baseline behavior|1|||
25167999|NCT01892501|50294798|FG000|Overall Study|Protocol Violation|2|||
25168000|NCT01892501|50294798|FG000|Overall Study|Puncture not carried out|9|||
25168001|NCT01892501|50294798|FG000|Overall Study|Radiological monitoring not carried out|5|||
25168002|NCT01892501|50294798|FG000|Overall Study|Non-contributory histological result|12|||
25168003|NCT01892345|50294813|FG000|Overall Study|Adverse Event|0|||
25168004|NCT01892345|50294814|FG001|Overall Study|Adverse Event|2|||
25168005|NCT01892345|50294813|FG000|Overall Study|Death|1|||
25168006|NCT01892345|50294814|FG001|Overall Study|Death|0|||
25168007|NCT01892345|50294813|FG000|Overall Study|Lost to Follow-up|3|||
25168008|NCT01892345|50294814|FG001|Overall Study|Lost to Follow-up|0|||
25168009|NCT01892345|50294813|FG000|Overall Study|Withdrawal by Subject|12|||
25168010|NCT01892345|50294814|FG001|Overall Study|Withdrawal by Subject|1|||
25168011|NCT01892189|50294891|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
25168012|NCT01892189|50294892|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
25168013|NCT01892189|50294893|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
25168014|NCT01892189|50294894|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
25168015|NCT01892189|50294895|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
25168016|NCT01892189|50294896|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
25168017|NCT01892189|50294897|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
25168018|NCT01892189|50294898|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
25168019|NCT01892189|50294899|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
25168020|NCT01892189|50294891|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
25168021|NCT01892189|50294892|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
25168022|NCT01892189|50294893|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
25168023|NCT01892189|50294894|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
25168024|NCT01892189|50294895|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
25168025|NCT01892189|50294896|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
25168026|NCT01892189|50294897|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
25168027|NCT01892189|50294898|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
25168028|NCT01892189|50294899|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
25168029|NCT01892189|50294891|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
25168030|NCT01892189|50294892|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
25168031|NCT01892189|50294893|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
25168032|NCT01892189|50294894|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
25168033|NCT01892189|50294895|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
25168034|NCT01892189|50294896|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
25168035|NCT01892189|50294897|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
25168036|NCT01892189|50294898|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
25168037|NCT01892189|50294899|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
25168038|NCT01881425|50294930|FG000|Overall Study|Death|5|||
25168039|NCT01881425|50294931|FG001|Overall Study|Death|1|||
25168040|NCT01881425|50294930|FG000|Overall Study|Withdrawal by Subject|8|||
25168041|NCT01881425|50294931|FG001|Overall Study|Withdrawal by Subject|3|||
25168042|NCT01881425|50294930|FG000|Overall Study|Physician Decision|2|||
25168043|NCT01881425|50294931|FG001|Overall Study|Physician Decision|1|||
25168044|NCT01881425|50294930|FG000|Overall Study|Adverse Event|3|||
25168045|NCT01881425|50294931|FG001|Overall Study|Adverse Event|0|||
25168046|NCT01881425|50294930|FG000|Overall Study|General Anesthesia panic attack|0|||
25168047|NCT01881425|50294931|FG001|Overall Study|General Anesthesia panic attack|1|||
25168048|NCT01881425|50294930|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
25168049|NCT01881425|50294931|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
25168050|NCT01881425|50294930|FG000|Overall Study|Lost to Follow-up|7|||
25168051|NCT01881425|50294931|FG001|Overall Study|Lost to Follow-up|2|||
25168052|NCT01891721|50294950|FG000|Overall Study|Lost to Follow-up|10|||
25168053|NCT01891721|50294951|FG001|Overall Study|Lost to Follow-up|5|||
25168054|NCT01891721|50294952|FG002|Overall Study|Lost to Follow-up|1|||
25168055|NCT01880957|50294971|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
25168056|NCT01880957|50294972|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
25168057|NCT01880957|50294971|FG000|Overall Study|Lost to Follow-up|11|||
25168058|NCT01880957|50294972|FG001|Overall Study|Lost to Follow-up|0|||
25168059|NCT01880957|50294971|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
25168060|NCT01880957|50294972|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
25168061|NCT04152837|50294987|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
25168062|NCT04152837|50294987|FG000|Maintenance Period|Adverse Event|1|||
25168063|NCT04152837|50294987|FG000|Maintenance Period|Withdrawal by Subject|1|||
25168064|NCT04152837|50294987|FG000|Maintenance Period|Sponsor Termination of Study|2|||
25168065|NCT01879553|50295006|FG000|Overall Study|Withdrawal by Subject|1|||
25168066|NCT01879553|50295007|FG001|Overall Study|Withdrawal by Subject|0|||
25168067|NCT01890785|50295028|FG000|Third Intervention|Withdrawal by Subject|0|||
25168068|NCT01890785|50295029|FG001|Third Intervention|Withdrawal by Subject|1|||
25168069|NCT01890785|50295030|FG002|Third Intervention|Withdrawal by Subject|0|||
25168070|NCT01890785|50295031|FG003|Third Intervention|Withdrawal by Subject|0|||
25168071|NCT01890785|50295032|FG004|Third Intervention|Withdrawal by Subject|0|||
25168072|NCT01890785|50295033|FG005|Third Intervention|Withdrawal by Subject|0|||
25168073|NCT01878383|50295057|FG000|Overall Study|Lost to Follow-up|0|||
25168074|NCT01878383|50295058|FG001|Overall Study|Lost to Follow-up|1499|||
25168075|NCT01878149|50295066|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
25168076|NCT01878149|50295067|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
25168077|NCT01863953|50295089|FG000|Overall Study|Adverse Event|0|||
25168078|NCT01863953|50295090|FG001|Overall Study|Adverse Event|0|||
25168079|NCT01863953|50295091|FG002|Overall Study|Adverse Event|1|||
25168080|NCT03049449|50295367|FG000|Overall Study|Did not receive treatment.|0|||
25168081|NCT03049449|50295368|FG001|Overall Study|Did not receive treatment.|0|||
25168082|NCT03049449|50295369|FG002|Overall Study|Did not receive treatment.|0|||
25168083|NCT03049449|50295370|FG003|Overall Study|Did not receive treatment.|0|||
25168084|NCT03049449|50295371|FG004|Overall Study|Did not receive treatment.|0|||
25168085|NCT03049449|50295372|FG005|Overall Study|Did not receive treatment.|0|||
25168086|NCT03049449|50295373|FG006|Overall Study|Did not receive treatment.|0|||
25168087|NCT03049449|50295374|FG007|Overall Study|Did not receive treatment.|0|||
25168088|NCT03049449|50295375|FG008|Overall Study|Did not receive treatment.|1|||
25168089|NCT03049449|50295376|FG009|Overall Study|Did not receive treatment.|0|||
25168090|NCT03049449|50295367|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
25168091|NCT03049449|50295368|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
25168092|NCT03049449|50295369|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
25168093|NCT03049449|50295370|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
25168094|NCT03049449|50295371|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
25168095|NCT03049449|50295372|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
25168096|NCT03049449|50295373|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
25168097|NCT03049449|50295374|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
25168098|NCT03049449|50295375|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
25168099|NCT03049449|50295376|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
25168100|NCT03049449|50295367|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
25168101|NCT03049449|50295368|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
25168102|NCT03049449|50295369|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
25168103|NCT03049449|50295370|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
25168104|NCT03049449|50295371|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
25168105|NCT03049449|50295372|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
25168106|NCT03049449|50295373|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
25168107|NCT03049449|50295374|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
25168108|NCT03049449|50295375|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
25168109|NCT03049449|50295376|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
25168110|NCT02989857|50295509|FG000|Randomization Phase|Not Treated|3|||
25168111|NCT02989857|50295510|FG001|Randomization Phase|Not Treated|2|||
25168112|NCT02989857|50295511|FG002|Randomization Phase|Not Treated|0|||
25168113|NCT01877915|50295522|FG000|Overall Study|Lost to Follow-up|10|||
25168114|NCT01877915|50295523|FG001|Overall Study|Lost to Follow-up|9|||
25168115|NCT01877915|50295522|FG000|Overall Study|Withdrawal by Subject|42|||
25168116|NCT01877915|50295523|FG001|Overall Study|Withdrawal by Subject|55|||
25168117|NCT01877915|50295522|FG000|Overall Study|Other|2|||
25168118|NCT01877915|50295523|FG001|Overall Study|Other|4|||
25168119|NCT01876979|50295531|FG000|Overall Study|Physician Decision|2|||
25168120|NCT01876979|50295532|FG001|Overall Study|Physician Decision|3|||
25168121|NCT01860989|50295538|FG000|Overall Study|Unsatisfactory therapeutic|5|||
25168122|NCT01860677|50295554|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
25168123|NCT01860677|50295555|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
25168124|NCT01876901|50295573|FG000|Overall Study|Protocol Violation|10|||
25168125|NCT01876901|50295574|FG001|Overall Study|Protocol Violation|2|||
25168126|NCT01876901|50295573|FG000|Overall Study|No or other surgical intervention|7|||
25168127|NCT01876901|50295574|FG001|Overall Study|No or other surgical intervention|5|||
25168128|NCT01876823|50295581|FG000|Overall Study|Withdrawal by Subject|5|||
25168129|NCT01876823|50295581|FG000|Overall Study|Physician Decision|2|||
25168130|NCT01876823|50295581|FG000|Overall Study|Patients moved|2|||
25168131|NCT01876511|50295588|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
25168132|NCT01876511|50295589|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
25168133|NCT01876511|50295590|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
25168134|NCT01876511|50295588|FG000|Overall Study|Death (unrelated)|3|||
25168135|NCT01876511|50295589|FG001|Overall Study|Death (unrelated)|0|||
25168136|NCT01876511|50295590|FG002|Overall Study|Death (unrelated)|2|||
25168137|NCT01876511|50295588|FG000|Overall Study|Drug-related Toxicity|5|||
25168138|NCT01876511|50295589|FG001|Overall Study|Drug-related Toxicity|1|||
25168139|NCT01876511|50295590|FG002|Overall Study|Drug-related Toxicity|6|||
25168140|NCT01876511|50295588|FG000|Overall Study|Patient Decision|3|||
25168141|NCT01876511|50295589|FG001|Overall Study|Patient Decision|0|||
25168142|NCT01876511|50295590|FG002|Overall Study|Patient Decision|6|||
25168143|NCT01876511|50295588|FG000|Overall Study|Physician Decision|1|||
25168144|NCT01876511|50295589|FG001|Overall Study|Physician Decision|0|||
25168145|NCT01876511|50295590|FG002|Overall Study|Physician Decision|1|||
25168146|NCT01993719|50295605|FG000|First Drug Administration|Not treated|1|||
25168147|NCT01993719|50295606|FG001|First Drug Administration|Not treated|0|||
25168148|NCT01993719|50295607|FG002|First Drug Administration|Not treated|0|||
25168149|NCT01993719|50295608|FG003|First Drug Administration|Not treated|0|||
25168150|NCT01993719|50295609|FG004|First Drug Administration|Not treated|0|||
25168151|NCT00638235|50295651|FG000|Overall Study|Lost to Follow-up|31|||
25168152|NCT00638235|50295652|FG001|Overall Study|Lost to Follow-up|3|||
25168153|NCT00638235|50295653|FG002|Overall Study|Lost to Follow-up|18|||
25168154|NCT00638235|50295654|FG003|Overall Study|Lost to Follow-up|10|||
25168155|NCT00638235|50295655|FG004|Overall Study|Lost to Follow-up|13|||
25168156|NCT00638235|50295656|FG005|Overall Study|Lost to Follow-up|26|||
25168157|NCT00638235|50295657|FG006|Overall Study|Lost to Follow-up|0|||
25168158|NCT00638235|50295658|FG007|Overall Study|Lost to Follow-up|1|||
25168159|NCT00638235|50295659|FG008|Overall Study|Lost to Follow-up|18|||
25168160|NCT00638157|50295688|FG000|Overall Study|Adverse Event|0|||
25168161|NCT00638157|50295689|FG001|Overall Study|Adverse Event|1|||
25168162|NCT00638157|50295688|FG000|Overall Study|Clinical (symptomatic) failure|1|||
25168163|NCT00638157|50295689|FG001|Overall Study|Clinical (symptomatic) failure|1|||
25168164|NCT00638157|50295688|FG000|Overall Study|Microbiological failure|1|||
25168165|NCT00638157|50295689|FG001|Overall Study|Microbiological failure|0|||
25168166|NCT00638157|50295688|FG000|Overall Study|Lost to Follow-up|1|||
25168167|NCT00638157|50295689|FG001|Overall Study|Lost to Follow-up|0|||
25168168|NCT00638157|50295688|FG000|Overall Study|Physician Decision|1|||
25168169|NCT00638157|50295689|FG001|Overall Study|Physician Decision|0|||
25168170|NCT00638157|50295688|FG000|Overall Study|Other|1|||
25168171|NCT00638157|50295689|FG001|Overall Study|Other|2|||
25168172|NCT00638157|50295688|FG000|Overall Study|Randomized, not treated|2|||
25168173|NCT00638157|50295689|FG001|Overall Study|Randomized, not treated|0|||
25168174|NCT00637377|50295700|FG000|Overall Study|Adverse Event|2|||
25168175|NCT00637377|50295701|FG001|Overall Study|Adverse Event|6|||
25168176|NCT00637377|50295702|FG002|Overall Study|Adverse Event|8|||
25168177|NCT00637377|50295703|FG003|Overall Study|Adverse Event|9|||
25168178|NCT00637377|50295700|FG000|Overall Study|Death|1|||
25168179|NCT00637377|50295701|FG001|Overall Study|Death|3|||
25168180|NCT00637377|50295702|FG002|Overall Study|Death|2|||
25168181|NCT00637377|50295703|FG003|Overall Study|Death|1|||
25168182|NCT00637377|50295700|FG000|Overall Study|Lack of Efficacy|0|||
25168183|NCT00637377|50295701|FG001|Overall Study|Lack of Efficacy|0|||
25168184|NCT00637377|50295702|FG002|Overall Study|Lack of Efficacy|1|||
25168185|NCT00637377|50295703|FG003|Overall Study|Lack of Efficacy|1|||
25168186|NCT00637377|50295700|FG000|Overall Study|Lost to Follow-up|4|||
25168187|NCT00637377|50295701|FG001|Overall Study|Lost to Follow-up|1|||
25168188|NCT00637377|50295702|FG002|Overall Study|Lost to Follow-up|2|||
25168189|NCT00637377|50295703|FG003|Overall Study|Lost to Follow-up|2|||
25168190|NCT00637377|50295700|FG000|Overall Study|Protocol Violation|2|||
25168191|NCT00637377|50295701|FG001|Overall Study|Protocol Violation|1|||
25168192|NCT00637377|50295702|FG002|Overall Study|Protocol Violation|1|||
25168193|NCT00637377|50295703|FG003|Overall Study|Protocol Violation|0|||
25168194|NCT00637377|50295700|FG000|Overall Study|Withdrawal by Subject|11|||
25168195|NCT00637377|50295701|FG001|Overall Study|Withdrawal by Subject|15|||
25168196|NCT00637377|50295702|FG002|Overall Study|Withdrawal by Subject|13|||
25168197|NCT00637377|50295703|FG003|Overall Study|Withdrawal by Subject|11|||
25168198|NCT00637377|50295700|FG000|Overall Study|Other (no further information available)|7|||
25168199|NCT00637377|50295701|FG001|Overall Study|Other (no further information available)|6|||
25168200|NCT00637377|50295702|FG002|Overall Study|Other (no further information available)|10|||
25168201|NCT00637377|50295703|FG003|Overall Study|Other (no further information available)|5|||
25168202|NCT00636987|50295713|FG000|Overall Study|Death|44|||
25168203|NCT00636987|50295713|FG000|Overall Study|Explanted|13|||
25168204|NCT00636987|50295713|FG000|Overall Study|Lost to Follow-up|63|||
25168205|NCT00636987|50295713|FG000|Overall Study|5 year visit window not complete|69|||
25168206|NCT00636441|50295868|FG000|Overall Study|Adverse Event|0|||
25168207|NCT00636441|50295869|FG001|Overall Study|Adverse Event|1|||
25168208|NCT00636441|50295870|FG002|Overall Study|Adverse Event|1|||
25168209|NCT00636441|50295871|FG003|Overall Study|Adverse Event|0|||
25168210|NCT00636441|50295872|FG004|Overall Study|Adverse Event|0|||
25168211|NCT00636441|50295873|FG005|Overall Study|Adverse Event|1|||
25168212|NCT00636441|50295874|FG006|Overall Study|Adverse Event|0|||
25168213|NCT00636441|50295868|FG000|Overall Study|Late, ineligible|0|||
25168214|NCT00636441|50295869|FG001|Overall Study|Late, ineligible|0|||
25168215|NCT00636441|50295870|FG002|Overall Study|Late, ineligible|0|||
25168216|NCT00636441|50295871|FG003|Overall Study|Late, ineligible|0|||
25168217|NCT00636441|50295872|FG004|Overall Study|Late, ineligible|0|||
25168218|NCT00636441|50295873|FG005|Overall Study|Late, ineligible|0|||
25168219|NCT00636441|50295874|FG006|Overall Study|Late, ineligible|1|||
25168220|NCT00636441|50295868|FG000|Overall Study|Screen Failure|0|||
25168221|NCT00636441|50295869|FG001|Overall Study|Screen Failure|0|||
25168222|NCT00636441|50295870|FG002|Overall Study|Screen Failure|0|||
25168223|NCT00636441|50295871|FG003|Overall Study|Screen Failure|0|||
25168224|NCT00636441|50295872|FG004|Overall Study|Screen Failure|0|||
25168225|NCT00636441|50295873|FG005|Overall Study|Screen Failure|0|||
25168226|NCT00636441|50295874|FG006|Overall Study|Screen Failure|17|||
25168227|NCT00636363|50295897|FG000|Overall Study|Conjunctivitis|0|||
25168228|NCT00636363|50295898|FG001|Overall Study|Conjunctivitis|0|||
25168229|NCT00636363|50295899|FG002|Overall Study|Conjunctivitis|1|||
25168230|NCT00636363|50295897|FG000|Overall Study|Adverse Event|0|||
25168231|NCT00636363|50295898|FG001|Overall Study|Adverse Event|0|||
25168232|NCT00636363|50295899|FG002|Overall Study|Adverse Event|1|||
25168233|NCT00636363|50295897|FG000|Overall Study|Positive slit lamp finding|0|||
25168234|NCT00636363|50295898|FG001|Overall Study|Positive slit lamp finding|2|||
25168235|NCT00636363|50295899|FG002|Overall Study|Positive slit lamp finding|1|||
25168236|NCT00636363|50295897|FG000|Overall Study|Study related symptoms/complaints|8|||
25168237|NCT00636363|50295898|FG001|Overall Study|Study related symptoms/complaints|7|||
25168238|NCT00636363|50295899|FG002|Overall Study|Study related symptoms/complaints|4|||
25168239|NCT00636363|50295897|FG000|Overall Study|Met ineligibility criteria|0|||
25168240|NCT00636363|50295898|FG001|Overall Study|Met ineligibility criteria|0|||
25168241|NCT00636363|50295899|FG002|Overall Study|Met ineligibility criteria|3|||
25168242|NCT00636363|50295897|FG000|Overall Study|Missed > 1 visit|0|||
25168243|NCT00636363|50295898|FG001|Overall Study|Missed > 1 visit|1|||
25168244|NCT00636363|50295899|FG002|Overall Study|Missed > 1 visit|3|||
25168245|NCT00636363|50295897|FG000|Overall Study|Lack of motivation|1|||
25168246|NCT00636363|50295898|FG001|Overall Study|Lack of motivation|0|||
25168247|NCT00636363|50295899|FG002|Overall Study|Lack of motivation|1|||
25168248|NCT00636363|50295897|FG000|Overall Study|Protocol Violation|0|||
25168249|NCT00636363|50295898|FG001|Overall Study|Protocol Violation|3|||
25168250|NCT00636363|50295899|FG002|Overall Study|Protocol Violation|0|||
25168251|NCT00636363|50295897|FG000|Overall Study|Lost to Follow-up|3|||
25168252|NCT00636363|50295898|FG001|Overall Study|Lost to Follow-up|4|||
25168253|NCT00636363|50295899|FG002|Overall Study|Lost to Follow-up|2|||
25168254|NCT00636363|50295897|FG000|Overall Study|Withdrawal by Subject|1|||
25168255|NCT00636363|50295898|FG001|Overall Study|Withdrawal by Subject|3|||
25168256|NCT00636363|50295899|FG002|Overall Study|Withdrawal by Subject|2|||
25168257|NCT00636207|50295941|FG000|Overall Study|Adverse Event|1|||
25168258|NCT00636207|50295942|FG001|Overall Study|Adverse Event|0|||
25168259|NCT00636207|50295943|FG002|Overall Study|Adverse Event|0|||
25168260|NCT00636207|50295944|FG003|Overall Study|Adverse Event|0|||
25168261|NCT00636207|50295945|FG004|Overall Study|Adverse Event|0|||
25168262|NCT00636207|50295946|FG005|Overall Study|Adverse Event|0|||
25168263|NCT00636207|50295947|FG006|Overall Study|Adverse Event|0|||
25187010|NCT01384019|50337749|FG001|Overall Study|Withdrawal by Subject|0|||
25187011|NCT01384019|50337748|FG000|Overall Study|Death|1|||
25187012|NCT01384019|50337749|FG001|Overall Study|Death|0|||
25187013|NCT01384019|50337748|FG000|Overall Study|MRI refusal|6|||
25187014|NCT01384019|50337749|FG001|Overall Study|MRI refusal|6|||
25187015|NCT00033631|50337757|FG000|Overall Study|Protocol Violation|14|||
25187016|NCT00033631|50337758|FG001|Overall Study|Protocol Violation|11|||
25187017|NCT00033631|50337757|FG000|Overall Study|Withdrawal by Subject|4|||
25187018|NCT00033631|50337758|FG001|Overall Study|Withdrawal by Subject|4|||
25187019|NCT01471574|50337769|FG000|Treatment Period|Lack of Efficacy|12|||
25187020|NCT01471574|50337770|FG001|Treatment Period|Lack of Efficacy|4|||
25187021|NCT01471574|50337771|FG002|Treatment Period|Lack of Efficacy|14|||
25187022|NCT01471574|50337772|FG003|Treatment Period|Lack of Efficacy|1|||
24964510|NCT00434759|50054332|FG000|Overall Study|family affairs|2|||
25187023|NCT01471574|50337769|FG000|Treatment Period|Adverse Event|7|||
25187024|NCT01471574|50337770|FG001|Treatment Period|Adverse Event|3|||
25187025|NCT01471574|50337771|FG002|Treatment Period|Adverse Event|6|||
25187026|NCT01471574|50337772|FG003|Treatment Period|Adverse Event|1|||
24964511|NCT00434759|50054333|FG001|Overall Study|family affairs|0|||
25187027|NCT01471574|50337769|FG000|Treatment Period|Withdrawal by Subject|5|||
25168264|NCT00636207|50295941|FG000|Overall Study|Withdrawal by Subject|0|||
25168265|NCT00636207|50295942|FG001|Overall Study|Withdrawal by Subject|1|||
25168266|NCT00636207|50295943|FG002|Overall Study|Withdrawal by Subject|0|||
25168267|NCT00636207|50295944|FG003|Overall Study|Withdrawal by Subject|0|||
25168268|NCT00636207|50295945|FG004|Overall Study|Withdrawal by Subject|1|||
25168269|NCT00636207|50295946|FG005|Overall Study|Withdrawal by Subject|0|||
25168270|NCT00636207|50295947|FG006|Overall Study|Withdrawal by Subject|0|||
25168271|NCT00635661|50295968|FG000|Overall Study|Withdrawal by Subject|4|||
25168272|NCT00635427|50296057|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
25168273|NCT00635427|50296058|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
25168274|NCT00635427|50296059|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
25168275|NCT00635427|50296060|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
25168276|NCT00635427|50296061|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
25168277|NCT00635427|50296057|FG000|Overall Study|Death|0|||
25187028|NCT01471574|50337770|FG001|Treatment Period|Withdrawal by Subject|1|||
25187029|NCT01471574|50337771|FG002|Treatment Period|Withdrawal by Subject|1|||
25187030|NCT01471574|50337772|FG003|Treatment Period|Withdrawal by Subject|0|||
24964512|NCT00440999|50054343|FG000|Overall Study|Adverse Event|0|||
25168278|NCT00635427|50296058|FG001|Overall Study|Death|0|||
25187031|NCT01471574|50337769|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
25187032|NCT01471574|50337770|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
25187033|NCT01471574|50337771|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
25187034|NCT01471574|50337772|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
25187035|NCT01471574|50337769|FG000|Treatment Period|Lost to Follow-up|1|||
25187036|NCT01471574|50337770|FG001|Treatment Period|Lost to Follow-up|2|||
25187037|NCT01471574|50337771|FG002|Treatment Period|Lost to Follow-up|2|||
25187038|NCT01471574|50337772|FG003|Treatment Period|Lost to Follow-up|0|||
25187039|NCT01471574|50337769|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
25187040|NCT01471574|50337770|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
25187041|NCT01471574|50337771|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
25187042|NCT01471574|50337772|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
25187043|NCT01471574|50337769|FG000|Treatment Period|Other|1|||
25187044|NCT01471574|50337770|FG001|Treatment Period|Other|0|||
25187045|NCT01471574|50337771|FG002|Treatment Period|Other|0|||
25187046|NCT01471574|50337772|FG003|Treatment Period|Other|0|||
25187047|NCT01471574|50337769|FG000|Follow-up Period|Withdrawal by Subject|3|||
25187048|NCT01471574|50337770|FG001|Follow-up Period|Withdrawal by Subject|0|||
25187049|NCT01471574|50337771|FG002|Follow-up Period|Withdrawal by Subject|3|||
25187050|NCT01471574|50337772|FG003|Follow-up Period|Withdrawal by Subject|1|||
25187051|NCT01471574|50337769|FG000|Follow-up Period|Lost to Follow-up|4|||
25187052|NCT01471574|50337770|FG001|Follow-up Period|Lost to Follow-up|1|||
25187053|NCT01471574|50337771|FG002|Follow-up Period|Lost to Follow-up|3|||
25187054|NCT01471574|50337772|FG003|Follow-up Period|Lost to Follow-up|2|||
25187055|NCT01471574|50337769|FG000|Follow-up Period|Death|0|||
25187056|NCT01471574|50337770|FG001|Follow-up Period|Death|0|||
25187057|NCT01471574|50337771|FG002|Follow-up Period|Death|1|||
25187058|NCT01471574|50337772|FG003|Follow-up Period|Death|0|||
25187059|NCT01471574|50337769|FG000|Follow-up Period|Follow-up no longer required|0|||
25187060|NCT01471574|50337770|FG001|Follow-up Period|Follow-up no longer required|1|||
25187061|NCT01471574|50337771|FG002|Follow-up Period|Follow-up no longer required|0|||
25187062|NCT01471574|50337772|FG003|Follow-up Period|Follow-up no longer required|0|||
25187063|NCT01383707|50337788|FG000|Overall Study|Consent withdrawal|6|||
25187064|NCT01383707|50337788|FG000|Overall Study|Death|19|||
25187065|NCT01383707|50337788|FG000|Overall Study|Other|8|||
25187066|NCT01383707|50337788|FG000|Overall Study|Sponsor's decision|2|||
25187067|NCT01383707|50337788|FG000|Overall Study|Adverse Event|14|||
25187068|NCT01383707|50337788|FG000|Overall Study|Progressive disease|23|||
25168279|NCT00635427|50296059|FG002|Overall Study|Death|0|||
25168280|NCT00635427|50296060|FG003|Overall Study|Death|1|||
25168281|NCT00635427|50296061|FG004|Overall Study|Death|0|||
25168282|NCT00635427|50296057|FG000|Overall Study|Termination Of Study By Sponsor|12|||
25168283|NCT00635427|50296058|FG001|Overall Study|Termination Of Study By Sponsor|6|||
25187069|NCT01383317|50337794|FG000|Overall Study|Lost to Follow-up|2|||
25187070|NCT01383317|50337795|FG001|Overall Study|Lost to Follow-up|1|||
25187071|NCT01383317|50337794|FG000|Overall Study|Death|1|||
25187072|NCT01383317|50337795|FG001|Overall Study|Death|0|||
25187073|NCT01383317|50337794|FG000|Overall Study|Adverse Event|0|||
25187074|NCT01383317|50337795|FG001|Overall Study|Adverse Event|1|||
25187075|NCT01455428|50337803|FG000|Overall Study|Protocol Violation|2|||
25187076|NCT01455428|50337804|FG001|Overall Study|Protocol Violation|1|||
25187077|NCT01455428|50337803|FG000|Overall Study|Adverse Event|6|||
25168284|NCT00635427|50296059|FG002|Overall Study|Termination Of Study By Sponsor|10|||
25187078|NCT01455428|50337804|FG001|Overall Study|Adverse Event|2|||
25187079|NCT01455428|50337803|FG000|Overall Study|Lost to Follow-up|1|||
25187080|NCT01455428|50337804|FG001|Overall Study|Lost to Follow-up|1|||
25187081|NCT01455428|50337803|FG000|Overall Study|Withdrawal by Subject|2|||
25187082|NCT01455428|50337804|FG001|Overall Study|Withdrawal by Subject|5|||
25187083|NCT01455428|50337803|FG000|Overall Study|Did not meet entrance criteria|0|||
25187084|NCT01455428|50337804|FG001|Overall Study|Did not meet entrance criteria|2|||
25187085|NCT01455428|50337803|FG000|Overall Study|Insufficient clinical response|0|||
25187086|NCT01455428|50337804|FG001|Overall Study|Insufficient clinical response|2|||
25187087|NCT01455428|50337803|FG000|Overall Study|Did not receive treatment|1|||
25187088|NCT01455428|50337804|FG001|Overall Study|Did not receive treatment|1|||
25187089|NCT01455428|50337803|FG000|Overall Study|Other|2|||
25187090|NCT01455428|50337804|FG001|Overall Study|Other|4|||
25187091|NCT01383161|50337812|FG000|Overall Study|Adverse Event|5|||
25187092|NCT01383161|50337813|FG001|Overall Study|Adverse Event|1|||
25187093|NCT01383161|50337812|FG000|Overall Study|Withdrawal by Subject|0|||
25187094|NCT01383161|50337813|FG001|Overall Study|Withdrawal by Subject|2|||
25187095|NCT01383161|50337812|FG000|Overall Study|Lack of Efficacy|0|||
25187096|NCT01383161|50337813|FG001|Overall Study|Lack of Efficacy|1|||
25187097|NCT01382225|50337839|FG000|Overall Study|Adverse Event|3|||
25187098|NCT01382225|50337840|FG001|Overall Study|Adverse Event|2|||
25187099|NCT01382225|50337839|FG000|Overall Study|Protocol Violation|2|||
25187100|NCT01382225|50337840|FG001|Overall Study|Protocol Violation|1|||
25187101|NCT01382225|50337839|FG000|Overall Study|Subject Withdrew Consent|5|||
25187102|NCT01382225|50337840|FG001|Overall Study|Subject Withdrew Consent|2|||
25187103|NCT01382225|50337839|FG000|Overall Study|Other|4|||
25187104|NCT01382225|50337840|FG001|Overall Study|Other|2|||
25187105|NCT01381679|50337846|FG000|Overall Study|Adverse Event|3|||
25187106|NCT01381679|50337846|FG000|Overall Study|Lost to Follow-up|885|||
25187107|NCT01455194|50337853|FG000|Overall Study|Screen Failure|20|||
25187108|NCT01455194|50337854|FG001|Overall Study|Screen Failure|0|||
25187109|NCT01455194|50337855|FG002|Overall Study|Screen Failure|0|||
25187110|NCT01455194|50337856|FG003|Overall Study|Screen Failure|0|||
25187111|NCT01455194|50337853|FG000|Overall Study|Randomisation Failure|90|||
25187112|NCT01455194|50337854|FG001|Overall Study|Randomisation Failure|0|||
25187113|NCT01455194|50337855|FG002|Overall Study|Randomisation Failure|0|||
25187114|NCT01455194|50337856|FG003|Overall Study|Randomisation Failure|0|||
25187115|NCT01455194|50337853|FG000|Overall Study|Deterioration in asthma|12|||
25187116|NCT01455194|50337854|FG001|Overall Study|Deterioration in asthma|6|||
25187117|NCT01455194|50337855|FG002|Overall Study|Deterioration in asthma|14|||
25187118|NCT01455194|50337856|FG003|Overall Study|Deterioration in asthma|9|||
25187119|NCT01455194|50337853|FG000|Overall Study|Adverse Event|1|||
25187120|NCT01455194|50337854|FG001|Overall Study|Adverse Event|1|||
25187121|NCT01455194|50337855|FG002|Overall Study|Adverse Event|1|||
25187122|NCT01455194|50337856|FG003|Overall Study|Adverse Event|3|||
25187123|NCT01455194|50337853|FG000|Overall Study|Withdrawal by Subject|21|||
25187124|NCT01455194|50337854|FG001|Overall Study|Withdrawal by Subject|16|||
25187125|NCT01455194|50337855|FG002|Overall Study|Withdrawal by Subject|12|||
25187126|NCT01455194|50337856|FG003|Overall Study|Withdrawal by Subject|9|||
25187127|NCT01455194|50337853|FG000|Overall Study|Lost to Follow-up|2|||
25187128|NCT01455194|50337854|FG001|Overall Study|Lost to Follow-up|0|||
25187129|NCT01455194|50337855|FG002|Overall Study|Lost to Follow-up|1|||
25187130|NCT01455194|50337856|FG003|Overall Study|Lost to Follow-up|1|||
25187131|NCT01455194|50337853|FG000|Overall Study|Pregnancy|0|||
25187132|NCT01455194|50337854|FG001|Overall Study|Pregnancy|1|||
25187133|NCT01455194|50337855|FG002|Overall Study|Pregnancy|1|||
25187134|NCT01455194|50337856|FG003|Overall Study|Pregnancy|0|||
25187135|NCT01455194|50337853|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
25187136|NCT01455194|50337854|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
25187137|NCT01455194|50337855|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
25187138|NCT01455194|50337856|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
25187139|NCT01455194|50337853|FG000|Overall Study|Miscellaneous|4|||
25187140|NCT01455194|50337854|FG001|Overall Study|Miscellaneous|5|||
25187141|NCT01455194|50337855|FG002|Overall Study|Miscellaneous|1|||
25187142|NCT01455194|50337856|FG003|Overall Study|Miscellaneous|4|||
25187143|NCT01454726|50337880|FG000|Overall Study|Withdrawal by Subject|0|||
25187144|NCT01454726|50337881|FG001|Overall Study|Withdrawal by Subject|1|||
25187145|NCT01361568|50337893|FG000|Overall Study|Adverse Event|0|||
25187146|NCT01361568|50337894|FG001|Overall Study|Adverse Event|0|||
25187147|NCT01361568|50337895|FG002|Overall Study|Adverse Event|0|||
25187148|NCT01361568|50337896|FG003|Overall Study|Adverse Event|0|||
25187149|NCT01361568|50337897|FG004|Overall Study|Adverse Event|1|||
25187150|NCT01361568|50337898|FG005|Overall Study|Adverse Event|0|||
25187151|NCT01361568|50337893|FG000|Overall Study|Physician Decision|0|||
25187152|NCT01361568|50337894|FG001|Overall Study|Physician Decision|0|||
25187153|NCT01361568|50337895|FG002|Overall Study|Physician Decision|0|||
25187154|NCT01361568|50337896|FG003|Overall Study|Physician Decision|0|||
25187155|NCT01361568|50337897|FG004|Overall Study|Physician Decision|0|||
25187156|NCT01361568|50337898|FG005|Overall Study|Physician Decision|1|||
25187157|NCT01361568|50337893|FG000|Overall Study|Withdrawal by Subject|2|||
25187158|NCT01361568|50337894|FG001|Overall Study|Withdrawal by Subject|1|||
25187159|NCT01361568|50337895|FG002|Overall Study|Withdrawal by Subject|0|||
25187160|NCT01361568|50337896|FG003|Overall Study|Withdrawal by Subject|0|||
25187161|NCT01361568|50337897|FG004|Overall Study|Withdrawal by Subject|0|||
25187162|NCT01361568|50337898|FG005|Overall Study|Withdrawal by Subject|1|||
25187163|NCT03084367|50337913|FG000|Overall Study|Lost to Follow-up|32|||
25187164|NCT03084367|50337913|FG000|Overall Study|Withdrawal by Subject|4|||
25187165|NCT03084367|50337913|FG000|Overall Study|Other|1|||
25187166|NCT01454570|50337926|FG000|Overall Study|Withdrawal by Subject|2|||
25187167|NCT01454570|50337926|FG000|Overall Study|Screen Failure|7|||
25187168|NCT01494350|50337939|FG000|Overall Study|Worsening of lesion|1|||
25187169|NCT03281629|50337949|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
25187170|NCT03281629|50337950|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
25187171|NCT03281629|50337949|FG000|Overall Study|Death|0|||
25187172|NCT03281629|50337950|FG001|Overall Study|Death|1|||
25187173|NCT03281629|50337949|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
25187174|NCT03281629|50337950|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
25187175|NCT00218543|50337956|FG000|Overall Study|Lost to Follow-up|8|||
25187176|NCT00218543|50337956|FG000|Overall Study|relocated|1|||
25187177|NCT00218543|50337956|FG000|Overall Study|Withdrawal by Subject|1|||
25187178|NCT00218543|50337956|FG000|Overall Study|Physician Decision|3|||
25187179|NCT00218543|50337956|FG000|Overall Study|Adverse Event|2|||
25187180|NCT00216671|50337971|FG000|Overall Study|Adverse Event|4|||
25187181|NCT00216671|50337972|FG001|Overall Study|Adverse Event|9|||
25187182|NCT00216671|50337971|FG000|Overall Study|Pregnancy|0|||
25187183|NCT00216671|50337972|FG001|Overall Study|Pregnancy|1|||
25187184|NCT00216671|50337971|FG000|Overall Study|Withdrawal by Subject|4|||
25187185|NCT00216671|50337972|FG001|Overall Study|Withdrawal by Subject|2|||
25187186|NCT00216671|50337971|FG000|Overall Study|Refused Injections|3|||
25187187|NCT00216671|50337972|FG001|Overall Study|Refused Injections|13|||
25187188|NCT00216671|50337971|FG000|Overall Study|No Need to Continue Medication|1|||
25187189|NCT00216671|50337972|FG001|Overall Study|No Need to Continue Medication|1|||
25187190|NCT00216671|50337971|FG000|Overall Study|Insufficient Response|9|||
25187191|NCT00216671|50337972|FG001|Overall Study|Insufficient Response|4|||
25187192|NCT00216671|50337971|FG000|Overall Study|Lost to Follow-up|3|||
25187193|NCT00216671|50337972|FG001|Overall Study|Lost to Follow-up|5|||
25187194|NCT00216671|50337971|FG000|Overall Study|Non compliant|2|||
25187195|NCT00216671|50337972|FG001|Overall Study|Non compliant|2|||
25187196|NCT00216671|50337971|FG000|Overall Study|Ineligible|0|||
25187197|NCT00216671|50337972|FG001|Overall Study|Ineligible|2|||
25187198|NCT00216671|50337971|FG000|Overall Study|Physician Decision|1|||
25187199|NCT00216671|50337972|FG001|Overall Study|Physician Decision|1|||
25187200|NCT00216671|50337971|FG000|Overall Study|Protocol Violation|3|||
25187201|NCT00216671|50337972|FG001|Overall Study|Protocol Violation|5|||
25187202|NCT00216671|50337971|FG000|Overall Study|Relapse|1|||
25187203|NCT00216671|50337972|FG001|Overall Study|Relapse|0|||
25187204|NCT00216671|50337971|FG000|Overall Study|Investigator Illness|0|||
25187205|NCT00216671|50337972|FG001|Overall Study|Investigator Illness|1|||
25187206|NCT00216671|50337971|FG000|Overall Study|Patient Moved|0|||
25187207|NCT00216671|50337972|FG001|Overall Study|Patient Moved|1|||
25187208|NCT00216671|50337971|FG000|Overall Study|Ineligible, no efficacy data|2|||
25187209|NCT00216671|50337972|FG001|Overall Study|Ineligible, no efficacy data|2|||
25187210|NCT00216671|50337971|FG000|Overall Study|Insufficient Response Adverse Event|2|||
25168285|NCT00635427|50296060|FG003|Overall Study|Termination Of Study By Sponsor|6|||
25168286|NCT00635427|50296061|FG004|Overall Study|Termination Of Study By Sponsor|6|||
25168287|NCT00635427|50296057|FG000|Overall Study|Withdrawal Of Consent|0|||
25168288|NCT00635427|50296058|FG001|Overall Study|Withdrawal Of Consent|0|||
25168289|NCT00635427|50296059|FG002|Overall Study|Withdrawal Of Consent|0|||
25168290|NCT00635427|50296060|FG003|Overall Study|Withdrawal Of Consent|2|||
25168291|NCT00635427|50296061|FG004|Overall Study|Withdrawal Of Consent|2|||
25168292|NCT00635349|50296073|FG000|Overall Study|Other|8|||
25168293|NCT00635349|50296074|FG001|Overall Study|Other|6|||
25187211|NCT00216671|50337972|FG001|Overall Study|Insufficient Response Adverse Event|1|||
25187212|NCT00216203|50337978|FG000|Overall Study|Withdrawal by Subject|2|||
25187213|NCT02644668|50338013|FG000|Overall Study|Adverse Event|2|||
25187214|NCT02644668|50338014|FG001|Overall Study|Adverse Event|0|||
25187215|NCT02644668|50338015|FG002|Overall Study|Adverse Event|1|||
25187216|NCT02644668|50338013|FG000|Overall Study|Protocol Violation|0|||
25187217|NCT02644668|50338014|FG001|Overall Study|Protocol Violation|0|||
25187218|NCT02644668|50338015|FG002|Overall Study|Protocol Violation|1|||
25187219|NCT02644668|50338013|FG000|Overall Study|Withdrawal by Subject|0|||
25187220|NCT02644668|50338014|FG001|Overall Study|Withdrawal by Subject|0|||
25187221|NCT02644668|50338015|FG002|Overall Study|Withdrawal by Subject|1|||
25187222|NCT02644356|50338034|FG000|Overall Study|Withdrawal by Subject|2|||
25187223|NCT01494038|50338075|FG000|Overall Study|Protocol Violation|1|||
25187224|NCT01494038|50338076|FG001|Overall Study|Protocol Violation|1|||
25187225|NCT01494038|50338075|FG000|Overall Study|Lost to Follow-up|18|||
25187226|NCT01494038|50338076|FG001|Overall Study|Lost to Follow-up|20|||
25187227|NCT01494038|50338075|FG000|Overall Study|Withdrawal by Subject|44|||
25187228|NCT01494038|50338076|FG001|Overall Study|Withdrawal by Subject|34|||
25187229|NCT01494038|50338075|FG000|Overall Study|Not able to get to clinic|21|||
25187230|NCT01494038|50338076|FG001|Overall Study|Not able to get to clinic|15|||
25187231|NCT01494038|50338075|FG000|Overall Study|Not willing to adhere to reqs|2|||
25187232|NCT01494038|50338076|FG001|Overall Study|Not willing to adhere to reqs|9|||
25187233|NCT01494038|50338075|FG000|Overall Study|Death|2|||
25187234|NCT01494038|50338076|FG001|Overall Study|Death|4|||
25187235|NCT02640612|50338113|FG000|Overall Study|Adverse Event|6|||
25187236|NCT02640612|50338114|FG001|Overall Study|Adverse Event|7|||
25187237|NCT02640612|50338115|FG002|Overall Study|Adverse Event|2|||
25187238|NCT02640612|50338113|FG000|Overall Study|Death|1|||
25187239|NCT02640612|50338114|FG001|Overall Study|Death|0|||
25187240|NCT02640612|50338115|FG002|Overall Study|Death|0|||
25187241|NCT02640612|50338113|FG000|Overall Study|Withdrawal by Subject|10|||
25187242|NCT02640612|50338114|FG001|Overall Study|Withdrawal by Subject|3|||
25187243|NCT02640612|50338115|FG002|Overall Study|Withdrawal by Subject|3|||
25187244|NCT02640612|50338113|FG000|Overall Study|Lost to Follow-up|4|||
25187245|NCT02640612|50338114|FG001|Overall Study|Lost to Follow-up|1|||
25187246|NCT02640612|50338115|FG002|Overall Study|Lost to Follow-up|1|||
25187247|NCT02640612|50338113|FG000|Overall Study|Protocol Violation|0|||
25187248|NCT02640612|50338114|FG001|Overall Study|Protocol Violation|2|||
25187249|NCT02640612|50338115|FG002|Overall Study|Protocol Violation|0|||
25187250|NCT02640612|50338113|FG000|Overall Study|Lack of Efficacy|1|||
25187251|NCT02640612|50338114|FG001|Overall Study|Lack of Efficacy|1|||
25187252|NCT02640612|50338115|FG002|Overall Study|Lack of Efficacy|0|||
25187253|NCT00639769|50338123|FG000|Overall Study|Death|2|||
25187254|NCT00639769|50338123|FG000|Overall Study|Adverse Event|7|||
25187255|NCT00639769|50338123|FG000|Overall Study|Lack of Efficacy|1|||
25187256|NCT00639769|50338123|FG000|Overall Study|Disease progression|26|||
25187257|NCT00639769|50338123|FG000|Overall Study|Withdrawal by Subject|4|||
25187258|NCT00639457|50338129|FG000|Overall Study|Withdrawal by Subject|2|||
25187259|NCT00639457|50338130|FG001|Overall Study|Withdrawal by Subject|3|||
25187260|NCT00639379|50338136|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
25187261|NCT00639379|50338137|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
25187262|NCT00639379|50338136|FG000|Period 1 - 2 Weeks|lens issue|3|||
25187263|NCT00639379|50338137|FG001|Period 1 - 2 Weeks|lens issue|0|||
25187264|NCT00639223|50338145|FG000|Overall Study|Lost to Follow-up|0|||
25187265|NCT00639223|50338146|FG001|Overall Study|Lost to Follow-up|2|||
25187266|NCT00638989|50338155|FG000|Overall Study|Lost to Follow-up|0|||
25187267|NCT00638989|50338156|FG001|Overall Study|Lost to Follow-up|0|||
25187268|NCT00638989|50338157|FG002|Overall Study|Lost to Follow-up|1|||
25187269|NCT00637273|50338178|FG000|Overall Study|Adverse Event|11|||
25187270|NCT00637273|50338179|FG001|Overall Study|Adverse Event|5|||
25187271|NCT00637273|50338180|FG002|Overall Study|Adverse Event|7|||
25187272|NCT00637273|50338178|FG000|Overall Study|Lost to Follow-up|8|||
25187273|NCT00637273|50338179|FG001|Overall Study|Lost to Follow-up|9|||
25187274|NCT00637273|50338180|FG002|Overall Study|Lost to Follow-up|13|||
25187275|NCT00637273|50338178|FG000|Overall Study|Protocol Violation|2|||
25187276|NCT00637273|50338179|FG001|Overall Study|Protocol Violation|4|||
25187277|NCT00637273|50338180|FG002|Overall Study|Protocol Violation|1|||
25187278|NCT00637273|50338178|FG000|Overall Study|Withdrawal of Consent|18|||
25187279|NCT00637273|50338179|FG001|Overall Study|Withdrawal of Consent|6|||
25187280|NCT00637273|50338180|FG002|Overall Study|Withdrawal of Consent|18|||
25187281|NCT00637273|50338178|FG000|Overall Study|Investigator Decision|1|||
25187282|NCT00637273|50338179|FG001|Overall Study|Investigator Decision|3|||
25187283|NCT00637273|50338180|FG002|Overall Study|Investigator Decision|1|||
25187284|NCT00637273|50338178|FG000|Overall Study|Administrative|2|||
24964513|NCT00440999|50054344|FG001|Overall Study|Adverse Event|2|||
25168294|NCT00635349|50296073|FG000|Overall Study|Protocol Violation|18|||
25168295|NCT00635349|50296074|FG001|Overall Study|Protocol Violation|22|||
25187285|NCT00637273|50338179|FG001|Overall Study|Administrative|0|||
24964514|NCT00440999|50054343|FG000|Overall Study|Lack of Efficacy|6|||
24964515|NCT00440999|50054344|FG001|Overall Study|Lack of Efficacy|7|||
24964516|NCT00440999|50054343|FG000|Overall Study|Lost to Follow-up|19|||
25168296|NCT00635349|50296073|FG000|Overall Study|Withdrawal by Subject|3|||
25168297|NCT00635349|50296074|FG001|Overall Study|Withdrawal by Subject|8|||
25168298|NCT00635349|50296073|FG000|Overall Study|Lost to Follow-up|4|||
25168299|NCT00635349|50296074|FG001|Overall Study|Lost to Follow-up|3|||
25168300|NCT00635349|50296073|FG000|Overall Study|Adverse Event|11|||
25168301|NCT00635349|50296074|FG001|Overall Study|Adverse Event|9|||
25168302|NCT00634803|50296083|FG000|Overall Study|Lost to Follow-up|6|||
25168303|NCT00634803|50296084|FG001|Overall Study|Lost to Follow-up|7|||
25168304|NCT00634803|50296085|FG002|Overall Study|Lost to Follow-up|7|||
25168305|NCT01217385|50296101|FG000|Overall Study|Withdrawal by Subject|3|||
25168306|NCT01217385|50296101|FG000|Overall Study|DOSI not performed/not eval|12|||
25168307|NCT01217385|50296101|FG000|Overall Study|Central Path not Available|1|||
25187286|NCT00637273|50338180|FG002|Overall Study|Administrative|0|||
25187287|NCT00637273|50338178|FG000|Overall Study|Loss of Glucose Control|1|||
25187288|NCT00637273|50338179|FG001|Overall Study|Loss of Glucose Control|1|||
25187289|NCT00637273|50338180|FG002|Overall Study|Loss of Glucose Control|1|||
25187290|NCT00988351|50338190|FG000|Overall Study|Withdrawal by Subject|8|||
25187291|NCT00988351|50338191|FG001|Overall Study|Withdrawal by Subject|0|||
25187292|NCT00988351|50338190|FG000|Overall Study|Lost to Follow-up|6|||
25187293|NCT00988351|50338191|FG001|Overall Study|Lost to Follow-up|9|||
25187294|NCT00988351|50338190|FG000|Overall Study|not using CPAP|5|||
25187295|NCT00988351|50338191|FG001|Overall Study|not using CPAP|3|||
25187296|NCT00988117|50338197|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
25187297|NCT00988117|50338197|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
25187298|NCT00637195|50338204|FG000|Overall Study|Lost to Follow-up|1|||
25187299|NCT00637195|50338205|FG001|Overall Study|Lost to Follow-up|0|||
25168308|NCT01217385|50296101|FG000|Overall Study|Normal Breast TOI not available|10|||
25168309|NCT01378104|50296453|FG000|Overall Study|Adverse Event|8|||
25168310|NCT01378104|50296454|FG001|Overall Study|Adverse Event|8|||
25168311|NCT01378104|50296453|FG000|Overall Study|Lack of Efficacy|7|||
25168312|NCT01378104|50296454|FG001|Overall Study|Lack of Efficacy|5|||
25168313|NCT01378104|50296453|FG000|Overall Study|Withdrawal by Subject|12|||
25168314|NCT01378104|50296454|FG001|Overall Study|Withdrawal by Subject|13|||
25168315|NCT01379274|50296495|FG000|Overall Study|funding withdrawn|1|||
25276902|NCT01040793|50590847|FG001|Overall Study|Protocol Violation|1|||
25276903|NCT01040793|50590848|FG002|Overall Study|Protocol Violation|1|||
25276904|NCT01040793|50590849|FG003|Overall Study|Protocol Violation|0|||
25276905|NCT01040793|50590850|FG004|Overall Study|Protocol Violation|1|||
25276906|NCT01040793|50590851|FG005|Overall Study|Protocol Violation|0|||
25276907|NCT01040793|50590846|FG000|Overall Study|Lost to Follow-up|0|||
25276908|NCT01040793|50590847|FG001|Overall Study|Lost to Follow-up|1|||
25276909|NCT01040793|50590848|FG002|Overall Study|Lost to Follow-up|1|||
25276910|NCT01040793|50590849|FG003|Overall Study|Lost to Follow-up|0|||
25276911|NCT01040793|50590850|FG004|Overall Study|Lost to Follow-up|0|||
25276912|NCT01040793|50590851|FG005|Overall Study|Lost to Follow-up|0|||
25276913|NCT01040793|50590846|FG000|Overall Study|Withdrawal by Subject|0|||
25276914|NCT01040793|50590847|FG001|Overall Study|Withdrawal by Subject|0|||
25276915|NCT01040793|50590848|FG002|Overall Study|Withdrawal by Subject|0|||
25276916|NCT01040793|50590849|FG003|Overall Study|Withdrawal by Subject|2|||
25276917|NCT01040793|50590850|FG004|Overall Study|Withdrawal by Subject|0|||
25276918|NCT01040793|50590851|FG005|Overall Study|Withdrawal by Subject|0|||
25276919|NCT01040793|50590846|FG000|Overall Study|Other reasons not listed above|0|||
25276920|NCT01040793|50590847|FG001|Overall Study|Other reasons not listed above|0|||
25276921|NCT01040793|50590848|FG002|Overall Study|Other reasons not listed above|1|||
25276922|NCT01040793|50590849|FG003|Overall Study|Other reasons not listed above|0|||
25276923|NCT01040793|50590850|FG004|Overall Study|Other reasons not listed above|1|||
25276924|NCT01040793|50590851|FG005|Overall Study|Other reasons not listed above|0|||
25276925|NCT00948064|50590864|FG000|Phase I|No treatment received|1|||
25276926|NCT00948064|50590865|FG001|Phase I|No treatment received|0|||
25276927|NCT00948064|50590866|FG002|Phase I|No treatment received|0|||
25187300|NCT00637195|50338204|FG000|Overall Study|Other|2|||
25187301|NCT00637195|50338205|FG001|Overall Study|Other|0|||
25187302|NCT00637195|50338204|FG000|Overall Study|Withdrawal by Subject|0|||
25187303|NCT00637195|50338205|FG001|Overall Study|Withdrawal by Subject|1|||
25187304|NCT00636961|50338223|FG000|Period 1|Administrative problems|1|||
25187305|NCT00636961|50338224|FG001|Period 1|Administrative problems|1|||
25187306|NCT00636961|50338223|FG000|Period 2|Adverse Event|1|||
25187307|NCT00636961|50338224|FG001|Period 2|Adverse Event|0|||
25187308|NCT00635089|50338239|FG000|Overall Study|Adverse Event|7|||
25187309|NCT00635089|50338239|FG000|Overall Study|Lack of Efficacy|28|||
25187310|NCT00635089|50338239|FG000|Overall Study|Protocol Deviation|4|||
25187311|NCT00635089|50338239|FG000|Overall Study|Lost to Follow-up|8|||
25187312|NCT00635089|50338239|FG000|Overall Study|Other|31|||
25187313|NCT01493414|50338256|FG000|Overall Study|Adverse Event|405|||
25187314|NCT01493414|50338256|FG000|Overall Study|Disease progression|204|||
25187315|NCT01493414|50338256|FG000|Overall Study|Death|101|||
25187316|NCT01493414|50338256|FG000|Overall Study|Physician Decision|93|||
25187317|NCT01493414|50338256|FG000|Overall Study|Withdrawal by Subject|79|||
25187318|NCT01493414|50338256|FG000|Overall Study|Protocol deviation|27|||
25187319|NCT01493414|50338256|FG000|Overall Study|Administrative problems|25|||
25187320|NCT01493414|50338256|FG000|Overall Study|Lost to Follow-up|16|||
25187321|NCT00634543|50338266|FG000|Overall Study|Other|1|||
25187322|NCT00634543|50338267|FG001|Overall Study|Other|2|||
25276928|NCT00948064|50590864|FG000|Phase II|Physician Decision|0|||
25276929|NCT00948064|50590865|FG001|Phase II|Physician Decision|0|||
25187323|NCT00634543|50338266|FG000|Overall Study|Protocol Violation|3|||
25187324|NCT00634543|50338267|FG001|Overall Study|Protocol Violation|3|||
25276930|NCT00948064|50590866|FG002|Phase II|Physician Decision|1|||
25187325|NCT00634543|50338266|FG000|Overall Study|Adverse Event|11|||
25187326|NCT00634543|50338267|FG001|Overall Study|Adverse Event|11|||
25187327|NCT00634543|50338266|FG000|Overall Study|Withdrawal by Subject|4|||
25067185|NCT02634788|50172754|FG001|Overall Study|Withdrawal by Subject|1|||
25067186|NCT02634788|50172755|FG002|Overall Study|Withdrawal by Subject|1|||
25067187|NCT02634788|50172756|FG003|Overall Study|Withdrawal by Subject|0|||
25276931|NCT00948064|50590864|FG000|Phase II|Withdrawal by Subject|0|||
24964517|NCT00440999|50054344|FG001|Overall Study|Lost to Follow-up|12|||
24964518|NCT00440999|50054343|FG000|Overall Study|Protocol Violation|1|||
24964519|NCT00440999|50054344|FG001|Overall Study|Protocol Violation|0|||
25276932|NCT00948064|50590865|FG001|Phase II|Withdrawal by Subject|1|||
25276933|NCT00948064|50590866|FG002|Phase II|Withdrawal by Subject|0|||
25276934|NCT00953524|50590880|FG000|Overall Study|Adverse Event|2|||
25276935|NCT00953524|50590881|FG001|Overall Study|Adverse Event|0|||
25276936|NCT00953524|50590882|FG002|Overall Study|Adverse Event|1|||
24964520|NCT00440999|50054343|FG000|Overall Study|Withdrawal by Subject|2|||
25187328|NCT00634543|50338267|FG001|Overall Study|Withdrawal by Subject|4|||
25187329|NCT00634543|50338266|FG000|Overall Study|Lost to Follow-up|0|||
25187330|NCT00634543|50338267|FG001|Overall Study|Lost to Follow-up|1|||
25187331|NCT00985465|50338275|FG000|Overall Study|Withdrawal by Subject|1|||
25187332|NCT00985465|50338276|FG001|Overall Study|Withdrawal by Subject|2|||
25187333|NCT00985465|50338275|FG000|Overall Study|Considered to be part of the other group|0|||
25187334|NCT00985465|50338276|FG001|Overall Study|Considered to be part of the other group|1|||
25187335|NCT01049919|50338285|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
25187336|NCT01049919|50338286|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
25187337|NCT01049919|50338285|FG000|Overall Study|Withdrawal by Subject|5|||
25187338|NCT01049919|50338286|FG001|Overall Study|Withdrawal by Subject|0|||
25187339|NCT01049919|50338285|FG000|Overall Study|Lost to Follow-up|6|||
25187340|NCT01049919|50338286|FG001|Overall Study|Lost to Follow-up|1|||
25187341|NCT01049919|50338285|FG000|Overall Study|Physician Decision|2|||
25187342|NCT01049919|50338286|FG001|Overall Study|Physician Decision|0|||
25187343|NCT01049919|50338285|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
25187344|NCT01049919|50338286|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
25187345|NCT01049919|50338285|FG000|Overall Study|Early study termination by sponsor.|2|||
25187346|NCT01049919|50338286|FG001|Overall Study|Early study termination by sponsor.|0|||
25187347|NCT01049373|50338294|FG000|Overall Study|Protocol Violation|9|||
25187348|NCT01049373|50338295|FG001|Overall Study|Protocol Violation|9|||
25187349|NCT01049373|50338294|FG000|Overall Study|Withdrawal by Subject|8|||
25187350|NCT01049373|50338295|FG001|Overall Study|Withdrawal by Subject|5|||
25187351|NCT01049373|50338294|FG000|Overall Study|Adverse Event|3|||
25187352|NCT01049373|50338295|FG001|Overall Study|Adverse Event|3|||
25187353|NCT01049373|50338294|FG000|Overall Study|Lost to Follow-up|9|||
25187354|NCT01049373|50338295|FG001|Overall Study|Lost to Follow-up|4|||
25187355|NCT01049373|50338294|FG000|Overall Study|no evaluable study values|9|||
25187356|NCT01049373|50338295|FG001|Overall Study|no evaluable study values|21|||
25187357|NCT01049373|50338294|FG000|Overall Study|Other|1|||
25187358|NCT01049373|50338295|FG001|Overall Study|Other|1|||
25187359|NCT01049373|50338294|FG000|Overall Study|Non-cooperation|0|||
25187360|NCT01049373|50338295|FG001|Overall Study|Non-cooperation|1|||
25187361|NCT00985231|50338305|FG000|Overall Study|ineligible|1|||
25187362|NCT00985231|50338306|FG001|Overall Study|ineligible|0|||
25187363|NCT00985231|50338305|FG000|Overall Study|Protocol Violation|1|||
25187364|NCT00985231|50338306|FG001|Overall Study|Protocol Violation|0|||
25187365|NCT00985231|50338305|FG000|Overall Study|Withdrawal by Subject|1|||
25187366|NCT00985231|50338306|FG001|Overall Study|Withdrawal by Subject|0|||
25187367|NCT00985231|50338305|FG000|Overall Study|Lost to Follow-up|0|||
25187368|NCT00985231|50338306|FG001|Overall Study|Lost to Follow-up|1|||
25187369|NCT00985231|50338305|FG000|Overall Study|Study related symptoms & complaints|0|||
25187370|NCT00985231|50338306|FG001|Overall Study|Study related symptoms & complaints|2|||
25187371|NCT01048671|50338326|FG000|Overall Study|Protocol Violation|0|||
25187372|NCT01048671|50338327|FG001|Overall Study|Protocol Violation|1|||
25187373|NCT01048671|50338328|FG002|Overall Study|Protocol Violation|1|||
25187374|NCT01360866|50338340|FG000|Overall Study|Lost to Follow-up|11|||
25187375|NCT01360866|50338341|FG001|Overall Study|Lost to Follow-up|28|||
25187376|NCT01360866|50338342|FG002|Overall Study|Lost to Follow-up|41|||
25187377|NCT01360866|50338343|FG003|Overall Study|Lost to Follow-up|0|||
25187378|NCT01360866|50338340|FG000|Overall Study|Adverse Event|56|||
25187379|NCT01360866|50338341|FG001|Overall Study|Adverse Event|61|||
25187380|NCT01360866|50338342|FG002|Overall Study|Adverse Event|134|||
25187381|NCT01360866|50338343|FG003|Overall Study|Adverse Event|6|||
25187382|NCT01360866|50338340|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
25187383|NCT01360866|50338341|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
25187384|NCT01360866|50338342|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
25187385|NCT01360866|50338343|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
25187386|NCT01360866|50338340|FG000|Overall Study|Withdrawn by Investigator|9|||
25187387|NCT01360866|50338341|FG001|Overall Study|Withdrawn by Investigator|8|||
25187388|NCT01360866|50338342|FG002|Overall Study|Withdrawn by Investigator|31|||
25187389|NCT01360866|50338343|FG003|Overall Study|Withdrawn by Investigator|2|||
25187390|NCT01360866|50338340|FG000|Overall Study|Withdrawal by participant|79|||
25187391|NCT01360866|50338341|FG001|Overall Study|Withdrawal by participant|89|||
25187392|NCT01360866|50338342|FG002|Overall Study|Withdrawal by participant|168|||
25187393|NCT01360866|50338343|FG003|Overall Study|Withdrawal by participant|8|||
25187394|NCT01360866|50338340|FG000|Overall Study|Protocol Deviation|25|||
25187395|NCT01360866|50338341|FG001|Overall Study|Protocol Deviation|33|||
25187396|NCT01360866|50338342|FG002|Overall Study|Protocol Deviation|61|||
25187397|NCT01360866|50338343|FG003|Overall Study|Protocol Deviation|2|||
25187398|NCT01360866|50338340|FG000|Overall Study|Lack of Efficacy|30|||
25187399|NCT01360866|50338341|FG001|Overall Study|Lack of Efficacy|40|||
25187400|NCT01360866|50338342|FG002|Overall Study|Lack of Efficacy|30|||
25187401|NCT01360866|50338343|FG003|Overall Study|Lack of Efficacy|4|||
25187402|NCT00985153|50338357|FG000|Overall Study|Lost to Follow-up|16|||
25187403|NCT00985153|50338358|FG001|Overall Study|Lost to Follow-up|19|||
25187404|NCT00985153|50338359|FG002|Overall Study|Lost to Follow-up|17|||
25187405|NCT00985153|50338360|FG003|Overall Study|Lost to Follow-up|20|||
25187406|NCT00985153|50338357|FG000|Overall Study|Protocol Violation|3|||
25187407|NCT00985153|50338358|FG001|Overall Study|Protocol Violation|2|||
25187408|NCT00985153|50338359|FG002|Overall Study|Protocol Violation|4|||
25187409|NCT00985153|50338360|FG003|Overall Study|Protocol Violation|3|||
25187410|NCT00985153|50338357|FG000|Overall Study|Withdrawal by Subject|6|||
25187411|NCT00985153|50338358|FG001|Overall Study|Withdrawal by Subject|11|||
25187412|NCT00985153|50338359|FG002|Overall Study|Withdrawal by Subject|11|||
25187413|NCT00985153|50338360|FG003|Overall Study|Withdrawal by Subject|10|||
25187414|NCT00985153|50338357|FG000|Overall Study|Missed One or More Bleeds|7|||
25187415|NCT00985153|50338358|FG001|Overall Study|Missed One or More Bleeds|7|||
25187416|NCT00985153|50338359|FG002|Overall Study|Missed One or More Bleeds|8|||
25187417|NCT00985153|50338360|FG003|Overall Study|Missed One or More Bleeds|10|||
25187418|NCT00985153|50338357|FG000|Overall Study|Incomplete Safety Follow-up|3|||
25187419|NCT00985153|50338358|FG001|Overall Study|Incomplete Safety Follow-up|5|||
25187420|NCT00985153|50338359|FG002|Overall Study|Incomplete Safety Follow-up|4|||
25187421|NCT00985153|50338360|FG003|Overall Study|Incomplete Safety Follow-up|4|||
25187422|NCT01047345|50338372|FG000|Base Study|Adverse Event|3|||
25187423|NCT01047345|50338373|FG001|Base Study|Adverse Event|0|||
25187424|NCT01047345|50338374|FG002|Base Study|Adverse Event|0|||
25187425|NCT01047345|50338372|FG000|Base Study|Lost to Follow-up|4|||
25187426|NCT01047345|50338373|FG001|Base Study|Lost to Follow-up|1|||
25187427|NCT01047345|50338374|FG002|Base Study|Lost to Follow-up|0|||
25187428|NCT01047345|50338372|FG000|Base Study|Protocol Violation|3|||
25067188|NCT02785939|50172768|FG000|Overall Study|Progression|25|||
25067189|NCT02785939|50172769|FG001|Overall Study|Progression|8|||
25067190|NCT02785939|50172768|FG000|Overall Study|Adverse Event|3|||
25067191|NCT02785939|50172769|FG001|Overall Study|Adverse Event|1|||
25067192|NCT02785939|50172768|FG000|Overall Study|Death|1|||
25187429|NCT01047345|50338373|FG001|Base Study|Protocol Violation|1|||
25187430|NCT01047345|50338374|FG002|Base Study|Protocol Violation|0|||
25187431|NCT01047345|50338372|FG000|Base Study|Withdrawal by Subject|12|||
25187432|NCT01047345|50338373|FG001|Base Study|Withdrawal by Subject|4|||
25187433|NCT01047345|50338374|FG002|Base Study|Withdrawal by Subject|0|||
25187434|NCT01047345|50338372|FG000|Extension|Withdrawal by Subject|0|||
25187435|NCT01047345|50338373|FG001|Extension|Withdrawal by Subject|0|||
25187436|NCT01047345|50338374|FG002|Extension|Withdrawal by Subject|1|||
25187437|NCT01047345|50338372|FG000|Extension|Lost to Follow-up|0|||
25187438|NCT01047345|50338373|FG001|Extension|Lost to Follow-up|0|||
25187439|NCT01047345|50338374|FG002|Extension|Lost to Follow-up|5|||
25187440|NCT01046877|50338382|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
25187441|NCT01046877|50338382|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
25187442|NCT00984061|50338386|FG000|Clarithromycin Alone|Protocol Violation|1|||
25187443|NCT01046643|50338395|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
25187444|NCT01046643|50338396|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
25187445|NCT01046643|50338397|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
25187446|NCT01046643|50338398|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
25187447|NCT00983905|50338408|FG000|Theophylline Alone|Adverse Event|1|||
25187448|NCT00983905|50338408|FG000|Colchicine Alone|Adverse Event|2|||
25187449|NCT01046565|50338415|FG000|Overall Study|Adverse Event|2|||
25187450|NCT01046565|50338415|FG000|Overall Study|Withdrawal by Subject|7|||
25187451|NCT00983827|50338424|FG000|Overall Study|Withdrawal by Subject|1|||
25187452|NCT00983749|50338430|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
25187453|NCT00983749|50338431|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
24964521|NCT00440999|50054344|FG001|Overall Study|Withdrawal by Subject|5|||
25067193|NCT02785939|50172769|FG001|Overall Study|Death|0|||
25067194|NCT02785939|50172768|FG000|Overall Study|Refusal|1|||
25067195|NCT02785939|50172769|FG001|Overall Study|Refusal|0|||
25067196|NCT02785939|50172768|FG000|Overall Study|Deteriorating health|1|||
25067197|NCT02785939|50172769|FG001|Overall Study|Deteriorating health|0|||
25067198|NCT02785939|50172768|FG000|Overall Study|Not protocol specified|0|||
25067199|NCT02785939|50172769|FG001|Overall Study|Not protocol specified|1|||
25067200|NCT02634320|50172783|FG000|Overall Study|Adverse Event|2|||
25067201|NCT02634320|50172783|FG000|Overall Study|Lost to Follow-up|3|||
25067202|NCT02634320|50172783|FG000|Overall Study|Moved out of area|2|||
25067203|NCT02634320|50172783|FG000|Overall Study|Out of window for study visits|1|||
25067204|NCT02634320|50172783|FG000|Overall Study|Protocol Violation|1|||
25187454|NCT01046253|50338439|FG000|Second Intervention|Adverse Event|0|||
25187455|NCT01046253|50338440|FG001|Second Intervention|Adverse Event|1|||
25187456|NCT01046253|50338439|FG000|Second Intervention|Protocol Violation|0|||
25187457|NCT01046253|50338440|FG001|Second Intervention|Protocol Violation|1|||
25187458|NCT00983515|50338446|FG000|Ritonavir Alone|liver panel out of range|6|||
25187459|NCT00983515|50338446|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
25187460|NCT00982735|50338453|FG000|Overall Study|Lost to Follow-up|6|||
25187461|NCT00982735|50338453|FG000|Overall Study|Patient ineligible for trial|224|||
25187462|NCT01361178|50338459|FG000|Overall Study|Death|13|||
25187463|NCT01361178|50338460|FG001|Overall Study|Death|0|||
25187464|NCT00981799|50338470|FG000|Overall Study|Adverse Event|1|||
25187465|NCT00981799|50338471|FG001|Overall Study|Adverse Event|1|||
25187466|NCT00981799|50338472|FG002|Overall Study|Adverse Event|0|||
25187467|NCT00981799|50338473|FG003|Overall Study|Adverse Event|0|||
25187468|NCT00981175|50338487|FG000|Primary Dose Vaccination|Adverse Event|1|||
25187469|NCT00981175|50338488|FG001|Primary Dose Vaccination|Adverse Event|0|||
25187470|NCT00981175|50338487|FG000|Primary Dose Vaccination|Protocol Violation|0|||
25187471|NCT00981175|50338488|FG001|Primary Dose Vaccination|Protocol Violation|1|||
25187472|NCT00981175|50338487|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
25187473|NCT00981175|50338488|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
25187474|NCT00981175|50338487|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
25187475|NCT00981175|50338488|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
25187476|NCT00981019|50338501|FG000|Overall Study|Did not respond|65|||
25187477|NCT00981019|50338501|FG000|Overall Study|Did not match target population|94|||
25187478|NCT00981019|50338501|FG000|Overall Study|Inadvertent exclusion|239|||
25187479|NCT00981019|50338501|FG000|Overall Study|Hit the survey after closure|79|||
25187480|NCT01045161|50338508|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
25187481|NCT01045161|50338509|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
25187482|NCT01045161|50338510|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
25187483|NCT01045161|50338508|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
25187484|NCT01045161|50338509|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
25187485|NCT01045161|50338510|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
25187486|NCT01045161|50338508|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
25187487|NCT01045161|50338509|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
25187488|NCT01045161|50338510|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
25187489|NCT01045161|50338508|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
25187490|NCT01045161|50338509|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
25187491|NCT01045161|50338510|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
25187492|NCT01045161|50338508|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
25187493|NCT01045161|50338509|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
25187494|NCT01045161|50338510|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
25187495|NCT01045161|50338508|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
25187496|NCT01045161|50338509|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
25187497|NCT01045161|50338510|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
25187498|NCT01045161|50338508|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
25187499|NCT01045161|50338509|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
25187500|NCT01045161|50338510|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
25187501|NCT01045161|50338508|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
25187502|NCT01045161|50338509|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
25187503|NCT01045161|50338510|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
25187504|NCT01045161|50338508|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
25187505|NCT01045161|50338509|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
25187506|NCT01045161|50338510|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
25187507|NCT01045161|50338508|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
25187508|NCT01045161|50338509|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
25187509|NCT01045161|50338510|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
25187510|NCT01045161|50338508|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
25187511|NCT01045161|50338509|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
25187512|NCT01045161|50338510|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
25187513|NCT01045161|50338508|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
25187514|NCT01045161|50338509|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
25187515|NCT01045161|50338510|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
25187516|NCT01045161|50338508|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
25187517|NCT01045161|50338509|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
25187518|NCT01045161|50338510|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
25187519|NCT01045161|50338508|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
25187520|NCT01045161|50338509|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
25187521|NCT01045161|50338510|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
25187522|NCT00633217|50338529|FG000|Overall Study|Adverse Event|5|||
25187523|NCT00633217|50338530|FG001|Overall Study|Adverse Event|9|||
25187524|NCT00633217|50338529|FG000|Overall Study|Lack of Efficacy|0|||
25187525|NCT00633217|50338530|FG001|Overall Study|Lack of Efficacy|2|||
25187526|NCT00633217|50338529|FG000|Overall Study|Protocol Violation|3|||
25187527|NCT00633217|50338530|FG001|Overall Study|Protocol Violation|7|||
25187528|NCT00633217|50338529|FG000|Overall Study|Lost to Follow-up|2|||
25187529|NCT00633217|50338530|FG001|Overall Study|Lost to Follow-up|2|||
25187530|NCT00633217|50338529|FG000|Overall Study|Investigator Discretion|2|||
25187531|NCT00633217|50338530|FG001|Overall Study|Investigator Discretion|0|||
25067205|NCT02634320|50172783|FG000|Overall Study|Withdrawal by Subject|5|||
25187532|NCT00633217|50338529|FG000|Overall Study|Withdrew Consent|3|||
25187533|NCT00633217|50338530|FG001|Overall Study|Withdrew Consent|3|||
25187534|NCT01673490|50338536|FG000|Overall Study|Lost to Follow-up|1|||
25187535|NCT01673490|50338536|FG000|Overall Study|Adverse Event|3|||
25187536|NCT01673490|50338536|FG000|Overall Study|Withdrawal by Subject|3|||
25187537|NCT00215657|50338548|FG000|Overall Study|Adverse Event|5|||
25187538|NCT00215657|50338549|FG001|Overall Study|Adverse Event|1|||
25187539|NCT00215657|50338550|FG002|Overall Study|Adverse Event|3|||
25187540|NCT00215657|50338551|FG003|Overall Study|Adverse Event|0|||
25187541|NCT00215657|50338552|FG004|Overall Study|Adverse Event|3|||
25187542|NCT00215657|50338553|FG005|Overall Study|Adverse Event|1|||
25187543|NCT00215657|50338554|FG006|Overall Study|Adverse Event|0|||
25187544|NCT00215657|50338555|FG007|Overall Study|Adverse Event|3|||
25187545|NCT00215657|50338548|FG000|Overall Study|Withdrawal by Subject|6|||
25187546|NCT00215657|50338549|FG001|Overall Study|Withdrawal by Subject|3|||
25187547|NCT00215657|50338550|FG002|Overall Study|Withdrawal by Subject|3|||
25187548|NCT00215657|50338551|FG003|Overall Study|Withdrawal by Subject|1|||
25187549|NCT00215657|50338552|FG004|Overall Study|Withdrawal by Subject|6|||
25187550|NCT00215657|50338553|FG005|Overall Study|Withdrawal by Subject|1|||
25187551|NCT00215657|50338554|FG006|Overall Study|Withdrawal by Subject|10|||
25187552|NCT00215657|50338555|FG007|Overall Study|Withdrawal by Subject|3|||
25187553|NCT00215657|50338548|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
25187554|NCT00215657|50338549|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
25187555|NCT00215657|50338550|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
25187556|NCT00215657|50338551|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
25187557|NCT00215657|50338552|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
25187558|NCT00215657|50338553|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
25187559|NCT00215657|50338554|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
25187560|NCT00215657|50338555|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
25187561|NCT00215657|50338548|FG000|Overall Study|Insufficient testosterone response|5|||
25067206|NCT02634320|50172783|FG000|Overall Study|Lack of Efficacy|2|||
25067207|NCT02435680|50172790|FG000|Overall Study|Physician Decision|3|||
25187562|NCT00215657|50338549|FG001|Overall Study|Insufficient testosterone response|4|||
25187563|NCT00215657|50338550|FG002|Overall Study|Insufficient testosterone response|1|||
25187564|NCT00215657|50338551|FG003|Overall Study|Insufficient testosterone response|12|||
25067208|NCT02435680|50172791|FG001|Overall Study|Physician Decision|0|||
25067209|NCT02435680|50172792|FG002|Overall Study|Physician Decision|0|||
25276937|NCT00953524|50590883|FG003|Overall Study|Adverse Event|2|||
25276938|NCT00953524|50590880|FG000|Overall Study|Protocol Violation|18|||
25276939|NCT00953524|50590881|FG001|Overall Study|Protocol Violation|10|||
25276940|NCT00953524|50590882|FG002|Overall Study|Protocol Violation|11|||
25276941|NCT00953524|50590883|FG003|Overall Study|Protocol Violation|6|||
25276942|NCT00953524|50590880|FG000|Overall Study|Lost to Follow-up|0|||
25276943|NCT00953524|50590881|FG001|Overall Study|Lost to Follow-up|1|||
25276944|NCT00953524|50590882|FG002|Overall Study|Lost to Follow-up|1|||
25276945|NCT00953524|50590883|FG003|Overall Study|Lost to Follow-up|0|||
25276946|NCT00953524|50590880|FG000|Overall Study|Withdrawal by Subject|2|||
25276947|NCT00953524|50590881|FG001|Overall Study|Withdrawal by Subject|4|||
25276948|NCT00953524|50590882|FG002|Overall Study|Withdrawal by Subject|1|||
25276949|NCT00953524|50590883|FG003|Overall Study|Withdrawal by Subject|0|||
25276950|NCT01040403|50590902|FG000|Overall Study|Adverse Event|10|||
25168367|NCT00634569|50296722|FG000|Overall Study|Withdrawal by Subject|0|||
25168368|NCT00634569|50296723|FG001|Overall Study|Withdrawal by Subject|4|||
25168369|NCT00634569|50296722|FG000|Overall Study|Physician Decision|0|||
25168370|NCT00634569|50296723|FG001|Overall Study|Physician Decision|1|||
25168371|NCT00634179|50296768|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
25168372|NCT03877926|50296843|FG000|Overall Study|Adverse Event|1|||
25168373|NCT03877926|50296844|FG001|Overall Study|Adverse Event|0|||
25168374|NCT03877926|50296845|FG002|Overall Study|Adverse Event|0|||
25168375|NCT03877926|50296846|FG003|Overall Study|Adverse Event|0|||
25168376|NCT03877926|50296843|FG000|Overall Study|Death|2|||
25168377|NCT03877926|50296844|FG001|Overall Study|Death|2|||
25168378|NCT03877926|50296845|FG002|Overall Study|Death|2|||
25168379|NCT03877926|50296846|FG003|Overall Study|Death|0|||
25187565|NCT00215657|50338552|FG004|Overall Study|Insufficient testosterone response|8|||
25276951|NCT01040403|50590902|FG000|Overall Study|Protocol Violation|2|||
24964522|NCT00440999|50054343|FG000|Overall Study|Subjets missed the visit|1|||
25067210|NCT02435680|50172790|FG000|Overall Study|subject / guardian decision|0|||
25168380|NCT03877926|50296843|FG000|Overall Study|Lost to Follow-up|41|||
25168381|NCT03877926|50296844|FG001|Overall Study|Lost to Follow-up|52|||
25168382|NCT03877926|50296845|FG002|Overall Study|Lost to Follow-up|45|||
25168383|NCT03877926|50296846|FG003|Overall Study|Lost to Follow-up|17|||
25168384|NCT03877926|50296843|FG000|Overall Study|Physician Decision|2|||
25168385|NCT03877926|50296844|FG001|Overall Study|Physician Decision|0|||
25168386|NCT03877926|50296845|FG002|Overall Study|Physician Decision|2|||
25168387|NCT03877926|50296846|FG003|Overall Study|Physician Decision|0|||
25187566|NCT00215657|50338553|FG005|Overall Study|Insufficient testosterone response|12|||
25187567|NCT00215657|50338554|FG006|Overall Study|Insufficient testosterone response|4|||
25187568|NCT00215657|50338555|FG007|Overall Study|Insufficient testosterone response|7|||
25187569|NCT00215657|50338548|FG000|Overall Study|Other|3|||
25067211|NCT02435680|50172791|FG001|Overall Study|subject / guardian decision|3|||
25067212|NCT02435680|50172792|FG002|Overall Study|subject / guardian decision|2|||
25067213|NCT02435680|50172790|FG000|Overall Study|Adverse Event|8|||
25067214|NCT02435680|50172791|FG001|Overall Study|Adverse Event|3|||
25067215|NCT02435680|50172792|FG002|Overall Study|Adverse Event|2|||
25067216|NCT02435680|50172790|FG000|Overall Study|progressive disease|10|||
25067217|NCT02435680|50172791|FG001|Overall Study|progressive disease|7|||
25067218|NCT02435680|50172792|FG002|Overall Study|progressive disease|11|||
25067219|NCT02435680|50172790|FG000|Overall Study|not treated|0|||
25067220|NCT02435680|50172791|FG001|Overall Study|not treated|0|||
25067221|NCT02435680|50172792|FG002|Overall Study|not treated|1|||
25168388|NCT03877926|50296843|FG000|Overall Study|Withdrawal by Subject|18|||
25168389|NCT03877926|50296844|FG001|Overall Study|Withdrawal by Subject|21|||
25168390|NCT03877926|50296845|FG002|Overall Study|Withdrawal by Subject|12|||
25168391|NCT03877926|50296846|FG003|Overall Study|Withdrawal by Subject|4|||
25187570|NCT00215657|50338549|FG001|Overall Study|Other|1|||
25187571|NCT00215657|50338550|FG002|Overall Study|Other|2|||
25187572|NCT00215657|50338551|FG003|Overall Study|Other|3|||
25187573|NCT00215657|50338552|FG004|Overall Study|Other|5|||
25187574|NCT00215657|50338553|FG005|Overall Study|Other|4|||
25168392|NCT03877926|50296843|FG000|Overall Study|Other - Various|4|||
25168393|NCT03877926|50296844|FG001|Overall Study|Other - Various|1|||
25168394|NCT03877926|50296845|FG002|Overall Study|Other - Various|1|||
25168395|NCT03877926|50296846|FG003|Overall Study|Other - Various|0|||
25168396|NCT03877926|50296843|FG000|Overall Study|Not Treated|3|||
25168397|NCT03877926|50296844|FG001|Overall Study|Not Treated|1|||
25168398|NCT03877926|50296845|FG002|Overall Study|Not Treated|1|||
25168399|NCT03877926|50296846|FG003|Overall Study|Not Treated|0|||
25168400|NCT02874144|50297069|FG000|Overall Study|Lost to Follow-up|3|||
25168401|NCT02874144|50297070|FG001|Overall Study|Lost to Follow-up|5|||
25168402|NCT02611830|50297100|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
25168403|NCT02611830|50297101|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
25187575|NCT00215657|50338554|FG006|Overall Study|Other|6|||
25187576|NCT00215657|50338555|FG007|Overall Study|Other|1|||
25187577|NCT00633061|50338575|FG000|Overall Study|Study closed|86|||
25187578|NCT00633061|50338576|FG001|Overall Study|Study closed|0|||
25187579|NCT00632827|50338584|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
25187580|NCT00632827|50338584|FG000|Overall Study|Death|2|||
25187581|NCT00632827|50338584|FG000|Overall Study|Adverse Event|5|||
25187582|NCT00632827|50338584|FG000|Overall Study|Lost to Follow-up|1|||
25187583|NCT00214019|50338589|FG000|Overall Study|Lost to Follow-up|11|||
25187584|NCT00214019|50338589|FG000|Overall Study|Withdrawal by Subject|2|||
25187585|NCT00214019|50338589|FG000|Overall Study|Screen Failed prior to randomization|17|||
25187586|NCT00210119|50338596|FG000|Overall Study|Protocol Violation|1|||
25187587|NCT00210119|50338596|FG000|Overall Study|Withdrawal by Subject|1|||
25187588|NCT01044459|50338602|FG000|Overall Study|Withdrawal by Subject|21|||
25187589|NCT01044459|50338603|FG001|Overall Study|Withdrawal by Subject|28|||
25187590|NCT01044459|50338602|FG000|Overall Study|Terminated by Sponsor|22|||
25187591|NCT01044459|50338603|FG001|Overall Study|Terminated by Sponsor|21|||
25187592|NCT01044459|50338602|FG000|Overall Study|Adverse Event|22|||
25187593|NCT01044459|50338603|FG001|Overall Study|Adverse Event|20|||
25187594|NCT01044459|50338602|FG000|Overall Study|Lack of Efficacy|23|||
25187595|NCT01044459|50338603|FG001|Overall Study|Lack of Efficacy|12|||
25187596|NCT01044459|50338602|FG000|Overall Study|Protocol Violation|11|||
25187597|NCT01044459|50338603|FG001|Overall Study|Protocol Violation|16|||
25187598|NCT01044459|50338602|FG000|Overall Study|Other Reason|7|||
25187599|NCT01044459|50338603|FG001|Overall Study|Other Reason|14|||
25187600|NCT01044459|50338602|FG000|Overall Study|COPD exacerbation|9|||
25187601|NCT01044459|50338603|FG001|Overall Study|COPD exacerbation|8|||
25187602|NCT01044459|50338602|FG000|Overall Study|Lost to Follow-up|18|||
25187603|NCT01044459|50338603|FG001|Overall Study|Lost to Follow-up|12|||
25187604|NCT00980005|50338611|FG000|Overall Study|Withdrawal by Subject|6|||
25187605|NCT00980005|50338612|FG001|Overall Study|Withdrawal by Subject|17|||
25067222|NCT03371732|50172806|FG000|Overall Study|Withdrawal by Subject|9|||
25168404|NCT02611830|50297102|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
25168405|NCT02611830|50297103|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
25168406|NCT02611830|50297100|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
25187606|NCT00980005|50338611|FG000|Overall Study|Lost to Follow-up|37|||
25187607|NCT00980005|50338612|FG001|Overall Study|Lost to Follow-up|43|||
25187608|NCT00980005|50338611|FG000|Overall Study|Other|4|||
25187609|NCT00980005|50338612|FG001|Overall Study|Other|3|||
25187610|NCT01044303|50338622|FG000|Overall Study|Lost to Follow-up|2|||
25187611|NCT00983437|50338629|FG000|Overall Study|Adverse Event|9|||
25187612|NCT00983437|50338629|FG000|Overall Study|Lack of Efficacy|1|||
25187613|NCT00983437|50338629|FG000|Overall Study|Withdrawal by Subject|8|||
25187614|NCT00983437|50338629|FG000|Overall Study|Noncompliance to Study Procedures|1|||
25187615|NCT00983437|50338629|FG000|Overall Study|Lost to Follow-up|2|||
25187616|NCT00983437|50338629|FG000|Overall Study|Other Reason|26|||
25187617|NCT01042977|50338635|FG000|Overall Study|Adverse Event|4|||
25187618|NCT01042977|50338636|FG001|Overall Study|Adverse Event|12|||
25187619|NCT01042977|50338635|FG000|Overall Study|Death|2|||
25187620|NCT01042977|50338636|FG001|Overall Study|Death|1|||
25187621|NCT01042977|50338635|FG000|Overall Study|Withdrawal by Subject|8|||
25187622|NCT01042977|50338636|FG001|Overall Study|Withdrawal by Subject|16|||
25187623|NCT01042977|50338635|FG000|Overall Study|Lost to Follow-up|0|||
25187624|NCT01042977|50338636|FG001|Overall Study|Lost to Follow-up|2|||
25168407|NCT02611830|50297101|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
25168408|NCT02611830|50297102|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
25168409|NCT02611830|50297103|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
25168410|NCT02611830|50297100|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
25168411|NCT02611830|50297101|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
25168412|NCT02611830|50297102|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
25168413|NCT02611830|50297103|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
25168414|NCT02611830|50297100|FG000|OL Induction Phase|Lack of Efficacy|9|||
25168415|NCT02611830|50297101|FG001|OL Induction Phase|Lack of Efficacy|0|||
25168416|NCT02611830|50297102|FG002|OL Induction Phase|Lack of Efficacy|0|||
25168417|NCT02611830|50297103|FG003|OL Induction Phase|Lack of Efficacy|0|||
25168418|NCT02611830|50297100|FG000|OL Induction Phase|Reason not specified|3|||
25168419|NCT02611830|50297101|FG001|OL Induction Phase|Reason not specified|0|||
25168420|NCT02611830|50297102|FG002|OL Induction Phase|Reason not specified|0|||
25168421|NCT02611830|50297103|FG003|OL Induction Phase|Reason not specified|0|||
25168422|NCT02611830|50297100|FG000|Maintenance Phase|Lack of Efficacy|0|||
25168423|NCT02611830|50297101|FG001|Maintenance Phase|Lack of Efficacy|29|||
25168424|NCT02611830|50297102|FG002|Maintenance Phase|Lack of Efficacy|18|||
25168425|NCT02611830|50297103|FG003|Maintenance Phase|Lack of Efficacy|6|||
25168426|NCT02611830|50297100|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
25168427|NCT02611830|50297101|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
25168428|NCT02611830|50297102|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
25168429|NCT02611830|50297103|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
25168430|NCT02611830|50297100|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
25168431|NCT02611830|50297101|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
25168432|NCT02611830|50297102|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
25168433|NCT02611830|50297103|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
25168434|NCT02611830|50297100|FG000|Maintenance Phase|Lost to Follow-up|0|||
25168435|NCT02611830|50297101|FG001|Maintenance Phase|Lost to Follow-up|0|||
25187625|NCT01042977|50338635|FG000|Overall Study|Poor/non-compliance|3|||
25187626|NCT01042977|50338636|FG001|Overall Study|Poor/non-compliance|4|||
25187627|NCT01042977|50338635|FG000|Overall Study|Subject no longer meets study criteria|15|||
25187628|NCT01042977|50338636|FG001|Overall Study|Subject no longer meets study criteria|13|||
25187629|NCT01042977|50338635|FG000|Overall Study|Incorrect enrollment|6|||
25187630|NCT01042977|50338636|FG001|Overall Study|Incorrect enrollment|4|||
25187631|NCT01042977|50338635|FG000|Overall Study|Safety|0|||
25187632|NCT01042977|50338636|FG001|Overall Study|Safety|2|||
25187633|NCT01042977|50338635|FG000|Overall Study|Administrative reason by sponsor|0|||
25187634|NCT01042977|50338636|FG001|Overall Study|Administrative reason by sponsor|1|||
25187635|NCT01042977|50338635|FG000|Overall Study|Various|3|||
25187636|NCT01042977|50338636|FG001|Overall Study|Various|0|||
25187637|NCT01041573|50338646|FG000|Overall Study|Withdrawal by Subject|2|||
25187638|NCT01041573|50338647|FG001|Overall Study|Withdrawal by Subject|5|||
25187639|NCT01041573|50338648|FG002|Overall Study|Withdrawal by Subject|2|||
25187640|NCT01041573|50338649|FG003|Overall Study|Withdrawal by Subject|0|||
25187641|NCT01041573|50338646|FG000|Overall Study|Death|1|||
25187642|NCT01041573|50338647|FG001|Overall Study|Death|0|||
25187643|NCT01041573|50338648|FG002|Overall Study|Death|0|||
25187644|NCT01041573|50338649|FG003|Overall Study|Death|0|||
25187645|NCT01041573|50338646|FG000|Overall Study|Lost to Follow-up|0|||
25187646|NCT01041573|50338647|FG001|Overall Study|Lost to Follow-up|1|||
25187647|NCT01041573|50338648|FG002|Overall Study|Lost to Follow-up|2|||
25187648|NCT01041573|50338649|FG003|Overall Study|Lost to Follow-up|1|||
25067223|NCT03371732|50172807|FG001|Overall Study|Withdrawal by Subject|3|||
25067224|NCT03371732|50172806|FG000|Overall Study|Refusal to continue|3|||
25168436|NCT02611830|50297102|FG002|Maintenance Phase|Lost to Follow-up|0|||
25187649|NCT01041573|50338646|FG000|Overall Study|Adverse Event|0|||
25187650|NCT01041573|50338647|FG001|Overall Study|Adverse Event|2|||
25187651|NCT01041573|50338648|FG002|Overall Study|Adverse Event|0|||
25187652|NCT01041573|50338649|FG003|Overall Study|Adverse Event|0|||
25187653|NCT01041573|50338646|FG000|Overall Study|relocation|1|||
25187654|NCT01041573|50338647|FG001|Overall Study|relocation|4|||
25187655|NCT01041573|50338648|FG002|Overall Study|relocation|3|||
25187656|NCT01041573|50338649|FG003|Overall Study|relocation|1|||
25187657|NCT01041573|50338646|FG000|Overall Study|further blood extraction|0|||
25187658|NCT01041573|50338647|FG001|Overall Study|further blood extraction|1|||
25187659|NCT01041573|50338648|FG002|Overall Study|further blood extraction|0|||
25187660|NCT01041573|50338649|FG003|Overall Study|further blood extraction|0|||
25187661|NCT01041573|50338646|FG000|Overall Study|positive to anti-HCV|1|||
25187662|NCT01041573|50338647|FG001|Overall Study|positive to anti-HCV|0|||
25187663|NCT01041573|50338648|FG002|Overall Study|positive to anti-HCV|0|||
25187664|NCT01041573|50338649|FG003|Overall Study|positive to anti-HCV|0|||
25187665|NCT01041495|50338676|FG000|Overall Study|Withdrawal by Subject|2|||
25187666|NCT01041495|50338677|FG001|Overall Study|Withdrawal by Subject|5|||
25187667|NCT01041495|50338676|FG000|Overall Study|Adverse Event|2|||
25187668|NCT01041495|50338677|FG001|Overall Study|Adverse Event|1|||
25187669|NCT01041495|50338676|FG000|Overall Study|Lost to Follow-up|0|||
25187670|NCT01041495|50338677|FG001|Overall Study|Lost to Follow-up|1|||
25187671|NCT01041417|50338685|FG000|Overall Study|Adverse Event|5|||
25187672|NCT01041417|50338686|FG001|Overall Study|Adverse Event|2|||
25187673|NCT01041417|50338685|FG000|Overall Study|Lost to Follow-up|1|||
25187674|NCT01041417|50338686|FG001|Overall Study|Lost to Follow-up|1|||
25187675|NCT01041417|50338685|FG000|Overall Study|Death|1|||
25187676|NCT01041417|50338686|FG001|Overall Study|Death|0|||
25168437|NCT02611830|50297103|FG003|Maintenance Phase|Lost to Follow-up|1|||
25168438|NCT02611830|50297100|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
25168439|NCT02611830|50297101|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
25168440|NCT02611830|50297102|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
25168441|NCT02611830|50297103|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
25168442|NCT02611830|50297100|FG000|Maintenance Phase|Pregnancy|0|||
25168443|NCT02611830|50297101|FG001|Maintenance Phase|Pregnancy|0|||
25168444|NCT02611830|50297102|FG002|Maintenance Phase|Pregnancy|1|||
25168445|NCT02611830|50297103|FG003|Maintenance Phase|Pregnancy|0|||
25168446|NCT02611830|50297100|FG000|Maintenance Phase|Reason not specified|0|||
25168447|NCT02611830|50297101|FG001|Maintenance Phase|Reason not specified|1|||
25168448|NCT02611830|50297102|FG002|Maintenance Phase|Reason not specified|4|||
25168449|NCT02611830|50297103|FG003|Maintenance Phase|Reason not specified|0|||
25168450|NCT01328574|50297289|FG000|Overall Study|Refused further treatment|1|||
25168451|NCT01328496|50297411|FG000|Overall Study|Significant Change in Health Status|1|||
25168452|NCT01328496|50297412|FG001|Overall Study|Significant Change in Health Status|0|||
25168453|NCT02734212|50297532|FG000|Overall Study|Lost to Follow-up|5|||
25168454|NCT02734212|50297533|FG001|Overall Study|Lost to Follow-up|10|||
25168455|NCT04604184|50297610|FG000|Overall Study|Adverse Event|5|||
25168456|NCT04604184|50297611|FG001|Overall Study|Adverse Event|5|||
25168457|NCT04604184|50297610|FG000|Overall Study|Death|2|||
25187677|NCT01040871|50338696|FG000|Overall Study|Adverse Event|6|||
25187678|NCT01040871|50338697|FG001|Overall Study|Adverse Event|2|||
25187679|NCT01040871|50338696|FG000|Overall Study|Withdrawal by Subject|2|||
25187680|NCT01040871|50338697|FG001|Overall Study|Withdrawal by Subject|0|||
25187681|NCT01040871|50338696|FG000|Overall Study|Death|1|||
25187682|NCT01040871|50338697|FG001|Overall Study|Death|3|||
25187683|NCT01040871|50338696|FG000|Overall Study|Lack of Efficacy|1|||
25187684|NCT01040871|50338697|FG001|Overall Study|Lack of Efficacy|1|||
25187685|NCT01040871|50338696|FG000|Overall Study|drug supply issue|1|||
25187686|NCT01040871|50338697|FG001|Overall Study|drug supply issue|0|||
25187687|NCT01040871|50338696|FG000|Overall Study|Randomized and Not Treated|2|||
25187688|NCT01040871|50338697|FG001|Overall Study|Randomized and Not Treated|1|||
25187689|NCT01040169|50338705|FG000|Overall Study|Lost to Follow-up|3|||
25187690|NCT01040169|50338706|FG001|Overall Study|Lost to Follow-up|8|||
25187691|NCT01673178|50338726|FG000|Overall Study|Lost to Follow-up|0|||
25187692|NCT01673178|50338727|FG001|Overall Study|Lost to Follow-up|1|||
25187693|NCT01673178|50338728|FG002|Overall Study|Lost to Follow-up|0|||
25187694|NCT01673178|50338729|FG003|Overall Study|Lost to Follow-up|0|||
25187695|NCT01673178|50338730|FG004|Overall Study|Lost to Follow-up|0|||
25187696|NCT01673178|50338726|FG000|Overall Study|Withdrawal by Subject|0|||
25187697|NCT01673178|50338727|FG001|Overall Study|Withdrawal by Subject|0|||
25187698|NCT01673178|50338728|FG002|Overall Study|Withdrawal by Subject|1|||
25187699|NCT01673178|50338729|FG003|Overall Study|Withdrawal by Subject|4|||
25168458|NCT04604184|50297611|FG001|Overall Study|Death|1|||
25187700|NCT01673178|50338730|FG004|Overall Study|Withdrawal by Subject|2|||
25168459|NCT04604184|50297610|FG000|Overall Study|Withdrawal by Subject|1|||
25168460|NCT04604184|50297611|FG001|Overall Study|Withdrawal by Subject|3|||
25187701|NCT01673178|50338726|FG000|Overall Study|Protocol Violation|1|||
25187702|NCT01673178|50338727|FG001|Overall Study|Protocol Violation|1|||
25187703|NCT01673178|50338728|FG002|Overall Study|Protocol Violation|0|||
25187704|NCT01673178|50338729|FG003|Overall Study|Protocol Violation|1|||
25187705|NCT01673178|50338730|FG004|Overall Study|Protocol Violation|0|||
25187706|NCT01673178|50338726|FG000|Overall Study|Adverse Event|1|||
25187707|NCT01673178|50338727|FG001|Overall Study|Adverse Event|0|||
25187708|NCT01673178|50338728|FG002|Overall Study|Adverse Event|0|||
25187709|NCT01673178|50338729|FG003|Overall Study|Adverse Event|2|||
25187710|NCT01673178|50338730|FG004|Overall Study|Adverse Event|0|||
25187711|NCT01673178|50338726|FG000|Overall Study|Other|1|||
25187712|NCT01673178|50338727|FG001|Overall Study|Other|0|||
25187713|NCT01673178|50338728|FG002|Overall Study|Other|2|||
25187714|NCT01673178|50338729|FG003|Overall Study|Other|1|||
25187715|NCT01673178|50338730|FG004|Overall Study|Other|0|||
25187716|NCT03593213|50338759|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
25187717|NCT03593213|50338760|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
25187718|NCT03593213|50338761|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
25187719|NCT03593213|50338762|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
25187720|NCT03593213|50338759|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
25187721|NCT03593213|50338760|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
25187722|NCT03593213|50338761|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
25187723|NCT03593213|50338762|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
25187724|NCT03593213|50338759|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
25187725|NCT03593213|50338760|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
25187726|NCT03593213|50338761|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
25187727|NCT03593213|50338762|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
24964523|NCT00440999|50054344|FG001|Overall Study|Subjets missed the visit|0|||
24964524|NCT00440999|50054343|FG000|Overall Study|Mixed infection at entry|1|||
24964525|NCT00440999|50054344|FG001|Overall Study|Mixed infection at entry|0|||
24964526|NCT00440999|50054343|FG000|Overall Study|P. falciparum malaria|5|||
24964527|NCT00440999|50054344|FG001|Overall Study|P. falciparum malaria|14|||
24964528|NCT00440999|50054343|FG000|Overall Study|Subj left hosp without inform staff|0|||
24964529|NCT00440999|50054344|FG001|Overall Study|Subj left hosp without inform staff|1|||
24964530|NCT00434213|50054352|FG000|Overall Study|Adverse Event|12|||
24964531|NCT00434213|50054352|FG000|Overall Study|Lack of Efficacy|9|||
24964532|NCT00434213|50054352|FG000|Overall Study|Lost to Follow-up|14|||
24964533|NCT00434213|50054352|FG000|Overall Study|Withdrawal by Subject|7|||
24964534|NCT00434213|50054352|FG000|Overall Study|Protocol Violation|3|||
24964535|NCT00434213|50054352|FG000|Overall Study|Unable to comply with study visit window|2|||
24964536|NCT00434213|50054352|FG000|Overall Study|Application site reaction|1|||
24964537|NCT00434213|50054352|FG000|Overall Study|Non-compliant to study schedule|1|||
25168461|NCT04604184|50297610|FG000|Overall Study|Not treated|2|||
25168462|NCT04604184|50297611|FG001|Overall Study|Not treated|2|||
25168463|NCT04604184|50297610|FG000|Overall Study|Due to sponsor decision|9|||
25168464|NCT04604184|50297611|FG001|Overall Study|Due to sponsor decision|7|||
25168465|NCT04604184|50297610|FG000|Overall Study|Physician Decision|0|||
25168466|NCT04604184|50297611|FG001|Overall Study|Physician Decision|1|||
25168467|NCT04604184|50297610|FG000|Overall Study|Transfer to healthcare|1|||
25168468|NCT04604184|50297611|FG001|Overall Study|Transfer to healthcare|0|||
25168469|NCT01859741|50297782|FG000|Overall Study|Death|3|||
25168470|NCT01859741|50297783|FG001|Overall Study|Death|2|||
25168471|NCT01859741|50297784|FG002|Overall Study|Death|4|||
25168472|NCT01859741|50297785|FG003|Overall Study|Death|3|||
25168473|NCT01859741|50297786|FG004|Overall Study|Death|5|||
25168474|NCT01859741|50297787|FG005|Overall Study|Death|4|||
25168475|NCT01859741|50297788|FG006|Overall Study|Death|51|||
25168476|NCT01859741|50297789|FG007|Overall Study|Death|51|||
25168477|NCT01859741|50297782|FG000|Overall Study|Lost to Follow-up|0|||
25168478|NCT01859741|50297783|FG001|Overall Study|Lost to Follow-up|0|||
25168479|NCT01859741|50297784|FG002|Overall Study|Lost to Follow-up|0|||
24964538|NCT00006184|50054358|FG000|Overall Study|Death|1|||
25168480|NCT01859741|50297785|FG003|Overall Study|Lost to Follow-up|0|||
25168481|NCT01859741|50297786|FG004|Overall Study|Lost to Follow-up|0|||
25187728|NCT03593213|50338759|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
25187729|NCT03593213|50338760|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
25187730|NCT03593213|50338761|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
25187731|NCT03593213|50338762|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
25187732|NCT03593213|50338759|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
25187733|NCT03593213|50338760|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
25187734|NCT03593213|50338761|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
25187735|NCT03593213|50338762|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
25187736|NCT03593213|50338759|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
25187737|NCT03593213|50338760|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
25187738|NCT03593213|50338761|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
25187739|NCT03593213|50338762|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
25187740|NCT03593213|50338759|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
25187741|NCT03593213|50338760|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
25187742|NCT03593213|50338761|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
25187743|NCT03593213|50338762|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
25187744|NCT03593213|50338759|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
25187745|NCT03593213|50338760|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
25187746|NCT03593213|50338761|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
25187747|NCT03593213|50338762|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
25187748|NCT03593213|50338759|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
25187749|NCT03593213|50338760|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
25187750|NCT03593213|50338761|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
25187751|NCT03593213|50338762|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
25187752|NCT03593213|50338759|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
25187753|NCT03593213|50338760|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
25187754|NCT03593213|50338761|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
25187755|NCT03593213|50338762|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
25187756|NCT03593213|50338759|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
25187757|NCT03593213|50338760|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
25187758|NCT03593213|50338761|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
25187759|NCT03593213|50338762|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
25187760|NCT03593213|50338759|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
25187761|NCT03593213|50338760|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
25187762|NCT03593213|50338761|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
25187763|NCT03593213|50338762|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
25187764|NCT03593213|50338759|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
25187765|NCT03593213|50338760|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
25187766|NCT03593213|50338761|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
25187767|NCT03593213|50338762|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
25168482|NCT01859741|50297787|FG005|Overall Study|Lost to Follow-up|1|||
25168483|NCT01859741|50297788|FG006|Overall Study|Lost to Follow-up|0|||
25168484|NCT01859741|50297789|FG007|Overall Study|Lost to Follow-up|4|||
25067225|NCT03371732|50172807|FG001|Overall Study|Refusal to continue|4|||
25067226|NCT02745119|50172819|FG000|Overall Study|Adverse Event|1|||
25067227|NCT02745119|50172820|FG001|Overall Study|Adverse Event|0|||
25067228|NCT02745119|50172821|FG002|Overall Study|Adverse Event|1|||
25067229|NCT02745119|50172822|FG003|Overall Study|Adverse Event|3|||
25067230|NCT02745119|50172819|FG000|Overall Study|Death|3|||
25067231|NCT02745119|50172820|FG001|Overall Study|Death|3|||
25187768|NCT03593213|50338759|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
25187769|NCT03593213|50338760|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
25187770|NCT03593213|50338761|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
25067232|NCT02745119|50172821|FG002|Overall Study|Death|0|||
25168485|NCT01859741|50297782|FG000|Overall Study|Withdrawal by Subject|0|||
25168486|NCT01859741|50297783|FG001|Overall Study|Withdrawal by Subject|1|||
25168487|NCT01859741|50297784|FG002|Overall Study|Withdrawal by Subject|2|||
25168488|NCT01859741|50297785|FG003|Overall Study|Withdrawal by Subject|0|||
25168489|NCT01859741|50297786|FG004|Overall Study|Withdrawal by Subject|0|||
25168490|NCT01859741|50297787|FG005|Overall Study|Withdrawal by Subject|1|||
25168491|NCT01859741|50297788|FG006|Overall Study|Withdrawal by Subject|1|||
25168492|NCT01859741|50297789|FG007|Overall Study|Withdrawal by Subject|1|||
25067233|NCT02745119|50172822|FG003|Overall Study|Death|4|||
25168493|NCT01859741|50297782|FG000|Overall Study|Study Terminated by Sponsor|0|||
25168494|NCT01859741|50297783|FG001|Overall Study|Study Terminated by Sponsor|0|||
25067234|NCT02745119|50172819|FG000|Overall Study|Lost to Follow-up|0|||
25168495|NCT01859741|50297784|FG002|Overall Study|Study Terminated by Sponsor|0|||
25168496|NCT01859741|50297785|FG003|Overall Study|Study Terminated by Sponsor|0|||
25168497|NCT01859741|50297786|FG004|Overall Study|Study Terminated by Sponsor|1|||
25168498|NCT01859741|50297787|FG005|Overall Study|Study Terminated by Sponsor|0|||
25168499|NCT01859741|50297788|FG006|Overall Study|Study Terminated by Sponsor|16|||
25168500|NCT01859741|50297789|FG007|Overall Study|Study Terminated by Sponsor|14|||
25168501|NCT01859741|50297782|FG000|Overall Study|Other|0|||
25168502|NCT01859741|50297783|FG001|Overall Study|Other|0|||
25168503|NCT01859741|50297784|FG002|Overall Study|Other|0|||
25168504|NCT01859741|50297785|FG003|Overall Study|Other|0|||
25168505|NCT01859741|50297786|FG004|Overall Study|Other|0|||
25168506|NCT01859741|50297787|FG005|Overall Study|Other|0|||
25168507|NCT01859741|50297788|FG006|Overall Study|Other|2|||
25168508|NCT01859741|50297789|FG007|Overall Study|Other|0|||
25168509|NCT01859507|50297835|FG000|Overall Study|left the country|4|||
25168510|NCT01876043|50297840|FG000|Overall Study|Death|1|||
25168511|NCT01876043|50297840|FG000|Overall Study|Withdrawal by Subject|1|||
25168512|NCT01875731|50297846|FG000|Overall Study|Fail to obtain lab sample|1|||
25168513|NCT01875731|50297847|FG001|Overall Study|Fail to obtain lab sample|0|||
25168514|NCT01873859|50297855|FG000|Overall Study|Withdrawal by Subject|0|||
25187771|NCT03593213|50338762|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
25187772|NCT03593213|50338759|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
25187773|NCT03593213|50338760|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
25187774|NCT03593213|50338761|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
25187775|NCT03593213|50338762|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
25187776|NCT03593213|50338759|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
25187777|NCT03593213|50338760|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
24964539|NCT00006184|50054359|FG001|Overall Study|Death|0|||
24964540|NCT00434057|50054365|FG000|Overall Study|Withdrawal by Subject|1|||
25067235|NCT02745119|50172820|FG001|Overall Study|Lost to Follow-up|0|||
25168515|NCT01873859|50297856|FG001|Overall Study|Withdrawal by Subject|4|||
25168516|NCT01857869|50297873|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
25168517|NCT01857869|50297874|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
25168518|NCT01857869|50297875|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
25168519|NCT01857869|50297876|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
25168520|NCT01857869|50297877|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
25168521|NCT01857869|50297878|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
25168522|NCT01857869|50297879|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
25168523|NCT01857869|50297880|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
25168524|NCT01857869|50297881|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
25168525|NCT01857869|50297882|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
25168526|NCT01857869|50297873|FG000|Primary/Challenge Phase|Pregnancy|1|||
25168527|NCT01857869|50297874|FG001|Primary/Challenge Phase|Pregnancy|0|||
25168528|NCT01857869|50297875|FG002|Primary/Challenge Phase|Pregnancy|0|||
25168529|NCT01857869|50297876|FG003|Primary/Challenge Phase|Pregnancy|0|||
25168530|NCT01857869|50297877|FG004|Primary/Challenge Phase|Pregnancy|0|||
25168531|NCT01857869|50297878|FG005|Primary/Challenge Phase|Pregnancy|0|||
25168532|NCT01857869|50297879|FG006|Primary/Challenge Phase|Pregnancy|0|||
25168533|NCT01857869|50297880|FG007|Primary/Challenge Phase|Pregnancy|0|||
25168534|NCT01857869|50297881|FG008|Primary/Challenge Phase|Pregnancy|0|||
25168535|NCT01857869|50297882|FG009|Primary/Challenge Phase|Pregnancy|0|||
25067236|NCT02745119|50172821|FG002|Overall Study|Lost to Follow-up|0|||
25067237|NCT02745119|50172822|FG003|Overall Study|Lost to Follow-up|1|||
25067238|NCT02745119|50172819|FG000|Overall Study|Protocol Deviation|0|||
25067239|NCT02745119|50172820|FG001|Overall Study|Protocol Deviation|0|||
25067240|NCT02745119|50172821|FG002|Overall Study|Protocol Deviation|0|||
25067241|NCT02745119|50172822|FG003|Overall Study|Protocol Deviation|1|||
25067242|NCT02745119|50172819|FG000|Overall Study|Withdrawal by Subject|7|||
25067243|NCT02745119|50172820|FG001|Overall Study|Withdrawal by Subject|15|||
25067244|NCT02745119|50172821|FG002|Overall Study|Withdrawal by Subject|8|||
25067245|NCT02745119|50172822|FG003|Overall Study|Withdrawal by Subject|14|||
25067246|NCT02745119|50172819|FG000|Overall Study|Study Terminated by Sponsor|134|||
25067247|NCT02745119|50172820|FG001|Overall Study|Study Terminated by Sponsor|252|||
25067248|NCT02745119|50172821|FG002|Overall Study|Study Terminated by Sponsor|135|||
25067249|NCT02745119|50172822|FG003|Overall Study|Study Terminated by Sponsor|251|||
25067250|NCT02745119|50172819|FG000|Overall Study|Physician Decision|0|||
25067251|NCT02745119|50172820|FG001|Overall Study|Physician Decision|2|||
25067252|NCT02745119|50172821|FG002|Overall Study|Physician Decision|2|||
25067253|NCT02745119|50172822|FG003|Overall Study|Physician Decision|2|||
25168536|NCT01857869|50297873|FG000|Primary/Challenge Phase|Protocol Violation|1|||
25168537|NCT01857869|50297874|FG001|Primary/Challenge Phase|Protocol Violation|0|||
25168538|NCT01857869|50297875|FG002|Primary/Challenge Phase|Protocol Violation|0|||
25168539|NCT01857869|50297876|FG003|Primary/Challenge Phase|Protocol Violation|0|||
25276952|NCT01040403|50590902|FG000|Overall Study|Lost to Follow-up|1|||
24964541|NCT00433199|50054371|FG000|Double-Blind Period|Adverse Event|0|||
25067254|NCT02745119|50172819|FG000|Overall Study|Reason Not Specified|0|||
25067255|NCT02745119|50172820|FG001|Overall Study|Reason Not Specified|2|||
25067484|NCT02396758|50173214|FG003|Overall Study|Randomized but not treated|0|||
25067485|NCT02632838|50173226|FG000|Overall Study|Withdrawal by Subject|3|||
25067486|NCT02632838|50173227|FG001|Overall Study|Withdrawal by Subject|0|||
25067487|NCT02632838|50173226|FG000|Overall Study|Lost to Follow-up|0|||
25067488|NCT02632838|50173227|FG001|Overall Study|Lost to Follow-up|2|||
25067489|NCT02396212|50173237|FG000|Overall Study|Adverse Event|1|||
25067490|NCT02396212|50173237|FG000|Overall Study|Lack of Efficacy|2|||
25067491|NCT02395822|50173241|FG000|Overall Study|Withdrawal by Subject|1|||
24964621|NCT00431951|50054449|FG000|Overall Study|Withdrawal by Subject|0|||
24964622|NCT00431951|50054450|FG001|Overall Study|Withdrawal by Subject|1|||
24964623|NCT00431951|50054451|FG002|Overall Study|Withdrawal by Subject|0|||
24964624|NCT00431951|50054452|FG003|Overall Study|Withdrawal by Subject|0|||
24964625|NCT00431951|50054449|FG000|Overall Study|Adverse Event|0|||
25067492|NCT02395822|50173241|FG000|Overall Study|Death|1|||
25067493|NCT01651936|50173247|FG000|Base Study|Adverse Event|3|||
25067494|NCT01651936|50173248|FG001|Base Study|Adverse Event|0|||
25067495|NCT01651936|50173249|FG002|Base Study|Adverse Event|0|||
24964626|NCT00431951|50054450|FG001|Overall Study|Adverse Event|0|||
24964627|NCT00431951|50054451|FG002|Overall Study|Adverse Event|1|||
24964628|NCT00431951|50054452|FG003|Overall Study|Adverse Event|0|||
24964629|NCT00004978|50054468|FG000|Overall Study|Death|107|||
24964630|NCT00004978|50054469|FG001|Overall Study|Death|116|||
24964631|NCT00004978|50054468|FG000|Overall Study|Lost to Follow-up|101|||
24964632|NCT00004978|50054469|FG001|Overall Study|Lost to Follow-up|108|||
24964633|NCT00004978|50054468|FG000|Overall Study|Withdrawal by Subject|17|||
24964634|NCT00004978|50054469|FG001|Overall Study|Withdrawal by Subject|26|||
24964635|NCT00004978|50054468|FG000|Overall Study|site closure - not in analysis cohort|19|||
24964636|NCT00004978|50054469|FG001|Overall Study|site closure - not in analysis cohort|20|||
24964637|NCT00430937|50054477|FG000|Overall Study|Adverse Event|3|||
24964638|NCT00430937|50054478|FG001|Overall Study|Adverse Event|8|||
24964639|NCT00430937|50054477|FG000|Overall Study|Death|0|||
24964640|NCT00430937|50054478|FG001|Overall Study|Death|1|||
24964641|NCT00430937|50054477|FG000|Overall Study|Lost to Follow-up|6|||
24964642|NCT00430937|50054478|FG001|Overall Study|Lost to Follow-up|6|||
24964643|NCT00430937|50054477|FG000|Overall Study|Withdrawal by Subject|5|||
24964644|NCT00430937|50054478|FG001|Overall Study|Withdrawal by Subject|2|||
24964645|NCT00430937|50054477|FG000|Overall Study|Protocol Violation|3|||
24964646|NCT00430937|50054478|FG001|Overall Study|Protocol Violation|2|||
24964647|NCT00430937|50054477|FG000|Overall Study|Lack of Efficacy|6|||
24964648|NCT00430937|50054478|FG001|Overall Study|Lack of Efficacy|5|||
24964649|NCT00430937|50054477|FG000|Overall Study|Inappropriate enrollment|2|||
24964650|NCT00430937|50054478|FG001|Overall Study|Inappropriate enrollment|1|||
24964651|NCT00430937|50054477|FG000|Overall Study|Administrative reasons|1|||
24964652|NCT00430937|50054478|FG001|Overall Study|Administrative reasons|0|||
24964653|NCT00430937|50054477|FG000|Overall Study|Protocol discontinuation criteria met|1|||
24964654|NCT00430937|50054478|FG001|Overall Study|Protocol discontinuation criteria met|2|||
24964655|NCT00430937|50054477|FG000|Overall Study|Unable to classify|0|||
25067496|NCT01651936|50173247|FG000|Base Study|Withdrawal by Subject|1|||
25067497|NCT01651936|50173248|FG001|Base Study|Withdrawal by Subject|1|||
25067498|NCT01651936|50173249|FG002|Base Study|Withdrawal by Subject|0|||
25067499|NCT01651936|50173247|FG000|Base Study|Early Escape|2|||
24964656|NCT00430937|50054478|FG001|Overall Study|Unable to classify|1|||
25067500|NCT01651936|50173248|FG001|Base Study|Early Escape|8|||
25067501|NCT01651936|50173249|FG002|Base Study|Early Escape|0|||
24964657|NCT00004888|50054486|FG000|Overall Study|Adverse Event|5|||
24964658|NCT00004888|50054487|FG001|Overall Study|Adverse Event|10|||
24964659|NCT00004888|50054486|FG000|Overall Study|Withdrawal by Subject|0|||
24964660|NCT00004888|50054487|FG001|Overall Study|Withdrawal by Subject|3|||
24964661|NCT00004888|50054486|FG000|Overall Study|Physician Decision|1|||
24964662|NCT00004888|50054487|FG001|Overall Study|Physician Decision|1|||
24964663|NCT00004888|50054486|FG000|Overall Study|Progressive Disease|4|||
24964664|NCT00004888|50054487|FG001|Overall Study|Progressive Disease|9|||
24964665|NCT00004888|50054486|FG000|Overall Study|Death without progressive disease|0|||
24964666|NCT00004888|50054487|FG001|Overall Study|Death without progressive disease|1|||
24964667|NCT00004888|50054486|FG000|Overall Study|Toxic death|1|||
24964668|NCT00004888|50054487|FG001|Overall Study|Toxic death|0|||
24964669|NCT00004732|50054495|FG000|Overall Study|Withdrawal by Subject|36|||
24964670|NCT00004732|50054496|FG001|Overall Study|Withdrawal by Subject|64|||
24964671|NCT00004732|50054495|FG000|Overall Study|Lost to Follow-up|33|||
24964672|NCT00004732|50054496|FG001|Overall Study|Lost to Follow-up|47|||
24964673|NCT00430781|50054507|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
24964674|NCT00430781|50054508|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
24964675|NCT00430781|50054509|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
24964676|NCT00430781|50054507|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
25067502|NCT01651936|50173247|FG000|Base Study|Study terminated by sponsor|21|||
24964677|NCT00430781|50054508|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
24964678|NCT00430781|50054509|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
24964679|NCT00430781|50054507|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
24964680|NCT00430781|50054508|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
24964681|NCT00430781|50054509|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
24964682|NCT00430781|50054507|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
24964683|NCT00430781|50054508|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
24964684|NCT00430781|50054509|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
25067503|NCT01651936|50173248|FG001|Base Study|Study terminated by sponsor|16|||
25067504|NCT01651936|50173249|FG002|Base Study|Study terminated by sponsor|0|||
25187780|NCT03593213|50338759|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
25187781|NCT03593213|50338760|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
25187782|NCT03593213|50338761|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
25187783|NCT03593213|50338762|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
25187784|NCT03593213|50338759|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
25187785|NCT03593213|50338760|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
24964685|NCT00430781|50054507|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
24964686|NCT00430781|50054508|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
24995108|NCT03015532|50085971|FG005|Overall Study|Adverse Event|2|||
24995109|NCT03015532|50085972|FG006|Overall Study|Adverse Event|1|||
24995110|NCT03015532|50085973|FG007|Overall Study|Adverse Event|0|||
24995111|NCT03015532|50085966|FG000|Overall Study|Withdrawal by Subject|0|||
24995112|NCT03015532|50085967|FG001|Overall Study|Withdrawal by Subject|0|||
24995113|NCT03015532|50085968|FG002|Overall Study|Withdrawal by Subject|0|||
24964687|NCT00430781|50054509|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
24964688|NCT00430781|50054507|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
24964689|NCT00430781|50054508|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
24964690|NCT00430781|50054509|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
24964691|NCT00430781|50054507|FG000|Interim Analysis; 11 February 2008|Death|0|||
24964692|NCT00430781|50054508|FG001|Interim Analysis; 11 February 2008|Death|1|||
24964693|NCT00430781|50054509|FG002|Interim Analysis; 11 February 2008|Death|0|||
24964694|NCT00430781|50054507|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
24964695|NCT00430781|50054508|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
24964696|NCT00430781|50054509|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
24964697|NCT00430781|50054507|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
24964698|NCT00430781|50054508|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
24964699|NCT00430781|50054509|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
24964700|NCT00430781|50054507|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
24964701|NCT00430781|50054508|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
24964702|NCT00430781|50054509|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
24964703|NCT00430781|50054507|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
24964704|NCT00430781|50054508|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
24964705|NCT00430781|50054509|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
24964706|NCT00430781|50054507|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
24964707|NCT00430781|50054508|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
24964708|NCT00430781|50054509|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
24964709|NCT00430781|50054507|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
24964710|NCT00430781|50054508|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
24964711|NCT00430781|50054509|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
24964712|NCT00430781|50054507|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
24964713|NCT00430781|50054508|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
24964714|NCT00430781|50054509|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
24964715|NCT00430781|50054507|FG000|Final Analysis; 31 July 2008|Other|0|||
24964716|NCT00430781|50054508|FG001|Final Analysis; 31 July 2008|Other|1|||
24964717|NCT00430781|50054509|FG002|Final Analysis; 31 July 2008|Other|0|||
24964718|NCT00430781|50054507|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
24964719|NCT00430781|50054508|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
24964720|NCT00430781|50054509|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
24964721|NCT00430781|50054507|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
24964722|NCT00430781|50054508|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
24964723|NCT00430781|50054509|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
24964724|NCT00430781|50054507|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
24964725|NCT00430781|50054508|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
24964726|NCT00430781|50054509|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
24964727|NCT00430781|50054507|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
24964728|NCT00430781|50054508|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
24964729|NCT00430781|50054509|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
24964730|NCT00430781|50054507|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
24964731|NCT00430781|50054508|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
24964732|NCT00430781|50054509|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
24964733|NCT00430781|50054507|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
24964734|NCT00430781|50054508|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
24964735|NCT00430781|50054509|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
24964736|NCT00430781|50054507|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
24964737|NCT00430781|50054508|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
24964738|NCT00430781|50054509|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
24964739|NCT00429299|50054523|FG000|Overall Study|Disease Progression|1|||
24964740|NCT00429299|50054524|FG001|Overall Study|Disease Progression|1|||
24964741|NCT00429299|50054525|FG002|Overall Study|Disease Progression|0|||
25187786|NCT03593213|50338761|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
24964742|NCT00429299|50054523|FG000|Overall Study|Adverse Event|2|||
24964743|NCT00429299|50054524|FG001|Overall Study|Adverse Event|5|||
24964744|NCT00429299|50054525|FG002|Overall Study|Adverse Event|1|||
24964745|NCT00429299|50054523|FG000|Overall Study|Protocol Violation|1|||
24964746|NCT00429299|50054524|FG001|Overall Study|Protocol Violation|0|||
24964747|NCT00429299|50054525|FG002|Overall Study|Protocol Violation|0|||
24964748|NCT00429299|50054523|FG000|Overall Study|Withdrawal by Subject|0|||
24964749|NCT00429299|50054524|FG001|Overall Study|Withdrawal by Subject|1|||
24964750|NCT00429299|50054525|FG002|Overall Study|Withdrawal by Subject|3|||
24964751|NCT00428597|50054535|FG000|Overall Study|Randomized but not treated|3|||
24964752|NCT00428597|50054536|FG001|Overall Study|Randomized but not treated|3|||
24964753|NCT00428597|50054535|FG000|Overall Study|Objective Progression or Relapse|19|||
24964754|NCT00428597|50054536|FG001|Overall Study|Objective Progression or Relapse|47|||
24964755|NCT00428597|50054535|FG000|Overall Study|Study Terminated by Sponsor|41|||
24964756|NCT00428597|50054536|FG001|Overall Study|Study Terminated by Sponsor|16|||
24964757|NCT00428597|50054535|FG000|Overall Study|Adverse Event|15|||
24964758|NCT00428597|50054536|FG001|Overall Study|Adverse Event|7|||
24964759|NCT00428597|50054535|FG000|Overall Study|Global Deterioration of Health Status|1|||
24964760|NCT00428597|50054536|FG001|Overall Study|Global Deterioration of Health Status|5|||
24964761|NCT00428597|50054535|FG000|Overall Study|Protocol Violation|2|||
24964762|NCT00428597|50054536|FG001|Overall Study|Protocol Violation|1|||
24964763|NCT00428597|50054535|FG000|Overall Study|Withdrawal by Subject|2|||
24964764|NCT00428597|50054536|FG001|Overall Study|Withdrawal by Subject|1|||
24964765|NCT00428597|50054535|FG000|Overall Study|Other|1|||
24964766|NCT00428597|50054536|FG001|Overall Study|Other|1|||
24964767|NCT00428597|50054535|FG000|Overall Study|Lost to Follow-up|0|||
24964768|NCT00428597|50054536|FG001|Overall Study|Lost to Follow-up|1|||
24964769|NCT00428597|50054535|FG000|Overall Study|Pregnancy|1|||
24964770|NCT00428597|50054536|FG001|Overall Study|Pregnancy|0|||
24964771|NCT00428597|50054535|FG000|Overall Study|Death|1|||
24964772|NCT00428597|50054536|FG001|Overall Study|Death|3|||
24964773|NCT00428441|50054542|FG000|Overall Study|Lost to Follow-up|1|||
24964774|NCT00144339|50054548|FG000|Overall Study|Adverse Event|746|||
24964775|NCT00144339|50054549|FG001|Overall Study|Adverse Event|627|||
24964776|NCT00144339|50054548|FG000|Overall Study|Protocol Violation|75|||
24964777|NCT00144339|50054549|FG001|Overall Study|Protocol Violation|48|||
24964778|NCT00144339|50054548|FG000|Overall Study|Withdrawal by Subject|403|||
24964779|NCT00144339|50054549|FG001|Overall Study|Withdrawal by Subject|300|||
24964780|NCT00144339|50054548|FG000|Overall Study|Lost to Follow-up|76|||
24964781|NCT00144339|50054549|FG001|Overall Study|Lost to Follow-up|64|||
24964782|NCT00144339|50054548|FG000|Overall Study|Other|58|||
24964783|NCT00144339|50054549|FG001|Overall Study|Other|60|||
24964784|NCT00144027|50054557|FG000|Overall Study|Lost to Follow-up|1|||
24964785|NCT00144027|50054558|FG001|Overall Study|Lost to Follow-up|3|||
24964786|NCT00144027|50054557|FG000|Overall Study|Withdrawal by Subject|2|||
24964787|NCT00144027|50054558|FG001|Overall Study|Withdrawal by Subject|2|||
24964788|NCT00144027|50054557|FG000|Overall Study|did not complete baseline assessment|0|||
24964789|NCT00144027|50054558|FG001|Overall Study|did not complete baseline assessment|6|||
24964790|NCT00127803|50054568|FG000|Overall Study|Adverse Event|2|||
24964791|NCT00127803|50054569|FG001|Overall Study|Adverse Event|0|||
24964792|NCT00127803|50054570|FG002|Overall Study|Adverse Event|0|||
24964793|NCT00127803|50054571|FG003|Overall Study|Adverse Event|0|||
24964794|NCT00127803|50054568|FG000|Overall Study|Withdrawal by Subject|1|||
24964795|NCT00127803|50054569|FG001|Overall Study|Withdrawal by Subject|0|||
24964796|NCT00127803|50054570|FG002|Overall Study|Withdrawal by Subject|0|||
24964797|NCT00127803|50054571|FG003|Overall Study|Withdrawal by Subject|0|||
24964798|NCT00127803|50054568|FG000|Overall Study|Lost to Follow-up|0|||
24964799|NCT00127803|50054569|FG001|Overall Study|Lost to Follow-up|0|||
24964800|NCT00127803|50054570|FG002|Overall Study|Lost to Follow-up|0|||
24964801|NCT00127803|50054571|FG003|Overall Study|Lost to Follow-up|1|||
24964802|NCT00127413|50054585|FG000|Overall Study|Lost to Follow-up|6|||
24964803|NCT00127413|50054586|FG001|Overall Study|Lost to Follow-up|4|||
24964804|NCT00127413|50054587|FG002|Overall Study|Lost to Follow-up|8|||
24964805|NCT00127413|50054588|FG003|Overall Study|Lost to Follow-up|2|||
24964806|NCT00143403|50054600|FG000|Overall Study|Adverse Event|3|||
24964807|NCT00143403|50054601|FG001|Overall Study|Adverse Event|8|||
24964808|NCT00143403|50054600|FG000|Overall Study|Death|1|||
24964809|NCT00143403|50054601|FG001|Overall Study|Death|0|||
24964810|NCT00143403|50054600|FG000|Overall Study|Withdrawal by Subject|3|||
24964811|NCT00143403|50054601|FG001|Overall Study|Withdrawal by Subject|12|||
24964812|NCT00143403|50054600|FG000|Overall Study|Relapse|15|||
24964813|NCT00143403|50054601|FG001|Overall Study|Relapse|7|||
24964814|NCT00143403|50054600|FG000|Overall Study|Protocol Violation|2|||
24964815|NCT00143403|50054601|FG001|Overall Study|Protocol Violation|2|||
24964816|NCT00143403|50054600|FG000|Overall Study|specified by site|4|||
24964817|NCT00143403|50054601|FG001|Overall Study|specified by site|9|||
24964818|NCT00143403|50054600|FG000|Overall Study|Randomized Not Treated|7|||
24964819|NCT00143403|50054601|FG001|Overall Study|Randomized Not Treated|8|||
24964820|NCT00220701|50054609|FG000|Overall Study|Lost to Follow-up|5|||
24964821|NCT00220701|50054610|FG001|Overall Study|Lost to Follow-up|4|||
24964822|NCT00127101|50054622|FG000|Base Protocol|Adverse Event|0|||
24964823|NCT00127101|50054623|FG001|Base Protocol|Adverse Event|2|||
24964824|NCT00127101|50054624|FG002|Base Protocol|Adverse Event|1|||
24964825|NCT00127101|50054625|FG003|Base Protocol|Adverse Event|0|||
24964826|NCT00127101|50054626|FG004|Base Protocol|Adverse Event|0|||
24964827|NCT00127101|50054627|FG005|Base Protocol|Adverse Event|0|||
24964828|NCT00127101|50054622|FG000|Base Protocol|Lack of Efficacy|1|||
24964829|NCT00127101|50054623|FG001|Base Protocol|Lack of Efficacy|0|||
24964830|NCT00127101|50054624|FG002|Base Protocol|Lack of Efficacy|0|||
24964831|NCT00127101|50054625|FG003|Base Protocol|Lack of Efficacy|0|||
24964832|NCT00127101|50054626|FG004|Base Protocol|Lack of Efficacy|2|||
24964833|NCT00127101|50054627|FG005|Base Protocol|Lack of Efficacy|0|||
24964834|NCT00127101|50054622|FG000|Base Protocol|Withdrawal by Subject|1|||
24964835|NCT00127101|50054623|FG001|Base Protocol|Withdrawal by Subject|2|||
24964836|NCT00127101|50054624|FG002|Base Protocol|Withdrawal by Subject|1|||
24964837|NCT00127101|50054625|FG003|Base Protocol|Withdrawal by Subject|0|||
24964838|NCT00127101|50054626|FG004|Base Protocol|Withdrawal by Subject|0|||
24964839|NCT00127101|50054627|FG005|Base Protocol|Withdrawal by Subject|1|||
24964840|NCT00127101|50054622|FG000|Continuation Phase|Adverse Event|0|||
24964841|NCT00127101|50054623|FG001|Continuation Phase|Adverse Event|0|||
24964842|NCT00127101|50054624|FG002|Continuation Phase|Adverse Event|0|||
24964843|NCT00127101|50054625|FG003|Continuation Phase|Adverse Event|0|||
24964844|NCT00127101|50054626|FG004|Continuation Phase|Adverse Event|1|||
24964845|NCT00127101|50054627|FG005|Continuation Phase|Adverse Event|1|||
24964846|NCT00127101|50054622|FG000|Continuation Phase|Lack of Efficacy|0|||
24964847|NCT00127101|50054623|FG001|Continuation Phase|Lack of Efficacy|0|||
24964848|NCT00127101|50054624|FG002|Continuation Phase|Lack of Efficacy|0|||
24964849|NCT00127101|50054625|FG003|Continuation Phase|Lack of Efficacy|0|||
24964850|NCT00127101|50054626|FG004|Continuation Phase|Lack of Efficacy|0|||
25067505|NCT01651936|50173247|FG000|Extension Study|Lack of Efficacy|0|||
25067506|NCT01651936|50173248|FG001|Extension Study|Lack of Efficacy|0|||
25067507|NCT01651936|50173249|FG002|Extension Study|Lack of Efficacy|1|||
25067508|NCT01651936|50173247|FG000|Extension Study|Study terminated by sponsor|0|||
25067509|NCT01651936|50173248|FG001|Extension Study|Study terminated by sponsor|0|||
24964851|NCT00127101|50054627|FG005|Continuation Phase|Lack of Efficacy|1|||
24964852|NCT00127101|50054622|FG000|Continuation Phase|Withdrawal by Subject|0|||
24964853|NCT00127101|50054623|FG001|Continuation Phase|Withdrawal by Subject|0|||
24964854|NCT00127101|50054624|FG002|Continuation Phase|Withdrawal by Subject|1|||
24964855|NCT00127101|50054625|FG003|Continuation Phase|Withdrawal by Subject|0|||
24964856|NCT00127101|50054626|FG004|Continuation Phase|Withdrawal by Subject|2|||
24964857|NCT00127101|50054627|FG005|Continuation Phase|Withdrawal by Subject|1|||
24964858|NCT00126555|50054641|FG000|Overall Study|Withdrawal by Subject|1|||
24964859|NCT00126555|50054641|FG000|Overall Study|Adverse Event|2|||
24964860|NCT00126555|50054641|FG000|Overall Study|Progressive Disease|3|||
25276958|NCT00957034|50590924|FG000|Overall Study|Sponsor Terminated Study|6|||
25276959|NCT00957034|50590925|FG001|Overall Study|Sponsor Terminated Study|1|||
24964861|NCT00004228|50054664|FG000|Overall Study|Adverse Event|0|||
24964862|NCT00004228|50054665|FG001|Overall Study|Adverse Event|1|||
24964863|NCT00004228|50054666|FG002|Overall Study|Adverse Event|0|||
24964864|NCT00004228|50054667|FG003|Overall Study|Adverse Event|0|||
24964865|NCT00004228|50054668|FG004|Overall Study|Adverse Event|1|||
24964866|NCT00004228|50054669|FG005|Overall Study|Adverse Event|0|||
24964867|NCT00004228|50054670|FG006|Overall Study|Adverse Event|0|||
24964868|NCT00004228|50054664|FG000|Overall Study|Death|0|||
24964869|NCT00004228|50054665|FG001|Overall Study|Death|1|||
24964870|NCT00004228|50054666|FG002|Overall Study|Death|2|||
24964871|NCT00004228|50054667|FG003|Overall Study|Death|0|||
24964872|NCT00004228|50054668|FG004|Overall Study|Death|1|||
24964873|NCT00004228|50054669|FG005|Overall Study|Death|0|||
24964874|NCT00004228|50054670|FG006|Overall Study|Death|0|||
24964875|NCT00004228|50054664|FG000|Overall Study|Lack of Efficacy|1|||
24964876|NCT00004228|50054665|FG001|Overall Study|Lack of Efficacy|6|||
24964877|NCT00004228|50054666|FG002|Overall Study|Lack of Efficacy|5|||
24964878|NCT00004228|50054667|FG003|Overall Study|Lack of Efficacy|3|||
24964879|NCT00004228|50054668|FG004|Overall Study|Lack of Efficacy|9|||
24964880|NCT00004228|50054669|FG005|Overall Study|Lack of Efficacy|8|||
24964881|NCT00004228|50054670|FG006|Overall Study|Lack of Efficacy|4|||
24964882|NCT00004228|50054664|FG000|Overall Study|Lost to Follow-up|0|||
24964883|NCT00004228|50054665|FG001|Overall Study|Lost to Follow-up|0|||
24964884|NCT00004228|50054666|FG002|Overall Study|Lost to Follow-up|1|||
24964885|NCT00004228|50054667|FG003|Overall Study|Lost to Follow-up|0|||
24964886|NCT00004228|50054668|FG004|Overall Study|Lost to Follow-up|0|||
24964887|NCT00004228|50054669|FG005|Overall Study|Lost to Follow-up|0|||
24964888|NCT00004228|50054670|FG006|Overall Study|Lost to Follow-up|0|||
24964889|NCT00004228|50054664|FG000|Overall Study|Physician Decision|1|||
24964890|NCT00004228|50054665|FG001|Overall Study|Physician Decision|0|||
24964891|NCT00004228|50054666|FG002|Overall Study|Physician Decision|3|||
24964892|NCT00004228|50054667|FG003|Overall Study|Physician Decision|2|||
24964893|NCT00004228|50054668|FG004|Overall Study|Physician Decision|1|||
24964894|NCT00004228|50054669|FG005|Overall Study|Physician Decision|1|||
24964895|NCT00004228|50054670|FG006|Overall Study|Physician Decision|1|||
25067510|NCT01651936|50173249|FG002|Extension Study|Study terminated by sponsor|13|||
25276960|NCT00957034|50590926|FG002|Overall Study|Sponsor Terminated Study|5|||
25276961|NCT00957034|50590924|FG000|Overall Study|Withdrawal by Subject|0|||
25276962|NCT00957034|50590925|FG001|Overall Study|Withdrawal by Subject|2|||
25276963|NCT00957034|50590926|FG002|Overall Study|Withdrawal by Subject|0|||
25276964|NCT00953056|50590940|FG000|Overall Study|Withdrew Consent|0|||
25276965|NCT00953056|50590941|FG001|Overall Study|Withdrew Consent|0|||
25276966|NCT00953056|50590942|FG002|Overall Study|Withdrew Consent|0|||
25276967|NCT00953056|50590943|FG003|Overall Study|Withdrew Consent|0|||
25276968|NCT00953056|50590944|FG004|Overall Study|Withdrew Consent|2|||
25276969|NCT00953056|50590945|FG005|Overall Study|Withdrew Consent|3|||
25276970|NCT00953056|50590940|FG000|Overall Study|Serious Adverse Event|0|||
25276971|NCT00953056|50590941|FG001|Overall Study|Serious Adverse Event|0|||
25276972|NCT00953056|50590942|FG002|Overall Study|Serious Adverse Event|0|||
25276973|NCT00953056|50590943|FG003|Overall Study|Serious Adverse Event|0|||
25276974|NCT00953056|50590944|FG004|Overall Study|Serious Adverse Event|0|||
25276975|NCT00953056|50590945|FG005|Overall Study|Serious Adverse Event|1|||
25276976|NCT00952822|50590970|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
25276977|NCT00952822|50590971|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
25276978|NCT00952822|50590972|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
25276979|NCT00952822|50590973|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
25276980|NCT00952822|50590970|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
25276981|NCT00952822|50590971|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
25276982|NCT00952822|50590972|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
25276983|NCT00952822|50590973|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
25276984|NCT01038297|50590987|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
25276985|NCT01038297|50590988|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
25276986|NCT01038297|50590989|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
25276987|NCT00955708|50591006|FG000|Overall Study|Death|269|||
25276988|NCT00955708|50591006|FG000|Overall Study|Lost to Follow-up|72|||
25276989|NCT00955708|50591006|FG000|Overall Study|Physician Decision|36|||
25276990|NCT00955708|50591006|FG000|Overall Study|Protocol Violation|134|||
25276991|NCT00955708|50591006|FG000|Overall Study|Registry Conclusion|186|||
25276992|NCT00955708|50591006|FG000|Overall Study|Product removed from service|94|||
25276993|NCT00955708|50591006|FG000|Overall Study|Patient Refused to participate further|116|||
25276994|NCT00955708|50591006|FG000|Overall Study|Closure of study location|60|||
25276995|NCT00955708|50591006|FG000|Overall Study|Patient changed care provider/moved|91|||
25276996|NCT01037985|50591010|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
25276997|NCT01037985|50591011|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
25276998|NCT01037985|50591010|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
25276999|NCT01037985|50591011|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
25277000|NCT01037985|50591010|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
25277001|NCT01037985|50591011|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
24964896|NCT00004228|50054664|FG000|Overall Study|Protocol Violation|0|||
25067511|NCT02395042|50173259|FG000|Treatment 1 Period|Adverse Event|1|||
24964897|NCT00004228|50054665|FG001|Overall Study|Protocol Violation|5|||
24964898|NCT00004228|50054666|FG002|Overall Study|Protocol Violation|2|||
24964899|NCT00004228|50054667|FG003|Overall Study|Protocol Violation|1|||
24964900|NCT00004228|50054668|FG004|Overall Study|Protocol Violation|1|||
24964901|NCT00004228|50054669|FG005|Overall Study|Protocol Violation|2|||
24964902|NCT00004228|50054670|FG006|Overall Study|Protocol Violation|0|||
25067512|NCT02395042|50173260|FG001|Treatment 1 Period|Adverse Event|3|||
25067513|NCT02395042|50173261|FG002|Treatment 1 Period|Adverse Event|1|||
24964903|NCT00004228|50054664|FG000|Overall Study|Withdrawal by Subject|3|||
24964904|NCT00004228|50054665|FG001|Overall Study|Withdrawal by Subject|0|||
24964905|NCT00004228|50054666|FG002|Overall Study|Withdrawal by Subject|1|||
24964906|NCT00004228|50054667|FG003|Overall Study|Withdrawal by Subject|0|||
24964907|NCT00004228|50054668|FG004|Overall Study|Withdrawal by Subject|2|||
24964908|NCT00004228|50054669|FG005|Overall Study|Withdrawal by Subject|1|||
24964909|NCT00004228|50054670|FG006|Overall Study|Withdrawal by Subject|2|||
24964910|NCT00004228|50054664|FG000|Overall Study|Other|0|||
24964911|NCT00004228|50054665|FG001|Overall Study|Other|0|||
24964912|NCT00004228|50054666|FG002|Overall Study|Other|1|||
24964913|NCT00004228|50054667|FG003|Overall Study|Other|0|||
24964914|NCT00004228|50054668|FG004|Overall Study|Other|0|||
24964915|NCT00004228|50054669|FG005|Overall Study|Other|0|||
24964916|NCT00004228|50054670|FG006|Overall Study|Other|0|||
24964917|NCT00004228|50054664|FG000|Overall Study|ineligible|4|||
24964918|NCT00004228|50054665|FG001|Overall Study|ineligible|2|||
24964919|NCT00004228|50054666|FG002|Overall Study|ineligible|4|||
24964920|NCT00004228|50054667|FG003|Overall Study|ineligible|1|||
24964921|NCT00004228|50054668|FG004|Overall Study|ineligible|1|||
24964922|NCT00004228|50054669|FG005|Overall Study|ineligible|2|||
24964923|NCT00004228|50054670|FG006|Overall Study|ineligible|5|||
24964924|NCT00003526|50054687|FG000|Overall Study|Not evaluable|6|||
24964925|NCT00195260|50054693|FG000|Part 1: Dose Escalation|Adverse Event|0|||
24964926|NCT00195260|50054694|FG001|Part 1: Dose Escalation|Adverse Event|1|||
24964927|NCT00195260|50054695|FG002|Part 1: Dose Escalation|Adverse Event|0|||
24964928|NCT00195260|50054696|FG003|Part 1: Dose Escalation|Adverse Event|1|||
24964929|NCT00195260|50054697|FG004|Part 1: Dose Escalation|Adverse Event|1|||
24964930|NCT00195260|50054698|FG005|Part 1: Dose Escalation|Adverse Event|0|||
24964931|NCT00195260|50054699|FG006|Part 1: Dose Escalation|Adverse Event|3|||
24964932|NCT00195260|50054700|FG007|Part 1: Dose Escalation|Adverse Event|0|||
24964933|NCT00195260|50054701|FG008|Part 1: Dose Escalation|Adverse Event|0|||
24964934|NCT00195260|50054702|FG009|Part 1: Dose Escalation|Adverse Event|0|||
24964935|NCT00195260|50054703|FG010|Part 1: Dose Escalation|Adverse Event|0|||
24964936|NCT00195260|50054693|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
24964937|NCT00195260|50054694|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
24964938|NCT00195260|50054695|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
24964939|NCT00195260|50054696|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
24964940|NCT00195260|50054697|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
24964941|NCT00195260|50054698|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
24964942|NCT00195260|50054699|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
24964943|NCT00195260|50054700|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
24964944|NCT00195260|50054701|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
24964945|NCT00195260|50054702|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
24964946|NCT00195260|50054703|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
24964947|NCT00195260|50054693|FG000|Part 1: Dose Escalation|Death|0|||
24964948|NCT00195260|50054694|FG001|Part 1: Dose Escalation|Death|0|||
24964949|NCT00195260|50054695|FG002|Part 1: Dose Escalation|Death|0|||
24964950|NCT00195260|50054696|FG003|Part 1: Dose Escalation|Death|0|||
24964951|NCT00195260|50054697|FG004|Part 1: Dose Escalation|Death|0|||
24964952|NCT00195260|50054698|FG005|Part 1: Dose Escalation|Death|0|||
24964953|NCT00195260|50054699|FG006|Part 1: Dose Escalation|Death|0|||
24964954|NCT00195260|50054700|FG007|Part 1: Dose Escalation|Death|1|||
24964955|NCT00195260|50054701|FG008|Part 1: Dose Escalation|Death|0|||
24964956|NCT00195260|50054702|FG009|Part 1: Dose Escalation|Death|0|||
24964957|NCT00195260|50054703|FG010|Part 1: Dose Escalation|Death|0|||
24964958|NCT00195260|50054693|FG000|Part 1: Dose Escalation|Disease Progression|3|||
24964959|NCT00195260|50054694|FG001|Part 1: Dose Escalation|Disease Progression|2|||
24964960|NCT00195260|50054695|FG002|Part 1: Dose Escalation|Disease Progression|5|||
24964961|NCT00195260|50054696|FG003|Part 1: Dose Escalation|Disease Progression|6|||
24964962|NCT00195260|50054697|FG004|Part 1: Dose Escalation|Disease Progression|4|||
24964963|NCT00195260|50054698|FG005|Part 1: Dose Escalation|Disease Progression|6|||
24964964|NCT00195260|50054699|FG006|Part 1: Dose Escalation|Disease Progression|7|||
24964965|NCT00195260|50054700|FG007|Part 1: Dose Escalation|Disease Progression|4|||
24964966|NCT00195260|50054701|FG008|Part 1: Dose Escalation|Disease Progression|0|||
24964967|NCT00195260|50054702|FG009|Part 1: Dose Escalation|Disease Progression|0|||
24964968|NCT00195260|50054703|FG010|Part 1: Dose Escalation|Disease Progression|0|||
24964969|NCT00195260|50054693|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
24964970|NCT00195260|50054694|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
24964971|NCT00195260|50054695|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
24964972|NCT00195260|50054696|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
24964973|NCT00195260|50054697|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
24964974|NCT00195260|50054698|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
24964975|NCT00195260|50054699|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
24964976|NCT00195260|50054700|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
24964977|NCT00195260|50054701|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
24964978|NCT00195260|50054702|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
24964979|NCT00195260|50054703|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
24964980|NCT00195260|50054693|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
24964981|NCT00195260|50054694|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
24964982|NCT00195260|50054695|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
24964983|NCT00195260|50054696|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
24964984|NCT00195260|50054697|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
24964985|NCT00195260|50054698|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
24964986|NCT00195260|50054699|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
24964987|NCT00195260|50054700|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
24964988|NCT00195260|50054701|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
24964989|NCT00195260|50054702|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
24964990|NCT00195260|50054703|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
24964991|NCT00195260|50054693|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
24964992|NCT00195260|50054694|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
24964993|NCT00195260|50054695|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
24964994|NCT00195260|50054696|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
24964995|NCT00195260|50054697|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
24964996|NCT00195260|50054698|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
24964997|NCT00195260|50054699|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
24964998|NCT00195260|50054700|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
24964999|NCT00195260|50054701|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
24965000|NCT00195260|50054702|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
24965001|NCT00195260|50054703|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
24965002|NCT00195260|50054693|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
24965003|NCT00195260|50054694|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
24965004|NCT00195260|50054695|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
24965005|NCT00195260|50054696|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
24965006|NCT00195260|50054697|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
24965007|NCT00195260|50054698|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
24965008|NCT00195260|50054699|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
24965009|NCT00195260|50054700|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
25187787|NCT03593213|50338762|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
25187788|NCT03593213|50338759|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
25187789|NCT03593213|50338760|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
25187790|NCT03593213|50338761|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
25187791|NCT03593213|50338762|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
25187792|NCT00013611|50338806|FG000|Overall Study|Lost to Follow-up|91|||
25187793|NCT00013611|50338807|FG001|Overall Study|Lost to Follow-up|100|||
25187794|NCT00010257|50338815|FG000|Overall Study|Withdrawal by Subject|1|||
24965010|NCT00195260|50054701|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
24965011|NCT00195260|50054702|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
24965012|NCT00195260|50054703|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
25187795|NCT00010257|50338816|FG001|Overall Study|Withdrawal by Subject|0|||
25187796|NCT00211757|50338854|FG000|Overall Study|Withdrawal by Subject|1|||
24965013|NCT00195260|50054693|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
24965014|NCT00195260|50054694|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
24965015|NCT00195260|50054695|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
24965016|NCT00195260|50054696|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
24965017|NCT00195260|50054697|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
24965018|NCT00195260|50054698|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
24965019|NCT00195260|50054699|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
24965020|NCT00195260|50054700|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
24965021|NCT00195260|50054701|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
24965022|NCT00195260|50054702|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
24965023|NCT00195260|50054703|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
24965024|NCT00031486|50054733|FG000|Overall Study|Adverse Event|1|||
24965025|NCT00031486|50054734|FG001|Overall Study|Adverse Event|0|||
24965026|NCT00031486|50054733|FG000|Overall Study|Lost to Follow-up|0|||
24965027|NCT00031486|50054734|FG001|Overall Study|Lost to Follow-up|1|||
24965028|NCT00031486|50054733|FG000|Overall Study|Withdrawal by Subject|3|||
24965029|NCT00031486|50054734|FG001|Overall Study|Withdrawal by Subject|2|||
24965030|NCT00031486|50054733|FG000|Overall Study|Death|0|||
24965031|NCT00031486|50054734|FG001|Overall Study|Death|3|||
24965032|NCT00031486|50054733|FG000|Overall Study|Non-compliant|0|||
24965033|NCT00031486|50054734|FG001|Overall Study|Non-compliant|4|||
24965034|NCT00031486|50054733|FG000|Overall Study|Did not meet eligibility requirement|2|||
24965035|NCT00031486|50054734|FG001|Overall Study|Did not meet eligibility requirement|1|||
24965036|NCT00031486|50054733|FG000|Overall Study|Other|1|||
24965037|NCT00031486|50054734|FG001|Overall Study|Other|1|||
24965038|NCT00003508|50054742|FG000|Overall Study|Not evaluable|5|||
24965039|NCT00003472|50054746|FG000|Overall Study|Not evaluable|3|||
24965040|NCT00003298|50054750|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
24965041|NCT00003298|50054750|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
24965042|NCT00003298|50054750|FG000|Surgery|Unresectable at surgery|3|||
24965043|NCT00003298|50054750|FG000|Surgery|Progression before surgery|2|||
24965044|NCT00003298|50054750|FG000|Surgery|Unevaluable and off study|2|||
24965045|NCT00003298|50054750|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
24965046|NCT00003298|50054750|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
24965047|NCT00003298|50054750|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
24965048|NCT00003298|50054750|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
24965049|NCT00003298|50054750|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
24965050|NCT00003298|50054750|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
24965051|NCT00003298|50054750|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
24965052|NCT00003298|50054750|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
24965053|NCT00003298|50054750|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
24965054|NCT00003298|50054750|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
24965055|NCT00002842|50054755|FG000|Overall Study|ineligible for surgical resection|27|||
24965056|NCT00143247|50054759|FG000|Overall Study|Death|8|||
24965057|NCT00143247|50054759|FG000|Overall Study|Adverse Event|19|||
24965058|NCT00143247|50054759|FG000|Overall Study|Lack of Efficacy|3|||
24965059|NCT00143247|50054759|FG000|Overall Study|Withdrawal by Subject|55|||
24965060|NCT00143247|50054759|FG000|Overall Study|Study terminated by sponsor|31|||
24965061|NCT00143247|50054759|FG000|Overall Study|Protocol Violation|15|||
24965062|NCT00143247|50054759|FG000|Overall Study|Lost to Follow-up|12|||
24965063|NCT00143247|50054759|FG000|Overall Study|following inaccurate lab adverse event|1|||
24965064|NCT00143247|50054759|FG000|Overall Study|Other|12|||
24965065|NCT00125853|50054763|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
24965066|NCT00125853|50054764|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
24965067|NCT00219141|50054773|FG000|Overall Study|Adverse Event|4|||
24965068|NCT00219141|50054774|FG001|Overall Study|Adverse Event|10|||
24965069|NCT00219141|50054775|FG002|Overall Study|Adverse Event|5|||
24965070|NCT00219141|50054773|FG000|Overall Study|Lack of Efficacy|3|||
24965071|NCT00219141|50054774|FG001|Overall Study|Lack of Efficacy|2|||
24965072|NCT00219141|50054775|FG002|Overall Study|Lack of Efficacy|0|||
24965073|NCT00219141|50054773|FG000|Overall Study|Administrative problems|0|||
24965074|NCT00219141|50054774|FG001|Overall Study|Administrative problems|1|||
24965075|NCT00219141|50054775|FG002|Overall Study|Administrative problems|0|||
24965076|NCT00219141|50054773|FG000|Overall Study|Lost to Follow-up|2|||
24965077|NCT00219141|50054774|FG001|Overall Study|Lost to Follow-up|4|||
24965078|NCT00219141|50054775|FG002|Overall Study|Lost to Follow-up|1|||
24965079|NCT00219141|50054773|FG000|Overall Study|Protocol Violation|3|||
24965080|NCT00219141|50054774|FG001|Overall Study|Protocol Violation|1|||
24965081|NCT00219141|50054775|FG002|Overall Study|Protocol Violation|1|||
24965082|NCT00219141|50054773|FG000|Overall Study|Withdrawal by Subject|1|||
24965083|NCT00219141|50054774|FG001|Overall Study|Withdrawal by Subject|3|||
24965084|NCT00219141|50054775|FG002|Overall Study|Withdrawal by Subject|5|||
24965085|NCT00219141|50054773|FG000|Overall Study|Condition no longer requires study drug|1|||
24965086|NCT00219141|50054774|FG001|Overall Study|Condition no longer requires study drug|0|||
24965087|NCT00219141|50054775|FG002|Overall Study|Condition no longer requires study drug|0|||
24965088|NCT00142935|50054786|FG000|Overall Study|Other reason|1|||
24965089|NCT00142935|50054787|FG001|Overall Study|Other reason|1|||
24965090|NCT00142935|50054788|FG002|Overall Study|Other reason|1|||
24965091|NCT00142935|50054786|FG000|Overall Study|Lost to Follow-up|2|||
24965092|NCT00142935|50054787|FG001|Overall Study|Lost to Follow-up|5|||
25168635|NCT01872689|50298245|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
24965093|NCT00142935|50054788|FG002|Overall Study|Lost to Follow-up|5|||
24965094|NCT00142935|50054786|FG000|Overall Study|Death|0|||
24965095|NCT00142935|50054787|FG001|Overall Study|Death|2|||
24965096|NCT00142935|50054788|FG002|Overall Study|Death|1|||
24965097|NCT00233948|50054802|FG000|Overall Study|Adverse Event|1|||
24965098|NCT00233948|50054803|FG001|Overall Study|Adverse Event|0|||
24965099|NCT00233948|50054804|FG002|Overall Study|Adverse Event|0|||
24965100|NCT00233948|50054805|FG003|Overall Study|Adverse Event|0|||
24965101|NCT00233948|50054806|FG004|Overall Study|Adverse Event|0|||
24965102|NCT00233948|50054807|FG005|Overall Study|Adverse Event|0|||
24965103|NCT00233480|50054824|FG000|Overall Study|Underwent status II heart transplant|0|||
24965104|NCT00233480|50054825|FG001|Overall Study|Underwent status II heart transplant|1|||
24965105|NCT03801928|50054839|FG000|Overall Study|Adverse Event|1|||
24965106|NCT03801928|50054840|FG001|Overall Study|Adverse Event|0|||
24965107|NCT03801928|50054841|FG002|Overall Study|Adverse Event|1|||
24965108|NCT03801928|50054842|FG003|Overall Study|Adverse Event|2|||
24965109|NCT03801928|50054843|FG004|Overall Study|Adverse Event|0|||
24965110|NCT03801928|50054844|FG005|Overall Study|Adverse Event|2|||
24965111|NCT03801928|50054839|FG000|Overall Study|Lack of Efficacy|0|||
24965112|NCT03801928|50054840|FG001|Overall Study|Lack of Efficacy|0|||
24965113|NCT03801928|50054841|FG002|Overall Study|Lack of Efficacy|1|||
24965114|NCT03801928|50054842|FG003|Overall Study|Lack of Efficacy|0|||
24965115|NCT03801928|50054843|FG004|Overall Study|Lack of Efficacy|0|||
24965116|NCT03801928|50054844|FG005|Overall Study|Lack of Efficacy|0|||
24965117|NCT03801928|50054839|FG000|Overall Study|Lost to Follow-up|5|||
24965118|NCT03801928|50054840|FG001|Overall Study|Lost to Follow-up|1|||
24965119|NCT03801928|50054841|FG002|Overall Study|Lost to Follow-up|1|||
24965120|NCT03801928|50054842|FG003|Overall Study|Lost to Follow-up|4|||
24965121|NCT03801928|50054843|FG004|Overall Study|Lost to Follow-up|4|||
24965122|NCT03801928|50054844|FG005|Overall Study|Lost to Follow-up|2|||
24965123|NCT03801928|50054839|FG000|Overall Study|Withdrawal by Subject|0|||
24965124|NCT03801928|50054840|FG001|Overall Study|Withdrawal by Subject|0|||
24965125|NCT03801928|50054841|FG002|Overall Study|Withdrawal by Subject|2|||
24965126|NCT03801928|50054842|FG003|Overall Study|Withdrawal by Subject|1|||
24965127|NCT03801928|50054843|FG004|Overall Study|Withdrawal by Subject|0|||
24965128|NCT03801928|50054844|FG005|Overall Study|Withdrawal by Subject|0|||
24965129|NCT03801928|50054839|FG000|Overall Study|Other|0|||
24965130|NCT03801928|50054840|FG001|Overall Study|Other|2|||
24965131|NCT03801928|50054841|FG002|Overall Study|Other|0|||
24965132|NCT03801928|50054842|FG003|Overall Study|Other|1|||
24965133|NCT03801928|50054843|FG004|Overall Study|Other|0|||
24965134|NCT03801928|50054844|FG005|Overall Study|Other|1|||
24965135|NCT00263588|50054863|FG000|Overall Study|Death|54|||
24965136|NCT00263588|50054864|FG001|Overall Study|Death|90|||
24965137|NCT00263588|50054863|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
24965138|NCT00263588|50054864|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
24965139|NCT00263588|50054863|FG000|Overall Study|Lost to Follow-up|7|||
24965140|NCT00263588|50054864|FG001|Overall Study|Lost to Follow-up|10|||
24965141|NCT00263588|50054863|FG000|Overall Study|Withdrawal by Subject|3|||
24965142|NCT00263588|50054864|FG001|Overall Study|Withdrawal by Subject|4|||
24965143|NCT00263588|50054863|FG000|Overall Study|Protocol Violation|0|||
24965144|NCT00263588|50054864|FG001|Overall Study|Protocol Violation|1|||
24965145|NCT00263588|50054863|FG000|Overall Study|Investigator decision|7|||
24965146|NCT00263588|50054864|FG001|Overall Study|Investigator decision|15|||
24965147|NCT00263588|50054863|FG000|Overall Study|Sponsor terminated study|0|||
24965148|NCT00263588|50054864|FG001|Overall Study|Sponsor terminated study|1|||
24965149|NCT00213135|50054874|FG000|Overall Study|Adverse Event|9|||
25067514|NCT02395042|50173259|FG000|Treatment 1 Period|Lack of Efficacy|1|||
25067515|NCT02395042|50173260|FG001|Treatment 1 Period|Lack of Efficacy|1|||
25067516|NCT02395042|50173261|FG002|Treatment 1 Period|Lack of Efficacy|0|||
25067517|NCT02395042|50173259|FG000|Treatment 1 Period|Lost to Follow-up|1|||
25067518|NCT02395042|50173260|FG001|Treatment 1 Period|Lost to Follow-up|0|||
25067519|NCT02395042|50173261|FG002|Treatment 1 Period|Lost to Follow-up|0|||
25067520|NCT02395042|50173259|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
25067521|NCT02395042|50173260|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
25067522|NCT02395042|50173261|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
25067523|NCT02395042|50173259|FG000|Treatment 2 Period|Lack of Efficacy|1|||
25067524|NCT02395042|50173260|FG001|Treatment 2 Period|Lack of Efficacy|1|||
25067525|NCT02395042|50173261|FG002|Treatment 2 Period|Lack of Efficacy|0|||
25067526|NCT02394808|50173272|FG000|Period 1|Unsatisfactory lens fitting|0|||
24965150|NCT00213135|50054875|FG001|Overall Study|Adverse Event|5|||
24965151|NCT00213135|50054876|FG002|Overall Study|Adverse Event|5|||
24965152|NCT00213135|50054874|FG000|Overall Study|Lost to Follow-up|11|||
24965153|NCT00213135|50054875|FG001|Overall Study|Lost to Follow-up|8|||
24965154|NCT00213135|50054876|FG002|Overall Study|Lost to Follow-up|4|||
24965155|NCT00213135|50054874|FG000|Overall Study|Protocol Violation|4|||
24965156|NCT00213135|50054875|FG001|Overall Study|Protocol Violation|4|||
24965157|NCT00213135|50054876|FG002|Overall Study|Protocol Violation|10|||
24965158|NCT00213135|50054874|FG000|Overall Study|Death|1|||
24965159|NCT00213135|50054875|FG001|Overall Study|Death|1|||
24965160|NCT00213135|50054876|FG002|Overall Study|Death|2|||
24965161|NCT00213135|50054874|FG000|Overall Study|Disease progression|4|||
24965162|NCT00213135|50054875|FG001|Overall Study|Disease progression|5|||
24965163|NCT00213135|50054876|FG002|Overall Study|Disease progression|21|||
24965164|NCT00213135|50054874|FG000|Overall Study|Other|21|||
24965165|NCT00213135|50054875|FG001|Overall Study|Other|12|||
24965166|NCT00213135|50054876|FG002|Overall Study|Other|15|||
25067527|NCT02394808|50173273|FG001|Period 1|Unsatisfactory lens fitting|1|||
25067528|NCT02394808|50173272|FG000|Period 2|Lost to Follow-up|1|||
25277002|NCT01037985|50591010|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
25277003|NCT01037985|50591011|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
25277004|NCT00955474|50591023|FG000|Overall Study|Physician Decision|7|||
25277005|NCT00955474|50591024|FG001|Overall Study|Physician Decision|5|||
25277006|NCT01229150|50591036|FG000|Overall Study|Toxicity|2|||
25277007|NCT01229150|50591037|FG001|Overall Study|Toxicity|2|||
25277008|NCT01229150|50591038|FG002|Overall Study|Toxicity|0|||
25277009|NCT01229150|50591039|FG003|Overall Study|Toxicity|0|||
25277010|NCT00952588|50591055|FG000|Overall Study|Death|28|||
25277011|NCT00952588|50591056|FG001|Overall Study|Death|13|||
25277012|NCT00952588|50591055|FG000|Overall Study|Withdrawal by Subject|2|||
25277013|NCT00952588|50591056|FG001|Overall Study|Withdrawal by Subject|5|||
25277014|NCT00952588|50591055|FG000|Overall Study|Adverse Event|2|||
25277015|NCT00952588|50591056|FG001|Overall Study|Adverse Event|3|||
24965167|NCT00077974|50054884|FG000|Overall Study|Adverse Event|22|||
24965168|NCT00077974|50054884|FG000|Overall Study|Protocol Violation|1|||
24965169|NCT00077974|50054884|FG000|Overall Study|Withdrawal by Subject|3|||
24965170|NCT00077974|50054884|FG000|Overall Study|Lack of Efficacy|76|||
24965171|NCT00077974|50054884|FG000|Overall Study|Decision of Sponsor|2|||
24965172|NCT00124917|50054888|FG000|Overall Study|Physician Decision|3|||
24965173|NCT00141921|50054893|FG000|Overall Study|Remain on Study|28|||
24965174|NCT00141921|50054893|FG000|Overall Study|Withdrawal by Subject|42|||
24965175|NCT00141921|50054893|FG000|Overall Study|Lost to Follow-up|19|||
24965176|NCT00141921|50054893|FG000|Overall Study|Noncompliance|17|||
24965177|NCT00141921|50054893|FG000|Overall Study|Disease Progression|7|||
24965178|NCT00141921|50054893|FG000|Overall Study|Protocol Deviation|7|||
24965179|NCT00141921|50054893|FG000|Overall Study|Adverse Event|5|||
24965180|NCT00141921|50054893|FG000|Overall Study|Administrative Decision|2|||
24965181|NCT00141921|50054893|FG000|Overall Study|Pregnancy|4|||
24965182|NCT00141921|50054893|FG000|Overall Study|Ineligibility Determined|2|||
24965183|NCT00141921|50054893|FG000|Overall Study|Other|8|||
24965184|NCT00029146|50054899|FG000|Overall Study|Lost to Follow-up|2|||
24965185|NCT00029146|50054900|FG001|Overall Study|Lost to Follow-up|1|||
24965186|NCT00026494|50054910|FG000|Overall Study|Withdrawal by Subject|1|||
24965187|NCT00026494|50054911|FG001|Overall Study|Withdrawal by Subject|0|||
24965188|NCT00026494|50054912|FG002|Overall Study|Withdrawal by Subject|1|||
24965189|NCT00026494|50054913|FG003|Overall Study|Withdrawal by Subject|0|||
24965190|NCT00026494|50054910|FG000|Overall Study|Patient non-compliance|1|||
24965191|NCT00026494|50054911|FG001|Overall Study|Patient non-compliance|0|||
24965192|NCT00026494|50054912|FG002|Overall Study|Patient non-compliance|0|||
24965193|NCT00026494|50054913|FG003|Overall Study|Patient non-compliance|0|||
24965194|NCT00026494|50054910|FG000|Overall Study|Patient not treated|0|||
24965195|NCT00026494|50054911|FG001|Overall Study|Patient not treated|0|||
24965196|NCT00026494|50054912|FG002|Overall Study|Patient not treated|2|||
24965197|NCT00026494|50054913|FG003|Overall Study|Patient not treated|0|||
24965198|NCT00026494|50054910|FG000|Overall Study|Clinical progression|0|||
24965199|NCT00026494|50054911|FG001|Overall Study|Clinical progression|0|||
24965200|NCT00026494|50054912|FG002|Overall Study|Clinical progression|3|||
24965201|NCT00026494|50054913|FG003|Overall Study|Clinical progression|0|||
24965202|NCT00023764|50054923|FG000|Overall Study|Other|1|||
24965203|NCT00023764|50054923|FG000|Overall Study|Adverse Event|4|||
24965204|NCT00023764|50054923|FG000|Overall Study|Withdrawal by Subject|1|||
24965205|NCT00023764|50054923|FG000|Overall Study|Progression of disease|6|||
24965206|NCT00023764|50054923|FG000|Overall Study|patient received other treatment|1|||
24965207|NCT00023764|50054923|FG000|Overall Study|delay in obtaining staging images|1|||
24965208|NCT00189488|50054930|FG000|Overall Study|Ineligibility determined|1|||
24965209|NCT00189488|50054931|FG001|Overall Study|Ineligibility determined|0|||
24965210|NCT00189488|50054930|FG000|Overall Study|Protocol deviation|2|||
24965211|NCT00189488|50054931|FG001|Overall Study|Protocol deviation|1|||
24965212|NCT00189488|50054930|FG000|Overall Study|Adverse Event|2|||
24965213|NCT00189488|50054931|FG001|Overall Study|Adverse Event|1|||
24965214|NCT00189488|50054930|FG000|Overall Study|Withdrawal by Subject|2|||
24965215|NCT00189488|50054931|FG001|Overall Study|Withdrawal by Subject|6|||
24965216|NCT00189488|50054930|FG000|Overall Study|Disease progression|2|||
24965217|NCT00189488|50054931|FG001|Overall Study|Disease progression|4|||
24965218|NCT00189488|50054930|FG000|Overall Study|Administrative Decision|0|||
24965219|NCT00189488|50054931|FG001|Overall Study|Administrative Decision|2|||
24965220|NCT00189488|50054930|FG000|Overall Study|Death|5|||
24965221|NCT00189488|50054931|FG001|Overall Study|Death|8|||
24965222|NCT00189488|50054930|FG000|Overall Study|Other|1|||
24965223|NCT00189488|50054931|FG001|Overall Study|Other|0|||
24965224|NCT00233402|50054940|FG000|Overall Study|No pathology data|12|||
24965225|NCT00233402|50054941|FG001|Overall Study|No pathology data|9|||
24965226|NCT00233402|50054940|FG000|Overall Study|No Ta/T1|89|||
24965227|NCT00233402|50054941|FG001|Overall Study|No Ta/T1|94|||
24965228|NCT00233402|50054940|FG000|Overall Study|Lost to follow up etc|3|||
24965229|NCT00233402|50054941|FG001|Overall Study|Lost to follow up etc|21|||
24965230|NCT00233324|50054953|FG000|Main Study|Death|68|||
24965231|NCT00233324|50054954|FG001|Main Study|Death|60|||
25277016|NCT00952588|50591055|FG000|Overall Study|Lost to Follow-up|2|||
24965232|NCT00233324|50054955|FG002|Main Study|Death|62|||
24965233|NCT00233324|50054956|FG003|Main Study|Death|47|||
24965234|NCT00233324|50054953|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
24965235|NCT00233324|50054954|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
24965236|NCT00233324|50054955|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
24965237|NCT00233324|50054956|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
24965238|NCT00233324|50054953|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
24965239|NCT00233324|50054954|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
24965240|NCT00233324|50054955|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
24965241|NCT00233324|50054956|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
24965242|NCT00023452|50054975|FG000|Overall Study|Ineligible for Study|163|||
24965243|NCT00023452|50054976|FG001|Overall Study|Ineligible for Study|159|||
24965244|NCT00023452|50054975|FG000|Overall Study|Out of Window|129|||
24965245|NCT00023452|50054976|FG001|Overall Study|Out of Window|69|||
24965246|NCT00023452|50054975|FG000|Overall Study|Death|2|||
24965247|NCT00023452|50054976|FG001|Overall Study|Death|0|||
24965248|NCT00023452|50054975|FG000|Overall Study|Withdrawal by Subject|66|||
24965249|NCT00023452|50054976|FG001|Overall Study|Withdrawal by Subject|54|||
24965250|NCT00023452|50054975|FG000|Overall Study|Adverse Event|139|||
24965251|NCT00023452|50054976|FG001|Overall Study|Adverse Event|196|||
24965252|NCT00023452|50054975|FG000|Overall Study|Lost to Follow-up|293|||
24965253|NCT00023452|50054976|FG001|Overall Study|Lost to Follow-up|60|||
24965254|NCT00023452|50054975|FG000|Overall Study|Physician Decision|49|||
24965255|NCT00023452|50054976|FG001|Overall Study|Physician Decision|21|||
24965256|NCT00023452|50054975|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
24965257|NCT00023452|50054976|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
24965258|NCT00023452|50054975|FG000|Overall Study|Pregnant|53|||
24965259|NCT00023452|50054976|FG001|Overall Study|Pregnant|20|||
24965260|NCT00023452|50054975|FG000|Overall Study|Other|204|||
24965261|NCT00023452|50054976|FG001|Overall Study|Other|69|||
24965262|NCT00022672|50054988|FG000|Main Phase: 24 Months|Adverse Event|6|||
24965263|NCT00022672|50054989|FG001|Main Phase: 24 Months|Adverse Event|0|||
24965264|NCT00022672|50054988|FG000|Main Phase: 24 Months|Death|0|||
24965265|NCT00022672|50054989|FG001|Main Phase: 24 Months|Death|3|||
24965266|NCT00022672|50054988|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
24965267|NCT00022672|50054989|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
24965268|NCT00022672|50054988|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
24965269|NCT00022672|50054989|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
24965270|NCT00022672|50054988|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
24965271|NCT00022672|50054989|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
24965272|NCT00022672|50054988|FG000|Main Phase: 24 Months|Refused Treatment|3|||
24965273|NCT00022672|50054989|FG001|Main Phase: 24 Months|Refused Treatment|4|||
24965274|NCT00022672|50054988|FG000|Main Phase: 24 Months|Failure to Return|1|||
24965275|NCT00022672|50054989|FG001|Main Phase: 24 Months|Failure to Return|1|||
24965276|NCT00022672|50054988|FG000|Main Phase: 24 Months|Other|1|||
24965277|NCT00022672|50054989|FG001|Main Phase: 24 Months|Other|0|||
25187797|NCT00211757|50338855|FG001|Overall Study|Withdrawal by Subject|1|||
25187798|NCT00211757|50338854|FG000|Overall Study|Lack of Efficacy|0|||
25187799|NCT00211757|50338855|FG001|Overall Study|Lack of Efficacy|1|||
25187800|NCT02639052|50338872|FG000|Overall Study|Lost to Follow-up|1|||
25187801|NCT02635776|50338979|FG000|Overall Study|Physician Decision|1|||
25187802|NCT02635776|50338980|FG001|Overall Study|Physician Decision|0|||
25187803|NCT02635776|50338979|FG000|Overall Study|Adverse Event|51|||
25187804|NCT02635776|50338980|FG001|Overall Study|Adverse Event|3|||
25187805|NCT02635776|50338979|FG000|Overall Study|Withdrawal by Subject|41|||
25187806|NCT02635776|50338980|FG001|Overall Study|Withdrawal by Subject|7|||
25187807|NCT02635776|50338979|FG000|Overall Study|Lost to Follow-up|4|||
25187808|NCT02635776|50338980|FG001|Overall Study|Lost to Follow-up|0|||
25187809|NCT02635776|50338979|FG000|Overall Study|Other reasons|5|||
25187810|NCT02635776|50338980|FG001|Overall Study|Other reasons|1|||
25187811|NCT02704403|50338994|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
25187812|NCT02704403|50338995|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
25187813|NCT02704403|50338994|FG000|Overall Study|Administrative reasons by sponsor|1251|||
25187814|NCT02704403|50338995|FG001|Overall Study|Administrative reasons by sponsor|616|||
25187815|NCT02704403|50338994|FG000|Overall Study|Death|4|||
25187816|NCT02704403|50338995|FG001|Overall Study|Death|3|||
25187817|NCT02704403|50338994|FG000|Overall Study|Endpoint event|52|||
25187818|NCT02704403|50338995|FG001|Overall Study|Endpoint event|24|||
25187819|NCT02704403|50338994|FG000|Overall Study|Lost to Follow-up|22|||
25187820|NCT02704403|50338995|FG001|Overall Study|Lost to Follow-up|11|||
25187821|NCT02704403|50338994|FG000|Overall Study|Protocol Violation|15|||
25187822|NCT02704403|50338995|FG001|Overall Study|Protocol Violation|15|||
25187823|NCT02704403|50338994|FG000|Overall Study|Adverse Event|2|||
25187824|NCT02704403|50338995|FG001|Overall Study|Adverse Event|0|||
25187825|NCT02704403|50338994|FG000|Overall Study|Withdrawal by Subject|85|||
24965278|NCT00022672|50054988|FG000|Extension Phase|Adverse Event|1|||
25187826|NCT02704403|50338995|FG001|Overall Study|Withdrawal by Subject|45|||
25187827|NCT02704403|50338994|FG000|Overall Study|Investigator decision|1|||
25187828|NCT02704403|50338995|FG001|Overall Study|Investigator decision|1|||
25187829|NCT02704403|50338994|FG000|Overall Study|Follow-up not possible|1|||
25187830|NCT02704403|50338995|FG001|Overall Study|Follow-up not possible|2|||
25187831|NCT02636868|50339030|FG000|Overall Study|Death|0|||
25277017|NCT00952588|50591056|FG001|Overall Study|Lost to Follow-up|0|||
24965279|NCT00022672|50054989|FG001|Extension Phase|Adverse Event|3|||
24965280|NCT00022672|50054988|FG000|Extension Phase|Death|0|||
24965281|NCT00022672|50054989|FG001|Extension Phase|Death|1|||
24965282|NCT00022672|50054988|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
25067529|NCT02394808|50173273|FG001|Period 2|Lost to Follow-up|0|||
25187832|NCT02636868|50339031|FG001|Overall Study|Death|1|||
25187833|NCT02636868|50339032|FG002|Overall Study|Death|2|||
25187834|NCT02635386|50339113|FG000|Overall Study|Pregnancy|2|||
25187835|NCT02635386|50339114|FG001|Overall Study|Pregnancy|0|||
24965283|NCT00022672|50054989|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
24965284|NCT00022672|50054988|FG000|Extension Phase|Refused Treatment|0|||
24965285|NCT00022672|50054989|FG001|Extension Phase|Refused Treatment|2|||
24965286|NCT00022672|50054988|FG000|Extension Phase|Other|1|||
24965287|NCT00022672|50054989|FG001|Extension Phase|Other|1|||
24965288|NCT00076804|50054998|FG000|Overall Study|Death|9|||
24965289|NCT00076804|50054999|FG001|Overall Study|Death|20|||
24965290|NCT00076804|50054998|FG000|Overall Study|Lost to Follow-up|9|||
24965291|NCT00076804|50054999|FG001|Overall Study|Lost to Follow-up|9|||
24965292|NCT00076804|50054998|FG000|Overall Study|Withdrawal by Subject|10|||
24965293|NCT00076804|50054999|FG001|Overall Study|Withdrawal by Subject|8|||
24965294|NCT00076804|50054998|FG000|Overall Study|Early study Closure|32|||
24965295|NCT00076804|50054999|FG001|Overall Study|Early study Closure|32|||
24965296|NCT00141453|50055007|FG000|Overall Study|Protocol Violation|6|||
24965297|NCT00141453|50055008|FG001|Overall Study|Protocol Violation|5|||
24965298|NCT00076570|50055016|FG000|Overall Study|Drug intolerance|8|||
24965299|NCT00076570|50055017|FG001|Overall Study|Drug intolerance|8|||
24965300|NCT00124449|50055025|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
24965301|NCT00124449|50055026|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
24965302|NCT00124449|50055025|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
24965303|NCT00124449|50055026|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
24965304|NCT00124449|50055025|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
24965305|NCT00124449|50055026|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
24965306|NCT00124449|50055025|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
24965307|NCT00124449|50055026|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
24965308|NCT00124449|50055025|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
24965309|NCT00124449|50055026|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
24965310|NCT00124449|50055025|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
24965311|NCT00124449|50055026|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
24965312|NCT00124449|50055025|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
24965313|NCT00124449|50055026|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
24965314|NCT00124449|50055025|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
24965315|NCT00124449|50055026|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
24965316|NCT00124449|50055025|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
24965317|NCT00124449|50055026|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
24965318|NCT00124449|50055025|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
24965319|NCT00124449|50055026|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
24965320|NCT00124449|50055025|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
24965321|NCT00124449|50055026|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
24965322|NCT00124449|50055025|FG000|18-Month Untreated Observation Period|Relocated|1|||
24965323|NCT00124449|50055026|FG001|18-Month Untreated Observation Period|Relocated|0|||
24965324|NCT00076336|50055035|FG000|Overall Study|Death|13|||
24965325|NCT00076336|50055036|FG001|Overall Study|Death|17|||
24965326|NCT00076336|50055035|FG000|Overall Study|Adverse Event|4|||
24965327|NCT00076336|50055036|FG001|Overall Study|Adverse Event|4|||
24965328|NCT00076336|50055035|FG000|Overall Study|Lost to Follow-up|4|||
24965329|NCT00076336|50055036|FG001|Overall Study|Lost to Follow-up|4|||
24965330|NCT00076336|50055035|FG000|Overall Study|Non-Compliance|2|||
24965331|NCT00076336|50055036|FG001|Overall Study|Non-Compliance|0|||
24965332|NCT00076336|50055035|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
24965333|NCT00076336|50055036|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
24965334|NCT00076336|50055035|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
24965335|NCT00076336|50055036|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
24965336|NCT00076336|50055035|FG000|Overall Study|Liver Transplantation|3|||
24965337|NCT00076336|50055036|FG001|Overall Study|Liver Transplantation|3|||
25187836|NCT02635386|50339115|FG002|Overall Study|Pregnancy|0|||
25187837|NCT02635386|50339116|FG003|Overall Study|Pregnancy|0|||
25187838|NCT02635386|50339117|FG004|Overall Study|Pregnancy|2|||
25187839|NCT02635386|50339113|FG000|Overall Study|Withdrawal by Subject|1|||
25187840|NCT02635386|50339114|FG001|Overall Study|Withdrawal by Subject|1|||
25187841|NCT02635386|50339115|FG002|Overall Study|Withdrawal by Subject|0|||
25187842|NCT02635386|50339116|FG003|Overall Study|Withdrawal by Subject|1|||
24965338|NCT00076336|50055035|FG000|Overall Study|Virologic Breakthrough|14|||
24965339|NCT00076336|50055036|FG001|Overall Study|Virologic Breakthrough|16|||
24965340|NCT00076336|50055035|FG000|Overall Study|Treatment failure|4|||
24965341|NCT00076336|50055036|FG001|Overall Study|Treatment failure|5|||
24965342|NCT00185588|50055046|FG000|Overall Study|Adverse Event|3|||
24965343|NCT00185588|50055047|FG001|Overall Study|Adverse Event|1|||
24965344|NCT00185588|50055048|FG002|Overall Study|Adverse Event|4|||
24965345|NCT00185588|50055049|FG003|Overall Study|Adverse Event|2|||
25277018|NCT00952588|50591055|FG000|Overall Study|Physician Decision|0|||
25277019|NCT00952588|50591056|FG001|Overall Study|Physician Decision|1|||
25187843|NCT02635386|50339117|FG004|Overall Study|Withdrawal by Subject|0|||
25277020|NCT00952588|50591055|FG000|Overall Study|Lack of Efficacy|2|||
25187844|NCT02635386|50339113|FG000|Overall Study|Physician Decision|0|||
25187845|NCT02635386|50339114|FG001|Overall Study|Physician Decision|1|||
25187846|NCT02635386|50339115|FG002|Overall Study|Physician Decision|0|||
25187847|NCT02635386|50339116|FG003|Overall Study|Physician Decision|0|||
25187848|NCT02635386|50339117|FG004|Overall Study|Physician Decision|0|||
25187849|NCT02635386|50339113|FG000|Overall Study|Moved Out of State|0|||
25187850|NCT02635386|50339114|FG001|Overall Study|Moved Out of State|1|||
25187851|NCT02635386|50339115|FG002|Overall Study|Moved Out of State|0|||
25187852|NCT02635386|50339116|FG003|Overall Study|Moved Out of State|0|||
25187853|NCT02635386|50339117|FG004|Overall Study|Moved Out of State|0|||
25187854|NCT02635386|50339113|FG000|Overall Study|Noncompliant|0|||
25187855|NCT02635386|50339114|FG001|Overall Study|Noncompliant|2|||
25187856|NCT02635386|50339115|FG002|Overall Study|Noncompliant|1|||
25187857|NCT02635386|50339116|FG003|Overall Study|Noncompliant|1|||
25187858|NCT02635386|50339117|FG004|Overall Study|Noncompliant|1|||
25187859|NCT02635386|50339113|FG000|Overall Study|side effects|0|||
25187860|NCT02635386|50339114|FG001|Overall Study|side effects|0|||
25187861|NCT02635386|50339115|FG002|Overall Study|side effects|1|||
25187862|NCT02635386|50339116|FG003|Overall Study|side effects|4|||
25187863|NCT02635386|50339117|FG004|Overall Study|side effects|6|||
25187864|NCT02635386|50339113|FG000|Overall Study|needed other major surgery|0|||
25187865|NCT02635386|50339114|FG001|Overall Study|needed other major surgery|1|||
25187866|NCT02635386|50339115|FG002|Overall Study|needed other major surgery|0|||
25187867|NCT02635386|50339116|FG003|Overall Study|needed other major surgery|0|||
25187868|NCT02635386|50339117|FG004|Overall Study|needed other major surgery|0|||
25187869|NCT02635386|50339113|FG000|Overall Study|Other medical problems not drug related|0|||
25187870|NCT02635386|50339114|FG001|Overall Study|Other medical problems not drug related|0|||
25187871|NCT02635386|50339115|FG002|Overall Study|Other medical problems not drug related|0|||
25187872|NCT02635386|50339116|FG003|Overall Study|Other medical problems not drug related|1|||
25187873|NCT02635386|50339117|FG004|Overall Study|Other medical problems not drug related|0|||
25187874|NCT02634606|50339224|FG000|Overall Study|unable to obtain the drug at start|13|||
25187875|NCT01672866|50339270|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
25187876|NCT01672866|50339271|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
25187877|NCT01672866|50339272|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
25187878|NCT01672866|50339270|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
25187879|NCT01672866|50339271|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
25187880|NCT01672866|50339272|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
25187881|NCT01672866|50339270|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
25187882|NCT01672866|50339271|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
25187883|NCT01672866|50339272|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
25187884|NCT01672866|50339270|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
25187885|NCT01672866|50339271|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
25187886|NCT01672866|50339272|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
25187887|NCT01672866|50339270|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
25187888|NCT01672866|50339271|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
25187889|NCT01672866|50339272|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
25187890|NCT01672866|50339270|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
25187891|NCT01672866|50339271|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
25187892|NCT01672866|50339272|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
25187893|NCT01672866|50339270|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
25187894|NCT01672866|50339271|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
25187895|NCT01672866|50339272|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
25187896|NCT01672866|50339270|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
25187897|NCT01672866|50339271|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
25187898|NCT01672866|50339272|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
25187899|NCT01672866|50339270|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
25187900|NCT01672866|50339271|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
25187901|NCT01672866|50339272|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
25187902|NCT01672866|50339270|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
25187903|NCT01672866|50339271|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
25187904|NCT01672866|50339272|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
25187905|NCT01672866|50339270|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
24965346|NCT00185588|50055046|FG000|Overall Study|Lost to Follow-up|0|||
24965347|NCT00185588|50055047|FG001|Overall Study|Lost to Follow-up|0|||
24965348|NCT00185588|50055048|FG002|Overall Study|Lost to Follow-up|1|||
24965349|NCT00185588|50055049|FG003|Overall Study|Lost to Follow-up|2|||
24965350|NCT00185588|50055046|FG000|Overall Study|Withdrawal by Subject|0|||
24965351|NCT00185588|50055047|FG001|Overall Study|Withdrawal by Subject|1|||
25277021|NCT00952588|50591056|FG001|Overall Study|Lack of Efficacy|2|||
25277022|NCT01227902|50591066|FG000|Overall Study|Adverse Event|12|||
25277023|NCT01227902|50591067|FG001|Overall Study|Adverse Event|8|||
25277024|NCT01227902|50591068|FG002|Overall Study|Adverse Event|11|||
25277025|NCT01227902|50591069|FG003|Overall Study|Adverse Event|4|||
25277026|NCT01227902|50591066|FG000|Overall Study|Lack of Efficacy|1|||
25277027|NCT01227902|50591067|FG001|Overall Study|Lack of Efficacy|2|||
25277028|NCT01227902|50591068|FG002|Overall Study|Lack of Efficacy|2|||
25277029|NCT01227902|50591069|FG003|Overall Study|Lack of Efficacy|1|||
25277030|NCT01227902|50591066|FG000|Overall Study|Protocol Violation|1|||
25277031|NCT01227902|50591067|FG001|Overall Study|Protocol Violation|0|||
25277032|NCT01227902|50591068|FG002|Overall Study|Protocol Violation|0|||
25277033|NCT01227902|50591069|FG003|Overall Study|Protocol Violation|0|||
25277034|NCT01227902|50591066|FG000|Overall Study|Lost to Follow-up|0|||
25277035|NCT01227902|50591067|FG001|Overall Study|Lost to Follow-up|0|||
25277036|NCT01227902|50591068|FG002|Overall Study|Lost to Follow-up|1|||
25277037|NCT01227902|50591069|FG003|Overall Study|Lost to Follow-up|2|||
25277038|NCT01227902|50591066|FG000|Overall Study|Physician Decision|0|||
25277039|NCT01227902|50591067|FG001|Overall Study|Physician Decision|1|||
25277040|NCT01227902|50591068|FG002|Overall Study|Physician Decision|1|||
25277041|NCT01227902|50591069|FG003|Overall Study|Physician Decision|0|||
24965352|NCT00185588|50055048|FG002|Overall Study|Withdrawal by Subject|0|||
24965353|NCT00185588|50055049|FG003|Overall Study|Withdrawal by Subject|0|||
25187906|NCT01672866|50339271|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
25187907|NCT01672866|50339272|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
25187908|NCT01672866|50339270|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
25187909|NCT01672866|50339271|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
25187910|NCT01672866|50339272|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
25187911|NCT01672866|50339270|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
25187912|NCT01672866|50339271|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
25187913|NCT01672866|50339272|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
25187914|NCT04465877|50339498|FG000|Overall Study|Noncompliant with study requirements|0|||
25187915|NCT04465877|50339499|FG001|Overall Study|Noncompliant with study requirements|0|||
25187916|NCT04465877|50339500|FG002|Overall Study|Noncompliant with study requirements|1|||
25187917|NCT04465877|50339501|FG003|Overall Study|Noncompliant with study requirements|0|||
25187918|NCT04267133|50339558|FG000|Overall Study|Withdrawal by Subject|1|||
25277042|NCT01227902|50591066|FG000|Overall Study|Withdrawal by Subject|4|||
25277043|NCT01227902|50591067|FG001|Overall Study|Withdrawal by Subject|2|||
25277044|NCT01227902|50591068|FG002|Overall Study|Withdrawal by Subject|4|||
25277045|NCT01227902|50591069|FG003|Overall Study|Withdrawal by Subject|3|||
25277046|NCT00946192|50591083|FG000|Overall Study|Lost to Follow-up|6|||
25277047|NCT00946192|50591084|FG001|Overall Study|Lost to Follow-up|11|||
25277048|NCT00946192|50591085|FG002|Overall Study|Lost to Follow-up|9|||
25277049|NCT00946192|50591083|FG000|Overall Study|Withdrawal by Subject|10|||
25277050|NCT00946192|50591084|FG001|Overall Study|Withdrawal by Subject|7|||
25277051|NCT00946192|50591085|FG002|Overall Study|Withdrawal by Subject|3|||
25277052|NCT00946192|50591083|FG000|Overall Study|Did not start medication|2|||
25277053|NCT00946192|50591084|FG001|Overall Study|Did not start medication|0|||
25277054|NCT00946192|50591085|FG002|Overall Study|Did not start medication|0|||
25277055|NCT01037127|50591095|FG000|Overall Study|Lost to Follow-up|2|||
25277056|NCT01037127|50591096|FG001|Overall Study|Lost to Follow-up|4|||
25277057|NCT01037127|50591095|FG000|Overall Study|Physician Decision|1|||
25277058|NCT01037127|50591096|FG001|Overall Study|Physician Decision|0|||
25277059|NCT01037127|50591095|FG000|Overall Study|Study Closed Terminated|2|||
25277060|NCT01037127|50591096|FG001|Overall Study|Study Closed Terminated|17|||
25277061|NCT00946114|50591114|FG000|Overall Study|Death|5|||
25187919|NCT04267133|50339558|FG000|Overall Study|Adverse Event|4|||
25187920|NCT02631876|50339689|FG000|Overall Study|Death|96|||
25187921|NCT02631876|50339690|FG001|Overall Study|Death|50|||
25187922|NCT02631876|50339689|FG000|Overall Study|Investigator's discretion|1|||
25187923|NCT02631876|50339690|FG001|Overall Study|Investigator's discretion|0|||
25187924|NCT02631876|50339689|FG000|Overall Study|Lost to Follow-up|2|||
25187925|NCT02631876|50339690|FG001|Overall Study|Lost to Follow-up|0|||
25187926|NCT02631876|50339689|FG000|Overall Study|Withdrawal by Subject|16|||
25187927|NCT02631876|50339690|FG001|Overall Study|Withdrawal by Subject|9|||
25187928|NCT02631876|50339689|FG000|Overall Study|Other than specified|4|||
25187929|NCT02631876|50339690|FG001|Overall Study|Other than specified|4|||
25187930|NCT02633046|50339719|FG000|Overall Study|Adverse Event|8|||
25187931|NCT02633046|50339719|FG000|Overall Study|Physician Decision|7|||
25187932|NCT02633046|50339719|FG000|Overall Study|Withdrawal by Subject|8|||
25187933|NCT02633046|50339719|FG000|Overall Study|Increased proteinuria|2|||
25187934|NCT02633046|50339719|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
25277062|NCT00946114|50591115|FG001|Overall Study|Death|2|||
25277063|NCT00946114|50591114|FG000|Overall Study|Other|1|||
25277064|NCT00946114|50591115|FG001|Overall Study|Other|0|||
24965354|NCT00185588|50055046|FG000|Overall Study|Physician Decision|0|||
24965355|NCT00185588|50055047|FG001|Overall Study|Physician Decision|0|||
24965356|NCT00185588|50055048|FG002|Overall Study|Physician Decision|1|||
24965357|NCT00185588|50055049|FG003|Overall Study|Physician Decision|0|||
24965358|NCT00232544|50055061|FG000|Overall Study|Lost to Follow-up|20|||
24965359|NCT00232544|50055062|FG001|Overall Study|Lost to Follow-up|15|||
24965360|NCT00231842|50055068|FG000|Overall Study|Withdrawal by Subject|3|||
24965361|NCT00231842|50055068|FG000|Overall Study|Did not complete the last 3 cycle|8|||
24965362|NCT00076102|50055073|FG000|Overall Study|Clinical progression|1|||
24965363|NCT00076102|50055073|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
24965364|NCT00076102|50055073|FG000|Overall Study|plexiform neurofibroma surgery|1|||
24965365|NCT00076102|50055073|FG000|Overall Study|refusal of further therapy|2|||
25168636|NCT01872689|50298242|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
25277065|NCT00946114|50591114|FG000|Overall Study|Withdrawal by Subject|2|||
25277066|NCT00946114|50591115|FG001|Overall Study|Withdrawal by Subject|0|||
25277067|NCT01038921|50591123|FG000|Overall Study|Withdrawal by Subject|1|||
25277068|NCT01038921|50591124|FG001|Overall Study|Withdrawal by Subject|0|||
25277069|NCT01038921|50591123|FG000|Overall Study|Physician Decision|1|||
25277070|NCT01038921|50591124|FG001|Overall Study|Physician Decision|0|||
25277071|NCT01038687|50591133|FG000|Overall Study|Adverse Event|0|||
25277072|NCT01038687|50591134|FG001|Overall Study|Adverse Event|2|||
25277073|NCT01038687|50591135|FG002|Overall Study|Adverse Event|1|||
25277074|NCT01081912|50591143|FG000|Conversion/Titration|Adverse Event|47|||
25277075|NCT01081912|50591144|FG001|Conversion/Titration|Adverse Event|0|||
25277076|NCT01081912|50591145|FG002|Conversion/Titration|Adverse Event|0|||
25277077|NCT01081912|50591143|FG000|Conversion/Titration|Lack of Efficacy|17|||
25277078|NCT01081912|50591144|FG001|Conversion/Titration|Lack of Efficacy|0|||
25277079|NCT01081912|50591145|FG002|Conversion/Titration|Lack of Efficacy|0|||
25277080|NCT01081912|50591143|FG000|Conversion/Titration|Lost to Follow-up|5|||
25277081|NCT01081912|50591144|FG001|Conversion/Titration|Lost to Follow-up|0|||
24965366|NCT00231062|50055087|FG000|Overall Study|Physician Decision|6|||
24965367|NCT00184028|50055091|FG000|Overall Study|Death|1|||
24965368|NCT00184028|50055091|FG000|Overall Study|Lack of Efficacy|4|||
25277082|NCT01081912|50591145|FG002|Conversion/Titration|Lost to Follow-up|0|||
25277083|NCT01081912|50591143|FG000|Conversion/Titration|Physician Decision|2|||
25277084|NCT01081912|50591144|FG001|Conversion/Titration|Physician Decision|0|||
25277085|NCT01081912|50591145|FG002|Conversion/Titration|Physician Decision|0|||
25277086|NCT01081912|50591143|FG000|Conversion/Titration|Protocol Violation|67|||
25277087|NCT01081912|50591144|FG001|Conversion/Titration|Protocol Violation|0|||
25277088|NCT01081912|50591145|FG002|Conversion/Titration|Protocol Violation|0|||
25277089|NCT01081912|50591143|FG000|Conversion/Titration|Withdrawal by Subject|23|||
25277090|NCT01081912|50591144|FG001|Conversion/Titration|Withdrawal by Subject|0|||
25277091|NCT01081912|50591145|FG002|Conversion/Titration|Withdrawal by Subject|0|||
25277092|NCT01081912|50591143|FG000|Conversion/Titration|Non-Compliance|47|||
25277093|NCT01081912|50591144|FG001|Conversion/Titration|Non-Compliance|0|||
25277094|NCT01081912|50591145|FG002|Conversion/Titration|Non-Compliance|0|||
25277095|NCT01081912|50591143|FG000|Maintenance Treatment|Adverse Event|0|||
25277096|NCT01081912|50591144|FG001|Maintenance Treatment|Adverse Event|2|||
25277097|NCT01081912|50591145|FG002|Maintenance Treatment|Adverse Event|12|||
25277098|NCT01081912|50591143|FG000|Maintenance Treatment|Lack of Efficacy|0|||
25277099|NCT01081912|50591144|FG001|Maintenance Treatment|Lack of Efficacy|14|||
25277100|NCT01081912|50591145|FG002|Maintenance Treatment|Lack of Efficacy|64|||
25277101|NCT01081912|50591143|FG000|Maintenance Treatment|Lost to Follow-up|0|||
25277102|NCT01081912|50591144|FG001|Maintenance Treatment|Lost to Follow-up|1|||
25277103|NCT01081912|50591145|FG002|Maintenance Treatment|Lost to Follow-up|0|||
25277104|NCT01081912|50591143|FG000|Maintenance Treatment|Physician Decision|0|||
25277105|NCT01081912|50591144|FG001|Maintenance Treatment|Physician Decision|0|||
25277106|NCT01081912|50591145|FG002|Maintenance Treatment|Physician Decision|1|||
25277107|NCT01081912|50591143|FG000|Maintenance Treatment|Protocol Violation|0|||
24965369|NCT00184028|50055091|FG000|Overall Study|Adverse Event|2|||
24965370|NCT00184028|50055091|FG000|Overall Study|Withdrawal by Subject|1|||
24965371|NCT00184028|50055091|FG000|Overall Study|Non-compliance|2|||
24965372|NCT00183872|50055096|FG000|Overall Study|Death|3|||
25067530|NCT02630966|50173281|FG000|Overall Study|Adverse Event|1|||
25067531|NCT02630966|50173282|FG001|Overall Study|Adverse Event|3|||
25187935|NCT02633046|50339719|FG000|Overall Study|Mutual decision patient and physician|1|||
25187936|NCT01672788|50339778|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
25187937|NCT01672788|50339779|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
25187938|NCT01672788|50339780|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
25187939|NCT01672788|50339781|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
25187940|NCT02632110|50339796|FG000|Overall Study|Withdrawal by Subject|1|||
25187941|NCT02632110|50339797|FG001|Overall Study|Withdrawal by Subject|1|||
25187942|NCT02632110|50339798|FG002|Overall Study|Withdrawal by Subject|0|||
25187943|NCT02632110|50339799|FG003|Overall Study|Withdrawal by Subject|0|||
25187944|NCT02632110|50339800|FG004|Overall Study|Withdrawal by Subject|1|||
25187945|NCT02632110|50339801|FG005|Overall Study|Withdrawal by Subject|1|||
25187946|NCT02632110|50339802|FG006|Overall Study|Withdrawal by Subject|3|||
25187947|NCT02632110|50339803|FG007|Overall Study|Withdrawal by Subject|3|||
25187948|NCT02632110|50339804|FG008|Overall Study|Withdrawal by Subject|1|||
25187949|NCT02632110|50339805|FG009|Overall Study|Withdrawal by Subject|1|||
25187950|NCT01672710|50340047|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
25187951|NCT01672710|50340048|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
25187952|NCT01672710|50340047|FG000|3 Month Follow up|Lost to Follow-up|2|||
25187953|NCT01672710|50340048|FG001|3 Month Follow up|Lost to Follow-up|3|||
25187954|NCT01672710|50340047|FG000|3 Month Follow up|follow up due after termination date|4|||
25187955|NCT01672710|50340048|FG001|3 Month Follow up|follow up due after termination date|1|||
25187956|NCT02630472|50340083|FG000|Overall Study|Physician Decision|10|||
25187957|NCT02630472|50340084|FG001|Overall Study|Physician Decision|0|||
25187958|NCT01670526|50340120|FG000|Overall Study|Withdrawal by Subject|3|||
25187959|NCT01670526|50340121|FG001|Overall Study|Withdrawal by Subject|1|||
25187960|NCT01670526|50340120|FG000|Overall Study|Lost to Follow-up|9|||
25277108|NCT01081912|50591144|FG001|Maintenance Treatment|Protocol Violation|1|||
25277109|NCT01081912|50591145|FG002|Maintenance Treatment|Protocol Violation|2|||
25277110|NCT01081912|50591143|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
25277111|NCT01081912|50591144|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
25277112|NCT01081912|50591145|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
25277113|NCT01081912|50591143|FG000|Maintenance Treatment|Non-Compliance|0|||
25277114|NCT01081912|50591144|FG001|Maintenance Treatment|Non-Compliance|4|||
25277115|NCT01081912|50591145|FG002|Maintenance Treatment|Non-Compliance|7|||
25277116|NCT01081912|50591143|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
25277117|NCT01081912|50591144|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
25277118|NCT01081912|50591145|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
25277119|NCT01038609|50591157|FG000|Overall Study|Adverse Event|0|||
25277120|NCT01038609|50591158|FG001|Overall Study|Adverse Event|0|||
25277121|NCT01038609|50591159|FG002|Overall Study|Adverse Event|1|||
25277122|NCT01038609|50591160|FG003|Overall Study|Adverse Event|0|||
25277123|NCT01038609|50591161|FG004|Overall Study|Adverse Event|0|||
25277124|NCT01038609|50591157|FG000|Overall Study|Dosing Error|0|||
25277125|NCT01038609|50591158|FG001|Overall Study|Dosing Error|0|||
25277126|NCT01038609|50591159|FG002|Overall Study|Dosing Error|0|||
25277127|NCT01038609|50591160|FG003|Overall Study|Dosing Error|1|||
25277128|NCT01038609|50591161|FG004|Overall Study|Dosing Error|1|||
25277129|NCT01038609|50591157|FG000|Overall Study|Death in the Family|1|||
25277130|NCT01038609|50591158|FG001|Overall Study|Death in the Family|0|||
25277131|NCT01038609|50591159|FG002|Overall Study|Death in the Family|0|||
25277132|NCT01038609|50591160|FG003|Overall Study|Death in the Family|0|||
25277133|NCT01038609|50591161|FG004|Overall Study|Death in the Family|0|||
25277134|NCT01038609|50591157|FG000|Overall Study|Refusal of Blood Draws|0|||
25277135|NCT01038609|50591158|FG001|Overall Study|Refusal of Blood Draws|1|||
25277136|NCT01038609|50591159|FG002|Overall Study|Refusal of Blood Draws|0|||
25277137|NCT01038609|50591160|FG003|Overall Study|Refusal of Blood Draws|0|||
25277138|NCT01038609|50591161|FG004|Overall Study|Refusal of Blood Draws|0|||
25277139|NCT02357134|50591177|FG000|Overall Study|Lost to Follow-up|1|||
25277140|NCT02357134|50591178|FG001|Overall Study|Lost to Follow-up|0|||
25277141|NCT02357134|50591179|FG002|Overall Study|Lost to Follow-up|0|||
25277142|NCT02357134|50591180|FG003|Overall Study|Lost to Follow-up|0|||
25277143|NCT00745420|50591190|FG000|Overall Study|Ineligible|1|||
25277144|NCT02853370|50591194|FG000|Overall Study|Physician Decision|1|||
25277145|NCT02853370|50591194|FG000|Overall Study|Lack of Efficacy|2|||
25277146|NCT02853370|50591194|FG000|Overall Study|Death|1|||
25277147|NCT02853370|50591194|FG000|Overall Study|Adverse Event|4|||
25277148|NCT02853370|50591194|FG000|Overall Study|Withdrawal by Subject|3|||
25277149|NCT01879072|50591199|FG000|Overall Study|Withdrawal by Subject|121|||
25277150|NCT01879072|50591199|FG000|Overall Study|Not Transplanted|30|||
25277151|NCT00954538|50591205|FG000|Part III|Withdrawal by Subject|0|||
25277152|NCT00954538|50591206|FG001|Part III|Withdrawal by Subject|0|||
25277153|NCT00954538|50591207|FG002|Part III|Withdrawal by Subject|0|||
25277154|NCT00954538|50591208|FG003|Part III|Withdrawal by Subject|0|||
25277155|NCT00954538|50591209|FG004|Part III|Withdrawal by Subject|1|||
25277156|NCT00954538|50591210|FG005|Part III|Withdrawal by Subject|0|||
25277157|NCT00943852|50591219|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
25277158|NCT00943852|50591220|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
25277159|NCT00943852|50591221|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
25277160|NCT00943852|50591222|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
25277161|NCT00943852|50591223|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
25277162|NCT00943852|50591224|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
25277163|NCT00943852|50591225|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
25277164|NCT00943852|50591226|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
25277165|NCT00943852|50591227|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
25277166|NCT00943852|50591228|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
25277167|NCT00943852|50591219|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
25277168|NCT00943852|50591220|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
25277169|NCT00943852|50591221|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
25277170|NCT00943852|50591222|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
25277171|NCT00943852|50591223|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
25277172|NCT00943852|50591224|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
25277173|NCT00943852|50591225|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
25277174|NCT00943852|50591226|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
25277175|NCT00943852|50591227|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
25277176|NCT00943852|50591228|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
25277177|NCT00943852|50591219|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
25277178|NCT00943852|50591220|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
25277179|NCT00943852|50591221|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
25277180|NCT00943852|50591222|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
25277181|NCT00943852|50591223|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
25277182|NCT00943852|50591224|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
25277183|NCT00943852|50591225|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
25277184|NCT00943852|50591226|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
25277185|NCT00943852|50591227|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
25277186|NCT00943852|50591228|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
25277187|NCT00943852|50591219|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
25277188|NCT00943852|50591220|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
25277189|NCT00943852|50591221|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
25277190|NCT00943852|50591222|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
24965373|NCT00183872|50055096|FG000|Overall Study|Adverse Event|9|||
24965374|NCT00183872|50055096|FG000|Overall Study|Withdrawal by Subject|2|||
24965375|NCT00183872|50055096|FG000|Overall Study|Drug delayed more than 28 days|2|||
24965376|NCT03815175|50055100|FG000|Overall Study|Subject Lost to Follow-up|6|||
24965377|NCT03815175|50055100|FG000|Overall Study|Subject Withdrew Consent|48|||
24965378|NCT03815175|50055100|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
24965379|NCT03815175|50055100|FG000|Overall Study|Death|86|||
24965380|NCT03815175|50055100|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
24965381|NCT03815175|50055100|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
24965382|NCT03815175|50055100|FG000|Overall Study|Other Status Change Reason|1|||
24965383|NCT03815175|50055100|FG000|Overall Study|Missed Visit|12|||
24965384|NCT00262028|50055113|FG000|Overall Study|Withdrawal by Subject|6|||
24965385|NCT00262028|50055114|FG001|Overall Study|Withdrawal by Subject|3|||
24965386|NCT00262028|50055115|FG002|Overall Study|Withdrawal by Subject|6|||
24965387|NCT00262028|50055116|FG003|Overall Study|Withdrawal by Subject|5|||
24965388|NCT00262028|50055117|FG004|Overall Study|Withdrawal by Subject|2|||
24965389|NCT00262028|50055118|FG005|Overall Study|Withdrawal by Subject|3|||
24965390|NCT00262028|50055119|FG006|Overall Study|Withdrawal by Subject|5|||
24965391|NCT00262028|50055120|FG007|Overall Study|Withdrawal by Subject|7|||
24965392|NCT00262028|50055121|FG008|Overall Study|Withdrawal by Subject|2|||
24965393|NCT00262028|50055113|FG000|Overall Study|Lost to Follow-up|7|||
24965394|NCT00262028|50055114|FG001|Overall Study|Lost to Follow-up|7|||
24965395|NCT00262028|50055115|FG002|Overall Study|Lost to Follow-up|5|||
24965396|NCT00262028|50055116|FG003|Overall Study|Lost to Follow-up|5|||
24965397|NCT00262028|50055117|FG004|Overall Study|Lost to Follow-up|4|||
24965398|NCT00262028|50055118|FG005|Overall Study|Lost to Follow-up|3|||
24965399|NCT00262028|50055119|FG006|Overall Study|Lost to Follow-up|3|||
24965400|NCT00262028|50055120|FG007|Overall Study|Lost to Follow-up|5|||
24965401|NCT00262028|50055121|FG008|Overall Study|Lost to Follow-up|6|||
24965402|NCT00262028|50055113|FG000|Overall Study|Administrative Reason|11|||
24965403|NCT00262028|50055114|FG001|Overall Study|Administrative Reason|14|||
24965404|NCT00262028|50055115|FG002|Overall Study|Administrative Reason|9|||
24965405|NCT00262028|50055116|FG003|Overall Study|Administrative Reason|12|||
24965406|NCT00262028|50055117|FG004|Overall Study|Administrative Reason|6|||
24965407|NCT00262028|50055118|FG005|Overall Study|Administrative Reason|7|||
24965408|NCT00262028|50055119|FG006|Overall Study|Administrative Reason|4|||
24965409|NCT00262028|50055120|FG007|Overall Study|Administrative Reason|6|||
24965410|NCT00262028|50055121|FG008|Overall Study|Administrative Reason|10|||
24965411|NCT00262028|50055113|FG000|Overall Study|Protocol Violation|0|||
24965412|NCT00262028|50055114|FG001|Overall Study|Protocol Violation|0|||
24965413|NCT00262028|50055115|FG002|Overall Study|Protocol Violation|0|||
24965414|NCT00262028|50055116|FG003|Overall Study|Protocol Violation|1|||
24965415|NCT00262028|50055117|FG004|Overall Study|Protocol Violation|0|||
24965416|NCT00262028|50055118|FG005|Overall Study|Protocol Violation|0|||
24965417|NCT00262028|50055119|FG006|Overall Study|Protocol Violation|0|||
24965418|NCT00262028|50055120|FG007|Overall Study|Protocol Violation|0|||
24965419|NCT00262028|50055121|FG008|Overall Study|Protocol Violation|0|||
24965420|NCT00262028|50055113|FG000|Overall Study|Unable to classify|0|||
24965421|NCT00262028|50055114|FG001|Overall Study|Unable to classify|3|||
24965422|NCT00262028|50055115|FG002|Overall Study|Unable to classify|0|||
24965423|NCT00262028|50055116|FG003|Overall Study|Unable to classify|0|||
24965424|NCT00262028|50055117|FG004|Overall Study|Unable to classify|0|||
24965425|NCT00262028|50055118|FG005|Overall Study|Unable to classify|0|||
24965426|NCT00262028|50055119|FG006|Overall Study|Unable to classify|0|||
24965427|NCT00262028|50055120|FG007|Overall Study|Unable to classify|0|||
24965428|NCT00262028|50055121|FG008|Overall Study|Unable to classify|1|||
24965429|NCT00183248|50055165|FG000|Overall Study|Lost to Follow-up|0|||
24965430|NCT00183248|50055166|FG001|Overall Study|Lost to Follow-up|1|||
24965431|NCT00183248|50055165|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
24965432|NCT00183248|50055166|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
24965433|NCT00183170|50055174|FG000|First Intervention|Did not complete study|1|||
25187961|NCT01670526|50340121|FG001|Overall Study|Lost to Follow-up|5|||
24965434|NCT00183170|50055175|FG001|First Intervention|Did not complete study|0|||
24965435|NCT00183170|50055174|FG000|First Intervention|Did not meet targeted BrAC|1|||
25187962|NCT02630706|50340165|FG000|Overall Study|Adverse Event|2|||
25187963|NCT02630706|50340166|FG001|Overall Study|Adverse Event|1|||
25187964|NCT02630706|50340167|FG002|Overall Study|Adverse Event|1|||
25187965|NCT02630706|50340165|FG000|Overall Study|Lost to Follow-up|0|||
25187966|NCT02630706|50340166|FG001|Overall Study|Lost to Follow-up|1|||
25187967|NCT02630706|50340167|FG002|Overall Study|Lost to Follow-up|2|||
25187968|NCT02630706|50340165|FG000|Overall Study|Physician Decision|1|||
25187969|NCT02630706|50340166|FG001|Overall Study|Physician Decision|1|||
25187970|NCT02630706|50340167|FG002|Overall Study|Physician Decision|0|||
25187971|NCT02630706|50340165|FG000|Overall Study|Pregnancy|0|||
25187972|NCT02630706|50340166|FG001|Overall Study|Pregnancy|1|||
25187973|NCT02630706|50340167|FG002|Overall Study|Pregnancy|0|||
25187974|NCT02630706|50340165|FG000|Overall Study|Withdrawal by Subject|4|||
25187975|NCT02630706|50340166|FG001|Overall Study|Withdrawal by Subject|5|||
24965436|NCT00183170|50055175|FG001|First Intervention|Did not meet targeted BrAC|0|||
24965437|NCT00183170|50055174|FG000|Washout 1 Week|Did not complete study|6|||
24965438|NCT00183170|50055175|FG001|Washout 1 Week|Did not complete study|8|||
24965439|NCT00183170|50055174|FG000|Second Intervention|Did not complete study|1|||
24965440|NCT00183170|50055175|FG001|Second Intervention|Did not complete study|0|||
24965441|NCT00183170|50055174|FG000|Second Intervention|Did not meet targeted BrAC|0|||
24965442|NCT00183170|50055175|FG001|Second Intervention|Did not meet targeted BrAC|2|||
24965443|NCT00230282|50055181|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
24965444|NCT00230282|50055181|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
24965445|NCT00230282|50055181|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
24965446|NCT00230282|50055181|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
24965447|NCT00261950|50055185|FG000|Overall Study|Lost to Follow-up|2|||
24965448|NCT00261950|50055185|FG000|Overall Study|Death|6|||
24965449|NCT00261950|50055185|FG000|Overall Study|Withdrawal by Subject|5|||
24965450|NCT00261950|50055185|FG000|Overall Study|Other|1|||
24965451|NCT00261950|50055185|FG000|Overall Study|Physician Decision|1|||
24965452|NCT00261950|50055185|FG000|Overall Study|Protocol specified Criteria|11|||
24965453|NCT00230048|50055191|FG000|Overall Study|Lost to Follow-up|13|||
24965454|NCT00230048|50055192|FG001|Overall Study|Lost to Follow-up|18|||
24965455|NCT00229658|50055202|FG000|Overall Study|Administrative|2|||
24965456|NCT00229658|50055203|FG001|Overall Study|Administrative|1|||
24965457|NCT00229658|50055202|FG000|Overall Study|Investigator decision|13|||
24965458|NCT00229658|50055203|FG001|Overall Study|Investigator decision|10|||
24965459|NCT00229658|50055202|FG000|Overall Study|Other|80|||
24965460|NCT00229658|50055203|FG001|Overall Study|Other|60|||
24965461|NCT00229658|50055202|FG000|Overall Study|Lost to Follow-up|82|||
24965462|NCT00229658|50055203|FG001|Overall Study|Lost to Follow-up|55|||
24965463|NCT00229658|50055202|FG000|Overall Study|Serious Adverse Event|2|||
24965464|NCT00229658|50055203|FG001|Overall Study|Serious Adverse Event|2|||
24965465|NCT00229658|50055202|FG000|Overall Study|Withdrawal of consent|46|||
24965466|NCT00229658|50055203|FG001|Overall Study|Withdrawal of consent|39|||
24965467|NCT00182078|50055211|FG000|Overall Study|Withdrawal by Subject|1|||
24965468|NCT00182078|50055212|FG001|Overall Study|Withdrawal by Subject|0|||
24965469|NCT00181844|50055218|FG000|Signed Consent|Withdrawal by Subject|5|||
24965470|NCT00181844|50055218|FG000|Signed Consent|Did not meet entrance criteria|7|||
24965471|NCT00181844|50055218|FG000|Exposed to Study Medication|Adverse Event|10|||
24965472|NCT00181844|50055218|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
24965473|NCT00181844|50055218|FG000|Exposed to Study Medication|Non-compliance|2|||
24965474|NCT00181844|50055218|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
24965475|NCT00181844|50055218|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
24965476|NCT00181766|50055222|FG000|Overall Study|Lost to Follow-up|6|||
24965477|NCT00181766|50055222|FG000|Overall Study|Adverse Event|4|||
24965478|NCT00181766|50055222|FG000|Overall Study|non-compliance|2|||
24965479|NCT00180674|50055226|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
25187976|NCT02630706|50340167|FG002|Overall Study|Withdrawal by Subject|7|||
24965480|NCT00180674|50055226|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
25187977|NCT02089997|50340344|FG000|Overall Study|Case report forms uncollected|99|||
25187978|NCT02089997|50340344|FG000|Overall Study|Protocol Violation|147|||
25187979|NCT01363661|50340350|FG000|Overall Study|Adverse Event|9|||
25187980|NCT01363661|50340351|FG001|Overall Study|Adverse Event|2|||
25067532|NCT02630966|50173281|FG000|Overall Study|Significant Protocol Deviation|0|||
25067533|NCT02630966|50173282|FG001|Overall Study|Significant Protocol Deviation|2|||
25067534|NCT02630966|50173281|FG000|Overall Study|Voluntary Withdrawal|1|||
25067535|NCT02630966|50173282|FG001|Overall Study|Voluntary Withdrawal|1|||
25067536|NCT02630966|50173281|FG000|Overall Study|Lack of Efficacy|0|||
25067537|NCT02630966|50173282|FG001|Overall Study|Lack of Efficacy|2|||
25067538|NCT01651780|50173290|FG000|Overall Study|Physician decision: No 30-day visit|2|||
25067539|NCT01651780|50173291|FG001|Overall Study|Physician decision: No 30-day visit|1|||
25067540|NCT01651780|50173290|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
25067541|NCT01651780|50173291|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
25067542|NCT01651780|50173290|FG000|Overall Study|Withdrawal by Subject|2|||
25067543|NCT01651780|50173291|FG001|Overall Study|Withdrawal by Subject|0|||
25067544|NCT01651780|50173290|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
25067545|NCT01651780|50173291|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
25067546|NCT01651780|50173290|FG000|Overall Study|Lost to Follow-up|1|||
25067547|NCT01651780|50173291|FG001|Overall Study|Lost to Follow-up|2|||
25067548|NCT01651780|50173290|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
25067549|NCT01651780|50173291|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
25067550|NCT02394730|50173303|FG000|Overall Study|Lost to Follow-up|1|||
25067551|NCT02394730|50173304|FG001|Overall Study|Lost to Follow-up|0|||
25067552|NCT02394730|50173303|FG000|Overall Study|Withdrawal by Subject|0|||
25067553|NCT02394730|50173304|FG001|Overall Study|Withdrawal by Subject|1|||
25067554|NCT02430532|50173312|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
25067555|NCT02430532|50173313|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
25067556|NCT02430532|50173312|FG000|Overall Study|Consent Withdrawn|0|||
25067557|NCT02430532|50173313|FG001|Overall Study|Consent Withdrawn|2|||
25067558|NCT02430532|50173312|FG000|Overall Study|Adverse Event|0|||
25067559|NCT02430532|50173313|FG001|Overall Study|Adverse Event|1|||
25067560|NCT02394340|50173321|FG000|Overall Study|Failed drug screen test|1|||
25067561|NCT02394340|50173321|FG000|Overall Study|Adverse Event|1|||
25067562|NCT01672736|50173325|FG000|Overall Study|Available drug expired on 31 May 16|3|||
25067563|NCT01560637|50173329|FG000|Overall Study|Adverse Event|63|||
25067564|NCT01560637|50173329|FG000|Overall Study|Death|69|||
25067565|NCT01560637|50173329|FG000|Overall Study|Lost to Follow-up|8|||
25067566|NCT01560637|50173329|FG000|Overall Study|Protocol Violation|8|||
25067567|NCT01560637|50173329|FG000|Overall Study|Withdrawal by Subject|24|||
25067568|NCT01560637|50173329|FG000|Overall Study|Progressive Disease|20|||
25067569|NCT01560637|50173329|FG000|Overall Study|Other Reason Not Specified|6|||
25067570|NCT01353911|50173341|FG000|Overall Study|Lost to Follow-up|2|||
25067571|NCT01353911|50173342|FG001|Overall Study|Lost to Follow-up|6|||
25067572|NCT01353911|50173343|FG002|Overall Study|Lost to Follow-up|4|||
25067573|NCT01353911|50173344|FG003|Overall Study|Lost to Follow-up|0|||
25067574|NCT01353911|50173345|FG004|Overall Study|Lost to Follow-up|4|||
25067575|NCT01353911|50173346|FG005|Overall Study|Lost to Follow-up|4|||
25067576|NCT01353911|50173347|FG006|Overall Study|Lost to Follow-up|3|||
25067577|NCT01353911|50173348|FG007|Overall Study|Lost to Follow-up|6|||
25067578|NCT01353911|50173341|FG000|Overall Study|Withdrawal by Subject|2|||
25067579|NCT01353911|50173342|FG001|Overall Study|Withdrawal by Subject|3|||
25067580|NCT01353911|50173343|FG002|Overall Study|Withdrawal by Subject|4|||
25067581|NCT01353911|50173344|FG003|Overall Study|Withdrawal by Subject|2|||
25067582|NCT01353911|50173345|FG004|Overall Study|Withdrawal by Subject|2|||
25067583|NCT01353911|50173346|FG005|Overall Study|Withdrawal by Subject|3|||
25067584|NCT01353911|50173347|FG006|Overall Study|Withdrawal by Subject|3|||
25067585|NCT01353911|50173348|FG007|Overall Study|Withdrawal by Subject|9|||
25067586|NCT01353911|50173341|FG000|Overall Study|Status Not Recorded|4|||
25067587|NCT01353911|50173342|FG001|Overall Study|Status Not Recorded|0|||
25067588|NCT01353911|50173343|FG002|Overall Study|Status Not Recorded|1|||
25067589|NCT01353911|50173344|FG003|Overall Study|Status Not Recorded|0|||
25067590|NCT01353911|50173345|FG004|Overall Study|Status Not Recorded|0|||
25067591|NCT01353911|50173346|FG005|Overall Study|Status Not Recorded|0|||
25067592|NCT01353911|50173347|FG006|Overall Study|Status Not Recorded|0|||
25067593|NCT01353911|50173348|FG007|Overall Study|Status Not Recorded|0|||
25067594|NCT01671488|50173366|FG000|Overall Study|Withdrawal by Subject|1|||
25067595|NCT02783911|50173372|FG000|Overall Study|Lost to Follow-up|3|||
25067596|NCT02783911|50173373|FG001|Overall Study|Lost to Follow-up|32|||
25067597|NCT01358357|50173381|FG000|Open Label Phase|Adverse Event|0|||
25067598|NCT01358357|50173382|FG001|Open Label Phase|Adverse Event|0|||
25067599|NCT01358357|50173383|FG002|Open Label Phase|Adverse Event|59|||
25067600|NCT01358357|50173381|FG000|Open Label Phase|Lack of Efficacy|0|||
25067601|NCT01358357|50173382|FG001|Open Label Phase|Lack of Efficacy|0|||
25067602|NCT01358357|50173383|FG002|Open Label Phase|Lack of Efficacy|107|||
25067603|NCT01358357|50173381|FG000|Open Label Phase|Lost to Follow-up|0|||
25067604|NCT01358357|50173382|FG001|Open Label Phase|Lost to Follow-up|0|||
25067605|NCT01358357|50173383|FG002|Open Label Phase|Lost to Follow-up|76|||
25067606|NCT01358357|50173381|FG000|Open Label Phase|Protocol Violation|0|||
25067607|NCT01358357|50173382|FG001|Open Label Phase|Protocol Violation|0|||
25067608|NCT01358357|50173383|FG002|Open Label Phase|Protocol Violation|45|||
25067609|NCT01358357|50173381|FG000|Open Label Phase|Withdrawal by Subject|0|||
25067610|NCT01358357|50173382|FG001|Open Label Phase|Withdrawal by Subject|0|||
25067611|NCT01358357|50173383|FG002|Open Label Phase|Withdrawal by Subject|112|||
25067612|NCT01358357|50173381|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
25067613|NCT01358357|50173382|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
25067614|NCT01358357|50173383|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
25067615|NCT01358357|50173381|FG000|Open Label Phase|Terminated at study completion|0|||
25067616|NCT01358357|50173382|FG001|Open Label Phase|Terminated at study completion|0|||
25067617|NCT01358357|50173383|FG002|Open Label Phase|Terminated at study completion|5|||
25067618|NCT01358357|50173381|FG000|Open Label Phase|Mood episode|0|||
25067619|NCT01358357|50173382|FG001|Open Label Phase|Mood episode|0|||
25067620|NCT01358357|50173383|FG002|Open Label Phase|Mood episode|42|||
25067621|NCT01358357|50173381|FG000|Double-Blind Phase|Adverse Event|8|||
25067622|NCT01358357|50173382|FG001|Double-Blind Phase|Adverse Event|5|||
25067623|NCT01358357|50173383|FG002|Double-Blind Phase|Adverse Event|0|||
25067624|NCT01358357|50173381|FG000|Double-Blind Phase|Lost to Follow-up|5|||
25067625|NCT01358357|50173382|FG001|Double-Blind Phase|Lost to Follow-up|7|||
25067626|NCT01358357|50173383|FG002|Double-Blind Phase|Lost to Follow-up|0|||
25067627|NCT01358357|50173381|FG000|Double-Blind Phase|Protocol Violation|1|||
25067628|NCT01358357|50173382|FG001|Double-Blind Phase|Protocol Violation|11|||
25067629|NCT01358357|50173383|FG002|Double-Blind Phase|Protocol Violation|0|||
25067630|NCT01358357|50173381|FG000|Double-Blind Phase|Protocol Violation|16|||
25067631|NCT01358357|50173382|FG001|Double-Blind Phase|Protocol Violation|12|||
25067632|NCT01358357|50173383|FG002|Double-Blind Phase|Protocol Violation|0|||
25067633|NCT01358357|50173381|FG000|Double-Blind Phase|Terminated at study completion|2|||
25067634|NCT01358357|50173382|FG001|Double-Blind Phase|Terminated at study completion|0|||
25067635|NCT01358357|50173383|FG002|Double-Blind Phase|Terminated at study completion|0|||
25067636|NCT01358357|50173381|FG000|Double-Blind Phase|Recurrence of mood event|48|||
25067637|NCT01358357|50173382|FG001|Double-Blind Phase|Recurrence of mood event|64|||
25067638|NCT01358357|50173383|FG002|Double-Blind Phase|Recurrence of mood event|0|||
25067639|NCT01358357|50173381|FG000|Double-Blind Phase|Administrative|0|||
25067640|NCT01358357|50173382|FG001|Double-Blind Phase|Administrative|1|||
25067641|NCT01358357|50173383|FG002|Double-Blind Phase|Administrative|0|||
25067642|NCT02831387|50173392|FG000|Overall Study|Withdrawal by Subject|1|||
25067643|NCT02831387|50173393|FG001|Overall Study|Withdrawal by Subject|1|||
25067644|NCT02831387|50173392|FG000|Overall Study|Discontinued due to stock recovery|0|||
25067645|NCT02831387|50173393|FG001|Overall Study|Discontinued due to stock recovery|1|||
25067646|NCT02831855|50173399|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
25067647|NCT02831855|50173400|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
25067648|NCT02831855|50173401|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
25067649|NCT02831855|50173399|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
25067650|NCT02831855|50173400|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
25067651|NCT02831855|50173401|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
25067652|NCT02831855|50173399|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
25067653|NCT02831855|50173400|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
25067654|NCT02831855|50173401|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
25067655|NCT02831855|50173399|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
25067656|NCT02831855|50173400|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
25067657|NCT02831855|50173401|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
25067658|NCT02831855|50173399|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
25067659|NCT02831855|50173400|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
25067660|NCT02831855|50173401|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
25067661|NCT02831855|50173399|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
25067662|NCT02831855|50173400|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
25067663|NCT02831855|50173401|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
25067664|NCT02831855|50173399|FG000|Open Label Phase (24 Weeks)|Other|4|||
25067665|NCT02831855|50173400|FG001|Open Label Phase (24 Weeks)|Other|0|||
25067666|NCT02831855|50173401|FG002|Open Label Phase (24 Weeks)|Other|0|||
25067667|NCT02831855|50173399|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
25067668|NCT02831855|50173400|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
25067669|NCT02831855|50173401|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
25187981|NCT01363661|50340350|FG000|Overall Study|Withdrawal by Subject|1|||
25067670|NCT02831855|50173399|FG000|Double Blind Phase (24 Weeks)|Death|0|||
25067671|NCT02831855|50173400|FG001|Double Blind Phase (24 Weeks)|Death|0|||
25067672|NCT02831855|50173401|FG002|Double Blind Phase (24 Weeks)|Death|2|||
25067673|NCT02831855|50173399|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
25067674|NCT02831855|50173400|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
25067675|NCT02831855|50173401|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
25067676|NCT02831855|50173399|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
25067677|NCT02831855|50173400|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
25067678|NCT02831855|50173401|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
25067679|NCT02831855|50173399|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
25067680|NCT02831855|50173400|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
25067681|NCT02831855|50173401|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
24965481|NCT00076024|50055237|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
24965482|NCT00076024|50055238|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
24965483|NCT00076024|50055239|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
24965484|NCT00076024|50055240|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
24965485|NCT00076024|50055237|FG000|Phase 1, Lead-in|Adverse Event|1|||
24965486|NCT00076024|50055238|FG001|Phase 1, Lead-in|Adverse Event|0|||
24965487|NCT00076024|50055239|FG002|Phase 1, Lead-in|Adverse Event|0|||
24965488|NCT00076024|50055240|FG003|Phase 1, Lead-in|Adverse Event|0|||
24965489|NCT00076024|50055237|FG000|Phase 1, Lead-in|Clinical progression|1|||
24965490|NCT00076024|50055238|FG001|Phase 1, Lead-in|Clinical progression|0|||
24965491|NCT00076024|50055239|FG002|Phase 1, Lead-in|Clinical progression|0|||
24965492|NCT00076024|50055240|FG003|Phase 1, Lead-in|Clinical progression|0|||
24965493|NCT00076024|50055237|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
24965494|NCT00076024|50055238|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
24965495|NCT00076024|50055239|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
24965496|NCT00076024|50055240|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
24965497|NCT00076024|50055237|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
24965498|NCT00076024|50055238|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
24965499|NCT00076024|50055239|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
24965500|NCT00076024|50055240|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
24965501|NCT00076024|50055237|FG000|Phase 2, Double-blind|Adverse Event|0|||
24965502|NCT00076024|50055238|FG001|Phase 2, Double-blind|Adverse Event|25|||
24965503|NCT00076024|50055239|FG002|Phase 2, Double-blind|Adverse Event|6|||
24965504|NCT00076024|50055240|FG003|Phase 2, Double-blind|Adverse Event|0|||
24965505|NCT00076024|50055237|FG000|Phase 2, Double-blind|Un-specified|0|||
24965506|NCT00076024|50055238|FG001|Phase 2, Double-blind|Un-specified|14|||
24965507|NCT00076024|50055239|FG002|Phase 2, Double-blind|Un-specified|6|||
24965508|NCT00076024|50055240|FG003|Phase 2, Double-blind|Un-specified|0|||
24965509|NCT00076024|50055237|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
24965510|NCT00076024|50055238|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
24965511|NCT00076024|50055239|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
24965512|NCT00076024|50055240|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
24965513|NCT00076024|50055237|FG000|Phase 2, Open-label|Adverse Event|0|||
24965514|NCT00076024|50055238|FG001|Phase 2, Open-label|Adverse Event|0|||
24965515|NCT00076024|50055239|FG002|Phase 2, Open-label|Adverse Event|0|||
24965516|NCT00076024|50055240|FG003|Phase 2, Open-label|Adverse Event|2|||
24965517|NCT00076024|50055237|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
24965518|NCT00076024|50055238|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
24965519|NCT00076024|50055239|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
24965520|NCT00076024|50055240|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
24965521|NCT00076024|50055237|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
24965522|NCT00076024|50055238|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
24965523|NCT00076024|50055239|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
24965524|NCT00076024|50055240|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
24965525|NCT00076024|50055237|FG000|Phase 2, Open-label|Other|0|||
24965526|NCT00076024|50055238|FG001|Phase 2, Open-label|Other|0|||
24965527|NCT00076024|50055239|FG002|Phase 2, Open-label|Other|0|||
24965528|NCT00076024|50055240|FG003|Phase 2, Open-label|Other|2|||
24965529|NCT00075478|50055251|FG000|Overall Study|not eligible|1|||
24965530|NCT00075478|50055252|FG001|Overall Study|not eligible|0|||
24965531|NCT00075478|50055251|FG000|Overall Study|Physician Decision|0|||
24965532|NCT00075478|50055252|FG001|Overall Study|Physician Decision|1|||
24965533|NCT00175916|50055258|FG000|Overall Study|Death|19|||
24965534|NCT00175916|50055258|FG000|Overall Study|Adverse Event|81|||
24965535|NCT00175916|50055258|FG000|Overall Study|Lack of Efficacy|354|||
24965536|NCT00175916|50055258|FG000|Overall Study|Lost to Follow-up|17|||
24965537|NCT00175916|50055258|FG000|Overall Study|Subject Choice|98|||
24965538|NCT00175916|50055258|FG000|Overall Study|Lack of compliance|8|||
24965539|NCT00175916|50055258|FG000|Overall Study|Patient cannot record seizures|1|||
24965540|NCT00175916|50055258|FG000|Overall Study|Sponsor decision|17|||
24965541|NCT00175916|50055258|FG000|Overall Study|Vigabatrin intake|1|||
24965542|NCT00175916|50055258|FG000|Overall Study|Suicidal behaviour|1|||
24965543|NCT00175916|50055258|FG000|Overall Study|Withdrawal by Subject|1|||
24965544|NCT00175916|50055258|FG000|Overall Study|Seizure - free|4|||
24965545|NCT00175916|50055258|FG000|Overall Study|Administrative reason|1|||
24965546|NCT00175916|50055258|FG000|Overall Study|Pregnancy|1|||
24965547|NCT00175916|50055258|FG000|Overall Study|Patient's request|2|||
24965548|NCT00175916|50055258|FG000|Overall Study|Treating physiciant's choice|1|||
24965549|NCT00175916|50055258|FG000|Overall Study|Moved overseas|1|||
24965550|NCT00175916|50055258|FG000|Overall Study|Loss of job and economic burden|1|||
25067682|NCT02831855|50173399|FG000|Double Blind Phase (24 Weeks)|Other|0|||
24965551|NCT00175916|50055258|FG000|Overall Study|Site was closed|9|||
25067683|NCT02831855|50173400|FG001|Double Blind Phase (24 Weeks)|Other|2|||
25067684|NCT02831855|50173401|FG002|Double Blind Phase (24 Weeks)|Other|5|||
25067685|NCT02831855|50173399|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
25067686|NCT02831855|50173400|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
25067687|NCT02831855|50173401|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
25067688|NCT02831855|50173399|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
25067689|NCT02831855|50173400|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
25067690|NCT02831855|50173401|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
25067691|NCT02831855|50173399|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
25067692|NCT02831855|50173400|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
25067693|NCT02831855|50173401|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
25067694|NCT02628938|50173414|FG000|Overall Study|Did not attend the follow up recall|2|||
24965552|NCT00175916|50055258|FG000|Overall Study|Patient went to prison|1|||
24965553|NCT00075400|50055263|FG000|Overall Study|Ineligible: wrong primary|1|||
24965554|NCT00075400|50055263|FG000|Overall Study|Never treated|2|||
24965555|NCT00228566|50055272|FG000|Overall Study|Adverse Event|31|||
24965556|NCT00228566|50055272|FG000|Overall Study|Lack of Efficacy|14|||
24965557|NCT00228566|50055272|FG000|Overall Study|Lost to Follow-up|16|||
24965558|NCT00228566|50055272|FG000|Overall Study|Physician Decision|5|||
24965559|NCT00228566|50055272|FG000|Overall Study|Withdrawal by Subject|4|||
25067695|NCT02628938|50173415|FG001|Overall Study|Did not attend the follow up recall|2|||
25277191|NCT00943852|50591223|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
24965560|NCT00228566|50055272|FG000|Overall Study|Miscellaneous|1|||
24965561|NCT00074152|50055278|FG000|Overall Study|Death|21|||
24965562|NCT00074152|50055279|FG001|Overall Study|Death|9|||
24965563|NCT00074152|50055278|FG000|Overall Study|Lack of Efficacy|34|||
25067696|NCT02628938|50173416|FG002|Overall Study|Did not attend the follow up recall|1|||
25067697|NCT02628938|50173414|FG000|Overall Study|Failure to comply with the instructions|3|||
25067698|NCT02628938|50173415|FG001|Overall Study|Failure to comply with the instructions|0|||
25067699|NCT02628938|50173416|FG002|Overall Study|Failure to comply with the instructions|3|||
25067700|NCT01356407|50173430|FG000|Overall Study|Lost to Follow-up|2|||
25067701|NCT01356407|50173431|FG001|Overall Study|Lost to Follow-up|0|||
25067702|NCT01356407|50173430|FG000|Overall Study|Patient Withdrew Consent|2|||
25067703|NCT01356407|50173431|FG001|Overall Study|Patient Withdrew Consent|1|||
25067704|NCT01356407|50173430|FG000|Overall Study|Could not afford IMP administration|0|||
25067705|NCT01356407|50173431|FG001|Overall Study|Could not afford IMP administration|1|||
25067706|NCT01356407|50173430|FG000|Overall Study|Not complete Endoscopy|2|||
25067707|NCT01356407|50173431|FG001|Overall Study|Not complete Endoscopy|2|||
25067708|NCT00109837|50173437|FG000|Overall Study|Adverse Event|2|||
25067709|NCT00109837|50173437|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
25067710|NCT00109837|50173437|FG000|Overall Study|Death|1|||
25067711|NCT00109837|50173437|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
25067712|NCT00109837|50173437|FG000|Overall Study|Not treated|1|||
25067713|NCT00109837|50173437|FG000|Overall Study|Ineligible|1|||
25067714|NCT02828111|50173450|FG000|Overall Study|Withdrawal by Subject|0|||
25067715|NCT02828111|50173451|FG001|Overall Study|Withdrawal by Subject|0|||
25067716|NCT02828111|50173452|FG002|Overall Study|Withdrawal by Subject|2|||
25067717|NCT02828111|50173453|FG003|Overall Study|Withdrawal by Subject|0|||
25067718|NCT02828111|50173454|FG004|Overall Study|Withdrawal by Subject|0|||
25067719|NCT02828111|50173450|FG000|Overall Study|Lost to Follow-up|0|||
25067720|NCT02828111|50173451|FG001|Overall Study|Lost to Follow-up|0|||
25067721|NCT02828111|50173452|FG002|Overall Study|Lost to Follow-up|0|||
25067722|NCT02828111|50173453|FG003|Overall Study|Lost to Follow-up|1|||
25067723|NCT02828111|50173454|FG004|Overall Study|Lost to Follow-up|1|||
25067724|NCT01671332|50173477|FG000|Overall Study|Withdrawal by Subject|1|||
25067725|NCT01671332|50173478|FG001|Overall Study|Withdrawal by Subject|1|||
25067726|NCT01355627|50173486|FG000|Overall Study|Request By the Patient to Discontinue|5|||
25067727|NCT01355627|50173487|FG001|Overall Study|Request By the Patient to Discontinue|7|||
25067728|NCT01355627|50173486|FG000|Overall Study|Lost to Follow-up|8|||
25067729|NCT01355627|50173487|FG001|Overall Study|Lost to Follow-up|7|||
25067730|NCT01355627|50173486|FG000|Overall Study|Fatal Adverse Event|19|||
25067731|NCT01355627|50173487|FG001|Overall Study|Fatal Adverse Event|23|||
25067732|NCT01355627|50173486|FG000|Overall Study|Other|1|||
25067733|NCT01355627|50173487|FG001|Overall Study|Other|1|||
25067734|NCT00100802|50173493|FG000|Overall Study|Adverse Event|9|||
25067735|NCT00100802|50173493|FG000|Overall Study|Death|1|||
25067736|NCT00100802|50173493|FG000|Overall Study|Lack of Efficacy|47|||
25067737|NCT00100802|50173493|FG000|Overall Study|Physician Decision|5|||
25067738|NCT00100802|50173493|FG000|Overall Study|Protocol Violation|1|||
25067739|NCT00100802|50173493|FG000|Overall Study|Withdrawal by Subject|5|||
25067740|NCT00100802|50173493|FG000|Overall Study|Ineligible|12|||
25067741|NCT01355159|50173499|FG000|Overall Study|Withdrew consent|39|||
25067742|NCT01355159|50173500|FG001|Overall Study|Withdrew consent|47|||
25067743|NCT01355159|50173499|FG000|Overall Study|No primary outcome data|17|||
25067744|NCT01355159|50173500|FG001|Overall Study|No primary outcome data|11|||
25067745|NCT01355159|50173499|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
25067746|NCT01355159|50173500|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
25067747|NCT01355159|50173499|FG000|Overall Study|Early intrauterine fetal death|6|||
25067748|NCT01355159|50173500|FG001|Overall Study|Early intrauterine fetal death|6|||
25277192|NCT00943852|50591224|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
24965564|NCT00074152|50055279|FG001|Overall Study|Lack of Efficacy|24|||
24965565|NCT00261846|50055295|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
24965566|NCT00261846|50055296|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
24965567|NCT00261846|50055297|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
25067749|NCT02630186|50173506|FG000|Overall Study|Withdrawal by Subject|1|||
25067750|NCT01669928|50173512|FG000|First Intervention|Withdrawal by Subject|3|||
25067751|NCT01669928|50173513|FG001|First Intervention|Withdrawal by Subject|5|||
25067752|NCT01355081|50173524|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
25067753|NCT01355081|50173525|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
24965568|NCT00261846|50055298|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
24965569|NCT00261846|50055299|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
24965570|NCT00261846|50055300|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
24965571|NCT00261846|50055301|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
24965572|NCT00261846|50055302|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
24965573|NCT00261846|50055303|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
24965574|NCT00261846|50055304|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
24965575|NCT00261846|50055305|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
24965576|NCT00261846|50055306|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
24965577|NCT00261846|50055295|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
24965578|NCT00261846|50055296|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
24965579|NCT00261846|50055297|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
24965580|NCT00261846|50055298|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
24965581|NCT00261846|50055299|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
24965582|NCT00261846|50055300|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
24965583|NCT00261846|50055301|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
24965584|NCT00261846|50055302|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
24965585|NCT00261846|50055303|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
24965586|NCT00261846|50055304|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
24965587|NCT00261846|50055305|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
24965588|NCT00261846|50055306|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
24965589|NCT00261846|50055295|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
24965590|NCT00261846|50055296|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
24965591|NCT00261846|50055297|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
24965592|NCT00261846|50055298|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
24965593|NCT00261846|50055299|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
24965594|NCT00261846|50055300|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
24965595|NCT00261846|50055301|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
25067754|NCT01355081|50173526|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
25067755|NCT01355081|50173524|FG000|Overall Study|Major Protocol Deviation|0|||
25067756|NCT01355081|50173525|FG001|Overall Study|Major Protocol Deviation|1|||
25067757|NCT01355081|50173526|FG002|Overall Study|Major Protocol Deviation|0|||
24965596|NCT00261846|50055302|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
24965597|NCT00261846|50055303|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
24965598|NCT00261846|50055304|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
24965599|NCT00261846|50055305|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
24965600|NCT00261846|50055306|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
24965601|NCT00261846|50055295|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
24965602|NCT00261846|50055296|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
24965603|NCT00261846|50055297|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
24965604|NCT00261846|50055298|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
24965605|NCT00261846|50055299|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
24965606|NCT00261846|50055300|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
24965607|NCT00261846|50055301|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
24965608|NCT00261846|50055302|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
24965609|NCT00261846|50055303|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
24965610|NCT00261846|50055304|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
24965611|NCT00261846|50055305|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
24965612|NCT00261846|50055306|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
24965613|NCT00261846|50055295|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
24965614|NCT00261846|50055296|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
25067758|NCT01355081|50173524|FG000|Overall Study|Lost to Follow-up|0|||
25067759|NCT01355081|50173525|FG001|Overall Study|Lost to Follow-up|0|||
25067760|NCT01355081|50173526|FG002|Overall Study|Lost to Follow-up|1|||
24965615|NCT00261846|50055297|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
24965616|NCT00261846|50055298|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
24965617|NCT00261846|50055299|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
24965618|NCT00261846|50055300|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
24965619|NCT00261846|50055301|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
24965620|NCT00261846|50055302|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
24965621|NCT00261846|50055303|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
24965622|NCT00261846|50055304|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
24965623|NCT00261846|50055305|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
24965624|NCT00261846|50055306|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
24965625|NCT00261846|50055295|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
24965626|NCT00261846|50055296|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
24965627|NCT00261846|50055297|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
24965628|NCT00261846|50055298|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
24965629|NCT00261846|50055299|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
24965630|NCT00261846|50055300|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
24965631|NCT00261846|50055301|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
25067761|NCT01355081|50173524|FG000|Overall Study|Withdrawal of Consent|2|||
25067762|NCT01355081|50173525|FG001|Overall Study|Withdrawal of Consent|3|||
25067763|NCT01355081|50173526|FG002|Overall Study|Withdrawal of Consent|3|||
25067764|NCT01355081|50173524|FG000|Overall Study|Lack of Efficacy|2|||
25067765|NCT01355081|50173525|FG001|Overall Study|Lack of Efficacy|1|||
25067766|NCT01355081|50173526|FG002|Overall Study|Lack of Efficacy|1|||
25067767|NCT01355081|50173524|FG000|Overall Study|Non Compliance with Study Medication|0|||
25067768|NCT01355081|50173525|FG001|Overall Study|Non Compliance with Study Medication|1|||
25067769|NCT01355081|50173526|FG002|Overall Study|Non Compliance with Study Medication|0|||
25067770|NCT01354223|50173536|FG000|Overall Study|Withdrawal by Subject|3|||
25067771|NCT01354223|50173537|FG001|Overall Study|Withdrawal by Subject|1|||
25168637|NCT01872689|50298243|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
24965632|NCT00261846|50055302|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
24965633|NCT00261846|50055303|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
24965634|NCT00261846|50055304|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
24965635|NCT00261846|50055305|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
24965636|NCT00261846|50055306|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
24965637|NCT00261846|50055295|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
24965638|NCT00261846|50055296|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
24965639|NCT00261846|50055297|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
24965640|NCT00261846|50055298|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
24965641|NCT00261846|50055299|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
24965642|NCT00261846|50055300|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
24965643|NCT00261846|50055301|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
24965644|NCT00261846|50055302|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
24965645|NCT00261846|50055303|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
24965646|NCT00261846|50055304|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
24965647|NCT00261846|50055305|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
24965648|NCT00261846|50055306|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
24965649|NCT00169442|50055351|FG000|Overall Study|Withdrawal by Subject|0|||
24965650|NCT00169442|50055352|FG001|Overall Study|Withdrawal by Subject|0|||
24965651|NCT00169442|50055353|FG002|Overall Study|Withdrawal by Subject|1|||
24965652|NCT00169442|50055354|FG003|Overall Study|Withdrawal by Subject|0|||
24965653|NCT00169442|50055355|FG004|Overall Study|Withdrawal by Subject|0|||
24965654|NCT00169442|50055356|FG005|Overall Study|Withdrawal by Subject|0|||
24965655|NCT00169442|50055351|FG000|Overall Study|Migrated/moved from study area|0|||
24965656|NCT00169442|50055352|FG001|Overall Study|Migrated/moved from study area|0|||
24965657|NCT00169442|50055353|FG002|Overall Study|Migrated/moved from study area|0|||
24965658|NCT00169442|50055354|FG003|Overall Study|Migrated/moved from study area|0|||
24965659|NCT00169442|50055355|FG004|Overall Study|Migrated/moved from study area|0|||
24965660|NCT00169442|50055356|FG005|Overall Study|Migrated/moved from study area|2|||
24965661|NCT00169442|50055351|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
24965662|NCT00169442|50055352|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
24965663|NCT00169442|50055353|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
24965664|NCT00169442|50055354|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
25067772|NCT04043455|50173547|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
24965665|NCT00169442|50055355|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
24965666|NCT00169442|50055356|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
24965667|NCT00169442|50055351|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
24965668|NCT00169442|50055352|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
24965669|NCT00169442|50055353|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
24965670|NCT00169442|50055354|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
24965671|NCT00169442|50055355|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
24965672|NCT00169442|50055356|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
24965673|NCT00261716|50055374|FG000|Overall Study|Withdrawal by Subject|6|||
24965674|NCT00261716|50055375|FG001|Overall Study|Withdrawal by Subject|8|||
24965675|NCT00261716|50055374|FG000|Overall Study|Lost to Follow-up|0|||
24965676|NCT00261716|50055375|FG001|Overall Study|Lost to Follow-up|2|||
24965677|NCT03809104|50055385|FG000|Overall Study|Withdrawal by Subject|3|||
24965678|NCT00203502|50055389|FG000|Overall Study|Death|1|||
24965679|NCT03799198|50055395|FG000|Overall Study|Lost to Follow-up|4|||
24965680|NCT03799198|50055396|FG001|Overall Study|Lost to Follow-up|8|||
24965681|NCT03799198|50055395|FG000|Overall Study|Death|0|||
24965682|NCT03799198|50055396|FG001|Overall Study|Death|1|||
24965683|NCT00232596|50055404|FG000|6-Week Titration Phase|Adverse Event|6|||
24965684|NCT00232596|50055405|FG001|6-Week Titration Phase|Adverse Event|19|||
24965685|NCT00232596|50055404|FG000|6-Week Titration Phase|Failed to Return|2|||
24965686|NCT00232596|50055405|FG001|6-Week Titration Phase|Failed to Return|1|||
24965687|NCT00232596|50055404|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
24965688|NCT00232596|50055405|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
24965689|NCT00232596|50055404|FG000|6-Week Titration Phase|Protocol Violation|1|||
24965690|NCT00232596|50055405|FG001|6-Week Titration Phase|Protocol Violation|3|||
24965691|NCT00232596|50055404|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
24965692|NCT00232596|50055405|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
24965693|NCT00232596|50055404|FG000|6-Week Titration Phase|Other|3|||
24965694|NCT00232596|50055405|FG001|6-Week Titration Phase|Other|3|||
24965695|NCT00232596|50055404|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
25067773|NCT04043455|50173548|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
25067774|NCT04043455|50173549|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
25067775|NCT04043455|50173550|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
25067776|NCT04043455|50173551|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
25067777|NCT04043455|50173552|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
25067778|NCT04043455|50173547|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
25067779|NCT04043455|50173548|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
25067780|NCT04043455|50173549|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
25067781|NCT04043455|50173550|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
24965696|NCT00232596|50055405|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
24965697|NCT00232596|50055404|FG000|12-Week Maintenance Phase|Adverse Event|7|||
24965698|NCT00232596|50055405|FG001|12-Week Maintenance Phase|Adverse Event|22|||
24965699|NCT00232596|50055404|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
24965700|NCT00232596|50055405|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
24965701|NCT00232596|50055404|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
24965702|NCT00232596|50055405|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
24965703|NCT00232596|50055404|FG000|12-Week Maintenance Phase|Other|1|||
24965704|NCT00232596|50055405|FG001|12-Week Maintenance Phase|Other|3|||
25067782|NCT04043455|50173551|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
25067783|NCT04043455|50173552|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
25067784|NCT04043455|50173547|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
25067785|NCT04043455|50173548|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
24965705|NCT00073918|50055423|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
24965706|NCT00073918|50055423|FG000|Overall Study|Rapid disease progression|2|||
24965707|NCT00073918|50055423|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
24965708|NCT00231894|50055429|FG000|Overall Study|Withdrawal by Subject|1|||
24965709|NCT00231894|50055430|FG001|Overall Study|Withdrawal by Subject|1|||
24965710|NCT00203424|50055442|FG000|Treatment Period|Withdrawal by Subject|4|||
24965711|NCT00203424|50055442|FG000|Treatment Period|Adverse Event|5|||
24965712|NCT00203424|50055442|FG000|Treatment Period|progressive disease|2|||
24965713|NCT00203424|50055442|FG000|Follow-up Period|Withdrawal by Subject|1|||
24965714|NCT00203424|50055442|FG000|Follow-up Period|progressive disease|4|||
24965715|NCT00203424|50055442|FG000|Follow-up Period|Lost to Follow-up|1|||
24965716|NCT00203268|50055446|FG000|Early Treatment|only treated one headache|2|||
24965717|NCT00203268|50055446|FG000|Early Treatment|Lost to Follow-up|1|||
24965718|NCT00203268|50055446|FG000|Early Treatment|Withdrawal by Subject|1|||
24965719|NCT00168818|50055455|FG000|Overall Study|Adverse Event|23|||
24965720|NCT00168818|50055456|FG001|Overall Study|Adverse Event|29|||
24965721|NCT00168818|50055457|FG002|Overall Study|Adverse Event|31|||
24965722|NCT00168818|50055455|FG000|Overall Study|Protocol Violation|16|||
24965723|NCT00168818|50055456|FG001|Overall Study|Protocol Violation|11|||
24965724|NCT00168818|50055457|FG002|Overall Study|Protocol Violation|11|||
24965725|NCT00168818|50055455|FG000|Overall Study|Lost to Follow-up|13|||
24965726|NCT00168818|50055456|FG001|Overall Study|Lost to Follow-up|4|||
24965727|NCT00168818|50055457|FG002|Overall Study|Lost to Follow-up|15|||
24965728|NCT00168818|50055455|FG000|Overall Study|Withdrawal by Subject|43|||
24965729|NCT00168818|50055456|FG001|Overall Study|Withdrawal by Subject|41|||
24965730|NCT00168818|50055457|FG002|Overall Study|Withdrawal by Subject|37|||
24965731|NCT00168818|50055455|FG000|Overall Study|Other|22|||
24965732|NCT00168818|50055456|FG001|Overall Study|Other|24|||
24965733|NCT00168818|50055457|FG002|Overall Study|Other|30|||
25067786|NCT04043455|50173549|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
25067787|NCT04043455|50173550|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
25067788|NCT04043455|50173551|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
25067789|NCT04043455|50173552|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
25067790|NCT04043455|50173547|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
25067791|NCT04043455|50173548|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
25067792|NCT04043455|50173549|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
25067793|NCT04043455|50173550|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
25067794|NCT04043455|50173551|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
25067795|NCT04043455|50173552|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
25067796|NCT04043455|50173547|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
25067797|NCT04043455|50173548|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
25067798|NCT04043455|50173549|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
25067799|NCT04043455|50173550|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
25067800|NCT04043455|50173551|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
25067801|NCT04043455|50173552|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
25067802|NCT04043455|50173547|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
25067803|NCT04043455|50173548|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
25067804|NCT04043455|50173549|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
25067805|NCT04043455|50173550|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
25067806|NCT04043455|50173551|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
25067807|NCT04043455|50173552|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
25067808|NCT04043455|50173547|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
25067809|NCT04043455|50173548|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
25067810|NCT04043455|50173549|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
25067811|NCT04043455|50173550|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
25067812|NCT04043455|50173551|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
25067813|NCT04043455|50173552|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
25067814|NCT04043455|50173547|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
25067815|NCT04043455|50173548|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
25067816|NCT04043455|50173549|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
25067817|NCT04043455|50173550|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
25067818|NCT04043455|50173551|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
25067819|NCT04043455|50173552|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
25067820|NCT04043455|50173547|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
25067821|NCT04043455|50173548|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
25067822|NCT04043455|50173549|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
25067823|NCT04043455|50173550|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
25067824|NCT04043455|50173551|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
25067825|NCT04043455|50173552|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
25067826|NCT04043455|50173547|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
25067827|NCT04043455|50173548|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
25067828|NCT04043455|50173549|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
25067829|NCT04043455|50173550|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
25067830|NCT04043455|50173551|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
25067831|NCT04043455|50173552|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
25067832|NCT04043455|50173547|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
25067833|NCT04043455|50173548|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
25067834|NCT04043455|50173549|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
25067835|NCT04043455|50173550|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
25067836|NCT04043455|50173551|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
25067837|NCT04043455|50173552|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
24965734|NCT00168818|50055455|FG000|Treatment|Adverse Event|77|||
24965735|NCT00168818|50055456|FG001|Treatment|Adverse Event|89|||
24965736|NCT00168818|50055457|FG002|Treatment|Adverse Event|68|||
24965737|NCT00168818|50055455|FG000|Treatment|Protocol Violation|8|||
24965738|NCT00168818|50055456|FG001|Treatment|Protocol Violation|11|||
24965739|NCT00168818|50055457|FG002|Treatment|Protocol Violation|11|||
24965740|NCT00168818|50055455|FG000|Treatment|Lost to Follow-up|0|||
24965741|NCT00168818|50055456|FG001|Treatment|Lost to Follow-up|2|||
24965742|NCT00168818|50055457|FG002|Treatment|Lost to Follow-up|1|||
24965743|NCT00168818|50055455|FG000|Treatment|Withdrawal by Subject|25|||
24965744|NCT00168818|50055456|FG001|Treatment|Withdrawal by Subject|20|||
24965745|NCT00168818|50055457|FG002|Treatment|Withdrawal by Subject|22|||
25067838|NCT02627144|50173570|FG000|Overall Study|Serious adverse event|32|||
25067839|NCT02627144|50173570|FG000|Overall Study|Cancer progression|171|||
24965746|NCT00168818|50055455|FG000|Treatment|Other|23|||
24965747|NCT00168818|50055456|FG001|Treatment|Other|29|||
24965748|NCT00168818|50055457|FG002|Treatment|Other|31|||
24965749|NCT00260832|50055467|FG000|Overall Study|Adverse Event|26|||
24965750|NCT00260832|50055468|FG001|Overall Study|Adverse Event|19|||
24965751|NCT00260832|50055467|FG000|Overall Study|Progression|116|||
24965752|NCT00260832|50055468|FG001|Overall Study|Progression|96|||
24965753|NCT00260832|50055467|FG000|Overall Study|Withdrawal by Subject|15|||
24965754|NCT00260832|50055468|FG001|Overall Study|Withdrawal by Subject|17|||
24965755|NCT00260832|50055467|FG000|Overall Study|Physician Decision|15|||
24965756|NCT00260832|50055468|FG001|Overall Study|Physician Decision|9|||
24965757|NCT00260832|50055467|FG000|Overall Study|Death|43|||
24965758|NCT00260832|50055468|FG001|Overall Study|Death|62|||
24965759|NCT00260832|50055467|FG000|Overall Study|Other|10|||
24965760|NCT00260832|50055468|FG001|Overall Study|Other|7|||
24965761|NCT00260832|50055467|FG000|Overall Study|Protocol Violation|3|||
24965762|NCT00260832|50055468|FG001|Overall Study|Protocol Violation|1|||
24965763|NCT00168038|50055474|FG000|Overall Study|Adverse Event|1|||
24965764|NCT00168038|50055474|FG000|Overall Study|Therapy failure|1|||
24965765|NCT00167414|50055478|FG000|Overall Study|Death|10|||
24965766|NCT00166712|50055484|FG000|Overall Study|Death|0|||
24965767|NCT00166712|50055485|FG001|Overall Study|Death|1|||
24965768|NCT00166712|50055484|FG000|Overall Study|Adverse Event|1|||
24965769|NCT00166712|50055485|FG001|Overall Study|Adverse Event|0|||
24965770|NCT00166712|50055484|FG000|Overall Study|Withdrawal by Subject|1|||
24965771|NCT00166712|50055485|FG001|Overall Study|Withdrawal by Subject|2|||
24965772|NCT00166712|50055484|FG000|Overall Study|Physician Decision|0|||
24965773|NCT00166712|50055485|FG001|Overall Study|Physician Decision|2|||
24965774|NCT00073528|50055497|FG000|Overall Study|Death|488|||
24965775|NCT00073528|50055498|FG001|Overall Study|Death|473|||
25067840|NCT02627144|50173570|FG000|Overall Study|Death from cancer|20|||
25067841|NCT02627144|50173570|FG000|Overall Study|Death from other cause|8|||
25277193|NCT00943852|50591225|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
24965776|NCT00073528|50055497|FG000|Overall Study|Lost to Follow-up|52|||
24965777|NCT00073528|50055498|FG001|Overall Study|Lost to Follow-up|45|||
24965778|NCT00073528|50055497|FG000|Overall Study|Withdrawal by Subject|50|||
24965779|NCT00073528|50055498|FG001|Overall Study|Withdrawal by Subject|45|||
24965780|NCT00073528|50055497|FG000|Overall Study|Study terminated by Sponsor|10|||
24965781|NCT00073528|50055498|FG001|Overall Study|Study terminated by Sponsor|29|||
24965782|NCT00073528|50055497|FG000|Overall Study|Other|18|||
24965783|NCT00073528|50055498|FG001|Overall Study|Other|19|||
24965784|NCT00073528|50055497|FG000|Overall Study|Other|9|||
24965785|NCT00073528|50055498|FG001|Overall Study|Other|12|||
24965786|NCT00073528|50055497|FG000|Overall Study|Protocol Violation|3|||
24965787|NCT00073528|50055498|FG001|Overall Study|Protocol Violation|5|||
24965788|NCT03801148|50055508|FG000|Period 1 (2 Days)|Adverse Event|1|||
24965789|NCT03801148|50055509|FG001|Period 1 (2 Days)|Adverse Event|1|||
24965790|NCT03801148|50055510|FG002|Period 1 (2 Days)|Adverse Event|0|||
24965791|NCT03801148|50055511|FG003|Period 1 (2 Days)|Adverse Event|0|||
24965792|NCT03801148|50055508|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
24965793|NCT03801148|50055509|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
24965794|NCT03801148|50055510|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
24965795|NCT03801148|50055511|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
24965796|NCT03801148|50055508|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
25277194|NCT00943852|50591226|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
25277195|NCT00943852|50591227|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
25277196|NCT00943852|50591228|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
25277197|NCT00943852|50591219|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
25277198|NCT00943852|50591220|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
25277199|NCT00943852|50591221|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
25277200|NCT00943852|50591222|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
25277201|NCT00943852|50591223|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
25277202|NCT00943852|50591224|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
25277203|NCT00943852|50591225|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
25277204|NCT00943852|50591226|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
25277205|NCT00943852|50591227|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
24965797|NCT03801148|50055509|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
24965798|NCT03801148|50055510|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
24965799|NCT03801148|50055511|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
24965800|NCT03801148|50055508|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
24965801|NCT03801148|50055509|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
24965802|NCT03801148|50055510|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
24965803|NCT03801148|50055511|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
24965804|NCT00072280|50055523|FG000|Treatment|Found ineligible|1|||
24965805|NCT00072280|50055524|FG001|Treatment|Found ineligible|2|||
24965806|NCT00072280|50055523|FG000|Follow-up|Early termination of study|2|||
24965807|NCT00072280|50055524|FG001|Follow-up|Early termination of study|2|||
24965808|NCT00071812|50055533|FG000|24-Week Double-Blind Period|Adverse Event|2|||
24965809|NCT00071812|50055534|FG001|24-Week Double-Blind Period|Adverse Event|3|||
24965810|NCT00071812|50055535|FG002|24-Week Double-Blind Period|Adverse Event|4|||
24965811|NCT00071812|50055536|FG003|24-Week Double-Blind Period|Adverse Event|4|||
24965812|NCT00071812|50055533|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
24965813|NCT00071812|50055534|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
24965814|NCT00071812|50055535|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
24965815|NCT00071812|50055536|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
25067842|NCT02627144|50173570|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
25277206|NCT00943852|50591228|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
25277207|NCT00952276|50591243|FG000|Overall Study|Withdrawal by Subject|1|||
25277208|NCT00952276|50591244|FG001|Overall Study|Withdrawal by Subject|0|||
25277209|NCT00952276|50591245|FG002|Overall Study|Withdrawal by Subject|0|||
24965816|NCT00071812|50055533|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
24965817|NCT00071812|50055534|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
24965818|NCT00071812|50055535|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
25067843|NCT02627144|50173570|FG000|Overall Study|Administrative reasons|65|||
25067844|NCT02627144|50173570|FG000|Overall Study|Lost to Follow-up|8|||
25067845|NCT02627144|50173570|FG000|Overall Study|Enrolled, not treated|6|||
25067846|NCT02627144|50173570|FG000|Overall Study|Other|17|||
25067847|NCT02626520|50173576|FG000|Overall Study|Physician Decision|1|||
25067848|NCT02626520|50173577|FG001|Overall Study|Physician Decision|1|||
25067849|NCT02626520|50173576|FG000|Overall Study|Adverse Event|0|||
25067850|NCT02626520|50173577|FG001|Overall Study|Adverse Event|4|||
25067851|NCT02626520|50173576|FG000|Overall Study|Lack of Efficacy|0|||
25067852|NCT02626520|50173577|FG001|Overall Study|Lack of Efficacy|2|||
25067853|NCT02626520|50173576|FG000|Overall Study|Did not start protocol therapy|0|||
25067854|NCT02626520|50173577|FG001|Overall Study|Did not start protocol therapy|2|||
25067855|NCT02626520|50173576|FG000|Overall Study|Study terminated|0|||
25067856|NCT02626520|50173577|FG001|Overall Study|Study terminated|1|||
25067857|NCT04522141|50173585|FG000|Overall Study|Withdrawal by Subject|1|||
25067858|NCT04522141|50173586|FG001|Overall Study|Withdrawal by Subject|0|||
25067859|NCT01329029|50173609|FG000|Overall Study|Withdrawal by Subject|117|||
25067860|NCT01329029|50173610|FG001|Overall Study|Withdrawal by Subject|87|||
25067861|NCT01329029|50173609|FG000|Overall Study|Adverse Event|82|||
25067862|NCT01329029|50173610|FG001|Overall Study|Adverse Event|29|||
25067863|NCT01329029|50173609|FG000|Overall Study|Death|16|||
25067864|NCT01329029|50173610|FG001|Overall Study|Death|19|||
25067865|NCT01329029|50173609|FG000|Overall Study|Other|14|||
25067866|NCT01329029|50173610|FG001|Overall Study|Other|20|||
25067867|NCT01329029|50173609|FG000|Overall Study|COPD Exacerbation|11|||
25067868|NCT01329029|50173610|FG001|Overall Study|COPD Exacerbation|18|||
25067869|NCT01329029|50173609|FG000|Overall Study|Physician Decision|16|||
25067870|NCT01329029|50173610|FG001|Overall Study|Physician Decision|13|||
25067871|NCT01329029|50173609|FG000|Overall Study|Lost to Follow-up|8|||
25067872|NCT01329029|50173610|FG001|Overall Study|Lost to Follow-up|5|||
25067873|NCT01329029|50173609|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
25067874|NCT01329029|50173610|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
25067875|NCT01372085|50173626|FG000|Washout Period 2|Physician Decision|0|||
25067876|NCT01372085|50173627|FG001|Washout Period 2|Physician Decision|0|||
25067877|NCT01372085|50173628|FG002|Washout Period 2|Physician Decision|0|||
25067878|NCT01372085|50173629|FG003|Washout Period 2|Physician Decision|0|||
25067879|NCT01372085|50173630|FG004|Washout Period 2|Physician Decision|1|||
25067880|NCT01372085|50173631|FG005|Washout Period 2|Physician Decision|0|||
25067881|NCT01372085|50173632|FG006|Washout Period 2|Physician Decision|0|||
25067882|NCT01372085|50173633|FG007|Washout Period 2|Physician Decision|0|||
24965819|NCT00071812|50055536|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
24965820|NCT00071812|50055533|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
24965821|NCT00071812|50055534|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
24965822|NCT00071812|50055535|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
24965823|NCT00071812|50055536|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
24965824|NCT00071812|50055533|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
24965825|NCT00071812|50055534|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
24965826|NCT00071812|50055535|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
24965827|NCT00071812|50055536|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
24965828|NCT00071812|50055533|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
24965829|NCT00071812|50055534|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
24965830|NCT00071812|50055535|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
24965831|NCT00071812|50055536|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
24965832|NCT00071812|50055533|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
24965833|NCT00071812|50055534|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
24965834|NCT00071812|50055535|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
24965835|NCT00071812|50055536|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
24965836|NCT00071812|50055533|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
24965837|NCT00071812|50055534|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
24965838|NCT00071812|50055535|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
24965839|NCT00071812|50055536|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
25067883|NCT01372085|50173634|FG008|Washout Period 2|Physician Decision|0|||
25067884|NCT01372085|50173635|FG009|Washout Period 2|Physician Decision|0|||
25067885|NCT01372085|50173626|FG000|Washout Period 3|Withdrawal by Subject|0|||
25067886|NCT01372085|50173627|FG001|Washout Period 3|Withdrawal by Subject|0|||
25067887|NCT01372085|50173628|FG002|Washout Period 3|Withdrawal by Subject|0|||
24965840|NCT00071812|50055533|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
24965841|NCT00071812|50055534|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
25067888|NCT01372085|50173629|FG003|Washout Period 3|Withdrawal by Subject|0|||
25067889|NCT01372085|50173630|FG004|Washout Period 3|Withdrawal by Subject|0|||
25067890|NCT01372085|50173631|FG005|Washout Period 3|Withdrawal by Subject|2|||
25067891|NCT01372085|50173632|FG006|Washout Period 3|Withdrawal by Subject|0|||
25067892|NCT01372085|50173633|FG007|Washout Period 3|Withdrawal by Subject|0|||
25067893|NCT01372085|50173634|FG008|Washout Period 3|Withdrawal by Subject|0|||
25067894|NCT01372085|50173635|FG009|Washout Period 3|Withdrawal by Subject|0|||
25067895|NCT04012853|50173661|FG000|Overall Study|Withdrawal by Subject|1|||
25067896|NCT04012853|50173662|FG001|Overall Study|Withdrawal by Subject|1|||
25067897|NCT04012853|50173661|FG000|Overall Study|Protocol Violation|1|||
25067898|NCT04012853|50173662|FG001|Overall Study|Protocol Violation|0|||
25067899|NCT04012853|50173661|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
25067900|NCT04012853|50173662|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
25067901|NCT02941549|50173671|FG000|Overall Study|Adverse Event|1|||
25067902|NCT02941549|50173672|FG001|Overall Study|Adverse Event|0|||
25067903|NCT02941549|50173673|FG002|Overall Study|Adverse Event|0|||
25067904|NCT02941549|50173671|FG000|Overall Study|Withdrawal by Subject|2|||
25067905|NCT02941549|50173672|FG001|Overall Study|Withdrawal by Subject|1|||
25067906|NCT02941549|50173673|FG002|Overall Study|Withdrawal by Subject|2|||
25067907|NCT02394028|50173695|FG000|Induction Phase|Adverse Event|2|||
25067908|NCT02394028|50173696|FG001|Induction Phase|Adverse Event|4|||
25067909|NCT02394028|50173697|FG002|Induction Phase|Adverse Event|1|||
25187982|NCT01363661|50340351|FG001|Overall Study|Withdrawal by Subject|1|||
25187983|NCT01363661|50340350|FG000|Overall Study|Protocol Violation|1|||
25187984|NCT01363661|50340351|FG001|Overall Study|Protocol Violation|0|||
25187985|NCT01363661|50340350|FG000|Overall Study|Lost to Follow-up|3|||
25187986|NCT01363661|50340351|FG001|Overall Study|Lost to Follow-up|1|||
25187987|NCT02628600|50340359|FG000|Overall Study|Death|2|||
25187988|NCT02628600|50340360|FG001|Overall Study|Death|1|||
25277210|NCT00952276|50591246|FG003|Overall Study|Withdrawal by Subject|1|||
25277211|NCT00952276|50591247|FG004|Overall Study|Withdrawal by Subject|0|||
25067910|NCT02394028|50173698|FG003|Induction Phase|Adverse Event|2|||
25067911|NCT02394028|50173699|FG004|Induction Phase|Adverse Event|5|||
25067912|NCT02394028|50173700|FG005|Induction Phase|Adverse Event|2|||
25067913|NCT02394028|50173701|FG006|Induction Phase|Adverse Event|0|||
25067914|NCT02394028|50173702|FG007|Induction Phase|Adverse Event|0|||
25067915|NCT02394028|50173703|FG008|Induction Phase|Adverse Event|0|||
25067916|NCT02394028|50173704|FG009|Induction Phase|Adverse Event|0|||
25067917|NCT02394028|50173705|FG010|Induction Phase|Adverse Event|0|||
25067918|NCT02394028|50173695|FG000|Induction Phase|Lack of Efficacy|3|||
25067919|NCT02394028|50173696|FG001|Induction Phase|Lack of Efficacy|6|||
25067920|NCT02394028|50173697|FG002|Induction Phase|Lack of Efficacy|2|||
25067921|NCT02394028|50173698|FG003|Induction Phase|Lack of Efficacy|17|||
25067922|NCT02394028|50173699|FG004|Induction Phase|Lack of Efficacy|14|||
24965842|NCT00071812|50055535|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
24965843|NCT00071812|50055536|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
24965844|NCT00071812|50055533|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
24965845|NCT00071812|50055534|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
24965846|NCT00071812|50055535|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
24965847|NCT00071812|50055536|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
24965848|NCT00071110|50055550|FG000|Overall Study|Protocol Violation|0|||
24965849|NCT00071110|50055551|FG001|Overall Study|Protocol Violation|4|||
24965850|NCT00071032|50055559|FG000|Overall Study|Lost to Follow-up|1|||
24965851|NCT00071032|50055560|FG001|Overall Study|Lost to Follow-up|1|||
24965852|NCT00071032|50055559|FG000|Overall Study|Withdrawal by Subject|8|||
24965853|NCT00071032|50055560|FG001|Overall Study|Withdrawal by Subject|6|||
25067923|NCT02394028|50173700|FG005|Induction Phase|Lack of Efficacy|8|||
25067924|NCT02394028|50173701|FG006|Induction Phase|Lack of Efficacy|17|||
25067925|NCT02394028|50173702|FG007|Induction Phase|Lack of Efficacy|23|||
25067926|NCT02394028|50173703|FG008|Induction Phase|Lack of Efficacy|0|||
25067927|NCT02394028|50173704|FG009|Induction Phase|Lack of Efficacy|0|||
25067928|NCT02394028|50173705|FG010|Induction Phase|Lack of Efficacy|0|||
25067929|NCT02394028|50173695|FG000|Induction Phase|Lost to Follow-up|1|||
25067930|NCT02394028|50173696|FG001|Induction Phase|Lost to Follow-up|0|||
25067931|NCT02394028|50173697|FG002|Induction Phase|Lost to Follow-up|0|||
25067932|NCT02394028|50173698|FG003|Induction Phase|Lost to Follow-up|1|||
25067933|NCT02394028|50173699|FG004|Induction Phase|Lost to Follow-up|0|||
25067934|NCT02394028|50173700|FG005|Induction Phase|Lost to Follow-up|0|||
25067935|NCT02394028|50173701|FG006|Induction Phase|Lost to Follow-up|1|||
25067936|NCT02394028|50173702|FG007|Induction Phase|Lost to Follow-up|0|||
25067937|NCT02394028|50173703|FG008|Induction Phase|Lost to Follow-up|0|||
25067938|NCT02394028|50173704|FG009|Induction Phase|Lost to Follow-up|0|||
25067939|NCT02394028|50173705|FG010|Induction Phase|Lost to Follow-up|0|||
25067940|NCT02394028|50173695|FG000|Induction Phase|Non-compliance|0|||
25067941|NCT02394028|50173696|FG001|Induction Phase|Non-compliance|1|||
25067942|NCT02394028|50173697|FG002|Induction Phase|Non-compliance|3|||
25187989|NCT02628600|50340359|FG000|Overall Study|Adverse Event|3|||
25187990|NCT02628600|50340360|FG001|Overall Study|Adverse Event|20|||
24965854|NCT00071032|50055559|FG000|Overall Study|Missing Primary Outcome|0|||
25067943|NCT02394028|50173698|FG003|Induction Phase|Non-compliance|1|||
25067944|NCT02394028|50173699|FG004|Induction Phase|Non-compliance|3|||
25067945|NCT02394028|50173700|FG005|Induction Phase|Non-compliance|0|||
25067946|NCT02394028|50173701|FG006|Induction Phase|Non-compliance|1|||
25187991|NCT02628600|50340359|FG000|Overall Study|Protocol Violation|0|||
25067947|NCT02394028|50173702|FG007|Induction Phase|Non-compliance|1|||
25067948|NCT02394028|50173703|FG008|Induction Phase|Non-compliance|0|||
25067949|NCT02394028|50173704|FG009|Induction Phase|Non-compliance|0|||
24965855|NCT00071032|50055560|FG001|Overall Study|Missing Primary Outcome|1|||
24965856|NCT00259610|50055571|FG000|Overall Study|Withdrawal by Subject|33|||
24965857|NCT00259610|50055572|FG001|Overall Study|Withdrawal by Subject|25|||
24965858|NCT00259610|50055573|FG002|Overall Study|Withdrawal by Subject|29|||
24965859|NCT00259610|50055574|FG003|Overall Study|Withdrawal by Subject|19|||
24965860|NCT00259610|50055571|FG000|Overall Study|Lost to Follow-up|19|||
25187992|NCT02628600|50340360|FG001|Overall Study|Protocol Violation|1|||
25187993|NCT02628600|50340359|FG000|Overall Study|Lack of Efficacy|2|||
25187994|NCT02628600|50340360|FG001|Overall Study|Lack of Efficacy|0|||
25187995|NCT02628600|50340359|FG000|Overall Study|Withdrawal by Subject|13|||
25187996|NCT02628600|50340360|FG001|Overall Study|Withdrawal by Subject|8|||
25187997|NCT02628600|50340359|FG000|Overall Study|Lost to Follow-up|1|||
25187998|NCT02628600|50340360|FG001|Overall Study|Lost to Follow-up|0|||
25187999|NCT02628600|50340359|FG000|Overall Study|Physician Decision|2|||
25188000|NCT02628600|50340360|FG001|Overall Study|Physician Decision|2|||
25188001|NCT02628600|50340359|FG000|Overall Study|Other not specified|1|||
24965861|NCT00259610|50055572|FG001|Overall Study|Lost to Follow-up|8|||
24965862|NCT00259610|50055573|FG002|Overall Study|Lost to Follow-up|18|||
24965863|NCT00259610|50055574|FG003|Overall Study|Lost to Follow-up|15|||
24965864|NCT00259610|50055571|FG000|Overall Study|Physician Decision|6|||
24965865|NCT00259610|50055572|FG001|Overall Study|Physician Decision|4|||
24965866|NCT00259610|50055573|FG002|Overall Study|Physician Decision|7|||
24965867|NCT00259610|50055574|FG003|Overall Study|Physician Decision|2|||
24965868|NCT00259610|50055571|FG000|Overall Study|Death|1|||
24965869|NCT00259610|50055572|FG001|Overall Study|Death|1|||
24965870|NCT00259610|50055573|FG002|Overall Study|Death|2|||
24965871|NCT00259610|50055574|FG003|Overall Study|Death|0|||
25067950|NCT02394028|50173705|FG010|Induction Phase|Non-compliance|0|||
25067951|NCT02394028|50173695|FG000|Induction Phase|Physician Decision|0|||
25067952|NCT02394028|50173696|FG001|Induction Phase|Physician Decision|0|||
25067953|NCT02394028|50173697|FG002|Induction Phase|Physician Decision|1|||
25067954|NCT02394028|50173698|FG003|Induction Phase|Physician Decision|4|||
25067955|NCT02394028|50173699|FG004|Induction Phase|Physician Decision|0|||
25067956|NCT02394028|50173700|FG005|Induction Phase|Physician Decision|2|||
25067957|NCT02394028|50173701|FG006|Induction Phase|Physician Decision|1|||
25067958|NCT02394028|50173702|FG007|Induction Phase|Physician Decision|0|||
25067959|NCT02394028|50173703|FG008|Induction Phase|Physician Decision|0|||
25067960|NCT02394028|50173704|FG009|Induction Phase|Physician Decision|0|||
25067961|NCT02394028|50173705|FG010|Induction Phase|Physician Decision|0|||
25067962|NCT02394028|50173695|FG000|Induction Phase|Protocol Violation|0|||
25067963|NCT02394028|50173696|FG001|Induction Phase|Protocol Violation|2|||
25067964|NCT02394028|50173697|FG002|Induction Phase|Protocol Violation|0|||
25067965|NCT02394028|50173698|FG003|Induction Phase|Protocol Violation|3|||
25067966|NCT02394028|50173699|FG004|Induction Phase|Protocol Violation|0|||
25067967|NCT02394028|50173700|FG005|Induction Phase|Protocol Violation|1|||
25067968|NCT02394028|50173701|FG006|Induction Phase|Protocol Violation|1|||
25067969|NCT02394028|50173702|FG007|Induction Phase|Protocol Violation|0|||
25067970|NCT02394028|50173703|FG008|Induction Phase|Protocol Violation|0|||
25067971|NCT02394028|50173704|FG009|Induction Phase|Protocol Violation|0|||
25067972|NCT02394028|50173705|FG010|Induction Phase|Protocol Violation|0|||
25067973|NCT02394028|50173695|FG000|Induction Phase|Withdrawal by Subject|1|||
24965872|NCT00259610|50055571|FG000|Overall Study|non medical reason|6|||
25188002|NCT02628600|50340360|FG001|Overall Study|Other not specified|0|||
24965873|NCT00259610|50055572|FG001|Overall Study|non medical reason|2|||
25067974|NCT02394028|50173696|FG001|Induction Phase|Withdrawal by Subject|2|||
25188003|NCT00591318|50340377|FG000|Overall Study|Lack of Efficacy|2|||
25067975|NCT02394028|50173697|FG002|Induction Phase|Withdrawal by Subject|4|||
25067976|NCT02394028|50173698|FG003|Induction Phase|Withdrawal by Subject|6|||
25067977|NCT02394028|50173699|FG004|Induction Phase|Withdrawal by Subject|7|||
25067978|NCT02394028|50173700|FG005|Induction Phase|Withdrawal by Subject|4|||
25067979|NCT02394028|50173701|FG006|Induction Phase|Withdrawal by Subject|3|||
25067980|NCT02394028|50173702|FG007|Induction Phase|Withdrawal by Subject|6|||
25067981|NCT02394028|50173703|FG008|Induction Phase|Withdrawal by Subject|0|||
25067982|NCT02394028|50173704|FG009|Induction Phase|Withdrawal by Subject|0|||
25067983|NCT02394028|50173705|FG010|Induction Phase|Withdrawal by Subject|0|||
25067984|NCT02394028|50173695|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
25067985|NCT02394028|50173696|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
25067986|NCT02394028|50173697|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
25067987|NCT02394028|50173698|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
25067988|NCT02394028|50173699|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
25067989|NCT02394028|50173700|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
25067990|NCT02394028|50173701|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
25067991|NCT02394028|50173702|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
25067992|NCT02394028|50173703|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
25067993|NCT02394028|50173704|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
25067994|NCT02394028|50173705|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
25067995|NCT02394028|50173695|FG000|Induction Phase|Sponsor decision|0|||
25067996|NCT02394028|50173696|FG001|Induction Phase|Sponsor decision|1|||
25067997|NCT02394028|50173697|FG002|Induction Phase|Sponsor decision|2|||
25067998|NCT02394028|50173698|FG003|Induction Phase|Sponsor decision|0|||
25067999|NCT02394028|50173699|FG004|Induction Phase|Sponsor decision|0|||
25068000|NCT02394028|50173700|FG005|Induction Phase|Sponsor decision|0|||
25068001|NCT02394028|50173701|FG006|Induction Phase|Sponsor decision|0|||
25068002|NCT02394028|50173702|FG007|Induction Phase|Sponsor decision|0|||
25068003|NCT02394028|50173703|FG008|Induction Phase|Sponsor decision|0|||
25068004|NCT02394028|50173704|FG009|Induction Phase|Sponsor decision|0|||
25068005|NCT02394028|50173705|FG010|Induction Phase|Sponsor decision|0|||
25068006|NCT02394028|50173695|FG000|Induction Phase|Technical reason|0|||
25068007|NCT02394028|50173696|FG001|Induction Phase|Technical reason|0|||
25068008|NCT02394028|50173697|FG002|Induction Phase|Technical reason|0|||
25068009|NCT02394028|50173698|FG003|Induction Phase|Technical reason|1|||
25068010|NCT02394028|50173699|FG004|Induction Phase|Technical reason|0|||
25068011|NCT02394028|50173700|FG005|Induction Phase|Technical reason|0|||
25068012|NCT02394028|50173701|FG006|Induction Phase|Technical reason|0|||
25068013|NCT02394028|50173702|FG007|Induction Phase|Technical reason|0|||
25068014|NCT02394028|50173703|FG008|Induction Phase|Technical reason|0|||
25068015|NCT02394028|50173704|FG009|Induction Phase|Technical reason|0|||
25188004|NCT00591318|50340378|FG001|Overall Study|Lack of Efficacy|0|||
25188005|NCT00591318|50340377|FG000|Overall Study|Adverse Event|2|||
24965874|NCT00259610|50055573|FG002|Overall Study|non medical reason|10|||
24965875|NCT00259610|50055574|FG003|Overall Study|non medical reason|3|||
24965876|NCT00259610|50055571|FG000|Overall Study|Adverse Event|3|||
24965877|NCT00259610|50055572|FG001|Overall Study|Adverse Event|4|||
24965878|NCT00259610|50055573|FG002|Overall Study|Adverse Event|5|||
24965879|NCT00259610|50055574|FG003|Overall Study|Adverse Event|2|||
24965880|NCT00259610|50055571|FG000|Overall Study|Serious Adverse Event|8|||
24965881|NCT00259610|50055572|FG001|Overall Study|Serious Adverse Event|2|||
24965882|NCT00259610|50055573|FG002|Overall Study|Serious Adverse Event|2|||
24965883|NCT00259610|50055574|FG003|Overall Study|Serious Adverse Event|2|||
24965884|NCT00165776|50055588|FG000|Overall Study|Lack of Efficacy|0|||
24965885|NCT00165776|50055589|FG001|Overall Study|Lack of Efficacy|0|||
24965886|NCT00165776|50055590|FG002|Overall Study|Lack of Efficacy|0|||
24965887|NCT00165776|50055591|FG003|Overall Study|Lack of Efficacy|1|||
24965888|NCT00165776|50055588|FG000|Overall Study|Withdrawal by Subject|4|||
24965889|NCT00165776|50055589|FG001|Overall Study|Withdrawal by Subject|1|||
24965890|NCT00165776|50055590|FG002|Overall Study|Withdrawal by Subject|2|||
24965891|NCT00165776|50055591|FG003|Overall Study|Withdrawal by Subject|0|||
24965892|NCT00165776|50055588|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
24965893|NCT00165776|50055589|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
24965894|NCT00165776|50055590|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
24965895|NCT00165776|50055591|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
24965896|NCT00165698|50055603|FG000|Overall Study|Adverse Event|2|||
25068016|NCT02394028|50173705|FG010|Induction Phase|Technical reason|0|||
25068017|NCT02394028|50173695|FG000|Induction Phase|:ack of calculation|0|||
25168638|NCT01872689|50298244|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
24965897|NCT00165698|50055604|FG001|Overall Study|Adverse Event|10|||
24965898|NCT00165698|50055603|FG000|Overall Study|Lost to Follow-up|2|||
24965899|NCT00165698|50055604|FG001|Overall Study|Lost to Follow-up|2|||
24965900|NCT00165698|50055603|FG000|Overall Study|Withdrawal by Subject|2|||
24965901|NCT00165698|50055604|FG001|Overall Study|Withdrawal by Subject|1|||
24965902|NCT00165698|50055603|FG000|Overall Study|Protocol Violation|1|||
24965903|NCT00165698|50055604|FG001|Overall Study|Protocol Violation|0|||
24965904|NCT00165698|50055603|FG000|Overall Study|Not Taken/Lost the medicine|1|||
24965905|NCT00165698|50055604|FG001|Overall Study|Not Taken/Lost the medicine|2|||
24965906|NCT00225758|50055610|FG000|Overall Study|Adverse Event|4|||
24965907|NCT00259298|50055616|FG000|Overall Study|Withdrawal by Subject|1|||
24965908|NCT00259298|50055616|FG000|Overall Study|Physician Decision|2|||
24965909|NCT03789292|50055626|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
24965910|NCT03789292|50055627|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
24965911|NCT03789292|50055628|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
24965912|NCT03789292|50055626|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
24965913|NCT03789292|50055627|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
24965914|NCT03789292|50055628|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
24965915|NCT03789292|50055626|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
24965916|NCT03789292|50055627|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
24965917|NCT03789292|50055628|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
24965918|NCT03789292|50055626|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
24965919|NCT03789292|50055627|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
24965920|NCT03789292|50055628|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
24965921|NCT03789292|50055626|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
24965922|NCT03789292|50055627|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
24965923|NCT03789292|50055628|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
24965924|NCT03789292|50055626|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
24965925|NCT03789292|50055627|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
24965926|NCT03789292|50055628|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
24965927|NCT03789292|50055626|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
24965928|NCT03789292|50055627|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
24965929|NCT03789292|50055628|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
24965930|NCT03789292|50055626|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
24965931|NCT03789292|50055627|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
24965932|NCT03789292|50055628|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
24965933|NCT03789292|50055626|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
24965934|NCT03789292|50055627|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
24965935|NCT03789292|50055628|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
24965936|NCT03789292|50055626|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
24965937|NCT03789292|50055627|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
24965938|NCT03789292|50055628|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
24965939|NCT03789292|50055626|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
24965940|NCT03789292|50055627|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
24965941|NCT03789292|50055628|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
24965942|NCT03789292|50055626|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
24965943|NCT03789292|50055627|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
24965944|NCT03789292|50055628|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
24965945|NCT03789292|50055626|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
24965946|NCT03789292|50055627|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
24965947|NCT03789292|50055628|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
24965948|NCT03781336|50055644|FG000|Overall Study|Withdrawal by Subject|2|||
24965949|NCT03781336|50055645|FG001|Overall Study|Withdrawal by Subject|2|||
24965950|NCT03780400|50055651|FG000|Overall Study|Lost to Follow-up|5|||
24965951|NCT03780400|50055651|FG000|Overall Study|Withdrawal by Subject|2|||
24965952|NCT03780244|50055657|FG000|Overall Study|Lost to Follow-up|1|||
24965953|NCT03780244|50055658|FG001|Overall Study|Lost to Follow-up|0|||
24965954|NCT03785548|50055666|FG000|Overall Study|age > 80|1|||
24965955|NCT03785548|50055667|FG001|Overall Study|age > 80|0|||
24965956|NCT03785548|50055666|FG000|Overall Study|no Postop queries|1|||
24965957|NCT03785548|50055667|FG001|Overall Study|no Postop queries|0|||
24965958|NCT00141297|50055675|FG000|Overall Study|Adverse Event|0|||
24965959|NCT00141297|50055676|FG001|Overall Study|Adverse Event|0|||
24965960|NCT00141297|50055677|FG002|Overall Study|Adverse Event|1|||
24965961|NCT00141297|50055678|FG003|Overall Study|Adverse Event|0|||
24965962|NCT00141297|50055679|FG004|Overall Study|Adverse Event|1|||
24965963|NCT00141297|50055680|FG005|Overall Study|Adverse Event|1|||
24965964|NCT00141297|50055681|FG006|Overall Study|Adverse Event|0|||
24965965|NCT00141297|50055682|FG007|Overall Study|Adverse Event|1|||
24965966|NCT00141297|50055683|FG008|Overall Study|Adverse Event|1|||
24965967|NCT00141297|50055684|FG009|Overall Study|Adverse Event|0|||
24965968|NCT00141297|50055675|FG000|Overall Study|Death|1|||
24965969|NCT00141297|50055676|FG001|Overall Study|Death|0|||
24965970|NCT00141297|50055677|FG002|Overall Study|Death|0|||
25068018|NCT02394028|50173696|FG001|Induction Phase|:ack of calculation|0|||
25068019|NCT02394028|50173697|FG002|Induction Phase|:ack of calculation|0|||
25068020|NCT02394028|50173698|FG003|Induction Phase|:ack of calculation|0|||
25068021|NCT02394028|50173699|FG004|Induction Phase|:ack of calculation|0|||
25068022|NCT02394028|50173700|FG005|Induction Phase|:ack of calculation|0|||
25068023|NCT02394028|50173701|FG006|Induction Phase|:ack of calculation|0|||
25068024|NCT02394028|50173702|FG007|Induction Phase|:ack of calculation|1|||
25068025|NCT02394028|50173703|FG008|Induction Phase|:ack of calculation|0|||
25068026|NCT02394028|50173704|FG009|Induction Phase|:ack of calculation|0|||
25068027|NCT02394028|50173705|FG010|Induction Phase|:ack of calculation|0|||
25068028|NCT02394028|50173695|FG000|Maintenance Phase|Protocol Violation|0|||
25068029|NCT02394028|50173696|FG001|Maintenance Phase|Protocol Violation|0|||
25068030|NCT02394028|50173697|FG002|Maintenance Phase|Protocol Violation|0|||
25068031|NCT02394028|50173698|FG003|Maintenance Phase|Protocol Violation|0|||
25068032|NCT02394028|50173699|FG004|Maintenance Phase|Protocol Violation|0|||
25068033|NCT02394028|50173700|FG005|Maintenance Phase|Protocol Violation|0|||
25068034|NCT02394028|50173701|FG006|Maintenance Phase|Protocol Violation|0|||
25068035|NCT02394028|50173702|FG007|Maintenance Phase|Protocol Violation|0|||
25068036|NCT02394028|50173703|FG008|Maintenance Phase|Protocol Violation|0|||
25068037|NCT02394028|50173704|FG009|Maintenance Phase|Protocol Violation|0|||
25068038|NCT02394028|50173705|FG010|Maintenance Phase|Protocol Violation|1|||
25068039|NCT02394028|50173695|FG000|Maintenance Phase|Physician Decision|0|||
25068040|NCT02394028|50173696|FG001|Maintenance Phase|Physician Decision|0|||
25068041|NCT02394028|50173697|FG002|Maintenance Phase|Physician Decision|0|||
25068042|NCT02394028|50173698|FG003|Maintenance Phase|Physician Decision|0|||
25068043|NCT02394028|50173699|FG004|Maintenance Phase|Physician Decision|0|||
25068044|NCT02394028|50173700|FG005|Maintenance Phase|Physician Decision|0|||
25068045|NCT02394028|50173701|FG006|Maintenance Phase|Physician Decision|0|||
25068046|NCT02394028|50173702|FG007|Maintenance Phase|Physician Decision|0|||
25068047|NCT02394028|50173703|FG008|Maintenance Phase|Physician Decision|1|||
25068048|NCT02394028|50173704|FG009|Maintenance Phase|Physician Decision|3|||
25068049|NCT02394028|50173705|FG010|Maintenance Phase|Physician Decision|2|||
25068050|NCT02394028|50173695|FG000|Maintenance Phase|Lack of Efficacy|0|||
25068051|NCT02394028|50173696|FG001|Maintenance Phase|Lack of Efficacy|0|||
25068052|NCT02394028|50173697|FG002|Maintenance Phase|Lack of Efficacy|0|||
25068053|NCT02394028|50173698|FG003|Maintenance Phase|Lack of Efficacy|0|||
25068054|NCT02394028|50173699|FG004|Maintenance Phase|Lack of Efficacy|0|||
25068055|NCT02394028|50173700|FG005|Maintenance Phase|Lack of Efficacy|0|||
25068056|NCT02394028|50173701|FG006|Maintenance Phase|Lack of Efficacy|0|||
24965971|NCT00141297|50055678|FG003|Overall Study|Death|0|||
24965972|NCT00141297|50055679|FG004|Overall Study|Death|0|||
24965973|NCT00141297|50055680|FG005|Overall Study|Death|0|||
24965974|NCT00141297|50055681|FG006|Overall Study|Death|0|||
24965975|NCT00141297|50055682|FG007|Overall Study|Death|0|||
24965976|NCT00141297|50055683|FG008|Overall Study|Death|1|||
24965977|NCT00141297|50055684|FG009|Overall Study|Death|0|||
24965978|NCT00141297|50055675|FG000|Overall Study|Withdrawal by Subject|0|||
24965979|NCT00141297|50055676|FG001|Overall Study|Withdrawal by Subject|0|||
24965980|NCT00141297|50055677|FG002|Overall Study|Withdrawal by Subject|0|||
24965981|NCT00141297|50055678|FG003|Overall Study|Withdrawal by Subject|0|||
24965982|NCT00141297|50055679|FG004|Overall Study|Withdrawal by Subject|0|||
24965983|NCT00141297|50055680|FG005|Overall Study|Withdrawal by Subject|0|||
24965984|NCT00141297|50055681|FG006|Overall Study|Withdrawal by Subject|0|||
24965985|NCT00141297|50055682|FG007|Overall Study|Withdrawal by Subject|0|||
24965986|NCT00141297|50055683|FG008|Overall Study|Withdrawal by Subject|1|||
24965987|NCT00141297|50055684|FG009|Overall Study|Withdrawal by Subject|0|||
24965988|NCT00141297|50055675|FG000|Overall Study|Other|0|||
24965989|NCT00141297|50055676|FG001|Overall Study|Other|0|||
24965990|NCT00141297|50055677|FG002|Overall Study|Other|0|||
24965991|NCT00141297|50055678|FG003|Overall Study|Other|1|||
24965992|NCT00141297|50055679|FG004|Overall Study|Other|5|||
24965993|NCT00141297|50055680|FG005|Overall Study|Other|0|||
24965994|NCT00141297|50055681|FG006|Overall Study|Other|0|||
24965995|NCT00141297|50055682|FG007|Overall Study|Other|0|||
24965996|NCT00141297|50055683|FG008|Overall Study|Other|2|||
24965997|NCT00141297|50055684|FG009|Overall Study|Other|0|||
24965998|NCT00141297|50055675|FG000|Overall Study|Progressive Disease|2|||
24965999|NCT00141297|50055676|FG001|Overall Study|Progressive Disease|3|||
24966000|NCT00141297|50055677|FG002|Overall Study|Progressive Disease|6|||
24966001|NCT00141297|50055678|FG003|Overall Study|Progressive Disease|2|||
25068057|NCT02394028|50173702|FG007|Maintenance Phase|Lack of Efficacy|0|||
25068058|NCT02394028|50173703|FG008|Maintenance Phase|Lack of Efficacy|7|||
24966002|NCT00141297|50055679|FG004|Overall Study|Progressive Disease|15|||
24966003|NCT00141297|50055680|FG005|Overall Study|Progressive Disease|2|||
24966004|NCT00141297|50055681|FG006|Overall Study|Progressive Disease|3|||
24966005|NCT00141297|50055682|FG007|Overall Study|Progressive Disease|3|||
24966006|NCT00141297|50055683|FG008|Overall Study|Progressive Disease|15|||
25068059|NCT02394028|50173704|FG009|Maintenance Phase|Lack of Efficacy|25|||
24966007|NCT00141297|50055684|FG009|Overall Study|Progressive Disease|6|||
24966008|NCT00141297|50055675|FG000|Overall Study|Transitioned|0|||
24966009|NCT00141297|50055676|FG001|Overall Study|Transitioned|0|||
24966010|NCT00141297|50055677|FG002|Overall Study|Transitioned|0|||
24966011|NCT00141297|50055678|FG003|Overall Study|Transitioned|0|||
24966012|NCT00141297|50055679|FG004|Overall Study|Transitioned|1|||
24966013|NCT00141297|50055680|FG005|Overall Study|Transitioned|0|||
24966014|NCT00141297|50055681|FG006|Overall Study|Transitioned|0|||
24966015|NCT00141297|50055682|FG007|Overall Study|Transitioned|0|||
24966016|NCT00141297|50055683|FG008|Overall Study|Transitioned|0|||
24966017|NCT00141297|50055684|FG009|Overall Study|Transitioned|0|||
24966018|NCT00141219|50055719|FG000|Overall Study|Protocol violations|5|||
24966019|NCT00141219|50055720|FG001|Overall Study|Protocol violations|4|||
24966020|NCT00141219|50055719|FG000|Overall Study|Adverse Event|8|||
24966021|NCT00141219|50055720|FG001|Overall Study|Adverse Event|6|||
24966022|NCT00141219|50055719|FG000|Overall Study|Lack of Efficacy|5|||
24966023|NCT00141219|50055720|FG001|Overall Study|Lack of Efficacy|4|||
24966024|NCT00141219|50055719|FG000|Overall Study|Withdrawal by Subject|6|||
24966025|NCT00141219|50055720|FG001|Overall Study|Withdrawal by Subject|2|||
24966026|NCT00162266|50055729|FG000|Double-Blind Period|Adverse Event|5|||
24966027|NCT00162266|50055730|FG001|Double-Blind Period|Adverse Event|9|||
24966028|NCT00162266|50055731|FG002|Double-Blind Period|Adverse Event|11|||
24966029|NCT00162266|50055732|FG003|Double-Blind Period|Adverse Event|0|||
24966030|NCT00162266|50055729|FG000|Double-Blind Period|Death|0|||
24966031|NCT00162266|50055730|FG001|Double-Blind Period|Death|1|||
24966032|NCT00162266|50055731|FG002|Double-Blind Period|Death|0|||
24966033|NCT00162266|50055732|FG003|Double-Blind Period|Death|0|||
25068060|NCT02394028|50173705|FG010|Maintenance Phase|Lack of Efficacy|33|||
25068061|NCT02394028|50173695|FG000|Maintenance Phase|Death|0|||
25068062|NCT02394028|50173696|FG001|Maintenance Phase|Death|0|||
25068063|NCT02394028|50173697|FG002|Maintenance Phase|Death|0|||
25068064|NCT02394028|50173698|FG003|Maintenance Phase|Death|0|||
25068065|NCT02394028|50173699|FG004|Maintenance Phase|Death|0|||
24966034|NCT00162266|50055729|FG000|Double-Blind Period|Lost to Follow-up|1|||
24966035|NCT00162266|50055730|FG001|Double-Blind Period|Lost to Follow-up|2|||
24966036|NCT00162266|50055731|FG002|Double-Blind Period|Lost to Follow-up|0|||
24966037|NCT00162266|50055732|FG003|Double-Blind Period|Lost to Follow-up|0|||
25068066|NCT02394028|50173700|FG005|Maintenance Phase|Death|0|||
25068067|NCT02394028|50173701|FG006|Maintenance Phase|Death|0|||
25068068|NCT02394028|50173702|FG007|Maintenance Phase|Death|0|||
25068069|NCT02394028|50173703|FG008|Maintenance Phase|Death|0|||
25068070|NCT02394028|50173704|FG009|Maintenance Phase|Death|0|||
25068071|NCT02394028|50173705|FG010|Maintenance Phase|Death|1|||
25068072|NCT02394028|50173695|FG000|Maintenance Phase|Adverse Event|0|||
25068073|NCT02394028|50173696|FG001|Maintenance Phase|Adverse Event|0|||
25068074|NCT02394028|50173697|FG002|Maintenance Phase|Adverse Event|0|||
25068075|NCT02394028|50173698|FG003|Maintenance Phase|Adverse Event|0|||
25068076|NCT02394028|50173699|FG004|Maintenance Phase|Adverse Event|0|||
25188006|NCT00591318|50340378|FG001|Overall Study|Adverse Event|0|||
24966038|NCT00162266|50055729|FG000|Double-Blind Period|Other Reason|1|||
24966039|NCT00162266|50055730|FG001|Double-Blind Period|Other Reason|0|||
24966040|NCT00162266|50055731|FG002|Double-Blind Period|Other Reason|1|||
24966041|NCT00162266|50055732|FG003|Double-Blind Period|Other Reason|0|||
24966042|NCT00162266|50055729|FG000|Double-Blind Period|Lack of Efficacy|13|||
24966043|NCT00162266|50055730|FG001|Double-Blind Period|Lack of Efficacy|17|||
24966044|NCT00162266|50055731|FG002|Double-Blind Period|Lack of Efficacy|30|||
24966045|NCT00162266|50055732|FG003|Double-Blind Period|Lack of Efficacy|0|||
24966046|NCT00162266|50055729|FG000|Double-Blind Period|Withdrawal by Subject|5|||
24966047|NCT00162266|50055730|FG001|Double-Blind Period|Withdrawal by Subject|2|||
24966048|NCT00162266|50055731|FG002|Double-Blind Period|Withdrawal by Subject|6|||
24966049|NCT00162266|50055732|FG003|Double-Blind Period|Withdrawal by Subject|0|||
24966050|NCT00162266|50055729|FG000|Open-Label Period|Death|0|||
24966051|NCT00162266|50055730|FG001|Open-Label Period|Death|0|||
24966052|NCT00162266|50055731|FG002|Open-Label Period|Death|0|||
24966053|NCT00162266|50055732|FG003|Open-Label Period|Death|7|||
24966054|NCT00162266|50055729|FG000|Open-Label Period|Adverse Event|0|||
24966055|NCT00162266|50055730|FG001|Open-Label Period|Adverse Event|0|||
25188007|NCT01360632|50340391|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
24966056|NCT00162266|50055731|FG002|Open-Label Period|Adverse Event|0|||
24966057|NCT00162266|50055732|FG003|Open-Label Period|Adverse Event|46|||
24966058|NCT00162266|50055729|FG000|Open-Label Period|Lack of Efficacy|0|||
25068077|NCT02394028|50173700|FG005|Maintenance Phase|Adverse Event|0|||
25068078|NCT02394028|50173701|FG006|Maintenance Phase|Adverse Event|0|||
25068079|NCT02394028|50173702|FG007|Maintenance Phase|Adverse Event|0|||
24966059|NCT00162266|50055730|FG001|Open-Label Period|Lack of Efficacy|0|||
24966060|NCT00162266|50055731|FG002|Open-Label Period|Lack of Efficacy|0|||
25188008|NCT01360632|50340392|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
24966061|NCT00162266|50055732|FG003|Open-Label Period|Lack of Efficacy|26|||
24966062|NCT00162266|50055729|FG000|Open-Label Period|Lost to Follow-up|0|||
25068080|NCT02394028|50173703|FG008|Maintenance Phase|Adverse Event|1|||
25068081|NCT02394028|50173704|FG009|Maintenance Phase|Adverse Event|1|||
24966063|NCT00162266|50055730|FG001|Open-Label Period|Lost to Follow-up|0|||
24966064|NCT00162266|50055731|FG002|Open-Label Period|Lost to Follow-up|0|||
24966065|NCT00162266|50055732|FG003|Open-Label Period|Lost to Follow-up|3|||
24966066|NCT00162266|50055729|FG000|Open-Label Period|Withdrawal by Subject|0|||
24966067|NCT00162266|50055730|FG001|Open-Label Period|Withdrawal by Subject|0|||
24966068|NCT00162266|50055731|FG002|Open-Label Period|Withdrawal by Subject|0|||
24966069|NCT00162266|50055732|FG003|Open-Label Period|Withdrawal by Subject|31|||
24966070|NCT00162266|50055729|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
24966071|NCT00162266|50055730|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
24966072|NCT00162266|50055731|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
24966073|NCT00162266|50055732|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
25068082|NCT02394028|50173705|FG010|Maintenance Phase|Adverse Event|3|||
25068083|NCT02394028|50173695|FG000|Maintenance Phase|Site closure|0|||
24966074|NCT00162266|50055729|FG000|Open-Label Period|Other Reasons|0|||
24966075|NCT00162266|50055730|FG001|Open-Label Period|Other Reasons|0|||
24966076|NCT00162266|50055731|FG002|Open-Label Period|Other Reasons|0|||
24966077|NCT00162266|50055732|FG003|Open-Label Period|Other Reasons|15|||
24966078|NCT00225212|50055784|FG000|Overall Study|Disease progression|2|||
24966079|NCT00225212|50055784|FG000|Overall Study|Death|1|||
24966080|NCT00225212|50055784|FG000|Overall Study|Adverse Event|2|||
24966081|NCT00225212|50055784|FG000|Overall Study|Intercurrent illness|1|||
24966082|NCT00162032|50055790|FG000|Overall Study|Lost to Follow-up|4|||
24966083|NCT00162032|50055791|FG001|Overall Study|Lost to Follow-up|2|||
24966084|NCT00162032|50055790|FG000|Overall Study|Reason not specified|1|||
24966085|NCT00162032|50055791|FG001|Overall Study|Reason not specified|0|||
24966086|NCT00258674|50055805|FG000|Overall Study|Death|32|||
24966087|NCT00258674|50055806|FG001|Overall Study|Death|53|||
24966088|NCT00258674|50055807|FG002|Overall Study|Death|34|||
24966089|NCT00258440|50055818|FG000|Overall Study|Withdrawal by Subject|0|||
24966090|NCT00258440|50055819|FG001|Overall Study|Withdrawal by Subject|0|||
24966091|NCT00258440|50055820|FG002|Overall Study|Withdrawal by Subject|1|||
24966092|NCT00224120|50055830|FG000|Overall Study|Adverse Event|10|||
24966093|NCT00224120|50055831|FG001|Overall Study|Adverse Event|4|||
24966094|NCT00224120|50055830|FG000|Overall Study|Protocol Violation|1|||
24966095|NCT00224120|50055831|FG001|Overall Study|Protocol Violation|0|||
24966096|NCT00224120|50055830|FG000|Overall Study|Withdrawal by Subject|5|||
24966097|NCT00224120|50055831|FG001|Overall Study|Withdrawal by Subject|10|||
24966098|NCT00224120|50055830|FG000|Overall Study|Lack of Efficacy|0|||
24966099|NCT00224120|50055831|FG001|Overall Study|Lack of Efficacy|2|||
24966100|NCT00224120|50055830|FG000|Overall Study|Lost to Follow-up|2|||
24966101|NCT00224120|50055831|FG001|Overall Study|Lost to Follow-up|3|||
24966102|NCT00224120|50055830|FG000|Overall Study|Other|4|||
24966103|NCT00224120|50055831|FG001|Overall Study|Other|5|||
24966104|NCT00257660|50055839|FG000|Overall Study|Lack of Efficacy|5|||
24966105|NCT00257660|50055840|FG001|Overall Study|Lack of Efficacy|23|||
24966106|NCT00257660|50055839|FG000|Overall Study|Withdrawal by Subject|2|||
24966107|NCT00257660|50055840|FG001|Overall Study|Withdrawal by Subject|0|||
24966108|NCT00257660|50055839|FG000|Overall Study|Lost to Follow-up|1|||
24966109|NCT00257660|50055840|FG001|Overall Study|Lost to Follow-up|0|||
24966110|NCT00257660|50055839|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
24966111|NCT00257660|50055840|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
25068084|NCT02394028|50173696|FG001|Maintenance Phase|Site closure|0|||
25068085|NCT02394028|50173697|FG002|Maintenance Phase|Site closure|0|||
25068086|NCT02394028|50173698|FG003|Maintenance Phase|Site closure|0|||
25068087|NCT02394028|50173699|FG004|Maintenance Phase|Site closure|0|||
25068088|NCT02394028|50173700|FG005|Maintenance Phase|Site closure|0|||
25068089|NCT02394028|50173701|FG006|Maintenance Phase|Site closure|0|||
25068090|NCT02394028|50173702|FG007|Maintenance Phase|Site closure|0|||
25068091|NCT02394028|50173703|FG008|Maintenance Phase|Site closure|0|||
25068092|NCT02394028|50173704|FG009|Maintenance Phase|Site closure|1|||
25068093|NCT02394028|50173705|FG010|Maintenance Phase|Site closure|0|||
25068094|NCT02394028|50173695|FG000|Maintenance Phase|Withdrawal by Subject|0|||
25068095|NCT02394028|50173696|FG001|Maintenance Phase|Withdrawal by Subject|0|||
25068096|NCT02394028|50173697|FG002|Maintenance Phase|Withdrawal by Subject|0|||
25068097|NCT02394028|50173698|FG003|Maintenance Phase|Withdrawal by Subject|0|||
25068098|NCT02394028|50173699|FG004|Maintenance Phase|Withdrawal by Subject|0|||
25068099|NCT02394028|50173700|FG005|Maintenance Phase|Withdrawal by Subject|0|||
25068100|NCT02394028|50173701|FG006|Maintenance Phase|Withdrawal by Subject|0|||
25068101|NCT02394028|50173702|FG007|Maintenance Phase|Withdrawal by Subject|0|||
25068102|NCT02394028|50173703|FG008|Maintenance Phase|Withdrawal by Subject|3|||
25068103|NCT02394028|50173704|FG009|Maintenance Phase|Withdrawal by Subject|12|||
25068104|NCT02394028|50173705|FG010|Maintenance Phase|Withdrawal by Subject|12|||
24966112|NCT00257660|50055839|FG000|Overall Study|No longer wanted to do blood draws|1|||
24966113|NCT00257660|50055840|FG001|Overall Study|No longer wanted to do blood draws|0|||
24966114|NCT00224042|50055848|FG000|Overall Study|Adverse Event|2|||
24966115|NCT00224042|50055849|FG001|Overall Study|Adverse Event|1|||
24966116|NCT00224042|50055848|FG000|Overall Study|Protocol Violation|0|||
24966117|NCT00224042|50055849|FG001|Overall Study|Protocol Violation|1|||
25068105|NCT01371539|50173759|FG000|Period One: One Week|Lost to Follow-up|0|||
25068106|NCT01371539|50173760|FG001|Period One: One Week|Lost to Follow-up|1|||
25068107|NCT01371539|50173759|FG000|Period Two: One Week|Lost to Follow-up|0|||
25068108|NCT01371539|50173760|FG001|Period Two: One Week|Lost to Follow-up|1|||
25068109|NCT01371539|50173759|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
25068110|NCT01371539|50173760|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
25068111|NCT01371539|50173759|FG000|Period Two: One Week|Time/job conflict|0|||
25068112|NCT01371539|50173760|FG001|Period Two: One Week|Time/job conflict|1|||
25068113|NCT03320330|50173769|FG000|Overall Study|Lack of Efficacy|5|||
25068114|NCT03320330|50173770|FG001|Overall Study|Lack of Efficacy|5|||
25068115|NCT03320330|50173771|FG002|Overall Study|Lack of Efficacy|14|||
25068116|NCT03320330|50173769|FG000|Overall Study|Physician Decision|1|||
25068117|NCT03320330|50173770|FG001|Overall Study|Physician Decision|0|||
25068118|NCT03320330|50173771|FG002|Overall Study|Physician Decision|0|||
25068119|NCT02819297|50173782|FG000|Overall Study|Withdrawal by Subject|25|||
25068120|NCT02819297|50173783|FG001|Overall Study|Withdrawal by Subject|13|||
25068121|NCT02819297|50173782|FG000|Overall Study|Lost to Follow-up|12|||
25068122|NCT02819297|50173783|FG001|Overall Study|Lost to Follow-up|14|||
25068123|NCT02819297|50173782|FG000|Overall Study|Adverse Event|12|||
25068124|NCT02819297|50173783|FG001|Overall Study|Adverse Event|10|||
25068125|NCT02819297|50173782|FG000|Overall Study|Physician Decision|5|||
25068126|NCT02819297|50173783|FG001|Overall Study|Physician Decision|5|||
25068127|NCT02819297|50173782|FG000|Overall Study|Lack of Efficacy|5|||
25068128|NCT02819297|50173783|FG001|Overall Study|Lack of Efficacy|8|||
25068129|NCT02819297|50173782|FG000|Overall Study|Protocol Violation|1|||
25068130|NCT02819297|50173783|FG001|Overall Study|Protocol Violation|2|||
25068131|NCT02429830|50173789|FG000|Overall Study|Lost to Follow-up|1|||
25068132|NCT02429830|50173789|FG000|Overall Study|Device Explant|2|||
25068133|NCT02821715|50173793|FG000|Overall Study|Protocol Violation|1|||
25068134|NCT02821715|50173794|FG001|Overall Study|Protocol Violation|0|||
25068135|NCT02821715|50173795|FG002|Overall Study|Protocol Violation|0|||
25068136|NCT02821715|50173796|FG003|Overall Study|Protocol Violation|0|||
24966118|NCT00224042|50055848|FG000|Overall Study|Physician Decision|0|||
24966119|NCT00224042|50055849|FG001|Overall Study|Physician Decision|1|||
24966120|NCT00224042|50055848|FG000|Overall Study|Did not meet lab incusion criteria|2|||
24966121|NCT00224042|50055849|FG001|Overall Study|Did not meet lab incusion criteria|3|||
24966122|NCT00224042|50055848|FG000|Overall Study|Other|2|||
24966123|NCT00224042|50055849|FG001|Overall Study|Other|0|||
24966124|NCT00160706|50055855|FG000|Overall Study|Adverse Event|53|||
24966125|NCT00160706|50055855|FG000|Overall Study|Adverse Event and Other Reason|105|||
24966126|NCT00160706|50055855|FG000|Overall Study|Protocol Violation|3|||
24966127|NCT00160706|50055855|FG000|Overall Study|Withdrawal by Subject|41|||
24966128|NCT00160706|50055855|FG000|Overall Study|Withdrawal by Subject and Other|12|||
24966129|NCT00160706|50055855|FG000|Overall Study|Physician Decision|10|||
24966130|NCT00160706|50055855|FG000|Overall Study|Physician Decision and Other|3|||
24966131|NCT00160706|50055855|FG000|Overall Study|Lost to Follow-up|4|||
24966132|NCT00160706|50055855|FG000|Overall Study|Lost to Follow-up and Other|1|||
24966133|NCT00160706|50055855|FG000|Overall Study|Lack of Efficacy|42|||
24966134|NCT00160706|50055855|FG000|Overall Study|Lack of Efficacy and Other|1|||
24966135|NCT00160706|50055855|FG000|Overall Study|Other Reason|11|||
24966136|NCT00257192|50055861|FG000|Overall Study|Adverse Event|21|||
24966137|NCT00257192|50055862|FG001|Overall Study|Adverse Event|10|||
24966138|NCT00257192|50055861|FG000|Overall Study|Laboratory abnormality|1|||
25068137|NCT02821715|50173797|FG004|Overall Study|Protocol Violation|0|||
25068138|NCT02821715|50173798|FG005|Overall Study|Protocol Violation|0|||
25068139|NCT02813681|50173809|FG000|Overall Study|Physician Decision|5|||
25068140|NCT02813681|50173810|FG001|Overall Study|Physician Decision|5|||
25068141|NCT02813681|50173811|FG002|Overall Study|Physician Decision|0|||
25068142|NCT02813681|50173809|FG000|Overall Study|Lost to Follow-up|0|||
25068143|NCT02813681|50173810|FG001|Overall Study|Lost to Follow-up|1|||
25068144|NCT02813681|50173811|FG002|Overall Study|Lost to Follow-up|0|||
25068145|NCT02393950|50173823|FG000|Overall Study|Adverse Event|1|||
25068146|NCT02393950|50173824|FG001|Overall Study|Adverse Event|0|||
25068147|NCT02393950|50173823|FG000|Overall Study|Withdrawal by Subject|0|||
25277212|NCT00943384|50591259|FG000|Overall Study|Dispositioned prior to treatment|23|||
25068148|NCT02393950|50173824|FG001|Overall Study|Withdrawal by Subject|1|||
25068149|NCT02815397|50173859|FG000|Overall Study|Physician Decision|2|||
25068150|NCT02427958|50173863|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
25277213|NCT00943384|50591259|FG000|Overall Study|Treated off protocol-protocol violation|5|||
24966139|NCT00257192|50055862|FG001|Overall Study|Laboratory abnormality|1|||
24966140|NCT00257192|50055861|FG000|Overall Study|Lost to Follow-up|3|||
24966141|NCT00257192|50055862|FG001|Overall Study|Lost to Follow-up|3|||
24966142|NCT00257192|50055861|FG000|Overall Study|Insufficient clinical response|18|||
25068151|NCT02427958|50173863|FG000|Overall Study|Lost to Follow-up|6|||
25068152|NCT02427958|50173863|FG000|Overall Study|Withdrawal by Subject|14|||
25068153|NCT02427958|50173863|FG000|Overall Study|Lack of Efficacy|1|||
25068154|NCT02392624|50173870|FG000|Overall Study|Withdrawal by Subject|15|||
24966143|NCT00257192|50055862|FG001|Overall Study|Insufficient clinical response|18|||
24966144|NCT00257192|50055861|FG000|Overall Study|Withdrawal by Subject|14|||
24966145|NCT00257192|50055862|FG001|Overall Study|Withdrawal by Subject|2|||
24966146|NCT00257192|50055861|FG000|Overall Study|Randomized but not treated|0|||
24966147|NCT00257192|50055862|FG001|Overall Study|Randomized but not treated|1|||
24966148|NCT00257192|50055861|FG000|Overall Study|Study terminated by sponsor|1|||
24966149|NCT00257192|50055862|FG001|Overall Study|Study terminated by sponsor|0|||
24966150|NCT00257192|50055861|FG000|Overall Study|Miscellaneous|0|||
24966151|NCT00257192|50055862|FG001|Overall Study|Miscellaneous|4|||
24966152|NCT00256724|50055870|FG000|Overall Study|Physician Decision|2|||
24966153|NCT00256724|50055871|FG001|Overall Study|Physician Decision|5|||
25068155|NCT02392624|50173871|FG001|Overall Study|Withdrawal by Subject|12|||
25068156|NCT02392624|50173872|FG002|Overall Study|Withdrawal by Subject|9|||
25068157|NCT02392624|50173870|FG000|Overall Study|Adverse Event|4|||
25068158|NCT02392624|50173871|FG001|Overall Study|Adverse Event|1|||
25068159|NCT02392624|50173872|FG002|Overall Study|Adverse Event|2|||
25068160|NCT02392624|50173870|FG000|Overall Study|Pregnancy|1|||
25068161|NCT02392624|50173871|FG001|Overall Study|Pregnancy|0|||
25068162|NCT02392624|50173872|FG002|Overall Study|Pregnancy|0|||
25068163|NCT02392624|50173870|FG000|Overall Study|Protocol Violation|0|||
25068164|NCT02392624|50173871|FG001|Overall Study|Protocol Violation|0|||
25068165|NCT02392624|50173872|FG002|Overall Study|Protocol Violation|1|||
25068166|NCT02392624|50173870|FG000|Overall Study|Sponsor/Investigator Decision|2|||
25068167|NCT02392624|50173871|FG001|Overall Study|Sponsor/Investigator Decision|1|||
25068168|NCT02392624|50173872|FG002|Overall Study|Sponsor/Investigator Decision|0|||
25068169|NCT02392624|50173870|FG000|Overall Study|Other|49|||
25068170|NCT02392624|50173871|FG001|Overall Study|Other|1|||
25068171|NCT02392624|50173872|FG002|Overall Study|Other|1|||
25068172|NCT02387164|50173882|FG000|Overall Study|Lost to Follow-up|2|||
25068173|NCT02387164|50173883|FG001|Overall Study|Lost to Follow-up|0|||
25068174|NCT02387164|50173882|FG000|Overall Study|Diagnosed|1|||
25068175|NCT02387164|50173883|FG001|Overall Study|Diagnosed|2|||
25068176|NCT02392234|50173901|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
25068177|NCT02392234|50173902|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
25068178|NCT02392234|50173903|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
25068179|NCT02392234|50173904|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
25068180|NCT02392234|50173905|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
25068181|NCT02392234|50173906|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
25068182|NCT02392234|50173901|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
25068183|NCT02392234|50173902|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
25068184|NCT02392234|50173903|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
25068185|NCT02392234|50173904|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
25068186|NCT02392234|50173905|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
25068187|NCT02392234|50173906|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
25068188|NCT02392234|50173901|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
25068189|NCT02392234|50173902|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
25068190|NCT02392234|50173903|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
25068191|NCT02392234|50173904|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
25068192|NCT02392234|50173905|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
24966154|NCT00256724|50055870|FG000|Overall Study|Protocol Violation|3|||
24966155|NCT00256724|50055871|FG001|Overall Study|Protocol Violation|3|||
24966156|NCT00157820|50055880|FG000|Randomized|Physician Decision|4|||
24966157|NCT00157820|50055881|FG001|Randomized|Physician Decision|2|||
24966158|NCT00157820|50055882|FG002|Randomized|Physician Decision|3|||
24966159|NCT00157820|50055880|FG000|Randomized|Withdrawal by Subject|1|||
24966160|NCT00157820|50055881|FG001|Randomized|Withdrawal by Subject|2|||
25068193|NCT02392234|50173906|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
25068194|NCT02392234|50173901|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
24966161|NCT00157820|50055882|FG002|Randomized|Withdrawal by Subject|3|||
24966162|NCT00157820|50055880|FG000|Randomized|Protocol Violation|2|||
25068195|NCT02392234|50173902|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
25068196|NCT02392234|50173903|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
24966163|NCT00157820|50055881|FG001|Randomized|Protocol Violation|1|||
24966164|NCT00157820|50055882|FG002|Randomized|Protocol Violation|2|||
24966165|NCT00157820|50055880|FG000|1st 8 Month|Death|7|||
24966166|NCT00157820|50055881|FG001|1st 8 Month|Death|8|||
24966167|NCT00157820|50055882|FG002|1st 8 Month|Death|3|||
24966168|NCT00157820|50055880|FG000|1st 8 Month|Lost to Follow-up|1|||
24966169|NCT00157820|50055881|FG001|1st 8 Month|Lost to Follow-up|2|||
24966170|NCT00157820|50055882|FG002|1st 8 Month|Lost to Follow-up|1|||
24966171|NCT00157820|50055880|FG000|1st 8 Month|Premature cross-over|0|||
24966172|NCT00157820|50055881|FG001|1st 8 Month|Premature cross-over|2|||
24966173|NCT00157820|50055882|FG002|1st 8 Month|Premature cross-over|2|||
24966174|NCT00157820|50055880|FG000|2nd 8 Months|Death|3|||
24966175|NCT00157820|50055881|FG001|2nd 8 Months|Death|1|||
24966176|NCT00157820|50055882|FG002|2nd 8 Months|Death|3|||
24966177|NCT00157820|50055880|FG000|2nd 8 Months|Lost to Follow-up|1|||
24966178|NCT00157820|50055881|FG001|2nd 8 Months|Lost to Follow-up|5|||
24966179|NCT00157820|50055882|FG002|2nd 8 Months|Lost to Follow-up|2|||
24966180|NCT00157820|50055880|FG000|2nd 8 Months|Premature cross-over|1|||
24966181|NCT00157820|50055881|FG001|2nd 8 Months|Premature cross-over|7|||
24966182|NCT00157820|50055882|FG002|2nd 8 Months|Premature cross-over|9|||
24966183|NCT00223808|50055894|FG000|Overall Study|<5 hrs therapy before discharge|3|||
24966184|NCT00223808|50055895|FG001|Overall Study|<5 hrs therapy before discharge|5|||
24966185|NCT00223808|50055896|FG002|Overall Study|<5 hrs therapy before discharge|5|||
24966186|NCT00154310|50055906|FG000|Overall Study|Adverse Event|19|||
24966187|NCT00154310|50055907|FG001|Overall Study|Adverse Event|9|||
24966188|NCT00154310|50055906|FG000|Overall Study|Lack of Efficacy|5|||
24966189|NCT00154310|50055907|FG001|Overall Study|Lack of Efficacy|4|||
24966190|NCT00154310|50055906|FG000|Overall Study|Protocol Violation|4|||
24966191|NCT00154310|50055907|FG001|Overall Study|Protocol Violation|2|||
24966192|NCT00154310|50055906|FG000|Overall Study|Withdrawal by Subject|9|||
24966193|NCT00154310|50055907|FG001|Overall Study|Withdrawal by Subject|3|||
24966194|NCT00154310|50055906|FG000|Overall Study|Lost to Follow-up|0|||
24966195|NCT00154310|50055907|FG001|Overall Study|Lost to Follow-up|8|||
24966196|NCT00154310|50055906|FG000|Overall Study|Administrative problems|0|||
24966197|NCT00154310|50055907|FG001|Overall Study|Administrative problems|1|||
24966198|NCT00154310|50055906|FG000|Overall Study|Death|0|||
24966199|NCT00154310|50055907|FG001|Overall Study|Death|1|||
24966200|NCT03771664|50055915|FG000|Overall Study|Adverse Event|1|||
24966201|NCT03771664|50055916|FG001|Overall Study|Adverse Event|0|||
24966202|NCT03771664|50055915|FG000|Overall Study|Lost to Follow-up|1|||
24966203|NCT03771664|50055916|FG001|Overall Study|Lost to Follow-up|0|||
24966204|NCT03771664|50055915|FG000|Overall Study|Withdrawal by Participant|1|||
24966205|NCT03771664|50055916|FG001|Overall Study|Withdrawal by Participant|4|||
24966206|NCT03771664|50055915|FG000|Overall Study|Randomized but not Treated|0|||
24966207|NCT03771664|50055916|FG001|Overall Study|Randomized but not Treated|1|||
24966208|NCT03771352|50055922|FG000|Overall Study|Screen failure|2|||
24966209|NCT03771352|50055922|FG000|Overall Study|Withdrawal by Subject|2|||
24966210|NCT03770728|50055930|FG000|Overall Study|Adverse Event|1|||
24966211|NCT03770728|50055931|FG001|Overall Study|Adverse Event|0|||
24966212|NCT03770728|50055932|FG002|Overall Study|Adverse Event|1|||
24966213|NCT03770728|50055933|FG003|Overall Study|Adverse Event|0|||
24966214|NCT03770728|50055930|FG000|Overall Study|Poor compliance to protocol|0|||
24966215|NCT03770728|50055931|FG001|Overall Study|Poor compliance to protocol|0|||
24966216|NCT03770728|50055932|FG002|Overall Study|Poor compliance to protocol|1|||
24966217|NCT03770728|50055933|FG003|Overall Study|Poor compliance to protocol|0|||
24966218|NCT03770728|50055930|FG000|Overall Study|Withdrawal by Subject|13|||
24966219|NCT03770728|50055931|FG001|Overall Study|Withdrawal by Subject|8|||
24966220|NCT03770728|50055932|FG002|Overall Study|Withdrawal by Subject|9|||
24966221|NCT03770728|50055933|FG003|Overall Study|Withdrawal by Subject|13|||
24966222|NCT03770728|50055930|FG000|Overall Study|Other than specified|24|||
24966223|NCT03770728|50055931|FG001|Overall Study|Other than specified|23|||
24966224|NCT03770728|50055932|FG002|Overall Study|Other than specified|21|||
24966225|NCT03770728|50055933|FG003|Overall Study|Other than specified|22|||
24966226|NCT03769090|50055948|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
24966227|NCT03769090|50055949|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
24966228|NCT03769090|50055950|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
24966229|NCT03769090|50055948|FG000|Overall Study|Withdrawal by Subject|52|||
24966230|NCT03769090|50055949|FG001|Overall Study|Withdrawal by Subject|62|||
24966231|NCT03769090|50055950|FG002|Overall Study|Withdrawal by Subject|74|||
24966232|NCT03769090|50055948|FG000|Overall Study|Death|4|||
25068197|NCT02392234|50173904|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
25068198|NCT02392234|50173905|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
25068199|NCT02392234|50173906|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
25068200|NCT02392234|50173901|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
24966233|NCT03769090|50055949|FG001|Overall Study|Death|2|||
24966234|NCT03769090|50055950|FG002|Overall Study|Death|2|||
24966235|NCT03769090|50055948|FG000|Overall Study|Adverse Event|7|||
24966236|NCT03769090|50055949|FG001|Overall Study|Adverse Event|7|||
24966237|NCT03769090|50055950|FG002|Overall Study|Adverse Event|8|||
24966238|NCT03769090|50055948|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
24966239|NCT03769090|50055949|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
24966240|NCT03769090|50055950|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
24966241|NCT03769090|50055948|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
24966242|NCT03769090|50055949|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
24966243|NCT03769090|50055950|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
24966244|NCT03769090|50055948|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
24966245|NCT03769090|50055949|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
24966246|NCT03769090|50055950|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
24966247|NCT03769090|50055948|FG000|Overall Study|Protocol Violation|5|||
24966248|NCT03769090|50055949|FG001|Overall Study|Protocol Violation|6|||
24966249|NCT03769090|50055950|FG002|Overall Study|Protocol Violation|8|||
24966250|NCT03769090|50055948|FG000|Overall Study|Pregnancy|1|||
24966251|NCT03769090|50055949|FG001|Overall Study|Pregnancy|0|||
24966252|NCT03769090|50055950|FG002|Overall Study|Pregnancy|3|||
24966253|NCT03769090|50055948|FG000|Overall Study|Lost to Follow-up|19|||
24966254|NCT03769090|50055949|FG001|Overall Study|Lost to Follow-up|25|||
24966255|NCT03769090|50055950|FG002|Overall Study|Lost to Follow-up|21|||
24966256|NCT03769090|50055948|FG000|Overall Study|Condition under investigation worsened|2|||
24966257|NCT03769090|50055949|FG001|Overall Study|Condition under investigation worsened|0|||
24966258|NCT03769090|50055950|FG002|Overall Study|Condition under investigation worsened|1|||
24966259|NCT03769090|50055948|FG000|Overall Study|Lack of Efficacy|1|||
24966260|NCT03769090|50055949|FG001|Overall Study|Lack of Efficacy|2|||
24966261|NCT03769090|50055950|FG002|Overall Study|Lack of Efficacy|2|||
24966262|NCT03769090|50055948|FG000|Overall Study|Other reasons|8|||
24966263|NCT03769090|50055949|FG001|Overall Study|Other reasons|12|||
24966264|NCT03769090|50055950|FG002|Overall Study|Other reasons|15|||
24966265|NCT03559270|50055974|FG000|Overall Study|Adverse Event|6|||
24966266|NCT03559270|50055975|FG001|Overall Study|Adverse Event|5|||
24966267|NCT03559270|50055976|FG002|Overall Study|Adverse Event|3|||
24966268|NCT03559270|50055977|FG003|Overall Study|Adverse Event|0|||
24966269|NCT03559270|50055974|FG000|Overall Study|Lack of Efficacy|34|||
24966270|NCT03559270|50055975|FG001|Overall Study|Lack of Efficacy|52|||
24966271|NCT03559270|50055976|FG002|Overall Study|Lack of Efficacy|37|||
24966272|NCT03559270|50055977|FG003|Overall Study|Lack of Efficacy|2|||
24966273|NCT03559270|50055974|FG000|Overall Study|Death|0|||
24966274|NCT03559270|50055975|FG001|Overall Study|Death|2|||
24966275|NCT03559270|50055976|FG002|Overall Study|Death|0|||
24966276|NCT03559270|50055977|FG003|Overall Study|Death|0|||
24966277|NCT03559270|50055974|FG000|Overall Study|Lost to Follow-up|16|||
24966278|NCT03559270|50055975|FG001|Overall Study|Lost to Follow-up|4|||
24966279|NCT03559270|50055976|FG002|Overall Study|Lost to Follow-up|12|||
24966280|NCT03559270|50055977|FG003|Overall Study|Lost to Follow-up|3|||
24966281|NCT03559270|50055974|FG000|Overall Study|Sponsor Decision|38|||
24966282|NCT03559270|50055975|FG001|Overall Study|Sponsor Decision|31|||
24966283|NCT03559270|50055976|FG002|Overall Study|Sponsor Decision|35|||
24966284|NCT03559270|50055977|FG003|Overall Study|Sponsor Decision|18|||
24966285|NCT03559270|50055974|FG000|Overall Study|Withdrawal by Subject|19|||
24966286|NCT03559270|50055975|FG001|Overall Study|Withdrawal by Subject|21|||
24966287|NCT03559270|50055976|FG002|Overall Study|Withdrawal by Subject|18|||
24966288|NCT03559270|50055977|FG003|Overall Study|Withdrawal by Subject|7|||
24966289|NCT03559270|50055974|FG000|Overall Study|Physician Decision|3|||
24966290|NCT03559270|50055975|FG001|Overall Study|Physician Decision|2|||
24966291|NCT03559270|50055976|FG002|Overall Study|Physician Decision|1|||
24966292|NCT03559270|50055977|FG003|Overall Study|Physician Decision|0|||
24966293|NCT03559270|50055974|FG000|Overall Study|Pregnancy|0|||
24966294|NCT03559270|50055975|FG001|Overall Study|Pregnancy|1|||
24966295|NCT03559270|50055976|FG002|Overall Study|Pregnancy|0|||
24966296|NCT03559270|50055977|FG003|Overall Study|Pregnancy|0|||
24966297|NCT03559270|50055974|FG000|Overall Study|Protocol Violation|1|||
24966298|NCT03559270|50055975|FG001|Overall Study|Protocol Violation|0|||
24966299|NCT03559270|50055976|FG002|Overall Study|Protocol Violation|2|||
24966300|NCT03559270|50055977|FG003|Overall Study|Protocol Violation|0|||
24966301|NCT02685826|50056032|FG000|Overall Study|Adverse Event|2|||
24966302|NCT02685826|50056033|FG001|Overall Study|Adverse Event|0|||
24966303|NCT02685826|50056034|FG002|Overall Study|Adverse Event|1|||
25068201|NCT02392234|50173902|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
25068202|NCT02392234|50173903|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
25068203|NCT02392234|50173904|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
24966304|NCT02685826|50056032|FG000|Overall Study|Progressive Disease|2|||
24966305|NCT02685826|50056033|FG001|Overall Study|Progressive Disease|1|||
24966306|NCT02685826|50056034|FG002|Overall Study|Progressive Disease|0|||
24966307|NCT02685826|50056032|FG000|Overall Study|Withdrawal by Subject|2|||
24966308|NCT02685826|50056033|FG001|Overall Study|Withdrawal by Subject|0|||
24966309|NCT02685826|50056034|FG002|Overall Study|Withdrawal by Subject|0|||
24966310|NCT02685826|50056032|FG000|Overall Study|Full Clinical Hold by FDA|19|||
24966311|NCT02685826|50056033|FG001|Overall Study|Full Clinical Hold by FDA|9|||
24966312|NCT02685826|50056034|FG002|Overall Study|Full Clinical Hold by FDA|20|||
24966313|NCT00114777|50056045|FG000|Randomization to Month 36|Death|10|||
24966314|NCT00114777|50056046|FG001|Randomization to Month 36|Death|4|||
24966315|NCT00114777|50056047|FG002|Randomization to Month 36|Death|3|||
24966316|NCT00114777|50056045|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
24966317|NCT00114777|50056046|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
24966318|NCT00114777|50056047|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
24966319|NCT00114777|50056045|FG000|Randomization to Month 36|Lack of Efficacy|19|||
24966320|NCT00114777|50056046|FG001|Randomization to Month 36|Lack of Efficacy|15|||
24966321|NCT00114777|50056047|FG002|Randomization to Month 36|Lack of Efficacy|17|||
24966322|NCT00114777|50056045|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
24966323|NCT00114777|50056046|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
24966324|NCT00114777|50056047|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
24966325|NCT00114777|50056045|FG000|Randomization to Month 36|Adverse Event|34|||
24966326|NCT00114777|50056046|FG001|Randomization to Month 36|Adverse Event|35|||
24966327|NCT00114777|50056047|FG002|Randomization to Month 36|Adverse Event|44|||
24966328|NCT00114777|50056045|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
24966329|NCT00114777|50056046|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
24966330|NCT00114777|50056047|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
24966331|NCT00114777|50056045|FG000|Randomization to Month 36|Other|9|||
24966332|NCT00114777|50056046|FG001|Randomization to Month 36|Other|3|||
24966333|NCT00114777|50056047|FG002|Randomization to Month 36|Other|12|||
24966334|NCT00114777|50056045|FG000|Long-Term Extension to Month 84|Death|8|||
24966335|NCT00114777|50056046|FG001|Long-Term Extension to Month 84|Death|13|||
24966336|NCT00114777|50056047|FG002|Long-Term Extension to Month 84|Death|7|||
24966337|NCT00114777|50056045|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
24966338|NCT00114777|50056046|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
24966339|NCT00114777|50056047|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
24966340|NCT00114777|50056045|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
24966341|NCT00114777|50056046|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
24966342|NCT00114777|50056047|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
24966343|NCT00114777|50056045|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
24966344|NCT00114777|50056046|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
24966345|NCT00114777|50056047|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
24966346|NCT00114777|50056045|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
24966347|NCT00114777|50056046|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
24966348|NCT00114777|50056047|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
24966349|NCT00114777|50056045|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
24966350|NCT00114777|50056046|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
24966351|NCT00114777|50056047|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
24966352|NCT00114777|50056045|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
24966353|NCT00114777|50056046|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
24966354|NCT00114777|50056047|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
24966355|NCT00114777|50056045|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
24966356|NCT00114777|50056046|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
24966357|NCT00114777|50056047|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
24966358|NCT00114777|50056045|FG000|Long-Term Extension to Month 84|Other|2|||
24966359|NCT00114777|50056046|FG001|Long-Term Extension to Month 84|Other|0|||
24966360|NCT00114777|50056047|FG002|Long-Term Extension to Month 84|Other|2|||
24966361|NCT00139737|50056056|FG000|Overall Study|Withdrawal by Subject|190|||
24966362|NCT00139737|50056056|FG000|Overall Study|Adverse Event|58|||
24966363|NCT00139737|50056056|FG000|Overall Study|Lack of Efficacy|40|||
24966364|NCT00139737|50056056|FG000|Overall Study|Lost to Follow-up|8|||
24966365|NCT00139737|50056056|FG000|Overall Study|Death|3|||
24966366|NCT00139737|50056056|FG000|Overall Study|Laboratory Abnormality|2|||
24966367|NCT00139737|50056056|FG000|Overall Study|Protocol Violation|18|||
24966368|NCT00139737|50056056|FG000|Overall Study|Withdrew During Screening Phase|8|||
24966369|NCT00139737|50056056|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
24966370|NCT00139737|50056056|FG000|Overall Study|Screened, Not Treated|13|||
24966371|NCT00122187|50056062|FG000|Overall Study|Withdrew because of resource limitations|2|||
24966372|NCT00122187|50056063|FG001|Overall Study|Withdrew because of resource limitations|2|||
24966373|NCT00139659|50056073|FG000|Overall Study|Adverse Event|12|||
24966374|NCT00139659|50056074|FG001|Overall Study|Adverse Event|1|||
24966375|NCT00139659|50056073|FG000|Overall Study|Lack of Efficacy|1|||
24966376|NCT00139659|50056074|FG001|Overall Study|Lack of Efficacy|1|||
24966377|NCT00139659|50056073|FG000|Overall Study|Lost to Follow-up|7|||
24966378|NCT00139659|50056074|FG001|Overall Study|Lost to Follow-up|3|||
24966379|NCT00139659|50056073|FG000|Overall Study|Reason not Specified|6|||
24966380|NCT00139659|50056074|FG001|Overall Study|Reason not Specified|3|||
24966381|NCT00139659|50056073|FG000|Overall Study|Withdrawal by Subject|14|||
24966382|NCT00139659|50056074|FG001|Overall Study|Withdrawal by Subject|10|||
25168639|NCT01872689|50298245|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
24966383|NCT00137631|50056086|FG000|Overall Study|Lost to Follow-up|37|||
24966384|NCT00137631|50056087|FG001|Overall Study|Lost to Follow-up|41|||
24966385|NCT00114231|50056095|FG000|Overall Study|No consent|2|||
24966386|NCT00114231|50056096|FG001|Overall Study|No consent|0|||
24966387|NCT00114231|50056095|FG000|Overall Study|QARC requirement not met|1|||
24966388|NCT00114231|50056096|FG001|Overall Study|QARC requirement not met|0|||
24966389|NCT00114231|50056095|FG000|Overall Study|Suspected metastatic disease|1|||
24966390|NCT00114231|50056096|FG001|Overall Study|Suspected metastatic disease|0|||
24966391|NCT00114231|50056095|FG000|Overall Study|No adenocarcinoma|1|||
24966392|NCT00114231|50056096|FG001|Overall Study|No adenocarcinoma|0|||
24966393|NCT00114231|50056095|FG000|Overall Study|Low creatinine clearance|0|||
24966394|NCT00114231|50056096|FG001|Overall Study|Low creatinine clearance|1|||
24966395|NCT00114231|50056095|FG000|Overall Study|Tumor size > 4cm|1|||
24966396|NCT00114231|50056096|FG001|Overall Study|Tumor size > 4cm|0|||
24966397|NCT00114231|50056095|FG000|Overall Study|Tumor fixed on digital exam|0|||
24966398|NCT00114231|50056096|FG001|Overall Study|Tumor fixed on digital exam|1|||
24966399|NCT00114231|50056095|FG000|Overall Study|No Absolute Neutrophil Count|2|||
24966400|NCT00114231|50056096|FG001|Overall Study|No Absolute Neutrophil Count|0|||
24966401|NCT00114231|50056095|FG000|Overall Study|Biopsy done after registration|1|||
24966402|NCT00114231|50056096|FG001|Overall Study|Biopsy done after registration|0|||
24966403|NCT00113919|50056101|FG000|Overall Study|Physician Decision|8|||
24966404|NCT00113919|50056101|FG000|Overall Study|Death|6|||
24966405|NCT00113841|50056107|FG000|Overall Study|Disease progression|0|||
24966406|NCT00113841|50056108|FG001|Overall Study|Disease progression|2|||
24966407|NCT00113841|50056107|FG000|Overall Study|Non-compliant|1|||
24966408|NCT00113841|50056108|FG001|Overall Study|Non-compliant|0|||
24966409|NCT00113607|50056116|FG000|Overall Study|Adverse Event|40|||
24966410|NCT00113607|50056117|FG001|Overall Study|Adverse Event|71|||
24966411|NCT00113607|50056116|FG000|Overall Study|Death|8|||
24966412|NCT00113607|50056117|FG001|Overall Study|Death|8|||
24966413|NCT00113607|50056116|FG000|Overall Study|Withdrawal by Subject|50|||
24966414|NCT00113607|50056117|FG001|Overall Study|Withdrawal by Subject|58|||
24966415|NCT00113607|50056116|FG000|Overall Study|Lost to Follow-up|0|||
24966416|NCT00113607|50056117|FG001|Overall Study|Lost to Follow-up|2|||
24966417|NCT00113607|50056116|FG000|Overall Study|Disease Progression|180|||
24966418|NCT00113607|50056117|FG001|Overall Study|Disease Progression|142|||
24966419|NCT00113607|50056116|FG000|Overall Study|Complete Response (Confirmed)|14|||
24966420|NCT00113607|50056117|FG001|Overall Study|Complete Response (Confirmed)|24|||
24966421|NCT00113607|50056116|FG000|Overall Study|Other|43|||
24966422|NCT00113607|50056117|FG001|Overall Study|Other|32|||
24966423|NCT00113529|50056124|FG000|Overall Study|Adverse Event|4|||
24966424|NCT00113529|50056124|FG000|Overall Study|Lack of Efficacy|20|||
24966425|NCT00113529|50056124|FG000|Overall Study|Decision of sponsor|6|||
24966426|NCT00113529|50056124|FG000|Overall Study|Withdrawal by Subject|4|||
24966427|NCT00134901|50056130|FG000|Overall Study|Lost to Follow-up|5|||
24966428|NCT00134901|50056131|FG001|Overall Study|Lost to Follow-up|5|||
24966429|NCT00134901|50056130|FG000|Overall Study|discontinued intervention|12|||
24966430|NCT00134901|50056131|FG001|Overall Study|discontinued intervention|10|||
24966431|NCT00122109|50056141|FG000|Overall Study|Did not meet criteria|6|||
24966432|NCT00122109|50056142|FG001|Overall Study|Did not meet criteria|7|||
24966433|NCT00113373|50056151|FG000|Overall Study|Ineligible: wrong primary|1|||
24966434|NCT00113373|50056151|FG000|Overall Study|Ineligible: second primary|1|||
24966435|NCT00113373|50056151|FG000|Overall Study|Never Treated|1|||
24966436|NCT00113295|50056162|FG000|Overall Study|Adverse Event|4|||
25068204|NCT02392234|50173905|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
25068205|NCT02392234|50173906|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
24966437|NCT00113295|50056163|FG001|Overall Study|Adverse Event|1|||
24966438|NCT00113295|50056162|FG000|Overall Study|Unrelated Medical Illness|1|||
24966439|NCT00113295|50056163|FG001|Overall Study|Unrelated Medical Illness|0|||
24966440|NCT00112905|50056171|FG000|Overall Study|Adverse Event|4|||
24966441|NCT00112905|50056171|FG000|Overall Study|Death|1|||
24966442|NCT00112905|50056171|FG000|Overall Study|Ineligibility|5|||
25068206|NCT02392234|50173901|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
24966443|NCT00112905|50056171|FG000|Overall Study|Alternative treatment|1|||
24966444|NCT00112905|50056171|FG000|Overall Study|performance status was deteiorating|1|||
24966445|NCT00427895|50056179|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
24966446|NCT00427895|50056180|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
24966447|NCT00427895|50056181|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
24966448|NCT00427895|50056182|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
24966449|NCT00427895|50056183|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
24966450|NCT00427895|50056184|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
24966451|NCT00427895|50056185|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
24966452|NCT00427895|50056186|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
24966453|NCT00427895|50056179|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
24966454|NCT00427895|50056180|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
24966455|NCT00427895|50056181|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
24966456|NCT00427895|50056182|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
24966457|NCT00427895|50056183|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
24966458|NCT00427895|50056184|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
24966459|NCT00427895|50056185|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
24966460|NCT00427895|50056186|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
24966461|NCT00427895|50056179|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
24966462|NCT00427895|50056180|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
24966463|NCT00427895|50056181|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
24966464|NCT00427895|50056182|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
25188009|NCT01360632|50340393|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
25188010|NCT01360632|50340394|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
25188011|NCT01360632|50340395|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
25188012|NCT01360632|50340391|FG000|Phase A (8 Weeks)|Adverse Event|60|||
25188013|NCT01360632|50340392|FG001|Phase A (8 Weeks)|Adverse Event|0|||
25188014|NCT01360632|50340393|FG002|Phase A (8 Weeks)|Adverse Event|0|||
25188015|NCT01360632|50340394|FG003|Phase A (8 Weeks)|Adverse Event|0|||
25188016|NCT01360632|50340395|FG004|Phase A (8 Weeks)|Adverse Event|0|||
25188017|NCT01360632|50340391|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
25188018|NCT01360632|50340392|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
24966465|NCT00427895|50056183|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
24966466|NCT00427895|50056184|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
24966467|NCT00427895|50056185|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
24966468|NCT00427895|50056186|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
25168640|NCT01872689|50298242|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
25168641|NCT01872689|50298243|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
25168642|NCT01872689|50298244|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
25168643|NCT01872689|50298245|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
25168644|NCT01872689|50298242|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
25168645|NCT01872689|50298243|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
25168646|NCT01872689|50298244|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
25168647|NCT01872689|50298245|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
25168648|NCT01872689|50298242|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
25168649|NCT01872689|50298243|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
25168650|NCT01872689|50298244|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
25168651|NCT01872689|50298245|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
25168652|NCT01872689|50298242|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
25168653|NCT01872689|50298243|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
25168654|NCT01872689|50298244|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
25168655|NCT01872689|50298245|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
25168656|NCT01872689|50298242|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
25188019|NCT01360632|50340393|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
25188020|NCT01360632|50340394|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
25188021|NCT01360632|50340395|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
24966469|NCT00427895|50056179|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
24966470|NCT00427895|50056180|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
24966471|NCT00427895|50056181|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
24966472|NCT00427895|50056182|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
24966473|NCT00427895|50056183|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
24966474|NCT00427895|50056184|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
24966475|NCT00427895|50056185|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
24966476|NCT00427895|50056186|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
24966477|NCT00427895|50056179|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
24966478|NCT00427895|50056180|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
24966479|NCT00427895|50056181|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
24966480|NCT00427895|50056182|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
24966481|NCT00427895|50056183|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
24966482|NCT00427895|50056184|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
24966483|NCT00427895|50056185|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
24966484|NCT00427895|50056186|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
24966485|NCT00427895|50056179|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
24966486|NCT00427895|50056180|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
24966487|NCT00427895|50056181|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
24966488|NCT00427895|50056182|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
24966489|NCT00427895|50056183|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
24966490|NCT00427895|50056184|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
24966491|NCT00427895|50056185|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
24966492|NCT00427895|50056186|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
24966493|NCT00427895|50056179|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
24966494|NCT00427895|50056180|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
24966495|NCT00427895|50056181|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
24966496|NCT00427895|50056182|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
24966497|NCT00427895|50056183|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
24966498|NCT00427895|50056184|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
24966499|NCT00427895|50056185|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
24966500|NCT00427895|50056186|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
24966501|NCT00427895|50056179|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
24966502|NCT00427895|50056180|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
24966503|NCT00427895|50056181|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
24966504|NCT00427895|50056182|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
24966505|NCT00427895|50056183|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
24966506|NCT00427895|50056184|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
24966507|NCT00427895|50056185|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
24966508|NCT00427895|50056186|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
24966509|NCT00427895|50056179|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
24966510|NCT00427895|50056180|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
24966511|NCT00427895|50056181|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
24966512|NCT00427895|50056182|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
24966513|NCT00427895|50056183|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
24966514|NCT00427895|50056184|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
24966515|NCT00427895|50056185|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
24966516|NCT00427895|50056186|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
24966517|NCT00427895|50056179|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
24966518|NCT00427895|50056180|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
24966519|NCT00427895|50056181|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
24966520|NCT00427895|50056182|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
24966521|NCT00427895|50056183|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
24966522|NCT00427895|50056184|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
25277214|NCT00943384|50591259|FG000|Overall Study|Lost to Follow-up|16|||
24966523|NCT00427895|50056185|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
24966524|NCT00427895|50056186|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
24966525|NCT00427895|50056179|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
24966526|NCT00427895|50056180|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
24966527|NCT00427895|50056181|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
24966528|NCT00427895|50056182|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
24966529|NCT00427895|50056183|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
24966530|NCT00427895|50056184|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
24966531|NCT00427895|50056185|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
25188022|NCT01360632|50340391|FG000|Phase A (8 Weeks)|Physician Decision|10|||
25188023|NCT01360632|50340392|FG001|Phase A (8 Weeks)|Physician Decision|0|||
25188024|NCT01360632|50340393|FG002|Phase A (8 Weeks)|Physician Decision|0|||
24966532|NCT00427895|50056186|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
25188025|NCT01360632|50340394|FG003|Phase A (8 Weeks)|Physician Decision|0|||
25188026|NCT01360632|50340395|FG004|Phase A (8 Weeks)|Physician Decision|0|||
25188027|NCT01360632|50340391|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
25188028|NCT01360632|50340392|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
25188029|NCT01360632|50340393|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
25188030|NCT01360632|50340394|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
25188031|NCT01360632|50340395|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
25188032|NCT01360632|50340391|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
25188033|NCT01360632|50340392|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
25188034|NCT01360632|50340393|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
25188035|NCT01360632|50340394|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
25188036|NCT01360632|50340395|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
25188037|NCT01360632|50340391|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
25188038|NCT01360632|50340392|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
25188039|NCT01360632|50340393|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
25188040|NCT01360632|50340394|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
25188041|NCT01360632|50340395|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
25188042|NCT01360632|50340391|FG000|Phase B (6 Weeks)|Adverse Event|0|||
25188043|NCT01360632|50340392|FG001|Phase B (6 Weeks)|Adverse Event|3|||
25188044|NCT01360632|50340393|FG002|Phase B (6 Weeks)|Adverse Event|9|||
25188045|NCT01360632|50340394|FG003|Phase B (6 Weeks)|Adverse Event|3|||
25188046|NCT01360632|50340395|FG004|Phase B (6 Weeks)|Adverse Event|0|||
25188047|NCT01360632|50340391|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
25188048|NCT01360632|50340392|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
25188049|NCT01360632|50340393|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
25188050|NCT01360632|50340394|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
25188051|NCT01360632|50340395|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
25188052|NCT01360632|50340391|FG000|Phase B (6 Weeks)|Physician Decision|0|||
25188053|NCT01360632|50340392|FG001|Phase B (6 Weeks)|Physician Decision|0|||
25188054|NCT01360632|50340393|FG002|Phase B (6 Weeks)|Physician Decision|0|||
25188055|NCT01360632|50340394|FG003|Phase B (6 Weeks)|Physician Decision|1|||
25188056|NCT01360632|50340395|FG004|Phase B (6 Weeks)|Physician Decision|0|||
25188057|NCT01360632|50340391|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
25188058|NCT01360632|50340392|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
25188059|NCT01360632|50340393|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
24966533|NCT00427895|50056179|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
24966534|NCT00427895|50056180|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
24966535|NCT00427895|50056181|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
25188060|NCT01360632|50340394|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
25188061|NCT01360632|50340395|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
25188062|NCT01360632|50340391|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
25188063|NCT01360632|50340392|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
25188064|NCT01360632|50340393|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
25188065|NCT01360632|50340394|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
25188066|NCT01360632|50340395|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
25188067|NCT01360632|50340391|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
24966536|NCT00427895|50056182|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
24966537|NCT00427895|50056183|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
24966538|NCT00427895|50056184|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
24966539|NCT00427895|50056185|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
24966540|NCT00427895|50056186|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
24966541|NCT00427895|50056179|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
24966542|NCT00427895|50056180|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
24966543|NCT00427895|50056181|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
24966544|NCT00427895|50056182|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
24966545|NCT00427895|50056183|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
24966546|NCT00427895|50056184|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
24966547|NCT00427895|50056185|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
24966548|NCT00427895|50056186|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
24966549|NCT00427895|50056179|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
24966550|NCT00427895|50056180|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
24966551|NCT00427895|50056181|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
24966552|NCT00427895|50056182|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
24966553|NCT00427895|50056183|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
24966554|NCT00427895|50056184|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
24966555|NCT00427895|50056185|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
24966556|NCT00427895|50056186|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
24966557|NCT00427895|50056179|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
24966558|NCT00427895|50056180|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
24966559|NCT00427895|50056181|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
24966560|NCT00427895|50056182|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
24966561|NCT00427895|50056183|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
24966562|NCT00427895|50056184|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
24966563|NCT00427895|50056185|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
24966564|NCT00427895|50056186|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
24966565|NCT00427895|50056179|FG000|Vax 1/Year 1 Follow-up|Death|1|||
24966566|NCT00427895|50056180|FG001|Vax 1/Year 1 Follow-up|Death|0|||
24966567|NCT00427895|50056181|FG002|Vax 1/Year 1 Follow-up|Death|0|||
24966568|NCT00427895|50056182|FG003|Vax 1/Year 1 Follow-up|Death|0|||
24966569|NCT00427895|50056183|FG004|Vax 1/Year 1 Follow-up|Death|0|||
24966570|NCT00427895|50056184|FG005|Vax 1/Year 1 Follow-up|Death|0|||
24966571|NCT00427895|50056185|FG006|Vax 1/Year 1 Follow-up|Death|0|||
24966572|NCT00427895|50056186|FG007|Vax 1/Year 1 Follow-up|Death|0|||
24966573|NCT00427895|50056179|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
24966574|NCT00427895|50056180|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
24966575|NCT00427895|50056181|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
24966576|NCT00427895|50056182|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
24966577|NCT00427895|50056183|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
24966578|NCT00427895|50056184|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
24966579|NCT00427895|50056185|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
24966580|NCT00427895|50056186|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
24966581|NCT00427895|50056179|FG000|Vax 1/Year 1 Follow-up|Other|0|||
24966582|NCT00427895|50056180|FG001|Vax 1/Year 1 Follow-up|Other|0|||
24966583|NCT00427895|50056181|FG002|Vax 1/Year 1 Follow-up|Other|0|||
24966584|NCT00427895|50056182|FG003|Vax 1/Year 1 Follow-up|Other|2|||
24966585|NCT00427895|50056183|FG004|Vax 1/Year 1 Follow-up|Other|0|||
24966586|NCT00427895|50056184|FG005|Vax 1/Year 1 Follow-up|Other|0|||
24966587|NCT00427895|50056185|FG006|Vax 1/Year 1 Follow-up|Other|0|||
24966588|NCT00427895|50056186|FG007|Vax 1/Year 1 Follow-up|Other|0|||
24966589|NCT00427895|50056179|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
24966590|NCT00427895|50056180|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
25188068|NCT01360632|50340392|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
25188069|NCT01360632|50340393|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
25188070|NCT01360632|50340394|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
25188071|NCT01360632|50340395|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
25188072|NCT01360632|50340391|FG000|Phase A+|Lost to Follow-up|0|||
25188073|NCT01360632|50340392|FG001|Phase A+|Lost to Follow-up|0|||
25188074|NCT01360632|50340393|FG002|Phase A+|Lost to Follow-up|0|||
25188075|NCT01360632|50340394|FG003|Phase A+|Lost to Follow-up|0|||
25188076|NCT01360632|50340395|FG004|Phase A+|Lost to Follow-up|2|||
25188077|NCT01360632|50340391|FG000|Phase A+|Adverse Event|0|||
25188078|NCT01360632|50340392|FG001|Phase A+|Adverse Event|0|||
25188079|NCT01360632|50340393|FG002|Phase A+|Adverse Event|0|||
25188080|NCT01360632|50340394|FG003|Phase A+|Adverse Event|0|||
25188081|NCT01360632|50340395|FG004|Phase A+|Adverse Event|2|||
25188082|NCT01360632|50340391|FG000|Phase A+|Met Withdrawal Criteria|0|||
25188083|NCT01360632|50340392|FG001|Phase A+|Met Withdrawal Criteria|0|||
25188084|NCT01360632|50340393|FG002|Phase A+|Met Withdrawal Criteria|0|||
25188085|NCT01360632|50340394|FG003|Phase A+|Met Withdrawal Criteria|0|||
25188086|NCT01360632|50340395|FG004|Phase A+|Met Withdrawal Criteria|7|||
25188087|NCT01360632|50340391|FG000|Phase A+|Physician Decision|0|||
25188088|NCT01360632|50340392|FG001|Phase A+|Physician Decision|0|||
25188089|NCT01360632|50340393|FG002|Phase A+|Physician Decision|0|||
25188090|NCT01360632|50340394|FG003|Phase A+|Physician Decision|0|||
25188091|NCT01360632|50340395|FG004|Phase A+|Physician Decision|3|||
25188092|NCT01360632|50340391|FG000|Phase A+|Withdrawal by Subject|0|||
25188093|NCT01360632|50340392|FG001|Phase A+|Withdrawal by Subject|0|||
25188094|NCT01360632|50340393|FG002|Phase A+|Withdrawal by Subject|0|||
25188095|NCT01360632|50340394|FG003|Phase A+|Withdrawal by Subject|0|||
25188096|NCT01360632|50340395|FG004|Phase A+|Withdrawal by Subject|8|||
24966591|NCT00427895|50056181|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
24966592|NCT00427895|50056182|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
24966593|NCT00427895|50056183|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
25188097|NCT01360632|50340391|FG000|Phase A+|Protocol Deviation|0|||
25188098|NCT01360632|50340392|FG001|Phase A+|Protocol Deviation|0|||
25188099|NCT01360632|50340393|FG002|Phase A+|Protocol Deviation|0|||
25188100|NCT01360632|50340394|FG003|Phase A+|Protocol Deviation|0|||
25188101|NCT01360632|50340395|FG004|Phase A+|Protocol Deviation|3|||
25188102|NCT04157400|50340441|FG000|Overall Study|Withdrawal by Subject|1|||
25188103|NCT04157400|50340441|FG000|Overall Study|Lost to Follow-up|3|||
24966594|NCT00427895|50056184|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
24966595|NCT00427895|50056185|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
24966596|NCT00427895|50056186|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
24966597|NCT00427349|50056225|FG000|Overall Study|Lack of Efficacy|23|||
24966598|NCT00427349|50056225|FG000|Overall Study|Adverse Event|14|||
24966599|NCT00427349|50056225|FG000|Overall Study|Death|1|||
24966600|NCT00427349|50056225|FG000|Overall Study|Withdrawal by Subject|3|||
24966601|NCT00427349|50056225|FG000|Overall Study|Alternative therapy|1|||
24966602|NCT00427349|50056225|FG000|Overall Study|Other|2|||
24966603|NCT00427349|50056225|FG000|Overall Study|Ineligible|1|||
24966604|NCT00427349|50056225|FG000|Overall Study|Never started therapy|1|||
24966605|NCT00425945|50056231|FG000|Overall Study|Concern about Supplement|2|||
24966606|NCT00425945|50056232|FG001|Overall Study|Concern about Supplement|0|||
24966607|NCT00425945|50056231|FG000|Overall Study|Inconvenience|0|||
24966608|NCT00425945|50056232|FG001|Overall Study|Inconvenience|2|||
24966609|NCT00425945|50056231|FG000|Overall Study|Lost to Follow-up|0|||
24966610|NCT00425945|50056232|FG001|Overall Study|Lost to Follow-up|2|||
24966611|NCT00425945|50056231|FG000|Overall Study|Began hypertension medication|1|||
24966612|NCT00425945|50056232|FG001|Overall Study|Began hypertension medication|0|||
24966613|NCT00425945|50056231|FG000|Overall Study|Began cancer treatments|1|||
24966614|NCT00425945|50056232|FG001|Overall Study|Began cancer treatments|0|||
24966615|NCT00425945|50056231|FG000|Overall Study|Moved from area|0|||
24966616|NCT00425945|50056232|FG001|Overall Study|Moved from area|1|||
24966617|NCT00416195|50056242|FG000|Overall Study|Adverse Event|1|||
24966618|NCT00416195|50056243|FG001|Overall Study|Adverse Event|2|||
25188104|NCT02626182|50340515|FG000|Overall Study|Adverse Event|2|||
25188105|NCT02626182|50340516|FG001|Overall Study|Adverse Event|0|||
25188106|NCT01669902|50340623|FG000|Overall Study|Adverse Event|11|||
24966619|NCT00416195|50056242|FG000|Overall Study|Protocol Violation|1|||
24966620|NCT00416195|50056243|FG001|Overall Study|Protocol Violation|1|||
24966621|NCT00416195|50056242|FG000|Overall Study|Other|0|||
24966622|NCT00416195|50056243|FG001|Overall Study|Other|1|||
25188107|NCT01669902|50340623|FG000|Overall Study|Lack of Efficacy|10|||
24966623|NCT00121641|50056253|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
24966624|NCT00121641|50056254|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
24966625|NCT00121641|50056255|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
24966626|NCT00121641|50056256|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
24966627|NCT00121641|50056257|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
24966628|NCT00121641|50056253|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
24966629|NCT00121641|50056254|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
24966630|NCT00121641|50056255|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
24966631|NCT00121641|50056256|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
24966632|NCT00121641|50056257|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
24966633|NCT00121641|50056253|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
24966634|NCT00121641|50056254|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
24966635|NCT00121641|50056255|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
24966636|NCT00121641|50056256|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
24966637|NCT00121641|50056257|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
24966638|NCT00121641|50056253|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
24966639|NCT00121641|50056254|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
24966640|NCT00121641|50056255|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
24966641|NCT00121641|50056256|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
24966642|NCT00121641|50056257|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
24966643|NCT00121641|50056253|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
24966644|NCT00121641|50056254|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
24966645|NCT00121641|50056255|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
24966646|NCT00121641|50056256|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
24966647|NCT00121641|50056257|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
24966648|NCT00121641|50056253|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
24966649|NCT00121641|50056254|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
24966650|NCT00121641|50056255|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
24966651|NCT00121641|50056256|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
24966652|NCT00121641|50056257|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
24966653|NCT00121641|50056253|FG000|24-week Short-term Treatment Period|Other Reason|1|||
24966654|NCT00121641|50056254|FG001|24-week Short-term Treatment Period|Other Reason|0|||
24966655|NCT00121641|50056255|FG002|24-week Short-term Treatment Period|Other Reason|0|||
24966656|NCT00121641|50056256|FG003|24-week Short-term Treatment Period|Other Reason|0|||
24966657|NCT00121641|50056257|FG004|24-week Short-term Treatment Period|Other Reason|0|||
24966658|NCT00121641|50056253|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
24966659|NCT00121641|50056254|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
25188108|NCT01669902|50340623|FG000|Overall Study|Other|8|||
25188109|NCT01670292|50340656|FG000|Overall Study|Lost to Follow-up|14|||
25188110|NCT01360554|50340893|FG000|Overall Study|Death|359|||
25188111|NCT01360554|50340894|FG001|Overall Study|Death|371|||
25188112|NCT01360554|50340893|FG000|Overall Study|Lost to Follow-up|4|||
25188113|NCT01360554|50340894|FG001|Overall Study|Lost to Follow-up|4|||
25188114|NCT01360554|50340893|FG000|Overall Study|Withdrawal by Subject|23|||
25188115|NCT01360554|50340894|FG001|Overall Study|Withdrawal by Subject|24|||
25188116|NCT01360554|50340893|FG000|Overall Study|Study terminated by sponsor|49|||
25188117|NCT01360554|50340894|FG001|Overall Study|Study terminated by sponsor|37|||
25188118|NCT01360554|50340893|FG000|Overall Study|Other, not specified|1|||
25188119|NCT01360554|50340894|FG001|Overall Study|Other, not specified|0|||
25188120|NCT01360554|50340893|FG000|Overall Study|Randomized but not treated.|3|||
25188121|NCT01360554|50340894|FG001|Overall Study|Randomized but not treated.|3|||
25188122|NCT01360398|50340916|FG000|Overall Study|Withdrawal by Subject|14|||
25188123|NCT01360398|50340916|FG000|Overall Study|Other|7|||
25188124|NCT01360398|50340916|FG000|Overall Study|Migrated/moved from study area|1|||
25188125|NCT02626026|50340926|FG000|Overall Study|Randomized but Never Treated|0|||
25188126|NCT02626026|50340927|FG001|Overall Study|Randomized but Never Treated|0|||
25188127|NCT02626026|50340928|FG002|Overall Study|Randomized but Never Treated|0|||
25068207|NCT02392234|50173902|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
25188128|NCT02626026|50340929|FG003|Overall Study|Randomized but Never Treated|0|||
25188129|NCT02626026|50340930|FG004|Overall Study|Randomized but Never Treated|1|||
25188130|NCT02626026|50340931|FG005|Overall Study|Randomized but Never Treated|0|||
25188131|NCT01765296|50341191|FG000|Overall Study|Protocol Violation|0|||
25188132|NCT01765296|50341192|FG001|Overall Study|Protocol Violation|5|||
25188133|NCT01765296|50341193|FG002|Overall Study|Protocol Violation|4|||
25188134|NCT01765296|50341191|FG000|Overall Study|Withdrawal by Subject|4|||
25188135|NCT01765296|50341192|FG001|Overall Study|Withdrawal by Subject|2|||
25188136|NCT01765296|50341193|FG002|Overall Study|Withdrawal by Subject|2|||
25188137|NCT01765296|50341191|FG000|Overall Study|Adverse Event|1|||
25188138|NCT01765296|50341192|FG001|Overall Study|Adverse Event|13|||
25188139|NCT01765296|50341193|FG002|Overall Study|Adverse Event|5|||
25188140|NCT01765296|50341191|FG000|Overall Study|Lack of Efficacy|0|||
25188141|NCT01765296|50341192|FG001|Overall Study|Lack of Efficacy|0|||
25188142|NCT01765296|50341193|FG002|Overall Study|Lack of Efficacy|2|||
25188143|NCT02089685|50341267|FG000|Overall Study|Adverse Event|1|||
25188144|NCT02089685|50341268|FG001|Overall Study|Adverse Event|0|||
25188145|NCT02089685|50341269|FG002|Overall Study|Adverse Event|0|||
25188146|NCT02089685|50341270|FG003|Overall Study|Adverse Event|0|||
25188147|NCT02089685|50341271|FG004|Overall Study|Adverse Event|1|||
25188148|NCT02089685|50341272|FG005|Overall Study|Adverse Event|0|||
25188149|NCT02089685|50341267|FG000|Overall Study|Clinical Progression|4|||
25188150|NCT02089685|50341268|FG001|Overall Study|Clinical Progression|0|||
25188151|NCT02089685|50341269|FG002|Overall Study|Clinical Progression|0|||
25188152|NCT02089685|50341270|FG003|Overall Study|Clinical Progression|5|||
25188153|NCT02089685|50341271|FG004|Overall Study|Clinical Progression|1|||
25188154|NCT02089685|50341272|FG005|Overall Study|Clinical Progression|2|||
25188155|NCT02089685|50341267|FG000|Overall Study|Excluded Medication|1|||
25188156|NCT02089685|50341268|FG001|Overall Study|Excluded Medication|0|||
25188157|NCT02089685|50341269|FG002|Overall Study|Excluded Medication|0|||
25188158|NCT02089685|50341270|FG003|Overall Study|Excluded Medication|11|||
25188159|NCT02089685|50341271|FG004|Overall Study|Excluded Medication|2|||
25188160|NCT02089685|50341272|FG005|Overall Study|Excluded Medication|1|||
25188161|NCT02089685|50341267|FG000|Overall Study|Progressive disease|13|||
25188162|NCT02089685|50341268|FG001|Overall Study|Progressive disease|10|||
25188163|NCT02089685|50341269|FG002|Overall Study|Progressive disease|3|||
25188164|NCT02089685|50341270|FG003|Overall Study|Progressive disease|51|||
25188165|NCT02089685|50341271|FG004|Overall Study|Progressive disease|17|||
25188166|NCT02089685|50341272|FG005|Overall Study|Progressive disease|12|||
25188167|NCT02089685|50341267|FG000|Overall Study|Follow up ended by sponsor|2|||
25188168|NCT02089685|50341268|FG001|Overall Study|Follow up ended by sponsor|2|||
25188169|NCT02089685|50341269|FG002|Overall Study|Follow up ended by sponsor|0|||
25188170|NCT02089685|50341270|FG003|Overall Study|Follow up ended by sponsor|70|||
25168657|NCT01872689|50298243|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
25188171|NCT02089685|50341271|FG004|Overall Study|Follow up ended by sponsor|26|||
25188172|NCT02089685|50341272|FG005|Overall Study|Follow up ended by sponsor|26|||
25188173|NCT02089685|50341267|FG000|Overall Study|Withdrawal by Subject|0|||
25188174|NCT02089685|50341268|FG001|Overall Study|Withdrawal by Subject|2|||
25188175|NCT02089685|50341269|FG002|Overall Study|Withdrawal by Subject|0|||
25188176|NCT02089685|50341270|FG003|Overall Study|Withdrawal by Subject|8|||
25188177|NCT02089685|50341271|FG004|Overall Study|Withdrawal by Subject|1|||
25188178|NCT02089685|50341272|FG005|Overall Study|Withdrawal by Subject|1|||
25188179|NCT02089685|50341267|FG000|Overall Study|Status not recorded|1|||
25188180|NCT02089685|50341268|FG001|Overall Study|Status not recorded|0|||
25188181|NCT02089685|50341269|FG002|Overall Study|Status not recorded|0|||
25188182|NCT02089685|50341270|FG003|Overall Study|Status not recorded|0|||
25188183|NCT02089685|50341271|FG004|Overall Study|Status not recorded|1|||
25188184|NCT02089685|50341272|FG005|Overall Study|Status not recorded|0|||
25188185|NCT02089685|50341267|FG000|Overall Study|Death|0|||
25188186|NCT02089685|50341268|FG001|Overall Study|Death|0|||
25188187|NCT02089685|50341269|FG002|Overall Study|Death|0|||
25188188|NCT02089685|50341270|FG003|Overall Study|Death|7|||
25188189|NCT02089685|50341271|FG004|Overall Study|Death|2|||
25188190|NCT02089685|50341272|FG005|Overall Study|Death|5|||
25188191|NCT02089685|50341267|FG000|Overall Study|Lost to Follow-up|0|||
25188192|NCT02089685|50341268|FG001|Overall Study|Lost to Follow-up|0|||
25188193|NCT02089685|50341269|FG002|Overall Study|Lost to Follow-up|0|||
25188194|NCT02089685|50341270|FG003|Overall Study|Lost to Follow-up|1|||
25188195|NCT02089685|50341271|FG004|Overall Study|Lost to Follow-up|0|||
25188196|NCT02089685|50341272|FG005|Overall Study|Lost to Follow-up|0|||
25188197|NCT02089685|50341267|FG000|Overall Study|Physician Decision|0|||
25188198|NCT02089685|50341268|FG001|Overall Study|Physician Decision|0|||
25188199|NCT02089685|50341269|FG002|Overall Study|Physician Decision|0|||
25188200|NCT02089685|50341270|FG003|Overall Study|Physician Decision|0|||
25188201|NCT02089685|50341271|FG004|Overall Study|Physician Decision|0|||
25188202|NCT02089685|50341272|FG005|Overall Study|Physician Decision|4|||
25188203|NCT02089685|50341267|FG000|Overall Study|Screen failure|1|||
25188204|NCT02089685|50341268|FG001|Overall Study|Screen failure|0|||
25188205|NCT02089685|50341269|FG002|Overall Study|Screen failure|0|||
25188206|NCT02089685|50341270|FG003|Overall Study|Screen failure|0|||
25188207|NCT02089685|50341271|FG004|Overall Study|Screen failure|0|||
25188208|NCT02089685|50341272|FG005|Overall Study|Screen failure|0|||
25188209|NCT05282004|50341330|FG000|Overall Study|Adverse Event|2|||
25188210|NCT05004649|50341334|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
25188211|NCT05004649|50341334|FG000|Overall Study|Lost to Follow-up|1|||
25188212|NCT05004649|50341334|FG000|Overall Study|Withdrawal by Subject|2|||
25188213|NCT05004649|50341334|FG000|Overall Study|COVID-19|1|||
25188214|NCT04666298|50341344|FG000|Overall Study|Subject decision|1|||
25188215|NCT04666298|50341345|FG001|Overall Study|Subject decision|0|||
25188216|NCT04666298|50341346|FG002|Overall Study|Subject decision|0|||
25188217|NCT04666298|50341347|FG003|Overall Study|Subject decision|2|||
25188218|NCT04666298|50341344|FG000|Overall Study|Death|1|||
25188219|NCT04666298|50341345|FG001|Overall Study|Death|0|||
25188220|NCT04666298|50341346|FG002|Overall Study|Death|0|||
25188221|NCT04666298|50341347|FG003|Overall Study|Death|0|||
25188222|NCT04666298|50341344|FG000|Overall Study|Lost to Follow-up|0|||
25188223|NCT04666298|50341345|FG001|Overall Study|Lost to Follow-up|0|||
25188224|NCT04666298|50341346|FG002|Overall Study|Lost to Follow-up|0|||
25188225|NCT04666298|50341347|FG003|Overall Study|Lost to Follow-up|1|||
25188226|NCT04666298|50341344|FG000|Overall Study|Physician Decision|0|||
25188227|NCT04666298|50341345|FG001|Overall Study|Physician Decision|0|||
25188228|NCT04666298|50341346|FG002|Overall Study|Physician Decision|0|||
25188229|NCT04666298|50341347|FG003|Overall Study|Physician Decision|1|||
25188230|NCT04666298|50341344|FG000|Overall Study|Protocol deviation|0|||
25188231|NCT04666298|50341345|FG001|Overall Study|Protocol deviation|0|||
25188232|NCT04666298|50341346|FG002|Overall Study|Protocol deviation|1|||
25188233|NCT04666298|50341347|FG003|Overall Study|Protocol deviation|0|||
25188234|NCT04581200|50341359|FG000|Overall Study|Lost to Follow-up|6|||
25188235|NCT04581200|50341360|FG001|Overall Study|Lost to Follow-up|5|||
25188236|NCT04303780|50341395|FG000|Overall Study|Death|104|||
25188237|NCT04303780|50341396|FG001|Overall Study|Death|85|||
25188238|NCT04303780|50341395|FG000|Overall Study|Lost to Follow-up|5|||
25188239|NCT04303780|50341396|FG001|Overall Study|Lost to Follow-up|2|||
25188240|NCT04303780|50341395|FG000|Overall Study|Withdrawal by Subject|12|||
25188241|NCT04303780|50341396|FG001|Overall Study|Withdrawal by Subject|39|||
25188242|NCT04303780|50341395|FG000|Overall Study|Ongoing in study|50|||
25188243|NCT04303780|50341396|FG001|Overall Study|Ongoing in study|45|||
25188244|NCT04188301|50341406|FG000|Month 3|Lost to Follow-up|0|||
25188245|NCT04188301|50341407|FG001|Month 3|Lost to Follow-up|0|||
25188246|NCT04188301|50341408|FG002|Month 3|Lost to Follow-up|1|||
25188247|NCT04188301|50341406|FG000|Month 12|Lost to Follow-up|0|||
25188248|NCT04188301|50341407|FG001|Month 12|Lost to Follow-up|0|||
25188249|NCT04188301|50341408|FG002|Month 12|Lost to Follow-up|2|||
25188250|NCT04188301|50341406|FG000|Month 12|Death|1|||
25188251|NCT04188301|50341407|FG001|Month 12|Death|1|||
25188252|NCT04188301|50341408|FG002|Month 12|Death|0|||
25188253|NCT04188301|50341406|FG000|Month 18|Lost to Follow-up|6|||
24966660|NCT00121641|50056255|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
24966661|NCT00121641|50056256|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
24966662|NCT00121641|50056257|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
24966663|NCT00121641|50056253|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
24966664|NCT00121641|50056254|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
24966665|NCT00121641|50056255|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
24966666|NCT00121641|50056256|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
24966667|NCT00121641|50056257|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
24966668|NCT00121641|50056253|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
24966669|NCT00121641|50056254|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
24966670|NCT00121641|50056255|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
24966671|NCT00121641|50056256|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
24966672|NCT00121641|50056257|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
24966673|NCT00121641|50056253|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
24966674|NCT00121641|50056254|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
24966675|NCT00121641|50056255|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
24966676|NCT00121641|50056256|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
24966677|NCT00121641|50056257|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
24966678|NCT00121641|50056253|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
24966679|NCT00121641|50056254|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
25068208|NCT02392234|50173903|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
25068209|NCT02392234|50173904|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
25068210|NCT02392234|50173905|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
25188254|NCT04188301|50341407|FG001|Month 18|Lost to Follow-up|0|||
25188255|NCT04188301|50341408|FG002|Month 18|Lost to Follow-up|0|||
25188256|NCT04006925|50341418|FG000|Overall Study|Side effects|2|||
25188257|NCT04006925|50341419|FG001|Overall Study|Side effects|0|||
25188258|NCT03599713|50341431|FG000|Overall Study|Death|26|||
25188259|NCT03599713|50341432|FG001|Overall Study|Death|3|||
25188260|NCT03599713|50341431|FG000|Overall Study|Withdrawal by Subject|6|||
25188261|NCT03599713|50341432|FG001|Overall Study|Withdrawal by Subject|0|||
25188262|NCT03599713|50341431|FG000|Overall Study|Ongoing|69|||
25188263|NCT03599713|50341432|FG001|Overall Study|Ongoing|3|||
25188264|NCT03597061|50341442|FG000|Overall Study|Lost to Follow-up|1|||
25188265|NCT03597061|50341443|FG001|Overall Study|Lost to Follow-up|0|||
25188266|NCT03597061|50341442|FG000|Overall Study|Protocol Violation|0|||
25188267|NCT03597061|50341443|FG001|Overall Study|Protocol Violation|1|||
25188268|NCT03148795|50341471|FG000|Overall Study|Death|6|||
25188269|NCT03148795|50341471|FG000|Overall Study|Adverse Event|5|||
25188270|NCT03148795|50341471|FG000|Overall Study|Other|15|||
25188271|NCT03148795|50341471|FG000|Overall Study|No Longer Clinically Benefitting|2|||
25188272|NCT03148795|50341471|FG000|Overall Study|Global Deterioration Of Health Status|6|||
25188273|NCT03148795|50341471|FG000|Overall Study|Withdrawal by Subject|2|||
25188274|NCT03148795|50341471|FG000|Overall Study|Progressive Disease|62|||
25277215|NCT00943384|50591259|FG000|Overall Study|Withdrawal by Subject|5|||
25277216|NCT00943306|50591263|FG000|Overall Study|Physician Decision|1|||
25277217|NCT00943306|50591263|FG000|Overall Study|Death|1|||
25277218|NCT00943306|50591263|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
25277219|NCT01198002|50591270|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
25277220|NCT01198002|50591271|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
25277221|NCT01198002|50591272|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
25277222|NCT01198002|50591270|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
25277223|NCT01198002|50591271|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
25277224|NCT01198002|50591272|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
25277225|NCT01198002|50591270|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
25277226|NCT01198002|50591271|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
24966680|NCT00121641|50056255|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
25277227|NCT01198002|50591272|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
25277228|NCT01198002|50591270|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
25277229|NCT01198002|50591271|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
25277230|NCT01198002|50591272|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
25277231|NCT01198002|50591270|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
25277232|NCT01198002|50591271|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
25277233|NCT01198002|50591272|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
25277234|NCT01198002|50591270|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
25277235|NCT01198002|50591271|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
25277236|NCT01198002|50591272|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
25168658|NCT01872689|50298244|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
24966681|NCT00121641|50056256|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
25188275|NCT03148795|50341471|FG000|Overall Study|Ongoing|30|||
25188276|NCT03146845|50341477|FG000|Overall Study|Reference ulcer healed|1|||
25188277|NCT03146845|50341478|FG001|Overall Study|Reference ulcer healed|0|||
25188278|NCT03146845|50341477|FG000|Overall Study|Physician Decision|1|||
25188279|NCT03146845|50341478|FG001|Overall Study|Physician Decision|0|||
25188280|NCT03146845|50341477|FG000|Overall Study|Adverse Event|1|||
25188281|NCT03146845|50341478|FG001|Overall Study|Adverse Event|0|||
25188282|NCT03146845|50341477|FG000|Overall Study|Withdrawal by Subject|2|||
25188283|NCT03146845|50341478|FG001|Overall Study|Withdrawal by Subject|0|||
25188284|NCT03146845|50341477|FG000|Overall Study|Noncompliance|0|||
25188285|NCT03146845|50341478|FG001|Overall Study|Noncompliance|1|||
25188286|NCT03146845|50341477|FG000|Overall Study|Protocol Violation|0|||
25188287|NCT03146845|50341478|FG001|Overall Study|Protocol Violation|2|||
25188288|NCT03146845|50341477|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
25188289|NCT03146845|50341478|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
25188290|NCT02975700|50341484|FG000|Overall Study|Adverse Event|1|||
25188291|NCT02975700|50341484|FG000|Overall Study|Progressive disease|3|||
25188292|NCT02975700|50341484|FG000|Overall Study|Failed screening criteria|2|||
25188293|NCT02895360|50341494|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
25188294|NCT02895360|50341495|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
25188295|NCT02895360|50341496|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
25188296|NCT02895360|50341497|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
25188297|NCT02895360|50341498|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
25188298|NCT02895360|50341499|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
25188299|NCT02895360|50341494|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
25188300|NCT02895360|50341495|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
25188301|NCT02895360|50341496|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
25188302|NCT02895360|50341497|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
25188303|NCT02895360|50341498|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
25188304|NCT02895360|50341499|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
24966682|NCT00121641|50056257|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
24966683|NCT00121641|50056253|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
25188305|NCT02895360|50341494|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
25188306|NCT02895360|50341495|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
25188307|NCT02895360|50341496|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
25188308|NCT02895360|50341497|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
25188309|NCT02895360|50341498|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
25188310|NCT02895360|50341499|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
25188311|NCT02895360|50341494|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
25188312|NCT02895360|50341495|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
25188313|NCT02895360|50341496|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
25188314|NCT02895360|50341497|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
25188315|NCT02895360|50341498|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
25188316|NCT02895360|50341499|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
25188317|NCT02895360|50341494|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
25188318|NCT02895360|50341495|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
25188319|NCT02895360|50341496|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
25188320|NCT02895360|50341497|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
25188321|NCT02895360|50341498|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
25188322|NCT02895360|50341499|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
25188323|NCT02895360|50341494|FG000|Phase 2a|Adverse Event|0|||
25188324|NCT02895360|50341495|FG001|Phase 2a|Adverse Event|0|||
25188325|NCT02895360|50341496|FG002|Phase 2a|Adverse Event|0|||
25188326|NCT02895360|50341497|FG003|Phase 2a|Adverse Event|0|||
25188327|NCT02895360|50341498|FG004|Phase 2a|Adverse Event|0|||
25188328|NCT02895360|50341499|FG005|Phase 2a|Adverse Event|1|||
25188329|NCT02895360|50341494|FG000|Phase 2a|Progressive disease|0|||
24966684|NCT00121641|50056254|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
24966685|NCT00121641|50056255|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
24966686|NCT00121641|50056256|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
24966687|NCT00121641|50056257|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
24966688|NCT00121641|50056253|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
24966689|NCT00121641|50056254|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
24966690|NCT00121641|50056255|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
24966691|NCT00121641|50056256|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
24966692|NCT00121641|50056257|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
24966693|NCT00121641|50056253|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
24966694|NCT00121641|50056254|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
24966695|NCT00121641|50056255|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
24966696|NCT00121641|50056256|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
24966697|NCT00121641|50056257|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
24966698|NCT00121641|50056253|FG000|48-month Short Term + Long Term Period|Death|0|||
24966699|NCT00121641|50056254|FG001|48-month Short Term + Long Term Period|Death|0|||
24966700|NCT00121641|50056255|FG002|48-month Short Term + Long Term Period|Death|0|||
24966701|NCT00121641|50056256|FG003|48-month Short Term + Long Term Period|Death|1|||
24966702|NCT00121641|50056257|FG004|48-month Short Term + Long Term Period|Death|0|||
24966703|NCT00121641|50056253|FG000|48-month Short Term + Long Term Period|Missing|0|||
24966704|NCT00121641|50056254|FG001|48-month Short Term + Long Term Period|Missing|0|||
24966705|NCT00121641|50056255|FG002|48-month Short Term + Long Term Period|Missing|1|||
24966706|NCT00121641|50056256|FG003|48-month Short Term + Long Term Period|Missing|0|||
24966707|NCT00121641|50056257|FG004|48-month Short Term + Long Term Period|Missing|0|||
24966708|NCT00121641|50056253|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
24966709|NCT00121641|50056254|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
24966710|NCT00121641|50056255|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
25188330|NCT02895360|50341495|FG001|Phase 2a|Progressive disease|0|||
25188331|NCT02895360|50341496|FG002|Phase 2a|Progressive disease|0|||
25188332|NCT02895360|50341497|FG003|Phase 2a|Progressive disease|0|||
25188333|NCT02895360|50341498|FG004|Phase 2a|Progressive disease|11|||
25188334|NCT02895360|50341499|FG005|Phase 2a|Progressive disease|11|||
25188335|NCT02863809|50341533|FG000|Overall Study|Adverse Event|8|||
25188336|NCT02863809|50341534|FG001|Overall Study|Adverse Event|8|||
24966711|NCT00121641|50056256|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
24966712|NCT00121641|50056257|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
24966713|NCT00425555|50056273|FG000|Overall Study|Withdrawal by Subject|11|||
24966714|NCT00425555|50056274|FG001|Overall Study|Withdrawal by Subject|8|||
24966715|NCT00425555|50056273|FG000|Overall Study|Lost to Follow-up|0|||
24966716|NCT00425555|50056274|FG001|Overall Study|Lost to Follow-up|1|||
24966717|NCT00425555|50056273|FG000|Overall Study|Administrative problems|3|||
24966718|NCT00425555|50056274|FG001|Overall Study|Administrative problems|0|||
24966719|NCT00425555|50056273|FG000|Overall Study|Death|1|||
24966720|NCT00425555|50056274|FG001|Overall Study|Death|2|||
24966721|NCT00425555|50056273|FG000|Overall Study|New cancer therapy|2|||
24966722|NCT00425555|50056274|FG001|Overall Study|New cancer therapy|1|||
24966723|NCT00425555|50056273|FG000|Overall Study|Disease progression|36|||
24966724|NCT00425555|50056274|FG001|Overall Study|Disease progression|33|||
24966725|NCT00425555|50056273|FG000|Overall Study|Adverse Event|25|||
24966726|NCT00425555|50056274|FG001|Overall Study|Adverse Event|15|||
24966727|NCT00425555|50056273|FG000|Overall Study|Protocol Violation|1|||
24966728|NCT00425555|50056274|FG001|Overall Study|Protocol Violation|0|||
24966729|NCT00424775|50056283|FG000|Overall Study|Adverse Event|2|||
24966730|NCT00424775|50056284|FG001|Overall Study|Adverse Event|0|||
24966731|NCT00424775|50056283|FG000|Overall Study|Lack of Efficacy|1|||
24966732|NCT00424775|50056284|FG001|Overall Study|Lack of Efficacy|0|||
24966733|NCT00121485|50056290|FG000|Overall Study|Not implanted|1|||
24966734|NCT00121485|50056291|FG001|Overall Study|Not implanted|5|||
24966735|NCT00121485|50056290|FG000|Overall Study|Crossover|0|||
24966736|NCT00121485|50056291|FG001|Overall Study|Crossover|2|||
24966737|NCT01763866|50056322|FG000|Overall Study|Withdrawal by Subject|2|||
24966738|NCT01763866|50056323|FG001|Overall Study|Withdrawal by Subject|1|||
24966739|NCT01763866|50056324|FG002|Overall Study|Withdrawal by Subject|4|||
24966740|NCT01763866|50056325|FG003|Overall Study|Withdrawal by Subject|0|||
24966741|NCT01763866|50056326|FG004|Overall Study|Withdrawal by Subject|0|||
24966742|NCT01763866|50056327|FG005|Overall Study|Withdrawal by Subject|3|||
24966743|NCT01763866|50056328|FG006|Overall Study|Withdrawal by Subject|4|||
25068211|NCT02392234|50173906|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
25068212|NCT02392234|50173901|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
25068213|NCT02392234|50173902|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
25068214|NCT02392234|50173903|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
25068215|NCT02392234|50173904|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
25068216|NCT02392234|50173905|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
25068217|NCT02392234|50173906|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
25068218|NCT02392234|50173901|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
25068219|NCT02392234|50173902|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
25068220|NCT02392234|50173903|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
25068221|NCT02392234|50173904|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
25068222|NCT02392234|50173905|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
24966744|NCT01763866|50056329|FG007|Overall Study|Withdrawal by Subject|0|||
24966745|NCT01763866|50056330|FG008|Overall Study|Withdrawal by Subject|1|||
24966746|NCT01763866|50056331|FG009|Overall Study|Withdrawal by Subject|1|||
24966747|NCT01763866|50056332|FG010|Overall Study|Withdrawal by Subject|2|||
24966748|NCT01763866|50056333|FG011|Overall Study|Withdrawal by Subject|2|||
24966749|NCT01763866|50056334|FG012|Overall Study|Withdrawal by Subject|2|||
24966750|NCT01763866|50056335|FG013|Overall Study|Withdrawal by Subject|0|||
24966751|NCT01763866|50056336|FG014|Overall Study|Withdrawal by Subject|6|||
24966752|NCT01763866|50056337|FG015|Overall Study|Withdrawal by Subject|3|||
24966753|NCT01763866|50056338|FG016|Overall Study|Withdrawal by Subject|0|||
24966754|NCT01763866|50056339|FG017|Overall Study|Withdrawal by Subject|1|||
24966755|NCT01763866|50056340|FG018|Overall Study|Withdrawal by Subject|1|||
24966756|NCT01763866|50056341|FG019|Overall Study|Withdrawal by Subject|1|||
25168659|NCT01872689|50298245|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
25168660|NCT01872689|50298242|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
25188337|NCT02863809|50341533|FG000|Overall Study|Withdrawal by Subject|0|||
25188338|NCT02863809|50341534|FG001|Overall Study|Withdrawal by Subject|1|||
25168661|NCT01872689|50298243|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
25168662|NCT01872689|50298244|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
25168663|NCT01872689|50298245|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
25168664|NCT01872689|50298242|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
25168665|NCT01872689|50298243|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
25168666|NCT01872689|50298244|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
24966757|NCT01763866|50056342|FG020|Overall Study|Withdrawal by Subject|2|||
24966758|NCT01763866|50056343|FG021|Overall Study|Withdrawal by Subject|1|||
24966759|NCT01763866|50056344|FG022|Overall Study|Withdrawal by Subject|2|||
24966760|NCT01763866|50056345|FG023|Overall Study|Withdrawal by Subject|1|||
24966761|NCT01763866|50056322|FG000|Overall Study|Decision by sponsor|0|||
24966762|NCT01763866|50056323|FG001|Overall Study|Decision by sponsor|0|||
25068223|NCT02392234|50173906|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
25068224|NCT02963090|50173920|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
25068225|NCT02963090|50173921|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
25068226|NCT02427802|50173933|FG000|Overall Study|Adverse Event|11|||
25068227|NCT02427802|50173934|FG001|Overall Study|Adverse Event|3|||
25068228|NCT02427802|50173935|FG002|Overall Study|Adverse Event|7|||
25068229|NCT02427802|50173933|FG000|Overall Study|Death|0|||
24966763|NCT01763866|50056324|FG002|Overall Study|Decision by sponsor|1|||
24966764|NCT01763866|50056325|FG003|Overall Study|Decision by sponsor|0|||
24966765|NCT01763866|50056326|FG004|Overall Study|Decision by sponsor|2|||
24966766|NCT01763866|50056327|FG005|Overall Study|Decision by sponsor|0|||
24966767|NCT01763866|50056328|FG006|Overall Study|Decision by sponsor|2|||
24966768|NCT01763866|50056329|FG007|Overall Study|Decision by sponsor|0|||
25068230|NCT02427802|50173934|FG001|Overall Study|Death|4|||
25068231|NCT02427802|50173935|FG002|Overall Study|Death|1|||
24966769|NCT01763866|50056330|FG008|Overall Study|Decision by sponsor|2|||
24966770|NCT01763866|50056331|FG009|Overall Study|Decision by sponsor|0|||
24966771|NCT01763866|50056332|FG010|Overall Study|Decision by sponsor|6|||
24966772|NCT01763866|50056333|FG011|Overall Study|Decision by sponsor|0|||
24966773|NCT01763866|50056334|FG012|Overall Study|Decision by sponsor|1|||
24966774|NCT01763866|50056335|FG013|Overall Study|Decision by sponsor|0|||
24966775|NCT01763866|50056336|FG014|Overall Study|Decision by sponsor|5|||
24966776|NCT01763866|50056337|FG015|Overall Study|Decision by sponsor|0|||
25068232|NCT02427802|50173933|FG000|Overall Study|Lost to Follow-up|13|||
25068233|NCT02427802|50173934|FG001|Overall Study|Lost to Follow-up|8|||
25068234|NCT02427802|50173935|FG002|Overall Study|Lost to Follow-up|8|||
25068235|NCT02427802|50173933|FG000|Overall Study|Physician Decision|4|||
25068236|NCT02427802|50173934|FG001|Overall Study|Physician Decision|2|||
25068237|NCT02427802|50173935|FG002|Overall Study|Physician Decision|4|||
24966777|NCT01763866|50056338|FG016|Overall Study|Decision by sponsor|0|||
24966778|NCT01763866|50056339|FG017|Overall Study|Decision by sponsor|0|||
24966779|NCT01763866|50056340|FG018|Overall Study|Decision by sponsor|4|||
24966780|NCT01763866|50056341|FG019|Overall Study|Decision by sponsor|0|||
24966781|NCT01763866|50056342|FG020|Overall Study|Decision by sponsor|2|||
24966782|NCT01763866|50056343|FG021|Overall Study|Decision by sponsor|0|||
24966783|NCT01763866|50056344|FG022|Overall Study|Decision by sponsor|1|||
24966784|NCT01763866|50056345|FG023|Overall Study|Decision by sponsor|0|||
24966785|NCT01763866|50056322|FG000|Overall Study|Lost to Follow-up|0|||
24966786|NCT01763866|50056323|FG001|Overall Study|Lost to Follow-up|0|||
24966787|NCT01763866|50056324|FG002|Overall Study|Lost to Follow-up|0|||
24966788|NCT01763866|50056325|FG003|Overall Study|Lost to Follow-up|0|||
24966789|NCT01763866|50056326|FG004|Overall Study|Lost to Follow-up|0|||
25068238|NCT02427802|50173933|FG000|Overall Study|Withdrawal by Subject|10|||
25068239|NCT02427802|50173934|FG001|Overall Study|Withdrawal by Subject|5|||
25068240|NCT02427802|50173935|FG002|Overall Study|Withdrawal by Subject|11|||
25068241|NCT02427802|50173933|FG000|Overall Study|Protocol Violation|3|||
25068242|NCT02427802|50173934|FG001|Overall Study|Protocol Violation|1|||
25068243|NCT02427802|50173935|FG002|Overall Study|Protocol Violation|1|||
25068244|NCT02427802|50173933|FG000|Overall Study|protocol specific treatment unrelated|18|||
25068245|NCT02427802|50173934|FG001|Overall Study|protocol specific treatment unrelated|11|||
25068246|NCT02427802|50173935|FG002|Overall Study|protocol specific treatment unrelated|11|||
25068247|NCT02427646|50173945|FG000|Overall Study|Lack of Efficacy|2|||
25068248|NCT02427646|50173946|FG001|Overall Study|Lack of Efficacy|3|||
25068249|NCT02427646|50173945|FG000|Overall Study|Physician Decision|1|||
25068250|NCT02427646|50173946|FG001|Overall Study|Physician Decision|4|||
25068251|NCT02427646|50173945|FG000|Overall Study|Protocol Violation|3|||
25068252|NCT02427646|50173946|FG001|Overall Study|Protocol Violation|3|||
25068253|NCT02427646|50173945|FG000|Overall Study|Bothersome hand weakness|2|||
25068254|NCT02427646|50173946|FG001|Overall Study|Bothersome hand weakness|4|||
25068255|NCT02392000|50173954|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
25068256|NCT02392000|50173954|FG000|Overall Study|Withdrawal by Subject|1|||
25068257|NCT02392000|50173954|FG000|Overall Study|Lost to Follow-up|8|||
25068258|NCT02385526|50173962|FG000|Overall Study|Withdrawal by Subject|0|||
25188339|NCT02863809|50341533|FG000|Overall Study|Lost to Follow-up|1|||
25188340|NCT02863809|50341534|FG001|Overall Study|Lost to Follow-up|1|||
24966790|NCT01763866|50056327|FG005|Overall Study|Lost to Follow-up|0|||
25068259|NCT02385526|50173963|FG001|Overall Study|Withdrawal by Subject|2|||
25068260|NCT02385526|50173964|FG002|Overall Study|Withdrawal by Subject|0|||
25068261|NCT02385526|50173962|FG000|Overall Study|Lost to Follow-up|0|||
25068262|NCT02385526|50173963|FG001|Overall Study|Lost to Follow-up|1|||
25068263|NCT02385526|50173964|FG002|Overall Study|Lost to Follow-up|0|||
25068264|NCT02385526|50173962|FG000|Overall Study|Physician Decision|1|||
25068265|NCT02385526|50173963|FG001|Overall Study|Physician Decision|0|||
24966791|NCT01763866|50056328|FG006|Overall Study|Lost to Follow-up|1|||
24966792|NCT01763866|50056329|FG007|Overall Study|Lost to Follow-up|0|||
24966793|NCT01763866|50056330|FG008|Overall Study|Lost to Follow-up|0|||
25188341|NCT02863809|50341533|FG000|Overall Study|Death|1|||
24966794|NCT01763866|50056331|FG009|Overall Study|Lost to Follow-up|0|||
24966795|NCT01763866|50056332|FG010|Overall Study|Lost to Follow-up|0|||
25068266|NCT02385526|50173964|FG002|Overall Study|Physician Decision|0|||
25068267|NCT02385526|50173962|FG000|Overall Study|Protocol Violation|1|||
24966796|NCT01763866|50056333|FG011|Overall Study|Lost to Follow-up|0|||
24966797|NCT01763866|50056334|FG012|Overall Study|Lost to Follow-up|1|||
24966798|NCT01763866|50056335|FG013|Overall Study|Lost to Follow-up|0|||
24966799|NCT01763866|50056336|FG014|Overall Study|Lost to Follow-up|1|||
25068268|NCT02385526|50173963|FG001|Overall Study|Protocol Violation|0|||
25068269|NCT02385526|50173964|FG002|Overall Study|Protocol Violation|0|||
24966800|NCT01763866|50056337|FG015|Overall Study|Lost to Follow-up|0|||
24966801|NCT01763866|50056338|FG016|Overall Study|Lost to Follow-up|0|||
24966802|NCT01763866|50056339|FG017|Overall Study|Lost to Follow-up|0|||
24966803|NCT01763866|50056340|FG018|Overall Study|Lost to Follow-up|1|||
24966804|NCT01763866|50056341|FG019|Overall Study|Lost to Follow-up|1|||
24966805|NCT01763866|50056342|FG020|Overall Study|Lost to Follow-up|0|||
24966806|NCT01763866|50056343|FG021|Overall Study|Lost to Follow-up|0|||
24966807|NCT01763866|50056344|FG022|Overall Study|Lost to Follow-up|0|||
24966808|NCT01763866|50056345|FG023|Overall Study|Lost to Follow-up|1|||
24966809|NCT01763866|50056322|FG000|Overall Study|Death|0|||
24966810|NCT01763866|50056323|FG001|Overall Study|Death|0|||
24966811|NCT01763866|50056324|FG002|Overall Study|Death|0|||
24966812|NCT01763866|50056325|FG003|Overall Study|Death|0|||
24966813|NCT01763866|50056326|FG004|Overall Study|Death|0|||
24966814|NCT01763866|50056327|FG005|Overall Study|Death|0|||
24966815|NCT01763866|50056328|FG006|Overall Study|Death|0|||
24966816|NCT01763866|50056329|FG007|Overall Study|Death|0|||
24966817|NCT01763866|50056330|FG008|Overall Study|Death|0|||
24966818|NCT01763866|50056331|FG009|Overall Study|Death|0|||
24966819|NCT01763866|50056332|FG010|Overall Study|Death|0|||
24966820|NCT01763866|50056333|FG011|Overall Study|Death|0|||
24966821|NCT01763866|50056334|FG012|Overall Study|Death|0|||
24966822|NCT01763866|50056335|FG013|Overall Study|Death|0|||
24966823|NCT01763866|50056336|FG014|Overall Study|Death|0|||
24966824|NCT01763866|50056337|FG015|Overall Study|Death|0|||
24966825|NCT01763866|50056338|FG016|Overall Study|Death|1|||
24966826|NCT01763866|50056339|FG017|Overall Study|Death|0|||
24966827|NCT01763866|50056340|FG018|Overall Study|Death|0|||
24966828|NCT01763866|50056341|FG019|Overall Study|Death|0|||
24966829|NCT01763866|50056342|FG020|Overall Study|Death|0|||
24966830|NCT01763866|50056343|FG021|Overall Study|Death|0|||
24966831|NCT01763866|50056344|FG022|Overall Study|Death|0|||
24966832|NCT01763866|50056345|FG023|Overall Study|Death|0|||
24966833|NCT00132873|50056395|FG000|Overall Study|Adverse Event|3|||
24966834|NCT00132873|50056395|FG000|Overall Study|Lost to Follow-up|1|||
24966835|NCT00132873|50056395|FG000|Overall Study|Lack of Efficacy|1|||
24966836|NCT00132873|50056395|FG000|Overall Study|Withdrawal by Subject|3|||
24966837|NCT00132873|50056395|FG000|Overall Study|Planned Pregnancy|1|||
24966838|NCT00120627|50056401|FG000|Overall Study|Withdrawal by Subject|5|||
24966839|NCT00120627|50056402|FG001|Overall Study|Withdrawal by Subject|5|||
24966840|NCT03762616|50056417|FG000|Overall Study|Protocol Violation|2|||
24966841|NCT04246996|50056425|FG000|Overall Study|Physician Decision|1|||
24966842|NCT04246996|50056426|FG001|Overall Study|Physician Decision|1|||
24966843|NCT04246996|50056425|FG000|Overall Study|Did not meet eligibility criteria|1|||
24966844|NCT04246996|50056426|FG001|Overall Study|Did not meet eligibility criteria|4|||
25277237|NCT01198002|50591270|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
25277238|NCT01198002|50591271|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
24966845|NCT00424463|50056435|FG000|Overall Study|Adverse Event|2|||
24966846|NCT00424463|50056436|FG001|Overall Study|Adverse Event|3|||
24966847|NCT00424463|50056437|FG002|Overall Study|Adverse Event|2|||
24966848|NCT00424463|50056435|FG000|Overall Study|Physician Decision|0|||
24966849|NCT00424463|50056436|FG001|Overall Study|Physician Decision|2|||
24966850|NCT00424463|50056437|FG002|Overall Study|Physician Decision|2|||
24966851|NCT00424463|50056435|FG000|Overall Study|Withdrawal by Subject|4|||
24966852|NCT00424463|50056436|FG001|Overall Study|Withdrawal by Subject|2|||
24966853|NCT00424463|50056437|FG002|Overall Study|Withdrawal by Subject|5|||
25068270|NCT02808143|50173974|FG000|Maintenance Phase|Disease recurrence|1|||
25068271|NCT02808143|50173975|FG001|Maintenance Phase|Disease recurrence|3|||
25068272|NCT02808143|50173974|FG000|Maintenance Phase|Disease progression|1|||
24966854|NCT00424463|50056435|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
24966855|NCT00424463|50056436|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
25068273|NCT02808143|50173975|FG001|Maintenance Phase|Disease progression|2|||
24966856|NCT00424463|50056437|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
24966857|NCT00424463|50056435|FG000|Overall Study|Patient's convenience|0|||
24966858|NCT00424463|50056436|FG001|Overall Study|Patient's convenience|0|||
24966859|NCT00424463|50056437|FG002|Overall Study|Patient's convenience|1|||
24966860|NCT00424385|50056445|FG000|Cohort 0|Withdrawal by Subject|5|||
24966861|NCT00424385|50056445|FG000|Cohort 0|Physician Decision|1|||
24966862|NCT00424385|50056445|FG000|Cohort 1|Withdrawal by Subject|1|||
24966863|NCT00423917|50056451|FG000|Overall Study|Cancel|2|||
24966864|NCT00423917|50056451|FG000|Overall Study|Ineligible|1|||
24966865|NCT00845026|50056457|FG000|Study Period III|Adverse Event|23|||
24966866|NCT00845026|50056458|FG001|Study Period III|Adverse Event|19|||
24966867|NCT00845026|50056457|FG000|Study Period III|Perceived lack of efficacy|27|||
24966868|NCT00845026|50056458|FG001|Study Period III|Perceived lack of efficacy|15|||
24966869|NCT00845026|50056457|FG000|Study Period III|Withdrawal by Subject|19|||
24966870|NCT00845026|50056458|FG001|Study Period III|Withdrawal by Subject|15|||
24966871|NCT00845026|50056457|FG000|Study Period III|Entry Criteria not met|8|||
24966872|NCT00845026|50056458|FG001|Study Period III|Entry Criteria not met|11|||
24966873|NCT00845026|50056457|FG000|Study Period III|Lost to Follow-up|4|||
24966874|NCT00845026|50056458|FG001|Study Period III|Lost to Follow-up|5|||
24966875|NCT00845026|50056457|FG000|Study Period III|Protocol Violation|8|||
24966876|NCT00845026|50056458|FG001|Study Period III|Protocol Violation|1|||
24966877|NCT00845026|50056457|FG000|Study Period III|Scheduled conflict|3|||
24966878|NCT00845026|50056458|FG001|Study Period III|Scheduled conflict|1|||
24966879|NCT00845026|50056457|FG000|Study Period III|Subject is moving or has moved|2|||
24966880|NCT00845026|50056458|FG001|Study Period III|Subject is moving or has moved|4|||
24966881|NCT00845026|50056457|FG000|Study Period III|Transportation issues|1|||
24966882|NCT00845026|50056458|FG001|Study Period III|Transportation issues|1|||
24966883|NCT00845026|50056457|FG000|Study Period IV|Adverse Event|4|||
24966884|NCT00845026|50056458|FG001|Study Period IV|Adverse Event|0|||
24966885|NCT00845026|50056457|FG000|Study Period IV|Perceived lack of efficacy|2|||
24966886|NCT00845026|50056458|FG001|Study Period IV|Perceived lack of efficacy|1|||
24966887|NCT00845026|50056457|FG000|Study Period IV|Protocol Violation|3|||
24966888|NCT00845026|50056458|FG001|Study Period IV|Protocol Violation|1|||
24966889|NCT00845026|50056457|FG000|Study Period IV|Lost to Follow-up|1|||
24966890|NCT00845026|50056458|FG001|Study Period IV|Lost to Follow-up|0|||
24966891|NCT00845026|50056457|FG000|Study Period IV|Withdrawal by Subject|4|||
24966892|NCT00845026|50056458|FG001|Study Period IV|Withdrawal by Subject|1|||
24966893|NCT00845026|50056457|FG000|Study Period IV|Entry Criteria Not Met|1|||
24966894|NCT00845026|50056458|FG001|Study Period IV|Entry Criteria Not Met|0|||
24966895|NCT00845026|50056457|FG000|Study Period IV|Subject is moving or has moved|0|||
24966896|NCT00845026|50056458|FG001|Study Period IV|Subject is moving or has moved|1|||
24966897|NCT00845026|50056457|FG000|Study Period IV|Scheduling conflict|1|||
24966898|NCT00845026|50056458|FG001|Study Period IV|Scheduling conflict|0|||
24966899|NCT00691678|50056466|FG000|Overall Study|Adverse Event|5|||
24966900|NCT00691678|50056466|FG000|Overall Study|life events, pain|11|||
24966901|NCT00423605|50056470|FG000|Overall Study|Adverse Event|129|||
24966902|NCT00423605|50056470|FG000|Overall Study|Withdrawal by Subject|36|||
24966903|NCT00423605|50056470|FG000|Overall Study|Lost to Follow-up|15|||
24966904|NCT00423605|50056470|FG000|Overall Study|Lack of Efficacy|38|||
24966905|NCT00423605|50056470|FG000|Overall Study|Sponsor Decision|3|||
24966906|NCT00423605|50056470|FG000|Overall Study|Physician Decision|8|||
24966907|NCT00423605|50056470|FG000|Overall Study|Protocol Violation|7|||
24966908|NCT00423605|50056470|FG000|Overall Study|Not one of the pre-specified options|5|||
24966909|NCT00003838|50056477|FG000|Overall Study|Death|0|||
24966910|NCT00003838|50056478|FG001|Overall Study|Death|12|||
24966911|NCT00003838|50056479|FG002|Overall Study|Death|7|||
24966912|NCT00003838|50056477|FG000|Overall Study|Lost to Follow-up|0|||
24966913|NCT00003838|50056478|FG001|Overall Study|Lost to Follow-up|1|||
24966914|NCT00003838|50056479|FG002|Overall Study|Lost to Follow-up|1|||
24966915|NCT00003838|50056477|FG000|Overall Study|Disease Progression|0|||
24966916|NCT00003838|50056478|FG001|Overall Study|Disease Progression|12|||
24966917|NCT00003838|50056479|FG002|Overall Study|Disease Progression|0|||
24966918|NCT00423449|50056486|FG000|Overall Study|Clinical Adverse Event|1|||
24966919|NCT00423449|50056487|FG001|Overall Study|Clinical Adverse Event|0|||
24966920|NCT00423449|50056488|FG002|Overall Study|Clinical Adverse Event|1|||
24966921|NCT00423449|50056489|FG003|Overall Study|Clinical Adverse Event|8|||
24966922|NCT00423449|50056490|FG004|Overall Study|Clinical Adverse Event|2|||
24966923|NCT00423449|50056486|FG000|Overall Study|Death|1|||
24966924|NCT00423449|50056487|FG001|Overall Study|Death|0|||
24966925|NCT00423449|50056488|FG002|Overall Study|Death|2|||
24966926|NCT00423449|50056489|FG003|Overall Study|Death|1|||
24966927|NCT00423449|50056490|FG004|Overall Study|Death|1|||
25068274|NCT02808143|50173974|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
25068275|NCT02808143|50173975|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
24966928|NCT00423449|50056486|FG000|Overall Study|Progressive Disease|1|||
24966929|NCT00423449|50056487|FG001|Overall Study|Progressive Disease|3|||
24966930|NCT00423449|50056488|FG002|Overall Study|Progressive Disease|8|||
24966931|NCT00423449|50056489|FG003|Overall Study|Progressive Disease|11|||
24966932|NCT00423449|50056490|FG004|Overall Study|Progressive Disease|4|||
24966933|NCT00423449|50056486|FG000|Overall Study|Laboratory Adverse Event|0|||
24966934|NCT00423449|50056487|FG001|Overall Study|Laboratory Adverse Event|1|||
24966935|NCT00423449|50056488|FG002|Overall Study|Laboratory Adverse Event|2|||
24966936|NCT00423449|50056489|FG003|Overall Study|Laboratory Adverse Event|0|||
24966937|NCT00423449|50056490|FG004|Overall Study|Laboratory Adverse Event|0|||
25068276|NCT02808143|50173974|FG000|Survival Follow-Up|Disease recurrence|0|||
25188342|NCT02863809|50341534|FG001|Overall Study|Death|0|||
24966938|NCT00423449|50056486|FG000|Overall Study|Other|0|||
24966939|NCT00423449|50056487|FG001|Overall Study|Other|0|||
24966940|NCT00423449|50056488|FG002|Overall Study|Other|0|||
25068277|NCT02808143|50173975|FG001|Survival Follow-Up|Disease recurrence|2|||
25188343|NCT02829957|50341542|FG000|Overall Study|Lost to Follow-up|2|||
25188344|NCT02829957|50341543|FG001|Overall Study|Lost to Follow-up|1|||
25188345|NCT02753530|50341567|FG000|Overall Study|Adverse Event|7|||
25188346|NCT02753530|50341568|FG001|Overall Study|Adverse Event|1|||
25188347|NCT02753530|50341567|FG000|Overall Study|Death|0|||
25188348|NCT02753530|50341568|FG001|Overall Study|Death|1|||
25188349|NCT02753530|50341567|FG000|Overall Study|Physician Decision|0|||
25188350|NCT02753530|50341568|FG001|Overall Study|Physician Decision|1|||
25188351|NCT02753530|50341567|FG000|Overall Study|Protocol Violation|1|||
25188352|NCT02753530|50341568|FG001|Overall Study|Protocol Violation|0|||
25188353|NCT02753530|50341567|FG000|Overall Study|Withdrawal by Subject|4|||
25188354|NCT02753530|50341568|FG001|Overall Study|Withdrawal by Subject|3|||
25188355|NCT02717611|50341574|FG000|Overall Study|Death|13|||
24966941|NCT00423449|50056489|FG003|Overall Study|Other|1|||
24966942|NCT00423449|50056490|FG004|Overall Study|Other|0|||
25188356|NCT02717611|50341574|FG000|Overall Study|Withdrawal by Subject|6|||
25188357|NCT02717611|50341574|FG000|Overall Study|Active, not recruiting|40|||
25188358|NCT02717611|50341574|FG000|Overall Study|Complicating disease|1|||
25188359|NCT02362035|50341582|FG000|Overall Study|Death|67|||
25188360|NCT02362035|50341582|FG000|Overall Study|Lost to Follow-up|3|||
25188361|NCT02362035|50341582|FG000|Overall Study|Adverse Event|1|||
25188362|NCT02362035|50341582|FG000|Overall Study|Physician Decision|1|||
25188363|NCT02362035|50341582|FG000|Overall Study|Subject started another cancer therapy|10|||
25188364|NCT02362035|50341582|FG000|Overall Study|Study terminated by sponsor|45|||
25188365|NCT02362035|50341582|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
25188366|NCT02362035|50341582|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
25188367|NCT02362035|50341582|FG000|Overall Study|Disease progression|11|||
25188368|NCT02362035|50341582|FG000|Overall Study|Withdrawal by Subject|20|||
25188369|NCT02328014|50341590|FG000|Overall Study|Adverse Event|1|||
25188370|NCT02328014|50341591|FG001|Overall Study|Adverse Event|0|||
25188371|NCT02328014|50341592|FG002|Overall Study|Adverse Event|0|||
25188372|NCT02328014|50341593|FG003|Overall Study|Adverse Event|1|||
25188373|NCT02328014|50341590|FG000|Overall Study|Death|0|||
25188374|NCT02328014|50341591|FG001|Overall Study|Death|0|||
25188375|NCT02328014|50341592|FG002|Overall Study|Death|0|||
25188376|NCT02328014|50341593|FG003|Overall Study|Death|4|||
25188377|NCT02328014|50341590|FG000|Overall Study|Physician Decision|0|||
25188378|NCT02328014|50341591|FG001|Overall Study|Physician Decision|0|||
25188379|NCT02328014|50341592|FG002|Overall Study|Physician Decision|0|||
25188380|NCT02328014|50341593|FG003|Overall Study|Physician Decision|1|||
25188381|NCT02328014|50341590|FG000|Overall Study|Disease Progression|1|||
25188382|NCT02328014|50341591|FG001|Overall Study|Disease Progression|0|||
25188383|NCT02328014|50341592|FG002|Overall Study|Disease Progression|1|||
25188384|NCT02328014|50341593|FG003|Overall Study|Disease Progression|3|||
25188385|NCT02328014|50341590|FG000|Overall Study|Study Terminated by Sponsor|4|||
25188386|NCT02328014|50341591|FG001|Overall Study|Study Terminated by Sponsor|1|||
25188387|NCT02328014|50341592|FG002|Overall Study|Study Terminated by Sponsor|1|||
25188388|NCT02328014|50341593|FG003|Overall Study|Study Terminated by Sponsor|0|||
25188389|NCT02328014|50341590|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
25188390|NCT02328014|50341591|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
25188391|NCT02328014|50341592|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
25188392|NCT02328014|50341593|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
25188393|NCT02328014|50341590|FG000|Overall Study|Withdrawal by Subject|0|||
25188394|NCT02328014|50341591|FG001|Overall Study|Withdrawal by Subject|0|||
25188395|NCT02328014|50341592|FG002|Overall Study|Withdrawal by Subject|0|||
25188396|NCT02328014|50341593|FG003|Overall Study|Withdrawal by Subject|1|||
25188397|NCT02289079|50341605|FG000|Overall Study|Physician Decision|2|||
25188398|NCT02289079|50341606|FG001|Overall Study|Physician Decision|0|||
24966943|NCT00423449|50056486|FG000|Overall Study|Protocol Violation|0|||
24966944|NCT00423449|50056487|FG001|Overall Study|Protocol Violation|0|||
24966945|NCT00423449|50056488|FG002|Overall Study|Protocol Violation|2|||
24966946|NCT00423449|50056489|FG003|Overall Study|Protocol Violation|1|||
24966947|NCT00423449|50056490|FG004|Overall Study|Protocol Violation|0|||
24966948|NCT00423293|50056503|FG000|Overall Study|Ineligible / No protocol treatment|11|||
24966949|NCT00423137|50056511|FG000|Overall Study|Lost to Follow-up|0|||
25188399|NCT02289079|50341605|FG000|Overall Study|Lost to Follow-up|0|||
25188400|NCT02289079|50341606|FG001|Overall Study|Lost to Follow-up|1|||
25188401|NCT02213926|50341636|FG000|Overall Study|Death|59|||
24966950|NCT00423137|50056512|FG001|Overall Study|Lost to Follow-up|0|||
24966951|NCT00423137|50056513|FG002|Overall Study|Lost to Follow-up|1|||
25068278|NCT02808143|50173974|FG000|Survival Follow-Up|Adverse Event|0|||
25188402|NCT02213926|50341636|FG000|Overall Study|Withdrawal by Subject|10|||
25188403|NCT02213926|50341636|FG000|Overall Study|study terminated by sponsor|51|||
24966952|NCT00423137|50056514|FG003|Overall Study|Lost to Follow-up|0|||
25188404|NCT02213926|50341636|FG000|Overall Study|Lost to Follow-up|3|||
25188405|NCT02213926|50341636|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
25188406|NCT02095132|50341665|FG000|Overall Study|Adverse Event|0|||
25188407|NCT02095132|50341666|FG001|Overall Study|Adverse Event|0|||
24966953|NCT00423137|50056511|FG000|Overall Study|Protocol Violation|0|||
24966954|NCT00423137|50056512|FG001|Overall Study|Protocol Violation|0|||
24966955|NCT00423137|50056513|FG002|Overall Study|Protocol Violation|0|||
24966956|NCT00423137|50056514|FG003|Overall Study|Protocol Violation|1|||
24966957|NCT00423137|50056511|FG000|Overall Study|Adverse Event Study disease worse|1|||
24966958|NCT00423137|50056512|FG001|Overall Study|Adverse Event Study disease worse|0|||
24966959|NCT00423137|50056513|FG002|Overall Study|Adverse Event Study disease worse|3|||
24966960|NCT00423137|50056514|FG003|Overall Study|Adverse Event Study disease worse|1|||
24966961|NCT00423137|50056511|FG000|Overall Study|Adverse Event Other|0|||
24966962|NCT00423137|50056512|FG001|Overall Study|Adverse Event Other|0|||
24966963|NCT00423137|50056513|FG002|Overall Study|Adverse Event Other|2|||
24966964|NCT00423137|50056514|FG003|Overall Study|Adverse Event Other|0|||
24966965|NCT00422903|50056529|FG000|Overall Study|Disease Progression|3|||
24966966|NCT00422903|50056530|FG001|Overall Study|Disease Progression|1|||
24966967|NCT00422903|50056529|FG000|Overall Study|Adverse Event|0|||
24966968|NCT00422903|50056530|FG001|Overall Study|Adverse Event|2|||
24966969|NCT00422903|50056529|FG000|Overall Study|Informed Consent Withdrawn|1|||
24966970|NCT00422903|50056530|FG001|Overall Study|Informed Consent Withdrawn|2|||
24966971|NCT00422669|50056539|FG000|Overall Study|The study was terminated early.|98|||
24966972|NCT00422669|50056540|FG001|Overall Study|The study was terminated early.|100|||
24966973|NCT00422669|50056541|FG002|Overall Study|The study was terminated early.|7|||
24966974|NCT00422591|50056547|FG000|Overall Study|Physician Decision|4|||
24966975|NCT00422591|50056547|FG000|Overall Study|Withdrawal by Subject|2|||
24966976|NCT00422513|50056553|FG000|Overall Study|Lack of Efficacy|4|||
24966977|NCT00422513|50056554|FG001|Overall Study|Lack of Efficacy|5|||
24966978|NCT00422513|50056553|FG000|Overall Study|Protocol Violation|23|||
24966979|NCT00422513|50056554|FG001|Overall Study|Protocol Violation|7|||
24966980|NCT00422513|50056553|FG000|Overall Study|Refused Treatment|4|||
24966981|NCT00422513|50056554|FG001|Overall Study|Refused Treatment|2|||
25068279|NCT02808143|50173975|FG001|Survival Follow-Up|Adverse Event|1|||
25068280|NCT02808143|50173974|FG000|Survival Follow-Up|Death|1|||
25068281|NCT02808143|50173975|FG001|Survival Follow-Up|Death|0|||
25068282|NCT02427100|50173985|FG000|Overall Study|Lost to Follow-up|0|||
25068283|NCT02427100|50173986|FG001|Overall Study|Lost to Follow-up|2|||
25068284|NCT02806973|50173992|FG000|Period 1|Withdrawal by Subject|0|||
25068285|NCT02806973|50173993|FG001|Period 1|Withdrawal by Subject|2|||
25068286|NCT02806973|50173994|FG002|Period 1|Withdrawal by Subject|1|||
24966982|NCT00422513|50056553|FG000|Overall Study|Withdrawal by Subject|2|||
24966983|NCT00422513|50056554|FG001|Overall Study|Withdrawal by Subject|1|||
25068287|NCT02806973|50173995|FG003|Period 1|Withdrawal by Subject|1|||
25068288|NCT02806973|50173992|FG000|Period 1|Adverse Event|0|||
25068289|NCT02806973|50173993|FG001|Period 1|Adverse Event|0|||
25068290|NCT02806973|50173994|FG002|Period 1|Adverse Event|0|||
25068291|NCT02806973|50173995|FG003|Period 1|Adverse Event|1|||
25068292|NCT02806973|50173992|FG000|Period 3|Withdrawal by Subject|0|||
25068293|NCT02806973|50173993|FG001|Period 3|Withdrawal by Subject|0|||
25168667|NCT01872689|50298245|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
25168668|NCT01872689|50298242|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
25168669|NCT01872689|50298243|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
25168670|NCT01872689|50298244|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
25168671|NCT01872689|50298245|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
25168672|NCT01872689|50298242|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
25168673|NCT01872689|50298243|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
25168674|NCT01872689|50298244|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
25168675|NCT01872689|50298245|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
25168676|NCT01872689|50298242|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
25168677|NCT01872689|50298243|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
25168678|NCT01872689|50298244|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
25168679|NCT01872689|50298245|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
25168680|NCT01872689|50298242|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
25168681|NCT01872689|50298243|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
25168682|NCT01872689|50298244|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
25168683|NCT01872689|50298245|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
25168684|NCT00632931|50298258|FG000|Part 1, Period 1|Protocol Violation|1|||
25168685|NCT00632931|50298259|FG001|Part 1, Period 1|Protocol Violation|0|||
25168686|NCT00632931|50298260|FG002|Part 1, Period 1|Protocol Violation|0|||
25168687|NCT00632931|50298258|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
25168688|NCT00632931|50298259|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
25168689|NCT00632931|50298260|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
25168690|NCT00632931|50298258|FG000|Part 2|Adverse Event|0|||
25168691|NCT00632931|50298259|FG001|Part 2|Adverse Event|0|||
25168692|NCT00632931|50298260|FG002|Part 2|Adverse Event|3|||
25168693|NCT00632931|50298258|FG000|Part 2|Death|0|||
25168694|NCT00632931|50298259|FG001|Part 2|Death|0|||
24966984|NCT00422513|50056553|FG000|Overall Study|early termination of the study|67|||
25068294|NCT02806973|50173994|FG002|Period 3|Withdrawal by Subject|0|||
25068295|NCT02806973|50173995|FG003|Period 3|Withdrawal by Subject|3|||
24966985|NCT00422513|50056554|FG001|Overall Study|early termination of the study|80|||
24966986|NCT00422513|50056553|FG000|Overall Study|Adverse Event|4|||
24966987|NCT00422513|50056554|FG001|Overall Study|Adverse Event|4|||
24966988|NCT00422513|50056553|FG000|Overall Study|Death|3|||
24966989|NCT00422513|50056554|FG001|Overall Study|Death|7|||
24966990|NCT00202878|50056562|FG000|Overall Study|Death|964|||
24966991|NCT00202878|50056563|FG001|Overall Study|Death|968|||
24966992|NCT00202878|50056562|FG000|Overall Study|Only Vital Status Known|357|||
24966993|NCT00202878|50056563|FG001|Overall Study|Only Vital Status Known|356|||
24966994|NCT00202878|50056562|FG000|Overall Study|Lost to Follow-up|44|||
24966995|NCT00202878|50056563|FG001|Overall Study|Lost to Follow-up|49|||
24966996|NCT00202878|50056562|FG000|Overall Study|Site Closure|39|||
24966997|NCT00202878|50056563|FG001|Overall Study|Site Closure|36|||
24966998|NCT00202878|50056562|FG000|Overall Study|Withdrawal by Subject|795|||
24966999|NCT00202878|50056563|FG001|Overall Study|Withdrawal by Subject|808|||
24967000|NCT00414011|50056569|FG000|Overall Study|Physician Decision|3|||
24967001|NCT00414011|50056569|FG000|Overall Study|Withdrawal by Subject|2|||
24967002|NCT00231816|50056576|FG000|Overall Study|Adverse Event|1|||
24967003|NCT00231816|50056577|FG001|Overall Study|Adverse Event|0|||
24967004|NCT00231816|50056576|FG000|Overall Study|Lost to Follow-up|8|||
24967005|NCT00231816|50056577|FG001|Overall Study|Lost to Follow-up|5|||
24967006|NCT00231816|50056576|FG000|Overall Study|Protocol Violation|2|||
24967007|NCT00231816|50056577|FG001|Overall Study|Protocol Violation|3|||
24967008|NCT00231816|50056576|FG000|Overall Study|Withdrawal by Subject|3|||
25068296|NCT02806973|50173992|FG000|Period 3|Adverse Event|0|||
25068297|NCT02806973|50173993|FG001|Period 3|Adverse Event|0|||
25068298|NCT02806973|50173994|FG002|Period 3|Adverse Event|1|||
25068299|NCT02806973|50173995|FG003|Period 3|Adverse Event|0|||
25068300|NCT02806505|50174007|FG000|Overall Study|Adverse event/intercurrent illness|1|||
25068301|NCT02806505|50174008|FG001|Overall Study|Adverse event/intercurrent illness|3|||
25068302|NCT02806505|50174007|FG000|Overall Study|Death|4|||
25068303|NCT02806505|50174008|FG001|Overall Study|Death|0|||
25068304|NCT02806505|50174007|FG000|Overall Study|Did not cooperate/refused treatment|3|||
25068305|NCT02806505|50174008|FG001|Overall Study|Did not cooperate/refused treatment|3|||
25068306|NCT02806505|50174007|FG000|Overall Study|Failure to return|0|||
25068307|NCT02806505|50174008|FG001|Overall Study|Failure to return|1|||
24967009|NCT00231816|50056577|FG001|Overall Study|Withdrawal by Subject|3|||
24967010|NCT00231816|50056576|FG000|Overall Study|Other|2|||
24967011|NCT00231816|50056577|FG001|Overall Study|Other|1|||
24967012|NCT00260208|50056586|FG000|Overall Study|Subject withdrew consent|11|||
24967013|NCT00260208|50056587|FG001|Overall Study|Subject withdrew consent|7|||
24967014|NCT00260208|50056586|FG000|Overall Study|Lost to Follow-up|6|||
24967015|NCT00260208|50056587|FG001|Overall Study|Lost to Follow-up|1|||
24967016|NCT00260208|50056586|FG000|Overall Study|Death|12|||
24967017|NCT00260208|50056587|FG001|Overall Study|Death|10|||
24967018|NCT00260208|50056586|FG000|Overall Study|Missing|18|||
24967019|NCT00260208|50056587|FG001|Overall Study|Missing|16|||
24967020|NCT00202644|50056595|FG000|Overall Study|Adverse Event|12|||
24967021|NCT00202644|50056596|FG001|Overall Study|Adverse Event|13|||
24967022|NCT00202644|50056595|FG000|Overall Study|Withdrawal by Subject|8|||
24967023|NCT00202644|50056596|FG001|Overall Study|Withdrawal by Subject|6|||
24967024|NCT00202644|50056595|FG000|Overall Study|Lack of Efficacy|6|||
24967025|NCT00202644|50056596|FG001|Overall Study|Lack of Efficacy|6|||
24967026|NCT00202644|50056595|FG000|Overall Study|Lost to Follow-up|0|||
24967027|NCT00202644|50056596|FG001|Overall Study|Lost to Follow-up|1|||
24967028|NCT00202644|50056595|FG000|Overall Study|Other|9|||
24967029|NCT00202644|50056596|FG001|Overall Study|Other|1|||
24967030|NCT01235962|50056606|FG000|Overall Study|Withdrawal by Subject|20|||
24967031|NCT01235962|50056607|FG001|Overall Study|Withdrawal by Subject|19|||
24967032|NCT01235962|50056608|FG002|Overall Study|Withdrawal by Subject|62|||
24967033|NCT01235962|50056609|FG003|Overall Study|Withdrawal by Subject|49|||
24967034|NCT01235962|50056606|FG000|Overall Study|Lost to Follow-up|21|||
24967035|NCT01235962|50056607|FG001|Overall Study|Lost to Follow-up|16|||
24967036|NCT01235962|50056608|FG002|Overall Study|Lost to Follow-up|47|||
24967037|NCT01235962|50056609|FG003|Overall Study|Lost to Follow-up|32|||
25068308|NCT02806505|50174007|FG000|Overall Study|Insufficient therapeutic response|2|||
25068309|NCT02806505|50174008|FG001|Overall Study|Insufficient therapeutic response|4|||
25068310|NCT02807363|50174018|FG000|Dosing Period|Adverse Event|0|||
25068311|NCT02807363|50174019|FG001|Dosing Period|Adverse Event|1|||
25068312|NCT02807363|50174020|FG002|Dosing Period|Adverse Event|0|||
25068313|NCT02807363|50174021|FG003|Dosing Period|Adverse Event|0|||
25068314|NCT02383966|50174035|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
25188408|NCT02095132|50341667|FG002|Overall Study|Adverse Event|0|||
24967038|NCT01235962|50056606|FG000|Overall Study|Physician Decision|5|||
24967039|NCT01235962|50056607|FG001|Overall Study|Physician Decision|0|||
24967040|NCT01235962|50056608|FG002|Overall Study|Physician Decision|9|||
24967041|NCT01235962|50056609|FG003|Overall Study|Physician Decision|5|||
24967042|NCT00259740|50056629|FG000|Overall Study|Physician Decision|1|||
24967043|NCT00259740|50056630|FG001|Overall Study|Physician Decision|1|||
24967044|NCT00259740|50056629|FG000|Overall Study|Adverse Event|0|||
24967045|NCT00259740|50056630|FG001|Overall Study|Adverse Event|2|||
24967046|NCT00259740|50056629|FG000|Overall Study|Withdrawal by Subject|2|||
24967047|NCT00259740|50056630|FG001|Overall Study|Withdrawal by Subject|6|||
24967048|NCT00259740|50056629|FG000|Overall Study|Death|1|||
24967049|NCT00259740|50056630|FG001|Overall Study|Death|1|||
24967050|NCT00259740|50056629|FG000|Overall Study|Disease progression|19|||
24967051|NCT00259740|50056630|FG001|Overall Study|Disease progression|36|||
24967052|NCT00259740|50056629|FG000|Overall Study|Ongoing|17|||
24967053|NCT00259740|50056630|FG001|Overall Study|Ongoing|3|||
24967054|NCT00259740|50056629|FG000|Overall Study|Other|3|||
24967055|NCT00259740|50056630|FG001|Overall Study|Other|0|||
24967056|NCT00259740|50056629|FG000|Overall Study|Requirement for alternative therapy|0|||
24967057|NCT00259740|50056630|FG001|Overall Study|Requirement for alternative therapy|4|||
24967058|NCT00201006|50056639|FG000|Overall Study|Withdrawal by Subject|7|||
24967059|NCT00201006|50056640|FG001|Overall Study|Withdrawal by Subject|2|||
24967060|NCT00201006|50056641|FG002|Overall Study|Withdrawal by Subject|3|||
24967061|NCT00201006|50056639|FG000|Overall Study|Adverse Event|1|||
24967062|NCT00201006|50056640|FG001|Overall Study|Adverse Event|0|||
24967063|NCT00201006|50056641|FG002|Overall Study|Adverse Event|1|||
24967064|NCT00200850|50056652|FG000|Overall Study|relocation|1|||
24967065|NCT00200850|50056653|FG001|Overall Study|relocation|0|||
24967066|NCT00200850|50056654|FG002|Overall Study|relocation|1|||
24967067|NCT00200850|50056652|FG000|Overall Study|too busy|1|||
24967068|NCT00200850|50056653|FG001|Overall Study|too busy|0|||
24967069|NCT00200850|50056654|FG002|Overall Study|too busy|0|||
24967070|NCT00200850|50056652|FG000|Overall Study|Pregnancy|0|||
24967071|NCT00200850|50056653|FG001|Overall Study|Pregnancy|0|||
24967072|NCT00200850|50056654|FG002|Overall Study|Pregnancy|1|||
24967073|NCT00200850|50056652|FG000|Overall Study|Poor adherence|0|||
24967074|NCT00200850|50056653|FG001|Overall Study|Poor adherence|0|||
24967075|NCT00200850|50056654|FG002|Overall Study|Poor adherence|1|||
24967076|NCT00200850|50056652|FG000|Overall Study|optic neuritis|0|||
24967077|NCT00200850|50056653|FG001|Overall Study|optic neuritis|0|||
24967078|NCT00200850|50056654|FG002|Overall Study|optic neuritis|1|||
24967079|NCT00200850|50056652|FG000|Overall Study|Adverse Event|1|||
24967080|NCT00200850|50056653|FG001|Overall Study|Adverse Event|1|||
24967081|NCT00200850|50056654|FG002|Overall Study|Adverse Event|2|||
24967082|NCT03812224|50056664|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
24967083|NCT03812224|50056665|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
24967084|NCT03812224|50056664|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
24967085|NCT03812224|50056665|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
24967086|NCT03812224|50056664|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
24967087|NCT03812224|50056665|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
24967088|NCT03812224|50056664|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
24967089|NCT03812224|50056665|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
24967090|NCT00231114|50056674|FG000|Randomized|Withdrawal by Subject|6|||
24967091|NCT00231114|50056675|FG001|Randomized|Withdrawal by Subject|3|||
24967092|NCT00231114|50056674|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
24967093|NCT00231114|50056675|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
24967094|NCT00231114|50056674|FG000|Post-Treatment Period|Lost to Follow-up|6|||
24967095|NCT00231114|50056675|FG001|Post-Treatment Period|Lost to Follow-up|1|||
24967096|NCT00231114|50056674|FG000|Post-Treatment Period|Physician Decision|1|||
24967097|NCT00231114|50056675|FG001|Post-Treatment Period|Physician Decision|0|||
24967098|NCT00231114|50056674|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
24967099|NCT00231114|50056675|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
24967100|NCT03543046|50056685|FG000|Overall Study|Adverse Event|1|||
24967101|NCT03543046|50056686|FG001|Overall Study|Adverse Event|1|||
24967102|NCT03543046|50056685|FG000|Overall Study|Physician Decision|1|||
24967103|NCT03543046|50056686|FG001|Overall Study|Physician Decision|1|||
24967104|NCT03543046|50056685|FG000|Overall Study|Protocol Violation|1|||
24967105|NCT03543046|50056686|FG001|Overall Study|Protocol Violation|0|||
24967106|NCT00259272|50056705|FG000|Overall Study|Adverse Event|2|||
25068315|NCT02383966|50174036|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
24967107|NCT00259272|50056706|FG001|Overall Study|Adverse Event|1|||
24967108|NCT00259272|50056707|FG002|Overall Study|Adverse Event|0|||
24967109|NCT00259272|50056708|FG003|Overall Study|Adverse Event|3|||
24967110|NCT00259272|50056705|FG000|Overall Study|Lack of Efficacy|5|||
24967111|NCT00259272|50056706|FG001|Overall Study|Lack of Efficacy|1|||
24967112|NCT00259272|50056707|FG002|Overall Study|Lack of Efficacy|2|||
24967113|NCT00259272|50056708|FG003|Overall Study|Lack of Efficacy|6|||
24967114|NCT00259272|50056705|FG000|Overall Study|Physician Decision|1|||
24967115|NCT00259272|50056706|FG001|Overall Study|Physician Decision|2|||
24967116|NCT00259272|50056707|FG002|Overall Study|Physician Decision|1|||
24967117|NCT00259272|50056708|FG003|Overall Study|Physician Decision|3|||
24967118|NCT00259272|50056705|FG000|Overall Study|Protocol Violation|2|||
24967119|NCT00259272|50056706|FG001|Overall Study|Protocol Violation|0|||
24967120|NCT00259272|50056707|FG002|Overall Study|Protocol Violation|0|||
24967121|NCT00259272|50056708|FG003|Overall Study|Protocol Violation|1|||
24967122|NCT00259272|50056705|FG000|Overall Study|Sponsor Decision|0|||
24967123|NCT00259272|50056706|FG001|Overall Study|Sponsor Decision|1|||
24967124|NCT00259272|50056707|FG002|Overall Study|Sponsor Decision|0|||
24967125|NCT00259272|50056708|FG003|Overall Study|Sponsor Decision|0|||
24967126|NCT00259272|50056705|FG000|Overall Study|Withdrawal by Subject|4|||
24967127|NCT00259272|50056706|FG001|Overall Study|Withdrawal by Subject|2|||
24967128|NCT00259272|50056707|FG002|Overall Study|Withdrawal by Subject|2|||
24967129|NCT00259272|50056708|FG003|Overall Study|Withdrawal by Subject|7|||
24967130|NCT00259272|50056705|FG000|Overall Study|Lost to Follow-up|1|||
24967131|NCT00259272|50056706|FG001|Overall Study|Lost to Follow-up|0|||
24967132|NCT00259272|50056707|FG002|Overall Study|Lost to Follow-up|0|||
24967133|NCT00259272|50056708|FG003|Overall Study|Lost to Follow-up|1|||
24967134|NCT00421889|50056741|FG000|Overall Study|Adverse Event|1|||
24967135|NCT00421889|50056742|FG001|Overall Study|Adverse Event|0|||
24967136|NCT00421889|50056743|FG002|Overall Study|Adverse Event|1|||
24967137|NCT00421889|50056744|FG003|Overall Study|Adverse Event|1|||
24967138|NCT00421889|50056745|FG004|Overall Study|Adverse Event|1|||
24967139|NCT00421889|50056746|FG005|Overall Study|Adverse Event|4|||
24967140|NCT00421889|50056747|FG006|Overall Study|Adverse Event|1|||
24967141|NCT00421889|50056748|FG007|Overall Study|Adverse Event|0|||
24967142|NCT00421889|50056749|FG008|Overall Study|Adverse Event|2|||
24967143|NCT00421889|50056741|FG000|Overall Study|Withdrawal by Subject|1|||
24967144|NCT00421889|50056742|FG001|Overall Study|Withdrawal by Subject|3|||
24967145|NCT00421889|50056743|FG002|Overall Study|Withdrawal by Subject|0|||
24967146|NCT00421889|50056744|FG003|Overall Study|Withdrawal by Subject|0|||
24967147|NCT00421889|50056745|FG004|Overall Study|Withdrawal by Subject|2|||
24967148|NCT00421889|50056746|FG005|Overall Study|Withdrawal by Subject|0|||
24967149|NCT00421889|50056747|FG006|Overall Study|Withdrawal by Subject|0|||
24967150|NCT00421889|50056748|FG007|Overall Study|Withdrawal by Subject|0|||
24967151|NCT00421889|50056749|FG008|Overall Study|Withdrawal by Subject|0|||
24967152|NCT00421889|50056741|FG000|Overall Study|Death|0|||
24967153|NCT00421889|50056742|FG001|Overall Study|Death|0|||
24967154|NCT00421889|50056743|FG002|Overall Study|Death|0|||
24967155|NCT00421889|50056744|FG003|Overall Study|Death|0|||
24967156|NCT00421889|50056745|FG004|Overall Study|Death|1|||
24967157|NCT00421889|50056746|FG005|Overall Study|Death|1|||
24967158|NCT00421889|50056747|FG006|Overall Study|Death|0|||
25068316|NCT02383966|50174035|FG000|Overall Study|Randomized, but not treated|1|||
25068317|NCT02383966|50174036|FG001|Overall Study|Randomized, but not treated|3|||
25068318|NCT02383576|50174044|FG000|Overall Study|Death|53|||
25068319|NCT02383576|50174045|FG001|Overall Study|Death|33|||
25068320|NCT02383576|50174044|FG000|Overall Study|Lost to Follow-up|7|||
25068321|NCT02383576|50174045|FG001|Overall Study|Lost to Follow-up|1|||
25068322|NCT02383576|50174044|FG000|Overall Study|Withdrew Consent|1|||
25068323|NCT02383576|50174045|FG001|Overall Study|Withdrew Consent|6|||
25068324|NCT02383576|50174044|FG000|Overall Study|Investigator's Decision|0|||
25068325|NCT02383576|50174045|FG001|Overall Study|Investigator's Decision|1|||
25068326|NCT02383576|50174044|FG000|Overall Study|Administrative/Other|2|||
25068327|NCT02383576|50174045|FG001|Overall Study|Administrative/Other|4|||
25068328|NCT02748317|50174051|FG000|Overall Study|Withdrawal by Subject|14|||
25068329|NCT02748317|50174051|FG000|Overall Study|Lost to Follow-up|8|||
25068330|NCT02748317|50174051|FG000|Overall Study|Death|1|||
25068331|NCT02426086|50174057|FG000|Overall Study|Death|33|||
25068332|NCT02426086|50174058|FG001|Overall Study|Death|36|||
25068333|NCT02426086|50174057|FG000|Overall Study|Lost to Follow-up|2|||
25068334|NCT02426086|50174058|FG001|Overall Study|Lost to Follow-up|0|||
25068335|NCT02426086|50174057|FG000|Overall Study|Study Terminated by Sponsor|5|||
25068336|NCT02426086|50174058|FG001|Overall Study|Study Terminated by Sponsor|14|||
25068337|NCT02426086|50174057|FG000|Overall Study|Withdrawal by Subject|8|||
25068338|NCT02426086|50174058|FG001|Overall Study|Withdrawal by Subject|9|||
25068339|NCT02422264|50174071|FG000|Overall Study|Serious Adverse Event|1|||
25068340|NCT02422264|50174072|FG001|Overall Study|Serious Adverse Event|0|||
25068341|NCT02422264|50174071|FG000|Overall Study|Withdrawal by Subject|1|||
25068342|NCT02422264|50174072|FG001|Overall Study|Withdrawal by Subject|2|||
25068343|NCT02422264|50174071|FG000|Overall Study|Migrated/moved from study area|3|||
25068344|NCT02422264|50174072|FG001|Overall Study|Migrated/moved from study area|1|||
25068345|NCT02422264|50174071|FG000|Overall Study|Subject vaccinated outside of the study|0|||
24967159|NCT00421889|50056748|FG007|Overall Study|Death|0|||
24967160|NCT00421889|50056749|FG008|Overall Study|Death|0|||
24967161|NCT00421889|50056741|FG000|Overall Study|Progressive disease|3|||
24967162|NCT00421889|50056742|FG001|Overall Study|Progressive disease|2|||
24967163|NCT00421889|50056743|FG002|Overall Study|Progressive disease|2|||
25068346|NCT02422264|50174072|FG001|Overall Study|Subject vaccinated outside of the study|1|||
25068347|NCT02390362|50174080|FG000|Overall Study|Withdrawal by Subject|0|||
25068348|NCT02390362|50174081|FG001|Overall Study|Withdrawal by Subject|1|||
25068349|NCT02389894|50174090|FG000|Overall Study|Death|4|||
24967164|NCT00421889|50056744|FG003|Overall Study|Progressive disease|3|||
24967165|NCT00421889|50056745|FG004|Overall Study|Progressive disease|2|||
25068350|NCT02389894|50174091|FG001|Overall Study|Death|5|||
25068351|NCT02389894|50174092|FG002|Overall Study|Death|3|||
25068352|NCT02389894|50174090|FG000|Overall Study|Withdrawal by Subject|2|||
25068353|NCT02389894|50174091|FG001|Overall Study|Withdrawal by Subject|4|||
25068354|NCT02389894|50174092|FG002|Overall Study|Withdrawal by Subject|5|||
25068355|NCT02389894|50174090|FG000|Overall Study|Lost to Follow-up|2|||
25068356|NCT02389894|50174091|FG001|Overall Study|Lost to Follow-up|1|||
25068357|NCT02389894|50174092|FG002|Overall Study|Lost to Follow-up|1|||
25068358|NCT02389816|50174103|FG000|Overall Study|Randomized but Not Treated|1|||
25068359|NCT02389816|50174104|FG001|Overall Study|Randomized but Not Treated|0|||
25068360|NCT02389816|50174105|FG002|Overall Study|Randomized but Not Treated|0|||
25068361|NCT02389816|50174103|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
25068362|NCT02389816|50174104|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
25068363|NCT02389816|50174105|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
25068364|NCT02389816|50174103|FG000|Overall Study|Major Protocol Deviation|1|||
25068365|NCT02389816|50174104|FG001|Overall Study|Major Protocol Deviation|0|||
25068366|NCT02389816|50174105|FG002|Overall Study|Major Protocol Deviation|0|||
25068367|NCT02389816|50174103|FG000|Overall Study|Lost to Follow-up|1|||
25068368|NCT02389816|50174104|FG001|Overall Study|Lost to Follow-up|0|||
25068369|NCT02389816|50174105|FG002|Overall Study|Lost to Follow-up|0|||
25068370|NCT02389816|50174103|FG000|Overall Study|Withdrawal of Consent|6|||
25068371|NCT02389816|50174104|FG001|Overall Study|Withdrawal of Consent|4|||
25068372|NCT02389816|50174105|FG002|Overall Study|Withdrawal of Consent|4|||
25068373|NCT02389816|50174103|FG000|Overall Study|Lack of Efficacy|1|||
25068374|NCT02389816|50174104|FG001|Overall Study|Lack of Efficacy|0|||
25068375|NCT02389816|50174105|FG002|Overall Study|Lack of Efficacy|0|||
25068376|NCT02389816|50174103|FG000|Overall Study|Non Compliance with Study Drug|1|||
25068377|NCT02389816|50174104|FG001|Overall Study|Non Compliance with Study Drug|1|||
25068378|NCT02389816|50174105|FG002|Overall Study|Non Compliance with Study Drug|1|||
25068379|NCT02389816|50174103|FG000|Overall Study|Reason not Specified|0|||
25068380|NCT02389816|50174104|FG001|Overall Study|Reason not Specified|2|||
24967166|NCT00421889|50056746|FG005|Overall Study|Progressive disease|21|||
25068381|NCT02389816|50174105|FG002|Overall Study|Reason not Specified|0|||
25068382|NCT02388724|50174115|FG000|Overall Study|Reason not Specified|0|||
25068383|NCT02388724|50174116|FG001|Overall Study|Reason not Specified|1|||
25068384|NCT02388724|50174115|FG000|Overall Study|Major Protocol Deviation|3|||
25068385|NCT02388724|50174116|FG001|Overall Study|Major Protocol Deviation|3|||
25068386|NCT02388724|50174115|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
25068387|NCT02388724|50174116|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
25068388|NCT02388724|50174115|FG000|Overall Study|Voluntary Withdrawal|6|||
25068389|NCT02388724|50174116|FG001|Overall Study|Voluntary Withdrawal|5|||
25068390|NCT02388724|50174115|FG000|Overall Study|Randomized but not Treated|0|||
25068391|NCT02388724|50174116|FG001|Overall Study|Randomized but not Treated|2|||
25068392|NCT02382796|50174122|FG000|Overall Study|Global deterioration of health status|1|||
25068393|NCT02382796|50174122|FG000|Overall Study|Objective progression or relapse|3|||
25068394|NCT02382796|50174122|FG000|Overall Study|Commercial dacomitinib became available|3|||
25068395|NCT02382640|50174130|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
25068396|NCT02382640|50174131|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
25068397|NCT02382640|50174132|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
25068398|NCT02382640|50174133|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
25068399|NCT02801669|50174145|FG000|Overall Study|Death|66|||
24967167|NCT00421889|50056747|FG006|Overall Study|Progressive disease|3|||
24967168|NCT00421889|50056748|FG007|Overall Study|Progressive disease|1|||
24967169|NCT00421889|50056749|FG008|Overall Study|Progressive disease|5|||
24967170|NCT00421889|50056741|FG000|Overall Study|Patient/Investigator request|0|||
24967171|NCT00421889|50056742|FG001|Overall Study|Patient/Investigator request|0|||
24967172|NCT00421889|50056743|FG002|Overall Study|Patient/Investigator request|0|||
24967173|NCT00421889|50056744|FG003|Overall Study|Patient/Investigator request|0|||
25068400|NCT02801669|50174146|FG001|Overall Study|Death|69|||
25068401|NCT02801669|50174145|FG000|Overall Study|Withdrawal by Subject|81|||
25068402|NCT02801669|50174146|FG001|Overall Study|Withdrawal by Subject|77|||
25068403|NCT02801669|50174145|FG000|Overall Study|Other|4|||
25068404|NCT02801669|50174146|FG001|Overall Study|Other|6|||
24967174|NCT00421889|50056745|FG004|Overall Study|Patient/Investigator request|0|||
24967175|NCT00421889|50056746|FG005|Overall Study|Patient/Investigator request|9|||
24967176|NCT00421889|50056747|FG006|Overall Study|Patient/Investigator request|0|||
24967177|NCT00421889|50056748|FG007|Overall Study|Patient/Investigator request|1|||
24967178|NCT00421889|50056749|FG008|Overall Study|Patient/Investigator request|3|||
24967179|NCT00421889|50056741|FG000|Overall Study|Lost to Follow-up|0|||
24967180|NCT00421889|50056742|FG001|Overall Study|Lost to Follow-up|0|||
24967181|NCT00421889|50056743|FG002|Overall Study|Lost to Follow-up|0|||
24967182|NCT00421889|50056744|FG003|Overall Study|Lost to Follow-up|0|||
24967183|NCT00421889|50056745|FG004|Overall Study|Lost to Follow-up|0|||
24967184|NCT00421889|50056746|FG005|Overall Study|Lost to Follow-up|0|||
24967185|NCT00421889|50056747|FG006|Overall Study|Lost to Follow-up|0|||
24967186|NCT00421889|50056748|FG007|Overall Study|Lost to Follow-up|0|||
24967187|NCT00421889|50056749|FG008|Overall Study|Lost to Follow-up|1|||
24967188|NCT00421733|50056776|FG000|Overall Study|Adverse Event|4|||
24967189|NCT00421733|50056777|FG001|Overall Study|Adverse Event|9|||
24967190|NCT00421733|50056778|FG002|Overall Study|Adverse Event|2|||
24967191|NCT00421733|50056776|FG000|Overall Study|Lost to Follow-up|1|||
24967192|NCT00421733|50056777|FG001|Overall Study|Lost to Follow-up|2|||
24967193|NCT00421733|50056778|FG002|Overall Study|Lost to Follow-up|4|||
24967194|NCT00421733|50056776|FG000|Overall Study|Withdrawal by Subject|1|||
24967195|NCT00421733|50056777|FG001|Overall Study|Withdrawal by Subject|2|||
25068405|NCT02804399|50174152|FG000|Period 2|Adverse Event|0|||
25068406|NCT02804399|50174153|FG001|Period 2|Adverse Event|1|||
25068407|NCT01333943|50174164|FG000|Overall Study|Known neuropathy|1|||
24967196|NCT00421733|50056778|FG002|Overall Study|Withdrawal by Subject|7|||
25068408|NCT01333943|50174165|FG001|Overall Study|Known neuropathy|0|||
25068409|NCT01333865|50174171|FG000|Overall Study|Adverse Event|2|||
25188409|NCT02095132|50341668|FG003|Overall Study|Adverse Event|0|||
25188410|NCT02095132|50341669|FG004|Overall Study|Adverse Event|1|||
25188411|NCT02095132|50341670|FG005|Overall Study|Adverse Event|0|||
25188412|NCT02095132|50341671|FG006|Overall Study|Adverse Event|1|||
25188413|NCT02095132|50341672|FG007|Overall Study|Adverse Event|0|||
25188414|NCT02095132|50341673|FG008|Overall Study|Adverse Event|0|||
25188415|NCT02095132|50341665|FG000|Overall Study|Death|0|||
25188416|NCT02095132|50341666|FG001|Overall Study|Death|0|||
25188417|NCT02095132|50341667|FG002|Overall Study|Death|0|||
25188418|NCT02095132|50341668|FG003|Overall Study|Death|0|||
25188419|NCT02095132|50341669|FG004|Overall Study|Death|0|||
25188420|NCT02095132|50341670|FG005|Overall Study|Death|0|||
25188421|NCT02095132|50341671|FG006|Overall Study|Death|1|||
25188422|NCT02095132|50341672|FG007|Overall Study|Death|0|||
25188423|NCT02095132|50341673|FG008|Overall Study|Death|0|||
25188424|NCT02095132|50341665|FG000|Overall Study|Lack of Efficacy|3|||
25188425|NCT02095132|50341666|FG001|Overall Study|Lack of Efficacy|5|||
25188426|NCT02095132|50341667|FG002|Overall Study|Lack of Efficacy|2|||
25188427|NCT02095132|50341668|FG003|Overall Study|Lack of Efficacy|8|||
25188428|NCT02095132|50341669|FG004|Overall Study|Lack of Efficacy|3|||
25188429|NCT02095132|50341670|FG005|Overall Study|Lack of Efficacy|6|||
25188430|NCT02095132|50341671|FG006|Overall Study|Lack of Efficacy|10|||
25188431|NCT02095132|50341672|FG007|Overall Study|Lack of Efficacy|9|||
25188432|NCT02095132|50341673|FG008|Overall Study|Lack of Efficacy|8|||
24967197|NCT00421733|50056776|FG000|Overall Study|Death|0|||
24967198|NCT00421733|50056777|FG001|Overall Study|Death|3|||
24967199|NCT00421733|50056778|FG002|Overall Study|Death|0|||
24967200|NCT00421733|50056776|FG000|Overall Study|Required dialysis|1|||
24967201|NCT00421733|50056777|FG001|Overall Study|Required dialysis|0|||
25068410|NCT01333475|50174177|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
25068411|NCT01333475|50174178|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
25068412|NCT01333475|50174177|FG000|Overall Study|Toxicity|1|||
25068413|NCT01333475|50174178|FG001|Overall Study|Toxicity|3|||
25188433|NCT02095132|50341665|FG000|Overall Study|Physician Decision|1|||
24967202|NCT00421733|50056778|FG002|Overall Study|Required dialysis|0|||
24967203|NCT00421733|50056776|FG000|Overall Study|Administrative|2|||
25188434|NCT02095132|50341666|FG001|Overall Study|Physician Decision|0|||
25188435|NCT02095132|50341667|FG002|Overall Study|Physician Decision|0|||
25188436|NCT02095132|50341668|FG003|Overall Study|Physician Decision|0|||
25188437|NCT02095132|50341669|FG004|Overall Study|Physician Decision|0|||
25068414|NCT01333397|50174190|FG000|Overall Study|Lost to Follow-up|1|||
25068415|NCT01333397|50174191|FG001|Overall Study|Lost to Follow-up|0|||
25068416|NCT01333397|50174192|FG002|Overall Study|Lost to Follow-up|0|||
25068417|NCT01333397|50174193|FG003|Overall Study|Lost to Follow-up|1|||
25068418|NCT01333397|50174194|FG004|Overall Study|Lost to Follow-up|0|||
25068419|NCT02798861|50174215|FG000|Overall Study|Lost to Follow-up|22|||
25068420|NCT02798861|50174215|FG000|Overall Study|Withdrawal by Subject|1|||
25068421|NCT02798315|50174219|FG000|Overall Study|Failure to return|1|||
25068422|NCT02796755|50174225|FG000|Overall Study|Adverse Event|2|||
25068423|NCT02796755|50174226|FG001|Overall Study|Adverse Event|0|||
25068424|NCT02382016|50174234|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
25068425|NCT02382016|50174235|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
25068426|NCT02382016|50174234|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
25068427|NCT02382016|50174235|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
25068428|NCT02382016|50174234|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
25068429|NCT02382016|50174235|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
25068430|NCT02382016|50174234|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
25068431|NCT02382016|50174235|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
25068432|NCT02382016|50174234|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
25068433|NCT02382016|50174235|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
25068434|NCT02382016|50174234|FG000|Open-label (OL) Treatment Period|Death|4|||
25068435|NCT02382016|50174235|FG001|Open-label (OL) Treatment Period|Death|0|||
25068436|NCT02382016|50174234|FG000|OL Extension Period|Physician Decision|3|||
25068437|NCT02382016|50174235|FG001|OL Extension Period|Physician Decision|0|||
25068438|NCT02382016|50174234|FG000|OL Extension Period|Death|2|||
25068439|NCT02382016|50174235|FG001|OL Extension Period|Death|0|||
25068440|NCT02382016|50174234|FG000|OL Extension Period|Withdrawal by Subject|1|||
25068441|NCT02382016|50174235|FG001|OL Extension Period|Withdrawal by Subject|0|||
25068442|NCT02380690|50174245|FG000|Overall Study|Lost to Follow-up|14|||
25068443|NCT02380690|50174246|FG001|Overall Study|Lost to Follow-up|4|||
25068444|NCT02380690|50174245|FG000|Overall Study|Withdrawal by Subject|20|||
25068445|NCT02380690|50174246|FG001|Overall Study|Withdrawal by Subject|8|||
25068446|NCT02422186|50174254|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
25068447|NCT02422186|50174255|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
25068448|NCT02422186|50174254|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
25068449|NCT02422186|50174255|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
25068450|NCT02422186|50174254|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
25068451|NCT02422186|50174255|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
25068452|NCT02422186|50174254|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
25068453|NCT02422186|50174255|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
25068454|NCT02422186|50174254|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
25068455|NCT02422186|50174255|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
25068456|NCT02422186|50174254|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
25068457|NCT02422186|50174255|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
25068458|NCT02422186|50174254|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
25068459|NCT02422186|50174255|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
24967204|NCT00421733|50056777|FG001|Overall Study|Administrative|0|||
24967205|NCT00421733|50056778|FG002|Overall Study|Administrative|0|||
25068460|NCT02422186|50174254|FG000|Follow-up Phase (2 Weeks)|Other|3|||
25068461|NCT02422186|50174255|FG001|Follow-up Phase (2 Weeks)|Other|0|||
25068462|NCT02421952|50174263|FG000|Overall Study|Diary Not Returned|93|||
25068463|NCT02421952|50174263|FG000|Overall Study|Failed seriation task|13|||
25068464|NCT02421952|50174263|FG000|Overall Study|Subject uncooperative for baseline test|2|||
25068465|NCT02421952|50174263|FG000|Overall Study|Surgery cancelled|1|||
25068466|NCT02796677|50174274|FG000|Overall Study|Adverse Event|11|||
25068467|NCT02796677|50174275|FG001|Overall Study|Adverse Event|22|||
25068468|NCT02796677|50174276|FG002|Overall Study|Adverse Event|14|||
25068469|NCT02796677|50174277|FG003|Overall Study|Adverse Event|14|||
25068470|NCT02796677|50174274|FG000|Overall Study|Protocol Violation|7|||
25068471|NCT02796677|50174275|FG001|Overall Study|Protocol Violation|5|||
25068472|NCT02796677|50174276|FG002|Overall Study|Protocol Violation|4|||
25068473|NCT02796677|50174277|FG003|Overall Study|Protocol Violation|8|||
25068474|NCT02796677|50174274|FG000|Overall Study|Lost to Follow-up|1|||
24967206|NCT00421733|50056776|FG000|Overall Study|Did not satisfy entry criteria|1|||
24967207|NCT00421733|50056777|FG001|Overall Study|Did not satisfy entry criteria|3|||
24967208|NCT00421733|50056778|FG002|Overall Study|Did not satisfy entry criteria|2|||
24967209|NCT00421733|50056776|FG000|Overall Study|Sponsor request|1|||
24967210|NCT00421733|50056777|FG001|Overall Study|Sponsor request|0|||
24967211|NCT00421733|50056778|FG002|Overall Study|Sponsor request|3|||
24967212|NCT00421733|50056776|FG000|Overall Study|Protocol deviation|4|||
24967213|NCT00421733|50056777|FG001|Overall Study|Protocol deviation|7|||
24967214|NCT00421733|50056778|FG002|Overall Study|Protocol deviation|2|||
24967215|NCT00421343|50056790|FG000|Overall Study|Death|1|||
24967216|NCT00421343|50056790|FG000|Overall Study|Withdrawal by Subject|2|||
24967217|NCT00421343|50056790|FG000|Overall Study|Lost to Follow-up|3|||
24967218|NCT00230178|50056797|FG000|Overall Study|Adverse Event|1|||
24967219|NCT00230178|50056798|FG001|Overall Study|Adverse Event|5|||
24967220|NCT00230178|50056799|FG002|Overall Study|Adverse Event|2|||
24967221|NCT00230178|50056797|FG000|Overall Study|Withdrawal by Subject|0|||
24967222|NCT00230178|50056798|FG001|Overall Study|Withdrawal by Subject|0|||
24967223|NCT00230178|50056799|FG002|Overall Study|Withdrawal by Subject|1|||
24967224|NCT00230178|50056797|FG000|Overall Study|Various other reasons|3|||
24967225|NCT00230178|50056798|FG001|Overall Study|Various other reasons|2|||
24967226|NCT00230178|50056799|FG002|Overall Study|Various other reasons|4|||
24967227|NCT00413777|50056809|FG000|Fixed-dose Period|Lost to Follow-up|1|||
24967228|NCT00413777|50056810|FG001|Fixed-dose Period|Lost to Follow-up|1|||
24967229|NCT00413777|50056809|FG000|Fixed-dose Period|Adverse Event|2|||
24967230|NCT00413777|50056810|FG001|Fixed-dose Period|Adverse Event|1|||
24967231|NCT00413777|50056809|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
24967232|NCT00413777|50056810|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
24967233|NCT00413777|50056809|FG000|Fixed-dose Period|Withdrew Consent|0|||
24967234|NCT00413777|50056810|FG001|Fixed-dose Period|Withdrew Consent|1|||
24967235|NCT00197028|50056818|FG000|Overall Study|Adverse Event|2|||
24967236|NCT00197028|50056819|FG001|Overall Study|Adverse Event|2|||
24967237|NCT00197028|50056818|FG000|Overall Study|Protocol Violation|2|||
24967238|NCT00197028|50056819|FG001|Overall Study|Protocol Violation|1|||
24967239|NCT00197028|50056818|FG000|Overall Study|Withdrawal by Subject|8|||
24967240|NCT00197028|50056819|FG001|Overall Study|Withdrawal by Subject|12|||
24967241|NCT00197028|50056818|FG000|Overall Study|Lost to Follow-up|1|||
24967242|NCT00197028|50056819|FG001|Overall Study|Lost to Follow-up|0|||
24967243|NCT00197028|50056818|FG000|Overall Study|Other|3|||
24967244|NCT00197028|50056819|FG001|Overall Study|Other|6|||
25068475|NCT02796677|50174275|FG001|Overall Study|Lost to Follow-up|5|||
25068476|NCT02796677|50174276|FG002|Overall Study|Lost to Follow-up|2|||
25068477|NCT02796677|50174277|FG003|Overall Study|Lost to Follow-up|2|||
25068478|NCT02796677|50174274|FG000|Overall Study|Lack of Efficacy|7|||
25068479|NCT02796677|50174275|FG001|Overall Study|Lack of Efficacy|9|||
24967245|NCT00420641|50056828|FG000|Overall Study|Adverse Event|3|||
24967246|NCT00420641|50056829|FG001|Overall Study|Adverse Event|25|||
24967247|NCT00420641|50056830|FG002|Overall Study|Adverse Event|10|||
24967248|NCT00420641|50056828|FG000|Overall Study|Lost to Follow-up|2|||
24967249|NCT00420641|50056829|FG001|Overall Study|Lost to Follow-up|4|||
24967250|NCT00420641|50056830|FG002|Overall Study|Lost to Follow-up|2|||
24967251|NCT00420641|50056828|FG000|Overall Study|Protocol Violation|8|||
24967252|NCT00420641|50056829|FG001|Overall Study|Protocol Violation|8|||
24967253|NCT00420641|50056830|FG002|Overall Study|Protocol Violation|7|||
24967254|NCT00420641|50056828|FG000|Overall Study|Withdrawal by Subject|15|||
24967255|NCT00420641|50056829|FG001|Overall Study|Withdrawal by Subject|21|||
24967256|NCT00420641|50056830|FG002|Overall Study|Withdrawal by Subject|14|||
24967257|NCT00420641|50056828|FG000|Overall Study|Lack of Efficacy|6|||
24967258|NCT00420641|50056829|FG001|Overall Study|Lack of Efficacy|5|||
24967259|NCT00420641|50056830|FG002|Overall Study|Lack of Efficacy|4|||
24967260|NCT00420641|50056828|FG000|Overall Study|Non-compliance|7|||
24967261|NCT00420641|50056829|FG001|Overall Study|Non-compliance|5|||
24967262|NCT00420641|50056830|FG002|Overall Study|Non-compliance|4|||
24967263|NCT00420641|50056828|FG000|Overall Study|Other|4|||
24967264|NCT00420641|50056829|FG001|Overall Study|Other|4|||
24967265|NCT00420641|50056830|FG002|Overall Study|Other|3|||
24967266|NCT00257556|50056840|FG000|Overall Study|Adverse Event|1|||
24967267|NCT00257556|50056841|FG001|Overall Study|Adverse Event|4|||
24967268|NCT00257556|50056840|FG000|Overall Study|Physician Decision|6|||
24967269|NCT00257556|50056841|FG001|Overall Study|Physician Decision|0|||
24967270|NCT00257556|50056840|FG000|Overall Study|Did not meet hCG criterion|3|||
24967271|NCT00257556|50056841|FG001|Overall Study|Did not meet hCG criterion|0|||
24967272|NCT00257556|50056840|FG000|Overall Study|other reason|4|||
25068480|NCT02796677|50174276|FG002|Overall Study|Lack of Efficacy|14|||
24967273|NCT00257556|50056841|FG001|Overall Study|other reason|6|||
24967274|NCT00228384|50056849|FG000|Overall Study|Death|9|||
24967275|NCT00228384|50056850|FG001|Overall Study|Death|3|||
24967276|NCT00228384|50056849|FG000|Overall Study|Lost to Follow-up|6|||
24967277|NCT00228384|50056850|FG001|Overall Study|Lost to Follow-up|10|||
24967278|NCT00228384|50056849|FG000|Overall Study|Surgical Intervention (bypass)|5|||
24967279|NCT00228384|50056850|FG001|Overall Study|Surgical Intervention (bypass)|5|||
24967280|NCT00228384|50056849|FG000|Overall Study|Withdrawal by Subject|9|||
24967281|NCT00228384|50056850|FG001|Overall Study|Withdrawal by Subject|10|||
24967282|NCT00228384|50056849|FG000|Overall Study|Physician Decision|0|||
24967283|NCT00228384|50056850|FG001|Overall Study|Physician Decision|1|||
24967284|NCT00257166|50056858|FG000|Overall Study|Adverse Event|18|||
24967285|NCT00257166|50056859|FG001|Overall Study|Adverse Event|13|||
24967286|NCT00257166|50056858|FG000|Overall Study|Laboratory abnormality|1|||
24967287|NCT00257166|50056859|FG001|Overall Study|Laboratory abnormality|0|||
25068481|NCT02796677|50174277|FG003|Overall Study|Lack of Efficacy|20|||
25068482|NCT02796677|50174274|FG000|Overall Study|Withdrawal by Subject|4|||
25068483|NCT02796677|50174275|FG001|Overall Study|Withdrawal by Subject|14|||
25068484|NCT02796677|50174276|FG002|Overall Study|Withdrawal by Subject|6|||
25068485|NCT02796677|50174277|FG003|Overall Study|Withdrawal by Subject|7|||
25068486|NCT02796677|50174274|FG000|Overall Study|Progressive disease|6|||
25068487|NCT02796677|50174275|FG001|Overall Study|Progressive disease|15|||
25068488|NCT02796677|50174276|FG002|Overall Study|Progressive disease|13|||
25068489|NCT02796677|50174277|FG003|Overall Study|Progressive disease|18|||
25068490|NCT02796677|50174274|FG000|Overall Study|Reason not mentioned|2|||
25068491|NCT02796677|50174275|FG001|Overall Study|Reason not mentioned|3|||
25068492|NCT02796677|50174276|FG002|Overall Study|Reason not mentioned|0|||
25068493|NCT02796677|50174277|FG003|Overall Study|Reason not mentioned|5|||
25068494|NCT02421172|50174291|FG000|Period 1|Adverse Event|1|||
25068495|NCT02421172|50174292|FG001|Period 1|Adverse Event|0|||
25068496|NCT02421172|50174293|FG002|Period 1|Adverse Event|0|||
25068497|NCT02421172|50174294|FG003|Period 1|Adverse Event|0|||
25068498|NCT02421172|50174295|FG004|Period 1|Adverse Event|0|||
25068499|NCT02421172|50174291|FG000|Period 1|Lost to Follow-up|3|||
25068500|NCT02421172|50174292|FG001|Period 1|Lost to Follow-up|1|||
25068501|NCT02421172|50174293|FG002|Period 1|Lost to Follow-up|0|||
25068502|NCT02421172|50174294|FG003|Period 1|Lost to Follow-up|0|||
25068503|NCT02421172|50174295|FG004|Period 1|Lost to Follow-up|0|||
25068504|NCT02421172|50174291|FG000|Period 1|Patient/guardian decision|0|||
25068505|NCT02421172|50174292|FG001|Period 1|Patient/guardian decision|1|||
25188438|NCT02095132|50341670|FG005|Overall Study|Physician Decision|0|||
25188439|NCT02095132|50341671|FG006|Overall Study|Physician Decision|1|||
25188440|NCT02095132|50341672|FG007|Overall Study|Physician Decision|0|||
25188441|NCT02095132|50341673|FG008|Overall Study|Physician Decision|2|||
25188442|NCT02095132|50341665|FG000|Overall Study|Withdrawal by Subject|0|||
25188443|NCT02095132|50341666|FG001|Overall Study|Withdrawal by Subject|0|||
25188444|NCT02095132|50341667|FG002|Overall Study|Withdrawal by Subject|2|||
25188445|NCT02095132|50341668|FG003|Overall Study|Withdrawal by Subject|2|||
25188446|NCT02095132|50341669|FG004|Overall Study|Withdrawal by Subject|3|||
25188447|NCT02095132|50341670|FG005|Overall Study|Withdrawal by Subject|0|||
25188448|NCT02095132|50341671|FG006|Overall Study|Withdrawal by Subject|5|||
25188449|NCT02095132|50341672|FG007|Overall Study|Withdrawal by Subject|0|||
25188450|NCT02095132|50341673|FG008|Overall Study|Withdrawal by Subject|0|||
25188451|NCT00602667|50341733|FG000|Overall Study|Still on Therapy|0|||
25068506|NCT02421172|50174293|FG002|Period 1|Patient/guardian decision|0|||
25068507|NCT02421172|50174294|FG003|Period 1|Patient/guardian decision|0|||
25068508|NCT02421172|50174295|FG004|Period 1|Patient/guardian decision|0|||
25068509|NCT02421172|50174291|FG000|Period 2|Adverse Event|0|||
25068510|NCT02421172|50174292|FG001|Period 2|Adverse Event|0|||
25068511|NCT02421172|50174293|FG002|Period 2|Adverse Event|4|||
25068512|NCT02421172|50174294|FG003|Period 2|Adverse Event|0|||
25068513|NCT02421172|50174295|FG004|Period 2|Adverse Event|0|||
25188452|NCT00602667|50341734|FG001|Overall Study|Still on Therapy|2|||
24967288|NCT00257166|50056858|FG000|Overall Study|Lost to Follow-up|8|||
25188453|NCT00602667|50341735|FG002|Overall Study|Still on Therapy|2|||
25188454|NCT00602667|50341733|FG000|Overall Study|Death|0|||
25188455|NCT00602667|50341734|FG001|Overall Study|Death|1|||
24967289|NCT00257166|50056859|FG001|Overall Study|Lost to Follow-up|1|||
24967290|NCT00257166|50056858|FG000|Overall Study|Withdrawal by Subject|9|||
24967291|NCT00257166|50056859|FG001|Overall Study|Withdrawal by Subject|2|||
25068514|NCT02421172|50174291|FG000|Period 2|Lost to Follow-up|0|||
25068515|NCT02421172|50174292|FG001|Period 2|Lost to Follow-up|0|||
25068516|NCT02421172|50174293|FG002|Period 2|Lost to Follow-up|0|||
25068517|NCT02421172|50174294|FG003|Period 2|Lost to Follow-up|1|||
25068518|NCT02421172|50174295|FG004|Period 2|Lost to Follow-up|0|||
25068519|NCT02421172|50174291|FG000|Period 2|Patient/guardian decision|0|||
25068520|NCT02421172|50174292|FG001|Period 2|Patient/guardian decision|0|||
25188456|NCT00602667|50341735|FG002|Overall Study|Death|1|||
25188457|NCT00602667|50341733|FG000|Overall Study|Family request|3|||
25068521|NCT02421172|50174293|FG002|Period 2|Patient/guardian decision|3|||
25188458|NCT00602667|50341734|FG001|Overall Study|Family request|25|||
25068522|NCT02421172|50174294|FG003|Period 2|Patient/guardian decision|2|||
25068523|NCT02421172|50174295|FG004|Period 2|Patient/guardian decision|1|||
25068524|NCT02379052|50174308|FG000|Overall Study|Protocol Violation|0|||
24967292|NCT00257166|50056858|FG000|Overall Study|Other|16|||
24967293|NCT00257166|50056859|FG001|Overall Study|Other|21|||
24967294|NCT00257166|50056858|FG000|Overall Study|Randomized, but not treated|1|||
25168695|NCT00632931|50298260|FG002|Part 2|Death|1|||
25168696|NCT00632931|50298258|FG000|Part 2|Lack of Efficacy|0|||
25168697|NCT00632931|50298259|FG001|Part 2|Lack of Efficacy|0|||
25168698|NCT00632931|50298260|FG002|Part 2|Lack of Efficacy|17|||
25168699|NCT00632931|50298258|FG000|Part 2|Withdrawal by Subject|0|||
25168700|NCT00632931|50298259|FG001|Part 2|Withdrawal by Subject|0|||
25168701|NCT00632931|50298260|FG002|Part 2|Withdrawal by Subject|3|||
25168702|NCT01857323|50298265|FG000|Overall Study|Adverse Event|1|||
25168703|NCT01857323|50298265|FG000|Overall Study|Withdrawal by Subject|3|||
25168704|NCT01857323|50298265|FG000|Overall Study|Non-compliance|1|||
25168705|NCT01857323|50298265|FG000|Overall Study|Protocol Violation|6|||
25168706|NCT01857323|50298265|FG000|Overall Study|Lost to Follow-up|1|||
25168707|NCT01857323|50298265|FG000|Overall Study|Other|4|||
25168708|NCT01857323|50298265|FG000|Overall Study|Did not complete 180 doses|48|||
25168709|NCT00632541|50298269|FG000|Overall Study|Adverse Event|7|||
25168710|NCT01872611|50298275|FG000|Overall Study|Adverse Event|3|||
25168711|NCT01872611|50298276|FG001|Overall Study|Adverse Event|1|||
25168712|NCT01872611|50298275|FG000|Overall Study|Adverse Event, prior to treatment|0|||
25168713|NCT01872611|50298276|FG001|Overall Study|Adverse Event, prior to treatment|1|||
25168714|NCT01872611|50298275|FG000|Overall Study|Death|0|||
25168715|NCT01872611|50298276|FG001|Overall Study|Death|1|||
25168716|NCT01872611|50298275|FG000|Overall Study|Death, prior to treatment|0|||
25068525|NCT02379052|50174309|FG001|Overall Study|Protocol Violation|1|||
25068526|NCT02379052|50174308|FG000|Overall Study|Adverse Event|0|||
25068527|NCT02379052|50174309|FG001|Overall Study|Adverse Event|1|||
25068528|NCT02379052|50174308|FG000|Overall Study|Physician Decision|1|||
25068529|NCT02379052|50174309|FG001|Overall Study|Physician Decision|1|||
25068530|NCT02379052|50174308|FG000|Overall Study|Withdrawal by Subject|2|||
25068531|NCT02379052|50174309|FG001|Overall Study|Withdrawal by Subject|0|||
25068532|NCT02379052|50174308|FG000|Overall Study|Lost to Follow-up|2|||
25068533|NCT02379052|50174309|FG001|Overall Study|Lost to Follow-up|1|||
25068534|NCT02379052|50174308|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
25068535|NCT02379052|50174309|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
25068536|NCT02379052|50174308|FG000|Overall Study|Subject was Incarcerated|0|||
25068537|NCT02379052|50174309|FG001|Overall Study|Subject was Incarcerated|1|||
25068538|NCT02378662|50174317|FG000|Overall Study|Early Discontinuation|2|||
25068539|NCT02378662|50174318|FG001|Overall Study|Early Discontinuation|0|||
25068540|NCT02378506|50174324|FG000|Overall Study|Lack of Efficacy|3|||
25068541|NCT02378506|50174324|FG000|Overall Study|Withdrawal by Subject|4|||
25068542|NCT02378506|50174324|FG000|Overall Study|Protocol Violation|2|||
25068543|NCT02378506|50174324|FG000|Overall Study|Death|1|||
25188459|NCT00602667|50341735|FG002|Overall Study|Family request|6|||
25188460|NCT00602667|50341733|FG000|Overall Study|Excessive toxicity|1|||
25188461|NCT00602667|50341734|FG001|Overall Study|Excessive toxicity|1|||
25188462|NCT00602667|50341735|FG002|Overall Study|Excessive toxicity|0|||
25188463|NCT00602667|50341733|FG000|Overall Study|Second malignancy|0|||
25188464|NCT00602667|50341734|FG001|Overall Study|Second malignancy|1|||
25188465|NCT00602667|50341735|FG002|Overall Study|Second malignancy|0|||
25188466|NCT00602667|50341733|FG000|Overall Study|Physician Decision|2|||
25188467|NCT00602667|50341734|FG001|Overall Study|Physician Decision|3|||
25188468|NCT00602667|50341735|FG002|Overall Study|Physician Decision|8|||
25188469|NCT00602667|50341733|FG000|Overall Study|Progressive disease|13|||
25188470|NCT00602667|50341734|FG001|Overall Study|Progressive disease|48|||
25188471|NCT00602667|50341735|FG002|Overall Study|Progressive disease|45|||
25188472|NCT00602667|50341733|FG000|Overall Study|Progressive disease prior to therapy|0|||
25188473|NCT00602667|50341734|FG001|Overall Study|Progressive disease prior to therapy|0|||
25188474|NCT00602667|50341735|FG002|Overall Study|Progressive disease prior to therapy|1|||
25068544|NCT02378506|50174324|FG000|Overall Study|Adverse Event|14|||
25068545|NCT02378506|50174324|FG000|Overall Study|Randomized But Not Treated|1|||
25068546|NCT02347774|50174331|FG000|Study Participation|Lost to Follow-up|3|||
25068547|NCT02347774|50174332|FG001|Study Participation|Lost to Follow-up|6|||
25188475|NCT00569127|50341774|FG000|Overall Study|Adverse Event|57|||
25168717|NCT01872611|50298276|FG001|Overall Study|Death, prior to treatment|1|||
25168718|NCT01872611|50298275|FG000|Overall Study|Lost to Follow-up|8|||
25168719|NCT01872611|50298276|FG001|Overall Study|Lost to Follow-up|1|||
25168720|NCT01872611|50298275|FG000|Overall Study|Physician Decision|1|||
25188476|NCT00569127|50341775|FG001|Overall Study|Adverse Event|47|||
25168721|NCT01872611|50298276|FG001|Overall Study|Physician Decision|0|||
25168722|NCT01872611|50298275|FG000|Overall Study|Withdrawal by Subject|6|||
25188477|NCT00569127|50341774|FG000|Overall Study|Withdrawal by Subject|13|||
25188478|NCT00569127|50341775|FG001|Overall Study|Withdrawal by Subject|27|||
25068548|NCT02347774|50174333|FG002|Study Participation|Lost to Follow-up|2|||
25168723|NCT01872611|50298276|FG001|Overall Study|Withdrawal by Subject|1|||
25068549|NCT02347774|50174331|FG000|Study Participation|Withdrawal by Subject|8|||
25068550|NCT02347774|50174332|FG001|Study Participation|Withdrawal by Subject|9|||
25068551|NCT02347774|50174333|FG002|Study Participation|Withdrawal by Subject|15|||
25068552|NCT02347774|50174331|FG000|Study Participation|Adverse Event|1|||
25068553|NCT02347774|50174332|FG001|Study Participation|Adverse Event|4|||
25068554|NCT02347774|50174333|FG002|Study Participation|Adverse Event|6|||
25068555|NCT02347774|50174331|FG000|Study Participation|withdrew consent|1|||
25068556|NCT02347774|50174332|FG001|Study Participation|withdrew consent|1|||
25068557|NCT02347774|50174333|FG002|Study Participation|withdrew consent|1|||
25068558|NCT02347774|50174331|FG000|Study Participation|Met Prolonged QT criteria|1|||
25068559|NCT02347774|50174332|FG001|Study Participation|Met Prolonged QT criteria|0|||
25068560|NCT02347774|50174333|FG002|Study Participation|Met Prolonged QT criteria|0|||
25068561|NCT02347774|50174331|FG000|Study Participation|non-compliance with study drug|0|||
25068562|NCT02347774|50174332|FG001|Study Participation|non-compliance with study drug|1|||
25068563|NCT02347774|50174333|FG002|Study Participation|non-compliance with study drug|0|||
25068564|NCT02347774|50174331|FG000|Study Participation|incarceration|1|||
25068565|NCT02347774|50174332|FG001|Study Participation|incarceration|0|||
25068566|NCT02347774|50174333|FG002|Study Participation|incarceration|0|||
25068567|NCT02347774|50174331|FG000|Study Participation|randomized in error|0|||
25068568|NCT02347774|50174332|FG001|Study Participation|randomized in error|0|||
25068569|NCT02347774|50174333|FG002|Study Participation|randomized in error|1|||
25068570|NCT02347774|50174331|FG000|On Study Treatment|Adverse Event|9|||
25068571|NCT02347774|50174332|FG001|On Study Treatment|Adverse Event|15|||
25068572|NCT02347774|50174333|FG002|On Study Treatment|Adverse Event|19|||
25068573|NCT02347774|50174331|FG000|On Study Treatment|Lack of Efficacy|3|||
25068574|NCT02347774|50174332|FG001|On Study Treatment|Lack of Efficacy|0|||
25068575|NCT02347774|50174333|FG002|On Study Treatment|Lack of Efficacy|2|||
25068576|NCT02347774|50174331|FG000|On Study Treatment|non-complicance with study medication|0|||
25068577|NCT02347774|50174332|FG001|On Study Treatment|non-complicance with study medication|2|||
25068578|NCT02347774|50174333|FG002|On Study Treatment|non-complicance with study medication|0|||
25068579|NCT02347774|50174331|FG000|On Study Treatment|Protocol Violation|0|||
25068580|NCT02347774|50174332|FG001|On Study Treatment|Protocol Violation|0|||
25068581|NCT02347774|50174333|FG002|On Study Treatment|Protocol Violation|1|||
25068582|NCT02347774|50174331|FG000|On Study Treatment|withdrew consent|9|||
25068583|NCT02347774|50174332|FG001|On Study Treatment|withdrew consent|8|||
25068584|NCT02347774|50174333|FG002|On Study Treatment|withdrew consent|12|||
25068585|NCT02347774|50174331|FG000|On Study Treatment|Lost to Follow-up|2|||
25068586|NCT02347774|50174332|FG001|On Study Treatment|Lost to Follow-up|6|||
25068587|NCT02347774|50174333|FG002|On Study Treatment|Lost to Follow-up|1|||
25068588|NCT02347774|50174331|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
25068589|NCT02347774|50174332|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
25068590|NCT02347774|50174333|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
25068591|NCT02347774|50174331|FG000|On Study Treatment|ranomized in error|0|||
25068592|NCT02347774|50174332|FG001|On Study Treatment|ranomized in error|0|||
25068593|NCT02347774|50174333|FG002|On Study Treatment|ranomized in error|1|||
25068594|NCT02794883|50174344|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
25068595|NCT02794883|50174345|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
25068596|NCT02794883|50174346|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
25068597|NCT02794883|50174344|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
25068598|NCT02794883|50174345|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
25068599|NCT02794883|50174346|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
25068600|NCT02794883|50174344|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
25068601|NCT02794883|50174345|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
25068602|NCT02794883|50174346|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
25068603|NCT02794883|50174344|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
25068604|NCT02794883|50174345|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
25068605|NCT02794883|50174346|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
25188479|NCT00569127|50341774|FG000|Overall Study|Progression|99|||
25188480|NCT00569127|50341775|FG001|Overall Study|Progression|100|||
25168724|NCT01872611|50298275|FG000|Overall Study|Reason not provided|6|||
25168725|NCT01872611|50298276|FG001|Overall Study|Reason not provided|6|||
25168726|NCT03089853|50298286|FG000|Overall Study|Lost to Follow-up|2|||
25168727|NCT03089853|50298287|FG001|Overall Study|Lost to Follow-up|1|||
25168728|NCT03086967|50298295|FG000|Overall Study|Screen Failure|2|||
25168729|NCT03086967|50298296|FG001|Overall Study|Screen Failure|2|||
25068606|NCT02794883|50174344|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
25068607|NCT02794883|50174345|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
25068608|NCT02794883|50174346|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
25068609|NCT02794883|50174344|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
25068610|NCT02794883|50174345|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
25168730|NCT01856543|50298304|FG000|Overall Study|Treatment discontinued|6|||
25168731|NCT01856543|50298305|FG001|Overall Study|Treatment discontinued|3|||
25168732|NCT01856543|50298304|FG000|Overall Study|Withdrawn before start|7|||
25068611|NCT02794883|50174346|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
25068612|NCT02794883|50174344|FG000|Follow-up Period (up to 2 Years)|Death|12|||
25068613|NCT02794883|50174345|FG001|Follow-up Period (up to 2 Years)|Death|10|||
25168733|NCT01856543|50298305|FG001|Overall Study|Withdrawn before start|3|||
25168734|NCT00632463|50298315|FG000|Overall Study|Adverse Event|0|||
25168735|NCT00632463|50298316|FG001|Overall Study|Adverse Event|1|||
25168736|NCT00632463|50298317|FG002|Overall Study|Adverse Event|0|||
25168737|NCT00632229|50298327|FG000|Overall Study|Adverse Event|6|||
25168738|NCT00632229|50298328|FG001|Overall Study|Adverse Event|0|||
25068614|NCT02794883|50174346|FG002|Follow-up Period (up to 2 Years)|Death|10|||
25068615|NCT01370603|50174356|FG000|Period 1|Adverse Event|5|||
25068616|NCT01370603|50174357|FG001|Period 1|Adverse Event|3|||
25068617|NCT01370603|50174356|FG000|Period 1|Lost to Follow-up|2|||
25068618|NCT01370603|50174357|FG001|Period 1|Lost to Follow-up|0|||
25068619|NCT01370603|50174356|FG000|Period 1|Protocol Violation|2|||
25068620|NCT01370603|50174357|FG001|Period 1|Protocol Violation|2|||
25068621|NCT01370603|50174356|FG000|Period 1|Withdrawal by Subject|5|||
25068622|NCT01370603|50174357|FG001|Period 1|Withdrawal by Subject|5|||
25068623|NCT01370603|50174356|FG000|Crossover Washout|Adverse Event|2|||
25068624|NCT01370603|50174357|FG001|Crossover Washout|Adverse Event|1|||
25068625|NCT01370603|50174356|FG000|Crossover Washout|Lost to Follow-up|2|||
25068626|NCT01370603|50174357|FG001|Crossover Washout|Lost to Follow-up|0|||
25068627|NCT01370603|50174356|FG000|Crossover Washout|Protocol Violation|1|||
25068628|NCT01370603|50174357|FG001|Crossover Washout|Protocol Violation|0|||
25068629|NCT01370603|50174356|FG000|Crossover Washout|Withdrawal by Subject|4|||
25068630|NCT01370603|50174357|FG001|Crossover Washout|Withdrawal by Subject|1|||
25068631|NCT01370603|50174356|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
25068632|NCT01370603|50174357|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
25068633|NCT01370603|50174356|FG000|Period 2|Adverse Event|1|||
25068634|NCT01370603|50174357|FG001|Period 2|Adverse Event|4|||
25068635|NCT01370603|50174356|FG000|Period 2|Lost to Follow-up|1|||
25068636|NCT01370603|50174357|FG001|Period 2|Lost to Follow-up|0|||
25068637|NCT01370603|50174356|FG000|Period 2|Withdrawal by Subject|1|||
25068638|NCT01370603|50174357|FG001|Period 2|Withdrawal by Subject|0|||
25068639|NCT02312206|50174365|FG000|Overall Study|Adverse Event|3|||
25068640|NCT02312206|50174366|FG001|Overall Study|Adverse Event|6|||
25068641|NCT02312206|50174365|FG000|Overall Study|Withdrawal by Subject|7|||
25068642|NCT02312206|50174366|FG001|Overall Study|Withdrawal by Subject|6|||
25068643|NCT02312206|50174365|FG000|Overall Study|Physician Decision|7|||
25068644|NCT02312206|50174366|FG001|Overall Study|Physician Decision|6|||
25068645|NCT02312206|50174365|FG000|Overall Study|Death|30|||
25068646|NCT02312206|50174366|FG001|Overall Study|Death|36|||
25068647|NCT02312206|50174365|FG000|Overall Study|Study Terminated by Sponsor|81|||
25068648|NCT02312206|50174366|FG001|Overall Study|Study Terminated by Sponsor|74|||
25068649|NCT02312206|50174365|FG000|Overall Study|Disease Progression|1|||
25068650|NCT02312206|50174366|FG001|Overall Study|Disease Progression|0|||
25068651|NCT02312206|50174365|FG000|Overall Study|Patient progression and new therapy|1|||
25068652|NCT02312206|50174366|FG001|Overall Study|Patient progression and new therapy|0|||
25188481|NCT00569127|50341774|FG000|Overall Study|Death|4|||
25188482|NCT00569127|50341775|FG001|Overall Study|Death|3|||
25188483|NCT00569127|50341774|FG000|Overall Study|Other|20|||
25188484|NCT00569127|50341775|FG001|Overall Study|Other|19|||
25188485|NCT00569127|50341774|FG000|Overall Study|Lost to Follow-up|0|||
25188486|NCT00569127|50341775|FG001|Overall Study|Lost to Follow-up|3|||
25188487|NCT00569127|50341774|FG000|Overall Study|Not Eligible|14|||
25188488|NCT00569127|50341775|FG001|Overall Study|Not Eligible|11|||
25188489|NCT00569127|50341774|FG000|Overall Study|Still on Treatment|7|||
25188490|NCT00569127|50341775|FG001|Overall Study|Still on Treatment|3|||
25188491|NCT02088905|50341812|FG000|Overall Study|Withdrawal by Subject|5|||
25277239|NCT01198002|50591272|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
25168739|NCT00632229|50298327|FG000|Overall Study|Lost to Follow-up|0|||
25168740|NCT00632229|50298328|FG001|Overall Study|Lost to Follow-up|3|||
25168741|NCT00632229|50298327|FG000|Overall Study|Lack of Efficacy|0|||
25188492|NCT02088905|50341813|FG001|Overall Study|Withdrawal by Subject|1|||
25068653|NCT02312206|50174365|FG000|Overall Study|Patient transferred to hospice|0|||
25068654|NCT02312206|50174366|FG001|Overall Study|Patient transferred to hospice|1|||
25068655|NCT02312206|50174365|FG000|Overall Study|Subject missed 3 consecutive tx visits|0|||
25188493|NCT02088047|50341821|FG000|Overall Study|Withdrawal by Subject|1|||
25068656|NCT02312206|50174366|FG001|Overall Study|Subject missed 3 consecutive tx visits|1|||
25068657|NCT02347072|50174372|FG000|Overall Study|Adverse Event|2|||
25068658|NCT02347072|50174372|FG000|Overall Study|Withdrawal by Subject|6|||
25068659|NCT02347072|50174372|FG000|Overall Study|Physician Decision|1|||
25068660|NCT02347072|50174372|FG000|Overall Study|Lost to Follow-up|2|||
25068661|NCT02347072|50174372|FG000|Overall Study|Protocol Violation|1|||
25068662|NCT02347072|50174372|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
25168742|NCT00632229|50298328|FG001|Overall Study|Lack of Efficacy|2|||
25168743|NCT00632229|50298327|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
25168744|NCT00632229|50298328|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
25188494|NCT02088047|50341822|FG001|Overall Study|Withdrawal by Subject|0|||
25188495|NCT02086565|50341848|FG000|Overall Study|Lost to Follow-up|9|||
25188496|NCT02086565|50341849|FG001|Overall Study|Lost to Follow-up|7|||
25188497|NCT02086565|50341848|FG000|Overall Study|Withdrawal by Subject|2|||
25188498|NCT02086565|50341849|FG001|Overall Study|Withdrawal by Subject|1|||
25188499|NCT02086565|50341848|FG000|Overall Study|Death|3|||
25188500|NCT02086565|50341849|FG001|Overall Study|Death|2|||
25188501|NCT02086565|50341848|FG000|Overall Study|withdrawn by research team|2|||
25188502|NCT02086565|50341849|FG001|Overall Study|withdrawn by research team|2|||
25188503|NCT02085941|50341857|FG000|Overall Study|Lack of Efficacy|1|||
25188504|NCT02085941|50341858|FG001|Overall Study|Lack of Efficacy|0|||
25188505|NCT02085941|50341857|FG000|Overall Study|Death|6|||
25188506|NCT02085941|50341858|FG001|Overall Study|Death|1|||
25188507|NCT02085941|50341857|FG000|Overall Study|Lost to Follow-up|1|||
25188508|NCT02085941|50341858|FG001|Overall Study|Lost to Follow-up|0|||
25188509|NCT02085941|50341857|FG000|Overall Study|Physician Decision|0|||
25188510|NCT02085941|50341858|FG001|Overall Study|Physician Decision|2|||
25188511|NCT02085785|50341866|FG000|Overall Study|Withdrawal by Subject|2|||
25188512|NCT02085785|50341867|FG001|Overall Study|Withdrawal by Subject|1|||
25188513|NCT02085785|50341866|FG000|Overall Study|Lost to Follow-up|0|||
25188514|NCT02085785|50341867|FG001|Overall Study|Lost to Follow-up|1|||
25188515|NCT02085161|50341895|FG000|Overall Study|Not Treated|1|||
25188516|NCT02085161|50341896|FG001|Overall Study|Not Treated|0|||
25188517|NCT02085161|50341897|FG002|Overall Study|Not Treated|0|||
25188518|NCT02085161|50341898|FG003|Overall Study|Not Treated|0|||
25188519|NCT02085161|50341895|FG000|Overall Study|Adverse Event|8|||
25188520|NCT02085161|50341896|FG001|Overall Study|Adverse Event|5|||
25188521|NCT02085161|50341897|FG002|Overall Study|Adverse Event|4|||
25188522|NCT02085161|50341898|FG003|Overall Study|Adverse Event|5|||
25188523|NCT02085161|50341895|FG000|Overall Study|Protocol Violation|0|||
25188524|NCT02085161|50341896|FG001|Overall Study|Protocol Violation|1|||
25188525|NCT02085161|50341897|FG002|Overall Study|Protocol Violation|0|||
25188526|NCT02085161|50341898|FG003|Overall Study|Protocol Violation|1|||
25188527|NCT02085161|50341895|FG000|Overall Study|Withdrawal by Subject|2|||
25188528|NCT02085161|50341896|FG001|Overall Study|Withdrawal by Subject|4|||
25188529|NCT02085161|50341897|FG002|Overall Study|Withdrawal by Subject|0|||
25188530|NCT02085161|50341898|FG003|Overall Study|Withdrawal by Subject|3|||
25188531|NCT02085161|50341895|FG000|Overall Study|Other Reason|1|||
25188532|NCT02085161|50341896|FG001|Overall Study|Other Reason|0|||
25188533|NCT02085161|50341897|FG002|Overall Study|Other Reason|1|||
25188534|NCT02085161|50341898|FG003|Overall Study|Other Reason|1|||
25188535|NCT02082977|50342781|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
25188536|NCT02082977|50342782|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
25188537|NCT02082977|50342783|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
25188538|NCT02082977|50342784|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
25188539|NCT02082977|50342785|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
25188540|NCT02082977|50342786|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
25188541|NCT02082977|50342787|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
25188542|NCT02082977|50342788|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
25188543|NCT02082977|50342789|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
25188544|NCT02082977|50342790|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
25188545|NCT02082977|50342781|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
25188546|NCT02082977|50342782|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
25188547|NCT02082977|50342783|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
25188548|NCT02082977|50342784|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
25188549|NCT02082977|50342785|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
25188550|NCT02082977|50342786|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
25188551|NCT02082977|50342787|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
25188552|NCT02082977|50342788|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
25188553|NCT02082977|50342789|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
25188554|NCT02082977|50342790|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
25188555|NCT02082977|50342781|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
25188556|NCT02082977|50342782|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
25188557|NCT02082977|50342783|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
25188558|NCT02082977|50342784|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
25188559|NCT02082977|50342785|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
25188560|NCT02082977|50342786|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
25188561|NCT02082977|50342787|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
25188562|NCT02082977|50342788|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
25188563|NCT02082977|50342789|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
25188564|NCT02082977|50342790|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
25188565|NCT02082977|50342781|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
25188566|NCT02082977|50342782|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
25188567|NCT02082977|50342783|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
25188568|NCT02082977|50342784|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
25188569|NCT02082977|50342785|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
25188570|NCT02082977|50342786|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
25068663|NCT02794103|50174380|FG000|Overall Study|Loss to follow up due to high sedation|3|||
25068664|NCT02346370|50174387|FG000|Overall Study|Not treated|1|||
25068665|NCT02346370|50174388|FG001|Overall Study|Not treated|0|||
25068666|NCT02346370|50174389|FG002|Overall Study|Not treated|0|||
25068667|NCT02346370|50174387|FG000|Overall Study|Withdrawal of consent|1|||
25068668|NCT02346370|50174388|FG001|Overall Study|Withdrawal of consent|0|||
25068669|NCT02346370|50174389|FG002|Overall Study|Withdrawal of consent|0|||
25068670|NCT02346370|50174387|FG000|Overall Study|Death|1|||
25068671|NCT02346370|50174388|FG001|Overall Study|Death|3|||
25068672|NCT02346370|50174389|FG002|Overall Study|Death|1|||
25068673|NCT02346370|50174387|FG000|Overall Study|Sponsor discontinued study|5|||
25068674|NCT02346370|50174388|FG001|Overall Study|Sponsor discontinued study|0|||
25068675|NCT02346370|50174389|FG002|Overall Study|Sponsor discontinued study|2|||
25068676|NCT02346370|50174387|FG000|Overall Study|Radiologic progression|0|||
25068677|NCT02346370|50174388|FG001|Overall Study|Radiologic progression|0|||
25068678|NCT02346370|50174389|FG002|Overall Study|Radiologic progression|1|||
25068679|NCT02346370|50174387|FG000|Overall Study|Physician Decision|0|||
25068680|NCT02346370|50174388|FG001|Overall Study|Physician Decision|1|||
25068681|NCT02346370|50174389|FG002|Overall Study|Physician Decision|0|||
25068682|NCT02346136|50174401|FG000|Overall Study|Withdrawal by Subject|7|||
25068683|NCT02346136|50174402|FG001|Overall Study|Withdrawal by Subject|5|||
25068684|NCT02346136|50174401|FG000|Overall Study|Death|1|||
25068685|NCT02346136|50174402|FG001|Overall Study|Death|0|||
25068686|NCT02346136|50174401|FG000|Overall Study|Study termination|14|||
25068687|NCT02346136|50174402|FG001|Overall Study|Study termination|18|||
25068688|NCT02793947|50174410|FG000|Overall Study|Death|1|||
25068689|NCT02793947|50174411|FG001|Overall Study|Death|0|||
25068690|NCT02793947|50174410|FG000|Overall Study|Physician Decision|1|||
25068691|NCT02793947|50174411|FG001|Overall Study|Physician Decision|5|||
25068692|NCT02345512|50174417|FG000|Overall Study|Adverse Event|1|||
25068693|NCT02345512|50174417|FG000|Overall Study|Withdrawal by Subject|1|||
25068694|NCT02345434|50174428|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
25068695|NCT02345434|50174429|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
25068696|NCT01370213|50174438|FG000|Overall Study|Early Death|1|||
25068697|NCT01370213|50174439|FG001|Overall Study|Early Death|0|||
25068698|NCT01370213|50174440|FG002|Overall Study|Early Death|0|||
25068699|NCT01370213|50174438|FG000|Overall Study|Not evaluable|0|||
25068700|NCT01370213|50174439|FG001|Overall Study|Not evaluable|2|||
25068701|NCT01370213|50174440|FG002|Overall Study|Not evaluable|0|||
25068702|NCT01370525|50174449|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
25068703|NCT01370525|50174450|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
25068704|NCT01370525|50174449|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
25068705|NCT01370525|50174450|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
25068706|NCT01370525|50174449|FG000|Overall Study|Adverse Event|0|||
25068707|NCT01370525|50174450|FG001|Overall Study|Adverse Event|1|||
25068708|NCT01370525|50174449|FG000|Overall Study|Protocol Violation|2|||
25068709|NCT01370525|50174450|FG001|Overall Study|Protocol Violation|1|||
25068710|NCT01370525|50174449|FG000|Overall Study|Lost to follow up|2|||
25068711|NCT01370525|50174450|FG001|Overall Study|Lost to follow up|6|||
25068712|NCT02792777|50174458|FG000|Overall Study|Withdrawal by Subject|2|||
25068713|NCT02792777|50174459|FG001|Overall Study|Withdrawal by Subject|0|||
25068714|NCT02792777|50174458|FG000|Overall Study|Recording malfunction|2|||
25068715|NCT02792777|50174459|FG001|Overall Study|Recording malfunction|0|||
25068716|NCT02792777|50174458|FG000|Overall Study|Later determined to be ineligible|2|||
25068717|NCT02792777|50174459|FG001|Overall Study|Later determined to be ineligible|0|||
25068718|NCT02792777|50174458|FG000|Overall Study|Participant interviewed twice|1|||
25068719|NCT02792777|50174459|FG001|Overall Study|Participant interviewed twice|0|||
25068720|NCT02625974|50174468|FG000|Overall Study|Adverse Event|12|||
25068721|NCT02625974|50174469|FG001|Overall Study|Adverse Event|2|||
25068722|NCT02625974|50174468|FG000|Overall Study|Withdrawal by Subject|3|||
25068723|NCT02625974|50174469|FG001|Overall Study|Withdrawal by Subject|1|||
25068724|NCT02625974|50174468|FG000|Overall Study|positive parasitemia|1|||
25068725|NCT02625974|50174469|FG001|Overall Study|positive parasitemia|0|||
25068726|NCT02625974|50174468|FG000|Overall Study|non-compliance with study drug|0|||
25068727|NCT02625974|50174469|FG001|Overall Study|non-compliance with study drug|2|||
25068728|NCT02625974|50174468|FG000|Overall Study|Protocol Violation|0|||
25068729|NCT02625974|50174469|FG001|Overall Study|Protocol Violation|1|||
25068730|NCT02792699|50174514|FG000|Overall Study|Adverse Event|1|||
25068731|NCT02792699|50174515|FG001|Overall Study|Adverse Event|2|||
25068732|NCT02792699|50174516|FG002|Overall Study|Adverse Event|4|||
25068733|NCT02792699|50174514|FG000|Overall Study|Withdrawal by Subject|4|||
25068734|NCT02792699|50174515|FG001|Overall Study|Withdrawal by Subject|4|||
25068735|NCT02792699|50174516|FG002|Overall Study|Withdrawal by Subject|3|||
25068736|NCT02792699|50174514|FG000|Overall Study|Lost to Follow-up|0|||
25068737|NCT02792699|50174515|FG001|Overall Study|Lost to Follow-up|1|||
25068738|NCT02792699|50174516|FG002|Overall Study|Lost to Follow-up|2|||
25068739|NCT02792699|50174514|FG000|Overall Study|Physician Decision|2|||
25068740|NCT02792699|50174515|FG001|Overall Study|Physician Decision|0|||
25068741|NCT02792699|50174516|FG002|Overall Study|Physician Decision|0|||
25068742|NCT02792699|50174514|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
25068743|NCT02792699|50174515|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
25068744|NCT02792699|50174516|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
25068745|NCT02792699|50174514|FG000|Overall Study|Other|1|||
25068746|NCT02792699|50174515|FG001|Overall Study|Other|0|||
25068747|NCT02792699|50174516|FG002|Overall Study|Other|0|||
25068748|NCT03010319|50174533|FG000|Overall Study|Adverse Event|15|||
25068749|NCT03010319|50174534|FG001|Overall Study|Adverse Event|9|||
25068750|NCT03010319|50174533|FG000|Overall Study|Withdrawal by Subject|1|||
25068751|NCT03010319|50174534|FG001|Overall Study|Withdrawal by Subject|6|||
25068752|NCT03010319|50174533|FG000|Overall Study|Physician Decision|2|||
25068753|NCT03010319|50174534|FG001|Overall Study|Physician Decision|4|||
25068754|NCT03010319|50174533|FG000|Overall Study|Sponsor requested withdrawal|2|||
25068755|NCT03010319|50174534|FG001|Overall Study|Sponsor requested withdrawal|2|||
25068756|NCT03010319|50174533|FG000|Overall Study|Death|1|||
25068757|NCT03010319|50174534|FG001|Overall Study|Death|0|||
25068758|NCT03010319|50174533|FG000|Overall Study|Lost to Follow-up|0|||
25068759|NCT03010319|50174534|FG001|Overall Study|Lost to Follow-up|1|||
25068760|NCT03010319|50174533|FG000|Overall Study|Other Reason|5|||
25068761|NCT03010319|50174534|FG001|Overall Study|Other Reason|7|||
25068762|NCT01369511|50174544|FG000|Overall Study|Adverse Event|1|||
25068763|NCT01369511|50174545|FG001|Overall Study|Adverse Event|1|||
25068764|NCT01369511|50174546|FG002|Overall Study|Adverse Event|5|||
25068765|NCT01369511|50174547|FG003|Overall Study|Adverse Event|0|||
25068766|NCT01369511|50174544|FG000|Overall Study|Entry criteria not met|2|||
25068767|NCT01369511|50174545|FG001|Overall Study|Entry criteria not met|0|||
25068768|NCT01369511|50174546|FG002|Overall Study|Entry criteria not met|0|||
25068769|NCT01369511|50174547|FG003|Overall Study|Entry criteria not met|1|||
25068770|NCT01369511|50174544|FG000|Overall Study|Lost to Follow-up|0|||
25068771|NCT01369511|50174545|FG001|Overall Study|Lost to Follow-up|1|||
25068772|NCT01369511|50174546|FG002|Overall Study|Lost to Follow-up|1|||
25068773|NCT01369511|50174547|FG003|Overall Study|Lost to Follow-up|2|||
25068774|NCT01369511|50174544|FG000|Overall Study|Protocol Violation|0|||
25068775|NCT01369511|50174545|FG001|Overall Study|Protocol Violation|1|||
25068776|NCT01369511|50174546|FG002|Overall Study|Protocol Violation|0|||
25068777|NCT01369511|50174547|FG003|Overall Study|Protocol Violation|2|||
25068778|NCT01369511|50174544|FG000|Overall Study|Physician Decision|3|||
25068779|NCT01369511|50174545|FG001|Overall Study|Physician Decision|4|||
25068780|NCT01369511|50174546|FG002|Overall Study|Physician Decision|0|||
25068781|NCT01369511|50174547|FG003|Overall Study|Physician Decision|0|||
25068782|NCT01369511|50174544|FG000|Overall Study|Sponsor decision|2|||
25068783|NCT01369511|50174545|FG001|Overall Study|Sponsor decision|0|||
25068784|NCT01369511|50174546|FG002|Overall Study|Sponsor decision|1|||
25068785|NCT01369511|50174547|FG003|Overall Study|Sponsor decision|0|||
25068786|NCT01369511|50174544|FG000|Overall Study|Withdrawal by Subject|5|||
25068787|NCT01369511|50174545|FG001|Overall Study|Withdrawal by Subject|6|||
25188571|NCT02082977|50342787|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
25188572|NCT02082977|50342788|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
25188573|NCT02082977|50342789|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
25188574|NCT02082977|50342790|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
25188575|NCT02082977|50342781|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
25188576|NCT02082977|50342782|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
25188577|NCT02082977|50342783|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
25188578|NCT02082977|50342784|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
25188579|NCT02082977|50342785|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
25188580|NCT02082977|50342786|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
25188581|NCT02082977|50342787|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
25188582|NCT02082977|50342788|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
25188583|NCT02082977|50342789|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
25188584|NCT02082977|50342790|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
25188585|NCT01624259|50342824|FG000|Overall Study|Adverse Event|18|||
25188586|NCT01624259|50342825|FG001|Overall Study|Adverse Event|18|||
25188587|NCT01624259|50342824|FG000|Overall Study|Protocol Violation|1|||
25188588|NCT01624259|50342825|FG001|Overall Study|Protocol Violation|2|||
25188589|NCT01624259|50342824|FG000|Overall Study|Withdrawal by Subject|5|||
25188590|NCT01624259|50342825|FG001|Overall Study|Withdrawal by Subject|7|||
25188591|NCT01624259|50342824|FG000|Overall Study|Physician Decision|1|||
25188592|NCT01624259|50342825|FG001|Overall Study|Physician Decision|1|||
25188593|NCT01624259|50342824|FG000|Overall Study|Lost to Follow-up|2|||
25188594|NCT01624259|50342825|FG001|Overall Study|Lost to Follow-up|3|||
25188595|NCT01624259|50342824|FG000|Overall Study|Abnormal laboratory measure|3|||
25188596|NCT01624259|50342825|FG001|Overall Study|Abnormal laboratory measure|0|||
25188597|NCT02081417|50342835|FG000|Overall Study|Lost to Follow-up|26|||
25188598|NCT02081417|50342836|FG001|Overall Study|Lost to Follow-up|23|||
25188599|NCT02081417|50342835|FG000|Overall Study|Moved Away|1|||
25188600|NCT02081417|50342836|FG001|Overall Study|Moved Away|2|||
25188601|NCT02081417|50342835|FG000|Overall Study|Incarcerated|2|||
25188602|NCT02081417|50342836|FG001|Overall Study|Incarcerated|2|||
25188603|NCT02081417|50342835|FG000|Overall Study|Death|4|||
25068788|NCT01369511|50174546|FG002|Overall Study|Withdrawal by Subject|4|||
25188604|NCT02081417|50342836|FG001|Overall Study|Death|3|||
25188605|NCT02081417|50342835|FG000|Overall Study|Withdrawal by Subject|4|||
25188606|NCT02081417|50342836|FG001|Overall Study|Withdrawal by Subject|0|||
25188607|NCT02081417|50342835|FG000|Overall Study|Admitted to Residential Treatment|2|||
25188608|NCT02081417|50342836|FG001|Overall Study|Admitted to Residential Treatment|0|||
25068789|NCT01369511|50174547|FG003|Overall Study|Withdrawal by Subject|6|||
25068790|NCT01369433|50174559|FG000|Overall Study|Adverse Event|31|||
25188609|NCT02081417|50342835|FG000|Overall Study|Did not start treatment|17|||
25068791|NCT01369433|50174560|FG001|Overall Study|Adverse Event|1|||
25068792|NCT01369433|50174559|FG000|Overall Study|Required significant surgical procedure|1|||
25068793|NCT01369433|50174560|FG001|Overall Study|Required significant surgical procedure|0|||
25068794|NCT01369433|50174559|FG000|Overall Study|Non-compliance|1|||
25068795|NCT01369433|50174560|FG001|Overall Study|Non-compliance|0|||
25068796|NCT01369433|50174559|FG000|Overall Study|Withdrawal by Subject|5|||
25068797|NCT01369433|50174560|FG001|Overall Study|Withdrawal by Subject|2|||
25068798|NCT01369433|50174559|FG000|Overall Study|Study terminated by Sponsor|67|||
25068799|NCT01369433|50174560|FG001|Overall Study|Study terminated by Sponsor|0|||
25168745|NCT00631137|50298336|FG000|Overall Study|Withdrawal by Subject|1|||
25168746|NCT00631137|50298337|FG001|Overall Study|Withdrawal by Subject|0|||
25168747|NCT03086343|50298345|FG000|Overall Study|Adverse Event|7|||
25168748|NCT03086343|50298346|FG001|Overall Study|Adverse Event|7|||
25168749|NCT03086343|50298345|FG000|Overall Study|Withdrawal by Subject|10|||
25168750|NCT03086343|50298346|FG001|Overall Study|Withdrawal by Subject|6|||
25168751|NCT03086343|50298345|FG000|Overall Study|Lost to Follow-up|3|||
25168752|NCT03086343|50298346|FG001|Overall Study|Lost to Follow-up|1|||
25168753|NCT03086343|50298345|FG000|Overall Study|Lack of Efficacy|4|||
25168754|NCT03086343|50298346|FG001|Overall Study|Lack of Efficacy|6|||
25168755|NCT03086343|50298345|FG000|Overall Study|Other, not specified|8|||
25168756|NCT03086343|50298346|FG001|Overall Study|Other, not specified|4|||
25168757|NCT03086343|50298345|FG000|Overall Study|Missing|0|||
25168758|NCT03086343|50298346|FG001|Overall Study|Missing|1|||
25188610|NCT02081417|50342836|FG001|Overall Study|Did not start treatment|21|||
25188611|NCT02081183|50342844|FG000|Overall Study|Lost to Follow-up|0|||
25168759|NCT00630825|50298365|FG000|Overall Study|Adverse Event|4|||
25168760|NCT00630825|50298366|FG001|Overall Study|Adverse Event|4|||
25168761|NCT00630825|50298367|FG002|Overall Study|Adverse Event|3|||
25168762|NCT00630825|50298368|FG003|Overall Study|Adverse Event|1|||
25168763|NCT00630825|50298365|FG000|Overall Study|Entry Criteria Not Met|1|||
25168764|NCT00630825|50298366|FG001|Overall Study|Entry Criteria Not Met|0|||
25168765|NCT00630825|50298367|FG002|Overall Study|Entry Criteria Not Met|2|||
25168766|NCT00630825|50298368|FG003|Overall Study|Entry Criteria Not Met|1|||
25168767|NCT00630825|50298365|FG000|Overall Study|Lost to Follow-up|1|||
25168768|NCT00630825|50298366|FG001|Overall Study|Lost to Follow-up|1|||
25168769|NCT00630825|50298367|FG002|Overall Study|Lost to Follow-up|1|||
25168770|NCT00630825|50298368|FG003|Overall Study|Lost to Follow-up|1|||
25168771|NCT00630825|50298365|FG000|Overall Study|Physician Decision|1|||
25168772|NCT00630825|50298366|FG001|Overall Study|Physician Decision|0|||
25168773|NCT00630825|50298367|FG002|Overall Study|Physician Decision|0|||
25168774|NCT00630825|50298368|FG003|Overall Study|Physician Decision|0|||
24967295|NCT00257166|50056859|FG001|Overall Study|Randomized, but not treated|0|||
24967296|NCT00227370|50056867|FG000|Overall Study|Withdrawal by Subject|1|||
24967297|NCT00227370|50056868|FG001|Overall Study|Withdrawal by Subject|2|||
24967298|NCT00227370|50056867|FG000|Overall Study|Death|3|||
24967299|NCT00227370|50056868|FG001|Overall Study|Death|4|||
24967300|NCT00227370|50056867|FG000|Overall Study|Adverse Event|6|||
24967301|NCT00227370|50056868|FG001|Overall Study|Adverse Event|11|||
24967302|NCT00227370|50056867|FG000|Overall Study|Physician Decision|9|||
24967303|NCT00227370|50056868|FG001|Overall Study|Physician Decision|6|||
24967304|NCT00227370|50056867|FG000|Overall Study|Other reasons|2|||
24967305|NCT00227370|50056868|FG001|Overall Study|Other reasons|1|||
24967306|NCT00191100|50056876|FG000|Overall Study|Adverse Event|18|||
24967307|NCT00191100|50056877|FG001|Overall Study|Adverse Event|1|||
25168775|NCT00630825|50298365|FG000|Overall Study|Withdrawal by Subject|2|||
25168776|NCT00630825|50298366|FG001|Overall Study|Withdrawal by Subject|2|||
25168777|NCT00630825|50298367|FG002|Overall Study|Withdrawal by Subject|2|||
24967308|NCT00191100|50056876|FG000|Overall Study|Lost to Follow-up|2|||
25168778|NCT00630825|50298368|FG003|Overall Study|Withdrawal by Subject|3|||
24967309|NCT00191100|50056877|FG001|Overall Study|Lost to Follow-up|0|||
24967310|NCT00191100|50056876|FG000|Overall Study|Patient Moved|0|||
24967311|NCT00191100|50056877|FG001|Overall Study|Patient Moved|1|||
24967312|NCT00191100|50056876|FG000|Overall Study|Withdrawal by Subject|9|||
24967313|NCT00191100|50056877|FG001|Overall Study|Withdrawal by Subject|3|||
24967314|NCT00191100|50056876|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
24967315|NCT00191100|50056877|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
24967316|NCT00191100|50056876|FG000|Overall Study|Clinical Relapse|2|||
24967317|NCT00191100|50056877|FG001|Overall Study|Clinical Relapse|1|||
24967318|NCT00191100|50056876|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
24967319|NCT00191100|50056877|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
24967320|NCT00191100|50056876|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
24967321|NCT00191100|50056877|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
24967322|NCT00191100|50056876|FG000|Overall Study|Physician Decision|3|||
24967323|NCT00191100|50056877|FG001|Overall Study|Physician Decision|1|||
24967324|NCT00191100|50056876|FG000|Overall Study|Death from Study Drug Toxicity|2|||
24967325|NCT00191100|50056877|FG001|Overall Study|Death from Study Drug Toxicity|0|||
24967326|NCT00191100|50056876|FG000|Overall Study|Protocol Violation|1|||
24967327|NCT00191100|50056877|FG001|Overall Study|Protocol Violation|1|||
24967328|NCT00191100|50056876|FG000|Overall Study|Death from Other Cause|1|||
24967329|NCT00191100|50056877|FG001|Overall Study|Death from Other Cause|0|||
24967330|NCT00191100|50056876|FG000|Overall Study|Reason Not Specified|0|||
24967331|NCT00191100|50056877|FG001|Overall Study|Reason Not Specified|1|||
24967332|NCT00189540|50056885|FG000|Overall Study|Withdrawal by Subject|3|||
24967333|NCT00189540|50056886|FG001|Overall Study|Withdrawal by Subject|0|||
24967334|NCT00189540|50056885|FG000|Overall Study|Death|4|||
24967335|NCT00189540|50056886|FG001|Overall Study|Death|1|||
24967336|NCT00257010|50056892|FG000|Overall Study|Lack of Efficacy|11|||
24967337|NCT00257010|50056892|FG000|Overall Study|Lost to Follow-up|53|||
24967338|NCT00257010|50056892|FG000|Overall Study|Withdrawal by Subject|34|||
24967339|NCT00257010|50056892|FG000|Overall Study|Adverse Event|10|||
24967340|NCT00257010|50056892|FG000|Overall Study|various|11|||
24967341|NCT00257010|50056892|FG000|Overall Study|no headache reported|9|||
24967342|NCT00256854|50056902|FG000|Overall Study|Withdrawal by Subject|2|||
24967343|NCT00256854|50056903|FG001|Overall Study|Withdrawal by Subject|3|||
24967344|NCT00256854|50056904|FG002|Overall Study|Withdrawal by Subject|0|||
24967345|NCT00256854|50056905|FG003|Overall Study|Withdrawal by Subject|0|||
24967346|NCT00256854|50056906|FG004|Overall Study|Withdrawal by Subject|0|||
24967347|NCT00256854|50056907|FG005|Overall Study|Withdrawal by Subject|0|||
24967348|NCT00256854|50056902|FG000|Overall Study|Lack of Efficacy|1|||
24967349|NCT00256854|50056903|FG001|Overall Study|Lack of Efficacy|0|||
24967350|NCT00256854|50056904|FG002|Overall Study|Lack of Efficacy|0|||
24967351|NCT00256854|50056905|FG003|Overall Study|Lack of Efficacy|0|||
24967352|NCT00256854|50056906|FG004|Overall Study|Lack of Efficacy|0|||
24967353|NCT00256854|50056907|FG005|Overall Study|Lack of Efficacy|0|||
24967354|NCT00256854|50056902|FG000|Overall Study|Protocol Violation|0|||
24967355|NCT00256854|50056903|FG001|Overall Study|Protocol Violation|1|||
24967356|NCT00256854|50056904|FG002|Overall Study|Protocol Violation|1|||
24967357|NCT00256854|50056905|FG003|Overall Study|Protocol Violation|1|||
24967358|NCT00256854|50056906|FG004|Overall Study|Protocol Violation|0|||
24967359|NCT00256854|50056907|FG005|Overall Study|Protocol Violation|0|||
24967360|NCT00256854|50056902|FG000|Overall Study|Adverse Event|0|||
24967361|NCT00256854|50056903|FG001|Overall Study|Adverse Event|0|||
24967362|NCT00256854|50056904|FG002|Overall Study|Adverse Event|2|||
24967363|NCT00256854|50056905|FG003|Overall Study|Adverse Event|2|||
24967364|NCT00256854|50056906|FG004|Overall Study|Adverse Event|0|||
24967365|NCT00256854|50056907|FG005|Overall Study|Adverse Event|1|||
24967366|NCT00256854|50056902|FG000|Overall Study|Not compliant with the study drug|0|||
24967367|NCT00256854|50056903|FG001|Overall Study|Not compliant with the study drug|0|||
24967368|NCT00256854|50056904|FG002|Overall Study|Not compliant with the study drug|0|||
24967369|NCT00256854|50056905|FG003|Overall Study|Not compliant with the study drug|0|||
24967370|NCT00256854|50056906|FG004|Overall Study|Not compliant with the study drug|1|||
24967371|NCT00256854|50056907|FG005|Overall Study|Not compliant with the study drug|0|||
24967372|NCT00189462|50056924|FG000|Overall Study|Lack of Efficacy|5|||
24967373|NCT00189462|50056925|FG001|Overall Study|Lack of Efficacy|1|||
24967374|NCT00189462|50056924|FG000|Overall Study|Lost to Follow-up|18|||
25168779|NCT04075734|50298674|FG000|Overall Study|Lost to Follow-up|1|||
24967375|NCT00189462|50056925|FG001|Overall Study|Lost to Follow-up|20|||
24967376|NCT00256698|50056933|FG000|Overall Study|Withdrawal by Subject|7|||
25168780|NCT04075734|50298675|FG001|Overall Study|Lost to Follow-up|1|||
24967377|NCT00256698|50056934|FG001|Overall Study|Withdrawal by Subject|7|||
24967378|NCT00256698|50056933|FG000|Overall Study|Adverse Event|13|||
24967379|NCT00256698|50056934|FG001|Overall Study|Adverse Event|6|||
24967380|NCT00256698|50056933|FG000|Overall Study|Protocol Violation|6|||
24967381|NCT00256698|50056934|FG001|Overall Study|Protocol Violation|5|||
24967382|NCT00256698|50056933|FG000|Overall Study|Lost to Follow-up|1|||
24967383|NCT00256698|50056934|FG001|Overall Study|Lost to Follow-up|3|||
24967384|NCT00256698|50056933|FG000|Overall Study|disease progression|97|||
25068800|NCT01369433|50174559|FG000|Overall Study|Lost to Follow-up|1|||
24967385|NCT00256698|50056934|FG001|Overall Study|disease progression|105|||
24967386|NCT00256698|50056933|FG000|Overall Study|still ongoing at data cut-off|41|||
24967387|NCT00256698|50056934|FG001|Overall Study|still ongoing at data cut-off|46|||
24967388|NCT00256698|50056933|FG000|Overall Study|withdrawn due to osteoporosis|1|||
24967389|NCT00256698|50056934|FG001|Overall Study|withdrawn due to osteoporosis|0|||
24967390|NCT00256698|50056933|FG000|Overall Study|Prematurely Discontinued|1|||
24967391|NCT00256698|50056934|FG001|Overall Study|Prematurely Discontinued|0|||
24967392|NCT00189306|50056940|FG000|Treatment Period|Withdrawal by Subject|2|||
24967393|NCT00189306|50056940|FG000|Treatment Period|Adverse Event|2|||
24967394|NCT00189306|50056940|FG000|Treatment Period|Protocol Violation|1|||
24967395|NCT00189306|50056940|FG000|Posttreatment Period|Death|1|||
25068801|NCT01369433|50174560|FG001|Overall Study|Lost to Follow-up|0|||
25068802|NCT01369433|50174559|FG000|Overall Study|Death|5|||
25068803|NCT01369433|50174560|FG001|Overall Study|Death|0|||
25068804|NCT01369433|50174559|FG000|Overall Study|Investigator discretion|6|||
25068805|NCT01369433|50174560|FG001|Overall Study|Investigator discretion|1|||
25068806|NCT01369433|50174559|FG000|Overall Study|Progressive Disease|92|||
25068807|NCT01369433|50174560|FG001|Overall Study|Progressive Disease|12|||
25068808|NCT02624492|50174569|FG000|Overall Study|Adverse Event|2|||
25068809|NCT02624492|50174570|FG001|Overall Study|Adverse Event|2|||
25068810|NCT02624492|50174571|FG002|Overall Study|Adverse Event|2|||
25188612|NCT02081183|50342845|FG001|Overall Study|Lost to Follow-up|1|||
25188613|NCT02081183|50342844|FG000|Overall Study|Protocol Violation|1|||
25188614|NCT02081183|50342845|FG001|Overall Study|Protocol Violation|0|||
25188615|NCT02081183|50342844|FG000|Overall Study|Other|3|||
25188616|NCT02081183|50342845|FG001|Overall Study|Other|3|||
25188617|NCT02080871|50342851|FG000|Overall Study|Death|1|||
25188618|NCT02080871|50342851|FG000|Overall Study|Lost to Follow-up|1|||
25188619|NCT02080481|50342857|FG000|Overall Study|Never received a block.|1|||
25188620|NCT02080481|50342858|FG001|Overall Study|Never received a block.|0|||
25188621|NCT02080403|50342866|FG000|Overall Study|Adverse Event|5|||
25188622|NCT02080403|50342867|FG001|Overall Study|Adverse Event|1|||
25188623|NCT02080403|50342866|FG000|Overall Study|Death|0|||
25188624|NCT02080403|50342867|FG001|Overall Study|Death|2|||
25188625|NCT02080403|50342866|FG000|Overall Study|Lost to Follow-up|2|||
25188626|NCT02080403|50342867|FG001|Overall Study|Lost to Follow-up|0|||
25188627|NCT02080403|50342866|FG000|Overall Study|Pregnancy|0|||
25188628|NCT02080403|50342867|FG001|Overall Study|Pregnancy|1|||
25188629|NCT02080403|50342866|FG000|Overall Study|Protocol Violation|3|||
25188630|NCT02080403|50342867|FG001|Overall Study|Protocol Violation|7|||
25188631|NCT02080403|50342866|FG000|Overall Study|Withdrawal by Subject|5|||
25188632|NCT02080403|50342867|FG001|Overall Study|Withdrawal by Subject|1|||
25277240|NCT01198002|50591270|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
25277241|NCT01198002|50591271|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
24967396|NCT00189306|50056940|FG000|Posttreatment Period|Withdrawal by Subject|2|||
24967397|NCT00189306|50056940|FG000|Posttreatment Period|Noncompliance|1|||
24967398|NCT00189306|50056940|FG000|Posttreatment Period|Target lesion excised|1|||
25068811|NCT02624492|50174569|FG000|Overall Study|Progressive disease|0|||
25068812|NCT02624492|50174570|FG001|Overall Study|Progressive disease|2|||
25188633|NCT02080091|50342873|FG000|Overall Study|Study Terminated|22|||
25188634|NCT02080091|50342873|FG000|Overall Study|Death|1|||
25188635|NCT02080091|50342873|FG000|Overall Study|Withdrawal by Subject|1|||
25277242|NCT01198002|50591272|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
25277243|NCT01198002|50591270|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
25277244|NCT01198002|50591271|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
25188636|NCT02080091|50342873|FG000|Overall Study|Other|1|||
25277245|NCT01198002|50591272|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
25188637|NCT02079077|50342879|FG000|Overall Study|Lost to Follow-up|5|||
25188638|NCT02079077|50342880|FG001|Overall Study|Lost to Follow-up|7|||
25188639|NCT02079077|50342879|FG000|Overall Study|Became STIs Positive|1|||
24967399|NCT00189306|50056940|FG000|Posttreatment Period|Protocol Violation|1|||
24967400|NCT00189306|50056940|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
24967401|NCT00189306|50056940|FG000|Posttreatment Period|Local skin reaction/sign|1|||
24967402|NCT00189306|50056940|FG000|Long-Term Follow-up|Adverse Event|2|||
24967403|NCT00189306|50056940|FG000|Long-Term Follow-up|Death|4|||
24967404|NCT00189306|50056940|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
24967405|NCT00189306|50056940|FG000|Long-Term Follow-up|Intercurrent disease|2|||
24967406|NCT00189306|50056940|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
24967407|NCT00189306|50056940|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
24967408|NCT00187278|50056946|FG000|Overall Study|Protocol Violation|10|||
24967409|NCT00187278|50056947|FG001|Overall Study|Protocol Violation|13|||
24967410|NCT00256308|50056955|FG000|Overall Study|Death|2|||
24967411|NCT00255840|50056961|FG000|Overall Study|Lost to Follow-up|10|||
24967412|NCT00255840|50056962|FG001|Overall Study|Lost to Follow-up|14|||
24967413|NCT00255840|50056961|FG000|Overall Study|Discontinued intervention|53|||
24967414|NCT00255840|50056962|FG001|Overall Study|Discontinued intervention|56|||
24967415|NCT00224874|50056972|FG000|Overall Study|Withdrawal by Subject|0|||
24967416|NCT00224874|50056973|FG001|Overall Study|Withdrawal by Subject|0|||
24967417|NCT00224874|50056974|FG002|Overall Study|Withdrawal by Subject|1|||
24967418|NCT00224874|50056975|FG003|Overall Study|Withdrawal by Subject|0|||
24967419|NCT00186186|50056985|FG000|Overall Study|Lack of Efficacy|3|||
24967420|NCT00186186|50056985|FG000|Overall Study|Withdrawal by Subject|3|||
24967421|NCT00186186|50056985|FG000|Overall Study|Not reported as to reason|2|||
24967422|NCT00185640|50056990|FG000|Overall Study|Not Eligible|4|||
24967423|NCT00185640|50056990|FG000|Overall Study|Withdrawal by Subject|3|||
24967424|NCT00185640|50056990|FG000|Overall Study|Death|138|||
24967425|NCT03760666|50056997|FG000|Overall Study|Adverse Event|2|||
24967426|NCT03760666|50056998|FG001|Overall Study|Adverse Event|4|||
24967427|NCT03760666|50056999|FG002|Overall Study|Adverse Event|1|||
24967428|NCT03760666|50056997|FG000|Overall Study|AML Disease Progression|3|||
25188640|NCT02079077|50342880|FG001|Overall Study|Became STIs Positive|2|||
25188641|NCT02078219|50342908|FG000|Overall Study|Other|2|||
25188642|NCT02078219|50342909|FG001|Overall Study|Other|2|||
25188643|NCT02078219|50342910|FG002|Overall Study|Other|3|||
25188644|NCT02078219|50342911|FG003|Overall Study|Other|0|||
25188645|NCT02078219|50342912|FG004|Overall Study|Other|1|||
25188646|NCT02078219|50342908|FG000|Overall Study|Withdrawal by Subject|0|||
25188647|NCT02078219|50342909|FG001|Overall Study|Withdrawal by Subject|1|||
25188648|NCT02078219|50342910|FG002|Overall Study|Withdrawal by Subject|0|||
25188649|NCT02078219|50342911|FG003|Overall Study|Withdrawal by Subject|1|||
25188650|NCT02078219|50342912|FG004|Overall Study|Withdrawal by Subject|1|||
25188651|NCT02078219|50342908|FG000|Overall Study|Protocol Violation|0|||
25188652|NCT02078219|50342909|FG001|Overall Study|Protocol Violation|0|||
25188653|NCT02078219|50342910|FG002|Overall Study|Protocol Violation|0|||
25188654|NCT02078219|50342911|FG003|Overall Study|Protocol Violation|1|||
25188655|NCT02078219|50342912|FG004|Overall Study|Protocol Violation|0|||
25188656|NCT02078219|50342908|FG000|Overall Study|Death|0|||
25188657|NCT02078219|50342909|FG001|Overall Study|Death|0|||
25188658|NCT02078219|50342910|FG002|Overall Study|Death|0|||
25188659|NCT02078219|50342911|FG003|Overall Study|Death|1|||
25188660|NCT02078219|50342912|FG004|Overall Study|Death|0|||
25188661|NCT02078219|50342908|FG000|Overall Study|Adverse Event|1|||
25188662|NCT02078219|50342909|FG001|Overall Study|Adverse Event|1|||
25188663|NCT02078219|50342910|FG002|Overall Study|Adverse Event|3|||
25188664|NCT02078219|50342911|FG003|Overall Study|Adverse Event|1|||
24967429|NCT03760666|50056998|FG001|Overall Study|AML Disease Progression|3|||
25188665|NCT02078219|50342912|FG004|Overall Study|Adverse Event|0|||
24967430|NCT03760666|50056999|FG002|Overall Study|AML Disease Progression|0|||
24967431|NCT03760666|50056997|FG000|Overall Study|Physician Decision|0|||
24967432|NCT03760666|50056998|FG001|Overall Study|Physician Decision|3|||
24967433|NCT03760666|50056999|FG002|Overall Study|Physician Decision|0|||
24967434|NCT03760666|50056997|FG000|Overall Study|Withdrawal by Subject|0|||
25188666|NCT02076113|50342926|FG000|Overall Study|Lost to Follow-up|4|||
25188667|NCT02076113|50342927|FG001|Overall Study|Lost to Follow-up|1|||
25188668|NCT02076113|50342926|FG000|Overall Study|Withdrawal by Subject|2|||
25188669|NCT02076113|50342927|FG001|Overall Study|Withdrawal by Subject|3|||
24967435|NCT03760666|50056998|FG001|Overall Study|Withdrawal by Subject|1|||
24967436|NCT03760666|50056999|FG002|Overall Study|Withdrawal by Subject|0|||
24967437|NCT03760510|50057012|FG000|Overall Study|Not ventilated for 24 hours|105|||
24967438|NCT03760510|50057013|FG001|Overall Study|Not ventilated for 24 hours|97|||
24967439|NCT00224484|50057022|FG000|Overall Study|Serious Adverse Event|1|||
24967440|NCT00224484|50057023|FG001|Overall Study|Serious Adverse Event|1|||
24967441|NCT00224484|50057024|FG002|Overall Study|Serious Adverse Event|0|||
24967442|NCT00224484|50057022|FG000|Overall Study|Non-Serious Adverse Event|5|||
24967443|NCT00224484|50057023|FG001|Overall Study|Non-Serious Adverse Event|7|||
24967444|NCT00224484|50057024|FG002|Overall Study|Non-Serious Adverse Event|3|||
24967445|NCT00224484|50057022|FG000|Overall Study|Protocol Violation|2|||
24967446|NCT00224484|50057023|FG001|Overall Study|Protocol Violation|2|||
24967447|NCT00224484|50057024|FG002|Overall Study|Protocol Violation|0|||
24967448|NCT00224484|50057022|FG000|Overall Study|Withdrawal by Subject|49|||
24967449|NCT00224484|50057023|FG001|Overall Study|Withdrawal by Subject|18|||
24967450|NCT00224484|50057024|FG002|Overall Study|Withdrawal by Subject|16|||
24967451|NCT00224484|50057022|FG000|Overall Study|Migrated/moved from study area|18|||
24967452|NCT00224484|50057023|FG001|Overall Study|Migrated/moved from study area|5|||
24967453|NCT00224484|50057024|FG002|Overall Study|Migrated/moved from study area|5|||
24967454|NCT00224484|50057022|FG000|Overall Study|Lost to Follow-up|66|||
24967455|NCT00224484|50057023|FG001|Overall Study|Lost to Follow-up|28|||
24967456|NCT00224484|50057024|FG002|Overall Study|Lost to Follow-up|36|||
24967457|NCT00224484|50057022|FG000|Overall Study|Reason not specified|5|||
24967458|NCT00224484|50057023|FG001|Overall Study|Reason not specified|4|||
24967459|NCT00224484|50057024|FG002|Overall Study|Reason not specified|2|||
24967460|NCT00254982|50057037|FG000|Overall Study|Other|2|||
24967461|NCT00254982|50057038|FG001|Overall Study|Other|1|||
24967462|NCT00254982|50057037|FG000|Overall Study|Lack of Efficacy|5|||
24967463|NCT00254982|50057038|FG001|Overall Study|Lack of Efficacy|3|||
24967464|NCT00254982|50057037|FG000|Overall Study|Lost to Follow-up|5|||
24967465|NCT00254982|50057038|FG001|Overall Study|Lost to Follow-up|3|||
24967466|NCT00254982|50057037|FG000|Overall Study|Adverse Event|18|||
24967467|NCT00254982|50057038|FG001|Overall Study|Adverse Event|16|||
24967468|NCT00254982|50057037|FG000|Overall Study|Withdrawal by Subject|1|||
24967469|NCT00254982|50057038|FG001|Overall Study|Withdrawal by Subject|1|||
24967470|NCT00254982|50057037|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
24967471|NCT00254982|50057038|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
24967472|NCT00254982|50057037|FG000|Overall Study|Protocol deviation|1|||
24967473|NCT00254982|50057038|FG001|Overall Study|Protocol deviation|1|||
24967474|NCT00254982|50057037|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
24967475|NCT00254982|50057038|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
24967476|NCT00254982|50057037|FG000|Overall Study|Malignancy|0|||
24967477|NCT00254982|50057038|FG001|Overall Study|Malignancy|2|||
24967478|NCT00254982|50057037|FG000|Overall Study|Opportunistic infection|1|||
24967479|NCT00254982|50057038|FG001|Overall Study|Opportunistic infection|0|||
24967480|NCT00254982|50057037|FG000|Overall Study|Abnormal liver function tests|2|||
24967481|NCT00254982|50057038|FG001|Overall Study|Abnormal liver function tests|1|||
24967482|NCT03759340|50057044|FG000|Overall Study|Adverse Event|2|||
24967483|NCT03759340|50057044|FG000|Overall Study|Lost to Follow-up|1|||
24967484|NCT03759340|50057044|FG000|Overall Study|Withdrawal by Subject|15|||
24967485|NCT03759340|50057044|FG000|Overall Study|Study Terminated by Sponsor|38|||
24967486|NCT00224016|50057050|FG000|Titration Period|Withdrawal by Subject|0|||
24967487|NCT00224016|50057051|FG001|Titration Period|Withdrawal by Subject|1|||
24967488|NCT00224016|50057050|FG000|Titration Period|Lost to Follow-up|1|||
24967489|NCT00224016|50057051|FG001|Titration Period|Lost to Follow-up|0|||
24967490|NCT00224016|50057050|FG000|Maintenance Period|Withdrawal by Subject|2|||
24967491|NCT00224016|50057051|FG001|Maintenance Period|Withdrawal by Subject|0|||
24967492|NCT00224016|50057050|FG000|Maintenance Period|Lost to Follow-up|0|||
25068813|NCT02624492|50174571|FG002|Overall Study|Progressive disease|3|||
25068814|NCT01975831|50174588|FG000|Overall Study|Adverse Event|1|||
25068815|NCT01975831|50174589|FG001|Overall Study|Adverse Event|2|||
25068816|NCT01975831|50174590|FG002|Overall Study|Adverse Event|2|||
25068817|NCT01975831|50174591|FG003|Overall Study|Adverse Event|0|||
25068818|NCT01975831|50174592|FG004|Overall Study|Adverse Event|1|||
25068819|NCT01975831|50174593|FG005|Overall Study|Adverse Event|1|||
25068820|NCT01975831|50174594|FG006|Overall Study|Adverse Event|3|||
25068821|NCT01975831|50174595|FG007|Overall Study|Adverse Event|4|||
25068822|NCT01975831|50174596|FG008|Overall Study|Adverse Event|1|||
25068823|NCT01975831|50174588|FG000|Overall Study|Death|1|||
25068824|NCT01975831|50174589|FG001|Overall Study|Death|1|||
25068825|NCT01975831|50174590|FG002|Overall Study|Death|0|||
25068826|NCT01975831|50174591|FG003|Overall Study|Death|0|||
25068827|NCT01975831|50174592|FG004|Overall Study|Death|1|||
25068828|NCT01975831|50174593|FG005|Overall Study|Death|0|||
25068829|NCT01975831|50174594|FG006|Overall Study|Death|1|||
25068830|NCT01975831|50174595|FG007|Overall Study|Death|0|||
25068831|NCT01975831|50174596|FG008|Overall Study|Death|0|||
25068832|NCT01975831|50174588|FG000|Overall Study|Progressive Disease|1|||
25068833|NCT01975831|50174589|FG001|Overall Study|Progressive Disease|3|||
25068834|NCT01975831|50174590|FG002|Overall Study|Progressive Disease|2|||
25068835|NCT01975831|50174591|FG003|Overall Study|Progressive Disease|4|||
25068836|NCT01975831|50174592|FG004|Overall Study|Progressive Disease|13|||
25068837|NCT01975831|50174593|FG005|Overall Study|Progressive Disease|9|||
25068838|NCT01975831|50174594|FG006|Overall Study|Progressive Disease|10|||
25068839|NCT01975831|50174595|FG007|Overall Study|Progressive Disease|8|||
25068840|NCT01975831|50174596|FG008|Overall Study|Progressive Disease|10|||
25068841|NCT01975831|50174588|FG000|Overall Study|Withdrawal by Subject|0|||
25068842|NCT01975831|50174589|FG001|Overall Study|Withdrawal by Subject|3|||
25068843|NCT01975831|50174590|FG002|Overall Study|Withdrawal by Subject|0|||
25068844|NCT01975831|50174591|FG003|Overall Study|Withdrawal by Subject|0|||
25068845|NCT01975831|50174592|FG004|Overall Study|Withdrawal by Subject|3|||
25068846|NCT01975831|50174593|FG005|Overall Study|Withdrawal by Subject|1|||
25068847|NCT01975831|50174594|FG006|Overall Study|Withdrawal by Subject|1|||
25068848|NCT01975831|50174595|FG007|Overall Study|Withdrawal by Subject|0|||
25068849|NCT01975831|50174596|FG008|Overall Study|Withdrawal by Subject|0|||
25068850|NCT01975831|50174588|FG000|Overall Study|Physician Decision|0|||
25068851|NCT01975831|50174589|FG001|Overall Study|Physician Decision|0|||
25068852|NCT01975831|50174590|FG002|Overall Study|Physician Decision|0|||
25068853|NCT01975831|50174591|FG003|Overall Study|Physician Decision|0|||
25068854|NCT01975831|50174592|FG004|Overall Study|Physician Decision|0|||
25068855|NCT01975831|50174593|FG005|Overall Study|Physician Decision|1|||
25068856|NCT01975831|50174594|FG006|Overall Study|Physician Decision|0|||
25068857|NCT01975831|50174595|FG007|Overall Study|Physician Decision|1|||
25068858|NCT01975831|50174596|FG008|Overall Study|Physician Decision|0|||
25068859|NCT01975831|50174588|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
25168781|NCT04075734|50298676|FG002|Overall Study|Lost to Follow-up|0|||
25068860|NCT01975831|50174589|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
25068861|NCT01975831|50174590|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
25068862|NCT01975831|50174591|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
25068863|NCT01975831|50174592|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
25068864|NCT01975831|50174593|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
25168782|NCT04075734|50298674|FG000|Overall Study|Withdrawal by Subject|3|||
25168783|NCT04075734|50298675|FG001|Overall Study|Withdrawal by Subject|0|||
25168784|NCT04075734|50298676|FG002|Overall Study|Withdrawal by Subject|0|||
25168785|NCT00989781|50298721|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
25168786|NCT00989781|50298722|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
25068865|NCT01975831|50174594|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
25068866|NCT01975831|50174595|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
25068867|NCT01975831|50174596|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
25068868|NCT01975831|50174588|FG000|Overall Study|Entered Hospice|0|||
24967493|NCT00224016|50057051|FG001|Maintenance Period|Lost to Follow-up|1|||
24967494|NCT03757234|50057062|FG000|Overall Study|Adverse Event|0|||
24967495|NCT03757234|50057063|FG001|Overall Study|Adverse Event|0|||
24967496|NCT03757234|50057064|FG002|Overall Study|Adverse Event|0|||
24967497|NCT03757234|50057065|FG003|Overall Study|Adverse Event|0|||
24967498|NCT03757234|50057066|FG004|Overall Study|Adverse Event|1|||
24967499|NCT03757234|50057062|FG000|Overall Study|Lost to Follow-up|1|||
24967500|NCT03757234|50057063|FG001|Overall Study|Lost to Follow-up|0|||
24967501|NCT03757234|50057064|FG002|Overall Study|Lost to Follow-up|0|||
25188670|NCT02076113|50342926|FG000|Overall Study|Death|1|||
25188671|NCT02076113|50342927|FG001|Overall Study|Death|3|||
25188672|NCT02075255|50342939|FG000|Overall Study|Study specific withdrawal criteria|0|||
25188673|NCT02075255|50342940|FG001|Overall Study|Study specific withdrawal criteria|1|||
25188674|NCT02075255|50342941|FG002|Overall Study|Study specific withdrawal criteria|1|||
25188675|NCT02075255|50342939|FG000|Overall Study|Withdrawal by Subject|4|||
25188676|NCT02075255|50342940|FG001|Overall Study|Withdrawal by Subject|1|||
25188677|NCT02075255|50342941|FG002|Overall Study|Withdrawal by Subject|0|||
25188678|NCT02075255|50342939|FG000|Overall Study|Lost to Follow-up|0|||
25188679|NCT02075255|50342940|FG001|Overall Study|Lost to Follow-up|0|||
25188680|NCT02075255|50342941|FG002|Overall Study|Lost to Follow-up|1|||
25188681|NCT02075255|50342939|FG000|Overall Study|Adverse Event|0|||
25188682|NCT02075255|50342940|FG001|Overall Study|Adverse Event|0|||
25188683|NCT02075255|50342941|FG002|Overall Study|Adverse Event|1|||
25188684|NCT02075255|50342939|FG000|Overall Study|Death|0|||
25188685|NCT02075255|50342940|FG001|Overall Study|Death|2|||
25188686|NCT02075255|50342941|FG002|Overall Study|Death|0|||
25188687|NCT02400671|50343112|FG000|Overall Study|Death|5|||
25188688|NCT02400671|50343113|FG001|Overall Study|Death|3|||
25188689|NCT02400671|50343114|FG002|Overall Study|Death|4|||
25188690|NCT02400671|50343112|FG000|Overall Study|Lost to Follow-up|20|||
25188691|NCT02400671|50343113|FG001|Overall Study|Lost to Follow-up|27|||
25188692|NCT02400671|50343114|FG002|Overall Study|Lost to Follow-up|24|||
25188693|NCT02400671|50343112|FG000|Overall Study|Withdrawal by Subject|2|||
25188694|NCT02400671|50343113|FG001|Overall Study|Withdrawal by Subject|2|||
25188695|NCT02400671|50343114|FG002|Overall Study|Withdrawal by Subject|0|||
25188696|NCT00089999|50343124|FG000|Overall Study|Adverse Event|4|||
25188697|NCT00089999|50343125|FG001|Overall Study|Adverse Event|7|||
25188698|NCT00089999|50343124|FG000|Overall Study|Withdrawal by Subject|0|||
25188699|NCT00089999|50343125|FG001|Overall Study|Withdrawal by Subject|4|||
25188700|NCT00089999|50343124|FG000|Overall Study|Lost to Follow-up|2|||
25188701|NCT00089999|50343125|FG001|Overall Study|Lost to Follow-up|1|||
25188702|NCT00089999|50343124|FG000|Overall Study|Radiological Progression of Cancer|52|||
25188703|NCT00089999|50343125|FG001|Overall Study|Radiological Progression of Cancer|44|||
25188704|NCT00089999|50343124|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
25188705|NCT00089999|50343125|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
25188706|NCT00089999|50343124|FG000|Overall Study|Death|3|||
25188707|NCT00089999|50343125|FG001|Overall Study|Death|3|||
25188708|NCT00089999|50343124|FG000|Overall Study|Poor General Condition|1|||
25188709|NCT00089999|50343125|FG001|Overall Study|Poor General Condition|0|||
25188710|NCT00089999|50343124|FG000|Overall Study|Clinical Progression|1|||
25188711|NCT00089999|50343125|FG001|Overall Study|Clinical Progression|2|||
25188712|NCT00089999|50343124|FG000|Overall Study|Physician Decision|2|||
25188713|NCT00089999|50343125|FG001|Overall Study|Physician Decision|2|||
25188714|NCT00089999|50343124|FG000|Overall Study|Patient Underwent Surgery|2|||
25188715|NCT00089999|50343125|FG001|Overall Study|Patient Underwent Surgery|0|||
25188716|NCT00089999|50343124|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
25188717|NCT00089999|50343125|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
25188718|NCT00089843|50343136|FG000|Overall Study|Withdrawal by Subject|1|||
25188719|NCT00089843|50343137|FG001|Overall Study|Withdrawal by Subject|4|||
25188720|NCT00089843|50343138|FG002|Overall Study|Withdrawal by Subject|5|||
25188721|NCT00089843|50343139|FG003|Overall Study|Withdrawal by Subject|6|||
25188722|NCT00089843|50343136|FG000|Overall Study|Physician Decision|1|||
25277246|NCT01198002|50591270|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
25277247|NCT01198002|50591271|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
25277248|NCT01198002|50591272|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
25188723|NCT00089843|50343137|FG001|Overall Study|Physician Decision|0|||
25188724|NCT00089843|50343138|FG002|Overall Study|Physician Decision|0|||
25188725|NCT00089843|50343139|FG003|Overall Study|Physician Decision|1|||
25188726|NCT00089297|50343149|FG000|Overall Study|Adverse Event|9|||
25188727|NCT00089297|50343149|FG000|Overall Study|Death|1|||
25188728|NCT00089297|50343149|FG000|Overall Study|Withdrawal by Subject|12|||
25188729|NCT00089297|50343149|FG000|Overall Study|Disease progression|2|||
25188730|NCT00089297|50343149|FG000|Overall Study|Ineligible|11|||
25188731|NCT00089297|50343149|FG000|Overall Study|Secondary malignancy|1|||
25188732|NCT00089297|50343149|FG000|Overall Study|IRB approval not ready|1|||
25188733|NCT00089297|50343149|FG000|Overall Study|Non-compliance|1|||
25188734|NCT00088907|50343191|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
25188735|NCT00088907|50343192|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
25188736|NCT00088907|50343191|FG000|Randomized Study (Step 1)|Adverse Event|14|||
25188737|NCT00088907|50343192|FG001|Randomized Study (Step 1)|Adverse Event|19|||
25188738|NCT00088907|50343191|FG000|Randomized Study (Step 1)|Death|11|||
25188739|NCT00088907|50343192|FG001|Randomized Study (Step 1)|Death|12|||
25188740|NCT00088907|50343191|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
25188741|NCT00088907|50343192|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
25188742|NCT00088907|50343191|FG000|Randomized Study (Step 1)|complicating disease|3|||
25188743|NCT00088907|50343192|FG001|Randomized Study (Step 1)|complicating disease|1|||
25188744|NCT00088907|50343191|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
25188745|NCT00088907|50343192|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
25188746|NCT00088907|50343191|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
25188747|NCT00088907|50343192|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
25188748|NCT00088907|50343191|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
25188749|NCT00088907|50343192|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
25188750|NCT00088907|50343191|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
25188751|NCT00088907|50343192|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
25188752|NCT00088907|50343191|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
25188753|NCT00088907|50343192|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
25188754|NCT00088907|50343191|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
25188755|NCT00088907|50343192|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
25188756|NCT00088829|50343199|FG000|Overall Study|PI left institution and study was close|22|||
25188757|NCT00088595|50343203|FG000|Overall Study|Adverse Event|11|||
25188758|NCT00088595|50343203|FG000|Overall Study|Withdrawal by Subject|8|||
25188759|NCT00088595|50343203|FG000|Overall Study|Ongoing (After Core)|7|||
25188760|NCT00088595|50343203|FG000|Overall Study|New Cancer Therapy|2|||
25188761|NCT00088205|50343217|FG000|Overall Study|Adverse Event|4|||
25188762|NCT00088205|50343217|FG000|Overall Study|Progressive Disease|51|||
25188763|NCT00088205|50343217|FG000|Overall Study|Physician Decision|1|||
25188764|NCT00088205|50343217|FG000|Overall Study|Death Due to Study Disease|4|||
25188765|NCT00085709|50343311|FG000|Overall Study|Adverse Event|8|||
25188766|NCT00085709|50343312|FG001|Overall Study|Adverse Event|0|||
25188767|NCT00085709|50343311|FG000|Overall Study|Death|8|||
25188768|NCT00085709|50343312|FG001|Overall Study|Death|2|||
25188769|NCT00085709|50343311|FG000|Overall Study|Refusal unrelated to adverse events|1|||
25188770|NCT00085709|50343312|FG001|Overall Study|Refusal unrelated to adverse events|2|||
25188771|NCT00085709|50343311|FG000|Overall Study|Progression|3|||
25188772|NCT00085709|50343312|FG001|Overall Study|Progression|4|||
25188773|NCT00085709|50343311|FG000|Overall Study|Not protocol specified|12|||
25188774|NCT00085709|50343312|FG001|Overall Study|Not protocol specified|22|||
25188775|NCT00085709|50343311|FG000|Overall Study|Not eligible|19|||
25188776|NCT00085709|50343312|FG001|Overall Study|Not eligible|19|||
25188777|NCT00085709|50343311|FG000|Overall Study|Withdrawal by Subject|2|||
25188778|NCT00085709|50343312|FG001|Overall Study|Withdrawal by Subject|1|||
25188779|NCT00085631|50343347|FG000|Overall Study|Missing Data|4|||
25188780|NCT00085631|50343348|FG001|Overall Study|Missing Data|11|||
25188781|NCT00085631|50343349|FG002|Overall Study|Missing Data|7|||
25188782|NCT00084929|50343365|FG000|Overall Study|ineligible - medical contraindication|1|||
25188783|NCT00084929|50343365|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
24967502|NCT03757234|50057065|FG003|Overall Study|Lost to Follow-up|0|||
25188784|NCT00084929|50343365|FG000|Overall Study|Ineligible - Medical history|6|||
25188785|NCT00084929|50343365|FG000|Overall Study|Withdrawal by Subject|10|||
25188786|NCT00084929|50343365|FG000|Overall Study|Missing/incomplete CTC exam|9|||
25188787|NCT00084929|50343365|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
25188788|NCT00084617|50343423|FG000|Overall Study|Withdrawal by Subject|7|||
25188789|NCT00084617|50343423|FG000|Overall Study|Lack of Efficacy|1|||
25188790|NCT00084617|50343423|FG000|Overall Study|Protocol Violation|1|||
25188791|NCT00083915|50343537|FG000|Overall Study|Death|6|||
25188792|NCT00083915|50343538|FG001|Overall Study|Death|3|||
25188793|NCT00083915|50343537|FG000|Overall Study|Physician Decision|11|||
25188794|NCT00083915|50343538|FG001|Overall Study|Physician Decision|6|||
25188795|NCT00083915|50343537|FG000|Overall Study|Withdrawal by Subject|8|||
25188796|NCT00083915|50343538|FG001|Overall Study|Withdrawal by Subject|3|||
25188797|NCT00083915|50343537|FG000|Overall Study|disease progression|18|||
25188798|NCT00083915|50343538|FG001|Overall Study|disease progression|23|||
25188799|NCT00083915|50343537|FG000|Overall Study|Failure to collect|3|||
25188800|NCT00083915|50343538|FG001|Overall Study|Failure to collect|0|||
25188801|NCT00083915|50343537|FG000|Overall Study|No response|3|||
25188802|NCT00083915|50343538|FG001|Overall Study|No response|1|||
25188803|NCT00083915|50343537|FG000|Overall Study|Insurance issues|1|||
25188804|NCT00083915|50343538|FG001|Overall Study|Insurance issues|1|||
25188805|NCT00632749|50344362|FG000|Overall Study|Progressive disease|3|||
25188806|NCT00632749|50344363|FG001|Overall Study|Progressive disease|2|||
25188807|NCT00632749|50344364|FG002|Overall Study|Progressive disease|2|||
25188808|NCT00632749|50344365|FG003|Overall Study|Progressive disease|2|||
25188809|NCT00632749|50344366|FG004|Overall Study|Progressive disease|4|||
25188810|NCT00632749|50344367|FG005|Overall Study|Progressive disease|4|||
25188811|NCT00632749|50344368|FG006|Overall Study|Progressive disease|3|||
25188812|NCT00632749|50344369|FG007|Overall Study|Progressive disease|2|||
25188813|NCT00632749|50344370|FG008|Overall Study|Progressive disease|3|||
25188814|NCT00632749|50344371|FG009|Overall Study|Progressive disease|2|||
25188815|NCT00632749|50344372|FG010|Overall Study|Progressive disease|4|||
25188816|NCT00632749|50344373|FG011|Overall Study|Progressive disease|3|||
25188817|NCT00632749|50344374|FG012|Overall Study|Progressive disease|2|||
25188818|NCT00632749|50344375|FG013|Overall Study|Progressive disease|4|||
25188819|NCT00632749|50344362|FG000|Overall Study|Other Adverse event|1|||
25188820|NCT00632749|50344363|FG001|Overall Study|Other Adverse event|1|||
25188821|NCT00632749|50344364|FG002|Overall Study|Other Adverse event|1|||
25188822|NCT00632749|50344365|FG003|Overall Study|Other Adverse event|1|||
25188823|NCT00632749|50344366|FG004|Overall Study|Other Adverse event|2|||
25188824|NCT00632749|50344367|FG005|Overall Study|Other Adverse event|4|||
25188825|NCT00632749|50344368|FG006|Overall Study|Other Adverse event|1|||
25188826|NCT00632749|50344369|FG007|Overall Study|Other Adverse event|2|||
25188827|NCT00632749|50344370|FG008|Overall Study|Other Adverse event|2|||
25168787|NCT00989235|50298763|FG000|Overall Study|Death|0|||
25168788|NCT00989235|50298764|FG001|Overall Study|Death|1|||
25168789|NCT00989235|50298763|FG000|Overall Study|Adverse Event|0|||
25168790|NCT00989235|50298764|FG001|Overall Study|Adverse Event|1|||
25168791|NCT00989235|50298763|FG000|Overall Study|Lack of Efficacy|1|||
25168792|NCT00989235|50298764|FG001|Overall Study|Lack of Efficacy|0|||
25168793|NCT00989235|50298763|FG000|Overall Study|Withdrawal of Consent|1|||
25168794|NCT00989235|50298764|FG001|Overall Study|Withdrawal of Consent|1|||
25168795|NCT00989235|50298763|FG000|Overall Study|Desire to Become Pregnant|1|||
25168796|NCT00989235|50298764|FG001|Overall Study|Desire to Become Pregnant|0|||
25168797|NCT00989235|50298763|FG000|Overall Study|Randomized by Mistake|0|||
24967503|NCT03757234|50057066|FG004|Overall Study|Lost to Follow-up|1|||
24967504|NCT03757234|50057062|FG000|Overall Study|Withdrawal by Subject|1|||
24967505|NCT03757234|50057063|FG001|Overall Study|Withdrawal by Subject|1|||
24967506|NCT03757234|50057064|FG002|Overall Study|Withdrawal by Subject|0|||
24967507|NCT03757234|50057065|FG003|Overall Study|Withdrawal by Subject|1|||
25168798|NCT00989235|50298764|FG001|Overall Study|Randomized by Mistake|2|||
25168799|NCT00989235|50298763|FG000|Overall Study|Lost to Follow-up|0|||
25168800|NCT00989235|50298764|FG001|Overall Study|Lost to Follow-up|1|||
25168801|NCT00988533|50298804|FG000|Overall Study|Lost to Follow-up|3|||
25168802|NCT03633396|50298836|FG000|Overall Study|Withdrawal by Subject|4|||
25188828|NCT00632749|50344371|FG009|Overall Study|Other Adverse event|0|||
24967508|NCT03757234|50057066|FG004|Overall Study|Withdrawal by Subject|2|||
24967509|NCT03757234|50057062|FG000|Overall Study|Other|1|||
24967510|NCT03757234|50057063|FG001|Overall Study|Other|1|||
24967511|NCT03757234|50057064|FG002|Overall Study|Other|0|||
25188829|NCT00632749|50344372|FG010|Overall Study|Other Adverse event|1|||
24967512|NCT03757234|50057065|FG003|Overall Study|Other|0|||
24967513|NCT03757234|50057066|FG004|Overall Study|Other|0|||
24967514|NCT00223080|50057080|FG000|Overall Study|Withdrawal by Subject|253|||
24967515|NCT00223080|50057081|FG001|Overall Study|Withdrawal by Subject|232|||
24967516|NCT00223080|50057080|FG000|Overall Study|Required contraindicated med|0|||
24967517|NCT00223080|50057081|FG001|Overall Study|Required contraindicated med|1|||
24967518|NCT00223080|50057080|FG000|Overall Study|Non-compliant|7|||
24967519|NCT00223080|50057081|FG001|Overall Study|Non-compliant|7|||
24967520|NCT00223080|50057080|FG000|Overall Study|Moved from study area|37|||
24967521|NCT00223080|50057081|FG001|Overall Study|Moved from study area|47|||
25168803|NCT03633396|50298837|FG001|Overall Study|Withdrawal by Subject|4|||
25188830|NCT00632749|50344373|FG011|Overall Study|Other Adverse event|0|||
25188831|NCT00632749|50344374|FG012|Overall Study|Other Adverse event|1|||
24967522|NCT00223080|50057080|FG000|Overall Study|Lost to Follow-up|259|||
25168804|NCT03633396|50298836|FG000|Overall Study|Adverse Event|1|||
25168805|NCT03633396|50298837|FG001|Overall Study|Adverse Event|1|||
25168806|NCT03633396|50298836|FG000|Overall Study|Lack of Efficacy|1|||
25168807|NCT03633396|50298837|FG001|Overall Study|Lack of Efficacy|0|||
25188832|NCT00632749|50344375|FG013|Overall Study|Other Adverse event|0|||
25188833|NCT00632749|50344362|FG000|Overall Study|Refuse to continue medication|0|||
25188834|NCT00632749|50344363|FG001|Overall Study|Refuse to continue medication|0|||
25188835|NCT00632749|50344364|FG002|Overall Study|Refuse to continue medication|0|||
25188836|NCT00632749|50344365|FG003|Overall Study|Refuse to continue medication|1|||
25168808|NCT03633396|50298836|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
25168809|NCT03633396|50298837|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
25168810|NCT00988065|50298850|FG000|Overall Study|Adverse Event|4|||
25168811|NCT00988065|50298851|FG001|Overall Study|Adverse Event|10|||
25168812|NCT00988065|50298852|FG002|Overall Study|Adverse Event|2|||
25168813|NCT00988065|50298850|FG000|Overall Study|Lost to Follow-up|1|||
25168814|NCT00988065|50298851|FG001|Overall Study|Lost to Follow-up|2|||
25168815|NCT00988065|50298852|FG002|Overall Study|Lost to Follow-up|2|||
25168816|NCT00988065|50298850|FG000|Overall Study|Subject withdrew consent|3|||
25168817|NCT00988065|50298851|FG001|Overall Study|Subject withdrew consent|5|||
25168818|NCT00988065|50298852|FG002|Overall Study|Subject withdrew consent|2|||
25168819|NCT00988065|50298850|FG000|Overall Study|Noncompliance with protocol|5|||
25168820|NCT00988065|50298851|FG001|Overall Study|Noncompliance with protocol|6|||
25168821|NCT00988065|50298852|FG002|Overall Study|Noncompliance with protocol|9|||
25168822|NCT00987831|50298876|FG000|Overall Study|Never flared in 12 months|1|||
25168823|NCT00987831|50298877|FG001|Overall Study|Never flared in 12 months|0|||
25168824|NCT00987831|50298878|FG002|Overall Study|Never flared in 12 months|0|||
25168825|NCT00987831|50298876|FG000|Overall Study|Lost to Follow-up|0|||
25168826|NCT00987831|50298877|FG001|Overall Study|Lost to Follow-up|3|||
25168827|NCT00987831|50298878|FG002|Overall Study|Lost to Follow-up|0|||
25168828|NCT00986973|50298909|FG000|Overall Study|Withdrawn by study team|1|||
25168829|NCT00986427|50298916|FG000|Overall Study|Lost to Follow-up|2|||
25168830|NCT00986427|50298917|FG001|Overall Study|Lost to Follow-up|0|||
25188837|NCT00632749|50344366|FG004|Overall Study|Refuse to continue medication|0|||
24967523|NCT00223080|50057081|FG001|Overall Study|Lost to Follow-up|284|||
24967524|NCT00223080|50057080|FG000|Overall Study|Death|85|||
24967525|NCT00223080|50057081|FG001|Overall Study|Death|74|||
24967526|NCT00223080|50057080|FG000|Overall Study|Other|14|||
24967527|NCT00223080|50057081|FG001|Overall Study|Other|11|||
24967528|NCT00223080|50057080|FG000|Overall Study|Reason not provided|141|||
24967529|NCT00223080|50057081|FG001|Overall Study|Reason not provided|140|||
24967530|NCT00223080|50057080|FG000|Overall Study|Adverse Event|0|||
24967531|NCT00223080|50057081|FG001|Overall Study|Adverse Event|1|||
24967532|NCT00220740|50057089|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
24967533|NCT00220740|50057090|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
24967534|NCT00220740|50057089|FG000|Efficacy Period|Adverse Event|1|||
24967535|NCT00220740|50057090|FG001|Efficacy Period|Adverse Event|1|||
24967536|NCT00220740|50057089|FG000|Efficacy Period|Withdrawal by Subject|1|||
24967537|NCT00220740|50057090|FG001|Efficacy Period|Withdrawal by Subject|0|||
24967538|NCT00220740|50057089|FG000|Efficacy Period|Protocol Violation|1|||
24967539|NCT00220740|50057090|FG001|Efficacy Period|Protocol Violation|0|||
24967540|NCT00220740|50057089|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
24967541|NCT00220740|50057090|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
24967542|NCT00184002|50057098|FG000|Overall Study|Adverse Event|9|||
24967543|NCT00184002|50057098|FG000|Overall Study|Death|3|||
24967544|NCT00184002|50057098|FG000|Overall Study|Physician Decision|1|||
24967545|NCT00184002|50057098|FG000|Overall Study|Withdrawal by Subject|4|||
24967546|NCT00165672|50057104|FG000|Overall Study|Adverse Event|0|||
24967547|NCT00165672|50057105|FG001|Overall Study|Adverse Event|1|||
24967548|NCT00180414|50057113|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
24967549|NCT00180414|50057114|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
24967550|NCT00174252|50057120|FG000|Overall Study|Protocol Violation|2|||
24967551|NCT00169104|50057128|FG000|Overall Study|Withdrawal by Subject|2|||
24967552|NCT00169104|50057129|FG001|Overall Study|Withdrawal by Subject|0|||
24967553|NCT00169104|50057128|FG000|Overall Study|Protocol Violation|0|||
24967554|NCT00169104|50057129|FG001|Overall Study|Protocol Violation|1|||
24967555|NCT00169104|50057128|FG000|Overall Study|Physician Decision|0|||
24967556|NCT00169104|50057129|FG001|Overall Study|Physician Decision|1|||
24967557|NCT00163020|50057138|FG000|Overall Study|Lost to Follow-up|0|||
24967558|NCT00163020|50057139|FG001|Overall Study|Lost to Follow-up|2|||
24967559|NCT00252720|50057149|FG000|Overall Study|Withdrawal by Subject|95|||
24967560|NCT00252720|50057150|FG001|Overall Study|Withdrawal by Subject|97|||
24967561|NCT00252720|50057149|FG000|Overall Study|Death|7|||
24967562|NCT00252720|50057150|FG001|Overall Study|Death|8|||
24967563|NCT00252720|50057149|FG000|Overall Study|Moving|23|||
24967564|NCT00252720|50057150|FG001|Overall Study|Moving|42|||
24967565|NCT00252720|50057149|FG000|Overall Study|Mainly patients lost to follow-up|7|||
24967566|NCT00252720|50057150|FG001|Overall Study|Mainly patients lost to follow-up|18|||
24967567|NCT00167778|50057156|FG000|Overall Study|Withdrawal by Subject|1|||
24967568|NCT00167310|50057163|FG000|Overall Study|Protocol Violation|5|||
24967569|NCT00167310|50057164|FG001|Overall Study|Protocol Violation|3|||
24967570|NCT00167310|50057163|FG000|Overall Study|Withdrawal by Subject|3|||
24967571|NCT00167310|50057164|FG001|Overall Study|Withdrawal by Subject|7|||
24967572|NCT03754582|50057170|FG000|Treatment Phase|Adverse Event|0|||
24967573|NCT03754582|50057171|FG001|Treatment Phase|Adverse Event|1|||
24967574|NCT03754582|50057172|FG002|Treatment Phase|Adverse Event|0|||
24967575|NCT03754582|50057170|FG000|Follow-up Phase|Other|0|||
24967576|NCT03754582|50057171|FG001|Follow-up Phase|Other|0|||
24967577|NCT03754582|50057172|FG002|Follow-up Phase|Other|1|||
24967578|NCT00161616|50057190|FG000|Overall Study|Withdrawal by Subject|6|||
24967579|NCT00161616|50057191|FG001|Overall Study|Withdrawal by Subject|5|||
24967580|NCT00161616|50057190|FG000|Overall Study|Physician Decision|1|||
24967581|NCT00161616|50057191|FG001|Overall Study|Physician Decision|0|||
24967582|NCT00161616|50057190|FG000|Overall Study|Death|1|||
24967583|NCT00161616|50057191|FG001|Overall Study|Death|1|||
24967584|NCT00161616|50057190|FG000|Overall Study|Lost to Follow-up|17|||
24967585|NCT00161616|50057191|FG001|Overall Study|Lost to Follow-up|13|||
24967586|NCT00161616|50057190|FG000|Overall Study|Protocol deviation|1|||
24967587|NCT00161616|50057191|FG001|Overall Study|Protocol deviation|0|||
24967588|NCT00252564|50057199|FG000|Overall Study|Adverse Event|17|||
24967589|NCT00252564|50057200|FG001|Overall Study|Adverse Event|13|||
24967590|NCT00252564|50057199|FG000|Overall Study|Unrelated Complication|2|||
24967591|NCT00252564|50057200|FG001|Overall Study|Unrelated Complication|1|||
24967592|NCT00252564|50057199|FG000|Overall Study|Disease Progression|14|||
24967593|NCT00252564|50057200|FG001|Overall Study|Disease Progression|20|||
24967594|NCT00252564|50057199|FG000|Overall Study|Death|0|||
24967595|NCT00252564|50057200|FG001|Overall Study|Death|3|||
24967596|NCT00252564|50057199|FG000|Overall Study|Physician Decision|1|||
24967597|NCT00252564|50057200|FG001|Overall Study|Physician Decision|0|||
25188838|NCT00632749|50344367|FG005|Overall Study|Refuse to continue medication|0|||
25188839|NCT00632749|50344368|FG006|Overall Study|Refuse to continue medication|0|||
25188840|NCT00632749|50344369|FG007|Overall Study|Refuse to continue medication|0|||
25188841|NCT00632749|50344370|FG008|Overall Study|Refuse to continue medication|0|||
25188842|NCT00632749|50344371|FG009|Overall Study|Refuse to continue medication|1|||
25188843|NCT00632749|50344372|FG010|Overall Study|Refuse to continue medication|0|||
25188844|NCT00632749|50344373|FG011|Overall Study|Refuse to continue medication|0|||
25188845|NCT00632749|50344374|FG012|Overall Study|Refuse to continue medication|0|||
25188846|NCT00632749|50344375|FG013|Overall Study|Refuse to continue medication|0|||
25188847|NCT00632749|50344362|FG000|Overall Study|Reason other than those specified above|0|||
25188848|NCT00632749|50344363|FG001|Overall Study|Reason other than those specified above|2|||
25188849|NCT00632749|50344364|FG002|Overall Study|Reason other than those specified above|0|||
25188850|NCT00632749|50344365|FG003|Overall Study|Reason other than those specified above|0|||
25188851|NCT00632749|50344366|FG004|Overall Study|Reason other than those specified above|1|||
25188852|NCT00632749|50344367|FG005|Overall Study|Reason other than those specified above|0|||
25188853|NCT00632749|50344368|FG006|Overall Study|Reason other than those specified above|1|||
25188854|NCT00632749|50344369|FG007|Overall Study|Reason other than those specified above|0|||
25188855|NCT00632749|50344370|FG008|Overall Study|Reason other than those specified above|0|||
25188856|NCT00632749|50344371|FG009|Overall Study|Reason other than those specified above|0|||
25188857|NCT00632749|50344372|FG010|Overall Study|Reason other than those specified above|2|||
25188858|NCT00632749|50344373|FG011|Overall Study|Reason other than those specified above|1|||
25188859|NCT00632749|50344374|FG012|Overall Study|Reason other than those specified above|0|||
25188860|NCT00632749|50344375|FG013|Overall Study|Reason other than those specified above|2|||
25188861|NCT00632359|50344445|FG000|Overall Study|Withdrawal by Subject|2|||
25188862|NCT00632203|50344452|FG000|Overall Study|Did not start study treatment|1|||
25188863|NCT00632203|50344453|FG001|Overall Study|Did not start study treatment|0|||
25188864|NCT03830333|50344474|FG000|Overall Study|Death|0|||
25188865|NCT03830333|50344475|FG001|Overall Study|Death|1|||
25188866|NCT03830333|50344474|FG000|Overall Study|Withdrawal by Subject|5|||
25188867|NCT03830333|50344475|FG001|Overall Study|Withdrawal by Subject|1|||
25188868|NCT03830333|50344474|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
25188869|NCT03830333|50344475|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
25188870|NCT00631969|50344561|FG000|Overall Study|Adverse Event|3|||
25188871|NCT00631969|50344562|FG001|Overall Study|Adverse Event|1|||
25188872|NCT00631969|50344561|FG000|Overall Study|Lack of Efficacy|2|||
25188873|NCT00631969|50344562|FG001|Overall Study|Lack of Efficacy|8|||
25188874|NCT00631969|50344561|FG000|Overall Study|Lost to Follow-up|2|||
25188875|NCT00631969|50344562|FG001|Overall Study|Lost to Follow-up|1|||
25188876|NCT00631969|50344561|FG000|Overall Study|Protocol Violation|1|||
25188877|NCT00631969|50344562|FG001|Overall Study|Protocol Violation|1|||
25188878|NCT00631969|50344561|FG000|Overall Study|Consent Withdrawn|5|||
25188879|NCT00631969|50344562|FG001|Overall Study|Consent Withdrawn|7|||
25188880|NCT00631969|50344561|FG000|Overall Study|Noncompliant With Study Medication|0|||
25188881|NCT00631969|50344562|FG001|Overall Study|Noncompliant With Study Medication|1|||
25188882|NCT00631969|50344561|FG000|Overall Study|No Drug Exposure|2|||
25188883|NCT00631969|50344562|FG001|Overall Study|No Drug Exposure|2|||
25188884|NCT00631657|50344598|FG000|6-Month Treatment Period|Adverse Event|47|||
25188885|NCT00631657|50344599|FG001|6-Month Treatment Period|Adverse Event|0|||
25188886|NCT00631657|50344600|FG002|6-Month Treatment Period|Adverse Event|7|||
25188887|NCT00631657|50344598|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
25188888|NCT00631657|50344599|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
25188889|NCT00631657|50344600|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
24967598|NCT00252564|50057199|FG000|Overall Study|Lost to Follow-up|1|||
24967599|NCT00252564|50057200|FG001|Overall Study|Lost to Follow-up|0|||
24967600|NCT00252564|50057199|FG000|Overall Study|Patient Request|4|||
24967601|NCT00252564|50057200|FG001|Overall Study|Patient Request|5|||
24967602|NCT00252564|50057199|FG000|Overall Study|Withdrawal by Subject|0|||
24967603|NCT00252564|50057200|FG001|Overall Study|Withdrawal by Subject|2|||
24967604|NCT00166296|50057208|FG000|Overall Study|Withdrawal by Subject|1|||
24967605|NCT00166296|50057209|FG001|Overall Study|Withdrawal by Subject|3|||
24967606|NCT00166296|50057208|FG000|Overall Study|Adverse Event|2|||
24967607|NCT00166296|50057209|FG001|Overall Study|Adverse Event|4|||
24967608|NCT00166296|50057208|FG000|Overall Study|Lost to Follow-up|4|||
24967609|NCT00166296|50057209|FG001|Overall Study|Lost to Follow-up|2|||
24967610|NCT00252174|50057218|FG000|Overall Study|Withdrawal by Subject|0|||
24967611|NCT00252174|50057219|FG001|Overall Study|Withdrawal by Subject|1|||
24967612|NCT00252174|50057220|FG002|Overall Study|Withdrawal by Subject|0|||
24967613|NCT00165984|50057228|FG000|Overall Study|Death|15|||
24967614|NCT00160680|50057237|FG000|Overall Study|Adverse Event|0|||
24967615|NCT00160680|50057238|FG001|Overall Study|Adverse Event|1|||
24967616|NCT00160680|50057237|FG000|Overall Study|Lack of Efficacy|2|||
24967617|NCT00160680|50057238|FG001|Overall Study|Lack of Efficacy|1|||
24967618|NCT00160680|50057237|FG000|Overall Study|Lost to Follow-up|3|||
24967619|NCT00160680|50057238|FG001|Overall Study|Lost to Follow-up|2|||
25168831|NCT00986427|50298916|FG000|Overall Study|Lack of Efficacy|1|||
25168832|NCT00986427|50298917|FG001|Overall Study|Lack of Efficacy|0|||
25168833|NCT00986427|50298916|FG000|Overall Study|Withdrawal by Subject|1|||
25168834|NCT00986427|50298917|FG001|Overall Study|Withdrawal by Subject|0|||
25168835|NCT00986349|50298927|FG000|Overall Study|Unsuccessful implant procedure|3|||
25168836|NCT00986349|50298927|FG000|Overall Study|Adverse Event|2|||
25168837|NCT00986349|50298927|FG000|Overall Study|Physician Decision|1|||
25168838|NCT00986349|50298927|FG000|Overall Study|device migration|1|||
25168839|NCT00985959|50298950|FG000|Overall Study|Adverse Event|0|||
25168840|NCT00985959|50298951|FG001|Overall Study|Adverse Event|0|||
25168841|NCT00985959|50298952|FG002|Overall Study|Adverse Event|19|||
25168842|NCT00985959|50298950|FG000|Overall Study|Withdrawal by Subject|0|||
25168843|NCT00985959|50298951|FG001|Overall Study|Withdrawal by Subject|0|||
25168844|NCT00985959|50298952|FG002|Overall Study|Withdrawal by Subject|8|||
25168845|NCT00985959|50298950|FG000|Overall Study|Progressive disease|1|||
25188890|NCT00631657|50344598|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
25188891|NCT00631657|50344599|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
25188892|NCT00631657|50344600|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
25188893|NCT00631657|50344598|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
25188894|NCT00631657|50344599|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
25188895|NCT00631657|50344600|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
25188896|NCT00631657|50344598|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
25188897|NCT00631657|50344599|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
25188898|NCT00631657|50344600|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
25188899|NCT00631657|50344598|FG000|6-Month Treatment Period|Other|16|||
25188900|NCT00631657|50344599|FG001|6-Month Treatment Period|Other|0|||
25188901|NCT00631657|50344600|FG002|6-Month Treatment Period|Other|4|||
25188902|NCT00631657|50344598|FG000|6-Month Treatment Period|Not Treated|2|||
25188903|NCT00631657|50344599|FG001|6-Month Treatment Period|Not Treated|0|||
25188904|NCT00631657|50344600|FG002|6-Month Treatment Period|Not Treated|1|||
25188905|NCT00631657|50344598|FG000|7-Day Discontinuation Period|Not Treated|1|||
25188906|NCT00631657|50344599|FG001|7-Day Discontinuation Period|Not Treated|1|||
25188907|NCT00631657|50344600|FG002|7-Day Discontinuation Period|Not Treated|1|||
25188908|NCT00631657|50344598|FG000|7-Day Discontinuation Period|Other|1|||
25188909|NCT00631657|50344599|FG001|7-Day Discontinuation Period|Other|0|||
25188910|NCT00631657|50344600|FG002|7-Day Discontinuation Period|Other|0|||
25188911|NCT00631189|50344638|FG000|Initial Phase|Protocol Violation|347|||
25188912|NCT00631189|50344639|FG001|Initial Phase|Protocol Violation|0|||
25188913|NCT00631189|50344640|FG002|Initial Phase|Protocol Violation|0|||
24967620|NCT00160680|50057237|FG000|Overall Study|Withdrawal by Subject|4|||
24967621|NCT00160680|50057238|FG001|Overall Study|Withdrawal by Subject|9|||
24967622|NCT00160524|50057244|FG000|Overall Study|Adverse Event|119|||
24967623|NCT00160524|50057244|FG000|Overall Study|Adverse Event and Other|94|||
24967624|NCT00160524|50057244|FG000|Overall Study|Protocol Violation|16|||
24967625|NCT00160524|50057244|FG000|Overall Study|Protocol Violation and Other|2|||
25168846|NCT00985959|50298951|FG001|Overall Study|Progressive disease|2|||
25168847|NCT00985959|50298952|FG002|Overall Study|Progressive disease|8|||
25168848|NCT00985959|50298950|FG000|Overall Study|Unrecovered toxicity|0|||
25168849|NCT00985959|50298951|FG001|Overall Study|Unrecovered toxicity|0|||
25168850|NCT00985959|50298952|FG002|Overall Study|Unrecovered toxicity|7|||
25168851|NCT00985959|50298950|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
25168852|NCT00985959|50298951|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
25188914|NCT00631189|50344641|FG003|Initial Phase|Protocol Violation|0|||
25188915|NCT00631189|50344638|FG000|Initial Phase|Withdrawal by Subject|4|||
25188916|NCT00631189|50344639|FG001|Initial Phase|Withdrawal by Subject|0|||
25188917|NCT00631189|50344640|FG002|Initial Phase|Withdrawal by Subject|0|||
25188918|NCT00631189|50344641|FG003|Initial Phase|Withdrawal by Subject|0|||
25188919|NCT00631189|50344638|FG000|Treatment Phase|Withdrawal by Subject|0|||
25188920|NCT00631189|50344639|FG001|Treatment Phase|Withdrawal by Subject|2|||
25188921|NCT00631189|50344640|FG002|Treatment Phase|Withdrawal by Subject|1|||
25188922|NCT00631189|50344641|FG003|Treatment Phase|Withdrawal by Subject|1|||
25188923|NCT00631189|50344638|FG000|Treatment Phase|Protocol Violation|0|||
25188924|NCT00631189|50344639|FG001|Treatment Phase|Protocol Violation|1|||
25188925|NCT00631189|50344640|FG002|Treatment Phase|Protocol Violation|6|||
25188926|NCT00631189|50344641|FG003|Treatment Phase|Protocol Violation|2|||
25188927|NCT00631189|50344638|FG000|Treatment Phase|Adverse Event|0|||
25188928|NCT00631189|50344639|FG001|Treatment Phase|Adverse Event|3|||
25188929|NCT00631189|50344640|FG002|Treatment Phase|Adverse Event|2|||
25188930|NCT00631189|50344641|FG003|Treatment Phase|Adverse Event|4|||
25188931|NCT00631189|50344638|FG000|Treatment Phase|Lost to Follow-up|0|||
25188932|NCT00631189|50344639|FG001|Treatment Phase|Lost to Follow-up|1|||
25188933|NCT00631189|50344640|FG002|Treatment Phase|Lost to Follow-up|0|||
25188934|NCT00631189|50344641|FG003|Treatment Phase|Lost to Follow-up|0|||
25188935|NCT00631189|50344638|FG000|Treatment Phase|Pregnancy|0|||
25188936|NCT00631189|50344639|FG001|Treatment Phase|Pregnancy|0|||
25188937|NCT00631189|50344640|FG002|Treatment Phase|Pregnancy|1|||
25188938|NCT00631189|50344641|FG003|Treatment Phase|Pregnancy|0|||
25188939|NCT00631189|50344638|FG000|Treatment Phase|patient did not take pravastatin|0|||
25188940|NCT00631189|50344639|FG001|Treatment Phase|patient did not take pravastatin|0|||
24967626|NCT00160524|50057244|FG000|Overall Study|Withdrawal by Subject|141|||
25188941|NCT00631189|50344640|FG002|Treatment Phase|patient did not take pravastatin|1|||
25188942|NCT00631189|50344641|FG003|Treatment Phase|patient did not take pravastatin|0|||
25188943|NCT00630877|50344654|FG000|Overall Study|Adverse Event|11|||
25188944|NCT00630877|50344655|FG001|Overall Study|Adverse Event|8|||
25188945|NCT00630877|50344656|FG002|Overall Study|Adverse Event|7|||
25188946|NCT00630877|50344654|FG000|Overall Study|Withdrawal by Subject|3|||
24967627|NCT00160524|50057244|FG000|Overall Study|Withdrawal by Subject and Other|17|||
24967628|NCT00160524|50057244|FG000|Overall Study|Physician Decision|27|||
25277249|NCT01198002|50591270|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
25277250|NCT01198002|50591271|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
24967629|NCT00160524|50057244|FG000|Overall Study|Physician Decision and Other|6|||
24967630|NCT00160524|50057244|FG000|Overall Study|Lost to Follow-up|13|||
24967631|NCT00160524|50057244|FG000|Overall Study|Lost to Follow-up and Other|1|||
24967632|NCT00160524|50057244|FG000|Overall Study|Lack of Efficacy|21|||
24967633|NCT00160524|50057244|FG000|Overall Study|Lack of Efficacy and Other|1|||
24967634|NCT00160524|50057244|FG000|Overall Study|Other|20|||
24967635|NCT00159822|50057248|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
24967636|NCT00159822|50057248|FG000|Voriconazole Treatment Period|Adverse Event|9|||
24967637|NCT00159822|50057248|FG000|Voriconazole Treatment Period|Death|4|||
24967638|NCT00159822|50057248|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
24967639|NCT00159822|50057248|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
24967640|NCT00159822|50057248|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
24967641|NCT00159822|50057248|FG000|Post-treatment Follow-up Period|Death|1|||
24967642|NCT00159822|50057248|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
24967643|NCT00159822|50057248|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
24967644|NCT00158262|50057254|FG000|Overall Study|Lost to Follow-up|1|||
24967645|NCT00158262|50057255|FG001|Overall Study|Lost to Follow-up|1|||
24967646|NCT00157950|50057263|FG000|Overall Study|Death|1|||
24967647|NCT00157950|50057264|FG001|Overall Study|Death|0|||
24967648|NCT03745768|50057272|FG000|Overall Study|discontinued study|2|||
24967649|NCT03745768|50057273|FG001|Overall Study|discontinued study|0|||
24967650|NCT03745222|50057282|FG000|Overall Study|Withdrawal by Subject|0|||
24967651|NCT03745222|50057283|FG001|Overall Study|Withdrawal by Subject|1|||
24967652|NCT03745222|50057284|FG002|Overall Study|Withdrawal by Subject|0|||
24967653|NCT03743038|50057292|FG000|Overall Study|Physician Decision|1|||
24967654|NCT00153816|50057304|FG000|Overall Study|Death|6|||
24967655|NCT00153816|50057305|FG001|Overall Study|Death|5|||
24967656|NCT00153816|50057306|FG002|Overall Study|Death|4|||
24967657|NCT00153816|50057307|FG003|Overall Study|Death|6|||
24967658|NCT00153816|50057308|FG004|Overall Study|Death|0|||
24967659|NCT00153816|50057309|FG005|Overall Study|Death|2|||
24967660|NCT00153816|50057304|FG000|Overall Study|Lost to Follow-up|7|||
25068869|NCT01975831|50174589|FG001|Overall Study|Entered Hospice|0|||
25068870|NCT01975831|50174590|FG002|Overall Study|Entered Hospice|0|||
25068871|NCT01975831|50174591|FG003|Overall Study|Entered Hospice|0|||
24967661|NCT00153816|50057305|FG001|Overall Study|Lost to Follow-up|8|||
24967662|NCT00153816|50057306|FG002|Overall Study|Lost to Follow-up|5|||
24967663|NCT00153816|50057307|FG003|Overall Study|Lost to Follow-up|8|||
24967664|NCT00153816|50057308|FG004|Overall Study|Lost to Follow-up|7|||
24967665|NCT00153816|50057309|FG005|Overall Study|Lost to Follow-up|9|||
24967666|NCT00153816|50057304|FG000|Overall Study|Withdrawal by Subject|9|||
24967667|NCT00153816|50057305|FG001|Overall Study|Withdrawal by Subject|9|||
24967668|NCT00153816|50057306|FG002|Overall Study|Withdrawal by Subject|9|||
24967669|NCT00153816|50057307|FG003|Overall Study|Withdrawal by Subject|4|||
24967670|NCT00153816|50057308|FG004|Overall Study|Withdrawal by Subject|1|||
24967671|NCT00153816|50057309|FG005|Overall Study|Withdrawal by Subject|5|||
24967672|NCT00153816|50057304|FG000|Overall Study|Follow-up exam not done|8|||
24967673|NCT00153816|50057305|FG001|Overall Study|Follow-up exam not done|7|||
24967674|NCT00153816|50057306|FG002|Overall Study|Follow-up exam not done|11|||
24967675|NCT00153816|50057307|FG003|Overall Study|Follow-up exam not done|10|||
24967676|NCT00153816|50057308|FG004|Overall Study|Follow-up exam not done|8|||
24967677|NCT00153816|50057309|FG005|Overall Study|Follow-up exam not done|9|||
24967678|NCT00153816|50057304|FG000|Overall Study|Follow-up exam done, histology missing|2|||
24967679|NCT00153816|50057305|FG001|Overall Study|Follow-up exam done, histology missing|3|||
24967680|NCT00153816|50057306|FG002|Overall Study|Follow-up exam done, histology missing|3|||
24967681|NCT00153816|50057307|FG003|Overall Study|Follow-up exam done, histology missing|3|||
24967682|NCT00153816|50057308|FG004|Overall Study|Follow-up exam done, histology missing|1|||
24967683|NCT00153816|50057309|FG005|Overall Study|Follow-up exam done, histology missing|2|||
24967684|NCT00151476|50057326|FG000|FAP Identified Subjects|Protocol Violation|0|||
24967685|NCT00151476|50057327|FG001|FAP Identified Subjects|Protocol Violation|1|||
24967686|NCT00151476|50057326|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
24967687|NCT00151476|50057327|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
24967688|NCT00151476|50057326|FG000|FAP Analyzed Subjects|Other study participation|0|||
24967689|NCT00151476|50057327|FG001|FAP Analyzed Subjects|Other study participation|1|||
24967690|NCT00149994|50057336|FG000|Overall Study|Administrative problems:|1|||
24967691|NCT00149994|50057337|FG001|Overall Study|Administrative problems:|0|||
24967692|NCT00149994|50057336|FG000|Overall Study|Protocol Violation|0|||
24967693|NCT00149994|50057337|FG001|Overall Study|Protocol Violation|1|||
24967694|NCT00149214|50057345|FG000|Overall Study|Adverse Event|12|||
24967695|NCT00149214|50057346|FG001|Overall Study|Adverse Event|9|||
24967696|NCT00149214|50057345|FG000|Overall Study|Withdrawal by Subject|4|||
24967697|NCT00149214|50057346|FG001|Overall Study|Withdrawal by Subject|1|||
24967698|NCT00149214|50057345|FG000|Overall Study|Physician Decision|3|||
24967699|NCT00149214|50057346|FG001|Overall Study|Physician Decision|3|||
24967700|NCT00149214|50057345|FG000|Overall Study|Sponsor Decision|0|||
24967701|NCT00149214|50057346|FG001|Overall Study|Sponsor Decision|1|||
24967702|NCT00149214|50057345|FG000|Overall Study|Progressive Disease|7|||
24967703|NCT00149214|50057346|FG001|Overall Study|Progressive Disease|3|||
24967704|NCT00114972|50057363|FG000|Overall Study|Withdrawal by Subject|40|||
24967705|NCT00114972|50057364|FG001|Overall Study|Withdrawal by Subject|7|||
24967706|NCT00114972|50057363|FG000|Overall Study|Lost to Follow-up|8|||
24967707|NCT00114972|50057364|FG001|Overall Study|Lost to Follow-up|5|||
24967708|NCT00129402|50057372|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
24967709|NCT00129402|50057373|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
24967710|NCT00129402|50057374|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
24967711|NCT00129402|50057375|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
24967712|NCT00129402|50057376|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
24967713|NCT00129402|50057377|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
24967714|NCT00129402|50057378|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
24967715|NCT00129402|50057372|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
24967716|NCT00129402|50057373|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
24967717|NCT00129402|50057374|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
24967718|NCT00129402|50057375|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
24967719|NCT00129402|50057376|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
24967720|NCT00129402|50057377|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
24967721|NCT00129402|50057378|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
24967722|NCT00129402|50057372|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
24967723|NCT00129402|50057373|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
24967724|NCT00129402|50057374|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
24967725|NCT00129402|50057375|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
24967726|NCT00129402|50057376|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
24967727|NCT00129402|50057377|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
24967728|NCT00129402|50057378|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
24967729|NCT00129402|50057372|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
24967730|NCT00129402|50057373|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
24967731|NCT00129402|50057374|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
24967732|NCT00129402|50057375|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
24967733|NCT00129402|50057376|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
24967734|NCT00129402|50057377|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
24967735|NCT00129402|50057378|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
24967736|NCT00129402|50057372|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
24967737|NCT00129402|50057373|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
24967738|NCT00129402|50057374|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
24967739|NCT00129402|50057375|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
24967740|NCT00129402|50057376|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
24967741|NCT00129402|50057377|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
24967742|NCT00129402|50057378|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
24967743|NCT00129402|50057372|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
24967744|NCT00129402|50057373|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
24967745|NCT00129402|50057374|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
24967746|NCT00129402|50057375|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
24967747|NCT00129402|50057376|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
24967748|NCT00129402|50057377|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
24967749|NCT00129402|50057378|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
24967750|NCT00129402|50057372|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
24967751|NCT00129402|50057373|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
24967752|NCT00129402|50057374|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
24967753|NCT00129402|50057375|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
24967754|NCT00129402|50057376|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
24967755|NCT00129402|50057377|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
24967756|NCT00129402|50057378|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
24967757|NCT00129402|50057372|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
24967758|NCT00129402|50057373|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
24967759|NCT00129402|50057374|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
24967760|NCT00129402|50057375|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
24967761|NCT00129402|50057376|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
24967762|NCT00129402|50057377|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
24967763|NCT00129402|50057378|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
24967764|NCT00129402|50057372|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
24967765|NCT00129402|50057373|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
24967766|NCT00129402|50057374|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
24967767|NCT00129402|50057375|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
24967768|NCT00129402|50057376|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
24967769|NCT00129402|50057377|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
24967770|NCT00129402|50057378|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
24967771|NCT00129402|50057372|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
24967772|NCT00129402|50057373|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
24967773|NCT00129402|50057374|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
24967774|NCT00129402|50057375|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
24967775|NCT00129402|50057376|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
24967776|NCT00129402|50057377|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
24967777|NCT00129402|50057378|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
24967778|NCT00129402|50057372|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
24967779|NCT00129402|50057373|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
24967780|NCT00129402|50057374|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
24967781|NCT00129402|50057375|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
24967782|NCT00129402|50057376|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
24967783|NCT00129402|50057377|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
24967784|NCT00129402|50057378|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
24967785|NCT00129402|50057372|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
24967786|NCT00129402|50057373|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
24967787|NCT00129402|50057374|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
24967788|NCT00129402|50057375|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
24967789|NCT00129402|50057376|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
24967790|NCT00129402|50057377|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
24967791|NCT00129402|50057378|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
24967792|NCT00129402|50057372|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
24967793|NCT00129402|50057373|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
24967794|NCT00129402|50057374|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
24967795|NCT00129402|50057375|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
24967796|NCT00129402|50057376|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
24967797|NCT00129402|50057377|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
24967798|NCT00129402|50057378|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
24967799|NCT03739528|50057388|FG000|Overall Study|Not treated|8|||
24967800|NCT03739528|50057389|FG001|Overall Study|Not treated|12|||
24967801|NCT03739528|50057388|FG000|Overall Study|Treatment and study discontinued|6|||
24967802|NCT03739528|50057389|FG001|Overall Study|Treatment and study discontinued|2|||
24967803|NCT03739528|50057388|FG000|Overall Study|Treatment discontinued + study completed|1|||
24967804|NCT03739528|50057389|FG001|Overall Study|Treatment discontinued + study completed|3|||
24967805|NCT00114738|50057398|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
24967806|NCT00114738|50057399|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
24967807|NCT00114738|50057400|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
24967808|NCT00114738|50057398|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
24967809|NCT00114738|50057399|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
24967810|NCT00114738|50057400|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
24967811|NCT00114738|50057398|FG000|Screening for Randomization|Neuropathy|17|||
24967812|NCT00114738|50057399|FG001|Screening for Randomization|Neuropathy|0|||
24967813|NCT00114738|50057400|FG002|Screening for Randomization|Neuropathy|0|||
24967814|NCT00114738|50057398|FG000|Screening for Randomization|Progressive disease|2|||
24967815|NCT00114738|50057399|FG001|Screening for Randomization|Progressive disease|0|||
25068872|NCT01975831|50174592|FG004|Overall Study|Entered Hospice|0|||
25068873|NCT01975831|50174593|FG005|Overall Study|Entered Hospice|1|||
24967816|NCT00114738|50057400|FG002|Screening for Randomization|Progressive disease|0|||
24967817|NCT00114738|50057398|FG000|Screening for Randomization|CNS Hemorrhage|1|||
24967818|NCT00114738|50057399|FG001|Screening for Randomization|CNS Hemorrhage|0|||
24967819|NCT00114738|50057400|FG002|Screening for Randomization|CNS Hemorrhage|0|||
24967820|NCT00114738|50057398|FG000|Screening for Randomization|Other|1|||
24967821|NCT00114738|50057399|FG001|Screening for Randomization|Other|0|||
24967822|NCT00114738|50057400|FG002|Screening for Randomization|Other|0|||
25068874|NCT01975831|50174594|FG006|Overall Study|Entered Hospice|0|||
25068875|NCT01975831|50174595|FG007|Overall Study|Entered Hospice|0|||
25068876|NCT01975831|50174596|FG008|Overall Study|Entered Hospice|0|||
25068877|NCT01975831|50174588|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
25068878|NCT01975831|50174589|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
25068879|NCT01975831|50174590|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
24967823|NCT00148122|50057407|FG000|Overall Study|Withdrawal by Subject|2|||
24967824|NCT00147498|50057415|FG000|Overall Study|Adverse Event|1|||
24967825|NCT00147498|50057416|FG001|Overall Study|Adverse Event|6|||
24967826|NCT00147498|50057417|FG002|Overall Study|Adverse Event|7|||
24967827|NCT00147498|50057418|FG003|Overall Study|Adverse Event|3|||
24967828|NCT00147498|50057415|FG000|Overall Study|Lack of Efficacy|1|||
24967829|NCT00147498|50057416|FG001|Overall Study|Lack of Efficacy|1|||
24967830|NCT00147498|50057417|FG002|Overall Study|Lack of Efficacy|1|||
24967831|NCT00147498|50057418|FG003|Overall Study|Lack of Efficacy|8|||
24967832|NCT00147498|50057415|FG000|Overall Study|Laboratory abnormality|0|||
24967833|NCT00147498|50057416|FG001|Overall Study|Laboratory abnormality|0|||
25168853|NCT00985959|50298952|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
25188947|NCT00630877|50344655|FG001|Overall Study|Withdrawal by Subject|4|||
25188948|NCT00630877|50344656|FG002|Overall Study|Withdrawal by Subject|0|||
25188949|NCT00630877|50344654|FG000|Overall Study|Lost to Follow-up|2|||
25188950|NCT00630877|50344655|FG001|Overall Study|Lost to Follow-up|0|||
25188951|NCT00630877|50344656|FG002|Overall Study|Lost to Follow-up|0|||
25188952|NCT00630877|50344654|FG000|Overall Study|Noncompliance|2|||
25188953|NCT00630877|50344655|FG001|Overall Study|Noncompliance|3|||
25188954|NCT00630877|50344656|FG002|Overall Study|Noncompliance|1|||
25188955|NCT00630877|50344654|FG000|Overall Study|Protocol violation|1|||
25188956|NCT00630877|50344655|FG001|Overall Study|Protocol violation|0|||
25188957|NCT00630877|50344656|FG002|Overall Study|Protocol violation|1|||
25188958|NCT00630877|50344654|FG000|Overall Study|Personal reasons|0|||
25188959|NCT00630877|50344655|FG001|Overall Study|Personal reasons|0|||
25188960|NCT00630877|50344656|FG002|Overall Study|Personal reasons|1|||
25188961|NCT02915783|50344668|FG000|Overall Study|Death|21|||
25188962|NCT02915783|50344668|FG000|Overall Study|Lost to Follow-up|1|||
25188963|NCT02915783|50344668|FG000|Overall Study|Withdrawal by Subject|2|||
25188964|NCT00630331|50344683|FG000|Overall Study|Death|2|||
25188965|NCT00630331|50344684|FG001|Overall Study|Death|1|||
25188966|NCT00630331|50344685|FG002|Overall Study|Death|1|||
25188967|NCT00630331|50344683|FG000|Overall Study|Adverse Event|1|||
25188968|NCT00630331|50344684|FG001|Overall Study|Adverse Event|0|||
25188969|NCT00630331|50344685|FG002|Overall Study|Adverse Event|0|||
25188970|NCT00630331|50344683|FG000|Overall Study|Withdrawal by Subject|12|||
25188971|NCT00630331|50344684|FG001|Overall Study|Withdrawal by Subject|7|||
25188972|NCT00630331|50344685|FG002|Overall Study|Withdrawal by Subject|5|||
25188973|NCT00630331|50344683|FG000|Overall Study|Lost to Follow-up|175|||
25188974|NCT00630331|50344684|FG001|Overall Study|Lost to Follow-up|143|||
25188975|NCT00630331|50344685|FG002|Overall Study|Lost to Follow-up|170|||
25188976|NCT00630331|50344683|FG000|Overall Study|Inappropriate enrollment|3|||
25188977|NCT00630331|50344684|FG001|Overall Study|Inappropriate enrollment|6|||
25188978|NCT00630331|50344685|FG002|Overall Study|Inappropriate enrollment|3|||
25188979|NCT00630331|50344683|FG000|Overall Study|Unable to classify|9|||
25188980|NCT00630331|50344684|FG001|Overall Study|Unable to classify|4|||
25188981|NCT00630331|50344685|FG002|Overall Study|Unable to classify|3|||
25188982|NCT00630331|50344683|FG000|Overall Study|Protocol Violation|4|||
25188983|NCT00630331|50344684|FG001|Overall Study|Protocol Violation|5|||
25188984|NCT00630331|50344685|FG002|Overall Study|Protocol Violation|6|||
25188985|NCT00639509|50344737|FG000|Overall Study|Death|1|||
25188986|NCT00638963|50344743|FG000|Overall Study|Withdrawal by Subject|1|||
25188987|NCT00638963|50344744|FG001|Overall Study|Withdrawal by Subject|0|||
25188988|NCT00638183|50344750|FG000|Overall Study|Adverse Event|23|||
25188989|NCT00638183|50344750|FG000|Overall Study|Lack of Efficacy|14|||
25188990|NCT00638183|50344750|FG000|Overall Study|Physician Decision|9|||
25188991|NCT00638183|50344750|FG000|Overall Study|Lost to Follow-up|46|||
25188992|NCT00638183|50344750|FG000|Overall Study|Other reason not defined above|27|||
25188993|NCT00638027|50344756|FG000|Overall Study|Adverse Event|0|||
25188994|NCT00638027|50344757|FG001|Overall Study|Adverse Event|2|||
25188995|NCT00636155|50344763|FG000|Overall Study|Adverse Event|8|||
25188996|NCT00636155|50344763|FG000|Overall Study|Lack of Efficacy|1|||
25188997|NCT00636155|50344763|FG000|Overall Study|Withdrawal by Subject|3|||
25188998|NCT00636155|50344763|FG000|Overall Study|Stem cell transplant|1|||
25188999|NCT00636155|50344763|FG000|Overall Study|Physician Decision|5|||
25189000|NCT00634907|50344769|FG000|Overall Study|Withdrawal by Subject|3|||
25189001|NCT00634907|50344770|FG001|Overall Study|Withdrawal by Subject|0|||
25189002|NCT00634907|50344769|FG000|Overall Study|Physician Decision|3|||
25189003|NCT00634907|50344770|FG001|Overall Study|Physician Decision|9|||
25189004|NCT00634907|50344769|FG000|Overall Study|Withdrawal by Subject|11|||
25189005|NCT00634907|50344770|FG001|Overall Study|Withdrawal by Subject|8|||
25189006|NCT00634751|50344784|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
25189007|NCT00634751|50344785|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
25189008|NCT00634751|50344786|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
25189009|NCT00634751|50344787|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
25189010|NCT00634751|50344784|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
25189011|NCT00634751|50344785|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
25189012|NCT00634751|50344786|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
25189013|NCT00634751|50344787|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
25189014|NCT00634751|50344784|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
25189015|NCT00634751|50344785|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
25189016|NCT00634751|50344786|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
25189017|NCT00634751|50344787|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
25189018|NCT00634049|50344826|FG000|Overall Study|Never received study drug|1|||
25189019|NCT00634049|50344826|FG000|Overall Study|Died prior to receiving study drug|1|||
25189020|NCT00634049|50344826|FG000|Overall Study|Screening failure|1|||
25189021|NCT00632099|50344865|FG000|Overall Study|Lost to Follow-up|3|||
25189022|NCT00632099|50344866|FG001|Overall Study|Lost to Follow-up|3|||
25189023|NCT00632021|50344874|FG000|Overall Study|Withdrawal/death|4|||
25189024|NCT00632021|50344875|FG001|Overall Study|Withdrawal/death|7|||
25189025|NCT00631475|50344882|FG000|Overall Study|Death|18|||
25189026|NCT00631475|50344882|FG000|Overall Study|Adverse Event|14|||
25189027|NCT00631475|50344882|FG000|Overall Study|Withdrew consent|5|||
25189028|NCT00631475|50344882|FG000|Overall Study|Preparation for lung transplant|8|||
25189029|NCT00631163|50344903|FG000|Number of Participants in Year 1|Adverse Event|12|||
25189030|NCT00631163|50344903|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
25189031|NCT00631163|50344903|FG000|Number of Participants in Year 1|Death|6|||
25189032|NCT00631163|50344903|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
25189033|NCT00631163|50344903|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
25189034|NCT00631163|50344903|FG000|Number of Participants in Year 1|Administrative problems|6|||
25189035|NCT00631163|50344903|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
25189036|NCT00631163|50344903|FG000|Number of Participants in Year 2|Adverse Event|1|||
25189037|NCT00631163|50344903|FG000|Number of Participants in Year 2|Protocol Violation|1|||
25189038|NCT00631163|50344903|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
25189039|NCT00631007|50344920|FG000|Overall Study|Adverse Event|0|||
25189040|NCT00631007|50344921|FG001|Overall Study|Adverse Event|2|||
25189041|NCT00631007|50344922|FG002|Overall Study|Adverse Event|0|||
25189042|NCT00631007|50344923|FG003|Overall Study|Adverse Event|2|||
25189043|NCT00631007|50344924|FG004|Overall Study|Adverse Event|3|||
25189044|NCT00631007|50344925|FG005|Overall Study|Adverse Event|2|||
25189045|NCT00631007|50344920|FG000|Overall Study|Lost to Follow-up|2|||
25189046|NCT00631007|50344921|FG001|Overall Study|Lost to Follow-up|1|||
25189047|NCT00631007|50344922|FG002|Overall Study|Lost to Follow-up|2|||
25189048|NCT00631007|50344923|FG003|Overall Study|Lost to Follow-up|4|||
25189049|NCT00631007|50344924|FG004|Overall Study|Lost to Follow-up|5|||
25189050|NCT00631007|50344925|FG005|Overall Study|Lost to Follow-up|3|||
25189051|NCT00631007|50344920|FG000|Overall Study|Physician Decision|1|||
25189052|NCT00631007|50344921|FG001|Overall Study|Physician Decision|0|||
25189053|NCT00631007|50344922|FG002|Overall Study|Physician Decision|1|||
25189054|NCT00631007|50344923|FG003|Overall Study|Physician Decision|0|||
25189055|NCT00631007|50344924|FG004|Overall Study|Physician Decision|0|||
25189056|NCT00631007|50344925|FG005|Overall Study|Physician Decision|2|||
25189057|NCT00631007|50344920|FG000|Overall Study|Persistent Hyperglycemia|2|||
25189058|NCT00631007|50344921|FG001|Overall Study|Persistent Hyperglycemia|2|||
25189059|NCT00631007|50344922|FG002|Overall Study|Persistent Hyperglycemia|5|||
25189060|NCT00631007|50344923|FG003|Overall Study|Persistent Hyperglycemia|1|||
25189061|NCT00631007|50344924|FG004|Overall Study|Persistent Hyperglycemia|2|||
25189062|NCT00631007|50344925|FG005|Overall Study|Persistent Hyperglycemia|5|||
25189063|NCT00631007|50344920|FG000|Overall Study|Withdrawal by Subject|4|||
25189064|NCT00631007|50344921|FG001|Overall Study|Withdrawal by Subject|5|||
25189065|NCT00631007|50344922|FG002|Overall Study|Withdrawal by Subject|2|||
25189066|NCT00631007|50344923|FG003|Overall Study|Withdrawal by Subject|2|||
25189067|NCT00631007|50344924|FG004|Overall Study|Withdrawal by Subject|1|||
25189068|NCT00631007|50344925|FG005|Overall Study|Withdrawal by Subject|3|||
25189069|NCT00631007|50344920|FG000|Overall Study|Other|2|||
25189070|NCT00631007|50344921|FG001|Overall Study|Other|1|||
25189071|NCT00631007|50344922|FG002|Overall Study|Other|0|||
25189072|NCT00631007|50344923|FG003|Overall Study|Other|0|||
25189073|NCT00631007|50344924|FG004|Overall Study|Other|1|||
25189074|NCT00631007|50344925|FG005|Overall Study|Other|0|||
25189075|NCT00630539|50344952|FG000|Overall Study|Adverse Event|1|||
25189076|NCT00630539|50344953|FG001|Overall Study|Adverse Event|3|||
25189077|NCT00630539|50344954|FG002|Overall Study|Adverse Event|1|||
25189078|NCT00630539|50344955|FG003|Overall Study|Adverse Event|2|||
25189079|NCT00630539|50344952|FG000|Overall Study|Withdrawal by Subject|0|||
25189080|NCT00630539|50344953|FG001|Overall Study|Withdrawal by Subject|1|||
25189081|NCT00630539|50344954|FG002|Overall Study|Withdrawal by Subject|0|||
25189082|NCT00630539|50344955|FG003|Overall Study|Withdrawal by Subject|1|||
24967834|NCT00147498|50057417|FG002|Overall Study|Laboratory abnormality|2|||
24967835|NCT00147498|50057418|FG003|Overall Study|Laboratory abnormality|0|||
24967836|NCT00147498|50057415|FG000|Overall Study|Participant defaulted|0|||
24967837|NCT00147498|50057416|FG001|Overall Study|Participant defaulted|1|||
24967838|NCT00147498|50057417|FG002|Overall Study|Participant defaulted|4|||
24967839|NCT00147498|50057418|FG003|Overall Study|Participant defaulted|3|||
24967840|NCT00147498|50057415|FG000|Overall Study|Other|1|||
24967841|NCT00147498|50057416|FG001|Overall Study|Other|1|||
24967842|NCT00147498|50057417|FG002|Overall Study|Other|3|||
24967843|NCT00147498|50057418|FG003|Overall Study|Other|3|||
24967844|NCT00113568|50057428|FG000|Overall Study|Adverse Event|97|||
24967845|NCT00113568|50057428|FG000|Overall Study|Death|1|||
24967846|NCT00113568|50057428|FG000|Overall Study|Lack of Efficacy|30|||
24967847|NCT00113568|50057428|FG000|Overall Study|Lost to Follow-up|156|||
24967848|NCT00113568|50057428|FG000|Overall Study|Protocol Violation|32|||
24967849|NCT00113568|50057428|FG000|Overall Study|Withdrawal by Subject|117|||
24967850|NCT00113568|50057428|FG000|Overall Study|Other|112|||
24967851|NCT00113490|50057434|FG000|Overall Study|Withdrawal by Subject|1|||
24967852|NCT00113490|50057435|FG001|Overall Study|Withdrawal by Subject|3|||
24967853|NCT00113490|50057434|FG000|Overall Study|Lost to Follow-up|1|||
24967854|NCT00113490|50057435|FG001|Overall Study|Lost to Follow-up|0|||
24967855|NCT00146640|50057443|FG000|Overall Study|Adverse Event|12|||
24967856|NCT00146640|50057444|FG001|Overall Study|Adverse Event|10|||
24967857|NCT00146640|50057443|FG000|Overall Study|Medical Reasons|3|||
24967858|NCT00146640|50057444|FG001|Overall Study|Medical Reasons|0|||
24967859|NCT00146640|50057443|FG000|Overall Study|Non-Medical Reasons|8|||
24967860|NCT00146640|50057444|FG001|Overall Study|Non-Medical Reasons|4|||
24967861|NCT03737110|50057461|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
24967862|NCT03737110|50057462|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
24967863|NCT03737110|50057463|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
24967864|NCT03737110|50057461|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
24967865|NCT03737110|50057462|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
25168854|NCT00985959|50298950|FG000|Overall Study|Complete response observed over 2 cycles|0|||
25168855|NCT00985959|50298951|FG001|Overall Study|Complete response observed over 2 cycles|1|||
25168856|NCT00985959|50298952|FG002|Overall Study|Complete response observed over 2 cycles|4|||
25168857|NCT00985959|50298950|FG000|Overall Study|Other|0|||
25168858|NCT00985959|50298951|FG001|Overall Study|Other|0|||
25168859|NCT00985959|50298952|FG002|Overall Study|Other|11|||
25189083|NCT00630305|50345033|FG000|Overall Study|Withdrawal by Subject|1|||
25189084|NCT00630305|50345033|FG000|Overall Study|Inability to insert contact lens|1|||
25189085|NCT01926197|50345259|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
25189086|NCT01926197|50345260|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
25189087|NCT01926197|50345259|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
25189088|NCT01926197|50345260|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
25189089|NCT00989963|50345285|FG000|Overall Study|Adverse Event|1|||
25189090|NCT00989963|50345286|FG001|Overall Study|Adverse Event|1|||
25189091|NCT00989963|50345287|FG002|Overall Study|Adverse Event|1|||
25189092|NCT00989573|50345325|FG000|Overall Study|Adverse Event|8|||
25189093|NCT00989573|50345326|FG001|Overall Study|Adverse Event|12|||
25189094|NCT00989573|50345327|FG002|Overall Study|Adverse Event|4|||
25189095|NCT00989573|50345325|FG000|Overall Study|Physician Decision|0|||
25189096|NCT00989573|50345326|FG001|Overall Study|Physician Decision|2|||
24967866|NCT03737110|50057463|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
24967867|NCT03737110|50057461|FG000|Run-in (RI) Period|Adverse Event|4|||
24967868|NCT03737110|50057462|FG001|Run-in (RI) Period|Adverse Event|0|||
25168860|NCT00985725|50298968|FG000|Overall Study|Adverse Event|4|||
25168861|NCT00985725|50298969|FG001|Overall Study|Adverse Event|1|||
25168862|NCT00985725|50298968|FG000|Overall Study|Protocol Violation|1|||
25168863|NCT00985725|50298969|FG001|Overall Study|Protocol Violation|3|||
25168864|NCT00985725|50298968|FG000|Overall Study|Withdrawal by Subject|4|||
25168865|NCT00985725|50298969|FG001|Overall Study|Withdrawal by Subject|4|||
25168866|NCT00985725|50298968|FG000|Overall Study|Lost to Follow-up|1|||
25168867|NCT00985725|50298969|FG001|Overall Study|Lost to Follow-up|1|||
25168868|NCT00985725|50298968|FG000|Overall Study|Lack of Efficacy|0|||
25168869|NCT00985725|50298969|FG001|Overall Study|Lack of Efficacy|1|||
25168870|NCT00985725|50298968|FG000|Overall Study|Non-compliance|1|||
25168871|NCT00985725|50298969|FG001|Overall Study|Non-compliance|2|||
25168872|NCT00985725|50298968|FG000|Overall Study|Out-of-window visits|0|||
25168873|NCT00985725|50298969|FG001|Overall Study|Out-of-window visits|1|||
25168874|NCT00985491|50298984|FG000|Overall Study|Adverse Event|8|||
25168875|NCT00985491|50298984|FG000|Overall Study|device migration|7|||
25168876|NCT00985491|50298984|FG000|Overall Study|Withdrawal by Subject|1|||
25168877|NCT00985491|50298984|FG000|Overall Study|implant failure|3|||
25168878|NCT00984867|50299019|FG000|Overall Study|Adverse Event|3|||
25168879|NCT00984867|50299020|FG001|Overall Study|Adverse Event|7|||
25168880|NCT00984867|50299019|FG000|Overall Study|Death|1|||
25189097|NCT00989573|50345327|FG002|Overall Study|Physician Decision|0|||
25189098|NCT00989573|50345325|FG000|Overall Study|Protocol Violation|1|||
25168881|NCT00984867|50299020|FG001|Overall Study|Death|0|||
25189099|NCT00989573|50345326|FG001|Overall Study|Protocol Violation|1|||
25189100|NCT00989573|50345327|FG002|Overall Study|Protocol Violation|1|||
25189101|NCT00989573|50345325|FG000|Overall Study|Withdrawal by Subject|4|||
25189102|NCT00989573|50345326|FG001|Overall Study|Withdrawal by Subject|7|||
24967869|NCT03737110|50057463|FG002|Run-in (RI) Period|Adverse Event|0|||
24967870|NCT03737110|50057461|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
25168882|NCT00984867|50299019|FG000|Overall Study|Withdrawal by Subject|13|||
25168883|NCT00984867|50299020|FG001|Overall Study|Withdrawal by Subject|4|||
24967871|NCT03737110|50057462|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
24967872|NCT03737110|50057463|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
24967873|NCT03737110|50057461|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
24967874|NCT03737110|50057462|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
24967875|NCT03737110|50057463|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
24967876|NCT00146328|50057484|FG000|Overall Study|Adverse Event|39|||
24967877|NCT00146328|50057485|FG001|Overall Study|Adverse Event|48|||
24967878|NCT00146328|50057486|FG002|Overall Study|Adverse Event|79|||
24967879|NCT00146328|50057484|FG000|Overall Study|Protocol Violation|11|||
24967880|NCT00146328|50057485|FG001|Overall Study|Protocol Violation|6|||
24967881|NCT00146328|50057486|FG002|Overall Study|Protocol Violation|12|||
24967882|NCT00146328|50057484|FG000|Overall Study|Lost to Follow-up|7|||
24967883|NCT00146328|50057485|FG001|Overall Study|Lost to Follow-up|4|||
24967884|NCT00146328|50057486|FG002|Overall Study|Lost to Follow-up|7|||
24967885|NCT00146328|50057484|FG000|Overall Study|Withdrawal by Subject|16|||
24967886|NCT00146328|50057485|FG001|Overall Study|Withdrawal by Subject|16|||
24967887|NCT00146328|50057486|FG002|Overall Study|Withdrawal by Subject|22|||
24967888|NCT00146328|50057484|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
24967889|NCT00146328|50057485|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
24967890|NCT00146328|50057486|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
24967891|NCT00146328|50057484|FG000|Overall Study|Trial ended/site closed|8|||
24967892|NCT00146328|50057485|FG001|Overall Study|Trial ended/site closed|2|||
24967893|NCT00146328|50057486|FG002|Overall Study|Trial ended/site closed|19|||
24967894|NCT00146328|50057484|FG000|Overall Study|Patient decision to end|0|||
24967895|NCT00146328|50057485|FG001|Overall Study|Patient decision to end|1|||
24967896|NCT00146328|50057486|FG002|Overall Study|Patient decision to end|6|||
24967897|NCT00146328|50057484|FG000|Overall Study|Enroll into other trial|2|||
24967898|NCT00146328|50057485|FG001|Overall Study|Enroll into other trial|4|||
24967899|NCT00146328|50057486|FG002|Overall Study|Enroll into other trial|2|||
24967900|NCT00146328|50057484|FG000|Overall Study|Death|0|||
24967901|NCT00146328|50057485|FG001|Overall Study|Death|1|||
24967902|NCT00146328|50057486|FG002|Overall Study|Death|1|||
24967903|NCT00146328|50057484|FG000|Overall Study|Moved|2|||
24967904|NCT00146328|50057485|FG001|Overall Study|Moved|0|||
24967905|NCT00146328|50057486|FG002|Overall Study|Moved|0|||
24967906|NCT00146328|50057484|FG000|Overall Study|Interaction with other medication|2|||
24967907|NCT00146328|50057485|FG001|Overall Study|Interaction with other medication|0|||
24967908|NCT00146328|50057486|FG002|Overall Study|Interaction with other medication|1|||
24967909|NCT03733444|50057497|FG000|Overall Study|Adverse Event|8|||
24967910|NCT03733444|50057498|FG001|Overall Study|Adverse Event|10|||
24967911|NCT03733444|50057499|FG002|Overall Study|Adverse Event|5|||
24967912|NCT03733444|50057497|FG000|Overall Study|Death|20|||
24967913|NCT03733444|50057498|FG001|Overall Study|Death|19|||
24967914|NCT03733444|50057499|FG002|Overall Study|Death|11|||
25168884|NCT00984867|50299019|FG000|Overall Study|Lost to Follow-up|3|||
25168885|NCT00984867|50299020|FG001|Overall Study|Lost to Follow-up|4|||
25168886|NCT00984867|50299019|FG000|Overall Study|Poor/non-compliance|0|||
25168887|NCT00984867|50299020|FG001|Overall Study|Poor/non-compliance|1|||
25168888|NCT00984867|50299019|FG000|Overall Study|Subject no longer meets study criteria|1|||
25168889|NCT00984867|50299020|FG001|Overall Study|Subject no longer meets study criteria|1|||
25168890|NCT00984867|50299019|FG000|Overall Study|site closing|1|||
25168891|NCT00984867|50299020|FG001|Overall Study|site closing|0|||
25168892|NCT00984867|50299019|FG000|Overall Study|lack of efficacy and subject compliance|1|||
25168893|NCT00984867|50299020|FG001|Overall Study|lack of efficacy and subject compliance|0|||
24967915|NCT03733444|50057497|FG000|Overall Study|Lost to Follow-up|3|||
25189103|NCT00989573|50345327|FG002|Overall Study|Withdrawal by Subject|3|||
25189104|NCT04126213|50345401|FG000|Overall Study|Lost to Follow-up|9|||
24967916|NCT03733444|50057498|FG001|Overall Study|Lost to Follow-up|0|||
24967917|NCT03733444|50057499|FG002|Overall Study|Lost to Follow-up|1|||
24967918|NCT03733444|50057497|FG000|Overall Study|Lack of Efficacy|0|||
25068880|NCT01975831|50174591|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
25068881|NCT01975831|50174592|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
25068882|NCT01975831|50174593|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
25068883|NCT01975831|50174594|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
25068884|NCT01975831|50174595|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
25068885|NCT01975831|50174596|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
25068886|NCT00700713|50174619|FG000|Overall Study|Protocol Violation|1|||
25068887|NCT00700713|50174620|FG001|Overall Study|Protocol Violation|0|||
25068888|NCT00700713|50174621|FG002|Overall Study|Protocol Violation|1|||
25068889|NCT00700713|50174619|FG000|Overall Study|Withdrawal by Subject|0|||
25068890|NCT00700713|50174620|FG001|Overall Study|Withdrawal by Subject|0|||
25068891|NCT00700713|50174621|FG002|Overall Study|Withdrawal by Subject|1|||
25068892|NCT02622386|50174629|FG000|First Assignment|Withdrawal by Subject|3|||
25068893|NCT02622386|50174630|FG001|First Assignment|Withdrawal by Subject|2|||
25068894|NCT02622386|50174629|FG000|Washout|Withdrawal by Subject|4|||
25068895|NCT02622386|50174630|FG001|Washout|Withdrawal by Subject|4|||
25068896|NCT02622386|50174629|FG000|Second Assignment|Withdrawal by Subject|0|||
25068897|NCT02622386|50174630|FG001|Second Assignment|Withdrawal by Subject|2|||
25068898|NCT02792231|50174638|FG000|Overall Study|Patient/guardian decision|32|||
25068899|NCT02792231|50174639|FG001|Overall Study|Patient/guardian decision|42|||
25068900|NCT02792231|50174638|FG000|Overall Study|Adverse Event|15|||
25068901|NCT02792231|50174639|FG001|Overall Study|Adverse Event|11|||
25068902|NCT02792231|50174638|FG000|Overall Study|Physician Decision|14|||
25068903|NCT02792231|50174639|FG001|Overall Study|Physician Decision|12|||
25068904|NCT02792231|50174638|FG000|Overall Study|Lack of Efficacy|7|||
25068905|NCT02792231|50174639|FG001|Overall Study|Lack of Efficacy|9|||
25068906|NCT02792231|50174638|FG000|Overall Study|Lost to Follow-up|9|||
25068907|NCT02792231|50174639|FG001|Overall Study|Lost to Follow-up|5|||
25068908|NCT02792231|50174638|FG000|Overall Study|Pregnancy|1|||
25189105|NCT04126213|50345402|FG001|Overall Study|Lost to Follow-up|1|||
24967919|NCT03733444|50057498|FG001|Overall Study|Lack of Efficacy|1|||
24967920|NCT03733444|50057499|FG002|Overall Study|Lack of Efficacy|1|||
24967921|NCT03733444|50057497|FG000|Overall Study|Physician Decision|2|||
24967922|NCT03733444|50057498|FG001|Overall Study|Physician Decision|1|||
24967923|NCT03733444|50057499|FG002|Overall Study|Physician Decision|0|||
24967924|NCT03733444|50057497|FG000|Overall Study|Protocol Violation|2|||
24967925|NCT03733444|50057498|FG001|Overall Study|Protocol Violation|1|||
24967926|NCT03733444|50057499|FG002|Overall Study|Protocol Violation|0|||
24967927|NCT03733444|50057497|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
24967928|NCT03733444|50057498|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
24967929|NCT03733444|50057499|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
24967930|NCT03733444|50057497|FG000|Overall Study|Study Terminated by Sponsor|203|||
24967931|NCT03733444|50057498|FG001|Overall Study|Study Terminated by Sponsor|209|||
24967932|NCT03733444|50057499|FG002|Overall Study|Study Terminated by Sponsor|221|||
24967933|NCT03733444|50057497|FG000|Overall Study|Withdrawal by Subject|19|||
24967934|NCT03733444|50057498|FG001|Overall Study|Withdrawal by Subject|18|||
24967935|NCT03733444|50057499|FG002|Overall Study|Withdrawal by Subject|16|||
24967936|NCT03733444|50057497|FG000|Overall Study|Miscellaneous|1|||
24967937|NCT03733444|50057498|FG001|Overall Study|Miscellaneous|0|||
24967938|NCT03733444|50057499|FG002|Overall Study|Miscellaneous|1|||
24967939|NCT03733444|50057497|FG000|Overall Study|Not Treated|1|||
24967940|NCT03733444|50057498|FG001|Overall Study|Not Treated|2|||
24967941|NCT03733444|50057499|FG002|Overall Study|Not Treated|1|||
24967942|NCT03731182|50057519|FG000|Overall Study|Lost to Follow-up|2|||
24967943|NCT03731182|50057520|FG001|Overall Study|Lost to Follow-up|0|||
24967944|NCT03731182|50057519|FG000|Overall Study|Physician Decision|1|||
25189106|NCT04126213|50345403|FG002|Overall Study|Lost to Follow-up|5|||
25189107|NCT04126213|50345404|FG003|Overall Study|Lost to Follow-up|10|||
25189108|NCT04126213|50345405|FG004|Overall Study|Lost to Follow-up|4|||
25189109|NCT04126213|50345406|FG005|Overall Study|Lost to Follow-up|7|||
25189110|NCT04126213|50345401|FG000|Overall Study|Withdrawal by Subject|3|||
25189111|NCT04126213|50345402|FG001|Overall Study|Withdrawal by Subject|2|||
25189112|NCT04126213|50345403|FG002|Overall Study|Withdrawal by Subject|1|||
25189113|NCT04126213|50345404|FG003|Overall Study|Withdrawal by Subject|1|||
25189114|NCT04126213|50345405|FG004|Overall Study|Withdrawal by Subject|1|||
24967945|NCT03731182|50057520|FG001|Overall Study|Physician Decision|0|||
25189115|NCT04126213|50345406|FG005|Overall Study|Withdrawal by Subject|1|||
24967946|NCT03731182|50057519|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
24967947|NCT03731182|50057520|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
24967948|NCT03730012|50057529|FG000|Overall Study|Adverse Event|0|||
25068909|NCT02792231|50174639|FG001|Overall Study|Pregnancy|3|||
25068910|NCT02792231|50174638|FG000|Overall Study|Non-compliance with study treatment|2|||
25068911|NCT02792231|50174639|FG001|Overall Study|Non-compliance with study treatment|1|||
25189116|NCT04126213|50345401|FG000|Overall Study|Other|0|||
24967949|NCT03730012|50057530|FG001|Overall Study|Adverse Event|1|||
24967950|NCT03730012|50057529|FG000|Overall Study|Lack of Efficacy|1|||
24967951|NCT03730012|50057530|FG001|Overall Study|Lack of Efficacy|5|||
24967952|NCT03730012|50057529|FG000|Overall Study|Withdrawal by Subject|0|||
24967953|NCT03730012|50057530|FG001|Overall Study|Withdrawal by Subject|1|||
24967954|NCT03730012|50057529|FG000|Overall Study|Miscellaneous|2|||
24967955|NCT03730012|50057530|FG001|Overall Study|Miscellaneous|1|||
24967956|NCT03728140|50057541|FG000|Overall Study|Abnormal embryo transfer operation|10|||
24967957|NCT03728140|50057542|FG001|Overall Study|Abnormal embryo transfer operation|7|||
24967958|NCT03725722|50057567|FG000|Overall Study|Lack of Efficacy|2|||
24967959|NCT03725722|50057568|FG001|Overall Study|Lack of Efficacy|1|||
24967960|NCT03725722|50057569|FG002|Overall Study|Lack of Efficacy|2|||
24967961|NCT03725722|50057570|FG003|Overall Study|Lack of Efficacy|0|||
24967962|NCT03725722|50057571|FG004|Overall Study|Lack of Efficacy|2|||
24967963|NCT03725722|50057567|FG000|Overall Study|Adverse Event|2|||
24967964|NCT03725722|50057568|FG001|Overall Study|Adverse Event|2|||
24967965|NCT03725722|50057569|FG002|Overall Study|Adverse Event|1|||
24967966|NCT03725722|50057570|FG003|Overall Study|Adverse Event|0|||
24967967|NCT03725722|50057571|FG004|Overall Study|Adverse Event|6|||
24967968|NCT03725722|50057567|FG000|Overall Study|Withdrawal by Subject|4|||
24967969|NCT03725722|50057568|FG001|Overall Study|Withdrawal by Subject|1|||
24967970|NCT03725722|50057569|FG002|Overall Study|Withdrawal by Subject|0|||
24967971|NCT03725722|50057570|FG003|Overall Study|Withdrawal by Subject|4|||
24967972|NCT03725722|50057571|FG004|Overall Study|Withdrawal by Subject|4|||
24967973|NCT03725722|50057567|FG000|Overall Study|Lost to Follow-up|3|||
24967974|NCT03725722|50057568|FG001|Overall Study|Lost to Follow-up|1|||
24967975|NCT03725722|50057569|FG002|Overall Study|Lost to Follow-up|2|||
24967976|NCT03725722|50057570|FG003|Overall Study|Lost to Follow-up|2|||
24967977|NCT03725722|50057571|FG004|Overall Study|Lost to Follow-up|1|||
24967978|NCT03725722|50057567|FG000|Overall Study|Personal reasons|0|||
24967979|NCT03725722|50057568|FG001|Overall Study|Personal reasons|0|||
24967980|NCT03725722|50057569|FG002|Overall Study|Personal reasons|1|||
25189117|NCT04126213|50345402|FG001|Overall Study|Other|0|||
25189118|NCT04126213|50345403|FG002|Overall Study|Other|2|||
25189119|NCT04126213|50345404|FG003|Overall Study|Other|2|||
25189120|NCT04126213|50345405|FG004|Overall Study|Other|0|||
25189121|NCT04126213|50345406|FG005|Overall Study|Other|1|||
25189122|NCT04126213|50345401|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
25189123|NCT04126213|50345402|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
25189124|NCT04126213|50345403|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
25189125|NCT04126213|50345404|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
25189126|NCT04126213|50345405|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
25189127|NCT04126213|50345406|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
25189128|NCT04128319|50345423|FG000|Overall Study|Death|3|||
25189129|NCT05038293|50345469|FG000|Overall Study|device was not operating properly for one subject.|1|||
25189130|NCT05038293|50345470|FG001|Overall Study|device was not operating properly for one subject.|0|||
25189131|NCT05038293|50345469|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
25189132|NCT05038293|50345470|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
25189133|NCT05013008|50345478|FG000|Overall Study|Exclusion from mBFAS|5|||
25189134|NCT05013008|50345479|FG001|Overall Study|Exclusion from mBFAS|25|||
24967981|NCT03725722|50057570|FG003|Overall Study|Personal reasons|0|||
24967982|NCT03725722|50057571|FG004|Overall Study|Personal reasons|1|||
25168894|NCT00984009|50299060|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
25168895|NCT00983931|50299067|FG000|14 Day Washout Period|Physician Decision|1|||
25168896|NCT00983853|50299079|FG000|Overall Study|Lost to Follow-up|1|||
25168897|NCT00983853|50299080|FG001|Overall Study|Lost to Follow-up|1|||
25168898|NCT00983853|50299081|FG002|Overall Study|Lost to Follow-up|2|||
25168899|NCT00983853|50299082|FG003|Overall Study|Lost to Follow-up|2|||
25168900|NCT00983853|50299083|FG004|Overall Study|Lost to Follow-up|2|||
25168901|NCT00983853|50299084|FG005|Overall Study|Lost to Follow-up|1|||
25168902|NCT00983853|50299079|FG000|Overall Study|Withdrawal by Subject|0|||
25168903|NCT00983853|50299080|FG001|Overall Study|Withdrawal by Subject|0|||
25168904|NCT00983853|50299081|FG002|Overall Study|Withdrawal by Subject|1|||
25168905|NCT00983853|50299082|FG003|Overall Study|Withdrawal by Subject|0|||
25168906|NCT00983853|50299083|FG004|Overall Study|Withdrawal by Subject|1|||
25168907|NCT00983853|50299084|FG005|Overall Study|Withdrawal by Subject|0|||
25168908|NCT00983853|50299079|FG000|Overall Study|Unable to come to study follow-up visits|0|||
25168909|NCT00983853|50299080|FG001|Overall Study|Unable to come to study follow-up visits|1|||
25168910|NCT00983853|50299081|FG002|Overall Study|Unable to come to study follow-up visits|0|||
24967983|NCT03725722|50057567|FG000|Overall Study|COVID-19 situation|0|||
24967984|NCT03725722|50057568|FG001|Overall Study|COVID-19 situation|1|||
24967985|NCT03725722|50057569|FG002|Overall Study|COVID-19 situation|0|||
24967986|NCT03725722|50057570|FG003|Overall Study|COVID-19 situation|0|||
24967987|NCT03725722|50057571|FG004|Overall Study|COVID-19 situation|0|||
24967988|NCT02966314|50057585|FG000|Overall Study|Lost to Follow-up|1|||
25168911|NCT00983853|50299082|FG003|Overall Study|Unable to come to study follow-up visits|0|||
24967989|NCT02966314|50057586|FG001|Overall Study|Lost to Follow-up|0|||
24967990|NCT03723070|50057592|FG000|Overall Study|Lost to Follow-up|2|||
24967991|NCT03723070|50057592|FG000|Overall Study|Physician Decision|1|||
24967992|NCT03723070|50057592|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
24967993|NCT03722524|50057600|FG000|Overall Study|Protocol Violation|86|||
24967994|NCT03722524|50057600|FG000|Overall Study|Adverse Event|7|||
24967995|NCT03722524|50057600|FG000|Overall Study|Lost to Follow-up|1|||
24967996|NCT03722524|50057600|FG000|Overall Study|Reason is not stated|1|||
24967997|NCT03722524|50057600|FG000|Overall Study|Physician Decision|1|||
24967998|NCT03722524|50057600|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
24967999|NCT03722446|50057606|FG000|Overall Study|Protocol Violation|15|||
24968000|NCT03722446|50057607|FG001|Overall Study|Protocol Violation|2|||
24968001|NCT00146172|50057621|FG000|Overall Study|Adverse Event|0|||
24968002|NCT00146172|50057622|FG001|Overall Study|Adverse Event|0|||
24968003|NCT00146172|50057623|FG002|Overall Study|Adverse Event|1|||
25068912|NCT02792231|50174638|FG000|Overall Study|Protocol deviation|2|||
25068913|NCT02792231|50174639|FG001|Overall Study|Protocol deviation|0|||
25068914|NCT02792231|50174638|FG000|Overall Study|Technical problems|0|||
25068915|NCT02792231|50174639|FG001|Overall Study|Technical problems|1|||
25068916|NCT00700401|50174645|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
25068917|NCT00700401|50174645|FG000|Overall Study|Adverse Event|5|||
25068918|NCT00700401|50174645|FG000|Overall Study|Refused Treatment|2|||
25068919|NCT00700401|50174645|FG000|Overall Study|Lost to Follow-up|1|||
25068920|NCT00700401|50174645|FG000|Overall Study|Treatment never started|1|||
25068921|NCT00700401|50174645|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
25068922|NCT00700401|50174645|FG000|Overall Study|Withdrawal by Subject|2|||
25068923|NCT02621606|50174652|FG000|Overall Study|Withdrawal by Subject|0|||
25068924|NCT02621606|50174653|FG001|Overall Study|Withdrawal by Subject|1|||
25068925|NCT02621606|50174654|FG002|Overall Study|Withdrawal by Subject|0|||
25068926|NCT02871401|50174664|FG000|Overall Study|Adverse Event|1|||
25068927|NCT02871401|50174665|FG001|Overall Study|Adverse Event|0|||
25068928|NCT02619812|50174675|FG000|Overall Study|Withdrawal by Subject|0|||
25068929|NCT02619812|50174676|FG001|Overall Study|Withdrawal by Subject|0|||
25068930|NCT02619812|50174677|FG002|Overall Study|Withdrawal by Subject|1|||
25068931|NCT02619812|50174678|FG003|Overall Study|Withdrawal by Subject|2|||
25068932|NCT02623322|50174691|FG000|Overall Study|Lost to Follow-up|2|||
25068933|NCT02623322|50174692|FG001|Overall Study|Lost to Follow-up|1|||
25068934|NCT02623322|50174693|FG002|Overall Study|Lost to Follow-up|0|||
25068935|NCT00105157|50174707|FG000|Double-Blind (DB)|Never Treated|1|||
25068936|NCT00105157|50174708|FG001|Double-Blind (DB)|Never Treated|0|||
25189135|NCT04753164|50345496|FG000|Overall Study|Adverse Event|0|||
25189136|NCT04753164|50345497|FG001|Overall Study|Adverse Event|2|||
25189137|NCT04753164|50345496|FG000|Overall Study|Withdrawal by Subject|9|||
25189138|NCT04753164|50345497|FG001|Overall Study|Withdrawal by Subject|7|||
25189139|NCT04753164|50345496|FG000|Overall Study|Lost to Follow-up|6|||
25189140|NCT04753164|50345497|FG001|Overall Study|Lost to Follow-up|6|||
25189141|NCT04753164|50345496|FG000|Overall Study|Other|12|||
25189142|NCT04753164|50345497|FG001|Overall Study|Other|5|||
25189143|NCT04729101|50345505|FG000|Overall Study|Adverse Event|1|||
25189144|NCT04729101|50345506|FG001|Overall Study|Adverse Event|0|||
25189145|NCT04729101|50345505|FG000|Overall Study|Physician Decision|1|||
25189146|NCT04729101|50345506|FG001|Overall Study|Physician Decision|0|||
25189147|NCT04729101|50345505|FG000|Overall Study|Withdrawal by Subject|1|||
25189148|NCT04729101|50345506|FG001|Overall Study|Withdrawal by Subject|0|||
25189149|NCT04569968|50345536|FG000|Overall Study|Lost to Follow-up|2|||
25189150|NCT04569968|50345537|FG001|Overall Study|Lost to Follow-up|5|||
25189151|NCT04569968|50345536|FG000|Overall Study|Story of head and/or neck surgery|2|||
25189152|NCT04569968|50345537|FG001|Overall Study|Story of head and/or neck surgery|2|||
25189153|NCT04569968|50345536|FG000|Overall Study|Time of stroke onset|8|||
24968004|NCT00146172|50057624|FG003|Overall Study|Adverse Event|1|||
24968005|NCT00146172|50057625|FG004|Overall Study|Adverse Event|0|||
25068937|NCT00105157|50174709|FG002|Double-Blind (DB)|Never Treated|0|||
25068938|NCT00105157|50174710|FG003|Double-Blind (DB)|Never Treated|0|||
25068939|NCT00105157|50174707|FG000|Double-Blind (DB)|Adverse Event|2|||
24968006|NCT00146172|50057626|FG005|Overall Study|Adverse Event|2|||
25068940|NCT00105157|50174708|FG001|Double-Blind (DB)|Adverse Event|0|||
25189154|NCT04569968|50345537|FG001|Overall Study|Time of stroke onset|7|||
25068941|NCT00105157|50174709|FG002|Double-Blind (DB)|Adverse Event|1|||
25068942|NCT00105157|50174710|FG003|Double-Blind (DB)|Adverse Event|1|||
24968007|NCT00146172|50057627|FG006|Overall Study|Adverse Event|3|||
24968008|NCT00146172|50057628|FG007|Overall Study|Adverse Event|10|||
24968009|NCT00146172|50057621|FG000|Overall Study|Lost to Follow-up|0|||
24968010|NCT00146172|50057622|FG001|Overall Study|Lost to Follow-up|0|||
24968011|NCT00146172|50057623|FG002|Overall Study|Lost to Follow-up|0|||
24968012|NCT00146172|50057624|FG003|Overall Study|Lost to Follow-up|0|||
24968013|NCT00146172|50057625|FG004|Overall Study|Lost to Follow-up|0|||
24968014|NCT00146172|50057626|FG005|Overall Study|Lost to Follow-up|0|||
24968015|NCT00146172|50057627|FG006|Overall Study|Lost to Follow-up|0|||
24968016|NCT00146172|50057628|FG007|Overall Study|Lost to Follow-up|1|||
24968017|NCT00146172|50057621|FG000|Overall Study|Disease Progression|2|||
24968018|NCT00146172|50057622|FG001|Overall Study|Disease Progression|4|||
25068943|NCT00105157|50174707|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
25068944|NCT00105157|50174708|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
25068945|NCT00105157|50174709|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
25068946|NCT00105157|50174710|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
25068947|NCT00105157|50174707|FG000|Open-Label Continuation of DB|Adverse Event|3|||
25068948|NCT00105157|50174708|FG001|Open-Label Continuation of DB|Adverse Event|1|||
25068949|NCT00105157|50174709|FG002|Open-Label Continuation of DB|Adverse Event|0|||
25068950|NCT00105157|50174710|FG003|Open-Label Continuation of DB|Adverse Event|0|||
25068951|NCT00105157|50174707|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
25068952|NCT00105157|50174708|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
25068953|NCT00105157|50174709|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
25068954|NCT00105157|50174710|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
24968019|NCT00146172|50057623|FG002|Overall Study|Disease Progression|2|||
25068955|NCT00105157|50174707|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
25068956|NCT00105157|50174708|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
25068957|NCT00105157|50174709|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
25068958|NCT00105157|50174710|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
25068959|NCT00105157|50174707|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
25068960|NCT00105157|50174708|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
25068961|NCT00105157|50174709|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
25068962|NCT00105157|50174710|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
25068963|NCT00105157|50174707|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
24968020|NCT00146172|50057624|FG003|Overall Study|Disease Progression|5|||
24968021|NCT00146172|50057625|FG004|Overall Study|Disease Progression|2|||
24968022|NCT00146172|50057626|FG005|Overall Study|Disease Progression|2|||
24968023|NCT00146172|50057627|FG006|Overall Study|Disease Progression|1|||
24968024|NCT00146172|50057628|FG007|Overall Study|Disease Progression|22|||
24968025|NCT00146172|50057621|FG000|Overall Study|Death|0|||
24968026|NCT00146172|50057622|FG001|Overall Study|Death|0|||
25068964|NCT00105157|50174708|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
25068965|NCT00105157|50174709|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
25068966|NCT00105157|50174710|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
25068967|NCT00105157|50174707|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
25068968|NCT00105157|50174708|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
25068969|NCT00105157|50174709|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
25068970|NCT00105157|50174710|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
25068971|NCT00105157|50174707|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
25068972|NCT00105157|50174708|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
25068973|NCT00105157|50174709|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
25068974|NCT00105157|50174710|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
25068975|NCT00105157|50174707|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
25068976|NCT00105157|50174708|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
25189155|NCT04569968|50345536|FG000|Overall Study|Type of strokr|12|||
24968027|NCT00146172|50057623|FG002|Overall Study|Death|0|||
24968028|NCT00146172|50057624|FG003|Overall Study|Death|0|||
24968029|NCT00146172|50057625|FG004|Overall Study|Death|0|||
24968030|NCT00146172|50057626|FG005|Overall Study|Death|0|||
24968031|NCT00146172|50057627|FG006|Overall Study|Death|1|||
25068977|NCT00105157|50174709|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
25068978|NCT00105157|50174710|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
25068979|NCT00105157|50174707|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
25068980|NCT00105157|50174708|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
25068981|NCT00105157|50174709|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
25068982|NCT00105157|50174710|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
25068983|NCT00105157|50174707|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
25068984|NCT00105157|50174708|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
25068985|NCT00105157|50174709|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
25068986|NCT00105157|50174710|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
25068987|NCT00105157|50174707|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
25068988|NCT00105157|50174708|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
25068989|NCT00105157|50174709|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
25068990|NCT00105157|50174710|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
25068991|NCT02148133|50174731|FG000|Overall Study|Investigator discretion|1|||
25068992|NCT02148133|50174731|FG000|Overall Study|Lack of Efficacy|1|||
25068993|NCT02148133|50174731|FG000|Overall Study|Protocol deviation|1|||
25068994|NCT02148133|50174731|FG000|Overall Study|Protocol-defined stopping criteria|2|||
25068995|NCT00803569|50174735|FG000|Overall Study|Progressive Disease|3|||
24968032|NCT00146172|50057628|FG007|Overall Study|Death|0|||
24968033|NCT00146172|50057621|FG000|Overall Study|Physician Decision|0|||
24968034|NCT00146172|50057622|FG001|Overall Study|Physician Decision|0|||
24968035|NCT00146172|50057623|FG002|Overall Study|Physician Decision|0|||
24968036|NCT00146172|50057624|FG003|Overall Study|Physician Decision|0|||
24968037|NCT00146172|50057625|FG004|Overall Study|Physician Decision|0|||
24968038|NCT00146172|50057626|FG005|Overall Study|Physician Decision|0|||
24968039|NCT00146172|50057627|FG006|Overall Study|Physician Decision|0|||
24968040|NCT00146172|50057628|FG007|Overall Study|Physician Decision|1|||
24968041|NCT00146172|50057621|FG000|Overall Study|Withdrawal by Subject|0|||
24968042|NCT00146172|50057622|FG001|Overall Study|Withdrawal by Subject|0|||
24968043|NCT00146172|50057623|FG002|Overall Study|Withdrawal by Subject|0|||
24968044|NCT00146172|50057624|FG003|Overall Study|Withdrawal by Subject|0|||
24968045|NCT00146172|50057625|FG004|Overall Study|Withdrawal by Subject|0|||
24968046|NCT00146172|50057626|FG005|Overall Study|Withdrawal by Subject|1|||
24968047|NCT00146172|50057627|FG006|Overall Study|Withdrawal by Subject|1|||
24968048|NCT00146172|50057628|FG007|Overall Study|Withdrawal by Subject|4|||
24968049|NCT00146172|50057621|FG000|Overall Study|Symptomatic Deterioration|1|||
24968050|NCT00146172|50057622|FG001|Overall Study|Symptomatic Deterioration|0|||
24968051|NCT00146172|50057623|FG002|Overall Study|Symptomatic Deterioration|1|||
24968052|NCT00146172|50057624|FG003|Overall Study|Symptomatic Deterioration|0|||
24968053|NCT00146172|50057625|FG004|Overall Study|Symptomatic Deterioration|1|||
24968054|NCT00146172|50057626|FG005|Overall Study|Symptomatic Deterioration|2|||
24968055|NCT00146172|50057627|FG006|Overall Study|Symptomatic Deterioration|0|||
24968056|NCT00146172|50057628|FG007|Overall Study|Symptomatic Deterioration|2|||
24968057|NCT00145626|50057656|FG000|Overall Study|Did not have NK infusions|2|||
24968058|NCT00145626|50057656|FG000|Overall Study|Turned 2 years old before treatment|1|||
24968059|NCT00145626|50057656|FG000|Overall Study|Death|1|||
24968060|NCT00145626|50057656|FG000|Overall Study|Withdrawal by Subject|1|||
24968061|NCT00153062|50057680|FG000|Overall Study|Death|360|||
24968062|NCT00153062|50057681|FG001|Overall Study|Death|352|||
24968063|NCT00153062|50057682|FG002|Overall Study|Death|369|||
24968064|NCT00153062|50057683|FG003|Overall Study|Death|365|||
24968065|NCT00153062|50057680|FG000|Overall Study|Withdrawal by Subject|14|||
24968066|NCT00153062|50057681|FG001|Overall Study|Withdrawal by Subject|30|||
24968067|NCT00153062|50057682|FG002|Overall Study|Withdrawal by Subject|27|||
24968068|NCT00153062|50057683|FG003|Overall Study|Withdrawal by Subject|28|||
24968069|NCT00153062|50057680|FG000|Overall Study|Lost to Follow-up|12|||
24968070|NCT00153062|50057681|FG001|Overall Study|Lost to Follow-up|20|||
24968071|NCT00153062|50057682|FG002|Overall Study|Lost to Follow-up|15|||
24968072|NCT00153062|50057683|FG003|Overall Study|Lost to Follow-up|16|||
24968073|NCT00153062|50057680|FG000|Overall Study|Adverse Event|0|||
24968074|NCT00153062|50057681|FG001|Overall Study|Adverse Event|1|||
24968075|NCT00153062|50057682|FG002|Overall Study|Adverse Event|1|||
24968076|NCT00153062|50057683|FG003|Overall Study|Adverse Event|0|||
24968077|NCT00153062|50057680|FG000|Overall Study|Protocol Violation|0|||
24968078|NCT00153062|50057681|FG001|Overall Study|Protocol Violation|2|||
24968079|NCT00153062|50057682|FG002|Overall Study|Protocol Violation|1|||
24968080|NCT00153062|50057683|FG003|Overall Study|Protocol Violation|1|||
24968081|NCT00153062|50057680|FG000|Overall Study|No disposition data available|1|||
24968082|NCT00153062|50057681|FG001|Overall Study|No disposition data available|1|||
24968083|NCT00153062|50057682|FG002|Overall Study|No disposition data available|1|||
24968084|NCT00153062|50057683|FG003|Overall Study|No disposition data available|1|||
24968085|NCT00153062|50057680|FG000|Overall Study|Other|0|||
24968086|NCT00153062|50057681|FG001|Overall Study|Other|0|||
24968087|NCT00153062|50057682|FG002|Overall Study|Other|1|||
24968088|NCT00153062|50057683|FG003|Overall Study|Other|0|||
24968089|NCT00145470|50057695|FG000|Overall Study|Adverse Event|19|||
24968090|NCT00145470|50057696|FG001|Overall Study|Adverse Event|25|||
24968091|NCT00145470|50057695|FG000|Overall Study|Lack of Efficacy|27|||
24968092|NCT00145470|50057696|FG001|Overall Study|Lack of Efficacy|13|||
24968093|NCT00145470|50057695|FG000|Overall Study|Withdrawal by Subject|36|||
24968094|NCT00145470|50057696|FG001|Overall Study|Withdrawal by Subject|34|||
24968095|NCT00145470|50057695|FG000|Overall Study|Lost to Follow-up|21|||
25068996|NCT00803569|50174735|FG000|Overall Study|Noncompliance|1|||
25068997|NCT00112957|50174739|FG000|Overall Study|Progressive disease|18|||
25068998|NCT00112957|50174739|FG000|Overall Study|Physician Decision|1|||
25068999|NCT02376790|50174746|FG000|Overall Study|Withdrawal by Subject|43|||
25069000|NCT02376790|50174747|FG001|Overall Study|Withdrawal by Subject|36|||
25069001|NCT02376790|50174748|FG002|Overall Study|Withdrawal by Subject|37|||
25069002|NCT02376790|50174746|FG000|Overall Study|Decision by Sponsor|2|||
25069003|NCT02376790|50174747|FG001|Overall Study|Decision by Sponsor|1|||
25069004|NCT02376790|50174748|FG002|Overall Study|Decision by Sponsor|4|||
25069005|NCT02376790|50174746|FG000|Overall Study|Lost to Follow-up|15|||
25069006|NCT02376790|50174747|FG001|Overall Study|Lost to Follow-up|10|||
25069007|NCT02376790|50174748|FG002|Overall Study|Lost to Follow-up|12|||
25069008|NCT02376166|50174756|FG000|Overall Study|Adverse Event|1|||
25069009|NCT02376166|50174756|FG000|Overall Study|Discontinued metformin early|2|||
25069010|NCT02311894|50174760|FG000|Overall Study|Discontinued in error|1|||
25069011|NCT02311894|50174760|FG000|Overall Study|Lost to Follow-up|1|||
25069012|NCT02311894|50174760|FG000|Overall Study|Adverse Event|1|||
25069013|NCT02311894|50174760|FG000|Overall Study|Withdrawal by Subject|1|||
25069014|NCT02310646|50174766|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
25069015|NCT02310646|50174767|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
25069016|NCT02310646|50174766|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
25069017|NCT02310646|50174767|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
25069018|NCT02375698|50174791|FG000|Overall Study|Withdrawal by Subject|0|||
25069019|NCT02375698|50174792|FG001|Overall Study|Withdrawal by Subject|2|||
25069020|NCT02375698|50174791|FG000|Overall Study|Physician Decision|2|||
25069021|NCT02375698|50174792|FG001|Overall Study|Physician Decision|0|||
25069022|NCT02374918|50174802|FG000|Overall Study|Protocol Violation|2|||
25069023|NCT02374918|50174803|FG001|Overall Study|Protocol Violation|0|||
25069024|NCT02374918|50174804|FG002|Overall Study|Protocol Violation|2|||
25069025|NCT02374918|50174805|FG003|Overall Study|Protocol Violation|1|||
25069026|NCT02374918|50174802|FG000|Overall Study|Withdrawal by Subject|1|||
25069027|NCT02374918|50174803|FG001|Overall Study|Withdrawal by Subject|1|||
25069028|NCT02374918|50174804|FG002|Overall Study|Withdrawal by Subject|1|||
25069029|NCT02374918|50174805|FG003|Overall Study|Withdrawal by Subject|0|||
25069030|NCT02374918|50174802|FG000|Overall Study|Lack of Efficacy|0|||
25069031|NCT02374918|50174803|FG001|Overall Study|Lack of Efficacy|0|||
25069032|NCT02374918|50174804|FG002|Overall Study|Lack of Efficacy|1|||
25069033|NCT02374918|50174805|FG003|Overall Study|Lack of Efficacy|1|||
25069034|NCT02344576|50174817|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
25069035|NCT02344576|50174818|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
25069036|NCT02344576|50174819|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
25069037|NCT02344576|50174820|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
25069038|NCT02344576|50174817|FG000|1-Month Follow-Up|Death|13|||
25069039|NCT02344576|50174818|FG001|1-Month Follow-Up|Death|8|||
25069040|NCT02344576|50174819|FG002|1-Month Follow-Up|Death|0|||
25069041|NCT02344576|50174820|FG003|1-Month Follow-Up|Death|0|||
25069042|NCT02344576|50174817|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
25069043|NCT02344576|50174818|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
25069044|NCT02344576|50174819|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
25069045|NCT02344576|50174820|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
25069046|NCT02344576|50174817|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
25069047|NCT02344576|50174818|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
25168912|NCT00983853|50299083|FG004|Overall Study|Unable to come to study follow-up visits|0|||
25168913|NCT00983853|50299084|FG005|Overall Study|Unable to come to study follow-up visits|0|||
25189156|NCT04569968|50345537|FG001|Overall Study|Type of strokr|8|||
25277251|NCT01198002|50591272|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
24968096|NCT00145470|50057696|FG001|Overall Study|Lost to Follow-up|17|||
24968097|NCT00145470|50057695|FG000|Overall Study|Reason Not Reported|9|||
24968098|NCT00145470|50057696|FG001|Overall Study|Reason Not Reported|9|||
24968099|NCT00152516|50057702|FG000|Overall Study|Adverse Event|18|||
25069048|NCT02344576|50174819|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
25069049|NCT02344576|50174820|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
25069050|NCT02344576|50174817|FG000|6-Month Follow-Up|Death|14|||
25069051|NCT02344576|50174818|FG001|6-Month Follow-Up|Death|14|||
25069052|NCT02344576|50174819|FG002|6-Month Follow-Up|Death|0|||
25069053|NCT02344576|50174820|FG003|6-Month Follow-Up|Death|0|||
25069054|NCT02344576|50174817|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
25069055|NCT02344576|50174818|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
24968100|NCT00152516|50057702|FG000|Overall Study|Lack and Loss of Efficacy|30|||
24968101|NCT00152516|50057702|FG000|Overall Study|Lost to Follow-up|5|||
24968102|NCT00152516|50057702|FG000|Overall Study|Withdrawal by Subject|8|||
24968103|NCT00152516|50057702|FG000|Overall Study|Protocol Violation|3|||
24968104|NCT00152516|50057702|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
24968105|NCT00152516|50057702|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
24968106|NCT00152516|50057702|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
24968107|NCT00152516|50057702|FG000|Overall Study|Other: Non-Compliance|2|||
24968108|NCT00152516|50057702|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
24968109|NCT00152516|50057702|FG000|Overall Study|Other: Moved Out Of State|1|||
24968110|NCT00152516|50057702|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
24968111|NCT00152516|50057702|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
24968112|NCT00145158|50057708|FG000|Overall Study|premature withdrawal|2|||
24968113|NCT00145158|50057709|FG001|Overall Study|premature withdrawal|3|||
24968114|NCT00150800|50057716|FG000|Overall Study|Adverse Event|89|||
24968115|NCT00150800|50057716|FG000|Overall Study|Death|18|||
24968116|NCT00150800|50057716|FG000|Overall Study|Lack of Efficacy|166|||
24968117|NCT00150800|50057716|FG000|Overall Study|Lost to Follow-up|58|||
24968118|NCT00150800|50057716|FG000|Overall Study|Subject's choice|90|||
24968119|NCT00150800|50057716|FG000|Overall Study|No compliance|18|||
24968120|NCT00150800|50057716|FG000|Overall Study|IP misshandling|1|||
24968121|NCT00150800|50057716|FG000|Overall Study|Site closure|24|||
24968122|NCT00150800|50057716|FG000|Overall Study|Protocol non-adherence|2|||
24968123|NCT00150800|50057716|FG000|Overall Study|Nobody to accompany patient|1|||
24968124|NCT00150800|50057716|FG000|Overall Study|Distance too long for patient|1|||
24968125|NCT00150800|50057716|FG000|Overall Study|Neurosurgery|2|||
24968126|NCT00150800|50057716|FG000|Overall Study|BRV monotherapy|1|||
24968127|NCT00150800|50057716|FG000|Overall Study|Visit refusal|3|||
24968128|NCT00150800|50057716|FG000|Overall Study|Sponsor's request|2|||
24968129|NCT00150800|50057716|FG000|Overall Study|Generalized Epilepsy|1|||
24968130|NCT00150800|50057716|FG000|Overall Study|Moved from area/country|8|||
24968131|NCT00150800|50057716|FG000|Overall Study|PI retiring|2|||
25069056|NCT02344576|50174819|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
24968132|NCT00150800|50057716|FG000|Overall Study|PI leaving site|2|||
24968133|NCT00150800|50057716|FG000|Overall Study|Patient insurance|1|||
24968134|NCT00150800|50057716|FG000|Overall Study|Surgical intervention|4|||
24968135|NCT00150800|50057716|FG000|Overall Study|Pregnancy planned|1|||
24968136|NCT00150800|50057716|FG000|Overall Study|PI discontinuation request|1|||
24968137|NCT00144300|50057723|FG000|Overall Study|Adverse Event|18|||
24968138|NCT00144300|50057724|FG001|Overall Study|Adverse Event|16|||
24968139|NCT00144300|50057723|FG000|Overall Study|Protocol Violation|1|||
24968140|NCT00144300|50057724|FG001|Overall Study|Protocol Violation|3|||
24968141|NCT00144300|50057723|FG000|Overall Study|Lost to Follow-up|3|||
24968142|NCT00144300|50057724|FG001|Overall Study|Lost to Follow-up|0|||
24968143|NCT00144300|50057723|FG000|Overall Study|Withdrawal by Subject|6|||
24968144|NCT00144300|50057724|FG001|Overall Study|Withdrawal by Subject|6|||
24968145|NCT00144300|50057723|FG000|Overall Study|Other reason (not specified)|1|||
24968146|NCT00144300|50057724|FG001|Overall Study|Other reason (not specified)|3|||
25069057|NCT02344576|50174820|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
25069058|NCT02344576|50174817|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
24968147|NCT00149630|50057732|FG000|Overall Study|Incarceration|2|||
24968148|NCT00149630|50057733|FG001|Overall Study|Incarceration|0|||
25189157|NCT04569968|50345536|FG000|Overall Study|Cooperation|8|||
25189158|NCT04569968|50345537|FG001|Overall Study|Cooperation|8|||
25189159|NCT04569968|50345536|FG000|Overall Study|Age interval|17|||
25189160|NCT04569968|50345537|FG001|Overall Study|Age interval|6|||
25189161|NCT04569968|50345536|FG000|Overall Study|Denial of participation to the study|0|||
25189162|NCT04569968|50345537|FG001|Overall Study|Denial of participation to the study|3|||
25189163|NCT04569968|50345536|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
25189164|NCT04569968|50345537|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
25189165|NCT04569968|50345536|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
25189166|NCT04569968|50345537|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
25189167|NCT04569968|50345536|FG000|Overall Study|Quarantine|1|||
25189168|NCT04569968|50345537|FG001|Overall Study|Quarantine|0|||
25189169|NCT04569968|50345536|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
25189170|NCT04569968|50345537|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
25189171|NCT04569968|50345536|FG000|Overall Study|Repetitive stroke|8|||
25189172|NCT04569968|50345537|FG001|Overall Study|Repetitive stroke|0|||
25189173|NCT04569968|50345536|FG000|Overall Study|Insufficient mastication|1|||
25189174|NCT04569968|50345537|FG001|Overall Study|Insufficient mastication|0|||
25189175|NCT04569968|50345536|FG000|Overall Study|Infection|1|||
25189176|NCT04569968|50345537|FG001|Overall Study|Infection|0|||
25189177|NCT03385304|50345545|FG000|Overall Study|Death|19|||
25189178|NCT03385304|50345546|FG001|Overall Study|Death|7|||
25189179|NCT03385304|50345545|FG000|Overall Study|Lost to Follow-up|17|||
25189180|NCT03385304|50345546|FG001|Overall Study|Lost to Follow-up|14|||
25189181|NCT03385304|50345545|FG000|Overall Study|Withdrawal by Subject|3|||
25189182|NCT03385304|50345546|FG001|Overall Study|Withdrawal by Subject|2|||
25189183|NCT03385304|50345545|FG000|Overall Study|Incarceration|2|||
25189184|NCT03385304|50345546|FG001|Overall Study|Incarceration|3|||
25189185|NCT03325608|50345556|FG000|Overall Study|Lost to Follow-up|47|||
25189186|NCT03325608|50345557|FG001|Overall Study|Lost to Follow-up|47|||
25189187|NCT03325608|50345558|FG002|Overall Study|Lost to Follow-up|41|||
25189188|NCT03325608|50345559|FG003|Overall Study|Lost to Follow-up|41|||
25189189|NCT03325608|50345556|FG000|Overall Study|Death|44|||
25189190|NCT03325608|50345557|FG001|Overall Study|Death|0|||
25189191|NCT03325608|50345558|FG002|Overall Study|Death|41|||
25189192|NCT03325608|50345559|FG003|Overall Study|Death|0|||
25189193|NCT03325608|50345556|FG000|Overall Study|Death of Care Recipient|0|||
25189194|NCT03325608|50345557|FG001|Overall Study|Death of Care Recipient|44|||
25189195|NCT03325608|50345558|FG002|Overall Study|Death of Care Recipient|0|||
25189196|NCT03325608|50345559|FG003|Overall Study|Death of Care Recipient|41|||
25189197|NCT03325608|50345556|FG000|Overall Study|Withdrawal by Subject|44|||
25189198|NCT03325608|50345557|FG001|Overall Study|Withdrawal by Subject|44|||
25189199|NCT03325608|50345558|FG002|Overall Study|Withdrawal by Subject|30|||
25189200|NCT03325608|50345559|FG003|Overall Study|Withdrawal by Subject|30|||
25189201|NCT03183141|50345569|FG000|Overall Study|Withdrawal by Subject|2|||
25189202|NCT03183141|50345570|FG001|Overall Study|Withdrawal by Subject|4|||
25189203|NCT03183141|50345569|FG000|Overall Study|Death|0|||
25189204|NCT03183141|50345570|FG001|Overall Study|Death|8|||
25189205|NCT02957539|50345579|FG000|Baseline to Week 16|Lost to Follow-up|8|||
25189206|NCT02957539|50345580|FG001|Baseline to Week 16|Lost to Follow-up|10|||
25189207|NCT02957539|50345581|FG002|Baseline to Week 16|Lost to Follow-up|16|||
25189208|NCT02957539|50345579|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
25189209|NCT02957539|50345580|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
25189210|NCT02957539|50345581|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
25189211|NCT02957539|50345579|FG000|Week 16 to 32|Withdrawal by Subject|3|||
25189212|NCT02957539|50345580|FG001|Week 16 to 32|Withdrawal by Subject|3|||
24968149|NCT00149630|50057732|FG000|Overall Study|Treatment Programs|4|||
24968150|NCT00149630|50057733|FG001|Overall Study|Treatment Programs|5|||
25189213|NCT02957539|50345581|FG002|Week 16 to 32|Withdrawal by Subject|1|||
25189214|NCT02957539|50345579|FG000|Week 16 to 32|Lost to Follow-up|8|||
25189215|NCT02957539|50345580|FG001|Week 16 to 32|Lost to Follow-up|7|||
25189216|NCT02957539|50345581|FG002|Week 16 to 32|Lost to Follow-up|5|||
25189217|NCT02957539|50345579|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
25189218|NCT02957539|50345580|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
25189219|NCT02957539|50345581|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
25189220|NCT02957539|50345579|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
25189221|NCT02957539|50345580|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
25189222|NCT02957539|50345581|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
24968151|NCT00149630|50057732|FG000|Overall Study|Adverse Event|2|||
24968152|NCT00149630|50057733|FG001|Overall Study|Adverse Event|0|||
24968153|NCT00127842|50057743|FG000|Overall Study|Adverse Event|15|||
24968154|NCT00127842|50057743|FG000|Overall Study|Withdrawal by Subject|3|||
24968155|NCT00127842|50057743|FG000|Overall Study|Lost to Follow-up|1|||
24968156|NCT00127842|50057743|FG000|Overall Study|Lack of Efficacy|12|||
24968157|NCT00127842|50057743|FG000|Overall Study|Noncompliance|2|||
24968158|NCT00127842|50057743|FG000|Overall Study|Protocol Violation|1|||
24968159|NCT00127842|50057743|FG000|Overall Study|Other|5|||
24968160|NCT03720652|50057749|FG000|Overall Study|Withdrawal by Subject|2|||
24968161|NCT03720652|50057750|FG001|Overall Study|Withdrawal by Subject|7|||
24968162|NCT03720652|50057749|FG000|Overall Study|Lost to Follow-up|0|||
24968163|NCT03720652|50057750|FG001|Overall Study|Lost to Follow-up|4|||
24968164|NCT00112866|50057760|FG000|Overall Study|Protocol Violation|1|||
24968165|NCT00112866|50057761|FG001|Overall Study|Protocol Violation|0|||
24968166|NCT00112866|50057760|FG000|Overall Study|did not start treatment post-op|1|||
24968167|NCT00112866|50057761|FG001|Overall Study|did not start treatment post-op|2|||
24968168|NCT00127608|50057775|FG000|Overall Study|VZV DNA negative|1|||
24968169|NCT00149396|50057779|FG000|Overall Study|Death|15|||
24968170|NCT00149396|50057779|FG000|Overall Study|Withdrawal by Subject|1|||
24968171|NCT00149396|50057779|FG000|Overall Study|Subject noncompliance|2|||
24968172|NCT00149396|50057779|FG000|Overall Study|other treatment|5|||
24968173|NCT00223496|50057790|FG000|Overall Study|screen failure|9|||
24968174|NCT00223496|50057790|FG000|Overall Study|Lost to Follow-up|4|||
24968175|NCT00223496|50057790|FG000|Overall Study|Lack of Efficacy|6|||
25069059|NCT02344576|50174818|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
25069060|NCT02344576|50174819|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
25069061|NCT02344576|50174820|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
25069062|NCT02344342|50174836|FG000|Overall Study|Industry partner dropped out|11|||
25069063|NCT02344342|50174837|FG001|Overall Study|Industry partner dropped out|9|||
25069064|NCT02344342|50174838|FG002|Overall Study|Industry partner dropped out|14|||
25069065|NCT02344342|50174839|FG003|Overall Study|Industry partner dropped out|10|||
25069066|NCT02343952|50174853|FG000|Study Treatment|Disease Progression|23|||
25069067|NCT02343952|50174853|FG000|Study Treatment|Death|3|||
25069068|NCT02343952|50174853|FG000|Study Treatment|Adverse Event|19|||
25069069|NCT02343952|50174853|FG000|Study Treatment|Withdrawal by Subject|7|||
25069070|NCT02343952|50174853|FG000|Study Treatment|other complicating Diseases|1|||
24968176|NCT00223496|50057790|FG000|Overall Study|Withdrawal by Subject|1|||
24968177|NCT00223496|50057790|FG000|Overall Study|Physician Decision|2|||
24968178|NCT00255944|50057796|FG000|Overall Study|Lost to Follow-up|797|||
24968179|NCT00255944|50057797|FG001|Overall Study|Lost to Follow-up|834|||
24968180|NCT00143598|50057805|FG000|Overall Study|Lost to Follow-up|23|||
24968181|NCT00143598|50057806|FG001|Overall Study|Lost to Follow-up|21|||
25069071|NCT02343952|50174853|FG000|Follow up|Withdrawal by Subject|3|||
25069072|NCT02343952|50174853|FG000|Follow up|Death|33|||
25069073|NCT02343952|50174853|FG000|Follow up|Patient does not meet eligibility for study.|1|||
24968182|NCT00143598|50057805|FG000|Overall Study|Withdrawal by Subject|33|||
24968183|NCT00143598|50057806|FG001|Overall Study|Withdrawal by Subject|37|||
25069074|NCT02343952|50174853|FG000|Follow up|Research department closed by the practice.|5|||
25069075|NCT02343952|50174853|FG000|Follow up|Patient went home to Russia|1|||
25069076|NCT02343952|50174853|FG000|Follow up|Disease Progression|1|||
25069077|NCT02343952|50174853|FG000|Follow up|study terminated|1|||
25069078|NCT02310568|50174862|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
25069079|NCT02310568|50174863|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
24968184|NCT00143598|50057805|FG000|Overall Study|Death|36|||
24968185|NCT00143598|50057806|FG001|Overall Study|Death|36|||
24968186|NCT00126672|50057812|FG000|Overall Study|Adverse Event|4|||
25069080|NCT02310568|50174864|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
25069081|NCT02310568|50174865|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
25069082|NCT02310568|50174866|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
25069083|NCT02310568|50174862|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
25069084|NCT02310568|50174863|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
25069085|NCT02310568|50174864|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
25069086|NCT02310568|50174865|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
25069087|NCT02310568|50174866|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
25069088|NCT02310568|50174862|FG000|Stage 1 ( 4 Weeks)|Other|1|||
25069089|NCT02310568|50174863|FG001|Stage 1 ( 4 Weeks)|Other|1|||
25069090|NCT02310568|50174864|FG002|Stage 1 ( 4 Weeks)|Other|0|||
25069091|NCT02310568|50174865|FG003|Stage 1 ( 4 Weeks)|Other|0|||
25069092|NCT02310568|50174866|FG004|Stage 1 ( 4 Weeks)|Other|0|||
25069093|NCT02310568|50174862|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
25069094|NCT02310568|50174863|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
25069095|NCT02310568|50174864|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
25069096|NCT02310568|50174865|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
25069097|NCT02310568|50174866|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
25069098|NCT02310568|50174862|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
24968187|NCT00126672|50057812|FG000|Overall Study|Lost to Follow-up|4|||
24968188|NCT00145574|50057819|FG000|Double Blind|Adverse Event|0|||
24968189|NCT00145574|50057820|FG001|Double Blind|Adverse Event|3|||
24968190|NCT00145574|50057821|FG002|Double Blind|Adverse Event|1|||
25069099|NCT02310568|50174863|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
24968191|NCT00145574|50057819|FG000|Double Blind|Withdrawal by Subject|1|||
24968192|NCT00145574|50057820|FG001|Double Blind|Withdrawal by Subject|1|||
25069100|NCT02310568|50174864|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
25069101|NCT02310568|50174865|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
25069102|NCT02310568|50174866|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
25069103|NCT02310568|50174862|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
25069104|NCT02310568|50174863|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
24968193|NCT00145574|50057821|FG002|Double Blind|Withdrawal by Subject|1|||
24968194|NCT00145574|50057819|FG000|Double Blind|required restricted medicine|0|||
24968195|NCT00145574|50057820|FG001|Double Blind|required restricted medicine|1|||
24968196|NCT00145574|50057821|FG002|Double Blind|required restricted medicine|0|||
24968197|NCT00145574|50057819|FG000|Open Label Long-term Extension|Adverse Event|0|||
24968198|NCT00145574|50057820|FG001|Open Label Long-term Extension|Adverse Event|0|||
24968199|NCT00145574|50057821|FG002|Open Label Long-term Extension|Adverse Event|5|||
24968200|NCT00145574|50057819|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
24968201|NCT00145574|50057820|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
24968202|NCT00145574|50057821|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
24968203|NCT00145574|50057819|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
24968204|NCT00145574|50057820|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
24968205|NCT00145574|50057821|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
24968206|NCT00145574|50057819|FG000|Open Label Long-term Extension|required restricted medicine|0|||
24968207|NCT00145574|50057820|FG001|Open Label Long-term Extension|required restricted medicine|0|||
24968208|NCT00145574|50057821|FG002|Open Label Long-term Extension|required restricted medicine|1|||
24968209|NCT00145496|50057836|FG000|Overall Study|Adverse Event|42|||
24968210|NCT00145496|50057837|FG001|Overall Study|Adverse Event|30|||
24968211|NCT00145496|50057836|FG000|Overall Study|Lack of Efficacy|12|||
24968212|NCT00145496|50057837|FG001|Overall Study|Lack of Efficacy|7|||
24968213|NCT00145496|50057836|FG000|Overall Study|Withdrawal by Subject|32|||
24968214|NCT00145496|50057837|FG001|Overall Study|Withdrawal by Subject|26|||
24968215|NCT00145496|50057836|FG000|Overall Study|Lost to Follow-up|12|||
24968216|NCT00145496|50057837|FG001|Overall Study|Lost to Follow-up|5|||
24968217|NCT00145496|50057836|FG000|Overall Study|Other|25|||
24968218|NCT00145496|50057837|FG001|Overall Study|Other|13|||
24968219|NCT00255164|50057846|FG000|Overall Study|Adverse Event|10|||
24968220|NCT00255164|50057847|FG001|Overall Study|Adverse Event|6|||
24968221|NCT00255164|50057848|FG002|Overall Study|Adverse Event|9|||
24968222|NCT00255164|50057846|FG000|Overall Study|Lost to Follow-up|4|||
24968223|NCT00255164|50057847|FG001|Overall Study|Lost to Follow-up|3|||
24968224|NCT00255164|50057848|FG002|Overall Study|Lost to Follow-up|4|||
24968225|NCT00255164|50057846|FG000|Overall Study|Withdrawal by Subject|18|||
24968226|NCT00255164|50057847|FG001|Overall Study|Withdrawal by Subject|17|||
24968227|NCT00255164|50057848|FG002|Overall Study|Withdrawal by Subject|8|||
24968228|NCT00255164|50057846|FG000|Overall Study|Noncompliance|0|||
24968229|NCT00255164|50057847|FG001|Overall Study|Noncompliance|1|||
24968230|NCT00255164|50057848|FG002|Overall Study|Noncompliance|2|||
24968231|NCT00255164|50057846|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
24968232|NCT00255164|50057847|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
24968233|NCT00255164|50057848|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
24968234|NCT00255164|50057846|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
24968235|NCT00255164|50057847|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
24968236|NCT00255164|50057848|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
24968237|NCT00255164|50057846|FG000|Overall Study|Possible Barrett's Esophagus|1|||
24968238|NCT00255164|50057847|FG001|Overall Study|Possible Barrett's Esophagus|3|||
24968239|NCT00255164|50057848|FG002|Overall Study|Possible Barrett's Esophagus|8|||
24968240|NCT00255164|50057846|FG000|Overall Study|Esophageal Stricture|0|||
24968241|NCT00255164|50057847|FG001|Overall Study|Esophageal Stricture|0|||
24968242|NCT00255164|50057848|FG002|Overall Study|Esophageal Stricture|1|||
24968243|NCT00255164|50057846|FG000|Overall Study|Therapeutic Failure|11|||
24968244|NCT00255164|50057847|FG001|Overall Study|Therapeutic Failure|2|||
25069105|NCT02310568|50174864|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
25069106|NCT02310568|50174865|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
25069107|NCT02310568|50174866|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
25069108|NCT02310568|50174862|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
25069109|NCT02310568|50174863|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
25069110|NCT02310568|50174864|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
24968245|NCT00255164|50057848|FG002|Overall Study|Therapeutic Failure|3|||
24968246|NCT00126594|50057858|FG000|Overall Study|Ineligible|2|||
24968247|NCT00126594|50057859|FG001|Overall Study|Ineligible|0|||
24968248|NCT00126594|50057858|FG000|Overall Study|Withdrawal by Subject|0|||
25069111|NCT02310568|50174865|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
25069112|NCT02310568|50174866|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
25069113|NCT02310568|50174862|FG000|Stage 2 (4 Weeks)|Other|0|||
25069114|NCT02310568|50174863|FG001|Stage 2 (4 Weeks)|Other|1|||
25069115|NCT02310568|50174864|FG002|Stage 2 (4 Weeks)|Other|1|||
25069116|NCT02310568|50174865|FG003|Stage 2 (4 Weeks)|Other|0|||
25069117|NCT02310568|50174866|FG004|Stage 2 (4 Weeks)|Other|0|||
25069118|NCT02310568|50174862|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
25069119|NCT02310568|50174863|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
25069120|NCT02310568|50174864|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
25069121|NCT02310568|50174865|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
25069122|NCT02310568|50174866|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
25069123|NCT02310568|50174862|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
25069124|NCT02310568|50174863|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
25069125|NCT02310568|50174864|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
25069126|NCT02310568|50174865|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
25069127|NCT02310568|50174866|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
25069128|NCT02310568|50174862|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
25069129|NCT02310568|50174863|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
25069130|NCT02310568|50174864|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
25069131|NCT02310568|50174865|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
25069132|NCT02310568|50174866|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
25069133|NCT02310100|50174884|FG000|Overall Study|Physician Decision|3|||
25069134|NCT02310100|50174884|FG000|Overall Study|Withdrawal by Subject|10|||
25069135|NCT02310100|50174884|FG000|Overall Study|Enrollment closure|1|||
25069136|NCT02310100|50174884|FG000|Overall Study|Unapproved ablation operator|1|||
25069137|NCT02310100|50174884|FG000|Overall Study|Visit compliance|1|||
25069138|NCT02310100|50174884|FG000|Overall Study|Lost to Follow-up|2|||
25069139|NCT02780167|50174894|FG000|Overall Study|Adverse Event|9|||
25069140|NCT02780167|50174895|FG001|Overall Study|Adverse Event|8|||
25069141|NCT02780167|50174896|FG002|Overall Study|Adverse Event|8|||
25069142|NCT02780167|50174897|FG003|Overall Study|Adverse Event|12|||
25069143|NCT02780167|50174898|FG004|Overall Study|Adverse Event|8|||
25069144|NCT02780167|50174894|FG000|Overall Study|Lack of Efficacy|6|||
25069145|NCT02780167|50174895|FG001|Overall Study|Lack of Efficacy|5|||
25069146|NCT02780167|50174896|FG002|Overall Study|Lack of Efficacy|6|||
25069147|NCT02780167|50174897|FG003|Overall Study|Lack of Efficacy|1|||
25069148|NCT02780167|50174898|FG004|Overall Study|Lack of Efficacy|0|||
25069149|NCT02780167|50174894|FG000|Overall Study|Lost to Follow-up|2|||
25069150|NCT02780167|50174895|FG001|Overall Study|Lost to Follow-up|0|||
25069151|NCT02780167|50174896|FG002|Overall Study|Lost to Follow-up|1|||
25189223|NCT02690077|50345594|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
25189224|NCT02690077|50345595|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
25189225|NCT02690077|50345594|FG000|Overall Study|Withdrawal by Subject|0|||
25189226|NCT02690077|50345595|FG001|Overall Study|Withdrawal by Subject|5|||
25189227|NCT02690077|50345594|FG000|Overall Study|Excluded by IRB|0|||
25189228|NCT02690077|50345595|FG001|Overall Study|Excluded by IRB|2|||
25189229|NCT02652949|50345601|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
25189230|NCT02652949|50345601|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
25189231|NCT02652949|50345601|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
25189232|NCT02652949|50345601|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
25189233|NCT02652949|50345601|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
25189234|NCT02652949|50345601|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
25189235|NCT02652949|50345601|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
25189236|NCT02652949|50345601|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
25189237|NCT02652949|50345601|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
25189238|NCT02652949|50345601|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
25189239|NCT02652949|50345601|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
25189240|NCT02652949|50345601|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
25189241|NCT02652949|50345601|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
25189242|NCT02652949|50345601|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
25189243|NCT02652949|50345601|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
25189244|NCT02275780|50345614|FG000|Base Study: 96 Weeks|Adverse Event|6|||
25189245|NCT02275780|50345615|FG001|Base Study: 96 Weeks|Adverse Event|14|||
25189246|NCT02275780|50345614|FG000|Base Study: 96 Weeks|Death|3|||
25189247|NCT02275780|50345615|FG001|Base Study: 96 Weeks|Death|1|||
25189248|NCT02275780|50345614|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
25189249|NCT02275780|50345615|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
25189250|NCT02275780|50345614|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
25189251|NCT02275780|50345615|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
25069152|NCT02780167|50174897|FG003|Overall Study|Lost to Follow-up|0|||
25069153|NCT02780167|50174898|FG004|Overall Study|Lost to Follow-up|0|||
25069154|NCT02780167|50174894|FG000|Overall Study|Does not meet entrance criteria|0|||
25069155|NCT02780167|50174895|FG001|Overall Study|Does not meet entrance criteria|0|||
25069156|NCT02780167|50174896|FG002|Overall Study|Does not meet entrance criteria|1|||
25069157|NCT02780167|50174897|FG003|Overall Study|Does not meet entrance criteria|0|||
25069158|NCT02780167|50174898|FG004|Overall Study|Does not meet entrance criteria|0|||
25069159|NCT02780167|50174894|FG000|Overall Study|No longer meets eligibility criteria|0|||
25069160|NCT02780167|50174895|FG001|Overall Study|No longer meets eligibility criteria|0|||
25069161|NCT02780167|50174896|FG002|Overall Study|No longer meets eligibility criteria|0|||
25069162|NCT02780167|50174897|FG003|Overall Study|No longer meets eligibility criteria|1|||
25069163|NCT02780167|50174898|FG004|Overall Study|No longer meets eligibility criteria|1|||
25069164|NCT02780167|50174894|FG000|Overall Study|Protocol Violation|5|||
25069165|NCT02780167|50174895|FG001|Overall Study|Protocol Violation|5|||
25069166|NCT02780167|50174896|FG002|Overall Study|Protocol Violation|1|||
25069167|NCT02780167|50174897|FG003|Overall Study|Protocol Violation|1|||
25069168|NCT02780167|50174898|FG004|Overall Study|Protocol Violation|2|||
25069169|NCT02780167|50174894|FG000|Overall Study|Withdrawal by Subject|6|||
25069170|NCT02780167|50174895|FG001|Overall Study|Withdrawal by Subject|4|||
25069171|NCT02780167|50174896|FG002|Overall Study|Withdrawal by Subject|4|||
25069172|NCT02780167|50174897|FG003|Overall Study|Withdrawal by Subject|3|||
25069173|NCT02780167|50174898|FG004|Overall Study|Withdrawal by Subject|4|||
25069174|NCT02780167|50174894|FG000|Overall Study|Other|0|||
25069175|NCT02780167|50174895|FG001|Overall Study|Other|0|||
25069176|NCT02780167|50174896|FG002|Overall Study|Other|3|||
25069177|NCT02780167|50174897|FG003|Overall Study|Other|1|||
25069178|NCT02780167|50174898|FG004|Overall Study|Other|2|||
25069179|NCT02779075|50174910|FG000|Overall Study|Withdrawal by Subject|1|||
25069180|NCT02779075|50174911|FG001|Overall Study|Withdrawal by Subject|3|||
25069181|NCT02779075|50174910|FG000|Overall Study|IV lost during 2nd study|1|||
25069182|NCT02779075|50174911|FG001|Overall Study|IV lost during 2nd study|0|||
25069183|NCT00105079|50174923|FG000|Overall Study|Adverse Event|5|||
25069184|NCT00105079|50174924|FG001|Overall Study|Adverse Event|12|||
25069185|NCT00105079|50174923|FG000|Overall Study|Death|3|||
25069186|NCT00105079|50174924|FG001|Overall Study|Death|1|||
25069187|NCT00105079|50174923|FG000|Overall Study|Lost to Follow-up|12|||
25069188|NCT00105079|50174924|FG001|Overall Study|Lost to Follow-up|12|||
25069189|NCT00105079|50174923|FG000|Overall Study|Lack of Efficacy|9|||
25069190|NCT00105079|50174924|FG001|Overall Study|Lack of Efficacy|3|||
25069191|NCT00105079|50174923|FG000|Overall Study|Refused treatment|6|||
25069192|NCT00105079|50174924|FG001|Overall Study|Refused treatment|4|||
25069193|NCT00105079|50174923|FG000|Overall Study|Violation of selection criteria at entry|0|||
25069194|NCT00105079|50174924|FG001|Overall Study|Violation of selection criteria at entry|2|||
25069195|NCT00105079|50174923|FG000|Overall Study|Protocol Violation|1|||
25069196|NCT00105079|50174924|FG001|Overall Study|Protocol Violation|0|||
25069197|NCT00105079|50174923|FG000|Overall Study|Other|3|||
25069198|NCT00105079|50174924|FG001|Overall Study|Other|1|||
25069199|NCT02777827|50174930|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
25069200|NCT02777827|50174931|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
25069201|NCT02777827|50174932|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
25069202|NCT02777827|50174933|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
25069203|NCT02777827|50174934|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
25069204|NCT02777827|50174935|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
25069205|NCT02712333|50174951|FG000|First Period|Withdrawal by Subject|3|||
25069206|NCT02712333|50174952|FG001|First Period|Withdrawal by Subject|2|||
24968249|NCT00126594|50057859|FG001|Overall Study|Withdrawal by Subject|4|||
24968250|NCT00126594|50057858|FG000|Overall Study|Physician Decision|1|||
24968251|NCT00126594|50057859|FG001|Overall Study|Physician Decision|3|||
24968252|NCT00126594|50057858|FG000|Overall Study|Adverse Event|7|||
24968253|NCT00126594|50057859|FG001|Overall Study|Adverse Event|5|||
24968254|NCT00126594|50057858|FG000|Overall Study|Non-compliance|0|||
24968255|NCT00126594|50057859|FG001|Overall Study|Non-compliance|1|||
24968256|NCT00126594|50057858|FG000|Overall Study|Disease Progression|29|||
24968257|NCT00126594|50057859|FG001|Overall Study|Disease Progression|24|||
24968258|NCT00126438|50057868|FG000|Overall Study|Withdrawal due to adverse event|1|||
24968259|NCT00126438|50057869|FG001|Overall Study|Withdrawal due to adverse event|0|||
24968260|NCT00126438|50057868|FG000|Overall Study|Lost to Follow-up|22|||
24968261|NCT00126438|50057869|FG001|Overall Study|Lost to Follow-up|0|||
24968262|NCT00126438|50057868|FG000|Overall Study|Protocol Violation|8|||
24968263|NCT00126438|50057869|FG001|Overall Study|Protocol Violation|8|||
24968264|NCT00126438|50057868|FG000|Overall Study|Withdrawal by Subject|3|||
24968265|NCT00126438|50057869|FG001|Overall Study|Withdrawal by Subject|2|||
24968266|NCT00142584|50057877|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
25069207|NCT02343406|50174968|FG000|Overall Study|Progressive disease|72|||
24968267|NCT00142584|50057878|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
24968268|NCT00142584|50057877|FG000|Overall Study|Withdrawal by Subject|30|||
25069208|NCT02343406|50174969|FG001|Overall Study|Progressive disease|70|||
24968269|NCT00142584|50057878|FG001|Overall Study|Withdrawal by Subject|16|||
25069209|NCT02343406|50174970|FG002|Overall Study|Progressive disease|43|||
25069210|NCT02343406|50174971|FG003|Overall Study|Progressive disease|15|||
24968270|NCT00142584|50057877|FG000|Overall Study|Lost to Follow-up|22|||
24968271|NCT00142584|50057878|FG001|Overall Study|Lost to Follow-up|12|||
24968272|NCT00142584|50057877|FG000|Overall Study|Adverse Event|14|||
24968273|NCT00142584|50057878|FG001|Overall Study|Adverse Event|5|||
24968274|NCT00142584|50057877|FG000|Overall Study|Protocol Violation|4|||
24968275|NCT00142584|50057878|FG001|Overall Study|Protocol Violation|7|||
24968276|NCT00142584|50057877|FG000|Overall Study|Treatment Failure|2|||
24968277|NCT00142584|50057878|FG001|Overall Study|Treatment Failure|0|||
24968278|NCT00126126|50057888|FG000|Overall Study|Lost to Follow-up|0|||
24968279|NCT00126126|50057889|FG001|Overall Study|Lost to Follow-up|2|||
24968280|NCT00125268|50057897|FG000|Overall Study|Withdrawal by Subject|1|||
24968281|NCT00125268|50057898|FG001|Overall Study|Withdrawal by Subject|1|||
24968282|NCT00125190|50057904|FG000|Overall Study|Subject/Parent Decision|7|||
24968283|NCT00125190|50057904|FG000|Overall Study|Non-compliance|2|||
24968284|NCT00125190|50057904|FG000|Overall Study|Adverse Event|1|||
24968285|NCT00125190|50057904|FG000|Overall Study|Other|1|||
24968286|NCT00125190|50057904|FG000|Overall Study|Lost to Follow-up|4|||
24968287|NCT00141726|50057909|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
24968288|NCT00111228|50057916|FG000|Overall Study|Withdrawal by Subject|5|||
24968289|NCT00111228|50057917|FG001|Overall Study|Withdrawal by Subject|1|||
24968290|NCT00111228|50057918|FG002|Overall Study|Withdrawal by Subject|0|||
24968291|NCT00110994|50057928|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
24968292|NCT00110994|50057929|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
25277252|NCT01198002|50591270|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
25277253|NCT01198002|50591271|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
25277254|NCT01198002|50591272|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
25277255|NCT01198002|50591270|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
25277256|NCT01198002|50591271|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
25277257|NCT01198002|50591272|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
25277258|NCT01198002|50591270|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
24968293|NCT00110994|50057928|FG000|Double-blind (DB) Treatment|Death|1|||
24968294|NCT00110994|50057929|FG001|Double-blind (DB) Treatment|Death|0|||
24968295|NCT00110994|50057928|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
24968296|NCT00110994|50057929|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
24968297|NCT00110994|50057928|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
24968298|NCT00110994|50057929|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
25069211|NCT02343406|50174972|FG004|Overall Study|Progressive disease|5|||
24968299|NCT00110994|50057928|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
24968300|NCT00110994|50057929|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
24968301|NCT00110994|50057928|FG000|Double-blind (DB) Treatment|other reasons|2|||
24968302|NCT00110994|50057929|FG001|Double-blind (DB) Treatment|other reasons|3|||
24968303|NCT00110994|50057928|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
24968304|NCT00110994|50057929|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
24968305|NCT00110994|50057928|FG000|Active Follow-up|Other reasons|0|||
24968306|NCT00110994|50057929|FG001|Active Follow-up|Other reasons|2|||
24968307|NCT00110994|50057928|FG000|Long Term Follow-up|Death|19|||
25069212|NCT02343406|50174968|FG000|Overall Study|Adverse Event|6|||
25069213|NCT02343406|50174969|FG001|Overall Study|Adverse Event|8|||
25069214|NCT02343406|50174970|FG002|Overall Study|Adverse Event|6|||
25069215|NCT02343406|50174971|FG003|Overall Study|Adverse Event|3|||
24968308|NCT00110994|50057929|FG001|Long Term Follow-up|Death|17|||
24968309|NCT00144170|50057937|FG000|Overall Study|Adverse Event|84|||
24968310|NCT00144170|50057938|FG001|Overall Study|Adverse Event|41|||
24968311|NCT00144170|50057937|FG000|Overall Study|Protocol Violation|23|||
25069216|NCT02343406|50174972|FG004|Overall Study|Adverse Event|0|||
25069217|NCT02343406|50174968|FG000|Overall Study|Withdrawal by Subject|6|||
25069218|NCT02343406|50174969|FG001|Overall Study|Withdrawal by Subject|4|||
25069219|NCT02343406|50174970|FG002|Overall Study|Withdrawal by Subject|8|||
25069220|NCT02343406|50174971|FG003|Overall Study|Withdrawal by Subject|3|||
25069221|NCT02343406|50174972|FG004|Overall Study|Withdrawal by Subject|0|||
24968312|NCT00144170|50057938|FG001|Overall Study|Protocol Violation|16|||
24968313|NCT00144170|50057937|FG000|Overall Study|Lost to Follow-up|5|||
25069222|NCT02343406|50174968|FG000|Overall Study|Death|2|||
25069223|NCT02343406|50174969|FG001|Overall Study|Death|1|||
25189252|NCT02275780|50345614|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
24968314|NCT00144170|50057938|FG001|Overall Study|Lost to Follow-up|10|||
24968315|NCT00144170|50057937|FG000|Overall Study|Withdrawal by Subject|29|||
25189253|NCT02275780|50345615|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
24968316|NCT00144170|50057938|FG001|Overall Study|Withdrawal by Subject|13|||
24968317|NCT00144170|50057937|FG000|Overall Study|Other reason not defined above|211|||
24968318|NCT00144170|50057938|FG001|Overall Study|Other reason not defined above|316|||
24968319|NCT00255086|50057946|FG000|Overall Study|Adverse Event|1|||
24968320|NCT00255086|50057947|FG001|Overall Study|Adverse Event|1|||
24968321|NCT00255086|50057946|FG000|Overall Study|Protocol Violation|1|||
24968322|NCT00255086|50057947|FG001|Overall Study|Protocol Violation|1|||
24968323|NCT00110214|50057956|FG000|Overall Study|Never started treatment|21|||
24968324|NCT00110214|50057957|FG001|Overall Study|Never started treatment|20|||
24968325|NCT00110214|50057956|FG000|Overall Study|Disease progression or death|260|||
24968326|NCT00110214|50057957|FG001|Overall Study|Disease progression or death|151|||
24968327|NCT00110214|50057956|FG000|Overall Study|Adverse Event|115|||
24968328|NCT00110214|50057957|FG001|Overall Study|Adverse Event|192|||
24968329|NCT00110214|50057956|FG000|Overall Study|Refused further treatment|52|||
24968330|NCT00110214|50057957|FG001|Overall Study|Refused further treatment|65|||
24968331|NCT00110214|50057956|FG000|Overall Study|Other (not specified)|61|||
24968332|NCT00110214|50057957|FG001|Overall Study|Other (not specified)|75|||
24968333|NCT00124020|50057965|FG000|Overall Study|Death|67|||
24968334|NCT00124020|50057966|FG001|Overall Study|Death|71|||
24968335|NCT00124020|50057965|FG000|Overall Study|Withdrawal by Subject|13|||
24968336|NCT00124020|50057966|FG001|Overall Study|Withdrawal by Subject|11|||
24968337|NCT00124020|50057965|FG000|Overall Study|Lost to Follow-up|5|||
24968338|NCT00124020|50057966|FG001|Overall Study|Lost to Follow-up|8|||
24968339|NCT00124020|50057965|FG000|Overall Study|Other|1|||
24968340|NCT00124020|50057966|FG001|Overall Study|Other|1|||
24968341|NCT00124020|50057965|FG000|Overall Study|Transfer to another hospital|2|||
24968342|NCT00124020|50057966|FG001|Overall Study|Transfer to another hospital|0|||
24968343|NCT00215540|50057975|FG000|Overall Study|Withdrew from study medication|1|||
24968344|NCT00215540|50057976|FG001|Overall Study|Withdrew from study medication|0|||
24968345|NCT00215540|50057977|FG002|Overall Study|Withdrew from study medication|0|||
24968346|NCT00143390|50057987|FG000|Overall Study|Death|2|||
24968347|NCT00143390|50057988|FG001|Overall Study|Death|0|||
24968348|NCT00143390|50057987|FG000|Overall Study|Not meeting entry criteria|2|||
24968349|NCT00143390|50057988|FG001|Overall Study|Not meeting entry criteria|5|||
24968350|NCT00143390|50057987|FG000|Overall Study|Withdrawal by Subject|4|||
24968351|NCT00143390|50057988|FG001|Overall Study|Withdrawal by Subject|4|||
24968352|NCT00143390|50057987|FG000|Overall Study|Progressive disease|119|||
24968353|NCT00143390|50057988|FG001|Overall Study|Progressive disease|115|||
24968354|NCT00143390|50057987|FG000|Overall Study|Protocol Violation|2|||
24968355|NCT00143390|50057988|FG001|Overall Study|Protocol Violation|0|||
24968356|NCT00143390|50057987|FG000|Overall Study|Study termination|10|||
24968357|NCT00143390|50057988|FG001|Overall Study|Study termination|15|||
24968358|NCT00143390|50057987|FG000|Overall Study|Adverse Event|9|||
24968359|NCT00143390|50057988|FG001|Overall Study|Adverse Event|8|||
24968360|NCT00143390|50057987|FG000|Overall Study|Other|1|||
24968361|NCT00143390|50057988|FG001|Overall Study|Other|2|||
24968362|NCT00141102|50057996|FG000|Overall Study|Adverse Event|233|||
24968363|NCT00141102|50057997|FG001|Overall Study|Adverse Event|305|||
25069224|NCT02343406|50174970|FG002|Overall Study|Death|0|||
25069225|NCT02343406|50174971|FG003|Overall Study|Death|0|||
25069226|NCT02343406|50174972|FG004|Overall Study|Death|0|||
25069227|NCT02343406|50174968|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
25069228|NCT02343406|50174969|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
25069229|NCT02343406|50174970|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
25069230|NCT02343406|50174971|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
25069231|NCT02343406|50174972|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
25069232|NCT02343406|50174968|FG000|Overall Study|Other primary malignancy|0|||
25069233|NCT02343406|50174969|FG001|Overall Study|Other primary malignancy|1|||
25069234|NCT02343406|50174970|FG002|Overall Study|Other primary malignancy|0|||
25069235|NCT02343406|50174971|FG003|Overall Study|Other primary malignancy|0|||
25069236|NCT02343406|50174972|FG004|Overall Study|Other primary malignancy|0|||
25069237|NCT02343406|50174968|FG000|Overall Study|Other, not specified|2|||
25069238|NCT02343406|50174969|FG001|Overall Study|Other, not specified|1|||
25069239|NCT02343406|50174970|FG002|Overall Study|Other, not specified|1|||
25069240|NCT02343406|50174971|FG003|Overall Study|Other, not specified|4|||
25069241|NCT02343406|50174972|FG004|Overall Study|Other, not specified|0|||
25069242|NCT02710071|50174985|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
25069243|NCT02710071|50174986|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
25069244|NCT02710071|50174985|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
24968364|NCT00141102|50057996|FG000|Overall Study|Laboratory Abnormality|9|||
24968365|NCT00141102|50057997|FG001|Overall Study|Laboratory Abnormality|33|||
24968366|NCT00141102|50057996|FG000|Overall Study|Lack of Efficacy|21|||
24968367|NCT00141102|50057997|FG001|Overall Study|Lack of Efficacy|26|||
25069245|NCT02710071|50174986|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
24968368|NCT00141102|50057996|FG000|Overall Study|Lost to Follow-up|29|||
24968369|NCT00141102|50057997|FG001|Overall Study|Lost to Follow-up|32|||
25069246|NCT02373202|50174997|FG000|Overall Study|Adverse Event|2|||
25069247|NCT02373202|50174998|FG001|Overall Study|Adverse Event|5|||
25069248|NCT02373202|50174999|FG002|Overall Study|Adverse Event|2|||
25069249|NCT02373202|50175000|FG003|Overall Study|Adverse Event|1|||
24968370|NCT00141102|50057996|FG000|Overall Study|Other|87|||
24968371|NCT00141102|50057997|FG001|Overall Study|Other|76|||
24968372|NCT00141102|50057996|FG000|Overall Study|Withdrawal by Subject|112|||
24968373|NCT00141102|50057997|FG001|Overall Study|Withdrawal by Subject|142|||
24968374|NCT00141102|50057996|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
24968375|NCT00141102|50057997|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
24968376|NCT00141102|50057996|FG000|Overall Study|Death|2|||
24968377|NCT00141102|50057997|FG001|Overall Study|Death|2|||
24968378|NCT00255008|50058008|FG000|Overall Study|Adverse Event|1|||
24968379|NCT00255008|50058009|FG001|Overall Study|Adverse Event|1|||
24968380|NCT00255008|50058010|FG002|Overall Study|Adverse Event|2|||
24968381|NCT00255008|50058011|FG003|Overall Study|Adverse Event|0|||
24968382|NCT00255008|50058008|FG000|Overall Study|Lost to Follow-up|1|||
24968383|NCT00255008|50058009|FG001|Overall Study|Lost to Follow-up|0|||
24968384|NCT00255008|50058010|FG002|Overall Study|Lost to Follow-up|1|||
24968385|NCT00255008|50058011|FG003|Overall Study|Lost to Follow-up|2|||
24968386|NCT00255008|50058008|FG000|Overall Study|Did not meet viral reduction criteria|4|||
24968387|NCT00255008|50058009|FG001|Overall Study|Did not meet viral reduction criteria|5|||
24968388|NCT00255008|50058010|FG002|Overall Study|Did not meet viral reduction criteria|0|||
24968389|NCT00255008|50058011|FG003|Overall Study|Did not meet viral reduction criteria|1|||
24968390|NCT00255008|50058008|FG000|Overall Study|Withdrew consent|0|||
24968391|NCT00255008|50058009|FG001|Overall Study|Withdrew consent|0|||
24968392|NCT00255008|50058010|FG002|Overall Study|Withdrew consent|2|||
24968393|NCT00255008|50058011|FG003|Overall Study|Withdrew consent|0|||
24968394|NCT00255008|50058008|FG000|Overall Study|Sponsor request|18|||
24968395|NCT00255008|50058009|FG001|Overall Study|Sponsor request|3|||
24968396|NCT00255008|50058010|FG002|Overall Study|Sponsor request|8|||
24968397|NCT00255008|50058011|FG003|Overall Study|Sponsor request|17|||
24968398|NCT00255008|50058008|FG000|Overall Study|Adverse lab experience|1|||
24968399|NCT00255008|50058009|FG001|Overall Study|Adverse lab experience|0|||
24968400|NCT00255008|50058010|FG002|Overall Study|Adverse lab experience|0|||
24968401|NCT00255008|50058011|FG003|Overall Study|Adverse lab experience|0|||
24968402|NCT00255008|50058008|FG000|Overall Study|Other|7|||
24968403|NCT00255008|50058009|FG001|Overall Study|Other|0|||
24968404|NCT00255008|50058010|FG002|Overall Study|Other|3|||
24968405|NCT00255008|50058011|FG003|Overall Study|Other|2|||
24968406|NCT03714022|50058023|FG000|Overall Study|Adverse Event|1|||
24968407|NCT03714022|50058024|FG001|Overall Study|Adverse Event|0|||
24968408|NCT03714022|50058023|FG000|Overall Study|Consent withdrawal|0|||
24968409|NCT03714022|50058024|FG001|Overall Study|Consent withdrawal|1|||
24968410|NCT03714022|50058023|FG000|Overall Study|Lost to Follow-up|3|||
24968411|NCT03714022|50058024|FG001|Overall Study|Lost to Follow-up|2|||
24968412|NCT00143312|50058030|FG000|Overall Study|Death|11|||
24968413|NCT00143312|50058030|FG000|Overall Study|Adverse Event|2|||
24968414|NCT00143312|50058030|FG000|Overall Study|Lost to Follow-up|1|||
24968415|NCT00143312|50058030|FG000|Overall Study|Other|1|||
24968416|NCT00143312|50058030|FG000|Overall Study|Withdrawal by Subject|1|||
24968417|NCT00254540|50058036|FG000|Overall Study|Adverse Event|6|||
24968418|NCT00254540|50058037|FG001|Overall Study|Adverse Event|7|||
24968419|NCT00254540|50058036|FG000|Overall Study|Lack of Efficacy|13|||
24968420|NCT00254540|50058037|FG001|Overall Study|Lack of Efficacy|13|||
25069250|NCT02373202|50174997|FG000|Overall Study|Lack of Efficacy|0|||
25069251|NCT02373202|50174998|FG001|Overall Study|Lack of Efficacy|0|||
25069252|NCT02373202|50174999|FG002|Overall Study|Lack of Efficacy|1|||
25069253|NCT02373202|50175000|FG003|Overall Study|Lack of Efficacy|0|||
25069254|NCT02373202|50174997|FG000|Overall Study|Other|0|||
25069255|NCT02373202|50174998|FG001|Overall Study|Other|1|||
25069256|NCT02373202|50174999|FG002|Overall Study|Other|0|||
24968421|NCT00254540|50058036|FG000|Overall Study|Death|0|||
24968422|NCT00254540|50058037|FG001|Overall Study|Death|1|||
24968423|NCT00254540|50058036|FG000|Overall Study|Laboratory Test Abnormality|0|||
24968424|NCT00254540|50058037|FG001|Overall Study|Laboratory Test Abnormality|1|||
24968425|NCT00139776|50058046|FG000|Period I|Did not enter Period II|575|||
24968426|NCT00139776|50058047|FG001|Period I|Did not enter Period II|0|||
24968427|NCT00139776|50058048|FG002|Period I|Did not enter Period II|0|||
24968428|NCT00139776|50058049|FG003|Period I|Did not enter Period II|0|||
25069257|NCT02373202|50175000|FG003|Overall Study|Other|0|||
24968429|NCT00139776|50058046|FG000|Period II|Not Randomized into Period III|0|||
24968430|NCT00139776|50058047|FG001|Period II|Not Randomized into Period III|322|||
24968431|NCT00139776|50058048|FG002|Period II|Not Randomized into Period III|0|||
24968432|NCT00139776|50058049|FG003|Period II|Not Randomized into Period III|0|||
24968433|NCT00139776|50058046|FG000|Period III|Adverse Event|0|||
24968434|NCT00139776|50058047|FG001|Period III|Adverse Event|0|||
24968435|NCT00139776|50058048|FG002|Period III|Adverse Event|22|||
24968436|NCT00139776|50058049|FG003|Period III|Adverse Event|23|||
25069258|NCT02622074|50175016|FG000|Overall Study|Death|4|||
24968437|NCT00139776|50058046|FG000|Period III|Other|0|||
24968438|NCT00139776|50058047|FG001|Period III|Other|0|||
24968439|NCT00139776|50058048|FG002|Period III|Other|23|||
24968440|NCT00139776|50058049|FG003|Period III|Other|34|||
24968441|NCT00139776|50058046|FG000|Period III|Lack of Efficacy|0|||
24968442|NCT00139776|50058047|FG001|Period III|Lack of Efficacy|0|||
24968443|NCT00139776|50058048|FG002|Period III|Lack of Efficacy|10|||
24968444|NCT00139776|50058049|FG003|Period III|Lack of Efficacy|24|||
24968445|NCT00139776|50058046|FG000|Period III|Lost to Follow-up|0|||
24968446|NCT00139776|50058047|FG001|Period III|Lost to Follow-up|0|||
24968447|NCT00139776|50058048|FG002|Period III|Lost to Follow-up|5|||
24968448|NCT00139776|50058049|FG003|Period III|Lost to Follow-up|4|||
24968449|NCT00139776|50058046|FG000|Period III|Withdrawal by Subject|0|||
24968450|NCT00139776|50058047|FG001|Period III|Withdrawal by Subject|0|||
24968451|NCT00139776|50058048|FG002|Period III|Withdrawal by Subject|16|||
24968452|NCT00139776|50058049|FG003|Period III|Withdrawal by Subject|21|||
24968453|NCT00413699|50058058|FG000|Initial Period|Death|25|||
24968454|NCT00413699|50058059|FG001|Initial Period|Death|30|||
24968455|NCT00413699|50058060|FG002|Initial Period|Death|0|||
24968456|NCT00413699|50058058|FG000|Initial Period|Lack of Efficacy|59|||
24968457|NCT00413699|50058059|FG001|Initial Period|Lack of Efficacy|115|||
24968458|NCT00413699|50058060|FG002|Initial Period|Lack of Efficacy|0|||
24968459|NCT00413699|50058058|FG000|Initial Period|Lost to Follow-up|31|||
24968460|NCT00413699|50058059|FG001|Initial Period|Lost to Follow-up|101|||
24968461|NCT00413699|50058060|FG002|Initial Period|Lost to Follow-up|0|||
24968462|NCT00413699|50058058|FG000|Initial Period|Protocol Violation|38|||
24968463|NCT00413699|50058059|FG001|Initial Period|Protocol Violation|89|||
24968464|NCT00413699|50058060|FG002|Initial Period|Protocol Violation|0|||
24968465|NCT00413699|50058058|FG000|Initial Period|Pregnancy|10|||
24968466|NCT00413699|50058059|FG001|Initial Period|Pregnancy|8|||
24968467|NCT00413699|50058060|FG002|Initial Period|Pregnancy|0|||
24968468|NCT00413699|50058058|FG000|Initial Period|Did not meet entrance criteria|2|||
24968469|NCT00413699|50058059|FG001|Initial Period|Did not meet entrance criteria|2|||
24968470|NCT00413699|50058060|FG002|Initial Period|Did not meet entrance criteria|0|||
24968471|NCT00413699|50058058|FG000|Initial Period|Medication error without adverse event|0|||
24968472|NCT00413699|50058059|FG001|Initial Period|Medication error without adverse event|1|||
24968473|NCT00413699|50058060|FG002|Initial Period|Medication error without adverse event|0|||
24968474|NCT00413699|50058058|FG000|Initial Period|Study terminated by Sponsor|0|||
24968475|NCT00413699|50058059|FG001|Initial Period|Study terminated by Sponsor|1|||
24968476|NCT00413699|50058060|FG002|Initial Period|Study terminated by Sponsor|0|||
24968477|NCT00413699|50058058|FG000|Initial Period|Other|67|||
24968478|NCT00413699|50058059|FG001|Initial Period|Other|211|||
24968479|NCT00413699|50058060|FG002|Initial Period|Other|0|||
24968480|NCT00413699|50058058|FG000|Initial Period|Adverse event related to study drug|178|||
24968481|NCT00413699|50058059|FG001|Initial Period|Adverse event related to study drug|527|||
24968482|NCT00413699|50058060|FG002|Initial Period|Adverse event related to study drug|0|||
24968483|NCT00413699|50058058|FG000|Initial Period|Adverse event not related to study drug|113|||
24968484|NCT00413699|50058059|FG001|Initial Period|Adverse event not related to study drug|248|||
24968485|NCT00413699|50058060|FG002|Initial Period|Adverse event not related to study drug|0|||
24968486|NCT00413699|50058058|FG000|Initial Period|Missing end of study page|0|||
24968487|NCT00413699|50058059|FG001|Initial Period|Missing end of study page|4|||
24968488|NCT00413699|50058060|FG002|Initial Period|Missing end of study page|0|||
24968489|NCT00413699|50058058|FG000|Initial Period|No longer willing to participate|116|||
24968490|NCT00413699|50058059|FG001|Initial Period|No longer willing to participate|368|||
24968491|NCT00413699|50058060|FG002|Initial Period|No longer willing to participate|0|||
24968492|NCT00413699|50058058|FG000|Extension Period|No Longer Willing to Participate|0|||
24968493|NCT00413699|50058059|FG001|Extension Period|No Longer Willing to Participate|0|||
24968494|NCT00413699|50058060|FG002|Extension Period|No Longer Willing to Participate|2|||
24968495|NCT00413699|50058058|FG000|Extension Period|Protocol Violation|0|||
24968496|NCT00413699|50058059|FG001|Extension Period|Protocol Violation|0|||
24968497|NCT00413699|50058060|FG002|Extension Period|Protocol Violation|1|||
24968498|NCT00413699|50058058|FG000|Extension Period|Adverse Event|0|||
24968499|NCT00413699|50058059|FG001|Extension Period|Adverse Event|0|||
24968500|NCT00413699|50058060|FG002|Extension Period|Adverse Event|2|||
24968501|NCT03713320|50058088|FG000|Randomized Period|Adverse Event|1|||
24968502|NCT03713320|50058089|FG001|Randomized Period|Adverse Event|5|||
24968503|NCT03713320|50058090|FG002|Randomized Period|Adverse Event|0|||
25277259|NCT01198002|50591271|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
24968504|NCT03713320|50058088|FG000|Randomized Period|Physician Decision|1|||
24968505|NCT03713320|50058089|FG001|Randomized Period|Physician Decision|1|||
24968506|NCT03713320|50058090|FG002|Randomized Period|Physician Decision|0|||
24968507|NCT03713320|50058088|FG000|Randomized Period|Withdrawal by Subject|4|||
24968508|NCT03713320|50058089|FG001|Randomized Period|Withdrawal by Subject|0|||
24968509|NCT03713320|50058090|FG002|Randomized Period|Withdrawal by Subject|0|||
24968510|NCT03713320|50058088|FG000|Randomized Period|Participant decision|3|||
24968511|NCT03713320|50058089|FG001|Randomized Period|Participant decision|1|||
24968512|NCT03713320|50058090|FG002|Randomized Period|Participant decision|0|||
24968513|NCT03713320|50058088|FG000|Randomized Period|Study terminated by sponsor|6|||
24968514|NCT03713320|50058089|FG001|Randomized Period|Study terminated by sponsor|3|||
24968515|NCT03713320|50058090|FG002|Randomized Period|Study terminated by sponsor|0|||
24968516|NCT03713320|50058088|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
24968517|NCT03713320|50058089|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
24968518|NCT03713320|50058090|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
24968519|NCT03713320|50058088|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
24968520|NCT03713320|50058089|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
24968521|NCT03713320|50058090|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
24968522|NCT03712930|50058097|FG000|Overall Study|Death|7|||
24968523|NCT03712930|50058097|FG000|Overall Study|Physician Decision|1|||
24968524|NCT03712930|50058097|FG000|Overall Study|Study Terminated by Sponsor|3|||
24968525|NCT03712930|50058097|FG000|Overall Study|Progressive Disease|2|||
24968526|NCT00420407|50058103|FG000|Overall Study|Lost to Follow-up|0|||
24968527|NCT00420407|50058104|FG001|Overall Study|Lost to Follow-up|3|||
24968528|NCT00420407|50058103|FG000|Overall Study|Physician Decision|2|||
24968529|NCT00420407|50058104|FG001|Overall Study|Physician Decision|1|||
24968530|NCT00420407|50058103|FG000|Overall Study|subject identified as detainee|1|||
24968531|NCT00420407|50058104|FG001|Overall Study|subject identified as detainee|0|||
24968532|NCT00420407|50058103|FG000|Overall Study|subject identified as Jehovah's witness|1|||
24968533|NCT00420407|50058104|FG001|Overall Study|subject identified as Jehovah's witness|0|||
24968534|NCT00420407|50058103|FG000|Overall Study|Withdrawal by Subject|0|||
24968535|NCT00420407|50058104|FG001|Overall Study|Withdrawal by Subject|2|||
24968536|NCT00420095|50058113|FG000|Overall Study|Adverse Event|1|||
24968537|NCT00420095|50058114|FG001|Overall Study|Adverse Event|0|||
24968538|NCT00420095|50058113|FG000|Overall Study|Protocol Violation|1|||
24968539|NCT00420095|50058114|FG001|Overall Study|Protocol Violation|1|||
24968540|NCT00420095|50058113|FG000|Overall Study|Lost to Follow-up|1|||
24968541|NCT00420095|50058114|FG001|Overall Study|Lost to Follow-up|0|||
24968542|NCT00419393|50058120|FG000|Overall Study|Adverse Event|5|||
24968543|NCT00419393|50058120|FG000|Overall Study|Protocol Violation|5|||
24968544|NCT00419393|50058120|FG000|Overall Study|Withdrawal by Subject|7|||
24968545|NCT00419393|50058120|FG000|Overall Study|Other: Sponsor request|3|||
24968546|NCT00419393|50058120|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
24968547|NCT00419393|50058120|FG000|Overall Study|Other: Site closure|1|||
24968548|NCT00419393|50058120|FG000|Overall Study|Other: Other health problems|1|||
24968549|NCT00419393|50058120|FG000|Overall Study|Other: Investigator decision|1|||
24968550|NCT00419159|50058126|FG000|Overall Study|Adverse Event|7|||
24968551|NCT00419159|50058127|FG001|Overall Study|Adverse Event|15|||
24968552|NCT00419159|50058126|FG000|Overall Study|Abnormal laboratory value(s)|0|||
24968553|NCT00419159|50058127|FG001|Overall Study|Abnormal laboratory value(s)|2|||
24968554|NCT00419159|50058126|FG000|Overall Study|Subject's no longer requires study drug|0|||
24968555|NCT00419159|50058127|FG001|Overall Study|Subject's no longer requires study drug|1|||
24968556|NCT00419159|50058126|FG000|Overall Study|Protocol Violation|1|||
24968557|NCT00419159|50058127|FG001|Overall Study|Protocol Violation|0|||
24968558|NCT00419159|50058126|FG000|Overall Study|Withdrawal by Subject|10|||
24968559|NCT00419159|50058127|FG001|Overall Study|Withdrawal by Subject|3|||
24968560|NCT00419159|50058126|FG000|Overall Study|Lost to Follow-up|0|||
24968561|NCT00419159|50058127|FG001|Overall Study|Lost to Follow-up|1|||
24968562|NCT00419159|50058126|FG000|Overall Study|Death|2|||
24968563|NCT00419159|50058127|FG001|Overall Study|Death|2|||
24968564|NCT00419159|50058126|FG000|Overall Study|Disease progression|79|||
24968565|NCT00419159|50058127|FG001|Overall Study|Disease progression|76|||
24968566|NCT03717064|50058141|FG000|Period 2|Adverse Event|1|||
24968567|NCT03716050|50058153|FG000|Overall Study|Lost to Follow-up|0|||
24968568|NCT03716050|50058154|FG001|Overall Study|Lost to Follow-up|0|||
24968569|NCT03716050|50058155|FG002|Overall Study|Lost to Follow-up|1|||
24968570|NCT03716050|50058156|FG003|Overall Study|Lost to Follow-up|0|||
24968571|NCT03716050|50058157|FG004|Overall Study|Lost to Follow-up|0|||
24968572|NCT03716050|50058158|FG005|Overall Study|Lost to Follow-up|0|||
24968573|NCT03716050|50058159|FG006|Overall Study|Lost to Follow-up|0|||
24968574|NCT03716050|50058160|FG007|Overall Study|Lost to Follow-up|0|||
24968575|NCT03716050|50058153|FG000|Overall Study|Physician Decision|0|||
24968576|NCT03716050|50058154|FG001|Overall Study|Physician Decision|0|||
24968577|NCT03716050|50058155|FG002|Overall Study|Physician Decision|0|||
24968578|NCT03716050|50058156|FG003|Overall Study|Physician Decision|1|||
24968579|NCT03716050|50058157|FG004|Overall Study|Physician Decision|0|||
24968580|NCT03716050|50058158|FG005|Overall Study|Physician Decision|0|||
24968581|NCT03716050|50058159|FG006|Overall Study|Physician Decision|0|||
24968582|NCT03716050|50058160|FG007|Overall Study|Physician Decision|0|||
24968583|NCT03716050|50058153|FG000|Overall Study|Protocol Violation|0|||
24968584|NCT03716050|50058154|FG001|Overall Study|Protocol Violation|0|||
24968585|NCT03716050|50058155|FG002|Overall Study|Protocol Violation|0|||
24968586|NCT03716050|50058156|FG003|Overall Study|Protocol Violation|1|||
24968587|NCT03716050|50058157|FG004|Overall Study|Protocol Violation|0|||
24968588|NCT03716050|50058158|FG005|Overall Study|Protocol Violation|0|||
24968589|NCT03716050|50058159|FG006|Overall Study|Protocol Violation|0|||
24968590|NCT03716050|50058160|FG007|Overall Study|Protocol Violation|2|||
24968591|NCT00413231|50058177|FG000|0 to 30-day Post Treatment|Death|5|||
24968592|NCT00413231|50058177|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
24968593|NCT00413231|50058177|FG000|30-day to 365-day Post Treatment|Death|13|||
24968594|NCT00413231|50058177|FG000|365-day to 60-month Post Treatment|Death|36|||
24968595|NCT00413231|50058177|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
24968596|NCT00413231|50058177|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
24968597|NCT00413231|50058177|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
24968598|NCT00413153|50058197|FG000|Overall Study|Withdrawal by Subject|1|||
24968599|NCT00413153|50058198|FG001|Overall Study|Withdrawal by Subject|1|||
24968600|NCT00413153|50058197|FG000|Overall Study|Adverse Event|1|||
24968601|NCT00413153|50058198|FG001|Overall Study|Adverse Event|0|||
24968602|NCT00412607|50058204|FG000|Overall Study|Withdrawal by Subject|9|||
24968603|NCT00412607|50058204|FG000|Overall Study|Lost to Follow-up|19|||
24968604|NCT00412607|50058204|FG000|Overall Study|Death|61|||
24968605|NCT00412607|50058204|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
24968606|NCT00419003|50058213|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
24968607|NCT00419003|50058214|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
24968608|NCT00419003|50058213|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
24968609|NCT00419003|50058214|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
24968610|NCT00418691|50058226|FG000|Overall Study|Lost to Follow-up|1|||
24968611|NCT00418691|50058227|FG001|Overall Study|Lost to Follow-up|2|||
24968612|NCT00418691|50058228|FG002|Overall Study|Lost to Follow-up|3|||
24968613|NCT00418691|50058226|FG000|Overall Study|Started new medication voiding entry|0|||
24968614|NCT00418691|50058227|FG001|Overall Study|Started new medication voiding entry|0|||
24968615|NCT00418691|50058228|FG002|Overall Study|Started new medication voiding entry|1|||
24968616|NCT00418691|50058226|FG000|Overall Study|Progressive Disease|1|||
24968617|NCT00418691|50058227|FG001|Overall Study|Progressive Disease|0|||
24968618|NCT00418691|50058228|FG002|Overall Study|Progressive Disease|1|||
24968619|NCT00412373|50058238|FG000|Overall Study|Adverse Event|8|||
24968620|NCT00412373|50058239|FG001|Overall Study|Adverse Event|13|||
24968621|NCT00412373|50058238|FG000|Overall Study|Lack of Efficacy|16|||
24968622|NCT00412373|50058239|FG001|Overall Study|Lack of Efficacy|22|||
24968623|NCT00412373|50058238|FG000|Overall Study|Lost to Follow-up|7|||
24968624|NCT00412373|50058239|FG001|Overall Study|Lost to Follow-up|13|||
25069259|NCT02622074|50175017|FG001|Overall Study|Death|0|||
25069260|NCT02622074|50175018|FG002|Overall Study|Death|0|||
25069261|NCT02622074|50175019|FG003|Overall Study|Death|1|||
25069262|NCT02622074|50175020|FG004|Overall Study|Death|1|||
25069263|NCT02622074|50175021|FG005|Overall Study|Death|0|||
25069264|NCT02622074|50175016|FG000|Overall Study|Withdrawal by Subject|0|||
24968625|NCT00412373|50058238|FG000|Overall Study|Withdrawal by Subject|8|||
24968626|NCT00412373|50058239|FG001|Overall Study|Withdrawal by Subject|27|||
24968627|NCT00412373|50058238|FG000|Overall Study|Other|2|||
24968628|NCT00412373|50058239|FG001|Overall Study|Other|2|||
24968629|NCT00418379|50058248|FG000|Year 1|Adverse Event|9|||
24968630|NCT00418379|50058249|FG001|Year 1|Adverse Event|15|||
24968631|NCT00418379|50058250|FG002|Year 1|Adverse Event|3|||
24968632|NCT00418379|50058248|FG000|Year 1|Withdrawal by Subject|7|||
24968633|NCT00418379|50058249|FG001|Year 1|Withdrawal by Subject|8|||
24968634|NCT00418379|50058250|FG002|Year 1|Withdrawal by Subject|5|||
24968635|NCT00418379|50058248|FG000|Year 1|Any other reason not above-mentioned|2|||
24968636|NCT00418379|50058249|FG001|Year 1|Any other reason not above-mentioned|5|||
24968637|NCT00418379|50058250|FG002|Year 1|Any other reason not above-mentioned|7|||
24968638|NCT00418379|50058248|FG000|Year 2|Adverse Event|5|||
24968639|NCT00418379|50058249|FG001|Year 2|Adverse Event|2|||
24968640|NCT00418379|50058250|FG002|Year 2|Adverse Event|1|||
24968641|NCT00418379|50058248|FG000|Year 2|Withdrawal by Subject|1|||
24968642|NCT00418379|50058249|FG001|Year 2|Withdrawal by Subject|1|||
24968643|NCT00418379|50058250|FG002|Year 2|Withdrawal by Subject|3|||
24968644|NCT00418379|50058248|FG000|Year 2|Any other reason not above-mentioned|2|||
24968645|NCT00418379|50058249|FG001|Year 2|Any other reason not above-mentioned|1|||
24968646|NCT00418379|50058250|FG002|Year 2|Any other reason not above-mentioned|6|||
24968647|NCT00418379|50058248|FG000|Year 3|Withdrawal by Subject|1|||
24968648|NCT00418379|50058249|FG001|Year 3|Withdrawal by Subject|1|||
24968649|NCT00418379|50058250|FG002|Year 3|Withdrawal by Subject|2|||
24968650|NCT00418379|50058248|FG000|Year 3|Any other reason not above-mentioned|2|||
24968651|NCT00418379|50058249|FG001|Year 3|Any other reason not above-mentioned|1|||
24968652|NCT00418379|50058250|FG002|Year 3|Any other reason not above-mentioned|1|||
24968653|NCT00418379|50058248|FG000|Year 4|Adverse Event|0|||
25069265|NCT02622074|50175017|FG001|Overall Study|Withdrawal by Subject|1|||
24968654|NCT00418379|50058249|FG001|Year 4|Adverse Event|1|||
25069266|NCT02622074|50175018|FG002|Overall Study|Withdrawal by Subject|0|||
24968655|NCT00418379|50058250|FG002|Year 4|Adverse Event|0|||
24968656|NCT00418379|50058248|FG000|Year 4|Withdrawal by Subject|2|||
24968657|NCT00418379|50058249|FG001|Year 4|Withdrawal by Subject|3|||
25069267|NCT02622074|50175019|FG003|Overall Study|Withdrawal by Subject|0|||
24968658|NCT00418379|50058250|FG002|Year 4|Withdrawal by Subject|2|||
24968659|NCT00418379|50058248|FG000|Year 4|Any other reason not above-mentioned|1|||
24968660|NCT00418379|50058249|FG001|Year 4|Any other reason not above-mentioned|1|||
24968661|NCT00418379|50058250|FG002|Year 4|Any other reason not above-mentioned|0|||
24968662|NCT00418379|50058248|FG000|Year 5|Adverse Event|0|||
24968663|NCT00418379|50058249|FG001|Year 5|Adverse Event|1|||
24968664|NCT00418379|50058250|FG002|Year 5|Adverse Event|0|||
24968665|NCT00418379|50058248|FG000|Year 5|Any other reason not above-mentioned|2|||
24968666|NCT00418379|50058249|FG001|Year 5|Any other reason not above-mentioned|4|||
24968667|NCT00418379|50058250|FG002|Year 5|Any other reason not above-mentioned|3|||
24968668|NCT00418145|50058258|FG000|Overall Study|study terminated|6|||
24968669|NCT00417989|50058266|FG000|Overall Study|Withdrawal by Subject|13|||
25069268|NCT02622074|50175020|FG004|Overall Study|Withdrawal by Subject|0|||
25069269|NCT02622074|50175021|FG005|Overall Study|Withdrawal by Subject|0|||
24968670|NCT00417989|50058267|FG001|Overall Study|Withdrawal by Subject|13|||
24968671|NCT00417989|50058266|FG000|Overall Study|Lost to Follow-up|1|||
24968672|NCT00417989|50058267|FG001|Overall Study|Lost to Follow-up|6|||
24968673|NCT00417989|50058266|FG000|Overall Study|Protocol Violation|1|||
24968674|NCT00417989|50058267|FG001|Overall Study|Protocol Violation|0|||
24968675|NCT00417989|50058266|FG000|Overall Study|Death|0|||
24968676|NCT00417989|50058267|FG001|Overall Study|Death|1|||
24968677|NCT00417989|50058266|FG000|Overall Study|Physician Decision|5|||
24968678|NCT00417989|50058267|FG001|Overall Study|Physician Decision|2|||
24968679|NCT00412217|50058277|FG000|Overall Study|Insufficient Data Available|8|||
24968680|NCT00412217|50058278|FG001|Overall Study|Insufficient Data Available|3|||
24968681|NCT00412217|50058277|FG000|Overall Study|Death|5|||
24968682|NCT00412217|50058278|FG001|Overall Study|Death|4|||
24968683|NCT00412217|50058277|FG000|Overall Study|Disease Progression|2|||
24968684|NCT00412217|50058278|FG001|Overall Study|Disease Progression|3|||
24968685|NCT00412217|50058277|FG000|Overall Study|Investigator Decision|1|||
24968686|NCT00412217|50058278|FG001|Overall Study|Investigator Decision|0|||
24968687|NCT00412217|50058277|FG000|Overall Study|Withdrawal by Subject|2|||
24968688|NCT00412217|50058278|FG001|Overall Study|Withdrawal by Subject|0|||
24968689|NCT00412217|50058277|FG000|Overall Study|Lost to Follow-up|1|||
24968690|NCT00412217|50058278|FG001|Overall Study|Lost to Follow-up|4|||
24968691|NCT00412217|50058277|FG000|Overall Study|Study Terminated by Sponsor|26|||
24968692|NCT00412217|50058278|FG001|Overall Study|Study Terminated by Sponsor|33|||
24968693|NCT00412217|50058277|FG000|Overall Study|Other|1|||
24968694|NCT00412217|50058278|FG001|Overall Study|Other|1|||
24968695|NCT05000164|50058284|FG000|Overall Study|Adverse Event|1|||
24968696|NCT05000164|50058284|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
24968697|NCT05000164|50058284|FG000|Overall Study|Lens Discomfort|3|||
24968698|NCT05000164|50058284|FG000|Overall Study|Withdrew Consent during Study|2|||
25069270|NCT02308696|50175037|FG000|Overall Study|Lost to Follow-up|28|||
25069271|NCT02308696|50175038|FG001|Overall Study|Lost to Follow-up|21|||
25069272|NCT02308696|50175037|FG000|Overall Study|Death|8|||
25069273|NCT02308696|50175038|FG001|Overall Study|Death|4|||
25069274|NCT02308696|50175037|FG000|Overall Study|Moved to a Higher Level of Care|17|||
25069275|NCT02308696|50175038|FG001|Overall Study|Moved to a Higher Level of Care|6|||
24968699|NCT05000164|50058284|FG000|Overall Study|Subject Withdrawn by PI|2|||
24968700|NCT05000164|50058284|FG000|Overall Study|Other Fractured Test Article|1|||
25069276|NCT02342704|50175046|FG000|Overall Study|Physician Decision|0|||
25069277|NCT02342704|50175047|FG001|Overall Study|Physician Decision|3|||
24968701|NCT00123474|50058292|FG000|Randomized to Treatment|Randomized, never treated|1|||
24968702|NCT00123474|50058293|FG001|Randomized to Treatment|Randomized, never treated|4|||
24968703|NCT00123474|50058294|FG002|Randomized to Treatment|Randomized, never treated|2|||
24968704|NCT00123474|50058295|FG003|Randomized to Treatment|Randomized, never treated|1|||
24968705|NCT00123474|50058292|FG000|As Treated at Study Closure|not reported when site closed|1|||
24968706|NCT00123474|50058293|FG001|As Treated at Study Closure|not reported when site closed|0|||
24968707|NCT00123474|50058294|FG002|As Treated at Study Closure|not reported when site closed|1|||
24968708|NCT00123474|50058295|FG003|As Treated at Study Closure|not reported when site closed|0|||
24968709|NCT00123474|50058292|FG000|As Treated at Study Closure|Adverse Event|10|||
24968710|NCT00123474|50058293|FG001|As Treated at Study Closure|Adverse Event|4|||
24968711|NCT00123474|50058294|FG002|As Treated at Study Closure|Adverse Event|10|||
24968712|NCT00123474|50058295|FG003|As Treated at Study Closure|Adverse Event|8|||
24968713|NCT00123474|50058292|FG000|As Treated at Study Closure|Disease Progression|35|||
25069278|NCT02342704|50175046|FG000|Overall Study|Sponsor Termination|49|||
24968714|NCT00123474|50058293|FG001|As Treated at Study Closure|Disease Progression|42|||
25069279|NCT02342704|50175047|FG001|Overall Study|Sponsor Termination|43|||
25069280|NCT02342704|50175046|FG000|Overall Study|Other|0|||
24968715|NCT00123474|50058294|FG002|As Treated at Study Closure|Disease Progression|29|||
24968716|NCT00123474|50058295|FG003|As Treated at Study Closure|Disease Progression|27|||
24968717|NCT00123474|50058292|FG000|As Treated at Study Closure|Investigator Request|12|||
24968718|NCT00123474|50058293|FG001|As Treated at Study Closure|Investigator Request|6|||
24968719|NCT00123474|50058294|FG002|As Treated at Study Closure|Investigator Request|7|||
24968720|NCT00123474|50058295|FG003|As Treated at Study Closure|Investigator Request|5|||
24968721|NCT00123474|50058292|FG000|As Treated at Study Closure|non-specified|54|||
24968722|NCT00123474|50058293|FG001|As Treated at Study Closure|non-specified|47|||
24968723|NCT00123474|50058294|FG002|As Treated at Study Closure|non-specified|57|||
24968724|NCT00123474|50058295|FG003|As Treated at Study Closure|non-specified|60|||
24968725|NCT00123474|50058292|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
24968726|NCT00123474|50058293|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
24968727|NCT00123474|50058294|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
24968728|NCT00123474|50058295|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
24968729|NCT00123474|50058292|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
24968730|NCT00123474|50058293|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
24968731|NCT00123474|50058294|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
24968732|NCT00123474|50058295|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
24968733|NCT00142298|50058336|FG000|Overall Study|Adverse Event|10|||
24968734|NCT00142298|50058337|FG001|Overall Study|Adverse Event|10|||
24968735|NCT00142298|50058338|FG002|Overall Study|Adverse Event|1|||
24968736|NCT00142298|50058339|FG003|Overall Study|Adverse Event|5|||
24968737|NCT00142298|50058340|FG004|Overall Study|Adverse Event|2|||
24968738|NCT00142298|50058341|FG005|Overall Study|Adverse Event|2|||
24968739|NCT00142298|50058342|FG006|Overall Study|Adverse Event|0|||
24968740|NCT00142298|50058343|FG007|Overall Study|Adverse Event|0|||
24968741|NCT00142298|50058344|FG008|Overall Study|Adverse Event|0|||
24968742|NCT00142298|50058345|FG009|Overall Study|Adverse Event|0|||
24968743|NCT00142298|50058336|FG000|Overall Study|Clinical disease progression|1|||
24968744|NCT00142298|50058337|FG001|Overall Study|Clinical disease progression|0|||
24968745|NCT00142298|50058338|FG002|Overall Study|Clinical disease progression|0|||
24968746|NCT00142298|50058339|FG003|Overall Study|Clinical disease progression|0|||
24968747|NCT00142298|50058340|FG004|Overall Study|Clinical disease progression|0|||
24968748|NCT00142298|50058341|FG005|Overall Study|Clinical disease progression|0|||
24968749|NCT00142298|50058342|FG006|Overall Study|Clinical disease progression|0|||
24968750|NCT00142298|50058343|FG007|Overall Study|Clinical disease progression|0|||
24968751|NCT00142298|50058344|FG008|Overall Study|Clinical disease progression|0|||
24968752|NCT00142298|50058345|FG009|Overall Study|Clinical disease progression|0|||
24968753|NCT00142298|50058336|FG000|Overall Study|Death|1|||
24968754|NCT00142298|50058337|FG001|Overall Study|Death|1|||
24968755|NCT00142298|50058338|FG002|Overall Study|Death|1|||
24968756|NCT00142298|50058339|FG003|Overall Study|Death|0|||
24968757|NCT00142298|50058340|FG004|Overall Study|Death|0|||
24968758|NCT00142298|50058341|FG005|Overall Study|Death|6|||
24968759|NCT00142298|50058342|FG006|Overall Study|Death|0|||
24968760|NCT00142298|50058343|FG007|Overall Study|Death|0|||
24968761|NCT00142298|50058344|FG008|Overall Study|Death|0|||
24968762|NCT00142298|50058345|FG009|Overall Study|Death|0|||
24968763|NCT00142298|50058336|FG000|Overall Study|Lack of Efficacy|44|||
24968764|NCT00142298|50058337|FG001|Overall Study|Lack of Efficacy|62|||
24968765|NCT00142298|50058338|FG002|Overall Study|Lack of Efficacy|9|||
24968766|NCT00142298|50058339|FG003|Overall Study|Lack of Efficacy|12|||
24968767|NCT00142298|50058340|FG004|Overall Study|Lack of Efficacy|1|||
24968768|NCT00142298|50058341|FG005|Overall Study|Lack of Efficacy|0|||
24968769|NCT00142298|50058342|FG006|Overall Study|Lack of Efficacy|0|||
24968770|NCT00142298|50058343|FG007|Overall Study|Lack of Efficacy|1|||
24968771|NCT00142298|50058344|FG008|Overall Study|Lack of Efficacy|0|||
24968772|NCT00142298|50058345|FG009|Overall Study|Lack of Efficacy|0|||
24968773|NCT00142298|50058336|FG000|Overall Study|Non-compliance|15|||
24968774|NCT00142298|50058337|FG001|Overall Study|Non-compliance|13|||
24968775|NCT00142298|50058338|FG002|Overall Study|Non-compliance|0|||
24968776|NCT00142298|50058339|FG003|Overall Study|Non-compliance|6|||
24968777|NCT00142298|50058340|FG004|Overall Study|Non-compliance|1|||
24968778|NCT00142298|50058341|FG005|Overall Study|Non-compliance|0|||
24968779|NCT00142298|50058342|FG006|Overall Study|Non-compliance|0|||
24968780|NCT00142298|50058343|FG007|Overall Study|Non-compliance|3|||
24968781|NCT00142298|50058344|FG008|Overall Study|Non-compliance|3|||
24968782|NCT00142298|50058345|FG009|Overall Study|Non-compliance|0|||
24968783|NCT00142298|50058336|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
24968784|NCT00142298|50058337|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
24968785|NCT00142298|50058338|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
24968786|NCT00142298|50058339|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
24968787|NCT00142298|50058340|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
24968788|NCT00142298|50058341|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
24968789|NCT00142298|50058342|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
24968790|NCT00142298|50058343|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
24968791|NCT00142298|50058344|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
24968792|NCT00142298|50058345|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
24968793|NCT00142298|50058336|FG000|Overall Study|Pregnancy|4|||
24968794|NCT00142298|50058337|FG001|Overall Study|Pregnancy|4|||
24968795|NCT00142298|50058338|FG002|Overall Study|Pregnancy|2|||
24968796|NCT00142298|50058339|FG003|Overall Study|Pregnancy|3|||
24968797|NCT00142298|50058340|FG004|Overall Study|Pregnancy|0|||
25069281|NCT02342704|50175047|FG001|Overall Study|Other|1|||
25069282|NCT02342704|50175046|FG000|Overall Study|Withdrawal by Subject|1|||
25069283|NCT02342704|50175047|FG001|Overall Study|Withdrawal by Subject|0|||
25069284|NCT02342704|50175046|FG000|Overall Study|Lost to Follow-up|2|||
25069285|NCT02342704|50175047|FG001|Overall Study|Lost to Follow-up|1|||
25069286|NCT02342704|50175046|FG000|Overall Study|Adverse Event|1|||
25069287|NCT02342704|50175047|FG001|Overall Study|Adverse Event|3|||
25069288|NCT02342548|50175056|FG000|Overall Study|Adverse Event|12|||
25069289|NCT02342548|50175057|FG001|Overall Study|Adverse Event|17|||
25069290|NCT02342548|50175058|FG002|Overall Study|Adverse Event|13|||
25069291|NCT02342548|50175056|FG000|Overall Study|Lost to Follow-up|0|||
25069292|NCT02342548|50175057|FG001|Overall Study|Lost to Follow-up|1|||
25069293|NCT02342548|50175058|FG002|Overall Study|Lost to Follow-up|0|||
25069294|NCT02342548|50175056|FG000|Overall Study|Study terminated by sponsor|20|||
25069295|NCT02342548|50175057|FG001|Overall Study|Study terminated by sponsor|39|||
25069296|NCT02342548|50175058|FG002|Overall Study|Study terminated by sponsor|25|||
25069297|NCT02342548|50175056|FG000|Overall Study|Protocol Violation|0|||
25069298|NCT02342548|50175057|FG001|Overall Study|Protocol Violation|1|||
25069299|NCT02342548|50175058|FG002|Overall Study|Protocol Violation|0|||
25069300|NCT02342548|50175056|FG000|Overall Study|Withdrawal by Subject|1|||
25069301|NCT02342548|50175057|FG001|Overall Study|Withdrawal by Subject|3|||
25069302|NCT02342548|50175058|FG002|Overall Study|Withdrawal by Subject|4|||
25189254|NCT02275780|50345614|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
25189255|NCT02275780|50345615|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
25189256|NCT02275780|50345614|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
24968798|NCT00142298|50058341|FG005|Overall Study|Pregnancy|0|||
24968799|NCT00142298|50058342|FG006|Overall Study|Pregnancy|0|||
24968800|NCT00142298|50058343|FG007|Overall Study|Pregnancy|0|||
24968801|NCT00142298|50058344|FG008|Overall Study|Pregnancy|1|||
24968802|NCT00142298|50058345|FG009|Overall Study|Pregnancy|0|||
24968803|NCT00142298|50058336|FG000|Overall Study|Virologic breakthrough|19|||
24968804|NCT00142298|50058337|FG001|Overall Study|Virologic breakthrough|23|||
24968805|NCT00142298|50058338|FG002|Overall Study|Virologic breakthrough|9|||
24968806|NCT00142298|50058339|FG003|Overall Study|Virologic breakthrough|7|||
25069303|NCT02342548|50175056|FG000|Overall Study|Other|1|||
25069304|NCT02342548|50175057|FG001|Overall Study|Other|1|||
25189257|NCT02275780|50345615|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
25189258|NCT02275780|50345614|FG000|Base Study: 96 Weeks|Physician Decision|2|||
25189259|NCT02275780|50345615|FG001|Base Study: 96 Weeks|Physician Decision|4|||
25189260|NCT02275780|50345614|FG000|Base Study: 96 Weeks|Pregnancy|2|||
25189261|NCT02275780|50345615|FG001|Base Study: 96 Weeks|Pregnancy|1|||
25069305|NCT02342548|50175058|FG002|Overall Study|Other|1|||
25189262|NCT02275780|50345614|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
25189263|NCT02275780|50345615|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
25277260|NCT01198002|50591272|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
25277261|NCT01198002|50591270|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
25277262|NCT01198002|50591271|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
25277263|NCT01198002|50591272|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
25277264|NCT01197534|50591305|FG000|Overall Study|Not reported|16|||
25277265|NCT01197534|50591306|FG001|Overall Study|Not reported|10|||
25277266|NCT01197534|50591307|FG002|Overall Study|Not reported|16|||
25277267|NCT01197534|50591305|FG000|Overall Study|Enrolment in long term extension|57|||
25277268|NCT01197534|50591306|FG001|Overall Study|Enrolment in long term extension|66|||
25277269|NCT01197534|50591307|FG002|Overall Study|Enrolment in long term extension|119|||
24968807|NCT00142298|50058340|FG004|Overall Study|Virologic breakthrough|2|||
25069306|NCT03142191|50175071|FG000|Placebo Controlled Period|Death|0|||
25069307|NCT03142191|50175072|FG001|Placebo Controlled Period|Death|1|||
25069308|NCT03142191|50175073|FG002|Placebo Controlled Period|Death|1|||
25069309|NCT03142191|50175074|FG003|Placebo Controlled Period|Death|0|||
25069310|NCT03142191|50175075|FG004|Placebo Controlled Period|Death|0|||
25069311|NCT03142191|50175071|FG000|Placebo Controlled Period|Adverse Event|4|||
25069312|NCT03142191|50175072|FG001|Placebo Controlled Period|Adverse Event|5|||
25069313|NCT03142191|50175073|FG002|Placebo Controlled Period|Adverse Event|1|||
25069314|NCT03142191|50175074|FG003|Placebo Controlled Period|Adverse Event|0|||
25069315|NCT03142191|50175075|FG004|Placebo Controlled Period|Adverse Event|0|||
25069316|NCT03142191|50175071|FG000|Placebo Controlled Period|Progressive Disease|1|||
25069317|NCT03142191|50175072|FG001|Placebo Controlled Period|Progressive Disease|0|||
24968808|NCT00142298|50058341|FG005|Overall Study|Virologic breakthrough|3|||
25189264|NCT02275780|50345614|FG000|Extension Study: up to 192 Weeks|Ongoing|260|||
24968809|NCT00142298|50058342|FG006|Overall Study|Virologic breakthrough|3|||
24968810|NCT00142298|50058343|FG007|Overall Study|Virologic breakthrough|0|||
24968811|NCT00142298|50058344|FG008|Overall Study|Virologic breakthrough|0|||
24968812|NCT00142298|50058345|FG009|Overall Study|Virologic breakthrough|0|||
24968813|NCT00142298|50058336|FG000|Overall Study|Other- not specified|0|||
24968814|NCT00142298|50058337|FG001|Overall Study|Other- not specified|3|||
24968815|NCT00142298|50058338|FG002|Overall Study|Other- not specified|0|||
24968816|NCT00142298|50058339|FG003|Overall Study|Other- not specified|1|||
24968817|NCT00142298|50058340|FG004|Overall Study|Other- not specified|0|||
24968818|NCT00142298|50058341|FG005|Overall Study|Other- not specified|0|||
24968819|NCT00142298|50058342|FG006|Overall Study|Other- not specified|0|||
24968820|NCT00142298|50058343|FG007|Overall Study|Other- not specified|0|||
24968821|NCT00142298|50058344|FG008|Overall Study|Other- not specified|0|||
24968822|NCT00142298|50058345|FG009|Overall Study|Other- not specified|0|||
24968823|NCT00142298|50058336|FG000|Overall Study|Lost to Follow-up|0|||
24968824|NCT00142298|50058337|FG001|Overall Study|Lost to Follow-up|0|||
24968825|NCT00142298|50058338|FG002|Overall Study|Lost to Follow-up|0|||
25069318|NCT03142191|50175073|FG002|Placebo Controlled Period|Progressive Disease|1|||
25069319|NCT03142191|50175074|FG003|Placebo Controlled Period|Progressive Disease|0|||
25069320|NCT03142191|50175075|FG004|Placebo Controlled Period|Progressive Disease|0|||
25069321|NCT03142191|50175071|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
25069322|NCT03142191|50175072|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
25069323|NCT03142191|50175073|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
25069324|NCT03142191|50175074|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
25069325|NCT03142191|50175075|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
25069326|NCT03142191|50175071|FG000|Placebo Controlled Period|Other Reasons|1|||
25069327|NCT03142191|50175072|FG001|Placebo Controlled Period|Other Reasons|0|||
25069328|NCT03142191|50175073|FG002|Placebo Controlled Period|Other Reasons|0|||
25069329|NCT03142191|50175074|FG003|Placebo Controlled Period|Other Reasons|0|||
25069330|NCT03142191|50175075|FG004|Placebo Controlled Period|Other Reasons|0|||
25069331|NCT03142191|50175071|FG000|Active Treatment Extension Period|Death|2|||
25069332|NCT03142191|50175072|FG001|Active Treatment Extension Period|Death|1|||
25069333|NCT03142191|50175073|FG002|Active Treatment Extension Period|Death|1|||
25069334|NCT03142191|50175074|FG003|Active Treatment Extension Period|Death|1|||
25069335|NCT03142191|50175075|FG004|Active Treatment Extension Period|Death|0|||
25069336|NCT03142191|50175071|FG000|Active Treatment Extension Period|Adverse Event|6|||
25069337|NCT03142191|50175072|FG001|Active Treatment Extension Period|Adverse Event|5|||
25069338|NCT03142191|50175073|FG002|Active Treatment Extension Period|Adverse Event|4|||
25069339|NCT03142191|50175074|FG003|Active Treatment Extension Period|Adverse Event|1|||
25069340|NCT03142191|50175075|FG004|Active Treatment Extension Period|Adverse Event|0|||
25069341|NCT03142191|50175071|FG000|Active Treatment Extension Period|Progressive Disease|10|||
25069342|NCT03142191|50175072|FG001|Active Treatment Extension Period|Progressive Disease|5|||
25069343|NCT03142191|50175073|FG002|Active Treatment Extension Period|Progressive Disease|4|||
25069344|NCT03142191|50175074|FG003|Active Treatment Extension Period|Progressive Disease|1|||
25069345|NCT03142191|50175075|FG004|Active Treatment Extension Period|Progressive Disease|2|||
25069346|NCT03142191|50175071|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
25069347|NCT03142191|50175072|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
25069348|NCT03142191|50175073|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
25069349|NCT03142191|50175074|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
25069350|NCT03142191|50175075|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
25069351|NCT03142191|50175071|FG000|Active Treatment Extension Period|Physician Decision|2|||
25069352|NCT03142191|50175072|FG001|Active Treatment Extension Period|Physician Decision|0|||
25069353|NCT03142191|50175073|FG002|Active Treatment Extension Period|Physician Decision|0|||
25069354|NCT03142191|50175074|FG003|Active Treatment Extension Period|Physician Decision|0|||
25069355|NCT03142191|50175075|FG004|Active Treatment Extension Period|Physician Decision|0|||
25069356|NCT03142191|50175071|FG000|Active Treatment Extension Period|Other Reasons|3|||
25069357|NCT03142191|50175072|FG001|Active Treatment Extension Period|Other Reasons|3|||
25069358|NCT03142191|50175073|FG002|Active Treatment Extension Period|Other Reasons|3|||
24968826|NCT00142298|50058339|FG003|Overall Study|Lost to Follow-up|0|||
24968827|NCT00142298|50058340|FG004|Overall Study|Lost to Follow-up|0|||
24968828|NCT00142298|50058341|FG005|Overall Study|Lost to Follow-up|0|||
24968829|NCT00142298|50058342|FG006|Overall Study|Lost to Follow-up|2|||
24968830|NCT00142298|50058343|FG007|Overall Study|Lost to Follow-up|0|||
24968831|NCT00142298|50058344|FG008|Overall Study|Lost to Follow-up|0|||
24968832|NCT00142298|50058345|FG009|Overall Study|Lost to Follow-up|0|||
24968833|NCT00142298|50058336|FG000|Overall Study|Treatment Failure|0|||
24968834|NCT00142298|50058337|FG001|Overall Study|Treatment Failure|0|||
24968835|NCT00142298|50058338|FG002|Overall Study|Treatment Failure|0|||
24968836|NCT00142298|50058339|FG003|Overall Study|Treatment Failure|0|||
24968837|NCT00142298|50058340|FG004|Overall Study|Treatment Failure|0|||
24968838|NCT00142298|50058341|FG005|Overall Study|Treatment Failure|2|||
24968839|NCT00142298|50058342|FG006|Overall Study|Treatment Failure|2|||
25069359|NCT03142191|50175074|FG003|Active Treatment Extension Period|Other Reasons|8|||
25069360|NCT03142191|50175075|FG004|Active Treatment Extension Period|Other Reasons|3|||
25069361|NCT03142191|50175071|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
25069362|NCT03142191|50175072|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
25069363|NCT03142191|50175073|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
25069364|NCT03142191|50175074|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
25069365|NCT03142191|50175075|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
25069366|NCT02617628|50175104|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
25069367|NCT02617628|50175105|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
25069368|NCT02308540|50175121|FG000|Overall Study|Lost to Follow-up|0|||
25069369|NCT02308540|50175122|FG001|Overall Study|Lost to Follow-up|0|||
25069370|NCT02308540|50175123|FG002|Overall Study|Lost to Follow-up|0|||
25069371|NCT02308540|50175124|FG003|Overall Study|Lost to Follow-up|0|||
25069372|NCT02308540|50175125|FG004|Overall Study|Lost to Follow-up|0|||
25069373|NCT02308540|50175126|FG005|Overall Study|Lost to Follow-up|1|||
25069374|NCT02308228|50175177|FG000|Overall Study|Adverse Event|3|||
25069375|NCT02308228|50175178|FG001|Overall Study|Adverse Event|4|||
25069376|NCT02308228|50175177|FG000|Overall Study|Withdrawal by Subject|5|||
25069377|NCT02308228|50175178|FG001|Overall Study|Withdrawal by Subject|3|||
24968840|NCT00142298|50058343|FG007|Overall Study|Treatment Failure|0|||
24968841|NCT00142298|50058344|FG008|Overall Study|Treatment Failure|0|||
24968842|NCT00142298|50058345|FG009|Overall Study|Treatment Failure|0|||
24968843|NCT03709654|50058369|FG000|Overall Study|Lost to Follow-up|1|||
24968844|NCT03709654|50058370|FG001|Overall Study|Lost to Follow-up|1|||
24968845|NCT03709654|50058369|FG000|Overall Study|Withdrawal by Subject|1|||
24968846|NCT03709654|50058370|FG001|Overall Study|Withdrawal by Subject|1|||
24968847|NCT03709654|50058369|FG000|Overall Study|Adverse Event|1|||
24968848|NCT03709654|50058370|FG001|Overall Study|Adverse Event|0|||
24968849|NCT00412061|50058378|FG000|Double Blind Phase|Disease Progression|101|||
24968850|NCT00412061|50058379|FG001|Double Blind Phase|Disease Progression|154|||
24968851|NCT00412061|50058378|FG000|Double Blind Phase|Adverse Event|61|||
24968852|NCT00412061|50058379|FG001|Double Blind Phase|Adverse Event|16|||
24968853|NCT00412061|50058378|FG000|Double Blind Phase|Final Primary Analysis|26|||
24968854|NCT00412061|50058379|FG001|Double Blind Phase|Final Primary Analysis|14|||
24968855|NCT00412061|50058378|FG000|Double Blind Phase|Withdrawal by Subject|18|||
24968856|NCT00412061|50058379|FG001|Double Blind Phase|Withdrawal by Subject|20|||
24968857|NCT00412061|50058378|FG000|Double Blind Phase|Death|6|||
24968858|NCT00412061|50058379|FG001|Double Blind Phase|Death|3|||
24968859|NCT00412061|50058378|FG000|Double Blind Phase|Protocol Violation|3|||
24968860|NCT00412061|50058379|FG001|Double Blind Phase|Protocol Violation|4|||
24968861|NCT00412061|50058378|FG000|Double Blind Phase|New Cander Therapy|1|||
24968862|NCT00412061|50058379|FG001|Double Blind Phase|New Cander Therapy|1|||
24968863|NCT00412061|50058378|FG000|Double Blind Phase|Lost to Follow-up|0|||
24968864|NCT00412061|50058379|FG001|Double Blind Phase|Lost to Follow-up|1|||
24968865|NCT00412061|50058378|FG000|Open Label Phase|Disease Progression|0|||
24968866|NCT00412061|50058379|FG001|Open Label Phase|Disease Progression|86|||
24968867|NCT00412061|50058378|FG000|Open Label Phase|Adverse Event|0|||
24968868|NCT00412061|50058379|FG001|Open Label Phase|Adverse Event|46|||
24968869|NCT00412061|50058378|FG000|Open Label Phase|Withdrawal by Subject|0|||
25069378|NCT02616614|50175196|FG000|Overall Study|Withdrawal by Subject|10|||
25069379|NCT02616614|50175197|FG001|Overall Study|Withdrawal by Subject|5|||
25069380|NCT02616614|50175198|FG002|Overall Study|Withdrawal by Subject|6|||
25069381|NCT02616614|50175196|FG000|Overall Study|Physician Decision|2|||
25069382|NCT02616614|50175197|FG001|Overall Study|Physician Decision|1|||
24968870|NCT00412061|50058379|FG001|Open Label Phase|Withdrawal by Subject|15|||
24968871|NCT00412061|50058378|FG000|Open Label Phase|Administrative Problems|0|||
24968872|NCT00412061|50058379|FG001|Open Label Phase|Administrative Problems|13|||
24968873|NCT00412061|50058378|FG000|Open Label Phase|Death|0|||
24968874|NCT00412061|50058379|FG001|Open Label Phase|Death|7|||
24968875|NCT00412061|50058378|FG000|Open Label Phase|Lost to Follow-up|0|||
24968876|NCT00412061|50058379|FG001|Open Label Phase|Lost to Follow-up|2|||
24968877|NCT00412061|50058378|FG000|Open Label Phase|New Cancer Therapy|0|||
24968878|NCT00412061|50058379|FG001|Open Label Phase|New Cancer Therapy|1|||
24968879|NCT00411671|50058397|FG000|Overall Study|Adverse Event|15|||
24968880|NCT00411671|50058397|FG000|Overall Study|Death|2|||
24968881|NCT00411671|50058397|FG000|Overall Study|Lost to Follow-up|3|||
24968882|NCT03835481|50058406|FG000|Double-blind Period|Other not stated below|0|||
24968883|NCT03835481|50058407|FG001|Double-blind Period|Other not stated below|0|||
24968884|NCT03835481|50058408|FG002|Double-blind Period|Other not stated below|0|||
24968885|NCT03835481|50058409|FG003|Double-blind Period|Other not stated below|1|||
24968886|NCT03835481|50058410|FG004|Double-blind Period|Other not stated below|1|||
24968887|NCT03835481|50058406|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
24968888|NCT03835481|50058407|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
24968889|NCT03835481|50058408|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
24968890|NCT03835481|50058409|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
24968891|NCT03835481|50058410|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
24968892|NCT03835481|50058406|FG000|Double-blind Period|Withdrawal by Subject|0|||
24968893|NCT03835481|50058407|FG001|Double-blind Period|Withdrawal by Subject|0|||
24968894|NCT03835481|50058408|FG002|Double-blind Period|Withdrawal by Subject|1|||
24968895|NCT03835481|50058409|FG003|Double-blind Period|Withdrawal by Subject|0|||
24968896|NCT03835481|50058410|FG004|Double-blind Period|Withdrawal by Subject|5|||
24968897|NCT03835481|50058406|FG000|Double-blind Period|Lost to Follow-up|0|||
24968898|NCT03835481|50058407|FG001|Double-blind Period|Lost to Follow-up|0|||
24968899|NCT03835481|50058408|FG002|Double-blind Period|Lost to Follow-up|0|||
25069383|NCT02616614|50175198|FG002|Overall Study|Physician Decision|0|||
25069384|NCT02616614|50175196|FG000|Overall Study|Adverse Event|1|||
25069385|NCT02616614|50175197|FG001|Overall Study|Adverse Event|4|||
25069386|NCT02616614|50175198|FG002|Overall Study|Adverse Event|1|||
25069387|NCT02616614|50175196|FG000|Overall Study|Protocol Violation|0|||
25069388|NCT02616614|50175197|FG001|Overall Study|Protocol Violation|3|||
25069389|NCT02616614|50175198|FG002|Overall Study|Protocol Violation|1|||
25069390|NCT02616614|50175196|FG000|Overall Study|Prohibited Medication|12|||
25069391|NCT02616614|50175197|FG001|Overall Study|Prohibited Medication|9|||
25069392|NCT02616614|50175198|FG002|Overall Study|Prohibited Medication|5|||
25069393|NCT02616614|50175196|FG000|Overall Study|More than 3 applications missed|6|||
25069394|NCT02616614|50175197|FG001|Overall Study|More than 3 applications missed|8|||
25069395|NCT02616614|50175198|FG002|Overall Study|More than 3 applications missed|1|||
25069396|NCT02616614|50175196|FG000|Overall Study|Lost to Follow-up|31|||
25069397|NCT02616614|50175197|FG001|Overall Study|Lost to Follow-up|28|||
25069398|NCT02616614|50175198|FG002|Overall Study|Lost to Follow-up|13|||
25069399|NCT02616614|50175196|FG000|Overall Study|Pregnancy|2|||
25069400|NCT02616614|50175197|FG001|Overall Study|Pregnancy|0|||
25069401|NCT02616614|50175198|FG002|Overall Study|Pregnancy|1|||
25069402|NCT02616614|50175196|FG000|Overall Study|Other|1|||
25069403|NCT02616614|50175197|FG001|Overall Study|Other|2|||
25069404|NCT02616614|50175198|FG002|Overall Study|Other|1|||
25277270|NCT01197534|50591305|FG000|Overall Study|Severe non-compliance to protocol|3|||
24968900|NCT03835481|50058409|FG003|Double-blind Period|Lost to Follow-up|1|||
24968901|NCT03835481|50058410|FG004|Double-blind Period|Lost to Follow-up|0|||
24968902|NCT03835481|50058406|FG000|Double-blind Period|Protocol Violation|0|||
24968903|NCT03835481|50058407|FG001|Double-blind Period|Protocol Violation|2|||
24968904|NCT03835481|50058408|FG002|Double-blind Period|Protocol Violation|0|||
24968905|NCT03835481|50058409|FG003|Double-blind Period|Protocol Violation|1|||
24968906|NCT03835481|50058410|FG004|Double-blind Period|Protocol Violation|0|||
25069405|NCT02616380|50175224|FG000|Overall Study|Lost to Follow-up|1|||
24968907|NCT03835481|50058406|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
24968908|NCT03835481|50058407|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
24968909|NCT03835481|50058408|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
24968910|NCT03835481|50058409|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
24968911|NCT03835481|50058410|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
24968912|NCT03835481|50058406|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
24968913|NCT03835481|50058407|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
24968914|NCT03835481|50058408|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
24968915|NCT03835481|50058409|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
24968916|NCT03835481|50058410|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
24968917|NCT03835481|50058406|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
24968918|NCT03835481|50058407|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
24968919|NCT03835481|50058408|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
24968920|NCT03835481|50058409|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
25189265|NCT02275780|50345615|FG001|Extension Study: up to 192 Weeks|Ongoing|233|||
25168914|NCT00983073|50299100|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
25168915|NCT00983073|50299100|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
25168916|NCT00983073|50299100|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
25168917|NCT00983073|50299100|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
25168918|NCT00983073|50299100|FG000|Titration and Optimal Dose Period|Other reason|4|||
25168919|NCT00983073|50299100|FG000|Maintenance Period|Adverse Event|5|||
25168920|NCT00983073|50299100|FG000|Maintenance Period|Withdrawal by Subject|2|||
25168921|NCT00983073|50299100|FG000|Maintenance Period|Lack of Efficacy|2|||
25168922|NCT00983073|50299100|FG000|Maintenance Period|Other Reason|7|||
25168923|NCT00982137|50299109|FG000|Overall Study|Lost to Follow-up|0|||
25168924|NCT00982137|50299110|FG001|Overall Study|Lost to Follow-up|0|||
25189266|NCT02158091|50345624|FG000|Overall Study|DLT|2|||
25168925|NCT00982137|50299111|FG002|Overall Study|Lost to Follow-up|0|||
25189267|NCT02158091|50345625|FG001|Overall Study|DLT|1|||
25168926|NCT00982137|50299112|FG003|Overall Study|Lost to Follow-up|1|||
25189268|NCT02158091|50345626|FG002|Overall Study|DLT|0|||
24968921|NCT03835481|50058410|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
24968922|NCT03835481|50058406|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
24968923|NCT03835481|50058407|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
24968924|NCT03835481|50058408|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
24968925|NCT03835481|50058409|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
24968926|NCT03835481|50058410|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
25069406|NCT02616380|50175224|FG000|Overall Study|Other|2|||
25069407|NCT04436822|50175234|FG000|Overall Study|Physician Decision|2|||
24968927|NCT03835481|50058406|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
24968928|NCT03835481|50058407|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
24968929|NCT03835481|50058408|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
24968930|NCT03835481|50058409|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
24968931|NCT03835481|50058410|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
24968932|NCT03835481|50058406|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
24968933|NCT03835481|50058407|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
24968934|NCT03835481|50058408|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
24968935|NCT03835481|50058409|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
24968936|NCT03835481|50058410|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
24968937|NCT03709576|50058457|FG000|Overall Study|progression prior to enrollment|1|||
24968938|NCT00122460|50058464|FG000|Overall Study|investigational study phase ongoing|7|||
24968939|NCT00122460|50058465|FG001|Overall Study|investigational study phase ongoing|1|||
24968940|NCT00137436|50058471|FG000|Overall Study|Adverse Event|13|||
24968941|NCT00137436|50058471|FG000|Overall Study|Death|2|||
24968942|NCT00137436|50058471|FG000|Overall Study|Lack of Efficacy|17|||
24968943|NCT00137436|50058471|FG000|Overall Study|Withdrawal by Subject|6|||
24968944|NCT00137436|50058471|FG000|Overall Study|Other|5|||
24968945|NCT03834623|50058477|FG000|Overall Study|Progression|0|||
24968946|NCT03834623|50058478|FG001|Overall Study|Progression|1|||
24968947|NCT00410813|50058486|FG000|Overall Study|Adverse Event|6|||
24968948|NCT00410813|50058487|FG001|Overall Study|Adverse Event|11|||
24968949|NCT00410813|50058486|FG000|Overall Study|Progression|32|||
24968950|NCT00410813|50058487|FG001|Overall Study|Progression|21|||
24968951|NCT00410813|50058486|FG000|Overall Study|Not protocol specified|3|||
24968952|NCT00410813|50058487|FG001|Overall Study|Not protocol specified|4|||
24968953|NCT00410813|50058486|FG000|Overall Study|Ineligible|2|||
24968954|NCT00410813|50058487|FG001|Overall Study|Ineligible|4|||
24968955|NCT00410813|50058486|FG000|Overall Study|Death|0|||
24968956|NCT00410813|50058487|FG001|Overall Study|Death|2|||
24968957|NCT03704194|50058518|FG000|Overall Study|Withdrawal by Subject|0|||
24968958|NCT03704194|50058519|FG001|Overall Study|Withdrawal by Subject|1|||
24968959|NCT00405821|50058529|FG000|Overall Study|Death|5|||
24968960|NCT00405821|50058530|FG001|Overall Study|Death|7|||
24968961|NCT00405821|50058529|FG000|Overall Study|Lost to Follow-up|7|||
24968962|NCT00405821|50058530|FG001|Overall Study|Lost to Follow-up|7|||
24968963|NCT00405821|50058529|FG000|Overall Study|Protocol Violation|1|||
24968964|NCT00405821|50058530|FG001|Overall Study|Protocol Violation|0|||
24968965|NCT00405821|50058529|FG000|Overall Study|initiated ART|9|||
24968966|NCT00405821|50058530|FG001|Overall Study|initiated ART|8|||
24968967|NCT01446016|50058536|FG000|Overall Study|Lost to Follow-up|3|||
24968968|NCT01446016|50058536|FG000|Overall Study|Withdrawal by Subject|1|||
24968969|NCT01446016|50058536|FG000|Overall Study|Toxicity|3|||
24968970|NCT00137046|50058542|FG000|Overall Study|Death|2|||
24968971|NCT00137046|50058543|FG001|Overall Study|Death|1|||
24968972|NCT00137046|50058542|FG000|Overall Study|Adverse Event|16|||
24968973|NCT00137046|50058543|FG001|Overall Study|Adverse Event|5|||
24968974|NCT00137046|50058542|FG000|Overall Study|Laboratory Abnormality|2|||
24968975|NCT00137046|50058543|FG001|Overall Study|Laboratory Abnormality|0|||
24968976|NCT00137046|50058542|FG000|Overall Study|Lack of Efficacy|13|||
24968977|NCT00137046|50058543|FG001|Overall Study|Lack of Efficacy|1|||
24968978|NCT00137046|50058542|FG000|Overall Study|Lost to Follow-up|8|||
24968979|NCT00137046|50058543|FG001|Overall Study|Lost to Follow-up|24|||
24968980|NCT00137046|50058542|FG000|Overall Study|Other|23|||
24968981|NCT00137046|50058543|FG001|Overall Study|Other|19|||
24968982|NCT00137046|50058542|FG000|Overall Study|Withdrawal by Subject|33|||
24968983|NCT00137046|50058543|FG001|Overall Study|Withdrawal by Subject|42|||
24968984|NCT00137046|50058542|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
25189269|NCT01828112|50345636|FG000|Overall Study|Adverse Event|6|||
25189270|NCT01828112|50345637|FG001|Overall Study|Adverse Event|8|||
24968985|NCT00137046|50058543|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
24968986|NCT00137046|50058542|FG000|Overall Study|Withdrew prior to study treatment|1|||
24968987|NCT00137046|50058543|FG001|Overall Study|Withdrew prior to study treatment|1|||
24968988|NCT00122382|50058555|FG000|Double-Blind Study|Adverse Event|9|||
24968989|NCT00122382|50058556|FG001|Double-Blind Study|Adverse Event|11|||
24968990|NCT00122382|50058557|FG002|Double-Blind Study|Adverse Event|0|||
24968991|NCT00122382|50058555|FG000|Double-Blind Study|Death|2|||
24968992|NCT00122382|50058556|FG001|Double-Blind Study|Death|2|||
24968993|NCT00122382|50058557|FG002|Double-Blind Study|Death|0|||
24968994|NCT00122382|50058555|FG000|Double-Blind Study|Lack of Efficacy|0|||
24968995|NCT00122382|50058556|FG001|Double-Blind Study|Lack of Efficacy|8|||
24968996|NCT00122382|50058557|FG002|Double-Blind Study|Lack of Efficacy|0|||
24968997|NCT00122382|50058555|FG000|Double-Blind Study|Lost to Follow-up|2|||
24968998|NCT00122382|50058556|FG001|Double-Blind Study|Lost to Follow-up|1|||
24968999|NCT00122382|50058557|FG002|Double-Blind Study|Lost to Follow-up|0|||
24969000|NCT00122382|50058555|FG000|Double-Blind Study|Pregnancy|2|||
24969001|NCT00122382|50058556|FG001|Double-Blind Study|Pregnancy|0|||
24969002|NCT00122382|50058557|FG002|Double-Blind Study|Pregnancy|0|||
25189271|NCT01828112|50345636|FG000|Overall Study|Death|9|||
25189272|NCT01828112|50345637|FG001|Overall Study|Death|5|||
24969003|NCT00122382|50058555|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
24969004|NCT00122382|50058556|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
24969005|NCT00122382|50058557|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
24969006|NCT00122382|50058555|FG000|Double-Blind Study|Withdrawal of Consent|7|||
24969007|NCT00122382|50058556|FG001|Double-Blind Study|Withdrawal of Consent|3|||
24969008|NCT00122382|50058557|FG002|Double-Blind Study|Withdrawal of Consent|0|||
24969009|NCT00122382|50058555|FG000|Double-Blind Study|Protocol Violation|1|||
25069408|NCT04436822|50175235|FG001|Overall Study|Physician Decision|0|||
25069409|NCT04436822|50175234|FG000|Overall Study|Sponsor request|1|||
25069410|NCT04436822|50175235|FG001|Overall Study|Sponsor request|0|||
25069411|NCT04436822|50175234|FG000|Overall Study|Withdrawal by parent/guardian|0|||
25069412|NCT04436822|50175235|FG001|Overall Study|Withdrawal by parent/guardian|3|||
25069413|NCT04436822|50175234|FG000|Overall Study|Unsuccessful procedure|0|||
24969010|NCT00122382|50058556|FG001|Double-Blind Study|Protocol Violation|0|||
24969011|NCT00122382|50058557|FG002|Double-Blind Study|Protocol Violation|0|||
24969012|NCT00122382|50058555|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
24969013|NCT00122382|50058556|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
24969014|NCT00122382|50058557|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
24969015|NCT00122382|50058555|FG000|Double-Blind Study|Randomized but not treated|0|||
24969016|NCT00122382|50058556|FG001|Double-Blind Study|Randomized but not treated|2|||
24969017|NCT00122382|50058557|FG002|Double-Blind Study|Randomized but not treated|0|||
24969018|NCT00122382|50058555|FG000|Open-Label Study|Adverse Event|0|||
25277271|NCT01197534|50591306|FG001|Overall Study|Severe non-compliance to protocol|4|||
25277272|NCT01197534|50591307|FG002|Overall Study|Severe non-compliance to protocol|1|||
25277273|NCT01197534|50591305|FG000|Overall Study|Lack of therapeutic response|9|||
25277274|NCT01197534|50591306|FG001|Overall Study|Lack of therapeutic response|4|||
25277275|NCT01197534|50591307|FG002|Overall Study|Lack of therapeutic response|9|||
25277276|NCT01197534|50591305|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
25277277|NCT01197534|50591306|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
25277278|NCT01197534|50591307|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
25277279|NCT01197534|50591305|FG000|Overall Study|Lost to Follow-up|1|||
25277280|NCT01197534|50591306|FG001|Overall Study|Lost to Follow-up|4|||
25277281|NCT01197534|50591307|FG002|Overall Study|Lost to Follow-up|2|||
25277282|NCT01197534|50591305|FG000|Overall Study|Adverse Event|35|||
25277283|NCT01197534|50591306|FG001|Overall Study|Adverse Event|36|||
25277284|NCT01197534|50591307|FG002|Overall Study|Adverse Event|24|||
25277285|NCT01197378|50591318|FG000|Overall Study|Adverse Event|3|||
25277286|NCT01197378|50591318|FG000|Overall Study|Withdrawal by Subject|1|||
25277287|NCT01197378|50591318|FG000|Overall Study|Physician Decision|1|||
25277288|NCT01197378|50591318|FG000|Overall Study|Other|2|||
25277289|NCT01197300|50591324|FG000|Overall Study|Lost to Follow-up|0|||
25277290|NCT01197300|50591325|FG001|Overall Study|Lost to Follow-up|1|||
25277291|NCT01197300|50591324|FG000|Overall Study|Protocol Violation|0|||
25277292|NCT01197300|50591325|FG001|Overall Study|Protocol Violation|1|||
25277293|NCT01196988|50591340|FG000|Overall Study|Adverse Event|1|||
25277294|NCT01196988|50591341|FG001|Overall Study|Adverse Event|2|||
25277295|NCT01196988|50591342|FG002|Overall Study|Adverse Event|0|||
25277296|NCT01196988|50591343|FG003|Overall Study|Adverse Event|0|||
25277297|NCT01196988|50591340|FG000|Overall Study|Withdrawal by Subject|5|||
25277298|NCT01196988|50591341|FG001|Overall Study|Withdrawal by Subject|1|||
25277299|NCT01196988|50591342|FG002|Overall Study|Withdrawal by Subject|4|||
25277300|NCT01196988|50591343|FG003|Overall Study|Withdrawal by Subject|0|||
25277301|NCT01196988|50591340|FG000|Overall Study|Lost to Follow-up|16|||
25277302|NCT01196988|50591341|FG001|Overall Study|Lost to Follow-up|29|||
25277303|NCT01196988|50591342|FG002|Overall Study|Lost to Follow-up|21|||
25277304|NCT01196988|50591343|FG003|Overall Study|Lost to Follow-up|1|||
25277305|NCT01196988|50591340|FG000|Overall Study|Other|2|||
25277306|NCT01196988|50591341|FG001|Overall Study|Other|0|||
25277307|NCT01196988|50591342|FG002|Overall Study|Other|0|||
25277308|NCT01196988|50591343|FG003|Overall Study|Other|0|||
25277309|NCT01196052|50591354|FG000|Overall Study|Adverse Event|9|||
25277310|NCT01196052|50591354|FG000|Overall Study|Lost to Follow-up|1|||
25277311|NCT01196052|50591354|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
25277312|NCT01196052|50591354|FG000|Overall Study|Reason not Specified|5|||
25277313|NCT01196052|50591354|FG000|Overall Study|Withdrawal by Subject|6|||
25277314|NCT01195662|50591361|FG000|Double Blind Treatment Period|Adverse Event|4|||
25277315|NCT01195662|50591362|FG001|Double Blind Treatment Period|Adverse Event|1|||
25277316|NCT01195662|50591363|FG002|Double Blind Treatment Period|Adverse Event|2|||
25277317|NCT01195662|50591361|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
25277318|NCT01195662|50591362|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
25277319|NCT01195662|50591363|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
25277320|NCT01195662|50591361|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
25277321|NCT01195662|50591362|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
25277322|NCT01195662|50591363|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
25277323|NCT01195662|50591361|FG000|Double Blind Treatment Period|Administrative reason|2|||
25277324|NCT01195662|50591362|FG001|Double Blind Treatment Period|Administrative reason|1|||
25277325|NCT01195662|50591363|FG002|Double Blind Treatment Period|Administrative reason|1|||
25277326|NCT01195662|50591361|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
25277327|NCT01195662|50591362|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
25277328|NCT01195662|50591363|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
25277329|NCT01195662|50591361|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
25277330|NCT01195662|50591362|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
25277331|NCT01195662|50591363|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
25277332|NCT01195662|50591361|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
25277333|NCT01195662|50591362|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
25277334|NCT01195662|50591363|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
25277335|NCT01195662|50591361|FG000|Double Blind Treatment Period|Non-specified|3|||
25277336|NCT01195662|50591362|FG001|Double Blind Treatment Period|Non-specified|0|||
25277337|NCT01195662|50591363|FG002|Double Blind Treatment Period|Non-specified|0|||
25277338|NCT01195662|50591361|FG000|Double Blind Treatment Period|Missing disposition information|0|||
25277339|NCT01195662|50591362|FG001|Double Blind Treatment Period|Missing disposition information|1|||
25277340|NCT01195662|50591363|FG002|Double Blind Treatment Period|Missing disposition information|1|||
25277341|NCT01195662|50591361|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
25277342|NCT01195662|50591362|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
25277343|NCT01195662|50591363|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
25277344|NCT01195662|50591361|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
25277345|NCT01195662|50591362|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
25277346|NCT01195662|50591363|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
25277347|NCT01195272|50591372|FG000|Overall Study|Adverse Event|1|||
25277348|NCT01195272|50591372|FG000|Overall Study|Lack of Efficacy|3|||
25277349|NCT01194804|50591376|FG000|Overall Study|Withdrawal by Subject|1|||
25277350|NCT01194414|50591400|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
25277351|NCT01194414|50591401|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
25277352|NCT01194414|50591402|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
25277353|NCT01194414|50591403|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
25277354|NCT01194414|50591400|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
25277355|NCT01194414|50591401|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
25277356|NCT01194414|50591402|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
25277357|NCT01194414|50591403|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
25277358|NCT01194414|50591400|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
25277359|NCT01194414|50591401|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
25277360|NCT01194414|50591402|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
25277361|NCT01194414|50591403|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
25277362|NCT01194414|50591400|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
25277363|NCT01194414|50591401|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
25277364|NCT01194414|50591402|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
25277365|NCT01194414|50591403|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
25277366|NCT01194414|50591400|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
25277367|NCT01194414|50591401|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
25277368|NCT01194414|50591402|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
25277369|NCT01194414|50591403|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
25277370|NCT01194414|50591400|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
25277371|NCT01194414|50591401|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
25277372|NCT01194414|50591402|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
25277373|NCT01194414|50591403|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
25277374|NCT01194414|50591400|FG000|24 Weeks Double Blind Period|Other|0|||
25277375|NCT01194414|50591401|FG001|24 Weeks Double Blind Period|Other|1|||
25277376|NCT01194414|50591402|FG002|24 Weeks Double Blind Period|Other|0|||
25277377|NCT01194414|50591403|FG003|24 Weeks Double Blind Period|Other|0|||
25277378|NCT01194414|50591400|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
25277379|NCT01194414|50591401|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
25277380|NCT01194414|50591402|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
25277381|NCT01194414|50591403|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
25277382|NCT01194414|50591400|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
25277383|NCT01194414|50591401|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
25277384|NCT01194414|50591402|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
25277385|NCT01194414|50591403|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
25277386|NCT01194414|50591400|FG000|24 Weeks Double Blind Period|Death|0|||
25277387|NCT01194414|50591401|FG001|24 Weeks Double Blind Period|Death|1|||
25277388|NCT01194414|50591402|FG002|24 Weeks Double Blind Period|Death|0|||
25277389|NCT01194414|50591403|FG003|24 Weeks Double Blind Period|Death|0|||
25277390|NCT01194414|50591400|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
25277391|NCT01194414|50591401|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
25277392|NCT01194414|50591402|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
25277393|NCT01194414|50591403|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
25277394|NCT01194414|50591400|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
25277395|NCT01194414|50591401|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
25277396|NCT01194414|50591402|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
25277397|NCT01194414|50591403|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
25277398|NCT01194414|50591400|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
25277399|NCT01194414|50591401|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
25277400|NCT01194414|50591402|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
25277401|NCT01194414|50591403|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
25277402|NCT01194414|50591400|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
25277403|NCT01194414|50591401|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
25069414|NCT04436822|50175235|FG001|Overall Study|Unsuccessful procedure|1|||
25189273|NCT01828112|50345636|FG000|Overall Study|Physician Decision|5|||
25189274|NCT01828112|50345637|FG001|Overall Study|Physician Decision|5|||
25189275|NCT01828112|50345636|FG000|Overall Study|Progressive disease|56|||
25189276|NCT01828112|50345637|FG001|Overall Study|Progressive disease|82|||
25189277|NCT01828112|50345636|FG000|Overall Study|Subject/guardian decision|6|||
25189278|NCT01828112|50345637|FG001|Overall Study|Subject/guardian decision|8|||
25189279|NCT00545077|50345645|FG000|Overall Study|Treatment not received|5|||
25189280|NCT00545077|50345646|FG001|Overall Study|Treatment not received|1|||
25189281|NCT00545077|50345645|FG000|Overall Study|Disease Progression|131|||
25189282|NCT00545077|50345646|FG001|Overall Study|Disease Progression|98|||
25189283|NCT00545077|50345645|FG000|Overall Study|Withdrawal by Subject|3|||
25189284|NCT00545077|50345646|FG001|Overall Study|Withdrawal by Subject|14|||
25189285|NCT00545077|50345645|FG000|Overall Study|Physician Decision|6|||
25189286|NCT00545077|50345646|FG001|Overall Study|Physician Decision|3|||
25189287|NCT00545077|50345645|FG000|Overall Study|Lost to Follow-up|2|||
25189288|NCT00545077|50345646|FG001|Overall Study|Lost to Follow-up|0|||
25189289|NCT00545077|50345645|FG000|Overall Study|Protocol Violation|1|||
25189290|NCT00545077|50345646|FG001|Overall Study|Protocol Violation|0|||
25189291|NCT00545077|50345645|FG000|Overall Study|Adverse Event|0|||
25189292|NCT00545077|50345646|FG001|Overall Study|Adverse Event|31|||
25189293|NCT00545077|50345645|FG000|Overall Study|Death|0|||
25189294|NCT00545077|50345646|FG001|Overall Study|Death|8|||
25189295|NCT00130533|50345654|FG000|Overall Study|Withdrawal by Subject|33|||
25189296|NCT00130533|50345655|FG001|Overall Study|Withdrawal by Subject|6|||
25189297|NCT00130533|50345654|FG000|Overall Study|Adverse Event|34|||
25189298|NCT00130533|50345655|FG001|Overall Study|Adverse Event|1|||
25189299|NCT00130533|50345654|FG000|Overall Study|Disease relapse|9|||
25189300|NCT00130533|50345655|FG001|Overall Study|Disease relapse|13|||
25189301|NCT00130533|50345654|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
25189302|NCT00130533|50345655|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
25189303|NCT00130533|50345654|FG000|Overall Study|Death|4|||
25189304|NCT00130533|50345655|FG001|Overall Study|Death|2|||
25189305|NCT00130533|50345654|FG000|Overall Study|Protocol Violation|5|||
25189306|NCT00130533|50345655|FG001|Overall Study|Protocol Violation|1|||
25189307|NCT00130533|50345654|FG000|Overall Study|Lost to Follow-up|1|||
25189308|NCT00130533|50345655|FG001|Overall Study|Lost to Follow-up|1|||
25189309|NCT00130533|50345654|FG000|Overall Study|Sponsor´s decision|2|||
25189310|NCT00130533|50345655|FG001|Overall Study|Sponsor´s decision|0|||
25189311|NCT00130533|50345654|FG000|Overall Study|Second Primary Malignancy|0|||
25189312|NCT00130533|50345655|FG001|Overall Study|Second Primary Malignancy|1|||
25189313|NCT00130533|50345654|FG000|Overall Study|Other|12|||
25189314|NCT00130533|50345655|FG001|Overall Study|Other|5|||
25189315|NCT00129935|50345663|FG000|Overall Study|Adverse Event|18|||
25189316|NCT00129935|50345664|FG001|Overall Study|Adverse Event|56|||
25189317|NCT00129935|50345663|FG000|Overall Study|Death|1|||
25189318|NCT00129935|50345664|FG001|Overall Study|Death|1|||
25189319|NCT00129935|50345663|FG000|Overall Study|Withdrawal by Subject|7|||
25189320|NCT00129935|50345664|FG001|Overall Study|Withdrawal by Subject|20|||
25189321|NCT00129935|50345663|FG000|Overall Study|Protocol Violation|0|||
25189322|NCT00129935|50345664|FG001|Overall Study|Protocol Violation|4|||
25189323|NCT00129935|50345663|FG000|Overall Study|Physician Decision|3|||
25189324|NCT00129935|50345664|FG001|Overall Study|Physician Decision|4|||
25189325|NCT00129935|50345663|FG000|Overall Study|Recurrence|1|||
25189326|NCT00129935|50345664|FG001|Overall Study|Recurrence|3|||
25189327|NCT00129935|50345663|FG000|Overall Study|Second primary|0|||
25189328|NCT00129935|50345664|FG001|Overall Study|Second primary|1|||
25189329|NCT00129935|50345663|FG000|Overall Study|Other|3|||
25189330|NCT00129935|50345664|FG001|Overall Study|Other|2|||
25189331|NCT00129935|50345663|FG000|Overall Study|Crossed to the other arm|2|||
25189332|NCT00129935|50345664|FG001|Overall Study|Crossed to the other arm|1|||
25189333|NCT00129935|50345663|FG000|Overall Study|Incorrect study treatment|1|||
25189334|NCT00129935|50345664|FG001|Overall Study|Incorrect study treatment|0|||
25189335|NCT01647828|50345679|FG000|Overall Study|Death|3|||
25189336|NCT01647828|50345680|FG001|Overall Study|Death|4|||
25189337|NCT01647828|50345681|FG002|Overall Study|Death|4|||
25189338|NCT01647828|50345682|FG003|Overall Study|Death|5|||
25189339|NCT01647828|50345683|FG004|Overall Study|Death|6|||
25189340|NCT01647828|50345684|FG005|Overall Study|Death|3|||
25069415|NCT04436822|50175234|FG000|Overall Study|Withdrawal due to Covid-19|8|||
25189341|NCT01647828|50345685|FG006|Overall Study|Death|10|||
25189342|NCT01647828|50345686|FG007|Overall Study|Death|60|||
25189343|NCT01647828|50345687|FG008|Overall Study|Death|71|||
25189344|NCT01647828|50345679|FG000|Overall Study|Withdrawal by Subject|2|||
25189345|NCT01647828|50345680|FG001|Overall Study|Withdrawal by Subject|0|||
25189346|NCT01647828|50345681|FG002|Overall Study|Withdrawal by Subject|0|||
25189347|NCT01647828|50345682|FG003|Overall Study|Withdrawal by Subject|1|||
25189348|NCT01647828|50345683|FG004|Overall Study|Withdrawal by Subject|0|||
25189349|NCT01647828|50345684|FG005|Overall Study|Withdrawal by Subject|0|||
25189350|NCT01647828|50345685|FG006|Overall Study|Withdrawal by Subject|1|||
25277404|NCT01194414|50591402|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
25277405|NCT01194414|50591403|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
25277406|NCT01194414|50591400|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
25277407|NCT01194414|50591401|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
25277408|NCT01194414|50591402|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
25277409|NCT01194414|50591403|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
25277410|NCT01194414|50591400|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
25277411|NCT01194414|50591401|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
25277412|NCT01194414|50591402|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
25277413|NCT01194414|50591403|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
25277414|NCT01194414|50591400|FG000|72 Weeks Open Label Extension|Other|2|||
25277415|NCT01194414|50591401|FG001|72 Weeks Open Label Extension|Other|1|||
25277416|NCT01194414|50591402|FG002|72 Weeks Open Label Extension|Other|0|||
25277417|NCT01194414|50591403|FG003|72 Weeks Open Label Extension|Other|0|||
25277418|NCT01194414|50591400|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
25277419|NCT01194414|50591401|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
25277420|NCT01194414|50591402|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
25277421|NCT01194414|50591403|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
25277422|NCT01194414|50591400|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
25277423|NCT01194414|50591401|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
25277424|NCT01194414|50591402|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
25277425|NCT01194414|50591403|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
25277426|NCT01194414|50591400|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
25277427|NCT01194414|50591401|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
25277428|NCT01194414|50591402|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
25277429|NCT01194414|50591403|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
25277430|NCT01194414|50591400|FG000|72 Weeks Open Label Extension|Death|1|||
25277431|NCT01194414|50591401|FG001|72 Weeks Open Label Extension|Death|2|||
25277432|NCT01194414|50591402|FG002|72 Weeks Open Label Extension|Death|0|||
25277433|NCT01194414|50591403|FG003|72 Weeks Open Label Extension|Death|2|||
25277434|NCT01194258|50591415|FG000|Titration Period|Withdrawal by Subject|6|||
25277435|NCT01194258|50591416|FG001|Titration Period|Withdrawal by Subject|0|||
25277436|NCT01194258|50591417|FG002|Titration Period|Withdrawal by Subject|0|||
25277437|NCT01194258|50591418|FG003|Titration Period|Withdrawal by Subject|0|||
25277438|NCT01194258|50591419|FG004|Titration Period|Withdrawal by Subject|0|||
25189351|NCT01647828|50345686|FG007|Overall Study|Withdrawal by Subject|0|||
25189352|NCT01647828|50345687|FG008|Overall Study|Withdrawal by Subject|2|||
25189353|NCT01647828|50345679|FG000|Overall Study|Study terminated by Sponsor|0|||
25189354|NCT01647828|50345680|FG001|Overall Study|Study terminated by Sponsor|0|||
25189355|NCT01647828|50345681|FG002|Overall Study|Study terminated by Sponsor|0|||
25189356|NCT01647828|50345682|FG003|Overall Study|Study terminated by Sponsor|0|||
25189357|NCT01647828|50345683|FG004|Overall Study|Study terminated by Sponsor|0|||
25189358|NCT01647828|50345684|FG005|Overall Study|Study terminated by Sponsor|0|||
25189359|NCT01647828|50345685|FG006|Overall Study|Study terminated by Sponsor|1|||
25189360|NCT01647828|50345686|FG007|Overall Study|Study terminated by Sponsor|26|||
25189361|NCT01647828|50345687|FG008|Overall Study|Study terminated by Sponsor|16|||
25189362|NCT01647828|50345679|FG000|Overall Study|Lost to Follow-up|0|||
25189363|NCT01647828|50345680|FG001|Overall Study|Lost to Follow-up|0|||
25189364|NCT01647828|50345681|FG002|Overall Study|Lost to Follow-up|0|||
25189365|NCT01647828|50345682|FG003|Overall Study|Lost to Follow-up|0|||
25189366|NCT01647828|50345683|FG004|Overall Study|Lost to Follow-up|0|||
25189367|NCT01647828|50345684|FG005|Overall Study|Lost to Follow-up|0|||
25189368|NCT01647828|50345685|FG006|Overall Study|Lost to Follow-up|0|||
25189369|NCT01647828|50345686|FG007|Overall Study|Lost to Follow-up|2|||
25189370|NCT01647828|50345687|FG008|Overall Study|Lost to Follow-up|0|||
25277439|NCT01194258|50591415|FG000|Titration Period|Lost to Follow-up|2|||
25277440|NCT01194258|50591416|FG001|Titration Period|Lost to Follow-up|0|||
25277441|NCT01194258|50591417|FG002|Titration Period|Lost to Follow-up|0|||
25277442|NCT01194258|50591418|FG003|Titration Period|Lost to Follow-up|0|||
25069416|NCT04436822|50175235|FG001|Overall Study|Withdrawal due to Covid-19|1|||
25189371|NCT00989261|50345709|FG000|Overall Study|Still in follow up|12|||
25189372|NCT00989261|50345710|FG001|Overall Study|Still in follow up|21|||
25189373|NCT00989261|50345709|FG000|Overall Study|Withdrawal by Subject|0|||
25189374|NCT00989261|50345710|FG001|Overall Study|Withdrawal by Subject|1|||
25189375|NCT00989261|50345709|FG000|Overall Study|Lost to Follow-up|3|||
25189376|NCT00989261|50345710|FG001|Overall Study|Lost to Follow-up|0|||
25277443|NCT01194258|50591419|FG004|Titration Period|Lost to Follow-up|0|||
25277444|NCT01194258|50591415|FG000|Titration Period|Titration failure|3|||
25277445|NCT01194258|50591416|FG001|Titration Period|Titration failure|0|||
25277446|NCT01194258|50591417|FG002|Titration Period|Titration failure|0|||
25277447|NCT01194258|50591418|FG003|Titration Period|Titration failure|0|||
25277448|NCT01194258|50591419|FG004|Titration Period|Titration failure|0|||
25277449|NCT01194258|50591415|FG000|Period 1 (12 Weeks)|Death|0|||
25189377|NCT00988559|50345729|FG000|Overall Study|Withdrawal by Subject|1|||
25189378|NCT00988559|50345730|FG001|Overall Study|Withdrawal by Subject|1|||
25189379|NCT00988559|50345731|FG002|Overall Study|Withdrawal by Subject|0|||
25189380|NCT00988559|50345732|FG003|Overall Study|Withdrawal by Subject|1|||
25189381|NCT00988559|50345729|FG000|Overall Study|Pregnancy|0|||
25189382|NCT00988559|50345730|FG001|Overall Study|Pregnancy|1|||
25189383|NCT00988559|50345731|FG002|Overall Study|Pregnancy|1|||
25277450|NCT01194258|50591416|FG001|Period 1 (12 Weeks)|Death|0|||
25277451|NCT01194258|50591417|FG002|Period 1 (12 Weeks)|Death|0|||
25277452|NCT01194258|50591418|FG003|Period 1 (12 Weeks)|Death|0|||
25277453|NCT01194258|50591419|FG004|Period 1 (12 Weeks)|Death|1|||
25277454|NCT01194258|50591415|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
25277455|NCT01194258|50591416|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
25277456|NCT01194258|50591417|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
25277457|NCT01194258|50591418|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
25277458|NCT01194258|50591419|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
25277459|NCT01194258|50591415|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
25277460|NCT01194258|50591416|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
25277461|NCT01194258|50591417|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
25277462|NCT01194258|50591418|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
25277463|NCT01194258|50591419|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
25277464|NCT01194258|50591415|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
25277465|NCT01194258|50591416|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
25189384|NCT00988559|50345732|FG003|Overall Study|Pregnancy|0|||
25277466|NCT01194258|50591417|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
25277467|NCT01194258|50591418|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
25277468|NCT01194258|50591419|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
25277469|NCT01193556|50591432|FG000|Overall Study|Study termination|26|||
25277470|NCT01193556|50591433|FG001|Overall Study|Study termination|25|||
25277471|NCT00951496|50591446|FG000|Overall Study|Did not initiate study treatment|10|||
25277472|NCT00951496|50591447|FG001|Overall Study|Did not initiate study treatment|8|||
25277473|NCT00951496|50591448|FG002|Overall Study|Did not initiate study treatment|13|||
25277474|NCT01193244|50591461|FG000|Overall Study|Withdrawal by Subject|79|||
25277475|NCT01193244|50591462|FG001|Overall Study|Withdrawal by Subject|97|||
25277476|NCT01193244|50591461|FG000|Overall Study|Other|303|||
25277477|NCT01193244|50591462|FG001|Overall Study|Other|278|||
25277478|NCT01193244|50591461|FG000|Overall Study|Lost to Follow-up|6|||
25277479|NCT01193244|50591462|FG001|Overall Study|Lost to Follow-up|15|||
25277480|NCT01192152|50591468|FG000|Period 1|left prematurely (while on treatment B)|0|||
25277481|NCT01192152|50591469|FG001|Period 1|left prematurely (while on treatment B)|1|||
25277482|NCT01192152|50591468|FG000|Period 3|family emergency|1|||
25277483|NCT01192152|50591469|FG001|Period 3|family emergency|0|||
25277484|NCT01191840|50591479|FG000|Overall Study|withdrew consent|2|||
25277485|NCT01191840|50591480|FG001|Overall Study|withdrew consent|1|||
25277486|NCT01191840|50591479|FG000|Overall Study|Subject discontinued treatment|1|||
25277487|NCT01191840|50591480|FG001|Overall Study|Subject discontinued treatment|2|||
25277488|NCT01191840|50591479|FG000|Overall Study|Lost to Follow-up|4|||
25277489|NCT01191840|50591480|FG001|Overall Study|Lost to Follow-up|6|||
25277490|NCT01191840|50591479|FG000|Overall Study|Non Staph Infection|4|||
25277491|NCT01191840|50591480|FG001|Overall Study|Non Staph Infection|3|||
25277492|NCT01191840|50591479|FG000|Overall Study|ineligible at enrollment|1|||
25277493|NCT01191840|50591480|FG001|Overall Study|ineligible at enrollment|0|||
25277494|NCT01191840|50591479|FG000|Overall Study|IRB approval lapse|0|||
25277495|NCT01191840|50591480|FG001|Overall Study|IRB approval lapse|2|||
25277496|NCT01191840|50591479|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
25277497|NCT01191840|50591480|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
25277498|NCT01191840|50591479|FG000|Overall Study|Withdrawal by Subject|2|||
25277499|NCT01191840|50591480|FG001|Overall Study|Withdrawal by Subject|0|||
25277500|NCT00943072|50591492|FG000|Overall Study|Adverse Event|0|||
25277501|NCT00943072|50591493|FG001|Overall Study|Adverse Event|3|||
25277502|NCT00943072|50591492|FG000|Overall Study|Death|0|||
24969019|NCT00122382|50058556|FG001|Open-Label Study|Adverse Event|0|||
25277503|NCT00943072|50591493|FG001|Overall Study|Death|2|||
25277504|NCT00943072|50591492|FG000|Overall Study|Withdrawal by Subject|3|||
25277505|NCT00943072|50591493|FG001|Overall Study|Withdrawal by Subject|1|||
25277506|NCT00943072|50591492|FG000|Overall Study|Protocol Violation|0|||
25277507|NCT00943072|50591493|FG001|Overall Study|Protocol Violation|1|||
25277508|NCT00943072|50591492|FG000|Overall Study|Lost to Follow-up|1|||
25277509|NCT00943072|50591493|FG001|Overall Study|Lost to Follow-up|2|||
25277510|NCT00943072|50591492|FG000|Overall Study|Lack of Efficacy|0|||
25277511|NCT00943072|50591493|FG001|Overall Study|Lack of Efficacy|4|||
25277512|NCT00943072|50591492|FG000|Overall Study|Other|1|||
25189385|NCT00988559|50345729|FG000|Overall Study|Lost to Follow-up|0|||
25277513|NCT00943072|50591493|FG001|Overall Study|Other|1|||
25277514|NCT00942994|50591503|FG000|Overall Study|Adverse Event|7|||
25277515|NCT00942994|50591504|FG001|Overall Study|Adverse Event|4|||
25277516|NCT00942994|50591503|FG000|Overall Study|Abnormal laboratory value(s)|1|||
25277517|NCT00942994|50591504|FG001|Overall Study|Abnormal laboratory value(s)|0|||
25277518|NCT00942994|50591503|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25069417|NCT04436822|50175234|FG000|Overall Study|Withdrawal by Subject|1|||
25069418|NCT04436822|50175235|FG001|Overall Study|Withdrawal by Subject|0|||
25069419|NCT04436822|50175234|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
25069420|NCT04436822|50175235|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
25069421|NCT01596062|50175245|FG000|Overall Study|Adverse Event|1|||
25069422|NCT01596062|50175246|FG001|Overall Study|Adverse Event|0|||
25069423|NCT01596062|50175247|FG002|Overall Study|Adverse Event|2|||
25069424|NCT01596062|50175245|FG000|Overall Study|Lack of Efficacy|0|||
25069425|NCT01596062|50175246|FG001|Overall Study|Lack of Efficacy|0|||
25069426|NCT01596062|50175247|FG002|Overall Study|Lack of Efficacy|1|||
25069427|NCT02614898|50175266|FG000|Overall Study|Participated until study termination|10|||
25069428|NCT02614898|50175267|FG001|Overall Study|Participated until study termination|26|||
25069429|NCT02614898|50175266|FG000|Overall Study|Lost to Follow-up|0|||
25069430|NCT02614898|50175267|FG001|Overall Study|Lost to Follow-up|2|||
25069431|NCT02614898|50175266|FG000|Overall Study|Physician Decision|1|||
25069432|NCT02614898|50175267|FG001|Overall Study|Physician Decision|8|||
25069433|NCT02614898|50175266|FG000|Overall Study|Study Terminated by Sponsor|3|||
25069434|NCT02614898|50175267|FG001|Overall Study|Study Terminated by Sponsor|0|||
25069435|NCT02614898|50175266|FG000|Overall Study|Withdrawal by Subject|0|||
25069436|NCT02614898|50175267|FG001|Overall Study|Withdrawal by Subject|2|||
25069437|NCT02614898|50175266|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
25069438|NCT02614898|50175267|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
25069439|NCT02614898|50175266|FG000|Overall Study|Other-Additional Information Unavailable|0|||
25069440|NCT02614898|50175267|FG001|Overall Study|Other-Additional Information Unavailable|11|||
25069441|NCT02614898|50175266|FG000|Overall Study|Missing|0|||
25069442|NCT02614898|50175267|FG001|Overall Study|Missing|1|||
25069443|NCT02777593|50175279|FG000|Overall Study|Still in study|66|||
25069444|NCT02777593|50175280|FG001|Overall Study|Still in study|105|||
25069445|NCT02777593|50175281|FG002|Overall Study|Still in study|10|||
25069446|NCT02777593|50175282|FG003|Overall Study|Still in study|8|||
25069447|NCT02777593|50175283|FG004|Overall Study|Still in study|6|||
25069448|NCT02777593|50175279|FG000|Overall Study|Death|11|||
25069449|NCT02777593|50175280|FG001|Overall Study|Death|19|||
25069450|NCT02777593|50175281|FG002|Overall Study|Death|0|||
25069451|NCT02777593|50175282|FG003|Overall Study|Death|4|||
25069452|NCT02777593|50175283|FG004|Overall Study|Death|0|||
25069453|NCT02777593|50175279|FG000|Overall Study|Withdrawal by Subject|5|||
25069454|NCT02777593|50175280|FG001|Overall Study|Withdrawal by Subject|1|||
25069455|NCT02777593|50175281|FG002|Overall Study|Withdrawal by Subject|0|||
25069456|NCT02777593|50175282|FG003|Overall Study|Withdrawal by Subject|1|||
25069457|NCT02777593|50175283|FG004|Overall Study|Withdrawal by Subject|0|||
25069458|NCT02777593|50175279|FG000|Overall Study|Lost to Follow-up|1|||
25069459|NCT02777593|50175280|FG001|Overall Study|Lost to Follow-up|6|||
25069460|NCT02777593|50175281|FG002|Overall Study|Lost to Follow-up|0|||
25069461|NCT02777593|50175282|FG003|Overall Study|Lost to Follow-up|0|||
25069462|NCT02777593|50175283|FG004|Overall Study|Lost to Follow-up|0|||
25069463|NCT02777593|50175279|FG000|Overall Study|Physician Decision|0|||
25069464|NCT02777593|50175280|FG001|Overall Study|Physician Decision|1|||
25069465|NCT02777593|50175281|FG002|Overall Study|Physician Decision|0|||
25069466|NCT02777593|50175282|FG003|Overall Study|Physician Decision|0|||
25069467|NCT02777593|50175283|FG004|Overall Study|Physician Decision|0|||
25069468|NCT02777593|50175279|FG000|Overall Study|Discontinued due to Other|2|||
25069469|NCT02777593|50175280|FG001|Overall Study|Discontinued due to Other|0|||
25189386|NCT00988559|50345730|FG001|Overall Study|Lost to Follow-up|0|||
25189387|NCT00988559|50345731|FG002|Overall Study|Lost to Follow-up|1|||
25189388|NCT00988559|50345732|FG003|Overall Study|Lost to Follow-up|0|||
25189389|NCT00988169|50345742|FG000|Overall Study|Withdrawal by Subject|1|||
25189390|NCT00988091|50345769|FG000|Double-blind Period|Withdrawal by Subject|15|||
25189391|NCT00988091|50345770|FG001|Double-blind Period|Withdrawal by Subject|13|||
25189392|NCT00988091|50345769|FG000|Double-blind Period|Lost to Follow-up|12|||
25189393|NCT00988091|50345770|FG001|Double-blind Period|Lost to Follow-up|14|||
25189394|NCT00988091|50345769|FG000|Double-blind Period|Other|8|||
25277519|NCT00942994|50591504|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
25069470|NCT02777593|50175281|FG002|Overall Study|Discontinued due to Other|0|||
25069471|NCT02777593|50175282|FG003|Overall Study|Discontinued due to Other|0|||
25069472|NCT02777593|50175283|FG004|Overall Study|Discontinued due to Other|0|||
25069473|NCT02776033|50175308|FG000|Overall Study|Withdrawal by Subject|0|||
25069474|NCT02776033|50175309|FG001|Overall Study|Withdrawal by Subject|0|||
25069475|NCT02776033|50175310|FG002|Overall Study|Withdrawal by Subject|2|||
25069476|NCT02776033|50175308|FG000|Overall Study|Physician Decision|2|||
25069477|NCT02776033|50175309|FG001|Overall Study|Physician Decision|0|||
25189395|NCT00988091|50345770|FG001|Double-blind Period|Other|8|||
25277520|NCT00942994|50591503|FG000|Overall Study|Patient withdrew consent|5|||
25277521|NCT00942994|50591504|FG001|Overall Study|Patient withdrew consent|8|||
25277522|NCT00942994|50591503|FG000|Overall Study|Lost to Follow-up|1|||
25277523|NCT00942994|50591504|FG001|Overall Study|Lost to Follow-up|4|||
25277524|NCT00942994|50591503|FG000|Overall Study|Protocol deviation|1|||
25277525|NCT00942994|50591504|FG001|Overall Study|Protocol deviation|2|||
25277526|NCT00942604|50591512|FG000|Overall Study|Protocol Violation|1|||
25277527|NCT00942604|50591513|FG001|Overall Study|Protocol Violation|1|||
25277528|NCT00942604|50591512|FG000|Overall Study|Adverse Event|0|||
25277529|NCT00942604|50591513|FG001|Overall Study|Adverse Event|1|||
25277530|NCT00942604|50591512|FG000|Overall Study|Withdrawal by Subject|0|||
25277531|NCT00942604|50591513|FG001|Overall Study|Withdrawal by Subject|1|||
25277532|NCT00942604|50591512|FG000|Overall Study|Patient relocation|1|||
25277533|NCT00942604|50591513|FG001|Overall Study|Patient relocation|1|||
25277534|NCT01188564|50591521|FG000|Double-blind Phase|randomized not treated|1|||
25277535|NCT01188564|50591522|FG001|Double-blind Phase|randomized not treated|0|||
25277536|NCT01187550|50591530|FG000|Overall Study|Protocol Violation|3|||
25277537|NCT01187550|50591531|FG001|Overall Study|Protocol Violation|1|||
25277538|NCT01187550|50591530|FG000|Overall Study|Other|3|||
25277539|NCT01187550|50591531|FG001|Overall Study|Other|0|||
25277540|NCT01187550|50591530|FG000|Overall Study|Randomized but not treated|8|||
25277541|NCT01187550|50591531|FG001|Overall Study|Randomized but not treated|0|||
25277542|NCT01186770|50591541|FG000|Overall Study|Ineligibility|0|||
25277543|NCT01186770|50591542|FG001|Overall Study|Ineligibility|0|||
25277544|NCT01186770|50591543|FG002|Overall Study|Ineligibility|2|||
25277545|NCT01186770|50591544|FG003|Overall Study|Ineligibility|0|||
25277546|NCT01186770|50591541|FG000|Overall Study|Protocol Violation|7|||
25277547|NCT01186770|50591542|FG001|Overall Study|Protocol Violation|9|||
25277548|NCT01186770|50591543|FG002|Overall Study|Protocol Violation|12|||
25277549|NCT01186770|50591544|FG003|Overall Study|Protocol Violation|14|||
25277550|NCT01186770|50591541|FG000|Overall Study|Adverse Event|2|||
25277551|NCT01186770|50591542|FG001|Overall Study|Adverse Event|9|||
25277552|NCT01186770|50591543|FG002|Overall Study|Adverse Event|7|||
25277553|NCT01186770|50591544|FG003|Overall Study|Adverse Event|9|||
25277554|NCT01186770|50591541|FG000|Overall Study|Withdrawal by Subject|15|||
25277555|NCT01186770|50591542|FG001|Overall Study|Withdrawal by Subject|13|||
25277556|NCT01186770|50591543|FG002|Overall Study|Withdrawal by Subject|11|||
25277557|NCT01186770|50591544|FG003|Overall Study|Withdrawal by Subject|17|||
25277558|NCT01186770|50591541|FG000|Overall Study|Lost to Follow-up|10|||
25277559|NCT01186770|50591542|FG001|Overall Study|Lost to Follow-up|6|||
25277560|NCT01186770|50591543|FG002|Overall Study|Lost to Follow-up|14|||
25277561|NCT01186770|50591544|FG003|Overall Study|Lost to Follow-up|9|||
25277562|NCT01186770|50591541|FG000|Overall Study|Insufficient response to treatment|7|||
25277563|NCT01186770|50591542|FG001|Overall Study|Insufficient response to treatment|8|||
25277564|NCT01186770|50591543|FG002|Overall Study|Insufficient response to treatment|5|||
25277565|NCT01186770|50591544|FG003|Overall Study|Insufficient response to treatment|7|||
25277566|NCT01186770|50591541|FG000|Overall Study|Other than specified|0|||
25277567|NCT01186770|50591542|FG001|Overall Study|Other than specified|1|||
25277568|NCT01186770|50591543|FG002|Overall Study|Other than specified|1|||
25277569|NCT01186770|50591544|FG003|Overall Study|Other than specified|2|||
25277570|NCT01186692|50591554|FG000|Overall Study|Not Catheterized|11|||
25277571|NCT01186692|50591554|FG000|Overall Study|Futher testing contraindicated implant|19|||
25277572|NCT01186692|50591554|FG000|Overall Study|Adverse Event|2|||
25277573|NCT01186458|50591562|FG000|Overall Study|Adverse Event|1|||
25277574|NCT01185834|50591566|FG000|Overall Study|Lost to Follow-up|2|||
25277575|NCT01185834|50591566|FG000|Overall Study|Discomfort|4|||
25277576|NCT01185834|50591566|FG000|Overall Study|Biomicroscopy|4|||
25277577|NCT01185834|50591566|FG000|Overall Study|Time/Job Conflict|2|||
25277578|NCT01185834|50591566|FG000|Overall Study|Early exit - Site error|2|||
25277579|NCT01185600|50591572|FG000|Overall Study|Adverse Event|1|||
24969020|NCT00122382|50058557|FG002|Open-Label Study|Adverse Event|11|||
24969021|NCT00122382|50058555|FG000|Open-Label Study|Death|0|||
24969022|NCT00122382|50058556|FG001|Open-Label Study|Death|0|||
24969023|NCT00122382|50058557|FG002|Open-Label Study|Death|2|||
24969024|NCT00122382|50058555|FG000|Open-Label Study|Lack of Efficacy|0|||
24969025|NCT00122382|50058556|FG001|Open-Label Study|Lack of Efficacy|0|||
25277580|NCT01185600|50591573|FG001|Overall Study|Adverse Event|1|||
25277581|NCT01185600|50591572|FG000|Overall Study|Death|0|||
25277582|NCT01185600|50591573|FG001|Overall Study|Death|1|||
24969026|NCT00122382|50058557|FG002|Open-Label Study|Lack of Efficacy|3|||
24969027|NCT00122382|50058555|FG000|Open-Label Study|Lost to Follow-up|0|||
25069478|NCT02776033|50175310|FG002|Overall Study|Physician Decision|0|||
25277583|NCT01185600|50591572|FG000|Overall Study|Lost to Follow-up|0|||
25277584|NCT01185600|50591573|FG001|Overall Study|Lost to Follow-up|5|||
25277585|NCT01185600|50591572|FG000|Overall Study|Physician Decision|29|||
25277586|NCT01185600|50591573|FG001|Overall Study|Physician Decision|35|||
25277587|NCT01185600|50591572|FG000|Overall Study|Withdrawal by Subject|1|||
25277588|NCT01185600|50591573|FG001|Overall Study|Withdrawal by Subject|1|||
25277589|NCT01185600|50591572|FG000|Overall Study|Hold by DSMB|1|||
25277590|NCT01185600|50591573|FG001|Overall Study|Hold by DSMB|2|||
25277591|NCT01185522|50591582|FG000|Overall Study|Lack of Efficacy|28|||
25277592|NCT01185522|50591582|FG000|Overall Study|Lost to Follow-up|19|||
25277593|NCT01185522|50591582|FG000|Overall Study|Withdrawal by Subject|10|||
25277594|NCT01185522|50591582|FG000|Overall Study|Poor tolerance|39|||
25277595|NCT01185522|50591582|FG000|Overall Study|Other reasons|12|||
25277596|NCT01185366|50591589|FG000|First Line Therapy|Insurance Coverage Denied|1|||
25277597|NCT01185366|50591590|FG001|First Line Therapy|Insurance Coverage Denied|1|||
25277598|NCT01185366|50591589|FG000|First Line Therapy|Withdrawal by Subject|1|||
25277599|NCT01185366|50591590|FG001|First Line Therapy|Withdrawal by Subject|0|||
25277600|NCT01185366|50591589|FG000|First Line Therapy|Lack of Metastatic Site|1|||
25277601|NCT01185366|50591590|FG001|First Line Therapy|Lack of Metastatic Site|0|||
25277602|NCT01185366|50591589|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
25277603|NCT01185366|50591590|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
25069479|NCT02776033|50175308|FG000|Overall Study|Lost to Follow-up|1|||
25277604|NCT01185366|50591589|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
25277605|NCT01185366|50591590|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
25277606|NCT01185366|50591589|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
25277607|NCT01185366|50591590|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
24969028|NCT00122382|50058556|FG001|Open-Label Study|Lost to Follow-up|0|||
24969029|NCT00122382|50058557|FG002|Open-Label Study|Lost to Follow-up|3|||
24969030|NCT00122382|50058555|FG000|Open-Label Study|Pregnancy|0|||
25189396|NCT00988091|50345769|FG000|Double-blind Period|Adverse Event|6|||
25189397|NCT00988091|50345770|FG001|Double-blind Period|Adverse Event|9|||
25189398|NCT00988091|50345769|FG000|Double-blind Period|Use of exclusionary medication|2|||
25189399|NCT00988091|50345770|FG001|Double-blind Period|Use of exclusionary medication|3|||
25189400|NCT00988091|50345769|FG000|Open-label Period|Adverse Event|4|||
25189401|NCT00988091|50345770|FG001|Open-label Period|Adverse Event|7|||
25189402|NCT00988091|50345769|FG000|Open-label Period|Use of exclusionary medication|1|||
24969031|NCT00122382|50058556|FG001|Open-Label Study|Pregnancy|0|||
25069480|NCT02776033|50175309|FG001|Overall Study|Lost to Follow-up|0|||
25069481|NCT02776033|50175310|FG002|Overall Study|Lost to Follow-up|0|||
25069482|NCT02776033|50175308|FG000|Overall Study|Adverse Event|1|||
25069483|NCT02776033|50175309|FG001|Overall Study|Adverse Event|2|||
25069484|NCT02776033|50175310|FG002|Overall Study|Adverse Event|0|||
25069485|NCT02777125|50175326|FG000|Overall Study|Consent form violation|14|||
25069486|NCT02777125|50175327|FG001|Overall Study|Consent form violation|12|||
25189403|NCT00988091|50345770|FG001|Open-label Period|Use of exclusionary medication|1|||
25189404|NCT00988091|50345769|FG000|Open-label Period|Protocol Violation|1|||
25189405|NCT00988091|50345770|FG001|Open-label Period|Protocol Violation|1|||
25189406|NCT00988091|50345769|FG000|Open-label Period|Withdrawal by Subject|10|||
25189407|NCT00988091|50345770|FG001|Open-label Period|Withdrawal by Subject|16|||
25189408|NCT00988091|50345769|FG000|Open-label Period|Lost to Follow-up|3|||
25189409|NCT00988091|50345770|FG001|Open-label Period|Lost to Follow-up|5|||
25189410|NCT00988091|50345769|FG000|Open-label Period|Other|2|||
25189411|NCT00988091|50345770|FG001|Open-label Period|Other|3|||
25189412|NCT02623218|50346060|FG000|Overall Study|Lost to Follow-up|0|||
25189413|NCT02623218|50346061|FG001|Overall Study|Lost to Follow-up|1|||
25189414|NCT02623218|50346062|FG002|Overall Study|Lost to Follow-up|0|||
25189415|NCT02623218|50346063|FG003|Overall Study|Lost to Follow-up|0|||
25189416|NCT02623218|50346064|FG004|Overall Study|Lost to Follow-up|0|||
25189417|NCT02622828|50346098|FG000|Overall Study|participant withdrew|3|||
25189418|NCT02621424|50346214|FG000|Overall Study|Withdrawal by Subject|1|||
25189419|NCT02621424|50346215|FG001|Overall Study|Withdrawal by Subject|2|||
25189420|NCT02621034|50346243|FG000|Overall Study|Lost to Follow-up|3|||
25189421|NCT02621034|50346244|FG001|Overall Study|Lost to Follow-up|2|||
25189422|NCT02621034|50346245|FG002|Overall Study|Lost to Follow-up|5|||
25277608|NCT01185366|50591589|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
25069487|NCT02777125|50175326|FG000|Overall Study|Assent form violation|21|||
25069488|NCT02777125|50175327|FG001|Overall Study|Assent form violation|23|||
25069489|NCT02777125|50175326|FG000|Overall Study|Protocol Violation|8|||
25069490|NCT02777125|50175327|FG001|Overall Study|Protocol Violation|12|||
25189423|NCT02620020|50346327|FG000|Overall Study|Adverse Event|8|||
25189424|NCT02620020|50346328|FG001|Overall Study|Adverse Event|4|||
25189425|NCT02620020|50346329|FG002|Overall Study|Adverse Event|3|||
25189426|NCT02620020|50346330|FG003|Overall Study|Adverse Event|5|||
25189427|NCT02620020|50346327|FG000|Overall Study|Lost to Follow-up|4|||
25277609|NCT01185366|50591590|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
25189428|NCT02620020|50346328|FG001|Overall Study|Lost to Follow-up|8|||
25277610|NCT01185288|50591600|FG000|Overall Study|Adverse Event|7|||
25277611|NCT01185288|50591601|FG001|Overall Study|Adverse Event|6|||
25277612|NCT01185288|50591600|FG000|Overall Study|Withdrawal by Subject|6|||
25277613|NCT01185288|50591601|FG001|Overall Study|Withdrawal by Subject|4|||
25277614|NCT01185288|50591600|FG000|Overall Study|Lost to Follow-up|2|||
25277615|NCT01185288|50591601|FG001|Overall Study|Lost to Follow-up|5|||
25277616|NCT01185288|50591600|FG000|Overall Study|Lack of Efficacy|2|||
25277617|NCT01185288|50591601|FG001|Overall Study|Lack of Efficacy|0|||
25277618|NCT01185288|50591600|FG000|Overall Study|Investigator discretion|1|||
25277619|NCT01185288|50591601|FG001|Overall Study|Investigator discretion|0|||
25277620|NCT01185288|50591600|FG000|Overall Study|Did not meet inclusion criteria|1|||
25277621|NCT01185288|50591601|FG001|Overall Study|Did not meet inclusion criteria|0|||
25277622|NCT01185288|50591600|FG000|Overall Study|Noncompliance|0|||
25277623|NCT01185288|50591601|FG001|Overall Study|Noncompliance|1|||
25277624|NCT01184508|50591609|FG000|Overall Study|Adverse Event|4|||
25277625|NCT01184508|50591610|FG001|Overall Study|Adverse Event|6|||
25277626|NCT01184508|50591609|FG000|Overall Study|Lack of Efficacy|1|||
25277627|NCT01184508|50591610|FG001|Overall Study|Lack of Efficacy|1|||
25277628|NCT01184508|50591609|FG000|Overall Study|Lost to Follow-up|1|||
25277629|NCT01184508|50591610|FG001|Overall Study|Lost to Follow-up|1|||
25277630|NCT01184508|50591609|FG000|Overall Study|Physician Decision|1|||
25277631|NCT01184508|50591610|FG001|Overall Study|Physician Decision|0|||
25277632|NCT01184508|50591609|FG000|Overall Study|Protocol Violation|3|||
25277633|NCT01184508|50591610|FG001|Overall Study|Protocol Violation|1|||
25277634|NCT01184508|50591609|FG000|Overall Study|Sponsor Decision|5|||
25277635|NCT01184508|50591610|FG001|Overall Study|Sponsor Decision|2|||
25277636|NCT01184508|50591609|FG000|Overall Study|Withdrawal by Subject|1|||
25277637|NCT01184508|50591610|FG001|Overall Study|Withdrawal by Subject|3|||
25277638|NCT01184508|50591609|FG000|Overall Study|Randomized, Not Treated|0|||
25277639|NCT01184508|50591610|FG001|Overall Study|Randomized, Not Treated|1|||
25277640|NCT01184118|50591617|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
25277641|NCT01184118|50591617|FG000|Overall Study|No physiologic confirmation of asthma|8|||
25277642|NCT01184118|50591617|FG000|Overall Study|FEV1 <60% predicted|2|||
25277643|NCT01184118|50591617|FG000|Overall Study|Exclusionary medical condition|2|||
25277644|NCT01184118|50591617|FG000|Overall Study|Withdrawal by Subject|5|||
25277645|NCT01183884|50591621|FG000|Overall Study|Progressive Disease|26|||
25277646|NCT01183884|50591621|FG000|Overall Study|Adverse Event|3|||
25277647|NCT01183884|50591621|FG000|Overall Study|Withdrawal by Subject|1|||
25277648|NCT01183884|50591621|FG000|Overall Study|Other Complicating Disease|3|||
25277649|NCT01183884|50591621|FG000|Overall Study|Not Treated|1|||
25189429|NCT02620020|50346329|FG002|Overall Study|Lost to Follow-up|1|||
25189430|NCT02620020|50346330|FG003|Overall Study|Lost to Follow-up|4|||
25277650|NCT01183884|50591621|FG000|Overall Study|Other|4|||
25277651|NCT01183260|50591627|FG000|Overall Study|Intraop screen failure|2|||
25277652|NCT01183260|50591628|FG001|Overall Study|Intraop screen failure|0|||
25277653|NCT01183260|50591627|FG000|Overall Study|Withdrawal by Subject|1|||
25277654|NCT01183260|50591628|FG001|Overall Study|Withdrawal by Subject|1|||
25277655|NCT01183260|50591627|FG000|Overall Study|Revised within 30 days|0|||
25277656|NCT01183260|50591628|FG001|Overall Study|Revised within 30 days|1|||
25277657|NCT01183260|50591627|FG000|Overall Study|Death|1|||
25277658|NCT01183260|50591628|FG001|Overall Study|Death|0|||
25189431|NCT02620020|50346327|FG000|Overall Study|Physician Decision|7|||
25189432|NCT02620020|50346328|FG001|Overall Study|Physician Decision|4|||
25189433|NCT02620020|50346329|FG002|Overall Study|Physician Decision|3|||
25189434|NCT02620020|50346330|FG003|Overall Study|Physician Decision|4|||
25189435|NCT02620020|50346327|FG000|Overall Study|Protocol Violation|5|||
25189436|NCT02620020|50346328|FG001|Overall Study|Protocol Violation|2|||
25189437|NCT02620020|50346329|FG002|Overall Study|Protocol Violation|1|||
25189438|NCT02620020|50346330|FG003|Overall Study|Protocol Violation|1|||
25189439|NCT02620020|50346327|FG000|Overall Study|Withdrawal by Subject|20|||
25189440|NCT02620020|50346328|FG001|Overall Study|Withdrawal by Subject|16|||
25189441|NCT02620020|50346329|FG002|Overall Study|Withdrawal by Subject|17|||
25277659|NCT01191762|50591636|FG000|Overall Study|Adverse Event|1|||
25277660|NCT01191762|50591637|FG001|Overall Study|Adverse Event|0|||
25277661|NCT01723774|50591646|FG000|Neoadjuvant|Ki67 > 10%|4|||
25277662|NCT01723774|50591647|FG001|Neoadjuvant|Ki67 > 10%|0|||
25277663|NCT01723774|50591648|FG002|Neoadjuvant|Ki67 > 10%|10|||
25277664|NCT01723774|50591649|FG003|Neoadjuvant|Ki67 > 10%|0|||
25277665|NCT01723774|50591646|FG000|Neoadjuvant|Withdrawal by Subject|3|||
25069491|NCT02769481|50175352|FG000|Overall Study|Protocol Violation|1|||
25189442|NCT02620020|50346330|FG003|Overall Study|Withdrawal by Subject|12|||
25189443|NCT02620020|50346327|FG000|Overall Study|Death|0|||
25277666|NCT01723774|50591647|FG001|Neoadjuvant|Withdrawal by Subject|1|||
25277667|NCT01723774|50591648|FG002|Neoadjuvant|Withdrawal by Subject|0|||
25277668|NCT01723774|50591649|FG003|Neoadjuvant|Withdrawal by Subject|0|||
25277669|NCT01723774|50591646|FG000|Neoadjuvant|Disease progression|0|||
25189444|NCT02620020|50346328|FG001|Overall Study|Death|1|||
25189445|NCT02620020|50346329|FG002|Overall Study|Death|0|||
25277670|NCT01723774|50591647|FG001|Neoadjuvant|Disease progression|1|||
25277671|NCT01723774|50591648|FG002|Neoadjuvant|Disease progression|1|||
25277672|NCT01723774|50591649|FG003|Neoadjuvant|Disease progression|0|||
25277673|NCT01723774|50591646|FG000|Neoadjuvant|Adverse Event|0|||
25277674|NCT01723774|50591647|FG001|Neoadjuvant|Adverse Event|1|||
25277675|NCT01723774|50591648|FG002|Neoadjuvant|Adverse Event|2|||
25277676|NCT01723774|50591649|FG003|Neoadjuvant|Adverse Event|0|||
25277677|NCT01723774|50591646|FG000|Neoadjuvant|High estradiol|0|||
25277678|NCT01723774|50591647|FG001|Neoadjuvant|High estradiol|1|||
25277679|NCT01723774|50591648|FG002|Neoadjuvant|High estradiol|0|||
24969032|NCT00122382|50058557|FG002|Open-Label Study|Pregnancy|2|||
24969033|NCT00122382|50058555|FG000|Open-Label Study|Poor/Non-Compliance|0|||
24969034|NCT00122382|50058556|FG001|Open-Label Study|Poor/Non-Compliance|0|||
24969035|NCT00122382|50058557|FG002|Open-Label Study|Poor/Non-Compliance|1|||
24969036|NCT00122382|50058555|FG000|Open-Label Study|Withdrawal of Consent|0|||
24969037|NCT00122382|50058556|FG001|Open-Label Study|Withdrawal of Consent|0|||
24969038|NCT00122382|50058557|FG002|Open-Label Study|Withdrawal of Consent|4|||
25069492|NCT02769481|50175353|FG001|Overall Study|Protocol Violation|0|||
25069493|NCT02769481|50175352|FG000|Overall Study|Adverse Event|3|||
25069494|NCT02769481|50175353|FG001|Overall Study|Adverse Event|6|||
25069495|NCT02769481|50175352|FG000|Overall Study|Entry Criteria Not Met|1|||
25069496|NCT02769481|50175353|FG001|Overall Study|Entry Criteria Not Met|2|||
25069497|NCT02769481|50175352|FG000|Overall Study|Withdrawal by Subject|14|||
25069498|NCT02769481|50175353|FG001|Overall Study|Withdrawal by Subject|16|||
25069499|NCT02769481|50175352|FG000|Overall Study|Lost to Follow-up|9|||
25069500|NCT02769481|50175353|FG001|Overall Study|Lost to Follow-up|9|||
25069501|NCT02769481|50175352|FG000|Overall Study|Physician Decision|0|||
25069502|NCT02769481|50175353|FG001|Overall Study|Physician Decision|1|||
25069503|NCT02769481|50175352|FG000|Overall Study|Terminated by Sponsor|1|||
25069504|NCT02769481|50175353|FG001|Overall Study|Terminated by Sponsor|0|||
25069505|NCT02769481|50175352|FG000|Overall Study|Death|0|||
25189446|NCT02620020|50346330|FG003|Overall Study|Death|0|||
25189447|NCT02549989|50346340|FG000|Overall Study|Adverse Event|4|||
25189448|NCT02549989|50346340|FG000|Overall Study|Death|1|||
25189449|NCT02549989|50346340|FG000|Overall Study|Lack of Efficacy|19|||
25189450|NCT02549989|50346340|FG000|Overall Study|Withdrawal by Subject|3|||
25189451|NCT00987935|50346499|FG000|Overall Study|Progressive disease|3|||
25189452|NCT00987935|50346500|FG001|Overall Study|Progressive disease|2|||
25189453|NCT00987935|50346501|FG002|Overall Study|Progressive disease|3|||
25189454|NCT00987935|50346502|FG003|Overall Study|Progressive disease|2|||
25189455|NCT00987935|50346503|FG004|Overall Study|Progressive disease|5|||
25189456|NCT00987935|50346504|FG005|Overall Study|Progressive disease|3|||
25189457|NCT00987935|50346505|FG006|Overall Study|Progressive disease|9|||
25189458|NCT00987935|50346506|FG007|Overall Study|Progressive disease|48|||
25189459|NCT00987935|50346507|FG008|Overall Study|Progressive disease|23|||
25189460|NCT00987935|50346499|FG000|Overall Study|Adverse Event|0|||
25189461|NCT00987935|50346500|FG001|Overall Study|Adverse Event|1|||
25189462|NCT00987935|50346501|FG002|Overall Study|Adverse Event|0|||
25189463|NCT00987935|50346502|FG003|Overall Study|Adverse Event|1|||
25189464|NCT00987935|50346503|FG004|Overall Study|Adverse Event|1|||
25189465|NCT00987935|50346504|FG005|Overall Study|Adverse Event|0|||
25189466|NCT00987935|50346505|FG006|Overall Study|Adverse Event|2|||
25189467|NCT00987935|50346506|FG007|Overall Study|Adverse Event|10|||
25189468|NCT00987935|50346507|FG008|Overall Study|Adverse Event|6|||
25189469|NCT00987935|50346499|FG000|Overall Study|Refused to continue taking trial med.|1|||
25189470|NCT00987935|50346500|FG001|Overall Study|Refused to continue taking trial med.|0|||
25189471|NCT00987935|50346501|FG002|Overall Study|Refused to continue taking trial med.|0|||
25189472|NCT00987935|50346502|FG003|Overall Study|Refused to continue taking trial med.|0|||
25189473|NCT00987935|50346503|FG004|Overall Study|Refused to continue taking trial med.|1|||
25189474|NCT00987935|50346504|FG005|Overall Study|Refused to continue taking trial med.|0|||
25189475|NCT00987935|50346505|FG006|Overall Study|Refused to continue taking trial med.|4|||
25189476|NCT00987935|50346506|FG007|Overall Study|Refused to continue taking trial med.|4|||
25277680|NCT01723774|50591649|FG003|Neoadjuvant|High estradiol|0|||
25277681|NCT01723774|50591646|FG000|Adjuvant|Still on active treatment|0|||
25277682|NCT01723774|50591647|FG001|Adjuvant|Still on active treatment|0|||
25277683|NCT01723774|50591648|FG002|Adjuvant|Still on active treatment|0|||
25277684|NCT01723774|50591649|FG003|Adjuvant|Still on active treatment|1|||
25069506|NCT02769481|50175353|FG001|Overall Study|Death|1|||
25069507|NCT02769481|50175352|FG000|Overall Study|Undefined|4|||
25189477|NCT00987935|50346507|FG008|Overall Study|Refused to continue taking trial med.|2|||
25189478|NCT00987935|50346499|FG000|Overall Study|Reason other than those specified above|0|||
25189479|NCT00987935|50346500|FG001|Overall Study|Reason other than those specified above|0|||
25189480|NCT00987935|50346501|FG002|Overall Study|Reason other than those specified above|0|||
25189481|NCT00987935|50346502|FG003|Overall Study|Reason other than those specified above|0|||
25189482|NCT00987935|50346503|FG004|Overall Study|Reason other than those specified above|0|||
25189483|NCT00987935|50346504|FG005|Overall Study|Reason other than those specified above|0|||
25189484|NCT00987935|50346505|FG006|Overall Study|Reason other than those specified above|0|||
25189485|NCT00987935|50346506|FG007|Overall Study|Reason other than those specified above|0|||
25189486|NCT00987935|50346507|FG008|Overall Study|Reason other than those specified above|1|||
25189487|NCT01597050|50346535|FG000|Overall Study|Withdrawal by Subject|1|||
25189488|NCT01597050|50346536|FG001|Overall Study|Withdrawal by Subject|0|||
25189489|NCT00987623|50346553|FG000|Overall Study|Lost to Follow-up|2|||
25189490|NCT00987623|50346554|FG001|Overall Study|Lost to Follow-up|1|||
25189491|NCT00987623|50346553|FG000|Overall Study|Time/job conflict|2|||
25189492|NCT00987623|50346554|FG001|Overall Study|Time/job conflict|0|||
25189493|NCT00987623|50346553|FG000|Overall Study|Discomfort|1|||
25189494|NCT00987623|50346554|FG001|Overall Study|Discomfort|0|||
25189495|NCT00987623|50346553|FG000|Overall Study|Biomicroscopy|0|||
25189496|NCT00987623|50346554|FG001|Overall Study|Biomicroscopy|1|||
25189497|NCT00987623|50346553|FG000|Overall Study|Influenza|0|||
25277685|NCT01190514|50591658|FG000|First Intervention (Period 1)|Adverse Event|1|||
25277686|NCT01190514|50591659|FG001|First Intervention (Period 1)|Adverse Event|0|||
25277687|NCT01190514|50591660|FG002|First Intervention (Period 1)|Adverse Event|0|||
25277688|NCT01190514|50591661|FG003|First Intervention (Period 1)|Adverse Event|0|||
25277689|NCT01190514|50591658|FG000|Third Intervention (Period 3)|Adverse Event|1|||
25277690|NCT01190514|50591659|FG001|Third Intervention (Period 3)|Adverse Event|0|||
25277691|NCT01190514|50591660|FG002|Third Intervention (Period 3)|Adverse Event|0|||
25277692|NCT01190514|50591661|FG003|Third Intervention (Period 3)|Adverse Event|0|||
25277693|NCT01190436|50591671|FG000|Overall Study|Lost to Follow-up|35|||
25277694|NCT01190436|50591671|FG000|Overall Study|Other|4|||
25277695|NCT01035255|50591678|FG000|Overall Study|Death|724|||
25277696|NCT01035255|50591679|FG001|Overall Study|Death|844|||
25277697|NCT01035255|50591678|FG000|Overall Study|Lost to Follow-up|2|||
25277698|NCT01035255|50591679|FG001|Overall Study|Lost to Follow-up|5|||
25277699|NCT01035255|50591678|FG000|Overall Study|patient's request|15|||
25277700|NCT01035255|50591679|FG001|Overall Study|patient's request|13|||
25277701|NCT01190124|50591688|FG000|Overall Study|Death|3|||
25277702|NCT01190124|50591689|FG001|Overall Study|Death|0|||
25277703|NCT01190124|50591690|FG002|Overall Study|Death|0|||
25277704|NCT01190124|50591688|FG000|Overall Study|Therapeutic Failure|12|||
25277705|NCT01190124|50591689|FG001|Overall Study|Therapeutic Failure|0|||
25277706|NCT01190124|50591690|FG002|Overall Study|Therapeutic Failure|1|||
25277707|NCT01190124|50591688|FG000|Overall Study|Lost to Follow-up|2|||
25277708|NCT01190124|50591689|FG001|Overall Study|Lost to Follow-up|0|||
25189498|NCT00987623|50346554|FG001|Overall Study|Influenza|1|||
25277709|NCT01190124|50591690|FG002|Overall Study|Lost to Follow-up|0|||
25277710|NCT01189890|50591703|FG000|Overall Study|Adverse Event|3|||
25277711|NCT01189890|50591704|FG001|Overall Study|Adverse Event|4|||
25277712|NCT01189890|50591703|FG000|Overall Study|Lack of Efficacy|7|||
25277713|NCT01189890|50591704|FG001|Overall Study|Lack of Efficacy|2|||
25277714|NCT01189890|50591703|FG000|Overall Study|Lost to Follow-up|1|||
25277715|NCT01189890|50591704|FG001|Overall Study|Lost to Follow-up|7|||
25277716|NCT01189890|50591703|FG000|Overall Study|Protocol Violation|1|||
25277717|NCT01189890|50591704|FG001|Overall Study|Protocol Violation|5|||
25277718|NCT01189890|50591703|FG000|Overall Study|Withdrawal by Subject|15|||
25277719|NCT01189890|50591704|FG001|Overall Study|Withdrawal by Subject|11|||
25277720|NCT01189890|50591703|FG000|Overall Study|Non Compliance|0|||
25277721|NCT01189890|50591704|FG001|Overall Study|Non Compliance|1|||
25277722|NCT01189890|50591703|FG000|Overall Study|Physician Decision|5|||
25277723|NCT01189890|50591704|FG001|Overall Study|Physician Decision|4|||
25277724|NCT01189890|50591703|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
25277725|NCT01189890|50591704|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
25277726|NCT01189812|50591712|FG000|Overall Study|Withdrawal by Subject|2|||
25277727|NCT01189812|50591713|FG001|Overall Study|Withdrawal by Subject|3|||
25277728|NCT01189812|50591712|FG000|Overall Study|Adverse Event|1|||
25277729|NCT01189812|50591713|FG001|Overall Study|Adverse Event|0|||
25277730|NCT01189812|50591712|FG000|Overall Study|Out of Window|4|||
25277731|NCT01189812|50591713|FG001|Overall Study|Out of Window|3|||
25277732|NCT01189812|50591712|FG000|Overall Study|Moved out of State|1|||
25277733|NCT01189812|50591713|FG001|Overall Study|Moved out of State|2|||
25277734|NCT00950950|50591721|FG000|Overall Study|Adverse Event|1|||
25277735|NCT00950950|50591722|FG001|Overall Study|Adverse Event|0|||
25277736|NCT00950950|50591721|FG000|Overall Study|Withdrawal by Subject|0|||
25277737|NCT00950950|50591722|FG001|Overall Study|Withdrawal by Subject|1|||
25277738|NCT00950872|50591729|FG000|Overall Study|Withdrawal by Subject|1|||
25277739|NCT00950872|50591729|FG000|Overall Study|Did not have surgery|2|||
25277740|NCT01189500|50591733|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
25189499|NCT00987467|50346560|FG000|Overall Study|Lost to Follow-up|2|||
25189500|NCT04990440|50346568|FG000|Overall Study|Sponsor's Decision|0|||
25189501|NCT04990440|50346569|FG001|Overall Study|Sponsor's Decision|0|||
25189502|NCT04990440|50346570|FG002|Overall Study|Sponsor's Decision|1|||
25189503|NCT04829747|50346578|FG000|Overall Study|Protocol Violation|1|||
25189504|NCT04408924|50346604|FG000|Overall Study|On Study Treatment|3|||
25189505|NCT04408924|50346604|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|14|||
25189506|NCT04408924|50346604|FG000|Overall Study|Lost to Follow-up|1|||
25277741|NCT01189500|50591733|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
25277742|NCT00938860|50591742|FG000|Overall Study|Adverse Event|2|||
25277743|NCT00938860|50591743|FG001|Overall Study|Adverse Event|1|||
25277744|NCT00938860|50591742|FG000|Overall Study|Abnormal laboratory values|2|||
25277745|NCT00938860|50591743|FG001|Overall Study|Abnormal laboratory values|2|||
25277746|NCT00938860|50591742|FG000|Overall Study|Withdrawal by Subject|11|||
25277747|NCT00938860|50591743|FG001|Overall Study|Withdrawal by Subject|8|||
25277748|NCT00938860|50591742|FG000|Overall Study|Lost to Follow-up|4|||
25277749|NCT00938860|50591743|FG001|Overall Study|Lost to Follow-up|4|||
25277750|NCT00938860|50591742|FG000|Overall Study|Administration problems|2|||
25277751|NCT00938860|50591743|FG001|Overall Study|Administration problems|0|||
25277752|NCT00938860|50591742|FG000|Overall Study|Death|1|||
25277753|NCT00938860|50591743|FG001|Overall Study|Death|1|||
25277754|NCT00938860|50591742|FG000|Overall Study|Protocol Violation|3|||
25277755|NCT00938860|50591743|FG001|Overall Study|Protocol Violation|1|||
25277756|NCT00938470|50591751|FG000|Overall Study|Disease Progression|3|||
25277757|NCT00938470|50591752|FG001|Overall Study|Disease Progression|0|||
25277758|NCT00938470|50591751|FG000|Overall Study|Alternate Treatment|1|||
25277759|NCT00938470|50591752|FG001|Overall Study|Alternate Treatment|0|||
25277760|NCT00938470|50591751|FG000|Overall Study|Death|3|||
25277761|NCT00938470|50591752|FG001|Overall Study|Death|2|||
25277762|NCT00938470|50591751|FG000|Overall Study|Other Reason|0|||
25277763|NCT00938470|50591752|FG001|Overall Study|Other Reason|1|||
25277764|NCT00938392|50591760|FG000|Overall Study|Adverse Event|0|||
25277765|NCT00938392|50591761|FG001|Overall Study|Adverse Event|1|||
25277766|NCT00938392|50591760|FG000|Overall Study|Withdrawal by Subject|0|||
25277767|NCT00938392|50591761|FG001|Overall Study|Withdrawal by Subject|1|||
25277768|NCT00938392|50591760|FG000|Overall Study|Lost to Follow-up|2|||
25277769|NCT00938392|50591761|FG001|Overall Study|Lost to Follow-up|2|||
25277770|NCT01022853|50591772|FG000|Overall Study|Progressive disease|2|||
25277771|NCT01022853|50591773|FG001|Overall Study|Progressive disease|3|||
25277772|NCT01022853|50591774|FG002|Overall Study|Progressive disease|11|||
25277773|NCT01022853|50591775|FG003|Overall Study|Progressive disease|7|||
25277774|NCT01022853|50591776|FG004|Overall Study|Progressive disease|1|||
25277775|NCT01022853|50591772|FG000|Overall Study|Dose-limiting toxicity|0|||
25277776|NCT01022853|50591773|FG001|Overall Study|Dose-limiting toxicity|0|||
25277777|NCT01022853|50591774|FG002|Overall Study|Dose-limiting toxicity|0|||
25277778|NCT01022853|50591775|FG003|Overall Study|Dose-limiting toxicity|0|||
25277779|NCT01022853|50591776|FG004|Overall Study|Dose-limiting toxicity|1|||
25277780|NCT01022853|50591772|FG000|Overall Study|Withdrawal by Subject|0|||
25277781|NCT01022853|50591773|FG001|Overall Study|Withdrawal by Subject|1|||
25277782|NCT01022853|50591774|FG002|Overall Study|Withdrawal by Subject|1|||
25277783|NCT01022853|50591775|FG003|Overall Study|Withdrawal by Subject|1|||
25277784|NCT01022853|50591776|FG004|Overall Study|Withdrawal by Subject|0|||
25277785|NCT01022853|50591772|FG000|Overall Study|Other not stated above|1|||
25277786|NCT01022853|50591773|FG001|Overall Study|Other not stated above|0|||
25277787|NCT01022853|50591774|FG002|Overall Study|Other not stated above|1|||
25277788|NCT01022853|50591775|FG003|Overall Study|Other not stated above|0|||
25277789|NCT01022853|50591776|FG004|Overall Study|Other not stated above|0|||
25277790|NCT01034709|50591793|FG000|Overall Study|Protocol Violation|9|||
25277791|NCT01034709|50591794|FG001|Overall Study|Protocol Violation|16|||
25277792|NCT00937768|50591802|FG000|Overall Study|Refused Further Treatment|3|||
25277793|NCT00937768|50591803|FG001|Overall Study|Refused Further Treatment|2|||
25277794|NCT00937768|50591802|FG000|Overall Study|Disease Progression|1|||
25277795|NCT00937768|50591803|FG001|Overall Study|Disease Progression|1|||
25277796|NCT00937768|50591802|FG000|Overall Study|Alternate Treatment|0|||
25277797|NCT00937768|50591803|FG001|Overall Study|Alternate Treatment|1|||
25277798|NCT00937768|50591802|FG000|Overall Study|No Further Funding|4|||
25277799|NCT00937768|50591803|FG001|Overall Study|No Further Funding|4|||
25277800|NCT00940888|50591809|FG000|Overall Study|Unsuccessful Implant|4|||
25277801|NCT00940888|50591809|FG000|Overall Study|Death|461|||
25277802|NCT00940888|50591809|FG000|Overall Study|Withdrawn - Non-Death|364|||
25277803|NCT00940888|50591809|FG000|Overall Study|Lost to Follow-up|6|||
25277804|NCT01189266|50591816|FG000|Overall Study|Adverse Event|1|||
25277805|NCT01189266|50591817|FG001|Overall Study|Adverse Event|0|||
25277806|NCT01189266|50591818|FG002|Overall Study|Adverse Event|5|||
25277807|NCT01189266|50591816|FG000|Overall Study|Death|0|||
25277808|NCT01189266|50591817|FG001|Overall Study|Death|0|||
25277809|NCT01189266|50591818|FG002|Overall Study|Death|5|||
24969039|NCT01028716|50058575|FG000|Overall Study|Physician Decision|1|||
25277810|NCT01189266|50591816|FG000|Overall Study|Lack of Efficacy|4|||
25277811|NCT01189266|50591817|FG001|Overall Study|Lack of Efficacy|5|||
25277812|NCT01189266|50591818|FG002|Overall Study|Lack of Efficacy|44|||
25277813|NCT01189266|50591816|FG000|Overall Study|Physician Decision|0|||
25277814|NCT01189266|50591817|FG001|Overall Study|Physician Decision|0|||
25277815|NCT01189266|50591818|FG002|Overall Study|Physician Decision|1|||
25277816|NCT01189266|50591816|FG000|Overall Study|Protocol Violation|0|||
25069508|NCT02769481|50175353|FG001|Overall Study|Undefined|1|||
25069509|NCT02769247|50175363|FG000|Overall Study|Withdrawal by Subject|1|||
25069510|NCT02769247|50175364|FG001|Overall Study|Withdrawal by Subject|0|||
25277817|NCT01189266|50591817|FG001|Overall Study|Protocol Violation|1|||
25277818|NCT01189266|50591818|FG002|Overall Study|Protocol Violation|1|||
25277819|NCT01189266|50591816|FG000|Overall Study|Withdrawal by Subject|0|||
25277820|NCT01189266|50591817|FG001|Overall Study|Withdrawal by Subject|0|||
25277821|NCT01189266|50591818|FG002|Overall Study|Withdrawal by Subject|1|||
25277822|NCT01189266|50591816|FG000|Overall Study|Patient refuses further therapy|1|||
25277823|NCT01189266|50591817|FG001|Overall Study|Patient refuses further therapy|0|||
25277824|NCT01189266|50591818|FG002|Overall Study|Patient refuses further therapy|7|||
25277825|NCT01189266|50591816|FG000|Overall Study|No treatment|0|||
25277826|NCT01189266|50591817|FG001|Overall Study|No treatment|0|||
25277827|NCT01189266|50591818|FG002|Overall Study|No treatment|1|||
25277828|NCT01189032|50591830|FG000|Overall Study|Adverse Event|1|||
25277829|NCT01189032|50591831|FG001|Overall Study|Adverse Event|3|||
25277830|NCT01189032|50591832|FG002|Overall Study|Adverse Event|4|||
25277831|NCT01189032|50591830|FG000|Overall Study|Lack of Efficacy|2|||
25277832|NCT01189032|50591831|FG001|Overall Study|Lack of Efficacy|3|||
25277833|NCT01189032|50591832|FG002|Overall Study|Lack of Efficacy|0|||
25277834|NCT01189032|50591830|FG000|Overall Study|Withdrawal by Subject|1|||
25277835|NCT01189032|50591831|FG001|Overall Study|Withdrawal by Subject|0|||
25277836|NCT01189032|50591832|FG002|Overall Study|Withdrawal by Subject|1|||
25277837|NCT01189032|50591830|FG000|Overall Study|Protocol Violation|1|||
25277838|NCT01189032|50591831|FG001|Overall Study|Protocol Violation|1|||
25277839|NCT01189032|50591832|FG002|Overall Study|Protocol Violation|1|||
25277840|NCT01188798|50591842|FG000|Overall Study|Death|0|||
25277841|NCT01188798|50591843|FG001|Overall Study|Death|1|||
25277842|NCT01188798|50591842|FG000|Overall Study|Required additional transplant|1|||
25277843|NCT01188798|50591843|FG001|Overall Study|Required additional transplant|1|||
25277844|NCT01188798|50591842|FG000|Overall Study|Protocol closure|1|||
25277845|NCT01188798|50591843|FG001|Overall Study|Protocol closure|1|||
25277846|NCT01183104|50591852|FG000|Overall Study|Adverse Event|8|||
25277847|NCT01183104|50591853|FG001|Overall Study|Adverse Event|6|||
25277848|NCT01183104|50591852|FG000|Overall Study|Death|0|||
25277849|NCT01183104|50591853|FG001|Overall Study|Death|1|||
25277850|NCT01183104|50591852|FG000|Overall Study|Lost to Follow-up|14|||
25277851|NCT01183104|50591853|FG001|Overall Study|Lost to Follow-up|7|||
25277852|NCT01183104|50591852|FG000|Overall Study|Physician Decision|5|||
25277853|NCT01183104|50591853|FG001|Overall Study|Physician Decision|8|||
25277854|NCT01183104|50591852|FG000|Overall Study|Withdrawal by Subject|6|||
25277855|NCT01183104|50591853|FG001|Overall Study|Withdrawal by Subject|11|||
25277856|NCT01183104|50591852|FG000|Overall Study|Nonparticipation in Extension Study|39|||
25277857|NCT01183104|50591853|FG001|Overall Study|Nonparticipation in Extension Study|50|||
25277858|NCT01183104|50591852|FG000|Overall Study|Did not receive study drug|5|||
25277859|NCT01183104|50591853|FG001|Overall Study|Did not receive study drug|9|||
25277860|NCT01163292|50591861|FG000|Overall Study|Lack of Efficacy|9|||
25277861|NCT01163292|50591862|FG001|Overall Study|Lack of Efficacy|0|||
25277862|NCT01163292|50591861|FG000|Overall Study|Adverse Event|6|||
25277863|NCT01163292|50591862|FG001|Overall Study|Adverse Event|0|||
25277864|NCT01163292|50591861|FG000|Overall Study|Initiation of biological therapy|0|||
25277865|NCT01163292|50591862|FG001|Overall Study|Initiation of biological therapy|15|||
25277866|NCT01163292|50591861|FG000|Overall Study|Sufficient response to adalimumab|8|||
25277867|NCT01163292|50591862|FG001|Overall Study|Sufficient response to adalimumab|0|||
25277868|NCT01163292|50591861|FG000|Overall Study|Refusal to receive adalimumab|7|||
25277869|NCT01163292|50591862|FG001|Overall Study|Refusal to receive adalimumab|0|||
25277870|NCT01163292|50591861|FG000|Overall Study|Economic reasons|6|||
25277871|NCT01163292|50591862|FG001|Overall Study|Economic reasons|0|||
25277872|NCT01163292|50591861|FG000|Overall Study|No further visits|5|||
25277873|NCT01163292|50591862|FG001|Overall Study|No further visits|7|||
25277874|NCT00950248|50591870|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
25277875|NCT00950248|50591871|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
25277876|NCT00950248|50591872|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
25277877|NCT00950248|50591870|FG000|Year 1: Baseline|worsening of symptoms|2|||
25277878|NCT00950248|50591871|FG001|Year 1: Baseline|worsening of symptoms|0|||
25277879|NCT00950248|50591872|FG002|Year 1: Baseline|worsening of symptoms|0|||
25277880|NCT00950248|50591870|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
25277881|NCT00950248|50591871|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
25277882|NCT00950248|50591872|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
25277883|NCT00950248|50591870|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
25277884|NCT00950248|50591871|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
25277885|NCT00950248|50591872|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
25277886|NCT00950248|50591870|FG000|Year 2&3 Treatment Randomization|Death|0|||
25277887|NCT00950248|50591871|FG001|Year 2&3 Treatment Randomization|Death|0|||
25069511|NCT02769247|50175365|FG002|Overall Study|Withdrawal by Subject|0|||
24969040|NCT00106704|50058582|FG000|Overall Study|Adverse Event|10|||
24969041|NCT00106704|50058583|FG001|Overall Study|Adverse Event|7|||
24969042|NCT00106704|50058582|FG000|Overall Study|Death|2|||
24969043|NCT00106704|50058583|FG001|Overall Study|Death|1|||
24969044|NCT00106704|50058582|FG000|Overall Study|Lack of Efficacy|67|||
24969045|NCT00106704|50058583|FG001|Overall Study|Lack of Efficacy|69|||
24969046|NCT00106704|50058582|FG000|Overall Study|Lost to Follow-up|7|||
24969047|NCT00106704|50058583|FG001|Overall Study|Lost to Follow-up|3|||
24969048|NCT00106704|50058582|FG000|Overall Study|Pregnancy|1|||
24969049|NCT00106704|50058583|FG001|Overall Study|Pregnancy|0|||
24969050|NCT00106704|50058582|FG000|Overall Study|Protocol Violation|4|||
24969051|NCT00106704|50058583|FG001|Overall Study|Protocol Violation|7|||
24969052|NCT00106704|50058582|FG000|Overall Study|Withdrawal by Subject|14|||
24969053|NCT00106704|50058583|FG001|Overall Study|Withdrawal by Subject|21|||
24969054|NCT00106704|50058582|FG000|Overall Study|Patient moved|1|||
24969055|NCT00106704|50058583|FG001|Overall Study|Patient moved|0|||
24969056|NCT00106704|50058582|FG000|Overall Study|Site terminated|0|||
24969057|NCT00106704|50058583|FG001|Overall Study|Site terminated|1|||
24969058|NCT00106704|50058582|FG000|Overall Study|Planned major surgery|1|||
24969059|NCT00106704|50058583|FG001|Overall Study|Planned major surgery|0|||
24969060|NCT00106704|50058582|FG000|Overall Study|Patient Received Glycemic Medication|22|||
24969061|NCT00106704|50058583|FG001|Overall Study|Patient Received Glycemic Medication|41|||
24969062|NCT00106704|50058582|FG000|Overall Study|Unable to re-enter US|1|||
24969063|NCT00106704|50058583|FG001|Overall Study|Unable to re-enter US|0|||
24969064|NCT00106704|50058582|FG000|Overall Study|Laboratory test|1|||
24969065|NCT00106704|50058583|FG001|Overall Study|Laboratory test|1|||
24969066|NCT00105066|50058591|FG000|Overall Study|Adverse Event|2|||
25069512|NCT02769247|50175366|FG003|Overall Study|Withdrawal by Subject|1|||
25189507|NCT04408924|50346604|FG000|Overall Study|Withdrawal by Subject|7|||
25189508|NCT04258423|50346620|FG000|Overall Study|Study Closure|2|||
25189509|NCT04258423|50346621|FG001|Overall Study|Study Closure|2|||
25189510|NCT04178967|50346629|FG000|Induction Period|Adverse Event|4|||
25189511|NCT04178967|50346630|FG001|Induction Period|Adverse Event|6|||
25189512|NCT04178967|50346631|FG002|Induction Period|Adverse Event|0|||
25189513|NCT04178967|50346632|FG003|Induction Period|Adverse Event|0|||
25189514|NCT04178967|50346633|FG004|Induction Period|Adverse Event|0|||
25189515|NCT04178967|50346634|FG005|Induction Period|Adverse Event|0|||
25189516|NCT04178967|50346635|FG006|Induction Period|Adverse Event|0|||
25189517|NCT04178967|50346636|FG007|Induction Period|Adverse Event|0|||
25189518|NCT04178967|50346637|FG008|Induction Period|Adverse Event|0|||
25189519|NCT04178967|50346638|FG009|Induction Period|Adverse Event|0|||
25189520|NCT04178967|50346639|FG010|Induction Period|Adverse Event|0|||
25189521|NCT04178967|50346629|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
25189522|NCT04178967|50346630|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
25189523|NCT04178967|50346631|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
25189524|NCT04178967|50346632|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
25189525|NCT04178967|50346633|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
25189526|NCT04178967|50346634|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
25189527|NCT04178967|50346635|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
25189528|NCT04178967|50346636|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
25189529|NCT04178967|50346637|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
25189530|NCT04178967|50346638|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
25189531|NCT04178967|50346639|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
25189532|NCT04178967|50346629|FG000|Induction Period|Lack of Efficacy|4|||
25189533|NCT04178967|50346630|FG001|Induction Period|Lack of Efficacy|1|||
25189534|NCT04178967|50346631|FG002|Induction Period|Lack of Efficacy|0|||
25189535|NCT04178967|50346632|FG003|Induction Period|Lack of Efficacy|0|||
25189536|NCT04178967|50346633|FG004|Induction Period|Lack of Efficacy|0|||
25189537|NCT04178967|50346634|FG005|Induction Period|Lack of Efficacy|0|||
25189538|NCT04178967|50346635|FG006|Induction Period|Lack of Efficacy|0|||
24969067|NCT00105066|50058592|FG001|Overall Study|Adverse Event|5|||
24969068|NCT00104520|50058600|FG000|Overall Study|Unrelated adverse event|34|||
24969069|NCT00104520|50058601|FG001|Overall Study|Unrelated adverse event|47|||
24969070|NCT00104520|50058600|FG000|Overall Study|Study drug intolerance|0|||
24969071|NCT00104520|50058601|FG001|Overall Study|Study drug intolerance|1|||
24969072|NCT00104520|50058600|FG000|Overall Study|Related adverse event|13|||
25069513|NCT02769247|50175363|FG000|Overall Study|Protocol Violation|0|||
25189539|NCT04178967|50346636|FG007|Induction Period|Lack of Efficacy|0|||
25189540|NCT04178967|50346637|FG008|Induction Period|Lack of Efficacy|0|||
25189541|NCT04178967|50346638|FG009|Induction Period|Lack of Efficacy|0|||
25189542|NCT04178967|50346639|FG010|Induction Period|Lack of Efficacy|0|||
25189543|NCT04178967|50346629|FG000|Induction Period|Protocol Violation|0|||
25189544|NCT04178967|50346630|FG001|Induction Period|Protocol Violation|6|||
25189545|NCT04178967|50346631|FG002|Induction Period|Protocol Violation|0|||
25189546|NCT04178967|50346632|FG003|Induction Period|Protocol Violation|0|||
25189547|NCT04178967|50346633|FG004|Induction Period|Protocol Violation|0|||
25189548|NCT04178967|50346634|FG005|Induction Period|Protocol Violation|0|||
25189549|NCT04178967|50346635|FG006|Induction Period|Protocol Violation|0|||
25189550|NCT04178967|50346636|FG007|Induction Period|Protocol Violation|0|||
25189551|NCT04178967|50346637|FG008|Induction Period|Protocol Violation|0|||
25189552|NCT04178967|50346638|FG009|Induction Period|Protocol Violation|0|||
25189553|NCT04178967|50346639|FG010|Induction Period|Protocol Violation|0|||
25189554|NCT04178967|50346629|FG000|Induction Period|Withdrawal by Subject|6|||
25189555|NCT04178967|50346630|FG001|Induction Period|Withdrawal by Subject|4|||
25189556|NCT04178967|50346631|FG002|Induction Period|Withdrawal by Subject|0|||
25277888|NCT00950248|50591872|FG002|Year 2&3 Treatment Randomization|Death|1|||
24969073|NCT00104520|50058601|FG001|Overall Study|Related adverse event|15|||
24969074|NCT00104520|50058600|FG000|Overall Study|Lost to Follow-up|1|||
24969075|NCT00104520|50058601|FG001|Overall Study|Lost to Follow-up|0|||
24969076|NCT00104520|50058600|FG000|Overall Study|Noncompliance|0|||
24969077|NCT00104520|50058601|FG001|Overall Study|Noncompliance|2|||
24969078|NCT00104520|50058600|FG000|Overall Study|Personal/administrative|1|||
24969079|NCT00104520|50058601|FG001|Overall Study|Personal/administrative|1|||
24969080|NCT00104520|50058600|FG000|Overall Study|Other|1|||
24969081|NCT00104520|50058601|FG001|Overall Study|Other|5|||
24969082|NCT00135330|50058610|FG000|Overall Study|Adverse Event|2|||
24969083|NCT00135330|50058611|FG001|Overall Study|Adverse Event|5|||
24969084|NCT00135330|50058612|FG002|Overall Study|Adverse Event|1|||
24969085|NCT00135330|50058610|FG000|Overall Study|Lost to Follow-up|0|||
24969086|NCT00135330|50058611|FG001|Overall Study|Lost to Follow-up|2|||
24969087|NCT00135330|50058612|FG002|Overall Study|Lost to Follow-up|3|||
24969088|NCT00135330|50058610|FG000|Overall Study|Physician Decision|1|||
24969089|NCT00135330|50058611|FG001|Overall Study|Physician Decision|1|||
24969090|NCT00135330|50058612|FG002|Overall Study|Physician Decision|0|||
24969091|NCT00135330|50058610|FG000|Overall Study|Protocol Violation|4|||
24969092|NCT00135330|50058611|FG001|Overall Study|Protocol Violation|3|||
24969093|NCT00135330|50058612|FG002|Overall Study|Protocol Violation|3|||
24969094|NCT00135330|50058610|FG000|Overall Study|Patient Decision|5|||
24969095|NCT00135330|50058611|FG001|Overall Study|Patient Decision|1|||
25069514|NCT02769247|50175364|FG001|Overall Study|Protocol Violation|0|||
25069515|NCT02769247|50175365|FG002|Overall Study|Protocol Violation|1|||
24969096|NCT00135330|50058612|FG002|Overall Study|Patient Decision|4|||
24969097|NCT00135330|50058610|FG000|Overall Study|Sponsor Decision|0|||
24969098|NCT00135330|50058611|FG001|Overall Study|Sponsor Decision|1|||
24969099|NCT00135330|50058612|FG002|Overall Study|Sponsor Decision|0|||
24969100|NCT00134784|50058624|FG000|Overall Study|Withdrawal by Subject|2|||
24969101|NCT00134784|50058625|FG001|Overall Study|Withdrawal by Subject|2|||
24969102|NCT00134784|50058626|FG002|Overall Study|Withdrawal by Subject|2|||
24969103|NCT00134784|50058627|FG003|Overall Study|Withdrawal by Subject|1|||
24969104|NCT00134082|50058634|FG000|Overall Study|Adverse Event|2|||
24969105|NCT00134082|50058634|FG000|Overall Study|Death|1|||
24969106|NCT03703336|50058640|FG000|Overall Study|Parent withdrew consent|29|||
25277889|NCT00950248|50591870|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
25277890|NCT00950248|50591871|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
25277891|NCT00950248|50591872|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
25277892|NCT00950170|50591879|FG000|Overall Study|Parent/Legal Guardian Request|1|||
25277893|NCT00950170|50591879|FG000|Overall Study|Adverse Event|2|||
25277894|NCT00950170|50591879|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
25277895|NCT01227824|50591903|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
25277896|NCT01227824|50591904|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
25277897|NCT01227824|50591905|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
25277898|NCT01227824|50591903|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
25277899|NCT01227824|50591904|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
25277900|NCT01227824|50591905|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
25277901|NCT01227824|50591903|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
25277902|NCT01227824|50591904|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
25277903|NCT01227824|50591905|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
25277904|NCT01227824|50591903|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
25277905|NCT01227824|50591904|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
25069516|NCT02769247|50175366|FG003|Overall Study|Protocol Violation|0|||
25069517|NCT02769247|50175363|FG000|Overall Study|Physician Decision|1|||
24969107|NCT03703336|50058641|FG001|Overall Study|Parent withdrew consent|8|||
24969108|NCT03703336|50058640|FG000|Overall Study|Migration|3|||
24969109|NCT03703336|50058641|FG001|Overall Study|Migration|3|||
24969110|NCT03703336|50058640|FG000|Overall Study|Protocol Violation|3|||
24969111|NCT03703336|50058641|FG001|Overall Study|Protocol Violation|1|||
24969112|NCT03703336|50058640|FG000|Overall Study|Physician Decision|2|||
24969113|NCT03703336|50058641|FG001|Overall Study|Physician Decision|0|||
24969114|NCT03703336|50058640|FG000|Overall Study|Adverse Event|0|||
24969115|NCT03703336|50058641|FG001|Overall Study|Adverse Event|2|||
25069518|NCT02769247|50175364|FG001|Overall Study|Physician Decision|0|||
24969116|NCT03703336|50058640|FG000|Overall Study|Lost to Follow-up|1|||
25189557|NCT04178967|50346632|FG003|Induction Period|Withdrawal by Subject|0|||
25277906|NCT01227824|50591905|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
25277907|NCT01227824|50591903|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
25277908|NCT01227824|50591904|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
25277909|NCT01227824|50591905|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
25277910|NCT01227824|50591903|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
25277911|NCT01227824|50591904|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
25277912|NCT01227824|50591905|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
25277913|NCT01227824|50591903|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
25277914|NCT01227824|50591904|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
25277915|NCT01227824|50591905|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
25277916|NCT01227824|50591903|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
25277917|NCT01227824|50591904|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
25277918|NCT01227824|50591905|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
25277919|NCT01227824|50591903|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
25277920|NCT01227824|50591904|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
25277921|NCT01227824|50591905|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
25277922|NCT01227824|50591903|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
25277923|NCT01227824|50591904|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
25277924|NCT01227824|50591905|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
25277925|NCT01227824|50591903|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
25277926|NCT01227824|50591904|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
25277927|NCT01227824|50591905|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
25277928|NCT01227824|50591903|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
25277929|NCT01227824|50591904|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
25277930|NCT01227824|50591905|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
25277931|NCT01227824|50591903|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
25277932|NCT01227824|50591904|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
25277933|NCT01227824|50591905|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
25277934|NCT01227824|50591903|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
25277935|NCT01227824|50591904|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
25277936|NCT01227824|50591905|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
25277937|NCT01227824|50591903|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
25277938|NCT01227824|50591904|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
25277939|NCT01227824|50591905|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
25277940|NCT00949702|50591912|FG000|Overall Study|Death|40|||
25277941|NCT00949702|50591912|FG000|Overall Study|Disease progression|7|||
25277942|NCT00949702|50591912|FG000|Overall Study|Withdrawal of consent|1|||
25277943|NCT01034631|50591919|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
25277944|NCT01034631|50591920|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
25277945|NCT01034631|50591921|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
25277946|NCT01034631|50591919|FG000|Phase II|Not Evaluable per protocol|0|||
25277947|NCT01034631|50591920|FG001|Phase II|Not Evaluable per protocol|0|||
25069519|NCT02769247|50175365|FG002|Overall Study|Physician Decision|0|||
25069520|NCT02769247|50175366|FG003|Overall Study|Physician Decision|0|||
25069521|NCT02773537|50175383|FG000|Overall Study|Lost to Follow-up|0|||
25069522|NCT02773537|50175384|FG001|Overall Study|Lost to Follow-up|1|||
25069523|NCT02773537|50175385|FG002|Overall Study|Lost to Follow-up|4|||
25069524|NCT02780713|50175393|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
25069525|NCT02780713|50175394|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
25069526|NCT02780713|50175395|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
25069527|NCT02780713|50175396|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
25069528|NCT02780713|50175397|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
25069529|NCT02767765|50175416|FG000|Overall Study|Adverse Event|4|||
25069530|NCT02767765|50175416|FG000|Overall Study|Death|1|||
25069531|NCT02767765|50175416|FG000|Overall Study|Insufficient response|1|||
25069532|NCT02767765|50175416|FG000|Overall Study|Lost to Follow-up|2|||
25069533|NCT02767765|50175416|FG000|Overall Study|Investigator decision|1|||
25069534|NCT02767765|50175416|FG000|Overall Study|Non-Compliance|1|||
25277948|NCT01034631|50591921|FG002|Phase II|Not Evaluable per protocol|2|||
25277949|NCT01034631|50591919|FG000|Phase II|Determined Ineligible per protocol|0|||
25277950|NCT01034631|50591920|FG001|Phase II|Determined Ineligible per protocol|1|||
25277951|NCT01034631|50591921|FG002|Phase II|Determined Ineligible per protocol|0|||
25277952|NCT01227668|50591933|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
25277953|NCT01227668|50591934|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
25277954|NCT01227668|50591933|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
25069535|NCT02767765|50175416|FG000|Overall Study|Withdrawal by Subject|1|||
25069536|NCT02772757|50175423|FG000|Overall Study|Withdrawal by Subject|1|||
25069537|NCT02772757|50175424|FG001|Overall Study|Withdrawal by Subject|0|||
24969117|NCT03703336|50058641|FG001|Overall Study|Lost to Follow-up|0|||
24969118|NCT03702166|50058647|FG000|Overall Study|Lost to Follow-up|1|||
24969119|NCT03702166|50058647|FG000|Overall Study|Withdrawal by Subject|1|||
24969120|NCT00132678|50058654|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
24969121|NCT00132678|50058655|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
25189558|NCT04178967|50346633|FG004|Induction Period|Withdrawal by Subject|0|||
25189559|NCT04178967|50346634|FG005|Induction Period|Withdrawal by Subject|0|||
25189560|NCT04178967|50346635|FG006|Induction Period|Withdrawal by Subject|0|||
25189561|NCT04178967|50346636|FG007|Induction Period|Withdrawal by Subject|0|||
25189562|NCT04178967|50346637|FG008|Induction Period|Withdrawal by Subject|0|||
25189563|NCT04178967|50346638|FG009|Induction Period|Withdrawal by Subject|0|||
25189564|NCT04178967|50346639|FG010|Induction Period|Withdrawal by Subject|0|||
25189565|NCT04178967|50346629|FG000|Induction Period|Lost to Follow-up|2|||
25189566|NCT04178967|50346630|FG001|Induction Period|Lost to Follow-up|0|||
25189567|NCT04178967|50346631|FG002|Induction Period|Lost to Follow-up|0|||
25189568|NCT04178967|50346632|FG003|Induction Period|Lost to Follow-up|0|||
25189569|NCT04178967|50346633|FG004|Induction Period|Lost to Follow-up|0|||
25189570|NCT04178967|50346634|FG005|Induction Period|Lost to Follow-up|0|||
25189571|NCT04178967|50346635|FG006|Induction Period|Lost to Follow-up|0|||
25189572|NCT04178967|50346636|FG007|Induction Period|Lost to Follow-up|0|||
25189573|NCT04178967|50346637|FG008|Induction Period|Lost to Follow-up|0|||
25189574|NCT04178967|50346638|FG009|Induction Period|Lost to Follow-up|0|||
25189575|NCT04178967|50346639|FG010|Induction Period|Lost to Follow-up|0|||
25189576|NCT04178967|50346629|FG000|Induction Period|Participant Missed Study Visits|0|||
25189577|NCT04178967|50346630|FG001|Induction Period|Participant Missed Study Visits|1|||
25189578|NCT04178967|50346631|FG002|Induction Period|Participant Missed Study Visits|0|||
25189579|NCT04178967|50346632|FG003|Induction Period|Participant Missed Study Visits|0|||
25189580|NCT04178967|50346633|FG004|Induction Period|Participant Missed Study Visits|0|||
25189581|NCT04178967|50346634|FG005|Induction Period|Participant Missed Study Visits|0|||
25189582|NCT04178967|50346635|FG006|Induction Period|Participant Missed Study Visits|0|||
25189583|NCT04178967|50346636|FG007|Induction Period|Participant Missed Study Visits|0|||
25189584|NCT04178967|50346637|FG008|Induction Period|Participant Missed Study Visits|0|||
25189585|NCT04178967|50346638|FG009|Induction Period|Participant Missed Study Visits|0|||
25189586|NCT04178967|50346639|FG010|Induction Period|Participant Missed Study Visits|0|||
25189587|NCT04178967|50346629|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
25189588|NCT04178967|50346630|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
25189589|NCT04178967|50346631|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
25189590|NCT04178967|50346632|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
25189591|NCT04178967|50346633|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
25189592|NCT04178967|50346634|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
25189593|NCT04178967|50346635|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
25189594|NCT04178967|50346636|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
25189595|NCT04178967|50346637|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
25189596|NCT04178967|50346638|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
25189597|NCT04178967|50346639|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
25189598|NCT04178967|50346629|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25189599|NCT04178967|50346630|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25189600|NCT04178967|50346631|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25189601|NCT04178967|50346632|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25189602|NCT04178967|50346633|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25189603|NCT04178967|50346634|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
25189604|NCT04178967|50346635|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25189605|NCT04178967|50346636|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25189606|NCT04178967|50346637|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25189607|NCT04178967|50346638|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25189608|NCT04178967|50346639|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
25189609|NCT04178967|50346629|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25189610|NCT04178967|50346630|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25189611|NCT04178967|50346631|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25189612|NCT04178967|50346632|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
25189613|NCT04178967|50346633|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25189614|NCT04178967|50346634|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25189615|NCT04178967|50346635|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25189616|NCT04178967|50346636|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25189617|NCT04178967|50346637|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25189618|NCT04178967|50346638|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25189619|NCT04178967|50346639|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
25189620|NCT04178967|50346629|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
25277955|NCT01227668|50591934|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
25277956|NCT01227668|50591933|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
25277957|NCT01227668|50591934|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
25277958|NCT01227668|50591933|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
25277959|NCT01227668|50591934|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
25277960|NCT01227668|50591933|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
25277961|NCT01227668|50591934|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
25277962|NCT01227668|50591933|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
25277963|NCT01227668|50591934|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
25277964|NCT01227668|50591933|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
25277965|NCT01227668|50591934|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
25277966|NCT01227668|50591933|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
25277967|NCT01227668|50591934|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
25277968|NCT01227668|50591933|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
25277969|NCT01227668|50591934|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
25277970|NCT01227668|50591933|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
25277971|NCT01227668|50591934|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
25277972|NCT01227668|50591933|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
25277973|NCT01227668|50591934|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
25277974|NCT01227668|50591933|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
25277975|NCT01227668|50591934|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
25277976|NCT01227512|50591946|FG000|Overall Study|Physician Decision|6|||
25277977|NCT01227512|50591947|FG001|Overall Study|Physician Decision|6|||
25277978|NCT01227512|50591946|FG000|Overall Study|Adverse Event|4|||
25277979|NCT01227512|50591947|FG001|Overall Study|Adverse Event|3|||
25277980|NCT01227512|50591946|FG000|Overall Study|Withdrawal by Subject|3|||
25277981|NCT01227512|50591947|FG001|Overall Study|Withdrawal by Subject|0|||
25277982|NCT01227512|50591946|FG000|Overall Study|Participant met withdrawal criteria|0|||
25277983|NCT01227512|50591947|FG001|Overall Study|Participant met withdrawal criteria|1|||
25277984|NCT01227278|50591957|FG000|Overall Study|Withdrawal by Subject|4|||
25277985|NCT01227278|50591958|FG001|Overall Study|Withdrawal by Subject|4|||
25277986|NCT01227278|50591957|FG000|Overall Study|Death|0|||
25277987|NCT01227278|50591958|FG001|Overall Study|Death|2|||
25277988|NCT01227278|50591957|FG000|Overall Study|Other|1|||
25277989|NCT01227278|50591958|FG001|Overall Study|Other|2|||
25277990|NCT01034397|50591966|FG000|Overall Study|Lack of compliance|0|||
25277991|NCT01034397|50591967|FG001|Overall Study|Lack of compliance|1|||
25277992|NCT01034397|50591966|FG000|Overall Study|Lack of Efficacy|3|||
25277993|NCT01034397|50591967|FG001|Overall Study|Lack of Efficacy|0|||
25277994|NCT01034397|50591966|FG000|Overall Study|Adverse Event|4|||
25277995|NCT01034397|50591967|FG001|Overall Study|Adverse Event|0|||
25277996|NCT01034397|50591966|FG000|Overall Study|Other|0|||
25277997|NCT01034397|50591967|FG001|Overall Study|Other|1|||
25277998|NCT01227044|50591984|FG000|Overall Study|Lost to Follow-up|5|||
25277999|NCT01227044|50591985|FG001|Overall Study|Lost to Follow-up|7|||
25278000|NCT01227044|50591984|FG000|Overall Study|Discontinued Intervention|1|||
25278001|NCT01227044|50591985|FG001|Overall Study|Discontinued Intervention|2|||
25278002|NCT01225952|50591994|FG000|Overall Study|Lost to Follow-up|1|||
25278003|NCT01225952|50591995|FG001|Overall Study|Lost to Follow-up|0|||
25278004|NCT01225952|50591996|FG002|Overall Study|Lost to Follow-up|0|||
25278005|NCT01225952|50591994|FG000|Overall Study|Study Eye Explanted|0|||
25278006|NCT01225952|50591995|FG001|Overall Study|Study Eye Explanted|0|||
25278007|NCT01225952|50591996|FG002|Overall Study|Study Eye Explanted|1|||
25278008|NCT01225952|50591994|FG000|Overall Study|Withdrawal by Subject|4|||
25278009|NCT01225952|50591995|FG001|Overall Study|Withdrawal by Subject|4|||
25278010|NCT01225952|50591996|FG002|Overall Study|Withdrawal by Subject|5|||
25278011|NCT01225952|50591994|FG000|Overall Study|Surgical complications|1|||
25278012|NCT01225952|50591995|FG001|Overall Study|Surgical complications|0|||
25278013|NCT01225952|50591996|FG002|Overall Study|Surgical complications|0|||
25278014|NCT01034163|50592006|FG000|Overall Study|Treatment completed as per protocol|8|||
25278015|NCT01034163|50592007|FG001|Overall Study|Treatment completed as per protocol|7|||
25278016|NCT01034163|50592006|FG000|Overall Study|Withdrawal by Subject|8|||
25278017|NCT01034163|50592007|FG001|Overall Study|Withdrawal by Subject|2|||
25278018|NCT01034163|50592006|FG000|Overall Study|Protocol deviation|1|||
25278019|NCT01034163|50592007|FG001|Overall Study|Protocol deviation|0|||
25278020|NCT01034163|50592006|FG000|Overall Study|Disease progression|3|||
25278021|NCT01034163|50592007|FG001|Overall Study|Disease progression|4|||
25278022|NCT01034163|50592006|FG000|Overall Study|Adverse Event|6|||
25278023|NCT01034163|50592007|FG001|Overall Study|Adverse Event|0|||
25278024|NCT01034163|50592006|FG000|Overall Study|Administrative problems|0|||
25069538|NCT02772757|50175425|FG002|Overall Study|Withdrawal by Subject|1|||
25278025|NCT01034163|50592007|FG001|Overall Study|Administrative problems|1|||
25278026|NCT01034163|50592006|FG000|Overall Study|Abnormal laboratory value|1|||
25278027|NCT01034163|50592007|FG001|Overall Study|Abnormal laboratory value|0|||
25278028|NCT01033851|50592015|FG000|Overall Study|Withdrawal by Subject|3|||
25278029|NCT01033851|50592016|FG001|Overall Study|Withdrawal by Subject|7|||
25278030|NCT01162122|50592024|FG000|Overall Study|Withdrawal by Subject|52|||
25278031|NCT01162122|50592025|FG001|Overall Study|Withdrawal by Subject|43|||
25278032|NCT01162122|50592024|FG000|Overall Study|Lost to Follow-up|73|||
25278033|NCT01162122|50592025|FG001|Overall Study|Lost to Follow-up|91|||
25278034|NCT01162122|50592024|FG000|Overall Study|Adverse Event|3|||
25278035|NCT01162122|50592025|FG001|Overall Study|Adverse Event|2|||
25278036|NCT01162122|50592024|FG000|Overall Study|Death|51|||
25278037|NCT01162122|50592025|FG001|Overall Study|Death|46|||
25278038|NCT01162122|50592024|FG000|Overall Study|Protocol Violation|2|||
25278039|NCT01162122|50592025|FG001|Overall Study|Protocol Violation|2|||
25278040|NCT01162122|50592024|FG000|Overall Study|Inappropriate enrollment|5|||
25278041|NCT01162122|50592025|FG001|Overall Study|Inappropriate enrollment|4|||
25278042|NCT01162122|50592024|FG000|Overall Study|Administrative reason|1|||
25278043|NCT01162122|50592025|FG001|Overall Study|Administrative reason|1|||
25278044|NCT01162122|50592024|FG000|Overall Study|Unable to classify|3|||
25278045|NCT01162122|50592025|FG001|Overall Study|Unable to classify|7|||
25278046|NCT01162122|50592024|FG000|Overall Study|Missing primary reason|1|||
25278047|NCT01162122|50592025|FG001|Overall Study|Missing primary reason|0|||
25278048|NCT01033071|50592037|FG000|Overall Study|Adverse Event|28|||
25278049|NCT01033071|50592038|FG001|Overall Study|Adverse Event|51|||
25278050|NCT01033071|50592039|FG002|Overall Study|Adverse Event|26|||
25278051|NCT01033071|50592037|FG000|Overall Study|Protocol Violation|0|||
25278052|NCT01033071|50592038|FG001|Overall Study|Protocol Violation|2|||
25278053|NCT01033071|50592039|FG002|Overall Study|Protocol Violation|1|||
25278054|NCT01033071|50592037|FG000|Overall Study|Lost to Follow-up|4|||
25278055|NCT01033071|50592038|FG001|Overall Study|Lost to Follow-up|5|||
25278056|NCT01033071|50592039|FG002|Overall Study|Lost to Follow-up|5|||
25278057|NCT01033071|50592037|FG000|Overall Study|Withdrawal by Subject|17|||
25278058|NCT01033071|50592038|FG001|Overall Study|Withdrawal by Subject|14|||
25278059|NCT01033071|50592039|FG002|Overall Study|Withdrawal by Subject|11|||
25278060|NCT01033071|50592037|FG000|Overall Study|Lack of Efficacy|0|||
25278061|NCT01033071|50592038|FG001|Overall Study|Lack of Efficacy|1|||
25278062|NCT01033071|50592039|FG002|Overall Study|Lack of Efficacy|1|||
25278063|NCT01033071|50592037|FG000|Overall Study|Other|6|||
25189621|NCT04178967|50346630|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
25278064|NCT01033071|50592038|FG001|Overall Study|Other|4|||
25278065|NCT01033071|50592039|FG002|Overall Study|Other|3|||
25278066|NCT01032915|50592051|FG000|Overall Study|Adverse Event|2|||
25278067|NCT01032915|50592052|FG001|Overall Study|Adverse Event|2|||
25278068|NCT01032915|50592053|FG002|Overall Study|Adverse Event|1|||
25278069|NCT01032915|50592054|FG003|Overall Study|Adverse Event|1|||
25278070|NCT01032915|50592051|FG000|Overall Study|Abnormal test procedure result|0|||
25278071|NCT01032915|50592052|FG001|Overall Study|Abnormal test procedure result|0|||
25278072|NCT01032915|50592053|FG002|Overall Study|Abnormal test procedure result|1|||
25278073|NCT01032915|50592054|FG003|Overall Study|Abnormal test procedure result|0|||
25278074|NCT01032915|50592051|FG000|Overall Study|Withdrawal by Subject|0|||
25278075|NCT01032915|50592052|FG001|Overall Study|Withdrawal by Subject|3|||
25278076|NCT01032915|50592053|FG002|Overall Study|Withdrawal by Subject|1|||
25278077|NCT01032915|50592054|FG003|Overall Study|Withdrawal by Subject|1|||
25278078|NCT01032915|50592051|FG000|Overall Study|Administrative reasons|5|||
25278079|NCT01032915|50592052|FG001|Overall Study|Administrative reasons|6|||
25278080|NCT01032915|50592053|FG002|Overall Study|Administrative reasons|4|||
25278081|NCT01032915|50592054|FG003|Overall Study|Administrative reasons|4|||
25278082|NCT01032915|50592051|FG000|Overall Study|Protocol Violation|1|||
25278083|NCT01032915|50592052|FG001|Overall Study|Protocol Violation|0|||
25278084|NCT01032915|50592053|FG002|Overall Study|Protocol Violation|0|||
25189622|NCT04178967|50346631|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
25189623|NCT04178967|50346632|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
25189624|NCT04178967|50346633|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
25189625|NCT04178967|50346634|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
25189626|NCT04178967|50346635|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
25189627|NCT04178967|50346636|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
25189628|NCT04178967|50346637|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
25189629|NCT04178967|50346638|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
25189630|NCT04178967|50346639|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
25189631|NCT04178967|50346629|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
25189632|NCT04178967|50346630|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
25189633|NCT04178967|50346631|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
25189634|NCT04178967|50346632|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
25278085|NCT01032915|50592054|FG003|Overall Study|Protocol Violation|1|||
25278086|NCT01161498|50592066|FG000|Overall Study|Disease Progression|0|||
25278087|NCT01161498|50592067|FG001|Overall Study|Disease Progression|1|||
25278088|NCT01180998|50592076|FG000|Overall Study|Poor Vision|0|||
25278089|NCT01180998|50592077|FG001|Overall Study|Poor Vision|2|||
25278090|NCT01180998|50592078|FG002|Overall Study|Poor Vision|2|||
25278091|NCT01180998|50592076|FG000|Overall Study|Lost to Follow-up|0|||
25278092|NCT01180998|50592077|FG001|Overall Study|Lost to Follow-up|0|||
25278093|NCT01180998|50592078|FG002|Overall Study|Lost to Follow-up|1|||
25278094|NCT01180998|50592076|FG000|Overall Study|Protocol Violation|1|||
25278095|NCT01180998|50592077|FG001|Overall Study|Protocol Violation|2|||
25278096|NCT01180998|50592078|FG002|Overall Study|Protocol Violation|0|||
25278097|NCT01180998|50592076|FG000|Overall Study|Withdrawal by Subject|0|||
24969122|NCT00132678|50058656|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
24969123|NCT00132678|50058654|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
25189635|NCT04178967|50346633|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
25189636|NCT04178967|50346634|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
25278098|NCT01180998|50592077|FG001|Overall Study|Withdrawal by Subject|0|||
25278099|NCT01180998|50592078|FG002|Overall Study|Withdrawal by Subject|1|||
25278100|NCT01180998|50592076|FG000|Overall Study|Poor comfort|3|||
25278101|NCT01180998|50592077|FG001|Overall Study|Poor comfort|0|||
25278102|NCT01180998|50592078|FG002|Overall Study|Poor comfort|4|||
25189637|NCT04178967|50346635|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
25189638|NCT04178967|50346636|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
25189639|NCT04178967|50346637|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
25189640|NCT04178967|50346638|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
25189641|NCT04178967|50346639|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
25189642|NCT04178967|50346629|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
25278103|NCT01180998|50592076|FG000|Overall Study|Poor lens handling|0|||
25278104|NCT01180998|50592077|FG001|Overall Study|Poor lens handling|0|||
25278105|NCT01180998|50592078|FG002|Overall Study|Poor lens handling|2|||
25278106|NCT01029795|50592089|FG000|Overall Study|Entry Criteria Not Met|2|||
25278107|NCT01029795|50592090|FG001|Overall Study|Entry Criteria Not Met|1|||
25278108|NCT01029795|50592089|FG000|Overall Study|Physician Decision|2|||
25278109|NCT01029795|50592090|FG001|Overall Study|Physician Decision|1|||
25278110|NCT01029795|50592089|FG000|Overall Study|Sponsor Decision|11|||
25278111|NCT01029795|50592090|FG001|Overall Study|Sponsor Decision|17|||
25278112|NCT01029795|50592089|FG000|Overall Study|Withdrawal by Subject|1|||
25278113|NCT01029795|50592090|FG001|Overall Study|Withdrawal by Subject|3|||
25278114|NCT01032837|50592100|FG000|Overall Study|Adverse event/internal illness|0|||
25278115|NCT01032837|50592101|FG001|Overall Study|Adverse event/internal illness|1|||
25278116|NCT01032837|50592102|FG002|Overall Study|Adverse event/internal illness|0|||
25278117|NCT01032837|50592103|FG003|Overall Study|Adverse event/internal illness|1|||
25278118|NCT01032837|50592100|FG000|Overall Study|Withdrew consent|0|||
25278119|NCT01032837|50592101|FG001|Overall Study|Withdrew consent|2|||
25278120|NCT01032837|50592102|FG002|Overall Study|Withdrew consent|0|||
25278121|NCT01032837|50592103|FG003|Overall Study|Withdrew consent|1|||
25278122|NCT01032837|50592100|FG000|Overall Study|Failed to return|0|||
25278123|NCT01032837|50592101|FG001|Overall Study|Failed to return|0|||
25278124|NCT01032837|50592102|FG002|Overall Study|Failed to return|1|||
25278125|NCT01032837|50592103|FG003|Overall Study|Failed to return|0|||
25278126|NCT01032837|50592100|FG000|Overall Study|Refused treatment|0|||
25278127|NCT01032837|50592101|FG001|Overall Study|Refused treatment|0|||
25278128|NCT01032837|50592102|FG002|Overall Study|Refused treatment|0|||
25278129|NCT01032837|50592103|FG003|Overall Study|Refused treatment|1|||
25278130|NCT01180296|50592115|FG000|Overall Study|Protocol Violation|1|||
25278131|NCT01180296|50592116|FG001|Overall Study|Protocol Violation|2|||
25278132|NCT01160640|50592126|FG000|Overall Study|Physician Decision|3|||
25278133|NCT01160640|50592127|FG001|Overall Study|Physician Decision|3|||
25278134|NCT01160640|50592126|FG000|Overall Study|Incarceration|1|||
25278135|NCT01160640|50592127|FG001|Overall Study|Incarceration|0|||
25278136|NCT01160640|50592126|FG000|Overall Study|Withdrawal by Subject|0|||
25278137|NCT01160640|50592127|FG001|Overall Study|Withdrawal by Subject|3|||
25278138|NCT01160484|50592135|FG000|Overall Study|Lack of Efficacy|9|||
25278139|NCT01160484|50592135|FG000|Overall Study|Adverse Event|6|||
25278140|NCT01160484|50592135|FG000|Overall Study|Withdrawal by Subject|2|||
25278141|NCT01160484|50592135|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
25278142|NCT01032291|50592142|FG000|Safety Lead-in|Adverse Event|1|||
25278143|NCT01032291|50592143|FG001|Safety Lead-in|Adverse Event|0|||
25278144|NCT01032291|50592144|FG002|Safety Lead-in|Adverse Event|0|||
25278145|NCT01032291|50592142|FG000|Safety Lead-in|Death|1|||
25278146|NCT01032291|50592143|FG001|Safety Lead-in|Death|0|||
25278147|NCT01032291|50592144|FG002|Safety Lead-in|Death|0|||
25278148|NCT01032291|50592142|FG000|Proof of Concept|Adverse Event|0|||
25278149|NCT01032291|50592143|FG001|Proof of Concept|Adverse Event|5|||
24969124|NCT00132678|50058655|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
25278150|NCT01032291|50592144|FG002|Proof of Concept|Adverse Event|1|||
25278151|NCT01032291|50592142|FG000|Proof of Concept|Death|0|||
25278152|NCT01032291|50592143|FG001|Proof of Concept|Death|1|||
25278153|NCT01032291|50592144|FG002|Proof of Concept|Death|2|||
25278154|NCT01032291|50592142|FG000|Proof of Concept|Lack of Efficacy|0|||
25278155|NCT01032291|50592143|FG001|Proof of Concept|Lack of Efficacy|1|||
25278156|NCT01032291|50592144|FG002|Proof of Concept|Lack of Efficacy|0|||
25278157|NCT01032291|50592142|FG000|Proof of Concept|Never Received Study Drug|0|||
25278158|NCT01032291|50592143|FG001|Proof of Concept|Never Received Study Drug|1|||
25278159|NCT01032291|50592144|FG002|Proof of Concept|Never Received Study Drug|0|||
25278160|NCT01159938|50592158|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
25278161|NCT01159938|50592159|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
25278162|NCT01159938|50592160|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
25278163|NCT01159938|50592161|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
25278164|NCT01159938|50592162|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
25278165|NCT01029405|50592187|FG000|Overall Study|Withdrawal by Subject|0|||
25278166|NCT01029405|50592188|FG001|Overall Study|Withdrawal by Subject|1|||
25278167|NCT01029405|50592189|FG002|Overall Study|Withdrawal by Subject|2|||
25278168|NCT01029405|50592190|FG003|Overall Study|Withdrawal by Subject|0|||
25278169|NCT01029405|50592187|FG000|Overall Study|Protocol Violation|0|||
25278170|NCT01029405|50592188|FG001|Overall Study|Protocol Violation|0|||
25278171|NCT01029405|50592189|FG002|Overall Study|Protocol Violation|0|||
25278172|NCT01029405|50592190|FG003|Overall Study|Protocol Violation|1|||
25278173|NCT01029405|50592187|FG000|Overall Study|Adverse Event|0|||
25278174|NCT01029405|50592188|FG001|Overall Study|Adverse Event|0|||
25278175|NCT01029405|50592189|FG002|Overall Study|Adverse Event|1|||
25278176|NCT01029405|50592190|FG003|Overall Study|Adverse Event|1|||
25278177|NCT01029405|50592187|FG000|Overall Study|Lost to Follow-up|2|||
25278178|NCT01029405|50592188|FG001|Overall Study|Lost to Follow-up|1|||
25278179|NCT01029405|50592189|FG002|Overall Study|Lost to Follow-up|1|||
25278180|NCT01029405|50592190|FG003|Overall Study|Lost to Follow-up|2|||
25278181|NCT01029405|50592187|FG000|Overall Study|Other|0|||
25278182|NCT01029405|50592188|FG001|Overall Study|Other|1|||
25278183|NCT01029405|50592189|FG002|Overall Study|Other|0|||
25278184|NCT01029405|50592190|FG003|Overall Study|Other|1|||
25278185|NCT01021683|50592200|FG000|Overall Study|Lack of Efficacy|12|||
25278186|NCT01021683|50592200|FG000|Overall Study|Recovery of neutrophil count|51|||
25278187|NCT01021683|50592200|FG000|Overall Study|Other|8|||
25189643|NCT04178967|50346630|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
25189644|NCT04178967|50346631|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
25189645|NCT04178967|50346632|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
25189646|NCT04178967|50346633|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
25189647|NCT04178967|50346634|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
25189648|NCT04178967|50346635|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
25189649|NCT04178967|50346636|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
25189650|NCT04178967|50346637|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
25189651|NCT04178967|50346638|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
25278188|NCT01021293|50592206|FG000|Overall Study|Serious Adverse Event|2|||
25278189|NCT01021293|50592207|FG001|Overall Study|Serious Adverse Event|1|||
25278190|NCT01021293|50592206|FG000|Overall Study|Adverse Event|2|||
25278191|NCT01021293|50592207|FG001|Overall Study|Adverse Event|1|||
25278192|NCT01021293|50592206|FG000|Overall Study|Withdrawal by Subject|1|||
25278193|NCT01021293|50592207|FG001|Overall Study|Withdrawal by Subject|3|||
25278194|NCT01021293|50592206|FG000|Overall Study|Migrated/moved from study area|6|||
25278195|NCT01021293|50592207|FG001|Overall Study|Migrated/moved from study area|18|||
25278196|NCT01021293|50592206|FG000|Overall Study|Lost to Follow-up|1|||
25189652|NCT04178967|50346639|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
25278197|NCT01021293|50592207|FG001|Overall Study|Lost to Follow-up|1|||
25278198|NCT04625725|50592216|FG000|Overall Study|Death|4|||
25278199|NCT04625725|50592217|FG001|Overall Study|Death|4|||
25278200|NCT04625725|50592216|FG000|Overall Study|Lost to Follow-up|11|||
25278201|NCT04625725|50592217|FG001|Overall Study|Lost to Follow-up|8|||
25278202|NCT04625725|50592216|FG000|Overall Study|Physician Decision|1|||
25278203|NCT04625725|50592217|FG001|Overall Study|Physician Decision|0|||
25278204|NCT04625725|50592216|FG000|Overall Study|Withdrawal by Subject|56|||
25278205|NCT04625725|50592217|FG001|Overall Study|Withdrawal by Subject|32|||
25278206|NCT04625725|50592216|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|18|||
25278207|NCT04625725|50592217|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|10|||
25278208|NCT04625725|50592216|FG000|Overall Study|Ongoing in study|3409|||
25278209|NCT04625725|50592217|FG001|Overall Study|Ongoing in study|1700|||
25278210|NCT04625725|50592216|FG000|Overall Study|Protocol Deviation|1|||
25278211|NCT04625725|50592217|FG001|Overall Study|Protocol Deviation|0|||
25278212|NCT01021215|50592225|FG000|Overall Study|Lost to Follow-up|3|||
25278213|NCT01021215|50592226|FG001|Overall Study|Lost to Follow-up|0|||
25278214|NCT01021137|50592236|FG000|Overall Study|Lost to Follow-up|9|||
25278215|NCT01021137|50592237|FG001|Overall Study|Lost to Follow-up|4|||
25278216|NCT01021137|50592238|FG002|Overall Study|Lost to Follow-up|2|||
25278217|NCT01021137|50592239|FG003|Overall Study|Lost to Follow-up|6|||
25189653|NCT04178967|50346629|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
25278218|NCT01021137|50592236|FG000|Overall Study|Withdrawal by Subject|1|||
25278219|NCT01021137|50592237|FG001|Overall Study|Withdrawal by Subject|0|||
25278220|NCT01021137|50592238|FG002|Overall Study|Withdrawal by Subject|0|||
25278221|NCT01021137|50592239|FG003|Overall Study|Withdrawal by Subject|3|||
25278222|NCT01020981|50592252|FG000|Overall Study|Did not return mailed survey|74|||
25278223|NCT01020981|50592253|FG001|Overall Study|Did not return mailed survey|58|||
25278224|NCT01020981|50592252|FG000|Overall Study|Survey returned undeliverable|8|||
25278225|NCT01020981|50592253|FG001|Overall Study|Survey returned undeliverable|32|||
25278226|NCT01020981|50592252|FG000|Overall Study|Participant declined to complete survey|2|||
25278227|NCT01020981|50592253|FG001|Overall Study|Participant declined to complete survey|0|||
25278228|NCT01020747|50592261|FG000|Overall Study|Withdrawal by Subject|1|||
25278229|NCT01020435|50592268|FG000|Overall Study|Lost to Follow-up|0|||
25278230|NCT01020435|50592269|FG001|Overall Study|Lost to Follow-up|1|||
25278231|NCT01031979|50592278|FG000|Overall Study|Lost to Follow-up|5|||
25278232|NCT01031979|50592279|FG001|Overall Study|Lost to Follow-up|4|||
25278233|NCT01020123|50592292|FG000|Main Period|Withdrawal by Subject|6|||
25278234|NCT01020123|50592293|FG001|Main Period|Withdrawal by Subject|5|||
24969125|NCT00132678|50058656|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
24969126|NCT00132678|50058654|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
24969127|NCT00132678|50058655|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
24969128|NCT00132678|50058656|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
24969129|NCT00132678|50058654|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
24969130|NCT00132678|50058655|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
24969131|NCT00132678|50058656|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
24969132|NCT00132678|50058654|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
24969133|NCT00132678|50058655|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
24969134|NCT00132678|50058656|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
24969135|NCT00132678|50058654|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
24969136|NCT00132678|50058655|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
24969137|NCT00132678|50058656|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
25278235|NCT01020123|50592294|FG002|Main Period|Withdrawal by Subject|3|||
25278236|NCT01020123|50592295|FG003|Main Period|Withdrawal by Subject|1|||
25278237|NCT01020123|50592296|FG004|Main Period|Withdrawal by Subject|6|||
25278238|NCT01020123|50592297|FG005|Main Period|Withdrawal by Subject|3|||
25278239|NCT01020123|50592298|FG006|Main Period|Withdrawal by Subject|2|||
25278240|NCT01020123|50592292|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
25278241|NCT01020123|50592293|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
25278242|NCT01020123|50592294|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
25278243|NCT01020123|50592295|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
25278244|NCT01020123|50592296|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
25278245|NCT01020123|50592297|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
25278246|NCT01020123|50592298|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
25278247|NCT01020123|50592292|FG000|Main Period|Adverse Event|5|||
25278248|NCT01020123|50592293|FG001|Main Period|Adverse Event|2|||
25278249|NCT01020123|50592294|FG002|Main Period|Adverse Event|2|||
25278250|NCT01020123|50592295|FG003|Main Period|Adverse Event|1|||
25278251|NCT01020123|50592296|FG004|Main Period|Adverse Event|1|||
25278252|NCT01020123|50592297|FG005|Main Period|Adverse Event|2|||
25278253|NCT01020123|50592298|FG006|Main Period|Adverse Event|1|||
25278254|NCT01020123|50592292|FG000|Main Period|Protocol Violation|4|||
25278255|NCT01020123|50592293|FG001|Main Period|Protocol Violation|4|||
25278256|NCT01020123|50592294|FG002|Main Period|Protocol Violation|2|||
25069539|NCT02772757|50175423|FG000|Overall Study|Protocol Violation|0|||
25189654|NCT04178967|50346630|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
25189655|NCT04178967|50346631|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
25189656|NCT04178967|50346632|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
25189657|NCT04178967|50346633|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
25189658|NCT04178967|50346634|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
25189659|NCT04178967|50346635|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
25189660|NCT04178967|50346636|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
25278257|NCT01020123|50592295|FG003|Main Period|Protocol Violation|5|||
25278258|NCT01020123|50592296|FG004|Main Period|Protocol Violation|2|||
25278259|NCT01020123|50592297|FG005|Main Period|Protocol Violation|3|||
25278260|NCT01020123|50592298|FG006|Main Period|Protocol Violation|2|||
25278261|NCT01020123|50592292|FG000|Main Period|Lost to Follow-up|0|||
25278262|NCT01020123|50592293|FG001|Main Period|Lost to Follow-up|2|||
25278263|NCT01020123|50592294|FG002|Main Period|Lost to Follow-up|0|||
25278264|NCT01020123|50592295|FG003|Main Period|Lost to Follow-up|0|||
25278265|NCT01020123|50592296|FG004|Main Period|Lost to Follow-up|0|||
25278266|NCT01020123|50592297|FG005|Main Period|Lost to Follow-up|0|||
25278267|NCT01020123|50592298|FG006|Main Period|Lost to Follow-up|0|||
25278268|NCT01020123|50592292|FG000|Main Period|Unclasified|2|||
25278269|NCT01020123|50592293|FG001|Main Period|Unclasified|0|||
25278270|NCT01020123|50592294|FG002|Main Period|Unclasified|1|||
25278271|NCT01020123|50592295|FG003|Main Period|Unclasified|0|||
25278272|NCT01020123|50592296|FG004|Main Period|Unclasified|1|||
25278273|NCT01020123|50592297|FG005|Main Period|Unclasified|3|||
25278274|NCT01020123|50592298|FG006|Main Period|Unclasified|6|||
25278275|NCT01020123|50592292|FG000|Extention Period|Withdrawal by Subject|2|||
25278276|NCT01020123|50592293|FG001|Extention Period|Withdrawal by Subject|1|||
25278277|NCT01020123|50592294|FG002|Extention Period|Withdrawal by Subject|1|||
25278278|NCT01020123|50592295|FG003|Extention Period|Withdrawal by Subject|0|||
25278279|NCT01020123|50592296|FG004|Extention Period|Withdrawal by Subject|0|||
25278280|NCT01020123|50592297|FG005|Extention Period|Withdrawal by Subject|0|||
25278281|NCT01020123|50592298|FG006|Extention Period|Withdrawal by Subject|0|||
25278282|NCT01020123|50592292|FG000|Extention Period|Adverse Event|0|||
25278283|NCT01020123|50592293|FG001|Extention Period|Adverse Event|0|||
25278284|NCT01020123|50592294|FG002|Extention Period|Adverse Event|0|||
25278285|NCT01020123|50592295|FG003|Extention Period|Adverse Event|1|||
25278286|NCT01020123|50592296|FG004|Extention Period|Adverse Event|0|||
25278287|NCT01020123|50592297|FG005|Extention Period|Adverse Event|0|||
25278288|NCT01020123|50592298|FG006|Extention Period|Adverse Event|0|||
25278289|NCT01020123|50592292|FG000|Extention Period|Protocol Violation|1|||
25278290|NCT01020123|50592293|FG001|Extention Period|Protocol Violation|1|||
25278291|NCT01020123|50592294|FG002|Extention Period|Protocol Violation|1|||
25278292|NCT01020123|50592295|FG003|Extention Period|Protocol Violation|0|||
25278293|NCT01020123|50592296|FG004|Extention Period|Protocol Violation|0|||
25278294|NCT01020123|50592297|FG005|Extention Period|Protocol Violation|0|||
25278295|NCT01020123|50592298|FG006|Extention Period|Protocol Violation|1|||
25278296|NCT01020123|50592292|FG000|Extention Period|Lost to Follow-up|0|||
25278297|NCT01020123|50592293|FG001|Extention Period|Lost to Follow-up|0|||
25278298|NCT01020123|50592294|FG002|Extention Period|Lost to Follow-up|0|||
25278299|NCT01020123|50592295|FG003|Extention Period|Lost to Follow-up|0|||
25278300|NCT01020123|50592296|FG004|Extention Period|Lost to Follow-up|0|||
25278301|NCT01020123|50592297|FG005|Extention Period|Lost to Follow-up|2|||
25278302|NCT01020123|50592298|FG006|Extention Period|Lost to Follow-up|0|||
25278303|NCT01028391|50592339|FG000|Overall Study|Adverse Event|4|||
25278304|NCT01028391|50592340|FG001|Overall Study|Adverse Event|0|||
25278305|NCT01028391|50592339|FG000|Overall Study|Lack of Efficacy|0|||
25278306|NCT01028391|50592340|FG001|Overall Study|Lack of Efficacy|2|||
25278307|NCT01028391|50592339|FG000|Overall Study|Lost to Follow-up|3|||
25278308|NCT01028391|50592340|FG001|Overall Study|Lost to Follow-up|4|||
25278309|NCT01028391|50592339|FG000|Overall Study|Physician Decision|0|||
25278310|NCT01028391|50592340|FG001|Overall Study|Physician Decision|1|||
25278311|NCT01028391|50592339|FG000|Overall Study|Withdrawal by Subject|6|||
25278312|NCT01028391|50592340|FG001|Overall Study|Withdrawal by Subject|3|||
25278313|NCT01028391|50592339|FG000|Overall Study|Needed excluded medication|1|||
25278314|NCT01028391|50592340|FG001|Overall Study|Needed excluded medication|1|||
25278315|NCT01179672|50592348|FG000|Overall Study|Adverse Event|17|||
25278316|NCT01179672|50592349|FG001|Overall Study|Adverse Event|8|||
25278317|NCT01179672|50592348|FG000|Overall Study|Withdrawal by Subject|10|||
25278318|NCT01179672|50592349|FG001|Overall Study|Withdrawal by Subject|12|||
25278319|NCT01179672|50592348|FG000|Overall Study|Entry Criteria Not Met|0|||
25278320|NCT01179672|50592349|FG001|Overall Study|Entry Criteria Not Met|2|||
25278321|NCT01179672|50592348|FG000|Overall Study|Lost to Follow-up|0|||
25278322|NCT01179672|50592349|FG001|Overall Study|Lost to Follow-up|1|||
25278323|NCT01179672|50592348|FG000|Overall Study|Protocol Violation|2|||
25278324|NCT01179672|50592349|FG001|Overall Study|Protocol Violation|2|||
25278325|NCT01179672|50592348|FG000|Overall Study|Physician Decision|1|||
25278326|NCT01179672|50592349|FG001|Overall Study|Physician Decision|1|||
25278327|NCT01030965|50592363|FG000|Overall Study|Lack of Efficacy|3|||
25278328|NCT01030965|50592364|FG001|Overall Study|Lack of Efficacy|2|||
25278329|NCT01030965|50592365|FG002|Overall Study|Lack of Efficacy|0|||
25278330|NCT01030965|50592366|FG003|Overall Study|Lack of Efficacy|3|||
25278331|NCT01030965|50592363|FG000|Overall Study|Protocol Violation|1|||
25278332|NCT01030965|50592364|FG001|Overall Study|Protocol Violation|1|||
25278333|NCT01030965|50592365|FG002|Overall Study|Protocol Violation|1|||
25278334|NCT01030965|50592366|FG003|Overall Study|Protocol Violation|1|||
25278335|NCT01030965|50592363|FG000|Overall Study|Adverse Event|0|||
25278336|NCT01030965|50592364|FG001|Overall Study|Adverse Event|1|||
25278337|NCT01030965|50592365|FG002|Overall Study|Adverse Event|2|||
25278338|NCT01030965|50592366|FG003|Overall Study|Adverse Event|1|||
25278339|NCT01030965|50592363|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
25278340|NCT01030965|50592364|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
25278341|NCT01030965|50592365|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
25278342|NCT01030965|50592366|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
25278343|NCT01030965|50592363|FG000|Overall Study|Withdrawal by Subject|0|||
25278344|NCT01030965|50592364|FG001|Overall Study|Withdrawal by Subject|1|||
25278345|NCT01030965|50592365|FG002|Overall Study|Withdrawal by Subject|0|||
25278346|NCT01030965|50592366|FG003|Overall Study|Withdrawal by Subject|2|||
25278347|NCT01179516|50592379|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
25278348|NCT01179516|50592380|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
25278349|NCT01179516|50592381|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
25278350|NCT01179516|50592379|FG000|Overall Study|Lack of Efficacy|4|||
25278351|NCT01179516|50592380|FG001|Overall Study|Lack of Efficacy|2|||
25278352|NCT01179516|50592381|FG002|Overall Study|Lack of Efficacy|0|||
25278353|NCT01179516|50592379|FG000|Overall Study|Noncompliance with Study Drug|2|||
25278354|NCT01179516|50592380|FG001|Overall Study|Noncompliance with Study Drug|0|||
25278355|NCT01179516|50592381|FG002|Overall Study|Noncompliance with Study Drug|1|||
25278356|NCT01179516|50592379|FG000|Overall Study|Protocol Deviations|4|||
25278357|NCT01179516|50592380|FG001|Overall Study|Protocol Deviations|3|||
25278358|NCT01179516|50592381|FG002|Overall Study|Protocol Deviations|3|||
25278359|NCT01179516|50592379|FG000|Overall Study|Withdrawal of Consent|2|||
25278360|NCT01179516|50592380|FG001|Overall Study|Withdrawal of Consent|6|||
25278361|NCT01179516|50592381|FG002|Overall Study|Withdrawal of Consent|10|||
25278362|NCT01179516|50592379|FG000|Overall Study|Lost to Follow-up|7|||
25278363|NCT01179516|50592380|FG001|Overall Study|Lost to Follow-up|7|||
25278364|NCT01179516|50592381|FG002|Overall Study|Lost to Follow-up|3|||
25278365|NCT01179516|50592379|FG000|Overall Study|Other|2|||
25278366|NCT01179516|50592380|FG001|Overall Study|Other|0|||
25278367|NCT01179516|50592381|FG002|Overall Study|Other|2|||
25278368|NCT01018953|50592389|FG000|Overall Study|Adverse Event|2|||
25278369|NCT01018953|50592389|FG000|Overall Study|Withdrawal by Subject|1|||
25278370|NCT01018953|50592389|FG000|Overall Study|Study termination by sponsor|5|||
25278371|NCT01158924|50592396|FG000|Overall Study|Withdrawal by Subject|1|||
25278372|NCT01158924|50592397|FG001|Overall Study|Withdrawal by Subject|2|||
25278373|NCT01158924|50592396|FG000|Overall Study|Lost to Follow-up|0|||
25278374|NCT01158924|50592397|FG001|Overall Study|Lost to Follow-up|1|||
25278375|NCT01027845|50592405|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
25278376|NCT01027845|50592406|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
25278377|NCT01027845|50592407|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
25278378|NCT01027845|50592408|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
25278379|NCT01027845|50592405|FG000|Primary Vaccination Phase|Adverse Event|1|||
25278380|NCT01027845|50592406|FG001|Primary Vaccination Phase|Adverse Event|0|||
25278381|NCT01027845|50592407|FG002|Primary Vaccination Phase|Adverse Event|0|||
25278382|NCT01027845|50592408|FG003|Primary Vaccination Phase|Adverse Event|0|||
25278383|NCT01027845|50592405|FG000|Primary Vaccination Phase|Protocol Violation|1|||
25278384|NCT01027845|50592406|FG001|Primary Vaccination Phase|Protocol Violation|0|||
25278385|NCT01027845|50592407|FG002|Primary Vaccination Phase|Protocol Violation|0|||
25278386|NCT01027845|50592408|FG003|Primary Vaccination Phase|Protocol Violation|0|||
25278387|NCT01027845|50592405|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
25278388|NCT01027845|50592406|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
25278389|NCT01027845|50592407|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
25278390|NCT01027845|50592408|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
25278391|NCT01027845|50592405|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
25278392|NCT01027845|50592406|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
25278393|NCT01027845|50592407|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
25278394|NCT01027845|50592408|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
25278395|NCT01027845|50592405|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
25278396|NCT01027845|50592406|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
25278397|NCT01027845|50592407|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
25278398|NCT01027845|50592408|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
25278399|NCT01017549|50592417|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
25278400|NCT01017549|50592417|FG000|One-year Follow-up|Lost to Follow-up|2|||
25069540|NCT02772757|50175424|FG001|Overall Study|Protocol Violation|0|||
25278401|NCT01017549|50592417|FG000|One-year Follow-up|Withdrawal by Subject|5|||
25278402|NCT01017549|50592417|FG000|5 Year Follow-up|Lost to Follow-up|9|||
25278403|NCT01017549|50592417|FG000|5 Year Follow-up|Mastectomy|3|||
25278404|NCT01030341|50592421|FG000|Overall Study|Withdrawal by Subject|1|||
25278405|NCT01030341|50592421|FG000|Overall Study|Lost to Follow-up|2|||
25278406|NCT01026831|50592427|FG000|Overall Study|Adverse Event|4|||
25278407|NCT01026831|50592428|FG001|Overall Study|Adverse Event|3|||
25278408|NCT01026831|50592427|FG000|Overall Study|Lost to Follow-up|2|||
25278409|NCT01026831|50592428|FG001|Overall Study|Lost to Follow-up|0|||
25278410|NCT01026831|50592427|FG000|Overall Study|Physician Decision|1|||
25278411|NCT01026831|50592428|FG001|Overall Study|Physician Decision|1|||
25278412|NCT01026831|50592427|FG000|Overall Study|Protocol Violation|0|||
25278413|NCT01026831|50592428|FG001|Overall Study|Protocol Violation|2|||
25278414|NCT01026831|50592427|FG000|Overall Study|Withdrawal by Subject|7|||
25278415|NCT01026831|50592428|FG001|Overall Study|Withdrawal by Subject|5|||
25278416|NCT01016067|50592436|FG000|Overall Study|Lost to Follow-up|1|||
25278417|NCT01016067|50592437|FG001|Overall Study|Lost to Follow-up|2|||
25278418|NCT01016067|50592436|FG000|Overall Study|Physician Decision|1|||
25278419|NCT01016067|50592437|FG001|Overall Study|Physician Decision|1|||
25278420|NCT01016067|50592436|FG000|Overall Study|Withdrew due to Relocation|0|||
25278421|NCT01016067|50592437|FG001|Overall Study|Withdrew due to Relocation|1|||
25278422|NCT01015833|50592445|FG000|Overall Study|Death|1|||
25278423|NCT01015833|50592446|FG001|Overall Study|Death|0|||
25278424|NCT01015833|50592445|FG000|Overall Study|Withdrawal by Subject|3|||
25278425|NCT01015833|50592446|FG001|Overall Study|Withdrawal by Subject|2|||
25278426|NCT01015833|50592445|FG000|Overall Study|Adverse Event|0|||
25278427|NCT01015833|50592446|FG001|Overall Study|Adverse Event|1|||
25278428|NCT01015833|50592445|FG000|Overall Study|Physician Decision|2|||
25278429|NCT01015833|50592446|FG001|Overall Study|Physician Decision|0|||
25278430|NCT01015833|50592445|FG000|Overall Study|Symptomatic deterioration|0|||
25278431|NCT01015833|50592446|FG001|Overall Study|Symptomatic deterioration|1|||
25278432|NCT01015833|50592445|FG000|Overall Study|Other|5|||
25278433|NCT01015833|50592446|FG001|Overall Study|Other|1|||
25278434|NCT01015833|50592445|FG000|Overall Study|Motor Vehicle Accidents|1|||
25278435|NCT01015833|50592446|FG001|Overall Study|Motor Vehicle Accidents|0|||
25278436|NCT01015833|50592445|FG000|Overall Study|Did not start treatment|1|||
25278437|NCT01015833|50592446|FG001|Overall Study|Did not start treatment|0|||
25278438|NCT01015677|50592464|FG000|Overall Study|Adverse Event|0|||
25278439|NCT01015677|50592465|FG001|Overall Study|Adverse Event|1|||
25278440|NCT01015677|50592466|FG002|Overall Study|Adverse Event|0|||
25168927|NCT00982137|50299109|FG000|Overall Study|Withdrawal by Subject|0|||
25168928|NCT00982137|50299110|FG001|Overall Study|Withdrawal by Subject|1|||
25168929|NCT00982137|50299111|FG002|Overall Study|Withdrawal by Subject|0|||
25168930|NCT00982137|50299112|FG003|Overall Study|Withdrawal by Subject|0|||
25168931|NCT00981747|50299129|FG000|Losartan|Withdrawal by Subject|1|||
25168932|NCT00981747|50299129|FG000|Losartan|Death|1|||
25168933|NCT00981747|50299129|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
25168934|NCT01856309|50299284|FG000|Overall Study|Death|4|||
25168935|NCT01856309|50299285|FG001|Overall Study|Death|6|||
25168936|NCT01856309|50299286|FG002|Overall Study|Death|11|||
25168937|NCT01856309|50299287|FG003|Overall Study|Death|6|||
25168938|NCT01856309|50299284|FG000|Overall Study|Lost to Follow-up|6|||
25168939|NCT01856309|50299285|FG001|Overall Study|Lost to Follow-up|2|||
25168940|NCT01856309|50299286|FG002|Overall Study|Lost to Follow-up|4|||
25168941|NCT01856309|50299287|FG003|Overall Study|Lost to Follow-up|8|||
25189661|NCT04178967|50346637|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
25189662|NCT04178967|50346638|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
25189663|NCT04178967|50346639|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
25189664|NCT04178967|50346629|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
25189665|NCT04178967|50346630|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
25189666|NCT04178967|50346631|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
25189667|NCT04178967|50346632|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
25189668|NCT04178967|50346633|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
25189669|NCT04178967|50346634|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
25189670|NCT04178967|50346635|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
25278441|NCT01015677|50592464|FG000|Overall Study|Lack of Efficacy|0|||
25278442|NCT01015677|50592465|FG001|Overall Study|Lack of Efficacy|1|||
25278443|NCT01015677|50592466|FG002|Overall Study|Lack of Efficacy|0|||
25278444|NCT01015677|50592464|FG000|Overall Study|Protocol Violation|0|||
25278445|NCT01015677|50592465|FG001|Overall Study|Protocol Violation|1|||
25278446|NCT01015677|50592466|FG002|Overall Study|Protocol Violation|0|||
25278447|NCT01015677|50592464|FG000|Overall Study|Withdrawal by Subject|1|||
25278448|NCT01015677|50592465|FG001|Overall Study|Withdrawal by Subject|1|||
25278449|NCT01015677|50592466|FG002|Overall Study|Withdrawal by Subject|0|||
25168942|NCT01856309|50299284|FG000|Overall Study|Withdrawal by Subject|11|||
25168943|NCT01856309|50299285|FG001|Overall Study|Withdrawal by Subject|13|||
25278450|NCT01225211|50592506|FG000|Overall Study|Adverse Event|0|||
25278451|NCT01225211|50592507|FG001|Overall Study|Adverse Event|0|||
25278452|NCT01225211|50592508|FG002|Overall Study|Adverse Event|1|||
25278453|NCT01225211|50592509|FG003|Overall Study|Adverse Event|0|||
25278454|NCT01225211|50592510|FG004|Overall Study|Adverse Event|0|||
25278455|NCT01225211|50592511|FG005|Overall Study|Adverse Event|0|||
25278456|NCT01225211|50592512|FG006|Overall Study|Adverse Event|0|||
25278457|NCT01225211|50592513|FG007|Overall Study|Adverse Event|0|||
24969138|NCT00132678|50058654|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
24969139|NCT00132678|50058655|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
24969140|NCT00132678|50058656|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
24969141|NCT00132678|50058654|FG000|Period III (Open-Label Stabilization)|Death|2|||
24969142|NCT00132678|50058655|FG001|Period III (Open-Label Stabilization)|Death|0|||
25069541|NCT02772757|50175425|FG002|Overall Study|Protocol Violation|1|||
25069542|NCT02772757|50175423|FG000|Overall Study|Physician Decision|0|||
25069543|NCT02772757|50175424|FG001|Overall Study|Physician Decision|3|||
25069544|NCT02772757|50175425|FG002|Overall Study|Physician Decision|3|||
25069545|NCT00103207|50175434|FG000|Overall Study|Adverse Event|3|||
25069546|NCT00103207|50175434|FG000|Overall Study|Death|1|||
25069547|NCT00103207|50175434|FG000|Overall Study|Withdrawal by Subject|2|||
25069548|NCT00103207|50175434|FG000|Overall Study|Other complicating disease|1|||
25189671|NCT04178967|50346636|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
25189672|NCT04178967|50346637|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
25069549|NCT00103207|50175434|FG000|Overall Study|Ineligible|4|||
25069550|NCT00103207|50175434|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
25069551|NCT01369355|50175446|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
25069552|NCT01369355|50175447|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
25069553|NCT01369355|50175448|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
25069554|NCT01369355|50175449|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
25069555|NCT01369355|50175450|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
25069556|NCT01369355|50175451|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
25069557|NCT01369355|50175452|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
25069558|NCT01369355|50175453|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
25069559|NCT01369355|50175454|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
25069560|NCT01369355|50175446|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
25069561|NCT01369355|50175447|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
25069562|NCT01369355|50175448|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
25069563|NCT01369355|50175449|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
25069564|NCT01369355|50175450|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
25069565|NCT01369355|50175451|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
25069566|NCT01369355|50175452|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
25069567|NCT01369355|50175453|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
25069568|NCT01369355|50175454|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
25069569|NCT01369355|50175446|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
25069570|NCT01369355|50175447|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
25069571|NCT01369355|50175448|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
25069572|NCT01369355|50175449|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
25168944|NCT01856309|50299286|FG002|Overall Study|Withdrawal by Subject|28|||
25168945|NCT01856309|50299287|FG003|Overall Study|Withdrawal by Subject|26|||
25168946|NCT01856309|50299284|FG000|Overall Study|Other|227|||
25168947|NCT01856309|50299285|FG001|Overall Study|Other|225|||
25168948|NCT01856309|50299286|FG002|Overall Study|Other|447|||
25168949|NCT01856309|50299287|FG003|Overall Study|Other|469|||
25168950|NCT01856309|50299284|FG000|Overall Study|Lack of Efficacy|14|||
25168951|NCT01856309|50299285|FG001|Overall Study|Lack of Efficacy|9|||
25189673|NCT04178967|50346638|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
25189674|NCT04178967|50346639|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
25189675|NCT04178967|50346629|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
25189676|NCT04178967|50346630|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
25189677|NCT04178967|50346631|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
25189678|NCT04178967|50346632|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
25189679|NCT04178967|50346633|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
25278458|NCT01225211|50592514|FG008|Overall Study|Adverse Event|0|||
25278459|NCT01225211|50592515|FG009|Overall Study|Adverse Event|1|||
25069573|NCT01369355|50175450|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
25168952|NCT01856309|50299286|FG002|Overall Study|Lack of Efficacy|40|||
25168953|NCT01856309|50299287|FG003|Overall Study|Lack of Efficacy|25|||
25168954|NCT01856309|50299284|FG000|Overall Study|Adverse Event|31|||
25278460|NCT01225211|50592506|FG000|Overall Study|Withdrawal by Subject|0|||
25278461|NCT01225211|50592507|FG001|Overall Study|Withdrawal by Subject|0|||
25278462|NCT01225211|50592508|FG002|Overall Study|Withdrawal by Subject|0|||
25278463|NCT01225211|50592509|FG003|Overall Study|Withdrawal by Subject|0|||
25278464|NCT01225211|50592510|FG004|Overall Study|Withdrawal by Subject|0|||
25278465|NCT01225211|50592511|FG005|Overall Study|Withdrawal by Subject|0|||
25278466|NCT01225211|50592512|FG006|Overall Study|Withdrawal by Subject|1|||
25278467|NCT01225211|50592513|FG007|Overall Study|Withdrawal by Subject|0|||
25278468|NCT01225211|50592514|FG008|Overall Study|Withdrawal by Subject|1|||
25278469|NCT01225211|50592515|FG009|Overall Study|Withdrawal by Subject|3|||
25278470|NCT01225211|50592506|FG000|Overall Study|Other|0|||
25278471|NCT01225211|50592507|FG001|Overall Study|Other|0|||
25278472|NCT01225211|50592508|FG002|Overall Study|Other|0|||
25278473|NCT01225211|50592509|FG003|Overall Study|Other|0|||
25278474|NCT01225211|50592510|FG004|Overall Study|Other|0|||
25278475|NCT01225211|50592511|FG005|Overall Study|Other|0|||
25278476|NCT01225211|50592512|FG006|Overall Study|Other|0|||
25278477|NCT01225211|50592513|FG007|Overall Study|Other|0|||
25278478|NCT01225211|50592514|FG008|Overall Study|Other|0|||
25278479|NCT01225211|50592515|FG009|Overall Study|Other|1|||
25278480|NCT01224821|50592598|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
25278481|NCT01224821|50592598|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
25278482|NCT01224821|50592598|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
25278483|NCT01224821|50592598|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
25278484|NCT01224821|50592598|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
25278485|NCT01224821|50592598|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
25278486|NCT01224821|50592598|FG000|Long-Term Follow-Up|Death|2|||
25278487|NCT01224821|50592598|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
25278488|NCT01224431|50592615|FG000|Overall Study|not randomized|0|||
25278489|NCT01224431|50592616|FG001|Overall Study|not randomized|4|||
25278490|NCT01224431|50592615|FG000|Overall Study|no video record|0|||
25278491|NCT01224431|50592616|FG001|Overall Study|no video record|1|||
25278492|NCT01223183|50592626|FG000|Imaging Day 1|Physician Decision|0|||
25278493|NCT01223183|50592627|FG001|Imaging Day 1|Physician Decision|1|||
25278494|NCT01223183|50592626|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
25278495|NCT01223183|50592627|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
25278496|NCT01223183|50592626|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
25278497|NCT01223183|50592627|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
25278498|NCT01223027|50592636|FG000|Overall Study|Adverse Event|20|||
25278499|NCT01223027|50592637|FG001|Overall Study|Adverse Event|10|||
25278500|NCT01223027|50592636|FG000|Overall Study|Death|42|||
25278501|NCT01223027|50592637|FG001|Overall Study|Death|42|||
25278502|NCT01223027|50592636|FG000|Overall Study|Lost to Follow-up|2|||
25278503|NCT01223027|50592637|FG001|Overall Study|Lost to Follow-up|1|||
25278504|NCT01223027|50592636|FG000|Overall Study|Physician Decision|4|||
25278505|NCT01223027|50592637|FG001|Overall Study|Physician Decision|8|||
25278506|NCT01223027|50592636|FG000|Overall Study|Progressive Disease|167|||
25278507|NCT01223027|50592637|FG001|Overall Study|Progressive Disease|183|||
25278508|NCT01223027|50592636|FG000|Overall Study|Protocol Violation|2|||
25278509|NCT01223027|50592637|FG001|Overall Study|Protocol Violation|1|||
25278510|NCT01223027|50592636|FG000|Overall Study|Subject/guardian decicion|18|||
25278511|NCT01223027|50592637|FG001|Overall Study|Subject/guardian decicion|16|||
25278512|NCT01223027|50592636|FG000|Overall Study|New therapy for study indication|17|||
25278513|NCT01223027|50592637|FG001|Overall Study|New therapy for study indication|8|||
25278514|NCT01223027|50592636|FG000|Overall Study|Study terminated by sponsor|2|||
25278515|NCT01223027|50592637|FG001|Overall Study|Study terminated by sponsor|8|||
25278516|NCT01015287|50592645|FG000|Overall Study|Death|21|||
25278517|NCT01015287|50592646|FG001|Overall Study|Death|16|||
25278518|NCT01015287|50592645|FG000|Overall Study|Adverse Event|1|||
25278519|NCT01015287|50592646|FG001|Overall Study|Adverse Event|0|||
25278520|NCT01015287|50592645|FG000|Overall Study|Sponsor Decision|3|||
25278521|NCT01015287|50592646|FG001|Overall Study|Sponsor Decision|7|||
25278522|NCT01015287|50592645|FG000|Overall Study|Physician Decision|19|||
25278523|NCT01015287|50592646|FG001|Overall Study|Physician Decision|21|||
25168955|NCT01856309|50299285|FG001|Overall Study|Adverse Event|31|||
25278524|NCT01015287|50592645|FG000|Overall Study|Withdrawal by Subject|14|||
25278525|NCT01015287|50592646|FG001|Overall Study|Withdrawal by Subject|19|||
25278526|NCT01015287|50592645|FG000|Overall Study|Entry Criteria not Met|11|||
25278527|NCT01015287|50592646|FG001|Overall Study|Entry Criteria not Met|14|||
25278528|NCT01015287|50592645|FG000|Overall Study|Lost to Follow-up|2|||
25278529|NCT01015287|50592646|FG001|Overall Study|Lost to Follow-up|1|||
25278530|NCT01015287|50592645|FG000|Overall Study|Protocol Violation|1|||
25278531|NCT01015287|50592646|FG001|Overall Study|Protocol Violation|1|||
25278532|NCT01015131|50592654|FG000|Overall Study|Physician Decision|1|||
25278533|NCT01015131|50592654|FG000|Overall Study|Protocol Violation|1|||
25278534|NCT01015131|50592654|FG000|Overall Study|Withdrawal by Subject|2|||
25278535|NCT01015131|50592654|FG000|Overall Study|Other Protocol Specified Criteria|4|||
25278536|NCT01222715|50592660|FG000|Overall Study|Adverse Event|0|||
25278537|NCT01222715|50592661|FG001|Overall Study|Adverse Event|4|||
25278538|NCT01222715|50592660|FG000|Overall Study|Death|0|||
25278539|NCT01222715|50592661|FG001|Overall Study|Death|1|||
25278540|NCT01222715|50592660|FG000|Overall Study|Lack of Efficacy|22|||
25278541|NCT01222715|50592661|FG001|Overall Study|Lack of Efficacy|14|||
25278542|NCT01222715|50592660|FG000|Overall Study|Physician Decision|12|||
25278543|NCT01222715|50592661|FG001|Overall Study|Physician Decision|2|||
25278544|NCT01222715|50592660|FG000|Overall Study|Refusal of further protocol therapy|0|||
25278545|NCT01222715|50592661|FG001|Overall Study|Refusal of further protocol therapy|4|||
25278546|NCT01222715|50592660|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
25278547|NCT01222715|50592661|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
25278548|NCT01222715|50592660|FG000|Overall Study|Ineligible|0|||
25278549|NCT01222715|50592661|FG001|Overall Study|Ineligible|1|||
24969143|NCT00132678|50058656|FG002|Period III (Open-Label Stabilization)|Death|0|||
24969144|NCT00132678|50058654|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
24969145|NCT00132678|50058655|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
24969146|NCT00132678|50058656|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
24969147|NCT00132678|50058654|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
24969148|NCT00132678|50058655|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
24969149|NCT00132678|50058656|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
25069574|NCT01369355|50175451|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
25189680|NCT04178967|50346634|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
25189681|NCT04178967|50346635|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
25189682|NCT04178967|50346636|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
25189683|NCT04178967|50346637|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
25189684|NCT04178967|50346638|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
25189685|NCT04178967|50346639|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
25189686|NCT04178967|50346629|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25189687|NCT04178967|50346630|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25189688|NCT04178967|50346631|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25189689|NCT04178967|50346632|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25189690|NCT04178967|50346633|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25189691|NCT04178967|50346634|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25189692|NCT04178967|50346635|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25189693|NCT04178967|50346636|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25189694|NCT04178967|50346637|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25189695|NCT04178967|50346638|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
25189696|NCT04178967|50346639|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
25189697|NCT04178967|50346629|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
25189698|NCT04178967|50346630|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
25189699|NCT04178967|50346631|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
25189700|NCT04178967|50346632|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
25189701|NCT04178967|50346633|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
25189702|NCT04178967|50346634|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
25189703|NCT04178967|50346635|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
25189704|NCT04178967|50346636|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
25189705|NCT04178967|50346637|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
25189706|NCT04178967|50346638|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
25189707|NCT04178967|50346639|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
25189708|NCT04178967|50346629|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
25189709|NCT04178967|50346630|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
25189710|NCT04178967|50346631|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
25189711|NCT04178967|50346632|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
25189712|NCT04178967|50346633|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
25189713|NCT04178967|50346634|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
25189714|NCT04178967|50346635|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
25189715|NCT04178967|50346636|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
25189716|NCT04178967|50346637|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
25189717|NCT04178967|50346638|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
25189718|NCT04178967|50346639|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
25189719|NCT04178967|50346629|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
25189720|NCT04178967|50346630|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
25189721|NCT04178967|50346631|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
25189722|NCT04178967|50346632|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
25189723|NCT04178967|50346633|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
25278550|NCT01222715|50592660|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
25278551|NCT01222715|50592661|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
25278552|NCT01222403|50592669|FG000|Overall Study|Inappropriate enrollment|0|||
25278553|NCT01222403|50592670|FG001|Overall Study|Inappropriate enrollment|2|||
25278554|NCT01222247|50592678|FG000|Overall Study|Lost to Follow-up|2|||
25278555|NCT01222247|50592679|FG001|Overall Study|Lost to Follow-up|2|||
25278556|NCT01014975|50592685|FG000|Overall Study|Withdrawal by Subject|1|||
25278557|NCT01014975|50592686|FG001|Overall Study|Withdrawal by Subject|0|||
25278558|NCT01014975|50592687|FG002|Overall Study|Withdrawal by Subject|1|||
25278559|NCT01014975|50592685|FG000|Overall Study|Death|3|||
25278560|NCT01014975|50592686|FG001|Overall Study|Death|3|||
25278561|NCT01014975|50592687|FG002|Overall Study|Death|4|||
25278562|NCT01014975|50592685|FG000|Overall Study|Lost to Follow-up|0|||
25278563|NCT01014975|50592686|FG001|Overall Study|Lost to Follow-up|0|||
25278564|NCT01014975|50592687|FG002|Overall Study|Lost to Follow-up|1|||
25278565|NCT01221623|50592697|FG000|Overall Study|Withdrawal by Subject|19|||
25278566|NCT01221623|50592698|FG001|Overall Study|Withdrawal by Subject|8|||
25278567|NCT01221623|50592697|FG000|Overall Study|Lost to Follow-up|7|||
25278568|NCT01221623|50592698|FG001|Overall Study|Lost to Follow-up|1|||
25278569|NCT01221623|50592697|FG000|Overall Study|Adverse Event|6|||
25278570|NCT01221623|50592698|FG001|Overall Study|Adverse Event|3|||
25278571|NCT01221623|50592697|FG000|Overall Study|Death|1|||
25278572|NCT01221623|50592698|FG001|Overall Study|Death|0|||
25278573|NCT01221623|50592697|FG000|Overall Study|Other|5|||
25278574|NCT01221623|50592698|FG001|Overall Study|Other|2|||
25278575|NCT01014585|50592708|FG000|Overall Study|Adverse Event|0|||
25278576|NCT01014585|50592709|FG001|Overall Study|Adverse Event|2|||
25278577|NCT01014585|50592710|FG002|Overall Study|Adverse Event|0|||
25278578|NCT01014585|50592711|FG003|Overall Study|Adverse Event|3|||
25278579|NCT01014585|50592708|FG000|Overall Study|Withdrawal by Subject|2|||
25278580|NCT01014585|50592709|FG001|Overall Study|Withdrawal by Subject|0|||
25278581|NCT01014585|50592710|FG002|Overall Study|Withdrawal by Subject|1|||
25278582|NCT01014585|50592711|FG003|Overall Study|Withdrawal by Subject|3|||
25278583|NCT01014585|50592708|FG000|Overall Study|Lost to Follow-up|0|||
25278584|NCT01014585|50592709|FG001|Overall Study|Lost to Follow-up|0|||
25278585|NCT01014585|50592710|FG002|Overall Study|Lost to Follow-up|0|||
25278586|NCT01014585|50592711|FG003|Overall Study|Lost to Follow-up|2|||
25278587|NCT01014585|50592708|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
25278588|NCT01014585|50592709|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
25278589|NCT01014585|50592710|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
25278590|NCT01014585|50592711|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
25278591|NCT01221233|50592723|FG000|Overall Study|Withdrawal by Subject|3|||
25278592|NCT01221233|50592724|FG001|Overall Study|Withdrawal by Subject|1|||
25278593|NCT01220609|50592730|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
25278594|NCT01220609|50592730|FG000|Overall Study|Ineligible- Wrong cell type|1|||
25278595|NCT01220609|50592730|FG000|Overall Study|Ineligible-Never treated|1|||
25278596|NCT01220297|50592742|FG000|Overall Study|Death|2|||
25278597|NCT01220297|50592742|FG000|Overall Study|Lost to Follow-up|1|||
25278598|NCT01219985|50592748|FG000|Overall Study|Physician Decision|20|||
25278599|NCT01218659|50592756|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
25278600|NCT01218659|50592757|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
25278601|NCT01218659|50592758|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
25278602|NCT01218659|50592756|FG000|18-Month Randomized Period|Did not receive study drug|0|||
25278603|NCT01218659|50592757|FG001|18-Month Randomized Period|Did not receive study drug|3|||
25278604|NCT01218659|50592758|FG002|18-Month Randomized Period|Did not receive study drug|0|||
24969150|NCT00132678|50058654|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
25168956|NCT01856309|50299286|FG002|Overall Study|Adverse Event|55|||
25168957|NCT01856309|50299287|FG003|Overall Study|Adverse Event|65|||
25168958|NCT01856309|50299284|FG000|Overall Study|Pregnancy|0|||
25168959|NCT01856309|50299285|FG001|Overall Study|Pregnancy|0|||
25168960|NCT01856309|50299286|FG002|Overall Study|Pregnancy|0|||
25168961|NCT01856309|50299287|FG003|Overall Study|Pregnancy|1|||
25168962|NCT01856309|50299284|FG000|Overall Study|Physician Decision|6|||
25168963|NCT01856309|50299285|FG001|Overall Study|Physician Decision|1|||
25168964|NCT01856309|50299286|FG002|Overall Study|Physician Decision|6|||
25168965|NCT01856309|50299287|FG003|Overall Study|Physician Decision|8|||
25168966|NCT01856309|50299284|FG000|Overall Study|Noncompliance With Study Drug|0|||
25168967|NCT01856309|50299285|FG001|Overall Study|Noncompliance With Study Drug|1|||
25278605|NCT01218659|50592756|FG000|12-Month OLE|Withdrawal by Subject|0|||
25278606|NCT01218659|50592757|FG001|12-Month OLE|Withdrawal by Subject|0|||
25278607|NCT01218659|50592758|FG002|12-Month OLE|Withdrawal by Subject|2|||
25278608|NCT01218659|50592756|FG000|12-Month OLE|Physician Decision|0|||
25278609|NCT01218659|50592757|FG001|12-Month OLE|Physician Decision|0|||
25278610|NCT01218659|50592758|FG002|12-Month OLE|Physician Decision|1|||
25168968|NCT01856309|50299286|FG002|Overall Study|Noncompliance With Study Drug|4|||
25168969|NCT01856309|50299287|FG003|Overall Study|Noncompliance With Study Drug|1|||
25168970|NCT01855919|50299485|FG000|Overall Study|Adverse Event|16|||
25168971|NCT01855919|50299486|FG001|Overall Study|Adverse Event|8|||
25278611|NCT01218659|50592756|FG000|12-Month OLE|Lost to Follow-up|0|||
25278612|NCT01218659|50592757|FG001|12-Month OLE|Lost to Follow-up|0|||
25278613|NCT01218659|50592758|FG002|12-Month OLE|Lost to Follow-up|1|||
25278614|NCT01218659|50592756|FG000|12-Month OLE|Pregnancy|0|||
25278615|NCT01218659|50592757|FG001|12-Month OLE|Pregnancy|0|||
25278616|NCT01218659|50592758|FG002|12-Month OLE|Pregnancy|1|||
25278617|NCT01218659|50592756|FG000|12-Month OLE|Lack of Efficacy|0|||
25278618|NCT01218659|50592757|FG001|12-Month OLE|Lack of Efficacy|0|||
25278619|NCT01218659|50592758|FG002|12-Month OLE|Lack of Efficacy|1|||
25278620|NCT01218659|50592756|FG000|12-Month OLE|Declined to participate in the OLE|0|||
25278621|NCT01218659|50592757|FG001|12-Month OLE|Declined to participate in the OLE|0|||
25278622|NCT01218659|50592758|FG002|12-Month OLE|Declined to participate in the OLE|4|||
25278623|NCT00940498|50592773|FG000|Overall Study|Death|2|||
25278624|NCT00940498|50592774|FG001|Overall Study|Death|0|||
25278625|NCT00940498|50592775|FG002|Overall Study|Death|0|||
25278626|NCT00940498|50592776|FG003|Overall Study|Death|1|||
25278627|NCT00940498|50592777|FG004|Overall Study|Death|5|||
25278628|NCT00940498|50592778|FG005|Overall Study|Death|0|||
25278629|NCT00940498|50592779|FG006|Overall Study|Death|1|||
25278630|NCT00940498|50592780|FG007|Overall Study|Death|0|||
25278631|NCT00940498|50592773|FG000|Overall Study|Lost to Follow-up|1|||
25278632|NCT00940498|50592774|FG001|Overall Study|Lost to Follow-up|1|||
25278633|NCT00940498|50592775|FG002|Overall Study|Lost to Follow-up|2|||
25278634|NCT00940498|50592776|FG003|Overall Study|Lost to Follow-up|0|||
25278635|NCT00940498|50592777|FG004|Overall Study|Lost to Follow-up|1|||
25278636|NCT00940498|50592778|FG005|Overall Study|Lost to Follow-up|0|||
25278637|NCT00940498|50592779|FG006|Overall Study|Lost to Follow-up|0|||
25278638|NCT00940498|50592780|FG007|Overall Study|Lost to Follow-up|1|||
25278639|NCT00940498|50592773|FG000|Overall Study|Disease Progression|0|||
25278640|NCT00940498|50592774|FG001|Overall Study|Disease Progression|0|||
25278641|NCT00940498|50592775|FG002|Overall Study|Disease Progression|1|||
25278642|NCT00940498|50592776|FG003|Overall Study|Disease Progression|1|||
25278643|NCT00940498|50592777|FG004|Overall Study|Disease Progression|0|||
25278644|NCT00940498|50592778|FG005|Overall Study|Disease Progression|1|||
25278645|NCT00940498|50592779|FG006|Overall Study|Disease Progression|0|||
25278646|NCT00940498|50592780|FG007|Overall Study|Disease Progression|0|||
25278647|NCT00940498|50592773|FG000|Overall Study|Physician Decision|0|||
25278648|NCT00940498|50592774|FG001|Overall Study|Physician Decision|0|||
25278649|NCT00940498|50592775|FG002|Overall Study|Physician Decision|0|||
25278650|NCT00940498|50592776|FG003|Overall Study|Physician Decision|0|||
25278651|NCT00940498|50592777|FG004|Overall Study|Physician Decision|2|||
25278652|NCT00940498|50592778|FG005|Overall Study|Physician Decision|0|||
25278653|NCT00940498|50592779|FG006|Overall Study|Physician Decision|0|||
25278654|NCT00940498|50592780|FG007|Overall Study|Physician Decision|0|||
25278655|NCT00940498|50592773|FG000|Overall Study|Not treated due to disease related pain|0|||
25278656|NCT00940498|50592774|FG001|Overall Study|Not treated due to disease related pain|0|||
25278657|NCT00940498|50592775|FG002|Overall Study|Not treated due to disease related pain|0|||
25278658|NCT00940498|50592776|FG003|Overall Study|Not treated due to disease related pain|0|||
25278659|NCT00940498|50592777|FG004|Overall Study|Not treated due to disease related pain|1|||
25278660|NCT00940498|50592778|FG005|Overall Study|Not treated due to disease related pain|0|||
25278661|NCT00940498|50592779|FG006|Overall Study|Not treated due to disease related pain|0|||
25278662|NCT00940498|50592780|FG007|Overall Study|Not treated due to disease related pain|0|||
25278663|NCT00940342|50592807|FG000|Overall Study|Adverse Event|0|||
25278664|NCT00940342|50592808|FG001|Overall Study|Adverse Event|2|||
25278665|NCT00940342|50592809|FG002|Overall Study|Adverse Event|1|||
25278666|NCT00936910|50592817|FG000|Overall Study|Lack of Efficacy|3|||
25278667|NCT00940108|50592826|FG000|Overall Study|Adverse Event|2|||
25278668|NCT00940108|50592827|FG001|Overall Study|Adverse Event|4|||
25278669|NCT00940108|50592828|FG002|Overall Study|Adverse Event|0|||
25278670|NCT00940108|50592829|FG003|Overall Study|Adverse Event|2|||
25278671|NCT00940108|50592826|FG000|Overall Study|Withdrew Consent|2|||
25278672|NCT00940108|50592827|FG001|Overall Study|Withdrew Consent|1|||
25278673|NCT00940108|50592828|FG002|Overall Study|Withdrew Consent|0|||
25278674|NCT00940108|50592829|FG003|Overall Study|Withdrew Consent|1|||
25278675|NCT00940108|50592826|FG000|Overall Study|Dose 2 contraindicated|1|||
25278676|NCT00940108|50592827|FG001|Overall Study|Dose 2 contraindicated|1|||
25278677|NCT00940108|50592828|FG002|Overall Study|Dose 2 contraindicated|0|||
25278678|NCT00940108|50592829|FG003|Overall Study|Dose 2 contraindicated|1|||
25278679|NCT00940108|50592826|FG000|Overall Study|Declined further vaccination|0|||
25278680|NCT00940108|50592827|FG001|Overall Study|Declined further vaccination|1|||
25278681|NCT00940108|50592828|FG002|Overall Study|Declined further vaccination|3|||
25278682|NCT00940108|50592829|FG003|Overall Study|Declined further vaccination|0|||
25278683|NCT00940108|50592826|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
25278684|NCT00940108|50592827|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
25278685|NCT00940108|50592828|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
25278686|NCT00940108|50592829|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
25278687|NCT00940108|50592826|FG000|Overall Study|Viral illness after Dose 1|0|||
25278688|NCT00940108|50592827|FG001|Overall Study|Viral illness after Dose 1|1|||
25278689|NCT00940108|50592828|FG002|Overall Study|Viral illness after Dose 1|0|||
25278690|NCT00940108|50592829|FG003|Overall Study|Viral illness after Dose 1|0|||
25278691|NCT00940108|50592826|FG000|Overall Study|Diagnosed with H1N1|0|||
25278692|NCT00940108|50592827|FG001|Overall Study|Diagnosed with H1N1|0|||
25278693|NCT00940108|50592828|FG002|Overall Study|Diagnosed with H1N1|0|||
25278694|NCT00940108|50592829|FG003|Overall Study|Diagnosed with H1N1|1|||
25278695|NCT00936598|50592841|FG000|Overall Study|Withdrawal by Subject|1|||
25278696|NCT00936598|50592842|FG001|Overall Study|Withdrawal by Subject|0|||
25278697|NCT00936598|50592841|FG000|Overall Study|Ineligible after consent|1|||
25278698|NCT00936598|50592842|FG001|Overall Study|Ineligible after consent|0|||
25278699|NCT01025817|50592850|FG000|Completed Study Medication|Adverse Event|66|||
25278700|NCT01025817|50592851|FG001|Completed Study Medication|Adverse Event|39|||
25278701|NCT01025817|50592850|FG000|Completed Study Medication|Protocol Deviation|9|||
25278702|NCT01025817|50592851|FG001|Completed Study Medication|Protocol Deviation|8|||
25278703|NCT01025817|50592850|FG000|Completed Study Medication|Withdrawal by Subject|8|||
25278704|NCT01025817|50592851|FG001|Completed Study Medication|Withdrawal by Subject|9|||
25278705|NCT01025817|50592850|FG000|Completed Study Medication|Administrative problems|7|||
25278706|NCT01025817|50592851|FG001|Completed Study Medication|Administrative problems|5|||
25278707|NCT01025817|50592850|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
25278708|NCT01025817|50592851|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
25278709|NCT01025817|50592850|FG000|Completed Study Medication|Abnormal test procedure|4|||
25278710|NCT01025817|50592851|FG001|Completed Study Medication|Abnormal test procedure|0|||
25278711|NCT01025817|50592850|FG000|Completed Study Medication|Graft loss|2|||
25278712|NCT01025817|50592851|FG001|Completed Study Medication|Graft loss|5|||
25278713|NCT01025817|50592850|FG000|Completed Study Medication|Death|2|||
25278714|NCT01025817|50592851|FG001|Completed Study Medication|Death|2|||
25278715|NCT01025817|50592850|FG000|Completed Study Medication|Abnormal lab values|0|||
25278716|NCT01025817|50592851|FG001|Completed Study Medication|Abnormal lab values|2|||
25278717|NCT01025817|50592850|FG000|Completed Study Medication|Subject no longer required study drug|0|||
25278718|NCT01025817|50592851|FG001|Completed Study Medication|Subject no longer required study drug|1|||
25278719|NCT01025817|50592850|FG000|Completed Study Medication|Lost to Follow-up|0|||
25278720|NCT01025817|50592851|FG001|Completed Study Medication|Lost to Follow-up|1|||
25278721|NCT01025817|50592850|FG000|Completed Study|Withdrawal by Subject|8|||
25278722|NCT01025817|50592851|FG001|Completed Study|Withdrawal by Subject|16|||
25278723|NCT01025817|50592850|FG000|Completed Study|Death|6|||
25278724|NCT01025817|50592851|FG001|Completed Study|Death|5|||
25278725|NCT01025817|50592850|FG000|Completed Study|Missing|2|||
25278726|NCT01025817|50592851|FG001|Completed Study|Missing|0|||
25278727|NCT01025817|50592850|FG000|Completed Study|Lost to Follow-up|0|||
25278728|NCT01025817|50592851|FG001|Completed Study|Lost to Follow-up|1|||
25278729|NCT00939640|50592857|FG000|Overall Study|Physician Decision|1|||
25278730|NCT01218113|50592869|FG000|Overall Study|Withdrawal by Subject|1|||
25278731|NCT01218113|50592870|FG001|Overall Study|Withdrawal by Subject|0|||
25278732|NCT01218113|50592871|FG002|Overall Study|Withdrawal by Subject|1|||
25278733|NCT01218113|50592869|FG000|Overall Study|Lost to Follow-up|4|||
25278734|NCT01218113|50592870|FG001|Overall Study|Lost to Follow-up|1|||
25278735|NCT01218113|50592871|FG002|Overall Study|Lost to Follow-up|4|||
25278736|NCT01218113|50592869|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
25278737|NCT01218113|50592870|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
25278738|NCT01218113|50592871|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
25278739|NCT03873493|50592886|FG000|Overall Study|Withdrawal by Subject|1|||
25278740|NCT03873493|50592886|FG000|Overall Study|Death|9|||
25278741|NCT03873493|50592886|FG000|Overall Study|Lost to Follow-up|1|||
25278742|NCT03873493|50592886|FG000|Overall Study|Study Terminated by Sponsor|1|||
25278743|NCT03873493|50592886|FG000|Overall Study|Other|2|||
25278744|NCT00939484|50592906|FG000|Overall Study|Progression/Relapse|8|||
25278745|NCT00939484|50592907|FG001|Overall Study|Progression/Relapse|20|||
25278746|NCT00939484|50592908|FG002|Overall Study|Progression/Relapse|3|||
25278747|NCT01010217|50592923|FG000|Overall Study|Lost to Follow-up|4|||
25278748|NCT01010217|50592924|FG001|Overall Study|Lost to Follow-up|5|||
25278749|NCT01010217|50592925|FG002|Overall Study|Lost to Follow-up|1|||
25278750|NCT01010217|50592926|FG003|Overall Study|Lost to Follow-up|0|||
25278751|NCT01010217|50592927|FG004|Overall Study|Lost to Follow-up|0|||
25278752|NCT01010217|50592923|FG000|Overall Study|Withdrawal by Subject|1|||
25278753|NCT01010217|50592924|FG001|Overall Study|Withdrawal by Subject|0|||
25278754|NCT01010217|50592925|FG002|Overall Study|Withdrawal by Subject|0|||
25278755|NCT01010217|50592926|FG003|Overall Study|Withdrawal by Subject|0|||
25278756|NCT01010217|50592927|FG004|Overall Study|Withdrawal by Subject|0|||
25278757|NCT01010217|50592923|FG000|Overall Study|Physician Decision|0|||
25278758|NCT01010217|50592924|FG001|Overall Study|Physician Decision|0|||
25278759|NCT01010217|50592925|FG002|Overall Study|Physician Decision|0|||
25189724|NCT04178967|50346634|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
25278760|NCT01010217|50592926|FG003|Overall Study|Physician Decision|6|||
25278761|NCT01010217|50592927|FG004|Overall Study|Physician Decision|3|||
25278762|NCT01217957|50592944|FG000|Phase 1|Withdrawal by Patient|1|||
25278763|NCT01217957|50592945|FG001|Phase 1|Withdrawal by Patient|0|||
25278764|NCT01217957|50592946|FG002|Phase 1|Withdrawal by Patient|1|||
25278765|NCT01217957|50592947|FG003|Phase 1|Withdrawal by Patient|1|||
25278766|NCT01217957|50592948|FG004|Phase 1|Withdrawal by Patient|0|||
25278767|NCT01217957|50592944|FG000|Phase 2|Withdrawal by Patient|0|||
25278768|NCT01217957|50592945|FG001|Phase 2|Withdrawal by Patient|0|||
25278769|NCT01217957|50592946|FG002|Phase 2|Withdrawal by Patient|0|||
25278770|NCT01217957|50592947|FG003|Phase 2|Withdrawal by Patient|0|||
25278771|NCT01217957|50592948|FG004|Phase 2|Withdrawal by Patient|1|||
25278772|NCT00939094|50592971|FG000|Overall Study|Adverse Event|9|||
25278773|NCT00939094|50592972|FG001|Overall Study|Adverse Event|0|||
25278774|NCT00939094|50592971|FG000|Overall Study|Withdrawal by Subject|1|||
25278775|NCT00939094|50592972|FG001|Overall Study|Withdrawal by Subject|6|||
25278776|NCT00939094|50592971|FG000|Overall Study|Lost to Follow-up|1|||
25278777|NCT00939094|50592972|FG001|Overall Study|Lost to Follow-up|1|||
25278778|NCT00939094|50592971|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
25278779|NCT00939094|50592972|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
25278780|NCT00939094|50592971|FG000|Overall Study|Severe non-compliance to protocol|0|||
25278781|NCT00939094|50592972|FG001|Overall Study|Severe non-compliance to protocol|1|||
25278782|NCT00939094|50592971|FG000|Overall Study|Study stopped by sponsor|0|||
25278783|NCT00939094|50592972|FG001|Overall Study|Study stopped by sponsor|2|||
25278784|NCT00939094|50592971|FG000|Overall Study|Abnormal ECG findings|1|||
25278785|NCT00939094|50592972|FG001|Overall Study|Abnormal ECG findings|0|||
25278786|NCT01217801|50592980|FG000|Period 1|Protocol Violation|1|||
25278787|NCT01217801|50592981|FG001|Period 1|Protocol Violation|1|||
25278788|NCT01217801|50592980|FG000|Period 1|Withdrawal by Subject|0|||
25278789|NCT01217801|50592981|FG001|Period 1|Withdrawal by Subject|1|||
25278790|NCT00935818|50592989|FG000|Overall Study|Withdrawal by Subject|45|||
25278791|NCT00935818|50592990|FG001|Overall Study|Withdrawal by Subject|50|||
25278792|NCT00935818|50592989|FG000|Overall Study|Lost to Follow-up|40|||
25278793|NCT00935818|50592990|FG001|Overall Study|Lost to Follow-up|42|||
25278794|NCT00935818|50592989|FG000|Overall Study|Adverse Event|6|||
25278795|NCT00935818|50592990|FG001|Overall Study|Adverse Event|7|||
25278796|NCT00935818|50592989|FG000|Overall Study|Physician Decision|0|||
25189725|NCT04178967|50346635|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
25189726|NCT04178967|50346636|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
25189727|NCT04178967|50346637|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
25189728|NCT04178967|50346638|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
25189729|NCT04178967|50346639|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
25189730|NCT04163900|50346661|FG000|Overall Study|Radiological disease progression|112|||
25189731|NCT04163900|50346662|FG001|Overall Study|Radiological disease progression|127|||
25189732|NCT04163900|50346661|FG000|Overall Study|Study closure|98|||
25189733|NCT04163900|50346662|FG001|Overall Study|Study closure|133|||
25189734|NCT04163900|50346661|FG000|Overall Study|Adverse Event|78|||
25189735|NCT04163900|50346662|FG001|Overall Study|Adverse Event|32|||
25189736|NCT04163900|50346661|FG000|Overall Study|Withdrawal by Subject|37|||
25189737|NCT04163900|50346662|FG001|Overall Study|Withdrawal by Subject|34|||
25189738|NCT04163900|50346661|FG000|Overall Study|Death|29|||
25189739|NCT04163900|50346662|FG001|Overall Study|Death|16|||
25189740|NCT04163900|50346661|FG000|Overall Study|Physician Decision|17|||
25189741|NCT04163900|50346662|FG001|Overall Study|Physician Decision|25|||
25189742|NCT04163900|50346661|FG000|Overall Study|Clinical disease progression|14|||
25189743|NCT04163900|50346662|FG001|Overall Study|Clinical disease progression|13|||
25278797|NCT00935818|50592990|FG001|Overall Study|Physician Decision|1|||
25278798|NCT01216319|50592996|FG000|Overall Study|Lost to Follow-up|2|||
25278799|NCT01216319|50592996|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
25278800|NCT00936208|50593002|FG000|Overall Study|Protocol Violation|37|||
25278801|NCT00936208|50593003|FG001|Overall Study|Protocol Violation|22|||
25278802|NCT01216163|50593012|FG000|Overall Study|Withdrawal by Subject|1|||
25278803|NCT01216163|50593013|FG001|Overall Study|Withdrawal by Subject|1|||
25278804|NCT01216163|50593014|FG002|Overall Study|Withdrawal by Subject|0|||
25278805|NCT00933244|50593025|FG000|Overall Study|Withdrawal by Subject|5|||
25278806|NCT00933244|50593026|FG001|Overall Study|Withdrawal by Subject|1|||
25189744|NCT04163900|50346661|FG000|Overall Study|Protocol Violation|3|||
25189745|NCT04163900|50346662|FG001|Overall Study|Protocol Violation|4|||
25189746|NCT04163900|50346661|FG000|Overall Study|Lost to Follow-up|0|||
25278807|NCT00933244|50593027|FG002|Overall Study|Withdrawal by Subject|3|||
25278808|NCT00930046|50593037|FG000|Overall Study|Wound catheter malfunctioned|1|||
25278809|NCT00930046|50593038|FG001|Overall Study|Wound catheter malfunctioned|2|||
25278810|NCT00935584|50593046|FG000|Overall Study|Withdrawal by Subject|9|||
25278811|NCT00935584|50593047|FG001|Overall Study|Withdrawal by Subject|0|||
25278812|NCT00935584|50593046|FG000|Overall Study|Death|3|||
25278813|NCT00935584|50593047|FG001|Overall Study|Death|0|||
25278814|NCT00935584|50593046|FG000|Overall Study|Lost to Follow-up|8|||
25278815|NCT00935584|50593047|FG001|Overall Study|Lost to Follow-up|0|||
25278816|NCT00935584|50593046|FG000|Overall Study|No show|9|||
25278817|NCT00935584|50593047|FG001|Overall Study|No show|0|||
25278818|NCT00935584|50593046|FG000|Overall Study|Relocated|3|||
25278819|NCT00935584|50593047|FG001|Overall Study|Relocated|0|||
25278820|NCT00935584|50593046|FG000|Overall Study|Patient changed provider|3|||
25278821|NCT00935584|50593047|FG001|Overall Study|Patient changed provider|0|||
24969151|NCT00132678|50058655|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
25278822|NCT00935584|50593046|FG000|Overall Study|Provider dropped out of study|14|||
25278823|NCT00935584|50593047|FG001|Overall Study|Provider dropped out of study|4|||
25278824|NCT01215851|50593057|FG000|Treatment Period|Adverse Event|1|||
25278825|NCT01215851|50593058|FG001|Treatment Period|Adverse Event|1|||
25278826|NCT01215851|50593059|FG002|Treatment Period|Adverse Event|1|||
25278827|NCT01215851|50593060|FG003|Treatment Period|Adverse Event|3|||
25278828|NCT01215851|50593061|FG004|Treatment Period|Adverse Event|0|||
25278829|NCT01215851|50593062|FG005|Treatment Period|Adverse Event|1|||
25278830|NCT01215851|50593057|FG000|Follow up Period|Lost to Follow-up|0|||
25278831|NCT01215851|50593058|FG001|Follow up Period|Lost to Follow-up|0|||
25278832|NCT01215851|50593059|FG002|Follow up Period|Lost to Follow-up|0|||
25278833|NCT01215851|50593060|FG003|Follow up Period|Lost to Follow-up|0|||
25278834|NCT01215851|50593061|FG004|Follow up Period|Lost to Follow-up|0|||
25278835|NCT01215851|50593062|FG005|Follow up Period|Lost to Follow-up|1|||
25278836|NCT00933166|50593077|FG000|Overall Study|Lost to Follow-up|4|||
25278837|NCT00933166|50593077|FG000|Overall Study|Lack of Efficacy|9|||
25278838|NCT00933166|50593077|FG000|Overall Study|Unavailable|4|||
25278839|NCT00933166|50593077|FG000|Overall Study|Withdrawal by Subject|1|||
25278840|NCT00935272|50593083|FG000|Overall Study|Lost to Follow-up|10|||
25278841|NCT00935272|50593084|FG001|Overall Study|Lost to Follow-up|3|||
25278842|NCT00935272|50593083|FG000|Overall Study|Withdrawal by Subject|8|||
25278843|NCT00935272|50593084|FG001|Overall Study|Withdrawal by Subject|2|||
25278844|NCT00935272|50593083|FG000|Overall Study|Physician Decision|1|||
25278845|NCT00935272|50593084|FG001|Overall Study|Physician Decision|0|||
25278846|NCT00935272|50593083|FG000|Overall Study|Protocol Violation|0|||
25278847|NCT00935272|50593084|FG001|Overall Study|Protocol Violation|1|||
25278848|NCT01010061|50593093|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
25278849|NCT01010061|50593094|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
25278850|NCT01010061|50593093|FG000|Overall Study|Disease Progression|2|||
25278851|NCT01010061|50593094|FG001|Overall Study|Disease Progression|8|||
25278852|NCT01010061|50593093|FG000|Overall Study|Withdrew Consent|5|||
25278853|NCT01010061|50593094|FG001|Overall Study|Withdrew Consent|1|||
25278854|NCT01010061|50593093|FG000|Overall Study|Death|3|||
25278855|NCT01010061|50593094|FG001|Overall Study|Death|6|||
25278856|NCT01010061|50593093|FG000|Overall Study|Administrative/Other|0|||
25278857|NCT01010061|50593094|FG001|Overall Study|Administrative/Other|1|||
24969152|NCT00132678|50058656|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
24969153|NCT00132678|50058654|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
25278858|NCT01010061|50593093|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
25278859|NCT01010061|50593094|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
25278860|NCT01010061|50593093|FG000|Overall Study|Insufficient Therapeutic Response|1|||
25278861|NCT01010061|50593094|FG001|Overall Study|Insufficient Therapeutic Response|5|||
25278862|NCT01010061|50593093|FG000|Overall Study|Violation of Selection Criteria|0|||
25278863|NCT01010061|50593094|FG001|Overall Study|Violation of Selection Criteria|1|||
25278864|NCT01010061|50593093|FG000|Overall Study|Did Not Receive Treatment|2|||
25278865|NCT01010061|50593094|FG001|Overall Study|Did Not Receive Treatment|2|||
25278866|NCT00929734|50593114|FG000|Overall Study|Lost to Follow-up|2|||
25278867|NCT00929734|50593115|FG001|Overall Study|Lost to Follow-up|1|||
25278868|NCT00929734|50593114|FG000|Overall Study|Withdrawal by Subject|0|||
25278869|NCT00929734|50593115|FG001|Overall Study|Withdrawal by Subject|2|||
25278870|NCT01013883|50593123|FG000|Overall Study|Lost to Follow-up|2|||
25278871|NCT01013883|50593124|FG001|Overall Study|Lost to Follow-up|2|||
25278872|NCT01009983|50593130|FG000|Overall Study|necessary scans not completed|1|||
25278873|NCT01215227|50593144|FG000|Overall Study|Adverse Event|11|||
25278874|NCT01215227|50593145|FG001|Overall Study|Adverse Event|11|||
25278875|NCT01215227|50593146|FG002|Overall Study|Adverse Event|4|||
25278876|NCT01215227|50593147|FG003|Overall Study|Adverse Event|8|||
25278877|NCT01215227|50593148|FG004|Overall Study|Adverse Event|7|||
25278878|NCT01215227|50593149|FG005|Overall Study|Adverse Event|6|||
25278879|NCT01215227|50593144|FG000|Overall Study|Treatment Failure|8|||
25278880|NCT01215227|50593145|FG001|Overall Study|Treatment Failure|4|||
25278881|NCT01215227|50593146|FG002|Overall Study|Treatment Failure|1|||
25278882|NCT01215227|50593147|FG003|Overall Study|Treatment Failure|5|||
25278883|NCT01215227|50593148|FG004|Overall Study|Treatment Failure|1|||
25278884|NCT01215227|50593149|FG005|Overall Study|Treatment Failure|1|||
25278885|NCT01215227|50593144|FG000|Overall Study|Lost to Follow-up|1|||
25278886|NCT01215227|50593145|FG001|Overall Study|Lost to Follow-up|4|||
25278887|NCT01215227|50593146|FG002|Overall Study|Lost to Follow-up|1|||
25278888|NCT01215227|50593147|FG003|Overall Study|Lost to Follow-up|1|||
25278889|NCT01215227|50593148|FG004|Overall Study|Lost to Follow-up|1|||
25278890|NCT01215227|50593149|FG005|Overall Study|Lost to Follow-up|2|||
25278891|NCT01215227|50593144|FG000|Overall Study|Subject Withdrew Consent|16|||
25278892|NCT01215227|50593145|FG001|Overall Study|Subject Withdrew Consent|20|||
25278893|NCT01215227|50593146|FG002|Overall Study|Subject Withdrew Consent|7|||
25278894|NCT01215227|50593147|FG003|Overall Study|Subject Withdrew Consent|10|||
25278895|NCT01215227|50593148|FG004|Overall Study|Subject Withdrew Consent|11|||
25278896|NCT01215227|50593149|FG005|Overall Study|Subject Withdrew Consent|8|||
25278897|NCT01215227|50593144|FG000|Overall Study|Non-Compliance With Protocol|2|||
25278898|NCT01215227|50593145|FG001|Overall Study|Non-Compliance With Protocol|6|||
25278899|NCT01215227|50593146|FG002|Overall Study|Non-Compliance With Protocol|1|||
25278900|NCT01215227|50593147|FG003|Overall Study|Non-Compliance With Protocol|0|||
25278901|NCT01215227|50593148|FG004|Overall Study|Non-Compliance With Protocol|0|||
25278902|NCT01215227|50593149|FG005|Overall Study|Non-Compliance With Protocol|0|||
25278903|NCT01215227|50593144|FG000|Overall Study|Administrative|83|||
25278904|NCT01215227|50593145|FG001|Overall Study|Administrative|73|||
25278905|NCT01215227|50593146|FG002|Overall Study|Administrative|42|||
25278906|NCT01215227|50593147|FG003|Overall Study|Administrative|24|||
25278907|NCT01215227|50593148|FG004|Overall Study|Administrative|28|||
25278908|NCT01215227|50593149|FG005|Overall Study|Administrative|40|||
25278909|NCT01215227|50593144|FG000|Overall Study|Missing Status|0|||
24969154|NCT00132678|50058655|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
25168972|NCT01855919|50299485|FG000|Overall Study|Lack of Efficacy|1|||
25189747|NCT04163900|50346662|FG001|Overall Study|Lost to Follow-up|1|||
25189748|NCT04161495|50346670|FG000|Overall Study|Withdrawal by Subject|3|||
25189749|NCT04161495|50346671|FG001|Overall Study|Withdrawal by Subject|0|||
25189750|NCT04161495|50346670|FG000|Overall Study|Protocol Violation|1|||
25189751|NCT04161495|50346671|FG001|Overall Study|Protocol Violation|0|||
25189752|NCT04161495|50346670|FG000|Overall Study|Prohibited concomitant medication|3|||
25189753|NCT04161495|50346671|FG001|Overall Study|Prohibited concomitant medication|0|||
25189754|NCT04161495|50346670|FG000|Overall Study|Adverse Event|1|||
25189755|NCT04161495|50346671|FG001|Overall Study|Adverse Event|0|||
25189756|NCT04161495|50346670|FG000|Overall Study|Other - Unspecified|1|||
25189757|NCT04161495|50346671|FG001|Overall Study|Other - Unspecified|0|||
25189758|NCT04161495|50346670|FG000|Overall Study|Death|0|||
25189759|NCT04161495|50346671|FG001|Overall Study|Death|1|||
25189760|NCT04108000|50346700|FG000|Overall Study|Death of patient|1|||
25189761|NCT04108000|50346701|FG001|Overall Study|Death of patient|0|||
25189762|NCT04108000|50346702|FG002|Overall Study|Death of patient|1|||
25189763|NCT04108000|50346703|FG003|Overall Study|Death of patient|0|||
25189764|NCT04108000|50346700|FG000|Overall Study|Withdrawal by Subject|2|||
25189765|NCT04108000|50346701|FG001|Overall Study|Withdrawal by Subject|2|||
25189766|NCT04108000|50346702|FG002|Overall Study|Withdrawal by Subject|0|||
25189767|NCT04108000|50346703|FG003|Overall Study|Withdrawal by Subject|0|||
25189768|NCT04108000|50346700|FG000|Overall Study|Death of surrogate partner|0|||
25189769|NCT04108000|50346701|FG001|Overall Study|Death of surrogate partner|1|||
25189770|NCT04108000|50346702|FG002|Overall Study|Death of surrogate partner|0|||
25189771|NCT04108000|50346703|FG003|Overall Study|Death of surrogate partner|1|||
25189772|NCT04098068|50346717|FG000|Overall Study|Disease Progression|7|||
25189773|NCT04098068|50346717|FG000|Overall Study|Withdrawal by Subject|2|||
25189774|NCT04098068|50346717|FG000|Overall Study|New Cancer Diagnosis|1|||
25189775|NCT03945266|50346723|FG000|Overall Study|Withdrawal by Subject|1|||
25189776|NCT03945266|50346724|FG001|Overall Study|Withdrawal by Subject|0|||
25189777|NCT03945266|50346723|FG000|Overall Study|Miscarriage|0|||
25189778|NCT03945266|50346724|FG001|Overall Study|Miscarriage|2|||
25189779|NCT03945266|50346723|FG000|Overall Study|Lost to Follow-up|1|||
25189780|NCT03945266|50346724|FG001|Overall Study|Lost to Follow-up|0|||
25278910|NCT01215227|50593145|FG001|Overall Study|Missing Status|1|||
25278911|NCT01215227|50593146|FG002|Overall Study|Missing Status|0|||
25189781|NCT03916484|50346738|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
25189782|NCT03916484|50346739|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
25189783|NCT03916484|50346740|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
25189784|NCT03916484|50346741|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
25189785|NCT03916484|50346738|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
25189786|NCT03916484|50346739|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
25278912|NCT01215227|50593147|FG003|Overall Study|Missing Status|0|||
25278913|NCT01215227|50593148|FG004|Overall Study|Missing Status|0|||
25278914|NCT01215227|50593149|FG005|Overall Study|Missing Status|0|||
25278915|NCT01215227|50593144|FG000|Overall Study|Randomized but not treated|0|||
25278916|NCT01215227|50593145|FG001|Overall Study|Randomized but not treated|0|||
25278917|NCT01215227|50593146|FG002|Overall Study|Randomized but not treated|1|||
25278918|NCT01215227|50593147|FG003|Overall Study|Randomized but not treated|1|||
25278919|NCT01215227|50593148|FG004|Overall Study|Randomized but not treated|0|||
25278920|NCT01215227|50593149|FG005|Overall Study|Randomized but not treated|1|||
25278921|NCT01009515|50593163|FG000|Overall Study|Withdrawal by Subject|3|||
25278922|NCT01214915|50593167|FG000|Overall Study|Adverse Event|8|||
25278923|NCT01214915|50593167|FG000|Overall Study|Lack of Efficacy|3|||
25278924|NCT01009281|50593171|FG000|Overall Study|Administrative problems|7|||
25278925|NCT01009203|50593175|FG000|Overall Study|Withdrawal by Subject|1|||
25278926|NCT01009203|50593175|FG000|Overall Study|Adverse Event|5|||
25278927|NCT01009203|50593175|FG000|Overall Study|Treatment-unrelated death|1|||
25278928|NCT01009047|50593181|FG000|Overall Study|Adverse Event|5|||
25278929|NCT01009047|50593182|FG001|Overall Study|Adverse Event|0|||
25278930|NCT01009047|50593181|FG000|Overall Study|Lost to Follow-up|0|||
25278931|NCT01009047|50593182|FG001|Overall Study|Lost to Follow-up|2|||
25278932|NCT01009047|50593181|FG000|Overall Study|Lack of Efficacy|4|||
25278933|NCT01009047|50593182|FG001|Overall Study|Lack of Efficacy|11|||
25278934|NCT01009047|50593181|FG000|Overall Study|Withdrawal by consent|16|||
25278935|NCT01009047|50593182|FG001|Overall Study|Withdrawal by consent|11|||
25278936|NCT01009047|50593181|FG000|Overall Study|Other|3|||
25278937|NCT01009047|50593182|FG001|Overall Study|Other|2|||
25278938|NCT01025193|50593188|FG000|Overall Study|Protocol Violation|1|||
25278939|NCT01025193|50593188|FG000|Overall Study|Adverse Event|3|||
25278940|NCT01025037|50593196|FG000|Overall Study|Adverse Event|3|||
25278941|NCT01025037|50593196|FG000|Overall Study|Lost to Follow-up|7|||
25278942|NCT01025037|50593196|FG000|Overall Study|Withdrawal by Subject|1|||
25278943|NCT01214837|50593203|FG000|Overall Study|Death|0|||
25278944|NCT01214837|50593204|FG001|Overall Study|Death|0|||
25278945|NCT01214837|50593205|FG002|Overall Study|Death|1|||
25278946|NCT01214837|50593203|FG000|Overall Study|Adverse Event|1|||
25278947|NCT01214837|50593204|FG001|Overall Study|Adverse Event|2|||
25278948|NCT01214837|50593205|FG002|Overall Study|Adverse Event|1|||
25278949|NCT01214837|50593203|FG000|Overall Study|Withdrawal by Subject|27|||
25278950|NCT01214837|50593204|FG001|Overall Study|Withdrawal by Subject|36|||
25278951|NCT01214837|50593205|FG002|Overall Study|Withdrawal by Subject|28|||
25278952|NCT01214837|50593203|FG000|Overall Study|Lost to Follow-up|20|||
25278953|NCT01214837|50593204|FG001|Overall Study|Lost to Follow-up|15|||
25278954|NCT01214837|50593205|FG002|Overall Study|Lost to Follow-up|21|||
25278955|NCT01214837|50593203|FG000|Overall Study|Inappropriate Enrolment|0|||
25278956|NCT01214837|50593204|FG001|Overall Study|Inappropriate Enrolment|1|||
25278957|NCT01214837|50593205|FG002|Overall Study|Inappropriate Enrolment|2|||
25278958|NCT01214837|50593203|FG000|Overall Study|Administrative Reason|2|||
25278959|NCT01214837|50593204|FG001|Overall Study|Administrative Reason|6|||
25278960|NCT01214837|50593205|FG002|Overall Study|Administrative Reason|4|||
25278961|NCT01214837|50593203|FG000|Overall Study|Protocol Violation|3|||
25278962|NCT01214837|50593204|FG001|Overall Study|Protocol Violation|1|||
25278963|NCT01214837|50593205|FG002|Overall Study|Protocol Violation|5|||
25278964|NCT01214837|50593203|FG000|Overall Study|Unable to Classify|1|||
25278965|NCT01214837|50593204|FG001|Overall Study|Unable to Classify|3|||
25278966|NCT01214837|50593205|FG002|Overall Study|Unable to Classify|0|||
25278967|NCT01024959|50593214|FG000|Overall Study|ineligible|12|||
25278968|NCT01024959|50593214|FG000|Overall Study|results not evaluable|12|||
25278969|NCT01024959|50593214|FG000|Overall Study|missing results required for analysis|17|||
25278970|NCT03672175|50593226|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
25278971|NCT03672175|50593227|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
25278972|NCT03672175|50593228|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
25189787|NCT03916484|50346740|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
25189788|NCT03916484|50346741|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
25189789|NCT03769311|50346756|FG000|Overall Study|Withdrawal by Subject|1|||
25189790|NCT03738566|50346764|FG000|Initial Study Phase|Withdrawal by Subject|1|||
25189791|NCT03738566|50346765|FG001|Initial Study Phase|Withdrawal by Subject|1|||
25189792|NCT03738566|50346766|FG002|Initial Study Phase|Withdrawal by Subject|2|||
25189793|NCT03738566|50346767|FG003|Initial Study Phase|Withdrawal by Subject|0|||
25189794|NCT03738566|50346764|FG000|Initial Study Phase|Death|0|||
25189795|NCT03738566|50346765|FG001|Initial Study Phase|Death|1|||
25189796|NCT03738566|50346766|FG002|Initial Study Phase|Death|0|||
25189797|NCT03738566|50346767|FG003|Initial Study Phase|Death|0|||
25278973|NCT03672175|50593226|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
25278974|NCT03672175|50593227|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
25278975|NCT03672175|50593228|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
25278976|NCT03672175|50593226|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
25278977|NCT03672175|50593227|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
25278978|NCT03672175|50593228|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
25278979|NCT03672175|50593226|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
25189798|NCT03738566|50346764|FG000|Initial Study Phase|Treatment failure|5|||
25189799|NCT03738566|50346765|FG001|Initial Study Phase|Treatment failure|0|||
25278980|NCT03672175|50593227|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
25278981|NCT03672175|50593228|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
25278982|NCT03672175|50593226|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
25278983|NCT03672175|50593227|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
25278984|NCT03672175|50593228|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
25278985|NCT03672175|50593226|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
25278986|NCT03672175|50593227|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
25278987|NCT03672175|50593228|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
25278988|NCT03672175|50593226|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
25278989|NCT03672175|50593227|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
25278990|NCT03672175|50593228|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
25278991|NCT03672175|50593226|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
25278992|NCT03672175|50593227|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
25278993|NCT03672175|50593228|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
25278994|NCT03672175|50593226|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
25278995|NCT03672175|50593227|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
25278996|NCT03672175|50593228|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
24969155|NCT00132678|50058656|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
24969156|NCT00132678|50058654|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
24969157|NCT00132678|50058655|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
24969158|NCT00132678|50058656|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
24969159|NCT00132678|50058654|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
24969160|NCT00132678|50058655|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
24969161|NCT00132678|50058656|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
24969162|NCT00132678|50058654|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
24969163|NCT00132678|50058655|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
24969164|NCT00132678|50058656|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
24969165|NCT00132678|50058654|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
24969166|NCT00132678|50058655|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
24969167|NCT00132678|50058656|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
24969168|NCT00132678|50058654|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
24969169|NCT00132678|50058655|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
25278997|NCT03672175|50593226|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
24969170|NCT00132678|50058656|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
24969171|NCT00132678|50058654|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
25069575|NCT01369355|50175452|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
25069576|NCT01369355|50175453|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
25069577|NCT01369355|50175454|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
25069578|NCT01369355|50175446|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
25069579|NCT01369355|50175447|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
25069580|NCT01369355|50175448|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
25069581|NCT01369355|50175449|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
25069582|NCT01369355|50175450|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
25168973|NCT01855919|50299486|FG001|Overall Study|Lack of Efficacy|3|||
25168974|NCT01855919|50299485|FG000|Overall Study|Withdrawal by Subject|4|||
25168975|NCT01855919|50299486|FG001|Overall Study|Withdrawal by Subject|10|||
25168976|NCT01855919|50299485|FG000|Overall Study|Entry Criteria Not Met|1|||
25189800|NCT03738566|50346766|FG002|Initial Study Phase|Treatment failure|0|||
25189801|NCT03738566|50346767|FG003|Initial Study Phase|Treatment failure|0|||
25278998|NCT03672175|50593227|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
25278999|NCT03672175|50593228|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
25189802|NCT03738566|50346764|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
25189803|NCT03738566|50346765|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
25189804|NCT03738566|50346766|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
25189805|NCT03738566|50346767|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
25189806|NCT03692052|50346797|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
25279000|NCT03672175|50593226|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
25279001|NCT03672175|50593227|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
25279002|NCT03672175|50593228|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
25189807|NCT03692052|50346797|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
25189808|NCT03692052|50346797|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
25189809|NCT03692052|50346797|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
25189810|NCT03533751|50346806|FG000|Overall Study|Withdrawal by Subject|12|||
25189811|NCT03533751|50346807|FG001|Overall Study|Withdrawal by Subject|6|||
25189812|NCT03533751|50346808|FG002|Overall Study|Withdrawal by Subject|11|||
25279003|NCT03672175|50593226|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
25279004|NCT03672175|50593227|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
25279005|NCT03672175|50593228|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
25279006|NCT01008423|50593256|FG000|Overall Study|Adverse Event|13|||
25279007|NCT01008423|50593257|FG001|Overall Study|Adverse Event|6|||
25279008|NCT01008423|50593256|FG000|Overall Study|Withdrawal by Subject|4|||
25279009|NCT01008423|50593257|FG001|Overall Study|Withdrawal by Subject|7|||
25279010|NCT01008423|50593256|FG000|Overall Study|Lost to Follow-up|0|||
25279011|NCT01008423|50593257|FG001|Overall Study|Lost to Follow-up|2|||
25279012|NCT01008423|50593256|FG000|Overall Study|Low Cortisol|0|||
25279013|NCT01008423|50593257|FG001|Overall Study|Low Cortisol|1|||
25279014|NCT01008423|50593256|FG000|Overall Study|Lack of Efficacy|0|||
25279015|NCT01008423|50593257|FG001|Overall Study|Lack of Efficacy|5|||
25279016|NCT01008423|50593256|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
25279017|NCT01008423|50593257|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
25279018|NCT01008423|50593256|FG000|Overall Study|Personal Conflict|1|||
25279019|NCT01008423|50593257|FG001|Overall Study|Personal Conflict|0|||
25279020|NCT01008423|50593256|FG000|Overall Study|Other|0|||
25279021|NCT01008423|50593257|FG001|Overall Study|Other|1|||
25279022|NCT01012947|50593268|FG000|Overall Study|Lost to Follow-up|131|||
25279023|NCT01012947|50593269|FG001|Overall Study|Lost to Follow-up|135|||
25279024|NCT01012947|50593270|FG002|Overall Study|Lost to Follow-up|130|||
25279025|NCT01012947|50593271|FG003|Overall Study|Lost to Follow-up|118|||
25279026|NCT01012947|50593272|FG004|Overall Study|Lost to Follow-up|142|||
25279027|NCT01214603|50593304|FG000|Overall Study|Adverse Event|0|||
25279028|NCT01214603|50593305|FG001|Overall Study|Adverse Event|0|||
25279029|NCT01214603|50593306|FG002|Overall Study|Adverse Event|1|||
25279030|NCT01214603|50593304|FG000|Overall Study|Death|1|||
25279031|NCT01214603|50593305|FG001|Overall Study|Death|0|||
25279032|NCT01214603|50593306|FG002|Overall Study|Death|0|||
25279033|NCT01214603|50593304|FG000|Overall Study|Progressive Disease|4|||
25279034|NCT01214603|50593305|FG001|Overall Study|Progressive Disease|1|||
25279035|NCT01214603|50593306|FG002|Overall Study|Progressive Disease|3|||
25279036|NCT01212185|50593317|FG000|Overall Study|Protocol Violation|2|||
25279037|NCT01212185|50593318|FG001|Overall Study|Protocol Violation|1|||
25279038|NCT01995175|50593324|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
25069583|NCT01369355|50175451|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
25189813|NCT03533751|50346809|FG003|Overall Study|Withdrawal by Subject|9|||
25189814|NCT03533751|50346810|FG004|Overall Study|Withdrawal by Subject|10|||
25189815|NCT03533751|50346806|FG000|Overall Study|Adverse Event|4|||
25189816|NCT03533751|50346807|FG001|Overall Study|Adverse Event|7|||
25189817|NCT03533751|50346808|FG002|Overall Study|Adverse Event|2|||
25189818|NCT03533751|50346809|FG003|Overall Study|Adverse Event|4|||
25189819|NCT03533751|50346810|FG004|Overall Study|Adverse Event|5|||
25189820|NCT03533751|50346806|FG000|Overall Study|Physician Decision|0|||
25189821|NCT03533751|50346807|FG001|Overall Study|Physician Decision|2|||
25189822|NCT03533751|50346808|FG002|Overall Study|Physician Decision|1|||
25189823|NCT03533751|50346809|FG003|Overall Study|Physician Decision|2|||
25189824|NCT03533751|50346810|FG004|Overall Study|Physician Decision|1|||
25189825|NCT03533751|50346806|FG000|Overall Study|Sponsor Decision|0|||
25189826|NCT03533751|50346807|FG001|Overall Study|Sponsor Decision|0|||
25189827|NCT03533751|50346808|FG002|Overall Study|Sponsor Decision|1|||
25189828|NCT03533751|50346809|FG003|Overall Study|Sponsor Decision|1|||
25189829|NCT03533751|50346810|FG004|Overall Study|Sponsor Decision|0|||
25189830|NCT03533751|50346806|FG000|Overall Study|Lost to Follow-up|3|||
25189831|NCT03533751|50346807|FG001|Overall Study|Lost to Follow-up|7|||
25279039|NCT01995175|50593324|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
25279040|NCT01995175|50593324|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
25279041|NCT01995175|50593324|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
25279042|NCT01995175|50593324|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
25279043|NCT01995175|50593324|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
25279044|NCT01995175|50593324|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
25279045|NCT01995175|50593324|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
25279046|NCT01995175|50593324|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
25279047|NCT02243605|50593404|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
25279048|NCT02243605|50593405|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
25279049|NCT02243605|50593404|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
25279050|NCT02243605|50593405|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
24969172|NCT00132678|50058655|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
24969173|NCT00132678|50058656|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
24969174|NCT00132678|50058654|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
25189832|NCT03533751|50346808|FG002|Overall Study|Lost to Follow-up|6|||
25189833|NCT03533751|50346809|FG003|Overall Study|Lost to Follow-up|4|||
25189834|NCT03533751|50346810|FG004|Overall Study|Lost to Follow-up|3|||
25189835|NCT03533751|50346806|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
25189836|NCT03533751|50346807|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
25189837|NCT03533751|50346808|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
24969175|NCT00132678|50058655|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
24969176|NCT00132678|50058656|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
24969177|NCT00132678|50058654|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
24969178|NCT00132678|50058655|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
24969179|NCT00132678|50058656|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
24969180|NCT00132678|50058654|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
24969181|NCT00132678|50058655|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
25189838|NCT03533751|50346809|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
25189839|NCT03533751|50346810|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
25189840|NCT03533751|50346806|FG000|Overall Study|Other|0|||
25189841|NCT03533751|50346807|FG001|Overall Study|Other|2|||
25189842|NCT03533751|50346808|FG002|Overall Study|Other|1|||
25189843|NCT03533751|50346809|FG003|Overall Study|Other|0|||
25189844|NCT03533751|50346810|FG004|Overall Study|Other|3|||
25189845|NCT04856917|50346829|FG000|Overall Study|Withdrawal by Subject|4|||
25189846|NCT04856917|50346830|FG001|Overall Study|Withdrawal by Subject|3|||
25189847|NCT04856917|50346831|FG002|Overall Study|Withdrawal by Subject|1|||
25189848|NCT04856917|50346829|FG000|Overall Study|Lost to Follow-up|3|||
25189849|NCT04856917|50346830|FG001|Overall Study|Lost to Follow-up|1|||
25189850|NCT04856917|50346831|FG002|Overall Study|Lost to Follow-up|1|||
25189851|NCT04856917|50346829|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
25189852|NCT04856917|50346830|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
25189853|NCT04856917|50346831|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
25189854|NCT04856917|50346829|FG000|Overall Study|Other|1|||
25189855|NCT04856917|50346830|FG001|Overall Study|Other|1|||
25189856|NCT04856917|50346831|FG002|Overall Study|Other|0|||
25189857|NCT04723394|50346860|FG000|Overall Study|Adverse Event|0|||
25189858|NCT04723394|50346861|FG001|Overall Study|Adverse Event|3|||
25189859|NCT04723394|50346860|FG000|Overall Study|Death|8|||
25189860|NCT04723394|50346861|FG001|Overall Study|Death|8|||
25189861|NCT04723394|50346860|FG000|Overall Study|Lost to Follow-up|20|||
25189862|NCT04723394|50346861|FG001|Overall Study|Lost to Follow-up|17|||
25189863|NCT04723394|50346860|FG000|Overall Study|Physician Decision|1|||
25189864|NCT04723394|50346861|FG001|Overall Study|Physician Decision|0|||
25189865|NCT04723394|50346860|FG000|Overall Study|Withdrawal by Subject|20|||
25189866|NCT04723394|50346861|FG001|Overall Study|Withdrawal by Subject|34|||
25189867|NCT04723394|50346860|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
25189868|NCT04723394|50346861|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
25189869|NCT04615247|50346879|FG000|Overall Study|Adverse Event|0|||
25189870|NCT04615247|50346880|FG001|Overall Study|Adverse Event|2|||
25189871|NCT04615247|50346879|FG000|Overall Study|Withdrawal by Subject|1|||
25189872|NCT04615247|50346880|FG001|Overall Study|Withdrawal by Subject|1|||
25189873|NCT04552132|50346901|FG000|Overall Study|Lost to Follow-up|4|||
25189874|NCT04552132|50346902|FG001|Overall Study|Lost to Follow-up|3|||
25189875|NCT04552132|50346901|FG000|Overall Study|Protocol Violation|1|||
25189876|NCT04552132|50346902|FG001|Overall Study|Protocol Violation|0|||
25189877|NCT04509076|50346910|FG000|Overall Study|Withdrawal by Subject|1|||
25189878|NCT04509076|50346911|FG001|Overall Study|Withdrawal by Subject|2|||
25189879|NCT04509076|50346910|FG000|Overall Study|Lost to Follow-up|1|||
25189880|NCT04509076|50346911|FG001|Overall Study|Lost to Follow-up|2|||
25189881|NCT04421456|50346920|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
25189882|NCT04421456|50346921|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
25189883|NCT04421456|50346922|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
25189884|NCT04421456|50346920|FG000|Randomized Treatment Period|Adverse Event|0|||
25189885|NCT04421456|50346921|FG001|Randomized Treatment Period|Adverse Event|1|||
25189886|NCT04421456|50346922|FG002|Randomized Treatment Period|Adverse Event|0|||
25189887|NCT04421456|50346920|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
25189888|NCT04421456|50346921|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
25189889|NCT04421456|50346922|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
25189890|NCT04421456|50346920|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
25189891|NCT04421456|50346921|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
25189892|NCT04421456|50346922|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
25189893|NCT04421456|50346920|FG000|Randomized Treatment Period|Participant non-compliance|1|||
25279051|NCT02243605|50593404|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
25279052|NCT02243605|50593405|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
25279053|NCT02243605|50593404|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
25279054|NCT02243605|50593405|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
25279055|NCT02243605|50593404|FG000|Stage 2 - Final Analysis Population|Progression|0|||
25279056|NCT02243605|50593405|FG001|Stage 2 - Final Analysis Population|Progression|1|||
25279057|NCT01752907|50593422|FG000|Overall Study|Withdrawal by Subject|4|||
25279058|NCT01752907|50593423|FG001|Overall Study|Withdrawal by Subject|10|||
25279059|NCT01752907|50593422|FG000|Overall Study|Lost to Follow-up|2|||
25279060|NCT01752907|50593423|FG001|Overall Study|Lost to Follow-up|1|||
25279061|NCT01752907|50593422|FG000|Overall Study|Decision by Sponsor|6|||
25279062|NCT01752907|50593423|FG001|Overall Study|Decision by Sponsor|9|||
25279063|NCT03439189|50593429|FG000|Overall Study|Protocol Violation|19|||
25279064|NCT03439189|50593429|FG000|Overall Study|Lack of Efficacy|63|||
25279065|NCT01211483|50593438|FG000|Phase 1b|Death|6|||
25279066|NCT01211483|50593439|FG001|Phase 1b|Death|0|||
25279067|NCT01211483|50593440|FG002|Phase 1b|Death|0|||
25279068|NCT01211483|50593441|FG003|Phase 1b|Death|0|||
25279069|NCT01211483|50593438|FG000|Phase 1b|Withdrawal by Subject|1|||
25279070|NCT01211483|50593439|FG001|Phase 1b|Withdrawal by Subject|0|||
25279071|NCT01211483|50593440|FG002|Phase 1b|Withdrawal by Subject|0|||
25279072|NCT01211483|50593441|FG003|Phase 1b|Withdrawal by Subject|0|||
25279073|NCT01211483|50593438|FG000|Phase 2|Lost to Follow-up|0|||
25279074|NCT01211483|50593439|FG001|Phase 2|Lost to Follow-up|1|||
25279075|NCT01211483|50593440|FG002|Phase 2|Lost to Follow-up|1|||
25279076|NCT01211483|50593441|FG003|Phase 2|Lost to Follow-up|2|||
25279077|NCT01211483|50593438|FG000|Phase 2|Death|0|||
25279078|NCT01211483|50593439|FG001|Phase 2|Death|64|||
25279079|NCT01211483|50593440|FG002|Phase 2|Death|53|||
25279080|NCT01211483|50593441|FG003|Phase 2|Death|53|||
25279081|NCT01211483|50593438|FG000|Phase 2|Withdrawal by Subject|0|||
25279082|NCT01211483|50593439|FG001|Phase 2|Withdrawal by Subject|1|||
25279083|NCT01211483|50593440|FG002|Phase 2|Withdrawal by Subject|10|||
25279084|NCT01211483|50593441|FG003|Phase 2|Withdrawal by Subject|5|||
25279085|NCT01211483|50593438|FG000|Phase 2|Study terminated by Sponsor|0|||
25279086|NCT01211483|50593439|FG001|Phase 2|Study terminated by Sponsor|6|||
25279087|NCT01211483|50593440|FG002|Phase 2|Study terminated by Sponsor|8|||
25279088|NCT01211483|50593441|FG003|Phase 2|Study terminated by Sponsor|11|||
25168977|NCT01855919|50299486|FG001|Overall Study|Entry Criteria Not Met|1|||
25279089|NCT01210001|50593458|FG000|Overall Study|Not treated|1|||
25279090|NCT01210001|50593459|FG001|Overall Study|Not treated|0|||
25279091|NCT01210001|50593460|FG002|Overall Study|Not treated|0|||
25279092|NCT01210001|50593458|FG000|Overall Study|Adverse Event|4|||
25279093|NCT01210001|50593459|FG001|Overall Study|Adverse Event|2|||
25279094|NCT01210001|50593460|FG002|Overall Study|Adverse Event|5|||
24969182|NCT00132678|50058656|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
24969183|NCT00132678|50058654|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
24969184|NCT00132678|50058655|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
24969185|NCT00132678|50058656|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
24969186|NCT00132678|50058654|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
24969187|NCT00132678|50058655|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
24969188|NCT00132678|50058656|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
24969189|NCT00101868|50058666|FG000|Overall Study|Death|10|||
24969190|NCT00101868|50058667|FG001|Overall Study|Death|10|||
24969191|NCT00101868|50058666|FG000|Overall Study|Withdrawal by Subject|8|||
25168978|NCT01855919|50299485|FG000|Overall Study|Protocol Violation|1|||
25279095|NCT01210001|50593458|FG000|Overall Study|Non compliant with protocol|2|||
25279096|NCT01210001|50593459|FG001|Overall Study|Non compliant with protocol|2|||
25279097|NCT01210001|50593460|FG002|Overall Study|Non compliant with protocol|3|||
25279098|NCT01210001|50593458|FG000|Overall Study|Lost to Follow-up|4|||
25279099|NCT01210001|50593459|FG001|Overall Study|Lost to Follow-up|3|||
25279100|NCT01210001|50593460|FG002|Overall Study|Lost to Follow-up|2|||
25279101|NCT01210001|50593458|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
25279102|NCT01210001|50593459|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
25279103|NCT01210001|50593460|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
25279104|NCT01210001|50593458|FG000|Overall Study|Other reason not defined above|2|||
25279105|NCT01210001|50593459|FG001|Overall Study|Other reason not defined above|2|||
25279106|NCT01210001|50593460|FG002|Overall Study|Other reason not defined above|1|||
25069584|NCT01369355|50175452|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
25069585|NCT01369355|50175453|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
25069586|NCT01369355|50175454|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
25069587|NCT01369355|50175446|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
25069588|NCT01369355|50175447|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
25069589|NCT01369355|50175448|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
25069590|NCT01369355|50175449|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
25069591|NCT01369355|50175450|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
25069592|NCT01369355|50175451|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
25069593|NCT01369355|50175452|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
25069594|NCT01369355|50175453|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
25069595|NCT01369355|50175454|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
25069596|NCT01369355|50175446|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
25069597|NCT01369355|50175447|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
25069598|NCT01369355|50175448|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
25069599|NCT01369355|50175449|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
25069600|NCT01369355|50175450|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
24969192|NCT00101868|50058667|FG001|Overall Study|Withdrawal by Subject|9|||
24969193|NCT00101868|50058666|FG000|Overall Study|Protocol Violation|3|||
25069601|NCT01369355|50175451|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
25069602|NCT01369355|50175452|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
25069603|NCT01369355|50175453|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
25069604|NCT01369355|50175454|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
25069605|NCT01369355|50175446|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
25069606|NCT01369355|50175447|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
25069607|NCT01369355|50175448|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
25189894|NCT04421456|50346921|FG001|Randomized Treatment Period|Participant non-compliance|1|||
25189895|NCT04421456|50346922|FG002|Randomized Treatment Period|Participant non-compliance|2|||
24969194|NCT00101868|50058667|FG001|Overall Study|Protocol Violation|0|||
24969195|NCT00101868|50058666|FG000|Overall Study|Lost to Follow-up|8|||
24969196|NCT00101868|50058667|FG001|Overall Study|Lost to Follow-up|13|||
24969197|NCT00101400|50058675|FG000|Survival Follow-Up|Alive|7|||
24969198|NCT03821064|50058679|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
24969199|NCT00141518|50058686|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
24969200|NCT00141518|50058687|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
24969201|NCT00141518|50058688|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
24969202|NCT00141518|50058686|FG000|Overall Study|Adverse Event|7|||
24969203|NCT00141518|50058687|FG001|Overall Study|Adverse Event|5|||
24969204|NCT00141518|50058688|FG002|Overall Study|Adverse Event|2|||
24969205|NCT00141518|50058686|FG000|Overall Study|Withdrawal by Subject|2|||
24969206|NCT00141518|50058687|FG001|Overall Study|Withdrawal by Subject|0|||
25069608|NCT01369355|50175449|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
25069609|NCT01369355|50175450|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
25189896|NCT04421456|50346920|FG000|Randomized Treatment Period|Other|0|||
25189897|NCT04421456|50346921|FG001|Randomized Treatment Period|Other|1|||
24969207|NCT00141518|50058688|FG002|Overall Study|Withdrawal by Subject|2|||
25189898|NCT04421456|50346922|FG002|Randomized Treatment Period|Other|3|||
25189899|NCT04341363|50346931|FG000|Overall Study|Adverse Event|1|||
25189900|NCT04341363|50346931|FG000|Overall Study|Withdrawal by Subject|1|||
25189901|NCT04268303|50346942|FG000|Overall Study|Lost to Follow-up|1|||
25189902|NCT04268303|50346943|FG001|Overall Study|Lost to Follow-up|1|||
25189903|NCT04268303|50346944|FG002|Overall Study|Lost to Follow-up|2|||
25189904|NCT04268303|50346942|FG000|Overall Study|Withdrawal by Subject|0|||
25189905|NCT04268303|50346943|FG001|Overall Study|Withdrawal by Subject|1|||
25189906|NCT04268303|50346944|FG002|Overall Study|Withdrawal by Subject|1|||
25189907|NCT04268303|50346942|FG000|Overall Study|Adverse Event|2|||
25189908|NCT04268303|50346943|FG001|Overall Study|Adverse Event|0|||
25189909|NCT04268303|50346944|FG002|Overall Study|Adverse Event|0|||
25189910|NCT04092452|50346988|FG000|Overall Study|Adverse Event|1|||
25189911|NCT04092452|50346989|FG001|Overall Study|Adverse Event|3|||
25189912|NCT04092452|50346990|FG002|Overall Study|Adverse Event|3|||
25189913|NCT04092452|50346991|FG003|Overall Study|Adverse Event|7|||
25279107|NCT01209689|50593501|FG000|Overall Study|Insufficient Therapeutic Response|7|||
25279108|NCT01209689|50593502|FG001|Overall Study|Insufficient Therapeutic Response|2|||
25279109|NCT01209689|50593501|FG000|Overall Study|Refused Treatment|8|||
25279110|NCT01209689|50593502|FG001|Overall Study|Refused Treatment|3|||
25279111|NCT01209689|50593501|FG000|Overall Study|Adverse Event|4|||
25279112|NCT01209689|50593502|FG001|Overall Study|Adverse Event|0|||
25279113|NCT01209689|50593501|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
25279114|NCT01209689|50593502|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
25279115|NCT01209689|50593501|FG000|Overall Study|Failure to Return|3|||
25279116|NCT01209689|50593502|FG001|Overall Study|Failure to Return|0|||
25279117|NCT01209689|50593501|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
25279118|NCT01209689|50593502|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
25279119|NCT01209143|50593510|FG000|Overall Study|Adverse Event|2|||
25279120|NCT01209143|50593511|FG001|Overall Study|Adverse Event|1|||
25279121|NCT01209143|50593510|FG000|Overall Study|Death|0|||
25279122|NCT01209143|50593511|FG001|Overall Study|Death|1|||
25279123|NCT01209143|50593510|FG000|Overall Study|Physician Decision|3|||
25279124|NCT01209143|50593511|FG001|Overall Study|Physician Decision|1|||
25279125|NCT01209143|50593510|FG000|Overall Study|Lost to Follow-up|1|||
25189914|NCT04092452|50346988|FG000|Overall Study|Lack of Efficacy|1|||
25189915|NCT04092452|50346989|FG001|Overall Study|Lack of Efficacy|1|||
25279126|NCT01209143|50593511|FG001|Overall Study|Lost to Follow-up|0|||
25279127|NCT01209143|50593510|FG000|Overall Study|Withdrawal by Subject|2|||
25069610|NCT01369355|50175451|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
25069611|NCT01369355|50175452|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
25069612|NCT01369355|50175453|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
25069613|NCT01369355|50175454|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
25069614|NCT01369355|50175446|FG000|Long-term Extension (Week 44-272)|Death|0|||
25069615|NCT01369355|50175447|FG001|Long-term Extension (Week 44-272)|Death|0|||
25069616|NCT01369355|50175448|FG002|Long-term Extension (Week 44-272)|Death|0|||
25069617|NCT01369355|50175449|FG003|Long-term Extension (Week 44-272)|Death|0|||
25069618|NCT01369355|50175450|FG004|Long-term Extension (Week 44-272)|Death|0|||
25069619|NCT01369355|50175451|FG005|Long-term Extension (Week 44-272)|Death|0|||
25189916|NCT04092452|50346990|FG002|Overall Study|Lack of Efficacy|1|||
25189917|NCT04092452|50346991|FG003|Overall Study|Lack of Efficacy|0|||
25189918|NCT04092452|50346988|FG000|Overall Study|Lost to Follow-up|4|||
25279128|NCT01209143|50593511|FG001|Overall Study|Withdrawal by Subject|1|||
25279129|NCT01209143|50593510|FG000|Overall Study|Disease progression|11|||
25279130|NCT01209143|50593511|FG001|Overall Study|Disease progression|16|||
25279131|NCT01023789|50593530|FG000|3 - Year Visit|Death|29|||
25279132|NCT01023789|50593530|FG000|3 - Year Visit|Withdrawal of consent|1|||
25279133|NCT01023789|50593530|FG000|3 - Year Visit|Lost to Follow-up|13|||
25279134|NCT01208207|50593537|FG000|Part I|Adverse Event|19|||
25279135|NCT01208207|50593538|FG001|Part I|Adverse Event|2|||
25279136|NCT01208207|50593539|FG002|Part I|Adverse Event|6|||
25279137|NCT01208207|50593540|FG003|Part I|Adverse Event|0|||
25069620|NCT01369355|50175452|FG006|Long-term Extension (Week 44-272)|Death|0|||
25069621|NCT01369355|50175453|FG007|Long-term Extension (Week 44-272)|Death|1|||
25069622|NCT01369355|50175454|FG008|Long-term Extension (Week 44-272)|Death|3|||
25189919|NCT04092452|50346989|FG001|Overall Study|Lost to Follow-up|3|||
25279138|NCT01208207|50593541|FG004|Part I|Adverse Event|0|||
25279139|NCT01208207|50593542|FG005|Part I|Adverse Event|0|||
25279140|NCT01208207|50593543|FG006|Part I|Adverse Event|0|||
25279141|NCT01208207|50593537|FG000|Part I|Lack of Efficacy|21|||
25279142|NCT01208207|50593538|FG001|Part I|Lack of Efficacy|3|||
25279143|NCT01208207|50593539|FG002|Part I|Lack of Efficacy|2|||
25279144|NCT01208207|50593540|FG003|Part I|Lack of Efficacy|0|||
25279145|NCT01208207|50593541|FG004|Part I|Lack of Efficacy|0|||
25279146|NCT01208207|50593542|FG005|Part I|Lack of Efficacy|0|||
25279147|NCT01208207|50593543|FG006|Part I|Lack of Efficacy|0|||
25279148|NCT01208207|50593537|FG000|Part I|Lost to Follow-up|6|||
25279149|NCT01208207|50593538|FG001|Part I|Lost to Follow-up|1|||
25279150|NCT01208207|50593539|FG002|Part I|Lost to Follow-up|0|||
25279151|NCT01208207|50593540|FG003|Part I|Lost to Follow-up|0|||
25279152|NCT01208207|50593541|FG004|Part I|Lost to Follow-up|0|||
25279153|NCT01208207|50593542|FG005|Part I|Lost to Follow-up|0|||
25279154|NCT01208207|50593543|FG006|Part I|Lost to Follow-up|0|||
25279155|NCT01208207|50593537|FG000|Part I|Non-Compliance With Study Drug|1|||
25279156|NCT01208207|50593538|FG001|Part I|Non-Compliance With Study Drug|0|||
25279157|NCT01208207|50593539|FG002|Part I|Non-Compliance With Study Drug|1|||
25279158|NCT01208207|50593540|FG003|Part I|Non-Compliance With Study Drug|0|||
25279159|NCT01208207|50593541|FG004|Part I|Non-Compliance With Study Drug|0|||
25279160|NCT01208207|50593542|FG005|Part I|Non-Compliance With Study Drug|0|||
25279161|NCT01208207|50593543|FG006|Part I|Non-Compliance With Study Drug|0|||
25279162|NCT01208207|50593537|FG000|Part I|Physician Decision|0|||
25279163|NCT01208207|50593538|FG001|Part I|Physician Decision|1|||
25279164|NCT01208207|50593539|FG002|Part I|Physician Decision|0|||
25279165|NCT01208207|50593540|FG003|Part I|Physician Decision|0|||
25279166|NCT01208207|50593541|FG004|Part I|Physician Decision|0|||
25279167|NCT01208207|50593542|FG005|Part I|Physician Decision|0|||
25279168|NCT01208207|50593543|FG006|Part I|Physician Decision|0|||
25279169|NCT01208207|50593537|FG000|Part I|Progressive Disease|1|||
25279170|NCT01208207|50593538|FG001|Part I|Progressive Disease|0|||
25279171|NCT01208207|50593539|FG002|Part I|Progressive Disease|0|||
25279172|NCT01208207|50593540|FG003|Part I|Progressive Disease|0|||
25279173|NCT01208207|50593541|FG004|Part I|Progressive Disease|0|||
25279174|NCT01208207|50593542|FG005|Part I|Progressive Disease|0|||
25279175|NCT01208207|50593543|FG006|Part I|Progressive Disease|0|||
25279176|NCT01208207|50593537|FG000|Part I|Protocol Violation|8|||
25279177|NCT01208207|50593538|FG001|Part I|Protocol Violation|0|||
25279178|NCT01208207|50593539|FG002|Part I|Protocol Violation|2|||
25279179|NCT01208207|50593540|FG003|Part I|Protocol Violation|0|||
25279180|NCT01208207|50593541|FG004|Part I|Protocol Violation|0|||
25279181|NCT01208207|50593542|FG005|Part I|Protocol Violation|0|||
25279182|NCT01208207|50593543|FG006|Part I|Protocol Violation|0|||
25279183|NCT01208207|50593537|FG000|Part I|Withdrawal by Subject|14|||
25279184|NCT01208207|50593538|FG001|Part I|Withdrawal by Subject|4|||
25279185|NCT01208207|50593539|FG002|Part I|Withdrawal by Subject|4|||
25279186|NCT01208207|50593540|FG003|Part I|Withdrawal by Subject|0|||
25279187|NCT01208207|50593541|FG004|Part I|Withdrawal by Subject|0|||
25279188|NCT01208207|50593542|FG005|Part I|Withdrawal by Subject|0|||
25279189|NCT01208207|50593543|FG006|Part I|Withdrawal by Subject|0|||
25279190|NCT01208207|50593537|FG000|Part II|Withdrawal by Subject|0|||
25279191|NCT01208207|50593538|FG001|Part II|Withdrawal by Subject|0|||
25279192|NCT01208207|50593539|FG002|Part II|Withdrawal by Subject|0|||
25279193|NCT01208207|50593540|FG003|Part II|Withdrawal by Subject|10|||
25279194|NCT01208207|50593541|FG004|Part II|Withdrawal by Subject|9|||
25279195|NCT01208207|50593542|FG005|Part II|Withdrawal by Subject|3|||
25279196|NCT01208207|50593543|FG006|Part II|Withdrawal by Subject|5|||
25279197|NCT01208207|50593537|FG000|Part II|Adverse Event|0|||
25279198|NCT01208207|50593538|FG001|Part II|Adverse Event|0|||
25279199|NCT01208207|50593539|FG002|Part II|Adverse Event|0|||
25069623|NCT01369355|50175446|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
25279200|NCT01208207|50593540|FG003|Part II|Adverse Event|5|||
25279201|NCT01208207|50593541|FG004|Part II|Adverse Event|9|||
25279202|NCT01208207|50593542|FG005|Part II|Adverse Event|4|||
25279203|NCT01208207|50593543|FG006|Part II|Adverse Event|2|||
25279204|NCT01208207|50593537|FG000|Part II|Lack of Efficacy|0|||
25279205|NCT01208207|50593538|FG001|Part II|Lack of Efficacy|0|||
25279206|NCT01208207|50593539|FG002|Part II|Lack of Efficacy|0|||
25279207|NCT01208207|50593540|FG003|Part II|Lack of Efficacy|6|||
25279208|NCT01208207|50593541|FG004|Part II|Lack of Efficacy|4|||
25279209|NCT01208207|50593542|FG005|Part II|Lack of Efficacy|3|||
25279210|NCT01208207|50593543|FG006|Part II|Lack of Efficacy|3|||
25279211|NCT01208207|50593537|FG000|Part II|Lost to Follow-up|0|||
25279212|NCT01208207|50593538|FG001|Part II|Lost to Follow-up|0|||
25279213|NCT01208207|50593539|FG002|Part II|Lost to Follow-up|0|||
25279214|NCT01208207|50593540|FG003|Part II|Lost to Follow-up|4|||
25279215|NCT01208207|50593541|FG004|Part II|Lost to Follow-up|0|||
25279216|NCT01208207|50593542|FG005|Part II|Lost to Follow-up|2|||
25279217|NCT01208207|50593543|FG006|Part II|Lost to Follow-up|1|||
25279218|NCT01208207|50593537|FG000|Part II|Non-Compliance With Study Drug|0|||
25189920|NCT04092452|50346990|FG002|Overall Study|Lost to Follow-up|5|||
25189921|NCT04092452|50346991|FG003|Overall Study|Lost to Follow-up|1|||
25189922|NCT04092452|50346988|FG000|Overall Study|Non-Compliance With Study Drug|0|||
25189923|NCT04092452|50346989|FG001|Overall Study|Non-Compliance With Study Drug|0|||
25189924|NCT04092452|50346990|FG002|Overall Study|Non-Compliance With Study Drug|1|||
25189925|NCT04092452|50346991|FG003|Overall Study|Non-Compliance With Study Drug|1|||
25279219|NCT01208207|50593538|FG001|Part II|Non-Compliance With Study Drug|0|||
25279220|NCT01208207|50593539|FG002|Part II|Non-Compliance With Study Drug|0|||
25189926|NCT04092452|50346988|FG000|Overall Study|Physician Decision|1|||
25189927|NCT04092452|50346989|FG001|Overall Study|Physician Decision|0|||
25189928|NCT04092452|50346990|FG002|Overall Study|Physician Decision|1|||
25189929|NCT04092452|50346991|FG003|Overall Study|Physician Decision|0|||
25189930|NCT04092452|50346988|FG000|Overall Study|Pregnancy|2|||
25189931|NCT04092452|50346989|FG001|Overall Study|Pregnancy|0|||
25189932|NCT04092452|50346990|FG002|Overall Study|Pregnancy|0|||
25189933|NCT04092452|50346991|FG003|Overall Study|Pregnancy|0|||
25189934|NCT04092452|50346988|FG000|Overall Study|Protocol Deviation|1|||
25189935|NCT04092452|50346989|FG001|Overall Study|Protocol Deviation|0|||
25189936|NCT04092452|50346990|FG002|Overall Study|Protocol Deviation|0|||
25189937|NCT04092452|50346991|FG003|Overall Study|Protocol Deviation|0|||
25189938|NCT04092452|50346988|FG000|Overall Study|Withdrawal by Subject|3|||
25189939|NCT04092452|50346989|FG001|Overall Study|Withdrawal by Subject|10|||
25189940|NCT04092452|50346990|FG002|Overall Study|Withdrawal by Subject|3|||
25189941|NCT04092452|50346991|FG003|Overall Study|Withdrawal by Subject|5|||
25189942|NCT04092452|50346988|FG000|Overall Study|Other|0|||
25189943|NCT04092452|50346989|FG001|Overall Study|Other|0|||
25189944|NCT04092452|50346990|FG002|Overall Study|Other|1|||
25189945|NCT04092452|50346991|FG003|Overall Study|Other|2|||
25189946|NCT04029116|50347006|FG000|Overall Study|Adverse Event|0|||
25189947|NCT04029116|50347007|FG001|Overall Study|Adverse Event|2|||
25189948|NCT04029116|50347006|FG000|Overall Study|Lost to Follow-up|3|||
25189949|NCT04029116|50347007|FG001|Overall Study|Lost to Follow-up|5|||
25189950|NCT04029116|50347006|FG000|Overall Study|Physician Decision|2|||
25189951|NCT04029116|50347007|FG001|Overall Study|Physician Decision|0|||
25189952|NCT04029116|50347006|FG000|Overall Study|Pregnancy|1|||
25189953|NCT04029116|50347007|FG001|Overall Study|Pregnancy|2|||
25189954|NCT04029116|50347006|FG000|Overall Study|Withdrawal by Subject|4|||
25189955|NCT04029116|50347007|FG001|Overall Study|Withdrawal by Subject|6|||
25189956|NCT04029116|50347006|FG000|Overall Study|Other|2|||
25189957|NCT04029116|50347007|FG001|Overall Study|Other|1|||
25189958|NCT03734029|50347038|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
25189959|NCT03734029|50347039|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
25189960|NCT03734029|50347038|FG000|Overall Study|Adverse Event|60|||
25189961|NCT03734029|50347039|FG001|Overall Study|Adverse Event|14|||
25189962|NCT03734029|50347038|FG000|Overall Study|Withdrawal by Subject|12|||
25189963|NCT03734029|50347039|FG001|Overall Study|Withdrawal by Subject|11|||
25189964|NCT03734029|50347038|FG000|Overall Study|Clinical progression by investigator|10|||
25189965|NCT03734029|50347039|FG001|Overall Study|Clinical progression by investigator|8|||
25189966|NCT03734029|50347038|FG000|Overall Study|Death|5|||
25189967|NCT03734029|50347039|FG001|Overall Study|Death|2|||
25189968|NCT03734029|50347038|FG000|Overall Study|Physician Decision|4|||
25189969|NCT03734029|50347039|FG001|Overall Study|Physician Decision|3|||
25189970|NCT03734029|50347038|FG000|Overall Study|Other|2|||
25189971|NCT03734029|50347039|FG001|Overall Study|Other|0|||
25189972|NCT03734029|50347038|FG000|Overall Study|Lost to Follow-up|0|||
25189973|NCT03734029|50347039|FG001|Overall Study|Lost to Follow-up|1|||
25189974|NCT03734029|50347038|FG000|Overall Study|Randomized, but not treated|2|||
25189975|NCT03734029|50347039|FG001|Overall Study|Randomized, but not treated|12|||
25189976|NCT03732820|50347047|FG000|Overall Study|Death|143|||
25189977|NCT03732820|50347048|FG001|Overall Study|Death|169|||
25189978|NCT03732820|50347047|FG000|Overall Study|Screen failure|0|||
25189979|NCT03732820|50347048|FG001|Overall Study|Screen failure|1|||
25189980|NCT03732820|50347047|FG000|Overall Study|Ongoing study at data cut off|239|||
25189981|NCT03732820|50347048|FG001|Overall Study|Ongoing study at data cut off|216|||
25189982|NCT03732820|50347047|FG000|Overall Study|Failure to meet randomisation criteria|1|||
25189983|NCT03732820|50347048|FG001|Overall Study|Failure to meet randomisation criteria|1|||
25189984|NCT03732820|50347047|FG000|Overall Study|Lost to Follow-up|1|||
25189985|NCT03732820|50347048|FG001|Overall Study|Lost to Follow-up|0|||
25189986|NCT03732820|50347047|FG000|Overall Study|Patient decision|13|||
25189987|NCT03732820|50347048|FG001|Overall Study|Patient decision|8|||
25189988|NCT03732820|50347047|FG000|Overall Study|Other|2|||
25189989|NCT03732820|50347048|FG001|Overall Study|Other|2|||
25189990|NCT03724032|50347057|FG000|Overall Study|Physician Decision|1|||
25189991|NCT03724032|50347058|FG001|Overall Study|Physician Decision|0|||
25189992|NCT03724032|50347059|FG002|Overall Study|Physician Decision|0|||
25189993|NCT03724032|50347057|FG000|Overall Study|Protocol Violation|2|||
25279221|NCT01208207|50593540|FG003|Part II|Non-Compliance With Study Drug|4|||
25279222|NCT01208207|50593541|FG004|Part II|Non-Compliance With Study Drug|1|||
25189994|NCT03724032|50347058|FG001|Overall Study|Protocol Violation|2|||
25189995|NCT03724032|50347059|FG002|Overall Study|Protocol Violation|1|||
25279223|NCT01208207|50593542|FG005|Part II|Non-Compliance With Study Drug|1|||
25189996|NCT03657797|50347096|FG000|Overall Study|Lost to Follow-up|0|||
25189997|NCT03657797|50347097|FG001|Overall Study|Lost to Follow-up|1|||
25189998|NCT03657797|50347098|FG002|Overall Study|Lost to Follow-up|1|||
25189999|NCT03657797|50347099|FG003|Overall Study|Lost to Follow-up|0|||
25190000|NCT03657797|50347096|FG000|Overall Study|Physician Decision|0|||
25190001|NCT03657797|50347097|FG001|Overall Study|Physician Decision|1|||
25190002|NCT03657797|50347098|FG002|Overall Study|Physician Decision|0|||
25279224|NCT01208207|50593543|FG006|Part II|Non-Compliance With Study Drug|0|||
25279225|NCT01208207|50593537|FG000|Part II|Physician Decision|0|||
25279226|NCT01208207|50593538|FG001|Part II|Physician Decision|0|||
25279227|NCT01208207|50593539|FG002|Part II|Physician Decision|0|||
25279228|NCT01208207|50593540|FG003|Part II|Physician Decision|1|||
25279229|NCT01208207|50593541|FG004|Part II|Physician Decision|0|||
25279230|NCT01208207|50593542|FG005|Part II|Physician Decision|2|||
25279231|NCT01208207|50593543|FG006|Part II|Physician Decision|0|||
25279232|NCT01208207|50593537|FG000|Part II|Protocol Violation|0|||
25279233|NCT01208207|50593538|FG001|Part II|Protocol Violation|0|||
25279234|NCT01208207|50593539|FG002|Part II|Protocol Violation|0|||
25279235|NCT01208207|50593540|FG003|Part II|Protocol Violation|1|||
25279236|NCT01208207|50593541|FG004|Part II|Protocol Violation|0|||
25279237|NCT01208207|50593542|FG005|Part II|Protocol Violation|0|||
25279238|NCT01208207|50593543|FG006|Part II|Protocol Violation|0|||
25279239|NCT01208207|50593537|FG000|Part II|Technical Problems|0|||
25279240|NCT01208207|50593538|FG001|Part II|Technical Problems|0|||
25279241|NCT01208207|50593539|FG002|Part II|Technical Problems|0|||
25279242|NCT01208207|50593540|FG003|Part II|Technical Problems|1|||
25279243|NCT01208207|50593541|FG004|Part II|Technical Problems|0|||
25279244|NCT01208207|50593542|FG005|Part II|Technical Problems|1|||
25279245|NCT01208207|50593543|FG006|Part II|Technical Problems|0|||
25279246|NCT01012713|50593574|FG000|Overall Study|Lack of Efficacy|3|||
25279247|NCT01007253|50593579|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
25279248|NCT01007253|50593580|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
25279249|NCT01007253|50593581|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
25279250|NCT01007253|50593582|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
25279251|NCT01006707|50593592|FG000|Study Session 1|Lost to Follow-up|2|||
25069624|NCT01369355|50175447|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
25069625|NCT01369355|50175448|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
25069626|NCT01369355|50175449|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
25069627|NCT01369355|50175450|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
25069628|NCT01369355|50175451|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
25069629|NCT01369355|50175452|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
25069630|NCT01369355|50175453|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
25069631|NCT01369355|50175454|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
25069632|NCT01369355|50175446|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
25069633|NCT01369355|50175447|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
25069634|NCT01369355|50175448|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
25069635|NCT01369355|50175449|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
25069636|NCT01369355|50175450|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
25069637|NCT01369355|50175451|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
25069638|NCT01369355|50175452|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
25069639|NCT01369355|50175453|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
25069640|NCT01369355|50175454|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
25069641|NCT01369355|50175446|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
25069642|NCT01369355|50175447|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
25069643|NCT01369355|50175448|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
25069644|NCT01369355|50175449|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
25069645|NCT01369355|50175450|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
25069646|NCT01369355|50175451|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
25069647|NCT01369355|50175452|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
25190003|NCT03657797|50347099|FG003|Overall Study|Physician Decision|0|||
25190004|NCT03657797|50347096|FG000|Overall Study|Withdrawal by Subject|0|||
25190005|NCT03657797|50347097|FG001|Overall Study|Withdrawal by Subject|1|||
25190006|NCT03657797|50347098|FG002|Overall Study|Withdrawal by Subject|2|||
25279252|NCT01006707|50593593|FG001|Study Session 1|Lost to Follow-up|0|||
25279253|NCT01006707|50593594|FG002|Study Session 1|Lost to Follow-up|0|||
25279254|NCT01006707|50593592|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
25279255|NCT01006707|50593593|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
25279256|NCT01006707|50593594|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
25279257|NCT01006629|50593602|FG000|Overall Study|Adverse Event|1|||
25190007|NCT03657797|50347099|FG003|Overall Study|Withdrawal by Subject|0|||
25190008|NCT03657797|50347096|FG000|Overall Study|Adverse Event|0|||
25279258|NCT01006629|50593602|FG000|Overall Study|Parent refused to continue participation|1|||
25279259|NCT01006629|50593602|FG000|Overall Study|Parent unable to perform site visit|4|||
25279260|NCT01012323|50593606|FG000|Overall Study|Investigator Judgment|1|||
25279261|NCT01011933|50593610|FG000|Overall Study|Wrong cell type|1|||
25279262|NCT01011933|50593610|FG000|Overall Study|Improper pre-protocol Rx|1|||
25279263|NCT01011933|50593610|FG000|Overall Study|Inadequate pathology|1|||
25279264|NCT01011933|50593610|FG000|Overall Study|Never treated|1|||
25279265|NCT01011465|50593632|FG000|Overall Study|Withdrawal by Subject|2|||
25279266|NCT01011465|50593633|FG001|Overall Study|Withdrawal by Subject|1|||
25279267|NCT01011465|50593634|FG002|Overall Study|Withdrawal by Subject|0|||
25279268|NCT01011465|50593635|FG003|Overall Study|Withdrawal by Subject|0|||
25279269|NCT01011465|50593636|FG004|Overall Study|Withdrawal by Subject|1|||
25279270|NCT01011465|50593637|FG005|Overall Study|Withdrawal by Subject|0|||
25279271|NCT01011465|50593638|FG006|Overall Study|Withdrawal by Subject|1|||
25279272|NCT01011465|50593639|FG007|Overall Study|Withdrawal by Subject|0|||
25279273|NCT01011387|50593664|FG000|Overall Study|Withdrawal by Subject|3|||
25279274|NCT01011387|50593664|FG000|Overall Study|Adverse Event|2|||
25279275|NCT01011387|50593664|FG000|Overall Study|Protocol Violation|1|||
25279276|NCT01011309|50593671|FG000|Overall Study|Adverse Event|2|||
25279277|NCT01011309|50593672|FG001|Overall Study|Adverse Event|1|||
25279278|NCT01011309|50593673|FG002|Overall Study|Adverse Event|2|||
25279279|NCT01011309|50593671|FG000|Overall Study|Lack of Efficacy|0|||
25069648|NCT01369355|50175453|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
25069649|NCT01369355|50175454|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
25069650|NCT01369355|50175446|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
25069651|NCT01369355|50175447|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
25069652|NCT01369355|50175448|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
25190009|NCT03657797|50347097|FG001|Overall Study|Adverse Event|0|||
25190010|NCT03657797|50347098|FG002|Overall Study|Adverse Event|2|||
25190011|NCT03657797|50347099|FG003|Overall Study|Adverse Event|0|||
25190012|NCT03551938|50347115|FG000|3-Month Follow Up|Lost to Follow-up|39|||
25190013|NCT03551938|50347116|FG001|3-Month Follow Up|Lost to Follow-up|38|||
25190014|NCT03551938|50347115|FG000|6-Month Follow Up|Lost to Follow-up|46|||
25190015|NCT03551938|50347116|FG001|6-Month Follow Up|Lost to Follow-up|42|||
25190016|NCT03551938|50347115|FG000|9-Month Follow Up|Lost to Follow-up|44|||
25190017|NCT03551938|50347116|FG001|9-Month Follow Up|Lost to Follow-up|43|||
25190018|NCT03536884|50347124|FG000|Initial Treatment Period Week 0-16|Adverse Event|8|||
25190019|NCT03536884|50347125|FG001|Initial Treatment Period Week 0-16|Adverse Event|6|||
25190020|NCT03536884|50347126|FG002|Initial Treatment Period Week 0-16|Adverse Event|0|||
25190021|NCT03536884|50347127|FG003|Initial Treatment Period Week 0-16|Adverse Event|0|||
25190022|NCT03536884|50347128|FG004|Initial Treatment Period Week 0-16|Adverse Event|0|||
25190023|NCT03536884|50347124|FG000|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
25190024|NCT03536884|50347125|FG001|Initial Treatment Period Week 0-16|Lost to Follow-up|3|||
25190025|NCT03536884|50347126|FG002|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
25190026|NCT03536884|50347127|FG003|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
25190027|NCT03536884|50347128|FG004|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
25190028|NCT03536884|50347124|FG000|Initial Treatment Period Week 0-16|Withdrawal by Subject|3|||
25190029|NCT03536884|50347125|FG001|Initial Treatment Period Week 0-16|Withdrawal by Subject|4|||
25190030|NCT03536884|50347126|FG002|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
25190031|NCT03536884|50347127|FG003|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
25190032|NCT03536884|50347128|FG004|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
25190033|NCT03536884|50347124|FG000|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
25190034|NCT03536884|50347125|FG001|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|1|||
25069653|NCT01369355|50175449|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
25069654|NCT01369355|50175450|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
25069655|NCT01369355|50175451|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
25069656|NCT01369355|50175452|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
25190035|NCT03536884|50347126|FG002|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
25190036|NCT03536884|50347127|FG003|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
25190037|NCT03536884|50347128|FG004|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
25190038|NCT03536884|50347124|FG000|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
25190039|NCT03536884|50347125|FG001|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|1|||
25190040|NCT03536884|50347126|FG002|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
25190041|NCT03536884|50347127|FG003|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
25279280|NCT01011309|50593672|FG001|Overall Study|Lack of Efficacy|1|||
25279281|NCT01011309|50593673|FG002|Overall Study|Lack of Efficacy|0|||
25279282|NCT01011309|50593671|FG000|Overall Study|Protocol Violation|0|||
25279283|NCT01011309|50593672|FG001|Overall Study|Protocol Violation|1|||
25190042|NCT03536884|50347128|FG004|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
25190043|NCT03536884|50347124|FG000|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
25190044|NCT03536884|50347125|FG001|Initial Treatment Period Week 0-16|Unable to attend visits|1|||
25190045|NCT03536884|50347126|FG002|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
25190046|NCT03536884|50347127|FG003|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
25190047|NCT03536884|50347128|FG004|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
25190048|NCT03536884|50347124|FG000|Maintenance Treatment Period Week 16-48|Death|0|||
25190049|NCT03536884|50347125|FG001|Maintenance Treatment Period Week 16-48|Death|0|||
25190050|NCT03536884|50347126|FG002|Maintenance Treatment Period Week 16-48|Death|1|||
25190051|NCT03536884|50347127|FG003|Maintenance Treatment Period Week 16-48|Death|0|||
25190052|NCT03536884|50347128|FG004|Maintenance Treatment Period Week 16-48|Death|1|||
25190053|NCT03536884|50347124|FG000|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
25190054|NCT03536884|50347125|FG001|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
25190055|NCT03536884|50347126|FG002|Maintenance Treatment Period Week 16-48|Adverse Event|1|||
25190056|NCT03536884|50347127|FG003|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
25190057|NCT03536884|50347128|FG004|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
25190058|NCT03536884|50347124|FG000|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
25190059|NCT03536884|50347125|FG001|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
25190060|NCT03536884|50347126|FG002|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
25190061|NCT03536884|50347127|FG003|Maintenance Treatment Period Week 16-48|Lack of Efficacy|1|||
25190062|NCT03536884|50347128|FG004|Maintenance Treatment Period Week 16-48|Lack of Efficacy|4|||
25190063|NCT03536884|50347124|FG000|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
25279284|NCT01011309|50593673|FG002|Overall Study|Protocol Violation|3|||
25279285|NCT01011153|50593684|FG000|Overall Study|Less than 78 cases completed|8|||
25279286|NCT01011153|50593685|FG001|Overall Study|Less than 78 cases completed|11|||
25279287|NCT01011153|50593686|FG002|Overall Study|Less than 78 cases completed|9|||
25279288|NCT00997893|50593718|FG000|Overall Study|Adverse Event|1|||
25279289|NCT00997893|50593719|FG001|Overall Study|Adverse Event|0|||
25279290|NCT00997893|50593720|FG002|Overall Study|Adverse Event|0|||
25279291|NCT00997893|50593718|FG000|Overall Study|Unable to meet study timelines|1|||
25279292|NCT00997893|50593719|FG001|Overall Study|Unable to meet study timelines|0|||
25279293|NCT00997893|50593720|FG002|Overall Study|Unable to meet study timelines|0|||
25279294|NCT00997893|50593718|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
25279295|NCT00997893|50593719|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
25279296|NCT00997893|50593720|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
25279297|NCT02905825|50593737|FG000|Overall Study|Protocol Violation|11|||
25279298|NCT02905825|50593737|FG000|Overall Study|Device Malfunction|1|||
25279299|NCT01208051|50593746|FG000|Total Enrollment|Withdrawal by Subject|0|||
25279300|NCT01208051|50593747|FG001|Total Enrollment|Withdrawal by Subject|1|||
25279301|NCT01208051|50593748|FG002|Total Enrollment|Withdrawal by Subject|0|||
25279302|NCT01208051|50593749|FG003|Total Enrollment|Withdrawal by Subject|0|||
25279303|NCT01208051|50593750|FG004|Total Enrollment|Withdrawal by Subject|2|||
25279304|NCT01208051|50593746|FG000|Total Enrollment|Brain metastases|0|||
25279305|NCT01208051|50593747|FG001|Total Enrollment|Brain metastases|0|||
25279306|NCT01208051|50593748|FG002|Total Enrollment|Brain metastases|1|||
25279307|NCT01208051|50593749|FG003|Total Enrollment|Brain metastases|0|||
25279308|NCT01208051|50593750|FG004|Total Enrollment|Brain metastases|0|||
25279309|NCT01207583|50593769|FG000|Overall Study|Withdrawal by Subject|0|||
25279310|NCT01207583|50593770|FG001|Overall Study|Withdrawal by Subject|3|||
25279311|NCT01207583|50593771|FG002|Overall Study|Withdrawal by Subject|1|||
25279312|NCT01207583|50593769|FG000|Overall Study|Participant failed to return|1|||
25279313|NCT01207583|50593770|FG001|Overall Study|Participant failed to return|0|||
25279314|NCT01207583|50593771|FG002|Overall Study|Participant failed to return|0|||
25279315|NCT01207583|50593769|FG000|Overall Study|Lost to Follow-up|0|||
25279316|NCT01207583|50593770|FG001|Overall Study|Lost to Follow-up|2|||
25279317|NCT01207583|50593771|FG002|Overall Study|Lost to Follow-up|0|||
25279318|NCT01207427|50593795|FG000|Double-blind Treatment Period|Adverse Event|0|||
25279319|NCT01207427|50593796|FG001|Double-blind Treatment Period|Adverse Event|1|||
25279320|NCT01207427|50593797|FG002|Double-blind Treatment Period|Adverse Event|0|||
25279321|NCT01207427|50593795|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
25279322|NCT01207427|50593796|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
25279323|NCT01207427|50593797|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
25279324|NCT01207427|50593795|FG000|Double-blind Treatment Period|Protocol Violation|2|||
24969208|NCT00141518|50058686|FG000|Overall Study|Protocol Violation|1|||
25279325|NCT01207427|50593796|FG001|Double-blind Treatment Period|Protocol Violation|1|||
25279326|NCT01207427|50593797|FG002|Double-blind Treatment Period|Protocol Violation|1|||
25279327|NCT01207427|50593795|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
25279328|NCT01207427|50593796|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
25279329|NCT01207427|50593797|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
25279330|NCT04713553|50593810|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
25069657|NCT01369355|50175453|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
25069658|NCT01369355|50175454|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
25069659|NCT01369355|50175446|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
25190064|NCT03536884|50347125|FG001|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
25190065|NCT03536884|50347126|FG002|Maintenance Treatment Period Week 16-48|Lost to Follow-up|1|||
25190066|NCT03536884|50347127|FG003|Maintenance Treatment Period Week 16-48|Lost to Follow-up|2|||
24969209|NCT00141518|50058687|FG001|Overall Study|Protocol Violation|1|||
24969210|NCT00141518|50058688|FG002|Overall Study|Protocol Violation|2|||
24969211|NCT00141518|50058686|FG000|Overall Study|Lack of Efficacy|5|||
24969212|NCT00141518|50058687|FG001|Overall Study|Lack of Efficacy|0|||
25279331|NCT04713553|50593811|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
25279332|NCT04713553|50593812|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
25279333|NCT04713553|50593813|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
25279334|NCT04713553|50593814|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
25279335|NCT04713553|50593815|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
25279336|NCT04713553|50593816|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
25279337|NCT04713553|50593810|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
25279338|NCT04713553|50593811|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
25279339|NCT04713553|50593812|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
25279340|NCT04713553|50593813|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
25279341|NCT04713553|50593814|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
25279342|NCT04713553|50593815|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
25279343|NCT04713553|50593816|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
25279344|NCT04713553|50593810|FG000|Primary Study (2 Months)|Other|1|||
25279345|NCT04713553|50593811|FG001|Primary Study (2 Months)|Other|2|||
25279346|NCT04713553|50593812|FG002|Primary Study (2 Months)|Other|0|||
25279347|NCT04713553|50593813|FG003|Primary Study (2 Months)|Other|0|||
25279348|NCT04713553|50593814|FG004|Primary Study (2 Months)|Other|1|||
25279349|NCT04713553|50593815|FG005|Primary Study (2 Months)|Other|0|||
25279350|NCT04713553|50593816|FG006|Primary Study (2 Months)|Other|0|||
25279351|NCT04713553|50593810|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
25279352|NCT04713553|50593811|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
25279353|NCT04713553|50593812|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
25190067|NCT03536884|50347128|FG004|Maintenance Treatment Period Week 16-48|Lost to Follow-up|8|||
25190068|NCT03536884|50347124|FG000|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
25190069|NCT03536884|50347125|FG001|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
25190070|NCT03536884|50347126|FG002|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|7|||
25190071|NCT03536884|50347127|FG003|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|3|||
25279354|NCT04713553|50593813|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
25279355|NCT04713553|50593814|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
25279356|NCT04713553|50593815|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
25279357|NCT04713553|50593816|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
25279358|NCT04713553|50593810|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
25279359|NCT04713553|50593811|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
25279360|NCT04713553|50593812|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
25279361|NCT04713553|50593813|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
25279362|NCT04713553|50593814|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
24969213|NCT00141518|50058688|FG002|Overall Study|Lack of Efficacy|0|||
24969214|NCT00253448|50058698|FG000|Overall Study|Withdrawal by Subject|1|||
24969215|NCT00098748|50058705|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
25069660|NCT01369355|50175447|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
25069661|NCT01369355|50175448|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
25190072|NCT03536884|50347128|FG004|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|12|||
25190073|NCT03536884|50347124|FG000|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
25190074|NCT03536884|50347125|FG001|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
25190075|NCT03536884|50347126|FG002|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
25190076|NCT03536884|50347127|FG003|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
25190077|NCT03536884|50347128|FG004|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|1|||
25190078|NCT03525600|50347146|FG000|Overall Study|Adverse Event|9|||
25190079|NCT03525600|50347147|FG001|Overall Study|Adverse Event|6|||
25190080|NCT03525600|50347148|FG002|Overall Study|Adverse Event|5|||
25190081|NCT03525600|50347149|FG003|Overall Study|Adverse Event|3|||
25190082|NCT03525600|50347146|FG000|Overall Study|Lost to Follow-up|2|||
25190083|NCT03525600|50347147|FG001|Overall Study|Lost to Follow-up|4|||
25190084|NCT03525600|50347148|FG002|Overall Study|Lost to Follow-up|4|||
25190085|NCT03525600|50347149|FG003|Overall Study|Lost to Follow-up|0|||
25279363|NCT04713553|50593815|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
25279364|NCT04713553|50593816|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
25279365|NCT01206101|50593839|FG000|Overall Study|Adverse Event|1|||
25279366|NCT01206101|50593840|FG001|Overall Study|Adverse Event|0|||
25279367|NCT01206101|50593839|FG000|Overall Study|Physician Decision|0|||
25279368|NCT01206101|50593840|FG001|Overall Study|Physician Decision|1|||
25279369|NCT01206101|50593839|FG000|Overall Study|Unclassified|1|||
25279370|NCT01206101|50593840|FG001|Overall Study|Unclassified|0|||
25279371|NCT01205165|50593846|FG000|Overall Study|Lost to Follow-up|2|||
25279372|NCT00997503|50593851|FG000|Overall Study|Death|53|||
25279373|NCT00997503|50593851|FG000|Overall Study|Withdrawal by Subject|76|||
25279374|NCT00997503|50593851|FG000|Overall Study|Lost to Follow-up|33|||
25279375|NCT00997503|50593851|FG000|Overall Study|Adverse Event|3|||
25279376|NCT00997503|50593851|FG000|Overall Study|Physician Decision|10|||
25190086|NCT03525600|50347146|FG000|Overall Study|Physician Decision|1|||
25190087|NCT03525600|50347147|FG001|Overall Study|Physician Decision|0|||
25190088|NCT03525600|50347148|FG002|Overall Study|Physician Decision|2|||
25190089|NCT03525600|50347149|FG003|Overall Study|Physician Decision|0|||
25190090|NCT03525600|50347146|FG000|Overall Study|Consent withdrawal|36|||
25190091|NCT03525600|50347147|FG001|Overall Study|Consent withdrawal|20|||
25279377|NCT00997503|50593851|FG000|Overall Study|Missed 12-month follow-up|85|||
25279378|NCT00997503|50593851|FG000|Overall Study|Other reason|13|||
25190092|NCT03525600|50347148|FG002|Overall Study|Consent withdrawal|6|||
25190093|NCT03525600|50347149|FG003|Overall Study|Consent withdrawal|13|||
25190094|NCT03525600|50347146|FG000|Overall Study|Death|7|||
25190095|NCT03525600|50347147|FG001|Overall Study|Death|6|||
25190096|NCT03525600|50347148|FG002|Overall Study|Death|4|||
25190097|NCT03525600|50347149|FG003|Overall Study|Death|3|||
25190098|NCT03525600|50347146|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
25190099|NCT03525600|50347147|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
25190100|NCT03525600|50347148|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
25190101|NCT03525600|50347149|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
25190102|NCT03525600|50347146|FG000|Overall Study|Other|0|||
25190103|NCT03525600|50347147|FG001|Overall Study|Other|1|||
25190104|NCT03525600|50347148|FG002|Overall Study|Other|0|||
25190105|NCT03525600|50347149|FG003|Overall Study|Other|0|||
25190106|NCT03472040|50347166|FG000|Overall Study|Physician Decision|0|||
25190107|NCT03472040|50347167|FG001|Overall Study|Physician Decision|3|||
25279379|NCT01204775|50593860|FG000|Overall Study|Poor/non-compliance|0|||
25279380|NCT01204775|50593861|FG001|Overall Study|Poor/non-compliance|1|||
25279381|NCT01204775|50593860|FG000|Overall Study|Withdrawal by Subject|1|||
25279382|NCT01204775|50593861|FG001|Overall Study|Withdrawal by Subject|0|||
25279383|NCT00997035|50593869|FG000|3-week Followup Visit|Lost to Follow-up|9|||
25279384|NCT00997035|50593870|FG001|3-week Followup Visit|Lost to Follow-up|6|||
25279385|NCT00997035|50593869|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
25279386|NCT00997035|50593870|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
25279387|NCT01204697|50593888|FG000|Overall Study|Death|26|||
25279388|NCT01204697|50593889|FG001|Overall Study|Death|27|||
25190108|NCT03472040|50347166|FG000|Overall Study|Withdrawal by Subject|10|||
25190109|NCT03472040|50347167|FG001|Overall Study|Withdrawal by Subject|23|||
25190110|NCT03472040|50347166|FG000|Overall Study|Perceived Lack of Efficacy|29|||
25190111|NCT03472040|50347167|FG001|Overall Study|Perceived Lack of Efficacy|30|||
25190112|NCT03472040|50347166|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
25279389|NCT01204697|50593888|FG000|Overall Study|Lost to Follow-up|3|||
25190113|NCT03472040|50347167|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
25190114|NCT03472040|50347166|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
25279390|NCT01204697|50593889|FG001|Overall Study|Lost to Follow-up|4|||
25279391|NCT01204697|50593888|FG000|Overall Study|Withdrawal by Subject|2|||
25279392|NCT01204697|50593889|FG001|Overall Study|Withdrawal by Subject|4|||
25279393|NCT01204697|50593888|FG000|Overall Study|Randomized, but not treated|0|||
25279394|NCT01204697|50593889|FG001|Overall Study|Randomized, but not treated|1|||
25279395|NCT01001325|50593897|FG000|Overall Study|Lost to Follow-up|16|||
25279396|NCT01001325|50593898|FG001|Overall Study|Lost to Follow-up|10|||
25279397|NCT01001325|50593897|FG000|Overall Study|Protocol Violation|2|||
25279398|NCT01001325|50593898|FG001|Overall Study|Protocol Violation|0|||
25279399|NCT01203917|50593904|FG000|Overall Study|Death|29|||
25279400|NCT01203917|50593904|FG000|Overall Study|Lost to Follow-up|2|||
25279401|NCT01203917|50593904|FG000|Overall Study|Withdrawal by Subject|3|||
25279402|NCT01203917|50593904|FG000|Overall Study|Due to objective disease progression|1|||
25279403|NCT01203917|50593904|FG000|Overall Study|Due to EGFR M+I patient|1|||
25279404|NCT01202903|50593910|FG000|Overall Study|Administrative Probelms|1|||
25279405|NCT01202903|50593911|FG001|Overall Study|Administrative Probelms|4|||
25279406|NCT01202903|50593910|FG000|Overall Study|Protocol Violation|0|||
25279407|NCT01202903|50593911|FG001|Overall Study|Protocol Violation|1|||
25279408|NCT01202903|50593910|FG000|Overall Study|Death|1|||
25190115|NCT03472040|50347167|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
25279409|NCT01202903|50593911|FG001|Overall Study|Death|0|||
25279410|NCT01202903|50593910|FG000|Overall Study|Lost to Follow-up|1|||
25279411|NCT01202903|50593911|FG001|Overall Study|Lost to Follow-up|1|||
25279412|NCT01202903|50593910|FG000|Overall Study|Lack of Efficacy|1|||
25279413|NCT01202903|50593911|FG001|Overall Study|Lack of Efficacy|3|||
25279414|NCT01202903|50593910|FG000|Overall Study|Adverse Event|3|||
25279415|NCT01202903|50593911|FG001|Overall Study|Adverse Event|3|||
25279416|NCT01202903|50593910|FG000|Overall Study|Withdrawal by Subject|4|||
25279417|NCT01202903|50593911|FG001|Overall Study|Withdrawal by Subject|4|||
25279418|NCT01001169|50593919|FG000|Overall Study|Withdrawal by Subject|2|||
25279419|NCT01001169|50593920|FG001|Overall Study|Withdrawal by Subject|1|||
25279420|NCT01202747|50593934|FG000|Overall Study|Withdrawal by Subject|1|||
25279421|NCT00996801|50593944|FG000|Overall Study|Adverse Event|6|||
25279422|NCT00996801|50593945|FG001|Overall Study|Adverse Event|4|||
25279423|NCT00996801|50593946|FG002|Overall Study|Adverse Event|12|||
25279424|NCT00996801|50593947|FG003|Overall Study|Adverse Event|17|||
25279425|NCT00996801|50593948|FG004|Overall Study|Adverse Event|31|||
25190116|NCT03472040|50347166|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
25190117|NCT03472040|50347167|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
25190118|NCT03472040|50347166|FG000|Overall Study|Subject Non-compliance|2|||
25190119|NCT03472040|50347167|FG001|Overall Study|Subject Non-compliance|5|||
25190120|NCT03472040|50347166|FG000|Overall Study|Discontinuation due to Rash|0|||
25190121|NCT03472040|50347167|FG001|Overall Study|Discontinuation due to Rash|1|||
25190122|NCT03472040|50347166|FG000|Overall Study|Subsequent Ineligibility|0|||
25190123|NCT03472040|50347167|FG001|Overall Study|Subsequent Ineligibility|2|||
25190124|NCT03472040|50347166|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
25190125|NCT03472040|50347167|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
25190126|NCT03323385|50347194|FG000|Overall Study|Withdrawal by Subject|1|||
25190127|NCT03323385|50347195|FG001|Overall Study|Withdrawal by Subject|2|||
25279426|NCT00996801|50593949|FG005|Overall Study|Adverse Event|3|||
25279427|NCT00996801|50593944|FG000|Overall Study|Lack of Efficacy|3|||
25279428|NCT00996801|50593945|FG001|Overall Study|Lack of Efficacy|0|||
25279429|NCT00996801|50593946|FG002|Overall Study|Lack of Efficacy|1|||
25279430|NCT00996801|50593947|FG003|Overall Study|Lack of Efficacy|3|||
25279431|NCT00996801|50593948|FG004|Overall Study|Lack of Efficacy|0|||
25279432|NCT00996801|50593949|FG005|Overall Study|Lack of Efficacy|1|||
25279433|NCT00996801|50593944|FG000|Overall Study|Lost to Follow-up|0|||
25279434|NCT00996801|50593945|FG001|Overall Study|Lost to Follow-up|0|||
25279435|NCT00996801|50593946|FG002|Overall Study|Lost to Follow-up|0|||
25279436|NCT00996801|50593947|FG003|Overall Study|Lost to Follow-up|3|||
25279437|NCT00996801|50593948|FG004|Overall Study|Lost to Follow-up|3|||
25279438|NCT00996801|50593949|FG005|Overall Study|Lost to Follow-up|2|||
25279439|NCT00996801|50593944|FG000|Overall Study|Physician Decision|0|||
25279440|NCT00996801|50593945|FG001|Overall Study|Physician Decision|0|||
25190128|NCT03323385|50347194|FG000|Overall Study|Noncompliance|0|||
25279441|NCT00996801|50593946|FG002|Overall Study|Physician Decision|0|||
25279442|NCT00996801|50593947|FG003|Overall Study|Physician Decision|1|||
25279443|NCT00996801|50593948|FG004|Overall Study|Physician Decision|0|||
25279444|NCT00996801|50593949|FG005|Overall Study|Physician Decision|0|||
25190129|NCT03323385|50347195|FG001|Overall Study|Noncompliance|1|||
25190130|NCT03298451|50347205|FG000|Overall Study|Death|275|||
25190131|NCT03298451|50347206|FG001|Overall Study|Death|260|||
25279445|NCT00996801|50593944|FG000|Overall Study|Progressive Disease|0|||
25279446|NCT00996801|50593945|FG001|Overall Study|Progressive Disease|1|||
25279447|NCT00996801|50593946|FG002|Overall Study|Progressive Disease|0|||
25279448|NCT00996801|50593947|FG003|Overall Study|Progressive Disease|0|||
25279449|NCT00996801|50593948|FG004|Overall Study|Progressive Disease|0|||
25279450|NCT00996801|50593949|FG005|Overall Study|Progressive Disease|0|||
25279451|NCT00996801|50593944|FG000|Overall Study|Protocol Violation|3|||
25279452|NCT00996801|50593945|FG001|Overall Study|Protocol Violation|4|||
25279453|NCT00996801|50593946|FG002|Overall Study|Protocol Violation|1|||
25279454|NCT00996801|50593947|FG003|Overall Study|Protocol Violation|2|||
25279455|NCT00996801|50593948|FG004|Overall Study|Protocol Violation|3|||
25279456|NCT00996801|50593949|FG005|Overall Study|Protocol Violation|4|||
25279457|NCT00996801|50593944|FG000|Overall Study|Study Terminated by Sponsor|0|||
25279458|NCT00996801|50593945|FG001|Overall Study|Study Terminated by Sponsor|1|||
25279459|NCT00996801|50593946|FG002|Overall Study|Study Terminated by Sponsor|0|||
25279460|NCT00996801|50593947|FG003|Overall Study|Study Terminated by Sponsor|0|||
25279461|NCT00996801|50593948|FG004|Overall Study|Study Terminated by Sponsor|46|||
25279462|NCT00996801|50593949|FG005|Overall Study|Study Terminated by Sponsor|0|||
25279463|NCT00996801|50593944|FG000|Overall Study|Withdrawal by Subject|8|||
25279464|NCT00996801|50593945|FG001|Overall Study|Withdrawal by Subject|6|||
25279465|NCT00996801|50593946|FG002|Overall Study|Withdrawal by Subject|9|||
25279466|NCT00996801|50593947|FG003|Overall Study|Withdrawal by Subject|5|||
25279467|NCT00996801|50593948|FG004|Overall Study|Withdrawal by Subject|5|||
25279468|NCT00996801|50593949|FG005|Overall Study|Withdrawal by Subject|9|||
25279469|NCT00996489|50593965|FG000|Overall Study|Device failure|45|||
25279470|NCT00996489|50593965|FG000|Overall Study|Discontinued|116|||
25279471|NCT01000311|50593971|FG000|Overall Study|Adverse Event|2|||
25279472|NCT01000311|50593972|FG001|Overall Study|Adverse Event|5|||
25279473|NCT01000311|50593971|FG000|Overall Study|Withdrawal by Subject|16|||
25279474|NCT01000311|50593972|FG001|Overall Study|Withdrawal by Subject|24|||
25279475|NCT01000311|50593971|FG000|Overall Study|Lost to Follow-up|15|||
25279476|NCT01000311|50593972|FG001|Overall Study|Lost to Follow-up|24|||
25279477|NCT01000311|50593971|FG000|Overall Study|Protocol Violation|1|||
25279478|NCT01000311|50593972|FG001|Overall Study|Protocol Violation|2|||
25279479|NCT01000311|50593971|FG000|Overall Study|Inappropriate enrollment|2|||
25279480|NCT01000311|50593972|FG001|Overall Study|Inappropriate enrollment|0|||
25279481|NCT01000311|50593971|FG000|Overall Study|Administrative reason|9|||
25279482|NCT01000311|50593972|FG001|Overall Study|Administrative reason|15|||
25279483|NCT01003899|50593978|FG000|Overall Study|Other Adverse Event|8|||
25279484|NCT01003899|50593978|FG000|Overall Study|Not entered|4|||
25279485|NCT01003899|50593978|FG000|Overall Study|Not treated|1|||
25279486|NCT01003899|50593978|FG000|Overall Study|Progressive disease|34|||
25279487|NCT01000155|50593982|FG000|Overall Study|Withdrawal by Subject|1|||
25279488|NCT01000155|50593982|FG000|Overall Study|Adverse Event|1|||
25279489|NCT00999921|50593988|FG000|Overall Study|Lost to Follow-up|10|||
25279490|NCT00999921|50593989|FG001|Overall Study|Lost to Follow-up|19|||
25279491|NCT01002573|50594000|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
25279492|NCT01002573|50594001|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
25279493|NCT00999687|50594007|FG000|First Intervention|Withdrawal by Subject|1|||
25279494|NCT00999687|50594007|FG000|Second Intervention|Withdrawal by Subject|2|||
25279495|NCT00999687|50594007|FG000|Second Intervention|Lack of Efficacy|1|||
25279496|NCT00996333|50594013|FG000|Overall Study|Screen failure|1|||
25279497|NCT00996333|50594013|FG000|Overall Study|Withdrawal by Subject|1|||
25279498|NCT00996333|50594013|FG000|Overall Study|Death|4|||
25190132|NCT03298451|50347207|FG002|Overall Study|Death|122|||
25190133|NCT03298451|50347208|FG003|Overall Study|Death|280|||
25190134|NCT03298451|50347205|FG000|Overall Study|Lost to Follow-up|1|||
25190135|NCT03298451|50347206|FG001|Overall Study|Lost to Follow-up|1|||
25190136|NCT03298451|50347207|FG002|Overall Study|Lost to Follow-up|0|||
25190137|NCT03298451|50347208|FG003|Overall Study|Lost to Follow-up|7|||
25190138|NCT03298451|50347205|FG000|Overall Study|Withdrawal by Subject|9|||
25190139|NCT03298451|50347206|FG001|Overall Study|Withdrawal by Subject|7|||
25190140|NCT03298451|50347207|FG002|Overall Study|Withdrawal by Subject|1|||
25190141|NCT03298451|50347208|FG003|Overall Study|Withdrawal by Subject|20|||
25190142|NCT03164616|50347225|FG000|Overall Study|Death|250|||
25190143|NCT03164616|50347226|FG001|Overall Study|Death|264|||
25190144|NCT03164616|50347227|FG002|Overall Study|Death|279|||
25279499|NCT00996333|50594013|FG000|Overall Study|Adverse Event|1|||
25279500|NCT00996333|50594013|FG000|Overall Study|Physician Decision|1|||
25279501|NCT00996333|50594013|FG000|Overall Study|Other|5|||
25279502|NCT00995865|50594020|FG000|Overall Study|Protocol Violation|2|||
25279503|NCT00995865|50594021|FG001|Overall Study|Protocol Violation|0|||
25279504|NCT00995865|50594022|FG002|Overall Study|Protocol Violation|0|||
25279505|NCT00995865|50594020|FG000|Overall Study|Lost to Follow-up|0|||
25279506|NCT00995865|50594021|FG001|Overall Study|Lost to Follow-up|0|||
25190145|NCT03164616|50347225|FG000|Overall Study|Lost to Follow-up|2|||
25279507|NCT00995865|50594022|FG002|Overall Study|Lost to Follow-up|1|||
25190146|NCT03164616|50347226|FG001|Overall Study|Lost to Follow-up|2|||
25190147|NCT03164616|50347227|FG002|Overall Study|Lost to Follow-up|2|||
25190148|NCT03164616|50347225|FG000|Overall Study|Withdrawal by Subject|6|||
25190149|NCT03164616|50347226|FG001|Overall Study|Withdrawal by Subject|7|||
25279508|NCT00995709|50594038|FG000|Overall Study|Adverse Event|4|||
25279509|NCT00995709|50594039|FG001|Overall Study|Adverse Event|2|||
25279510|NCT00995709|50594040|FG002|Overall Study|Adverse Event|0|||
25279511|NCT00995709|50594038|FG000|Overall Study|Lack of Efficacy|0|||
25279512|NCT00995709|50594039|FG001|Overall Study|Lack of Efficacy|1|||
25279513|NCT00995709|50594040|FG002|Overall Study|Lack of Efficacy|4|||
25279514|NCT00995709|50594038|FG000|Overall Study|Withdrawal by Subject|0|||
25279515|NCT00995709|50594039|FG001|Overall Study|Withdrawal by Subject|4|||
25279516|NCT00995709|50594040|FG002|Overall Study|Withdrawal by Subject|1|||
25279517|NCT00995709|50594038|FG000|Overall Study|Lost to Follow-up|1|||
25279518|NCT00995709|50594039|FG001|Overall Study|Lost to Follow-up|0|||
25279519|NCT00995709|50594040|FG002|Overall Study|Lost to Follow-up|0|||
25279520|NCT00995709|50594038|FG000|Overall Study|Death|0|||
25279521|NCT00995709|50594039|FG001|Overall Study|Death|1|||
25279522|NCT00995709|50594040|FG002|Overall Study|Death|0|||
25279523|NCT00995709|50594038|FG000|Overall Study|Protocol Violation|2|||
25190150|NCT03164616|50347227|FG002|Overall Study|Withdrawal by Subject|16|||
25279524|NCT00995709|50594039|FG001|Overall Study|Protocol Violation|1|||
25279525|NCT00995709|50594040|FG002|Overall Study|Protocol Violation|0|||
25279526|NCT00998985|50594062|FG000|Overall Study|Withdrawal by Subject|0|||
25279527|NCT00998985|50594063|FG001|Overall Study|Withdrawal by Subject|0|||
25279528|NCT00998985|50594064|FG002|Overall Study|Withdrawal by Subject|0|||
25279529|NCT00998985|50594065|FG003|Overall Study|Withdrawal by Subject|0|||
25279530|NCT00998985|50594066|FG004|Overall Study|Withdrawal by Subject|0|||
25279531|NCT00998985|50594067|FG005|Overall Study|Withdrawal by Subject|0|||
24969216|NCT00098748|50058706|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
24969217|NCT00098748|50058707|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
24969218|NCT00098748|50058705|FG000|Received Study Treatment|Death|2|||
24969219|NCT00098748|50058706|FG001|Received Study Treatment|Death|1|||
24969220|NCT00098748|50058707|FG002|Received Study Treatment|Death|2|||
24969221|NCT00098748|50058705|FG000|Received Study Treatment|Adverse Event|1|||
24969222|NCT00098748|50058706|FG001|Received Study Treatment|Adverse Event|2|||
24969223|NCT00098748|50058707|FG002|Received Study Treatment|Adverse Event|5|||
24969224|NCT00098748|50058705|FG000|Received Study Treatment|Lack of Efficacy|40|||
24969225|NCT00098748|50058706|FG001|Received Study Treatment|Lack of Efficacy|27|||
24969226|NCT00098748|50058707|FG002|Received Study Treatment|Lack of Efficacy|27|||
24969227|NCT00098748|50058705|FG000|Received Study Treatment|Other|2|||
24969228|NCT00098748|50058706|FG001|Received Study Treatment|Other|2|||
24969229|NCT00098748|50058707|FG002|Received Study Treatment|Other|6|||
24969230|NCT00098748|50058705|FG000|Received Study Treatment|Subject defaulted|3|||
24969231|NCT00098748|50058706|FG001|Received Study Treatment|Subject defaulted|4|||
25069662|NCT01369355|50175449|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
24969232|NCT00098748|50058707|FG002|Received Study Treatment|Subject defaulted|4|||
24969233|NCT00098748|50058705|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
24969234|NCT00098748|50058706|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
24969235|NCT00098748|50058707|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
24969236|NCT00098748|50058705|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
24969237|NCT00098748|50058706|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
25069663|NCT01369355|50175450|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
25069664|NCT01369355|50175451|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
25190151|NCT03161483|50347241|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
25190152|NCT03161483|50347242|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
25190153|NCT03161483|50347243|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
25190154|NCT03161483|50347244|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
25190155|NCT03161483|50347241|FG000|Treatment Period|Death|1|||
25190156|NCT03161483|50347242|FG001|Treatment Period|Death|0|||
25190157|NCT03161483|50347243|FG002|Treatment Period|Death|0|||
25190158|NCT03161483|50347244|FG003|Treatment Period|Death|0|||
25190159|NCT03161483|50347241|FG000|Treatment Period|Adverse Event|5|||
25190160|NCT03161483|50347242|FG001|Treatment Period|Adverse Event|2|||
25190161|NCT03161483|50347243|FG002|Treatment Period|Adverse Event|1|||
25190162|NCT03161483|50347244|FG003|Treatment Period|Adverse Event|11|||
25190163|NCT03161483|50347241|FG000|Treatment Period|Pregnancy|1|||
25190164|NCT03161483|50347242|FG001|Treatment Period|Pregnancy|0|||
25190165|NCT03161483|50347243|FG002|Treatment Period|Pregnancy|0|||
25190166|NCT03161483|50347244|FG003|Treatment Period|Pregnancy|0|||
25190167|NCT03161483|50347241|FG000|Treatment Period|Lack of Efficacy|0|||
25190168|NCT03161483|50347242|FG001|Treatment Period|Lack of Efficacy|0|||
24969238|NCT00098748|50058707|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
24995114|NCT03015532|50085969|FG003|Overall Study|Withdrawal by Subject|0|||
25168979|NCT01855919|50299486|FG001|Overall Study|Protocol Violation|4|||
25190169|NCT03161483|50347243|FG002|Treatment Period|Lack of Efficacy|0|||
25190170|NCT03161483|50347244|FG003|Treatment Period|Lack of Efficacy|1|||
25190171|NCT03161483|50347241|FG000|Treatment Period|Withdrawal by Subject|2|||
25190172|NCT03161483|50347242|FG001|Treatment Period|Withdrawal by Subject|5|||
25279532|NCT00998985|50594068|FG006|Overall Study|Withdrawal by Subject|0|||
25279533|NCT00998985|50594069|FG007|Overall Study|Withdrawal by Subject|0|||
25279534|NCT00998985|50594070|FG008|Overall Study|Withdrawal by Subject|1|||
25279535|NCT00998985|50594071|FG009|Overall Study|Withdrawal by Subject|0|||
25279536|NCT00998985|50594072|FG010|Overall Study|Withdrawal by Subject|0|||
25279537|NCT00998985|50594073|FG011|Overall Study|Withdrawal by Subject|0|||
25279538|NCT00998985|50594074|FG012|Overall Study|Withdrawal by Subject|0|||
25279539|NCT00998985|50594075|FG013|Overall Study|Withdrawal by Subject|0|||
25279540|NCT00998985|50594062|FG000|Overall Study|Protocol Violation|0|||
25279541|NCT00998985|50594063|FG001|Overall Study|Protocol Violation|0|||
25279542|NCT00998985|50594064|FG002|Overall Study|Protocol Violation|0|||
25279543|NCT00998985|50594065|FG003|Overall Study|Protocol Violation|0|||
25279544|NCT00998985|50594066|FG004|Overall Study|Protocol Violation|0|||
25279545|NCT00998985|50594067|FG005|Overall Study|Protocol Violation|1|||
25279546|NCT00998985|50594068|FG006|Overall Study|Protocol Violation|0|||
25279547|NCT00998985|50594069|FG007|Overall Study|Protocol Violation|0|||
25279548|NCT00998985|50594070|FG008|Overall Study|Protocol Violation|0|||
25279549|NCT00998985|50594071|FG009|Overall Study|Protocol Violation|0|||
25279550|NCT00998985|50594072|FG010|Overall Study|Protocol Violation|0|||
25279551|NCT00998985|50594073|FG011|Overall Study|Protocol Violation|0|||
25279552|NCT00998985|50594074|FG012|Overall Study|Protocol Violation|0|||
25279553|NCT00998985|50594075|FG013|Overall Study|Protocol Violation|0|||
25279554|NCT00995553|50594122|FG000|Overall Study|Withdrawal by Subject|2|||
25279555|NCT00995553|50594123|FG001|Overall Study|Withdrawal by Subject|6|||
25279556|NCT00991887|50594131|FG000|Overall Study|Lost to Follow-up|2|||
25279557|NCT00991887|50594132|FG001|Overall Study|Lost to Follow-up|1|||
25069665|NCT01369355|50175452|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
25069666|NCT01369355|50175453|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
25069667|NCT01369355|50175454|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
25190173|NCT03161483|50347243|FG002|Treatment Period|Withdrawal by Subject|2|||
25190174|NCT03161483|50347244|FG003|Treatment Period|Withdrawal by Subject|6|||
25190175|NCT03161483|50347241|FG000|Treatment Period|Lost to Follow-up|0|||
25190176|NCT03161483|50347242|FG001|Treatment Period|Lost to Follow-up|0|||
25190177|NCT03161483|50347243|FG002|Treatment Period|Lost to Follow-up|0|||
25190178|NCT03161483|50347244|FG003|Treatment Period|Lost to Follow-up|1|||
25190179|NCT03161483|50347241|FG000|Treatment Period|Protocol Violation|0|||
25190180|NCT03161483|50347242|FG001|Treatment Period|Protocol Violation|0|||
25190181|NCT03161483|50347243|FG002|Treatment Period|Protocol Violation|0|||
25190182|NCT03161483|50347244|FG003|Treatment Period|Protocol Violation|1|||
25190183|NCT03161483|50347241|FG000|Treatment Period|Other reasons|1|||
25190184|NCT03161483|50347242|FG001|Treatment Period|Other reasons|1|||
25190185|NCT03161483|50347243|FG002|Treatment Period|Other reasons|0|||
25190186|NCT03161483|50347244|FG003|Treatment Period|Other reasons|0|||
25190187|NCT03132636|50347258|FG000|Overall Study|Adverse Event|1|||
25190188|NCT03132636|50347259|FG001|Overall Study|Adverse Event|2|||
25190189|NCT03132636|50347258|FG000|Overall Study|Death|4|||
25190190|NCT03132636|50347259|FG001|Overall Study|Death|7|||
25190191|NCT03132636|50347258|FG000|Overall Study|Lost to Follow-up|2|||
25190192|NCT03132636|50347259|FG001|Overall Study|Lost to Follow-up|2|||
25190193|NCT03132636|50347258|FG000|Overall Study|Protocol Violation|1|||
25190194|NCT03132636|50347259|FG001|Overall Study|Protocol Violation|1|||
25190195|NCT03132636|50347258|FG000|Overall Study|Participant Decision|1|||
25190196|NCT03132636|50347259|FG001|Overall Study|Participant Decision|9|||
25190197|NCT03132636|50347258|FG000|Overall Study|Sponsor Decision|0|||
25190198|NCT03132636|50347259|FG001|Overall Study|Sponsor Decision|1|||
25190199|NCT03132636|50347258|FG000|Overall Study|Progressive disease|32|||
25190200|NCT03132636|50347259|FG001|Overall Study|Progressive disease|36|||
25190201|NCT03132636|50347258|FG000|Overall Study|Withdrawal of consent|2|||
25190202|NCT03132636|50347259|FG001|Overall Study|Withdrawal of consent|5|||
25190203|NCT03132636|50347258|FG000|Overall Study|Study ongoing|9|||
25190204|NCT03132636|50347259|FG001|Overall Study|Study ongoing|10|||
25190205|NCT03132636|50347258|FG000|Overall Study|Other|1|||
25190206|NCT03132636|50347259|FG001|Overall Study|Other|2|||
25190207|NCT02906202|50347265|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
25190208|NCT02890355|50347271|FG000|Overall Study|Adverse Event|5|||
25190209|NCT02890355|50347272|FG001|Overall Study|Adverse Event|5|||
25190210|NCT02890355|50347271|FG000|Overall Study|Refusal unrelated to adverse event|5|||
25190211|NCT02890355|50347272|FG001|Overall Study|Refusal unrelated to adverse event|10|||
25190212|NCT02890355|50347271|FG000|Overall Study|Progression/relapse|46|||
25190213|NCT02890355|50347272|FG001|Overall Study|Progression/relapse|39|||
25279558|NCT01002339|50594141|FG000|Overall Study|Withdrawal by Subject|0|||
25279559|NCT01002339|50594142|FG001|Overall Study|Withdrawal by Subject|1|||
25279560|NCT01002339|50594143|FG002|Overall Study|Withdrawal by Subject|0|||
25190214|NCT02890355|50347271|FG000|Overall Study|Not protocol specified|3|||
25190215|NCT02890355|50347272|FG001|Overall Study|Not protocol specified|4|||
25190216|NCT02869789|50347284|FG000|Overall Study|Disease progression|184|||
25190217|NCT02869789|50347285|FG001|Overall Study|Disease progression|109|||
25190218|NCT02869789|50347286|FG002|Overall Study|Disease progression|260|||
25190219|NCT02869789|50347287|FG003|Overall Study|Disease progression|19|||
25279561|NCT01002339|50594141|FG000|Overall Study|Incorrect treatment assignment|0|||
25279562|NCT01002339|50594142|FG001|Overall Study|Incorrect treatment assignment|0|||
25279563|NCT01002339|50594143|FG002|Overall Study|Incorrect treatment assignment|1|||
25279564|NCT01002339|50594141|FG000|Overall Study|Protocol Violation|0|||
25279565|NCT01002339|50594142|FG001|Overall Study|Protocol Violation|0|||
25279566|NCT01002339|50594143|FG002|Overall Study|Protocol Violation|2|||
25279567|NCT01002339|50594141|FG000|Overall Study|Lung cancer detected before transplant|0|||
25279568|NCT01002339|50594142|FG001|Overall Study|Lung cancer detected before transplant|0|||
25279569|NCT01002339|50594143|FG002|Overall Study|Lung cancer detected before transplant|1|||
25279570|NCT01002339|50594141|FG000|Overall Study|Randomized. Not transplanted|0|||
25279571|NCT01002339|50594142|FG001|Overall Study|Randomized. Not transplanted|0|||
25279572|NCT01002339|50594143|FG002|Overall Study|Randomized. Not transplanted|1|||
25279573|NCT01002105|50594153|FG000|Overall Study|Lost to Follow-up|10|||
25279574|NCT01002105|50594154|FG001|Overall Study|Lost to Follow-up|16|||
25279575|NCT01002105|50594153|FG000|Overall Study|non compliance|5|||
25279576|NCT01002105|50594154|FG001|Overall Study|non compliance|3|||
25279577|NCT01002105|50594153|FG000|Overall Study|condition worsened|4|||
25279578|NCT01002105|50594154|FG001|Overall Study|condition worsened|2|||
25279579|NCT02605993|50594167|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
25279580|NCT02605993|50594168|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
25279581|NCT02605993|50594169|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
25279582|NCT02605993|50594170|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
25279583|NCT00995085|50594180|FG000|Overall Study|Withdrawal by Subject|5|||
25279584|NCT00603733|50594186|FG000|Active Phase ITT|Adverse Event|8|||
25279585|NCT00603733|50594187|FG001|Active Phase ITT|Adverse Event|7|||
25279586|NCT00603733|50594186|FG000|Active Phase ITT|Withdrawal by Subject|0|||
25279587|NCT00603733|50594187|FG001|Active Phase ITT|Withdrawal by Subject|3|||
25279588|NCT00603733|50594186|FG000|Active Phase ITT|Lost to Follow-up|0|||
25279589|NCT00603733|50594187|FG001|Active Phase ITT|Lost to Follow-up|1|||
25069668|NCT01369355|50175446|FG000|Long-term Extension (Week 44-272)|Other|0|||
25069669|NCT01369355|50175447|FG001|Long-term Extension (Week 44-272)|Other|0|||
25279590|NCT00603733|50594186|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
25279591|NCT00603733|50594187|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
25279592|NCT00603733|50594186|FG000|Active Phase ITT|Lack of Efficacy|1|||
25279593|NCT00603733|50594187|FG001|Active Phase ITT|Lack of Efficacy|2|||
25279594|NCT00603733|50594186|FG000|Active Phase ITT|Subject moved, site closed|1|||
25279595|NCT00603733|50594187|FG001|Active Phase ITT|Subject moved, site closed|1|||
25279596|NCT00603733|50594186|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
25279597|NCT00603733|50594187|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
25279598|NCT00603733|50594186|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
25279599|NCT00603733|50594187|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
25279600|NCT00603733|50594186|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
25279601|NCT00603733|50594187|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
25279602|NCT00603733|50594186|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
25279603|NCT00603733|50594187|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
25279604|NCT00603733|50594186|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
25279605|NCT00603733|50594187|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
25279606|NCT00603733|50594186|FG000|Maintenance Phase ITT|Adverse Event|3|||
25279607|NCT00603733|50594187|FG001|Maintenance Phase ITT|Adverse Event|6|||
25279608|NCT00603733|50594186|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
25279609|NCT00603733|50594187|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
25279610|NCT00603733|50594186|FG000|Maintenance Phase ITT|Protocol Violation|1|||
25279611|NCT00603733|50594187|FG001|Maintenance Phase ITT|Protocol Violation|1|||
25279612|NCT00603733|50594186|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
25279613|NCT00603733|50594187|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
25279614|NCT00603733|50594186|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
25279615|NCT00603733|50594187|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
25279616|NCT00603733|50594186|FG000|Maintenance Phase ITT|Physician Decision|0|||
25279617|NCT00603733|50594187|FG001|Maintenance Phase ITT|Physician Decision|1|||
25279618|NCT00603733|50594186|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
25279619|NCT00603733|50594187|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
25279620|NCT04631107|50594193|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
25279621|NCT04631107|50594193|FG000|Second Intervention (1 Night)|Adverse Event|1|||
25279622|NCT04631107|50594193|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
25279623|NCT04631107|50594193|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
25279624|NCT00995007|50594203|FG000|Overall Study|Withdrew consent|1|||
25279625|NCT00995007|50594204|FG001|Overall Study|Withdrew consent|0|||
25279626|NCT00995007|50594203|FG000|Overall Study|Refused further treatment|8|||
25279627|NCT00995007|50594204|FG001|Overall Study|Refused further treatment|2|||
25279628|NCT00995007|50594203|FG000|Overall Study|Toxicity|8|||
25279629|NCT00995007|50594204|FG001|Overall Study|Toxicity|0|||
25279630|NCT00994461|50594222|FG000|Overall Study|Adverse Event|2|||
25279631|NCT00994461|50594223|FG001|Overall Study|Adverse Event|1|||
25279632|NCT00994461|50594224|FG002|Overall Study|Adverse Event|0|||
25279633|NCT00993915|50594232|FG000|Overall Study|Insufficient clinical response|3|||
25279634|NCT00993915|50594232|FG000|Overall Study|Withdrawal by Subject|2|||
25279635|NCT00993915|50594232|FG000|Overall Study|Other|1|||
25279636|NCT00993915|50594232|FG000|Overall Study|Ongoing|3|||
25279637|NCT01202591|50594242|FG000|Overall Study|Adverse Event|2|||
25279638|NCT01202591|50594243|FG001|Overall Study|Adverse Event|1|||
25279639|NCT01202591|50594244|FG002|Overall Study|Adverse Event|4|||
25279640|NCT01202591|50594245|FG003|Overall Study|Adverse Event|4|||
25279641|NCT01202591|50594246|FG004|Overall Study|Adverse Event|0|||
25279642|NCT01202591|50594247|FG005|Overall Study|Adverse Event|0|||
25190220|NCT02869789|50347284|FG000|Overall Study|Study drug toxicity|90|||
25190221|NCT02869789|50347285|FG001|Overall Study|Study drug toxicity|32|||
25190222|NCT02869789|50347286|FG002|Overall Study|Study drug toxicity|55|||
25279643|NCT01202591|50594242|FG000|Overall Study|Other reason as per investigator|3|||
25279644|NCT01202591|50594243|FG001|Overall Study|Other reason as per investigator|4|||
25279645|NCT01202591|50594244|FG002|Overall Study|Other reason as per investigator|7|||
25279646|NCT01202591|50594245|FG003|Overall Study|Other reason as per investigator|3|||
25279647|NCT01202591|50594246|FG004|Overall Study|Other reason as per investigator|1|||
25279648|NCT01202591|50594247|FG005|Overall Study|Other reason as per investigator|3|||
25279649|NCT01202591|50594242|FG000|Overall Study|Withdrawal by Subject|0|||
25279650|NCT01202591|50594243|FG001|Overall Study|Withdrawal by Subject|0|||
25279651|NCT01202591|50594244|FG002|Overall Study|Withdrawal by Subject|0|||
25279652|NCT01202591|50594245|FG003|Overall Study|Withdrawal by Subject|0|||
25279653|NCT01202591|50594246|FG004|Overall Study|Withdrawal by Subject|2|||
25279654|NCT01202591|50594247|FG005|Overall Study|Withdrawal by Subject|1|||
25279655|NCT01202591|50594242|FG000|Overall Study|Objective Disease Progression|0|||
25279656|NCT01202591|50594243|FG001|Overall Study|Objective Disease Progression|0|||
25279657|NCT01202591|50594244|FG002|Overall Study|Objective Disease Progression|0|||
25279658|NCT01202591|50594245|FG003|Overall Study|Objective Disease Progression|0|||
25279659|NCT01202591|50594246|FG004|Overall Study|Objective Disease Progression|2|||
25279660|NCT01202591|50594247|FG005|Overall Study|Objective Disease Progression|0|||
25279661|NCT01202279|50594263|FG000|Overall Study|Adverse Event|8|||
25279662|NCT01202279|50594264|FG001|Overall Study|Adverse Event|6|||
25279663|NCT01202279|50594263|FG000|Overall Study|Withdrawal by Subject|13|||
25279664|NCT01202279|50594264|FG001|Overall Study|Withdrawal by Subject|10|||
25279665|NCT01202279|50594263|FG000|Overall Study|Physician Decision|0|||
25279666|NCT01202279|50594264|FG001|Overall Study|Physician Decision|1|||
25279667|NCT01202279|50594263|FG000|Overall Study|Lost to Follow-up|10|||
25279668|NCT01202279|50594264|FG001|Overall Study|Lost to Follow-up|7|||
25279669|NCT01202279|50594263|FG000|Overall Study|Protocol Violation|1|||
25279670|NCT01202279|50594264|FG001|Overall Study|Protocol Violation|1|||
25190223|NCT02869789|50347287|FG003|Overall Study|Study drug toxicity|14|||
25190224|NCT02869789|50347284|FG000|Overall Study|Death|7|||
25190225|NCT02869789|50347285|FG001|Overall Study|Death|3|||
25190226|NCT02869789|50347286|FG002|Overall Study|Death|5|||
25190227|NCT02869789|50347287|FG003|Overall Study|Death|1|||
25190228|NCT02869789|50347284|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
25190229|NCT02869789|50347285|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
25190230|NCT02869789|50347286|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
25190231|NCT02869789|50347287|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
25190232|NCT02869789|50347284|FG000|Overall Study|Participant request to discontinue study treatment|10|||
25190233|NCT02869789|50347285|FG001|Overall Study|Participant request to discontinue study treatment|5|||
25190234|NCT02869789|50347286|FG002|Overall Study|Participant request to discontinue study treatment|5|||
25190235|NCT02869789|50347287|FG003|Overall Study|Participant request to discontinue study treatment|3|||
25190236|NCT02869789|50347284|FG000|Overall Study|Withdrawal by Subject|5|||
25190237|NCT02869789|50347285|FG001|Overall Study|Withdrawal by Subject|2|||
25190238|NCT02869789|50347286|FG002|Overall Study|Withdrawal by Subject|7|||
25190239|NCT02869789|50347287|FG003|Overall Study|Withdrawal by Subject|2|||
25190240|NCT02869789|50347284|FG000|Overall Study|Lost to Follow-up|0|||
25190241|NCT02869789|50347285|FG001|Overall Study|Lost to Follow-up|0|||
25190242|NCT02869789|50347286|FG002|Overall Study|Lost to Follow-up|2|||
25190243|NCT02869789|50347287|FG003|Overall Study|Lost to Follow-up|0|||
25190244|NCT02869789|50347284|FG000|Overall Study|Maximum clinical benefit|5|||
25190245|NCT02869789|50347285|FG001|Overall Study|Maximum clinical benefit|2|||
25190246|NCT02869789|50347286|FG002|Overall Study|Maximum clinical benefit|1|||
25190247|NCT02869789|50347287|FG003|Overall Study|Maximum clinical benefit|0|||
25190248|NCT02869789|50347284|FG000|Overall Study|Poor/Non-compliance|0|||
25190249|NCT02869789|50347285|FG001|Overall Study|Poor/Non-compliance|2|||
25190250|NCT02869789|50347286|FG002|Overall Study|Poor/Non-compliance|1|||
25190251|NCT02869789|50347287|FG003|Overall Study|Poor/Non-compliance|0|||
25190252|NCT02869789|50347284|FG000|Overall Study|Participant no longer meets study criteria|0|||
25190253|NCT02869789|50347285|FG001|Overall Study|Participant no longer meets study criteria|1|||
25279671|NCT01202279|50594263|FG000|Overall Study|study compliance|5|||
25279672|NCT01202279|50594264|FG001|Overall Study|study compliance|2|||
25279673|NCT01201967|50594272|FG000|Overall Study|Lost to Follow-up|6|||
25279674|NCT01201967|50594273|FG001|Overall Study|Lost to Follow-up|5|||
25279675|NCT01201811|50594289|FG000|Overall Study|Adverse Event|6|||
25279676|NCT01201811|50594289|FG000|Overall Study|Disease progression|3|||
25279677|NCT01201811|50594289|FG000|Overall Study|Withdrawal by Subject|3|||
25279678|NCT01201811|50594289|FG000|Overall Study|Death|4|||
25279679|NCT01201811|50594289|FG000|Overall Study|Treatment Failure|2|||
25279680|NCT01201811|50594289|FG000|Overall Study|Physician Decision|1|||
25279681|NCT01201343|50594293|FG000|Overall Study|Adverse Event|6|||
25279682|NCT01201343|50594293|FG000|Overall Study|Withdrawal by Subject|5|||
25279683|NCT01201343|50594293|FG000|Overall Study|Lost to Follow-up|2|||
25279684|NCT01201343|50594293|FG000|Overall Study|Lack of Efficacy|2|||
25279685|NCT01201343|50594293|FG000|Overall Study|Participant wrongly included in trial|1|||
25279686|NCT01201343|50594293|FG000|Overall Study|Randomized, not treated|3|||
25279687|NCT01201265|50594297|FG000|Overall Study|Death|14|||
25279688|NCT01201265|50594297|FG000|Overall Study|Insufficient Therapeutic Response|3|||
25279689|NCT01201265|50594297|FG000|Overall Study|Lost to Follow-up|10|||
25279690|NCT01201265|50594297|FG000|Overall Study|Withdrawal by Subject|7|||
25279691|NCT01201265|50594297|FG000|Overall Study|Disease Progression|4|||
25279692|NCT04246801|50594303|FG000|Overall Study|Adverse Event|1|||
25190254|NCT02869789|50347286|FG002|Overall Study|Participant no longer meets study criteria|1|||
25190255|NCT02869789|50347287|FG003|Overall Study|Participant no longer meets study criteria|0|||
25190256|NCT02869789|50347284|FG000|Overall Study|Administrative reason by sponsor|0|||
25190257|NCT02869789|50347285|FG001|Overall Study|Administrative reason by sponsor|0|||
25190258|NCT02869789|50347286|FG002|Overall Study|Administrative reason by sponsor|1|||
25190259|NCT02869789|50347287|FG003|Overall Study|Administrative reason by sponsor|0|||
25190260|NCT02869789|50347284|FG000|Overall Study|Other reasons|4|||
25190261|NCT02869789|50347285|FG001|Overall Study|Other reasons|8|||
25190262|NCT02869789|50347286|FG002|Overall Study|Other reasons|6|||
25190263|NCT02869789|50347287|FG003|Overall Study|Other reasons|0|||
25190264|NCT02760485|50347308|FG000|Phase 1|Death|3|||
25190265|NCT02760485|50347309|FG001|Phase 1|Death|6|||
25190266|NCT02760485|50347310|FG002|Phase 1|Death|0|||
25190267|NCT02760485|50347308|FG000|Phase 1|Withdrawal by Subject|2|||
25190268|NCT02760485|50347309|FG001|Phase 1|Withdrawal by Subject|0|||
25190269|NCT02760485|50347310|FG002|Phase 1|Withdrawal by Subject|0|||
25190270|NCT02760485|50347308|FG000|Phase 1|Progressive Disease|1|||
25190271|NCT02760485|50347309|FG001|Phase 1|Progressive Disease|0|||
25279693|NCT04246801|50594304|FG001|Overall Study|Adverse Event|1|||
25279694|NCT04246801|50594303|FG000|Overall Study|Protocol Violation|1|||
25279695|NCT04246801|50594304|FG001|Overall Study|Protocol Violation|1|||
25279696|NCT04246801|50594303|FG000|Overall Study|Lack of Efficacy|0|||
25279697|NCT04246801|50594304|FG001|Overall Study|Lack of Efficacy|2|||
25279698|NCT04246801|50594303|FG000|Overall Study|Lost to Follow-up|1|||
25279699|NCT04246801|50594304|FG001|Overall Study|Lost to Follow-up|1|||
25279700|NCT04246801|50594303|FG000|Overall Study|Withdrawal by Subject|2|||
25279701|NCT04246801|50594304|FG001|Overall Study|Withdrawal by Subject|1|||
25279702|NCT01200797|50594310|FG000|Overall Study|symptomatic deterioration|2|||
25279703|NCT01200797|50594310|FG000|Overall Study|Adverse Event|4|||
25279704|NCT01200797|50594310|FG000|Overall Study|Disease Progression|13|||
25279705|NCT01200485|50594315|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
25279706|NCT01200485|50594316|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
25279707|NCT01200485|50594317|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
25279708|NCT01200485|50594315|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
25279709|NCT01200485|50594316|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
25279710|NCT01200485|50594317|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
25279711|NCT01200407|50594324|FG000|Overall Study|Lost to Follow-up|56|||
25190272|NCT02760485|50347310|FG002|Phase 1|Progressive Disease|0|||
25190273|NCT02760485|50347308|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
25190274|NCT02760485|50347309|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
25190275|NCT02760485|50347310|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
25190276|NCT02760485|50347308|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
25190277|NCT02760485|50347309|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
25190278|NCT02760485|50347310|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
25190279|NCT02760485|50347308|FG000|Phase 2|Death|0|||
25190280|NCT02760485|50347309|FG001|Phase 2|Death|0|||
25190281|NCT02760485|50347310|FG002|Phase 2|Death|12|||
25190282|NCT02760485|50347308|FG000|Phase 2|Withdrawal by Subject|0|||
25190283|NCT02760485|50347309|FG001|Phase 2|Withdrawal by Subject|0|||
25190284|NCT02760485|50347310|FG002|Phase 2|Withdrawal by Subject|3|||
25190285|NCT02760485|50347308|FG000|Phase 2|Progressive Disease|0|||
25190286|NCT02760485|50347309|FG001|Phase 2|Progressive Disease|0|||
25279712|NCT01200407|50594324|FG000|Overall Study|Adverse Event|3|||
25279713|NCT01200407|50594324|FG000|Overall Study|Withdrawal by Subject|4|||
25279714|NCT01200407|50594324|FG000|Overall Study|Other|19|||
25279715|NCT01200329|50594328|FG000|Overall Study|Lack of financial coverage|2|||
25279716|NCT01200329|50594328|FG000|Overall Study|Progressive disease|1|||
25190287|NCT02760485|50347310|FG002|Phase 2|Progressive Disease|1|||
25279717|NCT01199939|50594332|FG000|Overall Study|Adverse Event|4|||
25279718|NCT01199939|50594332|FG000|Overall Study|Protocol Violation|3|||
25279719|NCT01199939|50594332|FG000|Overall Study|Lost to Follow-up|2|||
25279720|NCT01199939|50594332|FG000|Overall Study|Reached a virologic endpoint|4|||
25279721|NCT01199861|50594338|FG000|Overall Study|Administrative problems|1|||
25279722|NCT01199861|50594339|FG001|Overall Study|Administrative problems|0|||
25279723|NCT01199861|50594338|FG000|Overall Study|Adverse Event|1|||
25279724|NCT01199861|50594339|FG001|Overall Study|Adverse Event|0|||
25279725|NCT01199705|50594359|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
25279726|NCT01199471|50594374|FG000|Overall Study|Protocol Violation|4|||
25279727|NCT01199471|50594374|FG000|Overall Study|Withdrawal by Subject|1|||
25279728|NCT01199471|50594374|FG000|Overall Study|Physician Decision|1|||
25279729|NCT01198145|50594381|FG000|Overall Study|Withdrawal by Subject|1|||
25279730|NCT01198145|50594382|FG001|Overall Study|Withdrawal by Subject|1|||
25279731|NCT01197911|50594392|FG000|Overall Study|Adverse Event|0|||
25279732|NCT01197911|50594393|FG001|Overall Study|Adverse Event|0|||
25279733|NCT01197911|50594394|FG002|Overall Study|Adverse Event|1|||
25279734|NCT01197755|50594406|FG000|Overall Study|Adverse Event|8|||
25279735|NCT01197755|50594407|FG001|Overall Study|Adverse Event|10|||
25279736|NCT01197755|50594408|FG002|Overall Study|Adverse Event|10|||
25279737|NCT01197755|50594406|FG000|Overall Study|Study-specific discontinuation criteria|2|||
25279738|NCT01197755|50594407|FG001|Overall Study|Study-specific discontinuation criteria|1|||
25279739|NCT01197755|50594408|FG002|Overall Study|Study-specific discontinuation criteria|0|||
25279740|NCT01197755|50594406|FG000|Overall Study|Entered the long-term extension study|18|||
25279741|NCT01197755|50594407|FG001|Overall Study|Entered the long-term extension study|21|||
25279742|NCT01197755|50594408|FG002|Overall Study|Entered the long-term extension study|35|||
25279743|NCT01197755|50594406|FG000|Overall Study|Lack of therapeutic response|0|||
25279744|NCT01197755|50594407|FG001|Overall Study|Lack of therapeutic response|7|||
25279745|NCT01197755|50594408|FG002|Overall Study|Lack of therapeutic response|4|||
25279746|NCT01197755|50594406|FG000|Overall Study|Severe non-compliance to the protocol|2|||
25279747|NCT01197755|50594407|FG001|Overall Study|Severe non-compliance to the protocol|1|||
25279748|NCT01197755|50594408|FG002|Overall Study|Severe non-compliance to the protocol|2|||
25279749|NCT01197755|50594406|FG000|Overall Study|Withdrawal by Subject|1|||
25279750|NCT01197755|50594407|FG001|Overall Study|Withdrawal by Subject|0|||
25279751|NCT01197755|50594408|FG002|Overall Study|Withdrawal by Subject|0|||
25279752|NCT01197755|50594406|FG000|Overall Study|Lost to Follow-up|0|||
25279753|NCT01197755|50594407|FG001|Overall Study|Lost to Follow-up|0|||
25279754|NCT01197755|50594408|FG002|Overall Study|Lost to Follow-up|1|||
25279755|NCT01197755|50594406|FG000|Overall Study|eg, change in circumstances|7|||
25279756|NCT01197755|50594407|FG001|Overall Study|eg, change in circumstances|3|||
25279757|NCT01197755|50594408|FG002|Overall Study|eg, change in circumstances|2|||
25279758|NCT01179048|50594420|FG000|Overall Study|Withdrawn - does not allow contact|4|||
25279759|NCT01179048|50594421|FG001|Overall Study|Withdrawn - does not allow contact|8|||
25279760|NCT01179048|50594420|FG000|Overall Study|Lost to Follow-up|8|||
25279761|NCT01179048|50594421|FG001|Overall Study|Lost to Follow-up|9|||
25279762|NCT01179048|50594420|FG000|Overall Study|Alive|127|||
25279763|NCT01179048|50594421|FG001|Overall Study|Alive|142|||
25279764|NCT00603265|50594430|FG000|Overall Study|Adverse Event|2|||
25279765|NCT00603265|50594431|FG001|Overall Study|Adverse Event|11|||
25279766|NCT00603265|50594432|FG002|Overall Study|Adverse Event|1|||
25279767|NCT00603265|50594430|FG000|Overall Study|Withdrawal by Subject|1|||
25279768|NCT00603265|50594431|FG001|Overall Study|Withdrawal by Subject|2|||
25279769|NCT00603265|50594432|FG002|Overall Study|Withdrawal by Subject|1|||
25279770|NCT00603265|50594430|FG000|Overall Study|Lack of Efficacy|3|||
25279771|NCT00603265|50594431|FG001|Overall Study|Lack of Efficacy|0|||
25279772|NCT00603265|50594432|FG002|Overall Study|Lack of Efficacy|3|||
25279773|NCT00603265|50594430|FG000|Overall Study|Lost to Follow-up|0|||
25279774|NCT00603265|50594431|FG001|Overall Study|Lost to Follow-up|1|||
25279775|NCT00603265|50594432|FG002|Overall Study|Lost to Follow-up|0|||
25279776|NCT00603265|50594430|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
25279777|NCT00603265|50594431|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
25279778|NCT00603265|50594432|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
25279779|NCT00603265|50594430|FG000|Overall Study|Participant Left Country, No Responses|0|||
25279780|NCT00603265|50594431|FG001|Overall Study|Participant Left Country, No Responses|1|||
25279781|NCT00603265|50594432|FG002|Overall Study|Participant Left Country, No Responses|0|||
25279782|NCT00603265|50594430|FG000|Overall Study|Protocol Violation|1|||
25279783|NCT00603265|50594431|FG001|Overall Study|Protocol Violation|0|||
25279784|NCT00603265|50594432|FG002|Overall Study|Protocol Violation|0|||
25279785|NCT04010227|50594442|FG000|Overall Study|Death|1|||
25279786|NCT04010227|50594443|FG001|Overall Study|Death|2|||
25279787|NCT04010227|50594442|FG000|Overall Study|Medical Reasons|4|||
25279788|NCT04010227|50594443|FG001|Overall Study|Medical Reasons|3|||
25279789|NCT04010227|50594442|FG000|Overall Study|Withdrawal by Subject|2|||
25279790|NCT04010227|50594443|FG001|Overall Study|Withdrawal by Subject|0|||
25279791|NCT04010227|50594442|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
25279792|NCT04010227|50594443|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
25279793|NCT01158534|50594450|FG000|Overall Study|Withdrawal by Subject|1|||
25279794|NCT01158534|50594450|FG000|Overall Study|Death|1|||
25279795|NCT01158534|50594450|FG000|Overall Study|Other|1|||
25279796|NCT01158378|50594456|FG000|Overall Study|Death|4|||
25279797|NCT01158378|50594457|FG001|Overall Study|Death|5|||
25279798|NCT01158378|50594456|FG000|Overall Study|Lost to Follow-up|2|||
25279799|NCT01158378|50594457|FG001|Overall Study|Lost to Follow-up|4|||
25279800|NCT01158378|50594456|FG000|Overall Study|Withdrawal by Subject|4|||
25279801|NCT01158378|50594457|FG001|Overall Study|Withdrawal by Subject|0|||
25279802|NCT00602797|50594464|FG000|Overall Study|Adverse Event|1|||
25279803|NCT01158222|50594469|FG000|Overall Study|Not eligible for intermediate phase|17|||
25279804|NCT01197521|50594476|FG000|Overall Study|Not reported|24|||
25279805|NCT01197521|50594477|FG001|Overall Study|Not reported|25|||
25279806|NCT01197521|50594478|FG002|Overall Study|Not reported|21|||
25279807|NCT01197521|50594476|FG000|Overall Study|Enrolment in long term extension|42|||
25279808|NCT01197521|50594477|FG001|Overall Study|Enrolment in long term extension|36|||
25279809|NCT01197521|50594478|FG002|Overall Study|Enrolment in long term extension|87|||
25279810|NCT01197521|50594476|FG000|Overall Study|Severe non-compliance to protocol|1|||
25279811|NCT01197521|50594477|FG001|Overall Study|Severe non-compliance to protocol|3|||
25279812|NCT01197521|50594478|FG002|Overall Study|Severe non-compliance to protocol|3|||
25279813|NCT01197521|50594476|FG000|Overall Study|Lack of therapeutic response|2|||
25279814|NCT01197521|50594477|FG001|Overall Study|Lack of therapeutic response|3|||
25279815|NCT01197521|50594478|FG002|Overall Study|Lack of therapeutic response|4|||
25279816|NCT01197521|50594476|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
25279817|NCT01197521|50594477|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
24969239|NCT00098748|50058705|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
24969240|NCT00098748|50058706|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
24969241|NCT00098748|50058707|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
24969242|NCT00098748|50058705|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
24969243|NCT00098748|50058706|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
24969244|NCT00098748|50058707|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
24969245|NCT00098748|50058705|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
24969246|NCT00098748|50058706|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
25069670|NCT01369355|50175448|FG002|Long-term Extension (Week 44-272)|Other|0|||
25069671|NCT01369355|50175449|FG003|Long-term Extension (Week 44-272)|Other|0|||
25190288|NCT02760485|50347308|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
25190289|NCT02760485|50347309|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
25190290|NCT02760485|50347310|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
25190291|NCT02634333|50347345|FG000|Overall Study|Completed out of Window|3|||
25190292|NCT02634333|50347346|FG001|Overall Study|Completed out of Window|2|||
25190293|NCT02634333|50347345|FG000|Overall Study|Missed Visit|5|||
25190294|NCT02634333|50347346|FG001|Overall Study|Missed Visit|2|||
25190295|NCT02634333|50347345|FG000|Overall Study|Lost to Follow-up|12|||
25190296|NCT02634333|50347346|FG001|Overall Study|Lost to Follow-up|7|||
25190297|NCT02634333|50347345|FG000|Overall Study|Withdrawal by Subject|9|||
25190298|NCT02634333|50347346|FG001|Overall Study|Withdrawal by Subject|13|||
25190299|NCT02634333|50347345|FG000|Overall Study|Death|11|||
25190300|NCT02634333|50347346|FG001|Overall Study|Death|8|||
25279818|NCT01197521|50594478|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
25279819|NCT01197521|50594476|FG000|Overall Study|Lost to Follow-up|3|||
25279820|NCT01197521|50594477|FG001|Overall Study|Lost to Follow-up|2|||
25279821|NCT01197521|50594478|FG002|Overall Study|Lost to Follow-up|2|||
25279822|NCT01197521|50594476|FG000|Overall Study|Adverse Event|25|||
25279823|NCT01197521|50594477|FG001|Overall Study|Adverse Event|28|||
25279824|NCT01197521|50594478|FG002|Overall Study|Adverse Event|24|||
25279825|NCT01157676|50594491|FG000|Randomization|Death|1|||
25190301|NCT02515630|50347364|FG000|Overall Study|Withdrawal by Subject|5|||
25190302|NCT02515630|50347364|FG000|Overall Study|Adverse Event|4|||
25279826|NCT01157676|50594492|FG001|Randomization|Death|1|||
25279827|NCT01157676|50594491|FG000|Randomization|unresectable|2|||
25279828|NCT01157676|50594492|FG001|Randomization|unresectable|3|||
25279829|NCT01157676|50594491|FG000|Randomization|Withdrawal by Subject|17|||
25279830|NCT01157676|50594492|FG001|Randomization|Withdrawal by Subject|13|||
25279831|NCT01157676|50594491|FG000|Randomization|Physician Decision|1|||
25279832|NCT01157676|50594492|FG001|Randomization|Physician Decision|0|||
25279833|NCT01157676|50594491|FG000|Surgery|underwent open cystectomy|0|||
25279834|NCT01157676|50594492|FG001|Surgery|underwent open cystectomy|4|||
25279835|NCT01157676|50594491|FG000|Surgery|converted to open procedure|0|||
25279836|NCT01157676|50594492|FG001|Surgery|converted to open procedure|5|||
25279837|NCT01157676|50594491|FG000|Surgery|underwent robotic cystectomy|1|||
25279838|NCT01157676|50594492|FG001|Surgery|underwent robotic cystectomy|0|||
25279839|NCT00991341|50594506|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
25279840|NCT00991341|50594507|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
25279841|NCT00991341|50594506|FG000|Overall Study|Death|3|||
25279842|NCT00991341|50594507|FG001|Overall Study|Death|0|||
25279843|NCT00991341|50594506|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
25279844|NCT00991341|50594507|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
25279845|NCT00991341|50594506|FG000|Overall Study|Physician Decision|1|||
25279846|NCT00991341|50594507|FG001|Overall Study|Physician Decision|2|||
25279847|NCT00991341|50594506|FG000|Overall Study|Withdrawal by Subject|3|||
25279848|NCT00991341|50594507|FG001|Overall Study|Withdrawal by Subject|4|||
25190303|NCT02515630|50347364|FG000|Overall Study|Physician Decision|4|||
25190304|NCT02515630|50347364|FG000|Overall Study|Death|2|||
25190305|NCT02515630|50347364|FG000|Overall Study|Disease Progression|1|||
25190306|NCT02450331|50347373|FG000|Overall Study|Death|162|||
25190307|NCT02450331|50347374|FG001|Overall Study|Death|171|||
25190308|NCT02450331|50347373|FG000|Overall Study|Lost to Follow-up|14|||
25190309|NCT02450331|50347374|FG001|Overall Study|Lost to Follow-up|12|||
25190310|NCT02450331|50347373|FG000|Overall Study|Withdrawal by Subject|55|||
25190311|NCT02450331|50347374|FG001|Overall Study|Withdrawal by Subject|44|||
25190312|NCT02450331|50347373|FG000|Overall Study|Non-specified other|1|||
25190313|NCT02450331|50347374|FG001|Overall Study|Non-specified other|1|||
25190314|NCT02335944|50347391|FG000|Treatment Phase|Progressive Disease|2|||
25190315|NCT02335944|50347392|FG001|Treatment Phase|Progressive Disease|5|||
25190316|NCT02335944|50347393|FG002|Treatment Phase|Progressive Disease|2|||
25190317|NCT02335944|50347394|FG003|Treatment Phase|Progressive Disease|11|||
25190318|NCT02335944|50347395|FG004|Treatment Phase|Progressive Disease|4|||
25190319|NCT02335944|50347396|FG005|Treatment Phase|Progressive Disease|25|||
25190320|NCT02335944|50347397|FG006|Treatment Phase|Progressive Disease|2|||
25190321|NCT02335944|50347398|FG007|Treatment Phase|Progressive Disease|30|||
25190322|NCT02335944|50347399|FG008|Treatment Phase|Progressive Disease|27|||
25190323|NCT02335944|50347400|FG009|Treatment Phase|Progressive Disease|0|||
25190324|NCT02335944|50347391|FG000|Treatment Phase|Adverse Event|2|||
25190325|NCT02335944|50347392|FG001|Treatment Phase|Adverse Event|0|||
25279849|NCT00990249|50594513|FG000|Overall Study|Disease Progression|8|||
25279850|NCT00990249|50594513|FG000|Overall Study|Non-Compliance|1|||
25279851|NCT00990249|50594513|FG000|Overall Study|Death|2|||
25279852|NCT00990249|50594513|FG000|Overall Study|Not treated|2|||
25279853|NCT02846545|50594519|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
25279854|NCT02846545|50594520|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
25279855|NCT02846545|50594519|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
25279856|NCT02846545|50594520|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
25279857|NCT02846545|50594519|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
25279858|NCT02846545|50594520|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
25279859|NCT02846545|50594519|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
25279860|NCT02846545|50594520|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
25279861|NCT02846545|50594519|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
25168980|NCT01871519|50299502|FG000|Overall Study|Death|26|||
25190326|NCT02335944|50347393|FG002|Treatment Phase|Adverse Event|0|||
25190327|NCT02335944|50347394|FG003|Treatment Phase|Adverse Event|2|||
25190328|NCT02335944|50347395|FG004|Treatment Phase|Adverse Event|1|||
25190329|NCT02335944|50347396|FG005|Treatment Phase|Adverse Event|15|||
25190330|NCT02335944|50347397|FG006|Treatment Phase|Adverse Event|0|||
25279862|NCT02846545|50594520|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
25190331|NCT02335944|50347398|FG007|Treatment Phase|Adverse Event|5|||
25190332|NCT02335944|50347399|FG008|Treatment Phase|Adverse Event|7|||
24969247|NCT00098748|50058707|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
25168981|NCT01871519|50299502|FG000|Overall Study|Lost to Follow-up|15|||
25168982|NCT01871519|50299502|FG000|Overall Study|Withdrawal by Subject|49|||
25168983|NCT01871285|50299509|FG000|First Intervention (1 Day)|Adverse Event|1|||
25168984|NCT01871285|50299510|FG001|First Intervention (1 Day)|Adverse Event|0|||
25168985|NCT01871285|50299511|FG002|First Intervention (1 Day)|Adverse Event|0|||
25168986|NCT01871285|50299512|FG003|First Intervention (1 Day)|Adverse Event|0|||
25168987|NCT01871285|50299509|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
25168988|NCT01871285|50299510|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
25168989|NCT01871285|50299511|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
25168990|NCT01871285|50299512|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
25168991|NCT01870973|50299538|FG000|Overall Study|Lost to Follow-up|10|||
25190333|NCT02335944|50347400|FG009|Treatment Phase|Adverse Event|0|||
25190334|NCT02335944|50347391|FG000|Treatment Phase|Physician Decision|0|||
25190335|NCT02335944|50347392|FG001|Treatment Phase|Physician Decision|0|||
25190336|NCT02335944|50347393|FG002|Treatment Phase|Physician Decision|0|||
25190337|NCT02335944|50347394|FG003|Treatment Phase|Physician Decision|1|||
25190338|NCT02335944|50347395|FG004|Treatment Phase|Physician Decision|0|||
25190339|NCT02335944|50347396|FG005|Treatment Phase|Physician Decision|6|||
25190340|NCT02335944|50347397|FG006|Treatment Phase|Physician Decision|1|||
25190341|NCT02335944|50347398|FG007|Treatment Phase|Physician Decision|2|||
25190342|NCT02335944|50347399|FG008|Treatment Phase|Physician Decision|1|||
25190343|NCT02335944|50347400|FG009|Treatment Phase|Physician Decision|0|||
25190344|NCT02335944|50347391|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
25168992|NCT01870973|50299539|FG001|Overall Study|Lost to Follow-up|3|||
24969248|NCT00130520|50058715|FG000|Overall Study|Adverse Event|11|||
24969249|NCT00130520|50058715|FG000|Overall Study|Death|1|||
25190345|NCT02335944|50347392|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
25279863|NCT00990093|50594530|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
25279864|NCT00990093|50594531|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
25279865|NCT00990093|50594530|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
25279866|NCT00990093|50594531|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
25279867|NCT00990093|50594530|FG000|Test Period 1 (1-14 Days)|Other|1|||
25279868|NCT00990093|50594531|FG001|Test Period 1 (1-14 Days)|Other|0|||
25279869|NCT00990093|50594530|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
25279870|NCT00990093|50594531|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
25279871|NCT00990093|50594530|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
25279872|NCT00990093|50594531|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
25279873|NCT00990093|50594530|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
25279874|NCT00990093|50594531|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
24969250|NCT00130520|50058715|FG000|Overall Study|Physician Decision|1|||
25190346|NCT02335944|50347393|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
25190347|NCT02335944|50347394|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
25190348|NCT02335944|50347395|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
25190349|NCT02335944|50347396|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
25190350|NCT02335944|50347397|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
25190351|NCT02335944|50347398|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
25190352|NCT02335944|50347399|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
25190353|NCT02335944|50347400|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
25190354|NCT02335944|50347391|FG000|Treatment Phase|Subject/Guardian Decision|0|||
25190355|NCT02335944|50347392|FG001|Treatment Phase|Subject/Guardian Decision|0|||
25190356|NCT02335944|50347393|FG002|Treatment Phase|Subject/Guardian Decision|1|||
25190357|NCT02335944|50347394|FG003|Treatment Phase|Subject/Guardian Decision|0|||
25190358|NCT02335944|50347395|FG004|Treatment Phase|Subject/Guardian Decision|0|||
25190359|NCT02335944|50347396|FG005|Treatment Phase|Subject/Guardian Decision|1|||
25168993|NCT01854827|50299558|FG000|Overall Study|Death|1|||
25190360|NCT02335944|50347397|FG006|Treatment Phase|Subject/Guardian Decision|0|||
25168994|NCT01854047|50299701|FG000|Overall Study|Lack of Efficacy|1|||
25168995|NCT01854047|50299702|FG001|Overall Study|Lack of Efficacy|0|||
25168996|NCT01854047|50299703|FG002|Overall Study|Lack of Efficacy|0|||
25168997|NCT01854047|50299704|FG003|Overall Study|Lack of Efficacy|0|||
25168998|NCT01854047|50299705|FG004|Overall Study|Lack of Efficacy|0|||
25168999|NCT01854047|50299701|FG000|Overall Study|Poor compliance to protocol|3|||
25169000|NCT01854047|50299702|FG001|Overall Study|Poor compliance to protocol|0|||
25169001|NCT01854047|50299703|FG002|Overall Study|Poor compliance to protocol|2|||
25169002|NCT01854047|50299704|FG003|Overall Study|Poor compliance to protocol|0|||
25190361|NCT02335944|50347398|FG007|Treatment Phase|Subject/Guardian Decision|4|||
25190362|NCT02335944|50347399|FG008|Treatment Phase|Subject/Guardian Decision|0|||
25190363|NCT02335944|50347400|FG009|Treatment Phase|Subject/Guardian Decision|0|||
25190364|NCT02335944|50347391|FG000|Post-treatment Follow-up|Progressive Disease|0|||
25190365|NCT02335944|50347392|FG001|Post-treatment Follow-up|Progressive Disease|0|||
25190366|NCT02335944|50347393|FG002|Post-treatment Follow-up|Progressive Disease|0|||
25190367|NCT02335944|50347394|FG003|Post-treatment Follow-up|Progressive Disease|1|||
25190368|NCT02335944|50347395|FG004|Post-treatment Follow-up|Progressive Disease|0|||
25190369|NCT02335944|50347396|FG005|Post-treatment Follow-up|Progressive Disease|9|||
25190370|NCT02335944|50347397|FG006|Post-treatment Follow-up|Progressive Disease|0|||
25190371|NCT02335944|50347398|FG007|Post-treatment Follow-up|Progressive Disease|2|||
25190372|NCT02335944|50347399|FG008|Post-treatment Follow-up|Progressive Disease|3|||
25190373|NCT02335944|50347400|FG009|Post-treatment Follow-up|Progressive Disease|0|||
25190374|NCT02335944|50347391|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
25190375|NCT02335944|50347392|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
25190376|NCT02335944|50347393|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
25190377|NCT02335944|50347394|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
25190378|NCT02335944|50347395|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
25190379|NCT02335944|50347396|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
25190380|NCT02335944|50347397|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
25190381|NCT02335944|50347398|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
25190382|NCT02335944|50347399|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
25190383|NCT02335944|50347400|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
25190384|NCT02335944|50347391|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
25190385|NCT02335944|50347392|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
25190386|NCT02335944|50347393|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
25190387|NCT02335944|50347394|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
25190388|NCT02335944|50347395|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
25190389|NCT02335944|50347396|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
25190390|NCT02335944|50347397|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
25190391|NCT02335944|50347398|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
25190392|NCT02335944|50347399|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
25190393|NCT02335944|50347400|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
25190394|NCT02335944|50347391|FG000|Post-treatment Follow-up|Adverse Event|0|||
25190395|NCT02335944|50347392|FG001|Post-treatment Follow-up|Adverse Event|0|||
25190396|NCT02335944|50347393|FG002|Post-treatment Follow-up|Adverse Event|0|||
25190397|NCT02335944|50347394|FG003|Post-treatment Follow-up|Adverse Event|0|||
25190398|NCT02335944|50347395|FG004|Post-treatment Follow-up|Adverse Event|0|||
25190399|NCT02335944|50347396|FG005|Post-treatment Follow-up|Adverse Event|1|||
25190400|NCT02335944|50347397|FG006|Post-treatment Follow-up|Adverse Event|0|||
25190401|NCT02335944|50347398|FG007|Post-treatment Follow-up|Adverse Event|0|||
25190402|NCT02335944|50347399|FG008|Post-treatment Follow-up|Adverse Event|0|||
25190403|NCT02335944|50347400|FG009|Post-treatment Follow-up|Adverse Event|0|||
25190404|NCT02335944|50347391|FG000|Post-treatment Follow-up|Death|0|||
25190405|NCT02335944|50347392|FG001|Post-treatment Follow-up|Death|0|||
25190406|NCT02335944|50347393|FG002|Post-treatment Follow-up|Death|0|||
25190407|NCT02335944|50347394|FG003|Post-treatment Follow-up|Death|1|||
25190408|NCT02335944|50347395|FG004|Post-treatment Follow-up|Death|0|||
25190409|NCT02335944|50347396|FG005|Post-treatment Follow-up|Death|1|||
25190410|NCT02335944|50347397|FG006|Post-treatment Follow-up|Death|0|||
25190411|NCT02335944|50347398|FG007|Post-treatment Follow-up|Death|0|||
25190412|NCT02335944|50347399|FG008|Post-treatment Follow-up|Death|0|||
25190413|NCT02335944|50347400|FG009|Post-treatment Follow-up|Death|0|||
25190414|NCT02335944|50347391|FG000|Post-treatment Follow-up|Physician Decision|1|||
25190415|NCT02335944|50347392|FG001|Post-treatment Follow-up|Physician Decision|0|||
25190416|NCT02335944|50347393|FG002|Post-treatment Follow-up|Physician Decision|0|||
25279875|NCT00990093|50594530|FG000|Test Period 2 (15-28 Days)|Other|0|||
25279876|NCT00990093|50594531|FG001|Test Period 2 (15-28 Days)|Other|1|||
25190417|NCT02335944|50347394|FG003|Post-treatment Follow-up|Physician Decision|0|||
25190418|NCT02335944|50347395|FG004|Post-treatment Follow-up|Physician Decision|0|||
25190419|NCT02335944|50347396|FG005|Post-treatment Follow-up|Physician Decision|0|||
25190420|NCT02335944|50347397|FG006|Post-treatment Follow-up|Physician Decision|0|||
25279877|NCT00984165|50594541|FG000|Overall Study|Death on study|2|||
25279878|NCT00984165|50594542|FG001|Overall Study|Death on study|0|||
25279879|NCT00984165|50594543|FG002|Overall Study|Death on study|0|||
25279880|NCT00984165|50594544|FG003|Overall Study|Death on study|0|||
25279881|NCT00984165|50594541|FG000|Overall Study|Disease progression on study|5|||
25279882|NCT00984165|50594542|FG001|Overall Study|Disease progression on study|1|||
25279883|NCT00984165|50594543|FG002|Overall Study|Disease progression on study|0|||
24969251|NCT00130520|50058715|FG000|Overall Study|Withdrawal by Subject|1|||
24969252|NCT00130520|50058715|FG000|Overall Study|Disease Progression|23|||
24969253|NCT00130520|50058715|FG000|Overall Study|Protocol non-compliance|1|||
24969254|NCT00130520|50058715|FG000|Overall Study|Did not meet re-treatment criteria|1|||
24969255|NCT00132132|50058721|FG000|Overall Study|Lost to Follow-up|7|||
24969256|NCT00132132|50058722|FG001|Overall Study|Lost to Follow-up|2|||
24969257|NCT00130442|50058730|FG000|Overall Study|Withdrawal by Subject|0|||
24969258|NCT00130442|50058731|FG001|Overall Study|Withdrawal by Subject|1|||
24969259|NCT00130442|50058730|FG000|Overall Study|did not meet criteria|1|||
24969260|NCT00130442|50058731|FG001|Overall Study|did not meet criteria|1|||
24969261|NCT00130208|50058741|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
24969262|NCT00130208|50058742|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
24969263|NCT00130208|50058741|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
24969264|NCT00130208|50058742|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
24969265|NCT00130208|50058741|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
24969266|NCT00130208|50058742|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
24969267|NCT00130208|50058741|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
24969268|NCT00130208|50058742|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
24969269|NCT00130208|50058741|FG000|Maintenance Period (26 Weeks)|Other|1|||
24969270|NCT00130208|50058742|FG001|Maintenance Period (26 Weeks)|Other|1|||
24969271|NCT00130208|50058741|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
25069672|NCT01369355|50175450|FG004|Long-term Extension (Week 44-272)|Other|0|||
25069673|NCT01369355|50175451|FG005|Long-term Extension (Week 44-272)|Other|0|||
25069674|NCT01369355|50175452|FG006|Long-term Extension (Week 44-272)|Other|110|||
25069675|NCT01369355|50175453|FG007|Long-term Extension (Week 44-272)|Other|9|||
25069676|NCT01369355|50175454|FG008|Long-term Extension (Week 44-272)|Other|17|||
25069677|NCT02614196|50175477|FG000|Double Blind Treatment Phase|Adverse Event|8|||
25069678|NCT02614196|50175478|FG001|Double Blind Treatment Phase|Adverse Event|5|||
25069679|NCT02614196|50175479|FG002|Double Blind Treatment Phase|Adverse Event|9|||
25069680|NCT02614196|50175480|FG003|Double Blind Treatment Phase|Adverse Event|0|||
25190421|NCT02335944|50347398|FG007|Post-treatment Follow-up|Physician Decision|1|||
25190422|NCT02335944|50347399|FG008|Post-treatment Follow-up|Physician Decision|0|||
25190423|NCT02335944|50347400|FG009|Post-treatment Follow-up|Physician Decision|0|||
25190424|NCT02326974|50347438|FG000|Overall Study|Withdrawal by Subject|2|||
25279884|NCT00984165|50594544|FG003|Overall Study|Disease progression on study|0|||
25279885|NCT00984165|50594541|FG000|Overall Study|Death of recipient|0|||
25279886|NCT00984165|50594542|FG001|Overall Study|Death of recipient|0|||
25279887|NCT00984165|50594543|FG002|Overall Study|Death of recipient|0|||
25279888|NCT00984165|50594544|FG003|Overall Study|Death of recipient|1|||
25279889|NCT00984165|50594541|FG000|Overall Study|New protocol|0|||
25279890|NCT00984165|50594542|FG001|Overall Study|New protocol|0|||
25279891|NCT00984165|50594543|FG002|Overall Study|New protocol|0|||
25279892|NCT00984165|50594544|FG003|Overall Study|New protocol|1|||
25279893|NCT00984165|50594541|FG000|Overall Study|P+/donor pair removed from protocol|0|||
25190425|NCT02326974|50347438|FG000|Overall Study|failed heterogenity evaluation|5|||
25190426|NCT02246621|50347466|FG000|Overall Study|Withdrawal by Subject|28|||
25190427|NCT02246621|50347467|FG001|Overall Study|Withdrawal by Subject|16|||
25190428|NCT02246621|50347466|FG000|Overall Study|Lost to Follow-up|1|||
25190429|NCT02246621|50347467|FG001|Overall Study|Lost to Follow-up|0|||
25190430|NCT02246621|50347466|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
25279894|NCT00984165|50594542|FG001|Overall Study|P+/donor pair removed from protocol|0|||
25279895|NCT00984165|50594543|FG002|Overall Study|P+/donor pair removed from protocol|0|||
24969272|NCT00130208|50058742|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
24969273|NCT00130208|50058741|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
24969274|NCT00130208|50058742|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
24969275|NCT00130208|50058741|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
24969276|NCT00130208|50058742|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
25190431|NCT02246621|50347467|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
25279896|NCT00984165|50594544|FG003|Overall Study|P+/donor pair removed from protocol|1|||
25279897|NCT00984165|50594541|FG000|Overall Study|removed with a pair recipient|0|||
25279898|NCT00984165|50594542|FG001|Overall Study|removed with a pair recipient|0|||
25279899|NCT00984165|50594543|FG002|Overall Study|removed with a pair recipient|0|||
25279900|NCT00984165|50594544|FG003|Overall Study|removed with a pair recipient|1|||
25279901|NCT00993291|50594555|FG000|Overall Study|Withdrawal by Subject|1|||
25279902|NCT01196975|50594564|FG000|Overall Study|Adverse Event|2|||
25279903|NCT01196975|50594565|FG001|Overall Study|Adverse Event|2|||
25279904|NCT01196975|50594566|FG002|Overall Study|Adverse Event|0|||
25279905|NCT01196975|50594567|FG003|Overall Study|Adverse Event|0|||
25279906|NCT01196975|50594568|FG004|Overall Study|Adverse Event|2|||
25279907|NCT01196975|50594564|FG000|Overall Study|Withdrawal by Subject|2|||
25279908|NCT01196975|50594565|FG001|Overall Study|Withdrawal by Subject|1|||
25279909|NCT01196975|50594566|FG002|Overall Study|Withdrawal by Subject|0|||
25279910|NCT01196975|50594567|FG003|Overall Study|Withdrawal by Subject|1|||
25279911|NCT01196975|50594568|FG004|Overall Study|Withdrawal by Subject|0|||
25279912|NCT01196975|50594564|FG000|Overall Study|Lost to Follow-up|11|||
25279913|NCT01196975|50594565|FG001|Overall Study|Lost to Follow-up|6|||
25279914|NCT01196975|50594566|FG002|Overall Study|Lost to Follow-up|5|||
25279915|NCT01196975|50594567|FG003|Overall Study|Lost to Follow-up|5|||
25279916|NCT01196975|50594568|FG004|Overall Study|Lost to Follow-up|11|||
25279917|NCT00992589|50594603|FG000|Open-Label Phase|Adverse Event|4|||
25279918|NCT00992589|50594604|FG001|Open-Label Phase|Adverse Event|0|||
25279919|NCT00992589|50594605|FG002|Open-Label Phase|Adverse Event|0|||
25279920|NCT00992589|50594606|FG003|Open-Label Phase|Adverse Event|0|||
25279921|NCT00992589|50594603|FG000|Open-Label Phase|Withdrawal by Subject|20|||
25279922|NCT00992589|50594604|FG001|Open-Label Phase|Withdrawal by Subject|0|||
25279923|NCT00992589|50594605|FG002|Open-Label Phase|Withdrawal by Subject|0|||
25279924|NCT00992589|50594606|FG003|Open-Label Phase|Withdrawal by Subject|0|||
25279925|NCT00992589|50594603|FG000|Open-Label Phase|Lost to Follow-up|1|||
25279926|NCT00992589|50594604|FG001|Open-Label Phase|Lost to Follow-up|0|||
25279927|NCT00992589|50594605|FG002|Open-Label Phase|Lost to Follow-up|0|||
25279928|NCT00992589|50594606|FG003|Open-Label Phase|Lost to Follow-up|0|||
25279929|NCT00992589|50594603|FG000|Open-Label Phase|Protocol Violation|3|||
25279930|NCT00992589|50594604|FG001|Open-Label Phase|Protocol Violation|0|||
25279931|NCT00992589|50594605|FG002|Open-Label Phase|Protocol Violation|0|||
25279932|NCT00992589|50594606|FG003|Open-Label Phase|Protocol Violation|0|||
25279933|NCT00992589|50594603|FG000|Open-Label Phase|Physician Decision|4|||
25279934|NCT00992589|50594604|FG001|Open-Label Phase|Physician Decision|0|||
25279935|NCT00992589|50594605|FG002|Open-Label Phase|Physician Decision|0|||
25279936|NCT00992589|50594606|FG003|Open-Label Phase|Physician Decision|0|||
25279937|NCT00992589|50594603|FG000|Open-Label Phase|Other|45|||
25279938|NCT00992589|50594604|FG001|Open-Label Phase|Other|0|||
25279939|NCT00992589|50594605|FG002|Open-Label Phase|Other|0|||
25279940|NCT00992589|50594606|FG003|Open-Label Phase|Other|0|||
24969277|NCT00130208|50058741|FG000|Washout Period (8 Weeks)|Other|1|||
25190432|NCT02200445|50347513|FG000|Overall Study|Lack of Efficacy|1|||
25279941|NCT00992589|50594603|FG000|Double-Blind Phase|Adverse Event|0|||
25279942|NCT00992589|50594604|FG001|Double-Blind Phase|Adverse Event|6|||
25279943|NCT00992589|50594605|FG002|Double-Blind Phase|Adverse Event|2|||
25279944|NCT00992589|50594606|FG003|Double-Blind Phase|Adverse Event|3|||
25279945|NCT00992589|50594603|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
25279946|NCT00992589|50594604|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
25279947|NCT00992589|50594605|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
25279948|NCT00992589|50594606|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
25279949|NCT00992589|50594603|FG000|Double-Blind Phase|Lost to Follow-up|0|||
25279950|NCT00992589|50594604|FG001|Double-Blind Phase|Lost to Follow-up|0|||
25279951|NCT00992589|50594605|FG002|Double-Blind Phase|Lost to Follow-up|0|||
25279952|NCT00992589|50594606|FG003|Double-Blind Phase|Lost to Follow-up|2|||
25279953|NCT00992589|50594603|FG000|Double-Blind Phase|Other|0|||
25279954|NCT00992589|50594604|FG001|Double-Blind Phase|Other|1|||
25279955|NCT00992589|50594605|FG002|Double-Blind Phase|Other|6|||
24969278|NCT00130208|50058742|FG001|Washout Period (8 Weeks)|Other|1|||
25190433|NCT02200445|50347514|FG001|Overall Study|Lack of Efficacy|2|||
25190434|NCT02200445|50347515|FG002|Overall Study|Lack of Efficacy|2|||
25190435|NCT02200445|50347513|FG000|Overall Study|Adverse Event|0|||
25190436|NCT02200445|50347514|FG001|Overall Study|Adverse Event|2|||
25190437|NCT02200445|50347515|FG002|Overall Study|Adverse Event|0|||
25190438|NCT02152982|50347525|FG000|Overall Study|Ineligible|4|||
25190439|NCT02152982|50347526|FG001|Overall Study|Ineligible|4|||
25190440|NCT02152982|50347525|FG000|Overall Study|Did not start treatment|12|||
25190441|NCT02152982|50347526|FG001|Overall Study|Did not start treatment|6|||
25190442|NCT02120352|50347538|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
25190443|NCT02120352|50347539|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
25190444|NCT02120352|50347540|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
25190445|NCT02120352|50347541|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
25190446|NCT02120352|50347538|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
25190447|NCT02120352|50347539|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
25190448|NCT02120352|50347540|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
25190449|NCT02120352|50347541|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
25279956|NCT00992589|50594606|FG003|Double-Blind Phase|Other|3|||
25279957|NCT01196741|50594626|FG000|Overall Study|Disease progression|34|||
25279958|NCT01196741|50594627|FG001|Overall Study|Disease progression|14|||
25279959|NCT01196741|50594626|FG000|Overall Study|Adverse Event|10|||
25279960|NCT01196741|50594627|FG001|Overall Study|Adverse Event|6|||
25279961|NCT01196741|50594626|FG000|Overall Study|Serious Adverse Event|3|||
25279962|NCT01196741|50594627|FG001|Overall Study|Serious Adverse Event|1|||
25279963|NCT01196741|50594626|FG000|Overall Study|Dose limiting Adverse Event|2|||
25279964|NCT01196741|50594627|FG001|Overall Study|Dose limiting Adverse Event|1|||
25279965|NCT01196741|50594626|FG000|Overall Study|Withdrawal by Subject|3|||
25279966|NCT01196741|50594627|FG001|Overall Study|Withdrawal by Subject|0|||
25279967|NCT01196741|50594626|FG000|Overall Study|Other reason|3|||
25279968|NCT01196741|50594627|FG001|Overall Study|Other reason|3|||
25279969|NCT01196741|50594626|FG000|Overall Study|Other|3|||
25279970|NCT01196741|50594627|FG001|Overall Study|Other|2|||
25279971|NCT01196741|50594626|FG000|Overall Study|Protocol Violation|2|||
25279972|NCT01196741|50594627|FG001|Overall Study|Protocol Violation|1|||
25279973|NCT00983385|50594633|FG000|Observation Period|Not eligible to be dosed|20|||
25279974|NCT00983385|50594633|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
25279975|NCT00992511|50594656|FG000|Overall Study|Migrated/moved from study area|1|||
25279976|NCT00992511|50594657|FG001|Overall Study|Migrated/moved from study area|0|||
25279977|NCT00992511|50594658|FG002|Overall Study|Migrated/moved from study area|1|||
25279978|NCT00992511|50594659|FG003|Overall Study|Migrated/moved from study area|2|||
25279979|NCT00992511|50594656|FG000|Overall Study|Lost to Follow-up|1|||
25279980|NCT00992511|50594657|FG001|Overall Study|Lost to Follow-up|0|||
25279981|NCT00992511|50594658|FG002|Overall Study|Lost to Follow-up|0|||
25279982|NCT00992511|50594659|FG003|Overall Study|Lost to Follow-up|2|||
25279983|NCT00992511|50594656|FG000|Overall Study|Withdrawal by Subject|0|||
25279984|NCT00992511|50594657|FG001|Overall Study|Withdrawal by Subject|0|||
25279985|NCT00992511|50594658|FG002|Overall Study|Withdrawal by Subject|1|||
25279986|NCT00992511|50594659|FG003|Overall Study|Withdrawal by Subject|1|||
25279987|NCT01196429|50594671|FG000|Overall Study|Ineligible - inadequate pathology|1|||
25279988|NCT01196429|50594672|FG001|Overall Study|Ineligible - inadequate pathology|0|||
25279989|NCT01196429|50594671|FG000|Overall Study|Ineligible - wrong cell type|1|||
25279990|NCT01196429|50594672|FG001|Overall Study|Ineligible - wrong cell type|0|||
25279991|NCT01196429|50594671|FG000|Overall Study|Refused - Never Treated|1|||
25279992|NCT01196429|50594672|FG001|Overall Study|Refused - Never Treated|0|||
25279993|NCT01157364|50594686|FG000|Overall Study|Other Reasons|1|||
25279994|NCT01157364|50594687|FG001|Overall Study|Other Reasons|1|||
25279995|NCT01157364|50594688|FG002|Overall Study|Other Reasons|2|||
25279996|NCT01157364|50594689|FG003|Overall Study|Other Reasons|1|||
25279997|NCT01157364|50594690|FG004|Overall Study|Other Reasons|0|||
25279998|NCT01157364|50594691|FG005|Overall Study|Other Reasons|0|||
25279999|NCT01157364|50594686|FG000|Overall Study|Personal Reasons|0|||
25280000|NCT01157364|50594687|FG001|Overall Study|Personal Reasons|2|||
25280001|NCT01157364|50594688|FG002|Overall Study|Personal Reasons|0|||
25280002|NCT01157364|50594689|FG003|Overall Study|Personal Reasons|0|||
25280003|NCT01157364|50594690|FG004|Overall Study|Personal Reasons|1|||
25280004|NCT01157364|50594691|FG005|Overall Study|Personal Reasons|1|||
25280005|NCT01157364|50594686|FG000|Overall Study|Lost to Follow-up|1|||
25280006|NCT01157364|50594687|FG001|Overall Study|Lost to Follow-up|0|||
25280007|NCT01157364|50594688|FG002|Overall Study|Lost to Follow-up|1|||
25280008|NCT01157364|50594689|FG003|Overall Study|Lost to Follow-up|0|||
25280009|NCT01157364|50594690|FG004|Overall Study|Lost to Follow-up|0|||
25280010|NCT01157364|50594691|FG005|Overall Study|Lost to Follow-up|0|||
25280011|NCT01157364|50594686|FG000|Overall Study|Lack of Efficacy|0|||
25280012|NCT01157364|50594687|FG001|Overall Study|Lack of Efficacy|0|||
25280013|NCT01157364|50594688|FG002|Overall Study|Lack of Efficacy|0|||
25280014|NCT01157364|50594689|FG003|Overall Study|Lack of Efficacy|1|||
25280015|NCT01157364|50594690|FG004|Overall Study|Lack of Efficacy|0|||
25280016|NCT01157364|50594691|FG005|Overall Study|Lack of Efficacy|0|||
25280017|NCT01157364|50594686|FG000|Overall Study|Adverse Event|0|||
25190450|NCT02120352|50347538|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
25190451|NCT02120352|50347539|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
25190452|NCT02120352|50347540|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
25190453|NCT02120352|50347541|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
25190454|NCT02120352|50347538|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
25190455|NCT02120352|50347539|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
25190456|NCT02120352|50347540|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
25190457|NCT02120352|50347541|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
25280018|NCT01157364|50594687|FG001|Overall Study|Adverse Event|1|||
25280019|NCT01157364|50594688|FG002|Overall Study|Adverse Event|1|||
25280020|NCT01157364|50594689|FG003|Overall Study|Adverse Event|0|||
25280021|NCT01157364|50594690|FG004|Overall Study|Adverse Event|1|||
25280022|NCT01157364|50594691|FG005|Overall Study|Adverse Event|0|||
25280023|NCT01195415|50594705|FG000|Overall Study|No repeat biopsy due to progression|2|||
25280024|NCT01195103|50594712|FG000|Overall Study|Withdrawal by Subject|1|||
25190458|NCT02120352|50347538|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
25190459|NCT02120352|50347539|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
25190460|NCT02120352|50347540|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
25190461|NCT02120352|50347541|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
25190462|NCT02120352|50347538|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
25190463|NCT02120352|50347539|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
25190464|NCT02120352|50347540|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
25190465|NCT02120352|50347541|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
25190466|NCT02120352|50347538|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
25190467|NCT02120352|50347539|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
25190468|NCT02120352|50347540|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
25190469|NCT02120352|50347541|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
25190470|NCT02120352|50347538|FG000|Maintenance Period (32 Weeks)|Adverse Event|0|||
25190471|NCT02120352|50347539|FG001|Maintenance Period (32 Weeks)|Adverse Event|0|||
25190472|NCT02120352|50347540|FG002|Maintenance Period (32 Weeks)|Adverse Event|6|||
25190473|NCT02120352|50347541|FG003|Maintenance Period (32 Weeks)|Adverse Event|1|||
25190474|NCT02120352|50347538|FG000|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
25190475|NCT02120352|50347539|FG001|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
25190476|NCT02120352|50347540|FG002|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
25280025|NCT01195103|50594713|FG001|Overall Study|Withdrawal by Subject|0|||
25280026|NCT01195103|50594714|FG002|Overall Study|Withdrawal by Subject|0|||
25280027|NCT01194869|50594722|FG000|Overall Study|Disease Progression|2|||
25280028|NCT01194869|50594722|FG000|Overall Study|Toxicity|2|||
25280029|NCT01177800|50594728|FG000|Overall Study|Adverse Event|9|||
25280030|NCT01177800|50594729|FG001|Overall Study|Adverse Event|3|||
25280031|NCT01177800|50594728|FG000|Overall Study|Protocol Violation|0|||
25280032|NCT01177800|50594729|FG001|Overall Study|Protocol Violation|1|||
25280033|NCT01177800|50594728|FG000|Overall Study|Physician Decision|1|||
25280034|NCT01177800|50594729|FG001|Overall Study|Physician Decision|0|||
25280035|NCT01177800|50594728|FG000|Overall Study|Withdrawal of informed consent|0|||
25280036|NCT01177800|50594729|FG001|Overall Study|Withdrawal of informed consent|1|||
24969279|NCT00253370|50058748|FG000|Overall Study|Adverse Event|18|||
25190477|NCT02120352|50347541|FG003|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
25280037|NCT01177722|50594739|FG000|Overall Study|Serious Adverse Event|0|||
25069681|NCT02614196|50175481|FG004|Double Blind Treatment Phase|Adverse Event|0|||
25280038|NCT01177722|50594740|FG001|Overall Study|Serious Adverse Event|0|||
25280039|NCT01177722|50594741|FG002|Overall Study|Serious Adverse Event|1|||
25280040|NCT01177722|50594742|FG003|Overall Study|Serious Adverse Event|0|||
25280041|NCT01177722|50594739|FG000|Overall Study|Protocol Violation|0|||
25280042|NCT01177722|50594740|FG001|Overall Study|Protocol Violation|0|||
25280043|NCT01177722|50594741|FG002|Overall Study|Protocol Violation|1|||
25280044|NCT01177722|50594742|FG003|Overall Study|Protocol Violation|0|||
25280045|NCT01177722|50594739|FG000|Overall Study|Lost to Follow-up|3|||
25280046|NCT01177722|50594740|FG001|Overall Study|Lost to Follow-up|4|||
25280047|NCT01177722|50594741|FG002|Overall Study|Lost to Follow-up|3|||
25280048|NCT01177722|50594742|FG003|Overall Study|Lost to Follow-up|1|||
25280049|NCT01177722|50594739|FG000|Overall Study|Withdrawal by Subject|10|||
25280050|NCT01177722|50594740|FG001|Overall Study|Withdrawal by Subject|6|||
25280051|NCT01177722|50594741|FG002|Overall Study|Withdrawal by Subject|4|||
25280052|NCT01177722|50594742|FG003|Overall Study|Withdrawal by Subject|6|||
25280053|NCT01177410|50594756|FG000|Overall Study|Adverse Event|0|||
25280054|NCT01177410|50594757|FG001|Overall Study|Adverse Event|2|||
25280055|NCT01177410|50594758|FG002|Overall Study|Adverse Event|2|||
25280056|NCT01177410|50594756|FG000|Overall Study|Withdrawal by Subject|1|||
25280057|NCT01177410|50594757|FG001|Overall Study|Withdrawal by Subject|4|||
25280058|NCT01177410|50594758|FG002|Overall Study|Withdrawal by Subject|3|||
25280059|NCT01177410|50594756|FG000|Overall Study|Lost to Follow-up|0|||
25280060|NCT01177410|50594757|FG001|Overall Study|Lost to Follow-up|1|||
25280061|NCT01177410|50594758|FG002|Overall Study|Lost to Follow-up|0|||
25280062|NCT01156116|50594768|FG000|Overall Study|Withdrawal by Subject|3|||
25280063|NCT01156116|50594769|FG001|Overall Study|Withdrawal by Subject|1|||
25280064|NCT01156116|50594768|FG000|Overall Study|CPAP intolerance|2|||
25069682|NCT02614196|50175482|FG005|Double Blind Treatment Phase|Adverse Event|0|||
25069683|NCT02614196|50175477|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
25069684|NCT02614196|50175478|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
25069685|NCT02614196|50175479|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
25069686|NCT02614196|50175480|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
25069687|NCT02614196|50175481|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
25069688|NCT02614196|50175482|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
25069689|NCT02614196|50175477|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
25069690|NCT02614196|50175478|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
25069691|NCT02614196|50175479|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
25069692|NCT02614196|50175480|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
25069693|NCT02614196|50175481|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
25069694|NCT02614196|50175482|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
25069695|NCT02614196|50175477|FG000|Double Blind Treatment Phase|Physician Decision|4|||
25069696|NCT02614196|50175478|FG001|Double Blind Treatment Phase|Physician Decision|0|||
25069697|NCT02614196|50175479|FG002|Double Blind Treatment Phase|Physician Decision|2|||
25069698|NCT02614196|50175480|FG003|Double Blind Treatment Phase|Physician Decision|0|||
25069699|NCT02614196|50175481|FG004|Double Blind Treatment Phase|Physician Decision|0|||
25069700|NCT02614196|50175482|FG005|Double Blind Treatment Phase|Physician Decision|0|||
25190478|NCT02120352|50347538|FG000|Maintenance Period (32 Weeks)|Protocol Violation|0|||
25190479|NCT02120352|50347539|FG001|Maintenance Period (32 Weeks)|Protocol Violation|0|||
25190480|NCT02120352|50347540|FG002|Maintenance Period (32 Weeks)|Protocol Violation|2|||
25190481|NCT02120352|50347541|FG003|Maintenance Period (32 Weeks)|Protocol Violation|0|||
25190482|NCT02120352|50347538|FG000|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
25190483|NCT02120352|50347539|FG001|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
25190484|NCT02120352|50347540|FG002|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
25190485|NCT02120352|50347541|FG003|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
25280065|NCT01156116|50594769|FG001|Overall Study|CPAP intolerance|0|||
25280066|NCT01155726|50594775|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
25069701|NCT02614196|50175477|FG000|Double Blind Treatment Phase|Pregnancy|1|||
25069702|NCT02614196|50175478|FG001|Double Blind Treatment Phase|Pregnancy|2|||
25280067|NCT01155726|50594776|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
25280068|NCT01155726|50594777|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
25280069|NCT01155726|50594778|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
25280070|NCT01155570|50594800|FG000|Overall Study|Adverse Event|39|||
25280071|NCT01155570|50594800|FG000|Overall Study|Lack of Efficacy|46|||
25280072|NCT01155570|50594800|FG000|Overall Study|Participant's Economic Reasons|17|||
25280073|NCT01155570|50594800|FG000|Overall Study|No Hospital Visits|7|||
25280074|NCT01155570|50594800|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
25190486|NCT02120352|50347538|FG000|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
25190487|NCT02120352|50347539|FG001|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
25190488|NCT02120352|50347540|FG002|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
25190489|NCT02120352|50347541|FG003|Maintenance Period (32 Weeks)|Lost to Follow-up|1|||
25190490|NCT02120352|50347538|FG000|Maintenance Period (32 Weeks)|Withdrawal by Subject|0|||
25190491|NCT02120352|50347539|FG001|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
25190492|NCT02120352|50347540|FG002|Maintenance Period (32 Weeks)|Withdrawal by Subject|1|||
25190493|NCT02120352|50347541|FG003|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
25190494|NCT02120352|50347538|FG000|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0|||
25190495|NCT02120352|50347539|FG001|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112|||
25190496|NCT02120352|50347540|FG002|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105|||
25190497|NCT02120352|50347541|FG003|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50|||
25190498|NCT02058693|50347557|FG000|Phase 1|Withdrawal by Subject|3|||
25190499|NCT02058693|50347558|FG001|Phase 1|Withdrawal by Subject|2|||
25190500|NCT02058693|50347557|FG000|Phase 1|Adverse Event|0|||
25190501|NCT02058693|50347558|FG001|Phase 1|Adverse Event|1|||
25190502|NCT02058693|50347557|FG000|Phase 1|Lack of Efficacy|1|||
25190503|NCT02058693|50347558|FG001|Phase 1|Lack of Efficacy|0|||
25190504|NCT02058693|50347557|FG000|Phase 1|Physician Decision|1|||
25190505|NCT02058693|50347558|FG001|Phase 1|Physician Decision|1|||
25190506|NCT02058693|50347557|FG000|Phase 2|Withdrawal by Subject|0|||
25190507|NCT02058693|50347558|FG001|Phase 2|Withdrawal by Subject|2|||
25190508|NCT02039856|50347568|FG000|Overall Study|Death|5|||
25190509|NCT02039856|50347569|FG001|Overall Study|Death|3|||
25190510|NCT02039856|50347568|FG000|Overall Study|Partial survey completion|61|||
25190511|NCT02039856|50347569|FG001|Overall Study|Partial survey completion|26|||
25190512|NCT02039856|50347568|FG000|Overall Study|Lost to Follow-up|388|||
25190513|NCT02039856|50347569|FG001|Overall Study|Lost to Follow-up|206|||
25190514|NCT02039856|50347568|FG000|Overall Study|Withdrawal by Subject|1573|||
25190515|NCT02039856|50347569|FG001|Overall Study|Withdrawal by Subject|618|||
25190516|NCT01796392|50347579|FG000|Overall Study|Withdrawal by Subject|2|||
25190517|NCT01796392|50347580|FG001|Overall Study|Withdrawal by Subject|0|||
25190518|NCT01796392|50347579|FG000|Overall Study|Death|5|||
25190519|NCT01796392|50347580|FG001|Overall Study|Death|1|||
25190520|NCT01796392|50347579|FG000|Overall Study|Excluded for medical reasons|1|||
25190521|NCT01796392|50347580|FG001|Overall Study|Excluded for medical reasons|2|||
25190522|NCT01796392|50347579|FG000|Overall Study|Lost to Follow-up|1|||
25190523|NCT01796392|50347580|FG001|Overall Study|Lost to Follow-up|0|||
25190524|NCT01571635|50347591|FG000|Overall Study|Adverse Event|3|||
25190525|NCT01571635|50347592|FG001|Overall Study|Adverse Event|0|||
25190526|NCT01571635|50347593|FG002|Overall Study|Adverse Event|2|||
25190527|NCT01571635|50347594|FG003|Overall Study|Adverse Event|3|||
25190528|NCT01571635|50347595|FG004|Overall Study|Adverse Event|5|||
25190529|NCT01571635|50347591|FG000|Overall Study|Other reasons|2|||
25190530|NCT01571635|50347592|FG001|Overall Study|Other reasons|1|||
25190531|NCT01571635|50347593|FG002|Overall Study|Other reasons|2|||
25190532|NCT01571635|50347594|FG003|Overall Study|Other reasons|2|||
25190533|NCT01571635|50347595|FG004|Overall Study|Other reasons|1|||
25190534|NCT01571635|50347591|FG000|Overall Study|Study terminated by sponsor|0|||
25190535|NCT01571635|50347592|FG001|Overall Study|Study terminated by sponsor|4|||
25190536|NCT01571635|50347593|FG002|Overall Study|Study terminated by sponsor|1|||
25190537|NCT01571635|50347594|FG003|Overall Study|Study terminated by sponsor|3|||
25190538|NCT01571635|50347595|FG004|Overall Study|Study terminated by sponsor|1|||
25190539|NCT01571635|50347591|FG000|Overall Study|Withdrew consent|1|||
25190540|NCT01571635|50347592|FG001|Overall Study|Withdrew consent|1|||
25190541|NCT01571635|50347593|FG002|Overall Study|Withdrew consent|2|||
25190542|NCT01571635|50347594|FG003|Overall Study|Withdrew consent|3|||
25190543|NCT01571635|50347595|FG004|Overall Study|Withdrew consent|0|||
25190544|NCT01571635|50347591|FG000|Overall Study|Lack of Efficacy|0|||
25190545|NCT01571635|50347592|FG001|Overall Study|Lack of Efficacy|2|||
25190546|NCT01571635|50347593|FG002|Overall Study|Lack of Efficacy|0|||
25190547|NCT01571635|50347594|FG003|Overall Study|Lack of Efficacy|1|||
25190548|NCT01571635|50347595|FG004|Overall Study|Lack of Efficacy|2|||
25190549|NCT01386385|50347612|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
25190550|NCT01386385|50347613|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
25190551|NCT01386385|50347614|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
25280075|NCT01155570|50594800|FG000|Overall Study|Adverse Event + Other Reasons|7|||
25190552|NCT01386385|50347615|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
25190553|NCT01386385|50347616|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
25190554|NCT01386385|50347617|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
25190555|NCT01386385|50347618|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
25190556|NCT01386385|50347619|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
25190557|NCT01386385|50347612|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
25190558|NCT01386385|50347613|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
25190559|NCT01386385|50347614|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
25190560|NCT01386385|50347615|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
25190561|NCT01386385|50347616|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
25190562|NCT01386385|50347617|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
25190563|NCT01386385|50347618|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
25190564|NCT01386385|50347619|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
25190565|NCT01386385|50347612|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
25280076|NCT01155570|50594800|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
25280077|NCT01155570|50594800|FG000|Overall Study|Other Reasons|23|||
25280078|NCT01155024|50594806|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
25280079|NCT01155024|50594807|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
25280080|NCT01155024|50594806|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
25280081|NCT01155024|50594807|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
25280082|NCT01155024|50594806|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
25280083|NCT01155024|50594807|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
25280084|NCT01176240|50594818|FG000|Study 306A|Lack of Efficacy|2|||
25280085|NCT01176240|50594819|FG001|Study 306A|Lack of Efficacy|1|||
25280086|NCT01176240|50594818|FG000|Study 306A|Protocol Violation|0|||
25280087|NCT01176240|50594819|FG001|Study 306A|Protocol Violation|1|||
25280088|NCT01176240|50594818|FG000|Study 306A|Withdrawal by Subject|0|||
25280089|NCT01176240|50594819|FG001|Study 306A|Withdrawal by Subject|1|||
25280090|NCT01176240|50594818|FG000|Study 306A|Stop due to diverse problems|1|||
25280091|NCT01176240|50594819|FG001|Study 306A|Stop due to diverse problems|0|||
25280092|NCT01176240|50594818|FG000|Study 306B|Lack of Efficacy|5|||
25280093|NCT01176240|50594819|FG001|Study 306B|Lack of Efficacy|3|||
25280094|NCT01176240|50594818|FG000|Study 306B|Adverse Event|10|||
25280095|NCT01176240|50594819|FG001|Study 306B|Adverse Event|5|||
25280096|NCT01176240|50594818|FG000|Study 306B|Protocol Violation|2|||
25280097|NCT01176240|50594819|FG001|Study 306B|Protocol Violation|3|||
25280098|NCT01176240|50594818|FG000|Study 306B|Withdrawal by Subject|4|||
25280099|NCT01176240|50594819|FG001|Study 306B|Withdrawal by Subject|1|||
25280100|NCT01176240|50594818|FG000|Study 306B|Physician Decision|2|||
25280101|NCT01176240|50594819|FG001|Study 306B|Physician Decision|1|||
25280102|NCT01176240|50594818|FG000|Study 306B|Supine Hypertension|1|||
25280103|NCT01176240|50594819|FG001|Study 306B|Supine Hypertension|2|||
25280104|NCT01176240|50594818|FG000|Study 306B|Lost to Follow-up|0|||
25280105|NCT01176240|50594819|FG001|Study 306B|Lost to Follow-up|1|||
25280106|NCT01176240|50594818|FG000|Study 306B|withdrew prior to dosing|2|||
25280107|NCT01176240|50594819|FG001|Study 306B|withdrew prior to dosing|1|||
25280108|NCT00988221|50594828|FG000|Part I|Adverse Event|0|||
25280109|NCT00988221|50594829|FG001|Part I|Adverse Event|1|||
25280110|NCT00988221|50594830|FG002|Part I|Adverse Event|2|||
25280111|NCT00988221|50594831|FG003|Part I|Adverse Event|0|||
25280112|NCT00988221|50594828|FG000|Part I|Insufficient Therapeutic Response|4|||
25280113|NCT00988221|50594829|FG001|Part I|Insufficient Therapeutic Response|6|||
25280114|NCT00988221|50594830|FG002|Part I|Insufficient Therapeutic Response|5|||
25280115|NCT00988221|50594831|FG003|Part I|Insufficient Therapeutic Response|0|||
25280116|NCT00988221|50594828|FG000|Part I|Refused Treatment|0|||
25280117|NCT00988221|50594829|FG001|Part I|Refused Treatment|2|||
25280118|NCT00988221|50594830|FG002|Part I|Refused Treatment|1|||
25280119|NCT00988221|50594831|FG003|Part I|Refused Treatment|0|||
25280120|NCT00988221|50594828|FG000|Part I|Lost to Follow-up|0|||
25280121|NCT00988221|50594829|FG001|Part I|Lost to Follow-up|1|||
25280122|NCT00988221|50594830|FG002|Part I|Lost to Follow-up|0|||
25280123|NCT00988221|50594831|FG003|Part I|Lost to Follow-up|0|||
25280124|NCT00988221|50594828|FG000|Part II|Adverse Event|1|||
25280125|NCT00988221|50594829|FG001|Part II|Adverse Event|0|||
25280126|NCT00988221|50594830|FG002|Part II|Adverse Event|0|||
25280127|NCT00988221|50594831|FG003|Part II|Adverse Event|1|||
25280128|NCT00988221|50594828|FG000|Part II|Withdrawal by Subject|0|||
25280129|NCT00988221|50594829|FG001|Part II|Withdrawal by Subject|0|||
25280130|NCT00988221|50594830|FG002|Part II|Withdrawal by Subject|2|||
25190566|NCT01386385|50347613|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
25280131|NCT00988221|50594831|FG003|Part II|Withdrawal by Subject|2|||
25280132|NCT00988221|50594828|FG000|Part II|Reason not Specified|0|||
25280133|NCT00988221|50594829|FG001|Part II|Reason not Specified|0|||
25280134|NCT00988221|50594830|FG002|Part II|Reason not Specified|1|||
25280135|NCT00988221|50594831|FG003|Part II|Reason not Specified|0|||
25190567|NCT01386385|50347614|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
25280136|NCT00988221|50594828|FG000|Part III|Adverse Event|1|||
25280137|NCT00988221|50594829|FG001|Part III|Adverse Event|0|||
25280138|NCT00988221|50594830|FG002|Part III|Adverse Event|1|||
25190568|NCT01386385|50347615|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
25190569|NCT01386385|50347616|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
25190570|NCT01386385|50347617|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
25190571|NCT01386385|50347618|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
25190572|NCT01386385|50347619|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
25190573|NCT01386385|50347612|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
25190574|NCT01386385|50347613|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
25190575|NCT01386385|50347614|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
25280139|NCT00988221|50594831|FG003|Part III|Adverse Event|0|||
25280140|NCT00988221|50594828|FG000|Part III|Insufficient Therapeutic Response|0|||
25280141|NCT00988221|50594829|FG001|Part III|Insufficient Therapeutic Response|1|||
25280142|NCT00988221|50594830|FG002|Part III|Insufficient Therapeutic Response|1|||
25280143|NCT00988221|50594831|FG003|Part III|Insufficient Therapeutic Response|0|||
25280144|NCT00988221|50594828|FG000|Part III|Refused Treatment|0|||
25280145|NCT00988221|50594829|FG001|Part III|Refused Treatment|0|||
25280146|NCT00988221|50594830|FG002|Part III|Refused Treatment|1|||
25280147|NCT00988221|50594831|FG003|Part III|Refused Treatment|0|||
25280148|NCT01149096|50594852|FG000|Overall Study|Lost to Follow-up|0|||
25280149|NCT01149096|50594853|FG001|Overall Study|Lost to Follow-up|1|||
25280150|NCT01175382|50594863|FG000|Overall Study|Lost to Follow-up|4|||
25280151|NCT01175382|50594864|FG001|Overall Study|Lost to Follow-up|3|||
25280152|NCT01175382|50594865|FG002|Overall Study|Lost to Follow-up|1|||
25280153|NCT01175382|50594863|FG000|Overall Study|Physician Decision|0|||
25280154|NCT01175382|50594864|FG001|Overall Study|Physician Decision|1|||
25280155|NCT01175382|50594865|FG002|Overall Study|Physician Decision|0|||
25280156|NCT01175382|50594863|FG000|Overall Study|Withdrawal by Subject|0|||
25280157|NCT01175382|50594864|FG001|Overall Study|Withdrawal by Subject|0|||
25280158|NCT01175382|50594865|FG002|Overall Study|Withdrawal by Subject|1|||
25280159|NCT01175382|50594863|FG000|Overall Study|No longer having problem|1|||
25280160|NCT01175382|50594864|FG001|Overall Study|No longer having problem|0|||
25280161|NCT01175382|50594865|FG002|Overall Study|No longer having problem|1|||
25280162|NCT01175382|50594863|FG000|Overall Study|Unable/unwilling to attend visits|3|||
25280163|NCT01175382|50594864|FG001|Overall Study|Unable/unwilling to attend visits|1|||
25280164|NCT01175382|50594865|FG002|Overall Study|Unable/unwilling to attend visits|2|||
25280165|NCT01175382|50594863|FG000|Overall Study|Unwilling to follow protocol|0|||
25280166|NCT01175382|50594864|FG001|Overall Study|Unwilling to follow protocol|1|||
25280167|NCT01175382|50594865|FG002|Overall Study|Unwilling to follow protocol|0|||
25280168|NCT01175382|50594863|FG000|Overall Study|Unable to tolerate study meds|0|||
24969280|NCT00253370|50058748|FG000|Overall Study|Disease progression|13|||
24969281|NCT00253370|50058748|FG000|Overall Study|Death|2|||
24969282|NCT00253370|50058748|FG000|Overall Study|Withdrawal by Subject|6|||
25069703|NCT02614196|50175479|FG002|Double Blind Treatment Phase|Pregnancy|0|||
25069704|NCT02614196|50175480|FG003|Double Blind Treatment Phase|Pregnancy|0|||
25069705|NCT02614196|50175481|FG004|Double Blind Treatment Phase|Pregnancy|0|||
25069706|NCT02614196|50175482|FG005|Double Blind Treatment Phase|Pregnancy|0|||
25069707|NCT02614196|50175477|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
25069708|NCT02614196|50175478|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
25069709|NCT02614196|50175479|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
25069710|NCT02614196|50175480|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
25069711|NCT02614196|50175481|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
25069712|NCT02614196|50175482|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
25069713|NCT02614196|50175477|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
25069714|NCT02614196|50175478|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
25069715|NCT02614196|50175479|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
25069716|NCT02614196|50175480|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
25069717|NCT02614196|50175481|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
25069718|NCT02614196|50175482|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
25069719|NCT02614196|50175477|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
25069720|NCT02614196|50175478|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
25069721|NCT02614196|50175479|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
25069722|NCT02614196|50175480|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
25069723|NCT02614196|50175481|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
25069724|NCT02614196|50175482|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
25069725|NCT02614196|50175477|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
25069726|NCT02614196|50175478|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
25069727|NCT02614196|50175479|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
25069728|NCT02614196|50175480|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
25069729|NCT02614196|50175481|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
25069730|NCT02614196|50175482|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
25069731|NCT02614196|50175477|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
25069732|NCT02614196|50175478|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
25069733|NCT02614196|50175479|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
25069734|NCT02614196|50175480|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
24969283|NCT00253370|50058748|FG000|Overall Study|Non-protocol therapy|1|||
24969284|NCT00253370|50058748|FG000|Overall Study|Physician Decision|1|||
24969285|NCT00253370|50058748|FG000|Overall Study|Protocol Violation|1|||
24969286|NCT00253370|50058748|FG000|Overall Study|Abdominal pain due to disease|1|||
25069735|NCT02614196|50175481|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
25069736|NCT02614196|50175482|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
25069737|NCT02614196|50175477|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
24969287|NCT00140426|50058755|FG000|Overall Study|Withdrawal by Subject|0|||
25069738|NCT02614196|50175478|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
24969288|NCT00140426|50058756|FG001|Overall Study|Withdrawal by Subject|3|||
24969289|NCT00121134|50058771|FG000|Overall Study|Progression of Disease|5|||
24969290|NCT00121134|50058772|FG001|Overall Study|Progression of Disease|3|||
24969291|NCT00121134|50058773|FG002|Overall Study|Progression of Disease|4|||
24969292|NCT00121134|50058774|FG003|Overall Study|Progression of Disease|2|||
24969293|NCT00121134|50058771|FG000|Overall Study|Toxicity|4|||
24969294|NCT00121134|50058772|FG001|Overall Study|Toxicity|7|||
24969295|NCT00121134|50058773|FG002|Overall Study|Toxicity|13|||
24969296|NCT00121134|50058774|FG003|Overall Study|Toxicity|5|||
24969297|NCT00121134|50058771|FG000|Overall Study|Physician Decision|6|||
24969298|NCT00121134|50058772|FG001|Overall Study|Physician Decision|4|||
24969299|NCT00121134|50058773|FG002|Overall Study|Physician Decision|4|||
24969300|NCT00121134|50058774|FG003|Overall Study|Physician Decision|1|||
24969301|NCT00121134|50058771|FG000|Overall Study|Treatment Delay|1|||
24969302|NCT00121134|50058772|FG001|Overall Study|Treatment Delay|0|||
24969303|NCT00121134|50058773|FG002|Overall Study|Treatment Delay|0|||
24969304|NCT00121134|50058774|FG003|Overall Study|Treatment Delay|0|||
24969305|NCT00121134|50058771|FG000|Overall Study|Intercurrent Illness|0|||
24969306|NCT00121134|50058772|FG001|Overall Study|Intercurrent Illness|0|||
24969307|NCT00121134|50058773|FG002|Overall Study|Intercurrent Illness|0|||
24969308|NCT00121134|50058774|FG003|Overall Study|Intercurrent Illness|1|||
24969309|NCT00121134|50058771|FG000|Overall Study|Patient Personal Reasons|0|||
24969310|NCT00121134|50058772|FG001|Overall Study|Patient Personal Reasons|1|||
24969311|NCT00121134|50058773|FG002|Overall Study|Patient Personal Reasons|0|||
24969312|NCT00121134|50058774|FG003|Overall Study|Patient Personal Reasons|0|||
24969313|NCT02657434|50058786|FG000|Overall Study|On-Going in Study|77|||
25069739|NCT02614196|50175479|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
25069740|NCT02614196|50175480|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
25069741|NCT02614196|50175481|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
25069742|NCT02614196|50175482|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
24969314|NCT02657434|50058787|FG001|Overall Study|On-Going in Study|91|||
24969315|NCT02657434|50058786|FG000|Overall Study|Death|177|||
24969316|NCT02657434|50058787|FG001|Overall Study|Death|183|||
24969317|NCT02657434|50058786|FG000|Overall Study|Lost to Follow-up|2|||
24969318|NCT02657434|50058787|FG001|Overall Study|Lost to Follow-up|2|||
24969319|NCT02657434|50058786|FG000|Overall Study|Randomization by Error|2|||
25069743|NCT02614196|50175477|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
24969320|NCT02657434|50058787|FG001|Overall Study|Randomization by Error|0|||
24969321|NCT02657434|50058786|FG000|Overall Study|Withdrawal by Subject|27|||
24969322|NCT02657434|50058787|FG001|Overall Study|Withdrawal by Subject|16|||
24969323|NCT02657434|50058786|FG000|Overall Study|Protocol Violation|1|||
24969324|NCT02657434|50058787|FG001|Overall Study|Protocol Violation|0|||
24969325|NCT00119262|50058796|FG000|Overall Study|Lack of Efficacy|0|||
24969326|NCT00119262|50058797|FG001|Overall Study|Lack of Efficacy|3|||
24969327|NCT00119262|50058796|FG000|Overall Study|Withdrawal by Subject|12|||
24969328|NCT00119262|50058797|FG001|Overall Study|Withdrawal by Subject|11|||
24969329|NCT00119262|50058796|FG000|Overall Study|Adverse Event|33|||
24969330|NCT00119262|50058797|FG001|Overall Study|Adverse Event|35|||
24969331|NCT00119262|50058796|FG000|Overall Study|other disease|0|||
24969332|NCT00119262|50058797|FG001|Overall Study|other disease|2|||
24969333|NCT00119262|50058796|FG000|Overall Study|ineligble|1|||
24969334|NCT00119262|50058797|FG001|Overall Study|ineligble|2|||
24969335|NCT00119262|50058796|FG000|Overall Study|others|0|||
24969336|NCT00119262|50058797|FG001|Overall Study|others|5|||
24969337|NCT03703882|50058805|FG000|Overall Study|Adverse Event|1|||
24969338|NCT03703882|50058806|FG001|Overall Study|Adverse Event|0|||
24969339|NCT03703882|50058805|FG000|Overall Study|Lost to Follow-up|0|||
24969340|NCT03703882|50058806|FG001|Overall Study|Lost to Follow-up|2|||
24969341|NCT03703882|50058805|FG000|Overall Study|Non-compliance with study drug|0|||
24969342|NCT03703882|50058806|FG001|Overall Study|Non-compliance with study drug|1|||
25069744|NCT02614196|50175478|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
25069745|NCT02614196|50175479|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
25280169|NCT01175382|50594864|FG001|Overall Study|Unable to tolerate study meds|1|||
24969343|NCT03703882|50058805|FG000|Overall Study|Physician Decision|0|||
24969344|NCT03703882|50058806|FG001|Overall Study|Physician Decision|1|||
24969345|NCT03703882|50058805|FG000|Overall Study|Progressive disease|1|||
24969346|NCT03703882|50058806|FG001|Overall Study|Progressive disease|0|||
24969347|NCT03703882|50058805|FG000|Overall Study|Withdrawal by parent/guardian|1|||
24969348|NCT03703882|50058806|FG001|Overall Study|Withdrawal by parent/guardian|0|||
24969349|NCT03703882|50058805|FG000|Overall Study|Starting another treatment|0|||
24969350|NCT03703882|50058806|FG001|Overall Study|Starting another treatment|1|||
25069746|NCT02614196|50175480|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
25069747|NCT02614196|50175481|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
25069748|NCT02614196|50175482|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
25069749|NCT02614196|50175477|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
25069750|NCT02614196|50175478|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
25069751|NCT02614196|50175479|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
25069752|NCT02614196|50175480|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
25069753|NCT02614196|50175481|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
25069754|NCT02614196|50175482|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
25069755|NCT02765035|50175512|FG000|First Intervention (90 Days)|Adverse Event|1|||
25069756|NCT02765035|50175513|FG001|First Intervention (90 Days)|Adverse Event|1|||
25069757|NCT02765035|50175512|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
25069758|NCT02765035|50175513|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
25069759|NCT02307682|50175523|FG000|Overall Study|Adverse Event|9|||
25069760|NCT02307682|50175524|FG001|Overall Study|Adverse Event|8|||
25069761|NCT02307682|50175525|FG002|Overall Study|Adverse Event|12|||
25069762|NCT02307682|50175523|FG000|Overall Study|Lack of Efficacy|1|||
25069763|NCT02307682|50175524|FG001|Overall Study|Lack of Efficacy|0|||
25069764|NCT02307682|50175525|FG002|Overall Study|Lack of Efficacy|1|||
25069765|NCT02307682|50175523|FG000|Overall Study|Physician Decision|2|||
25069766|NCT02307682|50175524|FG001|Overall Study|Physician Decision|2|||
25069767|NCT02307682|50175525|FG002|Overall Study|Physician Decision|8|||
25069768|NCT02307682|50175523|FG000|Overall Study|Progressive Disease|1|||
25069769|NCT02307682|50175524|FG001|Overall Study|Progressive Disease|0|||
25069770|NCT02307682|50175525|FG002|Overall Study|Progressive Disease|0|||
25069771|NCT02307682|50175523|FG000|Overall Study|Withdrawal by Subject|26|||
25069772|NCT02307682|50175524|FG001|Overall Study|Withdrawal by Subject|34|||
25069773|NCT02307682|50175525|FG002|Overall Study|Withdrawal by Subject|23|||
25069774|NCT02307682|50175523|FG000|Overall Study|Death|9|||
25069775|NCT02307682|50175524|FG001|Overall Study|Death|7|||
25069776|NCT02307682|50175525|FG002|Overall Study|Death|12|||
25069777|NCT02307682|50175523|FG000|Overall Study|Lost to Follow-up|1|||
25069778|NCT02307682|50175524|FG001|Overall Study|Lost to Follow-up|5|||
25069779|NCT02307682|50175525|FG002|Overall Study|Lost to Follow-up|6|||
25069780|NCT02307682|50175523|FG000|Overall Study|Protocol Deviation|0|||
25069781|NCT02307682|50175524|FG001|Overall Study|Protocol Deviation|0|||
25069782|NCT02307682|50175525|FG002|Overall Study|Protocol Deviation|2|||
25069783|NCT02307682|50175523|FG000|Overall Study|Other|1|||
25069784|NCT02307682|50175524|FG001|Overall Study|Other|1|||
25069785|NCT02307682|50175525|FG002|Overall Study|Other|0|||
25069786|NCT02615990|50175535|FG000|Overall Study|study terminated|1|||
25069787|NCT02615990|50175536|FG001|Overall Study|study terminated|1|||
25069788|NCT02613884|50175542|FG000|Overall Study|Death|1|||
25280170|NCT01175382|50594865|FG002|Overall Study|Unable to tolerate study meds|1|||
24969351|NCT03703882|50058805|FG000|Overall Study|noncompliance with study procedures|0|||
24969352|NCT03703882|50058806|FG001|Overall Study|noncompliance with study procedures|1|||
24969353|NCT00131664|50058815|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
24969354|NCT00131664|50058816|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
25069789|NCT02613884|50175542|FG000|Overall Study|Lost to Follow-up|1|||
25069790|NCT02791763|50175550|FG000|Overall Study|Protocol Violation|0|||
25069791|NCT02791763|50175551|FG001|Overall Study|Protocol Violation|0|||
25280171|NCT01194245|50594878|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
24969355|NCT00131664|50058817|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
25069792|NCT02791763|50175552|FG002|Overall Study|Protocol Violation|1|||
25069793|NCT02791763|50175550|FG000|Overall Study|Withdrawal by Subject|5|||
25069794|NCT02791763|50175551|FG001|Overall Study|Withdrawal by Subject|1|||
25069795|NCT02791763|50175552|FG002|Overall Study|Withdrawal by Subject|0|||
25069796|NCT02791763|50175550|FG000|Overall Study|Physician Decision|0|||
25069797|NCT02791763|50175551|FG001|Overall Study|Physician Decision|1|||
24969356|NCT00131664|50058818|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
24969357|NCT00131664|50058819|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
24969358|NCT00131664|50058820|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
24969359|NCT00131664|50058815|FG000|First Period (First 6 Months)|Death|0|||
24969360|NCT00131664|50058816|FG001|First Period (First 6 Months)|Death|1|||
24969361|NCT00131664|50058817|FG002|First Period (First 6 Months)|Death|0|||
24969362|NCT00131664|50058818|FG003|First Period (First 6 Months)|Death|0|||
24969363|NCT00131664|50058819|FG004|First Period (First 6 Months)|Death|0|||
24969364|NCT00131664|50058820|FG005|First Period (First 6 Months)|Death|0|||
24969365|NCT00131664|50058815|FG000|First Period (First 6 Months)|Protocol Violation|2|||
24969366|NCT00131664|50058816|FG001|First Period (First 6 Months)|Protocol Violation|2|||
24969367|NCT00131664|50058817|FG002|First Period (First 6 Months)|Protocol Violation|1|||
24969368|NCT00131664|50058818|FG003|First Period (First 6 Months)|Protocol Violation|0|||
24969369|NCT00131664|50058819|FG004|First Period (First 6 Months)|Protocol Violation|0|||
24969370|NCT00131664|50058820|FG005|First Period (First 6 Months)|Protocol Violation|0|||
24969371|NCT00131664|50058815|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
24969372|NCT00131664|50058816|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
24969373|NCT00131664|50058817|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
24969374|NCT00131664|50058818|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
24969375|NCT00131664|50058819|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
24969376|NCT00131664|50058820|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
24969377|NCT00131664|50058815|FG000|First Period (First 6 Months)|Adverse Event|9|||
24969378|NCT00131664|50058816|FG001|First Period (First 6 Months)|Adverse Event|4|||
24969379|NCT00131664|50058817|FG002|First Period (First 6 Months)|Adverse Event|5|||
24969380|NCT00131664|50058818|FG003|First Period (First 6 Months)|Adverse Event|0|||
24969381|NCT00131664|50058819|FG004|First Period (First 6 Months)|Adverse Event|0|||
24969382|NCT00131664|50058820|FG005|First Period (First 6 Months)|Adverse Event|0|||
24969383|NCT00131664|50058815|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
24969384|NCT00131664|50058816|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
24969385|NCT00131664|50058817|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
24969386|NCT00131664|50058818|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
24969387|NCT00131664|50058819|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
24969388|NCT00131664|50058820|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
24969389|NCT00131664|50058815|FG000|First Period (First 6 Months)|Administrative reasons|2|||
24969390|NCT00131664|50058816|FG001|First Period (First 6 Months)|Administrative reasons|0|||
24969391|NCT00131664|50058817|FG002|First Period (First 6 Months)|Administrative reasons|5|||
24969392|NCT00131664|50058818|FG003|First Period (First 6 Months)|Administrative reasons|0|||
24969393|NCT00131664|50058819|FG004|First Period (First 6 Months)|Administrative reasons|0|||
24969394|NCT00131664|50058820|FG005|First Period (First 6 Months)|Administrative reasons|0|||
24969395|NCT00131664|50058815|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
24969396|NCT00131664|50058816|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
24969397|NCT00131664|50058817|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
24969398|NCT00131664|50058818|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
24969399|NCT00131664|50058819|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
24969400|NCT00131664|50058820|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
24969401|NCT00131664|50058815|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
24969402|NCT00131664|50058816|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
24969403|NCT00131664|50058817|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
24969404|NCT00131664|50058818|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
24969405|NCT00131664|50058819|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
24969406|NCT00131664|50058820|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
25069798|NCT02791763|50175552|FG002|Overall Study|Physician Decision|0|||
25280172|NCT01194245|50594879|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
25280173|NCT01194245|50594880|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
25280174|NCT01194245|50594881|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
25280175|NCT01194245|50594882|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
25280176|NCT01194245|50594878|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
25280177|NCT01194245|50594879|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
25280178|NCT01194245|50594880|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
25280179|NCT01194245|50594881|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
25280180|NCT01194245|50594882|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
25280181|NCT01194245|50594878|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
25280182|NCT01194245|50594879|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
25280183|NCT01194245|50594880|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
25280184|NCT01194245|50594881|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
25280185|NCT01194245|50594882|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
25280186|NCT01194245|50594878|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
25280187|NCT01194245|50594879|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
25280188|NCT01194245|50594880|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
25280189|NCT01194245|50594881|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
25280190|NCT01194245|50594882|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
25280191|NCT01194245|50594878|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25280192|NCT01194245|50594879|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25280193|NCT01194245|50594880|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25280194|NCT01194245|50594881|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
25280195|NCT01194245|50594882|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
25280196|NCT01194245|50594878|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
25280197|NCT01194245|50594879|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
25280198|NCT01194245|50594880|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
25280199|NCT01194245|50594881|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
25280200|NCT01194245|50594882|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
25280201|NCT00979407|50594893|FG000|Overall Study|Withdrawal by Subject|3|||
25280202|NCT00979407|50594894|FG001|Overall Study|Withdrawal by Subject|4|||
25280203|NCT00979407|50594893|FG000|Overall Study|Lost to Follow-up|3|||
25280204|NCT00979407|50594894|FG001|Overall Study|Lost to Follow-up|3|||
25280205|NCT01148862|50594902|FG000|Second Intervention|Withdrawal by Subject|0|||
25280206|NCT01148862|50594903|FG001|Second Intervention|Withdrawal by Subject|2|||
25280207|NCT00975975|50594909|FG000|Overall Study|Death|6|||
25069799|NCT02791763|50175550|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
25280208|NCT01193153|50594913|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
25280209|NCT01193153|50594914|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
25280210|NCT01193153|50594913|FG000|Open-label Lead in Period|Pregnancy|1|||
25280211|NCT01193153|50594914|FG001|Open-label Lead in Period|Pregnancy|0|||
25280212|NCT01193153|50594913|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
25280213|NCT01193153|50594914|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
25280214|NCT01193153|50594913|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
25280215|NCT01193153|50594914|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
25280216|NCT01193153|50594913|FG000|Open-label Lead in Period|Other|14|||
25280217|NCT01193153|50594914|FG001|Open-label Lead in Period|Other|0|||
25280218|NCT01193153|50594913|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
25280219|NCT01193153|50594914|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
25280220|NCT01193153|50594913|FG000|Open-label Lead in Period|Adverse Event|41|||
25280221|NCT01193153|50594914|FG001|Open-label Lead in Period|Adverse Event|0|||
25280222|NCT01193153|50594913|FG000|Open-label Lead in Period|Death|1|||
25280223|NCT01193153|50594914|FG001|Open-label Lead in Period|Death|0|||
25280224|NCT01193153|50594913|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
25280225|NCT01193153|50594914|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
25190576|NCT01386385|50347615|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
25190577|NCT01386385|50347616|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
25190578|NCT01386385|50347617|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
25280226|NCT01193153|50594913|FG000|Open-label Stabilization Period|Adverse Event|9|||
25280227|NCT01193153|50594914|FG001|Open-label Stabilization Period|Adverse Event|0|||
25069800|NCT02791763|50175551|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
25069801|NCT02791763|50175552|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
25190579|NCT01386385|50347618|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
25190580|NCT01386385|50347619|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
25190581|NCT01386385|50347612|FG000|Phase II Concurrent CRT|Adverse Event|0|||
25190582|NCT01386385|50347613|FG001|Phase II Concurrent CRT|Adverse Event|0|||
25190583|NCT01386385|50347614|FG002|Phase II Concurrent CRT|Adverse Event|0|||
25190584|NCT01386385|50347615|FG003|Phase II Concurrent CRT|Adverse Event|0|||
25190585|NCT01386385|50347616|FG004|Phase II Concurrent CRT|Adverse Event|0|||
25190586|NCT01386385|50347617|FG005|Phase II Concurrent CRT|Adverse Event|0|||
25190587|NCT01386385|50347618|FG006|Phase II Concurrent CRT|Adverse Event|3|||
25190588|NCT01386385|50347619|FG007|Phase II Concurrent CRT|Adverse Event|3|||
25190589|NCT01386385|50347612|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
25190590|NCT01386385|50347613|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
25190591|NCT01386385|50347614|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
25190592|NCT01386385|50347615|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
25190593|NCT01386385|50347616|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
25190594|NCT01386385|50347617|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
25190595|NCT01386385|50347618|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
25190596|NCT01386385|50347619|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
25190597|NCT01386385|50347612|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
25190598|NCT01386385|50347613|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
25190599|NCT01386385|50347614|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
25190600|NCT01386385|50347615|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
25190601|NCT01386385|50347616|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
25190602|NCT01386385|50347617|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
25190603|NCT01386385|50347618|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
25190604|NCT01386385|50347619|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
25190605|NCT01386385|50347612|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
25190606|NCT01386385|50347613|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
25190607|NCT01386385|50347614|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
25190608|NCT01386385|50347615|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
25190609|NCT01386385|50347616|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
25190610|NCT01386385|50347617|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
25190611|NCT01386385|50347618|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
25190612|NCT01386385|50347619|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
25190613|NCT01386385|50347612|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
25190614|NCT01386385|50347613|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
25190615|NCT01386385|50347614|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
25190616|NCT01386385|50347615|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
25190617|NCT01386385|50347616|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
25190618|NCT01386385|50347617|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
25190619|NCT01386385|50347618|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
25190620|NCT01386385|50347619|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
25190621|NCT01248715|50347646|FG000|Overall Study|Not influenza positive|501|||
25190622|NCT01248715|50347647|FG001|Overall Study|Not influenza positive|510|||
25190623|NCT01065454|50347666|FG000|Treatment|Adverse Event|7|||
25280228|NCT01193153|50594913|FG000|Open-label Stabilization Period|Death|2|||
25280229|NCT01193153|50594914|FG001|Open-label Stabilization Period|Death|0|||
25280230|NCT01193153|50594913|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
25280231|NCT01193153|50594914|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
25280232|NCT01193153|50594913|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
25280233|NCT01193153|50594914|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
25280234|NCT01193153|50594913|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
25280235|NCT01193153|50594914|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
25280236|NCT01193153|50594913|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
25280237|NCT01193153|50594914|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
25280238|NCT01193153|50594913|FG000|Open-label Stabilization Period|Other|8|||
25280239|NCT01193153|50594914|FG001|Open-label Stabilization Period|Other|0|||
25280240|NCT01193153|50594913|FG000|Double Blind Relapse Prevention Period|Other|2|||
25280241|NCT01193153|50594914|FG001|Double Blind Relapse Prevention Period|Other|3|||
25280242|NCT01193153|50594913|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
25280243|NCT01193153|50594914|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
25280244|NCT01193153|50594913|FG000|Double Blind Relapse Prevention Period|Death|2|||
25280245|NCT01193153|50594914|FG001|Double Blind Relapse Prevention Period|Death|0|||
25280246|NCT01193153|50594913|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
25280247|NCT01193153|50594914|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
25280248|NCT01193153|50594913|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
25280249|NCT01193153|50594914|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
25280250|NCT01193153|50594913|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
25280251|NCT01193153|50594914|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
25280252|NCT01193153|50594913|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
25280253|NCT01193153|50594914|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
25280254|NCT01193153|50594913|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
25280255|NCT01193153|50594914|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
25169003|NCT01854047|50299705|FG004|Overall Study|Poor compliance to protocol|0|||
25169004|NCT01854047|50299701|FG000|Overall Study|Adverse Event|5|||
25169005|NCT01854047|50299702|FG001|Overall Study|Adverse Event|4|||
25169006|NCT01854047|50299703|FG002|Overall Study|Adverse Event|6|||
25169007|NCT01854047|50299704|FG003|Overall Study|Adverse Event|10|||
25169008|NCT01854047|50299705|FG004|Overall Study|Adverse Event|7|||
25169009|NCT01854047|50299701|FG000|Overall Study|Randomized but not treated|0|||
25169010|NCT01854047|50299702|FG001|Overall Study|Randomized but not treated|1|||
25169011|NCT01854047|50299703|FG002|Overall Study|Randomized but not treated|2|||
25169012|NCT01854047|50299704|FG003|Overall Study|Randomized but not treated|0|||
25190624|NCT01065454|50347667|FG001|Treatment|Adverse Event|4|||
25190625|NCT01065454|50347668|FG002|Treatment|Adverse Event|3|||
25190626|NCT01065454|50347669|FG003|Treatment|Adverse Event|6|||
25190627|NCT01065454|50347666|FG000|Treatment|Death|1|||
25190628|NCT01065454|50347667|FG001|Treatment|Death|0|||
25190629|NCT01065454|50347668|FG002|Treatment|Death|0|||
25190630|NCT01065454|50347669|FG003|Treatment|Death|0|||
25190631|NCT01065454|50347666|FG000|Treatment|Non-compliance|1|||
25190632|NCT01065454|50347667|FG001|Treatment|Non-compliance|0|||
25190633|NCT01065454|50347668|FG002|Treatment|Non-compliance|0|||
25190634|NCT01065454|50347669|FG003|Treatment|Non-compliance|1|||
25190635|NCT01065454|50347666|FG000|Treatment|Protocol Decision|0|||
25190636|NCT01065454|50347667|FG001|Treatment|Protocol Decision|0|||
25190637|NCT01065454|50347668|FG002|Treatment|Protocol Decision|3|||
25190638|NCT01065454|50347669|FG003|Treatment|Protocol Decision|2|||
25190639|NCT01065454|50347666|FG000|Treatment|Protocol Violation|1|||
25190640|NCT01065454|50347667|FG001|Treatment|Protocol Violation|0|||
25190641|NCT01065454|50347668|FG002|Treatment|Protocol Violation|1|||
25190642|NCT01065454|50347669|FG003|Treatment|Protocol Violation|0|||
25190643|NCT01065454|50347666|FG000|Treatment|Withdrawal by Subject|3|||
25190644|NCT01065454|50347667|FG001|Treatment|Withdrawal by Subject|1|||
25190645|NCT01065454|50347668|FG002|Treatment|Withdrawal by Subject|2|||
25190646|NCT01065454|50347669|FG003|Treatment|Withdrawal by Subject|3|||
25190647|NCT01065454|50347666|FG000|Follow up|Adverse Event|1|||
25190648|NCT01065454|50347667|FG001|Follow up|Adverse Event|0|||
25190649|NCT01065454|50347668|FG002|Follow up|Adverse Event|0|||
25190650|NCT01065454|50347669|FG003|Follow up|Adverse Event|1|||
25190651|NCT01065454|50347666|FG000|Follow up|Death|0|||
25190652|NCT01065454|50347667|FG001|Follow up|Death|1|||
25190653|NCT01065454|50347668|FG002|Follow up|Death|1|||
25190654|NCT01065454|50347669|FG003|Follow up|Death|0|||
25169013|NCT01854047|50299705|FG004|Overall Study|Randomized but not treated|4|||
25190655|NCT01065454|50347666|FG000|Follow up|Lost to Follow-up|0|||
25190656|NCT01065454|50347667|FG001|Follow up|Lost to Follow-up|0|||
25190657|NCT01065454|50347668|FG002|Follow up|Lost to Follow-up|0|||
25280256|NCT01192295|50594925|FG000|Overall Study|Adverse Event|3|||
25280257|NCT01192295|50594926|FG001|Overall Study|Adverse Event|7|||
25280258|NCT01192295|50594925|FG000|Overall Study|Withdrawal by Subject|3|||
25280259|NCT01192295|50594926|FG001|Overall Study|Withdrawal by Subject|4|||
25280260|NCT01192295|50594925|FG000|Overall Study|Lost to Follow-up|0|||
25280261|NCT01192295|50594926|FG001|Overall Study|Lost to Follow-up|1|||
25280262|NCT01192295|50594925|FG000|Overall Study|Lack of Efficacy|0|||
25280263|NCT01192295|50594926|FG001|Overall Study|Lack of Efficacy|5|||
25280264|NCT01192295|50594925|FG000|Overall Study|Administrative|4|||
25280265|NCT01192295|50594926|FG001|Overall Study|Administrative|6|||
25280266|NCT01154166|50594936|FG000|Overall Study|Adverse Event|14|||
25280267|NCT01154166|50594937|FG001|Overall Study|Adverse Event|9|||
25280268|NCT01154166|50594936|FG000|Overall Study|Lost to Follow-up|1|||
25280269|NCT01154166|50594937|FG001|Overall Study|Lost to Follow-up|1|||
25280270|NCT01154166|50594936|FG000|Overall Study|Protocol Violation|4|||
25280271|NCT01154166|50594937|FG001|Overall Study|Protocol Violation|1|||
25280272|NCT01154166|50594936|FG000|Overall Study|Withdrawal by Subject|10|||
25280273|NCT01154166|50594937|FG001|Overall Study|Withdrawal by Subject|1|||
25280274|NCT01154166|50594936|FG000|Overall Study|Lack of Efficacy|3|||
25280275|NCT01154166|50594937|FG001|Overall Study|Lack of Efficacy|0|||
25280276|NCT01154166|50594936|FG000|Overall Study|Disease Progression|1|||
25280277|NCT01154166|50594937|FG001|Overall Study|Disease Progression|0|||
25280278|NCT01154166|50594936|FG000|Overall Study|Poor Compliance|1|||
25280279|NCT01154166|50594937|FG001|Overall Study|Poor Compliance|0|||
24969407|NCT00131664|50058815|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
25280280|NCT00975585|50594945|FG000|Overall Study|Adverse Event|0|||
25280281|NCT00975585|50594946|FG001|Overall Study|Adverse Event|4|||
25280282|NCT00975585|50594945|FG000|Overall Study|Lost to Follow-up|3|||
25280283|NCT00975585|50594946|FG001|Overall Study|Lost to Follow-up|5|||
25280284|NCT00975585|50594945|FG000|Overall Study|Withdrawal by Subject|2|||
25280285|NCT00975585|50594946|FG001|Overall Study|Withdrawal by Subject|1|||
25280286|NCT00975585|50594945|FG000|Overall Study|Lens issue|2|||
25280287|NCT00975585|50594946|FG001|Overall Study|Lens issue|2|||
25280288|NCT01181921|50594954|FG000|Overall Study|Lost to Follow-up|1|||
25280289|NCT01174446|50594958|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
25280290|NCT01174446|50594959|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
25280291|NCT01174446|50594960|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
25280292|NCT01174446|50594961|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
25280293|NCT01174446|50594958|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
25280294|NCT01174446|50594959|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
25280295|NCT01174446|50594960|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
25280296|NCT01174446|50594961|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
25280297|NCT01174446|50594958|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
25280298|NCT01174446|50594959|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
24969408|NCT00131664|50058816|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
24969409|NCT00131664|50058817|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
24969410|NCT00131664|50058818|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
24969411|NCT00131664|50058819|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
24969412|NCT00131664|50058820|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
25280299|NCT01174446|50594960|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
25280300|NCT01174446|50594961|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
25190658|NCT01065454|50347669|FG003|Follow up|Lost to Follow-up|1|||
25190659|NCT01065454|50347666|FG000|Follow up|Progressive disease|0|||
25190660|NCT01065454|50347667|FG001|Follow up|Progressive disease|0|||
25190661|NCT01065454|50347668|FG002|Follow up|Progressive disease|0|||
25190662|NCT01065454|50347669|FG003|Follow up|Progressive disease|1|||
25190663|NCT01065454|50347666|FG000|Follow up|Withdrawal by Subject|1|||
25190664|NCT01065454|50347667|FG001|Follow up|Withdrawal by Subject|1|||
25190665|NCT01065454|50347668|FG002|Follow up|Withdrawal by Subject|1|||
25190666|NCT01065454|50347669|FG003|Follow up|Withdrawal by Subject|0|||
25190667|NCT01065454|50347666|FG000|Follow up|study ongoing|37|||
25190668|NCT01065454|50347667|FG001|Follow up|study ongoing|22|||
25190669|NCT01065454|50347668|FG002|Follow up|study ongoing|15|||
25190670|NCT01065454|50347669|FG003|Follow up|study ongoing|41|||
25190671|NCT00937937|50347696|FG000|Overall Study|Adverse Event|6|||
25190672|NCT00937937|50347696|FG000|Overall Study|Withdrawal by Subject|2|||
25190673|NCT00937937|50347696|FG000|Overall Study|Progression/relapse|61|||
25190674|NCT00937937|50347696|FG000|Overall Study|Death|1|||
25190675|NCT00937937|50347696|FG000|Overall Study|Other|2|||
25190676|NCT00812214|50347730|FG000|Overall Study|Lost to Follow-up|3|||
25190677|NCT00812214|50347731|FG001|Overall Study|Lost to Follow-up|1|||
25190678|NCT00792948|50347738|FG000|Overall Study|Adverse Event|6|||
25190679|NCT00792948|50347738|FG000|Overall Study|Death|4|||
25190680|NCT00792948|50347738|FG000|Overall Study|Withdrawal by Subject|3|||
25190681|NCT00792948|50347738|FG000|Overall Study|Ineligible|2|||
25190682|NCT00792948|50347738|FG000|Overall Study|Insurance denial - not treated|1|||
25190683|NCT00792948|50347738|FG000|Overall Study|Physician Decision|11|||
25190684|NCT00792948|50347738|FG000|Overall Study|Protocol Violation|1|||
25190685|NCT00658814|50347747|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
25190686|NCT00658814|50347748|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
25190687|NCT00658814|50347747|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
25190688|NCT00658814|50347748|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
25190689|NCT00658814|50347747|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
25190690|NCT00658814|50347748|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
25190691|NCT00658814|50347747|FG000|Remission Induction Chemotherapy|Death|1|||
25190692|NCT00658814|50347748|FG001|Remission Induction Chemotherapy|Death|4|||
25190693|NCT00658814|50347747|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
25190694|NCT00658814|50347748|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
25190695|NCT00658814|50347747|FG000|Remission Induction Chemotherapy|Not eligible|1|||
25190696|NCT00658814|50347748|FG001|Remission Induction Chemotherapy|Not eligible|2|||
25190697|NCT00658814|50347747|FG000|Consolidation Therapy|Not protocol specified|0|||
25190698|NCT00658814|50347748|FG001|Consolidation Therapy|Not protocol specified|1|||
25190699|NCT00658814|50347747|FG000|Consolidation Therapy|Not eligible|2|||
25280301|NCT01174446|50594958|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
25169014|NCT01854047|50299701|FG000|Overall Study|Other than specified above|3|||
25169015|NCT01854047|50299702|FG001|Overall Study|Other than specified above|3|||
25169016|NCT01854047|50299703|FG002|Overall Study|Other than specified above|3|||
25169017|NCT01854047|50299704|FG003|Overall Study|Other than specified above|5|||
25169018|NCT01854047|50299705|FG004|Overall Study|Other than specified above|8|||
25169019|NCT01870739|50299755|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
25169020|NCT01870739|50299756|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
25169021|NCT01870739|50299755|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
25169022|NCT01870739|50299756|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
25169023|NCT01870739|50299755|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
25169024|NCT01870739|50299756|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
25190700|NCT00658814|50347748|FG001|Consolidation Therapy|Not eligible|2|||
25190701|NCT00658814|50347747|FG000|Maintenance Therapy|Adverse Event|1|||
25190702|NCT00658814|50347748|FG001|Maintenance Therapy|Adverse Event|1|||
24969413|NCT00131664|50058815|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
24969414|NCT00131664|50058816|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
24969415|NCT00131664|50058817|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
24969416|NCT00131664|50058818|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
25280302|NCT01174446|50594959|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
25280303|NCT01174446|50594960|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
25280304|NCT01174446|50594961|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
25280305|NCT00932698|50595019|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
25280306|NCT00932698|50595020|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
25280307|NCT00932698|50595021|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
25280308|NCT00932698|50595022|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
25280309|NCT00932698|50595023|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
25280310|NCT00932698|50595024|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
25280311|NCT00932698|50595025|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
25280312|NCT00932698|50595026|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
25280313|NCT00932698|50595027|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
25280314|NCT00932698|50595028|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
25280315|NCT00932698|50595029|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
25280316|NCT00932698|50595019|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
25280317|NCT00932698|50595020|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
25280318|NCT00932698|50595021|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
25280319|NCT00932698|50595022|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
25280320|NCT00932698|50595023|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
25280321|NCT00932698|50595024|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
25280322|NCT00932698|50595025|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
25280323|NCT00932698|50595026|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
25280324|NCT00932698|50595027|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
25280325|NCT00932698|50595028|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
25280326|NCT00932698|50595029|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
25280327|NCT00932698|50595019|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
25280328|NCT00932698|50595020|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
25280329|NCT00932698|50595021|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
25280330|NCT00932698|50595022|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
25280331|NCT00932698|50595023|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
25280332|NCT00932698|50595024|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
25280333|NCT00932698|50595025|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
25280334|NCT00932698|50595026|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
25280335|NCT00932698|50595027|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
25280336|NCT00932698|50595028|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
25280337|NCT00932698|50595029|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
25280338|NCT00932698|50595019|FG000|Part 1 (Dose Escalation)|Other|0|||
25280339|NCT00932698|50595020|FG001|Part 1 (Dose Escalation)|Other|0|||
25280340|NCT00932698|50595021|FG002|Part 1 (Dose Escalation)|Other|1|||
25280341|NCT00932698|50595022|FG003|Part 1 (Dose Escalation)|Other|0|||
25280342|NCT00932698|50595023|FG004|Part 1 (Dose Escalation)|Other|0|||
25280343|NCT00932698|50595024|FG005|Part 1 (Dose Escalation)|Other|0|||
25280344|NCT00932698|50595025|FG006|Part 1 (Dose Escalation)|Other|1|||
25280345|NCT00932698|50595026|FG007|Part 1 (Dose Escalation)|Other|0|||
25280346|NCT00932698|50595027|FG008|Part 1 (Dose Escalation)|Other|0|||
25280347|NCT00932698|50595028|FG009|Part 1 (Dose Escalation)|Other|0|||
25280348|NCT00932698|50595029|FG010|Part 1 (Dose Escalation)|Other|0|||
25280349|NCT00932698|50595019|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
25280350|NCT00932698|50595020|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
25280351|NCT00932698|50595021|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
25280352|NCT00932698|50595022|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
25280353|NCT00932698|50595023|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
25280354|NCT00932698|50595024|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
25280355|NCT00932698|50595025|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
25280356|NCT00932698|50595026|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
25280357|NCT00932698|50595027|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
25280358|NCT00932698|50595028|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
25280359|NCT00932698|50595029|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
25280360|NCT00932698|50595019|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
25280361|NCT00932698|50595020|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
25280362|NCT00932698|50595021|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
25280363|NCT00932698|50595022|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
25280364|NCT00932698|50595023|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
25280365|NCT00932698|50595024|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
25280366|NCT00932698|50595025|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
25069802|NCT02791763|50175550|FG000|Overall Study|Cancer event|1|||
25280367|NCT00932698|50595026|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
25280368|NCT00932698|50595027|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
25280369|NCT00932698|50595028|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
25280370|NCT00932698|50595029|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
25280371|NCT00932698|50595019|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
25280372|NCT00932698|50595020|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
25280373|NCT00932698|50595021|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
25280374|NCT00932698|50595022|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
25280375|NCT00932698|50595023|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
25280376|NCT00932698|50595024|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
25280377|NCT00932698|50595025|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
25280378|NCT00932698|50595026|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
25280379|NCT00932698|50595027|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
25280380|NCT00932698|50595028|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
25280381|NCT00932698|50595029|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
25280382|NCT00978627|50595057|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
25280383|NCT00978627|50595058|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
25280384|NCT00978627|50595057|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
25280385|NCT00978627|50595058|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
25280386|NCT00978627|50595057|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
25280387|NCT00978627|50595058|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
25280388|NCT00978627|50595057|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
25280389|NCT00978627|50595058|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
25280390|NCT00978627|50595057|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
25280391|NCT00978627|50595058|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
25280392|NCT00978627|50595057|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
25280393|NCT00978627|50595058|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
25280394|NCT00978627|50595057|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
25280395|NCT00978627|50595058|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
25280396|NCT00978627|50595057|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
25280397|NCT00978627|50595058|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
25280398|NCT00978627|50595057|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
25280399|NCT00978627|50595058|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
25280400|NCT01181609|50595064|FG000|Overall Study|Adverse Event|1|||
25280401|NCT01181609|50595064|FG000|Overall Study|Withdrawal by Subject|1|||
25280402|NCT01181609|50595064|FG000|Overall Study|Lost to Follow-up|1|||
25280403|NCT01181609|50595064|FG000|Overall Study|Death|50|||
25280404|NCT01154010|50595070|FG000|Overall Study|Lost to Follow-up|0|||
25280405|NCT01154010|50595071|FG001|Overall Study|Lost to Follow-up|1|||
25280406|NCT01153698|50595077|FG000|Overall Study|Adverse Event|12|||
25280407|NCT01153698|50595077|FG000|Overall Study|Lost to Follow-up|4|||
25280408|NCT01153698|50595077|FG000|Overall Study|Withdrawal by Subject|2|||
25280409|NCT01153698|50595077|FG000|Overall Study|Switch to other anticoagulants|4|||
25280410|NCT01153698|50595077|FG000|Overall Study|Other|2|||
25280411|NCT01153698|50595077|FG000|Overall Study|Not treated with Pradaxa|5|||
25280412|NCT01174368|50595082|FG000|Overall Study|Withdrawal by Subject|1|||
25280413|NCT01147926|50595088|FG000|Overall Study|Subject Withdrew Consent|9|||
25280414|NCT01147926|50595089|FG001|Overall Study|Subject Withdrew Consent|10|||
25280415|NCT01147926|50595088|FG000|Overall Study|Adverse Event|7|||
25280416|NCT01147926|50595089|FG001|Overall Study|Adverse Event|6|||
25280417|NCT01147926|50595088|FG000|Overall Study|Subject Non-Compliant|5|||
25280418|NCT01147926|50595089|FG001|Overall Study|Subject Non-Compliant|4|||
25280419|NCT01147926|50595088|FG000|Overall Study|Principal investigator left hospital|1|||
25280420|NCT01147926|50595089|FG001|Overall Study|Principal investigator left hospital|3|||
25280421|NCT01147926|50595088|FG000|Overall Study|Selection criteria not met|3|||
25280422|NCT01147926|50595089|FG001|Overall Study|Selection criteria not met|1|||
25280423|NCT01147926|50595088|FG000|Overall Study|Lost to Follow-up|0|||
25280424|NCT01147926|50595089|FG001|Overall Study|Lost to Follow-up|2|||
25280425|NCT01147926|50595088|FG000|Overall Study|Sponsor's Decision|0|||
25280426|NCT01147926|50595089|FG001|Overall Study|Sponsor's Decision|1|||
25280427|NCT01147926|50595088|FG000|Overall Study|Lack of Efficacy|1|||
25280428|NCT01147926|50595089|FG001|Overall Study|Lack of Efficacy|0|||
25280429|NCT01147926|50595088|FG000|Overall Study|Too busy, no time for study|1|||
25280430|NCT01147926|50595089|FG001|Overall Study|Too busy, no time for study|0|||
25280431|NCT01147926|50595088|FG000|Overall Study|Went on holiday|0|||
25280432|NCT01147926|50595089|FG001|Overall Study|Went on holiday|1|||
25280433|NCT01147926|50595088|FG000|Overall Study|Colonoscopy result|0|||
25280434|NCT01147926|50595089|FG001|Overall Study|Colonoscopy result|1|||
25280435|NCT00975507|50595097|FG000|Overall Study|Adverse Event|1|||
25280436|NCT00975507|50595098|FG001|Overall Study|Adverse Event|0|||
25280437|NCT00975507|50595097|FG000|Overall Study|Lost to Follow-up|7|||
25280438|NCT00975507|50595098|FG001|Overall Study|Lost to Follow-up|1|||
25280439|NCT00975507|50595097|FG000|Overall Study|Protocol Violation|2|||
25280440|NCT00975507|50595098|FG001|Overall Study|Protocol Violation|0|||
25280441|NCT00975507|50595097|FG000|Overall Study|Withdrawal by Subject|10|||
25280442|NCT00975507|50595098|FG001|Overall Study|Withdrawal by Subject|3|||
25280443|NCT01147848|50595108|FG000|Run-in Period|Screen Failure|623|||
25280444|NCT01147848|50595109|FG001|Run-in Period|Screen Failure|0|||
25280445|NCT01147848|50595110|FG002|Run-in Period|Screen Failure|0|||
25280446|NCT01147848|50595108|FG000|Run-in Period|Run-in Failure|135|||
25280447|NCT01147848|50595109|FG001|Run-in Period|Run-in Failure|0|||
25280448|NCT01147848|50595110|FG002|Run-in Period|Run-in Failure|0|||
25280449|NCT01147848|50595108|FG000|Randomized Phase|Adverse Event|0|||
25280450|NCT01147848|50595109|FG001|Randomized Phase|Adverse Event|6|||
25280451|NCT01147848|50595110|FG002|Randomized Phase|Adverse Event|8|||
25280452|NCT01147848|50595108|FG000|Randomized Phase|Lack of Efficacy|0|||
25280453|NCT01147848|50595109|FG001|Randomized Phase|Lack of Efficacy|20|||
25280454|NCT01147848|50595110|FG002|Randomized Phase|Lack of Efficacy|11|||
25280455|NCT01147848|50595108|FG000|Randomized Phase|Protocol Violation|0|||
25280456|NCT01147848|50595109|FG001|Randomized Phase|Protocol Violation|7|||
25280457|NCT01147848|50595110|FG002|Randomized Phase|Protocol Violation|10|||
25280458|NCT01147848|50595108|FG000|Randomized Phase|Lost to Follow-up|0|||
25280459|NCT01147848|50595109|FG001|Randomized Phase|Lost to Follow-up|5|||
25280460|NCT01147848|50595110|FG002|Randomized Phase|Lost to Follow-up|7|||
25280461|NCT01147848|50595108|FG000|Randomized Phase|Physician Decision|0|||
25280462|NCT01147848|50595109|FG001|Randomized Phase|Physician Decision|0|||
25280463|NCT01147848|50595110|FG002|Randomized Phase|Physician Decision|1|||
25280464|NCT01147848|50595108|FG000|Randomized Phase|Withdrawal by Subject|0|||
25280465|NCT01147848|50595109|FG001|Randomized Phase|Withdrawal by Subject|7|||
25280466|NCT01147848|50595110|FG002|Randomized Phase|Withdrawal by Subject|9|||
25280467|NCT00929656|50595119|FG000|Overall Study|Lost to Follow-up|0|||
25280468|NCT00929656|50595120|FG001|Overall Study|Lost to Follow-up|1|||
25280469|NCT00977613|50595126|FG000|Overall Study|Lost to Follow-up|16|||
25280470|NCT01152996|50595130|FG000|Overall Study|Withdrawal by Subject|142|||
25280471|NCT01152996|50595130|FG000|Overall Study|Adverse Event|115|||
25280472|NCT01152996|50595130|FG000|Overall Study|Lost to Follow-up|112|||
25190703|NCT00658814|50347747|FG000|Maintenance Therapy|Not protocol specified|1|||
25190704|NCT00658814|50347748|FG001|Maintenance Therapy|Not protocol specified|0|||
25190705|NCT00658814|50347747|FG000|Maintenance Therapy|Not eligible|1|||
25190706|NCT00658814|50347748|FG001|Maintenance Therapy|Not eligible|0|||
25190707|NCT00601900|50347760|FG000|Overall Study|Withdrawal by Subject|0|||
25190708|NCT00601900|50347761|FG001|Overall Study|Withdrawal by Subject|3|||
25190709|NCT00588770|50347769|FG000|Overall Study|Disease progression|85|||
25190710|NCT00588770|50347770|FG001|Overall Study|Disease progression|68|||
25190711|NCT00588770|50347769|FG000|Overall Study|Adverse Event|29|||
25190712|NCT00588770|50347770|FG001|Overall Study|Adverse Event|58|||
25190713|NCT00588770|50347769|FG000|Overall Study|Death|13|||
25190714|NCT00588770|50347770|FG001|Overall Study|Death|22|||
25190715|NCT00588770|50347769|FG000|Overall Study|Withdrawal by Subject|15|||
25190716|NCT00588770|50347770|FG001|Overall Study|Withdrawal by Subject|25|||
25190717|NCT00588770|50347769|FG000|Overall Study|Alternative therapy|2|||
25190718|NCT00588770|50347770|FG001|Overall Study|Alternative therapy|4|||
25190719|NCT00588770|50347769|FG000|Overall Study|Other complicating disease|3|||
25190720|NCT00588770|50347770|FG001|Overall Study|Other complicating disease|2|||
25190721|NCT00588770|50347769|FG000|Overall Study|Not start protocol therapy|0|||
25190722|NCT00588770|50347770|FG001|Overall Study|Not start protocol therapy|9|||
25190723|NCT00588770|50347769|FG000|Overall Study|Lack of Efficacy|8|||
25190724|NCT00588770|50347770|FG001|Overall Study|Lack of Efficacy|10|||
25190725|NCT00588770|50347769|FG000|Overall Study|Physician discretion|2|||
25190726|NCT00588770|50347770|FG001|Overall Study|Physician discretion|0|||
25190727|NCT00588770|50347769|FG000|Overall Study|Patient non-compliance|2|||
25190728|NCT00588770|50347770|FG001|Overall Study|Patient non-compliance|2|||
25190729|NCT00433511|50347779|FG000|Step 1|Adverse Event|50|||
25190730|NCT00433511|50347780|FG001|Step 1|Adverse Event|157|||
25190731|NCT00433511|50347781|FG002|Step 1|Adverse Event|153|||
25190732|NCT00433511|50347779|FG000|Step 1|Withdrawal by Subject|45|||
25190733|NCT00433511|50347780|FG001|Step 1|Withdrawal by Subject|143|||
25190734|NCT00433511|50347781|FG002|Step 1|Withdrawal by Subject|154|||
25280473|NCT01152996|50595130|FG000|Overall Study|Lack of Efficacy|68|||
25280474|NCT01152996|50595130|FG000|Overall Study|Noncompliance|41|||
25280475|NCT01152996|50595130|FG000|Overall Study|Other|36|||
25280476|NCT01152996|50595130|FG000|Overall Study|Protocol Violation|22|||
25190735|NCT00433511|50347779|FG000|Step 1|Death|3|||
25190736|NCT00433511|50347780|FG001|Step 1|Death|1|||
25190737|NCT00433511|50347781|FG002|Step 1|Death|1|||
25190738|NCT00433511|50347779|FG000|Step 1|Physician Decision|1|||
25190739|NCT00433511|50347780|FG001|Step 1|Physician Decision|4|||
25280477|NCT01152996|50595130|FG000|Overall Study|Elevated liver enzymes|1|||
25280478|NCT00979953|50595138|FG000|Overall Study|Adverse Event|5|||
25280479|NCT00979953|50595139|FG001|Overall Study|Adverse Event|2|||
25190740|NCT00433511|50347781|FG002|Step 1|Physician Decision|3|||
25190741|NCT00433511|50347779|FG000|Step 1|Never started protocol therapy|28|||
25190742|NCT00433511|50347780|FG001|Step 1|Never started protocol therapy|64|||
25280480|NCT00979953|50595140|FG002|Overall Study|Adverse Event|17|||
25280481|NCT00979953|50595141|FG003|Overall Study|Adverse Event|4|||
25190743|NCT00433511|50347781|FG002|Step 1|Never started protocol therapy|66|||
25190744|NCT00433511|50347779|FG000|Step 1|Alternative therapy|2|||
25190745|NCT00433511|50347780|FG001|Step 1|Alternative therapy|1|||
25190746|NCT00433511|50347781|FG002|Step 1|Alternative therapy|3|||
25190747|NCT00433511|50347779|FG000|Step 1|Disease progression, relapse|5|||
25190748|NCT00433511|50347780|FG001|Step 1|Disease progression, relapse|3|||
25190749|NCT00433511|50347781|FG002|Step 1|Disease progression, relapse|3|||
25190750|NCT00433511|50347779|FG000|Step 1|Other complicating disease|2|||
25190751|NCT00433511|50347780|FG001|Step 1|Other complicating disease|6|||
25190752|NCT00433511|50347781|FG002|Step 1|Other complicating disease|3|||
25190753|NCT00433511|50347779|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
25190754|NCT00433511|50347780|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
25190755|NCT00433511|50347781|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
25190756|NCT00433511|50347779|FG000|Step 1|Suspected recurrence|0|||
25190757|NCT00433511|50347780|FG001|Step 1|Suspected recurrence|1|||
25190758|NCT00433511|50347781|FG002|Step 1|Suspected recurrence|0|||
25190759|NCT00433511|50347779|FG000|Step 1|Insurance/drug distribution issues|0|||
25190760|NCT00433511|50347780|FG001|Step 1|Insurance/drug distribution issues|1|||
25190761|NCT00433511|50347781|FG002|Step 1|Insurance/drug distribution issues|2|||
25280482|NCT00979953|50595138|FG000|Overall Study|Lack of Efficacy|1|||
25280483|NCT00979953|50595139|FG001|Overall Study|Lack of Efficacy|2|||
25280484|NCT00979953|50595140|FG002|Overall Study|Lack of Efficacy|0|||
25280485|NCT00979953|50595141|FG003|Overall Study|Lack of Efficacy|0|||
25280486|NCT00979953|50595138|FG000|Overall Study|Lost to Follow-up|1|||
25280487|NCT00979953|50595139|FG001|Overall Study|Lost to Follow-up|1|||
25280488|NCT00979953|50595140|FG002|Overall Study|Lost to Follow-up|1|||
25280489|NCT00979953|50595141|FG003|Overall Study|Lost to Follow-up|0|||
25280490|NCT00979953|50595138|FG000|Overall Study|Withdrawal by Subject|0|||
25280491|NCT00979953|50595139|FG001|Overall Study|Withdrawal by Subject|0|||
25280492|NCT00979953|50595140|FG002|Overall Study|Withdrawal by Subject|2|||
25280493|NCT00979953|50595141|FG003|Overall Study|Withdrawal by Subject|1|||
25280494|NCT00979953|50595138|FG000|Overall Study|Protocol Violation|1|||
25280495|NCT00979953|50595139|FG001|Overall Study|Protocol Violation|0|||
25280496|NCT00979953|50595140|FG002|Overall Study|Protocol Violation|2|||
25280497|NCT00979953|50595141|FG003|Overall Study|Protocol Violation|2|||
25280498|NCT01181531|50595153|FG000|Overall Study|Other|17|||
25280499|NCT01181531|50595154|FG001|Overall Study|Other|12|||
25280500|NCT01181531|50595153|FG000|Overall Study|Partial consent by subject withdrawn|0|||
25280501|NCT01181531|50595154|FG001|Overall Study|Partial consent by subject withdrawn|1|||
25280502|NCT01181531|50595153|FG000|Overall Study|Physician Decision|3|||
25280503|NCT01181531|50595154|FG001|Overall Study|Physician Decision|1|||
25280504|NCT01181531|50595153|FG000|Overall Study|Noncompliance|2|||
25280505|NCT01181531|50595154|FG001|Overall Study|Noncompliance|2|||
25280506|NCT01181531|50595153|FG000|Overall Study|Ineligibility determined|1|||
25280507|NCT01181531|50595154|FG001|Overall Study|Ineligibility determined|2|||
25280508|NCT01181531|50595153|FG000|Overall Study|Protocol Specified Criteria|15|||
25280509|NCT01181531|50595154|FG001|Overall Study|Protocol Specified Criteria|8|||
25280510|NCT01181531|50595153|FG000|Overall Study|Pregnancy|0|||
25280511|NCT01181531|50595154|FG001|Overall Study|Pregnancy|1|||
25280512|NCT01181531|50595153|FG000|Overall Study|Withdrawal by Subject|8|||
25280513|NCT01181531|50595154|FG001|Overall Study|Withdrawal by Subject|7|||
25280514|NCT01181531|50595153|FG000|Overall Study|Protocol Violation|6|||
25280515|NCT01181531|50595154|FG001|Overall Study|Protocol Violation|6|||
25280516|NCT01181531|50595153|FG000|Overall Study|Death|9|||
25280517|NCT01181531|50595154|FG001|Overall Study|Death|12|||
25280518|NCT01181531|50595153|FG000|Overall Study|Adverse Event|0|||
25280519|NCT01181531|50595154|FG001|Overall Study|Adverse Event|1|||
25280520|NCT01152450|50595160|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
25280521|NCT01152450|50595161|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
25280522|NCT01152450|50595162|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
25280523|NCT01152450|50595163|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
25280524|NCT01152450|50595164|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
25280525|NCT01152450|50595165|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
25280526|NCT01152450|50595160|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
25190762|NCT00433511|50347779|FG000|Step 1|Patient moved|0|||
25190763|NCT00433511|50347780|FG001|Step 1|Patient moved|0|||
25190764|NCT00433511|50347781|FG002|Step 1|Patient moved|1|||
25190765|NCT00433511|50347779|FG000|Step 2 (Arm D)|Adverse Event|0|||
25190766|NCT00433511|50347780|FG001|Step 2 (Arm D)|Adverse Event|0|||
25280527|NCT01152450|50595161|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
25280528|NCT01152450|50595162|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
25280529|NCT01152450|50595163|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
25280530|NCT01152450|50595164|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
25280531|NCT01152450|50595165|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
25280532|NCT01152450|50595160|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
25280533|NCT01152450|50595161|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
25190767|NCT00433511|50347781|FG002|Step 2 (Arm D)|Adverse Event|135|||
25280534|NCT01152450|50595162|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
25280535|NCT01152450|50595163|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
25280536|NCT01152450|50595164|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
25280537|NCT01152450|50595165|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
25280538|NCT01181141|50595175|FG000|Overall Study|Adverse Event|2|||
25280539|NCT01181141|50595176|FG001|Overall Study|Adverse Event|1|||
25280540|NCT01181141|50595175|FG000|Overall Study|Lack of Efficacy|1|||
25280541|NCT01181141|50595176|FG001|Overall Study|Lack of Efficacy|0|||
25280542|NCT01181141|50595175|FG000|Overall Study|Lost to Follow-up|1|||
25280543|NCT01181141|50595176|FG001|Overall Study|Lost to Follow-up|1|||
25280544|NCT01181141|50595175|FG000|Overall Study|Physician Decision|2|||
25280545|NCT01181141|50595176|FG001|Overall Study|Physician Decision|0|||
25280546|NCT01181141|50595175|FG000|Overall Study|Protocol Violation|3|||
25280547|NCT01181141|50595176|FG001|Overall Study|Protocol Violation|1|||
25280548|NCT01181141|50595175|FG000|Overall Study|Withdrawal by Subject|3|||
25280549|NCT01181141|50595176|FG001|Overall Study|Withdrawal by Subject|1|||
25169025|NCT01870739|50299755|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
25169026|NCT01870739|50299756|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
25169027|NCT01870739|50299755|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
25169028|NCT01870739|50299756|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
25169029|NCT01870739|50299755|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
25169030|NCT01870739|50299756|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
25169031|NCT01870739|50299755|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
25169032|NCT01870739|50299756|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
25169033|NCT01613417|50299783|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
25169034|NCT01613417|50299784|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
25169035|NCT01870583|50299812|FG000|Overall Study|Protocol Violation|0|||
25169036|NCT01870583|50299813|FG001|Overall Study|Protocol Violation|5|||
25169037|NCT01870583|50299814|FG002|Overall Study|Protocol Violation|3|||
25169038|NCT01870583|50299812|FG000|Overall Study|Lost to Follow-up|11|||
25169039|NCT01870583|50299813|FG001|Overall Study|Lost to Follow-up|13|||
25169040|NCT01870583|50299814|FG002|Overall Study|Lost to Follow-up|5|||
25169041|NCT01869959|50299872|FG000|Randomization Period|Physician Decision|0|||
25169042|NCT01869959|50299873|FG001|Randomization Period|Physician Decision|0|||
25190768|NCT00433511|50347779|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
25280550|NCT01173120|50595182|FG000|Overall Study|Lack of Efficacy|2|||
25280551|NCT01173120|50595182|FG000|Overall Study|Lost to Follow-up|1|||
25280552|NCT01173120|50595182|FG000|Overall Study|Participant Decision|2|||
25280553|NCT01173120|50595182|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
25280554|NCT01173120|50595182|FG000|Overall Study|Switch-Participant Decision|12|||
25280555|NCT01173120|50595182|FG000|Overall Study|Switch-Difficulty With Device|12|||
25280556|NCT00977379|50595190|FG000|Overall Study|Withdrawal by Subject|1|||
25280557|NCT00977379|50595191|FG001|Overall Study|Withdrawal by Subject|1|||
25280558|NCT00977379|50595190|FG000|Overall Study|Death|7|||
25169043|NCT01869959|50299874|FG002|Randomization Period|Physician Decision|0|||
25169044|NCT01869959|50299875|FG003|Randomization Period|Physician Decision|0|||
25169045|NCT01869959|50299876|FG004|Randomization Period|Physician Decision|1|||
25169046|NCT01869959|50299872|FG000|Treatment Period|Adverse Event|1|||
25190769|NCT00433511|50347780|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
25190770|NCT00433511|50347781|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
25190771|NCT00433511|50347779|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
25190772|NCT00433511|50347780|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
25190773|NCT00433511|50347781|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
25190774|NCT00433511|50347779|FG000|Step 2 (Arm D)|Physician Decision|0|||
25190775|NCT00433511|50347780|FG001|Step 2 (Arm D)|Physician Decision|0|||
25190776|NCT00433511|50347781|FG002|Step 2 (Arm D)|Physician Decision|9|||
25190777|NCT00433511|50347779|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
25190778|NCT00433511|50347780|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
25190779|NCT00433511|50347781|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
25190780|NCT00433511|50347779|FG000|Step 2 (Arm D)|Other complicating disease|0|||
25190781|NCT00433511|50347780|FG001|Step 2 (Arm D)|Other complicating disease|0|||
25190782|NCT00433511|50347781|FG002|Step 2 (Arm D)|Other complicating disease|3|||
25190783|NCT00433511|50347779|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
25190784|NCT00433511|50347780|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
25190785|NCT00433511|50347781|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
25190786|NCT00433511|50347779|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
25190787|NCT00433511|50347780|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
25190788|NCT00433511|50347781|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
25190789|NCT00433511|50347779|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
25190790|NCT00433511|50347780|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
25190791|NCT00433511|50347781|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
25190792|NCT00433511|50347779|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
25190793|NCT00433511|50347780|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
25190794|NCT00433511|50347781|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
25280559|NCT00977379|50595191|FG001|Overall Study|Death|9|||
25280560|NCT00977379|50595190|FG000|Overall Study|Premature Study Termination|4|||
25280561|NCT00977379|50595191|FG001|Overall Study|Premature Study Termination|0|||
25280562|NCT00977379|50595190|FG000|Overall Study|Participant Moving House|0|||
25280563|NCT00977379|50595191|FG001|Overall Study|Participant Moving House|1|||
25280564|NCT00977379|50595190|FG000|Overall Study|Randomization Error|0|||
25280565|NCT00977379|50595191|FG001|Overall Study|Randomization Error|1|||
25280566|NCT01180985|50595197|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
25280567|NCT01180985|50595198|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
25280568|NCT01147536|50595205|FG000|Overall Study|Administrative study close|2|||
25280569|NCT01147536|50595205|FG000|Overall Study|Death|1|||
25280570|NCT01154088|50595212|FG000|Overall Study|Lost to Follow-up|4|||
25280571|NCT01154088|50595213|FG001|Overall Study|Lost to Follow-up|6|||
25280572|NCT01154088|50595214|FG002|Overall Study|Lost to Follow-up|7|||
25280573|NCT01180049|50595225|FG000|Overall Study|Other|9|||
25280574|NCT01180049|50595226|FG001|Overall Study|Other|7|||
25280575|NCT01180049|50595225|FG000|Overall Study|Lost to Follow-up|8|||
25280576|NCT01180049|50595226|FG001|Overall Study|Lost to Follow-up|6|||
25280577|NCT01180049|50595225|FG000|Overall Study|Death|36|||
25280578|NCT01180049|50595226|FG001|Overall Study|Death|35|||
25280579|NCT01147458|50595232|FG000|First Intervention|Study terminated by sponsor|8|||
25280580|NCT01147458|50595233|FG001|First Intervention|Study terminated by sponsor|8|||
25280581|NCT01147458|50595234|FG002|First Intervention|Study terminated by sponsor|7|||
25280582|NCT01147458|50595235|FG003|First Intervention|Study terminated by sponsor|8|||
25280583|NCT01147458|50595232|FG000|First Intervention|Protocol Violation|2|||
25280584|NCT01147458|50595233|FG001|First Intervention|Protocol Violation|3|||
25280585|NCT01147458|50595234|FG002|First Intervention|Protocol Violation|2|||
25280586|NCT01147458|50595235|FG003|First Intervention|Protocol Violation|3|||
25280587|NCT01147458|50595232|FG000|First Intervention|Withdrawal by Subject|3|||
25280588|NCT01147458|50595233|FG001|First Intervention|Withdrawal by Subject|0|||
25280589|NCT01147458|50595234|FG002|First Intervention|Withdrawal by Subject|1|||
25280590|NCT01147458|50595235|FG003|First Intervention|Withdrawal by Subject|0|||
25280591|NCT01147458|50595232|FG000|First Intervention|Adverse Event|0|||
25280592|NCT01147458|50595233|FG001|First Intervention|Adverse Event|3|||
25280593|NCT01147458|50595234|FG002|First Intervention|Adverse Event|2|||
25280594|NCT01147458|50595235|FG003|First Intervention|Adverse Event|3|||
25280595|NCT01147458|50595232|FG000|First Intervention|Other|1|||
25280596|NCT01147458|50595233|FG001|First Intervention|Other|2|||
25280597|NCT01147458|50595234|FG002|First Intervention|Other|0|||
25280598|NCT01147458|50595235|FG003|First Intervention|Other|0|||
25280599|NCT01147458|50595232|FG000|Second Intervention|Study terminated by sponsor|7|||
25280600|NCT01147458|50595233|FG001|Second Intervention|Study terminated by sponsor|5|||
25280601|NCT01147458|50595234|FG002|Second Intervention|Study terminated by sponsor|5|||
25280602|NCT01147458|50595235|FG003|Second Intervention|Study terminated by sponsor|3|||
25280603|NCT01147458|50595232|FG000|Second Intervention|Protocol Violation|0|||
25280604|NCT01147458|50595233|FG001|Second Intervention|Protocol Violation|1|||
25280605|NCT01147458|50595234|FG002|Second Intervention|Protocol Violation|1|||
25280606|NCT01147458|50595235|FG003|Second Intervention|Protocol Violation|0|||
25280607|NCT01147458|50595232|FG000|Second Intervention|Withdrawal by Subject|0|||
25280608|NCT01147458|50595233|FG001|Second Intervention|Withdrawal by Subject|1|||
25280609|NCT01147458|50595234|FG002|Second Intervention|Withdrawal by Subject|0|||
25280610|NCT01147458|50595235|FG003|Second Intervention|Withdrawal by Subject|0|||
25280611|NCT01147458|50595232|FG000|Second Intervention|Adverse Event|2|||
25280612|NCT01147458|50595233|FG001|Second Intervention|Adverse Event|0|||
25280613|NCT01147458|50595234|FG002|Second Intervention|Adverse Event|1|||
25280614|NCT01147458|50595235|FG003|Second Intervention|Adverse Event|1|||
25280615|NCT01147458|50595232|FG000|Second Intervention|Other|0|||
25280616|NCT01147458|50595233|FG001|Second Intervention|Other|0|||
25280617|NCT01147458|50595234|FG002|Second Intervention|Other|1|||
25069803|NCT02791763|50175551|FG001|Overall Study|Cancer event|3|||
25280618|NCT01147458|50595235|FG003|Second Intervention|Other|0|||
25069804|NCT02791763|50175552|FG002|Overall Study|Cancer event|0|||
25169047|NCT01869959|50299873|FG001|Treatment Period|Adverse Event|0|||
25169048|NCT01869959|50299874|FG002|Treatment Period|Adverse Event|3|||
25169049|NCT01869959|50299875|FG003|Treatment Period|Adverse Event|1|||
25169050|NCT01869959|50299876|FG004|Treatment Period|Adverse Event|0|||
25169051|NCT01869959|50299872|FG000|Treatment Period|Sponsor decision|0|||
25169052|NCT01869959|50299873|FG001|Treatment Period|Sponsor decision|1|||
25169053|NCT01869959|50299874|FG002|Treatment Period|Sponsor decision|0|||
25169054|NCT01869959|50299875|FG003|Treatment Period|Sponsor decision|1|||
25169055|NCT01869959|50299876|FG004|Treatment Period|Sponsor decision|0|||
25169056|NCT01869959|50299872|FG000|Treatment Period|Withdrawal by Subject|0|||
25280619|NCT01172808|50595251|FG000|Overall Study|Adverse Event|8|||
25280620|NCT01172808|50595252|FG001|Overall Study|Adverse Event|4|||
25280621|NCT01172808|50595253|FG002|Overall Study|Adverse Event|8|||
25280622|NCT01172808|50595254|FG003|Overall Study|Adverse Event|3|||
25280623|NCT01172808|50595251|FG000|Overall Study|Lack of Efficacy|1|||
25280624|NCT01172808|50595252|FG001|Overall Study|Lack of Efficacy|0|||
25280625|NCT01172808|50595253|FG002|Overall Study|Lack of Efficacy|0|||
25280626|NCT01172808|50595254|FG003|Overall Study|Lack of Efficacy|0|||
25280627|NCT01172808|50595251|FG000|Overall Study|Protocol Violation|2|||
25280628|NCT01172808|50595252|FG001|Overall Study|Protocol Violation|2|||
25280629|NCT01172808|50595253|FG002|Overall Study|Protocol Violation|2|||
25280630|NCT01172808|50595254|FG003|Overall Study|Protocol Violation|0|||
25280631|NCT01172808|50595251|FG000|Overall Study|Lost to Follow-up|0|||
25280632|NCT01172808|50595252|FG001|Overall Study|Lost to Follow-up|1|||
25280633|NCT01172808|50595253|FG002|Overall Study|Lost to Follow-up|1|||
25280634|NCT01172808|50595254|FG003|Overall Study|Lost to Follow-up|3|||
25069805|NCT02791763|50175550|FG000|Overall Study|Participant had renal transplant|3|||
25069806|NCT02791763|50175551|FG001|Overall Study|Participant had renal transplant|0|||
25069807|NCT02791763|50175552|FG002|Overall Study|Participant had renal transplant|0|||
25069808|NCT02791763|50175550|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
25069809|NCT02791763|50175551|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
25069810|NCT02791763|50175552|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
25069811|NCT02791763|50175550|FG000|Overall Study|Adverse Event|12|||
25069812|NCT02791763|50175551|FG001|Overall Study|Adverse Event|13|||
25069813|NCT02791763|50175552|FG002|Overall Study|Adverse Event|7|||
25069814|NCT02613572|50175572|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
25069815|NCT02613572|50175573|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
25069816|NCT02613572|50175574|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
25069817|NCT02613572|50175572|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
25069818|NCT02613572|50175573|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
25069819|NCT02613572|50175574|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
25069820|NCT02087189|50175586|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
25069821|NCT02341456|50175593|FG000|Overall Study|Disease progression|2|||
25280635|NCT01172808|50595251|FG000|Overall Study|Withdrawal by Subject|4|||
25280636|NCT01172808|50595252|FG001|Overall Study|Withdrawal by Subject|1|||
25280637|NCT01172808|50595253|FG002|Overall Study|Withdrawal by Subject|3|||
25280638|NCT01172808|50595254|FG003|Overall Study|Withdrawal by Subject|2|||
25280639|NCT01172808|50595251|FG000|Overall Study|Other|6|||
25280640|NCT01172808|50595252|FG001|Overall Study|Other|5|||
25280641|NCT01172808|50595253|FG002|Overall Study|Other|9|||
25280642|NCT01172808|50595254|FG003|Overall Study|Other|7|||
25280643|NCT04066491|50595267|FG000|Overall Study|Treatment ongoing|2|||
25280644|NCT04066491|50595268|FG001|Overall Study|Treatment ongoing|72|||
25280645|NCT04066491|50595269|FG002|Overall Study|Treatment ongoing|66|||
25280646|NCT04066491|50595267|FG000|Overall Study|Treatment completed/discontinued and in follow-up,|2|||
25280647|NCT04066491|50595268|FG001|Overall Study|Treatment completed/discontinued and in follow-up,|39|||
25280648|NCT04066491|50595269|FG002|Overall Study|Treatment completed/discontinued and in follow-up,|41|||
25280649|NCT04066491|50595267|FG000|Overall Study|Randomized, not treated|0|||
25280650|NCT04066491|50595268|FG001|Overall Study|Randomized, not treated|0|||
25280651|NCT04066491|50595269|FG002|Overall Study|Randomized, not treated|2|||
25280652|NCT01151280|50595278|FG000|Overall Study|Adverse Event|1|||
25280653|NCT01151280|50595278|FG000|Overall Study|Lack of Efficacy|3|||
25280654|NCT01149486|50595284|FG000|First Intervention|Adverse Event|0|||
25280655|NCT01149486|50595285|FG001|First Intervention|Adverse Event|1|||
25280656|NCT00601705|50595291|FG000|Overall Study|Withdrawal by Subject|1|||
25280657|NCT01179737|50595300|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
25280658|NCT01179737|50595301|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
25280659|NCT01179737|50595302|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
25280660|NCT01179737|50595303|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
25280661|NCT01179737|50595300|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
25280662|NCT01179737|50595301|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
25280663|NCT01179737|50595302|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
25280664|NCT01179737|50595303|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
25280665|NCT01179737|50595300|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
25280666|NCT01179737|50595301|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
25280667|NCT01179737|50595302|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
25280668|NCT01179737|50595303|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
25280669|NCT01179737|50595300|FG000|Cohort 1 & Cohort 2|Death|0|||
25280670|NCT01179737|50595301|FG001|Cohort 1 & Cohort 2|Death|0|||
25069822|NCT02341456|50175594|FG001|Overall Study|Disease progression|3|||
25069823|NCT02341456|50175595|FG002|Overall Study|Disease progression|1|||
25069824|NCT02341456|50175593|FG000|Overall Study|Death|1|||
25069825|NCT02341456|50175594|FG001|Overall Study|Death|1|||
25069826|NCT02341456|50175595|FG002|Overall Study|Death|1|||
25069827|NCT02341456|50175593|FG000|Overall Study|Withdrawal by Subject|0|||
25280671|NCT01179737|50595302|FG002|Cohort 1 & Cohort 2|Death|1|||
25280672|NCT01179737|50595303|FG003|Cohort 1 & Cohort 2|Death|0|||
25280673|NCT01179737|50595300|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
25280674|NCT01179737|50595301|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
25280675|NCT01179737|50595302|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
25280676|NCT01179737|50595303|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
25280677|NCT01179737|50595300|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
25280678|NCT01179737|50595301|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
25280679|NCT01179737|50595302|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
25280680|NCT01179737|50595303|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
25280681|NCT01179737|50595300|FG000|Extension|The study was terminated|3|||
25280682|NCT01179737|50595301|FG001|Extension|The study was terminated|0|||
25280683|NCT01179737|50595302|FG002|Extension|The study was terminated|0|||
25280684|NCT01179737|50595303|FG003|Extension|The study was terminated|0|||
25280685|NCT00929110|50595315|FG000|Overall Study|Adverse Event|40|||
25280686|NCT00929110|50595316|FG001|Overall Study|Adverse Event|29|||
25280687|NCT00929110|50595317|FG002|Overall Study|Adverse Event|18|||
25280688|NCT00929110|50595315|FG000|Overall Study|Subject withdrew consent|40|||
25280689|NCT00929110|50595316|FG001|Overall Study|Subject withdrew consent|23|||
25280690|NCT00929110|50595317|FG002|Overall Study|Subject withdrew consent|26|||
25280691|NCT00929110|50595315|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
25280692|NCT00929110|50595316|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
25280693|NCT00929110|50595317|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
25280694|NCT00929110|50595315|FG000|Overall Study|Lost to Follow-up|7|||
25280695|NCT00929110|50595316|FG001|Overall Study|Lost to Follow-up|7|||
25280696|NCT00929110|50595317|FG002|Overall Study|Lost to Follow-up|3|||
25280697|NCT00929110|50595315|FG000|Overall Study|Protocol deviation|5|||
25280698|NCT00929110|50595316|FG001|Overall Study|Protocol deviation|2|||
25280699|NCT00929110|50595317|FG002|Overall Study|Protocol deviation|4|||
25280700|NCT00929110|50595315|FG000|Overall Study|Administrative problems|4|||
25280701|NCT00929110|50595316|FG001|Overall Study|Administrative problems|1|||
25280702|NCT00929110|50595317|FG002|Overall Study|Administrative problems|2|||
25280703|NCT00929110|50595315|FG000|Overall Study|Death|2|||
25280704|NCT00929110|50595316|FG001|Overall Study|Death|2|||
25280705|NCT00929110|50595317|FG002|Overall Study|Death|2|||
25280706|NCT00929110|50595315|FG000|Overall Study|Abnormal laboratory value(s)|0|||
25280707|NCT00929110|50595316|FG001|Overall Study|Abnormal laboratory value(s)|1|||
25280708|NCT00929110|50595317|FG002|Overall Study|Abnormal laboratory value(s)|0|||
25280709|NCT00929110|50595315|FG000|Overall Study|Abnormal test procedure result(s)|0|||
25280710|NCT00929110|50595316|FG001|Overall Study|Abnormal test procedure result(s)|1|||
25280711|NCT00929110|50595317|FG002|Overall Study|Abnormal test procedure result(s)|1|||
25280712|NCT00929110|50595315|FG000|Overall Study|Patient inability to use the device|0|||
25280713|NCT00929110|50595316|FG001|Overall Study|Patient inability to use the device|1|||
25280714|NCT00929110|50595317|FG002|Overall Study|Patient inability to use the device|0|||
25280715|NCT01147068|50595332|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
25280716|NCT01147068|50595333|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
25280717|NCT01147068|50595334|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
25280718|NCT01147068|50595335|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
25280719|NCT01147068|50595336|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
25280720|NCT01147068|50595337|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
25280721|NCT01147068|50595338|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
25280722|NCT01147068|50595332|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
25280723|NCT01147068|50595333|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
25280724|NCT01147068|50595334|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
25280725|NCT01147068|50595335|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
25280726|NCT01147068|50595336|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
25280727|NCT01147068|50595337|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
25280728|NCT01147068|50595338|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
25280729|NCT01147068|50595332|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
25280730|NCT01147068|50595333|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
25280731|NCT01147068|50595334|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
25280732|NCT01147068|50595335|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
25280733|NCT01147068|50595336|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
25280734|NCT01147068|50595337|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
25280735|NCT01147068|50595338|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
25280736|NCT01147068|50595332|FG000|Subjects That Received 2nd Dose|Other|0|||
25280737|NCT01147068|50595333|FG001|Subjects That Received 2nd Dose|Other|3|||
25280738|NCT01147068|50595334|FG002|Subjects That Received 2nd Dose|Other|3|||
25280739|NCT01147068|50595335|FG003|Subjects That Received 2nd Dose|Other|0|||
25280740|NCT01147068|50595336|FG004|Subjects That Received 2nd Dose|Other|1|||
25280741|NCT01147068|50595337|FG005|Subjects That Received 2nd Dose|Other|0|||
25280742|NCT01147068|50595338|FG006|Subjects That Received 2nd Dose|Other|0|||
25280743|NCT01147068|50595332|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
25280744|NCT01147068|50595333|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
25280745|NCT01147068|50595334|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
25280746|NCT01147068|50595335|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
25280747|NCT01147068|50595336|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
25280748|NCT01147068|50595337|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
25280749|NCT01147068|50595338|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
25280750|NCT01147068|50595332|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
25280751|NCT01147068|50595333|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
25280752|NCT01147068|50595334|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
25280753|NCT01147068|50595335|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
25280754|NCT01147068|50595336|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
25280755|NCT01147068|50595337|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
25280756|NCT01147068|50595338|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
25280757|NCT01147068|50595332|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
25280758|NCT01147068|50595333|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
25280759|NCT01147068|50595334|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
25280760|NCT01147068|50595335|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
25280761|NCT01147068|50595336|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
25280762|NCT01147068|50595337|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
25280763|NCT01147068|50595338|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
25280764|NCT01146912|50595361|FG000|Overall Study|Already received influenza vaccination|817|||
25280765|NCT01146912|50595362|FG001|Overall Study|Already received influenza vaccination|822|||
25280766|NCT01146912|50595363|FG002|Overall Study|Already received influenza vaccination|13|||
25280767|NCT01146912|50595364|FG003|Overall Study|Already received influenza vaccination|15|||
25280768|NCT01146912|50595365|FG004|Overall Study|Already received influenza vaccination|41|||
25280769|NCT01146912|50595366|FG005|Overall Study|Already received influenza vaccination|61|||
25280770|NCT01146912|50595367|FG006|Overall Study|Already received influenza vaccination|56|||
25280771|NCT01146912|50595368|FG007|Overall Study|Already received influenza vaccination|0|||
25280772|NCT01146912|50595361|FG000|Overall Study|< 14 weeks gestational age|0|||
25280773|NCT01146912|50595362|FG001|Overall Study|< 14 weeks gestational age|0|||
25280774|NCT01146912|50595363|FG002|Overall Study|< 14 weeks gestational age|3|||
25280775|NCT01146912|50595364|FG003|Overall Study|< 14 weeks gestational age|2|||
25280776|NCT01146912|50595365|FG004|Overall Study|< 14 weeks gestational age|0|||
25280777|NCT01146912|50595366|FG005|Overall Study|< 14 weeks gestational age|0|||
25280778|NCT01146912|50595367|FG006|Overall Study|< 14 weeks gestational age|0|||
25280779|NCT01146912|50595368|FG007|Overall Study|< 14 weeks gestational age|0|||
25280780|NCT01146912|50595361|FG000|Overall Study|Duplicate patient|0|||
25280781|NCT01146912|50595362|FG001|Overall Study|Duplicate patient|0|||
25190795|NCT00324805|50347794|FG000|Overall Study|Adverse Event|62|||
25190796|NCT00324805|50347795|FG001|Overall Study|Adverse Event|203|||
25190797|NCT00324805|50347794|FG000|Overall Study|Progression|7|||
25190798|NCT00324805|50347795|FG001|Overall Study|Progression|35|||
25190799|NCT00324805|50347794|FG000|Overall Study|Withdrawal by Subject|51|||
25190800|NCT00324805|50347795|FG001|Overall Study|Withdrawal by Subject|174|||
25190801|NCT00324805|50347794|FG000|Overall Study|Death|6|||
25190802|NCT00324805|50347795|FG001|Overall Study|Death|9|||
25190803|NCT00324805|50347794|FG000|Overall Study|Alternative therapy|4|||
25190804|NCT00324805|50347795|FG001|Overall Study|Alternative therapy|8|||
25190805|NCT00324805|50347794|FG000|Overall Study|Other complicating disease|1|||
25190806|NCT00324805|50347795|FG001|Overall Study|Other complicating disease|9|||
25190807|NCT00324805|50347794|FG000|Overall Study|Other reasons|7|||
25190808|NCT00324805|50347795|FG001|Overall Study|Other reasons|26|||
25190809|NCT00324805|50347794|FG000|Overall Study|Other|0|||
25190810|NCT00324805|50347795|FG001|Overall Study|Other|2|||
25190811|NCT00324805|50347794|FG000|Overall Study|Did not start therapy|12|||
25190812|NCT00324805|50347795|FG001|Overall Study|Did not start therapy|17|||
25190813|NCT00217425|50347818|FG000|Overall Study|Never started treatment|2|||
25190814|NCT00217425|50347818|FG000|Overall Study|Patient ineligible|5|||
25190815|NCT00217425|50347818|FG000|Overall Study|Lack of Efficacy|13|||
25190816|NCT00217425|50347818|FG000|Overall Study|Adverse Event|8|||
25190817|NCT00217425|50347818|FG000|Overall Study|Withdrawal by Subject|4|||
25190818|NCT00217425|50347818|FG000|Overall Study|Other complicating disease|1|||
25190819|NCT00217425|50347818|FG000|Overall Study|Other|4|||
25190820|NCT00070499|50347826|FG000|Overall Study|Adverse Event|6|||
25190821|NCT00070499|50347827|FG001|Overall Study|Adverse Event|6|||
25190822|NCT00070499|50347828|FG002|Overall Study|Adverse Event|19|||
25190823|NCT00070499|50347829|FG003|Overall Study|Adverse Event|15|||
25190824|NCT00070499|50347826|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
25190825|NCT00070499|50347827|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
25190826|NCT00070499|50347828|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
25280782|NCT01146912|50595363|FG002|Overall Study|Duplicate patient|1|||
25280783|NCT01146912|50595364|FG003|Overall Study|Duplicate patient|0|||
25190827|NCT00070499|50347829|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
25190828|NCT00070499|50347826|FG000|Overall Study|Progression/relapse|4|||
25190829|NCT00070499|50347827|FG001|Overall Study|Progression/relapse|2|||
25190830|NCT00070499|50347828|FG002|Overall Study|Progression/relapse|1|||
25190831|NCT00070499|50347829|FG003|Overall Study|Progression/relapse|4|||
25190832|NCT00070499|50347826|FG000|Overall Study|Death|1|||
25190833|NCT00070499|50347827|FG001|Overall Study|Death|1|||
25190834|NCT00070499|50347828|FG002|Overall Study|Death|1|||
25190835|NCT00070499|50347829|FG003|Overall Study|Death|2|||
25190836|NCT00070499|50347826|FG000|Overall Study|Other - not protocol specified|7|||
25190837|NCT00070499|50347827|FG001|Overall Study|Other - not protocol specified|3|||
25190838|NCT00070499|50347828|FG002|Overall Study|Other - not protocol specified|12|||
25190839|NCT00070499|50347829|FG003|Overall Study|Other - not protocol specified|20|||
25190840|NCT00070499|50347826|FG000|Overall Study|Still on protocol treatment|10|||
25190841|NCT00070499|50347827|FG001|Overall Study|Still on protocol treatment|4|||
25190842|NCT00070499|50347828|FG002|Overall Study|Still on protocol treatment|79|||
25190843|NCT00070499|50347829|FG003|Overall Study|Still on protocol treatment|57|||
25190844|NCT00070499|50347826|FG000|Overall Study|Did not start treatment|1|||
25190845|NCT00070499|50347827|FG001|Overall Study|Did not start treatment|0|||
25190846|NCT00070499|50347828|FG002|Overall Study|Did not start treatment|0|||
25190847|NCT00070499|50347829|FG003|Overall Study|Did not start treatment|2|||
25190848|NCT00070499|50347826|FG000|Overall Study|Not eligible|2|||
25190849|NCT00070499|50347827|FG001|Overall Study|Not eligible|5|||
25280784|NCT01146912|50595365|FG004|Overall Study|Duplicate patient|0|||
25280785|NCT01146912|50595366|FG005|Overall Study|Duplicate patient|0|||
25280786|NCT01146912|50595367|FG006|Overall Study|Duplicate patient|0|||
25280787|NCT01146912|50595368|FG007|Overall Study|Duplicate patient|0|||
25280788|NCT01134042|50595390|FG000|Overall Study|Adverse Event|3|||
25280789|NCT01134042|50595391|FG001|Overall Study|Adverse Event|7|||
25280790|NCT01134042|50595392|FG002|Overall Study|Adverse Event|2|||
25280791|NCT01134042|50595390|FG000|Overall Study|Lack of Efficacy|21|||
25280792|NCT01134042|50595391|FG001|Overall Study|Lack of Efficacy|6|||
25280793|NCT01134042|50595392|FG002|Overall Study|Lack of Efficacy|18|||
25280794|NCT01134042|50595390|FG000|Overall Study|Protocol Violation|5|||
25280795|NCT01134042|50595391|FG001|Overall Study|Protocol Violation|3|||
25280796|NCT01134042|50595392|FG002|Overall Study|Protocol Violation|5|||
25280797|NCT01134042|50595390|FG000|Overall Study|Lost to Follow-up|2|||
25280798|NCT01134042|50595391|FG001|Overall Study|Lost to Follow-up|0|||
25280799|NCT01134042|50595392|FG002|Overall Study|Lost to Follow-up|1|||
25280800|NCT01134042|50595390|FG000|Overall Study|Physician Decision|4|||
25280801|NCT01134042|50595391|FG001|Overall Study|Physician Decision|8|||
25280802|NCT01134042|50595392|FG002|Overall Study|Physician Decision|1|||
25280803|NCT01134042|50595390|FG000|Overall Study|Withdrawal by Subject|13|||
25280804|NCT01134042|50595391|FG001|Overall Study|Withdrawal by Subject|4|||
25280805|NCT01134042|50595392|FG002|Overall Study|Withdrawal by Subject|7|||
25280806|NCT01179347|50595403|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
25280807|NCT01179347|50595404|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
25280808|NCT01179347|50595403|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
25280809|NCT01179347|50595404|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
25280810|NCT01179347|50595403|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
25280811|NCT01179347|50595404|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
25280812|NCT01179347|50595403|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
25280813|NCT01179347|50595404|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
25280814|NCT01179347|50595403|FG000|Double-blind Period (12 Weeks)|Other|2|||
25280815|NCT01179347|50595404|FG001|Double-blind Period (12 Weeks)|Other|4|||
25280816|NCT01179347|50595403|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
25280817|NCT01179347|50595404|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
25280818|NCT01179347|50595403|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
25280819|NCT01179347|50595404|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
25280820|NCT01179347|50595403|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
25280821|NCT01179347|50595404|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
25280822|NCT01179347|50595403|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
25280823|NCT01179347|50595404|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
25280824|NCT01179347|50595403|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
25280825|NCT01179347|50595404|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
25280826|NCT01179347|50595403|FG000|Open-label Period (12 Weeks)|Other|7|||
25280827|NCT01179347|50595404|FG001|Open-label Period (12 Weeks)|Other|4|||
24969417|NCT00131664|50058819|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
25190850|NCT00070499|50347828|FG002|Overall Study|Not eligible|3|||
25190851|NCT00070499|50347829|FG003|Overall Study|Not eligible|2|||
25190852|NCT03208231|50347887|FG000|Overall Study|Death|1|||
25280828|NCT01146288|50595414|FG000|First Intervention(1 Day)|Adverse Event|0|||
25280829|NCT01146288|50595415|FG001|First Intervention(1 Day)|Adverse Event|1|||
25280830|NCT01146054|50595422|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
25280831|NCT01146054|50595422|FG000|Overall Study|Rapid tumor progression|2|||
24969418|NCT00131664|50058820|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
25190853|NCT03208231|50347888|FG001|Overall Study|Death|2|||
25280832|NCT01146054|50595422|FG000|Overall Study|Other illness precluded treatment|2|||
25280833|NCT01146054|50595422|FG000|Overall Study|Lost to Follow-up|1|||
25190854|NCT03208231|50347887|FG000|Overall Study|Moved and unable to get to clinic|1|||
25190855|NCT03208231|50347888|FG001|Overall Study|Moved and unable to get to clinic|0|||
25190856|NCT03208231|50347887|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
25190857|NCT03208231|50347888|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
25190858|NCT03106779|50347913|FG000|Overall Study|Lack of Efficacy|33|||
25190859|NCT03106779|50347914|FG001|Overall Study|Lack of Efficacy|24|||
25190860|NCT03106779|50347913|FG000|Overall Study|Adverse Event|8|||
25190861|NCT03106779|50347914|FG001|Overall Study|Adverse Event|16|||
25190862|NCT03106779|50347913|FG000|Overall Study|Physician Decision|10|||
25190863|NCT03106779|50347914|FG001|Overall Study|Physician Decision|6|||
25190864|NCT03106779|50347913|FG000|Overall Study|Patient/guardian decision|4|||
25190865|NCT03106779|50347914|FG001|Overall Study|Patient/guardian decision|3|||
25190866|NCT03106779|50347913|FG000|Overall Study|Progressive disease|1|||
25280834|NCT01145898|50595428|FG000|3-year Treatment|medication change by treating physician|3|||
25280835|NCT01145898|50595429|FG001|3-year Treatment|medication change by treating physician|16|||
25280836|NCT01133418|50595436|FG000|Overall Study|Lost to Follow-up|5|||
25280837|NCT01133418|50595437|FG001|Overall Study|Lost to Follow-up|6|||
25280838|NCT00931918|50595445|FG000|Overall Study|Adverse Event|4|||
25280839|NCT00931918|50595446|FG001|Overall Study|Adverse Event|6|||
25280840|NCT00931918|50595445|FG000|Overall Study|Progressive Disease|2|||
25280841|NCT00931918|50595446|FG001|Overall Study|Progressive Disease|1|||
25280842|NCT00931918|50595445|FG000|Overall Study|Symptomatic Deterioration|1|||
25280843|NCT00931918|50595446|FG001|Overall Study|Symptomatic Deterioration|0|||
25280844|NCT00931918|50595445|FG000|Overall Study|Withdrawal by Patient|3|||
25280845|NCT00931918|50595446|FG001|Overall Study|Withdrawal by Patient|4|||
25280846|NCT00931918|50595445|FG000|Overall Study|Other Reason not Specified|4|||
25280847|NCT00931918|50595446|FG001|Overall Study|Other Reason not Specified|4|||
25280848|NCT00931918|50595445|FG000|Overall Study|Did not receive study drug|3|||
25280849|NCT00931918|50595446|FG001|Overall Study|Did not receive study drug|2|||
25280850|NCT01179191|50595452|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
25280851|NCT01179191|50595452|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
25280852|NCT01179191|50595452|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
25280853|NCT01179191|50595452|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
25280854|NCT01179191|50595452|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
25280855|NCT01179191|50595452|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
25280856|NCT01179191|50595452|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
25280857|NCT01179191|50595452|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
25280858|NCT01179191|50595452|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
25280859|NCT01179191|50595452|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
25280860|NCT01179191|50595452|FG000|Maintenance Phase (8 Weeks)|Other|66|||
25280861|NCT01169844|50595458|FG000|Overall Study|Adverse Event|0|||
25190867|NCT03106779|50347914|FG001|Overall Study|Progressive disease|3|||
25190868|NCT03106779|50347913|FG000|Overall Study|Lost to Follow-up|1|||
25190869|NCT03106779|50347914|FG001|Overall Study|Lost to Follow-up|2|||
25190870|NCT03106779|50347913|FG000|Overall Study|Death|1|||
25190871|NCT03106779|50347914|FG001|Overall Study|Death|0|||
25190872|NCT03106779|50347913|FG000|Overall Study|Protocol Violation|1|||
25190873|NCT03106779|50347914|FG001|Overall Study|Protocol Violation|0|||
25190874|NCT03106779|50347913|FG000|Overall Study|Not treated|1|||
25190875|NCT03106779|50347914|FG001|Overall Study|Not treated|0|||
25190876|NCT03102242|50347920|FG000|Overall Study|Adverse Event|2|||
25280862|NCT01169844|50595459|FG001|Overall Study|Adverse Event|1|||
25280863|NCT01169844|50595458|FG000|Overall Study|Patient withdrew consent|4|||
25280864|NCT01169844|50595459|FG001|Overall Study|Patient withdrew consent|0|||
25190877|NCT03097328|50347924|FG000|Overall Study|Still on Therapy|2|||
25280865|NCT01169844|50595458|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25280866|NCT01169844|50595459|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
25280867|NCT01132482|50595467|FG000|Overall Study|Adverse Event|1|||
25280868|NCT01132482|50595468|FG001|Overall Study|Adverse Event|0|||
25280869|NCT00931762|50595474|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
25280870|NCT00931762|50595474|FG000|Overall Study|Administrative Problems|5|||
25280871|NCT00931762|50595474|FG000|Overall Study|Death|1|||
24969419|NCT00131664|50058815|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
25190878|NCT03097328|50347924|FG000|Overall Study|Progressive Disease|29|||
25190879|NCT03097328|50347924|FG000|Overall Study|Adverse Event|4|||
25190880|NCT03097328|50347924|FG000|Overall Study|Withdrawal by Subject|1|||
25190881|NCT03097328|50347924|FG000|Overall Study|Physician Decision|1|||
25190882|NCT03097328|50347924|FG000|Overall Study|Patient Decision|1|||
25190883|NCT03097328|50347924|FG000|Overall Study|Ineligible for Study Drug|1|||
25280872|NCT00931762|50595474|FG000|Overall Study|Disease Progression|3|||
25190884|NCT03033602|50347930|FG000|Overall Study|Withdrawal by Subject|11|||
25190885|NCT03033602|50347931|FG001|Overall Study|Withdrawal by Subject|21|||
25190886|NCT03033602|50347930|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
25190887|NCT03033602|50347931|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
25280873|NCT00931762|50595474|FG000|Overall Study|Adverse Event (s)|11|||
25280874|NCT00931762|50595474|FG000|Overall Study|Subject withdrew consent|13|||
25280875|NCT01132326|50595478|FG000|Overall Study|Lack of Efficacy|25|||
25280876|NCT01132326|50595478|FG000|Overall Study|Adverse Event|37|||
25190888|NCT02994784|50347942|FG000|6 Months Follow-up|Lost to Follow-up|3|||
25190889|NCT02948829|50347946|FG000|Overall Study|Lost to Follow-up|2|||
25190890|NCT02948829|50347946|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
25280877|NCT01132326|50595478|FG000|Overall Study|Protocol Violation|1|||
25280878|NCT01132326|50595478|FG000|Overall Study|Lost to Follow-up|16|||
25280879|NCT01132326|50595478|FG000|Overall Study|Withdrawal by Subject|40|||
25280880|NCT01132326|50595478|FG000|Overall Study|Physician Decision|10|||
25280881|NCT01132326|50595478|FG000|Overall Study|Study Termination|80|||
25280882|NCT01132326|50595478|FG000|Overall Study|Declining Health|1|||
25280883|NCT01132326|50595478|FG000|Overall Study|Pregnancy|1|||
25280884|NCT01132326|50595478|FG000|Overall Study|Caregiver Withdrew Consent|1|||
25280885|NCT01132326|50595478|FG000|Overall Study|Death|5|||
25280886|NCT01132326|50595478|FG000|Overall Study|Subject Unable to Come To Visits|1|||
25280887|NCT01178411|50595482|FG000|Overall Study|Adverse Event|5|||
25280888|NCT01178411|50595482|FG000|Overall Study|Withdrawal by Subject|4|||
25280889|NCT01178411|50595482|FG000|Overall Study|Protocol Violation|1|||
25280890|NCT01178411|50595482|FG000|Overall Study|Progressive disease per RECIST|32|||
25280891|NCT01178411|50595482|FG000|Overall Study|Progressive disease per clinician|9|||
25280892|NCT01178411|50595482|FG000|Overall Study|Physician Decision|6|||
25280893|NCT01178411|50595482|FG000|Overall Study|Death|1|||
25280894|NCT01178411|50595482|FG000|Overall Study|No reason provided|1|||
25280895|NCT01178411|50595482|FG000|Overall Study|Drug manufacturing ended|1|||
25280896|NCT01145508|50595488|FG000|Overall Study|Adverse Event|1|||
25280897|NCT01145508|50595489|FG001|Overall Study|Adverse Event|0|||
25280898|NCT01145508|50595488|FG000|Overall Study|Death|1|||
25280899|NCT01145508|50595489|FG001|Overall Study|Death|0|||
25280900|NCT01145508|50595488|FG000|Overall Study|Physician Decision|2|||
25280901|NCT01145508|50595489|FG001|Overall Study|Physician Decision|1|||
25280902|NCT01145508|50595488|FG000|Overall Study|Never started treatment|1|||
25280903|NCT01145508|50595489|FG001|Overall Study|Never started treatment|1|||
25280904|NCT00931528|50595497|FG000|Overall Study|Protocol Violation|9|||
25280905|NCT00931528|50595498|FG001|Overall Study|Protocol Violation|12|||
25280906|NCT00931528|50595497|FG000|Overall Study|Withdrawal by Subject|4|||
25280907|NCT00931528|50595498|FG001|Overall Study|Withdrawal by Subject|12|||
25280908|NCT00931528|50595497|FG000|Overall Study|Lost to Follow-up|6|||
25190891|NCT02948829|50347946|FG000|Overall Study|Pregnancy|1|||
25190892|NCT02948829|50347946|FG000|Overall Study|Other: Reason not Specified|8|||
25190893|NCT02908685|50347977|FG000|Part 1 Exploratory|Withdrawal by Subject|0|||
25190894|NCT02908685|50347978|FG001|Part 1 Exploratory|Withdrawal by Subject|1|||
25190895|NCT02908685|50347979|FG002|Part 1 Exploratory|Withdrawal by Subject|0|||
25190896|NCT02908685|50347980|FG003|Part 1 Exploratory|Withdrawal by Subject|0|||
25190897|NCT02908685|50347981|FG004|Part 1 Exploratory|Withdrawal by Subject|0|||
25190898|NCT02908685|50347982|FG005|Part 1 Exploratory|Withdrawal by Subject|0|||
25280909|NCT00931528|50595498|FG001|Overall Study|Lost to Follow-up|13|||
25280910|NCT00931528|50595497|FG000|Overall Study|Assessment outside of Time Frame|22|||
25280911|NCT00931528|50595498|FG001|Overall Study|Assessment outside of Time Frame|23|||
25280912|NCT00975195|50595507|FG000|Overall Study|Adverse Event|108|||
25280913|NCT00975195|50595508|FG001|Overall Study|Adverse Event|101|||
25280914|NCT00975195|50595507|FG000|Overall Study|Lack of Efficacy|6|||
25280915|NCT00975195|50595508|FG001|Overall Study|Lack of Efficacy|6|||
25280916|NCT00975195|50595507|FG000|Overall Study|Protocol Violation|27|||
25280917|NCT00975195|50595508|FG001|Overall Study|Protocol Violation|23|||
25280918|NCT00975195|50595507|FG000|Overall Study|Lost to Follow-up|9|||
25280919|NCT00975195|50595508|FG001|Overall Study|Lost to Follow-up|7|||
25280920|NCT00975195|50595507|FG000|Overall Study|Withdrawal by Subject|48|||
25280921|NCT00975195|50595508|FG001|Overall Study|Withdrawal by Subject|61|||
25280922|NCT00975195|50595507|FG000|Overall Study|Other reason not defined above|29|||
25280923|NCT00975195|50595508|FG001|Overall Study|Other reason not defined above|33|||
25280924|NCT00975195|50595507|FG000|Overall Study|Not treated|1|||
25280925|NCT00975195|50595508|FG001|Overall Study|Not treated|2|||
25280926|NCT01145352|50595514|FG000|Overall Study|Found to have been registered twice|6|||
25280927|NCT01145352|50595514|FG000|Overall Study|Treated before marketing approval|4|||
25280928|NCT01145352|50595514|FG000|Overall Study|Syringe formulation was used|1|||
25280929|NCT01178099|50595522|FG000|Overall Study|Physician Decision|0|||
25280930|NCT01178099|50595523|FG001|Overall Study|Physician Decision|1|||
25190899|NCT02908685|50347983|FG006|Part 1 Exploratory|Withdrawal by Subject|0|||
25190900|NCT02908685|50347984|FG007|Part 1 Exploratory|Withdrawal by Subject|0|||
25280931|NCT01169532|50595533|FG000|Overall Study|Withdrawal by Subject|1|||
25280932|NCT00928564|50595539|FG000|Overall Study|Lost to Follow-up|6|||
25280933|NCT00928564|50595540|FG001|Overall Study|Lost to Follow-up|0|||
25280934|NCT01177943|50595548|FG000|First Intervention|Withdrawal by Subject|2|||
25280935|NCT01177943|50595549|FG001|First Intervention|Withdrawal by Subject|0|||
25280936|NCT01131312|50595558|FG000|Overall Study|Lost to Follow-up|425|||
25280937|NCT01131312|50595559|FG001|Overall Study|Lost to Follow-up|229|||
25280938|NCT01131312|50595560|FG002|Overall Study|Lost to Follow-up|351|||
25280939|NCT01177787|50595568|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
25280940|NCT01177787|50595568|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
25280941|NCT01177787|50595568|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
25280942|NCT00928486|50595580|FG000|Overall Study|Adverse Event|2|||
25280943|NCT00928486|50595580|FG000|Overall Study|Disease Progression|7|||
25280944|NCT00928486|50595580|FG000|Overall Study|Withdrawal by Subject|1|||
25280945|NCT01168596|50595586|FG000|Overall Study|Withdrawal by Subject|3|||
25280946|NCT01168596|50595587|FG001|Overall Study|Withdrawal by Subject|1|||
25280947|NCT01177553|50595595|FG000|Overall Study|babies not yet 6 months of age|1|||
25190901|NCT02908685|50347985|FG008|Part 1 Exploratory|Withdrawal by Subject|0|||
25190902|NCT02908685|50347986|FG009|Part 1 Exploratory|Withdrawal by Subject|0|||
25190903|NCT02908685|50347987|FG010|Part 1 Exploratory|Withdrawal by Subject|0|||
25190904|NCT02908685|50347988|FG011|Part 1 Exploratory|Withdrawal by Subject|0|||
25190905|NCT02908685|50347977|FG000|Part 2 Confirmatory|Changed to Spinraza|0|||
25190906|NCT02908685|50347978|FG001|Part 2 Confirmatory|Changed to Spinraza|0|||
25190907|NCT02908685|50347979|FG002|Part 2 Confirmatory|Changed to Spinraza|0|||
25190908|NCT02908685|50347980|FG003|Part 2 Confirmatory|Changed to Spinraza|0|||
25190909|NCT02908685|50347981|FG004|Part 2 Confirmatory|Changed to Spinraza|0|||
25190910|NCT02908685|50347982|FG005|Part 2 Confirmatory|Changed to Spinraza|0|||
25190911|NCT02908685|50347983|FG006|Part 2 Confirmatory|Changed to Spinraza|0|||
25190912|NCT02908685|50347984|FG007|Part 2 Confirmatory|Changed to Spinraza|0|||
25190913|NCT02908685|50347985|FG008|Part 2 Confirmatory|Changed to Spinraza|0|||
25190914|NCT02908685|50347986|FG009|Part 2 Confirmatory|Changed to Spinraza|0|||
25190915|NCT02908685|50347987|FG010|Part 2 Confirmatory|Changed to Spinraza|2|||
25190916|NCT02908685|50347988|FG011|Part 2 Confirmatory|Changed to Spinraza|1|||
25190917|NCT02908685|50347977|FG000|Part 2 Confirmatory|Changed to other treatment|0|||
25190918|NCT02908685|50347978|FG001|Part 2 Confirmatory|Changed to other treatment|0|||
25190919|NCT02908685|50347979|FG002|Part 2 Confirmatory|Changed to other treatment|0|||
25190920|NCT02908685|50347980|FG003|Part 2 Confirmatory|Changed to other treatment|0|||
25190921|NCT02908685|50347981|FG004|Part 2 Confirmatory|Changed to other treatment|0|||
25190922|NCT02908685|50347982|FG005|Part 2 Confirmatory|Changed to other treatment|0|||
25190923|NCT02908685|50347983|FG006|Part 2 Confirmatory|Changed to other treatment|0|||
25190924|NCT02908685|50347984|FG007|Part 2 Confirmatory|Changed to other treatment|0|||
25190925|NCT02908685|50347985|FG008|Part 2 Confirmatory|Changed to other treatment|0|||
25190926|NCT02908685|50347986|FG009|Part 2 Confirmatory|Changed to other treatment|0|||
25190927|NCT02908685|50347987|FG010|Part 2 Confirmatory|Changed to other treatment|1|||
25190928|NCT02908685|50347988|FG011|Part 2 Confirmatory|Changed to other treatment|0|||
25190929|NCT02617446|50348017|FG000|Overall Study|Withdrawal by Subject|0|||
25190930|NCT02617446|50348018|FG001|Overall Study|Withdrawal by Subject|2|||
25190931|NCT02617446|50348019|FG002|Overall Study|Withdrawal by Subject|0|||
25190932|NCT02617446|50348017|FG000|Overall Study|Adverse Event|1|||
25190933|NCT02617446|50348018|FG001|Overall Study|Adverse Event|0|||
25190934|NCT02617446|50348019|FG002|Overall Study|Adverse Event|5|||
25190935|NCT02617446|50348017|FG000|Overall Study|Lost to Follow-up|3|||
25190936|NCT02617446|50348018|FG001|Overall Study|Lost to Follow-up|0|||
25190937|NCT02617446|50348019|FG002|Overall Study|Lost to Follow-up|0|||
25190938|NCT02617446|50348017|FG000|Overall Study|Death|0|||
25190939|NCT02617446|50348018|FG001|Overall Study|Death|0|||
25190940|NCT02617446|50348019|FG002|Overall Study|Death|2|||
25190941|NCT02549170|50348033|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
25190942|NCT02549170|50348034|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
25190943|NCT02549170|50348035|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
25190944|NCT02549170|50348036|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
25190945|NCT02549170|50348037|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
25190946|NCT02549170|50348033|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
25190947|NCT02549170|50348034|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
25190948|NCT02549170|50348035|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
25190949|NCT02549170|50348036|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
25190950|NCT02549170|50348037|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
25190951|NCT02549170|50348033|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
25190952|NCT02549170|50348034|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
25190953|NCT02549170|50348035|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
25190954|NCT02549170|50348036|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
25190955|NCT02549170|50348037|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
25190956|NCT02476916|50348054|FG000|Core Period|Adverse Event|2|||
25190957|NCT02476916|50348055|FG001|Core Period|Adverse Event|2|||
25190958|NCT02476916|50348054|FG000|Core Period|Investigator decision|1|||
25190959|NCT02476916|50348055|FG001|Core Period|Investigator decision|1|||
25190960|NCT02476916|50348054|FG000|Core Period|Withdrawal by Subject|3|||
25190961|NCT02476916|50348055|FG001|Core Period|Withdrawal by Subject|0|||
25190962|NCT02476916|50348054|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
25190963|NCT02476916|50348055|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
25280948|NCT01177553|50595596|FG001|Overall Study|babies not yet 6 months of age|0|||
25280949|NCT00928408|50595602|FG000|Overall Study|Other|2|||
25280950|NCT00928408|50595602|FG000|Overall Study|Withdrawal by Subject|4|||
25280951|NCT00928408|50595602|FG000|Overall Study|Death|5|||
25280952|NCT00928408|50595602|FG000|Overall Study|Lost to Follow-up|12|||
25280953|NCT00928252|50595606|FG000|Overall Study|Physician Decision|3|||
25280954|NCT01177007|50595612|FG000|Overall Study|Lost to Follow-up|2|||
25280955|NCT01177007|50595612|FG000|Overall Study|Death|4|||
25280956|NCT01177007|50595612|FG000|Overall Study|Entered hospice care|5|||
25280957|NCT01177007|50595612|FG000|Overall Study|Required additional Y90 treatment|6|||
25280958|NCT01177007|50595612|FG000|Overall Study|Change in treatment modality|21|||
25280959|NCT00930982|50595620|FG000|Overall Study|Adverse Event|19|||
25280960|NCT00930982|50595621|FG001|Overall Study|Adverse Event|23|||
25280961|NCT00930982|50595620|FG000|Overall Study|Protocol Violation|1|||
25280962|NCT00930982|50595621|FG001|Overall Study|Protocol Violation|5|||
25280963|NCT00930982|50595620|FG000|Overall Study|Withdrawal by Subject|1|||
25280964|NCT00930982|50595621|FG001|Overall Study|Withdrawal by Subject|1|||
25280965|NCT01176773|50595627|FG000|Overall Study|Screen Failure|2|||
25280966|NCT01176773|50595627|FG000|Overall Study|Withdrew consent|1|||
25280967|NCT00928018|50595634|FG000|Overall Study|Withdrawal by Subject|1|||
25280968|NCT00928018|50595635|FG001|Overall Study|Withdrawal by Subject|0|||
25280969|NCT00927940|50595645|FG000|Overall Study|Death|1|||
25280970|NCT00927862|50595652|FG000|Overall Study|Missing data needed for endpt analyses|27|||
25280971|NCT00927862|50595653|FG001|Overall Study|Missing data needed for endpt analyses|45|||
25280972|NCT00976989|50595664|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
25280973|NCT00976989|50595665|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
25280974|NCT00976989|50595666|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
25280975|NCT00976989|50595664|FG000|Overall Study|Death|5|||
25280976|NCT00976989|50595665|FG001|Overall Study|Death|7|||
25280977|NCT00976989|50595666|FG002|Overall Study|Death|10|||
25280978|NCT00976989|50595664|FG000|Overall Study|Refused Treatment|4|||
25280979|NCT00976989|50595665|FG001|Overall Study|Refused Treatment|3|||
25280980|NCT00976989|50595666|FG002|Overall Study|Refused Treatment|5|||
25280981|NCT00976989|50595664|FG000|Overall Study|Failure to Return|2|||
25280982|NCT00976989|50595665|FG001|Overall Study|Failure to Return|1|||
25280983|NCT00976989|50595666|FG002|Overall Study|Failure to Return|0|||
25280984|NCT00976989|50595664|FG000|Overall Study|Recurrence of Disease|0|||
25280985|NCT00976989|50595665|FG001|Overall Study|Recurrence of Disease|1|||
25280986|NCT00976989|50595666|FG002|Overall Study|Recurrence of Disease|0|||
25280987|NCT00976989|50595664|FG000|Overall Study|Other|1|||
25280988|NCT00976989|50595665|FG001|Overall Study|Other|0|||
25280989|NCT00976989|50595666|FG002|Overall Study|Other|1|||
25280990|NCT00927784|50595676|FG000|Overall Study|Death|1|||
25190964|NCT02476916|50348054|FG000|Extension Period|On Treatment|12|||
25190965|NCT02476916|50348055|FG001|Extension Period|On Treatment|17|||
25190966|NCT02410902|50348064|FG000|Overall Study|Adverse Event|2|||
25280991|NCT00927784|50595677|FG001|Overall Study|Death|0|||
25280992|NCT00927784|50595676|FG000|Overall Study|Withdrawal by Subject|1|||
25280993|NCT00927784|50595677|FG001|Overall Study|Withdrawal by Subject|0|||
25190967|NCT02410902|50348065|FG001|Overall Study|Adverse Event|3|||
25190968|NCT02410902|50348064|FG000|Overall Study|Lost to Follow-up|4|||
25190969|NCT02410902|50348065|FG001|Overall Study|Lost to Follow-up|1|||
25190970|NCT02410902|50348064|FG000|Overall Study|Protocol Violation|1|||
25190971|NCT02410902|50348065|FG001|Overall Study|Protocol Violation|4|||
25280994|NCT05056987|50595694|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
25280995|NCT05056987|50595695|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
25280996|NCT05056987|50595694|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
25280997|NCT05056987|50595695|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
25280998|NCT04654468|50595704|FG000|Overall Study|Death|1|||
25280999|NCT04654468|50595704|FG000|Overall Study|Ongoing in the Study|50|||
25281000|NCT03834506|50595723|FG000|Overall Study|Death|268|||
25281001|NCT03834506|50595724|FG001|Overall Study|Death|285|||
25281002|NCT03834506|50595723|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
25281003|NCT03834506|50595724|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
25281004|NCT03834506|50595723|FG000|Overall Study|Withdrawal by Subject|12|||
25281005|NCT03834506|50595724|FG001|Overall Study|Withdrawal by Subject|8|||
25281006|NCT03834506|50595723|FG000|Overall Study|Participants ongoing in the study|234|||
25281007|NCT03834506|50595724|FG001|Overall Study|Participants ongoing in the study|221|||
25281008|NCT03512197|50595741|FG000|Overall Study|Guardian decision|1|||
25281009|NCT03512197|50595742|FG001|Overall Study|Guardian decision|1|||
25281010|NCT03512197|50595741|FG000|Overall Study|Lack of Efficacy|19|||
25281011|NCT03512197|50595742|FG001|Overall Study|Lack of Efficacy|11|||
25281012|NCT03512197|50595741|FG000|Overall Study|New Therapy for Study Indication|16|||
25281013|NCT03512197|50595742|FG001|Overall Study|New Therapy for Study Indication|16|||
25281014|NCT03512197|50595741|FG000|Overall Study|Physician Decision|60|||
25190972|NCT02410902|50348064|FG000|Overall Study|Withdrawal by Subject|6|||
25190973|NCT02410902|50348065|FG001|Overall Study|Withdrawal by Subject|8|||
25281015|NCT03512197|50595742|FG001|Overall Study|Physician Decision|60|||
25281016|NCT03512197|50595741|FG000|Overall Study|Protocol Violation|0|||
25281017|NCT03512197|50595742|FG001|Overall Study|Protocol Violation|2|||
25281018|NCT03512197|50595741|FG000|Overall Study|Terminated by Sponsored|46|||
25281019|NCT03512197|50595742|FG001|Overall Study|Terminated by Sponsored|50|||
25281020|NCT03512197|50595741|FG000|Overall Study|Subject Decision|15|||
25281021|NCT03512197|50595742|FG001|Overall Study|Subject Decision|12|||
25281022|NCT03512197|50595741|FG000|Overall Study|Withdrawal of informed consent|20|||
25281023|NCT03512197|50595742|FG001|Overall Study|Withdrawal of informed consent|14|||
25281024|NCT03512197|50595741|FG000|Overall Study|Adverse Event|30|||
25281025|NCT03512197|50595742|FG001|Overall Study|Adverse Event|34|||
25281026|NCT03512197|50595741|FG000|Overall Study|Death|14|||
25281027|NCT03512197|50595742|FG001|Overall Study|Death|9|||
25281028|NCT03512197|50595741|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
25281029|NCT03512197|50595742|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
25281030|NCT03512197|50595741|FG000|Overall Study|Missing|3|||
25281031|NCT03512197|50595742|FG001|Overall Study|Missing|13|||
25281032|NCT03439852|50595756|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
25281033|NCT03439852|50595757|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
25281034|NCT03439852|50595756|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
25281035|NCT03439852|50595757|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
25281036|NCT03439852|50595756|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
25281037|NCT03439852|50595757|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
25281038|NCT03355300|50595768|FG000|Overall Study|Physician Decision|0|||
25281039|NCT03355300|50595769|FG001|Overall Study|Physician Decision|1|||
25281040|NCT03355300|50595768|FG000|Overall Study|Lack of Efficacy|2|||
25281041|NCT03355300|50595769|FG001|Overall Study|Lack of Efficacy|1|||
25281042|NCT03355300|50595768|FG000|Overall Study|Other reason|1|||
25281043|NCT03355300|50595769|FG001|Overall Study|Other reason|0|||
25281044|NCT03332056|50595777|FG000|Overall Study|Incomplete questionnaires|8|||
25281045|NCT03332056|50595778|FG001|Overall Study|Incomplete questionnaires|9|||
25281046|NCT03332056|50595777|FG000|Overall Study|Passed stone prior to surgery date|1|||
25281047|NCT03332056|50595778|FG001|Overall Study|Passed stone prior to surgery date|0|||
25281048|NCT03332056|50595777|FG000|Overall Study|Did not require a ureteral stent|0|||
25281049|NCT03332056|50595778|FG001|Overall Study|Did not require a ureteral stent|1|||
25281050|NCT03093350|50595784|FG000|Overall Study|Death|1|||
25281051|NCT03093350|50595784|FG000|Overall Study|Signed consent, never began treartment|1|||
25281052|NCT02901041|50595790|FG000|Overall Study|Withdrawal by PI|4|||
25281053|NCT02901041|50595791|FG001|Overall Study|Withdrawal by PI|8|||
25281054|NCT02901041|50595790|FG000|Overall Study|Withdrawal by Subject|7|||
25281055|NCT02901041|50595791|FG001|Overall Study|Withdrawal by Subject|3|||
25281056|NCT02547987|50595829|FG000|Overall Study|Withdrawal by Subject|1|||
25281057|NCT02547987|50595829|FG000|Overall Study|Adverse Event|2|||
25281058|NCT02513199|50595833|FG000|Treatment|Death|1|||
25281059|NCT02513199|50595833|FG000|Treatment|Lost to Follow-up|1|||
25281060|NCT02513199|50595833|FG000|Follow-Up|Death|11|||
25281061|NCT02181413|50595846|FG000|Overall Study|Adverse Event|7|||
25281062|NCT02181413|50595847|FG001|Overall Study|Adverse Event|24|||
25281063|NCT02181413|50595846|FG000|Overall Study|Progressive Disease|121|||
25281064|NCT02181413|50595847|FG001|Overall Study|Progressive Disease|143|||
25281065|NCT02181413|50595846|FG000|Overall Study|Withdrawal by Subject|5|||
25281066|NCT02181413|50595847|FG001|Overall Study|Withdrawal by Subject|8|||
25281067|NCT02181413|50595846|FG000|Overall Study|Reason Not Specified|19|||
25281068|NCT02181413|50595847|FG001|Overall Study|Reason Not Specified|20|||
25281069|NCT02181413|50595846|FG000|Overall Study|Ongoing Study Treatment|0|||
25281070|NCT02181413|50595847|FG001|Overall Study|Ongoing Study Treatment|1|||
25281071|NCT02181413|50595846|FG000|Overall Study|Lost to Follow-up|0|||
25281072|NCT02181413|50595847|FG001|Overall Study|Lost to Follow-up|1|||
25281073|NCT02151981|50595855|FG000|Overall Study|Death|184|||
25281074|NCT02151981|50595856|FG001|Overall Study|Death|88|||
25281075|NCT02151981|50595855|FG000|Overall Study|Lost to Follow-up|7|||
25281076|NCT02151981|50595856|FG001|Overall Study|Lost to Follow-up|1|||
25281077|NCT02151981|50595855|FG000|Overall Study|Withdrawal by Subject|27|||
25281078|NCT02151981|50595856|FG001|Overall Study|Withdrawal by Subject|21|||
25281079|NCT02151981|50595855|FG000|Overall Study|Ongoing Study at Data Cut-off|60|||
25281080|NCT02151981|50595856|FG001|Overall Study|Ongoing Study at Data Cut-off|27|||
25281081|NCT02151981|50595855|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
25281082|NCT02151981|50595856|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
25281083|NCT02151981|50595855|FG000|Overall Study|Patient had no clinical benefit|1|||
25281084|NCT02151981|50595856|FG001|Overall Study|Patient had no clinical benefit|0|||
25281085|NCT02151981|50595855|FG000|Overall Study|Unwilling to continue to follow up visit|0|||
25281086|NCT02151981|50595856|FG001|Overall Study|Unwilling to continue to follow up visit|1|||
25281087|NCT02151981|50595855|FG000|Overall Study|Study terminated|0|||
25281088|NCT02151981|50595856|FG001|Overall Study|Study terminated|1|||
25281089|NCT02097134|50595862|FG000|Overall Study|Physician Decision|4|||
25281090|NCT02097134|50595862|FG000|Overall Study|Non-Protocol Therapy|1|||
25281091|NCT02097134|50595862|FG000|Overall Study|Progressive Disease|3|||
25281092|NCT02097134|50595862|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
25281093|NCT01231906|50595884|FG000|Overall Study|Lack of Efficacy|75|||
25281094|NCT01231906|50595885|FG001|Overall Study|Lack of Efficacy|68|||
25281095|NCT01231906|50595884|FG000|Overall Study|Lost to Follow-up|1|||
25281096|NCT01231906|50595885|FG001|Overall Study|Lost to Follow-up|0|||
25281097|NCT01231906|50595884|FG000|Overall Study|Physician Decision|34|||
25281098|NCT01231906|50595885|FG001|Overall Study|Physician Decision|24|||
25281099|NCT01231906|50595884|FG000|Overall Study|Withdrawal by Subject|0|||
25281100|NCT01231906|50595885|FG001|Overall Study|Withdrawal by Subject|4|||
25281101|NCT01231906|50595884|FG000|Overall Study|Ineligible|10|||
25281102|NCT01231906|50595885|FG001|Overall Study|Ineligible|3|||
25281103|NCT01231906|50595884|FG000|Overall Study|No treatment|1|||
25281104|NCT01231906|50595885|FG001|Overall Study|No treatment|2|||
25281105|NCT00999804|50595893|FG000|Overall Study|Lack of Efficacy|9|||
25281106|NCT00999804|50595894|FG001|Overall Study|Lack of Efficacy|2|||
25281107|NCT00999804|50595893|FG000|Overall Study|Adverse Event|4|||
25281108|NCT00999804|50595894|FG001|Overall Study|Adverse Event|3|||
25281109|NCT00999804|50595893|FG000|Overall Study|Withdrawal by Subject|4|||
25281110|NCT00999804|50595894|FG001|Overall Study|Withdrawal by Subject|0|||
25281111|NCT00999804|50595893|FG000|Overall Study|Death|1|||
25281112|NCT00999804|50595894|FG001|Overall Study|Death|0|||
25281113|NCT00999804|50595893|FG000|Overall Study|Ineligible|3|||
25281114|NCT00999804|50595894|FG001|Overall Study|Ineligible|0|||
25281115|NCT00927472|50595906|FG000|Overall Study|Withdrawal by Subject|10|||
25281116|NCT00927472|50595907|FG001|Overall Study|Withdrawal by Subject|11|||
25281117|NCT00927472|50595906|FG000|Overall Study|Lost to Follow-up|1|||
25281118|NCT00927472|50595907|FG001|Overall Study|Lost to Follow-up|6|||
25281119|NCT00927472|50595906|FG000|Overall Study|Protocol Violation|0|||
25281120|NCT00927472|50595907|FG001|Overall Study|Protocol Violation|1|||
25281121|NCT00927472|50595906|FG000|Overall Study|Post treatment Assessment out of window|0|||
25281122|NCT00927472|50595907|FG001|Overall Study|Post treatment Assessment out of window|4|||
25281123|NCT00927394|50595915|FG000|Overall Study|Adverse Event|14|||
25281124|NCT00927394|50595916|FG001|Overall Study|Adverse Event|9|||
25281125|NCT00927394|50595915|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
25281126|NCT00927394|50595916|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
25281127|NCT00927394|50595915|FG000|Overall Study|Withdrawal by Subject|20|||
25281128|NCT00927394|50595916|FG001|Overall Study|Withdrawal by Subject|24|||
25281129|NCT00927394|50595915|FG000|Overall Study|Lost to Follow-up|8|||
25281130|NCT00927394|50595916|FG001|Overall Study|Lost to Follow-up|14|||
25281131|NCT00927394|50595915|FG000|Overall Study|Administrative Problem|1|||
25281132|NCT00927394|50595916|FG001|Overall Study|Administrative Problem|0|||
25281133|NCT00927394|50595915|FG000|Overall Study|Death|1|||
25281134|NCT00927394|50595916|FG001|Overall Study|Death|1|||
25281135|NCT00927394|50595915|FG000|Overall Study|Protocol deviation|16|||
25281136|NCT00927394|50595916|FG001|Overall Study|Protocol deviation|13|||
25281137|NCT00927394|50595915|FG000|Overall Study|Randomized in error|0|||
25281138|NCT00927394|50595916|FG001|Overall Study|Randomized in error|1|||
25281139|NCT00976911|50595925|FG000|Overall Study|Withdrawal by Subject|4|||
25281140|NCT00976911|50595926|FG001|Overall Study|Withdrawal by Subject|6|||
25281141|NCT00976911|50595925|FG000|Overall Study|Death|138|||
25281142|NCT00976911|50595926|FG001|Overall Study|Death|126|||
25281143|NCT00976911|50595925|FG000|Overall Study|Adverse Event|0|||
25169057|NCT01869959|50299873|FG001|Treatment Period|Withdrawal by Subject|1|||
25169058|NCT01869959|50299874|FG002|Treatment Period|Withdrawal by Subject|0|||
25169059|NCT01869959|50299875|FG003|Treatment Period|Withdrawal by Subject|0|||
25169060|NCT01869959|50299876|FG004|Treatment Period|Withdrawal by Subject|0|||
25169061|NCT01613027|50299937|FG000|Overall Study|Lost to Follow-up|5|||
25169062|NCT01613027|50299937|FG000|Overall Study|Switched Physician|1|||
25169063|NCT01613027|50299937|FG000|Overall Study|Lack of Efficacy|1|||
25169064|NCT01613027|50299937|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
25169065|NCT01869725|50299955|FG000|Overall Study|ineligible after registration|1|||
25169066|NCT01869725|50299955|FG000|Overall Study|Death|1|||
25281144|NCT00976911|50595926|FG001|Overall Study|Adverse Event|1|||
25281145|NCT00976911|50595925|FG000|Overall Study|Protocol Violation|2|||
25281146|NCT00976911|50595926|FG001|Overall Study|Protocol Violation|0|||
25281147|NCT00976911|50595925|FG000|Overall Study|Other|8|||
25281148|NCT00976911|50595926|FG001|Overall Study|Other|9|||
25281149|NCT00976911|50595925|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
25281150|NCT00976911|50595926|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
25281151|NCT00934648|50595932|FG000|Overall Study|Failure to return|8|||
25281152|NCT00934648|50595932|FG000|Overall Study|Withdrawal by Subject|1|||
25281153|NCT01175213|50595940|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
25190974|NCT02410902|50348064|FG000|Overall Study|Non-Compliance|8|||
25190975|NCT02410902|50348065|FG001|Overall Study|Non-Compliance|2|||
25190976|NCT02101736|50348075|FG000|Overall Study|Protocol Violation|3|||
25190977|NCT02101736|50348076|FG001|Overall Study|Protocol Violation|0|||
25190978|NCT02101736|50348075|FG000|Overall Study|Withdrawal by Subject|1|||
25190979|NCT02101736|50348076|FG001|Overall Study|Withdrawal by Subject|1|||
25281154|NCT01175213|50595941|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
25281155|NCT01175213|50595940|FG000|IGSC, 10%/rHuPH20|Death|1|||
25281156|NCT01175213|50595941|FG001|IGSC, 10%/rHuPH20|Death|0|||
25281157|NCT01175213|50595940|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
25281158|NCT01175213|50595941|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
25281159|NCT01175213|50595940|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
25281160|NCT01175213|50595941|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
25281161|NCT01175213|50595940|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
25281162|NCT01175213|50595941|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
25281163|NCT01175213|50595940|FG000|Safety Follow-up|Adverse Event|1|||
25281164|NCT01175213|50595941|FG001|Safety Follow-up|Adverse Event|0|||
25281165|NCT00974259|50595952|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
25281166|NCT00974259|50595953|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
25281167|NCT00927082|50595963|FG000|Overall Study|Lost to Follow-up|9|||
25281168|NCT00927082|50595964|FG001|Overall Study|Lost to Follow-up|8|||
25281169|NCT00927082|50595965|FG002|Overall Study|Lost to Follow-up|12|||
25281170|NCT00927082|50595966|FG003|Overall Study|Lost to Follow-up|16|||
25281171|NCT00927082|50595963|FG000|Overall Study|Withdrawal by Subject|3|||
25281172|NCT00927082|50595964|FG001|Overall Study|Withdrawal by Subject|2|||
25281173|NCT00927082|50595965|FG002|Overall Study|Withdrawal by Subject|7|||
25281174|NCT00927082|50595966|FG003|Overall Study|Withdrawal by Subject|2|||
25281175|NCT00927082|50595963|FG000|Overall Study|Death|0|||
25281176|NCT00927082|50595964|FG001|Overall Study|Death|0|||
25281177|NCT00927082|50595965|FG002|Overall Study|Death|1|||
25281178|NCT00927082|50595966|FG003|Overall Study|Death|0|||
25281179|NCT00927082|50595963|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
25281180|NCT00927082|50595964|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
25281181|NCT00927082|50595965|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
25281182|NCT00927082|50595966|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
25281183|NCT00976677|50595982|FG000|Overall Study|Adverse Event|1|||
25281184|NCT00976677|50595983|FG001|Overall Study|Adverse Event|0|||
25281185|NCT00976677|50595982|FG000|Overall Study|Withdrawal by Subject|0|||
25281186|NCT00976677|50595983|FG001|Overall Study|Withdrawal by Subject|2|||
25281187|NCT00976677|50595982|FG000|Overall Study|Disease progression|1|||
25281188|NCT00976677|50595983|FG001|Overall Study|Disease progression|1|||
25281189|NCT00976677|50595982|FG000|Overall Study|Trial unblinded|2|||
25190980|NCT01918397|50348088|FG000|Overall Study|Never started treatment|2|||
25190981|NCT01918397|50348089|FG001|Overall Study|Never started treatment|1|||
25190982|NCT01918397|50348090|FG002|Overall Study|Never started treatment|0|||
25190983|NCT01918397|50348091|FG003|Overall Study|Never started treatment|0|||
25281190|NCT00976677|50595983|FG001|Overall Study|Trial unblinded|2|||
25281191|NCT00976677|50595982|FG000|Overall Study|Unknown/Missing|1|||
25281192|NCT00976677|50595983|FG001|Overall Study|Unknown/Missing|0|||
25281193|NCT00926536|50595991|FG000|Overall Study|Physician Decision|1|||
25281194|NCT00926536|50595992|FG001|Overall Study|Physician Decision|2|||
25281195|NCT00923260|50596000|FG000|Overall Study|Lost to Follow-up|1|||
25281196|NCT00923260|50596001|FG001|Overall Study|Lost to Follow-up|1|||
25281197|NCT00934102|50596007|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
25281198|NCT00934102|50596008|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
25281199|NCT00934102|50596009|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
25281200|NCT00970281|50596028|FG000|Overall Study|Lack of Efficacy|1|||
25281201|NCT00970281|50596029|FG001|Overall Study|Lack of Efficacy|14|||
25281202|NCT00970281|50596028|FG000|Overall Study|Withdrawal by Subject|0|||
25281203|NCT00970281|50596029|FG001|Overall Study|Withdrawal by Subject|1|||
25281204|NCT00970281|50596028|FG000|Overall Study|Physician Decision|1|||
25190984|NCT01918397|50348088|FG000|Overall Study|Adverse Event|1|||
25281205|NCT00970281|50596029|FG001|Overall Study|Physician Decision|1|||
25281206|NCT00976209|50596037|FG000|Treatment Period 1|Protocol Violation|1|||
25281207|NCT00976209|50596038|FG001|Treatment Period 1|Protocol Violation|0|||
25281208|NCT00976209|50596037|FG000|Treatment Period 1|Lost to Follow-up|2|||
25281209|NCT00976209|50596038|FG001|Treatment Period 1|Lost to Follow-up|0|||
25281210|NCT00976209|50596037|FG000|Treatment Period 1|Other|0|||
25281211|NCT00976209|50596038|FG001|Treatment Period 1|Other|1|||
25190985|NCT01918397|50348089|FG001|Overall Study|Adverse Event|1|||
25190986|NCT01918397|50348090|FG002|Overall Study|Adverse Event|1|||
25190987|NCT01918397|50348091|FG003|Overall Study|Adverse Event|0|||
25190988|NCT01918397|50348088|FG000|Overall Study|Lack of compliance|2|||
25281212|NCT00976209|50596037|FG000|Wash-out Period|Adverse Event|1|||
25281213|NCT00976209|50596038|FG001|Wash-out Period|Adverse Event|2|||
25281214|NCT00976209|50596037|FG000|Wash-out Period|Lost to Follow-up|1|||
25281215|NCT00976209|50596038|FG001|Wash-out Period|Lost to Follow-up|0|||
25281216|NCT00976209|50596037|FG000|Wash-out Period|Protocol Violation|1|||
25281217|NCT00976209|50596038|FG001|Wash-out Period|Protocol Violation|0|||
25281218|NCT00976209|50596037|FG000|Wash-out Period|Other|1|||
25281219|NCT00976209|50596038|FG001|Wash-out Period|Other|0|||
25281220|NCT00976209|50596037|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25281221|NCT00976209|50596038|FG001|Treatment Period 2|Withdrawal by Subject|1|||
25281222|NCT00976209|50596037|FG000|Treatment Period 2|Lost to Follow-up|0|||
25281223|NCT00976209|50596038|FG001|Treatment Period 2|Lost to Follow-up|1|||
25281224|NCT00925990|50596045|FG000|Overall Study|Adverse Event|1|||
25281225|NCT00925990|50596046|FG001|Overall Study|Adverse Event|3|||
25281226|NCT00925990|50596045|FG000|Overall Study|Withdrawal by Subject|2|||
25281227|NCT00925990|50596046|FG001|Overall Study|Withdrawal by Subject|2|||
25281228|NCT00925990|50596045|FG000|Overall Study|Lost to Follow-up|1|||
25281229|NCT00925990|50596046|FG001|Overall Study|Lost to Follow-up|3|||
25281230|NCT00925990|50596045|FG000|Overall Study|Physician Decision|1|||
25281231|NCT00925990|50596046|FG001|Overall Study|Physician Decision|1|||
25281232|NCT00925990|50596045|FG000|Overall Study|moved out of state, missed medication|0|||
25281233|NCT00925990|50596046|FG001|Overall Study|moved out of state, missed medication|2|||
25281234|NCT01131078|50596055|FG000|Overall Study|Adverse Event|22|||
25281235|NCT01131078|50596056|FG001|Overall Study|Adverse Event|12|||
25281236|NCT01131078|50596057|FG002|Overall Study|Adverse Event|17|||
25281237|NCT01131078|50596055|FG000|Overall Study|Progressive Disease|58|||
25281238|NCT01131078|50596056|FG001|Overall Study|Progressive Disease|77|||
25281239|NCT01131078|50596057|FG002|Overall Study|Progressive Disease|71|||
25281240|NCT01131078|50596055|FG000|Overall Study|Protocol Violation|1|||
25281241|NCT01131078|50596056|FG001|Overall Study|Protocol Violation|0|||
25281242|NCT01131078|50596057|FG002|Overall Study|Protocol Violation|0|||
25281243|NCT01131078|50596055|FG000|Overall Study|Lost to Follow-up|1|||
25281244|NCT01131078|50596056|FG001|Overall Study|Lost to Follow-up|1|||
25281245|NCT01131078|50596057|FG002|Overall Study|Lost to Follow-up|1|||
25281246|NCT01131078|50596055|FG000|Overall Study|Withdrawal by Subject|2|||
25281247|NCT01131078|50596056|FG001|Overall Study|Withdrawal by Subject|4|||
25281248|NCT01131078|50596057|FG002|Overall Study|Withdrawal by Subject|3|||
25281249|NCT01131078|50596055|FG000|Overall Study|Non-compliance|3|||
25281250|NCT01131078|50596056|FG001|Overall Study|Non-compliance|0|||
25281251|NCT01131078|50596057|FG002|Overall Study|Non-compliance|0|||
25281252|NCT01131078|50596055|FG000|Overall Study|Physician Decision|10|||
25281253|NCT01131078|50596056|FG001|Overall Study|Physician Decision|6|||
25281254|NCT01131078|50596057|FG002|Overall Study|Physician Decision|8|||
25281255|NCT01131078|50596055|FG000|Overall Study|Death|4|||
25281256|NCT01131078|50596056|FG001|Overall Study|Death|0|||
25281257|NCT01131078|50596057|FG002|Overall Study|Death|2|||
25281258|NCT01131078|50596055|FG000|Overall Study|Other|0|||
25281259|NCT01131078|50596056|FG001|Overall Study|Other|1|||
25281260|NCT01131078|50596057|FG002|Overall Study|Other|0|||
25281261|NCT01167582|50596069|FG000|Overall Study|Lost to Follow-up|0|||
25281262|NCT01167582|50596070|FG001|Overall Study|Lost to Follow-up|1|||
25281263|NCT01167426|50596076|FG000|Overall Study|Lost to Follow-up|6|||
25281264|NCT01167426|50596076|FG000|Overall Study|Protocol Violation|1|||
25281265|NCT01167426|50596076|FG000|Overall Study|Withdrawal by Subject|2|||
25281266|NCT01167426|50596076|FG000|Overall Study|Sponsor Decision|1|||
25281267|NCT00968799|50596081|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
25281268|NCT00922636|50596090|FG000|Overall Study|Adverse Event|3|||
25281269|NCT00922636|50596091|FG001|Overall Study|Adverse Event|3|||
25281270|NCT00922636|50596092|FG002|Overall Study|Adverse Event|2|||
25281271|NCT00922636|50596093|FG003|Overall Study|Adverse Event|3|||
25281272|NCT00922636|50596094|FG004|Overall Study|Adverse Event|2|||
25281273|NCT00922636|50596090|FG000|Overall Study|Lack of Efficacy|1|||
25281274|NCT00922636|50596091|FG001|Overall Study|Lack of Efficacy|7|||
25281275|NCT00922636|50596092|FG002|Overall Study|Lack of Efficacy|3|||
25281276|NCT00922636|50596093|FG003|Overall Study|Lack of Efficacy|2|||
25281277|NCT00922636|50596094|FG004|Overall Study|Lack of Efficacy|4|||
25281278|NCT00922636|50596090|FG000|Overall Study|Sponsor Decision|0|||
25281279|NCT00922636|50596091|FG001|Overall Study|Sponsor Decision|0|||
25281280|NCT00922636|50596092|FG002|Overall Study|Sponsor Decision|2|||
25281281|NCT00922636|50596093|FG003|Overall Study|Sponsor Decision|0|||
25281282|NCT00922636|50596094|FG004|Overall Study|Sponsor Decision|0|||
25281283|NCT00922636|50596090|FG000|Overall Study|Withdrawal by Subject|0|||
25190989|NCT01918397|50348089|FG001|Overall Study|Lack of compliance|2|||
25190990|NCT01918397|50348090|FG002|Overall Study|Lack of compliance|3|||
25190991|NCT01918397|50348091|FG003|Overall Study|Lack of compliance|0|||
25190992|NCT01918397|50348088|FG000|Overall Study|Pregnancy|0|||
25190993|NCT01918397|50348089|FG001|Overall Study|Pregnancy|1|||
25190994|NCT01918397|50348090|FG002|Overall Study|Pregnancy|0|||
25281284|NCT00922636|50596091|FG001|Overall Study|Withdrawal by Subject|0|||
25281285|NCT00922636|50596092|FG002|Overall Study|Withdrawal by Subject|5|||
25190995|NCT01918397|50348091|FG003|Overall Study|Pregnancy|0|||
25190996|NCT01918397|50348088|FG000|Overall Study|Rifampin susceptible|0|||
25281286|NCT00922636|50596093|FG003|Overall Study|Withdrawal by Subject|2|||
25281287|NCT00922636|50596094|FG004|Overall Study|Withdrawal by Subject|4|||
25281288|NCT00922636|50596090|FG000|Overall Study|Protocol Violation|0|||
25281289|NCT00922636|50596091|FG001|Overall Study|Protocol Violation|0|||
25281290|NCT00922636|50596092|FG002|Overall Study|Protocol Violation|2|||
25281291|NCT00922636|50596093|FG003|Overall Study|Protocol Violation|2|||
25281292|NCT00922636|50596094|FG004|Overall Study|Protocol Violation|0|||
25281293|NCT00922636|50596090|FG000|Overall Study|Entry Criteria Not Met|0|||
25281294|NCT00922636|50596091|FG001|Overall Study|Entry Criteria Not Met|0|||
25281295|NCT00922636|50596092|FG002|Overall Study|Entry Criteria Not Met|1|||
25281296|NCT00922636|50596093|FG003|Overall Study|Entry Criteria Not Met|1|||
25281297|NCT00922636|50596094|FG004|Overall Study|Entry Criteria Not Met|0|||
25281298|NCT00922636|50596090|FG000|Overall Study|Parent/Caregiver Decision|2|||
25281299|NCT00922636|50596091|FG001|Overall Study|Parent/Caregiver Decision|4|||
25281300|NCT00922636|50596092|FG002|Overall Study|Parent/Caregiver Decision|3|||
25281301|NCT00922636|50596093|FG003|Overall Study|Parent/Caregiver Decision|5|||
25281302|NCT00922636|50596094|FG004|Overall Study|Parent/Caregiver Decision|2|||
25190997|NCT01918397|50348089|FG001|Overall Study|Rifampin susceptible|0|||
25190998|NCT01918397|50348090|FG002|Overall Study|Rifampin susceptible|0|||
25190999|NCT01918397|50348091|FG003|Overall Study|Rifampin susceptible|2|||
25191000|NCT01918397|50348088|FG000|Overall Study|Treatment failure|0|||
25191001|NCT01918397|50348089|FG001|Overall Study|Treatment failure|0|||
25191002|NCT01918397|50348090|FG002|Overall Study|Treatment failure|0|||
25191003|NCT01918397|50348091|FG003|Overall Study|Treatment failure|1|||
25191004|NCT01918397|50348088|FG000|Overall Study|Withdrawal by Subject|3|||
25191005|NCT01918397|50348089|FG001|Overall Study|Withdrawal by Subject|2|||
25191006|NCT01918397|50348090|FG002|Overall Study|Withdrawal by Subject|1|||
25191007|NCT01918397|50348091|FG003|Overall Study|Withdrawal by Subject|1|||
25191008|NCT01918397|50348088|FG000|Overall Study|XDR at baseline|0|||
25191009|NCT01918397|50348089|FG001|Overall Study|XDR at baseline|0|||
25191010|NCT01918397|50348090|FG002|Overall Study|XDR at baseline|1|||
25191011|NCT01918397|50348091|FG003|Overall Study|XDR at baseline|0|||
25191012|NCT01918397|50348088|FG000|Overall Study|Lost to Follow-up|2|||
25191013|NCT01918397|50348089|FG001|Overall Study|Lost to Follow-up|1|||
25191014|NCT01918397|50348090|FG002|Overall Study|Lost to Follow-up|1|||
25191015|NCT01918397|50348091|FG003|Overall Study|Lost to Follow-up|1|||
25191016|NCT01918397|50348088|FG000|Overall Study|Increased QTc|1|||
25191017|NCT01918397|50348089|FG001|Overall Study|Increased QTc|0|||
25191018|NCT01918397|50348090|FG002|Overall Study|Increased QTc|0|||
25191019|NCT01918397|50348091|FG003|Overall Study|Increased QTc|1|||
25191020|NCT01918397|50348088|FG000|Overall Study|Death|0|||
25191021|NCT01918397|50348089|FG001|Overall Study|Death|0|||
25191022|NCT01918397|50348090|FG002|Overall Study|Death|1|||
25191023|NCT01918397|50348091|FG003|Overall Study|Death|0|||
25191024|NCT01918397|50348088|FG000|Overall Study|Involved in another investigative trial|0|||
25191025|NCT01918397|50348089|FG001|Overall Study|Involved in another investigative trial|0|||
25191026|NCT01918397|50348090|FG002|Overall Study|Involved in another investigative trial|0|||
25191027|NCT01918397|50348091|FG003|Overall Study|Involved in another investigative trial|1|||
25191028|NCT00986921|50348125|FG000|Overall Study|Physician Decision|1|||
25191029|NCT00986921|50348126|FG001|Overall Study|Physician Decision|0|||
25191030|NCT01596972|50348137|FG000|Overall Study|Physician Decision|1|||
25191031|NCT01596972|50348138|FG001|Overall Study|Physician Decision|9|||
25191032|NCT01596972|50348137|FG000|Overall Study|Lost to Follow-up|0|||
25191033|NCT01596972|50348138|FG001|Overall Study|Lost to Follow-up|4|||
25191034|NCT01596972|50348137|FG000|Overall Study|Withdrawal by Subject|0|||
25191035|NCT01596972|50348138|FG001|Overall Study|Withdrawal by Subject|1|||
25191036|NCT00985751|50348239|FG000|Overall Study|Adverse Event|0|||
25191037|NCT00985751|50348240|FG001|Overall Study|Adverse Event|0|||
25191038|NCT00985751|50348241|FG002|Overall Study|Adverse Event|0|||
25191039|NCT00985751|50348242|FG003|Overall Study|Adverse Event|0|||
25191040|NCT00985751|50348243|FG004|Overall Study|Adverse Event|1|||
25191041|NCT01596582|50348288|FG000|Overall Study|Deemed ineligible after study visit|3|||
25191042|NCT01596582|50348289|FG001|Overall Study|Deemed ineligible after study visit|6|||
25191043|NCT01596582|50348288|FG000|Overall Study|Missing all outcome data|1|||
25191044|NCT01596582|50348289|FG001|Overall Study|Missing all outcome data|1|||
25191045|NCT01596504|50348305|FG000|Overall Study|Participant's Private Reason|0|||
25191046|NCT01596504|50348306|FG001|Overall Study|Participant's Private Reason|1|||
25191047|NCT01596504|50348307|FG002|Overall Study|Participant's Private Reason|0|||
25281303|NCT00922636|50596090|FG000|Overall Study|Lost to Follow-up|1|||
25281304|NCT00922636|50596091|FG001|Overall Study|Lost to Follow-up|2|||
25281305|NCT00922636|50596092|FG002|Overall Study|Lost to Follow-up|2|||
25191048|NCT01596504|50348305|FG000|Overall Study|Adverse Event|1|||
25191049|NCT01596504|50348306|FG001|Overall Study|Adverse Event|2|||
25191050|NCT01596504|50348307|FG002|Overall Study|Adverse Event|1|||
25191051|NCT01596504|50348305|FG000|Overall Study|Withdrawal by Subject|1|||
25191052|NCT01596504|50348306|FG001|Overall Study|Withdrawal by Subject|0|||
25191053|NCT01596504|50348307|FG002|Overall Study|Withdrawal by Subject|0|||
25281306|NCT00922636|50596093|FG003|Overall Study|Lost to Follow-up|2|||
25281307|NCT00922636|50596094|FG004|Overall Study|Lost to Follow-up|4|||
25191054|NCT02616900|50348362|FG000|Overall Study|Lack of Efficacy|7|||
25191055|NCT02616900|50348362|FG000|Overall Study|Lost to Follow-up|2|||
25191056|NCT02616900|50348362|FG000|Overall Study|Protocol Violation|5|||
25191057|NCT02616900|50348362|FG000|Overall Study|Withdrawal by Subject|3|||
25281308|NCT01175135|50596115|FG000|Overall Study|Adverse Event|2|||
25281309|NCT01175135|50596116|FG001|Overall Study|Adverse Event|5|||
25281310|NCT01175135|50596117|FG002|Overall Study|Adverse Event|3|||
25281311|NCT01175135|50596118|FG003|Overall Study|Adverse Event|4|||
25281312|NCT01175135|50596115|FG000|Overall Study|Death|1|||
25281313|NCT01175135|50596116|FG001|Overall Study|Death|0|||
25281314|NCT01175135|50596117|FG002|Overall Study|Death|0|||
25281315|NCT01175135|50596118|FG003|Overall Study|Death|0|||
25281316|NCT01175135|50596115|FG000|Overall Study|Lack of Efficacy|4|||
25281317|NCT01175135|50596116|FG001|Overall Study|Lack of Efficacy|5|||
25281318|NCT01175135|50596117|FG002|Overall Study|Lack of Efficacy|0|||
25281319|NCT01175135|50596118|FG003|Overall Study|Lack of Efficacy|5|||
25281320|NCT01175135|50596115|FG000|Overall Study|Lost to Follow-up|1|||
25281321|NCT01175135|50596116|FG001|Overall Study|Lost to Follow-up|2|||
25281322|NCT01175135|50596117|FG002|Overall Study|Lost to Follow-up|0|||
25281323|NCT01175135|50596118|FG003|Overall Study|Lost to Follow-up|0|||
25281324|NCT01175135|50596115|FG000|Overall Study|Protocol Violation|1|||
25281325|NCT01175135|50596116|FG001|Overall Study|Protocol Violation|1|||
25281326|NCT01175135|50596117|FG002|Overall Study|Protocol Violation|0|||
25281327|NCT01175135|50596118|FG003|Overall Study|Protocol Violation|0|||
25281328|NCT01175135|50596115|FG000|Overall Study|Withdrawal by Subject|4|||
25281329|NCT01175135|50596116|FG001|Overall Study|Withdrawal by Subject|8|||
25281330|NCT01175135|50596117|FG002|Overall Study|Withdrawal by Subject|5|||
25281331|NCT01175135|50596118|FG003|Overall Study|Withdrawal by Subject|5|||
25281332|NCT01175135|50596115|FG000|Overall Study|Other|3|||
25281333|NCT01175135|50596116|FG001|Overall Study|Other|1|||
25281334|NCT01175135|50596117|FG002|Overall Study|Other|3|||
25281335|NCT01175135|50596118|FG003|Overall Study|Other|0|||
25281336|NCT01175135|50596115|FG000|Overall Study|Randomized But Not Treated|0|||
25281337|NCT01175135|50596116|FG001|Overall Study|Randomized But Not Treated|0|||
25281338|NCT01175135|50596117|FG002|Overall Study|Randomized But Not Treated|1|||
25281339|NCT01175135|50596118|FG003|Overall Study|Randomized But Not Treated|0|||
25281340|NCT00922480|50596130|FG000|Main Study|Protocol Violation|3|||
25281341|NCT00922480|50596131|FG001|Main Study|Protocol Violation|6|||
25281342|NCT00922480|50596130|FG000|Main Study|Adverse Event|6|||
25281343|NCT00922480|50596131|FG001|Main Study|Adverse Event|7|||
25281344|NCT00922480|50596130|FG000|Main Study|Lack of Efficacy|3|||
25281345|NCT00922480|50596131|FG001|Main Study|Lack of Efficacy|0|||
25281346|NCT00922480|50596130|FG000|Main Study|Withdrawal by Subject|20|||
25281347|NCT00922480|50596131|FG001|Main Study|Withdrawal by Subject|15|||
25281348|NCT00922480|50596130|FG000|Main Study|Lost to Follow-up|5|||
25281349|NCT00922480|50596131|FG001|Main Study|Lost to Follow-up|0|||
25281350|NCT00922480|50596130|FG000|Main Study|Physician Decision|0|||
25281351|NCT00922480|50596131|FG001|Main Study|Physician Decision|1|||
25281352|NCT00922480|50596130|FG000|Extension Study|Protocol Violation|3|||
25281353|NCT00922480|50596131|FG001|Extension Study|Protocol Violation|0|||
25281354|NCT00922480|50596130|FG000|Extension Study|Adverse Event|1|||
25281355|NCT00922480|50596131|FG001|Extension Study|Adverse Event|1|||
25281356|NCT00922480|50596130|FG000|Extension Study|Withdrawal by Subject|1|||
25281357|NCT00922480|50596131|FG001|Extension Study|Withdrawal by Subject|1|||
25281358|NCT00922480|50596130|FG000|Extension Study|Others|0|||
25281359|NCT00922480|50596131|FG001|Extension Study|Others|1|||
25281360|NCT00973479|50596141|FG000|Overall Study|Lost to Follow-up|0|||
25281361|NCT00973479|50596142|FG001|Overall Study|Lost to Follow-up|3|||
25281362|NCT00973479|50596141|FG000|Overall Study|Death|2|||
25281363|NCT00973479|50596142|FG001|Overall Study|Death|2|||
25281364|NCT00973479|50596141|FG000|Overall Study|Withdrawal by Subject|15|||
25281365|NCT00973479|50596142|FG001|Overall Study|Withdrawal by Subject|16|||
25281366|NCT00973479|50596141|FG000|Overall Study|Lack of Efficacy|5|||
25281367|NCT00973479|50596142|FG001|Overall Study|Lack of Efficacy|7|||
25281368|NCT00973479|50596141|FG000|Overall Study|Adverse Event|12|||
25281369|NCT00973479|50596142|FG001|Overall Study|Adverse Event|32|||
25191058|NCT02616900|50348362|FG000|Overall Study|Incomplete data|6|||
25191059|NCT00985673|50348474|FG000|Overall Study|Lost to Follow-up|6|||
25191060|NCT00985673|50348475|FG001|Overall Study|Lost to Follow-up|7|||
25191061|NCT00985673|50348476|FG002|Overall Study|Lost to Follow-up|6|||
25191062|NCT00985673|50348477|FG003|Overall Study|Lost to Follow-up|10|||
25191063|NCT00985673|50348478|FG004|Overall Study|Lost to Follow-up|5|||
25191064|NCT00985673|50348479|FG005|Overall Study|Lost to Follow-up|3|||
25191065|NCT00985673|50348474|FG000|Overall Study|Withdrawal by Subject|0|||
25191066|NCT00985673|50348475|FG001|Overall Study|Withdrawal by Subject|4|||
25191067|NCT00985673|50348476|FG002|Overall Study|Withdrawal by Subject|5|||
25281370|NCT00973479|50596141|FG000|Overall Study|Protocol Violation|2|||
25281371|NCT00973479|50596142|FG001|Overall Study|Protocol Violation|2|||
25281372|NCT00973479|50596141|FG000|Overall Study|Other|1|||
25281373|NCT00973479|50596142|FG001|Overall Study|Other|7|||
25281374|NCT01174043|50596150|FG000|Overall Study|Disease progression|5|||
25281375|NCT01174043|50596150|FG000|Overall Study|Adverse Event|3|||
25281376|NCT01174043|50596150|FG000|Overall Study|Death|1|||
25281377|NCT01174043|50596150|FG000|Overall Study|Withdrawal by Subject|2|||
25281378|NCT01173653|50596156|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
25281379|NCT01173653|50596157|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
25281380|NCT01172873|50596165|FG000|Overall Study|Withdrawal by Subject|3|||
25281381|NCT01172873|50596166|FG001|Overall Study|Withdrawal by Subject|2|||
25281382|NCT00925600|50596178|FG000|Overall Study|Withdrawal by Subject|16|||
25281383|NCT00925600|50596179|FG001|Overall Study|Withdrawal by Subject|14|||
25281384|NCT00925600|50596178|FG000|Overall Study|Death|4|||
25281385|NCT00925600|50596179|FG001|Overall Study|Death|3|||
25281386|NCT00925600|50596178|FG000|Overall Study|Lost to Follow-up|2|||
25191068|NCT00985673|50348477|FG003|Overall Study|Withdrawal by Subject|2|||
25281387|NCT00925600|50596179|FG001|Overall Study|Lost to Follow-up|2|||
25281388|NCT00925600|50596178|FG000|Overall Study|Disease Progression|1|||
25281389|NCT00925600|50596179|FG001|Overall Study|Disease Progression|3|||
25281390|NCT00925600|50596178|FG000|Overall Study|Administrative Decision|1|||
25281391|NCT00925600|50596179|FG001|Overall Study|Administrative Decision|1|||
25281392|NCT00925600|50596178|FG000|Overall Study|Noncompliance|2|||
25281393|NCT00925600|50596179|FG001|Overall Study|Noncompliance|0|||
25281394|NCT00925600|50596178|FG000|Overall Study|Ineligibility Determined|2|||
25281395|NCT00925600|50596179|FG001|Overall Study|Ineligibility Determined|0|||
25281396|NCT00925600|50596178|FG000|Overall Study|Protocol Deviation|0|||
25281397|NCT00925600|50596179|FG001|Overall Study|Protocol Deviation|1|||
25281398|NCT00925600|50596178|FG000|Overall Study|Requirement for Alternative Therapy|0|||
25281399|NCT00925600|50596179|FG001|Overall Study|Requirement for Alternative Therapy|1|||
25281400|NCT00925600|50596178|FG000|Overall Study|Other|3|||
25281401|NCT00925600|50596179|FG001|Overall Study|Other|1|||
25281402|NCT00925600|50596178|FG000|Overall Study|Adverse Event|1|||
25281403|NCT00925600|50596179|FG001|Overall Study|Adverse Event|2|||
25281404|NCT00968253|50596192|FG000|Overall Study|Death|0|||
25281405|NCT00968253|50596193|FG001|Overall Study|Death|0|||
25281406|NCT00968253|50596194|FG002|Overall Study|Death|2|||
25281407|NCT00968253|50596192|FG000|Overall Study|Withdrawal by Subject|0|||
25281408|NCT00968253|50596193|FG001|Overall Study|Withdrawal by Subject|0|||
25281409|NCT00968253|50596194|FG002|Overall Study|Withdrawal by Subject|1|||
25281410|NCT00968253|50596192|FG000|Overall Study|Disease Progression|0|||
25281411|NCT00968253|50596193|FG001|Overall Study|Disease Progression|3|||
25169067|NCT01869725|50299955|FG000|Overall Study|Lost to Follow-up|2|||
25169068|NCT01851863|50299976|FG000|Overall Study|Did not receive study medication|2|||
25169069|NCT01851863|50299977|FG001|Overall Study|Did not receive study medication|5|||
25169070|NCT01851863|50299978|FG002|Overall Study|Did not receive study medication|3|||
25169071|NCT01851863|50299979|FG003|Overall Study|Did not receive study medication|0|||
25169072|NCT01851863|50299976|FG000|Overall Study|Lost to Follow-up|3|||
25169073|NCT01851863|50299977|FG001|Overall Study|Lost to Follow-up|4|||
25169074|NCT01851863|50299978|FG002|Overall Study|Lost to Follow-up|2|||
25169075|NCT01851863|50299979|FG003|Overall Study|Lost to Follow-up|3|||
25169076|NCT01850615|50300007|FG000|Overall Study|Protocol Violation|4|||
25169077|NCT01850615|50300008|FG001|Overall Study|Protocol Violation|1|||
25169078|NCT01850615|50300007|FG000|Overall Study|Adverse Event|2|||
25191069|NCT00985673|50348478|FG004|Overall Study|Withdrawal by Subject|2|||
25191070|NCT00985673|50348479|FG005|Overall Study|Withdrawal by Subject|3|||
25191071|NCT00985673|50348474|FG000|Overall Study|Other|1|||
25191072|NCT00985673|50348475|FG001|Overall Study|Other|0|||
25191073|NCT00985673|50348476|FG002|Overall Study|Other|1|||
25191074|NCT00985673|50348477|FG003|Overall Study|Other|0|||
25191075|NCT00985673|50348478|FG004|Overall Study|Other|1|||
25191076|NCT00985673|50348479|FG005|Overall Study|Other|0|||
25191077|NCT00985439|50348525|FG000|Overall Study|Adverse Event|0|||
25191078|NCT00985439|50348526|FG001|Overall Study|Adverse Event|0|||
25191079|NCT00985439|50348527|FG002|Overall Study|Adverse Event|1|||
25191080|NCT00985439|50348528|FG003|Overall Study|Adverse Event|0|||
25191081|NCT02618928|50348538|FG000|Overall Study|Failure to Return|28|||
25191082|NCT02618928|50348538|FG000|Overall Study|Insufficient Virological Response|1|||
25191083|NCT02618928|50348538|FG000|Overall Study|Withdrawal by Subject|2|||
25191084|NCT02618928|50348538|FG000|Overall Study|Death|3|||
25191085|NCT02618928|50348538|FG000|Overall Study|Other|11|||
25191086|NCT02618928|50348538|FG000|Overall Study|Missing|6|||
25191087|NCT02618928|50348538|FG000|Overall Study|Treatment Never Started|7|||
25191088|NCT00983957|50348549|FG000|Overall Study|Adverse Event|1|||
25191089|NCT00983957|50348549|FG000|Overall Study|Personal Reasons|1|||
25191090|NCT00981149|50348603|FG000|Overall Study|Lost to Follow-up|1|||
25281412|NCT00968253|50596194|FG002|Overall Study|Disease Progression|3|||
25191091|NCT00981149|50348604|FG001|Overall Study|Lost to Follow-up|2|||
25281413|NCT00968253|50596192|FG000|Overall Study|Adverse Event|0|||
25281414|NCT00968253|50596193|FG001|Overall Study|Adverse Event|0|||
25281415|NCT00968253|50596194|FG002|Overall Study|Adverse Event|1|||
25281416|NCT00964743|50596203|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
25281417|NCT00925522|50596207|FG000|Overall Study|study closed -- business decision|20|||
25281418|NCT01130532|50596214|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
25281419|NCT01130532|50596215|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
25281420|NCT01130532|50596216|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
25281421|NCT01130532|50596217|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
25281422|NCT01130532|50596214|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
25281423|NCT01130532|50596215|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
25281424|NCT01130532|50596216|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
25281425|NCT01130532|50596217|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
25281426|NCT01130532|50596214|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
25281427|NCT01130532|50596215|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
25281428|NCT01130532|50596216|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
25281429|NCT01130532|50596217|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
25281430|NCT01130532|50596214|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
25281431|NCT01130532|50596215|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
25281432|NCT01130532|50596216|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
25281433|NCT01130532|50596217|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
25281434|NCT01130532|50596214|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
25281435|NCT01130532|50596215|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
25281436|NCT01130532|50596216|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
25281437|NCT01130532|50596217|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
25281438|NCT01130532|50596214|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
25281439|NCT01130532|50596215|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
25281440|NCT01130532|50596216|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
25281441|NCT01130532|50596217|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
25281442|NCT01130532|50596214|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
25281443|NCT01130532|50596215|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
25281444|NCT01130532|50596216|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
25281445|NCT01130532|50596217|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
25281446|NCT01130532|50596214|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
25281447|NCT01130532|50596215|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
25281448|NCT01130532|50596216|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
25281449|NCT01130532|50596217|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
25281450|NCT01130532|50596214|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
25281451|NCT01130532|50596215|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
25281452|NCT01130532|50596216|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
25281453|NCT01130532|50596217|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
25281454|NCT01130532|50596214|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
25281455|NCT01130532|50596215|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
25281456|NCT01130532|50596216|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
25281457|NCT01130532|50596217|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
25281458|NCT01130532|50596214|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
25281459|NCT01130532|50596215|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
25281460|NCT01130532|50596216|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
25281461|NCT01130532|50596217|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
25281462|NCT00972777|50596231|FG000|Overall Study|Adverse Event|3|||
25281463|NCT00972777|50596232|FG001|Overall Study|Adverse Event|2|||
25281464|NCT00972777|50596231|FG000|Overall Study|Lost to Follow-up|0|||
25281465|NCT00972777|50596232|FG001|Overall Study|Lost to Follow-up|4|||
25281466|NCT00972777|50596231|FG000|Overall Study|Withdrawal by Subject|4|||
25281467|NCT00972777|50596232|FG001|Overall Study|Withdrawal by Subject|5|||
25281468|NCT00972777|50596231|FG000|Overall Study|Physician Decision|4|||
25281469|NCT00972777|50596232|FG001|Overall Study|Physician Decision|0|||
25281470|NCT00972777|50596231|FG000|Overall Study|Protocol Violation|0|||
25281471|NCT00972777|50596232|FG001|Overall Study|Protocol Violation|2|||
25281472|NCT00972777|50596231|FG000|Overall Study|Screening Failure|2|||
25281473|NCT00972777|50596232|FG001|Overall Study|Screening Failure|1|||
25281474|NCT00972777|50596231|FG000|Overall Study|Missed visit|1|||
25281475|NCT00972777|50596232|FG001|Overall Study|Missed visit|0|||
25281476|NCT00918736|50596238|FG000|Overall Study|Withdrawal by Subject|4|||
25281477|NCT01172639|50596247|FG000|Overall Study|Death|1|||
25281478|NCT01172639|50596248|FG001|Overall Study|Death|1|||
25281479|NCT01172639|50596249|FG002|Overall Study|Death|0|||
25281480|NCT01172639|50596250|FG003|Overall Study|Death|0|||
25281481|NCT01172639|50596251|FG004|Overall Study|Death|0|||
25281482|NCT01172639|50596247|FG000|Overall Study|Lost to Follow-up|9|||
25169079|NCT01850615|50300008|FG001|Overall Study|Adverse Event|1|||
25281483|NCT01172639|50596248|FG001|Overall Study|Lost to Follow-up|7|||
25281484|NCT01172639|50596249|FG002|Overall Study|Lost to Follow-up|11|||
25281485|NCT01172639|50596250|FG003|Overall Study|Lost to Follow-up|6|||
25281486|NCT01172639|50596251|FG004|Overall Study|Lost to Follow-up|6|||
25281487|NCT01172639|50596247|FG000|Overall Study|Withdrawal by Subject|3|||
25281488|NCT01172639|50596248|FG001|Overall Study|Withdrawal by Subject|3|||
25281489|NCT01172639|50596249|FG002|Overall Study|Withdrawal by Subject|5|||
25281490|NCT01172639|50596250|FG003|Overall Study|Withdrawal by Subject|5|||
25281491|NCT01172639|50596251|FG004|Overall Study|Withdrawal by Subject|0|||
25281492|NCT01144182|50596265|FG000|Overall Study|Death|5|||
25281493|NCT01144182|50596266|FG001|Overall Study|Death|6|||
25281494|NCT01144182|50596265|FG000|Overall Study|Withdrawal by Subject|3|||
25281495|NCT01144182|50596266|FG001|Overall Study|Withdrawal by Subject|6|||
25281496|NCT01144182|50596265|FG000|Overall Study|Lost to Follow-up|9|||
25281497|NCT01144182|50596266|FG001|Overall Study|Lost to Follow-up|9|||
25281498|NCT01225562|50596276|FG000|Overall Study|Withdrawal by Subject|52|||
25281499|NCT01225562|50596277|FG001|Overall Study|Withdrawal by Subject|50|||
25281500|NCT01225562|50596278|FG002|Overall Study|Withdrawal by Subject|52|||
25281501|NCT01225562|50596276|FG000|Overall Study|Lost to Follow-up|3|||
25191092|NCT00981149|50348603|FG000|Overall Study|Withdrawal by Subject|1|||
25191093|NCT00981149|50348604|FG001|Overall Study|Withdrawal by Subject|1|||
25191094|NCT01595646|50348662|FG000|Overall Study|Withdrawal by Subject|1|||
25191095|NCT01595646|50348663|FG001|Overall Study|Withdrawal by Subject|0|||
25191096|NCT01595646|50348664|FG002|Overall Study|Withdrawal by Subject|0|||
25191097|NCT00981461|50348692|FG000|Overall Study|Lost to Follow-up|5|||
25191098|NCT00981461|50348693|FG001|Overall Study|Lost to Follow-up|2|||
25191099|NCT02618616|50348710|FG000|Overall Study|Lack of Efficacy|4|||
25191100|NCT02618616|50348711|FG001|Overall Study|Lack of Efficacy|0|||
25191101|NCT02618616|50348710|FG000|Overall Study|Pregnancy|0|||
25191102|NCT02618616|50348711|FG001|Overall Study|Pregnancy|1|||
25191103|NCT02618616|50348710|FG000|Overall Study|Adverse Event|8|||
25191104|NCT02618616|50348711|FG001|Overall Study|Adverse Event|0|||
25191105|NCT02618616|50348710|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
25281502|NCT01225562|50596277|FG001|Overall Study|Lost to Follow-up|6|||
25281503|NCT01225562|50596278|FG002|Overall Study|Lost to Follow-up|1|||
25281504|NCT00925288|50596288|FG000|Overall Study|Lost to Follow-up|9|||
25281505|NCT00925288|50596289|FG001|Overall Study|Lost to Follow-up|7|||
25281506|NCT01143714|50596299|FG000|Overall Study|Adverse Event|4|||
25281507|NCT01143714|50596300|FG001|Overall Study|Adverse Event|2|||
25281508|NCT01143714|50596299|FG000|Overall Study|Withdrawal by Subject|1|||
25281509|NCT01143714|50596300|FG001|Overall Study|Withdrawal by Subject|0|||
25281510|NCT01143714|50596299|FG000|Overall Study|Subject non-compliance|0|||
25281511|NCT01143714|50596300|FG001|Overall Study|Subject non-compliance|1|||
25281512|NCT01143714|50596299|FG000|Overall Study|wound closed = deemed healed|1|||
25281513|NCT01143714|50596300|FG001|Overall Study|wound closed = deemed healed|0|||
25281514|NCT01143714|50596299|FG000|Overall Study|wound size increased|1|||
25281515|NCT01143714|50596300|FG001|Overall Study|wound size increased|0|||
25281516|NCT00972543|50596321|FG000|Overall Study|Adverse Event|1|||
25281517|NCT00972543|50596322|FG001|Overall Study|Adverse Event|0|||
25281518|NCT00972543|50596321|FG000|Overall Study|Early study termination by sponsor|4|||
25281519|NCT00972543|50596322|FG001|Overall Study|Early study termination by sponsor|1|||
25281520|NCT00925132|50596328|FG000|Overall Study|Withdrawal by Subject|2|||
25281521|NCT00925132|50596329|FG001|Overall Study|Withdrawal by Subject|0|||
25281522|NCT00925132|50596330|FG002|Overall Study|Withdrawal by Subject|0|||
25281523|NCT00925132|50596331|FG003|Overall Study|Withdrawal by Subject|0|||
25281524|NCT00925132|50596332|FG004|Overall Study|Withdrawal by Subject|1|||
25281525|NCT00925132|50596328|FG000|Overall Study|Removed due to disease progression|0|||
25281526|NCT00925132|50596329|FG001|Overall Study|Removed due to disease progression|0|||
25281527|NCT00925132|50596330|FG002|Overall Study|Removed due to disease progression|0|||
25281528|NCT00925132|50596331|FG003|Overall Study|Removed due to disease progression|0|||
25281529|NCT00925132|50596332|FG004|Overall Study|Removed due to disease progression|4|||
25281530|NCT01143402|50596341|FG000|Overall Study|Rapid clinical decline|1|||
25281531|NCT01143402|50596342|FG001|Overall Study|Rapid clinical decline|1|||
25281532|NCT01143402|50596343|FG002|Overall Study|Rapid clinical decline|0|||
25281533|NCT01143402|50596341|FG000|Overall Study|Not Treated|0|||
25281534|NCT01143402|50596342|FG001|Overall Study|Not Treated|0|||
25281535|NCT01143402|50596343|FG002|Overall Study|Not Treated|1|||
25281536|NCT01171625|50596350|FG000|Overall Study|On-Protocol|67|||
25281537|NCT01171625|50596350|FG000|Overall Study|Death|38|||
25191106|NCT02618616|50348711|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
25191107|NCT02618616|50348710|FG000|Overall Study|Consent withdrawn by subject|8|||
25191108|NCT02618616|50348711|FG001|Overall Study|Consent withdrawn by subject|5|||
25191109|NCT02618616|50348710|FG000|Overall Study|Lost to Follow-up|0|||
25281538|NCT01171625|50596350|FG000|Overall Study|Withdrawal by Subject|31|||
25281539|NCT01171625|50596350|FG000|Overall Study|Explanted|10|||
25191110|NCT02618616|50348711|FG001|Overall Study|Lost to Follow-up|1|||
25191111|NCT02618382|50348790|FG000|Overall Study|Physician Decision|1|||
25281540|NCT01171625|50596350|FG000|Overall Study|Lost to Follow-up|5|||
25281541|NCT01171625|50596350|FG000|Overall Study|Patient received valve-in-valve|3|||
25069828|NCT02341456|50175594|FG001|Overall Study|Withdrawal by Subject|1|||
25281542|NCT01171625|50596350|FG000|Overall Study|Other|1|||
25281543|NCT01171625|50596350|FG000|Overall Study|Consented but did not receive device|25|||
25281544|NCT00924898|50596362|FG000|Overall Study|Withdrawal by Subject|2|||
25281545|NCT01167192|50596371|FG000|Overall Study|Adverse Event|1|||
25281546|NCT01167192|50596371|FG000|Overall Study|Death|1|||
25281547|NCT01167192|50596371|FG000|Overall Study|Withdrawal by Subject|1|||
25281548|NCT01167192|50596371|FG000|Overall Study|Insurance denial|1|||
25281549|NCT01166958|50596377|FG000|Overall Study|Withdrawal by Subject|1|||
25281550|NCT01166958|50596378|FG001|Overall Study|Withdrawal by Subject|0|||
25281551|NCT01170221|50596386|FG000|Overall Study|Lost to Follow-up|22|||
25191112|NCT02618382|50348790|FG000|Overall Study|Withdrawal by Subject|1|||
25191113|NCT02618382|50348790|FG000|Overall Study|Protocol Violation|1|||
25281552|NCT01170221|50596387|FG001|Overall Study|Lost to Follow-up|21|||
25281553|NCT01170221|50596386|FG000|Overall Study|Withdrawal by Subject|9|||
25281554|NCT01170221|50596387|FG001|Overall Study|Withdrawal by Subject|7|||
25281555|NCT01170221|50596386|FG000|Overall Study|Subject completed only screening and LFU|1|||
25281556|NCT01170221|50596387|FG001|Overall Study|Subject completed only screening and LFU|0|||
25281557|NCT01170221|50596386|FG000|Overall Study|Randomized but not treated|1|||
25281558|NCT01170221|50596387|FG001|Overall Study|Randomized but not treated|0|||
25281559|NCT01166646|50596395|FG000|Overall Study|Protocol Violation|0|||
25281560|NCT01166646|50596396|FG001|Overall Study|Protocol Violation|1|||
25281561|NCT01166646|50596395|FG000|Overall Study|Adverse Event|1|||
25281562|NCT01166646|50596396|FG001|Overall Study|Adverse Event|0|||
25281563|NCT01129284|50596405|FG000|Overall Study|Adverse Event|2|||
25281564|NCT01129284|50596406|FG001|Overall Study|Adverse Event|0|||
25191114|NCT00980057|50348834|FG000|Overall Study|Death|13|||
25191115|NCT00980057|50348835|FG001|Overall Study|Death|3|||
25191116|NCT00980057|50348834|FG000|Overall Study|Adverse Event|0|||
25191117|NCT00980057|50348835|FG001|Overall Study|Adverse Event|1|||
25191118|NCT00980057|50348834|FG000|Overall Study|Physician Decision|4|||
25191119|NCT00980057|50348835|FG001|Overall Study|Physician Decision|0|||
25191120|NCT00980057|50348834|FG000|Overall Study|Lost to Follow-up|1|||
25191121|NCT00980057|50348835|FG001|Overall Study|Lost to Follow-up|0|||
25191122|NCT00980057|50348834|FG000|Overall Study|Withdrawal by Subject|1|||
25191123|NCT00980057|50348835|FG001|Overall Study|Withdrawal by Subject|1|||
25191124|NCT04126733|50348947|FG000|Treatment Period|Other Reason|1|||
25191125|NCT04126733|50348947|FG000|Treatment Period|Death|1|||
25191126|NCT04126733|50348947|FG000|Treatment Period|Physician Decision|3|||
25191127|NCT04126733|50348947|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
25191128|NCT04126733|50348947|FG000|Treatment Period|Adverse Event|7|||
25191129|NCT04126733|50348947|FG000|Treatment Period|Progressive Disease - Radiological Progression|44|||
25191130|NCT04126733|50348947|FG000|Treatment Period|Ongoing with Study Treatment|7|||
25191131|NCT04126733|50348947|FG000|Active Follow-up Period|Death|13|||
25191132|NCT04126733|50348947|FG000|Active Follow-up Period|Other Reason|1|||
25191133|NCT04126733|50348947|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
25191134|NCT04126733|50348947|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
25191135|NCT04126733|50348947|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
25191136|NCT04126733|50348947|FG000|Long-term Follow-up Period|Death|5|||
25191137|NCT02614794|50348982|FG000|Overall Study|On treatment|118|||
25281565|NCT01129284|50596407|FG002|Overall Study|Adverse Event|1|||
25281566|NCT01166568|50596418|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
25281567|NCT01166568|50596419|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
25281568|NCT01166568|50596420|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
25281569|NCT01166568|50596418|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
25281570|NCT01166568|50596419|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
25281571|NCT01166568|50596420|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
25281572|NCT01166568|50596418|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
25281573|NCT01166568|50596419|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
25281574|NCT01166568|50596420|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
25069829|NCT02341456|50175595|FG002|Overall Study|Withdrawal by Subject|1|||
25069830|NCT02341456|50175593|FG000|Overall Study|Moved to local access programme.|0|||
25281575|NCT01166178|50596428|FG000|Overall Study|Withdrawal by Subject|1|||
25281576|NCT01166178|50596429|FG001|Overall Study|Withdrawal by Subject|0|||
25281577|NCT01166178|50596428|FG000|Overall Study|Study was terminated|20|||
25281578|NCT01166178|50596429|FG001|Overall Study|Study was terminated|8|||
25069831|NCT02341456|50175594|FG001|Overall Study|Moved to local access programme.|1|||
25069832|NCT02341456|50175595|FG002|Overall Study|Moved to local access programme.|1|||
25191138|NCT02614794|50348983|FG001|Overall Study|On treatment|27|||
25281579|NCT00924820|50596435|FG000|Overall Study|Death|2|||
25281580|NCT00924820|50596435|FG000|Overall Study|Ineligible, Screen Failure|5|||
25191139|NCT02614794|50348982|FG000|Overall Study|In long term follow up|148|||
25281581|NCT01225172|50596441|FG000|Overall Study|Subject decision to stop|1|||
25281582|NCT01225172|50596442|FG001|Overall Study|Subject decision to stop|0|||
25281583|NCT01225172|50596441|FG000|Overall Study|Subject request to discontinue treatment|3|||
25281584|NCT01225172|50596442|FG001|Overall Study|Subject request to discontinue treatment|1|||
25281585|NCT01225172|50596441|FG000|Overall Study|Subject no longer meets study criteria|1|||
25281586|NCT01225172|50596442|FG001|Overall Study|Subject no longer meets study criteria|0|||
25281587|NCT01225172|50596441|FG000|Overall Study|Withdrawal by Subject|1|||
25281588|NCT01225172|50596442|FG001|Overall Study|Withdrawal by Subject|0|||
25281589|NCT01143324|50596448|FG000|Overall Study|Lost to Follow-up|11|||
25281590|NCT01143324|50596448|FG000|Overall Study|Withdrawal by Subject|4|||
25281591|NCT01143324|50596448|FG000|Overall Study|Explant of the device|4|||
25281592|NCT01224782|50596452|FG000|Overall Study|Lost to Follow-up|177|||
25281593|NCT01224782|50596452|FG000|Overall Study|Withdrawal by Subject|16|||
25281594|NCT01224782|50596452|FG000|Overall Study|Death|14|||
25281595|NCT01224782|50596452|FG000|Overall Study|Improvement|13|||
25281596|NCT01224782|50596452|FG000|Overall Study|Adverse Event|12|||
25281597|NCT01224782|50596452|FG000|Overall Study|Adverse Reaction|11|||
25281598|NCT01224782|50596452|FG000|Overall Study|Noncompliance|10|||
25281599|NCT01224782|50596452|FG000|Overall Study|Other|4|||
25281600|NCT01224782|50596452|FG000|Overall Study|Start of Dialysis|3|||
25191140|NCT02614794|50348983|FG001|Overall Study|In long term follow up|85|||
25191141|NCT02614794|50348982|FG000|Overall Study|Death|126|||
25191142|NCT02614794|50348983|FG001|Overall Study|Death|84|||
25191143|NCT02614794|50348982|FG000|Overall Study|Withdrawal by Subject|16|||
25191144|NCT02614794|50348983|FG001|Overall Study|Withdrawal by Subject|5|||
25191145|NCT02614794|50348982|FG000|Overall Study|Lost to Follow-up|2|||
25191146|NCT02614794|50348983|FG001|Overall Study|Lost to Follow-up|0|||
25191147|NCT02614794|50348982|FG000|Overall Study|Physician Decision|0|||
25191148|NCT02614794|50348983|FG001|Overall Study|Physician Decision|1|||
25191149|NCT00988247|50348991|FG000|Overall Study|Adverse Event|17|||
25191150|NCT00988247|50348992|FG001|Overall Study|Adverse Event|3|||
25191151|NCT00988247|50348991|FG000|Overall Study|Withdrawal by Subject|44|||
25191152|NCT00988247|50348992|FG001|Overall Study|Withdrawal by Subject|13|||
25191153|NCT00988247|50348991|FG000|Overall Study|Pregnancy|1|||
25191154|NCT00988247|50348992|FG001|Overall Study|Pregnancy|2|||
25191155|NCT00988247|50348991|FG000|Overall Study|Lost to Follow-up|11|||
25191156|NCT00988247|50348992|FG001|Overall Study|Lost to Follow-up|2|||
25191157|NCT00988247|50348991|FG000|Overall Study|Protocol Violation|4|||
25191158|NCT00988247|50348992|FG001|Overall Study|Protocol Violation|5|||
25191159|NCT00988247|50348991|FG000|Overall Study|Sponsor requested withdrawal|3|||
25191160|NCT00988247|50348992|FG001|Overall Study|Sponsor requested withdrawal|1|||
25191161|NCT00988247|50348991|FG000|Overall Study|Other|3|||
25191162|NCT00988247|50348992|FG001|Overall Study|Other|0|||
25191163|NCT00984659|50349002|FG000|2-week Run-in Period|Adverse Event|8|||
25191164|NCT00984659|50349003|FG001|2-week Run-in Period|Adverse Event|0|||
25191165|NCT00984659|50349004|FG002|2-week Run-in Period|Adverse Event|0|||
25191166|NCT00984659|50349005|FG003|2-week Run-in Period|Adverse Event|0|||
25191167|NCT00984659|50349002|FG000|2-week Run-in Period|Protocol Violation|5|||
25281601|NCT01224782|50596452|FG000|Overall Study|Change of Treatment|1|||
25281602|NCT01224782|50596452|FG000|Overall Study|Financial Reasons|1|||
25281603|NCT01224782|50596452|FG000|Overall Study|Deterioration|1|||
25281604|NCT01224782|50596452|FG000|Overall Study|Transplantation|1|||
25281605|NCT01224158|50596458|FG000|Overall Study|Withdrawal by Subject|1|||
25281606|NCT01224158|50596459|FG001|Overall Study|Withdrawal by Subject|0|||
25281607|NCT01129128|50596468|FG000|Overall Study|Lost to Follow-up|2|||
25281608|NCT01129128|50596469|FG001|Overall Study|Lost to Follow-up|2|||
25281609|NCT01129128|50596470|FG002|Overall Study|Lost to Follow-up|1|||
25281610|NCT01129128|50596468|FG000|Overall Study|Protocol Violation|0|||
25281611|NCT01129128|50596469|FG001|Overall Study|Protocol Violation|1|||
25281612|NCT01129128|50596470|FG002|Overall Study|Protocol Violation|0|||
25281613|NCT01129128|50596468|FG000|Overall Study|Withdrawal by Subject|0|||
25281614|NCT01129128|50596469|FG001|Overall Study|Withdrawal by Subject|1|||
25281615|NCT01129128|50596470|FG002|Overall Study|Withdrawal by Subject|3|||
25281616|NCT01129128|50596468|FG000|Overall Study|Physician Decision|1|||
25281617|NCT01129128|50596469|FG001|Overall Study|Physician Decision|0|||
25281618|NCT01129128|50596470|FG002|Overall Study|Physician Decision|0|||
25191168|NCT00984659|50349003|FG001|2-week Run-in Period|Protocol Violation|0|||
25191169|NCT00984659|50349004|FG002|2-week Run-in Period|Protocol Violation|0|||
25281619|NCT01222520|50596480|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
25281620|NCT01222520|50596481|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
25191170|NCT00984659|50349005|FG003|2-week Run-in Period|Protocol Violation|0|||
25191171|NCT00984659|50349002|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
25191172|NCT00984659|50349003|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
25191173|NCT00984659|50349004|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
25281621|NCT01222520|50596480|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
25281622|NCT01222520|50596481|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
25191174|NCT00984659|50349005|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
25191175|NCT00984659|50349002|FG000|2-week Run-in Period|Lost to Follow-up|3|||
25191176|NCT00984659|50349003|FG001|2-week Run-in Period|Lost to Follow-up|0|||
25191177|NCT00984659|50349004|FG002|2-week Run-in Period|Lost to Follow-up|0|||
25191178|NCT00984659|50349005|FG003|2-week Run-in Period|Lost to Follow-up|0|||
25191179|NCT00984659|50349002|FG000|2-week Run-in Period|Physician Decision|10|||
25191180|NCT00984659|50349003|FG001|2-week Run-in Period|Physician Decision|0|||
25191181|NCT00984659|50349004|FG002|2-week Run-in Period|Physician Decision|0|||
25191182|NCT00984659|50349005|FG003|2-week Run-in Period|Physician Decision|0|||
25191183|NCT00984659|50349002|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
25281623|NCT01222520|50596480|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
25281624|NCT01222520|50596481|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
25281625|NCT01222520|50596480|FG000|Double-blind Period|Adverse Event|0|||
25281626|NCT01222520|50596481|FG001|Double-blind Period|Adverse Event|1|||
25281627|NCT01222520|50596480|FG000|Double-blind Period|Lack of Efficacy|0|||
25281628|NCT01222520|50596481|FG001|Double-blind Period|Lack of Efficacy|1|||
25281629|NCT01222520|50596480|FG000|Double-blind Period|Study medication stolen|1|||
25281630|NCT01222520|50596481|FG001|Double-blind Period|Study medication stolen|0|||
25281631|NCT01221350|50596489|FG000|Overall Study|Discontinued intervention (GERD)|1|||
25281632|NCT01221350|50596490|FG001|Overall Study|Discontinued intervention (GERD)|0|||
25281633|NCT01221350|50596489|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
25281634|NCT01221350|50596490|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
25281635|NCT01221350|50596489|FG000|Overall Study|Withdrawal by Subject|4|||
25281636|NCT01221350|50596490|FG001|Overall Study|Withdrawal by Subject|2|||
25281637|NCT01221272|50596498|FG000|Period 1|Adverse Event|2|||
25281638|NCT01221272|50596499|FG001|Period 1|Adverse Event|0|||
25281639|NCT01221272|50596498|FG000|Period 1|Consent Withdrawal|0|||
25281640|NCT01221272|50596499|FG001|Period 1|Consent Withdrawal|1|||
25281641|NCT01221272|50596498|FG000|Period 1|Significant Dosing Noncompliance|0|||
25281642|NCT01221272|50596499|FG001|Period 1|Significant Dosing Noncompliance|1|||
25281643|NCT01221272|50596498|FG000|Period 2|Adverse Event|0|||
25281644|NCT01221272|50596499|FG001|Period 2|Adverse Event|2|||
25281645|NCT01220414|50596510|FG000|Overall Study|Withdrawal by Subject|1|||
25281646|NCT01220414|50596511|FG001|Overall Study|Withdrawal by Subject|0|||
25281647|NCT01220414|50596512|FG002|Overall Study|Withdrawal by Subject|0|||
25281648|NCT01220414|50596513|FG003|Overall Study|Withdrawal by Subject|1|||
25281649|NCT01128894|50596522|FG000|Overall Study|Adverse Event|31|||
25281650|NCT01128894|50596523|FG001|Overall Study|Adverse Event|41|||
25281651|NCT01128894|50596522|FG000|Overall Study|Protocol Violation|2|||
25281652|NCT01128894|50596523|FG001|Overall Study|Protocol Violation|1|||
25281653|NCT01128894|50596522|FG000|Overall Study|Noncompliance|4|||
25281654|NCT01128894|50596523|FG001|Overall Study|Noncompliance|5|||
25281655|NCT01128894|50596522|FG000|Overall Study|Lost to Follow-up|8|||
25281656|NCT01128894|50596523|FG001|Overall Study|Lost to Follow-up|8|||
25281657|NCT01128894|50596522|FG000|Overall Study|Withdrawal by Subject|10|||
25281658|NCT01128894|50596523|FG001|Overall Study|Withdrawal by Subject|12|||
25281659|NCT01128894|50596522|FG000|Overall Study|Physician Decision|2|||
25281660|NCT01128894|50596523|FG001|Overall Study|Physician Decision|1|||
25281661|NCT01128894|50596522|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
25281662|NCT01128894|50596523|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
25281663|NCT01220180|50596532|FG000|Overall Study|Lost to Follow-up|76|||
25281664|NCT01220180|50596532|FG000|Overall Study|Other|72|||
25281665|NCT01220180|50596532|FG000|Overall Study|Adverse Event|35|||
25281666|NCT01220180|50596532|FG000|Overall Study|Lack of Efficacy|22|||
25281667|NCT01220180|50596532|FG000|Overall Study|Death|1|||
25281668|NCT01220180|50596532|FG000|Overall Study|Randomized but not treated|1|||
25281669|NCT01220024|50596538|FG000|Overall Study|Lost to Follow-up|1|||
25281670|NCT01220024|50596539|FG001|Overall Study|Lost to Follow-up|1|||
25281671|NCT01128738|50596547|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
25281672|NCT01128738|50596548|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
25281673|NCT01128738|50596547|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
25281674|NCT01128738|50596548|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
25281675|NCT01128738|50596547|FG000|Second TP|Lost to Follow-up|0|||
25281676|NCT01128738|50596548|FG001|Second TP|Lost to Follow-up|1|||
25281677|NCT01128738|50596547|FG000|Second TP|Withdrawal by Subject|0|||
25281678|NCT01128738|50596548|FG001|Second TP|Withdrawal by Subject|2|||
25281679|NCT01143090|50596555|FG000|Overall Study|Lack of Efficacy|2|||
25281680|NCT01143090|50596555|FG000|Overall Study|Adverse Event|17|||
25281681|NCT01143090|50596555|FG000|Overall Study|Lost to Follow-up|9|||
25281682|NCT01143090|50596555|FG000|Overall Study|Protocol Violation|2|||
25281683|NCT01143090|50596555|FG000|Overall Study|Withdrawal by Subject|18|||
25191184|NCT00984659|50349003|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
25281684|NCT01143090|50596555|FG000|Overall Study|Non-compliance with study drug|1|||
25281685|NCT01143090|50596555|FG000|Overall Study|Failure to meet eligibility criteria|1|||
25281686|NCT01143090|50596555|FG000|Overall Study|Administrative|1|||
25281687|NCT01165554|50596559|FG000|Overall Study|Withdrawal by Subject|23|||
25281688|NCT01218308|50596568|FG000|Overall Study|Adverse Event|1|||
25281689|NCT01218308|50596569|FG001|Overall Study|Adverse Event|2|||
25281690|NCT01218308|50596568|FG000|Overall Study|Protocol Violation|0|||
25281691|NCT01218308|50596569|FG001|Overall Study|Protocol Violation|2|||
25191185|NCT00984659|50349004|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
25191186|NCT00984659|50349005|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
25191187|NCT00984659|50349002|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
25281692|NCT01218308|50596568|FG000|Overall Study|Withdrawal by Subject|61|||
25281693|NCT01218308|50596569|FG001|Overall Study|Withdrawal by Subject|64|||
25281694|NCT01218308|50596568|FG000|Overall Study|Lost to Follow-up|27|||
25281695|NCT01218308|50596569|FG001|Overall Study|Lost to Follow-up|31|||
25281696|NCT01218308|50596568|FG000|Overall Study|Other|14|||
25281697|NCT01218308|50596569|FG001|Overall Study|Other|21|||
25281698|NCT01165320|50596577|FG000|Overall Study|Clinical adverse experience|2|||
25281699|NCT01165320|50596578|FG001|Overall Study|Clinical adverse experience|1|||
25281700|NCT01165320|50596579|FG002|Overall Study|Clinical adverse experience|0|||
25281701|NCT01165320|50596577|FG000|Overall Study|Laboratory adverse experience|1|||
25281702|NCT01165320|50596578|FG001|Overall Study|Laboratory adverse experience|0|||
25281703|NCT01165320|50596579|FG002|Overall Study|Laboratory adverse experience|0|||
25281704|NCT01165320|50596577|FG000|Overall Study|Lack of Efficacy|0|||
25281705|NCT01165320|50596578|FG001|Overall Study|Lack of Efficacy|2|||
25281706|NCT01165320|50596579|FG002|Overall Study|Lack of Efficacy|0|||
25281707|NCT01165320|50596577|FG000|Overall Study|Reason unknown|0|||
25281708|NCT01165320|50596578|FG001|Overall Study|Reason unknown|1|||
25281709|NCT01165320|50596579|FG002|Overall Study|Reason unknown|0|||
25281710|NCT01217606|50596587|FG000|Initial Treatment Phase|Other Reasons|0|||
25281711|NCT01217606|50596588|FG001|Initial Treatment Phase|Other Reasons|2|||
25281712|NCT01217606|50596587|FG000|Initial Treatment Phase|Protocol Violation|3|||
25191188|NCT00984659|50349003|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
25191189|NCT00984659|50349004|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
25191190|NCT00984659|50349005|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
25281713|NCT01217606|50596588|FG001|Initial Treatment Phase|Protocol Violation|2|||
25281714|NCT01217606|50596587|FG000|Initial Treatment Phase|Personal Reasons|0|||
25281715|NCT01217606|50596588|FG001|Initial Treatment Phase|Personal Reasons|2|||
25281716|NCT01217606|50596587|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
25281717|NCT01217606|50596588|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
25281718|NCT01217606|50596587|FG000|Initial Treatment Phase|Adverse Event|10|||
25281719|NCT01217606|50596588|FG001|Initial Treatment Phase|Adverse Event|6|||
25281720|NCT01217606|50596587|FG000|9-Month Masked Extension|Adverse Event|3|||
25281721|NCT01217606|50596588|FG001|9-Month Masked Extension|Adverse Event|6|||
25281722|NCT01217606|50596587|FG000|9-Month Masked Extension|Other Reasons|4|||
25281723|NCT01217606|50596588|FG001|9-Month Masked Extension|Other Reasons|4|||
25281724|NCT01217606|50596587|FG000|9-Month Masked Extension|Personal Reasons|2|||
25281725|NCT01217606|50596588|FG001|9-Month Masked Extension|Personal Reasons|1|||
25281726|NCT01217606|50596587|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
25281727|NCT01217606|50596588|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
25281728|NCT01217606|50596587|FG000|9-Month Masked Extension|Pregnancy|1|||
25281729|NCT01217606|50596588|FG001|9-Month Masked Extension|Pregnancy|0|||
25281730|NCT01217606|50596587|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
25281731|NCT01217606|50596588|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
25281732|NCT01128114|50596594|FG000|Overall Study|Treatment Withdrawn|6|||
25281733|NCT01128114|50596594|FG000|Overall Study|Screening Failed|2|||
25281734|NCT01217060|50596598|FG000|Overall Study|Withdrawal by Subject|1|||
25281735|NCT01216202|50596604|FG000|Overall Study|Withdrawal by Subject|8|||
25281736|NCT01216202|50596605|FG001|Overall Study|Withdrawal by Subject|0|||
25281737|NCT01216202|50596604|FG000|Overall Study|Death|0|||
25191191|NCT00984659|50349002|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
25191192|NCT00984659|50349003|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
25191193|NCT00984659|50349004|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
25281738|NCT01216202|50596605|FG001|Overall Study|Death|2|||
25281739|NCT01216202|50596604|FG000|Overall Study|Lost to Follow-up|14|||
25281740|NCT01216202|50596605|FG001|Overall Study|Lost to Follow-up|0|||
25281741|NCT04816669|50596617|FG000|Part 1|Adverse Event|1|||
25281742|NCT04816669|50596618|FG001|Part 1|Adverse Event|1|||
25281743|NCT04816669|50596619|FG002|Part 1|Adverse Event|0|||
25281744|NCT04816669|50596620|FG003|Part 1|Adverse Event|0|||
25281745|NCT04816669|50596617|FG000|Part 1|Lost to Follow-up|2|||
25281746|NCT04816669|50596618|FG001|Part 1|Lost to Follow-up|2|||
25281747|NCT04816669|50596619|FG002|Part 1|Lost to Follow-up|0|||
25281748|NCT04816669|50596620|FG003|Part 1|Lost to Follow-up|0|||
25281749|NCT04816669|50596617|FG000|Part 1|Protocol Violation|0|||
25281750|NCT04816669|50596618|FG001|Part 1|Protocol Violation|1|||
25281751|NCT04816669|50596619|FG002|Part 1|Protocol Violation|0|||
25191194|NCT00984659|50349005|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
25281752|NCT04816669|50596620|FG003|Part 1|Protocol Violation|0|||
25281753|NCT04816669|50596617|FG000|Part 1|Withdrawal by Subject|1|||
25281754|NCT04816669|50596618|FG001|Part 1|Withdrawal by Subject|2|||
25281755|NCT04816669|50596619|FG002|Part 1|Withdrawal by Subject|0|||
25281756|NCT04816669|50596620|FG003|Part 1|Withdrawal by Subject|0|||
25281757|NCT04816669|50596617|FG000|Part 2|Other|0|||
25281758|NCT04816669|50596618|FG001|Part 2|Other|0|||
25281759|NCT04816669|50596619|FG002|Part 2|Other|1|||
25281760|NCT04816669|50596620|FG003|Part 2|Other|0|||
25281761|NCT04816669|50596617|FG000|Part 2|Withdrawal by Subject|0|||
25281762|NCT04816669|50596618|FG001|Part 2|Withdrawal by Subject|0|||
25281763|NCT04816669|50596619|FG002|Part 2|Withdrawal by Subject|0|||
25281764|NCT04816669|50596620|FG003|Part 2|Withdrawal by Subject|1|||
25281765|NCT04816669|50596617|FG000|Part 2|Lost to Follow-up|0|||
25281766|NCT04816669|50596618|FG001|Part 2|Lost to Follow-up|0|||
25281767|NCT04816669|50596619|FG002|Part 2|Lost to Follow-up|1|||
25281768|NCT04816669|50596620|FG003|Part 2|Lost to Follow-up|0|||
25281769|NCT01165242|50596637|FG000|Overall Study|Unreachable Subjects|1|||
25281770|NCT01165242|50596638|FG001|Overall Study|Unreachable Subjects|0|||
25281771|NCT01165242|50596639|FG002|Overall Study|Unreachable Subjects|0|||
25281772|NCT01165242|50596637|FG000|Overall Study|Incarcerated Subjects|0|||
25281773|NCT01165242|50596638|FG001|Overall Study|Incarcerated Subjects|1|||
25281774|NCT01165242|50596639|FG002|Overall Study|Incarcerated Subjects|0|||
25281775|NCT01165242|50596637|FG000|Overall Study|Visit 2 Declined by Subject|0|||
25281776|NCT01165242|50596638|FG001|Overall Study|Visit 2 Declined by Subject|0|||
25281777|NCT01165242|50596639|FG002|Overall Study|Visit 2 Declined by Subject|1|||
25281778|NCT01165242|50596637|FG000|Overall Study|Withdrawal by Subject|0|||
25281779|NCT01165242|50596638|FG001|Overall Study|Withdrawal by Subject|2|||
25281780|NCT01165242|50596639|FG002|Overall Study|Withdrawal by Subject|2|||
25281781|NCT01165242|50596637|FG000|Overall Study|Extended Holiday|0|||
25281782|NCT01165242|50596638|FG001|Overall Study|Extended Holiday|0|||
25281783|NCT01165242|50596639|FG002|Overall Study|Extended Holiday|1|||
25281784|NCT01165242|50596637|FG000|Overall Study|Lost to Follow-up|9|||
25281785|NCT01165242|50596638|FG001|Overall Study|Lost to Follow-up|7|||
25281786|NCT01165242|50596639|FG002|Overall Study|Lost to Follow-up|10|||
25281787|NCT01170065|50596652|FG000|Overall Study|Adverse Event|17|||
25281788|NCT01170065|50596653|FG001|Overall Study|Adverse Event|50|||
25281789|NCT01170065|50596654|FG002|Overall Study|Adverse Event|10|||
25281790|NCT01170065|50596652|FG000|Overall Study|Lost to Follow-up|1|||
25281791|NCT01170065|50596653|FG001|Overall Study|Lost to Follow-up|4|||
25281792|NCT01170065|50596654|FG002|Overall Study|Lost to Follow-up|1|||
25281793|NCT01170065|50596652|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
25281794|NCT01170065|50596653|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
25281795|NCT01170065|50596654|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
25281796|NCT01170065|50596652|FG000|Overall Study|Reason other than specified|3|||
25281797|NCT01170065|50596653|FG001|Overall Study|Reason other than specified|8|||
25281798|NCT01170065|50596654|FG002|Overall Study|Reason other than specified|3|||
25281799|NCT01170065|50596652|FG000|Overall Study|Ongoing after planned observation time|5|||
25281800|NCT01170065|50596653|FG001|Overall Study|Ongoing after planned observation time|26|||
25281801|NCT01170065|50596654|FG002|Overall Study|Ongoing after planned observation time|10|||
25281802|NCT00966693|50596666|FG000|Overall Study|Adverse Event|0|||
25281803|NCT00966693|50596667|FG001|Overall Study|Adverse Event|0|||
25281804|NCT00966693|50596668|FG002|Overall Study|Adverse Event|1|||
25281805|NCT00966693|50596669|FG003|Overall Study|Adverse Event|2|||
25281806|NCT00966693|50596666|FG000|Overall Study|Death|0|||
25281807|NCT00966693|50596667|FG001|Overall Study|Death|0|||
25281808|NCT00966693|50596668|FG002|Overall Study|Death|1|||
25281809|NCT00966693|50596669|FG003|Overall Study|Death|0|||
25281810|NCT00966693|50596666|FG000|Overall Study|Withdrawal by Subject|1|||
25281811|NCT00966693|50596667|FG001|Overall Study|Withdrawal by Subject|0|||
25281812|NCT00966693|50596668|FG002|Overall Study|Withdrawal by Subject|0|||
25281813|NCT00966693|50596669|FG003|Overall Study|Withdrawal by Subject|5|||
25281814|NCT00966693|50596666|FG000|Overall Study|Disease Progression|0|||
25281815|NCT00966693|50596667|FG001|Overall Study|Disease Progression|0|||
25281816|NCT00966693|50596668|FG002|Overall Study|Disease Progression|1|||
25281817|NCT00966693|50596669|FG003|Overall Study|Disease Progression|16|||
25281818|NCT01215968|50596681|FG000|Overall Study|Adverse Event|0|||
25281819|NCT01215968|50596682|FG001|Overall Study|Adverse Event|2|||
25281820|NCT01215968|50596681|FG000|Overall Study|Protocol Violation|2|||
25281821|NCT01215968|50596682|FG001|Overall Study|Protocol Violation|4|||
25281822|NCT01215968|50596681|FG000|Overall Study|Not received study drug|0|||
25281823|NCT01215968|50596682|FG001|Overall Study|Not received study drug|1|||
25281824|NCT00963807|50596691|FG000|Overall Study|Physician Decision|2|||
25281825|NCT00963807|50596691|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
25281826|NCT00963807|50596691|FG000|Overall Study|Disease progression|15|||
25281827|NCT01142466|50596699|FG000|Overall Study|Adverse Event|2|||
25281828|NCT01142466|50596700|FG001|Overall Study|Adverse Event|1|||
25281829|NCT01142466|50596699|FG000|Overall Study|Withdrawal by Subject|1|||
25281830|NCT01142466|50596700|FG001|Overall Study|Withdrawal by Subject|1|||
25281831|NCT01215734|50596708|FG000|Overall Study|Death|0|||
25281832|NCT01215734|50596709|FG001|Overall Study|Death|1|||
25281833|NCT01169987|50596715|FG000|Overall Study|Withdrawal by Subject|3|||
25281834|NCT01169987|50596715|FG000|Overall Study|Lost to Follow-up|24|||
25281835|NCT01169987|50596715|FG000|Overall Study|Other|4|||
25281836|NCT01215422|50596729|FG000|Overall Study|Relocation|1|||
25281837|NCT01215422|50596730|FG001|Overall Study|Relocation|0|||
25281838|NCT01215422|50596731|FG002|Overall Study|Relocation|0|||
25281839|NCT01215422|50596732|FG003|Overall Study|Relocation|0|||
25281840|NCT01215422|50596729|FG000|Overall Study|Failed intubations|0|||
25281841|NCT01215422|50596730|FG001|Overall Study|Failed intubations|0|||
25281842|NCT01215422|50596731|FG002|Overall Study|Failed intubations|3|||
25281843|NCT01215422|50596732|FG003|Overall Study|Failed intubations|8|||
25281844|NCT01215422|50596729|FG000|Overall Study|Did not complete all intubations|7|||
25281845|NCT01215422|50596730|FG001|Overall Study|Did not complete all intubations|0|||
25281846|NCT01215422|50596731|FG002|Overall Study|Did not complete all intubations|0|||
25281847|NCT01215422|50596732|FG003|Overall Study|Did not complete all intubations|0|||
25281848|NCT00972153|50596757|FG000|Overall Study|Equipment malfunction during case|0|||
25281849|NCT00972153|50596758|FG001|Overall Study|Equipment malfunction during case|1|||
25281850|NCT00972153|50596759|FG002|Overall Study|Equipment malfunction during case|0|||
25281851|NCT00971997|50596767|FG000|Overall Study|Adverse Event|2|||
25281852|NCT00971997|50596767|FG000|Overall Study|Death|1|||
25281853|NCT00971997|50596767|FG000|Overall Study|Protocol Violation|4|||
25281854|NCT00971997|50596767|FG000|Overall Study|Withdrawal by Subject|5|||
25281855|NCT00971997|50596767|FG000|Overall Study|Physician Decision|7|||
25281856|NCT01142388|50596776|FG000|Overall Study|Lack of Efficacy|21|||
25281857|NCT01142388|50596777|FG001|Overall Study|Lack of Efficacy|31|||
25191195|NCT00984659|50349002|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
25191196|NCT00984659|50349003|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
25191197|NCT00984659|50349004|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
25191198|NCT00984659|50349005|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
25191199|NCT00984659|50349002|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
25191200|NCT00984659|50349003|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
25191201|NCT00984659|50349004|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
25281858|NCT01142388|50596776|FG000|Overall Study|Adverse Event|9|||
25281859|NCT01142388|50596777|FG001|Overall Study|Adverse Event|5|||
25281860|NCT01142388|50596776|FG000|Overall Study|Death|3|||
25281861|NCT01142388|50596777|FG001|Overall Study|Death|2|||
25281862|NCT01142388|50596776|FG000|Overall Study|Withdrawal by Subject|5|||
25281863|NCT01142388|50596777|FG001|Overall Study|Withdrawal by Subject|3|||
25281864|NCT01142388|50596776|FG000|Overall Study|Alternative therapy|1|||
25281865|NCT01142388|50596777|FG001|Overall Study|Alternative therapy|0|||
25281866|NCT01142388|50596776|FG000|Overall Study|Other complications|0|||
25281867|NCT01142388|50596777|FG001|Overall Study|Other complications|2|||
25281868|NCT01142388|50596776|FG000|Overall Study|Other|1|||
25281869|NCT01142388|50596777|FG001|Overall Study|Other|1|||
25281870|NCT01142388|50596776|FG000|Overall Study|Never started therapy|7|||
25281871|NCT01142388|50596777|FG001|Overall Study|Never started therapy|3|||
25281872|NCT01127646|50596785|FG000|Overall Study|Entry Criteria Not Met|1|||
25281873|NCT01127646|50596786|FG001|Overall Study|Entry Criteria Not Met|0|||
25281874|NCT01127646|50596785|FG000|Overall Study|Protocol Violation|0|||
25281875|NCT01127646|50596786|FG001|Overall Study|Protocol Violation|1|||
25281876|NCT01215188|50596797|FG000|Overall Study|Lost to Follow-up|22|||
25281877|NCT01215188|50596798|FG001|Overall Study|Lost to Follow-up|22|||
25281878|NCT01215188|50596799|FG002|Overall Study|Lost to Follow-up|16|||
25281879|NCT01215188|50596797|FG000|Overall Study|Adverse Event|1|||
25281880|NCT01215188|50596798|FG001|Overall Study|Adverse Event|1|||
25281881|NCT01215188|50596799|FG002|Overall Study|Adverse Event|3|||
25281882|NCT01215188|50596797|FG000|Overall Study|Physician Decision|2|||
25281883|NCT01215188|50596798|FG001|Overall Study|Physician Decision|1|||
25281884|NCT01215188|50596799|FG002|Overall Study|Physician Decision|0|||
25281885|NCT01215188|50596797|FG000|Overall Study|Lack of Efficacy|0|||
25281886|NCT01215188|50596798|FG001|Overall Study|Lack of Efficacy|0|||
25281887|NCT01215188|50596799|FG002|Overall Study|Lack of Efficacy|1|||
25281888|NCT01215188|50596797|FG000|Overall Study|Protocol Violation|1|||
25281889|NCT01215188|50596798|FG001|Overall Study|Protocol Violation|1|||
25281890|NCT01215188|50596799|FG002|Overall Study|Protocol Violation|1|||
25281891|NCT01215188|50596797|FG000|Overall Study|Withdrawal by Subject|32|||
25281892|NCT01215188|50596798|FG001|Overall Study|Withdrawal by Subject|34|||
25281893|NCT01215188|50596799|FG002|Overall Study|Withdrawal by Subject|31|||
25281894|NCT01215032|50596807|FG000|Overall Study|Adverse Event|3|||
25281895|NCT01215032|50596807|FG000|Overall Study|Lack of Efficacy|17|||
25281896|NCT00962247|50596813|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
25281897|NCT00962247|50596813|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
25281898|NCT00918580|50596819|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
25281899|NCT00918580|50596819|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
25281900|NCT00918580|50596819|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
25281901|NCT00918580|50596819|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
25281902|NCT00918580|50596819|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
25281903|NCT00918580|50596819|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
25281904|NCT00918580|50596819|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
25281905|NCT00920686|50596829|FG000|Overall Study|Lost to Follow-up|2|||
25281906|NCT00920686|50596830|FG001|Overall Study|Lost to Follow-up|3|||
25281907|NCT00920686|50596831|FG002|Overall Study|Lost to Follow-up|1|||
25281908|NCT00920686|50596829|FG000|Overall Study|Study drug dosing criteria not met|17|||
25281909|NCT00920686|50596830|FG001|Overall Study|Study drug dosing criteria not met|19|||
25281910|NCT00920686|50596831|FG002|Overall Study|Study drug dosing criteria not met|12|||
25281911|NCT01214720|50596845|FG000|Overall Study|Alive and still on treatment|34|||
25281912|NCT01214720|50596846|FG001|Overall Study|Alive and still on treatment|18|||
25281913|NCT01214720|50596845|FG000|Overall Study|Alive and in follow-up|45|||
25281914|NCT01214720|50596846|FG001|Overall Study|Alive and in follow-up|48|||
25281915|NCT01214720|50596845|FG000|Overall Study|Lost to Follow-up|6|||
25281916|NCT01214720|50596846|FG001|Overall Study|Lost to Follow-up|2|||
25281917|NCT01142232|50596857|FG000|Overall Study|Adverse Event|1|||
25281918|NCT01142232|50596858|FG001|Overall Study|Adverse Event|2|||
25281919|NCT01142232|50596859|FG002|Overall Study|Adverse Event|1|||
25281920|NCT01142232|50596860|FG003|Overall Study|Adverse Event|0|||
25281921|NCT01142232|50596861|FG004|Overall Study|Adverse Event|4|||
25281922|NCT01142232|50596857|FG000|Overall Study|Death|0|||
25281923|NCT01142232|50596858|FG001|Overall Study|Death|0|||
25281924|NCT01142232|50596859|FG002|Overall Study|Death|0|||
25281925|NCT01142232|50596860|FG003|Overall Study|Death|0|||
25281926|NCT01142232|50596861|FG004|Overall Study|Death|1|||
25281927|NCT01142232|50596857|FG000|Overall Study|Disease Progression|2|||
25281928|NCT01142232|50596858|FG001|Overall Study|Disease Progression|0|||
25281929|NCT01142232|50596859|FG002|Overall Study|Disease Progression|1|||
25281930|NCT01142232|50596860|FG003|Overall Study|Disease Progression|2|||
25281931|NCT01142232|50596861|FG004|Overall Study|Disease Progression|12|||
25281932|NCT01142232|50596857|FG000|Overall Study|Withdrawal by Subject|0|||
25281933|NCT01142232|50596858|FG001|Overall Study|Withdrawal by Subject|0|||
25281934|NCT01142232|50596859|FG002|Overall Study|Withdrawal by Subject|0|||
25281935|NCT01142232|50596860|FG003|Overall Study|Withdrawal by Subject|1|||
25281936|NCT01142232|50596861|FG004|Overall Study|Withdrawal by Subject|3|||
25281937|NCT01142232|50596857|FG000|Overall Study|Physician Decision|0|||
25281938|NCT01142232|50596858|FG001|Overall Study|Physician Decision|1|||
25281939|NCT01142232|50596859|FG002|Overall Study|Physician Decision|0|||
25281940|NCT01142232|50596860|FG003|Overall Study|Physician Decision|2|||
25281941|NCT01142232|50596861|FG004|Overall Study|Physician Decision|10|||
25281942|NCT01142232|50596857|FG000|Overall Study|Alternative Therapy|0|||
25281943|NCT01142232|50596858|FG001|Overall Study|Alternative Therapy|1|||
25281944|NCT01142232|50596859|FG002|Overall Study|Alternative Therapy|1|||
25281945|NCT01142232|50596860|FG003|Overall Study|Alternative Therapy|0|||
25281946|NCT01142232|50596861|FG004|Overall Study|Alternative Therapy|1|||
25281947|NCT01142232|50596857|FG000|Overall Study|Off Trt for other complicating disease|0|||
25281948|NCT01142232|50596858|FG001|Overall Study|Off Trt for other complicating disease|0|||
25281949|NCT01142232|50596859|FG002|Overall Study|Off Trt for other complicating disease|0|||
25281950|NCT01142232|50596860|FG003|Overall Study|Off Trt for other complicating disease|0|||
25281951|NCT01142232|50596861|FG004|Overall Study|Off Trt for other complicating disease|1|||
25281952|NCT01142232|50596857|FG000|Overall Study|Noncompliance|0|||
25281953|NCT01142232|50596858|FG001|Overall Study|Noncompliance|0|||
25281954|NCT01142232|50596859|FG002|Overall Study|Noncompliance|0|||
25281955|NCT01142232|50596860|FG003|Overall Study|Noncompliance|0|||
25281956|NCT01142232|50596861|FG004|Overall Study|Noncompliance|2|||
25281957|NCT01140906|50596877|FG000|Overall Study|Adverse Event|7|||
25281958|NCT01140906|50596878|FG001|Overall Study|Adverse Event|10|||
25281959|NCT01140906|50596879|FG002|Overall Study|Adverse Event|17|||
25281960|NCT01140906|50596880|FG003|Overall Study|Adverse Event|7|||
25281961|NCT01140906|50596877|FG000|Overall Study|Lack of Efficacy|6|||
25281962|NCT01140906|50596878|FG001|Overall Study|Lack of Efficacy|8|||
25281963|NCT01140906|50596879|FG002|Overall Study|Lack of Efficacy|2|||
25281964|NCT01140906|50596880|FG003|Overall Study|Lack of Efficacy|1|||
25281965|NCT01140906|50596877|FG000|Overall Study|Non-compliance|0|||
25069833|NCT02341456|50175593|FG000|Overall Study|Physician Decision|1|||
25281966|NCT01140906|50596878|FG001|Overall Study|Non-compliance|1|||
25281967|NCT01140906|50596879|FG002|Overall Study|Non-compliance|0|||
25281968|NCT01140906|50596880|FG003|Overall Study|Non-compliance|1|||
25281969|NCT01140906|50596877|FG000|Overall Study|Protocol Violation|5|||
25281970|NCT01140906|50596878|FG001|Overall Study|Protocol Violation|3|||
25281971|NCT01140906|50596879|FG002|Overall Study|Protocol Violation|2|||
25281972|NCT01140906|50596880|FG003|Overall Study|Protocol Violation|1|||
25281973|NCT01140906|50596877|FG000|Overall Study|Withdrawal of consent|6|||
24995115|NCT03015532|50085970|FG004|Overall Study|Withdrawal by Subject|0|||
25281974|NCT01140906|50596878|FG001|Overall Study|Withdrawal of consent|6|||
25281975|NCT01140906|50596879|FG002|Overall Study|Withdrawal of consent|2|||
25281976|NCT01140906|50596880|FG003|Overall Study|Withdrawal of consent|2|||
25281977|NCT01140906|50596877|FG000|Overall Study|Lost to Follow-up|1|||
25281978|NCT01140906|50596878|FG001|Overall Study|Lost to Follow-up|1|||
25281979|NCT01140906|50596879|FG002|Overall Study|Lost to Follow-up|0|||
25281980|NCT01140906|50596880|FG003|Overall Study|Lost to Follow-up|2|||
25281981|NCT01140906|50596877|FG000|Overall Study|Administrative or other reason|0|||
25281982|NCT01140906|50596878|FG001|Overall Study|Administrative or other reason|5|||
25281983|NCT01140906|50596879|FG002|Overall Study|Administrative or other reason|3|||
25281984|NCT01140906|50596880|FG003|Overall Study|Administrative or other reason|2|||
25281985|NCT00962091|50596897|FG000|Overall Study|Withdrawal by Subject|1|||
25281986|NCT00962091|50596898|FG001|Overall Study|Withdrawal by Subject|2|||
25281987|NCT00962091|50596899|FG002|Overall Study|Withdrawal by Subject|1|||
25281988|NCT00962091|50596900|FG003|Overall Study|Withdrawal by Subject|1|||
25281989|NCT00962091|50596901|FG004|Overall Study|Withdrawal by Subject|0|||
25281990|NCT00962091|50596902|FG005|Overall Study|Withdrawal by Subject|1|||
25281991|NCT00962091|50596903|FG006|Overall Study|Withdrawal by Subject|0|||
25281992|NCT00962091|50596897|FG000|Overall Study|Adverse Event|0|||
25281993|NCT00962091|50596898|FG001|Overall Study|Adverse Event|0|||
25281994|NCT00962091|50596899|FG002|Overall Study|Adverse Event|0|||
25281995|NCT00962091|50596900|FG003|Overall Study|Adverse Event|0|||
25281996|NCT00962091|50596901|FG004|Overall Study|Adverse Event|0|||
25281997|NCT00962091|50596902|FG005|Overall Study|Adverse Event|0|||
25281998|NCT00962091|50596903|FG006|Overall Study|Adverse Event|1|||
25281999|NCT01163916|50596930|FG000|Overall Study|Withdrawal by Subject|2|||
25282000|NCT01163916|50596931|FG001|Overall Study|Withdrawal by Subject|0|||
25282001|NCT01163916|50596932|FG002|Overall Study|Withdrawal by Subject|2|||
25282002|NCT01163916|50596930|FG000|Overall Study|Adverse Event|2|||
25282003|NCT01163916|50596931|FG001|Overall Study|Adverse Event|0|||
25282004|NCT01163916|50596932|FG002|Overall Study|Adverse Event|1|||
25282005|NCT01163916|50596930|FG000|Overall Study|Lack of Efficacy|2|||
25282006|NCT01163916|50596931|FG001|Overall Study|Lack of Efficacy|0|||
25282007|NCT01163916|50596932|FG002|Overall Study|Lack of Efficacy|1|||
25282008|NCT01163916|50596930|FG000|Overall Study|Other|24|||
25282009|NCT01163916|50596931|FG001|Overall Study|Other|4|||
25282010|NCT01163916|50596932|FG002|Overall Study|Other|16|||
25282011|NCT01122576|50596948|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
25282012|NCT01122576|50596949|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
25282013|NCT01122576|50596950|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
25282014|NCT01122576|50596948|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
25282015|NCT01122576|50596949|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
25282016|NCT01122576|50596950|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
25282017|NCT01122576|50596948|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
25282018|NCT01122576|50596949|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
25282019|NCT01122576|50596950|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
25282020|NCT00965523|50596961|FG000|Study 221|Progressive Disease|4|||
25282021|NCT00965523|50596961|FG000|Study 221|Physician Decision|3|||
25282022|NCT00965523|50596961|FG000|Study 224|Progressive Disease|5|||
25282023|NCT00965523|50596961|FG000|Study 224|Physician Decision|1|||
25282024|NCT01122264|50596968|FG000|Overall Study|Adverse Event|6|||
25282025|NCT01122264|50596969|FG001|Overall Study|Adverse Event|5|||
25282026|NCT01122264|50596970|FG002|Overall Study|Adverse Event|7|||
25282027|NCT01122264|50596968|FG000|Overall Study|Death|1|||
25282028|NCT01122264|50596969|FG001|Overall Study|Death|0|||
25282029|NCT01122264|50596970|FG002|Overall Study|Death|0|||
25282030|NCT01122264|50596968|FG000|Overall Study|Lost to Follow-up|5|||
25282031|NCT01122264|50596969|FG001|Overall Study|Lost to Follow-up|9|||
25282032|NCT01122264|50596970|FG002|Overall Study|Lost to Follow-up|13|||
25282033|NCT01122264|50596968|FG000|Overall Study|Entry Criteria Not Met|1|||
25282034|NCT01122264|50596969|FG001|Overall Study|Entry Criteria Not Met|0|||
25282035|NCT01122264|50596970|FG002|Overall Study|Entry Criteria Not Met|0|||
25282036|NCT01122264|50596968|FG000|Overall Study|Protocol Violation|7|||
25282037|NCT01122264|50596969|FG001|Overall Study|Protocol Violation|7|||
25282038|NCT01122264|50596970|FG002|Overall Study|Protocol Violation|9|||
25282039|NCT01122264|50596968|FG000|Overall Study|Withdrawal by Subject|6|||
25282040|NCT01122264|50596969|FG001|Overall Study|Withdrawal by Subject|6|||
25282041|NCT01122264|50596970|FG002|Overall Study|Withdrawal by Subject|16|||
25282042|NCT01122264|50596968|FG000|Overall Study|Physician Decision|3|||
25282043|NCT01122264|50596969|FG001|Overall Study|Physician Decision|1|||
25282044|NCT01122264|50596970|FG002|Overall Study|Physician Decision|1|||
25282045|NCT01122264|50596968|FG000|Overall Study|Lack of Efficacy|3|||
25282046|NCT01122264|50596969|FG001|Overall Study|Lack of Efficacy|1|||
25282047|NCT01122264|50596970|FG002|Overall Study|Lack of Efficacy|1|||
25282048|NCT00920218|50596986|FG000|Overall Study|Serious Adverse Event|2|||
25282049|NCT00920218|50596987|FG001|Overall Study|Serious Adverse Event|0|||
25282050|NCT00920218|50596988|FG002|Overall Study|Serious Adverse Event|2|||
25282051|NCT00920218|50596989|FG003|Overall Study|Serious Adverse Event|1|||
25282052|NCT00920218|50596986|FG000|Overall Study|Withdrawal by Subject|0|||
25282053|NCT00920218|50596987|FG001|Overall Study|Withdrawal by Subject|3|||
25282054|NCT00920218|50596988|FG002|Overall Study|Withdrawal by Subject|2|||
25282055|NCT00920218|50596989|FG003|Overall Study|Withdrawal by Subject|0|||
25282056|NCT00920218|50596986|FG000|Overall Study|Migrated/moved from study area|0|||
25282057|NCT00920218|50596987|FG001|Overall Study|Migrated/moved from study area|0|||
25282058|NCT00920218|50596988|FG002|Overall Study|Migrated/moved from study area|1|||
25282059|NCT00920218|50596989|FG003|Overall Study|Migrated/moved from study area|0|||
25282060|NCT00920218|50596986|FG000|Overall Study|Lost to Follow-up|0|||
25282061|NCT00920218|50596987|FG001|Overall Study|Lost to Follow-up|1|||
25282062|NCT00920218|50596988|FG002|Overall Study|Lost to Follow-up|0|||
25282063|NCT00920218|50596989|FG003|Overall Study|Lost to Follow-up|3|||
25282064|NCT00920218|50596986|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
25282065|NCT00920218|50596987|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
25282066|NCT00920218|50596988|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
25282067|NCT00920218|50596989|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
25282068|NCT00920218|50596986|FG000|Overall Study|Other|0|||
25282069|NCT00920218|50596987|FG001|Overall Study|Other|0|||
25282070|NCT00920218|50596988|FG002|Overall Study|Other|1|||
25282071|NCT00920218|50596989|FG003|Overall Study|Other|0|||
25282072|NCT01121562|50597003|FG000|Overall Study|Objective progression or relapse|8|||
25282073|NCT01121562|50597003|FG000|Overall Study|Withdrawal by Subject|1|||
25282074|NCT01121562|50597003|FG000|Overall Study|Adverse Event|1|||
25282075|NCT01121562|50597003|FG000|Overall Study|Sponsor Decision|1|||
25282076|NCT01121562|50597003|FG000|Overall Study|Met study discontinuation criteria|1|||
25282077|NCT01121484|50597009|FG000|Overall Study|Adverse Event|12|||
25282078|NCT01121484|50597010|FG001|Overall Study|Adverse Event|5|||
25282079|NCT01121484|50597009|FG000|Overall Study|Lack of Efficacy|3|||
25282080|NCT01121484|50597010|FG001|Overall Study|Lack of Efficacy|11|||
25282081|NCT01121484|50597009|FG000|Overall Study|Lost to Follow-up|5|||
25282082|NCT01121484|50597010|FG001|Overall Study|Lost to Follow-up|9|||
25282083|NCT01121484|50597009|FG000|Overall Study|Physician Decision|0|||
25282084|NCT01121484|50597010|FG001|Overall Study|Physician Decision|3|||
25282085|NCT01121484|50597009|FG000|Overall Study|Protocol Violation|1|||
25282086|NCT01121484|50597010|FG001|Overall Study|Protocol Violation|0|||
24969420|NCT00131664|50058816|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
24969421|NCT00131664|50058817|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
24969422|NCT00131664|50058818|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
25282087|NCT01121484|50597009|FG000|Overall Study|Withdrawal by Subject|8|||
25282088|NCT01121484|50597010|FG001|Overall Study|Withdrawal by Subject|7|||
25282089|NCT01121484|50597009|FG000|Overall Study|Discontinuation of study by sponsor|0|||
25282090|NCT01121484|50597010|FG001|Overall Study|Discontinuation of study by sponsor|1|||
25282091|NCT01121484|50597009|FG000|Overall Study|Other|3|||
25282092|NCT01121484|50597010|FG001|Overall Study|Other|3|||
25282093|NCT01121484|50597009|FG000|Overall Study|Randomized, not treated|1|||
25282094|NCT01121484|50597010|FG001|Overall Study|Randomized, not treated|4|||
25282095|NCT01169675|50597021|FG000|Overall Study|Progressive disease|13|||
25282096|NCT01169675|50597022|FG001|Overall Study|Progressive disease|2|||
25282097|NCT01169675|50597023|FG002|Overall Study|Progressive disease|5|||
25282098|NCT01169675|50597024|FG003|Overall Study|Progressive disease|15|||
25282099|NCT01169675|50597025|FG004|Overall Study|Progressive disease|1|||
25282100|NCT01169675|50597021|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
25282101|NCT01169675|50597022|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
25282102|NCT01169675|50597023|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
25282103|NCT01169675|50597024|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
25282104|NCT01169675|50597025|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
25282105|NCT01169675|50597021|FG000|Overall Study|Adverse Event|5|||
25282106|NCT01169675|50597022|FG001|Overall Study|Adverse Event|1|||
24969423|NCT00131664|50058819|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
24969424|NCT00131664|50058820|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
24969425|NCT00131664|50058815|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
25282107|NCT01169675|50597023|FG002|Overall Study|Adverse Event|2|||
25282108|NCT01169675|50597024|FG003|Overall Study|Adverse Event|0|||
25282109|NCT01169675|50597025|FG004|Overall Study|Adverse Event|0|||
25282110|NCT01169675|50597021|FG000|Overall Study|Withdrawal by Subject|1|||
25282111|NCT01169675|50597022|FG001|Overall Study|Withdrawal by Subject|0|||
25282112|NCT01169675|50597023|FG002|Overall Study|Withdrawal by Subject|0|||
25282113|NCT01169675|50597024|FG003|Overall Study|Withdrawal by Subject|1|||
25282114|NCT01169675|50597025|FG004|Overall Study|Withdrawal by Subject|2|||
25282115|NCT01169675|50597021|FG000|Overall Study|Other Reason Not Defined Above|0|||
25282116|NCT01169675|50597022|FG001|Overall Study|Other Reason Not Defined Above|0|||
25282117|NCT01169675|50597023|FG002|Overall Study|Other Reason Not Defined Above|0|||
25282118|NCT01169675|50597024|FG003|Overall Study|Other Reason Not Defined Above|1|||
25282119|NCT01169675|50597025|FG004|Overall Study|Other Reason Not Defined Above|1|||
25191202|NCT00984659|50349005|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
25191203|NCT00984659|50349002|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
25191204|NCT00984659|50349003|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
25191205|NCT00984659|50349004|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
25191206|NCT00984659|50349005|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
25191207|NCT00984659|50349002|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
25191208|NCT00984659|50349003|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
25191209|NCT00984659|50349004|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
25191210|NCT00984659|50349005|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
25191211|NCT00982319|50349014|FG000|Overall Study|Surgery date change|1|||
25191212|NCT00982319|50349015|FG001|Overall Study|Surgery date change|0|||
25191213|NCT00982319|50349014|FG000|Overall Study|Preop values out of acceptable range|1|||
25191214|NCT00982319|50349015|FG001|Overall Study|Preop values out of acceptable range|1|||
25191215|NCT00982319|50349014|FG000|Overall Study|Pregnancy|0|||
25191216|NCT00982319|50349015|FG001|Overall Study|Pregnancy|1|||
25191217|NCT02612064|50349027|FG000|Overall Study|Withdrawal by Subject|1|||
25191218|NCT02612064|50349028|FG001|Overall Study|Withdrawal by Subject|1|||
25191219|NCT02612064|50349027|FG000|Overall Study|Other|0|||
25191220|NCT02612064|50349028|FG001|Overall Study|Other|2|||
25191221|NCT02614560|50349047|FG000|Overall Study|Death|6|||
25191222|NCT02614560|50349048|FG001|Overall Study|Death|2|||
25191223|NCT01669122|50349076|FG000|Period I|Lost to Follow-up|1|||
25191224|NCT01669122|50349076|FG000|Washout Period II|Protocol Violation|2|||
25191225|NCT02611752|50349109|FG000|Overall Study|Adverse Event|0|||
25191226|NCT02611752|50349110|FG001|Overall Study|Adverse Event|1|||
25191227|NCT02611362|50349131|FG000|Overall Study|Withdrawal by Subject|7|||
25191228|NCT02611362|50349132|FG001|Overall Study|Withdrawal by Subject|2|||
25191229|NCT02611362|50349131|FG000|Overall Study|Lost to Follow-up|2|||
25191230|NCT02611362|50349132|FG001|Overall Study|Lost to Follow-up|4|||
25191231|NCT01594476|50349152|FG000|Overall Study|Protocol Violation|1|||
25191232|NCT01594476|50349153|FG001|Overall Study|Protocol Violation|3|||
25191233|NCT01668966|50349167|FG000|Overall Study|Withdrawal by Subject|1|||
25191234|NCT01668966|50349167|FG000|Overall Study|Death|1|||
25191235|NCT01668966|50349167|FG000|Overall Study|Not treated|2|||
25191236|NCT02609724|50349174|FG000|Overall Study|Death|2|||
25191237|NCT02609724|50349175|FG001|Overall Study|Death|0|||
25191238|NCT02609724|50349176|FG002|Overall Study|Death|1|||
25191239|NCT02609724|50349174|FG000|Overall Study|Withdrawal by Subject|1|||
25191240|NCT02609724|50349175|FG001|Overall Study|Withdrawal by Subject|2|||
25191241|NCT02609724|50349176|FG002|Overall Study|Withdrawal by Subject|3|||
25191242|NCT02609724|50349174|FG000|Overall Study|Illness|2|||
25191243|NCT02609724|50349175|FG001|Overall Study|Illness|1|||
25191244|NCT02609724|50349176|FG002|Overall Study|Illness|0|||
25191245|NCT02610816|50349209|FG000|Phase 1|Withdrawal by Subject|2|||
25191246|NCT02610816|50349210|FG001|Phase 1|Withdrawal by Subject|6|||
25191247|NCT02610816|50349211|FG002|Phase 1|Withdrawal by Subject|0|||
25191248|NCT02610816|50349212|FG003|Phase 1|Withdrawal by Subject|0|||
25191249|NCT02610816|50349209|FG000|Phase 1|Lost to Follow-up|2|||
25191250|NCT02610816|50349210|FG001|Phase 1|Lost to Follow-up|1|||
25191251|NCT02610816|50349211|FG002|Phase 1|Lost to Follow-up|0|||
25191252|NCT02610816|50349212|FG003|Phase 1|Lost to Follow-up|0|||
25191253|NCT02610816|50349209|FG000|Phase 1|Physician Decision|0|||
25191254|NCT02610816|50349210|FG001|Phase 1|Physician Decision|1|||
25191255|NCT02610816|50349211|FG002|Phase 1|Physician Decision|0|||
25191256|NCT02610816|50349212|FG003|Phase 1|Physician Decision|0|||
25191257|NCT02610816|50349209|FG000|Phase 2|Withdrawal by Subject|0|||
25191258|NCT02610816|50349210|FG001|Phase 2|Withdrawal by Subject|0|||
25191259|NCT02610816|50349211|FG002|Phase 2|Withdrawal by Subject|9|||
25191260|NCT02610816|50349212|FG003|Phase 2|Withdrawal by Subject|3|||
25191261|NCT02610816|50349209|FG000|Phase 2|Lost to Follow-up|0|||
25191262|NCT02610816|50349210|FG001|Phase 2|Lost to Follow-up|0|||
25191263|NCT02610816|50349211|FG002|Phase 2|Lost to Follow-up|2|||
25191264|NCT02610816|50349212|FG003|Phase 2|Lost to Follow-up|0|||
25191265|NCT02610816|50349209|FG000|Phase 2|Physician Decision|0|||
25191266|NCT02610816|50349210|FG001|Phase 2|Physician Decision|0|||
25191267|NCT02610816|50349211|FG002|Phase 2|Physician Decision|0|||
25191268|NCT02610816|50349212|FG003|Phase 2|Physician Decision|2|||
25191269|NCT02610816|50349209|FG000|Phase 2|Pregnancy|0|||
25191270|NCT02610816|50349210|FG001|Phase 2|Pregnancy|0|||
25191271|NCT02610816|50349211|FG002|Phase 2|Pregnancy|0|||
25282120|NCT00924664|50597039|FG000|Overall Study|Adverse Event|23|||
25191272|NCT02610816|50349212|FG003|Phase 2|Pregnancy|1|||
25191273|NCT02612610|50349308|FG000|Overall Study|Withdrawal by Subject|1|||
25191274|NCT02612610|50349309|FG001|Overall Study|Withdrawal by Subject|1|||
25191275|NCT02612610|50349310|FG002|Overall Study|Withdrawal by Subject|0|||
25191276|NCT02612610|50349311|FG003|Overall Study|Withdrawal by Subject|2|||
25191277|NCT02612610|50349308|FG000|Overall Study|Adverse Event|2|||
25191278|NCT02612610|50349309|FG001|Overall Study|Adverse Event|2|||
25282121|NCT00924664|50597040|FG001|Overall Study|Adverse Event|39|||
25282122|NCT00924664|50597039|FG000|Overall Study|Lack of Efficacy|10|||
25282123|NCT00924664|50597040|FG001|Overall Study|Lack of Efficacy|15|||
25282124|NCT00924664|50597039|FG000|Overall Study|Lost to Follow-up|10|||
25282125|NCT00924664|50597040|FG001|Overall Study|Lost to Follow-up|12|||
25282126|NCT00924664|50597039|FG000|Overall Study|Withdrawal by Subject|47|||
25282127|NCT00924664|50597040|FG001|Overall Study|Withdrawal by Subject|71|||
25282128|NCT00924664|50597039|FG000|Overall Study|Protocol Violation|2|||
25282129|NCT00924664|50597040|FG001|Overall Study|Protocol Violation|5|||
25282130|NCT00924664|50597039|FG000|Overall Study|Pregnancy|1|||
25282131|NCT00924664|50597040|FG001|Overall Study|Pregnancy|1|||
25282132|NCT00924664|50597039|FG000|Overall Study|Death|0|||
25282133|NCT00924664|50597040|FG001|Overall Study|Death|2|||
25282134|NCT00924664|50597039|FG000|Overall Study|Study terminated by sponsor|199|||
25282135|NCT00924664|50597040|FG001|Overall Study|Study terminated by sponsor|330|||
25282136|NCT00924664|50597039|FG000|Overall Study|Other|29|||
25282137|NCT00924664|50597040|FG001|Overall Study|Other|52|||
25282138|NCT00924664|50597039|FG000|Overall Study|Randomized but not Treated|1|||
25282139|NCT00924664|50597040|FG001|Overall Study|Randomized but not Treated|0|||
25282140|NCT00600067|50597048|FG000|Overall Study|Adverse Event|0|||
25282141|NCT00600067|50597049|FG001|Overall Study|Adverse Event|1|||
25282142|NCT00600067|50597048|FG000|Overall Study|Lost to Follow-up|2|||
25282143|NCT00600067|50597049|FG001|Overall Study|Lost to Follow-up|3|||
25282144|NCT00600067|50597048|FG000|Overall Study|protocol non-compliance|0|||
25282145|NCT00600067|50597049|FG001|Overall Study|protocol non-compliance|3|||
25282146|NCT00600067|50597048|FG000|Overall Study|Lack of Efficacy|1|||
25282147|NCT00600067|50597049|FG001|Overall Study|Lack of Efficacy|0|||
25282148|NCT00970593|50597063|FG000|Overall Study|Adverse Event|1|||
25282149|NCT00970593|50597064|FG001|Overall Study|Adverse Event|1|||
25282150|NCT00970593|50597065|FG002|Overall Study|Adverse Event|0|||
25282151|NCT00970593|50597066|FG003|Overall Study|Adverse Event|0|||
25282152|NCT00970593|50597067|FG004|Overall Study|Adverse Event|0|||
25282153|NCT00970593|50597068|FG005|Overall Study|Adverse Event|0|||
25282154|NCT00970593|50597069|FG006|Overall Study|Adverse Event|0|||
25282155|NCT00970593|50597063|FG000|Overall Study|Discontinuation of study by sponsor|0|||
25282156|NCT00970593|50597064|FG001|Overall Study|Discontinuation of study by sponsor|0|||
25282157|NCT00970593|50597065|FG002|Overall Study|Discontinuation of study by sponsor|5|||
25282158|NCT00970593|50597066|FG003|Overall Study|Discontinuation of study by sponsor|0|||
25282159|NCT00970593|50597067|FG004|Overall Study|Discontinuation of study by sponsor|0|||
25282160|NCT00970593|50597068|FG005|Overall Study|Discontinuation of study by sponsor|0|||
25282161|NCT00970593|50597069|FG006|Overall Study|Discontinuation of study by sponsor|2|||
25282162|NCT00970593|50597063|FG000|Overall Study|Withdrawal by Subject|0|||
25282163|NCT00970593|50597064|FG001|Overall Study|Withdrawal by Subject|0|||
25282164|NCT00970593|50597065|FG002|Overall Study|Withdrawal by Subject|1|||
25282165|NCT00970593|50597066|FG003|Overall Study|Withdrawal by Subject|0|||
25282166|NCT00970593|50597067|FG004|Overall Study|Withdrawal by Subject|0|||
25282167|NCT00970593|50597068|FG005|Overall Study|Withdrawal by Subject|0|||
25282168|NCT00970593|50597069|FG006|Overall Study|Withdrawal by Subject|0|||
25282169|NCT00962013|50597089|FG000|Overall Study|Did not have surgery|1|||
25282170|NCT00962013|50597089|FG000|Overall Study|Death|8|||
25282171|NCT00962013|50597089|FG000|Overall Study|Lost to Follow-up|12|||
25282172|NCT00962013|50597089|FG000|Overall Study|Unable/Unwilling to return|6|||
25282173|NCT00962013|50597089|FG000|Overall Study|Withdrawal by Subject|8|||
25282174|NCT00962013|50597089|FG000|Overall Study|Removal of study device|3|||
25282175|NCT00962013|50597089|FG000|Overall Study|Site Termination|24|||
25282176|NCT00962013|50597089|FG000|Overall Study|No 5 year evaluation|6|||
25282177|NCT00970359|50597093|FG000|Overall Study|Not Treated|4|||
25282178|NCT01121406|50597099|FG000|Overall Study|Progressive disease RECIST|44|||
25282179|NCT01121406|50597100|FG001|Overall Study|Progressive disease RECIST|28|||
25282180|NCT01121406|50597099|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
25282181|NCT01121406|50597100|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
25282182|NCT01121406|50597099|FG000|Overall Study|Other AE|3|||
25282183|NCT01121406|50597100|FG001|Overall Study|Other AE|10|||
25282184|NCT01121406|50597099|FG000|Overall Study|Non-compliant with protocol|0|||
25282185|NCT01121406|50597100|FG001|Overall Study|Non-compliant with protocol|2|||
25282186|NCT01121406|50597099|FG000|Overall Study|Lost to Follow-up|0|||
25282187|NCT01121406|50597100|FG001|Overall Study|Lost to Follow-up|1|||
25282188|NCT01121406|50597099|FG000|Overall Study|Refused continuation of study med.|1|||
25282189|NCT01121406|50597100|FG001|Overall Study|Refused continuation of study med.|2|||
25282190|NCT01121406|50597099|FG000|Overall Study|Reason other than specified above|2|||
25282191|NCT01121406|50597100|FG001|Overall Study|Reason other than specified above|6|||
25282192|NCT01121406|50597099|FG000|Overall Study|Not treated|1|||
25282193|NCT01121406|50597100|FG001|Overall Study|Not treated|0|||
25282194|NCT00960687|50597109|FG000|Washout Period of 7 Days|Adverse Event|3|||
25282195|NCT00960687|50597110|FG001|Washout Period of 7 Days|Adverse Event|2|||
25282196|NCT00960687|50597109|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
25282197|NCT00960687|50597110|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
25282198|NCT00920140|50597121|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
25282199|NCT00920140|50597122|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
25282200|NCT00920140|50597123|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
25282201|NCT00920140|50597124|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
25282202|NCT00920140|50597125|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
25282203|NCT00920140|50597121|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
25282204|NCT00920140|50597122|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
25282205|NCT00920140|50597123|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
25282206|NCT00920140|50597124|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
25282207|NCT00920140|50597125|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
25282208|NCT00920140|50597121|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
25282209|NCT00920140|50597122|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
25282210|NCT00920140|50597123|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
25282211|NCT00920140|50597124|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
25282212|NCT00920140|50597125|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
25282213|NCT00920140|50597121|FG000|Phase 2|Adverse Event|0|||
25282214|NCT00920140|50597122|FG001|Phase 2|Adverse Event|0|||
25282215|NCT00920140|50597123|FG002|Phase 2|Adverse Event|14|||
25282216|NCT00920140|50597124|FG003|Phase 2|Adverse Event|2|||
25282217|NCT00920140|50597125|FG004|Phase 2|Adverse Event|3|||
25282218|NCT00920140|50597121|FG000|Phase 2|Lack of Efficacy|0|||
25282219|NCT00920140|50597122|FG001|Phase 2|Lack of Efficacy|0|||
25282220|NCT00920140|50597123|FG002|Phase 2|Lack of Efficacy|29|||
25282221|NCT00920140|50597124|FG003|Phase 2|Lack of Efficacy|14|||
25282222|NCT00920140|50597125|FG004|Phase 2|Lack of Efficacy|5|||
25282223|NCT00920140|50597121|FG000|Phase 2|Lost to Follow-up|0|||
25282224|NCT00920140|50597122|FG001|Phase 2|Lost to Follow-up|0|||
25282225|NCT00920140|50597123|FG002|Phase 2|Lost to Follow-up|0|||
25282226|NCT00920140|50597124|FG003|Phase 2|Lost to Follow-up|1|||
25282227|NCT00920140|50597125|FG004|Phase 2|Lost to Follow-up|0|||
25282228|NCT00920140|50597121|FG000|Phase 2|Physician Decision|0|||
25282229|NCT00920140|50597122|FG001|Phase 2|Physician Decision|0|||
25282230|NCT00920140|50597123|FG002|Phase 2|Physician Decision|3|||
25282231|NCT00920140|50597124|FG003|Phase 2|Physician Decision|3|||
25282232|NCT00920140|50597125|FG004|Phase 2|Physician Decision|2|||
25282233|NCT00920140|50597121|FG000|Phase 2|Withdrawal by Subject|0|||
25282234|NCT00920140|50597122|FG001|Phase 2|Withdrawal by Subject|0|||
25282235|NCT00920140|50597123|FG002|Phase 2|Withdrawal by Subject|4|||
25282236|NCT00920140|50597124|FG003|Phase 2|Withdrawal by Subject|2|||
25282237|NCT00920140|50597125|FG004|Phase 2|Withdrawal by Subject|1|||
25282238|NCT01120782|50597138|FG000|Overall Study|Test article shipping error|11|||
25282239|NCT01120626|50597144|FG000|Overall Study|Withdrawal by Subject|1|||
25282240|NCT01120626|50597145|FG001|Overall Study|Withdrawal by Subject|0|||
25282241|NCT00924508|50597151|FG000|Overall Study|Withdrawal by Subject|3|||
25282242|NCT01139658|50597160|FG000|Overall Study|Adverse Event|10|||
25282243|NCT01139658|50597161|FG001|Overall Study|Adverse Event|27|||
25282244|NCT01139658|50597160|FG000|Overall Study|Lack of Efficacy|15|||
25169080|NCT01850615|50300007|FG000|Overall Study|Withdrawal by Subject|3|||
25169081|NCT01850615|50300008|FG001|Overall Study|Withdrawal by Subject|1|||
25169082|NCT01850615|50300007|FG000|Overall Study|Lost to Follow-up|0|||
25169083|NCT01850615|50300008|FG001|Overall Study|Lost to Follow-up|1|||
25169084|NCT01850615|50300007|FG000|Overall Study|Unclassified|0|||
25169085|NCT01850615|50300008|FG001|Overall Study|Unclassified|1|||
25169086|NCT01868477|50300104|FG000|Overall Study|Adverse Event|2|||
25191279|NCT02612610|50349310|FG002|Overall Study|Adverse Event|3|||
25191280|NCT02612610|50349311|FG003|Overall Study|Adverse Event|10|||
25191281|NCT02612610|50349308|FG000|Overall Study|Lost to Follow-up|0|||
25191282|NCT02612610|50349309|FG001|Overall Study|Lost to Follow-up|1|||
25191283|NCT02612610|50349310|FG002|Overall Study|Lost to Follow-up|0|||
25191284|NCT02612610|50349311|FG003|Overall Study|Lost to Follow-up|0|||
25169087|NCT01868477|50300105|FG001|Overall Study|Adverse Event|4|||
25191285|NCT02612610|50349308|FG000|Overall Study|Protocol Violation|0|||
25191286|NCT02612610|50349309|FG001|Overall Study|Protocol Violation|1|||
25282245|NCT01139658|50597161|FG001|Overall Study|Lack of Efficacy|7|||
25282246|NCT01139658|50597160|FG000|Overall Study|Withdrawal by Subject|2|||
25282247|NCT01139658|50597161|FG001|Overall Study|Withdrawal by Subject|4|||
25282248|NCT01139658|50597160|FG000|Overall Study|No documentation of treatment|1|||
25282249|NCT01139658|50597161|FG001|Overall Study|No documentation of treatment|0|||
25282250|NCT01139658|50597160|FG000|Overall Study|Other|28|||
25282251|NCT01139658|50597161|FG001|Overall Study|Other|75|||
25282252|NCT01139580|50597169|FG000|Overall Study|Adverse Event|5|||
25282253|NCT01139580|50597170|FG001|Overall Study|Adverse Event|4|||
25282254|NCT01139580|50597169|FG000|Overall Study|Lost to Follow-up|9|||
25191287|NCT02612610|50349310|FG002|Overall Study|Protocol Violation|1|||
25282255|NCT01139580|50597170|FG001|Overall Study|Lost to Follow-up|1|||
25282256|NCT01139580|50597169|FG000|Overall Study|Lack of Efficacy|0|||
25282257|NCT01139580|50597170|FG001|Overall Study|Lack of Efficacy|2|||
25282258|NCT01139580|50597169|FG000|Overall Study|Withdrawal by Subject|6|||
25282259|NCT01139580|50597170|FG001|Overall Study|Withdrawal by Subject|9|||
25282260|NCT01139580|50597169|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
25282261|NCT01139580|50597170|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
25282262|NCT01139580|50597169|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
25282263|NCT01139580|50597170|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
25282264|NCT01139580|50597169|FG000|Overall Study|Misrandomized|1|||
25282265|NCT01139580|50597170|FG001|Overall Study|Misrandomized|0|||
25282266|NCT01139580|50597169|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
25282267|NCT01139580|50597170|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
25282268|NCT01139580|50597169|FG000|Overall Study|Participant Randomization in Error|0|||
25282269|NCT01139580|50597170|FG001|Overall Study|Participant Randomization in Error|1|||
25282270|NCT00917644|50597176|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
25282271|NCT00917644|50597177|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
25282272|NCT00917644|50597176|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
25282273|NCT00917644|50597177|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
25282274|NCT00917644|50597176|FG000|Period 2: Second Intervention|family emergency|1|||
25282275|NCT00917644|50597177|FG001|Period 2: Second Intervention|family emergency|0|||
25282276|NCT01137786|50597185|FG000|Overall Study|Lost to Follow-up|0|||
25282277|NCT01137786|50597186|FG001|Overall Study|Lost to Follow-up|2|||
25282278|NCT01137786|50597185|FG000|Overall Study|Withdrawal by Subject|1|||
25282279|NCT01137786|50597186|FG001|Overall Study|Withdrawal by Subject|1|||
25282280|NCT00599755|50597194|FG000|Overall Study|Adverse Event|11|||
25282281|NCT00599755|50597194|FG000|Overall Study|Withdrawal by Subject|2|||
25282282|NCT00599755|50597194|FG000|Overall Study|Progression of Disease|3|||
25282283|NCT00599755|50597194|FG000|Overall Study|Other Reason|2|||
25282284|NCT00599755|50597194|FG000|Overall Study|No data available|1|||
25282285|NCT00600613|50597198|FG000|Overall Study|Protocol Deviation|1|||
25282286|NCT01125930|50597204|FG000|Overall Study|Adverse Event|0|||
25282287|NCT01125930|50597205|FG001|Overall Study|Adverse Event|1|||
25282288|NCT01125930|50597204|FG000|Overall Study|Withdrawal by Subject|1|||
25282289|NCT01125930|50597205|FG001|Overall Study|Withdrawal by Subject|6|||
25282290|NCT01125930|50597204|FG000|Overall Study|Protocol Violation|0|||
24969426|NCT00131664|50058816|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
24969427|NCT00131664|50058817|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
24969428|NCT00131664|50058818|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
24969429|NCT00131664|50058819|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
24969430|NCT00131664|50058820|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
24969431|NCT00131508|50058833|FG000|Overall Study|Disease progression|0|||
24969432|NCT00131508|50058834|FG001|Overall Study|Disease progression|2|||
24969433|NCT00131508|50058833|FG000|Overall Study|Non-Compliance|2|||
24969434|NCT00131508|50058834|FG001|Overall Study|Non-Compliance|4|||
24969435|NCT00131508|50058833|FG000|Overall Study|Withdrawal by Subject|1|||
24969436|NCT00131508|50058834|FG001|Overall Study|Withdrawal by Subject|2|||
24969437|NCT05050318|50058843|FG000|Overall Study|Protocol Deviation|1|||
24969438|NCT05050318|50058844|FG001|Overall Study|Protocol Deviation|0|||
24969439|NCT05050318|50058845|FG002|Overall Study|Protocol Deviation|0|||
24969440|NCT03699124|50058856|FG000|Overall Study|Adverse Event|6|||
24969441|NCT03699124|50058857|FG001|Overall Study|Adverse Event|5|||
24969442|NCT03699124|50058858|FG002|Overall Study|Adverse Event|2|||
24969443|NCT03699124|50058856|FG000|Overall Study|Death|0|||
24969444|NCT03699124|50058857|FG001|Overall Study|Death|2|||
24969445|NCT03699124|50058858|FG002|Overall Study|Death|0|||
24969446|NCT03699124|50058856|FG000|Overall Study|Lost to Follow-up|20|||
24969447|NCT03699124|50058857|FG001|Overall Study|Lost to Follow-up|16|||
24969448|NCT03699124|50058858|FG002|Overall Study|Lost to Follow-up|15|||
25191288|NCT02612610|50349311|FG003|Overall Study|Protocol Violation|0|||
25191289|NCT02612610|50349308|FG000|Overall Study|Lack of Efficacy|1|||
25191290|NCT02612610|50349309|FG001|Overall Study|Lack of Efficacy|2|||
25191291|NCT02612610|50349310|FG002|Overall Study|Lack of Efficacy|0|||
25191292|NCT02612610|50349311|FG003|Overall Study|Lack of Efficacy|1|||
24969449|NCT03699124|50058856|FG000|Overall Study|Protocol Violation|1|||
24969450|NCT03699124|50058857|FG001|Overall Study|Protocol Violation|0|||
24969451|NCT03699124|50058858|FG002|Overall Study|Protocol Violation|0|||
25191293|NCT02612610|50349308|FG000|Overall Study|Physician Decision|0|||
25191294|NCT02612610|50349309|FG001|Overall Study|Physician Decision|1|||
25282291|NCT01125930|50597205|FG001|Overall Study|Protocol Violation|1|||
25282292|NCT01125930|50597204|FG000|Overall Study|Lost to Follow-up|0|||
25282293|NCT01125930|50597205|FG001|Overall Study|Lost to Follow-up|2|||
24969452|NCT03699124|50058856|FG000|Overall Study|Withdrawal by Subject|13|||
24969453|NCT03699124|50058857|FG001|Overall Study|Withdrawal by Subject|14|||
24969454|NCT03699124|50058858|FG002|Overall Study|Withdrawal by Subject|13|||
24969455|NCT03699124|50058856|FG000|Overall Study|Other reasons|5|||
24969456|NCT03699124|50058857|FG001|Overall Study|Other reasons|3|||
24969457|NCT03699124|50058858|FG002|Overall Study|Other reasons|10|||
24969458|NCT05002972|50058866|FG000|Overall Study|Withdrawal by Subject|2|||
24969459|NCT04651114|50058870|FG000|Overall Study|Withdrawal by Subject|8|||
24969460|NCT04980040|50058874|FG000|Overall Study|Violated the Inclusion Criteria|260|||
24969461|NCT04980040|50058874|FG000|Overall Study|Violated the Administration & Dosage|225|||
24969462|NCT04980040|50058874|FG000|Overall Study|Lost to Safety-Follow-up|4|||
24969463|NCT04980040|50058874|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
24969464|NCT00131352|50058880|FG000|Initial Treatment Period|Adverse Event|1|||
24969465|NCT00131352|50058881|FG001|Initial Treatment Period|Adverse Event|3|||
24969466|NCT00131352|50058880|FG000|Initial Treatment Period|Non-compliant|1|||
24969467|NCT00131352|50058881|FG001|Initial Treatment Period|Non-compliant|2|||
24969468|NCT00131352|50058880|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
24969469|NCT00131352|50058881|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
24969470|NCT00131352|50058880|FG000|Initial Treatment Period|Lack of Efficacy|6|||
24969471|NCT00131352|50058881|FG001|Initial Treatment Period|Lack of Efficacy|4|||
24969472|NCT00131352|50058880|FG000|Initial Treatment Period|Other|0|||
24969473|NCT00131352|50058881|FG001|Initial Treatment Period|Other|2|||
24969474|NCT00131352|50058880|FG000|Repeat Treatment Period|Adverse Event|1|||
25169088|NCT01868477|50300104|FG000|Overall Study|Disease progression|1|||
25169089|NCT01868477|50300105|FG001|Overall Study|Disease progression|1|||
25169090|NCT01868477|50300104|FG000|Overall Study|Withdrawal by Subject|1|||
25282294|NCT00918346|50597236|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
25282295|NCT00918346|50597237|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
25282296|NCT00913978|50597248|FG000|Overall Study|Surgeon choice|1|||
25282297|NCT00913978|50597249|FG001|Overall Study|Surgeon choice|3|||
25282298|NCT01137474|50597259|FG000|Overall Study|Adverse Event|3|||
25282299|NCT01137474|50597260|FG001|Overall Study|Adverse Event|5|||
25282300|NCT01137474|50597261|FG002|Overall Study|Adverse Event|1|||
25282301|NCT01137474|50597262|FG003|Overall Study|Adverse Event|3|||
25282302|NCT01137474|50597259|FG000|Overall Study|Withdrawal by Subject|7|||
25282303|NCT01137474|50597260|FG001|Overall Study|Withdrawal by Subject|2|||
25282304|NCT01137474|50597261|FG002|Overall Study|Withdrawal by Subject|6|||
25282305|NCT01137474|50597262|FG003|Overall Study|Withdrawal by Subject|9|||
25282306|NCT01137474|50597259|FG000|Overall Study|No longer met study criteria|6|||
25282307|NCT01137474|50597260|FG001|Overall Study|No longer met study criteria|1|||
25282308|NCT01137474|50597261|FG002|Overall Study|No longer met study criteria|0|||
25282309|NCT01137474|50597262|FG003|Overall Study|No longer met study criteria|5|||
25282310|NCT01137474|50597259|FG000|Overall Study|Lost to Follow-up|5|||
25282311|NCT01137474|50597260|FG001|Overall Study|Lost to Follow-up|1|||
25282312|NCT01137474|50597261|FG002|Overall Study|Lost to Follow-up|0|||
25282313|NCT01137474|50597262|FG003|Overall Study|Lost to Follow-up|2|||
25282314|NCT01137474|50597259|FG000|Overall Study|Lack of Efficacy|0|||
25282315|NCT01137474|50597260|FG001|Overall Study|Lack of Efficacy|0|||
25282316|NCT01137474|50597261|FG002|Overall Study|Lack of Efficacy|0|||
25282317|NCT01137474|50597262|FG003|Overall Study|Lack of Efficacy|2|||
25282318|NCT01137474|50597259|FG000|Overall Study|Other|3|||
25282319|NCT01137474|50597260|FG001|Overall Study|Other|1|||
25282320|NCT01137474|50597261|FG002|Overall Study|Other|0|||
25282321|NCT01137474|50597262|FG003|Overall Study|Other|0|||
25282322|NCT01137474|50597259|FG000|Overall Study|Pregnancy|0|||
25282323|NCT01137474|50597260|FG001|Overall Study|Pregnancy|1|||
25282324|NCT01137474|50597261|FG002|Overall Study|Pregnancy|0|||
25282325|NCT01137474|50597262|FG003|Overall Study|Pregnancy|0|||
25282326|NCT01137474|50597259|FG000|Overall Study|Administrative reason by sponsor|0|||
25282327|NCT01137474|50597260|FG001|Overall Study|Administrative reason by sponsor|1|||
25282328|NCT01137474|50597261|FG002|Overall Study|Administrative reason by sponsor|0|||
24969475|NCT00131352|50058881|FG001|Repeat Treatment Period|Adverse Event|0|||
24969476|NCT00131352|50058880|FG000|Repeat Treatment Period|Other|1|||
25169091|NCT01868477|50300105|FG001|Overall Study|Withdrawal by Subject|0|||
25169092|NCT01849289|50300120|FG000|Overall Study|Adverse Event|3|||
25169093|NCT01849289|50300121|FG001|Overall Study|Adverse Event|3|||
25169094|NCT01849289|50300120|FG000|Overall Study|Protocol Violation|3|||
25169095|NCT01849289|50300121|FG001|Overall Study|Protocol Violation|3|||
25169096|NCT01849289|50300120|FG000|Overall Study|Withdrawal criteria|1|||
25169097|NCT01849289|50300121|FG001|Overall Study|Withdrawal criteria|0|||
25169098|NCT01849289|50300120|FG000|Overall Study|Unclassified|25|||
25169099|NCT01849289|50300121|FG001|Overall Study|Unclassified|18|||
25169100|NCT01868243|50300129|FG000|Overall Study|Death|0|||
25169101|NCT01868243|50300130|FG001|Overall Study|Death|1|||
25169102|NCT01611935|50300138|FG000|Overall Study|Family Declined Participation|1|||
25169103|NCT01611935|50300139|FG001|Overall Study|Family Declined Participation|0|||
25169104|NCT01868165|50300145|FG000|Overall Study|Withdrawal by Subject|36|||
25169105|NCT01868165|50300145|FG000|Overall Study|Physician Decision|2|||
25169106|NCT01868165|50300145|FG000|Overall Study|Lost to Follow-up|3|||
25169107|NCT01868165|50300145|FG000|Overall Study|Death|4|||
25169108|NCT01868009|50300184|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
25282329|NCT01137474|50597262|FG003|Overall Study|Administrative reason by sponsor|0|||
25282330|NCT01168973|50597274|FG000|Overall Study|Progressive Disease|341|||
25282331|NCT01168973|50597275|FG001|Overall Study|Progressive Disease|429|||
25282332|NCT01168973|50597274|FG000|Overall Study|Adverse Event|94|||
25282333|NCT01168973|50597275|FG001|Overall Study|Adverse Event|55|||
25282334|NCT01168973|50597274|FG000|Overall Study|Withdrawal by Subject|90|||
25282335|NCT01168973|50597275|FG001|Overall Study|Withdrawal by Subject|53|||
24969477|NCT00131352|50058881|FG001|Repeat Treatment Period|Other|0|||
25069834|NCT02341456|50175594|FG001|Overall Study|Physician Decision|0|||
25069835|NCT02341456|50175595|FG002|Overall Study|Physician Decision|0|||
25069836|NCT02370784|50175605|FG000|Overall Study|Patient started prohibited medication|0|||
25069837|NCT02370784|50175606|FG001|Overall Study|Patient started prohibited medication|1|||
25069838|NCT02307370|50175614|FG000|Overall Study|Death|5|||
25069839|NCT02307370|50175614|FG000|Overall Study|Lost to Follow-up|1|||
25069840|NCT02307370|50175614|FG000|Overall Study|Withdrawal by Subject|1|||
25069841|NCT02307370|50175614|FG000|Overall Study|Declined Addendum ICF|6|||
25069842|NCT02307370|50175614|FG000|Overall Study|No response during telephone contact|5|||
25069843|NCT02307370|50175614|FG000|Overall Study|Protocol Violation|1|||
25069844|NCT02370394|50175622|FG000|Overall Study|Lost to Follow-up|2|||
25069845|NCT02370394|50175623|FG001|Overall Study|Lost to Follow-up|1|||
25069846|NCT02370394|50175622|FG000|Overall Study|Withdrawal by Subject|0|||
25069847|NCT02370394|50175623|FG001|Overall Study|Withdrawal by Subject|1|||
25069848|NCT01595438|50175632|FG000|Overall Study|Lost to Follow-up|20|||
25069849|NCT01595438|50175633|FG001|Overall Study|Lost to Follow-up|20|||
25069850|NCT01595438|50175632|FG000|Overall Study|Withdrawal by Subject|12|||
25069851|NCT01595438|50175633|FG001|Overall Study|Withdrawal by Subject|12|||
25069852|NCT01595438|50175632|FG000|Overall Study|Other Eligibility criteria|11|||
25069853|NCT01595438|50175633|FG001|Overall Study|Other Eligibility criteria|9|||
25069854|NCT02340520|50175639|FG000|Overall Study|Lost to Follow-up|1|||
25069855|NCT02340520|50175639|FG000|Overall Study|Patient did not take drug as specified|1|||
25069856|NCT02340520|50175639|FG000|Overall Study|Withdrawal by Subject|1|||
25069857|NCT02339584|50175645|FG000|Overall Study|Adverse Event|11|||
25069858|NCT02339584|50175646|FG001|Overall Study|Adverse Event|7|||
25069859|NCT02339584|50175645|FG000|Overall Study|Lack of Efficacy|0|||
25069860|NCT02339584|50175646|FG001|Overall Study|Lack of Efficacy|1|||
25069861|NCT02339584|50175645|FG000|Overall Study|Physician Decision|1|||
25069862|NCT02339584|50175646|FG001|Overall Study|Physician Decision|2|||
25069863|NCT02339584|50175645|FG000|Overall Study|Protocol Violation|1|||
25069864|NCT02339584|50175646|FG001|Overall Study|Protocol Violation|1|||
25069865|NCT02339584|50175645|FG000|Overall Study|Withdrawal by Subject|2|||
25069866|NCT02339584|50175646|FG001|Overall Study|Withdrawal by Subject|4|||
25069867|NCT02339506|50175652|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
25069868|NCT02339506|50175653|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
25069869|NCT02339506|50175652|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
25069870|NCT02339506|50175653|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
25069871|NCT02305888|50175662|FG000|Overall Study|Lost to Follow-up|0|||
25069872|NCT02305888|50175663|FG001|Overall Study|Lost to Follow-up|0|||
25069873|NCT02305888|50175664|FG002|Overall Study|Lost to Follow-up|1|||
25069874|NCT02305888|50175662|FG000|Overall Study|Adverse Event|0|||
25069875|NCT02305888|50175663|FG001|Overall Study|Adverse Event|1|||
25069876|NCT02305888|50175664|FG002|Overall Study|Adverse Event|0|||
25069877|NCT02338882|50175674|FG000|Overall Study|Death|1|||
25069878|NCT02338882|50175675|FG001|Overall Study|Death|0|||
25069879|NCT02338882|50175674|FG000|Overall Study|Lost to Follow-up|6|||
25069880|NCT02338882|50175675|FG001|Overall Study|Lost to Follow-up|3|||
25069881|NCT01594970|50175687|FG000|Overall Study|Non-Adverse Event Related|4|||
25282336|NCT01168973|50597274|FG000|Overall Study|Death|42|||
25069882|NCT01594970|50175688|FG001|Overall Study|Non-Adverse Event Related|5|||
25069883|NCT01594970|50175689|FG002|Overall Study|Non-Adverse Event Related|6|||
25069884|NCT01594970|50175687|FG000|Overall Study|Adverse Event|17|||
25069885|NCT01594970|50175688|FG001|Overall Study|Adverse Event|23|||
25069886|NCT01594970|50175689|FG002|Overall Study|Adverse Event|23|||
25069887|NCT01594970|50175687|FG000|Overall Study|Lost to Follow-up|54|||
25069888|NCT01594970|50175688|FG001|Overall Study|Lost to Follow-up|54|||
25069889|NCT01594970|50175689|FG002|Overall Study|Lost to Follow-up|37|||
25069890|NCT02338492|50175697|FG000|Overall Study|Death|32|||
25069891|NCT02338492|50175697|FG000|Overall Study|Adverse Event|3|||
25069892|NCT02338492|50175697|FG000|Overall Study|Lost to Follow-up|4|||
25069893|NCT02338492|50175697|FG000|Overall Study|Reason not captured above|6|||
25069894|NCT02337946|50175701|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
25069895|NCT02337946|50175702|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
25069896|NCT02337946|50175703|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
25069897|NCT02337946|50175701|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
25069898|NCT02337946|50175702|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
25069899|NCT02337946|50175703|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
25069900|NCT02337946|50175701|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
25069901|NCT02337946|50175702|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
25069902|NCT02337946|50175703|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
25069903|NCT02337946|50175701|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
25069904|NCT02337946|50175702|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
25069905|NCT02337946|50175703|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
25069906|NCT02337946|50175701|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
25282337|NCT01168973|50597275|FG001|Overall Study|Death|45|||
25282338|NCT01168973|50597274|FG000|Overall Study|Physician Decision|37|||
25282339|NCT01168973|50597275|FG001|Overall Study|Physician Decision|19|||
25282340|NCT01168973|50597274|FG000|Overall Study|Sponsor Decision|2|||
25282341|NCT01168973|50597275|FG001|Overall Study|Sponsor Decision|1|||
25282342|NCT01168973|50597274|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
25282343|NCT01168973|50597275|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
25282344|NCT03918109|50597285|FG000|Overall Study|Withdrawal by Subject|0|||
25282345|NCT03918109|50597286|FG001|Overall Study|Withdrawal by Subject|0|||
25282346|NCT03918109|50597287|FG002|Overall Study|Withdrawal by Subject|2|||
25282347|NCT03918109|50597288|FG003|Overall Study|Withdrawal by Subject|1|||
25282348|NCT03918109|50597285|FG000|Overall Study|Lost to Follow-up|0|||
25282349|NCT03918109|50597286|FG001|Overall Study|Lost to Follow-up|0|||
25282350|NCT03918109|50597287|FG002|Overall Study|Lost to Follow-up|0|||
25282351|NCT03918109|50597288|FG003|Overall Study|Lost to Follow-up|1|||
25282352|NCT01168427|50597298|FG000|Overall Study|Patient exited prior to implant|1|||
25282353|NCT01124916|50597304|FG000|Overall Study|Lost to Follow-up|3|||
25282354|NCT01124916|50597305|FG001|Overall Study|Lost to Follow-up|2|||
25282355|NCT00916006|50597313|FG000|Overall Study|Adverse Event|1|||
25282356|NCT00916006|50597314|FG001|Overall Study|Adverse Event|1|||
25282357|NCT00916006|50597313|FG000|Overall Study|Withdrawal by Subject|2|||
25282358|NCT00916006|50597314|FG001|Overall Study|Withdrawal by Subject|5|||
25282359|NCT00916006|50597313|FG000|Overall Study|Protocol Violation|0|||
25282360|NCT00916006|50597314|FG001|Overall Study|Protocol Violation|1|||
25282361|NCT01168349|50597331|FG000|Overall Study|Death|157|||
25282362|NCT01168349|50597331|FG000|Overall Study|Lost to Follow-up|34|||
25282363|NCT01168349|50597331|FG000|Overall Study|Withdrawal by Subject|9|||
25282364|NCT01168349|50597331|FG000|Overall Study|Kidney transplantation|3|||
25282365|NCT01168349|50597331|FG000|Overall Study|Other|22|||
25282366|NCT01168349|50597331|FG000|Overall Study|Protocol Violation|76|||
25282367|NCT00915772|50597354|FG000|Overall Study|Adverse Event|12|||
25282368|NCT00915772|50597355|FG001|Overall Study|Adverse Event|13|||
25282369|NCT00915772|50597356|FG002|Overall Study|Adverse Event|11|||
25282370|NCT00915772|50597354|FG000|Overall Study|Protocol Violation|4|||
25282371|NCT00915772|50597355|FG001|Overall Study|Protocol Violation|1|||
25282372|NCT00915772|50597356|FG002|Overall Study|Protocol Violation|2|||
25282373|NCT00915772|50597354|FG000|Overall Study|Lost to Follow-up|1|||
25282374|NCT00915772|50597355|FG001|Overall Study|Lost to Follow-up|2|||
25282375|NCT00915772|50597356|FG002|Overall Study|Lost to Follow-up|2|||
25282376|NCT00915772|50597354|FG000|Overall Study|Lack of Efficacy|9|||
25282377|NCT00915772|50597355|FG001|Overall Study|Lack of Efficacy|15|||
25282378|NCT00915772|50597356|FG002|Overall Study|Lack of Efficacy|3|||
25282379|NCT00915772|50597354|FG000|Overall Study|Refused to continue trial medication|6|||
25282380|NCT00915772|50597355|FG001|Overall Study|Refused to continue trial medication|8|||
25282381|NCT00915772|50597356|FG002|Overall Study|Refused to continue trial medication|4|||
25282382|NCT00915772|50597354|FG000|Overall Study|Any other reason|4|||
25282383|NCT00915772|50597355|FG001|Overall Study|Any other reason|7|||
25282384|NCT00915772|50597356|FG002|Overall Study|Any other reason|7|||
25282385|NCT00912964|50597368|FG000|Overall Study|Eligibility criterion not met|1|||
25282386|NCT00912964|50597369|FG001|Overall Study|Eligibility criterion not met|1|||
25282387|NCT00912964|50597370|FG002|Overall Study|Eligibility criterion not met|0|||
25282388|NCT00912964|50597368|FG000|Overall Study|Adverse Event|15|||
25282389|NCT00912964|50597369|FG001|Overall Study|Adverse Event|18|||
25282390|NCT00912964|50597370|FG002|Overall Study|Adverse Event|12|||
25282391|NCT00912964|50597368|FG000|Overall Study|Lack of Efficacy|11|||
25282392|NCT00912964|50597369|FG001|Overall Study|Lack of Efficacy|4|||
25282393|NCT00912964|50597370|FG002|Overall Study|Lack of Efficacy|3|||
25282394|NCT00912964|50597368|FG000|Overall Study|Withdrawal by Subject|20|||
25282395|NCT00912964|50597369|FG001|Overall Study|Withdrawal by Subject|12|||
25282396|NCT00912964|50597370|FG002|Overall Study|Withdrawal by Subject|18|||
25282397|NCT00912964|50597368|FG000|Overall Study|Lost to Follow-up|4|||
25282398|NCT00912964|50597369|FG001|Overall Study|Lost to Follow-up|3|||
25282399|NCT00912964|50597370|FG002|Overall Study|Lost to Follow-up|3|||
25282400|NCT00912964|50597368|FG000|Overall Study|Protocol Violation|5|||
25282401|NCT00912964|50597369|FG001|Overall Study|Protocol Violation|3|||
25282402|NCT00912964|50597370|FG002|Overall Study|Protocol Violation|8|||
25282403|NCT00912964|50597368|FG000|Overall Study|Taking exclusionary medications|7|||
25282404|NCT00912964|50597369|FG001|Overall Study|Taking exclusionary medications|4|||
25169109|NCT01868009|50300185|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
25169110|NCT01868009|50300184|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
25282405|NCT00912964|50597370|FG002|Overall Study|Taking exclusionary medications|8|||
25282406|NCT00912964|50597368|FG000|Overall Study|Medical History|1|||
25282407|NCT00912964|50597369|FG001|Overall Study|Medical History|0|||
25282408|NCT00912964|50597370|FG002|Overall Study|Medical History|0|||
25282409|NCT00912964|50597368|FG000|Overall Study|Non-compliance with study procedures|2|||
25282410|NCT00912964|50597369|FG001|Overall Study|Non-compliance with study procedures|0|||
25282411|NCT00912964|50597370|FG002|Overall Study|Non-compliance with study procedures|0|||
25282412|NCT00912964|50597368|FG000|Overall Study|Violation of exclusion criterion|0|||
25282413|NCT00912964|50597369|FG001|Overall Study|Violation of exclusion criterion|0|||
25282414|NCT00912964|50597370|FG002|Overall Study|Violation of exclusion criterion|2|||
25282415|NCT00912964|50597368|FG000|Overall Study|Randomized but never received study drug|0|||
25282416|NCT00912964|50597369|FG001|Overall Study|Randomized but never received study drug|1|||
25282417|NCT00912964|50597370|FG002|Overall Study|Randomized but never received study drug|0|||
25282418|NCT00913744|50597380|FG000|Overall Study|Adverse Event|2|||
25282419|NCT00913744|50597381|FG001|Overall Study|Adverse Event|0|||
25282420|NCT00913744|50597380|FG000|Overall Study|Withdrawal by Subject|2|||
25282421|NCT00913744|50597381|FG001|Overall Study|Withdrawal by Subject|1|||
25282422|NCT00913744|50597380|FG000|Overall Study|Death|1|||
25191295|NCT02612610|50349310|FG002|Overall Study|Physician Decision|0|||
25191296|NCT02612610|50349311|FG003|Overall Study|Physician Decision|0|||
25191297|NCT02612610|50349308|FG000|Overall Study|Noncompliance|1|||
25191298|NCT02612610|50349309|FG001|Overall Study|Noncompliance|0|||
25191299|NCT02612610|50349310|FG002|Overall Study|Noncompliance|0|||
25191300|NCT02612610|50349311|FG003|Overall Study|Noncompliance|0|||
25191301|NCT02612610|50349308|FG000|Overall Study|Cough Improvement|0|||
25191302|NCT02612610|50349309|FG001|Overall Study|Cough Improvement|0|||
25191303|NCT02612610|50349310|FG002|Overall Study|Cough Improvement|1|||
25191304|NCT02612610|50349311|FG003|Overall Study|Cough Improvement|0|||
25191305|NCT02610192|50349520|FG000|Overall Study|Received other treatment|8|||
25191306|NCT02610192|50349520|FG000|Overall Study|Physician Decision|1|||
25191307|NCT02609178|50349673|FG000|First Crown|Withdrawal by Subject|0|||
25191308|NCT02609178|50349674|FG001|First Crown|Withdrawal by Subject|0|||
25191309|NCT02609178|50349675|FG002|First Crown|Withdrawal by Subject|1|||
25191310|NCT02609178|50349676|FG003|First Crown|Withdrawal by Subject|1|||
25191311|NCT02609178|50349677|FG004|First Crown|Withdrawal by Subject|0|||
25191312|NCT02609178|50349678|FG005|First Crown|Withdrawal by Subject|0|||
25191313|NCT02607228|50349902|FG000|Overall Study|Progressive Disease|4|||
25191314|NCT02607228|50349903|FG001|Overall Study|Progressive Disease|3|||
25191315|NCT02607228|50349904|FG002|Overall Study|Progressive Disease|1|||
25282423|NCT00913744|50597381|FG001|Overall Study|Death|0|||
25282424|NCT00912808|50597389|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
25282425|NCT00912808|50597390|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
25282426|NCT00912808|50597389|FG000|Washout|Withdrawal by Subject|0|||
25282427|NCT00912808|50597390|FG001|Washout|Withdrawal by Subject|1|||
25282428|NCT00912808|50597389|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
25282429|NCT00912808|50597390|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
25282430|NCT00912808|50597389|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
25282431|NCT00912808|50597390|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
25282432|NCT00960531|50597407|FG000|Overall Study|Lack of Efficacy|1|||
25282433|NCT00960531|50597408|FG001|Overall Study|Lack of Efficacy|0|||
25191316|NCT02607228|50349905|FG003|Overall Study|Progressive Disease|5|||
25191317|NCT02607228|50349906|FG004|Overall Study|Progressive Disease|4|||
25191318|NCT02607228|50349907|FG005|Overall Study|Progressive Disease|3|||
25191319|NCT02607228|50349908|FG006|Overall Study|Progressive Disease|1|||
25191320|NCT02607228|50349902|FG000|Overall Study|Adverse Event|1|||
25191321|NCT02607228|50349903|FG001|Overall Study|Adverse Event|0|||
25282434|NCT00960531|50597409|FG002|Overall Study|Lack of Efficacy|0|||
25282435|NCT00960531|50597410|FG003|Overall Study|Lack of Efficacy|0|||
25282436|NCT00960531|50597411|FG004|Overall Study|Lack of Efficacy|0|||
25282437|NCT00960531|50597412|FG005|Overall Study|Lack of Efficacy|0|||
25282438|NCT00960531|50597413|FG006|Overall Study|Lack of Efficacy|0|||
25282439|NCT00960531|50597414|FG007|Overall Study|Lack of Efficacy|0|||
25282440|NCT00960531|50597415|FG008|Overall Study|Lack of Efficacy|0|||
25282441|NCT00960531|50597416|FG009|Overall Study|Lack of Efficacy|0|||
25282442|NCT00960531|50597407|FG000|Overall Study|Withdrawal by Subject|1|||
25282443|NCT00960531|50597408|FG001|Overall Study|Withdrawal by Subject|0|||
25282444|NCT00960531|50597409|FG002|Overall Study|Withdrawal by Subject|5|||
25282445|NCT00960531|50597410|FG003|Overall Study|Withdrawal by Subject|2|||
25282446|NCT00960531|50597411|FG004|Overall Study|Withdrawal by Subject|0|||
25282447|NCT00960531|50597412|FG005|Overall Study|Withdrawal by Subject|0|||
25282448|NCT00960531|50597413|FG006|Overall Study|Withdrawal by Subject|2|||
25282449|NCT00960531|50597414|FG007|Overall Study|Withdrawal by Subject|0|||
25282450|NCT00960531|50597415|FG008|Overall Study|Withdrawal by Subject|1|||
25169111|NCT01868009|50300185|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
25169112|NCT01868009|50300184|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
25169113|NCT01868009|50300185|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
25169114|NCT01849055|50300239|FG000|Overall Study|Withdrawal by Subject|0|||
25169115|NCT01849055|50300240|FG001|Overall Study|Withdrawal by Subject|0|||
25169116|NCT01849055|50300241|FG002|Overall Study|Withdrawal by Subject|1|||
25169117|NCT01849055|50300242|FG003|Overall Study|Withdrawal by Subject|0|||
25169118|NCT01849055|50300243|FG004|Overall Study|Withdrawal by Subject|0|||
25191322|NCT02607228|50349904|FG002|Overall Study|Adverse Event|1|||
25191323|NCT02607228|50349905|FG003|Overall Study|Adverse Event|0|||
25191324|NCT02607228|50349906|FG004|Overall Study|Adverse Event|1|||
25191325|NCT02607228|50349907|FG005|Overall Study|Adverse Event|1|||
25282451|NCT00960531|50597416|FG009|Overall Study|Withdrawal by Subject|0|||
25282452|NCT00960531|50597407|FG000|Overall Study|Caregiver Request|2|||
25282453|NCT00960531|50597408|FG001|Overall Study|Caregiver Request|0|||
25282454|NCT00960531|50597409|FG002|Overall Study|Caregiver Request|6|||
25282455|NCT00960531|50597410|FG003|Overall Study|Caregiver Request|5|||
25282456|NCT00960531|50597411|FG004|Overall Study|Caregiver Request|0|||
25282457|NCT00960531|50597412|FG005|Overall Study|Caregiver Request|2|||
25282458|NCT00960531|50597413|FG006|Overall Study|Caregiver Request|3|||
25282459|NCT00960531|50597414|FG007|Overall Study|Caregiver Request|1|||
25282460|NCT00960531|50597415|FG008|Overall Study|Caregiver Request|3|||
25282461|NCT00960531|50597416|FG009|Overall Study|Caregiver Request|0|||
25282462|NCT00960531|50597407|FG000|Overall Study|Investigator Request|0|||
25282463|NCT00960531|50597408|FG001|Overall Study|Investigator Request|0|||
25282464|NCT00960531|50597409|FG002|Overall Study|Investigator Request|1|||
25282465|NCT00960531|50597410|FG003|Overall Study|Investigator Request|0|||
25282466|NCT00960531|50597411|FG004|Overall Study|Investigator Request|0|||
25282467|NCT00960531|50597412|FG005|Overall Study|Investigator Request|0|||
25282468|NCT00960531|50597413|FG006|Overall Study|Investigator Request|0|||
25282469|NCT00960531|50597414|FG007|Overall Study|Investigator Request|0|||
25282470|NCT00960531|50597415|FG008|Overall Study|Investigator Request|0|||
25282471|NCT00960531|50597416|FG009|Overall Study|Investigator Request|0|||
25282472|NCT00960531|50597407|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
25282473|NCT00960531|50597408|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
25282474|NCT00960531|50597409|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
25282475|NCT00960531|50597410|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
25282476|NCT00960531|50597411|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
25282477|NCT00960531|50597412|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
25282478|NCT00960531|50597413|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
25282479|NCT00960531|50597414|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
25282480|NCT00960531|50597415|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
25282481|NCT00960531|50597416|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
25282482|NCT00960531|50597407|FG000|Overall Study|Lost to Follow-up|0|||
25282483|NCT00960531|50597408|FG001|Overall Study|Lost to Follow-up|0|||
25282484|NCT00960531|50597409|FG002|Overall Study|Lost to Follow-up|1|||
25282485|NCT00960531|50597410|FG003|Overall Study|Lost to Follow-up|0|||
25282486|NCT00960531|50597411|FG004|Overall Study|Lost to Follow-up|0|||
25282487|NCT00960531|50597412|FG005|Overall Study|Lost to Follow-up|0|||
25282488|NCT00960531|50597413|FG006|Overall Study|Lost to Follow-up|1|||
25282489|NCT00960531|50597414|FG007|Overall Study|Lost to Follow-up|0|||
25282490|NCT00960531|50597415|FG008|Overall Study|Lost to Follow-up|0|||
25282491|NCT00960531|50597416|FG009|Overall Study|Lost to Follow-up|0|||
25282492|NCT00960531|50597407|FG000|Overall Study|Failed to Return|2|||
25282493|NCT00960531|50597408|FG001|Overall Study|Failed to Return|0|||
25282494|NCT00960531|50597409|FG002|Overall Study|Failed to Return|0|||
25282495|NCT00960531|50597410|FG003|Overall Study|Failed to Return|0|||
25282496|NCT00960531|50597411|FG004|Overall Study|Failed to Return|0|||
25282497|NCT00960531|50597412|FG005|Overall Study|Failed to Return|0|||
25282498|NCT00960531|50597413|FG006|Overall Study|Failed to Return|0|||
25282499|NCT00960531|50597414|FG007|Overall Study|Failed to Return|2|||
25282500|NCT00960531|50597415|FG008|Overall Study|Failed to Return|0|||
25282501|NCT00960531|50597416|FG009|Overall Study|Failed to Return|0|||
25282502|NCT00960531|50597407|FG000|Overall Study|Adverse Event (AE)|2|||
25282503|NCT00960531|50597408|FG001|Overall Study|Adverse Event (AE)|0|||
25282504|NCT00960531|50597409|FG002|Overall Study|Adverse Event (AE)|0|||
25282505|NCT00960531|50597410|FG003|Overall Study|Adverse Event (AE)|0|||
25282506|NCT00960531|50597411|FG004|Overall Study|Adverse Event (AE)|0|||
25282507|NCT00960531|50597412|FG005|Overall Study|Adverse Event (AE)|1|||
25282508|NCT00960531|50597413|FG006|Overall Study|Adverse Event (AE)|2|||
25282509|NCT00960531|50597414|FG007|Overall Study|Adverse Event (AE)|0|||
25282510|NCT00960531|50597415|FG008|Overall Study|Adverse Event (AE)|2|||
25282511|NCT00960531|50597416|FG009|Overall Study|Adverse Event (AE)|0|||
25282512|NCT00960531|50597407|FG000|Overall Study|Reason not Specified|2|||
25282513|NCT00960531|50597408|FG001|Overall Study|Reason not Specified|1|||
25282514|NCT00960531|50597409|FG002|Overall Study|Reason not Specified|13|||
25282515|NCT00960531|50597410|FG003|Overall Study|Reason not Specified|1|||
25282516|NCT00960531|50597411|FG004|Overall Study|Reason not Specified|2|||
25282517|NCT00960531|50597412|FG005|Overall Study|Reason not Specified|0|||
25282518|NCT00960531|50597413|FG006|Overall Study|Reason not Specified|16|||
25282519|NCT00960531|50597414|FG007|Overall Study|Reason not Specified|0|||
25282520|NCT00960531|50597415|FG008|Overall Study|Reason not Specified|8|||
25282521|NCT00960531|50597416|FG009|Overall Study|Reason not Specified|1|||
25282522|NCT00960375|50597444|FG000|Overall Study|Lost to Follow-up|20|||
25282523|NCT00960375|50597445|FG001|Overall Study|Lost to Follow-up|22|||
25282524|NCT00957801|50597464|FG000|Overall Study|Withdrawal by Subject|0|||
25282525|NCT00957801|50597465|FG001|Overall Study|Withdrawal by Subject|0|||
25282526|NCT00957801|50597466|FG002|Overall Study|Withdrawal by Subject|0|||
25282527|NCT00957801|50597467|FG003|Overall Study|Withdrawal by Subject|1|||
25282528|NCT00957723|50597477|FG000|Overall Study|Death|3|||
25282529|NCT00957723|50597477|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
25282530|NCT00957723|50597477|FG000|Overall Study|Lost to Follow-up|8|||
25282531|NCT00957723|50597477|FG000|Overall Study|Withdrawal by Subject|24|||
25282532|NCT00957723|50597477|FG000|Overall Study|Investigative Site Terminated|61|||
25282533|NCT00957723|50597477|FG000|Overall Study|Intercurrent Illness|2|||
25282534|NCT00957723|50597477|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
25282535|NCT03778021|50597485|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
25282536|NCT03778021|50597486|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
25282537|NCT00911170|50597495|FG000|Treatment Period|Randomized in error|1|||
25282538|NCT00911170|50597496|FG001|Treatment Period|Randomized in error|1|||
25282539|NCT00911170|50597495|FG000|Treatment Period|Ineligibility determined|1|||
25282540|NCT00911170|50597496|FG001|Treatment Period|Ineligibility determined|3|||
25282541|NCT00911170|50597495|FG000|Treatment Period|Protocol deviation|1|||
25282542|NCT00911170|50597496|FG001|Treatment Period|Protocol deviation|2|||
25282543|NCT00911170|50597495|FG000|Treatment Period|Adverse Event|9|||
25282544|NCT00911170|50597496|FG001|Treatment Period|Adverse Event|10|||
25191326|NCT02607228|50349908|FG006|Overall Study|Adverse Event|1|||
25191327|NCT02607228|50349902|FG000|Overall Study|Investigator's Discretion|0|||
25191328|NCT02607228|50349903|FG001|Overall Study|Investigator's Discretion|0|||
25191329|NCT02607228|50349904|FG002|Overall Study|Investigator's Discretion|1|||
25191330|NCT02607228|50349905|FG003|Overall Study|Investigator's Discretion|0|||
25191331|NCT02607228|50349906|FG004|Overall Study|Investigator's Discretion|0|||
25191332|NCT02607228|50349907|FG005|Overall Study|Investigator's Discretion|1|||
25191333|NCT02607228|50349908|FG006|Overall Study|Investigator's Discretion|0|||
25191334|NCT02607228|50349902|FG000|Overall Study|Withdrew Consent|0|||
25191335|NCT02607228|50349903|FG001|Overall Study|Withdrew Consent|1|||
25282545|NCT00911170|50597495|FG000|Treatment Period|Withdrawal by Subject|4|||
25282546|NCT00911170|50597496|FG001|Treatment Period|Withdrawal by Subject|4|||
25282547|NCT00911170|50597495|FG000|Treatment Period|Disease progression|0|||
25282548|NCT00911170|50597496|FG001|Treatment Period|Disease progression|2|||
25282549|NCT00911170|50597495|FG000|Treatment Period|Physician Decision|5|||
25282550|NCT00911170|50597496|FG001|Treatment Period|Physician Decision|5|||
25282551|NCT00911170|50597495|FG000|Treatment Period|Lost to Follow-up|0|||
25282552|NCT00911170|50597496|FG001|Treatment Period|Lost to Follow-up|1|||
25282553|NCT00911170|50597495|FG000|Treatment Period|Death|6|||
25282554|NCT00911170|50597496|FG001|Treatment Period|Death|9|||
25282555|NCT00911170|50597495|FG000|Long Term Follow-Up|Continuing in study|274|||
25282556|NCT00911170|50597496|FG001|Long Term Follow-Up|Continuing in study|269|||
25282557|NCT00911170|50597495|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
25282558|NCT00911170|50597496|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
25282559|NCT00911170|50597495|FG000|Long Term Follow-Up|Physician Decision|5|||
25282560|NCT00911170|50597496|FG001|Long Term Follow-Up|Physician Decision|4|||
25282561|NCT00911170|50597495|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
25282562|NCT00911170|50597496|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
25282563|NCT00911170|50597495|FG000|Long Term Follow-Up|Death|116|||
25282564|NCT00911170|50597496|FG001|Long Term Follow-Up|Death|121|||
25282565|NCT01167881|50597504|FG000|Overall Study|Adverse Event|47|||
25282566|NCT01167881|50597505|FG001|Overall Study|Adverse Event|51|||
25282567|NCT01167881|50597504|FG000|Overall Study|Lack of Efficacy|4|||
25282568|NCT01167881|50597505|FG001|Overall Study|Lack of Efficacy|7|||
25282569|NCT01167881|50597504|FG000|Overall Study|Non compliant with protocol|9|||
25282570|NCT01167881|50597505|FG001|Overall Study|Non compliant with protocol|18|||
25282571|NCT01167881|50597504|FG000|Overall Study|Lost to Follow-up|19|||
25282572|NCT01167881|50597505|FG001|Overall Study|Lost to Follow-up|20|||
25282573|NCT01167881|50597504|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
25282574|NCT01167881|50597505|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
25282575|NCT01167881|50597504|FG000|Overall Study|Not treated|4|||
25282576|NCT01167881|50597505|FG001|Overall Study|Not treated|0|||
25282577|NCT01167881|50597504|FG000|Overall Study|Other not defined above|31|||
25282578|NCT01167881|50597505|FG001|Overall Study|Other not defined above|55|||
25282579|NCT00960063|50597514|FG000|Overall Study|Adverse Event|1|||
25282580|NCT00960063|50597515|FG001|Overall Study|Adverse Event|0|||
25282581|NCT00960063|50597516|FG002|Overall Study|Adverse Event|0|||
25282582|NCT00960063|50597514|FG000|Overall Study|Progression of Disease|0|||
25282583|NCT00960063|50597515|FG001|Overall Study|Progression of Disease|0|||
25282584|NCT00960063|50597516|FG002|Overall Study|Progression of Disease|3|||
25282585|NCT00959907|50597526|FG000|Overall Study|Protocol Violation|0|||
25282586|NCT00959907|50597527|FG001|Overall Study|Protocol Violation|1|||
25282587|NCT00959907|50597526|FG000|Overall Study|Adverse Event|1|||
25282588|NCT00959907|50597527|FG001|Overall Study|Adverse Event|0|||
25191336|NCT02607228|50349904|FG002|Overall Study|Withdrew Consent|0|||
25191337|NCT02607228|50349905|FG003|Overall Study|Withdrew Consent|0|||
25282589|NCT00959907|50597526|FG000|Overall Study|Withdrawal by Subject|2|||
25282590|NCT00959907|50597527|FG001|Overall Study|Withdrawal by Subject|0|||
25282591|NCT00912340|50597536|FG000|Overall Study|Adverse Event|2|||
25282592|NCT00912340|50597537|FG001|Overall Study|Adverse Event|4|||
25282593|NCT00912340|50597538|FG002|Overall Study|Adverse Event|0|||
25282594|NCT00912340|50597536|FG000|Overall Study|Protocol revised to remove arm|0|||
25282595|NCT00912340|50597537|FG001|Overall Study|Protocol revised to remove arm|0|||
25282596|NCT00912340|50597538|FG002|Overall Study|Protocol revised to remove arm|4|||
25282597|NCT01167257|50597548|FG000|Overall Study|Lost to Follow-up|2|||
25282598|NCT01167257|50597549|FG001|Overall Study|Lost to Follow-up|2|||
25282599|NCT01167257|50597548|FG000|Overall Study|Withdrew consent|1|||
25282600|NCT01167257|50597549|FG001|Overall Study|Withdrew consent|1|||
25282601|NCT01119846|50597562|FG000|Overall Study|Adverse Event|1|||
25282602|NCT01119846|50597563|FG001|Overall Study|Adverse Event|0|||
25282603|NCT01119846|50597564|FG002|Overall Study|Adverse Event|6|||
25282604|NCT01119846|50597562|FG000|Overall Study|Physician Decision|1|||
25282605|NCT01119846|50597563|FG001|Overall Study|Physician Decision|0|||
25282606|NCT01119846|50597564|FG002|Overall Study|Physician Decision|0|||
25282607|NCT01119846|50597562|FG000|Overall Study|Protocol Violation|0|||
25282608|NCT01119846|50597563|FG001|Overall Study|Protocol Violation|0|||
25282609|NCT01119846|50597564|FG002|Overall Study|Protocol Violation|1|||
25282610|NCT01119846|50597562|FG000|Overall Study|Withdrawal by Subject|0|||
25282611|NCT01119846|50597563|FG001|Overall Study|Withdrawal by Subject|0|||
25282612|NCT01119846|50597564|FG002|Overall Study|Withdrawal by Subject|4|||
25282613|NCT01167179|50597601|FG000|Overall Study|disease recurrence|4|||
25282614|NCT01167179|50597602|FG001|Overall Study|disease recurrence|4|||
25282615|NCT01167179|50597601|FG000|Overall Study|Death|4|||
25282616|NCT01167179|50597602|FG001|Overall Study|Death|10|||
25282617|NCT01167179|50597601|FG000|Overall Study|Withdrawal by Subject|1|||
25282618|NCT01167179|50597602|FG001|Overall Study|Withdrawal by Subject|2|||
25282619|NCT01167179|50597601|FG000|Overall Study|diverse|6|||
25282620|NCT01167179|50597602|FG001|Overall Study|diverse|5|||
25282621|NCT01167023|50597675|FG000|Overall Study|Lost to Follow-up|0|||
25282622|NCT01167023|50597676|FG001|Overall Study|Lost to Follow-up|1|||
25282623|NCT01167023|50597677|FG002|Overall Study|Lost to Follow-up|1|||
25282624|NCT01167023|50597675|FG000|Overall Study|Screen Failure|0|||
25282625|NCT01167023|50597676|FG001|Overall Study|Screen Failure|1|||
25282626|NCT01167023|50597677|FG002|Overall Study|Screen Failure|0|||
25282627|NCT01167023|50597675|FG000|Overall Study|Sponsor Decision|0|||
25282628|NCT01167023|50597676|FG001|Overall Study|Sponsor Decision|1|||
25282629|NCT01167023|50597677|FG002|Overall Study|Sponsor Decision|0|||
25282630|NCT01167023|50597675|FG000|Overall Study|Withdrawal by Subject|0|||
25282631|NCT01167023|50597676|FG001|Overall Study|Withdrawal by Subject|0|||
25282632|NCT01167023|50597677|FG002|Overall Study|Withdrawal by Subject|1|||
25282633|NCT03484117|50597685|FG000|Overall Study|Lost to Follow-up|1|||
25282634|NCT03484117|50597686|FG001|Overall Study|Lost to Follow-up|3|||
25282635|NCT03484117|50597685|FG000|Overall Study|Declined participation in exit assess|1|||
25282636|NCT03484117|50597686|FG001|Overall Study|Declined participation in exit assess|1|||
25282637|NCT01166945|50597694|FG000|Randomized|diagnosed with Group A strep|4|||
25282638|NCT01166945|50597695|FG001|Randomized|diagnosed with Group A strep|4|||
25282639|NCT01166945|50597694|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
25282640|NCT01166945|50597695|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
25282641|NCT01166945|50597694|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
25282642|NCT01166945|50597695|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
25282643|NCT01166945|50597694|FG000|Day 30|Lost to Follow-up|4|||
25282644|NCT01166945|50597695|FG001|Day 30|Lost to Follow-up|3|||
25282645|NCT00910000|50597709|FG000|Overall Study|Adverse Event|0|||
25282646|NCT00910000|50597710|FG001|Overall Study|Adverse Event|3|||
25282647|NCT00910000|50597711|FG002|Overall Study|Adverse Event|2|||
25282648|NCT00910000|50597712|FG003|Overall Study|Adverse Event|2|||
25282649|NCT00910000|50597713|FG004|Overall Study|Adverse Event|0|||
25282650|NCT00910000|50597714|FG005|Overall Study|Adverse Event|1|||
25282651|NCT00910000|50597709|FG000|Overall Study|Withdrawal by Subject|0|||
25282652|NCT00910000|50597710|FG001|Overall Study|Withdrawal by Subject|0|||
25282653|NCT00910000|50597711|FG002|Overall Study|Withdrawal by Subject|1|||
25282654|NCT00910000|50597712|FG003|Overall Study|Withdrawal by Subject|0|||
25169119|NCT01849055|50300244|FG005|Overall Study|Withdrawal by Subject|0|||
25282655|NCT00910000|50597713|FG004|Overall Study|Withdrawal by Subject|1|||
25169120|NCT01848353|50300270|FG000|Phase 1|Withdrawal by Subject|3|||
25169121|NCT01848353|50300271|FG001|Phase 1|Withdrawal by Subject|1|||
25282656|NCT00910000|50597714|FG005|Overall Study|Withdrawal by Subject|0|||
25282657|NCT01119768|50597735|FG000|Treatment Period|Lack of Efficacy|18|||
25282658|NCT01119768|50597736|FG001|Treatment Period|Lack of Efficacy|25|||
25282659|NCT01165307|50597744|FG000|Overall Study|Lost to Follow-up|11|||
25282660|NCT01165307|50597745|FG001|Overall Study|Lost to Follow-up|3|||
25282661|NCT01165307|50597744|FG000|Overall Study|Withdrawal by Subject|2|||
25282662|NCT01165307|50597745|FG001|Overall Study|Withdrawal by Subject|0|||
25282663|NCT01165307|50597744|FG000|Overall Study|Subject not available for contact|1|||
25282664|NCT01165307|50597745|FG001|Overall Study|Subject not available for contact|0|||
25282665|NCT00960999|50597753|FG000|Overall Study|Withdrawal by Subject|1|||
25282666|NCT00960999|50597754|FG001|Overall Study|Withdrawal by Subject|0|||
25282667|NCT00960999|50597753|FG000|Overall Study|Protocol Violation|5|||
25282668|NCT00960999|50597754|FG001|Overall Study|Protocol Violation|2|||
25282669|NCT00960999|50597753|FG000|Overall Study|RT dose constraints not met|2|||
25282670|NCT00960999|50597754|FG001|Overall Study|RT dose constraints not met|0|||
25282671|NCT01124838|50597762|FG000|Overall Study|Miscellaneous|4|||
25282672|NCT01124838|50597763|FG001|Overall Study|Miscellaneous|2|||
25282673|NCT01124838|50597762|FG000|Overall Study|Adverse Event|7|||
25282674|NCT01124838|50597763|FG001|Overall Study|Adverse Event|11|||
25282675|NCT01124838|50597762|FG000|Overall Study|Lack of Efficacy|2|||
25282676|NCT01124838|50597763|FG001|Overall Study|Lack of Efficacy|0|||
25282677|NCT01124838|50597762|FG000|Overall Study|Withdrawal by Subject|3|||
25282678|NCT01124838|50597763|FG001|Overall Study|Withdrawal by Subject|2|||
25282679|NCT01124838|50597762|FG000|Overall Study|Lost to Follow-up|2|||
25282680|NCT01124838|50597763|FG001|Overall Study|Lost to Follow-up|0|||
25282681|NCT00959751|50597773|FG000|Overall Study|Lost to Follow-up|2|||
25282682|NCT00959751|50597774|FG001|Overall Study|Lost to Follow-up|3|||
25282683|NCT00959751|50597773|FG000|Overall Study|Consent Withdrawn|0|||
25282684|NCT00959751|50597774|FG001|Overall Study|Consent Withdrawn|1|||
25282685|NCT00959751|50597773|FG000|Overall Study|Non-compliance to Study Procedures|0|||
25282686|NCT00959751|50597774|FG001|Overall Study|Non-compliance to Study Procedures|1|||
25282687|NCT00959751|50597773|FG000|Overall Study|No migraine headache without aura|7|||
25282688|NCT00959751|50597774|FG001|Overall Study|No migraine headache without aura|7|||
25282689|NCT00910858|50597783|FG000|Pharmacokinetic Phase|Adverse Event|1|||
25282690|NCT00910858|50597784|FG001|Pharmacokinetic Phase|Adverse Event|0|||
25282691|NCT00910858|50597785|FG002|Pharmacokinetic Phase|Adverse Event|0|||
25282692|NCT00910858|50597783|FG000|Monotherapy Phase|Adverse Event|3|||
25282693|NCT00910858|50597784|FG001|Monotherapy Phase|Adverse Event|2|||
25282694|NCT00910858|50597785|FG002|Monotherapy Phase|Adverse Event|0|||
25282695|NCT00910858|50597783|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
25282696|NCT00910858|50597784|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
25282697|NCT00910858|50597785|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
25282698|NCT00910858|50597783|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
25282699|NCT00910858|50597784|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
25282700|NCT00910858|50597785|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
25282701|NCT00910858|50597783|FG000|Monotherapy Phase|Protocol Violation|1|||
25282702|NCT00910858|50597784|FG001|Monotherapy Phase|Protocol Violation|0|||
25282703|NCT00910858|50597785|FG002|Monotherapy Phase|Protocol Violation|0|||
25282704|NCT00910858|50597783|FG000|Monotherapy Phase|Other|3|||
25282705|NCT00910858|50597784|FG001|Monotherapy Phase|Other|4|||
25282706|NCT00910858|50597785|FG002|Monotherapy Phase|Other|2|||
25282707|NCT00910858|50597783|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
25282708|NCT00910858|50597784|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
25282709|NCT00910858|50597785|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
25282710|NCT00910858|50597783|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
25282711|NCT00910858|50597784|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
25282712|NCT00910858|50597785|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
25282713|NCT00910858|50597783|FG000|Combined Treatment Phase|Protocol Violation|1|||
25282714|NCT00910858|50597784|FG001|Combined Treatment Phase|Protocol Violation|0|||
25282715|NCT00910858|50597785|FG002|Combined Treatment Phase|Protocol Violation|0|||
25282716|NCT00910858|50597783|FG000|Combined Treatment Phase|Other|0|||
25282717|NCT00910858|50597784|FG001|Combined Treatment Phase|Other|2|||
25191338|NCT02607228|50349906|FG004|Overall Study|Withdrew Consent|0|||
25191339|NCT02607228|50349907|FG005|Overall Study|Withdrew Consent|1|||
25191340|NCT02607228|50349908|FG006|Overall Study|Withdrew Consent|0|||
25191341|NCT02607228|50349902|FG000|Overall Study|Study Terminated by Sponsor|0|||
25191342|NCT02607228|50349903|FG001|Overall Study|Study Terminated by Sponsor|0|||
25191343|NCT02607228|50349904|FG002|Overall Study|Study Terminated by Sponsor|0|||
25191344|NCT02607228|50349905|FG003|Overall Study|Study Terminated by Sponsor|1|||
25191345|NCT02607228|50349906|FG004|Overall Study|Study Terminated by Sponsor|0|||
25282718|NCT00910858|50597785|FG002|Combined Treatment Phase|Other|1|||
25282719|NCT00598975|50597803|FG000|Overall Study|Adverse Event|1|||
25191346|NCT02607228|50349907|FG005|Overall Study|Study Terminated by Sponsor|0|||
25282720|NCT00598975|50597804|FG001|Overall Study|Adverse Event|1|||
25282721|NCT00598975|50597803|FG000|Overall Study|Brain metastases|1|||
25282722|NCT00598975|50597804|FG001|Overall Study|Brain metastases|0|||
25282723|NCT00598975|50597803|FG000|Overall Study|Withdrawal by Subject|1|||
25282724|NCT00598975|50597804|FG001|Overall Study|Withdrawal by Subject|1|||
25191347|NCT02607228|50349908|FG006|Overall Study|Study Terminated by Sponsor|0|||
25191348|NCT01668654|50349950|FG000|Overall Study|Study Closed/Terminated|3|||
25282725|NCT00598975|50597803|FG000|Overall Study|Withdrawal of consent|0|||
25282726|NCT00598975|50597804|FG001|Overall Study|Withdrawal of consent|1|||
25282727|NCT00598975|50597803|FG000|Overall Study|Disease progression|8|||
25282728|NCT00598975|50597804|FG001|Overall Study|Disease progression|3|||
25282729|NCT00598975|50597803|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
25282730|NCT00598975|50597804|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
25282731|NCT00957021|50597812|FG000|Overall Study|Death|5|||
25282732|NCT00957021|50597812|FG000|Overall Study|Lost to Follow-up|8|||
25191349|NCT01668654|50349950|FG000|Overall Study|Withdrawal by Subject|1|||
25191350|NCT02608476|50350044|FG000|Overall Study|Withdrawal by Subject|30|||
25191351|NCT02608476|50350045|FG001|Overall Study|Withdrawal by Subject|37|||
25191352|NCT02608476|50350044|FG000|Overall Study|Lost to Follow-up|24|||
25191353|NCT02608476|50350045|FG001|Overall Study|Lost to Follow-up|24|||
25191354|NCT02608476|50350044|FG000|Overall Study|Adverse Event|2|||
25191355|NCT02608476|50350045|FG001|Overall Study|Adverse Event|8|||
25191356|NCT02608476|50350044|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
25191357|NCT02608476|50350045|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
25282733|NCT00957021|50597812|FG000|Overall Study|Withdrawal by Subject|34|||
25282734|NCT00957021|50597812|FG000|Overall Study|No 2 yr ROM data|35|||
25282735|NCT00957021|50597812|FG000|Overall Study|Revised study component by 2 yr visit|8|||
25282736|NCT00957021|50597812|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
25282737|NCT00957021|50597812|FG000|Overall Study|Surgery Cancelled|9|||
25282738|NCT00957021|50597812|FG000|Overall Study|Termination due to language issue|2|||
25282739|NCT01124604|50597819|FG000|Overall Study|Adverse Event|10|||
25282740|NCT01124604|50597820|FG001|Overall Study|Adverse Event|1|||
25282741|NCT01124604|50597819|FG000|Overall Study|Lack of Efficacy|1|||
25282742|NCT01124604|50597820|FG001|Overall Study|Lack of Efficacy|0|||
25282743|NCT01124604|50597819|FG000|Overall Study|Withdrawal by Subject|4|||
25282744|NCT01124604|50597820|FG001|Overall Study|Withdrawal by Subject|0|||
25282745|NCT01124604|50597819|FG000|Overall Study|Disease Progression|0|||
25282746|NCT01124604|50597820|FG001|Overall Study|Disease Progression|1|||
25282747|NCT00909844|50597826|FG000|Overall Study|Adverse Event|1|||
25282748|NCT00909844|50597826|FG000|Overall Study|Withdrawal by Subject|1|||
25282749|NCT00909844|50597826|FG000|Overall Study|Lost to Follow-up|2|||
25282750|NCT01124448|50597833|FG000|Overall Study|Lost to Follow-up|0|||
25282751|NCT01124448|50597834|FG001|Overall Study|Lost to Follow-up|3|||
25282752|NCT01124448|50597833|FG000|Overall Study|Protocol Violation|2|||
25282753|NCT01124448|50597834|FG001|Overall Study|Protocol Violation|0|||
25282754|NCT01124292|50597843|FG000|Overall Study|Lost to Follow-up|2|||
25282755|NCT01124292|50597844|FG001|Overall Study|Lost to Follow-up|4|||
25282756|NCT01124292|50597845|FG002|Overall Study|Lost to Follow-up|3|||
25282757|NCT01124292|50597843|FG000|Overall Study|Physician Decision|0|||
25282758|NCT01124292|50597844|FG001|Overall Study|Physician Decision|3|||
25282759|NCT01124292|50597845|FG002|Overall Study|Physician Decision|2|||
25282760|NCT01124292|50597843|FG000|Overall Study|Withdrawal by Subject|0|||
25282761|NCT01124292|50597844|FG001|Overall Study|Withdrawal by Subject|6|||
25282762|NCT01124292|50597845|FG002|Overall Study|Withdrawal by Subject|2|||
25282763|NCT01124292|50597843|FG000|Overall Study|medical issue unrelated to the study|0|||
25191358|NCT02608476|50350044|FG000|Overall Study|Noncompliance with treatment|1|||
25191359|NCT02608476|50350045|FG001|Overall Study|Noncompliance with treatment|5|||
25191360|NCT02608476|50350044|FG000|Overall Study|Lack of Efficacy|3|||
25191361|NCT02608476|50350045|FG001|Overall Study|Lack of Efficacy|1|||
25191362|NCT02608476|50350044|FG000|Overall Study|Other|0|||
25191363|NCT02608476|50350045|FG001|Overall Study|Other|1|||
25191364|NCT02608476|50350044|FG000|Overall Study|Physician Decision|1|||
25191365|NCT02608476|50350045|FG001|Overall Study|Physician Decision|0|||
25282764|NCT01124292|50597844|FG001|Overall Study|medical issue unrelated to the study|0|||
25282765|NCT01124292|50597845|FG002|Overall Study|medical issue unrelated to the study|2|||
25282766|NCT01124292|50597843|FG000|Overall Study|piercing track closed|0|||
25282767|NCT01124292|50597844|FG001|Overall Study|piercing track closed|2|||
25282768|NCT01124292|50597845|FG002|Overall Study|piercing track closed|1|||
25282769|NCT01136772|50597858|FG000|Overall Study|Adverse Event|15|||
25282770|NCT01136772|50597859|FG001|Overall Study|Adverse Event|14|||
25282771|NCT01136772|50597858|FG000|Overall Study|Lack of Efficacy|42|||
25191366|NCT02608476|50350044|FG000|Overall Study|Pregnancy|0|||
25191367|NCT02608476|50350045|FG001|Overall Study|Pregnancy|1|||
25282772|NCT01136772|50597859|FG001|Overall Study|Lack of Efficacy|39|||
25282773|NCT01136772|50597858|FG000|Overall Study|Administrative|14|||
25282774|NCT01136772|50597859|FG001|Overall Study|Administrative|12|||
25282775|NCT01136772|50597858|FG000|Overall Study|Withdrawal by Subject|33|||
25282776|NCT01136772|50597859|FG001|Overall Study|Withdrawal by Subject|36|||
25282777|NCT01136772|50597858|FG000|Overall Study|Did not receive injection|10|||
25282778|NCT01136772|50597859|FG001|Overall Study|Did not receive injection|7|||
25282779|NCT01136772|50597858|FG000|Overall Study|Did not follow up after first injection|2|||
25191368|NCT02608476|50350044|FG000|Overall Study|Progressive disease|1|||
25191369|NCT02608476|50350045|FG001|Overall Study|Progressive disease|0|||
25191370|NCT02607306|50350183|FG000|Overall Study|Adverse Event|8|||
25282780|NCT01136772|50597859|FG001|Overall Study|Did not follow up after first injection|2|||
25282781|NCT00909532|50597867|FG000|Overall Study|Adverse Event|4|||
25282782|NCT00909532|50597868|FG001|Overall Study|Adverse Event|1|||
25282783|NCT00909532|50597867|FG000|Overall Study|Pregnancy|0|||
25282784|NCT00909532|50597868|FG001|Overall Study|Pregnancy|1|||
25282785|NCT00909532|50597867|FG000|Overall Study|Prohibited Medication|2|||
25282786|NCT00909532|50597868|FG001|Overall Study|Prohibited Medication|1|||
25282787|NCT00909532|50597867|FG000|Overall Study|Withdrawal of Consent|1|||
25282788|NCT00909532|50597868|FG001|Overall Study|Withdrawal of Consent|1|||
25282789|NCT00909532|50597867|FG000|Overall Study|Noncompliance with Study Requirements|0|||
25282790|NCT00909532|50597868|FG001|Overall Study|Noncompliance with Study Requirements|2|||
25282791|NCT00909532|50597867|FG000|Overall Study|Physician Decision|1|||
25282792|NCT00909532|50597868|FG001|Overall Study|Physician Decision|0|||
25282793|NCT00909532|50597867|FG000|Overall Study|Wrong Genotype|1|||
25282794|NCT00909532|50597868|FG001|Overall Study|Wrong Genotype|0|||
25282795|NCT00909532|50597867|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
25282796|NCT00909532|50597868|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
25282797|NCT01136382|50597877|FG000|Overall Study|Other|8|||
25282798|NCT01136382|50597878|FG001|Overall Study|Other|3|||
25282799|NCT01136382|50597877|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
25191371|NCT02607306|50350184|FG001|Overall Study|Adverse Event|6|||
25191372|NCT02607306|50350185|FG002|Overall Study|Adverse Event|6|||
25191373|NCT02607306|50350183|FG000|Overall Study|Unclassified|1|||
25191374|NCT02607306|50350184|FG001|Overall Study|Unclassified|4|||
25191375|NCT02607306|50350185|FG002|Overall Study|Unclassified|0|||
25191376|NCT02607306|50350183|FG000|Overall Study|Withdrawal by Subject|8|||
25191377|NCT02607306|50350184|FG001|Overall Study|Withdrawal by Subject|10|||
25191378|NCT02607306|50350185|FG002|Overall Study|Withdrawal by Subject|2|||
25282800|NCT01136382|50597878|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
25282801|NCT01136382|50597877|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
25282802|NCT01136382|50597878|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
25282803|NCT01136382|50597877|FG000|Overall Study|Withdrawal by Subject|4|||
25169122|NCT01848353|50300272|FG002|Phase 1|Withdrawal by Subject|0|||
25169123|NCT01848353|50300273|FG003|Phase 1|Withdrawal by Subject|0|||
25169124|NCT01848353|50300270|FG000|Phase 2|Withdrawal by Subject|3|||
25169125|NCT01848353|50300271|FG001|Phase 2|Withdrawal by Subject|2|||
25169126|NCT01848353|50300272|FG002|Phase 2|Withdrawal by Subject|0|||
25169127|NCT01848353|50300273|FG003|Phase 2|Withdrawal by Subject|0|||
25169128|NCT01848353|50300270|FG000|Phase 3|Withdrawal by Subject|1|||
25169129|NCT01848353|50300271|FG001|Phase 3|Withdrawal by Subject|1|||
25169130|NCT01848353|50300272|FG002|Phase 3|Withdrawal by Subject|0|||
25169131|NCT01848353|50300273|FG003|Phase 3|Withdrawal by Subject|0|||
25169132|NCT01847885|50300302|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
25169133|NCT01847885|50300303|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
25169134|NCT01847885|50300304|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
25169135|NCT01847885|50300302|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
25169136|NCT01847885|50300303|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
25169137|NCT01847885|50300304|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
25169138|NCT01847885|50300302|FG000|Initial Enrollment (Consented)|Screen failure|39|||
25169139|NCT01847885|50300303|FG001|Initial Enrollment (Consented)|Screen failure|0|||
25169140|NCT01847885|50300304|FG002|Initial Enrollment (Consented)|Screen failure|0|||
25169141|NCT01847885|50300302|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
25169142|NCT01847885|50300303|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
25169143|NCT01847885|50300304|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
25169144|NCT01847885|50300302|FG000|Randomization|Protocol Violation|0|||
25169145|NCT01847885|50300303|FG001|Randomization|Protocol Violation|1|||
25169146|NCT01847885|50300304|FG002|Randomization|Protocol Violation|0|||
25169147|NCT01847885|50300302|FG000|Randomization|Withdrawal by Subject|0|||
25169148|NCT01847885|50300303|FG001|Randomization|Withdrawal by Subject|0|||
25169149|NCT01847885|50300304|FG002|Randomization|Withdrawal by Subject|2|||
25169150|NCT01847885|50300302|FG000|Randomization|Screen Failure|0|||
25169151|NCT01847885|50300303|FG001|Randomization|Screen Failure|3|||
25169152|NCT01847885|50300304|FG002|Randomization|Screen Failure|0|||
25169153|NCT01867307|50300342|FG000|Overall Study|Protocol Violation|2|||
25169154|NCT01867307|50300343|FG001|Overall Study|Protocol Violation|0|||
25169155|NCT01867307|50300342|FG000|Overall Study|Other Adverse Event|1|||
25169156|NCT01867307|50300343|FG001|Overall Study|Other Adverse Event|3|||
25169157|NCT01845077|50300352|FG000|Washout Period|Lost to Follow-up|0|||
25169158|NCT01845077|50300353|FG001|Washout Period|Lost to Follow-up|1|||
25169159|NCT01845077|50300354|FG002|Washout Period|Lost to Follow-up|0|||
25169160|NCT01845077|50300355|FG003|Washout Period|Lost to Follow-up|1|||
25282804|NCT01136382|50597878|FG001|Overall Study|Withdrawal by Subject|1|||
25169161|NCT01845077|50300356|FG004|Washout Period|Lost to Follow-up|0|||
25169162|NCT01845077|50300357|FG005|Washout Period|Lost to Follow-up|1|||
25191379|NCT02607306|50350183|FG000|Overall Study|Lack of Efficacy|0|||
25191380|NCT02607306|50350184|FG001|Overall Study|Lack of Efficacy|1|||
25282805|NCT00912028|50597887|FG000|Overall Study|Lost to Follow-up|2|||
25282806|NCT00912028|50597888|FG001|Overall Study|Lost to Follow-up|3|||
25282807|NCT00912028|50597889|FG002|Overall Study|Lost to Follow-up|0|||
25282808|NCT00912028|50597890|FG003|Overall Study|Lost to Follow-up|1|||
25282809|NCT00912028|50597891|FG004|Overall Study|Lost to Follow-up|3|||
25282810|NCT00912028|50597887|FG000|Overall Study|Withdrawal by Subject|3|||
25282811|NCT00912028|50597888|FG001|Overall Study|Withdrawal by Subject|0|||
25282812|NCT00912028|50597889|FG002|Overall Study|Withdrawal by Subject|0|||
25282813|NCT00912028|50597890|FG003|Overall Study|Withdrawal by Subject|0|||
25282814|NCT00912028|50597891|FG004|Overall Study|Withdrawal by Subject|0|||
25282815|NCT02731729|50597903|FG000|Overall Study|Death|2|||
25282816|NCT02731729|50597904|FG001|Overall Study|Death|2|||
25282817|NCT02731729|50597903|FG000|Overall Study|Study terminated by Sponsor|6|||
25282818|NCT02731729|50597904|FG001|Overall Study|Study terminated by Sponsor|6|||
25282819|NCT02731729|50597903|FG000|Overall Study|Withdrawal by Subject|1|||
25282820|NCT02731729|50597904|FG001|Overall Study|Withdrawal by Subject|0|||
25282821|NCT01119066|50597914|FG000|Overall Study|Withdrawal by Subject|4|||
25282822|NCT01119066|50597915|FG001|Overall Study|Withdrawal by Subject|6|||
25282823|NCT01119066|50597916|FG002|Overall Study|Withdrawal by Subject|0|||
25282824|NCT01119066|50597917|FG003|Overall Study|Withdrawal by Subject|0|||
25282825|NCT01119066|50597914|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
25282826|NCT01119066|50597915|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
25282827|NCT01119066|50597916|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
25282828|NCT01119066|50597917|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
25282829|NCT01119066|50597914|FG000|Overall Study|Relapse identified before transplant|1|||
25282830|NCT01119066|50597915|FG001|Overall Study|Relapse identified before transplant|0|||
25282831|NCT01119066|50597916|FG002|Overall Study|Relapse identified before transplant|0|||
25282832|NCT01119066|50597917|FG003|Overall Study|Relapse identified before transplant|0|||
25282833|NCT01119066|50597914|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
25282834|NCT01119066|50597915|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
25282835|NCT01119066|50597916|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
25282836|NCT01119066|50597917|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
25282837|NCT01119066|50597914|FG000|Overall Study|Relapse identified before transplant|0|||
25282838|NCT01119066|50597915|FG001|Overall Study|Relapse identified before transplant|4|||
25282839|NCT01119066|50597916|FG002|Overall Study|Relapse identified before transplant|0|||
25282840|NCT01119066|50597917|FG003|Overall Study|Relapse identified before transplant|0|||
25282841|NCT00910624|50597931|FG000|Treatment Phase|Adverse Event|2|||
25282842|NCT00910624|50597932|FG001|Treatment Phase|Adverse Event|6|||
25282843|NCT00910624|50597933|FG002|Treatment Phase|Adverse Event|6|||
25282844|NCT00910624|50597934|FG003|Treatment Phase|Adverse Event|0|||
25282845|NCT00910624|50597931|FG000|Treatment Phase|Treatment Failure|23|||
25282846|NCT00910624|50597932|FG001|Treatment Phase|Treatment Failure|10|||
25282847|NCT00910624|50597933|FG002|Treatment Phase|Treatment Failure|0|||
25282848|NCT00910624|50597934|FG003|Treatment Phase|Treatment Failure|0|||
25282849|NCT00910624|50597931|FG000|Treatment Phase|Lost to Follow-up|0|||
25282850|NCT00910624|50597932|FG001|Treatment Phase|Lost to Follow-up|0|||
25282851|NCT00910624|50597933|FG002|Treatment Phase|Lost to Follow-up|1|||
25282852|NCT00910624|50597934|FG003|Treatment Phase|Lost to Follow-up|0|||
25282853|NCT00910624|50597931|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
25282854|NCT00910624|50597932|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
25282855|NCT00910624|50597933|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
25282856|NCT00910624|50597934|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
25282857|NCT00910624|50597931|FG000|Treatment Phase|Withdrawal by Subject|2|||
25282858|NCT00910624|50597932|FG001|Treatment Phase|Withdrawal by Subject|1|||
25282859|NCT00910624|50597933|FG002|Treatment Phase|Withdrawal by Subject|0|||
25282860|NCT00910624|50597934|FG003|Treatment Phase|Withdrawal by Subject|0|||
25282861|NCT00910624|50597931|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
25282862|NCT00910624|50597932|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
25282863|NCT00910624|50597933|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
25282864|NCT00910624|50597934|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
25282865|NCT00910624|50597931|FG000|Follow-Up Phase|Adverse Event|0|||
25282866|NCT00910624|50597932|FG001|Follow-Up Phase|Adverse Event|0|||
25282867|NCT00910624|50597933|FG002|Follow-Up Phase|Adverse Event|1|||
25282868|NCT00910624|50597934|FG003|Follow-Up Phase|Adverse Event|0|||
25282869|NCT00910624|50597931|FG000|Follow-Up Phase|Lost to Follow-up|3|||
25282870|NCT00910624|50597932|FG001|Follow-Up Phase|Lost to Follow-up|1|||
25282871|NCT00910624|50597933|FG002|Follow-Up Phase|Lost to Follow-up|2|||
25282872|NCT00910624|50597934|FG003|Follow-Up Phase|Lost to Follow-up|0|||
25282873|NCT00910624|50597931|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
25282874|NCT00910624|50597932|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
25282875|NCT00910624|50597933|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
25282876|NCT00910624|50597934|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
25282877|NCT00910624|50597931|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
25282878|NCT00910624|50597932|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
25282879|NCT00910624|50597933|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
25282880|NCT00910624|50597934|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
25282881|NCT00910624|50597931|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
25282882|NCT00910624|50597932|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
25282883|NCT00910624|50597933|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
25282884|NCT00910624|50597934|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
25282885|NCT00910624|50597931|FG000|Follow-Up Phase|Administrative|0|||
25282886|NCT00910624|50597932|FG001|Follow-Up Phase|Administrative|1|||
25282887|NCT00910624|50597933|FG002|Follow-Up Phase|Administrative|1|||
25282888|NCT00910624|50597934|FG003|Follow-Up Phase|Administrative|0|||
25282889|NCT01123980|50597948|FG000|Overall Study|Adverse Event|1|||
25282890|NCT01123980|50597949|FG001|Overall Study|Adverse Event|1|||
25282891|NCT01123980|50597948|FG000|Overall Study|Lack of Efficacy|1|||
25282892|NCT01123980|50597949|FG001|Overall Study|Lack of Efficacy|0|||
25282893|NCT01123980|50597948|FG000|Overall Study|Physician Decision|0|||
25282894|NCT01123980|50597949|FG001|Overall Study|Physician Decision|1|||
25282895|NCT01123980|50597948|FG000|Overall Study|Lost to Follow-up|0|||
25282896|NCT01123980|50597949|FG001|Overall Study|Lost to Follow-up|6|||
25282897|NCT01123980|50597948|FG000|Overall Study|Protocol Violation|6|||
25282898|NCT01123980|50597949|FG001|Overall Study|Protocol Violation|6|||
25282899|NCT01123980|50597948|FG000|Overall Study|Withdrawal by Subject|5|||
25282900|NCT01123980|50597949|FG001|Overall Study|Withdrawal by Subject|3|||
25282901|NCT01123980|50597948|FG000|Overall Study|Unclassified|6|||
25282902|NCT01123980|50597949|FG001|Overall Study|Unclassified|7|||
25282903|NCT01118520|50597958|FG000|Overall Study|AAA repair|9|||
25282904|NCT01118520|50597959|FG001|Overall Study|AAA repair|7|||
25282905|NCT01118520|50597960|FG002|Overall Study|AAA repair|9|||
25282906|NCT01118520|50597958|FG000|Overall Study|Adverse Event|3|||
25282907|NCT01118520|50597959|FG001|Overall Study|Adverse Event|3|||
25282908|NCT01118520|50597960|FG002|Overall Study|Adverse Event|3|||
25282909|NCT01118520|50597958|FG000|Overall Study|Withdrawal by Subject|8|||
25282910|NCT01118520|50597959|FG001|Overall Study|Withdrawal by Subject|13|||
25282911|NCT01118520|50597960|FG002|Overall Study|Withdrawal by Subject|8|||
25282912|NCT01135992|50597968|FG000|Overall Study|Adverse Event|1|||
25282913|NCT01135992|50597968|FG000|Overall Study|Lack of Efficacy|1|||
25282914|NCT01135992|50597968|FG000|Overall Study|Protocol Violation|2|||
25282915|NCT01135992|50597968|FG000|Overall Study|Withdrawal criteria|10|||
25282916|NCT01135992|50597968|FG000|Overall Study|Unclassified|7|||
25282917|NCT00959049|50597978|FG000|Overall Study|Adverse Event|1|||
25282918|NCT00959049|50597979|FG001|Overall Study|Adverse Event|0|||
25282919|NCT00959049|50597980|FG002|Overall Study|Adverse Event|0|||
25282920|NCT00959049|50597981|FG003|Overall Study|Adverse Event|0|||
25282921|NCT00959049|50597982|FG004|Overall Study|Adverse Event|0|||
25282922|NCT00959049|50597983|FG005|Overall Study|Adverse Event|0|||
25282923|NCT00959049|50597978|FG000|Overall Study|Lost to Follow-up|17|||
25282924|NCT00959049|50597979|FG001|Overall Study|Lost to Follow-up|5|||
25282925|NCT00959049|50597980|FG002|Overall Study|Lost to Follow-up|1|||
25282926|NCT00959049|50597981|FG003|Overall Study|Lost to Follow-up|10|||
25282927|NCT00959049|50597982|FG004|Overall Study|Lost to Follow-up|9|||
25282928|NCT00959049|50597983|FG005|Overall Study|Lost to Follow-up|1|||
25282929|NCT00959049|50597978|FG000|Overall Study|Contraindicated medication|0|||
25282930|NCT00959049|50597979|FG001|Overall Study|Contraindicated medication|0|||
25282931|NCT00959049|50597980|FG002|Overall Study|Contraindicated medication|0|||
25282932|NCT00959049|50597981|FG003|Overall Study|Contraindicated medication|1|||
25282933|NCT00959049|50597982|FG004|Overall Study|Contraindicated medication|0|||
25282934|NCT00959049|50597983|FG005|Overall Study|Contraindicated medication|0|||
25282935|NCT00959049|50597978|FG000|Overall Study|Withdrawal by Subject|0|||
25282936|NCT00959049|50597979|FG001|Overall Study|Withdrawal by Subject|2|||
25282937|NCT00959049|50597980|FG002|Overall Study|Withdrawal by Subject|0|||
25282938|NCT00959049|50597981|FG003|Overall Study|Withdrawal by Subject|0|||
25282939|NCT00959049|50597982|FG004|Overall Study|Withdrawal by Subject|0|||
25282940|NCT00959049|50597983|FG005|Overall Study|Withdrawal by Subject|0|||
25169163|NCT01845077|50300352|FG000|Washout Period|Adverse Event|1|||
25282941|NCT00956943|50598010|FG000|Overall Study|Lost to Follow-up|9|||
25282942|NCT00956943|50598011|FG001|Overall Study|Lost to Follow-up|10|||
25282943|NCT00958893|50598017|FG000|Overall Study|Study prematurely terminated|4|||
25282944|NCT01135914|50598024|FG000|Overall Study|Withdrawal by Subject|1|||
25282945|NCT01135914|50598025|FG001|Overall Study|Withdrawal by Subject|3|||
25282946|NCT01135914|50598026|FG002|Overall Study|Withdrawal by Subject|6|||
25282947|NCT01135914|50598024|FG000|Overall Study|Lost to Follow-up|1|||
25282948|NCT01135914|50598025|FG001|Overall Study|Lost to Follow-up|0|||
25282949|NCT01135914|50598026|FG002|Overall Study|Lost to Follow-up|1|||
25282950|NCT01135914|50598024|FG000|Overall Study|Protocol Violation|0|||
25282951|NCT01135914|50598025|FG001|Overall Study|Protocol Violation|0|||
25282952|NCT01135914|50598026|FG002|Overall Study|Protocol Violation|3|||
25282953|NCT01135914|50598024|FG000|Overall Study|Lack of Efficacy|2|||
25282954|NCT01135914|50598025|FG001|Overall Study|Lack of Efficacy|1|||
25282955|NCT01135914|50598026|FG002|Overall Study|Lack of Efficacy|10|||
25282956|NCT01135914|50598024|FG000|Overall Study|Adverse Event|0|||
25282957|NCT01135914|50598025|FG001|Overall Study|Adverse Event|1|||
25282958|NCT01135914|50598026|FG002|Overall Study|Adverse Event|2|||
25282959|NCT00907738|50598039|FG000|Overall Study|Adverse Event|2|||
25282960|NCT00907738|50598040|FG001|Overall Study|Adverse Event|0|||
25282961|NCT00907738|50598041|FG002|Overall Study|Adverse Event|1|||
25282962|NCT00907738|50598042|FG003|Overall Study|Adverse Event|0|||
25282963|NCT00907738|50598043|FG004|Overall Study|Adverse Event|0|||
25282964|NCT00907738|50598039|FG000|Overall Study|not specified or withdrew consent|3|||
25282965|NCT00907738|50598040|FG001|Overall Study|not specified or withdrew consent|0|||
25282966|NCT00907738|50598041|FG002|Overall Study|not specified or withdrew consent|0|||
25282967|NCT00907738|50598042|FG003|Overall Study|not specified or withdrew consent|0|||
25282968|NCT00907738|50598043|FG004|Overall Study|not specified or withdrew consent|0|||
25282969|NCT00907738|50598039|FG000|Overall Study|Disease progression|8|||
25282970|NCT00907738|50598040|FG001|Overall Study|Disease progression|1|||
25282971|NCT00907738|50598041|FG002|Overall Study|Disease progression|6|||
25282972|NCT00907738|50598042|FG003|Overall Study|Disease progression|4|||
25282973|NCT00907738|50598043|FG004|Overall Study|Disease progression|2|||
25282974|NCT01123356|50598059|FG000|Overall Study|Adverse Event|2|||
25282975|NCT01123356|50598059|FG000|Overall Study|Lack of Efficacy|4|||
25282976|NCT01123356|50598059|FG000|Overall Study|Withdrawal by Subject|1|||
25282977|NCT00908596|50598068|FG000|Overall Study|Other reasons|46|||
25282978|NCT00908596|50598069|FG001|Overall Study|Other reasons|6|||
25282979|NCT00908596|50598070|FG002|Overall Study|Other reasons|2|||
25282980|NCT00908596|50598071|FG003|Overall Study|Other reasons|0|||
25282981|NCT00908596|50598068|FG000|Overall Study|Lost to Follow-up|0|||
25282982|NCT00908596|50598069|FG001|Overall Study|Lost to Follow-up|1|||
25282983|NCT00908596|50598070|FG002|Overall Study|Lost to Follow-up|12|||
25282984|NCT00908596|50598071|FG003|Overall Study|Lost to Follow-up|4|||
25282985|NCT00908596|50598068|FG000|Overall Study|Death|0|||
25282986|NCT00908596|50598069|FG001|Overall Study|Death|5|||
25282987|NCT00908596|50598070|FG002|Overall Study|Death|57|||
25282988|NCT00908596|50598071|FG003|Overall Study|Death|32|||
25282989|NCT00908596|50598068|FG000|Overall Study|Protocol Violation|1|||
25282990|NCT00908596|50598069|FG001|Overall Study|Protocol Violation|0|||
25282991|NCT00908596|50598070|FG002|Overall Study|Protocol Violation|0|||
25282992|NCT00908596|50598071|FG003|Overall Study|Protocol Violation|0|||
25282993|NCT00908596|50598068|FG000|Overall Study|Withdrawal by Subject|0|||
25282994|NCT00908596|50598069|FG001|Overall Study|Withdrawal by Subject|1|||
25282995|NCT00908596|50598070|FG002|Overall Study|Withdrawal by Subject|3|||
25282996|NCT00908596|50598071|FG003|Overall Study|Withdrawal by Subject|1|||
25282997|NCT01118052|50598081|FG000|Overall Study|Never treated|2|||
25282998|NCT01123200|50598091|FG000|Overall Study|Withdrawal by Subject|1|||
25282999|NCT00955617|50598095|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
25283000|NCT00955617|50598096|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
25283001|NCT00955617|50598095|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
25283002|NCT00955617|50598096|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
25283003|NCT00955617|50598095|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
25283004|NCT00955617|50598096|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
25283005|NCT00955617|50598095|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
25283006|NCT00955617|50598096|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
25283007|NCT00958347|50598102|FG000|Overall Study|Death|43|||
25283008|NCT00958347|50598102|FG000|Overall Study|Withdrawal by Subject|23|||
25283009|NCT00958347|50598102|FG000|Overall Study|Lost to Follow-up|15|||
25283010|NCT00958347|50598102|FG000|Overall Study|revision/removal|10|||
25283011|NCT00958347|50598102|FG000|Overall Study|study termination|135|||
25283012|NCT00958191|50598106|FG000|Overall Study|Death|4|||
25283013|NCT00958191|50598106|FG000|Overall Study|Lost to Follow-up|5|||
25283014|NCT00958191|50598106|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
25283015|NCT00958191|50598106|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
25283016|NCT00958191|50598106|FG000|Overall Study|Revision of study device|4|||
25283017|NCT00958191|50598106|FG000|Overall Study|Site termination|11|||
25283018|NCT00958191|50598106|FG000|Overall Study|No 5 yr x-rays|56|||
25283019|NCT00960843|50598114|FG000|Overall Study|Lost to Follow-up|2|||
25283020|NCT00960843|50598115|FG001|Overall Study|Lost to Follow-up|0|||
25283021|NCT00960843|50598114|FG000|Overall Study|Protocol Violation|0|||
25283022|NCT00960843|50598115|FG001|Overall Study|Protocol Violation|4|||
25283023|NCT00960843|50598114|FG000|Overall Study|Repeated needle dislodgment|0|||
25283024|NCT00960843|50598115|FG001|Overall Study|Repeated needle dislodgment|1|||
25283025|NCT01874353|50598123|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
25169164|NCT01845077|50300353|FG001|Washout Period|Adverse Event|0|||
25283026|NCT01874353|50598124|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
25283027|NCT01874353|50598125|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
25283028|NCT01874353|50598126|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
25283029|NCT01874353|50598123|FG000|Overall Study|Lost to Follow-up|2|||
25283030|NCT01874353|50598124|FG001|Overall Study|Lost to Follow-up|2|||
25283031|NCT01874353|50598125|FG002|Overall Study|Lost to Follow-up|2|||
25283032|NCT01874353|50598126|FG003|Overall Study|Lost to Follow-up|0|||
25283033|NCT01874353|50598123|FG000|Overall Study|Death|110|||
25283034|NCT01874353|50598124|FG001|Overall Study|Death|60|||
25283035|NCT01874353|50598125|FG002|Overall Study|Death|13|||
25283036|NCT01874353|50598126|FG003|Overall Study|Death|7|||
25283037|NCT01874353|50598123|FG000|Overall Study|Withdrawal by Subject|13|||
25283038|NCT01874353|50598124|FG001|Overall Study|Withdrawal by Subject|11|||
25283039|NCT01874353|50598125|FG002|Overall Study|Withdrawal by Subject|0|||
25283040|NCT01874353|50598126|FG003|Overall Study|Withdrawal by Subject|0|||
25283041|NCT02396199|50598138|FG000|Overall Study|Lost to Follow-up|1|||
25283042|NCT02396199|50598138|FG000|Overall Study|Death|4|||
25283043|NCT01605253|50598144|FG000|Overall Study|Physician Decision|3|||
25283044|NCT01605253|50598145|FG001|Overall Study|Physician Decision|2|||
25283045|NCT01605253|50598144|FG000|Overall Study|Lost to Follow-up|3|||
25283046|NCT01605253|50598145|FG001|Overall Study|Lost to Follow-up|1|||
25283047|NCT00955305|50598155|FG000|Overall Study|Disease progression|39|||
25283048|NCT00955305|50598156|FG001|Overall Study|Disease progression|41|||
25283049|NCT00955305|50598155|FG000|Overall Study|Adverse Event|22|||
25283050|NCT00955305|50598156|FG001|Overall Study|Adverse Event|22|||
25283051|NCT00955305|50598155|FG000|Overall Study|Death|2|||
25283052|NCT00955305|50598156|FG001|Overall Study|Death|1|||
25283053|NCT00955305|50598155|FG000|Overall Study|Withdrawal by Subject|5|||
25283054|NCT00955305|50598156|FG001|Overall Study|Withdrawal by Subject|4|||
25283055|NCT00955305|50598155|FG000|Overall Study|Alternative therapy|4|||
25283056|NCT00955305|50598156|FG001|Overall Study|Alternative therapy|0|||
25283057|NCT00955305|50598155|FG000|Overall Study|Other complicating disease|2|||
25283058|NCT00955305|50598156|FG001|Overall Study|Other complicating disease|4|||
25283059|NCT00955305|50598155|FG000|Overall Study|Physician Decision|1|||
25283060|NCT00955305|50598156|FG001|Overall Study|Physician Decision|0|||
25283061|NCT00955305|50598155|FG000|Overall Study|Continued presence of residual disease|0|||
25283062|NCT00955305|50598156|FG001|Overall Study|Continued presence of residual disease|1|||
25283063|NCT00955305|50598155|FG000|Overall Study|Functional decline|2|||
25283064|NCT00955305|50598156|FG001|Overall Study|Functional decline|0|||
25283065|NCT00955305|50598155|FG000|Overall Study|Maximum response achieved|0|||
25283066|NCT00955305|50598156|FG001|Overall Study|Maximum response achieved|1|||
25283067|NCT00955305|50598155|FG000|Overall Study|Lost to Follow-up|0|||
25283068|NCT00955305|50598156|FG001|Overall Study|Lost to Follow-up|1|||
25283069|NCT00955305|50598155|FG000|Overall Study|No off-treatment reason submitted|1|||
25283070|NCT00955305|50598156|FG001|Overall Study|No off-treatment reason submitted|0|||
25283071|NCT00955305|50598155|FG000|Overall Study|Never started protocol treatment|5|||
25283072|NCT00955305|50598156|FG001|Overall Study|Never started protocol treatment|5|||
25283073|NCT00955305|50598155|FG000|Overall Study|Ineligible|5|||
25283074|NCT00955305|50598156|FG001|Overall Study|Ineligible|7|||
25283075|NCT00598585|50598164|FG000|Overall Study|Lost to Follow-up|1|||
25283076|NCT00598585|50598165|FG001|Overall Study|Lost to Follow-up|0|||
25283077|NCT00953667|50598171|FG000|Overall Study|Lost to Follow-up|11|||
25283078|NCT00953667|50598171|FG000|Overall Study|Physician Decision|35|||
25283079|NCT00953667|50598171|FG000|Overall Study|Withdrawal by Subject|63|||
25283080|NCT00953667|50598171|FG000|Overall Study|Adverse Event|10|||
25283081|NCT00953667|50598171|FG000|Overall Study|poor venous access,unable to draw blood|4|||
25283082|NCT00883129|50598177|FG000|Overall Study|Adverse Event|7|||
25283083|NCT00883129|50598178|FG001|Overall Study|Adverse Event|15|||
25283084|NCT00883129|50598177|FG000|Overall Study|Withdrawal by Subject|8|||
25283085|NCT00883129|50598178|FG001|Overall Study|Withdrawal by Subject|9|||
25283086|NCT00883129|50598177|FG000|Overall Study|Non-compliance|3|||
25283087|NCT00883129|50598178|FG001|Overall Study|Non-compliance|6|||
25283088|NCT00883129|50598177|FG000|Overall Study|Lost to Follow-up|1|||
25283089|NCT00883129|50598178|FG001|Overall Study|Lost to Follow-up|2|||
25283090|NCT00883129|50598177|FG000|Overall Study|Death|1|||
25283091|NCT00883129|50598178|FG001|Overall Study|Death|2|||
25283092|NCT00883129|50598177|FG000|Overall Study|Defined Treatment Failure|0|||
25283093|NCT00883129|50598178|FG001|Overall Study|Defined Treatment Failure|2|||
25283094|NCT00905632|50598209|FG000|Overall Study|Adverse Event|0|||
25283095|NCT00905632|50598210|FG001|Overall Study|Adverse Event|0|||
25283096|NCT00905632|50598211|FG002|Overall Study|Adverse Event|0|||
25283097|NCT00905632|50598212|FG003|Overall Study|Adverse Event|0|||
25283098|NCT00905632|50598213|FG004|Overall Study|Adverse Event|0|||
25283099|NCT00905632|50598214|FG005|Overall Study|Adverse Event|1|||
25283100|NCT00905632|50598215|FG006|Overall Study|Adverse Event|4|||
25283101|NCT00954447|50598240|FG000|Overall Study|Adverse Event|33|||
25283102|NCT00954447|50598241|FG001|Overall Study|Adverse Event|25|||
25283103|NCT00954447|50598240|FG000|Overall Study|Lack of Efficacy|17|||
25283104|NCT00954447|50598241|FG001|Overall Study|Lack of Efficacy|3|||
25283105|NCT00954447|50598240|FG000|Overall Study|Protocol Violation|5|||
25283106|NCT00954447|50598241|FG001|Overall Study|Protocol Violation|7|||
25283107|NCT00954447|50598240|FG000|Overall Study|Lost to Follow-up|8|||
25283108|NCT00954447|50598241|FG001|Overall Study|Lost to Follow-up|14|||
25283109|NCT00954447|50598240|FG000|Overall Study|Withdrawal by Subject|26|||
25283110|NCT00954447|50598241|FG001|Overall Study|Withdrawal by Subject|21|||
25283111|NCT00954447|50598240|FG000|Overall Study|Other|21|||
25283112|NCT00954447|50598241|FG001|Overall Study|Other|18|||
25283113|NCT00904150|50598249|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
25283114|NCT00904150|50598250|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
25283115|NCT00904150|50598249|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
25283116|NCT00904150|50598250|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
25283117|NCT00903760|50598258|FG000|Overall Study|Disease Progression/Death|8|||
25283118|NCT00903760|50598259|FG001|Overall Study|Disease Progression/Death|6|||
25191381|NCT02607306|50350185|FG002|Overall Study|Lack of Efficacy|1|||
25191382|NCT02607306|50350183|FG000|Overall Study|Protocol Violation|4|||
25191383|NCT02607306|50350184|FG001|Overall Study|Protocol Violation|2|||
25191384|NCT02607306|50350185|FG002|Overall Study|Protocol Violation|1|||
25283119|NCT00903760|50598258|FG000|Overall Study|Stem Cell Transplant|8|||
25283120|NCT00903760|50598259|FG001|Overall Study|Stem Cell Transplant|4|||
25283121|NCT00903760|50598258|FG000|Overall Study|Physician Decision|1|||
25283122|NCT00903760|50598259|FG001|Overall Study|Physician Decision|2|||
25283123|NCT00903760|50598258|FG000|Overall Study|Death|0|||
25283124|NCT00903760|50598259|FG001|Overall Study|Death|1|||
25283125|NCT00903760|50598258|FG000|Overall Study|Lost to Follow-up|1|||
25283126|NCT00903760|50598259|FG001|Overall Study|Lost to Follow-up|0|||
25283127|NCT00903760|50598258|FG000|Overall Study|Withdrawal by Subject|1|||
25283128|NCT00903760|50598259|FG001|Overall Study|Withdrawal by Subject|2|||
25283129|NCT00903760|50598258|FG000|Overall Study|Off treatment for long period|0|||
25283130|NCT00903760|50598259|FG001|Overall Study|Off treatment for long period|1|||
25283131|NCT00883051|50598270|FG000|Overall Study|Lost to Follow-up|0|||
25283132|NCT00883051|50598271|FG001|Overall Study|Lost to Follow-up|0|||
25283133|NCT00883051|50598272|FG002|Overall Study|Lost to Follow-up|0|||
25283134|NCT00883051|50598273|FG003|Overall Study|Lost to Follow-up|0|||
25283135|NCT00883051|50598274|FG004|Overall Study|Lost to Follow-up|1|||
25283136|NCT00883051|50598270|FG000|Overall Study|Did not use study medication|24|||
25283137|NCT00883051|50598271|FG001|Overall Study|Did not use study medication|22|||
25283138|NCT00883051|50598272|FG002|Overall Study|Did not use study medication|29|||
25283139|NCT00883051|50598273|FG003|Overall Study|Did not use study medication|29|||
25283140|NCT00883051|50598274|FG004|Overall Study|Did not use study medication|17|||
25283141|NCT00903682|50598288|FG000|Overall Study|Adverse Event|6|||
25283142|NCT00903682|50598289|FG001|Overall Study|Adverse Event|13|||
25283143|NCT00903682|50598288|FG000|Overall Study|Lost to Follow-up|1|||
25283144|NCT00903682|50598289|FG001|Overall Study|Lost to Follow-up|0|||
25283145|NCT00903682|50598288|FG000|Overall Study|Withdrawal by Subject|5|||
25283146|NCT00903682|50598289|FG001|Overall Study|Withdrawal by Subject|0|||
25283147|NCT00903682|50598288|FG000|Overall Study|Pregnancy|0|||
25283148|NCT00903682|50598289|FG001|Overall Study|Pregnancy|1|||
25283149|NCT00903682|50598288|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
25283150|NCT00903682|50598289|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
25283151|NCT00903682|50598288|FG000|Overall Study|Subject Non-Compliant|1|||
25283152|NCT00903682|50598289|FG001|Overall Study|Subject Non-Compliant|0|||
25283153|NCT00903682|50598288|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
25283154|NCT00903682|50598289|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
25283155|NCT00903682|50598288|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
25283156|NCT00903682|50598289|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
25283157|NCT01117428|50598301|FG000|Overall Study|Lack of Efficacy|1|||
25283158|NCT01117428|50598302|FG001|Overall Study|Lack of Efficacy|0|||
25283159|NCT01117428|50598303|FG002|Overall Study|Lack of Efficacy|0|||
25283160|NCT01117428|50598304|FG003|Overall Study|Lack of Efficacy|0|||
25283161|NCT01117428|50598305|FG004|Overall Study|Lack of Efficacy|0|||
25283162|NCT01117428|50598306|FG005|Overall Study|Lack of Efficacy|0|||
25283163|NCT01117428|50598301|FG000|Overall Study|Adverse Event|4|||
25283164|NCT01117428|50598302|FG001|Overall Study|Adverse Event|0|||
25283165|NCT01117428|50598303|FG002|Overall Study|Adverse Event|0|||
25283166|NCT01117428|50598304|FG003|Overall Study|Adverse Event|0|||
25283167|NCT01117428|50598305|FG004|Overall Study|Adverse Event|1|||
25283168|NCT01117428|50598306|FG005|Overall Study|Adverse Event|2|||
25283169|NCT01117428|50598301|FG000|Overall Study|Death|0|||
25191385|NCT02603952|50350508|FG000|Overall Study|Withdrawal by Subject|1|||
25191386|NCT02603952|50350509|FG001|Overall Study|Withdrawal by Subject|0|||
25191387|NCT02603952|50350510|FG002|Overall Study|Withdrawal by Subject|0|||
25191388|NCT02603952|50350511|FG003|Overall Study|Withdrawal by Subject|0|||
25283170|NCT01117428|50598302|FG001|Overall Study|Death|1|||
25283171|NCT01117428|50598303|FG002|Overall Study|Death|2|||
25191389|NCT02603952|50350508|FG000|Overall Study|Received oseltamivir by error|0|||
25283172|NCT01117428|50598304|FG003|Overall Study|Death|0|||
25283173|NCT01117428|50598305|FG004|Overall Study|Death|0|||
25283174|NCT01117428|50598306|FG005|Overall Study|Death|1|||
25283175|NCT01117428|50598301|FG000|Overall Study|Physician Decision|0|||
25283176|NCT01117428|50598302|FG001|Overall Study|Physician Decision|1|||
25283177|NCT01117428|50598303|FG002|Overall Study|Physician Decision|0|||
25283178|NCT01117428|50598304|FG003|Overall Study|Physician Decision|0|||
25283179|NCT01117428|50598305|FG004|Overall Study|Physician Decision|0|||
25283180|NCT01117428|50598306|FG005|Overall Study|Physician Decision|0|||
25283181|NCT01117428|50598301|FG000|Overall Study|Withdrawal by Subject|0|||
25283182|NCT01117428|50598302|FG001|Overall Study|Withdrawal by Subject|0|||
25283183|NCT01117428|50598303|FG002|Overall Study|Withdrawal by Subject|1|||
25283184|NCT01117428|50598304|FG003|Overall Study|Withdrawal by Subject|0|||
25283185|NCT01117428|50598305|FG004|Overall Study|Withdrawal by Subject|0|||
25283186|NCT01117428|50598306|FG005|Overall Study|Withdrawal by Subject|0|||
25283187|NCT01117428|50598301|FG000|Overall Study|Progressive disease|15|||
25283188|NCT01117428|50598302|FG001|Overall Study|Progressive disease|27|||
25283189|NCT01117428|50598303|FG002|Overall Study|Progressive disease|10|||
25283190|NCT01117428|50598304|FG003|Overall Study|Progressive disease|12|||
25283191|NCT01117428|50598305|FG004|Overall Study|Progressive disease|16|||
25283192|NCT01117428|50598306|FG005|Overall Study|Progressive disease|17|||
25283193|NCT01135524|50598335|FG000|Overall Study|Withdrawal by Subject|14|||
25283194|NCT01135524|50598335|FG000|Overall Study|Adverse Event|20|||
25283195|NCT01135524|50598335|FG000|Overall Study|Lost to Follow-up|3|||
25283196|NCT01135524|50598335|FG000|Overall Study|Administrative|151|||
25283197|NCT01135524|50598335|FG000|Overall Study|Lack of Efficacy|8|||
25283198|NCT00948675|50598341|FG000|Overall Study|Lost to Follow-up|1|||
25283199|NCT00948675|50598342|FG001|Overall Study|Lost to Follow-up|0|||
25283200|NCT00903370|50598350|FG000|Overall Study|Death|13|||
25283201|NCT00903370|50598351|FG001|Overall Study|Death|10|||
25283202|NCT00903370|50598350|FG000|Overall Study|Withdrawal by Subject|9|||
25283203|NCT00903370|50598351|FG001|Overall Study|Withdrawal by Subject|6|||
25283204|NCT00903370|50598350|FG000|Overall Study|Lost to Follow-up|6|||
25283205|NCT00903370|50598351|FG001|Overall Study|Lost to Follow-up|8|||
25283206|NCT01110408|50598359|FG000|Overall Study|Protocol Violation|1|||
25283207|NCT01110408|50598360|FG001|Overall Study|Protocol Violation|0|||
25283208|NCT00953043|50598368|FG000|Overall Study|Withdrawal by Subject|4|||
25283209|NCT00953043|50598369|FG001|Overall Study|Withdrawal by Subject|0|||
25283210|NCT00953043|50598368|FG000|Overall Study|Physician Decision|0|||
25283211|NCT00953043|50598369|FG001|Overall Study|Physician Decision|2|||
25283212|NCT01135134|50598377|FG000|Overall Study|Adverse Event|1|||
25283213|NCT01135134|50598378|FG001|Overall Study|Adverse Event|1|||
25283214|NCT01135134|50598377|FG000|Overall Study|Did not meet protocol eligibility|1|||
25283215|NCT01135134|50598378|FG001|Overall Study|Did not meet protocol eligibility|0|||
25283216|NCT00948441|50598386|FG000|Overall Study|no longer meet inclusion criteria|1|||
25283217|NCT00948441|50598387|FG001|Overall Study|no longer meet inclusion criteria|4|||
25283218|NCT01117350|50598397|FG000|Comparative Period|Not Treated|5|||
25283219|NCT01117350|50598398|FG001|Comparative Period|Not Treated|8|||
25283220|NCT01117350|50598397|FG000|Comparative Period|Adverse Event|6|||
25283221|NCT01117350|50598398|FG001|Comparative Period|Adverse Event|33|||
25283222|NCT01117350|50598397|FG000|Comparative Period|Lost to Follow-up|11|||
25283223|NCT01117350|50598398|FG001|Comparative Period|Lost to Follow-up|7|||
25283224|NCT01117350|50598397|FG000|Comparative Period|Withdrawal by Subject|9|||
25283225|NCT01117350|50598398|FG001|Comparative Period|Withdrawal by Subject|13|||
25283226|NCT01117350|50598397|FG000|Comparative Period|Protocol Violation|8|||
25283227|NCT01117350|50598398|FG001|Comparative Period|Protocol Violation|12|||
25283228|NCT01117350|50598397|FG000|Comparative Period|Lack of Efficacy|1|||
25283229|NCT01117350|50598398|FG001|Comparative Period|Lack of Efficacy|0|||
25283230|NCT01117350|50598397|FG000|Comparative Period|Physician Decision|0|||
25283231|NCT01117350|50598398|FG001|Comparative Period|Physician Decision|1|||
25283232|NCT01117350|50598397|FG000|Comparative Period|Move to another city/country|2|||
25283233|NCT01117350|50598398|FG001|Comparative Period|Move to another city/country|1|||
25283234|NCT01117350|50598397|FG000|Extension Period|Not included in extension, not treated|0|||
25283235|NCT01117350|50598398|FG001|Extension Period|Not included in extension, not treated|50|||
25283236|NCT01117350|50598397|FG000|Extension Period|Adverse Event|0|||
25283237|NCT01117350|50598398|FG001|Extension Period|Adverse Event|2|||
25283238|NCT01117350|50598397|FG000|Extension Period|Protocol Violation|0|||
25283239|NCT01117350|50598398|FG001|Extension Period|Protocol Violation|2|||
25283240|NCT01117350|50598397|FG000|Extension Period|Lost to Follow-up|0|||
25283241|NCT01117350|50598398|FG001|Extension Period|Lost to Follow-up|2|||
25283242|NCT01117350|50598397|FG000|Extension Period|Withdrawal by Subject|0|||
25283243|NCT01117350|50598398|FG001|Extension Period|Withdrawal by Subject|3|||
25283244|NCT01117350|50598397|FG000|Extension Period|Lack of Efficacy|0|||
25283245|NCT01117350|50598398|FG001|Extension Period|Lack of Efficacy|2|||
25283246|NCT01117350|50598397|FG000|Extension Period|Inclusion criteria not respected|0|||
25169165|NCT01845077|50300354|FG002|Washout Period|Adverse Event|0|||
25283247|NCT01117350|50598398|FG001|Extension Period|Inclusion criteria not respected|1|||
25283248|NCT01117350|50598397|FG000|Extension Period|Prohibited medication|0|||
25283249|NCT01117350|50598398|FG001|Extension Period|Prohibited medication|1|||
25283250|NCT00952731|50598409|FG000|Overall Study|Drug supply expired|1|||
25283251|NCT00952731|50598410|FG001|Overall Study|Drug supply expired|0|||
25169166|NCT01845077|50300355|FG003|Washout Period|Adverse Event|0|||
25283252|NCT00947427|50598418|FG000|Overall Study|Withdrawal by Subject|1|||
25283253|NCT00947427|50598419|FG001|Overall Study|Withdrawal by Subject|3|||
25283254|NCT00947427|50598418|FG000|Overall Study|Protocol Violation|0|||
25283255|NCT00947427|50598419|FG001|Overall Study|Protocol Violation|1|||
25283256|NCT01116882|50598427|FG000|30-day|Lost to Follow-up|50|||
25283257|NCT01116882|50598428|FG001|30-day|Lost to Follow-up|21|||
25283258|NCT01116882|50598427|FG000|30-day|Withdrawal by Subject|2|||
25283259|NCT01116882|50598428|FG001|30-day|Withdrawal by Subject|4|||
25283260|NCT01116882|50598427|FG000|30-day|Other Reasons|16|||
25283261|NCT01116882|50598428|FG001|30-day|Other Reasons|6|||
25283262|NCT01116882|50598427|FG000|12-month|Lost to Follow-up|111|||
25283263|NCT01116882|50598428|FG001|12-month|Lost to Follow-up|42|||
25283264|NCT01116882|50598427|FG000|12-month|Other Reasons|151|||
25283265|NCT01116882|50598428|FG001|12-month|Other Reasons|49|||
25283266|NCT01116882|50598427|FG000|12-month|Withdrawal by Subject|5|||
25283267|NCT01116882|50598428|FG001|12-month|Withdrawal by Subject|8|||
25283268|NCT00953745|50598439|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
25283269|NCT00953745|50598440|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
25283270|NCT00953745|50598439|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
25283271|NCT00953745|50598440|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
25283272|NCT00953745|50598439|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
25283273|NCT00953745|50598440|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
25283274|NCT00953745|50598439|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
25283275|NCT00953745|50598440|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
25283276|NCT00953745|50598439|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
25283277|NCT00953745|50598440|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
25283278|NCT00953745|50598439|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
25283279|NCT00953745|50598440|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
25283280|NCT00902746|50598457|FG000|Overall Study|Protocol Violation|7|||
25283281|NCT00902746|50598457|FG000|Overall Study|Withdrawal by Subject|16|||
25283282|NCT00902746|50598457|FG000|Overall Study|Adverse Event|8|||
25283283|NCT00902746|50598457|FG000|Overall Study|Lost to Follow-up|3|||
25283284|NCT00902746|50598457|FG000|Overall Study|Physician Decision|2|||
25283285|NCT00902668|50598470|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
25283286|NCT00947349|50598478|FG000|Triple Treatment Combination Period|Adverse Event|0|||
25283287|NCT00947349|50598479|FG001|Triple Treatment Combination Period|Adverse Event|1|||
25283288|NCT00947349|50598480|FG002|Triple Treatment Combination Period|Adverse Event|0|||
25283289|NCT00947349|50598481|FG003|Triple Treatment Combination Period|Adverse Event|0|||
25283290|NCT00947349|50598478|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
25283291|NCT00947349|50598479|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
25283292|NCT00947349|50598480|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
25283293|NCT00947349|50598481|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
25283294|NCT00947349|50598478|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
25283295|NCT00947349|50598479|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
25283296|NCT00947349|50598480|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
25283297|NCT00947349|50598481|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
25283298|NCT00947349|50598478|FG000|Overall Study Standard of Care|Other|0|||
25283299|NCT00947349|50598479|FG001|Overall Study Standard of Care|Other|0|||
25283300|NCT00947349|50598480|FG002|Overall Study Standard of Care|Other|0|||
25283301|NCT00947349|50598481|FG003|Overall Study Standard of Care|Other|1|||
25283302|NCT00947193|50598509|FG000|Overall Study|Lost to Follow-up|1|||
25283303|NCT00947193|50598510|FG001|Overall Study|Lost to Follow-up|0|||
25283304|NCT00947193|50598509|FG000|Overall Study|Withdrawal by Subject|1|||
25283305|NCT00947193|50598510|FG001|Overall Study|Withdrawal by Subject|0|||
25283306|NCT00947193|50598509|FG000|Overall Study|Factor VIII >1%|1|||
25283307|NCT00947193|50598510|FG001|Overall Study|Factor VIII >1%|0|||
25283308|NCT00947115|50598518|FG000|Overall Study|Missed reporting interval|3|||
25283309|NCT00947115|50598519|FG001|Overall Study|Missed reporting interval|4|||
25283310|NCT00947115|50598520|FG002|Overall Study|Missed reporting interval|2|||
25283311|NCT00947115|50598518|FG000|Overall Study|Physician Decision|0|||
25283312|NCT00947115|50598519|FG001|Overall Study|Physician Decision|2|||
25283313|NCT00947115|50598520|FG002|Overall Study|Physician Decision|0|||
25283314|NCT00947115|50598518|FG000|Overall Study|Death|0|||
25283315|NCT00947115|50598519|FG001|Overall Study|Death|1|||
25283316|NCT00947115|50598520|FG002|Overall Study|Death|1|||
25283317|NCT00947115|50598518|FG000|Overall Study|Migrated from study area|2|||
25283318|NCT00947115|50598519|FG001|Overall Study|Migrated from study area|0|||
25283319|NCT00947115|50598520|FG002|Overall Study|Migrated from study area|0|||
25283320|NCT00947115|50598518|FG000|Overall Study|Withdrawal by Subject|1|||
25283321|NCT00947115|50598519|FG001|Overall Study|Withdrawal by Subject|3|||
25283322|NCT00947115|50598520|FG002|Overall Study|Withdrawal by Subject|4|||
25283323|NCT00947115|50598518|FG000|Overall Study|Lost to Follow-up|11|||
25283324|NCT00947115|50598519|FG001|Overall Study|Lost to Follow-up|12|||
25283325|NCT00947115|50598520|FG002|Overall Study|Lost to Follow-up|8|||
25169167|NCT01845077|50300356|FG004|Washout Period|Adverse Event|0|||
25283326|NCT00952419|50598531|FG000|Overall Study|Adverse Event|2|||
25283327|NCT00952419|50598532|FG001|Overall Study|Adverse Event|0|||
25283328|NCT00952419|50598533|FG002|Overall Study|Adverse Event|0|||
25283329|NCT00952419|50598531|FG000|Overall Study|Protocol Violation|3|||
25283330|NCT00952419|50598532|FG001|Overall Study|Protocol Violation|7|||
25283331|NCT00952419|50598533|FG002|Overall Study|Protocol Violation|0|||
25283332|NCT00952419|50598531|FG000|Overall Study|Withdrawal by Subject|1|||
25283333|NCT00952419|50598532|FG001|Overall Study|Withdrawal by Subject|3|||
25283334|NCT00952419|50598533|FG002|Overall Study|Withdrawal by Subject|0|||
25283335|NCT00902278|50598546|FG000|Overall Study|Physician Decision|1|||
25283336|NCT00902278|50598547|FG001|Overall Study|Physician Decision|0|||
25283337|NCT00902278|50598548|FG002|Overall Study|Physician Decision|2|||
25283338|NCT00902278|50598549|FG003|Overall Study|Physician Decision|0|||
25283339|NCT00902278|50598550|FG004|Overall Study|Physician Decision|1|||
25283340|NCT00902278|50598546|FG000|Overall Study|Lost to Follow-up|3|||
25283341|NCT00902278|50598547|FG001|Overall Study|Lost to Follow-up|2|||
25283342|NCT00902278|50598548|FG002|Overall Study|Lost to Follow-up|3|||
25283343|NCT00902278|50598549|FG003|Overall Study|Lost to Follow-up|0|||
25283344|NCT00902278|50598550|FG004|Overall Study|Lost to Follow-up|1|||
25283345|NCT01998633|50598564|FG000|Overall Study|Death|1|||
25283346|NCT00952341|50598574|FG000|Cycle 1|Adverse Event|4|||
25283347|NCT00952341|50598575|FG001|Cycle 1|Adverse Event|1|||
25283348|NCT00952341|50598574|FG000|Cycle 1|Withdrawal by Subject|3|||
25283349|NCT00952341|50598575|FG001|Cycle 1|Withdrawal by Subject|8|||
25283350|NCT00952341|50598574|FG000|Cycle 1|Protocol Violation|2|||
25283351|NCT00952341|50598575|FG001|Cycle 1|Protocol Violation|1|||
25283352|NCT00952341|50598574|FG000|Cycle 1|Lost to Follow-up|11|||
25283353|NCT00952341|50598575|FG001|Cycle 1|Lost to Follow-up|2|||
25283354|NCT00952341|50598574|FG000|Cycle 1|Physician Decision|0|||
25283355|NCT00952341|50598575|FG001|Cycle 1|Physician Decision|1|||
25283356|NCT00952341|50598574|FG000|Cycle 2|Withdrawal by Subject|1|||
25283357|NCT00952341|50598575|FG001|Cycle 2|Withdrawal by Subject|1|||
25283358|NCT00952341|50598574|FG000|Cycle 2|Protocol Violation|1|||
25283359|NCT00952341|50598575|FG001|Cycle 2|Protocol Violation|0|||
25283360|NCT00952341|50598574|FG000|Cycle 2|Lost to Follow-up|6|||
25283361|NCT00952341|50598575|FG001|Cycle 2|Lost to Follow-up|9|||
25283362|NCT00952341|50598574|FG000|Cycle 2|Physician Decision|1|||
25283363|NCT00952341|50598575|FG001|Cycle 2|Physician Decision|1|||
25283364|NCT00952341|50598574|FG000|Cycle 2|Progressive Disease|0|||
25283365|NCT00952341|50598575|FG001|Cycle 2|Progressive Disease|1|||
25283366|NCT00946881|50598581|FG000|First Treatment|Withdrawal by Subject|1|||
25283367|NCT00946881|50598581|FG000|First Treatment|Patient relocated to another state|1|||
25283368|NCT00946881|50598581|FG000|Retreatment|Withdrawal by Subject|1|||
25283369|NCT01214642|50598618|FG000|Overall Study|Progressive Disease|3|||
25283370|NCT01214642|50598619|FG001|Overall Study|Progressive Disease|2|||
25283371|NCT01214642|50598620|FG002|Overall Study|Progressive Disease|3|||
25283372|NCT01214642|50598621|FG003|Overall Study|Progressive Disease|5|||
25283373|NCT01214642|50598622|FG004|Overall Study|Progressive Disease|5|||
25283374|NCT01214642|50598623|FG005|Overall Study|Progressive Disease|3|||
25283375|NCT01214642|50598624|FG006|Overall Study|Progressive Disease|5|||
25283376|NCT01214642|50598625|FG007|Overall Study|Progressive Disease|3|||
25283377|NCT01214642|50598626|FG008|Overall Study|Progressive Disease|10|||
25283378|NCT01214642|50598627|FG009|Overall Study|Progressive Disease|2|||
25283379|NCT01214642|50598628|FG010|Overall Study|Progressive Disease|1|||
25283380|NCT01214642|50598629|FG011|Overall Study|Progressive Disease|4|||
25283381|NCT01214642|50598618|FG000|Overall Study|Adverse Event|0|||
25283382|NCT01214642|50598619|FG001|Overall Study|Adverse Event|1|||
25283383|NCT01214642|50598620|FG002|Overall Study|Adverse Event|0|||
25283384|NCT01214642|50598621|FG003|Overall Study|Adverse Event|0|||
25283385|NCT01214642|50598622|FG004|Overall Study|Adverse Event|0|||
25283386|NCT01214642|50598623|FG005|Overall Study|Adverse Event|0|||
25283387|NCT01214642|50598624|FG006|Overall Study|Adverse Event|1|||
25283388|NCT01214642|50598625|FG007|Overall Study|Adverse Event|0|||
25283389|NCT01214642|50598626|FG008|Overall Study|Adverse Event|0|||
25283390|NCT01214642|50598627|FG009|Overall Study|Adverse Event|1|||
25283391|NCT01214642|50598628|FG010|Overall Study|Adverse Event|1|||
25283392|NCT01214642|50598629|FG011|Overall Study|Adverse Event|0|||
25283393|NCT01214642|50598618|FG000|Overall Study|Death|0|||
25283394|NCT01214642|50598619|FG001|Overall Study|Death|0|||
25283395|NCT01214642|50598620|FG002|Overall Study|Death|1|||
25283396|NCT01214642|50598621|FG003|Overall Study|Death|0|||
25283397|NCT01214642|50598622|FG004|Overall Study|Death|0|||
25283398|NCT01214642|50598623|FG005|Overall Study|Death|0|||
25283399|NCT01214642|50598624|FG006|Overall Study|Death|0|||
25283400|NCT01214642|50598625|FG007|Overall Study|Death|0|||
25283401|NCT01214642|50598626|FG008|Overall Study|Death|0|||
25283402|NCT01214642|50598627|FG009|Overall Study|Death|0|||
25283403|NCT01214642|50598628|FG010|Overall Study|Death|1|||
25283404|NCT01214642|50598629|FG011|Overall Study|Death|0|||
25283405|NCT01214642|50598618|FG000|Overall Study|Withdrawal by Subject|0|||
25283406|NCT01214642|50598619|FG001|Overall Study|Withdrawal by Subject|0|||
25283407|NCT01214642|50598620|FG002|Overall Study|Withdrawal by Subject|1|||
25283408|NCT01214642|50598621|FG003|Overall Study|Withdrawal by Subject|0|||
25283409|NCT01214642|50598622|FG004|Overall Study|Withdrawal by Subject|0|||
25283410|NCT01214642|50598623|FG005|Overall Study|Withdrawal by Subject|0|||
25283411|NCT01214642|50598624|FG006|Overall Study|Withdrawal by Subject|0|||
25283412|NCT01214642|50598625|FG007|Overall Study|Withdrawal by Subject|0|||
25283413|NCT01214642|50598626|FG008|Overall Study|Withdrawal by Subject|3|||
25283414|NCT01214642|50598627|FG009|Overall Study|Withdrawal by Subject|1|||
25283415|NCT01214642|50598628|FG010|Overall Study|Withdrawal by Subject|1|||
25283416|NCT01214642|50598629|FG011|Overall Study|Withdrawal by Subject|0|||
25283417|NCT01214642|50598618|FG000|Overall Study|Physician Decision|0|||
25283418|NCT01214642|50598619|FG001|Overall Study|Physician Decision|0|||
25283419|NCT01214642|50598620|FG002|Overall Study|Physician Decision|1|||
25283420|NCT01214642|50598621|FG003|Overall Study|Physician Decision|1|||
25283421|NCT01214642|50598622|FG004|Overall Study|Physician Decision|1|||
25283422|NCT01214642|50598623|FG005|Overall Study|Physician Decision|0|||
25283423|NCT01214642|50598624|FG006|Overall Study|Physician Decision|0|||
25283424|NCT01214642|50598625|FG007|Overall Study|Physician Decision|0|||
25283425|NCT01214642|50598626|FG008|Overall Study|Physician Decision|0|||
25283426|NCT01214642|50598627|FG009|Overall Study|Physician Decision|0|||
25283427|NCT01214642|50598628|FG010|Overall Study|Physician Decision|0|||
25283428|NCT01214642|50598629|FG011|Overall Study|Physician Decision|2|||
25283429|NCT01214252|50598672|FG000|Overall Study|Not eligible per protocol|82|||
25283430|NCT01214174|50598680|FG000|Overall Study|Withdrawal by Subject|0|||
25283431|NCT01214174|50598681|FG001|Overall Study|Withdrawal by Subject|0|||
25283432|NCT01214174|50598682|FG002|Overall Study|Withdrawal by Subject|1|||
25283433|NCT00901342|50598690|FG000|Overall Study|Adverse Event|1|||
25283434|NCT00901342|50598690|FG000|Overall Study|Death|4|||
25283435|NCT00901342|50598690|FG000|Overall Study|Disease progression|1|||
25283436|NCT00901342|50598690|FG000|Overall Study|Withdrawal by Subject|9|||
25283437|NCT00901186|50598696|FG000|Overall Study|Lack of Efficacy|0|||
25283438|NCT00901186|50598697|FG001|Overall Study|Lack of Efficacy|1|||
25283439|NCT00901186|50598696|FG000|Overall Study|Abnormal laboratory values|0|||
25283440|NCT00901186|50598697|FG001|Overall Study|Abnormal laboratory values|1|||
25283441|NCT00901186|50598696|FG000|Overall Study|Lost to Follow-up|2|||
25283442|NCT00901186|50598697|FG001|Overall Study|Lost to Follow-up|0|||
25283443|NCT00901186|50598696|FG000|Overall Study|Adverse Event|2|||
25283444|NCT00901186|50598697|FG001|Overall Study|Adverse Event|4|||
25283445|NCT00901186|50598696|FG000|Overall Study|Administration problems|0|||
25283446|NCT00901186|50598697|FG001|Overall Study|Administration problems|1|||
25283447|NCT00901186|50598696|FG000|Overall Study|Protocol deviations|5|||
25283448|NCT00901186|50598697|FG001|Overall Study|Protocol deviations|4|||
25283449|NCT01213472|50598703|FG000|Overall Study|Recurrence/Progressive disease|25|||
25283450|NCT01213472|50598703|FG000|Overall Study|Withdrawal by Subject|1|||
25283451|NCT01213472|50598703|FG000|Overall Study|Physician Decision|1|||
25283452|NCT00900796|50598707|FG000|Phase 1|Lacked sufficient information|4|||
25283453|NCT00900796|50598707|FG000|Phase 1|Missing information at Week 16|7|||
25283454|NCT00900796|50598707|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
25283455|NCT00900796|50598707|FG000|Phase 2|Lost to Follow-up|5|||
25283456|NCT01213082|50598715|FG000|Overall Study|Lost to Follow-up|6|||
25283457|NCT01213082|50598716|FG001|Overall Study|Lost to Follow-up|7|||
25283458|NCT01213082|50598717|FG002|Overall Study|Lost to Follow-up|4|||
25283459|NCT01213082|50598715|FG000|Overall Study|Physician Decision|0|||
25283460|NCT01213082|50598716|FG001|Overall Study|Physician Decision|0|||
25283461|NCT01213082|50598717|FG002|Overall Study|Physician Decision|1|||
25283462|NCT00885703|50598732|FG000|Overall Study|Death|9|||
25283463|NCT00885703|50598733|FG001|Overall Study|Death|7|||
25283464|NCT00885703|50598734|FG002|Overall Study|Death|8|||
25283465|NCT00885703|50598735|FG003|Overall Study|Death|7|||
25283466|NCT00885703|50598736|FG004|Overall Study|Death|7|||
25169168|NCT01845077|50300357|FG005|Washout Period|Adverse Event|0|||
25169169|NCT01845077|50300352|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
25283467|NCT00885703|50598737|FG005|Overall Study|Death|8|||
25283468|NCT00885703|50598738|FG006|Overall Study|Death|4|||
25283469|NCT00885703|50598732|FG000|Overall Study|Lost to Follow-up|0|||
25283470|NCT00885703|50598733|FG001|Overall Study|Lost to Follow-up|0|||
25283471|NCT00885703|50598734|FG002|Overall Study|Lost to Follow-up|1|||
25283472|NCT00885703|50598735|FG003|Overall Study|Lost to Follow-up|0|||
25283473|NCT00885703|50598736|FG004|Overall Study|Lost to Follow-up|0|||
25283474|NCT00885703|50598737|FG005|Overall Study|Lost to Follow-up|1|||
25283475|NCT00885703|50598738|FG006|Overall Study|Lost to Follow-up|0|||
25283476|NCT00885703|50598732|FG000|Overall Study|Withdrawal by Subject|0|||
25283477|NCT00885703|50598733|FG001|Overall Study|Withdrawal by Subject|0|||
25283478|NCT00885703|50598734|FG002|Overall Study|Withdrawal by Subject|0|||
25283479|NCT00885703|50598735|FG003|Overall Study|Withdrawal by Subject|1|||
25283480|NCT00885703|50598736|FG004|Overall Study|Withdrawal by Subject|3|||
25283481|NCT00885703|50598737|FG005|Overall Study|Withdrawal by Subject|1|||
25283482|NCT00885703|50598738|FG006|Overall Study|Withdrawal by Subject|1|||
25283483|NCT00885703|50598732|FG000|Overall Study|Ineligible (no CM)|1|||
25283484|NCT00885703|50598733|FG001|Overall Study|Ineligible (no CM)|3|||
25283485|NCT00885703|50598734|FG002|Overall Study|Ineligible (no CM)|2|||
25283486|NCT00885703|50598735|FG003|Overall Study|Ineligible (no CM)|1|||
25283487|NCT00885703|50598736|FG004|Overall Study|Ineligible (no CM)|2|||
25283488|NCT00885703|50598737|FG005|Overall Study|Ineligible (no CM)|3|||
25283489|NCT00885703|50598738|FG006|Overall Study|Ineligible (no CM)|1|||
25283490|NCT00901576|50598764|FG000|Second Intervention|Withdrawal by Subject|0|||
25283491|NCT00901576|50598765|FG001|Second Intervention|Withdrawal by Subject|0|||
25283492|NCT00901576|50598766|FG002|Second Intervention|Withdrawal by Subject|0|||
25283493|NCT00901576|50598767|FG003|Second Intervention|Withdrawal by Subject|1|||
25069907|NCT02337946|50175702|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
25069908|NCT02337946|50175703|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
25069909|NCT02337946|50175701|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
25069910|NCT02337946|50175702|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
25069911|NCT02337946|50175703|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
25069912|NCT02337946|50175701|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
25069913|NCT02337946|50175702|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
25069914|NCT02337946|50175703|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
25069915|NCT02337946|50175701|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
25069916|NCT02337946|50175702|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
25069917|NCT02337946|50175703|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
25069918|NCT02337946|50175701|FG000|In-between Period|Without Informed Consent|1|||
25069919|NCT02337946|50175702|FG001|In-between Period|Without Informed Consent|0|||
25069920|NCT02337946|50175703|FG002|In-between Period|Without Informed Consent|0|||
25069921|NCT02337946|50175701|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
25069922|NCT02337946|50175702|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
25069923|NCT02337946|50175703|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
25069924|NCT02337946|50175701|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
25069925|NCT02337946|50175702|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
25069926|NCT02337946|50175703|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
25069927|NCT02337946|50175701|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
25069928|NCT02337946|50175702|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
25069929|NCT02337946|50175703|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
25069930|NCT02337946|50175701|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
25069931|NCT02337946|50175702|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
25069932|NCT02337946|50175703|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
25069933|NCT02337946|50175701|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
25069934|NCT02337946|50175702|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
25069935|NCT02337946|50175703|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
25069936|NCT02337946|50175701|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
25069937|NCT02337946|50175702|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
25069938|NCT02337946|50175703|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
25069939|NCT01369199|50175709|FG000|Overall Study|Withdrawal by Subject|1|||
25069940|NCT01369199|50175709|FG000|Overall Study|Lost to Follow-up|2|||
25069941|NCT01368965|50175713|FG000|Overall Study|Lost to Follow-up|12|||
25069942|NCT02610140|50175721|FG000|Randomization and Treatment Period|Radiological progression|23|||
25069943|NCT02610140|50175722|FG001|Randomization and Treatment Period|Radiological progression|15|||
25069944|NCT02610140|50175721|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
25069945|NCT02610140|50175722|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
25069946|NCT02610140|50175721|FG000|Randomization and Treatment Period|Protocol Violation|1|||
25069947|NCT02610140|50175722|FG001|Randomization and Treatment Period|Protocol Violation|0|||
25069948|NCT02610140|50175721|FG000|Randomization and Treatment Period|Physician Decision|0|||
25069949|NCT02610140|50175722|FG001|Randomization and Treatment Period|Physician Decision|1|||
25069950|NCT02610140|50175721|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
25069951|NCT02610140|50175722|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
25069952|NCT02610140|50175721|FG000|Randomization and Treatment Period|Death|7|||
25069953|NCT02610140|50175722|FG001|Randomization and Treatment Period|Death|1|||
25069954|NCT02610140|50175721|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
25069955|NCT02610140|50175722|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
25069956|NCT02610140|50175721|FG000|Randomization and Treatment Period|Adverse Event|44|||
25069957|NCT02610140|50175722|FG001|Randomization and Treatment Period|Adverse Event|13|||
25069958|NCT02610140|50175721|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
25069959|NCT02610140|50175722|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
25283494|NCT00901576|50598768|FG004|Second Intervention|Withdrawal by Subject|0|||
25283495|NCT00901576|50598769|FG005|Second Intervention|Withdrawal by Subject|1|||
25283496|NCT00901576|50598764|FG000|Second Intervention|Physician Decision|1|||
25283497|NCT00901576|50598765|FG001|Second Intervention|Physician Decision|0|||
25283498|NCT00901576|50598766|FG002|Second Intervention|Physician Decision|0|||
25283499|NCT00901576|50598767|FG003|Second Intervention|Physician Decision|0|||
25283500|NCT00901576|50598768|FG004|Second Intervention|Physician Decision|0|||
25283501|NCT00901576|50598769|FG005|Second Intervention|Physician Decision|0|||
25283502|NCT00882583|50598779|FG000|Overall Study|Physician Decision|1|||
25283503|NCT00882583|50598780|FG001|Overall Study|Physician Decision|0|||
25283504|NCT00882583|50598779|FG000|Overall Study|Adverse Event|0|||
25283505|NCT00882583|50598780|FG001|Overall Study|Adverse Event|1|||
25283506|NCT00900562|50598788|FG000|Overall Study|Progressive disease|9|||
25283507|NCT00900562|50598789|FG001|Overall Study|Progressive disease|5|||
25283508|NCT00900562|50598788|FG000|Overall Study|Toxicity|1|||
25283509|NCT00900562|50598789|FG001|Overall Study|Toxicity|0|||
25283510|NCT00900562|50598788|FG000|Overall Study|Death|1|||
25283511|NCT00900562|50598789|FG001|Overall Study|Death|1|||
25283512|NCT00900562|50598788|FG000|Overall Study|Withdrawal by Subject|0|||
25283513|NCT00900562|50598789|FG001|Overall Study|Withdrawal by Subject|1|||
25283514|NCT00900562|50598788|FG000|Overall Study|Unrelated adverse event|1|||
25283515|NCT00900562|50598789|FG001|Overall Study|Unrelated adverse event|0|||
25283516|NCT00599521|50598798|FG000|Overall Study|Lack of Efficacy|4|||
25283517|NCT00599521|50598799|FG001|Overall Study|Lack of Efficacy|8|||
25283518|NCT00599521|50598798|FG000|Overall Study|Adverse Event|4|||
25283519|NCT00599521|50598799|FG001|Overall Study|Adverse Event|1|||
25283520|NCT00599521|50598798|FG000|Overall Study|Withdrawal by Subject|28|||
25283521|NCT00599521|50598799|FG001|Overall Study|Withdrawal by Subject|34|||
25283522|NCT00599521|50598798|FG000|Overall Study|Protocol Violation|1|||
25283523|NCT00599521|50598799|FG001|Overall Study|Protocol Violation|1|||
25283524|NCT00599521|50598798|FG000|Overall Study|Lost to Follow-up|23|||
25283525|NCT00599521|50598799|FG001|Overall Study|Lost to Follow-up|23|||
25283526|NCT00599521|50598798|FG000|Overall Study|Pregnancy|0|||
25283527|NCT00599521|50598799|FG001|Overall Study|Pregnancy|2|||
25283528|NCT00882115|50598805|FG000|Overall Study|Withdrawal by Subject|3|||
25283529|NCT00882115|50598805|FG000|Overall Study|did not respond to DEP challe|6|||
25283530|NCT00881959|50598811|FG000|Overall Study|Lost to Follow-up|2|||
25283531|NCT00881959|50598812|FG001|Overall Study|Lost to Follow-up|4|||
25283532|NCT00884377|50598820|FG000|Overall Study|Withdrawal by Subject|1|||
25283533|NCT00884377|50598821|FG001|Overall Study|Withdrawal by Subject|0|||
25283534|NCT00884377|50598820|FG000|Overall Study|Could not confirm diagnosis|1|||
25283535|NCT00884377|50598821|FG001|Overall Study|Could not confirm diagnosis|0|||
25283536|NCT00884377|50598820|FG000|Overall Study|Physician Decision|0|||
25283537|NCT00884377|50598821|FG001|Overall Study|Physician Decision|1|||
25283538|NCT00884221|50598835|FG000|Overall Study|Withdrawal by Subject|0|||
25283539|NCT00884221|50598836|FG001|Overall Study|Withdrawal by Subject|3|||
25283540|NCT00884221|50598835|FG000|Overall Study|Adverse Event|6|||
25283541|NCT00884221|50598836|FG001|Overall Study|Adverse Event|3|||
25283542|NCT00884221|50598835|FG000|Overall Study|Protocol Violation|16|||
25283543|NCT00884221|50598836|FG001|Overall Study|Protocol Violation|13|||
25283544|NCT00884221|50598835|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
25283545|NCT00884221|50598836|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
25283546|NCT00899548|50598857|FG000|Overall Study|Physician Decision|3|||
25283547|NCT00899392|50598867|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
25283548|NCT00899392|50598868|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
25283549|NCT00690898|50598874|FG000|SCREENING|Screen failure|18|||
25283550|NCT00690898|50598874|FG000|TREATMENT|Adverse Event|3|||
25283551|NCT00690898|50598874|FG000|TREATMENT|Lack of Efficacy|18|||
25283552|NCT00690898|50598874|FG000|TREATMENT|Withdrawal by Subject|4|||
25283553|NCT00690898|50598874|FG000|TREATMENT|Other (not otherwise specified)|1|||
25283554|NCT00895414|50598878|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
25283555|NCT00895414|50598879|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
25283556|NCT00895414|50598878|FG000|First Intervention (14 Days)|Physician Decision|0|||
25283557|NCT00895414|50598879|FG001|First Intervention (14 Days)|Physician Decision|1|||
25283558|NCT01212770|50598888|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
25283559|NCT01212770|50598889|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
25283560|NCT01212770|50598890|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
25283561|NCT01212770|50598891|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25283562|NCT01212770|50598892|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25283563|NCT01212770|50598893|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25283564|NCT01212770|50598894|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25283565|NCT01212770|50598895|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25283566|NCT01212770|50598896|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25283567|NCT01212770|50598888|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
25283568|NCT01212770|50598889|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
25283569|NCT01212770|50598890|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
25283570|NCT01212770|50598891|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25283571|NCT01212770|50598892|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25283572|NCT01212770|50598893|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25283573|NCT01212770|50598894|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25283574|NCT01212770|50598895|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25283575|NCT01212770|50598896|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25283576|NCT01212770|50598888|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
25283577|NCT01212770|50598889|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
25283578|NCT01212770|50598890|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
25283579|NCT01212770|50598891|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
25283580|NCT01212770|50598892|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
25283581|NCT01212770|50598893|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
25283582|NCT01212770|50598894|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
25283583|NCT01212770|50598895|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
25283584|NCT01212770|50598896|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
25283585|NCT01212770|50598888|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
25283586|NCT01212770|50598889|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25283587|NCT01212770|50598890|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
25283588|NCT01212770|50598891|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25283589|NCT01212770|50598892|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25283590|NCT01212770|50598893|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25283591|NCT01212770|50598894|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25283592|NCT01212770|50598895|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25283593|NCT01212770|50598896|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25283594|NCT01212770|50598888|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25283595|NCT01212770|50598889|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25283596|NCT01212770|50598890|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
25283597|NCT01212770|50598891|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25283598|NCT01212770|50598892|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25283599|NCT01212770|50598893|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25283600|NCT01212770|50598894|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25283601|NCT01212770|50598895|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25283602|NCT01212770|50598896|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25283603|NCT01212770|50598888|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
25283604|NCT01212770|50598889|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
25283605|NCT01212770|50598890|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
25283606|NCT01212770|50598891|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
25283607|NCT01212770|50598892|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
25283608|NCT01212770|50598893|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
25283609|NCT01212770|50598894|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
25283610|NCT01212770|50598895|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
25283611|NCT01212770|50598896|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
25283612|NCT01212770|50598888|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
25283613|NCT01212770|50598889|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
25283614|NCT01212770|50598890|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
25283615|NCT01212770|50598891|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
25283616|NCT01212770|50598892|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
25283617|NCT01212770|50598893|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
25283618|NCT01212770|50598894|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
25283619|NCT01212770|50598895|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
25283620|NCT01212770|50598896|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
25283621|NCT01212770|50598888|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
25283622|NCT01212770|50598889|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
25283623|NCT01212770|50598890|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
25283624|NCT01212770|50598891|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
25283625|NCT01212770|50598892|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
25283626|NCT01212770|50598893|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
25191390|NCT02603952|50350509|FG001|Overall Study|Received oseltamivir by error|0|||
25283627|NCT01212770|50598894|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
25283628|NCT01212770|50598895|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
25283629|NCT01212770|50598896|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
25283630|NCT01212770|50598888|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
25283631|NCT01212770|50598889|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
25283632|NCT01212770|50598890|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
25283633|NCT01212770|50598891|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
25283634|NCT01212770|50598892|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
25283635|NCT01212770|50598893|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
25283636|NCT01212770|50598894|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
25283637|NCT01212770|50598895|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
25283638|NCT01212770|50598896|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
25283639|NCT01212770|50598888|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
25283640|NCT01212770|50598889|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
25283641|NCT01212770|50598890|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
25283642|NCT01212770|50598891|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
25283643|NCT01212770|50598892|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
25283644|NCT01212770|50598893|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
25283645|NCT01212770|50598894|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
25283646|NCT01212770|50598895|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
25283647|NCT01212770|50598896|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
25283648|NCT01212770|50598888|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
25283649|NCT01212770|50598889|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
25283650|NCT01212770|50598890|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
25283651|NCT01212770|50598891|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
25283652|NCT01212770|50598892|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
25283653|NCT01212770|50598893|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
25283654|NCT01212770|50598894|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
25283655|NCT01212770|50598895|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
25283656|NCT01212770|50598896|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
25283657|NCT01212770|50598888|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
25283658|NCT01212770|50598889|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
25283659|NCT01212770|50598890|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
25283660|NCT01212770|50598891|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
25283661|NCT01212770|50598892|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
25283662|NCT01212770|50598893|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
25283663|NCT01212770|50598894|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
25283664|NCT01212770|50598895|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
25283665|NCT01212770|50598896|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
25283666|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
25283667|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
25283668|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
25283669|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
25283670|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
25283671|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
25283672|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
25283673|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
25283674|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
25283675|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
24969478|NCT04633642|50058891|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
24969479|NCT04633642|50058892|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
24969480|NCT00136916|50058900|FG000|Overall Study|Never received study treatment|3|||
24969481|NCT00136916|50058901|FG001|Overall Study|Never received study treatment|5|||
24969482|NCT00136916|50058900|FG000|Overall Study|Death|1|||
24969483|NCT00136916|50058901|FG001|Overall Study|Death|3|||
24969484|NCT00136916|50058900|FG000|Overall Study|Adverse Event|27|||
24969485|NCT00136916|50058901|FG001|Overall Study|Adverse Event|8|||
24969486|NCT00136916|50058900|FG000|Overall Study|Laboratory abnormality|0|||
24969487|NCT00136916|50058901|FG001|Overall Study|Laboratory abnormality|1|||
24969488|NCT00136916|50058900|FG000|Overall Study|Lack of Efficacy|13|||
24969489|NCT00136916|50058901|FG001|Overall Study|Lack of Efficacy|3|||
24969490|NCT00136916|50058900|FG000|Overall Study|Lost to Follow-up|12|||
24969491|NCT00136916|50058901|FG001|Overall Study|Lost to Follow-up|14|||
24969492|NCT00136916|50058900|FG000|Overall Study|Withdrawal by Subject|44|||
24969493|NCT00136916|50058901|FG001|Overall Study|Withdrawal by Subject|46|||
24969494|NCT00136916|50058900|FG000|Overall Study|Other|22|||
25283676|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
24969495|NCT00136916|50058901|FG001|Overall Study|Other|24|||
24969496|NCT00136916|50058900|FG000|Overall Study|Discontinued in follow up period|3|||
25283677|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
24969497|NCT00136916|50058901|FG001|Overall Study|Discontinued in follow up period|0|||
24969498|NCT04633564|50058911|FG000|Period 1|Adverse Event|28|||
24969499|NCT04633564|50058912|FG001|Period 1|Adverse Event|19|||
24969500|NCT04633564|50058911|FG000|Period 1|Death|8|||
24969501|NCT04633564|50058912|FG001|Period 1|Death|7|||
24969502|NCT04633564|50058911|FG000|Period 1|Lost to Follow-up|3|||
24969503|NCT04633564|50058912|FG001|Period 1|Lost to Follow-up|5|||
24969504|NCT04633564|50058911|FG000|Period 1|Physician Decision|4|||
24969505|NCT04633564|50058912|FG001|Period 1|Physician Decision|12|||
24969506|NCT04633564|50058911|FG000|Period 1|Protocol Violation|0|||
24969507|NCT04633564|50058912|FG001|Period 1|Protocol Violation|1|||
24969508|NCT04633564|50058911|FG000|Period 1|Withdrawal by Subject|10|||
24969509|NCT04633564|50058912|FG001|Period 1|Withdrawal by Subject|8|||
24969510|NCT04633564|50058911|FG000|Period 1|Progressive disease|47|||
24969511|NCT04633564|50058912|FG001|Period 1|Progressive disease|51|||
24969512|NCT04633564|50058911|FG000|Period 1|Terminated by Sponsor|8|||
24969513|NCT04633564|50058912|FG001|Period 1|Terminated by Sponsor|6|||
24969514|NCT04633564|50058911|FG000|Period 2|Adverse Event|3|||
24969515|NCT04633564|50058912|FG001|Period 2|Adverse Event|4|||
24969516|NCT04633564|50058911|FG000|Period 2|Death|0|||
24969517|NCT04633564|50058912|FG001|Period 2|Death|2|||
24969518|NCT04633564|50058911|FG000|Period 2|Lost to Follow-up|0|||
24969519|NCT04633564|50058912|FG001|Period 2|Lost to Follow-up|1|||
24969520|NCT04633564|50058911|FG000|Period 2|Physician Decision|2|||
24969521|NCT04633564|50058912|FG001|Period 2|Physician Decision|4|||
24969522|NCT04633564|50058911|FG000|Period 2|Withdrawal by Subject|5|||
24969523|NCT04633564|50058912|FG001|Period 2|Withdrawal by Subject|1|||
24969524|NCT04633564|50058911|FG000|Period 2|Progressive Disease|74|||
24969525|NCT04633564|50058912|FG001|Period 2|Progressive Disease|82|||
24969526|NCT04633564|50058911|FG000|Period 2|Terminated by Sponsor|9|||
24969527|NCT04633564|50058912|FG001|Period 2|Terminated by Sponsor|3|||
24969528|NCT04960228|50058920|FG000|Overall Study|Withdrawal by Subject|216|||
24969529|NCT04960228|50058921|FG001|Overall Study|Withdrawal by Subject|35|||
24969530|NCT04960228|50058920|FG000|Overall Study|Failed attention check|69|||
24969531|NCT04960228|50058921|FG001|Overall Study|Failed attention check|148|||
24969532|NCT04960228|50058920|FG000|Overall Study|Flagged for response quality by Dynata|3|||
24969533|NCT04960228|50058921|FG001|Overall Study|Flagged for response quality by Dynata|3|||
24969534|NCT04619992|50058929|FG000|Overall Study|Withdrawal by Subject|1|||
24969535|NCT04619992|50058930|FG001|Overall Study|Withdrawal by Subject|0|||
24969536|NCT00136604|50058941|FG000|Overall Study|Lost to Follow-up|1|||
24969537|NCT00136604|50058942|FG001|Overall Study|Lost to Follow-up|0|||
24969538|NCT00136604|50058943|FG002|Overall Study|Lost to Follow-up|0|||
24969539|NCT00136604|50058944|FG003|Overall Study|Lost to Follow-up|0|||
24969540|NCT00136604|50058945|FG004|Overall Study|Lost to Follow-up|1|||
24969541|NCT00136604|50058941|FG000|Overall Study|Migrated/moved from study area|0|||
24969542|NCT00136604|50058942|FG001|Overall Study|Migrated/moved from study area|1|||
24969543|NCT00136604|50058943|FG002|Overall Study|Migrated/moved from study area|0|||
24969544|NCT00136604|50058944|FG003|Overall Study|Migrated/moved from study area|0|||
24969545|NCT00136604|50058945|FG004|Overall Study|Migrated/moved from study area|0|||
24969546|NCT00135512|50058961|FG000|Overall Study|Adverse Event|56|||
24969547|NCT00135512|50058961|FG000|Overall Study|Lack of Efficacy|25|||
24969548|NCT00135512|50058961|FG000|Overall Study|Other|42|||
24969549|NCT00130728|50058967|FG000|Overall Study|Death|258|||
25069960|NCT02610140|50175721|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
25069961|NCT02610140|50175722|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
25191391|NCT02603952|50350510|FG002|Overall Study|Received oseltamivir by error|0|||
24969550|NCT00130728|50058968|FG001|Overall Study|Death|258|||
24969551|NCT00130728|50058967|FG000|Overall Study|Lost to Follow-up|4|||
24969552|NCT00130728|50058968|FG001|Overall Study|Lost to Follow-up|0|||
24969553|NCT00130728|50058967|FG000|Overall Study|Withdrawal by Subject|0|||
24969554|NCT00130728|50058968|FG001|Overall Study|Withdrawal by Subject|2|||
24969555|NCT00129974|50058974|FG000|Overall Study|Other|1|||
24969556|NCT04947436|50058981|FG000|Overall Study|Lost to Follow-up|3|||
24969557|NCT04947436|50058982|FG001|Overall Study|Lost to Follow-up|7|||
24969558|NCT04947436|50058983|FG002|Overall Study|Lost to Follow-up|5|||
24969559|NCT04947436|50058981|FG000|Overall Study|Death|1|||
24969560|NCT04947436|50058982|FG001|Overall Study|Death|1|||
25283678|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
25283679|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
25283680|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
25283681|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
25283682|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
25283683|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
25283684|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
25283685|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
25283686|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
25283687|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
25283688|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
25283689|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
25283690|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
25283691|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
25283692|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
25283693|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
25283694|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
25283695|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
25283696|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
25283697|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
25283698|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
25283699|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
25283700|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
25283701|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
25283702|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
25283703|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
25283704|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
25283705|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
25283706|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
25283707|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
25283708|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
25283709|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
25283710|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
25283711|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
25283712|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
25283713|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
25283714|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
25283715|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
25283716|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
25283717|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
25283718|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
25283719|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
25283720|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
25283721|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
25283722|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
25283723|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
25283724|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
25283725|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
25283726|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
25283727|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
25283728|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
25283729|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
25283730|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
25283731|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
25283732|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
25283733|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
25283734|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
25283735|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
25283736|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
25283737|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
25283738|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
25283739|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
25283740|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
25283741|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
25283742|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
25191392|NCT02603952|50350511|FG003|Overall Study|Received oseltamivir by error|1|||
25191393|NCT02603172|50351025|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
25283743|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
25283744|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
25283745|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
25283746|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
25283747|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
25283748|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
25283749|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
25283750|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
25283751|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
25283752|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
25283753|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
25283754|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
25283755|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
25283756|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
25283757|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
25283758|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
25283759|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
25283760|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
25283761|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
25283762|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
25283763|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
25283764|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
25283765|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
25283766|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
25283767|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
25283768|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
25283769|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
25283770|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
25283771|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
25283772|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
25283773|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
25283774|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
25283775|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
25283776|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
25283777|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
25283778|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
25283779|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
25283780|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
25283781|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
25283782|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
25283783|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
25283784|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
25283785|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
25283786|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
25283787|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
25283788|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
25283789|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
25283790|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
25283791|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
25283792|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
25283793|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
25283794|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
25283795|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
25283796|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
25283797|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
25283798|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
25283799|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
25283800|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
25283801|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
25283802|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
24969561|NCT04947436|50058983|FG002|Overall Study|Death|1|||
24969562|NCT00119106|50058993|FG000|Overall Study|HIV infected at baseline|179|||
25069962|NCT02610140|50175721|FG000|Randomization and Treatment Period|Not treated|3|||
25069963|NCT02610140|50175722|FG001|Randomization and Treatment Period|Not treated|10|||
25283803|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
25283804|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
25283805|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
25283806|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
25283807|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
25283808|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
25283809|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
25283810|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
25283811|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
25283812|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
25283813|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
25283814|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
25283815|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
25283816|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
25283817|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
25283818|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
25283819|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
25283820|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
25283821|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
25283822|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
25283823|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
25283824|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
25283825|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
25283826|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
25283827|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
25283828|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
25283829|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
25283830|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
25283831|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
25283832|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
25283833|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
25283834|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
25283835|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
25283836|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
25283837|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
25283838|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
25283839|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
25283840|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
25283841|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
25283842|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
25283843|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
25283844|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
25283845|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
25283846|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
25283847|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
25283848|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
25283849|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
25283850|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
25283851|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
25283852|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
25283853|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
25283854|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
25283855|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
25283856|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
25283857|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
25283858|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
25283859|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
25283860|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
25283861|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
25283862|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
25283863|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
25283864|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
25283865|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
25283866|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
25283867|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
25283868|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
25283869|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
25283870|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
25283871|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
25283872|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
25283873|NCT01212770|50598888|FG000|Long-term Safety Phase (Year 5)|Death|0|||
25283874|NCT01212770|50598889|FG001|Long-term Safety Phase (Year 5)|Death|0|||
25283875|NCT01212770|50598890|FG002|Long-term Safety Phase (Year 5)|Death|0|||
25283876|NCT01212770|50598891|FG003|Long-term Safety Phase (Year 5)|Death|0|||
25283877|NCT01212770|50598892|FG004|Long-term Safety Phase (Year 5)|Death|0|||
25283878|NCT01212770|50598893|FG005|Long-term Safety Phase (Year 5)|Death|0|||
25283879|NCT01212770|50598894|FG006|Long-term Safety Phase (Year 5)|Death|0|||
25283880|NCT01212770|50598895|FG007|Long-term Safety Phase (Year 5)|Death|1|||
25283881|NCT01212770|50598896|FG008|Long-term Safety Phase (Year 5)|Death|0|||
25283882|NCT00598273|50598921|FG000|Overall Study|Adverse Event|4|||
25283883|NCT00598273|50598922|FG001|Overall Study|Adverse Event|5|||
25283884|NCT00598273|50598923|FG002|Overall Study|Adverse Event|2|||
25283885|NCT00598273|50598921|FG000|Overall Study|Death|6|||
25283886|NCT00598273|50598922|FG001|Overall Study|Death|12|||
25283887|NCT00598273|50598923|FG002|Overall Study|Death|8|||
25283888|NCT00598273|50598921|FG000|Overall Study|Lost to Follow-up|8|||
25283889|NCT00598273|50598922|FG001|Overall Study|Lost to Follow-up|3|||
25283890|NCT00598273|50598923|FG002|Overall Study|Lost to Follow-up|5|||
25283891|NCT00598273|50598921|FG000|Overall Study|Physician Decision|0|||
25283892|NCT00598273|50598922|FG001|Overall Study|Physician Decision|0|||
25283893|NCT00598273|50598923|FG002|Overall Study|Physician Decision|1|||
25283894|NCT00598273|50598921|FG000|Overall Study|Withdrawal by Subject|12|||
25283895|NCT00598273|50598922|FG001|Overall Study|Withdrawal by Subject|10|||
25283896|NCT00598273|50598923|FG002|Overall Study|Withdrawal by Subject|10|||
25283897|NCT00598273|50598921|FG000|Overall Study|Noncompliance|3|||
25283898|NCT00598273|50598922|FG001|Overall Study|Noncompliance|2|||
25283899|NCT00598273|50598923|FG002|Overall Study|Noncompliance|3|||
25283900|NCT00598273|50598921|FG000|Overall Study|Relocation|0|||
25283901|NCT00598273|50598922|FG001|Overall Study|Relocation|2|||
25283902|NCT00598273|50598923|FG002|Overall Study|Relocation|4|||
25283903|NCT00598273|50598921|FG000|Overall Study|Renal transplant|1|||
25283904|NCT00598273|50598922|FG001|Overall Study|Renal transplant|0|||
25283905|NCT00598273|50598923|FG002|Overall Study|Renal transplant|1|||
25283906|NCT00598273|50598921|FG000|Overall Study|Site elected to close|1|||
25283907|NCT00598273|50598922|FG001|Overall Study|Site elected to close|0|||
25283908|NCT00598273|50598923|FG002|Overall Study|Site elected to close|0|||
25283909|NCT00598273|50598921|FG000|Overall Study|Started dialysis|6|||
25283910|NCT00598273|50598922|FG001|Overall Study|Started dialysis|4|||
25283911|NCT00598273|50598923|FG002|Overall Study|Started dialysis|5|||
25283912|NCT01211522|50598934|FG000|Overall Study|Withdrawal by Subject|3|||
25283913|NCT01211522|50598935|FG001|Overall Study|Withdrawal by Subject|7|||
25283914|NCT01211522|50598936|FG002|Overall Study|Withdrawal by Subject|5|||
25283915|NCT01211288|50598946|FG000|Overall Study|Lost to Follow-up|1|||
25283916|NCT01211288|50598947|FG001|Overall Study|Lost to Follow-up|1|||
25283917|NCT00883753|50598955|FG000|Overall Study|Adverse Event|37|||
25283918|NCT00883753|50598955|FG000|Overall Study|Death|2|||
25283919|NCT00883753|50598955|FG000|Overall Study|Insufficient therapeutic response|16|||
25283920|NCT00883753|50598955|FG000|Overall Study|Lost to Follow-up|4|||
25283921|NCT00883753|50598955|FG000|Overall Study|Violation of selection criteria at entry|7|||
25283922|NCT00883753|50598955|FG000|Overall Study|Protocol Violation|2|||
25283923|NCT00883753|50598955|FG000|Overall Study|Refused treatment|4|||
25283924|NCT00883753|50598955|FG000|Overall Study|Withdrew consent|10|||
25283925|NCT00883753|50598955|FG000|Overall Study|Investigator's decision|17|||
25283926|NCT00883753|50598955|FG000|Overall Study|Administrative/Other|8|||
25283927|NCT01210664|50598962|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
25283928|NCT01210664|50598963|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
25283929|NCT01210664|50598964|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
25283930|NCT01210664|50598965|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
25283931|NCT01210664|50598962|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
25283932|NCT01210664|50598963|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
25283933|NCT01210664|50598964|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
25283934|NCT01210664|50598965|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
25283935|NCT01210664|50598962|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
25069964|NCT02610140|50175721|FG000|Safety Follow-up|Other|0|||
25069965|NCT02610140|50175722|FG001|Safety Follow-up|Other|2|||
25069966|NCT02610140|50175721|FG000|Safety Follow-up|Lost to Follow-up|1|||
25283936|NCT01210664|50598963|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
25283937|NCT01210664|50598964|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
25283938|NCT01210664|50598965|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
25283939|NCT00881569|50598977|FG000|Overall Study|Disease progression|1|||
25283940|NCT00881569|50598978|FG001|Overall Study|Disease progression|1|||
25283941|NCT00881335|50598986|FG000|Overall Study|Lost to Follow-up|3|||
25283942|NCT00881335|50598987|FG001|Overall Study|Lost to Follow-up|2|||
25283943|NCT00879775|50599004|FG000|Overall Study|Lost to Follow-up|2|||
25283944|NCT00879775|50599005|FG001|Overall Study|Lost to Follow-up|1|||
25283945|NCT00894790|50599013|FG000|Overall Study|Protocol Violation|0|||
25283946|NCT00894790|50599014|FG001|Overall Study|Protocol Violation|1|||
25283947|NCT00894790|50599013|FG000|Overall Study|Lost to Follow-up|0|||
25283948|NCT00894790|50599014|FG001|Overall Study|Lost to Follow-up|1|||
25283949|NCT00894790|50599013|FG000|Overall Study|Did not meet entrance criteria|1|||
25283950|NCT00894790|50599014|FG001|Overall Study|Did not meet entrance criteria|0|||
25283951|NCT00879229|50599022|FG000|Overall Study|Study terminated by Sponsor|13|||
25283952|NCT00879229|50599023|FG001|Overall Study|Study terminated by Sponsor|12|||
25283953|NCT00879229|50599022|FG000|Overall Study|Death|4|||
25283954|NCT00879229|50599023|FG001|Overall Study|Death|2|||
25283955|NCT00879229|50599022|FG000|Overall Study|Adverse Event|2|||
25283956|NCT00879229|50599023|FG001|Overall Study|Adverse Event|0|||
25283957|NCT00879229|50599022|FG000|Overall Study|Withdrawal by Subject|1|||
25283958|NCT00879229|50599023|FG001|Overall Study|Withdrawal by Subject|0|||
25283959|NCT00879229|50599022|FG000|Overall Study|Clinical status did not improve|1|||
25283960|NCT00879229|50599023|FG001|Overall Study|Clinical status did not improve|0|||
25283961|NCT00879229|50599022|FG000|Overall Study|Other|1|||
25283962|NCT00879229|50599023|FG001|Overall Study|Other|0|||
25283963|NCT00878995|50599031|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
25283964|NCT00878995|50599032|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
25283965|NCT00879697|50599040|FG000|Overall Study|Physician Decision|2|||
25283966|NCT00879697|50599041|FG001|Overall Study|Physician Decision|2|||
25283967|NCT00894556|50599050|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
25283968|NCT00894556|50599051|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
25283969|NCT00894556|50599052|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
25283970|NCT00894556|50599053|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
25283971|NCT00894556|50599050|FG000|Treatment Phase|Lost to Follow-up|2|||
25283972|NCT00894556|50599051|FG001|Treatment Phase|Lost to Follow-up|3|||
25283973|NCT00894556|50599052|FG002|Treatment Phase|Lost to Follow-up|1|||
25283974|NCT00894556|50599053|FG003|Treatment Phase|Lost to Follow-up|0|||
25283975|NCT00894556|50599050|FG000|Treatment Phase|Lack of Qualifying Event|2|||
25283976|NCT00894556|50599051|FG001|Treatment Phase|Lack of Qualifying Event|1|||
25283977|NCT00894556|50599052|FG002|Treatment Phase|Lack of Qualifying Event|0|||
25283978|NCT00894556|50599053|FG003|Treatment Phase|Lack of Qualifying Event|0|||
25283979|NCT01210352|50599069|FG000|Overall Study|Adverse Event|0|||
25283980|NCT01210352|50599070|FG001|Overall Study|Adverse Event|0|||
25283981|NCT01210352|50599071|FG002|Overall Study|Adverse Event|0|||
25283982|NCT01210352|50599072|FG003|Overall Study|Adverse Event|0|||
25283983|NCT01210352|50599073|FG004|Overall Study|Adverse Event|0|||
25283984|NCT01210352|50599074|FG005|Overall Study|Adverse Event|0|||
25283985|NCT01210352|50599075|FG006|Overall Study|Adverse Event|0|||
25283986|NCT01210352|50599076|FG007|Overall Study|Adverse Event|2|||
25283987|NCT01210352|50599077|FG008|Overall Study|Adverse Event|1|||
25283988|NCT01210352|50599069|FG000|Overall Study|Lack of Efficacy|0|||
25283989|NCT01210352|50599070|FG001|Overall Study|Lack of Efficacy|0|||
25283990|NCT01210352|50599071|FG002|Overall Study|Lack of Efficacy|0|||
25283991|NCT01210352|50599072|FG003|Overall Study|Lack of Efficacy|0|||
25283992|NCT01210352|50599073|FG004|Overall Study|Lack of Efficacy|0|||
25283993|NCT01210352|50599074|FG005|Overall Study|Lack of Efficacy|0|||
25283994|NCT01210352|50599075|FG006|Overall Study|Lack of Efficacy|1|||
25283995|NCT01210352|50599076|FG007|Overall Study|Lack of Efficacy|0|||
25283996|NCT01210352|50599077|FG008|Overall Study|Lack of Efficacy|0|||
25283997|NCT01210352|50599069|FG000|Overall Study|Physician Decision|0|||
25283998|NCT01210352|50599070|FG001|Overall Study|Physician Decision|0|||
25283999|NCT01210352|50599071|FG002|Overall Study|Physician Decision|0|||
25284000|NCT01210352|50599072|FG003|Overall Study|Physician Decision|0|||
25284001|NCT01210352|50599073|FG004|Overall Study|Physician Decision|0|||
25284002|NCT01210352|50599074|FG005|Overall Study|Physician Decision|0|||
25284003|NCT01210352|50599075|FG006|Overall Study|Physician Decision|0|||
25284004|NCT01210352|50599076|FG007|Overall Study|Physician Decision|1|||
25284005|NCT01210352|50599077|FG008|Overall Study|Physician Decision|2|||
25284006|NCT01210352|50599069|FG000|Overall Study|Withdrawal by Subject|0|||
25191394|NCT02603172|50351026|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
25191395|NCT02603172|50351027|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
25191396|NCT02603172|50351028|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
25191397|NCT02603172|50351029|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
25191398|NCT02603172|50351030|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
25191399|NCT02603172|50351031|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
25191400|NCT02603172|50351032|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
25191401|NCT02605824|50351153|FG000|Overall Study|Physician Decision|1|||
25191402|NCT02605824|50351154|FG001|Overall Study|Physician Decision|0|||
25191403|NCT02605122|50351284|FG000|Overall Study|Withdrawal by Subject|4|||
25191404|NCT02605122|50351285|FG001|Overall Study|Withdrawal by Subject|1|||
25191405|NCT02605122|50351284|FG000|Overall Study|Lost to Follow-up|1|||
25284007|NCT01210352|50599070|FG001|Overall Study|Withdrawal by Subject|0|||
25284008|NCT01210352|50599071|FG002|Overall Study|Withdrawal by Subject|1|||
25284009|NCT01210352|50599072|FG003|Overall Study|Withdrawal by Subject|0|||
25284010|NCT01210352|50599073|FG004|Overall Study|Withdrawal by Subject|0|||
25284011|NCT01210352|50599074|FG005|Overall Study|Withdrawal by Subject|0|||
25284012|NCT01210352|50599075|FG006|Overall Study|Withdrawal by Subject|1|||
25284013|NCT01210352|50599076|FG007|Overall Study|Withdrawal by Subject|0|||
25284014|NCT01210352|50599077|FG008|Overall Study|Withdrawal by Subject|1|||
25284015|NCT01210352|50599069|FG000|Overall Study|Patient Discharged Early|0|||
25284016|NCT01210352|50599070|FG001|Overall Study|Patient Discharged Early|0|||
25284017|NCT01210352|50599071|FG002|Overall Study|Patient Discharged Early|1|||
25284018|NCT01210352|50599072|FG003|Overall Study|Patient Discharged Early|0|||
25284019|NCT01210352|50599073|FG004|Overall Study|Patient Discharged Early|0|||
25284020|NCT01210352|50599074|FG005|Overall Study|Patient Discharged Early|0|||
25284021|NCT01210352|50599075|FG006|Overall Study|Patient Discharged Early|0|||
25284022|NCT01210352|50599076|FG007|Overall Study|Patient Discharged Early|0|||
25284023|NCT01210352|50599077|FG008|Overall Study|Patient Discharged Early|0|||
25284024|NCT01210118|50599184|FG000|Overall Study|Lost to Follow-up|1|||
25284025|NCT01210118|50599185|FG001|Overall Study|Lost to Follow-up|1|||
25284026|NCT01210118|50599184|FG000|Overall Study|Protocol Violation|1|||
25284027|NCT01210118|50599185|FG001|Overall Study|Protocol Violation|1|||
25284028|NCT01210118|50599184|FG000|Overall Study|Spontaneous abortion|1|||
25284029|NCT01210118|50599185|FG001|Overall Study|Spontaneous abortion|3|||
25284030|NCT01208870|50599196|FG000|Overall Study|Lost to Follow-up|2|||
25284031|NCT01208870|50599197|FG001|Overall Study|Lost to Follow-up|8|||
25284032|NCT00880555|50599208|FG000|Overall Study|Physician Decision|0|||
25284033|NCT00880555|50599209|FG001|Overall Study|Physician Decision|8|||
25284034|NCT00880555|50599210|FG002|Overall Study|Physician Decision|0|||
25284035|NCT00880555|50599211|FG003|Overall Study|Physician Decision|2|||
25284036|NCT00880555|50599212|FG004|Overall Study|Physician Decision|1|||
25284037|NCT00880555|50599213|FG005|Overall Study|Physician Decision|0|||
25284038|NCT00880555|50599208|FG000|Overall Study|Withdrawal by Subject|1|||
25284039|NCT00880555|50599209|FG001|Overall Study|Withdrawal by Subject|1|||
25284040|NCT00880555|50599210|FG002|Overall Study|Withdrawal by Subject|0|||
25284041|NCT00880555|50599211|FG003|Overall Study|Withdrawal by Subject|0|||
25284042|NCT00880555|50599212|FG004|Overall Study|Withdrawal by Subject|0|||
25284043|NCT00880555|50599213|FG005|Overall Study|Withdrawal by Subject|0|||
25284044|NCT00880555|50599208|FG000|Overall Study|Lack of resources (hired rater)|9|||
25284045|NCT00880555|50599209|FG001|Overall Study|Lack of resources (hired rater)|7|||
25284046|NCT00880555|50599210|FG002|Overall Study|Lack of resources (hired rater)|5|||
25284047|NCT00880555|50599211|FG003|Overall Study|Lack of resources (hired rater)|0|||
25284048|NCT00880555|50599212|FG004|Overall Study|Lack of resources (hired rater)|0|||
25284049|NCT00880555|50599213|FG005|Overall Study|Lack of resources (hired rater)|0|||
25284050|NCT00880555|50599208|FG000|Overall Study|Death|0|||
25284051|NCT00880555|50599209|FG001|Overall Study|Death|0|||
25284052|NCT00880555|50599210|FG002|Overall Study|Death|0|||
25284053|NCT00880555|50599211|FG003|Overall Study|Death|0|||
25284054|NCT00880555|50599212|FG004|Overall Study|Death|0|||
25284055|NCT00880555|50599213|FG005|Overall Study|Death|1|||
25284056|NCT00880555|50599208|FG000|Overall Study|Lost to Follow-up|0|||
25191406|NCT02605122|50351285|FG001|Overall Study|Lost to Follow-up|1|||
25284057|NCT00880555|50599209|FG001|Overall Study|Lost to Follow-up|1|||
25284058|NCT00880555|50599210|FG002|Overall Study|Lost to Follow-up|0|||
25284059|NCT00880555|50599211|FG003|Overall Study|Lost to Follow-up|0|||
25284060|NCT00880555|50599212|FG004|Overall Study|Lost to Follow-up|0|||
25284061|NCT00880555|50599213|FG005|Overall Study|Lost to Follow-up|0|||
25284062|NCT01208402|50599226|FG000|Overall Study|Withdrawal by Subject|1|||
25284063|NCT01208402|50599227|FG001|Overall Study|Withdrawal by Subject|0|||
25284064|NCT01208324|50599237|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
25284065|NCT01208324|50599238|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
25284066|NCT01208324|50599239|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
25284067|NCT01208324|50599240|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
25284068|NCT00880399|50599253|FG000|Overall Study|Adverse Event|4|||
25284069|NCT00880399|50599254|FG001|Overall Study|Adverse Event|6|||
25284070|NCT00880399|50599255|FG002|Overall Study|Adverse Event|5|||
25284071|NCT00880399|50599253|FG000|Overall Study|Lack of Efficacy|1|||
25169170|NCT01845077|50300353|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
25284072|NCT00880399|50599254|FG001|Overall Study|Lack of Efficacy|4|||
25284073|NCT00880399|50599255|FG002|Overall Study|Lack of Efficacy|2|||
25169171|NCT01845077|50300354|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
25169172|NCT01845077|50300355|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
25169173|NCT01845077|50300356|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
25169174|NCT01845077|50300357|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
25169175|NCT01845077|50300352|FG000|Washout Period|Protocol Violation|0|||
25169176|NCT01845077|50300353|FG001|Washout Period|Protocol Violation|0|||
25169177|NCT01845077|50300354|FG002|Washout Period|Protocol Violation|0|||
25169178|NCT01845077|50300355|FG003|Washout Period|Protocol Violation|1|||
25169179|NCT01845077|50300356|FG004|Washout Period|Protocol Violation|1|||
25284074|NCT00880399|50599253|FG000|Overall Study|Protocol Violation|4|||
25284075|NCT00880399|50599254|FG001|Overall Study|Protocol Violation|4|||
25284076|NCT00880399|50599255|FG002|Overall Study|Protocol Violation|6|||
25284077|NCT00880399|50599253|FG000|Overall Study|Study closed/terminated|3|||
25284078|NCT00880399|50599254|FG001|Overall Study|Study closed/terminated|7|||
25284079|NCT00880399|50599255|FG002|Overall Study|Study closed/terminated|4|||
25284080|NCT00880399|50599253|FG000|Overall Study|Lost to Follow-up|8|||
25284081|NCT00880399|50599254|FG001|Overall Study|Lost to Follow-up|5|||
25284082|NCT00880399|50599255|FG002|Overall Study|Lost to Follow-up|3|||
25284083|NCT00880399|50599253|FG000|Overall Study|Physician Decision|5|||
25284084|NCT00880399|50599254|FG001|Overall Study|Physician Decision|0|||
25284085|NCT00880399|50599255|FG002|Overall Study|Physician Decision|3|||
25284086|NCT00880399|50599253|FG000|Overall Study|Withdrawal by Subject|6|||
25284087|NCT00880399|50599254|FG001|Overall Study|Withdrawal by Subject|3|||
25284088|NCT00880399|50599255|FG002|Overall Study|Withdrawal by Subject|3|||
25284089|NCT01207388|50599263|FG000|Overall Study|Death|67|||
25284090|NCT01207388|50599263|FG000|Overall Study|Withdrawal by Subject|1|||
25284091|NCT01206764|50599275|FG000|Overall Study|Adverse Event|20|||
25284092|NCT01206764|50599275|FG000|Overall Study|Abnormal laboratory value|2|||
25284093|NCT01206764|50599275|FG000|Overall Study|Abnormal test procedure result|1|||
25284094|NCT01206764|50599275|FG000|Overall Study|Patient withdrew consent|5|||
25284095|NCT01206764|50599275|FG000|Overall Study|Lost to Follow-up|6|||
25284096|NCT01206764|50599275|FG000|Overall Study|Death|11|||
25284097|NCT01206764|50599275|FG000|Overall Study|New cancer therapy|2|||
25284098|NCT01206764|50599275|FG000|Overall Study|Disease progression|88|||
25284099|NCT01206764|50599275|FG000|Overall Study|Protocol deviation|3|||
25284100|NCT00894322|50599282|FG000|Overall Study|Withdrawal by Subject|1|||
25284101|NCT00894322|50599283|FG001|Overall Study|Withdrawal by Subject|0|||
25284102|NCT00894322|50599284|FG002|Overall Study|Withdrawal by Subject|0|||
25284103|NCT00596635|50599297|FG000|Overall Study|Lost to Follow-up|0|||
25284104|NCT00596635|50599298|FG001|Overall Study|Lost to Follow-up|2|||
25284105|NCT00596635|50599299|FG002|Overall Study|Lost to Follow-up|0|||
25284106|NCT00596635|50599297|FG000|Overall Study|Treatment for symptomatic UTI|4|||
25284107|NCT00596635|50599298|FG001|Overall Study|Treatment for symptomatic UTI|6|||
25284108|NCT00596635|50599299|FG002|Overall Study|Treatment for symptomatic UTI|3|||
25284109|NCT00596635|50599297|FG000|Overall Study|Hip fracture|2|||
25284110|NCT00596635|50599298|FG001|Overall Study|Hip fracture|3|||
25284111|NCT00596635|50599299|FG002|Overall Study|Hip fracture|3|||
25284112|NCT00596635|50599297|FG000|Overall Study|Could not provide urine specimen|1|||
25284113|NCT00596635|50599298|FG001|Overall Study|Could not provide urine specimen|2|||
25284114|NCT00596635|50599299|FG002|Overall Study|Could not provide urine specimen|2|||
25284115|NCT00894166|50599315|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
25284116|NCT00894166|50599316|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
25284117|NCT00894166|50599317|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
25284118|NCT00894166|50599318|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
25284119|NCT00894166|50599319|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
25284120|NCT00894166|50599320|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
25284121|NCT00894166|50599321|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
25284122|NCT00894166|50599322|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
25284123|NCT00894166|50599315|FG000|Overall Study|Death|0|||
25284124|NCT00894166|50599316|FG001|Overall Study|Death|0|||
25284125|NCT00894166|50599317|FG002|Overall Study|Death|0|||
25284126|NCT00894166|50599318|FG003|Overall Study|Death|1|||
25284127|NCT00894166|50599319|FG004|Overall Study|Death|0|||
25284128|NCT00894166|50599320|FG005|Overall Study|Death|0|||
25284129|NCT00894166|50599321|FG006|Overall Study|Death|0|||
25284130|NCT00894166|50599322|FG007|Overall Study|Death|0|||
25284131|NCT00880165|50599347|FG000|Overall Study|Withdrawal by Subject|27|||
25284132|NCT00880165|50599348|FG001|Overall Study|Withdrawal by Subject|23|||
25284133|NCT00880165|50599347|FG000|Overall Study|Not diagnosed with OSA|14|||
25284134|NCT00880165|50599348|FG001|Overall Study|Not diagnosed with OSA|8|||
25284135|NCT00880165|50599347|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
25284136|NCT00880165|50599348|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
25284137|NCT00880165|50599347|FG000|Overall Study|Lost to follow|9|||
25284138|NCT00880165|50599348|FG001|Overall Study|Lost to follow|15|||
25284139|NCT01165229|50599356|FG000|Overall Study|Serious Adverse Event|456|||
25284140|NCT01165229|50599357|FG001|Overall Study|Serious Adverse Event|487|||
25284141|NCT01165229|50599356|FG000|Overall Study|Non-Serious Adverse Event|47|||
25284142|NCT01165229|50599357|FG001|Overall Study|Non-Serious Adverse Event|15|||
25284143|NCT01165229|50599356|FG000|Overall Study|Protocol Violation|6|||
25284144|NCT01165229|50599357|FG001|Overall Study|Protocol Violation|8|||
25284145|NCT01165229|50599356|FG000|Overall Study|Withdrawal by Subject|387|||
25284146|NCT01165229|50599357|FG001|Overall Study|Withdrawal by Subject|396|||
25284147|NCT01165229|50599356|FG000|Overall Study|Migrated/moved from study area|51|||
25284148|NCT01165229|50599357|FG001|Overall Study|Migrated/moved from study area|46|||
25284149|NCT01165229|50599356|FG000|Overall Study|Lost to Follow-up|123|||
25284150|NCT01165229|50599357|FG001|Overall Study|Lost to Follow-up|133|||
25284151|NCT01165229|50599356|FG000|Overall Study|Suspected HZ Episode|2|||
25284152|NCT01165229|50599357|FG001|Overall Study|Suspected HZ Episode|2|||
25284153|NCT01165229|50599356|FG000|Overall Study|No reason from the subject|108|||
25284154|NCT01165229|50599357|FG001|Overall Study|No reason from the subject|102|||
25284155|NCT01165229|50599356|FG000|Overall Study|Unknown completion status|0|||
25284156|NCT01165229|50599357|FG001|Overall Study|Unknown completion status|1|||
25284157|NCT00596011|50599395|FG000|Overall Study|Withdrawal by Subject|2|||
25284158|NCT00596011|50599396|FG001|Overall Study|Withdrawal by Subject|3|||
25284159|NCT00596011|50599395|FG000|Overall Study|Adverse Event|11|||
25284160|NCT00596011|50599396|FG001|Overall Study|Adverse Event|7|||
25284161|NCT01163747|50599404|FG000|Overall Study|Adverse Event|0|||
25284162|NCT01163747|50599405|FG001|Overall Study|Adverse Event|5|||
25284163|NCT01163747|50599404|FG000|Overall Study|Insufficient Therapeutic Response|0|||
25284164|NCT01163747|50599405|FG001|Overall Study|Insufficient Therapeutic Response|1|||
25284165|NCT01163747|50599404|FG000|Overall Study|Protocol Violation|0|||
25284166|NCT01163747|50599405|FG001|Overall Study|Protocol Violation|1|||
25284167|NCT01163747|50599404|FG000|Overall Study|Refused Treatment|6|||
25284168|NCT01163747|50599405|FG001|Overall Study|Refused Treatment|4|||
25284169|NCT01163279|50599413|FG000|Overall Study|Withdrawal by Subject|2|||
25284170|NCT01163279|50599414|FG001|Overall Study|Withdrawal by Subject|0|||
25284171|NCT01162499|50599421|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
25284172|NCT01162499|50599422|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
25284173|NCT01206140|50599432|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
25284174|NCT01206140|50599433|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
25284175|NCT01162421|50599441|FG000|Overall Study|Did not receive study drug|2|||
25284176|NCT01162421|50599442|FG001|Overall Study|Did not receive study drug|1|||
25284177|NCT01162421|50599441|FG000|Overall Study|Adverse Event|2|||
25284178|NCT01162421|50599442|FG001|Overall Study|Adverse Event|5|||
25284179|NCT01162421|50599441|FG000|Overall Study|Lost to Follow-up|0|||
25284180|NCT01162421|50599442|FG001|Overall Study|Lost to Follow-up|2|||
25284181|NCT01162421|50599441|FG000|Overall Study|Lack of Efficacy|2|||
25284182|NCT01162421|50599442|FG001|Overall Study|Lack of Efficacy|2|||
25284183|NCT01162421|50599441|FG000|Overall Study|Other|2|||
25284184|NCT01162421|50599442|FG001|Overall Study|Other|3|||
25284185|NCT01162343|50599448|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
25284186|NCT01162343|50599448|FG000|Overall Study|Refused psychiatrist assessment|12|||
25284187|NCT01188551|50599456|FG000|Overall Study|Pharmacy issues|1|||
25284188|NCT01188551|50599457|FG001|Overall Study|Pharmacy issues|0|||
25284189|NCT01188551|50599458|FG002|Overall Study|Pharmacy issues|0|||
25284190|NCT01188551|50599459|FG003|Overall Study|Pharmacy issues|0|||
25284191|NCT01161407|50599471|FG000|Overall Study|Protocol Violation|3|||
25284192|NCT01161407|50599472|FG001|Overall Study|Protocol Violation|1|||
25284193|NCT01161173|50599478|FG000|Overall Study|Protocol Violation|13|||
25284194|NCT01161173|50599478|FG000|Overall Study|Lost to Follow-up|7|||
25284195|NCT01161173|50599478|FG000|Overall Study|Progressive Disease|82|||
25284196|NCT01161173|50599478|FG000|Overall Study|Withdrawal of Consent|5|||
25284197|NCT01161173|50599478|FG000|Overall Study|Unacceptable Toxicity|21|||
25284198|NCT01161173|50599478|FG000|Overall Study|Death|194|||
25284199|NCT01161173|50599478|FG000|Overall Study|End of Study|2|||
25284200|NCT01161173|50599478|FG000|Overall Study|Reasons Not Specified|23|||
25284201|NCT01159769|50599482|FG000|Overall Study|Adverse Event|1|||
25284202|NCT01159691|50599486|FG000|Overall Study|Lost to Follow-up|2|||
25284203|NCT01159691|50599486|FG000|Overall Study|Unknown reasons|1|||
25284204|NCT01159691|50599486|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
25284205|NCT01159691|50599486|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
25284206|NCT01159691|50599486|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
25284207|NCT01159691|50599486|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
25284208|NCT01159691|50599486|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
25284209|NCT01159691|50599486|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
25284210|NCT01157897|50599494|FG000|Overall Study|Lost to Follow-up|2|||
25284211|NCT01157897|50599495|FG001|Overall Study|Lost to Follow-up|0|||
25284212|NCT01157897|50599496|FG002|Overall Study|Lost to Follow-up|0|||
25284213|NCT01157897|50599497|FG003|Overall Study|Lost to Follow-up|1|||
25284214|NCT01157897|50599494|FG000|Overall Study|Relocated|0|||
25284215|NCT01157897|50599495|FG001|Overall Study|Relocated|2|||
25284216|NCT01157897|50599496|FG002|Overall Study|Relocated|0|||
25284217|NCT01157897|50599497|FG003|Overall Study|Relocated|0|||
25284218|NCT01185821|50599512|FG000|Overall Study|Abnormal laboratory value(s)|1|||
25284219|NCT01185821|50599513|FG001|Overall Study|Abnormal laboratory value(s)|2|||
25284220|NCT01185821|50599514|FG002|Overall Study|Abnormal laboratory value(s)|1|||
25284221|NCT01185821|50599515|FG003|Overall Study|Abnormal laboratory value(s)|0|||
25284222|NCT01185821|50599516|FG004|Overall Study|Abnormal laboratory value(s)|0|||
25284223|NCT01185821|50599512|FG000|Overall Study|Protocol Violation|0|||
25284224|NCT01185821|50599513|FG001|Overall Study|Protocol Violation|0|||
25284225|NCT01185821|50599514|FG002|Overall Study|Protocol Violation|0|||
25284226|NCT01185821|50599515|FG003|Overall Study|Protocol Violation|1|||
25284227|NCT01185821|50599516|FG004|Overall Study|Protocol Violation|1|||
25284228|NCT01185821|50599512|FG000|Overall Study|Abnormal test procedure result|0|||
25284229|NCT01185821|50599513|FG001|Overall Study|Abnormal test procedure result|0|||
25284230|NCT01185821|50599514|FG002|Overall Study|Abnormal test procedure result|0|||
25284231|NCT01185821|50599515|FG003|Overall Study|Abnormal test procedure result|0|||
25284232|NCT01185821|50599516|FG004|Overall Study|Abnormal test procedure result|1|||
25284233|NCT01185821|50599512|FG000|Overall Study|Death|0|||
25284234|NCT01185821|50599513|FG001|Overall Study|Death|1|||
25284235|NCT01185821|50599514|FG002|Overall Study|Death|0|||
25284236|NCT01185821|50599515|FG003|Overall Study|Death|0|||
25284237|NCT01185821|50599516|FG004|Overall Study|Death|0|||
25284238|NCT01185821|50599512|FG000|Overall Study|Condition no longer required study drug|0|||
25284239|NCT01185821|50599513|FG001|Overall Study|Condition no longer required study drug|0|||
25284240|NCT01185821|50599514|FG002|Overall Study|Condition no longer required study drug|0|||
25284241|NCT01185821|50599515|FG003|Overall Study|Condition no longer required study drug|0|||
25284242|NCT01185821|50599516|FG004|Overall Study|Condition no longer required study drug|1|||
25284243|NCT01185821|50599512|FG000|Overall Study|Adverse Event|2|||
25284244|NCT01185821|50599513|FG001|Overall Study|Adverse Event|3|||
25284245|NCT01185821|50599514|FG002|Overall Study|Adverse Event|1|||
25284246|NCT01185821|50599515|FG003|Overall Study|Adverse Event|2|||
25284247|NCT01185821|50599516|FG004|Overall Study|Adverse Event|5|||
25284248|NCT01185821|50599512|FG000|Overall Study|Lack of Efficacy|0|||
25284249|NCT01185821|50599513|FG001|Overall Study|Lack of Efficacy|0|||
25284250|NCT01185821|50599514|FG002|Overall Study|Lack of Efficacy|3|||
25284251|NCT01185821|50599515|FG003|Overall Study|Lack of Efficacy|0|||
25284252|NCT01185821|50599516|FG004|Overall Study|Lack of Efficacy|9|||
25284253|NCT01185821|50599512|FG000|Overall Study|Withdrawal by Subject|3|||
25284254|NCT01185821|50599513|FG001|Overall Study|Withdrawal by Subject|2|||
25284255|NCT01185821|50599514|FG002|Overall Study|Withdrawal by Subject|2|||
25284256|NCT01185821|50599515|FG003|Overall Study|Withdrawal by Subject|1|||
25284257|NCT01185821|50599516|FG004|Overall Study|Withdrawal by Subject|3|||
25284258|NCT01185821|50599512|FG000|Overall Study|Lost to Follow-up|1|||
25284259|NCT01185821|50599513|FG001|Overall Study|Lost to Follow-up|1|||
25284260|NCT01185821|50599514|FG002|Overall Study|Lost to Follow-up|2|||
25284261|NCT01185821|50599515|FG003|Overall Study|Lost to Follow-up|1|||
25284262|NCT01185821|50599516|FG004|Overall Study|Lost to Follow-up|2|||
25284263|NCT01185821|50599512|FG000|Overall Study|Administrative problems|0|||
25284264|NCT01185821|50599513|FG001|Overall Study|Administrative problems|0|||
25284265|NCT01185821|50599514|FG002|Overall Study|Administrative problems|1|||
25284266|NCT01185821|50599515|FG003|Overall Study|Administrative problems|1|||
25284267|NCT01185821|50599516|FG004|Overall Study|Administrative problems|2|||
25284268|NCT00893464|50599538|FG000|Overall Study|Did not complete therapy/experience PD|0|||
25284269|NCT00893464|50599539|FG001|Overall Study|Did not complete therapy/experience PD|0|||
25284270|NCT00893464|50599540|FG002|Overall Study|Did not complete therapy/experience PD|0|||
25284271|NCT00893464|50599541|FG003|Overall Study|Did not complete therapy/experience PD|0|||
25284272|NCT00893464|50599542|FG004|Overall Study|Did not complete therapy/experience PD|0|||
25284273|NCT00893464|50599543|FG005|Overall Study|Did not complete therapy/experience PD|0|||
25284274|NCT00893464|50599544|FG006|Overall Study|Did not complete therapy/experience PD|2|||
25284275|NCT00893464|50599545|FG007|Overall Study|Did not complete therapy/experience PD|2|||
25284276|NCT00891904|50599568|FG000|Overall Study|Death|1|||
25284277|NCT00891904|50599568|FG000|Overall Study|Adverse Event|1|||
25284278|NCT01157351|50599574|FG000|Overall Study|Adverse Event|5|||
25284279|NCT01157351|50599575|FG001|Overall Study|Adverse Event|4|||
25284280|NCT01157351|50599574|FG000|Overall Study|Death|1|||
25284281|NCT01157351|50599575|FG001|Overall Study|Death|0|||
25284282|NCT01157351|50599574|FG000|Overall Study|Lost to Follow-up|53|||
25284283|NCT01157351|50599575|FG001|Overall Study|Lost to Follow-up|55|||
25284284|NCT01157351|50599574|FG000|Overall Study|Withdrawal by Subject|37|||
25284285|NCT01157351|50599575|FG001|Overall Study|Withdrawal by Subject|27|||
25284286|NCT01157351|50599574|FG000|Overall Study|Physician Decision|5|||
25284287|NCT01157351|50599575|FG001|Overall Study|Physician Decision|4|||
25284288|NCT01157351|50599574|FG000|Overall Study|Protocol Violation|0|||
25284289|NCT01157351|50599575|FG001|Overall Study|Protocol Violation|1|||
25284290|NCT01157351|50599574|FG000|Overall Study|Other|32|||
25284291|NCT01157351|50599575|FG001|Overall Study|Other|36|||
25284292|NCT01157351|50599574|FG000|Overall Study|Noncompliance with Study Drug|0|||
25284293|NCT01157351|50599575|FG001|Overall Study|Noncompliance with Study Drug|3|||
25284294|NCT01157351|50599574|FG000|Overall Study|Randomized but not Treated|4|||
25284295|NCT01157351|50599575|FG001|Overall Study|Randomized but not Treated|2|||
25284296|NCT01157117|50599584|FG000|Overall Study|Dosing Symptoms|0|||
25284297|NCT01157117|50599585|FG001|Overall Study|Dosing Symptoms|4|||
25284298|NCT01157117|50599586|FG002|Overall Study|Dosing Symptoms|0|||
25284299|NCT01157117|50599584|FG000|Overall Study|Withdrawal by Subject|4|||
25284300|NCT01157117|50599585|FG001|Overall Study|Withdrawal by Subject|1|||
25284301|NCT01157117|50599586|FG002|Overall Study|Withdrawal by Subject|1|||
25284302|NCT01157117|50599584|FG000|Overall Study|Lack of Efficacy|1|||
25284303|NCT01157117|50599585|FG001|Overall Study|Lack of Efficacy|1|||
25284304|NCT01157117|50599586|FG002|Overall Study|Lack of Efficacy|0|||
25284305|NCT01157117|50599584|FG000|Overall Study|Lost to Follow-up|0|||
25284306|NCT01157117|50599585|FG001|Overall Study|Lost to Follow-up|0|||
25284307|NCT01157117|50599586|FG002|Overall Study|Lost to Follow-up|1|||
25284308|NCT01157117|50599584|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
25284309|NCT01157117|50599585|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
25284310|NCT01157117|50599586|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
25284311|NCT00891202|50599596|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
25284312|NCT00891202|50599597|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
25284313|NCT00891202|50599598|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
25284314|NCT00891202|50599599|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
25284315|NCT00891202|50599596|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
25284316|NCT00891202|50599597|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
25284317|NCT00891202|50599598|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
25284318|NCT00891202|50599599|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
25284319|NCT00891202|50599596|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
25284320|NCT00891202|50599597|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
25284321|NCT00891202|50599598|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
25284322|NCT00891202|50599599|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
25284323|NCT00891202|50599596|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
25284324|NCT00891202|50599597|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
25284325|NCT00891202|50599598|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
25284326|NCT00891202|50599599|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
25284327|NCT01185509|50599609|FG000|Overall Study|Progression/Relapse|9|||
25284328|NCT01185509|50599610|FG001|Overall Study|Progression/Relapse|15|||
25284329|NCT01185509|50599609|FG000|Overall Study|Physician Decision|2|||
25284330|NCT01185509|50599610|FG001|Overall Study|Physician Decision|2|||
25284331|NCT01185509|50599609|FG000|Overall Study|Withdrawal by Subject|0|||
25284332|NCT01185509|50599610|FG001|Overall Study|Withdrawal by Subject|1|||
25284333|NCT01185509|50599609|FG000|Overall Study|Death|0|||
25284334|NCT01185509|50599610|FG001|Overall Study|Death|1|||
25284335|NCT01185509|50599609|FG000|Overall Study|Intercurrent Illness|0|||
25284336|NCT01185509|50599610|FG001|Overall Study|Intercurrent Illness|1|||
25284337|NCT00891046|50599622|FG000|Overall Study|Protocol Violation|1|||
25284338|NCT00891046|50599623|FG001|Overall Study|Protocol Violation|1|||
25284339|NCT00891046|50599624|FG002|Overall Study|Protocol Violation|0|||
25284340|NCT00891046|50599625|FG003|Overall Study|Protocol Violation|0|||
25284341|NCT00891046|50599626|FG004|Overall Study|Protocol Violation|1|||
25284342|NCT00891046|50599622|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
25284343|NCT00891046|50599623|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
25284344|NCT00891046|50599624|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
25284345|NCT00891046|50599625|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
25284346|NCT00891046|50599626|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
25284347|NCT00891046|50599622|FG000|Overall Study|Administrative problems|0|||
25284348|NCT00891046|50599623|FG001|Overall Study|Administrative problems|0|||
25284349|NCT00891046|50599624|FG002|Overall Study|Administrative problems|0|||
25284350|NCT00891046|50599625|FG003|Overall Study|Administrative problems|0|||
25284351|NCT00891046|50599626|FG004|Overall Study|Administrative problems|1|||
25284352|NCT00891046|50599622|FG000|Overall Study|Participant no longer required drug|0|||
25284353|NCT00891046|50599623|FG001|Overall Study|Participant no longer required drug|2|||
25284354|NCT00891046|50599624|FG002|Overall Study|Participant no longer required drug|0|||
25284355|NCT00891046|50599625|FG003|Overall Study|Participant no longer required drug|0|||
25284356|NCT00891046|50599626|FG004|Overall Study|Participant no longer required drug|1|||
25284357|NCT00891046|50599622|FG000|Overall Study|Adverse Event|4|||
25284358|NCT00891046|50599623|FG001|Overall Study|Adverse Event|3|||
25284359|NCT00891046|50599624|FG002|Overall Study|Adverse Event|2|||
25284360|NCT00891046|50599625|FG003|Overall Study|Adverse Event|0|||
25284361|NCT00891046|50599626|FG004|Overall Study|Adverse Event|14|||
25284362|NCT00891046|50599622|FG000|Overall Study|Withdrawal by Subject|2|||
25284363|NCT00891046|50599623|FG001|Overall Study|Withdrawal by Subject|1|||
25284364|NCT00891046|50599624|FG002|Overall Study|Withdrawal by Subject|2|||
25284365|NCT00891046|50599625|FG003|Overall Study|Withdrawal by Subject|1|||
25284366|NCT00891046|50599626|FG004|Overall Study|Withdrawal by Subject|1|||
25284367|NCT00891046|50599622|FG000|Overall Study|Lost to Follow-up|0|||
25284368|NCT00891046|50599623|FG001|Overall Study|Lost to Follow-up|0|||
25284369|NCT00891046|50599624|FG002|Overall Study|Lost to Follow-up|0|||
25284370|NCT00891046|50599625|FG003|Overall Study|Lost to Follow-up|0|||
25284371|NCT00891046|50599626|FG004|Overall Study|Lost to Follow-up|1|||
25284372|NCT00889720|50599653|FG000|Overall Study|Withdrawal by Subject|4|||
25284373|NCT00889720|50599653|FG000|Overall Study|Other|4|||
25284374|NCT01116648|50599672|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
25284375|NCT01116648|50599673|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
25284376|NCT01116648|50599674|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
25284377|NCT01116648|50599675|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
25284378|NCT01116648|50599676|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
25284379|NCT01116648|50599677|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
25284380|NCT01116648|50599678|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
25284381|NCT01116648|50599679|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
25284382|NCT01116648|50599680|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
25284383|NCT01116648|50599681|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
25284384|NCT01116648|50599682|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
25284385|NCT01116648|50599683|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
25284386|NCT01116648|50599684|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
25284387|NCT01116648|50599685|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
25284388|NCT01116648|50599686|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
25284389|NCT00880087|50599713|FG000|Overall Study|Lost to Follow-up|0|||
25284390|NCT00880087|50599714|FG001|Overall Study|Lost to Follow-up|2|||
25284391|NCT00889252|50599722|FG000|Overall Study|Adverse Event|2|||
25284392|NCT00889252|50599723|FG001|Overall Study|Adverse Event|4|||
25284393|NCT00889252|50599722|FG000|Overall Study|Withdrawal by Subject|3|||
25284394|NCT00889252|50599723|FG001|Overall Study|Withdrawal by Subject|0|||
25284395|NCT00889252|50599722|FG000|Overall Study|Protocol Violation|2|||
25284396|NCT00889252|50599723|FG001|Overall Study|Protocol Violation|0|||
25284397|NCT01110330|50599732|FG000|Overall Study|Adverse Event|0|||
25284398|NCT01110330|50599733|FG001|Overall Study|Adverse Event|4|||
25284399|NCT01110330|50599734|FG002|Overall Study|Adverse Event|3|||
25284400|NCT01110330|50599732|FG000|Overall Study|Lack of Efficacy|3|||
25284401|NCT01110330|50599733|FG001|Overall Study|Lack of Efficacy|1|||
25284402|NCT01110330|50599734|FG002|Overall Study|Lack of Efficacy|1|||
25284403|NCT01110330|50599732|FG000|Overall Study|Lost to Follow-up|9|||
25284404|NCT01110330|50599733|FG001|Overall Study|Lost to Follow-up|10|||
25284405|NCT01110330|50599734|FG002|Overall Study|Lost to Follow-up|15|||
25284406|NCT01110330|50599732|FG000|Overall Study|Physician Decision|0|||
25284407|NCT01110330|50599733|FG001|Overall Study|Physician Decision|1|||
25284408|NCT01110330|50599734|FG002|Overall Study|Physician Decision|0|||
25284409|NCT01110330|50599732|FG000|Overall Study|Protocol Violation|2|||
25284410|NCT01110330|50599733|FG001|Overall Study|Protocol Violation|0|||
25284411|NCT01110330|50599734|FG002|Overall Study|Protocol Violation|4|||
25284412|NCT01110330|50599732|FG000|Overall Study|Withdrawal by Subject|0|||
25284413|NCT01110330|50599733|FG001|Overall Study|Withdrawal by Subject|6|||
25284414|NCT01110330|50599734|FG002|Overall Study|Withdrawal by Subject|2|||
25284415|NCT01110330|50599732|FG000|Overall Study|Other|1|||
25284416|NCT01110330|50599733|FG001|Overall Study|Other|1|||
25284417|NCT01110330|50599734|FG002|Overall Study|Other|1|||
25069967|NCT02610140|50175722|FG001|Safety Follow-up|Lost to Follow-up|0|||
24969563|NCT00119106|50058994|FG001|Overall Study|HIV infected at baseline|178|||
25169180|NCT01845077|50300357|FG005|Washout Period|Protocol Violation|0|||
25284418|NCT00596947|50599744|FG000|Overall Study|study halted due to low enrollment|5|||
25284419|NCT00596947|50599745|FG001|Overall Study|study halted due to low enrollment|3|||
25284420|NCT00596947|50599744|FG000|Overall Study|Lost to Follow-up|1|||
25284421|NCT00596947|50599745|FG001|Overall Study|Lost to Follow-up|0|||
25284422|NCT00888940|50599753|FG000|Overall Study|Adverse Event|12|||
25284423|NCT00888940|50599754|FG001|Overall Study|Adverse Event|3|||
25169181|NCT01866917|50300374|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
25284424|NCT00888940|50599753|FG000|Overall Study|Lost to Follow-up|5|||
25284425|NCT00888940|50599754|FG001|Overall Study|Lost to Follow-up|5|||
25284426|NCT00888940|50599753|FG000|Overall Study|Randomized Not Treated|11|||
25284427|NCT00888940|50599754|FG001|Overall Study|Randomized Not Treated|13|||
25284428|NCT00595621|50599762|FG000|Open Label Run in|Adverse Event|1|||
25284429|NCT00595621|50599763|FG001|Open Label Run in|Adverse Event|0|||
25284430|NCT00595621|50599762|FG000|Open Label Run in|Physician Decision|1|||
25284431|NCT00595621|50599763|FG001|Open Label Run in|Physician Decision|0|||
25284432|NCT00595621|50599762|FG000|Open Label Run in|Withdrawal by Subject|1|||
25284433|NCT00595621|50599763|FG001|Open Label Run in|Withdrawal by Subject|0|||
25284434|NCT00595621|50599762|FG000|Randomization and Study|Adverse Event|2|||
25284435|NCT00595621|50599763|FG001|Randomization and Study|Adverse Event|0|||
25284436|NCT00595621|50599762|FG000|Randomization and Study|Withdrawal by Subject|0|||
25284437|NCT00595621|50599763|FG001|Randomization and Study|Withdrawal by Subject|1|||
25284438|NCT00888238|50599770|FG000|Washout Period After Period 2|Adverse Event|0|||
25284439|NCT00888238|50599771|FG001|Washout Period After Period 2|Adverse Event|0|||
25284440|NCT00888238|50599772|FG002|Washout Period After Period 2|Adverse Event|1|||
25284441|NCT00595465|50599781|FG000|Overall Study|Adverse Event|4|||
25284442|NCT00595465|50599782|FG001|Overall Study|Adverse Event|3|||
25284443|NCT00595465|50599783|FG002|Overall Study|Adverse Event|3|||
25284444|NCT00595465|50599781|FG000|Overall Study|Pregnancy|0|||
25284445|NCT00595465|50599782|FG001|Overall Study|Pregnancy|0|||
25284446|NCT00595465|50599783|FG002|Overall Study|Pregnancy|1|||
25284447|NCT00595465|50599781|FG000|Overall Study|Protocol Violation|2|||
25284448|NCT00595465|50599782|FG001|Overall Study|Protocol Violation|1|||
25284449|NCT00595465|50599783|FG002|Overall Study|Protocol Violation|0|||
25284450|NCT00595465|50599781|FG000|Overall Study|Lost to Follow-up|0|||
25284451|NCT00595465|50599782|FG001|Overall Study|Lost to Follow-up|0|||
25284452|NCT00595465|50599783|FG002|Overall Study|Lost to Follow-up|2|||
25284453|NCT00595465|50599781|FG000|Overall Study|administrative reason|0|||
25284454|NCT00595465|50599782|FG001|Overall Study|administrative reason|0|||
25284455|NCT00595465|50599783|FG002|Overall Study|administrative reason|1|||
25284456|NCT01205438|50599794|FG000|Overall Study|Adverse Event|19|||
25284457|NCT01205438|50599795|FG001|Overall Study|Adverse Event|17|||
25284458|NCT01205438|50599796|FG002|Overall Study|Adverse Event|24|||
25284459|NCT01205438|50599794|FG000|Overall Study|Death|1|||
25284460|NCT01205438|50599795|FG001|Overall Study|Death|1|||
25284461|NCT01205438|50599796|FG002|Overall Study|Death|3|||
25284462|NCT01205438|50599794|FG000|Overall Study|Entry Criteria Not Met|16|||
25284463|NCT01205438|50599795|FG001|Overall Study|Entry Criteria Not Met|15|||
25284464|NCT01205438|50599796|FG002|Overall Study|Entry Criteria Not Met|13|||
25284465|NCT01205438|50599794|FG000|Overall Study|Lack of Efficacy|14|||
25284466|NCT01205438|50599795|FG001|Overall Study|Lack of Efficacy|11|||
25284467|NCT01205438|50599796|FG002|Overall Study|Lack of Efficacy|14|||
25284468|NCT01205438|50599794|FG000|Overall Study|Lost to Follow-up|6|||
25284469|NCT01205438|50599795|FG001|Overall Study|Lost to Follow-up|7|||
25284470|NCT01205438|50599796|FG002|Overall Study|Lost to Follow-up|8|||
25284471|NCT01205438|50599794|FG000|Overall Study|Withdrawal by Subject|19|||
25284472|NCT01205438|50599795|FG001|Overall Study|Withdrawal by Subject|25|||
25284473|NCT01205438|50599796|FG002|Overall Study|Withdrawal by Subject|19|||
25284474|NCT01205438|50599794|FG000|Overall Study|Physician Decision|0|||
25284475|NCT01205438|50599795|FG001|Overall Study|Physician Decision|3|||
25284476|NCT01205438|50599796|FG002|Overall Study|Physician Decision|2|||
25284477|NCT01205438|50599794|FG000|Overall Study|Protocol Violation|2|||
25284478|NCT01205438|50599795|FG001|Overall Study|Protocol Violation|7|||
25284479|NCT01205438|50599796|FG002|Overall Study|Protocol Violation|4|||
25284480|NCT01205438|50599794|FG000|Overall Study|Sponsor Decision|0|||
25284481|NCT01205438|50599795|FG001|Overall Study|Sponsor Decision|1|||
25284482|NCT01205438|50599796|FG002|Overall Study|Sponsor Decision|1|||
25284483|NCT01104870|50599810|FG000|Overall Study|Adverse Event|1|||
25284484|NCT01104870|50599811|FG001|Overall Study|Adverse Event|1|||
25284485|NCT01104870|50599812|FG002|Overall Study|Adverse Event|0|||
25284486|NCT01104870|50599810|FG000|Overall Study|Death|0|||
25284487|NCT01104870|50599811|FG001|Overall Study|Death|0|||
25191407|NCT01454102|50351336|FG000|Overall Study|Continuing in the treatment period|0|||
25191408|NCT01454102|50351337|FG001|Overall Study|Continuing in the treatment period|0|||
25284488|NCT01104870|50599812|FG002|Overall Study|Death|1|||
25284489|NCT01104870|50599810|FG000|Overall Study|Withdrawal by Subject|0|||
25284490|NCT01104870|50599811|FG001|Overall Study|Withdrawal by Subject|0|||
25284491|NCT01104870|50599812|FG002|Overall Study|Withdrawal by Subject|1|||
25284492|NCT01104792|50599820|FG000|Overall Study|Adverse Event|77|||
25284493|NCT01104792|50599820|FG000|Overall Study|Insufficient Therapeutic Response|22|||
24969564|NCT00135356|50059010|FG000|Overall Study|Adverse Event|6|||
25284494|NCT01104792|50599820|FG000|Overall Study|Protocol Violation|45|||
25284495|NCT01104792|50599820|FG000|Overall Study|Withdrawal of Consent|179|||
25284496|NCT01104792|50599820|FG000|Overall Study|Lost to Follow-up|43|||
25284497|NCT01104792|50599820|FG000|Overall Study|Reasons Not Specified|27|||
25284498|NCT01104792|50599820|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
24969565|NCT00135356|50059011|FG001|Overall Study|Adverse Event|2|||
25284499|NCT01205126|50599826|FG000|Titration Phase|Adverse Event|5|||
25284500|NCT01205126|50599827|FG001|Titration Phase|Adverse Event|3|||
25284501|NCT01205126|50599826|FG000|Titration Phase|Withdrawal by Subject|5|||
25191409|NCT01454102|50351338|FG002|Overall Study|Continuing in the treatment period|0|||
25191410|NCT01454102|50351339|FG003|Overall Study|Continuing in the treatment period|0|||
25191411|NCT01454102|50351340|FG004|Overall Study|Continuing in the treatment period|3|||
25191412|NCT01454102|50351341|FG005|Overall Study|Continuing in the treatment period|3|||
25191413|NCT01454102|50351342|FG006|Overall Study|Continuing in the treatment period|2|||
25191414|NCT01454102|50351343|FG007|Overall Study|Continuing in the treatment period|0|||
25191415|NCT01454102|50351344|FG008|Overall Study|Continuing in the treatment period|1|||
25191416|NCT01454102|50351345|FG009|Overall Study|Continuing in the treatment period|0|||
25191417|NCT01454102|50351346|FG010|Overall Study|Continuing in the treatment period|0|||
25191418|NCT01454102|50351347|FG011|Overall Study|Continuing in the treatment period|4|||
25191419|NCT01454102|50351348|FG012|Overall Study|Continuing in the treatment period|7|||
25191420|NCT01454102|50351349|FG013|Overall Study|Continuing in the treatment period|4|||
25191421|NCT01454102|50351350|FG014|Overall Study|Continuing in the treatment period|3|||
25191422|NCT01454102|50351351|FG015|Overall Study|Continuing in the treatment period|1|||
25284502|NCT01205126|50599827|FG001|Titration Phase|Withdrawal by Subject|5|||
25284503|NCT01205126|50599826|FG000|Titration Phase|Lost to Follow-up|2|||
25284504|NCT01205126|50599827|FG001|Titration Phase|Lost to Follow-up|2|||
25284505|NCT01205126|50599826|FG000|Titration Phase|No stable titration dose|1|||
25284506|NCT01205126|50599827|FG001|Titration Phase|No stable titration dose|0|||
25284507|NCT01205126|50599826|FG000|Titration Phase|More than maximum dosage required|2|||
25169182|NCT01866917|50300375|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
25169183|NCT01844765|50300510|FG000|Overall Study|Adverse Event|6|||
25169184|NCT01844765|50300511|FG001|Overall Study|Adverse Event|8|||
25169185|NCT01844765|50300510|FG000|Overall Study|Withdrawal by Subject|2|||
25169186|NCT01844765|50300511|FG001|Overall Study|Withdrawal by Subject|3|||
25169187|NCT01844765|50300510|FG000|Overall Study|Disease progression|1|||
25169188|NCT01844765|50300511|FG001|Overall Study|Disease progression|0|||
25169189|NCT01844765|50300510|FG000|Overall Study|Administrative problems|3|||
25169190|NCT01844765|50300511|FG001|Overall Study|Administrative problems|4|||
25169191|NCT01844765|50300510|FG000|Overall Study|Protocol deviation|2|||
25191423|NCT02602080|50351445|FG000|Overall Study|Protocol Violation|6|||
25191424|NCT02602080|50351446|FG001|Overall Study|Protocol Violation|1|||
25191425|NCT02602080|50351447|FG002|Overall Study|Protocol Violation|3|||
25191426|NCT02604342|50351531|FG000|Overall Study|Death|32|||
25191427|NCT02604342|50351532|FG001|Overall Study|Death|16|||
25191428|NCT02604342|50351531|FG000|Overall Study|Progression of disease|1|||
25191429|NCT02604342|50351532|FG001|Overall Study|Progression of disease|0|||
25191430|NCT02604342|50351531|FG000|Overall Study|Withdrawal by Subject|5|||
25191431|NCT02604342|50351532|FG001|Overall Study|Withdrawal by Subject|6|||
25191432|NCT02604342|50351531|FG000|Overall Study|Other|1|||
25191433|NCT02604342|50351532|FG001|Overall Study|Other|0|||
25191434|NCT02604342|50351531|FG000|Overall Study|Study Termination by Sponsor|1|||
25191435|NCT02604342|50351532|FG001|Overall Study|Study Termination by Sponsor|0|||
25191436|NCT02604342|50351531|FG000|Overall Study|Lost to Follow-up|1|||
25191437|NCT02604342|50351532|FG001|Overall Study|Lost to Follow-up|1|||
25191438|NCT02604342|50351531|FG000|Overall Study|Physician Decision|2|||
25191439|NCT02604342|50351532|FG001|Overall Study|Physician Decision|0|||
25191440|NCT02604264|50351561|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
25191441|NCT02604264|50351562|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
25191442|NCT02601300|50351599|FG000|Induction Phase|Lack of Efficacy|2|||
25191443|NCT02601300|50351599|FG000|Induction Phase|Protocol Violation|1|||
25191444|NCT02601300|50351599|FG000|Extension Phase|Withdrawal by Subject|3|||
25191445|NCT02601300|50351599|FG000|Extension Phase|Adverse Event|4|||
25191446|NCT02601300|50351599|FG000|Extension Phase|Lack of Efficacy|10|||
25191447|NCT01471340|50351638|FG000|Overall Study|Death|5|||
25191448|NCT01471340|50351639|FG001|Overall Study|Death|4|||
25191449|NCT01471340|50351638|FG000|Overall Study|Lost to Follow-up|0|||
25191450|NCT01471340|50351639|FG001|Overall Study|Lost to Follow-up|1|||
25191451|NCT01471340|50351638|FG000|Overall Study|Investigational site closure|0|||
25191452|NCT01471340|50351639|FG001|Overall Study|Investigational site closure|1|||
25191453|NCT01471340|50351638|FG000|Overall Study|Invalid informed consent|1|||
25191454|NCT01471340|50351639|FG001|Overall Study|Invalid informed consent|0|||
25284508|NCT01205126|50599827|FG001|Titration Phase|More than maximum dosage required|3|||
25284509|NCT01205126|50599826|FG000|Titration Phase|Other|8|||
25284510|NCT01205126|50599827|FG001|Titration Phase|Other|6|||
25284511|NCT01205126|50599826|FG000|Between Titration & Maintenance Phase|Other|0|||
25284512|NCT01205126|50599827|FG001|Between Titration & Maintenance Phase|Other|4|||
25284513|NCT01205126|50599826|FG000|Maintenance Phase|Adverse Event|3|||
25284514|NCT01205126|50599827|FG001|Maintenance Phase|Adverse Event|7|||
25284515|NCT01205126|50599826|FG000|Maintenance Phase|Death|4|||
25284516|NCT01205126|50599827|FG001|Maintenance Phase|Death|4|||
25284517|NCT01205126|50599826|FG000|Maintenance Phase|More than the maximum dosage required|5|||
25284518|NCT01205126|50599827|FG001|Maintenance Phase|More than the maximum dosage required|5|||
25284519|NCT01205126|50599826|FG000|Maintenance Phase|Prohibited drugs used|1|||
25284520|NCT01205126|50599827|FG001|Maintenance Phase|Prohibited drugs used|0|||
25284521|NCT01205126|50599826|FG000|Maintenance Phase|Other|11|||
25284522|NCT01205126|50599827|FG001|Maintenance Phase|Other|8|||
25284523|NCT01205126|50599826|FG000|Maintenance Phase|Lost to Follow-up|5|||
25284524|NCT01205126|50599827|FG001|Maintenance Phase|Lost to Follow-up|5|||
25284525|NCT01205126|50599826|FG000|Maintenance Phase|Withdrawal by Subject|8|||
25284526|NCT01205126|50599827|FG001|Maintenance Phase|Withdrawal by Subject|11|||
25284527|NCT00946647|50599838|FG000|Phase 1 Part|Adverse Event|2|||
25284528|NCT00946647|50599839|FG001|Phase 1 Part|Adverse Event|5|||
25284529|NCT00946647|50599840|FG002|Phase 1 Part|Adverse Event|3|||
25284530|NCT00946647|50599841|FG003|Phase 1 Part|Adverse Event|0|||
25284531|NCT00946647|50599842|FG004|Phase 1 Part|Adverse Event|0|||
25284532|NCT00946647|50599838|FG000|Phase 1 Part|Disease progression|3|||
25284533|NCT00946647|50599839|FG001|Phase 1 Part|Disease progression|6|||
25284534|NCT00946647|50599840|FG002|Phase 1 Part|Disease progression|1|||
25284535|NCT00946647|50599841|FG003|Phase 1 Part|Disease progression|0|||
25284536|NCT00946647|50599842|FG004|Phase 1 Part|Disease progression|0|||
25284537|NCT00946647|50599838|FG000|Phase 1 Part|Withdrawal by Subject|1|||
25284538|NCT00946647|50599839|FG001|Phase 1 Part|Withdrawal by Subject|4|||
25284539|NCT00946647|50599840|FG002|Phase 1 Part|Withdrawal by Subject|3|||
25284540|NCT00946647|50599841|FG003|Phase 1 Part|Withdrawal by Subject|0|||
25284541|NCT00946647|50599842|FG004|Phase 1 Part|Withdrawal by Subject|0|||
25284542|NCT00946647|50599838|FG000|Phase 1 Part|Abnormal values|0|||
25284543|NCT00946647|50599839|FG001|Phase 1 Part|Abnormal values|2|||
25284544|NCT00946647|50599840|FG002|Phase 1 Part|Abnormal values|0|||
25284545|NCT00946647|50599841|FG003|Phase 1 Part|Abnormal values|0|||
25284546|NCT00946647|50599842|FG004|Phase 1 Part|Abnormal values|0|||
25284547|NCT00946647|50599838|FG000|Phase 1 Part|Reason missing|0|||
25284548|NCT00946647|50599839|FG001|Phase 1 Part|Reason missing|1|||
25284549|NCT00946647|50599840|FG002|Phase 1 Part|Reason missing|0|||
25284550|NCT00946647|50599841|FG003|Phase 1 Part|Reason missing|0|||
25284551|NCT00946647|50599842|FG004|Phase 1 Part|Reason missing|0|||
25284552|NCT00946647|50599838|FG000|Phase ll Part|Untreated|0|||
25284553|NCT00946647|50599839|FG001|Phase ll Part|Untreated|0|||
25284554|NCT00946647|50599840|FG002|Phase ll Part|Untreated|0|||
25284555|NCT00946647|50599841|FG003|Phase ll Part|Untreated|0|||
25284556|NCT00946647|50599842|FG004|Phase ll Part|Untreated|2|||
25284557|NCT00946647|50599838|FG000|Phase ll Part|Adverse Event|0|||
25284558|NCT00946647|50599839|FG001|Phase ll Part|Adverse Event|0|||
25284559|NCT00946647|50599840|FG002|Phase ll Part|Adverse Event|0|||
25284560|NCT00946647|50599841|FG003|Phase ll Part|Adverse Event|10|||
25284561|NCT00946647|50599842|FG004|Phase ll Part|Adverse Event|6|||
25284562|NCT00946647|50599838|FG000|Phase ll Part|Withdrawal by Subject|0|||
25284563|NCT00946647|50599839|FG001|Phase ll Part|Withdrawal by Subject|0|||
25284564|NCT00946647|50599840|FG002|Phase ll Part|Withdrawal by Subject|0|||
25284565|NCT00946647|50599841|FG003|Phase ll Part|Withdrawal by Subject|8|||
25284566|NCT00946647|50599842|FG004|Phase ll Part|Withdrawal by Subject|6|||
25284567|NCT00946647|50599838|FG000|Phase ll Part|Administrative problems|0|||
25284568|NCT00946647|50599839|FG001|Phase ll Part|Administrative problems|0|||
25284569|NCT00946647|50599840|FG002|Phase ll Part|Administrative problems|0|||
25284570|NCT00946647|50599841|FG003|Phase ll Part|Administrative problems|3|||
25284571|NCT00946647|50599842|FG004|Phase ll Part|Administrative problems|8|||
25284572|NCT00946647|50599838|FG000|Phase ll Part|Death|0|||
25284573|NCT00946647|50599839|FG001|Phase ll Part|Death|0|||
25284574|NCT00946647|50599840|FG002|Phase ll Part|Death|0|||
25284575|NCT00946647|50599841|FG003|Phase ll Part|Death|7|||
25284576|NCT00946647|50599842|FG004|Phase ll Part|Death|4|||
25284577|NCT00946647|50599838|FG000|Phase ll Part|Disease progression|0|||
25284578|NCT00946647|50599839|FG001|Phase ll Part|Disease progression|0|||
25284579|NCT00946647|50599840|FG002|Phase ll Part|Disease progression|0|||
25284580|NCT00946647|50599841|FG003|Phase ll Part|Disease progression|6|||
25284581|NCT00946647|50599842|FG004|Phase ll Part|Disease progression|14|||
25284582|NCT00946647|50599838|FG000|Phase ll Part|Protocol Violation|0|||
25284583|NCT00946647|50599839|FG001|Phase ll Part|Protocol Violation|0|||
25284584|NCT00946647|50599840|FG002|Phase ll Part|Protocol Violation|0|||
24969566|NCT00135356|50059010|FG000|Overall Study|Lack of Efficacy|2|||
24969567|NCT00135356|50059011|FG001|Overall Study|Lack of Efficacy|0|||
24969568|NCT00135356|50059010|FG000|Overall Study|Lost to Follow-up|3|||
24969569|NCT00135356|50059011|FG001|Overall Study|Lost to Follow-up|1|||
24969570|NCT00135356|50059010|FG000|Overall Study|Surgery for abdominal fat|1|||
24969571|NCT00135356|50059011|FG001|Overall Study|Surgery for abdominal fat|0|||
24969572|NCT00135356|50059010|FG000|Overall Study|Change in antiviral regimen|0|||
24969573|NCT00135356|50059011|FG001|Overall Study|Change in antiviral regimen|1|||
24969574|NCT00135356|50059010|FG000|Overall Study|Poor/noncompliance|1|||
24969575|NCT00135356|50059011|FG001|Overall Study|Poor/noncompliance|1|||
24969576|NCT00135356|50059010|FG000|Overall Study|No longer meets study criteria|2|||
24969577|NCT00135356|50059011|FG001|Overall Study|No longer meets study criteria|0|||
24969578|NCT00135356|50059010|FG000|Overall Study|Withdrawal by Subject|2|||
24969579|NCT00135356|50059011|FG001|Overall Study|Withdrawal by Subject|4|||
24969580|NCT00118716|50059019|FG000|Overall Study|Adverse Event|2|||
24969581|NCT00118716|50059020|FG001|Overall Study|Adverse Event|7|||
24969582|NCT00118716|50059019|FG000|Overall Study|Protocol Violation|5|||
24969583|NCT00118716|50059020|FG001|Overall Study|Protocol Violation|4|||
24969584|NCT00118716|50059019|FG000|Overall Study|Withdrawal by Subject|0|||
24969585|NCT00118716|50059020|FG001|Overall Study|Withdrawal by Subject|1|||
24969586|NCT00118716|50059019|FG000|Overall Study|Exacerbation|2|||
24969587|NCT00118716|50059020|FG001|Overall Study|Exacerbation|2|||
24969588|NCT00118716|50059019|FG000|Overall Study|Discontinued by sponsor|1|||
24969589|NCT00118716|50059020|FG001|Overall Study|Discontinued by sponsor|1|||
24969590|NCT00118716|50059019|FG000|Overall Study|Non-compliance|1|||
24969591|NCT00118716|50059020|FG001|Overall Study|Non-compliance|3|||
24969592|NCT00118716|50059019|FG000|Overall Study|misrandomized|1|||
24969593|NCT00118716|50059020|FG001|Overall Study|misrandomized|1|||
24969594|NCT00118716|50059019|FG000|Overall Study|Expired drug use|1|||
24969595|NCT00118716|50059020|FG001|Overall Study|Expired drug use|2|||
24969596|NCT00118716|50059019|FG000|Overall Study|Investigator discretion|0|||
24969597|NCT00118716|50059020|FG001|Overall Study|Investigator discretion|1|||
24969598|NCT04584346|50059028|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
24969599|NCT04584346|50059029|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
24969600|NCT00118482|50059039|FG000|Overall Study|Lost to Follow-up|7|||
25284585|NCT00946647|50599841|FG003|Phase ll Part|Protocol Violation|4|||
25284586|NCT00946647|50599842|FG004|Phase ll Part|Protocol Violation|2|||
25284587|NCT00946647|50599838|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
24969601|NCT00118482|50059040|FG001|Overall Study|Lost to Follow-up|7|||
24969602|NCT00118482|50059039|FG000|Overall Study|Withdrawal by Subject|23|||
24969603|NCT00118482|50059040|FG001|Overall Study|Withdrawal by Subject|22|||
25284588|NCT00946647|50599839|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
25069968|NCT02610140|50175721|FG000|Safety Follow-up|No follow-up|5|||
25069969|NCT02610140|50175722|FG001|Safety Follow-up|No follow-up|3|||
25069970|NCT02610140|50175721|FG000|Safety Follow-up|Death|12|||
25069971|NCT02610140|50175722|FG001|Safety Follow-up|Death|2|||
25069972|NCT02610140|50175721|FG000|Safety Follow-up|Deterioration of general conditions|15|||
25069973|NCT02610140|50175722|FG001|Safety Follow-up|Deterioration of general conditions|5|||
25069974|NCT02610140|50175721|FG000|Safety Follow-up|Withdrawal by Subject|12|||
25069975|NCT02610140|50175722|FG001|Safety Follow-up|Withdrawal by Subject|12|||
25069976|NCT02610140|50175721|FG000|Active Follow-up|Progressive disease - radiological|30|||
25069977|NCT02610140|50175722|FG001|Active Follow-up|Progressive disease - radiological|22|||
25069978|NCT02610140|50175721|FG000|Active Follow-up|Death|8|||
25069979|NCT02610140|50175722|FG001|Active Follow-up|Death|1|||
25069980|NCT02610140|50175721|FG000|Active Follow-up|Withdrawal by Subject|4|||
25069981|NCT02610140|50175722|FG001|Active Follow-up|Withdrawal by Subject|0|||
25069982|NCT02610140|50175721|FG000|Active Follow-up|Progressive disease - clinical|1|||
25069983|NCT02610140|50175722|FG001|Active Follow-up|Progressive disease - clinical|2|||
25069984|NCT02610140|50175721|FG000|Active Follow-up|Deterioration of general conditions|1|||
25069985|NCT02610140|50175722|FG001|Active Follow-up|Deterioration of general conditions|0|||
25069986|NCT02610140|50175721|FG000|Active Follow-up|Ongoing but not completed|4|||
25069987|NCT02610140|50175722|FG001|Active Follow-up|Ongoing but not completed|1|||
25069988|NCT02610140|50175721|FG000|Long-term Follow-up|Death|86|||
25069989|NCT02610140|50175722|FG001|Long-term Follow-up|Death|44|||
25069990|NCT02610140|50175721|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
25069991|NCT02610140|50175722|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
25069992|NCT02610140|50175721|FG000|Long-term Follow-up|Lost to Follow-up|1|||
25069993|NCT02610140|50175722|FG001|Long-term Follow-up|Lost to Follow-up|2|||
25069994|NCT02610140|50175721|FG000|Long-term Follow-up|Ongoing but not completed|30|||
25069995|NCT02610140|50175722|FG001|Long-term Follow-up|Ongoing but not completed|17|||
25069996|NCT02789657|50175732|FG000|Overall Study|Withdrawal by Subject|2|||
25069997|NCT02789657|50175733|FG001|Overall Study|Withdrawal by Subject|0|||
25069998|NCT02789657|50175734|FG002|Overall Study|Withdrawal by Subject|0|||
25069999|NCT02789657|50175735|FG003|Overall Study|Withdrawal by Subject|0|||
25070000|NCT02609984|50175746|FG000|Overall Study|Death|29|||
25070001|NCT02609984|50175747|FG001|Overall Study|Death|26|||
25070002|NCT02609984|50175746|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
25070003|NCT02609984|50175747|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
25070004|NCT02609984|50175746|FG000|Overall Study|Lost to Follow-up|1|||
25070005|NCT02609984|50175747|FG001|Overall Study|Lost to Follow-up|2|||
25070006|NCT02609984|50175746|FG000|Overall Study|Withdrawal by Subject|0|||
25070007|NCT02609984|50175747|FG001|Overall Study|Withdrawal by Subject|1|||
25070008|NCT02609984|50175746|FG000|Overall Study|Disease Progression|2|||
25070009|NCT02609984|50175747|FG001|Overall Study|Disease Progression|0|||
25070010|NCT02609672|50175755|FG000|Overall Study|Lost to Follow-up|3|||
25070011|NCT02609672|50175756|FG001|Overall Study|Lost to Follow-up|1|||
25070012|NCT02611778|50175764|FG000|Overall Study|Withdrawal by Subject|2|||
25070013|NCT02611778|50175765|FG001|Overall Study|Withdrawal by Subject|8|||
25070014|NCT02611778|50175764|FG000|Overall Study|Adverse Event|1|||
25070015|NCT02611778|50175765|FG001|Overall Study|Adverse Event|2|||
25070016|NCT02611778|50175764|FG000|Overall Study|Death|2|||
25070017|NCT02611778|50175765|FG001|Overall Study|Death|1|||
25070018|NCT02611778|50175764|FG000|Overall Study|Protocol Violation|1|||
25070019|NCT02611778|50175765|FG001|Overall Study|Protocol Violation|0|||
25070020|NCT02611778|50175764|FG000|Overall Study|Lost to Follow-up|3|||
25070021|NCT02611778|50175765|FG001|Overall Study|Lost to Follow-up|1|||
25070022|NCT02611778|50175764|FG000|Overall Study|Need for alternative treatment|1|||
25070023|NCT02611778|50175765|FG001|Overall Study|Need for alternative treatment|0|||
25070024|NCT02611778|50175764|FG000|Overall Study|Other Reason|2|||
25070025|NCT02611778|50175765|FG001|Overall Study|Other Reason|1|||
25070026|NCT02711553|50175776|FG000|Overall Study|Withdrawal by Subject|2|||
25070027|NCT02711553|50175777|FG001|Overall Study|Withdrawal by Subject|1|||
25070028|NCT02711553|50175778|FG002|Overall Study|Withdrawal by Subject|1|||
25070029|NCT02711553|50175779|FG003|Overall Study|Withdrawal by Subject|0|||
25070030|NCT02711553|50175776|FG000|Overall Study|Lost to Follow-up|3|||
25191455|NCT01492400|50351661|FG000|Overall Study|Miscellaneous Reasons|2|||
25191456|NCT01492400|50351662|FG001|Overall Study|Miscellaneous Reasons|3|||
25070031|NCT02711553|50175777|FG001|Overall Study|Lost to Follow-up|3|||
25070032|NCT02711553|50175778|FG002|Overall Study|Lost to Follow-up|6|||
25070033|NCT02711553|50175779|FG003|Overall Study|Lost to Follow-up|3|||
25070034|NCT02711553|50175776|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
25070035|NCT02711553|50175777|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
25070036|NCT02711553|50175778|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
25070037|NCT02711553|50175779|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
25070038|NCT02709369|50175791|FG000|Overall Study|Lost to Follow-up|15|||
25070039|NCT02709369|50175791|FG000|Overall Study|Withdrawal by Subject|10|||
25070040|NCT02709369|50175791|FG000|Overall Study|Did not received intervention|2|||
25070041|NCT02613182|50175795|FG000|Overall Study|Death|6|||
25284589|NCT00946647|50599840|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
25284590|NCT00946647|50599841|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
25284591|NCT00946647|50599842|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
25284592|NCT00946101|50599857|FG000|Overall Study|Lost to Follow-up|2|||
25284593|NCT00946101|50599858|FG001|Overall Study|Lost to Follow-up|1|||
25284594|NCT00946101|50599857|FG000|Overall Study|Withdrawal of consent|2|||
25284595|NCT00946101|50599858|FG001|Overall Study|Withdrawal of consent|0|||
25284596|NCT00946101|50599857|FG000|Overall Study|Physician Decision|0|||
25284597|NCT00946101|50599858|FG001|Overall Study|Physician Decision|1|||
25284598|NCT01109940|50599872|FG000|Overall Study|Administrative problems|2|||
25284599|NCT01109940|50599873|FG001|Overall Study|Administrative problems|0|||
25284600|NCT01109940|50599874|FG002|Overall Study|Administrative problems|0|||
25284601|NCT01109940|50599875|FG003|Overall Study|Administrative problems|0|||
25284602|NCT01109940|50599872|FG000|Overall Study|Serious Adverse Event|2|||
25284603|NCT01109940|50599873|FG001|Overall Study|Serious Adverse Event|1|||
25284604|NCT01109940|50599874|FG002|Overall Study|Serious Adverse Event|0|||
25284605|NCT01109940|50599875|FG003|Overall Study|Serious Adverse Event|0|||
25284606|NCT01109940|50599872|FG000|Overall Study|Lost to Follow-up|1|||
25284607|NCT01109940|50599873|FG001|Overall Study|Lost to Follow-up|0|||
25284608|NCT01109940|50599874|FG002|Overall Study|Lost to Follow-up|0|||
25284609|NCT01109940|50599875|FG003|Overall Study|Lost to Follow-up|0|||
25284610|NCT01109940|50599872|FG000|Overall Study|Patient withdrew consent|1|||
25284611|NCT01109940|50599873|FG001|Overall Study|Patient withdrew consent|1|||
25284612|NCT01109940|50599874|FG002|Overall Study|Patient withdrew consent|0|||
25284613|NCT01109940|50599875|FG003|Overall Study|Patient withdrew consent|0|||
25284614|NCT01109940|50599872|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
25284615|NCT01109940|50599873|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
25284616|NCT01109940|50599874|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
25284617|NCT01109940|50599875|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
25284618|NCT00595309|50599885|FG000|Overall Study|Lost to Follow-up|1|||
25284619|NCT00595309|50599885|FG000|Overall Study|planned vaccination against yellow fever|1|||
25284620|NCT00595309|50599885|FG000|Overall Study|acute infection after V0|1|||
25284621|NCT00595309|50599885|FG000|Overall Study|personal reason|1|||
25284622|NCT00595075|50599891|FG000|Overall Study|Withdrawal by Subject|1|||
25284623|NCT00595075|50599892|FG001|Overall Study|Withdrawal by Subject|0|||
25284624|NCT00887224|50599901|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
25284625|NCT00887224|50599902|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
25284626|NCT00887224|50599903|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
25284627|NCT00887224|50599901|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
25284628|NCT00887224|50599902|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
25284629|NCT00887224|50599903|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
25284630|NCT00887224|50599901|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
25284631|NCT00887224|50599902|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
25284632|NCT00887224|50599903|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
25284633|NCT00887224|50599901|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
25284634|NCT00887224|50599902|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
25284635|NCT00887224|50599903|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
25284636|NCT00887224|50599901|FG000|Open-label Response (OLR) Phase|Other|1|||
25284637|NCT00887224|50599902|FG001|Open-label Response (OLR) Phase|Other|0|||
25284638|NCT00887224|50599903|FG002|Open-label Response (OLR) Phase|Other|0|||
25284639|NCT00887224|50599901|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
25284640|NCT00887224|50599902|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
25284641|NCT00887224|50599903|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
25284642|NCT00887224|50599901|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
25284643|NCT00887224|50599902|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
25284644|NCT00887224|50599903|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
25284645|NCT00887224|50599901|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
25284646|NCT00887224|50599902|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
25284647|NCT00887224|50599903|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
25284648|NCT00887224|50599901|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
25284649|NCT00887224|50599902|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
24969604|NCT00129272|50059048|FG000|Overall Study|Lost to Follow-up|12|||
24969605|NCT00129272|50059049|FG001|Overall Study|Lost to Follow-up|11|||
24969606|NCT00129272|50059048|FG000|Overall Study|Withdrawal by Subject|5|||
24969607|NCT00129272|50059049|FG001|Overall Study|Withdrawal by Subject|11|||
25284650|NCT00887224|50599903|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
25284651|NCT00887224|50599901|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
25284652|NCT00887224|50599902|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
25284653|NCT00887224|50599903|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
25284654|NCT00887224|50599901|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
25284655|NCT00887224|50599902|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
25284656|NCT00887224|50599903|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
25284657|NCT00887224|50599901|FG000|Open-label Stability (OLS) Phase|Other|1|||
25284658|NCT00887224|50599902|FG001|Open-label Stability (OLS) Phase|Other|0|||
25284659|NCT00887224|50599903|FG002|Open-label Stability (OLS) Phase|Other|0|||
25284660|NCT00887224|50599901|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
25284661|NCT00887224|50599902|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
25284662|NCT00887224|50599903|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
25284663|NCT00887224|50599901|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
25284664|NCT00887224|50599902|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
25284665|NCT00887224|50599903|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
25284666|NCT00887224|50599901|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
25284667|NCT00887224|50599902|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
25284668|NCT00887224|50599903|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
25284669|NCT00887224|50599901|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
25284670|NCT00887224|50599902|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
25284671|NCT00887224|50599903|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
25284672|NCT00887224|50599901|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
25284673|NCT00887224|50599902|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
25284674|NCT00887224|50599903|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
25284675|NCT00887224|50599901|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
25284676|NCT00887224|50599902|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
25284677|NCT00887224|50599903|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
25284678|NCT00887224|50599901|FG000|OL Taper Phase / OL Follow Up|Other|30|||
25284679|NCT00887224|50599902|FG001|OL Taper Phase / OL Follow Up|Other|0|||
25284680|NCT00887224|50599903|FG002|OL Taper Phase / OL Follow Up|Other|0|||
25284681|NCT00887224|50599901|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
25284682|NCT00887224|50599902|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
25284683|NCT00887224|50599903|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
25284684|NCT00887224|50599901|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
25284685|NCT00887224|50599902|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
25284686|NCT00887224|50599903|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
25284687|NCT00887224|50599901|FG000|Double-blind (DB) Phase|Adverse Event|0|||
25284688|NCT00887224|50599902|FG001|Double-blind (DB) Phase|Adverse Event|7|||
25284689|NCT00887224|50599903|FG002|Double-blind (DB) Phase|Adverse Event|2|||
25284690|NCT00887224|50599901|FG000|Double-blind (DB) Phase|Failed to return|0|||
25284691|NCT00887224|50599902|FG001|Double-blind (DB) Phase|Failed to return|2|||
25284692|NCT00887224|50599903|FG002|Double-blind (DB) Phase|Failed to return|2|||
25284693|NCT00887224|50599901|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
25284694|NCT00887224|50599902|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
25284695|NCT00887224|50599903|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
25284696|NCT00887224|50599901|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
25284697|NCT00887224|50599902|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
25284698|NCT00887224|50599903|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
25284699|NCT00887224|50599901|FG000|Double-blind (DB) Phase|Other|0|||
25284700|NCT00887224|50599902|FG001|Double-blind (DB) Phase|Other|2|||
25284701|NCT00887224|50599903|FG002|Double-blind (DB) Phase|Other|0|||
25284702|NCT00887224|50599901|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
25284703|NCT00887224|50599902|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
25284704|NCT00887224|50599903|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
25284705|NCT00887224|50599901|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
25284706|NCT00887224|50599902|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
25284707|NCT00887224|50599903|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
25284708|NCT00887224|50599901|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
25284709|NCT00887224|50599902|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
25284710|NCT00887224|50599903|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
25284711|NCT00887224|50599901|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
25284712|NCT00887224|50599902|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
25284713|NCT00887224|50599903|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
25284714|NCT00887224|50599901|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
25284715|NCT00887224|50599902|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
25284716|NCT00887224|50599903|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
25284717|NCT00887224|50599901|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
25284718|NCT00887224|50599902|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
25284719|NCT00887224|50599903|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
25284720|NCT00887224|50599901|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
25284721|NCT00887224|50599902|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
25284722|NCT00887224|50599903|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
25284723|NCT00887224|50599901|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
25284724|NCT00887224|50599902|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
25284725|NCT00887224|50599903|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
25284726|NCT00887224|50599901|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
25284727|NCT00887224|50599902|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
25284728|NCT00887224|50599903|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
25284729|NCT01109316|50599921|FG000|Study Period 1|Adverse Event|0|||
25284730|NCT01109316|50599922|FG001|Study Period 1|Adverse Event|0|||
25284731|NCT01109316|50599923|FG002|Study Period 1|Adverse Event|1|||
25284732|NCT01109316|50599924|FG003|Study Period 1|Adverse Event|0|||
25284733|NCT01109316|50599925|FG004|Study Period 1|Adverse Event|0|||
25284734|NCT01109316|50599926|FG005|Study Period 1|Adverse Event|0|||
25284735|NCT01109316|50599921|FG000|Study Period 1|Lost to Follow-up|0|||
25284736|NCT01109316|50599922|FG001|Study Period 1|Lost to Follow-up|0|||
25284737|NCT01109316|50599923|FG002|Study Period 1|Lost to Follow-up|1|||
25284738|NCT01109316|50599924|FG003|Study Period 1|Lost to Follow-up|1|||
25284739|NCT01109316|50599925|FG004|Study Period 1|Lost to Follow-up|0|||
25284740|NCT01109316|50599926|FG005|Study Period 1|Lost to Follow-up|0|||
25284741|NCT01109316|50599921|FG000|Study Period 1|Withdrawal by Subject|0|||
25284742|NCT01109316|50599922|FG001|Study Period 1|Withdrawal by Subject|0|||
25284743|NCT01109316|50599923|FG002|Study Period 1|Withdrawal by Subject|1|||
25284744|NCT01109316|50599924|FG003|Study Period 1|Withdrawal by Subject|0|||
25284745|NCT01109316|50599925|FG004|Study Period 1|Withdrawal by Subject|2|||
25284746|NCT01109316|50599926|FG005|Study Period 1|Withdrawal by Subject|0|||
25284747|NCT01109316|50599921|FG000|Study Period 1|Sponsor Decision|0|||
25284748|NCT01109316|50599922|FG001|Study Period 1|Sponsor Decision|0|||
25284749|NCT01109316|50599923|FG002|Study Period 1|Sponsor Decision|0|||
25284750|NCT01109316|50599924|FG003|Study Period 1|Sponsor Decision|0|||
25284751|NCT01109316|50599925|FG004|Study Period 1|Sponsor Decision|0|||
25284752|NCT01109316|50599926|FG005|Study Period 1|Sponsor Decision|2|||
25284753|NCT01109316|50599921|FG000|Study Period 2|Entry Criteria Not Met|0|||
25284754|NCT01109316|50599922|FG001|Study Period 2|Entry Criteria Not Met|1|||
25284755|NCT01109316|50599923|FG002|Study Period 2|Entry Criteria Not Met|0|||
25284756|NCT01109316|50599924|FG003|Study Period 2|Entry Criteria Not Met|0|||
25284757|NCT01109316|50599925|FG004|Study Period 2|Entry Criteria Not Met|0|||
25284758|NCT01109316|50599926|FG005|Study Period 2|Entry Criteria Not Met|0|||
25284759|NCT01109316|50599921|FG000|Study Period 2|Physician Decision|0|||
25284760|NCT01109316|50599922|FG001|Study Period 2|Physician Decision|0|||
25284761|NCT01109316|50599923|FG002|Study Period 2|Physician Decision|0|||
25284762|NCT01109316|50599924|FG003|Study Period 2|Physician Decision|1|||
25284763|NCT01109316|50599925|FG004|Study Period 2|Physician Decision|0|||
25284764|NCT01109316|50599926|FG005|Study Period 2|Physician Decision|0|||
25284765|NCT01109316|50599921|FG000|Study Period 2|Protocol Violation|1|||
25284766|NCT01109316|50599922|FG001|Study Period 2|Protocol Violation|0|||
25284767|NCT01109316|50599923|FG002|Study Period 2|Protocol Violation|0|||
25284768|NCT01109316|50599924|FG003|Study Period 2|Protocol Violation|0|||
25284769|NCT01109316|50599925|FG004|Study Period 2|Protocol Violation|0|||
25284770|NCT01109316|50599926|FG005|Study Period 2|Protocol Violation|0|||
25284771|NCT01109316|50599921|FG000|Study Period 2|Withdrawal by Subject|0|||
25284772|NCT01109316|50599922|FG001|Study Period 2|Withdrawal by Subject|0|||
25284773|NCT01109316|50599923|FG002|Study Period 2|Withdrawal by Subject|1|||
25284774|NCT01109316|50599924|FG003|Study Period 2|Withdrawal by Subject|0|||
25284775|NCT01109316|50599925|FG004|Study Period 2|Withdrawal by Subject|0|||
25284776|NCT01109316|50599926|FG005|Study Period 2|Withdrawal by Subject|1|||
25284777|NCT01109316|50599921|FG000|Study Period 3|Lost to Follow-up|0|||
25284778|NCT01109316|50599922|FG001|Study Period 3|Lost to Follow-up|0|||
25284779|NCT01109316|50599923|FG002|Study Period 3|Lost to Follow-up|0|||
25284780|NCT01109316|50599924|FG003|Study Period 3|Lost to Follow-up|0|||
25284781|NCT01109316|50599925|FG004|Study Period 3|Lost to Follow-up|1|||
25284782|NCT01109316|50599926|FG005|Study Period 3|Lost to Follow-up|0|||
25284783|NCT01109316|50599921|FG000|Study Period 3|Withdrawal by Subject|1|||
25284784|NCT01109316|50599922|FG001|Study Period 3|Withdrawal by Subject|0|||
25284785|NCT01109316|50599923|FG002|Study Period 3|Withdrawal by Subject|0|||
25284786|NCT01109316|50599924|FG003|Study Period 3|Withdrawal by Subject|0|||
25284787|NCT01109316|50599925|FG004|Study Period 3|Withdrawal by Subject|1|||
25284788|NCT01109316|50599926|FG005|Study Period 3|Withdrawal by Subject|0|||
25284789|NCT00887068|50599936|FG000|Overall Study|Withdrawal by Subject|2|||
25284790|NCT00887068|50599937|FG001|Overall Study|Withdrawal by Subject|0|||
25284791|NCT00887068|50599936|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
25284792|NCT00887068|50599937|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
25284793|NCT00941031|50599947|FG000|Induction Period|Lack of Efficacy|2|||
25284794|NCT00941031|50599948|FG001|Induction Period|Lack of Efficacy|1|||
25284795|NCT00941031|50599949|FG002|Induction Period|Lack of Efficacy|0|||
25284796|NCT00941031|50599950|FG003|Induction Period|Lack of Efficacy|5|||
25284797|NCT00941031|50599951|FG004|Induction Period|Lack of Efficacy|0|||
25284798|NCT00941031|50599952|FG005|Induction Period|Lack of Efficacy|0|||
25284799|NCT00941031|50599953|FG006|Induction Period|Lack of Efficacy|0|||
25284800|NCT00941031|50599947|FG000|Induction Period|Withdrawal by Subject|1|||
25284801|NCT00941031|50599948|FG001|Induction Period|Withdrawal by Subject|2|||
25284802|NCT00941031|50599949|FG002|Induction Period|Withdrawal by Subject|2|||
25284803|NCT00941031|50599950|FG003|Induction Period|Withdrawal by Subject|2|||
25284804|NCT00941031|50599951|FG004|Induction Period|Withdrawal by Subject|0|||
25284805|NCT00941031|50599952|FG005|Induction Period|Withdrawal by Subject|0|||
25284806|NCT00941031|50599953|FG006|Induction Period|Withdrawal by Subject|0|||
25284807|NCT00941031|50599947|FG000|Induction Period|Adminstative Problems|1|||
25284808|NCT00941031|50599948|FG001|Induction Period|Adminstative Problems|1|||
25284809|NCT00941031|50599949|FG002|Induction Period|Adminstative Problems|1|||
25284810|NCT00941031|50599950|FG003|Induction Period|Adminstative Problems|0|||
25284811|NCT00941031|50599951|FG004|Induction Period|Adminstative Problems|0|||
25284812|NCT00941031|50599952|FG005|Induction Period|Adminstative Problems|0|||
25284813|NCT00941031|50599953|FG006|Induction Period|Adminstative Problems|0|||
25284814|NCT00941031|50599947|FG000|Induction Period|Adverse Event|1|||
25284815|NCT00941031|50599948|FG001|Induction Period|Adverse Event|0|||
25284816|NCT00941031|50599949|FG002|Induction Period|Adverse Event|3|||
25284817|NCT00941031|50599950|FG003|Induction Period|Adverse Event|2|||
25284818|NCT00941031|50599951|FG004|Induction Period|Adverse Event|0|||
25284819|NCT00941031|50599952|FG005|Induction Period|Adverse Event|0|||
25284820|NCT00941031|50599953|FG006|Induction Period|Adverse Event|0|||
25284821|NCT00941031|50599947|FG000|Maintenance Period|Withdrawal by Subject|0|||
25284822|NCT00941031|50599948|FG001|Maintenance Period|Withdrawal by Subject|0|||
25284823|NCT00941031|50599949|FG002|Maintenance Period|Withdrawal by Subject|0|||
25284824|NCT00941031|50599950|FG003|Maintenance Period|Withdrawal by Subject|0|||
25284825|NCT00941031|50599951|FG004|Maintenance Period|Withdrawal by Subject|6|||
25284826|NCT00941031|50599952|FG005|Maintenance Period|Withdrawal by Subject|2|||
25284827|NCT00941031|50599953|FG006|Maintenance Period|Withdrawal by Subject|13|||
25284828|NCT00941031|50599947|FG000|Maintenance Period|Administrative Problems|0|||
25284829|NCT00941031|50599948|FG001|Maintenance Period|Administrative Problems|0|||
25284830|NCT00941031|50599949|FG002|Maintenance Period|Administrative Problems|0|||
25284831|NCT00941031|50599950|FG003|Maintenance Period|Administrative Problems|0|||
25284832|NCT00941031|50599951|FG004|Maintenance Period|Administrative Problems|1|||
25284833|NCT00941031|50599952|FG005|Maintenance Period|Administrative Problems|0|||
25284834|NCT00941031|50599953|FG006|Maintenance Period|Administrative Problems|1|||
25284835|NCT00941031|50599947|FG000|Maintenance Period|Protocol Violation|0|||
25284836|NCT00941031|50599948|FG001|Maintenance Period|Protocol Violation|0|||
25284837|NCT00941031|50599949|FG002|Maintenance Period|Protocol Violation|0|||
25284838|NCT00941031|50599950|FG003|Maintenance Period|Protocol Violation|0|||
25284839|NCT00941031|50599951|FG004|Maintenance Period|Protocol Violation|0|||
25284840|NCT00941031|50599952|FG005|Maintenance Period|Protocol Violation|0|||
25284841|NCT00941031|50599953|FG006|Maintenance Period|Protocol Violation|1|||
25284842|NCT00941031|50599947|FG000|Maintenance Period|Adverse Event|0|||
25284843|NCT00941031|50599948|FG001|Maintenance Period|Adverse Event|0|||
25284844|NCT00941031|50599949|FG002|Maintenance Period|Adverse Event|0|||
25284845|NCT00941031|50599950|FG003|Maintenance Period|Adverse Event|0|||
25284846|NCT00941031|50599951|FG004|Maintenance Period|Adverse Event|0|||
25284847|NCT00941031|50599952|FG005|Maintenance Period|Adverse Event|2|||
25284848|NCT00941031|50599953|FG006|Maintenance Period|Adverse Event|8|||
25284849|NCT00941031|50599947|FG000|Maintenance Period|Lost to Follow-up|0|||
25284850|NCT00941031|50599948|FG001|Maintenance Period|Lost to Follow-up|0|||
25284851|NCT00941031|50599949|FG002|Maintenance Period|Lost to Follow-up|0|||
25284852|NCT00941031|50599950|FG003|Maintenance Period|Lost to Follow-up|0|||
25284853|NCT00941031|50599951|FG004|Maintenance Period|Lost to Follow-up|2|||
25284854|NCT00941031|50599952|FG005|Maintenance Period|Lost to Follow-up|2|||
25284855|NCT00941031|50599953|FG006|Maintenance Period|Lost to Follow-up|7|||
25284856|NCT00941031|50599947|FG000|Maintenance Period|Lack of Efficacy|0|||
25284857|NCT00941031|50599948|FG001|Maintenance Period|Lack of Efficacy|0|||
25284858|NCT00941031|50599949|FG002|Maintenance Period|Lack of Efficacy|0|||
25284859|NCT00941031|50599950|FG003|Maintenance Period|Lack of Efficacy|0|||
25284860|NCT00941031|50599951|FG004|Maintenance Period|Lack of Efficacy|0|||
25284861|NCT00941031|50599952|FG005|Maintenance Period|Lack of Efficacy|0|||
25284862|NCT00941031|50599953|FG006|Maintenance Period|Lack of Efficacy|13|||
25284863|NCT00886834|50599974|FG000|Overall Study|Protocol Violation|0|||
25284864|NCT00886834|50599975|FG001|Overall Study|Protocol Violation|3|||
25284865|NCT00880009|50599981|FG000|Overall Study|Study terminated by sponsor|14|||
25284866|NCT00880009|50599981|FG000|Overall Study|Withdrawal by Subject|1|||
25284867|NCT00880009|50599981|FG000|Overall Study|Protocol Violation|1|||
25284868|NCT01104636|50599988|FG000|Overall Study|Lack of Efficacy|43|||
25284869|NCT01104636|50599988|FG000|Overall Study|Lost to Follow-up|24|||
25284870|NCT01104636|50599988|FG000|Overall Study|Withdrawal by Subject|4|||
25284871|NCT01104636|50599988|FG000|Overall Study|Other|43|||
25284872|NCT01104636|50599988|FG000|Overall Study|Study terminated by sponsor|1|||
25284873|NCT01104636|50599988|FG000|Overall Study|Pregnancy|2|||
25284874|NCT01104636|50599988|FG000|Overall Study|Adverse Event|40|||
25284875|NCT01104636|50599988|FG000|Overall Study|Ongoing|21|||
25284876|NCT01104558|50599992|FG000|Overall Study|Protocol Violation|6|||
25284877|NCT01104558|50599992|FG000|Overall Study|Missing of primary efficacy assessment|10|||
25284878|NCT01104558|50599992|FG000|Overall Study|Missing of genetic analysis results|1|||
25284879|NCT00886288|50599998|FG000|Overall Study|no respect of the 12 weeks period|657|||
25284880|NCT00886288|50599999|FG001|Overall Study|no respect of the 12 weeks period|227|||
25284881|NCT00886288|50599998|FG000|Overall Study|Lost to Follow-up|86|||
25284882|NCT00886288|50599999|FG001|Overall Study|Lost to Follow-up|0|||
25284883|NCT01204658|50600011|FG000|Primary Phase|Adverse Event|0|||
25284884|NCT01204658|50600012|FG001|Primary Phase|Adverse Event|0|||
25284885|NCT01204658|50600013|FG002|Primary Phase|Adverse Event|1|||
25284886|NCT01204658|50600014|FG003|Primary Phase|Adverse Event|0|||
25284887|NCT00951483|50600029|FG000|Overall Study|Physician Decision|4|||
25284888|NCT00951483|50600030|FG001|Overall Study|Physician Decision|0|||
25284889|NCT00951483|50600029|FG000|Overall Study|Withdrawal by Subject|15|||
25284890|NCT00951483|50600030|FG001|Overall Study|Withdrawal by Subject|0|||
25284891|NCT01104246|50600038|FG000|Overall Study|Withdrawal by Subject|1|||
25284892|NCT01104246|50600038|FG000|Overall Study|did not meet inclusion criteria|4|||
25284893|NCT01103778|50600042|FG000|Overall Study|Lost to Follow-up|1|||
25284894|NCT01103778|50600042|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
25284895|NCT01103778|50600042|FG000|Overall Study|Screen failure|1|||
25284896|NCT01103466|50600048|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
25284897|NCT01103466|50600049|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
25284898|NCT01103466|50600050|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
25284899|NCT01103466|50600048|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
25284900|NCT01103466|50600049|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
25284901|NCT01103466|50600050|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
25284902|NCT01103466|50600048|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
25284903|NCT01103466|50600049|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
25284904|NCT01103466|50600050|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
25284905|NCT01103466|50600048|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
25284906|NCT01103466|50600049|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
25284907|NCT01103466|50600050|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
25284908|NCT01103466|50600048|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
25284909|NCT01103466|50600049|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
25284910|NCT01103466|50600050|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
25284911|NCT01103466|50600048|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
25284912|NCT01103466|50600049|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
25284913|NCT01103466|50600050|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
25284914|NCT00945945|50600060|FG000|Overall Study|Adverse Event|15|||
25284915|NCT00945945|50600061|FG001|Overall Study|Adverse Event|35|||
25284916|NCT00945945|50600060|FG000|Overall Study|Withdrawal by Subject|7|||
25284917|NCT00945945|50600061|FG001|Overall Study|Withdrawal by Subject|10|||
25284918|NCT00945945|50600060|FG000|Overall Study|Lost to Follow-up|4|||
25284919|NCT00945945|50600061|FG001|Overall Study|Lost to Follow-up|5|||
25284920|NCT00945945|50600060|FG000|Overall Study|Lack of Efficacy|6|||
25284921|NCT00945945|50600061|FG001|Overall Study|Lack of Efficacy|2|||
25284922|NCT00945945|50600060|FG000|Overall Study|Protocol Violation|4|||
25284923|NCT00945945|50600061|FG001|Overall Study|Protocol Violation|2|||
25284924|NCT00945945|50600060|FG000|Overall Study|Entry Criteria Not Met|0|||
25284925|NCT00945945|50600061|FG001|Overall Study|Entry Criteria Not Met|1|||
25284926|NCT01203956|50600067|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
25284927|NCT01203956|50600068|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
25284928|NCT01103232|50600077|FG000|Overall Study|Withdrawal by Subject|1|||
25284929|NCT01103232|50600078|FG001|Overall Study|Withdrawal by Subject|1|||
25284930|NCT01103232|50600077|FG000|Overall Study|Protocol Violation|0|||
25284931|NCT01103232|50600078|FG001|Overall Study|Protocol Violation|1|||
25284932|NCT01112982|50600084|FG000|Overall Study|Withdrawal by Subject|1|||
25284933|NCT01112982|50600084|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
25284934|NCT01203878|50600094|FG000|Overall Study|Withdrawal by Subject|0|||
25284935|NCT01203878|50600095|FG001|Overall Study|Withdrawal by Subject|0|||
25284936|NCT01203878|50600096|FG002|Overall Study|Withdrawal by Subject|1|||
25284937|NCT01203878|50600094|FG000|Overall Study|Adverse Event|0|||
25284938|NCT01203878|50600095|FG001|Overall Study|Adverse Event|0|||
24969608|NCT04899232|50059058|FG000|Screening Period|Physician Decision|1|||
25070042|NCT02613182|50175795|FG000|Overall Study|Physician Decision|1|||
25191457|NCT01492400|50351661|FG000|Overall Study|Personal Reasons|0|||
25191458|NCT01492400|50351662|FG001|Overall Study|Personal Reasons|5|||
25191459|NCT01492400|50351661|FG000|Overall Study|Lost to Follow-up|3|||
25191460|NCT01492400|50351662|FG001|Overall Study|Lost to Follow-up|1|||
25191461|NCT01492400|50351661|FG000|Overall Study|Pregnancy|0|||
25191462|NCT01492400|50351662|FG001|Overall Study|Pregnancy|1|||
25284939|NCT01203878|50600096|FG002|Overall Study|Adverse Event|2|||
25284940|NCT01112514|50600103|FG000|Overall Study|Lost to Follow-up|1|||
25284941|NCT01203098|50600110|FG000|Overall Study|Adverse Event|3|||
25070043|NCT02613182|50175795|FG000|Overall Study|Study Terminated by Sponsor|21|||
25070044|NCT02613182|50175795|FG000|Overall Study|Withdrawal by Subject|6|||
25284942|NCT01203098|50600111|FG001|Overall Study|Adverse Event|1|||
25284943|NCT01203098|50600112|FG002|Overall Study|Adverse Event|7|||
25284944|NCT01203098|50600110|FG000|Overall Study|Lost to Follow-up|0|||
25284945|NCT01203098|50600111|FG001|Overall Study|Lost to Follow-up|0|||
25284946|NCT01203098|50600112|FG002|Overall Study|Lost to Follow-up|1|||
25284947|NCT01203098|50600110|FG000|Overall Study|Physician Decision|2|||
25284948|NCT01203098|50600111|FG001|Overall Study|Physician Decision|2|||
25284949|NCT01203098|50600112|FG002|Overall Study|Physician Decision|0|||
25284950|NCT01203098|50600110|FG000|Overall Study|Withdrawal by Subject|1|||
25284951|NCT01203098|50600111|FG001|Overall Study|Withdrawal by Subject|1|||
25284952|NCT01203098|50600112|FG002|Overall Study|Withdrawal by Subject|3|||
25284953|NCT00945555|50600120|FG000|Overall Study|Referred to another hospital|5|||
25284954|NCT00945555|50600120|FG000|Overall Study|Worsening condition, intensive care unit|1|||
25284955|NCT00945555|50600120|FG000|Overall Study|Withdrawal by Subject|2|||
25284956|NCT00945555|50600120|FG000|Overall Study|Participant continued treatment at home|1|||
25284957|NCT00945555|50600120|FG000|Overall Study|Death|18|||
25284958|NCT00945555|50600120|FG000|Overall Study|Other|1|||
25284959|NCT01108458|50600124|FG000|Overall Study|Withdrawal by Subject|1|||
25284960|NCT01108068|50600130|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
25284961|NCT01108068|50600131|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
25284962|NCT01201850|50600138|FG000|Overall Study|Tumor progression|4|||
25284963|NCT00951171|50600144|FG000|Overall Study|Adverse Event|2|||
25284964|NCT00951171|50600145|FG001|Overall Study|Adverse Event|0|||
25284965|NCT01200992|50600153|FG000|Overall Study|Study terminated early|35|||
25284966|NCT01200992|50600154|FG001|Overall Study|Study terminated early|41|||
25284967|NCT01200992|50600153|FG000|Overall Study|Randomized but not treated|2|||
25284968|NCT01200992|50600154|FG001|Overall Study|Randomized but not treated|0|||
25284969|NCT00878215|50600166|FG000|Overall Study|Determined to be ineligible|0|||
25284970|NCT00878215|50600167|FG001|Overall Study|Determined to be ineligible|10|||
25284971|NCT00878215|50600168|FG002|Overall Study|Determined to be ineligible|0|||
25284972|NCT00878215|50600169|FG003|Overall Study|Determined to be ineligible|0|||
25284973|NCT01200758|50600181|FG000|Stage I|Death|0|||
25284974|NCT01200758|50600182|FG001|Stage I|Death|1|||
25284975|NCT01200758|50600183|FG002|Stage I|Death|0|||
25284976|NCT01200758|50600184|FG003|Stage I|Death|0|||
25284977|NCT01200758|50600181|FG000|Stage I|Physician Decision|1|||
25284978|NCT01200758|50600182|FG001|Stage I|Physician Decision|1|||
25284979|NCT01200758|50600183|FG002|Stage I|Physician Decision|0|||
25284980|NCT01200758|50600184|FG003|Stage I|Physician Decision|0|||
25284981|NCT01200758|50600181|FG000|Stage I|Lack of Efficacy|2|||
25284982|NCT01200758|50600182|FG001|Stage I|Lack of Efficacy|1|||
25284983|NCT01200758|50600183|FG002|Stage I|Lack of Efficacy|0|||
25284984|NCT01200758|50600184|FG003|Stage I|Lack of Efficacy|0|||
25284985|NCT01200758|50600181|FG000|Stage I|Adverse Event|5|||
25284986|NCT01200758|50600182|FG001|Stage I|Adverse Event|5|||
25284987|NCT01200758|50600183|FG002|Stage I|Adverse Event|0|||
25284988|NCT01200758|50600184|FG003|Stage I|Adverse Event|0|||
25284989|NCT01200758|50600181|FG000|Stage I|Withdrawal by Subject|1|||
25284990|NCT01200758|50600182|FG001|Stage I|Withdrawal by Subject|2|||
25284991|NCT01200758|50600183|FG002|Stage I|Withdrawal by Subject|0|||
25284992|NCT01200758|50600184|FG003|Stage I|Withdrawal by Subject|0|||
25284993|NCT01200758|50600181|FG000|Stage I|Disease Progression|9|||
25284994|NCT01200758|50600182|FG001|Stage I|Disease Progression|7|||
25284995|NCT01200758|50600183|FG002|Stage I|Disease Progression|0|||
25284996|NCT01200758|50600184|FG003|Stage I|Disease Progression|0|||
25284997|NCT01200758|50600181|FG000|Stage 2|Disease Progression|0|||
25284998|NCT01200758|50600182|FG001|Stage 2|Disease Progression|0|||
25284999|NCT01200758|50600183|FG002|Stage 2|Disease Progression|16|||
25285000|NCT01200758|50600184|FG003|Stage 2|Disease Progression|21|||
25285001|NCT01200758|50600181|FG000|Stage 2|Lack of Efficacy|0|||
25285002|NCT01200758|50600182|FG001|Stage 2|Lack of Efficacy|0|||
25285003|NCT01200758|50600183|FG002|Stage 2|Lack of Efficacy|4|||
25285004|NCT01200758|50600184|FG003|Stage 2|Lack of Efficacy|2|||
25285005|NCT01200758|50600181|FG000|Stage 2|Physician Decision|0|||
25285006|NCT01200758|50600182|FG001|Stage 2|Physician Decision|0|||
25285007|NCT01200758|50600183|FG002|Stage 2|Physician Decision|5|||
25285008|NCT01200758|50600184|FG003|Stage 2|Physician Decision|7|||
25285009|NCT01200758|50600181|FG000|Stage 2|Adverse Event|0|||
25285010|NCT01200758|50600182|FG001|Stage 2|Adverse Event|0|||
25285011|NCT01200758|50600183|FG002|Stage 2|Adverse Event|5|||
25285012|NCT01200758|50600184|FG003|Stage 2|Adverse Event|9|||
25285013|NCT01200758|50600181|FG000|Stage 2|Withdrawal by Subject|0|||
25285014|NCT01200758|50600182|FG001|Stage 2|Withdrawal by Subject|0|||
25285015|NCT01200758|50600183|FG002|Stage 2|Withdrawal by Subject|4|||
25285016|NCT01200758|50600184|FG003|Stage 2|Withdrawal by Subject|1|||
25285017|NCT01200758|50600181|FG000|Stage 2|Lost to Follow-up|0|||
25285018|NCT01200758|50600182|FG001|Stage 2|Lost to Follow-up|0|||
25285019|NCT01200758|50600183|FG002|Stage 2|Lost to Follow-up|3|||
25285020|NCT01200758|50600184|FG003|Stage 2|Lost to Follow-up|1|||
25285021|NCT01200758|50600181|FG000|Stage 2|Protocol Violation|0|||
25285022|NCT01200758|50600182|FG001|Stage 2|Protocol Violation|0|||
25285023|NCT01200758|50600183|FG002|Stage 2|Protocol Violation|1|||
25285024|NCT01200758|50600184|FG003|Stage 2|Protocol Violation|4|||
25285025|NCT01200758|50600181|FG000|Stage 2|Death|0|||
25285026|NCT01200758|50600182|FG001|Stage 2|Death|0|||
25285027|NCT01200758|50600183|FG002|Stage 2|Death|3|||
25285028|NCT01200758|50600184|FG003|Stage 2|Death|5|||
25285029|NCT00876343|50600199|FG000|Overall Study|Adverse Event|7|||
25285030|NCT00876343|50600200|FG001|Overall Study|Adverse Event|8|||
25285031|NCT00876343|50600201|FG002|Overall Study|Adverse Event|2|||
25285032|NCT00876343|50600199|FG000|Overall Study|Withdrawal by Subject|4|||
25285033|NCT00876343|50600200|FG001|Overall Study|Withdrawal by Subject|4|||
25285034|NCT00876343|50600201|FG002|Overall Study|Withdrawal by Subject|3|||
25285035|NCT00876343|50600199|FG000|Overall Study|Lack of Efficacy|0|||
25285036|NCT00876343|50600200|FG001|Overall Study|Lack of Efficacy|0|||
25285037|NCT00876343|50600201|FG002|Overall Study|Lack of Efficacy|1|||
25285038|NCT00876343|50600199|FG000|Overall Study|Protocol Violation|4|||
25285039|NCT00876343|50600200|FG001|Overall Study|Protocol Violation|1|||
25285040|NCT00876343|50600201|FG002|Overall Study|Protocol Violation|1|||
25285041|NCT00876343|50600199|FG000|Overall Study|Physician Decision|0|||
25285042|NCT00876343|50600200|FG001|Overall Study|Physician Decision|1|||
25285043|NCT00876343|50600201|FG002|Overall Study|Physician Decision|1|||
25285044|NCT00876343|50600199|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
25285045|NCT00876343|50600200|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
25285046|NCT00876343|50600201|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
25285047|NCT00876343|50600199|FG000|Overall Study|Change of residence or other commitments|2|||
25285048|NCT00876343|50600200|FG001|Overall Study|Change of residence or other commitments|2|||
25285049|NCT00876343|50600201|FG002|Overall Study|Change of residence or other commitments|3|||
25285050|NCT01107912|50600213|FG000|Period 1|Adverse Event|0|||
25285051|NCT01107912|50600214|FG001|Period 1|Adverse Event|0|||
25285052|NCT01107912|50600215|FG002|Period 1|Adverse Event|0|||
25285053|NCT01107912|50600216|FG003|Period 1|Adverse Event|0|||
25285054|NCT01107912|50600217|FG004|Period 1|Adverse Event|2|||
25285055|NCT01107912|50600218|FG005|Period 1|Adverse Event|0|||
25169192|NCT01844765|50300511|FG001|Overall Study|Protocol deviation|0|||
25169193|NCT01844765|50300510|FG000|Overall Study|Untreated|1|||
25169194|NCT01844765|50300511|FG001|Overall Study|Untreated|0|||
25169195|NCT01866293|50300526|FG000|Overall Study|Adverse Event|2|||
25169196|NCT01844687|50300530|FG000|Visit 1|Protocol Violation|3|||
25169197|NCT01844687|50300530|FG000|Visit 1|Lost to Follow-up|5|||
25169198|NCT01844687|50300530|FG000|Visit 2|Withdrawal by Subject|1|||
25169199|NCT01844687|50300530|FG000|Visit 2|Protocol Violation|1|||
25169200|NCT01844687|50300530|FG000|Visit 3|Lost to Follow-up|1|||
25169201|NCT01844687|50300530|FG000|Visit 3|Withdrawal by Subject|3|||
25169202|NCT01844687|50300530|FG000|Visit 3|child care problems|1|||
25169203|NCT01844687|50300530|FG000|Visit 4|Pregnancy|1|||
25169204|NCT01844687|50300530|FG000|Visit 4|Lost to Follow-up|1|||
25169205|NCT01844687|50300530|FG000|Visit 4|Withdrawal by Subject|2|||
25285056|NCT01107912|50600213|FG000|Period 1|Physician Decision|0|||
25285057|NCT01107912|50600214|FG001|Period 1|Physician Decision|0|||
25285058|NCT01107912|50600215|FG002|Period 1|Physician Decision|0|||
25285059|NCT01107912|50600216|FG003|Period 1|Physician Decision|0|||
25285060|NCT01107912|50600217|FG004|Period 1|Physician Decision|1|||
25285061|NCT01107912|50600218|FG005|Period 1|Physician Decision|0|||
25285062|NCT01107912|50600213|FG000|Period 1|Withdrawal by Subject|1|||
25285063|NCT01107912|50600214|FG001|Period 1|Withdrawal by Subject|0|||
25285064|NCT01107912|50600215|FG002|Period 1|Withdrawal by Subject|0|||
25285065|NCT01107912|50600216|FG003|Period 1|Withdrawal by Subject|0|||
25285066|NCT01107912|50600217|FG004|Period 1|Withdrawal by Subject|0|||
25285067|NCT01107912|50600218|FG005|Period 1|Withdrawal by Subject|0|||
25285068|NCT01107912|50600213|FG000|Period 2|Physician Decision|0|||
25285069|NCT01107912|50600214|FG001|Period 2|Physician Decision|0|||
25285070|NCT01107912|50600215|FG002|Period 2|Physician Decision|1|||
25285071|NCT01107912|50600216|FG003|Period 2|Physician Decision|0|||
25285072|NCT01107912|50600217|FG004|Period 2|Physician Decision|0|||
25285073|NCT01107912|50600218|FG005|Period 2|Physician Decision|0|||
25285074|NCT01107912|50600213|FG000|Period 3|Adverse Event|0|||
25285075|NCT01107912|50600214|FG001|Period 3|Adverse Event|1|||
25285076|NCT01107912|50600215|FG002|Period 3|Adverse Event|1|||
25285077|NCT01107912|50600216|FG003|Period 3|Adverse Event|0|||
25285078|NCT01107912|50600217|FG004|Period 3|Adverse Event|0|||
25285079|NCT01107912|50600218|FG005|Period 3|Adverse Event|0|||
25285080|NCT01107912|50600213|FG000|Period 3|Withdrawal by Subject|0|||
25285081|NCT01107912|50600214|FG001|Period 3|Withdrawal by Subject|0|||
25285082|NCT01107912|50600215|FG002|Period 3|Withdrawal by Subject|0|||
25285083|NCT01107912|50600216|FG003|Period 3|Withdrawal by Subject|1|||
25285084|NCT01107912|50600217|FG004|Period 3|Withdrawal by Subject|0|||
25285085|NCT01107912|50600218|FG005|Period 3|Withdrawal by Subject|0|||
25285086|NCT01200524|50600236|FG000|Overall Study|Withdrawal by Subject|1|||
24969609|NCT04899232|50059059|FG001|Screening Period|Physician Decision|0|||
25169206|NCT01844531|50300556|FG000|Overall Study|Withdrawal by Subject|0|||
25169207|NCT01844531|50300557|FG001|Overall Study|Withdrawal by Subject|1|||
25169208|NCT01844531|50300558|FG002|Overall Study|Withdrawal by Subject|0|||
25285087|NCT01200524|50600237|FG001|Overall Study|Withdrawal by Subject|1|||
25285088|NCT01200524|50600238|FG002|Overall Study|Withdrawal by Subject|3|||
25285089|NCT01200524|50600236|FG000|Overall Study|Adverse Event|1|||
25285090|NCT01200524|50600237|FG001|Overall Study|Adverse Event|0|||
25285091|NCT01200524|50600238|FG002|Overall Study|Adverse Event|0|||
25285092|NCT01200524|50600236|FG000|Overall Study|Non availability of study nurse|0|||
25285093|NCT01200524|50600237|FG001|Overall Study|Non availability of study nurse|0|||
25285094|NCT01200524|50600238|FG002|Overall Study|Non availability of study nurse|1|||
25285095|NCT01100034|50600246|FG000|Overall Study|Lost to Follow-up|11|||
25285096|NCT01100034|50600246|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
25285097|NCT01100034|50600246|FG000|Overall Study|Withdrawal by Subject|4|||
25285098|NCT01100034|50600246|FG000|Overall Study|Sponsor decision|21|||
25285099|NCT01100034|50600246|FG000|Overall Study|Participated in another clinical trial|1|||
25285100|NCT01100034|50600246|FG000|Overall Study|Participants moved to another hospital|4|||
25285101|NCT01100034|50600246|FG000|Overall Study|Site closed due to non-responsiveness|1|||
25285102|NCT00876265|50600250|FG000|Overall Study|Miscellaneous reasons|4|||
25285103|NCT00876265|50600250|FG000|Overall Study|Lost to Follow-up|6|||
25285104|NCT00876265|50600250|FG000|Overall Study|Withdrawal by Subject|2|||
25285105|NCT01107444|50600258|FG000|Overall Study|Withdrawal by Subject|8|||
25285106|NCT01107444|50600259|FG001|Overall Study|Withdrawal by Subject|12|||
25285107|NCT01107444|50600258|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
25285108|NCT01107444|50600259|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
25285109|NCT00876187|50600273|FG000|Overall Study|Adverse Event|14|||
25285110|NCT00876187|50600274|FG001|Overall Study|Adverse Event|12|||
25285111|NCT00876187|50600275|FG002|Overall Study|Adverse Event|19|||
25285112|NCT00876187|50600276|FG003|Overall Study|Adverse Event|29|||
25285113|NCT00876187|50600277|FG004|Overall Study|Adverse Event|10|||
25285114|NCT00876187|50600273|FG000|Overall Study|Lack of Efficacy|59|||
25285115|NCT00876187|50600274|FG001|Overall Study|Lack of Efficacy|34|||
25285116|NCT00876187|50600275|FG002|Overall Study|Lack of Efficacy|45|||
25285117|NCT00876187|50600276|FG003|Overall Study|Lack of Efficacy|34|||
25285118|NCT00876187|50600277|FG004|Overall Study|Lack of Efficacy|59|||
25285119|NCT00876187|50600273|FG000|Overall Study|Lost to Follow-up|9|||
25285120|NCT00876187|50600274|FG001|Overall Study|Lost to Follow-up|10|||
25285121|NCT00876187|50600275|FG002|Overall Study|Lost to Follow-up|8|||
25285122|NCT00876187|50600276|FG003|Overall Study|Lost to Follow-up|8|||
25285123|NCT00876187|50600277|FG004|Overall Study|Lost to Follow-up|11|||
25285124|NCT00876187|50600273|FG000|Overall Study|Protocol Violation|6|||
25285125|NCT00876187|50600274|FG001|Overall Study|Protocol Violation|7|||
25285126|NCT00876187|50600275|FG002|Overall Study|Protocol Violation|7|||
25285127|NCT00876187|50600276|FG003|Overall Study|Protocol Violation|6|||
25285128|NCT00876187|50600277|FG004|Overall Study|Protocol Violation|3|||
25285129|NCT00876187|50600273|FG000|Overall Study|Withdrawal by Subject|16|||
25285130|NCT00876187|50600274|FG001|Overall Study|Withdrawal by Subject|26|||
25285131|NCT00876187|50600275|FG002|Overall Study|Withdrawal by Subject|32|||
25285132|NCT00876187|50600276|FG003|Overall Study|Withdrawal by Subject|38|||
25285133|NCT00876187|50600277|FG004|Overall Study|Withdrawal by Subject|37|||
25285134|NCT00876187|50600273|FG000|Overall Study|Entered extension study|101|||
25285135|NCT00876187|50600274|FG001|Overall Study|Entered extension study|120|||
25285136|NCT00876187|50600275|FG002|Overall Study|Entered extension study|156|||
25285137|NCT00876187|50600276|FG003|Overall Study|Entered extension study|151|||
25285138|NCT00876187|50600277|FG004|Overall Study|Entered extension study|144|||
25285139|NCT00876187|50600273|FG000|Overall Study|Randomized but not treated|3|||
25285140|NCT00876187|50600274|FG001|Overall Study|Randomized but not treated|1|||
25285141|NCT00876187|50600275|FG002|Overall Study|Randomized but not treated|3|||
25285142|NCT00876187|50600276|FG003|Overall Study|Randomized but not treated|2|||
25285143|NCT00876187|50600277|FG004|Overall Study|Randomized but not treated|3|||
25285144|NCT00876187|50600273|FG000|Overall Study|Other|2|||
25285145|NCT00876187|50600274|FG001|Overall Study|Other|5|||
25285146|NCT00876187|50600275|FG002|Overall Study|Other|9|||
25285147|NCT00876187|50600276|FG003|Overall Study|Other|7|||
25285148|NCT00876187|50600277|FG004|Overall Study|Other|4|||
25285149|NCT01102374|50600294|FG000|Overall Study|Death|9|||
25285150|NCT01102374|50600295|FG001|Overall Study|Death|13|||
25285151|NCT01102374|50600294|FG000|Overall Study|Lost to Follow-up|7|||
25285152|NCT01102374|50600295|FG001|Overall Study|Lost to Follow-up|6|||
25285153|NCT01106976|50600301|FG000|Overall Study|Lost to Follow-up|8|||
25285154|NCT00875485|50600307|FG000|Challenge Dose Epoch|Pregnancy|1|||
25285155|NCT00875485|50600308|FG001|Challenge Dose Epoch|Pregnancy|0|||
25285156|NCT04547140|50600316|FG000|Overall Study|Adverse Event|0|||
25285157|NCT04547140|50600317|FG001|Overall Study|Adverse Event|1|||
25285158|NCT04547140|50600316|FG000|Overall Study|Withdrawal by Subject|0|||
25285159|NCT04547140|50600317|FG001|Overall Study|Withdrawal by Subject|1|||
25285160|NCT04547140|50600316|FG000|Overall Study|Lost to Follow-up|3|||
25285161|NCT04547140|50600317|FG001|Overall Study|Lost to Follow-up|1|||
25285162|NCT04547140|50600316|FG000|Overall Study|Death|2|||
25285163|NCT04547140|50600317|FG001|Overall Study|Death|1|||
25285164|NCT04547140|50600316|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
25285165|NCT04547140|50600317|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
25285166|NCT04547140|50600316|FG000|Overall Study|Pregnancy|1|||
25285167|NCT04547140|50600317|FG001|Overall Study|Pregnancy|0|||
25285168|NCT04547140|50600316|FG000|Overall Study|Reason Not Specified|4|||
25285169|NCT04547140|50600317|FG001|Overall Study|Reason Not Specified|1|||
25285170|NCT01098474|50600329|FG000|Active Phase|Other|0|||
25285171|NCT01098474|50600330|FG001|Active Phase|Other|0|||
25285172|NCT01098474|50600331|FG002|Active Phase|Other|3|||
25285173|NCT01098474|50600332|FG003|Active Phase|Other|0|||
25285174|NCT01098474|50600333|FG004|Active Phase|Other|0|||
25285175|NCT01098474|50600334|FG005|Active Phase|Other|0|||
25285176|NCT01098474|50600329|FG000|Active Phase|Withdrawal by Subject|1|||
25285177|NCT01098474|50600330|FG001|Active Phase|Withdrawal by Subject|1|||
25285178|NCT01098474|50600331|FG002|Active Phase|Withdrawal by Subject|2|||
25285179|NCT01098474|50600332|FG003|Active Phase|Withdrawal by Subject|0|||
25285180|NCT01098474|50600333|FG004|Active Phase|Withdrawal by Subject|0|||
25285181|NCT01098474|50600334|FG005|Active Phase|Withdrawal by Subject|0|||
25285182|NCT01098474|50600329|FG000|Active Phase|Lost to Follow-up|1|||
25285183|NCT01098474|50600330|FG001|Active Phase|Lost to Follow-up|0|||
25285184|NCT01098474|50600331|FG002|Active Phase|Lost to Follow-up|0|||
25285185|NCT01098474|50600332|FG003|Active Phase|Lost to Follow-up|0|||
25285186|NCT01098474|50600333|FG004|Active Phase|Lost to Follow-up|0|||
25285187|NCT01098474|50600334|FG005|Active Phase|Lost to Follow-up|0|||
25285188|NCT01098474|50600329|FG000|Follow Up Phase|Travelled out of study area|0|||
25285189|NCT01098474|50600330|FG001|Follow Up Phase|Travelled out of study area|0|||
25285190|NCT01098474|50600331|FG002|Follow Up Phase|Travelled out of study area|0|||
25285191|NCT01098474|50600332|FG003|Follow Up Phase|Travelled out of study area|0|||
25285192|NCT01098474|50600333|FG004|Follow Up Phase|Travelled out of study area|1|||
25285193|NCT01098474|50600334|FG005|Follow Up Phase|Travelled out of study area|0|||
25285194|NCT01098474|50600329|FG000|Follow Up Phase|Other|0|||
25285195|NCT01098474|50600330|FG001|Follow Up Phase|Other|0|||
25285196|NCT01098474|50600331|FG002|Follow Up Phase|Other|0|||
25285197|NCT01098474|50600332|FG003|Follow Up Phase|Other|0|||
25285198|NCT01098474|50600333|FG004|Follow Up Phase|Other|0|||
25285199|NCT01098474|50600334|FG005|Follow Up Phase|Other|4|||
25285200|NCT01098474|50600329|FG000|Follow Up Phase|Withdrawal by Subject|0|||
25285201|NCT01098474|50600330|FG001|Follow Up Phase|Withdrawal by Subject|0|||
25285202|NCT01098474|50600331|FG002|Follow Up Phase|Withdrawal by Subject|0|||
25285203|NCT01098474|50600332|FG003|Follow Up Phase|Withdrawal by Subject|2|||
25285204|NCT01098474|50600333|FG004|Follow Up Phase|Withdrawal by Subject|0|||
25285205|NCT01098474|50600334|FG005|Follow Up Phase|Withdrawal by Subject|1|||
25285206|NCT01098474|50600329|FG000|Follow Up Phase|Lost to Follow-up|0|||
25285207|NCT01098474|50600330|FG001|Follow Up Phase|Lost to Follow-up|0|||
25285208|NCT01098474|50600331|FG002|Follow Up Phase|Lost to Follow-up|0|||
25285209|NCT01098474|50600332|FG003|Follow Up Phase|Lost to Follow-up|0|||
25285210|NCT01098474|50600333|FG004|Follow Up Phase|Lost to Follow-up|1|||
25285211|NCT01098474|50600334|FG005|Follow Up Phase|Lost to Follow-up|0|||
25285212|NCT01106898|50600358|FG000|Overall Study|Adverse Event|6|||
25285213|NCT00876733|50600366|FG000|Overall Study|Adverse Event|34|||
25285214|NCT00876733|50600367|FG001|Overall Study|Adverse Event|20|||
25285215|NCT00876733|50600368|FG002|Overall Study|Adverse Event|10|||
25285216|NCT00876733|50600369|FG003|Overall Study|Adverse Event|3|||
25285217|NCT00876733|50600366|FG000|Overall Study|Lack of Efficacy|17|||
25285218|NCT00876733|50600367|FG001|Overall Study|Lack of Efficacy|9|||
25285219|NCT00876733|50600368|FG002|Overall Study|Lack of Efficacy|10|||
25285220|NCT00876733|50600369|FG003|Overall Study|Lack of Efficacy|1|||
25285221|NCT00876733|50600366|FG000|Overall Study|Lost to Follow-up|26|||
25285222|NCT00876733|50600367|FG001|Overall Study|Lost to Follow-up|10|||
25285223|NCT00876733|50600368|FG002|Overall Study|Lost to Follow-up|3|||
25285224|NCT00876733|50600369|FG003|Overall Study|Lost to Follow-up|2|||
25285225|NCT00876733|50600366|FG000|Overall Study|Data not available|14|||
25285226|NCT00876733|50600367|FG001|Overall Study|Data not available|3|||
25285227|NCT00876733|50600368|FG002|Overall Study|Data not available|7|||
25285228|NCT00876733|50600369|FG003|Overall Study|Data not available|1|||
25285229|NCT00875017|50600389|FG000|First Intervention|Withdrawal by Subject|1|||
25285230|NCT00875017|50600390|FG001|First Intervention|Withdrawal by Subject|0|||
25285231|NCT00875017|50600391|FG002|First Intervention|Withdrawal by Subject|1|||
25285232|NCT00875017|50600392|FG003|First Intervention|Withdrawal by Subject|0|||
25285233|NCT00875017|50600393|FG004|First Intervention|Withdrawal by Subject|0|||
25285234|NCT00875017|50600394|FG005|First Intervention|Withdrawal by Subject|0|||
25285235|NCT00875017|50600389|FG000|First Intervention|Adverse Event|0|||
25285236|NCT00875017|50600390|FG001|First Intervention|Adverse Event|0|||
25285237|NCT00875017|50600391|FG002|First Intervention|Adverse Event|0|||
25285238|NCT00875017|50600392|FG003|First Intervention|Adverse Event|1|||
25285239|NCT00875017|50600393|FG004|First Intervention|Adverse Event|0|||
25285240|NCT00875017|50600394|FG005|First Intervention|Adverse Event|0|||
25285241|NCT00875017|50600389|FG000|First Intervention|Problems collecting rectal effluent|1|||
25285242|NCT00875017|50600390|FG001|First Intervention|Problems collecting rectal effluent|0|||
25285243|NCT00875017|50600391|FG002|First Intervention|Problems collecting rectal effluent|0|||
25285244|NCT00875017|50600392|FG003|First Intervention|Problems collecting rectal effluent|0|||
25285245|NCT00875017|50600393|FG004|First Intervention|Problems collecting rectal effluent|0|||
25285246|NCT00875017|50600394|FG005|First Intervention|Problems collecting rectal effluent|0|||
25285247|NCT00875017|50600389|FG000|First Intervention|Intolerance to nasogastric tube|0|||
25285248|NCT00875017|50600390|FG001|First Intervention|Intolerance to nasogastric tube|0|||
25285249|NCT00875017|50600391|FG002|First Intervention|Intolerance to nasogastric tube|0|||
25285250|NCT00875017|50600392|FG003|First Intervention|Intolerance to nasogastric tube|0|||
25285251|NCT00875017|50600393|FG004|First Intervention|Intolerance to nasogastric tube|1|||
25285252|NCT00875017|50600394|FG005|First Intervention|Intolerance to nasogastric tube|0|||
25285253|NCT00875017|50600389|FG000|Washout|Problem collecting rectal effluent|0|||
25285254|NCT00875017|50600390|FG001|Washout|Problem collecting rectal effluent|0|||
25285255|NCT00875017|50600391|FG002|Washout|Problem collecting rectal effluent|1|||
25285256|NCT00875017|50600392|FG003|Washout|Problem collecting rectal effluent|0|||
25285257|NCT00875017|50600393|FG004|Washout|Problem collecting rectal effluent|0|||
25285258|NCT00875017|50600394|FG005|Washout|Problem collecting rectal effluent|0|||
25285259|NCT00875017|50600389|FG000|Second Intervention|Adverse Event|0|||
25285260|NCT00875017|50600390|FG001|Second Intervention|Adverse Event|0|||
25285261|NCT00875017|50600391|FG002|Second Intervention|Adverse Event|0|||
25285262|NCT00875017|50600392|FG003|Second Intervention|Adverse Event|1|||
25285263|NCT00875017|50600393|FG004|Second Intervention|Adverse Event|0|||
25285264|NCT00875017|50600394|FG005|Second Intervention|Adverse Event|0|||
25285265|NCT00875017|50600389|FG000|Washout|Problems collecting rectal effluent|0|||
25285266|NCT00875017|50600390|FG001|Washout|Problems collecting rectal effluent|1|||
25285267|NCT00875017|50600391|FG002|Washout|Problems collecting rectal effluent|0|||
25285268|NCT00875017|50600392|FG003|Washout|Problems collecting rectal effluent|0|||
25285269|NCT00875017|50600393|FG004|Washout|Problems collecting rectal effluent|0|||
25285270|NCT00875017|50600394|FG005|Washout|Problems collecting rectal effluent|0|||
25285271|NCT00875017|50600389|FG000|Third Intervention|Adverse Event|0|||
25285272|NCT00875017|50600390|FG001|Third Intervention|Adverse Event|1|||
25285273|NCT00875017|50600391|FG002|Third Intervention|Adverse Event|1|||
25285274|NCT00875017|50600392|FG003|Third Intervention|Adverse Event|0|||
25285275|NCT00875017|50600393|FG004|Third Intervention|Adverse Event|0|||
25285276|NCT00875017|50600394|FG005|Third Intervention|Adverse Event|0|||
25285277|NCT00875017|50600389|FG000|Washout|Withdrawal by Subject|0|||
25285278|NCT00875017|50600390|FG001|Washout|Withdrawal by Subject|0|||
25285279|NCT00875017|50600391|FG002|Washout|Withdrawal by Subject|0|||
25285280|NCT00875017|50600392|FG003|Washout|Withdrawal by Subject|0|||
25285281|NCT00875017|50600393|FG004|Washout|Withdrawal by Subject|1|||
25070045|NCT02610842|50175799|FG000|Overall Study|Lost to Follow-up|5|||
25285282|NCT00875017|50600394|FG005|Washout|Withdrawal by Subject|0|||
25285283|NCT00875017|50600389|FG000|Fourth Intervention|Inability to comply with fasting|0|||
25285284|NCT00875017|50600390|FG001|Fourth Intervention|Inability to comply with fasting|0|||
25285285|NCT00875017|50600391|FG002|Fourth Intervention|Inability to comply with fasting|0|||
25285286|NCT00875017|50600392|FG003|Fourth Intervention|Inability to comply with fasting|0|||
25285287|NCT00875017|50600393|FG004|Fourth Intervention|Inability to comply with fasting|0|||
25285288|NCT00875017|50600394|FG005|Fourth Intervention|Inability to comply with fasting|1|||
25285289|NCT00875797|50600419|FG000|Overall Study|Protocol Violation|6|||
25285290|NCT00875797|50600420|FG001|Overall Study|Protocol Violation|3|||
25285291|NCT00874939|50600446|FG000|Overall Study|Study terminated|4|||
25285292|NCT00875563|50600456|FG000|Overall Study|Death|4|||
25285293|NCT00875563|50600456|FG000|Overall Study|Withdrawal by Subject|7|||
25285294|NCT00875563|50600456|FG000|Overall Study|No long-term (3-5 year) consent|6|||
25285295|NCT00875563|50600456|FG000|Overall Study|Still be eligible for follow-up|7|||
25285296|NCT01155869|50600462|FG000|Overall Study|Lost to Follow-up|3|||
25285297|NCT01155869|50600463|FG001|Overall Study|Lost to Follow-up|1|||
25285298|NCT01185353|50600474|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
25285299|NCT01185353|50600475|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
25285300|NCT01185353|50600476|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
25285301|NCT01185353|50600477|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
25285302|NCT01185353|50600478|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
25285303|NCT01185353|50600479|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
25285304|NCT01185353|50600480|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
25285305|NCT01185353|50600481|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
25285306|NCT01185353|50600482|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
25285307|NCT01185353|50600483|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
25285308|NCT01185353|50600474|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
25285309|NCT01185353|50600475|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
25285310|NCT01185353|50600476|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
25285311|NCT01185353|50600477|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
25285312|NCT01185353|50600478|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
25285313|NCT01185353|50600479|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
25285314|NCT01185353|50600480|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
25285315|NCT01185353|50600481|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
25285316|NCT01185353|50600482|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
25285317|NCT01185353|50600483|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
25285318|NCT01185353|50600474|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
25285319|NCT01185353|50600475|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
25285320|NCT01185353|50600476|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
25285321|NCT01185353|50600477|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
25285322|NCT01185353|50600478|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
25285323|NCT01185353|50600479|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
25285324|NCT01185353|50600480|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
25285325|NCT01185353|50600481|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
25285326|NCT01185353|50600482|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
25285327|NCT01185353|50600483|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
25285328|NCT01185353|50600474|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
25285329|NCT01185353|50600475|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
25285330|NCT01185353|50600476|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
25285331|NCT01185353|50600477|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
25285332|NCT01185353|50600478|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
25285333|NCT01185353|50600479|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
25285334|NCT01185353|50600480|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
25285335|NCT01185353|50600481|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
25285336|NCT01185353|50600482|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
25285337|NCT01185353|50600483|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
25285338|NCT01185353|50600474|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
25285339|NCT01185353|50600475|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
25285340|NCT01185353|50600476|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
25285341|NCT01185353|50600477|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
25285342|NCT01185353|50600478|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
25285343|NCT01185353|50600479|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
25285344|NCT01185353|50600480|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
25285345|NCT01185353|50600481|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
25285346|NCT01185353|50600482|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
25285347|NCT01185353|50600483|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
25285348|NCT01185353|50600474|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
25285349|NCT01185353|50600475|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
25285350|NCT01185353|50600476|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
25070046|NCT01648582|50175808|FG000|Overall Study|Adverse Event|6|||
25070047|NCT01648582|50175809|FG001|Overall Study|Adverse Event|11|||
25070048|NCT01648582|50175810|FG002|Overall Study|Adverse Event|2|||
25285351|NCT01185353|50600477|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
25285352|NCT01185353|50600478|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
25285353|NCT01185353|50600479|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
25285354|NCT01185353|50600480|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
25285355|NCT01185353|50600481|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
25285356|NCT01185353|50600482|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
25285357|NCT01185353|50600483|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
25285358|NCT01185353|50600474|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
25285359|NCT01185353|50600475|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
25285360|NCT01185353|50600476|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
25285361|NCT01185353|50600477|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
25169209|NCT01844531|50300559|FG003|Overall Study|Withdrawal by Subject|0|||
25169210|NCT01844375|50300571|FG000|Overall Study|Protocol Violation|1|||
25169211|NCT01844375|50300572|FG001|Overall Study|Protocol Violation|1|||
25169212|NCT02367456|50300581|FG000|Overall Study|Death|8|||
25169213|NCT02367456|50300582|FG001|Overall Study|Death|21|||
25285362|NCT01185353|50600478|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
25285363|NCT01185353|50600479|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
25285364|NCT01185353|50600480|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
25285365|NCT01185353|50600481|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
25285366|NCT01185353|50600482|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
25285367|NCT01185353|50600483|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
25285368|NCT01185353|50600474|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
25285369|NCT01185353|50600475|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
25285370|NCT01185353|50600476|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
25285371|NCT01185353|50600477|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
25285372|NCT01185353|50600478|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
25285373|NCT01185353|50600479|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
25285374|NCT01185353|50600480|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
25285375|NCT01185353|50600481|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
25285376|NCT01185353|50600482|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
25285377|NCT01185353|50600483|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
25285378|NCT01185353|50600474|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
25285379|NCT01185353|50600475|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
25285380|NCT01185353|50600476|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
25285381|NCT01185353|50600477|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
25285382|NCT01185353|50600478|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
25285383|NCT01185353|50600479|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
25285384|NCT01185353|50600480|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
25285385|NCT01185353|50600481|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
25285386|NCT01185353|50600482|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
25285387|NCT01185353|50600483|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
25285388|NCT01185353|50600474|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
25285389|NCT01185353|50600475|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
25285390|NCT01185353|50600476|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
25285391|NCT01185353|50600477|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
25285392|NCT01185353|50600478|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
25285393|NCT01185353|50600479|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
25285394|NCT01185353|50600480|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
25285395|NCT01185353|50600481|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
25285396|NCT01185353|50600482|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
25285397|NCT01185353|50600483|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
25285398|NCT01185353|50600474|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
25285399|NCT01185353|50600475|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
25285400|NCT01185353|50600476|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
25285401|NCT01185353|50600477|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
25285402|NCT01185353|50600478|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
25285403|NCT01185353|50600479|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
25285404|NCT01185353|50600480|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
25285405|NCT01185353|50600481|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
25285406|NCT01185353|50600482|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
25285407|NCT01185353|50600483|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
25285408|NCT01185353|50600474|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
25285409|NCT01185353|50600475|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
25285410|NCT01185353|50600476|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
25285411|NCT01185353|50600477|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
25169214|NCT02367456|50300583|FG002|Overall Study|Death|14|||
25169215|NCT02367456|50300581|FG000|Overall Study|Lost to Follow-up|1|||
25285412|NCT01185353|50600478|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
25285413|NCT01185353|50600479|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
25285414|NCT01185353|50600480|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
25285415|NCT01185353|50600481|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
25285416|NCT01185353|50600482|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
25285417|NCT01185353|50600483|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
25285418|NCT01185353|50600474|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
25285419|NCT01185353|50600475|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
25285420|NCT01185353|50600476|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
25285421|NCT01185353|50600477|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
25285422|NCT01185353|50600478|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
25285423|NCT01185353|50600479|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
25285424|NCT01185353|50600480|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
25285425|NCT01185353|50600481|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
25285426|NCT01185353|50600482|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
25285427|NCT01185353|50600483|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
25285428|NCT01185353|50600474|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
25285429|NCT01185353|50600475|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
25285430|NCT01185353|50600476|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
25285431|NCT01185353|50600477|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
25285432|NCT01185353|50600478|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
25285433|NCT01185353|50600479|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
25285434|NCT01185353|50600480|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
25285435|NCT01185353|50600481|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
25285436|NCT01185353|50600482|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
25285437|NCT01185353|50600483|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
25285438|NCT01185353|50600474|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
25285439|NCT01185353|50600475|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
25285440|NCT01185353|50600476|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
25285441|NCT01185353|50600477|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
25285442|NCT01185353|50600478|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
25285443|NCT01185353|50600479|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
25285444|NCT01185353|50600480|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
25285445|NCT01185353|50600481|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
25285446|NCT01185353|50600482|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
25285447|NCT01185353|50600483|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
25285448|NCT01185353|50600474|FG000|Part C (Weeks 24 Through 76)|Death|0|||
25285449|NCT01185353|50600475|FG001|Part C (Weeks 24 Through 76)|Death|0|||
25285450|NCT01185353|50600476|FG002|Part C (Weeks 24 Through 76)|Death|0|||
25285451|NCT01185353|50600477|FG003|Part C (Weeks 24 Through 76)|Death|0|||
25285452|NCT01185353|50600478|FG004|Part C (Weeks 24 Through 76)|Death|0|||
25285453|NCT01185353|50600479|FG005|Part C (Weeks 24 Through 76)|Death|0|||
25285454|NCT01185353|50600480|FG006|Part C (Weeks 24 Through 76)|Death|0|||
25285455|NCT01185353|50600481|FG007|Part C (Weeks 24 Through 76)|Death|0|||
25285456|NCT01185353|50600482|FG008|Part C (Weeks 24 Through 76)|Death|0|||
25285457|NCT01185353|50600483|FG009|Part C (Weeks 24 Through 76)|Death|1|||
25285458|NCT01185353|50600474|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
25285459|NCT01185353|50600475|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
25285460|NCT01185353|50600476|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
25285461|NCT01185353|50600477|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
25285462|NCT01185353|50600478|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
25285463|NCT01185353|50600479|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
25285464|NCT01185353|50600480|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
25285465|NCT01185353|50600481|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
25285466|NCT01185353|50600482|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
25285467|NCT01185353|50600483|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
25285468|NCT01185353|50600474|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
25285469|NCT01185353|50600475|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
25285470|NCT01185353|50600476|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
25285471|NCT01185353|50600477|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
25285472|NCT01185353|50600478|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
25285473|NCT01185353|50600479|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
25285474|NCT01185353|50600480|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
24969610|NCT04899232|50059060|FG002|Screening Period|Physician Decision|0|||
25285475|NCT01185353|50600481|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
25285476|NCT01185353|50600482|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
25285477|NCT01185353|50600483|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
25285478|NCT01185353|50600474|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
25285479|NCT01185353|50600475|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
24969611|NCT04899232|50059058|FG000|Screening Period|Withdrawal by Subject|1|||
25285480|NCT01185353|50600476|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
25285481|NCT01185353|50600477|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
25285482|NCT01185353|50600478|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
25285483|NCT01185353|50600479|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
25285484|NCT01185353|50600480|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
25285485|NCT01185353|50600481|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
25285486|NCT01185353|50600482|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
25285487|NCT01185353|50600483|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
25285488|NCT01185353|50600474|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
25285489|NCT01185353|50600475|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
25285490|NCT01185353|50600476|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
25285491|NCT01185353|50600477|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
25285492|NCT01185353|50600478|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
25191463|NCT01492400|50351661|FG000|Overall Study|Lack of Efficacy|1|||
25191464|NCT01492400|50351662|FG001|Overall Study|Lack of Efficacy|1|||
25191465|NCT01492400|50351661|FG000|Overall Study|Adverse Event|10|||
25191466|NCT01492400|50351662|FG001|Overall Study|Adverse Event|5|||
25191467|NCT02596854|50351787|FG000|Overall Study|Withdrawn|8|||
25285493|NCT01185353|50600479|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
25285494|NCT01185353|50600480|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
25285495|NCT01185353|50600481|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
25285496|NCT01185353|50600482|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
25285497|NCT01185353|50600483|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
25285498|NCT01185353|50600474|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
25285499|NCT01185353|50600475|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
25285500|NCT01185353|50600476|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
25285501|NCT01185353|50600477|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
25285502|NCT01185353|50600478|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
25285503|NCT01185353|50600479|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
25285504|NCT01185353|50600480|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
25285505|NCT01185353|50600481|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
25285506|NCT01185353|50600482|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
25285507|NCT01185353|50600483|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
25285508|NCT01185353|50600474|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
25285509|NCT01185353|50600475|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
25285510|NCT01185353|50600476|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
25285511|NCT01185353|50600477|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
25285512|NCT01185353|50600478|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
25285513|NCT01185353|50600479|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
25285514|NCT01185353|50600480|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
25285515|NCT01185353|50600481|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
25285516|NCT01185353|50600482|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
25285517|NCT01185353|50600483|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
25285518|NCT01098240|50600522|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
25285519|NCT01098240|50600523|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
25285520|NCT01098240|50600524|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
25285521|NCT01098240|50600522|FG000|Open-Label Phase|Protocol Violation|4|||
25285522|NCT01098240|50600523|FG001|Open-Label Phase|Protocol Violation|0|||
25285523|NCT01098240|50600524|FG002|Open-Label Phase|Protocol Violation|0|||
25285524|NCT01098240|50600522|FG000|Open-Label Phase|Lost to Follow-up|13|||
25285525|NCT01098240|50600523|FG001|Open-Label Phase|Lost to Follow-up|0|||
25285526|NCT01098240|50600524|FG002|Open-Label Phase|Lost to Follow-up|0|||
25285527|NCT01098240|50600522|FG000|Open-Label Phase|Other|19|||
25285528|NCT01098240|50600523|FG001|Open-Label Phase|Other|0|||
25285529|NCT01098240|50600524|FG002|Open-Label Phase|Other|0|||
25285530|NCT01098240|50600522|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
25285531|NCT01098240|50600523|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
25285532|NCT01098240|50600524|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
25285533|NCT01098240|50600522|FG000|Open-Label Phase|Pregnancy|1|||
25285534|NCT01098240|50600523|FG001|Open-Label Phase|Pregnancy|0|||
25285535|NCT01098240|50600524|FG002|Open-Label Phase|Pregnancy|0|||
25285536|NCT01098240|50600522|FG000|Open-Label Phase|Withdrawal by Subject|9|||
25285537|NCT01098240|50600523|FG001|Open-Label Phase|Withdrawal by Subject|0|||
25191468|NCT02592876|50351924|FG000|Overall Study|Withdrawal by Subject|3|||
25191469|NCT02592876|50351925|FG001|Overall Study|Withdrawal by Subject|3|||
25191470|NCT02592876|50351924|FG000|Overall Study|Study Termination by Sponsor|32|||
24969612|NCT04899232|50059059|FG001|Screening Period|Withdrawal by Subject|0|||
24969613|NCT04899232|50059060|FG002|Screening Period|Withdrawal by Subject|0|||
24969614|NCT04899232|50059058|FG000|Screening Period|Participant discharged before receiving intervention|3|||
24969615|NCT04899232|50059059|FG001|Screening Period|Participant discharged before receiving intervention|0|||
24969616|NCT04899232|50059060|FG002|Screening Period|Participant discharged before receiving intervention|0|||
25285538|NCT01098240|50600524|FG002|Open-Label Phase|Withdrawal by Subject|0|||
25285539|NCT01098240|50600522|FG000|Open-Label Phase|Adverse Event|12|||
25285540|NCT01098240|50600523|FG001|Open-Label Phase|Adverse Event|0|||
25285541|NCT01098240|50600524|FG002|Open-Label Phase|Adverse Event|0|||
25285542|NCT01098240|50600522|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
25285543|NCT01098240|50600523|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
25285544|NCT01098240|50600524|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
25285545|NCT01098240|50600522|FG000|Double-Blind Phase|Protocol Violation|0|||
25285546|NCT01098240|50600523|FG001|Double-Blind Phase|Protocol Violation|2|||
25285547|NCT01098240|50600524|FG002|Double-Blind Phase|Protocol Violation|4|||
25285548|NCT01098240|50600522|FG000|Double-Blind Phase|Lost to Follow-up|0|||
25285549|NCT01098240|50600523|FG001|Double-Blind Phase|Lost to Follow-up|2|||
25285550|NCT01098240|50600524|FG002|Double-Blind Phase|Lost to Follow-up|0|||
25285551|NCT01098240|50600522|FG000|Double-Blind Phase|Other|0|||
25285552|NCT01098240|50600523|FG001|Double-Blind Phase|Other|2|||
25285553|NCT01098240|50600524|FG002|Double-Blind Phase|Other|2|||
25285554|NCT01098240|50600522|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
25285555|NCT01098240|50600523|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
25285556|NCT01098240|50600524|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
25285557|NCT01098240|50600522|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
25285558|NCT01098240|50600523|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
25285559|NCT01098240|50600524|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
25285560|NCT01098240|50600522|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
25285561|NCT01098240|50600523|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
25285562|NCT01098240|50600524|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
25285563|NCT01098240|50600522|FG000|Double-Blind Phase|Adverse Event|0|||
25285564|NCT01098240|50600523|FG001|Double-Blind Phase|Adverse Event|3|||
25285565|NCT01098240|50600524|FG002|Double-Blind Phase|Adverse Event|3|||
25285566|NCT01098162|50600531|FG000|Overall Study|Adverse Event|37|||
25285567|NCT01098162|50600531|FG000|Overall Study|Lack of Efficacy|4|||
25285568|NCT01098162|50600531|FG000|Overall Study|Wish of Patient|7|||
25285569|NCT01098162|50600531|FG000|Overall Study|Lost to Follow-up|9|||
25285570|NCT01098162|50600531|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
25285571|NCT01098162|50600531|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
25285572|NCT01098162|50600531|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
25285573|NCT01098162|50600531|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
25285574|NCT01098162|50600531|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
25285575|NCT01098162|50600531|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
25285576|NCT01098162|50600531|FG000|Overall Study|Other Reason|1|||
25285577|NCT01098162|50600531|FG000|Overall Study|Reason Unknown|26|||
25285578|NCT01097694|50600537|FG000|Overall Study|Adverse Event|5|||
25285579|NCT01097694|50600538|FG001|Overall Study|Adverse Event|0|||
25285580|NCT01097694|50600537|FG000|Overall Study|Lost to Follow-up|0|||
25070049|NCT01648582|50175808|FG000|Overall Study|Lost to Follow-up|9|||
25070050|NCT01648582|50175809|FG001|Overall Study|Lost to Follow-up|6|||
25070051|NCT01648582|50175810|FG002|Overall Study|Lost to Follow-up|8|||
25070052|NCT01648582|50175808|FG000|Overall Study|Protocol Violation|1|||
25070053|NCT01648582|50175809|FG001|Overall Study|Protocol Violation|2|||
25070054|NCT01648582|50175810|FG002|Overall Study|Protocol Violation|1|||
25070055|NCT01648582|50175808|FG000|Overall Study|Withdrawal by Subject|15|||
25070056|NCT01648582|50175809|FG001|Overall Study|Withdrawal by Subject|17|||
25070057|NCT01648582|50175810|FG002|Overall Study|Withdrawal by Subject|17|||
25070058|NCT01648582|50175808|FG000|Overall Study|Physician Decision|0|||
25070059|NCT01648582|50175809|FG001|Overall Study|Physician Decision|1|||
25070060|NCT01648582|50175810|FG002|Overall Study|Physician Decision|3|||
25070061|NCT01648582|50175808|FG000|Overall Study|Death|1|||
25070062|NCT01648582|50175809|FG001|Overall Study|Death|0|||
25070063|NCT01648582|50175810|FG002|Overall Study|Death|0|||
25070064|NCT01648582|50175808|FG000|Overall Study|Sponsor Decision|0|||
25070065|NCT01648582|50175809|FG001|Overall Study|Sponsor Decision|1|||
25070066|NCT01648582|50175810|FG002|Overall Study|Sponsor Decision|1|||
25070067|NCT02607800|50175823|FG000|Overall Study|Lost to Follow-up|7|||
25070068|NCT02607800|50175824|FG001|Overall Study|Lost to Follow-up|10|||
25070069|NCT02607800|50175823|FG000|Overall Study|Withdrew Consent|2|||
25070070|NCT02607800|50175824|FG001|Overall Study|Withdrew Consent|0|||
25070071|NCT02607800|50175823|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
25070072|NCT02607800|50175824|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
25070073|NCT02304484|50175831|FG000|Overall Study|Death|9|||
25070074|NCT02304484|50175831|FG000|Overall Study|Withdrawal by Subject|14|||
25070075|NCT02304484|50175831|FG000|Overall Study|Lost to Follow-up|2|||
25285581|NCT01097694|50600538|FG001|Overall Study|Lost to Follow-up|3|||
25285582|NCT01097694|50600537|FG000|Overall Study|Withdrawal by Subject|3|||
25285583|NCT01097694|50600538|FG001|Overall Study|Withdrawal by Subject|1|||
25070076|NCT02708355|50175838|FG000|Overall Study|Adverse Event|1|||
25285584|NCT01102140|50600546|FG000|Overall Study|Lost to Follow-up|1|||
25285585|NCT01102140|50600547|FG001|Overall Study|Lost to Follow-up|0|||
25285586|NCT01102140|50600546|FG000|Overall Study|Investigator terminated study|2|||
25285587|NCT01102140|50600547|FG001|Overall Study|Investigator terminated study|2|||
25285588|NCT00874549|50600559|FG000|Overall Study|Adverse Event|0|||
25285589|NCT00874549|50600560|FG001|Overall Study|Adverse Event|0|||
25285590|NCT00874549|50600561|FG002|Overall Study|Adverse Event|1|||
25285591|NCT00874549|50600562|FG003|Overall Study|Adverse Event|0|||
25285592|NCT00874549|50600559|FG000|Overall Study|Protocol Violation|1|||
25285593|NCT00874549|50600560|FG001|Overall Study|Protocol Violation|0|||
25285594|NCT00874549|50600561|FG002|Overall Study|Protocol Violation|2|||
25070077|NCT02708355|50175839|FG001|Overall Study|Adverse Event|0|||
25070078|NCT02708355|50175840|FG002|Overall Study|Adverse Event|0|||
25070079|NCT02708277|50175850|FG000|Overall Study|Lost to Follow-up|7|||
25070080|NCT02708277|50175851|FG001|Overall Study|Lost to Follow-up|4|||
25070081|NCT02337478|50175857|FG000|Overall Study|Lack of Efficacy|5|||
25070082|NCT02303704|50175863|FG000|Overall Study|Protocol Violation|5|||
25070083|NCT02303704|50175864|FG001|Overall Study|Protocol Violation|9|||
25070084|NCT02608892|50175872|FG000|Overall Study|Lost to Follow-up|1|||
25070085|NCT02608892|50175873|FG001|Overall Study|Lost to Follow-up|0|||
25070086|NCT02706951|50175883|FG000|Overall Study|Adverse Event|1|||
25070087|NCT02706951|50175884|FG001|Overall Study|Adverse Event|5|||
25070088|NCT02706951|50175885|FG002|Overall Study|Adverse Event|3|||
25070089|NCT02706951|50175883|FG000|Overall Study|Withdrawal by Subject|11|||
25070090|NCT02706951|50175884|FG001|Overall Study|Withdrawal by Subject|6|||
25070091|NCT02706951|50175885|FG002|Overall Study|Withdrawal by Subject|6|||
25070092|NCT02706951|50175883|FG000|Overall Study|Lost to Follow-up|0|||
25070093|NCT02706951|50175884|FG001|Overall Study|Lost to Follow-up|4|||
25070094|NCT02706951|50175885|FG002|Overall Study|Lost to Follow-up|1|||
25070095|NCT02706951|50175883|FG000|Overall Study|Other|2|||
25070096|NCT02706951|50175884|FG001|Overall Study|Other|1|||
25070097|NCT02706951|50175885|FG002|Overall Study|Other|0|||
25070098|NCT02708121|50175895|FG000|Overall Study|Withdrawn by Study Team|1|||
25070099|NCT02708121|50175896|FG001|Overall Study|Withdrawn by Study Team|1|||
25070100|NCT02708121|50175895|FG000|Overall Study|Withdrawal by Subject|0|||
25070101|NCT02708121|50175896|FG001|Overall Study|Withdrawal by Subject|4|||
25070102|NCT02707965|50175911|FG000|Overall Study|Withdrawal by Subject|0|||
25070103|NCT02707965|50175912|FG001|Overall Study|Withdrawal by Subject|0|||
25070104|NCT02707965|50175913|FG002|Overall Study|Withdrawal by Subject|1|||
25070105|NCT02707965|50175914|FG003|Overall Study|Withdrawal by Subject|0|||
25070106|NCT02707965|50175915|FG004|Overall Study|Withdrawal by Subject|0|||
25070107|NCT02707965|50175916|FG005|Overall Study|Withdrawal by Subject|0|||
25070108|NCT02707965|50175917|FG006|Overall Study|Withdrawal by Subject|0|||
25070109|NCT02707965|50175918|FG007|Overall Study|Withdrawal by Subject|2|||
25070110|NCT02707965|50175919|FG008|Overall Study|Withdrawal by Subject|0|||
25070111|NCT02707965|50175920|FG009|Overall Study|Withdrawal by Subject|0|||
25070112|NCT02707965|50175921|FG010|Overall Study|Withdrawal by Subject|0|||
25070113|NCT02707965|50175922|FG011|Overall Study|Withdrawal by Subject|0|||
25070114|NCT02707965|50175923|FG012|Overall Study|Withdrawal by Subject|0|||
25070115|NCT02707965|50175924|FG013|Overall Study|Withdrawal by Subject|0|||
25070116|NCT02707965|50175925|FG014|Overall Study|Withdrawal by Subject|0|||
25070117|NCT02707965|50175926|FG015|Overall Study|Withdrawal by Subject|0|||
25070118|NCT02707965|50175911|FG000|Overall Study|PI decisions|0|||
25070119|NCT02707965|50175912|FG001|Overall Study|PI decisions|0|||
25070120|NCT02707965|50175913|FG002|Overall Study|PI decisions|0|||
25070121|NCT02707965|50175914|FG003|Overall Study|PI decisions|0|||
25070122|NCT02707965|50175915|FG004|Overall Study|PI decisions|0|||
25070123|NCT02707965|50175916|FG005|Overall Study|PI decisions|0|||
25070124|NCT02707965|50175917|FG006|Overall Study|PI decisions|0|||
25070125|NCT02707965|50175918|FG007|Overall Study|PI decisions|0|||
25070126|NCT02707965|50175919|FG008|Overall Study|PI decisions|0|||
25285595|NCT00874549|50600562|FG003|Overall Study|Protocol Violation|1|||
25285596|NCT00874549|50600559|FG000|Overall Study|Lost to Follow-up|0|||
25285597|NCT00874549|50600560|FG001|Overall Study|Lost to Follow-up|0|||
25285598|NCT00874549|50600561|FG002|Overall Study|Lost to Follow-up|1|||
25070127|NCT02707965|50175920|FG009|Overall Study|PI decisions|0|||
25070128|NCT02707965|50175921|FG010|Overall Study|PI decisions|0|||
25070129|NCT02707965|50175922|FG011|Overall Study|PI decisions|0|||
25070130|NCT02707965|50175923|FG012|Overall Study|PI decisions|0|||
25070131|NCT02707965|50175924|FG013|Overall Study|PI decisions|0|||
25070132|NCT02707965|50175925|FG014|Overall Study|PI decisions|2|||
25070133|NCT02707965|50175926|FG015|Overall Study|PI decisions|0|||
25070134|NCT02707965|50175911|FG000|Overall Study|Protocol deviation|1|||
25070135|NCT02707965|50175912|FG001|Overall Study|Protocol deviation|1|||
25070136|NCT02707965|50175913|FG002|Overall Study|Protocol deviation|0|||
25070137|NCT02707965|50175914|FG003|Overall Study|Protocol deviation|0|||
25070138|NCT02707965|50175915|FG004|Overall Study|Protocol deviation|0|||
25285599|NCT00874549|50600562|FG003|Overall Study|Lost to Follow-up|0|||
25285600|NCT00874549|50600559|FG000|Overall Study|Withdrawal by Subject|0|||
25285601|NCT00874549|50600560|FG001|Overall Study|Withdrawal by Subject|1|||
25285602|NCT00874549|50600561|FG002|Overall Study|Withdrawal by Subject|0|||
25285603|NCT00874549|50600562|FG003|Overall Study|Withdrawal by Subject|1|||
25285604|NCT01155479|50600577|FG000|Part I|Adverse Event|13|||
25285605|NCT01155479|50600578|FG001|Part I|Adverse Event|8|||
25285606|NCT01155479|50600579|FG002|Part I|Adverse Event|18|||
25285607|NCT01155479|50600580|FG003|Part I|Adverse Event|7|||
25285608|NCT01155479|50600581|FG004|Part I|Adverse Event|6|||
25285609|NCT01155479|50600577|FG000|Part I|Administrative|2|||
25285610|NCT01155479|50600578|FG001|Part I|Administrative|2|||
25285611|NCT01155479|50600579|FG002|Part I|Administrative|2|||
25285612|NCT01155479|50600580|FG003|Part I|Administrative|0|||
25285613|NCT01155479|50600581|FG004|Part I|Administrative|0|||
25285614|NCT01155479|50600577|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
25285615|NCT01155479|50600578|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
25285616|NCT01155479|50600579|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
24969624|NCT04559698|50059083|FG000|Overall Study|Lost to Follow-up|14|||
24969625|NCT04559698|50059084|FG001|Overall Study|Lost to Follow-up|15|||
24969626|NCT04559698|50059083|FG000|Overall Study|Withdrawal by Subject|0|||
24969627|NCT04559698|50059084|FG001|Overall Study|Withdrawal by Subject|1|||
24969628|NCT00133952|50059092|FG000|Overall Study|Adverse Event|1|||
24969629|NCT00133952|50059093|FG001|Overall Study|Adverse Event|2|||
24969630|NCT00133952|50059092|FG000|Overall Study|Death|3|||
24969631|NCT00133952|50059093|FG001|Overall Study|Death|2|||
24969632|NCT00133952|50059092|FG000|Overall Study|Lost to Follow-up|9|||
24969633|NCT00133952|50059093|FG001|Overall Study|Lost to Follow-up|14|||
24969634|NCT00133952|50059092|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
24969635|NCT00133952|50059093|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
24969636|NCT00133952|50059092|FG000|Overall Study|Protocol Violation|1|||
25285617|NCT01155479|50600580|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
25285618|NCT01155479|50600581|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
24969637|NCT00133952|50059093|FG001|Overall Study|Protocol Violation|1|||
25070139|NCT02707965|50175916|FG005|Overall Study|Protocol deviation|0|||
25285619|NCT01155479|50600577|FG000|Part I|Withdrawal by Subject|11|||
25285620|NCT01155479|50600578|FG001|Part I|Withdrawal by Subject|13|||
25285621|NCT01155479|50600579|FG002|Part I|Withdrawal by Subject|8|||
25285622|NCT01155479|50600580|FG003|Part I|Withdrawal by Subject|8|||
25285623|NCT01155479|50600581|FG004|Part I|Withdrawal by Subject|9|||
25285624|NCT01155479|50600577|FG000|Part I|Lost to Follow-up|0|||
25285625|NCT01155479|50600578|FG001|Part I|Lost to Follow-up|0|||
25285626|NCT01155479|50600579|FG002|Part I|Lost to Follow-up|1|||
25285627|NCT01155479|50600580|FG003|Part I|Lost to Follow-up|1|||
25285628|NCT01155479|50600581|FG004|Part I|Lost to Follow-up|0|||
25285629|NCT01155479|50600577|FG000|Part I|Treatment Failure|3|||
25285630|NCT01155479|50600578|FG001|Part I|Treatment Failure|0|||
25285631|NCT01155479|50600579|FG002|Part I|Treatment Failure|3|||
25285632|NCT01155479|50600580|FG003|Part I|Treatment Failure|1|||
25285633|NCT01155479|50600581|FG004|Part I|Treatment Failure|2|||
25285634|NCT01155479|50600577|FG000|Part I|Did Not Receive Treatment|4|||
25285635|NCT01155479|50600578|FG001|Part I|Did Not Receive Treatment|2|||
25285636|NCT01155479|50600579|FG002|Part I|Did Not Receive Treatment|2|||
25285637|NCT01155479|50600580|FG003|Part I|Did Not Receive Treatment|6|||
25285638|NCT01155479|50600581|FG004|Part I|Did Not Receive Treatment|1|||
25285639|NCT01155479|50600577|FG000|Part I|Non-Compliance with Protocol|2|||
25285640|NCT01155479|50600578|FG001|Part I|Non-Compliance with Protocol|1|||
25285641|NCT01155479|50600579|FG002|Part I|Non-Compliance with Protocol|3|||
25285642|NCT01155479|50600580|FG003|Part I|Non-Compliance with Protocol|3|||
25285643|NCT01155479|50600581|FG004|Part I|Non-Compliance with Protocol|2|||
25285644|NCT01155479|50600577|FG000|Part II|Adverse Event|7|||
25285645|NCT01155479|50600578|FG001|Part II|Adverse Event|6|||
25285646|NCT01155479|50600579|FG002|Part II|Adverse Event|8|||
25285647|NCT01155479|50600580|FG003|Part II|Adverse Event|3|||
25285648|NCT01155479|50600581|FG004|Part II|Adverse Event|4|||
25285649|NCT01155479|50600577|FG000|Part II|Administrative|43|||
25285650|NCT01155479|50600578|FG001|Part II|Administrative|49|||
25285651|NCT01155479|50600579|FG002|Part II|Administrative|36|||
25285652|NCT01155479|50600580|FG003|Part II|Administrative|38|||
25285653|NCT01155479|50600581|FG004|Part II|Administrative|46|||
25285654|NCT01155479|50600577|FG000|Part II|Withdrawal by Subject|8|||
25285655|NCT01155479|50600578|FG001|Part II|Withdrawal by Subject|4|||
25285656|NCT01155479|50600579|FG002|Part II|Withdrawal by Subject|12|||
25285657|NCT01155479|50600580|FG003|Part II|Withdrawal by Subject|7|||
25285658|NCT01155479|50600581|FG004|Part II|Withdrawal by Subject|3|||
25285659|NCT01155479|50600577|FG000|Part II|Lost to Follow-up|1|||
25285660|NCT01155479|50600578|FG001|Part II|Lost to Follow-up|0|||
25285661|NCT01155479|50600579|FG002|Part II|Lost to Follow-up|0|||
25285662|NCT01155479|50600580|FG003|Part II|Lost to Follow-up|0|||
25285663|NCT01155479|50600581|FG004|Part II|Lost to Follow-up|1|||
25285664|NCT01155479|50600577|FG000|Part II|Treatment Failure|0|||
25285665|NCT01155479|50600578|FG001|Part II|Treatment Failure|1|||
25285666|NCT01155479|50600579|FG002|Part II|Treatment Failure|2|||
25285667|NCT01155479|50600580|FG003|Part II|Treatment Failure|0|||
25285668|NCT01155479|50600581|FG004|Part II|Treatment Failure|1|||
25285669|NCT01155479|50600577|FG000|Part II|Non-Compliance with Protocol|0|||
25285670|NCT01155479|50600578|FG001|Part II|Non-Compliance with Protocol|1|||
25285671|NCT01155479|50600579|FG002|Part II|Non-Compliance with Protocol|0|||
25285672|NCT01155479|50600580|FG003|Part II|Non-Compliance with Protocol|2|||
25285673|NCT01155479|50600581|FG004|Part II|Non-Compliance with Protocol|0|||
25285674|NCT01155323|50600609|FG000|First Intervention|exclusion criteria|1|||
25285675|NCT01155323|50600610|FG001|First Intervention|exclusion criteria|1|||
25285676|NCT01155323|50600609|FG000|Second Intervention|Lost to Follow-up|1|||
25285677|NCT01155323|50600610|FG001|Second Intervention|Lost to Follow-up|1|||
25285678|NCT01155167|50600618|FG000|Overall Study|Insufficient ultrasound data|2|||
25285679|NCT01155167|50600619|FG001|Overall Study|Insufficient ultrasound data|0|||
25285680|NCT01155167|50600618|FG000|Overall Study|Access site changed to femoral artery|1|||
25285681|NCT01155167|50600619|FG001|Overall Study|Access site changed to femoral artery|0|||
25285682|NCT01106586|50600627|FG000|Overall Study|Adverse Event|9|||
25285683|NCT01106586|50600628|FG001|Overall Study|Adverse Event|15|||
25285684|NCT01106586|50600627|FG000|Overall Study|Death|1|||
25285685|NCT01106586|50600628|FG001|Overall Study|Death|3|||
25285686|NCT01106586|50600627|FG000|Overall Study|Pregnancy|2|||
25285687|NCT01106586|50600628|FG001|Overall Study|Pregnancy|2|||
25285688|NCT01106586|50600627|FG000|Overall Study|Lack of Efficacy|1|||
25285689|NCT01106586|50600628|FG001|Overall Study|Lack of Efficacy|0|||
25285690|NCT01106586|50600627|FG000|Overall Study|Investigator's Discretion|5|||
25285691|NCT01106586|50600628|FG001|Overall Study|Investigator's Discretion|8|||
25285692|NCT01106586|50600627|FG000|Overall Study|Withdrew Consent|18|||
25285693|NCT01106586|50600628|FG001|Overall Study|Withdrew Consent|30|||
25285694|NCT01106586|50600627|FG000|Overall Study|Lost to Follow-up|24|||
25285695|NCT01106586|50600628|FG001|Overall Study|Lost to Follow-up|20|||
25285696|NCT01106586|50600627|FG000|Overall Study|Participant Noncompliance|12|||
25285697|NCT01106586|50600628|FG001|Overall Study|Participant Noncompliance|10|||
25285698|NCT01106586|50600627|FG000|Overall Study|Protocol Violation|1|||
25285699|NCT01106586|50600628|FG001|Overall Study|Protocol Violation|0|||
25285700|NCT01106586|50600627|FG000|Overall Study|Participant Transferred to Another Study|212|||
25285701|NCT01106586|50600628|FG001|Overall Study|Participant Transferred to Another Study|197|||
25285702|NCT01155011|50600636|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
25285703|NCT01155011|50600637|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
25285704|NCT01155011|50600636|FG000|Baseline to 6 Months|investigator decision, moved|4|||
25285705|NCT01155011|50600637|FG001|Baseline to 6 Months|investigator decision, moved|5|||
25285706|NCT01155011|50600636|FG000|Baseline to 6 Months|Death|0|||
25285707|NCT01155011|50600637|FG001|Baseline to 6 Months|Death|1|||
25285708|NCT01155011|50600636|FG000|6 to 12 Months|Withdrawal by Subject|8|||
25285709|NCT01155011|50600637|FG001|6 to 12 Months|Withdrawal by Subject|5|||
25285710|NCT01155011|50600636|FG000|6 to 12 Months|Death|1|||
25285711|NCT01155011|50600637|FG001|6 to 12 Months|Death|5|||
25285712|NCT01106430|50600649|FG000|Overall Study|Adverse Event|8|||
25285713|NCT01106430|50600650|FG001|Overall Study|Adverse Event|10|||
25285714|NCT01106430|50600649|FG000|Overall Study|Lack of Efficacy|2|||
25285715|NCT01106430|50600650|FG001|Overall Study|Lack of Efficacy|13|||
25285716|NCT01106430|50600649|FG000|Overall Study|Lost to Follow-up|5|||
25285717|NCT01106430|50600650|FG001|Overall Study|Lost to Follow-up|1|||
25285718|NCT01106430|50600649|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
25285719|NCT01106430|50600650|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
25285720|NCT01106430|50600649|FG000|Overall Study|Moved Out Of State|0|||
25285721|NCT01106430|50600650|FG001|Overall Study|Moved Out Of State|1|||
25285722|NCT01106430|50600649|FG000|Overall Study|Refused To Take Medication|0|||
25285723|NCT01106430|50600650|FG001|Overall Study|Refused To Take Medication|1|||
25285724|NCT01106430|50600649|FG000|Overall Study|Noncompliance|0|||
25285725|NCT01106430|50600650|FG001|Overall Study|Noncompliance|1|||
25285726|NCT01106430|50600649|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
25285727|NCT01106430|50600650|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
25285728|NCT01106430|50600649|FG000|Overall Study|Previous Use Of Marijuana|1|||
25285729|NCT01106430|50600650|FG001|Overall Study|Previous Use Of Marijuana|0|||
25285730|NCT01106430|50600649|FG000|Overall Study|Protocol Violation|7|||
25285731|NCT01106430|50600650|FG001|Overall Study|Protocol Violation|2|||
25191471|NCT02592876|50351925|FG001|Overall Study|Study Termination by Sponsor|27|||
25191472|NCT02592876|50351924|FG000|Overall Study|Lost to Follow-up|0|||
25191473|NCT02592876|50351925|FG001|Overall Study|Lost to Follow-up|1|||
25285732|NCT01106430|50600649|FG000|Overall Study|Withdrawal by Subject|8|||
25285733|NCT01106430|50600650|FG001|Overall Study|Withdrawal by Subject|4|||
25285734|NCT01154231|50600656|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
25285735|NCT01154231|50600656|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
25285736|NCT01154153|50600662|FG000|Overall Study|Poor compliance to protocol|2|||
25285737|NCT01154153|50600663|FG001|Overall Study|Poor compliance to protocol|0|||
25285738|NCT01154153|50600662|FG000|Overall Study|Unable to use labs|2|||
25285739|NCT01154153|50600663|FG001|Overall Study|Unable to use labs|3|||
25285740|NCT01154153|50600662|FG000|Overall Study|Withdrew consent|1|||
25285741|NCT01154153|50600663|FG001|Overall Study|Withdrew consent|0|||
25285742|NCT00874237|50600669|FG000|Overall Study|Physician Decision|0|||
25285743|NCT00874237|50600670|FG001|Overall Study|Physician Decision|1|||
25285744|NCT00874237|50600671|FG002|Overall Study|Physician Decision|0|||
25285745|NCT00874237|50600672|FG003|Overall Study|Physician Decision|0|||
25285746|NCT00874237|50600673|FG004|Overall Study|Physician Decision|0|||
25285747|NCT00874237|50600674|FG005|Overall Study|Physician Decision|0|||
25285748|NCT00874237|50600669|FG000|Overall Study|Withdrawal by Subject|0|||
25285749|NCT00874237|50600670|FG001|Overall Study|Withdrawal by Subject|0|||
25285750|NCT00874237|50600671|FG002|Overall Study|Withdrawal by Subject|1|||
25285751|NCT00874237|50600672|FG003|Overall Study|Withdrawal by Subject|0|||
25285752|NCT00874237|50600673|FG004|Overall Study|Withdrawal by Subject|0|||
25285753|NCT00874237|50600674|FG005|Overall Study|Withdrawal by Subject|0|||
25285754|NCT01153841|50600686|FG000|Overall Study|Adverse Event|1|||
25285755|NCT01153841|50600687|FG001|Overall Study|Adverse Event|0|||
25285756|NCT01153841|50600686|FG000|Overall Study|Withdrawal by Subject|1|||
25285757|NCT01153841|50600687|FG001|Overall Study|Withdrawal by Subject|0|||
25285758|NCT01153841|50600686|FG000|Overall Study|Protocol Violation|2|||
25285759|NCT01153841|50600687|FG001|Overall Study|Protocol Violation|0|||
25285760|NCT01153841|50600686|FG000|Overall Study|Lost to Follow-up|2|||
25285761|NCT01153841|50600687|FG001|Overall Study|Lost to Follow-up|0|||
25285762|NCT01153763|50600693|FG000|Overall Study|Study Closed|16|||
25285763|NCT01153763|50600693|FG000|Overall Study|Lost to Follow-up|1|||
25285764|NCT01153763|50600693|FG000|Overall Study|Physician Decision|2|||
25285765|NCT01153763|50600693|FG000|Overall Study|Withdrawal by Subject|2|||
25285766|NCT00871741|50600699|FG000|Overall Study|Premature study termination|9|||
25285767|NCT00871741|50600700|FG001|Overall Study|Premature study termination|7|||
25285768|NCT01152437|50600709|FG000|Overall Study|Other Adverse Event|8|||
25285769|NCT01152437|50600710|FG001|Overall Study|Other Adverse Event|1|||
25285770|NCT01152437|50600711|FG002|Overall Study|Other Adverse Event|7|||
25285771|NCT01152437|50600709|FG000|Overall Study|Not treated|0|||
25285772|NCT01152437|50600710|FG001|Overall Study|Not treated|1|||
25285773|NCT01152437|50600711|FG002|Overall Study|Not treated|2|||
25285774|NCT01152437|50600709|FG000|Overall Study|Progressive disease|27|||
25285775|NCT01152437|50600710|FG001|Overall Study|Progressive disease|13|||
25285776|NCT01152437|50600711|FG002|Overall Study|Progressive disease|32|||
25285777|NCT01152437|50600709|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
25285778|NCT01152437|50600710|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
25285779|NCT01152437|50600711|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
25285780|NCT01151579|50600723|FG000|Overall Study|Physician Decision|3|||
25285781|NCT01151579|50600724|FG001|Overall Study|Physician Decision|1|||
25285782|NCT01151579|50600723|FG000|Overall Study|Withdrawal by Subject|3|||
25285783|NCT01151579|50600724|FG001|Overall Study|Withdrawal by Subject|2|||
25285784|NCT01151579|50600723|FG000|Overall Study|Not meet inclusion criteria|6|||
25285785|NCT01151579|50600724|FG001|Overall Study|Not meet inclusion criteria|4|||
25285786|NCT01097616|50600733|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
25285787|NCT01097616|50600734|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
25285788|NCT01097616|50600735|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
25285789|NCT01097616|50600736|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
25285790|NCT01097616|50600737|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
25285791|NCT01097616|50600738|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
25285792|NCT01097616|50600739|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
25285793|NCT01097616|50600740|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
25285794|NCT01097616|50600733|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
25285795|NCT01097616|50600734|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
25285796|NCT01097616|50600735|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
25285797|NCT01097616|50600736|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
25285798|NCT01097616|50600737|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
25285799|NCT01097616|50600738|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
25285800|NCT01097616|50600739|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
25285801|NCT01097616|50600740|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
25285802|NCT01097616|50600733|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
25191474|NCT02592876|50351924|FG000|Overall Study|Death|6|||
25191475|NCT02592876|50351925|FG001|Overall Study|Death|9|||
25191476|NCT01492088|50351942|FG000|Overall Study|Withdrawal by Patient|0|||
25191477|NCT01492088|50351943|FG001|Overall Study|Withdrawal by Patient|2|||
25191478|NCT01492088|50351944|FG002|Overall Study|Withdrawal by Patient|0|||
25191479|NCT01492088|50351942|FG000|Overall Study|Death|1|||
25191480|NCT01492088|50351943|FG001|Overall Study|Death|6|||
25191481|NCT01492088|50351944|FG002|Overall Study|Death|2|||
25191482|NCT01492088|50351942|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
25191483|NCT01492088|50351943|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
25191484|NCT01492088|50351944|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
25285803|NCT01097616|50600734|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
25285804|NCT01097616|50600735|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
25285805|NCT01097616|50600736|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
25285806|NCT01097616|50600737|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
25285807|NCT01097616|50600738|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
25285808|NCT01097616|50600739|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
25285809|NCT01097616|50600740|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
25285810|NCT01097616|50600733|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
25285811|NCT01097616|50600734|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
25285812|NCT01097616|50600735|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
25285813|NCT01097616|50600736|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
25285814|NCT01097616|50600737|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
25285815|NCT01097616|50600738|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
25285816|NCT01097616|50600739|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
25285817|NCT01097616|50600740|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
25285818|NCT01097616|50600733|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
25285819|NCT01097616|50600734|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
25285820|NCT01097616|50600735|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
25285821|NCT01097616|50600736|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
25285822|NCT01097616|50600737|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
25285823|NCT01097616|50600738|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
25285824|NCT01097616|50600739|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
25285825|NCT01097616|50600740|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
25285826|NCT01097616|50600733|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
25285827|NCT01097616|50600734|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
25285828|NCT01097616|50600735|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
25285829|NCT01097616|50600736|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
25285830|NCT01097616|50600737|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
25285831|NCT01097616|50600738|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
25285832|NCT01097616|50600739|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
25285833|NCT01097616|50600740|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
25285834|NCT01097616|50600733|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
25285835|NCT01097616|50600734|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
25285836|NCT01097616|50600735|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
25285837|NCT01097616|50600736|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
25285838|NCT01097616|50600737|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
25285839|NCT01097616|50600738|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
25285840|NCT01097616|50600739|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
25285841|NCT01097616|50600740|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
25285842|NCT01097616|50600733|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
25285843|NCT01097616|50600734|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
25285844|NCT01097616|50600735|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
25285845|NCT01097616|50600736|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
25285846|NCT01097616|50600737|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
25285847|NCT01097616|50600738|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
25285848|NCT01097616|50600739|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
25285849|NCT01097616|50600740|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
25285850|NCT01097616|50600733|FG000|Optional DB EXT Phase|Adverse Event|0|||
25285851|NCT01097616|50600734|FG001|Optional DB EXT Phase|Adverse Event|7|||
25285852|NCT01097616|50600735|FG002|Optional DB EXT Phase|Adverse Event|2|||
25285853|NCT01097616|50600736|FG003|Optional DB EXT Phase|Adverse Event|0|||
25285854|NCT01097616|50600737|FG004|Optional DB EXT Phase|Adverse Event|0|||
25285855|NCT01097616|50600738|FG005|Optional DB EXT Phase|Adverse Event|0|||
25285856|NCT01097616|50600739|FG006|Optional DB EXT Phase|Adverse Event|0|||
25285857|NCT01097616|50600740|FG007|Optional DB EXT Phase|Adverse Event|0|||
25285858|NCT01097616|50600733|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
25285859|NCT01097616|50600734|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
25285860|NCT01097616|50600735|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
25285861|NCT01097616|50600736|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
25285862|NCT01097616|50600737|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
25285863|NCT01097616|50600738|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
25285864|NCT01097616|50600739|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
25285865|NCT01097616|50600740|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
25285866|NCT01097616|50600733|FG000|Optional DB EXT Phase|Protocol Violation|0|||
25285867|NCT01097616|50600734|FG001|Optional DB EXT Phase|Protocol Violation|2|||
25285868|NCT01097616|50600735|FG002|Optional DB EXT Phase|Protocol Violation|3|||
25285869|NCT01097616|50600736|FG003|Optional DB EXT Phase|Protocol Violation|0|||
25285870|NCT01097616|50600737|FG004|Optional DB EXT Phase|Protocol Violation|0|||
25285871|NCT01097616|50600738|FG005|Optional DB EXT Phase|Protocol Violation|0|||
25285872|NCT01097616|50600739|FG006|Optional DB EXT Phase|Protocol Violation|0|||
25285873|NCT01097616|50600740|FG007|Optional DB EXT Phase|Protocol Violation|0|||
25285874|NCT01097616|50600733|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
25285875|NCT01097616|50600734|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
25285876|NCT01097616|50600735|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
25285877|NCT01097616|50600736|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
25285878|NCT01097616|50600737|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
25285879|NCT01097616|50600738|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
25285880|NCT01097616|50600739|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
25285881|NCT01097616|50600740|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
25285882|NCT01097616|50600733|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
25285883|NCT01097616|50600734|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
25285884|NCT01097616|50600735|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
25285885|NCT01097616|50600736|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
25285886|NCT01097616|50600737|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
25285887|NCT01097616|50600738|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
25285888|NCT01097616|50600739|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
25285889|NCT01097616|50600740|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
25285890|NCT01097616|50600733|FG000|Optional DB EXT Phase|Physician Decision|1|||
25285891|NCT01097616|50600734|FG001|Optional DB EXT Phase|Physician Decision|0|||
25285892|NCT01097616|50600735|FG002|Optional DB EXT Phase|Physician Decision|0|||
25285893|NCT01097616|50600736|FG003|Optional DB EXT Phase|Physician Decision|0|||
25285894|NCT01097616|50600737|FG004|Optional DB EXT Phase|Physician Decision|0|||
25285895|NCT01097616|50600738|FG005|Optional DB EXT Phase|Physician Decision|0|||
25285896|NCT01097616|50600739|FG006|Optional DB EXT Phase|Physician Decision|0|||
25285897|NCT01097616|50600740|FG007|Optional DB EXT Phase|Physician Decision|0|||
25285898|NCT01097616|50600733|FG000|DB RO Phase|Adverse Event|0|||
25285899|NCT01097616|50600734|FG001|DB RO Phase|Adverse Event|0|||
25285900|NCT01097616|50600735|FG002|DB RO Phase|Adverse Event|0|||
25285901|NCT01097616|50600736|FG003|DB RO Phase|Adverse Event|0|||
25285902|NCT01097616|50600737|FG004|DB RO Phase|Adverse Event|0|||
25285903|NCT01097616|50600738|FG005|DB RO Phase|Adverse Event|0|||
25285904|NCT01097616|50600739|FG006|DB RO Phase|Adverse Event|1|||
25285905|NCT01097616|50600740|FG007|DB RO Phase|Adverse Event|0|||
25285906|NCT01097616|50600733|FG000|DB RO Phase|Withdrawal by Subject|0|||
25285907|NCT01097616|50600734|FG001|DB RO Phase|Withdrawal by Subject|0|||
25285908|NCT01097616|50600735|FG002|DB RO Phase|Withdrawal by Subject|0|||
25285909|NCT01097616|50600736|FG003|DB RO Phase|Withdrawal by Subject|0|||
25285910|NCT01097616|50600737|FG004|DB RO Phase|Withdrawal by Subject|0|||
25285911|NCT01097616|50600738|FG005|DB RO Phase|Withdrawal by Subject|1|||
25285912|NCT01097616|50600739|FG006|DB RO Phase|Withdrawal by Subject|0|||
25285913|NCT01097616|50600740|FG007|DB RO Phase|Withdrawal by Subject|0|||
25285914|NCT01097616|50600733|FG000|DB RO Phase|Lost to Follow-up|0|||
25285915|NCT01097616|50600734|FG001|DB RO Phase|Lost to Follow-up|0|||
25285916|NCT01097616|50600735|FG002|DB RO Phase|Lost to Follow-up|0|||
25285917|NCT01097616|50600736|FG003|DB RO Phase|Lost to Follow-up|1|||
25285918|NCT01097616|50600737|FG004|DB RO Phase|Lost to Follow-up|1|||
25285919|NCT01097616|50600738|FG005|DB RO Phase|Lost to Follow-up|0|||
25285920|NCT01097616|50600739|FG006|DB RO Phase|Lost to Follow-up|0|||
25285921|NCT01097616|50600740|FG007|DB RO Phase|Lost to Follow-up|1|||
25285922|NCT01097616|50600733|FG000|DB RO Phase|Not Treated in RO|0|||
25285923|NCT01097616|50600734|FG001|DB RO Phase|Not Treated in RO|0|||
25285924|NCT01097616|50600735|FG002|DB RO Phase|Not Treated in RO|0|||
25285925|NCT01097616|50600736|FG003|DB RO Phase|Not Treated in RO|0|||
25285926|NCT01097616|50600737|FG004|DB RO Phase|Not Treated in RO|0|||
25285927|NCT01097616|50600738|FG005|DB RO Phase|Not Treated in RO|1|||
25285928|NCT01097616|50600739|FG006|DB RO Phase|Not Treated in RO|0|||
25285929|NCT01097616|50600740|FG007|DB RO Phase|Not Treated in RO|0|||
25285930|NCT00871429|50600766|FG000|Overall Study|Lost to Follow-up|6|||
25285931|NCT00871429|50600766|FG000|Overall Study|Withdrawal by Subject|17|||
25285932|NCT00871429|50600766|FG000|Overall Study|Questionnaire not completed|1|||
25285933|NCT01151345|50600774|FG000|First Intervention Period|Protocol Violation|0|||
25285934|NCT01151345|50600775|FG001|First Intervention Period|Protocol Violation|1|||
25285935|NCT00593827|50600783|FG000|Overall Study|On Active Treatment/Pending|0|||
25285936|NCT00593827|50600784|FG001|Overall Study|On Active Treatment/Pending|2|||
25285937|NCT01150097|50600793|FG000|Months 24 to 36 Post-transplantation|Death|2|||
25285938|NCT01150097|50600794|FG001|Months 24 to 36 Post-transplantation|Death|0|||
25285939|NCT01150097|50600795|FG002|Months 24 to 36 Post-transplantation|Death|0|||
25285940|NCT01150097|50600793|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
25285941|NCT01150097|50600794|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
25285942|NCT01150097|50600795|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
25285943|NCT01150097|50600793|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
25285944|NCT01150097|50600794|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
25285945|NCT01150097|50600795|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
24969638|NCT00133952|50059092|FG000|Overall Study|Withdrawal by Subject|20|||
25285946|NCT01150097|50600793|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
25285947|NCT01150097|50600794|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
25285948|NCT01150097|50600795|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
25285949|NCT01150097|50600793|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
25285950|NCT01150097|50600794|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
25285951|NCT01150097|50600795|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
25285952|NCT01150097|50600793|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
25285953|NCT01150097|50600794|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
25285954|NCT01150097|50600795|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
25285955|NCT01150097|50600793|FG000|Months 24 to 48 Post-transplantation|Death|2|||
25285956|NCT01150097|50600794|FG001|Months 24 to 48 Post-transplantation|Death|0|||
25285957|NCT01150097|50600795|FG002|Months 24 to 48 Post-transplantation|Death|0|||
25285958|NCT01149863|50600805|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
25285959|NCT01149473|50600811|FG000|First Intervention|Adverse Event|1|||
25285960|NCT01149473|50600812|FG001|First Intervention|Adverse Event|1|||
25285961|NCT01149473|50600811|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
25285962|NCT01149473|50600812|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
25285963|NCT00872989|50600820|FG000|Overall Study|Adverse Event|7|||
25285964|NCT00872989|50600821|FG001|Overall Study|Adverse Event|15|||
25285965|NCT00872989|50600820|FG000|Overall Study|Withdrawal by Subject|8|||
25285966|NCT00872989|50600821|FG001|Overall Study|Withdrawal by Subject|5|||
25285967|NCT00872989|50600820|FG000|Overall Study|Progression/relapse|47|||
25285968|NCT00872989|50600821|FG001|Overall Study|Progression/relapse|35|||
25285969|NCT00872989|50600820|FG000|Overall Study|Not protocol specified|3|||
25285970|NCT00872989|50600821|FG001|Overall Study|Not protocol specified|8|||
25285971|NCT01148771|50600835|FG000|Washout Period|Withdrawal by Subject|0|||
25285972|NCT01148771|50600836|FG001|Washout Period|Withdrawal by Subject|1|||
25285973|NCT01148693|50600848|FG000|Overall Study|Attempts for cannulation were failed|13|||
25285974|NCT01148693|50600849|FG001|Overall Study|Attempts for cannulation were failed|10|||
25285975|NCT00872599|50600855|FG000|Second Washout Period|Adverse Event|1|||
25285976|NCT00872599|50600856|FG001|Second Washout Period|Adverse Event|1|||
25285977|NCT01148537|50600865|FG000|Overall Study|Withdrawal by Subject|1|||
25285978|NCT01148537|50600866|FG001|Overall Study|Withdrawal by Subject|0|||
25285979|NCT01148537|50600867|FG002|Overall Study|Withdrawal by Subject|2|||
25285980|NCT01148537|50600865|FG000|Overall Study|Adverse Event|2|||
25285981|NCT01148537|50600866|FG001|Overall Study|Adverse Event|0|||
25285982|NCT01148537|50600867|FG002|Overall Study|Adverse Event|1|||
25285983|NCT01148459|50600878|FG000|Overall Study|Serious Adverse Event|5|||
25285984|NCT01148459|50600879|FG001|Overall Study|Serious Adverse Event|4|||
25285985|NCT01148459|50600878|FG000|Overall Study|Withdrawal by Subject|1|||
25285986|NCT01148459|50600879|FG001|Overall Study|Withdrawal by Subject|0|||
25285987|NCT01148459|50600878|FG000|Overall Study|Migrated/moved from study area|3|||
25285988|NCT01148459|50600879|FG001|Overall Study|Migrated/moved from study area|6|||
25285989|NCT01148459|50600878|FG000|Overall Study|Lost to Follow-up|2|||
25285990|NCT01148459|50600879|FG001|Overall Study|Lost to Follow-up|0|||
25285991|NCT01148459|50600878|FG000|Overall Study|Refusal|1|||
25285992|NCT01148459|50600879|FG001|Overall Study|Refusal|0|||
25285993|NCT01148459|50600878|FG000|Overall Study|Failure to comply with study procedures|0|||
25285994|NCT01148459|50600879|FG001|Overall Study|Failure to comply with study procedures|1|||
25285995|NCT00872521|50600888|FG000|Completed PAD Induction|Patient choice|0|||
25285996|NCT00872521|50600889|FG001|Completed PAD Induction|Patient choice|1|||
25285997|NCT00872521|50600890|FG002|Completed PAD Induction|Patient choice|0|||
25285998|NCT00872521|50600888|FG000|Completed PAD Induction|Disease progression|0|||
25285999|NCT00872521|50600889|FG001|Completed PAD Induction|Disease progression|2|||
25286000|NCT00872521|50600890|FG002|Completed PAD Induction|Disease progression|0|||
25286001|NCT00872521|50600888|FG000|Completed PAD Induction|Adverse Event|4|||
25286002|NCT00872521|50600889|FG001|Completed PAD Induction|Adverse Event|0|||
25286003|NCT00872521|50600890|FG002|Completed PAD Induction|Adverse Event|0|||
25286004|NCT00872521|50600888|FG000|Completed PAD Induction|Death|1|||
25286005|NCT00872521|50600889|FG001|Completed PAD Induction|Death|1|||
25286006|NCT00872521|50600890|FG002|Completed PAD Induction|Death|0|||
25286007|NCT00872521|50600888|FG000|Primary Endpoint Analysis|Other|1|||
25286008|NCT00872521|50600889|FG001|Primary Endpoint Analysis|Other|2|||
25286009|NCT00872521|50600890|FG002|Primary Endpoint Analysis|Other|0|||
25286010|NCT00872521|50600888|FG000|Primary Endpoint Analysis|Patient choice|0|||
25286011|NCT00872521|50600889|FG001|Primary Endpoint Analysis|Patient choice|1|||
25286012|NCT00872521|50600890|FG002|Primary Endpoint Analysis|Patient choice|0|||
25286013|NCT00872521|50600888|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
25286014|NCT00872521|50600889|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
25286015|NCT00872521|50600890|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
25286016|NCT00872521|50600888|FG000|Primary Endpoint Analysis|Patient response missing|0|||
25286017|NCT00872521|50600889|FG001|Primary Endpoint Analysis|Patient response missing|0|||
25286018|NCT00872521|50600890|FG002|Primary Endpoint Analysis|Patient response missing|1|||
25286019|NCT00872521|50600888|FG000|Completed 3-month Follow up|Other|0|||
25286020|NCT00872521|50600889|FG001|Completed 3-month Follow up|Other|2|||
25286021|NCT00872521|50600890|FG002|Completed 3-month Follow up|Other|0|||
25286022|NCT00872521|50600888|FG000|Completed 3-month Follow up|Physician Decision|0|||
25286023|NCT00872521|50600889|FG001|Completed 3-month Follow up|Physician Decision|1|||
25286024|NCT00872521|50600890|FG002|Completed 3-month Follow up|Physician Decision|0|||
25286025|NCT00872521|50600888|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
25286026|NCT00872521|50600889|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
25286027|NCT00872521|50600890|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
25286028|NCT01148225|50600909|FG000|Overall Study|Other|185|||
25286029|NCT01190891|50600918|FG000|Overall Study|Protocol Violation|1|||
25286030|NCT01190891|50600919|FG001|Overall Study|Protocol Violation|0|||
25286031|NCT01190891|50600918|FG000|Overall Study|Withdrawal by Subject|5|||
25286032|NCT01190891|50600919|FG001|Overall Study|Withdrawal by Subject|0|||
25286033|NCT00871975|50600925|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
25286034|NCT00871975|50600925|FG000|Overall Study|Catheters could not be inserted|1|||
25286035|NCT00871975|50600925|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
25286036|NCT00871975|50600925|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
25286037|NCT01190813|50600931|FG000|Overall Study|Lost to Follow-up|1|||
25286038|NCT01190813|50600932|FG001|Overall Study|Lost to Follow-up|2|||
25286039|NCT01190813|50600931|FG000|Overall Study|Withdrawal by Subject|2|||
25286040|NCT01190813|50600932|FG001|Overall Study|Withdrawal by Subject|1|||
25286041|NCT01190813|50600931|FG000|Overall Study|Refused study treatment after randomized|1|||
25286042|NCT01190813|50600932|FG001|Overall Study|Refused study treatment after randomized|0|||
25286043|NCT01190813|50600931|FG000|Overall Study|Adverse Event|0|||
25286044|NCT01190813|50600932|FG001|Overall Study|Adverse Event|1|||
25286045|NCT00870727|50600954|FG000|Overall Study|Lost to Follow-up|0|||
25286046|NCT00870727|50600955|FG001|Overall Study|Lost to Follow-up|1|||
25286047|NCT00870727|50600954|FG000|Overall Study|Lack of Efficacy|1|||
25286048|NCT00870727|50600955|FG001|Overall Study|Lack of Efficacy|3|||
25286049|NCT00870727|50600954|FG000|Overall Study|Adverse Event|0|||
25286050|NCT00870727|50600955|FG001|Overall Study|Adverse Event|1|||
25286051|NCT01147055|50600961|FG000|First Intervention Period|Lost to Follow-up|1|||
25286052|NCT01147055|50600962|FG001|First Intervention Period|Lost to Follow-up|0|||
25286053|NCT01146665|50600970|FG000|Overall Study|Withdrawal by Subject|10|||
25286054|NCT01146665|50600971|FG001|Overall Study|Withdrawal by Subject|16|||
25286055|NCT01145885|50600986|FG000|Overall Study|Progressive Disease|7|||
25286056|NCT01190267|50600998|FG000|Overall Study|Adverse Event|10|||
25286057|NCT01190267|50600999|FG001|Overall Study|Adverse Event|0|||
25286058|NCT01190267|50600998|FG000|Overall Study|Treatment Failure|8|||
24969639|NCT00133952|50059093|FG001|Overall Study|Withdrawal by Subject|4|||
25286059|NCT01190267|50600999|FG001|Overall Study|Treatment Failure|2|||
25286060|NCT01190267|50600998|FG000|Overall Study|Lost to Follow-up|2|||
25286061|NCT01190267|50600999|FG001|Overall Study|Lost to Follow-up|0|||
25286062|NCT01190267|50600998|FG000|Overall Study|Withdrawal by Subject|13|||
25286063|NCT01190267|50600999|FG001|Overall Study|Withdrawal by Subject|1|||
25286064|NCT01190267|50600998|FG000|Overall Study|Protocol Violation|8|||
25286065|NCT01190267|50600999|FG001|Overall Study|Protocol Violation|1|||
25286066|NCT00869089|50601005|FG000|Overall Study|Lost to Follow-up|1|||
25286067|NCT00869089|50601005|FG000|Overall Study|Withdrawal by Subject|1|||
25286068|NCT00869089|50601005|FG000|Overall Study|Screen Fail|1|||
25286069|NCT01190189|50601009|FG000|Overall Study|Lost to Follow-up|4|||
25286070|NCT01190189|50601009|FG000|Overall Study|Withdrawal by Subject|1|||
25286071|NCT01190189|50601009|FG000|Overall Study|Migrated/moved from study area|1|||
25286072|NCT00871117|50601015|FG000|Overall Study|Lost to Follow-up|5|||
25286073|NCT00871117|50601016|FG001|Overall Study|Lost to Follow-up|6|||
25286074|NCT00871117|50601015|FG000|Overall Study|Other|0|||
25286075|NCT00871117|50601016|FG001|Overall Study|Other|4|||
25286076|NCT00870103|50601023|FG000|Overall Study|Physician Decision|2|||
25286077|NCT00870103|50601023|FG000|Overall Study|Lost to Follow-up|2|||
25286078|NCT01145417|50601042|FG000|Overall Study|Death|1|||
25286079|NCT01145417|50601043|FG001|Overall Study|Death|0|||
25286080|NCT01145417|50601042|FG000|Overall Study|Lost to Follow-up|2|||
25286081|NCT01145417|50601043|FG001|Overall Study|Lost to Follow-up|1|||
25286082|NCT01145417|50601042|FG000|Overall Study|Withdrawal by Subject|1|||
25286083|NCT01145417|50601043|FG001|Overall Study|Withdrawal by Subject|2|||
25286084|NCT01145417|50601042|FG000|Overall Study|Pregnancy|1|||
25286085|NCT01145417|50601043|FG001|Overall Study|Pregnancy|0|||
25286086|NCT01145417|50601042|FG000|Overall Study|Adverse Event|0|||
25286087|NCT01145417|50601043|FG001|Overall Study|Adverse Event|1|||
25286088|NCT01145417|50601042|FG000|Overall Study|Study terminated by sponsor|35|||
25286089|NCT01145417|50601043|FG001|Overall Study|Study terminated by sponsor|43|||
25286090|NCT01145417|50601042|FG000|Overall Study|Other|1|||
25286091|NCT01145417|50601043|FG001|Overall Study|Other|0|||
25286092|NCT01144715|50601051|FG000|Overall Study|Lost to Follow-up|2|||
25286093|NCT01144715|50601052|FG001|Overall Study|Lost to Follow-up|1|||
25286094|NCT01144715|50601051|FG000|Overall Study|Withdrawal by Subject|2|||
25286095|NCT01144715|50601052|FG001|Overall Study|Withdrawal by Subject|1|||
25286096|NCT01144715|50601051|FG000|Overall Study|Adverse Event|0|||
25286097|NCT01144715|50601052|FG001|Overall Study|Adverse Event|1|||
25286098|NCT01189487|50601058|FG000|Overall Study|Lack of Efficacy|2|||
25286099|NCT01189487|50601058|FG000|Overall Study|Adverse Event|1|||
25286100|NCT01106352|50601067|FG000|Overall Study|Subjects untreated|0|||
25286101|NCT01106352|50601068|FG001|Overall Study|Subjects untreated|0|||
25286102|NCT01106352|50601069|FG002|Overall Study|Subjects untreated|0|||
25286103|NCT01106352|50601070|FG003|Overall Study|Subjects untreated|3|||
25286104|NCT01106352|50601071|FG004|Overall Study|Subjects untreated|4|||
25286105|NCT01106352|50601067|FG000|Overall Study|Sponsor Decision|1|||
25286106|NCT01106352|50601068|FG001|Overall Study|Sponsor Decision|0|||
25286107|NCT01106352|50601069|FG002|Overall Study|Sponsor Decision|0|||
25286108|NCT01106352|50601070|FG003|Overall Study|Sponsor Decision|0|||
25286109|NCT01106352|50601071|FG004|Overall Study|Sponsor Decision|0|||
25286110|NCT01106352|50601067|FG000|Overall Study|Too ill to come in for the visit|0|||
25286111|NCT01106352|50601068|FG001|Overall Study|Too ill to come in for the visit|0|||
25286112|NCT01106352|50601069|FG002|Overall Study|Too ill to come in for the visit|1|||
25286113|NCT01106352|50601070|FG003|Overall Study|Too ill to come in for the visit|0|||
25286114|NCT01106352|50601071|FG004|Overall Study|Too ill to come in for the visit|0|||
25286115|NCT01106352|50601067|FG000|Overall Study|Lost to Follow-up|0|||
25286116|NCT01106352|50601068|FG001|Overall Study|Lost to Follow-up|0|||
25286117|NCT01106352|50601069|FG002|Overall Study|Lost to Follow-up|0|||
25286118|NCT01106352|50601070|FG003|Overall Study|Lost to Follow-up|0|||
25286119|NCT01106352|50601071|FG004|Overall Study|Lost to Follow-up|1|||
25286120|NCT01106352|50601067|FG000|Overall Study|Death|0|||
25286121|NCT01106352|50601068|FG001|Overall Study|Death|0|||
25286122|NCT01106352|50601069|FG002|Overall Study|Death|1|||
25286123|NCT01106352|50601070|FG003|Overall Study|Death|3|||
25286124|NCT01106352|50601071|FG004|Overall Study|Death|1|||
25286125|NCT01106352|50601067|FG000|Overall Study|Disease progression|0|||
25286126|NCT01106352|50601068|FG001|Overall Study|Disease progression|0|||
25286127|NCT01106352|50601069|FG002|Overall Study|Disease progression|0|||
25286128|NCT01106352|50601070|FG003|Overall Study|Disease progression|1|||
25286129|NCT01106352|50601071|FG004|Overall Study|Disease progression|0|||
25286130|NCT01106352|50601067|FG000|Overall Study|Withdrawal by Subject|0|||
25286131|NCT01106352|50601068|FG001|Overall Study|Withdrawal by Subject|0|||
25286132|NCT01106352|50601069|FG002|Overall Study|Withdrawal by Subject|0|||
25286133|NCT01106352|50601070|FG003|Overall Study|Withdrawal by Subject|3|||
25286134|NCT01106352|50601071|FG004|Overall Study|Withdrawal by Subject|2|||
25169216|NCT02367456|50300582|FG001|Overall Study|Lost to Follow-up|3|||
24969640|NCT00133952|50059092|FG000|Overall Study|Physician Decision|4|||
25286135|NCT01106352|50601067|FG000|Overall Study|Went on hospice|0|||
25286136|NCT01106352|50601068|FG001|Overall Study|Went on hospice|0|||
25286137|NCT01106352|50601069|FG002|Overall Study|Went on hospice|0|||
25286138|NCT01106352|50601070|FG003|Overall Study|Went on hospice|1|||
25286139|NCT01106352|50601071|FG004|Overall Study|Went on hospice|0|||
25286140|NCT01106352|50601067|FG000|Overall Study|Subject entered hospice|0|||
25286141|NCT01106352|50601068|FG001|Overall Study|Subject entered hospice|0|||
25286142|NCT01106352|50601069|FG002|Overall Study|Subject entered hospice|0|||
25286143|NCT01106352|50601070|FG003|Overall Study|Subject entered hospice|1|||
25286144|NCT01106352|50601071|FG004|Overall Study|Subject entered hospice|0|||
25286145|NCT01106352|50601067|FG000|Overall Study|Home hospice since July 2013|0|||
25286146|NCT01106352|50601068|FG001|Overall Study|Home hospice since July 2013|0|||
25286147|NCT01106352|50601069|FG002|Overall Study|Home hospice since July 2013|0|||
25286148|NCT01106352|50601070|FG003|Overall Study|Home hospice since July 2013|1|||
25286149|NCT01106352|50601071|FG004|Overall Study|Home hospice since July 2013|0|||
25286150|NCT01144403|50601087|FG000|Overall Study|Lost to Follow-up|3|||
25286151|NCT01144403|50601087|FG000|Overall Study|Death|1|||
25286152|NCT01144403|50601087|FG000|Overall Study|Adverse Event|1|||
25286153|NCT01143389|50601094|FG000|Overall Study|Lost to Follow-up|26|||
25286154|NCT01143389|50601095|FG001|Overall Study|Lost to Follow-up|25|||
25286155|NCT00868231|50601101|FG000|Treatment Period 1|Adverse Event|0|||
25286156|NCT00868231|50601102|FG001|Treatment Period 1|Adverse Event|0|||
25286157|NCT00868231|50601103|FG002|Treatment Period 1|Adverse Event|0|||
25286158|NCT00868231|50601104|FG003|Treatment Period 1|Adverse Event|0|||
25286159|NCT00868231|50601105|FG004|Treatment Period 1|Adverse Event|1|||
25286160|NCT00868231|50601106|FG005|Treatment Period 1|Adverse Event|0|||
25286161|NCT00868231|50601101|FG000|Treatment Period 2|Adverse Event|1|||
25286162|NCT00868231|50601102|FG001|Treatment Period 2|Adverse Event|0|||
25286163|NCT00868231|50601103|FG002|Treatment Period 2|Adverse Event|0|||
25286164|NCT00868231|50601104|FG003|Treatment Period 2|Adverse Event|0|||
25286165|NCT00868231|50601105|FG004|Treatment Period 2|Adverse Event|0|||
25286166|NCT00868231|50601106|FG005|Treatment Period 2|Adverse Event|0|||
25286167|NCT00868231|50601101|FG000|Treatment Period 3|Adverse Event|0|||
25286168|NCT00868231|50601102|FG001|Treatment Period 3|Adverse Event|0|||
25286169|NCT00868231|50601103|FG002|Treatment Period 3|Adverse Event|1|||
25286170|NCT00868231|50601104|FG003|Treatment Period 3|Adverse Event|0|||
25286171|NCT00868231|50601105|FG004|Treatment Period 3|Adverse Event|0|||
25286172|NCT00868231|50601106|FG005|Treatment Period 3|Adverse Event|0|||
25286173|NCT01101438|50601116|FG000|Overall Study|Withdrawal by Subject|8|||
25286174|NCT01101438|50601117|FG001|Overall Study|Withdrawal by Subject|9|||
25286175|NCT01143077|50601130|FG000|Overall Study|Lack of Efficacy|0|||
25286176|NCT01143077|50601131|FG001|Overall Study|Lack of Efficacy|2|||
25286177|NCT01143077|50601132|FG002|Overall Study|Lack of Efficacy|1|||
25286178|NCT01143077|50601130|FG000|Overall Study|Adverse Event|5|||
25286179|NCT01143077|50601131|FG001|Overall Study|Adverse Event|6|||
25286180|NCT01143077|50601132|FG002|Overall Study|Adverse Event|5|||
25286181|NCT01143077|50601130|FG000|Overall Study|Lost to Follow-up|2|||
25286182|NCT01143077|50601131|FG001|Overall Study|Lost to Follow-up|3|||
25286183|NCT01143077|50601132|FG002|Overall Study|Lost to Follow-up|4|||
25286184|NCT01143077|50601130|FG000|Overall Study|Protocol Violation|2|||
25286185|NCT01143077|50601131|FG001|Overall Study|Protocol Violation|0|||
25286186|NCT01143077|50601132|FG002|Overall Study|Protocol Violation|0|||
25286187|NCT01143077|50601130|FG000|Overall Study|Withdrawal by Subject|4|||
25286188|NCT01143077|50601131|FG001|Overall Study|Withdrawal by Subject|3|||
25286189|NCT01143077|50601132|FG002|Overall Study|Withdrawal by Subject|3|||
25286190|NCT01143077|50601130|FG000|Overall Study|Non-compliance with study drug|0|||
25286191|NCT01143077|50601131|FG001|Overall Study|Non-compliance with study drug|1|||
25286192|NCT01143077|50601132|FG002|Overall Study|Non-compliance with study drug|1|||
25286193|NCT01143077|50601130|FG000|Overall Study|Administrative|1|||
25286194|NCT01143077|50601131|FG001|Overall Study|Administrative|0|||
25286195|NCT01143077|50601132|FG002|Overall Study|Administrative|0|||
25286196|NCT01143077|50601130|FG000|Overall Study|Principal Investigator Decision|2|||
25286197|NCT01143077|50601131|FG001|Overall Study|Principal Investigator Decision|0|||
25286198|NCT01143077|50601132|FG002|Overall Study|Principal Investigator Decision|1|||
25286199|NCT01096446|50601142|FG000|Overall Study|Death|1|||
25286200|NCT01096446|50601143|FG001|Overall Study|Death|0|||
25286201|NCT01096446|50601142|FG000|Overall Study|Protocol Violation|2|||
25286202|NCT01096446|50601143|FG001|Overall Study|Protocol Violation|0|||
25286203|NCT00864721|50601148|FG000|Overall Study|Patient request|11|||
25286204|NCT00864721|50601148|FG000|Overall Study|Hospitalized|1|||
25286205|NCT00864721|50601148|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
25286206|NCT00864721|50601148|FG000|Overall Study|Adverse Event|21|||
25286207|NCT01095666|50601155|FG000|Overall Study|Lack of Efficacy|0|||
25286208|NCT01095666|50601156|FG001|Overall Study|Lack of Efficacy|0|||
25286209|NCT01095666|50601157|FG002|Overall Study|Lack of Efficacy|1|||
25286210|NCT01095666|50601155|FG000|Overall Study|Adverse Event|2|||
25286211|NCT01095666|50601156|FG001|Overall Study|Adverse Event|1|||
25286212|NCT01095666|50601157|FG002|Overall Study|Adverse Event|3|||
25286213|NCT01095666|50601155|FG000|Overall Study|Lost to Follow-up|2|||
25286214|NCT01095666|50601156|FG001|Overall Study|Lost to Follow-up|2|||
25286215|NCT01095666|50601157|FG002|Overall Study|Lost to Follow-up|0|||
25286216|NCT01095666|50601155|FG000|Overall Study|Withdrawal by Subject|6|||
25286217|NCT01095666|50601156|FG001|Overall Study|Withdrawal by Subject|6|||
25286218|NCT01095666|50601157|FG002|Overall Study|Withdrawal by Subject|1|||
25286219|NCT01095666|50601155|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
25286220|NCT01095666|50601156|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
25286221|NCT01095666|50601157|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
25286222|NCT01100658|50601165|FG000|Overall Study|Withdrawal by Subject|1|||
25286223|NCT01100502|50601171|FG000|Overall Study|Withdrawal by Subject|18|||
25286224|NCT01100502|50601172|FG001|Overall Study|Withdrawal by Subject|25|||
25286225|NCT01100502|50601171|FG000|Overall Study|Lost to Follow-up|13|||
25286226|NCT01100502|50601172|FG001|Overall Study|Lost to Follow-up|28|||
25286227|NCT01100502|50601171|FG000|Overall Study|Site request to end participation in study|0|||
25286228|NCT01100502|50601172|FG001|Overall Study|Site request to end participation in study|1|||
25286229|NCT01100502|50601171|FG000|Overall Study|Death|45|||
25286230|NCT01100502|50601172|FG001|Overall Study|Death|40|||
25286231|NCT01094886|50601178|FG000|Overall Study|Adverse Event|2|||
25286232|NCT01094886|50601178|FG000|Overall Study|Withdrawal by Subject|5|||
25286233|NCT01094808|50601185|FG000|Overall Study|Withdrawal by Subject|1|||
25286234|NCT01094808|50601186|FG001|Overall Study|Withdrawal by Subject|1|||
25286235|NCT01094808|50601187|FG002|Overall Study|Withdrawal by Subject|0|||
25286236|NCT00864253|50601197|FG000|Overall Study|Adverse Event|56|||
25286237|NCT00864253|50601198|FG001|Overall Study|Adverse Event|11|||
25286238|NCT00864253|50601197|FG000|Overall Study|Unrelated Adverse Event|3|||
25286239|NCT00864253|50601198|FG001|Overall Study|Unrelated Adverse Event|1|||
25286240|NCT00864253|50601197|FG000|Overall Study|Physician Decision|11|||
25286241|NCT00864253|50601198|FG001|Overall Study|Physician Decision|15|||
25286242|NCT00864253|50601197|FG000|Overall Study|Protocol Violation|0|||
25286243|NCT00864253|50601198|FG001|Overall Study|Protocol Violation|2|||
25286244|NCT00864253|50601197|FG000|Overall Study|Lost to Follow-up|1|||
25286245|NCT00864253|50601198|FG001|Overall Study|Lost to Follow-up|1|||
25286246|NCT00864253|50601197|FG000|Overall Study|Withdrawal by Subject|18|||
25286247|NCT00864253|50601198|FG001|Overall Study|Withdrawal by Subject|18|||
25286248|NCT00864253|50601197|FG000|Overall Study|Death|1|||
25286249|NCT00864253|50601198|FG001|Overall Study|Death|0|||
25286250|NCT00864253|50601197|FG000|Overall Study|Ongoing|2|||
25286251|NCT00864253|50601198|FG001|Overall Study|Ongoing|3|||
25286252|NCT00864253|50601197|FG000|Overall Study|Untreated|7|||
25286253|NCT00864253|50601198|FG001|Overall Study|Untreated|7|||
25286254|NCT01094730|50601206|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
25286255|NCT01094730|50601207|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
25286256|NCT01094730|50601206|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
25286257|NCT01094730|50601207|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
25286258|NCT01094730|50601206|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
25286259|NCT01094730|50601207|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
25286260|NCT01094730|50601206|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
25286261|NCT01094730|50601207|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
25286262|NCT01094730|50601206|FG000|Period 2 (14 Days)|Protocol Violation|2|||
25286263|NCT01094730|50601207|FG001|Period 2 (14 Days)|Protocol Violation|0|||
25286264|NCT01094730|50601206|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
24969641|NCT00133952|50059093|FG001|Overall Study|Physician Decision|3|||
24969642|NCT00133952|50059092|FG000|Overall Study|Sponsor Decision|0|||
24969643|NCT00133952|50059093|FG001|Overall Study|Sponsor Decision|1|||
24969644|NCT00118092|50059099|FG000|Overall Study|Withdrawal by Subject|1|||
24969645|NCT00118092|50059099|FG000|Overall Study|Protocol Violation|1|||
24969646|NCT04555096|50059106|FG000|Overall Study|Death|4|||
24969647|NCT04555096|50059107|FG001|Overall Study|Death|4|||
25286265|NCT01094730|50601207|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
25286266|NCT01094730|50601206|FG000|Period 2 (14 Days)|Adverse Event|0|||
25286267|NCT01094730|50601207|FG001|Period 2 (14 Days)|Adverse Event|1|||
25286268|NCT01094730|50601206|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
25286269|NCT01094730|50601207|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
25286270|NCT00864097|50601222|FG000|Overall Study|Death|0|||
25286271|NCT00864097|50601223|FG001|Overall Study|Death|1|||
25286272|NCT00864097|50601224|FG002|Overall Study|Death|0|||
25286273|NCT00864097|50601225|FG003|Overall Study|Death|0|||
24969648|NCT04555096|50059106|FG000|Overall Study|Withdrawal by Subject|1|||
24969649|NCT04555096|50059107|FG001|Overall Study|Withdrawal by Subject|0|||
25286274|NCT00864097|50601222|FG000|Overall Study|Adverse Event|6|||
25286275|NCT00864097|50601223|FG001|Overall Study|Adverse Event|8|||
25286276|NCT00864097|50601224|FG002|Overall Study|Adverse Event|11|||
25286277|NCT00864097|50601225|FG003|Overall Study|Adverse Event|9|||
25286278|NCT00864097|50601222|FG000|Overall Study|Lack of Efficacy|9|||
25286279|NCT00864097|50601223|FG001|Overall Study|Lack of Efficacy|3|||
25286280|NCT00864097|50601224|FG002|Overall Study|Lack of Efficacy|7|||
25286281|NCT00864097|50601225|FG003|Overall Study|Lack of Efficacy|2|||
25286282|NCT00864097|50601222|FG000|Overall Study|Lost to Follow-up|0|||
25286283|NCT00864097|50601223|FG001|Overall Study|Lost to Follow-up|1|||
25286284|NCT00864097|50601224|FG002|Overall Study|Lost to Follow-up|0|||
25286285|NCT00864097|50601225|FG003|Overall Study|Lost to Follow-up|1|||
25286286|NCT00864097|50601222|FG000|Overall Study|Withdrawal by Subject|15|||
25286287|NCT00864097|50601223|FG001|Overall Study|Withdrawal by Subject|11|||
25286288|NCT00864097|50601224|FG002|Overall Study|Withdrawal by Subject|11|||
25286289|NCT00864097|50601225|FG003|Overall Study|Withdrawal by Subject|12|||
25286290|NCT00864097|50601222|FG000|Overall Study|Protocol Violation|2|||
25286291|NCT00864097|50601223|FG001|Overall Study|Protocol Violation|1|||
25286292|NCT00864097|50601224|FG002|Overall Study|Protocol Violation|0|||
25286293|NCT00864097|50601225|FG003|Overall Study|Protocol Violation|1|||
25286294|NCT00864097|50601222|FG000|Overall Study|Terminated by sponsor|105|||
25286295|NCT00864097|50601223|FG001|Overall Study|Terminated by sponsor|112|||
25286296|NCT00864097|50601224|FG002|Overall Study|Terminated by sponsor|102|||
25286297|NCT00864097|50601225|FG003|Overall Study|Terminated by sponsor|99|||
25286298|NCT00864097|50601222|FG000|Overall Study|Randomized but not treated|2|||
25286299|NCT00864097|50601223|FG001|Overall Study|Randomized but not treated|0|||
25286300|NCT00864097|50601224|FG002|Overall Study|Randomized but not treated|1|||
25286301|NCT00864097|50601225|FG003|Overall Study|Randomized but not treated|0|||
25286302|NCT00864097|50601222|FG000|Overall Study|Other|0|||
25286303|NCT00864097|50601223|FG001|Overall Study|Other|0|||
25286304|NCT00864097|50601224|FG002|Overall Study|Other|0|||
25286305|NCT00864097|50601225|FG003|Overall Study|Other|1|||
25286306|NCT01183013|50601242|FG000|Overall Study|Adverse Event|6|||
25286307|NCT01183013|50601243|FG001|Overall Study|Adverse Event|8|||
25286308|NCT01183013|50601244|FG002|Overall Study|Adverse Event|5|||
25286309|NCT01183013|50601245|FG003|Overall Study|Adverse Event|5|||
25286310|NCT01183013|50601246|FG004|Overall Study|Adverse Event|10|||
25286311|NCT01183013|50601247|FG005|Overall Study|Adverse Event|10|||
25286312|NCT01183013|50601248|FG006|Overall Study|Adverse Event|6|||
25286313|NCT01183013|50601242|FG000|Overall Study|Lack of Efficacy|3|||
25286314|NCT01183013|50601243|FG001|Overall Study|Lack of Efficacy|2|||
25286315|NCT01183013|50601244|FG002|Overall Study|Lack of Efficacy|1|||
25286316|NCT01183013|50601245|FG003|Overall Study|Lack of Efficacy|2|||
25286317|NCT01183013|50601246|FG004|Overall Study|Lack of Efficacy|1|||
25286318|NCT01183013|50601247|FG005|Overall Study|Lack of Efficacy|2|||
25286319|NCT01183013|50601248|FG006|Overall Study|Lack of Efficacy|0|||
25286320|NCT01183013|50601242|FG000|Overall Study|Protocol Violation|5|||
25286321|NCT01183013|50601243|FG001|Overall Study|Protocol Violation|2|||
25286322|NCT01183013|50601244|FG002|Overall Study|Protocol Violation|4|||
25286323|NCT01183013|50601245|FG003|Overall Study|Protocol Violation|0|||
25286324|NCT01183013|50601246|FG004|Overall Study|Protocol Violation|4|||
25286325|NCT01183013|50601247|FG005|Overall Study|Protocol Violation|3|||
25286326|NCT01183013|50601248|FG006|Overall Study|Protocol Violation|3|||
25286327|NCT01183013|50601242|FG000|Overall Study|Lost to Follow-up|7|||
25286328|NCT01183013|50601243|FG001|Overall Study|Lost to Follow-up|3|||
25286329|NCT01183013|50601244|FG002|Overall Study|Lost to Follow-up|4|||
25286330|NCT01183013|50601245|FG003|Overall Study|Lost to Follow-up|3|||
25286331|NCT01183013|50601246|FG004|Overall Study|Lost to Follow-up|2|||
25286332|NCT01183013|50601247|FG005|Overall Study|Lost to Follow-up|6|||
25286333|NCT01183013|50601248|FG006|Overall Study|Lost to Follow-up|5|||
25286334|NCT01183013|50601242|FG000|Overall Study|Withdrawal by Subject|9|||
25286335|NCT01183013|50601243|FG001|Overall Study|Withdrawal by Subject|13|||
25286336|NCT01183013|50601244|FG002|Overall Study|Withdrawal by Subject|10|||
25286337|NCT01183013|50601245|FG003|Overall Study|Withdrawal by Subject|8|||
25286338|NCT01183013|50601246|FG004|Overall Study|Withdrawal by Subject|7|||
25286339|NCT01183013|50601247|FG005|Overall Study|Withdrawal by Subject|9|||
25286340|NCT01183013|50601248|FG006|Overall Study|Withdrawal by Subject|10|||
25286341|NCT01183013|50601242|FG000|Overall Study|Reasons other than stated above|15|||
25286342|NCT01183013|50601243|FG001|Overall Study|Reasons other than stated above|11|||
25286343|NCT01183013|50601244|FG002|Overall Study|Reasons other than stated above|17|||
25286344|NCT01183013|50601245|FG003|Overall Study|Reasons other than stated above|12|||
25286345|NCT01183013|50601246|FG004|Overall Study|Reasons other than stated above|12|||
25286346|NCT01183013|50601247|FG005|Overall Study|Reasons other than stated above|15|||
25286347|NCT01183013|50601248|FG006|Overall Study|Reasons other than stated above|13|||
25286348|NCT01141283|50601272|FG000|Overall Study|Adverse Event|56|||
25286349|NCT01141283|50601272|FG000|Overall Study|Lost to Follow-up|4|||
25286350|NCT01141283|50601272|FG000|Overall Study|Withdrawal by Subject|14|||
25286351|NCT01141283|50601272|FG000|Overall Study|Administrative|4|||
25286352|NCT01141283|50601272|FG000|Overall Study|Lack of Efficacy|10|||
25286353|NCT00863707|50601278|FG000|Overall Study|Randomized, but drug not received|4|||
25286354|NCT00863707|50601279|FG001|Overall Study|Randomized, but drug not received|3|||
25286355|NCT01094184|50601287|FG000|Overall Study|Death|35|||
25286356|NCT01094184|50601288|FG001|Overall Study|Death|11|||
25286357|NCT01134731|50601297|FG000|Overall Study|Adverse Event|3|||
25286358|NCT01134731|50601298|FG001|Overall Study|Adverse Event|2|||
25286359|NCT01134731|50601299|FG002|Overall Study|Adverse Event|1|||
25286360|NCT01134731|50601297|FG000|Overall Study|Physician Decision|2|||
25286361|NCT01134731|50601298|FG001|Overall Study|Physician Decision|2|||
25286362|NCT01134731|50601299|FG002|Overall Study|Physician Decision|2|||
25286363|NCT01134731|50601297|FG000|Overall Study|Lack of Efficacy|0|||
25286364|NCT01134731|50601298|FG001|Overall Study|Lack of Efficacy|0|||
25286365|NCT01134731|50601299|FG002|Overall Study|Lack of Efficacy|1|||
25286366|NCT01134731|50601297|FG000|Overall Study|Withdrawal by Subject|3|||
25286367|NCT01134731|50601298|FG001|Overall Study|Withdrawal by Subject|3|||
25286368|NCT01134731|50601299|FG002|Overall Study|Withdrawal by Subject|1|||
25286369|NCT01134731|50601297|FG000|Overall Study|Lost to Follow-up|5|||
25286370|NCT01134731|50601298|FG001|Overall Study|Lost to Follow-up|4|||
25286371|NCT01134731|50601299|FG002|Overall Study|Lost to Follow-up|3|||
25286372|NCT01141205|50601310|FG000|Overall Study|Physician Decision|1|||
25286373|NCT01141205|50601311|FG001|Overall Study|Physician Decision|1|||
25286374|NCT01141205|50601310|FG000|Overall Study|Lost to Follow-up|1|||
25286375|NCT01141205|50601311|FG001|Overall Study|Lost to Follow-up|0|||
25286376|NCT01141205|50601310|FG000|Overall Study|Withdrawal by Subject|1|||
25286377|NCT01141205|50601311|FG001|Overall Study|Withdrawal by Subject|1|||
25286378|NCT01140503|50601321|FG000|Overall Study|Withdrawal by Subject|1|||
25286379|NCT00863317|50601327|FG000|Overall Study|Lost to Follow-up|8|||
25286380|NCT00863317|50601328|FG001|Overall Study|Lost to Follow-up|9|||
25286381|NCT01200368|50601337|FG000|Infant Series|Adverse Event|2|||
25286382|NCT01200368|50601338|FG001|Infant Series|Adverse Event|2|||
25286383|NCT01200368|50601339|FG002|Infant Series|Adverse Event|3|||
25286384|NCT01200368|50601337|FG000|Infant Series|Withdrawal by Subject|0|||
25286385|NCT01200368|50601338|FG001|Infant Series|Withdrawal by Subject|2|||
25286386|NCT01200368|50601339|FG002|Infant Series|Withdrawal by Subject|2|||
25286387|NCT01200368|50601337|FG000|Infant Series|Did not meet entrance criteria|0|||
25286388|NCT01200368|50601338|FG001|Infant Series|Did not meet entrance criteria|1|||
25286389|NCT01200368|50601339|FG002|Infant Series|Did not meet entrance criteria|0|||
25286390|NCT01200368|50601337|FG000|Infant Series|Randomized, not vaccinated|0|||
25286391|NCT01200368|50601338|FG001|Infant Series|Randomized, not vaccinated|1|||
25286392|NCT01200368|50601339|FG002|Infant Series|Randomized, not vaccinated|1|||
25286393|NCT01200368|50601337|FG000|Infant Series|Other|1|||
25286394|NCT01200368|50601338|FG001|Infant Series|Other|0|||
25286395|NCT01200368|50601339|FG002|Infant Series|Other|0|||
25286396|NCT01200368|50601337|FG000|After Infant Series|Adverse Event|6|||
25286397|NCT01200368|50601338|FG001|After Infant Series|Adverse Event|6|||
25286398|NCT01200368|50601339|FG002|After Infant Series|Adverse Event|3|||
25286399|NCT01200368|50601337|FG000|After Infant Series|Withdrawal by Subject|10|||
25286400|NCT01200368|50601338|FG001|After Infant Series|Withdrawal by Subject|8|||
25286401|NCT01200368|50601339|FG002|After Infant Series|Withdrawal by Subject|4|||
25286402|NCT01200368|50601337|FG000|After Infant Series|Lost to Follow-up|1|||
25286403|NCT01200368|50601338|FG001|After Infant Series|Lost to Follow-up|0|||
25286404|NCT01200368|50601339|FG002|After Infant Series|Lost to Follow-up|0|||
25286405|NCT01200368|50601337|FG000|After Infant Series|Other|1|||
25286406|NCT01200368|50601338|FG001|After Infant Series|Other|2|||
25286407|NCT01200368|50601339|FG002|After Infant Series|Other|2|||
25286408|NCT01200368|50601337|FG000|Toddler Dose|Adverse Event|0|||
25070140|NCT02707965|50175917|FG006|Overall Study|Protocol deviation|0|||
25286409|NCT01200368|50601338|FG001|Toddler Dose|Adverse Event|3|||
25286410|NCT01200368|50601339|FG002|Toddler Dose|Adverse Event|1|||
25286411|NCT01079130|50601360|FG000|Overall Study|Adverse Event|1|||
25286412|NCT01079130|50601361|FG001|Overall Study|Adverse Event|1|||
25286413|NCT01079130|50601362|FG002|Overall Study|Adverse Event|0|||
25286414|NCT01079130|50601363|FG003|Overall Study|Adverse Event|1|||
25286415|NCT01079130|50601364|FG004|Overall Study|Adverse Event|5|||
25070141|NCT02707965|50175918|FG007|Overall Study|Protocol deviation|1|||
24969650|NCT04555096|50059106|FG000|Overall Study|Other|0|||
24969651|NCT04555096|50059107|FG001|Overall Study|Other|1|||
25286416|NCT01079130|50601365|FG005|Overall Study|Adverse Event|1|||
25286417|NCT01079130|50601360|FG000|Overall Study|Administrative problems|1|||
25286418|NCT01079130|50601361|FG001|Overall Study|Administrative problems|3|||
25286419|NCT01079130|50601362|FG002|Overall Study|Administrative problems|0|||
25286420|NCT01079130|50601363|FG003|Overall Study|Administrative problems|0|||
25286421|NCT01079130|50601364|FG004|Overall Study|Administrative problems|0|||
25286422|NCT01079130|50601365|FG005|Overall Study|Administrative problems|1|||
25070142|NCT02707965|50175919|FG008|Overall Study|Protocol deviation|0|||
25286423|NCT01079130|50601360|FG000|Overall Study|Withdrawal by Subject|0|||
25286424|NCT01079130|50601361|FG001|Overall Study|Withdrawal by Subject|1|||
25286425|NCT01079130|50601362|FG002|Overall Study|Withdrawal by Subject|0|||
25286426|NCT01079130|50601363|FG003|Overall Study|Withdrawal by Subject|0|||
25286427|NCT01079130|50601364|FG004|Overall Study|Withdrawal by Subject|1|||
25286428|NCT01079130|50601365|FG005|Overall Study|Withdrawal by Subject|3|||
25286429|NCT01079130|50601360|FG000|Overall Study|Protocol deviation|0|||
25286430|NCT01079130|50601361|FG001|Overall Study|Protocol deviation|2|||
25286431|NCT01079130|50601362|FG002|Overall Study|Protocol deviation|1|||
25286432|NCT01079130|50601363|FG003|Overall Study|Protocol deviation|2|||
25286433|NCT01079130|50601364|FG004|Overall Study|Protocol deviation|0|||
25286434|NCT01079130|50601365|FG005|Overall Study|Protocol deviation|0|||
25286435|NCT01079130|50601360|FG000|Overall Study|Abnormal test procedure result(s)|0|||
25286436|NCT01079130|50601361|FG001|Overall Study|Abnormal test procedure result(s)|0|||
25286437|NCT01079130|50601362|FG002|Overall Study|Abnormal test procedure result(s)|0|||
25286438|NCT01079130|50601363|FG003|Overall Study|Abnormal test procedure result(s)|0|||
25286439|NCT01079130|50601364|FG004|Overall Study|Abnormal test procedure result(s)|1|||
25286440|NCT01079130|50601365|FG005|Overall Study|Abnormal test procedure result(s)|0|||
25286441|NCT01079130|50601360|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25286442|NCT01079130|50601361|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
25286443|NCT01079130|50601362|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
25286444|NCT01079130|50601363|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
25286445|NCT01079130|50601364|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
25286446|NCT01079130|50601365|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
25286447|NCT01079130|50601360|FG000|Overall Study|Lost to Follow-up|0|||
25286448|NCT01079130|50601361|FG001|Overall Study|Lost to Follow-up|0|||
25286449|NCT01079130|50601362|FG002|Overall Study|Lost to Follow-up|0|||
25286450|NCT01079130|50601363|FG003|Overall Study|Lost to Follow-up|0|||
25286451|NCT01079130|50601364|FG004|Overall Study|Lost to Follow-up|1|||
25286452|NCT01079130|50601365|FG005|Overall Study|Lost to Follow-up|0|||
25286453|NCT01078974|50601379|FG000|Overall Study|Adverse Event|3|||
25286454|NCT00869557|50601385|FG000|Randomized Phase|Lost to Follow-up|2|||
25286455|NCT00869557|50601386|FG001|Randomized Phase|Lost to Follow-up|1|||
25286456|NCT00869557|50601385|FG000|Randomized Phase|Investigator's Discretion|1|||
25286457|NCT00869557|50601386|FG001|Randomized Phase|Investigator's Discretion|0|||
25286458|NCT00869557|50601385|FG000|Randomized Phase|Withdrew Consent|0|||
25286459|NCT00869557|50601386|FG001|Randomized Phase|Withdrew Consent|1|||
25286460|NCT00869557|50601385|FG000|Extension Phase|Adverse Event|2|||
25286461|NCT00869557|50601386|FG001|Extension Phase|Adverse Event|2|||
25286462|NCT00869557|50601385|FG000|Extension Phase|Lack of Efficacy|1|||
25286463|NCT00869557|50601386|FG001|Extension Phase|Lack of Efficacy|0|||
25286464|NCT00869557|50601385|FG000|Extension Phase|Lost to Follow-up|3|||
25286465|NCT00869557|50601386|FG001|Extension Phase|Lost to Follow-up|1|||
25286466|NCT00869557|50601385|FG000|Extension Phase|Investigator's Discretion|2|||
25286467|NCT00869557|50601386|FG001|Extension Phase|Investigator's Discretion|0|||
25286468|NCT00869557|50601385|FG000|Extension Phase|Withdrew Consent|2|||
25286469|NCT00869557|50601386|FG001|Extension Phase|Withdrew Consent|0|||
25286470|NCT01200290|50601393|FG000|Treatment Period|Adverse Event|1|||
25286471|NCT01200290|50601393|FG000|Post-Treatment Follow-Up Period|Death|2|||
25286472|NCT01134263|50601402|FG000|Overall Study|Serious adverse event|2|||
25286473|NCT01134263|50601403|FG001|Overall Study|Serious adverse event|1|||
25286474|NCT01134263|50601404|FG002|Overall Study|Serious adverse event|1|||
25286475|NCT01134263|50601405|FG003|Overall Study|Serious adverse event|1|||
25286476|NCT01134263|50601406|FG004|Overall Study|Serious adverse event|1|||
25286477|NCT01134263|50601402|FG000|Overall Study|Other adverse event|1|||
25286478|NCT01134263|50601403|FG001|Overall Study|Other adverse event|2|||
25286479|NCT01134263|50601404|FG002|Overall Study|Other adverse event|5|||
25286480|NCT01134263|50601405|FG003|Overall Study|Other adverse event|3|||
25286481|NCT01134263|50601406|FG004|Overall Study|Other adverse event|0|||
25286482|NCT01134263|50601402|FG000|Overall Study|Protocol Violation|8|||
25286483|NCT01134263|50601403|FG001|Overall Study|Protocol Violation|7|||
25286484|NCT01134263|50601404|FG002|Overall Study|Protocol Violation|2|||
25286485|NCT01134263|50601405|FG003|Overall Study|Protocol Violation|4|||
25286486|NCT01134263|50601406|FG004|Overall Study|Protocol Violation|2|||
25286487|NCT01134263|50601402|FG000|Overall Study|Lost to Follow-up|4|||
25286488|NCT01134263|50601403|FG001|Overall Study|Lost to Follow-up|3|||
25286489|NCT01134263|50601404|FG002|Overall Study|Lost to Follow-up|5|||
25286490|NCT01134263|50601405|FG003|Overall Study|Lost to Follow-up|3|||
25286491|NCT01134263|50601406|FG004|Overall Study|Lost to Follow-up|1|||
25286492|NCT01134263|50601402|FG000|Overall Study|Withdrawal by Subject|8|||
25286493|NCT01134263|50601403|FG001|Overall Study|Withdrawal by Subject|6|||
25286494|NCT01134263|50601404|FG002|Overall Study|Withdrawal by Subject|16|||
25286495|NCT01134263|50601405|FG003|Overall Study|Withdrawal by Subject|7|||
25286496|NCT01134263|50601406|FG004|Overall Study|Withdrawal by Subject|5|||
25286497|NCT01134263|50601402|FG000|Overall Study|Enrolled, but not treated|1|||
25286498|NCT01134263|50601403|FG001|Overall Study|Enrolled, but not treated|1|||
25286499|NCT01134263|50601404|FG002|Overall Study|Enrolled, but not treated|0|||
25286500|NCT01134263|50601405|FG003|Overall Study|Enrolled, but not treated|1|||
25286501|NCT01134263|50601406|FG004|Overall Study|Enrolled, but not treated|0|||
25286502|NCT01199822|50601427|FG000|Overall Study|Investigator discontinued therapy|0|||
25286503|NCT01199822|50601428|FG001|Overall Study|Investigator discontinued therapy|1|||
25286504|NCT01199822|50601429|FG002|Overall Study|Investigator discontinued therapy|0|||
25286505|NCT01096056|50601446|FG000|Overall Study|Lost to Follow-up|0|||
25286506|NCT01096056|50601447|FG001|Overall Study|Lost to Follow-up|1|||
25286507|NCT00866359|50601455|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
25286508|NCT00866359|50601456|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
25286509|NCT00866359|50601457|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
25286510|NCT00866359|50601458|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
25286511|NCT00866359|50601455|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
25286512|NCT00866359|50601456|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
25286513|NCT00866359|50601457|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
25286514|NCT00866359|50601458|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
25286515|NCT00866359|50601455|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
25286516|NCT00866359|50601456|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
25286517|NCT00866359|50601457|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
25070143|NCT02707965|50175920|FG009|Overall Study|Protocol deviation|0|||
25070144|NCT02707965|50175921|FG010|Overall Study|Protocol deviation|0|||
25286518|NCT00866359|50601458|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
25286519|NCT00866359|50601455|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
25286520|NCT00866359|50601456|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
25286521|NCT00866359|50601457|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
25286522|NCT00866359|50601458|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
25286523|NCT00866359|50601455|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
25286524|NCT00866359|50601456|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
25286525|NCT00866359|50601457|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
25286526|NCT00866359|50601458|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
25286527|NCT00866359|50601455|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
25286528|NCT00866359|50601456|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
25286529|NCT00866359|50601457|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
25286530|NCT00866359|50601458|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
25286531|NCT01199198|50601487|FG000|Overall Study|Adverse Event|3|||
25286532|NCT01199198|50601488|FG001|Overall Study|Adverse Event|0|||
25286533|NCT01199198|50601487|FG000|Overall Study|Lost to Follow-up|1|||
25286534|NCT01199198|50601488|FG001|Overall Study|Lost to Follow-up|5|||
25286535|NCT01199198|50601487|FG000|Overall Study|Withdrawal by Subject|1|||
25286536|NCT01199198|50601488|FG001|Overall Study|Withdrawal by Subject|2|||
25286537|NCT01199198|50601487|FG000|Overall Study|ICU Transfer|1|||
25286538|NCT01199198|50601488|FG001|Overall Study|ICU Transfer|2|||
25286539|NCT01199198|50601487|FG000|Overall Study|Hospice-care transfer|1|||
25286540|NCT01199198|50601488|FG001|Overall Study|Hospice-care transfer|2|||
25286541|NCT01095978|50601494|FG000|Overall Study|Did not take Klacid SR|2|||
25286542|NCT01095978|50601494|FG000|Overall Study|Adverse Event|1|||
25286543|NCT01134107|50601502|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
25286544|NCT01134107|50601503|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
25286545|NCT01134107|50601502|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
25286546|NCT01134107|50601503|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
25286547|NCT01134107|50601502|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
25286548|NCT01134107|50601503|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
25286549|NCT01134107|50601502|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
25286550|NCT01134107|50601503|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
25286551|NCT01134107|50601502|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
25286552|NCT01134107|50601503|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
25286553|NCT01134107|50601502|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
25286554|NCT01134107|50601503|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
25286555|NCT01134107|50601502|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
25286556|NCT01134107|50601503|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
25286557|NCT01199042|50601509|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
25286558|NCT01199042|50601509|FG000|At Home (3 Months)|Lost to Follow-up|1|||
25286559|NCT01198574|50601522|FG000|Overall Study|Resigned from schools|4|||
25286560|NCT01198574|50601523|FG001|Overall Study|Resigned from schools|1|||
25286561|NCT01198574|50601524|FG002|Overall Study|Resigned from schools|1|||
25286562|NCT01198574|50601525|FG003|Overall Study|Resigned from schools|4|||
25286563|NCT01198028|50601535|FG000|Overall Study|Adverse Event|5|||
25286564|NCT01198028|50601535|FG000|Overall Study|Death|3|||
25286565|NCT01198028|50601535|FG000|Overall Study|Physician Decision|2|||
25286566|NCT01197950|50601542|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
25286567|NCT01197950|50601543|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
24969652|NCT00097500|50059115|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
24969653|NCT00097500|50059116|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
24969654|NCT00097500|50059115|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
24969655|NCT00097500|50059116|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
24969656|NCT00097500|50059115|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
24969657|NCT00097500|50059116|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
24969658|NCT00097500|50059115|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
24969659|NCT00097500|50059116|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
24969660|NCT00097500|50059115|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
24969661|NCT00097500|50059116|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
25286568|NCT01197950|50601544|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
25286569|NCT01092780|50601552|FG000|Washout Period 1|Adverse Event|0|||
25286570|NCT01092780|50601553|FG001|Washout Period 1|Adverse Event|1|||
25286571|NCT01092780|50601554|FG002|Washout Period 1|Adverse Event|0|||
25286572|NCT01092780|50601555|FG003|Washout Period 1|Adverse Event|0|||
25286573|NCT01092780|50601552|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
25286574|NCT01092780|50601553|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
25286575|NCT01092780|50601554|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
25286576|NCT01092780|50601555|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
25286577|NCT01092780|50601552|FG000|Washout Period 2|Adverse Event|0|||
25286578|NCT01092780|50601553|FG001|Washout Period 2|Adverse Event|1|||
25286579|NCT01092780|50601554|FG002|Washout Period 2|Adverse Event|1|||
25286580|NCT01092780|50601555|FG003|Washout Period 2|Adverse Event|0|||
25286581|NCT01092702|50601565|FG000|Overall Study|Withdrawal by Subject|7|||
25286582|NCT01092702|50601565|FG000|Overall Study|Lost to Follow-up|2|||
25286583|NCT01092546|50601569|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
25286584|NCT01197794|50601580|FG000|Overall Study|Adverse Event|3|||
25286585|NCT01197794|50601581|FG001|Overall Study|Adverse Event|2|||
25286586|NCT01197794|50601582|FG002|Overall Study|Adverse Event|4|||
25286587|NCT01197794|50601583|FG003|Overall Study|Adverse Event|4|||
25286588|NCT01197794|50601584|FG004|Overall Study|Adverse Event|4|||
25286589|NCT01197794|50601585|FG005|Overall Study|Adverse Event|2|||
25286590|NCT01197794|50601586|FG006|Overall Study|Adverse Event|3|||
25286591|NCT01197794|50601580|FG000|Overall Study|Protocol Violation|0|||
25286592|NCT01197794|50601581|FG001|Overall Study|Protocol Violation|0|||
25286593|NCT01197794|50601582|FG002|Overall Study|Protocol Violation|0|||
25286594|NCT01197794|50601583|FG003|Overall Study|Protocol Violation|0|||
25286595|NCT01197794|50601584|FG004|Overall Study|Protocol Violation|2|||
25286596|NCT01197794|50601585|FG005|Overall Study|Protocol Violation|0|||
25286597|NCT01197794|50601586|FG006|Overall Study|Protocol Violation|1|||
25286598|NCT01197794|50601580|FG000|Overall Study|Development of study withdrawal criteria|3|||
25286599|NCT01197794|50601581|FG001|Overall Study|Development of study withdrawal criteria|0|||
25286600|NCT01197794|50601582|FG002|Overall Study|Development of study withdrawal criteria|0|||
25286601|NCT01197794|50601583|FG003|Overall Study|Development of study withdrawal criteria|1|||
25286602|NCT01197794|50601584|FG004|Overall Study|Development of study withdrawal criteria|0|||
25286603|NCT01197794|50601585|FG005|Overall Study|Development of study withdrawal criteria|0|||
25286604|NCT01197794|50601586|FG006|Overall Study|Development of study withdrawal criteria|1|||
25286605|NCT01197794|50601580|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
25286606|NCT01197794|50601581|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
25286607|NCT01197794|50601582|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
25286608|NCT01197794|50601583|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
25191485|NCT01492088|50351942|FG000|Overall Study|Alive at Last Follow-up|0|||
25191486|NCT01492088|50351943|FG001|Overall Study|Alive at Last Follow-up|6|||
25286609|NCT01197794|50601584|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
25286610|NCT01197794|50601585|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
25286611|NCT01197794|50601586|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
25286612|NCT01197794|50601580|FG000|Overall Study|Withdrawal by Subject|3|||
25286613|NCT01197794|50601581|FG001|Overall Study|Withdrawal by Subject|3|||
25286614|NCT01197794|50601582|FG002|Overall Study|Withdrawal by Subject|4|||
25286615|NCT01197794|50601583|FG003|Overall Study|Withdrawal by Subject|1|||
25286616|NCT01197794|50601584|FG004|Overall Study|Withdrawal by Subject|1|||
25286617|NCT01197794|50601585|FG005|Overall Study|Withdrawal by Subject|5|||
25286618|NCT01197794|50601586|FG006|Overall Study|Withdrawal by Subject|6|||
25286619|NCT01197794|50601580|FG000|Overall Study|Lost to Follow-up|1|||
25286620|NCT01197794|50601581|FG001|Overall Study|Lost to Follow-up|1|||
25286621|NCT01197794|50601582|FG002|Overall Study|Lost to Follow-up|0|||
25286622|NCT01197794|50601583|FG003|Overall Study|Lost to Follow-up|1|||
25286623|NCT01197794|50601584|FG004|Overall Study|Lost to Follow-up|0|||
25286624|NCT01197794|50601585|FG005|Overall Study|Lost to Follow-up|1|||
25286625|NCT01197794|50601586|FG006|Overall Study|Lost to Follow-up|0|||
25286626|NCT01197794|50601580|FG000|Overall Study|Other|1|||
25286627|NCT01197794|50601581|FG001|Overall Study|Other|1|||
25286628|NCT01197794|50601582|FG002|Overall Study|Other|3|||
25286629|NCT01197794|50601583|FG003|Overall Study|Other|0|||
25286630|NCT01197794|50601584|FG004|Overall Study|Other|2|||
25286631|NCT01197794|50601585|FG005|Overall Study|Other|2|||
25286632|NCT01197794|50601586|FG006|Overall Study|Other|4|||
25286633|NCT01078662|50601608|FG000|Overall Study|Death|41|||
25286634|NCT01078662|50601609|FG001|Overall Study|Death|103|||
25286635|NCT01078662|50601610|FG002|Overall Study|Death|18|||
25286636|NCT01078662|50601611|FG003|Overall Study|Death|5|||
25286637|NCT01078662|50601612|FG004|Overall Study|Death|8|||
25286638|NCT01078662|50601608|FG000|Overall Study|Patients reached data cut-off|12|||
25286639|NCT01078662|50601609|FG001|Overall Study|Patients reached data cut-off|53|||
25286640|NCT01078662|50601610|FG002|Overall Study|Patients reached data cut-off|2|||
25286641|NCT01078662|50601611|FG003|Overall Study|Patients reached data cut-off|2|||
25286642|NCT01078662|50601612|FG004|Overall Study|Patients reached data cut-off|3|||
25191487|NCT01492088|50351944|FG002|Overall Study|Alive at Last Follow-up|11|||
25191488|NCT02592798|50352186|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
25191489|NCT02592798|50352187|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
25191490|NCT02592798|50352186|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
25191491|NCT02592798|50352187|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
25191492|NCT02592798|50352186|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
25191493|NCT02592798|50352187|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
25191494|NCT02592798|50352186|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
25191495|NCT02592798|50352187|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
25191496|NCT02592798|50352186|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
25191497|NCT02592798|50352187|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
25191498|NCT02592798|50352186|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
25191499|NCT02592798|50352187|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
25191500|NCT02592798|50352186|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
25191501|NCT02592798|50352187|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
25191502|NCT02592798|50352186|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
25286643|NCT01078662|50601608|FG000|Overall Study|Withdrawal by Subject|4|||
24969662|NCT00097500|50059115|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
25191503|NCT02592798|50352187|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
25286644|NCT01078662|50601609|FG001|Overall Study|Withdrawal by Subject|11|||
25286645|NCT01078662|50601610|FG002|Overall Study|Withdrawal by Subject|1|||
25286646|NCT01078662|50601611|FG003|Overall Study|Withdrawal by Subject|0|||
25286647|NCT01078662|50601612|FG004|Overall Study|Withdrawal by Subject|0|||
25286648|NCT01078662|50601608|FG000|Overall Study|Protocol Violation|0|||
25286649|NCT01078662|50601609|FG001|Overall Study|Protocol Violation|1|||
25286650|NCT01078662|50601610|FG002|Overall Study|Protocol Violation|0|||
25286651|NCT01078662|50601611|FG003|Overall Study|Protocol Violation|0|||
25286652|NCT01078662|50601612|FG004|Overall Study|Protocol Violation|0|||
25286653|NCT01078662|50601608|FG000|Overall Study|Lost to Follow-up|1|||
25286654|NCT01078662|50601609|FG001|Overall Study|Lost to Follow-up|0|||
25286655|NCT01078662|50601610|FG002|Overall Study|Lost to Follow-up|0|||
25286656|NCT01078662|50601611|FG003|Overall Study|Lost to Follow-up|0|||
25286657|NCT01078662|50601612|FG004|Overall Study|Lost to Follow-up|0|||
25286658|NCT01091454|50601621|FG000|Overall Study|Ineligible|1|||
25286659|NCT01140347|50601627|FG000|Overall Study|Lost to Follow-up|5|||
25286660|NCT01140347|50601628|FG001|Overall Study|Lost to Follow-up|6|||
25286661|NCT01140347|50601627|FG000|Overall Study|Withdrawal by Subject|13|||
25286662|NCT01140347|50601628|FG001|Overall Study|Withdrawal by Subject|8|||
25286663|NCT01197560|50601636|FG000|Overall Study|Adverse Event|6|||
25286664|NCT01197560|50601637|FG001|Overall Study|Adverse Event|8|||
25286665|NCT01197560|50601636|FG000|Overall Study|Death|3|||
25286666|NCT01197560|50601637|FG001|Overall Study|Death|5|||
25286667|NCT01197560|50601636|FG000|Overall Study|Withdrawal by Subject|1|||
25286668|NCT01197560|50601637|FG001|Overall Study|Withdrawal by Subject|1|||
25286669|NCT01197560|50601636|FG000|Overall Study|Disease progression|40|||
25286670|NCT01197560|50601637|FG001|Overall Study|Disease progression|35|||
25286671|NCT01197560|50601636|FG000|Overall Study|Miscellaneous|4|||
25286672|NCT01197560|50601637|FG001|Overall Study|Miscellaneous|3|||
25286673|NCT01197560|50601636|FG000|Overall Study|Missing|0|||
25286674|NCT01197560|50601637|FG001|Overall Study|Missing|1|||
25286675|NCT01133405|50601654|FG000|Period 1|Withdrawal by Subject|0|||
25286676|NCT01133405|50601655|FG001|Period 1|Withdrawal by Subject|1|||
25286677|NCT01133405|50601656|FG002|Period 1|Withdrawal by Subject|0|||
25286678|NCT01133405|50601657|FG003|Period 1|Withdrawal by Subject|1|||
25286679|NCT01133405|50601658|FG004|Period 1|Withdrawal by Subject|0|||
25286680|NCT01133405|50601659|FG005|Period 1|Withdrawal by Subject|1|||
25286681|NCT01133405|50601660|FG006|Period 1|Withdrawal by Subject|0|||
25286682|NCT01133405|50601661|FG007|Period 1|Withdrawal by Subject|0|||
25286683|NCT01133405|50601662|FG008|Period 1|Withdrawal by Subject|0|||
25286684|NCT01133405|50601663|FG009|Period 1|Withdrawal by Subject|0|||
25286685|NCT01133405|50601654|FG000|Period 1|Physician Decision|0|||
25286686|NCT01133405|50601655|FG001|Period 1|Physician Decision|0|||
25286687|NCT01133405|50601656|FG002|Period 1|Physician Decision|0|||
25286688|NCT01133405|50601657|FG003|Period 1|Physician Decision|1|||
25286689|NCT01133405|50601658|FG004|Period 1|Physician Decision|0|||
25286690|NCT01133405|50601659|FG005|Period 1|Physician Decision|0|||
25286691|NCT01133405|50601660|FG006|Period 1|Physician Decision|0|||
25286692|NCT01133405|50601661|FG007|Period 1|Physician Decision|0|||
25286693|NCT01133405|50601662|FG008|Period 1|Physician Decision|0|||
25286694|NCT01133405|50601663|FG009|Period 1|Physician Decision|0|||
25286695|NCT01133405|50601654|FG000|Period 1|Discontinued after randomization|1|||
25286696|NCT01133405|50601655|FG001|Period 1|Discontinued after randomization|0|||
25070145|NCT02707965|50175922|FG011|Overall Study|Protocol deviation|0|||
25070146|NCT02707965|50175923|FG012|Overall Study|Protocol deviation|0|||
25070147|NCT02707965|50175924|FG013|Overall Study|Protocol deviation|0|||
25070148|NCT02707965|50175925|FG014|Overall Study|Protocol deviation|0|||
25070149|NCT02707965|50175926|FG015|Overall Study|Protocol deviation|0|||
25070150|NCT01667900|50175964|FG000|Part B|Death|0|||
25070151|NCT01667900|50175965|FG001|Part B|Death|0|||
25070152|NCT01667900|50175966|FG002|Part B|Death|0|||
25070153|NCT01667900|50175967|FG003|Part B|Death|0|||
25070154|NCT01667900|50175968|FG004|Part B|Death|0|||
25070155|NCT01667900|50175969|FG005|Part B|Death|0|||
25070156|NCT01667900|50175970|FG006|Part B|Death|0|||
25070157|NCT01667900|50175971|FG007|Part B|Death|0|||
25070158|NCT01667900|50175972|FG008|Part B|Death|0|||
25070159|NCT01667900|50175973|FG009|Part B|Death|0|||
25070160|NCT01667900|50175974|FG010|Part B|Death|0|||
25070161|NCT01667900|50175975|FG011|Part B|Death|0|||
25070162|NCT01667900|50175976|FG012|Part B|Death|0|||
25070163|NCT01667900|50175977|FG013|Part B|Death|0|||
25070164|NCT01667900|50175978|FG014|Part B|Death|0|||
25070165|NCT01667900|50175979|FG015|Part B|Death|0|||
25070166|NCT01667900|50175980|FG016|Part B|Death|1|||
25286697|NCT01133405|50601656|FG002|Period 1|Discontinued after randomization|0|||
25286698|NCT01133405|50601657|FG003|Period 1|Discontinued after randomization|0|||
25286699|NCT01133405|50601658|FG004|Period 1|Discontinued after randomization|0|||
25286700|NCT01133405|50601659|FG005|Period 1|Discontinued after randomization|0|||
25286701|NCT01133405|50601660|FG006|Period 1|Discontinued after randomization|1|||
25070167|NCT01667900|50175981|FG017|Part B|Death|0|||
25070168|NCT01667900|50175982|FG018|Part B|Death|0|||
25070169|NCT01667900|50175983|FG019|Part B|Death|0|||
25070170|NCT02605928|50176012|FG000|Overall Study|Model tuning phase|28|||
25070171|NCT02605928|50176012|FG000|Overall Study|Lack of Efficacy|5|||
25070172|NCT02706717|50176018|FG000|Overall Study|Withdrawal by Subject|1|||
25286702|NCT01133405|50601661|FG007|Period 1|Discontinued after randomization|0|||
25286703|NCT01133405|50601662|FG008|Period 1|Discontinued after randomization|0|||
25286704|NCT01133405|50601663|FG009|Period 1|Discontinued after randomization|0|||
25286705|NCT01133405|50601654|FG000|Period 1|Received drug only in period 2|0|||
25286706|NCT01133405|50601655|FG001|Period 1|Received drug only in period 2|1|||
25286707|NCT01133405|50601656|FG002|Period 1|Received drug only in period 2|0|||
25286708|NCT01133405|50601657|FG003|Period 1|Received drug only in period 2|2|||
25286709|NCT01133405|50601658|FG004|Period 1|Received drug only in period 2|0|||
25286710|NCT01133405|50601659|FG005|Period 1|Received drug only in period 2|1|||
25286711|NCT01133405|50601660|FG006|Period 1|Received drug only in period 2|0|||
25286712|NCT01133405|50601661|FG007|Period 1|Received drug only in period 2|0|||
25286713|NCT01133405|50601662|FG008|Period 1|Received drug only in period 2|0|||
25286714|NCT01133405|50601663|FG009|Period 1|Received drug only in period 2|0|||
25286715|NCT01133405|50601654|FG000|Period 1|Received drug only in period 3|0|||
25286716|NCT01133405|50601655|FG001|Period 1|Received drug only in period 3|1|||
25286717|NCT01133405|50601656|FG002|Period 1|Received drug only in period 3|1|||
25286718|NCT01133405|50601657|FG003|Period 1|Received drug only in period 3|0|||
25286719|NCT01133405|50601658|FG004|Period 1|Received drug only in period 3|0|||
25286720|NCT01133405|50601659|FG005|Period 1|Received drug only in period 3|0|||
25286721|NCT01133405|50601660|FG006|Period 1|Received drug only in period 3|0|||
25286722|NCT01133405|50601661|FG007|Period 1|Received drug only in period 3|0|||
25286723|NCT01133405|50601662|FG008|Period 1|Received drug only in period 3|0|||
25286724|NCT01133405|50601663|FG009|Period 1|Received drug only in period 3|0|||
25286725|NCT01133405|50601654|FG000|Period 2|Adverse Event|0|||
25286726|NCT01133405|50601655|FG001|Period 2|Adverse Event|0|||
25286727|NCT01133405|50601656|FG002|Period 2|Adverse Event|1|||
25286728|NCT01133405|50601657|FG003|Period 2|Adverse Event|0|||
25286729|NCT01133405|50601658|FG004|Period 2|Adverse Event|0|||
25286730|NCT01133405|50601659|FG005|Period 2|Adverse Event|0|||
25286731|NCT01133405|50601660|FG006|Period 2|Adverse Event|0|||
25286732|NCT01133405|50601661|FG007|Period 2|Adverse Event|0|||
25286733|NCT01133405|50601662|FG008|Period 2|Adverse Event|0|||
25286734|NCT01133405|50601663|FG009|Period 2|Adverse Event|0|||
25286735|NCT01133405|50601654|FG000|Period 2|Withdrawal by Subject|0|||
25286736|NCT01133405|50601655|FG001|Period 2|Withdrawal by Subject|0|||
25286737|NCT01133405|50601656|FG002|Period 2|Withdrawal by Subject|0|||
25286738|NCT01133405|50601657|FG003|Period 2|Withdrawal by Subject|1|||
25286739|NCT01133405|50601658|FG004|Period 2|Withdrawal by Subject|0|||
25286740|NCT01133405|50601659|FG005|Period 2|Withdrawal by Subject|1|||
25286741|NCT01133405|50601660|FG006|Period 2|Withdrawal by Subject|0|||
25286742|NCT01133405|50601661|FG007|Period 2|Withdrawal by Subject|0|||
25286743|NCT01133405|50601662|FG008|Period 2|Withdrawal by Subject|0|||
25286744|NCT01133405|50601663|FG009|Period 2|Withdrawal by Subject|0|||
25286745|NCT01133405|50601654|FG000|Period 2|Entry Criteria Not Met|0|||
25286746|NCT01133405|50601655|FG001|Period 2|Entry Criteria Not Met|1|||
25286747|NCT01133405|50601656|FG002|Period 2|Entry Criteria Not Met|0|||
25286748|NCT01133405|50601657|FG003|Period 2|Entry Criteria Not Met|0|||
25286749|NCT01133405|50601658|FG004|Period 2|Entry Criteria Not Met|0|||
25286750|NCT01133405|50601659|FG005|Period 2|Entry Criteria Not Met|0|||
25286751|NCT01133405|50601660|FG006|Period 2|Entry Criteria Not Met|0|||
25286752|NCT01133405|50601661|FG007|Period 2|Entry Criteria Not Met|0|||
25286753|NCT01133405|50601662|FG008|Period 2|Entry Criteria Not Met|0|||
25286754|NCT01133405|50601663|FG009|Period 2|Entry Criteria Not Met|0|||
25286755|NCT01133405|50601654|FG000|Period 2|Physician Decision|0|||
25286756|NCT01133405|50601655|FG001|Period 2|Physician Decision|0|||
25286757|NCT01133405|50601656|FG002|Period 2|Physician Decision|0|||
25286758|NCT01133405|50601657|FG003|Period 2|Physician Decision|0|||
25286759|NCT01133405|50601658|FG004|Period 2|Physician Decision|0|||
25286760|NCT01133405|50601659|FG005|Period 2|Physician Decision|1|||
25286761|NCT01133405|50601660|FG006|Period 2|Physician Decision|0|||
25286762|NCT01133405|50601661|FG007|Period 2|Physician Decision|0|||
25286763|NCT01133405|50601662|FG008|Period 2|Physician Decision|0|||
25286764|NCT01133405|50601663|FG009|Period 2|Physician Decision|0|||
25286765|NCT01196078|50601695|FG000|Overall Study|Withdrawal by Subject|3|||
25286766|NCT01196078|50601696|FG001|Overall Study|Withdrawal by Subject|5|||
25286767|NCT01196078|50601695|FG000|Overall Study|Adverse Event|4|||
25286768|NCT01196078|50601696|FG001|Overall Study|Adverse Event|4|||
25286769|NCT01196078|50601695|FG000|Overall Study|Protocol Violation|2|||
25286770|NCT01196078|50601696|FG001|Overall Study|Protocol Violation|1|||
25286771|NCT01196078|50601695|FG000|Overall Study|Lack of Efficacy|17|||
25286772|NCT01196078|50601696|FG001|Overall Study|Lack of Efficacy|23|||
25286773|NCT01196078|50601695|FG000|Overall Study|Lost to Follow-up|1|||
25286774|NCT01196078|50601696|FG001|Overall Study|Lost to Follow-up|0|||
25286775|NCT01196078|50601695|FG000|Overall Study|Death|6|||
25286776|NCT01196078|50601696|FG001|Overall Study|Death|4|||
25286777|NCT01078584|50601702|FG000|Overall Study|Final Status Unknown|1073|||
25286778|NCT01078584|50601702|FG000|Overall Study|Lost to Follow-up|670|||
25286779|NCT01078584|50601702|FG000|Overall Study|Non-serious Adverse Event|577|||
25286780|NCT01078584|50601702|FG000|Overall Study|Withdrawal of Consent|244|||
25286781|NCT01078584|50601702|FG000|Overall Study|Physician Withdrew from Study|90|||
25286782|NCT01078584|50601702|FG000|Overall Study|Non-compliance|67|||
25286783|NCT01078584|50601702|FG000|Overall Study|Blood Pressure Controlled|49|||
25286784|NCT01078584|50601702|FG000|Overall Study|Physician Switched Medication|26|||
25286785|NCT01078584|50601702|FG000|Overall Study|Physician Discontinued Patient|12|||
25286786|NCT01078584|50601702|FG000|Overall Study|Lack of Efficacy|98|||
25286787|NCT01078584|50601702|FG000|Overall Study|Protocol Violation|75|||
25286788|NCT01078584|50601702|FG000|Overall Study|Serious Adverse Event|27|||
25286789|NCT01078584|50601702|FG000|Overall Study|Multiple Reasons|2|||
25286790|NCT01133171|50601722|FG000|Overall Study|Withdrawal by Subject|1|||
25286791|NCT01133171|50601723|FG001|Overall Study|Withdrawal by Subject|2|||
25286792|NCT01133171|50601724|FG002|Overall Study|Withdrawal by Subject|0|||
25286793|NCT01195844|50601732|FG000|Overall Study|Fecal sample not collected|40|||
25286794|NCT01132547|50601748|FG000|Overall Study|Withdrawal by Subject|3|||
25286795|NCT01132547|50601749|FG001|Overall Study|Withdrawal by Subject|1|||
25286796|NCT01132547|50601748|FG000|Overall Study|Death|1|||
25286797|NCT01132547|50601749|FG001|Overall Study|Death|0|||
25286798|NCT01194830|50601757|FG000|Overall Study|Adverse Event|3|||
25286799|NCT01194830|50601758|FG001|Overall Study|Adverse Event|2|||
25286800|NCT01194830|50601757|FG000|Overall Study|Protocol Violation|5|||
25286801|NCT01194830|50601758|FG001|Overall Study|Protocol Violation|4|||
25286802|NCT01194830|50601757|FG000|Overall Study|Lost to Follow-up|9|||
25286803|NCT01194830|50601758|FG001|Overall Study|Lost to Follow-up|7|||
25286804|NCT01194830|50601757|FG000|Overall Study|Withdrawal by Subject|2|||
25286805|NCT01194830|50601758|FG001|Overall Study|Withdrawal by Subject|1|||
25286806|NCT01194830|50601757|FG000|Overall Study|Lack of Efficacy|1|||
25286807|NCT01194830|50601758|FG001|Overall Study|Lack of Efficacy|1|||
25286808|NCT01194830|50601757|FG000|Overall Study|Non-compliance issues|4|||
25286809|NCT01194830|50601758|FG001|Overall Study|Non-compliance issues|4|||
25286810|NCT01194830|50601757|FG000|Overall Study|Other Reason|12|||
25286811|NCT01194830|50601758|FG001|Overall Study|Other Reason|8|||
25286812|NCT01194440|50601764|FG000|Baseline (First Dose)|Reason not specified|4|||
25286813|NCT01194440|50601764|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
25286814|NCT01194440|50601764|FG000|Baseline (First Dose)|Change in therapy|1|||
25286815|NCT01194440|50601764|FG000|Baseline (First Dose)|Adverse Event|1|||
25286816|NCT01194440|50601764|FG000|6-months (2nd Dose)|Change in therapy|4|||
25286817|NCT00951015|50601773|FG000|Randomization Phase 96 Week|Adverse Event|1|||
25286818|NCT00951015|50601774|FG001|Randomization Phase 96 Week|Adverse Event|1|||
25286819|NCT00951015|50601775|FG002|Randomization Phase 96 Week|Adverse Event|2|||
25286820|NCT00951015|50601776|FG003|Randomization Phase 96 Week|Adverse Event|5|||
25286821|NCT00951015|50601777|FG004|Randomization Phase 96 Week|Adverse Event|0|||
25286822|NCT00951015|50601773|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
25191504|NCT02592798|50352186|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
25191505|NCT02592798|50352187|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
25191506|NCT02592798|50352186|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
25191507|NCT02592798|50352187|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
25191508|NCT02592798|50352186|FG000|Transition From DB2 to OLE|Other reasons|1|||
25286823|NCT00951015|50601774|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
25286824|NCT00951015|50601775|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
25286825|NCT00951015|50601776|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
25286826|NCT00951015|50601777|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
25286827|NCT00951015|50601773|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
25286828|NCT00951015|50601774|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
25286829|NCT00951015|50601775|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
25286830|NCT00951015|50601776|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
25286831|NCT00951015|50601777|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
25286832|NCT00951015|50601773|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
25286833|NCT00951015|50601774|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
25286834|NCT00951015|50601775|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
25286835|NCT00951015|50601776|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
25286836|NCT00951015|50601777|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
25286837|NCT00951015|50601773|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
25286838|NCT00951015|50601774|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
25286839|NCT00951015|50601775|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
25286840|NCT00951015|50601776|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
25286841|NCT00951015|50601777|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
25286842|NCT00951015|50601773|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
25286843|NCT00951015|50601774|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
25286844|NCT00951015|50601775|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
25286845|NCT00951015|50601776|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
25286846|NCT00951015|50601777|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
25286847|NCT00951015|50601773|FG000|Open-label Phase|Adverse Event|0|||
25286848|NCT00951015|50601774|FG001|Open-label Phase|Adverse Event|0|||
25286849|NCT00951015|50601775|FG002|Open-label Phase|Adverse Event|0|||
25286850|NCT00951015|50601776|FG003|Open-label Phase|Adverse Event|0|||
25286851|NCT00951015|50601777|FG004|Open-label Phase|Adverse Event|3|||
25286852|NCT00951015|50601773|FG000|Open-label Phase|Lack of Efficacy|0|||
25286853|NCT00951015|50601774|FG001|Open-label Phase|Lack of Efficacy|0|||
25286854|NCT00951015|50601775|FG002|Open-label Phase|Lack of Efficacy|0|||
25286855|NCT00951015|50601776|FG003|Open-label Phase|Lack of Efficacy|0|||
25286856|NCT00951015|50601777|FG004|Open-label Phase|Lack of Efficacy|1|||
25286857|NCT00951015|50601773|FG000|Open-label Phase|Protocol Violation|0|||
25286858|NCT00951015|50601774|FG001|Open-label Phase|Protocol Violation|0|||
25286859|NCT00951015|50601775|FG002|Open-label Phase|Protocol Violation|0|||
25286860|NCT00951015|50601776|FG003|Open-label Phase|Protocol Violation|0|||
25286861|NCT00951015|50601777|FG004|Open-label Phase|Protocol Violation|12|||
25286862|NCT00951015|50601773|FG000|Open-label Phase|Lost to Follow-up|0|||
25286863|NCT00951015|50601774|FG001|Open-label Phase|Lost to Follow-up|0|||
25286864|NCT00951015|50601775|FG002|Open-label Phase|Lost to Follow-up|0|||
25286865|NCT00951015|50601776|FG003|Open-label Phase|Lost to Follow-up|0|||
25286866|NCT00951015|50601777|FG004|Open-label Phase|Lost to Follow-up|12|||
25286867|NCT00951015|50601773|FG000|Open-label Phase|Withdrawal by Subject|0|||
25286868|NCT00951015|50601774|FG001|Open-label Phase|Withdrawal by Subject|0|||
25286869|NCT00951015|50601775|FG002|Open-label Phase|Withdrawal by Subject|0|||
25286870|NCT00951015|50601776|FG003|Open-label Phase|Withdrawal by Subject|0|||
25286871|NCT00951015|50601777|FG004|Open-label Phase|Withdrawal by Subject|14|||
25286872|NCT00951015|50601773|FG000|Open-label Phase|Physician Decision|0|||
25286873|NCT00951015|50601774|FG001|Open-label Phase|Physician Decision|0|||
25286874|NCT00951015|50601775|FG002|Open-label Phase|Physician Decision|0|||
25286875|NCT00951015|50601776|FG003|Open-label Phase|Physician Decision|0|||
25286876|NCT00951015|50601777|FG004|Open-label Phase|Physician Decision|8|||
25286877|NCT01139021|50601806|FG000|Overall Study|Adverse Event|0|||
25286878|NCT01139021|50601807|FG001|Overall Study|Adverse Event|0|||
25286879|NCT01139021|50601808|FG002|Overall Study|Adverse Event|0|||
25286880|NCT01139021|50601809|FG003|Overall Study|Adverse Event|0|||
25286881|NCT01139021|50601810|FG004|Overall Study|Adverse Event|1|||
25286882|NCT01139021|50601811|FG005|Overall Study|Adverse Event|0|||
25286883|NCT01139021|50601806|FG000|Overall Study|Lost to Follow-up|0|||
25286884|NCT01139021|50601807|FG001|Overall Study|Lost to Follow-up|0|||
25286885|NCT01139021|50601808|FG002|Overall Study|Lost to Follow-up|0|||
25286886|NCT01139021|50601809|FG003|Overall Study|Lost to Follow-up|0|||
25286887|NCT01139021|50601810|FG004|Overall Study|Lost to Follow-up|2|||
25286888|NCT01139021|50601811|FG005|Overall Study|Lost to Follow-up|0|||
25286889|NCT01139021|50601806|FG000|Overall Study|Protocol Violation|1|||
25286890|NCT01139021|50601807|FG001|Overall Study|Protocol Violation|0|||
25286891|NCT01139021|50601808|FG002|Overall Study|Protocol Violation|0|||
25286892|NCT01139021|50601809|FG003|Overall Study|Protocol Violation|0|||
25286893|NCT01139021|50601810|FG004|Overall Study|Protocol Violation|2|||
25286894|NCT01139021|50601811|FG005|Overall Study|Protocol Violation|0|||
25286895|NCT01139021|50601806|FG000|Overall Study|Withdrawal by Subject|0|||
25286896|NCT01139021|50601807|FG001|Overall Study|Withdrawal by Subject|0|||
25286897|NCT01139021|50601808|FG002|Overall Study|Withdrawal by Subject|0|||
25286898|NCT01139021|50601809|FG003|Overall Study|Withdrawal by Subject|1|||
25286899|NCT01139021|50601810|FG004|Overall Study|Withdrawal by Subject|4|||
24969663|NCT00097500|50059116|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
25286900|NCT01139021|50601811|FG005|Overall Study|Withdrawal by Subject|0|||
25286901|NCT01193660|50601829|FG000|Overall Study|Withdrawal by Subject|2|||
25286902|NCT01193660|50601830|FG001|Overall Study|Withdrawal by Subject|3|||
25286903|NCT01193660|50601831|FG002|Overall Study|Withdrawal by Subject|1|||
25286904|NCT01193660|50601829|FG000|Overall Study|Death|1|||
25286905|NCT01193660|50601830|FG001|Overall Study|Death|0|||
25286906|NCT01193660|50601831|FG002|Overall Study|Death|0|||
25286907|NCT01193660|50601829|FG000|Overall Study|Physician Decision|1|||
25286908|NCT01193660|50601830|FG001|Overall Study|Physician Decision|0|||
25286909|NCT01193660|50601831|FG002|Overall Study|Physician Decision|1|||
25286910|NCT01076166|50601839|FG000|Overall Study|Adverse Event|3|||
25286911|NCT01076166|50601839|FG000|Overall Study|Symptoms improved/resolved|6|||
25286912|NCT01193582|50601850|FG000|Vaccination Series|Withdrawal by Subject|11|||
25286913|NCT01193582|50601851|FG001|Vaccination Series|Withdrawal by Subject|13|||
25286914|NCT01193582|50601852|FG002|Vaccination Series|Withdrawal by Subject|8|||
25286915|NCT01193582|50601853|FG003|Vaccination Series|Withdrawal by Subject|3|||
25286916|NCT01193582|50601850|FG000|12 Month Follow-up|Death|0|||
25286917|NCT01193582|50601851|FG001|12 Month Follow-up|Death|0|||
25286918|NCT01193582|50601852|FG002|12 Month Follow-up|Death|1|||
25286919|NCT01193582|50601853|FG003|12 Month Follow-up|Death|0|||
25286920|NCT01193582|50601850|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
25286921|NCT01193582|50601851|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
25286922|NCT01193582|50601852|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
25286923|NCT01193582|50601853|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
25286924|NCT00945477|50601865|FG000|Overall Study|Adverse Event|3|||
25286925|NCT00945477|50601865|FG000|Overall Study|Lack of Efficacy|2|||
25286926|NCT00945477|50601865|FG000|Overall Study|Withdrawal by Subject|1|||
25286927|NCT01076088|50601876|FG000|Overall Study|Adverse Event|1|||
25286928|NCT01076088|50601877|FG001|Overall Study|Adverse Event|6|||
25286929|NCT01076088|50601878|FG002|Overall Study|Adverse Event|3|||
25286930|NCT01076088|50601879|FG003|Overall Study|Adverse Event|2|||
25286931|NCT01076088|50601880|FG004|Overall Study|Adverse Event|3|||
25286932|NCT01076088|50601881|FG005|Overall Study|Adverse Event|3|||
25286933|NCT01076088|50601876|FG000|Overall Study|Lost to Follow-up|1|||
25286934|NCT01076088|50601877|FG001|Overall Study|Lost to Follow-up|1|||
25286935|NCT01076088|50601878|FG002|Overall Study|Lost to Follow-up|0|||
25286936|NCT01076088|50601879|FG003|Overall Study|Lost to Follow-up|1|||
25286937|NCT01076088|50601880|FG004|Overall Study|Lost to Follow-up|1|||
25286938|NCT01076088|50601881|FG005|Overall Study|Lost to Follow-up|2|||
25286939|NCT01076088|50601876|FG000|Overall Study|Non-compliance with study drug|0|||
25070173|NCT02706717|50176019|FG001|Overall Study|Withdrawal by Subject|8|||
25070174|NCT02706717|50176018|FG000|Overall Study|Lost to Follow-up|0|||
25070175|NCT02706717|50176019|FG001|Overall Study|Lost to Follow-up|1|||
25070176|NCT02706717|50176018|FG000|Overall Study|Physician Decision|0|||
25070177|NCT02706717|50176019|FG001|Overall Study|Physician Decision|1|||
25286940|NCT01076088|50601877|FG001|Overall Study|Non-compliance with study drug|0|||
25286941|NCT01076088|50601878|FG002|Overall Study|Non-compliance with study drug|0|||
25286942|NCT01076088|50601879|FG003|Overall Study|Non-compliance with study drug|1|||
25286943|NCT01076088|50601880|FG004|Overall Study|Non-compliance with study drug|0|||
25286944|NCT01076088|50601881|FG005|Overall Study|Non-compliance with study drug|0|||
25286945|NCT01076088|50601876|FG000|Overall Study|Physician Decision|1|||
25286946|NCT01076088|50601877|FG001|Overall Study|Physician Decision|3|||
25286947|NCT01076088|50601878|FG002|Overall Study|Physician Decision|0|||
25286948|NCT01076088|50601879|FG003|Overall Study|Physician Decision|1|||
25286949|NCT01076088|50601880|FG004|Overall Study|Physician Decision|1|||
25286950|NCT01076088|50601881|FG005|Overall Study|Physician Decision|0|||
25286951|NCT01076088|50601876|FG000|Overall Study|Withdrawal by Subject|8|||
25286952|NCT01076088|50601877|FG001|Overall Study|Withdrawal by Subject|8|||
25286953|NCT01076088|50601878|FG002|Overall Study|Withdrawal by Subject|14|||
25286954|NCT01076088|50601879|FG003|Overall Study|Withdrawal by Subject|10|||
25286955|NCT01076088|50601880|FG004|Overall Study|Withdrawal by Subject|11|||
25286956|NCT01076088|50601881|FG005|Overall Study|Withdrawal by Subject|17|||
25286957|NCT01076088|50601876|FG000|Overall Study|Other protocol specified criteria|0|||
25286958|NCT01076088|50601877|FG001|Overall Study|Other protocol specified criteria|0|||
25286959|NCT01076088|50601878|FG002|Overall Study|Other protocol specified criteria|0|||
25286960|NCT01076088|50601879|FG003|Overall Study|Other protocol specified criteria|0|||
25286961|NCT01076088|50601880|FG004|Overall Study|Other protocol specified criteria|0|||
25286962|NCT01076088|50601881|FG005|Overall Study|Other protocol specified criteria|1|||
25286963|NCT01193348|50601896|FG000|Screening Period|Screen Failure|5|||
25286964|NCT01193348|50601896|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
25286965|NCT01193348|50601896|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
25286966|NCT01193348|50601896|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
25286967|NCT01193348|50601896|FG000|Extension Treatment Period|Physician Decision|1|||
25286968|NCT01193348|50601896|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
25169217|NCT02367456|50300583|FG002|Overall Study|Lost to Follow-up|1|||
25286969|NCT00945321|50601905|FG000|Period 1|Adverse Event|0|||
25286970|NCT00945321|50601906|FG001|Period 1|Adverse Event|0|||
25286971|NCT00945321|50601907|FG002|Period 1|Adverse Event|0|||
25286972|NCT00945321|50601908|FG003|Period 1|Adverse Event|0|||
25286973|NCT00945321|50601909|FG004|Period 1|Adverse Event|1|||
25286974|NCT00945321|50601910|FG005|Period 1|Adverse Event|0|||
25286975|NCT00945321|50601905|FG000|Period 4|Lost to Follow-up|0|||
25286976|NCT00945321|50601906|FG001|Period 4|Lost to Follow-up|0|||
25169218|NCT02367456|50300581|FG000|Overall Study|Ongoing|0|||
25286977|NCT00945321|50601907|FG002|Period 4|Lost to Follow-up|0|||
25286978|NCT00945321|50601908|FG003|Period 4|Lost to Follow-up|0|||
25286979|NCT00945321|50601909|FG004|Period 4|Lost to Follow-up|0|||
25286980|NCT00945321|50601910|FG005|Period 4|Lost to Follow-up|1|||
25286981|NCT00945243|50601928|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
25286982|NCT01192412|50601934|FG000|Overall Study|Lost to Follow-up|2|||
25286983|NCT01192412|50601935|FG001|Overall Study|Lost to Follow-up|1|||
25286984|NCT01192412|50601934|FG000|Overall Study|Withdrawal by Subject|2|||
25286985|NCT01192412|50601935|FG001|Overall Study|Withdrawal by Subject|1|||
25286986|NCT01192178|50601943|FG000|Overall Study|Withdrawal by Subject|6|||
25286987|NCT01192178|50601944|FG001|Overall Study|Withdrawal by Subject|10|||
25286988|NCT01192178|50601943|FG000|Overall Study|Protocol Violation|10|||
25286989|NCT01192178|50601944|FG001|Overall Study|Protocol Violation|3|||
25286990|NCT01192178|50601943|FG000|Overall Study|Physician Decision|2|||
25286991|NCT01192178|50601944|FG001|Overall Study|Physician Decision|4|||
25286992|NCT01192178|50601943|FG000|Overall Study|Lost to Follow-up|3|||
25286993|NCT01192178|50601944|FG001|Overall Study|Lost to Follow-up|3|||
25286994|NCT01192178|50601943|FG000|Overall Study|Adverse Event|2|||
25286995|NCT01192178|50601944|FG001|Overall Study|Adverse Event|1|||
25286996|NCT01192178|50601943|FG000|Overall Study|Lack of Efficacy|1|||
25286997|NCT01192178|50601944|FG001|Overall Study|Lack of Efficacy|2|||
25286998|NCT01192100|50601952|FG000|Overall Study|Withdrawal by Subject|0|||
25286999|NCT01192100|50601953|FG001|Overall Study|Withdrawal by Subject|0|||
25287000|NCT01192100|50601954|FG002|Overall Study|Withdrawal by Subject|0|||
25287001|NCT01192100|50601955|FG003|Overall Study|Withdrawal by Subject|0|||
25287002|NCT01192100|50601956|FG004|Overall Study|Withdrawal by Subject|1|||
25287003|NCT01192100|50601957|FG005|Overall Study|Withdrawal by Subject|0|||
25287004|NCT01192100|50601952|FG000|Overall Study|Protocol Violation|0|||
25287005|NCT01192100|50601953|FG001|Overall Study|Protocol Violation|0|||
25287006|NCT01192100|50601954|FG002|Overall Study|Protocol Violation|0|||
25287007|NCT01192100|50601955|FG003|Overall Study|Protocol Violation|1|||
25287008|NCT01192100|50601956|FG004|Overall Study|Protocol Violation|0|||
25287009|NCT01192100|50601957|FG005|Overall Study|Protocol Violation|0|||
25287010|NCT00869401|50601970|FG000|Overall Study|Withdrawal by Subject|0|||
25287011|NCT00869401|50601971|FG001|Overall Study|Withdrawal by Subject|0|||
25287012|NCT00869401|50601972|FG002|Overall Study|Withdrawal by Subject|0|||
25287013|NCT00869401|50601973|FG003|Overall Study|Withdrawal by Subject|5|||
25287014|NCT00869401|50601974|FG004|Overall Study|Withdrawal by Subject|3|||
25287015|NCT01076010|50601989|FG000|Overall Study|Death|15|||
25287016|NCT01076010|50601990|FG001|Overall Study|Death|1|||
25287017|NCT01076010|50601991|FG002|Overall Study|Death|0|||
25287018|NCT01076010|50601989|FG000|Overall Study|Adverse Event|7|||
25287019|NCT01076010|50601990|FG001|Overall Study|Adverse Event|2|||
25287020|NCT01076010|50601991|FG002|Overall Study|Adverse Event|0|||
25287021|NCT01076010|50601989|FG000|Overall Study|Progressive disease|90|||
25287022|NCT01076010|50601990|FG001|Overall Study|Progressive disease|30|||
25287023|NCT01076010|50601991|FG002|Overall Study|Progressive disease|1|||
25287024|NCT01076010|50601989|FG000|Overall Study|Lack of Efficacy|4|||
25070178|NCT02706717|50176018|FG000|Overall Study|Death|0|||
25070179|NCT02706717|50176019|FG001|Overall Study|Death|1|||
25287025|NCT01076010|50601990|FG001|Overall Study|Lack of Efficacy|0|||
25287026|NCT01076010|50601991|FG002|Overall Study|Lack of Efficacy|0|||
25287027|NCT01076010|50601989|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
25287028|NCT01076010|50601990|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
25287029|NCT01076010|50601991|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
25287030|NCT01076010|50601989|FG000|Overall Study|Significant Surgical Procedure|0|||
25287031|NCT01076010|50601990|FG001|Overall Study|Significant Surgical Procedure|1|||
25287032|NCT01076010|50601991|FG002|Overall Study|Significant Surgical Procedure|0|||
25287033|NCT01076010|50601989|FG000|Overall Study|Protocol Violation|0|||
25287034|NCT01076010|50601990|FG001|Overall Study|Protocol Violation|1|||
25287035|NCT01076010|50601991|FG002|Overall Study|Protocol Violation|0|||
25287036|NCT01076010|50601989|FG000|Overall Study|Noncompliance|1|||
25287037|NCT01076010|50601990|FG001|Overall Study|Noncompliance|1|||
25287038|NCT01076010|50601991|FG002|Overall Study|Noncompliance|0|||
25287039|NCT01076010|50601989|FG000|Overall Study|Withdrawal by Subject|3|||
25287040|NCT01076010|50601990|FG001|Overall Study|Withdrawal by Subject|0|||
25287041|NCT01076010|50601991|FG002|Overall Study|Withdrawal by Subject|1|||
25287042|NCT01076010|50601989|FG000|Overall Study|Other|5|||
25287043|NCT01076010|50601990|FG001|Overall Study|Other|2|||
25287044|NCT01076010|50601991|FG002|Overall Study|Other|0|||
25287045|NCT01075152|50602001|FG000|Overall Study|Withdrawal by Subject|1|||
25287046|NCT01075152|50602002|FG001|Overall Study|Withdrawal by Subject|0|||
25287047|NCT01078116|50602010|FG000|Overall Study|Lost to Follow-up|17|||
25287048|NCT01078116|50602010|FG000|Overall Study|Adverse Event|5|||
25287049|NCT01078116|50602010|FG000|Overall Study|Withdrawal by Subject|8|||
25287050|NCT01078116|50602010|FG000|Overall Study|Lack of effectiveness|15|||
25287051|NCT01078116|50602010|FG000|Overall Study|Case report form not completed|3|||
25287052|NCT00950859|50602016|FG000|Overall Study|Adverse Event|3|||
25287053|NCT00950859|50602017|FG001|Overall Study|Adverse Event|3|||
25287054|NCT00950859|50602016|FG000|Overall Study|Insufficient Viral Load Response|12|||
25287055|NCT00950859|50602017|FG001|Overall Study|Insufficient Viral Load Response|3|||
25287056|NCT00950859|50602016|FG000|Overall Study|Protocol Violation|1|||
25287057|NCT00950859|50602017|FG001|Overall Study|Protocol Violation|1|||
25287058|NCT00950859|50602016|FG000|Overall Study|Lost to Follow-up|0|||
25287059|NCT00950859|50602017|FG001|Overall Study|Lost to Follow-up|3|||
25287060|NCT00862849|50602023|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
25287061|NCT00862849|50602024|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
25287062|NCT00862849|50602025|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
25287063|NCT00862849|50602026|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
25287064|NCT00862849|50602027|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
25287065|NCT00862849|50602028|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
25287066|NCT00862849|50602023|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
25287067|NCT00862849|50602024|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
25287068|NCT00862849|50602025|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
25287069|NCT00862849|50602026|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
25287070|NCT00862849|50602027|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
25287071|NCT00862849|50602028|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
25287072|NCT01090050|50602038|FG000|Overall Study|Lost to Follow-up|0|||
25287073|NCT01090050|50602039|FG001|Overall Study|Lost to Follow-up|1|||
25287074|NCT01090050|50602038|FG000|Overall Study|Lack of Efficacy|1|||
25287075|NCT01090050|50602039|FG001|Overall Study|Lack of Efficacy|5|||
25287076|NCT01090050|50602038|FG000|Overall Study|Physician Decision|0|||
25287077|NCT01090050|50602039|FG001|Overall Study|Physician Decision|1|||
25287078|NCT00944229|50602049|FG000|Overall Study|Withdrawal by Subject|11|||
25287079|NCT00944229|50602049|FG000|Overall Study|Physician Decision|14|||
25287080|NCT01077960|50602053|FG000|Overall Study|Adverse Event|6|||
25287081|NCT01077960|50602053|FG000|Overall Study|Protocol Violation|3|||
25287082|NCT01077960|50602053|FG000|Overall Study|Lost to Follow-up|5|||
25287083|NCT01077960|50602053|FG000|Overall Study|Subject decision|1|||
25287084|NCT01077960|50602053|FG000|Overall Study|Reason unspecified|1|||
25287085|NCT00944697|50602059|FG000|Overall Study|Withdrawal by Subject|1|||
25287086|NCT00944697|50602060|FG001|Overall Study|Withdrawal by Subject|1|||
25287087|NCT00944697|50602059|FG000|Overall Study|Adverse Event|0|||
25287088|NCT00944697|50602060|FG001|Overall Study|Adverse Event|3|||
25287089|NCT00944697|50602059|FG000|Overall Study|Administrative|1|||
25287090|NCT00944697|50602060|FG001|Overall Study|Administrative|1|||
25287091|NCT01077804|50602066|FG000|Overall Study|Unreachable|102|||
25287092|NCT01077804|50602066|FG000|Overall Study|Refused to continue|79|||
25287093|NCT01077804|50602066|FG000|Overall Study|Other|18|||
25287094|NCT01075074|50602090|FG000|Overall Study|Surgeon changed to open incisional case|1|||
25287095|NCT01075074|50602091|FG001|Overall Study|Surgeon changed to open incisional case|2|||
25070180|NCT01331837|50176027|FG000|Overall Study|Death|30|||
25287096|NCT01075074|50602092|FG002|Overall Study|Surgeon changed to open incisional case|2|||
25287097|NCT00866281|50602106|FG000|Overall Study|Adverse Event|1|||
25287098|NCT00866281|50602107|FG001|Overall Study|Adverse Event|0|||
25287099|NCT00866281|50602106|FG000|Overall Study|Withdrawal by participants|3|||
25287100|NCT00866281|50602107|FG001|Overall Study|Withdrawal by participants|0|||
25070181|NCT01331837|50176028|FG001|Overall Study|Death|34|||
25287101|NCT00866281|50602106|FG000|Overall Study|Disease progression|3|||
25287102|NCT00866281|50602107|FG001|Overall Study|Disease progression|11|||
25287103|NCT00866281|50602106|FG000|Overall Study|New cancer therapy|0|||
25287104|NCT00866281|50602107|FG001|Overall Study|New cancer therapy|4|||
25287105|NCT01077258|50602116|FG000|Overall Study|Lost to Follow-up|1390|||
25287106|NCT01077258|50602116|FG000|Overall Study|Adverse drug reaction|218|||
25287107|NCT01077258|50602116|FG000|Overall Study|Lack of Efficacy|663|||
25287108|NCT01077258|50602116|FG000|Overall Study|Clinical remission|37|||
25287109|NCT01077258|50602116|FG000|Overall Study|Other reasons|260|||
25287110|NCT00943917|50602144|FG000|Stage I|Adverse Event|1|||
25287111|NCT00943917|50602145|FG001|Stage I|Adverse Event|2|||
25287112|NCT00943917|50602146|FG002|Stage I|Adverse Event|2|||
25287113|NCT00943917|50602147|FG003|Stage I|Adverse Event|0|||
25287114|NCT00943917|50602148|FG004|Stage I|Adverse Event|0|||
25287115|NCT00943917|50602149|FG005|Stage I|Adverse Event|0|||
25287116|NCT00943917|50602150|FG006|Stage I|Adverse Event|0|||
25287117|NCT00943917|50602151|FG007|Stage I|Adverse Event|0|||
25287118|NCT00943917|50602152|FG008|Stage I|Adverse Event|0|||
25287119|NCT00943917|50602153|FG009|Stage I|Adverse Event|0|||
25287120|NCT00943917|50602154|FG010|Stage I|Adverse Event|0|||
25287121|NCT00943917|50602155|FG011|Stage I|Adverse Event|0|||
25287122|NCT00943917|50602156|FG012|Stage I|Adverse Event|0|||
25287123|NCT00943917|50602157|FG013|Stage I|Adverse Event|0|||
25287124|NCT00943917|50602158|FG014|Stage I|Adverse Event|0|||
25287125|NCT00943917|50602144|FG000|Stage I|Lost to Follow-up|0|||
25287126|NCT00943917|50602145|FG001|Stage I|Lost to Follow-up|0|||
25287127|NCT00943917|50602146|FG002|Stage I|Lost to Follow-up|1|||
25287128|NCT00943917|50602147|FG003|Stage I|Lost to Follow-up|0|||
25287129|NCT00943917|50602148|FG004|Stage I|Lost to Follow-up|0|||
25287130|NCT00943917|50602149|FG005|Stage I|Lost to Follow-up|0|||
25287131|NCT00943917|50602150|FG006|Stage I|Lost to Follow-up|0|||
25287132|NCT00943917|50602151|FG007|Stage I|Lost to Follow-up|0|||
25287133|NCT00943917|50602152|FG008|Stage I|Lost to Follow-up|0|||
25287134|NCT00943917|50602153|FG009|Stage I|Lost to Follow-up|0|||
25287135|NCT00943917|50602154|FG010|Stage I|Lost to Follow-up|0|||
25287136|NCT00943917|50602155|FG011|Stage I|Lost to Follow-up|0|||
25287137|NCT00943917|50602156|FG012|Stage I|Lost to Follow-up|0|||
25287138|NCT00943917|50602157|FG013|Stage I|Lost to Follow-up|0|||
25287139|NCT00943917|50602158|FG014|Stage I|Lost to Follow-up|0|||
25287140|NCT00943917|50602144|FG000|Stage I|hyperglycemia|0|||
25287141|NCT00943917|50602145|FG001|Stage I|hyperglycemia|0|||
25287142|NCT00943917|50602146|FG002|Stage I|hyperglycemia|1|||
25287143|NCT00943917|50602147|FG003|Stage I|hyperglycemia|0|||
25287144|NCT00943917|50602148|FG004|Stage I|hyperglycemia|0|||
25287145|NCT00943917|50602149|FG005|Stage I|hyperglycemia|0|||
25287146|NCT00943917|50602150|FG006|Stage I|hyperglycemia|0|||
25287147|NCT00943917|50602151|FG007|Stage I|hyperglycemia|0|||
25287148|NCT00943917|50602152|FG008|Stage I|hyperglycemia|0|||
25287149|NCT00943917|50602153|FG009|Stage I|hyperglycemia|0|||
25287150|NCT00943917|50602154|FG010|Stage I|hyperglycemia|0|||
25287151|NCT00943917|50602155|FG011|Stage I|hyperglycemia|0|||
25287152|NCT00943917|50602156|FG012|Stage I|hyperglycemia|0|||
25287153|NCT00943917|50602157|FG013|Stage I|hyperglycemia|0|||
25287154|NCT00943917|50602158|FG014|Stage I|hyperglycemia|0|||
25287155|NCT00943917|50602144|FG000|Stage I|A1C elevation|1|||
25287156|NCT00943917|50602145|FG001|Stage I|A1C elevation|0|||
25287157|NCT00943917|50602146|FG002|Stage I|A1C elevation|0|||
25287158|NCT00943917|50602147|FG003|Stage I|A1C elevation|0|||
25287159|NCT00943917|50602148|FG004|Stage I|A1C elevation|0|||
25287160|NCT00943917|50602149|FG005|Stage I|A1C elevation|0|||
25287161|NCT00943917|50602150|FG006|Stage I|A1C elevation|0|||
25287162|NCT00943917|50602151|FG007|Stage I|A1C elevation|0|||
25287163|NCT00943917|50602152|FG008|Stage I|A1C elevation|0|||
25287164|NCT00943917|50602153|FG009|Stage I|A1C elevation|0|||
25287165|NCT00943917|50602154|FG010|Stage I|A1C elevation|0|||
25287166|NCT00943917|50602155|FG011|Stage I|A1C elevation|0|||
25287167|NCT00943917|50602156|FG012|Stage I|A1C elevation|0|||
25287168|NCT00943917|50602157|FG013|Stage I|A1C elevation|0|||
25070182|NCT01331837|50176027|FG000|Overall Study|Lost to Follow-up|3|||
25287169|NCT00943917|50602158|FG014|Stage I|A1C elevation|0|||
25287170|NCT00943917|50602144|FG000|Stage I|Withdrawal by Subject|2|||
25287171|NCT00943917|50602145|FG001|Stage I|Withdrawal by Subject|1|||
25287172|NCT00943917|50602146|FG002|Stage I|Withdrawal by Subject|2|||
25287173|NCT00943917|50602147|FG003|Stage I|Withdrawal by Subject|0|||
25287174|NCT00943917|50602148|FG004|Stage I|Withdrawal by Subject|0|||
25287175|NCT00943917|50602149|FG005|Stage I|Withdrawal by Subject|0|||
25287176|NCT00943917|50602150|FG006|Stage I|Withdrawal by Subject|0|||
25287177|NCT00943917|50602151|FG007|Stage I|Withdrawal by Subject|0|||
25287178|NCT00943917|50602152|FG008|Stage I|Withdrawal by Subject|0|||
25287179|NCT00943917|50602153|FG009|Stage I|Withdrawal by Subject|0|||
25287180|NCT00943917|50602154|FG010|Stage I|Withdrawal by Subject|0|||
25287181|NCT00943917|50602155|FG011|Stage I|Withdrawal by Subject|0|||
25287182|NCT00943917|50602156|FG012|Stage I|Withdrawal by Subject|0|||
25287183|NCT00943917|50602157|FG013|Stage I|Withdrawal by Subject|0|||
25287184|NCT00943917|50602158|FG014|Stage I|Withdrawal by Subject|0|||
25287185|NCT00943917|50602144|FG000|Stage II|Adverse Event|0|||
25287186|NCT00943917|50602145|FG001|Stage II|Adverse Event|0|||
25287187|NCT00943917|50602146|FG002|Stage II|Adverse Event|0|||
25287188|NCT00943917|50602147|FG003|Stage II|Adverse Event|0|||
25287189|NCT00943917|50602148|FG004|Stage II|Adverse Event|0|||
25287190|NCT00943917|50602149|FG005|Stage II|Adverse Event|1|||
25287191|NCT00943917|50602150|FG006|Stage II|Adverse Event|3|||
25287192|NCT00943917|50602151|FG007|Stage II|Adverse Event|0|||
25287193|NCT00943917|50602152|FG008|Stage II|Adverse Event|1|||
25287194|NCT00943917|50602153|FG009|Stage II|Adverse Event|0|||
25287195|NCT00943917|50602154|FG010|Stage II|Adverse Event|0|||
25287196|NCT00943917|50602155|FG011|Stage II|Adverse Event|0|||
25287197|NCT00943917|50602156|FG012|Stage II|Adverse Event|0|||
25287198|NCT00943917|50602157|FG013|Stage II|Adverse Event|0|||
25287199|NCT00943917|50602158|FG014|Stage II|Adverse Event|0|||
25287200|NCT00943917|50602144|FG000|Stage II|Withdrawal by Subject|0|||
25287201|NCT00943917|50602145|FG001|Stage II|Withdrawal by Subject|0|||
25287202|NCT00943917|50602146|FG002|Stage II|Withdrawal by Subject|0|||
25287203|NCT00943917|50602147|FG003|Stage II|Withdrawal by Subject|0|||
25287204|NCT00943917|50602148|FG004|Stage II|Withdrawal by Subject|0|||
25287205|NCT00943917|50602149|FG005|Stage II|Withdrawal by Subject|1|||
25287206|NCT00943917|50602150|FG006|Stage II|Withdrawal by Subject|0|||
25287207|NCT00943917|50602151|FG007|Stage II|Withdrawal by Subject|0|||
25287208|NCT00943917|50602152|FG008|Stage II|Withdrawal by Subject|0|||
25287209|NCT00943917|50602153|FG009|Stage II|Withdrawal by Subject|0|||
25287210|NCT00943917|50602154|FG010|Stage II|Withdrawal by Subject|0|||
25287211|NCT00943917|50602155|FG011|Stage II|Withdrawal by Subject|0|||
25287212|NCT00943917|50602156|FG012|Stage II|Withdrawal by Subject|0|||
25287213|NCT00943917|50602157|FG013|Stage II|Withdrawal by Subject|0|||
25287214|NCT00943917|50602158|FG014|Stage II|Withdrawal by Subject|0|||
25287215|NCT00943917|50602144|FG000|Stage II|Pregnancy|0|||
25287216|NCT00943917|50602145|FG001|Stage II|Pregnancy|0|||
25287217|NCT00943917|50602146|FG002|Stage II|Pregnancy|0|||
25287218|NCT00943917|50602147|FG003|Stage II|Pregnancy|0|||
25287219|NCT00943917|50602148|FG004|Stage II|Pregnancy|0|||
25287220|NCT00943917|50602149|FG005|Stage II|Pregnancy|1|||
25287221|NCT00943917|50602150|FG006|Stage II|Pregnancy|0|||
25287222|NCT00943917|50602151|FG007|Stage II|Pregnancy|0|||
25287223|NCT00943917|50602152|FG008|Stage II|Pregnancy|0|||
25287224|NCT00943917|50602153|FG009|Stage II|Pregnancy|0|||
25287225|NCT00943917|50602154|FG010|Stage II|Pregnancy|0|||
25287226|NCT00943917|50602155|FG011|Stage II|Pregnancy|0|||
25287227|NCT00943917|50602156|FG012|Stage II|Pregnancy|0|||
25287228|NCT00943917|50602157|FG013|Stage II|Pregnancy|0|||
25287229|NCT00943917|50602158|FG014|Stage II|Pregnancy|0|||
25287230|NCT00943917|50602144|FG000|Stage II Continuation|Adverse Event|0|||
25287231|NCT00943917|50602145|FG001|Stage II Continuation|Adverse Event|0|||
25287232|NCT00943917|50602146|FG002|Stage II Continuation|Adverse Event|0|||
25287233|NCT00943917|50602147|FG003|Stage II Continuation|Adverse Event|0|||
25287234|NCT00943917|50602148|FG004|Stage II Continuation|Adverse Event|0|||
25287235|NCT00943917|50602149|FG005|Stage II Continuation|Adverse Event|0|||
25287236|NCT00943917|50602150|FG006|Stage II Continuation|Adverse Event|0|||
25287237|NCT00943917|50602151|FG007|Stage II Continuation|Adverse Event|0|||
25287238|NCT00943917|50602152|FG008|Stage II Continuation|Adverse Event|0|||
25287239|NCT00943917|50602153|FG009|Stage II Continuation|Adverse Event|0|||
25287240|NCT00943917|50602154|FG010|Stage II Continuation|Adverse Event|0|||
25287241|NCT00943917|50602155|FG011|Stage II Continuation|Adverse Event|1|||
25287242|NCT00943917|50602156|FG012|Stage II Continuation|Adverse Event|2|||
25287243|NCT00943917|50602157|FG013|Stage II Continuation|Adverse Event|1|||
25287244|NCT00943917|50602158|FG014|Stage II Continuation|Adverse Event|1|||
25287245|NCT00943917|50602144|FG000|Stage II Continuation|Withdrawal by Subject|0|||
25287246|NCT00943917|50602145|FG001|Stage II Continuation|Withdrawal by Subject|0|||
25287247|NCT00943917|50602146|FG002|Stage II Continuation|Withdrawal by Subject|0|||
25287248|NCT00943917|50602147|FG003|Stage II Continuation|Withdrawal by Subject|0|||
25287249|NCT00943917|50602148|FG004|Stage II Continuation|Withdrawal by Subject|0|||
25287250|NCT00943917|50602149|FG005|Stage II Continuation|Withdrawal by Subject|0|||
25287251|NCT00943917|50602150|FG006|Stage II Continuation|Withdrawal by Subject|0|||
25287252|NCT00943917|50602151|FG007|Stage II Continuation|Withdrawal by Subject|0|||
25287253|NCT00943917|50602152|FG008|Stage II Continuation|Withdrawal by Subject|0|||
25287254|NCT00943917|50602153|FG009|Stage II Continuation|Withdrawal by Subject|0|||
25287255|NCT00943917|50602154|FG010|Stage II Continuation|Withdrawal by Subject|0|||
25287256|NCT00943917|50602155|FG011|Stage II Continuation|Withdrawal by Subject|0|||
25287257|NCT00943917|50602156|FG012|Stage II Continuation|Withdrawal by Subject|0|||
25287258|NCT00943917|50602157|FG013|Stage II Continuation|Withdrawal by Subject|1|||
25287259|NCT00943917|50602158|FG014|Stage II Continuation|Withdrawal by Subject|3|||
25287260|NCT00943917|50602144|FG000|Stage II Continuation|Protocol Violation|0|||
25287261|NCT00943917|50602145|FG001|Stage II Continuation|Protocol Violation|0|||
25287262|NCT00943917|50602146|FG002|Stage II Continuation|Protocol Violation|0|||
25287263|NCT00943917|50602147|FG003|Stage II Continuation|Protocol Violation|0|||
25287264|NCT00943917|50602148|FG004|Stage II Continuation|Protocol Violation|0|||
25287265|NCT00943917|50602149|FG005|Stage II Continuation|Protocol Violation|0|||
25287266|NCT00943917|50602150|FG006|Stage II Continuation|Protocol Violation|0|||
25287267|NCT00943917|50602151|FG007|Stage II Continuation|Protocol Violation|0|||
25287268|NCT00943917|50602152|FG008|Stage II Continuation|Protocol Violation|0|||
25287269|NCT00943917|50602153|FG009|Stage II Continuation|Protocol Violation|1|||
25287270|NCT00943917|50602154|FG010|Stage II Continuation|Protocol Violation|0|||
25287271|NCT00943917|50602155|FG011|Stage II Continuation|Protocol Violation|1|||
25287272|NCT00943917|50602156|FG012|Stage II Continuation|Protocol Violation|0|||
25287273|NCT00943917|50602157|FG013|Stage II Continuation|Protocol Violation|0|||
25287274|NCT00943917|50602158|FG014|Stage II Continuation|Protocol Violation|0|||
25287275|NCT00943917|50602144|FG000|Stage II Continuation|hypoglycemia|0|||
25287276|NCT00943917|50602145|FG001|Stage II Continuation|hypoglycemia|0|||
25287277|NCT00943917|50602146|FG002|Stage II Continuation|hypoglycemia|0|||
25287278|NCT00943917|50602147|FG003|Stage II Continuation|hypoglycemia|0|||
25287279|NCT00943917|50602148|FG004|Stage II Continuation|hypoglycemia|0|||
25287280|NCT00943917|50602149|FG005|Stage II Continuation|hypoglycemia|0|||
25287281|NCT00943917|50602150|FG006|Stage II Continuation|hypoglycemia|0|||
25287282|NCT00943917|50602151|FG007|Stage II Continuation|hypoglycemia|0|||
25287283|NCT00943917|50602152|FG008|Stage II Continuation|hypoglycemia|0|||
25287284|NCT00943917|50602153|FG009|Stage II Continuation|hypoglycemia|0|||
25287285|NCT00943917|50602154|FG010|Stage II Continuation|hypoglycemia|0|||
25287286|NCT00943917|50602155|FG011|Stage II Continuation|hypoglycemia|0|||
25287287|NCT00943917|50602156|FG012|Stage II Continuation|hypoglycemia|1|||
25287288|NCT00943917|50602157|FG013|Stage II Continuation|hypoglycemia|0|||
25287289|NCT00943917|50602158|FG014|Stage II Continuation|hypoglycemia|0|||
25287290|NCT00943917|50602144|FG000|Stage II Continuation|A1C elevation|0|||
25287291|NCT00943917|50602145|FG001|Stage II Continuation|A1C elevation|0|||
25287292|NCT00943917|50602146|FG002|Stage II Continuation|A1C elevation|0|||
25287293|NCT00943917|50602147|FG003|Stage II Continuation|A1C elevation|0|||
25287294|NCT00943917|50602148|FG004|Stage II Continuation|A1C elevation|0|||
25287295|NCT00943917|50602149|FG005|Stage II Continuation|A1C elevation|0|||
25287296|NCT00943917|50602150|FG006|Stage II Continuation|A1C elevation|0|||
25287297|NCT00943917|50602151|FG007|Stage II Continuation|A1C elevation|0|||
25287298|NCT00943917|50602152|FG008|Stage II Continuation|A1C elevation|0|||
25287299|NCT00943917|50602153|FG009|Stage II Continuation|A1C elevation|0|||
25287300|NCT00943917|50602154|FG010|Stage II Continuation|A1C elevation|0|||
25287301|NCT00943917|50602155|FG011|Stage II Continuation|A1C elevation|0|||
25287302|NCT00943917|50602156|FG012|Stage II Continuation|A1C elevation|0|||
25287303|NCT00943917|50602157|FG013|Stage II Continuation|A1C elevation|1|||
25287304|NCT00943917|50602158|FG014|Stage II Continuation|A1C elevation|0|||
25287305|NCT01077024|50602193|FG000|Overall Study|Lost to Follow-up|20|||
25287306|NCT01077024|50602194|FG001|Overall Study|Lost to Follow-up|14|||
25287307|NCT01077024|50602193|FG000|Overall Study|Withdrawal by Subject|0|||
25287308|NCT01077024|50602194|FG001|Overall Study|Withdrawal by Subject|2|||
25287309|NCT01077024|50602193|FG000|Overall Study|Incarcerated|7|||
25287310|NCT01077024|50602194|FG001|Overall Study|Incarcerated|8|||
25287311|NCT01077024|50602193|FG000|Overall Study|Other|4|||
25287312|NCT01077024|50602194|FG001|Overall Study|Other|4|||
25287313|NCT01089582|50602200|FG000|Overall Study|Death|2|||
25287314|NCT01089582|50602200|FG000|Overall Study|Adverse Event|15|||
25287315|NCT01089582|50602200|FG000|Overall Study|Lost to Follow-up|8|||
25287316|NCT01089582|50602200|FG000|Overall Study|Other|4|||
25287317|NCT01089582|50602200|FG000|Overall Study|Withdrawal by Subject|1|||
25287318|NCT00862459|50602207|FG000|Overall Study|Lost to Follow-up|1|||
25287319|NCT00862459|50602208|FG001|Overall Study|Lost to Follow-up|2|||
25287320|NCT00862459|50602209|FG002|Overall Study|Lost to Follow-up|2|||
25287321|NCT00862459|50602207|FG000|Overall Study|Protocol Violation|1|||
25287322|NCT00862459|50602208|FG001|Overall Study|Protocol Violation|0|||
25287323|NCT00862459|50602209|FG002|Overall Study|Protocol Violation|0|||
25287324|NCT00862459|50602207|FG000|Overall Study|Withdrawal by Subject|1|||
25287325|NCT00862459|50602208|FG001|Overall Study|Withdrawal by Subject|1|||
25287326|NCT00862459|50602209|FG002|Overall Study|Withdrawal by Subject|3|||
25287327|NCT00862459|50602207|FG000|Overall Study|Adverse Event|0|||
25287328|NCT00862459|50602208|FG001|Overall Study|Adverse Event|1|||
25287329|NCT00862459|50602209|FG002|Overall Study|Adverse Event|0|||
25287330|NCT00862459|50602207|FG000|Overall Study|Personal reasons|1|||
25287331|NCT00862459|50602208|FG001|Overall Study|Personal reasons|0|||
25287332|NCT00862459|50602209|FG002|Overall Study|Personal reasons|0|||
25287333|NCT00862459|50602207|FG000|Overall Study|Operation|1|||
25287334|NCT00862459|50602208|FG001|Overall Study|Operation|1|||
25287335|NCT00862459|50602209|FG002|Overall Study|Operation|0|||
25287336|NCT00862459|50602207|FG000|Overall Study|Intravenous (IV) site problems|1|||
25287337|NCT00862459|50602208|FG001|Overall Study|Intravenous (IV) site problems|0|||
25287338|NCT00862459|50602209|FG002|Overall Study|Intravenous (IV) site problems|1|||
25287339|NCT00862459|50602207|FG000|Overall Study|Unable to hold still for imaging|0|||
25287340|NCT00862459|50602208|FG001|Overall Study|Unable to hold still for imaging|1|||
25287341|NCT00862459|50602209|FG002|Overall Study|Unable to hold still for imaging|0|||
25287342|NCT00862459|50602207|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
25287343|NCT00862459|50602208|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
25287344|NCT00862459|50602209|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
25287345|NCT00862459|50602207|FG000|Overall Study|Administrative problems|0|||
25287346|NCT00862459|50602208|FG001|Overall Study|Administrative problems|1|||
25287347|NCT00862459|50602209|FG002|Overall Study|Administrative problems|0|||
25287348|NCT00580047|50602221|FG000|Overall Study|Lost to Follow-up|1|||
25287349|NCT00580047|50602222|FG001|Overall Study|Lost to Follow-up|1|||
25287350|NCT00580047|50602223|FG002|Overall Study|Lost to Follow-up|0|||
25287351|NCT00580047|50602221|FG000|Overall Study|Withdrawal by Subject|1|||
25287352|NCT00580047|50602222|FG001|Overall Study|Withdrawal by Subject|1|||
25287353|NCT00580047|50602223|FG002|Overall Study|Withdrawal by Subject|2|||
25287354|NCT00580047|50602221|FG000|Overall Study|Withdrawal by Subject|1|||
25287355|NCT00580047|50602222|FG001|Overall Study|Withdrawal by Subject|0|||
25287356|NCT00580047|50602223|FG002|Overall Study|Withdrawal by Subject|0|||
25287357|NCT01074450|50602236|FG000|First Intervention|Emesis in Dosing Interval|0|||
25287358|NCT01074450|50602237|FG001|First Intervention|Emesis in Dosing Interval|2|||
25287359|NCT01074450|50602236|FG000|Second Intervention|Protocol Violation|1|||
25287360|NCT01074450|50602237|FG001|Second Intervention|Protocol Violation|0|||
25287361|NCT01074450|50602236|FG000|Second Intervention|Physician Decision|0|||
25287362|NCT01074450|50602237|FG001|Second Intervention|Physician Decision|1|||
25287363|NCT00943761|50602245|FG000|Overall Study|Lost to Follow-up|2|||
25287364|NCT00943761|50602246|FG001|Overall Study|Lost to Follow-up|0|||
25287365|NCT00943761|50602245|FG000|Overall Study|Withdrawal by Subject|2|||
25287366|NCT00943761|50602246|FG001|Overall Study|Withdrawal by Subject|1|||
24969664|NCT00097500|50059115|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
24969665|NCT00097500|50059116|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
24969666|NCT04551898|50059126|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
24969667|NCT04551898|50059127|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
24969668|NCT04551898|50059128|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
24969669|NCT04551898|50059129|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
25287367|NCT00949533|50602254|FG000|Overall Study|Lost to Follow-up|0|||
25287368|NCT00949533|50602255|FG001|Overall Study|Lost to Follow-up|1|||
25287369|NCT00866047|50602261|FG000|Treatment Period|Progressive disease|13|||
25287370|NCT00866047|50602261|FG000|Treatment Period|Adverse Event|16|||
25287371|NCT00866047|50602261|FG000|Treatment Period|Physician Decision|14|||
25287372|NCT00866047|50602261|FG000|Treatment Period|Withdrawal by Subject|5|||
25287373|NCT00866047|50602261|FG000|Follow-up Period|Lost to Follow-up|5|||
25287374|NCT00869323|50602265|FG000|Maintenance Therapy|concurrent illness|1|||
25287375|NCT01192022|50602273|FG000|Overall Study|Withdrawal of Consent|3|||
25287376|NCT01192022|50602274|FG001|Overall Study|Withdrawal of Consent|1|||
25287377|NCT01192022|50602275|FG002|Overall Study|Withdrawal of Consent|0|||
25287378|NCT01192022|50602276|FG003|Overall Study|Withdrawal of Consent|0|||
25287379|NCT01192022|50602277|FG004|Overall Study|Withdrawal of Consent|0|||
25287380|NCT01192022|50602273|FG000|Overall Study|Lost to Follow-up|4|||
25287381|NCT01192022|50602274|FG001|Overall Study|Lost to Follow-up|2|||
25287382|NCT01192022|50602275|FG002|Overall Study|Lost to Follow-up|1|||
25287383|NCT01192022|50602276|FG003|Overall Study|Lost to Follow-up|1|||
25287384|NCT01192022|50602277|FG004|Overall Study|Lost to Follow-up|0|||
25287385|NCT01192022|50602273|FG000|Overall Study|Adverse Event|1|||
25287386|NCT01192022|50602274|FG001|Overall Study|Adverse Event|0|||
25287387|NCT01192022|50602275|FG002|Overall Study|Adverse Event|0|||
25287388|NCT01192022|50602276|FG003|Overall Study|Adverse Event|0|||
25287389|NCT01192022|50602277|FG004|Overall Study|Adverse Event|0|||
25287390|NCT01192022|50602273|FG000|Overall Study|Fatal Adverse Event|4|||
25287391|NCT01192022|50602274|FG001|Overall Study|Fatal Adverse Event|6|||
25287392|NCT01192022|50602275|FG002|Overall Study|Fatal Adverse Event|0|||
25287393|NCT01192022|50602276|FG003|Overall Study|Fatal Adverse Event|0|||
25287394|NCT01192022|50602277|FG004|Overall Study|Fatal Adverse Event|1|||
25287395|NCT01192022|50602273|FG000|Overall Study|Physician withdrew-patient hardship|1|||
25287396|NCT01192022|50602274|FG001|Overall Study|Physician withdrew-patient hardship|0|||
25287397|NCT01192022|50602275|FG002|Overall Study|Physician withdrew-patient hardship|0|||
25287398|NCT01192022|50602276|FG003|Overall Study|Physician withdrew-patient hardship|0|||
25287399|NCT01192022|50602277|FG004|Overall Study|Physician withdrew-patient hardship|0|||
25287400|NCT01192022|50602273|FG000|Overall Study|Patient too sick from chemotherapy|0|||
25287401|NCT01192022|50602274|FG001|Overall Study|Patient too sick from chemotherapy|1|||
25287402|NCT01192022|50602275|FG002|Overall Study|Patient too sick from chemotherapy|0|||
25287403|NCT01192022|50602276|FG003|Overall Study|Patient too sick from chemotherapy|0|||
25287404|NCT01192022|50602277|FG004|Overall Study|Patient too sick from chemotherapy|0|||
25287405|NCT01192022|50602273|FG000|Overall Study|Patient needed surgery|0|||
25287406|NCT01192022|50602274|FG001|Overall Study|Patient needed surgery|1|||
25287407|NCT01192022|50602275|FG002|Overall Study|Patient needed surgery|0|||
25287408|NCT01192022|50602276|FG003|Overall Study|Patient needed surgery|0|||
25287409|NCT01192022|50602277|FG004|Overall Study|Patient needed surgery|0|||
25287410|NCT01192022|50602273|FG000|Overall Study|Parents did not allow all follow up|0|||
25287411|NCT01192022|50602274|FG001|Overall Study|Parents did not allow all follow up|0|||
25287412|NCT01192022|50602275|FG002|Overall Study|Parents did not allow all follow up|0|||
25287413|NCT01192022|50602276|FG003|Overall Study|Parents did not allow all follow up|1|||
25287414|NCT01192022|50602277|FG004|Overall Study|Parents did not allow all follow up|0|||
25287415|NCT01191944|50602290|FG000|Overall Study|Adverse Event|11|||
25287416|NCT01191944|50602291|FG001|Overall Study|Adverse Event|12|||
25070183|NCT01331837|50176028|FG001|Overall Study|Lost to Follow-up|1|||
25070184|NCT01331837|50176027|FG000|Overall Study|Info not recorded|10|||
25287417|NCT01191944|50602290|FG000|Overall Study|Protocol Violation|1|||
25287418|NCT01191944|50602291|FG001|Overall Study|Protocol Violation|2|||
25287419|NCT01191944|50602290|FG000|Overall Study|Withdrawal by Subject|4|||
25287420|NCT01191944|50602291|FG001|Overall Study|Withdrawal by Subject|2|||
25287421|NCT01191944|50602290|FG000|Overall Study|Other|1|||
25287422|NCT01191944|50602291|FG001|Overall Study|Other|3|||
25287423|NCT01191788|50602299|FG000|Overall Study|Lost to Follow-up|21|||
25287424|NCT01191788|50602300|FG001|Overall Study|Lost to Follow-up|22|||
25287425|NCT00940875|50602309|FG000|Treatment Phase|Adverse Event|9|||
25287426|NCT00940875|50602310|FG001|Treatment Phase|Adverse Event|3|||
25287427|NCT00940875|50602309|FG000|Treatment Phase|Death|3|||
25287428|NCT00940875|50602310|FG001|Treatment Phase|Death|5|||
25287429|NCT00940875|50602309|FG000|Treatment Phase|Lack of Efficacy|1|||
25287430|NCT00940875|50602310|FG001|Treatment Phase|Lack of Efficacy|0|||
25287431|NCT00940875|50602309|FG000|Treatment Phase|Withdrawal by Subject|3|||
25287432|NCT00940875|50602310|FG001|Treatment Phase|Withdrawal by Subject|0|||
25287433|NCT00940875|50602309|FG000|Treatment Phase|Disease progression|9|||
25287434|NCT00940875|50602310|FG001|Treatment Phase|Disease progression|11|||
25287435|NCT00940875|50602309|FG000|Treatment Phase|Physician Decision|1|||
25287436|NCT00940875|50602310|FG001|Treatment Phase|Physician Decision|0|||
25287437|NCT00940875|50602309|FG000|Post-Study Treatment|Death|0|||
25287438|NCT00940875|50602310|FG001|Post-Study Treatment|Death|1|||
25287439|NCT00940875|50602309|FG000|Post-Study Treatment|Disease Progression|0|||
25287440|NCT00940875|50602310|FG001|Post-Study Treatment|Disease Progression|2|||
25287441|NCT00940485|50602319|FG000|Overall Study|HBeAb positive at Baseline|3|||
25287442|NCT00940485|50602320|FG001|Overall Study|HBeAb positive at Baseline|2|||
25287443|NCT00940485|50602319|FG000|Overall Study|Lost to Follow-up|2|||
25287444|NCT00940485|50602320|FG001|Overall Study|Lost to Follow-up|3|||
25287445|NCT00940485|50602319|FG000|Overall Study|Adverse Event|8|||
25287446|NCT00940485|50602320|FG001|Overall Study|Adverse Event|0|||
25287447|NCT00940485|50602319|FG000|Overall Study|Withdrawal by Subject|1|||
25287448|NCT00940485|50602320|FG001|Overall Study|Withdrawal by Subject|1|||
25287449|NCT00940485|50602319|FG000|Overall Study|Others|1|||
25287450|NCT00940485|50602320|FG001|Overall Study|Others|1|||
25287451|NCT00943605|50602328|FG000|Overall Study|Study termination|30|||
25287452|NCT00943605|50602329|FG001|Overall Study|Study termination|30|||
24969670|NCT04551898|50059126|FG000|Overall Study|Withdrawal by Subject|5|||
25287453|NCT01132313|50602347|FG000|Overall Study|Lack of Efficacy|1|||
25287454|NCT01132313|50602348|FG001|Overall Study|Lack of Efficacy|0|||
25287455|NCT01132313|50602349|FG002|Overall Study|Lack of Efficacy|0|||
25287456|NCT01132313|50602350|FG003|Overall Study|Lack of Efficacy|0|||
25287457|NCT01132313|50602351|FG004|Overall Study|Lack of Efficacy|0|||
25287458|NCT01132313|50602352|FG005|Overall Study|Lack of Efficacy|0|||
25287459|NCT01132313|50602353|FG006|Overall Study|Lack of Efficacy|0|||
25287460|NCT01132313|50602354|FG007|Overall Study|Lack of Efficacy|3|||
25287461|NCT01132313|50602355|FG008|Overall Study|Lack of Efficacy|14|||
25287462|NCT01132313|50602356|FG009|Overall Study|Lack of Efficacy|16|||
25287463|NCT01132313|50602357|FG010|Overall Study|Lack of Efficacy|0|||
25287464|NCT01132313|50602358|FG011|Overall Study|Lack of Efficacy|0|||
25287465|NCT01132313|50602347|FG000|Overall Study|Not treated|2|||
25287466|NCT01132313|50602348|FG001|Overall Study|Not treated|0|||
25287467|NCT01132313|50602349|FG002|Overall Study|Not treated|0|||
25287468|NCT01132313|50602350|FG003|Overall Study|Not treated|0|||
25287469|NCT01132313|50602351|FG004|Overall Study|Not treated|2|||
25287470|NCT01132313|50602352|FG005|Overall Study|Not treated|1|||
25287471|NCT01132313|50602353|FG006|Overall Study|Not treated|3|||
25287472|NCT01132313|50602354|FG007|Overall Study|Not treated|0|||
25287473|NCT01132313|50602355|FG008|Overall Study|Not treated|0|||
25287474|NCT01132313|50602356|FG009|Overall Study|Not treated|0|||
25287475|NCT01132313|50602357|FG010|Overall Study|Not treated|0|||
25287476|NCT01132313|50602358|FG011|Overall Study|Not treated|0|||
25287477|NCT01132313|50602347|FG000|Overall Study|Adverse Event|0|||
25287478|NCT01132313|50602348|FG001|Overall Study|Adverse Event|0|||
25287479|NCT01132313|50602349|FG002|Overall Study|Adverse Event|4|||
25287480|NCT01132313|50602350|FG003|Overall Study|Adverse Event|10|||
25287481|NCT01132313|50602351|FG004|Overall Study|Adverse Event|19|||
25287482|NCT01132313|50602352|FG005|Overall Study|Adverse Event|6|||
25287483|NCT01132313|50602353|FG006|Overall Study|Adverse Event|5|||
25287484|NCT01132313|50602354|FG007|Overall Study|Adverse Event|3|||
25287485|NCT01132313|50602355|FG008|Overall Study|Adverse Event|7|||
25287486|NCT01132313|50602356|FG009|Overall Study|Adverse Event|2|||
25287487|NCT01132313|50602357|FG010|Overall Study|Adverse Event|0|||
25287488|NCT01132313|50602358|FG011|Overall Study|Adverse Event|0|||
25287489|NCT01132313|50602347|FG000|Overall Study|Protocol Violation|0|||
25287490|NCT01132313|50602348|FG001|Overall Study|Protocol Violation|0|||
25287491|NCT01132313|50602349|FG002|Overall Study|Protocol Violation|0|||
25287492|NCT01132313|50602350|FG003|Overall Study|Protocol Violation|1|||
25287493|NCT01132313|50602351|FG004|Overall Study|Protocol Violation|0|||
25287494|NCT01132313|50602352|FG005|Overall Study|Protocol Violation|0|||
25287495|NCT01132313|50602353|FG006|Overall Study|Protocol Violation|0|||
25287496|NCT01132313|50602354|FG007|Overall Study|Protocol Violation|0|||
25287497|NCT01132313|50602355|FG008|Overall Study|Protocol Violation|0|||
25287498|NCT01132313|50602356|FG009|Overall Study|Protocol Violation|0|||
25287499|NCT01132313|50602357|FG010|Overall Study|Protocol Violation|0|||
25287500|NCT01132313|50602358|FG011|Overall Study|Protocol Violation|0|||
25287501|NCT01132313|50602347|FG000|Overall Study|Lost to Follow-up|0|||
25287502|NCT01132313|50602348|FG001|Overall Study|Lost to Follow-up|0|||
25287503|NCT01132313|50602349|FG002|Overall Study|Lost to Follow-up|1|||
25287504|NCT01132313|50602350|FG003|Overall Study|Lost to Follow-up|0|||
25287505|NCT01132313|50602351|FG004|Overall Study|Lost to Follow-up|0|||
25287506|NCT01132313|50602352|FG005|Overall Study|Lost to Follow-up|0|||
25287507|NCT01132313|50602353|FG006|Overall Study|Lost to Follow-up|0|||
25287508|NCT01132313|50602354|FG007|Overall Study|Lost to Follow-up|1|||
25287509|NCT01132313|50602355|FG008|Overall Study|Lost to Follow-up|0|||
25287510|NCT01132313|50602356|FG009|Overall Study|Lost to Follow-up|0|||
25287511|NCT01132313|50602357|FG010|Overall Study|Lost to Follow-up|0|||
25287512|NCT01132313|50602358|FG011|Overall Study|Lost to Follow-up|0|||
25287513|NCT01132313|50602347|FG000|Overall Study|Withdrawal by Subject|0|||
25287514|NCT01132313|50602348|FG001|Overall Study|Withdrawal by Subject|0|||
25287515|NCT01132313|50602349|FG002|Overall Study|Withdrawal by Subject|3|||
25287516|NCT01132313|50602350|FG003|Overall Study|Withdrawal by Subject|3|||
25287517|NCT01132313|50602351|FG004|Overall Study|Withdrawal by Subject|6|||
25287518|NCT01132313|50602352|FG005|Overall Study|Withdrawal by Subject|0|||
25287519|NCT01132313|50602353|FG006|Overall Study|Withdrawal by Subject|1|||
25287520|NCT01132313|50602354|FG007|Overall Study|Withdrawal by Subject|0|||
25287521|NCT01132313|50602355|FG008|Overall Study|Withdrawal by Subject|0|||
24969671|NCT04551898|50059127|FG001|Overall Study|Withdrawal by Subject|1|||
25287522|NCT01132313|50602356|FG009|Overall Study|Withdrawal by Subject|2|||
24969672|NCT04551898|50059128|FG002|Overall Study|Withdrawal by Subject|2|||
25287523|NCT01132313|50602357|FG010|Overall Study|Withdrawal by Subject|0|||
25287524|NCT01132313|50602358|FG011|Overall Study|Withdrawal by Subject|0|||
25287525|NCT01132313|50602347|FG000|Overall Study|Lack of antiviral response|0|||
24969673|NCT04551898|50059129|FG003|Overall Study|Withdrawal by Subject|2|||
25287526|NCT01132313|50602348|FG001|Overall Study|Lack of antiviral response|0|||
25287527|NCT01132313|50602349|FG002|Overall Study|Lack of antiviral response|12|||
25287528|NCT01132313|50602350|FG003|Overall Study|Lack of antiviral response|18|||
25287529|NCT01132313|50602351|FG004|Overall Study|Lack of antiviral response|18|||
25287530|NCT01132313|50602352|FG005|Overall Study|Lack of antiviral response|18|||
25287531|NCT01132313|50602353|FG006|Overall Study|Lack of antiviral response|21|||
25287532|NCT01132313|50602354|FG007|Overall Study|Lack of antiviral response|0|||
25287533|NCT01132313|50602355|FG008|Overall Study|Lack of antiviral response|0|||
25287534|NCT01132313|50602356|FG009|Overall Study|Lack of antiviral response|0|||
25287535|NCT01132313|50602357|FG010|Overall Study|Lack of antiviral response|1|||
25287536|NCT01132313|50602358|FG011|Overall Study|Lack of antiviral response|0|||
25287537|NCT01132313|50602347|FG000|Overall Study|Other reason not defined above|0|||
25287538|NCT01132313|50602348|FG001|Overall Study|Other reason not defined above|0|||
25287539|NCT01132313|50602349|FG002|Overall Study|Other reason not defined above|0|||
25287540|NCT01132313|50602350|FG003|Overall Study|Other reason not defined above|0|||
25287541|NCT01132313|50602351|FG004|Overall Study|Other reason not defined above|0|||
25287542|NCT01132313|50602352|FG005|Overall Study|Other reason not defined above|0|||
25287543|NCT01132313|50602353|FG006|Overall Study|Other reason not defined above|0|||
25287544|NCT01132313|50602354|FG007|Overall Study|Other reason not defined above|1|||
25287545|NCT01132313|50602355|FG008|Overall Study|Other reason not defined above|0|||
25287546|NCT01132313|50602356|FG009|Overall Study|Other reason not defined above|0|||
25287547|NCT01132313|50602357|FG010|Overall Study|Other reason not defined above|0|||
25287548|NCT01132313|50602358|FG011|Overall Study|Other reason not defined above|0|||
25287549|NCT00861757|50602393|FG000|Overall Study|Adverse Event|1|||
25287550|NCT00861757|50602394|FG001|Overall Study|Adverse Event|5|||
25287551|NCT00861757|50602395|FG002|Overall Study|Adverse Event|7|||
25287552|NCT00861757|50602396|FG003|Overall Study|Adverse Event|2|||
25287553|NCT00861757|50602393|FG000|Overall Study|Entry Criteria Not Met|1|||
25287554|NCT00861757|50602394|FG001|Overall Study|Entry Criteria Not Met|2|||
25287555|NCT00861757|50602395|FG002|Overall Study|Entry Criteria Not Met|1|||
25287556|NCT00861757|50602396|FG003|Overall Study|Entry Criteria Not Met|1|||
25287557|NCT00861757|50602393|FG000|Overall Study|Lack of Efficacy|3|||
25287558|NCT00861757|50602394|FG001|Overall Study|Lack of Efficacy|1|||
25287559|NCT00861757|50602395|FG002|Overall Study|Lack of Efficacy|0|||
25287560|NCT00861757|50602396|FG003|Overall Study|Lack of Efficacy|1|||
25287561|NCT00861757|50602393|FG000|Overall Study|Lost to Follow-up|1|||
25287562|NCT00861757|50602394|FG001|Overall Study|Lost to Follow-up|0|||
25287563|NCT00861757|50602395|FG002|Overall Study|Lost to Follow-up|1|||
25287564|NCT00861757|50602396|FG003|Overall Study|Lost to Follow-up|1|||
25287565|NCT00861757|50602393|FG000|Overall Study|Physician Decision|0|||
25287566|NCT00861757|50602394|FG001|Overall Study|Physician Decision|0|||
25287567|NCT00861757|50602395|FG002|Overall Study|Physician Decision|0|||
25287568|NCT00861757|50602396|FG003|Overall Study|Physician Decision|1|||
25287569|NCT00861757|50602393|FG000|Overall Study|Protocol Violation|2|||
25287570|NCT00861757|50602394|FG001|Overall Study|Protocol Violation|2|||
25287571|NCT00861757|50602395|FG002|Overall Study|Protocol Violation|4|||
25287572|NCT00861757|50602396|FG003|Overall Study|Protocol Violation|1|||
25287573|NCT00861757|50602393|FG000|Overall Study|Withdrawal by Subject|1|||
25287574|NCT00861757|50602394|FG001|Overall Study|Withdrawal by Subject|5|||
25287575|NCT00861757|50602395|FG002|Overall Study|Withdrawal by Subject|5|||
25287576|NCT00861757|50602396|FG003|Overall Study|Withdrawal by Subject|2|||
25287577|NCT01131455|50602413|FG000|Overall Study|Death of PI|6|||
25287578|NCT01131455|50602414|FG001|Overall Study|Death of PI|4|||
25287579|NCT01131455|50602415|FG002|Overall Study|Death of PI|0|||
25287580|NCT01138007|50602426|FG000|Overall Study|Adverse Event|4|||
25287581|NCT01138007|50602427|FG001|Overall Study|Adverse Event|12|||
25287582|NCT01138007|50602428|FG002|Overall Study|Adverse Event|9|||
25287583|NCT01138007|50602426|FG000|Overall Study|Lack of Efficacy|2|||
25287584|NCT01138007|50602427|FG001|Overall Study|Lack of Efficacy|0|||
25287585|NCT01138007|50602428|FG002|Overall Study|Lack of Efficacy|6|||
25287586|NCT01138007|50602426|FG000|Overall Study|Protocol Violation|2|||
25287587|NCT01138007|50602427|FG001|Overall Study|Protocol Violation|3|||
25287588|NCT01138007|50602428|FG002|Overall Study|Protocol Violation|2|||
25287589|NCT01138007|50602426|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
25287590|NCT01138007|50602427|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
25287591|NCT01138007|50602428|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
25287592|NCT01138007|50602426|FG000|Overall Study|Lost to Follow-up|3|||
25287593|NCT01138007|50602427|FG001|Overall Study|Lost to Follow-up|3|||
25287594|NCT01138007|50602428|FG002|Overall Study|Lost to Follow-up|5|||
25287595|NCT01138007|50602426|FG000|Overall Study|Physician Decision|0|||
25287596|NCT01138007|50602427|FG001|Overall Study|Physician Decision|5|||
25287597|NCT01138007|50602428|FG002|Overall Study|Physician Decision|3|||
25287598|NCT01138007|50602426|FG000|Overall Study|Withdrawal by Subject|5|||
25287599|NCT01138007|50602427|FG001|Overall Study|Withdrawal by Subject|6|||
25287600|NCT01138007|50602428|FG002|Overall Study|Withdrawal by Subject|15|||
25287601|NCT00865345|50602438|FG000|Overall Study|Withdrawal by Subject|2|||
24969674|NCT04551898|50059126|FG000|Overall Study|Lost to Follow-up|2|||
25287602|NCT01131299|50602442|FG000|Overall Study|Withdrawal by Subject|4|||
25287603|NCT01131299|50602443|FG001|Overall Study|Withdrawal by Subject|7|||
25287604|NCT01130831|50602448|FG000|Overall Study|Withdrawal by Subject|7|||
25287605|NCT01130831|50602448|FG000|Overall Study|Death|4|||
25287606|NCT01130831|50602448|FG000|Overall Study|Information was missing|3|||
25287607|NCT01130597|50602464|FG000|Overall Study|Protocol-specified (High K+)|1|||
25287608|NCT01130597|50602464|FG000|Overall Study|Adverse Event|4|||
25287609|NCT01130597|50602464|FG000|Overall Study|Death|1|||
25287610|NCT01130597|50602464|FG000|Overall Study|Protocol Violation|1|||
25287611|NCT00939003|50602470|FG000|Double-blind Treatment Period|Adverse Event|1|||
25287612|NCT00939003|50602471|FG001|Double-blind Treatment Period|Adverse Event|1|||
25287613|NCT00939003|50602470|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
25287614|NCT00939003|50602471|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
25287615|NCT00939003|50602470|FG000|Double-blind Treatment Period|Pregnancy|0|||
25287616|NCT00939003|50602471|FG001|Double-blind Treatment Period|Pregnancy|1|||
25287617|NCT00939003|50602470|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
25287618|NCT00939003|50602471|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
25287619|NCT00939003|50602470|FG000|Open-label Treatment Period|Adverse Event|4|||
25287620|NCT00939003|50602471|FG001|Open-label Treatment Period|Adverse Event|8|||
25287621|NCT00939003|50602470|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
25287622|NCT00939003|50602471|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
25287623|NCT00939003|50602470|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
25287624|NCT00939003|50602471|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
25287625|NCT00939003|50602470|FG000|Open-label Treatment Period|Pregnancy|1|||
25287626|NCT00939003|50602471|FG001|Open-label Treatment Period|Pregnancy|1|||
25287627|NCT00939003|50602470|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
25287628|NCT00939003|50602471|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
25287629|NCT00939003|50602470|FG000|Open-label Treatment Period|Site Closure|3|||
25287630|NCT00939003|50602471|FG001|Open-label Treatment Period|Site Closure|4|||
25287631|NCT01188668|50602480|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
25287632|NCT01188668|50602480|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
25287633|NCT01188668|50602480|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
25287634|NCT01130051|50602487|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
25287635|NCT01130051|50602488|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
25287636|NCT01130051|50602487|FG000|Washout Period of 14 Days|Protocol Violation|1|||
25287637|NCT01130051|50602488|FG001|Washout Period of 14 Days|Protocol Violation|1|||
25287638|NCT00865189|50602496|FG000|Overall Study|Other|1|||
25287639|NCT00865189|50602497|FG001|Overall Study|Other|2|||
25287640|NCT00865189|50602496|FG000|Overall Study|Death|4|||
25287641|NCT00865189|50602497|FG001|Overall Study|Death|11|||
25287642|NCT00865189|50602496|FG000|Overall Study|Lost to Follow-up|6|||
25287643|NCT00865189|50602497|FG001|Overall Study|Lost to Follow-up|6|||
25287644|NCT00865189|50602496|FG000|Overall Study|Withdrawal by Subject|1|||
25287645|NCT00865189|50602497|FG001|Overall Study|Withdrawal by Subject|0|||
25287646|NCT01182194|50602505|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
25287647|NCT01182194|50602506|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
25287648|NCT01181726|50602514|FG000|First Intervention|Adverse Event|1|||
25287649|NCT01181726|50602515|FG001|First Intervention|Adverse Event|0|||
25287650|NCT01137071|50602521|FG000|Overall Study|Disease Progression|11|||
25287651|NCT01137071|50602521|FG000|Overall Study|Withdrawal by Subject|2|||
25287652|NCT01137071|50602521|FG000|Overall Study|Wrongly Included|1|||
25287653|NCT00860743|50602536|FG000|Overall Study|Withdrawal by Subject|3|||
25287654|NCT00860743|50602537|FG001|Overall Study|Withdrawal by Subject|0|||
25287655|NCT01186796|50602545|FG000|Overall Study|Adverse Event|3|||
25287656|NCT01186796|50602546|FG001|Overall Study|Adverse Event|0|||
25287657|NCT01186796|50602545|FG000|Overall Study|Withdrawal by Subject|1|||
25287658|NCT01186796|50602546|FG001|Overall Study|Withdrawal by Subject|1|||
25287659|NCT01186796|50602545|FG000|Overall Study|Protocol Violation|0|||
25287660|NCT01186796|50602546|FG001|Overall Study|Protocol Violation|1|||
25287661|NCT01136915|50602554|FG000|Overall Study|Lost to Follow-up|2|||
25287662|NCT01136915|50602555|FG001|Overall Study|Lost to Follow-up|0|||
25287663|NCT01136915|50602554|FG000|Overall Study|Exclusion criterion met|0|||
25287664|NCT01136915|50602555|FG001|Overall Study|Exclusion criterion met|1|||
25287665|NCT00940017|50602563|FG000|Overall Study|did not meet entrance criteria|3|||
25287666|NCT00940017|50602563|FG000|Overall Study|Adverse Event|1|||
25287667|NCT01129583|50602569|FG000|Overall Study|Death|1|||
25287668|NCT01129583|50602570|FG001|Overall Study|Death|0|||
25287669|NCT01129583|50602569|FG000|Overall Study|Lost to Follow-up|1|||
25287670|NCT01129583|50602570|FG001|Overall Study|Lost to Follow-up|1|||
25287671|NCT01129583|50602569|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
25287672|NCT01129583|50602570|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
25287673|NCT01186328|50602576|FG000|Overall Study|Death|1|||
25287674|NCT01186328|50602577|FG001|Overall Study|Death|0|||
25287675|NCT01186328|50602578|FG002|Overall Study|Death|0|||
25287676|NCT00848497|50602585|FG000|Overall Study|Screen failure|2|||
25287677|NCT00848497|50602586|FG001|Overall Study|Screen failure|0|||
25287678|NCT00848497|50602585|FG000|Overall Study|Withdrawal by Subject|0|||
25287679|NCT00848497|50602586|FG001|Overall Study|Withdrawal by Subject|1|||
25287680|NCT00857623|50602596|FG000|Overall Study|Adverse Event|5|||
25287681|NCT00857623|50602597|FG001|Overall Study|Adverse Event|2|||
25287682|NCT00857623|50602596|FG000|Overall Study|Study-specific discontinuation criteria|5|||
25287683|NCT00857623|50602597|FG001|Overall Study|Study-specific discontinuation criteria|3|||
25287684|NCT00857623|50602596|FG000|Overall Study|Withdrawal by Subject|2|||
25287685|NCT00857623|50602597|FG001|Overall Study|Withdrawal by Subject|1|||
25287686|NCT00857623|50602596|FG000|Overall Study|Lack of Efficacy|1|||
25287687|NCT00857623|50602597|FG001|Overall Study|Lack of Efficacy|1|||
25287688|NCT00857623|50602596|FG000|Overall Study|Severe non-compliance to protocol|1|||
25287689|NCT00857623|50602597|FG001|Overall Study|Severe non-compliance to protocol|1|||
25287690|NCT00857623|50602596|FG000|Overall Study|Intake of prohibited medication|0|||
25287691|NCT00857623|50602597|FG001|Overall Study|Intake of prohibited medication|1|||
25287692|NCT00857623|50602596|FG000|Overall Study|Positive for HEP C|0|||
25287693|NCT00857623|50602597|FG001|Overall Study|Positive for HEP C|1|||
25287694|NCT01185782|50602605|FG000|Overall Study|Adverse Event|0|||
25287695|NCT01185782|50602606|FG001|Overall Study|Adverse Event|1|||
25287696|NCT01185782|50602605|FG000|Overall Study|Protocol Violation|1|||
25287697|NCT01185782|50602606|FG001|Overall Study|Protocol Violation|0|||
25287698|NCT01185782|50602605|FG000|Overall Study|Poor Response to Treatment|3|||
25287699|NCT01185782|50602606|FG001|Overall Study|Poor Response to Treatment|1|||
25287700|NCT01185782|50602605|FG000|Overall Study|Other|2|||
25287701|NCT01185782|50602606|FG001|Overall Study|Other|5|||
25287702|NCT01185782|50602605|FG000|Overall Study|Randomized but not treated|0|||
25287703|NCT01185782|50602606|FG001|Overall Study|Randomized but not treated|4|||
25287704|NCT01129115|50602616|FG000|Overall Study|Adverse Event|1|||
25287705|NCT01129115|50602617|FG001|Overall Study|Adverse Event|2|||
25287706|NCT01129115|50602618|FG002|Overall Study|Adverse Event|3|||
25287707|NCT01129115|50602619|FG003|Overall Study|Adverse Event|3|||
25287708|NCT01129115|50602616|FG000|Overall Study|Withdrawal by Subject|1|||
25287709|NCT01129115|50602617|FG001|Overall Study|Withdrawal by Subject|3|||
25287710|NCT01129115|50602618|FG002|Overall Study|Withdrawal by Subject|1|||
25287711|NCT01129115|50602619|FG003|Overall Study|Withdrawal by Subject|4|||
25287712|NCT01129115|50602616|FG000|Overall Study|Protocol Violation|0|||
25287713|NCT01129115|50602617|FG001|Overall Study|Protocol Violation|2|||
25287714|NCT01129115|50602618|FG002|Overall Study|Protocol Violation|2|||
25287715|NCT01129115|50602619|FG003|Overall Study|Protocol Violation|2|||
25287716|NCT01185704|50602631|FG000|Overall Study|Randomized but not treated|3|||
25287717|NCT01185704|50602632|FG001|Overall Study|Randomized but not treated|3|||
25287718|NCT01185704|50602631|FG000|Overall Study|Lack of ovarian response|5|||
25287719|NCT01185704|50602632|FG001|Overall Study|Lack of ovarian response|1|||
25287720|NCT01185704|50602631|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
25287721|NCT01185704|50602632|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
25287722|NCT01185704|50602631|FG000|Overall Study|Ectopic pregnancy|0|||
25287723|NCT01185704|50602632|FG001|Overall Study|Ectopic pregnancy|1|||
25287724|NCT01128959|50602638|FG000|Lead in Period|Adverse Event|3|||
25287725|NCT01128959|50602638|FG000|Treatment Period|Adverse Event|3|||
25287726|NCT01128959|50602638|FG000|Treatment Period|Withdrawal by Subject|1|||
25287727|NCT00859573|50602646|FG000|Overall Study|Withdrawal by Subject|4|||
25287728|NCT00859573|50602647|FG001|Overall Study|Withdrawal by Subject|1|||
25287729|NCT00859573|50602646|FG000|Overall Study|Physician Decision|1|||
25287730|NCT00859573|50602647|FG001|Overall Study|Physician Decision|1|||
24969675|NCT04551898|50059127|FG001|Overall Study|Lost to Follow-up|1|||
24969676|NCT04551898|50059128|FG002|Overall Study|Lost to Follow-up|2|||
24969677|NCT04551898|50059129|FG003|Overall Study|Lost to Follow-up|2|||
25169219|NCT02367456|50300582|FG001|Overall Study|Ongoing|6|||
25169220|NCT02367456|50300583|FG002|Overall Study|Ongoing|15|||
25287731|NCT01136291|50602655|FG000|Overall Study|Lost to Follow-up|1|||
25287732|NCT01136291|50602656|FG001|Overall Study|Lost to Follow-up|1|||
25287733|NCT01185548|50602662|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
25287734|NCT01128569|50602675|FG000|Washout Period 1|Adverse Event|0|||
25287735|NCT01128569|50602676|FG001|Washout Period 1|Adverse Event|0|||
25287736|NCT01128569|50602677|FG002|Washout Period 1|Adverse Event|1|||
25287737|NCT01128569|50602678|FG003|Washout Period 1|Adverse Event|0|||
25287738|NCT01128569|50602679|FG004|Washout Period 1|Adverse Event|0|||
25287739|NCT01128569|50602680|FG005|Washout Period 1|Adverse Event|0|||
25287740|NCT01128569|50602675|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25287741|NCT01128569|50602676|FG001|Treatment Period 2|Withdrawal by Subject|1|||
25287742|NCT01128569|50602677|FG002|Treatment Period 2|Withdrawal by Subject|0|||
25287743|NCT01128569|50602678|FG003|Treatment Period 2|Withdrawal by Subject|0|||
25169221|NCT02367456|50300581|FG000|Overall Study|Other reason|3|||
25287744|NCT01128569|50602679|FG004|Treatment Period 2|Withdrawal by Subject|0|||
25287745|NCT01128569|50602680|FG005|Treatment Period 2|Withdrawal by Subject|0|||
25287746|NCT01128413|50602690|FG000|Overall Study|Withdrawal by Subject|1|||
25287747|NCT01128413|50602691|FG001|Overall Study|Withdrawal by Subject|0|||
25287748|NCT01128413|50602690|FG000|Overall Study|NICOM Monitor Problems|2|||
25287749|NCT01128413|50602691|FG001|Overall Study|NICOM Monitor Problems|1|||
25287750|NCT01128413|50602690|FG000|Overall Study|Pt made DNR|1|||
25287751|NCT01128413|50602691|FG001|Overall Study|Pt made DNR|0|||
25287752|NCT01185080|50602700|FG000|Overall Study|Adverse Event|1|||
25287753|NCT01185080|50602701|FG001|Overall Study|Adverse Event|1|||
25287754|NCT01185080|50602702|FG002|Overall Study|Adverse Event|0|||
25287755|NCT01185080|50602700|FG000|Overall Study|Personal reasons|0|||
25287756|NCT01185080|50602701|FG001|Overall Study|Personal reasons|0|||
25287757|NCT01185080|50602702|FG002|Overall Study|Personal reasons|1|||
25287758|NCT01128179|50602712|FG000|Overall Study|Death|1|||
25287759|NCT01128179|50602713|FG001|Overall Study|Death|0|||
25287760|NCT01128179|50602712|FG000|Overall Study|Protocol Violation|1|||
25287761|NCT01128179|50602713|FG001|Overall Study|Protocol Violation|0|||
25287762|NCT01181102|50602721|FG000|Overall Study|Adverse Event|28|||
25287763|NCT01181102|50602722|FG001|Overall Study|Adverse Event|26|||
25287764|NCT01181102|50602721|FG000|Overall Study|Lack of Efficacy|3|||
25287765|NCT01181102|50602722|FG001|Overall Study|Lack of Efficacy|1|||
25287766|NCT01181102|50602721|FG000|Overall Study|Lost to Follow-up|2|||
25070185|NCT01331837|50176028|FG001|Overall Study|Info not recorded|16|||
25070186|NCT01331837|50176027|FG000|Overall Study|Withdrawal by Subject|13|||
25070187|NCT01331837|50176028|FG001|Overall Study|Withdrawal by Subject|16|||
25070188|NCT02706483|50176034|FG000|Overall Study|Adverse Event|97|||
25070189|NCT02706483|50176034|FG000|Overall Study|Death|1|||
25070190|NCT02706483|50176034|FG000|Overall Study|Lack of Efficacy|39|||
25070191|NCT02706483|50176034|FG000|Overall Study|Lost to Follow-up|101|||
25070192|NCT02706483|50176034|FG000|Overall Study|Non-compliance with study drug|15|||
25070193|NCT02706483|50176034|FG000|Overall Study|Physician Decision|6|||
25070194|NCT02706483|50176034|FG000|Overall Study|Pregnancy|6|||
25070195|NCT02706483|50176034|FG000|Overall Study|Protocol Violation|18|||
25070196|NCT02706483|50176034|FG000|Overall Study|Withdrawal by Subject|136|||
25070197|NCT02706483|50176034|FG000|Overall Study|Non-compliance with visits|6|||
25070198|NCT02706483|50176034|FG000|Overall Study|Site closure|4|||
25287767|NCT01181102|50602722|FG001|Overall Study|Lost to Follow-up|0|||
25070199|NCT02706483|50176034|FG000|Overall Study|Subject moved|1|||
25070200|NCT01648348|50176041|FG000|Overall Study|Cancel|1|||
25070201|NCT01648348|50176042|FG001|Overall Study|Cancel|0|||
25070202|NCT01648348|50176043|FG002|Overall Study|Cancel|0|||
25070203|NCT01648348|50176044|FG003|Overall Study|Cancel|0|||
25070204|NCT01648348|50176045|FG004|Overall Study|Cancel|3|||
25070205|NCT01648348|50176046|FG005|Overall Study|Cancel|6|||
25070206|NCT01648348|50176041|FG000|Overall Study|Replaced for MTD analysis|1|||
25070207|NCT01648348|50176042|FG001|Overall Study|Replaced for MTD analysis|0|||
25070208|NCT01648348|50176043|FG002|Overall Study|Replaced for MTD analysis|1|||
25070209|NCT01648348|50176044|FG003|Overall Study|Replaced for MTD analysis|0|||
25070210|NCT01648348|50176045|FG004|Overall Study|Replaced for MTD analysis|0|||
25070211|NCT01648348|50176046|FG005|Overall Study|Replaced for MTD analysis|0|||
25070212|NCT01648270|50176059|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
25070213|NCT02302846|50176069|FG000|Overall Study|Withdrawal by Subject|1|||
25070214|NCT02336230|50176073|FG000|Overall Study|Adverse Event|1|||
25070215|NCT02336230|50176073|FG000|Overall Study|Withdrawal of consent|1|||
25070216|NCT02336230|50176073|FG000|Overall Study|Death|9|||
25070217|NCT02336230|50176073|FG000|Overall Study|Dose not received due to shipping delay|1|||
25070218|NCT02336230|50176073|FG000|Overall Study|Discontinuation of MSC infusion|1|||
25070219|NCT02302222|50176079|FG000|Overall Study|Physician Decision|0|||
25070220|NCT02302222|50176080|FG001|Overall Study|Physician Decision|4|||
25070221|NCT02302222|50176079|FG000|Overall Study|Lost to Follow-up|1|||
25070222|NCT02302222|50176080|FG001|Overall Study|Lost to Follow-up|0|||
25070223|NCT02302222|50176079|FG000|Overall Study|Treatment discontinued before day 5|0|||
25070224|NCT02302222|50176080|FG001|Overall Study|Treatment discontinued before day 5|1|||
25070225|NCT02302222|50176079|FG000|Overall Study|Withdrawn prior to any treatment|0|||
25070226|NCT02302222|50176080|FG001|Overall Study|Withdrawn prior to any treatment|1|||
25070227|NCT02336074|50176088|FG000|Overall Study|Adverse Event|0|||
25070228|NCT02336074|50176089|FG001|Overall Study|Adverse Event|2|||
25070229|NCT02335450|50176100|FG000|Overall Study|Pregnancy|1|||
25070230|NCT04826900|50176112|FG000|Overall Study|Family factor|1|||
25070231|NCT04826900|50176113|FG001|Overall Study|Family factor|1|||
25070232|NCT02302066|50176123|FG000|Overall Study|Adverse Event|1|||
25070233|NCT02302066|50176124|FG001|Overall Study|Adverse Event|1|||
25070234|NCT02302066|50176125|FG002|Overall Study|Adverse Event|3|||
25070235|NCT02302066|50176126|FG003|Overall Study|Adverse Event|0|||
25070236|NCT02302066|50176123|FG000|Overall Study|Lost to Follow-up|4|||
25287768|NCT01181102|50602721|FG000|Overall Study|Physician Decision|3|||
25287769|NCT01181102|50602722|FG001|Overall Study|Physician Decision|1|||
25070237|NCT02302066|50176124|FG001|Overall Study|Lost to Follow-up|5|||
25070238|NCT02302066|50176125|FG002|Overall Study|Lost to Follow-up|24|||
25287770|NCT01181102|50602721|FG000|Overall Study|Protocol Violation|5|||
25070239|NCT02302066|50176126|FG003|Overall Study|Lost to Follow-up|7|||
25070240|NCT02302066|50176123|FG000|Overall Study|Withdrawal by Subject|25|||
25070241|NCT02302066|50176124|FG001|Overall Study|Withdrawal by Subject|58|||
25169222|NCT02367456|50300582|FG001|Overall Study|Other reason|0|||
25287771|NCT01181102|50602722|FG001|Overall Study|Protocol Violation|6|||
25287772|NCT01181102|50602721|FG000|Overall Study|Withdrawal by Subject|10|||
25287773|NCT01181102|50602722|FG001|Overall Study|Withdrawal by Subject|12|||
25287774|NCT00858637|50602730|FG000|Active Comparison Phase|Adverse Event|14|||
25287775|NCT00858637|50602731|FG001|Active Comparison Phase|Adverse Event|0|||
25287776|NCT00858637|50602732|FG002|Active Comparison Phase|Adverse Event|0|||
25287777|NCT00858637|50602733|FG003|Active Comparison Phase|Adverse Event|9|||
25287778|NCT00858637|50602734|FG004|Active Comparison Phase|Adverse Event|0|||
25287779|NCT00858637|50602735|FG005|Active Comparison Phase|Adverse Event|0|||
25287780|NCT00858637|50602730|FG000|Active Comparison Phase|Death|1|||
25287781|NCT00858637|50602731|FG001|Active Comparison Phase|Death|0|||
25287782|NCT00858637|50602732|FG002|Active Comparison Phase|Death|0|||
25287783|NCT00858637|50602733|FG003|Active Comparison Phase|Death|1|||
25287784|NCT00858637|50602734|FG004|Active Comparison Phase|Death|0|||
25287785|NCT00858637|50602735|FG005|Active Comparison Phase|Death|0|||
25287786|NCT00858637|50602730|FG000|Active Comparison Phase|Physician Decision|1|||
25287787|NCT00858637|50602731|FG001|Active Comparison Phase|Physician Decision|0|||
25287788|NCT00858637|50602732|FG002|Active Comparison Phase|Physician Decision|0|||
25287789|NCT00858637|50602733|FG003|Active Comparison Phase|Physician Decision|1|||
25287790|NCT00858637|50602734|FG004|Active Comparison Phase|Physician Decision|0|||
25287791|NCT00858637|50602735|FG005|Active Comparison Phase|Physician Decision|0|||
25287792|NCT00858637|50602730|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
25287793|NCT00858637|50602731|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
25287794|NCT00858637|50602732|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
25287795|NCT00858637|50602733|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
25287796|NCT00858637|50602734|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
25287797|NCT00858637|50602735|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
25287798|NCT00858637|50602730|FG000|Active Comparison Phase|Other Reasons|1|||
25287799|NCT00858637|50602731|FG001|Active Comparison Phase|Other Reasons|0|||
25287800|NCT00858637|50602732|FG002|Active Comparison Phase|Other Reasons|0|||
25287801|NCT00858637|50602733|FG003|Active Comparison Phase|Other Reasons|1|||
25287802|NCT00858637|50602734|FG004|Active Comparison Phase|Other Reasons|0|||
25287803|NCT00858637|50602735|FG005|Active Comparison Phase|Other Reasons|0|||
25287804|NCT00858637|50602730|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
25287805|NCT00858637|50602731|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
25287806|NCT00858637|50602732|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
25287807|NCT00858637|50602733|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
25287808|NCT00858637|50602734|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
25287809|NCT00858637|50602735|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
25287810|NCT00858637|50602730|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
25287811|NCT00858637|50602731|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
25287812|NCT00858637|50602732|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
25287813|NCT00858637|50602733|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
25287814|NCT00858637|50602734|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
25287815|NCT00858637|50602735|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
25287816|NCT00858403|50602745|FG000|Overall Study|Withdrawal by Subject|1|||
25287817|NCT00858403|50602745|FG000|Overall Study|Death|3|||
25287818|NCT00858403|50602745|FG000|Overall Study|Disease Progression|1|||
25287819|NCT00858247|50602751|FG000|Baseline Assessment|Withdrawal by Subject|1|||
25287820|NCT00858247|50602752|FG001|Baseline Assessment|Withdrawal by Subject|1|||
25287821|NCT00858247|50602751|FG000|Baseline Assessment|Poor IV access|1|||
25287822|NCT00858247|50602752|FG001|Baseline Assessment|Poor IV access|0|||
25287823|NCT00858247|50602751|FG000|Baseline Assessment|Protocol Violation|0|||
25287824|NCT00858247|50602752|FG001|Baseline Assessment|Protocol Violation|1|||
25287825|NCT00858247|50602751|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
25287826|NCT00858247|50602752|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
25287827|NCT00838435|50602758|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
24969678|NCT04551898|50059126|FG000|Overall Study|Death|1|||
25191509|NCT02592798|50352187|FG001|Transition From DB2 to OLE|Other reasons|0|||
25191510|NCT02592798|50352186|FG000|Open Label Period (OLE)|Other reasons|0|||
25191511|NCT02592798|50352187|FG001|Open Label Period (OLE)|Other reasons|2|||
25191512|NCT02592798|50352186|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
25191513|NCT02592798|50352187|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
25191514|NCT02592798|50352186|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
25191515|NCT02592798|50352187|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
25191516|NCT02592798|50352186|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
25191517|NCT02592798|50352187|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
25287828|NCT00838435|50602758|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
25287829|NCT00838435|50602758|FG000|Part 2 (7 Years)|Adverse Event|2|||
25287830|NCT00838435|50602758|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
25287831|NCT00838435|50602758|FG000|Part 2 (7 Years)|Physician Decision|1|||
25287832|NCT00838435|50602758|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
25287833|NCT00838435|50602758|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
24969679|NCT04551898|50059127|FG001|Overall Study|Death|0|||
25287834|NCT00838201|50602767|FG000|Overall Study|Investigator decision, or other reasons|2|||
25287835|NCT00838201|50602768|FG001|Overall Study|Investigator decision, or other reasons|3|||
25287836|NCT00838201|50602767|FG000|Overall Study|Noncompliance|0|||
25287837|NCT00838201|50602768|FG001|Overall Study|Noncompliance|1|||
25287838|NCT00838201|50602767|FG000|Overall Study|Administrative decision|1|||
25287839|NCT00838201|50602768|FG001|Overall Study|Administrative decision|2|||
25287840|NCT00838201|50602767|FG000|Overall Study|Disease progression|3|||
25287841|NCT00838201|50602768|FG001|Overall Study|Disease progression|3|||
25287842|NCT00838201|50602767|FG000|Overall Study|Consent withdrawn|16|||
25287843|NCT00838201|50602768|FG001|Overall Study|Consent withdrawn|19|||
25287844|NCT00838201|50602767|FG000|Overall Study|Lost to Follow-up|4|||
25287845|NCT00838201|50602768|FG001|Overall Study|Lost to Follow-up|3|||
25287846|NCT00838201|50602767|FG000|Overall Study|Adverse Event|5|||
25287847|NCT00838201|50602768|FG001|Overall Study|Adverse Event|9|||
25287848|NCT00838201|50602767|FG000|Overall Study|Death|11|||
25287849|NCT00838201|50602768|FG001|Overall Study|Death|13|||
25287850|NCT00837967|50602774|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
25287851|NCT00837967|50602775|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
25287852|NCT02756806|50602781|FG000|Overall Study|Study terminated early|5|||
25287853|NCT00942357|50602787|FG000|Overall Study|Ineligible|37|||
25287854|NCT00942357|50602788|FG001|Overall Study|Ineligible|40|||
25287855|NCT00939783|50602794|FG000|Overall Study|Death|6|||
25287856|NCT00939783|50602794|FG000|Overall Study|Adverse Event|39|||
25287857|NCT00939783|50602794|FG000|Overall Study|Study Terminated by Sponsor|498|||
25287858|NCT00939783|50602794|FG000|Overall Study|Withdrawal by Subject|78|||
25287859|NCT00939783|50602794|FG000|Overall Study|Other|16|||
25287860|NCT00939783|50602794|FG000|Overall Study|Lost to Follow-up|8|||
25287861|NCT00939783|50602794|FG000|Overall Study|Protocol Violation|3|||
25287862|NCT00939783|50602794|FG000|Overall Study|Enrolled but not treated|1|||
25287863|NCT00939627|50602800|FG000|Overall Study|Disease Progression|16|||
25287864|NCT00939627|50602801|FG001|Overall Study|Disease Progression|12|||
25287865|NCT00939627|50602802|FG002|Overall Study|Disease Progression|0|||
25287866|NCT00939627|50602800|FG000|Overall Study|Adverse Event|6|||
25287867|NCT00939627|50602801|FG001|Overall Study|Adverse Event|7|||
25287868|NCT00939627|50602802|FG002|Overall Study|Adverse Event|0|||
25287869|NCT00939627|50602800|FG000|Overall Study|Death|0|||
25287870|NCT00939627|50602801|FG001|Overall Study|Death|2|||
25287871|NCT00939627|50602802|FG002|Overall Study|Death|0|||
25287872|NCT00939627|50602800|FG000|Overall Study|Withdrawal by Subject|2|||
25287873|NCT00939627|50602801|FG001|Overall Study|Withdrawal by Subject|4|||
25287874|NCT00939627|50602802|FG002|Overall Study|Withdrawal by Subject|0|||
25287875|NCT00939627|50602800|FG000|Overall Study|Other complicating disease|1|||
25287876|NCT00939627|50602801|FG001|Overall Study|Other complicating disease|1|||
25287877|NCT00939627|50602802|FG002|Overall Study|Other complicating disease|0|||
25287878|NCT00939627|50602800|FG000|Overall Study|Not compliant|2|||
25287879|NCT00939627|50602801|FG001|Overall Study|Not compliant|0|||
25287880|NCT00939627|50602802|FG002|Overall Study|Not compliant|0|||
25287881|NCT00939627|50602800|FG000|Overall Study|No off-tx reason given|0|||
25287882|NCT00939627|50602801|FG001|Overall Study|No off-tx reason given|2|||
25287883|NCT00939627|50602802|FG002|Overall Study|No off-tx reason given|0|||
25287884|NCT00937833|50602810|FG000|Overall Study|Protocol Violation|1|||
25287885|NCT00937833|50602811|FG001|Overall Study|Protocol Violation|2|||
25287886|NCT00937833|50602810|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
25287887|NCT00937833|50602811|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
25287888|NCT00937833|50602810|FG000|Overall Study|Lost to Follow-up|10|||
25287889|NCT00937833|50602811|FG001|Overall Study|Lost to Follow-up|8|||
25287890|NCT00937833|50602810|FG000|Overall Study|Withdrawal by Subject|4|||
25287891|NCT00937833|50602811|FG001|Overall Study|Withdrawal by Subject|6|||
25287892|NCT01135511|50602826|FG000|Overall Study|Adverse Event|0|||
25287893|NCT01135511|50602827|FG001|Overall Study|Adverse Event|1|||
25287894|NCT01135511|50602828|FG002|Overall Study|Adverse Event|2|||
25287895|NCT01135511|50602829|FG003|Overall Study|Adverse Event|0|||
25287896|NCT01135511|50602830|FG004|Overall Study|Adverse Event|0|||
25287897|NCT01135511|50602831|FG005|Overall Study|Adverse Event|1|||
25287898|NCT01135511|50602832|FG006|Overall Study|Adverse Event|0|||
25287899|NCT01135511|50602833|FG007|Overall Study|Adverse Event|1|||
25287900|NCT01135511|50602834|FG008|Overall Study|Adverse Event|0|||
25287901|NCT01135511|50602826|FG000|Overall Study|Lack of Efficacy|0|||
25287902|NCT01135511|50602827|FG001|Overall Study|Lack of Efficacy|1|||
25287903|NCT01135511|50602828|FG002|Overall Study|Lack of Efficacy|1|||
25287904|NCT01135511|50602829|FG003|Overall Study|Lack of Efficacy|2|||
25287905|NCT01135511|50602830|FG004|Overall Study|Lack of Efficacy|0|||
25287906|NCT01135511|50602831|FG005|Overall Study|Lack of Efficacy|0|||
25287907|NCT01135511|50602832|FG006|Overall Study|Lack of Efficacy|0|||
25287908|NCT01135511|50602833|FG007|Overall Study|Lack of Efficacy|0|||
25287909|NCT01135511|50602834|FG008|Overall Study|Lack of Efficacy|0|||
25287910|NCT01135511|50602826|FG000|Overall Study|Protocol Violation|0|||
25287911|NCT01135511|50602827|FG001|Overall Study|Protocol Violation|0|||
25287912|NCT01135511|50602828|FG002|Overall Study|Protocol Violation|3|||
25287913|NCT01135511|50602829|FG003|Overall Study|Protocol Violation|0|||
25287914|NCT01135511|50602830|FG004|Overall Study|Protocol Violation|0|||
25287915|NCT01135511|50602831|FG005|Overall Study|Protocol Violation|0|||
25287916|NCT01135511|50602832|FG006|Overall Study|Protocol Violation|0|||
25287917|NCT01135511|50602833|FG007|Overall Study|Protocol Violation|0|||
25287918|NCT01135511|50602834|FG008|Overall Study|Protocol Violation|0|||
25287919|NCT01135511|50602826|FG000|Overall Study|Pregnancy|0|||
25287920|NCT01135511|50602827|FG001|Overall Study|Pregnancy|0|||
25287921|NCT01135511|50602828|FG002|Overall Study|Pregnancy|0|||
25287922|NCT01135511|50602829|FG003|Overall Study|Pregnancy|1|||
25287923|NCT01135511|50602830|FG004|Overall Study|Pregnancy|0|||
25287924|NCT01135511|50602831|FG005|Overall Study|Pregnancy|0|||
25287925|NCT01135511|50602832|FG006|Overall Study|Pregnancy|0|||
25287926|NCT01135511|50602833|FG007|Overall Study|Pregnancy|0|||
25287927|NCT01135511|50602834|FG008|Overall Study|Pregnancy|0|||
25287928|NCT01135511|50602826|FG000|Overall Study|could not visit the clinic|0|||
25287929|NCT01135511|50602827|FG001|Overall Study|could not visit the clinic|1|||
25287930|NCT01135511|50602828|FG002|Overall Study|could not visit the clinic|2|||
25287931|NCT01135511|50602829|FG003|Overall Study|could not visit the clinic|0|||
25287932|NCT01135511|50602830|FG004|Overall Study|could not visit the clinic|0|||
25287933|NCT01135511|50602831|FG005|Overall Study|could not visit the clinic|0|||
25287934|NCT01135511|50602832|FG006|Overall Study|could not visit the clinic|0|||
25287935|NCT01135511|50602833|FG007|Overall Study|could not visit the clinic|0|||
25287936|NCT01135511|50602834|FG008|Overall Study|could not visit the clinic|0|||
25287937|NCT01135511|50602826|FG000|Overall Study|noncompliance with study drug taken|0|||
25287938|NCT01135511|50602827|FG001|Overall Study|noncompliance with study drug taken|0|||
25287939|NCT01135511|50602828|FG002|Overall Study|noncompliance with study drug taken|0|||
25287940|NCT01135511|50602829|FG003|Overall Study|noncompliance with study drug taken|0|||
25287941|NCT01135511|50602830|FG004|Overall Study|noncompliance with study drug taken|1|||
25287942|NCT01135511|50602831|FG005|Overall Study|noncompliance with study drug taken|0|||
25287943|NCT01135511|50602832|FG006|Overall Study|noncompliance with study drug taken|0|||
25287944|NCT01135511|50602833|FG007|Overall Study|noncompliance with study drug taken|0|||
25287945|NCT01135511|50602834|FG008|Overall Study|noncompliance with study drug taken|0|||
25287946|NCT01135511|50602826|FG000|Overall Study|Withdrawal by Subject|0|||
25287947|NCT01135511|50602827|FG001|Overall Study|Withdrawal by Subject|0|||
25287948|NCT01135511|50602828|FG002|Overall Study|Withdrawal by Subject|0|||
25287949|NCT01135511|50602829|FG003|Overall Study|Withdrawal by Subject|0|||
25287950|NCT01135511|50602830|FG004|Overall Study|Withdrawal by Subject|0|||
25287951|NCT01135511|50602831|FG005|Overall Study|Withdrawal by Subject|0|||
25169223|NCT02367456|50300583|FG002|Overall Study|Other reason|0|||
25191518|NCT02592798|50352186|FG000|Open Label Period (OLE)|Adverse Event|0|||
25191519|NCT02592798|50352187|FG001|Open Label Period (OLE)|Adverse Event|1|||
25287952|NCT01135511|50602832|FG006|Overall Study|Withdrawal by Subject|1|||
25287953|NCT01135511|50602833|FG007|Overall Study|Withdrawal by Subject|0|||
25287954|NCT01135511|50602834|FG008|Overall Study|Withdrawal by Subject|1|||
25169224|NCT01865747|50300614|FG000|Overall Study (ITT)|Adverse Event|32|||
25169225|NCT01865747|50300615|FG001|Overall Study (ITT)|Adverse Event|31|||
25169226|NCT01865747|50300614|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
25169227|NCT01865747|50300615|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
25169228|NCT01865747|50300614|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
25169229|NCT01865747|50300615|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
24969680|NCT04551898|50059128|FG002|Overall Study|Death|0|||
25287955|NCT01180790|50602870|FG000|Overall Study|Adverse Event|1|||
25287956|NCT01180790|50602871|FG001|Overall Study|Adverse Event|1|||
25287957|NCT01180790|50602872|FG002|Overall Study|Adverse Event|2|||
25287958|NCT01180790|50602873|FG003|Overall Study|Adverse Event|0|||
25287959|NCT01180790|50602874|FG004|Overall Study|Adverse Event|1|||
25287960|NCT01180790|50602875|FG005|Overall Study|Adverse Event|3|||
25287961|NCT01180790|50602876|FG006|Overall Study|Adverse Event|0|||
25287962|NCT01180790|50602870|FG000|Overall Study|Withdrawal by Subject|3|||
25287963|NCT01180790|50602871|FG001|Overall Study|Withdrawal by Subject|0|||
25287964|NCT01180790|50602872|FG002|Overall Study|Withdrawal by Subject|5|||
25287965|NCT01180790|50602873|FG003|Overall Study|Withdrawal by Subject|0|||
25287966|NCT01180790|50602874|FG004|Overall Study|Withdrawal by Subject|2|||
25287967|NCT01180790|50602875|FG005|Overall Study|Withdrawal by Subject|1|||
25287968|NCT01180790|50602876|FG006|Overall Study|Withdrawal by Subject|0|||
25070242|NCT02302066|50176125|FG002|Overall Study|Withdrawal by Subject|124|||
25287969|NCT01180790|50602870|FG000|Overall Study|Lost to Follow-up|3|||
25287970|NCT01180790|50602871|FG001|Overall Study|Lost to Follow-up|1|||
25287971|NCT01180790|50602872|FG002|Overall Study|Lost to Follow-up|0|||
25287972|NCT01180790|50602873|FG003|Overall Study|Lost to Follow-up|2|||
25287973|NCT01180790|50602874|FG004|Overall Study|Lost to Follow-up|1|||
25287974|NCT01180790|50602875|FG005|Overall Study|Lost to Follow-up|0|||
25287975|NCT01180790|50602876|FG006|Overall Study|Lost to Follow-up|1|||
25287976|NCT01180790|50602870|FG000|Overall Study|Physician Decision|1|||
25287977|NCT01180790|50602871|FG001|Overall Study|Physician Decision|0|||
25287978|NCT01180790|50602872|FG002|Overall Study|Physician Decision|0|||
25287979|NCT01180790|50602873|FG003|Overall Study|Physician Decision|1|||
25287980|NCT01180790|50602874|FG004|Overall Study|Physician Decision|0|||
25287981|NCT01180790|50602875|FG005|Overall Study|Physician Decision|0|||
25287982|NCT01180790|50602876|FG006|Overall Study|Physician Decision|0|||
25287983|NCT01180790|50602870|FG000|Overall Study|Lack of Efficacy|1|||
25287984|NCT01180790|50602871|FG001|Overall Study|Lack of Efficacy|2|||
25287985|NCT01180790|50602872|FG002|Overall Study|Lack of Efficacy|5|||
25287986|NCT01180790|50602873|FG003|Overall Study|Lack of Efficacy|6|||
25287987|NCT01180790|50602874|FG004|Overall Study|Lack of Efficacy|1|||
25287988|NCT01180790|50602875|FG005|Overall Study|Lack of Efficacy|3|||
25287989|NCT01180790|50602876|FG006|Overall Study|Lack of Efficacy|0|||
25287990|NCT01180790|50602870|FG000|Overall Study|compliance|0|||
25287991|NCT01180790|50602871|FG001|Overall Study|compliance|1|||
25287992|NCT01180790|50602872|FG002|Overall Study|compliance|0|||
25287993|NCT01180790|50602873|FG003|Overall Study|compliance|0|||
25287994|NCT01180790|50602874|FG004|Overall Study|compliance|0|||
25287995|NCT01180790|50602875|FG005|Overall Study|compliance|0|||
25287996|NCT01180790|50602876|FG006|Overall Study|compliance|0|||
25287997|NCT01180790|50602870|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
25287998|NCT01180790|50602871|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
25287999|NCT01180790|50602872|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
25288000|NCT01180790|50602873|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
25288001|NCT01180790|50602874|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
25288002|NCT01180790|50602875|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
25288003|NCT01180790|50602876|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
25288004|NCT01184846|50602920|FG000|Overall Study|Adverse Event|2|||
25288005|NCT01184846|50602920|FG000|Overall Study|Insufficient response|1|||
25288006|NCT01180400|50602928|FG000|Overall Study|Withdrawal by Subject|5|||
25070243|NCT02302066|50176126|FG003|Overall Study|Withdrawal by Subject|33|||
25070244|NCT02302066|50176123|FG000|Overall Study|Pregnancy|2|||
25288007|NCT01180400|50602929|FG001|Overall Study|Withdrawal by Subject|6|||
25288008|NCT01180400|50602928|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
25288009|NCT01180400|50602929|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
25288010|NCT01180400|50602928|FG000|Overall Study|Adverse Event|12|||
25288011|NCT01180400|50602929|FG001|Overall Study|Adverse Event|10|||
25288012|NCT01180400|50602928|FG000|Overall Study|Severe non-compliance to protocol|1|||
25288013|NCT01180400|50602929|FG001|Overall Study|Severe non-compliance to protocol|2|||
25288014|NCT01180400|50602928|FG000|Overall Study|Condition under investigation worsened|2|||
25288015|NCT01180400|50602929|FG001|Overall Study|Condition under investigation worsened|1|||
25288016|NCT01180400|50602928|FG000|Overall Study|Lack of Efficacy|2|||
25288017|NCT01180400|50602929|FG001|Overall Study|Lack of Efficacy|0|||
25288018|NCT01180400|50602928|FG000|Overall Study|Study-specific withdrawal criteria|1|||
25288019|NCT01180400|50602929|FG001|Overall Study|Study-specific withdrawal criteria|2|||
25288020|NCT01180400|50602928|FG000|Overall Study|Lost to Follow-up|2|||
25288021|NCT01180400|50602929|FG001|Overall Study|Lost to Follow-up|3|||
25288022|NCT01180400|50602928|FG000|Overall Study|Other|0|||
25288023|NCT01180400|50602929|FG001|Overall Study|Other|1|||
25288024|NCT01180244|50602937|FG000|Overall Study|Lack of Efficacy|0|||
25288025|NCT01180244|50602938|FG001|Overall Study|Lack of Efficacy|7|||
25288026|NCT01180244|50602937|FG000|Overall Study|Physician Decision|3|||
25288027|NCT01180244|50602938|FG001|Overall Study|Physician Decision|0|||
25288028|NCT01180244|50602937|FG000|Overall Study|Adverse Event|1|||
25288029|NCT01180244|50602938|FG001|Overall Study|Adverse Event|0|||
25288030|NCT01180244|50602937|FG000|Overall Study|Withdrawal by Subject|0|||
25288031|NCT01180244|50602938|FG001|Overall Study|Withdrawal by Subject|1|||
25288032|NCT01180244|50602937|FG000|Overall Study|Protocol Violation|1|||
25288033|NCT01180244|50602938|FG001|Overall Study|Protocol Violation|0|||
25288034|NCT01180244|50602937|FG000|Overall Study|Lost to Follow-up|1|||
25288035|NCT01180244|50602938|FG001|Overall Study|Lost to Follow-up|0|||
25288036|NCT01191086|50602944|FG000|Overall Study|Adverse Event|20|||
25288037|NCT01191086|50602944|FG000|Overall Study|Lack of Efficacy|10|||
25288038|NCT01191086|50602944|FG000|Overall Study|Lost to Follow-up|4|||
25288039|NCT01191086|50602944|FG000|Overall Study|Physician Decision|2|||
25288040|NCT01191086|50602944|FG000|Overall Study|Withdrawal by Subject|24|||
25288041|NCT01191086|50602944|FG000|Overall Study|Discontinuation criterion met|1|||
25288042|NCT01191086|50602944|FG000|Overall Study|Other|1|||
25288043|NCT01088412|50602951|FG000|Overall Study|Adverse Event|38|||
25288044|NCT01088412|50602952|FG001|Overall Study|Adverse Event|0|||
25288045|NCT01088412|50602953|FG002|Overall Study|Adverse Event|0|||
25288046|NCT01088412|50602951|FG000|Overall Study|Death|42|||
25288047|NCT01088412|50602952|FG001|Overall Study|Death|6|||
25288048|NCT01088412|50602953|FG002|Overall Study|Death|0|||
25288049|NCT01088412|50602951|FG000|Overall Study|Other Reason per Case Report Form|2089|||
25288050|NCT01088412|50602952|FG001|Overall Study|Other Reason per Case Report Form|103|||
25288051|NCT01088412|50602953|FG002|Overall Study|Other Reason per Case Report Form|9|||
25288052|NCT01088412|50602951|FG000|Overall Study|Withdrawal by Subject|1761|||
25288053|NCT01088412|50602952|FG001|Overall Study|Withdrawal by Subject|25|||
25288054|NCT01088412|50602953|FG002|Overall Study|Withdrawal by Subject|1|||
25288055|NCT01088412|50602951|FG000|Overall Study|Received Another GH Product|79|||
25288056|NCT01088412|50602952|FG001|Overall Study|Received Another GH Product|0|||
25288057|NCT01088412|50602953|FG002|Overall Study|Received Another GH Product|0|||
25288058|NCT01088412|50602951|FG000|Overall Study|Participant Moved|601|||
25288059|NCT01088412|50602952|FG001|Overall Study|Participant Moved|21|||
25288060|NCT01088412|50602953|FG002|Overall Study|Participant Moved|2|||
25288061|NCT01088412|50602951|FG000|Overall Study|Physician Decision|1041|||
25288062|NCT01088412|50602952|FG001|Overall Study|Physician Decision|8|||
25288063|NCT01088412|50602953|FG002|Overall Study|Physician Decision|4|||
25288064|NCT01088412|50602951|FG000|Overall Study|Sponsor Decision|4467|||
25288065|NCT01088412|50602952|FG001|Overall Study|Sponsor Decision|79|||
25288066|NCT01088412|50602953|FG002|Overall Study|Sponsor Decision|23|||
25288067|NCT01088412|50602951|FG000|Overall Study|Third Party Required to Change Brand|487|||
25288068|NCT01088412|50602952|FG001|Overall Study|Third Party Required to Change Brand|0|||
25288069|NCT01088412|50602953|FG002|Overall Study|Third Party Required to Change Brand|0|||
25288070|NCT01088412|50602951|FG000|Overall Study|Lost to Follow-up|3052|||
25288071|NCT01088412|50602952|FG001|Overall Study|Lost to Follow-up|130|||
25288072|NCT01088412|50602953|FG002|Overall Study|Lost to Follow-up|11|||
25288073|NCT01088412|50602951|FG000|Overall Study|Study Summary Not Completed|4360|||
25288074|NCT01088412|50602952|FG001|Overall Study|Study Summary Not Completed|64|||
25288075|NCT01088412|50602953|FG002|Overall Study|Study Summary Not Completed|22|||
25288076|NCT01076400|50602964|FG000|Overall Study|Adverse Event|2|||
25288077|NCT01076400|50602965|FG001|Overall Study|Adverse Event|0|||
25288078|NCT01076400|50602966|FG002|Overall Study|Adverse Event|0|||
25288079|NCT01076400|50602964|FG000|Overall Study|Progressive Disease|5|||
25288080|NCT01076400|50602965|FG001|Overall Study|Progressive Disease|0|||
25288081|NCT01076400|50602966|FG002|Overall Study|Progressive Disease|0|||
25288082|NCT01086384|50602972|FG000|2-week Run-in Period|Adverse Event|1|||
25288083|NCT01086384|50602973|FG001|2-week Run-in Period|Adverse Event|0|||
25288084|NCT01086384|50602974|FG002|2-week Run-in Period|Adverse Event|0|||
25288085|NCT01086384|50602972|FG000|2-week Run-in Period|Protocol Violation|1|||
25288086|NCT01086384|50602973|FG001|2-week Run-in Period|Protocol Violation|0|||
25288087|NCT01086384|50602974|FG002|2-week Run-in Period|Protocol Violation|0|||
25288088|NCT01086384|50602972|FG000|2-week Run-in Period|Lost to Follow-up|1|||
25288089|NCT01086384|50602973|FG001|2-week Run-in Period|Lost to Follow-up|0|||
25288090|NCT01086384|50602974|FG002|2-week Run-in Period|Lost to Follow-up|0|||
25288091|NCT01086384|50602972|FG000|2-week Run-in Period|Physician Decision|6|||
25288092|NCT01086384|50602973|FG001|2-week Run-in Period|Physician Decision|0|||
25288093|NCT01086384|50602974|FG002|2-week Run-in Period|Physician Decision|0|||
25288094|NCT01086384|50602972|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
25288095|NCT01086384|50602973|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
25288096|NCT01086384|50602974|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
25288097|NCT01086384|50602972|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
25288098|NCT01086384|50602973|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
25288099|NCT01086384|50602974|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
25288100|NCT01086384|50602972|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
25288101|NCT01086384|50602973|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
25288102|NCT01086384|50602974|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
25288103|NCT01086384|50602972|FG000|2-week Run-in Period|Randomized in Error|1|||
25288104|NCT01086384|50602973|FG001|2-week Run-in Period|Randomized in Error|0|||
25288105|NCT01086384|50602974|FG002|2-week Run-in Period|Randomized in Error|0|||
25288106|NCT01086384|50602972|FG000|Treatment Period|Withdrawal by Subject|0|||
25288107|NCT01086384|50602973|FG001|Treatment Period|Withdrawal by Subject|53|||
25288108|NCT01086384|50602974|FG002|Treatment Period|Withdrawal by Subject|55|||
25288109|NCT01086384|50602972|FG000|Treatment Period|Protocol Violation|0|||
25288110|NCT01086384|50602973|FG001|Treatment Period|Protocol Violation|26|||
25288111|NCT01086384|50602974|FG002|Treatment Period|Protocol Violation|17|||
25288112|NCT01086384|50602972|FG000|Treatment Period|Lack of Efficacy|0|||
25288113|NCT01086384|50602973|FG001|Treatment Period|Lack of Efficacy|22|||
25288114|NCT01086384|50602974|FG002|Treatment Period|Lack of Efficacy|13|||
25288115|NCT01086384|50602972|FG000|Treatment Period|Adverse Event|0|||
25288116|NCT01086384|50602973|FG001|Treatment Period|Adverse Event|19|||
25288117|NCT01086384|50602974|FG002|Treatment Period|Adverse Event|15|||
25288118|NCT01086384|50602972|FG000|Treatment Period|Lost to Follow-up|0|||
25288119|NCT01086384|50602973|FG001|Treatment Period|Lost to Follow-up|11|||
25288120|NCT01086384|50602974|FG002|Treatment Period|Lost to Follow-up|9|||
25288121|NCT01086384|50602972|FG000|Treatment Period|Physician Decision|0|||
25288122|NCT01086384|50602973|FG001|Treatment Period|Physician Decision|9|||
25288123|NCT01086384|50602974|FG002|Treatment Period|Physician Decision|6|||
25288124|NCT01086384|50602972|FG000|Treatment Period|Study Closed/Terminated|0|||
25288125|NCT01086384|50602973|FG001|Treatment Period|Study Closed/Terminated|7|||
25288126|NCT01086384|50602974|FG002|Treatment Period|Study Closed/Terminated|8|||
25288127|NCT01086384|50602972|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
25288128|NCT01086384|50602973|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
25288129|NCT01086384|50602974|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
25288130|NCT01086384|50602972|FG000|Treatment Period|Received Treatment in Error|0|||
25288131|NCT01086384|50602973|FG001|Treatment Period|Received Treatment in Error|1|||
25288132|NCT01086384|50602974|FG002|Treatment Period|Received Treatment in Error|0|||
25288133|NCT01127633|50602995|FG000|Overall Study|Adverse Event|74|||
25288134|NCT01127633|50602996|FG001|Overall Study|Adverse Event|73|||
25288135|NCT01127633|50602995|FG000|Overall Study|Death|40|||
24969681|NCT04551898|50059129|FG003|Overall Study|Death|0|||
24969682|NCT04551898|50059126|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
24969683|NCT04551898|50059127|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
25288136|NCT01127633|50602996|FG001|Overall Study|Death|43|||
25288137|NCT01127633|50602995|FG000|Overall Study|Lost to Follow-up|4|||
25288138|NCT01127633|50602996|FG001|Overall Study|Lost to Follow-up|0|||
25288139|NCT01127633|50602995|FG000|Overall Study|Parent/Caregiver Decision|246|||
25288140|NCT01127633|50602996|FG001|Overall Study|Parent/Caregiver Decision|228|||
25288141|NCT01127633|50602995|FG000|Overall Study|Physician Decision|60|||
25288142|NCT01127633|50602996|FG001|Overall Study|Physician Decision|45|||
25288143|NCT01127633|50602995|FG000|Overall Study|Withdrawal by Subject|57|||
25288144|NCT01127633|50602996|FG001|Overall Study|Withdrawal by Subject|72|||
25288145|NCT01127633|50602995|FG000|Overall Study|Sponsor Decision|163|||
25288146|NCT01127633|50602996|FG001|Overall Study|Sponsor Decision|195|||
25288147|NCT01127633|50602995|FG000|Overall Study|Protocol Violation|8|||
25288148|NCT01127633|50602996|FG001|Overall Study|Protocol Violation|16|||
25288149|NCT01127633|50602995|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
25288150|NCT01127633|50602996|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
25288151|NCT01127633|50602995|FG000|Overall Study|Not treated|1|||
25288152|NCT01127633|50602996|FG001|Overall Study|Not treated|0|||
25288153|NCT01122173|50603002|FG000|Overall Study|Lost to Follow-up|3|||
25288154|NCT01122173|50603002|FG000|Overall Study|Withdrawal by Subject|3|||
25191520|NCT00081653|50352227|FG000|Overall Study|Adverse Event|23|||
25191521|NCT00081653|50352228|FG001|Overall Study|Adverse Event|17|||
25191522|NCT00081653|50352227|FG000|Overall Study|Lost to Follow-up|2|||
25191523|NCT00081653|50352228|FG001|Overall Study|Lost to Follow-up|4|||
25191524|NCT00081653|50352227|FG000|Overall Study|Refused Treatment|18|||
25191525|NCT00081653|50352228|FG001|Overall Study|Refused Treatment|14|||
25191526|NCT00081653|50352227|FG000|Overall Study|Low bone mineral density|1|||
25191527|NCT00081653|50352228|FG001|Overall Study|Low bone mineral density|0|||
25191528|NCT00081653|50352227|FG000|Overall Study|Bone loss|2|||
25191529|NCT00081653|50352228|FG001|Overall Study|Bone loss|0|||
25288155|NCT01122173|50603002|FG000|Overall Study|Left study for other reasons|3|||
25288156|NCT01127165|50603009|FG000|Overall Study|Adverse Event|2|||
25288157|NCT01127165|50603010|FG001|Overall Study|Adverse Event|2|||
25288158|NCT01127165|50603009|FG000|Overall Study|Lack of Efficacy|10|||
24969684|NCT04551898|50059128|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
25191530|NCT00081653|50352227|FG000|Overall Study|Participant leaving country|1|||
25191531|NCT00081653|50352228|FG001|Overall Study|Participant leaving country|0|||
24969685|NCT04551898|50059129|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
24969686|NCT04849780|50059147|FG000|Period 1|Covid-19 Related|1|||
24969687|NCT04849780|50059148|FG001|Period 1|Covid-19 Related|0|||
24969688|NCT04849780|50059147|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
24969689|NCT04849780|50059148|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
24969690|NCT04849780|50059147|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
24969691|NCT04849780|50059148|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
24969692|NCT04823494|50059162|FG000|Overall Study|Programming software malfunction.|1|||
24969693|NCT04823494|50059163|FG001|Overall Study|Programming software malfunction.|0|||
24969694|NCT04823494|50059162|FG000|Overall Study|Withdrawal by Subject|1|||
24969695|NCT04823494|50059163|FG001|Overall Study|Withdrawal by Subject|0|||
24969696|NCT04823494|50059162|FG000|Overall Study|Devices lost|0|||
25288159|NCT01127165|50603010|FG001|Overall Study|Lack of Efficacy|8|||
25288160|NCT01127165|50603009|FG000|Overall Study|Lost to Follow-up|3|||
25288161|NCT01127165|50603010|FG001|Overall Study|Lost to Follow-up|5|||
25288162|NCT01127165|50603009|FG000|Overall Study|Withdrawal by Subject|1|||
25288163|NCT01127165|50603010|FG001|Overall Study|Withdrawal by Subject|3|||
25288164|NCT01127165|50603009|FG000|Overall Study|Protocol Violation|0|||
25288165|NCT01127165|50603010|FG001|Overall Study|Protocol Violation|1|||
25288166|NCT01126619|50603016|FG000|Overall Study|Not eligible for the study|2|||
25288167|NCT01126619|50603016|FG000|Overall Study|Investigator decision|4|||
25288168|NCT01126619|50603016|FG000|Overall Study|Serious adverse event|1|||
25288169|NCT01126619|50603016|FG000|Overall Study|Withdrawal by Subject|9|||
25288170|NCT01126619|50603016|FG000|Overall Study|Non-compliance|1|||
25288171|NCT00941733|50603024|FG000|Overall Study|Death|24|||
25288172|NCT00941733|50603025|FG001|Overall Study|Death|10|||
25288173|NCT00941733|50603024|FG000|Overall Study|Withdrawal by Subject|14|||
25288174|NCT00941733|50603025|FG001|Overall Study|Withdrawal by Subject|6|||
25288175|NCT00941733|50603024|FG000|Overall Study|Adverse Event|20|||
25288176|NCT00941733|50603025|FG001|Overall Study|Adverse Event|4|||
25288177|NCT00941733|50603024|FG000|Overall Study|Lost to Follow-up|1|||
25288178|NCT00941733|50603025|FG001|Overall Study|Lost to Follow-up|2|||
25288179|NCT00941733|50603024|FG000|Overall Study|Protocol Violation|15|||
25288180|NCT00941733|50603025|FG001|Overall Study|Protocol Violation|6|||
25288181|NCT00941655|50603033|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
25288182|NCT00941655|50603034|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
25288183|NCT00941655|50603033|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
25288184|NCT00941655|50603034|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
25288185|NCT00941655|50603033|FG000|Overall Study|progressed while on chemo|0|||
25288186|NCT00941655|50603034|FG001|Overall Study|progressed while on chemo|2|||
25288187|NCT00941655|50603033|FG000|Overall Study|refused further treatment|0|||
25288188|NCT00941655|50603034|FG001|Overall Study|refused further treatment|1|||
25288189|NCT00941655|50603033|FG000|Overall Study|withdrew consent|0|||
25288190|NCT00941655|50603034|FG001|Overall Study|withdrew consent|1|||
25288191|NCT00941655|50603033|FG000|Overall Study|non-compliant|0|||
25288192|NCT00941655|50603034|FG001|Overall Study|non-compliant|1|||
25288193|NCT00939393|50603043|FG000|Overall Study|Withdrawal by Subject|1|||
25288194|NCT00939393|50603044|FG001|Overall Study|Withdrawal by Subject|0|||
25288195|NCT00939393|50603043|FG000|Overall Study|Lost to Follow-up|3|||
25288196|NCT00939393|50603044|FG001|Overall Study|Lost to Follow-up|0|||
25288197|NCT00936117|50603061|FG000|Overall Study|Adverse Event|7|||
25288198|NCT00936117|50603061|FG000|Overall Study|Unable to continue oral medication|3|||
25288199|NCT04088500|50603066|FG000|Overall Study|Reason unknown|1|||
25288200|NCT04088500|50603066|FG000|Overall Study|Participant withdrew consent|1|||
25288201|NCT04088500|50603066|FG000|Overall Study|Disease progression|3|||
25288202|NCT01082874|50603074|FG000|Overall Study|Lost to Follow-up|10|||
25288203|NCT01082874|50603075|FG001|Overall Study|Lost to Follow-up|10|||
25288204|NCT01082874|50603076|FG002|Overall Study|Lost to Follow-up|6|||
25288205|NCT01082874|50603077|FG003|Overall Study|Lost to Follow-up|10|||
25288206|NCT01082874|50603074|FG000|Overall Study|Withdrawal by Subject|1|||
25288207|NCT01082874|50603075|FG001|Overall Study|Withdrawal by Subject|2|||
25288208|NCT01082874|50603076|FG002|Overall Study|Withdrawal by Subject|5|||
25288209|NCT01082874|50603077|FG003|Overall Study|Withdrawal by Subject|3|||
25288210|NCT00933543|50603089|FG000|Overall Study|Adverse Event|2|||
25288211|NCT00933543|50603090|FG001|Overall Study|Adverse Event|1|||
25288212|NCT00933543|50603089|FG000|Overall Study|Lost to Follow-up|0|||
25288213|NCT00933543|50603090|FG001|Overall Study|Lost to Follow-up|1|||
25288214|NCT00933543|50603089|FG000|Overall Study|Withdrawal by Subject|0|||
25288215|NCT00933543|50603090|FG001|Overall Study|Withdrawal by Subject|1|||
25288216|NCT00933543|50603089|FG000|Overall Study|Lack of Efficacy|0|||
25288217|NCT00933543|50603090|FG001|Overall Study|Lack of Efficacy|3|||
25288218|NCT00933543|50603089|FG000|Overall Study|Other|1|||
25288219|NCT00933543|50603090|FG001|Overall Study|Other|1|||
25288220|NCT01082328|50603096|FG000|Overall Study|Adverse Event|1|||
25288221|NCT01079988|50603105|FG000|Overall Study|Lost to Follow-up|0|||
25288222|NCT01079988|50603106|FG001|Overall Study|Lost to Follow-up|0|||
25288223|NCT01079988|50603107|FG002|Overall Study|Lost to Follow-up|0|||
25288224|NCT01079988|50603108|FG003|Overall Study|Lost to Follow-up|1|||
25288225|NCT01079988|50603109|FG004|Overall Study|Lost to Follow-up|0|||
25288226|NCT01079988|50603105|FG000|Overall Study|Lack of Efficacy|1|||
25288227|NCT01079988|50603106|FG001|Overall Study|Lack of Efficacy|0|||
25288228|NCT01079988|50603107|FG002|Overall Study|Lack of Efficacy|0|||
25288229|NCT01079988|50603108|FG003|Overall Study|Lack of Efficacy|0|||
25288230|NCT01079988|50603109|FG004|Overall Study|Lack of Efficacy|0|||
25288231|NCT01079988|50603105|FG000|Overall Study|Other|0|||
25288232|NCT01079988|50603106|FG001|Overall Study|Other|0|||
25288233|NCT01079988|50603107|FG002|Overall Study|Other|0|||
25288234|NCT01079988|50603108|FG003|Overall Study|Other|2|||
25288235|NCT01079988|50603109|FG004|Overall Study|Other|1|||
25288236|NCT01074216|50603121|FG000|Overall Study|Physician Decision|1|||
25288237|NCT01074216|50603121|FG000|Overall Study|Not Treated|12|||
25288238|NCT01079832|50603125|FG000|Overall Study|Withdrawal by Subject|1|||
25288239|NCT01072344|50603131|FG000|Overall Study|Relasped-reached end point|7|||
25288240|NCT01072344|50603132|FG001|Overall Study|Relasped-reached end point|12|||
25288241|NCT01072344|50603131|FG000|Overall Study|Protocol Violation|1|||
25288242|NCT01072344|50603132|FG001|Overall Study|Protocol Violation|2|||
25288243|NCT01072344|50603131|FG000|Overall Study|Lost to Follow-up|3|||
25288244|NCT01072344|50603132|FG001|Overall Study|Lost to Follow-up|4|||
25288245|NCT01071954|50603138|FG000|Overall Study|Noncompliance|4|||
25288246|NCT01071954|50603138|FG000|Overall Study|Adverse Event|1|||
25288247|NCT01071954|50603138|FG000|Overall Study|Withdrawal by Subject|11|||
25288248|NCT01071954|50603138|FG000|Overall Study|Requirement for Alternative Therapy|5|||
25288249|NCT01071954|50603138|FG000|Overall Study|Administrative Decision|5|||
25288250|NCT01071954|50603138|FG000|Overall Study|Protocol Specified Criteria|1|||
25288251|NCT00837811|50603145|FG000|Overall Study|Adverse Event|4|||
25070245|NCT02302066|50176124|FG001|Overall Study|Pregnancy|10|||
25070246|NCT02302066|50176125|FG002|Overall Study|Pregnancy|12|||
25070247|NCT02302066|50176126|FG003|Overall Study|Pregnancy|0|||
25070248|NCT02302066|50176123|FG000|Overall Study|Reason Not Specified|1|||
25070249|NCT02302066|50176124|FG001|Overall Study|Reason Not Specified|1|||
25070250|NCT02302066|50176125|FG002|Overall Study|Reason Not Specified|9|||
25070251|NCT02302066|50176126|FG003|Overall Study|Reason Not Specified|1|||
25070252|NCT02301988|50176148|FG000|Overall Study|Withdrawal by Subject|2|||
25288252|NCT00837811|50603146|FG001|Overall Study|Adverse Event|6|||
25288253|NCT00837811|50603147|FG002|Overall Study|Adverse Event|0|||
25288254|NCT00837811|50603145|FG000|Overall Study|Death|1|||
25288255|NCT00837811|50603146|FG001|Overall Study|Death|1|||
25288256|NCT00837811|50603147|FG002|Overall Study|Death|0|||
25288257|NCT00837811|50603145|FG000|Overall Study|Lack of Efficacy|0|||
25288258|NCT00837811|50603146|FG001|Overall Study|Lack of Efficacy|11|||
25288259|NCT00837811|50603147|FG002|Overall Study|Lack of Efficacy|0|||
25288260|NCT00837811|50603145|FG000|Overall Study|Lost to Follow-up|1|||
25288261|NCT00837811|50603146|FG001|Overall Study|Lost to Follow-up|3|||
25288262|NCT00837811|50603147|FG002|Overall Study|Lost to Follow-up|0|||
25288263|NCT00837811|50603145|FG000|Overall Study|Physician Decision|0|||
25288264|NCT00837811|50603146|FG001|Overall Study|Physician Decision|2|||
25288265|NCT00837811|50603147|FG002|Overall Study|Physician Decision|1|||
25288266|NCT00837811|50603145|FG000|Overall Study|Withdrawal by Subject|1|||
25288267|NCT00837811|50603146|FG001|Overall Study|Withdrawal by Subject|9|||
25288268|NCT00837811|50603147|FG002|Overall Study|Withdrawal by Subject|0|||
25288269|NCT00837811|50603145|FG000|Overall Study|Sponsor Decision|0|||
25288270|NCT00837811|50603146|FG001|Overall Study|Sponsor Decision|2|||
25288271|NCT00837811|50603147|FG002|Overall Study|Sponsor Decision|0|||
25288272|NCT00857389|50603164|FG000|Overall Study|Did not proceed to transplant|2|||
25288273|NCT01071798|50603168|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
25288274|NCT01071798|50603168|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
25288275|NCT01071798|50603168|FG000|Participants Who Received One Cycle|Patient requirement|20|||
25288276|NCT01071798|50603168|FG000|Participants Who Received One Cycle|Death|5|||
25288277|NCT01071798|50603168|FG000|Participants Who Received One Cycle|Change of therapy|6|||
25288278|NCT01071798|50603168|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
25288279|NCT01071798|50603168|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
25288280|NCT01071798|50603168|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
25288281|NCT01071798|50603168|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
25288282|NCT01071798|50603168|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
25288283|NCT00857311|50603186|FG000|Overall Study|Lost to Follow-up|1|||
25288284|NCT00857311|50603187|FG001|Overall Study|Lost to Follow-up|0|||
25288285|NCT00857311|50603188|FG002|Overall Study|Lost to Follow-up|0|||
25288286|NCT00857311|50603189|FG003|Overall Study|Lost to Follow-up|0|||
25288287|NCT00857233|50603195|FG000|Overall Study|Adverse Event|24|||
25288288|NCT00857233|50603195|FG000|Overall Study|Lack of Efficacy|1|||
25288289|NCT00857233|50603195|FG000|Overall Study|Non-compliance|1|||
25288290|NCT00857233|50603195|FG000|Overall Study|Withdrawal of Consent|9|||
25288291|NCT00857233|50603195|FG000|Overall Study|Lost to Follow-up|4|||
25288292|NCT00857233|50603195|FG000|Overall Study|Nursing Home Placement|14|||
25288293|NCT00857233|50603195|FG000|Overall Study|Other Reasons|2|||
25288294|NCT00856999|50603199|FG000|Overall Study|Withdrawal by Subject|5|||
25288295|NCT01071252|50603209|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
25288296|NCT01071252|50603210|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
25288297|NCT01071252|50603211|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
25288298|NCT01071252|50603212|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
25288299|NCT01071252|50603213|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
25288300|NCT01071252|50603209|FG000|Overall Study|Withdrawal by Subject|8|||
24969697|NCT04823494|50059163|FG001|Overall Study|Devices lost|1|||
25070253|NCT02301988|50176149|FG001|Overall Study|Withdrawal by Subject|1|||
25288301|NCT01071252|50603210|FG001|Overall Study|Withdrawal by Subject|2|||
25288302|NCT01071252|50603211|FG002|Overall Study|Withdrawal by Subject|1|||
25288303|NCT01071252|50603212|FG003|Overall Study|Withdrawal by Subject|2|||
25288304|NCT01071252|50603213|FG004|Overall Study|Withdrawal by Subject|3|||
25288305|NCT01071252|50603209|FG000|Overall Study|administrative problems|1|||
25288306|NCT01071252|50603210|FG001|Overall Study|administrative problems|1|||
25288307|NCT01071252|50603211|FG002|Overall Study|administrative problems|0|||
24969698|NCT04542694|50059173|FG000|Overall Study|The need for prohibited therapy|2|||
25288308|NCT01071252|50603212|FG003|Overall Study|administrative problems|2|||
25288309|NCT01071252|50603213|FG004|Overall Study|administrative problems|1|||
25288310|NCT01071252|50603209|FG000|Overall Study|Lost to Follow-up|1|||
25288311|NCT01071252|50603210|FG001|Overall Study|Lost to Follow-up|0|||
25288312|NCT01071252|50603211|FG002|Overall Study|Lost to Follow-up|1|||
25288313|NCT01071252|50603212|FG003|Overall Study|Lost to Follow-up|2|||
25288314|NCT01071252|50603213|FG004|Overall Study|Lost to Follow-up|0|||
25288315|NCT01071252|50603209|FG000|Overall Study|Adverse Event|1|||
25288316|NCT01071252|50603210|FG001|Overall Study|Adverse Event|1|||
25288317|NCT01071252|50603211|FG002|Overall Study|Adverse Event|0|||
25288318|NCT01071252|50603212|FG003|Overall Study|Adverse Event|1|||
25288319|NCT01071252|50603213|FG004|Overall Study|Adverse Event|0|||
25288320|NCT01071252|50603209|FG000|Overall Study|Death|0|||
25288321|NCT01071252|50603210|FG001|Overall Study|Death|0|||
25288322|NCT01071252|50603211|FG002|Overall Study|Death|0|||
25288323|NCT01071252|50603212|FG003|Overall Study|Death|0|||
25288324|NCT01071252|50603213|FG004|Overall Study|Death|1|||
25288325|NCT00856843|50603227|FG000|Overall Study|Withdrawal by Subject|1|||
25288326|NCT00856843|50603228|FG001|Overall Study|Withdrawal by Subject|5|||
25288327|NCT00856843|50603227|FG000|Overall Study|Lack of Efficacy|1|||
25288328|NCT00856843|50603228|FG001|Overall Study|Lack of Efficacy|0|||
25288329|NCT00856609|50603236|FG000|Overall Study|Adverse Event|1|||
25288330|NCT00856609|50603237|FG001|Overall Study|Adverse Event|0|||
25288331|NCT01071096|50603243|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
25288332|NCT01071096|50603244|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
25288333|NCT00856375|50603263|FG000|Overall Study|Other|0|||
25288334|NCT00856375|50603264|FG001|Overall Study|Other|1|||
25288335|NCT00856375|50603263|FG000|Overall Study|Death|32|||
25288336|NCT00856375|50603264|FG001|Overall Study|Death|30|||
25288337|NCT00856375|50603263|FG000|Overall Study|Sponsor Terminated Study|7|||
25288338|NCT00856375|50603264|FG001|Overall Study|Sponsor Terminated Study|7|||
25288339|NCT00856375|50603263|FG000|Overall Study|Withdrawal by Subject|2|||
25288340|NCT00856375|50603264|FG001|Overall Study|Withdrawal by Subject|1|||
25288341|NCT00856375|50603263|FG000|Overall Study|Lost to Follow-up|1|||
25288342|NCT00856375|50603264|FG001|Overall Study|Lost to Follow-up|2|||
25288343|NCT01070784|50603272|FG000|Overall Study|Withdrawal by Subject|6|||
25288344|NCT01070784|50603273|FG001|Overall Study|Withdrawal by Subject|9|||
25288345|NCT01070784|50603272|FG000|Overall Study|Adverse Event|14|||
25288346|NCT01070784|50603273|FG001|Overall Study|Adverse Event|9|||
25288347|NCT00837577|50603281|FG000|Double-blind Period|Clinical Adverse Event|1|||
25288348|NCT00837577|50603282|FG001|Double-blind Period|Clinical Adverse Event|0|||
25288349|NCT00837577|50603281|FG000|Double-blind Period|Withdrawal by Subject|1|||
25288350|NCT00837577|50603282|FG001|Double-blind Period|Withdrawal by Subject|0|||
25288351|NCT00837577|50603281|FG000|Open-label Period|Clinical Adverse Event|2|||
25288352|NCT00837577|50603282|FG001|Open-label Period|Clinical Adverse Event|2|||
25288353|NCT00837577|50603281|FG000|Open-label Period|Laboratory Adverse Event|0|||
25288354|NCT00837577|50603282|FG001|Open-label Period|Laboratory Adverse Event|1|||
25288355|NCT00837577|50603281|FG000|Open-label Period|Lack of Efficacy|4|||
25288356|NCT00837577|50603282|FG001|Open-label Period|Lack of Efficacy|3|||
25288357|NCT00837577|50603281|FG000|Open-label Period|Withdrawal by Subject|1|||
25288358|NCT00837577|50603282|FG001|Open-label Period|Withdrawal by Subject|2|||
25288359|NCT00837577|50603281|FG000|Open-label Period|Other Reason|1|||
25288360|NCT00837577|50603282|FG001|Open-label Period|Other Reason|1|||
25288361|NCT01070550|50603295|FG000|Overall Study|Adverse Event|43|||
25288362|NCT01070550|50603296|FG001|Overall Study|Adverse Event|1|||
25288363|NCT01070550|50603297|FG002|Overall Study|Adverse Event|3|||
25288364|NCT01070550|50603298|FG003|Overall Study|Adverse Event|0|||
25288365|NCT01070550|50603299|FG004|Overall Study|Adverse Event|0|||
25288366|NCT01070550|50603300|FG005|Overall Study|Adverse Event|0|||
25288367|NCT01070550|50603295|FG000|Overall Study|Death|20|||
25288368|NCT01070550|50603296|FG001|Overall Study|Death|4|||
25288369|NCT01070550|50603297|FG002|Overall Study|Death|3|||
25288370|NCT01070550|50603298|FG003|Overall Study|Death|0|||
25288371|NCT01070550|50603299|FG004|Overall Study|Death|0|||
25288372|NCT01070550|50603300|FG005|Overall Study|Death|0|||
25288373|NCT01070550|50603295|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
25288374|NCT01070550|50603296|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
25288375|NCT01070550|50603297|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
25288376|NCT01070550|50603298|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
25288377|NCT01070550|50603299|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
25288378|NCT01070550|50603300|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
25288379|NCT01070550|50603295|FG000|Overall Study|Early termination|3|||
25070254|NCT02301988|50176148|FG000|Overall Study|Physician Decision|2|||
25169230|NCT01865747|50300614|FG000|Overall Study (ITT)|Protocol Violation|1|||
25169231|NCT01865747|50300615|FG001|Overall Study (ITT)|Protocol Violation|1|||
25288380|NCT01070550|50603296|FG001|Overall Study|Early termination|0|||
25288381|NCT01070550|50603297|FG002|Overall Study|Early termination|0|||
25288382|NCT01070550|50603298|FG003|Overall Study|Early termination|0|||
25288383|NCT01070550|50603299|FG004|Overall Study|Early termination|0|||
25288384|NCT01070550|50603300|FG005|Overall Study|Early termination|0|||
25288385|NCT01070550|50603295|FG000|Overall Study|Failed to return|450|||
25288386|NCT01070550|50603296|FG001|Overall Study|Failed to return|33|||
25288387|NCT01070550|50603297|FG002|Overall Study|Failed to return|144|||
25288388|NCT01070550|50603298|FG003|Overall Study|Failed to return|40|||
25288389|NCT01070550|50603299|FG004|Overall Study|Failed to return|1|||
25288390|NCT01070550|50603300|FG005|Overall Study|Failed to return|2|||
25288391|NCT01070550|50603295|FG000|Overall Study|Incomplete treatment|2|||
25288392|NCT01070550|50603296|FG001|Overall Study|Incomplete treatment|0|||
25288393|NCT01070550|50603297|FG002|Overall Study|Incomplete treatment|0|||
25288394|NCT01070550|50603298|FG003|Overall Study|Incomplete treatment|0|||
25288395|NCT01070550|50603299|FG004|Overall Study|Incomplete treatment|0|||
25288396|NCT01070550|50603300|FG005|Overall Study|Incomplete treatment|0|||
25288397|NCT01070550|50603295|FG000|Overall Study|Lab test not done|22|||
25288398|NCT01070550|50603296|FG001|Overall Study|Lab test not done|3|||
25288399|NCT01070550|50603297|FG002|Overall Study|Lab test not done|4|||
25288400|NCT01070550|50603298|FG003|Overall Study|Lab test not done|1|||
25288401|NCT01070550|50603299|FG004|Overall Study|Lab test not done|0|||
25288402|NCT01070550|50603300|FG005|Overall Study|Lab test not done|1|||
25288403|NCT01070550|50603295|FG000|Overall Study|Lack of Efficacy|65|||
25288404|NCT01070550|50603296|FG001|Overall Study|Lack of Efficacy|1|||
25288405|NCT01070550|50603297|FG002|Overall Study|Lack of Efficacy|5|||
25288406|NCT01070550|50603298|FG003|Overall Study|Lack of Efficacy|5|||
25288407|NCT01070550|50603299|FG004|Overall Study|Lack of Efficacy|0|||
25288408|NCT01070550|50603300|FG005|Overall Study|Lack of Efficacy|1|||
25288409|NCT01070550|50603295|FG000|Overall Study|Miscellaneous|12|||
25288410|NCT01070550|50603296|FG001|Overall Study|Miscellaneous|2|||
25288411|NCT01070550|50603297|FG002|Overall Study|Miscellaneous|3|||
25288412|NCT01070550|50603298|FG003|Overall Study|Miscellaneous|1|||
25288413|NCT01070550|50603299|FG004|Overall Study|Miscellaneous|0|||
25288414|NCT01070550|50603300|FG005|Overall Study|Miscellaneous|0|||
25288415|NCT01070550|50603295|FG000|Overall Study|New treatment started|3|||
25288416|NCT01070550|50603296|FG001|Overall Study|New treatment started|1|||
25288417|NCT01070550|50603297|FG002|Overall Study|New treatment started|0|||
25288418|NCT01070550|50603298|FG003|Overall Study|New treatment started|2|||
25288419|NCT01070550|50603299|FG004|Overall Study|New treatment started|0|||
25288420|NCT01070550|50603300|FG005|Overall Study|New treatment started|0|||
25288421|NCT01070550|50603295|FG000|Overall Study|Non-responders|493|||
25288422|NCT01070550|50603296|FG001|Overall Study|Non-responders|4|||
25288423|NCT01070550|50603297|FG002|Overall Study|Non-responders|21|||
25191532|NCT00081653|50352227|FG000|Overall Study|Loss of bone mass|0|||
25191533|NCT00081653|50352228|FG001|Overall Study|Loss of bone mass|2|||
25191534|NCT02596620|50352298|FG000|Overall Study|Lost to Follow-up|1|||
25191535|NCT02596620|50352299|FG001|Overall Study|Lost to Follow-up|1|||
25191536|NCT02596230|50352455|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
25191537|NCT02596230|50352456|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
25191538|NCT02596230|50352457|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
25191539|NCT02596230|50352458|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
25191540|NCT02596230|50352459|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
25191541|NCT02596230|50352455|FG000|Objective 2, One Year|Lost to Follow-up|0|||
25191542|NCT02596230|50352456|FG001|Objective 2, One Year|Lost to Follow-up|41|||
25191543|NCT02596230|50352457|FG002|Objective 2, One Year|Lost to Follow-up|41|||
25191544|NCT02596230|50352458|FG003|Objective 2, One Year|Lost to Follow-up|32|||
25191545|NCT02596230|50352459|FG004|Objective 2, One Year|Lost to Follow-up|46|||
25191546|NCT02596230|50352455|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
25191547|NCT02596230|50352456|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
25191548|NCT02596230|50352457|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
25191549|NCT02596230|50352458|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
25288424|NCT01070550|50603298|FG003|Overall Study|Non-responders|20|||
25288425|NCT01070550|50603299|FG004|Overall Study|Non-responders|0|||
25288426|NCT01070550|50603300|FG005|Overall Study|Non-responders|2|||
25288427|NCT01070550|50603295|FG000|Overall Study|Not categorized|33|||
25288428|NCT01070550|50603296|FG001|Overall Study|Not categorized|2|||
25288429|NCT01070550|50603297|FG002|Overall Study|Not categorized|6|||
25288430|NCT01070550|50603298|FG003|Overall Study|Not categorized|1|||
25288431|NCT01070550|50603299|FG004|Overall Study|Not categorized|0|||
25288432|NCT01070550|50603300|FG005|Overall Study|Not categorized|1|||
24969699|NCT04542694|50059174|FG001|Overall Study|The need for prohibited therapy|0|||
24969700|NCT04542694|50059173|FG000|Overall Study|Adverse Event|1|||
25070255|NCT02301988|50176149|FG001|Overall Study|Physician Decision|2|||
25191550|NCT02596230|50352459|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
25288433|NCT01070550|50603295|FG000|Overall Study|Protocol Violation|15|||
25288434|NCT01070550|50603296|FG001|Overall Study|Protocol Violation|1|||
25288435|NCT01070550|50603297|FG002|Overall Study|Protocol Violation|1|||
25288436|NCT01070550|50603298|FG003|Overall Study|Protocol Violation|1|||
25288437|NCT01070550|50603299|FG004|Overall Study|Protocol Violation|0|||
25288438|NCT01070550|50603300|FG005|Overall Study|Protocol Violation|0|||
25288439|NCT01070550|50603295|FG000|Overall Study|Relapse|44|||
25288440|NCT01070550|50603296|FG001|Overall Study|Relapse|5|||
25288441|NCT01070550|50603297|FG002|Overall Study|Relapse|14|||
25288442|NCT01070550|50603298|FG003|Overall Study|Relapse|4|||
25288443|NCT01070550|50603299|FG004|Overall Study|Relapse|0|||
25288444|NCT01070550|50603300|FG005|Overall Study|Relapse|0|||
25288445|NCT01070550|50603295|FG000|Overall Study|Result not available|3|||
25288446|NCT01070550|50603296|FG001|Overall Study|Result not available|1|||
25288447|NCT01070550|50603297|FG002|Overall Study|Result not available|3|||
25288448|NCT01070550|50603298|FG003|Overall Study|Result not available|0|||
25288449|NCT01070550|50603299|FG004|Overall Study|Result not available|0|||
25288450|NCT01070550|50603300|FG005|Overall Study|Result not available|0|||
25288451|NCT01070550|50603295|FG000|Overall Study|Screen failure|1|||
25288452|NCT01070550|50603296|FG001|Overall Study|Screen failure|0|||
25288453|NCT01070550|50603297|FG002|Overall Study|Screen failure|0|||
25288454|NCT01070550|50603298|FG003|Overall Study|Screen failure|0|||
25288455|NCT01070550|50603299|FG004|Overall Study|Screen failure|0|||
25288456|NCT01070550|50603300|FG005|Overall Study|Screen failure|0|||
25288457|NCT01070550|50603295|FG000|Overall Study|Sponsor decision|1|||
25288458|NCT01070550|50603296|FG001|Overall Study|Sponsor decision|0|||
25288459|NCT01070550|50603297|FG002|Overall Study|Sponsor decision|0|||
25288460|NCT01070550|50603298|FG003|Overall Study|Sponsor decision|0|||
25288461|NCT01070550|50603299|FG004|Overall Study|Sponsor decision|0|||
25288462|NCT01070550|50603300|FG005|Overall Study|Sponsor decision|0|||
25288463|NCT01070550|50603295|FG000|Overall Study|Treatment duration shortened|1|||
25288464|NCT01070550|50603296|FG001|Overall Study|Treatment duration shortened|0|||
25288465|NCT01070550|50603297|FG002|Overall Study|Treatment duration shortened|0|||
25288466|NCT01070550|50603298|FG003|Overall Study|Treatment duration shortened|0|||
25288467|NCT01070550|50603299|FG004|Overall Study|Treatment duration shortened|0|||
25288468|NCT01070550|50603300|FG005|Overall Study|Treatment duration shortened|0|||
25288469|NCT01070550|50603295|FG000|Overall Study|Treatment interrupted|7|||
25288470|NCT01070550|50603296|FG001|Overall Study|Treatment interrupted|0|||
25288471|NCT01070550|50603297|FG002|Overall Study|Treatment interrupted|1|||
25288472|NCT01070550|50603298|FG003|Overall Study|Treatment interrupted|1|||
25288473|NCT01070550|50603299|FG004|Overall Study|Treatment interrupted|0|||
25288474|NCT01070550|50603300|FG005|Overall Study|Treatment interrupted|0|||
25288475|NCT01070550|50603295|FG000|Overall Study|Treatment not started|14|||
25288476|NCT01070550|50603296|FG001|Overall Study|Treatment not started|2|||
25288477|NCT01070550|50603297|FG002|Overall Study|Treatment not started|4|||
25288478|NCT01070550|50603298|FG003|Overall Study|Treatment not started|0|||
25288479|NCT01070550|50603299|FG004|Overall Study|Treatment not started|0|||
25288480|NCT01070550|50603300|FG005|Overall Study|Treatment not started|0|||
25288481|NCT01070550|50603295|FG000|Overall Study|Treatment restarted|0|||
25288482|NCT01070550|50603296|FG001|Overall Study|Treatment restarted|1|||
25288483|NCT01070550|50603297|FG002|Overall Study|Treatment restarted|0|||
25288484|NCT01070550|50603298|FG003|Overall Study|Treatment restarted|0|||
25288485|NCT01070550|50603299|FG004|Overall Study|Treatment restarted|0|||
25288486|NCT01070550|50603300|FG005|Overall Study|Treatment restarted|0|||
25288487|NCT01070550|50603295|FG000|Overall Study|Treatment stopped|3|||
25288488|NCT01070550|50603296|FG001|Overall Study|Treatment stopped|0|||
25288489|NCT01070550|50603297|FG002|Overall Study|Treatment stopped|0|||
25288490|NCT01070550|50603298|FG003|Overall Study|Treatment stopped|0|||
25288491|NCT01070550|50603299|FG004|Overall Study|Treatment stopped|0|||
25288492|NCT01070550|50603300|FG005|Overall Study|Treatment stopped|0|||
25288493|NCT01070550|50603295|FG000|Overall Study|Treatment unavailable|1|||
25288494|NCT01070550|50603296|FG001|Overall Study|Treatment unavailable|0|||
25288495|NCT01070550|50603297|FG002|Overall Study|Treatment unavailable|0|||
25288496|NCT01070550|50603298|FG003|Overall Study|Treatment unavailable|0|||
25288497|NCT01070550|50603299|FG004|Overall Study|Treatment unavailable|0|||
25288498|NCT01070550|50603300|FG005|Overall Study|Treatment unavailable|0|||
25288499|NCT01070550|50603295|FG000|Overall Study|Treatment was stopped early|7|||
25288500|NCT01070550|50603296|FG001|Overall Study|Treatment was stopped early|0|||
25288501|NCT01070550|50603297|FG002|Overall Study|Treatment was stopped early|0|||
25288502|NCT01070550|50603298|FG003|Overall Study|Treatment was stopped early|0|||
25288503|NCT01070550|50603299|FG004|Overall Study|Treatment was stopped early|0|||
25288504|NCT01070550|50603300|FG005|Overall Study|Treatment was stopped early|0|||
25288505|NCT01070550|50603295|FG000|Overall Study|Other|5|||
25288506|NCT01070550|50603296|FG001|Overall Study|Other|0|||
25288507|NCT01070550|50603297|FG002|Overall Study|Other|0|||
25288508|NCT01070550|50603298|FG003|Overall Study|Other|1|||
25288509|NCT01070550|50603299|FG004|Overall Study|Other|0|||
25288510|NCT01070550|50603300|FG005|Overall Study|Other|0|||
25288511|NCT01070550|50603295|FG000|Overall Study|Withdrawal by Subject|35|||
25288512|NCT01070550|50603296|FG001|Overall Study|Withdrawal by Subject|0|||
25288513|NCT01070550|50603297|FG002|Overall Study|Withdrawal by Subject|3|||
25288514|NCT01070550|50603298|FG003|Overall Study|Withdrawal by Subject|0|||
25288515|NCT01070550|50603299|FG004|Overall Study|Withdrawal by Subject|0|||
25288516|NCT01070550|50603300|FG005|Overall Study|Withdrawal by Subject|0|||
25288517|NCT00848107|50603315|FG000|Overall Study|Lost to Follow-up|2|||
25288518|NCT00848107|50603315|FG000|Overall Study|Withdrawal by Subject|8|||
25288519|NCT00848107|50603315|FG000|Overall Study|Adverse Event|9|||
25288520|NCT00848107|50603315|FG000|Overall Study|Death|1|||
25288521|NCT00848107|50603315|FG000|Overall Study|Pregnancy|1|||
25288522|NCT00856297|50603324|FG000|Overall Study|Unable to classify|2|||
25288523|NCT00856297|50603325|FG001|Overall Study|Unable to classify|0|||
25288524|NCT00856297|50603326|FG002|Overall Study|Unable to classify|0|||
25288525|NCT00856297|50603327|FG003|Overall Study|Unable to classify|0|||
25288526|NCT00856297|50603328|FG004|Overall Study|Unable to classify|0|||
25288527|NCT01046136|50603347|FG000|Overall Study|Withdrawal by Subject|0|||
25288528|NCT01046136|50603348|FG001|Overall Study|Withdrawal by Subject|4|||
25288529|NCT01046136|50603347|FG000|Overall Study|Physician Decision|1|||
25288530|NCT01046136|50603348|FG001|Overall Study|Physician Decision|1|||
25288531|NCT01046136|50603347|FG000|Overall Study|Lost to Follow-up|3|||
25288532|NCT01046136|50603348|FG001|Overall Study|Lost to Follow-up|3|||
25288533|NCT01070394|50603356|FG000|Overall Study|Adverse Event|6|||
25288534|NCT01070394|50603356|FG000|Overall Study|Withdrawal by Subject|1|||
25288535|NCT00836953|50603362|FG000|Overall Study|Withdrawal by Subject|1|||
25288536|NCT00836953|50603362|FG000|Overall Study|Lost to Follow-up|1|||
25288537|NCT01070316|50603366|FG000|Extension Phase|Lack of Efficacy|3|||
25288538|NCT01070316|50603366|FG000|Extension Phase|Withdrawal by Subject|1|||
25288539|NCT01126541|50603373|FG000|Overall Study|Adverse Event|0|||
25288540|NCT01126541|50603374|FG001|Overall Study|Adverse Event|2|||
25288541|NCT01126541|50603375|FG002|Overall Study|Adverse Event|4|||
25288542|NCT01126541|50603373|FG000|Overall Study|Death|0|||
25288543|NCT01126541|50603374|FG001|Overall Study|Death|1|||
25288544|NCT01126541|50603375|FG002|Overall Study|Death|0|||
25288545|NCT01126541|50603373|FG000|Overall Study|Lack of Efficacy|6|||
25288546|NCT01126541|50603374|FG001|Overall Study|Lack of Efficacy|1|||
25288547|NCT01126541|50603375|FG002|Overall Study|Lack of Efficacy|11|||
25288548|NCT01126541|50603373|FG000|Overall Study|Lost to Follow-up|1|||
25288549|NCT01126541|50603374|FG001|Overall Study|Lost to Follow-up|2|||
25288550|NCT01126541|50603375|FG002|Overall Study|Lost to Follow-up|2|||
25288551|NCT01126541|50603373|FG000|Overall Study|Withdrawal by Subject|2|||
25288552|NCT01126541|50603374|FG001|Overall Study|Withdrawal by Subject|5|||
25288553|NCT01126541|50603375|FG002|Overall Study|Withdrawal by Subject|6|||
25288554|NCT01126541|50603373|FG000|Overall Study|Protocol Violation|0|||
25288555|NCT01126541|50603374|FG001|Overall Study|Protocol Violation|0|||
25288556|NCT01126541|50603375|FG002|Overall Study|Protocol Violation|1|||
25288557|NCT01126541|50603373|FG000|Overall Study|Administrative reason or other|1|||
25288558|NCT01126541|50603374|FG001|Overall Study|Administrative reason or other|1|||
25288559|NCT01126541|50603375|FG002|Overall Study|Administrative reason or other|2|||
25288560|NCT00836875|50603387|FG000|Overall Study|Death|3|||
25288561|NCT00836875|50603388|FG001|Overall Study|Death|2|||
25288562|NCT00836875|50603387|FG000|Overall Study|Withdrawal by Subject|0|||
25288563|NCT00836875|50603388|FG001|Overall Study|Withdrawal by Subject|1|||
25288564|NCT01125917|50603394|FG000|Overall Study|Adverse Event|43|||
25288565|NCT01125917|50603394|FG000|Overall Study|Lost to Follow-up|23|||
25288566|NCT01125917|50603394|FG000|Overall Study|Withdrawal by Subject|31|||
25288567|NCT01125917|50603394|FG000|Overall Study|Administrative|223|||
25288568|NCT01125917|50603394|FG000|Overall Study|Lack of Efficacy|19|||
25288569|NCT00847561|50603400|FG000|Overall Study|Withdrawal by Subject|4|||
25288570|NCT00847561|50603401|FG001|Overall Study|Withdrawal by Subject|3|||
25288571|NCT00847561|50603400|FG000|Overall Study|Unable to schedule|9|||
25288572|NCT00847561|50603401|FG001|Overall Study|Unable to schedule|1|||
25288573|NCT01121549|50603407|FG000|Overall Study|Adverse Event|10|||
25288574|NCT01121549|50603407|FG000|Overall Study|Lack of Efficacy|11|||
25288575|NCT01121549|50603407|FG000|Overall Study|Lost to Follow-up|12|||
25288576|NCT01121549|50603407|FG000|Overall Study|Did not meet entrance criteria|9|||
25288577|NCT01121549|50603407|FG000|Overall Study|Study terminated by sponsor|197|||
25288578|NCT01121549|50603407|FG000|Overall Study|Pregnancy|1|||
25288579|NCT01121549|50603407|FG000|Overall Study|Protocol Violation|33|||
25288580|NCT01121549|50603407|FG000|Overall Study|Withdrawal by Subject|16|||
25070256|NCT02301988|50176148|FG000|Overall Study|Unknown Reason|1|||
25288581|NCT01121549|50603407|FG000|Overall Study|Other|58|||
25288582|NCT00847405|50603413|FG000|First Intervention|Adverse Event|0|||
25288583|NCT00847405|50603414|FG001|First Intervention|Adverse Event|1|||
25288584|NCT00847405|50603413|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
25288585|NCT00847405|50603414|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
24969701|NCT04542694|50059174|FG001|Overall Study|Adverse Event|0|||
25288586|NCT00836095|50603420|FG000|Overall Study|Physician Decision|0|||
25288587|NCT00836095|50603421|FG001|Overall Study|Physician Decision|3|||
25288588|NCT00835237|50603438|FG000|Overall Study|Lost to Follow-up|4|||
25288589|NCT00835237|50603439|FG001|Overall Study|Lost to Follow-up|0|||
25288590|NCT00835237|50603438|FG000|Overall Study|Withdrawal by Subject|2|||
25288591|NCT00835237|50603439|FG001|Overall Study|Withdrawal by Subject|0|||
25288592|NCT01072500|50603447|FG000|Overall Study|Death|2|||
25288593|NCT01072500|50603448|FG001|Overall Study|Death|2|||
25288594|NCT01072500|50603447|FG000|Overall Study|Lost to Follow-up|5|||
25288595|NCT01072500|50603448|FG001|Overall Study|Lost to Follow-up|2|||
25288596|NCT01072500|50603447|FG000|Overall Study|Withdrawal by Subject|17|||
25288597|NCT01072500|50603448|FG001|Overall Study|Withdrawal by Subject|10|||
25288598|NCT00847015|50603456|FG000|Overall Study|Withdrawal by Subject|1|||
25288599|NCT00847015|50603456|FG000|Overall Study|declined any surgery|1|||
25288600|NCT00847015|50603456|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
25288601|NCT00855595|50603462|FG000|Overall Study|Withdrawal by Subject|1|||
25288602|NCT00855595|50603463|FG001|Overall Study|Withdrawal by Subject|2|||
25288603|NCT00855595|50603462|FG000|Overall Study|Lost to Follow-up|3|||
25288604|NCT00855595|50603463|FG001|Overall Study|Lost to Follow-up|3|||
25288605|NCT00855595|50603462|FG000|Overall Study|Adverse Event|1|||
25288606|NCT00855595|50603463|FG001|Overall Study|Adverse Event|1|||
25288607|NCT00855595|50603462|FG000|Overall Study|patient moved out of state|1|||
25288608|NCT00855595|50603463|FG001|Overall Study|patient moved out of state|0|||
25288609|NCT00855595|50603462|FG000|Overall Study|patient left country|0|||
25288610|NCT00855595|50603463|FG001|Overall Study|patient left country|1|||
25288611|NCT00855439|50603471|FG000|Overall Study|Withdrawal by Subject|2|||
25288612|NCT00855439|50603472|FG001|Overall Study|Withdrawal by Subject|0|||
25288613|NCT00855439|50603471|FG000|Overall Study|Pregnancy|1|||
25288614|NCT00855439|50603472|FG001|Overall Study|Pregnancy|0|||
25288615|NCT01064856|50603480|FG000|Double-blind (DB) Period|Adverse Event|1|||
25288616|NCT01064856|50603481|FG001|Double-blind (DB) Period|Adverse Event|0|||
25288617|NCT01064856|50603482|FG002|Double-blind (DB) Period|Adverse Event|0|||
25288618|NCT01064856|50603483|FG003|Double-blind (DB) Period|Adverse Event|0|||
25288619|NCT01064856|50603480|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
25288620|NCT01064856|50603481|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
25288621|NCT01064856|50603482|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
25288622|NCT01064856|50603483|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
25288623|NCT01064856|50603480|FG000|Open-label (OL) Period|Adverse Event|0|||
25288624|NCT01064856|50603481|FG001|Open-label (OL) Period|Adverse Event|0|||
25288625|NCT01064856|50603482|FG002|Open-label (OL) Period|Adverse Event|12|||
25288626|NCT01064856|50603483|FG003|Open-label (OL) Period|Adverse Event|6|||
25288627|NCT01064856|50603480|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
25288628|NCT01064856|50603481|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
25288629|NCT01064856|50603482|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
25288630|NCT01064856|50603483|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
25288631|NCT01064856|50603480|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
25288632|NCT01064856|50603481|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
25288633|NCT01064856|50603482|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
25070257|NCT02301988|50176149|FG001|Overall Study|Unknown Reason|3|||
25070258|NCT02301988|50176148|FG000|Overall Study|Lack of Efficacy|3|||
25070259|NCT02301988|50176149|FG001|Overall Study|Lack of Efficacy|2|||
25070260|NCT02301988|50176148|FG000|Overall Study|Death|1|||
25070261|NCT02301988|50176149|FG001|Overall Study|Death|0|||
25070262|NCT02301988|50176148|FG000|Overall Study|Adverse Event|1|||
25288634|NCT01064856|50603483|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
25288635|NCT01064856|50603480|FG000|Open-label (OL) Period|Other|0|||
25288636|NCT01064856|50603481|FG001|Open-label (OL) Period|Other|0|||
25288637|NCT01064856|50603482|FG002|Open-label (OL) Period|Other|7|||
25288638|NCT01064856|50603483|FG003|Open-label (OL) Period|Other|7|||
25288639|NCT00846391|50603493|FG000|Overall Study|Physician Decision|0|||
25288640|NCT00846391|50603494|FG001|Overall Study|Physician Decision|0|||
25288641|NCT00846391|50603495|FG002|Overall Study|Physician Decision|1|||
25288642|NCT00846391|50603493|FG000|Overall Study|Study Terminated by Sponsor|1|||
25288643|NCT00846391|50603494|FG001|Overall Study|Study Terminated by Sponsor|2|||
25288644|NCT00846391|50603495|FG002|Overall Study|Study Terminated by Sponsor|2|||
25288645|NCT01042392|50603505|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
25288646|NCT01042392|50603506|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
25288647|NCT01042392|50603507|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
25288648|NCT01042392|50603508|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
25288649|NCT01042392|50603505|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
25288650|NCT01042392|50603506|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
25288651|NCT01042392|50603507|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
25288652|NCT01042392|50603508|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
25288653|NCT01042392|50603505|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
25288654|NCT01042392|50603506|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
25288655|NCT01042392|50603507|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
25288656|NCT01042392|50603508|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
25288657|NCT01042392|50603505|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
25288658|NCT01042392|50603506|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
25288659|NCT01042392|50603507|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
25288660|NCT01042392|50603508|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
25288661|NCT01042392|50603505|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
25288662|NCT01042392|50603506|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
25288663|NCT01042392|50603507|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
25288664|NCT01042392|50603508|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
25288665|NCT01042392|50603505|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
25288666|NCT01042392|50603506|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
25288667|NCT01042392|50603507|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
25288668|NCT01042392|50603508|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
25288669|NCT01042392|50603505|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
25288670|NCT01042392|50603506|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
25288671|NCT01042392|50603507|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
25288672|NCT01042392|50603508|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
25288673|NCT01042392|50603505|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
25288674|NCT01042392|50603506|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
25288675|NCT01042392|50603507|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
25288676|NCT01042392|50603508|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
25288677|NCT01042392|50603505|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
25288678|NCT01042392|50603506|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
25288679|NCT01042392|50603507|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
25288680|NCT01042392|50603508|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
25288681|NCT01064310|50603522|FG000|Period 1|Adverse Event|7|||
25288682|NCT01064310|50603523|FG001|Period 1|Adverse Event|10|||
25288683|NCT01064310|50603524|FG002|Period 1|Adverse Event|0|||
25288684|NCT01064310|50603522|FG000|Period 1|Physician Decision|1|||
25288685|NCT01064310|50603523|FG001|Period 1|Physician Decision|0|||
25288686|NCT01064310|50603524|FG002|Period 1|Physician Decision|0|||
25288687|NCT01064310|50603522|FG000|Period 1|Withdrawal by Subject|2|||
25288688|NCT01064310|50603523|FG001|Period 1|Withdrawal by Subject|2|||
25288689|NCT01064310|50603524|FG002|Period 1|Withdrawal by Subject|0|||
25288690|NCT01064310|50603522|FG000|Period 1|Lack of Efficacy|3|||
25288691|NCT01064310|50603523|FG001|Period 1|Lack of Efficacy|5|||
25288692|NCT01064310|50603524|FG002|Period 1|Lack of Efficacy|0|||
25288693|NCT01064310|50603522|FG000|Period 1|Entered Open-label Period|1|||
25288694|NCT01064310|50603523|FG001|Period 1|Entered Open-label Period|1|||
25288695|NCT01064310|50603524|FG002|Period 1|Entered Open-label Period|0|||
25288696|NCT01064310|50603522|FG000|Period 2|Adverse Event|2|||
25288697|NCT01064310|50603523|FG001|Period 2|Adverse Event|1|||
25288698|NCT01064310|50603524|FG002|Period 2|Adverse Event|0|||
25288699|NCT01064310|50603522|FG000|Period 2|Physician Decision|0|||
25288700|NCT01064310|50603523|FG001|Period 2|Physician Decision|1|||
25288701|NCT01064310|50603524|FG002|Period 2|Physician Decision|0|||
25288702|NCT01064310|50603522|FG000|Period 2|Entered Open-label Period|1|||
25288703|NCT01064310|50603523|FG001|Period 2|Entered Open-label Period|0|||
25288704|NCT01064310|50603524|FG002|Period 2|Entered Open-label Period|0|||
25169232|NCT01865747|50300614|FG000|Overall Study (ITT)|Physician Decision|5|||
25169233|NCT01865747|50300615|FG001|Overall Study (ITT)|Physician Decision|2|||
25169234|NCT01865747|50300614|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
25169235|NCT01865747|50300615|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
25288705|NCT01064310|50603522|FG000|Period 2|Lack of Efficacy|1|||
25288706|NCT01064310|50603523|FG001|Period 2|Lack of Efficacy|4|||
25288707|NCT01064310|50603524|FG002|Period 2|Lack of Efficacy|0|||
25288708|NCT01064310|50603522|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
25288709|NCT01064310|50603523|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
25288710|NCT01064310|50603524|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
25288711|NCT01064310|50603522|FG000|Open Label Pazopinib|Adverse Event|0|||
25288712|NCT01064310|50603523|FG001|Open Label Pazopinib|Adverse Event|0|||
25288713|NCT01064310|50603524|FG002|Open Label Pazopinib|Adverse Event|12|||
25288714|NCT01064310|50603522|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
25288715|NCT01064310|50603523|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
25288716|NCT01064310|50603524|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
25288717|NCT01064310|50603522|FG000|Open Label Pazopinib|Physician Decision|0|||
25288718|NCT01064310|50603523|FG001|Open Label Pazopinib|Physician Decision|0|||
25288719|NCT01064310|50603524|FG002|Open Label Pazopinib|Physician Decision|20|||
25288720|NCT01037244|50603537|FG000|Overall Study|Adverse Event|3|||
25288721|NCT01037244|50603538|FG001|Overall Study|Adverse Event|2|||
25288722|NCT01037244|50603539|FG002|Overall Study|Adverse Event|6|||
25288723|NCT01037244|50603540|FG003|Overall Study|Adverse Event|3|||
25288724|NCT01037244|50603537|FG000|Overall Study|Lack of Efficacy|1|||
25288725|NCT01037244|50603538|FG001|Overall Study|Lack of Efficacy|1|||
25288726|NCT01037244|50603539|FG002|Overall Study|Lack of Efficacy|0|||
25288727|NCT01037244|50603540|FG003|Overall Study|Lack of Efficacy|1|||
25288728|NCT01037244|50603537|FG000|Overall Study|Lost to Follow-up|3|||
25288729|NCT01037244|50603538|FG001|Overall Study|Lost to Follow-up|3|||
25288730|NCT01037244|50603539|FG002|Overall Study|Lost to Follow-up|4|||
25288731|NCT01037244|50603540|FG003|Overall Study|Lost to Follow-up|4|||
25288732|NCT01037244|50603537|FG000|Overall Study|Withdrawal by Subject|1|||
25288733|NCT01037244|50603538|FG001|Overall Study|Withdrawal by Subject|5|||
25288734|NCT01037244|50603539|FG002|Overall Study|Withdrawal by Subject|3|||
25288735|NCT01037244|50603540|FG003|Overall Study|Withdrawal by Subject|5|||
25288736|NCT01037244|50603537|FG000|Overall Study|Partner Withdrew Consent|2|||
25288737|NCT01037244|50603538|FG001|Overall Study|Partner Withdrew Consent|1|||
25288738|NCT01037244|50603539|FG002|Overall Study|Partner Withdrew Consent|0|||
25288739|NCT01037244|50603540|FG003|Overall Study|Partner Withdrew Consent|0|||
25288740|NCT01037244|50603537|FG000|Overall Study|Various|3|||
25288741|NCT01037244|50603538|FG001|Overall Study|Various|2|||
25288742|NCT01037244|50603539|FG002|Overall Study|Various|1|||
25288743|NCT01037244|50603540|FG003|Overall Study|Various|1|||
25288744|NCT00833989|50603554|FG000|Overall Study|Physician Decision|0|||
25288745|NCT00833989|50603555|FG001|Overall Study|Physician Decision|0|||
25288746|NCT00833989|50603556|FG002|Overall Study|Physician Decision|0|||
25288747|NCT00833989|50603557|FG003|Overall Study|Physician Decision|1|||
25288748|NCT00833989|50603554|FG000|Overall Study|Withdrawal by Subject|3|||
25288749|NCT00833989|50603555|FG001|Overall Study|Withdrawal by Subject|0|||
25288750|NCT00833989|50603556|FG002|Overall Study|Withdrawal by Subject|1|||
25288751|NCT00833989|50603557|FG003|Overall Study|Withdrawal by Subject|1|||
25288752|NCT01037088|50603570|FG000|Overall Study|Withdrawal by Subject|3|||
25288753|NCT01042236|50603579|FG000|Treatment Period 1|Adverse Event|0|||
25288754|NCT01042236|50603580|FG001|Treatment Period 1|Adverse Event|1|||
25288755|NCT01042236|50603581|FG002|Treatment Period 1|Adverse Event|0|||
25288756|NCT01042236|50603582|FG003|Treatment Period 1|Adverse Event|0|||
25288757|NCT01042236|50603583|FG004|Treatment Period 1|Adverse Event|1|||
25288758|NCT01042236|50603584|FG005|Treatment Period 1|Adverse Event|0|||
25288759|NCT01042236|50603579|FG000|Treatment Period 3|Adverse Event|0|||
25288760|NCT01042236|50603580|FG001|Treatment Period 3|Adverse Event|0|||
25288761|NCT01042236|50603581|FG002|Treatment Period 3|Adverse Event|0|||
25288762|NCT01042236|50603582|FG003|Treatment Period 3|Adverse Event|1|||
25288763|NCT01042236|50603583|FG004|Treatment Period 3|Adverse Event|0|||
25288764|NCT01042236|50603584|FG005|Treatment Period 3|Adverse Event|0|||
25288765|NCT01042236|50603579|FG000|Treatment Period 3|Protocol Violation|0|||
25288766|NCT01042236|50603580|FG001|Treatment Period 3|Protocol Violation|0|||
25288767|NCT01042236|50603581|FG002|Treatment Period 3|Protocol Violation|0|||
25288768|NCT01042236|50603582|FG003|Treatment Period 3|Protocol Violation|1|||
25288769|NCT01042236|50603583|FG004|Treatment Period 3|Protocol Violation|0|||
25288770|NCT01042236|50603584|FG005|Treatment Period 3|Protocol Violation|0|||
25288771|NCT00592501|50603592|FG000|Overall Study|Withdrawal by Subject|1|||
25288772|NCT00592501|50603592|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
25288773|NCT01040832|50603598|FG000|Overall Study|Adverse Event|4|||
25288774|NCT01040832|50603599|FG001|Overall Study|Adverse Event|5|||
25288775|NCT01040832|50603598|FG000|Overall Study|Death|4|||
25288776|NCT01040832|50603599|FG001|Overall Study|Death|6|||
25288777|NCT01040832|50603598|FG000|Overall Study|Withdrawal by Subject|2|||
25288778|NCT01040832|50603599|FG001|Overall Study|Withdrawal by Subject|3|||
25288779|NCT01040832|50603598|FG000|Overall Study|Progressive disease|32|||
25288780|NCT01040832|50603599|FG001|Overall Study|Progressive disease|17|||
25288781|NCT01040832|50603598|FG000|Overall Study|Symptomatic deterioration|2|||
25288782|NCT01040832|50603599|FG001|Overall Study|Symptomatic deterioration|5|||
25288783|NCT01040832|50603598|FG000|Overall Study|Other|2|||
25288784|NCT01040832|50603599|FG001|Overall Study|Other|1|||
25288785|NCT00854581|50603605|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
25288786|NCT00854581|50603605|FG000|Induction (Up to Day 21)|Death|1|||
25288787|NCT00854581|50603605|FG000|Induction (Up to Day 21)|Physician Decision|1|||
25288788|NCT00854581|50603605|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
25288789|NCT00833911|50603614|FG000|Titration|Adverse Event|18|||
25288790|NCT00833911|50603614|FG000|Titration|Withdrawal by Subject|3|||
25288791|NCT00833911|50603614|FG000|Maintenance Phase I|Adverse Event|73|||
25288792|NCT00833911|50603614|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
25288793|NCT00833911|50603614|FG000|Maintenance Phase I|Physician Decision|10|||
25288794|NCT00833911|50603614|FG000|Maintenance Phase I|Lack of Efficacy|4|||
25288795|NCT00833911|50603614|FG000|Maintenance Phase II|Adverse Event|6|||
25288796|NCT00833911|50603614|FG000|Maintenance Phase II|Physician Decision|2|||
25288797|NCT00833911|50603614|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
25288798|NCT00833911|50603614|FG000|Maintenance Phase II|Lack of Efficacy|1|||
25288799|NCT01125293|50603628|FG000|Overall Study|Disease Progression|1|||
25288800|NCT01125293|50603629|FG001|Overall Study|Disease Progression|3|||
25288801|NCT01125293|50603630|FG002|Overall Study|Disease Progression|4|||
25288802|NCT01125293|50603631|FG003|Overall Study|Disease Progression|3|||
25288803|NCT01125293|50603632|FG004|Overall Study|Disease Progression|5|||
25288804|NCT01125293|50603633|FG005|Overall Study|Disease Progression|12|||
25288805|NCT01125293|50603628|FG000|Overall Study|Adverse Event|1|||
25288806|NCT01125293|50603629|FG001|Overall Study|Adverse Event|0|||
25288807|NCT01125293|50603630|FG002|Overall Study|Adverse Event|0|||
25288808|NCT01125293|50603631|FG003|Overall Study|Adverse Event|0|||
25288809|NCT01125293|50603632|FG004|Overall Study|Adverse Event|2|||
25288810|NCT01125293|50603633|FG005|Overall Study|Adverse Event|8|||
25288811|NCT01125293|50603628|FG000|Overall Study|Symptomatic Deterioration|1|||
25288812|NCT01125293|50603629|FG001|Overall Study|Symptomatic Deterioration|0|||
25288813|NCT01125293|50603630|FG002|Overall Study|Symptomatic Deterioration|0|||
25288814|NCT01125293|50603631|FG003|Overall Study|Symptomatic Deterioration|0|||
25288815|NCT01125293|50603632|FG004|Overall Study|Symptomatic Deterioration|0|||
25288816|NCT01125293|50603633|FG005|Overall Study|Symptomatic Deterioration|0|||
25288817|NCT01125293|50603628|FG000|Overall Study|Death|0|||
25288818|NCT01125293|50603629|FG001|Overall Study|Death|0|||
25288819|NCT01125293|50603630|FG002|Overall Study|Death|0|||
25288820|NCT01125293|50603631|FG003|Overall Study|Death|0|||
25288821|NCT01125293|50603632|FG004|Overall Study|Death|1|||
25288822|NCT01125293|50603633|FG005|Overall Study|Death|0|||
25288823|NCT01125293|50603628|FG000|Overall Study|Withdrawal by Subject|0|||
25288824|NCT01125293|50603629|FG001|Overall Study|Withdrawal by Subject|0|||
25288825|NCT01125293|50603630|FG002|Overall Study|Withdrawal by Subject|0|||
25288826|NCT01125293|50603631|FG003|Overall Study|Withdrawal by Subject|0|||
25288827|NCT01125293|50603632|FG004|Overall Study|Withdrawal by Subject|2|||
25288828|NCT01125293|50603633|FG005|Overall Study|Withdrawal by Subject|1|||
25288829|NCT01125293|50603628|FG000|Overall Study|Physician Decision|0|||
25288830|NCT01125293|50603629|FG001|Overall Study|Physician Decision|0|||
25288831|NCT01125293|50603630|FG002|Overall Study|Physician Decision|0|||
25288832|NCT01125293|50603631|FG003|Overall Study|Physician Decision|0|||
25288833|NCT01125293|50603632|FG004|Overall Study|Physician Decision|0|||
25288834|NCT01125293|50603633|FG005|Overall Study|Physician Decision|2|||
25288835|NCT01121393|50603652|FG000|Overall Study|Progressive disease|201|||
25288836|NCT01121393|50603653|FG001|Overall Study|Progressive disease|20|||
25288837|NCT01121393|50603652|FG000|Overall Study|Other Adverse events|24|||
25288838|NCT01121393|50603653|FG001|Overall Study|Other Adverse events|45|||
25288839|NCT01121393|50603652|FG000|Overall Study|Non-compliant with protocol|0|||
25288840|NCT01121393|50603653|FG001|Overall Study|Non-compliant with protocol|3|||
25288841|NCT01121393|50603652|FG000|Overall Study|Lost to Follow-up|1|||
25288842|NCT01121393|50603653|FG001|Overall Study|Lost to Follow-up|0|||
25288843|NCT01121393|50603652|FG000|Overall Study|Refused cont. medication|7|||
25288844|NCT01121393|50603653|FG001|Overall Study|Refused cont. medication|7|||
25288845|NCT01121393|50603652|FG000|Overall Study|Not treated|3|||
25288846|NCT01121393|50603653|FG001|Overall Study|Not treated|9|||
25288847|NCT01121393|50603652|FG000|Overall Study|Other than listed|6|||
25288848|NCT01121393|50603653|FG001|Overall Study|Other than listed|0|||
25288849|NCT00937521|50603691|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
25288850|NCT00937521|50603692|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
25288851|NCT00937521|50603693|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
25288852|NCT00937521|50603694|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
25288853|NCT00937521|50603695|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
25288854|NCT00937521|50603696|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
25288855|NCT00937521|50603697|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
25288856|NCT00937521|50603698|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
25288857|NCT00937521|50603691|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
25070263|NCT02301988|50176149|FG001|Overall Study|Adverse Event|1|||
25288858|NCT00937521|50603692|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
25288859|NCT00937521|50603693|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
25288860|NCT00937521|50603694|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
25288861|NCT00937521|50603695|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
25288862|NCT00937521|50603696|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
25288863|NCT00937521|50603697|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
25288864|NCT00937521|50603698|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
25288865|NCT00937521|50603691|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
25288866|NCT00937521|50603692|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
25288867|NCT00937521|50603693|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
25288868|NCT00937521|50603694|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
25288869|NCT00937521|50603695|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
25288870|NCT00937521|50603696|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
25288871|NCT00937521|50603697|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
25288872|NCT00937521|50603698|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
25288873|NCT00937521|50603691|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
25288874|NCT00937521|50603692|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
25288875|NCT00937521|50603693|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
25288876|NCT00937521|50603694|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
25288877|NCT00937521|50603695|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
25288878|NCT00937521|50603696|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
25288879|NCT00937521|50603697|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
25288880|NCT00937521|50603698|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
25288881|NCT00937521|50603691|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
25288882|NCT00937521|50603692|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
25288883|NCT00937521|50603693|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
25288884|NCT00937521|50603694|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
25288885|NCT00937521|50603695|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
25288886|NCT00937521|50603696|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
25288887|NCT00937521|50603697|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
25288888|NCT00937521|50603698|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
25288889|NCT00937521|50603691|FG000|Booster Phase|Adverse Event|0|||
25288890|NCT00937521|50603692|FG001|Booster Phase|Adverse Event|0|||
25288891|NCT00937521|50603693|FG002|Booster Phase|Adverse Event|0|||
25288892|NCT00937521|50603694|FG003|Booster Phase|Adverse Event|0|||
25288893|NCT00937521|50603695|FG004|Booster Phase|Adverse Event|0|||
25288894|NCT00937521|50603696|FG005|Booster Phase|Adverse Event|0|||
25288895|NCT00937521|50603697|FG006|Booster Phase|Adverse Event|1|||
25288896|NCT00937521|50603698|FG007|Booster Phase|Adverse Event|0|||
25288897|NCT00937521|50603691|FG000|Booster Phase|Withdrawal by Subject|1|||
25288898|NCT00937521|50603692|FG001|Booster Phase|Withdrawal by Subject|0|||
25288899|NCT00937521|50603693|FG002|Booster Phase|Withdrawal by Subject|0|||
25288900|NCT00937521|50603694|FG003|Booster Phase|Withdrawal by Subject|1|||
25288901|NCT00937521|50603695|FG004|Booster Phase|Withdrawal by Subject|0|||
25288902|NCT00937521|50603696|FG005|Booster Phase|Withdrawal by Subject|0|||
25288903|NCT00937521|50603697|FG006|Booster Phase|Withdrawal by Subject|0|||
25288904|NCT00937521|50603698|FG007|Booster Phase|Withdrawal by Subject|2|||
25288905|NCT00937521|50603691|FG000|Booster Phase|Lost to Follow-up|2|||
25288906|NCT00937521|50603692|FG001|Booster Phase|Lost to Follow-up|2|||
25288907|NCT00937521|50603693|FG002|Booster Phase|Lost to Follow-up|4|||
25288908|NCT00937521|50603694|FG003|Booster Phase|Lost to Follow-up|2|||
25288909|NCT00937521|50603695|FG004|Booster Phase|Lost to Follow-up|4|||
25288910|NCT00937521|50603696|FG005|Booster Phase|Lost to Follow-up|4|||
25288911|NCT00937521|50603697|FG006|Booster Phase|Lost to Follow-up|3|||
25288912|NCT00937521|50603698|FG007|Booster Phase|Lost to Follow-up|0|||
25288913|NCT00937521|50603691|FG000|Booster Phase|Administrative Reason|0|||
25288914|NCT00937521|50603692|FG001|Booster Phase|Administrative Reason|0|||
25288915|NCT00937521|50603693|FG002|Booster Phase|Administrative Reason|1|||
25288916|NCT00937521|50603694|FG003|Booster Phase|Administrative Reason|0|||
25288917|NCT00937521|50603695|FG004|Booster Phase|Administrative Reason|1|||
25288918|NCT00937521|50603696|FG005|Booster Phase|Administrative Reason|1|||
25288919|NCT00937521|50603697|FG006|Booster Phase|Administrative Reason|0|||
25288920|NCT00937521|50603698|FG007|Booster Phase|Administrative Reason|0|||
25288921|NCT00937521|50603691|FG000|Booster Phase|Protocol Deviation|0|||
25288922|NCT00937521|50603692|FG001|Booster Phase|Protocol Deviation|0|||
25288923|NCT00937521|50603693|FG002|Booster Phase|Protocol Deviation|0|||
25288924|NCT00937521|50603694|FG003|Booster Phase|Protocol Deviation|0|||
25288925|NCT00937521|50603695|FG004|Booster Phase|Protocol Deviation|0|||
25288926|NCT00937521|50603696|FG005|Booster Phase|Protocol Deviation|0|||
25288927|NCT00937521|50603697|FG006|Booster Phase|Protocol Deviation|1|||
25288928|NCT00937521|50603698|FG007|Booster Phase|Protocol Deviation|0|||
25288929|NCT00935883|50603733|FG000|Treatment Period|Physician Decision|1|||
25288930|NCT00935883|50603734|FG001|Treatment Period|Physician Decision|0|||
25288931|NCT00935883|50603733|FG000|Treatment Period|Withdrawal by Subject|0|||
25288932|NCT00935883|50603734|FG001|Treatment Period|Withdrawal by Subject|2|||
25288933|NCT00936975|50603740|FG000|Overall Study|Withdrawal by Subject|1|||
25288934|NCT00936975|50603740|FG000|Overall Study|Disease progression|3|||
25288935|NCT00936975|50603740|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
25288936|NCT00936897|50603747|FG000|Overall Study|Withdrawal by Subject|9|||
25288937|NCT00936897|50603748|FG001|Overall Study|Withdrawal by Subject|19|||
25288938|NCT00936897|50603747|FG000|Overall Study|Adverse Event|4|||
25288939|NCT00936897|50603748|FG001|Overall Study|Adverse Event|13|||
25288940|NCT00936897|50603747|FG000|Overall Study|Other|3|||
25288941|NCT00936897|50603748|FG001|Overall Study|Other|9|||
25288942|NCT00936897|50603747|FG000|Overall Study|Lost to Follow-up|1|||
25288943|NCT00936897|50603748|FG001|Overall Study|Lost to Follow-up|10|||
25288944|NCT00936897|50603747|FG000|Overall Study|Administrative Decision|1|||
25288945|NCT00936897|50603748|FG001|Overall Study|Administrative Decision|2|||
24969702|NCT04542694|50059173|FG000|Overall Study|Protocol Violation|1|||
24969703|NCT04542694|50059174|FG001|Overall Study|Protocol Violation|0|||
24969704|NCT00117312|50059184|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
24969705|NCT00117312|50059185|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
24969706|NCT00117312|50059186|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
24969707|NCT00117312|50059187|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
25288946|NCT00936897|50603747|FG000|Overall Study|Protocol Violation|1|||
25288947|NCT00936897|50603748|FG001|Overall Study|Protocol Violation|1|||
25288948|NCT00936897|50603747|FG000|Overall Study|Ineligibility Determined|0|||
25288949|NCT00936897|50603748|FG001|Overall Study|Ineligibility Determined|3|||
25288950|NCT00936897|50603747|FG000|Overall Study|Noncompliance|0|||
25288951|NCT00936897|50603748|FG001|Overall Study|Noncompliance|2|||
25288952|NCT00936897|50603747|FG000|Overall Study|Death|0|||
25288953|NCT00936897|50603748|FG001|Overall Study|Death|1|||
25288954|NCT01120691|50603757|FG000|Overall Study|Adverse Event|59|||
25288955|NCT01120691|50603758|FG001|Overall Study|Adverse Event|67|||
25288956|NCT01120691|50603759|FG002|Overall Study|Adverse Event|47|||
25288957|NCT01120691|50603757|FG000|Overall Study|Subject withdrew consent|33|||
25288958|NCT01120691|50603758|FG001|Overall Study|Subject withdrew consent|50|||
25288959|NCT01120691|50603759|FG002|Overall Study|Subject withdrew consent|44|||
25288960|NCT01120691|50603757|FG000|Overall Study|Death|21|||
25288961|NCT01120691|50603758|FG001|Overall Study|Death|22|||
25288962|NCT01120691|50603759|FG002|Overall Study|Death|24|||
25288963|NCT01120691|50603757|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
25288964|NCT01120691|50603758|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
25288965|NCT01120691|50603759|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
25288966|NCT01120691|50603757|FG000|Overall Study|Administrative problems|15|||
25288967|NCT01120691|50603758|FG001|Overall Study|Administrative problems|8|||
25288968|NCT01120691|50603759|FG002|Overall Study|Administrative problems|9|||
25288969|NCT01120691|50603757|FG000|Overall Study|Protocol deviation|13|||
25288970|NCT01120691|50603758|FG001|Overall Study|Protocol deviation|12|||
25288971|NCT01120691|50603759|FG002|Overall Study|Protocol deviation|12|||
25288972|NCT01120691|50603757|FG000|Overall Study|Lost to Follow-up|5|||
25288973|NCT01120691|50603758|FG001|Overall Study|Lost to Follow-up|6|||
25288974|NCT01120691|50603759|FG002|Overall Study|Lost to Follow-up|4|||
25288975|NCT01120691|50603757|FG000|Overall Study|Abnormal test procedure result(s)|3|||
25288976|NCT01120691|50603758|FG001|Overall Study|Abnormal test procedure result(s)|2|||
25288977|NCT01120691|50603759|FG002|Overall Study|Abnormal test procedure result(s)|1|||
25288978|NCT01120691|50603757|FG000|Overall Study|Patient's inability to use the device|3|||
25288979|NCT01120691|50603758|FG001|Overall Study|Patient's inability to use the device|1|||
25288980|NCT01120691|50603759|FG002|Overall Study|Patient's inability to use the device|0|||
25288981|NCT01120691|50603757|FG000|Overall Study|Abnormal laboratory value(s)|1|||
25288982|NCT01120691|50603758|FG001|Overall Study|Abnormal laboratory value(s)|3|||
25288983|NCT01120691|50603759|FG002|Overall Study|Abnormal laboratory value(s)|4|||
24969708|NCT00117312|50059184|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
25288984|NCT00935493|50603783|FG000|Overall Study|Lost to Follow-up|1|||
25288985|NCT00935493|50603784|FG001|Overall Study|Lost to Follow-up|1|||
25288986|NCT00935493|50603785|FG002|Overall Study|Lost to Follow-up|1|||
25288987|NCT00935493|50603783|FG000|Overall Study|Treatment Discontinued|0|||
25288988|NCT00935493|50603784|FG001|Overall Study|Treatment Discontinued|1|||
25288989|NCT00935493|50603785|FG002|Overall Study|Treatment Discontinued|0|||
25288990|NCT03856996|50603795|FG000|Overall Study|Withdrawal by Subject|1|||
25288991|NCT03856996|50603796|FG001|Overall Study|Withdrawal by Subject|0|||
25288992|NCT03856996|50603795|FG000|Overall Study|Lost to Follow-up|0|||
25288993|NCT03856996|50603796|FG001|Overall Study|Lost to Follow-up|1|||
25288994|NCT03856996|50603795|FG000|Overall Study|Adverse Event|1|||
24969709|NCT00117312|50059185|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
25288995|NCT03856996|50603796|FG001|Overall Study|Adverse Event|1|||
25288996|NCT03856996|50603795|FG000|Overall Study|Other|1|||
25288997|NCT03856996|50603796|FG001|Overall Study|Other|0|||
25288998|NCT00935259|50603802|FG000|Period 1|Administrative (scheduling conflict)|1|||
25288999|NCT00935259|50603803|FG001|Period 1|Administrative (scheduling conflict)|1|||
25289000|NCT01120379|50603820|FG000|One Year Timepoint|Withdrawal by Subject|41|||
25289001|NCT01120379|50603820|FG000|One Year Timepoint|Lost to Follow-up|115|||
25289002|NCT01120379|50603820|FG000|One Year Timepoint|Death|108|||
25289003|NCT01120379|50603820|FG000|One Year Timepoint|Physician Decision|9|||
25289004|NCT01120379|50603820|FG000|One Year Timepoint|Any other reason for early termination|5|||
25289005|NCT01120379|50603820|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
25289006|NCT01120379|50603820|FG000|Two Year Timepoint|Lost to Follow-up|87|||
25289007|NCT01120379|50603820|FG000|Two Year Timepoint|Death|123|||
25289008|NCT01120379|50603820|FG000|Two Year Timepoint|Physician Decision|12|||
25289009|NCT01120379|50603820|FG000|Two Year Timepoint|Any other reason for early termination|4|||
25289010|NCT01120379|50603820|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
25289011|NCT01120379|50603820|FG000|Three Year Timepoint|Lost to Follow-up|43|||
25289012|NCT01120379|50603820|FG000|Three Year Timepoint|Death|120|||
25289013|NCT01120379|50603820|FG000|Three Year Timepoint|Physician Decision|9|||
25289014|NCT01120379|50603820|FG000|Three Year Timepoint|Any other reason for early termination|17|||
25289015|NCT01120379|50603820|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
25289016|NCT01120379|50603820|FG000|Four Year Timepoint|Lost to Follow-up|10|||
25289017|NCT01120379|50603820|FG000|Four Year Timepoint|Death|131|||
25289018|NCT01120379|50603820|FG000|Four Year Timepoint|Physician Decision|5|||
25289019|NCT01120379|50603820|FG000|Four Year Timepoint|Any other reason for early termination|217|||
25289020|NCT01120067|50603826|FG000|Overall Study|Lost to Follow-up|3|||
25289021|NCT01120067|50603827|FG001|Overall Study|Lost to Follow-up|1|||
25289022|NCT01120067|50603826|FG000|Overall Study|fail to engage >3 sessions|2|||
25289023|NCT01120067|50603827|FG001|Overall Study|fail to engage >3 sessions|0|||
25289024|NCT01124045|50603835|FG000|Overall Study|Lost to Follow-up|0|||
25289025|NCT01124045|50603836|FG001|Overall Study|Lost to Follow-up|1|||
25289026|NCT01124045|50603835|FG000|Overall Study|Physician Decision|0|||
25289027|NCT01124045|50603836|FG001|Overall Study|Physician Decision|2|||
25289028|NCT01123889|50603844|FG000|Overall Study|Lost to Follow-up|3|||
25289029|NCT01123889|50603845|FG001|Overall Study|Lost to Follow-up|1|||
25289030|NCT00934947|50603853|FG000|Overall Study|Adverse Event|0|||
25289031|NCT00934947|50603854|FG001|Overall Study|Adverse Event|2|||
25289032|NCT01123655|50603864|FG000|Overall Study|Medication for RA had to be changed|1|||
25289033|NCT01123655|50603865|FG001|Overall Study|Medication for RA had to be changed|0|||
25289034|NCT01123655|50603866|FG002|Overall Study|Medication for RA had to be changed|0|||
25289035|NCT01123655|50603864|FG000|Overall Study|new illness|0|||
25289036|NCT01123655|50603865|FG001|Overall Study|new illness|1|||
25289037|NCT01123655|50603866|FG002|Overall Study|new illness|0|||
25289038|NCT01123655|50603864|FG000|Overall Study|began prohibitive drug|0|||
25289039|NCT01123655|50603865|FG001|Overall Study|began prohibitive drug|0|||
25289040|NCT01123655|50603866|FG002|Overall Study|began prohibitive drug|1|||
25289041|NCT00934791|50603874|FG000|Overall Study|Withdrawal by Subject|1|||
25289042|NCT00934791|50603875|FG001|Overall Study|Withdrawal by Subject|0|||
25289043|NCT01119443|50603883|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
25289044|NCT01119443|50603884|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
25289045|NCT01111019|50603893|FG000|Overall Study|Withdrew Prematurely|2|||
25289046|NCT01111019|50603893|FG000|Overall Study|Other|1|||
25289047|NCT01119287|50603912|FG000|Overall Study|Patient Decision, not related to AE|0|||
25289048|NCT01119287|50603913|FG001|Overall Study|Patient Decision, not related to AE|0|||
25289049|NCT01119287|50603914|FG002|Overall Study|Patient Decision, not related to AE|2|||
25289050|NCT01119287|50603915|FG003|Overall Study|Patient Decision, not related to AE|2|||
25289051|NCT01119287|50603916|FG004|Overall Study|Patient Decision, not related to AE|1|||
25289052|NCT01119287|50603917|FG005|Overall Study|Patient Decision, not related to AE|0|||
25289053|NCT01110707|50603931|FG000|Overall Study|Protocol Violation|0|||
25289054|NCT01110707|50603932|FG001|Overall Study|Protocol Violation|3|||
25289055|NCT01119131|50603942|FG000|Overall Study|Adverse Event|1|||
25289056|NCT01119131|50603943|FG001|Overall Study|Adverse Event|1|||
25289057|NCT01119131|50603944|FG002|Overall Study|Adverse Event|1|||
25289058|NCT01119131|50603942|FG000|Overall Study|Non-Compliance|1|||
25289059|NCT01119131|50603943|FG001|Overall Study|Non-Compliance|0|||
25289060|NCT01119131|50603944|FG002|Overall Study|Non-Compliance|4|||
25289061|NCT01119131|50603942|FG000|Overall Study|Physician Decision|0|||
25289062|NCT01119131|50603943|FG001|Overall Study|Physician Decision|0|||
25289063|NCT01119131|50603944|FG002|Overall Study|Physician Decision|1|||
25289064|NCT01118975|50603954|FG000|Overall Study|Adverse Event|0|||
25289065|NCT01118975|50603955|FG001|Overall Study|Adverse Event|1|||
25289066|NCT01110239|50603965|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
25289067|NCT01110239|50603966|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
25289068|NCT01110239|50603967|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
25289069|NCT01110239|50603968|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
25289070|NCT01110239|50603965|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
25289071|NCT01110239|50603966|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
25289072|NCT01110239|50603967|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
25289073|NCT01110239|50603968|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
25289074|NCT01118663|50603981|FG000|Overall Study|Adverse Event|2|||
25289075|NCT01118663|50603982|FG001|Overall Study|Adverse Event|1|||
25289076|NCT01118663|50603981|FG000|Overall Study|Withdrawal by Subject|0|||
25289077|NCT01118663|50603982|FG001|Overall Study|Withdrawal by Subject|1|||
25289078|NCT01118351|50603988|FG000|Overall Study|Adverse Event|3|||
25289079|NCT01118351|50603988|FG000|Overall Study|Withdrawal by Subject|1|||
25289080|NCT01110005|50603994|FG000|Overall Study|ineligible|1|||
25289081|NCT01110005|50603995|FG001|Overall Study|ineligible|2|||
25289082|NCT01110005|50603994|FG000|Overall Study|missing consent|3|||
25289083|NCT01110005|50603995|FG001|Overall Study|missing consent|2|||
25289084|NCT01110005|50603994|FG000|Overall Study|Withdrawal by Subject|0|||
25289085|NCT01110005|50603995|FG001|Overall Study|Withdrawal by Subject|1|||
25289086|NCT01118117|50604018|FG000|Overall Study|Death|8|||
25289087|NCT01118117|50604019|FG001|Overall Study|Death|0|||
25289088|NCT01118117|50604018|FG000|Overall Study|Lost to Follow-up|6|||
25289089|NCT01118117|50604019|FG001|Overall Study|Lost to Follow-up|0|||
25289090|NCT01118117|50604018|FG000|Overall Study|Missed 12 Month Visit|7|||
25289091|NCT01118117|50604019|FG001|Overall Study|Missed 12 Month Visit|0|||
25289092|NCT01109849|50604027|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
25289093|NCT01109849|50604028|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
25289094|NCT01109849|50604029|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
25289095|NCT01109849|50604030|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
25289096|NCT01109849|50604031|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
25289097|NCT01109849|50604027|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
25289098|NCT01109849|50604028|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
25289099|NCT01109849|50604029|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
25289100|NCT01109849|50604030|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
25289101|NCT01109849|50604031|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
25289102|NCT01109849|50604027|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
25289103|NCT01109849|50604028|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
25289104|NCT01109849|50604029|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
25289105|NCT01109849|50604030|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
25289106|NCT01109849|50604031|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
25289107|NCT01109849|50604027|FG000|Initial Randomization: ADHD Treatment|move away|2|||
25289108|NCT01109849|50604028|FG001|Initial Randomization: ADHD Treatment|move away|7|||
25289109|NCT01109849|50604029|FG002|Initial Randomization: ADHD Treatment|move away|0|||
25289110|NCT01109849|50604030|FG003|Initial Randomization: ADHD Treatment|move away|0|||
25289111|NCT01109849|50604031|FG004|Initial Randomization: ADHD Treatment|move away|0|||
25289112|NCT01109849|50604027|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
25289113|NCT01109849|50604028|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
25289114|NCT01109849|50604029|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
25289115|NCT01109849|50604030|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
25070264|NCT02334748|50176164|FG000|Overall Study|Adverse Event|1|||
25070265|NCT02334748|50176164|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
25070266|NCT02334748|50176164|FG000|Overall Study|Patient no longer required study drug|2|||
25070267|NCT02334748|50176164|FG000|Overall Study|Lack of Efficacy|4|||
25070268|NCT02332876|50176170|FG000|Overall Study|Lost to Follow-up|1|||
25070269|NCT02332876|50176171|FG001|Overall Study|Lost to Follow-up|1|||
25070270|NCT02332798|50176180|FG000|Overall Study|Unwilling to Participate in Study|0|||
25070271|NCT02332798|50176181|FG001|Overall Study|Unwilling to Participate in Study|1|||
25070272|NCT02332798|50176182|FG002|Overall Study|Unwilling to Participate in Study|1|||
25070273|NCT02332798|50176180|FG000|Overall Study|Positive Urine Drug Test|0|||
25070274|NCT02332798|50176181|FG001|Overall Study|Positive Urine Drug Test|1|||
25070275|NCT02332798|50176182|FG002|Overall Study|Positive Urine Drug Test|0|||
25070276|NCT02332798|50176180|FG000|Overall Study|Abnormal Laboratory Findings|1|||
25070277|NCT02332798|50176181|FG001|Overall Study|Abnormal Laboratory Findings|0|||
25070278|NCT02332798|50176182|FG002|Overall Study|Abnormal Laboratory Findings|0|||
25070279|NCT02790437|50176192|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
25070280|NCT02790437|50176193|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
25289116|NCT01109849|50604031|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
25289117|NCT01109849|50604027|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
25289118|NCT01109849|50604028|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
25289119|NCT01109849|50604029|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
25289120|NCT01109849|50604030|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
25289121|NCT01109849|50604031|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
25191551|NCT02596230|50352455|FG000|Objective 2, One Year|Adverse drug reaction|0|||
25289122|NCT01061736|50604061|FG000|Overall Study|Dose regimen not selected|0|||
25289123|NCT01061736|50604062|FG001|Overall Study|Dose regimen not selected|0|||
25070281|NCT02790437|50176192|FG000|Overall Study|Adverse Event|1|||
25289124|NCT01061736|50604063|FG002|Overall Study|Dose regimen not selected|0|||
25289125|NCT01061736|50604064|FG003|Overall Study|Dose regimen not selected|0|||
25289126|NCT01061736|50604065|FG004|Overall Study|Dose regimen not selected|0|||
25289127|NCT01061736|50604066|FG005|Overall Study|Dose regimen not selected|0|||
25289128|NCT01061736|50604067|FG006|Overall Study|Dose regimen not selected|79|||
25289129|NCT01061736|50604068|FG007|Overall Study|Dose regimen not selected|0|||
25289130|NCT01061736|50604069|FG008|Overall Study|Dose regimen not selected|0|||
25289131|NCT01061736|50604070|FG009|Overall Study|Dose regimen not selected|0|||
25289132|NCT01061736|50604061|FG000|Overall Study|Adverse Event|13|||
25289133|NCT01061736|50604062|FG001|Overall Study|Adverse Event|1|||
25289134|NCT01061736|50604063|FG002|Overall Study|Adverse Event|3|||
25289135|NCT01061736|50604064|FG003|Overall Study|Adverse Event|2|||
25289136|NCT01061736|50604065|FG004|Overall Study|Adverse Event|4|||
25289137|NCT01061736|50604066|FG005|Overall Study|Adverse Event|1|||
25289138|NCT01061736|50604067|FG006|Overall Study|Adverse Event|4|||
25289139|NCT01061736|50604068|FG007|Overall Study|Adverse Event|63|||
25289140|NCT01061736|50604069|FG008|Overall Study|Adverse Event|67|||
25289141|NCT01061736|50604070|FG009|Overall Study|Adverse Event|34|||
25289142|NCT01061736|50604061|FG000|Overall Study|Lack of Efficacy|0|||
25289143|NCT01061736|50604062|FG001|Overall Study|Lack of Efficacy|2|||
25289144|NCT01061736|50604063|FG002|Overall Study|Lack of Efficacy|1|||
25289145|NCT01061736|50604064|FG003|Overall Study|Lack of Efficacy|1|||
25289146|NCT01061736|50604065|FG004|Overall Study|Lack of Efficacy|1|||
25289147|NCT01061736|50604066|FG005|Overall Study|Lack of Efficacy|2|||
25289148|NCT01061736|50604067|FG006|Overall Study|Lack of Efficacy|1|||
25289149|NCT01061736|50604068|FG007|Overall Study|Lack of Efficacy|9|||
25289150|NCT01061736|50604069|FG008|Overall Study|Lack of Efficacy|9|||
25289151|NCT01061736|50604070|FG009|Overall Study|Lack of Efficacy|10|||
25289152|NCT01061736|50604061|FG000|Overall Study|Poor compliance to protocol|0|||
25289153|NCT01061736|50604062|FG001|Overall Study|Poor compliance to protocol|0|||
25289154|NCT01061736|50604063|FG002|Overall Study|Poor compliance to protocol|0|||
25289155|NCT01061736|50604064|FG003|Overall Study|Poor compliance to protocol|0|||
25289156|NCT01061736|50604065|FG004|Overall Study|Poor compliance to protocol|0|||
25289157|NCT01061736|50604066|FG005|Overall Study|Poor compliance to protocol|0|||
25289158|NCT01061736|50604067|FG006|Overall Study|Poor compliance to protocol|0|||
25289159|NCT01061736|50604068|FG007|Overall Study|Poor compliance to protocol|2|||
25289160|NCT01061736|50604069|FG008|Overall Study|Poor compliance to protocol|5|||
25289161|NCT01061736|50604070|FG009|Overall Study|Poor compliance to protocol|9|||
25289162|NCT01061736|50604061|FG000|Overall Study|Not treated|0|||
25289163|NCT01061736|50604062|FG001|Overall Study|Not treated|0|||
25289164|NCT01061736|50604063|FG002|Overall Study|Not treated|0|||
25289165|NCT01061736|50604064|FG003|Overall Study|Not treated|0|||
25289166|NCT01061736|50604065|FG004|Overall Study|Not treated|1|||
25289167|NCT01061736|50604066|FG005|Overall Study|Not treated|0|||
25289168|NCT01061736|50604067|FG006|Overall Study|Not treated|0|||
25289169|NCT01061736|50604068|FG007|Overall Study|Not treated|2|||
25289170|NCT01061736|50604069|FG008|Overall Study|Not treated|1|||
25289171|NCT01061736|50604070|FG009|Overall Study|Not treated|0|||
25289172|NCT01061736|50604061|FG000|Overall Study|Other than specified above|0|||
25289173|NCT01061736|50604062|FG001|Overall Study|Other than specified above|1|||
25289174|NCT01061736|50604063|FG002|Overall Study|Other than specified above|2|||
25289175|NCT01061736|50604064|FG003|Overall Study|Other than specified above|0|||
25289176|NCT01061736|50604065|FG004|Overall Study|Other than specified above|1|||
25289177|NCT01061736|50604066|FG005|Overall Study|Other than specified above|0|||
25289178|NCT01061736|50604067|FG006|Overall Study|Other than specified above|0|||
25289179|NCT01061736|50604068|FG007|Overall Study|Other than specified above|18|||
25289180|NCT01061736|50604069|FG008|Overall Study|Other than specified above|15|||
25289181|NCT01061736|50604070|FG009|Overall Study|Other than specified above|21|||
25289182|NCT01117337|50604097|FG000|Overall Study|Lost to Follow-up|4|||
25070282|NCT02790437|50176193|FG001|Overall Study|Adverse Event|0|||
25289183|NCT01117337|50604098|FG001|Overall Study|Lost to Follow-up|0|||
25289184|NCT01108523|50604108|FG000|Overall Study|Protocol Violation|4|||
25289185|NCT01035606|50604115|FG000|Overall Study|change in health, job demands,family|3|||
25289186|NCT01035606|50604116|FG001|Overall Study|change in health, job demands,family|3|||
25289187|NCT01035606|50604117|FG002|Overall Study|change in health, job demands,family|4|||
25289188|NCT01117181|50604127|FG000|Overall Study|Lost to Follow-up|1|||
25289189|NCT01117181|50604128|FG001|Overall Study|Lost to Follow-up|0|||
25289190|NCT01117181|50604127|FG000|Overall Study|Withdrawal by Subject|0|||
25289191|NCT01117181|50604128|FG001|Overall Study|Withdrawal by Subject|2|||
25289192|NCT01040130|50604136|FG000|Overall Study|Adverse Event|1|||
25289193|NCT01040130|50604137|FG001|Overall Study|Adverse Event|1|||
25289194|NCT01040130|50604138|FG002|Overall Study|Adverse Event|0|||
25289195|NCT01040130|50604139|FG003|Overall Study|Adverse Event|5|||
25289196|NCT01040130|50604140|FG004|Overall Study|Adverse Event|0|||
25289197|NCT01040130|50604141|FG005|Overall Study|Adverse Event|3|||
25289198|NCT01040130|50604136|FG000|Overall Study|Protocol Violation|0|||
25289199|NCT01040130|50604137|FG001|Overall Study|Protocol Violation|0|||
25289200|NCT01040130|50604138|FG002|Overall Study|Protocol Violation|2|||
25289201|NCT01040130|50604139|FG003|Overall Study|Protocol Violation|0|||
25289202|NCT01040130|50604140|FG004|Overall Study|Protocol Violation|0|||
25289203|NCT01040130|50604141|FG005|Overall Study|Protocol Violation|0|||
25289204|NCT01040130|50604136|FG000|Overall Study|Withdrawal by Subject|0|||
25289205|NCT01040130|50604137|FG001|Overall Study|Withdrawal by Subject|2|||
25289206|NCT01040130|50604138|FG002|Overall Study|Withdrawal by Subject|0|||
25289207|NCT01040130|50604139|FG003|Overall Study|Withdrawal by Subject|0|||
25289208|NCT01040130|50604140|FG004|Overall Study|Withdrawal by Subject|0|||
25289209|NCT01040130|50604141|FG005|Overall Study|Withdrawal by Subject|1|||
25289210|NCT01040130|50604136|FG000|Overall Study|Other reasons not listed above|2|||
25289211|NCT01040130|50604137|FG001|Overall Study|Other reasons not listed above|0|||
25289212|NCT01040130|50604138|FG002|Overall Study|Other reasons not listed above|0|||
25289213|NCT01040130|50604139|FG003|Overall Study|Other reasons not listed above|0|||
25289214|NCT01040130|50604140|FG004|Overall Study|Other reasons not listed above|0|||
25289215|NCT01040130|50604141|FG005|Overall Study|Other reasons not listed above|0|||
25289216|NCT00932451|50604151|FG000|Overall Study|Withdrawal by Subject|69|||
25289217|NCT00932451|50604151|FG000|Overall Study|Lost to Follow-up|22|||
25289218|NCT00932451|50604151|FG000|Overall Study|Death|726|||
25289219|NCT00932451|50604151|FG000|Overall Study|Other reasons|5|||
25289220|NCT01039584|50604162|FG000|Overall Study|Withdrawal by Subject|4|||
25289221|NCT01039584|50604163|FG001|Overall Study|Withdrawal by Subject|2|||
25289222|NCT01039584|50604164|FG002|Overall Study|Withdrawal by Subject|1|||
25289223|NCT01039584|50604162|FG000|Overall Study|Protocol Violation|10|||
25289224|NCT01039584|50604163|FG001|Overall Study|Protocol Violation|4|||
25289225|NCT01039584|50604164|FG002|Overall Study|Protocol Violation|6|||
25289226|NCT01039584|50604162|FG000|Overall Study|Lost to Follow-up|5|||
25289227|NCT01039584|50604163|FG001|Overall Study|Lost to Follow-up|3|||
25289228|NCT01039584|50604164|FG002|Overall Study|Lost to Follow-up|4|||
25289229|NCT01039584|50604162|FG000|Overall Study|Negative Baseline culture for Candida|59|||
25289230|NCT01039584|50604163|FG001|Overall Study|Negative Baseline culture for Candida|59|||
25289231|NCT01039584|50604164|FG002|Overall Study|Negative Baseline culture for Candida|24|||
25289232|NCT01039584|50604162|FG000|Overall Study|Lack of Efficacy|7|||
25289233|NCT01039584|50604163|FG001|Overall Study|Lack of Efficacy|6|||
25289234|NCT01039584|50604164|FG002|Overall Study|Lack of Efficacy|10|||
25289235|NCT01039584|50604162|FG000|Overall Study|other|1|||
25289236|NCT01039584|50604163|FG001|Overall Study|other|3|||
25289237|NCT01039584|50604164|FG002|Overall Study|other|1|||
25289238|NCT01039584|50604162|FG000|Overall Study|Pap smear with significant pathology|10|||
25289239|NCT01039584|50604163|FG001|Overall Study|Pap smear with significant pathology|10|||
25289240|NCT01039584|50604164|FG002|Overall Study|Pap smear with significant pathology|3|||
25289241|NCT01039584|50604162|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
25289242|NCT01039584|50604163|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
25289243|NCT01039584|50604164|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
25289244|NCT01108055|50604172|FG000|Overall Study|Ineligible|11|||
25289245|NCT01108055|50604172|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
25289246|NCT01107899|50604179|FG000|Overall Study|Physician Decision|5|||
25289247|NCT01107899|50604180|FG001|Overall Study|Physician Decision|0|||
25289248|NCT01107899|50604181|FG002|Overall Study|Physician Decision|3|||
25289249|NCT01107899|50604179|FG000|Overall Study|Withdrawal by Subject|0|||
25289250|NCT01107899|50604180|FG001|Overall Study|Withdrawal by Subject|0|||
25289251|NCT01107899|50604181|FG002|Overall Study|Withdrawal by Subject|1|||
25289252|NCT01115933|50604192|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
25289253|NCT01107743|50604249|FG000|Overall Study|Protocol Violation|46|||
25289254|NCT01059864|50604298|FG000|Open-Label Run-In Phase|Adverse Event|7|||
25169236|NCT01865747|50300614|FG000|Overall Study (ITT)|Sponsor Decision|0|||
25289255|NCT01059864|50604299|FG001|Open-Label Run-In Phase|Adverse Event|0|||
25289256|NCT01059864|50604300|FG002|Open-Label Run-In Phase|Adverse Event|0|||
25289257|NCT01059864|50604298|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
25289258|NCT01059864|50604299|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
25289259|NCT01059864|50604300|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
25289260|NCT01059864|50604298|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
25289261|NCT01059864|50604299|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
25289262|NCT01059864|50604300|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
25289263|NCT01059864|50604298|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
25289264|NCT01059864|50604299|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
25289265|NCT01059864|50604300|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
25289266|NCT01059864|50604298|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
25289267|NCT01059864|50604299|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
25289268|NCT01059864|50604300|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
25289269|NCT01059864|50604298|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
25289270|NCT01059864|50604299|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
25169237|NCT01865747|50300615|FG001|Overall Study (ITT)|Sponsor Decision|1|||
25289271|NCT01059864|50604300|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
25289272|NCT01035138|50604310|FG000|Overall Study|Adverse Event|4|||
25289273|NCT01035138|50604311|FG001|Overall Study|Adverse Event|0|||
25289274|NCT01035138|50604312|FG002|Overall Study|Adverse Event|2|||
25289275|NCT01035138|50604310|FG000|Overall Study|Caregiver Decision|2|||
25289276|NCT01035138|50604311|FG001|Overall Study|Caregiver Decision|0|||
25289277|NCT01035138|50604312|FG002|Overall Study|Caregiver Decision|1|||
25289278|NCT01035138|50604310|FG000|Overall Study|Withdrawal by Subject|1|||
25289279|NCT01035138|50604311|FG001|Overall Study|Withdrawal by Subject|0|||
25289280|NCT01035138|50604312|FG002|Overall Study|Withdrawal by Subject|0|||
25289281|NCT01035138|50604310|FG000|Overall Study|Physician Decision|0|||
25289282|NCT01035138|50604311|FG001|Overall Study|Physician Decision|0|||
25289283|NCT01035138|50604312|FG002|Overall Study|Physician Decision|1|||
25289284|NCT01035138|50604310|FG000|Overall Study|Sponsor Decision|66|||
25289285|NCT01035138|50604311|FG001|Overall Study|Sponsor Decision|60|||
25289286|NCT01035138|50604312|FG002|Overall Study|Sponsor Decision|42|||
25289287|NCT01035138|50604310|FG000|Overall Study|Lost to Follow-up|0|||
25289288|NCT01035138|50604311|FG001|Overall Study|Lost to Follow-up|0|||
25289289|NCT01035138|50604312|FG002|Overall Study|Lost to Follow-up|1|||
25289290|NCT03739840|50604326|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
25289291|NCT03739840|50604327|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
25289292|NCT03739840|50604328|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
25289293|NCT03739840|50604329|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
25289294|NCT03739840|50604326|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
25289295|NCT03739840|50604327|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
25289296|NCT03739840|50604328|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
25289297|NCT03739840|50604329|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
25289298|NCT03739840|50604326|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
25289299|NCT03739840|50604327|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
25289300|NCT03739840|50604328|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
25289301|NCT03739840|50604329|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
25289302|NCT03739840|50604326|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
25289303|NCT03739840|50604327|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
25289304|NCT03739840|50604328|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
25289305|NCT03739840|50604329|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
25289306|NCT03739840|50604326|FG000|Treatment Period: Wk0-16|Program Termination|3|||
25289307|NCT03739840|50604327|FG001|Treatment Period: Wk0-16|Program Termination|0|||
25289308|NCT03739840|50604328|FG002|Treatment Period: Wk0-16|Program Termination|1|||
25289309|NCT03739840|50604329|FG003|Treatment Period: Wk0-16|Program Termination|1|||
25289310|NCT03739840|50604326|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
25289311|NCT03739840|50604327|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
25289312|NCT03739840|50604328|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
25289313|NCT03739840|50604329|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
25289314|NCT03739840|50604326|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
25289315|NCT03739840|50604327|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
25289316|NCT03739840|50604328|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
25289317|NCT03739840|50604329|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
25289318|NCT03739840|50604326|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
25289319|NCT03739840|50604327|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
25289320|NCT03739840|50604328|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
25289321|NCT03739840|50604329|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
25289322|NCT03739840|50604326|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
25289323|NCT03739840|50604327|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
25289324|NCT03739840|50604328|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
25289325|NCT03739840|50604329|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
25289326|NCT03739840|50604326|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
25289327|NCT03739840|50604327|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
25289328|NCT03739840|50604328|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
25289329|NCT03739840|50604329|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
25289330|NCT03739840|50604326|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
25289331|NCT03739840|50604327|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
25289332|NCT03739840|50604328|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
25289333|NCT03739840|50604329|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
25289334|NCT03739840|50604326|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
25289335|NCT03739840|50604327|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
25289336|NCT03739840|50604328|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
25289337|NCT03739840|50604329|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
25289338|NCT03739840|50604326|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
25289339|NCT03739840|50604327|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
25289340|NCT03739840|50604328|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
25289341|NCT03739840|50604329|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
25289342|NCT03739840|50604326|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
25289343|NCT03739840|50604327|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
25289344|NCT03739840|50604328|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
25289345|NCT03739840|50604329|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
25191552|NCT02596230|50352456|FG001|Objective 2, One Year|Adverse drug reaction|1|||
25191553|NCT02596230|50352457|FG002|Objective 2, One Year|Adverse drug reaction|0|||
25191554|NCT02596230|50352458|FG003|Objective 2, One Year|Adverse drug reaction|0|||
25289346|NCT03739840|50604326|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
25289347|NCT03739840|50604327|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
25289348|NCT03739840|50604328|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
25289349|NCT03739840|50604329|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
25289350|NCT03739840|50604326|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
25289351|NCT03739840|50604327|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
25289352|NCT03739840|50604328|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
25289353|NCT03739840|50604329|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
25289354|NCT03739840|50604326|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
25289355|NCT03739840|50604327|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
25289356|NCT03739840|50604328|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
25289357|NCT03739840|50604329|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
25289358|NCT03739840|50604326|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
25289359|NCT03739840|50604327|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
25289360|NCT03739840|50604328|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
25289361|NCT03739840|50604329|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
25289362|NCT03739840|50604326|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
25289363|NCT03739840|50604327|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
25289364|NCT03739840|50604328|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
25289365|NCT03739840|50604329|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
25289366|NCT03739840|50604326|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
25289367|NCT03739840|50604327|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
25289368|NCT03739840|50604328|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
25289369|NCT03739840|50604329|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
25289370|NCT03739840|50604326|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
25289371|NCT03739840|50604327|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
25289372|NCT03739840|50604328|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
25289373|NCT03739840|50604329|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
25289374|NCT03739840|50604326|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
24969710|NCT00117312|50059186|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
24969711|NCT00117312|50059187|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
24969712|NCT00117312|50059184|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
24969713|NCT00117312|50059185|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
24969714|NCT00117312|50059186|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
25070283|NCT02790437|50176192|FG000|Overall Study|Withdrawal by Subject|1|||
25070284|NCT02790437|50176193|FG001|Overall Study|Withdrawal by Subject|0|||
25070285|NCT02604212|50176210|FG000|Overall Study|Study Terminated by Sponsor|2|||
25191555|NCT02596230|50352459|FG004|Objective 2, One Year|Adverse drug reaction|0|||
25191556|NCT02596230|50352455|FG000|Objective 2, One Year|Death|0|||
25191557|NCT02596230|50352456|FG001|Objective 2, One Year|Death|12|||
25070286|NCT02604212|50176211|FG001|Overall Study|Study Terminated by Sponsor|1|||
24969715|NCT00117312|50059187|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
24969716|NCT00117312|50059184|FG000|Overall Study|Other|0|||
25289375|NCT03739840|50604327|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
25289376|NCT03739840|50604328|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
25289377|NCT03739840|50604329|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
25289378|NCT03739840|50604326|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
25289379|NCT03739840|50604327|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
25289380|NCT03739840|50604328|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
25289381|NCT03739840|50604329|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
25289382|NCT03739840|50604326|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
25289383|NCT03739840|50604327|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
25289384|NCT03739840|50604328|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
25289385|NCT03739840|50604329|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
25289386|NCT03739840|50604326|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
25289387|NCT03739840|50604327|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
25289388|NCT03739840|50604328|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
25289389|NCT03739840|50604329|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
25289390|NCT01035060|50604353|FG000|Overall Study|Lost to Follow-up|0|||
25289391|NCT01035060|50604354|FG001|Overall Study|Lost to Follow-up|7|||
25289392|NCT01035060|50604353|FG000|Overall Study|Did not quality after 2nd screening|14|||
25289393|NCT01035060|50604354|FG001|Overall Study|Did not quality after 2nd screening|1|||
25289394|NCT01035060|50604353|FG000|Overall Study|Withdrawal by Subject|8|||
25289395|NCT01035060|50604354|FG001|Overall Study|Withdrawal by Subject|6|||
25289396|NCT01035060|50604353|FG000|Overall Study|Physician Decision|2|||
25289397|NCT01035060|50604354|FG001|Overall Study|Physician Decision|0|||
25289398|NCT01039428|50604362|FG000|Overall Study|Protocol Violation|1|||
25289399|NCT01039428|50604363|FG001|Overall Study|Protocol Violation|0|||
25289400|NCT01039428|50604362|FG000|Overall Study|Withdrawal by Subject|1|||
25289401|NCT01039428|50604363|FG001|Overall Study|Withdrawal by Subject|0|||
25289402|NCT01034358|50604369|FG000|Overall Study|Withdrawal by Subject|1|||
25289403|NCT01034358|50604369|FG000|Overall Study|Protocol Violation|1|||
25289404|NCT01033734|50604377|FG000|Overall Study|Withdrawal by Subject|1|||
25289405|NCT01115855|50604392|FG000|Overall Study|Adverse Event|16|||
25289406|NCT01115855|50604393|FG001|Overall Study|Adverse Event|18|||
25289407|NCT01115855|50604392|FG000|Overall Study|Death|6|||
25289408|NCT01115855|50604393|FG001|Overall Study|Death|5|||
25289409|NCT01115855|50604392|FG000|Overall Study|Lab Abnormality|1|||
25289410|NCT01115855|50604393|FG001|Overall Study|Lab Abnormality|1|||
25289411|NCT01115855|50604392|FG000|Overall Study|Protocol Violation|0|||
25289412|NCT01115855|50604393|FG001|Overall Study|Protocol Violation|1|||
25289413|NCT01115855|50604392|FG000|Overall Study|Withdrawal by Subject|5|||
25289414|NCT01115855|50604393|FG001|Overall Study|Withdrawal by Subject|5|||
25289415|NCT01115855|50604392|FG000|Overall Study|Other|8|||
25289416|NCT01115855|50604393|FG001|Overall Study|Other|6|||
25289417|NCT01115309|50604403|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
25289418|NCT01115309|50604403|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
25289419|NCT01115309|50604403|FG000|Long-term Follow-up|Lost to Follow-up|6|||
25289420|NCT03638128|50604411|FG000|Overall Study|Withdrawal by Subject|1|||
25289421|NCT03638128|50604412|FG001|Overall Study|Withdrawal by Subject|7|||
25289422|NCT03638128|50604413|FG002|Overall Study|Withdrawal by Subject|6|||
25289423|NCT03638128|50604411|FG000|Overall Study|Sponsor Decision|15|||
25289424|NCT03638128|50604412|FG001|Overall Study|Sponsor Decision|12|||
25289425|NCT03638128|50604413|FG002|Overall Study|Sponsor Decision|19|||
25289426|NCT03638128|50604411|FG000|Overall Study|Lost to Follow-up|0|||
25289427|NCT03638128|50604412|FG001|Overall Study|Lost to Follow-up|0|||
25289428|NCT03638128|50604413|FG002|Overall Study|Lost to Follow-up|1|||
25289429|NCT01059630|50604426|FG000|Overall Study|Death|100|||
25289430|NCT01059630|50604427|FG001|Overall Study|Death|84|||
25289431|NCT01059630|50604426|FG000|Overall Study|Lost to Follow-up|4|||
25289432|NCT01059630|50604427|FG001|Overall Study|Lost to Follow-up|1|||
25289433|NCT01059630|50604426|FG000|Overall Study|Physician Decision|2|||
25289434|NCT01059630|50604427|FG001|Overall Study|Physician Decision|4|||
25289435|NCT01059630|50604426|FG000|Overall Study|Withdrawal by Subject|21|||
25289436|NCT01059630|50604427|FG001|Overall Study|Withdrawal by Subject|14|||
25289437|NCT00932373|50604444|FG000|Overall Study|Progressive disease|3|||
25289438|NCT00932373|50604445|FG001|Overall Study|Progressive disease|1|||
25070287|NCT02604212|50176212|FG002|Overall Study|Study Terminated by Sponsor|3|||
25289439|NCT00932373|50604446|FG002|Overall Study|Progressive disease|0|||
25289440|NCT00932373|50604447|FG003|Overall Study|Progressive disease|0|||
25289441|NCT00932373|50604448|FG004|Overall Study|Progressive disease|10|||
25289442|NCT00932373|50604449|FG005|Overall Study|Progressive disease|1|||
25289443|NCT00932373|50604450|FG006|Overall Study|Progressive disease|0|||
25289444|NCT00932373|50604451|FG007|Overall Study|Progressive disease|2|||
25289445|NCT00932373|50604452|FG008|Overall Study|Progressive disease|1|||
25289446|NCT00932373|50604453|FG009|Overall Study|Progressive disease|9|||
25289447|NCT00932373|50604454|FG010|Overall Study|Progressive disease|2|||
25289448|NCT00932373|50604444|FG000|Overall Study|Adverse Event|0|||
25289449|NCT00932373|50604445|FG001|Overall Study|Adverse Event|0|||
25289450|NCT00932373|50604446|FG002|Overall Study|Adverse Event|0|||
25289451|NCT00932373|50604447|FG003|Overall Study|Adverse Event|0|||
25289452|NCT00932373|50604448|FG004|Overall Study|Adverse Event|2|||
25289453|NCT00932373|50604449|FG005|Overall Study|Adverse Event|1|||
25289454|NCT00932373|50604450|FG006|Overall Study|Adverse Event|0|||
25289455|NCT00932373|50604451|FG007|Overall Study|Adverse Event|1|||
25289456|NCT00932373|50604452|FG008|Overall Study|Adverse Event|0|||
25289457|NCT00932373|50604453|FG009|Overall Study|Adverse Event|2|||
25289458|NCT00932373|50604454|FG010|Overall Study|Adverse Event|1|||
25289459|NCT00932373|50604444|FG000|Overall Study|Physician Decision|0|||
25289460|NCT00932373|50604445|FG001|Overall Study|Physician Decision|0|||
25289461|NCT00932373|50604446|FG002|Overall Study|Physician Decision|1|||
25289462|NCT00932373|50604447|FG003|Overall Study|Physician Decision|0|||
25289463|NCT00932373|50604448|FG004|Overall Study|Physician Decision|2|||
25289464|NCT00932373|50604449|FG005|Overall Study|Physician Decision|0|||
25289465|NCT00932373|50604450|FG006|Overall Study|Physician Decision|0|||
25289466|NCT00932373|50604451|FG007|Overall Study|Physician Decision|0|||
25289467|NCT00932373|50604452|FG008|Overall Study|Physician Decision|0|||
25289468|NCT00932373|50604453|FG009|Overall Study|Physician Decision|1|||
25289469|NCT00932373|50604454|FG010|Overall Study|Physician Decision|0|||
25289470|NCT00932373|50604444|FG000|Overall Study|Dose limiting toxicity|0|||
25289471|NCT00932373|50604445|FG001|Overall Study|Dose limiting toxicity|0|||
25289472|NCT00932373|50604446|FG002|Overall Study|Dose limiting toxicity|0|||
25289473|NCT00932373|50604447|FG003|Overall Study|Dose limiting toxicity|0|||
25289474|NCT00932373|50604448|FG004|Overall Study|Dose limiting toxicity|0|||
25289475|NCT00932373|50604449|FG005|Overall Study|Dose limiting toxicity|1|||
25289476|NCT00932373|50604450|FG006|Overall Study|Dose limiting toxicity|0|||
25289477|NCT00932373|50604451|FG007|Overall Study|Dose limiting toxicity|0|||
25289478|NCT00932373|50604452|FG008|Overall Study|Dose limiting toxicity|0|||
25289479|NCT00932373|50604453|FG009|Overall Study|Dose limiting toxicity|0|||
25289480|NCT00932373|50604454|FG010|Overall Study|Dose limiting toxicity|0|||
25289481|NCT00932373|50604444|FG000|Overall Study|Withdrawal by Subject|0|||
25289482|NCT00932373|50604445|FG001|Overall Study|Withdrawal by Subject|0|||
25289483|NCT00932373|50604446|FG002|Overall Study|Withdrawal by Subject|0|||
25289484|NCT00932373|50604447|FG003|Overall Study|Withdrawal by Subject|0|||
25289485|NCT00932373|50604448|FG004|Overall Study|Withdrawal by Subject|0|||
25289486|NCT00932373|50604449|FG005|Overall Study|Withdrawal by Subject|0|||
25289487|NCT00932373|50604450|FG006|Overall Study|Withdrawal by Subject|0|||
25289488|NCT00932373|50604451|FG007|Overall Study|Withdrawal by Subject|0|||
25289489|NCT00932373|50604452|FG008|Overall Study|Withdrawal by Subject|1|||
25289490|NCT00932373|50604453|FG009|Overall Study|Withdrawal by Subject|0|||
25289491|NCT00932373|50604454|FG010|Overall Study|Withdrawal by Subject|0|||
25289492|NCT00932373|50604444|FG000|Overall Study|Clinical progression|0|||
25289493|NCT00932373|50604445|FG001|Overall Study|Clinical progression|0|||
25289494|NCT00932373|50604446|FG002|Overall Study|Clinical progression|0|||
25289495|NCT00932373|50604447|FG003|Overall Study|Clinical progression|0|||
25289496|NCT00932373|50604448|FG004|Overall Study|Clinical progression|0|||
25289497|NCT00932373|50604449|FG005|Overall Study|Clinical progression|0|||
25289498|NCT00932373|50604450|FG006|Overall Study|Clinical progression|1|||
25289499|NCT00932373|50604451|FG007|Overall Study|Clinical progression|0|||
25289500|NCT00932373|50604452|FG008|Overall Study|Clinical progression|0|||
25289501|NCT00932373|50604453|FG009|Overall Study|Clinical progression|0|||
25289502|NCT00932373|50604454|FG010|Overall Study|Clinical progression|0|||
25289503|NCT00932373|50604444|FG000|Overall Study|Lack of Efficacy|0|||
25289504|NCT00932373|50604445|FG001|Overall Study|Lack of Efficacy|0|||
25289505|NCT00932373|50604446|FG002|Overall Study|Lack of Efficacy|0|||
25289506|NCT00932373|50604447|FG003|Overall Study|Lack of Efficacy|0|||
25289507|NCT00932373|50604448|FG004|Overall Study|Lack of Efficacy|0|||
25289508|NCT00932373|50604449|FG005|Overall Study|Lack of Efficacy|0|||
25289509|NCT00932373|50604450|FG006|Overall Study|Lack of Efficacy|0|||
25289510|NCT00932373|50604451|FG007|Overall Study|Lack of Efficacy|0|||
25289511|NCT00932373|50604452|FG008|Overall Study|Lack of Efficacy|0|||
25289512|NCT00932373|50604453|FG009|Overall Study|Lack of Efficacy|1|||
25289513|NCT00932373|50604454|FG010|Overall Study|Lack of Efficacy|0|||
25289514|NCT01055496|50604488|FG000|Overall Study|Withdrawal by Subject|2|||
25289515|NCT01055496|50604489|FG001|Overall Study|Withdrawal by Subject|4|||
24969717|NCT00117312|50059185|FG001|Overall Study|Other|1|||
25289516|NCT01055496|50604488|FG000|Overall Study|Death|13|||
25289517|NCT01055496|50604489|FG001|Overall Study|Death|23|||
25289518|NCT01055496|50604488|FG000|Overall Study|Lost to Follow-up|0|||
25289519|NCT01055496|50604489|FG001|Overall Study|Lost to Follow-up|2|||
25289520|NCT01055496|50604488|FG000|Overall Study|Other - Unspecified|0|||
25289521|NCT01055496|50604489|FG001|Overall Study|Other - Unspecified|1|||
25289522|NCT01055262|50604516|FG000|Overall Study|Adverse Event|5|||
25289523|NCT01055262|50604516|FG000|Overall Study|Protocol Violation|3|||
25289524|NCT01055262|50604516|FG000|Overall Study|Uncooperativeness|1|||
24969718|NCT00117312|50059186|FG002|Overall Study|Other|3|||
25289525|NCT01052844|50604522|FG000|Overall Study|Adverse Event|0|||
25289526|NCT01052844|50604523|FG001|Overall Study|Adverse Event|1|||
25289527|NCT01049412|50604531|FG000|Period I|Withdrawal by Subject|4|||
25289528|NCT01049412|50604532|FG001|Period I|Withdrawal by Subject|6|||
25289529|NCT01049412|50604531|FG000|Period I|Lost to Follow-up|2|||
25289530|NCT01049412|50604532|FG001|Period I|Lost to Follow-up|2|||
25289531|NCT01049412|50604531|FG000|Period I|Physician Decision|0|||
25289532|NCT01049412|50604532|FG001|Period I|Physician Decision|3|||
25289533|NCT01049412|50604531|FG000|Period I|Protocol Violation|1|||
25289534|NCT01049412|50604532|FG001|Period I|Protocol Violation|2|||
25191558|NCT02596230|50352457|FG002|Objective 2, One Year|Death|41|||
25191559|NCT02596230|50352458|FG003|Objective 2, One Year|Death|21|||
25191560|NCT02596230|50352459|FG004|Objective 2, One Year|Death|30|||
25191561|NCT02596230|50352455|FG000|Objective 2, One Year|Other|0|||
25191562|NCT02596230|50352456|FG001|Objective 2, One Year|Other|3|||
25191563|NCT02596230|50352457|FG002|Objective 2, One Year|Other|2|||
25191564|NCT02596230|50352458|FG003|Objective 2, One Year|Other|0|||
25191565|NCT02596230|50352459|FG004|Objective 2, One Year|Other|0|||
25191566|NCT01667562|50352508|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
25191567|NCT01667562|50352509|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
25191568|NCT01667562|50352508|FG000|Erlotinib Phase|Lost to Follow-up|0|||
25191569|NCT01667562|50352509|FG001|Erlotinib Phase|Lost to Follow-up|1|||
25191570|NCT01667562|50352508|FG000|Erlotinib Phase|Adverse Event|0|||
25191571|NCT01667562|50352509|FG001|Erlotinib Phase|Adverse Event|1|||
25191572|NCT01667562|50352508|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
25191573|NCT01667562|50352509|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
25191574|NCT02595528|50352546|FG000|Overall Study|Withdrawal by Subject|1|||
25191575|NCT02595528|50352547|FG001|Overall Study|Withdrawal by Subject|2|||
25191576|NCT02595528|50352548|FG002|Overall Study|Withdrawal by Subject|1|||
25191577|NCT02595528|50352549|FG003|Overall Study|Withdrawal by Subject|3|||
25191578|NCT02595528|50352546|FG000|Overall Study|Lost to Follow-up|1|||
25191579|NCT02595528|50352547|FG001|Overall Study|Lost to Follow-up|1|||
25191580|NCT02595528|50352548|FG002|Overall Study|Lost to Follow-up|0|||
25191581|NCT02595528|50352549|FG003|Overall Study|Lost to Follow-up|1|||
25191582|NCT02595450|50352577|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
25191583|NCT02595450|50352577|FG000|Overall Study|Enrolled, but not treated|8|||
25191584|NCT02592018|50352581|FG000|Overall Study|Adverse Event|1|||
25191585|NCT02592018|50352581|FG000|Overall Study|Lost to Follow-up|1|||
25191586|NCT02591238|50352589|FG000|Overall Study|Pregnancy|1|||
25191587|NCT02591238|50352590|FG001|Overall Study|Pregnancy|0|||
25191588|NCT02591238|50352591|FG002|Overall Study|Pregnancy|0|||
25191589|NCT02591238|50352592|FG003|Overall Study|Pregnancy|0|||
25191590|NCT02591238|50352589|FG000|Overall Study|Withdrawal by Subject|0|||
25191591|NCT02591238|50352590|FG001|Overall Study|Withdrawal by Subject|0|||
25191592|NCT02591238|50352591|FG002|Overall Study|Withdrawal by Subject|0|||
25191593|NCT02591238|50352592|FG003|Overall Study|Withdrawal by Subject|1|||
25191594|NCT02591238|50352589|FG000|Overall Study|influenza|0|||
25191595|NCT02591238|50352590|FG001|Overall Study|influenza|0|||
25191596|NCT02591238|50352591|FG002|Overall Study|influenza|0|||
25191597|NCT02591238|50352592|FG003|Overall Study|influenza|1|||
25191598|NCT02591238|50352589|FG000|Overall Study|personal circumstances|0|||
25191599|NCT02591238|50352590|FG001|Overall Study|personal circumstances|0|||
25191600|NCT02591238|50352591|FG002|Overall Study|personal circumstances|0|||
25191601|NCT02591238|50352592|FG003|Overall Study|personal circumstances|1|||
25191602|NCT02591238|50352589|FG000|Overall Study|personal circumstances|0|||
25191603|NCT02591238|50352590|FG001|Overall Study|personal circumstances|1|||
25191604|NCT02591238|50352591|FG002|Overall Study|personal circumstances|0|||
25191605|NCT02591238|50352592|FG003|Overall Study|personal circumstances|0|||
25191606|NCT02597946|50352674|FG000|Overall Study|Withdrawal by Subject|1|||
25191607|NCT02597946|50352674|FG000|Overall Study|Progressive disease|16|||
25191608|NCT02597946|50352674|FG000|Overall Study|Other than above|1|||
25191609|NCT02597712|50352680|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
25191610|NCT02597712|50352681|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
25191611|NCT02597712|50352680|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
25191612|NCT02597712|50352681|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
25191613|NCT02597712|50352680|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
25191614|NCT02597712|50352681|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
25191615|NCT02597478|50352689|FG000|Overall Study|Withdrawal by Subject|2|||
25191616|NCT02597478|50352690|FG001|Overall Study|Withdrawal by Subject|0|||
25289535|NCT01049412|50604531|FG000|Period I|Adverse Event|1|||
25289536|NCT01049412|50604532|FG001|Period I|Adverse Event|0|||
25289537|NCT01049412|50604531|FG000|Period II|Withdrawal by Subject|2|||
25070288|NCT02604212|50176213|FG003|Overall Study|Study Terminated by Sponsor|3|||
25191617|NCT02597478|50352689|FG000|Overall Study|Change of opioid dose|1|||
25191618|NCT02597478|50352690|FG001|Overall Study|Change of opioid dose|0|||
25289538|NCT01049412|50604532|FG001|Period II|Withdrawal by Subject|3|||
25289539|NCT01049412|50604531|FG000|Period II|Adverse Event|1|||
25289540|NCT01049412|50604532|FG001|Period II|Adverse Event|0|||
25289541|NCT01049412|50604531|FG000|Period II|Lost to Follow-up|1|||
25289542|NCT01049412|50604532|FG001|Period II|Lost to Follow-up|0|||
25289543|NCT00934089|50604542|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
25289544|NCT00934089|50604543|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
25289545|NCT00934089|50604542|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
25289546|NCT00934089|50604543|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
25289547|NCT01032174|50604551|FG000|Overall Study|Adverse Event|0|||
25289548|NCT01032174|50604552|FG001|Overall Study|Adverse Event|1|||
25289549|NCT00933933|50604563|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
25289550|NCT00933933|50604564|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
25289551|NCT00933933|50604565|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
25289552|NCT00933933|50604563|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
25289553|NCT00933933|50604564|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
25289554|NCT00933933|50604565|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
25289555|NCT01032018|50604583|FG000|Overall Study|Lost to Follow-up|6|||
25289556|NCT01032018|50604584|FG001|Overall Study|Lost to Follow-up|5|||
25289557|NCT01032018|50604583|FG000|Overall Study|Death|0|||
25289558|NCT01032018|50604584|FG001|Overall Study|Death|1|||
25289559|NCT01031706|50604592|FG000|Overall Study|Adverse Event|1|||
25289560|NCT01031706|50604593|FG001|Overall Study|Adverse Event|0|||
25289561|NCT01031706|50604592|FG000|Overall Study|Withdrawal by Subject|1|||
25289562|NCT01031706|50604593|FG001|Overall Study|Withdrawal by Subject|1|||
25289563|NCT00927069|50604601|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
25289564|NCT00927069|50604602|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
25289565|NCT00927069|50604603|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
25289566|NCT00927069|50604604|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
25289567|NCT00927069|50604601|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
25289568|NCT00927069|50604602|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
25289569|NCT00927069|50604603|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
25289570|NCT00927069|50604604|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
25289571|NCT00927069|50604601|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
25289572|NCT00927069|50604602|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
25289573|NCT00927069|50604603|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
24969719|NCT00117312|50059187|FG003|Overall Study|Other|1|||
24969720|NCT00117312|50059184|FG000|Overall Study|Patient choice|0|||
25289574|NCT00927069|50604604|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
25289575|NCT00927069|50604601|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
25289576|NCT00927069|50604602|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
25289577|NCT00927069|50604603|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
25289578|NCT00927069|50604604|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
25289579|NCT00927069|50604601|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
25289580|NCT00927069|50604602|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
25289581|NCT00927069|50604603|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
25289582|NCT00927069|50604604|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
25289583|NCT01031628|50604618|FG000|Overall Study|Study terminated early|0|||
25289584|NCT01031628|50604619|FG001|Overall Study|Study terminated early|1|||
25289585|NCT01031628|50604620|FG002|Overall Study|Study terminated early|3|||
25289586|NCT01031628|50604621|FG003|Overall Study|Study terminated early|0|||
25289587|NCT01031004|50604633|FG000|Overall Study|Protocol Violation|0|||
25289588|NCT01031004|50604634|FG001|Overall Study|Protocol Violation|1|||
25289589|NCT01031004|50604633|FG000|Overall Study|Lost to Follow-up|1|||
25289590|NCT01031004|50604634|FG001|Overall Study|Lost to Follow-up|0|||
25289591|NCT00931515|50604642|FG000|Overall Study|Lost to Follow-up|2|||
25289592|NCT00931515|50604643|FG001|Overall Study|Lost to Follow-up|5|||
25289593|NCT01028352|50604649|FG000|Overall Study|Ineligible due to baseline average pain|5|||
25289594|NCT01028352|50604649|FG000|Overall Study|Withdrawal by Subject|1|||
25289595|NCT00929643|50604666|FG000|Overall Study|Protocol Violation|2|||
25289596|NCT00926367|50604672|FG000|Overall Study|Withdrawal by Subject|0|||
25289597|NCT00926367|50604673|FG001|Overall Study|Withdrawal by Subject|1|||
25289598|NCT00926367|50604672|FG000|Overall Study|Lost to Follow-up|1|||
25289599|NCT00926367|50604673|FG001|Overall Study|Lost to Follow-up|0|||
25289600|NCT00926367|50604672|FG000|Overall Study|Skin Irritation|1|||
25289601|NCT00926367|50604673|FG001|Overall Study|Skin Irritation|2|||
25289602|NCT01114529|50604684|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
25289603|NCT01114529|50604685|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
25289604|NCT01114529|50604686|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
25289605|NCT01114529|50604684|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
25289606|NCT01114529|50604685|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
25289607|NCT01114529|50604686|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
24969721|NCT00117312|50059185|FG001|Overall Study|Patient choice|0|||
25289608|NCT01114529|50604684|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
25289609|NCT01114529|50604685|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
25289610|NCT01114529|50604686|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
25289611|NCT01114529|50604684|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
25289612|NCT01114529|50604685|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
25289613|NCT01114529|50604686|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
25289614|NCT01114529|50604684|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
25289615|NCT01114529|50604685|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
25289616|NCT01114529|50604686|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
25289617|NCT01114529|50604684|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
25289618|NCT01114529|50604685|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
25289619|NCT01114529|50604686|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
25289620|NCT01114529|50604684|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
25289621|NCT01114529|50604685|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
25289622|NCT01114529|50604686|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
25289623|NCT01114529|50604684|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
25289624|NCT01114529|50604685|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
25289625|NCT01114529|50604686|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
25289626|NCT01114529|50604684|FG000|Completed Study Medication at Month 24|Death|2|||
25289627|NCT01114529|50604685|FG001|Completed Study Medication at Month 24|Death|1|||
25289628|NCT01114529|50604686|FG002|Completed Study Medication at Month 24|Death|2|||
25289629|NCT01114529|50604684|FG000|Completed Study Medication at Month 24|Graft loss|0|||
25289630|NCT01114529|50604685|FG001|Completed Study Medication at Month 24|Graft loss|2|||
25289631|NCT01114529|50604686|FG002|Completed Study Medication at Month 24|Graft loss|0|||
25289632|NCT01114529|50604684|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
25289633|NCT01114529|50604685|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
25289634|NCT01114529|50604686|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
25289635|NCT01114529|50604684|FG000|Completed Study Medication at Month 24|Missing|2|||
25289636|NCT01114529|50604685|FG001|Completed Study Medication at Month 24|Missing|0|||
25289637|NCT01114529|50604686|FG002|Completed Study Medication at Month 24|Missing|0|||
25289638|NCT01114529|50604684|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
25289639|NCT01114529|50604685|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
25289640|NCT01114529|50604686|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
25289641|NCT01114529|50604684|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
25289642|NCT01114529|50604685|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
25289643|NCT01114529|50604686|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
25289644|NCT01114529|50604684|FG000|Completed Study Phase at Month 24|Death|8|||
25289645|NCT01114529|50604685|FG001|Completed Study Phase at Month 24|Death|5|||
25289646|NCT01114529|50604686|FG002|Completed Study Phase at Month 24|Death|4|||
25289647|NCT01114529|50604684|FG000|Completed Study Phase at Month 24|Other|2|||
25289648|NCT01114529|50604685|FG001|Completed Study Phase at Month 24|Other|0|||
25289649|NCT01114529|50604686|FG002|Completed Study Phase at Month 24|Other|0|||
25289650|NCT01114529|50604684|FG000|Completed Study Phase at Month 24|Missing|2|||
25289651|NCT01114529|50604685|FG001|Completed Study Phase at Month 24|Missing|0|||
25289652|NCT01114529|50604686|FG002|Completed Study Phase at Month 24|Missing|0|||
25289653|NCT00926289|50604698|FG000|Overall Study|Adverse Event|9|||
25289654|NCT00926289|50604699|FG001|Overall Study|Adverse Event|11|||
25289655|NCT00926289|50604698|FG000|Overall Study|Protocol Violation|8|||
25289656|NCT00926289|50604699|FG001|Overall Study|Protocol Violation|12|||
25289657|NCT00926289|50604698|FG000|Overall Study|Lost to Follow-up|3|||
25289658|NCT00926289|50604699|FG001|Overall Study|Lost to Follow-up|6|||
25289659|NCT00926289|50604698|FG000|Overall Study|Withdrawal by Subject|4|||
25289660|NCT00926289|50604699|FG001|Overall Study|Withdrawal by Subject|4|||
25289661|NCT00926289|50604698|FG000|Overall Study|Other|1|||
25289662|NCT00926289|50604699|FG001|Overall Study|Other|3|||
25289663|NCT03208036|50604724|FG000|Baseline Assessment|Withdrawal by Subject|1|||
25289664|NCT03208036|50604725|FG001|Baseline Assessment|Withdrawal by Subject|1|||
25289665|NCT03208036|50604724|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
25289666|NCT03208036|50604725|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
25289667|NCT03208036|50604724|FG000|Intervention|Withdrawal by Subject|3|||
25289668|NCT03208036|50604725|FG001|Intervention|Withdrawal by Subject|2|||
25289669|NCT03208036|50604724|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
25289670|NCT03208036|50604725|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
25289671|NCT00926211|50604731|FG000|Overall Study|Lost to Follow-up|1|||
25289672|NCT01114373|50604736|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
25289673|NCT01114373|50604737|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
25169238|NCT01865747|50300614|FG000|Overall Study (ITT)|Progressive Disease|122|||
25169239|NCT01865747|50300615|FG001|Overall Study (ITT)|Progressive Disease|158|||
25289674|NCT01114373|50604736|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
25289675|NCT01114373|50604737|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
25289676|NCT01114373|50604736|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
25289677|NCT01114373|50604737|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
25289678|NCT01114373|50604736|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
25289679|NCT01114373|50604737|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
25289680|NCT00925899|50604749|FG000|Part 1|Death|1|||
25289681|NCT00925899|50604750|FG001|Part 1|Death|2|||
25289682|NCT00925899|50604749|FG000|Part 1|Withdrawal by Subject|10|||
25289683|NCT00925899|50604750|FG001|Part 1|Withdrawal by Subject|9|||
25289684|NCT01114217|50604759|FG000|Overall Study|Adverse Event|5|||
25289685|NCT01114217|50604760|FG001|Overall Study|Adverse Event|3|||
25289686|NCT01114217|50604759|FG000|Overall Study|Lost to Follow-up|17|||
25289687|NCT01114217|50604760|FG001|Overall Study|Lost to Follow-up|33|||
25289688|NCT01114217|50604759|FG000|Overall Study|Withdrawal by Subject|21|||
25289689|NCT01114217|50604760|FG001|Overall Study|Withdrawal by Subject|28|||
25289690|NCT01114217|50604759|FG000|Overall Study|Other-Clerical Error|3|||
25289691|NCT01114217|50604760|FG001|Overall Study|Other-Clerical Error|0|||
25289692|NCT01114217|50604759|FG000|Overall Study|Other-Early termination|6|||
25289693|NCT01114217|50604760|FG001|Overall Study|Other-Early termination|10|||
25289694|NCT01114217|50604759|FG000|Overall Study|Other-Procedure|1|||
25289695|NCT01114217|50604760|FG001|Overall Study|Other-Procedure|1|||
25289696|NCT01114217|50604759|FG000|Overall Study|Other-Pregnancy|2|||
25289697|NCT01114217|50604760|FG001|Overall Study|Other-Pregnancy|4|||
25289698|NCT01114217|50604759|FG000|Overall Study|Other-Protocol Violation|1|||
25289699|NCT01114217|50604760|FG001|Overall Study|Other-Protocol Violation|3|||
25289700|NCT01114217|50604759|FG000|Overall Study|Other-Lack of Efficacy|1|||
25289701|NCT01114217|50604760|FG001|Overall Study|Other-Lack of Efficacy|0|||
25289702|NCT01114217|50604759|FG000|Overall Study|Other-Non Compliance|2|||
25289703|NCT01114217|50604760|FG001|Overall Study|Other-Non Compliance|0|||
25289704|NCT01114217|50604759|FG000|Overall Study|Other-Physician Decision|1|||
25289705|NCT01114217|50604760|FG001|Overall Study|Other-Physician Decision|1|||
25289706|NCT01114217|50604759|FG000|Overall Study|Other-Sponsor Decision|10|||
25289707|NCT01114217|50604760|FG001|Overall Study|Other-Sponsor Decision|12|||
25289708|NCT01114217|50604759|FG000|Overall Study|Other-Study Termination|0|||
25289709|NCT01114217|50604760|FG001|Overall Study|Other-Study Termination|1|||
25289710|NCT01114217|50604759|FG000|Overall Study|Other-Study Withdrawn|1|||
25289711|NCT01114217|50604760|FG001|Overall Study|Other-Study Withdrawn|1|||
25289712|NCT01114217|50604759|FG000|Overall Study|Other-Site Stopped Communicating|2|||
25289713|NCT01114217|50604760|FG001|Overall Study|Other-Site Stopped Communicating|0|||
25289714|NCT01114217|50604759|FG000|Overall Study|Other-Lost to Follow-up|1|||
25289715|NCT01114217|50604760|FG001|Overall Study|Other-Lost to Follow-up|0|||
25289716|NCT01114217|50604759|FG000|Overall Study|Other-Withdrawal by Subject|1|||
25289717|NCT01114217|50604760|FG001|Overall Study|Other-Withdrawal by Subject|1|||
25289718|NCT01030536|50604769|FG000|Overall Study|Withdrawal by Subject|0|||
25289719|NCT01030536|50604770|FG001|Overall Study|Withdrawal by Subject|0|||
25289720|NCT01030536|50604771|FG002|Overall Study|Withdrawal by Subject|1|||
25289721|NCT01030536|50604772|FG003|Overall Study|Withdrawal by Subject|0|||
25289722|NCT01030536|50604773|FG004|Overall Study|Withdrawal by Subject|0|||
25289723|NCT01030536|50604769|FG000|Overall Study|undefined|1|||
25289724|NCT01030536|50604770|FG001|Overall Study|undefined|0|||
25289725|NCT01030536|50604771|FG002|Overall Study|undefined|1|||
25289726|NCT01030536|50604772|FG003|Overall Study|undefined|1|||
25289727|NCT01030536|50604773|FG004|Overall Study|undefined|0|||
25289728|NCT01030536|50604769|FG000|Overall Study|Adverse Event|0|||
25289729|NCT01030536|50604770|FG001|Overall Study|Adverse Event|3|||
25289730|NCT01030536|50604771|FG002|Overall Study|Adverse Event|1|||
25289731|NCT01030536|50604772|FG003|Overall Study|Adverse Event|0|||
25289732|NCT01030536|50604773|FG004|Overall Study|Adverse Event|1|||
25289733|NCT01030536|50604769|FG000|Overall Study|Progressive disease|6|||
25289734|NCT01030536|50604770|FG001|Overall Study|Progressive disease|2|||
25289735|NCT01030536|50604771|FG002|Overall Study|Progressive disease|3|||
25289736|NCT01030536|50604772|FG003|Overall Study|Progressive disease|2|||
25289737|NCT01030536|50604773|FG004|Overall Study|Progressive disease|0|||
25289738|NCT01030536|50604769|FG000|Overall Study|Death|0|||
25289739|NCT01030536|50604770|FG001|Overall Study|Death|1|||
25289740|NCT01030536|50604771|FG002|Overall Study|Death|0|||
25289741|NCT01030536|50604772|FG003|Overall Study|Death|0|||
25289742|NCT01030536|50604773|FG004|Overall Study|Death|0|||
25289743|NCT01030458|50604791|FG000|Overall Study|Lost to Follow-up|9|||
25289744|NCT01030458|50604792|FG001|Overall Study|Lost to Follow-up|10|||
24969722|NCT00117312|50059186|FG002|Overall Study|Patient choice|2|||
25289745|NCT01030458|50604791|FG000|Overall Study|Withdrawal by Subject|2|||
25289746|NCT01030458|50604792|FG001|Overall Study|Withdrawal by Subject|3|||
25289747|NCT01030458|50604791|FG000|Overall Study|Logistical reasons|9|||
25289748|NCT01030458|50604792|FG001|Overall Study|Logistical reasons|5|||
25289749|NCT01030458|50604791|FG000|Overall Study|Moved or changed job|6|||
25289750|NCT01030458|50604792|FG001|Overall Study|Moved or changed job|13|||
25289751|NCT01030458|50604791|FG000|Overall Study|Side effect of medication|1|||
25289752|NCT01030458|50604792|FG001|Overall Study|Side effect of medication|1|||
25289753|NCT00930969|50604798|FG000|Overall Study|Death|5|||
25289754|NCT00930969|50604798|FG000|Overall Study|Lost to Follow-up|1|||
25289755|NCT00930969|50604798|FG000|Overall Study|Physician Decision|13|||
25289756|NCT00930969|50604798|FG000|Overall Study|Withdrawal by Subject|19|||
25289757|NCT01114139|50604804|FG000|Overall Study|Adverse Event|3|||
25289758|NCT01114139|50604805|FG001|Overall Study|Adverse Event|2|||
25289759|NCT01114139|50604804|FG000|Overall Study|Lost to Follow-up|15|||
25289760|NCT01114139|50604805|FG001|Overall Study|Lost to Follow-up|3|||
25289761|NCT01114139|50604804|FG000|Overall Study|Withdrawal by Subject|17|||
25289762|NCT01114139|50604805|FG001|Overall Study|Withdrawal by Subject|6|||
25289763|NCT01114139|50604804|FG000|Overall Study|Other-Missed 1 visit|1|||
25289764|NCT01114139|50604805|FG001|Overall Study|Other-Missed 1 visit|0|||
25289765|NCT01114139|50604804|FG000|Overall Study|Other-Protocol Violation|1|||
25289766|NCT01114139|50604805|FG001|Overall Study|Other-Protocol Violation|0|||
25289767|NCT01114139|50604804|FG000|Overall Study|Other-Out of window for study drug dose|1|||
25289768|NCT01114139|50604805|FG001|Overall Study|Other-Out of window for study drug dose|0|||
25289769|NCT01114139|50604804|FG000|Overall Study|Other-Participant falsified records|0|||
25289770|NCT01114139|50604805|FG001|Overall Study|Other-Participant falsified records|1|||
25289771|NCT01114139|50604804|FG000|Overall Study|Other-Participant went on hospice|0|||
25289772|NCT01114139|50604805|FG001|Overall Study|Other-Participant went on hospice|1|||
25289773|NCT01114139|50604804|FG000|Overall Study|Other-Physician changed treatment|1|||
25289774|NCT01114139|50604805|FG001|Overall Study|Other-Physician changed treatment|0|||
25289775|NCT01114139|50604804|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
25289776|NCT01114139|50604805|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
25289777|NCT01027884|50604813|FG000|Overall Study|Adverse Event|2|||
25289778|NCT01027884|50604814|FG001|Overall Study|Adverse Event|1|||
25289779|NCT01027884|50604813|FG000|Overall Study|Protocol Violation|1|||
25289780|NCT01027884|50604814|FG001|Overall Study|Protocol Violation|0|||
25289781|NCT01027884|50604813|FG000|Overall Study|Non-compliance|1|||
25289782|NCT01027884|50604814|FG001|Overall Study|Non-compliance|1|||
25289783|NCT01027884|50604813|FG000|Overall Study|Withdrawal by Subject|0|||
25289784|NCT01027884|50604814|FG001|Overall Study|Withdrawal by Subject|1|||
25289785|NCT01027884|50604813|FG000|Overall Study|Lost to Follow-up|0|||
25289786|NCT01027884|50604814|FG001|Overall Study|Lost to Follow-up|1|||
25289787|NCT01027884|50604813|FG000|Overall Study|Spinal fixation surgery|0|||
25289788|NCT01027884|50604814|FG001|Overall Study|Spinal fixation surgery|3|||
25289789|NCT03387514|50604822|FG000|Overall Study|Withdrawal by Subject|2|||
25289790|NCT03387514|50604822|FG000|Overall Study|Physician Decision|1|||
25289791|NCT03387514|50604822|FG000|Overall Study|Lost to Follow-up|2|||
25289792|NCT01113749|50604837|FG000|Overall Study|Lost to Follow-up|1|||
25289793|NCT01113749|50604838|FG001|Overall Study|Lost to Follow-up|2|||
25289794|NCT01022580|50604846|FG000|Overall Study|Death|18|||
25289795|NCT01022580|50604847|FG001|Overall Study|Death|22|||
25289796|NCT01107353|50604861|FG000|Overall Study|Positive Drug Screen|1|||
25289797|NCT01107353|50604862|FG001|Overall Study|Positive Drug Screen|0|||
25289798|NCT01107197|50604870|FG000|Overall Study|Death|12|||
25289799|NCT01107197|50604871|FG001|Overall Study|Death|10|||
25289800|NCT01107197|50604870|FG000|Overall Study|Lost to Follow-up|5|||
25289801|NCT01107197|50604871|FG001|Overall Study|Lost to Follow-up|8|||
25289802|NCT01107197|50604870|FG000|Overall Study|Withdrawal by Subject|3|||
25289803|NCT01107197|50604871|FG001|Overall Study|Withdrawal by Subject|5|||
25289804|NCT01112579|50604888|FG000|Overall Study|Missed Visit|1|||
25289805|NCT01112579|50604889|FG001|Overall Study|Missed Visit|1|||
25289806|NCT01112579|50604888|FG000|Overall Study|Death|0|||
25289807|NCT01112579|50604889|FG001|Overall Study|Death|2|||
25289808|NCT01112267|50604897|FG000|Overall Study|Adverse Event|24|||
25289809|NCT01112267|50604898|FG001|Overall Study|Adverse Event|6|||
25289810|NCT01112267|50604897|FG000|Overall Study|Withdrawal by Subject|3|||
25289811|NCT01112267|50604898|FG001|Overall Study|Withdrawal by Subject|5|||
25289812|NCT01112267|50604897|FG000|Overall Study|Protocol Violation|5|||
25289813|NCT01112267|50604898|FG001|Overall Study|Protocol Violation|3|||
25289814|NCT01112267|50604897|FG000|Overall Study|Participants not compliant|1|||
25289815|NCT01112267|50604898|FG001|Overall Study|Participants not compliant|2|||
25289816|NCT01112267|50604897|FG000|Overall Study|Participants not receive any study drug|1|||
25289817|NCT01112267|50604898|FG001|Overall Study|Participants not receive any study drug|2|||
25289818|NCT00925587|50604906|FG000|Overall Study|Protocol Specified Criteria|6|||
25289819|NCT00925587|50604907|FG001|Overall Study|Protocol Specified Criteria|6|||
25289820|NCT00925587|50604906|FG000|Overall Study|Physician Decision|4|||
25289821|NCT00925587|50604907|FG001|Overall Study|Physician Decision|1|||
25289822|NCT00925587|50604906|FG000|Overall Study|Protocol Violation|6|||
25289823|NCT00925587|50604907|FG001|Overall Study|Protocol Violation|4|||
25289824|NCT00925587|50604906|FG000|Overall Study|Withdrawal by Subject|9|||
25289825|NCT00925587|50604907|FG001|Overall Study|Withdrawal by Subject|6|||
25289826|NCT00925587|50604906|FG000|Overall Study|Death|5|||
25289827|NCT00925587|50604907|FG001|Overall Study|Death|5|||
25289828|NCT00925587|50604906|FG000|Overall Study|Adverse Event|6|||
25289829|NCT00925587|50604907|FG001|Overall Study|Adverse Event|2|||
25289830|NCT00925587|50604906|FG000|Overall Study|Lost to Follow-up|0|||
25289831|NCT00925587|50604907|FG001|Overall Study|Lost to Follow-up|1|||
25289832|NCT00928707|50604919|FG000|Overall Study|Protocol Violation|1|||
25289833|NCT00928707|50604920|FG001|Overall Study|Protocol Violation|0|||
25289834|NCT00930813|50604928|FG000|Overall Study|Death|4|||
25289835|NCT00930813|50604929|FG001|Overall Study|Death|5|||
25289836|NCT00930813|50604928|FG000|Overall Study|Withdrawal by Subject|2|||
25289837|NCT00930813|50604929|FG001|Overall Study|Withdrawal by Subject|5|||
25289838|NCT00930813|50604928|FG000|Overall Study|Lost to Follow-up|2|||
25289839|NCT00930813|50604929|FG001|Overall Study|Lost to Follow-up|4|||
25289840|NCT00930579|50604937|FG000|Overall Study|Withdrawal by Subject|1|||
25289841|NCT00930579|50604937|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
25289842|NCT03367156|50604943|FG000|Overall Study|Lack of interest|3|||
25289843|NCT03367156|50604944|FG001|Overall Study|Lack of interest|1|||
25289844|NCT03367156|50604943|FG000|Overall Study|Death|2|||
25289845|NCT03367156|50604944|FG001|Overall Study|Death|0|||
25289846|NCT03367156|50604943|FG000|Overall Study|Lost to Follow-up|2|||
25289847|NCT03367156|50604944|FG001|Overall Study|Lost to Follow-up|1|||
25289848|NCT03367156|50604943|FG000|Overall Study|Became ineligible|1|||
25289849|NCT03367156|50604944|FG001|Overall Study|Became ineligible|2|||
25289850|NCT03367156|50604943|FG000|Overall Study|Hospitalization|1|||
25289851|NCT03367156|50604944|FG001|Overall Study|Hospitalization|0|||
25289852|NCT03367156|50604943|FG000|Overall Study|Concerned about Treatment|11|||
25289853|NCT03367156|50604944|FG001|Overall Study|Concerned about Treatment|3|||
25289854|NCT03367156|50604943|FG000|Overall Study|Started new treatment|4|||
25289855|NCT03367156|50604944|FG001|Overall Study|Started new treatment|1|||
25289856|NCT00925353|50604952|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
25289857|NCT01106651|50604976|FG000|Overall Study|Adverse Event|17|||
25289858|NCT01106651|50604977|FG001|Overall Study|Adverse Event|9|||
25289859|NCT01106651|50604978|FG002|Overall Study|Adverse Event|23|||
25289860|NCT01106651|50604976|FG000|Overall Study|Lost to Follow-up|8|||
25289861|NCT01106651|50604977|FG001|Overall Study|Lost to Follow-up|2|||
25289862|NCT01106651|50604978|FG002|Overall Study|Lost to Follow-up|6|||
25289863|NCT01106651|50604976|FG000|Overall Study|Physician Decision|4|||
25289864|NCT01106651|50604977|FG001|Overall Study|Physician Decision|3|||
25289865|NCT01106651|50604978|FG002|Overall Study|Physician Decision|1|||
25289866|NCT01106651|50604976|FG000|Overall Study|Protocol Violation|1|||
25289867|NCT01106651|50604977|FG001|Overall Study|Protocol Violation|2|||
25289868|NCT01106651|50604978|FG002|Overall Study|Protocol Violation|1|||
25289869|NCT01106651|50604976|FG000|Overall Study|Withdrawal by Subject|14|||
25289870|NCT01106651|50604977|FG001|Overall Study|Withdrawal by Subject|7|||
25289871|NCT01106651|50604978|FG002|Overall Study|Withdrawal by Subject|4|||
25289872|NCT01106651|50604976|FG000|Overall Study|Noncompliance with study drug|1|||
24969723|NCT00117312|50059187|FG003|Overall Study|Patient choice|1|||
24969724|NCT00117312|50059184|FG000|Overall Study|Adverse Event|0|||
25289873|NCT01106651|50604977|FG001|Overall Study|Noncompliance with study drug|0|||
25289874|NCT01106651|50604978|FG002|Overall Study|Noncompliance with study drug|2|||
25289875|NCT01106651|50604976|FG000|Overall Study|Other|34|||
25289876|NCT01106651|50604977|FG001|Overall Study|Other|31|||
25289877|NCT01106651|50604978|FG002|Overall Study|Other|21|||
25289878|NCT01106651|50604976|FG000|Overall Study|Death|0|||
25289879|NCT01106651|50604977|FG001|Overall Study|Death|3|||
25289880|NCT01106651|50604978|FG002|Overall Study|Death|0|||
25289881|NCT01027650|50604997|FG000|Overall Study|Personal Reasons|0|||
25289882|NCT01027650|50604998|FG001|Overall Study|Personal Reasons|0|||
25289883|NCT01027650|50604999|FG002|Overall Study|Personal Reasons|0|||
25289884|NCT01027650|50605000|FG003|Overall Study|Personal Reasons|0|||
25289885|NCT01027650|50605001|FG004|Overall Study|Personal Reasons|2|||
25289886|NCT01027650|50605002|FG005|Overall Study|Personal Reasons|1|||
25289887|NCT01027650|50605003|FG006|Overall Study|Personal Reasons|0|||
25289888|NCT01027650|50605004|FG007|Overall Study|Personal Reasons|0|||
25289889|NCT01027650|50604997|FG000|Overall Study|Lost to Follow-up|0|||
25289890|NCT01027650|50604998|FG001|Overall Study|Lost to Follow-up|0|||
25289891|NCT01027650|50604999|FG002|Overall Study|Lost to Follow-up|0|||
25289892|NCT01027650|50605000|FG003|Overall Study|Lost to Follow-up|0|||
25289893|NCT01027650|50605001|FG004|Overall Study|Lost to Follow-up|0|||
25289894|NCT01027650|50605002|FG005|Overall Study|Lost to Follow-up|0|||
25289895|NCT01027650|50605003|FG006|Overall Study|Lost to Follow-up|1|||
25289896|NCT01027650|50605004|FG007|Overall Study|Lost to Follow-up|0|||
25289897|NCT01027650|50604997|FG000|Overall Study|Lack of Efficacy|0|||
25289898|NCT01027650|50604998|FG001|Overall Study|Lack of Efficacy|0|||
24969725|NCT00117312|50059185|FG001|Overall Study|Adverse Event|2|||
25289899|NCT01027650|50604999|FG002|Overall Study|Lack of Efficacy|0|||
25289900|NCT01027650|50605000|FG003|Overall Study|Lack of Efficacy|0|||
25289901|NCT01027650|50605001|FG004|Overall Study|Lack of Efficacy|0|||
25289902|NCT01027650|50605002|FG005|Overall Study|Lack of Efficacy|1|||
25289903|NCT01027650|50605003|FG006|Overall Study|Lack of Efficacy|0|||
25289904|NCT01027650|50605004|FG007|Overall Study|Lack of Efficacy|0|||
25289905|NCT01106027|50605022|FG000|Overall Study|Lost graft early, discontinued|1|||
25289906|NCT00927927|50605041|FG000|Overall Study|Withdrawal by Subject|0|||
25289907|NCT00927927|50605042|FG001|Overall Study|Withdrawal by Subject|0|||
25289908|NCT00927927|50605043|FG002|Overall Study|Withdrawal by Subject|0|||
25289909|NCT00927927|50605044|FG003|Overall Study|Withdrawal by Subject|0|||
25289910|NCT00927927|50605045|FG004|Overall Study|Withdrawal by Subject|0|||
25289911|NCT00927927|50605046|FG005|Overall Study|Withdrawal by Subject|0|||
25289912|NCT00927927|50605047|FG006|Overall Study|Withdrawal by Subject|0|||
25289913|NCT00927927|50605048|FG007|Overall Study|Withdrawal by Subject|2|||
25289914|NCT00927927|50605049|FG008|Overall Study|Withdrawal by Subject|0|||
25289915|NCT00927927|50605050|FG009|Overall Study|Withdrawal by Subject|0|||
25289916|NCT00927927|50605051|FG010|Overall Study|Withdrawal by Subject|0|||
25289917|NCT00927927|50605052|FG011|Overall Study|Withdrawal by Subject|2|||
25289918|NCT00927927|50605053|FG012|Overall Study|Withdrawal by Subject|0|||
25289919|NCT00927927|50605054|FG013|Overall Study|Withdrawal by Subject|0|||
25289920|NCT00927927|50605055|FG014|Overall Study|Withdrawal by Subject|0|||
25289921|NCT01027416|50605089|FG000|Overall Study|Withdrawal by Subject|0|||
25289922|NCT01027416|50605090|FG001|Overall Study|Withdrawal by Subject|1|||
25289923|NCT01027416|50605089|FG000|Overall Study|Physician Decision|1|||
25289924|NCT01027416|50605090|FG001|Overall Study|Physician Decision|4|||
25289925|NCT00923559|50605098|FG000|Overall Study|Lost to Follow-up|2|||
25289926|NCT00923559|50605099|FG001|Overall Study|Lost to Follow-up|3|||
25289927|NCT01015638|50605109|FG000|Overall Study|Withdrawal by Subject|1|||
25289928|NCT01015638|50605110|FG001|Overall Study|Withdrawal by Subject|0|||
25289929|NCT01022502|50605116|FG000|Overall Study|Adverse Event|1|||
25289930|NCT01022502|50605116|FG000|Overall Study|employment related reasons|1|||
25289931|NCT01022502|50605116|FG000|Overall Study|Withdrawal by Subject|1|||
25289932|NCT01105091|50605124|FG000|Overall Study|Death|2|||
25289933|NCT01105091|50605125|FG001|Overall Study|Death|0|||
25289934|NCT00924729|50605135|FG000|Overall Study|insufficient volume for analysis|1|||
25289935|NCT00924729|50605136|FG001|Overall Study|insufficient volume for analysis|0|||
25289936|NCT00924729|50605135|FG000|Overall Study|Protocol Violation|1|||
25289937|NCT00924729|50605136|FG001|Overall Study|Protocol Violation|0|||
25289938|NCT01099709|50605144|FG000|Period 1|Withdrawal by Subject|0|||
25289939|NCT01099709|50605145|FG001|Period 1|Withdrawal by Subject|1|||
25289940|NCT01099709|50605144|FG000|Period 1|Positive cotinine test|0|||
25289941|NCT01099709|50605145|FG001|Period 1|Positive cotinine test|1|||
25289942|NCT01099709|50605144|FG000|Period 1|Adverse Event|1|||
25289943|NCT01099709|50605145|FG001|Period 1|Adverse Event|0|||
25289944|NCT01099397|50605152|FG000|Overall Study|Lost to Follow-up|4|||
25289945|NCT01099397|50605152|FG000|Overall Study|Protocol Violation|4|||
25289946|NCT01099397|50605152|FG000|Overall Study|Withdrawal by Subject|5|||
25289947|NCT01022424|50605157|FG000|Overall Study|Adverse Event|1|||
25289948|NCT01022424|50605157|FG000|Overall Study|Physician Decision|1|||
25289949|NCT01022424|50605157|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
25289950|NCT01098851|50605167|FG000|Overall Study|Equipment failure|1|||
25289951|NCT01098851|50605168|FG001|Overall Study|Equipment failure|0|||
25289952|NCT01026948|50605174|FG000|Overall Study|Physician Decision|8|||
25289953|NCT01104779|50605182|FG000|Overall Study|Protocol Violation|1|||
25289954|NCT01104779|50605183|FG001|Overall Study|Protocol Violation|2|||
25289955|NCT01104779|50605184|FG002|Overall Study|Protocol Violation|2|||
25289956|NCT01104779|50605182|FG000|Overall Study|Lack of Efficacy|26|||
25289957|NCT01104779|50605183|FG001|Overall Study|Lack of Efficacy|12|||
25289958|NCT01104779|50605184|FG002|Overall Study|Lack of Efficacy|13|||
25289959|NCT01104779|50605182|FG000|Overall Study|Adverse Event|13|||
25289960|NCT01104779|50605183|FG001|Overall Study|Adverse Event|14|||
25289961|NCT01104779|50605184|FG002|Overall Study|Adverse Event|13|||
25289962|NCT01104779|50605182|FG000|Overall Study|Did not meet inc/exc criteria|1|||
25289963|NCT01104779|50605183|FG001|Overall Study|Did not meet inc/exc criteria|1|||
25289964|NCT01104779|50605184|FG002|Overall Study|Did not meet inc/exc criteria|1|||
25289965|NCT01104779|50605182|FG000|Overall Study|Other reasons|0|||
25289966|NCT01104779|50605183|FG001|Overall Study|Other reasons|1|||
25289967|NCT01104779|50605184|FG002|Overall Study|Other reasons|0|||
25289968|NCT01104779|50605182|FG000|Overall Study|Lost to Follow-up|2|||
25289969|NCT01104779|50605183|FG001|Overall Study|Lost to Follow-up|0|||
25289970|NCT01104779|50605184|FG002|Overall Study|Lost to Follow-up|1|||
25289971|NCT01104779|50605182|FG000|Overall Study|Withdrawal by Subject|16|||
25289972|NCT01104779|50605183|FG001|Overall Study|Withdrawal by Subject|25|||
25289973|NCT01104779|50605184|FG002|Overall Study|Withdrawal by Subject|32|||
25289974|NCT00918957|50605194|FG000|Overall Study|Adverse Event|2|||
25289975|NCT00918957|50605195|FG001|Overall Study|Adverse Event|0|||
25289976|NCT00918957|50605194|FG000|Overall Study|Withdrawal by Subject|1|||
25289977|NCT00918957|50605195|FG001|Overall Study|Withdrawal by Subject|0|||
25289978|NCT01022268|50605203|FG000|Overall Study|Withdrawal by Subject|1|||
25289979|NCT01022268|50605204|FG001|Overall Study|Withdrawal by Subject|0|||
25289980|NCT01022268|50605203|FG000|Overall Study|Withdrawal by Subject|1|||
25289981|NCT01022268|50605204|FG001|Overall Study|Withdrawal by Subject|0|||
25289982|NCT01015560|50605210|FG000|Overall Study|Adverse Event|1|||
25289983|NCT01015560|50605210|FG000|Overall Study|Not protocol specified|1|||
25289984|NCT01015560|50605210|FG000|Overall Study|Withdrawal by Subject|1|||
25289985|NCT00918879|50605216|FG000|Overall Study|Withdrawal by Subject|4|||
25289986|NCT00918879|50605217|FG001|Overall Study|Withdrawal by Subject|4|||
25289987|NCT00918879|50605216|FG000|Overall Study|Lost to Follow-up|1|||
25289988|NCT00918879|50605217|FG001|Overall Study|Lost to Follow-up|1|||
25289989|NCT00918879|50605216|FG000|Overall Study|Severe non-compliance to protocol|1|||
25289990|NCT00918879|50605217|FG001|Overall Study|Severe non-compliance to protocol|1|||
25289991|NCT01026792|50605223|FG000|Overall Study|Protocol Violation|1|||
25289992|NCT01026324|50605230|FG000|Follow up/Survival|Withdrawal by Subject|1|||
25289993|NCT01026324|50605231|FG001|Follow up/Survival|Withdrawal by Subject|0|||
25289994|NCT01026324|50605232|FG002|Follow up/Survival|Withdrawal by Subject|0|||
25289995|NCT01098539|50605243|FG000|Overall Study|Adverse Event|26|||
25289996|NCT01098539|50605244|FG001|Overall Study|Adverse Event|26|||
25289997|NCT01098539|50605243|FG000|Overall Study|Protocol Violation|1|||
25289998|NCT01098539|50605244|FG001|Overall Study|Protocol Violation|4|||
25289999|NCT01098539|50605243|FG000|Overall Study|Noncompliance|3|||
25290000|NCT01098539|50605244|FG001|Overall Study|Noncompliance|5|||
25290001|NCT01098539|50605243|FG000|Overall Study|Lost to Follow-up|4|||
25290002|NCT01098539|50605244|FG001|Overall Study|Lost to Follow-up|4|||
25290003|NCT01098539|50605243|FG000|Overall Study|Withdrawal by Subject|12|||
25290004|NCT01098539|50605244|FG001|Overall Study|Withdrawal by Subject|26|||
25290005|NCT01098539|50605243|FG000|Overall Study|Physician Decision|5|||
25290006|NCT01098539|50605244|FG001|Overall Study|Physician Decision|3|||
25290007|NCT01098461|50605254|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
25290008|NCT01098461|50605255|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
25290009|NCT01098461|50605256|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
25290010|NCT01098461|50605257|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
25290011|NCT01098461|50605254|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
25290012|NCT01098461|50605255|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
25290013|NCT01098461|50605256|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
25290014|NCT01098461|50605257|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
25290015|NCT01098461|50605254|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
25290016|NCT01098461|50605255|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
25290017|NCT01098461|50605256|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
25290018|NCT01098461|50605257|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
25290019|NCT01098461|50605254|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
25290020|NCT01098461|50605255|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
25290021|NCT01098461|50605256|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
25290022|NCT01098461|50605257|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
25290023|NCT01098461|50605254|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
25290024|NCT01098461|50605255|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
25290025|NCT01098461|50605256|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
25290026|NCT01098461|50605257|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
25290027|NCT01098461|50605254|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
25290028|NCT01098461|50605255|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
25290029|NCT01098461|50605256|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
25290030|NCT01098461|50605257|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
25290031|NCT01098461|50605254|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
25290032|NCT01098461|50605255|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
25290033|NCT01098461|50605256|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
25290034|NCT01098461|50605257|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
25290035|NCT01098305|50605270|FG000|Overall Study|Lost to Follow-up|31|||
25290036|NCT01098305|50605271|FG001|Overall Study|Lost to Follow-up|33|||
25290037|NCT00833833|50605283|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
25290038|NCT00833833|50605284|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
25290039|NCT00833833|50605285|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
25290040|NCT00833833|50605286|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
25290041|NCT00833833|50605287|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
25290042|NCT00833833|50605288|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
25290043|NCT00833833|50605283|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
25290044|NCT00833833|50605284|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
25290045|NCT00833833|50605285|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
25290046|NCT00833833|50605286|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
25290047|NCT00833833|50605287|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
25290048|NCT00833833|50605288|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
25290049|NCT00833833|50605283|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
25290050|NCT00833833|50605284|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
25290051|NCT00833833|50605285|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
25290052|NCT00833833|50605286|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
25290053|NCT00833833|50605287|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
25290054|NCT00833833|50605288|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
25290055|NCT00833833|50605283|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
25290056|NCT00833833|50605284|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
25290057|NCT00833833|50605285|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
25290058|NCT00833833|50605286|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
25290059|NCT00833833|50605287|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
25290060|NCT00833833|50605288|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
25290061|NCT00833833|50605283|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
25290062|NCT00833833|50605284|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
25290063|NCT00833833|50605285|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
25290064|NCT00833833|50605286|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
25290065|NCT00833833|50605287|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
25290066|NCT00833833|50605288|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
25290067|NCT00833833|50605283|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
25290068|NCT00833833|50605284|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
25290069|NCT00833833|50605285|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
25290070|NCT00833833|50605286|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
25290071|NCT00833833|50605287|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
25290072|NCT00833833|50605288|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
25290073|NCT00833833|50605283|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
25290074|NCT00833833|50605284|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
25290075|NCT00833833|50605285|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
25290076|NCT00833833|50605286|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
25290077|NCT00833833|50605287|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
25290078|NCT00833833|50605288|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
25290079|NCT00833833|50605283|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
25290080|NCT00833833|50605284|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
25290081|NCT00833833|50605285|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
25290082|NCT00833833|50605286|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
25290083|NCT00833833|50605287|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
25290084|NCT00833833|50605288|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
25290085|NCT00833833|50605283|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
25290086|NCT00833833|50605284|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
25290087|NCT00833833|50605285|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
25290088|NCT00833833|50605286|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
25290089|NCT00833833|50605287|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
25290090|NCT00833833|50605288|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
25290091|NCT00833833|50605283|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
25290092|NCT00833833|50605284|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
25290093|NCT00833833|50605285|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
25290094|NCT00833833|50605286|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
25290095|NCT00833833|50605287|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
25290096|NCT00833833|50605288|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
25290097|NCT00833833|50605283|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
25290098|NCT00833833|50605284|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
25290099|NCT00833833|50605285|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
25290100|NCT00833833|50605286|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
25290101|NCT00833833|50605287|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
25290102|NCT00833833|50605288|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
24969726|NCT00117312|50059186|FG002|Overall Study|Adverse Event|0|||
25290103|NCT00833833|50605283|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
25290104|NCT00833833|50605284|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
25290105|NCT00833833|50605285|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
24969727|NCT00117312|50059187|FG003|Overall Study|Adverse Event|0|||
25290106|NCT00833833|50605286|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
25290107|NCT00833833|50605287|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
25290108|NCT00833833|50605288|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
25290109|NCT00833833|50605283|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
25290110|NCT00833833|50605284|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
25290111|NCT00833833|50605285|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
25290112|NCT00833833|50605286|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
25290113|NCT00833833|50605287|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
25290114|NCT00833833|50605288|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
25290115|NCT01098071|50605308|FG000|Overall Study|Surgery (adenoidectomy)|2|||
25290116|NCT01098071|50605308|FG000|Overall Study|Lost to Follow-up|13|||
25290117|NCT01097057|50605312|FG000|Overall Study|Physician Decision|3|||
25290118|NCT01022112|50605321|FG000|Overall Study|Adverse Event|1|||
25290119|NCT01022112|50605322|FG001|Overall Study|Adverse Event|2|||
25290120|NCT01022112|50605323|FG002|Overall Study|Adverse Event|0|||
25290121|NCT01022112|50605324|FG003|Overall Study|Adverse Event|1|||
25290122|NCT01022112|50605325|FG004|Overall Study|Adverse Event|0|||
25290123|NCT01022112|50605321|FG000|Overall Study|Lack of Efficacy|1|||
25290124|NCT01022112|50605322|FG001|Overall Study|Lack of Efficacy|0|||
25290125|NCT01022112|50605323|FG002|Overall Study|Lack of Efficacy|0|||
25290126|NCT01022112|50605324|FG003|Overall Study|Lack of Efficacy|0|||
25290127|NCT01022112|50605325|FG004|Overall Study|Lack of Efficacy|1|||
25290128|NCT01022112|50605321|FG000|Overall Study|Physician Decision|0|||
25290129|NCT01022112|50605322|FG001|Overall Study|Physician Decision|0|||
25290130|NCT01022112|50605323|FG002|Overall Study|Physician Decision|1|||
25290131|NCT01022112|50605324|FG003|Overall Study|Physician Decision|0|||
25290132|NCT01022112|50605325|FG004|Overall Study|Physician Decision|1|||
25290133|NCT01022112|50605321|FG000|Overall Study|Withdrawal by Subject|0|||
25290134|NCT01022112|50605322|FG001|Overall Study|Withdrawal by Subject|1|||
25290135|NCT01022112|50605323|FG002|Overall Study|Withdrawal by Subject|2|||
25290136|NCT01022112|50605324|FG003|Overall Study|Withdrawal by Subject|2|||
25290137|NCT01022112|50605325|FG004|Overall Study|Withdrawal by Subject|1|||
25290138|NCT01022112|50605321|FG000|Overall Study|Fasting plasma glucose level increased|1|||
25290139|NCT01022112|50605322|FG001|Overall Study|Fasting plasma glucose level increased|0|||
25290140|NCT01022112|50605323|FG002|Overall Study|Fasting plasma glucose level increased|0|||
25290141|NCT01022112|50605324|FG003|Overall Study|Fasting plasma glucose level increased|0|||
25290142|NCT01022112|50605325|FG004|Overall Study|Fasting plasma glucose level increased|7|||
25290143|NCT01096667|50605342|FG000|Overall Study|Lost to Follow-up|1|||
25290144|NCT01096667|50605343|FG001|Overall Study|Lost to Follow-up|1|||
25290145|NCT01096667|50605344|FG002|Overall Study|Lost to Follow-up|1|||
25290146|NCT01096667|50605345|FG003|Overall Study|Lost to Follow-up|0|||
25290147|NCT01096667|50605346|FG004|Overall Study|Lost to Follow-up|0|||
25290148|NCT01096667|50605342|FG000|Overall Study|Withdrawal by Subject|1|||
25290149|NCT01096667|50605343|FG001|Overall Study|Withdrawal by Subject|0|||
25290150|NCT01096667|50605344|FG002|Overall Study|Withdrawal by Subject|0|||
25290151|NCT01096667|50605345|FG003|Overall Study|Withdrawal by Subject|1|||
25290152|NCT01096667|50605346|FG004|Overall Study|Withdrawal by Subject|0|||
25290153|NCT01096667|50605342|FG000|Overall Study|Reason not available|0|||
25290154|NCT01096667|50605343|FG001|Overall Study|Reason not available|1|||
25290155|NCT01096667|50605344|FG002|Overall Study|Reason not available|1|||
25290156|NCT01096667|50605345|FG003|Overall Study|Reason not available|1|||
25290157|NCT01096667|50605346|FG004|Overall Study|Reason not available|0|||
25290158|NCT01096667|50605342|FG000|Overall Study|Protocol Violation|0|||
25290159|NCT01096667|50605343|FG001|Overall Study|Protocol Violation|0|||
25290160|NCT01096667|50605344|FG002|Overall Study|Protocol Violation|0|||
25290161|NCT01096667|50605345|FG003|Overall Study|Protocol Violation|1|||
25290162|NCT01096667|50605346|FG004|Overall Study|Protocol Violation|0|||
25290163|NCT01096667|50605342|FG000|Overall Study|Not treated|1|||
25290164|NCT01096667|50605343|FG001|Overall Study|Not treated|0|||
25290165|NCT01096667|50605344|FG002|Overall Study|Not treated|0|||
25290166|NCT01096667|50605345|FG003|Overall Study|Not treated|0|||
25290167|NCT01096667|50605346|FG004|Overall Study|Not treated|0|||
25290168|NCT01014624|50605361|FG000|Overall Study|Adverse Event|0|||
25290169|NCT01014624|50605362|FG001|Overall Study|Adverse Event|1|||
25290170|NCT01014624|50605361|FG000|Overall Study|Protocol Violation|1|||
25290171|NCT01014624|50605362|FG001|Overall Study|Protocol Violation|0|||
25290172|NCT01014624|50605361|FG000|Overall Study|Withdrawal by Subject|1|||
25290173|NCT01014624|50605362|FG001|Overall Study|Withdrawal by Subject|0|||
25290174|NCT01021878|50605372|FG000|Overall Study|Lost to Follow-up|4|||
25290175|NCT01021878|50605373|FG001|Overall Study|Lost to Follow-up|3|||
25290176|NCT01021878|50605372|FG000|Overall Study|Death|0|||
25290177|NCT01021878|50605373|FG001|Overall Study|Death|1|||
25290178|NCT01021878|50605372|FG000|Overall Study|Adverse Event|6|||
25290179|NCT01021878|50605373|FG001|Overall Study|Adverse Event|5|||
25290180|NCT01021878|50605372|FG000|Overall Study|Transplantation|6|||
25290181|NCT01021878|50605373|FG001|Overall Study|Transplantation|1|||
25290182|NCT00854113|50605393|FG000|Overall Study|Adverse Event|0|||
25290183|NCT00854113|50605394|FG001|Overall Study|Adverse Event|0|||
25290184|NCT00854113|50605395|FG002|Overall Study|Adverse Event|0|||
25290185|NCT00854113|50605396|FG003|Overall Study|Adverse Event|0|||
25290186|NCT00854113|50605397|FG004|Overall Study|Adverse Event|0|||
25290187|NCT00854113|50605398|FG005|Overall Study|Adverse Event|0|||
25290188|NCT00854113|50605399|FG006|Overall Study|Adverse Event|0|||
25290189|NCT00854113|50605400|FG007|Overall Study|Adverse Event|2|||
25290190|NCT00854113|50605401|FG008|Overall Study|Adverse Event|0|||
25290191|NCT00854113|50605402|FG009|Overall Study|Adverse Event|0|||
25290192|NCT00854113|50605403|FG010|Overall Study|Adverse Event|0|||
25290193|NCT00854113|50605393|FG000|Overall Study|Withdrawal by Subject|0|||
25290194|NCT00854113|50605394|FG001|Overall Study|Withdrawal by Subject|0|||
25290195|NCT00854113|50605395|FG002|Overall Study|Withdrawal by Subject|0|||
25290196|NCT00854113|50605396|FG003|Overall Study|Withdrawal by Subject|0|||
25290197|NCT00854113|50605397|FG004|Overall Study|Withdrawal by Subject|0|||
25290198|NCT00854113|50605398|FG005|Overall Study|Withdrawal by Subject|0|||
25290199|NCT00854113|50605399|FG006|Overall Study|Withdrawal by Subject|0|||
25290200|NCT00854113|50605400|FG007|Overall Study|Withdrawal by Subject|1|||
25290201|NCT00854113|50605401|FG008|Overall Study|Withdrawal by Subject|1|||
25290202|NCT00854113|50605402|FG009|Overall Study|Withdrawal by Subject|0|||
25290203|NCT00854113|50605403|FG010|Overall Study|Withdrawal by Subject|0|||
25290204|NCT00845845|50605429|FG000|Overall Study|Lost to Follow-up|0|||
25290205|NCT00845845|50605430|FG001|Overall Study|Lost to Follow-up|4|||
25290206|NCT01104701|50605440|FG000|Overall Study|Withdrawal by Subject|0|||
25290207|NCT01104701|50605441|FG001|Overall Study|Withdrawal by Subject|1|||
25290208|NCT01104701|50605442|FG002|Overall Study|Withdrawal by Subject|2|||
25290209|NCT01104701|50605443|FG003|Overall Study|Withdrawal by Subject|1|||
25290210|NCT01104701|50605440|FG000|Overall Study|Adverse Event|0|||
25290211|NCT01104701|50605441|FG001|Overall Study|Adverse Event|0|||
25290212|NCT01104701|50605442|FG002|Overall Study|Adverse Event|0|||
25290213|NCT01104701|50605443|FG003|Overall Study|Adverse Event|1|||
25290214|NCT01104701|50605440|FG000|Overall Study|Physician Decision|0|||
25290215|NCT01104701|50605441|FG001|Overall Study|Physician Decision|2|||
25290216|NCT01104701|50605442|FG002|Overall Study|Physician Decision|0|||
25290217|NCT01104701|50605443|FG003|Overall Study|Physician Decision|0|||
25290218|NCT00833755|50605457|FG000|Overall Study|Physician Decision|4|||
25290219|NCT00833755|50605458|FG001|Overall Study|Physician Decision|4|||
25290220|NCT00833755|50605459|FG002|Overall Study|Physician Decision|2|||
25290221|NCT00833755|50605460|FG003|Overall Study|Physician Decision|6|||
25290222|NCT00833755|50605457|FG000|Overall Study|Subject had scheduling issues|0|||
25290223|NCT00833755|50605458|FG001|Overall Study|Subject had scheduling issues|1|||
25290224|NCT00833755|50605459|FG002|Overall Study|Subject had scheduling issues|0|||
25290225|NCT00833755|50605460|FG003|Overall Study|Subject had scheduling issues|0|||
25290226|NCT01021332|50605471|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
25290227|NCT01021332|50605471|FG000|Overall Study|Adverse Event|43|||
25290228|NCT01021332|50605471|FG000|Overall Study|Lack of Efficacy|19|||
25290229|NCT01021332|50605471|FG000|Overall Study|Withdrawal of Consent|23|||
25290230|NCT01021332|50605471|FG000|Overall Study|Lost to Follow-up|4|||
25290231|NCT01021332|50605471|FG000|Overall Study|Protocol Violation|9|||
25290232|NCT01021332|50605471|FG000|Overall Study|Miscellaneous|3|||
25290233|NCT00923091|50605485|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
25290234|NCT00923091|50605486|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
25290235|NCT00923091|50605487|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
25290236|NCT00923091|50605488|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
25290237|NCT00923091|50605489|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
25290238|NCT00923091|50605490|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
25290239|NCT00923091|50605491|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
25290240|NCT00923091|50605492|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
25290241|NCT00923091|50605493|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
25290242|NCT00923091|50605494|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
25290243|NCT00923091|50605495|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
25290244|NCT00923091|50605496|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
24969728|NCT00117312|50059184|FG000|Overall Study|Protocol Violation|0|||
24969729|NCT00117312|50059185|FG001|Overall Study|Protocol Violation|1|||
25290245|NCT00923091|50605497|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
25290246|NCT00923091|50605485|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
25290247|NCT00923091|50605486|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
25290248|NCT00923091|50605487|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
25290249|NCT00923091|50605488|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
25290250|NCT00923091|50605489|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
25290251|NCT00923091|50605490|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
24969730|NCT00117312|50059186|FG002|Overall Study|Protocol Violation|3|||
25290252|NCT00923091|50605491|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
25290253|NCT00923091|50605492|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
25290254|NCT00923091|50605493|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
25290255|NCT00923091|50605494|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
25290256|NCT00923091|50605495|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
25290257|NCT00923091|50605496|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
25290258|NCT00923091|50605497|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
25290259|NCT00923091|50605485|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
25290260|NCT00923091|50605486|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
25290261|NCT00923091|50605487|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
25290262|NCT00923091|50605488|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
25290263|NCT00923091|50605489|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
25290264|NCT00923091|50605490|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
25290265|NCT00923091|50605491|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
25290266|NCT00923091|50605492|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
25290267|NCT00923091|50605493|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
25290268|NCT00923091|50605494|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
25290269|NCT00923091|50605495|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
25290270|NCT00923091|50605496|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
25290271|NCT00923091|50605497|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
25290272|NCT00923091|50605485|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
25290273|NCT00923091|50605486|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
25290274|NCT00923091|50605487|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
25290275|NCT00923091|50605488|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
25290276|NCT00923091|50605489|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
25290277|NCT00923091|50605490|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
25290278|NCT00923091|50605491|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
25290279|NCT00923091|50605492|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
25290280|NCT00923091|50605493|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
25290281|NCT00923091|50605494|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
25290282|NCT00923091|50605495|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
25290283|NCT00923091|50605496|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
25290284|NCT00923091|50605497|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
25290285|NCT00923091|50605485|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
25290286|NCT00923091|50605486|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
25290287|NCT00923091|50605487|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
25290288|NCT00923091|50605488|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
25290289|NCT00923091|50605489|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
25290290|NCT00923091|50605490|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
25290291|NCT00923091|50605491|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
25290292|NCT00923091|50605492|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
25290293|NCT00923091|50605493|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
25290294|NCT00923091|50605494|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
25290295|NCT00923091|50605495|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
25290296|NCT00923091|50605496|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
25290297|NCT00923091|50605497|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
25290298|NCT00923091|50605485|FG000|Period III (Single-Blind)|Adverse Event|5|||
25290299|NCT00923091|50605486|FG001|Period III (Single-Blind)|Adverse Event|0|||
25290300|NCT00923091|50605487|FG002|Period III (Single-Blind)|Adverse Event|0|||
25290301|NCT00923091|50605488|FG003|Period III (Single-Blind)|Adverse Event|0|||
25290302|NCT00923091|50605489|FG004|Period III (Single-Blind)|Adverse Event|0|||
25290303|NCT00923091|50605490|FG005|Period III (Single-Blind)|Adverse Event|0|||
25290304|NCT00923091|50605491|FG006|Period III (Single-Blind)|Adverse Event|0|||
25290305|NCT00923091|50605492|FG007|Period III (Single-Blind)|Adverse Event|0|||
25290306|NCT00923091|50605493|FG008|Period III (Single-Blind)|Adverse Event|0|||
25290307|NCT00923091|50605494|FG009|Period III (Single-Blind)|Adverse Event|0|||
25290308|NCT00923091|50605495|FG010|Period III (Single-Blind)|Adverse Event|0|||
25290309|NCT00923091|50605496|FG011|Period III (Single-Blind)|Adverse Event|0|||
25290310|NCT00923091|50605497|FG012|Period III (Single-Blind)|Adverse Event|0|||
25290311|NCT00923091|50605485|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
25290312|NCT00923091|50605486|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
25290313|NCT00923091|50605487|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
25290314|NCT00923091|50605488|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
25290315|NCT00923091|50605489|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
25290316|NCT00923091|50605490|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
24969731|NCT00117312|50059187|FG003|Overall Study|Protocol Violation|0|||
24969732|NCT00117312|50059184|FG000|Overall Study|PSA decrease <=50%|0|||
25290317|NCT00923091|50605491|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
25290318|NCT00923091|50605492|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
25290319|NCT00923091|50605493|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
25290320|NCT00923091|50605494|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
25290321|NCT00923091|50605495|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
25290322|NCT00923091|50605496|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
25290323|NCT00923091|50605497|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
25290324|NCT00923091|50605485|FG000|Period III (Single-Blind)|Protocol Violation|3|||
25290325|NCT00923091|50605486|FG001|Period III (Single-Blind)|Protocol Violation|0|||
25290326|NCT00923091|50605487|FG002|Period III (Single-Blind)|Protocol Violation|0|||
25290327|NCT00923091|50605488|FG003|Period III (Single-Blind)|Protocol Violation|0|||
25290328|NCT00923091|50605489|FG004|Period III (Single-Blind)|Protocol Violation|0|||
25070289|NCT02604212|50176210|FG000|Overall Study|Withdrawal by Subject|0|||
25070290|NCT02604212|50176211|FG001|Overall Study|Withdrawal by Subject|0|||
25070291|NCT02604212|50176212|FG002|Overall Study|Withdrawal by Subject|1|||
25070292|NCT02604212|50176213|FG003|Overall Study|Withdrawal by Subject|0|||
25070293|NCT02789111|50176230|FG000|Overall Study|Withdrawal by Subject|1|||
25070294|NCT02789111|50176231|FG001|Overall Study|Withdrawal by Subject|4|||
25070295|NCT01359644|50176249|FG000|Treatment Period|Lack of Efficacy|0|||
25070296|NCT01359644|50176250|FG001|Treatment Period|Lack of Efficacy|1|||
25070297|NCT01359644|50176251|FG002|Treatment Period|Lack of Efficacy|0|||
25070298|NCT01359644|50176252|FG003|Treatment Period|Lack of Efficacy|0|||
25070299|NCT01359644|50176253|FG004|Treatment Period|Lack of Efficacy|0|||
25070300|NCT01359644|50176254|FG005|Treatment Period|Lack of Efficacy|0|||
25070301|NCT01359644|50176255|FG006|Treatment Period|Lack of Efficacy|0|||
25070302|NCT01359644|50176256|FG007|Treatment Period|Lack of Efficacy|0|||
25070303|NCT01359644|50176257|FG008|Treatment Period|Lack of Efficacy|0|||
25070304|NCT01359644|50176258|FG009|Treatment Period|Lack of Efficacy|0|||
25070305|NCT01359644|50176249|FG000|Treatment Period|Adverse Event|0|||
25070306|NCT01359644|50176250|FG001|Treatment Period|Adverse Event|0|||
25070307|NCT01359644|50176251|FG002|Treatment Period|Adverse Event|1|||
25070308|NCT01359644|50176252|FG003|Treatment Period|Adverse Event|0|||
25070309|NCT01359644|50176253|FG004|Treatment Period|Adverse Event|0|||
25070310|NCT01359644|50176254|FG005|Treatment Period|Adverse Event|1|||
25070311|NCT01359644|50176255|FG006|Treatment Period|Adverse Event|0|||
25070312|NCT01359644|50176256|FG007|Treatment Period|Adverse Event|0|||
25070313|NCT01359644|50176257|FG008|Treatment Period|Adverse Event|0|||
25070314|NCT01359644|50176258|FG009|Treatment Period|Adverse Event|0|||
25070315|NCT01359644|50176249|FG000|Treatment Period|Lost to Follow-up|0|||
25070316|NCT01359644|50176250|FG001|Treatment Period|Lost to Follow-up|0|||
25070317|NCT01359644|50176251|FG002|Treatment Period|Lost to Follow-up|0|||
25070318|NCT01359644|50176252|FG003|Treatment Period|Lost to Follow-up|0|||
25070319|NCT01359644|50176253|FG004|Treatment Period|Lost to Follow-up|0|||
25070320|NCT01359644|50176254|FG005|Treatment Period|Lost to Follow-up|1|||
25070321|NCT01359644|50176255|FG006|Treatment Period|Lost to Follow-up|0|||
25070322|NCT01359644|50176256|FG007|Treatment Period|Lost to Follow-up|0|||
25070323|NCT01359644|50176257|FG008|Treatment Period|Lost to Follow-up|0|||
25070324|NCT01359644|50176258|FG009|Treatment Period|Lost to Follow-up|0|||
25070325|NCT01359644|50176249|FG000|Follow-up Period|Withdrawal by Subject|0|||
25070326|NCT01359644|50176250|FG001|Follow-up Period|Withdrawal by Subject|0|||
25070327|NCT01359644|50176251|FG002|Follow-up Period|Withdrawal by Subject|0|||
25070328|NCT01359644|50176252|FG003|Follow-up Period|Withdrawal by Subject|0|||
25070329|NCT01359644|50176253|FG004|Follow-up Period|Withdrawal by Subject|0|||
25070330|NCT01359644|50176254|FG005|Follow-up Period|Withdrawal by Subject|1|||
25070331|NCT01359644|50176255|FG006|Follow-up Period|Withdrawal by Subject|0|||
25070332|NCT01359644|50176256|FG007|Follow-up Period|Withdrawal by Subject|0|||
25070333|NCT01359644|50176257|FG008|Follow-up Period|Withdrawal by Subject|0|||
25070334|NCT01359644|50176258|FG009|Follow-up Period|Withdrawal by Subject|0|||
25070335|NCT01359644|50176249|FG000|Follow-up Period|Lost to Follow-up|0|||
25070336|NCT01359644|50176250|FG001|Follow-up Period|Lost to Follow-up|0|||
25070337|NCT01359644|50176251|FG002|Follow-up Period|Lost to Follow-up|0|||
25070338|NCT01359644|50176252|FG003|Follow-up Period|Lost to Follow-up|0|||
25070339|NCT01359644|50176253|FG004|Follow-up Period|Lost to Follow-up|0|||
25070340|NCT01359644|50176254|FG005|Follow-up Period|Lost to Follow-up|0|||
25070341|NCT01359644|50176255|FG006|Follow-up Period|Lost to Follow-up|1|||
25070342|NCT01359644|50176256|FG007|Follow-up Period|Lost to Follow-up|2|||
25290329|NCT00923091|50605490|FG005|Period III (Single-Blind)|Protocol Violation|0|||
25290330|NCT00923091|50605491|FG006|Period III (Single-Blind)|Protocol Violation|0|||
25070343|NCT01359644|50176257|FG008|Follow-up Period|Lost to Follow-up|0|||
25070344|NCT01359644|50176258|FG009|Follow-up Period|Lost to Follow-up|0|||
25070345|NCT02603120|50176293|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
25070346|NCT02603120|50176294|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
25070347|NCT02603120|50176293|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
25070348|NCT02603120|50176294|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
25290331|NCT00923091|50605492|FG007|Period III (Single-Blind)|Protocol Violation|0|||
25290332|NCT00923091|50605493|FG008|Period III (Single-Blind)|Protocol Violation|0|||
25290333|NCT00923091|50605494|FG009|Period III (Single-Blind)|Protocol Violation|0|||
25290334|NCT00923091|50605495|FG010|Period III (Single-Blind)|Protocol Violation|0|||
25290335|NCT00923091|50605496|FG011|Period III (Single-Blind)|Protocol Violation|0|||
25290336|NCT00923091|50605497|FG012|Period III (Single-Blind)|Protocol Violation|0|||
25290337|NCT00923091|50605485|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
25290338|NCT00923091|50605486|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
25290339|NCT00923091|50605487|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
25290340|NCT00923091|50605488|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
25290341|NCT00923091|50605489|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
25290342|NCT00923091|50605490|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
25290343|NCT00923091|50605491|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
25290344|NCT00923091|50605492|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
25290345|NCT00923091|50605493|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
25290346|NCT00923091|50605494|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
25290347|NCT00923091|50605495|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
25290348|NCT00923091|50605496|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
25290349|NCT00923091|50605497|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
25290350|NCT00923091|50605485|FG000|Period IV (Double-Blind)|Adverse Event|2|||
25290351|NCT00923091|50605486|FG001|Period IV (Double-Blind)|Adverse Event|0|||
25290352|NCT00923091|50605487|FG002|Period IV (Double-Blind)|Adverse Event|0|||
25290353|NCT00923091|50605488|FG003|Period IV (Double-Blind)|Adverse Event|0|||
25290354|NCT00923091|50605489|FG004|Period IV (Double-Blind)|Adverse Event|0|||
25290355|NCT00923091|50605490|FG005|Period IV (Double-Blind)|Adverse Event|0|||
25290356|NCT00923091|50605491|FG006|Period IV (Double-Blind)|Adverse Event|0|||
25290357|NCT00923091|50605492|FG007|Period IV (Double-Blind)|Adverse Event|0|||
25290358|NCT00923091|50605493|FG008|Period IV (Double-Blind)|Adverse Event|0|||
25290359|NCT00923091|50605494|FG009|Period IV (Double-Blind)|Adverse Event|0|||
25290360|NCT00923091|50605495|FG010|Period IV (Double-Blind)|Adverse Event|0|||
25290361|NCT00923091|50605496|FG011|Period IV (Double-Blind)|Adverse Event|0|||
25290362|NCT00923091|50605497|FG012|Period IV (Double-Blind)|Adverse Event|0|||
25290363|NCT00923091|50605485|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
25290364|NCT00923091|50605486|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
25290365|NCT00923091|50605487|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
25290366|NCT00923091|50605488|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
25290367|NCT00923091|50605489|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
25290368|NCT00923091|50605490|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
25290369|NCT00923091|50605491|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
25290370|NCT00923091|50605492|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
25290371|NCT00923091|50605493|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
25290372|NCT00923091|50605494|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
25290373|NCT00923091|50605495|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
25290374|NCT00923091|50605496|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
25290375|NCT00923091|50605497|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
25290376|NCT00923091|50605485|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
25290377|NCT00923091|50605486|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
25290378|NCT00923091|50605487|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
25290379|NCT00923091|50605488|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
25290380|NCT00923091|50605489|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
25290381|NCT00923091|50605490|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
25290382|NCT00923091|50605491|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
25290383|NCT00923091|50605492|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
25290384|NCT00923091|50605493|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
25290385|NCT00923091|50605494|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
25290386|NCT00923091|50605495|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
25290387|NCT00923091|50605496|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
25290388|NCT00923091|50605497|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
25290389|NCT00923091|50605485|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
25290390|NCT00923091|50605486|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
25290391|NCT00923091|50605487|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
25290392|NCT00923091|50605488|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
25290393|NCT00923091|50605489|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
25290394|NCT00923091|50605490|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
25290395|NCT00923091|50605491|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
25290396|NCT00923091|50605492|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
25290397|NCT00923091|50605493|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
25290398|NCT00923091|50605494|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
25290399|NCT00923091|50605495|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
25290400|NCT00923091|50605496|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
25290401|NCT00923091|50605497|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
25290402|NCT00923091|50605485|FG000|Period V (Double -Blind)|Protocol Violation|0|||
25290403|NCT00923091|50605486|FG001|Period V (Double -Blind)|Protocol Violation|0|||
25290404|NCT00923091|50605487|FG002|Period V (Double -Blind)|Protocol Violation|0|||
25290405|NCT00923091|50605488|FG003|Period V (Double -Blind)|Protocol Violation|0|||
25290406|NCT00923091|50605489|FG004|Period V (Double -Blind)|Protocol Violation|0|||
25290407|NCT00923091|50605490|FG005|Period V (Double -Blind)|Protocol Violation|0|||
25290408|NCT00923091|50605491|FG006|Period V (Double -Blind)|Protocol Violation|0|||
25290409|NCT00923091|50605492|FG007|Period V (Double -Blind)|Protocol Violation|0|||
25290410|NCT00923091|50605493|FG008|Period V (Double -Blind)|Protocol Violation|0|||
25290411|NCT00923091|50605494|FG009|Period V (Double -Blind)|Protocol Violation|0|||
25290412|NCT00923091|50605495|FG010|Period V (Double -Blind)|Protocol Violation|0|||
25290413|NCT00923091|50605496|FG011|Period V (Double -Blind)|Protocol Violation|0|||
25290414|NCT00923091|50605497|FG012|Period V (Double -Blind)|Protocol Violation|1|||
25290415|NCT00923091|50605485|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
25290416|NCT00923091|50605486|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
25290417|NCT00923091|50605487|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
25290418|NCT00923091|50605488|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
25290419|NCT00923091|50605489|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
25290420|NCT00923091|50605490|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
25290421|NCT00923091|50605491|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
25290422|NCT00923091|50605492|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
25290423|NCT00923091|50605493|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
25290424|NCT00923091|50605494|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
25290425|NCT00923091|50605495|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
25290426|NCT00923091|50605496|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
25290427|NCT00923091|50605497|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
25290428|NCT00923091|50605485|FG000|Period VI (Open-Label)|Adverse Event|17|||
25290429|NCT00923091|50605486|FG001|Period VI (Open-Label)|Adverse Event|0|||
25290430|NCT00923091|50605487|FG002|Period VI (Open-Label)|Adverse Event|4|||
25290431|NCT00923091|50605488|FG003|Period VI (Open-Label)|Adverse Event|1|||
25290432|NCT00923091|50605489|FG004|Period VI (Open-Label)|Adverse Event|1|||
25290433|NCT00923091|50605490|FG005|Period VI (Open-Label)|Adverse Event|0|||
25290434|NCT00923091|50605491|FG006|Period VI (Open-Label)|Adverse Event|0|||
25290435|NCT00923091|50605492|FG007|Period VI (Open-Label)|Adverse Event|0|||
25290436|NCT00923091|50605493|FG008|Period VI (Open-Label)|Adverse Event|0|||
25290437|NCT00923091|50605494|FG009|Period VI (Open-Label)|Adverse Event|0|||
25290438|NCT00923091|50605495|FG010|Period VI (Open-Label)|Adverse Event|0|||
25290439|NCT00923091|50605496|FG011|Period VI (Open-Label)|Adverse Event|0|||
25290440|NCT00923091|50605497|FG012|Period VI (Open-Label)|Adverse Event|0|||
25290441|NCT00923091|50605485|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
25290442|NCT00923091|50605486|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
25290443|NCT00923091|50605487|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
25290444|NCT00923091|50605488|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
25290445|NCT00923091|50605489|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
25290446|NCT00923091|50605490|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
25290447|NCT00923091|50605491|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
25290448|NCT00923091|50605492|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
25290449|NCT00923091|50605493|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
25290450|NCT00923091|50605494|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
25290451|NCT00923091|50605495|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
25290452|NCT00923091|50605496|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
25290453|NCT00923091|50605497|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
25290454|NCT00923091|50605485|FG000|Period VI (Open-Label)|Protocol Violation|6|||
25290455|NCT00923091|50605486|FG001|Period VI (Open-Label)|Protocol Violation|1|||
25290456|NCT00923091|50605487|FG002|Period VI (Open-Label)|Protocol Violation|3|||
25290457|NCT00923091|50605488|FG003|Period VI (Open-Label)|Protocol Violation|1|||
25290458|NCT00923091|50605489|FG004|Period VI (Open-Label)|Protocol Violation|4|||
25290459|NCT00923091|50605490|FG005|Period VI (Open-Label)|Protocol Violation|0|||
25290460|NCT00923091|50605491|FG006|Period VI (Open-Label)|Protocol Violation|0|||
25290461|NCT00923091|50605492|FG007|Period VI (Open-Label)|Protocol Violation|0|||
25290462|NCT00923091|50605493|FG008|Period VI (Open-Label)|Protocol Violation|0|||
25290463|NCT00923091|50605494|FG009|Period VI (Open-Label)|Protocol Violation|0|||
25290464|NCT00923091|50605495|FG010|Period VI (Open-Label)|Protocol Violation|0|||
25290465|NCT00923091|50605496|FG011|Period VI (Open-Label)|Protocol Violation|0|||
25290466|NCT00923091|50605497|FG012|Period VI (Open-Label)|Protocol Violation|0|||
25290467|NCT00923091|50605485|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
25191619|NCT02597478|50352689|FG000|Overall Study|Insufficient exertional dyspnea|0|||
25290468|NCT00923091|50605486|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
25290469|NCT00923091|50605487|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
25290470|NCT00923091|50605488|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
25290471|NCT00923091|50605489|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
25290472|NCT00923091|50605490|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
25290473|NCT00923091|50605491|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
25290474|NCT00923091|50605492|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
25290475|NCT00923091|50605493|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
25290476|NCT00923091|50605494|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
25290477|NCT00923091|50605495|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
25290478|NCT00923091|50605496|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
25290479|NCT00923091|50605497|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
25290480|NCT00923091|50605485|FG000|Period VI (Open-Label)|Other Reason|0|||
25290481|NCT00923091|50605486|FG001|Period VI (Open-Label)|Other Reason|0|||
25290482|NCT00923091|50605487|FG002|Period VI (Open-Label)|Other Reason|0|||
25290483|NCT00923091|50605488|FG003|Period VI (Open-Label)|Other Reason|1|||
25290484|NCT00923091|50605489|FG004|Period VI (Open-Label)|Other Reason|1|||
25290485|NCT00923091|50605490|FG005|Period VI (Open-Label)|Other Reason|0|||
25290486|NCT00923091|50605491|FG006|Period VI (Open-Label)|Other Reason|0|||
25290487|NCT00923091|50605492|FG007|Period VI (Open-Label)|Other Reason|0|||
25290488|NCT00923091|50605493|FG008|Period VI (Open-Label)|Other Reason|0|||
25290489|NCT00923091|50605494|FG009|Period VI (Open-Label)|Other Reason|0|||
25290490|NCT00923091|50605495|FG010|Period VI (Open-Label)|Other Reason|0|||
25290491|NCT00923091|50605496|FG011|Period VI (Open-Label)|Other Reason|0|||
25290492|NCT00923091|50605497|FG012|Period VI (Open-Label)|Other Reason|0|||
25290493|NCT00853957|50605524|FG000|Overall Study|Adverse Event|9|||
25290494|NCT00853957|50605525|FG001|Overall Study|Adverse Event|3|||
25290495|NCT00853957|50605524|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25290496|NCT00853957|50605525|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
25290497|NCT00853957|50605524|FG000|Overall Study|Subject withdrew consent|4|||
25290498|NCT00853957|50605525|FG001|Overall Study|Subject withdrew consent|5|||
25290499|NCT00853957|50605524|FG000|Overall Study|Lost to Follow-up|1|||
25290500|NCT00853957|50605525|FG001|Overall Study|Lost to Follow-up|6|||
25290501|NCT00853957|50605524|FG000|Overall Study|Protocol deviation|0|||
25290502|NCT00853957|50605525|FG001|Overall Study|Protocol deviation|3|||
25290503|NCT01021020|50605531|FG000|Period I|Protocol Violation|1|||
25290504|NCT01021020|50605531|FG000|Period I|Withdrawal by Subject|1|||
25290505|NCT01021020|50605531|FG000|14 Day Washout Period A|Physician Decision|1|||
25290506|NCT00833053|50605545|FG000|Overall Study|Adverse Event|4|||
25290507|NCT00833053|50605546|FG001|Overall Study|Adverse Event|0|||
25290508|NCT00833053|50605545|FG000|Overall Study|Treatment Failure|3|||
25290509|NCT00833053|50605546|FG001|Overall Study|Treatment Failure|1|||
25290510|NCT00833053|50605545|FG000|Overall Study|Withdrawal by Subject|0|||
25290511|NCT00833053|50605546|FG001|Overall Study|Withdrawal by Subject|1|||
25290512|NCT00833053|50605545|FG000|Overall Study|Protocol Violation|2|||
25290513|NCT00833053|50605546|FG001|Overall Study|Protocol Violation|1|||
25290514|NCT00832975|50605552|FG000|Overall Study|Lost to Follow-up|7|||
25290515|NCT00832975|50605552|FG000|Overall Study|Protocol Violation|6|||
25290516|NCT00832975|50605552|FG000|Overall Study|Death|5|||
25290517|NCT00832975|50605552|FG000|Overall Study|Physician Decision|4|||
25290518|NCT00832975|50605552|FG000|Overall Study|Withdrawal by Subject|3|||
25290519|NCT00832975|50605552|FG000|Overall Study|Other reasons|14|||
25290520|NCT01020786|50605556|FG000|Induction Period|Entry Criteria Not Met|2|||
25290521|NCT01020786|50605556|FG000|Induction Period|Adverse Event|10|||
25290522|NCT01020786|50605556|FG000|Induction Period|Progressive Disease|31|||
25290523|NCT01020786|50605556|FG000|Induction Period|Investigator Decision|3|||
25290524|NCT01020786|50605556|FG000|Induction Period|Withdrawal by Subject|3|||
25290525|NCT01020786|50605556|FG000|Maintenance Period|Adverse Event|8|||
25290526|NCT01020786|50605556|FG000|Maintenance Period|Progressive Disease|43|||
25290527|NCT01020786|50605556|FG000|Maintenance Period|Withdrawal by Subject|8|||
25290528|NCT01020786|50605556|FG000|Maintenance Period|Sponsor Decision|1|||
25290529|NCT00918645|50605561|FG000|Overall Study|Withdrawal by Subject|1|||
25290530|NCT00922935|50605568|FG000|Overall Study|Protocol Violation|0|||
25290531|NCT00922935|50605569|FG001|Overall Study|Protocol Violation|3|||
25290532|NCT00922935|50605570|FG002|Overall Study|Protocol Violation|0|||
25290533|NCT00922935|50605568|FG000|Overall Study|Physician Decision|1|||
25290534|NCT00922935|50605569|FG001|Overall Study|Physician Decision|1|||
25290535|NCT00922935|50605570|FG002|Overall Study|Physician Decision|0|||
25290536|NCT00922935|50605568|FG000|Overall Study|Lost to Follow-up|0|||
25290537|NCT00922935|50605569|FG001|Overall Study|Lost to Follow-up|1|||
25290538|NCT00922935|50605570|FG002|Overall Study|Lost to Follow-up|0|||
25290539|NCT01020474|50605580|FG000|Overall Study|Adverse Event|4|||
25290540|NCT01020474|50605581|FG001|Overall Study|Adverse Event|4|||
25290541|NCT01020474|50605580|FG000|Overall Study|Protocol Violation|0|||
25290542|NCT01020474|50605581|FG001|Overall Study|Protocol Violation|2|||
25290543|NCT01020474|50605580|FG000|Overall Study|Withdrawal by Subject|5|||
25290544|NCT01020474|50605581|FG001|Overall Study|Withdrawal by Subject|7|||
25290545|NCT01020474|50605580|FG000|Overall Study|Other Reasons|1|||
25290546|NCT01020474|50605581|FG001|Overall Study|Other Reasons|1|||
25290547|NCT01020474|50605580|FG000|Overall Study|Insufficient Clinical Response|0|||
25290548|NCT01020474|50605581|FG001|Overall Study|Insufficient Clinical Response|3|||
25290549|NCT00922779|50605587|FG000|Overall Study|Adverse Event|67|||
25290550|NCT00922779|50605587|FG000|Overall Study|Pregnancy|7|||
25290551|NCT00922779|50605587|FG000|Overall Study|Withdrawal by Subject|308|||
25290552|NCT00922779|50605587|FG000|Overall Study|Lost to Follow-up|44|||
25290553|NCT00922779|50605587|FG000|Overall Study|Other|27|||
25290554|NCT00922779|50605587|FG000|Overall Study|Missing|1874|||
25290555|NCT00924651|50605593|FG000|Overall Study|Chemo started too soon|2|||
25290556|NCT00924651|50605594|FG001|Overall Study|Chemo started too soon|3|||
25290557|NCT00924651|50605593|FG000|Overall Study|No Reason|3|||
25290558|NCT00924651|50605594|FG001|Overall Study|No Reason|7|||
25290559|NCT00924651|50605593|FG000|Overall Study|Overwhelmed|6|||
25290560|NCT00924651|50605594|FG001|Overall Study|Overwhelmed|6|||
25290561|NCT00924651|50605593|FG000|Overall Study|Noncompliant|1|||
25290562|NCT00924651|50605594|FG001|Overall Study|Noncompliant|4|||
25290563|NCT00924651|50605593|FG000|Overall Study|Medical|1|||
25290564|NCT00924651|50605594|FG001|Overall Study|Medical|3|||
25290565|NCT00924651|50605593|FG000|Overall Study|Changed Mind|10|||
25290566|NCT00924651|50605594|FG001|Overall Study|Changed Mind|1|||
25290567|NCT00924651|50605593|FG000|Overall Study|Incomplete Form|2|||
25290568|NCT00924651|50605594|FG001|Overall Study|Incomplete Form|1|||
25290569|NCT00922623|50605600|FG000|Overall Study|Other|4|||
25290570|NCT00922623|50605600|FG000|Overall Study|Lost to Follow-up|1|||
25290571|NCT01025232|50605608|FG000|Overall Study|Study drug no longer available|3|||
25290572|NCT01025232|50605609|FG001|Overall Study|Study drug no longer available|6|||
25290573|NCT01025154|50605615|FG000|Overall Study|Lost to Follow-up|1|||
25290574|NCT01025154|50605615|FG000|Overall Study|Withdrawal by Subject|1|||
25290575|NCT00832819|50605622|FG000|Overall Study|Adverse Event|0|||
25290576|NCT00832819|50605623|FG001|Overall Study|Adverse Event|1|||
25290577|NCT00832819|50605624|FG002|Overall Study|Adverse Event|0|||
25290578|NCT00832819|50605622|FG000|Overall Study|Protocol Violation|0|||
25290579|NCT00832819|50605623|FG001|Overall Study|Protocol Violation|0|||
25290580|NCT00832819|50605624|FG002|Overall Study|Protocol Violation|1|||
25290581|NCT00853723|50605633|FG000|Overall Study|Adverse Event|3|||
25290582|NCT00853723|50605634|FG001|Overall Study|Adverse Event|4|||
25290583|NCT00853723|50605635|FG002|Overall Study|Adverse Event|1|||
25290584|NCT00853723|50605633|FG000|Overall Study|Withdrawal by Subject|2|||
25290585|NCT00853723|50605634|FG001|Overall Study|Withdrawal by Subject|1|||
25290586|NCT00853723|50605635|FG002|Overall Study|Withdrawal by Subject|0|||
25290587|NCT00853723|50605633|FG000|Overall Study|Protocol Violation|1|||
25290588|NCT00853723|50605634|FG001|Overall Study|Protocol Violation|2|||
25290589|NCT00853723|50605635|FG002|Overall Study|Protocol Violation|1|||
25290590|NCT01104545|50605649|FG000|Overall Study|Adverse Event|0|||
25290591|NCT01104545|50605650|FG001|Overall Study|Adverse Event|1|||
25290592|NCT01104545|50605651|FG002|Overall Study|Adverse Event|2|||
25290593|NCT00918255|50605699|FG000|Overall Study|Adverse Event|1|||
25290594|NCT00918255|50605700|FG001|Overall Study|Adverse Event|0|||
25290595|NCT00918255|50605701|FG002|Overall Study|Adverse Event|0|||
25290596|NCT00918255|50605699|FG000|Overall Study|Withdrawal by Subject|1|||
25290597|NCT00918255|50605700|FG001|Overall Study|Withdrawal by Subject|0|||
25290598|NCT00918255|50605701|FG002|Overall Study|Withdrawal by Subject|2|||
25290599|NCT00918255|50605699|FG000|Overall Study|Lack of Efficacy|1|||
25290600|NCT00918255|50605700|FG001|Overall Study|Lack of Efficacy|0|||
25290601|NCT00918255|50605701|FG002|Overall Study|Lack of Efficacy|0|||
25290602|NCT00918255|50605699|FG000|Overall Study|Lost to Follow-up|1|||
25290603|NCT00918255|50605700|FG001|Overall Study|Lost to Follow-up|0|||
25290604|NCT00918255|50605701|FG002|Overall Study|Lost to Follow-up|2|||
25290605|NCT00918255|50605699|FG000|Overall Study|Exceeded allowed number of interventions|0|||
25290606|NCT00918255|50605700|FG001|Overall Study|Exceeded allowed number of interventions|0|||
25290607|NCT00918255|50605701|FG002|Overall Study|Exceeded allowed number of interventions|1|||
25290608|NCT00918255|50605699|FG000|Overall Study|Non-compliance|1|||
25290609|NCT00918255|50605700|FG001|Overall Study|Non-compliance|0|||
25290610|NCT00918255|50605701|FG002|Overall Study|Non-compliance|0|||
25290611|NCT00918255|50605699|FG000|Overall Study|Investigator discretion|1|||
25290612|NCT00918255|50605700|FG001|Overall Study|Investigator discretion|0|||
25290613|NCT00918255|50605701|FG002|Overall Study|Investigator discretion|0|||
25290614|NCT01096589|50605713|FG000|Overall Study|Adverse Event|2|||
25070349|NCT02603120|50176293|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
25290615|NCT01096589|50605714|FG001|Overall Study|Adverse Event|1|||
25290616|NCT01096589|50605715|FG002|Overall Study|Adverse Event|2|||
25290617|NCT01096589|50605716|FG003|Overall Study|Adverse Event|1|||
25290618|NCT01096589|50605713|FG000|Overall Study|Withdrawal by Subject|2|||
25290619|NCT01096589|50605714|FG001|Overall Study|Withdrawal by Subject|1|||
25290620|NCT01096589|50605715|FG002|Overall Study|Withdrawal by Subject|1|||
25290621|NCT01096589|50605716|FG003|Overall Study|Withdrawal by Subject|1|||
25290622|NCT01096589|50605713|FG000|Overall Study|Compliance with protocol|0|||
25290623|NCT01096589|50605714|FG001|Overall Study|Compliance with protocol|0|||
25290624|NCT01096589|50605715|FG002|Overall Study|Compliance with protocol|1|||
25290625|NCT01096589|50605716|FG003|Overall Study|Compliance with protocol|0|||
25290626|NCT01096589|50605713|FG000|Overall Study|found treatment exhausting|0|||
25290627|NCT01096589|50605714|FG001|Overall Study|found treatment exhausting|0|||
25290628|NCT01096589|50605715|FG002|Overall Study|found treatment exhausting|0|||
25290629|NCT01096589|50605716|FG003|Overall Study|found treatment exhausting|1|||
25290630|NCT00845065|50605732|FG000|Overall Study|Adverse Event|3|||
25290631|NCT00845065|50605733|FG001|Overall Study|Adverse Event|23|||
25290632|NCT00845065|50605732|FG000|Overall Study|Lack of Efficacy|43|||
25290633|NCT00845065|50605733|FG001|Overall Study|Lack of Efficacy|21|||
25290634|NCT00845065|50605732|FG000|Overall Study|Non-Medical Reasons|1|||
25290635|NCT00845065|50605733|FG001|Overall Study|Non-Medical Reasons|11|||
25290636|NCT00832585|50605739|FG000|Overall Study|Withdrawal by Subject|1|||
25290637|NCT00832585|50605739|FG000|Overall Study|Lost to Follow-up|1|||
25290638|NCT00918567|50605745|FG000|Overall Study|Lack of Efficacy|3|||
25290639|NCT00918567|50605746|FG001|Overall Study|Lack of Efficacy|1|||
25290640|NCT00918567|50605745|FG000|Overall Study|Withdrawal by Subject|1|||
25290641|NCT00918567|50605746|FG001|Overall Study|Withdrawal by Subject|1|||
25290642|NCT00918567|50605745|FG000|Overall Study|Adverse Event|1|||
25290643|NCT00918567|50605746|FG001|Overall Study|Adverse Event|0|||
25290644|NCT01024920|50605754|FG000|Overall Study|Progressive disease|47|||
25290645|NCT01024920|50605755|FG001|Overall Study|Progressive disease|25|||
25290646|NCT01024920|50605754|FG000|Overall Study|Adverse Event|8|||
25290647|NCT01024920|50605755|FG001|Overall Study|Adverse Event|4|||
25290648|NCT01024920|50605754|FG000|Overall Study|Lost to Follow-up|0|||
25290649|NCT01024920|50605755|FG001|Overall Study|Lost to Follow-up|1|||
25290650|NCT01024920|50605754|FG000|Overall Study|Patient refusal to continue|4|||
25290651|NCT01024920|50605755|FG001|Overall Study|Patient refusal to continue|0|||
25290652|NCT01024920|50605754|FG000|Overall Study|Other than listed|5|||
25290653|NCT01024920|50605755|FG001|Overall Study|Other than listed|1|||
25290654|NCT01024920|50605754|FG000|Overall Study|Not treated|3|||
25290655|NCT01024920|50605755|FG001|Overall Study|Not treated|0|||
25290656|NCT01024920|50605754|FG000|Overall Study|Protocol Violation|0|||
25290657|NCT01024920|50605755|FG001|Overall Study|Protocol Violation|1|||
25290658|NCT00832117|50605763|FG000|Overall Study|Death|1|||
25290659|NCT00832117|50605763|FG000|Overall Study|Disease Progression|11|||
25290660|NCT01104311|50605772|FG000|Overall Study|Withdrawal by Subject|6|||
25290661|NCT01104311|50605773|FG001|Overall Study|Withdrawal by Subject|6|||
25290662|NCT01104311|50605772|FG000|Overall Study|Protocol Violation|0|||
25290663|NCT01104311|50605773|FG001|Overall Study|Protocol Violation|1|||
25290664|NCT01104311|50605772|FG000|Overall Study|Physician Decision|2|||
25290665|NCT01104311|50605773|FG001|Overall Study|Physician Decision|2|||
25290666|NCT01104311|50605772|FG000|Overall Study|low compliance|1|||
25290667|NCT01104311|50605773|FG001|Overall Study|low compliance|1|||
25290668|NCT01104311|50605772|FG000|Overall Study|Adverse Event|1|||
25290669|NCT01104311|50605773|FG001|Overall Study|Adverse Event|2|||
25070350|NCT02603120|50176294|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
25070351|NCT02603120|50176293|FG000|Double-Blind Treatment Phase|Death|2|||
25290670|NCT00831493|50605783|FG000|Overall Study|Intractable nausea and vomiting|1|||
25290671|NCT00853567|50605790|FG000|Overall Study|Study prematurely terminated|71|||
25290672|NCT00853489|50605800|FG000|Overall Study|Lost to Follow-up|5|||
25290673|NCT00853489|50605801|FG001|Overall Study|Lost to Follow-up|2|||
25290674|NCT01019694|50605810|FG000|Overall Study|Adverse Event|12|||
25191620|NCT02597478|50352690|FG001|Overall Study|Insufficient exertional dyspnea|1|||
25191621|NCT01471028|50352785|FG000|VTI-208|Adverse Event|39|||
25191622|NCT01471028|50352786|FG001|VTI-208|Adverse Event|41|||
25191623|NCT01471028|50352785|FG000|VTI-208|Withdrawal by Subject|0|||
25191624|NCT01471028|50352786|FG001|VTI-208|Withdrawal by Subject|2|||
25191625|NCT01471028|50352785|FG000|VTI-208|Lost to Follow-up|1|||
25191626|NCT01471028|50352786|FG001|VTI-208|Lost to Follow-up|1|||
25191627|NCT01471028|50352785|FG000|VTI-208E|Death|7|||
25191628|NCT01471028|50352786|FG001|VTI-208E|Death|10|||
25191629|NCT01471028|50352785|FG000|VTI-208E|Withdrawal by Subject|1|||
25191630|NCT01471028|50352786|FG001|VTI-208E|Withdrawal by Subject|0|||
25191631|NCT01471028|50352785|FG000|VTI-208E|Lost to Follow-up|0|||
25191632|NCT01471028|50352786|FG001|VTI-208E|Lost to Follow-up|2|||
25191633|NCT01491854|50352800|FG000|Overall Study|mainly due to premature termination|93|||
25191634|NCT01491854|50352800|FG000|Overall Study|Death|1|||
25191635|NCT01491854|50352800|FG000|Overall Study|Withdrawal by Subject|3|||
25191636|NCT01491854|50352800|FG000|Overall Study|Lost to Follow-up|33|||
25191637|NCT01470248|50352808|FG000|Overall Study|Withdrawal by Subject|1|||
25191638|NCT01490918|50352828|FG000|Overall Study|Lost to Follow-up|2|||
25290675|NCT01019694|50605811|FG001|Overall Study|Adverse Event|16|||
25290676|NCT01019694|50605812|FG002|Overall Study|Adverse Event|19|||
25290677|NCT01019694|50605810|FG000|Overall Study|Protocol Violation|2|||
25290678|NCT01019694|50605811|FG001|Overall Study|Protocol Violation|6|||
25290679|NCT01019694|50605812|FG002|Overall Study|Protocol Violation|4|||
25290680|NCT01019694|50605810|FG000|Overall Study|Lost to Follow-up|5|||
25290681|NCT01019694|50605811|FG001|Overall Study|Lost to Follow-up|3|||
25290682|NCT01019694|50605812|FG002|Overall Study|Lost to Follow-up|3|||
25290683|NCT01019694|50605810|FG000|Overall Study|Withdrawal by Subject|4|||
25290684|NCT01019694|50605811|FG001|Overall Study|Withdrawal by Subject|6|||
25290685|NCT01019694|50605812|FG002|Overall Study|Withdrawal by Subject|12|||
25290686|NCT01019694|50605810|FG000|Overall Study|Not treated|0|||
25290687|NCT01019694|50605811|FG001|Overall Study|Not treated|2|||
25290688|NCT01019694|50605812|FG002|Overall Study|Not treated|3|||
25290689|NCT01019694|50605810|FG000|Overall Study|Other reason (not specified)|1|||
25290690|NCT01019694|50605811|FG001|Overall Study|Other reason (not specified)|5|||
25290691|NCT01019694|50605812|FG002|Overall Study|Other reason (not specified)|6|||
25290692|NCT00831415|50605820|FG000|Overall Study|Adverse Event|14|||
25290693|NCT00831415|50605820|FG000|Overall Study|Failed to return|3|||
25290694|NCT00831415|50605820|FG000|Overall Study|Physician Decision|6|||
25290695|NCT00831415|50605820|FG000|Overall Study|Lost to Follow-up|9|||
25290696|NCT00831415|50605820|FG000|Overall Study|Protocol Violation|3|||
25290697|NCT00831415|50605820|FG000|Overall Study|Withdrawal by Subject|35|||
25290698|NCT00831415|50605820|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
25290699|NCT00831415|50605820|FG000|Overall Study|Death|1|||
25290700|NCT01095653|50605827|FG000|Overall Study|Lack of Efficacy|3|||
25290701|NCT01095653|50605828|FG001|Overall Study|Lack of Efficacy|0|||
25290702|NCT01095653|50605829|FG002|Overall Study|Lack of Efficacy|0|||
25290703|NCT01095653|50605827|FG000|Overall Study|Adverse Event|1|||
25290704|NCT01095653|50605828|FG001|Overall Study|Adverse Event|4|||
25290705|NCT01095653|50605829|FG002|Overall Study|Adverse Event|4|||
25290706|NCT01095653|50605827|FG000|Overall Study|Lost to Follow-up|1|||
25290707|NCT01095653|50605828|FG001|Overall Study|Lost to Follow-up|0|||
25290708|NCT01095653|50605829|FG002|Overall Study|Lost to Follow-up|4|||
25290709|NCT01095653|50605827|FG000|Overall Study|Withdrawal by Subject|4|||
25290710|NCT01095653|50605828|FG001|Overall Study|Withdrawal by Subject|5|||
25290711|NCT01095653|50605829|FG002|Overall Study|Withdrawal by Subject|3|||
25290712|NCT01095653|50605827|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
25290713|NCT01095653|50605828|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
25290714|NCT01095653|50605829|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
25290715|NCT00920907|50605839|FG000|Induction Period|Adverse Event|0|||
25290716|NCT00920907|50605840|FG001|Induction Period|Adverse Event|2|||
25290717|NCT00920907|50605839|FG000|Induction Period|Death|1|||
25290718|NCT00920907|50605840|FG001|Induction Period|Death|1|||
25290719|NCT00920907|50605839|FG000|Induction Period|Disease Progression|12|||
25290720|NCT00920907|50605840|FG001|Induction Period|Disease Progression|11|||
25290721|NCT00920907|50605839|FG000|Induction Period|Study Drug Toxicity|8|||
25290722|NCT00920907|50605840|FG001|Induction Period|Study Drug Toxicity|6|||
25290723|NCT00920907|50605839|FG000|Induction Period|No longer meets study criteria|0|||
25290724|NCT00920907|50605840|FG001|Induction Period|No longer meets study criteria|1|||
25290725|NCT00920907|50605839|FG000|Induction Period|Withdrawal by Subject|1|||
25290726|NCT00920907|50605840|FG001|Induction Period|Withdrawal by Subject|1|||
25290727|NCT00920907|50605839|FG000|Maintenance Period|Disease Progression|3|||
25290728|NCT00920907|50605840|FG001|Maintenance Period|Disease Progression|7|||
25290729|NCT00920907|50605839|FG000|Maintenance Period|Administrative (study closure)|7|||
25290730|NCT00920907|50605840|FG001|Maintenance Period|Administrative (study closure)|2|||
25290731|NCT00920907|50605839|FG000|Maintenance Period|Study Drug Toxicity|0|||
25290732|NCT00920907|50605840|FG001|Maintenance Period|Study Drug Toxicity|2|||
25290733|NCT00920907|50605839|FG000|Maintenance Period|Death|1|||
25290734|NCT00920907|50605840|FG001|Maintenance Period|Death|1|||
25290735|NCT00920907|50605839|FG000|Maintenance Period|Withdrawal by Subject|1|||
25290736|NCT00920907|50605840|FG001|Maintenance Period|Withdrawal by Subject|0|||
25290737|NCT00920907|50605839|FG000|Maintenance Period|Adverse Event|0|||
25290738|NCT00920907|50605840|FG001|Maintenance Period|Adverse Event|1|||
25290739|NCT01103141|50605850|FG000|Overall Study|Death|0|||
25290740|NCT01103141|50605851|FG001|Overall Study|Death|1|||
25290741|NCT01103141|50605850|FG000|Overall Study|Lost to Follow-up|2|||
25290742|NCT01103141|50605851|FG001|Overall Study|Lost to Follow-up|1|||
25290743|NCT00844831|50605857|FG000|Overall Study|Withdrawal by Subject|4|||
25290744|NCT00844831|50605857|FG000|Overall Study|Adverse Event|1|||
25290745|NCT00844831|50605857|FG000|Overall Study|Physician Decision|1|||
25290746|NCT00920829|50605869|FG000|Allocation|No post randomization data|3|||
25290747|NCT00920829|50605870|FG001|Allocation|No post randomization data|1|||
25290748|NCT00920829|50605871|FG002|Allocation|No post randomization data|0|||
25290749|NCT00920829|50605872|FG003|Allocation|No post randomization data|2|||
25290750|NCT00920829|50605869|FG000|Available for Analysis|Withdrawal by Subject|6|||
25290751|NCT00920829|50605870|FG001|Available for Analysis|Withdrawal by Subject|6|||
25290752|NCT00920829|50605871|FG002|Available for Analysis|Withdrawal by Subject|6|||
25290753|NCT00920829|50605872|FG003|Available for Analysis|Withdrawal by Subject|10|||
25290754|NCT00920829|50605869|FG000|Available for Analysis|Required Medical Treatment|0|||
25290755|NCT00920829|50605870|FG001|Available for Analysis|Required Medical Treatment|1|||
25290756|NCT00920829|50605871|FG002|Available for Analysis|Required Medical Treatment|2|||
25290757|NCT00920829|50605872|FG003|Available for Analysis|Required Medical Treatment|0|||
25290758|NCT00920829|50605869|FG000|Available for Analysis|Adverse Event|1|||
25290759|NCT00920829|50605870|FG001|Available for Analysis|Adverse Event|2|||
25290760|NCT00920829|50605871|FG002|Available for Analysis|Adverse Event|1|||
25290761|NCT00920829|50605872|FG003|Available for Analysis|Adverse Event|0|||
25290762|NCT00920829|50605869|FG000|Available for Analysis|Death|1|||
25290763|NCT00920829|50605870|FG001|Available for Analysis|Death|0|||
25191639|NCT01490918|50352829|FG001|Overall Study|Lost to Follow-up|1|||
24969733|NCT00117312|50059185|FG001|Overall Study|PSA decrease <=50%|2|||
25290764|NCT00920829|50605871|FG002|Available for Analysis|Death|0|||
25290765|NCT00920829|50605872|FG003|Available for Analysis|Death|0|||
25290766|NCT00920829|50605869|FG000|Available for Analysis|Protocol Violation|0|||
25290767|NCT00920829|50605870|FG001|Available for Analysis|Protocol Violation|0|||
25290768|NCT00920829|50605871|FG002|Available for Analysis|Protocol Violation|1|||
25290769|NCT00920829|50605872|FG003|Available for Analysis|Protocol Violation|0|||
25290770|NCT00920829|50605869|FG000|Available for Analysis|Required more treatment|0|||
25290771|NCT00920829|50605870|FG001|Available for Analysis|Required more treatment|2|||
25290772|NCT00920829|50605871|FG002|Available for Analysis|Required more treatment|0|||
25290773|NCT00920829|50605872|FG003|Available for Analysis|Required more treatment|1|||
25290774|NCT00831181|50605882|FG000|Overall Study|Adverse Event|12|||
25290775|NCT01023672|50605887|FG000|Overall Study|Worsening disease|2|||
25290776|NCT01023672|50605887|FG000|Overall Study|Death|1|||
25290777|NCT01094171|50605891|FG000|Overall Study|Lost to Follow-up|2|||
25290778|NCT01094171|50605891|FG000|Overall Study|Informed consent withdrawal|4|||
25290779|NCT01094171|50605891|FG000|Overall Study|Migration from the study area|3|||
25290780|NCT01094171|50605891|FG000|Overall Study|Other|1|||
25290781|NCT01093625|50605897|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
25290782|NCT01093625|50605898|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
25290783|NCT01093625|50605897|FG000|2-Week Visit|Withdrawal by Subject|1|||
25290784|NCT01093625|50605898|FG001|2-Week Visit|Withdrawal by Subject|0|||
25290785|NCT01093625|50605897|FG000|1-Month Visit|Lost to Follow-up|2|||
25290786|NCT01093625|50605898|FG001|1-Month Visit|Lost to Follow-up|0|||
25290787|NCT01093625|50605897|FG000|3-Month Visit|Lost to Follow-up|2|||
25290788|NCT01093625|50605898|FG001|3-Month Visit|Lost to Follow-up|0|||
25290789|NCT01093625|50605897|FG000|6-Month Visit|Withdrawal by Subject|6|||
25290790|NCT01093625|50605898|FG001|6-Month Visit|Withdrawal by Subject|7|||
25290791|NCT01093625|50605897|FG000|6-Month Visit|Lost to Follow-up|2|||
25290792|NCT01093625|50605898|FG001|6-Month Visit|Lost to Follow-up|2|||
25290793|NCT01093625|50605897|FG000|1-Year Visit|Lost to Follow-up|5|||
25290794|NCT01093625|50605898|FG001|1-Year Visit|Lost to Follow-up|3|||
25290795|NCT01023516|50605906|FG000|Overall Study|Voluntary discontinuation|7|||
25290796|NCT01023516|50605907|FG001|Overall Study|Voluntary discontinuation|5|||
25290797|NCT01023516|50605906|FG000|Overall Study|Adverse Event|9|||
25290798|NCT01023516|50605907|FG001|Overall Study|Adverse Event|6|||
25290799|NCT01023516|50605906|FG000|Overall Study|Safety reason|0|||
25290800|NCT01023516|50605907|FG001|Overall Study|Safety reason|3|||
25290801|NCT01023516|50605906|FG000|Overall Study|Study-specific criteria|4|||
25290802|NCT01023516|50605907|FG001|Overall Study|Study-specific criteria|2|||
25290803|NCT01023516|50605906|FG000|Overall Study|Incorrect enrolment|4|||
25290804|NCT01023516|50605907|FG001|Overall Study|Incorrect enrolment|2|||
25290805|NCT00844753|50605917|FG000|Overall Study|Lack of Efficacy|1|||
25290806|NCT00844753|50605918|FG001|Overall Study|Lack of Efficacy|0|||
25290807|NCT00844753|50605919|FG002|Overall Study|Lack of Efficacy|2|||
25290808|NCT00844753|50605920|FG003|Overall Study|Lack of Efficacy|2|||
25290809|NCT00844753|50605917|FG000|Overall Study|Adverse Event|3|||
25290810|NCT00844753|50605918|FG001|Overall Study|Adverse Event|2|||
25290811|NCT00844753|50605919|FG002|Overall Study|Adverse Event|5|||
25290812|NCT00844753|50605920|FG003|Overall Study|Adverse Event|5|||
25290813|NCT00844753|50605917|FG000|Overall Study|Lost to Follow-up|1|||
25290814|NCT00844753|50605918|FG001|Overall Study|Lost to Follow-up|1|||
25290815|NCT00844753|50605919|FG002|Overall Study|Lost to Follow-up|0|||
25290816|NCT00844753|50605920|FG003|Overall Study|Lost to Follow-up|1|||
25290817|NCT00844753|50605917|FG000|Overall Study|could not swallow medication|2|||
25290818|NCT00844753|50605918|FG001|Overall Study|could not swallow medication|0|||
25290819|NCT00844753|50605919|FG002|Overall Study|could not swallow medication|0|||
25070352|NCT02603120|50176294|FG001|Double-Blind Treatment Phase|Death|0|||
25070353|NCT02603120|50176293|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
25070354|NCT02603120|50176294|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
25070355|NCT02603120|50176293|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
25070356|NCT02603120|50176294|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
25070357|NCT02603120|50176293|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
25070358|NCT02603120|50176294|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
25070359|NCT02603120|50176293|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
25191640|NCT01490918|50352830|FG002|Overall Study|Lost to Follow-up|0|||
25290820|NCT00844753|50605920|FG003|Overall Study|could not swallow medication|0|||
25290821|NCT00844753|50605917|FG000|Overall Study|Withdrawal by Subject|1|||
25290822|NCT00844753|50605918|FG001|Overall Study|Withdrawal by Subject|0|||
25290823|NCT00844753|50605919|FG002|Overall Study|Withdrawal by Subject|0|||
25290824|NCT00844753|50605920|FG003|Overall Study|Withdrawal by Subject|3|||
25290825|NCT00830947|50605930|FG000|Overall Study|Lost to Follow-up|4|||
25290826|NCT00830947|50605931|FG001|Overall Study|Lost to Follow-up|4|||
25290827|NCT01018992|50605939|FG000|Overall Study|Adverse Event|8|||
25290828|NCT01018992|50605940|FG001|Overall Study|Adverse Event|3|||
25290829|NCT01018992|50605939|FG000|Overall Study|Withdrawal by Subject|3|||
25290830|NCT01018992|50605940|FG001|Overall Study|Withdrawal by Subject|8|||
25290831|NCT01018992|50605939|FG000|Overall Study|Protocol Violation|0|||
25290832|NCT01018992|50605940|FG001|Overall Study|Protocol Violation|4|||
25290833|NCT01018992|50605939|FG000|Overall Study|Lost to Follow-up|5|||
25290834|NCT01018992|50605940|FG001|Overall Study|Lost to Follow-up|1|||
25290835|NCT00917553|50605948|FG000|Overall Study|Lost to Follow-up|2|||
25290836|NCT00917553|50605949|FG001|Overall Study|Lost to Follow-up|1|||
25290837|NCT01018680|50605957|FG000|Overall Study|Adverse Event|23|||
25290838|NCT01018680|50605958|FG001|Overall Study|Adverse Event|40|||
25290839|NCT01018680|50605957|FG000|Overall Study|Withdrawal by Subject|10|||
25290840|NCT01018680|50605958|FG001|Overall Study|Withdrawal by Subject|10|||
25290841|NCT01018680|50605957|FG000|Overall Study|Protocol Violation|5|||
25290842|NCT01018680|50605958|FG001|Overall Study|Protocol Violation|8|||
25290843|NCT01018680|50605957|FG000|Overall Study|Sponsor Decision|6|||
25290844|NCT01018680|50605958|FG001|Overall Study|Sponsor Decision|7|||
25290845|NCT01018680|50605957|FG000|Overall Study|Lack of Efficacy|8|||
25290846|NCT01018680|50605958|FG001|Overall Study|Lack of Efficacy|2|||
25290847|NCT01018680|50605957|FG000|Overall Study|Lost to Follow-up|5|||
25290848|NCT01018680|50605958|FG001|Overall Study|Lost to Follow-up|3|||
25290849|NCT01018680|50605957|FG000|Overall Study|Entry Criteria Not Met|1|||
25290850|NCT01018680|50605958|FG001|Overall Study|Entry Criteria Not Met|4|||
25290851|NCT01018680|50605957|FG000|Overall Study|Physician Decision|3|||
25290852|NCT01018680|50605958|FG001|Overall Study|Physician Decision|1|||
25290853|NCT01012440|50605964|FG000|Overall Study|Withdrawal by Subject|2|||
25290854|NCT00916929|50605970|FG000|Overall Study|Lost to Follow-up|1|||
25290855|NCT00916929|50605971|FG001|Overall Study|Lost to Follow-up|3|||
25290856|NCT00916929|50605970|FG000|Overall Study|Death|5|||
25290857|NCT00916929|50605971|FG001|Overall Study|Death|10|||
25290858|NCT00916929|50605970|FG000|Overall Study|Withdrawal by Subject|1|||
25290859|NCT00916929|50605971|FG001|Overall Study|Withdrawal by Subject|5|||
25290860|NCT00916929|50605970|FG000|Overall Study|Left ventricular epicardial lead|1|||
25290861|NCT00916929|50605971|FG001|Overall Study|Left ventricular epicardial lead|2|||
25290862|NCT00916929|50605970|FG000|Overall Study|Transferred to hospice care|1|||
25290863|NCT00916929|50605971|FG001|Overall Study|Transferred to hospice care|1|||
25290864|NCT00916929|50605970|FG000|Overall Study|System explant|1|||
25290865|NCT00916929|50605971|FG001|Overall Study|System explant|0|||
25290866|NCT00916929|50605970|FG000|Overall Study|Moved to another state|0|||
25290867|NCT00916929|50605971|FG001|Overall Study|Moved to another state|1|||
25290868|NCT00916929|50605970|FG000|Overall Study|Device unable to process impedance data|0|||
25290869|NCT00916929|50605971|FG001|Overall Study|Device unable to process impedance data|7|||
25290870|NCT00844597|50605985|FG000|Overall Study|Adverse Event|0|||
25290871|NCT00844597|50605986|FG001|Overall Study|Adverse Event|0|||
25290872|NCT00844597|50605987|FG002|Overall Study|Adverse Event|0|||
25290873|NCT00844597|50605988|FG003|Overall Study|Adverse Event|1|||
25290874|NCT00844597|50605989|FG004|Overall Study|Adverse Event|0|||
25290875|NCT00844597|50605990|FG005|Overall Study|Adverse Event|0|||
25290876|NCT01017120|50606008|FG000|Overall Study|Adverse Event|9|||
25290877|NCT01017120|50606009|FG001|Overall Study|Adverse Event|0|||
25290878|NCT01017120|50606008|FG000|Overall Study|Lost to Follow-up|13|||
25290879|NCT01017120|50606009|FG001|Overall Study|Lost to Follow-up|11|||
25290880|NCT01017120|50606008|FG000|Overall Study|Lack of Efficacy|1|||
25290881|NCT01017120|50606009|FG001|Overall Study|Lack of Efficacy|0|||
25290882|NCT01017120|50606008|FG000|Overall Study|Withdrawal by Subject|39|||
25290883|NCT01017120|50606009|FG001|Overall Study|Withdrawal by Subject|21|||
25290884|NCT01017120|50606008|FG000|Overall Study|Pregnancy|1|||
25290885|NCT01017120|50606009|FG001|Overall Study|Pregnancy|1|||
25290886|NCT01017120|50606008|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
25290887|NCT01017120|50606009|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
25290888|NCT01017120|50606008|FG000|Overall Study|Relocated Out of Town|0|||
25290889|NCT01017120|50606009|FG001|Overall Study|Relocated Out of Town|2|||
25290890|NCT01017120|50606008|FG000|Overall Study|Protocol Violation|1|||
25290891|NCT01017120|50606009|FG001|Overall Study|Protocol Violation|0|||
25290892|NCT01017120|50606008|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
25290893|NCT01017120|50606009|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
25290894|NCT01016964|50606017|FG000|Overall Study|Lost to Follow-up|3|||
25290895|NCT01016964|50606018|FG001|Overall Study|Lost to Follow-up|3|||
25290896|NCT02996110|50606029|FG000|Pre-Treatment|Other Reasons|0|||
25290897|NCT02996110|50606030|FG001|Pre-Treatment|Other Reasons|1|||
25290898|NCT02996110|50606031|FG002|Pre-Treatment|Other Reasons|0|||
25290899|NCT02996110|50606032|FG003|Pre-Treatment|Other Reasons|0|||
25290900|NCT02996110|50606033|FG004|Pre-Treatment|Other Reasons|1|||
25290901|NCT02996110|50606029|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
25290902|NCT02996110|50606030|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
25290903|NCT02996110|50606031|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
25290904|NCT02996110|50606032|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
25290905|NCT02996110|50606033|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
25290906|NCT02996110|50606029|FG000|Track 1|Disease Progression|15|||
25290907|NCT02996110|50606030|FG001|Track 1|Disease Progression|17|||
25290908|NCT02996110|50606031|FG002|Track 1|Disease Progression|0|||
25290909|NCT02996110|50606032|FG003|Track 1|Disease Progression|0|||
25290910|NCT02996110|50606033|FG004|Track 1|Disease Progression|0|||
25290911|NCT02996110|50606029|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
25290912|NCT02996110|50606030|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
25290913|NCT02996110|50606031|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
25290914|NCT02996110|50606032|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
25290915|NCT02996110|50606033|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
25290916|NCT02996110|50606029|FG000|Track 1|Study Drug Toxicity|5|||
25290917|NCT02996110|50606030|FG001|Track 1|Study Drug Toxicity|3|||
25290918|NCT02996110|50606031|FG002|Track 1|Study Drug Toxicity|0|||
25290919|NCT02996110|50606032|FG003|Track 1|Study Drug Toxicity|0|||
25290920|NCT02996110|50606033|FG004|Track 1|Study Drug Toxicity|0|||
25290921|NCT02996110|50606029|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
25290922|NCT02996110|50606030|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
25290923|NCT02996110|50606031|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
25290924|NCT02996110|50606032|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
25290925|NCT02996110|50606033|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
25290926|NCT02996110|50606029|FG000|Track 1|Administrative Reason by Sponsor|0|||
25290927|NCT02996110|50606030|FG001|Track 1|Administrative Reason by Sponsor|1|||
25290928|NCT02996110|50606031|FG002|Track 1|Administrative Reason by Sponsor|0|||
25290929|NCT02996110|50606032|FG003|Track 1|Administrative Reason by Sponsor|0|||
25290930|NCT02996110|50606033|FG004|Track 1|Administrative Reason by Sponsor|0|||
25290931|NCT02996110|50606029|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
25290932|NCT02996110|50606030|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
25290933|NCT02996110|50606031|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
25290934|NCT02996110|50606032|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
25290935|NCT02996110|50606033|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
25290936|NCT02996110|50606029|FG000|Track 2|Disease Progression|33|||
25290937|NCT02996110|50606030|FG001|Track 2|Disease Progression|26|||
25290938|NCT02996110|50606031|FG002|Track 2|Disease Progression|19|||
25290939|NCT02996110|50606032|FG003|Track 2|Disease Progression|16|||
25290940|NCT02996110|50606033|FG004|Track 2|Disease Progression|15|||
25290941|NCT02996110|50606029|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
25290942|NCT02996110|50606030|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
25290943|NCT02996110|50606031|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
25290944|NCT02996110|50606032|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
25290945|NCT02996110|50606033|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
25290946|NCT02996110|50606029|FG000|Track 2|Death|0|||
25290947|NCT02996110|50606030|FG001|Track 2|Death|0|||
25290948|NCT02996110|50606031|FG002|Track 2|Death|1|||
25290949|NCT02996110|50606032|FG003|Track 2|Death|0|||
25290950|NCT02996110|50606033|FG004|Track 2|Death|1|||
25290951|NCT02996110|50606029|FG000|Track 2|Study Drug Toxicity|4|||
25290952|NCT02996110|50606030|FG001|Track 2|Study Drug Toxicity|1|||
25290953|NCT02996110|50606031|FG002|Track 2|Study Drug Toxicity|4|||
25290954|NCT02996110|50606032|FG003|Track 2|Study Drug Toxicity|1|||
25290955|NCT02996110|50606033|FG004|Track 2|Study Drug Toxicity|0|||
25290956|NCT02996110|50606029|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
25290957|NCT02996110|50606030|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
25290958|NCT02996110|50606031|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
25290959|NCT02996110|50606032|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
25290960|NCT02996110|50606033|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
25290961|NCT02996110|50606029|FG000|Track 2|Participant Withdrew Consent|1|||
25290962|NCT02996110|50606030|FG001|Track 2|Participant Withdrew Consent|2|||
25290963|NCT02996110|50606031|FG002|Track 2|Participant Withdrew Consent|3|||
25290964|NCT02996110|50606032|FG003|Track 2|Participant Withdrew Consent|1|||
25290965|NCT02996110|50606033|FG004|Track 2|Participant Withdrew Consent|1|||
25290966|NCT02996110|50606029|FG000|Track 2|Other Reasons|0|||
25290967|NCT02996110|50606030|FG001|Track 2|Other Reasons|0|||
25290968|NCT02996110|50606031|FG002|Track 2|Other Reasons|1|||
25290969|NCT02996110|50606032|FG003|Track 2|Other Reasons|0|||
25290970|NCT02996110|50606033|FG004|Track 2|Other Reasons|1|||
25290971|NCT00916617|50606051|FG000|Overall Study|Adverse Event|3|||
25290972|NCT00916617|50606052|FG001|Overall Study|Adverse Event|2|||
25290973|NCT00916617|50606053|FG002|Overall Study|Adverse Event|6|||
25290974|NCT00916617|50606054|FG003|Overall Study|Adverse Event|3|||
25290975|NCT00916617|50606051|FG000|Overall Study|Withdrawal by Subject|3|||
25290976|NCT00916617|50606052|FG001|Overall Study|Withdrawal by Subject|2|||
25169240|NCT01865747|50300614|FG000|Overall Study (ITT)|Reason Not Provided|0|||
25191641|NCT01490918|50352828|FG000|Overall Study|Withdrawal by Subject|7|||
25290977|NCT00916617|50606053|FG002|Overall Study|Withdrawal by Subject|0|||
25290978|NCT00916617|50606054|FG003|Overall Study|Withdrawal by Subject|1|||
25290979|NCT00916617|50606051|FG000|Overall Study|Caregiver Request|3|||
25290980|NCT00916617|50606052|FG001|Overall Study|Caregiver Request|2|||
25290981|NCT00916617|50606053|FG002|Overall Study|Caregiver Request|1|||
25290982|NCT00916617|50606054|FG003|Overall Study|Caregiver Request|0|||
25290983|NCT00916617|50606051|FG000|Overall Study|Physician Decision|1|||
25290984|NCT00916617|50606052|FG001|Overall Study|Physician Decision|1|||
25290985|NCT00916617|50606053|FG002|Overall Study|Physician Decision|0|||
25290986|NCT00916617|50606054|FG003|Overall Study|Physician Decision|0|||
25290987|NCT00916617|50606051|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
25290988|NCT00916617|50606052|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
25290989|NCT00916617|50606053|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
25290990|NCT00916617|50606054|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
25290991|NCT00916617|50606051|FG000|Overall Study|Lost to Follow-up|2|||
25290992|NCT00916617|50606052|FG001|Overall Study|Lost to Follow-up|1|||
25290993|NCT00916617|50606053|FG002|Overall Study|Lost to Follow-up|0|||
25290994|NCT00916617|50606054|FG003|Overall Study|Lost to Follow-up|0|||
25290995|NCT00916617|50606051|FG000|Overall Study|Lack of Efficacy|1|||
25290996|NCT00916617|50606052|FG001|Overall Study|Lack of Efficacy|0|||
25290997|NCT00916617|50606053|FG002|Overall Study|Lack of Efficacy|0|||
25290998|NCT00916617|50606054|FG003|Overall Study|Lack of Efficacy|0|||
25290999|NCT00916617|50606051|FG000|Overall Study|Other|2|||
25169241|NCT01865747|50300615|FG001|Overall Study (ITT)|Reason Not Provided|1|||
25169242|NCT01865747|50300614|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
25169243|NCT01865747|50300615|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
25169244|NCT01865747|50300614|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
25169245|NCT01865747|50300615|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
25169246|NCT01865747|50300614|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
25169247|NCT01865747|50300615|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
25169248|NCT01865747|50300614|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
25169249|NCT01865747|50300615|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
25169250|NCT01865747|50300614|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
25169251|NCT01865747|50300615|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
25169252|NCT01865747|50300614|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
25169253|NCT01865747|50300615|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
25191642|NCT01490918|50352829|FG001|Overall Study|Withdrawal by Subject|8|||
25191643|NCT01490918|50352830|FG002|Overall Study|Withdrawal by Subject|3|||
25191644|NCT01490918|50352828|FG000|Overall Study|Adverse Event|0|||
25291000|NCT00916617|50606052|FG001|Overall Study|Other|0|||
25291001|NCT00916617|50606053|FG002|Overall Study|Other|0|||
25291002|NCT00916617|50606054|FG003|Overall Study|Other|2|||
25291003|NCT01103063|50606066|FG000|Overall Study|Adverse Event|3|||
25291004|NCT01103063|50606067|FG001|Overall Study|Adverse Event|1|||
25291005|NCT01103063|50606066|FG000|Overall Study|Lost to Follow-up|68|||
25291006|NCT01103063|50606067|FG001|Overall Study|Lost to Follow-up|51|||
25191645|NCT01490918|50352829|FG001|Overall Study|Adverse Event|0|||
25191646|NCT01490918|50352830|FG002|Overall Study|Adverse Event|1|||
25191647|NCT01490918|50352828|FG000|Overall Study|other cause|4|||
25191648|NCT01490918|50352829|FG001|Overall Study|other cause|5|||
25191649|NCT01490918|50352830|FG002|Overall Study|other cause|8|||
25191650|NCT01490840|50352862|FG000|Phase 1|Lost to Follow-up|1|||
25191651|NCT01490840|50352863|FG001|Phase 1|Lost to Follow-up|0|||
25191652|NCT01490840|50352862|FG000|Phase 1|Adverse Event|2|||
25191653|NCT01490840|50352863|FG001|Phase 1|Adverse Event|1|||
25191654|NCT01490840|50352862|FG000|Phase 1|Withdrawal by Subject|6|||
25191655|NCT01490840|50352863|FG001|Phase 1|Withdrawal by Subject|5|||
25191656|NCT01490840|50352862|FG000|Phase 1|Visit 6a omitted|1|||
25191657|NCT01490840|50352863|FG001|Phase 1|Visit 6a omitted|0|||
25191658|NCT01490840|50352862|FG000|Phase 2|Withdrawal by Subject|4|||
25191659|NCT01490840|50352863|FG001|Phase 2|Withdrawal by Subject|3|||
25191660|NCT01490840|50352862|FG000|Phase 2|Permanent interruption of fingolimod|0|||
25191661|NCT01490840|50352863|FG001|Phase 2|Permanent interruption of fingolimod|1|||
25191662|NCT01490840|50352862|FG000|Phase 2|Lost to Follow-up|1|||
25191663|NCT01490840|50352863|FG001|Phase 2|Lost to Follow-up|1|||
25191664|NCT01490840|50352862|FG000|Phase 2|Adverse Event|1|||
25191665|NCT01490840|50352863|FG001|Phase 2|Adverse Event|1|||
25191666|NCT01490450|50352895|FG000|Period 1|Lack of Efficacy|2|||
25191667|NCT01490450|50352896|FG001|Period 1|Lack of Efficacy|0|||
25191668|NCT01490450|50352897|FG002|Period 1|Lack of Efficacy|3|||
25191669|NCT01490450|50352898|FG003|Period 1|Lack of Efficacy|0|||
25291007|NCT01103063|50606066|FG000|Overall Study|Withdrawal by Subject|60|||
25191670|NCT01490450|50352895|FG000|Period 1|Adverse Event|0|||
25291008|NCT01103063|50606067|FG001|Overall Study|Withdrawal by Subject|15|||
25291009|NCT01103063|50606066|FG000|Overall Study|Other|16|||
25291010|NCT01103063|50606067|FG001|Overall Study|Other|11|||
25291011|NCT01103063|50606066|FG000|Overall Study|Protocol Violation|1|||
25291012|NCT01103063|50606067|FG001|Overall Study|Protocol Violation|0|||
25291013|NCT01103063|50606066|FG000|Overall Study|Study terminated by Sponsor|326|||
25291014|NCT01103063|50606067|FG001|Overall Study|Study terminated by Sponsor|342|||
25191671|NCT01490450|50352896|FG001|Period 1|Adverse Event|0|||
25191672|NCT01490450|50352897|FG002|Period 1|Adverse Event|0|||
25191673|NCT01490450|50352898|FG003|Period 1|Adverse Event|5|||
25291015|NCT01103063|50606066|FG000|Overall Study|Death|3|||
25291016|NCT01103063|50606067|FG001|Overall Study|Death|1|||
25291017|NCT01091675|50606075|FG000|Overall Study|Adverse Event|7|||
25291018|NCT01091675|50606075|FG000|Overall Study|Lack of Efficacy|27|||
25291019|NCT01091519|50606081|FG000|Overall Study|Adverse Event|12|||
25291020|NCT01091519|50606082|FG001|Overall Study|Adverse Event|16|||
25291021|NCT01091519|50606081|FG000|Overall Study|Death|1|||
25291022|NCT01091519|50606082|FG001|Overall Study|Death|0|||
25291023|NCT01091519|50606081|FG000|Overall Study|Lack of Efficacy|16|||
25291024|NCT01091519|50606082|FG001|Overall Study|Lack of Efficacy|19|||
25291025|NCT01091519|50606081|FG000|Overall Study|Lost to Follow-up|14|||
25291026|NCT01091519|50606082|FG001|Overall Study|Lost to Follow-up|24|||
25291027|NCT01091519|50606081|FG000|Overall Study|Withdrawal by Subject|2|||
25291028|NCT01091519|50606082|FG001|Overall Study|Withdrawal by Subject|2|||
25291029|NCT01091519|50606081|FG000|Overall Study|Other|6|||
25291030|NCT01091519|50606082|FG001|Overall Study|Other|8|||
25291031|NCT01091519|50606081|FG000|Overall Study|Randomized not treated|4|||
25291032|NCT01091519|50606082|FG001|Overall Study|Randomized not treated|4|||
25291033|NCT01011738|50606091|FG000|Overall Study|Death|12|||
25291034|NCT01011738|50606092|FG001|Overall Study|Death|3|||
25291035|NCT01011738|50606093|FG002|Overall Study|Death|0|||
25291036|NCT01011738|50606091|FG000|Overall Study|Unknown reasons|312|||
25291037|NCT01011738|50606092|FG001|Overall Study|Unknown reasons|291|||
25291038|NCT01011738|50606093|FG002|Overall Study|Unknown reasons|17|||
25291039|NCT00918333|50606104|FG000|Overall Study|Drug not taken per protocol|1|||
25291040|NCT00918333|50606105|FG001|Overall Study|Drug not taken per protocol|0|||
25291041|NCT00918333|50606104|FG000|Overall Study|Inadequate amount of drugs provided|1|||
25291042|NCT00918333|50606105|FG001|Overall Study|Inadequate amount of drugs provided|4|||
25291043|NCT00918333|50606104|FG000|Overall Study|Ineligible|1|||
25291044|NCT00918333|50606105|FG001|Overall Study|Ineligible|0|||
25291045|NCT00918333|50606104|FG000|Overall Study|Withdrawal by Subject|0|||
25291046|NCT00918333|50606105|FG001|Overall Study|Withdrawal by Subject|1|||
25291047|NCT01091363|50606116|FG000|Overall Study|Withdrawal by Subject|11|||
25291048|NCT01091363|50606117|FG001|Overall Study|Withdrawal by Subject|15|||
25291049|NCT01091363|50606116|FG000|Overall Study|Lost to Follow-up|2|||
25291050|NCT01091363|50606117|FG001|Overall Study|Lost to Follow-up|2|||
25291051|NCT01090973|50606123|FG000|Overall Study|Disease progression|1|||
25291052|NCT01090739|50606127|FG000|Enrollment|Withdrawal by Subject|24|||
25291053|NCT01090739|50606127|FG000|Enrollment|Protocol Violation|14|||
25291054|NCT01090739|50606127|FG000|Enrollment|Lost to Follow-up|5|||
25291055|NCT01090739|50606127|FG000|Enrollment|Physician Decision|5|||
25291056|NCT01090739|50606127|FG000|Enrollment|Sponsor termination of site|4|||
25291057|NCT01090739|50606127|FG000|Enrollment|Study implant limit reached|2|||
25291058|NCT01090739|50606127|FG000|Enrollment|Adverse Event|1|||
25291059|NCT01090739|50606127|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
25291060|NCT01090739|50606127|FG000|12 Month Follow-up|Lost to Follow-up|1|||
25291061|NCT01090739|50606127|FG000|12 Month Follow-up|Physician Decision|1|||
25291062|NCT01090739|50606127|FG000|12 Month Follow-up|Death|1|||
25291063|NCT01090739|50606127|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
25291064|NCT01090739|50606127|FG000|24 Month Follow-up|Lost to Follow-up|1|||
25291065|NCT01090739|50606127|FG000|24 Month Follow-up|Death|1|||
25291066|NCT01090739|50606127|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
25291067|NCT01090739|50606127|FG000|36 Month Follow-up|Visit still pending|17|||
25291068|NCT00916383|50606145|FG000|Overall Study|Adverse Event|1|||
25291069|NCT00916383|50606145|FG000|Overall Study|Death|1|||
25291070|NCT00916383|50606145|FG000|Overall Study|Protocol Violation|1|||
25291071|NCT00916305|50606155|FG000|Overall Study|Lost to Follow-up|21|||
25291072|NCT00916305|50606156|FG001|Overall Study|Lost to Follow-up|27|||
25291073|NCT00916305|50606155|FG000|Overall Study|Withdrawal by Subject|0|||
25291074|NCT00916305|50606156|FG001|Overall Study|Withdrawal by Subject|1|||
25291075|NCT00916149|50606165|FG000|Overall Study|Lost to Follow-up|3|||
25291076|NCT00916149|50606166|FG001|Overall Study|Lost to Follow-up|2|||
25291077|NCT00916149|50606167|FG002|Overall Study|Lost to Follow-up|0|||
25291078|NCT00916149|50606165|FG000|Overall Study|Unable to place scalp EEG leads|1|||
25291079|NCT00916149|50606166|FG001|Overall Study|Unable to place scalp EEG leads|0|||
25291080|NCT00916149|50606167|FG002|Overall Study|Unable to place scalp EEG leads|0|||
25291081|NCT01090427|50606177|FG000|After Controlled Period|Death|0|||
25291082|NCT01090427|50606178|FG001|After Controlled Period|Death|0|||
25291083|NCT01090427|50606179|FG002|After Controlled Period|Death|0|||
25291084|NCT01090427|50606180|FG003|After Controlled Period|Death|0|||
25291085|NCT01090427|50606181|FG004|After Controlled Period|Death|0|||
25291086|NCT01090427|50606182|FG005|After Controlled Period|Death|1|||
25291087|NCT01090427|50606183|FG006|After Controlled Period|Death|0|||
25291088|NCT01090427|50606177|FG000|After Controlled Period|Lack of Efficacy|0|||
25291089|NCT01090427|50606178|FG001|After Controlled Period|Lack of Efficacy|0|||
25291090|NCT01090427|50606179|FG002|After Controlled Period|Lack of Efficacy|0|||
25291091|NCT01090427|50606180|FG003|After Controlled Period|Lack of Efficacy|0|||
25291092|NCT01090427|50606181|FG004|After Controlled Period|Lack of Efficacy|0|||
25291093|NCT01090427|50606182|FG005|After Controlled Period|Lack of Efficacy|3|||
25291094|NCT01090427|50606183|FG006|After Controlled Period|Lack of Efficacy|2|||
25291095|NCT01090427|50606177|FG000|After Controlled Period|Adverse Event|0|||
25291096|NCT01090427|50606178|FG001|After Controlled Period|Adverse Event|0|||
25291097|NCT01090427|50606179|FG002|After Controlled Period|Adverse Event|0|||
25291098|NCT01090427|50606180|FG003|After Controlled Period|Adverse Event|2|||
25291099|NCT01090427|50606181|FG004|After Controlled Period|Adverse Event|0|||
25291100|NCT01090427|50606182|FG005|After Controlled Period|Adverse Event|1|||
25291101|NCT01090427|50606183|FG006|After Controlled Period|Adverse Event|0|||
25291102|NCT01016262|50606207|FG000|Double-blind Phase|Adverse Event|0|||
25291103|NCT01016262|50606208|FG001|Double-blind Phase|Adverse Event|0|||
25291104|NCT01016262|50606209|FG002|Double-blind Phase|Adverse Event|1|||
25291105|NCT01016262|50606210|FG003|Double-blind Phase|Adverse Event|0|||
25291106|NCT01016262|50606211|FG004|Double-blind Phase|Adverse Event|0|||
25291107|NCT01016262|50606212|FG005|Double-blind Phase|Adverse Event|0|||
25291108|NCT01016262|50606207|FG000|Double-blind Phase|Lack of Efficacy|1|||
25291109|NCT01016262|50606208|FG001|Double-blind Phase|Lack of Efficacy|0|||
25291110|NCT01016262|50606209|FG002|Double-blind Phase|Lack of Efficacy|5|||
25291111|NCT01016262|50606210|FG003|Double-blind Phase|Lack of Efficacy|0|||
25291112|NCT01016262|50606211|FG004|Double-blind Phase|Lack of Efficacy|0|||
25291113|NCT01016262|50606212|FG005|Double-blind Phase|Lack of Efficacy|0|||
25291114|NCT01016262|50606207|FG000|Double-blind Phase|Disease Progression|0|||
25291115|NCT01016262|50606208|FG001|Double-blind Phase|Disease Progression|1|||
25291116|NCT01016262|50606209|FG002|Double-blind Phase|Disease Progression|2|||
25291117|NCT01016262|50606210|FG003|Double-blind Phase|Disease Progression|0|||
25291118|NCT01016262|50606211|FG004|Double-blind Phase|Disease Progression|0|||
25291119|NCT01016262|50606212|FG005|Double-blind Phase|Disease Progression|0|||
25291120|NCT01016262|50606207|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
25291121|NCT01016262|50606208|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
25291122|NCT01016262|50606209|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
25291123|NCT01016262|50606210|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
25291124|NCT01016262|50606211|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
25291125|NCT01016262|50606212|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
25291126|NCT01016262|50606207|FG000|Open-Label Phase|Adverse Event|0|||
25291127|NCT01016262|50606208|FG001|Open-Label Phase|Adverse Event|0|||
25291128|NCT01016262|50606209|FG002|Open-Label Phase|Adverse Event|0|||
25291129|NCT01016262|50606210|FG003|Open-Label Phase|Adverse Event|1|||
25291130|NCT01016262|50606211|FG004|Open-Label Phase|Adverse Event|0|||
25291131|NCT01016262|50606212|FG005|Open-Label Phase|Adverse Event|0|||
25291132|NCT01016262|50606207|FG000|Open-Label Phase|Lost to Follow-up|0|||
25291133|NCT01016262|50606208|FG001|Open-Label Phase|Lost to Follow-up|0|||
25291134|NCT01016262|50606209|FG002|Open-Label Phase|Lost to Follow-up|0|||
25291135|NCT01016262|50606210|FG003|Open-Label Phase|Lost to Follow-up|0|||
25291136|NCT01016262|50606211|FG004|Open-Label Phase|Lost to Follow-up|1|||
25291137|NCT01016262|50606212|FG005|Open-Label Phase|Lost to Follow-up|0|||
25291138|NCT01016262|50606207|FG000|Open-Label Phase|Lack of Efficacy|0|||
25291139|NCT01016262|50606208|FG001|Open-Label Phase|Lack of Efficacy|0|||
25291140|NCT01016262|50606209|FG002|Open-Label Phase|Lack of Efficacy|0|||
25291141|NCT01016262|50606210|FG003|Open-Label Phase|Lack of Efficacy|1|||
25291142|NCT01016262|50606211|FG004|Open-Label Phase|Lack of Efficacy|0|||
25291143|NCT01016262|50606212|FG005|Open-Label Phase|Lack of Efficacy|0|||
25291144|NCT01016262|50606207|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
25291145|NCT01016262|50606208|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
25291146|NCT01016262|50606209|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
25291147|NCT01016262|50606210|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
25291148|NCT01016262|50606211|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
25291149|NCT01016262|50606212|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
25291150|NCT01001910|50606223|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
25291151|NCT01009554|50606229|FG000|Overall Study|Adverse Event|1|||
25291152|NCT01009554|50606230|FG001|Overall Study|Adverse Event|1|||
25291153|NCT01009554|50606229|FG000|Overall Study|Withdrawal by Subject|1|||
25291154|NCT01009554|50606230|FG001|Overall Study|Withdrawal by Subject|3|||
25291155|NCT01009554|50606229|FG000|Overall Study|Noncompliant with Study Product|0|||
25291156|NCT01009554|50606230|FG001|Overall Study|Noncompliant with Study Product|3|||
25291157|NCT01006590|50606238|FG000|Overall Study|Adverse Event|2|||
25291158|NCT01006590|50606239|FG001|Overall Study|Adverse Event|3|||
25291159|NCT01006590|50606238|FG000|Overall Study|Death|1|||
25291160|NCT01006590|50606239|FG001|Overall Study|Death|1|||
25291161|NCT01006590|50606238|FG000|Overall Study|Lost to Follow-up|1|||
25291162|NCT01006590|50606239|FG001|Overall Study|Lost to Follow-up|1|||
25291163|NCT01006590|50606238|FG000|Overall Study|Protocol Violation|1|||
25291164|NCT01006590|50606239|FG001|Overall Study|Protocol Violation|0|||
25291165|NCT01006590|50606238|FG000|Overall Study|Withdrawal by Subject|4|||
24969734|NCT00117312|50059186|FG002|Overall Study|PSA decrease <=50%|2|||
25291166|NCT01006590|50606239|FG001|Overall Study|Withdrawal by Subject|2|||
25291167|NCT01006590|50606238|FG000|Overall Study|Study specific discontinuation criteria|16|||
25291168|NCT01006590|50606239|FG001|Overall Study|Study specific discontinuation criteria|23|||
25291169|NCT01006590|50606238|FG000|Overall Study|Other|3|||
25291170|NCT01006590|50606239|FG001|Overall Study|Other|2|||
25291171|NCT01001832|50606247|FG000|Short-term Period|Adverse Event|2|||
25291172|NCT01001832|50606248|FG001|Short-term Period|Adverse Event|3|||
25291173|NCT01001832|50606247|FG000|Long-term Period|Adverse Event|2|||
25291174|NCT01001832|50606248|FG001|Long-term Period|Adverse Event|1|||
25291175|NCT01001832|50606247|FG000|Long-term Period|Withdrawal by Subject|1|||
25291176|NCT01001832|50606248|FG001|Long-term Period|Withdrawal by Subject|0|||
25291177|NCT01001832|50606247|FG000|Long-term Period|Lack of Efficacy|0|||
25291178|NCT01001832|50606248|FG001|Long-term Period|Lack of Efficacy|2|||
25291179|NCT01001832|50606247|FG000|Long-term Period|Other|1|||
25291180|NCT01001832|50606248|FG001|Long-term Period|Other|2|||
25291181|NCT01001832|50606247|FG000|Follow-up Period|Withdrawal by Subject|1|||
25291182|NCT01001832|50606248|FG001|Follow-up Period|Withdrawal by Subject|0|||
25291183|NCT01001832|50606247|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
25291184|NCT01001832|50606248|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
25291185|NCT01001832|50606247|FG000|Follow-up Period|Other|2|||
25291186|NCT01001832|50606248|FG001|Follow-up Period|Other|1|||
25291187|NCT01001598|50606257|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
25291188|NCT01001598|50606257|FG000|Overall Study|Adverse Event|1|||
25291189|NCT01006356|50606261|FG000|Overall Study|Adverse Event|6|||
25291190|NCT01006356|50606261|FG000|Overall Study|Physician Decision|1|||
25291191|NCT01006356|50606261|FG000|Overall Study|Paticipants did not cooperate|6|||
25291192|NCT01006356|50606261|FG000|Overall Study|Withdrawal by Subject|1|||
25291193|NCT01006356|50606261|FG000|Overall Study|Choice by participants|2|||
25291194|NCT01006356|50606261|FG000|Overall Study|Protocol Violation|3|||
25291195|NCT01006356|50606261|FG000|Overall Study|Other|23|||
25291196|NCT01089725|50606270|FG000|Overall Study|Adverse Event|1|||
25291197|NCT01089725|50606271|FG001|Overall Study|Adverse Event|1|||
25291198|NCT01089725|50606272|FG002|Overall Study|Adverse Event|0|||
25291199|NCT01089725|50606273|FG003|Overall Study|Adverse Event|0|||
25291200|NCT01089725|50606274|FG004|Overall Study|Adverse Event|2|||
25291201|NCT01089725|50606270|FG000|Overall Study|Lack of Efficacy|4|||
25291202|NCT01089725|50606271|FG001|Overall Study|Lack of Efficacy|3|||
25291203|NCT01089725|50606272|FG002|Overall Study|Lack of Efficacy|1|||
25291204|NCT01089725|50606273|FG003|Overall Study|Lack of Efficacy|0|||
25291205|NCT01089725|50606274|FG004|Overall Study|Lack of Efficacy|4|||
25291206|NCT01089725|50606270|FG000|Overall Study|Lost to Follow-up|2|||
25291207|NCT01089725|50606271|FG001|Overall Study|Lost to Follow-up|2|||
25291208|NCT01089725|50606272|FG002|Overall Study|Lost to Follow-up|0|||
25291209|NCT01089725|50606273|FG003|Overall Study|Lost to Follow-up|3|||
25291210|NCT01089725|50606274|FG004|Overall Study|Lost to Follow-up|0|||
25291211|NCT01089725|50606270|FG000|Overall Study|Protocol Violation|0|||
25291212|NCT01089725|50606271|FG001|Overall Study|Protocol Violation|0|||
25291213|NCT01089725|50606272|FG002|Overall Study|Protocol Violation|1|||
25291214|NCT01089725|50606273|FG003|Overall Study|Protocol Violation|1|||
25291215|NCT01089725|50606274|FG004|Overall Study|Protocol Violation|0|||
25291216|NCT01089725|50606270|FG000|Overall Study|Withdrawal by Subject|5|||
25291217|NCT01089725|50606271|FG001|Overall Study|Withdrawal by Subject|5|||
25291218|NCT01089725|50606272|FG002|Overall Study|Withdrawal by Subject|4|||
25291219|NCT01089725|50606273|FG003|Overall Study|Withdrawal by Subject|5|||
25291220|NCT01089725|50606274|FG004|Overall Study|Withdrawal by Subject|4|||
25291221|NCT01089725|50606270|FG000|Overall Study|Study Terminated by Sponsor|51|||
25291222|NCT01089725|50606271|FG001|Overall Study|Study Terminated by Sponsor|56|||
25291223|NCT01089725|50606272|FG002|Overall Study|Study Terminated by Sponsor|53|||
25291224|NCT01089725|50606273|FG003|Overall Study|Study Terminated by Sponsor|68|||
25291225|NCT01089725|50606274|FG004|Overall Study|Study Terminated by Sponsor|68|||
25291226|NCT01089725|50606270|FG000|Overall Study|Randomized, but not treated|0|||
25291227|NCT01089725|50606271|FG001|Overall Study|Randomized, but not treated|1|||
25291228|NCT01089725|50606272|FG002|Overall Study|Randomized, but not treated|2|||
25291229|NCT01089725|50606273|FG003|Overall Study|Randomized, but not treated|1|||
25291230|NCT01089725|50606274|FG004|Overall Study|Randomized, but not treated|2|||
25291231|NCT01089725|50606270|FG000|Overall Study|Other|3|||
25291232|NCT01089725|50606271|FG001|Overall Study|Other|0|||
25291233|NCT01089725|50606272|FG002|Overall Study|Other|0|||
25291234|NCT01089725|50606273|FG003|Overall Study|Other|1|||
25291235|NCT01089725|50606274|FG004|Overall Study|Other|0|||
25291236|NCT01190930|50606292|FG000|Induction|Adverse Event|17|||
25291237|NCT01190930|50606293|FG001|Induction|Adverse Event|0|||
25291238|NCT01190930|50606294|FG002|Induction|Adverse Event|0|||
25291239|NCT01190930|50606295|FG003|Induction|Adverse Event|0|||
24969735|NCT00117312|50059187|FG003|Overall Study|PSA decrease <=50%|4|||
25291240|NCT01190930|50606296|FG004|Induction|Adverse Event|0|||
25291241|NCT01190930|50606297|FG005|Induction|Adverse Event|0|||
25291242|NCT01190930|50606298|FG006|Induction|Adverse Event|0|||
25291243|NCT01190930|50606299|FG007|Induction|Adverse Event|0|||
25291244|NCT01190930|50606300|FG008|Induction|Adverse Event|0|||
25291245|NCT01190930|50606301|FG009|Induction|Adverse Event|0|||
25291246|NCT01190930|50606292|FG000|Induction|Death|34|||
25291247|NCT01190930|50606293|FG001|Induction|Death|0|||
25291248|NCT01190930|50606294|FG002|Induction|Death|0|||
25291249|NCT01190930|50606295|FG003|Induction|Death|0|||
25291250|NCT01190930|50606296|FG004|Induction|Death|0|||
25291251|NCT01190930|50606297|FG005|Induction|Death|0|||
25291252|NCT01190930|50606298|FG006|Induction|Death|0|||
25291253|NCT01190930|50606299|FG007|Induction|Death|0|||
25291254|NCT01190930|50606300|FG008|Induction|Death|0|||
25291255|NCT01190930|50606301|FG009|Induction|Death|0|||
25291256|NCT01190930|50606292|FG000|Induction|Lost to Follow-up|1|||
25291257|NCT01190930|50606293|FG001|Induction|Lost to Follow-up|0|||
25291258|NCT01190930|50606294|FG002|Induction|Lost to Follow-up|0|||
25291259|NCT01190930|50606295|FG003|Induction|Lost to Follow-up|0|||
25291260|NCT01190930|50606296|FG004|Induction|Lost to Follow-up|0|||
25291261|NCT01190930|50606297|FG005|Induction|Lost to Follow-up|0|||
25291262|NCT01190930|50606298|FG006|Induction|Lost to Follow-up|0|||
25291263|NCT01190930|50606299|FG007|Induction|Lost to Follow-up|0|||
25291264|NCT01190930|50606300|FG008|Induction|Lost to Follow-up|0|||
25291265|NCT01190930|50606301|FG009|Induction|Lost to Follow-up|0|||
25291266|NCT01190930|50606292|FG000|Induction|Physician Decision|125|||
25291267|NCT01190930|50606293|FG001|Induction|Physician Decision|3|||
25291268|NCT01190930|50606294|FG002|Induction|Physician Decision|0|||
25291269|NCT01190930|50606295|FG003|Induction|Physician Decision|0|||
25291270|NCT01190930|50606296|FG004|Induction|Physician Decision|0|||
25291271|NCT01190930|50606297|FG005|Induction|Physician Decision|0|||
25291272|NCT01190930|50606298|FG006|Induction|Physician Decision|0|||
25291273|NCT01190930|50606299|FG007|Induction|Physician Decision|0|||
25291274|NCT01190930|50606300|FG008|Induction|Physician Decision|0|||
25291275|NCT01190930|50606301|FG009|Induction|Physician Decision|0|||
25291276|NCT01190930|50606292|FG000|Induction|Withdrawal by Subject|9|||
25291277|NCT01190930|50606293|FG001|Induction|Withdrawal by Subject|0|||
25291278|NCT01190930|50606294|FG002|Induction|Withdrawal by Subject|0|||
25291279|NCT01190930|50606295|FG003|Induction|Withdrawal by Subject|0|||
25291280|NCT01190930|50606296|FG004|Induction|Withdrawal by Subject|0|||
25291281|NCT01190930|50606297|FG005|Induction|Withdrawal by Subject|0|||
25291282|NCT01190930|50606298|FG006|Induction|Withdrawal by Subject|0|||
25291283|NCT01190930|50606299|FG007|Induction|Withdrawal by Subject|0|||
25291284|NCT01190930|50606300|FG008|Induction|Withdrawal by Subject|0|||
25291285|NCT01190930|50606301|FG009|Induction|Withdrawal by Subject|0|||
25291286|NCT01190930|50606292|FG000|Induction|Refusal|235|||
25291287|NCT01190930|50606293|FG001|Induction|Refusal|0|||
25291288|NCT01190930|50606294|FG002|Induction|Refusal|0|||
25291289|NCT01190930|50606295|FG003|Induction|Refusal|0|||
25291290|NCT01190930|50606296|FG004|Induction|Refusal|0|||
25291291|NCT01190930|50606297|FG005|Induction|Refusal|0|||
25291292|NCT01190930|50606298|FG006|Induction|Refusal|0|||
25291293|NCT01190930|50606299|FG007|Induction|Refusal|0|||
25291294|NCT01190930|50606300|FG008|Induction|Refusal|0|||
25291295|NCT01190930|50606301|FG009|Induction|Refusal|0|||
25291296|NCT01190930|50606292|FG000|Induction|Inevaluable|23|||
25291297|NCT01190930|50606293|FG001|Induction|Inevaluable|1|||
25291298|NCT01190930|50606294|FG002|Induction|Inevaluable|0|||
25291299|NCT01190930|50606295|FG003|Induction|Inevaluable|0|||
25291300|NCT01190930|50606296|FG004|Induction|Inevaluable|0|||
25291301|NCT01190930|50606297|FG005|Induction|Inevaluable|0|||
25291302|NCT01190930|50606298|FG006|Induction|Inevaluable|0|||
25291303|NCT01190930|50606299|FG007|Induction|Inevaluable|0|||
25291304|NCT01190930|50606300|FG008|Induction|Inevaluable|0|||
25291305|NCT01190930|50606301|FG009|Induction|Inevaluable|0|||
25291306|NCT01190930|50606292|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
25291307|NCT01190930|50606293|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
25291308|NCT01190930|50606294|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
25291309|NCT01190930|50606295|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
25291310|NCT01190930|50606296|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
25291311|NCT01190930|50606297|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
25291312|NCT01190930|50606298|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
25291313|NCT01190930|50606299|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
24969736|NCT00117312|50059184|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
25191674|NCT01490450|50352895|FG000|Period 1|Request to discontinue treatment|1|||
25291314|NCT01190930|50606300|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
25291315|NCT01190930|50606301|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
25291316|NCT01190930|50606292|FG000|Induction|High Risk Downs|80|||
25291317|NCT01190930|50606293|FG001|Induction|High Risk Downs|0|||
25291318|NCT01190930|50606294|FG002|Induction|High Risk Downs|0|||
25291319|NCT01190930|50606295|FG003|Induction|High Risk Downs|0|||
25291320|NCT01190930|50606296|FG004|Induction|High Risk Downs|0|||
25291321|NCT01190930|50606297|FG005|Induction|High Risk Downs|0|||
25291322|NCT01190930|50606298|FG006|Induction|High Risk Downs|0|||
25291323|NCT01190930|50606299|FG007|Induction|High Risk Downs|0|||
25291324|NCT01190930|50606300|FG008|Induction|High Risk Downs|0|||
25291325|NCT01190930|50606301|FG009|Induction|High Risk Downs|0|||
25291326|NCT01190930|50606292|FG000|Induction|Enrollment onto another COG Protocol|1|||
25291327|NCT01190930|50606293|FG001|Induction|Enrollment onto another COG Protocol|0|||
25291328|NCT01190930|50606294|FG002|Induction|Enrollment onto another COG Protocol|0|||
25291329|NCT01190930|50606295|FG003|Induction|Enrollment onto another COG Protocol|0|||
25291330|NCT01190930|50606296|FG004|Induction|Enrollment onto another COG Protocol|0|||
25291331|NCT01190930|50606297|FG005|Induction|Enrollment onto another COG Protocol|0|||
25291332|NCT01190930|50606298|FG006|Induction|Enrollment onto another COG Protocol|0|||
25291333|NCT01190930|50606299|FG007|Induction|Enrollment onto another COG Protocol|0|||
25291334|NCT01190930|50606300|FG008|Induction|Enrollment onto another COG Protocol|0|||
25291335|NCT01190930|50606301|FG009|Induction|Enrollment onto another COG Protocol|0|||
25291336|NCT01190930|50606292|FG000|Induction|Average Risk|1847|||
25291337|NCT01190930|50606293|FG001|Induction|Average Risk|0|||
25291338|NCT01190930|50606294|FG002|Induction|Average Risk|0|||
25291339|NCT01190930|50606295|FG003|Induction|Average Risk|0|||
25291340|NCT01190930|50606296|FG004|Induction|Average Risk|0|||
25291341|NCT01190930|50606297|FG005|Induction|Average Risk|0|||
25291342|NCT01190930|50606298|FG006|Induction|Average Risk|0|||
25291343|NCT01190930|50606299|FG007|Induction|Average Risk|0|||
25291344|NCT01190930|50606300|FG008|Induction|Average Risk|0|||
25291345|NCT01190930|50606301|FG009|Induction|Average Risk|0|||
25291346|NCT01190930|50606292|FG000|Induction|High Risk|1227|||
25291347|NCT01190930|50606293|FG001|Induction|High Risk|0|||
25291348|NCT01190930|50606294|FG002|Induction|High Risk|0|||
25291349|NCT01190930|50606295|FG003|Induction|High Risk|0|||
25291350|NCT01190930|50606296|FG004|Induction|High Risk|0|||
25291351|NCT01190930|50606297|FG005|Induction|High Risk|0|||
25291352|NCT01190930|50606298|FG006|Induction|High Risk|0|||
25291353|NCT01190930|50606299|FG007|Induction|High Risk|0|||
25291354|NCT01190930|50606300|FG008|Induction|High Risk|0|||
25291355|NCT01190930|50606301|FG009|Induction|High Risk|0|||
25291356|NCT01190930|50606292|FG000|Induction|Low Risk|443|||
25291357|NCT01190930|50606293|FG001|Induction|Low Risk|0|||
25291358|NCT01190930|50606294|FG002|Induction|Low Risk|0|||
25291359|NCT01190930|50606295|FG003|Induction|Low Risk|0|||
25291360|NCT01190930|50606296|FG004|Induction|Low Risk|0|||
25291361|NCT01190930|50606297|FG005|Induction|Low Risk|0|||
25291362|NCT01190930|50606298|FG006|Induction|Low Risk|0|||
25291363|NCT01190930|50606299|FG007|Induction|Low Risk|0|||
25291364|NCT01190930|50606300|FG008|Induction|Low Risk|0|||
25291365|NCT01190930|50606301|FG009|Induction|Low Risk|0|||
25291366|NCT01190930|50606292|FG000|Induction|Very High Risk|1012|||
25291367|NCT01190930|50606293|FG001|Induction|Very High Risk|0|||
25291368|NCT01190930|50606294|FG002|Induction|Very High Risk|0|||
25291369|NCT01190930|50606295|FG003|Induction|Very High Risk|0|||
25291370|NCT01190930|50606296|FG004|Induction|Very High Risk|0|||
25291371|NCT01190930|50606297|FG005|Induction|Very High Risk|0|||
25291372|NCT01190930|50606298|FG006|Induction|Very High Risk|0|||
25291373|NCT01190930|50606299|FG007|Induction|Very High Risk|0|||
25291374|NCT01190930|50606300|FG008|Induction|Very High Risk|0|||
25291375|NCT01190930|50606301|FG009|Induction|Very High Risk|0|||
25291376|NCT01190930|50606292|FG000|Induction|Philadelphia chromosome-positive|99|||
25291377|NCT01190930|50606293|FG001|Induction|Philadelphia chromosome-positive|0|||
25291378|NCT01190930|50606294|FG002|Induction|Philadelphia chromosome-positive|0|||
25291379|NCT01190930|50606295|FG003|Induction|Philadelphia chromosome-positive|0|||
25291380|NCT01190930|50606296|FG004|Induction|Philadelphia chromosome-positive|0|||
25291381|NCT01190930|50606297|FG005|Induction|Philadelphia chromosome-positive|0|||
25291382|NCT01190930|50606298|FG006|Induction|Philadelphia chromosome-positive|0|||
25291383|NCT01190930|50606299|FG007|Induction|Philadelphia chromosome-positive|0|||
25291384|NCT01190930|50606300|FG008|Induction|Philadelphia chromosome-positive|0|||
25291385|NCT01190930|50606301|FG009|Induction|Philadelphia chromosome-positive|0|||
25291386|NCT01190930|50606292|FG000|Induction|Incomplete Induction data|63|||
25291387|NCT01190930|50606293|FG001|Induction|Incomplete Induction data|0|||
25291388|NCT01190930|50606294|FG002|Induction|Incomplete Induction data|0|||
25291389|NCT01190930|50606295|FG003|Induction|Incomplete Induction data|0|||
25291390|NCT01190930|50606296|FG004|Induction|Incomplete Induction data|0|||
25291391|NCT01190930|50606297|FG005|Induction|Incomplete Induction data|0|||
25070360|NCT02603120|50176294|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
25291392|NCT01190930|50606298|FG006|Induction|Incomplete Induction data|0|||
25291393|NCT01190930|50606299|FG007|Induction|Incomplete Induction data|0|||
25291394|NCT01190930|50606300|FG008|Induction|Incomplete Induction data|0|||
25291395|NCT01190930|50606301|FG009|Induction|Incomplete Induction data|0|||
25291396|NCT01190930|50606292|FG000|Induction|Progressive disease|0|||
25291397|NCT01190930|50606293|FG001|Induction|Progressive disease|1|||
25291398|NCT01190930|50606294|FG002|Induction|Progressive disease|0|||
25291399|NCT01190930|50606295|FG003|Induction|Progressive disease|0|||
25291400|NCT01190930|50606296|FG004|Induction|Progressive disease|0|||
25291401|NCT01190930|50606297|FG005|Induction|Progressive disease|0|||
25291402|NCT01190930|50606298|FG006|Induction|Progressive disease|0|||
25291403|NCT01190930|50606299|FG007|Induction|Progressive disease|0|||
25291404|NCT01190930|50606300|FG008|Induction|Progressive disease|0|||
25291405|NCT01190930|50606301|FG009|Induction|Progressive disease|0|||
25291406|NCT01190930|50606292|FG000|Induction|No treatment|3|||
25291407|NCT01190930|50606293|FG001|Induction|No treatment|0|||
25291408|NCT01190930|50606294|FG002|Induction|No treatment|0|||
25291409|NCT01190930|50606295|FG003|Induction|No treatment|0|||
25291410|NCT01190930|50606296|FG004|Induction|No treatment|0|||
25291411|NCT01190930|50606297|FG005|Induction|No treatment|0|||
25291412|NCT01190930|50606298|FG006|Induction|No treatment|0|||
25291413|NCT01190930|50606299|FG007|Induction|No treatment|0|||
25291414|NCT01190930|50606300|FG008|Induction|No treatment|0|||
25291415|NCT01190930|50606301|FG009|Induction|No treatment|0|||
25291416|NCT01190930|50606292|FG000|Induction|Ineligible|69|||
25169254|NCT01865747|50300614|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
25169255|NCT01865747|50300615|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
25169256|NCT01865747|50300614|FG000|Primary Intent to Treat (PITT)|Other|0|||
25169257|NCT01865747|50300615|FG001|Primary Intent to Treat (PITT)|Other|1|||
25169258|NCT01843673|50300656|FG000|Overall Study|Lack of Efficacy|2|||
25169259|NCT01843673|50300656|FG000|Overall Study|Withdrawal by Subject|4|||
25169260|NCT01843205|50300675|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
25291417|NCT01190930|50606293|FG001|Induction|Ineligible|4|||
25291418|NCT01190930|50606294|FG002|Induction|Ineligible|0|||
25291419|NCT01190930|50606295|FG003|Induction|Ineligible|0|||
25291420|NCT01190930|50606296|FG004|Induction|Ineligible|0|||
25291421|NCT01190930|50606297|FG005|Induction|Ineligible|0|||
25291422|NCT01190930|50606298|FG006|Induction|Ineligible|0|||
25291423|NCT01190930|50606299|FG007|Induction|Ineligible|0|||
25291424|NCT01190930|50606300|FG008|Induction|Ineligible|0|||
25291425|NCT01190930|50606301|FG009|Induction|Ineligible|0|||
25291426|NCT01190930|50606292|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
25291427|NCT01190930|50606293|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
25291428|NCT01190930|50606294|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
25291429|NCT01190930|50606295|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
25291430|NCT01190930|50606296|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
25291431|NCT01190930|50606297|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
25291432|NCT01190930|50606298|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
25291433|NCT01190930|50606299|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
25291434|NCT01190930|50606300|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
25291435|NCT01190930|50606301|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
25291436|NCT01190930|50606292|FG000|Post Induction Pre-Maintenance|Death|0|||
25291437|NCT01190930|50606293|FG001|Post Induction Pre-Maintenance|Death|0|||
25291438|NCT01190930|50606294|FG002|Post Induction Pre-Maintenance|Death|8|||
25291439|NCT01190930|50606295|FG003|Post Induction Pre-Maintenance|Death|4|||
25291440|NCT01190930|50606296|FG004|Post Induction Pre-Maintenance|Death|0|||
25291441|NCT01190930|50606297|FG005|Post Induction Pre-Maintenance|Death|0|||
25291442|NCT01190930|50606298|FG006|Post Induction Pre-Maintenance|Death|0|||
25291443|NCT01190930|50606299|FG007|Post Induction Pre-Maintenance|Death|0|||
25291444|NCT01190930|50606300|FG008|Post Induction Pre-Maintenance|Death|0|||
25291445|NCT01190930|50606301|FG009|Post Induction Pre-Maintenance|Death|0|||
25291446|NCT01190930|50606292|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
25291447|NCT01190930|50606293|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
25291448|NCT01190930|50606294|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
25291449|NCT01190930|50606295|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
25291450|NCT01190930|50606296|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
25291451|NCT01190930|50606297|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
25291452|NCT01190930|50606298|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
25291453|NCT01190930|50606299|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
25291454|NCT01190930|50606300|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
25291455|NCT01190930|50606301|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
25291456|NCT01190930|50606292|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
25291457|NCT01190930|50606293|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
25291458|NCT01190930|50606294|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
25291459|NCT01190930|50606295|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
25291460|NCT01190930|50606296|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
25291461|NCT01190930|50606297|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
25291462|NCT01190930|50606298|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
25291463|NCT01190930|50606299|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
25169261|NCT01843205|50300676|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
25291464|NCT01190930|50606300|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
25291465|NCT01190930|50606301|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
25291466|NCT01190930|50606292|FG000|Post Induction Pre-Maintenance|Refusal|0|||
25291467|NCT01190930|50606293|FG001|Post Induction Pre-Maintenance|Refusal|2|||
25291468|NCT01190930|50606294|FG002|Post Induction Pre-Maintenance|Refusal|694|||
25291469|NCT01190930|50606295|FG003|Post Induction Pre-Maintenance|Refusal|4|||
25291470|NCT01190930|50606296|FG004|Post Induction Pre-Maintenance|Refusal|0|||
25291471|NCT01190930|50606297|FG005|Post Induction Pre-Maintenance|Refusal|3|||
25291472|NCT01190930|50606298|FG006|Post Induction Pre-Maintenance|Refusal|0|||
25291473|NCT01190930|50606299|FG007|Post Induction Pre-Maintenance|Refusal|0|||
25291474|NCT01190930|50606300|FG008|Post Induction Pre-Maintenance|Refusal|0|||
25291475|NCT01190930|50606301|FG009|Post Induction Pre-Maintenance|Refusal|0|||
25291476|NCT01190930|50606292|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
25291477|NCT01190930|50606293|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
25291478|NCT01190930|50606294|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
25291479|NCT01190930|50606295|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
25291480|NCT01190930|50606296|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
25291481|NCT01190930|50606297|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
25291482|NCT01190930|50606298|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
25291483|NCT01190930|50606299|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
25291484|NCT01190930|50606300|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
25291485|NCT01190930|50606301|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
25291486|NCT01190930|50606292|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
25291487|NCT01190930|50606293|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
25291488|NCT01190930|50606294|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
25291489|NCT01190930|50606295|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
25291490|NCT01190930|50606296|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
25291491|NCT01190930|50606297|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
25291492|NCT01190930|50606298|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
25291493|NCT01190930|50606299|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
25291494|NCT01190930|50606300|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
25291495|NCT01190930|50606301|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
25291496|NCT01190930|50606292|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
25291497|NCT01190930|50606293|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
25291498|NCT01190930|50606294|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
25291499|NCT01190930|50606295|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
25291500|NCT01190930|50606296|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
25291501|NCT01190930|50606297|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
25291502|NCT01190930|50606298|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
25291503|NCT01190930|50606299|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
25291504|NCT01190930|50606300|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
25291505|NCT01190930|50606301|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
25291506|NCT01190930|50606292|FG000|Post Induction Pre-Maintenance|Relapse|0|||
25291507|NCT01190930|50606293|FG001|Post Induction Pre-Maintenance|Relapse|0|||
25291508|NCT01190930|50606294|FG002|Post Induction Pre-Maintenance|Relapse|1|||
25291509|NCT01190930|50606295|FG003|Post Induction Pre-Maintenance|Relapse|0|||
25291510|NCT01190930|50606296|FG004|Post Induction Pre-Maintenance|Relapse|0|||
25291511|NCT01190930|50606297|FG005|Post Induction Pre-Maintenance|Relapse|0|||
25291512|NCT01190930|50606298|FG006|Post Induction Pre-Maintenance|Relapse|0|||
25291513|NCT01190930|50606299|FG007|Post Induction Pre-Maintenance|Relapse|0|||
25291514|NCT01190930|50606300|FG008|Post Induction Pre-Maintenance|Relapse|0|||
25291515|NCT01190930|50606301|FG009|Post Induction Pre-Maintenance|Relapse|0|||
25291516|NCT01190930|50606292|FG000|Maintenance|Adverse Event|0|||
25291517|NCT01190930|50606293|FG001|Maintenance|Adverse Event|0|||
25291518|NCT01190930|50606294|FG002|Maintenance|Adverse Event|0|||
25291519|NCT01190930|50606295|FG003|Maintenance|Adverse Event|0|||
25291520|NCT01190930|50606296|FG004|Maintenance|Adverse Event|0|||
25291521|NCT01190930|50606297|FG005|Maintenance|Adverse Event|1|||
25291522|NCT01190930|50606298|FG006|Maintenance|Adverse Event|1|||
25291523|NCT01190930|50606299|FG007|Maintenance|Adverse Event|3|||
25291524|NCT01190930|50606300|FG008|Maintenance|Adverse Event|3|||
25291525|NCT01190930|50606301|FG009|Maintenance|Adverse Event|0|||
25291526|NCT01190930|50606292|FG000|Maintenance|Death|0|||
25291527|NCT01190930|50606293|FG001|Maintenance|Death|0|||
25291528|NCT01190930|50606294|FG002|Maintenance|Death|0|||
25291529|NCT01190930|50606295|FG003|Maintenance|Death|1|||
25291530|NCT01190930|50606296|FG004|Maintenance|Death|0|||
25291531|NCT01190930|50606297|FG005|Maintenance|Death|0|||
25291532|NCT01190930|50606298|FG006|Maintenance|Death|2|||
25291533|NCT01190930|50606299|FG007|Maintenance|Death|2|||
25291534|NCT01190930|50606300|FG008|Maintenance|Death|2|||
25291535|NCT01190930|50606301|FG009|Maintenance|Death|2|||
25191675|NCT01490450|50352896|FG001|Period 1|Request to discontinue treatment|0|||
25291536|NCT01190930|50606292|FG000|Maintenance|Lost to Follow-up|0|||
25291537|NCT01190930|50606293|FG001|Maintenance|Lost to Follow-up|0|||
25291538|NCT01190930|50606294|FG002|Maintenance|Lost to Follow-up|0|||
25291539|NCT01190930|50606295|FG003|Maintenance|Lost to Follow-up|0|||
25291540|NCT01190930|50606296|FG004|Maintenance|Lost to Follow-up|0|||
25291541|NCT01190930|50606297|FG005|Maintenance|Lost to Follow-up|0|||
25291542|NCT01190930|50606298|FG006|Maintenance|Lost to Follow-up|1|||
25291543|NCT01190930|50606299|FG007|Maintenance|Lost to Follow-up|1|||
25291544|NCT01190930|50606300|FG008|Maintenance|Lost to Follow-up|1|||
25291545|NCT01190930|50606301|FG009|Maintenance|Lost to Follow-up|0|||
25291546|NCT01190930|50606292|FG000|Maintenance|Physician Decision|0|||
25291547|NCT01190930|50606293|FG001|Maintenance|Physician Decision|1|||
25291548|NCT01190930|50606294|FG002|Maintenance|Physician Decision|0|||
25070361|NCT02603120|50176293|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
25070362|NCT02603120|50176294|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
25070363|NCT02603120|50176293|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
25070364|NCT02603120|50176294|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
25070365|NCT02603120|50176293|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
25070366|NCT02603120|50176294|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
25070367|NCT02603120|50176293|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
25070368|NCT02603120|50176294|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
25070369|NCT02603120|50176293|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
25070370|NCT02603120|50176294|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
25070371|NCT02603120|50176293|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
25070372|NCT02603120|50176294|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
25070373|NCT02599688|50176302|FG000|Overall Study|Lack of Efficacy|1|||
25070374|NCT02599688|50176302|FG000|Overall Study|Withdrawal by Subject|1|||
25070375|NCT02599688|50176302|FG000|Overall Study|Termination by Sponsor|2|||
25070376|NCT01331681|50176309|FG000|Overall Study|Adverse Event|10|||
25070377|NCT01331681|50176310|FG001|Overall Study|Adverse Event|13|||
25070378|NCT01331681|50176311|FG002|Overall Study|Adverse Event|10|||
25070379|NCT01331681|50176309|FG000|Overall Study|Death|6|||
25070380|NCT01331681|50176310|FG001|Overall Study|Death|6|||
25070381|NCT01331681|50176311|FG002|Overall Study|Death|2|||
25070382|NCT01331681|50176309|FG000|Overall Study|Lack of Efficacy|0|||
25070383|NCT01331681|50176310|FG001|Overall Study|Lack of Efficacy|1|||
25070384|NCT01331681|50176311|FG002|Overall Study|Lack of Efficacy|0|||
25070385|NCT01331681|50176309|FG000|Overall Study|Withdrawal by Subject|12|||
25070386|NCT01331681|50176310|FG001|Overall Study|Withdrawal by Subject|8|||
25070387|NCT01331681|50176311|FG002|Overall Study|Withdrawal by Subject|15|||
25070388|NCT01331681|50176309|FG000|Overall Study|Protocol Violation|1|||
25070389|NCT01331681|50176310|FG001|Overall Study|Protocol Violation|1|||
25070390|NCT01331681|50176311|FG002|Overall Study|Protocol Violation|0|||
25070391|NCT01331681|50176309|FG000|Overall Study|Lost to Follow-up|2|||
25070392|NCT01331681|50176310|FG001|Overall Study|Lost to Follow-up|4|||
25070393|NCT01331681|50176311|FG002|Overall Study|Lost to Follow-up|1|||
25070394|NCT01331681|50176309|FG000|Overall Study|Physician Decision|2|||
25070395|NCT01331681|50176310|FG001|Overall Study|Physician Decision|0|||
25070396|NCT01331681|50176311|FG002|Overall Study|Physician Decision|4|||
25070397|NCT01331681|50176309|FG000|Overall Study|Therapeutic procedure required|1|||
25070398|NCT01331681|50176310|FG001|Overall Study|Therapeutic procedure required|0|||
25070399|NCT01331681|50176311|FG002|Overall Study|Therapeutic procedure required|0|||
25070400|NCT01331681|50176309|FG000|Overall Study|Sponsor decision|1|||
25070401|NCT01331681|50176310|FG001|Overall Study|Sponsor decision|1|||
25070402|NCT01331681|50176311|FG002|Overall Study|Sponsor decision|0|||
25070403|NCT01331681|50176309|FG000|Overall Study|Switching to other therapy|0|||
25070404|NCT01331681|50176310|FG001|Overall Study|Switching to other therapy|0|||
25070405|NCT01331681|50176311|FG002|Overall Study|Switching to other therapy|1|||
25070406|NCT01331681|50176309|FG000|Overall Study|Not Received Study Treatment|0|||
25070407|NCT01331681|50176310|FG001|Overall Study|Not Received Study Treatment|0|||
25070408|NCT01331681|50176311|FG002|Overall Study|Not Received Study Treatment|2|||
25070409|NCT01331291|50176321|FG000|Overall Study|Lack of Efficacy|2|||
25070410|NCT01331291|50176322|FG001|Overall Study|Lack of Efficacy|8|||
25070411|NCT01331291|50176321|FG000|Overall Study|Death|0|||
25070412|NCT01331291|50176322|FG001|Overall Study|Death|1|||
25070413|NCT02601560|50176335|FG000|Overall Study|Other|0|||
25070414|NCT02601560|50176336|FG001|Overall Study|Other|0|||
25070415|NCT02601560|50176337|FG002|Overall Study|Other|0|||
25070416|NCT02601560|50176338|FG003|Overall Study|Other|0|||
25070417|NCT02601560|50176339|FG004|Overall Study|Other|0|||
25070418|NCT02601560|50176340|FG005|Overall Study|Other|0|||
25070419|NCT02601560|50176341|FG006|Overall Study|Other|1|||
25070420|NCT02601560|50176342|FG007|Overall Study|Other|0|||
25070421|NCT02595398|50176373|FG000|Overall Study|Non-compliance|1|||
25070422|NCT02595398|50176374|FG001|Overall Study|Non-compliance|0|||
25070423|NCT02595398|50176373|FG000|Overall Study|Withdrawal by Subject|2|||
25070424|NCT02595398|50176374|FG001|Overall Study|Withdrawal by Subject|1|||
25070425|NCT02595398|50176373|FG000|Overall Study|Lost to Follow-up|1|||
25070426|NCT02595398|50176374|FG001|Overall Study|Lost to Follow-up|0|||
25070427|NCT01368497|50176380|FG000|Overall Study|Lost to Follow-up|2|||
25169262|NCT01835015|50300763|FG000|Overall Study|Adverse Event|0|||
25169263|NCT01835015|50300764|FG001|Overall Study|Adverse Event|0|||
25070428|NCT02595008|50176386|FG000|Overall Study|Enrolled In Error|1|||
25070429|NCT02595008|50176387|FG001|Overall Study|Enrolled In Error|0|||
25070430|NCT02598128|50176393|FG000|Period A: Days -7 to -1|Adverse Event|1|||
25070431|NCT02598128|50176394|FG001|Period A: Days -7 to -1|Adverse Event|0|||
25070432|NCT02598128|50176395|FG002|Period A: Days -7 to -1|Adverse Event|0|||
25070433|NCT02598128|50176396|FG003|Period A: Days -7 to -1|Adverse Event|0|||
25070434|NCT02788175|50176408|FG000|Overall Study|Protocol Violation|3|||
25070435|NCT02788175|50176408|FG000|Overall Study|Withdrawal by Subject|4|||
25291549|NCT01190930|50606295|FG003|Maintenance|Physician Decision|5|||
25291550|NCT01190930|50606296|FG004|Maintenance|Physician Decision|9|||
25291551|NCT01190930|50606297|FG005|Maintenance|Physician Decision|4|||
25291552|NCT01190930|50606298|FG006|Maintenance|Physician Decision|8|||
25291553|NCT01190930|50606299|FG007|Maintenance|Physician Decision|8|||
25291554|NCT01190930|50606300|FG008|Maintenance|Physician Decision|10|||
25291555|NCT01190930|50606301|FG009|Maintenance|Physician Decision|17|||
25291556|NCT01190930|50606292|FG000|Maintenance|Withdrawal by Subject|0|||
25291557|NCT01190930|50606293|FG001|Maintenance|Withdrawal by Subject|0|||
25291558|NCT01190930|50606294|FG002|Maintenance|Withdrawal by Subject|0|||
25291559|NCT01190930|50606295|FG003|Maintenance|Withdrawal by Subject|0|||
25291560|NCT01190930|50606296|FG004|Maintenance|Withdrawal by Subject|0|||
25291561|NCT01190930|50606297|FG005|Maintenance|Withdrawal by Subject|0|||
25291562|NCT01190930|50606298|FG006|Maintenance|Withdrawal by Subject|2|||
25291563|NCT01190930|50606299|FG007|Maintenance|Withdrawal by Subject|1|||
25291564|NCT01190930|50606300|FG008|Maintenance|Withdrawal by Subject|4|||
25291565|NCT01190930|50606301|FG009|Maintenance|Withdrawal by Subject|1|||
25291566|NCT01190930|50606292|FG000|Maintenance|Refusal|0|||
25291567|NCT01190930|50606293|FG001|Maintenance|Refusal|1|||
25291568|NCT01190930|50606294|FG002|Maintenance|Refusal|0|||
25291569|NCT01190930|50606295|FG003|Maintenance|Refusal|2|||
25291570|NCT01190930|50606296|FG004|Maintenance|Refusal|0|||
25291571|NCT01190930|50606297|FG005|Maintenance|Refusal|4|||
25291572|NCT01190930|50606298|FG006|Maintenance|Refusal|5|||
25291573|NCT01190930|50606299|FG007|Maintenance|Refusal|17|||
25291574|NCT01190930|50606300|FG008|Maintenance|Refusal|13|||
25291575|NCT01190930|50606301|FG009|Maintenance|Refusal|6|||
25291576|NCT01190930|50606292|FG000|Maintenance|second malignant neoplasm|0|||
25291577|NCT01190930|50606293|FG001|Maintenance|second malignant neoplasm|0|||
25291578|NCT01190930|50606294|FG002|Maintenance|second malignant neoplasm|0|||
25291579|NCT01190930|50606295|FG003|Maintenance|second malignant neoplasm|1|||
25291580|NCT01190930|50606296|FG004|Maintenance|second malignant neoplasm|0|||
25291581|NCT01190930|50606297|FG005|Maintenance|second malignant neoplasm|1|||
25291582|NCT01190930|50606298|FG006|Maintenance|second malignant neoplasm|0|||
25291583|NCT01190930|50606299|FG007|Maintenance|second malignant neoplasm|0|||
25291584|NCT01190930|50606300|FG008|Maintenance|second malignant neoplasm|1|||
25291585|NCT01190930|50606301|FG009|Maintenance|second malignant neoplasm|0|||
25291586|NCT01190930|50606292|FG000|Maintenance|Inevaluable|0|||
25291587|NCT01190930|50606293|FG001|Maintenance|Inevaluable|0|||
25291588|NCT01190930|50606294|FG002|Maintenance|Inevaluable|0|||
25291589|NCT01190930|50606295|FG003|Maintenance|Inevaluable|0|||
25291590|NCT01190930|50606296|FG004|Maintenance|Inevaluable|0|||
25291591|NCT01190930|50606297|FG005|Maintenance|Inevaluable|1|||
25291592|NCT01190930|50606298|FG006|Maintenance|Inevaluable|1|||
25291593|NCT01190930|50606299|FG007|Maintenance|Inevaluable|1|||
25291594|NCT01190930|50606300|FG008|Maintenance|Inevaluable|0|||
25291595|NCT01190930|50606301|FG009|Maintenance|Inevaluable|0|||
25291596|NCT01190930|50606292|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
25291597|NCT01190930|50606293|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
25291598|NCT01190930|50606294|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
25291599|NCT01190930|50606295|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
25291600|NCT01190930|50606296|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
25291601|NCT01190930|50606297|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
25291602|NCT01190930|50606298|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
25291603|NCT01190930|50606299|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
25291604|NCT01190930|50606300|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
25291605|NCT01190930|50606301|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
25291606|NCT01190930|50606292|FG000|Maintenance|Relapse|0|||
25291607|NCT01190930|50606293|FG001|Maintenance|Relapse|0|||
25291608|NCT01190930|50606294|FG002|Maintenance|Relapse|0|||
25291609|NCT01190930|50606295|FG003|Maintenance|Relapse|2|||
25291610|NCT01190930|50606296|FG004|Maintenance|Relapse|0|||
25291611|NCT01190930|50606297|FG005|Maintenance|Relapse|1|||
24969737|NCT00117312|50059185|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
25070436|NCT02788175|50176408|FG000|Overall Study|Ineligible prior to study agent|6|||
25291612|NCT01190930|50606298|FG006|Maintenance|Relapse|6|||
25291613|NCT01190930|50606299|FG007|Maintenance|Relapse|13|||
25291614|NCT01190930|50606300|FG008|Maintenance|Relapse|11|||
24969738|NCT00117312|50059186|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
25291615|NCT01190930|50606301|FG009|Maintenance|Relapse|11|||
25291616|NCT01190930|50606292|FG000|Maintenance|Still on therapy|0|||
25291617|NCT01190930|50606293|FG001|Maintenance|Still on therapy|8|||
25291618|NCT01190930|50606294|FG002|Maintenance|Still on therapy|0|||
25291619|NCT01190930|50606295|FG003|Maintenance|Still on therapy|29|||
25291620|NCT01190930|50606296|FG004|Maintenance|Still on therapy|0|||
25291621|NCT01190930|50606297|FG005|Maintenance|Still on therapy|0|||
25291622|NCT01190930|50606298|FG006|Maintenance|Still on therapy|0|||
25291623|NCT01190930|50606299|FG007|Maintenance|Still on therapy|0|||
25291624|NCT01190930|50606300|FG008|Maintenance|Still on therapy|0|||
25291625|NCT01190930|50606301|FG009|Maintenance|Still on therapy|0|||
25291626|NCT01101191|50606325|FG000|Period 1|Withdrawal by Subject|1|||
25291627|NCT01101191|50606326|FG001|Period 1|Withdrawal by Subject|0|||
25291628|NCT01101191|50606325|FG000|Period 1|Adverse Event|1|||
25291629|NCT01101191|50606326|FG001|Period 1|Adverse Event|2|||
25291630|NCT01178762|50606333|FG000|Overall Study|Lost to Follow-up|15|||
25291631|NCT01178294|50606337|FG000|Overall Study|Adverse Event|4|||
25291632|NCT01178294|50606337|FG000|Overall Study|Lost to Follow-up|2|||
25291633|NCT01178294|50606337|FG000|Overall Study|Lack of Efficacy|1|||
25291634|NCT01178294|50606337|FG000|Overall Study|Death|1|||
25291635|NCT01178294|50606337|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
25291636|NCT01178294|50606337|FG000|Overall Study|Subject status is terminal|1|||
25291637|NCT01178294|50606337|FG000|Overall Study|Completion status could not be verified|1|||
25291638|NCT01178138|50606341|FG000|Overall Study|Lost to Follow-up|8|||
25291639|NCT01178138|50606341|FG000|Overall Study|Withdrawal by Subject|7|||
25291640|NCT01178138|50606341|FG000|Overall Study|Physician Decision|8|||
25291641|NCT01177670|50606350|FG000|Overall Study|Study Terminated|115|||
25291642|NCT01177670|50606350|FG000|Overall Study|Physician Decision|50|||
25291643|NCT01177670|50606350|FG000|Overall Study|Withdrawal by Subject|4|||
25291644|NCT01190228|50606357|FG000|Overall Study|Protocol Violation|4|||
25291645|NCT01190228|50606358|FG001|Overall Study|Protocol Violation|0|||
25291646|NCT01190228|50606359|FG002|Overall Study|Protocol Violation|0|||
25291647|NCT01190228|50606357|FG000|Overall Study|Withdrawal by Subject|1|||
25291648|NCT01190228|50606358|FG001|Overall Study|Withdrawal by Subject|0|||
25291649|NCT01190228|50606359|FG002|Overall Study|Withdrawal by Subject|0|||
25291650|NCT01009086|50606372|FG000|Overall Study|Lack of Efficacy|16|||
25291651|NCT01009086|50606373|FG001|Overall Study|Lack of Efficacy|15|||
25291652|NCT01009086|50606374|FG002|Overall Study|Lack of Efficacy|9|||
25291653|NCT01009086|50606372|FG000|Overall Study|Lost to Follow-up|4|||
25291654|NCT01009086|50606373|FG001|Overall Study|Lost to Follow-up|5|||
25291655|NCT01009086|50606374|FG002|Overall Study|Lost to Follow-up|3|||
25291656|NCT01009086|50606372|FG000|Overall Study|Adverse Event|12|||
25291657|NCT01009086|50606373|FG001|Overall Study|Adverse Event|11|||
25291658|NCT01009086|50606374|FG002|Overall Study|Adverse Event|8|||
25291659|NCT01009086|50606372|FG000|Overall Study|Withdrawal by Subject|9|||
25291660|NCT01009086|50606373|FG001|Overall Study|Withdrawal by Subject|11|||
25291661|NCT01009086|50606374|FG002|Overall Study|Withdrawal by Subject|13|||
25291662|NCT01009086|50606372|FG000|Overall Study|Other|3|||
25291663|NCT01009086|50606373|FG001|Overall Study|Other|5|||
25291664|NCT01009086|50606374|FG002|Overall Study|Other|1|||
25291665|NCT01190150|50606389|FG000|First Treatment|Withdrawal by Subject|1|||
25291666|NCT01190150|50606390|FG001|First Treatment|Withdrawal by Subject|0|||
25291667|NCT01190150|50606389|FG000|Washout|Withdrawal by Subject|0|||
25291668|NCT01190150|50606390|FG001|Washout|Withdrawal by Subject|1|||
25291669|NCT01190150|50606389|FG000|Washout|Difficulty in adherence|0|||
25291670|NCT01190150|50606390|FG001|Washout|Difficulty in adherence|1|||
25291671|NCT01001520|50606396|FG000|Medication Period 1|Withdrawal by Subject|2|||
25291672|NCT01001520|50606397|FG001|Medication Period 1|Withdrawal by Subject|2|||
25291673|NCT01001520|50606396|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
25291674|NCT01001520|50606397|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
25291675|NCT01001520|50606396|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
25291676|NCT01001520|50606397|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
25291677|NCT01001520|50606396|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
25291678|NCT01001520|50606397|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
25291679|NCT01001520|50606396|FG000|Washout Period|Withdrawal by Subject|2|||
25291680|NCT01001520|50606397|FG001|Washout Period|Withdrawal by Subject|1|||
25291681|NCT01001520|50606396|FG000|Medication Period 2|Withdrawal by Subject|0|||
25291682|NCT01001520|50606397|FG001|Medication Period 2|Withdrawal by Subject|3|||
25291683|NCT01189604|50606421|FG000|Overall Study|Impossible to visit|0|||
25291684|NCT01189604|50606422|FG001|Overall Study|Impossible to visit|0|||
25291685|NCT01189604|50606423|FG002|Overall Study|Impossible to visit|0|||
25291686|NCT01189604|50606424|FG003|Overall Study|Impossible to visit|0|||
25291687|NCT01189604|50606425|FG004|Overall Study|Impossible to visit|0|||
25291688|NCT01189604|50606426|FG005|Overall Study|Impossible to visit|1|||
25291689|NCT01189604|50606427|FG006|Overall Study|Impossible to visit|0|||
25291690|NCT01189604|50606421|FG000|Overall Study|Adverse Event|0|||
25291691|NCT01189604|50606422|FG001|Overall Study|Adverse Event|1|||
25291692|NCT01189604|50606423|FG002|Overall Study|Adverse Event|0|||
25291693|NCT01189604|50606424|FG003|Overall Study|Adverse Event|0|||
25291694|NCT01189604|50606425|FG004|Overall Study|Adverse Event|2|||
25291695|NCT01189604|50606426|FG005|Overall Study|Adverse Event|0|||
25291696|NCT01189604|50606427|FG006|Overall Study|Adverse Event|1|||
25291697|NCT01189604|50606421|FG000|Overall Study|Withdrawal by Subject|1|||
25291698|NCT01189604|50606422|FG001|Overall Study|Withdrawal by Subject|0|||
25291699|NCT01189604|50606423|FG002|Overall Study|Withdrawal by Subject|0|||
25291700|NCT01189604|50606424|FG003|Overall Study|Withdrawal by Subject|0|||
25291701|NCT01189604|50606425|FG004|Overall Study|Withdrawal by Subject|0|||
25291702|NCT01189604|50606426|FG005|Overall Study|Withdrawal by Subject|0|||
25169264|NCT01835015|50300765|FG002|Overall Study|Adverse Event|1|||
25291703|NCT01189604|50606427|FG006|Overall Study|Withdrawal by Subject|0|||
25291704|NCT01008696|50606445|FG000|Overall Study|Participant's evasion of hospital visit|5|||
25291705|NCT01008696|50606446|FG001|Overall Study|Participant's evasion of hospital visit|4|||
25169265|NCT01835015|50300766|FG003|Overall Study|Adverse Event|0|||
25291706|NCT01008696|50606445|FG000|Overall Study|Withdrawal by Subject|2|||
25291707|NCT01008696|50606446|FG001|Overall Study|Withdrawal by Subject|4|||
25291708|NCT01008696|50606445|FG000|Overall Study|Physician Decision|5|||
25291709|NCT01008696|50606446|FG001|Overall Study|Physician Decision|1|||
25169266|NCT01835015|50300767|FG004|Overall Study|Adverse Event|0|||
25291710|NCT01008696|50606445|FG000|Overall Study|Adverse Event|1|||
25291711|NCT01008696|50606446|FG001|Overall Study|Adverse Event|0|||
25291712|NCT01008696|50606445|FG000|Overall Study|Participants' non-cooperation|2|||
25291713|NCT01008696|50606446|FG001|Overall Study|Participants' non-cooperation|3|||
25291714|NCT01008696|50606445|FG000|Overall Study|Other|2|||
25291715|NCT01008696|50606446|FG001|Overall Study|Other|3|||
25291716|NCT01008696|50606445|FG000|Overall Study|Other|0|||
25291717|NCT01008696|50606446|FG001|Overall Study|Other|2|||
25291718|NCT01176968|50606465|FG000|Overall Study|Adverse Event|10|||
25291719|NCT01176968|50606466|FG001|Overall Study|Adverse Event|11|||
25291720|NCT01176968|50606465|FG000|Overall Study|Death|2|||
25291721|NCT01176968|50606466|FG001|Overall Study|Death|3|||
25291722|NCT01176968|50606465|FG000|Overall Study|Lack of Efficacy|0|||
25291723|NCT01176968|50606466|FG001|Overall Study|Lack of Efficacy|1|||
25291724|NCT01176968|50606465|FG000|Overall Study|Lost to Follow-up|16|||
25291725|NCT01176968|50606466|FG001|Overall Study|Lost to Follow-up|14|||
25291726|NCT01176968|50606465|FG000|Overall Study|Withdrawal by Subject|48|||
25291727|NCT01176968|50606466|FG001|Overall Study|Withdrawal by Subject|48|||
25291728|NCT01176968|50606465|FG000|Overall Study|Protocol Violation|2|||
25291729|NCT01176968|50606466|FG001|Overall Study|Protocol Violation|1|||
25291730|NCT01176968|50606465|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
25291731|NCT01176968|50606466|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
25291732|NCT01176968|50606465|FG000|Overall Study|Study terminated by sponsor|0|||
25291733|NCT01176968|50606466|FG001|Overall Study|Study terminated by sponsor|1|||
25291734|NCT01176968|50606465|FG000|Overall Study|Reason not defined|5|||
25291735|NCT01176968|50606466|FG001|Overall Study|Reason not defined|3|||
25291736|NCT01006122|50606477|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
25291737|NCT01006122|50606478|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
25291738|NCT01006122|50606477|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
25291739|NCT01006122|50606478|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
25291740|NCT01006122|50606477|FG000|First Double-blind Intervention Period|Pregnancy|0|||
25291741|NCT01006122|50606478|FG001|First Double-blind Intervention Period|Pregnancy|1|||
25291742|NCT01006122|50606477|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
25291743|NCT01006122|50606478|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
25291744|NCT01006122|50606477|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
25291745|NCT01006122|50606478|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
25291746|NCT01006122|50606477|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
25291747|NCT01006122|50606478|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
25291748|NCT01006122|50606477|FG000|First Double-blind Intervention Period|Other|3|||
25291749|NCT01006122|50606478|FG001|First Double-blind Intervention Period|Other|0|||
25291750|NCT01006122|50606477|FG000|First Double-blind Intervention Period|Adverse Event|0|||
25291751|NCT01006122|50606478|FG001|First Double-blind Intervention Period|Adverse Event|4|||
25291752|NCT01006122|50606477|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
25291753|NCT01006122|50606478|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
25291754|NCT01006122|50606477|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
25291755|NCT01006122|50606478|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
25291756|NCT01006122|50606477|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
25291757|NCT01006122|50606478|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
25291758|NCT01006122|50606477|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
25291759|NCT01006122|50606478|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
25291760|NCT01006122|50606477|FG000|Second Double-blind Intervention Period|Death|0|||
25291761|NCT01006122|50606478|FG001|Second Double-blind Intervention Period|Death|1|||
25291762|NCT01005966|50606484|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
25291763|NCT01005966|50606485|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
25291764|NCT01005966|50606486|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
25291765|NCT01005966|50606487|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
25291766|NCT01005966|50606488|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
25291767|NCT01005966|50606484|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
25291768|NCT01005966|50606485|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
25291769|NCT01005966|50606486|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
25291770|NCT01005966|50606487|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
25291771|NCT01005966|50606488|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
25291772|NCT01005966|50606484|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
25291773|NCT01005966|50606485|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
25291774|NCT01005966|50606486|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
25291775|NCT01005966|50606487|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
25291776|NCT01005966|50606488|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
25291777|NCT01005966|50606484|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
25291778|NCT01005966|50606485|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
25070437|NCT02787083|50176414|FG000|Overall Study|Adverse Event|1|||
25291779|NCT01005966|50606486|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
25291780|NCT01005966|50606487|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
25291781|NCT01005966|50606488|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
25291782|NCT01005966|50606484|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
25291783|NCT01005966|50606485|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
25291784|NCT01005966|50606486|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
25291785|NCT01005966|50606487|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
25291786|NCT01005966|50606488|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
25291787|NCT01005966|50606484|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
25291788|NCT01005966|50606485|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
25291789|NCT01005966|50606486|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
25291790|NCT01005966|50606487|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
25291791|NCT01005966|50606488|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
25291792|NCT01005966|50606484|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
25291793|NCT01005966|50606485|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
25291794|NCT01005966|50606486|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
25291795|NCT01005966|50606487|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
25291796|NCT01005966|50606488|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
25291797|NCT01005966|50606484|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
25291798|NCT01005966|50606485|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
25291799|NCT01005966|50606486|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
25291800|NCT01005966|50606487|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
25291801|NCT01005966|50606488|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
25291802|NCT01005966|50606484|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
25291803|NCT01005966|50606485|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
25291804|NCT01005966|50606486|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
25291805|NCT01005966|50606487|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
25291806|NCT01005966|50606488|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
25291807|NCT01005732|50606514|FG000|Overall Study|Lost to Follow-up|10|||
25291808|NCT01005732|50606514|FG000|Overall Study|Death|1|||
25291809|NCT00603382|50606528|FG000|Overall Study|Adverse Event|0|||
25291810|NCT00603382|50606529|FG001|Overall Study|Adverse Event|1|||
25291811|NCT00603382|50606530|FG002|Overall Study|Adverse Event|1|||
25291812|NCT00603382|50606531|FG003|Overall Study|Adverse Event|2|||
25291813|NCT00603382|50606532|FG004|Overall Study|Adverse Event|1|||
25291814|NCT00603382|50606533|FG005|Overall Study|Adverse Event|2|||
25291815|NCT00603382|50606528|FG000|Overall Study|Lack of Efficacy|14|||
25291816|NCT00603382|50606529|FG001|Overall Study|Lack of Efficacy|9|||
25291817|NCT00603382|50606530|FG002|Overall Study|Lack of Efficacy|3|||
25291818|NCT00603382|50606531|FG003|Overall Study|Lack of Efficacy|6|||
25291819|NCT00603382|50606532|FG004|Overall Study|Lack of Efficacy|6|||
25291820|NCT00603382|50606533|FG005|Overall Study|Lack of Efficacy|11|||
25291821|NCT00603382|50606528|FG000|Overall Study|Protocol Violation|1|||
25291822|NCT00603382|50606529|FG001|Overall Study|Protocol Violation|0|||
25291823|NCT00603382|50606530|FG002|Overall Study|Protocol Violation|1|||
25291824|NCT00603382|50606531|FG003|Overall Study|Protocol Violation|2|||
25291825|NCT00603382|50606532|FG004|Overall Study|Protocol Violation|1|||
25291826|NCT00603382|50606533|FG005|Overall Study|Protocol Violation|0|||
25291827|NCT00603382|50606528|FG000|Overall Study|Lost to Follow-up|0|||
25291828|NCT00603382|50606529|FG001|Overall Study|Lost to Follow-up|1|||
25291829|NCT00603382|50606530|FG002|Overall Study|Lost to Follow-up|1|||
25291830|NCT00603382|50606531|FG003|Overall Study|Lost to Follow-up|1|||
25291831|NCT00603382|50606532|FG004|Overall Study|Lost to Follow-up|0|||
25291832|NCT00603382|50606533|FG005|Overall Study|Lost to Follow-up|1|||
25291833|NCT00603382|50606528|FG000|Overall Study|Physician Decision|0|||
25291834|NCT00603382|50606529|FG001|Overall Study|Physician Decision|0|||
25291835|NCT00603382|50606530|FG002|Overall Study|Physician Decision|2|||
25291836|NCT00603382|50606531|FG003|Overall Study|Physician Decision|0|||
25291837|NCT00603382|50606532|FG004|Overall Study|Physician Decision|1|||
25291838|NCT00603382|50606533|FG005|Overall Study|Physician Decision|3|||
25291839|NCT00603382|50606528|FG000|Overall Study|Withdrawal by Subject|3|||
25291840|NCT00603382|50606529|FG001|Overall Study|Withdrawal by Subject|3|||
25291841|NCT00603382|50606530|FG002|Overall Study|Withdrawal by Subject|1|||
25291842|NCT00603382|50606531|FG003|Overall Study|Withdrawal by Subject|1|||
25291843|NCT00603382|50606532|FG004|Overall Study|Withdrawal by Subject|0|||
25291844|NCT00603382|50606533|FG005|Overall Study|Withdrawal by Subject|1|||
25291845|NCT01176266|50606547|FG000|Overall Study|Death|6|||
25291846|NCT01176266|50606547|FG000|Overall Study|Withdrawal by Subject|3|||
25291847|NCT01182428|50606557|FG000|Overall Study|Physician Decision|1|||
25291848|NCT01182428|50606558|FG001|Overall Study|Physician Decision|0|||
25291849|NCT01182428|50606557|FG000|Overall Study|Lost to Follow-up|9|||
25291850|NCT01182428|50606558|FG001|Overall Study|Lost to Follow-up|1|||
25291851|NCT01182428|50606557|FG000|Overall Study|Withdrawal by Subject|1|||
25291852|NCT01182428|50606558|FG001|Overall Study|Withdrawal by Subject|0|||
25291853|NCT00603304|50606566|FG000|Overall Study|Lost to Follow-up|5|||
25291854|NCT00603304|50606567|FG001|Overall Study|Lost to Follow-up|7|||
25291855|NCT00603304|50606566|FG000|Overall Study|Withdrawal by Subject|8|||
25291856|NCT00603304|50606567|FG001|Overall Study|Withdrawal by Subject|5|||
25291857|NCT00603304|50606566|FG000|Overall Study|Protocol Violation|1|||
25291858|NCT00603304|50606567|FG001|Overall Study|Protocol Violation|0|||
25291859|NCT00603304|50606566|FG000|Overall Study|Adverse Event|4|||
25291860|NCT00603304|50606567|FG001|Overall Study|Adverse Event|2|||
25291861|NCT00603304|50606566|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
25291862|NCT00603304|50606567|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
25291863|NCT00603304|50606566|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
25291864|NCT00603304|50606567|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
25291865|NCT00603304|50606566|FG000|Overall Study|Exclusionary Medication|2|||
25291866|NCT00603304|50606567|FG001|Overall Study|Exclusionary Medication|3|||
25291867|NCT00603304|50606566|FG000|Overall Study|Non-Compliant|0|||
25291868|NCT00603304|50606567|FG001|Overall Study|Non-Compliant|1|||
25291869|NCT00603304|50606566|FG000|Overall Study|Moved Away|0|||
25291870|NCT00603304|50606567|FG001|Overall Study|Moved Away|2|||
25291871|NCT00603304|50606566|FG000|Overall Study|Other|2|||
25291872|NCT00603304|50606567|FG001|Overall Study|Other|0|||
25291873|NCT00603304|50606566|FG000|Overall Study|Patient Decision|2|||
25291874|NCT00603304|50606567|FG001|Overall Study|Patient Decision|0|||
25291875|NCT01176032|50606577|FG000|Overall Study|Adverse Event|1|||
25291876|NCT01176032|50606578|FG001|Overall Study|Adverse Event|0|||
25291877|NCT01176032|50606577|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25291878|NCT01176032|50606578|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
25291879|NCT01176032|50606577|FG000|Overall Study|Protocol Violation|1|||
25291880|NCT01176032|50606578|FG001|Overall Study|Protocol Violation|0|||
25291881|NCT01176032|50606577|FG000|Overall Study|Informed consent withdrawn|3|||
25291882|NCT01176032|50606578|FG001|Overall Study|Informed consent withdrawn|0|||
25291883|NCT01176032|50606577|FG000|Overall Study|Other|1|||
25291884|NCT01176032|50606578|FG001|Overall Study|Other|0|||
25291885|NCT01008618|50606589|FG000|Period 1 (Titration Period)|Physician Decision|2|||
25291886|NCT01008618|50606590|FG001|Period 1 (Titration Period)|Physician Decision|0|||
25291887|NCT01008618|50606591|FG002|Period 1 (Titration Period)|Physician Decision|0|||
25291888|NCT01008618|50606589|FG000|Period 1 (Titration Period)|Adverse Event|33|||
25291889|NCT01008618|50606590|FG001|Period 1 (Titration Period)|Adverse Event|0|||
25291890|NCT01008618|50606591|FG002|Period 1 (Titration Period)|Adverse Event|0|||
25291891|NCT01008618|50606589|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
25291892|NCT01008618|50606590|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
25291893|NCT01008618|50606591|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
25291894|NCT01008618|50606589|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
25291895|NCT01008618|50606590|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
25291896|NCT01008618|50606591|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
25291897|NCT01008618|50606589|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
25291898|NCT01008618|50606590|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
25291899|NCT01008618|50606591|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
25291900|NCT01008618|50606589|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
25291901|NCT01008618|50606590|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
25291902|NCT01008618|50606591|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
25291903|NCT01008618|50606589|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
25291904|NCT01008618|50606590|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
25291905|NCT01008618|50606591|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
25291906|NCT01008618|50606589|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
25291907|NCT01008618|50606590|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
25291908|NCT01008618|50606591|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
25291909|NCT01008618|50606589|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
25291910|NCT01008618|50606590|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
25291911|NCT01008618|50606591|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
25291912|NCT01008618|50606589|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
25291913|NCT01008618|50606590|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
25291914|NCT01008618|50606591|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
25291915|NCT01008618|50606589|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
25291916|NCT01008618|50606590|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
25291917|NCT01008618|50606591|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
25291918|NCT01008618|50606589|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
25291919|NCT01008618|50606590|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
25291920|NCT01008618|50606591|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
25291921|NCT01001208|50606602|FG000|Overall Study|Adverse Event|10|||
25291922|NCT01001208|50606603|FG001|Overall Study|Adverse Event|5|||
25291923|NCT01001208|50606602|FG000|Overall Study|Lost to Follow-up|5|||
25291924|NCT01001208|50606603|FG001|Overall Study|Lost to Follow-up|9|||
25291925|NCT01001208|50606602|FG000|Overall Study|Physician Decision|1|||
25291926|NCT01001208|50606603|FG001|Overall Study|Physician Decision|0|||
25291927|NCT01001208|50606602|FG000|Overall Study|Withdrawal by Subject|4|||
25291928|NCT01001208|50606603|FG001|Overall Study|Withdrawal by Subject|5|||
25291929|NCT01001208|50606602|FG000|Overall Study|Ineligibility Determined|4|||
25291930|NCT01001208|50606603|FG001|Overall Study|Ineligibility Determined|2|||
25291931|NCT01001208|50606602|FG000|Overall Study|Noncompliance|4|||
25291932|NCT01001208|50606603|FG001|Overall Study|Noncompliance|7|||
25291933|NCT01001208|50606602|FG000|Overall Study|Disease Progression|0|||
25291934|NCT01001208|50606603|FG001|Overall Study|Disease Progression|3|||
25291935|NCT01001208|50606602|FG000|Overall Study|Other|0|||
25291936|NCT01001208|50606603|FG001|Overall Study|Other|2|||
25291937|NCT01000974|50606612|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
25291938|NCT01000974|50606613|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
25291939|NCT01000974|50606614|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
25291940|NCT01000974|50606612|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
25291941|NCT01000974|50606613|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
25291942|NCT01000974|50606614|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
25291943|NCT01000974|50606612|FG000|Primary Vaccination Phase|Protocol Violation|40|||
25291944|NCT01000974|50606613|FG001|Primary Vaccination Phase|Protocol Violation|3|||
25291945|NCT01000974|50606614|FG002|Primary Vaccination Phase|Protocol Violation|2|||
25291946|NCT01000974|50606612|FG000|Primary Vaccination Phase|Adverse Event|14|||
25291947|NCT01000974|50606613|FG001|Primary Vaccination Phase|Adverse Event|2|||
25291948|NCT01000974|50606614|FG002|Primary Vaccination Phase|Adverse Event|2|||
25291949|NCT01000974|50606612|FG000|Primary Vaccination Phase|Other|4|||
25291950|NCT01000974|50606613|FG001|Primary Vaccination Phase|Other|9|||
25291951|NCT01000974|50606614|FG002|Primary Vaccination Phase|Other|12|||
25291952|NCT01000974|50606612|FG000|Booster Vaccination Phase|Protocol Violation|0|||
25291953|NCT01000974|50606613|FG001|Booster Vaccination Phase|Protocol Violation|0|||
25291954|NCT01000974|50606614|FG002|Booster Vaccination Phase|Protocol Violation|2|||
25291955|NCT01000974|50606612|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
25291956|NCT01000974|50606613|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
25291957|NCT01000974|50606614|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
25291958|NCT01000974|50606612|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
25291959|NCT01000974|50606613|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
25291960|NCT01000974|50606614|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
25291961|NCT01000974|50606612|FG000|Booster Vaccination Phase|Other|24|||
25291962|NCT01000974|50606613|FG001|Booster Vaccination Phase|Other|6|||
25291963|NCT01000974|50606614|FG002|Booster Vaccination Phase|Other|4|||
25291964|NCT01193842|50606630|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
25291965|NCT01193842|50606631|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
25291966|NCT01193842|50606632|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
25291967|NCT01193842|50606633|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
25291968|NCT01193842|50606634|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
25291969|NCT01193842|50606630|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
25291970|NCT01193842|50606631|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
25291971|NCT01193842|50606632|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
25291972|NCT01193842|50606633|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
25291973|NCT01193842|50606634|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
25291974|NCT01193842|50606630|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
25291975|NCT01193842|50606631|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
25291976|NCT01193842|50606632|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
25291977|NCT01193842|50606633|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
25291978|NCT01193842|50606634|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
25291979|NCT01193842|50606630|FG000|Phase II: Randomized Groups|Death|0|||
25291980|NCT01193842|50606631|FG001|Phase II: Randomized Groups|Death|0|||
25291981|NCT01193842|50606632|FG002|Phase II: Randomized Groups|Death|0|||
25291982|NCT01193842|50606633|FG003|Phase II: Randomized Groups|Death|1|||
25291983|NCT01193842|50606634|FG004|Phase II: Randomized Groups|Death|1|||
25291984|NCT01193842|50606630|FG000|Phase II: Randomized Groups|Adverse Event|0|||
25291985|NCT01193842|50606631|FG001|Phase II: Randomized Groups|Adverse Event|0|||
25291986|NCT01193842|50606632|FG002|Phase II: Randomized Groups|Adverse Event|0|||
25291987|NCT01193842|50606633|FG003|Phase II: Randomized Groups|Adverse Event|5|||
25291988|NCT01193842|50606634|FG004|Phase II: Randomized Groups|Adverse Event|3|||
25291989|NCT01193842|50606630|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
25291990|NCT01193842|50606631|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
25291991|NCT01193842|50606632|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
25191676|NCT01490450|50352897|FG002|Period 1|Request to discontinue treatment|0|||
25191677|NCT01490450|50352898|FG003|Period 1|Request to discontinue treatment|0|||
25291992|NCT01193842|50606633|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
25291993|NCT01193842|50606634|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
25291994|NCT01193842|50606630|FG000|Phase II: Randomized Groups|Ineligible|0|||
25291995|NCT01193842|50606631|FG001|Phase II: Randomized Groups|Ineligible|0|||
25291996|NCT01193842|50606632|FG002|Phase II: Randomized Groups|Ineligible|0|||
25291997|NCT01193842|50606633|FG003|Phase II: Randomized Groups|Ineligible|0|||
25291998|NCT01193842|50606634|FG004|Phase II: Randomized Groups|Ineligible|1|||
25291999|NCT01193842|50606630|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
25292000|NCT01193842|50606631|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
25292001|NCT01193842|50606632|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
25292002|NCT01193842|50606633|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
25292003|NCT01193842|50606634|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
25292004|NCT01004406|50606653|FG000|Overall Study|Withdrawal by Subject|2|||
25292005|NCT01004406|50606654|FG001|Overall Study|Withdrawal by Subject|0|||
25292006|NCT01004406|50606653|FG000|Overall Study|Lost to Follow-up|1|||
25292007|NCT01004406|50606654|FG001|Overall Study|Lost to Follow-up|0|||
25292008|NCT01182350|50606669|FG000|Overall Study|Adverse Event|5|||
25292009|NCT01182350|50606670|FG001|Overall Study|Adverse Event|0|||
25292010|NCT01182350|50606671|FG002|Overall Study|Adverse Event|0|||
25292011|NCT01182350|50606672|FG003|Overall Study|Adverse Event|0|||
25292012|NCT01182350|50606673|FG004|Overall Study|Adverse Event|0|||
25292013|NCT01182350|50606669|FG000|Overall Study|Disease Progression|15|||
25292014|NCT01182350|50606670|FG001|Overall Study|Disease Progression|12|||
25292015|NCT01182350|50606671|FG002|Overall Study|Disease Progression|0|||
25292016|NCT01182350|50606672|FG003|Overall Study|Disease Progression|1|||
25292017|NCT01182350|50606673|FG004|Overall Study|Disease Progression|0|||
25292018|NCT01182350|50606669|FG000|Overall Study|Death|0|||
25292019|NCT01182350|50606670|FG001|Overall Study|Death|1|||
25292020|NCT01182350|50606671|FG002|Overall Study|Death|1|||
25292021|NCT01182350|50606672|FG003|Overall Study|Death|0|||
25292022|NCT01182350|50606673|FG004|Overall Study|Death|0|||
25292023|NCT01182350|50606669|FG000|Overall Study|Withdrawal by Subject|3|||
25292024|NCT01182350|50606670|FG001|Overall Study|Withdrawal by Subject|1|||
25292025|NCT01182350|50606671|FG002|Overall Study|Withdrawal by Subject|0|||
25292026|NCT01182350|50606672|FG003|Overall Study|Withdrawal by Subject|1|||
25292027|NCT01182350|50606673|FG004|Overall Study|Withdrawal by Subject|0|||
25292028|NCT01182350|50606669|FG000|Overall Study|Alternative Therapy|2|||
25292029|NCT01182350|50606670|FG001|Overall Study|Alternative Therapy|0|||
25292030|NCT01182350|50606671|FG002|Overall Study|Alternative Therapy|1|||
25292031|NCT01182350|50606672|FG003|Overall Study|Alternative Therapy|0|||
25292032|NCT01182350|50606673|FG004|Overall Study|Alternative Therapy|0|||
25292033|NCT01182350|50606669|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
25292034|NCT01182350|50606670|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
25292035|NCT01182350|50606671|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
25292036|NCT01182350|50606672|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
25292037|NCT01182350|50606673|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
25292038|NCT01182350|50606669|FG000|Overall Study|Unevaluable for Biopsy|0|||
25292039|NCT01182350|50606670|FG001|Overall Study|Unevaluable for Biopsy|0|||
25292040|NCT01182350|50606671|FG002|Overall Study|Unevaluable for Biopsy|0|||
25292041|NCT01182350|50606672|FG003|Overall Study|Unevaluable for Biopsy|0|||
25292042|NCT01182350|50606673|FG004|Overall Study|Unevaluable for Biopsy|3|||
25292043|NCT01163474|50606689|FG000|Overall Study|Withdrawal by Subject|1|||
25292044|NCT01163474|50606689|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
25292045|NCT01163474|50606689|FG000|Overall Study|Lost to Follow-up|3|||
25292046|NCT00603538|50606699|FG000|Overall Study|Adverse Event|0|||
25292047|NCT00603538|50606700|FG001|Overall Study|Adverse Event|4|||
25292048|NCT00603538|50606701|FG002|Overall Study|Adverse Event|2|||
25292049|NCT00603538|50606699|FG000|Overall Study|Objective progression or relapse|3|||
25292050|NCT00603538|50606700|FG001|Overall Study|Objective progression or relapse|0|||
25292051|NCT00603538|50606701|FG002|Overall Study|Objective progression or relapse|0|||
25292052|NCT01163318|50606712|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
25292053|NCT01163318|50606712|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
25292054|NCT01163318|50606712|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
25292055|NCT01163318|50606712|FG000|Overall Study|Participants Without Case Report Form|7|||
25292056|NCT01163318|50606712|FG000|Overall Study|Multiple Reasons Per Participant|224|||
25292057|NCT01162304|50606716|FG000|Overall Study|Beck scale to high|11|||
25292058|NCT04515394|50606722|FG000|Overall Study|Participant did not receive treatment|1|||
25292059|NCT01175018|50606728|FG000|Overall Study|Adverse Event|3|||
25292060|NCT01175018|50606729|FG001|Overall Study|Adverse Event|1|||
25292061|NCT01174784|50606737|FG000|Overall Study|Screen fails|4|||
25292062|NCT01174550|50606744|FG000|Overall Study|Death|75|||
25292063|NCT01174550|50606745|FG001|Overall Study|Death|74|||
25292064|NCT01174550|50606744|FG000|Overall Study|Lost to Follow-up|652|||
25292065|NCT01174550|50606745|FG001|Overall Study|Lost to Follow-up|510|||
25292066|NCT01174550|50606744|FG000|Overall Study|Withdrawal by Subject|543|||
25292067|NCT01174550|50606745|FG001|Overall Study|Withdrawal by Subject|289|||
25070438|NCT02787083|50176415|FG001|Overall Study|Adverse Event|0|||
25292068|NCT01008150|50606755|FG000|Overall Study|did not receive study drug|1|||
25292069|NCT01008150|50606756|FG001|Overall Study|did not receive study drug|1|||
25292070|NCT01008150|50606757|FG002|Overall Study|did not receive study drug|1|||
25292071|NCT01008150|50606758|FG003|Overall Study|did not receive study drug|0|||
25292072|NCT01007916|50606769|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
25292073|NCT01007916|50606770|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
25292074|NCT01007916|50606769|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
25292075|NCT01007916|50606770|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
25292076|NCT01007838|50606780|FG000|Overall Study|Withdrawal by Subject|1|||
25292077|NCT01007838|50606781|FG001|Overall Study|Withdrawal by Subject|0|||
25292078|NCT01007838|50606782|FG002|Overall Study|Withdrawal by Subject|0|||
25292079|NCT01007838|50606783|FG003|Overall Study|Withdrawal by Subject|0|||
25292080|NCT01007838|50606780|FG000|Overall Study|Physician Decision|1|||
25292081|NCT01007838|50606781|FG001|Overall Study|Physician Decision|0|||
25292082|NCT01007838|50606782|FG002|Overall Study|Physician Decision|0|||
25292083|NCT01007838|50606783|FG003|Overall Study|Physician Decision|0|||
25292084|NCT01007838|50606780|FG000|Overall Study|Started home haemodialysis|1|||
25292085|NCT01007838|50606781|FG001|Overall Study|Started home haemodialysis|0|||
25292086|NCT01007838|50606782|FG002|Overall Study|Started home haemodialysis|0|||
25292087|NCT01007838|50606783|FG003|Overall Study|Started home haemodialysis|0|||
25292088|NCT01007448|50606795|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
25292089|NCT01007448|50606796|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
25292090|NCT01007448|50606795|FG000|Overall Study|Staph Skin Infection Flare|1|||
25292091|NCT01007448|50606796|FG001|Overall Study|Staph Skin Infection Flare|0|||
25292092|NCT01007448|50606795|FG000|Overall Study|Participant Leaving the Country|1|||
25292093|NCT01007448|50606796|FG001|Overall Study|Participant Leaving the Country|0|||
25292094|NCT01007448|50606795|FG000|Overall Study|Participant Given Prohibited Medication|1|||
25292095|NCT01007448|50606796|FG001|Overall Study|Participant Given Prohibited Medication|0|||
25292096|NCT01007448|50606795|FG000|Overall Study|Progressive Disease|1|||
25292097|NCT01007448|50606796|FG001|Overall Study|Progressive Disease|2|||
25292098|NCT01007448|50606795|FG000|Overall Study|Lack of Efficacy|2|||
25292099|NCT01007448|50606796|FG001|Overall Study|Lack of Efficacy|0|||
25292100|NCT01007448|50606795|FG000|Overall Study|Withdrawal by Subject|2|||
25292101|NCT01007448|50606796|FG001|Overall Study|Withdrawal by Subject|3|||
25292102|NCT01007448|50606795|FG000|Overall Study|Adverse Event|1|||
25292103|NCT01007448|50606796|FG001|Overall Study|Adverse Event|4|||
25292104|NCT03538756|50606802|FG000|Long-Term Follow-up|Adverse Event|0|||
25292105|NCT03538756|50606803|FG001|Long-Term Follow-up|Adverse Event|0|||
25292106|NCT03538756|50606804|FG002|Long-Term Follow-up|Adverse Event|6|||
25292107|NCT03538756|50606802|FG000|Long-Term Follow-up|Death|0|||
25292108|NCT03538756|50606803|FG001|Long-Term Follow-up|Death|0|||
25292109|NCT03538756|50606804|FG002|Long-Term Follow-up|Death|1|||
25292110|NCT03538756|50606802|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
25292111|NCT03538756|50606803|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
25292112|NCT03538756|50606804|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
25292113|NCT03538756|50606802|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
25292114|NCT03538756|50606803|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
25292115|NCT03538756|50606804|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
25292116|NCT03538756|50606802|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
25292117|NCT03538756|50606803|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
25292118|NCT03538756|50606804|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
25292119|NCT01004250|50606814|FG000|Induction Therapy Period|Adverse Event|10|||
25292120|NCT01004250|50606814|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
25292121|NCT01004250|50606814|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
25292122|NCT01004250|50606814|FG000|Induction Therapy Period|Physician Decision|2|||
25292123|NCT01004250|50606814|FG000|Maintenance Therapy Period|Adverse Event|15|||
25292124|NCT01004250|50606814|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
25292125|NCT01004250|50606814|FG000|Maintenance Therapy Period|Protocol Violation|1|||
25292126|NCT01004250|50606814|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
25292127|NCT01004250|50606814|FG000|Maintenance Therapy Period|Physician Decision|4|||
25292128|NCT01004250|50606814|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
25292129|NCT01004172|50606822|FG000|Overall Study|Progressive Disease in CNS Only|16|||
25292130|NCT01004172|50606822|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
25292131|NCT01004172|50606822|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
25292132|NCT01004172|50606822|FG000|Overall Study|Adverse Event|1|||
25292133|NCT01004172|50606822|FG000|Overall Study|Physician Decision|1|||
25292134|NCT01004172|50606822|FG000|Overall Study|Symptomatic Deterioration|2|||
25292135|NCT01161524|50606829|FG000|Core Study (23 Weeks)|Adverse Event|3|||
25292136|NCT01161524|50606830|FG001|Core Study (23 Weeks)|Adverse Event|0|||
25292137|NCT01161524|50606831|FG002|Core Study (23 Weeks)|Adverse Event|0|||
25292138|NCT01161524|50606829|FG000|Core Study (23 Weeks)|Other|1|||
25292139|NCT01161524|50606830|FG001|Core Study (23 Weeks)|Other|0|||
25292140|NCT01161524|50606831|FG002|Core Study (23 Weeks)|Other|0|||
25292141|NCT01161524|50606829|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
25292142|NCT01161524|50606830|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
25292143|NCT01161524|50606831|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
25292144|NCT01161524|50606829|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
25292145|NCT01161524|50606830|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
25292146|NCT01161524|50606831|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
25292147|NCT01161524|50606829|FG000|Core Study (23 Weeks)|Subject Choice|3|||
25292148|NCT01161524|50606830|FG001|Core Study (23 Weeks)|Subject Choice|2|||
25292149|NCT01161524|50606831|FG002|Core Study (23 Weeks)|Subject Choice|0|||
25292150|NCT01161524|50606829|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
25292151|NCT01161524|50606830|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
25292152|NCT01161524|50606831|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
25292153|NCT01161524|50606829|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
25292154|NCT01161524|50606830|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
25292155|NCT01161524|50606831|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
25292156|NCT01161524|50606829|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
25292157|NCT01161524|50606830|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
25292158|NCT01161524|50606831|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
25292159|NCT01161524|50606829|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
25292160|NCT01161524|50606830|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
25292161|NCT01161524|50606831|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
25292162|NCT01161524|50606829|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
25292163|NCT01161524|50606830|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
25292164|NCT01161524|50606831|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
25292165|NCT01000506|50606844|FG000|Overall Study|Adverse Event|6|||
25292166|NCT01000506|50606845|FG001|Overall Study|Adverse Event|5|||
25292167|NCT01000506|50606846|FG002|Overall Study|Adverse Event|8|||
25292168|NCT01000506|50606847|FG003|Overall Study|Adverse Event|9|||
25292169|NCT01000506|50606844|FG000|Overall Study|Lack of Efficacy|8|||
25292170|NCT01000506|50606845|FG001|Overall Study|Lack of Efficacy|6|||
25292171|NCT01000506|50606846|FG002|Overall Study|Lack of Efficacy|4|||
25292172|NCT01000506|50606847|FG003|Overall Study|Lack of Efficacy|4|||
25292173|NCT01000506|50606844|FG000|Overall Study|Protocol Violation|1|||
25292174|NCT01000506|50606845|FG001|Overall Study|Protocol Violation|1|||
25292175|NCT01000506|50606846|FG002|Overall Study|Protocol Violation|0|||
25292176|NCT01000506|50606847|FG003|Overall Study|Protocol Violation|0|||
25292177|NCT01000506|50606844|FG000|Overall Study|Lost to Follow-up|1|||
25292178|NCT01000506|50606845|FG001|Overall Study|Lost to Follow-up|1|||
25292179|NCT01000506|50606846|FG002|Overall Study|Lost to Follow-up|4|||
25292180|NCT01000506|50606847|FG003|Overall Study|Lost to Follow-up|0|||
25292181|NCT01000506|50606844|FG000|Overall Study|Physician Decision|1|||
25292182|NCT01000506|50606845|FG001|Overall Study|Physician Decision|3|||
25292183|NCT01000506|50606846|FG002|Overall Study|Physician Decision|3|||
25292184|NCT01000506|50606847|FG003|Overall Study|Physician Decision|3|||
25292185|NCT01000506|50606844|FG000|Overall Study|Withdrawal by Subject|11|||
25292186|NCT01000506|50606845|FG001|Overall Study|Withdrawal by Subject|8|||
25292187|NCT01000506|50606846|FG002|Overall Study|Withdrawal by Subject|2|||
25292188|NCT01000506|50606847|FG003|Overall Study|Withdrawal by Subject|7|||
25292189|NCT01174238|50606857|FG000|Overall Study|Lost to Follow-up|2|||
25292190|NCT01174160|50606866|FG000|Overall Study|Adverse Event|1|||
25292191|NCT01174160|50606867|FG001|Overall Study|Adverse Event|0|||
25292192|NCT01174160|50606866|FG000|Overall Study|Lost to Follow-up|1|||
25292193|NCT01174160|50606867|FG001|Overall Study|Lost to Follow-up|0|||
25292194|NCT01174160|50606866|FG000|Overall Study|Physician Decision|1|||
25292195|NCT01174160|50606867|FG001|Overall Study|Physician Decision|0|||
25292196|NCT01174160|50606866|FG000|Overall Study|Protocol Violation|4|||
25292197|NCT01174160|50606867|FG001|Overall Study|Protocol Violation|6|||
25292198|NCT01174160|50606866|FG000|Overall Study|Withdrawal by Subject|1|||
25292199|NCT01174160|50606867|FG001|Overall Study|Withdrawal by Subject|0|||
25292200|NCT01161446|50606875|FG000|Overall Study|Lost to Follow-up|18|||
25292201|NCT01161446|50606876|FG001|Overall Study|Lost to Follow-up|14|||
25292202|NCT01161446|50606875|FG000|Overall Study|Withdrawal by Subject|0|||
25292203|NCT01161446|50606876|FG001|Overall Study|Withdrawal by Subject|1|||
25292204|NCT01174004|50606884|FG000|Overall Study|Adverse Event|2|||
25292205|NCT01174004|50606885|FG001|Overall Study|Adverse Event|10|||
25292206|NCT01174004|50606884|FG000|Overall Study|Withdrawal by Subject|2|||
25292207|NCT01174004|50606885|FG001|Overall Study|Withdrawal by Subject|3|||
25292208|NCT01174004|50606884|FG000|Overall Study|At Discretion of Sponsor|2|||
25292209|NCT01174004|50606885|FG001|Overall Study|At Discretion of Sponsor|2|||
25292210|NCT01174004|50606884|FG000|Overall Study|Protocol Violation|0|||
25292211|NCT01174004|50606885|FG001|Overall Study|Protocol Violation|1|||
25292212|NCT01174004|50606884|FG000|Overall Study|Physician Decision|1|||
25292213|NCT01174004|50606885|FG001|Overall Study|Physician Decision|0|||
25292214|NCT01173692|50606893|FG000|Overall Study|Adverse Event|1|||
25292215|NCT01173692|50606894|FG001|Overall Study|Adverse Event|2|||
25292216|NCT01173692|50606893|FG000|Overall Study|Withdrawal by Subject|1|||
25292217|NCT01173692|50606894|FG001|Overall Study|Withdrawal by Subject|3|||
25292218|NCT01101035|50606902|FG000|Overall Study|Adverse Event|191|||
25292219|NCT01101035|50606903|FG001|Overall Study|Adverse Event|172|||
25292220|NCT01101035|50606902|FG000|Overall Study|Major Protocol Deviation|52|||
25292221|NCT01101035|50606903|FG001|Overall Study|Major Protocol Deviation|46|||
25292222|NCT01101035|50606902|FG000|Overall Study|Lost to Follow-up|226|||
25292223|NCT01101035|50606903|FG001|Overall Study|Lost to Follow-up|223|||
25292224|NCT01101035|50606902|FG000|Overall Study|Voluntary Withdrawal|595|||
25292225|NCT01101035|50606903|FG001|Overall Study|Voluntary Withdrawal|587|||
25292226|NCT01101035|50606902|FG000|Overall Study|Reason not Specified|333|||
25292227|NCT01101035|50606903|FG001|Overall Study|Reason not Specified|363|||
25292228|NCT01100567|50606911|FG000|Overall Study|Withdrawal by Subject|5|||
25292229|NCT01100567|50606912|FG001|Overall Study|Withdrawal by Subject|8|||
25292230|NCT01100567|50606911|FG000|Overall Study|Early Hospital Discharge|6|||
25292231|NCT01100567|50606912|FG001|Overall Study|Early Hospital Discharge|4|||
25292232|NCT01100567|50606911|FG000|Overall Study|Lost to Follow-up|1|||
25292233|NCT01100567|50606912|FG001|Overall Study|Lost to Follow-up|2|||
25292234|NCT01100567|50606911|FG000|Overall Study|Physician Decision|0|||
25292235|NCT01100567|50606912|FG001|Overall Study|Physician Decision|1|||
25292236|NCT01100567|50606911|FG000|Overall Study|Deemed ineligible after consent|0|||
25292237|NCT01100567|50606912|FG001|Overall Study|Deemed ineligible after consent|1|||
25292238|NCT01160822|50606925|FG000|Overall Study|Adverse Event|0|||
25292239|NCT01160822|50606926|FG001|Overall Study|Adverse Event|0|||
25292240|NCT01160822|50606927|FG002|Overall Study|Adverse Event|0|||
25292241|NCT01160822|50606928|FG003|Overall Study|Adverse Event|0|||
25292242|NCT01160822|50606929|FG004|Overall Study|Adverse Event|1|||
25292243|NCT01160822|50606930|FG005|Overall Study|Adverse Event|2|||
25292244|NCT01160822|50606931|FG006|Overall Study|Adverse Event|5|||
25292245|NCT01160822|50606925|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25292246|NCT01160822|50606926|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
25292247|NCT01160822|50606927|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
25292248|NCT01160822|50606928|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
25292249|NCT01160822|50606929|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
25292250|NCT01160822|50606930|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
25292251|NCT01160822|50606931|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
25292252|NCT01160822|50606925|FG000|Overall Study|Withdrawal by Subject|0|||
25292253|NCT01160822|50606926|FG001|Overall Study|Withdrawal by Subject|0|||
25292254|NCT01160822|50606927|FG002|Overall Study|Withdrawal by Subject|0|||
25292255|NCT01160822|50606928|FG003|Overall Study|Withdrawal by Subject|0|||
25292256|NCT01160822|50606929|FG004|Overall Study|Withdrawal by Subject|0|||
25292257|NCT01160822|50606930|FG005|Overall Study|Withdrawal by Subject|0|||
25292258|NCT01160822|50606931|FG006|Overall Study|Withdrawal by Subject|1|||
25292259|NCT01160822|50606925|FG000|Overall Study|Lost to Follow-up|0|||
25292260|NCT01160822|50606926|FG001|Overall Study|Lost to Follow-up|0|||
25292261|NCT01160822|50606927|FG002|Overall Study|Lost to Follow-up|0|||
25292262|NCT01160822|50606928|FG003|Overall Study|Lost to Follow-up|0|||
25292263|NCT01160822|50606929|FG004|Overall Study|Lost to Follow-up|1|||
25292264|NCT01160822|50606930|FG005|Overall Study|Lost to Follow-up|0|||
25292265|NCT01160822|50606931|FG006|Overall Study|Lost to Follow-up|0|||
25292266|NCT01160822|50606925|FG000|Overall Study|Administrative problems|0|||
25292267|NCT01160822|50606926|FG001|Overall Study|Administrative problems|0|||
25292268|NCT01160822|50606927|FG002|Overall Study|Administrative problems|0|||
25292269|NCT01160822|50606928|FG003|Overall Study|Administrative problems|0|||
25292270|NCT01160822|50606929|FG004|Overall Study|Administrative problems|1|||
25292271|NCT01160822|50606930|FG005|Overall Study|Administrative problems|0|||
25292272|NCT01160822|50606931|FG006|Overall Study|Administrative problems|0|||
25292273|NCT01160822|50606925|FG000|Overall Study|Protocol deviation|0|||
25292274|NCT01160822|50606926|FG001|Overall Study|Protocol deviation|0|||
25292275|NCT01160822|50606927|FG002|Overall Study|Protocol deviation|0|||
25292276|NCT01160822|50606928|FG003|Overall Study|Protocol deviation|0|||
25292277|NCT01160822|50606929|FG004|Overall Study|Protocol deviation|2|||
25292278|NCT01160822|50606930|FG005|Overall Study|Protocol deviation|0|||
25292279|NCT01160822|50606931|FG006|Overall Study|Protocol deviation|0|||
25292280|NCT01006980|50606950|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
25292281|NCT01006980|50606951|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
25292282|NCT01006980|50606950|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
25070439|NCT02787083|50176414|FG000|Overall Study|Withdrawal by Subject|2|||
25169267|NCT01842581|50300795|FG000|Overall Study|Adverse Event|6|||
25169268|NCT01842581|50300796|FG001|Overall Study|Adverse Event|4|||
25169269|NCT01842581|50300795|FG000|Overall Study|HE breakthrough|26|||
25292283|NCT01006980|50606951|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
25292284|NCT01006980|50606950|FG000|Vemurafenib and Dacarbazine|Death|13|||
25292285|NCT01006980|50606951|FG001|Vemurafenib and Dacarbazine|Death|12|||
25292286|NCT01006980|50606950|FG000|Vemurafenib and Dacarbazine|Progression|257|||
25292287|NCT01006980|50606951|FG001|Vemurafenib and Dacarbazine|Progression|218|||
25292288|NCT01006980|50606950|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
25292289|NCT01006980|50606951|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
25292290|NCT01006980|50606950|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
25292291|NCT01006980|50606951|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
25292292|NCT01006980|50606950|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
25292293|NCT01006980|50606951|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
25292294|NCT01006980|50606950|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
25292295|NCT01006980|50606951|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
25292296|NCT01006980|50606950|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
25292297|NCT01006980|50606951|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
25292298|NCT01006980|50606950|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
25292299|NCT01006980|50606951|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
25292300|NCT01006980|50606950|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
25292301|NCT01006980|50606951|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
25292302|NCT01006980|50606950|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
25292303|NCT01006980|50606951|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
25292304|NCT01006980|50606950|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
25292305|NCT01006980|50606951|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
25292306|NCT00887926|50606962|FG000|Overall Study|Withdrawal by Subject|0|||
25292307|NCT00887926|50606963|FG001|Overall Study|Withdrawal by Subject|1|||
25292308|NCT00887926|50606964|FG002|Overall Study|Withdrawal by Subject|0|||
25292309|NCT00887926|50606965|FG003|Overall Study|Withdrawal by Subject|0|||
25292310|NCT00998400|50606983|FG000|Overall Study|Lack of interest/motivation|1|||
25292311|NCT00998400|50606984|FG001|Overall Study|Lack of interest/motivation|2|||
25292312|NCT00998400|50606983|FG000|Overall Study|Logistical problems|1|||
25292313|NCT00998400|50606984|FG001|Overall Study|Logistical problems|0|||
25292314|NCT00997386|50606991|FG000|Overall Study|Death|7|||
25292315|NCT00996996|50606995|FG000|Overall Study|Progressive Disease|10|||
25292316|NCT00996996|50606995|FG000|Overall Study|Non-compliance|8|||
25292317|NCT00996996|50606995|FG000|Overall Study|Lost to Follow-up|9|||
25292318|NCT00996996|50606995|FG000|Overall Study|Death|5|||
25292319|NCT00996996|50606995|FG000|Overall Study|Did Not Receive Study Medications|1|||
25292320|NCT00996918|50607004|FG000|Overall Study|Lack of Efficacy|1|||
25292321|NCT00996918|50607005|FG001|Overall Study|Lack of Efficacy|1|||
25292322|NCT00996918|50607006|FG002|Overall Study|Lack of Efficacy|2|||
25292323|NCT00996918|50607007|FG003|Overall Study|Lack of Efficacy|2|||
25292324|NCT00996918|50607008|FG004|Overall Study|Lack of Efficacy|0|||
25292325|NCT00996918|50607004|FG000|Overall Study|Adverse Event|2|||
25292326|NCT00996918|50607005|FG001|Overall Study|Adverse Event|5|||
25292327|NCT00996918|50607006|FG002|Overall Study|Adverse Event|2|||
25292328|NCT00996918|50607007|FG003|Overall Study|Adverse Event|6|||
25292329|NCT00996918|50607008|FG004|Overall Study|Adverse Event|0|||
25292330|NCT00996918|50607004|FG000|Overall Study|Withdrawal by Subject|1|||
25292331|NCT00996918|50607005|FG001|Overall Study|Withdrawal by Subject|4|||
25292332|NCT00996918|50607006|FG002|Overall Study|Withdrawal by Subject|3|||
25292333|NCT00996918|50607007|FG003|Overall Study|Withdrawal by Subject|3|||
25292334|NCT00996918|50607008|FG004|Overall Study|Withdrawal by Subject|2|||
25292335|NCT00996918|50607004|FG000|Overall Study|Physician Decision|1|||
25292336|NCT00996918|50607005|FG001|Overall Study|Physician Decision|0|||
25292337|NCT00996918|50607006|FG002|Overall Study|Physician Decision|0|||
25292338|NCT00996918|50607007|FG003|Overall Study|Physician Decision|0|||
25292339|NCT00996918|50607008|FG004|Overall Study|Physician Decision|0|||
25292340|NCT00996918|50607004|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
25292341|NCT00996918|50607005|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
25292342|NCT00996918|50607006|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
25292343|NCT00996918|50607007|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
25292344|NCT00996918|50607008|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
25292345|NCT00996918|50607004|FG000|Overall Study|Loss of Caregiver|0|||
25292346|NCT00996918|50607005|FG001|Overall Study|Loss of Caregiver|1|||
25292347|NCT00996918|50607006|FG002|Overall Study|Loss of Caregiver|0|||
25292348|NCT00996918|50607007|FG003|Overall Study|Loss of Caregiver|0|||
25292349|NCT00996918|50607008|FG004|Overall Study|Loss of Caregiver|0|||
25292350|NCT00996918|50607004|FG000|Overall Study|Other|3|||
25292351|NCT00996918|50607005|FG001|Overall Study|Other|1|||
25292352|NCT00996918|50607006|FG002|Overall Study|Other|0|||
25292353|NCT00996918|50607007|FG003|Overall Study|Other|0|||
25292354|NCT00996918|50607008|FG004|Overall Study|Other|0|||
25292355|NCT01160744|50607024|FG000|Overall Study|Withdrawal by Subject|11|||
25292356|NCT01160744|50607025|FG001|Overall Study|Withdrawal by Subject|5|||
25292357|NCT01160744|50607026|FG002|Overall Study|Withdrawal by Subject|6|||
25292358|NCT01160744|50607027|FG003|Overall Study|Withdrawal by Subject|4|||
25292359|NCT01160744|50607024|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
25292360|NCT01160744|50607025|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
25292361|NCT01160744|50607026|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
25292362|NCT01160744|50607027|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
25292363|NCT01160354|50607042|FG000|Overall Study|Death|0|||
25292364|NCT01160354|50607043|FG001|Overall Study|Death|1|||
25292365|NCT01160354|50607044|FG002|Overall Study|Death|1|||
25292366|NCT01160198|50607055|FG000|Overall Study|Withdrawal by Subject|2|||
25292367|NCT01160198|50607056|FG001|Overall Study|Withdrawal by Subject|1|||
25292368|NCT01160198|50607057|FG002|Overall Study|Withdrawal by Subject|0|||
25292369|NCT01160198|50607055|FG000|Overall Study|Adverse Event|0|||
25292370|NCT01160198|50607056|FG001|Overall Study|Adverse Event|1|||
25292371|NCT01160198|50607057|FG002|Overall Study|Adverse Event|0|||
25292372|NCT01160198|50607055|FG000|Overall Study|Lost to Follow-up|0|||
25292373|NCT01160198|50607056|FG001|Overall Study|Lost to Follow-up|1|||
25292374|NCT01160198|50607057|FG002|Overall Study|Lost to Follow-up|0|||
25292375|NCT01160198|50607055|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
25292376|NCT01160198|50607056|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
25292377|NCT01160198|50607057|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
25292378|NCT01159574|50607065|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
25292379|NCT01159574|50607065|FG000|Treatment Phase|Adverse Event|3|||
25292380|NCT01159574|50607065|FG000|Treatment Phase|Death|6|||
25292381|NCT01159574|50607065|FG000|Treatment Phase|Physician Decision|2|||
25292382|NCT01159574|50607065|FG000|Treatment Phase|Withdrawal by Subject|7|||
25292383|NCT01159574|50607065|FG000|Treatment Phase|still on treatment|2|||
25292384|NCT01159574|50607065|FG000|Follow Up Phase|Lost to Follow-up|2|||
25292385|NCT01159574|50607065|FG000|Follow Up Phase|still being followed for overall surviva|18|||
25292386|NCT01158950|50607069|FG000|1st Intervention (1 Day)|Physician Decision|1|||
25292387|NCT01158950|50607070|FG001|1st Intervention (1 Day)|Physician Decision|2|||
25292388|NCT01172288|50607077|FG000|Overall Study|Adverse Event|1|||
25292389|NCT01172288|50607078|FG001|Overall Study|Adverse Event|0|||
25292390|NCT01172288|50607077|FG000|Overall Study|Protocol Violation|0|||
25292391|NCT01172288|50607078|FG001|Overall Study|Protocol Violation|1|||
25292392|NCT00996840|50607089|FG000|Overall Study|Adverse Event|0|||
25292393|NCT00996840|50607090|FG001|Overall Study|Adverse Event|1|||
25292394|NCT00996840|50607091|FG002|Overall Study|Adverse Event|0|||
25292395|NCT00996840|50607092|FG003|Overall Study|Adverse Event|0|||
25292396|NCT00996840|50607093|FG004|Overall Study|Adverse Event|0|||
25292397|NCT00996840|50607089|FG000|Overall Study|Physician Decision|0|||
25292398|NCT00996840|50607090|FG001|Overall Study|Physician Decision|0|||
25292399|NCT00996840|50607091|FG002|Overall Study|Physician Decision|1|||
25292400|NCT00996840|50607092|FG003|Overall Study|Physician Decision|1|||
25292401|NCT00996840|50607093|FG004|Overall Study|Physician Decision|2|||
25292402|NCT00996840|50607089|FG000|Overall Study|Withdrawal by Subject|1|||
25292403|NCT00996840|50607090|FG001|Overall Study|Withdrawal by Subject|1|||
25292404|NCT00996840|50607091|FG002|Overall Study|Withdrawal by Subject|0|||
25292405|NCT00996840|50607092|FG003|Overall Study|Withdrawal by Subject|0|||
25292406|NCT00996840|50607093|FG004|Overall Study|Withdrawal by Subject|0|||
25292407|NCT00998946|50607109|FG000|Overall Study|Lost to Follow-up|1|||
25292408|NCT00998946|50607109|FG000|Overall Study|Withdrawal by Subject|1|||
25292409|NCT00998946|50607109|FG000|Overall Study|Death|2|||
25292410|NCT00998946|50607109|FG000|Overall Study|Reason Unspecified|3|||
25292411|NCT00998946|50607109|FG000|Overall Study|Enrolled but not Dosed|2|||
25292412|NCT01158404|50607121|FG000|Overall Study|Withdrawal by Subject|0|||
25070440|NCT02787083|50176415|FG001|Overall Study|Withdrawal by Subject|2|||
25070441|NCT02787863|50176429|FG000|Overall Study|Death|1|||
25070442|NCT02787863|50176430|FG001|Overall Study|Death|0|||
25070443|NCT02787863|50176431|FG002|Overall Study|Death|1|||
25070444|NCT02787863|50176432|FG003|Overall Study|Death|0|||
25070445|NCT02787863|50176433|FG004|Overall Study|Death|0|||
25070446|NCT02787863|50176434|FG005|Overall Study|Death|0|||
25070447|NCT02787863|50176435|FG006|Overall Study|Death|0|||
25070448|NCT02787863|50176436|FG007|Overall Study|Death|0|||
25070449|NCT02787863|50176429|FG000|Overall Study|Withdrawal by Subject|0|||
25070450|NCT02787863|50176430|FG001|Overall Study|Withdrawal by Subject|1|||
25070451|NCT02787863|50176431|FG002|Overall Study|Withdrawal by Subject|1|||
25070452|NCT02787863|50176432|FG003|Overall Study|Withdrawal by Subject|0|||
25070453|NCT02787863|50176433|FG004|Overall Study|Withdrawal by Subject|0|||
25070454|NCT02787863|50176434|FG005|Overall Study|Withdrawal by Subject|0|||
25070455|NCT02787863|50176435|FG006|Overall Study|Withdrawal by Subject|0|||
25070456|NCT02787863|50176436|FG007|Overall Study|Withdrawal by Subject|0|||
25070457|NCT02596958|50176477|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
25070458|NCT02596958|50176477|FG000|Overall Study|Cancer Progression|441|||
25070459|NCT02596958|50176477|FG000|Overall Study|Death From Cancer|112|||
25292413|NCT01158404|50607122|FG001|Overall Study|Withdrawal by Subject|1|||
25292414|NCT01158404|50607123|FG002|Overall Study|Withdrawal by Subject|0|||
25292415|NCT01158404|50607124|FG003|Overall Study|Withdrawal by Subject|0|||
25292416|NCT01158404|50607125|FG004|Overall Study|Withdrawal by Subject|3|||
25292417|NCT01158404|50607126|FG005|Overall Study|Withdrawal by Subject|1|||
25292418|NCT01158404|50607127|FG006|Overall Study|Withdrawal by Subject|0|||
25292419|NCT01158404|50607128|FG007|Overall Study|Withdrawal by Subject|1|||
25292420|NCT01158404|50607121|FG000|Overall Study|Physician Decision|0|||
25292421|NCT01158404|50607122|FG001|Overall Study|Physician Decision|0|||
25292422|NCT01158404|50607123|FG002|Overall Study|Physician Decision|0|||
25292423|NCT01158404|50607124|FG003|Overall Study|Physician Decision|0|||
25292424|NCT01158404|50607125|FG004|Overall Study|Physician Decision|0|||
25292425|NCT01158404|50607126|FG005|Overall Study|Physician Decision|0|||
25292426|NCT01158404|50607127|FG006|Overall Study|Physician Decision|0|||
25070460|NCT02596958|50176477|FG000|Overall Study|Death From Other Cause|33|||
25070461|NCT02596958|50176477|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
25070462|NCT02596958|50176477|FG000|Overall Study|Administrative Reasons/Other|231|||
25070463|NCT02596958|50176477|FG000|Overall Study|Lost to Follow-up|33|||
25070464|NCT02596958|50176477|FG000|Overall Study|Missing|32|||
25070465|NCT02596958|50176477|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
25070466|NCT01367249|50176483|FG000|Overall Study|Withdrawal by Subject|6|||
25070467|NCT01367249|50176484|FG001|Overall Study|Withdrawal by Subject|6|||
25070468|NCT01367249|50176483|FG000|Overall Study|Other|3|||
25070469|NCT01367249|50176484|FG001|Overall Study|Other|10|||
25292427|NCT01158404|50607128|FG007|Overall Study|Physician Decision|1|||
25292428|NCT01158404|50607121|FG000|Overall Study|Progressive Disease|0|||
25292429|NCT01158404|50607122|FG001|Overall Study|Progressive Disease|0|||
25292430|NCT01158404|50607123|FG002|Overall Study|Progressive Disease|0|||
25292431|NCT01158404|50607124|FG003|Overall Study|Progressive Disease|0|||
25292432|NCT01158404|50607125|FG004|Overall Study|Progressive Disease|0|||
25292433|NCT01158404|50607126|FG005|Overall Study|Progressive Disease|0|||
25292434|NCT01158404|50607127|FG006|Overall Study|Progressive Disease|1|||
25292435|NCT01158404|50607128|FG007|Overall Study|Progressive Disease|0|||
25292436|NCT00998790|50607148|FG000|Overall Study|Withdrawal by Subject|21|||
25292437|NCT01001988|50607152|FG000|Overall Study|Protocol Violation|84|||
25292438|NCT01001988|50607152|FG000|Overall Study|Withdrawal by Subject|18|||
25292439|NCT01001988|50607152|FG000|Overall Study|Lost to Follow-up|15|||
25292440|NCT00996606|50607156|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
25292441|NCT00996606|50607156|FG000|Overall Study|Insufficient Therapeutic Response|2|||
25292442|NCT00996606|50607156|FG000|Overall Study|Protocol Violation|1|||
25292443|NCT00996606|50607156|FG000|Overall Study|Withdrawal by Subject|3|||
25292444|NCT00995436|50607163|FG000|Overall Study|Withdrawal by Subject|2|||
25292445|NCT00995436|50607164|FG001|Overall Study|Withdrawal by Subject|5|||
25292446|NCT00995436|50607165|FG002|Overall Study|Withdrawal by Subject|0|||
25292447|NCT00994890|50607176|FG000|Overall Study|Adverse Event|13|||
25292448|NCT00994890|50607177|FG001|Overall Study|Adverse Event|9|||
25292449|NCT00994890|50607178|FG002|Overall Study|Adverse Event|11|||
25292450|NCT00994890|50607176|FG000|Overall Study|Lack of Efficacy|0|||
25292451|NCT00994890|50607177|FG001|Overall Study|Lack of Efficacy|0|||
25292452|NCT00994890|50607178|FG002|Overall Study|Lack of Efficacy|1|||
25292453|NCT00994890|50607176|FG000|Overall Study|Lost to Follow-up|6|||
25292454|NCT00994890|50607177|FG001|Overall Study|Lost to Follow-up|1|||
25292455|NCT00994890|50607178|FG002|Overall Study|Lost to Follow-up|3|||
25292456|NCT00994890|50607176|FG000|Overall Study|No longer willing to participate|8|||
25292457|NCT00994890|50607177|FG001|Overall Study|No longer willing to participate|5|||
25292458|NCT00994890|50607178|FG002|Overall Study|No longer willing to participate|13|||
25292459|NCT00994890|50607176|FG000|Overall Study|Protocol Violation|2|||
25292460|NCT00994890|50607177|FG001|Overall Study|Protocol Violation|4|||
25292461|NCT00994890|50607178|FG002|Overall Study|Protocol Violation|0|||
25292462|NCT00994890|50607176|FG000|Overall Study|Study terminated by sponsor|199|||
25292463|NCT00994890|50607177|FG001|Overall Study|Study terminated by sponsor|201|||
25292464|NCT00994890|50607178|FG002|Overall Study|Study terminated by sponsor|197|||
25292465|NCT00994890|50607176|FG000|Overall Study|Randomized, but not treated|1|||
25292466|NCT00994890|50607177|FG001|Overall Study|Randomized, but not treated|0|||
25292467|NCT00994890|50607178|FG002|Overall Study|Randomized, but not treated|0|||
25292468|NCT00994890|50607176|FG000|Overall Study|Other|2|||
25292469|NCT00994890|50607177|FG001|Overall Study|Other|2|||
25292470|NCT00994890|50607178|FG002|Overall Study|Other|1|||
25292471|NCT00994422|50607188|FG000|Overall Study|Lost to Follow-up|7|||
25292472|NCT00994422|50607189|FG001|Overall Study|Lost to Follow-up|1|||
25292473|NCT01171976|50607200|FG000|Overall Study|Protocol Violation|0|||
25292474|NCT01171976|50607201|FG001|Overall Study|Protocol Violation|0|||
25070470|NCT02786927|50176490|FG000|Overall Study|Adverse Event|1|||
25070471|NCT02786927|50176490|FG000|Overall Study|Protocol Violation|4|||
25070472|NCT02592434|50176495|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
25292475|NCT01171976|50607202|FG002|Overall Study|Protocol Violation|1|||
25292476|NCT01171976|50607200|FG000|Overall Study|Death|2|||
25292477|NCT01171976|50607201|FG001|Overall Study|Death|4|||
25292478|NCT01171976|50607202|FG002|Overall Study|Death|1|||
25292479|NCT01171976|50607200|FG000|Overall Study|Lost to Follow-up|4|||
25292480|NCT01171976|50607201|FG001|Overall Study|Lost to Follow-up|0|||
25292481|NCT01171976|50607202|FG002|Overall Study|Lost to Follow-up|2|||
25292482|NCT01171976|50607200|FG000|Overall Study|Withdrawal by Subject|1|||
25292483|NCT01171976|50607201|FG001|Overall Study|Withdrawal by Subject|5|||
25292484|NCT01171976|50607202|FG002|Overall Study|Withdrawal by Subject|6|||
25292485|NCT01171976|50607200|FG000|Overall Study|Abnormal test result|1|||
25292486|NCT01171976|50607201|FG001|Overall Study|Abnormal test result|0|||
25292487|NCT01171976|50607202|FG002|Overall Study|Abnormal test result|0|||
25292488|NCT01171976|50607200|FG000|Overall Study|Adverse Event|6|||
25292489|NCT01171976|50607201|FG001|Overall Study|Adverse Event|2|||
25292490|NCT01171976|50607202|FG002|Overall Study|Adverse Event|5|||
25292491|NCT00996216|50607210|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
25292492|NCT00996216|50607210|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
25292493|NCT00996216|50607210|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
25292494|NCT00830869|50607227|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
25292495|NCT00830869|50607228|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
25292496|NCT00830869|50607229|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
25292497|NCT00830869|50607230|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
25292498|NCT00830869|50607231|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
25292499|NCT00830869|50607232|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
25292500|NCT00830869|50607233|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
25292501|NCT00830869|50607234|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
25292502|NCT00830869|50607235|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
25292503|NCT00830869|50607236|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
24969739|NCT00117312|50059187|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
24969740|NCT00117312|50059184|FG000|Overall Study|Hepatic abnormality|0|||
24969741|NCT00117312|50059185|FG001|Overall Study|Hepatic abnormality|1|||
24969742|NCT00117312|50059186|FG002|Overall Study|Hepatic abnormality|0|||
24969743|NCT00117312|50059187|FG003|Overall Study|Hepatic abnormality|1|||
24969744|NCT00117312|50059184|FG000|Overall Study|Withdrawal by Subject|0|||
24969745|NCT00117312|50059185|FG001|Overall Study|Withdrawal by Subject|2|||
24969746|NCT00117312|50059186|FG002|Overall Study|Withdrawal by Subject|0|||
24969747|NCT00117312|50059187|FG003|Overall Study|Withdrawal by Subject|0|||
24969748|NCT00129116|50059202|FG000|Primary Phase|Lost to Follow-up|1|||
24969749|NCT00129116|50059203|FG001|Primary Phase|Lost to Follow-up|1|||
24969750|NCT00129116|50059204|FG002|Primary Phase|Lost to Follow-up|0|||
24969751|NCT00129116|50059205|FG003|Primary Phase|Lost to Follow-up|1|||
25292504|NCT00830869|50607237|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
25292505|NCT00830869|50607238|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
25292506|NCT00830869|50607227|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
25292507|NCT00830869|50607228|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
25292508|NCT00830869|50607229|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
25292509|NCT00830869|50607230|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
25292510|NCT00830869|50607231|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
25292511|NCT00830869|50607232|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
25292512|NCT00830869|50607233|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
25292513|NCT00830869|50607234|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
25292514|NCT00830869|50607235|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
25292515|NCT00830869|50607236|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
25292516|NCT00830869|50607237|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
25292517|NCT00830869|50607238|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
25292518|NCT00830869|50607227|FG000|Period 1: Part 1|Adverse Event|0|||
25292519|NCT00830869|50607228|FG001|Period 1: Part 1|Adverse Event|0|||
25292520|NCT00830869|50607229|FG002|Period 1: Part 1|Adverse Event|0|||
25292521|NCT00830869|50607230|FG003|Period 1: Part 1|Adverse Event|0|||
25292522|NCT00830869|50607231|FG004|Period 1: Part 1|Adverse Event|0|||
25292523|NCT00830869|50607232|FG005|Period 1: Part 1|Adverse Event|1|||
25292524|NCT00830869|50607233|FG006|Period 1: Part 1|Adverse Event|1|||
25292525|NCT00830869|50607234|FG007|Period 1: Part 1|Adverse Event|0|||
25292526|NCT00830869|50607235|FG008|Period 1: Part 1|Adverse Event|0|||
25292527|NCT00830869|50607236|FG009|Period 1: Part 1|Adverse Event|0|||
25292528|NCT00830869|50607237|FG010|Period 1: Part 1|Adverse Event|0|||
25292529|NCT00830869|50607238|FG011|Period 1: Part 1|Adverse Event|0|||
25292530|NCT00830869|50607227|FG000|Period 1: Part 1|Progressive disease|1|||
25292531|NCT00830869|50607228|FG001|Period 1: Part 1|Progressive disease|0|||
25292532|NCT00830869|50607229|FG002|Period 1: Part 1|Progressive disease|1|||
25292533|NCT00830869|50607230|FG003|Period 1: Part 1|Progressive disease|6|||
25292534|NCT00830869|50607231|FG004|Period 1: Part 1|Progressive disease|4|||
25292535|NCT00830869|50607232|FG005|Period 1: Part 1|Progressive disease|4|||
25292536|NCT00830869|50607233|FG006|Period 1: Part 1|Progressive disease|1|||
24969752|NCT00129116|50059206|FG004|Primary Phase|Lost to Follow-up|1|||
24969753|NCT00129116|50059202|FG000|Primary Phase|Protocol Violation|0|||
24969754|NCT00129116|50059203|FG001|Primary Phase|Protocol Violation|1|||
24969755|NCT00129116|50059204|FG002|Primary Phase|Protocol Violation|0|||
24969756|NCT00129116|50059205|FG003|Primary Phase|Protocol Violation|0|||
25292537|NCT00830869|50607234|FG007|Period 1: Part 1|Progressive disease|0|||
25292538|NCT00830869|50607235|FG008|Period 1: Part 1|Progressive disease|0|||
25292539|NCT00830869|50607236|FG009|Period 1: Part 1|Progressive disease|0|||
25292540|NCT00830869|50607237|FG010|Period 1: Part 1|Progressive disease|0|||
25292541|NCT00830869|50607238|FG011|Period 1: Part 1|Progressive disease|0|||
25292542|NCT00830869|50607227|FG000|Period 2: Part 2|Protocol Violation|0|||
25292543|NCT00830869|50607228|FG001|Period 2: Part 2|Protocol Violation|0|||
25292544|NCT00830869|50607229|FG002|Period 2: Part 2|Protocol Violation|0|||
25292545|NCT00830869|50607230|FG003|Period 2: Part 2|Protocol Violation|0|||
25292546|NCT00830869|50607231|FG004|Period 2: Part 2|Protocol Violation|0|||
25292547|NCT00830869|50607232|FG005|Period 2: Part 2|Protocol Violation|0|||
25292548|NCT00830869|50607233|FG006|Period 2: Part 2|Protocol Violation|0|||
25292549|NCT00830869|50607234|FG007|Period 2: Part 2|Protocol Violation|1|||
25292550|NCT00830869|50607235|FG008|Period 2: Part 2|Protocol Violation|0|||
25292551|NCT00830869|50607236|FG009|Period 2: Part 2|Protocol Violation|1|||
25292552|NCT00830869|50607237|FG010|Period 2: Part 2|Protocol Violation|0|||
25292553|NCT00830869|50607238|FG011|Period 2: Part 2|Protocol Violation|0|||
25292554|NCT00830869|50607227|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
25292555|NCT00830869|50607228|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
25292556|NCT00830869|50607229|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
25292557|NCT00830869|50607230|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
25292558|NCT00830869|50607231|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
25292559|NCT00830869|50607232|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
25292560|NCT00830869|50607233|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
25292561|NCT00830869|50607234|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
25292562|NCT00830869|50607235|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
25292563|NCT00830869|50607236|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
25292564|NCT00830869|50607237|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
25292565|NCT00830869|50607238|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
25292566|NCT00830869|50607227|FG000|Period 2: Part 2|Adverse Event|0|||
25292567|NCT00830869|50607228|FG001|Period 2: Part 2|Adverse Event|0|||
25292568|NCT00830869|50607229|FG002|Period 2: Part 2|Adverse Event|0|||
25292569|NCT00830869|50607230|FG003|Period 2: Part 2|Adverse Event|0|||
25292570|NCT00830869|50607231|FG004|Period 2: Part 2|Adverse Event|0|||
25292571|NCT00830869|50607232|FG005|Period 2: Part 2|Adverse Event|0|||
25292572|NCT00830869|50607233|FG006|Period 2: Part 2|Adverse Event|0|||
25292573|NCT00830869|50607234|FG007|Period 2: Part 2|Adverse Event|4|||
25292574|NCT00830869|50607235|FG008|Period 2: Part 2|Adverse Event|3|||
25292575|NCT00830869|50607236|FG009|Period 2: Part 2|Adverse Event|2|||
25292576|NCT00830869|50607237|FG010|Period 2: Part 2|Adverse Event|2|||
25292577|NCT00830869|50607238|FG011|Period 2: Part 2|Adverse Event|0|||
25292578|NCT00830869|50607227|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
25292579|NCT00830869|50607228|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
25292580|NCT00830869|50607229|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
25292581|NCT00830869|50607230|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
25292582|NCT00830869|50607231|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
25292583|NCT00830869|50607232|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
25292584|NCT00830869|50607233|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
25292585|NCT00830869|50607234|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
25292586|NCT00830869|50607235|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
25292587|NCT00830869|50607236|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
25292588|NCT00830869|50607237|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
25292589|NCT00830869|50607238|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
25292590|NCT00830869|50607227|FG000|Period 2: Part 2|Progressive disease|0|||
25292591|NCT00830869|50607228|FG001|Period 2: Part 2|Progressive disease|0|||
25292592|NCT00830869|50607229|FG002|Period 2: Part 2|Progressive disease|0|||
25292593|NCT00830869|50607230|FG003|Period 2: Part 2|Progressive disease|0|||
25292594|NCT00830869|50607231|FG004|Period 2: Part 2|Progressive disease|0|||
25292595|NCT00830869|50607232|FG005|Period 2: Part 2|Progressive disease|0|||
25292596|NCT00830869|50607233|FG006|Period 2: Part 2|Progressive disease|0|||
25292597|NCT00830869|50607234|FG007|Period 2: Part 2|Progressive disease|14|||
25292598|NCT00830869|50607235|FG008|Period 2: Part 2|Progressive disease|11|||
25292599|NCT00830869|50607236|FG009|Period 2: Part 2|Progressive disease|12|||
25292600|NCT00830869|50607237|FG010|Period 2: Part 2|Progressive disease|8|||
25292601|NCT00830869|50607238|FG011|Period 2: Part 2|Progressive disease|15|||
25292602|NCT00830869|50607227|FG000|Period 2: Part 2|Other|0|||
25292603|NCT00830869|50607228|FG001|Period 2: Part 2|Other|0|||
25292604|NCT00830869|50607229|FG002|Period 2: Part 2|Other|0|||
25292605|NCT00830869|50607230|FG003|Period 2: Part 2|Other|0|||
25292606|NCT00830869|50607231|FG004|Period 2: Part 2|Other|0|||
25292607|NCT00830869|50607232|FG005|Period 2: Part 2|Other|0|||
25292608|NCT00830869|50607233|FG006|Period 2: Part 2|Other|0|||
25292609|NCT00830869|50607234|FG007|Period 2: Part 2|Other|0|||
25292610|NCT00830869|50607235|FG008|Period 2: Part 2|Other|0|||
25292611|NCT00830869|50607236|FG009|Period 2: Part 2|Other|1|||
25292612|NCT00830869|50607237|FG010|Period 2: Part 2|Other|0|||
25292613|NCT00830869|50607238|FG011|Period 2: Part 2|Other|0|||
25292614|NCT00844519|50607267|FG000|Overall Study|Withdrawal by Subject|1|||
25292615|NCT00844519|50607268|FG001|Overall Study|Withdrawal by Subject|1|||
25292616|NCT00844519|50607267|FG000|Overall Study|Adverse Event|1|||
25292617|NCT00844519|50607268|FG001|Overall Study|Adverse Event|0|||
25292618|NCT01171820|50607276|FG000|Overall Study|Death|3|||
25292619|NCT01171820|50607277|FG001|Overall Study|Death|3|||
25292620|NCT01171820|50607276|FG000|Overall Study|Lost to Follow-up|0|||
25292621|NCT01171820|50607277|FG001|Overall Study|Lost to Follow-up|1|||
25292622|NCT01171820|50607276|FG000|Overall Study|Withdrawal by Subject|2|||
25292623|NCT01171820|50607277|FG001|Overall Study|Withdrawal by Subject|0|||
25292624|NCT01171820|50607276|FG000|Overall Study|Physician Decision|0|||
25292625|NCT01171820|50607277|FG001|Overall Study|Physician Decision|1|||
25292626|NCT01171820|50607276|FG000|Overall Study|1-Year Missed Visit|1|||
25292627|NCT01171820|50607277|FG001|Overall Study|1-Year Missed Visit|1|||
25292628|NCT00994110|50607285|FG000|Overall Study|Withdrawal by Subject|9|||
25292629|NCT00994110|50607286|FG001|Overall Study|Withdrawal by Subject|9|||
25292630|NCT00994110|50607285|FG000|Overall Study|Not Treated|4|||
25292631|NCT00994110|50607286|FG001|Overall Study|Not Treated|8|||
25292632|NCT00994110|50607285|FG000|Overall Study|Adverse Event|1|||
25292633|NCT00994110|50607286|FG001|Overall Study|Adverse Event|0|||
25292634|NCT00994110|50607285|FG000|Overall Study|Patient not resected|41|||
25292635|NCT00994110|50607286|FG001|Overall Study|Patient not resected|52|||
25191678|NCT01490450|50352895|FG000|Period 1|Withdrawal by Subject|0|||
25191679|NCT01490450|50352896|FG001|Period 1|Withdrawal by Subject|0|||
25191680|NCT01490450|50352897|FG002|Period 1|Withdrawal by Subject|0|||
25191681|NCT01490450|50352898|FG003|Period 1|Withdrawal by Subject|3|||
25191682|NCT01490450|50352895|FG000|Period 1|No longer met study criteria|0|||
25191683|NCT01490450|50352896|FG001|Period 1|No longer met study criteria|1|||
25191684|NCT01490450|50352897|FG002|Period 1|No longer met study criteria|1|||
25191685|NCT01490450|50352898|FG003|Period 1|No longer met study criteria|0|||
25191686|NCT01490450|50352895|FG000|Period 2|Lack of Efficacy|0|||
25191687|NCT01490450|50352896|FG001|Period 2|Lack of Efficacy|0|||
25191688|NCT01490450|50352897|FG002|Period 2|Lack of Efficacy|0|||
25191689|NCT01490450|50352898|FG003|Period 2|Lack of Efficacy|1|||
25191690|NCT01490450|50352895|FG000|Period 2|Adverse Event|1|||
25191691|NCT01490450|50352896|FG001|Period 2|Adverse Event|1|||
25191692|NCT01490450|50352897|FG002|Period 2|Adverse Event|0|||
25292636|NCT00994110|50607285|FG000|Overall Study|Pt not eligible|10|||
25292637|NCT00994110|50607286|FG001|Overall Study|Pt not eligible|5|||
25292638|NCT00993954|50607294|FG000|Overall Study|Protocol Violation|21|||
25292639|NCT00993954|50607295|FG001|Overall Study|Protocol Violation|2|||
25292640|NCT01157234|50607303|FG000|Overall Study|Withdrawal by Subject|1|||
25292641|NCT01157234|50607304|FG001|Overall Study|Withdrawal by Subject|0|||
25292642|NCT00991302|50607319|FG000|Overall Study|Death|0|||
25292643|NCT00991302|50607320|FG001|Overall Study|Death|1|||
25292644|NCT00991302|50607319|FG000|Overall Study|Lost to Follow-up|14|||
25292645|NCT00991302|50607320|FG001|Overall Study|Lost to Follow-up|12|||
25292646|NCT00995670|50607329|FG000|Overall Study|Failed arterial cannulation|1|||
25292647|NCT00995670|50607330|FG001|Overall Study|Failed arterial cannulation|0|||
25292648|NCT00995670|50607331|FG002|Overall Study|Failed arterial cannulation|3|||
25292649|NCT00601354|50607341|FG000|Overall Study|Lost to Follow-up|4|||
25292650|NCT00601354|50607342|FG001|Overall Study|Lost to Follow-up|5|||
25292651|NCT00853099|50607351|FG000|Double-blind Period|Adverse Event|7|||
25292652|NCT00853099|50607352|FG001|Double-blind Period|Adverse Event|9|||
25292653|NCT00853099|50607353|FG002|Double-blind Period|Adverse Event|13|||
25292654|NCT00853099|50607354|FG003|Double-blind Period|Adverse Event|0|||
25292655|NCT00853099|50607351|FG000|Double-blind Period|Withdrawal by Subject|2|||
25070473|NCT02592434|50176496|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
25191693|NCT01490450|50352898|FG003|Period 2|Adverse Event|1|||
25191694|NCT01490450|50352895|FG000|Period 2|Withdrawal by Subject|1|||
25191695|NCT01490450|50352896|FG001|Period 2|Withdrawal by Subject|0|||
25191696|NCT01490450|50352897|FG002|Period 2|Withdrawal by Subject|0|||
25191697|NCT01490450|50352898|FG003|Period 2|Withdrawal by Subject|0|||
25191698|NCT01490450|50352895|FG000|Period 2|Lost to Follow-up|0|||
25191699|NCT01490450|50352896|FG001|Period 2|Lost to Follow-up|0|||
25191700|NCT01490450|50352897|FG002|Period 2|Lost to Follow-up|0|||
25191701|NCT01490450|50352898|FG003|Period 2|Lost to Follow-up|2|||
25292656|NCT00853099|50607352|FG001|Double-blind Period|Withdrawal by Subject|3|||
25292657|NCT00853099|50607353|FG002|Double-blind Period|Withdrawal by Subject|0|||
25292658|NCT00853099|50607354|FG003|Double-blind Period|Withdrawal by Subject|0|||
25292659|NCT00853099|50607351|FG000|Double-blind Period|Lack of Efficacy|14|||
25292660|NCT00853099|50607352|FG001|Double-blind Period|Lack of Efficacy|17|||
25292661|NCT00853099|50607353|FG002|Double-blind Period|Lack of Efficacy|16|||
25292662|NCT00853099|50607354|FG003|Double-blind Period|Lack of Efficacy|0|||
25292663|NCT00853099|50607351|FG000|Double-blind Period|Other|0|||
25292664|NCT00853099|50607352|FG001|Double-blind Period|Other|0|||
25292665|NCT00853099|50607353|FG002|Double-blind Period|Other|1|||
25292666|NCT00853099|50607354|FG003|Double-blind Period|Other|0|||
25292667|NCT00853099|50607351|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
25292668|NCT00853099|50607352|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
25292669|NCT00853099|50607353|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
25292670|NCT00853099|50607354|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
25292671|NCT00853099|50607351|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
25292672|NCT00853099|50607352|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
25292673|NCT00853099|50607353|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
25292674|NCT00853099|50607354|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
25292675|NCT00853099|50607351|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
25292676|NCT00853099|50607352|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
25292677|NCT00853099|50607353|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
25292678|NCT00853099|50607354|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
25292679|NCT00853099|50607351|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
25292680|NCT00853099|50607352|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
25292681|NCT00853099|50607353|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
25292682|NCT00853099|50607354|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
25292683|NCT00853099|50607351|FG000|Double-blind + Open-label Periods|Other|0|||
25292684|NCT00853099|50607352|FG001|Double-blind + Open-label Periods|Other|0|||
25292685|NCT00853099|50607353|FG002|Double-blind + Open-label Periods|Other|0|||
25292686|NCT00853099|50607354|FG003|Double-blind + Open-label Periods|Other|6|||
25292687|NCT00992784|50607367|FG000|Overall Study|Adverse Event|2|||
25292688|NCT00992784|50607368|FG001|Overall Study|Adverse Event|1|||
25292689|NCT00992784|50607369|FG002|Overall Study|Adverse Event|0|||
25292690|NCT00992784|50607367|FG000|Overall Study|Withdrawal by Subject|1|||
25292691|NCT00992784|50607368|FG001|Overall Study|Withdrawal by Subject|1|||
25292692|NCT00992784|50607369|FG002|Overall Study|Withdrawal by Subject|1|||
25292693|NCT00830167|50607379|FG000|Overall Study|Lack of Efficacy|26|||
25292694|NCT00830167|50607380|FG001|Overall Study|Lack of Efficacy|10|||
25292695|NCT00830167|50607379|FG000|Overall Study|Adverse Event|8|||
25292696|NCT00830167|50607380|FG001|Overall Study|Adverse Event|24|||
25292697|NCT00830167|50607379|FG000|Overall Study|Not meeting entrance criteria|2|||
25292698|NCT00830167|50607380|FG001|Overall Study|Not meeting entrance criteria|5|||
25292699|NCT00830167|50607379|FG000|Overall Study|Withdrawal by Subject|2|||
25292700|NCT00830167|50607380|FG001|Overall Study|Withdrawal by Subject|0|||
25292701|NCT00830167|50607379|FG000|Overall Study|Lost to Follow-up|0|||
25292702|NCT00830167|50607380|FG001|Overall Study|Lost to Follow-up|1|||
25292703|NCT00830167|50607379|FG000|Overall Study|Protocol Violation|0|||
25292704|NCT00830167|50607380|FG001|Overall Study|Protocol Violation|1|||
25292705|NCT00830167|50607379|FG000|Overall Study|Other|2|||
25292706|NCT00830167|50607380|FG001|Overall Study|Other|2|||
25292707|NCT00992394|50607388|FG000|Overall Study|Lack of Efficacy|6|||
25292708|NCT00992394|50607389|FG001|Overall Study|Lack of Efficacy|3|||
25292709|NCT00992394|50607388|FG000|Overall Study|Adverse Event|4|||
25292710|NCT00992394|50607389|FG001|Overall Study|Adverse Event|5|||
25292711|NCT00992394|50607388|FG000|Overall Study|Withdrawal by Subject|8|||
25292712|NCT00992394|50607389|FG001|Overall Study|Withdrawal by Subject|2|||
25292713|NCT00992394|50607388|FG000|Overall Study|Physician Decision|1|||
25292714|NCT00992394|50607389|FG001|Overall Study|Physician Decision|0|||
25292715|NCT00992394|50607388|FG000|Overall Study|Protocol Violation|2|||
25292716|NCT00992394|50607389|FG001|Overall Study|Protocol Violation|4|||
25292717|NCT00992394|50607388|FG000|Overall Study|Lost to Follow-up|2|||
25292718|NCT00992394|50607389|FG001|Overall Study|Lost to Follow-up|0|||
25292719|NCT00992394|50607388|FG000|Overall Study|Other event|1|||
25292720|NCT00992394|50607389|FG001|Overall Study|Other event|0|||
25292721|NCT00829933|50607399|FG000|Overall Study|Adverse Event|2|||
25292722|NCT00829933|50607400|FG001|Overall Study|Adverse Event|3|||
25292723|NCT00829933|50607401|FG002|Overall Study|Adverse Event|2|||
25292724|NCT00829933|50607402|FG003|Overall Study|Adverse Event|1|||
24969757|NCT00129116|50059206|FG004|Primary Phase|Protocol Violation|0|||
24969758|NCT00129116|50059202|FG000|Primary Phase|Adverse Event|1|||
24969759|NCT00129116|50059203|FG001|Primary Phase|Adverse Event|1|||
25169270|NCT01842581|50300796|FG001|Overall Study|HE breakthrough|13|||
25169271|NCT01842581|50300795|FG000|Overall Study|Liver transplant|2|||
25292725|NCT00829933|50607399|FG000|Overall Study|Death|0|||
25292726|NCT00829933|50607400|FG001|Overall Study|Death|0|||
25292727|NCT00829933|50607401|FG002|Overall Study|Death|1|||
25292728|NCT00829933|50607402|FG003|Overall Study|Death|1|||
25292729|NCT00829933|50607399|FG000|Overall Study|Lack of Efficacy|0|||
25292730|NCT00829933|50607400|FG001|Overall Study|Lack of Efficacy|1|||
25292731|NCT00829933|50607401|FG002|Overall Study|Lack of Efficacy|0|||
25292732|NCT00829933|50607402|FG003|Overall Study|Lack of Efficacy|0|||
25292733|NCT00829933|50607399|FG000|Overall Study|Physician Decision|5|||
25292734|NCT00829933|50607400|FG001|Overall Study|Physician Decision|7|||
25292735|NCT00829933|50607401|FG002|Overall Study|Physician Decision|8|||
25292736|NCT00829933|50607402|FG003|Overall Study|Physician Decision|1|||
25292737|NCT00829933|50607399|FG000|Overall Study|Pregnancy|0|||
25292738|NCT00829933|50607400|FG001|Overall Study|Pregnancy|0|||
25292739|NCT00829933|50607401|FG002|Overall Study|Pregnancy|0|||
25292740|NCT00829933|50607402|FG003|Overall Study|Pregnancy|2|||
25292741|NCT00829933|50607399|FG000|Overall Study|Protocol Violation|2|||
25292742|NCT00829933|50607400|FG001|Overall Study|Protocol Violation|1|||
25292743|NCT00829933|50607401|FG002|Overall Study|Protocol Violation|0|||
25292744|NCT00829933|50607402|FG003|Overall Study|Protocol Violation|0|||
25292745|NCT00829933|50607399|FG000|Overall Study|withdrew before treatment started|5|||
25292746|NCT00829933|50607400|FG001|Overall Study|withdrew before treatment started|1|||
25292747|NCT00829933|50607401|FG002|Overall Study|withdrew before treatment started|2|||
25292748|NCT00829933|50607402|FG003|Overall Study|withdrew before treatment started|9|||
25292749|NCT01170962|50607415|FG000|Treatment Period|Lack of Efficacy|96|||
25292750|NCT01170962|50607416|FG001|Treatment Period|Lack of Efficacy|91|||
25292751|NCT01170962|50607417|FG002|Treatment Period|Lack of Efficacy|7|||
25292752|NCT01170962|50607415|FG000|Treatment Period|Adverse Event|11|||
25292753|NCT01170962|50607416|FG001|Treatment Period|Adverse Event|12|||
25292754|NCT01170962|50607417|FG002|Treatment Period|Adverse Event|3|||
25292755|NCT01170962|50607415|FG000|Treatment Period|Withdrawal by Subject|2|||
25292756|NCT01170962|50607416|FG001|Treatment Period|Withdrawal by Subject|1|||
24969760|NCT00129116|50059204|FG002|Primary Phase|Adverse Event|0|||
25070474|NCT02592434|50176497|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
25070475|NCT02592434|50176495|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
25070476|NCT02592434|50176496|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
25070477|NCT02592434|50176497|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
25070478|NCT02592434|50176495|FG000|Open-Label Phase (18 Weeks)|Other|3|||
25070479|NCT02592434|50176496|FG001|Open-Label Phase (18 Weeks)|Other|0|||
25070480|NCT02592434|50176497|FG002|Open-Label Phase (18 Weeks)|Other|0|||
25070481|NCT02592434|50176495|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
25070482|NCT02592434|50176496|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
25070483|NCT02592434|50176497|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
25070484|NCT02592434|50176495|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
25070485|NCT02592434|50176496|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
25070486|NCT02592434|50176497|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
25070487|NCT02592434|50176495|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
25070488|NCT02592434|50176496|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
25070489|NCT02592434|50176497|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
25070490|NCT02592434|50176495|FG000|Double Blind Phase (26 Weeks)|Other|0|||
25070491|NCT02592434|50176496|FG001|Double Blind Phase (26 Weeks)|Other|1|||
25070492|NCT02592434|50176497|FG002|Double Blind Phase (26 Weeks)|Other|0|||
25070493|NCT02592434|50176495|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
25070494|NCT02592434|50176496|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
25070495|NCT02592434|50176497|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
25070496|NCT02592434|50176495|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
25070497|NCT02592434|50176496|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
25070498|NCT02592434|50176497|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
25070499|NCT02592434|50176495|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
25070500|NCT02592434|50176496|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
25070501|NCT02592434|50176497|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
25070502|NCT02785913|50176505|FG000|Overall Study|Adverse Event|5|||
25070503|NCT02785913|50176505|FG000|Overall Study|Death|2|||
25070504|NCT02785913|50176505|FG000|Overall Study|Progression|18|||
25070505|NCT02785913|50176505|FG000|Overall Study|Not protocol specified|1|||
25070506|NCT02590562|50176514|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
25070507|NCT02783729|50176541|FG000|Overall Study|Lack of Efficacy|1|||
25070508|NCT02783729|50176542|FG001|Overall Study|Lack of Efficacy|0|||
25070509|NCT02783729|50176543|FG002|Overall Study|Lack of Efficacy|0|||
25070510|NCT02783729|50176544|FG003|Overall Study|Lack of Efficacy|0|||
25070511|NCT02783729|50176541|FG000|Overall Study|Adverse Event|2|||
25070512|NCT02783729|50176542|FG001|Overall Study|Adverse Event|6|||
25169272|NCT01842581|50300796|FG001|Overall Study|Liver transplant|0|||
25169273|NCT01842581|50300795|FG000|Overall Study|Lost to Follow-up|2|||
24969761|NCT00129116|50059205|FG003|Primary Phase|Adverse Event|0|||
24969762|NCT00129116|50059206|FG004|Primary Phase|Adverse Event|0|||
25070513|NCT02783729|50176543|FG002|Overall Study|Adverse Event|2|||
25070514|NCT02783729|50176544|FG003|Overall Study|Adverse Event|3|||
25070515|NCT02783729|50176541|FG000|Overall Study|Other|1|||
25070516|NCT02783729|50176542|FG001|Overall Study|Other|6|||
25070517|NCT02783729|50176543|FG002|Overall Study|Other|2|||
25292757|NCT01170962|50607417|FG002|Treatment Period|Withdrawal by Subject|0|||
25292758|NCT01170962|50607415|FG000|Treatment Period|Lost to Follow-up|1|||
25292759|NCT01170962|50607416|FG001|Treatment Period|Lost to Follow-up|1|||
25292760|NCT01170962|50607417|FG002|Treatment Period|Lost to Follow-up|1|||
25292761|NCT01170962|50607415|FG000|Treatment Period|Participant no longer meets criteria|0|||
25292762|NCT01170962|50607416|FG001|Treatment Period|Participant no longer meets criteria|1|||
25292763|NCT01170962|50607417|FG002|Treatment Period|Participant no longer meets criteria|0|||
25292764|NCT01170962|50607415|FG000|Treatment Period|Request to discontinue treatment|7|||
25292765|NCT01170962|50607416|FG001|Treatment Period|Request to discontinue treatment|3|||
25292766|NCT01170962|50607417|FG002|Treatment Period|Request to discontinue treatment|1|||
25292767|NCT01170962|50607415|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
25292768|NCT01170962|50607416|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
25292769|NCT01170962|50607417|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
25292770|NCT01170962|50607415|FG000|Follow up Period|Withdrawal by Subject|14|||
25292771|NCT01170962|50607416|FG001|Follow up Period|Withdrawal by Subject|10|||
25292772|NCT01170962|50607417|FG002|Follow up Period|Withdrawal by Subject|2|||
25292773|NCT01170962|50607415|FG000|Follow up Period|Lost to Follow-up|13|||
25292774|NCT01170962|50607416|FG001|Follow up Period|Lost to Follow-up|8|||
25292775|NCT01170962|50607417|FG002|Follow up Period|Lost to Follow-up|1|||
25292776|NCT01170962|50607415|FG000|Follow up Period|Death|2|||
25292777|NCT01170962|50607416|FG001|Follow up Period|Death|2|||
25292778|NCT01170962|50607417|FG002|Follow up Period|Death|0|||
25292779|NCT01170962|50607415|FG000|Follow up Period|Others|10|||
25292780|NCT01170962|50607416|FG001|Follow up Period|Others|7|||
25292781|NCT01170962|50607417|FG002|Follow up Period|Others|3|||
25292782|NCT00843193|50607436|FG000|Overall Study|Adverse Event|2|||
25292783|NCT00843193|50607437|FG001|Overall Study|Adverse Event|4|||
25292784|NCT00843193|50607436|FG000|Overall Study|Lack of Efficacy|1|||
25292785|NCT00843193|50607437|FG001|Overall Study|Lack of Efficacy|1|||
25292786|NCT00843193|50607436|FG000|Overall Study|Protocol Violation|1|||
25292787|NCT00843193|50607437|FG001|Overall Study|Protocol Violation|2|||
25292788|NCT00843193|50607436|FG000|Overall Study|Lost to Follow-up|1|||
25292789|NCT00843193|50607437|FG001|Overall Study|Lost to Follow-up|0|||
25292790|NCT00843193|50607436|FG000|Overall Study|Physician Decision|0|||
25292791|NCT00843193|50607437|FG001|Overall Study|Physician Decision|1|||
25292792|NCT00843193|50607436|FG000|Overall Study|Withdrawal by Subject|3|||
25292793|NCT00843193|50607437|FG001|Overall Study|Withdrawal by Subject|3|||
25292794|NCT00829621|50607446|FG000|Overall Study|Death|1|||
25292795|NCT00829621|50607447|FG001|Overall Study|Death|0|||
25292796|NCT00829621|50607446|FG000|Overall Study|Lost to Follow-up|3|||
25292797|NCT00829621|50607447|FG001|Overall Study|Lost to Follow-up|4|||
25292798|NCT01157078|50607455|FG000|Overall Study|Withdrawal by Subject|12|||
25292799|NCT01157078|50607456|FG001|Overall Study|Withdrawal by Subject|14|||
25292800|NCT01157078|50607455|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
25292801|NCT01157078|50607456|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
25292802|NCT01157078|50607455|FG000|Overall Study|Adverse Event|6|||
25292803|NCT01157078|50607456|FG001|Overall Study|Adverse Event|6|||
25292804|NCT01157078|50607455|FG000|Overall Study|Severe non-compliance to protocol|2|||
25292805|NCT01157078|50607456|FG001|Overall Study|Severe non-compliance to protocol|4|||
25292806|NCT01157078|50607455|FG000|Overall Study|Condition under investigation worsened|0|||
25292807|NCT01157078|50607456|FG001|Overall Study|Condition under investigation worsened|1|||
25292808|NCT01157078|50607455|FG000|Overall Study|Lack of Efficacy|2|||
25292809|NCT01157078|50607456|FG001|Overall Study|Lack of Efficacy|0|||
25292810|NCT01157078|50607455|FG000|Overall Study|Study-specific withdrawal criteria|2|||
25292811|NCT01157078|50607456|FG001|Overall Study|Study-specific withdrawal criteria|2|||
25292812|NCT01157078|50607455|FG000|Overall Study|Lost to Follow-up|7|||
25191702|NCT01469546|50352942|FG000|Received 5 mg Dose|Adverse Event|13|||
25292813|NCT01157078|50607456|FG001|Overall Study|Lost to Follow-up|5|||
25292814|NCT01157078|50607455|FG000|Overall Study|Other|2|||
25292815|NCT01157078|50607456|FG001|Overall Study|Other|4|||
25292816|NCT00591721|50607464|FG000|Overall Study|Withdrawal by Subject|10|||
25292817|NCT00591721|50607465|FG001|Overall Study|Withdrawal by Subject|10|||
25292818|NCT00591721|50607464|FG000|Overall Study|Lost to Follow-up|1|||
25292819|NCT00591721|50607465|FG001|Overall Study|Lost to Follow-up|4|||
25292820|NCT00591721|50607464|FG000|Overall Study|Intervention not received|10|||
25292821|NCT00591721|50607465|FG001|Overall Study|Intervention not received|8|||
25292822|NCT01156844|50607475|FG000|Overall Study|Adverse Event|0|||
25292823|NCT01156844|50607476|FG001|Overall Study|Adverse Event|0|||
25292824|NCT01156844|50607477|FG002|Overall Study|Adverse Event|1|||
25292825|NCT01156844|50607478|FG003|Overall Study|Adverse Event|1|||
25292826|NCT01156844|50607475|FG000|Overall Study|Abnormal test procedure result(s)|0|||
25292827|NCT01156844|50607476|FG001|Overall Study|Abnormal test procedure result(s)|1|||
25292828|NCT01156844|50607477|FG002|Overall Study|Abnormal test procedure result(s)|2|||
25292829|NCT01156844|50607478|FG003|Overall Study|Abnormal test procedure result(s)|2|||
25292830|NCT01156844|50607475|FG000|Overall Study|Withdrawal by Subject|0|||
25292831|NCT01156844|50607476|FG001|Overall Study|Withdrawal by Subject|0|||
25292832|NCT01156844|50607477|FG002|Overall Study|Withdrawal by Subject|2|||
25292833|NCT01156844|50607478|FG003|Overall Study|Withdrawal by Subject|2|||
25292834|NCT01156844|50607475|FG000|Overall Study|Lost to Follow-up|0|||
25292835|NCT01156844|50607476|FG001|Overall Study|Lost to Follow-up|0|||
25292836|NCT01156844|50607477|FG002|Overall Study|Lost to Follow-up|1|||
25292837|NCT01156844|50607478|FG003|Overall Study|Lost to Follow-up|0|||
25292838|NCT01156844|50607475|FG000|Overall Study|Administrative problems|0|||
25292839|NCT01156844|50607476|FG001|Overall Study|Administrative problems|1|||
25292840|NCT01156844|50607477|FG002|Overall Study|Administrative problems|0|||
25292841|NCT01156844|50607478|FG003|Overall Study|Administrative problems|1|||
25292842|NCT01156844|50607475|FG000|Overall Study|Protocol deviation|2|||
25292843|NCT01156844|50607476|FG001|Overall Study|Protocol deviation|0|||
25292844|NCT01156844|50607477|FG002|Overall Study|Protocol deviation|0|||
25292845|NCT01156844|50607478|FG003|Overall Study|Protocol deviation|0|||
25292846|NCT00853021|50607491|FG000|Overall Study|Adverse Event|2|||
25292847|NCT00853021|50607491|FG000|Overall Study|Withdrawal by Subject|2|||
25292848|NCT00853021|50607491|FG000|Overall Study|Death|1|||
25292849|NCT01156532|50607495|FG000|Overall Study|Family Reasons|1|||
25292850|NCT01156532|50607495|FG000|Overall Study|Lost to Follow-up|1|||
25292851|NCT00843115|50607499|FG000|Overall Study|Death|4|||
25292852|NCT00843115|50607499|FG000|Overall Study|Adverse Event|30|||
25292853|NCT00843115|50607499|FG000|Overall Study|Lost to Follow-up|4|||
25292854|NCT00843115|50607499|FG000|Overall Study|Withdrawal by Subject|17|||
25292855|NCT00843115|50607499|FG000|Overall Study|Family wanted meds stopped|1|||
25292856|NCT00843115|50607499|FG000|Overall Study|Family does not want continuation|1|||
25292857|NCT00843115|50607499|FG000|Overall Study|Patient forgot to take meds|1|||
25292858|NCT00843115|50607499|FG000|Overall Study|Does not meet entrance criteria|1|||
25292859|NCT00843115|50607499|FG000|Overall Study|Physician Decision|1|||
25292860|NCT00843115|50607499|FG000|Overall Study|Family discontinued meds|1|||
25292861|NCT00843115|50607499|FG000|Overall Study|patient took for 2 days then stopped|1|||
25292862|NCT00843115|50607499|FG000|Overall Study|patient never took the medication|1|||
25292863|NCT00843115|50607499|FG000|Overall Study|hospitalized due to deterioration|1|||
25292864|NCT00843115|50607499|FG000|Overall Study|week 12 not done|1|||
25292865|NCT00843115|50607499|FG000|Overall Study|Syndrome De Glissement|1|||
25292866|NCT01156376|50607506|FG000|Overall Study|Adverse Event|1|||
25292867|NCT01156376|50607507|FG001|Overall Study|Adverse Event|0|||
25292868|NCT01156376|50607508|FG002|Overall Study|Adverse Event|1|||
25292869|NCT01156376|50607506|FG000|Overall Study|Withdrawal by Subject|0|||
25292870|NCT01156376|50607507|FG001|Overall Study|Withdrawal by Subject|0|||
25292871|NCT01156376|50607508|FG002|Overall Study|Withdrawal by Subject|3|||
25292872|NCT00829387|50607518|FG000|Overall Study|Withdrawal by Subject|2|||
25292873|NCT00829387|50607519|FG001|Overall Study|Withdrawal by Subject|3|||
25292874|NCT00829387|50607518|FG000|Overall Study|Disqualified by PI|1|||
25292875|NCT00829387|50607519|FG001|Overall Study|Disqualified by PI|0|||
25292876|NCT01156142|50607527|FG000|Overall Study|Withdrawal by Subject|8|||
25292877|NCT01156142|50607528|FG001|Overall Study|Withdrawal by Subject|6|||
25292878|NCT01156142|50607527|FG000|Overall Study|Ineligible|0|||
25292879|NCT01156142|50607528|FG001|Overall Study|Ineligible|1|||
25292880|NCT00842257|50607534|FG000|Overall Study|Adverse Event|1|||
25292881|NCT00852475|50607540|FG000|Overall Study|Lost to Follow-up|3|||
25292882|NCT00852475|50607541|FG001|Overall Study|Lost to Follow-up|4|||
25292883|NCT01155284|50607551|FG000|Overall Study|Withdrawal by Subject|4|||
25292884|NCT01155284|50607552|FG001|Overall Study|Withdrawal by Subject|3|||
25292885|NCT01155284|50607551|FG000|Overall Study|Lost to Follow-up|1|||
25292886|NCT01155284|50607552|FG001|Overall Study|Lost to Follow-up|2|||
25292887|NCT01155284|50607551|FG000|Overall Study|Physician Decision|1|||
25292888|NCT01155284|50607552|FG001|Overall Study|Physician Decision|0|||
25292889|NCT01155284|50607551|FG000|Overall Study|Adverse Event|1|||
25292890|NCT01155284|50607552|FG001|Overall Study|Adverse Event|0|||
25169274|NCT01842581|50300796|FG001|Overall Study|Lost to Follow-up|5|||
25169275|NCT01842581|50300795|FG000|Overall Study|Withdrawal by Subject|5|||
25191703|NCT01469546|50352942|FG000|Received 5 mg Dose|Death|2|||
25292891|NCT00852397|50607563|FG000|Overall Study|Adverse Event|4|||
25292892|NCT00852397|50607564|FG001|Overall Study|Adverse Event|6|||
25292893|NCT00852397|50607565|FG002|Overall Study|Adverse Event|4|||
25292894|NCT00852397|50607563|FG000|Overall Study|Death|0|||
25292895|NCT00852397|50607564|FG001|Overall Study|Death|0|||
25292896|NCT00852397|50607565|FG002|Overall Study|Death|1|||
25169276|NCT01842581|50300796|FG001|Overall Study|Withdrawal by Subject|7|||
25292897|NCT00852397|50607563|FG000|Overall Study|Withdrawal by Subject|4|||
25292898|NCT00852397|50607564|FG001|Overall Study|Withdrawal by Subject|1|||
25292899|NCT00852397|50607565|FG002|Overall Study|Withdrawal by Subject|2|||
25292900|NCT00852397|50607563|FG000|Overall Study|Study terminated by sponsor|2|||
25292901|NCT00852397|50607564|FG001|Overall Study|Study terminated by sponsor|1|||
25292902|NCT00852397|50607565|FG002|Overall Study|Study terminated by sponsor|6|||
25292903|NCT00852397|50607563|FG000|Overall Study|Difficulty in study site visit|1|||
25292904|NCT00852397|50607564|FG001|Overall Study|Difficulty in study site visit|0|||
25292905|NCT00852397|50607565|FG002|Overall Study|Difficulty in study site visit|0|||
25292906|NCT00852397|50607563|FG000|Overall Study|Protocol Violation|0|||
25292907|NCT00852397|50607564|FG001|Overall Study|Protocol Violation|0|||
25292908|NCT00852397|50607565|FG002|Overall Study|Protocol Violation|1|||
25292909|NCT00841321|50607575|FG000|Overall Study|Lost to Follow-up|1|||
25292910|NCT00841321|50607576|FG001|Overall Study|Lost to Follow-up|1|||
25292911|NCT00841321|50607575|FG000|Overall Study|Adverse Event|0|||
25292912|NCT00841321|50607576|FG001|Overall Study|Adverse Event|2|||
25292913|NCT00986232|50607588|FG000|Overall Study|Adverse Event|1|||
25292914|NCT00986232|50607589|FG001|Overall Study|Adverse Event|2|||
25292915|NCT00986232|50607590|FG002|Overall Study|Adverse Event|3|||
25292916|NCT00986232|50607591|FG003|Overall Study|Adverse Event|0|||
25292917|NCT00986232|50607588|FG000|Overall Study|Lost to Follow-up|19|||
25292918|NCT00986232|50607589|FG001|Overall Study|Lost to Follow-up|12|||
25292919|NCT00986232|50607590|FG002|Overall Study|Lost to Follow-up|12|||
25292920|NCT00986232|50607591|FG003|Overall Study|Lost to Follow-up|7|||
25292921|NCT00986232|50607588|FG000|Overall Study|Protocol Violation|2|||
25292922|NCT00986232|50607589|FG001|Overall Study|Protocol Violation|3|||
25292923|NCT00986232|50607590|FG002|Overall Study|Protocol Violation|0|||
25292924|NCT00986232|50607591|FG003|Overall Study|Protocol Violation|1|||
25292925|NCT00986232|50607588|FG000|Overall Study|Withdrawal by Subject|13|||
25292926|NCT00986232|50607589|FG001|Overall Study|Withdrawal by Subject|16|||
25292927|NCT00986232|50607590|FG002|Overall Study|Withdrawal by Subject|12|||
25292928|NCT00986232|50607591|FG003|Overall Study|Withdrawal by Subject|3|||
25292929|NCT00986232|50607588|FG000|Overall Study|Missed one or more bleeds|13|||
25292930|NCT00986232|50607589|FG001|Overall Study|Missed one or more bleeds|10|||
25292931|NCT00986232|50607590|FG002|Overall Study|Missed one or more bleeds|6|||
25292932|NCT00986232|50607591|FG003|Overall Study|Missed one or more bleeds|7|||
25292933|NCT00986232|50607588|FG000|Overall Study|Incomplete safety follow-up|3|||
25292934|NCT00986232|50607589|FG001|Overall Study|Incomplete safety follow-up|7|||
25292935|NCT00986232|50607590|FG002|Overall Study|Incomplete safety follow-up|2|||
25292936|NCT00986232|50607591|FG003|Overall Study|Incomplete safety follow-up|2|||
25292937|NCT00852241|50607607|FG000|Overall Study|Physician Decision|18|||
25292938|NCT01169636|50607616|FG000|Overall Study|Adverse Event|0|||
25292939|NCT01169636|50607617|FG001|Overall Study|Adverse Event|0|||
25292940|NCT01169636|50607618|FG002|Overall Study|Adverse Event|1|||
25292941|NCT01169636|50607619|FG003|Overall Study|Adverse Event|1|||
25292942|NCT01169636|50607620|FG004|Overall Study|Adverse Event|0|||
25292943|NCT01169636|50607616|FG000|Overall Study|Screen failure|0|||
25292944|NCT01169636|50607617|FG001|Overall Study|Screen failure|0|||
25292945|NCT01169636|50607618|FG002|Overall Study|Screen failure|2|||
25292946|NCT01169636|50607619|FG003|Overall Study|Screen failure|0|||
25292947|NCT01169636|50607620|FG004|Overall Study|Screen failure|0|||
25292948|NCT01169636|50607616|FG000|Overall Study|Withdrawal by Subject|0|||
25292949|NCT01169636|50607617|FG001|Overall Study|Withdrawal by Subject|0|||
25292950|NCT01169636|50607618|FG002|Overall Study|Withdrawal by Subject|0|||
25292951|NCT01169636|50607619|FG003|Overall Study|Withdrawal by Subject|0|||
25292952|NCT01169636|50607620|FG004|Overall Study|Withdrawal by Subject|3|||
25292953|NCT01169558|50607630|FG000|Overall Study|Disease progression|98|||
25292954|NCT01169558|50607630|FG000|Overall Study|Adverse Event|25|||
25292955|NCT01169558|50607630|FG000|Overall Study|Withdrawal of Consent|8|||
25292956|NCT01169558|50607630|FG000|Overall Study|Medical Decision|7|||
25292957|NCT01169558|50607630|FG000|Overall Study|Stable Disease|4|||
25292958|NCT01169558|50607630|FG000|Overall Study|Lost to Follow-up|4|||
25292959|NCT01169558|50607630|FG000|Overall Study|Need for Surgery|4|||
25292960|NCT01169558|50607630|FG000|Overall Study|Non-compliance|2|||
25292961|NCT01169558|50607630|FG000|Overall Study|Protocol Violation|2|||
25292962|NCT01169558|50607630|FG000|Overall Study|Partial response|2|||
25292963|NCT00840463|50607636|FG000|Overall Study|Adverse Event|1|||
25292964|NCT00840463|50607637|FG001|Overall Study|Adverse Event|0|||
25292965|NCT01155050|50607647|FG000|Overall Study|Lost to Follow-up|15|||
25292966|NCT01155050|50607648|FG001|Overall Study|Lost to Follow-up|20|||
25292967|NCT01155050|50607649|FG002|Overall Study|Lost to Follow-up|19|||
25292968|NCT01155050|50607650|FG003|Overall Study|Lost to Follow-up|22|||
25292969|NCT01168856|50607662|FG000|Overall Study|Lost to Follow-up|4|||
25292970|NCT01168856|50607663|FG001|Overall Study|Lost to Follow-up|34|||
25292971|NCT01168856|50607662|FG000|Overall Study|Withdrawal by Subject|6|||
25292972|NCT01168856|50607663|FG001|Overall Study|Withdrawal by Subject|8|||
25292973|NCT01168856|50607662|FG000|Overall Study|Physician Decision|2|||
25292974|NCT01168856|50607663|FG001|Overall Study|Physician Decision|1|||
25292975|NCT01168856|50607662|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
25292976|NCT01168856|50607663|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
25292977|NCT01168856|50607662|FG000|Overall Study|Participant received anti-HCV treatment|1|||
25292978|NCT01168856|50607663|FG001|Overall Study|Participant received anti-HCV treatment|0|||
25292979|NCT01168856|50607662|FG000|Overall Study|Death|0|||
25292980|NCT01168856|50607663|FG001|Overall Study|Death|2|||
25292981|NCT01168856|50607662|FG000|Overall Study|Other|1|||
25292982|NCT01168856|50607663|FG001|Overall Study|Other|291|||
25292983|NCT01168856|50607662|FG000|Overall Study|Protocol Violation|4|||
25292984|NCT01168856|50607663|FG001|Overall Study|Protocol Violation|6|||
25292985|NCT00828451|50607674|FG000|Overall Study|Death|2|||
25292986|NCT00828451|50607674|FG000|Overall Study|Lack of intravenous line|7|||
25292987|NCT00828451|50607674|FG000|Overall Study|Withdrawal by Subject|1|||
25292988|NCT00828451|50607674|FG000|Overall Study|Deterioration in clinical status|1|||
25292989|NCT00839917|50607680|FG000|Overall Study|Lost to Follow-up|1|||
25292990|NCT00839917|50607681|FG001|Overall Study|Lost to Follow-up|0|||
25292991|NCT00839917|50607680|FG000|Overall Study|Did not receive vaccine|0|||
25292992|NCT00839917|50607681|FG001|Overall Study|Did not receive vaccine|1|||
25292993|NCT00839527|50607690|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
25292994|NCT00839527|50607691|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
25292995|NCT00839527|50607692|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
25292996|NCT00839527|50607690|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
25292997|NCT00839527|50607691|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
25292998|NCT00839527|50607692|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
25292999|NCT00839527|50607690|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
25293000|NCT00839527|50607691|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
25293001|NCT00839527|50607692|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
25293002|NCT00839527|50607690|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
25293003|NCT00839527|50607691|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
25293004|NCT00839527|50607692|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
25293005|NCT00839527|50607690|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
25293006|NCT00839527|50607691|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
25293007|NCT00839527|50607692|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
25293008|NCT00839527|50607690|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
25070518|NCT02783729|50176544|FG003|Overall Study|Other|3|||
25070519|NCT02783729|50176541|FG000|Overall Study|Withdrawal by Subject|2|||
25293009|NCT00839527|50607691|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
25293010|NCT00839527|50607692|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
25293011|NCT00839527|50607690|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
25293012|NCT00839527|50607691|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
25293013|NCT00839527|50607692|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
25293014|NCT00839527|50607690|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
25293015|NCT00839527|50607691|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
25293016|NCT00839527|50607692|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
25293017|NCT00839527|50607690|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
25293018|NCT00839527|50607691|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
25293019|NCT00839527|50607692|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
25293020|NCT00839527|50607690|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
25293021|NCT00839527|50607691|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
25293022|NCT00839527|50607692|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
25293023|NCT00839527|50607690|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
25293024|NCT00839527|50607691|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
25293025|NCT00839527|50607692|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
25293026|NCT00839527|50607690|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
25293027|NCT00839527|50607691|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
25293028|NCT00839527|50607692|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
25293029|NCT00839527|50607690|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
25293030|NCT00839527|50607691|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
25293031|NCT00839527|50607692|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
25293032|NCT00839527|50607690|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
25293033|NCT00839527|50607691|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
25293034|NCT00839527|50607692|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
25293035|NCT00839527|50607690|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
25293036|NCT00839527|50607691|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
25293037|NCT00839527|50607692|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
25293038|NCT00839527|50607690|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
25293039|NCT00839527|50607691|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
25070520|NCT02783729|50176542|FG001|Overall Study|Withdrawal by Subject|3|||
25293040|NCT00839527|50607692|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
25293041|NCT00839527|50607690|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
25293042|NCT00839527|50607691|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
25070521|NCT02783729|50176543|FG002|Overall Study|Withdrawal by Subject|1|||
25293043|NCT00839527|50607692|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
25293044|NCT00839527|50607690|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
25293045|NCT00839527|50607691|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
25293046|NCT00839527|50607692|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
25293047|NCT00839527|50607690|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
25293048|NCT00839527|50607691|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
25293049|NCT00839527|50607692|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
25293050|NCT00839527|50607690|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
25293051|NCT00839527|50607691|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
25293052|NCT00839527|50607692|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
25293053|NCT00839527|50607690|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
25293054|NCT00839527|50607691|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
25293055|NCT00839527|50607692|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
25293056|NCT00839527|50607690|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
25293057|NCT00839527|50607691|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
25293058|NCT00839527|50607692|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
25293059|NCT00839527|50607690|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
25293060|NCT00839527|50607691|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
25293061|NCT00839527|50607692|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
25293062|NCT00839527|50607690|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
25293063|NCT00839527|50607691|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
25293064|NCT00839527|50607692|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
25293065|NCT00600886|50607704|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
25293066|NCT00600886|50607705|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
25293067|NCT00600886|50607704|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
25293068|NCT00600886|50607705|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
25293069|NCT00600886|50607704|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
25293070|NCT00600886|50607705|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
25293071|NCT00600886|50607704|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
25293072|NCT00600886|50607705|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
25293073|NCT00600886|50607704|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
25293074|NCT00600886|50607705|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
25293075|NCT00600886|50607704|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
25293076|NCT00600886|50607705|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
25293077|NCT00600886|50607704|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
25293078|NCT00600886|50607705|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
25293079|NCT00600886|50607704|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
25293080|NCT00600886|50607705|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
25293081|NCT00600886|50607704|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
25293082|NCT00600886|50607705|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
25293083|NCT00600886|50607704|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
25293084|NCT00600886|50607705|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
25293085|NCT00600886|50607704|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
25293086|NCT00600886|50607705|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
25293087|NCT00600886|50607704|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
25293088|NCT00600886|50607705|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
25293089|NCT00600886|50607704|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
25293090|NCT00600886|50607705|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
25293091|NCT00600886|50607704|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
25293092|NCT00600886|50607705|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
25293093|NCT00600886|50607704|FG000|Extension - Same Treatment (FAS)|Death|1|||
25293094|NCT00600886|50607705|FG001|Extension - Same Treatment (FAS)|Death|1|||
25293095|NCT00600886|50607704|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
25293096|NCT00600886|50607705|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
25293097|NCT00600886|50607704|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
25293098|NCT00600886|50607705|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
25293099|NCT00600886|50607704|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
25293100|NCT00600886|50607705|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
25293101|NCT00600886|50607704|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
25293102|NCT00600886|50607705|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
24969763|NCT00129116|50059202|FG000|Primary Phase|Withdrawal by Subject|0|||
24969764|NCT00129116|50059203|FG001|Primary Phase|Withdrawal by Subject|1|||
24969765|NCT00129116|50059204|FG002|Primary Phase|Withdrawal by Subject|0|||
24969766|NCT00129116|50059205|FG003|Primary Phase|Withdrawal by Subject|0|||
25293103|NCT00600886|50607704|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
25293104|NCT00600886|50607705|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
25293105|NCT00600886|50607704|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
25293106|NCT00600886|50607705|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
25293107|NCT00600886|50607704|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
25293108|NCT00600886|50607705|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
25293109|NCT00600886|50607704|FG000|Extension - After Crossover (CAS)|Death|1|||
25293110|NCT00600886|50607705|FG001|Extension - After Crossover (CAS)|Death|0|||
25293111|NCT00838903|50607729|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
25293112|NCT00838903|50607730|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
25293113|NCT00838903|50607731|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
25293114|NCT00838903|50607732|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
25293115|NCT00838903|50607729|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
25293116|NCT00838903|50607730|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
25293117|NCT00838903|50607731|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
25293118|NCT00838903|50607732|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
25293119|NCT00838903|50607729|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
25293120|NCT00838903|50607730|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
25293121|NCT00838903|50607731|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
25293122|NCT00838903|50607732|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
25293123|NCT00838903|50607729|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
25293124|NCT00838903|50607730|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
25293125|NCT00838903|50607731|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
25293126|NCT00838903|50607732|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
25293127|NCT00838903|50607729|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
25293128|NCT00838903|50607730|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
25293129|NCT00838903|50607731|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
25293130|NCT00838903|50607732|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
25293131|NCT00838903|50607729|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
25293132|NCT00838903|50607730|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
25293133|NCT00838903|50607731|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
25293134|NCT00838903|50607732|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
25293135|NCT00838903|50607729|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
25293136|NCT00838903|50607730|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
25293137|NCT00838903|50607731|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
25293138|NCT00838903|50607732|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
25293139|NCT00838903|50607729|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
25293140|NCT00838903|50607730|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
25293141|NCT00838903|50607731|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
25293142|NCT00838903|50607732|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
25293143|NCT00838903|50607729|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
25293144|NCT00838903|50607730|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
25293145|NCT00838903|50607731|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
25293146|NCT00838903|50607732|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
25293147|NCT00838903|50607729|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
25293148|NCT00838903|50607730|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
25293149|NCT00838903|50607731|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
25293150|NCT00838903|50607732|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
25293151|NCT00838903|50607729|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
25293152|NCT00838903|50607730|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
25293153|NCT00838903|50607731|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
25293154|NCT00838903|50607732|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
25293155|NCT00838903|50607729|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
25293156|NCT00838903|50607730|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
25293157|NCT00838903|50607731|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
25293158|NCT00838903|50607732|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
25293159|NCT00838903|50607729|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
25293160|NCT00838903|50607730|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
25293161|NCT00838903|50607731|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
25293162|NCT00838903|50607732|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
25293163|NCT00838903|50607729|FG000|Treatment Period (156 Weeks)|Site closed|0|||
25293164|NCT00838903|50607730|FG001|Treatment Period (156 Weeks)|Site closed|0|||
25293165|NCT00838903|50607731|FG002|Treatment Period (156 Weeks)|Site closed|1|||
25293166|NCT00838903|50607732|FG003|Treatment Period (156 Weeks)|Site closed|0|||
25293167|NCT00838903|50607729|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
25293168|NCT00838903|50607730|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
25070522|NCT02783729|50176544|FG003|Overall Study|Withdrawal by Subject|2|||
25293169|NCT00838903|50607731|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
25293170|NCT00838903|50607732|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
25293171|NCT00838903|50607729|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
25293172|NCT00838903|50607730|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
25293173|NCT00838903|50607731|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
25293174|NCT00838903|50607732|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
25293175|NCT00838903|50607729|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
25293176|NCT00838903|50607730|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
25293177|NCT00838903|50607731|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
25293178|NCT00838903|50607732|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
25293179|NCT00838903|50607729|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
25293180|NCT00838903|50607730|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
25293181|NCT00838903|50607731|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
25293182|NCT00838903|50607732|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
25293183|NCT00838903|50607729|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
25293184|NCT00838903|50607730|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
25293185|NCT00838903|50607731|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
25293186|NCT00838903|50607732|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
25293187|NCT00838903|50607729|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
25293188|NCT00838903|50607730|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
25293189|NCT00838903|50607731|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
25293190|NCT00838903|50607732|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
25293191|NCT00838903|50607729|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
25293192|NCT00838903|50607730|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
25293193|NCT00838903|50607731|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
25293194|NCT00838903|50607732|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
25293195|NCT00838903|50607729|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
25293196|NCT00838903|50607730|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
25293197|NCT00838903|50607731|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
25293198|NCT00838903|50607732|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
25293199|NCT00838903|50607729|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
25293200|NCT00838903|50607730|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
25293201|NCT00838903|50607731|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
25293202|NCT00838903|50607732|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
25293203|NCT00838903|50607729|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
25293204|NCT00838903|50607730|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
25293205|NCT00838903|50607731|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
25293206|NCT00838903|50607732|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
25293207|NCT00838903|50607729|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
25293208|NCT00838903|50607730|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
25293209|NCT00838903|50607731|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
25293210|NCT00838903|50607732|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
25293211|NCT00838903|50607729|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
25293212|NCT00838903|50607730|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
25293213|NCT00838903|50607731|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
25293214|NCT00838903|50607732|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
25293215|NCT00838903|50607729|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
25293216|NCT00838903|50607730|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
25293217|NCT00838903|50607731|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
25293218|NCT00838903|50607732|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
25293219|NCT00838903|50607729|FG000|Follow-up Period (8 Weeks)|Missing|1|||
25293220|NCT00838903|50607730|FG001|Follow-up Period (8 Weeks)|Missing|2|||
25293221|NCT00838903|50607731|FG002|Follow-up Period (8 Weeks)|Missing|1|||
25293222|NCT00838903|50607732|FG003|Follow-up Period (8 Weeks)|Missing|1|||
25293223|NCT00828139|50607746|FG000|Overall Study|Adverse Event|8|||
25293224|NCT00828139|50607747|FG001|Overall Study|Adverse Event|1|||
25293225|NCT00828139|50607748|FG002|Overall Study|Adverse Event|10|||
25293226|NCT00828139|50607749|FG003|Overall Study|Adverse Event|5|||
25293227|NCT00828139|50607746|FG000|Overall Study|Death|2|||
25293228|NCT00828139|50607747|FG001|Overall Study|Death|1|||
25293229|NCT00828139|50607748|FG002|Overall Study|Death|0|||
25293230|NCT00828139|50607749|FG003|Overall Study|Death|2|||
25293231|NCT00828139|50607746|FG000|Overall Study|Refusal unrelated to toxicity|3|||
25293232|NCT00828139|50607747|FG001|Overall Study|Refusal unrelated to toxicity|4|||
25293233|NCT00828139|50607748|FG002|Overall Study|Refusal unrelated to toxicity|5|||
25293234|NCT00828139|50607749|FG003|Overall Study|Refusal unrelated to toxicity|3|||
25293235|NCT00828139|50607746|FG000|Overall Study|Disease Progression|24|||
25293236|NCT00828139|50607747|FG001|Overall Study|Disease Progression|33|||
25293237|NCT00828139|50607748|FG002|Overall Study|Disease Progression|35|||
25293238|NCT00828139|50607749|FG003|Overall Study|Disease Progression|39|||
25293239|NCT00828139|50607746|FG000|Overall Study|Other|4|||
25293240|NCT00828139|50607747|FG001|Overall Study|Other|2|||
25293241|NCT00828139|50607748|FG002|Overall Study|Other|5|||
25293242|NCT00828139|50607749|FG003|Overall Study|Other|2|||
25293243|NCT00838513|50607759|FG000|Screening Period|Screen Failure|3|||
25293244|NCT00838513|50607759|FG000|Extension Treatment Period|Death|1|||
25293245|NCT00838513|50607759|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
25293246|NCT00600106|50607765|FG000|Overall Study|Withdrawal by Subject|1|||
25293247|NCT00600106|50607766|FG001|Overall Study|Withdrawal by Subject|1|||
25293248|NCT00850993|50607776|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
25293249|NCT00850993|50607777|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
25293250|NCT00850993|50607778|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
25293251|NCT00850993|50607779|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
25293252|NCT00818779|50607791|FG000|Overall Study|Protocol Violation|1|||
25293253|NCT00818779|50607792|FG001|Overall Study|Protocol Violation|0|||
25293254|NCT00818779|50607791|FG000|Overall Study|Lost to Follow-up|1|||
25293255|NCT00818779|50607792|FG001|Overall Study|Lost to Follow-up|0|||
25293256|NCT00818779|50607791|FG000|Overall Study|Adverse Event|4|||
25293257|NCT00818779|50607792|FG001|Overall Study|Adverse Event|1|||
25293258|NCT00850759|50607802|FG000|Overall Study|Lost to Follow-up|7|||
25293259|NCT00850759|50607803|FG001|Overall Study|Lost to Follow-up|5|||
25293260|NCT00850759|50607804|FG002|Overall Study|Lost to Follow-up|5|||
25293261|NCT00850759|50607805|FG003|Overall Study|Lost to Follow-up|3|||
25293262|NCT00827827|50607817|FG000|Overall Study|Lost to Follow-up|3|||
25293263|NCT00827827|50607818|FG001|Overall Study|Lost to Follow-up|0|||
25293264|NCT00827827|50607817|FG000|Overall Study|Fall at home- hospitalization|1|||
25293265|NCT00827827|50607818|FG001|Overall Study|Fall at home- hospitalization|0|||
25293266|NCT00827827|50607817|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
25293267|NCT00827827|50607818|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
25293268|NCT00827827|50607817|FG000|Overall Study|Gout|1|||
25293269|NCT00827827|50607818|FG001|Overall Study|Gout|0|||
25293270|NCT00827827|50607817|FG000|Overall Study|Transportation issues|1|||
25293271|NCT00827827|50607818|FG001|Overall Study|Transportation issues|0|||
25293272|NCT00827827|50607817|FG000|Overall Study|Burned with water at home|1|||
25293273|NCT00827827|50607818|FG001|Overall Study|Burned with water at home|0|||
25293274|NCT00600028|50607827|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
25293275|NCT00600028|50607828|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
25293276|NCT00600028|50607827|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
25293277|NCT00600028|50607828|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
25293278|NCT00600028|50607827|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
25293279|NCT00600028|50607828|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
25293280|NCT03542266|50607837|FG000|Treatment Phase|Withdrawal by Subject|1|||
25293281|NCT03542266|50607837|FG000|Treatment Phase|Adverse Event|1|||
25293282|NCT03542266|50607837|FG000|Treatment Phase|PD|1|||
25293283|NCT03201250|50607844|FG000|Overall Study|screen failures|3|||
25293284|NCT03201250|50607845|FG001|Overall Study|screen failures|0|||
25293285|NCT03201250|50607846|FG002|Overall Study|screen failures|0|||
25293286|NCT00818623|50607863|FG000|Overall Study|Adverse Event|1|||
25293287|NCT00818623|50607864|FG001|Overall Study|Adverse Event|0|||
25293288|NCT00818623|50607865|FG002|Overall Study|Adverse Event|1|||
25293289|NCT00818623|50607866|FG003|Overall Study|Adverse Event|0|||
25293290|NCT00818623|50607867|FG004|Overall Study|Adverse Event|0|||
25293291|NCT00818623|50607868|FG005|Overall Study|Adverse Event|1|||
25293292|NCT00818623|50607869|FG006|Overall Study|Adverse Event|0|||
25293293|NCT00818623|50607870|FG007|Overall Study|Adverse Event|0|||
25293294|NCT00818623|50607863|FG000|Overall Study|Bad prostate specific antigen response|0|||
25293295|NCT00818623|50607864|FG001|Overall Study|Bad prostate specific antigen response|3|||
25293296|NCT00818623|50607865|FG002|Overall Study|Bad prostate specific antigen response|2|||
25293297|NCT00818623|50607866|FG003|Overall Study|Bad prostate specific antigen response|5|||
25293298|NCT00818623|50607867|FG004|Overall Study|Bad prostate specific antigen response|0|||
25293299|NCT00818623|50607868|FG005|Overall Study|Bad prostate specific antigen response|1|||
25293300|NCT00818623|50607869|FG006|Overall Study|Bad prostate specific antigen response|0|||
25293301|NCT00818623|50607870|FG007|Overall Study|Bad prostate specific antigen response|0|||
25293302|NCT00818623|50607863|FG000|Overall Study|Withdrawal by Subject|0|||
25293303|NCT00818623|50607864|FG001|Overall Study|Withdrawal by Subject|1|||
25293304|NCT00818623|50607865|FG002|Overall Study|Withdrawal by Subject|1|||
25293305|NCT00818623|50607866|FG003|Overall Study|Withdrawal by Subject|0|||
25293306|NCT00818623|50607867|FG004|Overall Study|Withdrawal by Subject|0|||
25293307|NCT00818623|50607868|FG005|Overall Study|Withdrawal by Subject|1|||
25293308|NCT00818623|50607869|FG006|Overall Study|Withdrawal by Subject|1|||
25293309|NCT00818623|50607870|FG007|Overall Study|Withdrawal by Subject|1|||
25293310|NCT00818623|50607863|FG000|Overall Study|Protocol Violation|1|||
25293311|NCT00818623|50607864|FG001|Overall Study|Protocol Violation|0|||
25293312|NCT00818623|50607865|FG002|Overall Study|Protocol Violation|0|||
25293313|NCT00818623|50607866|FG003|Overall Study|Protocol Violation|0|||
25293314|NCT00818623|50607867|FG004|Overall Study|Protocol Violation|1|||
25293315|NCT00818623|50607868|FG005|Overall Study|Protocol Violation|0|||
25293316|NCT00818623|50607869|FG006|Overall Study|Protocol Violation|1|||
25293317|NCT00818623|50607870|FG007|Overall Study|Protocol Violation|0|||
25293318|NCT00818623|50607863|FG000|Overall Study|Need of additional treatment|0|||
25293319|NCT00818623|50607864|FG001|Overall Study|Need of additional treatment|0|||
25293320|NCT00818623|50607865|FG002|Overall Study|Need of additional treatment|0|||
25293321|NCT00818623|50607866|FG003|Overall Study|Need of additional treatment|0|||
25293322|NCT00818623|50607867|FG004|Overall Study|Need of additional treatment|1|||
25293323|NCT00818623|50607868|FG005|Overall Study|Need of additional treatment|0|||
25293324|NCT00818623|50607869|FG006|Overall Study|Need of additional treatment|0|||
25293325|NCT00818623|50607870|FG007|Overall Study|Need of additional treatment|0|||
25293326|NCT00818623|50607863|FG000|Overall Study|Lack of trial drug at site|0|||
25293327|NCT00818623|50607864|FG001|Overall Study|Lack of trial drug at site|0|||
25293328|NCT00818623|50607865|FG002|Overall Study|Lack of trial drug at site|0|||
25293329|NCT00818623|50607866|FG003|Overall Study|Lack of trial drug at site|0|||
25293330|NCT00818623|50607867|FG004|Overall Study|Lack of trial drug at site|2|||
25293331|NCT00818623|50607868|FG005|Overall Study|Lack of trial drug at site|0|||
25293332|NCT00818623|50607869|FG006|Overall Study|Lack of trial drug at site|1|||
25293333|NCT00818623|50607870|FG007|Overall Study|Lack of trial drug at site|0|||
25293334|NCT00818623|50607863|FG000|Overall Study|Disease progression|0|||
25293335|NCT00818623|50607864|FG001|Overall Study|Disease progression|0|||
25293336|NCT00818623|50607865|FG002|Overall Study|Disease progression|0|||
25293337|NCT00818623|50607866|FG003|Overall Study|Disease progression|0|||
25293338|NCT00818623|50607867|FG004|Overall Study|Disease progression|0|||
25293339|NCT00818623|50607868|FG005|Overall Study|Disease progression|0|||
25293340|NCT00818623|50607869|FG006|Overall Study|Disease progression|1|||
25293341|NCT00818623|50607870|FG007|Overall Study|Disease progression|0|||
25293342|NCT00827359|50607888|FG000|Overall Study|Progressive Diseas|19|||
25293343|NCT00827359|50607888|FG000|Overall Study|Unacceptable Toxicity|5|||
25293344|NCT00827359|50607888|FG000|Overall Study|Ineligible|1|||
25293345|NCT00818389|50607894|FG000|Overall Study|Death|1|||
25293346|NCT00818389|50607895|FG001|Overall Study|Death|3|||
25293347|NCT00818389|50607894|FG000|Overall Study|ALS Disease Progression|1|||
25293348|NCT00818389|50607895|FG001|Overall Study|ALS Disease Progression|0|||
25293349|NCT00818389|50607894|FG000|Overall Study|Withdrawal by Subject|2|||
25293350|NCT00818389|50607895|FG001|Overall Study|Withdrawal by Subject|2|||
25293351|NCT00818389|50607894|FG000|Overall Study|Adverse Event|0|||
25293352|NCT00818389|50607895|FG001|Overall Study|Adverse Event|1|||
25293353|NCT00850135|50607901|FG000|Overall Study|Physician Decision|1|||
25293354|NCT01154816|50607919|FG000|Overall Study|Withdrawal by Subject|1|||
25293355|NCT01154816|50607920|FG001|Overall Study|Withdrawal by Subject|0|||
25293356|NCT01154816|50607921|FG002|Overall Study|Withdrawal by Subject|0|||
25293357|NCT01154816|50607922|FG003|Overall Study|Withdrawal by Subject|1|||
25293358|NCT01154816|50607923|FG004|Overall Study|Withdrawal by Subject|0|||
25293359|NCT01154816|50607924|FG005|Overall Study|Withdrawal by Subject|0|||
25293360|NCT01154816|50607925|FG006|Overall Study|Withdrawal by Subject|0|||
25293361|NCT01154816|50607926|FG007|Overall Study|Withdrawal by Subject|0|||
25293362|NCT01154816|50607927|FG008|Overall Study|Withdrawal by Subject|1|||
25293363|NCT01154816|50607928|FG009|Overall Study|Withdrawal by Subject|3|||
25293364|NCT01154816|50607929|FG010|Overall Study|Withdrawal by Subject|0|||
25293365|NCT01154816|50607930|FG011|Overall Study|Withdrawal by Subject|0|||
25293366|NCT01154816|50607919|FG000|Overall Study|Progressive Disease|13|||
25293367|NCT01154816|50607920|FG001|Overall Study|Progressive Disease|8|||
25293368|NCT01154816|50607921|FG002|Overall Study|Progressive Disease|9|||
25293369|NCT01154816|50607922|FG003|Overall Study|Progressive Disease|9|||
25293370|NCT01154816|50607923|FG004|Overall Study|Progressive Disease|8|||
25293371|NCT01154816|50607924|FG005|Overall Study|Progressive Disease|8|||
25293372|NCT01154816|50607925|FG006|Overall Study|Progressive Disease|5|||
25293373|NCT01154816|50607926|FG007|Overall Study|Progressive Disease|6|||
25293374|NCT01154816|50607927|FG008|Overall Study|Progressive Disease|8|||
25293375|NCT01154816|50607928|FG009|Overall Study|Progressive Disease|6|||
25293376|NCT01154816|50607929|FG010|Overall Study|Progressive Disease|10|||
25293377|NCT01154816|50607930|FG011|Overall Study|Progressive Disease|3|||
25293378|NCT01154816|50607919|FG000|Overall Study|Physician Decision|1|||
25293379|NCT01154816|50607920|FG001|Overall Study|Physician Decision|0|||
25293380|NCT01154816|50607921|FG002|Overall Study|Physician Decision|1|||
25293381|NCT01154816|50607922|FG003|Overall Study|Physician Decision|0|||
25293382|NCT01154816|50607923|FG004|Overall Study|Physician Decision|2|||
25293383|NCT01154816|50607924|FG005|Overall Study|Physician Decision|0|||
25293384|NCT01154816|50607925|FG006|Overall Study|Physician Decision|0|||
25293385|NCT01154816|50607926|FG007|Overall Study|Physician Decision|0|||
25293386|NCT01154816|50607927|FG008|Overall Study|Physician Decision|0|||
25293387|NCT01154816|50607928|FG009|Overall Study|Physician Decision|1|||
25293388|NCT01154816|50607929|FG010|Overall Study|Physician Decision|1|||
25293389|NCT01154816|50607930|FG011|Overall Study|Physician Decision|1|||
25293390|NCT01154816|50607919|FG000|Overall Study|Adverse Event|5|||
25293391|NCT01154816|50607920|FG001|Overall Study|Adverse Event|2|||
25293392|NCT01154816|50607921|FG002|Overall Study|Adverse Event|0|||
25293393|NCT01154816|50607922|FG003|Overall Study|Adverse Event|0|||
25293394|NCT01154816|50607923|FG004|Overall Study|Adverse Event|0|||
25293395|NCT01154816|50607924|FG005|Overall Study|Adverse Event|0|||
25293396|NCT01154816|50607925|FG006|Overall Study|Adverse Event|1|||
25293397|NCT01154816|50607926|FG007|Overall Study|Adverse Event|1|||
25293398|NCT01154816|50607927|FG008|Overall Study|Adverse Event|0|||
25293399|NCT01154816|50607928|FG009|Overall Study|Adverse Event|0|||
25293400|NCT01154816|50607929|FG010|Overall Study|Adverse Event|0|||
25293401|NCT01154816|50607930|FG011|Overall Study|Adverse Event|0|||
25293402|NCT00849901|50607976|FG000|Acute Treatment Phase|Adverse Event|9|||
25293403|NCT00849901|50607977|FG001|Acute Treatment Phase|Adverse Event|1|||
25293404|NCT00849901|50607978|FG002|Acute Treatment Phase|Adverse Event|3|||
25293405|NCT00849901|50607976|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
25293406|NCT00849901|50607977|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
25293407|NCT00849901|50607978|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
25293408|NCT00849901|50607976|FG000|Acute Treatment Phase|Protocol Violation|0|||
25293409|NCT00849901|50607977|FG001|Acute Treatment Phase|Protocol Violation|2|||
25293410|NCT00849901|50607978|FG002|Acute Treatment Phase|Protocol Violation|1|||
25293411|NCT00849901|50607976|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
25293412|NCT00849901|50607977|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
25293413|NCT00849901|50607978|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
25293414|NCT00849901|50607976|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
25293415|NCT00849901|50607977|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
24969767|NCT00129116|50059206|FG004|Primary Phase|Withdrawal by Subject|0|||
24969768|NCT00129116|50059202|FG000|Primary Phase|Other|0|||
25293416|NCT00849901|50607978|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
25293417|NCT00849901|50607976|FG000|Acute Treatment Phase|Physician Decision|1|||
25293418|NCT00849901|50607977|FG001|Acute Treatment Phase|Physician Decision|1|||
25293419|NCT00849901|50607978|FG002|Acute Treatment Phase|Physician Decision|1|||
25070523|NCT02783729|50176541|FG000|Overall Study|Participant's choice|2|||
25293420|NCT00849901|50607976|FG000|Acute Treatment Phase|Sponsor Decision|1|||
25293421|NCT00849901|50607977|FG001|Acute Treatment Phase|Sponsor Decision|0|||
25293422|NCT00849901|50607978|FG002|Acute Treatment Phase|Sponsor Decision|0|||
25293423|NCT00849901|50607976|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
25293424|NCT00849901|50607977|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
25293425|NCT00849901|50607978|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
25293426|NCT00849901|50607976|FG000|Extension Phase|Adverse Event|2|||
25293427|NCT00849901|50607977|FG001|Extension Phase|Adverse Event|8|||
25293428|NCT00849901|50607978|FG002|Extension Phase|Adverse Event|4|||
25293429|NCT00849901|50607976|FG000|Extension Phase|Lost to Follow-up|3|||
25293430|NCT00849901|50607977|FG001|Extension Phase|Lost to Follow-up|0|||
25293431|NCT00849901|50607978|FG002|Extension Phase|Lost to Follow-up|1|||
25293432|NCT00849901|50607976|FG000|Extension Phase|Protocol Violation|2|||
25293433|NCT00849901|50607977|FG001|Extension Phase|Protocol Violation|2|||
25070524|NCT02783729|50176542|FG001|Overall Study|Participant's choice|1|||
25070525|NCT02783729|50176543|FG002|Overall Study|Participant's choice|2|||
25070526|NCT02783729|50176544|FG003|Overall Study|Participant's choice|1|||
25070527|NCT02783729|50176541|FG000|Overall Study|Lost to Follow-up|2|||
25070528|NCT02783729|50176542|FG001|Overall Study|Lost to Follow-up|1|||
25070529|NCT02783729|50176543|FG002|Overall Study|Lost to Follow-up|1|||
25070530|NCT02783729|50176544|FG003|Overall Study|Lost to Follow-up|0|||
25070531|NCT02784431|50176566|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
25070532|NCT02784431|50176566|FG000|Overall Study|Early Study Termination|19|||
25191704|NCT01469546|50352942|FG000|Received 5 mg Dose|Protocol Violation|2|||
25293434|NCT00849901|50607978|FG002|Extension Phase|Protocol Violation|4|||
25293435|NCT00849901|50607976|FG000|Extension Phase|Withdrawal by Subject|7|||
25293436|NCT00849901|50607977|FG001|Extension Phase|Withdrawal by Subject|6|||
25293437|NCT00849901|50607978|FG002|Extension Phase|Withdrawal by Subject|3|||
25293438|NCT00849901|50607976|FG000|Extension Phase|Parent or Caregiver Decision|10|||
25293439|NCT00849901|50607977|FG001|Extension Phase|Parent or Caregiver Decision|4|||
25293440|NCT00849901|50607978|FG002|Extension Phase|Parent or Caregiver Decision|4|||
25293441|NCT00849901|50607976|FG000|Extension Phase|Physician Decision|1|||
25293442|NCT00849901|50607977|FG001|Extension Phase|Physician Decision|2|||
25293443|NCT00849901|50607978|FG002|Extension Phase|Physician Decision|0|||
25293444|NCT00849901|50607976|FG000|Extension Phase|Lack of Efficacy|2|||
25293445|NCT00849901|50607977|FG001|Extension Phase|Lack of Efficacy|4|||
25293446|NCT00849901|50607978|FG002|Extension Phase|Lack of Efficacy|1|||
25293447|NCT01168232|50607992|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
25293448|NCT01168232|50607992|FG000|Overall Study|Ineligible- Wrong cell type|6|||
25293449|NCT01168232|50607992|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
25293450|NCT00817531|50607996|FG000|Overall Study|Adverse Event|1|||
25293451|NCT00817531|50607996|FG000|Overall Study|Lack of Efficacy|1|||
25293452|NCT00817063|50608002|FG000|Overall Study|Adverse Event|32|||
25293453|NCT00817063|50608003|FG001|Overall Study|Adverse Event|13|||
25293454|NCT00817063|50608002|FG000|Overall Study|Death|1|||
25293455|NCT00817063|50608003|FG001|Overall Study|Death|1|||
25293456|NCT00817063|50608002|FG000|Overall Study|Lack of Efficacy|33|||
25293457|NCT00817063|50608003|FG001|Overall Study|Lack of Efficacy|86|||
25070533|NCT02590406|50176572|FG000|Overall Study|Adverse Event|1|||
25070534|NCT02590406|50176573|FG001|Overall Study|Adverse Event|0|||
25070535|NCT02590406|50176572|FG000|Overall Study|Saturometer malfunction|0|||
25070536|NCT02590406|50176573|FG001|Overall Study|Saturometer malfunction|1|||
25293458|NCT00817063|50608002|FG000|Overall Study|Failure to Return|13|||
25293459|NCT00817063|50608003|FG001|Overall Study|Failure to Return|12|||
25293460|NCT00817063|50608002|FG000|Overall Study|Violation of Selection at Entry|7|||
25293461|NCT00817063|50608003|FG001|Overall Study|Violation of Selection at Entry|4|||
25293462|NCT00817063|50608002|FG000|Overall Study|Protocol Violation|3|||
25293463|NCT00817063|50608003|FG001|Overall Study|Protocol Violation|8|||
25293464|NCT00817063|50608002|FG000|Overall Study|Withdrawal by Subject|17|||
25293465|NCT00817063|50608003|FG001|Overall Study|Withdrawal by Subject|37|||
25293466|NCT00817063|50608002|FG000|Overall Study|Early Improvement|19|||
25293467|NCT00817063|50608003|FG001|Overall Study|Early Improvement|4|||
25293468|NCT00817063|50608002|FG000|Overall Study|Administrative|10|||
25293469|NCT00817063|50608003|FG001|Overall Study|Administrative|4|||
25293470|NCT00817063|50608002|FG000|Overall Study|Abnormality of Laboratory Test|2|||
25293471|NCT00817063|50608003|FG001|Overall Study|Abnormality of Laboratory Test|1|||
25293472|NCT01167140|50608009|FG000|Overall Study|Withdrawal by Subject|1|||
25293473|NCT01166750|50608015|FG000|Overall Study|Lost to Follow-up|1|||
25293474|NCT01166750|50608016|FG001|Overall Study|Lost to Follow-up|0|||
25293475|NCT00826267|50608025|FG000|Overall Study|Other Adverse Event|1|||
25293476|NCT00826267|50608026|FG001|Overall Study|Other Adverse Event|0|||
25293477|NCT00826267|50608027|FG002|Overall Study|Other Adverse Event|0|||
25293478|NCT00986154|50608038|FG000|Overall Study|Death|136|||
25293479|NCT00986154|50608039|FG001|Overall Study|Death|127|||
25293480|NCT00986154|50608038|FG000|Overall Study|Lost to Follow-up|7|||
25293481|NCT00986154|50608039|FG001|Overall Study|Lost to Follow-up|4|||
25293482|NCT00986154|50608038|FG000|Overall Study|Withdrawal by Subject|32|||
25293483|NCT00986154|50608039|FG001|Overall Study|Withdrawal by Subject|33|||
25293484|NCT00986154|50608038|FG000|Overall Study|investigator/subject decide not continue|6|||
25293485|NCT00986154|50608039|FG001|Overall Study|investigator/subject decide not continue|3|||
25293486|NCT00986154|50608038|FG000|Overall Study|never received study drug|25|||
25293487|NCT00986154|50608039|FG001|Overall Study|never received study drug|27|||
25293488|NCT00848965|50608045|FG000|Overall Study|Adverse Event|1|||
25293489|NCT00848965|50608045|FG000|Overall Study|Withdrawal by Subject|1|||
25293490|NCT01154036|50608064|FG000|Phase I|Physician Decision|0|||
25293491|NCT01154036|50608065|FG001|Phase I|Physician Decision|1|||
25293492|NCT01154036|50608066|FG002|Phase I|Physician Decision|0|||
25293493|NCT01154036|50608067|FG003|Phase I|Physician Decision|0|||
25293494|NCT01154036|50608068|FG004|Phase I|Physician Decision|0|||
25293495|NCT01154036|50608069|FG005|Phase I|Physician Decision|0|||
25293496|NCT01154036|50608070|FG006|Phase I|Physician Decision|0|||
25293497|NCT01154036|50608071|FG007|Phase I|Physician Decision|0|||
25293498|NCT01154036|50608064|FG000|Phase I|Lost to Follow-up|0|||
25293499|NCT01154036|50608065|FG001|Phase I|Lost to Follow-up|3|||
25293500|NCT01154036|50608066|FG002|Phase I|Lost to Follow-up|6|||
25293501|NCT01154036|50608067|FG003|Phase I|Lost to Follow-up|0|||
25293502|NCT01154036|50608068|FG004|Phase I|Lost to Follow-up|0|||
25293503|NCT01154036|50608069|FG005|Phase I|Lost to Follow-up|0|||
25293504|NCT01154036|50608070|FG006|Phase I|Lost to Follow-up|0|||
25293505|NCT01154036|50608071|FG007|Phase I|Lost to Follow-up|0|||
25293506|NCT01154036|50608064|FG000|Phase I|Protocol Violation|0|||
25293507|NCT01154036|50608065|FG001|Phase I|Protocol Violation|3|||
25293508|NCT01154036|50608066|FG002|Phase I|Protocol Violation|9|||
25293509|NCT01154036|50608067|FG003|Phase I|Protocol Violation|0|||
25293510|NCT01154036|50608068|FG004|Phase I|Protocol Violation|0|||
25293511|NCT01154036|50608069|FG005|Phase I|Protocol Violation|0|||
25293512|NCT01154036|50608070|FG006|Phase I|Protocol Violation|0|||
25293513|NCT01154036|50608071|FG007|Phase I|Protocol Violation|0|||
25293514|NCT01154036|50608064|FG000|Phase I|Withdrawal by Subject|2|||
25293515|NCT01154036|50608065|FG001|Phase I|Withdrawal by Subject|10|||
25293516|NCT01154036|50608066|FG002|Phase I|Withdrawal by Subject|29|||
25293517|NCT01154036|50608067|FG003|Phase I|Withdrawal by Subject|0|||
25293518|NCT01154036|50608068|FG004|Phase I|Withdrawal by Subject|0|||
25293519|NCT01154036|50608069|FG005|Phase I|Withdrawal by Subject|0|||
25293520|NCT01154036|50608070|FG006|Phase I|Withdrawal by Subject|0|||
25293521|NCT01154036|50608071|FG007|Phase I|Withdrawal by Subject|0|||
25293522|NCT01154036|50608064|FG000|Phase I|Adverse Event|1|||
25293523|NCT01154036|50608065|FG001|Phase I|Adverse Event|11|||
25293524|NCT01154036|50608066|FG002|Phase I|Adverse Event|12|||
25293525|NCT01154036|50608067|FG003|Phase I|Adverse Event|0|||
25293526|NCT01154036|50608068|FG004|Phase I|Adverse Event|0|||
24969769|NCT00129116|50059203|FG001|Primary Phase|Other|0|||
24969770|NCT00129116|50059204|FG002|Primary Phase|Other|1|||
25169277|NCT01842581|50300795|FG000|Overall Study|Other than specified|3|||
25293527|NCT01154036|50608069|FG005|Phase I|Adverse Event|0|||
25293528|NCT01154036|50608070|FG006|Phase I|Adverse Event|0|||
25293529|NCT01154036|50608071|FG007|Phase I|Adverse Event|0|||
25293530|NCT01154036|50608064|FG000|Phase II|Adverse Event|0|||
25293531|NCT01154036|50608065|FG001|Phase II|Adverse Event|0|||
25293532|NCT01154036|50608066|FG002|Phase II|Adverse Event|0|||
25293533|NCT01154036|50608067|FG003|Phase II|Adverse Event|0|||
25293534|NCT01154036|50608068|FG004|Phase II|Adverse Event|1|||
25293535|NCT01154036|50608069|FG005|Phase II|Adverse Event|1|||
25293536|NCT01154036|50608070|FG006|Phase II|Adverse Event|1|||
25293537|NCT01154036|50608071|FG007|Phase II|Adverse Event|1|||
25293538|NCT01154036|50608064|FG000|Phase II|Physician Decision|0|||
25293539|NCT01154036|50608065|FG001|Phase II|Physician Decision|0|||
25293540|NCT01154036|50608066|FG002|Phase II|Physician Decision|0|||
25293541|NCT01154036|50608067|FG003|Phase II|Physician Decision|0|||
25293542|NCT01154036|50608068|FG004|Phase II|Physician Decision|0|||
25293543|NCT01154036|50608069|FG005|Phase II|Physician Decision|0|||
25293544|NCT01154036|50608070|FG006|Phase II|Physician Decision|1|||
25293545|NCT01154036|50608071|FG007|Phase II|Physician Decision|0|||
25293546|NCT01154036|50608064|FG000|Phase II|Lost to Follow-up|0|||
25293547|NCT01154036|50608065|FG001|Phase II|Lost to Follow-up|0|||
25293548|NCT01154036|50608066|FG002|Phase II|Lost to Follow-up|0|||
25293549|NCT01154036|50608067|FG003|Phase II|Lost to Follow-up|1|||
25293550|NCT01154036|50608068|FG004|Phase II|Lost to Follow-up|2|||
25293551|NCT01154036|50608069|FG005|Phase II|Lost to Follow-up|0|||
25293552|NCT01154036|50608070|FG006|Phase II|Lost to Follow-up|2|||
25293553|NCT01154036|50608071|FG007|Phase II|Lost to Follow-up|1|||
25293554|NCT01154036|50608064|FG000|Phase II|Protocol Violation|0|||
25293555|NCT01154036|50608065|FG001|Phase II|Protocol Violation|0|||
25293556|NCT01154036|50608066|FG002|Phase II|Protocol Violation|0|||
25293557|NCT01154036|50608067|FG003|Phase II|Protocol Violation|0|||
25293558|NCT01154036|50608068|FG004|Phase II|Protocol Violation|1|||
25293559|NCT01154036|50608069|FG005|Phase II|Protocol Violation|2|||
25293560|NCT01154036|50608070|FG006|Phase II|Protocol Violation|0|||
25293561|NCT01154036|50608071|FG007|Phase II|Protocol Violation|0|||
25293562|NCT01154036|50608064|FG000|Phase II|Withdrawal by Subject|0|||
25293563|NCT01154036|50608065|FG001|Phase II|Withdrawal by Subject|0|||
24969771|NCT00129116|50059205|FG003|Primary Phase|Other|0|||
25293564|NCT01154036|50608066|FG002|Phase II|Withdrawal by Subject|0|||
25293565|NCT01154036|50608067|FG003|Phase II|Withdrawal by Subject|0|||
25293566|NCT01154036|50608068|FG004|Phase II|Withdrawal by Subject|4|||
25293567|NCT01154036|50608069|FG005|Phase II|Withdrawal by Subject|2|||
25293568|NCT01154036|50608070|FG006|Phase II|Withdrawal by Subject|5|||
25293569|NCT01154036|50608071|FG007|Phase II|Withdrawal by Subject|4|||
25293570|NCT00816595|50608093|FG000|Overall Study|Withdrawal by Subject|2|||
25293571|NCT00816595|50608094|FG001|Overall Study|Withdrawal by Subject|0|||
25293572|NCT01166438|50608104|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
25293573|NCT01166438|50608105|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
25293574|NCT01166438|50608104|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
25293575|NCT01166438|50608105|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
25293576|NCT01166438|50608104|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
25293577|NCT01166438|50608105|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
25293578|NCT01166438|50608104|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
25293579|NCT01166438|50608105|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
25293580|NCT01166438|50608104|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
25293581|NCT01166438|50608105|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
25293582|NCT01166438|50608104|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
25293583|NCT01166438|50608105|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
25293584|NCT01153958|50608114|FG000|Overall Study|Study Terminated|36|||
25293585|NCT01153958|50608115|FG001|Overall Study|Study Terminated|32|||
25293586|NCT00599638|50608125|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
25293587|NCT00599638|50608126|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
25293588|NCT00599638|50608127|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
25293589|NCT00599638|50608128|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
25293590|NCT00599638|50608125|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
25293591|NCT00599638|50608126|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
25293592|NCT00599638|50608127|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
25293593|NCT00599638|50608128|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
25293594|NCT00599638|50608125|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
25293595|NCT00599638|50608126|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
25293596|NCT00599638|50608127|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
25293597|NCT00599638|50608128|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
25293598|NCT00599638|50608125|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
25293599|NCT00599638|50608126|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
25293600|NCT00599638|50608127|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
25293601|NCT00599638|50608128|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
25293602|NCT00599638|50608125|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
25293603|NCT00599638|50608126|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
25293604|NCT00599638|50608127|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
25293605|NCT00599638|50608128|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
25293606|NCT00599638|50608125|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
25293607|NCT00599638|50608126|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
25293608|NCT00599638|50608127|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
25293609|NCT00599638|50608128|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
25293610|NCT00599638|50608125|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
25293611|NCT00599638|50608126|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
25293612|NCT00599638|50608127|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
25293613|NCT00599638|50608128|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
25293614|NCT00599638|50608125|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
25293615|NCT00599638|50608126|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
25293616|NCT00599638|50608127|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
25293617|NCT00599638|50608128|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
25293618|NCT00599638|50608125|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
25293619|NCT00599638|50608126|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
25293620|NCT00599638|50608127|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
25293621|NCT00599638|50608128|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
25293622|NCT01166282|50608138|FG000|Open-label Period|Adverse Event|0|||
25293623|NCT01166282|50608139|FG001|Open-label Period|Adverse Event|0|||
25293624|NCT01166282|50608140|FG002|Open-label Period|Adverse Event|6|||
25293625|NCT01166282|50608138|FG000|Open-label Period|Withdrawal by Subject|0|||
25293626|NCT01166282|50608139|FG001|Open-label Period|Withdrawal by Subject|0|||
25293627|NCT01166282|50608140|FG002|Open-label Period|Withdrawal by Subject|4|||
25293628|NCT01166282|50608138|FG000|Open-label Period|Lack of Efficacy|0|||
25293629|NCT01166282|50608139|FG001|Open-label Period|Lack of Efficacy|0|||
25293630|NCT01166282|50608140|FG002|Open-label Period|Lack of Efficacy|2|||
25293631|NCT01166282|50608138|FG000|Open-label Period|Remission|0|||
25293632|NCT01166282|50608139|FG001|Open-label Period|Remission|0|||
24969772|NCT00129116|50059206|FG004|Primary Phase|Other|0|||
24969773|NCT00129116|50059202|FG000|Booster Phase|Lost to Follow-up|2|||
24969774|NCT00129116|50059203|FG001|Booster Phase|Lost to Follow-up|0|||
24969775|NCT00129116|50059204|FG002|Booster Phase|Lost to Follow-up|0|||
24969776|NCT00129116|50059205|FG003|Booster Phase|Lost to Follow-up|0|||
25293633|NCT01166282|50608140|FG002|Open-label Period|Remission|4|||
25293634|NCT01166282|50608138|FG000|Open-label Period|Irregular Compliance|0|||
25293635|NCT01166282|50608139|FG001|Open-label Period|Irregular Compliance|0|||
24969777|NCT00129116|50059206|FG004|Booster Phase|Lost to Follow-up|1|||
25293636|NCT01166282|50608140|FG002|Open-label Period|Irregular Compliance|1|||
25293637|NCT01153724|50608148|FG000|Treatment Period 1|Withdrawal by Subject|1|||
25293638|NCT01153724|50608148|FG000|Treatment Period 2|Adverse Event|1|||
25293639|NCT01153724|50608148|FG000|Treatment Period 2|Other reason not defined above|1|||
25293640|NCT01152788|50608156|FG000|Overall Study|Withdrawal by Subject|0|||
25293641|NCT01152788|50608157|FG001|Overall Study|Withdrawal by Subject|3|||
25293642|NCT01152788|50608156|FG000|Overall Study|No treatment|0|||
25293643|NCT01152788|50608157|FG001|Overall Study|No treatment|1|||
25293644|NCT01165424|50608163|FG000|Overall Study|Clinical adverse experiences|1|||
25293645|NCT01165424|50608163|FG000|Overall Study|Laboratory adverse experiences|1|||
25293646|NCT01165424|50608163|FG000|Overall Study|Did not meet entry criteria|1|||
25293647|NCT01165424|50608163|FG000|Overall Study|Participant moved (relocated)|1|||
25293648|NCT01152554|50608169|FG000|Overall Study|Withdrawal by Subject|73|||
25293649|NCT01152554|50608170|FG001|Overall Study|Withdrawal by Subject|28|||
25293650|NCT01152554|50608169|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
25293651|NCT01152554|50608170|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
25293652|NCT01152554|50608169|FG000|Overall Study|Adverse Event|67|||
25293653|NCT01152554|50608170|FG001|Overall Study|Adverse Event|14|||
25293654|NCT01152554|50608169|FG000|Overall Study|Severe non-compliance to protocol|36|||
25293655|NCT01152554|50608170|FG001|Overall Study|Severe non-compliance to protocol|14|||
25293656|NCT01152554|50608169|FG000|Overall Study|Condition under investigation worsened|5|||
25293657|NCT01152554|50608170|FG001|Overall Study|Condition under investigation worsened|2|||
25293658|NCT01152554|50608169|FG000|Overall Study|Lack of Efficacy|20|||
25293659|NCT01152554|50608170|FG001|Overall Study|Lack of Efficacy|3|||
25293660|NCT01152554|50608169|FG000|Overall Study|Study-specific withdrawal criteria|17|||
25293661|NCT01152554|50608170|FG001|Overall Study|Study-specific withdrawal criteria|8|||
25293662|NCT01152554|50608169|FG000|Overall Study|Lost to Follow-up|87|||
25293663|NCT01152554|50608170|FG001|Overall Study|Lost to Follow-up|32|||
25293664|NCT01152554|50608169|FG000|Overall Study|Other|28|||
25293665|NCT01152554|50608170|FG001|Overall Study|Other|8|||
25293666|NCT01152554|50608169|FG000|Overall Study|Death|1|||
25293667|NCT01152554|50608170|FG001|Overall Study|Death|1|||
25293668|NCT00598702|50608184|FG000|Overall Study|Other|0|||
25293669|NCT00598702|50608185|FG001|Overall Study|Other|2|||
25293670|NCT00598702|50608186|FG002|Overall Study|Other|0|||
25293671|NCT00598702|50608187|FG003|Overall Study|Other|0|||
25293672|NCT00598702|50608188|FG004|Overall Study|Other|0|||
25293673|NCT00598702|50608189|FG005|Overall Study|Other|1|||
25293674|NCT00598702|50608190|FG006|Overall Study|Other|0|||
25293675|NCT00598702|50608191|FG007|Overall Study|Other|0|||
25070537|NCT01359254|50176581|FG000|Overall Study|Death|1|||
25070538|NCT01359254|50176582|FG001|Overall Study|Death|0|||
25070539|NCT01667432|50176588|FG000|Overall Study|Premature Study Termination|26|||
25070540|NCT01667432|50176588|FG000|Overall Study|Failure to Return|10|||
25070541|NCT01667432|50176588|FG000|Overall Study|Moved to Another Center|3|||
25070542|NCT01667432|50176588|FG000|Overall Study|Lost to Follow-up|3|||
25070543|NCT01667432|50176588|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
25070544|NCT01667432|50176588|FG000|Overall Study|Insufficient Therapeutic Response|4|||
25070545|NCT01667432|50176588|FG000|Overall Study|Adverse Event|1|||
25070546|NCT01667432|50176588|FG000|Overall Study|Protocol Deviation|2|||
25070547|NCT01667432|50176588|FG000|Overall Study|Principal Investigator Decision|1|||
25070548|NCT01667432|50176588|FG000|Overall Study|Reason Not Specified|2|||
25070549|NCT01667432|50176588|FG000|Overall Study|Missing Information|4|||
25070550|NCT01563107|50176596|FG000|Overall Study|Physician Decision|0|||
25070551|NCT01563107|50176597|FG001|Overall Study|Physician Decision|1|||
25070552|NCT01563107|50176598|FG002|Overall Study|Physician Decision|1|||
25070553|NCT01563107|50176599|FG003|Overall Study|Physician Decision|3|||
25293676|NCT00598702|50608184|FG000|Overall Study|Early discharge from hospital|0|||
25293677|NCT00598702|50608185|FG001|Overall Study|Early discharge from hospital|0|||
25293678|NCT00598702|50608186|FG002|Overall Study|Early discharge from hospital|2|||
25293679|NCT00598702|50608187|FG003|Overall Study|Early discharge from hospital|5|||
25293680|NCT00598702|50608188|FG004|Overall Study|Early discharge from hospital|0|||
25293681|NCT00598702|50608189|FG005|Overall Study|Early discharge from hospital|10|||
25293682|NCT00598702|50608190|FG006|Overall Study|Early discharge from hospital|1|||
25293683|NCT00598702|50608191|FG007|Overall Study|Early discharge from hospital|0|||
25293684|NCT00598702|50608184|FG000|Overall Study|Adverse Event|0|||
25293685|NCT00598702|50608185|FG001|Overall Study|Adverse Event|0|||
25293686|NCT00598702|50608186|FG002|Overall Study|Adverse Event|0|||
25070554|NCT01563107|50176596|FG000|Overall Study|Withdrawal by Subject|1|||
25070555|NCT01563107|50176597|FG001|Overall Study|Withdrawal by Subject|2|||
25070556|NCT01563107|50176598|FG002|Overall Study|Withdrawal by Subject|1|||
25293687|NCT00598702|50608187|FG003|Overall Study|Adverse Event|1|||
25293688|NCT00598702|50608188|FG004|Overall Study|Adverse Event|0|||
25293689|NCT00598702|50608189|FG005|Overall Study|Adverse Event|0|||
25293690|NCT00598702|50608190|FG006|Overall Study|Adverse Event|0|||
25293691|NCT00598702|50608191|FG007|Overall Study|Adverse Event|0|||
25293692|NCT00598702|50608184|FG000|Overall Study|Withdrawal by Subject|0|||
25293693|NCT00598702|50608185|FG001|Overall Study|Withdrawal by Subject|0|||
25293694|NCT00598702|50608186|FG002|Overall Study|Withdrawal by Subject|0|||
25293695|NCT00598702|50608187|FG003|Overall Study|Withdrawal by Subject|1|||
25293696|NCT00598702|50608188|FG004|Overall Study|Withdrawal by Subject|1|||
25293697|NCT00598702|50608189|FG005|Overall Study|Withdrawal by Subject|0|||
25293698|NCT00598702|50608190|FG006|Overall Study|Withdrawal by Subject|0|||
25293699|NCT00598702|50608191|FG007|Overall Study|Withdrawal by Subject|0|||
25293700|NCT00598702|50608184|FG000|Overall Study|Physician Decision|0|||
25293701|NCT00598702|50608185|FG001|Overall Study|Physician Decision|0|||
25293702|NCT00598702|50608186|FG002|Overall Study|Physician Decision|0|||
25293703|NCT00598702|50608187|FG003|Overall Study|Physician Decision|0|||
25293704|NCT00598702|50608188|FG004|Overall Study|Physician Decision|1|||
25293705|NCT00598702|50608189|FG005|Overall Study|Physician Decision|0|||
25293706|NCT00598702|50608190|FG006|Overall Study|Physician Decision|0|||
25293707|NCT00598702|50608191|FG007|Overall Study|Physician Decision|0|||
25293708|NCT00598702|50608184|FG000|Overall Study|Dose limiting toxicity|0|||
25293709|NCT00598702|50608185|FG001|Overall Study|Dose limiting toxicity|0|||
25293710|NCT00598702|50608186|FG002|Overall Study|Dose limiting toxicity|0|||
25293711|NCT00598702|50608187|FG003|Overall Study|Dose limiting toxicity|1|||
25293712|NCT00598702|50608188|FG004|Overall Study|Dose limiting toxicity|1|||
25293713|NCT00598702|50608189|FG005|Overall Study|Dose limiting toxicity|1|||
25293714|NCT00598702|50608190|FG006|Overall Study|Dose limiting toxicity|0|||
25293715|NCT00598702|50608191|FG007|Overall Study|Dose limiting toxicity|0|||
25293716|NCT01148810|50608211|FG000|Overall Study|Adverse Event|0|||
25293717|NCT01148810|50608212|FG001|Overall Study|Adverse Event|2|||
25293718|NCT01148810|50608211|FG000|Overall Study|Lack of Efficacy|0|||
25293719|NCT01148810|50608212|FG001|Overall Study|Lack of Efficacy|1|||
25293720|NCT01148810|50608211|FG000|Overall Study|Withdrawal by Subject|0|||
25293721|NCT01148810|50608212|FG001|Overall Study|Withdrawal by Subject|2|||
25293722|NCT01148810|50608211|FG000|Overall Study|Protocol Violation|1|||
25293723|NCT01148810|50608212|FG001|Overall Study|Protocol Violation|0|||
25293724|NCT01151618|50608219|FG000|Overall Study|Adverse Event|2|||
25293725|NCT01151618|50608219|FG000|Overall Study|Withdrawal by Subject|7|||
25293726|NCT01164956|50608223|FG000|Overall Study|Side Effects|1|||
25293727|NCT01164956|50608224|FG001|Overall Study|Side Effects|0|||
25293728|NCT01164956|50608225|FG002|Overall Study|Side Effects|1|||
25293729|NCT01164722|50608235|FG000|Overall Study|Adverse Event|0|||
25293730|NCT01164722|50608236|FG001|Overall Study|Adverse Event|1|||
25293731|NCT01164722|50608235|FG000|Overall Study|Withdrawal by Subject|3|||
25293732|NCT01164722|50608236|FG001|Overall Study|Withdrawal by Subject|4|||
25293733|NCT01164722|50608235|FG000|Overall Study|Lost to Follow-up|3|||
25293734|NCT01164722|50608236|FG001|Overall Study|Lost to Follow-up|6|||
25293735|NCT01164722|50608235|FG000|Overall Study|met protocol criteria for non-treatment|11|||
25293736|NCT01164722|50608236|FG001|Overall Study|met protocol criteria for non-treatment|1|||
25293737|NCT01164722|50608235|FG000|Overall Study|enrolled on other study, concomitant med|1|||
25293738|NCT01164722|50608236|FG001|Overall Study|enrolled on other study, concomitant med|3|||
25293739|NCT01151540|50608242|FG000|Overall Study|Other|2|||
25293740|NCT01151540|50608242|FG000|Overall Study|Adverse event, non-fatal|4|||
25293741|NCT01151540|50608242|FG000|Overall Study|Withdrawal by Subject|7|||
25293742|NCT01163786|50608246|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
25293743|NCT01163786|50608246|FG000|Treatment With Bortezomib|Adverse Event|2|||
25293744|NCT01163786|50608246|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
25293745|NCT00984282|50608252|FG000|Double Blind Treatment|Adverse Event|40|||
25293746|NCT00984282|50608253|FG001|Double Blind Treatment|Adverse Event|6|||
25293747|NCT00984282|50608252|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
25293748|NCT00984282|50608253|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
25293749|NCT00984282|50608252|FG000|Double Blind Treatment|Physician Decision|1|||
25293750|NCT00984282|50608253|FG001|Double Blind Treatment|Physician Decision|2|||
25293751|NCT00984282|50608252|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
25293752|NCT00984282|50608253|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
25293753|NCT00984282|50608252|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
25293754|NCT00984282|50608253|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
25293755|NCT00984282|50608252|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
25191705|NCT01469546|50352942|FG000|Received 5 mg Dose|Progressive Disease|3|||
25191706|NCT01469546|50352942|FG000|Received 5 mg Dose|Physician Decision|3|||
25293756|NCT00984282|50608253|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
25293757|NCT00984282|50608252|FG000|Double Blind Treatment|Lost to Follow-up|3|||
25293758|NCT00984282|50608253|FG001|Double Blind Treatment|Lost to Follow-up|0|||
25293759|NCT00984282|50608252|FG000|Double Blind Treatment|Death|8|||
25293760|NCT00984282|50608253|FG001|Double Blind Treatment|Death|4|||
25293761|NCT00984282|50608252|FG000|Double Blind Treatment|Not treated|0|||
25293762|NCT00984282|50608253|FG001|Double Blind Treatment|Not treated|1|||
25293763|NCT00984282|50608252|FG000|Double Blind Treatment|Switched to commercial drug|6|||
25293764|NCT00984282|50608253|FG001|Double Blind Treatment|Switched to commercial drug|1|||
25293765|NCT00984282|50608252|FG000|Double Blind Treatment|protocol driven decision point|1|||
25293766|NCT00984282|50608253|FG001|Double Blind Treatment|protocol driven decision point|1|||
25293767|NCT00984282|50608252|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
25293768|NCT00984282|50608253|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
25293769|NCT00984282|50608252|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
25293770|NCT00984282|50608253|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
25293771|NCT00984282|50608252|FG000|Open-label Treatment|Adverse Event|20|||
25293772|NCT00984282|50608253|FG001|Open-label Treatment|Adverse Event|30|||
25293773|NCT00984282|50608252|FG000|Open-label Treatment|Withdrawal by Subject|6|||
25293774|NCT00984282|50608253|FG001|Open-label Treatment|Withdrawal by Subject|21|||
25293775|NCT00984282|50608252|FG000|Open-label Treatment|Death|7|||
25293776|NCT00984282|50608253|FG001|Open-label Treatment|Death|15|||
25293777|NCT00984282|50608252|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
25293778|NCT00984282|50608253|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
25293779|NCT00984282|50608252|FG000|Open-label Treatment|Lost to Follow-up|1|||
25293780|NCT00984282|50608253|FG001|Open-label Treatment|Lost to Follow-up|1|||
25293781|NCT00984282|50608252|FG000|Open-label Treatment|Patient convenience|1|||
24969778|NCT00117156|50059218|FG000|Overall Study|Adverse Event|9|||
24969779|NCT00117156|50059218|FG000|Overall Study|Physician Decision|1|||
24969780|NCT00117156|50059218|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
24969781|NCT00096954|50059224|FG000|Overall Study|Adverse Event|3|||
24969782|NCT00096954|50059225|FG001|Overall Study|Adverse Event|1|||
25293782|NCT00984282|50608253|FG001|Open-label Treatment|Patient convenience|0|||
25293783|NCT00984282|50608252|FG000|Open-label Treatment|Non-compliant with study medication|1|||
25293784|NCT00984282|50608253|FG001|Open-label Treatment|Non-compliant with study medication|0|||
25293785|NCT00984282|50608252|FG000|Open-label Treatment|Target lesion removed|0|||
25293786|NCT00984282|50608253|FG001|Open-label Treatment|Target lesion removed|1|||
25293787|NCT00984282|50608252|FG000|Open-label Treatment|Protocol driven decision point|1|||
25293788|NCT00984282|50608253|FG001|Open-label Treatment|Protocol driven decision point|1|||
25293789|NCT00984282|50608252|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
25293790|NCT00984282|50608253|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
25293791|NCT00984282|50608252|FG000|Open-label Treatment|Switched to commercial drug|6|||
25293792|NCT00984282|50608253|FG001|Open-label Treatment|Switched to commercial drug|7|||
25293793|NCT00984282|50608252|FG000|Open-label Treatment|Physician Decision|1|||
25293794|NCT00984282|50608253|FG001|Open-label Treatment|Physician Decision|0|||
25293795|NCT00984282|50608252|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
25293796|NCT00984282|50608253|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
25293797|NCT00984282|50608252|FG000|Long Term Follow-up|Death|27|||
25293798|NCT00984282|50608253|FG001|Long Term Follow-up|Death|68|||
25293799|NCT00984282|50608252|FG000|Long Term Follow-up|Lost to Follow-up|3|||
25293800|NCT00984282|50608253|FG001|Long Term Follow-up|Lost to Follow-up|6|||
25293801|NCT00984282|50608252|FG000|Long Term Follow-up|Protocol driven decision point|25|||
25293802|NCT00984282|50608253|FG001|Long Term Follow-up|Protocol driven decision point|26|||
25293803|NCT00984282|50608252|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
25293804|NCT00984282|50608253|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
25293805|NCT00984282|50608252|FG000|Long Term Follow-up|Switched to commercial drug|4|||
25293806|NCT00984282|50608253|FG001|Long Term Follow-up|Switched to commercial drug|2|||
25293807|NCT00984282|50608252|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
25293808|NCT00984282|50608253|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
25293809|NCT01147874|50608261|FG000|Overall Study|Adverse Event|5|||
25293810|NCT01147874|50608261|FG000|Overall Study|Investigator's Request|1|||
25293811|NCT01147874|50608261|FG000|Overall Study|Lost to Follow-up|25|||
25293812|NCT01147874|50608261|FG000|Overall Study|Other|5|||
25293813|NCT01147874|50608261|FG000|Overall Study|Protocol Violation|5|||
25293814|NCT01147874|50608261|FG000|Overall Study|Sponsor's Decision|2|||
25293815|NCT01147874|50608261|FG000|Overall Study|Withdrawal by Subject|24|||
25293816|NCT01147640|50608267|FG000|Overall Study|Adverse Event|2|||
25293817|NCT01147640|50608268|FG001|Overall Study|Adverse Event|0|||
25293818|NCT01147640|50608267|FG000|Overall Study|Physician Decision|1|||
25293819|NCT01147640|50608268|FG001|Overall Study|Physician Decision|0|||
25293820|NCT01147640|50608267|FG000|Overall Study|Withdrawal by Subject|1|||
25293821|NCT01147640|50608268|FG001|Overall Study|Withdrawal by Subject|0|||
25293822|NCT01147640|50608267|FG000|Overall Study|Lost to Follow-up|0|||
25293823|NCT01147640|50608268|FG001|Overall Study|Lost to Follow-up|1|||
24969783|NCT00096954|50059224|FG000|Overall Study|Withdrawal by Subject|9|||
24969784|NCT00096954|50059225|FG001|Overall Study|Withdrawal by Subject|8|||
25293824|NCT01147640|50608267|FG000|Overall Study|Didn't meet eligibility criteria|1|||
25293825|NCT01147640|50608268|FG001|Overall Study|Didn't meet eligibility criteria|0|||
25293826|NCT01121900|50608274|FG000|First Intervention Period|Adverse Event|1|||
25293827|NCT01121900|50608275|FG001|First Intervention Period|Adverse Event|1|||
25293828|NCT01121900|50608274|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
25293829|NCT01121900|50608275|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
25293830|NCT01121666|50608283|FG000|Overall Study|Protocol Violation|29|||
25293831|NCT01121666|50608284|FG001|Overall Study|Protocol Violation|10|||
25293832|NCT00984126|50608294|FG000|Overall Study|Protocol Violation|0|||
25293833|NCT00984126|50608295|FG001|Overall Study|Protocol Violation|0|||
25293834|NCT00984126|50608296|FG002|Overall Study|Protocol Violation|1|||
25293835|NCT00984126|50608297|FG003|Overall Study|Protocol Violation|2|||
25293836|NCT00984126|50608294|FG000|Overall Study|Adverse Event|0|||
25293837|NCT00984126|50608295|FG001|Overall Study|Adverse Event|0|||
25293838|NCT00984126|50608296|FG002|Overall Study|Adverse Event|0|||
25293839|NCT00984126|50608297|FG003|Overall Study|Adverse Event|2|||
25293840|NCT00984126|50608294|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
25293841|NCT00984126|50608295|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
25293842|NCT00984126|50608296|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
25293843|NCT00984126|50608297|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
25293844|NCT00984126|50608294|FG000|Overall Study|Withdrawal criteria|0|||
25293845|NCT00984126|50608295|FG001|Overall Study|Withdrawal criteria|1|||
25293846|NCT00984126|50608296|FG002|Overall Study|Withdrawal criteria|3|||
25293847|NCT00984126|50608297|FG003|Overall Study|Withdrawal criteria|9|||
25293848|NCT00979602|50608318|FG000|Overall Study|Serious Adverse Event|5|||
25293849|NCT00979602|50608319|FG001|Overall Study|Serious Adverse Event|3|||
25293850|NCT00979602|50608318|FG000|Overall Study|Protocol Violation|3|||
25293851|NCT00979602|50608319|FG001|Overall Study|Protocol Violation|0|||
25293852|NCT00979602|50608318|FG000|Overall Study|Withdrawal by Subject|31|||
25293853|NCT00979602|50608319|FG001|Overall Study|Withdrawal by Subject|25|||
25293854|NCT00979602|50608318|FG000|Overall Study|Lost to Follow-up|100|||
25293855|NCT00979602|50608319|FG001|Overall Study|Lost to Follow-up|96|||
25293856|NCT00979602|50608318|FG000|Overall Study|Migrated/moved from study area|3|||
25293857|NCT00979602|50608319|FG001|Overall Study|Migrated/moved from study area|6|||
25293858|NCT00979602|50608318|FG000|Overall Study|Others|3|||
25293859|NCT00979602|50608319|FG001|Overall Study|Others|3|||
25293860|NCT00816361|50608344|FG000|Overall Study|Withdrawal by Subject|0|||
25293861|NCT00816361|50608345|FG001|Overall Study|Withdrawal by Subject|0|||
25293862|NCT00816361|50608346|FG002|Overall Study|Withdrawal by Subject|0|||
25293863|NCT00816361|50608347|FG003|Overall Study|Withdrawal by Subject|0|||
25293864|NCT00816361|50608348|FG004|Overall Study|Withdrawal by Subject|1|||
25293865|NCT00816361|50608349|FG005|Overall Study|Withdrawal by Subject|2|||
25293866|NCT00816361|50608350|FG006|Overall Study|Withdrawal by Subject|0|||
25293867|NCT00816361|50608351|FG007|Overall Study|Withdrawal by Subject|2|||
25293868|NCT00816361|50608352|FG008|Overall Study|Withdrawal by Subject|1|||
25293869|NCT00816361|50608344|FG000|Overall Study|Death|4|||
25293870|NCT00816361|50608345|FG001|Overall Study|Death|3|||
25293871|NCT00816361|50608346|FG002|Overall Study|Death|3|||
25293872|NCT00816361|50608347|FG003|Overall Study|Death|3|||
25293873|NCT00816361|50608348|FG004|Overall Study|Death|1|||
25293874|NCT00816361|50608349|FG005|Overall Study|Death|1|||
25293875|NCT00816361|50608350|FG006|Overall Study|Death|3|||
25293876|NCT00816361|50608351|FG007|Overall Study|Death|7|||
25293877|NCT00816361|50608352|FG008|Overall Study|Death|8|||
25293878|NCT00816361|50608344|FG000|Overall Study|Other|0|||
25293879|NCT00816361|50608345|FG001|Overall Study|Other|0|||
25293880|NCT00816361|50608346|FG002|Overall Study|Other|0|||
25293881|NCT00816361|50608347|FG003|Overall Study|Other|0|||
25293882|NCT00816361|50608348|FG004|Overall Study|Other|0|||
25293883|NCT00816361|50608349|FG005|Overall Study|Other|0|||
25293884|NCT00816361|50608350|FG006|Overall Study|Other|0|||
25293885|NCT00816361|50608351|FG007|Overall Study|Other|0|||
25293886|NCT00816361|50608352|FG008|Overall Study|Other|1|||
25293887|NCT00826111|50608375|FG000|Overall Study|Lost to Follow-up|0|||
25293888|NCT00826111|50608376|FG001|Overall Study|Lost to Follow-up|1|||
25293889|NCT00826111|50608375|FG000|Overall Study|Protocol Violation|1|||
25293890|NCT00826111|50608376|FG001|Overall Study|Protocol Violation|0|||
25293891|NCT00826111|50608375|FG000|Overall Study|Withdrawal by Subject|5|||
25293892|NCT00826111|50608376|FG001|Overall Study|Withdrawal by Subject|0|||
25293893|NCT00826111|50608375|FG000|Overall Study|Physician Decision|1|||
25293894|NCT00826111|50608376|FG001|Overall Study|Physician Decision|1|||
25293895|NCT00982644|50608387|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
25293896|NCT00982644|50608388|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
25293897|NCT00982644|50608387|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
25293898|NCT00982644|50608388|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
25293899|NCT00982644|50608387|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
25293900|NCT00982644|50608388|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
25293901|NCT00982644|50608387|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
25293902|NCT00982644|50608388|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
25293903|NCT00982644|50608387|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
25293904|NCT00982644|50608388|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
25293905|NCT00982644|50608387|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
25293906|NCT00982644|50608388|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
25293907|NCT00982644|50608387|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
25293908|NCT00982644|50608388|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
25293909|NCT00982644|50608387|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
25293910|NCT00982644|50608388|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
25293911|NCT00982644|50608387|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
25293912|NCT00982644|50608388|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
25293913|NCT00982644|50608387|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
25293914|NCT00982644|50608388|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
25293915|NCT00815659|50608394|FG000|Overall Study|Adverse Event|9|||
25293916|NCT00815659|50608394|FG000|Overall Study|Withdrawal by Subject|9|||
25293917|NCT00815659|50608394|FG000|Overall Study|Lost to Follow-up|4|||
25293918|NCT00815659|50608394|FG000|Overall Study|Protocol Violation|1|||
25293919|NCT00825175|50608400|FG000|Overall Study|Withdrawal by Subject|0|||
25293920|NCT00825175|50608401|FG001|Overall Study|Withdrawal by Subject|5|||
25293921|NCT00824473|50608409|FG000|Overall Study|Adverse Event|4|||
25293922|NCT00824473|50608410|FG001|Overall Study|Adverse Event|5|||
25293923|NCT00824473|50608409|FG000|Overall Study|Lack of Efficacy|2|||
25293924|NCT00824473|50608410|FG001|Overall Study|Lack of Efficacy|2|||
25293925|NCT00824473|50608409|FG000|Overall Study|Protocol Violation|2|||
25293926|NCT00824473|50608410|FG001|Overall Study|Protocol Violation|0|||
25293927|NCT00824473|50608409|FG000|Overall Study|Non-Compliance|4|||
25293928|NCT00824473|50608410|FG001|Overall Study|Non-Compliance|2|||
25293929|NCT00824473|50608409|FG000|Overall Study|Withdrawal by Subject|2|||
25293930|NCT00824473|50608410|FG001|Overall Study|Withdrawal by Subject|3|||
25293931|NCT00824473|50608409|FG000|Overall Study|Other|1|||
25293932|NCT00824473|50608410|FG001|Overall Study|Other|1|||
25293933|NCT00815191|50608422|FG000|Overall Study|Protocol Violation|1|||
25293934|NCT00815191|50608423|FG001|Overall Study|Protocol Violation|1|||
25293935|NCT00812929|50608429|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
25293936|NCT00812929|50608430|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
25293937|NCT00812929|50608431|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
25293938|NCT00812929|50608432|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
25293939|NCT00812929|50608433|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
25293940|NCT00812929|50608434|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
25293941|NCT00812929|50608435|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
25293942|NCT00812929|50608436|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
25293943|NCT00812929|50608437|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
25293944|NCT00812929|50608438|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
25293945|NCT00812929|50608429|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
25293946|NCT00812929|50608430|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
25293947|NCT00812929|50608431|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
25293948|NCT00812929|50608432|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
25293949|NCT00812929|50608433|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
25293950|NCT00812929|50608434|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
25293951|NCT00812929|50608435|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
25293952|NCT00812929|50608436|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
25293953|NCT00812929|50608437|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
25293954|NCT00812929|50608438|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
25293955|NCT00812929|50608429|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
25293956|NCT00812929|50608430|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
25293957|NCT00812929|50608431|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
25293958|NCT00812929|50608432|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
25293959|NCT00812929|50608433|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
25293960|NCT00812929|50608434|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
25293961|NCT00812929|50608435|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
25293962|NCT00812929|50608436|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
25293963|NCT00812929|50608437|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
25293964|NCT00812929|50608438|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
25293965|NCT00824161|50608455|FG000|Overall Study|Withdrawal by Subject|1|||
25293966|NCT00824161|50608455|FG000|Overall Study|Screen Failure|1|||
25293967|NCT00979134|50608464|FG000|Overall Study|Disease progression|18|||
25293968|NCT00979134|50608465|FG001|Overall Study|Disease progression|2|||
25293969|NCT00979134|50608466|FG002|Overall Study|Disease progression|5|||
25293970|NCT00979134|50608464|FG000|Overall Study|Adverse Event|0|||
25293971|NCT00979134|50608465|FG001|Overall Study|Adverse Event|0|||
25293972|NCT00979134|50608466|FG002|Overall Study|Adverse Event|2|||
25293973|NCT00979134|50608464|FG000|Overall Study|Withdrawal by Subject|1|||
25293974|NCT00979134|50608465|FG001|Overall Study|Withdrawal by Subject|1|||
25293975|NCT00979134|50608466|FG002|Overall Study|Withdrawal by Subject|2|||
25293976|NCT00979134|50608464|FG000|Overall Study|Lost to Follow-up|2|||
25293977|NCT00979134|50608465|FG001|Overall Study|Lost to Follow-up|2|||
25293978|NCT00979134|50608466|FG002|Overall Study|Lost to Follow-up|0|||
25293979|NCT00979134|50608464|FG000|Overall Study|Death|4|||
25293980|NCT00979134|50608465|FG001|Overall Study|Death|0|||
25293981|NCT00979134|50608466|FG002|Overall Study|Death|26|||
25293982|NCT00979134|50608464|FG000|Overall Study|Other|8|||
25293983|NCT00979134|50608465|FG001|Overall Study|Other|1|||
25293984|NCT00979134|50608466|FG002|Overall Study|Other|5|||
25293985|NCT00824005|50608481|FG000|Overall Study|Death|0|||
25293986|NCT00824005|50608482|FG001|Overall Study|Death|1|||
25293987|NCT00824005|50608481|FG000|Overall Study|Lost to Follow-up|0|||
25293988|NCT00824005|50608482|FG001|Overall Study|Lost to Follow-up|1|||
25293989|NCT00814879|50608490|FG000|By Week 24|Cancer Diagnosis|1|||
25293990|NCT00814879|50608491|FG001|By Week 24|Cancer Diagnosis|0|||
25293991|NCT00814879|50608490|FG000|By Week 24|Incarceration|0|||
25293992|NCT00814879|50608491|FG001|By Week 24|Incarceration|1|||
25293993|NCT00814879|50608490|FG000|By Week 48|Lost to Follow-up|2|||
25293994|NCT00814879|50608491|FG001|By Week 48|Lost to Follow-up|2|||
25293995|NCT00814879|50608490|FG000|By Week 48|Death|0|||
25293996|NCT00814879|50608491|FG001|By Week 48|Death|1|||
25293997|NCT03347422|50608500|FG000|Part A (26 Weeks)|Adverse Event|3|||
25293998|NCT03347422|50608501|FG001|Part A (26 Weeks)|Adverse Event|0|||
25293999|NCT03347422|50608500|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
25294000|NCT03347422|50608501|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
25294001|NCT03347422|50608500|FG000|Part B (149 Weeks)|Adverse Event|0|||
25294002|NCT03347422|50608501|FG001|Part B (149 Weeks)|Adverse Event|1|||
25294003|NCT03347422|50608500|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
25294004|NCT03347422|50608501|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
25294005|NCT03347422|50608500|FG000|Part B (149 Weeks)|Other|1|||
25294006|NCT03347422|50608501|FG001|Part B (149 Weeks)|Other|0|||
25294007|NCT00814801|50608517|FG000|Overall Study|Adverse Event|15|||
25294008|NCT00814801|50608518|FG001|Overall Study|Adverse Event|16|||
25294009|NCT00814801|50608519|FG002|Overall Study|Adverse Event|19|||
25294010|NCT00814801|50608517|FG000|Overall Study|Withdrawal by Subject|9|||
25294011|NCT00814801|50608518|FG001|Overall Study|Withdrawal by Subject|11|||
25294012|NCT00814801|50608519|FG002|Overall Study|Withdrawal by Subject|14|||
25294013|NCT00814801|50608517|FG000|Overall Study|Inappropriate as a subject|1|||
25294014|NCT00814801|50608518|FG001|Overall Study|Inappropriate as a subject|1|||
25294015|NCT00814801|50608519|FG002|Overall Study|Inappropriate as a subject|1|||
25294016|NCT00814801|50608517|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
25294017|NCT00814801|50608518|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
25294018|NCT00814801|50608519|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
24969785|NCT00096954|50059224|FG000|Overall Study|Physician Decision|1|||
25294019|NCT00814801|50608517|FG000|Overall Study|Missing or change of caregiver|6|||
25294020|NCT00814801|50608518|FG001|Overall Study|Missing or change of caregiver|2|||
25294021|NCT00814801|50608519|FG002|Overall Study|Missing or change of caregiver|4|||
25294022|NCT00814801|50608517|FG000|Overall Study|Non-compliance|0|||
25294023|NCT00814801|50608518|FG001|Overall Study|Non-compliance|1|||
25294024|NCT00814801|50608519|FG002|Overall Study|Non-compliance|1|||
25294025|NCT00814801|50608517|FG000|Overall Study|Other|2|||
25294026|NCT00814801|50608518|FG001|Overall Study|Other|6|||
25294027|NCT00814801|50608519|FG002|Overall Study|Other|4|||
25294028|NCT00823615|50608527|FG000|Period 2|Lost to Follow-up|2|||
25294029|NCT00823615|50608528|FG001|Period 2|Lost to Follow-up|0|||
25294030|NCT00823615|50608527|FG000|Period 2|Time/Job Conflict|1|||
25294031|NCT00823615|50608528|FG001|Period 2|Time/Job Conflict|2|||
25294032|NCT00812461|50608536|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
25294033|NCT00812461|50608537|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
25294034|NCT00812461|50608536|FG000|All Treated Patients|Adverse Event|8|||
25294035|NCT00812461|50608537|FG001|All Treated Patients|Adverse Event|15|||
25294036|NCT00812461|50608536|FG000|All Treated Patients|Lack of Efficacy|13|||
25294037|NCT00812461|50608537|FG001|All Treated Patients|Lack of Efficacy|7|||
25294038|NCT00812461|50608536|FG000|All Treated Patients|Non-compliance|6|||
25294039|NCT00812461|50608537|FG001|All Treated Patients|Non-compliance|9|||
25294040|NCT00812461|50608536|FG000|All Treated Patients|Protocol Violation|36|||
25294041|NCT00812461|50608537|FG001|All Treated Patients|Protocol Violation|27|||
25294042|NCT00812461|50608536|FG000|All Treated Patients|Withdrawal by Subject|45|||
25294043|NCT00812461|50608537|FG001|All Treated Patients|Withdrawal by Subject|54|||
25294044|NCT00812461|50608536|FG000|All Treated Patients|Lost to Follow-up|11|||
25294045|NCT00812461|50608537|FG001|All Treated Patients|Lost to Follow-up|14|||
25294046|NCT00812461|50608536|FG000|All Treated Patients|Other Reason|13|||
25294047|NCT00812461|50608537|FG001|All Treated Patients|Other Reason|21|||
25294048|NCT00599326|50608543|FG000|Overall Study|Lost to Follow-up|1|||
25294049|NCT00599326|50608543|FG000|Overall Study|Noncompliant|1|||
25294050|NCT00978432|50608550|FG000|Overall Study|Withdrawal by Subject|0|||
25294051|NCT00978432|50608551|FG001|Overall Study|Withdrawal by Subject|0|||
25294052|NCT00978432|50608552|FG002|Overall Study|Withdrawal by Subject|1|||
25070557|NCT01563107|50176599|FG003|Overall Study|Withdrawal by Subject|2|||
25070558|NCT02589626|50176661|FG000|Overall Study|Other than the reason specified|1|||
25070559|NCT02589626|50176662|FG001|Overall Study|Other than the reason specified|0|||
25070560|NCT02589626|50176661|FG000|Overall Study|Withdrawal by Subject|1|||
25070561|NCT02589626|50176662|FG001|Overall Study|Withdrawal by Subject|1|||
25070562|NCT02589626|50176661|FG000|Overall Study|Adverse Event|1|||
25070563|NCT02589626|50176662|FG001|Overall Study|Adverse Event|1|||
25070564|NCT01666730|50176677|FG000|Overall Study|Adverse Event|16|||
25070565|NCT01666730|50176677|FG000|Overall Study|Death|2|||
25070566|NCT01666730|50176677|FG000|Overall Study|Physician Decision|5|||
25070567|NCT01666730|50176677|FG000|Overall Study|Withdrawal by Subject|9|||
25070568|NCT01666730|50176677|FG000|Overall Study|Disease progression/relapse|18|||
25070569|NCT00103285|50176690|FG000|Induction|Adverse Event|14|||
25070570|NCT00103285|50176691|FG001|Induction|Adverse Event|0|||
25070571|NCT00103285|50176692|FG002|Induction|Adverse Event|0|||
25070572|NCT00103285|50176693|FG003|Induction|Adverse Event|0|||
25070573|NCT00103285|50176694|FG004|Induction|Adverse Event|0|||
25070574|NCT00103285|50176695|FG005|Induction|Adverse Event|0|||
25070575|NCT00103285|50176696|FG006|Induction|Adverse Event|0|||
25070576|NCT00103285|50176697|FG007|Induction|Adverse Event|0|||
25070577|NCT00103285|50176690|FG000|Induction|Death|24|||
25070578|NCT00103285|50176691|FG001|Induction|Death|0|||
25070579|NCT00103285|50176692|FG002|Induction|Death|0|||
25070580|NCT00103285|50176693|FG003|Induction|Death|0|||
25070581|NCT00103285|50176694|FG004|Induction|Death|0|||
25070582|NCT00103285|50176695|FG005|Induction|Death|0|||
25070583|NCT00103285|50176696|FG006|Induction|Death|0|||
25070584|NCT00103285|50176697|FG007|Induction|Death|0|||
25169278|NCT01842581|50300796|FG001|Overall Study|Other than specified|1|||
25169279|NCT01833533|50300804|FG000|Overall Study|Adverse Event|0|||
25169280|NCT01833533|50300805|FG001|Overall Study|Adverse Event|1|||
25169281|NCT01833533|50300804|FG000|Overall Study|Lost to Follow-up|4|||
25169282|NCT01833533|50300805|FG001|Overall Study|Lost to Follow-up|9|||
25169283|NCT01833533|50300804|FG000|Overall Study|To Enter an Extension Study|0|||
25294053|NCT00978432|50608550|FG000|Overall Study|Lack of Efficacy|1|||
25294054|NCT00978432|50608551|FG001|Overall Study|Lack of Efficacy|1|||
25294055|NCT00978432|50608552|FG002|Overall Study|Lack of Efficacy|3|||
25070585|NCT00103285|50176690|FG000|Induction|Physician Decision|103|||
25070586|NCT00103285|50176691|FG001|Induction|Physician Decision|0|||
25070587|NCT00103285|50176692|FG002|Induction|Physician Decision|0|||
25070588|NCT00103285|50176693|FG003|Induction|Physician Decision|0|||
25070589|NCT00103285|50176694|FG004|Induction|Physician Decision|0|||
25070590|NCT00103285|50176695|FG005|Induction|Physician Decision|0|||
25169284|NCT01833533|50300805|FG001|Overall Study|To Enter an Extension Study|4|||
25294056|NCT00978432|50608550|FG000|Overall Study|Adverse Event|2|||
25294057|NCT00978432|50608551|FG001|Overall Study|Adverse Event|0|||
25294058|NCT00978432|50608552|FG002|Overall Study|Adverse Event|1|||
25294059|NCT00975780|50608562|FG000|Follow Up|Death|88|||
25294060|NCT00975780|50608563|FG001|Follow Up|Death|122|||
25294061|NCT00975780|50608562|FG000|Follow Up|Facility Withdrawal|7|||
25294062|NCT00975780|50608563|FG001|Follow Up|Facility Withdrawal|23|||
25294063|NCT00975780|50608562|FG000|Follow Up|Discharged from Facility|7|||
25294064|NCT00975780|50608563|FG001|Follow Up|Discharged from Facility|12|||
25294065|NCT00814489|50608572|FG000|Overall Study|Other|2|||
25294066|NCT00814489|50608573|FG001|Overall Study|Other|0|||
25294067|NCT00814489|50608574|FG002|Overall Study|Other|1|||
25294068|NCT00814333|50608586|FG000|Enrollment|Lost to Follow-up|1|||
25294069|NCT00814333|50608587|FG001|Enrollment|Lost to Follow-up|0|||
25294070|NCT01147250|50608595|FG000|Overall Study|Lost to Follow-up|14|||
25294071|NCT01147250|50608596|FG001|Overall Study|Lost to Follow-up|11|||
25294072|NCT01147250|50608595|FG000|Overall Study|Withdrawal by Subject|83|||
25294073|NCT01147250|50608596|FG001|Overall Study|Withdrawal by Subject|88|||
25294074|NCT01147250|50608595|FG000|Overall Study|Site termination by sponsor|13|||
25294075|NCT01147250|50608596|FG001|Overall Study|Site termination by sponsor|5|||
25294076|NCT01147250|50608595|FG000|Overall Study|Other than specified|0|||
25294077|NCT01147250|50608596|FG001|Overall Study|Other than specified|1|||
25294078|NCT00813943|50608605|FG000|Overall Study|Ongoing at cut-off date|5|||
25294079|NCT00813943|50608606|FG001|Overall Study|Ongoing at cut-off date|5|||
25294080|NCT00813943|50608607|FG002|Overall Study|Ongoing at cut-off date|3|||
25294081|NCT00821509|50608619|FG000|Overall Study|Withdrawal by Subject|12|||
24969786|NCT00096954|50059225|FG001|Overall Study|Physician Decision|1|||
24969787|NCT00096954|50059224|FG000|Overall Study|Sponsors Decision|1|||
25294082|NCT00821509|50608620|FG001|Overall Study|Withdrawal by Subject|11|||
25294083|NCT00821509|50608621|FG002|Overall Study|Withdrawal by Subject|34|||
25294084|NCT00821431|50608631|FG000|Overall Study|Adverse Event|6|||
25294085|NCT00821431|50608632|FG001|Overall Study|Adverse Event|3|||
24969788|NCT00096954|50059225|FG001|Overall Study|Sponsors Decision|1|||
24969789|NCT00096954|50059224|FG000|Overall Study|Pregnancy|1|||
24969790|NCT00096954|50059225|FG001|Overall Study|Pregnancy|1|||
24969791|NCT00096954|50059224|FG000|Overall Study|Initiation of immunotherapy|1|||
24969792|NCT00096954|50059225|FG001|Overall Study|Initiation of immunotherapy|0|||
25070591|NCT00103285|50176696|FG006|Induction|Physician Decision|0|||
25070592|NCT00103285|50176697|FG007|Induction|Physician Decision|0|||
25070593|NCT00103285|50176690|FG000|Induction|Withdrawal by Subject|1|||
25070594|NCT00103285|50176691|FG001|Induction|Withdrawal by Subject|0|||
25070595|NCT00103285|50176692|FG002|Induction|Withdrawal by Subject|0|||
25070596|NCT00103285|50176693|FG003|Induction|Withdrawal by Subject|0|||
25070597|NCT00103285|50176694|FG004|Induction|Withdrawal by Subject|0|||
25070598|NCT00103285|50176695|FG005|Induction|Withdrawal by Subject|0|||
25070599|NCT00103285|50176696|FG006|Induction|Withdrawal by Subject|0|||
25070600|NCT00103285|50176697|FG007|Induction|Withdrawal by Subject|0|||
25070601|NCT00103285|50176690|FG000|Induction|Ineligible|43|||
25070602|NCT00103285|50176691|FG001|Induction|Ineligible|0|||
25070603|NCT00103285|50176692|FG002|Induction|Ineligible|0|||
25070604|NCT00103285|50176693|FG003|Induction|Ineligible|0|||
25070605|NCT00103285|50176694|FG004|Induction|Ineligible|0|||
25070606|NCT00103285|50176695|FG005|Induction|Ineligible|0|||
25070607|NCT00103285|50176696|FG006|Induction|Ineligible|0|||
25070608|NCT00103285|50176697|FG007|Induction|Ineligible|0|||
25070609|NCT00103285|50176690|FG000|Induction|Refusal|906|||
24969793|NCT00096954|50059224|FG000|Overall Study|Non-compliance|0|||
25070610|NCT00103285|50176691|FG001|Induction|Refusal|0|||
25294086|NCT00821431|50608631|FG000|Overall Study|Withdrawal by Subject|5|||
25294087|NCT00821431|50608632|FG001|Overall Study|Withdrawal by Subject|0|||
24969794|NCT00096954|50059225|FG001|Overall Study|Non-compliance|3|||
24969795|NCT00096954|50059224|FG000|Overall Study|Lost to Follow-up|8|||
24969796|NCT00096954|50059225|FG001|Overall Study|Lost to Follow-up|5|||
24969797|NCT00096486|50059235|FG000|Overall Study|Withdrawal by Subject|0|||
25070611|NCT00103285|50176692|FG002|Induction|Refusal|0|||
25070612|NCT00103285|50176693|FG003|Induction|Refusal|0|||
25070613|NCT00103285|50176694|FG004|Induction|Refusal|0|||
25070614|NCT00103285|50176695|FG005|Induction|Refusal|0|||
25070615|NCT00103285|50176696|FG006|Induction|Refusal|0|||
25294088|NCT00821431|50608631|FG000|Overall Study|Lost to Follow-up|1|||
25294089|NCT00821431|50608632|FG001|Overall Study|Lost to Follow-up|0|||
25294090|NCT00821431|50608631|FG000|Overall Study|Protocol Violation|3|||
24969798|NCT00096486|50059236|FG001|Overall Study|Withdrawal by Subject|0|||
25070616|NCT00103285|50176697|FG007|Induction|Refusal|0|||
25070617|NCT00103285|50176690|FG000|Induction|Other|258|||
25070618|NCT00103285|50176691|FG001|Induction|Other|0|||
25070619|NCT00103285|50176692|FG002|Induction|Other|0|||
25070620|NCT00103285|50176693|FG003|Induction|Other|0|||
25070621|NCT00103285|50176694|FG004|Induction|Other|0|||
24969799|NCT00096486|50059237|FG002|Overall Study|Withdrawal by Subject|1|||
24969800|NCT00096486|50059238|FG003|Overall Study|Withdrawal by Subject|1|||
24969801|NCT00096486|50059235|FG000|Overall Study|Not Treated|0|||
24969802|NCT00096486|50059236|FG001|Overall Study|Not Treated|0|||
24969803|NCT00096486|50059237|FG002|Overall Study|Not Treated|1|||
24969804|NCT00096486|50059238|FG003|Overall Study|Not Treated|1|||
24969805|NCT00116844|50059250|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
24969806|NCT00116844|50059251|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
24969807|NCT00116844|50059250|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
25191707|NCT00081497|50352948|FG000|Overall Study|Adverse Event|2|||
25191708|NCT00081497|50352949|FG001|Overall Study|Adverse Event|0|||
25294091|NCT00821431|50608632|FG001|Overall Study|Protocol Violation|1|||
25294092|NCT00821431|50608631|FG000|Overall Study|Physician Decision|0|||
25294093|NCT00821431|50608632|FG001|Overall Study|Physician Decision|1|||
25294094|NCT01134614|50608640|FG000|Overall Study|Still on treatment as of March 2013|21|||
25294095|NCT01134614|50608641|FG001|Overall Study|Still on treatment as of March 2013|13|||
25294096|NCT01134614|50608640|FG000|Overall Study|Progressive disease|60|||
25294097|NCT01134614|50608641|FG001|Overall Study|Progressive disease|54|||
25294098|NCT01134614|50608640|FG000|Overall Study|Adverse Event|26|||
25294099|NCT01134614|50608641|FG001|Overall Study|Adverse Event|39|||
25294100|NCT01134614|50608640|FG000|Overall Study|Death|5|||
25294101|NCT01134614|50608641|FG001|Overall Study|Death|8|||
25294102|NCT01134614|50608640|FG000|Overall Study|Withdrawal by Subject|3|||
25294103|NCT01134614|50608641|FG001|Overall Study|Withdrawal by Subject|2|||
25294104|NCT01134614|50608640|FG000|Overall Study|Alternative therapy|2|||
25294105|NCT01134614|50608641|FG001|Overall Study|Alternative therapy|0|||
25294106|NCT01134614|50608640|FG000|Overall Study|Complicating disease|2|||
25294107|NCT01134614|50608641|FG001|Overall Study|Complicating disease|1|||
25294108|NCT01134614|50608640|FG000|Overall Study|Physician's decision|0|||
25294109|NCT01134614|50608641|FG001|Overall Study|Physician's decision|1|||
25294110|NCT01134614|50608640|FG000|Overall Study|Never started treatment|4|||
25294111|NCT01134614|50608641|FG001|Overall Study|Never started treatment|1|||
25294112|NCT01134614|50608640|FG000|Overall Study|Pt received tx not allowed on study|0|||
25294113|NCT01134614|50608641|FG001|Overall Study|Pt received tx not allowed on study|1|||
25294114|NCT01134614|50608640|FG000|Overall Study|Symptomatic deterioration|0|||
25294115|NCT01134614|50608641|FG001|Overall Study|Symptomatic deterioration|1|||
25294116|NCT01134614|50608640|FG000|Overall Study|Patient in hospice care|0|||
25294117|NCT01134614|50608641|FG001|Overall Study|Patient in hospice care|1|||
25294118|NCT03982368|50608650|FG000|Overall Study|Adverse Event|6|||
25294119|NCT03982368|50608651|FG001|Overall Study|Adverse Event|4|||
25294120|NCT03982368|50608652|FG002|Overall Study|Adverse Event|3|||
25294121|NCT03982368|50608650|FG000|Overall Study|Lost to Follow-up|2|||
25294122|NCT03982368|50608651|FG001|Overall Study|Lost to Follow-up|1|||
25294123|NCT03982368|50608652|FG002|Overall Study|Lost to Follow-up|0|||
25294124|NCT03982368|50608650|FG000|Overall Study|Withdrawal by Subject|1|||
25294125|NCT03982368|50608651|FG001|Overall Study|Withdrawal by Subject|2|||
25294126|NCT03982368|50608652|FG002|Overall Study|Withdrawal by Subject|0|||
25294127|NCT03982368|50608650|FG000|Overall Study|unknow|4|||
25294128|NCT03982368|50608651|FG001|Overall Study|unknow|0|||
25294129|NCT03982368|50608652|FG002|Overall Study|unknow|2|||
25294130|NCT00813865|50608663|FG000|Overall Study|Failure to Respond|3|||
25294131|NCT00813865|50608663|FG000|Overall Study|Lost to Follow-up|3|||
25294132|NCT00813865|50608663|FG000|Overall Study|Withdrawal by Subject|1|||
25294133|NCT01147172|50608667|FG000|Overall Study|Withdrawal by Subject|2|||
25294134|NCT01147172|50608667|FG000|Overall Study|Lost to Follow-up|2|||
25294135|NCT01120964|50608675|FG000|Overall Study|Did not receive full treatment|1|||
25294136|NCT01120964|50608676|FG001|Overall Study|Did not receive full treatment|0|||
25294137|NCT01146860|50608684|FG000|Overall Study|Withdrawal by Subject|0|||
25294138|NCT01146860|50608685|FG001|Overall Study|Withdrawal by Subject|1|||
25294139|NCT00591565|50608691|FG000|Overall Study|lost follow up, withdrawn|5|||
24969808|NCT00116844|50059251|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
24969809|NCT00116844|50059250|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
25070622|NCT00103285|50176695|FG005|Induction|Other|0|||
25191709|NCT00081497|50352948|FG000|Overall Study|Death|0|||
25070623|NCT00103285|50176696|FG006|Induction|Other|0|||
25070624|NCT00103285|50176697|FG007|Induction|Other|0|||
25070625|NCT00103285|50176690|FG000|Response Assignment|Adverse Event|0|||
25070626|NCT00103285|50176691|FG001|Response Assignment|Adverse Event|8|||
25294140|NCT01146782|50608695|FG000|Screening Cohort|Screen Failure|187|||
25294141|NCT01146782|50608695|FG000|Screening Cohort|Lost to Follow-up|4|||
25294142|NCT01146782|50608695|FG000|Screening Cohort|Physician Decision|1|||
25294143|NCT01146782|50608695|FG000|Screening Cohort|Withdrawal by Subject|29|||
25294144|NCT01146782|50608695|FG000|Safety Cohort|Screen Failure|61|||
25294145|NCT01146782|50608695|FG000|Safety Cohort|Withdrawal by Subject|4|||
25294146|NCT01146782|50608695|FG000|Safety Cohort|Control AHI <5|4|||
25294147|NCT01146782|50608695|FG000|Safety Cohort|TST <4 hrs|14|||
25294148|NCT01146782|50608695|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
25294149|NCT01146782|50608695|FG000|Primary Endpoint Cohort|Physician Decision|1|||
25294150|NCT00978120|50608704|FG000|Overall Study|Death|0|||
25294151|NCT00978120|50608705|FG001|Overall Study|Death|0|||
25294152|NCT00978120|50608706|FG002|Overall Study|Death|0|||
25294153|NCT00978120|50608707|FG003|Overall Study|Death|1|||
25294154|NCT00978120|50608704|FG000|Overall Study|Lost to Follow-up|0|||
25294155|NCT00978120|50608705|FG001|Overall Study|Lost to Follow-up|0|||
25294156|NCT00978120|50608706|FG002|Overall Study|Lost to Follow-up|3|||
25294157|NCT00978120|50608707|FG003|Overall Study|Lost to Follow-up|0|||
25294158|NCT00978120|50608704|FG000|Overall Study|Withdrawal by Subject|2|||
25294159|NCT00978120|50608705|FG001|Overall Study|Withdrawal by Subject|0|||
25294160|NCT00978120|50608706|FG002|Overall Study|Withdrawal by Subject|0|||
25294161|NCT00978120|50608707|FG003|Overall Study|Withdrawal by Subject|0|||
25294162|NCT00978120|50608704|FG000|Overall Study|Moved out of state|0|||
25294163|NCT00978120|50608705|FG001|Overall Study|Moved out of state|0|||
25294164|NCT00978120|50608706|FG002|Overall Study|Moved out of state|0|||
25294165|NCT00978120|50608707|FG003|Overall Study|Moved out of state|1|||
25294166|NCT00978042|50608723|FG000|Initial Treatment Period|Treated in Error|0|||
25294167|NCT00978042|50608724|FG001|Initial Treatment Period|Treated in Error|3|||
25294168|NCT00978042|50608723|FG000|Initial Treatment Period|Ineligibility|1|||
25294169|NCT00978042|50608724|FG001|Initial Treatment Period|Ineligibility|0|||
25294170|NCT00978042|50608723|FG000|Initial Treatment Period|Lost to Follow-up|21|||
25294171|NCT00978042|50608724|FG001|Initial Treatment Period|Lost to Follow-up|3|||
25294172|NCT00978042|50608723|FG000|Initial Treatment Period|Adverse Event|2|||
25294173|NCT00978042|50608724|FG001|Initial Treatment Period|Adverse Event|0|||
25294174|NCT00978042|50608723|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
25294175|NCT00978042|50608724|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
25294176|NCT00978042|50608723|FG000|Initial Treatment Period|Consent withdrawn|22|||
25294177|NCT00978042|50608724|FG001|Initial Treatment Period|Consent withdrawn|9|||
25294178|NCT00978042|50608723|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
25294179|NCT00978042|50608724|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
25294180|NCT01133678|50608732|FG000|Overall Study|Death|1|||
25294181|NCT01133678|50608733|FG001|Overall Study|Death|1|||
25294182|NCT01133522|50608749|FG000|Overall Study|Withdrawal by Subject|0|||
25294183|NCT01133522|50608750|FG001|Overall Study|Withdrawal by Subject|1|||
25294184|NCT01133522|50608751|FG002|Overall Study|Withdrawal by Subject|0|||
25294185|NCT01133522|50608752|FG003|Overall Study|Withdrawal by Subject|1|||
25294186|NCT01133522|50608753|FG004|Overall Study|Withdrawal by Subject|0|||
25294187|NCT01133522|50608754|FG005|Overall Study|Withdrawal by Subject|0|||
25294188|NCT01133522|50608755|FG006|Overall Study|Withdrawal by Subject|0|||
25294189|NCT01133522|50608756|FG007|Overall Study|Withdrawal by Subject|0|||
25294190|NCT01133522|50608757|FG008|Overall Study|Withdrawal by Subject|0|||
25294191|NCT01133522|50608758|FG009|Overall Study|Withdrawal by Subject|0|||
25294192|NCT01133522|50608749|FG000|Overall Study|Physician Decision|0|||
25294193|NCT01133522|50608750|FG001|Overall Study|Physician Decision|0|||
25294194|NCT01133522|50608751|FG002|Overall Study|Physician Decision|0|||
25294195|NCT01133522|50608752|FG003|Overall Study|Physician Decision|0|||
25294196|NCT01133522|50608753|FG004|Overall Study|Physician Decision|1|||
25294197|NCT01133522|50608754|FG005|Overall Study|Physician Decision|0|||
25294198|NCT01133522|50608755|FG006|Overall Study|Physician Decision|0|||
25294199|NCT01133522|50608756|FG007|Overall Study|Physician Decision|0|||
25294200|NCT01133522|50608757|FG008|Overall Study|Physician Decision|0|||
25294201|NCT01133522|50608758|FG009|Overall Study|Physician Decision|0|||
25294202|NCT01133288|50608787|FG000|Eligibility Assessment|met exclusion criteria|5|||
25294203|NCT01133288|50608787|FG000|Intervention Allocation|study terminated|2|||
25294204|NCT00883090|50608795|FG000|Overall Study|Sponsor's decision|1|||
25294205|NCT00883090|50608795|FG000|Overall Study|Withdrawal by Subject|1|||
25294206|NCT01132820|50608799|FG000|Overall Study|Ineligible: wrong cell type|1|||
25294207|NCT01132820|50608799|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
25294208|NCT01132820|50608799|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
25294209|NCT01132820|50608799|FG000|Overall Study|Never treated|1|||
25294210|NCT01132820|50608799|FG000|Overall Study|Inadequate data|1|||
25294211|NCT00885352|50608818|FG000|Overall Study|Adverse Event|2|||
25294212|NCT00885352|50608819|FG001|Overall Study|Adverse Event|3|||
25294213|NCT00885352|50608818|FG000|Overall Study|Lost to Follow-up|2|||
25294214|NCT00885352|50608819|FG001|Overall Study|Lost to Follow-up|2|||
25294215|NCT00885352|50608818|FG000|Overall Study|Physician Decision|0|||
25294216|NCT00885352|50608819|FG001|Overall Study|Physician Decision|3|||
25294217|NCT00885352|50608818|FG000|Overall Study|Protocol Violation|0|||
25294218|NCT00885352|50608819|FG001|Overall Study|Protocol Violation|2|||
25294219|NCT00885352|50608818|FG000|Overall Study|Withdrawal by Subject|1|||
25294220|NCT00885352|50608819|FG001|Overall Study|Withdrawal by Subject|5|||
25294221|NCT00885352|50608818|FG000|Overall Study|Contradiction to study medication|0|||
25294222|NCT00885352|50608819|FG001|Overall Study|Contradiction to study medication|2|||
25294223|NCT00885352|50608818|FG000|Overall Study|Excluded medication|2|||
25294224|NCT00885352|50608819|FG001|Overall Study|Excluded medication|2|||
25294225|NCT00885352|50608818|FG000|Overall Study|Lab abnormalities|1|||
25294226|NCT00885352|50608819|FG001|Overall Study|Lab abnormalities|1|||
25294227|NCT00885118|50608830|FG000|Overall Study|Adverse Event|1|||
25294228|NCT00885118|50608831|FG001|Overall Study|Adverse Event|0|||
25294229|NCT00885118|50608832|FG002|Overall Study|Adverse Event|0|||
25294230|NCT00885118|50608833|FG003|Overall Study|Adverse Event|0|||
25294231|NCT00885118|50608834|FG004|Overall Study|Adverse Event|0|||
25294232|NCT00885118|50608830|FG000|Overall Study|Withdrawal by Subject|0|||
25294233|NCT00885118|50608831|FG001|Overall Study|Withdrawal by Subject|0|||
25294234|NCT00885118|50608832|FG002|Overall Study|Withdrawal by Subject|0|||
25294235|NCT00885118|50608833|FG003|Overall Study|Withdrawal by Subject|0|||
25294236|NCT00885118|50608834|FG004|Overall Study|Withdrawal by Subject|1|||
25294237|NCT00885118|50608830|FG000|Overall Study|Other reason not defined above|0|||
25294238|NCT00885118|50608831|FG001|Overall Study|Other reason not defined above|0|||
25294239|NCT00885118|50608832|FG002|Overall Study|Other reason not defined above|1|||
25294240|NCT00885118|50608833|FG003|Overall Study|Other reason not defined above|0|||
25294241|NCT00885118|50608834|FG004|Overall Study|Other reason not defined above|0|||
25294242|NCT00880906|50608852|FG000|Overall Study|Lost to Follow-up|0|||
25294243|NCT00880906|50608853|FG001|Overall Study|Lost to Follow-up|1|||
25294244|NCT00880906|50608852|FG000|Overall Study|Did not meet criteria following patholog|12|||
25294245|NCT00880906|50608853|FG001|Overall Study|Did not meet criteria following patholog|6|||
25294246|NCT00882310|50608859|FG000|Overall Study|Screen Failure|10|||
25294247|NCT00882310|50608859|FG000|Overall Study|Never received treatment|1|||
25294248|NCT00882310|50608859|FG000|Overall Study|Death|6|||
25294249|NCT00882310|50608859|FG000|Overall Study|Progression of disease|4|||
25294250|NCT00882310|50608859|FG000|Overall Study|Adverse Event|1|||
25294251|NCT00884650|50608865|FG000|Overall Study|Did not return complete pain diaries|7|||
25294252|NCT00884650|50608866|FG001|Overall Study|Did not return complete pain diaries|7|||
25294253|NCT00884650|50608865|FG000|Overall Study|Admitted Post-Op|1|||
25294254|NCT00884650|50608866|FG001|Overall Study|Admitted Post-Op|0|||
25294255|NCT00884650|50608865|FG000|Overall Study|Femoral Stress Fracture|1|||
25294256|NCT00884650|50608866|FG001|Overall Study|Femoral Stress Fracture|0|||
25294257|NCT00884650|50608865|FG000|Overall Study|Pain Pump Complication|0|||
25294258|NCT00884650|50608866|FG001|Overall Study|Pain Pump Complication|1|||
25294259|NCT00881608|50608878|FG000|Overall Study|Study prematurely terminated|11|||
25294260|NCT01088399|50608893|FG000|Overall Study|Adverse Event|211|||
25294261|NCT01088399|50608894|FG001|Overall Study|Adverse Event|16|||
25294262|NCT01088399|50608895|FG002|Overall Study|Adverse Event|0|||
25294263|NCT01088399|50608893|FG000|Overall Study|Death|204|||
25294264|NCT01088399|50608894|FG001|Overall Study|Death|45|||
25294265|NCT01088399|50608895|FG002|Overall Study|Death|0|||
25294266|NCT01088399|50608893|FG000|Overall Study|Lack of Efficacy|298|||
25294267|NCT01088399|50608894|FG001|Overall Study|Lack of Efficacy|7|||
25294268|NCT01088399|50608895|FG002|Overall Study|Lack of Efficacy|5|||
25294269|NCT01088399|50608893|FG000|Overall Study|Lost to Follow-up|1070|||
25294270|NCT01088399|50608894|FG001|Overall Study|Lost to Follow-up|278|||
25294271|NCT01088399|50608895|FG002|Overall Study|Lost to Follow-up|58|||
25294272|NCT01088399|50608893|FG000|Overall Study|Physician Decision|531|||
25294273|NCT01088399|50608894|FG001|Overall Study|Physician Decision|88|||
25294274|NCT01088399|50608895|FG002|Overall Study|Physician Decision|16|||
25294275|NCT01088399|50608893|FG000|Overall Study|Withdrawal by Subject|544|||
25294276|NCT01088399|50608894|FG001|Overall Study|Withdrawal by Subject|195|||
25294277|NCT01088399|50608895|FG002|Overall Study|Withdrawal by Subject|33|||
25294278|NCT01088399|50608893|FG000|Overall Study|Change to or start of somatropin therapy|234|||
25294279|NCT01088399|50608894|FG001|Overall Study|Change to or start of somatropin therapy|17|||
25294280|NCT01088399|50608895|FG002|Overall Study|Change to or start of somatropin therapy|12|||
25294281|NCT01088399|50608893|FG000|Overall Study|Sponsor decision|1573|||
25294282|NCT01088399|50608894|FG001|Overall Study|Sponsor decision|298|||
25070627|NCT00103285|50176692|FG002|Response Assignment|Adverse Event|3|||
25294283|NCT01088399|50608895|FG002|Overall Study|Sponsor decision|7|||
25294284|NCT01088399|50608893|FG000|Overall Study|Protocol Violation|10|||
25294285|NCT01088399|50608894|FG001|Overall Study|Protocol Violation|1|||
25294286|NCT01088399|50608895|FG002|Overall Study|Protocol Violation|0|||
25294287|NCT01088399|50608893|FG000|Overall Study|Enrollment criteria not met|48|||
25294288|NCT01088399|50608894|FG001|Overall Study|Enrollment criteria not met|119|||
25294289|NCT01088399|50608895|FG002|Overall Study|Enrollment criteria not met|70|||
25294290|NCT01088399|50608893|FG000|Overall Study|Study summary visit not completed|2398|||
25294291|NCT01088399|50608894|FG001|Overall Study|Study summary visit not completed|283|||
25294292|NCT01088399|50608895|FG002|Overall Study|Study summary visit not completed|80|||
25294293|NCT00598078|50608903|FG000|Period 2 (Day 2)|Adverse Event|1|||
25294294|NCT00598078|50608904|FG001|Period 2 (Day 2)|Adverse Event|0|||
25294295|NCT01079195|50608912|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
25294296|NCT01079195|50608912|FG000|Overall Study|No Documentation Available|437|||
25294297|NCT01079195|50608912|FG000|Overall Study|Adverse Event|157|||
25294298|NCT01079195|50608912|FG000|Overall Study|Reason Unknown|39|||
25294299|NCT01079195|50608912|FG000|Overall Study|Withdrawal by Subject|18|||
25294300|NCT01079195|50608912|FG000|Overall Study|Financial Reasons|15|||
25294301|NCT01079195|50608912|FG000|Overall Study|Lack of Effectiveness|12|||
25294302|NCT01079195|50608912|FG000|Overall Study|Physician Decision|4|||
25294303|NCT01079195|50608912|FG000|Overall Study|Improved Status of Participant|4|||
25294304|NCT01079195|50608912|FG000|Overall Study|No Follow-up Documentation Available|4|||
25294305|NCT01079195|50608912|FG000|Overall Study|Non-compliance|2|||
25294306|NCT00883558|50608916|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
25294307|NCT00883558|50608917|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
25294308|NCT00883558|50608918|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
25294309|NCT00883558|50608916|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
25294310|NCT00883558|50608917|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
25294311|NCT00883558|50608918|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
25294312|NCT00883558|50608916|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
25294313|NCT00883558|50608917|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
25294314|NCT00883558|50608918|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
25294315|NCT00883558|50608916|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
25294316|NCT00883558|50608917|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
25294317|NCT00883558|50608918|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
25294318|NCT00883558|50608916|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
25294319|NCT00883558|50608917|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
25294320|NCT00883558|50608918|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
25294321|NCT00880750|50608926|FG000|First Intervention|Adverse Event|1|||
25294322|NCT00880750|50608927|FG001|First Intervention|Adverse Event|0|||
25294323|NCT00880750|50608926|FG000|First Intervention|Unable to collect urine|4|||
25294324|NCT00880750|50608927|FG001|First Intervention|Unable to collect urine|0|||
25294325|NCT00880750|50608926|FG000|First Intervention|Non-compliance with meals|0|||
25294326|NCT00880750|50608927|FG001|First Intervention|Non-compliance with meals|1|||
25294327|NCT00880750|50608926|FG000|First Intervention|Withdrawal by Subject|2|||
25294328|NCT00880750|50608927|FG001|First Intervention|Withdrawal by Subject|0|||
25294329|NCT00880750|50608926|FG000|First Intervention|Lost to Follow-up|2|||
25294330|NCT00880750|50608927|FG001|First Intervention|Lost to Follow-up|0|||
25294331|NCT00880750|50608926|FG000|Second Intervention|Withdrawal by Subject|2|||
25294332|NCT00880750|50608927|FG001|Second Intervention|Withdrawal by Subject|2|||
25294333|NCT00880750|50608926|FG000|Second Intervention|Protocol Violation|1|||
25294334|NCT00880750|50608927|FG001|Second Intervention|Protocol Violation|0|||
25294335|NCT00880750|50608926|FG000|Second Intervention|Unable to collect urine|1|||
25294336|NCT00880750|50608927|FG001|Second Intervention|Unable to collect urine|0|||
25294337|NCT00597766|50608936|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
25294338|NCT00597766|50608937|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
25294339|NCT00597766|50608938|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
25294340|NCT00597766|50608936|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
25294341|NCT00597766|50608937|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
25294342|NCT00597766|50608938|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
25294343|NCT00979992|50608946|FG000|Overall Study|Ineligible - inadequate pathology|1|||
25294344|NCT00979992|50608946|FG000|Overall Study|Ineligible - wrong cell type|2|||
25294345|NCT00979992|50608946|FG000|Overall Study|Refused - Never Treated|2|||
25294346|NCT01079741|50608955|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
25294347|NCT01079741|50608956|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
25294348|NCT01079741|50608957|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
25294349|NCT01079741|50608958|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
25294350|NCT01079741|50608959|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
25294351|NCT01079741|50608955|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
25294352|NCT01079741|50608956|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
25294353|NCT01079741|50608957|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
25294354|NCT01079741|50608958|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
25294355|NCT01079741|50608959|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
24969810|NCT00116844|50059251|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
24969811|NCT00116844|50059250|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
25070628|NCT00103285|50176693|FG003|Response Assignment|Adverse Event|2|||
25169285|NCT01833533|50300804|FG000|Overall Study|Other|2|||
25294356|NCT01079663|50608973|FG000|Overall Study|Adverse Event|0|||
25294357|NCT01079663|50608974|FG001|Overall Study|Adverse Event|2|||
25294358|NCT01079663|50608973|FG000|Overall Study|Protocol Violation|0|||
25294359|NCT01079663|50608974|FG001|Overall Study|Protocol Violation|2|||
25294360|NCT00879814|50608984|FG000|Overall Study|Adverse Event|0|||
25294361|NCT00879814|50608985|FG001|Overall Study|Adverse Event|1|||
25294362|NCT00879814|50608986|FG002|Overall Study|Adverse Event|0|||
25294363|NCT00879814|50608987|FG003|Overall Study|Adverse Event|0|||
25294364|NCT00879814|50608984|FG000|Overall Study|Lost to Follow-up|1|||
25294365|NCT00879814|50608985|FG001|Overall Study|Lost to Follow-up|0|||
25294366|NCT00879814|50608986|FG002|Overall Study|Lost to Follow-up|0|||
25294367|NCT00879814|50608987|FG003|Overall Study|Lost to Follow-up|2|||
25294368|NCT00879814|50608984|FG000|Overall Study|Participant Failed to Return|0|||
25294369|NCT00879814|50608985|FG001|Overall Study|Participant Failed to Return|0|||
25294370|NCT00879814|50608986|FG002|Overall Study|Participant Failed to Return|0|||
25294371|NCT00879814|50608987|FG003|Overall Study|Participant Failed to Return|1|||
25294372|NCT00879814|50608984|FG000|Overall Study|Withdrawal by Subject|3|||
25294373|NCT00879814|50608985|FG001|Overall Study|Withdrawal by Subject|1|||
25294374|NCT00879814|50608986|FG002|Overall Study|Withdrawal by Subject|1|||
25294375|NCT00879814|50608987|FG003|Overall Study|Withdrawal by Subject|2|||
25294376|NCT00879814|50608984|FG000|Overall Study|Physician Decision|0|||
25294377|NCT00879814|50608985|FG001|Overall Study|Physician Decision|0|||
25294378|NCT00879814|50608986|FG002|Overall Study|Physician Decision|1|||
25294379|NCT00879814|50608987|FG003|Overall Study|Physician Decision|0|||
25294380|NCT00879814|50608984|FG000|Overall Study|Other|0|||
25294381|NCT00879814|50608985|FG001|Overall Study|Other|0|||
25294382|NCT00879814|50608986|FG002|Overall Study|Other|1|||
25294383|NCT00879814|50608987|FG003|Overall Study|Other|0|||
25294384|NCT01132664|50609002|FG000|Phase lb|Adverse Event|0|||
25294385|NCT01132664|50609003|FG001|Phase lb|Adverse Event|1|||
25294386|NCT01132664|50609004|FG002|Phase lb|Adverse Event|0|||
25294387|NCT01132664|50609005|FG003|Phase lb|Adverse Event|0|||
25294388|NCT01132664|50609006|FG004|Phase lb|Adverse Event|0|||
25294389|NCT01132664|50609002|FG000|Phase lb|Withdrawal by Subject|1|||
25294390|NCT01132664|50609003|FG001|Phase lb|Withdrawal by Subject|2|||
25294391|NCT01132664|50609004|FG002|Phase lb|Withdrawal by Subject|0|||
25294392|NCT01132664|50609005|FG003|Phase lb|Withdrawal by Subject|0|||
25294393|NCT01132664|50609006|FG004|Phase lb|Withdrawal by Subject|0|||
25294394|NCT01132664|50609002|FG000|Phase lb|Disease Progression|4|||
25294395|NCT01132664|50609003|FG001|Phase lb|Disease Progression|9|||
25294396|NCT01132664|50609004|FG002|Phase lb|Disease Progression|0|||
25294397|NCT01132664|50609005|FG003|Phase lb|Disease Progression|0|||
25294398|NCT01132664|50609006|FG004|Phase lb|Disease Progression|0|||
25294399|NCT01132664|50609002|FG000|Phase ll|Death|0|||
25294400|NCT01132664|50609003|FG001|Phase ll|Death|0|||
25294401|NCT01132664|50609004|FG002|Phase ll|Death|2|||
25294402|NCT01132664|50609005|FG003|Phase ll|Death|0|||
25294403|NCT01132664|50609006|FG004|Phase ll|Death|0|||
25294404|NCT01132664|50609002|FG000|Phase ll|Adverse Event|0|||
25294405|NCT01132664|50609003|FG001|Phase ll|Adverse Event|0|||
25169286|NCT01833533|50300805|FG001|Overall Study|Other|7|||
25169287|NCT01833455|50300813|FG000|Overall Study|Withdrawal by Subject|1|||
25169288|NCT01833455|50300814|FG001|Overall Study|Withdrawal by Subject|0|||
25169289|NCT01833143|50300832|FG000|Overall Study|Not Treated|1|||
25169290|NCT01841567|50300836|FG000|Overall Study|Adverse Event|3|||
25169291|NCT01833065|50300843|FG000|Overall Study|Adverse Event|6|||
25191710|NCT00081497|50352949|FG001|Overall Study|Death|1|||
25191711|NCT00081497|50352948|FG000|Overall Study|Withdrawal by Subject|1|||
25191712|NCT00081497|50352949|FG001|Overall Study|Withdrawal by Subject|0|||
25191713|NCT00081497|50352948|FG000|Overall Study|Non-compliance|0|||
25191714|NCT00081497|50352949|FG001|Overall Study|Non-compliance|1|||
25191715|NCT00081263|50352963|FG000|Overall Study|clerical error|1|||
25191716|NCT00081263|50352964|FG001|Overall Study|clerical error|0|||
25191717|NCT00081263|50352963|FG000|Overall Study|wrong cell type|7|||
25191718|NCT00081263|50352964|FG001|Overall Study|wrong cell type|5|||
25191719|NCT00081263|50352963|FG000|Overall Study|improper pre-protocol therapy|0|||
25169292|NCT01833065|50300844|FG001|Overall Study|Adverse Event|1|||
25169293|NCT01833065|50300845|FG002|Overall Study|Adverse Event|0|||
25169294|NCT01833065|50300846|FG003|Overall Study|Adverse Event|2|||
25169295|NCT01833065|50300847|FG004|Overall Study|Adverse Event|3|||
25191720|NCT00081263|50352964|FG001|Overall Study|improper pre-protocol therapy|1|||
25191721|NCT00081263|50352963|FG000|Overall Study|Inadequate pathology|0|||
25294406|NCT01132664|50609004|FG002|Phase ll|Adverse Event|10|||
25294407|NCT01132664|50609005|FG003|Phase ll|Adverse Event|0|||
25294408|NCT01132664|50609006|FG004|Phase ll|Adverse Event|0|||
25294409|NCT01132664|50609002|FG000|Phase ll|Withdrawal by Subject|0|||
25294410|NCT01132664|50609003|FG001|Phase ll|Withdrawal by Subject|0|||
25294411|NCT01132664|50609004|FG002|Phase ll|Withdrawal by Subject|3|||
25294412|NCT01132664|50609005|FG003|Phase ll|Withdrawal by Subject|0|||
25294413|NCT01132664|50609006|FG004|Phase ll|Withdrawal by Subject|0|||
25294414|NCT01132664|50609002|FG000|Phase ll|Disease progression|0|||
25294415|NCT01132664|50609003|FG001|Phase ll|Disease progression|0|||
25294416|NCT01132664|50609004|FG002|Phase ll|Disease progression|35|||
25294417|NCT01132664|50609005|FG003|Phase ll|Disease progression|0|||
25294418|NCT01132664|50609006|FG004|Phase ll|Disease progression|0|||
25294419|NCT01132664|50609002|FG000|BM Cohort|Disease progression|0|||
25294420|NCT01132664|50609003|FG001|BM Cohort|Disease progression|0|||
25294421|NCT01132664|50609004|FG002|BM Cohort|Disease progression|0|||
25294422|NCT01132664|50609005|FG003|BM Cohort|Disease progression|3|||
25294423|NCT01132664|50609006|FG004|BM Cohort|Disease progression|4|||
25294424|NCT01132664|50609002|FG000|BM Cohort|Adverse Event|0|||
25294425|NCT01132664|50609003|FG001|BM Cohort|Adverse Event|0|||
25294426|NCT01132664|50609004|FG002|BM Cohort|Adverse Event|0|||
25294427|NCT01132664|50609005|FG003|BM Cohort|Adverse Event|0|||
25294428|NCT01132664|50609006|FG004|BM Cohort|Adverse Event|1|||
25294429|NCT01132664|50609002|FG000|BM Cohort|Withdrawal by Subject|0|||
25294430|NCT01132664|50609003|FG001|BM Cohort|Withdrawal by Subject|0|||
25294431|NCT01132664|50609004|FG002|BM Cohort|Withdrawal by Subject|0|||
25294432|NCT01132664|50609005|FG003|BM Cohort|Withdrawal by Subject|0|||
25294433|NCT01132664|50609006|FG004|BM Cohort|Withdrawal by Subject|1|||
25294434|NCT00591409|50609028|FG000|Overall Study|Not Treated|0|||
25294435|NCT00591409|50609029|FG001|Overall Study|Not Treated|0|||
25294436|NCT00591409|50609030|FG002|Overall Study|Not Treated|0|||
25294437|NCT00591409|50609031|FG003|Overall Study|Not Treated|0|||
25294438|NCT00591409|50609032|FG004|Overall Study|Not Treated|1|||
25294439|NCT00591409|50609033|FG005|Overall Study|Not Treated|0|||
25294440|NCT00591409|50609034|FG006|Overall Study|Not Treated|0|||
25294441|NCT00591409|50609035|FG007|Overall Study|Not Treated|0|||
25294442|NCT00591409|50609036|FG008|Overall Study|Not Treated|0|||
25294443|NCT00591409|50609037|FG009|Overall Study|Not Treated|1|||
25294444|NCT01078805|50609059|FG000|Overall Study|Clinically significant abnormal lab|5|||
25294445|NCT01078805|50609059|FG000|Overall Study|Death|134|||
25294446|NCT01078805|50609059|FG000|Overall Study|Lost to Follow-up|676|||
25294447|NCT01078805|50609059|FG000|Overall Study|Physician Decision|169|||
25294448|NCT01078805|50609059|FG000|Overall Study|Serious adverse event|26|||
25294449|NCT01078805|50609059|FG000|Overall Study|Sponsor decision|46|||
25294450|NCT01078805|50609059|FG000|Overall Study|Withdrawal by Subject|739|||
25294451|NCT01078805|50609059|FG000|Overall Study|Other|173|||
25294452|NCT01078805|50609059|FG000|Overall Study|Didn't take study drug|82|||
25294453|NCT00820027|50609067|FG000|Overall Study|Adverse Event|15|||
25294454|NCT00820027|50609068|FG001|Overall Study|Adverse Event|8|||
25294455|NCT00820027|50609069|FG002|Overall Study|Adverse Event|10|||
25294456|NCT00820027|50609070|FG003|Overall Study|Adverse Event|5|||
25294457|NCT00820027|50609067|FG000|Overall Study|Lack of Efficacy|2|||
25294458|NCT00820027|50609068|FG001|Overall Study|Lack of Efficacy|1|||
25294459|NCT00820027|50609069|FG002|Overall Study|Lack of Efficacy|2|||
25294460|NCT00820027|50609070|FG003|Overall Study|Lack of Efficacy|2|||
25294461|NCT00820027|50609067|FG000|Overall Study|Physician Decision|0|||
25294462|NCT00820027|50609068|FG001|Overall Study|Physician Decision|1|||
25294463|NCT00820027|50609069|FG002|Overall Study|Physician Decision|1|||
25294464|NCT00820027|50609070|FG003|Overall Study|Physician Decision|0|||
25294465|NCT00820027|50609067|FG000|Overall Study|Protocol Violation|3|||
25294466|NCT00820027|50609068|FG001|Overall Study|Protocol Violation|0|||
25294467|NCT00820027|50609069|FG002|Overall Study|Protocol Violation|4|||
25294468|NCT00820027|50609070|FG003|Overall Study|Protocol Violation|0|||
25294469|NCT00820027|50609067|FG000|Overall Study|Withdrawal by Subject|6|||
25294470|NCT00820027|50609068|FG001|Overall Study|Withdrawal by Subject|4|||
25294471|NCT00820027|50609069|FG002|Overall Study|Withdrawal by Subject|4|||
25294472|NCT00820027|50609070|FG003|Overall Study|Withdrawal by Subject|6|||
25294473|NCT01076153|50609081|FG000|Overall Study|Symptoms improved/resolved|10|||
25294474|NCT01076153|50609081|FG000|Overall Study|Adverse Event|1|||
25294475|NCT01076075|50609091|FG000|Overall Study|Adverse Event|3|||
25294476|NCT01076075|50609092|FG001|Overall Study|Adverse Event|9|||
25294477|NCT01076075|50609091|FG000|Overall Study|Lack of Efficacy|5|||
25294478|NCT01076075|50609092|FG001|Overall Study|Lack of Efficacy|4|||
25294479|NCT01076075|50609091|FG000|Overall Study|Lost to Follow-up|6|||
25294480|NCT01076075|50609092|FG001|Overall Study|Lost to Follow-up|5|||
25294481|NCT01076075|50609091|FG000|Overall Study|other|19|||
25294482|NCT01076075|50609092|FG001|Overall Study|other|9|||
25294483|NCT01076075|50609091|FG000|Overall Study|Protocol Violation|0|||
25294484|NCT01076075|50609092|FG001|Overall Study|Protocol Violation|1|||
25294485|NCT01076075|50609091|FG000|Overall Study|Withdrawal by Subject|8|||
25294486|NCT01076075|50609092|FG001|Overall Study|Withdrawal by Subject|19|||
25294487|NCT01075763|50609103|FG000|Overall Study|Lost to Follow-up|2|||
25294488|NCT01075763|50609104|FG001|Overall Study|Lost to Follow-up|1|||
25294489|NCT01075763|50609103|FG000|Overall Study|Lack of Efficacy|0|||
25294490|NCT01075763|50609104|FG001|Overall Study|Lack of Efficacy|1|||
25294491|NCT01075763|50609103|FG000|Overall Study|Withdrawal by Subject|2|||
25294492|NCT01075763|50609104|FG001|Overall Study|Withdrawal by Subject|2|||
25294493|NCT00881530|50609116|FG000|Overall Study|Adverse Event|5|||
25294494|NCT00881530|50609117|FG001|Overall Study|Adverse Event|1|||
25294495|NCT00881530|50609118|FG002|Overall Study|Adverse Event|1|||
25294496|NCT00881530|50609119|FG003|Overall Study|Adverse Event|4|||
25294497|NCT00881530|50609120|FG004|Overall Study|Adverse Event|10|||
25294498|NCT00881530|50609121|FG005|Overall Study|Adverse Event|2|||
25294499|NCT00881530|50609116|FG000|Overall Study|Lack of Efficacy|1|||
25294500|NCT00881530|50609117|FG001|Overall Study|Lack of Efficacy|0|||
25294501|NCT00881530|50609118|FG002|Overall Study|Lack of Efficacy|0|||
25294502|NCT00881530|50609119|FG003|Overall Study|Lack of Efficacy|0|||
25294503|NCT00881530|50609120|FG004|Overall Study|Lack of Efficacy|1|||
25294504|NCT00881530|50609121|FG005|Overall Study|Lack of Efficacy|1|||
25294505|NCT00881530|50609116|FG000|Overall Study|Not compliant with the protocol|0|||
25294506|NCT00881530|50609117|FG001|Overall Study|Not compliant with the protocol|0|||
25294507|NCT00881530|50609118|FG002|Overall Study|Not compliant with the protocol|0|||
25294508|NCT00881530|50609119|FG003|Overall Study|Not compliant with the protocol|0|||
25294509|NCT00881530|50609120|FG004|Overall Study|Not compliant with the protocol|2|||
25294510|NCT00881530|50609121|FG005|Overall Study|Not compliant with the protocol|0|||
25294511|NCT00881530|50609116|FG000|Overall Study|Lost to Follow-up|0|||
25294512|NCT00881530|50609117|FG001|Overall Study|Lost to Follow-up|1|||
25294513|NCT00881530|50609118|FG002|Overall Study|Lost to Follow-up|1|||
25294514|NCT00881530|50609119|FG003|Overall Study|Lost to Follow-up|3|||
25294515|NCT00881530|50609120|FG004|Overall Study|Lost to Follow-up|1|||
25294516|NCT00881530|50609121|FG005|Overall Study|Lost to Follow-up|0|||
25294517|NCT00881530|50609116|FG000|Overall Study|Refused to continue medication|7|||
25294518|NCT00881530|50609117|FG001|Overall Study|Refused to continue medication|2|||
25294519|NCT00881530|50609118|FG002|Overall Study|Refused to continue medication|1|||
25294520|NCT00881530|50609119|FG003|Overall Study|Refused to continue medication|2|||
25294521|NCT00881530|50609120|FG004|Overall Study|Refused to continue medication|0|||
25294522|NCT00881530|50609121|FG005|Overall Study|Refused to continue medication|0|||
25294523|NCT00881530|50609116|FG000|Overall Study|Other reason not defined above|1|||
25294524|NCT00881530|50609117|FG001|Overall Study|Other reason not defined above|1|||
25294525|NCT00881530|50609118|FG002|Overall Study|Other reason not defined above|2|||
25294526|NCT00881530|50609119|FG003|Overall Study|Other reason not defined above|0|||
25294527|NCT00881530|50609120|FG004|Overall Study|Other reason not defined above|0|||
25294528|NCT00881530|50609121|FG005|Overall Study|Other reason not defined above|2|||
25294529|NCT01075685|50609137|FG000|Overall Study|Protocol Violation|9|||
25294530|NCT01075685|50609138|FG001|Overall Study|Protocol Violation|1|||
25294531|NCT01075685|50609137|FG000|Overall Study|Withdrawal by Subject|20|||
25294532|NCT01075685|50609138|FG001|Overall Study|Withdrawal by Subject|5|||
25294533|NCT01075685|50609137|FG000|Overall Study|Lost to Follow-up|563|||
25294534|NCT01075685|50609138|FG001|Overall Study|Lost to Follow-up|220|||
25294535|NCT01075217|50609146|FG000|Overall Study|Adverse Event|1|||
25294536|NCT01075217|50609147|FG001|Overall Study|Adverse Event|1|||
25294537|NCT01075217|50609146|FG000|Overall Study|Physician Decision|1|||
25294538|NCT01075217|50609147|FG001|Overall Study|Physician Decision|0|||
25294539|NCT01078571|50609161|FG000|Overall Study|Adverse Event|36|||
25294540|NCT01078571|50609161|FG000|Overall Study|Lack of effectiveness|36|||
25294541|NCT01078571|50609161|FG000|Overall Study|Reason not reported|21|||
25294542|NCT01078571|50609161|FG000|Overall Study|Withdrawal by Subject|12|||
25294543|NCT01078571|50609161|FG000|Overall Study|Lost to Follow-up|8|||
25294544|NCT01078571|50609161|FG000|Overall Study|Protocol Violation|2|||
25294545|NCT00977106|50609172|FG000|Overall Study|Adverse Event|5|||
25294546|NCT00977106|50609173|FG001|Overall Study|Adverse Event|6|||
25294547|NCT00977106|50609172|FG000|Overall Study|Withdrawal by Subject|2|||
25294548|NCT00977106|50609173|FG001|Overall Study|Withdrawal by Subject|2|||
25294549|NCT00977106|50609172|FG000|Overall Study|Lack of Efficacy|2|||
25294550|NCT00977106|50609173|FG001|Overall Study|Lack of Efficacy|2|||
25294551|NCT00977106|50609172|FG000|Overall Study|Protocol Violation|0|||
25294552|NCT00977106|50609173|FG001|Overall Study|Protocol Violation|1|||
25294553|NCT00977106|50609172|FG000|Overall Study|Other|1|||
25294554|NCT00977106|50609173|FG001|Overall Study|Other|0|||
25294555|NCT01077713|50609183|FG000|Overall Study|Withdrawal by Subject|1|||
25294556|NCT01077713|50609184|FG001|Overall Study|Withdrawal by Subject|2|||
25294557|NCT01077713|50609183|FG000|Overall Study|Progressive Disease (PD)|0|||
25294558|NCT01077713|50609184|FG001|Overall Study|Progressive Disease (PD)|1|||
25294559|NCT01077713|50609183|FG000|Overall Study|Death|28|||
25294560|NCT01077713|50609184|FG001|Overall Study|Death|29|||
25294561|NCT01077713|50609183|FG000|Overall Study|Lost to Follow-up|1|||
25294562|NCT01077713|50609184|FG001|Overall Study|Lost to Follow-up|1|||
25294563|NCT01077713|50609183|FG000|Overall Study|Adverse Event|2|||
25294564|NCT01077713|50609184|FG001|Overall Study|Adverse Event|1|||
25294565|NCT01077713|50609183|FG000|Overall Study|Other|4|||
25294566|NCT01077713|50609184|FG001|Overall Study|Other|2|||
25294567|NCT00813709|50609193|FG000|Double Blind Period|Adverse Event|4|||
25294568|NCT00813709|50609194|FG001|Double Blind Period|Adverse Event|1|||
25294569|NCT00813709|50609195|FG002|Double Blind Period|Adverse Event|4|||
25294570|NCT00813709|50609196|FG003|Double Blind Period|Adverse Event|0|||
25294571|NCT00813709|50609197|FG004|Double Blind Period|Adverse Event|0|||
25294572|NCT00813709|50609198|FG005|Double Blind Period|Adverse Event|0|||
25294573|NCT00813709|50609193|FG000|Double Blind Period|Lost to Follow-up|3|||
25294574|NCT00813709|50609194|FG001|Double Blind Period|Lost to Follow-up|2|||
25294575|NCT00813709|50609195|FG002|Double Blind Period|Lost to Follow-up|2|||
25294576|NCT00813709|50609196|FG003|Double Blind Period|Lost to Follow-up|0|||
25294577|NCT00813709|50609197|FG004|Double Blind Period|Lost to Follow-up|0|||
25294578|NCT00813709|50609198|FG005|Double Blind Period|Lost to Follow-up|0|||
25294579|NCT00813709|50609193|FG000|Double Blind Period|Switched to open label phase|9|||
25294580|NCT00813709|50609194|FG001|Double Blind Period|Switched to open label phase|26|||
25294581|NCT00813709|50609195|FG002|Double Blind Period|Switched to open label phase|18|||
25294582|NCT00813709|50609196|FG003|Double Blind Period|Switched to open label phase|0|||
25294583|NCT00813709|50609197|FG004|Double Blind Period|Switched to open label phase|0|||
25294584|NCT00813709|50609198|FG005|Double Blind Period|Switched to open label phase|0|||
25294585|NCT00813709|50609193|FG000|Double Blind Period|Randomized but not treated|1|||
25294586|NCT00813709|50609194|FG001|Double Blind Period|Randomized but not treated|3|||
25294587|NCT00813709|50609195|FG002|Double Blind Period|Randomized but not treated|1|||
25294588|NCT00813709|50609196|FG003|Double Blind Period|Randomized but not treated|0|||
25294589|NCT00813709|50609197|FG004|Double Blind Period|Randomized but not treated|0|||
25294590|NCT00813709|50609198|FG005|Double Blind Period|Randomized but not treated|0|||
25294591|NCT00813709|50609193|FG000|Double Blind Period|Other|14|||
25294592|NCT00813709|50609194|FG001|Double Blind Period|Other|9|||
25070629|NCT00103285|50176694|FG004|Response Assignment|Adverse Event|3|||
25070630|NCT00103285|50176695|FG005|Response Assignment|Adverse Event|1|||
25070631|NCT00103285|50176696|FG006|Response Assignment|Adverse Event|1|||
25070632|NCT00103285|50176697|FG007|Response Assignment|Adverse Event|2|||
25070633|NCT00103285|50176690|FG000|Response Assignment|Death|0|||
25070634|NCT00103285|50176691|FG001|Response Assignment|Death|5|||
25294593|NCT00813709|50609195|FG002|Double Blind Period|Other|6|||
25294594|NCT00813709|50609196|FG003|Double Blind Period|Other|0|||
25294595|NCT00813709|50609197|FG004|Double Blind Period|Other|0|||
25294596|NCT00813709|50609198|FG005|Double Blind Period|Other|0|||
25294597|NCT00813709|50609193|FG000|Open Label Period|Adverse Event|0|||
25294598|NCT00813709|50609194|FG001|Open Label Period|Adverse Event|0|||
25294599|NCT00813709|50609195|FG002|Open Label Period|Adverse Event|0|||
25294600|NCT00813709|50609196|FG003|Open Label Period|Adverse Event|5|||
25294601|NCT00813709|50609197|FG004|Open Label Period|Adverse Event|4|||
25070635|NCT00103285|50176692|FG002|Response Assignment|Death|2|||
25070636|NCT00103285|50176693|FG003|Response Assignment|Death|2|||
25294602|NCT00813709|50609198|FG005|Open Label Period|Adverse Event|3|||
25070637|NCT00103285|50176694|FG004|Response Assignment|Death|3|||
25070638|NCT00103285|50176695|FG005|Response Assignment|Death|1|||
25294603|NCT00813709|50609193|FG000|Open Label Period|Lack of Efficacy|0|||
25294604|NCT00813709|50609194|FG001|Open Label Period|Lack of Efficacy|0|||
25294605|NCT00813709|50609195|FG002|Open Label Period|Lack of Efficacy|0|||
25294606|NCT00813709|50609196|FG003|Open Label Period|Lack of Efficacy|3|||
25294607|NCT00813709|50609197|FG004|Open Label Period|Lack of Efficacy|1|||
25294608|NCT00813709|50609198|FG005|Open Label Period|Lack of Efficacy|1|||
25294609|NCT00813709|50609193|FG000|Open Label Period|Randomized but not treated|0|||
25294610|NCT00813709|50609194|FG001|Open Label Period|Randomized but not treated|0|||
25294611|NCT00813709|50609195|FG002|Open Label Period|Randomized but not treated|0|||
25294612|NCT00813709|50609196|FG003|Open Label Period|Randomized but not treated|1|||
25294613|NCT00813709|50609197|FG004|Open Label Period|Randomized but not treated|0|||
25294614|NCT00813709|50609198|FG005|Open Label Period|Randomized but not treated|1|||
25294615|NCT00813709|50609193|FG000|Open Label Period|Other|0|||
25294616|NCT00813709|50609194|FG001|Open Label Period|Other|0|||
25294617|NCT00813709|50609195|FG002|Open Label Period|Other|0|||
25294618|NCT00813709|50609196|FG003|Open Label Period|Other|11|||
25294619|NCT00813709|50609197|FG004|Open Label Period|Other|5|||
25294620|NCT00813709|50609198|FG005|Open Label Period|Other|6|||
25294621|NCT01077323|50609230|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
25294622|NCT01077323|50609231|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
25294623|NCT01077323|50609232|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
25294624|NCT01077323|50609230|FG000|Overall Study|Dispensing of drug in baseline period|0|||
25294625|NCT01077323|50609231|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
25294626|NCT01077323|50609232|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
25294627|NCT01077323|50609230|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
25294628|NCT01077323|50609231|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
25294629|NCT01077323|50609232|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
25294630|NCT00976950|50609240|FG000|Overall Study|Adverse Event|3|||
25294631|NCT00976950|50609240|FG000|Overall Study|Events with no relationship to Aptivus|3|||
25294632|NCT00976716|50609244|FG000|Overall Study|Adverse Event|1|||
25294633|NCT00819247|50609252|FG000|Overall Study|Adverse Event|0|||
25294634|NCT00819247|50609253|FG001|Overall Study|Adverse Event|5|||
25294635|NCT00819247|50609254|FG002|Overall Study|Adverse Event|3|||
25294636|NCT00819247|50609252|FG000|Overall Study|Insufficient testosterone response|5|||
25294637|NCT00819247|50609253|FG001|Overall Study|Insufficient testosterone response|8|||
25294638|NCT00819247|50609254|FG002|Overall Study|Insufficient testosterone response|10|||
25294639|NCT00819247|50609252|FG000|Overall Study|Withdrawal by Subject|1|||
25294640|NCT00819247|50609253|FG001|Overall Study|Withdrawal by Subject|0|||
25294641|NCT00819247|50609254|FG002|Overall Study|Withdrawal by Subject|0|||
25294642|NCT00819247|50609252|FG000|Overall Study|Protocol Violation|1|||
25294643|NCT00819247|50609253|FG001|Overall Study|Protocol Violation|0|||
25294644|NCT00819247|50609254|FG002|Overall Study|Protocol Violation|1|||
25294645|NCT00819247|50609252|FG000|Overall Study|Mistakenly withdrawn|0|||
25294646|NCT00819247|50609253|FG001|Overall Study|Mistakenly withdrawn|1|||
25294647|NCT00819247|50609254|FG002|Overall Study|Mistakenly withdrawn|0|||
25294648|NCT00819247|50609252|FG000|Overall Study|Bad prostate-specific antigen response|3|||
25294649|NCT00819247|50609253|FG001|Overall Study|Bad prostate-specific antigen response|2|||
25294650|NCT00819247|50609254|FG002|Overall Study|Bad prostate-specific antigen response|0|||
25294651|NCT00819247|50609252|FG000|Overall Study|Other|1|||
25294652|NCT00819247|50609253|FG001|Overall Study|Other|0|||
25294653|NCT00819247|50609254|FG002|Overall Study|Other|0|||
25294654|NCT00973674|50609264|FG000|Overall Study|Protocol Violation|2|||
25294655|NCT00973674|50609265|FG001|Overall Study|Protocol Violation|0|||
25294656|NCT00819091|50609274|FG000|Overall Study|Adverse Event|3|||
25294657|NCT00819091|50609275|FG001|Overall Study|Adverse Event|5|||
25294658|NCT00819091|50609274|FG000|Overall Study|Protocol Violation|0|||
25294659|NCT00819091|50609275|FG001|Overall Study|Protocol Violation|1|||
25294660|NCT00819091|50609274|FG000|Overall Study|Lost to Follow-up|2|||
25294661|NCT00819091|50609275|FG001|Overall Study|Lost to Follow-up|0|||
25294662|NCT00819091|50609274|FG000|Overall Study|Withdrawal by Subject|1|||
25294663|NCT00819091|50609275|FG001|Overall Study|Withdrawal by Subject|2|||
25294664|NCT00819091|50609274|FG000|Overall Study|Other|1|||
25294665|NCT00819091|50609275|FG001|Overall Study|Other|2|||
25294666|NCT00973362|50609283|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
25294667|NCT00973362|50609284|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
25294668|NCT00973362|50609283|FG000|Baseline Evaluation|No colposcopy visit|62|||
25294669|NCT00973362|50609284|FG001|Baseline Evaluation|No colposcopy visit|0|||
25294670|NCT00973362|50609283|FG000|Baseline Evaluation|Inevaluable|686|||
25294671|NCT00973362|50609284|FG001|Baseline Evaluation|Inevaluable|223|||
25294672|NCT00973362|50609283|FG000|3-Year Follow-up|Lost to Follow-up|17|||
25294673|NCT00973362|50609284|FG001|3-Year Follow-up|Lost to Follow-up|0|||
25294674|NCT00819013|50609297|FG000|Overall Study|Not meeting continuing study eligibility|2|||
25294675|NCT00819013|50609298|FG001|Overall Study|Not meeting continuing study eligibility|1|||
25294676|NCT00819013|50609299|FG002|Overall Study|Not meeting continuing study eligibility|2|||
25294677|NCT00819013|50609300|FG003|Overall Study|Not meeting continuing study eligibility|1|||
25294678|NCT00819013|50609297|FG000|Overall Study|Adverse Event|0|||
25294679|NCT00819013|50609298|FG001|Overall Study|Adverse Event|0|||
25294680|NCT00819013|50609299|FG002|Overall Study|Adverse Event|1|||
25294681|NCT00819013|50609300|FG003|Overall Study|Adverse Event|0|||
25294682|NCT00819013|50609297|FG000|Overall Study|Withdrawal by Subject|1|||
25294683|NCT00819013|50609298|FG001|Overall Study|Withdrawal by Subject|0|||
25294684|NCT00819013|50609299|FG002|Overall Study|Withdrawal by Subject|1|||
25294685|NCT00819013|50609300|FG003|Overall Study|Withdrawal by Subject|0|||
25294686|NCT00819013|50609297|FG000|Overall Study|Lost to Follow-up|0|||
25294687|NCT00819013|50609298|FG001|Overall Study|Lost to Follow-up|0|||
25294688|NCT00819013|50609299|FG002|Overall Study|Lost to Follow-up|1|||
25294689|NCT00819013|50609300|FG003|Overall Study|Lost to Follow-up|2|||
25294690|NCT00819013|50609297|FG000|Overall Study|Death|0|||
25294691|NCT00819013|50609298|FG001|Overall Study|Death|0|||
25294692|NCT00819013|50609299|FG002|Overall Study|Death|0|||
25294693|NCT00819013|50609300|FG003|Overall Study|Death|1|||
25294694|NCT00976560|50609312|FG000|Overall Study|Adverse Event|5|||
25294695|NCT00976560|50609313|FG001|Overall Study|Adverse Event|5|||
25294696|NCT00976560|50609312|FG000|Overall Study|Lack of Efficacy|3|||
25294697|NCT00976560|50609313|FG001|Overall Study|Lack of Efficacy|5|||
25294698|NCT00976560|50609312|FG000|Overall Study|Protocol Violation|1|||
25294699|NCT00976560|50609313|FG001|Overall Study|Protocol Violation|0|||
25294700|NCT00976560|50609312|FG000|Overall Study|Lost to Follow-up|1|||
25294701|NCT00976560|50609313|FG001|Overall Study|Lost to Follow-up|0|||
25294702|NCT00976560|50609312|FG000|Overall Study|Physician Decision|2|||
25294703|NCT00976560|50609313|FG001|Overall Study|Physician Decision|0|||
25294704|NCT00976560|50609312|FG000|Overall Study|Withdrawal by Subject|2|||
25294705|NCT00976560|50609313|FG001|Overall Study|Withdrawal by Subject|3|||
25294706|NCT00976482|50609319|FG000|Overall Study|Death|208|||
25294707|NCT00976482|50609319|FG000|Overall Study|Withdrawal by Subject|45|||
25294708|NCT00976482|50609319|FG000|Overall Study|Center terminated|1|||
25294709|NCT00976482|50609319|FG000|Overall Study|Protocol Violation|5|||
25294710|NCT00975156|50609325|FG000|Overall Study|Protocol Violation|0|||
25294711|NCT00975156|50609326|FG001|Overall Study|Protocol Violation|1|||
25294712|NCT00810043|50609338|FG000|Overall Study|Withdrawal by Subject|1|||
25294713|NCT00810043|50609339|FG001|Overall Study|Withdrawal by Subject|0|||
25294714|NCT00810043|50609340|FG002|Overall Study|Withdrawal by Subject|2|||
25294715|NCT00810043|50609338|FG000|Overall Study|Lost to Follow-up|1|||
25294716|NCT00810043|50609339|FG001|Overall Study|Lost to Follow-up|0|||
25294717|NCT00810043|50609340|FG002|Overall Study|Lost to Follow-up|0|||
25294718|NCT00810043|50609338|FG000|Overall Study|Physician Decision|0|||
25294719|NCT00810043|50609339|FG001|Overall Study|Physician Decision|0|||
25294720|NCT00810043|50609340|FG002|Overall Study|Physician Decision|2|||
25294721|NCT00810043|50609338|FG000|Overall Study|Death|2|||
25294722|NCT00810043|50609339|FG001|Overall Study|Death|0|||
25294723|NCT00810043|50609340|FG002|Overall Study|Death|0|||
25294724|NCT00810043|50609338|FG000|Overall Study|Unrelated medical problem|0|||
25294725|NCT00810043|50609339|FG001|Overall Study|Unrelated medical problem|1|||
25294726|NCT00810043|50609340|FG002|Overall Study|Unrelated medical problem|0|||
25294727|NCT00810043|50609338|FG000|Overall Study|Non-medical problem|0|||
25294728|NCT00810043|50609339|FG001|Overall Study|Non-medical problem|0|||
25294729|NCT00810043|50609340|FG002|Overall Study|Non-medical problem|1|||
25294730|NCT00810043|50609338|FG000|Overall Study|No longer met enrollment criteria|0|||
25294731|NCT00810043|50609339|FG001|Overall Study|No longer met enrollment criteria|0|||
25294732|NCT00810043|50609340|FG002|Overall Study|No longer met enrollment criteria|3|||
25294733|NCT01120184|50609352|FG000|Overall Study|Adverse Event|0|||
25294734|NCT01120184|50609353|FG001|Overall Study|Adverse Event|1|||
25294735|NCT01120184|50609354|FG002|Overall Study|Adverse Event|0|||
25294736|NCT01120184|50609352|FG000|Overall Study|Lost to Follow-up|13|||
25294737|NCT01120184|50609353|FG001|Overall Study|Lost to Follow-up|13|||
25294738|NCT01120184|50609354|FG002|Overall Study|Lost to Follow-up|11|||
25070639|NCT00103285|50176696|FG006|Response Assignment|Death|0|||
25294739|NCT01120184|50609352|FG000|Overall Study|Physician Decision|9|||
25294740|NCT01120184|50609353|FG001|Overall Study|Physician Decision|1|||
25294741|NCT01120184|50609354|FG002|Overall Study|Physician Decision|3|||
25294742|NCT01120184|50609352|FG000|Overall Study|Reason not Specified|8|||
25294743|NCT01120184|50609353|FG001|Overall Study|Reason not Specified|3|||
25294744|NCT01120184|50609354|FG002|Overall Study|Reason not Specified|12|||
25294745|NCT01120184|50609352|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
25294746|NCT01120184|50609353|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
25294747|NCT01120184|50609354|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
25294748|NCT01120184|50609352|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
25294749|NCT01120184|50609353|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
25294750|NCT01120184|50609354|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
25294751|NCT01120184|50609352|FG000|Overall Study|Death|170|||
25294752|NCT01120184|50609353|FG001|Overall Study|Death|176|||
25294753|NCT01120184|50609354|FG002|Overall Study|Death|169|||
25294754|NCT01120028|50609366|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
25294755|NCT01120028|50609367|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
25294756|NCT01120028|50609368|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
25294757|NCT01120028|50609369|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
25294758|NCT01120028|50609366|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
25294759|NCT01120028|50609367|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
25294760|NCT01120028|50609368|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
25294761|NCT01120028|50609369|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
25294762|NCT00878800|50609385|FG000|Overall Study|Adverse Event|0|||
25294763|NCT00878800|50609386|FG001|Overall Study|Adverse Event|0|||
25294764|NCT00878800|50609387|FG002|Overall Study|Adverse Event|2|||
25294765|NCT00878800|50609388|FG003|Overall Study|Adverse Event|0|||
25294766|NCT00878800|50609389|FG004|Overall Study|Adverse Event|1|||
25294767|NCT00878800|50609385|FG000|Overall Study|Progressive disease|1|||
25294768|NCT00878800|50609386|FG001|Overall Study|Progressive disease|5|||
25294769|NCT00878800|50609387|FG002|Overall Study|Progressive disease|6|||
25294770|NCT00878800|50609388|FG003|Overall Study|Progressive disease|5|||
25294771|NCT00878800|50609389|FG004|Overall Study|Progressive disease|13|||
25294772|NCT00878800|50609385|FG000|Overall Study|Withdrew consent|1|||
25294773|NCT00878800|50609386|FG001|Overall Study|Withdrew consent|1|||
25294774|NCT00878800|50609387|FG002|Overall Study|Withdrew consent|0|||
25294775|NCT00878800|50609388|FG003|Overall Study|Withdrew consent|1|||
25294776|NCT00878800|50609389|FG004|Overall Study|Withdrew consent|1|||
25294777|NCT00878800|50609385|FG000|Overall Study|Death|0|||
25294778|NCT00878800|50609386|FG001|Overall Study|Death|0|||
25294779|NCT00878800|50609387|FG002|Overall Study|Death|1|||
25294780|NCT00878800|50609388|FG003|Overall Study|Death|0|||
25294781|NCT00878800|50609389|FG004|Overall Study|Death|0|||
25294782|NCT00878800|50609385|FG000|Overall Study|Other|1|||
25294783|NCT00878800|50609386|FG001|Overall Study|Other|1|||
25294784|NCT00878800|50609387|FG002|Overall Study|Other|0|||
25294785|NCT00878800|50609388|FG003|Overall Study|Other|0|||
25294786|NCT00878800|50609389|FG004|Overall Study|Other|1|||
25294787|NCT01119950|50609400|FG000|Overall Study|Adverse Event|25|||
25294788|NCT01119950|50609400|FG000|Overall Study|Withdrawal by Subject|9|||
25294789|NCT01119950|50609400|FG000|Overall Study|Protocol Violation|5|||
25294790|NCT01119950|50609400|FG000|Overall Study|Lost to Follow-up|4|||
25294791|NCT01119950|50609400|FG000|Overall Study|Administrative|2|||
25294792|NCT01119950|50609400|FG000|Overall Study|Abnormal lab value|1|||
25294793|NCT01119950|50609400|FG000|Overall Study|Death|1|||
25294794|NCT01145222|50609430|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
25294795|NCT01145222|50609431|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
25294796|NCT01145222|50609432|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
25294797|NCT01145222|50609433|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
25294798|NCT01145222|50609430|FG000|Overall Study|Poor bowel preparation|0|||
25294799|NCT01145222|50609431|FG001|Overall Study|Poor bowel preparation|0|||
25294800|NCT01145222|50609432|FG002|Overall Study|Poor bowel preparation|0|||
25294801|NCT01145222|50609433|FG003|Overall Study|Poor bowel preparation|1|||
25294802|NCT01145066|50609446|FG000|Overall Study|To resume NSAIDs|2|||
25294803|NCT01145066|50609447|FG001|Overall Study|To resume NSAIDs|2|||
25294804|NCT01145066|50609448|FG002|Overall Study|To resume NSAIDs|1|||
25294805|NCT01145066|50609446|FG000|Overall Study|Non-related surgery|0|||
25294806|NCT01145066|50609447|FG001|Overall Study|Non-related surgery|0|||
25294807|NCT01145066|50609448|FG002|Overall Study|Non-related surgery|1|||
25294808|NCT01145066|50609446|FG000|Overall Study|Withdrawal by Subject|0|||
25294809|NCT01145066|50609447|FG001|Overall Study|Withdrawal by Subject|0|||
25294810|NCT01145066|50609448|FG002|Overall Study|Withdrawal by Subject|2|||
25294811|NCT01145066|50609446|FG000|Overall Study|To start new med|1|||
25294812|NCT01145066|50609447|FG001|Overall Study|To start new med|0|||
25294813|NCT01145066|50609448|FG002|Overall Study|To start new med|0|||
25294814|NCT01145066|50609446|FG000|Overall Study|problems swallowing capsule|1|||
25294815|NCT01145066|50609447|FG001|Overall Study|problems swallowing capsule|0|||
25294816|NCT01145066|50609448|FG002|Overall Study|problems swallowing capsule|0|||
25294817|NCT01145066|50609446|FG000|Overall Study|Abdominal discomfort|0|||
25294818|NCT01145066|50609447|FG001|Overall Study|Abdominal discomfort|1|||
25294819|NCT01145066|50609448|FG002|Overall Study|Abdominal discomfort|0|||
25294820|NCT01145066|50609446|FG000|Overall Study|Low platelet count|0|||
25294821|NCT01145066|50609447|FG001|Overall Study|Low platelet count|1|||
25294822|NCT01145066|50609448|FG002|Overall Study|Low platelet count|0|||
25294823|NCT01132118|50609458|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
25294824|NCT01132118|50609459|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
25294825|NCT01132118|50609458|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
25294826|NCT01132118|50609459|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
25294827|NCT01132118|50609458|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
25294828|NCT01132118|50609459|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
25294829|NCT00972816|50609473|FG000|Overall Study|Adverse Event|0|||
25294830|NCT00972816|50609474|FG001|Overall Study|Adverse Event|0|||
25294831|NCT00972816|50609475|FG002|Overall Study|Adverse Event|1|||
25294832|NCT00972816|50609476|FG003|Overall Study|Adverse Event|0|||
25294833|NCT00972816|50609477|FG004|Overall Study|Adverse Event|0|||
25294834|NCT00972816|50609478|FG005|Overall Study|Adverse Event|0|||
25294835|NCT00972816|50609479|FG006|Overall Study|Adverse Event|0|||
25294836|NCT00972816|50609480|FG007|Overall Study|Adverse Event|0|||
25294837|NCT00972816|50609473|FG000|Overall Study|Withdrawal by Subject|4|||
25294838|NCT00972816|50609474|FG001|Overall Study|Withdrawal by Subject|2|||
25294839|NCT00972816|50609475|FG002|Overall Study|Withdrawal by Subject|1|||
25294840|NCT00972816|50609476|FG003|Overall Study|Withdrawal by Subject|3|||
25294841|NCT00972816|50609477|FG004|Overall Study|Withdrawal by Subject|0|||
25294842|NCT00972816|50609478|FG005|Overall Study|Withdrawal by Subject|1|||
25294843|NCT00972816|50609479|FG006|Overall Study|Withdrawal by Subject|1|||
25294844|NCT00972816|50609480|FG007|Overall Study|Withdrawal by Subject|2|||
25294845|NCT00972816|50609473|FG000|Overall Study|Lost to Follow-up|11|||
25294846|NCT00972816|50609474|FG001|Overall Study|Lost to Follow-up|9|||
25294847|NCT00972816|50609475|FG002|Overall Study|Lost to Follow-up|7|||
25294848|NCT00972816|50609476|FG003|Overall Study|Lost to Follow-up|5|||
25294849|NCT00972816|50609477|FG004|Overall Study|Lost to Follow-up|11|||
25294850|NCT00972816|50609478|FG005|Overall Study|Lost to Follow-up|10|||
25294851|NCT00972816|50609479|FG006|Overall Study|Lost to Follow-up|7|||
25294852|NCT00972816|50609480|FG007|Overall Study|Lost to Follow-up|7|||
25294853|NCT00972816|50609473|FG000|Overall Study|Inappropriate enrolment|0|||
25294854|NCT00972816|50609474|FG001|Overall Study|Inappropriate enrolment|0|||
25294855|NCT00972816|50609475|FG002|Overall Study|Inappropriate enrolment|0|||
25294856|NCT00972816|50609476|FG003|Overall Study|Inappropriate enrolment|0|||
25294857|NCT00972816|50609477|FG004|Overall Study|Inappropriate enrolment|0|||
25294858|NCT00972816|50609478|FG005|Overall Study|Inappropriate enrolment|0|||
25294859|NCT00972816|50609479|FG006|Overall Study|Inappropriate enrolment|2|||
25294860|NCT00972816|50609480|FG007|Overall Study|Inappropriate enrolment|0|||
25294861|NCT00972816|50609473|FG000|Overall Study|Unable to classify|2|||
25294862|NCT00972816|50609474|FG001|Overall Study|Unable to classify|0|||
25294863|NCT00972816|50609475|FG002|Overall Study|Unable to classify|0|||
25294864|NCT00972816|50609476|FG003|Overall Study|Unable to classify|0|||
25294865|NCT00972816|50609477|FG004|Overall Study|Unable to classify|1|||
25294866|NCT00972816|50609478|FG005|Overall Study|Unable to classify|0|||
25294867|NCT00972816|50609479|FG006|Overall Study|Unable to classify|0|||
25294868|NCT00972816|50609480|FG007|Overall Study|Unable to classify|0|||
25294869|NCT00969618|50609498|FG000|Overall Study|Adverse Event|29|||
25294870|NCT00969618|50609498|FG000|Overall Study|Entry Criteria Not Met|3|||
25294871|NCT00969618|50609498|FG000|Overall Study|Lack of Efficacy|2|||
25294872|NCT00969618|50609498|FG000|Overall Study|Lost to Follow-up|7|||
25294873|NCT00969618|50609498|FG000|Overall Study|Physician Decision|1|||
25294874|NCT00969618|50609498|FG000|Overall Study|Protocol Violation|9|||
25294875|NCT00969618|50609498|FG000|Overall Study|Withdrawal by Subject|27|||
25294876|NCT00969540|50609504|FG000|Overall Study|Lost to Follow-up|1|||
25294877|NCT00969540|50609505|FG001|Overall Study|Lost to Follow-up|1|||
25294878|NCT00975000|50609525|FG000|Overall Study|Other|1|||
25294879|NCT00975000|50609526|FG001|Overall Study|Other|0|||
25294880|NCT00975000|50609525|FG000|Overall Study|Adverse Event|1|||
25294881|NCT00975000|50609526|FG001|Overall Study|Adverse Event|1|||
25294882|NCT00975000|50609525|FG000|Overall Study|Withdrawal by Subject|2|||
25294883|NCT00975000|50609526|FG001|Overall Study|Withdrawal by Subject|2|||
25294884|NCT00975000|50609525|FG000|Overall Study|Lost to Follow-up|0|||
25294885|NCT00975000|50609526|FG001|Overall Study|Lost to Follow-up|1|||
25294886|NCT00975000|50609525|FG000|Overall Study|Protocol-specified Criteria|1|||
25294887|NCT00975000|50609526|FG001|Overall Study|Protocol-specified Criteria|0|||
25294888|NCT00975000|50609525|FG000|Overall Study|Non-compliance|0|||
25294889|NCT00975000|50609526|FG001|Overall Study|Non-compliance|1|||
25294890|NCT00974922|50609532|FG000|Overall Study|study terminated|24|||
25294891|NCT00972504|50609536|FG000|Overall Study|Adverse Event|2|||
25294892|NCT00972504|50609536|FG000|Overall Study|Investigator discretion|1|||
25294893|NCT00969228|50609548|FG000|Overall Study|Adverse Event|1|||
25294894|NCT00969228|50609549|FG001|Overall Study|Adverse Event|0|||
25294895|NCT00969228|50609548|FG000|Overall Study|Withdrawal by Subject|4|||
25294896|NCT00969228|50609549|FG001|Overall Study|Withdrawal by Subject|0|||
25294897|NCT00969228|50609548|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
25294898|NCT00969228|50609549|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
25294899|NCT00969150|50609557|FG000|Overall Study|Adverse Event|4|||
25294900|NCT00969150|50609558|FG001|Overall Study|Adverse Event|14|||
25294901|NCT00969150|50609557|FG000|Overall Study|Lack of Efficacy|1|||
25294902|NCT00969150|50609558|FG001|Overall Study|Lack of Efficacy|1|||
25294903|NCT00969150|50609557|FG000|Overall Study|Protocol Violation|9|||
25294904|NCT00969150|50609558|FG001|Overall Study|Protocol Violation|12|||
25294905|NCT00969150|50609557|FG000|Overall Study|Withdrawal by Subject|13|||
25294906|NCT00969150|50609558|FG001|Overall Study|Withdrawal by Subject|9|||
25294907|NCT00969150|50609557|FG000|Overall Study|Lost to Follow-up|5|||
25294908|NCT00969150|50609558|FG001|Overall Study|Lost to Follow-up|4|||
25294909|NCT00969150|50609557|FG000|Overall Study|Other reasons|1|||
25294910|NCT00969150|50609558|FG001|Overall Study|Other reasons|0|||
25294911|NCT00974220|50609566|FG000|Treatment Period 1|Adverse Event|2|||
25294912|NCT00974220|50609567|FG001|Treatment Period 1|Adverse Event|1|||
25294913|NCT00974220|50609566|FG000|Treatment Period 1|noncompliant subjects|0|||
25294914|NCT00974220|50609567|FG001|Treatment Period 1|noncompliant subjects|1|||
25294915|NCT00971178|50609576|FG000|Overall Study|Lost to Follow-up|2|||
25294916|NCT00971178|50609577|FG001|Overall Study|Lost to Follow-up|2|||
25294917|NCT00971178|50609578|FG002|Overall Study|Lost to Follow-up|2|||
25294918|NCT03670602|50609588|FG000|Overall Study|Lost to Follow-up|1|||
25294919|NCT03670602|50609589|FG001|Overall Study|Lost to Follow-up|0|||
25294920|NCT03670602|50609588|FG000|Overall Study|Withdrawal by Subject|0|||
25294921|NCT03670602|50609589|FG001|Overall Study|Withdrawal by Subject|3|||
25294922|NCT00968526|50609597|FG000|Overall Study|Adverse Event|2|||
25294923|NCT00968526|50609598|FG001|Overall Study|Adverse Event|0|||
25294924|NCT00968526|50609597|FG000|Overall Study|Migrated/moved from study area|1|||
25294925|NCT00968526|50609598|FG001|Overall Study|Migrated/moved from study area|0|||
25294926|NCT03664674|50609615|FG000|Overall Study|Adverse Event|1|||
25294927|NCT03664674|50609616|FG001|Overall Study|Adverse Event|1|||
25294928|NCT03664674|50609615|FG000|Overall Study|Physician Decision|0|||
25294929|NCT03664674|50609616|FG001|Overall Study|Physician Decision|1|||
25294930|NCT03664674|50609615|FG000|Overall Study|Withdrawal by Subject|2|||
25294931|NCT03664674|50609616|FG001|Overall Study|Withdrawal by Subject|0|||
25294932|NCT00967668|50609627|FG000|Overall Study|Withdrawal by Subject|13|||
25294933|NCT00967668|50609628|FG001|Overall Study|Withdrawal by Subject|8|||
25294934|NCT00967668|50609629|FG002|Overall Study|Withdrawal by Subject|8|||
25294935|NCT00967668|50609627|FG000|Overall Study|Death|0|||
25294936|NCT00967668|50609628|FG001|Overall Study|Death|2|||
25294937|NCT00967668|50609629|FG002|Overall Study|Death|4|||
25294938|NCT00967668|50609627|FG000|Overall Study|Removed due to behavior|1|||
25294939|NCT00967668|50609628|FG001|Overall Study|Removed due to behavior|1|||
25294940|NCT00967668|50609629|FG002|Overall Study|Removed due to behavior|2|||
25294941|NCT00967668|50609627|FG000|Overall Study|Refused Year 2|11|||
25294942|NCT00967668|50609628|FG001|Overall Study|Refused Year 2|6|||
25294943|NCT00967668|50609629|FG002|Overall Study|Refused Year 2|4|||
25294944|NCT00967668|50609627|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
25294945|NCT00967668|50609628|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
25294946|NCT00967668|50609629|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
25294947|NCT00967668|50609627|FG000|Overall Study|Lost to Follow-up|15|||
25294948|NCT00967668|50609628|FG001|Overall Study|Lost to Follow-up|9|||
25294949|NCT00967668|50609629|FG002|Overall Study|Lost to Follow-up|16|||
25294950|NCT00967668|50609627|FG000|Overall Study|Refused 12-mo assessment|3|||
25294951|NCT00967668|50609628|FG001|Overall Study|Refused 12-mo assessment|1|||
25294952|NCT00967668|50609629|FG002|Overall Study|Refused 12-mo assessment|9|||
25294953|NCT00967668|50609627|FG000|Overall Study|Pregnancy|1|||
25294954|NCT00967668|50609628|FG001|Overall Study|Pregnancy|0|||
25294955|NCT00967668|50609629|FG002|Overall Study|Pregnancy|0|||
25294956|NCT00970944|50609642|FG000|Overall Study|Death|1|||
25294957|NCT00970944|50609643|FG001|Overall Study|Death|0|||
25294958|NCT00970944|50609642|FG000|Overall Study|Physician Decision|0|||
25294959|NCT00970944|50609643|FG001|Overall Study|Physician Decision|2|||
25294960|NCT04839289|50609652|FG000|Overall Study|Withdrawal by Subject|1|||
25294961|NCT04839289|50609653|FG001|Overall Study|Withdrawal by Subject|0|||
25294962|NCT04440813|50609661|FG000|Overall Study|Lost to Follow-up|5|||
25294963|NCT04440813|50609662|FG001|Overall Study|Lost to Follow-up|5|||
25294964|NCT04233073|50609676|FG000|Overall Study|Death|5|||
25294965|NCT04120116|50609684|FG000|Overall Study|Lost to Follow-up|0|||
25294966|NCT04120116|50609685|FG001|Overall Study|Lost to Follow-up|1|||
25294967|NCT04120116|50609686|FG002|Overall Study|Lost to Follow-up|0|||
25294968|NCT04120116|50609687|FG003|Overall Study|Lost to Follow-up|2|||
25294969|NCT04120116|50609684|FG000|Overall Study|Withdrawal by Subject|1|||
25294970|NCT04120116|50609685|FG001|Overall Study|Withdrawal by Subject|0|||
25294971|NCT04120116|50609686|FG002|Overall Study|Withdrawal by Subject|1|||
25294972|NCT04120116|50609687|FG003|Overall Study|Withdrawal by Subject|1|||
25294973|NCT04120116|50609684|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
25294974|NCT04120116|50609685|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
25294975|NCT04120116|50609686|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
25294976|NCT04120116|50609687|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
25294977|NCT03657810|50609710|FG000|Overall Study|Adverse Event|0|||
25294978|NCT03657810|50609711|FG001|Overall Study|Adverse Event|1|||
25294979|NCT03657810|50609712|FG002|Overall Study|Adverse Event|0|||
25294980|NCT03657810|50609710|FG000|Overall Study|Lack of Efficacy|4|||
25294981|NCT03657810|50609711|FG001|Overall Study|Lack of Efficacy|1|||
25294982|NCT03657810|50609712|FG002|Overall Study|Lack of Efficacy|3|||
25294983|NCT03657810|50609710|FG000|Overall Study|Protocol Violation|1|||
25294984|NCT03657810|50609711|FG001|Overall Study|Protocol Violation|0|||
25294985|NCT03657810|50609712|FG002|Overall Study|Protocol Violation|0|||
25294986|NCT03657810|50609710|FG000|Overall Study|Lost to Follow-up|0|||
25294987|NCT03657810|50609711|FG001|Overall Study|Lost to Follow-up|1|||
25294988|NCT03657810|50609712|FG002|Overall Study|Lost to Follow-up|0|||
25294989|NCT03657810|50609710|FG000|Overall Study|Not provided|0|||
25294990|NCT03657810|50609711|FG001|Overall Study|Not provided|1|||
25294991|NCT03657810|50609712|FG002|Overall Study|Not provided|0|||
25294992|NCT03370341|50609734|FG000|Overall Study|Lost to Follow-up|0|||
25294993|NCT03370341|50609735|FG001|Overall Study|Lost to Follow-up|1|||
25294994|NCT02614066|50609796|FG000|Overall Study|Initiated KTE-X19 and Died|5|||
25294995|NCT02614066|50609797|FG001|Overall Study|Initiated KTE-X19 and Died|12|||
25294996|NCT02614066|50609798|FG002|Overall Study|Initiated KTE-X19 and Died|11|||
25294997|NCT02614066|50609799|FG003|Overall Study|Initiated KTE-X19 and Died|20|||
25294998|NCT02614066|50609796|FG000|Overall Study|Full Consent Withdrawn|0|||
25294999|NCT02614066|50609797|FG001|Overall Study|Full Consent Withdrawn|1|||
25295000|NCT02614066|50609798|FG002|Overall Study|Full Consent Withdrawn|0|||
24969812|NCT00116844|50059251|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
24969813|NCT00116844|50059250|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
25295001|NCT02614066|50609799|FG003|Overall Study|Full Consent Withdrawn|3|||
25295002|NCT02614066|50609796|FG000|Overall Study|Lost to Follow-up|0|||
25295003|NCT02614066|50609797|FG001|Overall Study|Lost to Follow-up|1|||
25295004|NCT02614066|50609798|FG002|Overall Study|Lost to Follow-up|0|||
25295005|NCT02614066|50609799|FG003|Overall Study|Lost to Follow-up|0|||
25295006|NCT02614066|50609796|FG000|Overall Study|Still on-study|1|||
25295007|NCT02614066|50609797|FG001|Overall Study|Still on-study|9|||
25295008|NCT02614066|50609798|FG002|Overall Study|Still on-study|5|||
25295009|NCT02614066|50609799|FG003|Overall Study|Still on-study|32|||
25295010|NCT02614066|50609796|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0|||
25295011|NCT02614066|50609797|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5|||
25295012|NCT02614066|50609798|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4|||
25295013|NCT02614066|50609799|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16|||
25295014|NCT02544074|50609828|FG000|Overall Study|Withdrawal by Subject|0|||
24969814|NCT00116844|50059251|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
25295015|NCT02544074|50609829|FG001|Overall Study|Withdrawal by Subject|1|||
25295016|NCT02544074|50609830|FG002|Overall Study|Withdrawal by Subject|0|||
24969815|NCT00116844|50059250|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
24969816|NCT00116844|50059251|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
24969817|NCT00116844|50059250|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
25295017|NCT02544074|50609831|FG003|Overall Study|Withdrawal by Subject|0|||
25295018|NCT02544074|50609832|FG004|Overall Study|Withdrawal by Subject|0|||
25295019|NCT02544074|50609833|FG005|Overall Study|Withdrawal by Subject|0|||
25295020|NCT02544074|50609834|FG006|Overall Study|Withdrawal by Subject|0|||
25295021|NCT02544074|50609835|FG007|Overall Study|Withdrawal by Subject|0|||
25295022|NCT02544074|50609836|FG008|Overall Study|Withdrawal by Subject|0|||
25295023|NCT02544074|50609837|FG009|Overall Study|Withdrawal by Subject|0|||
25295024|NCT02544074|50609838|FG010|Overall Study|Withdrawal by Subject|0|||
25295025|NCT02544074|50609839|FG011|Overall Study|Withdrawal by Subject|0|||
25295026|NCT02544074|50609840|FG012|Overall Study|Withdrawal by Subject|0|||
25295027|NCT02544074|50609841|FG013|Overall Study|Withdrawal by Subject|0|||
25295028|NCT02544074|50609842|FG014|Overall Study|Withdrawal by Subject|0|||
25295029|NCT02544074|50609843|FG015|Overall Study|Withdrawal by Subject|0|||
25295030|NCT02544074|50609844|FG016|Overall Study|Withdrawal by Subject|0|||
25295031|NCT02544074|50609845|FG017|Overall Study|Withdrawal by Subject|0|||
25295032|NCT02544074|50609846|FG018|Overall Study|Withdrawal by Subject|0|||
25295033|NCT02544074|50609847|FG019|Overall Study|Withdrawal by Subject|0|||
25295034|NCT02544074|50609848|FG020|Overall Study|Withdrawal by Subject|0|||
25295035|NCT02544074|50609828|FG000|Overall Study|Tablet error|0|||
25295036|NCT02544074|50609829|FG001|Overall Study|Tablet error|0|||
25295037|NCT02544074|50609830|FG002|Overall Study|Tablet error|0|||
25295038|NCT02544074|50609831|FG003|Overall Study|Tablet error|0|||
25295039|NCT02544074|50609832|FG004|Overall Study|Tablet error|0|||
25295040|NCT02544074|50609833|FG005|Overall Study|Tablet error|1|||
25295041|NCT02544074|50609834|FG006|Overall Study|Tablet error|0|||
25295042|NCT02544074|50609835|FG007|Overall Study|Tablet error|0|||
25295043|NCT02544074|50609836|FG008|Overall Study|Tablet error|0|||
25295044|NCT02544074|50609837|FG009|Overall Study|Tablet error|1|||
25295045|NCT02544074|50609838|FG010|Overall Study|Tablet error|0|||
25295046|NCT02544074|50609839|FG011|Overall Study|Tablet error|0|||
25295047|NCT02544074|50609840|FG012|Overall Study|Tablet error|0|||
25295048|NCT02544074|50609841|FG013|Overall Study|Tablet error|0|||
25295049|NCT02544074|50609842|FG014|Overall Study|Tablet error|0|||
25295050|NCT02544074|50609843|FG015|Overall Study|Tablet error|0|||
25295051|NCT02544074|50609844|FG016|Overall Study|Tablet error|0|||
25295052|NCT02544074|50609845|FG017|Overall Study|Tablet error|0|||
25295053|NCT02544074|50609846|FG018|Overall Study|Tablet error|0|||
25295054|NCT02544074|50609847|FG019|Overall Study|Tablet error|0|||
25295055|NCT02544074|50609848|FG020|Overall Study|Tablet error|0|||
25295056|NCT02502799|50609886|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
25295057|NCT02502799|50609887|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
25295058|NCT02502799|50609888|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
25295059|NCT02502799|50609889|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
25295060|NCT02502799|50609886|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
25295061|NCT02502799|50609887|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
25295062|NCT02502799|50609888|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
25295063|NCT02502799|50609889|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
25295064|NCT02502799|50609886|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
25295065|NCT02502799|50609887|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
25295066|NCT02502799|50609888|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
25295067|NCT02502799|50609889|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
25295068|NCT02502799|50609886|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
25295069|NCT02502799|50609887|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
25295070|NCT02502799|50609888|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
25295071|NCT02502799|50609889|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
25295072|NCT02502799|50609886|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
25295073|NCT02502799|50609887|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
25295074|NCT02502799|50609888|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
25295075|NCT02502799|50609889|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
25295076|NCT02086448|50609902|FG000|Overall Study|Withdrawal by Subject|1|||
25295077|NCT02086448|50609903|FG001|Overall Study|Withdrawal by Subject|0|||
25295078|NCT02086448|50609904|FG002|Overall Study|Withdrawal by Subject|0|||
25295079|NCT02086448|50609905|FG003|Overall Study|Withdrawal by Subject|2|||
25295080|NCT01993836|50609918|FG000|Overall Study|Surgery Cancelled|3|||
25295081|NCT01993836|50609919|FG001|Overall Study|Surgery Cancelled|0|||
25295082|NCT01993836|50609920|FG002|Overall Study|Surgery Cancelled|0|||
25295083|NCT01993836|50609918|FG000|Overall Study|Physician Decision|2|||
25295084|NCT01993836|50609919|FG001|Overall Study|Physician Decision|1|||
25295085|NCT01993836|50609920|FG002|Overall Study|Physician Decision|0|||
25295086|NCT01993836|50609918|FG000|Overall Study|Death|0|||
25295087|NCT01993836|50609919|FG001|Overall Study|Death|2|||
25295088|NCT01993836|50609920|FG002|Overall Study|Death|0|||
25295089|NCT01993836|50609918|FG000|Overall Study|Withdrawal by Subject|12|||
25295090|NCT01993836|50609919|FG001|Overall Study|Withdrawal by Subject|10|||
25295091|NCT01993836|50609920|FG002|Overall Study|Withdrawal by Subject|5|||
25295092|NCT00753545|50609935|FG000|Overall Study|Death|98|||
25295093|NCT00753545|50609936|FG001|Overall Study|Death|112|||
25295094|NCT00753545|50609935|FG000|Overall Study|Lost to Follow-up|2|||
25295095|NCT00753545|50609936|FG001|Overall Study|Lost to Follow-up|3|||
25295096|NCT00753545|50609935|FG000|Overall Study|Protocol Violation|1|||
25295097|NCT00753545|50609936|FG001|Overall Study|Protocol Violation|0|||
25295098|NCT00753545|50609935|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
25295099|NCT00753545|50609936|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
25295100|NCT00278915|50609951|FG000|Overall Study|Lack of Efficacy|1|||
25295101|NCT00970632|50609958|FG000|Overall Study|Adverse Event|2|||
25295102|NCT00970632|50609959|FG001|Overall Study|Adverse Event|2|||
25295103|NCT00970632|50609960|FG002|Overall Study|Adverse Event|1|||
25295104|NCT00970632|50609958|FG000|Overall Study|Lack of Efficacy|3|||
25295105|NCT00970632|50609959|FG001|Overall Study|Lack of Efficacy|0|||
25295106|NCT00970632|50609960|FG002|Overall Study|Lack of Efficacy|0|||
25295107|NCT00970632|50609958|FG000|Overall Study|Lost to Follow-up|3|||
25295108|NCT00970632|50609959|FG001|Overall Study|Lost to Follow-up|0|||
25295109|NCT00970632|50609960|FG002|Overall Study|Lost to Follow-up|2|||
25295110|NCT00970632|50609958|FG000|Overall Study|Protocol Violation|8|||
25295111|NCT00970632|50609959|FG001|Overall Study|Protocol Violation|5|||
25295112|NCT00970632|50609960|FG002|Overall Study|Protocol Violation|8|||
25295113|NCT00970632|50609958|FG000|Overall Study|Withdrawal by Subject|7|||
25295114|NCT00970632|50609959|FG001|Overall Study|Withdrawal by Subject|6|||
25295115|NCT00970632|50609960|FG002|Overall Study|Withdrawal by Subject|4|||
25295116|NCT00970632|50609958|FG000|Overall Study|Entry criteria not met|0|||
25295117|NCT00970632|50609959|FG001|Overall Study|Entry criteria not met|2|||
25295118|NCT00970632|50609960|FG002|Overall Study|Entry criteria not met|2|||
25295119|NCT00970632|50609958|FG000|Overall Study|Sponsor decision|1|||
25295120|NCT00970632|50609959|FG001|Overall Study|Sponsor decision|0|||
25295121|NCT00970632|50609960|FG002|Overall Study|Sponsor decision|1|||
25295122|NCT01144364|50609970|FG000|Induction Phase|Disease progression|14|||
25295123|NCT01144364|50609971|FG001|Induction Phase|Disease progression|0|||
25295124|NCT01144364|50609972|FG002|Induction Phase|Disease progression|0|||
25295125|NCT01144364|50609970|FG000|Induction Phase|Adverse Event|9|||
25295126|NCT01144364|50609971|FG001|Induction Phase|Adverse Event|0|||
25295127|NCT01144364|50609972|FG002|Induction Phase|Adverse Event|0|||
25295128|NCT01144364|50609970|FG000|Induction Phase|Death|1|||
25295129|NCT01144364|50609971|FG001|Induction Phase|Death|0|||
25295130|NCT01144364|50609972|FG002|Induction Phase|Death|0|||
25295131|NCT01144364|50609970|FG000|Induction Phase|Withdrawal by Subject|1|||
25295132|NCT01144364|50609971|FG001|Induction Phase|Withdrawal by Subject|0|||
25295133|NCT01144364|50609972|FG002|Induction Phase|Withdrawal by Subject|0|||
25295134|NCT01144364|50609970|FG000|Induction Phase|Lost to Follow-up|2|||
25295135|NCT01144364|50609971|FG001|Induction Phase|Lost to Follow-up|0|||
25295136|NCT01144364|50609972|FG002|Induction Phase|Lost to Follow-up|0|||
25295137|NCT01144364|50609970|FG000|Induction Phase|Physician Decision|1|||
25295138|NCT01144364|50609971|FG001|Induction Phase|Physician Decision|0|||
25295139|NCT01144364|50609972|FG002|Induction Phase|Physician Decision|0|||
25295140|NCT01144364|50609970|FG000|Induction Phase|Stable disease|2|||
25295141|NCT01144364|50609971|FG001|Induction Phase|Stable disease|0|||
25295142|NCT01144364|50609972|FG002|Induction Phase|Stable disease|0|||
25295143|NCT01144364|50609970|FG000|Induction Phase|Secondary neoplasia|1|||
25295144|NCT01144364|50609971|FG001|Induction Phase|Secondary neoplasia|0|||
25295145|NCT01144364|50609972|FG002|Induction Phase|Secondary neoplasia|0|||
25295146|NCT01144364|50609970|FG000|Induction Phase|Protocol Violation|1|||
25295147|NCT01144364|50609971|FG001|Induction Phase|Protocol Violation|0|||
25295148|NCT01144364|50609972|FG002|Induction Phase|Protocol Violation|0|||
25295149|NCT01144364|50609970|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
25295150|NCT01144364|50609971|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
25295151|NCT01144364|50609972|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
25295152|NCT01144364|50609970|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
25295153|NCT01144364|50609971|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
25295154|NCT01144364|50609972|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
25295155|NCT01144364|50609970|FG000|Follow-Up/Maintenance Phase|Death|0|||
25295156|NCT01144364|50609971|FG001|Follow-Up/Maintenance Phase|Death|2|||
25295157|NCT01144364|50609972|FG002|Follow-Up/Maintenance Phase|Death|0|||
25295158|NCT01144364|50609970|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
25295159|NCT01144364|50609971|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
24969818|NCT00116844|50059251|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
25295160|NCT01144364|50609972|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
25295161|NCT01144364|50609970|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
25295162|NCT01144364|50609971|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
25295163|NCT01144364|50609972|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
25070640|NCT00103285|50176697|FG007|Response Assignment|Death|8|||
25295164|NCT01144364|50609970|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
25295165|NCT01144364|50609971|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
25295166|NCT01144364|50609972|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
25295167|NCT01144364|50609970|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
25295168|NCT01144364|50609971|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
25295169|NCT01144364|50609972|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
25295170|NCT01119248|50609982|FG000|Overall Study|Physician Decision|5|||
25295171|NCT01131494|50609987|FG000|Overall Study|Withdrawal by Subject|2|||
25295172|NCT01131260|50609994|FG000|Overall Study|Randomization error|5|||
25295173|NCT01131260|50609995|FG001|Overall Study|Randomization error|1|||
25295174|NCT01131260|50609994|FG000|Overall Study|Declined to continue participation|8|||
25295175|NCT01131260|50609995|FG001|Overall Study|Declined to continue participation|13|||
25295176|NCT01131260|50609994|FG000|Overall Study|Physician Decision|22|||
25295177|NCT01131260|50609995|FG001|Overall Study|Physician Decision|24|||
25295178|NCT01131260|50609994|FG000|Overall Study|Technical problems|7|||
25295179|NCT01131260|50609995|FG001|Overall Study|Technical problems|6|||
25295180|NCT01131260|50609994|FG000|Overall Study|Staff error|2|||
25295181|NCT01131260|50609995|FG001|Overall Study|Staff error|1|||
25295182|NCT01131260|50609994|FG000|Overall Study|Ineligible|0|||
25295183|NCT01131260|50609995|FG001|Overall Study|Ineligible|2|||
25295184|NCT00965094|50610005|FG000|Overall Study|Adverse Event|5|||
25295185|NCT00965094|50610006|FG001|Overall Study|Adverse Event|0|||
25295186|NCT00965094|50610005|FG000|Overall Study|Lost to Follow-up|0|||
25295187|NCT00965094|50610006|FG001|Overall Study|Lost to Follow-up|1|||
25295188|NCT01131182|50610015|FG000|Overall Study|Withdrawal by Subject|1|||
25295189|NCT01131182|50610016|FG001|Overall Study|Withdrawal by Subject|1|||
25295190|NCT01131182|50610015|FG000|Overall Study|Lost to Follow-up|14|||
25295191|NCT01131182|50610016|FG001|Overall Study|Lost to Follow-up|15|||
25295192|NCT01131182|50610015|FG000|Overall Study|Other Reason|1|||
25295193|NCT01131182|50610016|FG001|Overall Study|Other Reason|0|||
25295194|NCT00964860|50610024|FG000|Overall Study|Withdrawal by Subject|0|||
25295195|NCT00964860|50610025|FG001|Overall Study|Withdrawal by Subject|1|||
25295196|NCT01131104|50610031|FG000|Overall Study|Withdrawal by Subject|3|||
25295197|NCT01131104|50610031|FG000|Overall Study|Physician Decision|4|||
25295198|NCT01131104|50610031|FG000|Overall Study|Information Not Available|5|||
25295199|NCT01131104|50610031|FG000|Overall Study|No Information on Index Date of Onset|1|||
25295200|NCT01118780|50610037|FG000|Overall Study|Adverse Event|15|||
25295201|NCT01118780|50610038|FG001|Overall Study|Adverse Event|15|||
25295202|NCT01118780|50610037|FG000|Overall Study|Death|1|||
25295203|NCT01118780|50610038|FG001|Overall Study|Death|0|||
25295204|NCT01118780|50610037|FG000|Overall Study|Lack of Efficacy|2|||
25295205|NCT01118780|50610038|FG001|Overall Study|Lack of Efficacy|6|||
25295206|NCT01118780|50610037|FG000|Overall Study|Physician Decision|2|||
25295207|NCT01118780|50610038|FG001|Overall Study|Physician Decision|0|||
25295208|NCT01118780|50610037|FG000|Overall Study|Protocol Violation|3|||
25295209|NCT01118780|50610038|FG001|Overall Study|Protocol Violation|6|||
25295210|NCT01118780|50610037|FG000|Overall Study|Withdrawal by Subject|13|||
25295211|NCT01118780|50610038|FG001|Overall Study|Withdrawal by Subject|8|||
25295212|NCT00964782|50610049|FG000|Overall Study|Lost to Follow-up|1|||
25295213|NCT00964782|50610050|FG001|Overall Study|Lost to Follow-up|0|||
25295214|NCT00966654|50610058|FG000|Overall Study|Study was terminated,PI left institution|12|||
25295215|NCT03262116|50610070|FG000|Overall Study|Physician Decision|0|||
25295216|NCT03262116|50610071|FG001|Overall Study|Physician Decision|2|||
25295217|NCT03262116|50610072|FG002|Overall Study|Physician Decision|1|||
25295218|NCT03262116|50610073|FG003|Overall Study|Physician Decision|1|||
25295219|NCT03262116|50610074|FG004|Overall Study|Physician Decision|1|||
25295220|NCT03262116|50610075|FG005|Overall Study|Physician Decision|2|||
25295221|NCT01130168|50610083|FG000|Period 1|Withdrawal by Subject|0|||
25295222|NCT01130168|50610084|FG001|Period 1|Withdrawal by Subject|1|||
25295223|NCT01130168|50610085|FG002|Period 1|Withdrawal by Subject|0|||
25295224|NCT01130168|50610086|FG003|Period 1|Withdrawal by Subject|1|||
25295225|NCT01130168|50610087|FG004|Period 1|Withdrawal by Subject|0|||
25295226|NCT01130168|50610088|FG005|Period 1|Withdrawal by Subject|0|||
25295227|NCT01130168|50610083|FG000|Period 1|Discontinued For Other Reason|0|||
25295228|NCT01130168|50610084|FG001|Period 1|Discontinued For Other Reason|0|||
25295229|NCT01130168|50610085|FG002|Period 1|Discontinued For Other Reason|1|||
25295230|NCT01130168|50610086|FG003|Period 1|Discontinued For Other Reason|1|||
25295231|NCT01130168|50610087|FG004|Period 1|Discontinued For Other Reason|0|||
25295232|NCT01130168|50610088|FG005|Period 1|Discontinued For Other Reason|0|||
25295233|NCT01130168|50610083|FG000|Period 1|Adverse Event|0|||
25295234|NCT01130168|50610084|FG001|Period 1|Adverse Event|0|||
25295235|NCT01130168|50610085|FG002|Period 1|Adverse Event|0|||
25295236|NCT01130168|50610086|FG003|Period 1|Adverse Event|1|||
25295237|NCT01130168|50610087|FG004|Period 1|Adverse Event|0|||
25295238|NCT01130168|50610088|FG005|Period 1|Adverse Event|0|||
25295239|NCT01144052|50610099|FG000|Overall Study|Withdrawal by Subject|1|||
25295240|NCT01144052|50610100|FG001|Overall Study|Withdrawal by Subject|1|||
25295241|NCT01143896|50610110|FG000|Overall Study|Did not complete Baseline Interview|5|||
25295242|NCT01143896|50610111|FG001|Overall Study|Did not complete Baseline Interview|4|||
25295243|NCT01143896|50610110|FG000|Overall Study|Lost to Follow-up|18|||
25295244|NCT01143896|50610111|FG001|Overall Study|Lost to Follow-up|13|||
25295245|NCT01143896|50610110|FG000|Overall Study|Withdrawal by Subject|13|||
25295246|NCT01143896|50610111|FG001|Overall Study|Withdrawal by Subject|5|||
25295247|NCT01143896|50610110|FG000|Overall Study|Death|6|||
25295248|NCT01143896|50610111|FG001|Overall Study|Death|3|||
25295249|NCT01118312|50610120|FG000|Overall Study|Lost to Follow-up|33|||
25295250|NCT01118312|50610121|FG001|Overall Study|Lost to Follow-up|32|||
25295251|NCT01118312|50610120|FG000|Overall Study|Withdrawal by Subject|1|||
25295252|NCT01118312|50610121|FG001|Overall Study|Withdrawal by Subject|3|||
25295253|NCT01117766|50610127|FG000|First Intervention|Adverse Event|0|||
25295254|NCT01117766|50610128|FG001|First Intervention|Adverse Event|1|||
25295255|NCT01117766|50610127|FG000|First Intervention|Protocol Violation|1|||
25295256|NCT01117766|50610128|FG001|First Intervention|Protocol Violation|0|||
25295257|NCT01117766|50610127|FG000|Washout Period|Protocol Violation|0|||
25295258|NCT01117766|50610128|FG001|Washout Period|Protocol Violation|2|||
25295259|NCT01117766|50610127|FG000|Second Intervention|Lost to Follow-up|1|||
25295260|NCT01117766|50610128|FG001|Second Intervention|Lost to Follow-up|0|||
25295261|NCT01117766|50610127|FG000|Second Intervention|Other|1|||
25295262|NCT01117766|50610128|FG001|Second Intervention|Other|2|||
25295263|NCT01117766|50610127|FG000|Second Intervention|Adverse Event|0|||
25295264|NCT01117766|50610128|FG001|Second Intervention|Adverse Event|2|||
25295265|NCT01117766|50610127|FG000|Second Intervention|Withdrawal by Subject|0|||
25295266|NCT01117766|50610128|FG001|Second Intervention|Withdrawal by Subject|1|||
25295267|NCT01117454|50610136|FG000|Overall Study|Pregnancy|0|||
25295268|NCT01117454|50610137|FG001|Overall Study|Pregnancy|1|||
25295269|NCT01116440|50610145|FG000|Treatment|Withdrawal by Subject|2|||
25295270|NCT01116440|50610146|FG001|Treatment|Withdrawal by Subject|2|||
25295271|NCT01116440|50610145|FG000|Treatment|Lost to Follow-up|1|||
25295272|NCT01116440|50610146|FG001|Treatment|Lost to Follow-up|1|||
25295273|NCT01116440|50610145|FG000|Treatment|Protocol Violation|0|||
25295274|NCT01116440|50610146|FG001|Treatment|Protocol Violation|2|||
25295275|NCT01116440|50610145|FG000|Treatment|Lack of Efficacy|0|||
25295276|NCT01116440|50610146|FG001|Treatment|Lack of Efficacy|1|||
25295277|NCT01116440|50610145|FG000|Treatment|Adverse Event|0|||
25295278|NCT01116440|50610146|FG001|Treatment|Adverse Event|1|||
25295279|NCT01116440|50610145|FG000|Withdrawal|Withdrawal by Subject|0|||
25295280|NCT01116440|50610146|FG001|Withdrawal|Withdrawal by Subject|1|||
25295281|NCT01116440|50610145|FG000|Withdrawal|Lost to Follow-up|0|||
25295282|NCT01116440|50610146|FG001|Withdrawal|Lost to Follow-up|1|||
25295283|NCT01116440|50610145|FG000|Follow-up|Lost to Follow-up|0|||
25295284|NCT01116440|50610146|FG001|Follow-up|Lost to Follow-up|1|||
25295285|NCT01116440|50610145|FG000|Follow-up|Withdrawal by Subject|0|||
25295286|NCT01116440|50610146|FG001|Follow-up|Withdrawal by Subject|1|||
25295287|NCT01129622|50610154|FG000|Overall Study|Withdrawal by Subject|2|||
25295288|NCT01128842|50610159|FG000|Overall Study|Adverse Event|1|||
25295289|NCT01128842|50610159|FG000|Overall Study|Disease Progression|6|||
25295290|NCT03624036|50610168|FG000|Overall Study|Still on Study|5|||
25295291|NCT03624036|50610169|FG001|Overall Study|Still on Study|1|||
25295292|NCT03624036|50610170|FG002|Overall Study|Still on Study|3|||
25295293|NCT03624036|50610171|FG003|Overall Study|Still on Study|3|||
25295294|NCT03624036|50610168|FG000|Overall Study|Death|1|||
25295295|NCT03624036|50610169|FG001|Overall Study|Death|2|||
25295296|NCT03624036|50610170|FG002|Overall Study|Death|0|||
25295297|NCT03624036|50610171|FG003|Overall Study|Death|0|||
25295298|NCT03624036|50610168|FG000|Overall Study|Enrolled but Never Treated|1|||
25295299|NCT03624036|50610169|FG001|Overall Study|Enrolled but Never Treated|0|||
25295300|NCT03624036|50610170|FG002|Overall Study|Enrolled but Never Treated|0|||
25295301|NCT03624036|50610171|FG003|Overall Study|Enrolled but Never Treated|0|||
25295302|NCT01143038|50610181|FG000|Overall Study|Withdrawal by Subject|4|||
25295303|NCT01143038|50610181|FG000|Overall Study|Requirement for alternative therapy|5|||
25295304|NCT01143038|50610181|FG000|Overall Study|Adverse Event|3|||
25295305|NCT01143038|50610181|FG000|Overall Study|Lost to Follow-up|2|||
25295306|NCT01143038|50610181|FG000|Overall Study|Protocol Deviation|1|||
25295307|NCT01143038|50610181|FG000|Overall Study|Death|1|||
25295308|NCT00966264|50610187|FG000|Overall Study|Lost to Follow-up|4|||
25295309|NCT00966264|50610188|FG001|Overall Study|Lost to Follow-up|3|||
25295310|NCT00915525|50610196|FG000|Overall Study|Protocol Violation|9|||
25295311|NCT00915525|50610197|FG001|Overall Study|Protocol Violation|4|||
25295312|NCT00915525|50610196|FG000|Overall Study|Withdrawal by Subject|59|||
25295313|NCT00915525|50610197|FG001|Overall Study|Withdrawal by Subject|21|||
25295314|NCT00915525|50610196|FG000|Overall Study|Lost to Follow-up|27|||
25295315|NCT00915525|50610197|FG001|Overall Study|Lost to Follow-up|16|||
25295316|NCT00915525|50610196|FG000|Overall Study|Pregnancy|2|||
25295317|NCT00915525|50610197|FG001|Overall Study|Pregnancy|0|||
25295318|NCT00915525|50610196|FG000|Overall Study|Lack of Efficacy|15|||
25295319|NCT00915525|50610197|FG001|Overall Study|Lack of Efficacy|32|||
25295320|NCT00915525|50610196|FG000|Overall Study|Adverse Event|29|||
25295321|NCT00915525|50610197|FG001|Overall Study|Adverse Event|13|||
25295322|NCT00915525|50610196|FG000|Overall Study|Missing|12|||
25295323|NCT00915525|50610197|FG001|Overall Study|Missing|1|||
25295324|NCT00915525|50610196|FG000|Overall Study|Other Reason|35|||
25295325|NCT00915525|50610197|FG001|Overall Study|Other Reason|12|||
25295326|NCT00915525|50610196|FG000|Overall Study|Site Closed|27|||
25295327|NCT00915525|50610197|FG001|Overall Study|Site Closed|9|||
25295328|NCT00915525|50610196|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
25295329|NCT00915525|50610197|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
25295330|NCT00915525|50610196|FG000|Overall Study|Study Burden|28|||
25295331|NCT00915525|50610197|FG001|Overall Study|Study Burden|12|||
25295332|NCT00915525|50610196|FG000|Overall Study|Non-Compliance|3|||
25295333|NCT00915525|50610197|FG001|Overall Study|Non-Compliance|1|||
25295334|NCT00915525|50610196|FG000|Overall Study|Patient Moved|15|||
25295335|NCT00915525|50610197|FG001|Overall Study|Patient Moved|9|||
25295336|NCT01074047|50610225|FG000|Treatment Phase|Adverse Event|89|||
25295337|NCT01074047|50610226|FG001|Treatment Phase|Adverse Event|66|||
25295338|NCT01074047|50610225|FG000|Treatment Phase|Disease Progression|16|||
25295339|NCT01074047|50610226|FG001|Treatment Phase|Disease Progression|21|||
25295340|NCT01074047|50610225|FG000|Treatment Phase|Withdrawal by Subject|27|||
25295341|NCT01074047|50610226|FG001|Treatment Phase|Withdrawal by Subject|48|||
25295342|NCT01074047|50610225|FG000|Treatment Phase|Death|53|||
25295343|NCT01074047|50610226|FG001|Treatment Phase|Death|58|||
25295344|NCT01074047|50610225|FG000|Treatment Phase|Lost to Follow-up|0|||
25295345|NCT01074047|50610226|FG001|Treatment Phase|Lost to Follow-up|1|||
25295346|NCT01074047|50610225|FG000|Treatment Phase|Protocol Violation|0|||
25295347|NCT01074047|50610226|FG001|Treatment Phase|Protocol Violation|1|||
25295348|NCT01074047|50610225|FG000|Treatment Phase|Miscellaneous|32|||
25295349|NCT01074047|50610226|FG001|Treatment Phase|Miscellaneous|39|||
25295350|NCT01074047|50610225|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
25295351|NCT01074047|50610226|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
25295352|NCT01074047|50610225|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
25295353|NCT01074047|50610226|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
25295354|NCT01074047|50610225|FG000|Survival Follow-Up Phase|Death|116|||
25295355|NCT01074047|50610226|FG001|Survival Follow-Up Phase|Death|124|||
25295356|NCT01074047|50610225|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
25295357|NCT01074047|50610226|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
25295358|NCT01074047|50610225|FG000|Extension Phase|Physician Decision|1|||
25295359|NCT01074047|50610226|FG001|Extension Phase|Physician Decision|0|||
25295360|NCT01074047|50610225|FG000|Extension Phase|Adverse Event|5|||
25295361|NCT01074047|50610226|FG001|Extension Phase|Adverse Event|0|||
25295362|NCT01074047|50610225|FG000|Extension Phase|Disease Progression|9|||
25295363|NCT01074047|50610226|FG001|Extension Phase|Disease Progression|0|||
25295364|NCT01074047|50610225|FG000|Extension Phase|Withdrawal by Subject|2|||
25295365|NCT01074047|50610226|FG001|Extension Phase|Withdrawal by Subject|0|||
25295366|NCT01074047|50610225|FG000|Extension Phase|Death|5|||
25295367|NCT01074047|50610226|FG001|Extension Phase|Death|0|||
25295368|NCT01142726|50610242|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
25295369|NCT01142726|50610243|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
25295370|NCT01142726|50610244|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
25295371|NCT01142726|50610242|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
25295372|NCT01142726|50610243|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
25295373|NCT01142726|50610244|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
25295374|NCT01142726|50610242|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
25295375|NCT01142726|50610243|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
25295376|NCT01142726|50610244|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
25295377|NCT01142726|50610242|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
25295378|NCT01142726|50610243|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
25295379|NCT01142726|50610244|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
25295380|NCT01142726|50610242|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
25295381|NCT01142726|50610243|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
25295382|NCT01142726|50610244|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
25295383|NCT01142726|50610242|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
25295384|NCT01142726|50610243|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
25295385|NCT01142726|50610244|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
25295386|NCT01142726|50610242|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
25295387|NCT01142726|50610243|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
25295388|NCT01142726|50610244|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
25295389|NCT01142726|50610242|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
25295390|NCT01142726|50610243|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
25295391|NCT01142726|50610244|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
25295392|NCT01142726|50610242|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
25295393|NCT01142726|50610243|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
25295394|NCT01142726|50610244|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
25295395|NCT01142726|50610242|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
25295396|NCT01142726|50610243|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
25295397|NCT01142726|50610244|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
25295398|NCT01142726|50610242|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
25295399|NCT01142726|50610243|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
25295400|NCT01142726|50610244|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
25295401|NCT01142726|50610242|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
25295402|NCT01142726|50610243|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
25295403|NCT01142726|50610244|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
25295404|NCT01142726|50610242|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
25295405|NCT01142726|50610243|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
25295406|NCT01142726|50610244|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
25295407|NCT01142726|50610242|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
25295408|NCT01142726|50610243|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
25295409|NCT01142726|50610244|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
25295410|NCT01142726|50610242|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
25295411|NCT01142726|50610243|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
25295412|NCT01142726|50610244|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
25295413|NCT01142726|50610242|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
25295414|NCT01142726|50610243|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
25295415|NCT01142726|50610244|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
25295416|NCT01073267|50610260|FG000|Overall Study|Disease Progression|3|||
25295417|NCT01142336|50610266|FG000|Overall Study|Adverse Event|1|||
25295418|NCT01142336|50610267|FG001|Overall Study|Adverse Event|1|||
25295419|NCT01142336|50610266|FG000|Overall Study|Lost to Follow-up|0|||
25295420|NCT01142336|50610267|FG001|Overall Study|Lost to Follow-up|1|||
25295421|NCT00915681|50610276|FG000|Overall Study|Screening failures|46|||
25295422|NCT01128296|50610280|FG000|Overall Study|Physician Decision|0|||
25295423|NCT01128296|50610281|FG001|Overall Study|Physician Decision|0|||
25295424|NCT01128296|50610282|FG002|Overall Study|Physician Decision|0|||
25295425|NCT01128296|50610283|FG003|Overall Study|Physician Decision|0|||
25295426|NCT01128296|50610284|FG004|Overall Study|Physician Decision|0|||
25295427|NCT01128296|50610285|FG005|Overall Study|Physician Decision|3|||
25295428|NCT01128296|50610280|FG000|Overall Study|Withdrawal by Subject|0|||
25295429|NCT01128296|50610281|FG001|Overall Study|Withdrawal by Subject|0|||
25295430|NCT01128296|50610282|FG002|Overall Study|Withdrawal by Subject|0|||
25295431|NCT01128296|50610283|FG003|Overall Study|Withdrawal by Subject|0|||
25295432|NCT01128296|50610284|FG004|Overall Study|Withdrawal by Subject|0|||
25295433|NCT01128296|50610285|FG005|Overall Study|Withdrawal by Subject|2|||
25295434|NCT01115738|50610299|FG000|Overall Study|Death|1|||
25295435|NCT01115738|50610300|FG001|Overall Study|Death|0|||
25295436|NCT01115738|50610301|FG002|Overall Study|Death|0|||
25295437|NCT01115738|50610299|FG000|Overall Study|Lost to Follow-up|0|||
25295438|NCT01115738|50610300|FG001|Overall Study|Lost to Follow-up|0|||
25295439|NCT01115738|50610301|FG002|Overall Study|Lost to Follow-up|1|||
25295440|NCT01115738|50610299|FG000|Overall Study|Physician Decision|18|||
25295441|NCT01115738|50610300|FG001|Overall Study|Physician Decision|15|||
25295442|NCT01115738|50610301|FG002|Overall Study|Physician Decision|17|||
25295443|NCT01115738|50610299|FG000|Overall Study|Withdrawal by Subject|6|||
25295444|NCT01115738|50610300|FG001|Overall Study|Withdrawal by Subject|6|||
25295445|NCT01115738|50610301|FG002|Overall Study|Withdrawal by Subject|9|||
25295446|NCT01141478|50610319|FG000|Overall Study|Withdrawal by Subject|1|||
25295447|NCT01141478|50610320|FG001|Overall Study|Withdrawal by Subject|1|||
25295448|NCT01114880|50610328|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
25295449|NCT01114880|50610329|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
25295450|NCT01114880|50610328|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
25295451|NCT01114880|50610329|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
25295452|NCT01114880|50610328|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
25295453|NCT01114880|50610329|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
25295454|NCT01114880|50610328|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
25295455|NCT01114880|50610329|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
25295456|NCT01114880|50610328|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
25295457|NCT01114880|50610329|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
25295458|NCT01114880|50610328|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
25295459|NCT01114880|50610329|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
25295460|NCT01114724|50610337|FG000|Overall Study|Death|8|||
25295461|NCT01114724|50610337|FG000|Overall Study|Lost to Follow-up|1|||
25295462|NCT01114724|50610337|FG000|Overall Study|Withdrawal by Subject|1|||
25295463|NCT00964392|50610344|FG000|Overall Study|Withdrawal by Subject|4|||
25295464|NCT00964392|50610345|FG001|Overall Study|Withdrawal by Subject|6|||
25295465|NCT00964392|50610344|FG000|Overall Study|Lost to Follow-up|4|||
25295466|NCT00964392|50610345|FG001|Overall Study|Lost to Follow-up|10|||
25295467|NCT00964392|50610344|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
25295468|NCT00964392|50610345|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
25295469|NCT00964392|50610344|FG000|Overall Study|Not completed|44|||
25295470|NCT00964392|50610345|FG001|Overall Study|Not completed|168|||
25295471|NCT00965718|50610351|FG000|Overall Study|Withdrawal by Subject|4|||
25295472|NCT00914589|50610358|FG000|Overall Study|Adverse Event|1|||
25295473|NCT00914589|50610359|FG001|Overall Study|Adverse Event|0|||
25295474|NCT00914589|50610360|FG002|Overall Study|Adverse Event|1|||
25295475|NCT00914589|50610358|FG000|Overall Study|Protocol Violation|8|||
25295476|NCT00914589|50610359|FG001|Overall Study|Protocol Violation|6|||
25295477|NCT00914589|50610360|FG002|Overall Study|Protocol Violation|3|||
25295478|NCT00914589|50610358|FG000|Overall Study|unclassified|16|||
25295479|NCT00914589|50610359|FG001|Overall Study|unclassified|9|||
25295480|NCT00914589|50610360|FG002|Overall Study|unclassified|7|||
25295481|NCT00914589|50610358|FG000|Overall Study|Death|0|||
25295482|NCT00914589|50610359|FG001|Overall Study|Death|1|||
25295483|NCT00914589|50610360|FG002|Overall Study|Death|1|||
25295484|NCT00912405|50610368|FG000|Overall Study|Lost to Follow-up|5|||
25295485|NCT00878722|50610380|FG000|Overall Study|Progressive disease|3|||
25295486|NCT00878722|50610381|FG001|Overall Study|Progressive disease|3|||
25295487|NCT00878722|50610382|FG002|Overall Study|Progressive disease|3|||
25295488|NCT00878722|50610383|FG003|Overall Study|Progressive disease|7|||
25295489|NCT00878722|50610384|FG004|Overall Study|Progressive disease|7|||
25295490|NCT00878722|50610385|FG005|Overall Study|Progressive disease|1|||
25295491|NCT00878722|50610386|FG006|Overall Study|Progressive disease|4|||
25295492|NCT00878722|50610387|FG007|Overall Study|Progressive disease|3|||
25295493|NCT00878722|50610380|FG000|Overall Study|Death|0|||
25295494|NCT00878722|50610381|FG001|Overall Study|Death|0|||
25295495|NCT00878722|50610382|FG002|Overall Study|Death|0|||
25295496|NCT00878722|50610383|FG003|Overall Study|Death|1|||
25295497|NCT00878722|50610384|FG004|Overall Study|Death|0|||
25295498|NCT00878722|50610385|FG005|Overall Study|Death|1|||
25295499|NCT00878722|50610386|FG006|Overall Study|Death|0|||
25295500|NCT00878722|50610387|FG007|Overall Study|Death|2|||
25295501|NCT00878722|50610380|FG000|Overall Study|Adverse Event|0|||
25295502|NCT00878722|50610381|FG001|Overall Study|Adverse Event|0|||
25295503|NCT00878722|50610382|FG002|Overall Study|Adverse Event|0|||
25295504|NCT00878722|50610383|FG003|Overall Study|Adverse Event|0|||
25295505|NCT00878722|50610384|FG004|Overall Study|Adverse Event|0|||
25295506|NCT00878722|50610385|FG005|Overall Study|Adverse Event|0|||
25295507|NCT00878722|50610386|FG006|Overall Study|Adverse Event|2|||
25295508|NCT00878722|50610387|FG007|Overall Study|Adverse Event|0|||
25295509|NCT00878722|50610380|FG000|Overall Study|Withdrawal by Subject|0|||
25295510|NCT00878722|50610381|FG001|Overall Study|Withdrawal by Subject|0|||
25295511|NCT00878722|50610382|FG002|Overall Study|Withdrawal by Subject|0|||
25295512|NCT00878722|50610383|FG003|Overall Study|Withdrawal by Subject|0|||
25295513|NCT00878722|50610384|FG004|Overall Study|Withdrawal by Subject|0|||
25295514|NCT00878722|50610385|FG005|Overall Study|Withdrawal by Subject|0|||
25295515|NCT00878722|50610386|FG006|Overall Study|Withdrawal by Subject|0|||
25295516|NCT00878722|50610387|FG007|Overall Study|Withdrawal by Subject|2|||
25295517|NCT00878722|50610380|FG000|Overall Study|Relapse|0|||
25295518|NCT00878722|50610381|FG001|Overall Study|Relapse|0|||
25295519|NCT00878722|50610382|FG002|Overall Study|Relapse|0|||
25295520|NCT00878722|50610383|FG003|Overall Study|Relapse|1|||
25295521|NCT00878722|50610384|FG004|Overall Study|Relapse|0|||
25295522|NCT00878722|50610385|FG005|Overall Study|Relapse|0|||
25295523|NCT00878722|50610386|FG006|Overall Study|Relapse|0|||
25295524|NCT00878722|50610387|FG007|Overall Study|Relapse|0|||
25295525|NCT00964158|50610415|FG000|Overall Study|Lost to Follow-up|0|||
25295526|NCT00964158|50610416|FG001|Overall Study|Lost to Follow-up|1|||
25295527|NCT00964158|50610417|FG002|Overall Study|Lost to Follow-up|2|||
25295528|NCT00964158|50610415|FG000|Overall Study|Withdrawal by Subject|0|||
25295529|NCT00964158|50610416|FG001|Overall Study|Withdrawal by Subject|0|||
25295530|NCT00964158|50610417|FG002|Overall Study|Withdrawal by Subject|6|||
25295531|NCT00961350|50610430|FG000|Overall Study|Adverse Event|18|||
25295532|NCT00961350|50610431|FG001|Overall Study|Adverse Event|33|||
25295533|NCT00961350|50610430|FG000|Overall Study|Withdrawal by Subject|10|||
25295534|NCT00961350|50610431|FG001|Overall Study|Withdrawal by Subject|10|||
25295535|NCT00961350|50610430|FG000|Overall Study|Lost to Follow-up|3|||
24969819|NCT00116844|50059250|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
25169296|NCT01833065|50300843|FG000|Overall Study|Protocol Violation|1|||
25295536|NCT00961350|50610431|FG001|Overall Study|Lost to Follow-up|3|||
25295537|NCT00961350|50610430|FG000|Overall Study|Misc|16|||
25295538|NCT00961350|50610431|FG001|Overall Study|Misc|21|||
25295539|NCT00963924|50610439|FG000|Overall Study|Adverse Event|1|||
25295540|NCT00963924|50610440|FG001|Overall Study|Adverse Event|0|||
25295541|NCT00963924|50610439|FG000|Overall Study|Withdrawal by Subject|0|||
25295542|NCT00963924|50610440|FG001|Overall Study|Withdrawal by Subject|1|||
25295543|NCT00963924|50610439|FG000|Overall Study|Changed antipsychotic|0|||
25295544|NCT00963924|50610440|FG001|Overall Study|Changed antipsychotic|1|||
25295545|NCT00963924|50610439|FG000|Overall Study|Lost to Follow-up|0|||
25295546|NCT00963924|50610440|FG001|Overall Study|Lost to Follow-up|1|||
25295547|NCT03265665|50610450|FG000|24-week Data Collection|Withdrawal by Subject|2|||
25295548|NCT03265665|50610451|FG001|24-week Data Collection|Withdrawal by Subject|2|||
25295549|NCT03265665|50610450|FG000|24-week Data Collection|Lost to Follow-up|4|||
25295550|NCT03265665|50610451|FG001|24-week Data Collection|Lost to Follow-up|5|||
25295551|NCT03265665|50610450|FG000|36-week Data Collection|Lost to Follow-up|6|||
25295552|NCT03265665|50610451|FG001|36-week Data Collection|Lost to Follow-up|8|||
25295553|NCT01114646|50610461|FG000|Overall Study|Withdrawal by Subject|3|||
25295554|NCT01114646|50610462|FG001|Overall Study|Withdrawal by Subject|2|||
25295555|NCT00965562|50610471|FG000|Overall Study|Lost to Follow-up|1|||
25295556|NCT00965562|50610472|FG001|Overall Study|Lost to Follow-up|2|||
25295557|NCT00965562|50610473|FG002|Overall Study|Lost to Follow-up|3|||
25295558|NCT00965562|50610471|FG000|Overall Study|Withdrawal by Subject|2|||
25295559|NCT00965562|50610472|FG001|Overall Study|Withdrawal by Subject|2|||
25295560|NCT00965562|50610473|FG002|Overall Study|Withdrawal by Subject|0|||
25295561|NCT00912093|50610487|FG000|The Controlled Phase|Death|0|||
25295562|NCT00912093|50610488|FG001|The Controlled Phase|Death|1|||
25295563|NCT00912093|50610489|FG002|The Controlled Phase|Death|0|||
25295564|NCT00912093|50610490|FG003|The Controlled Phase|Death|0|||
25295565|NCT00912093|50610491|FG004|The Controlled Phase|Death|0|||
25295566|NCT00912093|50610487|FG000|The Controlled Phase|Medical Condition|0|||
25295567|NCT00912093|50610488|FG001|The Controlled Phase|Medical Condition|1|||
25295568|NCT00912093|50610489|FG002|The Controlled Phase|Medical Condition|0|||
25295569|NCT00912093|50610490|FG003|The Controlled Phase|Medical Condition|0|||
25295570|NCT00912093|50610491|FG004|The Controlled Phase|Medical Condition|0|||
25295571|NCT00912093|50610487|FG000|The Controlled Phase|Lost to Follow-up|0|||
25295572|NCT00912093|50610488|FG001|The Controlled Phase|Lost to Follow-up|0|||
25295573|NCT00912093|50610489|FG002|The Controlled Phase|Lost to Follow-up|0|||
25295574|NCT00912093|50610490|FG003|The Controlled Phase|Lost to Follow-up|0|||
25295575|NCT00912093|50610491|FG004|The Controlled Phase|Lost to Follow-up|1|||
25295576|NCT00965484|50610499|FG000|Overall Study|Protocol Violation|1|||
25295577|NCT00965484|50610499|FG000|Overall Study|Withdrawal by Subject|1|||
25295578|NCT00961116|50610503|FG000|Washout Period of 7 Days|Adverse Event|1|||
25295579|NCT00961116|50610504|FG001|Washout Period of 7 Days|Adverse Event|1|||
25295580|NCT00961116|50610503|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
25295581|NCT00961116|50610504|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
25295582|NCT00961116|50610503|FG000|Washout Period of 7 Days|Protocol Violation|0|||
25295583|NCT00961116|50610504|FG001|Washout Period of 7 Days|Protocol Violation|1|||
25295584|NCT00912015|50610515|FG000|Overall Study|Lack of Efficacy|1|||
25295585|NCT00912015|50610516|FG001|Overall Study|Lack of Efficacy|0|||
25295586|NCT00912015|50610517|FG002|Overall Study|Lack of Efficacy|0|||
25295587|NCT00912015|50610518|FG003|Overall Study|Lack of Efficacy|0|||
25295588|NCT00912015|50610515|FG000|Overall Study|Withdrawal by Subject|8|||
25295589|NCT00912015|50610516|FG001|Overall Study|Withdrawal by Subject|8|||
25295590|NCT00912015|50610517|FG002|Overall Study|Withdrawal by Subject|3|||
24969820|NCT00116844|50059251|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
24969821|NCT00116844|50059250|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
24969822|NCT00116844|50059251|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
24969823|NCT00128492|50059259|FG000|Overall Study|AE unrelated to study|2|||
24969824|NCT00128492|50059260|FG001|Overall Study|AE unrelated to study|9|||
24969825|NCT00128492|50059259|FG000|Overall Study|Study drug intolerance (AE)|2|||
25191722|NCT00081263|50352964|FG001|Overall Study|Inadequate pathology|1|||
24969826|NCT00128492|50059260|FG001|Overall Study|Study drug intolerance (AE)|8|||
24969827|NCT00128492|50059259|FG000|Overall Study|AE related to study|1|||
25295591|NCT00912015|50610518|FG003|Overall Study|Withdrawal by Subject|0|||
25295592|NCT00912015|50610515|FG000|Overall Study|Protocol Violation|1|||
25295593|NCT00912015|50610516|FG001|Overall Study|Protocol Violation|0|||
25295594|NCT00912015|50610517|FG002|Overall Study|Protocol Violation|0|||
25295595|NCT00912015|50610518|FG003|Overall Study|Protocol Violation|1|||
25295596|NCT00912015|50610515|FG000|Overall Study|Adverse Event|6|||
25295597|NCT00912015|50610516|FG001|Overall Study|Adverse Event|0|||
25295598|NCT00912015|50610517|FG002|Overall Study|Adverse Event|0|||
25191723|NCT00081263|50352963|FG000|Overall Study|Never treated|4|||
25191724|NCT00081263|50352964|FG001|Overall Study|Never treated|5|||
25191725|NCT00081263|50352963|FG000|Overall Study|Inadequate data|5|||
25295599|NCT00912015|50610518|FG003|Overall Study|Adverse Event|1|||
25295600|NCT00960804|50610531|FG000|Overall Study|Adverse Event|1|||
25295601|NCT00960804|50610532|FG001|Overall Study|Adverse Event|0|||
25295602|NCT00960804|50610533|FG002|Overall Study|Adverse Event|0|||
25295603|NCT00960804|50610531|FG000|Overall Study|Withdrawal by Subject|1|||
25295604|NCT00960804|50610532|FG001|Overall Study|Withdrawal by Subject|0|||
25295605|NCT00960804|50610533|FG002|Overall Study|Withdrawal by Subject|0|||
25295606|NCT00960804|50610531|FG000|Overall Study|Study terminated by the sponsor|5|||
25295607|NCT00960804|50610532|FG001|Overall Study|Study terminated by the sponsor|4|||
25295608|NCT00960804|50610533|FG002|Overall Study|Study terminated by the sponsor|10|||
25295609|NCT01126580|50610544|FG000|Overall Study|Adverse Event|14|||
25295610|NCT01126580|50610545|FG001|Overall Study|Adverse Event|8|||
25295611|NCT01126580|50610546|FG002|Overall Study|Adverse Event|12|||
25295612|NCT01126580|50610544|FG000|Overall Study|Withdrawal by Subject|11|||
25295613|NCT01126580|50610545|FG001|Overall Study|Withdrawal by Subject|19|||
25295614|NCT01126580|50610546|FG002|Overall Study|Withdrawal by Subject|14|||
25295615|NCT01126580|50610544|FG000|Overall Study|Sponsor Decision|5|||
25295616|NCT01126580|50610545|FG001|Overall Study|Sponsor Decision|4|||
25295617|NCT01126580|50610546|FG002|Overall Study|Sponsor Decision|7|||
25295618|NCT01126580|50610544|FG000|Overall Study|Physician Decision|1|||
25295619|NCT01126580|50610545|FG001|Overall Study|Physician Decision|1|||
25295620|NCT01126580|50610546|FG002|Overall Study|Physician Decision|2|||
25295621|NCT01126580|50610544|FG000|Overall Study|Entry Criteria Not Met|1|||
25295622|NCT01126580|50610545|FG001|Overall Study|Entry Criteria Not Met|1|||
25295623|NCT01126580|50610546|FG002|Overall Study|Entry Criteria Not Met|2|||
25295624|NCT01126580|50610544|FG000|Overall Study|Lack of Efficacy|2|||
25295625|NCT01126580|50610545|FG001|Overall Study|Lack of Efficacy|3|||
25295626|NCT01126580|50610546|FG002|Overall Study|Lack of Efficacy|4|||
25295627|NCT01126580|50610544|FG000|Overall Study|Protocol Violation|0|||
25295628|NCT01126580|50610545|FG001|Overall Study|Protocol Violation|1|||
25295629|NCT01126580|50610546|FG002|Overall Study|Protocol Violation|2|||
25295630|NCT01126580|50610544|FG000|Overall Study|Lost to Follow-up|15|||
25295631|NCT01126580|50610545|FG001|Overall Study|Lost to Follow-up|13|||
25295632|NCT01126580|50610546|FG002|Overall Study|Lost to Follow-up|9|||
25295633|NCT01126580|50610544|FG000|Overall Study|Treatment Non-compliance|0|||
25295634|NCT01126580|50610545|FG001|Overall Study|Treatment Non-compliance|2|||
25295635|NCT01126580|50610546|FG002|Overall Study|Treatment Non-compliance|3|||
25295636|NCT00911157|50610557|FG000|Overall Study|Adverse Event|4|||
25295637|NCT00911157|50610558|FG001|Overall Study|Adverse Event|1|||
25295638|NCT00911157|50610557|FG000|Overall Study|Withdrawal by Subject|1|||
25295639|NCT00911157|50610558|FG001|Overall Study|Withdrawal by Subject|1|||
25295640|NCT00911157|50610557|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
25295641|NCT00911157|50610558|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
25295642|NCT00911157|50610557|FG000|Overall Study|Need to treat for lung cancer|1|||
25295643|NCT00911157|50610558|FG001|Overall Study|Need to treat for lung cancer|0|||
25295644|NCT00960570|50610564|FG000|21 Day Washout Period|Adverse Event|1|||
25295645|NCT00960570|50610564|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
25295646|NCT00960570|50610564|FG000|1 Day Period Between Dosing|Adverse Event|2|||
25295647|NCT00960570|50610564|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
25191726|NCT00081263|50352964|FG001|Overall Study|Inadequate data|10|||
25191727|NCT01490294|50352974|FG000|Overall Study|Prematurely discontinuation|4|||
25295648|NCT01126424|50610577|FG000|Overall Study|Adverse Event|0|||
25295649|NCT01126424|50610578|FG001|Overall Study|Adverse Event|0|||
25295650|NCT01126424|50610579|FG002|Overall Study|Adverse Event|0|||
25295651|NCT01126424|50610580|FG003|Overall Study|Adverse Event|0|||
25295652|NCT01126424|50610581|FG004|Overall Study|Adverse Event|1|||
25295653|NCT01126424|50610582|FG005|Overall Study|Adverse Event|0|||
25295654|NCT01126424|50610577|FG000|Overall Study|Withdrawal by Subject|0|||
25295655|NCT01126424|50610578|FG001|Overall Study|Withdrawal by Subject|0|||
25295656|NCT01126424|50610579|FG002|Overall Study|Withdrawal by Subject|1|||
25295657|NCT01126424|50610580|FG003|Overall Study|Withdrawal by Subject|3|||
25070641|NCT00103285|50176690|FG000|Response Assignment|Lost to Follow-up|0|||
25295658|NCT01126424|50610581|FG004|Overall Study|Withdrawal by Subject|1|||
25295659|NCT01126424|50610582|FG005|Overall Study|Withdrawal by Subject|0|||
25295660|NCT01126268|50610590|FG000|Overall Study|Adverse Event|1|||
25295661|NCT00879658|50610601|FG000|Overall Study|Abnormal laboratory value(s)|3|||
25295662|NCT00879658|50610602|FG001|Overall Study|Abnormal laboratory value(s)|0|||
25295663|NCT00879658|50610603|FG002|Overall Study|Abnormal laboratory value(s)|0|||
25295664|NCT00879658|50610604|FG003|Overall Study|Abnormal laboratory value(s)|1|||
25295665|NCT00879658|50610605|FG004|Overall Study|Abnormal laboratory value(s)|0|||
25295666|NCT00879658|50610606|FG005|Overall Study|Abnormal laboratory value(s)|0|||
25295667|NCT00879658|50610607|FG006|Overall Study|Abnormal laboratory value(s)|0|||
25295668|NCT00879658|50610601|FG000|Overall Study|Administrative problems|2|||
25295669|NCT00879658|50610602|FG001|Overall Study|Administrative problems|1|||
25295670|NCT00879658|50610603|FG002|Overall Study|Administrative problems|0|||
25295671|NCT00879658|50610604|FG003|Overall Study|Administrative problems|1|||
25295672|NCT00879658|50610605|FG004|Overall Study|Administrative problems|0|||
25295673|NCT00879658|50610606|FG005|Overall Study|Administrative problems|0|||
25295674|NCT00879658|50610607|FG006|Overall Study|Administrative problems|0|||
25295675|NCT00879658|50610601|FG000|Overall Study|Adverse Event|6|||
25295676|NCT00879658|50610602|FG001|Overall Study|Adverse Event|4|||
25295677|NCT00879658|50610603|FG002|Overall Study|Adverse Event|3|||
25295678|NCT00879658|50610604|FG003|Overall Study|Adverse Event|1|||
25295679|NCT00879658|50610605|FG004|Overall Study|Adverse Event|2|||
25070642|NCT00103285|50176691|FG001|Response Assignment|Lost to Follow-up|9|||
25070643|NCT00103285|50176692|FG002|Response Assignment|Lost to Follow-up|5|||
25070644|NCT00103285|50176693|FG003|Response Assignment|Lost to Follow-up|5|||
25070645|NCT00103285|50176694|FG004|Response Assignment|Lost to Follow-up|1|||
25070646|NCT00103285|50176695|FG005|Response Assignment|Lost to Follow-up|2|||
25070647|NCT00103285|50176696|FG006|Response Assignment|Lost to Follow-up|2|||
25070648|NCT00103285|50176697|FG007|Response Assignment|Lost to Follow-up|5|||
25070649|NCT00103285|50176690|FG000|Response Assignment|Physician Decision|0|||
25070650|NCT00103285|50176691|FG001|Response Assignment|Physician Decision|13|||
25070651|NCT00103285|50176692|FG002|Response Assignment|Physician Decision|14|||
25070652|NCT00103285|50176693|FG003|Response Assignment|Physician Decision|9|||
25070653|NCT00103285|50176694|FG004|Response Assignment|Physician Decision|13|||
25070654|NCT00103285|50176695|FG005|Response Assignment|Physician Decision|7|||
25070655|NCT00103285|50176696|FG006|Response Assignment|Physician Decision|4|||
25070656|NCT00103285|50176697|FG007|Response Assignment|Physician Decision|35|||
25070657|NCT00103285|50176690|FG000|Response Assignment|Protocol Violation|0|||
25070658|NCT00103285|50176691|FG001|Response Assignment|Protocol Violation|2|||
25070659|NCT00103285|50176692|FG002|Response Assignment|Protocol Violation|0|||
25070660|NCT00103285|50176693|FG003|Response Assignment|Protocol Violation|0|||
25070661|NCT00103285|50176694|FG004|Response Assignment|Protocol Violation|0|||
25070662|NCT00103285|50176695|FG005|Response Assignment|Protocol Violation|0|||
25070663|NCT00103285|50176696|FG006|Response Assignment|Protocol Violation|0|||
25070664|NCT00103285|50176697|FG007|Response Assignment|Protocol Violation|0|||
25070665|NCT00103285|50176690|FG000|Response Assignment|Withdrawal by Subject|0|||
25070666|NCT00103285|50176691|FG001|Response Assignment|Withdrawal by Subject|4|||
25070667|NCT00103285|50176692|FG002|Response Assignment|Withdrawal by Subject|1|||
25070668|NCT00103285|50176693|FG003|Response Assignment|Withdrawal by Subject|1|||
25070669|NCT00103285|50176694|FG004|Response Assignment|Withdrawal by Subject|2|||
25070670|NCT00103285|50176695|FG005|Response Assignment|Withdrawal by Subject|2|||
25070671|NCT00103285|50176696|FG006|Response Assignment|Withdrawal by Subject|0|||
25070672|NCT00103285|50176697|FG007|Response Assignment|Withdrawal by Subject|2|||
25070673|NCT00103285|50176690|FG000|Response Assignment|Ineligible|0|||
25070674|NCT00103285|50176691|FG001|Response Assignment|Ineligible|8|||
25070675|NCT00103285|50176692|FG002|Response Assignment|Ineligible|6|||
25169297|NCT01833065|50300844|FG001|Overall Study|Protocol Violation|0|||
25070676|NCT00103285|50176693|FG003|Response Assignment|Ineligible|2|||
25070677|NCT00103285|50176694|FG004|Response Assignment|Ineligible|0|||
25070678|NCT00103285|50176695|FG005|Response Assignment|Ineligible|3|||
25295680|NCT00879658|50610606|FG005|Overall Study|Adverse Event|0|||
25295681|NCT00879658|50610607|FG006|Overall Study|Adverse Event|0|||
25295682|NCT00879658|50610601|FG000|Overall Study|Protocol Violation|1|||
25295683|NCT00879658|50610602|FG001|Overall Study|Protocol Violation|0|||
25169298|NCT01833065|50300845|FG002|Overall Study|Protocol Violation|0|||
25295684|NCT00879658|50610603|FG002|Overall Study|Protocol Violation|0|||
25295685|NCT00879658|50610604|FG003|Overall Study|Protocol Violation|0|||
25295686|NCT00879658|50610605|FG004|Overall Study|Protocol Violation|0|||
25295687|NCT00879658|50610606|FG005|Overall Study|Protocol Violation|0|||
25295688|NCT00879658|50610607|FG006|Overall Study|Protocol Violation|0|||
25295689|NCT00879658|50610601|FG000|Overall Study|Withdrawal by Subject|3|||
25295690|NCT00879658|50610602|FG001|Overall Study|Withdrawal by Subject|0|||
25295691|NCT00879658|50610603|FG002|Overall Study|Withdrawal by Subject|2|||
25295692|NCT00879658|50610604|FG003|Overall Study|Withdrawal by Subject|0|||
25295693|NCT00879658|50610605|FG004|Overall Study|Withdrawal by Subject|0|||
25295694|NCT00879658|50610606|FG005|Overall Study|Withdrawal by Subject|1|||
25295695|NCT00879658|50610607|FG006|Overall Study|Withdrawal by Subject|0|||
25295696|NCT00879658|50610601|FG000|Overall Study|Lack of Efficacy|0|||
25295697|NCT00879658|50610602|FG001|Overall Study|Lack of Efficacy|0|||
25295698|NCT00879658|50610603|FG002|Overall Study|Lack of Efficacy|2|||
25295699|NCT00879658|50610604|FG003|Overall Study|Lack of Efficacy|0|||
25295700|NCT00879658|50610605|FG004|Overall Study|Lack of Efficacy|0|||
25295701|NCT00879658|50610606|FG005|Overall Study|Lack of Efficacy|0|||
25295702|NCT00879658|50610607|FG006|Overall Study|Lack of Efficacy|0|||
25295703|NCT00879658|50610601|FG000|Overall Study|misrandomized (never received study med)|0|||
25295704|NCT00879658|50610602|FG001|Overall Study|misrandomized (never received study med)|0|||
25295705|NCT00879658|50610603|FG002|Overall Study|misrandomized (never received study med)|0|||
25295706|NCT00879658|50610604|FG003|Overall Study|misrandomized (never received study med)|1|||
25295707|NCT00879658|50610605|FG004|Overall Study|misrandomized (never received study med)|0|||
25295708|NCT00879658|50610606|FG005|Overall Study|misrandomized (never received study med)|0|||
25295709|NCT00879658|50610607|FG006|Overall Study|misrandomized (never received study med)|0|||
25295710|NCT00959946|50610637|FG000|Overall Study|Adverse Event|0|||
25295711|NCT00959946|50610638|FG001|Overall Study|Adverse Event|0|||
25295712|NCT00959946|50610639|FG002|Overall Study|Adverse Event|2|||
25295713|NCT00959946|50610640|FG003|Overall Study|Adverse Event|1|||
25295714|NCT00959946|50610641|FG004|Overall Study|Adverse Event|0|||
25295715|NCT00959946|50610642|FG005|Overall Study|Adverse Event|1|||
25295716|NCT00959946|50610643|FG006|Overall Study|Adverse Event|0|||
25295717|NCT00959946|50610644|FG007|Overall Study|Adverse Event|0|||
25295718|NCT00959946|50610637|FG000|Overall Study|Death|0|||
25295719|NCT00959946|50610638|FG001|Overall Study|Death|0|||
25295720|NCT00959946|50610639|FG002|Overall Study|Death|0|||
25295721|NCT00959946|50610640|FG003|Overall Study|Death|0|||
25295722|NCT00959946|50610641|FG004|Overall Study|Death|0|||
25295723|NCT00959946|50610642|FG005|Overall Study|Death|1|||
25295724|NCT00959946|50610643|FG006|Overall Study|Death|0|||
25295725|NCT00959946|50610644|FG007|Overall Study|Death|0|||
25295726|NCT00959946|50610637|FG000|Overall Study|Disease Progression|2|||
25295727|NCT00959946|50610638|FG001|Overall Study|Disease Progression|4|||
25295728|NCT00959946|50610639|FG002|Overall Study|Disease Progression|2|||
25295729|NCT00959946|50610640|FG003|Overall Study|Disease Progression|4|||
25295730|NCT00959946|50610641|FG004|Overall Study|Disease Progression|4|||
25295731|NCT00959946|50610642|FG005|Overall Study|Disease Progression|6|||
25295732|NCT00959946|50610643|FG006|Overall Study|Disease Progression|2|||
25295733|NCT00959946|50610644|FG007|Overall Study|Disease Progression|2|||
25295734|NCT00959946|50610637|FG000|Overall Study|Withdrawal by Subject|0|||
25295735|NCT00959946|50610638|FG001|Overall Study|Withdrawal by Subject|0|||
25295736|NCT00959946|50610639|FG002|Overall Study|Withdrawal by Subject|0|||
25295737|NCT00959946|50610640|FG003|Overall Study|Withdrawal by Subject|0|||
25295738|NCT00959946|50610641|FG004|Overall Study|Withdrawal by Subject|0|||
25295739|NCT00959946|50610642|FG005|Overall Study|Withdrawal by Subject|1|||
25295740|NCT00959946|50610643|FG006|Overall Study|Withdrawal by Subject|0|||
25295741|NCT00959946|50610644|FG007|Overall Study|Withdrawal by Subject|0|||
25295742|NCT00911937|50610669|FG000|Overall Study|Death|1|||
25295743|NCT00911937|50610670|FG001|Overall Study|Death|0|||
25295744|NCT00911937|50610669|FG000|Overall Study|Lost to Follow-up|8|||
25295745|NCT00911937|50610670|FG001|Overall Study|Lost to Follow-up|5|||
25295746|NCT00911937|50610669|FG000|Overall Study|Withdrawal by Subject|10|||
25295747|NCT00911937|50610670|FG001|Overall Study|Withdrawal by Subject|7|||
25295748|NCT00911937|50610669|FG000|Overall Study|Withdrawn due to pregnancy|1|||
25295749|NCT00911937|50610670|FG001|Overall Study|Withdrawn due to pregnancy|0|||
25295750|NCT00911937|50610669|FG000|Overall Study|Adverse Event|11|||
25295751|NCT00911937|50610670|FG001|Overall Study|Adverse Event|25|||
25295752|NCT00911937|50610669|FG000|Overall Study|Lack of Efficacy|11|||
25169299|NCT01833065|50300846|FG003|Overall Study|Protocol Violation|0|||
25169300|NCT01833065|50300847|FG004|Overall Study|Protocol Violation|2|||
25169301|NCT01833065|50300843|FG000|Overall Study|Lost to Follow-up|1|||
25169302|NCT01833065|50300844|FG001|Overall Study|Lost to Follow-up|0|||
25169303|NCT01833065|50300845|FG002|Overall Study|Lost to Follow-up|0|||
25169304|NCT01833065|50300846|FG003|Overall Study|Lost to Follow-up|0|||
25169305|NCT01833065|50300847|FG004|Overall Study|Lost to Follow-up|3|||
25169306|NCT01833065|50300843|FG000|Overall Study|Withdrawal by Subject|6|||
25169307|NCT01833065|50300844|FG001|Overall Study|Withdrawal by Subject|2|||
25169308|NCT01833065|50300845|FG002|Overall Study|Withdrawal by Subject|4|||
25169309|NCT01833065|50300846|FG003|Overall Study|Withdrawal by Subject|3|||
25169310|NCT01833065|50300847|FG004|Overall Study|Withdrawal by Subject|11|||
25169311|NCT01833065|50300843|FG000|Overall Study|Subject's substantial non-compliance|0|||
25169312|NCT01833065|50300844|FG001|Overall Study|Subject's substantial non-compliance|1|||
25169313|NCT01833065|50300845|FG002|Overall Study|Subject's substantial non-compliance|0|||
25169314|NCT01833065|50300846|FG003|Overall Study|Subject's substantial non-compliance|0|||
25169315|NCT01833065|50300847|FG004|Overall Study|Subject's substantial non-compliance|0|||
25169316|NCT01833065|50300843|FG000|Overall Study|Trial terminated by sponsor|8|||
25169317|NCT01833065|50300844|FG001|Overall Study|Trial terminated by sponsor|8|||
25169318|NCT01833065|50300845|FG002|Overall Study|Trial terminated by sponsor|7|||
25169319|NCT01833065|50300846|FG003|Overall Study|Trial terminated by sponsor|3|||
25169320|NCT01833065|50300847|FG004|Overall Study|Trial terminated by sponsor|13|||
25169321|NCT01833065|50300843|FG000|Overall Study|Others|2|||
25169322|NCT01833065|50300844|FG001|Overall Study|Others|1|||
25169323|NCT01833065|50300845|FG002|Overall Study|Others|1|||
25169324|NCT01833065|50300846|FG003|Overall Study|Others|1|||
25191728|NCT01490294|50352975|FG001|Overall Study|Prematurely discontinuation|0|||
25295753|NCT00911937|50610670|FG001|Overall Study|Lack of Efficacy|6|||
25295754|NCT00911937|50610669|FG000|Overall Study|Did not meet inclusion criteria|9|||
25295755|NCT00911937|50610670|FG001|Overall Study|Did not meet inclusion criteria|11|||
25295756|NCT00911937|50610669|FG000|Overall Study|Protocol Violation|14|||
25295757|NCT00911937|50610670|FG001|Overall Study|Protocol Violation|23|||
25295758|NCT00911937|50610669|FG000|Overall Study|Randomized but not treated|13|||
25295759|NCT00911937|50610670|FG001|Overall Study|Randomized but not treated|13|||
25295760|NCT00911937|50610669|FG000|Overall Study|Other|9|||
25295761|NCT00911937|50610670|FG001|Overall Study|Other|5|||
25169325|NCT01833065|50300847|FG004|Overall Study|Others|4|||
25169326|NCT01831817|50300861|FG000|Overall Study|Lost to Follow-up|1|||
25169327|NCT01831817|50300862|FG001|Overall Study|Lost to Follow-up|0|||
25191729|NCT01490294|50352976|FG002|Overall Study|Prematurely discontinuation|1|||
25295762|NCT00880048|50610679|FG000|Overall Study|Adverse Event|2|||
25169328|NCT01831817|50300863|FG002|Overall Study|Lost to Follow-up|0|||
25169329|NCT01831817|50300864|FG003|Overall Study|Lost to Follow-up|0|||
25169330|NCT01831817|50300861|FG000|Overall Study|Withdrawl of Consent|3|||
25295763|NCT00880048|50610680|FG001|Overall Study|Adverse Event|3|||
25295764|NCT00880048|50610681|FG002|Overall Study|Adverse Event|5|||
25295765|NCT00880048|50610679|FG000|Overall Study|Lack of Efficacy|1|||
25169331|NCT01831817|50300862|FG001|Overall Study|Withdrawl of Consent|0|||
25169332|NCT01831817|50300863|FG002|Overall Study|Withdrawl of Consent|0|||
25295766|NCT00880048|50610680|FG001|Overall Study|Lack of Efficacy|2|||
25295767|NCT00880048|50610681|FG002|Overall Study|Lack of Efficacy|2|||
25295768|NCT00880048|50610679|FG000|Overall Study|Protocol Violation|4|||
25295769|NCT00880048|50610680|FG001|Overall Study|Protocol Violation|6|||
25295770|NCT00880048|50610681|FG002|Overall Study|Protocol Violation|5|||
25191730|NCT01490294|50352977|FG003|Overall Study|Prematurely discontinuation|1|||
25191731|NCT01490294|50352974|FG000|Overall Study|Adverse Event|1|||
25191732|NCT01490294|50352975|FG001|Overall Study|Adverse Event|0|||
25191733|NCT01490294|50352976|FG002|Overall Study|Adverse Event|0|||
25191734|NCT01490294|50352977|FG003|Overall Study|Adverse Event|0|||
25191735|NCT00080483|50353004|FG000|Overall Study|Lost to Follow-up|1|||
25191736|NCT00080483|50353005|FG001|Overall Study|Lost to Follow-up|1|||
25191737|NCT00080483|50353004|FG000|Overall Study|Physician Decision|1|||
25191738|NCT00080483|50353005|FG001|Overall Study|Physician Decision|1|||
25191739|NCT00089141|50353026|FG000|Overall Study|Termination of trial|18|||
25295771|NCT00880048|50610679|FG000|Overall Study|Lost to Follow-up|6|||
25295772|NCT00880048|50610680|FG001|Overall Study|Lost to Follow-up|6|||
25295773|NCT00880048|50610681|FG002|Overall Study|Lost to Follow-up|5|||
25295774|NCT00880048|50610679|FG000|Overall Study|Physician Decision|1|||
25295775|NCT00880048|50610680|FG001|Overall Study|Physician Decision|1|||
25295776|NCT00880048|50610681|FG002|Overall Study|Physician Decision|7|||
25295777|NCT00880048|50610679|FG000|Overall Study|Withdrawal by Subject|5|||
25295778|NCT00880048|50610680|FG001|Overall Study|Withdrawal by Subject|8|||
25295779|NCT00880048|50610681|FG002|Overall Study|Withdrawal by Subject|5|||
25295780|NCT00880048|50610679|FG000|Overall Study|Study closed/terminated|9|||
25295781|NCT00880048|50610680|FG001|Overall Study|Study closed/terminated|7|||
25295782|NCT00880048|50610681|FG002|Overall Study|Study closed/terminated|6|||
25295783|NCT00962208|50610691|FG000|Overall Study|Could not achieve good vision|9|||
25295784|NCT00962208|50610692|FG001|Overall Study|Could not achieve good vision|0|||
25295785|NCT00962208|50610691|FG000|Overall Study|Contraindicated to continue study|5|||
25295786|NCT00962208|50610692|FG001|Overall Study|Contraindicated to continue study|1|||
25295787|NCT00962208|50610691|FG000|Overall Study|Lost to Follow-up|0|||
25295788|NCT00962208|50610692|FG001|Overall Study|Lost to Follow-up|9|||
25295789|NCT01076543|50610704|FG000|Overall Study|Withdrawal by Subject|2|||
25295790|NCT01076543|50610705|FG001|Overall Study|Withdrawal by Subject|0|||
25295791|NCT01076543|50610706|FG002|Overall Study|Withdrawal by Subject|0|||
25295792|NCT01076543|50610707|FG003|Overall Study|Withdrawal by Subject|0|||
25295793|NCT01076543|50610708|FG004|Overall Study|Withdrawal by Subject|0|||
25295794|NCT01076543|50610709|FG005|Overall Study|Withdrawal by Subject|0|||
25295795|NCT01072877|50610729|FG000|Overall Study|Lost to Follow-up|1|||
25295796|NCT01072877|50610730|FG001|Overall Study|Lost to Follow-up|1|||
25295797|NCT01072877|50610731|FG002|Overall Study|Lost to Follow-up|0|||
25295798|NCT01072877|50610732|FG003|Overall Study|Lost to Follow-up|2|||
25295799|NCT01072877|50610733|FG004|Overall Study|Lost to Follow-up|0|||
25295800|NCT00961896|50610750|FG000|Overall Study|Abnormal laboratory value|0|||
25295801|NCT00961896|50610751|FG001|Overall Study|Abnormal laboratory value|0|||
25295802|NCT00961896|50610752|FG002|Overall Study|Abnormal laboratory value|1|||
25295803|NCT00957528|50610766|FG000|Overall Study|Protocol Violation|0|||
25295804|NCT00957528|50610767|FG001|Overall Study|Protocol Violation|1|||
25295805|NCT00957528|50610768|FG002|Overall Study|Protocol Violation|0|||
25295806|NCT00957528|50610766|FG000|Overall Study|Withdrawal by Subject|0|||
25295807|NCT00957528|50610767|FG001|Overall Study|Withdrawal by Subject|0|||
25295808|NCT00957528|50610768|FG002|Overall Study|Withdrawal by Subject|1|||
25295809|NCT00958776|50610778|FG000|Overall Study|Adverse Event|0|||
25295810|NCT00958776|50610779|FG001|Overall Study|Adverse Event|1|||
25295811|NCT00958776|50610778|FG000|Overall Study|Physician Decision|1|||
25295812|NCT00958776|50610779|FG001|Overall Study|Physician Decision|0|||
25191740|NCT00089141|50353027|FG001|Overall Study|Termination of trial|24|||
25295813|NCT00958776|50610778|FG000|Overall Study|Lost to Follow-up|2|||
25295814|NCT00958776|50610779|FG001|Overall Study|Lost to Follow-up|6|||
25295815|NCT00958776|50610778|FG000|Overall Study|Withdrawal by Subject|7|||
25295816|NCT00958776|50610779|FG001|Overall Study|Withdrawal by Subject|16|||
25295817|NCT00958776|50610778|FG000|Overall Study|Protocol Violation|1|||
25191741|NCT02588664|50353073|FG000|Overall Study|Death|56|||
25191742|NCT02588664|50353074|FG001|Overall Study|Death|55|||
25295818|NCT00958776|50610779|FG001|Overall Study|Protocol Violation|1|||
25295819|NCT00958776|50610778|FG000|Overall Study|Death|2|||
25295820|NCT00958776|50610779|FG001|Overall Study|Death|1|||
25295821|NCT00958776|50610778|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
25295822|NCT00958776|50610779|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
25295823|NCT00958776|50610778|FG000|Overall Study|Missing|1|||
25295824|NCT00958776|50610779|FG001|Overall Study|Missing|1|||
25295825|NCT00596830|50610788|FG000|Overall Study|Death|258|||
25295826|NCT00596830|50610789|FG001|Overall Study|Death|247|||
25295827|NCT00596830|50610788|FG000|Overall Study|Lost to Follow-up|7|||
25295828|NCT00596830|50610789|FG001|Overall Study|Lost to Follow-up|11|||
25295829|NCT00596830|50610788|FG000|Overall Study|Withdrawal by Subject|22|||
25295830|NCT00596830|50610789|FG001|Overall Study|Withdrawal by Subject|12|||
25295831|NCT00596830|50610788|FG000|Overall Study|Study terminated by sponsor|51|||
25295832|NCT00596830|50610789|FG001|Overall Study|Study terminated by sponsor|62|||
25295833|NCT00596830|50610788|FG000|Overall Study|Follow-up was discontinued|1|||
25295834|NCT00596830|50610789|FG001|Overall Study|Follow-up was discontinued|0|||
25295835|NCT00596830|50610788|FG000|Overall Study|Randomized but not treated|3|||
25295836|NCT00596830|50610789|FG001|Overall Study|Randomized but not treated|7|||
25295837|NCT00957372|50610798|FG000|PART I|Lost to Follow-up|0|||
25295838|NCT00957372|50610799|FG001|PART I|Lost to Follow-up|0|||
25295839|NCT00957372|50610800|FG002|PART I|Lost to Follow-up|1|||
25295840|NCT00957372|50610801|FG003|PART I|Lost to Follow-up|0|||
25295841|NCT00957372|50610798|FG000|PART II|Withdrawal by Subject|0|||
25295842|NCT00957372|50610799|FG001|PART II|Withdrawal by Subject|0|||
25295843|NCT00957372|50610800|FG002|PART II|Withdrawal by Subject|0|||
25295844|NCT00957372|50610801|FG003|PART II|Withdrawal by Subject|8|||
25295845|NCT00957372|50610798|FG000|PART II|Physician Decision|0|||
25295846|NCT00957372|50610799|FG001|PART II|Physician Decision|0|||
25295847|NCT00957372|50610800|FG002|PART II|Physician Decision|0|||
25295848|NCT00957372|50610801|FG003|PART II|Physician Decision|1|||
25295849|NCT00957372|50610798|FG000|PART II|Pregnancy|0|||
25295850|NCT00957372|50610799|FG001|PART II|Pregnancy|0|||
25295851|NCT00957372|50610800|FG002|PART II|Pregnancy|0|||
25295852|NCT00957372|50610801|FG003|PART II|Pregnancy|1|||
25295853|NCT00957372|50610798|FG000|PART II|Not Know|0|||
25295854|NCT00957372|50610799|FG001|PART II|Not Know|0|||
25295855|NCT00957372|50610800|FG002|PART II|Not Know|0|||
25295856|NCT00957372|50610801|FG003|PART II|Not Know|20|||
25295857|NCT00957372|50610798|FG000|PART II|Adverse Event|0|||
25295858|NCT00957372|50610799|FG001|PART II|Adverse Event|0|||
25295859|NCT00957372|50610800|FG002|PART II|Adverse Event|0|||
25295860|NCT00957372|50610801|FG003|PART II|Adverse Event|10|||
25295861|NCT00957372|50610798|FG000|PART II|Patient non-compliance|0|||
25295862|NCT00957372|50610799|FG001|PART II|Patient non-compliance|0|||
25295863|NCT00957372|50610800|FG002|PART II|Patient non-compliance|0|||
25295864|NCT00957372|50610801|FG003|PART II|Patient non-compliance|4|||
25295865|NCT00953160|50610817|FG000|Overall Study|Lost to Follow-up|23|||
25295866|NCT00953160|50610817|FG000|Overall Study|Withdrawal by Subject|4|||
25295867|NCT00952848|50610821|FG000|Overall Study|Withdrawal by Subject|4|||
25295868|NCT00952614|50610825|FG000|Overall Study|Death|3|||
25295869|NCT00952614|50610825|FG000|Overall Study|Lost to Follow-up|3|||
25295870|NCT00952614|50610825|FG000|Overall Study|other reason|1|||
25295871|NCT00911859|50610833|FG000|Treatment Period|Adverse Event|3|||
25295872|NCT00911859|50610834|FG001|Treatment Period|Adverse Event|3|||
25295873|NCT00911859|50610835|FG002|Treatment Period|Adverse Event|7|||
25295874|NCT00911859|50610833|FG000|Treatment Period|Death|1|||
25295875|NCT00911859|50610834|FG001|Treatment Period|Death|3|||
25295876|NCT00911859|50610835|FG002|Treatment Period|Death|5|||
25295877|NCT00911859|50610833|FG000|Treatment Period|Lack of Efficacy|1|||
25295878|NCT00911859|50610834|FG001|Treatment Period|Lack of Efficacy|7|||
25295879|NCT00911859|50610835|FG002|Treatment Period|Lack of Efficacy|5|||
25295880|NCT00911859|50610833|FG000|Treatment Period|Physician Decision|3|||
25295881|NCT00911859|50610834|FG001|Treatment Period|Physician Decision|3|||
25295882|NCT00911859|50610835|FG002|Treatment Period|Physician Decision|3|||
25295883|NCT00911859|50610833|FG000|Treatment Period|Withdrawal by Subject|0|||
25295884|NCT00911859|50610834|FG001|Treatment Period|Withdrawal by Subject|4|||
25295885|NCT00911859|50610835|FG002|Treatment Period|Withdrawal by Subject|5|||
25295886|NCT00911859|50610833|FG000|Treatment Period|Did not receive study treatment|0|||
25295887|NCT00911859|50610834|FG001|Treatment Period|Did not receive study treatment|1|||
25295888|NCT00911859|50610835|FG002|Treatment Period|Did not receive study treatment|0|||
25295889|NCT00911859|50610833|FG000|Maintainance Period|Lack of Efficacy|0|||
25295890|NCT00911859|50610834|FG001|Maintainance Period|Lack of Efficacy|0|||
25295891|NCT00911859|50610835|FG002|Maintainance Period|Lack of Efficacy|9|||
25295892|NCT00911859|50610833|FG000|Maintainance Period|Physician Decision|0|||
25295893|NCT00911859|50610834|FG001|Maintainance Period|Physician Decision|0|||
25295894|NCT00911859|50610835|FG002|Maintainance Period|Physician Decision|9|||
25295895|NCT00911859|50610833|FG000|Maintainance Period|Withdrawal by Subject|0|||
25295896|NCT00911859|50610834|FG001|Maintainance Period|Withdrawal by Subject|0|||
25295897|NCT00911859|50610835|FG002|Maintainance Period|Withdrawal by Subject|3|||
25295898|NCT00911859|50610833|FG000|Follow-up Period|Death|5|||
25295899|NCT00911859|50610834|FG001|Follow-up Period|Death|8|||
25295900|NCT00911859|50610835|FG002|Follow-up Period|Death|10|||
25295901|NCT00911859|50610833|FG000|Follow-up Period|Lost to Follow-up|1|||
25295902|NCT00911859|50610834|FG001|Follow-up Period|Lost to Follow-up|1|||
25295903|NCT00911859|50610835|FG002|Follow-up Period|Lost to Follow-up|0|||
25295904|NCT00911859|50610833|FG000|Follow-up Period|Withdrawal by Subject|0|||
25295905|NCT00911859|50610834|FG001|Follow-up Period|Withdrawal by Subject|4|||
25295906|NCT00911859|50610835|FG002|Follow-up Period|Withdrawal by Subject|4|||
25295907|NCT00911859|50610833|FG000|Follow-up Period|Study terminated by sponsor|5|||
25295908|NCT00911859|50610834|FG001|Follow-up Period|Study terminated by sponsor|33|||
25295909|NCT00911859|50610835|FG002|Follow-up Period|Study terminated by sponsor|27|||
25295910|NCT00956592|50610845|FG000|Overall Study|Protocol Violation|1|||
25295911|NCT00956592|50610846|FG001|Overall Study|Protocol Violation|3|||
25295912|NCT00955968|50610856|FG000|Overall Study|Death|2|||
25295913|NCT00955968|50610857|FG001|Overall Study|Death|4|||
25295914|NCT00955968|50610856|FG000|Overall Study|Withdrawal by Subject|35|||
25295915|NCT00955968|50610857|FG001|Overall Study|Withdrawal by Subject|31|||
25295916|NCT00955968|50610856|FG000|Overall Study|Lost to Follow-up|45|||
25295917|NCT00955968|50610857|FG001|Overall Study|Lost to Follow-up|39|||
25295918|NCT00955968|50610856|FG000|Overall Study|Site closed|55|||
25295919|NCT00955968|50610857|FG001|Overall Study|Site closed|52|||
25295920|NCT02725593|50610868|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
25295921|NCT02725593|50610869|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
25295922|NCT02725593|50610868|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
25295923|NCT02725593|50610869|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
25295924|NCT02725593|50610868|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
25295925|NCT02725593|50610869|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
25295926|NCT02725593|50610868|FG000|Long Term Extension|Withdrawal by Subject|1|||
25295927|NCT02725593|50610869|FG001|Long Term Extension|Withdrawal by Subject|3|||
25295928|NCT00911625|50610877|FG000|Overall Study|Lost to Follow-up|7|||
25295929|NCT00911625|50610878|FG001|Overall Study|Lost to Follow-up|0|||
25295930|NCT00596752|50610886|FG000|Overall Study|Other Reason|44|||
25295931|NCT00596752|50610887|FG001|Overall Study|Other Reason|49|||
25295932|NCT00596752|50610886|FG000|Overall Study|Adverse Event|34|||
25295933|NCT00596752|50610887|FG001|Overall Study|Adverse Event|34|||
25295934|NCT00596752|50610886|FG000|Overall Study|Lost to Follow-up|22|||
25295935|NCT00596752|50610887|FG001|Overall Study|Lost to Follow-up|38|||
25295936|NCT00596752|50610886|FG000|Overall Study|Withdrawal by Subject|12|||
25295937|NCT00596752|50610887|FG001|Overall Study|Withdrawal by Subject|9|||
25295938|NCT00596752|50610886|FG000|Overall Study|Unsatisfactory Compliance|9|||
25295939|NCT00596752|50610887|FG001|Overall Study|Unsatisfactory Compliance|6|||
25295940|NCT00596752|50610886|FG000|Overall Study|Lack of Efficacy|4|||
25295941|NCT00596752|50610887|FG001|Overall Study|Lack of Efficacy|7|||
25295942|NCT00596752|50610886|FG000|Overall Study|Protocol Violation|1|||
25295943|NCT00596752|50610887|FG001|Overall Study|Protocol Violation|0|||
25295944|NCT00958074|50610895|FG000|Overall Study|Withdrawal by Subject|0|||
25295945|NCT00958074|50610896|FG001|Overall Study|Withdrawal by Subject|1|||
25295946|NCT00809965|50610905|FG000|Overall Study|Death|194|||
25295947|NCT00809965|50610906|FG001|Overall Study|Death|147|||
25295948|NCT00809965|50610907|FG002|Overall Study|Death|196|||
25295949|NCT00809965|50610905|FG000|Overall Study|Lost to Follow-up|17|||
25295950|NCT00809965|50610906|FG001|Overall Study|Lost to Follow-up|10|||
25295951|NCT00809965|50610907|FG002|Overall Study|Lost to Follow-up|18|||
25295952|NCT00809965|50610905|FG000|Overall Study|Withdrawal by Subject|405|||
25295953|NCT00809965|50610906|FG001|Overall Study|Withdrawal by Subject|448|||
25295954|NCT00809965|50610907|FG002|Overall Study|Withdrawal by Subject|441|||
25295955|NCT00809965|50610905|FG000|Overall Study|Other Reason|167|||
25295956|NCT00809965|50610906|FG001|Overall Study|Other Reason|170|||
25295957|NCT00809965|50610907|FG002|Overall Study|Other Reason|189|||
25295958|NCT00597376|50610917|FG000|Overall Study|Withdrawal by Subject|4|||
25295959|NCT00597376|50610918|FG001|Overall Study|Withdrawal by Subject|3|||
25295960|NCT00597376|50610917|FG000|Overall Study|Adverse Event|4|||
25295961|NCT00597376|50610918|FG001|Overall Study|Adverse Event|1|||
25295962|NCT00910689|50610954|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
25295963|NCT00910689|50610955|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
25295964|NCT00910689|50610956|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
25295965|NCT00910689|50610957|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
25295966|NCT00910689|50610954|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
25295967|NCT00910689|50610955|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
25295968|NCT00910689|50610956|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
25295969|NCT00910689|50610957|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
25295970|NCT00910689|50610954|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
25295971|NCT00910689|50610955|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
25295972|NCT00910689|50610956|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
25295973|NCT00910689|50610957|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
25295974|NCT00910689|50610954|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
25295975|NCT00910689|50610955|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
25295976|NCT00910689|50610956|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
25295977|NCT00910689|50610957|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
25295978|NCT00910689|50610954|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
25295979|NCT00910689|50610955|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
25295980|NCT00910689|50610956|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
25295981|NCT00910689|50610957|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
25295982|NCT00910689|50610954|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
25295983|NCT00910689|50610955|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
25295984|NCT00910689|50610956|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
25295985|NCT00910689|50610957|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
25295986|NCT00910689|50610954|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
25295987|NCT00910689|50610955|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
25295988|NCT00910689|50610956|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
25295989|NCT00910689|50610957|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
25295990|NCT00910689|50610954|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
25295991|NCT00910689|50610955|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
25295992|NCT00910689|50610956|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
25295993|NCT00910689|50610957|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
25295994|NCT00910689|50610954|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
25295995|NCT00910689|50610955|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
25295996|NCT00910689|50610956|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
25295997|NCT00910689|50610957|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
25295998|NCT00910689|50610954|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
25295999|NCT00910689|50610955|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
25296000|NCT00910689|50610956|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
25296001|NCT00910689|50610957|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
25296002|NCT00910689|50610954|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
25296003|NCT00910689|50610955|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
25296004|NCT00910689|50610956|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
25296005|NCT00910689|50610957|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
25296006|NCT00910689|50610954|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
25296007|NCT00910689|50610955|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
25296008|NCT00910689|50610956|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
25296009|NCT00910689|50610957|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
25296010|NCT00910689|50610954|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
25296011|NCT00910689|50610955|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
25296012|NCT00910689|50610956|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
25296013|NCT00910689|50610957|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
25296014|NCT00910689|50610954|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
25296015|NCT00910689|50610955|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
25296016|NCT00910689|50610956|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
25296017|NCT00910689|50610957|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
25296018|NCT00910689|50610954|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
25296019|NCT00910689|50610955|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
25296020|NCT00910689|50610956|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
25296021|NCT00910689|50610957|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
25296022|NCT00910689|50610954|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
25296023|NCT00910689|50610955|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
25296024|NCT00910689|50610956|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
25296025|NCT00910689|50610957|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
25296026|NCT00910689|50610954|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
25296027|NCT00910689|50610955|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
25296028|NCT00910689|50610956|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
25296029|NCT00910689|50610957|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
25296030|NCT00910689|50610954|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
25296031|NCT00910689|50610955|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
25296032|NCT00910689|50610956|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
25296033|NCT00910689|50610957|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
25296034|NCT00910689|50610954|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
25296035|NCT00910689|50610955|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
25296036|NCT00910689|50610956|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
25296037|NCT00910689|50610957|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
25296038|NCT00910689|50610954|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
25296039|NCT00910689|50610955|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
25296040|NCT00910689|50610956|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
25296041|NCT00910689|50610957|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
25296042|NCT00910689|50610954|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
25296043|NCT00910689|50610955|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
25296044|NCT00910689|50610956|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
25296045|NCT00910689|50610957|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
25296046|NCT00807001|50610972|FG000|Overall Study|Non-compliance|0|||
25296047|NCT00807001|50610973|FG001|Overall Study|Non-compliance|1|||
25296048|NCT00807001|50610974|FG002|Overall Study|Non-compliance|0|||
25296049|NCT00807001|50610975|FG003|Overall Study|Non-compliance|0|||
25296050|NCT00807001|50610976|FG004|Overall Study|Non-compliance|0|||
25296051|NCT00809341|50610990|FG000|Overall Study|Physician Decision|0|||
25296052|NCT00809341|50610991|FG001|Overall Study|Physician Decision|1|||
25296053|NCT01125800|50611002|FG000|Phase I|Protocol Violation|0|||
25296054|NCT01125800|50611003|FG001|Phase I|Protocol Violation|3|||
25296055|NCT01125800|50611004|FG002|Phase I|Protocol Violation|1|||
25296056|NCT01125800|50611005|FG003|Phase I|Protocol Violation|1|||
25296057|NCT01125800|50611006|FG004|Phase I|Protocol Violation|0|||
25296058|NCT01125800|50611002|FG000|Phase I|Adverse Event|2|||
25296059|NCT01125800|50611003|FG001|Phase I|Adverse Event|2|||
25296060|NCT01125800|50611004|FG002|Phase I|Adverse Event|1|||
25296061|NCT01125800|50611005|FG003|Phase I|Adverse Event|7|||
25296062|NCT01125800|50611006|FG004|Phase I|Adverse Event|0|||
25296063|NCT01125800|50611002|FG000|Phase I|Administrative problems|1|||
25296064|NCT01125800|50611003|FG001|Phase I|Administrative problems|0|||
25296065|NCT01125800|50611004|FG002|Phase I|Administrative problems|0|||
25296066|NCT01125800|50611005|FG003|Phase I|Administrative problems|0|||
25296067|NCT01125800|50611006|FG004|Phase I|Administrative problems|0|||
25296068|NCT01125800|50611002|FG000|Phase I|Withdrawal by Subject|0|||
25296069|NCT01125800|50611003|FG001|Phase I|Withdrawal by Subject|0|||
25296070|NCT01125800|50611004|FG002|Phase I|Withdrawal by Subject|1|||
25296071|NCT01125800|50611005|FG003|Phase I|Withdrawal by Subject|0|||
25296072|NCT01125800|50611006|FG004|Phase I|Withdrawal by Subject|0|||
25296073|NCT01125800|50611002|FG000|Phase I|Disease progression|5|||
25296074|NCT01125800|50611003|FG001|Phase I|Disease progression|4|||
25296075|NCT01125800|50611004|FG002|Phase I|Disease progression|1|||
25296076|NCT01125800|50611005|FG003|Phase I|Disease progression|3|||
25296077|NCT01125800|50611006|FG004|Phase I|Disease progression|0|||
25296078|NCT01125800|50611002|FG000|Phase II|Protocol Violation|0|||
25296079|NCT01125800|50611003|FG001|Phase II|Protocol Violation|0|||
25296080|NCT01125800|50611004|FG002|Phase II|Protocol Violation|0|||
25296081|NCT01125800|50611005|FG003|Phase II|Protocol Violation|0|||
25296082|NCT01125800|50611006|FG004|Phase II|Protocol Violation|1|||
25296083|NCT01125800|50611002|FG000|Phase II|Adverse Event|0|||
25296084|NCT01125800|50611003|FG001|Phase II|Adverse Event|0|||
25296085|NCT01125800|50611004|FG002|Phase II|Adverse Event|0|||
25296086|NCT01125800|50611005|FG003|Phase II|Adverse Event|0|||
25296087|NCT01125800|50611006|FG004|Phase II|Adverse Event|2|||
25296088|NCT01125800|50611002|FG000|Phase II|Disease progression|0|||
25296089|NCT01125800|50611003|FG001|Phase II|Disease progression|0|||
25296090|NCT01125800|50611004|FG002|Phase II|Disease progression|0|||
25296091|NCT01125800|50611005|FG003|Phase II|Disease progression|1|||
25296092|NCT01125800|50611006|FG004|Phase II|Disease progression|8|||
25296093|NCT01125722|50611023|FG000|Overall Study|Withdrawal by Subject|2|||
25296094|NCT01125722|50611024|FG001|Overall Study|Withdrawal by Subject|1|||
25296095|NCT01125722|50611023|FG000|Overall Study|Lost to Follow-up|1|||
25296096|NCT01125722|50611024|FG001|Overall Study|Lost to Follow-up|0|||
25296097|NCT00811135|50611030|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
25296098|NCT00811135|50611030|FG000|Overall Study|Death|3|||
25296099|NCT00811135|50611030|FG000|Overall Study|Protocol Violation|2|||
25296100|NCT00811135|50611030|FG000|Overall Study|Violation of Selection Criteria|1|||
25296101|NCT00811135|50611030|FG000|Overall Study|Refused Treatment|1|||
25296102|NCT00811135|50611030|FG000|Overall Study|Withdrawal by Subject|3|||
25296103|NCT00811135|50611030|FG000|Overall Study|Administrative/Other Unspecified|11|||
25296104|NCT00811135|50611030|FG000|Overall Study|Ongoing|59|||
25296105|NCT00811057|50611037|FG000|Overall Study|Protocol Violation|5|||
25296106|NCT00811057|50611038|FG001|Overall Study|Protocol Violation|10|||
25296107|NCT00811057|50611039|FG002|Overall Study|Protocol Violation|10|||
25296108|NCT00879970|50611050|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
25296109|NCT00879970|50611051|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
25296110|NCT00879970|50611052|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
25296111|NCT00879970|50611053|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
25296112|NCT00879970|50611054|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
24969828|NCT00128492|50059260|FG001|Overall Study|AE related to study|4|||
25296113|NCT00879970|50611050|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
25296114|NCT00879970|50611051|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
25296115|NCT00879970|50611052|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
25296116|NCT00879970|50611053|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
25296117|NCT00879970|50611054|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
25296118|NCT00879970|50611050|FG000|Period 1 TZD Randomization|Death|2|||
25296119|NCT00879970|50611051|FG001|Period 1 TZD Randomization|Death|1|||
25296120|NCT00879970|50611052|FG002|Period 1 TZD Randomization|Death|0|||
25296121|NCT00879970|50611053|FG003|Period 1 TZD Randomization|Death|0|||
25296122|NCT00879970|50611054|FG004|Period 1 TZD Randomization|Death|0|||
25296123|NCT00879970|50611050|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
25296124|NCT00879970|50611051|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
24969829|NCT00128492|50059259|FG000|Overall Study|Death|1|||
24969830|NCT00128492|50059260|FG001|Overall Study|Death|0|||
25296125|NCT00879970|50611052|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
25296126|NCT00879970|50611053|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
25296127|NCT00879970|50611054|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
25296128|NCT00879970|50611050|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
25296129|NCT00879970|50611051|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
25296130|NCT00879970|50611052|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
25296131|NCT00879970|50611053|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
25296132|NCT00879970|50611054|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
25296133|NCT00879970|50611050|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
25296134|NCT00879970|50611051|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
25296135|NCT00879970|50611052|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
25296136|NCT00879970|50611053|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
25296137|NCT00879970|50611054|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
25296138|NCT00879970|50611050|FG000|Period 2 Vitamin D Randomization|Death|0|||
25296139|NCT00879970|50611051|FG001|Period 2 Vitamin D Randomization|Death|0|||
25296140|NCT00879970|50611052|FG002|Period 2 Vitamin D Randomization|Death|0|||
25296141|NCT00879970|50611053|FG003|Period 2 Vitamin D Randomization|Death|2|||
25296142|NCT00879970|50611054|FG004|Period 2 Vitamin D Randomization|Death|0|||
25296143|NCT00808639|50611072|FG000|Overall Study|Disease progression before surgery.|1|||
25296144|NCT00810901|50611078|FG000|Overall Study|Lost to Follow-up|88|||
25296145|NCT00810901|50611079|FG001|Overall Study|Lost to Follow-up|58|||
25296146|NCT00910299|50611087|FG000|Overall Study|Withdrawal by Subject|16|||
25296147|NCT00910299|50611088|FG001|Overall Study|Withdrawal by Subject|13|||
25296148|NCT00910299|50611087|FG000|Overall Study|Sponsor Decision|58|||
25296149|NCT00910299|50611088|FG001|Overall Study|Sponsor Decision|60|||
25296150|NCT00910299|50611087|FG000|Overall Study|Didn't receive any study drug|2|||
25296151|NCT00910299|50611088|FG001|Overall Study|Didn't receive any study drug|1|||
25296152|NCT00595504|50611096|FG000|Overall Study|Withdrawal by Subject|1|||
25296153|NCT00595504|50611097|FG001|Overall Study|Withdrawal by Subject|3|||
25296154|NCT00595504|50611096|FG000|Overall Study|Physician Decision|1|||
25296155|NCT00595504|50611097|FG001|Overall Study|Physician Decision|0|||
25296156|NCT00808483|50611105|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
25296157|NCT00808483|50611106|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
25296158|NCT00808483|50611105|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
25296159|NCT00808483|50611106|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
25296160|NCT00808483|50611105|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
25296161|NCT00808483|50611106|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
25296162|NCT00810511|50611121|FG000|Overall Study|Protocol Violation|0|||
25296163|NCT00810511|50611122|FG001|Overall Study|Protocol Violation|1|||
25296164|NCT00810511|50611121|FG000|Overall Study|Lack of Efficacy|9|||
25296165|NCT00810511|50611122|FG001|Overall Study|Lack of Efficacy|1|||
25296166|NCT00810511|50611121|FG000|Overall Study|death in the family|0|||
25296167|NCT00810511|50611122|FG001|Overall Study|death in the family|1|||
25296168|NCT00810511|50611121|FG000|Overall Study|Lost to Follow-up|1|||
25296169|NCT00810511|50611122|FG001|Overall Study|Lost to Follow-up|0|||
25296170|NCT00810511|50611121|FG000|Overall Study|deposits on contact lens|0|||
25296171|NCT00810511|50611122|FG001|Overall Study|deposits on contact lens|1|||
25296172|NCT00596362|50611128|FG000|Overall Study|Progressive Disease|1|||
25296173|NCT00907803|50611135|FG000|Overall Study|Withdrawal of consent - long commute|1|||
25296174|NCT00907803|50611136|FG001|Overall Study|Withdrawal of consent - long commute|0|||
25296175|NCT00907803|50611137|FG002|Overall Study|Withdrawal of consent - long commute|0|||
25296176|NCT00907803|50611135|FG000|Overall Study|Adverse Event|2|||
25296177|NCT00907803|50611136|FG001|Overall Study|Adverse Event|0|||
25296178|NCT00907803|50611137|FG002|Overall Study|Adverse Event|0|||
25296179|NCT00907803|50611135|FG000|Overall Study|Withdrawal by Subject|0|||
25296180|NCT00907803|50611136|FG001|Overall Study|Withdrawal by Subject|1|||
25296181|NCT00907803|50611137|FG002|Overall Study|Withdrawal by Subject|0|||
25296182|NCT00907803|50611135|FG000|Overall Study|Lost to Follow-up|0|||
25296183|NCT00907803|50611136|FG001|Overall Study|Lost to Follow-up|1|||
25296184|NCT00907803|50611137|FG002|Overall Study|Lost to Follow-up|0|||
25296185|NCT00907803|50611135|FG000|Overall Study|Protocol Violation|0|||
25296186|NCT00907803|50611136|FG001|Overall Study|Protocol Violation|1|||
25296187|NCT00907803|50611137|FG002|Overall Study|Protocol Violation|0|||
25296188|NCT00808249|50611149|FG000|Overall Study|Adverse Event|4|||
25296189|NCT00808249|50611150|FG001|Overall Study|Adverse Event|7|||
25296190|NCT00808249|50611151|FG002|Overall Study|Adverse Event|10|||
25296191|NCT00808249|50611152|FG003|Overall Study|Adverse Event|6|||
25296192|NCT00808249|50611149|FG000|Overall Study|Lost to Follow-up|2|||
25296193|NCT00808249|50611150|FG001|Overall Study|Lost to Follow-up|3|||
25296194|NCT00808249|50611151|FG002|Overall Study|Lost to Follow-up|3|||
25296195|NCT00808249|50611152|FG003|Overall Study|Lost to Follow-up|5|||
25296196|NCT00808249|50611149|FG000|Overall Study|Withdrawal by Subject|4|||
25191743|NCT02588664|50353073|FG000|Overall Study|Lost to Follow-up|1305|||
25296197|NCT00808249|50611150|FG001|Overall Study|Withdrawal by Subject|0|||
25296198|NCT00808249|50611151|FG002|Overall Study|Withdrawal by Subject|2|||
25296199|NCT00808249|50611152|FG003|Overall Study|Withdrawal by Subject|4|||
25296200|NCT00808249|50611149|FG000|Overall Study|Protocol Violation|3|||
25296201|NCT00808249|50611150|FG001|Overall Study|Protocol Violation|3|||
25296202|NCT00808249|50611151|FG002|Overall Study|Protocol Violation|3|||
25296203|NCT00808249|50611152|FG003|Overall Study|Protocol Violation|0|||
25296204|NCT00808249|50611149|FG000|Overall Study|Lack of Efficacy|1|||
25296205|NCT00808249|50611150|FG001|Overall Study|Lack of Efficacy|1|||
25296206|NCT00808249|50611151|FG002|Overall Study|Lack of Efficacy|0|||
25296207|NCT00808249|50611152|FG003|Overall Study|Lack of Efficacy|0|||
25296208|NCT00808249|50611149|FG000|Overall Study|study specific discontinuation criteria|1|||
25296209|NCT00808249|50611150|FG001|Overall Study|study specific discontinuation criteria|0|||
25296210|NCT00808249|50611151|FG002|Overall Study|study specific discontinuation criteria|1|||
25296211|NCT00808249|50611152|FG003|Overall Study|study specific discontinuation criteria|0|||
25296212|NCT00808249|50611149|FG000|Overall Study|All other reasons|2|||
25296213|NCT00808249|50611150|FG001|Overall Study|All other reasons|1|||
25296214|NCT00808249|50611151|FG002|Overall Study|All other reasons|3|||
25296215|NCT00808249|50611152|FG003|Overall Study|All other reasons|1|||
25296216|NCT00908895|50611164|FG000|Overall Study|Lost to Follow-up|1|||
25296217|NCT00908895|50611165|FG001|Overall Study|Lost to Follow-up|3|||
25296218|NCT00908895|50611164|FG000|Overall Study|algodystrophy|2|||
25296219|NCT00908895|50611165|FG001|Overall Study|algodystrophy|2|||
25296220|NCT00908895|50611164|FG000|Overall Study|Adverse Event|1|||
25296221|NCT00908895|50611165|FG001|Overall Study|Adverse Event|1|||
25296222|NCT00591253|50611174|FG000|Overall Study|Adverse Event|3|||
25296223|NCT00591253|50611175|FG001|Overall Study|Adverse Event|3|||
25296224|NCT00591253|50611176|FG002|Overall Study|Adverse Event|1|||
25296225|NCT00591253|50611174|FG000|Overall Study|Protocol Violation|2|||
25296226|NCT00591253|50611175|FG001|Overall Study|Protocol Violation|2|||
25296227|NCT00591253|50611176|FG002|Overall Study|Protocol Violation|2|||
25296228|NCT00591253|50611174|FG000|Overall Study|Lost to Follow-up|2|||
25296229|NCT00591253|50611175|FG001|Overall Study|Lost to Follow-up|4|||
25296230|NCT00591253|50611176|FG002|Overall Study|Lost to Follow-up|0|||
25296231|NCT00591253|50611174|FG000|Overall Study|Withdrawal by Subject|1|||
25296232|NCT00591253|50611175|FG001|Overall Study|Withdrawal by Subject|7|||
25296233|NCT00591253|50611176|FG002|Overall Study|Withdrawal by Subject|6|||
25296234|NCT00591253|50611174|FG000|Overall Study|Lack of Efficacy|1|||
25296235|NCT00591253|50611175|FG001|Overall Study|Lack of Efficacy|0|||
25296236|NCT00591253|50611176|FG002|Overall Study|Lack of Efficacy|3|||
25296237|NCT00591253|50611174|FG000|Overall Study|Other|5|||
25296238|NCT00591253|50611175|FG001|Overall Study|Other|5|||
25296239|NCT00591253|50611176|FG002|Overall Study|Other|3|||
25296240|NCT00908583|50611184|FG000|Phase 1|Withdrawal by Subject|1|||
25296241|NCT00908583|50611184|FG000|Phase 1|Adverse Event|4|||
25296242|NCT00908583|50611184|FG000|Phase 2|Physician Decision|1|||
25296243|NCT00908583|50611184|FG000|Phase 2|Adverse Event|1|||
25296244|NCT00908583|50611184|FG000|Phase 3|Adverse Event|2|||
25296245|NCT00908583|50611184|FG000|Phase 4|Adverse Event|1|||
25296246|NCT00908583|50611184|FG000|Phase 4|Physician Decision|1|||
25296247|NCT00908583|50611184|FG000|Phase 5|Adverse Event|3|||
25296248|NCT00909363|50611205|FG000|Overall Study|Withdrawal by Subject|1|||
25296249|NCT00909363|50611206|FG001|Overall Study|Withdrawal by Subject|0|||
25296250|NCT00909363|50611207|FG002|Overall Study|Withdrawal by Subject|0|||
25296251|NCT00909363|50611205|FG000|Overall Study|Lack of Efficacy|1|||
25296252|NCT00909363|50611206|FG001|Overall Study|Lack of Efficacy|0|||
25296253|NCT00909363|50611207|FG002|Overall Study|Lack of Efficacy|0|||
25296254|NCT00810355|50611221|FG000|Overall Study|Lost to Follow-up|13|||
25296255|NCT00810355|50611222|FG001|Overall Study|Lost to Follow-up|17|||
25296256|NCT00810355|50611223|FG002|Overall Study|Lost to Follow-up|11|||
25296257|NCT00810355|50611221|FG000|Overall Study|Withdrawal by Subject|1|||
25296258|NCT00810355|50611222|FG001|Overall Study|Withdrawal by Subject|0|||
25296259|NCT00810355|50611223|FG002|Overall Study|Withdrawal by Subject|0|||
25296260|NCT00908349|50611231|FG000|Overall Study|Adverse Event|10|||
25296261|NCT00908349|50611231|FG000|Overall Study|Withdrawal by Subject|9|||
25296262|NCT00908349|50611231|FG000|Overall Study|Physician Decision|5|||
25296263|NCT00908349|50611231|FG000|Overall Study|Lost to Follow-up|5|||
25296264|NCT00908349|50611231|FG000|Overall Study|Various|6|||
25296265|NCT01125566|50611237|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
25296266|NCT01125566|50611238|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
25296267|NCT01125566|50611239|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
25296268|NCT01125566|50611237|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
25296269|NCT01125566|50611238|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
25296270|NCT01125566|50611239|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
25296271|NCT01125566|50611237|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
25296272|NCT01125566|50611238|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
25296273|NCT01125566|50611239|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
25296274|NCT01125566|50611237|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
25296275|NCT01125566|50611238|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
25296276|NCT01125566|50611239|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
25296277|NCT01125566|50611237|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
25296278|NCT01125566|50611238|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
25296279|NCT01125566|50611239|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
25296280|NCT01125566|50611237|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
25296281|NCT01125566|50611238|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
25296282|NCT01125566|50611239|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
25296283|NCT01125566|50611237|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
25296284|NCT01125566|50611238|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
25296285|NCT01125566|50611239|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
25296286|NCT01125566|50611237|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
25296287|NCT01125566|50611238|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
25296288|NCT01125566|50611239|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
25296289|NCT01125566|50611237|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
25296290|NCT01125566|50611238|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
25296291|NCT01125566|50611239|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
25296292|NCT01125566|50611237|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
25296293|NCT01125566|50611238|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
25296294|NCT01125566|50611239|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
25296295|NCT01125566|50611237|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
25296296|NCT01125566|50611238|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
25296297|NCT01125566|50611239|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
25296298|NCT01125566|50611237|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
25296299|NCT01125566|50611238|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
25296300|NCT01125566|50611239|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
25296301|NCT00810277|50611246|FG000|Overall Study|Adverse Event|1|||
25296302|NCT00595582|50611250|FG000|Overall Study|Pilot study that PI terminated|2|||
25296303|NCT00595582|50611250|FG000|Overall Study|Lost to Follow-up|1|||
25296304|NCT00595582|50611250|FG000|Overall Study|Adverse Event|2|||
25296305|NCT00595582|50611250|FG000|Overall Study|Physician Decision|5|||
25296306|NCT00808015|50611254|FG000|Overall Study|Death|1|||
25296307|NCT00808015|50611254|FG000|Overall Study|Lack of Efficacy|58|||
25296308|NCT00808015|50611254|FG000|Overall Study|Lost to Follow-up|76|||
25296309|NCT00808015|50611254|FG000|Overall Study|Participants not willing to participate|158|||
25296310|NCT00808015|50611254|FG000|Overall Study|Adverse Event|22|||
25296311|NCT00808015|50611254|FG000|Overall Study|Other|25|||
25296312|NCT00808015|50611254|FG000|Overall Study|Enrolled but not treated|4|||
25296313|NCT00810199|50611260|FG000|Overall Study|Adverse Event|24|||
25296314|NCT00810199|50611261|FG001|Overall Study|Adverse Event|26|||
25296315|NCT00810199|50611260|FG000|Overall Study|Death|4|||
25296316|NCT00810199|50611261|FG001|Overall Study|Death|6|||
25296317|NCT00810199|50611260|FG000|Overall Study|Withdrew consent|9|||
25296318|NCT00810199|50611261|FG001|Overall Study|Withdrew consent|12|||
25296319|NCT00810199|50611260|FG000|Overall Study|Insufficient therapeutic response|5|||
25296320|NCT00810199|50611261|FG001|Overall Study|Insufficient therapeutic response|14|||
25296321|NCT00810199|50611260|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
25296322|NCT00810199|50611261|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
25296323|NCT00810199|50611260|FG000|Overall Study|Administrative/Other|5|||
25296324|NCT00810199|50611261|FG001|Overall Study|Administrative/Other|6|||
25296325|NCT00810199|50611260|FG000|Overall Study|Protocol Violation|2|||
25296326|NCT00810199|50611261|FG001|Overall Study|Protocol Violation|6|||
25296327|NCT00810199|50611260|FG000|Overall Study|Failure to return|1|||
25296328|NCT00810199|50611261|FG001|Overall Study|Failure to return|4|||
25296329|NCT00810199|50611260|FG000|Overall Study|Did not receive study drug|2|||
25296330|NCT00810199|50611261|FG001|Overall Study|Did not receive study drug|1|||
25296331|NCT00877006|50611275|FG000|Treatment Period|Death|2|||
25296332|NCT00877006|50611276|FG001|Treatment Period|Death|1|||
25296333|NCT00877006|50611275|FG000|Treatment Period|Adverse Event|10|||
25296334|NCT00877006|50611276|FG001|Treatment Period|Adverse Event|3|||
25296335|NCT00877006|50611275|FG000|Treatment Period|Withdrawal by Subject|2|||
25296336|NCT00877006|50611276|FG001|Treatment Period|Withdrawal by Subject|3|||
25296337|NCT00877006|50611275|FG000|Treatment Period|Protocol Violation|1|||
25296338|NCT00877006|50611276|FG001|Treatment Period|Protocol Violation|0|||
25296339|NCT00877006|50611275|FG000|Treatment Period|Lost to Follow-up|0|||
25296340|NCT00877006|50611276|FG001|Treatment Period|Lost to Follow-up|1|||
25296341|NCT00877006|50611275|FG000|Treatment Period|Disease Progression|1|||
25296342|NCT00877006|50611276|FG001|Treatment Period|Disease Progression|2|||
25296343|NCT00877006|50611275|FG000|Treatment Period|Started New Treatment Regimen|2|||
25296344|NCT00877006|50611276|FG001|Treatment Period|Started New Treatment Regimen|5|||
25296345|NCT00877006|50611275|FG000|Treatment Period|Other|4|||
25296346|NCT00877006|50611276|FG001|Treatment Period|Other|4|||
25296347|NCT00877006|50611275|FG000|Treatment Period|Randomized but Not Treated|3|||
25296348|NCT00877006|50611276|FG001|Treatment Period|Randomized but Not Treated|8|||
25296349|NCT00877006|50611275|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
25296350|NCT00877006|50611276|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
25296351|NCT00877006|50611275|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
25296352|NCT00877006|50611276|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
25296353|NCT00877006|50611275|FG000|Long-Term Follow-up Period|Death|26|||
25296354|NCT00877006|50611276|FG001|Long-Term Follow-up Period|Death|18|||
25296355|NCT00877006|50611275|FG000|Long-Term Follow-up Period|Other|7|||
25296356|NCT00877006|50611276|FG001|Long-Term Follow-up Period|Other|9|||
25296357|NCT00876928|50611286|FG000|Overall Study|Lost to Follow-up|2|||
25296358|NCT00876928|50611287|FG001|Overall Study|Lost to Follow-up|5|||
25296359|NCT00876928|50611286|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
25296360|NCT00876928|50611287|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
25296361|NCT00807937|50611297|FG000|Overall Study|Adverse Event|12|||
25296362|NCT00807937|50611298|FG001|Overall Study|Adverse Event|12|||
25296363|NCT00807937|50611299|FG002|Overall Study|Adverse Event|5|||
25296364|NCT00807937|50611300|FG003|Overall Study|Adverse Event|4|||
25296365|NCT00807937|50611297|FG000|Overall Study|Protocol Violation|4|||
25296366|NCT00807937|50611298|FG001|Overall Study|Protocol Violation|5|||
25296367|NCT00807937|50611299|FG002|Overall Study|Protocol Violation|3|||
25296368|NCT00807937|50611300|FG003|Overall Study|Protocol Violation|3|||
25296369|NCT00807937|50611297|FG000|Overall Study|Withdrawal by Subject|5|||
25296370|NCT00807937|50611298|FG001|Overall Study|Withdrawal by Subject|4|||
25296371|NCT00807937|50611299|FG002|Overall Study|Withdrawal by Subject|1|||
25296372|NCT00807937|50611300|FG003|Overall Study|Withdrawal by Subject|4|||
25296373|NCT00807937|50611297|FG000|Overall Study|Lost to Follow-up|4|||
25296374|NCT00807937|50611298|FG001|Overall Study|Lost to Follow-up|0|||
25296375|NCT00807937|50611299|FG002|Overall Study|Lost to Follow-up|2|||
25296376|NCT00807937|50611300|FG003|Overall Study|Lost to Follow-up|1|||
25296377|NCT00807937|50611297|FG000|Overall Study|Lack of Efficacy|0|||
25296378|NCT00807937|50611298|FG001|Overall Study|Lack of Efficacy|0|||
25296379|NCT00807937|50611299|FG002|Overall Study|Lack of Efficacy|1|||
25296380|NCT00807937|50611300|FG003|Overall Study|Lack of Efficacy|2|||
25296381|NCT00807937|50611297|FG000|Overall Study|Intake of prohibited medicine|0|||
25296382|NCT00807937|50611298|FG001|Overall Study|Intake of prohibited medicine|0|||
25296383|NCT00807937|50611299|FG002|Overall Study|Intake of prohibited medicine|2|||
25296384|NCT00807937|50611300|FG003|Overall Study|Intake of prohibited medicine|0|||
25296385|NCT00807937|50611297|FG000|Overall Study|All other reasons (not provided)|2|||
25296386|NCT00807937|50611298|FG001|Overall Study|All other reasons (not provided)|4|||
25296387|NCT00807937|50611299|FG002|Overall Study|All other reasons (not provided)|0|||
25296388|NCT00807937|50611300|FG003|Overall Study|All other reasons (not provided)|1|||
25296389|NCT00906945|50611315|FG000|Overall Study|Found to be not eligible|0|||
25296390|NCT00906945|50611316|FG001|Overall Study|Found to be not eligible|0|||
25296391|NCT00906945|50611317|FG002|Overall Study|Found to be not eligible|0|||
25296392|NCT00906945|50611318|FG003|Overall Study|Found to be not eligible|1|||
25296393|NCT00906945|50611319|FG004|Overall Study|Found to be not eligible|1|||
25296394|NCT00906945|50611320|FG005|Overall Study|Found to be not eligible|1|||
25296395|NCT00906945|50611315|FG000|Overall Study|Physician Decision|0|||
25296396|NCT00906945|50611316|FG001|Overall Study|Physician Decision|0|||
25296397|NCT00906945|50611317|FG002|Overall Study|Physician Decision|0|||
24969831|NCT00128492|50059259|FG000|Overall Study|Lost to Follow-up|1|||
25296398|NCT00906945|50611318|FG003|Overall Study|Physician Decision|0|||
25296399|NCT00906945|50611319|FG004|Overall Study|Physician Decision|0|||
25296400|NCT00906945|50611320|FG005|Overall Study|Physician Decision|1|||
25296401|NCT00807235|50611338|FG000|Overall Study|Adverse Event|1|||
25296402|NCT00807235|50611339|FG001|Overall Study|Adverse Event|0|||
25296403|NCT00876694|50611347|FG000|Overall Study|Adverse Event|10|||
25296404|NCT00876694|50611348|FG001|Overall Study|Adverse Event|7|||
25296405|NCT00876694|50611347|FG000|Overall Study|Subject withdrew consent|6|||
25296406|NCT00876694|50611348|FG001|Overall Study|Subject withdrew consent|4|||
25296407|NCT00876694|50611347|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
25296408|NCT00876694|50611348|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
25296409|NCT00876694|50611347|FG000|Overall Study|Abnormal test procedure result(s)|1|||
25296410|NCT00876694|50611348|FG001|Overall Study|Abnormal test procedure result(s)|0|||
25296411|NCT00876694|50611347|FG000|Overall Study|Administrative problems|1|||
25296412|NCT00876694|50611348|FG001|Overall Study|Administrative problems|1|||
25296413|NCT00876694|50611347|FG000|Overall Study|Death|1|||
25296414|NCT00876694|50611348|FG001|Overall Study|Death|0|||
25296415|NCT00805441|50611356|FG000|Overall Study|Adverse Event|5|||
25296416|NCT00805441|50611357|FG001|Overall Study|Adverse Event|2|||
25296417|NCT00805441|50611356|FG000|Overall Study|Lack of Efficacy|0|||
25296418|NCT00805441|50611357|FG001|Overall Study|Lack of Efficacy|2|||
25296419|NCT00805441|50611356|FG000|Overall Study|Protocol Violation|4|||
25296420|NCT00805441|50611357|FG001|Overall Study|Protocol Violation|8|||
25296421|NCT00805441|50611356|FG000|Overall Study|Lost to Follow-up|10|||
25296422|NCT00805441|50611357|FG001|Overall Study|Lost to Follow-up|13|||
25296423|NCT00805441|50611356|FG000|Overall Study|Withdrawal by Subject|15|||
25296424|NCT00805441|50611357|FG001|Overall Study|Withdrawal by Subject|9|||
25296425|NCT00805441|50611356|FG000|Overall Study|Physician Decision|0|||
25296426|NCT00805441|50611357|FG001|Overall Study|Physician Decision|1|||
25296427|NCT00805441|50611356|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
25296428|NCT00805441|50611357|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
25296429|NCT00590317|50611365|FG000|Overall Study|Lack of Efficacy|1|||
25296430|NCT00590317|50611366|FG001|Overall Study|Lack of Efficacy|5|||
25296431|NCT01139762|50611375|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
25296432|NCT01139762|50611376|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
25296433|NCT01139762|50611377|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
25296434|NCT01139762|50611375|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
25296435|NCT01139762|50611376|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
25296436|NCT01139762|50611377|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
25296437|NCT01139762|50611375|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
25296438|NCT01139762|50611376|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
25296439|NCT01139762|50611377|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
25296440|NCT01139762|50611375|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
25296441|NCT01139762|50611376|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
25296442|NCT01139762|50611377|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
25296443|NCT01139762|50611375|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
25296444|NCT01139762|50611376|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
25296445|NCT01139762|50611377|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
25296446|NCT01139762|50611375|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
25296447|NCT01139762|50611376|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
25296448|NCT01139762|50611377|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
25296449|NCT01139762|50611375|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
25296450|NCT01139762|50611376|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
25296451|NCT01139762|50611377|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
25296452|NCT01139762|50611375|FG000|Double-Blind Randomized Active Treatment|Death|0|||
25296453|NCT01139762|50611376|FG001|Double-Blind Randomized Active Treatment|Death|1|||
25296454|NCT01139762|50611377|FG002|Double-Blind Randomized Active Treatment|Death|1|||
25296455|NCT01139762|50611375|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
25296456|NCT01139762|50611376|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
25296457|NCT01139762|50611377|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
25296458|NCT01139762|50611375|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
25296459|NCT01139762|50611376|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
25296460|NCT01139762|50611377|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
25296461|NCT01139762|50611375|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
25296462|NCT01139762|50611376|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
25296463|NCT01139762|50611377|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
25296464|NCT01139762|50611375|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
25296465|NCT01139762|50611376|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
25296466|NCT01139762|50611377|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
25296467|NCT01139762|50611375|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
25296468|NCT01139762|50611376|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
25296469|NCT01139762|50611377|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
25296470|NCT01139762|50611375|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
25296471|NCT01139762|50611376|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
25296472|NCT01139762|50611377|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
25296473|NCT01139762|50611375|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
25296474|NCT01139762|50611376|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
25296475|NCT01139762|50611377|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
25296476|NCT00805285|50611384|FG000|Overall Study|Lack of Efficacy|1|||
25296477|NCT01139450|50611391|FG000|Overall Study|Withdrawal by Subject|7|||
25296478|NCT01139450|50611392|FG001|Overall Study|Withdrawal by Subject|10|||
25296479|NCT01139450|50611393|FG002|Overall Study|Withdrawal by Subject|13|||
25296480|NCT01139450|50611391|FG000|Overall Study|Lack of Efficacy|3|||
25296481|NCT01139450|50611392|FG001|Overall Study|Lack of Efficacy|1|||
25296482|NCT01139450|50611393|FG002|Overall Study|Lack of Efficacy|8|||
25296483|NCT01139450|50611391|FG000|Overall Study|Protocol Violation|6|||
25296484|NCT01139450|50611392|FG001|Overall Study|Protocol Violation|5|||
25296485|NCT01139450|50611393|FG002|Overall Study|Protocol Violation|2|||
25296486|NCT01139450|50611391|FG000|Overall Study|Lost to Follow-up|9|||
25296487|NCT01139450|50611392|FG001|Overall Study|Lost to Follow-up|7|||
25296488|NCT01139450|50611393|FG002|Overall Study|Lost to Follow-up|11|||
25296489|NCT01139450|50611391|FG000|Overall Study|Administrative|0|||
25296490|NCT01139450|50611392|FG001|Overall Study|Administrative|0|||
25296491|NCT01139450|50611393|FG002|Overall Study|Administrative|1|||
25296492|NCT01139450|50611391|FG000|Overall Study|Adverse Event|2|||
25296493|NCT01139450|50611392|FG001|Overall Study|Adverse Event|2|||
25296494|NCT01139450|50611393|FG002|Overall Study|Adverse Event|3|||
25296495|NCT00805207|50611410|FG000|Overall Study|Protocol Violation|0|||
25296496|NCT00805207|50611411|FG001|Overall Study|Protocol Violation|0|||
25296497|NCT00805207|50611412|FG002|Overall Study|Protocol Violation|1|||
25296498|NCT00805207|50611413|FG003|Overall Study|Protocol Violation|0|||
25296499|NCT00805207|50611414|FG004|Overall Study|Protocol Violation|0|||
25296500|NCT00805207|50611415|FG005|Overall Study|Protocol Violation|0|||
25296501|NCT00805207|50611416|FG006|Overall Study|Protocol Violation|0|||
25296502|NCT00805207|50611417|FG007|Overall Study|Protocol Violation|0|||
25296503|NCT00805207|50611418|FG008|Overall Study|Protocol Violation|0|||
25296504|NCT00805207|50611410|FG000|Overall Study|Physician Decision|0|||
25296505|NCT00805207|50611411|FG001|Overall Study|Physician Decision|1|||
25296506|NCT00805207|50611412|FG002|Overall Study|Physician Decision|0|||
25296507|NCT00805207|50611413|FG003|Overall Study|Physician Decision|0|||
25296508|NCT00805207|50611414|FG004|Overall Study|Physician Decision|0|||
25296509|NCT00805207|50611415|FG005|Overall Study|Physician Decision|1|||
25296510|NCT00805207|50611416|FG006|Overall Study|Physician Decision|0|||
25296511|NCT00805207|50611417|FG007|Overall Study|Physician Decision|0|||
25296512|NCT00805207|50611418|FG008|Overall Study|Physician Decision|0|||
25296513|NCT00805207|50611410|FG000|Overall Study|Withdrawal by Subject|0|||
25296514|NCT00805207|50611411|FG001|Overall Study|Withdrawal by Subject|1|||
25296515|NCT00805207|50611412|FG002|Overall Study|Withdrawal by Subject|0|||
25296516|NCT00805207|50611413|FG003|Overall Study|Withdrawal by Subject|0|||
25296517|NCT00805207|50611414|FG004|Overall Study|Withdrawal by Subject|1|||
25296518|NCT00805207|50611415|FG005|Overall Study|Withdrawal by Subject|2|||
25296519|NCT00805207|50611416|FG006|Overall Study|Withdrawal by Subject|0|||
25296520|NCT00805207|50611417|FG007|Overall Study|Withdrawal by Subject|0|||
25296521|NCT00805207|50611418|FG008|Overall Study|Withdrawal by Subject|0|||
25296522|NCT00805675|50611445|FG000|Overall Study|Adverse Event|0|||
25296523|NCT00805675|50611446|FG001|Overall Study|Adverse Event|0|||
25296524|NCT00805675|50611447|FG002|Overall Study|Adverse Event|1|||
25296525|NCT00589303|50611461|FG000|Overall Study|Withdrawal by Subject|2|||
25296526|NCT00589303|50611462|FG001|Overall Study|Withdrawal by Subject|1|||
25296527|NCT00952380|50611473|FG000|Overall Study|Other|0|||
25296528|NCT00952380|50611474|FG001|Overall Study|Other|0|||
25296529|NCT00952380|50611475|FG002|Overall Study|Other|0|||
25296530|NCT00952380|50611476|FG003|Overall Study|Other|0|||
25296531|NCT00952380|50611477|FG004|Overall Study|Other|1|||
25296532|NCT00952380|50611473|FG000|Overall Study|Withdrawal by Subject|0|||
25296533|NCT00952380|50611474|FG001|Overall Study|Withdrawal by Subject|0|||
25296534|NCT00952380|50611475|FG002|Overall Study|Withdrawal by Subject|1|||
25296535|NCT00952380|50611476|FG003|Overall Study|Withdrawal by Subject|0|||
25296536|NCT00952380|50611477|FG004|Overall Study|Withdrawal by Subject|2|||
25296537|NCT00952380|50611473|FG000|Overall Study|Adverse Event|0|||
25296538|NCT00952380|50611474|FG001|Overall Study|Adverse Event|1|||
25296539|NCT00952380|50611475|FG002|Overall Study|Adverse Event|0|||
25296540|NCT00952380|50611476|FG003|Overall Study|Adverse Event|0|||
25296541|NCT00952380|50611477|FG004|Overall Study|Adverse Event|3|||
25296542|NCT00952380|50611473|FG000|Overall Study|Physician Decision|0|||
25296543|NCT00952380|50611474|FG001|Overall Study|Physician Decision|0|||
25296544|NCT00952380|50611475|FG002|Overall Study|Physician Decision|1|||
25296545|NCT00952380|50611476|FG003|Overall Study|Physician Decision|2|||
25296546|NCT00952380|50611477|FG004|Overall Study|Physician Decision|0|||
25296547|NCT00952380|50611473|FG000|Overall Study|Non-compliant to protocol|0|||
25296548|NCT00952380|50611474|FG001|Overall Study|Non-compliant to protocol|0|||
25296549|NCT00952380|50611475|FG002|Overall Study|Non-compliant to protocol|0|||
25296550|NCT00952380|50611476|FG003|Overall Study|Non-compliant to protocol|1|||
25296551|NCT00952380|50611477|FG004|Overall Study|Non-compliant to protocol|0|||
25296552|NCT00803179|50611494|FG000|Overall Study|Lost to Follow-up|3|||
25296553|NCT00804193|50611501|FG000|Overall Study|Lack of baseline fungus|32|||
25296554|NCT00804193|50611502|FG001|Overall Study|Lack of baseline fungus|31|||
25296555|NCT00804193|50611503|FG002|Overall Study|Lack of baseline fungus|19|||
25296556|NCT00804193|50611501|FG000|Overall Study|Adverse Event|0|||
25296557|NCT00804193|50611502|FG001|Overall Study|Adverse Event|0|||
25296558|NCT00804193|50611503|FG002|Overall Study|Adverse Event|2|||
25296559|NCT00804193|50611501|FG000|Overall Study|Lack of Efficacy|1|||
25296560|NCT00804193|50611502|FG001|Overall Study|Lack of Efficacy|1|||
25296561|NCT00804193|50611503|FG002|Overall Study|Lack of Efficacy|3|||
25296562|NCT00804193|50611501|FG000|Overall Study|Protocol Violation|0|||
25296563|NCT00804193|50611502|FG001|Overall Study|Protocol Violation|8|||
25296564|NCT00804193|50611503|FG002|Overall Study|Protocol Violation|2|||
25296565|NCT00804193|50611501|FG000|Overall Study|Lost to Follow-up|3|||
25070679|NCT00103285|50176696|FG006|Response Assignment|Ineligible|1|||
25070680|NCT00103285|50176697|FG007|Response Assignment|Ineligible|5|||
25070681|NCT00103285|50176690|FG000|Response Assignment|Refusal|0|||
25070682|NCT00103285|50176691|FG001|Response Assignment|Refusal|53|||
25070683|NCT00103285|50176692|FG002|Response Assignment|Refusal|5|||
25070684|NCT00103285|50176693|FG003|Response Assignment|Refusal|3|||
25070685|NCT00103285|50176694|FG004|Response Assignment|Refusal|25|||
25070686|NCT00103285|50176695|FG005|Response Assignment|Refusal|15|||
25070687|NCT00103285|50176696|FG006|Response Assignment|Refusal|30|||
25070688|NCT00103285|50176697|FG007|Response Assignment|Refusal|10|||
25070689|NCT00103285|50176690|FG000|Response Assignment|Other|0|||
25070690|NCT00103285|50176691|FG001|Response Assignment|Other|30|||
25070691|NCT00103285|50176692|FG002|Response Assignment|Other|48|||
25070692|NCT00103285|50176693|FG003|Response Assignment|Other|38|||
25070693|NCT00103285|50176694|FG004|Response Assignment|Other|37|||
25070694|NCT00103285|50176695|FG005|Response Assignment|Other|17|||
25070695|NCT00103285|50176696|FG006|Response Assignment|Other|11|||
25070696|NCT00103285|50176697|FG007|Response Assignment|Other|53|||
25070697|NCT02783573|50176725|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
25070698|NCT02783573|50176726|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
25070699|NCT02783573|50176727|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
25070700|NCT02783573|50176725|FG000|Placebo-Controlled Treatment Period|Death|4|||
25070701|NCT02783573|50176726|FG001|Placebo-Controlled Treatment Period|Death|2|||
25070702|NCT02783573|50176727|FG002|Placebo-Controlled Treatment Period|Death|3|||
25070703|NCT02783573|50176725|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
25070704|NCT02783573|50176726|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
25070705|NCT02783573|50176727|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
25070706|NCT02783573|50176725|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
25070707|NCT02783573|50176726|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
25070708|NCT02783573|50176727|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
25070709|NCT02783573|50176725|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
25070710|NCT02783573|50176726|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
25070711|NCT02783573|50176727|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
25070712|NCT02783573|50176725|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
25070713|NCT02783573|50176726|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
25070714|NCT02783573|50176727|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
25070715|NCT02783573|50176725|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
25070716|NCT02783573|50176726|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
25070717|NCT02783573|50176727|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
25070718|NCT02783573|50176725|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
25070719|NCT02783573|50176726|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
25070720|NCT02783573|50176727|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
25070721|NCT02783573|50176725|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
25070722|NCT02783573|50176726|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
25070723|NCT02783573|50176727|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
25070724|NCT02783573|50176725|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
25070725|NCT02783573|50176726|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
25070726|NCT02783573|50176727|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
25070727|NCT02783573|50176725|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
25070728|NCT02783573|50176726|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
25191744|NCT02588664|50353074|FG001|Overall Study|Lost to Follow-up|990|||
25296566|NCT00804193|50611502|FG001|Overall Study|Lost to Follow-up|3|||
25296567|NCT00804193|50611503|FG002|Overall Study|Lost to Follow-up|4|||
25296568|NCT00804193|50611501|FG000|Overall Study|Withdrawal by Subject|3|||
25296569|NCT00804193|50611502|FG001|Overall Study|Withdrawal by Subject|1|||
25296570|NCT00804193|50611503|FG002|Overall Study|Withdrawal by Subject|2|||
25296571|NCT00957996|50611513|FG000|Overall Study|Death|4|||
25296572|NCT00957996|50611514|FG001|Overall Study|Death|10|||
25296573|NCT00957996|50611513|FG000|Overall Study|Lost to Follow-up|4|||
25296574|NCT00957996|50611514|FG001|Overall Study|Lost to Follow-up|7|||
25296575|NCT00957996|50611513|FG000|Overall Study|Withdrawal by Subject|9|||
25296576|NCT00957996|50611514|FG001|Overall Study|Withdrawal by Subject|2|||
25296577|NCT00957996|50611513|FG000|Overall Study|Adverse Event|2|||
25296578|NCT00957996|50611514|FG001|Overall Study|Adverse Event|1|||
25296579|NCT00957996|50611513|FG000|Overall Study|Physician Decision|1|||
25296580|NCT00957996|50611514|FG001|Overall Study|Physician Decision|1|||
25296581|NCT00957996|50611513|FG000|Overall Study|Influenza-related complication|0|||
25070729|NCT02783573|50176727|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
25296582|NCT00957996|50611514|FG001|Overall Study|Influenza-related complication|1|||
25296583|NCT00957996|50611513|FG000|Overall Study|Missing|1|||
25296584|NCT00957996|50611514|FG001|Overall Study|Missing|0|||
25296585|NCT00957996|50611513|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
25296586|NCT00957996|50611514|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
25296587|NCT00589693|50611524|FG000|Overall Study|randomized in error|12|||
25296588|NCT00589693|50611525|FG001|Overall Study|randomized in error|6|||
25296589|NCT00589693|50611524|FG000|Overall Study|Adverse Event|4|||
25296590|NCT00589693|50611525|FG001|Overall Study|Adverse Event|4|||
25296591|NCT00589693|50611524|FG000|Overall Study|Death|26|||
25296592|NCT00589693|50611525|FG001|Overall Study|Death|16|||
25296593|NCT00589693|50611524|FG000|Overall Study|Lack of Efficacy|0|||
25296594|NCT00589693|50611525|FG001|Overall Study|Lack of Efficacy|1|||
25296595|NCT00589693|50611524|FG000|Overall Study|Lost to Follow-up|1|||
25296596|NCT00589693|50611525|FG001|Overall Study|Lost to Follow-up|0|||
25296597|NCT00589693|50611524|FG000|Overall Study|Physician Decision|0|||
25296598|NCT00589693|50611525|FG001|Overall Study|Physician Decision|1|||
25296599|NCT00589693|50611524|FG000|Overall Study|Protocol Violation|1|||
25296600|NCT00589693|50611525|FG001|Overall Study|Protocol Violation|1|||
25296601|NCT00803101|50611533|FG000|Overall Study|Death / Serious Adverse Event|4|||
25296602|NCT00803101|50611534|FG001|Overall Study|Death / Serious Adverse Event|6|||
25296603|NCT00803101|50611533|FG000|Overall Study|Withdrawal by Subject|6|||
25296604|NCT00803101|50611534|FG001|Overall Study|Withdrawal by Subject|4|||
25296605|NCT00803101|50611533|FG000|Overall Study|Lost to Follow-up|2|||
25296606|NCT00803101|50611534|FG001|Overall Study|Lost to Follow-up|2|||
25296607|NCT00803101|50611533|FG000|Overall Study|Protocol Violation|1|||
25296608|NCT00803101|50611534|FG001|Overall Study|Protocol Violation|7|||
25296609|NCT00803101|50611533|FG000|Overall Study|Surgery finished outside protocol window|1|||
25296610|NCT00803101|50611534|FG001|Overall Study|Surgery finished outside protocol window|1|||
25296611|NCT00803101|50611533|FG000|Overall Study|Patient died outside SAE report period|1|||
25296612|NCT00803101|50611534|FG001|Overall Study|Patient died outside SAE report period|0|||
25296613|NCT00803101|50611533|FG000|Overall Study|Patient did not attend scheduled visit|2|||
25296614|NCT00803101|50611534|FG001|Overall Study|Patient did not attend scheduled visit|1|||
25296615|NCT00803101|50611533|FG000|Overall Study|Patient did not have surgery|1|||
25296616|NCT00803101|50611534|FG001|Overall Study|Patient did not have surgery|1|||
25296617|NCT00801229|50611542|FG000|Signed Consent|Withdrawal by Subject|2|||
25296618|NCT00801229|50611543|FG001|Signed Consent|Withdrawal by Subject|2|||
25296619|NCT00801229|50611542|FG000|Signed Consent|Found Ineligible|1|||
25296620|NCT00801229|50611543|FG001|Signed Consent|Found Ineligible|1|||
25296621|NCT00801229|50611542|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
25296622|NCT00801229|50611543|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
25296623|NCT00801229|50611542|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
25296624|NCT00801229|50611543|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
25296625|NCT00801229|50611542|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
25296626|NCT00801229|50611543|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
25296627|NCT00801229|50611542|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
25296628|NCT00801229|50611543|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
25296629|NCT00801229|50611542|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
25296630|NCT00801229|50611543|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
25296631|NCT00801229|50611542|FG000|Received Study Drug/Placebo|Adverse Event|1|||
25296632|NCT00801229|50611543|FG001|Received Study Drug/Placebo|Adverse Event|1|||
25296633|NCT00948246|50611549|FG000|Overall Study|Lost to Follow-up|11|||
25296634|NCT00948246|50611549|FG000|Overall Study|Adverse Event|11|||
25296635|NCT00948246|50611549|FG000|Overall Study|Death|1|||
25296636|NCT00948246|50611549|FG000|Overall Study|Withdrawal by Subject|1|||
25296637|NCT00800683|50611555|FG000|Overall Study|Adverse Event|11|||
25296638|NCT00800683|50611556|FG001|Overall Study|Adverse Event|8|||
25296639|NCT00800683|50611555|FG000|Overall Study|Lost to Follow-up|3|||
25296640|NCT00800683|50611556|FG001|Overall Study|Lost to Follow-up|1|||
25296641|NCT00800683|50611555|FG000|Overall Study|Withdrawal by Subject|1|||
25296642|NCT00800683|50611556|FG001|Overall Study|Withdrawal by Subject|7|||
25296643|NCT00800683|50611555|FG000|Overall Study|Lack of Efficacy|1|||
25296644|NCT00800683|50611556|FG001|Overall Study|Lack of Efficacy|1|||
25296645|NCT00800683|50611555|FG000|Overall Study|Other|1|||
25296646|NCT00800683|50611556|FG001|Overall Study|Other|2|||
25296647|NCT01124864|50611568|FG000|Overall Study|Follow up phase competed as per protocol|18|||
25296648|NCT01124864|50611569|FG001|Overall Study|Follow up phase competed as per protocol|22|||
25296649|NCT01124864|50611570|FG002|Overall Study|Follow up phase competed as per protocol|24|||
25296650|NCT01124864|50611571|FG003|Overall Study|Follow up phase competed as per protocol|18|||
25296651|NCT01124864|50611572|FG004|Overall Study|Follow up phase competed as per protocol|26|||
25296652|NCT01124864|50611573|FG005|Overall Study|Follow up phase competed as per protocol|2|||
25296653|NCT01124864|50611568|FG000|Overall Study|Death|6|||
24969832|NCT00128492|50059260|FG001|Overall Study|Lost to Follow-up|5|||
25296654|NCT01124864|50611569|FG001|Overall Study|Death|9|||
25296655|NCT01124864|50611570|FG002|Overall Study|Death|6|||
25296656|NCT01124864|50611571|FG003|Overall Study|Death|2|||
25296657|NCT01124864|50611572|FG004|Overall Study|Death|1|||
25296658|NCT01124864|50611573|FG005|Overall Study|Death|0|||
25296659|NCT01124864|50611568|FG000|Overall Study|Withdrawal by Subject|2|||
25296660|NCT01124864|50611569|FG001|Overall Study|Withdrawal by Subject|3|||
25296661|NCT01124864|50611570|FG002|Overall Study|Withdrawal by Subject|4|||
25296662|NCT01124864|50611571|FG003|Overall Study|Withdrawal by Subject|0|||
25296663|NCT01124864|50611572|FG004|Overall Study|Withdrawal by Subject|2|||
25296664|NCT01124864|50611573|FG005|Overall Study|Withdrawal by Subject|1|||
25296665|NCT01124864|50611568|FG000|Overall Study|Lost to Follow-up|1|||
25296666|NCT01124864|50611569|FG001|Overall Study|Lost to Follow-up|1|||
25296667|NCT01124864|50611570|FG002|Overall Study|Lost to Follow-up|0|||
25296668|NCT01124864|50611571|FG003|Overall Study|Lost to Follow-up|1|||
25296669|NCT01124864|50611572|FG004|Overall Study|Lost to Follow-up|0|||
25296670|NCT01124864|50611573|FG005|Overall Study|Lost to Follow-up|0|||
25296671|NCT01124864|50611568|FG000|Overall Study|Protocol Violation|1|||
25296672|NCT01124864|50611569|FG001|Overall Study|Protocol Violation|0|||
25296673|NCT01124864|50611570|FG002|Overall Study|Protocol Violation|0|||
25296674|NCT01124864|50611571|FG003|Overall Study|Protocol Violation|0|||
25296675|NCT01124864|50611572|FG004|Overall Study|Protocol Violation|1|||
25296676|NCT01124864|50611573|FG005|Overall Study|Protocol Violation|0|||
25296677|NCT01113710|50611589|FG000|Overall Study|Adverse Event|64|||
25296678|NCT01113710|50611589|FG000|Overall Study|Lack of Efficacy|41|||
25296679|NCT01113710|50611589|FG000|Overall Study|No Information Available|40|||
25296680|NCT01113710|50611589|FG000|Overall Study|Withdrawal by Subject|28|||
25296681|NCT01113710|50611589|FG000|Overall Study|Lost to Follow-up|20|||
25296682|NCT01113710|50611589|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
25296683|NCT01113710|50611589|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
25296684|NCT01113710|50611589|FG000|Overall Study|Lack of Patient's Compliance|8|||
25296685|NCT01113710|50611589|FG000|Overall Study|Other|7|||
25296686|NCT01113710|50611589|FG000|Overall Study|Adverse Event/Other|5|||
25296687|NCT01113710|50611589|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
25296688|NCT01113710|50611589|FG000|Overall Study|Lack of Efficacy/Other|4|||
25296689|NCT01113710|50611589|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
25296690|NCT01113710|50611589|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
25296691|NCT01113710|50611589|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
25296692|NCT01113710|50611589|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
25296693|NCT01113710|50611589|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
25296694|NCT01113710|50611589|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
25296695|NCT01113710|50611589|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
25296696|NCT01113710|50611589|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
25296697|NCT01113710|50611589|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
25296698|NCT01113710|50611589|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
25296699|NCT01113710|50611589|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
25296700|NCT01113710|50611589|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
25296701|NCT01113710|50611589|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
25296702|NCT01124162|50611595|FG000|First Intervention|Adverse Event|2|||
25296703|NCT01124162|50611596|FG001|First Intervention|Adverse Event|0|||
25296704|NCT01124162|50611595|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
25296705|NCT01124162|50611596|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
25296706|NCT00906399|50611605|FG000|Year 1|Randomized But Not Treated|0|||
25296707|NCT00906399|50611606|FG001|Year 1|Randomized But Not Treated|1|||
25296708|NCT00906399|50611607|FG002|Year 1|Randomized But Not Treated|3|||
25296709|NCT00906399|50611608|FG003|Year 1|Randomized But Not Treated|0|||
25296710|NCT00906399|50611609|FG004|Year 1|Randomized But Not Treated|0|||
25296711|NCT00906399|50611610|FG005|Year 1|Randomized But Not Treated|0|||
25296712|NCT00906399|50611611|FG006|Year 1|Randomized But Not Treated|0|||
25296713|NCT00906399|50611605|FG000|Year 1|Adverse Event|4|||
25296714|NCT00906399|50611606|FG001|Year 1|Adverse Event|22|||
25296715|NCT00906399|50611607|FG002|Year 1|Adverse Event|24|||
25296716|NCT00906399|50611608|FG003|Year 1|Adverse Event|0|||
25296717|NCT00906399|50611609|FG004|Year 1|Adverse Event|0|||
25296718|NCT00906399|50611610|FG005|Year 1|Adverse Event|0|||
25296719|NCT00906399|50611611|FG006|Year 1|Adverse Event|0|||
25296720|NCT00906399|50611605|FG000|Year 1|Lost to Follow-up|4|||
25296721|NCT00906399|50611606|FG001|Year 1|Lost to Follow-up|4|||
25296722|NCT00906399|50611607|FG002|Year 1|Lost to Follow-up|2|||
25296723|NCT00906399|50611608|FG003|Year 1|Lost to Follow-up|0|||
25296724|NCT00906399|50611609|FG004|Year 1|Lost to Follow-up|0|||
25296725|NCT00906399|50611610|FG005|Year 1|Lost to Follow-up|0|||
25296726|NCT00906399|50611611|FG006|Year 1|Lost to Follow-up|0|||
25296727|NCT00906399|50611605|FG000|Year 1|Withdrawal by Subject|30|||
25296728|NCT00906399|50611606|FG001|Year 1|Withdrawal by Subject|32|||
25296729|NCT00906399|50611607|FG002|Year 1|Withdrawal by Subject|36|||
25296730|NCT00906399|50611608|FG003|Year 1|Withdrawal by Subject|0|||
25296731|NCT00906399|50611609|FG004|Year 1|Withdrawal by Subject|0|||
25296732|NCT00906399|50611610|FG005|Year 1|Withdrawal by Subject|0|||
25296733|NCT00906399|50611611|FG006|Year 1|Withdrawal by Subject|0|||
25296734|NCT00906399|50611605|FG000|Year 1|Physician Decision|0|||
25296735|NCT00906399|50611606|FG001|Year 1|Physician Decision|1|||
25296736|NCT00906399|50611607|FG002|Year 1|Physician Decision|3|||
25296737|NCT00906399|50611608|FG003|Year 1|Physician Decision|0|||
25296738|NCT00906399|50611609|FG004|Year 1|Physician Decision|0|||
25296739|NCT00906399|50611610|FG005|Year 1|Physician Decision|0|||
25296740|NCT00906399|50611611|FG006|Year 1|Physician Decision|0|||
25296741|NCT00906399|50611605|FG000|Year 1|Death|2|||
25296742|NCT00906399|50611606|FG001|Year 1|Death|1|||
25296743|NCT00906399|50611607|FG002|Year 1|Death|1|||
25296744|NCT00906399|50611608|FG003|Year 1|Death|0|||
25296745|NCT00906399|50611609|FG004|Year 1|Death|0|||
25296746|NCT00906399|50611610|FG005|Year 1|Death|0|||
25296747|NCT00906399|50611611|FG006|Year 1|Death|0|||
25296748|NCT00906399|50611605|FG000|Year 1|Other|4|||
25296749|NCT00906399|50611606|FG001|Year 1|Other|2|||
25296750|NCT00906399|50611607|FG002|Year 1|Other|7|||
25296751|NCT00906399|50611608|FG003|Year 1|Other|0|||
25296752|NCT00906399|50611609|FG004|Year 1|Other|0|||
25296753|NCT00906399|50611610|FG005|Year 1|Other|0|||
25296754|NCT00906399|50611611|FG006|Year 1|Other|0|||
25296755|NCT00906399|50611605|FG000|Year 2|Adverse Event|0|||
25296756|NCT00906399|50611606|FG001|Year 2|Adverse Event|0|||
25296757|NCT00906399|50611607|FG002|Year 2|Adverse Event|0|||
25296758|NCT00906399|50611608|FG003|Year 2|Adverse Event|9|||
25296759|NCT00906399|50611609|FG004|Year 2|Adverse Event|8|||
25296760|NCT00906399|50611610|FG005|Year 2|Adverse Event|11|||
25296761|NCT00906399|50611611|FG006|Year 2|Adverse Event|6|||
25296762|NCT00906399|50611605|FG000|Year 2|Lost to Follow-up|0|||
25296763|NCT00906399|50611606|FG001|Year 2|Lost to Follow-up|0|||
25296764|NCT00906399|50611607|FG002|Year 2|Lost to Follow-up|0|||
25296765|NCT00906399|50611608|FG003|Year 2|Lost to Follow-up|1|||
25296766|NCT00906399|50611609|FG004|Year 2|Lost to Follow-up|4|||
25296767|NCT00906399|50611610|FG005|Year 2|Lost to Follow-up|2|||
25296768|NCT00906399|50611611|FG006|Year 2|Lost to Follow-up|4|||
25296769|NCT00906399|50611605|FG000|Year 2|Withdrawal by Subject|0|||
25296770|NCT00906399|50611606|FG001|Year 2|Withdrawal by Subject|0|||
25296771|NCT00906399|50611607|FG002|Year 2|Withdrawal by Subject|0|||
25296772|NCT00906399|50611608|FG003|Year 2|Withdrawal by Subject|17|||
25296773|NCT00906399|50611609|FG004|Year 2|Withdrawal by Subject|18|||
25296774|NCT00906399|50611610|FG005|Year 2|Withdrawal by Subject|27|||
25296775|NCT00906399|50611611|FG006|Year 2|Withdrawal by Subject|13|||
25296776|NCT00906399|50611605|FG000|Year 2|Physician Decision|0|||
25296777|NCT00906399|50611606|FG001|Year 2|Physician Decision|0|||
25296778|NCT00906399|50611607|FG002|Year 2|Physician Decision|0|||
25296779|NCT00906399|50611608|FG003|Year 2|Physician Decision|0|||
25296780|NCT00906399|50611609|FG004|Year 2|Physician Decision|2|||
25296781|NCT00906399|50611610|FG005|Year 2|Physician Decision|6|||
25296782|NCT00906399|50611611|FG006|Year 2|Physician Decision|3|||
25296783|NCT00906399|50611605|FG000|Year 2|Death|0|||
25296784|NCT00906399|50611606|FG001|Year 2|Death|0|||
25296785|NCT00906399|50611607|FG002|Year 2|Death|0|||
25296786|NCT00906399|50611608|FG003|Year 2|Death|1|||
25296787|NCT00906399|50611609|FG004|Year 2|Death|0|||
25296788|NCT00906399|50611610|FG005|Year 2|Death|0|||
25296789|NCT00906399|50611611|FG006|Year 2|Death|3|||
25296790|NCT00906399|50611605|FG000|Year 2|Other|0|||
25296791|NCT00906399|50611606|FG001|Year 2|Other|0|||
25296792|NCT00906399|50611607|FG002|Year 2|Other|0|||
25296793|NCT00906399|50611608|FG003|Year 2|Other|2|||
25296794|NCT00906399|50611609|FG004|Year 2|Other|3|||
25296795|NCT00906399|50611610|FG005|Year 2|Other|1|||
25296796|NCT00906399|50611611|FG006|Year 2|Other|0|||
25296797|NCT01111838|50611623|FG000|Overall Study|Patient Ineligible|2|||
25296798|NCT01111838|50611623|FG000|Overall Study|Not Treated|3|||
25296799|NCT01111838|50611623|FG000|Overall Study|Clinical deterioration|1|||
25296800|NCT01111838|50611623|FG000|Overall Study|Other Complicating Disease|1|||
25296801|NCT00947856|50611629|FG000|Treatment Period|Progressive Disease|33|||
25296802|NCT00947856|50611630|FG001|Treatment Period|Progressive Disease|12|||
25296803|NCT00947856|50611629|FG000|Treatment Period|Adverse Event|15|||
25296804|NCT00947856|50611630|FG001|Treatment Period|Adverse Event|9|||
25296805|NCT00947856|50611629|FG000|Treatment Period|Physician Decision|14|||
25296806|NCT00947856|50611630|FG001|Treatment Period|Physician Decision|6|||
25296807|NCT00947856|50611629|FG000|Treatment Period|Study Stopped by Sponsor|4|||
25296808|NCT00947856|50611630|FG001|Treatment Period|Study Stopped by Sponsor|4|||
25296809|NCT00947856|50611629|FG000|Treatment Period|Withdrawal by Subject|12|||
25296810|NCT00947856|50611630|FG001|Treatment Period|Withdrawal by Subject|1|||
25296811|NCT00947856|50611629|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
25296812|NCT00947856|50611630|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
25296813|NCT00947856|50611629|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
25296814|NCT00947856|50611630|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
25296815|NCT00947856|50611629|FG000|Follow-up Period|Lost to Follow-up|7|||
25296816|NCT00947856|50611630|FG001|Follow-up Period|Lost to Follow-up|0|||
25296817|NCT00947856|50611629|FG000|Follow-up Period|Patient unavailable for site visits|1|||
25296818|NCT00947856|50611630|FG001|Follow-up Period|Patient unavailable for site visits|0|||
25296819|NCT00947856|50611629|FG000|Follow-up Period|Withdrawal by Subject|1|||
25296820|NCT00947856|50611630|FG001|Follow-up Period|Withdrawal by Subject|0|||
25296821|NCT00947544|50611645|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
25296822|NCT00947544|50611646|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
25296823|NCT00907335|50611658|FG000|Overall Study|Withdrawal by Subject|2|||
25296824|NCT00907335|50611659|FG001|Overall Study|Withdrawal by Subject|0|||
25296825|NCT00907335|50611658|FG000|Overall Study|Adverse Event|4|||
25296826|NCT00907335|50611659|FG001|Overall Study|Adverse Event|1|||
25296827|NCT00907335|50611658|FG000|Overall Study|Lost to Follow-up|2|||
25296828|NCT00907335|50611659|FG001|Overall Study|Lost to Follow-up|0|||
25296829|NCT00947154|50611665|FG000|Overall Study|Lost to Follow-up|1|||
25296830|NCT01124006|50611673|FG000|Overall Study|Withdrawal by Subject|2|||
25296831|NCT01124006|50611674|FG001|Overall Study|Withdrawal by Subject|2|||
25296832|NCT01124006|50611675|FG002|Overall Study|Withdrawal by Subject|0|||
25296833|NCT01124006|50611673|FG000|Overall Study|Lost to Follow-up|1|||
25296834|NCT01124006|50611674|FG001|Overall Study|Lost to Follow-up|0|||
25296835|NCT01124006|50611675|FG002|Overall Study|Lost to Follow-up|1|||
25296836|NCT01124006|50611673|FG000|Overall Study|Other|0|||
25296837|NCT01124006|50611674|FG001|Overall Study|Other|0|||
25296838|NCT01124006|50611675|FG002|Overall Study|Other|1|||
25296839|NCT00952068|50611683|FG000|Overall Study|Adverse Event|3|||
24969833|NCT00128492|50059259|FG000|Overall Study|Noncompliance|0|||
25296840|NCT00952068|50611683|FG000|Overall Study|Withdrawal by Subject|4|||
25296841|NCT01123850|50611687|FG000|Overall Study|Slow enrollment|45|||
25296842|NCT01123382|50611693|FG000|Overall Study|Withdrawal by Subject|1|||
25296843|NCT01123382|50611694|FG001|Overall Study|Withdrawal by Subject|4|||
25296844|NCT01123382|50611693|FG000|Overall Study|Lost to Follow-up|1|||
25296845|NCT01123382|50611694|FG001|Overall Study|Lost to Follow-up|2|||
25296846|NCT00951912|50611703|FG000|Overall Study|Lack of Efficacy|1|||
25296847|NCT00951912|50611704|FG001|Overall Study|Lack of Efficacy|0|||
25296848|NCT00951912|50611705|FG002|Overall Study|Lack of Efficacy|0|||
25296849|NCT00951912|50611703|FG000|Overall Study|Adverse Event|0|||
25296850|NCT00951912|50611704|FG001|Overall Study|Adverse Event|1|||
25296851|NCT00951912|50611705|FG002|Overall Study|Adverse Event|1|||
25296852|NCT00951912|50611703|FG000|Overall Study|Lost to Follow-up|2|||
25296853|NCT00951912|50611704|FG001|Overall Study|Lost to Follow-up|2|||
25296854|NCT00951912|50611705|FG002|Overall Study|Lost to Follow-up|0|||
25296855|NCT00951912|50611703|FG000|Overall Study|Physician Decision|1|||
25296856|NCT00951912|50611704|FG001|Overall Study|Physician Decision|0|||
25296857|NCT00951912|50611705|FG002|Overall Study|Physician Decision|1|||
25296858|NCT00951912|50611703|FG000|Overall Study|Withdrawal by Subject|1|||
25296859|NCT00951912|50611704|FG001|Overall Study|Withdrawal by Subject|1|||
25296860|NCT00951912|50611705|FG002|Overall Study|Withdrawal by Subject|0|||
25296861|NCT00951912|50611703|FG000|Overall Study|Other:Depression|1|||
25296862|NCT00951912|50611704|FG001|Overall Study|Other:Depression|0|||
25296863|NCT00951912|50611705|FG002|Overall Study|Other:Depression|0|||
25296864|NCT00951912|50611703|FG000|Overall Study|Other: Colon cancer|1|||
25296865|NCT00951912|50611704|FG001|Overall Study|Other: Colon cancer|0|||
25296866|NCT00951912|50611705|FG002|Overall Study|Other: Colon cancer|0|||
25296867|NCT00951912|50611703|FG000|Overall Study|Other: Stroke|0|||
25296868|NCT00951912|50611704|FG001|Overall Study|Other: Stroke|1|||
25296869|NCT00951912|50611705|FG002|Overall Study|Other: Stroke|0|||
25296870|NCT01123148|50611713|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
25296871|NCT01123148|50611713|FG000|Overall Study|Didn't meet milestone criteria|1|||
25296872|NCT01123070|50611721|FG000|Part B Double Blind Period|Protocol Violation|0|||
25296873|NCT01123070|50611722|FG001|Part B Double Blind Period|Protocol Violation|0|||
25296874|NCT01123070|50611723|FG002|Part B Double Blind Period|Protocol Violation|0|||
25296875|NCT01123070|50611724|FG003|Part B Double Blind Period|Protocol Violation|1|||
25296876|NCT01123070|50611721|FG000|Part B Double Blind Period|Adverse Event|0|||
25296877|NCT01123070|50611722|FG001|Part B Double Blind Period|Adverse Event|0|||
25296878|NCT01123070|50611723|FG002|Part B Double Blind Period|Adverse Event|2|||
25296879|NCT01123070|50611724|FG003|Part B Double Blind Period|Adverse Event|0|||
25296880|NCT01123070|50611721|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
25296881|NCT01123070|50611722|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
25296882|NCT01123070|50611723|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
25296883|NCT01123070|50611724|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
25296884|NCT01122680|50611735|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
25296885|NCT01122680|50611736|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
25296886|NCT01122680|50611737|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
25296887|NCT01122680|50611738|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
25296888|NCT01122680|50611735|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
25296889|NCT01122680|50611736|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
25296890|NCT01122680|50611737|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
25296891|NCT01122680|50611738|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
25296892|NCT01122680|50611735|FG000|Period 1 (4 Weeks)|Other|1|||
25296893|NCT01122680|50611736|FG001|Period 1 (4 Weeks)|Other|1|||
25296894|NCT01122680|50611737|FG002|Period 1 (4 Weeks)|Other|0|||
25296895|NCT01122680|50611738|FG003|Period 1 (4 Weeks)|Other|0|||
25296896|NCT01122680|50611735|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
25296897|NCT01122680|50611736|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
25296898|NCT01122680|50611737|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
25296899|NCT01122680|50611738|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
25296900|NCT01122680|50611735|FG000|Period 2 (4 Weeks)|Other|1|||
25296901|NCT01122680|50611736|FG001|Period 2 (4 Weeks)|Other|0|||
25296902|NCT01122680|50611737|FG002|Period 2 (4 Weeks)|Other|0|||
25296903|NCT01122680|50611738|FG003|Period 2 (4 Weeks)|Other|0|||
25296904|NCT01122680|50611735|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
25296905|NCT01122680|50611736|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
25296906|NCT01122680|50611737|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
25296907|NCT01122680|50611738|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
25296908|NCT01122680|50611735|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
25296909|NCT01122680|50611736|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
25296910|NCT01122680|50611737|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
25296911|NCT01122680|50611738|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
25296912|NCT00946998|50611750|FG000|Overall Study|Exited prior to first outcome assessment|5|||
25296913|NCT00946998|50611751|FG001|Overall Study|Exited prior to first outcome assessment|3|||
25296914|NCT01138826|50611757|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
25296915|NCT01138826|50611758|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
25296916|NCT01138826|50611759|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
25296917|NCT01138826|50611760|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
25296918|NCT01138826|50611761|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
25296919|NCT01138826|50611762|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
25296920|NCT00906087|50611770|FG000|Initial Washout|Withdrawal by Subject|1|||
25296921|NCT00906087|50611770|FG000|Initial Washout|Physician Decision|1|||
25296922|NCT00907257|50611779|FG000|Overall Study|Adverse Event|0|||
25296923|NCT00907257|50611780|FG001|Overall Study|Adverse Event|4|||
25296924|NCT00907257|50611779|FG000|Overall Study|Protocol Violation|1|||
25296925|NCT00907257|50611780|FG001|Overall Study|Protocol Violation|2|||
25296926|NCT00907257|50611779|FG000|Overall Study|Lost to Follow-up|3|||
25296927|NCT00907257|50611780|FG001|Overall Study|Lost to Follow-up|3|||
25296928|NCT00907257|50611779|FG000|Overall Study|Withdrawal by Subject|1|||
25296929|NCT00907257|50611780|FG001|Overall Study|Withdrawal by Subject|2|||
25296930|NCT00907257|50611779|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
25296931|NCT00907257|50611780|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
25296932|NCT00907257|50611779|FG000|Overall Study|Moved|1|||
25296933|NCT00907257|50611780|FG001|Overall Study|Moved|0|||
25296934|NCT00907257|50611779|FG000|Overall Study|Personal Reasons|6|||
25296935|NCT00907257|50611780|FG001|Overall Study|Personal Reasons|1|||
25296936|NCT01138046|50611786|FG000|Overall Study|Withdrawal due to death|6|||
25296937|NCT00876460|50611798|FG000|Combination Therapy Phase|Progressive disease|2|||
25296938|NCT00876460|50611799|FG001|Combination Therapy Phase|Progressive disease|3|||
25296939|NCT00876460|50611800|FG002|Combination Therapy Phase|Progressive disease|3|||
25296940|NCT00876460|50611801|FG003|Combination Therapy Phase|Progressive disease|3|||
25296941|NCT00876460|50611802|FG004|Combination Therapy Phase|Progressive disease|3|||
25296942|NCT00876460|50611803|FG005|Combination Therapy Phase|Progressive disease|1|||
25296943|NCT00876460|50611804|FG006|Combination Therapy Phase|Progressive disease|1|||
25296944|NCT00876460|50611805|FG007|Combination Therapy Phase|Progressive disease|1|||
25296945|NCT00876460|50611798|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
25296946|NCT00876460|50611799|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
25296947|NCT00876460|50611800|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
25296948|NCT00876460|50611801|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
25296949|NCT00876460|50611802|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
25296950|NCT00876460|50611803|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
25296951|NCT00876460|50611804|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
25296952|NCT00876460|50611805|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
25296953|NCT00876460|50611798|FG000|Combination Therapy Phase|Adverse Event|0|||
25296954|NCT00876460|50611799|FG001|Combination Therapy Phase|Adverse Event|2|||
25296955|NCT00876460|50611800|FG002|Combination Therapy Phase|Adverse Event|0|||
25296956|NCT00876460|50611801|FG003|Combination Therapy Phase|Adverse Event|2|||
25296957|NCT00876460|50611802|FG004|Combination Therapy Phase|Adverse Event|2|||
25296958|NCT00876460|50611803|FG005|Combination Therapy Phase|Adverse Event|0|||
25296959|NCT00876460|50611804|FG006|Combination Therapy Phase|Adverse Event|3|||
25296960|NCT00876460|50611805|FG007|Combination Therapy Phase|Adverse Event|2|||
25296961|NCT00876460|50611798|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
25296962|NCT00876460|50611799|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
25296963|NCT00876460|50611800|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
25296964|NCT00876460|50611801|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
25296965|NCT00876460|50611802|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
25296966|NCT00876460|50611803|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
25296967|NCT00876460|50611804|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
25296968|NCT00876460|50611805|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
25296969|NCT00876460|50611798|FG000|Combination Therapy Phase|Other reason not defined above|0|||
25296970|NCT00876460|50611799|FG001|Combination Therapy Phase|Other reason not defined above|0|||
25296971|NCT00876460|50611800|FG002|Combination Therapy Phase|Other reason not defined above|0|||
25296972|NCT00876460|50611801|FG003|Combination Therapy Phase|Other reason not defined above|0|||
25296973|NCT00876460|50611802|FG004|Combination Therapy Phase|Other reason not defined above|0|||
25296974|NCT00876460|50611803|FG005|Combination Therapy Phase|Other reason not defined above|0|||
25296975|NCT00876460|50611804|FG006|Combination Therapy Phase|Other reason not defined above|1|||
25296976|NCT00876460|50611805|FG007|Combination Therapy Phase|Other reason not defined above|2|||
25296977|NCT00876460|50611798|FG000|Combination Therapy Phase|Not treated|0|||
25296978|NCT00876460|50611799|FG001|Combination Therapy Phase|Not treated|0|||
25296979|NCT00876460|50611800|FG002|Combination Therapy Phase|Not treated|0|||
25296980|NCT00876460|50611801|FG003|Combination Therapy Phase|Not treated|0|||
25296981|NCT00876460|50611802|FG004|Combination Therapy Phase|Not treated|0|||
25296982|NCT00876460|50611803|FG005|Combination Therapy Phase|Not treated|0|||
25296983|NCT00876460|50611804|FG006|Combination Therapy Phase|Not treated|1|||
25296984|NCT00876460|50611805|FG007|Combination Therapy Phase|Not treated|0|||
25296985|NCT00876460|50611798|FG000|Mono Therapy Phase|Progressive disease|0|||
25296986|NCT00876460|50611799|FG001|Mono Therapy Phase|Progressive disease|0|||
25296987|NCT00876460|50611800|FG002|Mono Therapy Phase|Progressive disease|0|||
25296988|NCT00876460|50611801|FG003|Mono Therapy Phase|Progressive disease|0|||
25296989|NCT00876460|50611802|FG004|Mono Therapy Phase|Progressive disease|2|||
25296990|NCT00876460|50611803|FG005|Mono Therapy Phase|Progressive disease|0|||
25296991|NCT00876460|50611804|FG006|Mono Therapy Phase|Progressive disease|1|||
25296992|NCT00876460|50611805|FG007|Mono Therapy Phase|Progressive disease|3|||
25296993|NCT00876460|50611798|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
25296994|NCT00876460|50611799|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
25296995|NCT00876460|50611800|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
25296996|NCT00876460|50611801|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
25296997|NCT00876460|50611802|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
25296998|NCT00876460|50611803|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
25296999|NCT00876460|50611804|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
25297000|NCT00876460|50611805|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
25297001|NCT00876460|50611798|FG000|Mono Therapy Phase|Adverse Event|0|||
25297002|NCT00876460|50611799|FG001|Mono Therapy Phase|Adverse Event|0|||
25297003|NCT00876460|50611800|FG002|Mono Therapy Phase|Adverse Event|0|||
25297004|NCT00876460|50611801|FG003|Mono Therapy Phase|Adverse Event|1|||
25297005|NCT00876460|50611802|FG004|Mono Therapy Phase|Adverse Event|0|||
25297006|NCT00876460|50611803|FG005|Mono Therapy Phase|Adverse Event|0|||
25297007|NCT00876460|50611804|FG006|Mono Therapy Phase|Adverse Event|0|||
25297008|NCT00876460|50611805|FG007|Mono Therapy Phase|Adverse Event|0|||
25297009|NCT00908115|50611835|FG000|Overall Study|Other|14|||
25297010|NCT01137812|50611841|FG000|Overall Study|Adverse Event|21|||
25297011|NCT01137812|50611842|FG001|Overall Study|Adverse Event|14|||
25297012|NCT01137812|50611841|FG000|Overall Study|Lost to Follow-up|6|||
25297013|NCT01137812|50611842|FG001|Overall Study|Lost to Follow-up|8|||
25297014|NCT01137812|50611841|FG000|Overall Study|Physician Decision|25|||
25297015|NCT01137812|50611842|FG001|Overall Study|Physician Decision|17|||
25297016|NCT01137812|50611841|FG000|Overall Study|Protocol Violation|5|||
25297017|NCT01137812|50611842|FG001|Overall Study|Protocol Violation|4|||
25297018|NCT01137812|50611841|FG000|Overall Study|Withdrawal by Subject|5|||
24969834|NCT00128492|50059260|FG001|Overall Study|Noncompliance|5|||
25070730|NCT02783573|50176725|FG000|Delayed-Start Period|Sponsor Decision|0|||
25070731|NCT02783573|50176726|FG001|Delayed-Start Period|Sponsor Decision|17|||
25297019|NCT01137812|50611842|FG001|Overall Study|Withdrawal by Subject|13|||
25297020|NCT01137812|50611841|FG000|Overall Study|Death|2|||
25297021|NCT01137812|50611842|FG001|Overall Study|Death|0|||
25297022|NCT01137812|50611841|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
25297023|NCT01137812|50611842|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
25297024|NCT01137812|50611841|FG000|Overall Study|Other|19|||
25297025|NCT01137812|50611842|FG001|Overall Study|Other|27|||
25297026|NCT01137578|50611848|FG000|Overall Study|Participant requested to Discontinue|3|||
25297027|NCT01137578|50611849|FG001|Overall Study|Participant requested to Discontinue|0|||
25297028|NCT01137578|50611850|FG002|Overall Study|Participant requested to Discontinue|0|||
25297029|NCT01137578|50611848|FG000|Overall Study|Withdrawal by Subject|1|||
25297030|NCT01137578|50611849|FG001|Overall Study|Withdrawal by Subject|0|||
25297031|NCT01137578|50611850|FG002|Overall Study|Withdrawal by Subject|0|||
25297032|NCT01137578|50611848|FG000|Overall Study|Other|12|||
25297033|NCT01137578|50611849|FG001|Overall Study|Other|2|||
25297034|NCT01137578|50611850|FG002|Overall Study|Other|6|||
25297035|NCT00946920|50611880|FG000|Overall Study|Withdrawal by Subject|28|||
25297036|NCT00946920|50611881|FG001|Overall Study|Withdrawal by Subject|15|||
25297037|NCT00946920|50611880|FG000|Overall Study|Lost to Follow-up|2|||
25297038|NCT00946920|50611881|FG001|Overall Study|Lost to Follow-up|2|||
25297039|NCT00946920|50611880|FG000|Overall Study|Physician Decision|5|||
25297040|NCT00946920|50611881|FG001|Overall Study|Physician Decision|2|||
25297041|NCT00946920|50611880|FG000|Overall Study|Adverse Event|41|||
25297042|NCT00946920|50611881|FG001|Overall Study|Adverse Event|14|||
25297043|NCT00946920|50611880|FG000|Overall Study|Protocol Violation|16|||
25297044|NCT00946920|50611881|FG001|Overall Study|Protocol Violation|8|||
25297045|NCT00946920|50611880|FG000|Overall Study|Miscellaneous reasons|18|||
25297046|NCT00946920|50611881|FG001|Overall Study|Miscellaneous reasons|3|||
25297047|NCT00946530|50611891|FG000|Overall Study|Withdrawal by Subject|0|||
25297048|NCT00946530|50611892|FG001|Overall Study|Withdrawal by Subject|3|||
25297049|NCT00946530|50611893|FG002|Overall Study|Withdrawal by Subject|0|||
25297050|NCT00946530|50611894|FG003|Overall Study|Withdrawal by Subject|3|||
25297051|NCT00946530|50611891|FG000|Overall Study|Physician Decision|1|||
25297052|NCT00946530|50611892|FG001|Overall Study|Physician Decision|1|||
25297053|NCT00946530|50611893|FG002|Overall Study|Physician Decision|1|||
25297054|NCT00946530|50611894|FG003|Overall Study|Physician Decision|1|||
25297055|NCT00946296|50611910|FG000|Overall Study|Physician Decision|3|||
25297056|NCT00946296|50611911|FG001|Overall Study|Physician Decision|0|||
25297057|NCT00945906|50611917|FG000|Overall Study|Withdrawal by Subject|1|||
25297058|NCT00945906|50611917|FG000|Overall Study|Did not want to return for last visit|2|||
25297059|NCT00945906|50611917|FG000|Overall Study|Unable to return for last visit|2|||
25297060|NCT00945906|50611917|FG000|Overall Study|Moved to another country|2|||
25297061|NCT00594646|50611921|FG000|Overall Study|Withdrawal by Subject|1|||
25297062|NCT00594646|50611921|FG000|Overall Study|Lost to Follow-up|15|||
24969835|NCT00128492|50059259|FG000|Overall Study|Personal or administrative|10|||
25191745|NCT00083759|50353137|FG000|Overall Study|Adverse Event|5|||
25297063|NCT01111604|50611929|FG000|Overall Study|Lost to Follow-up|0|||
25297064|NCT01111604|50611930|FG001|Overall Study|Lost to Follow-up|0|||
25297065|NCT01111604|50611931|FG002|Overall Study|Lost to Follow-up|1|||
25297066|NCT01111604|50611929|FG000|Overall Study|Withdrew Consent|3|||
25297067|NCT01111604|50611930|FG001|Overall Study|Withdrew Consent|0|||
25070732|NCT02783573|50176727|FG002|Delayed-Start Period|Sponsor Decision|12|||
25297068|NCT01111604|50611931|FG002|Overall Study|Withdrew Consent|2|||
25297069|NCT01111604|50611929|FG000|Overall Study|Withdrawal by Subject|2|||
25297070|NCT01111604|50611930|FG001|Overall Study|Withdrawal by Subject|0|||
25297071|NCT01111604|50611931|FG002|Overall Study|Withdrawal by Subject|0|||
25297072|NCT01111604|50611929|FG000|Overall Study|Death|1|||
25297073|NCT01111604|50611930|FG001|Overall Study|Death|0|||
25297074|NCT01111604|50611931|FG002|Overall Study|Death|0|||
25297075|NCT01111604|50611929|FG000|Overall Study|Met Exclusion Criteria|2|||
25297076|NCT01111604|50611930|FG001|Overall Study|Met Exclusion Criteria|0|||
25297077|NCT01111604|50611931|FG002|Overall Study|Met Exclusion Criteria|0|||
25297078|NCT00950742|50611959|FG000|Overall Study|Other Adverse Event|1|||
25297079|NCT00950742|50611960|FG001|Overall Study|Other Adverse Event|0|||
25297080|NCT00950742|50611959|FG000|Overall Study|Withdrawal by Subject|3|||
25297081|NCT00950742|50611960|FG001|Overall Study|Withdrawal by Subject|0|||
25297082|NCT00950742|50611959|FG000|Overall Study|Progressive Disease|6|||
25297083|NCT00950742|50611960|FG001|Overall Study|Progressive Disease|2|||
25297084|NCT00950742|50611959|FG000|Overall Study|Dose limiting toxicity|6|||
25297085|NCT00950742|50611960|FG001|Overall Study|Dose limiting toxicity|0|||
25297086|NCT00955110|50611970|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
25297087|NCT00955110|50611970|FG000|Treatment Phase|Adverse Event|2|||
25297088|NCT00955110|50611970|FG000|Treatment Phase|Administrative reasons|2|||
25297089|NCT00955110|50611970|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
25297090|NCT00955110|50611970|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
25297091|NCT00950664|50611984|FG000|First Intervention|Lost to Follow-up|1|||
25297092|NCT00950664|50611985|FG001|First Intervention|Lost to Follow-up|3|||
25297093|NCT00950664|50611984|FG000|First Intervention|Withdrawal by Subject|2|||
25297094|NCT00950664|50611985|FG001|First Intervention|Withdrawal by Subject|2|||
25297095|NCT01111526|50611991|FG000|Overall Study|GVHD Disease Progression|0|||
25297096|NCT01111526|50611992|FG001|Overall Study|GVHD Disease Progression|1|||
25297097|NCT01111526|50611993|FG002|Overall Study|GVHD Disease Progression|2|||
25297098|NCT01111292|50611999|FG000|Treatment|Physician Decision|1|||
25297099|NCT01111292|50612000|FG001|Treatment|Physician Decision|1|||
25297100|NCT00944658|50612008|FG000|Treatment 12 Weeks|Adverse Event|0|||
25297101|NCT00944658|50612009|FG001|Treatment 12 Weeks|Adverse Event|2|||
25297102|NCT01110200|50612017|FG000|Overall Study|Adverse Event|28|||
25297103|NCT01110200|50612018|FG001|Overall Study|Adverse Event|28|||
25297104|NCT01110200|50612017|FG000|Overall Study|Withdrawal by Subject|25|||
25297105|NCT01110200|50612018|FG001|Overall Study|Withdrawal by Subject|32|||
25297106|NCT01110200|50612017|FG000|Overall Study|Lack of Efficacy|16|||
25297107|NCT01110200|50612018|FG001|Overall Study|Lack of Efficacy|25|||
25297108|NCT01110200|50612017|FG000|Overall Study|Protocol Violation|14|||
25297109|NCT01110200|50612018|FG001|Overall Study|Protocol Violation|12|||
25297110|NCT01110200|50612017|FG000|Overall Study|Physician Decision|13|||
25297111|NCT01110200|50612018|FG001|Overall Study|Physician Decision|17|||
25297112|NCT01110200|50612017|FG000|Overall Study|Lost to Follow-up|10|||
25297113|NCT01110200|50612018|FG001|Overall Study|Lost to Follow-up|7|||
25297114|NCT01108796|50612028|FG000|Overall Study|Adverse Event|0|||
25297115|NCT01108796|50612029|FG001|Overall Study|Adverse Event|1|||
25297116|NCT01108796|50612028|FG000|Overall Study|Lost to Follow-up|7|||
25297117|NCT01108796|50612029|FG001|Overall Study|Lost to Follow-up|6|||
25297118|NCT01108718|50612039|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
25297119|NCT01108718|50612040|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
25297120|NCT01137110|50612047|FG000|Overall Study|Protocol Violation|1|||
25297121|NCT01137110|50612048|FG001|Overall Study|Protocol Violation|0|||
25297122|NCT01136954|50612056|FG000|Overall Study|Adverse Event|3|||
25297123|NCT01136954|50612057|FG001|Overall Study|Adverse Event|2|||
25297124|NCT01136954|50612056|FG000|Overall Study|Withdrawal by Subject|6|||
25297125|NCT01136954|50612057|FG001|Overall Study|Withdrawal by Subject|2|||
25297126|NCT01136954|50612056|FG000|Overall Study|Lack of Efficacy|14|||
25297127|NCT01136954|50612057|FG001|Overall Study|Lack of Efficacy|13|||
25297128|NCT01136954|50612056|FG000|Overall Study|Physician Decision|0|||
25191746|NCT00083759|50353138|FG001|Overall Study|Adverse Event|3|||
25297129|NCT01136954|50612057|FG001|Overall Study|Physician Decision|1|||
25297130|NCT01136954|50612056|FG000|Overall Study|Other|1|||
25191747|NCT00083759|50353137|FG000|Overall Study|Lost to Follow-up|1|||
25191748|NCT00083759|50353138|FG001|Overall Study|Lost to Follow-up|0|||
25191749|NCT00083759|50353137|FG000|Overall Study|Death|1|||
25297131|NCT01136954|50612057|FG001|Overall Study|Other|3|||
25297132|NCT01136876|50612066|FG000|Overall Study|Lost to Follow-up|0|||
25297133|NCT01136876|50612067|FG001|Overall Study|Lost to Follow-up|1|||
25297134|NCT01136876|50612066|FG000|Overall Study|Physician Decision|3|||
25297135|NCT01136876|50612067|FG001|Overall Study|Physician Decision|5|||
25297136|NCT01136876|50612066|FG000|Overall Study|Missing NGAL measurement|2|||
25297137|NCT01136876|50612067|FG001|Overall Study|Missing NGAL measurement|5|||
25297138|NCT01105130|50612078|FG000|Overall Study|Withdrawal by Subject|4|||
25297139|NCT01105130|50612079|FG001|Overall Study|Withdrawal by Subject|6|||
25297140|NCT01105130|50612080|FG002|Overall Study|Withdrawal by Subject|2|||
25191750|NCT00083759|50353138|FG001|Overall Study|Death|1|||
25297141|NCT01105130|50612078|FG000|Overall Study|Never Started|2|||
25297142|NCT01105130|50612079|FG001|Overall Study|Never Started|2|||
25297143|NCT01105130|50612080|FG002|Overall Study|Never Started|4|||
25297144|NCT01105130|50612078|FG000|Overall Study|Toxicity|1|||
25297145|NCT01105130|50612079|FG001|Overall Study|Toxicity|3|||
25297146|NCT01105130|50612080|FG002|Overall Study|Toxicity|2|||
25297147|NCT01105130|50612078|FG000|Overall Study|Multiple Reasons|3|||
25297148|NCT01105130|50612079|FG001|Overall Study|Multiple Reasons|0|||
25297149|NCT01105130|50612080|FG002|Overall Study|Multiple Reasons|2|||
25297150|NCT01108094|50612092|FG000|Overall Study|Adverse Event|2|||
25297151|NCT01108094|50612093|FG001|Overall Study|Adverse Event|0|||
25297152|NCT01108094|50612094|FG002|Overall Study|Adverse Event|0|||
25297153|NCT01108094|50612095|FG003|Overall Study|Adverse Event|0|||
25297154|NCT01108094|50612092|FG000|Overall Study|Withdrawal by Subject|1|||
25297155|NCT01108094|50612093|FG001|Overall Study|Withdrawal by Subject|0|||
25297156|NCT01108094|50612094|FG002|Overall Study|Withdrawal by Subject|0|||
25297157|NCT01108094|50612095|FG003|Overall Study|Withdrawal by Subject|0|||
25297158|NCT00954174|50612112|FG000|Overall Study|Adverse Event|28|||
25297159|NCT00954174|50612113|FG001|Overall Study|Adverse Event|23|||
25297160|NCT00954174|50612114|FG002|Overall Study|Adverse Event|4|||
25297161|NCT00954174|50612115|FG003|Overall Study|Adverse Event|9|||
25297162|NCT00954174|50612112|FG000|Overall Study|Death|4|||
25297163|NCT00954174|50612113|FG001|Overall Study|Death|2|||
25297164|NCT00954174|50612114|FG002|Overall Study|Death|0|||
25297165|NCT00954174|50612115|FG003|Overall Study|Death|0|||
25297166|NCT00954174|50612112|FG000|Overall Study|Lack of Efficacy|32|||
25297167|NCT00954174|50612113|FG001|Overall Study|Lack of Efficacy|22|||
25297168|NCT00954174|50612114|FG002|Overall Study|Lack of Efficacy|8|||
25297169|NCT00954174|50612115|FG003|Overall Study|Lack of Efficacy|6|||
25297170|NCT00954174|50612112|FG000|Overall Study|Withdrawal by Subject|14|||
25297171|NCT00954174|50612113|FG001|Overall Study|Withdrawal by Subject|10|||
25297172|NCT00954174|50612114|FG002|Overall Study|Withdrawal by Subject|4|||
25297173|NCT00954174|50612115|FG003|Overall Study|Withdrawal by Subject|3|||
25297174|NCT00954174|50612112|FG000|Overall Study|Medical Reason|4|||
25297175|NCT00954174|50612113|FG001|Overall Study|Medical Reason|2|||
25297176|NCT00954174|50612114|FG002|Overall Study|Medical Reason|1|||
25297177|NCT00954174|50612115|FG003|Overall Study|Medical Reason|0|||
25297178|NCT00954174|50612112|FG000|Overall Study|Ineligible|40|||
25297179|NCT00954174|50612113|FG001|Overall Study|Ineligible|47|||
25297180|NCT00954174|50612114|FG002|Overall Study|Ineligible|7|||
25297181|NCT00954174|50612115|FG003|Overall Study|Ineligible|4|||
25297182|NCT00954174|50612112|FG000|Overall Study|Never Treated|4|||
25297183|NCT00954174|50612113|FG001|Overall Study|Never Treated|17|||
25297184|NCT00954174|50612114|FG002|Overall Study|Never Treated|0|||
25297185|NCT00954174|50612115|FG003|Overall Study|Never Treated|3|||
25297186|NCT01107626|50612132|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
25297187|NCT01107626|50612133|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
25297188|NCT01107626|50612134|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
25297189|NCT01107626|50612135|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
25297190|NCT01107626|50612132|FG000|Step 1: Induction Therapy|Adverse Event|198|||
25297191|NCT01107626|50612133|FG001|Step 1: Induction Therapy|Adverse Event|0|||
25297192|NCT01107626|50612134|FG002|Step 1: Induction Therapy|Adverse Event|0|||
25297193|NCT01107626|50612135|FG003|Step 1: Induction Therapy|Adverse Event|0|||
25297194|NCT01107626|50612132|FG000|Step 1: Induction Therapy|Death|62|||
25297195|NCT01107626|50612133|FG001|Step 1: Induction Therapy|Death|0|||
25297196|NCT01107626|50612134|FG002|Step 1: Induction Therapy|Death|0|||
25297197|NCT01107626|50612135|FG003|Step 1: Induction Therapy|Death|0|||
25297198|NCT01107626|50612132|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
25297199|NCT01107626|50612133|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
25297200|NCT01107626|50612134|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
25297201|NCT01107626|50612135|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
25297202|NCT01107626|50612132|FG000|Step 1: Induction Therapy|Complicating disease|13|||
25297203|NCT01107626|50612133|FG001|Step 1: Induction Therapy|Complicating disease|0|||
25297204|NCT01107626|50612134|FG002|Step 1: Induction Therapy|Complicating disease|0|||
25297205|NCT01107626|50612135|FG003|Step 1: Induction Therapy|Complicating disease|0|||
25297206|NCT01107626|50612132|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
25297207|NCT01107626|50612133|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
25297208|NCT01107626|50612134|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
25297209|NCT01107626|50612135|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
25297210|NCT01107626|50612132|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
25297211|NCT01107626|50612133|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
25297212|NCT01107626|50612134|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
25297213|NCT01107626|50612135|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
25297214|NCT01107626|50612132|FG000|Step 1: Induction Therapy|Non-compliance|4|||
25297215|NCT01107626|50612133|FG001|Step 1: Induction Therapy|Non-compliance|0|||
25297216|NCT01107626|50612134|FG002|Step 1: Induction Therapy|Non-compliance|0|||
25297217|NCT01107626|50612135|FG003|Step 1: Induction Therapy|Non-compliance|0|||
25297218|NCT01107626|50612132|FG000|Step 1: Induction Therapy|Pain|4|||
25297219|NCT01107626|50612133|FG001|Step 1: Induction Therapy|Pain|0|||
25297220|NCT01107626|50612134|FG002|Step 1: Induction Therapy|Pain|0|||
25297221|NCT01107626|50612135|FG003|Step 1: Induction Therapy|Pain|0|||
25297222|NCT01107626|50612132|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
25297223|NCT01107626|50612133|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
25297224|NCT01107626|50612134|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
25297225|NCT01107626|50612135|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
25297226|NCT01107626|50612132|FG000|Step 1: Induction Therapy|Hospice care|1|||
25297227|NCT01107626|50612133|FG001|Step 1: Induction Therapy|Hospice care|0|||
25297228|NCT01107626|50612134|FG002|Step 1: Induction Therapy|Hospice care|0|||
25297229|NCT01107626|50612135|FG003|Step 1: Induction Therapy|Hospice care|0|||
25297230|NCT01107626|50612132|FG000|Step 1: Induction Therapy|Physician Decision|1|||
25297231|NCT01107626|50612133|FG001|Step 1: Induction Therapy|Physician Decision|0|||
25297232|NCT01107626|50612134|FG002|Step 1: Induction Therapy|Physician Decision|0|||
25297233|NCT01107626|50612135|FG003|Step 1: Induction Therapy|Physician Decision|0|||
25297234|NCT01107626|50612132|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
25297235|NCT01107626|50612133|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
25297236|NCT01107626|50612134|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
25297237|NCT01107626|50612135|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
25297238|NCT01107626|50612132|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
25297239|NCT01107626|50612133|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
25297240|NCT01107626|50612134|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
25297241|NCT01107626|50612135|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
25297242|NCT01107626|50612132|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
25297243|NCT01107626|50612133|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
25297244|NCT01107626|50612134|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
25297245|NCT01107626|50612135|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
25297246|NCT01107626|50612132|FG000|Step 2: Maintenance Therapy|Death|0|||
25297247|NCT01107626|50612133|FG001|Step 2: Maintenance Therapy|Death|8|||
25297248|NCT01107626|50612134|FG002|Step 2: Maintenance Therapy|Death|2|||
25297249|NCT01107626|50612135|FG003|Step 2: Maintenance Therapy|Death|13|||
25297250|NCT01107626|50612132|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
25297251|NCT01107626|50612133|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
25297252|NCT01107626|50612134|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
25297253|NCT01107626|50612135|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
25297254|NCT01107626|50612132|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
25297255|NCT01107626|50612133|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
25297256|NCT01107626|50612134|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
25297257|NCT01107626|50612135|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
25297258|NCT01107626|50612132|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
25297259|NCT01107626|50612133|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
25297260|NCT01107626|50612134|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
25297261|NCT01107626|50612135|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
25297262|NCT01107626|50612132|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
25297263|NCT01107626|50612133|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
25297264|NCT01107626|50612134|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
25297265|NCT01107626|50612135|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
25297266|NCT01107626|50612132|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
25297267|NCT01107626|50612133|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
25297268|NCT01107626|50612134|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
25297269|NCT01107626|50612135|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
25297270|NCT01107626|50612132|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
25297271|NCT01107626|50612133|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
25297272|NCT01107626|50612134|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
25297273|NCT01107626|50612135|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
25297274|NCT01107626|50612132|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
25297275|NCT01107626|50612133|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
25297276|NCT01107626|50612134|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
25169333|NCT01831817|50300864|FG003|Overall Study|Withdrawl of Consent|0|||
25297277|NCT01107626|50612135|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
25297278|NCT01107626|50612132|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
25297279|NCT01107626|50612133|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
25297280|NCT01107626|50612134|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
25297281|NCT01107626|50612135|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
25297282|NCT01107626|50612132|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
25297283|NCT01107626|50612133|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
25297284|NCT01107626|50612134|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
25297285|NCT01107626|50612135|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
25297286|NCT01107626|50612132|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
25297287|NCT01107626|50612133|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
25297288|NCT01107626|50612134|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
25297289|NCT01107626|50612135|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
25297290|NCT01107626|50612132|FG000|Step 2: Maintenance Therapy|Pain|0|||
25297291|NCT01107626|50612133|FG001|Step 2: Maintenance Therapy|Pain|0|||
25297292|NCT01107626|50612134|FG002|Step 2: Maintenance Therapy|Pain|0|||
25297293|NCT01107626|50612135|FG003|Step 2: Maintenance Therapy|Pain|1|||
25297294|NCT01107626|50612132|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
25297295|NCT01107626|50612133|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
25297296|NCT01107626|50612134|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
25297297|NCT01107626|50612135|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
25297298|NCT01136408|50612147|FG000|Overall Study|Adverse Event|4|||
25297299|NCT01136408|50612148|FG001|Overall Study|Adverse Event|8|||
25297300|NCT01136408|50612149|FG002|Overall Study|Adverse Event|4|||
25297301|NCT01136408|50612147|FG000|Overall Study|Protocol Violation|1|||
25297302|NCT01136408|50612148|FG001|Overall Study|Protocol Violation|1|||
25297303|NCT01136408|50612149|FG002|Overall Study|Protocol Violation|1|||
25297304|NCT01136174|50612165|FG000|Overall Study|Adverse Event|0|||
25297305|NCT01136174|50612166|FG001|Overall Study|Adverse Event|0|||
25297306|NCT01136174|50612167|FG002|Overall Study|Adverse Event|0|||
25297307|NCT01136174|50612168|FG003|Overall Study|Adverse Event|4|||
25297308|NCT01135394|50612187|FG000|Screening|Lost to Follow-up|2|||
25297309|NCT01135394|50612187|FG000|Screening|Withdrawal by Subject|10|||
25297310|NCT01135394|50612187|FG000|Screening|Screening failure|16|||
25297311|NCT01135394|50612187|FG000|Screening|Physician Decision|5|||
25297312|NCT01135394|50612187|FG000|Baseline Assessment|Withdrawal by Subject|9|||
25297313|NCT01135394|50612187|FG000|Baseline Assessment|Physician Decision|3|||
25297314|NCT01135394|50612187|FG000|Baseline Assessment|Lost to Follow-up|2|||
25297315|NCT01135394|50612187|FG000|Baseline Assessment|Adverse Event|1|||
25297316|NCT01135394|50612187|FG000|Study Treatment|Withdrawal by Subject|1|||
25297317|NCT01135394|50612187|FG000|Study Treatment|Physician Decision|1|||
25297318|NCT01135394|50612187|FG000|Study Treatment|Adverse Event|2|||
25297319|NCT00949884|50612194|FG000|Overall Study|Adverse Event|14|||
25297320|NCT00949884|50612195|FG001|Overall Study|Adverse Event|3|||
25297321|NCT00949884|50612196|FG002|Overall Study|Adverse Event|12|||
25297322|NCT00949884|50612194|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
25297323|NCT00949884|50612195|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
25297324|NCT00949884|50612196|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
25297325|NCT00949884|50612194|FG000|Overall Study|Lost to Follow-up|7|||
25297326|NCT00949884|50612195|FG001|Overall Study|Lost to Follow-up|5|||
25297327|NCT00949884|50612196|FG002|Overall Study|Lost to Follow-up|5|||
25297328|NCT00949884|50612194|FG000|Overall Study|Physician Decision|5|||
25297329|NCT00949884|50612195|FG001|Overall Study|Physician Decision|0|||
25297330|NCT00949884|50612196|FG002|Overall Study|Physician Decision|6|||
25297331|NCT00949884|50612194|FG000|Overall Study|Treatment non-compliance|5|||
25297332|NCT00949884|50612195|FG001|Overall Study|Treatment non-compliance|0|||
25297333|NCT00949884|50612196|FG002|Overall Study|Treatment non-compliance|8|||
25297334|NCT00949884|50612194|FG000|Overall Study|Withdrawal by Subject|13|||
25297335|NCT00949884|50612195|FG001|Overall Study|Withdrawal by Subject|4|||
25297336|NCT00949884|50612196|FG002|Overall Study|Withdrawal by Subject|16|||
25297337|NCT00949884|50612194|FG000|Overall Study|Lack of Efficacy|4|||
25297338|NCT00949884|50612195|FG001|Overall Study|Lack of Efficacy|2|||
25297339|NCT00949884|50612196|FG002|Overall Study|Lack of Efficacy|7|||
25297340|NCT00949884|50612194|FG000|Overall Study|Study terminated by sponsor|0|||
25169334|NCT01840943|50300889|FG000|Overall Study|Withdrawal by Subject|5|||
25297341|NCT00949884|50612195|FG001|Overall Study|Study terminated by sponsor|0|||
25297342|NCT00949884|50612196|FG002|Overall Study|Study terminated by sponsor|1|||
25297343|NCT00949650|50612207|FG000|Overall Study|Progressive disease|188|||
25297344|NCT00949650|50612208|FG001|Overall Study|Progressive disease|19|||
25297345|NCT00949650|50612207|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
25297346|NCT00949650|50612208|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
25297347|NCT00949650|50612207|FG000|Overall Study|Other Adverse Event (AE)|28|||
25297348|NCT00949650|50612208|FG001|Overall Study|Other Adverse Event (AE)|17|||
25297349|NCT00949650|50612207|FG000|Overall Study|Protocol Violation|1|||
25297350|NCT00949650|50612208|FG001|Overall Study|Protocol Violation|4|||
25297351|NCT00949650|50612207|FG000|Overall Study|Refusal to continue medication|7|||
25297352|NCT00949650|50612208|FG001|Overall Study|Refusal to continue medication|11|||
25297353|NCT00949650|50612207|FG000|Overall Study|Not treated|1|||
25297354|NCT00949650|50612208|FG001|Overall Study|Not treated|4|||
25297355|NCT00949650|50612207|FG000|Overall Study|Other not specified above|5|||
25297356|NCT00949650|50612208|FG001|Overall Study|Other not specified above|0|||
25297357|NCT00908037|50612225|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
25297358|NCT00908037|50612226|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
25297359|NCT00908037|50612227|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
25297360|NCT00908037|50612228|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
25297361|NCT00908037|50612229|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
25297362|NCT00908037|50612230|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
25297363|NCT00908037|50612231|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
25297364|NCT00908037|50612232|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
25297365|NCT00908037|50612233|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
25297366|NCT00908037|50612234|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
25297367|NCT00908037|50612235|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
25297368|NCT00908037|50612236|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
25297369|NCT00908037|50612225|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
25297370|NCT00908037|50612226|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
25297371|NCT00908037|50612227|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
25297372|NCT00908037|50612228|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
25297373|NCT00908037|50612229|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
25297374|NCT00908037|50612230|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
25297375|NCT00908037|50612231|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
25297376|NCT00908037|50612232|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
25297377|NCT00908037|50612233|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
25297378|NCT00908037|50612234|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
25297379|NCT00908037|50612235|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
25297380|NCT00908037|50612236|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
25297381|NCT00908037|50612225|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
25297382|NCT00908037|50612226|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
25297383|NCT00908037|50612227|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
25297384|NCT00908037|50612228|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
25297385|NCT00908037|50612229|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
25297386|NCT00908037|50612230|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
25297387|NCT00908037|50612231|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
25297388|NCT00908037|50612232|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
25297389|NCT00908037|50612233|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
25297390|NCT00908037|50612234|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
25297391|NCT00908037|50612235|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
25297392|NCT00908037|50612236|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
25297393|NCT00908037|50612225|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
25297394|NCT00908037|50612226|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
25297395|NCT00908037|50612227|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
25297396|NCT00908037|50612228|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
25297397|NCT00908037|50612229|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
25297398|NCT00908037|50612230|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
25297399|NCT00908037|50612231|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
25297400|NCT00908037|50612232|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
25297401|NCT00908037|50612233|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
25297402|NCT00908037|50612234|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
25297403|NCT00908037|50612235|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
25297404|NCT00908037|50612236|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
25297405|NCT00908037|50612225|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
25297406|NCT00908037|50612226|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
25297407|NCT00908037|50612227|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
25297408|NCT00908037|50612228|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
25297409|NCT00908037|50612229|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
25297410|NCT00908037|50612230|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
25297411|NCT00908037|50612231|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
24969836|NCT00128492|50059260|FG001|Overall Study|Personal or administrative|22|||
25297412|NCT00908037|50612232|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
25297413|NCT00908037|50612233|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
25297414|NCT00908037|50612234|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
25297415|NCT00908037|50612235|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
25297416|NCT00908037|50612236|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
25297417|NCT00908037|50612225|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
25297418|NCT00908037|50612226|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
25297419|NCT00908037|50612227|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
25297420|NCT00908037|50612228|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
25297421|NCT00908037|50612229|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
25297422|NCT00908037|50612230|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
25297423|NCT00908037|50612231|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
25297424|NCT00908037|50612232|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
25297425|NCT00908037|50612233|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
25297426|NCT00908037|50612234|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
25297427|NCT00908037|50612235|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
25297428|NCT00908037|50612236|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
25297429|NCT00908037|50612225|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
25297430|NCT00908037|50612226|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
25297431|NCT00908037|50612227|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
25297432|NCT00908037|50612228|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
25297433|NCT00908037|50612229|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
25297434|NCT00908037|50612230|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
25297435|NCT00908037|50612231|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
25297436|NCT00908037|50612232|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
25297437|NCT00908037|50612233|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
25297438|NCT00908037|50612234|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
25297439|NCT00908037|50612235|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
25297440|NCT00908037|50612236|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
25297441|NCT00908037|50612225|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
25297442|NCT00908037|50612226|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
25297443|NCT00908037|50612227|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
25297444|NCT00908037|50612228|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
25297445|NCT00908037|50612229|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
25297446|NCT00908037|50612230|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
25297447|NCT00908037|50612231|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
25297448|NCT00908037|50612232|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
25297449|NCT00908037|50612233|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
25297450|NCT00908037|50612234|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
25297451|NCT00908037|50612235|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
25297452|NCT00908037|50612236|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
25297453|NCT00908037|50612225|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
25297454|NCT00908037|50612226|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
25297455|NCT00908037|50612227|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
25297456|NCT00908037|50612228|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
25297457|NCT00908037|50612229|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
25297458|NCT00908037|50612230|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
25297459|NCT00908037|50612231|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
25297460|NCT00908037|50612232|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
25297461|NCT00908037|50612233|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
25297462|NCT00908037|50612234|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
25297463|NCT00908037|50612235|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
25297464|NCT00908037|50612236|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
25297465|NCT00904215|50612288|FG000|Overall Study|Adverse Event|25|||
25297466|NCT00904215|50612288|FG000|Overall Study|Protocol Violation|10|||
25297467|NCT00904215|50612288|FG000|Overall Study|Lost to Follow-up|63|||
25297468|NCT00904215|50612288|FG000|Overall Study|Withdrawal by Subject|9|||
25297469|NCT00904215|50612288|FG000|Overall Study|Other|28|||
25297470|NCT00905307|50612298|FG000|Overall Study|Switched to Open Label Rescue|7|||
25297471|NCT00905307|50612299|FG001|Overall Study|Switched to Open Label Rescue|17|||
25297472|NCT00905307|50612300|FG002|Overall Study|Switched to Open Label Rescue|11|||
25297473|NCT00905307|50612301|FG003|Overall Study|Switched to Open Label Rescue|11|||
25297474|NCT00905307|50612302|FG004|Overall Study|Switched to Open Label Rescue|4|||
25297475|NCT00905307|50612303|FG005|Overall Study|Switched to Open Label Rescue|15|||
25297476|NCT00905307|50612298|FG000|Overall Study|Lost to Follow-up|0|||
25297477|NCT00905307|50612299|FG001|Overall Study|Lost to Follow-up|0|||
25297478|NCT00905307|50612300|FG002|Overall Study|Lost to Follow-up|0|||
25297479|NCT00905307|50612301|FG003|Overall Study|Lost to Follow-up|0|||
25297480|NCT00905307|50612302|FG004|Overall Study|Lost to Follow-up|1|||
25297481|NCT00905307|50612303|FG005|Overall Study|Lost to Follow-up|1|||
25297482|NCT00905307|50612298|FG000|Overall Study|Adverse Event|3|||
25297483|NCT00905307|50612299|FG001|Overall Study|Adverse Event|4|||
25297484|NCT00905307|50612300|FG002|Overall Study|Adverse Event|5|||
25297485|NCT00905307|50612301|FG003|Overall Study|Adverse Event|11|||
25297486|NCT00905307|50612302|FG004|Overall Study|Adverse Event|3|||
25297487|NCT00905307|50612303|FG005|Overall Study|Adverse Event|5|||
25297488|NCT00905307|50612298|FG000|Overall Study|Withdrawal by Subject|5|||
25297489|NCT00905307|50612299|FG001|Overall Study|Withdrawal by Subject|13|||
25297490|NCT00905307|50612300|FG002|Overall Study|Withdrawal by Subject|15|||
25297491|NCT00905307|50612301|FG003|Overall Study|Withdrawal by Subject|11|||
25297492|NCT00905307|50612302|FG004|Overall Study|Withdrawal by Subject|4|||
24969837|NCT00128492|50059259|FG000|Overall Study|Withdrawal by Subject|3|||
25297493|NCT00905307|50612303|FG005|Overall Study|Withdrawal by Subject|13|||
25297494|NCT00905307|50612298|FG000|Overall Study|Protocol Violation|1|||
25297495|NCT00905307|50612299|FG001|Overall Study|Protocol Violation|0|||
25297496|NCT00905307|50612300|FG002|Overall Study|Protocol Violation|1|||
25297497|NCT00905307|50612301|FG003|Overall Study|Protocol Violation|0|||
25070733|NCT01666652|50176743|FG000|Overall Study|Serious Adverse Event|0|||
25297498|NCT00905307|50612302|FG004|Overall Study|Protocol Violation|0|||
25297499|NCT00905307|50612303|FG005|Overall Study|Protocol Violation|0|||
25297500|NCT00905307|50612298|FG000|Overall Study|Lack of Efficacy|6|||
25297501|NCT00905307|50612299|FG001|Overall Study|Lack of Efficacy|3|||
25297502|NCT00905307|50612300|FG002|Overall Study|Lack of Efficacy|5|||
25297503|NCT00905307|50612301|FG003|Overall Study|Lack of Efficacy|4|||
25297504|NCT00905307|50612302|FG004|Overall Study|Lack of Efficacy|4|||
25297505|NCT00905307|50612303|FG005|Overall Study|Lack of Efficacy|8|||
25297506|NCT00907881|50612330|FG000|Overall Study|Lost to Follow-up|59|||
25297507|NCT00907881|50612330|FG000|Overall Study|Noncompliance|5|||
25297508|NCT00907881|50612330|FG000|Overall Study|Withdrawal by Subject|5|||
25297509|NCT00907881|50612330|FG000|Overall Study|Protocol Violation|1|||
25297510|NCT00907881|50612330|FG000|Overall Study|Missing discontinuation information|15|||
25297511|NCT00904917|50612338|FG000|Overall Study|Lost to Follow-up|2|||
25297512|NCT00904917|50612339|FG001|Overall Study|Lost to Follow-up|2|||
25297513|NCT00904917|50612340|FG002|Overall Study|Lost to Follow-up|2|||
25297514|NCT00904917|50612341|FG003|Overall Study|Lost to Follow-up|2|||
25297515|NCT00904839|50612356|FG000|Overall Study|Adverse Event|0|||
25297516|NCT00904839|50612357|FG001|Overall Study|Adverse Event|5|||
25297517|NCT00904839|50612358|FG002|Overall Study|Adverse Event|4|||
25297518|NCT00904839|50612356|FG000|Overall Study|Protocol Violation|0|||
25297519|NCT00904839|50612357|FG001|Overall Study|Protocol Violation|1|||
25297520|NCT00904839|50612358|FG002|Overall Study|Protocol Violation|1|||
25297521|NCT00904839|50612356|FG000|Overall Study|Lost to Follow-up|0|||
25297522|NCT00904839|50612357|FG001|Overall Study|Lost to Follow-up|1|||
25297523|NCT00904839|50612358|FG002|Overall Study|Lost to Follow-up|2|||
25297524|NCT00904839|50612356|FG000|Overall Study|Withdrawal by Subject|0|||
25070734|NCT01666652|50176744|FG001|Overall Study|Serious Adverse Event|0|||
25070735|NCT01666652|50176745|FG002|Overall Study|Serious Adverse Event|0|||
25070736|NCT01666652|50176746|FG003|Overall Study|Serious Adverse Event|1|||
25070737|NCT01666652|50176747|FG004|Overall Study|Serious Adverse Event|0|||
25070738|NCT01666652|50176743|FG000|Overall Study|Withdrawal by Subject|0|||
25070739|NCT01666652|50176744|FG001|Overall Study|Withdrawal by Subject|0|||
25070740|NCT01666652|50176745|FG002|Overall Study|Withdrawal by Subject|0|||
25070741|NCT01666652|50176746|FG003|Overall Study|Withdrawal by Subject|0|||
25070742|NCT01666652|50176747|FG004|Overall Study|Withdrawal by Subject|1|||
25070743|NCT01666652|50176743|FG000|Overall Study|Moved from study area|1|||
25070744|NCT01666652|50176744|FG001|Overall Study|Moved from study area|0|||
25070745|NCT01666652|50176745|FG002|Overall Study|Moved from study area|0|||
25070746|NCT01666652|50176746|FG003|Overall Study|Moved from study area|2|||
25070747|NCT01666652|50176747|FG004|Overall Study|Moved from study area|0|||
25070748|NCT01666652|50176743|FG000|Overall Study|Lost to Follow-up|1|||
25070749|NCT01666652|50176744|FG001|Overall Study|Lost to Follow-up|1|||
25070750|NCT01666652|50176745|FG002|Overall Study|Lost to Follow-up|1|||
25070751|NCT01666652|50176746|FG003|Overall Study|Lost to Follow-up|1|||
25169335|NCT01840943|50300890|FG001|Overall Study|Withdrawal by Subject|6|||
25297525|NCT00904839|50612357|FG001|Overall Study|Withdrawal by Subject|2|||
25297526|NCT00904839|50612358|FG002|Overall Study|Withdrawal by Subject|0|||
25297527|NCT00904839|50612356|FG000|Overall Study|Not treated|1|||
25070752|NCT01666652|50176747|FG004|Overall Study|Lost to Follow-up|0|||
25297528|NCT00904839|50612357|FG001|Overall Study|Not treated|0|||
25297529|NCT00904839|50612358|FG002|Overall Study|Not treated|1|||
25070753|NCT00109733|50176761|FG000|Overall Study|Protocol Violation|0|||
25070754|NCT00109733|50176762|FG001|Overall Study|Protocol Violation|1|||
25297530|NCT00904839|50612356|FG000|Overall Study|Other than above|0|||
25297531|NCT00904839|50612357|FG001|Overall Study|Other than above|9|||
25297532|NCT00904839|50612358|FG002|Overall Study|Other than above|7|||
25297533|NCT00903357|50612369|FG000|First Intervention|Withdrawal by Subject|5|||
25297534|NCT00903357|50612370|FG001|First Intervention|Withdrawal by Subject|3|||
25297535|NCT00903357|50612369|FG000|First Intervention|Flu|0|||
25297536|NCT00903357|50612370|FG001|First Intervention|Flu|1|||
25297537|NCT00903357|50612369|FG000|Wash Out Period of 2 Weeks|Flu|0|||
25297538|NCT00903357|50612370|FG001|Wash Out Period of 2 Weeks|Flu|1|||
25297539|NCT00903357|50612369|FG000|Second Intervention|Lost to Follow-up|1|||
25297540|NCT00903357|50612370|FG001|Second Intervention|Lost to Follow-up|0|||
25297541|NCT00904371|50612380|FG000|Overall Study|Adverse Event|2|||
25297542|NCT00904371|50612380|FG000|Overall Study|Lost to Follow-up|4|||
25297543|NCT00904371|50612380|FG000|Overall Study|Discontinued at target blood pressure|2|||
25297544|NCT00904371|50612380|FG000|Overall Study|Continued with Tritace|1|||
25297545|NCT01104662|50612392|FG000|Overall Study|Adverse Event|2|||
25297546|NCT01104662|50612393|FG001|Overall Study|Adverse Event|2|||
25297547|NCT01104662|50612394|FG002|Overall Study|Adverse Event|0|||
25297548|NCT01104662|50612395|FG003|Overall Study|Adverse Event|1|||
25297549|NCT01104662|50612396|FG004|Overall Study|Adverse Event|1|||
25297550|NCT01104662|50612397|FG005|Overall Study|Adverse Event|1|||
25297551|NCT01104662|50612398|FG006|Overall Study|Adverse Event|0|||
25297552|NCT01104662|50612399|FG007|Overall Study|Adverse Event|0|||
25297553|NCT01104662|50612392|FG000|Overall Study|Clinical Failure|1|||
25297554|NCT01104662|50612393|FG001|Overall Study|Clinical Failure|0|||
25297555|NCT01104662|50612394|FG002|Overall Study|Clinical Failure|0|||
25297556|NCT01104662|50612395|FG003|Overall Study|Clinical Failure|0|||
25297557|NCT01104662|50612396|FG004|Overall Study|Clinical Failure|0|||
25297558|NCT01104662|50612397|FG005|Overall Study|Clinical Failure|1|||
25297559|NCT01104662|50612398|FG006|Overall Study|Clinical Failure|0|||
25297560|NCT01104662|50612399|FG007|Overall Study|Clinical Failure|0|||
25297561|NCT01104662|50612392|FG000|Overall Study|Participant left investigator's care|1|||
25297562|NCT01104662|50612393|FG001|Overall Study|Participant left investigator's care|1|||
25297563|NCT01104662|50612394|FG002|Overall Study|Participant left investigator's care|0|||
25297564|NCT01104662|50612395|FG003|Overall Study|Participant left investigator's care|0|||
25297565|NCT01104662|50612396|FG004|Overall Study|Participant left investigator's care|0|||
25297566|NCT01104662|50612397|FG005|Overall Study|Participant left investigator's care|0|||
25297567|NCT01104662|50612398|FG006|Overall Study|Participant left investigator's care|0|||
25297568|NCT01104662|50612399|FG007|Overall Study|Participant left investigator's care|0|||
25297569|NCT01104662|50612392|FG000|Overall Study|Reason not specified|3|||
25297570|NCT01104662|50612393|FG001|Overall Study|Reason not specified|3|||
25297571|NCT01104662|50612394|FG002|Overall Study|Reason not specified|0|||
25297572|NCT01104662|50612395|FG003|Overall Study|Reason not specified|0|||
25297573|NCT01104662|50612396|FG004|Overall Study|Reason not specified|0|||
25297574|NCT01104662|50612397|FG005|Overall Study|Reason not specified|1|||
25297575|NCT01104662|50612398|FG006|Overall Study|Reason not specified|0|||
25297576|NCT01104662|50612399|FG007|Overall Study|Reason not specified|0|||
25297577|NCT01104662|50612392|FG000|Overall Study|Randomized but not treated|3|||
25297578|NCT01104662|50612393|FG001|Overall Study|Randomized but not treated|4|||
25297579|NCT01104662|50612394|FG002|Overall Study|Randomized but not treated|1|||
25297580|NCT01104662|50612395|FG003|Overall Study|Randomized but not treated|0|||
25297581|NCT01104662|50612396|FG004|Overall Study|Randomized but not treated|0|||
25297582|NCT01104662|50612397|FG005|Overall Study|Randomized but not treated|1|||
25297583|NCT01104662|50612398|FG006|Overall Study|Randomized but not treated|0|||
25297584|NCT01104662|50612399|FG007|Overall Study|Randomized but not treated|0|||
25297585|NCT01104584|50612418|FG000|Overall Study|Study drug never administered|21|||
25297586|NCT01104584|50612418|FG000|Overall Study|Study prematurely discontinued|2|||
25297587|NCT01103960|50612442|FG000|Overall Study|Adverse Event|2|||
25297588|NCT01103960|50612443|FG001|Overall Study|Adverse Event|1|||
25297589|NCT01103960|50612442|FG000|Overall Study|Withdrawal by Subject|2|||
25297590|NCT01103960|50612443|FG001|Overall Study|Withdrawal by Subject|1|||
25297591|NCT01103960|50612442|FG000|Overall Study|Other|1|||
25297592|NCT01103960|50612443|FG001|Overall Study|Other|0|||
25297593|NCT01107392|50612451|FG000|Overall Study|Adverse Event|2|||
25297594|NCT01107392|50612452|FG001|Overall Study|Adverse Event|0|||
25297595|NCT01107392|50612451|FG000|Overall Study|Personal Reasons|2|||
25297596|NCT01107392|50612452|FG001|Overall Study|Personal Reasons|3|||
25297597|NCT01107392|50612451|FG000|Overall Study|Administrative decision|1|||
25297598|NCT01107392|50612452|FG001|Overall Study|Administrative decision|0|||
25070755|NCT00109733|50176761|FG000|Overall Study|Stopped taking study drug|1|||
25070756|NCT00109733|50176762|FG001|Overall Study|Stopped taking study drug|1|||
25297599|NCT01106846|50612460|FG000|Overall Study|Change in surgical procedure|0|||
25297600|NCT01106846|50612461|FG001|Overall Study|Change in surgical procedure|1|||
25297601|NCT00902577|50612467|FG000|Overall Study|Withdrawal by Subject|6|||
25297602|NCT00902577|50612467|FG000|Overall Study|FMISO production failure|2|||
25297603|NCT01106690|50612502|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
25297604|NCT01106690|50612503|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
25297605|NCT01106690|50612504|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
25297606|NCT01106690|50612502|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
25297607|NCT01106690|50612503|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
25297608|NCT01106690|50612504|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
25297609|NCT01106690|50612502|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
25297610|NCT01106690|50612503|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
25297611|NCT01106690|50612504|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
25297612|NCT01106690|50612502|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
25297613|NCT01106690|50612503|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
25297614|NCT01106690|50612504|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
25297615|NCT01106690|50612502|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
25297616|NCT01106690|50612503|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
25297617|NCT01106690|50612504|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
25297618|NCT01106690|50612502|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
25297619|NCT01106690|50612503|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
25297620|NCT01106690|50612504|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
25297621|NCT01106690|50612502|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
25297622|NCT01106690|50612503|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
25297623|NCT01106690|50612504|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
25297624|NCT01106690|50612502|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
25297625|NCT01106690|50612503|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
25297626|NCT01106690|50612504|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
25297627|NCT01106690|50612502|FG000|Core Period: Baseline to Week 26|Other|10|||
25297628|NCT01106690|50612503|FG001|Core Period: Baseline to Week 26|Other|2|||
25297629|NCT01106690|50612504|FG002|Core Period: Baseline to Week 26|Other|6|||
25297630|NCT01106690|50612502|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
25297631|NCT01106690|50612503|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
25297632|NCT01106690|50612504|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
25169336|NCT01840943|50300889|FG000|Overall Study|Physician Decision|4|||
25169337|NCT01840943|50300890|FG001|Overall Study|Physician Decision|2|||
25169338|NCT01840943|50300889|FG000|Overall Study|Lost to Follow-up|4|||
25169339|NCT01840943|50300890|FG001|Overall Study|Lost to Follow-up|4|||
25169340|NCT01840163|50300898|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
25169341|NCT01840163|50300899|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
25169342|NCT01840163|50300898|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
25169343|NCT01840163|50300899|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
25169344|NCT01840163|50300898|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
25191751|NCT00083759|50353137|FG000|Overall Study|Inadequate Therapeutic Response|32|||
25191752|NCT00083759|50353138|FG001|Overall Study|Inadequate Therapeutic Response|35|||
25191753|NCT00083759|50353137|FG000|Overall Study|Subject Withdrew Consent|2|||
25191754|NCT00083759|50353138|FG001|Overall Study|Subject Withdrew Consent|2|||
25191755|NCT00083759|50353137|FG000|Overall Study|Non-Compliance|1|||
25297633|NCT01106690|50612502|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
25297634|NCT01106690|50612503|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
25297635|NCT01106690|50612504|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
25297636|NCT01106690|50612502|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
25297637|NCT01106690|50612503|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
25297638|NCT01106690|50612504|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
25297639|NCT01106690|50612502|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
25297640|NCT01106690|50612503|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
25297641|NCT01106690|50612504|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
25297642|NCT01106690|50612502|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
25297643|NCT01106690|50612503|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
25297644|NCT01106690|50612504|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
25297645|NCT01106690|50612502|FG000|Extension Period: Week 26 to Week 52|Other|8|||
25297646|NCT01106690|50612503|FG001|Extension Period: Week 26 to Week 52|Other|3|||
25297647|NCT01106690|50612504|FG002|Extension Period: Week 26 to Week 52|Other|4|||
25297648|NCT01106690|50612502|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
25297649|NCT01106690|50612503|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
25297650|NCT01106690|50612504|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
25297651|NCT01103180|50612534|FG000|Overall Study|Withdrawal by Subject|8|||
25297652|NCT01103180|50612535|FG001|Overall Study|Withdrawal by Subject|13|||
25297653|NCT01103180|50612534|FG000|Overall Study|Lost to Follow-up|13|||
25297654|NCT01103180|50612535|FG001|Overall Study|Lost to Follow-up|7|||
25297655|NCT01103180|50612534|FG000|Overall Study|Physician Decision|1|||
25169345|NCT01840163|50300899|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
25297656|NCT01103180|50612535|FG001|Overall Study|Physician Decision|0|||
25297657|NCT01103180|50612534|FG000|Overall Study|Protocol Violation|0|||
25297658|NCT01103180|50612535|FG001|Overall Study|Protocol Violation|1|||
25297659|NCT00944034|50612553|FG000|Overall Study|Inappropriate enrollment|0|||
25297660|NCT00944034|50612554|FG001|Overall Study|Inappropriate enrollment|1|||
25297661|NCT00944034|50612555|FG002|Overall Study|Inappropriate enrollment|0|||
25297662|NCT00944034|50612556|FG003|Overall Study|Inappropriate enrollment|1|||
25297663|NCT00944034|50612557|FG004|Overall Study|Inappropriate enrollment|2|||
25297664|NCT00944034|50612558|FG005|Overall Study|Inappropriate enrollment|1|||
25297665|NCT00944034|50612559|FG006|Overall Study|Inappropriate enrollment|0|||
25297666|NCT00944034|50612560|FG007|Overall Study|Inappropriate enrollment|0|||
25297667|NCT00944034|50612561|FG008|Overall Study|Inappropriate enrollment|1|||
25297668|NCT00944034|50612562|FG009|Overall Study|Inappropriate enrollment|1|||
25297669|NCT00944034|50612563|FG010|Overall Study|Inappropriate enrollment|0|||
25297670|NCT00944034|50612564|FG011|Overall Study|Inappropriate enrollment|0|||
25297671|NCT00944034|50612553|FG000|Overall Study|Withdrawal by Subject|3|||
25297672|NCT00944034|50612554|FG001|Overall Study|Withdrawal by Subject|2|||
25297673|NCT00944034|50612555|FG002|Overall Study|Withdrawal by Subject|6|||
25297674|NCT00944034|50612556|FG003|Overall Study|Withdrawal by Subject|2|||
25297675|NCT00944034|50612557|FG004|Overall Study|Withdrawal by Subject|5|||
25297676|NCT00944034|50612558|FG005|Overall Study|Withdrawal by Subject|8|||
25297677|NCT00944034|50612559|FG006|Overall Study|Withdrawal by Subject|2|||
25297678|NCT00944034|50612560|FG007|Overall Study|Withdrawal by Subject|2|||
25297679|NCT00944034|50612561|FG008|Overall Study|Withdrawal by Subject|3|||
25297680|NCT00944034|50612562|FG009|Overall Study|Withdrawal by Subject|4|||
25297681|NCT00944034|50612563|FG010|Overall Study|Withdrawal by Subject|0|||
25297682|NCT00944034|50612564|FG011|Overall Study|Withdrawal by Subject|4|||
25297683|NCT00944034|50612553|FG000|Overall Study|Lost to Follow-up|0|||
25297684|NCT00944034|50612554|FG001|Overall Study|Lost to Follow-up|4|||
25297685|NCT00944034|50612555|FG002|Overall Study|Lost to Follow-up|2|||
25297686|NCT00944034|50612556|FG003|Overall Study|Lost to Follow-up|0|||
25297687|NCT00944034|50612557|FG004|Overall Study|Lost to Follow-up|5|||
25297688|NCT00944034|50612558|FG005|Overall Study|Lost to Follow-up|7|||
25297689|NCT00944034|50612559|FG006|Overall Study|Lost to Follow-up|0|||
25297690|NCT00944034|50612560|FG007|Overall Study|Lost to Follow-up|1|||
25297691|NCT00944034|50612561|FG008|Overall Study|Lost to Follow-up|5|||
25297692|NCT00944034|50612562|FG009|Overall Study|Lost to Follow-up|1|||
25169346|NCT01831427|50301052|FG000|Overall Study|Adverse Event|0|||
25297693|NCT00944034|50612563|FG010|Overall Study|Lost to Follow-up|1|||
25297694|NCT00944034|50612564|FG011|Overall Study|Lost to Follow-up|0|||
25297695|NCT00944034|50612553|FG000|Overall Study|Death|0|||
25297696|NCT00944034|50612554|FG001|Overall Study|Death|0|||
25297697|NCT00944034|50612555|FG002|Overall Study|Death|1|||
25297698|NCT00944034|50612556|FG003|Overall Study|Death|0|||
25297699|NCT00944034|50612557|FG004|Overall Study|Death|0|||
25297700|NCT00944034|50612558|FG005|Overall Study|Death|0|||
25297701|NCT00944034|50612559|FG006|Overall Study|Death|0|||
25297702|NCT00944034|50612560|FG007|Overall Study|Death|0|||
25297703|NCT00944034|50612561|FG008|Overall Study|Death|0|||
25297704|NCT00944034|50612562|FG009|Overall Study|Death|0|||
25297705|NCT00944034|50612563|FG010|Overall Study|Death|0|||
25297706|NCT00944034|50612564|FG011|Overall Study|Death|0|||
25297707|NCT00944034|50612553|FG000|Overall Study|Protocol Violation|2|||
25169347|NCT01831427|50301053|FG001|Overall Study|Adverse Event|1|||
25169348|NCT01831427|50301054|FG002|Overall Study|Adverse Event|0|||
25169349|NCT01831427|50301055|FG003|Overall Study|Adverse Event|0|||
25169350|NCT01831427|50301056|FG004|Overall Study|Adverse Event|0|||
25169351|NCT01831427|50301057|FG005|Overall Study|Adverse Event|1|||
25169352|NCT01831427|50301058|FG006|Overall Study|Adverse Event|0|||
25169353|NCT01831427|50301059|FG007|Overall Study|Adverse Event|1|||
25297708|NCT00944034|50612554|FG001|Overall Study|Protocol Violation|0|||
25297709|NCT00944034|50612555|FG002|Overall Study|Protocol Violation|0|||
25297710|NCT00944034|50612556|FG003|Overall Study|Protocol Violation|1|||
25297711|NCT00944034|50612557|FG004|Overall Study|Protocol Violation|2|||
25297712|NCT00944034|50612558|FG005|Overall Study|Protocol Violation|3|||
25297713|NCT00944034|50612559|FG006|Overall Study|Protocol Violation|0|||
25297714|NCT00944034|50612560|FG007|Overall Study|Protocol Violation|1|||
25297715|NCT00944034|50612561|FG008|Overall Study|Protocol Violation|1|||
25297716|NCT00944034|50612562|FG009|Overall Study|Protocol Violation|4|||
25297717|NCT00944034|50612563|FG010|Overall Study|Protocol Violation|0|||
25297718|NCT00944034|50612564|FG011|Overall Study|Protocol Violation|0|||
25297719|NCT00944034|50612553|FG000|Overall Study|Unable to classify|0|||
25297720|NCT00944034|50612554|FG001|Overall Study|Unable to classify|0|||
25297721|NCT00944034|50612555|FG002|Overall Study|Unable to classify|0|||
25297722|NCT00944034|50612556|FG003|Overall Study|Unable to classify|0|||
25297723|NCT00944034|50612557|FG004|Overall Study|Unable to classify|0|||
25297724|NCT00944034|50612558|FG005|Overall Study|Unable to classify|1|||
25297725|NCT00944034|50612559|FG006|Overall Study|Unable to classify|1|||
25297726|NCT00944034|50612560|FG007|Overall Study|Unable to classify|1|||
25297727|NCT00944034|50612561|FG008|Overall Study|Unable to classify|0|||
25297728|NCT00944034|50612562|FG009|Overall Study|Unable to classify|0|||
25297729|NCT00944034|50612563|FG010|Overall Study|Unable to classify|0|||
25297730|NCT00944034|50612564|FG011|Overall Study|Unable to classify|0|||
25297731|NCT00944034|50612553|FG000|Overall Study|Administrative reason|0|||
25297732|NCT00944034|50612554|FG001|Overall Study|Administrative reason|0|||
25297733|NCT00944034|50612555|FG002|Overall Study|Administrative reason|0|||
25297734|NCT00944034|50612556|FG003|Overall Study|Administrative reason|0|||
25297735|NCT00944034|50612557|FG004|Overall Study|Administrative reason|0|||
25297736|NCT00944034|50612558|FG005|Overall Study|Administrative reason|0|||
25297737|NCT00944034|50612559|FG006|Overall Study|Administrative reason|1|||
25297738|NCT00944034|50612560|FG007|Overall Study|Administrative reason|0|||
25297739|NCT00944034|50612561|FG008|Overall Study|Administrative reason|0|||
25297740|NCT00944034|50612562|FG009|Overall Study|Administrative reason|0|||
25297741|NCT00944034|50612563|FG010|Overall Study|Administrative reason|0|||
25297742|NCT00944034|50612564|FG011|Overall Study|Administrative reason|0|||
25297743|NCT01106534|50612607|FG000|Overall Study|Withdrawal by Subject|18|||
25297744|NCT01106534|50612607|FG000|Overall Study|Lost to Follow-up|2|||
25297745|NCT01106534|50612607|FG000|Overall Study|Death|16|||
25297746|NCT01106534|50612607|FG000|Overall Study|Physician Decision|1|||
25297747|NCT00941304|50612617|FG000|Overall Study|Lost to Follow-up|1|||
25297748|NCT00941304|50612618|FG001|Overall Study|Lost to Follow-up|0|||
25297749|NCT00941304|50612619|FG002|Overall Study|Lost to Follow-up|0|||
25297750|NCT00941304|50612620|FG003|Overall Study|Lost to Follow-up|0|||
25297751|NCT00941304|50612621|FG004|Overall Study|Lost to Follow-up|0|||
25297752|NCT00941070|50612633|FG000|Overall Study|Patient non-compliant|1|||
25297753|NCT01098812|50612642|FG000|Overall Study|Death|2|||
25297754|NCT01098812|50612643|FG001|Overall Study|Death|0|||
25297755|NCT01098812|50612644|FG002|Overall Study|Death|1|||
25297756|NCT01098812|50612642|FG000|Overall Study|Lost to Follow-up|0|||
25297757|NCT01098812|50612643|FG001|Overall Study|Lost to Follow-up|1|||
25297758|NCT01098812|50612644|FG002|Overall Study|Lost to Follow-up|0|||
25297759|NCT00903201|50612654|FG000|Overall Study|Adverse Event|1|||
25297760|NCT00903201|50612655|FG001|Overall Study|Adverse Event|4|||
25297761|NCT00903201|50612656|FG002|Overall Study|Adverse Event|0|||
25297762|NCT00903201|50612654|FG000|Overall Study|Protocol Violation|2|||
25297763|NCT00903201|50612655|FG001|Overall Study|Protocol Violation|1|||
25297764|NCT00903201|50612656|FG002|Overall Study|Protocol Violation|0|||
25297765|NCT00903201|50612654|FG000|Overall Study|Lost to Follow-up|0|||
25297766|NCT00903201|50612655|FG001|Overall Study|Lost to Follow-up|1|||
25297767|NCT00903201|50612656|FG002|Overall Study|Lost to Follow-up|0|||
25297768|NCT00903201|50612654|FG000|Overall Study|Physician Decision|1|||
25297769|NCT00903201|50612655|FG001|Overall Study|Physician Decision|0|||
25297770|NCT00903201|50612656|FG002|Overall Study|Physician Decision|1|||
25297771|NCT00903201|50612654|FG000|Overall Study|Withdrawal by Subject|1|||
25297772|NCT00903201|50612655|FG001|Overall Study|Withdrawal by Subject|0|||
25297773|NCT00903201|50612656|FG002|Overall Study|Withdrawal by Subject|1|||
25297774|NCT00902265|50612666|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
25297775|NCT00902265|50612666|FG000|Overall Study|Adverse Event|2|||
25297776|NCT00902265|50612666|FG000|Overall Study|Lack of Efficacy|2|||
25297777|NCT00902265|50612666|FG000|Overall Study|Protocol Violation|1|||
25297778|NCT00943722|50612684|FG000|Base Study|Adverse Event|0|||
25297779|NCT00943722|50612685|FG001|Base Study|Adverse Event|0|||
25297780|NCT00943722|50612686|FG002|Base Study|Adverse Event|0|||
25297781|NCT00943722|50612687|FG003|Base Study|Adverse Event|1|||
25297782|NCT00943722|50612688|FG004|Base Study|Adverse Event|0|||
25297783|NCT00943722|50612689|FG005|Base Study|Adverse Event|0|||
25297784|NCT00943722|50612690|FG006|Base Study|Adverse Event|0|||
25297785|NCT00943722|50612684|FG000|Base Study|Lost to Follow-up|12|||
25297786|NCT00943722|50612685|FG001|Base Study|Lost to Follow-up|8|||
25297787|NCT00943722|50612686|FG002|Base Study|Lost to Follow-up|10|||
25297788|NCT00943722|50612687|FG003|Base Study|Lost to Follow-up|8|||
25297789|NCT00943722|50612688|FG004|Base Study|Lost to Follow-up|11|||
25297790|NCT00943722|50612689|FG005|Base Study|Lost to Follow-up|0|||
25297791|NCT00943722|50612690|FG006|Base Study|Lost to Follow-up|0|||
25297792|NCT00943722|50612684|FG000|Base Study|Physician Decision|1|||
25297793|NCT00943722|50612685|FG001|Base Study|Physician Decision|0|||
25297794|NCT00943722|50612686|FG002|Base Study|Physician Decision|0|||
25297795|NCT00943722|50612687|FG003|Base Study|Physician Decision|0|||
25297796|NCT00943722|50612688|FG004|Base Study|Physician Decision|1|||
25297797|NCT00943722|50612689|FG005|Base Study|Physician Decision|0|||
25297798|NCT00943722|50612690|FG006|Base Study|Physician Decision|0|||
25297799|NCT00943722|50612684|FG000|Base Study|Pregnancy|0|||
25297800|NCT00943722|50612685|FG001|Base Study|Pregnancy|0|||
25297801|NCT00943722|50612686|FG002|Base Study|Pregnancy|1|||
25297802|NCT00943722|50612687|FG003|Base Study|Pregnancy|0|||
25297803|NCT00943722|50612688|FG004|Base Study|Pregnancy|2|||
25297804|NCT00943722|50612689|FG005|Base Study|Pregnancy|0|||
25297805|NCT00943722|50612690|FG006|Base Study|Pregnancy|0|||
25297806|NCT00943722|50612684|FG000|Base Study|Protocol Violation|0|||
25297807|NCT00943722|50612685|FG001|Base Study|Protocol Violation|1|||
25297808|NCT00943722|50612686|FG002|Base Study|Protocol Violation|0|||
25297809|NCT00943722|50612687|FG003|Base Study|Protocol Violation|0|||
25297810|NCT00943722|50612688|FG004|Base Study|Protocol Violation|2|||
25297811|NCT00943722|50612689|FG005|Base Study|Protocol Violation|0|||
25297812|NCT00943722|50612690|FG006|Base Study|Protocol Violation|0|||
25297813|NCT00943722|50612684|FG000|Base Study|Withdrawal by Subject|12|||
25297814|NCT00943722|50612685|FG001|Base Study|Withdrawal by Subject|13|||
25297815|NCT00943722|50612686|FG002|Base Study|Withdrawal by Subject|2|||
25297816|NCT00943722|50612687|FG003|Base Study|Withdrawal by Subject|13|||
25297817|NCT00943722|50612688|FG004|Base Study|Withdrawal by Subject|8|||
25297818|NCT00943722|50612689|FG005|Base Study|Withdrawal by Subject|0|||
25297819|NCT00943722|50612690|FG006|Base Study|Withdrawal by Subject|0|||
25297820|NCT00943722|50612684|FG000|Base Study|Month 12 visit not completed|0|||
25297821|NCT00943722|50612685|FG001|Base Study|Month 12 visit not completed|0|||
25297822|NCT00943722|50612686|FG002|Base Study|Month 12 visit not completed|0|||
25297823|NCT00943722|50612687|FG003|Base Study|Month 12 visit not completed|0|||
25297824|NCT00943722|50612688|FG004|Base Study|Month 12 visit not completed|2|||
25297825|NCT00943722|50612689|FG005|Base Study|Month 12 visit not completed|0|||
25297826|NCT00943722|50612690|FG006|Base Study|Month 12 visit not completed|0|||
25297827|NCT00943722|50612684|FG000|First Extension Study: EXT 1|Adverse Event|0|||
25297828|NCT00943722|50612685|FG001|First Extension Study: EXT 1|Adverse Event|0|||
25297829|NCT00943722|50612686|FG002|First Extension Study: EXT 1|Adverse Event|0|||
25297830|NCT00943722|50612687|FG003|First Extension Study: EXT 1|Adverse Event|0|||
25297831|NCT00943722|50612688|FG004|First Extension Study: EXT 1|Adverse Event|0|||
25297832|NCT00943722|50612689|FG005|First Extension Study: EXT 1|Adverse Event|1|||
25297833|NCT00943722|50612690|FG006|First Extension Study: EXT 1|Adverse Event|0|||
25297834|NCT00943722|50612684|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
25297835|NCT00943722|50612685|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
25297836|NCT00943722|50612686|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
25297837|NCT00943722|50612687|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
25297838|NCT00943722|50612688|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
25297839|NCT00943722|50612689|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
25297840|NCT00943722|50612690|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
25297841|NCT00943722|50612684|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
25297842|NCT00943722|50612685|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
25297843|NCT00943722|50612686|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
25297844|NCT00943722|50612687|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
25297845|NCT00943722|50612688|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
25297846|NCT00943722|50612689|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
25297847|NCT00943722|50612690|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
25297848|NCT00943722|50612684|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
25297849|NCT00943722|50612685|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
25297850|NCT00943722|50612686|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
25297851|NCT00943722|50612687|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
25297852|NCT00943722|50612688|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
25297853|NCT00943722|50612689|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
25297854|NCT00943722|50612690|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
25297855|NCT00943722|50612684|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
25297856|NCT00943722|50612685|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
25297857|NCT00943722|50612686|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
25297858|NCT00943722|50612687|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
25297859|NCT00943722|50612688|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
25297860|NCT00943722|50612689|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
25297861|NCT00943722|50612690|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
25297862|NCT00943722|50612684|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
25297863|NCT00943722|50612685|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
25297864|NCT00943722|50612686|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
25297865|NCT00943722|50612687|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
25297866|NCT00943722|50612688|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
25297867|NCT00943722|50612689|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
25297868|NCT00943722|50612690|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
25297869|NCT00943722|50612684|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
25297870|NCT00943722|50612685|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
25297871|NCT00943722|50612686|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
25297872|NCT00943722|50612687|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
25297873|NCT00943722|50612688|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
25297874|NCT00943722|50612689|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
25297875|NCT00943722|50612690|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
25297876|NCT00943722|50612684|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
25297877|NCT00943722|50612685|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
25297878|NCT00943722|50612686|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
25297879|NCT00943722|50612687|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
25297880|NCT00943722|50612688|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
25297881|NCT00943722|50612689|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
25297882|NCT00943722|50612690|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
25297883|NCT00943722|50612684|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
25297884|NCT00943722|50612685|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
25297885|NCT00943722|50612686|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
25297886|NCT00943722|50612687|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
25297887|NCT00943722|50612688|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
25297888|NCT00943722|50612689|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
25297889|NCT00943722|50612690|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
25297890|NCT00901485|50612713|FG000|Overall Study|Lack of Efficacy|0|||
25297891|NCT00901485|50612714|FG001|Overall Study|Lack of Efficacy|2|||
25297892|NCT00901485|50612713|FG000|Overall Study|Withdrawal by Subject|1|||
25297893|NCT00901485|50612714|FG001|Overall Study|Withdrawal by Subject|2|||
25297894|NCT00896337|50612720|FG000|Overall Study|Death|7|||
25297895|NCT00896337|50612720|FG000|Overall Study|Withdrawal by Subject|7|||
25297896|NCT00896337|50612720|FG000|Overall Study|Lost to Follow-up|11|||
25297897|NCT00953706|50612740|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
25297898|NCT00953706|50612741|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
25297899|NCT00953706|50612742|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
25297900|NCT00953706|50612743|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
25297901|NCT00953706|50612740|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
25297902|NCT00953706|50612741|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
25297903|NCT00953706|50612742|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
25297904|NCT00953706|50612743|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
25297905|NCT00953706|50612740|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
25297906|NCT00953706|50612741|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
25297907|NCT00953706|50612742|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
25297908|NCT00953706|50612743|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
25297909|NCT00953706|50612740|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
25297910|NCT00953706|50612741|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
25297911|NCT00953706|50612742|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
25297912|NCT00953706|50612743|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
25297913|NCT00953706|50612740|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
25297914|NCT00953706|50612741|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
25297915|NCT00953706|50612742|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
25297916|NCT00953706|50612743|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
25297917|NCT00953706|50612740|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
25297918|NCT00953706|50612741|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
25297919|NCT00953706|50612742|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
25297920|NCT00953706|50612743|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
25297921|NCT00953706|50612740|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
25297922|NCT00953706|50612741|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
25297923|NCT00953706|50612742|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
25297924|NCT00953706|50612743|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
25297925|NCT00953706|50612740|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
25297926|NCT00953706|50612741|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
25297927|NCT00953706|50612742|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
25297928|NCT00953706|50612743|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
25297929|NCT00953706|50612740|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
25297930|NCT00953706|50612741|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
25297931|NCT00953706|50612742|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
25297932|NCT00953706|50612743|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
25297933|NCT00953706|50612740|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
25297934|NCT00953706|50612741|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
25297935|NCT00953706|50612742|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
25297936|NCT00953706|50612743|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
25297937|NCT00953706|50612740|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
25297938|NCT00953706|50612741|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
25297939|NCT00953706|50612742|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
25297940|NCT00953706|50612743|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
25297941|NCT00940992|50612756|FG000|Overall Study|Adverse Event|2|||
25297942|NCT00940992|50612757|FG001|Overall Study|Adverse Event|0|||
25297943|NCT00940992|50612758|FG002|Overall Study|Adverse Event|1|||
25297944|NCT00940992|50612756|FG000|Overall Study|subject request|2|||
25297945|NCT00940992|50612757|FG001|Overall Study|subject request|1|||
25297946|NCT00940992|50612758|FG002|Overall Study|subject request|0|||
25297947|NCT00940992|50612756|FG000|Overall Study|Lost to Follow-up|0|||
25297948|NCT00940992|50612757|FG001|Overall Study|Lost to Follow-up|1|||
25297949|NCT00940992|50612758|FG002|Overall Study|Lost to Follow-up|1|||
25297950|NCT00938964|50612768|FG000|Overall Study|Death|3|||
25297951|NCT00938964|50612769|FG001|Overall Study|Death|3|||
25297952|NCT00938964|50612768|FG000|Overall Study|Lost to Follow-up|2|||
25297953|NCT00938964|50612769|FG001|Overall Study|Lost to Follow-up|3|||
25297954|NCT00938964|50612768|FG000|Overall Study|Withdrawal by Subject|22|||
25297955|NCT00938964|50612769|FG001|Overall Study|Withdrawal by Subject|18|||
25297956|NCT00938964|50612768|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
25297957|NCT00938964|50612769|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
25297958|NCT00938886|50612777|FG000|Overall Study|Death|0|||
25297959|NCT00938886|50612778|FG001|Overall Study|Death|1|||
25297960|NCT00938886|50612777|FG000|Overall Study|Withdrawal by Subject|4|||
25297961|NCT00938886|50612778|FG001|Overall Study|Withdrawal by Subject|7|||
25297962|NCT00938886|50612777|FG000|Overall Study|Lost to Follow-up|3|||
25297963|NCT00938886|50612778|FG001|Overall Study|Lost to Follow-up|2|||
25070757|NCT00109733|50176761|FG000|Overall Study|Non-compliant|0|||
25297964|NCT00938340|50612784|FG000|Overall Study|Withdrawal by Subject|3|||
25191756|NCT00083759|50353138|FG001|Overall Study|Non-Compliance|0|||
25297965|NCT00938340|50612784|FG000|Overall Study|Protocol Violation|1|||
25297966|NCT00938340|50612784|FG000|Overall Study|Adverse Event|1|||
25297967|NCT00942708|50612830|FG000|Overall Study|Withdrawal by Subject|1|||
25169354|NCT01831427|50301060|FG008|Overall Study|Adverse Event|0|||
25297968|NCT00937950|50612835|FG000|Overall Study|Withdrawal by Subject|23|||
25297969|NCT00937950|50612835|FG000|Overall Study|Migrated/moved from study area|27|||
25297970|NCT00937950|50612835|FG000|Overall Study|Lost to Follow-up|144|||
25297971|NCT00937950|50612835|FG000|Overall Study|Missing confirmed|4|||
25297972|NCT00937950|50612835|FG000|Overall Study|Other|18|||
25297973|NCT00942162|50612842|FG000|Overall Study|Death|45|||
25297974|NCT00942162|50612843|FG001|Overall Study|Death|35|||
25297975|NCT00942162|50612844|FG002|Overall Study|Death|0|||
25297976|NCT00942162|50612842|FG000|Overall Study|Withdrawal by Subject|7|||
25297977|NCT00942162|50612843|FG001|Overall Study|Withdrawal by Subject|2|||
25297978|NCT00942162|50612844|FG002|Overall Study|Withdrawal by Subject|0|||
25297979|NCT00942162|50612842|FG000|Overall Study|Lost to Follow-up|4|||
25297980|NCT00942162|50612843|FG001|Overall Study|Lost to Follow-up|0|||
25297981|NCT00942162|50612844|FG002|Overall Study|Lost to Follow-up|0|||
25169355|NCT01831427|50301061|FG009|Overall Study|Adverse Event|0|||
25169356|NCT01831427|50301062|FG010|Overall Study|Adverse Event|2|||
25169357|NCT01831427|50301052|FG000|Overall Study|Investigator's Discretion|0|||
25297982|NCT00942162|50612842|FG000|Overall Study|Other|14|||
25297983|NCT00942162|50612843|FG001|Overall Study|Other|13|||
25297984|NCT00942162|50612844|FG002|Overall Study|Other|2|||
25297985|NCT00942084|50612854|FG000|Overall Study|Death|2|||
25297986|NCT00941928|50612858|FG000|Overall Study|Withdrawal by Subject|1|||
25297987|NCT00941928|50612858|FG000|Overall Study|Disease Progression|1|||
25297988|NCT00937560|50612862|FG000|Initial Treatment|Death|6|||
25297989|NCT00937560|50612862|FG000|Initial Treatment|Withdraw consent|3|||
25297990|NCT00937560|50612862|FG000|Initial Treatment|Adverse Event|1|||
25297991|NCT00937560|50612862|FG000|Initial Treatment|Lost to Follow-up|1|||
25297992|NCT00937560|50612862|FG000|Initial Treatment|No end of study page|10|||
25297993|NCT00937560|50612862|FG000|Maintenance Treatment|Death|12|||
25297994|NCT00937560|50612862|FG000|Maintenance Treatment|Withdraw consent|5|||
25297995|NCT00937560|50612862|FG000|Maintenance Treatment|According to protocol|1|||
25297996|NCT00594568|50612869|FG000|Initial Treatment|Adverse Event|51|||
25297997|NCT00594568|50612870|FG001|Initial Treatment|Adverse Event|121|||
25297998|NCT00594568|50612871|FG002|Initial Treatment|Adverse Event|144|||
25297999|NCT00594568|50612869|FG000|Initial Treatment|Death|6|||
25298000|NCT00594568|50612870|FG001|Initial Treatment|Death|11|||
25298001|NCT00594568|50612871|FG002|Initial Treatment|Death|15|||
25298002|NCT00594568|50612869|FG000|Initial Treatment|Lost to Follow-up|4|||
25298003|NCT00594568|50612870|FG001|Initial Treatment|Lost to Follow-up|1|||
25298004|NCT00594568|50612871|FG002|Initial Treatment|Lost to Follow-up|4|||
25298005|NCT00594568|50612869|FG000|Initial Treatment|Physician Decision|3|||
25298006|NCT00594568|50612870|FG001|Initial Treatment|Physician Decision|2|||
25298007|NCT00594568|50612871|FG002|Initial Treatment|Physician Decision|4|||
25298008|NCT00594568|50612869|FG000|Initial Treatment|Protocol Violation|2|||
25298009|NCT00594568|50612870|FG001|Initial Treatment|Protocol Violation|2|||
25298010|NCT00594568|50612871|FG002|Initial Treatment|Protocol Violation|5|||
25298011|NCT00594568|50612869|FG000|Initial Treatment|Withdrawal by Subject|25|||
25298012|NCT00594568|50612870|FG001|Initial Treatment|Withdrawal by Subject|31|||
25298013|NCT00594568|50612871|FG002|Initial Treatment|Withdrawal by Subject|46|||
25298014|NCT00594568|50612869|FG000|Initial Treatment|Sponsor decision|193|||
25298015|NCT00594568|50612870|FG001|Initial Treatment|Sponsor decision|142|||
25298016|NCT00594568|50612871|FG002|Initial Treatment|Sponsor decision|147|||
25298017|NCT00594568|50612869|FG000|Initial Treatment|Caregiver decision|21|||
25298018|NCT00594568|50612870|FG001|Initial Treatment|Caregiver decision|36|||
25298019|NCT00594568|50612871|FG002|Initial Treatment|Caregiver decision|36|||
25298020|NCT00594568|50612869|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
25298021|NCT00594568|50612870|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
25298022|NCT00594568|50612871|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
25298023|NCT00594568|50612869|FG000|Initial Treatment|Entry criteria exclusion|0|||
25298024|NCT00594568|50612870|FG001|Initial Treatment|Entry criteria exclusion|1|||
25298025|NCT00594568|50612871|FG002|Initial Treatment|Entry criteria exclusion|1|||
25298026|NCT00594568|50612869|FG000|Delayed Start|Death|0|||
25298027|NCT00594568|50612870|FG001|Delayed Start|Death|0|||
25298028|NCT00594568|50612871|FG002|Delayed Start|Death|1|||
25298029|NCT00594568|50612869|FG000|Delayed Start|Adverse Event|12|||
25298030|NCT00594568|50612870|FG001|Delayed Start|Adverse Event|2|||
25298031|NCT00594568|50612871|FG002|Delayed Start|Adverse Event|2|||
25298032|NCT00594568|50612869|FG000|Delayed Start|Withdrawal by Subject|4|||
25298033|NCT00594568|50612870|FG001|Delayed Start|Withdrawal by Subject|3|||
25298034|NCT00594568|50612871|FG002|Delayed Start|Withdrawal by Subject|0|||
25298035|NCT00594568|50612869|FG000|Delayed Start|Physician Decision|0|||
25298036|NCT00594568|50612870|FG001|Delayed Start|Physician Decision|0|||
25298037|NCT00594568|50612871|FG002|Delayed Start|Physician Decision|1|||
25298038|NCT00594568|50612869|FG000|Delayed Start|Lost to Follow-up|0|||
25298039|NCT00594568|50612870|FG001|Delayed Start|Lost to Follow-up|0|||
25298040|NCT00594568|50612871|FG002|Delayed Start|Lost to Follow-up|1|||
25298041|NCT00594568|50612869|FG000|Delayed Start|Caregiver Decision|5|||
25298042|NCT00594568|50612870|FG001|Delayed Start|Caregiver Decision|6|||
25298043|NCT00594568|50612871|FG002|Delayed Start|Caregiver Decision|2|||
25298044|NCT00594568|50612869|FG000|Delayed Start|Sponsor Decision|77|||
25298045|NCT00594568|50612870|FG001|Delayed Start|Sponsor Decision|66|||
25298046|NCT00594568|50612871|FG002|Delayed Start|Sponsor Decision|59|||
25298047|NCT00594568|50612869|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
25298048|NCT00594568|50612870|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
25298049|NCT00594568|50612871|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
25298050|NCT00594568|50612869|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
25298051|NCT00594568|50612870|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
25298052|NCT00594568|50612871|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
25298053|NCT00594568|50612869|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
25298054|NCT00594568|50612870|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
25298055|NCT00594568|50612871|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
25298056|NCT00594568|50612869|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
25298057|NCT00594568|50612870|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
25298058|NCT00594568|50612871|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
25298059|NCT00594568|50612869|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
25298060|NCT00594568|50612870|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
25298061|NCT00594568|50612871|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
25298062|NCT00594568|50612869|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
25298063|NCT00594568|50612870|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
25298064|NCT00594568|50612871|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
25298065|NCT00875056|50612899|FG000|Overall Study|Adverse Event|6|||
25298066|NCT00875056|50612900|FG001|Overall Study|Adverse Event|1|||
25298067|NCT00875056|50612901|FG002|Overall Study|Adverse Event|2|||
25298068|NCT00875056|50612899|FG000|Overall Study|Progressive Disease|14|||
25298069|NCT00875056|50612900|FG001|Overall Study|Progressive Disease|8|||
25298070|NCT00875056|50612901|FG002|Overall Study|Progressive Disease|3|||
25298071|NCT00875056|50612899|FG000|Overall Study|Withdrawal by Subject|3|||
25298072|NCT00875056|50612900|FG001|Overall Study|Withdrawal by Subject|0|||
25298073|NCT00875056|50612901|FG002|Overall Study|Withdrawal by Subject|1|||
25298074|NCT00940602|50612911|FG000|Overall Study|Administrative problems|1|||
25298075|NCT00940602|50612912|FG001|Overall Study|Administrative problems|1|||
25298076|NCT00940602|50612911|FG000|Overall Study|Patient/guardian decision|13|||
25298077|NCT00940602|50612912|FG001|Overall Study|Patient/guardian decision|28|||
25298078|NCT00940602|50612911|FG000|Overall Study|Physician Decision|8|||
25298079|NCT00940602|50612912|FG001|Overall Study|Physician Decision|5|||
25298080|NCT00940602|50612911|FG000|Overall Study|Pregnancy|1|||
25298081|NCT00940602|50612912|FG001|Overall Study|Pregnancy|0|||
25298082|NCT00940602|50612911|FG000|Overall Study|Protocol Deviation (untreated)|1|||
25298083|NCT00940602|50612912|FG001|Overall Study|Protocol Deviation (untreated)|0|||
25298084|NCT00940602|50612911|FG000|Overall Study|Disease progression|8|||
24969838|NCT00128492|50059260|FG001|Overall Study|Withdrawal by Subject|5|||
25298085|NCT00940602|50612912|FG001|Overall Study|Disease progression|2|||
25298086|NCT00940602|50612911|FG000|Overall Study|Death|38|||
25298087|NCT00940602|50612912|FG001|Overall Study|Death|19|||
25298088|NCT00940602|50612911|FG000|Overall Study|Lost to Follow-up|3|||
25298089|NCT00940602|50612912|FG001|Overall Study|Lost to Follow-up|1|||
25298090|NCT00940602|50612911|FG000|Overall Study|Patient withdrew consent|26|||
25298091|NCT00940602|50612912|FG001|Overall Study|Patient withdrew consent|13|||
25298092|NCT00940602|50612911|FG000|Overall Study|Adverse Event|7|||
25298093|NCT00940602|50612912|FG001|Overall Study|Adverse Event|2|||
25298094|NCT00940602|50612911|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
25298095|NCT00940602|50612912|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
25298096|NCT00874822|50612919|FG000|Overall Study|excluded by criteria|8|||
25298097|NCT00875524|50612925|FG000|Overall Study|Serious adverse event|0|||
25298098|NCT00875524|50612926|FG001|Overall Study|Serious adverse event|1|||
25298099|NCT00875524|50612925|FG000|Overall Study|Protocol Violation|4|||
25298100|NCT00875524|50612926|FG001|Overall Study|Protocol Violation|0|||
25298101|NCT00875524|50612925|FG000|Overall Study|Lost to Follow-up|1|||
25298102|NCT00875524|50612926|FG001|Overall Study|Lost to Follow-up|0|||
25298103|NCT00875524|50612925|FG000|Overall Study|Withdrawal by Subject|3|||
25298104|NCT00875524|50612926|FG001|Overall Study|Withdrawal by Subject|5|||
25298105|NCT01094288|50612940|FG000|Overall Study|Adverse Event|0|||
25298106|NCT01094288|50612941|FG001|Overall Study|Adverse Event|3|||
25298107|NCT01094288|50612942|FG002|Overall Study|Adverse Event|1|||
25298108|NCT01094288|50612943|FG003|Overall Study|Adverse Event|1|||
25298109|NCT01094288|50612944|FG004|Overall Study|Adverse Event|0|||
25298110|NCT01094288|50612945|FG005|Overall Study|Adverse Event|0|||
25298111|NCT01094288|50612946|FG006|Overall Study|Adverse Event|0|||
25298112|NCT01094288|50612947|FG007|Overall Study|Adverse Event|0|||
25298113|NCT01094288|50612940|FG000|Overall Study|Withdrawal by Subject|0|||
25298114|NCT01094288|50612941|FG001|Overall Study|Withdrawal by Subject|1|||
25298115|NCT01094288|50612942|FG002|Overall Study|Withdrawal by Subject|2|||
25298116|NCT01094288|50612943|FG003|Overall Study|Withdrawal by Subject|0|||
25298117|NCT01094288|50612944|FG004|Overall Study|Withdrawal by Subject|0|||
25298118|NCT01094288|50612945|FG005|Overall Study|Withdrawal by Subject|0|||
25298119|NCT01094288|50612946|FG006|Overall Study|Withdrawal by Subject|0|||
25298120|NCT01094288|50612947|FG007|Overall Study|Withdrawal by Subject|2|||
25298121|NCT01094288|50612940|FG000|Overall Study|Initiation of Alternative Therapy|0|||
25298122|NCT01094288|50612941|FG001|Overall Study|Initiation of Alternative Therapy|0|||
25298123|NCT01094288|50612942|FG002|Overall Study|Initiation of Alternative Therapy|1|||
25298124|NCT01094288|50612943|FG003|Overall Study|Initiation of Alternative Therapy|0|||
25298125|NCT01094288|50612944|FG004|Overall Study|Initiation of Alternative Therapy|0|||
25298126|NCT01094288|50612945|FG005|Overall Study|Initiation of Alternative Therapy|0|||
25298127|NCT01094288|50612946|FG006|Overall Study|Initiation of Alternative Therapy|0|||
25298128|NCT01094288|50612947|FG007|Overall Study|Initiation of Alternative Therapy|0|||
25298129|NCT01094288|50612940|FG000|Overall Study|Reason not Specified|2|||
25298130|NCT01094288|50612941|FG001|Overall Study|Reason not Specified|3|||
25298131|NCT01094288|50612942|FG002|Overall Study|Reason not Specified|0|||
25298132|NCT01094288|50612943|FG003|Overall Study|Reason not Specified|1|||
25298133|NCT01094288|50612944|FG004|Overall Study|Reason not Specified|0|||
25298134|NCT01094288|50612945|FG005|Overall Study|Reason not Specified|0|||
25298135|NCT01094288|50612946|FG006|Overall Study|Reason not Specified|0|||
25298136|NCT01094288|50612947|FG007|Overall Study|Reason not Specified|0|||
25298137|NCT01094288|50612940|FG000|Overall Study|Ongoing Participants|0|||
25298138|NCT01094288|50612941|FG001|Overall Study|Ongoing Participants|3|||
25298139|NCT01094288|50612942|FG002|Overall Study|Ongoing Participants|0|||
25298140|NCT01094288|50612943|FG003|Overall Study|Ongoing Participants|0|||
25298141|NCT01094288|50612944|FG004|Overall Study|Ongoing Participants|0|||
25070758|NCT00109733|50176762|FG001|Overall Study|Non-compliant|1|||
25070759|NCT00109733|50176761|FG000|Overall Study|Could not commit time for study|1|||
25070760|NCT00109733|50176762|FG001|Overall Study|Could not commit time for study|1|||
25070761|NCT02706405|50176776|FG000|Overall Study|Death|3|||
25070762|NCT02706405|50176777|FG001|Overall Study|Death|2|||
25070763|NCT02706405|50176778|FG002|Overall Study|Death|0|||
25070764|NCT02706405|50176779|FG003|Overall Study|Death|1|||
25070765|NCT02706405|50176780|FG004|Overall Study|Death|0|||
25070766|NCT02706405|50176781|FG005|Overall Study|Death|0|||
25070767|NCT02706405|50176782|FG006|Overall Study|Death|3|||
25070768|NCT02706405|50176783|FG007|Overall Study|Death|4|||
25070769|NCT02706405|50176776|FG000|Overall Study|Disease progression|0|||
25298142|NCT01094288|50612945|FG005|Overall Study|Ongoing Participants|0|||
25298143|NCT01094288|50612946|FG006|Overall Study|Ongoing Participants|0|||
25298144|NCT01094288|50612947|FG007|Overall Study|Ongoing Participants|0|||
25298145|NCT00874120|50612971|FG000|First Intervention|Adverse Event|0|||
25298146|NCT00874120|50612972|FG001|First Intervention|Adverse Event|1|||
25298147|NCT00874120|50612971|FG000|First Intervention|Withdrawal by Subject|2|||
25298148|NCT00874120|50612972|FG001|First Intervention|Withdrawal by Subject|0|||
25298149|NCT00874120|50612971|FG000|First Intervention|Lost to Follow-up|0|||
25298150|NCT00874120|50612972|FG001|First Intervention|Lost to Follow-up|1|||
25070770|NCT02706405|50176777|FG001|Overall Study|Disease progression|0|||
25070771|NCT02706405|50176778|FG002|Overall Study|Disease progression|0|||
25070772|NCT02706405|50176779|FG003|Overall Study|Disease progression|0|||
25070773|NCT02706405|50176780|FG004|Overall Study|Disease progression|0|||
25070774|NCT02706405|50176781|FG005|Overall Study|Disease progression|0|||
25070775|NCT02706405|50176782|FG006|Overall Study|Disease progression|0|||
25070776|NCT02706405|50176783|FG007|Overall Study|Disease progression|1|||
25070777|NCT02706405|50176776|FG000|Overall Study|Pt moved to new therapy|0|||
25070778|NCT02706405|50176777|FG001|Overall Study|Pt moved to new therapy|0|||
25070779|NCT02706405|50176778|FG002|Overall Study|Pt moved to new therapy|0|||
25298151|NCT00874120|50612971|FG000|First Intervention|Protocol Violation|3|||
25298152|NCT00874120|50612972|FG001|First Intervention|Protocol Violation|0|||
25298153|NCT00874120|50612971|FG000|First Intervention|positive drug test|1|||
25298154|NCT00874120|50612972|FG001|First Intervention|positive drug test|0|||
25298155|NCT00874120|50612971|FG000|Second Intervention|Withdrawal by Subject|1|||
25298156|NCT00874120|50612972|FG001|Second Intervention|Withdrawal by Subject|0|||
25298157|NCT00874120|50612971|FG000|Second Intervention|Protocol Violation|1|||
25298158|NCT00874120|50612972|FG001|Second Intervention|Protocol Violation|0|||
25298159|NCT00939822|50612980|FG000|Overall Study|Lost to Follow-up|1|||
25298160|NCT00939822|50612981|FG001|Overall Study|Lost to Follow-up|0|||
25298161|NCT00939822|50612980|FG000|Overall Study|withdrew from study due to busy schedule|1|||
25298162|NCT00939822|50612981|FG001|Overall Study|withdrew from study due to busy schedule|1|||
25298163|NCT00939822|50612980|FG000|Overall Study|Mental health issues|0|||
25298164|NCT00939822|50612981|FG001|Overall Study|Mental health issues|2|||
25298165|NCT00939510|50612987|FG000|Overall Study|Withdrawal by Subject|1|||
25298166|NCT01098266|50612993|FG000|Overall Study|Physician Decision|1|||
25298167|NCT01098266|50612994|FG001|Overall Study|Physician Decision|0|||
25298168|NCT01098266|50612993|FG000|Overall Study|Death|3|||
25298169|NCT01098266|50612994|FG001|Overall Study|Death|2|||
25298170|NCT01098266|50612993|FG000|Overall Study|Withdrawal by Subject|3|||
25298171|NCT01098266|50612994|FG001|Overall Study|Withdrawal by Subject|5|||
25298172|NCT00935532|50613002|FG000|Overall Study|Adverse Event|11|||
25298173|NCT00935532|50613003|FG001|Overall Study|Adverse Event|6|||
25298174|NCT00935532|50613002|FG000|Overall Study|Death|1|||
25298175|NCT00935532|50613003|FG001|Overall Study|Death|0|||
25298176|NCT00935532|50613002|FG000|Overall Study|Lost to Follow-up|1|||
25298177|NCT00935532|50613003|FG001|Overall Study|Lost to Follow-up|0|||
25298178|NCT00935532|50613002|FG000|Overall Study|Physician Decision|1|||
25298179|NCT00935532|50613003|FG001|Overall Study|Physician Decision|2|||
25298180|NCT00935532|50613002|FG000|Overall Study|Protocol Violation|2|||
25298181|NCT00935532|50613003|FG001|Overall Study|Protocol Violation|1|||
25298182|NCT00935532|50613002|FG000|Overall Study|Subject Decision|2|||
25298183|NCT00935532|50613003|FG001|Overall Study|Subject Decision|1|||
25298184|NCT00935532|50613002|FG000|Overall Study|Sponsor Decision|0|||
25298185|NCT00935532|50613003|FG001|Overall Study|Sponsor Decision|1|||
25298186|NCT00935532|50613002|FG000|Overall Study|Loss Glucose Control|4|||
25298187|NCT00935532|50613003|FG001|Overall Study|Loss Glucose Control|0|||
25298188|NCT01093586|50613009|FG000|Overall Study|Failed to engraft|3|||
25298189|NCT00937404|50613013|FG000|Overall Study|Protocol Violation|1|||
25298190|NCT00937404|50613013|FG000|Overall Study|Withdrawal by Subject|1|||
25070780|NCT02706405|50176779|FG003|Overall Study|Pt moved to new therapy|0|||
25070781|NCT02706405|50176780|FG004|Overall Study|Pt moved to new therapy|0|||
25070782|NCT02706405|50176781|FG005|Overall Study|Pt moved to new therapy|1|||
25298191|NCT01098110|50613020|FG000|Overall Study|Withdrawal by Subject|14|||
25298192|NCT01098110|50613021|FG001|Overall Study|Withdrawal by Subject|24|||
25298193|NCT01098110|50613022|FG002|Overall Study|Withdrawal by Subject|19|||
25298194|NCT01098110|50613020|FG000|Overall Study|Adverse Event|30|||
25298195|NCT01098110|50613021|FG001|Overall Study|Adverse Event|32|||
25298196|NCT01098110|50613022|FG002|Overall Study|Adverse Event|43|||
25298197|NCT01098110|50613020|FG000|Overall Study|Lack of Efficacy|13|||
25298198|NCT01098110|50613021|FG001|Overall Study|Lack of Efficacy|9|||
25298199|NCT01098110|50613022|FG002|Overall Study|Lack of Efficacy|27|||
25298200|NCT01098110|50613020|FG000|Overall Study|Other|4|||
25298201|NCT01098110|50613021|FG001|Overall Study|Other|7|||
25298202|NCT01098110|50613022|FG002|Overall Study|Other|5|||
25298203|NCT01098110|50613020|FG000|Overall Study|Untreated|1|||
25298204|NCT01098110|50613021|FG001|Overall Study|Untreated|1|||
25298205|NCT01098110|50613022|FG002|Overall Study|Untreated|0|||
25298206|NCT01092728|50613032|FG000|Overall Study|Withdrawal by Subject|2|||
25298207|NCT01092728|50613033|FG001|Overall Study|Withdrawal by Subject|0|||
25298208|NCT01092728|50613032|FG000|Overall Study|Adverse Event|0|||
25298209|NCT01092728|50613033|FG001|Overall Study|Adverse Event|1|||
25298210|NCT01092728|50613032|FG000|Overall Study|Disease Progression|1|||
25298211|NCT01092728|50613033|FG001|Overall Study|Disease Progression|13|||
25298212|NCT01092728|50613032|FG000|Overall Study|Prohibited Concomitant Medications|1|||
25298213|NCT01092728|50613033|FG001|Overall Study|Prohibited Concomitant Medications|0|||
24969839|NCT00128492|50059259|FG000|Overall Study|Pregnancy|0|||
24969840|NCT00128492|50059260|FG001|Overall Study|Pregnancy|1|||
25169358|NCT01831427|50301053|FG001|Overall Study|Investigator's Discretion|0|||
25298214|NCT01096550|50613041|FG000|Overall Study|discontinued site|10|||
25298215|NCT01096550|50613042|FG001|Overall Study|discontinued site|11|||
25298216|NCT01096550|50613041|FG000|Overall Study|non-regular treatment track at clinic|1|||
25298217|NCT01096550|50613042|FG001|Overall Study|non-regular treatment track at clinic|1|||
25298218|NCT01096550|50613041|FG000|Overall Study|clinic readmission|1|||
25298219|NCT01096550|50613042|FG001|Overall Study|clinic readmission|1|||
25298220|NCT01096550|50613041|FG000|Overall Study|Withdrawal by Subject|0|||
25298221|NCT01096550|50613042|FG001|Overall Study|Withdrawal by Subject|1|||
25298222|NCT01096550|50613041|FG000|Overall Study|non-African American participant|13|||
25298223|NCT01096550|50613042|FG001|Overall Study|non-African American participant|6|||
25298224|NCT01096550|50613041|FG000|Overall Study|Lost to Follow-up|12|||
25298225|NCT01096550|50613042|FG001|Overall Study|Lost to Follow-up|9|||
25298226|NCT01101542|50613048|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
25298227|NCT01101542|50613048|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
25298228|NCT01101542|50613048|FG000|Year 4 Surveillance Period|Other|287|||
25298229|NCT01101542|50613048|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
25298230|NCT01101542|50613048|FG000|Year 5 Surveillance Period|Pregnancy|1|||
25298231|NCT01101542|50613048|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
25298232|NCT01101542|50613048|FG000|Year 6 Surveillance Period|Pregnancy|1|||
25298233|NCT01101542|50613048|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
25298234|NCT00937326|50613057|FG000|Overall Study|Adverse Event|0|||
25298235|NCT00937326|50613058|FG001|Overall Study|Adverse Event|3|||
25298236|NCT00937326|50613059|FG002|Overall Study|Adverse Event|1|||
25298237|NCT00937326|50613060|FG003|Overall Study|Adverse Event|1|||
25298238|NCT00937326|50613061|FG004|Overall Study|Adverse Event|2|||
25298239|NCT00937326|50613057|FG000|Overall Study|Death|0|||
25298240|NCT00937326|50613058|FG001|Overall Study|Death|0|||
25298241|NCT00937326|50613059|FG002|Overall Study|Death|1|||
25298242|NCT00937326|50613060|FG003|Overall Study|Death|0|||
25298243|NCT00937326|50613061|FG004|Overall Study|Death|0|||
25298244|NCT00937326|50613057|FG000|Overall Study|Withdrawal by Subject|3|||
25298245|NCT00937326|50613058|FG001|Overall Study|Withdrawal by Subject|4|||
25298246|NCT00937326|50613059|FG002|Overall Study|Withdrawal by Subject|1|||
25298247|NCT00937326|50613060|FG003|Overall Study|Withdrawal by Subject|4|||
25298248|NCT00937326|50613061|FG004|Overall Study|Withdrawal by Subject|3|||
25298249|NCT00937326|50613057|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
25298250|NCT00937326|50613058|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
25298251|NCT00937326|50613059|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
25298252|NCT00937326|50613060|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
25298253|NCT00937326|50613061|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
25298254|NCT00873730|50613080|FG000|Overall Study|Protocol Deviation|5|||
25298255|NCT00873730|50613081|FG001|Overall Study|Protocol Deviation|2|||
25298256|NCT00873730|50613080|FG000|Overall Study|Adverse Event|0|||
25298257|NCT00873730|50613081|FG001|Overall Study|Adverse Event|2|||
25298258|NCT00873730|50613080|FG000|Overall Study|Withdrawal by Subject|0|||
25298259|NCT00873730|50613081|FG001|Overall Study|Withdrawal by Subject|1|||
25298260|NCT00873730|50613080|FG000|Overall Study|Sponsor decision|1|||
25298261|NCT00873730|50613081|FG001|Overall Study|Sponsor decision|0|||
25298262|NCT01092416|50613087|FG000|Enrollment|Atherectomy device not inserted|3|||
25298263|NCT01092416|50613087|FG000|30-Day Follow-up|Death|2|||
25298264|NCT01092416|50613087|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
25298265|NCT01092416|50613087|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
25169359|NCT01831427|50301054|FG002|Overall Study|Investigator's Discretion|0|||
25298266|NCT01092416|50613087|FG000|12-Month Follow-up|Death|16|||
25298267|NCT01092416|50613087|FG000|12-Month Follow-up|Lost to Follow-up|4|||
25298268|NCT01092416|50613087|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
25298269|NCT01092416|50613087|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
25298270|NCT01092416|50613087|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
25298271|NCT00874432|50613098|FG000|Overall Study|Withdrawal by Subject|1|||
25298272|NCT00874432|50613099|FG001|Overall Study|Withdrawal by Subject|0|||
25298273|NCT00874432|50613100|FG002|Overall Study|Withdrawal by Subject|0|||
25298274|NCT00874432|50613101|FG003|Overall Study|Withdrawal by Subject|0|||
25298275|NCT00874432|50613098|FG000|Overall Study|Physician Decision|1|||
25298276|NCT00874432|50613099|FG001|Overall Study|Physician Decision|0|||
25298277|NCT00874432|50613100|FG002|Overall Study|Physician Decision|0|||
25298278|NCT00874432|50613101|FG003|Overall Study|Physician Decision|0|||
25298279|NCT00874432|50613098|FG000|Overall Study|Other|1|||
25298280|NCT00874432|50613099|FG001|Overall Study|Other|2|||
25298281|NCT00874432|50613100|FG002|Overall Study|Other|8|||
25298282|NCT00874432|50613101|FG003|Overall Study|Other|3|||
25298283|NCT00935220|50613113|FG000|Overall Study|Adverse Event|1|||
25298284|NCT00935220|50613113|FG000|Overall Study|Other reason (not specified)|1|||
25298285|NCT00874276|50613119|FG000|Overall Study|Withdrawal by Subject|1|||
25298286|NCT00874276|50613120|FG001|Overall Study|Withdrawal by Subject|1|||
25298287|NCT00594958|50613131|FG000|Overall Study|Withdrawal by Subject|1|||
25298288|NCT00594958|50613132|FG001|Overall Study|Withdrawal by Subject|0|||
25298289|NCT00594958|50613133|FG002|Overall Study|Withdrawal by Subject|1|||
25298290|NCT00594958|50613131|FG000|Overall Study|Adverse Event|4|||
25298291|NCT00594958|50613132|FG001|Overall Study|Adverse Event|1|||
25298292|NCT00594958|50613133|FG002|Overall Study|Adverse Event|2|||
25298293|NCT00594958|50613131|FG000|Overall Study|Pregnancy|0|||
25298294|NCT00594958|50613132|FG001|Overall Study|Pregnancy|2|||
25298295|NCT00594958|50613133|FG002|Overall Study|Pregnancy|0|||
25298296|NCT00594958|50613131|FG000|Overall Study|Protocol Violation|1|||
25298297|NCT00594958|50613132|FG001|Overall Study|Protocol Violation|0|||
25298298|NCT00594958|50613133|FG002|Overall Study|Protocol Violation|2|||
25298299|NCT00594958|50613131|FG000|Overall Study|Lost to Follow-up|5|||
25298300|NCT00594958|50613132|FG001|Overall Study|Lost to Follow-up|0|||
25298301|NCT00594958|50613133|FG002|Overall Study|Lost to Follow-up|3|||
25298302|NCT00594958|50613131|FG000|Overall Study|administrative|3|||
25298303|NCT00594958|50613132|FG001|Overall Study|administrative|0|||
25298304|NCT00594958|50613133|FG002|Overall Study|administrative|2|||
25298305|NCT00594880|50613143|FG000|Overall Study|Withdrawal by Subject|1|||
25298306|NCT00594880|50613144|FG001|Overall Study|Withdrawal by Subject|1|||
25298307|NCT00594880|50613143|FG000|Overall Study|Lost to Follow-up|1|||
25298308|NCT00594880|50613144|FG001|Overall Study|Lost to Follow-up|0|||
25298309|NCT00871858|50613156|FG000|Overall Study|Protocol Violation|3|||
25298310|NCT00871858|50613157|FG001|Overall Study|Protocol Violation|4|||
25298311|NCT00871858|50613156|FG000|Overall Study|Adverse Event|1|||
25298312|NCT00871858|50613157|FG001|Overall Study|Adverse Event|1|||
25298313|NCT00871858|50613156|FG000|Overall Study|Withdrawal by Subject|1|||
25298314|NCT00871858|50613157|FG001|Overall Study|Withdrawal by Subject|1|||
25298315|NCT00871858|50613156|FG000|Overall Study|Lost to Follow-up|0|||
25298316|NCT00871858|50613157|FG001|Overall Study|Lost to Follow-up|1|||
25298317|NCT00871780|50613163|FG000|Overall Study|Enrolled But Not Treated|6|||
25298318|NCT00871780|50613163|FG000|Overall Study|Withdrawal by Subject|9|||
25298319|NCT00871780|50613163|FG000|Overall Study|Adverse Event|6|||
25298320|NCT00871780|50613163|FG000|Overall Study|Voluntary Discontinuation|4|||
25298321|NCT00871780|50613163|FG000|Overall Study|Death|1|||
25298322|NCT00871780|50613163|FG000|Overall Study|Physician Decision|1|||
25298323|NCT00594178|50613170|FG000|Overall Study|Physician Decision|5|||
25298324|NCT00933270|50613174|FG000|Overall Study|Withdrawal by Subject|26|||
25298325|NCT00933270|50613174|FG000|Overall Study|Insufficient Follow-up|10|||
25298326|NCT00933270|50613174|FG000|Overall Study|Lost to Follow-up|14|||
25298327|NCT00933270|50613174|FG000|Overall Study|Adverse Event|1|||
25298328|NCT00933270|50613174|FG000|Overall Study|Missed Visit|2|||
25298329|NCT00933270|50613174|FG000|Overall Study|Death|24|||
25298330|NCT00933270|50613174|FG000|Overall Study|Moved or would not return|10|||
25298331|NCT00936858|50613179|FG000|Overall Study|Death|3|||
25298332|NCT00936858|50613179|FG000|Overall Study|Progression|29|||
25298333|NCT00936858|50613179|FG000|Overall Study|Withdrawal by Subject|5|||
25298334|NCT00936858|50613179|FG000|Overall Study|Adverse Event|1|||
25298335|NCT00936858|50613179|FG000|Overall Study|Physician Decision|7|||
25298336|NCT00936858|50613179|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
25298337|NCT00936858|50613179|FG000|Overall Study|Lost to Follow-up|1|||
25298338|NCT00872170|50613186|FG000|Overall Study|Adverse Event|1|||
25298339|NCT00872170|50613187|FG001|Overall Study|Adverse Event|0|||
25298340|NCT00936702|50613192|FG000|Overall Study|Disease progression|34|||
25298341|NCT00936702|50613192|FG000|Overall Study|Adverse Event|8|||
25298342|NCT00936702|50613192|FG000|Overall Study|Withdrawal by Subject|2|||
25298343|NCT00936702|50613192|FG000|Overall Study|Alternative Treatment|1|||
25298344|NCT00936702|50613192|FG000|Overall Study|Other|1|||
25298345|NCT00594100|50613196|FG000|Procedure|Technical Failure|9|||
25298346|NCT00594100|50613196|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
25298347|NCT00594100|50613196|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
25298348|NCT00594100|50613196|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
25298349|NCT01092182|50613203|FG000|Overall Study|Death|0|||
25298350|NCT01092182|50613204|FG001|Overall Study|Death|5|||
25298351|NCT01092182|50613205|FG002|Overall Study|Death|3|||
25298352|NCT01092182|50613203|FG000|Overall Study|participant safety|1|||
25298353|NCT01092182|50613204|FG001|Overall Study|participant safety|2|||
25298354|NCT01092182|50613205|FG002|Overall Study|participant safety|0|||
25298355|NCT01092182|50613203|FG000|Overall Study|Physician Decision|0|||
25298356|NCT01092182|50613204|FG001|Overall Study|Physician Decision|6|||
25298357|NCT01092182|50613205|FG002|Overall Study|Physician Decision|0|||
25298358|NCT01092182|50613203|FG000|Overall Study|Did not meet criteria|0|||
25298359|NCT01092182|50613204|FG001|Overall Study|Did not meet criteria|0|||
25298360|NCT01092182|50613205|FG002|Overall Study|Did not meet criteria|25|||
25298361|NCT01092182|50613203|FG000|Overall Study|Non-compliance|0|||
25298362|NCT01092182|50613204|FG001|Overall Study|Non-compliance|3|||
25298363|NCT01092182|50613205|FG002|Overall Study|Non-compliance|0|||
25298364|NCT01092182|50613203|FG000|Overall Study|Participant refused follow-up|0|||
25298365|NCT01092182|50613204|FG001|Overall Study|Participant refused follow-up|2|||
25298366|NCT01092182|50613205|FG002|Overall Study|Participant refused follow-up|0|||
25298367|NCT00932646|50613213|FG000|Overall Study|Adverse Event|2|||
25298368|NCT00932646|50613214|FG001|Overall Study|Adverse Event|1|||
25298369|NCT00932646|50613215|FG002|Overall Study|Adverse Event|1|||
25298370|NCT00932646|50613216|FG003|Overall Study|Adverse Event|1|||
25298371|NCT00932646|50613213|FG000|Overall Study|Lost to Follow-up|2|||
25298372|NCT00932646|50613214|FG001|Overall Study|Lost to Follow-up|1|||
25298373|NCT00932646|50613215|FG002|Overall Study|Lost to Follow-up|0|||
25298374|NCT00932646|50613216|FG003|Overall Study|Lost to Follow-up|0|||
25298375|NCT00932646|50613213|FG000|Overall Study|Withdrawal by Subject|1|||
25298376|NCT00932646|50613214|FG001|Overall Study|Withdrawal by Subject|1|||
25298377|NCT00932646|50613215|FG002|Overall Study|Withdrawal by Subject|3|||
25298378|NCT00932646|50613216|FG003|Overall Study|Withdrawal by Subject|0|||
25298379|NCT00871234|50613230|FG000|Overall Study|Adverse Event|2|||
25298380|NCT00871234|50613230|FG000|Overall Study|Lost to Follow-up|3|||
25298381|NCT01091246|50613237|FG000|Overall Study|Lost to Follow-up|23|||
25298382|NCT01091246|50613238|FG001|Overall Study|Lost to Follow-up|11|||
25298383|NCT01091246|50613239|FG002|Overall Study|Lost to Follow-up|7|||
25298384|NCT01091246|50613237|FG000|Overall Study|Adverse Event|1|||
25298385|NCT01091246|50613238|FG001|Overall Study|Adverse Event|0|||
25298386|NCT01091246|50613239|FG002|Overall Study|Adverse Event|1|||
25298387|NCT01091246|50613237|FG000|Overall Study|Withdrawal by Subject|9|||
25298388|NCT01091246|50613238|FG001|Overall Study|Withdrawal by Subject|5|||
25298389|NCT01091246|50613239|FG002|Overall Study|Withdrawal by Subject|4|||
25298390|NCT01091246|50613237|FG000|Overall Study|Subject not dosed|2|||
25298391|NCT01091246|50613238|FG001|Overall Study|Subject not dosed|0|||
25298392|NCT01091246|50613239|FG002|Overall Study|Subject not dosed|1|||
25298393|NCT01097330|50613251|FG000|Overall Study|Study terminated early|7|||
25298394|NCT01097330|50613252|FG001|Overall Study|Study terminated early|5|||
25298395|NCT00934440|50613258|FG000|Overall Study|Lost to Follow-up|1|||
25070783|NCT02706405|50176782|FG006|Overall Study|Pt moved to new therapy|0|||
25298396|NCT00934362|50613265|FG000|Overall Study|Adverse Event|1|||
25298397|NCT00934362|50613266|FG001|Overall Study|Adverse Event|0|||
25298398|NCT00934128|50613274|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
25298399|NCT00934128|50613275|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
25298400|NCT00934128|50613274|FG000|First Intervention (2 Hours)|Adverse Event|4|||
25298401|NCT00934128|50613275|FG001|First Intervention (2 Hours)|Adverse Event|1|||
25298402|NCT00934128|50613274|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
25298403|NCT00934128|50613275|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
25298404|NCT00934128|50613274|FG000|Washout Period (1 Hour)|Patient preference|1|||
25298405|NCT00934128|50613275|FG001|Washout Period (1 Hour)|Patient preference|3|||
25298406|NCT00934128|50613274|FG000|Washout Period (1 Hour)|Pain|1|||
25298407|NCT00934128|50613275|FG001|Washout Period (1 Hour)|Pain|0|||
25298408|NCT00934128|50613274|FG000|Washout Period (1 Hour)|Too tired|1|||
25298409|NCT00934128|50613275|FG001|Washout Period (1 Hour)|Too tired|0|||
25298410|NCT00934128|50613274|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
25298411|NCT00934128|50613275|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
25298412|NCT00934128|50613274|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
25298413|NCT00934128|50613275|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
25298414|NCT00871000|50613283|FG000|Overall Study|Withdrawal by Subject|1|||
25298415|NCT00871000|50613284|FG001|Overall Study|Withdrawal by Subject|0|||
25298416|NCT01096784|50613292|FG000|Overall Study|Withdrawal by Subject|2|||
25298417|NCT01096784|50613293|FG001|Overall Study|Withdrawal by Subject|1|||
25298418|NCT01096784|50613292|FG000|Overall Study|Adverse Event|11|||
25298419|NCT01096784|50613293|FG001|Overall Study|Adverse Event|9|||
25298420|NCT01096784|50613292|FG000|Overall Study|Protocol Deviation|2|||
25298421|NCT01096784|50613293|FG001|Overall Study|Protocol Deviation|2|||
25298422|NCT01096784|50613292|FG000|Overall Study|Administrative Decision|0|||
25298423|NCT01096784|50613293|FG001|Overall Study|Administrative Decision|1|||
25298424|NCT01096784|50613292|FG000|Overall Study|Other Unspecified|0|||
25298425|NCT01096784|50613293|FG001|Overall Study|Other Unspecified|1|||
25298426|NCT00934050|50613307|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
25298427|NCT00934050|50613308|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
25298428|NCT00934050|50613309|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
25298429|NCT00934050|50613310|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
25298430|NCT00934050|50613311|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
25298431|NCT00934050|50613312|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
25298432|NCT00934050|50613307|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
25298433|NCT00934050|50613308|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
25298434|NCT00934050|50613309|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
25298435|NCT00934050|50613310|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
25298436|NCT00934050|50613311|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
25298437|NCT00934050|50613312|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
25298438|NCT00934050|50613307|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
25298439|NCT00934050|50613308|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
25298440|NCT00934050|50613309|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
25298441|NCT00934050|50613310|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
24969841|NCT00132314|50059268|FG000|Overall Study|Lost to Follow-up|70|||
24969842|NCT00132314|50059269|FG001|Overall Study|Lost to Follow-up|62|||
25298442|NCT00934050|50613311|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
25298443|NCT00934050|50613312|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
25298444|NCT00934050|50613307|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
25298445|NCT00934050|50613308|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
25298446|NCT00934050|50613309|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
25298447|NCT00934050|50613310|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
25298448|NCT00934050|50613311|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
25298449|NCT00934050|50613312|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
25298450|NCT00934050|50613307|FG000|Enrolled After 15 Dec 2009|Death|0|||
25298451|NCT00934050|50613308|FG001|Enrolled After 15 Dec 2009|Death|0|||
25298452|NCT00934050|50613309|FG002|Enrolled After 15 Dec 2009|Death|0|||
25298453|NCT00934050|50613310|FG003|Enrolled After 15 Dec 2009|Death|0|||
25298454|NCT00934050|50613311|FG004|Enrolled After 15 Dec 2009|Death|0|||
25298455|NCT00934050|50613312|FG005|Enrolled After 15 Dec 2009|Death|1|||
25298456|NCT00934050|50613307|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
25298457|NCT00934050|50613308|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
25298458|NCT00934050|50613309|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
25298459|NCT00934050|50613310|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
25298460|NCT00934050|50613311|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
25298461|NCT00934050|50613312|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
25298462|NCT00934050|50613307|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
25298463|NCT00934050|50613308|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
25298464|NCT00934050|50613309|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
25298465|NCT00934050|50613310|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
25298466|NCT00934050|50613311|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
24969843|NCT00132314|50059268|FG000|Overall Study|Lacked SSN|1|||
24969844|NCT00132314|50059269|FG001|Overall Study|Lacked SSN|3|||
24969845|NCT00132314|50059268|FG000|Overall Study|Refused intervention at baseline|2|||
25298467|NCT00934050|50613312|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
25298468|NCT01091168|50613324|FG000|Overall Study|Progressive disease|250|||
25298469|NCT01091168|50613325|FG001|Overall Study|Progressive disease|234|||
25298470|NCT01091168|50613324|FG000|Overall Study|Adverse Event|21|||
25298471|NCT01091168|50613325|FG001|Overall Study|Adverse Event|24|||
25298472|NCT01091168|50613324|FG000|Overall Study|Lost to Follow-up|0|||
25298473|NCT01091168|50613325|FG001|Overall Study|Lost to Follow-up|1|||
25298474|NCT01091168|50613324|FG000|Overall Study|Physician, patient's decision, other|27|||
25298475|NCT01091168|50613325|FG001|Overall Study|Physician, patient's decision, other|37|||
25298476|NCT00864916|50613333|FG000|Overall Study|Lost to Follow-up|4|||
25298477|NCT00864916|50613334|FG001|Overall Study|Lost to Follow-up|4|||
25298478|NCT00864916|50613333|FG000|Overall Study|Protocol Violation|1|||
25298479|NCT00864916|50613334|FG001|Overall Study|Protocol Violation|0|||
25298480|NCT00864916|50613333|FG000|Overall Study|Withdrawal by Subject|1|||
25298481|NCT00864916|50613334|FG001|Overall Study|Withdrawal by Subject|0|||
25298482|NCT00864682|50613343|FG000|Overall Study|Protocol Violation|2|||
25298483|NCT00864682|50613344|FG001|Overall Study|Protocol Violation|1|||
25298484|NCT00864682|50613345|FG002|Overall Study|Protocol Violation|2|||
25298485|NCT00931944|50613353|FG000|Overall Study|Adverse Event|4|||
25298486|NCT00931944|50613353|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
25298487|NCT00931944|50613353|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
25298488|NCT00931944|50613353|FG000|Overall Study|Death|28|||
25298489|NCT00931944|50613353|FG000|Overall Study|Other|2|||
25298490|NCT00929994|50613357|FG000|Overall Study|Withdrawal by Subject|1|||
25298491|NCT00929994|50613357|FG000|Overall Study|medical issue unrelated to intervention|4|||
25298492|NCT00929994|50613357|FG000|Overall Study|employment|1|||
25298493|NCT01090310|50613368|FG000|Core Study|Adverse Event|2|||
25298494|NCT01090310|50613369|FG001|Core Study|Adverse Event|2|||
25298495|NCT01090310|50613370|FG002|Core Study|Adverse Event|1|||
25298496|NCT01090310|50613371|FG003|Core Study|Adverse Event|1|||
25298497|NCT01090310|50613368|FG000|Core Study|Subject withdrew consent|0|||
25298498|NCT01090310|50613369|FG001|Core Study|Subject withdrew consent|3|||
25298499|NCT01090310|50613370|FG002|Core Study|Subject withdrew consent|1|||
25298500|NCT01090310|50613371|FG003|Core Study|Subject withdrew consent|1|||
25298501|NCT01090310|50613368|FG000|Core Study|Abnormal test procedure result|0|||
25298502|NCT01090310|50613369|FG001|Core Study|Abnormal test procedure result|0|||
25298503|NCT01090310|50613370|FG002|Core Study|Abnormal test procedure result|1|||
25298504|NCT01090310|50613371|FG003|Core Study|Abnormal test procedure result|0|||
25298505|NCT01090310|50613368|FG000|Core Study|Administrative reasons|5|||
25298506|NCT01090310|50613369|FG001|Core Study|Administrative reasons|6|||
25298507|NCT01090310|50613370|FG002|Core Study|Administrative reasons|4|||
25298508|NCT01090310|50613371|FG003|Core Study|Administrative reasons|4|||
25298509|NCT01090310|50613368|FG000|Core Study|Protocol deviation|1|||
25298510|NCT01090310|50613369|FG001|Core Study|Protocol deviation|0|||
25298511|NCT01090310|50613370|FG002|Core Study|Protocol deviation|0|||
25298512|NCT01090310|50613371|FG003|Core Study|Protocol deviation|1|||
25298513|NCT01090310|50613368|FG000|Extension Study|Aministrative problems|13|||
25298514|NCT01090310|50613369|FG001|Extension Study|Aministrative problems|15|||
25298515|NCT01090310|50613370|FG002|Extension Study|Aministrative problems|14|||
25298516|NCT01090310|50613371|FG003|Extension Study|Aministrative problems|18|||
25298517|NCT01090310|50613368|FG000|Extension Study|Adverse Event|0|||
25298518|NCT01090310|50613369|FG001|Extension Study|Adverse Event|0|||
25298519|NCT01090310|50613370|FG002|Extension Study|Adverse Event|0|||
25298520|NCT01090310|50613371|FG003|Extension Study|Adverse Event|1|||
25298521|NCT01090310|50613368|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
25298522|NCT01090310|50613369|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
25298523|NCT01090310|50613370|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
25298524|NCT01090310|50613371|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
25298525|NCT01090310|50613368|FG000|Extension Study|Subject withdrew consent|0|||
25298526|NCT01090310|50613369|FG001|Extension Study|Subject withdrew consent|1|||
25298527|NCT01090310|50613370|FG002|Extension Study|Subject withdrew consent|0|||
25298528|NCT01090310|50613371|FG003|Extension Study|Subject withdrew consent|0|||
25298529|NCT01090076|50613383|FG000|Overall Study|Death|1|||
25298530|NCT01090076|50613384|FG001|Overall Study|Death|1|||
25298531|NCT01090076|50613383|FG000|Overall Study|Withdrawal by Subject|0|||
25298532|NCT01090076|50613384|FG001|Overall Study|Withdrawal by Subject|1|||
25298533|NCT00869050|50613392|FG000|Overall Study|Screen Failure|3|||
25298534|NCT00927186|50613398|FG000|12 Months Primary Study|Adverse Event|5|||
25298535|NCT00927186|50613399|FG001|12 Months Primary Study|Adverse Event|2|||
25298536|NCT00927186|50613398|FG000|12 Months Primary Study|Lost to Follow-up|1|||
25298537|NCT00927186|50613399|FG001|12 Months Primary Study|Lost to Follow-up|0|||
25298538|NCT00927186|50613398|FG000|12 Months Primary Study|Protocol Violation|0|||
25298539|NCT00927186|50613399|FG001|12 Months Primary Study|Protocol Violation|1|||
25298540|NCT00927186|50613398|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
25298541|NCT00927186|50613399|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
25298542|NCT00593554|50613410|FG000|Overall Study|Death|1|||
25298543|NCT00593554|50613411|FG001|Overall Study|Death|2|||
25298544|NCT00593554|50613410|FG000|Overall Study|Physician Decision|0|||
25298545|NCT00593554|50613411|FG001|Overall Study|Physician Decision|1|||
25298546|NCT00593554|50613410|FG000|Overall Study|Withdrawal by Subject|1|||
25298547|NCT00593554|50613411|FG001|Overall Study|Withdrawal by Subject|0|||
25298548|NCT00593554|50613410|FG000|Overall Study|Disease Progression|1|||
25298549|NCT00593554|50613411|FG001|Overall Study|Disease Progression|2|||
25298550|NCT01101308|50613417|FG000|Period 1|Adverse Event|2|||
25298551|NCT01101308|50613418|FG001|Period 1|Adverse Event|1|||
25298552|NCT01101308|50613417|FG000|Period 1|Positive for cotinine|1|||
25298553|NCT01101308|50613418|FG001|Period 1|Positive for cotinine|0|||
25298554|NCT00926796|50613427|FG000|Overall Study|Did not receive randomized treatment|4|||
25298555|NCT00926796|50613428|FG001|Overall Study|Did not receive randomized treatment|7|||
25298556|NCT00926796|50613427|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
25298557|NCT00926796|50613428|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
25070784|NCT02706405|50176783|FG007|Overall Study|Pt moved to new therapy|1|||
25070785|NCT02706405|50176776|FG000|Overall Study|Physician Decision|1|||
25070786|NCT02706405|50176777|FG001|Overall Study|Physician Decision|0|||
25070787|NCT02706405|50176778|FG002|Overall Study|Physician Decision|0|||
25070788|NCT02706405|50176779|FG003|Overall Study|Physician Decision|0|||
25070789|NCT02706405|50176780|FG004|Overall Study|Physician Decision|0|||
25070790|NCT02706405|50176781|FG005|Overall Study|Physician Decision|0|||
25070791|NCT02706405|50176782|FG006|Overall Study|Physician Decision|0|||
25070792|NCT02706405|50176783|FG007|Overall Study|Physician Decision|0|||
25070793|NCT02761993|50176812|FG000|Overall Study|Adverse Event|0|||
25070794|NCT02761993|50176813|FG001|Overall Study|Adverse Event|2|||
25070795|NCT02761993|50176814|FG002|Overall Study|Adverse Event|0|||
25070796|NCT02761993|50176812|FG000|Overall Study|Lost to Follow-up|1|||
25070797|NCT02761993|50176813|FG001|Overall Study|Lost to Follow-up|3|||
25070798|NCT02761993|50176814|FG002|Overall Study|Lost to Follow-up|2|||
25070799|NCT02761993|50176812|FG000|Overall Study|Withdrawal by Subject|1|||
25070800|NCT02761993|50176813|FG001|Overall Study|Withdrawal by Subject|1|||
25070801|NCT02761993|50176814|FG002|Overall Study|Withdrawal by Subject|2|||
25070802|NCT02766283|50176822|FG000|Overall Study|Lost to Follow-up|27|||
25070803|NCT02761915|50176845|FG000|Overall Study|Death|3|||
25070804|NCT02761915|50176846|FG001|Overall Study|Death|1|||
25070805|NCT02761915|50176847|FG002|Overall Study|Death|1|||
25070806|NCT02761915|50176848|FG003|Overall Study|Death|1|||
25070807|NCT02761915|50176849|FG004|Overall Study|Death|0|||
25070808|NCT02761915|50176850|FG005|Overall Study|Death|1|||
25070809|NCT02761915|50176845|FG000|Overall Study|Withdrawal by Subject|1|||
25070810|NCT02761915|50176846|FG001|Overall Study|Withdrawal by Subject|0|||
25070811|NCT02761915|50176847|FG002|Overall Study|Withdrawal by Subject|0|||
25070812|NCT02761915|50176848|FG003|Overall Study|Withdrawal by Subject|0|||
25070813|NCT02761915|50176849|FG004|Overall Study|Withdrawal by Subject|1|||
25070814|NCT02761915|50176850|FG005|Overall Study|Withdrawal by Subject|2|||
25070815|NCT02761915|50176845|FG000|Overall Study|Disease Progression|0|||
25070816|NCT02761915|50176846|FG001|Overall Study|Disease Progression|0|||
25070817|NCT02761915|50176847|FG002|Overall Study|Disease Progression|0|||
25070818|NCT02761915|50176848|FG003|Overall Study|Disease Progression|2|||
25070819|NCT02761915|50176849|FG004|Overall Study|Disease Progression|2|||
25070820|NCT02761915|50176850|FG005|Overall Study|Disease Progression|2|||
25070821|NCT02706327|50176871|FG000|Overall Study|Lost to Follow-up|1|||
25070822|NCT02706327|50176872|FG001|Overall Study|Lost to Follow-up|1|||
25070823|NCT02706327|50176873|FG002|Overall Study|Lost to Follow-up|2|||
25070824|NCT02764333|50176881|FG000|Overall Study|Ineligible|1|||
25070825|NCT02705625|50176888|FG000|Overall Study|Protocol Violation|1|||
25191757|NCT00083759|50353137|FG000|Overall Study|Sponsor's Discretion|28|||
25070826|NCT02705625|50176889|FG001|Overall Study|Protocol Violation|0|||
25070827|NCT02705625|50176890|FG002|Overall Study|Protocol Violation|0|||
25070828|NCT02705625|50176888|FG000|Overall Study|Adverse Event|6|||
25070829|NCT02705625|50176889|FG001|Overall Study|Adverse Event|5|||
25070830|NCT02705625|50176890|FG002|Overall Study|Adverse Event|2|||
25070831|NCT02705625|50176888|FG000|Overall Study|Death|0|||
25070832|NCT02705625|50176889|FG001|Overall Study|Death|0|||
25070833|NCT02705625|50176890|FG002|Overall Study|Death|1|||
25070834|NCT02705625|50176888|FG000|Overall Study|Withdrawal by Subject|1|||
25070835|NCT02705625|50176889|FG001|Overall Study|Withdrawal by Subject|4|||
25070836|NCT02705625|50176890|FG002|Overall Study|Withdrawal by Subject|5|||
25191758|NCT00083759|50353138|FG001|Overall Study|Sponsor's Discretion|29|||
25070837|NCT02705625|50176888|FG000|Overall Study|Lost to Follow-up|0|||
25070838|NCT02705625|50176889|FG001|Overall Study|Lost to Follow-up|0|||
25070839|NCT02705625|50176890|FG002|Overall Study|Lost to Follow-up|1|||
25070840|NCT02705625|50176888|FG000|Overall Study|Non-compliance|0|||
25070841|NCT02705625|50176889|FG001|Overall Study|Non-compliance|1|||
25070842|NCT02705625|50176890|FG002|Overall Study|Non-compliance|1|||
25070843|NCT02705625|50176888|FG000|Overall Study|Overdosing|0|||
25070844|NCT02705625|50176889|FG001|Overall Study|Overdosing|0|||
25070845|NCT02705625|50176890|FG002|Overall Study|Overdosing|1|||
25070846|NCT02588612|50176898|FG000|Overall Study|Physician Decision|1|||
25070847|NCT02588612|50176898|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
25070848|NCT02588612|50176898|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
25070849|NCT02588612|50176898|FG000|Overall Study|Death prior to T-cell infusion|1|||
25298558|NCT00926796|50613427|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
25070850|NCT02704689|50176915|FG000|Overall Study|Physician Decision|1|||
25298559|NCT00926796|50613428|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
25298560|NCT00926796|50613427|FG000|Overall Study|Adverse Event|7|||
25298561|NCT00926796|50613428|FG001|Overall Study|Adverse Event|14|||
25298562|NCT00926796|50613427|FG000|Overall Study|Lost to Follow-up|22|||
25298563|NCT00926796|50613428|FG001|Overall Study|Lost to Follow-up|13|||
25298564|NCT00926796|50613427|FG000|Overall Study|Protocol Violation|15|||
25298565|NCT00926796|50613428|FG001|Overall Study|Protocol Violation|11|||
25298566|NCT00926796|50613427|FG000|Overall Study|Withdrawal by Subject|1|||
25298567|NCT00926796|50613428|FG001|Overall Study|Withdrawal by Subject|0|||
25298568|NCT01087736|50613438|FG000|Overall Study|Lost to Follow-up|1|||
25298569|NCT01087736|50613439|FG001|Overall Study|Lost to Follow-up|0|||
25298570|NCT01087736|50613438|FG000|Overall Study|Death|0|||
25298571|NCT01087736|50613439|FG001|Overall Study|Death|1|||
25298572|NCT01087736|50613438|FG000|Overall Study|Withdrawal by Subject|0|||
25298573|NCT01087736|50613439|FG001|Overall Study|Withdrawal by Subject|1|||
25298574|NCT01079936|50613449|FG000|Phase I: MTD|First Remission Status|2|||
25298575|NCT01079936|50613450|FG001|Phase I: MTD|First Remission Status|0|||
25298576|NCT01079936|50613451|FG002|Phase I: MTD|First Remission Status|0|||
25298577|NCT01079936|50613452|FG003|Phase I: MTD|First Remission Status|0|||
25298578|NCT01079936|50613453|FG004|Phase I: MTD|First Remission Status|0|||
25298579|NCT01079936|50613449|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
25298580|NCT01079936|50613450|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
25298581|NCT01079936|50613451|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
25298582|NCT01079936|50613452|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
25298583|NCT01079936|50613453|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
25298584|NCT01079936|50613449|FG000|Phase II|Adverse Event|0|||
25298585|NCT01079936|50613450|FG001|Phase II|Adverse Event|0|||
25298586|NCT01079936|50613451|FG002|Phase II|Adverse Event|1|||
25298587|NCT01079936|50613452|FG003|Phase II|Adverse Event|0|||
25298588|NCT01079936|50613453|FG004|Phase II|Adverse Event|0|||
25298589|NCT01079936|50613449|FG000|Phase II|Insurance Issue|0|||
25298590|NCT01079936|50613450|FG001|Phase II|Insurance Issue|0|||
25298591|NCT01079936|50613451|FG002|Phase II|Insurance Issue|0|||
25298592|NCT01079936|50613452|FG003|Phase II|Insurance Issue|0|||
25298593|NCT01079936|50613453|FG004|Phase II|Insurance Issue|1|||
25298594|NCT00931710|50613466|FG000|Overall Study|Adverse Event|16|||
25298595|NCT00931710|50613467|FG001|Overall Study|Adverse Event|10|||
25298596|NCT00931710|50613466|FG000|Overall Study|Abnormal test procedure results|2|||
25298597|NCT00931710|50613467|FG001|Overall Study|Abnormal test procedure results|0|||
25298598|NCT00931710|50613466|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
25298599|NCT00931710|50613467|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
25298600|NCT00931710|50613466|FG000|Overall Study|Patient withdrew consent|4|||
25298601|NCT00931710|50613467|FG001|Overall Study|Patient withdrew consent|9|||
25298602|NCT00931710|50613466|FG000|Overall Study|Lost to Follow-up|6|||
25298603|NCT00931710|50613467|FG001|Overall Study|Lost to Follow-up|5|||
25298604|NCT00931710|50613466|FG000|Overall Study|Protocol deviation|1|||
24969846|NCT00132314|50059269|FG001|Overall Study|Refused intervention at baseline|7|||
25191759|NCT00083759|50353137|FG000|Overall Study|Other|14|||
25191760|NCT00083759|50353138|FG001|Overall Study|Other|13|||
25298605|NCT00931710|50613467|FG001|Overall Study|Protocol deviation|2|||
25298606|NCT01100528|50613473|FG000|Overall Study|Death|1|||
25298607|NCT01100528|50613473|FG000|Overall Study|Withdrawal by Subject|2|||
25298608|NCT01079234|50613480|FG000|Main: Week 0 to 26|Adverse Event|5|||
25298609|NCT01079234|50613481|FG001|Main: Week 0 to 26|Adverse Event|4|||
25298610|NCT01079234|50613482|FG002|Main: Week 0 to 26|Adverse Event|1|||
25298611|NCT01079234|50613483|FG003|Main: Week 0 to 26|Adverse Event|0|||
25298612|NCT01079234|50613480|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
25298613|NCT01079234|50613481|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
25298614|NCT01079234|50613482|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
25298615|NCT01079234|50613483|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
25298616|NCT01079234|50613480|FG000|Main: Week 0 to 26|Protocol Violation|6|||
25298617|NCT01079234|50613481|FG001|Main: Week 0 to 26|Protocol Violation|2|||
25298618|NCT01079234|50613482|FG002|Main: Week 0 to 26|Protocol Violation|4|||
25298619|NCT01079234|50613483|FG003|Main: Week 0 to 26|Protocol Violation|0|||
25298620|NCT01079234|50613480|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
25298621|NCT01079234|50613481|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
25298622|NCT01079234|50613482|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
25298623|NCT01079234|50613483|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
25298624|NCT01079234|50613480|FG000|Main: Week 0 to 26|Unclassified|7|||
25298625|NCT01079234|50613481|FG001|Main: Week 0 to 26|Unclassified|13|||
25298626|NCT01079234|50613482|FG002|Main: Week 0 to 26|Unclassified|4|||
25298627|NCT01079234|50613483|FG003|Main: Week 0 to 26|Unclassified|0|||
25298628|NCT01079234|50613480|FG000|Extension: Week 27 to 52|Adverse Event|0|||
25298629|NCT01079234|50613481|FG001|Extension: Week 27 to 52|Adverse Event|0|||
25298630|NCT01079234|50613482|FG002|Extension: Week 27 to 52|Adverse Event|1|||
25298631|NCT01079234|50613483|FG003|Extension: Week 27 to 52|Adverse Event|0|||
25298632|NCT01079234|50613480|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
25298633|NCT01079234|50613481|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
25298634|NCT01079234|50613482|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
25298635|NCT01079234|50613483|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
25298636|NCT01079234|50613480|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
25298637|NCT01079234|50613481|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
25298638|NCT01079234|50613482|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
25298639|NCT01079234|50613483|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
25298640|NCT01079234|50613480|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
25298641|NCT01079234|50613481|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
25298642|NCT01079234|50613482|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
25298643|NCT01079234|50613483|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
25298644|NCT01079234|50613480|FG000|Extension: Week 27 to 52|Unclassified|0|||
25298645|NCT01079234|50613481|FG001|Extension: Week 27 to 52|Unclassified|0|||
25298646|NCT01079234|50613482|FG002|Extension: Week 27 to 52|Unclassified|4|||
25298647|NCT01079234|50613483|FG003|Extension: Week 27 to 52|Unclassified|7|||
25298648|NCT00931632|50613494|FG000|Overall Study|Withdrawal by Subject|2|||
25298649|NCT00931632|50613495|FG001|Overall Study|Withdrawal by Subject|3|||
25298650|NCT00931632|50613494|FG000|Overall Study|Adverse Event|19|||
25298651|NCT00931632|50613495|FG001|Overall Study|Adverse Event|15|||
25298652|NCT01078922|50613501|FG000|Overall Study|Adverse Event|1|||
25298653|NCT00863746|50613508|FG000|Treatment|Not treated|4|||
25298654|NCT00863746|50613509|FG001|Treatment|Not treated|2|||
25298655|NCT00863746|50613508|FG000|Treatment|Adverse Event|41|||
25298656|NCT00863746|50613509|FG001|Treatment|Adverse Event|16|||
25298657|NCT00863746|50613508|FG000|Treatment|non-compliant with study medication|4|||
25298658|NCT00863746|50613509|FG001|Treatment|non-compliant with study medication|0|||
25298659|NCT00863746|50613508|FG000|Treatment|Consent withdrawn|15|||
25298660|NCT00863746|50613509|FG001|Treatment|Consent withdrawn|14|||
25298661|NCT00863746|50613508|FG000|Treatment|Lost to Follow-up|1|||
25298662|NCT00863746|50613509|FG001|Treatment|Lost to Follow-up|0|||
25298663|NCT00863746|50613508|FG000|Treatment|Protocol Violation|5|||
25298664|NCT00863746|50613509|FG001|Treatment|Protocol Violation|3|||
25298665|NCT00863746|50613508|FG000|Treatment|Other|1|||
25298666|NCT00863746|50613509|FG001|Treatment|Other|0|||
25298667|NCT00863746|50613508|FG000|Survival Follow up|Death|244|||
25298668|NCT00863746|50613509|FG001|Survival Follow up|Death|271|||
25298669|NCT00863746|50613508|FG000|Survival Follow up|Lost to Follow-up|2|||
25298670|NCT00863746|50613509|FG001|Survival Follow up|Lost to Follow-up|1|||
25298671|NCT00863746|50613508|FG000|Survival Follow up|Consent Withdrawn|7|||
25298672|NCT00863746|50613509|FG001|Survival Follow up|Consent Withdrawn|8|||
25298673|NCT00926328|50613517|FG000|Overall Study|Lost to Follow-up|12|||
25298674|NCT00926328|50613518|FG001|Overall Study|Lost to Follow-up|14|||
25298675|NCT00863512|50613526|FG000|Overall Study|Adverse Event|2|||
25298676|NCT00863512|50613527|FG001|Overall Study|Adverse Event|0|||
25298677|NCT00863512|50613526|FG000|Overall Study|Withdrawal by Subject|11|||
25298678|NCT00863512|50613527|FG001|Overall Study|Withdrawal by Subject|0|||
25298679|NCT00863512|50613526|FG000|Overall Study|Physician Decision|1|||
25298680|NCT00863512|50613527|FG001|Overall Study|Physician Decision|0|||
25298681|NCT00868192|50613533|FG000|Overall Study|Ineligible|4|||
25298682|NCT00867568|50613537|FG000|Overall Study|Lack of Efficacy|10|||
25298683|NCT00867568|50613537|FG000|Overall Study|Adverse Event|4|||
25298684|NCT00867568|50613537|FG000|Overall Study|Withdrawal by Subject|1|||
25298685|NCT00930930|50613543|FG000|Overall Study|Death|1|||
25298686|NCT00930930|50613544|FG001|Overall Study|Death|0|||
25298687|NCT00930930|50613543|FG000|Overall Study|Physician Decision|1|||
25298688|NCT00930930|50613544|FG001|Overall Study|Physician Decision|0|||
25298689|NCT00930930|50613543|FG000|Overall Study|Adverse Event|13|||
25298690|NCT00930930|50613544|FG001|Overall Study|Adverse Event|3|||
25298691|NCT00930930|50613543|FG000|Overall Study|Withdrawal by Subject|3|||
25298692|NCT00930930|50613544|FG001|Overall Study|Withdrawal by Subject|1|||
25298693|NCT00930930|50613543|FG000|Overall Study|Disease progression|2|||
25298694|NCT00930930|50613544|FG001|Overall Study|Disease progression|3|||
25298695|NCT00930930|50613543|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
25298696|NCT00930930|50613544|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
25298697|NCT00930930|50613543|FG000|Overall Study|patients not compliant|1|||
25298698|NCT00930930|50613544|FG001|Overall Study|patients not compliant|1|||
25298699|NCT00862654|50613554|FG000|Overall Study|Lack of Efficacy|1|||
25298700|NCT00862654|50613555|FG001|Overall Study|Lack of Efficacy|0|||
25298701|NCT00862654|50613556|FG002|Overall Study|Lack of Efficacy|1|||
25298702|NCT00862654|50613557|FG003|Overall Study|Lack of Efficacy|0|||
25298703|NCT00862654|50613554|FG000|Overall Study|Lost to Follow-up|1|||
25298704|NCT00862654|50613555|FG001|Overall Study|Lost to Follow-up|2|||
25298705|NCT00862654|50613556|FG002|Overall Study|Lost to Follow-up|1|||
25298706|NCT00862654|50613557|FG003|Overall Study|Lost to Follow-up|3|||
25298707|NCT00862654|50613554|FG000|Overall Study|Adverse Event|0|||
25298708|NCT00862654|50613555|FG001|Overall Study|Adverse Event|1|||
25298709|NCT00862654|50613556|FG002|Overall Study|Adverse Event|1|||
25298710|NCT00862654|50613557|FG003|Overall Study|Adverse Event|0|||
25298711|NCT00862654|50613554|FG000|Overall Study|Pregnancy|1|||
25298712|NCT00862654|50613555|FG001|Overall Study|Pregnancy|1|||
25298713|NCT00862654|50613556|FG002|Overall Study|Pregnancy|0|||
25298714|NCT00862654|50613557|FG003|Overall Study|Pregnancy|0|||
25298715|NCT00862654|50613554|FG000|Overall Study|Withdrawal by Subject|2|||
25298716|NCT00862654|50613555|FG001|Overall Study|Withdrawal by Subject|2|||
25298717|NCT00862654|50613556|FG002|Overall Study|Withdrawal by Subject|2|||
25298718|NCT00862654|50613557|FG003|Overall Study|Withdrawal by Subject|3|||
25298719|NCT00862654|50613554|FG000|Overall Study|Subject mistake|0|||
25298720|NCT00862654|50613555|FG001|Overall Study|Subject mistake|1|||
25298721|NCT00862654|50613556|FG002|Overall Study|Subject mistake|0|||
25298722|NCT00862654|50613557|FG003|Overall Study|Subject mistake|0|||
25298723|NCT00862654|50613554|FG000|Overall Study|Familly constraint|0|||
25298724|NCT00862654|50613555|FG001|Overall Study|Familly constraint|1|||
25298725|NCT00862654|50613556|FG002|Overall Study|Familly constraint|0|||
25298726|NCT00862654|50613557|FG003|Overall Study|Familly constraint|0|||
25298727|NCT00862654|50613554|FG000|Overall Study|Never used study drugs|1|||
25298728|NCT00862654|50613555|FG001|Overall Study|Never used study drugs|0|||
25298729|NCT00862654|50613556|FG002|Overall Study|Never used study drugs|0|||
25298730|NCT00862654|50613557|FG003|Overall Study|Never used study drugs|0|||
25298731|NCT00862654|50613554|FG000|Overall Study|Included after end of inclusions|0|||
25298732|NCT00862654|50613555|FG001|Overall Study|Included after end of inclusions|0|||
25298733|NCT00862654|50613556|FG002|Overall Study|Included after end of inclusions|1|||
25298734|NCT00862654|50613557|FG003|Overall Study|Included after end of inclusions|0|||
25298735|NCT00867490|50613567|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
25298736|NCT00867490|50613567|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
25298737|NCT00867490|50613567|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
25298738|NCT00867490|50613567|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
25298739|NCT00867490|50613567|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
25298740|NCT00930774|50613578|FG000|Overall Study|Withdrawal by Subject|1|||
25298741|NCT00930774|50613579|FG001|Overall Study|Withdrawal by Subject|9|||
25298742|NCT00930774|50613580|FG002|Overall Study|Withdrawal by Subject|2|||
25298743|NCT00930774|50613581|FG003|Overall Study|Withdrawal by Subject|0|||
25298744|NCT00867334|50613594|FG000|Overall Study|Withdrawal by Subject|0|||
25298745|NCT00867334|50613595|FG001|Overall Study|Withdrawal by Subject|1|||
25298746|NCT00867334|50613594|FG000|Overall Study|Withdrawal by Subject|1|||
25298747|NCT00867334|50613595|FG001|Overall Study|Withdrawal by Subject|0|||
25298748|NCT00867334|50613594|FG000|Overall Study|Withdrawal by Subject|1|||
25298749|NCT00867334|50613595|FG001|Overall Study|Withdrawal by Subject|0|||
25298750|NCT00925704|50613607|FG000|First Intervention|Withdrew consent|0|||
25298751|NCT00925704|50613608|FG001|First Intervention|Withdrew consent|0|||
25298752|NCT00925704|50613609|FG002|First Intervention|Withdrew consent|0|||
25298753|NCT00925704|50613610|FG003|First Intervention|Withdrew consent|1|||
25298754|NCT00925704|50613611|FG004|First Intervention|Withdrew consent|1|||
25298755|NCT00925704|50613612|FG005|First Intervention|Withdrew consent|0|||
25298756|NCT00925704|50613607|FG000|Second Intervention|Withdrawal by Subject|1|||
25298757|NCT00925704|50613608|FG001|Second Intervention|Withdrawal by Subject|0|||
25298758|NCT00925704|50613609|FG002|Second Intervention|Withdrawal by Subject|0|||
25298759|NCT00925704|50613610|FG003|Second Intervention|Withdrawal by Subject|0|||
25298760|NCT00925704|50613611|FG004|Second Intervention|Withdrawal by Subject|1|||
25298761|NCT00925704|50613612|FG005|Second Intervention|Withdrawal by Subject|0|||
25298762|NCT00925704|50613607|FG000|Third Intervention|Withdrew consent|0|||
25298763|NCT00925704|50613608|FG001|Third Intervention|Withdrew consent|0|||
25298764|NCT00925704|50613609|FG002|Third Intervention|Withdrew consent|0|||
25298765|NCT00925704|50613610|FG003|Third Intervention|Withdrew consent|0|||
25298766|NCT00925704|50613611|FG004|Third Intervention|Withdrew consent|0|||
25298767|NCT00925704|50613612|FG005|Third Intervention|Withdrew consent|1|||
25298768|NCT01076192|50613623|FG000|Overall Study|Other|197|||
25298769|NCT01076036|50613628|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
25298770|NCT01075958|50613632|FG000|Overall Study|Blood sample could not be obtained|44|||
25298771|NCT01096316|50613638|FG000|Overall Study|Lost to Follow-up|15|||
25298772|NCT01096316|50613639|FG001|Overall Study|Lost to Follow-up|9|||
25298773|NCT00925548|50613647|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
25298774|NCT00925548|50613648|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
25298775|NCT00866788|50613659|FG000|Overall Study|Adverse Event|0|||
25298776|NCT00866788|50613660|FG001|Overall Study|Adverse Event|2|||
25298777|NCT00866788|50613661|FG002|Overall Study|Adverse Event|0|||
25298778|NCT00866788|50613662|FG003|Overall Study|Adverse Event|1|||
25298779|NCT00866788|50613659|FG000|Overall Study|Lost to Follow-up|1|||
25298780|NCT00866788|50613660|FG001|Overall Study|Lost to Follow-up|1|||
25298781|NCT00866788|50613661|FG002|Overall Study|Lost to Follow-up|0|||
25298782|NCT00866788|50613662|FG003|Overall Study|Lost to Follow-up|2|||
25298783|NCT00866788|50613659|FG000|Overall Study|Withdrawal by Subject|2|||
25298784|NCT00866788|50613660|FG001|Overall Study|Withdrawal by Subject|1|||
25298785|NCT00866788|50613661|FG002|Overall Study|Withdrawal by Subject|0|||
25298786|NCT00866788|50613662|FG003|Overall Study|Withdrawal by Subject|1|||
25298787|NCT00866788|50613659|FG000|Overall Study|Pregnancy|0|||
25298788|NCT00866788|50613660|FG001|Overall Study|Pregnancy|1|||
25298789|NCT00866788|50613661|FG002|Overall Study|Pregnancy|0|||
25298790|NCT00866788|50613662|FG003|Overall Study|Pregnancy|0|||
25298791|NCT00866788|50613659|FG000|Overall Study|Disease progression|3|||
25298792|NCT00866788|50613660|FG001|Overall Study|Disease progression|1|||
25298793|NCT00866788|50613661|FG002|Overall Study|Disease progression|1|||
25298794|NCT00866788|50613662|FG003|Overall Study|Disease progression|0|||
25298795|NCT00866788|50613659|FG000|Overall Study|Physician Decision|0|||
25298796|NCT00866788|50613660|FG001|Overall Study|Physician Decision|0|||
25298797|NCT00866788|50613661|FG002|Overall Study|Physician Decision|1|||
25298798|NCT00866788|50613662|FG003|Overall Study|Physician Decision|1|||
25298799|NCT00860470|50613677|FG000|Overall Study|Death|6|||
25298800|NCT00860470|50613678|FG001|Overall Study|Death|10|||
25298801|NCT00860470|50613677|FG000|Overall Study|Moved away|8|||
25298802|NCT00860470|50613678|FG001|Overall Study|Moved away|10|||
25298803|NCT00860470|50613677|FG000|Overall Study|Lost to Follow-up|34|||
25298804|NCT00860470|50613678|FG001|Overall Study|Lost to Follow-up|39|||
25298805|NCT00923364|50613684|FG000|Overall Study|Death|3|||
25298806|NCT00923364|50613685|FG001|Overall Study|Death|0|||
25298807|NCT00923364|50613684|FG000|Overall Study|Did not go to transplant|1|||
25298808|NCT00923364|50613685|FG001|Overall Study|Did not go to transplant|0|||
25298809|NCT01096160|50613700|FG000|Overall Study|Adverse Event|0|||
25298810|NCT01096160|50613701|FG001|Overall Study|Adverse Event|0|||
25298811|NCT01096160|50613702|FG002|Overall Study|Adverse Event|1|||
25298812|NCT01096160|50613703|FG003|Overall Study|Adverse Event|0|||
25298813|NCT01096160|50613704|FG004|Overall Study|Adverse Event|0|||
25298814|NCT01096160|50613705|FG005|Overall Study|Adverse Event|0|||
25298815|NCT01096160|50613706|FG006|Overall Study|Adverse Event|0|||
25298816|NCT01096160|50613707|FG007|Overall Study|Adverse Event|0|||
25298817|NCT01096160|50613708|FG008|Overall Study|Adverse Event|0|||
25298818|NCT01096160|50613709|FG009|Overall Study|Adverse Event|1|||
25298819|NCT01096160|50613700|FG000|Overall Study|Met stopping criteria per protocol|0|||
25298820|NCT01096160|50613701|FG001|Overall Study|Met stopping criteria per protocol|0|||
25298821|NCT01096160|50613702|FG002|Overall Study|Met stopping criteria per protocol|0|||
25298822|NCT01096160|50613703|FG003|Overall Study|Met stopping criteria per protocol|0|||
25298823|NCT01096160|50613704|FG004|Overall Study|Met stopping criteria per protocol|1|||
25298824|NCT01096160|50613705|FG005|Overall Study|Met stopping criteria per protocol|0|||
25298825|NCT01096160|50613706|FG006|Overall Study|Met stopping criteria per protocol|2|||
25298826|NCT01096160|50613707|FG007|Overall Study|Met stopping criteria per protocol|0|||
25298827|NCT01096160|50613708|FG008|Overall Study|Met stopping criteria per protocol|2|||
25298828|NCT01096160|50613709|FG009|Overall Study|Met stopping criteria per protocol|0|||
25298829|NCT00860158|50613744|FG000|Overall Study|Study Terminated|1|||
25298830|NCT00929526|50613750|FG000|Overall Study|Withdrawal by Subject|1|||
25298831|NCT00929526|50613751|FG001|Overall Study|Withdrawal by Subject|11|||
25298832|NCT00929526|50613750|FG000|Overall Study|Lost to Follow-up|8|||
25298833|NCT00929526|50613751|FG001|Overall Study|Lost to Follow-up|12|||
25298834|NCT00929526|50613750|FG000|Overall Study|Other|8|||
25298835|NCT00929526|50613751|FG001|Overall Study|Other|6|||
25191761|NCT00089609|50353273|FG000|Overall Study|Withdrawal by Subject|3|||
25191762|NCT00089609|50353274|FG001|Overall Study|Withdrawal by Subject|1|||
25191763|NCT02440581|50353406|FG000|Overall Study|Death|0|||
25191764|NCT02440581|50353407|FG001|Overall Study|Death|0|||
25191765|NCT02440581|50353408|FG002|Overall Study|Death|7|||
25191766|NCT02440581|50353409|FG003|Overall Study|Death|5|||
25191767|NCT02440581|50353406|FG000|Overall Study|Transplanted|1|||
25191768|NCT02440581|50353407|FG001|Overall Study|Transplanted|0|||
25298836|NCT00859456|50613757|FG000|Overall Study|Adverse Event|3|||
25298837|NCT00859456|50613757|FG000|Overall Study|Progressive disease|2|||
25298838|NCT00859456|50613757|FG000|Overall Study|Non-compliance|3|||
25298839|NCT01075646|50613765|FG000|Overall Study|Lost to Follow-up|4|||
25191769|NCT02440581|50353408|FG002|Overall Study|Transplanted|3|||
25298840|NCT01075646|50613766|FG001|Overall Study|Lost to Follow-up|3|||
25298841|NCT01075646|50613767|FG002|Overall Study|Lost to Follow-up|1|||
25298842|NCT01075646|50613768|FG003|Overall Study|Lost to Follow-up|2|||
25298843|NCT01075412|50613780|FG000|Overall Study|Withdrawal by Subject|0|||
25298844|NCT01075412|50613781|FG001|Overall Study|Withdrawal by Subject|1|||
25298845|NCT00799903|50613788|FG000|Overall Study|Investigator Site Closed|25|||
25298846|NCT00799903|50613789|FG001|Overall Study|Investigator Site Closed|23|||
25298847|NCT00799903|50613788|FG000|Overall Study|Withdrawal by Subject|179|||
25298848|NCT00799903|50613789|FG001|Overall Study|Withdrawal by Subject|175|||
25298849|NCT00799903|50613788|FG000|Overall Study|Lost to Follow-up|69|||
25298850|NCT00799903|50613789|FG001|Overall Study|Lost to Follow-up|80|||
25298851|NCT01075256|50613798|FG000|Overall Study|Withdrawal by Subject|1|||
25298852|NCT01075256|50613799|FG001|Overall Study|Withdrawal by Subject|0|||
25298853|NCT01075256|50613800|FG002|Overall Study|Withdrawal by Subject|0|||
25298854|NCT00923130|50613813|FG000|Overall Study|Stopped treatment due to progression|17|||
25298855|NCT00923130|50613813|FG000|Overall Study|Death|1|||
25298856|NCT00923130|50613813|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
25298857|NCT00923130|50613813|FG000|Overall Study|Switched to alternative treatment|2|||
25298858|NCT00923130|50613813|FG000|Overall Study|Refused further treatment|2|||
25298859|NCT03253627|50613819|FG000|Overall Study|Lost to Follow-up|1|||
25298860|NCT03253627|50613820|FG001|Overall Study|Lost to Follow-up|2|||
25298861|NCT03253627|50613819|FG000|Overall Study|Withdrawal by Subject|0|||
25298862|NCT03253627|50613820|FG001|Overall Study|Withdrawal by Subject|2|||
25298863|NCT03253627|50613819|FG000|Overall Study|Inability to complete MRI|1|||
25298864|NCT03253627|50613820|FG001|Overall Study|Inability to complete MRI|0|||
25298865|NCT01075178|50613828|FG000|Subject Matching|eligible but not matched|130|||
25298866|NCT01075178|50613829|FG001|Subject Matching|eligible but not matched|403|||
25298867|NCT01075178|50613828|FG000|Subject Chart Review|died before chart review period|0|||
25298868|NCT01075178|50613829|FG001|Subject Chart Review|died before chart review period|2|||
25298869|NCT01075178|50613828|FG000|Subject Chart Review|no data collected due to site closure|3|||
25298870|NCT01075178|50613829|FG001|Subject Chart Review|no data collected due to site closure|4|||
25298871|NCT01075178|50613828|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
25298872|NCT01075178|50613829|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
25298873|NCT00799825|50613835|FG000|Overall Study|Adverse Event|1|||
25298874|NCT00799825|50613835|FG000|Overall Study|Withdrawal by Subject|6|||
25298875|NCT00799825|50613835|FG000|Overall Study|Lost to Follow-up|38|||
25298876|NCT00799825|50613835|FG000|Overall Study|Pregnancy|3|||
25298877|NCT00799591|50613839|FG000|Overall Study|De-escalation of doses|20|||
25298878|NCT00799591|50613839|FG000|Overall Study|Death|14|||
25298879|NCT00799591|50613839|FG000|Overall Study|Technical failure|12|||
25298880|NCT00799591|50613839|FG000|Overall Study|Resistant germ|11|||
25298881|NCT00799591|50613839|FG000|Overall Study|New infection|4|||
25298882|NCT00799591|50613839|FG000|Overall Study|Resistance germ and technical failure|2|||
25298883|NCT00799591|50613839|FG000|Overall Study|Persistance of fever undetermined origin|1|||
25298884|NCT00799591|50613839|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
25298885|NCT00799591|50613839|FG000|Overall Study|Infectious origin not probable|1|||
25298886|NCT01075100|50613845|FG000|Overall Study|Adverse Event|15|||
25298887|NCT01075100|50613846|FG001|Overall Study|Adverse Event|18|||
25298888|NCT01075100|50613845|FG000|Overall Study|Patient Request|4|||
25298889|NCT01075100|50613846|FG001|Overall Study|Patient Request|4|||
25298890|NCT01075100|50613845|FG000|Overall Study|Investigator Request|2|||
25298891|NCT01075100|50613846|FG001|Overall Study|Investigator Request|1|||
25298892|NCT01075100|50613845|FG000|Overall Study|Disease Progression|25|||
25298893|NCT01075100|50613846|FG001|Overall Study|Disease Progression|29|||
25298894|NCT01075100|50613845|FG000|Overall Study|Other|3|||
25298895|NCT01075100|50613846|FG001|Overall Study|Other|1|||
25298896|NCT00803023|50613858|FG000|Overall Study|Adverse Event|5|||
25298897|NCT00803023|50613859|FG001|Overall Study|Adverse Event|4|||
25298898|NCT00803023|50613860|FG002|Overall Study|Adverse Event|8|||
25298899|NCT00803023|50613861|FG003|Overall Study|Adverse Event|6|||
25298900|NCT00803023|50613858|FG000|Overall Study|Withdrawal by Subject|0|||
25298901|NCT00803023|50613859|FG001|Overall Study|Withdrawal by Subject|2|||
25298902|NCT00803023|50613860|FG002|Overall Study|Withdrawal by Subject|0|||
25298903|NCT00803023|50613861|FG003|Overall Study|Withdrawal by Subject|0|||
25298904|NCT00803023|50613858|FG000|Overall Study|Lost to Follow-up|0|||
25298905|NCT00803023|50613859|FG001|Overall Study|Lost to Follow-up|1|||
25298906|NCT00803023|50613860|FG002|Overall Study|Lost to Follow-up|2|||
25298907|NCT00803023|50613861|FG003|Overall Study|Lost to Follow-up|1|||
25298908|NCT00803023|50613858|FG000|Overall Study|Lack of Efficacy|0|||
25298909|NCT00803023|50613859|FG001|Overall Study|Lack of Efficacy|1|||
25298910|NCT00803023|50613860|FG002|Overall Study|Lack of Efficacy|1|||
25298911|NCT00803023|50613861|FG003|Overall Study|Lack of Efficacy|1|||
25298912|NCT00859222|50613874|FG000|Overall Study|Adverse Event|2|||
25298913|NCT00859222|50613875|FG001|Overall Study|Adverse Event|3|||
25298914|NCT00859222|50613876|FG002|Overall Study|Adverse Event|6|||
25298915|NCT00859222|50613877|FG003|Overall Study|Adverse Event|24|||
25298916|NCT00859222|50613878|FG004|Overall Study|Adverse Event|15|||
25298917|NCT00859222|50613874|FG000|Overall Study|DLT|1|||
25298918|NCT00859222|50613875|FG001|Overall Study|DLT|0|||
25298919|NCT00859222|50613876|FG002|Overall Study|DLT|0|||
25298920|NCT00859222|50613877|FG003|Overall Study|DLT|0|||
25298921|NCT00859222|50613878|FG004|Overall Study|DLT|0|||
25298922|NCT01072448|50613895|FG000|Overall Study|Adverse Event|9|||
25298923|NCT01072448|50613896|FG001|Overall Study|Adverse Event|10|||
25298924|NCT01072448|50613895|FG000|Overall Study|Subject withdrew consent|4|||
25298925|NCT01072448|50613896|FG001|Overall Study|Subject withdrew consent|9|||
25298926|NCT01072448|50613895|FG000|Overall Study|Protocol deviation|3|||
25298927|NCT01072448|50613896|FG001|Overall Study|Protocol deviation|4|||
25298928|NCT01072448|50613895|FG000|Overall Study|Abnormal test procedure result(s)|1|||
25298929|NCT01072448|50613896|FG001|Overall Study|Abnormal test procedure result(s)|0|||
25298930|NCT01072448|50613895|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25298931|NCT01072448|50613896|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
25298932|NCT01072448|50613895|FG000|Overall Study|Lost to Follow-up|1|||
25298933|NCT01072448|50613896|FG001|Overall Study|Lost to Follow-up|1|||
25298934|NCT01072448|50613895|FG000|Overall Study|Abnormal laboratory value(s)|0|||
25298935|NCT01072448|50613896|FG001|Overall Study|Abnormal laboratory value(s)|1|||
25298936|NCT01072448|50613895|FG000|Overall Study|Death|0|||
25298937|NCT01072448|50613896|FG001|Overall Study|Death|2|||
25298938|NCT00922974|50613905|FG000|Phase II Component|Protocol Violation|2|||
25298939|NCT00922974|50613906|FG001|Phase II Component|Protocol Violation|0|||
25298940|NCT00922974|50613905|FG000|Phase II Component|Not evaluable for treatment review|5|||
25298941|NCT00922974|50613906|FG001|Phase II Component|Not evaluable for treatment review|0|||
25298942|NCT00922974|50613905|FG000|Phase III Component|Protocol Violation|8|||
25298943|NCT00922974|50613906|FG001|Phase III Component|Protocol Violation|6|||
25298944|NCT00858988|50613916|FG000|Analysis|Lactulose unable to be detected in urine|2|||
25298945|NCT00858988|50613917|FG001|Analysis|Lactulose unable to be detected in urine|1|||
25298946|NCT00858832|50613925|FG000|Overall Study|became ineligible: delivered vaginally|1|||
25298947|NCT00858832|50613926|FG001|Overall Study|became ineligible: delivered vaginally|0|||
25298948|NCT00858832|50613925|FG000|Overall Study|Adverse Event|0|||
25298949|NCT00858832|50613926|FG001|Overall Study|Adverse Event|1|||
25298950|NCT01071512|50613932|FG000|Overall Study|Adverse Event|1|||
25298951|NCT01071512|50613932|FG000|Overall Study|Development of antibodies to drug|2|||
25298952|NCT01071512|50613932|FG000|Overall Study|positive anti-JC virus antibody test|2|||
25298953|NCT00858442|50613938|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
25298954|NCT00858442|50613939|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
25298955|NCT01071278|50613946|FG000|Overall Study|Premature Discontinuation|254|||
25298956|NCT01071278|50613946|FG000|Overall Study|Completion Status Unknown|459|||
25298957|NCT00858208|50613952|FG000|Overall Study|Adverse Event|3|||
25298958|NCT00858208|50613952|FG000|Overall Study|Lost to Follow-up|26|||
25298959|NCT00858208|50613952|FG000|Overall Study|Participant refused|40|||
25298960|NCT00858208|50613952|FG000|Overall Study|Other|10|||
25298961|NCT01071200|50613958|FG000|Overall Study|Lack of ovarian response|1|||
25298962|NCT01071200|50613959|FG001|Overall Study|Lack of ovarian response|1|||
25298963|NCT01071200|50613958|FG000|Overall Study|No fertilization|4|||
25298964|NCT01071200|50613959|FG001|Overall Study|No fertilization|0|||
25298965|NCT01071200|50613958|FG000|Overall Study|No oocytes retrieved|1|||
25298966|NCT01071200|50613959|FG001|Overall Study|No oocytes retrieved|1|||
25298967|NCT01071200|50613958|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
25298968|NCT01071200|50613959|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
25298969|NCT01071200|50613958|FG000|Overall Study|No viable embryos|0|||
25298970|NCT01071200|50613959|FG001|Overall Study|No viable embryos|1|||
25298971|NCT02207569|50613965|FG000|1-Month|Death|6|||
25298972|NCT02207569|50613965|FG000|1-Month|Withdrawal by Subject|2|||
25298973|NCT02207569|50613965|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
25298974|NCT02207569|50613965|FG000|6-Month|Death|8|||
25298975|NCT02207569|50613965|FG000|6-Month|Withdrawal by Subject|2|||
25298976|NCT02207569|50613965|FG000|12-Month|Death|14|||
25298977|NCT02207569|50613965|FG000|12-Month|Withdrawal by Subject|2|||
25298978|NCT02207569|50613965|FG000|24-Month|Death|23|||
25298979|NCT02207569|50613965|FG000|24-Month|Withdrawal by Subject|3|||
25298980|NCT02207569|50613965|FG000|36-Month|Death|23|||
25298981|NCT02207569|50613965|FG000|36-Month|Withdrawal by Subject|4|||
25298982|NCT02207569|50613965|FG000|48-Month|Death|25|||
25298983|NCT02207569|50613965|FG000|48-Month|Withdrawal by Subject|2|||
25298984|NCT02207569|50613965|FG000|48-Month|Lost to Follow-up|4|||
25298985|NCT02207569|50613965|FG000|60-Month|Death|1|||
25298986|NCT02207569|50613965|FG000|60-Month|Lost to Follow-up|1|||
25298987|NCT02207569|50613965|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
25298988|NCT02207569|50613965|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
25298989|NCT01070966|50613969|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
25298990|NCT01070966|50613969|FG000|Participants for Safety Evaluation|Off-label use|9|||
25298991|NCT01070966|50613969|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
25298992|NCT01070966|50613969|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
25298993|NCT01070966|50613969|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
25298994|NCT01070966|50613969|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
25298995|NCT01070966|50613969|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
25298996|NCT01070966|50613969|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
25298997|NCT01070888|50613982|FG000|First Intervention (14 Days)|Adverse Event|0|||
25298998|NCT01070888|50613983|FG001|First Intervention (14 Days)|Adverse Event|1|||
25298999|NCT01070888|50613982|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
25299000|NCT01070888|50613983|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
25299001|NCT01070888|50613982|FG000|Washout (14 Days)|Physician Decision|1|||
25299002|NCT01070888|50613983|FG001|Washout (14 Days)|Physician Decision|0|||
25299003|NCT00857896|50613989|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
25299004|NCT00857818|50613996|FG000|Overall Study|Lack of Efficacy|1|||
25299005|NCT00857818|50613997|FG001|Overall Study|Lack of Efficacy|0|||
25299006|NCT00857818|50613996|FG000|Overall Study|Adverse Event|3|||
25299007|NCT00857818|50613997|FG001|Overall Study|Adverse Event|0|||
25299008|NCT00857818|50613996|FG000|Overall Study|Withdrawal by Subject|0|||
25299009|NCT00857818|50613997|FG001|Overall Study|Withdrawal by Subject|4|||
25299010|NCT00857818|50613996|FG000|Overall Study|Sponsor terminated study|6|||
25299011|NCT00857818|50613997|FG001|Overall Study|Sponsor terminated study|4|||
25299012|NCT00857818|50613996|FG000|Overall Study|Investigator decision|1|||
25299013|NCT00857818|50613997|FG001|Overall Study|Investigator decision|0|||
25299014|NCT01074944|50614003|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
25299015|NCT01074944|50614004|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
25299016|NCT01074944|50614005|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
25299017|NCT01074944|50614006|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
25299018|NCT01074944|50614007|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
25299019|NCT01074944|50614003|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
25299020|NCT01074944|50614004|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
25299021|NCT01074944|50614005|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
25299022|NCT01074944|50614006|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
25299023|NCT01074944|50614007|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
25299024|NCT01074944|50614003|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
25299025|NCT01074944|50614004|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
25299026|NCT01074944|50614005|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
25299027|NCT01074944|50614006|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
25299028|NCT01074944|50614007|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
25299029|NCT01074944|50614003|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
25299030|NCT01074944|50614004|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
25299031|NCT01074944|50614005|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
25299032|NCT01074944|50614006|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
25299033|NCT01074944|50614007|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
24969847|NCT04539262|50059283|FG000|Overall Study|Adverse Event|0|||
24969848|NCT04539262|50059284|FG001|Overall Study|Adverse Event|0|||
24969849|NCT04539262|50059285|FG002|Overall Study|Adverse Event|1|||
25299034|NCT01074944|50614003|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
25299035|NCT01074944|50614004|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
25299036|NCT01074944|50614005|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
25299037|NCT01074944|50614006|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
25299038|NCT01074944|50614007|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
25299039|NCT01074944|50614003|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
24969850|NCT04539262|50059286|FG003|Overall Study|Adverse Event|0|||
24969851|NCT04539262|50059287|FG004|Overall Study|Adverse Event|0|||
24969852|NCT04539262|50059288|FG005|Overall Study|Adverse Event|0|||
25299040|NCT01074944|50614004|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
25299041|NCT01074944|50614005|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
25299042|NCT01074944|50614006|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
25299043|NCT01074944|50614007|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
25299044|NCT01074944|50614003|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
25299045|NCT01074944|50614004|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
25299046|NCT01074944|50614005|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
25299047|NCT01074944|50614006|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
25299048|NCT01074944|50614007|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
25299049|NCT01074944|50614003|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
25299050|NCT01074944|50614004|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
25299051|NCT01074944|50614005|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
25299052|NCT01074944|50614006|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
25299053|NCT01074944|50614007|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
25299054|NCT01074944|50614003|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
25299055|NCT01074944|50614004|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
25299056|NCT01074944|50614005|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
25299057|NCT01074944|50614006|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
25299058|NCT01074944|50614007|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
25299059|NCT01074944|50614003|FG000|Long Term Treatment|Adverse Event|0|||
25299060|NCT01074944|50614004|FG001|Long Term Treatment|Adverse Event|0|||
25299061|NCT01074944|50614005|FG002|Long Term Treatment|Adverse Event|0|||
25299062|NCT01074944|50614006|FG003|Long Term Treatment|Adverse Event|3|||
25299063|NCT01074944|50614007|FG004|Long Term Treatment|Adverse Event|0|||
25299064|NCT01074944|50614003|FG000|Long Term Treatment|Lost to Follow-up|0|||
25299065|NCT01074944|50614004|FG001|Long Term Treatment|Lost to Follow-up|0|||
25299066|NCT01074944|50614005|FG002|Long Term Treatment|Lost to Follow-up|0|||
25299067|NCT01074944|50614006|FG003|Long Term Treatment|Lost to Follow-up|2|||
25299068|NCT01074944|50614007|FG004|Long Term Treatment|Lost to Follow-up|0|||
25299069|NCT01074944|50614003|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
25299070|NCT01074944|50614004|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
25299071|NCT01074944|50614005|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
25299072|NCT01074944|50614006|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
25299073|NCT01074944|50614007|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
25299074|NCT01074944|50614003|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
25299075|NCT01074944|50614004|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
25299076|NCT01074944|50614005|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
25299077|NCT01074944|50614006|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
25299078|NCT01074944|50614007|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
25299079|NCT01074944|50614003|FG000|Long Term Treatment|Withdrawal by Subject|0|||
25299080|NCT01074944|50614004|FG001|Long Term Treatment|Withdrawal by Subject|0|||
25299081|NCT01074944|50614005|FG002|Long Term Treatment|Withdrawal by Subject|0|||
25299082|NCT01074944|50614006|FG003|Long Term Treatment|Withdrawal by Subject|2|||
25299083|NCT01074944|50614007|FG004|Long Term Treatment|Withdrawal by Subject|0|||
25299084|NCT01074944|50614003|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
25299085|NCT01074944|50614004|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
25299086|NCT01074944|50614005|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
25299087|NCT01074944|50614006|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
25299088|NCT01074944|50614007|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
25299089|NCT01074944|50614003|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
25299090|NCT01074944|50614004|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
25299091|NCT01074944|50614005|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
25299092|NCT01074944|50614006|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
25299093|NCT01074944|50614007|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
25299094|NCT00802945|50614017|FG000|Overall Study|Death|27|||
25299095|NCT00802945|50614018|FG001|Overall Study|Death|23|||
25299096|NCT00802945|50614017|FG000|Overall Study|Terminated by sponsor|8|||
25299097|NCT00802945|50614018|FG001|Overall Study|Terminated by sponsor|12|||
25299098|NCT01074554|50614028|FG000|Overall Study|Adverse Event|3|||
25299099|NCT01074554|50614029|FG001|Overall Study|Adverse Event|3|||
25299100|NCT01074554|50614028|FG000|Overall Study|Lost to Follow-up|0|||
25299101|NCT01074554|50614029|FG001|Overall Study|Lost to Follow-up|1|||
25299102|NCT00857584|50614037|FG000|Overall Study|Lack of Efficacy|1|||
25299103|NCT00857584|50614038|FG001|Overall Study|Lack of Efficacy|2|||
25299104|NCT00857584|50614037|FG000|Overall Study|Adverse Event|2|||
25299105|NCT00857584|50614038|FG001|Overall Study|Adverse Event|2|||
25299106|NCT00857584|50614037|FG000|Overall Study|Physician Decision|1|||
25299107|NCT00857584|50614038|FG001|Overall Study|Physician Decision|1|||
25299108|NCT00798967|50614046|FG000|Overall Study|Adverse Event|2|||
25299109|NCT00798967|50614047|FG001|Overall Study|Adverse Event|3|||
25299110|NCT00798967|50614046|FG000|Overall Study|Withdrawal by Subject|0|||
25299111|NCT00798967|50614047|FG001|Overall Study|Withdrawal by Subject|1|||
25299112|NCT00798967|50614046|FG000|Overall Study|Physician Decision|1|||
25299113|NCT00798967|50614047|FG001|Overall Study|Physician Decision|0|||
25299114|NCT00798967|50614046|FG000|Overall Study|Randomized in error by site|1|||
25299115|NCT00798967|50614047|FG001|Overall Study|Randomized in error by site|0|||
25299116|NCT01074242|50614054|FG000|Overall Study|Case report before date of contract|40|||
25299117|NCT01074242|50614054|FG000|Overall Study|Lost to Follow-up|1|||
25299118|NCT01074242|50614054|FG000|Overall Study|Case report unclear|6|||
25299119|NCT01074242|50614054|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
25299120|NCT01074242|50614054|FG000|Overall Study|Duplicate Case Report Form|5|||
25299121|NCT00798889|50614058|FG000|Overall Study|Adverse Event|53|||
25299122|NCT00798889|50614058|FG000|Overall Study|Protocol Violation|2|||
25299123|NCT00798889|50614058|FG000|Overall Study|Withdrawal by Subject|31|||
25299124|NCT00798889|50614058|FG000|Overall Study|Lost to Follow-up|1|||
25299125|NCT00798889|50614058|FG000|Overall Study|Lack of Efficacy|213|||
25299126|NCT00798889|50614058|FG000|Overall Study|Decision of Sponsor|11|||
25299127|NCT00798889|50614058|FG000|Overall Study|Enrolled, Not treated|3|||
25299128|NCT00796861|50614062|FG000|Overall Study|Withdrawal by Subject|2|||
25299129|NCT00796861|50614062|FG000|Overall Study|Death|2|||
25299130|NCT00802867|50614066|FG000|Overall Study|Lost to Follow-up|6|||
25299131|NCT00802867|50614066|FG000|Overall Study|Protocol Violation|6|||
25299132|NCT00802867|50614066|FG000|Overall Study|Withdrawal by Subject|1|||
25299133|NCT00798655|50614070|FG000|Overall Study|Did not receive at least one dose of pan|2|||
25299134|NCT00796549|50614074|FG000|Overall Study|Adverse Event|11|||
25299135|NCT00796549|50614074|FG000|Overall Study|not entered|149|||
25299136|NCT00796549|50614074|FG000|Overall Study|Other|2|||
25299137|NCT00796549|50614074|FG000|Overall Study|Progressive disease|56|||
25299138|NCT00856492|50614083|FG000|Overall Study|Ineligible or withdrew consent|1|||
25299139|NCT00856492|50614084|FG001|Overall Study|Ineligible or withdrew consent|1|||
25299140|NCT00856492|50614085|FG002|Overall Study|Ineligible or withdrew consent|2|||
25299141|NCT00856180|50614096|FG000|Overall Study|Adverse Event|4|||
25299142|NCT00856180|50614096|FG000|Overall Study|Progressive Disease|16|||
25299143|NCT00900627|50614108|FG000|Overall Study|Condition under investigation worsened|4|||
25299144|NCT00900627|50614109|FG001|Overall Study|Condition under investigation worsened|0|||
25299145|NCT00900627|50614110|FG002|Overall Study|Condition under investigation worsened|5|||
25299146|NCT00900627|50614111|FG003|Overall Study|Condition under investigation worsened|3|||
25299147|NCT00900627|50614112|FG004|Overall Study|Condition under investigation worsened|0|||
25299148|NCT00900627|50614113|FG005|Overall Study|Condition under investigation worsened|0|||
25299149|NCT00900627|50614108|FG000|Overall Study|Withdrawal by Subject|1|||
25299150|NCT00900627|50614109|FG001|Overall Study|Withdrawal by Subject|0|||
25299151|NCT00900627|50614110|FG002|Overall Study|Withdrawal by Subject|1|||
25299152|NCT00900627|50614111|FG003|Overall Study|Withdrawal by Subject|0|||
25299153|NCT00900627|50614112|FG004|Overall Study|Withdrawal by Subject|1|||
25299154|NCT00900627|50614113|FG005|Overall Study|Withdrawal by Subject|2|||
25299155|NCT00900627|50614108|FG000|Overall Study|Adverse Event|1|||
25299156|NCT00900627|50614109|FG001|Overall Study|Adverse Event|2|||
25299157|NCT00900627|50614110|FG002|Overall Study|Adverse Event|0|||
25299158|NCT00900627|50614111|FG003|Overall Study|Adverse Event|3|||
25299159|NCT00900627|50614112|FG004|Overall Study|Adverse Event|0|||
25299160|NCT00900627|50614113|FG005|Overall Study|Adverse Event|0|||
25299161|NCT00900627|50614108|FG000|Overall Study|Death|0|||
25299162|NCT00900627|50614109|FG001|Overall Study|Death|0|||
25299163|NCT00900627|50614110|FG002|Overall Study|Death|0|||
25299164|NCT00900627|50614111|FG003|Overall Study|Death|0|||
25299165|NCT00900627|50614112|FG004|Overall Study|Death|28|||
25299166|NCT00900627|50614113|FG005|Overall Study|Death|24|||
25299167|NCT00866320|50614127|FG000|Overall Study|Withdrawal by Subject|4|||
25299168|NCT00866320|50614127|FG000|Overall Study|Death|2|||
25299169|NCT00869518|50614135|FG000|Overall Study|Lost to Follow-up|1|||
25299170|NCT00869518|50614136|FG001|Overall Study|Lost to Follow-up|1|||
25299171|NCT00797563|50614142|FG000|Overall Study|Adverse Event|1|||
25299172|NCT00869440|50614150|FG000|Overall Study|Withdrawal by Subject|1|||
25299173|NCT00869440|50614151|FG001|Overall Study|Withdrawal by Subject|0|||
25299174|NCT00869440|50614152|FG002|Overall Study|Withdrawal by Subject|0|||
25299175|NCT00869440|50614153|FG003|Overall Study|Withdrawal by Subject|0|||
25299176|NCT00869440|50614150|FG000|Overall Study|Physician Decision|1|||
25299177|NCT00869440|50614151|FG001|Overall Study|Physician Decision|1|||
25299178|NCT00869440|50614152|FG002|Overall Study|Physician Decision|0|||
25299179|NCT00869440|50614153|FG003|Overall Study|Physician Decision|0|||
25299180|NCT00895947|50614165|FG000|Overall Study|Adverse Event|3|||
25299181|NCT00895947|50614166|FG001|Overall Study|Adverse Event|4|||
25299182|NCT00895947|50614165|FG000|Overall Study|Lost to Follow-up|3|||
25299183|NCT00895947|50614166|FG001|Overall Study|Lost to Follow-up|4|||
25299184|NCT00895947|50614165|FG000|Overall Study|Protocol Violation|4|||
25299185|NCT00895947|50614166|FG001|Overall Study|Protocol Violation|2|||
25299186|NCT00895947|50614165|FG000|Overall Study|Withdrawal by Subject|2|||
25299187|NCT00895947|50614166|FG001|Overall Study|Withdrawal by Subject|0|||
25299188|NCT00869362|50614174|FG000|Overall Study|Death|0|||
24969853|NCT04539262|50059289|FG006|Overall Study|Adverse Event|0|||
24969854|NCT04539262|50059290|FG007|Overall Study|Adverse Event|0|||
24969855|NCT04539262|50059283|FG000|Overall Study|Withdrew Consent|0|||
24969856|NCT04539262|50059284|FG001|Overall Study|Withdrew Consent|0|||
25299189|NCT00869362|50614175|FG001|Overall Study|Death|2|||
25299190|NCT00869362|50614174|FG000|Overall Study|Lost to Follow-up|1|||
25299191|NCT00869362|50614175|FG001|Overall Study|Lost to Follow-up|3|||
25299192|NCT00588445|50614182|FG000|Overall Study|Protocol Violation|1|||
25299193|NCT00588445|50614182|FG000|Overall Study|Withdrawal by Subject|3|||
25299194|NCT00588445|50614182|FG000|Overall Study|Disease Progression|1|||
25299195|NCT00588445|50614182|FG000|Overall Study|Not Treated|10|||
25299196|NCT00796315|50614188|FG000|Overall Study|Protocol Violation|0|||
25299197|NCT00796315|50614189|FG001|Overall Study|Protocol Violation|1|||
25299198|NCT00796315|50614190|FG002|Overall Study|Protocol Violation|0|||
25299199|NCT00855166|50614203|FG000|Overall Study|Adverse Event|0|||
25299200|NCT00855166|50614204|FG001|Overall Study|Adverse Event|2|||
25299201|NCT00855166|50614203|FG000|Overall Study|Death|0|||
25299202|NCT00855166|50614204|FG001|Overall Study|Death|1|||
25299203|NCT00855166|50614203|FG000|Overall Study|Withdrawal by Subject|1|||
24969857|NCT04539262|50059285|FG002|Overall Study|Withdrew Consent|0|||
24969858|NCT04539262|50059286|FG003|Overall Study|Withdrew Consent|1|||
25070851|NCT02704689|50176915|FG000|Overall Study|Study device not implanted|2|||
25299204|NCT00855166|50614204|FG001|Overall Study|Withdrawal by Subject|4|||
25299205|NCT00855166|50614203|FG000|Overall Study|Poor/non-compliance|2|||
25299206|NCT00855166|50614204|FG001|Overall Study|Poor/non-compliance|0|||
25299207|NCT00855166|50614203|FG000|Overall Study|Administrative reasons by sponsor|1|||
25299208|NCT00855166|50614204|FG001|Overall Study|Administrative reasons by sponsor|0|||
25299209|NCT00855166|50614203|FG000|Overall Study|Subject no longer meets study criteria|1|||
25299210|NCT00855166|50614204|FG001|Overall Study|Subject no longer meets study criteria|1|||
25299211|NCT00587587|50614214|FG000|Overall Study|Lost to Follow-up|6|||
25299212|NCT00587587|50614215|FG001|Overall Study|Lost to Follow-up|1|||
25299213|NCT00854620|50614223|FG000|Overall Study|Adverse Event|1|||
25299214|NCT00793585|50614229|FG000|Overall Study|Adverse Event|1|||
25299215|NCT00793585|50614230|FG001|Overall Study|Adverse Event|1|||
25299216|NCT00793585|50614229|FG000|Overall Study|Protocol Violation|1|||
25299217|NCT00793585|50614230|FG001|Overall Study|Protocol Violation|2|||
25299218|NCT00898443|50614238|FG000|Overall Study|Withdrawal by Subject|1|||
25299219|NCT00898443|50614239|FG001|Overall Study|Withdrawal by Subject|0|||
25299220|NCT00900159|50614247|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
25299221|NCT00900159|50614248|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
25299222|NCT00854308|50614267|FG000|Overall Study|Disease progression|42|||
25299223|NCT00854308|50614268|FG001|Overall Study|Disease progression|50|||
25299224|NCT00854308|50614267|FG000|Overall Study|Adverse Event|8|||
25299225|NCT00854308|50614268|FG001|Overall Study|Adverse Event|3|||
25299226|NCT00854308|50614267|FG000|Overall Study|Death|2|||
25299227|NCT00854308|50614268|FG001|Overall Study|Death|5|||
25299228|NCT00854308|50614267|FG000|Overall Study|Physician Decision|6|||
25299229|NCT00854308|50614268|FG001|Overall Study|Physician Decision|6|||
25299230|NCT00854308|50614267|FG000|Overall Study|Withdrawal by Subject|4|||
25299231|NCT00854308|50614268|FG001|Overall Study|Withdrawal by Subject|2|||
25299232|NCT00854308|50614267|FG000|Overall Study|Sponsor's decision to terminate study|0|||
25299233|NCT00854308|50614268|FG001|Overall Study|Sponsor's decision to terminate study|1|||
25299234|NCT00592852|50614274|FG000|Overall Study|Non-compliance|1|||
25299235|NCT00592852|50614274|FG000|Overall Study|Adverse Event|3|||
25299236|NCT00592852|50614274|FG000|Overall Study|Found ineligible|1|||
25299237|NCT00592852|50614274|FG000|Overall Study|Withdrawal by Subject|1|||
25299238|NCT00895245|50614278|FG000|Overall Study|Lack of Efficacy|6|||
25299239|NCT00865306|50614284|FG000|Controlled Trial|Lost to Follow-up|1|||
25299240|NCT00865306|50614285|FG001|Controlled Trial|Lost to Follow-up|1|||
25299241|NCT00865306|50614284|FG000|Controlled Trial|Difficulty commuting|2|||
25299242|NCT00865306|50614285|FG001|Controlled Trial|Difficulty commuting|0|||
25299243|NCT00865306|50614284|FG000|Controlled Trial|Improved btw baseline and first session|1|||
24969859|NCT04539262|50059287|FG004|Overall Study|Withdrew Consent|0|||
25191770|NCT02440581|50353409|FG003|Overall Study|Transplanted|2|||
25299244|NCT00865306|50614285|FG001|Controlled Trial|Improved btw baseline and first session|0|||
25299245|NCT00865306|50614284|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
25299246|NCT00865306|50614285|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
25191771|NCT02440581|50353406|FG000|Overall Study|Withdrawal by Subject|4|||
25299247|NCT00865306|50614284|FG000|Controlled Trial|Withdrawal by Subject|0|||
25299248|NCT00865306|50614285|FG001|Controlled Trial|Withdrawal by Subject|1|||
25299249|NCT00896649|50614291|FG000|Overall Study|Physician Decision|1|||
25299250|NCT00896649|50614291|FG000|Overall Study|Pregnancy|1|||
25299251|NCT00896649|50614291|FG000|Overall Study|missing documentation|1|||
25299252|NCT00896649|50614291|FG000|Overall Study|technical difficulties|2|||
25299253|NCT00796003|50614298|FG000|Overall Study|Disease Progression|2|||
25299254|NCT00796003|50614299|FG001|Overall Study|Disease Progression|13|||
25299255|NCT00796003|50614298|FG000|Overall Study|Adverse Event|1|||
25299256|NCT00796003|50614299|FG001|Overall Study|Adverse Event|7|||
25299257|NCT00796003|50614298|FG000|Overall Study|Specified organ function not met|0|||
25299258|NCT00796003|50614299|FG001|Overall Study|Specified organ function not met|1|||
25299259|NCT00796003|50614298|FG000|Overall Study|Physician Decision|0|||
25299260|NCT00796003|50614299|FG001|Overall Study|Physician Decision|4|||
25299261|NCT00796003|50614298|FG000|Overall Study|Withdrawal by Subject|0|||
25299262|NCT00796003|50614299|FG001|Overall Study|Withdrawal by Subject|1|||
25299263|NCT00796003|50614298|FG000|Overall Study|Other|0|||
25299264|NCT00796003|50614299|FG001|Overall Study|Other|1|||
25299265|NCT00796003|50614298|FG000|Overall Study|Participants Not treated|0|||
25299266|NCT00796003|50614299|FG001|Overall Study|Participants Not treated|2|||
25299267|NCT00895011|50614311|FG000|Overall Study|Withdrawal by Subject|14|||
25299268|NCT00895011|50614312|FG001|Overall Study|Withdrawal by Subject|7|||
25299269|NCT00895011|50614313|FG002|Overall Study|Withdrawal by Subject|2|||
25299270|NCT00895011|50614311|FG000|Overall Study|Lost to Follow-up|5|||
25299271|NCT00895011|50614312|FG001|Overall Study|Lost to Follow-up|4|||
25299272|NCT00895011|50614313|FG002|Overall Study|Lost to Follow-up|1|||
25299273|NCT00895011|50614311|FG000|Overall Study|Protocol Violation|3|||
25299274|NCT00895011|50614312|FG001|Overall Study|Protocol Violation|1|||
25299275|NCT00895011|50614313|FG002|Overall Study|Protocol Violation|3|||
25299276|NCT00895011|50614311|FG000|Overall Study|Adverse Event|1|||
25299277|NCT00895011|50614312|FG001|Overall Study|Adverse Event|2|||
25299278|NCT00895011|50614313|FG002|Overall Study|Adverse Event|2|||
25299279|NCT00895011|50614311|FG000|Overall Study|schedule conflict|1|||
25299280|NCT00895011|50614312|FG001|Overall Study|schedule conflict|0|||
25299281|NCT00895011|50614313|FG002|Overall Study|schedule conflict|0|||
25299282|NCT00899847|50614322|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
25299283|NCT00795535|50614328|FG000|Overall Study|incomplete data and technical problems|20|||
25299284|NCT00853762|50614336|FG000|Overall Study|Premature Termination|16|||
25299285|NCT00853762|50614337|FG001|Overall Study|Premature Termination|15|||
25299286|NCT00853762|50614338|FG002|Overall Study|Premature Termination|14|||
25299287|NCT00853762|50614339|FG003|Overall Study|Premature Termination|21|||
25299288|NCT00853762|50614336|FG000|Overall Study|Protocol Violation|0|||
25299289|NCT00853762|50614337|FG001|Overall Study|Protocol Violation|0|||
25299290|NCT00853762|50614338|FG002|Overall Study|Protocol Violation|0|||
25299291|NCT00853762|50614339|FG003|Overall Study|Protocol Violation|1|||
25299292|NCT00853762|50614336|FG000|Overall Study|Withdrawal by Subject|0|||
25299293|NCT00853762|50614337|FG001|Overall Study|Withdrawal by Subject|0|||
25299294|NCT00853762|50614338|FG002|Overall Study|Withdrawal by Subject|1|||
24969860|NCT04539262|50059288|FG005|Overall Study|Withdrew Consent|0|||
24969861|NCT04539262|50059289|FG006|Overall Study|Withdrew Consent|0|||
25299295|NCT00853762|50614339|FG003|Overall Study|Withdrawal by Subject|0|||
25299296|NCT00853762|50614336|FG000|Overall Study|Other|0|||
25299297|NCT00853762|50614337|FG001|Overall Study|Other|2|||
24969862|NCT04539262|50059290|FG007|Overall Study|Withdrew Consent|0|||
25299298|NCT00853762|50614338|FG002|Overall Study|Other|0|||
25299299|NCT00853762|50614339|FG003|Overall Study|Other|0|||
25299300|NCT00853762|50614336|FG000|Overall Study|Randomised but not Treated|0|||
25299301|NCT00853762|50614337|FG001|Overall Study|Randomised but not Treated|2|||
25299302|NCT00853762|50614338|FG002|Overall Study|Randomised but not Treated|2|||
25299303|NCT00853762|50614339|FG003|Overall Study|Randomised but not Treated|0|||
25299304|NCT00789529|50614351|FG000|Overall Study|Withdrawal by Subject|0|||
25299305|NCT00789529|50614352|FG001|Overall Study|Withdrawal by Subject|1|||
25299306|NCT00789529|50614351|FG000|Overall Study|Other Reason|1|||
25299307|NCT00789529|50614352|FG001|Overall Study|Other Reason|0|||
25299308|NCT00894933|50614358|FG000|Overall Study|Lost to Follow-up|2|||
25299309|NCT00894933|50614358|FG000|Overall Study|Cancelled Procedure|1|||
25299310|NCT00894933|50614358|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
25299311|NCT00792805|50614365|FG000|Overall Study|Adverse Event|12|||
25299312|NCT00792805|50614366|FG001|Overall Study|Adverse Event|10|||
25299313|NCT00792805|50614367|FG002|Overall Study|Adverse Event|10|||
25299314|NCT00792805|50614365|FG000|Overall Study|Subject withdrew consent|5|||
25299315|NCT00792805|50614366|FG001|Overall Study|Subject withdrew consent|6|||
25299316|NCT00792805|50614367|FG002|Overall Study|Subject withdrew consent|5|||
25299317|NCT00792805|50614365|FG000|Overall Study|Administrative problems|2|||
25299318|NCT00792805|50614366|FG001|Overall Study|Administrative problems|0|||
25299319|NCT00792805|50614367|FG002|Overall Study|Administrative problems|4|||
25299320|NCT00792805|50614365|FG000|Overall Study|Abnormal test procedure result(s)|1|||
25299321|NCT00792805|50614366|FG001|Overall Study|Abnormal test procedure result(s)|2|||
25299322|NCT00792805|50614367|FG002|Overall Study|Abnormal test procedure result(s)|0|||
25299323|NCT00792805|50614365|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25299324|NCT00792805|50614366|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
25299325|NCT00792805|50614367|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
25299326|NCT00792805|50614365|FG000|Overall Study|Lost to Follow-up|1|||
25299327|NCT00792805|50614366|FG001|Overall Study|Lost to Follow-up|1|||
25299328|NCT00792805|50614367|FG002|Overall Study|Lost to Follow-up|6|||
25299329|NCT00792805|50614365|FG000|Overall Study|Abnormal laboratory value(s)|0|||
25299330|NCT00792805|50614366|FG001|Overall Study|Abnormal laboratory value(s)|0|||
25299331|NCT00792805|50614367|FG002|Overall Study|Abnormal laboratory value(s)|1|||
25299332|NCT00792805|50614365|FG000|Overall Study|Protocol deviation|0|||
25299333|NCT00792805|50614366|FG001|Overall Study|Protocol deviation|1|||
25299334|NCT00792805|50614367|FG002|Overall Study|Protocol deviation|1|||
25299335|NCT00925002|50614378|FG000|Overall Study|Other|1|||
25299336|NCT00925002|50614379|FG001|Overall Study|Other|4|||
25299337|NCT00925002|50614380|FG002|Overall Study|Other|0|||
25299338|NCT00925002|50614378|FG000|Overall Study|Death|1|||
25299339|NCT00925002|50614379|FG001|Overall Study|Death|1|||
25299340|NCT00925002|50614380|FG002|Overall Study|Death|5|||
25299341|NCT00925002|50614378|FG000|Overall Study|Adverse Event|3|||
25299342|NCT00925002|50614379|FG001|Overall Study|Adverse Event|1|||
25299343|NCT00925002|50614380|FG002|Overall Study|Adverse Event|2|||
25299344|NCT00925002|50614378|FG000|Overall Study|Participant withdrew consent|1|||
25299345|NCT00925002|50614379|FG001|Overall Study|Participant withdrew consent|3|||
25299346|NCT00925002|50614380|FG002|Overall Study|Participant withdrew consent|3|||
25299347|NCT00928746|50614389|FG000|Overall Study|Adverse Event|2|||
25299348|NCT00928746|50614389|FG000|Overall Study|Protocol Violation|1|||
25299349|NCT00928746|50614389|FG000|Overall Study|Withdrawal by Subject|1|||
25299350|NCT00928746|50614389|FG000|Overall Study|Other|2|||
25299351|NCT00922428|50614395|FG000|Overall Study|retrospective/extremely implausible data|2|||
25299352|NCT00922428|50614395|FG000|Overall Study|no medication use or questionable use|13|||
25299353|NCT00894543|50614407|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
25299354|NCT00894543|50614408|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
25299355|NCT00894543|50614407|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
25299356|NCT00894543|50614408|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
25299357|NCT00922272|50614414|FG000|Open-label Phase|Adverse Event|5|||
25299358|NCT00922272|50614415|FG001|Open-label Phase|Adverse Event|0|||
25299359|NCT00922272|50614414|FG000|Open-label Phase|Protocol Violation|1|||
25299360|NCT00922272|50614415|FG001|Open-label Phase|Protocol Violation|0|||
25299361|NCT00922272|50614414|FG000|Open-label Phase|Withdrawal by Subject|11|||
25299362|NCT00922272|50614415|FG001|Open-label Phase|Withdrawal by Subject|0|||
25299363|NCT00922272|50614414|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
25299364|NCT00922272|50614415|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
25299365|NCT00922272|50614414|FG000|Open-label Phase|Withdrawal criteria met|5|||
25299366|NCT00922272|50614415|FG001|Open-label Phase|Withdrawal criteria met|0|||
25299367|NCT00922272|50614414|FG000|Double-blind Phase|Adverse Event|1|||
25299368|NCT00922272|50614415|FG001|Double-blind Phase|Adverse Event|1|||
25299369|NCT00922272|50614414|FG000|Double-blind Phase|Withdrawal by Subject|1|||
25299370|NCT00922272|50614415|FG001|Double-blind Phase|Withdrawal by Subject|1|||
25299371|NCT00922272|50614414|FG000|Double-blind Phase|Lost to Follow-up|2|||
25299372|NCT00922272|50614415|FG001|Double-blind Phase|Lost to Follow-up|1|||
25299373|NCT00922272|50614414|FG000|Double-blind Phase|Withdrawal criteria met|1|||
25299374|NCT00922272|50614415|FG001|Double-blind Phase|Withdrawal criteria met|1|||
25299375|NCT00922272|50614414|FG000|Double-blind Phase|Noncompliance|1|||
25299376|NCT00922272|50614415|FG001|Double-blind Phase|Noncompliance|1|||
25299377|NCT00922272|50614414|FG000|Double-blind Phase|Positive urine drug screen|1|||
25299378|NCT00922272|50614415|FG001|Double-blind Phase|Positive urine drug screen|1|||
25299379|NCT00853372|50614425|FG000|Overall Study|Death|30|||
25299380|NCT00853372|50614426|FG001|Overall Study|Death|26|||
25299381|NCT00853372|50614425|FG000|Overall Study|Lost to Follow-up|1|||
25299382|NCT00853372|50614426|FG001|Overall Study|Lost to Follow-up|2|||
25299383|NCT00853372|50614425|FG000|Overall Study|Full Consent Withdrawn|1|||
25299384|NCT00853372|50614426|FG001|Overall Study|Full Consent Withdrawn|1|||
25299385|NCT00848536|50614434|FG000|Overall Study|Adverse Event|2|||
25299386|NCT00848536|50614435|FG001|Overall Study|Adverse Event|2|||
25299387|NCT00848536|50614434|FG000|Overall Study|Withdrawal by Subject|0|||
25299388|NCT00848536|50614435|FG001|Overall Study|Withdrawal by Subject|1|||
25299389|NCT00848536|50614434|FG000|Overall Study|Protocol Violation|0|||
25299390|NCT00848536|50614435|FG001|Overall Study|Protocol Violation|1|||
25299391|NCT00848536|50614434|FG000|Overall Study|Noncompliance|1|||
25299392|NCT00848536|50614435|FG001|Overall Study|Noncompliance|0|||
25299393|NCT00848536|50614434|FG000|Overall Study|Inadequate Control of IOP|1|||
25299394|NCT00848536|50614435|FG001|Overall Study|Inadequate Control of IOP|1|||
25299395|NCT00848536|50614434|FG000|Overall Study|Patient Moved|0|||
25299396|NCT00848536|50614435|FG001|Overall Study|Patient Moved|2|||
25299397|NCT00922116|50614441|FG000|Overall Study|Adverse Event|4|||
25299398|NCT00922116|50614441|FG000|Overall Study|Death|1|||
25299399|NCT00922116|50614441|FG000|Overall Study|Lost to Follow-up|1|||
25299400|NCT00922116|50614441|FG000|Overall Study|Withdrawal by Subject|4|||
25299401|NCT00922116|50614441|FG000|Overall Study|Other|5|||
25299402|NCT00921024|50614447|FG000|Overall Study|Lost to Follow-up|2|||
25299403|NCT00921024|50614448|FG001|Overall Study|Lost to Follow-up|0|||
25299404|NCT00921024|50614447|FG000|Overall Study|Received concomittant therapy|2|||
25299405|NCT00921024|50614448|FG001|Overall Study|Received concomittant therapy|0|||
25299406|NCT00921024|50614447|FG000|Overall Study|Withdrawal by Subject|0|||
25299407|NCT00921024|50614448|FG001|Overall Study|Withdrawal by Subject|3|||
25299408|NCT00928668|50614454|FG000|Overall Study|Adverse Event|1|||
25299409|NCT00928668|50614455|FG001|Overall Study|Adverse Event|0|||
25299410|NCT00928668|50614456|FG002|Overall Study|Adverse Event|0|||
25299411|NCT00928668|50614457|FG003|Overall Study|Adverse Event|0|||
25299412|NCT00928668|50614458|FG004|Overall Study|Adverse Event|0|||
25169360|NCT01831427|50301055|FG003|Overall Study|Investigator's Discretion|1|||
25169361|NCT01831427|50301056|FG004|Overall Study|Investigator's Discretion|0|||
25169362|NCT01831427|50301057|FG005|Overall Study|Investigator's Discretion|0|||
25299413|NCT00928668|50614454|FG000|Overall Study|Protocol Violation|0|||
25299414|NCT00928668|50614455|FG001|Overall Study|Protocol Violation|0|||
25299415|NCT00928668|50614456|FG002|Overall Study|Protocol Violation|0|||
25299416|NCT00928668|50614457|FG003|Overall Study|Protocol Violation|0|||
25299417|NCT00928668|50614458|FG004|Overall Study|Protocol Violation|1|||
25299418|NCT00928668|50614454|FG000|Overall Study|Withdrawal by Subject|0|||
25299419|NCT00928668|50614455|FG001|Overall Study|Withdrawal by Subject|1|||
25299420|NCT00928668|50614456|FG002|Overall Study|Withdrawal by Subject|1|||
25299421|NCT00928668|50614457|FG003|Overall Study|Withdrawal by Subject|0|||
25299422|NCT00928668|50614458|FG004|Overall Study|Withdrawal by Subject|0|||
25299423|NCT00928668|50614454|FG000|Overall Study|Other reasons not listed above|0|||
25299424|NCT00928668|50614455|FG001|Overall Study|Other reasons not listed above|0|||
25299425|NCT00928668|50614456|FG002|Overall Study|Other reasons not listed above|0|||
25299426|NCT00928668|50614457|FG003|Overall Study|Other reasons not listed above|1|||
25299427|NCT00928668|50614458|FG004|Overall Study|Other reasons not listed above|0|||
25299428|NCT00592774|50614480|FG000|Overall Study|Adverse Event|5|||
25299429|NCT00592774|50614481|FG001|Overall Study|Adverse Event|19|||
25299430|NCT00592774|50614482|FG002|Overall Study|Adverse Event|2|||
25299431|NCT00592774|50614483|FG003|Overall Study|Adverse Event|14|||
25299432|NCT00592774|50614484|FG004|Overall Study|Adverse Event|8|||
25299433|NCT00592774|50614480|FG000|Overall Study|Protocol Violation|0|||
25299434|NCT00592774|50614481|FG001|Overall Study|Protocol Violation|1|||
25299435|NCT00592774|50614482|FG002|Overall Study|Protocol Violation|0|||
25299436|NCT00592774|50614483|FG003|Overall Study|Protocol Violation|0|||
25299437|NCT00592774|50614484|FG004|Overall Study|Protocol Violation|1|||
25299438|NCT00592774|50614480|FG000|Overall Study|Withdrawal by Subject|3|||
25299439|NCT00592774|50614481|FG001|Overall Study|Withdrawal by Subject|7|||
25299440|NCT00592774|50614482|FG002|Overall Study|Withdrawal by Subject|0|||
25299441|NCT00592774|50614483|FG003|Overall Study|Withdrawal by Subject|0|||
25299442|NCT00592774|50614484|FG004|Overall Study|Withdrawal by Subject|0|||
25299443|NCT00592774|50614480|FG000|Overall Study|Lack of Efficacy|3|||
25299444|NCT00592774|50614481|FG001|Overall Study|Lack of Efficacy|3|||
25299445|NCT00592774|50614482|FG002|Overall Study|Lack of Efficacy|0|||
25299446|NCT00592774|50614483|FG003|Overall Study|Lack of Efficacy|0|||
25299447|NCT00592774|50614484|FG004|Overall Study|Lack of Efficacy|2|||
25299448|NCT00592774|50614480|FG000|Overall Study|Physician Decision|0|||
25299449|NCT00592774|50614481|FG001|Overall Study|Physician Decision|1|||
25299450|NCT00592774|50614482|FG002|Overall Study|Physician Decision|1|||
25299451|NCT00592774|50614483|FG003|Overall Study|Physician Decision|0|||
25299452|NCT00592774|50614484|FG004|Overall Study|Physician Decision|1|||
25299453|NCT00592774|50614480|FG000|Overall Study|Other|0|||
25299454|NCT00592774|50614481|FG001|Overall Study|Other|1|||
25299455|NCT00592774|50614482|FG002|Overall Study|Other|1|||
25299456|NCT00592774|50614483|FG003|Overall Study|Other|0|||
25299457|NCT00592774|50614484|FG004|Overall Study|Other|2|||
25299458|NCT00837694|50614502|FG000|Overall Study|Lost to Follow-up|2|||
25299459|NCT00837694|50614503|FG001|Overall Study|Lost to Follow-up|0|||
25299460|NCT00837694|50614504|FG002|Overall Study|Lost to Follow-up|2|||
25299461|NCT00837694|50614505|FG003|Overall Study|Lost to Follow-up|1|||
25299462|NCT00837694|50614506|FG004|Overall Study|Lost to Follow-up|1|||
25299463|NCT00837694|50614507|FG005|Overall Study|Lost to Follow-up|1|||
25299464|NCT00852202|50614524|FG000|Overall Study|Adverse Event|2|||
25299465|NCT00852202|50614525|FG001|Overall Study|Adverse Event|3|||
25299466|NCT00852202|50614526|FG002|Overall Study|Adverse Event|7|||
25299467|NCT00852202|50614524|FG000|Overall Study|Lack of Efficacy|4|||
25299468|NCT00852202|50614525|FG001|Overall Study|Lack of Efficacy|1|||
25299469|NCT00852202|50614526|FG002|Overall Study|Lack of Efficacy|2|||
25299470|NCT00852202|50614524|FG000|Overall Study|Protocol Violation|2|||
25299471|NCT00852202|50614525|FG001|Overall Study|Protocol Violation|2|||
25299472|NCT00852202|50614526|FG002|Overall Study|Protocol Violation|7|||
25299473|NCT00852202|50614524|FG000|Overall Study|Withdrawal by Subject|3|||
25299474|NCT00852202|50614525|FG001|Overall Study|Withdrawal by Subject|1|||
25070852|NCT02704143|50176919|FG000|Overall Study|disease progression|10|||
25070853|NCT02586506|50176923|FG000|Overall Study|Protocol Violation|6|||
25070854|NCT02586506|50176923|FG000|Overall Study|Lost to Follow-up|1|||
25299475|NCT00852202|50614526|FG002|Overall Study|Withdrawal by Subject|2|||
25299476|NCT00852202|50614524|FG000|Overall Study|Lost to Follow-up|5|||
25299477|NCT00852202|50614525|FG001|Overall Study|Lost to Follow-up|5|||
25299478|NCT00852202|50614526|FG002|Overall Study|Lost to Follow-up|6|||
25299479|NCT00852202|50614524|FG000|Overall Study|pregnancy,moving away and surgery|1|||
25299480|NCT00852202|50614525|FG001|Overall Study|pregnancy,moving away and surgery|0|||
25299481|NCT00852202|50614526|FG002|Overall Study|pregnancy,moving away and surgery|2|||
25299482|NCT01074008|50614544|FG000|Overall Study|Adverse Event|0|||
25299483|NCT01074008|50614545|FG001|Overall Study|Adverse Event|1|||
25299484|NCT01074008|50614546|FG002|Overall Study|Adverse Event|0|||
25299485|NCT01074008|50614547|FG003|Overall Study|Adverse Event|0|||
25299486|NCT01074008|50614548|FG004|Overall Study|Adverse Event|0|||
25299487|NCT01074008|50614549|FG005|Overall Study|Adverse Event|0|||
25299488|NCT01074008|50614550|FG006|Overall Study|Adverse Event|0|||
25299489|NCT01074008|50614551|FG007|Overall Study|Adverse Event|0|||
25299490|NCT01074008|50614552|FG008|Overall Study|Adverse Event|0|||
25299491|NCT01074008|50614544|FG000|Overall Study|Withdrawal by Subject|1|||
25299492|NCT01074008|50614545|FG001|Overall Study|Withdrawal by Subject|1|||
25299493|NCT01074008|50614546|FG002|Overall Study|Withdrawal by Subject|1|||
25070855|NCT02586506|50176923|FG000|Overall Study|Other Reason|2|||
25070856|NCT00109031|50176931|FG000|Overall Study|Adverse Event|0|||
25070857|NCT00109031|50176932|FG001|Overall Study|Adverse Event|0|||
25070858|NCT00109031|50176933|FG002|Overall Study|Adverse Event|1|||
25070859|NCT00109031|50176934|FG003|Overall Study|Adverse Event|0|||
25070860|NCT00109031|50176931|FG000|Overall Study|Withdrawal by Subject|0|||
25070861|NCT00109031|50176932|FG001|Overall Study|Withdrawal by Subject|1|||
25070862|NCT00109031|50176933|FG002|Overall Study|Withdrawal by Subject|0|||
25070863|NCT00109031|50176934|FG003|Overall Study|Withdrawal by Subject|0|||
25070864|NCT00109031|50176931|FG000|Overall Study|Physician Decision|0|||
25070865|NCT00109031|50176932|FG001|Overall Study|Physician Decision|1|||
25070866|NCT00109031|50176933|FG002|Overall Study|Physician Decision|0|||
25070867|NCT00109031|50176934|FG003|Overall Study|Physician Decision|0|||
25070868|NCT00109031|50176931|FG000|Overall Study|Protocol Violation|0|||
25070869|NCT00109031|50176932|FG001|Overall Study|Protocol Violation|0|||
25070870|NCT00109031|50176933|FG002|Overall Study|Protocol Violation|1|||
25070871|NCT00109031|50176934|FG003|Overall Study|Protocol Violation|0|||
25070872|NCT01664624|50176948|FG000|Overall Study|Adverse Event|0|||
25070873|NCT01664624|50176949|FG001|Overall Study|Adverse Event|1|||
25070874|NCT01664624|50176950|FG002|Overall Study|Adverse Event|0|||
25070875|NCT01664624|50176951|FG003|Overall Study|Adverse Event|0|||
25070876|NCT02702193|50176963|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
25070877|NCT02702193|50176964|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
25169363|NCT01831427|50301058|FG006|Overall Study|Investigator's Discretion|0|||
25299494|NCT01074008|50614547|FG003|Overall Study|Withdrawal by Subject|0|||
25299495|NCT01074008|50614548|FG004|Overall Study|Withdrawal by Subject|1|||
25299496|NCT01074008|50614549|FG005|Overall Study|Withdrawal by Subject|0|||
25299497|NCT01074008|50614550|FG006|Overall Study|Withdrawal by Subject|0|||
25070878|NCT02702193|50176963|FG000|4 Month Follow up|Withdrawal by Subject|1|||
25070879|NCT02702193|50176964|FG001|4 Month Follow up|Withdrawal by Subject|0|||
25299498|NCT01074008|50614551|FG007|Overall Study|Withdrawal by Subject|0|||
25299499|NCT01074008|50614552|FG008|Overall Study|Withdrawal by Subject|0|||
25070880|NCT02702193|50176963|FG000|4 Month Follow up|Lost to Follow-up|17|||
25299500|NCT01074008|50614544|FG000|Overall Study|Lost to Follow-up|0|||
25299501|NCT01074008|50614545|FG001|Overall Study|Lost to Follow-up|1|||
25070881|NCT02702193|50176964|FG001|4 Month Follow up|Lost to Follow-up|18|||
25070882|NCT02702193|50176963|FG000|8 Month Follow up|Withdrawal by Subject|1|||
25299502|NCT01074008|50614546|FG002|Overall Study|Lost to Follow-up|1|||
25299503|NCT01074008|50614547|FG003|Overall Study|Lost to Follow-up|1|||
25299504|NCT01074008|50614548|FG004|Overall Study|Lost to Follow-up|1|||
25299505|NCT01074008|50614549|FG005|Overall Study|Lost to Follow-up|0|||
25299506|NCT01074008|50614550|FG006|Overall Study|Lost to Follow-up|1|||
25299507|NCT01074008|50614551|FG007|Overall Study|Lost to Follow-up|0|||
25299508|NCT01074008|50614552|FG008|Overall Study|Lost to Follow-up|4|||
25299509|NCT01073930|50614583|FG000|Overall Study|Withdrawal by Subject|3|||
25299510|NCT01073930|50614584|FG001|Overall Study|Withdrawal by Subject|2|||
25299511|NCT01073930|50614583|FG000|Overall Study|Lost to Follow-up|0|||
25299512|NCT01073930|50614584|FG001|Overall Study|Lost to Follow-up|1|||
25299513|NCT01073930|50614583|FG000|Overall Study|Adverse Event|0|||
25299514|NCT01073930|50614584|FG001|Overall Study|Adverse Event|1|||
25299515|NCT01073930|50614583|FG000|Overall Study|Noncompliance with study drug|0|||
25299516|NCT01073930|50614584|FG001|Overall Study|Noncompliance with study drug|1|||
25299517|NCT01073930|50614583|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
25299518|NCT01073930|50614584|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
25299519|NCT01073618|50614590|FG000|Overall Study|Death|208|||
25299520|NCT01073618|50614590|FG000|Overall Study|Adverse Event|19|||
25299521|NCT01073618|50614590|FG000|Overall Study|Other|80|||
25299522|NCT01073462|50614594|FG000|Overall Study|Death|14|||
25299523|NCT01073462|50614594|FG000|Overall Study|Kidney transplant|10|||
25299524|NCT01073462|50614594|FG000|Overall Study|Low parathyroid hormone levels|8|||
25299525|NCT01073462|50614594|FG000|Overall Study|Serious adverse event|2|||
25299526|NCT01073462|50614594|FG000|Overall Study|Lost to Follow-up|7|||
25299527|NCT00789373|50614598|FG000|Induction|Adverse Event|64|||
25299528|NCT00789373|50614599|FG001|Induction|Adverse Event|0|||
25070883|NCT02702193|50176964|FG001|8 Month Follow up|Withdrawal by Subject|0|||
25299529|NCT00789373|50614600|FG002|Induction|Adverse Event|0|||
25299530|NCT00789373|50614598|FG000|Induction|Death Due to study disease|24|||
25070884|NCT02702193|50176963|FG000|8 Month Follow up|Lost to Follow-up|14|||
25299531|NCT00789373|50614599|FG001|Induction|Death Due to study disease|0|||
25299532|NCT00789373|50614600|FG002|Induction|Death Due to study disease|0|||
25299533|NCT00789373|50614598|FG000|Induction|Death due to adverse event|19|||
25299534|NCT00789373|50614599|FG001|Induction|Death due to adverse event|0|||
25299535|NCT00789373|50614600|FG002|Induction|Death due to adverse event|0|||
25299536|NCT00789373|50614598|FG000|Induction|Death due to toxicity|11|||
25299537|NCT00789373|50614599|FG001|Induction|Death due to toxicity|0|||
25299538|NCT00789373|50614600|FG002|Induction|Death due to toxicity|0|||
25299539|NCT00789373|50614598|FG000|Induction|Death due to procedure|1|||
25299540|NCT00789373|50614599|FG001|Induction|Death due to procedure|0|||
25299541|NCT00789373|50614600|FG002|Induction|Death due to procedure|0|||
25299542|NCT00789373|50614598|FG000|Induction|Investigator decision|7|||
25299543|NCT00789373|50614599|FG001|Induction|Investigator decision|0|||
25299544|NCT00789373|50614600|FG002|Induction|Investigator decision|0|||
25299545|NCT00789373|50614598|FG000|Induction|Protocol entry criteria not met|9|||
25299546|NCT00789373|50614599|FG001|Induction|Protocol entry criteria not met|0|||
25299547|NCT00789373|50614600|FG002|Induction|Protocol entry criteria not met|0|||
25299548|NCT00789373|50614598|FG000|Induction|Lost to Follow-up|6|||
25299549|NCT00789373|50614599|FG001|Induction|Lost to Follow-up|0|||
25299550|NCT00789373|50614600|FG002|Induction|Lost to Follow-up|0|||
25299551|NCT00789373|50614598|FG000|Induction|Protocol Violation|1|||
25299552|NCT00789373|50614599|FG001|Induction|Protocol Violation|0|||
25299553|NCT00789373|50614600|FG002|Induction|Protocol Violation|0|||
25299554|NCT00789373|50614598|FG000|Induction|Progressive Disease|220|||
25299555|NCT00789373|50614599|FG001|Induction|Progressive Disease|0|||
25299556|NCT00789373|50614600|FG002|Induction|Progressive Disease|0|||
25299557|NCT00789373|50614598|FG000|Induction|Withdrawal by Subject|37|||
25299558|NCT00789373|50614599|FG001|Induction|Withdrawal by Subject|0|||
25299559|NCT00789373|50614600|FG002|Induction|Withdrawal by Subject|0|||
25299560|NCT00789373|50614598|FG000|Maintenance|Adverse Event|0|||
25299561|NCT00789373|50614599|FG001|Maintenance|Adverse Event|65|||
25299562|NCT00789373|50614600|FG002|Maintenance|Adverse Event|12|||
25299563|NCT00789373|50614598|FG000|Maintenance|Death due to study disease|0|||
25299564|NCT00789373|50614599|FG001|Maintenance|Death due to study disease|3|||
25299565|NCT00789373|50614600|FG002|Maintenance|Death due to study disease|1|||
25299566|NCT00789373|50614598|FG000|Maintenance|Death due to adverse event|0|||
25299567|NCT00789373|50614599|FG001|Maintenance|Death due to adverse event|4|||
25299568|NCT00789373|50614600|FG002|Maintenance|Death due to adverse event|1|||
25299569|NCT00789373|50614598|FG000|Maintenance|Death due to toxicity|0|||
25299570|NCT00789373|50614599|FG001|Maintenance|Death due to toxicity|1|||
25299571|NCT00789373|50614600|FG002|Maintenance|Death due to toxicity|2|||
25299572|NCT00789373|50614598|FG000|Maintenance|Investigator Decision|0|||
25299573|NCT00789373|50614599|FG001|Maintenance|Investigator Decision|4|||
25299574|NCT00789373|50614600|FG002|Maintenance|Investigator Decision|2|||
25299575|NCT00789373|50614598|FG000|Maintenance|Protocol entry criteria not met|0|||
25299576|NCT00789373|50614599|FG001|Maintenance|Protocol entry criteria not met|2|||
25299577|NCT00789373|50614600|FG002|Maintenance|Protocol entry criteria not met|0|||
25299578|NCT00789373|50614598|FG000|Maintenance|Lost to Follow-up|0|||
25299579|NCT00789373|50614599|FG001|Maintenance|Lost to Follow-up|2|||
25299580|NCT00789373|50614600|FG002|Maintenance|Lost to Follow-up|0|||
25299581|NCT00789373|50614598|FG000|Maintenance|Progressive Disease|0|||
25299582|NCT00789373|50614599|FG001|Maintenance|Progressive Disease|253|||
25299583|NCT00789373|50614600|FG002|Maintenance|Progressive Disease|152|||
25299584|NCT00789373|50614598|FG000|Maintenance|Withdrawal by Subject|0|||
25299585|NCT00789373|50614599|FG001|Maintenance|Withdrawal by Subject|21|||
25299586|NCT00789373|50614600|FG002|Maintenance|Withdrawal by Subject|8|||
25299587|NCT00789373|50614598|FG000|Maintenance|Sponsor Decision|0|||
25299588|NCT00789373|50614599|FG001|Maintenance|Sponsor Decision|0|||
25299589|NCT00789373|50614600|FG002|Maintenance|Sponsor Decision|2|||
25299590|NCT00789373|50614598|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
25299591|NCT00789373|50614599|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
25299592|NCT00789373|50614600|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
25299593|NCT00851890|50614615|FG000|Overall Study|Lost to Follow-up|0|||
25299594|NCT00851890|50614616|FG001|Overall Study|Lost to Follow-up|1|||
25299595|NCT00851890|50614617|FG002|Overall Study|Lost to Follow-up|0|||
25299596|NCT00851890|50614618|FG003|Overall Study|Lost to Follow-up|1|||
25299597|NCT00788827|50614628|FG000|Overall Study|Lack of Efficacy|2|||
25299598|NCT00592072|50614634|FG000|Wash Out Period|Lost to Follow-up|1|||
25299599|NCT00592072|50614635|FG001|Wash Out Period|Lost to Follow-up|1|||
25299600|NCT00792571|50614641|FG000|Overall Study|Death|1|||
25299601|NCT00792571|50614641|FG000|Overall Study|Adverse Event|4|||
25299602|NCT00792571|50614641|FG000|Overall Study|Withdrawal by Subject|1|||
25299603|NCT00792571|50614641|FG000|Overall Study|Other|4|||
25299604|NCT01069484|50614647|FG000|Overall Study|Death-in-near-family|1|||
25299605|NCT01069484|50614648|FG001|Overall Study|Death-in-near-family|0|||
25299606|NCT01069484|50614647|FG000|Overall Study|No specific reason|8|||
25299607|NCT01069484|50614648|FG001|Overall Study|No specific reason|2|||
25299608|NCT01069484|50614647|FG000|Overall Study|Illness mother or child|3|||
25299609|NCT01069484|50614648|FG001|Overall Study|Illness mother or child|1|||
25299610|NCT00794365|50614655|FG000|Overall Study|Lost to Follow-up|38|||
25299611|NCT00794365|50614655|FG000|Overall Study|Other|17|||
25299612|NCT00794365|50614655|FG000|Overall Study|Poor Compliance|11|||
25299613|NCT00794365|50614655|FG000|Overall Study|Adverse Event|10|||
25299614|NCT00794365|50614655|FG000|Overall Study|Lack of Efficacy|3|||
25299615|NCT01067144|50614661|FG000|Treatment|Did not receive allocated intervention|4|||
25299616|NCT01067144|50614662|FG001|Treatment|Did not receive allocated intervention|7|||
25299617|NCT01067144|50614661|FG000|Follow-up|Lost to Follow-up|22|||
25299618|NCT01067144|50614662|FG001|Follow-up|Lost to Follow-up|12|||
25299619|NCT01067144|50614661|FG000|Follow-up|Censored owing to second surgery|19|||
25299620|NCT01067144|50614662|FG001|Follow-up|Censored owing to second surgery|28|||
25299621|NCT01067144|50614661|FG000|Follow-up|Withdrawal by Subject|18|||
25299622|NCT01067144|50614662|FG001|Follow-up|Withdrawal by Subject|14|||
25299623|NCT01067144|50614661|FG000|Follow-up|Surgery cancelled|0|||
25299624|NCT01067144|50614662|FG001|Follow-up|Surgery cancelled|1|||
25299625|NCT01067144|50614661|FG000|Follow-up|Death|0|||
25299626|NCT01067144|50614662|FG001|Follow-up|Death|1|||
25299627|NCT01078298|50614670|FG000|Overall Study|Lost to Follow-up|12|||
25299628|NCT01078298|50614671|FG001|Overall Study|Lost to Follow-up|13|||
25299629|NCT01078298|50614670|FG000|Overall Study|Withdrawal by Subject|31|||
25299630|NCT01078298|50614671|FG001|Overall Study|Withdrawal by Subject|33|||
25299631|NCT01078298|50614670|FG000|Overall Study|Protocol Violation|6|||
25299632|NCT01078298|50614671|FG001|Overall Study|Protocol Violation|6|||
25299633|NCT01078298|50614670|FG000|Overall Study|Adverse Event|6|||
25299634|NCT01078298|50614671|FG001|Overall Study|Adverse Event|5|||
25299635|NCT01078298|50614670|FG000|Overall Study|Death|2|||
25299636|NCT01078298|50614671|FG001|Overall Study|Death|0|||
25299637|NCT01078298|50614670|FG000|Overall Study|Did not meet entrance criteria|0|||
25299638|NCT01078298|50614671|FG001|Overall Study|Did not meet entrance criteria|1|||
25299639|NCT01078298|50614670|FG000|Overall Study|Other|24|||
25299640|NCT01078298|50614671|FG001|Overall Study|Other|32|||
25299641|NCT00788593|50614677|FG000|Placebo Run-in Phase|Adverse Event|2|||
25299642|NCT00788593|50614678|FG001|Placebo Run-in Phase|Adverse Event|0|||
25299643|NCT00788593|50614679|FG002|Placebo Run-in Phase|Adverse Event|0|||
25299644|NCT00788593|50614677|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
25299645|NCT00788593|50614678|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
25299646|NCT00788593|50614679|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
25299647|NCT00788593|50614677|FG000|Placebo Run-in Phase|Protocol Violation|2|||
25299648|NCT00788593|50614678|FG001|Placebo Run-in Phase|Protocol Violation|0|||
25299649|NCT00788593|50614679|FG002|Placebo Run-in Phase|Protocol Violation|0|||
25299650|NCT00788593|50614677|FG000|First Intervention Period|Adverse Event|0|||
25299651|NCT00788593|50614678|FG001|First Intervention Period|Adverse Event|1|||
25299652|NCT00788593|50614679|FG002|First Intervention Period|Adverse Event|0|||
25299653|NCT00788593|50614677|FG000|Second Intervention Period|Lost to Follow-up|0|||
25299654|NCT00788593|50614678|FG001|Second Intervention Period|Lost to Follow-up|1|||
25299655|NCT00788593|50614679|FG002|Second Intervention Period|Lost to Follow-up|0|||
25299656|NCT00788593|50614677|FG000|Second Intervention Period|Other|0|||
25299657|NCT00788593|50614678|FG001|Second Intervention Period|Other|0|||
25299658|NCT00788593|50614679|FG002|Second Intervention Period|Other|1|||
25299659|NCT00793819|50614691|FG000|Overall Study|Adverse Event|8|||
25299660|NCT00793819|50614692|FG001|Overall Study|Adverse Event|4|||
25299661|NCT00793819|50614691|FG000|Overall Study|Lack of Efficacy|1|||
25299662|NCT00793819|50614692|FG001|Overall Study|Lack of Efficacy|1|||
25299663|NCT00793819|50614691|FG000|Overall Study|Withdrawal by Subject|4|||
25299664|NCT00793819|50614692|FG001|Overall Study|Withdrawal by Subject|3|||
25299665|NCT00793819|50614691|FG000|Overall Study|Lost to Follow-up|1|||
25299666|NCT00793819|50614692|FG001|Overall Study|Lost to Follow-up|1|||
25299667|NCT00792259|50614701|FG000|Overall Study|Poor Quality Scans|1|||
25299668|NCT00792259|50614702|FG001|Overall Study|Poor Quality Scans|0|||
25299669|NCT00792259|50614703|FG002|Overall Study|Poor Quality Scans|0|||
25299670|NCT00894387|50614713|FG000|Overall Study|Adverse Event|44|||
25299671|NCT00894387|50614714|FG001|Overall Study|Adverse Event|45|||
25299672|NCT00894387|50614713|FG000|Overall Study|Abnormal Laboratory values|2|||
25299673|NCT00894387|50614714|FG001|Overall Study|Abnormal Laboratory values|2|||
25299674|NCT00894387|50614713|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25299675|NCT00894387|50614714|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
25299676|NCT00894387|50614713|FG000|Overall Study|Lost to Follow-up|3|||
25299677|NCT00894387|50614714|FG001|Overall Study|Lost to Follow-up|5|||
25299678|NCT00894387|50614713|FG000|Overall Study|Administrative problems|2|||
25299679|NCT00894387|50614714|FG001|Overall Study|Administrative problems|2|||
25169364|NCT01831427|50301059|FG007|Overall Study|Investigator's Discretion|0|||
25299680|NCT00894387|50614713|FG000|Overall Study|Death|77|||
25299681|NCT00894387|50614714|FG001|Overall Study|Death|76|||
25299682|NCT00894387|50614713|FG000|Overall Study|Protocol Deviation|4|||
25299683|NCT00894387|50614714|FG001|Overall Study|Protocol Deviation|0|||
25299684|NCT00894387|50614713|FG000|Overall Study|Patient's request|25|||
25299685|NCT00894387|50614714|FG001|Overall Study|Patient's request|30|||
25299686|NCT00894387|50614713|FG000|Overall Study|Other (Missing)|5|||
25299687|NCT00894387|50614714|FG001|Overall Study|Other (Missing)|3|||
25299688|NCT00894387|50614713|FG000|Overall Study|Mis-randomized|13|||
25299689|NCT00894387|50614714|FG001|Overall Study|Mis-randomized|9|||
25299690|NCT00894387|50614713|FG000|Overall Study|GCP non-compliance|0|||
25299691|NCT00894387|50614714|FG001|Overall Study|GCP non-compliance|2|||
25299692|NCT00928512|50614725|FG000|Overall Study|Adverse Event|4|||
25299693|NCT00928512|50614726|FG001|Overall Study|Adverse Event|3|||
25299694|NCT00928512|50614727|FG002|Overall Study|Adverse Event|2|||
25299695|NCT00928512|50614728|FG003|Overall Study|Adverse Event|8|||
25299696|NCT00928512|50614729|FG004|Overall Study|Adverse Event|6|||
25299697|NCT00928512|50614725|FG000|Overall Study|Lack of Efficacy|2|||
25299698|NCT00928512|50614726|FG001|Overall Study|Lack of Efficacy|0|||
25299699|NCT00928512|50614727|FG002|Overall Study|Lack of Efficacy|4|||
25299700|NCT00928512|50614728|FG003|Overall Study|Lack of Efficacy|7|||
25299701|NCT00928512|50614729|FG004|Overall Study|Lack of Efficacy|3|||
25299702|NCT00928512|50614725|FG000|Overall Study|Protocol Violation|0|||
25299703|NCT00928512|50614726|FG001|Overall Study|Protocol Violation|1|||
25299704|NCT00928512|50614727|FG002|Overall Study|Protocol Violation|0|||
25299705|NCT00928512|50614728|FG003|Overall Study|Protocol Violation|1|||
25299706|NCT00928512|50614729|FG004|Overall Study|Protocol Violation|3|||
25299707|NCT00928512|50614725|FG000|Overall Study|Withdrawal by Subject|3|||
25299708|NCT00928512|50614726|FG001|Overall Study|Withdrawal by Subject|0|||
25299709|NCT00928512|50614727|FG002|Overall Study|Withdrawal by Subject|3|||
25299710|NCT00928512|50614728|FG003|Overall Study|Withdrawal by Subject|4|||
25299711|NCT00928512|50614729|FG004|Overall Study|Withdrawal by Subject|0|||
25299712|NCT00928512|50614725|FG000|Overall Study|Lost to Follow-up|1|||
25299713|NCT00928512|50614726|FG001|Overall Study|Lost to Follow-up|1|||
25299714|NCT00928512|50614727|FG002|Overall Study|Lost to Follow-up|2|||
25299715|NCT00928512|50614728|FG003|Overall Study|Lost to Follow-up|1|||
25299716|NCT00928512|50614729|FG004|Overall Study|Lost to Follow-up|3|||
25299717|NCT00928512|50614725|FG000|Overall Study|Administrative Problems|0|||
25299718|NCT00928512|50614726|FG001|Overall Study|Administrative Problems|1|||
25299719|NCT00928512|50614727|FG002|Overall Study|Administrative Problems|0|||
25299720|NCT00928512|50614728|FG003|Overall Study|Administrative Problems|0|||
25299721|NCT00928512|50614729|FG004|Overall Study|Administrative Problems|0|||
25299722|NCT00787891|50614747|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
25299723|NCT00787891|50614748|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
25299724|NCT00787891|50614747|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
25299725|NCT00787891|50614748|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
25299726|NCT00787891|50614747|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
25299727|NCT00787891|50614748|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
25299728|NCT00787891|50614747|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
25299729|NCT00787891|50614748|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
25299730|NCT00787891|50614747|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
25299731|NCT00787891|50614748|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
25299732|NCT00787891|50614747|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
25299733|NCT00787891|50614748|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
25299734|NCT00787891|50614747|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
25299735|NCT00787891|50614748|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
25299736|NCT00787891|50614747|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
25299737|NCT00787891|50614748|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
25299738|NCT00787891|50614747|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
25299739|NCT00787891|50614748|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
25299740|NCT00787891|50614747|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
25299741|NCT00787891|50614748|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
25299742|NCT00892437|50614758|FG000|Randomized Phase|Randomized but not treated|6|||
25299743|NCT00892437|50614759|FG001|Randomized Phase|Randomized but not treated|0|||
25299744|NCT00892437|50614758|FG000|Randomized Phase|Adverse Event|2|||
25299745|NCT00892437|50614759|FG001|Randomized Phase|Adverse Event|2|||
25299746|NCT00892437|50614758|FG000|Randomized Phase|Lost to Follow-up|1|||
25299747|NCT00892437|50614759|FG001|Randomized Phase|Lost to Follow-up|3|||
25299748|NCT00892437|50614758|FG000|Randomized Phase|Investigator's Discretion|1|||
25299749|NCT00892437|50614759|FG001|Randomized Phase|Investigator's Discretion|0|||
25299750|NCT00892437|50614758|FG000|Randomized Phase|Withdrew Consent|1|||
25299751|NCT00892437|50614759|FG001|Randomized Phase|Withdrew Consent|0|||
25299752|NCT00892437|50614758|FG000|Open-Label Extension Phase|Adverse Event|4|||
25299753|NCT00892437|50614759|FG001|Open-Label Extension Phase|Adverse Event|2|||
25299754|NCT00892437|50614758|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
25299755|NCT00892437|50614759|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
25299756|NCT00892437|50614758|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
25299757|NCT00892437|50614759|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
25299758|NCT00892437|50614758|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
25299759|NCT00892437|50614759|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
25299760|NCT00892437|50614758|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
25299761|NCT00892437|50614759|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
25299762|NCT00792103|50614766|FG000|Overall Study|Enrolled, not treated|15|||
25299763|NCT00792103|50614766|FG000|Overall Study|Lost to Follow-up|17|||
25299764|NCT00792103|50614766|FG000|Overall Study|Adverse Event|25|||
25299765|NCT00792103|50614766|FG000|Overall Study|Withdrawal by Subject|52|||
25299766|NCT00792103|50614766|FG000|Overall Study|Protocol Violation|10|||
25299767|NCT00792103|50614766|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
25299768|NCT00892281|50614772|FG000|Overall Study|Adverse Event|65|||
25299769|NCT00892281|50614773|FG001|Overall Study|Adverse Event|8|||
25299770|NCT00892281|50614772|FG000|Overall Study|Lost to Follow-up|81|||
25299771|NCT00892281|50614773|FG001|Overall Study|Lost to Follow-up|8|||
25299772|NCT00892281|50614772|FG000|Overall Study|Pregnancy|1|||
25299773|NCT00892281|50614773|FG001|Overall Study|Pregnancy|0|||
25299774|NCT00892281|50614772|FG000|Overall Study|Protocol Violation|7|||
25299775|NCT00892281|50614773|FG001|Overall Study|Protocol Violation|2|||
25299776|NCT00892281|50614772|FG000|Overall Study|Withdrawal by Subject|86|||
25299777|NCT00892281|50614773|FG001|Overall Study|Withdrawal by Subject|14|||
25299778|NCT00892281|50614772|FG000|Overall Study|Subject failed to return for final visit|2|||
25299779|NCT00892281|50614773|FG001|Overall Study|Subject failed to return for final visit|0|||
25299780|NCT00892281|50614772|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
25299781|NCT00892281|50614773|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
25299782|NCT00892281|50614772|FG000|Overall Study|Final visit completed 4 weeks late|0|||
25299783|NCT00892281|50614773|FG001|Overall Study|Final visit completed 4 weeks late|1|||
25299784|NCT00892281|50614772|FG000|Overall Study|Subject completed day after study closed|1|||
25299785|NCT00892281|50614773|FG001|Overall Study|Subject completed day after study closed|0|||
25299786|NCT00892281|50614772|FG000|Overall Study|Family emergency|1|||
25299787|NCT00892281|50614773|FG001|Overall Study|Family emergency|0|||
25299788|NCT00892281|50614772|FG000|Overall Study|Last visit not done - death in family|1|||
25299789|NCT00892281|50614773|FG001|Overall Study|Last visit not done - death in family|0|||
25299790|NCT00892281|50614772|FG000|Overall Study|Did not meet incl/excl criteria|1|||
25299791|NCT00892281|50614773|FG001|Overall Study|Did not meet incl/excl criteria|0|||
25299792|NCT00892281|50614772|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
25299793|NCT00892281|50614773|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
25299794|NCT00892281|50614772|FG000|Overall Study|Unable to redeem the drug voucher|1|||
25299795|NCT00892281|50614773|FG001|Overall Study|Unable to redeem the drug voucher|0|||
25299796|NCT00892281|50614772|FG000|Overall Study|Subject not good candidate for study|1|||
25299797|NCT00892281|50614773|FG001|Overall Study|Subject not good candidate for study|0|||
25299798|NCT00892281|50614772|FG000|Overall Study|Subject did not return for any visits|1|||
25299799|NCT00892281|50614773|FG001|Overall Study|Subject did not return for any visits|0|||
25299800|NCT00892281|50614772|FG000|Overall Study|Subject missed several visits/lost meds|1|||
25299801|NCT00892281|50614773|FG001|Overall Study|Subject missed several visits/lost meds|0|||
25299802|NCT00892281|50614772|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
25299803|NCT00892281|50614773|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
25299804|NCT00892281|50614772|FG000|Overall Study|Scheduled for knee replacement|0|||
25299805|NCT00892281|50614773|FG001|Overall Study|Scheduled for knee replacement|1|||
25299806|NCT00892281|50614772|FG000|Overall Study|PI complained of inadequate compensation|3|||
25299807|NCT00892281|50614773|FG001|Overall Study|PI complained of inadequate compensation|0|||
25299808|NCT00892281|50614772|FG000|Overall Study|Subject lost interest in program|0|||
25299809|NCT00892281|50614773|FG001|Overall Study|Subject lost interest in program|1|||
25299810|NCT00892281|50614772|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
25299811|NCT00892281|50614773|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
25299812|NCT00892281|50614772|FG000|Overall Study|Death in family|1|||
25299813|NCT00892281|50614773|FG001|Overall Study|Death in family|0|||
25299814|NCT00892281|50614772|FG000|Overall Study|Lack of efficacy of study product|2|||
25299815|NCT00892281|50614773|FG001|Overall Study|Lack of efficacy of study product|0|||
25299816|NCT00892281|50614772|FG000|Overall Study|Subject not seen by PI at final visit|1|||
25299817|NCT00892281|50614773|FG001|Overall Study|Subject not seen by PI at final visit|0|||
25299818|NCT00892281|50614772|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
25299819|NCT00892281|50614773|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
25299820|NCT00892281|50614772|FG000|Overall Study|Missed multiple visits|1|||
25299821|NCT00892281|50614773|FG001|Overall Study|Missed multiple visits|0|||
25299822|NCT00892281|50614772|FG000|Overall Study|Missed visits rescheduled out of window|1|||
25299823|NCT00892281|50614773|FG001|Overall Study|Missed visits rescheduled out of window|0|||
25299824|NCT00892281|50614772|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
25299825|NCT00892281|50614773|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
25299826|NCT00892281|50614772|FG000|Overall Study|Subject had history of drug abuse|1|||
25299827|NCT00892281|50614773|FG001|Overall Study|Subject had history of drug abuse|0|||
25299828|NCT00892281|50614772|FG000|Overall Study|Rash on hand|1|||
25299829|NCT00892281|50614773|FG001|Overall Study|Rash on hand|0|||
25299830|NCT00892281|50614772|FG000|Overall Study|Visit 4 date out of window|1|||
25299831|NCT00892281|50614773|FG001|Overall Study|Visit 4 date out of window|0|||
25299832|NCT00784693|50614781|FG000|Overall Study|Lost to Follow-up|0|||
25299833|NCT00784693|50614782|FG001|Overall Study|Lost to Follow-up|1|||
25299834|NCT00784693|50614781|FG000|Overall Study|Lack of Efficacy|1|||
25299835|NCT00784693|50614782|FG001|Overall Study|Lack of Efficacy|1|||
25299836|NCT00784693|50614781|FG000|Overall Study|Withdrawal by Subject|0|||
25299837|NCT00784693|50614782|FG001|Overall Study|Withdrawal by Subject|4|||
25299838|NCT00784693|50614781|FG000|Overall Study|Randomized but not Treated|1|||
25299839|NCT00784693|50614782|FG001|Overall Study|Randomized but not Treated|0|||
25299840|NCT00784693|50614781|FG000|Overall Study|Other|1|||
25299841|NCT00784693|50614782|FG001|Overall Study|Other|0|||
25299842|NCT00893763|50614790|FG000|Overall Study|extubated|110|||
25299843|NCT00893763|50614791|FG001|Overall Study|extubated|110|||
25299844|NCT00892047|50614801|FG000|Overall Study|Adverse Event|2|||
25299845|NCT00892047|50614802|FG001|Overall Study|Adverse Event|2|||
25299846|NCT00892047|50614801|FG000|Overall Study|subject burden|2|||
25299847|NCT00892047|50614802|FG001|Overall Study|subject burden|3|||
25299848|NCT00892047|50614801|FG000|Overall Study|Lack of Efficacy|0|||
25299849|NCT00892047|50614802|FG001|Overall Study|Lack of Efficacy|2|||
25299850|NCT00787267|50614810|FG000|Overall Study|Screen failure/Ineligible|10|||
25299851|NCT00787267|50614810|FG000|Overall Study|No Reason Provided|1|||
25299852|NCT00787267|50614810|FG000|Overall Study|Withdrawal by Subject|1|||
25299853|NCT00928434|50614817|FG000|Overall Study|Adverse Event|14|||
25299854|NCT00928434|50614818|FG001|Overall Study|Adverse Event|5|||
25299855|NCT00928434|50614819|FG002|Overall Study|Adverse Event|18|||
25299856|NCT00928434|50614817|FG000|Overall Study|Protocol Violation|5|||
25299857|NCT00928434|50614818|FG001|Overall Study|Protocol Violation|0|||
25299858|NCT00928434|50614819|FG002|Overall Study|Protocol Violation|8|||
25299859|NCT00928434|50614817|FG000|Overall Study|Physician Decision|2|||
25299860|NCT00928434|50614818|FG001|Overall Study|Physician Decision|0|||
25299861|NCT00928434|50614819|FG002|Overall Study|Physician Decision|3|||
25299862|NCT00928434|50614817|FG000|Overall Study|Lost to Follow-up|1|||
25299863|NCT00928434|50614818|FG001|Overall Study|Lost to Follow-up|0|||
25299864|NCT00928434|50614819|FG002|Overall Study|Lost to Follow-up|3|||
25299865|NCT00928434|50614817|FG000|Overall Study|Withdrawal by Subject|5|||
25299866|NCT00928434|50614818|FG001|Overall Study|Withdrawal by Subject|3|||
25299867|NCT00928434|50614819|FG002|Overall Study|Withdrawal by Subject|2|||
25299868|NCT00928434|50614817|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
25299869|NCT00928434|50614818|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
25299870|NCT00928434|50614819|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
25299871|NCT00928434|50614817|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
25299872|NCT00928434|50614818|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
25299873|NCT00928434|50614819|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
25299874|NCT00928434|50614817|FG000|Overall Study|Other (not meeting above criteria)|5|||
25299875|NCT00928434|50614818|FG001|Overall Study|Other (not meeting above criteria)|1|||
25299876|NCT00928434|50614819|FG002|Overall Study|Other (not meeting above criteria)|2|||
25299877|NCT00787189|50614837|FG000|Overall Study|Lost to Follow-up|2|||
25299878|NCT00787189|50614838|FG001|Overall Study|Lost to Follow-up|2|||
25299879|NCT00784459|50614846|FG000|Overall Study|Adverse Event|0|||
25299880|NCT00784459|50614847|FG001|Overall Study|Adverse Event|2|||
25299881|NCT00786799|50614855|FG000|Overall Study|Lost to Follow-up|1|||
25299882|NCT00786799|50614856|FG001|Overall Study|Lost to Follow-up|1|||
25299883|NCT00786565|50614867|FG000|Enrollment Prior to Surgery|Site Closed|3|||
25299884|NCT00786565|50614867|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
25299885|NCT00786565|50614867|FG000|Post Surgery|Abnormal macular pucker|1|||
25299886|NCT00786565|50614867|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
25299887|NCT00784147|50614875|FG000|Overall Study|Lost to Follow-up|2|||
25299888|NCT00784147|50614876|FG001|Overall Study|Lost to Follow-up|4|||
25299889|NCT00784147|50614875|FG000|Overall Study|Withdrawal by Subject|1|||
25299890|NCT00784147|50614876|FG001|Overall Study|Withdrawal by Subject|3|||
25299891|NCT00784147|50614875|FG000|Overall Study|Physician Decision|2|||
25191772|NCT02440581|50353407|FG001|Overall Study|Withdrawal by Subject|11|||
25191773|NCT02440581|50353408|FG002|Overall Study|Withdrawal by Subject|3|||
25299892|NCT00784147|50614876|FG001|Overall Study|Physician Decision|1|||
25299893|NCT00784147|50614875|FG000|Overall Study|Protocol Violation|1|||
25299894|NCT00784147|50614876|FG001|Overall Study|Protocol Violation|1|||
25299895|NCT00784147|50614875|FG000|Overall Study|Death|2|||
25299896|NCT00784147|50614876|FG001|Overall Study|Death|0|||
25299897|NCT00891813|50614882|FG000|Overall Study|Adverse Event|3|||
25299898|NCT00891813|50614882|FG000|Overall Study|Withdrawal by Subject|1|||
25299899|NCT00891813|50614882|FG000|Overall Study|Patient Noncompliance|6|||
25299900|NCT00891813|50614882|FG000|Overall Study|Protocol Violation|2|||
25299901|NCT00783835|50614899|FG000|Overall Study|Adverse Event|3|||
25299902|NCT00783835|50614899|FG000|Overall Study|Medical Criteria|1|||
25299903|NCT00783835|50614899|FG000|Overall Study|Withdrawal by Subject|2|||
25299904|NCT00783835|50614899|FG000|Overall Study|Lost to Follow-up|1|||
25299905|NCT00783835|50614899|FG000|Overall Study|Participant not Adherent|3|||
25299906|NCT00783289|50614907|FG000|Overall Study|Protocol Violation|0|||
25299907|NCT00783289|50614908|FG001|Overall Study|Protocol Violation|1|||
25299908|NCT00783289|50614909|FG002|Overall Study|Protocol Violation|0|||
25299909|NCT00783289|50614910|FG003|Overall Study|Protocol Violation|0|||
25299910|NCT00847912|50614925|FG000|Overall Study|Protocol Violation|6|||
25299911|NCT00847912|50614926|FG001|Overall Study|Protocol Violation|7|||
25299912|NCT00847912|50614925|FG000|Overall Study|Withdrawal by Subject|3|||
25299913|NCT00847912|50614926|FG001|Overall Study|Withdrawal by Subject|6|||
25299914|NCT00850564|50614933|FG000|Overall Study|Withdrawal by Subject|2|||
25299915|NCT00837148|50614937|FG000|Overall Study|Adverse Event|1|||
25299916|NCT00837148|50614937|FG000|Overall Study|Death|1|||
25299917|NCT00849940|50614941|FG000|Overall Study|Physician Decision|4|||
25299918|NCT00849472|50614945|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
25299919|NCT00849472|50614945|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
25299920|NCT00849472|50614945|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
25299921|NCT00849472|50614945|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
25299922|NCT00849472|50614945|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
25299923|NCT00849472|50614945|FG000|Weekly Paclitaxel|Disease Progression|1|||
25299924|NCT00849472|50614945|FG000|Weekly Paclitaxel|Adverse Event|11|||
25299925|NCT00849472|50614945|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
25299926|NCT00849472|50614945|FG000|Weekly Paclitaxel|Physician Decision|3|||
25299927|NCT00849472|50614945|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
25299928|NCT00849472|50614945|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
25299929|NCT00849472|50614945|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
25299930|NCT00849472|50614945|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
25299931|NCT00849472|50614945|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
25299932|NCT00849472|50614945|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
25299933|NCT00849472|50614945|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
25299934|NCT00849472|50614945|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
25299935|NCT00782509|50614953|FG000|Overall Study|Adverse Event|20|||
25299936|NCT00782509|50614954|FG001|Overall Study|Adverse Event|10|||
25299937|NCT00782509|50614955|FG002|Overall Study|Adverse Event|20|||
25299938|NCT00782509|50614953|FG000|Overall Study|Lost to Follow-up|1|||
25299939|NCT00782509|50614954|FG001|Overall Study|Lost to Follow-up|2|||
25299940|NCT00782509|50614955|FG002|Overall Study|Lost to Follow-up|3|||
25299941|NCT00782509|50614953|FG000|Overall Study|Withdrawal by Subject|3|||
25299942|NCT00782509|50614954|FG001|Overall Study|Withdrawal by Subject|5|||
25299943|NCT00782509|50614955|FG002|Overall Study|Withdrawal by Subject|8|||
25299944|NCT00782509|50614953|FG000|Overall Study|Non compliance with protocol|2|||
25299945|NCT00782509|50614954|FG001|Overall Study|Non compliance with protocol|0|||
25299946|NCT00782509|50614955|FG002|Overall Study|Non compliance with protocol|0|||
25299947|NCT00782509|50614953|FG000|Overall Study|Other reasons not stated above|5|||
25299948|NCT00782509|50614954|FG001|Overall Study|Other reasons not stated above|2|||
25299949|NCT00782509|50614955|FG002|Overall Study|Other reasons not stated above|3|||
25299950|NCT00782509|50614953|FG000|Overall Study|Lack of Efficacy|10|||
25299951|NCT00782509|50614954|FG001|Overall Study|Lack of Efficacy|5|||
25299952|NCT00782509|50614955|FG002|Overall Study|Lack of Efficacy|2|||
25299953|NCT00927810|50614974|FG000|Overall Study|Withdrawal by Subject|0|||
25299954|NCT00927810|50614975|FG001|Overall Study|Withdrawal by Subject|3|||
25299955|NCT00927810|50614976|FG002|Overall Study|Withdrawal by Subject|0|||
25299956|NCT00927810|50614977|FG003|Overall Study|Withdrawal by Subject|1|||
25299957|NCT00927810|50614974|FG000|Overall Study|Lost to Follow-up|0|||
25299958|NCT00927810|50614975|FG001|Overall Study|Lost to Follow-up|2|||
25299959|NCT00927810|50614976|FG002|Overall Study|Lost to Follow-up|1|||
25299960|NCT00927810|50614977|FG003|Overall Study|Lost to Follow-up|1|||
25299961|NCT00927810|50614974|FG000|Overall Study|Death|0|||
25299962|NCT00927810|50614975|FG001|Overall Study|Death|2|||
25299963|NCT00927810|50614976|FG002|Overall Study|Death|0|||
25299964|NCT00927810|50614977|FG003|Overall Study|Death|0|||
25299965|NCT00927810|50614974|FG000|Overall Study|Abnormal laboratory value(s)|0|||
25299966|NCT00927810|50614975|FG001|Overall Study|Abnormal laboratory value(s)|1|||
25299967|NCT00927810|50614976|FG002|Overall Study|Abnormal laboratory value(s)|0|||
25299968|NCT00927810|50614977|FG003|Overall Study|Abnormal laboratory value(s)|0|||
24969863|NCT04539262|50059283|FG000|Overall Study|Randomized, Not treated|0|||
24969864|NCT04539262|50059284|FG001|Overall Study|Randomized, Not treated|1|||
25299969|NCT00848926|50614995|FG000|Treatment Period|Progressive disease|45|||
25299970|NCT00848926|50614995|FG000|Treatment Period|Adverse Event|20|||
25299971|NCT00848926|50614995|FG000|Treatment Period|Physician Decision|12|||
25299972|NCT00848926|50614995|FG000|Treatment Period|Withdrawal by Subject|7|||
25299973|NCT00848926|50614995|FG000|Follow-up Period|Lost to Follow-up|7|||
25299974|NCT00848926|50614995|FG000|Follow-up Period|Withdrawal by Subject|3|||
25299975|NCT00848926|50614995|FG000|Follow-up Period|Other|2|||
25299976|NCT00847132|50615001|FG000|Overall Study|Death|1|||
25299977|NCT00847132|50615002|FG001|Overall Study|Death|1|||
25299978|NCT00918138|50615010|FG000|Overall Study|Subject withdrew consent|1|||
25299979|NCT00918138|50615011|FG001|Overall Study|Subject withdrew consent|1|||
25299980|NCT00918138|50615010|FG000|Overall Study|Death|1|||
25299981|NCT00918138|50615011|FG001|Overall Study|Death|0|||
25299982|NCT00782275|50615017|FG000|Overall Study|Adverse Event|11|||
25299983|NCT00782275|50615017|FG000|Overall Study|Withdrawal by Subject|1|||
25299984|NCT00782275|50615017|FG000|Overall Study|Progressive Disease|21|||
25299985|NCT00782275|50615017|FG000|Overall Study|Physician Decision|4|||
25299986|NCT00782275|50615017|FG000|Overall Study|Not started treatment|1|||
25299987|NCT00782275|50615017|FG000|Overall Study|Other|3|||
25299988|NCT00791557|50615021|FG000|Overall Study|Adverse Event|1|||
25299989|NCT00920790|50615025|FG000|Overall Study|aggravation of general condition|14|||
25299990|NCT00781963|50615031|FG000|Overall Study|Death|3|||
25299991|NCT00781963|50615032|FG001|Overall Study|Death|0|||
25299992|NCT00781963|50615031|FG000|Overall Study|Lost to Follow-up|2|||
25299993|NCT00781963|50615032|FG001|Overall Study|Lost to Follow-up|1|||
25299994|NCT00781963|50615031|FG000|Overall Study|Withdrawal by Subject|3|||
25299995|NCT00781963|50615032|FG001|Overall Study|Withdrawal by Subject|1|||
25299996|NCT00781963|50615031|FG000|Overall Study|Refused follow-up|9|||
25299997|NCT00781963|50615032|FG001|Overall Study|Refused follow-up|0|||
25299998|NCT00920556|50615038|FG000|Overall Study|Adverse Event|16|||
25299999|NCT00920556|50615038|FG000|Overall Study|Physician Decision|7|||
25300000|NCT00920556|50615038|FG000|Overall Study|Withdrawal by Subject|1|||
25300001|NCT00781885|50615046|FG000|Overall Study|Physician Decision|1|||
25300002|NCT00918684|50615050|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
25300003|NCT00918684|50615050|FG000|Treatment Phase|Lack of Efficacy|6|||
25300004|NCT00918684|50615050|FG000|Treatment Phase|Lost to Follow-up|2|||
25300005|NCT00918684|50615050|FG000|Treatment Phase|Physician Decision|8|||
25300006|NCT00918684|50615050|FG000|Treatment Phase|Protocol Violation|1|||
25300007|NCT00918684|50615050|FG000|Treatment Phase|Withdrawal by Subject|8|||
25300008|NCT00786409|50615054|FG000|Overall Study|Withdrawal by Subject|2|||
25300009|NCT00786409|50615054|FG000|Overall Study|Adverse Event|2|||
25300010|NCT00786409|50615054|FG000|Overall Study|Pregnancy|2|||
25300011|NCT00786409|50615054|FG000|Overall Study|Lost to Follow-up|1|||
25300012|NCT00919854|50615058|FG000|Overall Study|Adverse Event|1|||
25300013|NCT00891735|50615066|FG000|Overall Study|Adverse Event|2|||
25300014|NCT00891735|50615067|FG001|Overall Study|Adverse Event|0|||
25300015|NCT00891735|50615068|FG002|Overall Study|Adverse Event|2|||
25300016|NCT00891735|50615069|FG003|Overall Study|Adverse Event|0|||
25300017|NCT00891735|50615066|FG000|Overall Study|Death|8|||
25300018|NCT00891735|50615067|FG001|Overall Study|Death|5|||
25300019|NCT00891735|50615068|FG002|Overall Study|Death|4|||
25300020|NCT00891735|50615069|FG003|Overall Study|Death|5|||
25300021|NCT00891735|50615066|FG000|Overall Study|Lost to Follow-up|2|||
25300022|NCT00891735|50615067|FG001|Overall Study|Lost to Follow-up|2|||
25300023|NCT00891735|50615068|FG002|Overall Study|Lost to Follow-up|2|||
25300024|NCT00891735|50615069|FG003|Overall Study|Lost to Follow-up|2|||
25300025|NCT00891735|50615066|FG000|Overall Study|Physician's decision to withdraw patient|1|||
25300026|NCT00891735|50615067|FG001|Overall Study|Physician's decision to withdraw patient|0|||
25300027|NCT00891735|50615068|FG002|Overall Study|Physician's decision to withdraw patient|0|||
25300028|NCT00891735|50615069|FG003|Overall Study|Physician's decision to withdraw patient|0|||
25300029|NCT00891735|50615066|FG000|Overall Study|Patient's decision to withdraw|4|||
25300030|NCT00891735|50615067|FG001|Overall Study|Patient's decision to withdraw|9|||
25300031|NCT00891735|50615068|FG002|Overall Study|Patient's decision to withdraw|4|||
25300032|NCT00891735|50615069|FG003|Overall Study|Patient's decision to withdraw|8|||
25300033|NCT00891657|50615081|FG000|Overall Study|Withdrawal by Subject|1|||
25300034|NCT00891657|50615082|FG001|Overall Study|Withdrawal by Subject|1|||
25300035|NCT00917124|50615090|FG000|Overall Study|Protocol Violation|4|||
25300036|NCT00917124|50615091|FG001|Overall Study|Protocol Violation|6|||
25300037|NCT00889863|50615097|FG000|Part I: Open Label|Death|1|||
25300038|NCT00889863|50615098|FG001|Part I: Open Label|Death|0|||
25300039|NCT00889863|50615097|FG000|Part I: Open Label|Adverse Event|4|||
25300040|NCT00889863|50615098|FG001|Part I: Open Label|Adverse Event|0|||
25300041|NCT00889863|50615097|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
25300042|NCT00889863|50615098|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
25300043|NCT00889863|50615097|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
25300044|NCT00889863|50615098|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
25300045|NCT00889863|50615097|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
25300046|NCT00889863|50615098|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
25300047|NCT00889863|50615097|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
25300048|NCT00889863|50615098|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
25300049|NCT00889863|50615097|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
25300050|NCT00889863|50615098|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
25300051|NCT00915018|50615108|FG000|Overall Study|Death|75|||
25300052|NCT00915018|50615109|FG001|Overall Study|Death|70|||
25300053|NCT00915018|50615108|FG000|Overall Study|Lost to Follow-up|10|||
25300054|NCT00915018|50615109|FG001|Overall Study|Lost to Follow-up|5|||
25300055|NCT00915018|50615108|FG000|Overall Study|Withdrawal by Subject|38|||
25300056|NCT00915018|50615109|FG001|Overall Study|Withdrawal by Subject|27|||
25300057|NCT00915018|50615108|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
25300058|NCT00915018|50615109|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
25300059|NCT00916578|50615115|FG000|Overall Study|Physician Decision|2|||
25300060|NCT00916578|50615115|FG000|Overall Study|Withdrawal by Subject|3|||
25300061|NCT00916578|50615115|FG000|Overall Study|Insurance Denial|2|||
25300062|NCT00889707|50615121|FG000|Overall Study|Adverse Event|1|||
25300063|NCT00889707|50615122|FG001|Overall Study|Adverse Event|0|||
25300064|NCT00889707|50615121|FG000|Overall Study|Withdrawal by Subject|4|||
25300065|NCT00889707|50615122|FG001|Overall Study|Withdrawal by Subject|3|||
25300066|NCT00889707|50615121|FG000|Overall Study|Lost to Follow-up|0|||
25300067|NCT00889707|50615122|FG001|Overall Study|Lost to Follow-up|2|||
25300068|NCT00889707|50615121|FG000|Overall Study|Lack of Efficacy|2|||
25300069|NCT00889707|50615122|FG001|Overall Study|Lack of Efficacy|5|||
25300070|NCT00914940|50615128|FG000|D0 to D100 Post-transplant|Death|2|||
25300071|NCT00914940|50615128|FG000|D101 to 2 Years Post-transplant|Death|8|||
25300072|NCT00914940|50615128|FG000|2 Years to 5 Years Post-transplant|Death|3|||
25300073|NCT00835978|50615136|FG000|Overall Study|Death|33|||
25300074|NCT00835978|50615137|FG001|Overall Study|Death|40|||
25300075|NCT00835978|50615138|FG002|Overall Study|Death|49|||
25300076|NCT00835978|50615139|FG003|Overall Study|Death|4|||
25300077|NCT00835978|50615136|FG000|Overall Study|Lost to Follow-up|3|||
25300078|NCT00835978|50615137|FG001|Overall Study|Lost to Follow-up|4|||
25300079|NCT00835978|50615138|FG002|Overall Study|Lost to Follow-up|2|||
25300080|NCT00835978|50615139|FG003|Overall Study|Lost to Follow-up|1|||
25300081|NCT00835978|50615136|FG000|Overall Study|Other|5|||
25300082|NCT00835978|50615137|FG001|Overall Study|Other|1|||
25300083|NCT00835978|50615138|FG002|Overall Study|Other|8|||
25300084|NCT00835978|50615139|FG003|Overall Study|Other|0|||
25300085|NCT00835978|50615136|FG000|Overall Study|Objective progression or relapse|2|||
25300086|NCT00835978|50615137|FG001|Overall Study|Objective progression or relapse|0|||
25300087|NCT00835978|50615138|FG002|Overall Study|Objective progression or relapse|1|||
25300088|NCT00835978|50615139|FG003|Overall Study|Objective progression or relapse|0|||
25300089|NCT00835978|50615136|FG000|Overall Study|Adverse Event|1|||
25300090|NCT00835978|50615137|FG001|Overall Study|Adverse Event|0|||
25300091|NCT00835978|50615138|FG002|Overall Study|Adverse Event|1|||
25300092|NCT00835978|50615139|FG003|Overall Study|Adverse Event|0|||
25300093|NCT00835978|50615136|FG000|Overall Study|Withdrawal by Subject|0|||
25300094|NCT00835978|50615137|FG001|Overall Study|Withdrawal by Subject|3|||
25300095|NCT00835978|50615138|FG002|Overall Study|Withdrawal by Subject|0|||
25300096|NCT00835978|50615139|FG003|Overall Study|Withdrawal by Subject|5|||
25300097|NCT00835978|50615136|FG000|Overall Study|Study terminated by sponsor|12|||
25300098|NCT00835978|50615137|FG001|Overall Study|Study terminated by sponsor|8|||
25300099|NCT00835978|50615138|FG002|Overall Study|Study terminated by sponsor|30|||
25300100|NCT00835978|50615139|FG003|Overall Study|Study terminated by sponsor|0|||
25300101|NCT00914628|50615156|FG000|Overall Study|Death|35|||
25300102|NCT00914628|50615157|FG001|Overall Study|Death|17|||
25300103|NCT00914628|50615156|FG000|Overall Study|Medical decision|4|||
25300104|NCT00914628|50615157|FG001|Overall Study|Medical decision|0|||
25300105|NCT00914628|50615156|FG000|Overall Study|Protocol Violation|1|||
25300106|NCT00914628|50615157|FG001|Overall Study|Protocol Violation|0|||
25300107|NCT00914628|50615156|FG000|Overall Study|Lack of Efficacy|1|||
25300108|NCT00914628|50615157|FG001|Overall Study|Lack of Efficacy|0|||
25300109|NCT00914628|50615156|FG000|Overall Study|non-randomized|1|||
25300110|NCT00914628|50615157|FG001|Overall Study|non-randomized|0|||
25300111|NCT00914628|50615156|FG000|Overall Study|Relapse|1|||
25300112|NCT00914628|50615157|FG001|Overall Study|Relapse|2|||
25300113|NCT00914628|50615156|FG000|Overall Study|Study terminated by Sponsor|14|||
25300114|NCT00914628|50615157|FG001|Overall Study|Study terminated by Sponsor|8|||
25300115|NCT00914628|50615156|FG000|Overall Study|Patients who did not receive a single dose|7|||
25300116|NCT00914628|50615157|FG001|Overall Study|Patients who did not receive a single dose|1|||
25300117|NCT01077518|50615169|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
25300118|NCT01077518|50615170|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
25300119|NCT01077518|50615171|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
25300120|NCT01077518|50615169|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
25300121|NCT01077518|50615170|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
25300122|NCT01077518|50615171|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
25300123|NCT01077518|50615169|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
25300124|NCT01077518|50615170|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
25300125|NCT01077518|50615171|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
25300126|NCT01077518|50615169|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
25300127|NCT01077518|50615170|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
25300128|NCT01077518|50615171|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
25300129|NCT01077518|50615169|FG000|Optional Ofa Phase|Physician Decision|0|||
25300130|NCT01077518|50615170|FG001|Optional Ofa Phase|Physician Decision|0|||
25300131|NCT01077518|50615171|FG002|Optional Ofa Phase|Physician Decision|1|||
25300132|NCT01077518|50615169|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
25300133|NCT01077518|50615170|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
25300134|NCT01077518|50615171|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
25300135|NCT01077518|50615169|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
25300136|NCT01077518|50615170|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
25300137|NCT01077518|50615171|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
25300138|NCT00835120|50615180|FG000|Overall Study|Lack of Efficacy|1|||
25300139|NCT00835120|50615180|FG000|Overall Study|Lost to Follow-up|3|||
25300140|NCT00835120|50615180|FG000|Overall Study|Adverse Event|2|||
25300141|NCT00835120|50615180|FG000|Overall Study|Withdrawal by Subject|2|||
25300142|NCT00914316|50615188|FG000|Phase 1|Physician Decision|4|||
25300143|NCT00914316|50615189|FG001|Phase 1|Physician Decision|0|||
25300144|NCT00914316|50615190|FG002|Phase 1|Physician Decision|1|||
25300145|NCT00914316|50615191|FG003|Phase 1|Physician Decision|2|||
25300146|NCT00914316|50615188|FG000|Phase 1|Withdrawal by Subject|0|||
25300147|NCT00914316|50615189|FG001|Phase 1|Withdrawal by Subject|2|||
25300148|NCT00914316|50615190|FG002|Phase 1|Withdrawal by Subject|4|||
25300149|NCT00914316|50615191|FG003|Phase 1|Withdrawal by Subject|0|||
25300150|NCT00914316|50615188|FG000|Phase 1|Adverse Event|1|||
25300151|NCT00914316|50615189|FG001|Phase 1|Adverse Event|0|||
25300152|NCT00914316|50615190|FG002|Phase 1|Adverse Event|0|||
25300153|NCT00914316|50615191|FG003|Phase 1|Adverse Event|0|||
25300154|NCT00914316|50615188|FG000|Phase 2|Withdrawal by Subject|1|||
25300155|NCT00914316|50615189|FG001|Phase 2|Withdrawal by Subject|0|||
25300156|NCT00914316|50615190|FG002|Phase 2|Withdrawal by Subject|1|||
25300157|NCT00914316|50615191|FG003|Phase 2|Withdrawal by Subject|0|||
25300158|NCT00827632|50615203|FG000|Overall Study|Lost to Follow-up|8|||
25300159|NCT00827632|50615204|FG001|Overall Study|Lost to Follow-up|12|||
25300160|NCT00827632|50615203|FG000|Overall Study|Early withdrawal|14|||
25300161|NCT00827632|50615204|FG001|Overall Study|Early withdrawal|11|||
25300162|NCT00827242|50615212|FG000|Overall Study|Withdrawal by Subject|2|||
25300163|NCT00827242|50615213|FG001|Overall Study|Withdrawal by Subject|4|||
25300164|NCT00827242|50615212|FG000|Overall Study|Protocol Violation|1|||
25300165|NCT00827242|50615213|FG001|Overall Study|Protocol Violation|3|||
25300166|NCT00827242|50615212|FG000|Overall Study|Lost to Follow-up|0|||
25300167|NCT00827242|50615213|FG001|Overall Study|Lost to Follow-up|3|||
25300168|NCT00827242|50615212|FG000|Overall Study|Adverse Event Excluding Death|2|||
25300169|NCT00827242|50615213|FG001|Overall Study|Adverse Event Excluding Death|1|||
25300170|NCT00827242|50615212|FG000|Overall Study|Entry Criteria Not Met|4|||
25300171|NCT00827242|50615213|FG001|Overall Study|Entry Criteria Not Met|1|||
25300172|NCT00827242|50615212|FG000|Overall Study|Physician Decision|2|||
25300173|NCT00827242|50615213|FG001|Overall Study|Physician Decision|0|||
25300174|NCT00827242|50615212|FG000|Overall Study|Death|1|||
25300175|NCT00827242|50615213|FG001|Overall Study|Death|0|||
25300176|NCT00827242|50615212|FG000|Overall Study|Lack of Efficacy|1|||
25300177|NCT00827242|50615213|FG001|Overall Study|Lack of Efficacy|0|||
25300178|NCT01077362|50615222|FG000|Overall Study|Lack of Efficacy|13|||
25300179|NCT01077362|50615223|FG001|Overall Study|Lack of Efficacy|8|||
25300180|NCT01077362|50615224|FG002|Overall Study|Lack of Efficacy|10|||
25300181|NCT01077362|50615222|FG000|Overall Study|Lost to Follow-up|1|||
25300182|NCT01077362|50615223|FG001|Overall Study|Lost to Follow-up|0|||
25300183|NCT01077362|50615224|FG002|Overall Study|Lost to Follow-up|3|||
25300184|NCT01077362|50615222|FG000|Overall Study|Adverse Event|12|||
25300185|NCT01077362|50615223|FG001|Overall Study|Adverse Event|7|||
25300186|NCT01077362|50615224|FG002|Overall Study|Adverse Event|4|||
25300187|NCT01077362|50615222|FG000|Overall Study|Withdrawal by Subject|5|||
25300188|NCT01077362|50615223|FG001|Overall Study|Withdrawal by Subject|3|||
25300189|NCT01077362|50615224|FG002|Overall Study|Withdrawal by Subject|5|||
25300190|NCT01077362|50615222|FG000|Overall Study|Other|0|||
25300191|NCT01077362|50615223|FG001|Overall Study|Other|1|||
25300192|NCT01077362|50615224|FG002|Overall Study|Other|2|||
25300193|NCT00846586|50615239|FG000|Overall Study|Adverse Event|20|||
25300194|NCT00846586|50615240|FG001|Overall Study|Adverse Event|10|||
25300195|NCT00846586|50615239|FG000|Overall Study|Subject withdrew consent|8|||
25300196|NCT00846586|50615240|FG001|Overall Study|Subject withdrew consent|10|||
25300197|NCT00846586|50615239|FG000|Overall Study|Administrative problems|5|||
25300198|NCT00846586|50615240|FG001|Overall Study|Administrative problems|4|||
25300199|NCT00846586|50615239|FG000|Overall Study|Death|2|||
25300200|NCT00846586|50615240|FG001|Overall Study|Death|0|||
25300201|NCT00846586|50615239|FG000|Overall Study|Protocol deviation|2|||
25300202|NCT00846586|50615240|FG001|Overall Study|Protocol deviation|6|||
25300203|NCT00846586|50615239|FG000|Overall Study|Abnormal test procedure result(s)|1|||
25300204|NCT00846586|50615240|FG001|Overall Study|Abnormal test procedure result(s)|0|||
25300205|NCT00846586|50615239|FG000|Overall Study|Lost to Follow-up|1|||
25300206|NCT00846586|50615240|FG001|Overall Study|Lost to Follow-up|4|||
25300207|NCT00846586|50615239|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25300208|NCT00846586|50615240|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
25300209|NCT00785785|50615248|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
25300210|NCT00785785|50615249|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
25300211|NCT00785785|50615248|FG000|Core Phase up to 36 Months|Adverse Event|31|||
25300212|NCT00785785|50615249|FG001|Core Phase up to 36 Months|Adverse Event|21|||
25300213|NCT00785785|50615248|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
25300214|NCT00785785|50615249|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
25300215|NCT00785785|50615248|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
25300216|NCT00785785|50615249|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
25300217|NCT00785785|50615248|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
25300218|NCT00785785|50615249|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
25300219|NCT00785785|50615248|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
25300220|NCT00785785|50615249|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
25300221|NCT00785785|50615248|FG000|Core Phase up to 36 Months|Administrative problems|3|||
25300222|NCT00785785|50615249|FG001|Core Phase up to 36 Months|Administrative problems|3|||
25300223|NCT00785785|50615248|FG000|Core Phase up to 36 Months|Death|5|||
25300224|NCT00785785|50615249|FG001|Core Phase up to 36 Months|Death|8|||
25300225|NCT00785785|50615248|FG000|Core Phase up to 36 Months|Disease progression|139|||
25300226|NCT00785785|50615249|FG001|Core Phase up to 36 Months|Disease progression|119|||
25300227|NCT00785785|50615248|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
25300228|NCT00785785|50615249|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
25300229|NCT00785785|50615248|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
25300230|NCT00785785|50615249|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
25300231|NCT00785785|50615248|FG000|Optional Extension Phase|Adverse Event|4|||
25300232|NCT00785785|50615249|FG001|Optional Extension Phase|Adverse Event|5|||
25300233|NCT00785785|50615248|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
25300234|NCT00785785|50615249|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
25300235|NCT00785785|50615248|FG000|Optional Extension Phase|Lost to Follow-up|1|||
25300236|NCT00785785|50615249|FG001|Optional Extension Phase|Lost to Follow-up|0|||
25300237|NCT00785785|50615248|FG000|Optional Extension Phase|Administrative problems|2|||
25300238|NCT00785785|50615249|FG001|Optional Extension Phase|Administrative problems|0|||
25300239|NCT00785785|50615248|FG000|Optional Extension Phase|Death|1|||
25300240|NCT00785785|50615249|FG001|Optional Extension Phase|Death|5|||
25300241|NCT00785785|50615248|FG000|Optional Extension Phase|Disease progression|22|||
25300242|NCT00785785|50615249|FG001|Optional Extension Phase|Disease progression|70|||
25300243|NCT00785785|50615248|FG000|Optional Extension Phase|Protocol deviation|0|||
25300244|NCT00785785|50615249|FG001|Optional Extension Phase|Protocol deviation|2|||
25300245|NCT00785785|50615248|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
25300246|NCT00785785|50615249|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
25300247|NCT01077284|50615260|FG000|Overall Study|Adverse Event|2|||
25300248|NCT01077284|50615261|FG001|Overall Study|Adverse Event|0|||
25300249|NCT01077284|50615262|FG002|Overall Study|Adverse Event|1|||
25300250|NCT01077284|50615260|FG000|Overall Study|Lost to Follow-up|1|||
25300251|NCT01077284|50615261|FG001|Overall Study|Lost to Follow-up|2|||
25300252|NCT01077284|50615262|FG002|Overall Study|Lost to Follow-up|0|||
25300253|NCT01077284|50615260|FG000|Overall Study|Withdrawal by Subject|2|||
25300254|NCT01077284|50615261|FG001|Overall Study|Withdrawal by Subject|3|||
25300255|NCT01077284|50615262|FG002|Overall Study|Withdrawal by Subject|1|||
25300256|NCT01077284|50615260|FG000|Overall Study|Other|0|||
25300257|NCT01077284|50615261|FG001|Overall Study|Other|0|||
25300258|NCT01077284|50615262|FG002|Overall Study|Other|1|||
25300259|NCT00826618|50615270|FG000|Overall Study|Withdrawal by Subject|1|||
25300260|NCT01077128|50615274|FG000|Overall Study|Adverse Event|8|||
25300261|NCT01077128|50615274|FG000|Overall Study|Lack of Efficacy|1|||
25300262|NCT01077128|50615274|FG000|Overall Study|Disease exacerbation|1|||
25300263|NCT01077128|50615274|FG000|Overall Study|Adverse event and consent withdrawal|1|||
25300264|NCT01077128|50615274|FG000|Overall Study|Adverse event and disease exacerbation|1|||
25300265|NCT01077128|50615274|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
25300266|NCT01077128|50615274|FG000|Overall Study|Other|54|||
25300267|NCT00826540|50615328|FG000|Overall Study|ineligible|3|||
25300268|NCT00826540|50615328|FG000|Overall Study|Withdrawal by Subject|1|||
25300269|NCT01077050|50615332|FG000|Overall Study|Subjects signed ICF could not be located|1|||
25300270|NCT01077050|50615332|FG000|Overall Study|Screen failure|8|||
25300271|NCT00592384|50615338|FG000|Overall Study|Withdrawal by Subject|5|||
25300272|NCT00592384|50615339|FG001|Overall Study|Withdrawal by Subject|6|||
24969865|NCT04539262|50059285|FG002|Overall Study|Randomized, Not treated|0|||
25169365|NCT01831427|50301060|FG008|Overall Study|Investigator's Discretion|0|||
25169366|NCT01831427|50301061|FG009|Overall Study|Investigator's Discretion|0|||
25169367|NCT01831427|50301062|FG010|Overall Study|Investigator's Discretion|0|||
25300273|NCT00846040|50615348|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
25300274|NCT00846040|50615349|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
25169368|NCT01831427|50301052|FG000|Overall Study|Withdrew Consent|0|||
25300275|NCT00846040|50615350|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
25169369|NCT01831427|50301053|FG001|Overall Study|Withdrew Consent|0|||
25169370|NCT01831427|50301054|FG002|Overall Study|Withdrew Consent|0|||
25169371|NCT01831427|50301055|FG003|Overall Study|Withdrew Consent|0|||
25169372|NCT01831427|50301056|FG004|Overall Study|Withdrew Consent|0|||
25169373|NCT01831427|50301057|FG005|Overall Study|Withdrew Consent|0|||
25300276|NCT00846040|50615348|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
25300277|NCT00846040|50615349|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
25300278|NCT00846040|50615350|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
25300279|NCT00826228|50615359|FG000|Overall Study|Withdrawal by Subject|1|||
25300280|NCT00825994|50615364|FG000|Overall Study|Withdrawal by Subject|2|||
25300281|NCT00825994|50615364|FG000|Overall Study|Lost to Follow-up|1|||
25300282|NCT00825994|50615364|FG000|Overall Study|Protocol Violation|1|||
25300283|NCT00825994|50615364|FG000|Overall Study|Placebo Responder at V2|1|||
25300284|NCT00825916|50615371|FG000|Overall Study|Lost to Follow-up|4|||
25300285|NCT00825916|50615372|FG001|Overall Study|Lost to Follow-up|2|||
25300286|NCT00825916|50615373|FG002|Overall Study|Lost to Follow-up|1|||
25300287|NCT00791479|50615420|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
25300288|NCT00791479|50615421|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
25300289|NCT00791479|50615422|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
25300290|NCT00791479|50615423|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
25300291|NCT00791479|50615424|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
25300292|NCT00791479|50615425|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
25300293|NCT00791479|50615420|FG000|Overall Study|Adverse Event|0|||
25300294|NCT00791479|50615421|FG001|Overall Study|Adverse Event|1|||
25300295|NCT00791479|50615422|FG002|Overall Study|Adverse Event|0|||
25300296|NCT00791479|50615423|FG003|Overall Study|Adverse Event|2|||
25300297|NCT00791479|50615424|FG004|Overall Study|Adverse Event|0|||
25300298|NCT00791479|50615425|FG005|Overall Study|Adverse Event|1|||
25300299|NCT00791479|50615420|FG000|Overall Study|Lost to Follow-up|0|||
25300300|NCT00791479|50615421|FG001|Overall Study|Lost to Follow-up|1|||
25300301|NCT00791479|50615422|FG002|Overall Study|Lost to Follow-up|0|||
25300302|NCT00791479|50615423|FG003|Overall Study|Lost to Follow-up|0|||
25300303|NCT00791479|50615424|FG004|Overall Study|Lost to Follow-up|0|||
25300304|NCT00791479|50615425|FG005|Overall Study|Lost to Follow-up|1|||
25300305|NCT00791479|50615420|FG000|Overall Study|Protocol Violation|2|||
25300306|NCT00791479|50615421|FG001|Overall Study|Protocol Violation|1|||
25300307|NCT00791479|50615422|FG002|Overall Study|Protocol Violation|0|||
25300308|NCT00791479|50615423|FG003|Overall Study|Protocol Violation|1|||
25300309|NCT00791479|50615424|FG004|Overall Study|Protocol Violation|0|||
25300310|NCT00791479|50615425|FG005|Overall Study|Protocol Violation|0|||
25300311|NCT00791479|50615420|FG000|Overall Study|Withdrawal by Subject|0|||
25300312|NCT00791479|50615421|FG001|Overall Study|Withdrawal by Subject|0|||
25300313|NCT00791479|50615422|FG002|Overall Study|Withdrawal by Subject|0|||
25300314|NCT00791479|50615423|FG003|Overall Study|Withdrawal by Subject|1|||
25300315|NCT00791479|50615424|FG004|Overall Study|Withdrawal by Subject|0|||
25300316|NCT00791479|50615425|FG005|Overall Study|Withdrawal by Subject|1|||
25300317|NCT00890097|50615449|FG000|Overall Study|Adverse Event|21|||
25300318|NCT00890097|50615450|FG001|Overall Study|Adverse Event|32|||
25300319|NCT00890097|50615451|FG002|Overall Study|Adverse Event|28|||
25300320|NCT00890097|50615449|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
25300321|NCT00890097|50615450|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
25300322|NCT00890097|50615451|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
25300323|NCT00890097|50615449|FG000|Overall Study|Withdrew Consent|9|||
25300324|NCT00890097|50615450|FG001|Overall Study|Withdrew Consent|6|||
25300325|NCT00890097|50615451|FG002|Overall Study|Withdrew Consent|9|||
25300326|NCT00890097|50615449|FG000|Overall Study|Lost to Follow-up|5|||
25300327|NCT00890097|50615450|FG001|Overall Study|Lost to Follow-up|5|||
25300328|NCT00890097|50615451|FG002|Overall Study|Lost to Follow-up|5|||
25300329|NCT00890097|50615449|FG000|Overall Study|Noncompliance|0|||
25300330|NCT00890097|50615450|FG001|Overall Study|Noncompliance|4|||
25300331|NCT00890097|50615451|FG002|Overall Study|Noncompliance|4|||
25300332|NCT00890097|50615449|FG000|Overall Study|Sponsor Decision|7|||
25300333|NCT00890097|50615450|FG001|Overall Study|Sponsor Decision|11|||
25300334|NCT00890097|50615451|FG002|Overall Study|Sponsor Decision|7|||
25300335|NCT00890097|50615449|FG000|Overall Study|Did not attend final visit|2|||
25300336|NCT00890097|50615450|FG001|Overall Study|Did not attend final visit|3|||
25169374|NCT01831427|50301058|FG006|Overall Study|Withdrew Consent|2|||
25300337|NCT00890097|50615451|FG002|Overall Study|Did not attend final visit|0|||
25300338|NCT00890097|50615449|FG000|Overall Study|Subject Decision|3|||
25300339|NCT00890097|50615450|FG001|Overall Study|Subject Decision|2|||
25300340|NCT00890097|50615451|FG002|Overall Study|Subject Decision|6|||
25300341|NCT00890097|50615449|FG000|Overall Study|Randomization Error|2|||
25300342|NCT00890097|50615450|FG001|Overall Study|Randomization Error|0|||
25300343|NCT00890097|50615451|FG002|Overall Study|Randomization Error|0|||
25300344|NCT00890097|50615449|FG000|Overall Study|Failed inclusion criteria|3|||
25300345|NCT00890097|50615450|FG001|Overall Study|Failed inclusion criteria|4|||
25300346|NCT00890097|50615451|FG002|Overall Study|Failed inclusion criteria|0|||
25169375|NCT01831427|50301059|FG007|Overall Study|Withdrew Consent|0|||
25300347|NCT00890097|50615449|FG000|Overall Study|Transportation|0|||
25300348|NCT00890097|50615450|FG001|Overall Study|Transportation|2|||
25300349|NCT00890097|50615451|FG002|Overall Study|Transportation|0|||
25300350|NCT00890097|50615449|FG000|Overall Study|Subject Moved|0|||
25300351|NCT00890097|50615450|FG001|Overall Study|Subject Moved|4|||
25300352|NCT00890097|50615451|FG002|Overall Study|Subject Moved|0|||
25300353|NCT00890097|50615449|FG000|Overall Study|Protocol Deviation|1|||
25300354|NCT00890097|50615450|FG001|Overall Study|Protocol Deviation|1|||
25300355|NCT00890097|50615451|FG002|Overall Study|Protocol Deviation|1|||
25300356|NCT00913458|50615459|FG000|Phase 1|Non-Responder|54|||
25300357|NCT00913458|50615460|FG001|Phase 1|Non-Responder|0|||
25300358|NCT00913458|50615461|FG002|Phase 1|Non-Responder|0|||
25300359|NCT00913458|50615462|FG003|Phase 1|Non-Responder|0|||
25300360|NCT00913458|50615463|FG004|Phase 1|Non-Responder|0|||
25300361|NCT00913458|50615464|FG005|Phase 1|Non-Responder|0|||
25300362|NCT00913458|50615465|FG006|Phase 1|Non-Responder|0|||
25300363|NCT00913458|50615459|FG000|Phase 1|Subject Request|17|||
25300364|NCT00913458|50615460|FG001|Phase 1|Subject Request|0|||
25300365|NCT00913458|50615461|FG002|Phase 1|Subject Request|0|||
25300366|NCT00913458|50615462|FG003|Phase 1|Subject Request|0|||
25300367|NCT00913458|50615463|FG004|Phase 1|Subject Request|0|||
25300368|NCT00913458|50615464|FG005|Phase 1|Subject Request|0|||
25300369|NCT00913458|50615465|FG006|Phase 1|Subject Request|0|||
25300370|NCT00913458|50615459|FG000|Phase 1|Adverse Event|20|||
25300371|NCT00913458|50615460|FG001|Phase 1|Adverse Event|0|||
25300372|NCT00913458|50615461|FG002|Phase 1|Adverse Event|0|||
25300373|NCT00913458|50615462|FG003|Phase 1|Adverse Event|0|||
25300374|NCT00913458|50615463|FG004|Phase 1|Adverse Event|0|||
25300375|NCT00913458|50615464|FG005|Phase 1|Adverse Event|0|||
25300376|NCT00913458|50615465|FG006|Phase 1|Adverse Event|0|||
25300377|NCT00913458|50615459|FG000|Phase 1|Lost to Follow-up|2|||
25300378|NCT00913458|50615460|FG001|Phase 1|Lost to Follow-up|0|||
25300379|NCT00913458|50615461|FG002|Phase 1|Lost to Follow-up|0|||
25300380|NCT00913458|50615462|FG003|Phase 1|Lost to Follow-up|0|||
25300381|NCT00913458|50615463|FG004|Phase 1|Lost to Follow-up|0|||
25300382|NCT00913458|50615464|FG005|Phase 1|Lost to Follow-up|0|||
25300383|NCT00913458|50615465|FG006|Phase 1|Lost to Follow-up|0|||
25300384|NCT00913458|50615459|FG000|Phase 1|Protocol Violation|10|||
25300385|NCT00913458|50615460|FG001|Phase 1|Protocol Violation|0|||
25300386|NCT00913458|50615461|FG002|Phase 1|Protocol Violation|0|||
25300387|NCT00913458|50615462|FG003|Phase 1|Protocol Violation|0|||
25300388|NCT00913458|50615463|FG004|Phase 1|Protocol Violation|0|||
25300389|NCT00913458|50615464|FG005|Phase 1|Protocol Violation|0|||
25300390|NCT00913458|50615465|FG006|Phase 1|Protocol Violation|0|||
25300391|NCT00913458|50615459|FG000|Phase 1|Sponsor|2|||
25300392|NCT00913458|50615460|FG001|Phase 1|Sponsor|0|||
25300393|NCT00913458|50615461|FG002|Phase 1|Sponsor|0|||
25300394|NCT00913458|50615462|FG003|Phase 1|Sponsor|0|||
25300395|NCT00913458|50615463|FG004|Phase 1|Sponsor|0|||
25300396|NCT00913458|50615464|FG005|Phase 1|Sponsor|0|||
25300397|NCT00913458|50615465|FG006|Phase 1|Sponsor|0|||
25300398|NCT00913458|50615459|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
25300399|NCT00913458|50615460|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
25300400|NCT00913458|50615461|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
25300401|NCT00913458|50615462|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
25300402|NCT00913458|50615463|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
25300403|NCT00913458|50615464|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
25300404|NCT00913458|50615465|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
25300405|NCT00913458|50615459|FG000|Phase 2|Non-Responder|0|||
25300406|NCT00913458|50615460|FG001|Phase 2|Non-Responder|5|||
25300407|NCT00913458|50615461|FG002|Phase 2|Non-Responder|7|||
25300408|NCT00913458|50615462|FG003|Phase 2|Non-Responder|12|||
25300409|NCT00913458|50615463|FG004|Phase 2|Non-Responder|0|||
25300410|NCT00913458|50615464|FG005|Phase 2|Non-Responder|0|||
25300411|NCT00913458|50615465|FG006|Phase 2|Non-Responder|0|||
25300412|NCT00913458|50615459|FG000|Phase 2|Subject Request|0|||
25300413|NCT00913458|50615460|FG001|Phase 2|Subject Request|0|||
25300414|NCT00913458|50615461|FG002|Phase 2|Subject Request|1|||
25300415|NCT00913458|50615462|FG003|Phase 2|Subject Request|2|||
25300416|NCT00913458|50615463|FG004|Phase 2|Subject Request|0|||
25300417|NCT00913458|50615464|FG005|Phase 2|Subject Request|0|||
25300418|NCT00913458|50615465|FG006|Phase 2|Subject Request|0|||
25300419|NCT00913458|50615459|FG000|Phase 2|Adverse Event|0|||
24969866|NCT04539262|50059286|FG003|Overall Study|Randomized, Not treated|0|||
24969867|NCT04539262|50059287|FG004|Overall Study|Randomized, Not treated|0|||
24969868|NCT04539262|50059288|FG005|Overall Study|Randomized, Not treated|0|||
25300420|NCT00913458|50615460|FG001|Phase 2|Adverse Event|3|||
25300421|NCT00913458|50615461|FG002|Phase 2|Adverse Event|0|||
25300422|NCT00913458|50615462|FG003|Phase 2|Adverse Event|1|||
25300423|NCT00913458|50615463|FG004|Phase 2|Adverse Event|0|||
25300424|NCT00913458|50615464|FG005|Phase 2|Adverse Event|0|||
25300425|NCT00913458|50615465|FG006|Phase 2|Adverse Event|0|||
25300426|NCT00913458|50615459|FG000|Phase 2|Lost to Follow-up|0|||
25300427|NCT00913458|50615460|FG001|Phase 2|Lost to Follow-up|0|||
25300428|NCT00913458|50615461|FG002|Phase 2|Lost to Follow-up|0|||
25300429|NCT00913458|50615462|FG003|Phase 2|Lost to Follow-up|1|||
25300430|NCT00913458|50615463|FG004|Phase 2|Lost to Follow-up|0|||
25300431|NCT00913458|50615464|FG005|Phase 2|Lost to Follow-up|0|||
25300432|NCT00913458|50615465|FG006|Phase 2|Lost to Follow-up|0|||
25300433|NCT00913458|50615459|FG000|Phase 2|Protocol Violation|0|||
25300434|NCT00913458|50615460|FG001|Phase 2|Protocol Violation|2|||
25300435|NCT00913458|50615461|FG002|Phase 2|Protocol Violation|0|||
25300436|NCT00913458|50615462|FG003|Phase 2|Protocol Violation|0|||
25300437|NCT00913458|50615463|FG004|Phase 2|Protocol Violation|0|||
25300438|NCT00913458|50615464|FG005|Phase 2|Protocol Violation|0|||
25300439|NCT00913458|50615465|FG006|Phase 2|Protocol Violation|0|||
25300440|NCT00913458|50615459|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
25300441|NCT00913458|50615460|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
25300442|NCT00913458|50615461|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
25300443|NCT00913458|50615462|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
25300444|NCT00913458|50615463|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
25300445|NCT00913458|50615464|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
25300446|NCT00913458|50615465|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
25300447|NCT00913458|50615459|FG000|Phase 3|Adverse Event|0|||
25300448|NCT00913458|50615460|FG001|Phase 3|Adverse Event|0|||
25300449|NCT00913458|50615461|FG002|Phase 3|Adverse Event|0|||
25300450|NCT00913458|50615462|FG003|Phase 3|Adverse Event|0|||
25300451|NCT00913458|50615463|FG004|Phase 3|Adverse Event|5|||
25300452|NCT00913458|50615464|FG005|Phase 3|Adverse Event|4|||
25300453|NCT00913458|50615465|FG006|Phase 3|Adverse Event|1|||
25300454|NCT00913458|50615459|FG000|Phase 3|Lost to Follow-up|0|||
25300455|NCT00913458|50615460|FG001|Phase 3|Lost to Follow-up|0|||
25300456|NCT00913458|50615461|FG002|Phase 3|Lost to Follow-up|0|||
25300457|NCT00913458|50615462|FG003|Phase 3|Lost to Follow-up|0|||
25300458|NCT00913458|50615463|FG004|Phase 3|Lost to Follow-up|2|||
25300459|NCT00913458|50615464|FG005|Phase 3|Lost to Follow-up|0|||
25300460|NCT00913458|50615465|FG006|Phase 3|Lost to Follow-up|0|||
25300461|NCT00913458|50615459|FG000|Phase 3|Non-Responder|0|||
25300462|NCT00913458|50615460|FG001|Phase 3|Non-Responder|0|||
25300463|NCT00913458|50615461|FG002|Phase 3|Non-Responder|0|||
25300464|NCT00913458|50615462|FG003|Phase 3|Non-Responder|0|||
25300465|NCT00913458|50615463|FG004|Phase 3|Non-Responder|0|||
25300466|NCT00913458|50615464|FG005|Phase 3|Non-Responder|1|||
25300467|NCT00913458|50615465|FG006|Phase 3|Non-Responder|3|||
25300468|NCT00913458|50615459|FG000|Phase 3|Withdrawal by Subject|0|||
25300469|NCT00913458|50615460|FG001|Phase 3|Withdrawal by Subject|0|||
25300470|NCT00913458|50615461|FG002|Phase 3|Withdrawal by Subject|0|||
25300471|NCT00913458|50615462|FG003|Phase 3|Withdrawal by Subject|0|||
25300472|NCT00913458|50615463|FG004|Phase 3|Withdrawal by Subject|1|||
25300473|NCT00913458|50615464|FG005|Phase 3|Withdrawal by Subject|2|||
25300474|NCT00913458|50615465|FG006|Phase 3|Withdrawal by Subject|0|||
25300475|NCT00913458|50615459|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
25300476|NCT00913458|50615460|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
25300477|NCT00913458|50615461|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
25300478|NCT00913458|50615462|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
25300479|NCT00913458|50615463|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
25300480|NCT00913458|50615464|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
25300481|NCT00913458|50615465|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
25300482|NCT00785707|50615482|FG000|Overall Study|Lost to Follow-up|7|||
25300483|NCT00913380|50615488|FG000|Clinical Outcomes|Lost to Follow-up|6|||
25300484|NCT00913380|50615489|FG001|Clinical Outcomes|Lost to Follow-up|6|||
25300485|NCT00785629|50615499|FG000|Overall Study|Adverse Event|2|||
25300486|NCT00785629|50615500|FG001|Overall Study|Adverse Event|1|||
25300487|NCT00785629|50615501|FG002|Overall Study|Adverse Event|1|||
25300488|NCT00785629|50615502|FG003|Overall Study|Adverse Event|5|||
25300489|NCT00785629|50615499|FG000|Overall Study|Protocol Violation|1|||
25300490|NCT00785629|50615500|FG001|Overall Study|Protocol Violation|2|||
25300491|NCT00785629|50615501|FG002|Overall Study|Protocol Violation|4|||
25300492|NCT00785629|50615502|FG003|Overall Study|Protocol Violation|5|||
25300493|NCT00785629|50615499|FG000|Overall Study|administrative decision|5|||
25300494|NCT00785629|50615500|FG001|Overall Study|administrative decision|1|||
25300495|NCT00785629|50615501|FG002|Overall Study|administrative decision|3|||
25300496|NCT00785629|50615502|FG003|Overall Study|administrative decision|4|||
25300497|NCT00785629|50615499|FG000|Overall Study|Withdrawal by Subject|0|||
25300498|NCT00785629|50615500|FG001|Overall Study|Withdrawal by Subject|1|||
25300499|NCT00785629|50615501|FG002|Overall Study|Withdrawal by Subject|2|||
25300500|NCT00785629|50615502|FG003|Overall Study|Withdrawal by Subject|2|||
25300501|NCT00916344|50615510|FG000|Overall Study|Death|2|||
25300502|NCT00916344|50615510|FG000|Overall Study|ICD upgrade|1|||
25300503|NCT00916344|50615510|FG000|Overall Study|Drop-out|5|||
25169376|NCT01831427|50301060|FG008|Overall Study|Withdrew Consent|0|||
25300504|NCT00913770|50615517|FG000|Overall Study|Unable to contact|24|||
25169377|NCT01831427|50301061|FG009|Overall Study|Withdrew Consent|1|||
25300505|NCT00913770|50615518|FG001|Overall Study|Unable to contact|19|||
25300506|NCT00913770|50615519|FG002|Overall Study|Unable to contact|13|||
25300507|NCT00913770|50615517|FG000|Overall Study|Refused|11|||
25300508|NCT00913770|50615518|FG001|Overall Study|Refused|10|||
25300509|NCT00913770|50615519|FG002|Overall Study|Refused|8|||
25300510|NCT00780559|50615529|FG000|Overall Study|Lost to Follow-up|2|||
25300511|NCT00780559|50615530|FG001|Overall Study|Lost to Follow-up|7|||
25300512|NCT00780559|50615529|FG000|Overall Study|Death|1|||
25300513|NCT00780559|50615530|FG001|Overall Study|Death|0|||
25300514|NCT00912912|50615538|FG000|Overall Study|Withdrawal by Subject|1|||
25300515|NCT00912912|50615538|FG000|Overall Study|Disease Progression|3|||
25300516|NCT00889005|50615544|FG000|Overall Study|Lost to Follow-up|4|||
25300517|NCT00889005|50615545|FG001|Overall Study|Lost to Follow-up|2|||
25300518|NCT00889005|50615544|FG000|Overall Study|Withdrawal by Subject|4|||
25300519|NCT00889005|50615545|FG001|Overall Study|Withdrawal by Subject|0|||
25300520|NCT00779857|50615551|FG000|Overall Study|Death|1|||
25300521|NCT00779857|50615551|FG000|Overall Study|Withdrawal by Subject|3|||
25300522|NCT00779857|50615551|FG000|Overall Study|Missed Visit|2|||
25300523|NCT00913692|50615555|FG000|Screening (4 Months)|Physician Decision|3|||
25300524|NCT00913692|50615555|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
25300525|NCT00913692|50615555|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
25300526|NCT00784927|50615562|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
25300527|NCT00784927|50615562|FG000|Overall Study|Protocol Violation|1|||
25300528|NCT00784927|50615562|FG000|Overall Study|Ineligible|1|||
25300529|NCT00779779|50615567|FG000|Overall Study|Adverse Event|1|||
25300530|NCT00779779|50615567|FG000|Overall Study|Protocol Violation|14|||
25300531|NCT00779779|50615567|FG000|Overall Study|Withdrawal by Subject|4|||
25300532|NCT00779779|50615567|FG000|Overall Study|Lost to Follow-up|5|||
25300533|NCT00845728|50615573|FG000|Overall Study|Abnormal laboratory value (s)|2|||
25300534|NCT00845728|50615574|FG001|Overall Study|Abnormal laboratory value (s)|2|||
25300535|NCT00845728|50615573|FG000|Overall Study|Patient's inability to use the device|4|||
25300536|NCT00845728|50615574|FG001|Overall Study|Patient's inability to use the device|6|||
25300537|NCT00845728|50615573|FG000|Overall Study|Abnormal test procedure result (s)|7|||
25300538|NCT00845728|50615574|FG001|Overall Study|Abnormal test procedure result (s)|2|||
25300539|NCT00845728|50615573|FG000|Overall Study|Lost to Follow-up|22|||
25300540|NCT00845728|50615574|FG001|Overall Study|Lost to Follow-up|13|||
25300541|NCT00845728|50615573|FG000|Overall Study|Death|24|||
25300542|NCT00845728|50615574|FG001|Overall Study|Death|26|||
25300543|NCT00845728|50615573|FG000|Overall Study|Administrative Problems|34|||
25300544|NCT00845728|50615574|FG001|Overall Study|Administrative Problems|26|||
25300545|NCT00845728|50615573|FG000|Overall Study|Protocol Violation|36|||
25300546|NCT00845728|50615574|FG001|Overall Study|Protocol Violation|24|||
25300547|NCT00845728|50615573|FG000|Overall Study|Lack of Efficacy|51|||
25300548|NCT00845728|50615574|FG001|Overall Study|Lack of Efficacy|39|||
25300549|NCT00845728|50615573|FG000|Overall Study|Adverse Event|101|||
25300550|NCT00845728|50615574|FG001|Overall Study|Adverse Event|96|||
25300551|NCT00845728|50615573|FG000|Overall Study|Withdrawal by Subject|105|||
25300552|NCT00845728|50615574|FG001|Overall Study|Withdrawal by Subject|108|||
25300553|NCT00779467|50615584|FG000|Overall Study|Lack of Efficacy|11|||
25300554|NCT00779467|50615585|FG001|Overall Study|Lack of Efficacy|2|||
25300555|NCT00779467|50615586|FG002|Overall Study|Lack of Efficacy|6|||
25300556|NCT00779467|50615587|FG003|Overall Study|Lack of Efficacy|11|||
25300557|NCT00779467|50615584|FG000|Overall Study|failed inclusion criteria|3|||
25300558|NCT00779467|50615585|FG001|Overall Study|failed inclusion criteria|3|||
25300559|NCT00779467|50615586|FG002|Overall Study|failed inclusion criteria|1|||
25300560|NCT00779467|50615587|FG003|Overall Study|failed inclusion criteria|2|||
25300561|NCT00779467|50615584|FG000|Overall Study|missing data|1|||
25300562|NCT00779467|50615585|FG001|Overall Study|missing data|0|||
25300563|NCT00779467|50615586|FG002|Overall Study|missing data|1|||
25300564|NCT00779467|50615587|FG003|Overall Study|missing data|4|||
25300565|NCT00779467|50615584|FG000|Overall Study|technical issue|0|||
25300566|NCT00779467|50615585|FG001|Overall Study|technical issue|0|||
25300567|NCT00779467|50615586|FG002|Overall Study|technical issue|2|||
25300568|NCT00779467|50615587|FG003|Overall Study|technical issue|1|||
25300569|NCT00779467|50615584|FG000|Overall Study|unavailable research staff|0|||
25300570|NCT00779467|50615585|FG001|Overall Study|unavailable research staff|0|||
25300571|NCT00779467|50615586|FG002|Overall Study|unavailable research staff|0|||
25300572|NCT00779467|50615587|FG003|Overall Study|unavailable research staff|1|||
25300573|NCT00778921|50615600|FG000|Overall Study|Adverse Event|9|||
25300574|NCT00778921|50615601|FG001|Overall Study|Adverse Event|10|||
25300575|NCT00778921|50615602|FG002|Overall Study|Adverse Event|14|||
25300576|NCT00778921|50615600|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
25300577|NCT00778921|50615601|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
25300578|NCT00778921|50615602|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
25300579|NCT00778921|50615600|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
25300580|NCT00778921|50615601|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
25300581|NCT00778921|50615602|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
25300582|NCT00778921|50615600|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
25300583|NCT00778921|50615601|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
25300584|NCT00778921|50615602|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
25300585|NCT00778921|50615600|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
25300586|NCT00778921|50615601|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
25300587|NCT00778921|50615602|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
25300588|NCT00778921|50615600|FG000|Overall Study|Patient withdrew request|3|||
25300589|NCT00778921|50615601|FG001|Overall Study|Patient withdrew request|1|||
25300590|NCT00778921|50615602|FG002|Overall Study|Patient withdrew request|6|||
25300591|NCT00778921|50615600|FG000|Overall Study|Lost to Follow-up|0|||
25300592|NCT00778921|50615601|FG001|Overall Study|Lost to Follow-up|2|||
25300593|NCT00778921|50615602|FG002|Overall Study|Lost to Follow-up|1|||
25300594|NCT00778921|50615600|FG000|Overall Study|Administrative Problems|1|||
25300595|NCT00778921|50615601|FG001|Overall Study|Administrative Problems|2|||
25300596|NCT00778921|50615602|FG002|Overall Study|Administrative Problems|0|||
25300597|NCT00778921|50615600|FG000|Overall Study|Protocol Violation|3|||
25300598|NCT00778921|50615601|FG001|Overall Study|Protocol Violation|0|||
25300599|NCT00778921|50615602|FG002|Overall Study|Protocol Violation|2|||
25300600|NCT00778921|50615600|FG000|Overall Study|Not treated|0|||
25300601|NCT00778921|50615601|FG001|Overall Study|Not treated|2|||
25300602|NCT00778921|50615602|FG002|Overall Study|Not treated|2|||
25300603|NCT00915876|50615612|FG000|Overall Study|Adverse Event|0|||
25300604|NCT00915876|50615613|FG001|Overall Study|Adverse Event|1|||
25300605|NCT00587431|50615621|FG000|Overall Study|Adverse Event|1|||
25300606|NCT00587431|50615622|FG001|Overall Study|Adverse Event|0|||
25300607|NCT00587431|50615621|FG000|Overall Study|Withdrawal by Subject|0|||
25300608|NCT00587431|50615622|FG001|Overall Study|Withdrawal by Subject|1|||
25300609|NCT00776659|50615631|FG000|Overall Study|Lost to Follow-up|15|||
25300610|NCT00776659|50615631|FG000|Overall Study|Withdrawal by Subject|10|||
25300611|NCT00776659|50615631|FG000|Overall Study|Study Terminated by Sponsor|1|||
25300612|NCT00825682|50615637|FG000|Overall Study|personal reasons/ inconvenience|13|||
25300613|NCT00825682|50615638|FG001|Overall Study|personal reasons/ inconvenience|5|||
25300614|NCT00833794|50615647|FG000|Open-label Phase|Adverse Event|225|||
25300615|NCT00833794|50615648|FG001|Open-label Phase|Adverse Event|0|||
25300616|NCT00833794|50615647|FG000|Open-label Phase|Lack of Efficacy|28|||
25300617|NCT00833794|50615648|FG001|Open-label Phase|Lack of Efficacy|0|||
25300618|NCT00833794|50615647|FG000|Open-label Phase|Withdrawal by Subject|48|||
25300619|NCT00833794|50615648|FG001|Open-label Phase|Withdrawal by Subject|0|||
25300620|NCT00833794|50615647|FG000|Open-label Phase|Physician Decision|20|||
25300621|NCT00833794|50615648|FG001|Open-label Phase|Physician Decision|0|||
25300622|NCT00833794|50615647|FG000|Open-label Phase|Administrative reason|1|||
25300623|NCT00833794|50615648|FG001|Open-label Phase|Administrative reason|0|||
25300624|NCT00833794|50615647|FG000|Open-label Phase|Protocol Violation|47|||
25300625|NCT00833794|50615648|FG001|Open-label Phase|Protocol Violation|0|||
25300626|NCT00833794|50615647|FG000|Open-label Phase|Did not complete wash-out period|12|||
25300627|NCT00833794|50615648|FG001|Open-label Phase|Did not complete wash-out period|0|||
25300628|NCT00833794|50615647|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
25300629|NCT00833794|50615648|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
25300630|NCT00833794|50615647|FG000|Double-blind Phase|Adverse Event|44|||
25300631|NCT00833794|50615648|FG001|Double-blind Phase|Adverse Event|11|||
25300632|NCT00833794|50615647|FG000|Double-blind Phase|Lack of Efficacy|34|||
25300633|NCT00833794|50615648|FG001|Double-blind Phase|Lack of Efficacy|22|||
25300634|NCT00833794|50615647|FG000|Double-blind Phase|Withdrawal by Subject|23|||
25300635|NCT00833794|50615648|FG001|Double-blind Phase|Withdrawal by Subject|6|||
25300636|NCT00833794|50615647|FG000|Double-blind Phase|Physician Decision|4|||
25300637|NCT00833794|50615648|FG001|Double-blind Phase|Physician Decision|7|||
25300638|NCT00833794|50615647|FG000|Double-blind Phase|Administrative reason|1|||
25300639|NCT00833794|50615648|FG001|Double-blind Phase|Administrative reason|3|||
25300640|NCT00912288|50615658|FG000|Overall Study|Death|0|||
25300641|NCT00912288|50615659|FG001|Overall Study|Death|1|||
24969869|NCT04539262|50059289|FG006|Overall Study|Randomized, Not treated|1|||
24969870|NCT04539262|50059290|FG007|Overall Study|Randomized, Not treated|0|||
25070885|NCT02702193|50176964|FG001|8 Month Follow up|Lost to Follow-up|18|||
25300642|NCT00912288|50615658|FG000|Overall Study|Adverse Event|1|||
25300643|NCT00912288|50615659|FG001|Overall Study|Adverse Event|1|||
25300644|NCT00912288|50615658|FG000|Overall Study|Lost to Follow-up|1|||
25300645|NCT00912288|50615659|FG001|Overall Study|Lost to Follow-up|0|||
25300646|NCT00912288|50615658|FG000|Overall Study|Protocol Violation|1|||
25300647|NCT00912288|50615659|FG001|Overall Study|Protocol Violation|0|||
25300648|NCT00912288|50615658|FG000|Overall Study|Withdrawal by Subject|3|||
25300649|NCT00912288|50615659|FG001|Overall Study|Withdrawal by Subject|3|||
25300650|NCT00912288|50615658|FG000|Overall Study|Study terminated by sponsor|34|||
25300651|NCT00912288|50615659|FG001|Overall Study|Study terminated by sponsor|35|||
25300652|NCT00912288|50615658|FG000|Overall Study|Other|1|||
25300653|NCT00912288|50615659|FG001|Overall Study|Other|0|||
24969871|NCT03702010|50059313|FG000|Follow-up (30days)|Lack of Efficacy|2|||
25300654|NCT00778375|50615665|FG000|Overall Study|Ineligible|3|||
25300655|NCT00777829|50615671|FG000|Overall Study|Withdrawal by Subject|0|||
25300656|NCT00777829|50615672|FG001|Overall Study|Withdrawal by Subject|2|||
25300657|NCT00775021|50615680|FG000|First Intervention|Lost to Follow-up|1|||
25300658|NCT00775021|50615681|FG001|First Intervention|Lost to Follow-up|0|||
25300659|NCT00775021|50615680|FG000|Second Intervention|Adverse Event|0|||
25300660|NCT00775021|50615681|FG001|Second Intervention|Adverse Event|1|||
25300661|NCT00777205|50615689|FG000|Overall Study|Lost to Follow-up|25|||
25300662|NCT00777205|50615690|FG001|Overall Study|Lost to Follow-up|9|||
25300663|NCT00777205|50615689|FG000|Overall Study|Withdrawal by Subject|6|||
25300664|NCT00777205|50615690|FG001|Overall Study|Withdrawal by Subject|4|||
25300665|NCT00777205|50615689|FG000|Overall Study|Death|0|||
25300666|NCT00777205|50615690|FG001|Overall Study|Death|2|||
25300667|NCT00777205|50615689|FG000|Overall Study|Protocol Violation|0|||
25300668|NCT00777205|50615690|FG001|Overall Study|Protocol Violation|56|||
25300669|NCT00833638|50615701|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
25300670|NCT00833638|50615702|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
25300671|NCT00833638|50615703|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
25300672|NCT00833638|50615701|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
25300673|NCT00833638|50615702|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
25300674|NCT00833638|50615703|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
25300675|NCT00833638|50615701|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
25300676|NCT00833638|50615702|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
25300677|NCT00833638|50615703|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
25300678|NCT00833638|50615701|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
25300679|NCT00833638|50615702|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
25300680|NCT00833638|50615703|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
25300681|NCT00833638|50615701|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
25300682|NCT00833638|50615702|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
25300683|NCT00833638|50615703|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
25300684|NCT00833638|50615701|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
25300685|NCT00833638|50615702|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
25300686|NCT00833638|50615703|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
25300687|NCT00833638|50615701|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
25300688|NCT00833638|50615702|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
25300689|NCT00833638|50615703|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
25300690|NCT00833638|50615701|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
25300691|NCT00833638|50615702|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
25300692|NCT00833638|50615703|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
25300693|NCT00833638|50615701|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
25300694|NCT00833638|50615702|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
25300695|NCT00833638|50615703|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
25300696|NCT01041404|50615721|FG000|Overall Study|Adverse Event|45|||
25300697|NCT01041404|50615722|FG001|Overall Study|Adverse Event|35|||
25300698|NCT01041404|50615721|FG000|Overall Study|Lack of Efficacy|200|||
25300699|NCT01041404|50615722|FG001|Overall Study|Lack of Efficacy|210|||
25300700|NCT01041404|50615721|FG000|Overall Study|Violation of Selection Criteria|0|||
25300701|NCT01041404|50615722|FG001|Overall Study|Violation of Selection Criteria|1|||
25300702|NCT01041404|50615721|FG000|Overall Study|Protocol Violation|4|||
25300703|NCT01041404|50615722|FG001|Overall Study|Protocol Violation|0|||
25300704|NCT01041404|50615721|FG000|Overall Study|Withdrawal by Subject|29|||
25300705|NCT01041404|50615722|FG001|Overall Study|Withdrawal by Subject|23|||
25300706|NCT01041404|50615721|FG000|Overall Study|Failure to Return|1|||
25300707|NCT01041404|50615722|FG001|Overall Study|Failure to Return|2|||
25300708|NCT01041404|50615721|FG000|Overall Study|Other|11|||
25300709|NCT01041404|50615722|FG001|Overall Study|Other|23|||
25300710|NCT00777049|50615733|FG000|Overall Study|Withdrawal by Subject|1|||
25300711|NCT00777049|50615734|FG001|Overall Study|Withdrawal by Subject|0|||
25300712|NCT00777049|50615733|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
25300713|NCT00777049|50615734|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
25300714|NCT00774787|50615740|FG000|Overall Study|Lost to Follow-up|1|||
25300715|NCT00888927|50615748|FG000|Overall Study|Adverse Event|0|||
25300716|NCT00888927|50615749|FG001|Overall Study|Adverse Event|0|||
25300717|NCT00888927|50615750|FG002|Overall Study|Adverse Event|0|||
25300718|NCT00888927|50615751|FG003|Overall Study|Adverse Event|1|||
25300719|NCT00888927|50615748|FG000|Overall Study|Withdrawal of consent|0|||
25300720|NCT00888927|50615749|FG001|Overall Study|Withdrawal of consent|0|||
25300721|NCT00888927|50615750|FG002|Overall Study|Withdrawal of consent|0|||
25300722|NCT00888927|50615751|FG003|Overall Study|Withdrawal of consent|1|||
25300723|NCT01040780|50615763|FG000|Overall Study|Protocol Violation|1|||
25300724|NCT01040780|50615764|FG001|Overall Study|Protocol Violation|3|||
25300725|NCT00888849|50615775|FG000|Overall Study|Death|4|||
25300726|NCT00888849|50615776|FG001|Overall Study|Death|7|||
25300727|NCT00888849|50615775|FG000|Overall Study|Lost to Follow-up|1|||
25300728|NCT00888849|50615776|FG001|Overall Study|Lost to Follow-up|2|||
25300729|NCT01059812|50615784|FG000|Overall Study|Adverse Event|9|||
25300730|NCT01059812|50615785|FG001|Overall Study|Adverse Event|5|||
25300731|NCT01059812|50615784|FG000|Overall Study|Lack of Efficacy|2|||
25300732|NCT01059812|50615785|FG001|Overall Study|Lack of Efficacy|2|||
25300733|NCT01059812|50615784|FG000|Overall Study|Protocol Violation|3|||
25300734|NCT01059812|50615785|FG001|Overall Study|Protocol Violation|1|||
25300735|NCT01059812|50615784|FG000|Overall Study|Withdrawal Criteria|9|||
25300736|NCT01059812|50615785|FG001|Overall Study|Withdrawal Criteria|4|||
25300737|NCT01059812|50615784|FG000|Overall Study|Unclassified|14|||
25300738|NCT01059812|50615785|FG001|Overall Study|Unclassified|4|||
25300739|NCT00888615|50615791|FG000|Overall Study|No treatment|2|||
25300740|NCT00845650|50615801|FG000|Overall Study|Withdrawal by Subject|0|||
25300741|NCT00845650|50615802|FG001|Overall Study|Withdrawal by Subject|0|||
25300742|NCT00845650|50615803|FG002|Overall Study|Withdrawal by Subject|0|||
25300743|NCT00845650|50615804|FG003|Overall Study|Withdrawal by Subject|0|||
25300744|NCT00845650|50615805|FG004|Overall Study|Withdrawal by Subject|2|||
25300745|NCT00845650|50615806|FG005|Overall Study|Withdrawal by Subject|0|||
25300746|NCT00845650|50615801|FG000|Overall Study|Lost to Follow-up|0|||
25300747|NCT00845650|50615802|FG001|Overall Study|Lost to Follow-up|0|||
25300748|NCT00845650|50615803|FG002|Overall Study|Lost to Follow-up|3|||
25300749|NCT00845650|50615804|FG003|Overall Study|Lost to Follow-up|1|||
25300750|NCT00845650|50615805|FG004|Overall Study|Lost to Follow-up|0|||
25300751|NCT00845650|50615806|FG005|Overall Study|Lost to Follow-up|1|||
25300752|NCT00845650|50615801|FG000|Overall Study|Sponsor hold on dosing|0|||
25300753|NCT00845650|50615802|FG001|Overall Study|Sponsor hold on dosing|0|||
25300754|NCT00845650|50615803|FG002|Overall Study|Sponsor hold on dosing|0|||
25300755|NCT00845650|50615804|FG003|Overall Study|Sponsor hold on dosing|0|||
25300756|NCT00845650|50615805|FG004|Overall Study|Sponsor hold on dosing|1|||
25300757|NCT00845650|50615806|FG005|Overall Study|Sponsor hold on dosing|1|||
25300758|NCT00845650|50615801|FG000|Overall Study|Unable to access IV line|1|||
25300759|NCT00845650|50615802|FG001|Overall Study|Unable to access IV line|0|||
25300760|NCT00845650|50615803|FG002|Overall Study|Unable to access IV line|0|||
25300761|NCT00845650|50615804|FG003|Overall Study|Unable to access IV line|0|||
25300762|NCT00845650|50615805|FG004|Overall Study|Unable to access IV line|0|||
25300763|NCT00845650|50615806|FG005|Overall Study|Unable to access IV line|0|||
25300764|NCT00888381|50615824|FG000|Overall Study|Lost to Follow-up|0|||
25300765|NCT00888381|50615825|FG001|Overall Study|Lost to Follow-up|1|||
25300766|NCT00887913|50615831|FG000|Overall Study|Withdrawal by Subject|6|||
25300767|NCT00833560|50615835|FG000|Overall Study|Toxicity|13|||
25300768|NCT00833560|50615835|FG000|Overall Study|Adverse Event|11|||
25300769|NCT00833560|50615835|FG000|Overall Study|Protocol Violation|6|||
25300770|NCT00833560|50615835|FG000|Overall Study|Lack of Efficacy|4|||
25300771|NCT00833560|50615835|FG000|Overall Study|Death|2|||
25300772|NCT00833560|50615835|FG000|Overall Study|Pregression of other disease|1|||
25300773|NCT00833560|50615835|FG000|Overall Study|Other|5|||
25300774|NCT00887679|50615839|FG000|Overall Study|Withdrawal by Subject|1|||
25300775|NCT00887679|50615839|FG000|Overall Study|Lost to Follow-up|4|||
25300776|NCT00887679|50615839|FG000|Overall Study|Physician Decision|5|||
25300777|NCT00833482|50615846|FG000|Days 11-20|Adverse Event|0|||
25300778|NCT00833482|50615847|FG001|Days 11-20|Adverse Event|2|||
25300779|NCT00833482|50615848|FG002|Days 11-20|Adverse Event|0|||
25300780|NCT00833482|50615849|FG003|Days 11-20|Adverse Event|0|||
25300781|NCT00833482|50615850|FG004|Days 11-20|Adverse Event|0|||
25300782|NCT00833482|50615851|FG005|Days 11-20|Adverse Event|0|||
25300783|NCT00833482|50615846|FG000|Days 11-20|Withdrawal by Subject|0|||
25300784|NCT00833482|50615847|FG001|Days 11-20|Withdrawal by Subject|1|||
25300785|NCT00833482|50615848|FG002|Days 11-20|Withdrawal by Subject|0|||
25300786|NCT00833482|50615849|FG003|Days 11-20|Withdrawal by Subject|0|||
25300787|NCT00833482|50615850|FG004|Days 11-20|Withdrawal by Subject|0|||
25300788|NCT00833482|50615851|FG005|Days 11-20|Withdrawal by Subject|0|||
25300789|NCT00833482|50615846|FG000|Days 21-30|Adverse Event|0|||
25300790|NCT00833482|50615847|FG001|Days 21-30|Adverse Event|0|||
25300791|NCT00833482|50615848|FG002|Days 21-30|Adverse Event|1|||
25300792|NCT00833482|50615849|FG003|Days 21-30|Adverse Event|0|||
25300793|NCT00833482|50615850|FG004|Days 21-30|Adverse Event|0|||
25300794|NCT00833482|50615851|FG005|Days 21-30|Adverse Event|0|||
25300795|NCT00833482|50615846|FG000|Days 21-30|Withdrawal by Subject|0|||
25300796|NCT00833482|50615847|FG001|Days 21-30|Withdrawal by Subject|0|||
25300797|NCT00833482|50615848|FG002|Days 21-30|Withdrawal by Subject|0|||
25300798|NCT00833482|50615849|FG003|Days 21-30|Withdrawal by Subject|0|||
25300799|NCT00833482|50615850|FG004|Days 21-30|Withdrawal by Subject|1|||
25300800|NCT00833482|50615851|FG005|Days 21-30|Withdrawal by Subject|0|||
25300801|NCT00845182|50615876|FG000|Overall Study|Lost to Follow-up|3|||
25300802|NCT00845182|50615877|FG001|Overall Study|Lost to Follow-up|3|||
25300803|NCT00845182|50615878|FG002|Overall Study|Lost to Follow-up|4|||
25300804|NCT00845182|50615876|FG000|Overall Study|Adverse Event|0|||
25300805|NCT00845182|50615877|FG001|Overall Study|Adverse Event|1|||
25300806|NCT00845182|50615878|FG002|Overall Study|Adverse Event|1|||
25300807|NCT00845182|50615876|FG000|Overall Study|Physician Decision|0|||
25300808|NCT00845182|50615877|FG001|Overall Study|Physician Decision|0|||
25300809|NCT00845182|50615878|FG002|Overall Study|Physician Decision|1|||
25300810|NCT00833248|50615892|FG000|Overall Study|Adverse Event|3|||
25300811|NCT00833248|50615893|FG001|Overall Study|Adverse Event|0|||
25300812|NCT00833248|50615892|FG000|Overall Study|Protocol Violation|1|||
25300813|NCT00833248|50615893|FG001|Overall Study|Protocol Violation|2|||
25300814|NCT00833248|50615892|FG000|Overall Study|Withdrawal by Subject|0|||
25300815|NCT00833248|50615893|FG001|Overall Study|Withdrawal by Subject|1|||
25300816|NCT00887289|50615899|FG000|Overall Study|Lack of Efficacy|14|||
25300817|NCT00887289|50615899|FG000|Overall Study|Adverse Event|27|||
25300818|NCT00887289|50615899|FG000|Overall Study|Withdrawal by Subject|26|||
25300819|NCT00887289|50615899|FG000|Overall Study|Lost to Follow-up|8|||
25300820|NCT00887289|50615899|FG000|Overall Study|Other|20|||
25300821|NCT00833092|50615905|FG000|Overall Study|Withdrawal by Subject|2|||
25300822|NCT00833092|50615906|FG001|Overall Study|Withdrawal by Subject|3|||
25300823|NCT00833092|50615905|FG000|Overall Study|Protocol Violation|2|||
25300824|NCT00833092|50615906|FG001|Overall Study|Protocol Violation|1|||
25300825|NCT00833092|50615905|FG000|Overall Study|Diarrhea|0|||
25300826|NCT00833092|50615906|FG001|Overall Study|Diarrhea|2|||
25300827|NCT00833092|50615905|FG000|Overall Study|constipation|0|||
25300828|NCT00833092|50615906|FG001|Overall Study|constipation|1|||
25300829|NCT00823264|50615914|FG000|Overall Study|Protocol Violation|2|||
25300830|NCT00823264|50615915|FG001|Overall Study|Protocol Violation|0|||
25300831|NCT00832780|50615921|FG000|Overall Study|Death|16|||
25300832|NCT00832780|50615921|FG000|Overall Study|Lost to Follow-up|4|||
25300833|NCT00832780|50615921|FG000|Overall Study|no reason given|2|||
25300834|NCT00832780|50615921|FG000|Overall Study|other complicating condition|2|||
25300835|NCT00832780|50615921|FG000|Overall Study|Physician Decision|1|||
25300836|NCT00591838|50615930|FG000|Overall Study|Withdrawal by Subject|0|||
25300837|NCT00591838|50615931|FG001|Overall Study|Withdrawal by Subject|0|||
24969872|NCT03702010|50059314|FG001|Follow-up (30days)|Lack of Efficacy|2|||
25300838|NCT00591838|50615932|FG002|Overall Study|Withdrawal by Subject|0|||
25300839|NCT00591838|50615933|FG003|Overall Study|Withdrawal by Subject|1|||
25300840|NCT00591838|50615934|FG004|Overall Study|Withdrawal by Subject|0|||
25300841|NCT00832624|50615947|FG000|Overall Study|Study Terminated|10|||
25300842|NCT00832078|50615951|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
25300843|NCT00832078|50615952|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
24969873|NCT04538170|50059328|FG000|Overall Study|Withdrawal by Subject|104|||
24969874|NCT04538170|50059329|FG001|Overall Study|Withdrawal by Subject|210|||
25300844|NCT00832078|50615951|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
25300845|NCT00832078|50615952|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
25300846|NCT00822172|50615960|FG000|Overall Study|Adverse Event|10|||
25300847|NCT00822172|50615961|FG001|Overall Study|Adverse Event|12|||
25300848|NCT00822172|50615960|FG000|Overall Study|Death|1|||
25300849|NCT00822172|50615961|FG001|Overall Study|Death|0|||
25300850|NCT00822172|50615960|FG000|Overall Study|Lost to Follow-up|3|||
25300851|NCT00822172|50615961|FG001|Overall Study|Lost to Follow-up|1|||
25300852|NCT00822172|50615960|FG000|Overall Study|Withdrawal by Subject|1|||
25300853|NCT00822172|50615961|FG001|Overall Study|Withdrawal by Subject|4|||
25300854|NCT00822172|50615960|FG000|Overall Study|site closed|0|||
25300855|NCT00822172|50615961|FG001|Overall Study|site closed|1|||
25300856|NCT00822172|50615960|FG000|Overall Study|Other|0|||
25300857|NCT00822172|50615961|FG001|Overall Study|Other|1|||
25300858|NCT00832000|50615967|FG000|Overall Study|Adverse Event|2|||
25300859|NCT00832000|50615968|FG001|Overall Study|Adverse Event|0|||
25300860|NCT00832000|50615967|FG000|Overall Study|Withdrawal by Subject|1|||
25300861|NCT00832000|50615968|FG001|Overall Study|Withdrawal by Subject|0|||
25300862|NCT00832000|50615967|FG000|Overall Study|No calls to IVR in either period|1|||
25300863|NCT00832000|50615968|FG001|Overall Study|No calls to IVR in either period|1|||
25300864|NCT00832000|50615967|FG000|Overall Study|No calls to IVR in period 2|2|||
25300865|NCT00832000|50615968|FG001|Overall Study|No calls to IVR in period 2|0|||
25300866|NCT00911508|50616005|FG000|Overall Study|Lost to Follow-up|27|||
25300867|NCT00911508|50616006|FG001|Overall Study|Lost to Follow-up|18|||
25300868|NCT00911508|50616005|FG000|Overall Study|Withdrawal by Subject|79|||
25300869|NCT00911508|50616006|FG001|Overall Study|Withdrawal by Subject|112|||
25300870|NCT00774397|50616032|FG000|Overall Study|Adverse Event|1|||
25300871|NCT00774397|50616033|FG001|Overall Study|Adverse Event|3|||
25300872|NCT00774397|50616034|FG002|Overall Study|Adverse Event|16|||
25300873|NCT00774397|50616035|FG003|Overall Study|Adverse Event|8|||
25300874|NCT00774397|50616036|FG004|Overall Study|Adverse Event|8|||
25300875|NCT00774397|50616037|FG005|Overall Study|Adverse Event|3|||
25300876|NCT00774397|50616038|FG006|Overall Study|Adverse Event|16|||
25300877|NCT00774397|50616032|FG000|Overall Study|Lack of Efficacy|11|||
25300878|NCT00774397|50616033|FG001|Overall Study|Lack of Efficacy|4|||
25300879|NCT00774397|50616034|FG002|Overall Study|Lack of Efficacy|5|||
25300880|NCT00774397|50616035|FG003|Overall Study|Lack of Efficacy|3|||
25300881|NCT00774397|50616036|FG004|Overall Study|Lack of Efficacy|27|||
25300882|NCT00774397|50616037|FG005|Overall Study|Lack of Efficacy|15|||
25300883|NCT00774397|50616038|FG006|Overall Study|Lack of Efficacy|9|||
25300884|NCT00774397|50616032|FG000|Overall Study|Protocol Violation|0|||
25300885|NCT00774397|50616033|FG001|Overall Study|Protocol Violation|1|||
25300886|NCT00774397|50616034|FG002|Overall Study|Protocol Violation|3|||
25300887|NCT00774397|50616035|FG003|Overall Study|Protocol Violation|1|||
25300888|NCT00774397|50616036|FG004|Overall Study|Protocol Violation|2|||
25300889|NCT00774397|50616037|FG005|Overall Study|Protocol Violation|1|||
25300890|NCT00774397|50616038|FG006|Overall Study|Protocol Violation|0|||
25300891|NCT00774397|50616032|FG000|Overall Study|Lost to Follow-up|0|||
25300892|NCT00774397|50616033|FG001|Overall Study|Lost to Follow-up|1|||
25300893|NCT00774397|50616034|FG002|Overall Study|Lost to Follow-up|1|||
25300894|NCT00774397|50616035|FG003|Overall Study|Lost to Follow-up|1|||
25300895|NCT00774397|50616036|FG004|Overall Study|Lost to Follow-up|0|||
25300896|NCT00774397|50616037|FG005|Overall Study|Lost to Follow-up|1|||
25300897|NCT00774397|50616038|FG006|Overall Study|Lost to Follow-up|0|||
25300898|NCT00774397|50616032|FG000|Overall Study|Refused to continue trial medication|1|||
25300899|NCT00774397|50616033|FG001|Overall Study|Refused to continue trial medication|3|||
25300900|NCT00774397|50616034|FG002|Overall Study|Refused to continue trial medication|2|||
25300901|NCT00774397|50616035|FG003|Overall Study|Refused to continue trial medication|2|||
25300902|NCT00774397|50616036|FG004|Overall Study|Refused to continue trial medication|6|||
25300903|NCT00774397|50616037|FG005|Overall Study|Refused to continue trial medication|2|||
25300904|NCT00774397|50616038|FG006|Overall Study|Refused to continue trial medication|3|||
25300905|NCT00774397|50616032|FG000|Overall Study|Not treated|0|||
25300906|NCT00774397|50616033|FG001|Overall Study|Not treated|0|||
25300907|NCT00774397|50616034|FG002|Overall Study|Not treated|0|||
25300908|NCT00774397|50616035|FG003|Overall Study|Not treated|0|||
25300909|NCT00774397|50616036|FG004|Overall Study|Not treated|1|||
25300910|NCT00774397|50616037|FG005|Overall Study|Not treated|0|||
25300911|NCT00774397|50616038|FG006|Overall Study|Not treated|1|||
25300912|NCT00774397|50616032|FG000|Overall Study|Other than those stated above|1|||
25300913|NCT00774397|50616033|FG001|Overall Study|Other than those stated above|1|||
25300914|NCT00774397|50616034|FG002|Overall Study|Other than those stated above|3|||
25300915|NCT00774397|50616035|FG003|Overall Study|Other than those stated above|2|||
25300916|NCT00774397|50616036|FG004|Overall Study|Other than those stated above|2|||
25300917|NCT00774397|50616037|FG005|Overall Study|Other than those stated above|0|||
25300918|NCT00774397|50616038|FG006|Overall Study|Other than those stated above|1|||
25300919|NCT00909870|50616093|FG000|Overall Study|Adverse Event|13|||
25300920|NCT00909870|50616094|FG001|Overall Study|Adverse Event|7|||
25300921|NCT00909870|50616093|FG000|Overall Study|Protocol Violation|1|||
25300922|NCT00909870|50616094|FG001|Overall Study|Protocol Violation|2|||
25300923|NCT00909870|50616093|FG000|Overall Study|Withdrawal by Subject|5|||
25300924|NCT00909870|50616094|FG001|Overall Study|Withdrawal by Subject|8|||
25300925|NCT00909870|50616093|FG000|Overall Study|Lost to Follow-up|3|||
25300926|NCT00909870|50616094|FG001|Overall Study|Lost to Follow-up|3|||
25300927|NCT00909870|50616093|FG000|Overall Study|Physician Decision|0|||
25300928|NCT00909870|50616094|FG001|Overall Study|Physician Decision|2|||
25300929|NCT00909870|50616093|FG000|Overall Study|Other|1|||
25300930|NCT00909870|50616094|FG001|Overall Study|Other|5|||
25300931|NCT00768469|50616103|FG000|Overall Study|Adverse Event|0|||
25300932|NCT00768469|50616104|FG001|Overall Study|Adverse Event|2|||
25300933|NCT00768469|50616103|FG000|Overall Study|Disease Progression|3|||
25300934|NCT00768469|50616104|FG001|Overall Study|Disease Progression|4|||
25300935|NCT00768469|50616103|FG000|Overall Study|Withdrawal by Subject|0|||
25300936|NCT00768469|50616104|FG001|Overall Study|Withdrawal by Subject|1|||
25300937|NCT00886821|50616125|FG000|Stage 2|Adverse Event|0|||
25300938|NCT00886821|50616126|FG001|Stage 2|Adverse Event|0|||
25300939|NCT00886821|50616127|FG002|Stage 2|Adverse Event|0|||
25300940|NCT00886821|50616128|FG003|Stage 2|Adverse Event|0|||
25300941|NCT00886821|50616129|FG004|Stage 2|Adverse Event|0|||
25300942|NCT00886821|50616130|FG005|Stage 2|Adverse Event|0|||
25300943|NCT00886821|50616131|FG006|Stage 2|Adverse Event|0|||
25300944|NCT00886821|50616132|FG007|Stage 2|Adverse Event|0|||
25300945|NCT00886821|50616133|FG008|Stage 2|Adverse Event|0|||
25300946|NCT00886821|50616134|FG009|Stage 2|Adverse Event|0|||
25300947|NCT00886821|50616135|FG010|Stage 2|Adverse Event|0|||
25300948|NCT00886821|50616136|FG011|Stage 2|Adverse Event|1|||
25300949|NCT00886821|50616137|FG012|Stage 2|Adverse Event|3|||
25300950|NCT00886821|50616138|FG013|Stage 2|Adverse Event|0|||
25300951|NCT00886821|50616125|FG000|Stage 2|Lost to Follow-up|0|||
25300952|NCT00886821|50616126|FG001|Stage 2|Lost to Follow-up|0|||
25300953|NCT00886821|50616127|FG002|Stage 2|Lost to Follow-up|0|||
25300954|NCT00886821|50616128|FG003|Stage 2|Lost to Follow-up|0|||
25300955|NCT00886821|50616129|FG004|Stage 2|Lost to Follow-up|0|||
25070886|NCT02702193|50176963|FG000|12 Month Follow up|Withdrawal by Subject|1|||
25070887|NCT02702193|50176964|FG001|12 Month Follow up|Withdrawal by Subject|0|||
25070888|NCT02702193|50176963|FG000|12 Month Follow up|Lost to Follow-up|16|||
25070889|NCT02702193|50176964|FG001|12 Month Follow up|Lost to Follow-up|18|||
25070890|NCT02761057|50176974|FG000|Overall Study|Currently On Study Treatment|0|||
25070891|NCT02761057|50176975|FG001|Overall Study|Currently On Study Treatment|3|||
25070892|NCT02761057|50176976|FG002|Overall Study|Currently On Study Treatment|0|||
25070893|NCT02761057|50176977|FG003|Overall Study|Currently On Study Treatment|0|||
25070894|NCT02761057|50176974|FG000|Overall Study|Adverse Event|11|||
25070895|NCT02761057|50176975|FG001|Overall Study|Adverse Event|9|||
25070896|NCT02761057|50176976|FG002|Overall Study|Adverse Event|5|||
25070897|NCT02761057|50176977|FG003|Overall Study|Adverse Event|3|||
25070898|NCT02761057|50176974|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
25070899|NCT02761057|50176975|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
25070900|NCT02761057|50176976|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
25070901|NCT02761057|50176977|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
25070902|NCT02761057|50176974|FG000|Overall Study|Progression/Relapse|29|||
25070903|NCT02761057|50176975|FG001|Overall Study|Progression/Relapse|27|||
25070904|NCT02761057|50176976|FG002|Overall Study|Progression/Relapse|20|||
25070905|NCT02761057|50176977|FG003|Overall Study|Progression/Relapse|23|||
25070906|NCT02761057|50176974|FG000|Overall Study|Death|2|||
25070907|NCT02761057|50176975|FG001|Overall Study|Death|2|||
25070908|NCT02761057|50176976|FG002|Overall Study|Death|1|||
25070909|NCT02761057|50176977|FG003|Overall Study|Death|1|||
25070910|NCT02761057|50176974|FG000|Overall Study|Other - Not Protocol Specified|2|||
25070911|NCT02761057|50176975|FG001|Overall Study|Other - Not Protocol Specified|1|||
25070912|NCT02761057|50176976|FG002|Overall Study|Other - Not Protocol Specified|2|||
25070913|NCT02761057|50176977|FG003|Overall Study|Other - Not Protocol Specified|0|||
25070914|NCT02701413|50176989|FG000|Overall Study|Withdrawal by Subject|7|||
25070915|NCT02701413|50176990|FG001|Overall Study|Withdrawal by Subject|11|||
25070916|NCT02582684|50176996|FG000|Overall Study|Unable to contact subject/parent|4|||
25070917|NCT02582684|50176996|FG000|Overall Study|Subject not able to get to clinic|10|||
25191774|NCT02440581|50353409|FG003|Overall Study|Withdrawal by Subject|7|||
24969875|NCT04537234|50059341|FG000|Overall Study|Withdrawal by Subject|2|||
25070918|NCT02582684|50176996|FG000|Overall Study|Subject withdrew consent|1|||
25070919|NCT02582684|50176996|FG000|Overall Study|Found to be ineligible after enrollment|2|||
25070920|NCT02585960|50177003|FG000|PK/Safety Assessment Period|Physician Decision|0|||
25070921|NCT02585960|50177004|FG001|PK/Safety Assessment Period|Physician Decision|1|||
25070922|NCT02585960|50177005|FG002|PK/Safety Assessment Period|Physician Decision|0|||
25300956|NCT00886821|50616130|FG005|Stage 2|Lost to Follow-up|0|||
25300957|NCT00886821|50616131|FG006|Stage 2|Lost to Follow-up|0|||
25300958|NCT00886821|50616132|FG007|Stage 2|Lost to Follow-up|0|||
25300959|NCT00886821|50616133|FG008|Stage 2|Lost to Follow-up|0|||
25300960|NCT00886821|50616134|FG009|Stage 2|Lost to Follow-up|0|||
25300961|NCT00886821|50616135|FG010|Stage 2|Lost to Follow-up|0|||
25300962|NCT00886821|50616136|FG011|Stage 2|Lost to Follow-up|0|||
25300963|NCT00886821|50616137|FG012|Stage 2|Lost to Follow-up|2|||
25300964|NCT00886821|50616138|FG013|Stage 2|Lost to Follow-up|1|||
25300965|NCT00886743|50616182|FG000|Overall Study|Adverse Event|3|||
25300966|NCT00886743|50616182|FG000|Overall Study|Other|1|||
25300967|NCT00886587|50616188|FG000|Overall Study|Adverse Event|2|||
25300968|NCT00886587|50616189|FG001|Overall Study|Adverse Event|1|||
25300969|NCT00886587|50616188|FG000|Overall Study|Protocol Violation|2|||
25300970|NCT00886587|50616189|FG001|Overall Study|Protocol Violation|0|||
25300971|NCT00886587|50616188|FG000|Overall Study|Withdrawal by Subject|0|||
25300972|NCT00886587|50616189|FG001|Overall Study|Withdrawal by Subject|1|||
25300973|NCT00886119|50616195|FG000|Period 1|Did not meet inclusion criteria|1|||
25300974|NCT00886119|50616196|FG001|Period 1|Did not meet inclusion criteria|0|||
25300975|NCT00768079|50616205|FG000|Overall Study|Lost to Follow-up|2|||
25300976|NCT00768079|50616206|FG001|Overall Study|Lost to Follow-up|0|||
25300977|NCT00768079|50616207|FG002|Overall Study|Lost to Follow-up|4|||
25300978|NCT00768079|50616205|FG000|Overall Study|Participant incarcerated|0|||
25300979|NCT00768079|50616206|FG001|Overall Study|Participant incarcerated|1|||
25300980|NCT00768079|50616207|FG002|Overall Study|Participant incarcerated|0|||
25300981|NCT00767455|50616217|FG000|Overall Study|Investigator error|19|||
25300982|NCT00766831|50616223|FG000|Overall Study|Withdrawal by Subject|4|||
25300983|NCT00766831|50616223|FG000|Overall Study|Lost to Follow-up|3|||
25300984|NCT00766831|50616223|FG000|Overall Study|Adverse Event|20|||
25300985|NCT00766831|50616223|FG000|Overall Study|Protocol Violation|15|||
25300986|NCT00766831|50616223|FG000|Overall Study|Physician Decision|5|||
25300987|NCT00766831|50616223|FG000|Overall Study|Withdrawal of consent|26|||
25300988|NCT00766831|50616223|FG000|Overall Study|Non cooperation by participants|14|||
25300989|NCT00766831|50616223|FG000|Overall Study|Other|28|||
25300990|NCT00766675|50616227|FG000|Overall Study|Adverse Event|16|||
25300991|NCT00766675|50616227|FG000|Overall Study|Lost to Follow-up|2|||
25300992|NCT00766675|50616227|FG000|Overall Study|Withdrawal by Subject|11|||
25300993|NCT00766675|50616227|FG000|Overall Study|Protocol Violation|8|||
25300994|NCT00766675|50616227|FG000|Overall Study|Participant took prohibited medication|1|||
25300995|NCT00766675|50616227|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
25300996|NCT00766675|50616227|FG000|Overall Study|Insufficient therapy|1|||
25300997|NCT00766597|50616231|FG000|Overall Study|Unexpected closure of study|4|||
25300998|NCT00766597|50616231|FG000|Overall Study|Without CCR5-tropic virus|5|||
25300999|NCT00910962|50616240|FG000|Overall Study|Adverse Event|5|||
25301000|NCT00910962|50616241|FG001|Overall Study|Adverse Event|20|||
25301001|NCT00910962|50616242|FG002|Overall Study|Adverse Event|17|||
25301002|NCT00910962|50616240|FG000|Overall Study|Protocol Violation|1|||
25301003|NCT00910962|50616241|FG001|Overall Study|Protocol Violation|3|||
25301004|NCT00910962|50616242|FG002|Overall Study|Protocol Violation|3|||
25301005|NCT00910962|50616240|FG000|Overall Study|Lost to Follow-up|0|||
25301006|NCT00910962|50616241|FG001|Overall Study|Lost to Follow-up|3|||
25301007|NCT00910962|50616242|FG002|Overall Study|Lost to Follow-up|1|||
25301008|NCT00910962|50616240|FG000|Overall Study|Physician Decision|0|||
25301009|NCT00910962|50616241|FG001|Overall Study|Physician Decision|6|||
25301010|NCT00910962|50616242|FG002|Overall Study|Physician Decision|6|||
25301011|NCT00910962|50616240|FG000|Overall Study|Withdrawal by Subject|25|||
25301012|NCT00910962|50616241|FG001|Overall Study|Withdrawal by Subject|32|||
25301013|NCT00910962|50616242|FG002|Overall Study|Withdrawal by Subject|32|||
25301014|NCT00910962|50616240|FG000|Overall Study|Reached defined stopping criteria|12|||
25301015|NCT00910962|50616241|FG001|Overall Study|Reached defined stopping criteria|14|||
25301016|NCT00910962|50616242|FG002|Overall Study|Reached defined stopping criteria|17|||
25301017|NCT00773461|50616254|FG000|Overall Study|Adverse Event|1|||
25301018|NCT00773461|50616255|FG001|Overall Study|Adverse Event|3|||
25301019|NCT00773461|50616254|FG000|Overall Study|Withdrawal by Subject|4|||
25301020|NCT00773461|50616255|FG001|Overall Study|Withdrawal by Subject|1|||
25301021|NCT00773383|50616262|FG000|Overall Study|Adverse Event|4|||
25301022|NCT00773383|50616262|FG000|Overall Study|Death|1|||
25301023|NCT00773383|50616262|FG000|Overall Study|Progression of Disease|23|||
25301024|NCT00773383|50616262|FG000|Overall Study|Other|2|||
25301025|NCT00773383|50616262|FG000|Overall Study|No study dose received|1|||
25301026|NCT00757003|50616270|FG000|Overall Study|Death|33|||
25301027|NCT00757003|50616270|FG000|Overall Study|Lost to Follow-up|9|||
25301028|NCT00757003|50616270|FG000|Overall Study|Withdrawal by Subject|4|||
25301029|NCT00757003|50616270|FG000|Overall Study|Surgically explanted|2|||
25301030|NCT00757003|50616270|FG000|Overall Study|Not implanted|1|||
25301031|NCT00766363|50616279|FG000|Overall Study|Withdrawal by Subject|1|||
25301032|NCT00766363|50616280|FG001|Overall Study|Withdrawal by Subject|0|||
25169378|NCT01831427|50301062|FG010|Overall Study|Withdrew Consent|1|||
25301033|NCT00766363|50616281|FG002|Overall Study|Withdrawal by Subject|0|||
25301034|NCT00766363|50616282|FG003|Overall Study|Withdrawal by Subject|0|||
25301035|NCT00766363|50616279|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
25301036|NCT00766363|50616280|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
25301037|NCT00766363|50616281|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
25301038|NCT00766363|50616282|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
25301039|NCT02636946|50616295|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
25301040|NCT02636946|50616296|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
25301041|NCT02636946|50616295|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
25301042|NCT02636946|50616296|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
25301043|NCT02636946|50616295|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
25301044|NCT02636946|50616296|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
25301045|NCT02636946|50616295|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
25301046|NCT02636946|50616296|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
25301047|NCT02636946|50616295|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
25301048|NCT02636946|50616296|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
25301049|NCT02636946|50616295|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
25301050|NCT02636946|50616296|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
25301051|NCT00766051|50616304|FG000|Overall Study|Withdrawal by Subject|2|||
25301052|NCT00766051|50616305|FG001|Overall Study|Withdrawal by Subject|0|||
25301053|NCT00909792|50616313|FG000|Period 1|Did not meet inclusion criteria|0|||
25301054|NCT00909792|50616314|FG001|Period 1|Did not meet inclusion criteria|1|||
25301055|NCT00909792|50616313|FG000|Period 2|Biomicroscopy|1|||
25301056|NCT00909792|50616314|FG001|Period 2|Biomicroscopy|0|||
25301057|NCT00909792|50616313|FG000|Period 2|Lost to Follow-up|0|||
25301058|NCT00909792|50616314|FG001|Period 2|Lost to Follow-up|1|||
25301059|NCT00765817|50616322|FG000|Overall Study|Adverse Event|13|||
25301060|NCT00765817|50616323|FG001|Overall Study|Adverse Event|1|||
25301061|NCT00765817|50616322|FG000|Overall Study|Death|0|||
25301062|NCT00765817|50616323|FG001|Overall Study|Death|1|||
25301063|NCT00765817|50616322|FG000|Overall Study|Entry criteria not met|2|||
25301064|NCT00765817|50616323|FG001|Overall Study|Entry criteria not met|2|||
25301065|NCT00765817|50616322|FG000|Overall Study|Loss of glucose control|0|||
25301066|NCT00765817|50616323|FG001|Overall Study|Loss of glucose control|2|||
25301067|NCT00765817|50616322|FG000|Overall Study|Lost to Follow-up|1|||
25301068|NCT00765817|50616323|FG001|Overall Study|Lost to Follow-up|3|||
25301069|NCT00765817|50616322|FG000|Overall Study|Physician Decision|2|||
25301070|NCT00765817|50616323|FG001|Overall Study|Physician Decision|1|||
25301071|NCT00765817|50616322|FG000|Overall Study|Protocol Violation|1|||
25301072|NCT00765817|50616323|FG001|Overall Study|Protocol Violation|1|||
25301073|NCT00765817|50616322|FG000|Overall Study|Subject decision|7|||
25301074|NCT00765817|50616323|FG001|Overall Study|Subject decision|11|||
25301075|NCT00772603|50616332|FG000|Overall Study|Withdrawal by Subject|11|||
25301076|NCT00772603|50616333|FG001|Overall Study|Withdrawal by Subject|10|||
25301077|NCT00772603|50616334|FG002|Overall Study|Withdrawal by Subject|6|||
25301078|NCT00772603|50616332|FG000|Overall Study|Adverse Event|37|||
25301079|NCT00772603|50616333|FG001|Overall Study|Adverse Event|18|||
25301080|NCT00772603|50616334|FG002|Overall Study|Adverse Event|10|||
25301081|NCT00772603|50616332|FG000|Overall Study|Subject Non-compliance|1|||
25301082|NCT00772603|50616333|FG001|Overall Study|Subject Non-compliance|6|||
25301083|NCT00772603|50616334|FG002|Overall Study|Subject Non-compliance|4|||
25301084|NCT00772603|50616332|FG000|Overall Study|Protocol Violation|0|||
24969876|NCT04537234|50059342|FG001|Overall Study|Withdrawal by Subject|0|||
25301085|NCT00772603|50616333|FG001|Overall Study|Protocol Violation|1|||
25301086|NCT00772603|50616334|FG002|Overall Study|Protocol Violation|1|||
25301087|NCT00772603|50616332|FG000|Overall Study|Lost to Follow-up|1|||
25301088|NCT00772603|50616333|FG001|Overall Study|Lost to Follow-up|5|||
25301089|NCT00772603|50616334|FG002|Overall Study|Lost to Follow-up|2|||
25301090|NCT00772603|50616332|FG000|Overall Study|Physician Decision|0|||
25301091|NCT00772603|50616333|FG001|Overall Study|Physician Decision|0|||
25301092|NCT00772603|50616334|FG002|Overall Study|Physician Decision|1|||
25301093|NCT00772603|50616332|FG000|Overall Study|Other|2|||
25301094|NCT00772603|50616333|FG001|Overall Study|Other|0|||
25301095|NCT00772603|50616334|FG002|Overall Study|Other|2|||
25301096|NCT00772447|50616347|FG000|Overall Study|Withdrawal by Subject|9|||
25301097|NCT00772447|50616348|FG001|Overall Study|Withdrawal by Subject|5|||
25301098|NCT00772447|50616347|FG000|Overall Study|Physician Decision|4|||
25301099|NCT00772447|50616348|FG001|Overall Study|Physician Decision|8|||
25301100|NCT00772447|50616347|FG000|Overall Study|Lost to Follow-up|2|||
24969877|NCT04537078|50059350|FG000|Overall Study|Protocol Violation|3|||
24969878|NCT04537078|50059351|FG001|Overall Study|Protocol Violation|2|||
24969879|NCT04537078|50059350|FG000|Overall Study|Lost to Follow-up|1|||
24969880|NCT04537078|50059351|FG001|Overall Study|Lost to Follow-up|0|||
24969881|NCT04537078|50059350|FG000|Overall Study|Withdrawal by Subject|0|||
25070923|NCT02585960|50177003|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
25070924|NCT02585960|50177004|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
25301101|NCT00772447|50616348|FG001|Overall Study|Lost to Follow-up|4|||
24969882|NCT04537078|50059351|FG001|Overall Study|Withdrawal by Subject|1|||
24969883|NCT04532164|50059364|FG000|Overall Study|Adverse Event|1|||
24969884|NCT04532164|50059364|FG000|Overall Study|Protocol Violation|5|||
25301102|NCT00772447|50616347|FG000|Overall Study|incorrect enrolment|3|||
25301103|NCT00772447|50616348|FG001|Overall Study|incorrect enrolment|4|||
25301104|NCT00772447|50616347|FG000|Overall Study|Protocol Violation|0|||
25301105|NCT00772447|50616348|FG001|Overall Study|Protocol Violation|1|||
25301106|NCT00772447|50616347|FG000|Overall Study|all others|2|||
25301107|NCT00772447|50616348|FG001|Overall Study|all others|2|||
25301108|NCT00765037|50616355|FG000|Overall Study|Lost to Follow-up|5|||
25301109|NCT00765037|50616355|FG000|Overall Study|Adverse Event|1|||
25301110|NCT00831844|50616369|FG000|Overall Study|Adverse Event|2|||
25301111|NCT00831844|50616370|FG001|Overall Study|Adverse Event|0|||
25301112|NCT00831844|50616371|FG002|Overall Study|Adverse Event|0|||
25301113|NCT00831844|50616372|FG003|Overall Study|Adverse Event|0|||
25301114|NCT00831844|50616373|FG004|Overall Study|Adverse Event|1|||
25301115|NCT00831844|50616374|FG005|Overall Study|Adverse Event|1|||
25301116|NCT00831844|50616375|FG006|Overall Study|Adverse Event|2|||
25301117|NCT00831844|50616376|FG007|Overall Study|Adverse Event|0|||
25301118|NCT00831844|50616377|FG008|Overall Study|Adverse Event|0|||
25301119|NCT00831844|50616378|FG009|Overall Study|Adverse Event|0|||
25301120|NCT00831844|50616369|FG000|Overall Study|Death|0|||
25301121|NCT00831844|50616370|FG001|Overall Study|Death|0|||
25301122|NCT00831844|50616371|FG002|Overall Study|Death|0|||
25301123|NCT00831844|50616372|FG003|Overall Study|Death|1|||
25301124|NCT00831844|50616373|FG004|Overall Study|Death|0|||
25301125|NCT00831844|50616374|FG005|Overall Study|Death|0|||
25301126|NCT00831844|50616375|FG006|Overall Study|Death|0|||
25301127|NCT00831844|50616376|FG007|Overall Study|Death|0|||
25301128|NCT00831844|50616377|FG008|Overall Study|Death|0|||
25301129|NCT00831844|50616378|FG009|Overall Study|Death|0|||
25301130|NCT00831844|50616369|FG000|Overall Study|Lack of Efficacy|8|||
25301131|NCT00831844|50616370|FG001|Overall Study|Lack of Efficacy|10|||
25301132|NCT00831844|50616371|FG002|Overall Study|Lack of Efficacy|15|||
25301133|NCT00831844|50616372|FG003|Overall Study|Lack of Efficacy|8|||
25301134|NCT00831844|50616373|FG004|Overall Study|Lack of Efficacy|11|||
25301135|NCT00831844|50616374|FG005|Overall Study|Lack of Efficacy|17|||
25301136|NCT00831844|50616375|FG006|Overall Study|Lack of Efficacy|8|||
25301137|NCT00831844|50616376|FG007|Overall Study|Lack of Efficacy|9|||
25301138|NCT00831844|50616377|FG008|Overall Study|Lack of Efficacy|7|||
25301139|NCT00831844|50616378|FG009|Overall Study|Lack of Efficacy|0|||
25301140|NCT00831844|50616369|FG000|Overall Study|Physician Decision|0|||
24969885|NCT04532164|50059364|FG000|Overall Study|Lost to Follow-up|1|||
25301141|NCT00831844|50616370|FG001|Overall Study|Physician Decision|1|||
25301142|NCT00831844|50616371|FG002|Overall Study|Physician Decision|3|||
25301143|NCT00831844|50616372|FG003|Overall Study|Physician Decision|1|||
25301144|NCT00831844|50616373|FG004|Overall Study|Physician Decision|1|||
25301145|NCT00831844|50616374|FG005|Overall Study|Physician Decision|1|||
25301146|NCT00831844|50616375|FG006|Overall Study|Physician Decision|0|||
25301147|NCT00831844|50616376|FG007|Overall Study|Physician Decision|0|||
25301148|NCT00831844|50616377|FG008|Overall Study|Physician Decision|1|||
25301149|NCT00831844|50616378|FG009|Overall Study|Physician Decision|0|||
25301150|NCT00831844|50616369|FG000|Overall Study|Withdrawal by Subject|0|||
25301151|NCT00831844|50616370|FG001|Overall Study|Withdrawal by Subject|0|||
25301152|NCT00831844|50616371|FG002|Overall Study|Withdrawal by Subject|1|||
25301153|NCT00831844|50616372|FG003|Overall Study|Withdrawal by Subject|0|||
25301154|NCT00831844|50616373|FG004|Overall Study|Withdrawal by Subject|0|||
25301155|NCT00831844|50616374|FG005|Overall Study|Withdrawal by Subject|0|||
25301156|NCT00831844|50616375|FG006|Overall Study|Withdrawal by Subject|0|||
25301157|NCT00831844|50616376|FG007|Overall Study|Withdrawal by Subject|1|||
25301158|NCT00831844|50616377|FG008|Overall Study|Withdrawal by Subject|1|||
25301159|NCT00831844|50616378|FG009|Overall Study|Withdrawal by Subject|0|||
25301160|NCT00831844|50616369|FG000|Overall Study|Ineligible|0|||
25301161|NCT00831844|50616370|FG001|Overall Study|Ineligible|1|||
25301162|NCT00831844|50616371|FG002|Overall Study|Ineligible|1|||
25301163|NCT00831844|50616372|FG003|Overall Study|Ineligible|0|||
25301164|NCT00831844|50616373|FG004|Overall Study|Ineligible|1|||
25301165|NCT00831844|50616374|FG005|Overall Study|Ineligible|0|||
25301166|NCT00831844|50616375|FG006|Overall Study|Ineligible|0|||
25301167|NCT00831844|50616376|FG007|Overall Study|Ineligible|0|||
25301168|NCT00831844|50616377|FG008|Overall Study|Ineligible|0|||
25301169|NCT00831844|50616378|FG009|Overall Study|Ineligible|0|||
25301170|NCT00764881|50616402|FG000|Overall Study|Adverse Event|5|||
25301171|NCT00764881|50616403|FG001|Overall Study|Adverse Event|1|||
25301172|NCT00764881|50616402|FG000|Overall Study|Withdrawal by Subject|1|||
25301173|NCT00764881|50616403|FG001|Overall Study|Withdrawal by Subject|3|||
25301174|NCT00764881|50616402|FG000|Overall Study|Protocol Violation|2|||
25301175|NCT00764881|50616403|FG001|Overall Study|Protocol Violation|2|||
25301176|NCT00764881|50616402|FG000|Overall Study|Lost to Follow-up|2|||
25301177|NCT00764881|50616403|FG001|Overall Study|Lost to Follow-up|0|||
25301178|NCT00764881|50616402|FG000|Overall Study|Noncompliant|1|||
25301179|NCT00764881|50616403|FG001|Overall Study|Noncompliant|0|||
25301180|NCT00764881|50616402|FG000|Overall Study|Accidentally discontinued study drug|1|||
25301181|NCT00764881|50616403|FG001|Overall Study|Accidentally discontinued study drug|0|||
25301182|NCT00764881|50616402|FG000|Overall Study|Wished to become pregnant|1|||
25301183|NCT00764881|50616403|FG001|Overall Study|Wished to become pregnant|0|||
25301184|NCT00764881|50616402|FG000|Overall Study|Carcinoma detected|1|||
25301185|NCT00764881|50616403|FG001|Overall Study|Carcinoma detected|0|||
25301186|NCT00764881|50616402|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
25301187|NCT00764881|50616403|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
25301188|NCT00764881|50616402|FG000|Overall Study|no treatment or no observation|2|||
25301189|NCT00764881|50616403|FG001|Overall Study|no treatment or no observation|2|||
25301190|NCT00844558|50616411|FG000|Overall Study|Withdrawal by Subject|9|||
25301191|NCT00844558|50616412|FG001|Overall Study|Withdrawal by Subject|2|||
25301192|NCT00844558|50616411|FG000|Overall Study|Death|1|||
25301193|NCT00844558|50616412|FG001|Overall Study|Death|0|||
25301194|NCT00844558|50616411|FG000|Overall Study|Protocol Violation|1|||
25301195|NCT00844558|50616412|FG001|Overall Study|Protocol Violation|1|||
25301196|NCT00844558|50616411|FG000|Overall Study|Lost to Follow-up|0|||
25301197|NCT00844558|50616412|FG001|Overall Study|Lost to Follow-up|1|||
25301198|NCT00844558|50616411|FG000|Overall Study|Physician Decision|1|||
25301199|NCT00844558|50616412|FG001|Overall Study|Physician Decision|0|||
25301200|NCT00772369|50616423|FG000|Overall Study|Did not return record release form|1|||
25301201|NCT00821236|50616430|FG000|Overall Study|Lost to Follow-up|3|||
25301202|NCT00756457|50616440|FG000|Overall Study|Lost to Follow-up|1|||
25301203|NCT00756457|50616441|FG001|Overall Study|Lost to Follow-up|2|||
25301204|NCT00844480|50616465|FG000|Overall Study|Withdrawal by Subject|2|||
25301205|NCT00844480|50616466|FG001|Overall Study|Withdrawal by Subject|3|||
25301206|NCT00771901|50616475|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
25301207|NCT00771901|50616476|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
25301208|NCT00771901|50616477|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
25301209|NCT00843856|50616487|FG000|Overall Study|Lost to Follow-up|1|||
25301210|NCT00843856|50616488|FG001|Overall Study|Lost to Follow-up|2|||
25301211|NCT00764491|50616496|FG000|Overall Study|Lost to Follow-up|35|||
25301212|NCT00764491|50616497|FG001|Overall Study|Lost to Follow-up|17|||
25301213|NCT00843778|50616503|FG000|Overall Study|Adverse Event|15|||
25301214|NCT00843778|50616503|FG000|Overall Study|Lack of Efficacy|14|||
25301215|NCT00843778|50616503|FG000|Overall Study|Loss of efficacy|2|||
25301216|NCT00843778|50616503|FG000|Overall Study|Withdrawal by Subject|4|||
25301217|NCT00591370|50616507|FG000|Overall Study|Not Treated|2|||
25301218|NCT00910728|50616520|FG000|Overall Study|Lack of Efficacy|2|||
25301219|NCT00910728|50616521|FG001|Overall Study|Lack of Efficacy|3|||
25301220|NCT00910728|50616522|FG002|Overall Study|Lack of Efficacy|1|||
25301221|NCT00910728|50616523|FG003|Overall Study|Lack of Efficacy|2|||
25301222|NCT00910728|50616524|FG004|Overall Study|Lack of Efficacy|1|||
25301223|NCT00910728|50616525|FG005|Overall Study|Lack of Efficacy|0|||
25301224|NCT00910728|50616526|FG006|Overall Study|Lack of Efficacy|2|||
25301225|NCT00910728|50616527|FG007|Overall Study|Lack of Efficacy|2|||
25301226|NCT00910728|50616528|FG008|Overall Study|Lack of Efficacy|2|||
25301227|NCT00910728|50616520|FG000|Overall Study|Withdrawal by Subject|0|||
25301228|NCT00910728|50616521|FG001|Overall Study|Withdrawal by Subject|0|||
25301229|NCT00910728|50616522|FG002|Overall Study|Withdrawal by Subject|0|||
25301230|NCT00910728|50616523|FG003|Overall Study|Withdrawal by Subject|0|||
25301231|NCT00910728|50616524|FG004|Overall Study|Withdrawal by Subject|3|||
25301232|NCT00910728|50616525|FG005|Overall Study|Withdrawal by Subject|1|||
25301233|NCT00910728|50616526|FG006|Overall Study|Withdrawal by Subject|2|||
25301234|NCT00910728|50616527|FG007|Overall Study|Withdrawal by Subject|0|||
25301235|NCT00910728|50616528|FG008|Overall Study|Withdrawal by Subject|0|||
25301236|NCT00910728|50616520|FG000|Overall Study|(not specified)|2|||
25301237|NCT00910728|50616521|FG001|Overall Study|(not specified)|0|||
25301238|NCT00910728|50616522|FG002|Overall Study|(not specified)|1|||
25301239|NCT00910728|50616523|FG003|Overall Study|(not specified)|0|||
25301240|NCT00910728|50616524|FG004|Overall Study|(not specified)|1|||
25301241|NCT00910728|50616525|FG005|Overall Study|(not specified)|0|||
25301242|NCT00910728|50616526|FG006|Overall Study|(not specified)|0|||
25301243|NCT00910728|50616527|FG007|Overall Study|(not specified)|0|||
25301244|NCT00910728|50616528|FG008|Overall Study|(not specified)|0|||
25301245|NCT00910728|50616520|FG000|Overall Study|Adverse Event|2|||
25301246|NCT00910728|50616521|FG001|Overall Study|Adverse Event|0|||
25301247|NCT00910728|50616522|FG002|Overall Study|Adverse Event|1|||
25301248|NCT00910728|50616523|FG003|Overall Study|Adverse Event|1|||
25301249|NCT00910728|50616524|FG004|Overall Study|Adverse Event|0|||
25301250|NCT00910728|50616525|FG005|Overall Study|Adverse Event|0|||
25191775|NCT01359150|50353421|FG000|Overall Study|Lack of Efficacy|1|||
25191776|NCT01359150|50353422|FG001|Overall Study|Lack of Efficacy|1|||
25191777|NCT01359150|50353421|FG000|Overall Study|Withdrawal by Subject|1|||
25191778|NCT01359150|50353422|FG001|Overall Study|Withdrawal by Subject|1|||
25301251|NCT00910728|50616526|FG006|Overall Study|Adverse Event|2|||
25301252|NCT00910728|50616527|FG007|Overall Study|Adverse Event|1|||
25301253|NCT00910728|50616528|FG008|Overall Study|Adverse Event|1|||
25301254|NCT00820222|50616550|FG000|Overall Study|Lost to Follow-up|10|||
25301255|NCT00820222|50616551|FG001|Overall Study|Lost to Follow-up|9|||
25301256|NCT00820222|50616550|FG000|Overall Study|Withdrawal by Subject|19|||
25301257|NCT00820222|50616551|FG001|Overall Study|Withdrawal by Subject|21|||
25301258|NCT00820222|50616550|FG000|Overall Study|Physician Decision|93|||
25301259|NCT00820222|50616551|FG001|Overall Study|Physician Decision|88|||
25301260|NCT00820222|50616550|FG000|Overall Study|Sponsor Terminated Study|43|||
25301261|NCT00820222|50616551|FG001|Overall Study|Sponsor Terminated Study|65|||
25191779|NCT01359150|50353421|FG000|Overall Study|Adverse Event|4|||
25301262|NCT00820222|50616550|FG000|Overall Study|Unkown|11|||
25301263|NCT00820222|50616551|FG001|Overall Study|Unkown|7|||
25301264|NCT01039688|50616560|FG000|Overall Study|Adverse Event|38|||
25191780|NCT01359150|50353422|FG001|Overall Study|Adverse Event|3|||
25191781|NCT01359150|50353421|FG000|Overall Study|Other|1|||
25191782|NCT01359150|50353422|FG001|Overall Study|Other|0|||
25191783|NCT01469000|50353483|FG000|Overall Study|Withdrawal by Subject|16|||
25191784|NCT01469000|50353484|FG001|Overall Study|Withdrawal by Subject|3|||
25191785|NCT01469000|50353483|FG000|Overall Study|Sponsor Decision|4|||
25191786|NCT01469000|50353484|FG001|Overall Study|Sponsor Decision|1|||
25191787|NCT01490060|50353497|FG000|Cycle 1|Change of Treatment|0|||
25191788|NCT01490060|50353498|FG001|Cycle 1|Change of Treatment|1|||
25191789|NCT01490060|50353499|FG002|Cycle 1|Change of Treatment|1|||
25191790|NCT01490060|50353500|FG003|Cycle 1|Change of Treatment|1|||
25191791|NCT01490060|50353497|FG000|Cycle 1|Insurance Denied|0|||
25191792|NCT01490060|50353498|FG001|Cycle 1|Insurance Denied|0|||
25191793|NCT01490060|50353499|FG002|Cycle 1|Insurance Denied|2|||
25191794|NCT01490060|50353500|FG003|Cycle 1|Insurance Denied|0|||
25191795|NCT01490060|50353497|FG000|Cycle 1|Withdrawal by Subject|0|||
25191796|NCT01490060|50353498|FG001|Cycle 1|Withdrawal by Subject|0|||
25191797|NCT01490060|50353499|FG002|Cycle 1|Withdrawal by Subject|0|||
25191798|NCT01490060|50353500|FG003|Cycle 1|Withdrawal by Subject|1|||
25191799|NCT01490060|50353497|FG000|Cycle 1|Treatment at Another Facility|0|||
25191800|NCT01490060|50353498|FG001|Cycle 1|Treatment at Another Facility|0|||
25191801|NCT01490060|50353499|FG002|Cycle 1|Treatment at Another Facility|0|||
25191802|NCT01490060|50353500|FG003|Cycle 1|Treatment at Another Facility|1|||
25191803|NCT01490060|50353497|FG000|Cycle 2|Change of Treatment|1|||
25191804|NCT01490060|50353498|FG001|Cycle 2|Change of Treatment|1|||
25191805|NCT01490060|50353499|FG002|Cycle 2|Change of Treatment|0|||
25191806|NCT01490060|50353500|FG003|Cycle 2|Change of Treatment|0|||
25191807|NCT01490060|50353497|FG000|Cycle 2|Non-Compliance|0|||
25191808|NCT01490060|50353498|FG001|Cycle 2|Non-Compliance|0|||
25191809|NCT01490060|50353499|FG002|Cycle 2|Non-Compliance|1|||
25191810|NCT01490060|50353500|FG003|Cycle 2|Non-Compliance|0|||
25191811|NCT01490060|50353497|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
25191812|NCT01490060|50353498|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
25191813|NCT01490060|50353499|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
25191814|NCT01490060|50353500|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
25191815|NCT01452152|50353552|FG000|Overall Study|Study termination by sponsor|5|||
25191816|NCT01452152|50353553|FG001|Overall Study|Study termination by sponsor|0|||
25191817|NCT01452152|50353554|FG002|Overall Study|Study termination by sponsor|4|||
25191818|NCT01451762|50353565|FG000|Overall Study|Lost to Follow-up|3|||
25191819|NCT01451762|50353566|FG001|Overall Study|Lost to Follow-up|6|||
25191820|NCT01451762|50353567|FG002|Overall Study|Lost to Follow-up|6|||
25191821|NCT01468844|50353602|FG000|Overall Study|Adverse Event|1|||
25191822|NCT01468844|50353603|FG001|Overall Study|Adverse Event|0|||
25191823|NCT01468844|50353602|FG000|Overall Study|Withdrawal by Subject|1|||
25191824|NCT01468844|50353603|FG001|Overall Study|Withdrawal by Subject|0|||
25191825|NCT01451606|50353627|FG000|Overall Study|Withdrawal by Subject|4|||
25191826|NCT01451606|50353628|FG001|Overall Study|Withdrawal by Subject|3|||
25191827|NCT00473343|50353683|FG000|Overall Study|Adverse Event|9|||
25191828|NCT00473343|50353683|FG000|Overall Study|Lost to Follow-up|8|||
25191829|NCT00473343|50353683|FG000|Overall Study|Treatment failure|27|||
25191830|NCT00473343|50353683|FG000|Overall Study|Withdrew consent|3|||
25191831|NCT00473343|50353683|FG000|Overall Study|Other un-specified reason|3|||
25191832|NCT02587962|50354140|FG000|Overall Study|Adverse Event|0|||
25191833|NCT02587962|50354141|FG001|Overall Study|Adverse Event|0|||
25191834|NCT02587962|50354142|FG002|Overall Study|Adverse Event|1|||
25191835|NCT02587962|50354143|FG003|Overall Study|Adverse Event|0|||
25191836|NCT02587962|50354144|FG004|Overall Study|Adverse Event|0|||
25191837|NCT02587962|50354140|FG000|Overall Study|Withdrawal by Subject|0|||
25191838|NCT02587962|50354141|FG001|Overall Study|Withdrawal by Subject|0|||
25191839|NCT02587962|50354142|FG002|Overall Study|Withdrawal by Subject|1|||
25301265|NCT01039688|50616561|FG001|Overall Study|Adverse Event|39|||
25301266|NCT01039688|50616562|FG002|Overall Study|Adverse Event|24|||
25301267|NCT01039688|50616560|FG000|Overall Study|Lack of Efficacy|20|||
25301268|NCT01039688|50616561|FG001|Overall Study|Lack of Efficacy|11|||
25301269|NCT01039688|50616562|FG002|Overall Study|Lack of Efficacy|26|||
25301270|NCT01039688|50616560|FG000|Overall Study|Lost to Follow-up|11|||
25301271|NCT01039688|50616561|FG001|Overall Study|Lost to Follow-up|9|||
25301272|NCT01039688|50616562|FG002|Overall Study|Lost to Follow-up|5|||
25301273|NCT01039688|50616560|FG000|Overall Study|Other|13|||
25301274|NCT01039688|50616561|FG001|Overall Study|Other|25|||
25301275|NCT01039688|50616562|FG002|Overall Study|Other|12|||
25301276|NCT01039688|50616560|FG000|Overall Study|Withdrawal by Subject|23|||
25301277|NCT01039688|50616561|FG001|Overall Study|Withdrawal by Subject|27|||
25301278|NCT01039688|50616562|FG002|Overall Study|Withdrawal by Subject|13|||
25301279|NCT01039688|50616560|FG000|Overall Study|Death|2|||
25301280|NCT01039688|50616561|FG001|Overall Study|Death|0|||
25301281|NCT01039688|50616562|FG002|Overall Study|Death|0|||
25301282|NCT02237508|50616583|FG000|Overall Study|Withdrawal by Subject|0|||
25301283|NCT02237508|50616584|FG001|Overall Study|Withdrawal by Subject|2|||
25301284|NCT02237508|50616585|FG002|Overall Study|Withdrawal by Subject|0|||
25301285|NCT02237508|50616586|FG003|Overall Study|Withdrawal by Subject|1|||
25301286|NCT02237508|50616587|FG004|Overall Study|Withdrawal by Subject|0|||
25301287|NCT02237508|50616588|FG005|Overall Study|Withdrawal by Subject|1|||
25301288|NCT02237508|50616589|FG006|Overall Study|Withdrawal by Subject|1|||
25301289|NCT02237508|50616590|FG007|Overall Study|Withdrawal by Subject|0|||
25301290|NCT02237508|50616591|FG008|Overall Study|Withdrawal by Subject|1|||
25301291|NCT02237508|50616592|FG009|Overall Study|Withdrawal by Subject|0|||
25301292|NCT02237508|50616583|FG000|Overall Study|Physician Decision|0|||
25301293|NCT02237508|50616584|FG001|Overall Study|Physician Decision|1|||
25301294|NCT02237508|50616585|FG002|Overall Study|Physician Decision|0|||
25301295|NCT02237508|50616586|FG003|Overall Study|Physician Decision|0|||
25301296|NCT02237508|50616587|FG004|Overall Study|Physician Decision|0|||
25301297|NCT02237508|50616588|FG005|Overall Study|Physician Decision|0|||
25301298|NCT02237508|50616589|FG006|Overall Study|Physician Decision|0|||
25301299|NCT02237508|50616590|FG007|Overall Study|Physician Decision|0|||
25301300|NCT02237508|50616591|FG008|Overall Study|Physician Decision|0|||
25301301|NCT02237508|50616592|FG009|Overall Study|Physician Decision|0|||
25301302|NCT02237508|50616583|FG000|Overall Study|Protocol Violation|0|||
25301303|NCT02237508|50616584|FG001|Overall Study|Protocol Violation|0|||
25301304|NCT02237508|50616585|FG002|Overall Study|Protocol Violation|1|||
25301305|NCT02237508|50616586|FG003|Overall Study|Protocol Violation|0|||
25301306|NCT02237508|50616587|FG004|Overall Study|Protocol Violation|0|||
25301307|NCT02237508|50616588|FG005|Overall Study|Protocol Violation|0|||
25301308|NCT02237508|50616589|FG006|Overall Study|Protocol Violation|0|||
25301309|NCT02237508|50616590|FG007|Overall Study|Protocol Violation|0|||
25301310|NCT02237508|50616591|FG008|Overall Study|Protocol Violation|0|||
25301311|NCT02237508|50616592|FG009|Overall Study|Protocol Violation|0|||
25301312|NCT00909090|50616612|FG000|Overall Study|Lost to Follow-up|17|||
25301313|NCT00909090|50616613|FG001|Overall Study|Lost to Follow-up|17|||
25301314|NCT00909480|50616624|FG000|Overall Study|Adverse Event|5|||
25301315|NCT00909480|50616625|FG001|Overall Study|Adverse Event|3|||
25301316|NCT00909480|50616624|FG000|Overall Study|Protocol Violation|6|||
25301317|NCT00909480|50616625|FG001|Overall Study|Protocol Violation|8|||
25301318|NCT00909480|50616624|FG000|Overall Study|Withdrawal criteria|9|||
25301319|NCT00909480|50616625|FG001|Overall Study|Withdrawal criteria|11|||
25301320|NCT00909480|50616624|FG000|Overall Study|Unclassified|18|||
25301321|NCT00909480|50616625|FG001|Overall Study|Unclassified|19|||
25301322|NCT01058096|50616633|FG000|Double-blind Treatment Phase|Adverse Event|11|||
25301323|NCT01058096|50616634|FG001|Double-blind Treatment Phase|Adverse Event|15|||
25301324|NCT01058096|50616633|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
25301325|NCT01058096|50616634|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
24969886|NCT04532164|50059364|FG000|Overall Study|Found to be Ineligible|3|||
24969887|NCT04532164|50059364|FG000|Overall Study|Withdrawal by Subject|14|||
24969888|NCT00116688|50059371|FG000|Overall Study|Protocol deviation|1|||
24969889|NCT00116688|50059372|FG001|Overall Study|Protocol deviation|0|||
25301326|NCT01058096|50616633|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
25301327|NCT01058096|50616634|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
25301328|NCT01058096|50616633|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
25301329|NCT01058096|50616634|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
25301330|NCT01058096|50616633|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
25301331|NCT01058096|50616634|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
25301332|NCT01058096|50616633|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
25301333|NCT01058096|50616634|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
25301334|NCT01057862|50616642|FG000|Overall Study|Withdrawal by Subject|1|||
25301335|NCT01057862|50616643|FG001|Overall Study|Withdrawal by Subject|2|||
25301336|NCT01038128|50616649|FG000|Overall Study|Lack of Efficacy|1|||
25301337|NCT01038128|50616649|FG000|Overall Study|Lost to Follow-up|1|||
25301338|NCT01038128|50616649|FG000|Overall Study|Withdrawal by Subject|2|||
25301339|NCT00842530|50616670|FG000|Overall Study|Serious adverse event|0|||
25301340|NCT00842530|50616671|FG001|Overall Study|Serious adverse event|6|||
25301341|NCT00842530|50616670|FG000|Overall Study|Other adverse event|6|||
25301342|NCT00842530|50616671|FG001|Overall Study|Other adverse event|1|||
25301343|NCT00842530|50616670|FG000|Overall Study|Protocol Violation|32|||
25301344|NCT00842530|50616671|FG001|Overall Study|Protocol Violation|14|||
25301345|NCT00842530|50616670|FG000|Overall Study|Lost to Follow-up|6|||
25301346|NCT00842530|50616671|FG001|Overall Study|Lost to Follow-up|8|||
25301347|NCT00842530|50616670|FG000|Overall Study|Withdrawal by Subject|73|||
25301348|NCT00842530|50616671|FG001|Overall Study|Withdrawal by Subject|28|||
25301349|NCT00819910|50616682|FG000|Overall Study|Adverse Event|0|||
25301350|NCT00819910|50616683|FG001|Overall Study|Adverse Event|0|||
25301351|NCT00819910|50616684|FG002|Overall Study|Adverse Event|2|||
25301352|NCT00819910|50616685|FG003|Overall Study|Adverse Event|1|||
25301353|NCT00819910|50616682|FG000|Overall Study|Withdrawal by Subject|1|||
25301354|NCT00819910|50616683|FG001|Overall Study|Withdrawal by Subject|1|||
25301355|NCT00819910|50616684|FG002|Overall Study|Withdrawal by Subject|1|||
25301356|NCT00819910|50616685|FG003|Overall Study|Withdrawal by Subject|0|||
25301357|NCT00819910|50616682|FG000|Overall Study|Lost to Follow-up|1|||
25301358|NCT00819910|50616683|FG001|Overall Study|Lost to Follow-up|0|||
25301359|NCT00819910|50616684|FG002|Overall Study|Lost to Follow-up|0|||
25301360|NCT00819910|50616685|FG003|Overall Study|Lost to Follow-up|0|||
25301361|NCT00830518|50616699|FG000|Overall Study|Progressive Disease|18|||
25301362|NCT00830518|50616700|FG001|Overall Study|Progressive Disease|8|||
25301363|NCT00830518|50616699|FG000|Overall Study|Symptomatic Deterioration|4|||
25301364|NCT00830518|50616700|FG001|Overall Study|Symptomatic Deterioration|1|||
24969890|NCT00116688|50059371|FG000|Overall Study|Noncompliance|3|||
25301365|NCT00830518|50616699|FG000|Overall Study|Adverse Event|14|||
25301366|NCT00830518|50616700|FG001|Overall Study|Adverse Event|1|||
25301367|NCT00830518|50616699|FG000|Overall Study|Withdrawal by Patient|2|||
25301368|NCT00830518|50616700|FG001|Overall Study|Withdrawal by Patient|0|||
25301369|NCT00830518|50616699|FG000|Overall Study|Reason not Specified|8|||
25301370|NCT00830518|50616700|FG001|Overall Study|Reason not Specified|1|||
25301371|NCT00908544|50616709|FG000|Overall Study|Withdrawal by Subject|2|||
25301372|NCT00908544|50616710|FG001|Overall Study|Withdrawal by Subject|4|||
25301373|NCT00908544|50616709|FG000|Overall Study|Lack of Efficacy|0|||
25301374|NCT00908544|50616710|FG001|Overall Study|Lack of Efficacy|1|||
25301375|NCT00908544|50616709|FG000|Overall Study|Pregnancy|1|||
25301376|NCT00908544|50616710|FG001|Overall Study|Pregnancy|0|||
25301377|NCT00908544|50616709|FG000|Overall Study|Relocation abroad|1|||
25301378|NCT00908544|50616710|FG001|Overall Study|Relocation abroad|1|||
25301379|NCT00908544|50616709|FG000|Overall Study|Unable to visit sutdy center|1|||
25301380|NCT00908544|50616710|FG001|Overall Study|Unable to visit sutdy center|0|||
25301381|NCT00830440|50616718|FG000|Overall Study|Protocol Violation|1|||
25301382|NCT00830440|50616719|FG001|Overall Study|Protocol Violation|0|||
25301383|NCT00830440|50616718|FG000|Overall Study|Withdrawal by Subject|1|||
25301384|NCT00830440|50616719|FG001|Overall Study|Withdrawal by Subject|0|||
25301385|NCT00830440|50616718|FG000|Overall Study|unsuccessful procedure|4|||
25301386|NCT00830440|50616719|FG001|Overall Study|unsuccessful procedure|0|||
25301387|NCT00830440|50616718|FG000|Overall Study|Adverse Event|2|||
25301388|NCT00830440|50616719|FG001|Overall Study|Adverse Event|0|||
25301389|NCT00908310|50616726|FG000|Overall Study|Death|37|||
25301390|NCT00908310|50616726|FG000|Overall Study|Withdrawal by Subject|7|||
25301391|NCT00908310|50616726|FG000|Overall Study|Lost to Follow-up|7|||
25301392|NCT00908310|50616726|FG000|Overall Study|Screening failure|5|||
25301393|NCT00908310|50616726|FG000|Overall Study|Other reasons|4|||
25301394|NCT00830128|50616730|FG000|Overall Study|Adverse Event|5|||
25301395|NCT00830128|50616730|FG000|Overall Study|Lack of Efficacy|7|||
25301396|NCT00830128|50616730|FG000|Overall Study|Protocol Violation|1|||
25301397|NCT00830128|50616730|FG000|Overall Study|Withdrawal by Subject|2|||
25301398|NCT00830128|50616730|FG000|Overall Study|Family obligation|1|||
25301399|NCT00830128|50616730|FG000|Overall Study|Relocation|1|||
25301400|NCT00830128|50616730|FG000|Overall Study|Work obligation|1|||
25301401|NCT00830128|50616730|FG000|Overall Study|Operating a vehicle|1|||
25301402|NCT00841906|50616736|FG000|Overall Study|Withdrawal by Subject|2|||
25301403|NCT00841906|50616737|FG001|Overall Study|Withdrawal by Subject|0|||
25301404|NCT00771667|50616749|FG000|Induction Phase|Adverse Event|5|||
25301405|NCT00771667|50616750|FG001|Induction Phase|Adverse Event|2|||
25301406|NCT00771667|50616751|FG002|Induction Phase|Adverse Event|4|||
25301407|NCT00771667|50616752|FG003|Induction Phase|Adverse Event|1|||
24969891|NCT00116688|50059372|FG001|Overall Study|Noncompliance|1|||
24969892|NCT00116688|50059371|FG000|Overall Study|Adverse Event|11|||
24969893|NCT00116688|50059372|FG001|Overall Study|Adverse Event|0|||
24969894|NCT00116688|50059371|FG000|Overall Study|Withdrawal by Subject|26|||
24969895|NCT00116688|50059372|FG001|Overall Study|Withdrawal by Subject|2|||
24969896|NCT00116688|50059371|FG000|Overall Study|Requirement for alternative therapy|11|||
24969897|NCT00116688|50059372|FG001|Overall Study|Requirement for alternative therapy|1|||
25191840|NCT02587962|50354143|FG003|Overall Study|Withdrawal by Subject|1|||
25301408|NCT00771667|50616753|FG004|Induction Phase|Adverse Event|0|||
25301409|NCT00771667|50616754|FG005|Induction Phase|Adverse Event|0|||
25301410|NCT00771667|50616755|FG006|Induction Phase|Adverse Event|0|||
25301411|NCT00771667|50616756|FG007|Induction Phase|Adverse Event|0|||
25301412|NCT00771667|50616757|FG008|Induction Phase|Adverse Event|0|||
25301413|NCT00771667|50616758|FG009|Induction Phase|Adverse Event|0|||
25301414|NCT00771667|50616749|FG000|Induction Phase|Lack of Efficacy|9|||
25301415|NCT00771667|50616750|FG001|Induction Phase|Lack of Efficacy|2|||
25301416|NCT00771667|50616751|FG002|Induction Phase|Lack of Efficacy|4|||
25301417|NCT00771667|50616752|FG003|Induction Phase|Lack of Efficacy|3|||
25301418|NCT00771667|50616753|FG004|Induction Phase|Lack of Efficacy|0|||
25301419|NCT00771667|50616754|FG005|Induction Phase|Lack of Efficacy|0|||
25301420|NCT00771667|50616755|FG006|Induction Phase|Lack of Efficacy|0|||
25301421|NCT00771667|50616756|FG007|Induction Phase|Lack of Efficacy|0|||
25301422|NCT00771667|50616757|FG008|Induction Phase|Lack of Efficacy|0|||
25301423|NCT00771667|50616758|FG009|Induction Phase|Lack of Efficacy|0|||
25301424|NCT00771667|50616749|FG000|Induction Phase|Lost to Follow-up|1|||
25301425|NCT00771667|50616750|FG001|Induction Phase|Lost to Follow-up|0|||
25301426|NCT00771667|50616751|FG002|Induction Phase|Lost to Follow-up|1|||
25301427|NCT00771667|50616752|FG003|Induction Phase|Lost to Follow-up|0|||
25301428|NCT00771667|50616753|FG004|Induction Phase|Lost to Follow-up|0|||
25301429|NCT00771667|50616754|FG005|Induction Phase|Lost to Follow-up|0|||
25301430|NCT00771667|50616755|FG006|Induction Phase|Lost to Follow-up|0|||
25301431|NCT00771667|50616756|FG007|Induction Phase|Lost to Follow-up|0|||
25301432|NCT00771667|50616757|FG008|Induction Phase|Lost to Follow-up|0|||
25301433|NCT00771667|50616758|FG009|Induction Phase|Lost to Follow-up|0|||
25301434|NCT00771667|50616749|FG000|Induction Phase|Other|4|||
25301435|NCT00771667|50616750|FG001|Induction Phase|Other|6|||
25301436|NCT00771667|50616751|FG002|Induction Phase|Other|3|||
25301437|NCT00771667|50616752|FG003|Induction Phase|Other|4|||
25301438|NCT00771667|50616753|FG004|Induction Phase|Other|0|||
25301439|NCT00771667|50616754|FG005|Induction Phase|Other|0|||
25301440|NCT00771667|50616755|FG006|Induction Phase|Other|0|||
25301441|NCT00771667|50616756|FG007|Induction Phase|Other|0|||
25301442|NCT00771667|50616757|FG008|Induction Phase|Other|0|||
25301443|NCT00771667|50616758|FG009|Induction Phase|Other|0|||
25301444|NCT00771667|50616749|FG000|Maintenance Phase|Adverse Event|0|||
25301445|NCT00771667|50616750|FG001|Maintenance Phase|Adverse Event|0|||
24969898|NCT00116688|50059371|FG000|Overall Study|Physician Decision|7|||
24969899|NCT00116688|50059372|FG001|Overall Study|Physician Decision|0|||
25301446|NCT00771667|50616751|FG002|Maintenance Phase|Adverse Event|0|||
25301447|NCT00771667|50616752|FG003|Maintenance Phase|Adverse Event|0|||
25301448|NCT00771667|50616753|FG004|Maintenance Phase|Adverse Event|1|||
25301449|NCT00771667|50616754|FG005|Maintenance Phase|Adverse Event|3|||
25301450|NCT00771667|50616755|FG006|Maintenance Phase|Adverse Event|5|||
25301451|NCT00771667|50616756|FG007|Maintenance Phase|Adverse Event|1|||
25301452|NCT00771667|50616757|FG008|Maintenance Phase|Adverse Event|8|||
25301453|NCT00771667|50616758|FG009|Maintenance Phase|Adverse Event|7|||
25301454|NCT00771667|50616749|FG000|Maintenance Phase|Lack of Efficacy|0|||
25301455|NCT00771667|50616750|FG001|Maintenance Phase|Lack of Efficacy|0|||
25301456|NCT00771667|50616751|FG002|Maintenance Phase|Lack of Efficacy|0|||
25301457|NCT00771667|50616752|FG003|Maintenance Phase|Lack of Efficacy|0|||
25301458|NCT00771667|50616753|FG004|Maintenance Phase|Lack of Efficacy|1|||
25301459|NCT00771667|50616754|FG005|Maintenance Phase|Lack of Efficacy|3|||
25301460|NCT00771667|50616755|FG006|Maintenance Phase|Lack of Efficacy|3|||
25301461|NCT00771667|50616756|FG007|Maintenance Phase|Lack of Efficacy|2|||
25301462|NCT00771667|50616757|FG008|Maintenance Phase|Lack of Efficacy|11|||
25301463|NCT00771667|50616758|FG009|Maintenance Phase|Lack of Efficacy|7|||
25301464|NCT00771667|50616749|FG000|Maintenance Phase|Other|0|||
25301465|NCT00771667|50616750|FG001|Maintenance Phase|Other|0|||
24969900|NCT00116688|50059371|FG000|Overall Study|Lost to Follow-up|3|||
24969901|NCT00116688|50059372|FG001|Overall Study|Lost to Follow-up|0|||
25301466|NCT00771667|50616751|FG002|Maintenance Phase|Other|0|||
25301467|NCT00771667|50616752|FG003|Maintenance Phase|Other|0|||
25301468|NCT00771667|50616753|FG004|Maintenance Phase|Other|0|||
25301469|NCT00771667|50616754|FG005|Maintenance Phase|Other|1|||
25301470|NCT00771667|50616755|FG006|Maintenance Phase|Other|2|||
25301471|NCT00771667|50616756|FG007|Maintenance Phase|Other|2|||
25301472|NCT00771667|50616757|FG008|Maintenance Phase|Other|3|||
25301473|NCT00771667|50616758|FG009|Maintenance Phase|Other|3|||
25301474|NCT00770965|50616780|FG000|Safety Set|Withdrawal by Subject|0|||
25301475|NCT00770965|50616781|FG001|Safety Set|Withdrawal by Subject|0|||
25301476|NCT00770965|50616782|FG002|Safety Set|Withdrawal by Subject|0|||
25301477|NCT00770965|50616783|FG003|Safety Set|Withdrawal by Subject|1|||
25301478|NCT00770965|50616780|FG000|Safety Set|Protocol deviation|0|||
25301479|NCT00770965|50616781|FG001|Safety Set|Protocol deviation|0|||
25301480|NCT00770965|50616782|FG002|Safety Set|Protocol deviation|1|||
25301481|NCT00770965|50616783|FG003|Safety Set|Protocol deviation|0|||
25301482|NCT00770965|50616780|FG000|Excluded Set|Administrative problems|14|||
25301483|NCT00770965|50616781|FG001|Excluded Set|Administrative problems|12|||
25301484|NCT00770965|50616782|FG002|Excluded Set|Administrative problems|12|||
25301485|NCT00770965|50616783|FG003|Excluded Set|Administrative problems|10|||
25301486|NCT00770965|50616780|FG000|Excluded Set|Withdrawal by Subject|1|||
25301487|NCT00770965|50616781|FG001|Excluded Set|Withdrawal by Subject|1|||
25301488|NCT00770965|50616782|FG002|Excluded Set|Withdrawal by Subject|2|||
25301489|NCT00770965|50616783|FG003|Excluded Set|Withdrawal by Subject|3|||
25301490|NCT00763555|50616795|FG000|Overall Study|Adverse Event|2|||
25301491|NCT00763555|50616796|FG001|Overall Study|Adverse Event|1|||
25301492|NCT00763555|50616795|FG000|Overall Study|Withdrawal by Subject|2|||
25301493|NCT00763555|50616796|FG001|Overall Study|Withdrawal by Subject|6|||
25301494|NCT00763555|50616795|FG000|Overall Study|Lost to Follow-up|0|||
25301495|NCT00763555|50616796|FG001|Overall Study|Lost to Follow-up|3|||
25301496|NCT00763321|50616805|FG000|Open-label Period|Adverse Event|24|||
25301497|NCT00763321|50616806|FG001|Open-label Period|Adverse Event|0|||
25301498|NCT00763321|50616807|FG002|Open-label Period|Adverse Event|0|||
25301499|NCT00763321|50616805|FG000|Open-label Period|Lost to Follow-up|14|||
25301500|NCT00763321|50616806|FG001|Open-label Period|Lost to Follow-up|0|||
25301501|NCT00763321|50616807|FG002|Open-label Period|Lost to Follow-up|0|||
25301502|NCT00763321|50616805|FG000|Open-label Period|Withdrawal by Subject|7|||
25301503|NCT00763321|50616806|FG001|Open-label Period|Withdrawal by Subject|0|||
25301504|NCT00763321|50616807|FG002|Open-label Period|Withdrawal by Subject|0|||
25301505|NCT00763321|50616805|FG000|Open-label Period|Subject noncompliant|7|||
25301506|NCT00763321|50616806|FG001|Open-label Period|Subject noncompliant|0|||
25301507|NCT00763321|50616807|FG002|Open-label Period|Subject noncompliant|0|||
25301508|NCT00763321|50616805|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
25301509|NCT00763321|50616806|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
25301510|NCT00763321|50616807|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
25301511|NCT00763321|50616805|FG000|Open-label Period|Lack of Efficacy|2|||
25301512|NCT00763321|50616806|FG001|Open-label Period|Lack of Efficacy|0|||
25301513|NCT00763321|50616807|FG002|Open-label Period|Lack of Efficacy|0|||
25301514|NCT00763321|50616805|FG000|Open-label Period|Other|4|||
25301515|NCT00763321|50616806|FG001|Open-label Period|Other|0|||
25301516|NCT00763321|50616807|FG002|Open-label Period|Other|0|||
24969902|NCT00116688|50059371|FG000|Overall Study|Death|15|||
25301517|NCT00763321|50616805|FG000|Double-blind Period|Lack of Efficacy|0|||
25301518|NCT00763321|50616806|FG001|Double-blind Period|Lack of Efficacy|9|||
25301519|NCT00763321|50616807|FG002|Double-blind Period|Lack of Efficacy|17|||
25301520|NCT00763321|50616805|FG000|Double-blind Period|Adverse Event|0|||
25301521|NCT00763321|50616806|FG001|Double-blind Period|Adverse Event|4|||
25301522|NCT00763321|50616807|FG002|Double-blind Period|Adverse Event|4|||
25301523|NCT00763321|50616805|FG000|Double-blind Period|Lost to Follow-up|0|||
25301524|NCT00763321|50616806|FG001|Double-blind Period|Lost to Follow-up|4|||
25301525|NCT00763321|50616807|FG002|Double-blind Period|Lost to Follow-up|2|||
25301526|NCT00763321|50616805|FG000|Double-blind Period|Withdrawal by Subject|0|||
25301527|NCT00763321|50616806|FG001|Double-blind Period|Withdrawal by Subject|2|||
25301528|NCT00763321|50616807|FG002|Double-blind Period|Withdrawal by Subject|3|||
25301529|NCT00763321|50616805|FG000|Double-blind Period|Other|0|||
25301530|NCT00763321|50616806|FG001|Double-blind Period|Other|2|||
25301531|NCT00763321|50616807|FG002|Double-blind Period|Other|3|||
25301532|NCT00770653|50616816|FG000|Overall Study|Adverse Event|13|||
25301533|NCT00770653|50616817|FG001|Overall Study|Adverse Event|5|||
25301534|NCT00770653|50616816|FG000|Overall Study|Protocol Violation|8|||
25301535|NCT00770653|50616817|FG001|Overall Study|Protocol Violation|6|||
25301536|NCT00770653|50616816|FG000|Overall Study|Withdrawal by Subject|4|||
25301537|NCT00770653|50616817|FG001|Overall Study|Withdrawal by Subject|7|||
25301538|NCT00770653|50616816|FG000|Overall Study|Lack of Compliance|1|||
25301539|NCT00770653|50616817|FG001|Overall Study|Lack of Compliance|4|||
25301540|NCT00770653|50616816|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
25301541|NCT00770653|50616817|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
25301542|NCT00770653|50616816|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
25301543|NCT00770653|50616817|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
25301544|NCT00770653|50616816|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
25301545|NCT00770653|50616817|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
25301546|NCT00770653|50616816|FG000|Overall Study|Lost to Follow-up|1|||
25301547|NCT00770653|50616817|FG001|Overall Study|Lost to Follow-up|2|||
25301548|NCT00770653|50616816|FG000|Overall Study|Physician Decision|1|||
25301549|NCT00770653|50616817|FG001|Overall Study|Physician Decision|0|||
25301550|NCT00819052|50616825|FG000|Overall Study|Adverse Event|0|||
25301551|NCT00819052|50616826|FG001|Overall Study|Adverse Event|5|||
25301552|NCT00819052|50616825|FG000|Overall Study|Protocol Violation|1|||
25301553|NCT00819052|50616826|FG001|Overall Study|Protocol Violation|2|||
25301554|NCT00819052|50616825|FG000|Overall Study|Lost to Follow-up|1|||
25301555|NCT00819052|50616826|FG001|Overall Study|Lost to Follow-up|2|||
25301556|NCT00819052|50616825|FG000|Overall Study|Withdrawal by Subject|1|||
25301557|NCT00819052|50616826|FG001|Overall Study|Withdrawal by Subject|2|||
25301558|NCT00819052|50616825|FG000|Overall Study|Lack of Efficacy|1|||
25301559|NCT00819052|50616826|FG001|Overall Study|Lack of Efficacy|1|||
25301560|NCT00819052|50616825|FG000|Overall Study|Pregnancy|1|||
25301561|NCT00819052|50616826|FG001|Overall Study|Pregnancy|2|||
25301562|NCT00819052|50616825|FG000|Overall Study|Death or events leading to death|1|||
25301563|NCT00819052|50616826|FG001|Overall Study|Death or events leading to death|0|||
25301564|NCT00763009|50616835|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
25301565|NCT00841672|50616842|FG000|Overall Study|Adverse Event|7|||
25301566|NCT00841672|50616843|FG001|Overall Study|Adverse Event|16|||
25301567|NCT00841672|50616842|FG000|Overall Study|Abnormal test procedure result(s)|0|||
25301568|NCT00841672|50616843|FG001|Overall Study|Abnormal test procedure result(s)|1|||
25301569|NCT00841672|50616842|FG000|Overall Study|Subject withdrew consent|2|||
25301570|NCT00841672|50616843|FG001|Overall Study|Subject withdrew consent|4|||
25301571|NCT00841672|50616842|FG000|Overall Study|Lost to Follow-up|1|||
25301572|NCT00841672|50616843|FG001|Overall Study|Lost to Follow-up|1|||
25301573|NCT00841672|50616842|FG000|Overall Study|Administrative problems|9|||
25301574|NCT00841672|50616843|FG001|Overall Study|Administrative problems|9|||
25301575|NCT00841672|50616842|FG000|Overall Study|Misrandomized|1|||
25301576|NCT00841672|50616843|FG001|Overall Study|Misrandomized|0|||
25301577|NCT00841672|50616842|FG000|Overall Study|Protocol Deviation|0|||
25301578|NCT00841672|50616843|FG001|Overall Study|Protocol Deviation|1|||
25301579|NCT00908232|50616849|FG000|Cycle 1 to 4|Death|5|||
25301580|NCT00908232|50616850|FG001|Cycle 1 to 4|Death|0|||
25301581|NCT00908232|50616851|FG002|Cycle 1 to 4|Death|0|||
25301582|NCT00908232|50616852|FG003|Cycle 1 to 4|Death|0|||
25301583|NCT00908232|50616849|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
25301584|NCT00908232|50616850|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
25301585|NCT00908232|50616851|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
25301586|NCT00908232|50616852|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
25301587|NCT00908232|50616849|FG000|Cycle 1 to 4|Progressive Disease|6|||
25301588|NCT00908232|50616850|FG001|Cycle 1 to 4|Progressive Disease|0|||
25301589|NCT00908232|50616851|FG002|Cycle 1 to 4|Progressive Disease|0|||
25301590|NCT00908232|50616852|FG003|Cycle 1 to 4|Progressive Disease|0|||
25301591|NCT00908232|50616849|FG000|Cycle 1 to 4|Adverse Event|12|||
25191841|NCT02587962|50354144|FG004|Overall Study|Withdrawal by Subject|4|||
25191842|NCT02587962|50354140|FG000|Overall Study|Radiological progression|2|||
25191843|NCT02587962|50354141|FG001|Overall Study|Radiological progression|2|||
25191844|NCT02587962|50354142|FG002|Overall Study|Radiological progression|2|||
25191845|NCT02587962|50354143|FG003|Overall Study|Radiological progression|5|||
25191846|NCT02587962|50354144|FG004|Overall Study|Radiological progression|10|||
25191847|NCT02587962|50354140|FG000|Overall Study|Clinical progression|0|||
25191848|NCT02587962|50354141|FG001|Overall Study|Clinical progression|1|||
25191849|NCT02587962|50354142|FG002|Overall Study|Clinical progression|2|||
25191850|NCT02587962|50354143|FG003|Overall Study|Clinical progression|0|||
25191851|NCT02587962|50354144|FG004|Overall Study|Clinical progression|1|||
25191852|NCT01440374|50354298|FG000|Part 1: Open-label Phase|Adverse Event|5|||
25191853|NCT01440374|50354299|FG001|Part 1: Open-label Phase|Adverse Event|0|||
25191854|NCT01440374|50354300|FG002|Part 1: Open-label Phase|Adverse Event|0|||
25191855|NCT01440374|50354301|FG003|Part 1: Open-label Phase|Adverse Event|0|||
25191856|NCT01440374|50354298|FG000|Part 1: Open-label Phase|Physician Decision|1|||
25191857|NCT01440374|50354299|FG001|Part 1: Open-label Phase|Physician Decision|0|||
25191858|NCT01440374|50354300|FG002|Part 1: Open-label Phase|Physician Decision|0|||
25191859|NCT01440374|50354301|FG003|Part 1: Open-label Phase|Physician Decision|0|||
25191860|NCT01440374|50354298|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
25191861|NCT01440374|50354299|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
25191862|NCT01440374|50354300|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
25191863|NCT01440374|50354301|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
25191864|NCT01440374|50354298|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
25191865|NCT01440374|50354299|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
25191866|NCT01440374|50354300|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
25191867|NCT01440374|50354301|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
25191868|NCT01440374|50354298|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
25191869|NCT01440374|50354299|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
25191870|NCT01440374|50354300|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
25191871|NCT01440374|50354301|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
25191872|NCT01440374|50354298|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
25191873|NCT01440374|50354299|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
25191874|NCT01440374|50354300|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
25191875|NCT01440374|50354301|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
25191876|NCT01440374|50354298|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
25191877|NCT01440374|50354299|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
25191878|NCT01440374|50354300|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
25191879|NCT01440374|50354301|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
25191880|NCT01440374|50354298|FG000|Part 2; Double-blind Phase|Not treated|0|||
25191881|NCT01440374|50354299|FG001|Part 2; Double-blind Phase|Not treated|0|||
25191882|NCT01440374|50354300|FG002|Part 2; Double-blind Phase|Not treated|1|||
25191883|NCT01440374|50354301|FG003|Part 2; Double-blind Phase|Not treated|0|||
25191884|NCT01440374|50354298|FG000|Part 3: Extension|Withdrawal by Subject|0|||
25301592|NCT00908232|50616850|FG001|Cycle 1 to 4|Adverse Event|0|||
25301593|NCT00908232|50616851|FG002|Cycle 1 to 4|Adverse Event|0|||
25301594|NCT00908232|50616852|FG003|Cycle 1 to 4|Adverse Event|0|||
25301595|NCT00908232|50616849|FG000|Cycle 1 to 4|Other|1|||
25301596|NCT00908232|50616850|FG001|Cycle 1 to 4|Other|0|||
25301597|NCT00908232|50616851|FG002|Cycle 1 to 4|Other|0|||
25191885|NCT01440374|50354299|FG001|Part 3: Extension|Withdrawal by Subject|0|||
25191886|NCT01440374|50354300|FG002|Part 3: Extension|Withdrawal by Subject|0|||
25191887|NCT01440374|50354301|FG003|Part 3: Extension|Withdrawal by Subject|5|||
25191888|NCT01440374|50354298|FG000|Part 3: Extension|Adverse Event|0|||
25191889|NCT01440374|50354299|FG001|Part 3: Extension|Adverse Event|0|||
25191890|NCT01440374|50354300|FG002|Part 3: Extension|Adverse Event|0|||
25191891|NCT01440374|50354301|FG003|Part 3: Extension|Adverse Event|13|||
25301598|NCT00908232|50616852|FG003|Cycle 1 to 4|Other|0|||
25301599|NCT00908232|50616849|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
25301600|NCT00908232|50616850|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
25301601|NCT00908232|50616851|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
25301602|NCT00908232|50616852|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
25301603|NCT00908232|50616849|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
25301604|NCT00908232|50616850|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
25301605|NCT00908232|50616851|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
25301606|NCT00908232|50616852|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
25301607|NCT00908232|50616849|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
25301608|NCT00908232|50616850|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
25301609|NCT00908232|50616851|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
25301610|NCT00908232|50616852|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
25301611|NCT00908232|50616849|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
25301612|NCT00908232|50616850|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
25301613|NCT00908232|50616851|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
25301614|NCT00908232|50616852|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
25301615|NCT00908232|50616849|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
25301616|NCT00908232|50616850|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
25301617|NCT00908232|50616851|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
25301618|NCT00908232|50616852|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
25191892|NCT01440374|50354298|FG000|Part 3: Extension|Physician Decision|0|||
25191893|NCT01440374|50354299|FG001|Part 3: Extension|Physician Decision|0|||
25301619|NCT00908232|50616849|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
25301620|NCT00908232|50616850|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
25301621|NCT00908232|50616851|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
25301622|NCT00908232|50616852|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
25301623|NCT00908232|50616849|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
25301624|NCT00908232|50616850|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
25301625|NCT00908232|50616851|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
25301626|NCT00908232|50616852|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
25301627|NCT00908232|50616849|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
25301628|NCT00908232|50616850|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
25301629|NCT00908232|50616851|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
25301630|NCT00908232|50616852|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
25070925|NCT02585960|50177005|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
25301631|NCT00770341|50616861|FG000|Overall Study|Did not meet eligibility criteria|1|||
25191894|NCT01440374|50354300|FG002|Part 3: Extension|Physician Decision|0|||
25191895|NCT01440374|50354301|FG003|Part 3: Extension|Physician Decision|14|||
25301632|NCT00770341|50616862|FG001|Overall Study|Did not meet eligibility criteria|0|||
25301633|NCT00770341|50616863|FG002|Overall Study|Did not meet eligibility criteria|0|||
25301634|NCT00770341|50616861|FG000|Overall Study|Withdrawal by Subject|0|||
25301635|NCT00770341|50616862|FG001|Overall Study|Withdrawal by Subject|1|||
25070926|NCT02585960|50177003|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
25070927|NCT02585960|50177004|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
25070928|NCT02585960|50177005|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
25301636|NCT00770341|50616863|FG002|Overall Study|Withdrawal by Subject|0|||
25301637|NCT00770341|50616861|FG000|Overall Study|Clinical Adverse Event|3|||
25301638|NCT00770341|50616862|FG001|Overall Study|Clinical Adverse Event|1|||
25301639|NCT00770341|50616863|FG002|Overall Study|Clinical Adverse Event|2|||
25301640|NCT00770341|50616861|FG000|Overall Study|Laboratory adverse event|3|||
25301641|NCT00770341|50616862|FG001|Overall Study|Laboratory adverse event|3|||
25301642|NCT00770341|50616863|FG002|Overall Study|Laboratory adverse event|0|||
25301643|NCT00770341|50616861|FG000|Overall Study|Lack of Efficacy|3|||
25301644|NCT00770341|50616862|FG001|Overall Study|Lack of Efficacy|0|||
25301645|NCT00770341|50616863|FG002|Overall Study|Lack of Efficacy|1|||
25301646|NCT00770341|50616861|FG000|Overall Study|Other|1|||
25301647|NCT00770341|50616862|FG001|Overall Study|Other|0|||
25301648|NCT00770341|50616863|FG002|Overall Study|Other|0|||
25301649|NCT00770341|50616861|FG000|Overall Study|Not treated|1|||
25301650|NCT00770341|50616862|FG001|Overall Study|Not treated|0|||
25301651|NCT00770341|50616863|FG002|Overall Study|Not treated|0|||
25070929|NCT02585960|50177003|FG000|PK/Safety Assessment Period|Other|4|||
25070930|NCT02585960|50177004|FG001|PK/Safety Assessment Period|Other|4|||
25070931|NCT02585960|50177005|FG002|PK/Safety Assessment Period|Other|0|||
25070932|NCT02585960|50177003|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
25070933|NCT02585960|50177004|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
25070934|NCT02585960|50177005|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
25070935|NCT02585960|50177003|FG000|PK/Safety Assessment Period|Screen Failure|0|||
25070936|NCT02585960|50177004|FG001|PK/Safety Assessment Period|Screen Failure|0|||
25070937|NCT02585960|50177005|FG002|PK/Safety Assessment Period|Screen Failure|1|||
25070938|NCT02585960|50177003|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
25070939|NCT02585960|50177004|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
25070940|NCT02585960|50177005|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
25070941|NCT02585960|50177003|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
25070942|NCT02585960|50177004|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
25070943|NCT02585960|50177005|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
25070944|NCT02760433|50177021|FG000|Overall Study|Lost to Follow-up|1|||
25070945|NCT02760433|50177022|FG001|Overall Study|Lost to Follow-up|0|||
25070946|NCT02760433|50177023|FG002|Overall Study|Lost to Follow-up|1|||
25070947|NCT02760433|50177024|FG003|Overall Study|Lost to Follow-up|0|||
25070948|NCT02760433|50177025|FG004|Overall Study|Lost to Follow-up|0|||
25070949|NCT02760433|50177021|FG000|Overall Study|Withdrawal by Subject|23|||
25070950|NCT02760433|50177022|FG001|Overall Study|Withdrawal by Subject|9|||
25070951|NCT02760433|50177023|FG002|Overall Study|Withdrawal by Subject|0|||
25070952|NCT02760433|50177024|FG003|Overall Study|Withdrawal by Subject|2|||
25070953|NCT02760433|50177025|FG004|Overall Study|Withdrawal by Subject|9|||
25070954|NCT02760433|50177021|FG000|Overall Study|Lack of Response At Week 14|0|||
25070955|NCT02760433|50177022|FG001|Overall Study|Lack of Response At Week 14|0|||
25070956|NCT02760433|50177023|FG002|Overall Study|Lack of Response At Week 14|0|||
25070957|NCT02760433|50177024|FG003|Overall Study|Lack of Response At Week 14|0|||
25070958|NCT02760433|50177025|FG004|Overall Study|Lack of Response At Week 14|1|||
25070959|NCT02760433|50177021|FG000|Overall Study|Subject refused to continue the study|1|||
25301652|NCT00762463|50616880|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
25070960|NCT02760433|50177022|FG001|Overall Study|Subject refused to continue the study|0|||
25301653|NCT00762463|50616881|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
25070961|NCT02760433|50177023|FG002|Overall Study|Subject refused to continue the study|0|||
25070962|NCT02760433|50177024|FG003|Overall Study|Subject refused to continue the study|0|||
25301654|NCT00762463|50616882|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
25301655|NCT00762463|50616883|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
25301656|NCT00762463|50616880|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
25301657|NCT00762463|50616881|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
25301658|NCT00762463|50616882|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
25301659|NCT00762463|50616883|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
25301660|NCT00762463|50616880|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
25301661|NCT00762463|50616881|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
25301662|NCT00762463|50616882|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
25301663|NCT00762463|50616883|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
25301664|NCT00762463|50616880|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
25301665|NCT00762463|50616881|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
25301666|NCT00762463|50616882|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
25301667|NCT00762463|50616883|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
25301668|NCT00762463|50616880|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
25301669|NCT00762463|50616881|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
25301670|NCT00762463|50616882|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
25301671|NCT00762463|50616883|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
25301672|NCT00762463|50616880|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
25301673|NCT00762463|50616881|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
25301674|NCT00762463|50616882|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
25301675|NCT00762463|50616883|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
25301676|NCT00762463|50616880|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
25301677|NCT00762463|50616881|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
25301678|NCT00762463|50616882|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
25301679|NCT00762463|50616883|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
25301680|NCT00762463|50616880|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
25301681|NCT00762463|50616881|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
25301682|NCT00762463|50616882|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
25301683|NCT00762463|50616883|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
25301684|NCT00762385|50616896|FG000|First Intervention|Lens Issue|1|||
25301685|NCT00762385|50616897|FG001|First Intervention|Lens Issue|1|||
25301686|NCT00762385|50616896|FG000|First Intervention|Lost to Follow-up|0|||
25301687|NCT00762385|50616897|FG001|First Intervention|Lost to Follow-up|2|||
25301688|NCT00762385|50616896|FG000|First Intervention|Ineligible|1|||
25301689|NCT00762385|50616897|FG001|First Intervention|Ineligible|0|||
25301690|NCT00762385|50616896|FG000|First Intervention|Protocol Violation|0|||
25301691|NCT00762385|50616897|FG001|First Intervention|Protocol Violation|1|||
25301692|NCT00762385|50616896|FG000|Second Intervention|Protocol Violation|3|||
25301693|NCT00762385|50616897|FG001|Second Intervention|Protocol Violation|3|||
25301694|NCT00906282|50616906|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
25301695|NCT00906282|50616906|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
25301696|NCT00906282|50616906|FG000|Preoperative Chemotherapy|Progressive disease|6|||
25301697|NCT00906282|50616906|FG000|Preoperative Chemotherapy|Toxicity|1|||
25301698|NCT00762229|50616913|FG000|Overall Study|Lost to Follow-up|1|||
25301699|NCT00762229|50616914|FG001|Overall Study|Lost to Follow-up|1|||
25301700|NCT00762229|50616913|FG000|Overall Study|did not recveive intervention|0|||
25301701|NCT00762229|50616914|FG001|Overall Study|did not recveive intervention|1|||
25301702|NCT00907374|50616922|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
25301703|NCT00907374|50616923|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
25301704|NCT00818662|50616933|FG000|Overall Study|Adverse Event|5|||
25301705|NCT00818662|50616934|FG001|Overall Study|Adverse Event|14|||
25301706|NCT00818662|50616935|FG002|Overall Study|Adverse Event|4|||
25301707|NCT00818662|50616936|FG003|Overall Study|Adverse Event|3|||
25301708|NCT00818662|50616933|FG000|Overall Study|Withdrawal by Subject|5|||
25301709|NCT00818662|50616934|FG001|Overall Study|Withdrawal by Subject|4|||
25301710|NCT00818662|50616935|FG002|Overall Study|Withdrawal by Subject|2|||
25301711|NCT00818662|50616936|FG003|Overall Study|Withdrawal by Subject|2|||
25301712|NCT00818662|50616933|FG000|Overall Study|Death|1|||
25301713|NCT00818662|50616934|FG001|Overall Study|Death|3|||
25301714|NCT00818662|50616935|FG002|Overall Study|Death|0|||
25301715|NCT00818662|50616936|FG003|Overall Study|Death|0|||
25301716|NCT00818662|50616933|FG000|Overall Study|Physician Decision|1|||
25301717|NCT00818662|50616934|FG001|Overall Study|Physician Decision|0|||
25301718|NCT00818662|50616935|FG002|Overall Study|Physician Decision|0|||
25301719|NCT00818662|50616936|FG003|Overall Study|Physician Decision|0|||
25301720|NCT00818662|50616933|FG000|Overall Study|Lost to Follow-up|0|||
25301721|NCT00818662|50616934|FG001|Overall Study|Lost to Follow-up|0|||
25301722|NCT00818662|50616935|FG002|Overall Study|Lost to Follow-up|0|||
25301723|NCT00818662|50616936|FG003|Overall Study|Lost to Follow-up|1|||
25301724|NCT00818662|50616933|FG000|Overall Study|Unwilling or Unable to Participate|4|||
25301725|NCT00818662|50616934|FG001|Overall Study|Unwilling or Unable to Participate|6|||
25301726|NCT00818662|50616935|FG002|Overall Study|Unwilling or Unable to Participate|2|||
25301727|NCT00818662|50616936|FG003|Overall Study|Unwilling or Unable to Participate|4|||
25301728|NCT00818662|50616933|FG000|Overall Study|Protocol Violation|1|||
25301729|NCT00818662|50616934|FG001|Overall Study|Protocol Violation|1|||
25301730|NCT00818662|50616935|FG002|Overall Study|Protocol Violation|0|||
25301731|NCT00818662|50616936|FG003|Overall Study|Protocol Violation|0|||
25301732|NCT00818662|50616933|FG000|Overall Study|Requires a Prohibited Medication|1|||
25301733|NCT00818662|50616934|FG001|Overall Study|Requires a Prohibited Medication|0|||
25301734|NCT00818662|50616935|FG002|Overall Study|Requires a Prohibited Medication|0|||
25301735|NCT00818662|50616936|FG003|Overall Study|Requires a Prohibited Medication|0|||
25301736|NCT00818662|50616933|FG000|Overall Study|Safety Risk|1|||
25301737|NCT00818662|50616934|FG001|Overall Study|Safety Risk|1|||
25301738|NCT00818662|50616935|FG002|Overall Study|Safety Risk|0|||
25301739|NCT00818662|50616936|FG003|Overall Study|Safety Risk|1|||
25301740|NCT00818662|50616933|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
25301741|NCT00818662|50616934|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
25301742|NCT00818662|50616935|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
25301743|NCT00818662|50616936|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
25301744|NCT00818662|50616933|FG000|Overall Study|Participant's health declined|0|||
25301745|NCT00818662|50616934|FG001|Overall Study|Participant's health declined|0|||
25301746|NCT00818662|50616935|FG002|Overall Study|Participant's health declined|0|||
25301747|NCT00818662|50616936|FG003|Overall Study|Participant's health declined|1|||
25301748|NCT00818662|50616933|FG000|Overall Study|Caregiver to pursue other treatment|0|||
25301749|NCT00818662|50616934|FG001|Overall Study|Caregiver to pursue other treatment|1|||
25301750|NCT00818662|50616935|FG002|Overall Study|Caregiver to pursue other treatment|0|||
25301751|NCT00818662|50616936|FG003|Overall Study|Caregiver to pursue other treatment|0|||
25301752|NCT00818662|50616933|FG000|Overall Study|Moving out of state|0|||
25301753|NCT00818662|50616934|FG001|Overall Study|Moving out of state|0|||
25301754|NCT00818662|50616935|FG002|Overall Study|Moving out of state|0|||
25301755|NCT00818662|50616936|FG003|Overall Study|Moving out of state|1|||
25301756|NCT00818662|50616933|FG000|Overall Study|Declined move to another study site|1|||
25301757|NCT00818662|50616934|FG001|Overall Study|Declined move to another study site|0|||
25301758|NCT00818662|50616935|FG002|Overall Study|Declined move to another study site|0|||
25301759|NCT00818662|50616936|FG003|Overall Study|Declined move to another study site|0|||
25301760|NCT00818662|50616933|FG000|Overall Study|Change in living situation|0|||
25301761|NCT00818662|50616934|FG001|Overall Study|Change in living situation|0|||
25301762|NCT00818662|50616935|FG002|Overall Study|Change in living situation|0|||
25301763|NCT00818662|50616936|FG003|Overall Study|Change in living situation|1|||
25301764|NCT00818662|50616933|FG000|Overall Study|Study partner decision|0|||
25301765|NCT00818662|50616934|FG001|Overall Study|Study partner decision|0|||
25301766|NCT00818662|50616935|FG002|Overall Study|Study partner decision|0|||
25301767|NCT00818662|50616936|FG003|Overall Study|Study partner decision|1|||
25301768|NCT00818662|50616933|FG000|Overall Study|Admitted to long term nursing care|0|||
25301769|NCT00818662|50616934|FG001|Overall Study|Admitted to long term nursing care|1|||
25301770|NCT00818662|50616935|FG002|Overall Study|Admitted to long term nursing care|0|||
25301771|NCT00818662|50616936|FG003|Overall Study|Admitted to long term nursing care|0|||
25301772|NCT00903786|50616947|FG000|Overall Study|Physician Decision|6|||
25301773|NCT00903786|50616947|FG000|Overall Study|Lack of Efficacy|5|||
25301774|NCT00903786|50616947|FG000|Overall Study|Reason other than lack of efficacy|4|||
25301775|NCT00762073|50616956|FG000|Overall Study|Lack of Efficacy|1|||
25301776|NCT00762073|50616957|FG001|Overall Study|Lack of Efficacy|1|||
25301777|NCT00762073|50616958|FG002|Overall Study|Lack of Efficacy|0|||
25301778|NCT00762073|50616959|FG003|Overall Study|Lack of Efficacy|0|||
25301779|NCT00762073|50616956|FG000|Overall Study|Adverse Event|1|||
25301780|NCT00762073|50616957|FG001|Overall Study|Adverse Event|0|||
25301781|NCT00762073|50616958|FG002|Overall Study|Adverse Event|1|||
25301782|NCT00762073|50616959|FG003|Overall Study|Adverse Event|1|||
25301783|NCT00762073|50616956|FG000|Overall Study|Significant Subject Noncompliance|0|||
25301784|NCT00762073|50616957|FG001|Overall Study|Significant Subject Noncompliance|1|||
25301785|NCT00762073|50616958|FG002|Overall Study|Significant Subject Noncompliance|0|||
25301786|NCT00762073|50616959|FG003|Overall Study|Significant Subject Noncompliance|1|||
24969903|NCT00116688|50059372|FG001|Overall Study|Death|0|||
25301787|NCT00762073|50616956|FG000|Overall Study|Withdrawal by Subject|1|||
25301788|NCT00762073|50616957|FG001|Overall Study|Withdrawal by Subject|2|||
25301789|NCT00762073|50616958|FG002|Overall Study|Withdrawal by Subject|1|||
25301790|NCT00762073|50616959|FG003|Overall Study|Withdrawal by Subject|1|||
25301791|NCT00762073|50616956|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
25301792|NCT00762073|50616957|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
25301793|NCT00762073|50616958|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
25301794|NCT00762073|50616959|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
25301795|NCT00761761|50616978|FG000|Overall Study|Lost to Follow-up|3|||
25301796|NCT00761761|50616979|FG001|Overall Study|Lost to Follow-up|1|||
25301797|NCT00761761|50616978|FG000|Overall Study|Withdrawal by Subject|3|||
25301798|NCT00761761|50616979|FG001|Overall Study|Withdrawal by Subject|0|||
25301799|NCT00761605|50616987|FG000|Overall Study|Adverse Event|26|||
25301800|NCT00761605|50616987|FG000|Overall Study|Death|2|||
25301801|NCT00761605|50616987|FG000|Overall Study|Lack of Efficacy|26|||
25301802|NCT00761605|50616987|FG000|Overall Study|Lost to Follow-up|29|||
25301803|NCT00761605|50616987|FG000|Overall Study|Withdrawal by Subject|37|||
25301804|NCT00761605|50616987|FG000|Overall Study|Other|21|||
25301805|NCT00761527|50616995|FG000|Overall Study|Adverse Event|3|||
25301806|NCT00761527|50616995|FG000|Overall Study|Poor Compliance|8|||
25301807|NCT00761527|50616995|FG000|Overall Study|Lost to Follow-up|9|||
25301808|NCT00761527|50616995|FG000|Overall Study|Unknown reason|2|||
25301809|NCT00770029|50617001|FG000|Overall Study|Lost to Follow-up|2|||
25301810|NCT00770029|50617002|FG001|Overall Study|Lost to Follow-up|0|||
25301811|NCT00770029|50617001|FG000|Overall Study|Withdrawal by Subject|3|||
25301812|NCT00770029|50617002|FG001|Overall Study|Withdrawal by Subject|3|||
25301813|NCT00770029|50617001|FG000|Overall Study|Adverse Event|1|||
25301814|NCT00770029|50617002|FG001|Overall Study|Adverse Event|0|||
25301815|NCT00817414|50617013|FG000|Overall Study|Adverse Event|1|||
25301816|NCT00817414|50617014|FG001|Overall Study|Adverse Event|1|||
25301817|NCT00817414|50617015|FG002|Overall Study|Adverse Event|1|||
25301818|NCT00817414|50617016|FG003|Overall Study|Adverse Event|0|||
25301819|NCT00817414|50617017|FG004|Overall Study|Adverse Event|0|||
25301820|NCT00817414|50617013|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
25301821|NCT00817414|50617014|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
25301822|NCT00817414|50617015|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
25301823|NCT00817414|50617016|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
25301824|NCT00817414|50617017|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
25301825|NCT00817414|50617013|FG000|Overall Study|Withdrawal by Subject|1|||
25301826|NCT00817414|50617014|FG001|Overall Study|Withdrawal by Subject|1|||
25301827|NCT00817414|50617015|FG002|Overall Study|Withdrawal by Subject|0|||
25301828|NCT00817414|50617016|FG003|Overall Study|Withdrawal by Subject|0|||
25301829|NCT00817414|50617017|FG004|Overall Study|Withdrawal by Subject|0|||
25301830|NCT00817414|50617013|FG000|Overall Study|Lost to Follow-up|0|||
25301831|NCT00817414|50617014|FG001|Overall Study|Lost to Follow-up|0|||
25301832|NCT00817414|50617015|FG002|Overall Study|Lost to Follow-up|1|||
25301833|NCT00817414|50617016|FG003|Overall Study|Lost to Follow-up|1|||
25301834|NCT00817414|50617017|FG004|Overall Study|Lost to Follow-up|1|||
25301835|NCT00817414|50617013|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
25301836|NCT00817414|50617014|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
25301837|NCT00817414|50617015|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
25301838|NCT00817414|50617016|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
25301839|NCT00817414|50617017|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
25301840|NCT00817414|50617013|FG000|Overall Study|Protocol Violation|0|||
25301841|NCT00817414|50617014|FG001|Overall Study|Protocol Violation|0|||
25301842|NCT00817414|50617015|FG002|Overall Study|Protocol Violation|0|||
25301843|NCT00817414|50617016|FG003|Overall Study|Protocol Violation|0|||
25301844|NCT00817414|50617017|FG004|Overall Study|Protocol Violation|1|||
25301845|NCT00769561|50617036|FG000|Overall Study|Withdrawal by Subject|2|||
25301846|NCT00769561|50617037|FG001|Overall Study|Withdrawal by Subject|2|||
25301847|NCT00769561|50617036|FG000|Overall Study|Lost to Follow-up|1|||
25301848|NCT00769561|50617037|FG001|Overall Study|Lost to Follow-up|3|||
25301849|NCT00817336|50617045|FG000|Overall Study|Withdrawal by Subject|1|||
25301850|NCT00817336|50617046|FG001|Overall Study|Withdrawal by Subject|1|||
25301851|NCT00761215|50617054|FG000|Overall Study|Randomized but didn't receive drug|1|||
25301852|NCT00761215|50617055|FG001|Overall Study|Randomized but didn't receive drug|1|||
25301853|NCT00761215|50617056|FG002|Overall Study|Randomized but didn't receive drug|2|||
25301854|NCT00761215|50617054|FG000|Overall Study|Lost to Follow-up|6|||
25301855|NCT00761215|50617055|FG001|Overall Study|Lost to Follow-up|3|||
25301856|NCT00761215|50617056|FG002|Overall Study|Lost to Follow-up|6|||
25301857|NCT00761215|50617054|FG000|Overall Study|Withdrawal by Subject|1|||
25301858|NCT00761215|50617055|FG001|Overall Study|Withdrawal by Subject|0|||
25301859|NCT00761215|50617056|FG002|Overall Study|Withdrawal by Subject|0|||
25301860|NCT00761215|50617054|FG000|Overall Study|Bacteremia|1|||
25301861|NCT00761215|50617055|FG001|Overall Study|Bacteremia|0|||
25301862|NCT00761215|50617056|FG002|Overall Study|Bacteremia|0|||
25301863|NCT05101122|50617089|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
25070963|NCT02760433|50177025|FG004|Overall Study|Subject refused to continue the study|0|||
25070964|NCT02760433|50177021|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
25301864|NCT05101122|50617089|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
25301865|NCT05101122|50617089|FG000|AD313 80/5|Withdrawal by Subject|1|||
25301866|NCT05101122|50617089|FG000|AD313 80/10|Physician Decision|1|||
25301867|NCT05038163|50617111|FG000|Stage 1|Did not complete survey|2186|||
25301868|NCT05038163|50617112|FG001|Stage 1|Did not complete survey|0|||
25301869|NCT05038163|50617113|FG002|Stage 1|Did not complete survey|0|||
25301870|NCT05038163|50617114|FG003|Stage 1|Did not complete survey|0|||
25301871|NCT05038163|50617115|FG004|Stage 1|Did not complete survey|0|||
25301872|NCT05038163|50617111|FG000|Stage 2|Did not complete Stage 2 survey|0|||
25301873|NCT05038163|50617112|FG001|Stage 2|Did not complete Stage 2 survey|74|||
25301874|NCT05038163|50617113|FG002|Stage 2|Did not complete Stage 2 survey|86|||
25301875|NCT05038163|50617114|FG003|Stage 2|Did not complete Stage 2 survey|96|||
25301876|NCT05038163|50617115|FG004|Stage 2|Did not complete Stage 2 survey|78|||
25301877|NCT04516746|50617142|FG000|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|21090|||
25301878|NCT04516746|50617143|FG001|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|10305|||
25301879|NCT04516746|50617142|FG000|Overall Study|Withdrawal by Subject|362|||
25301880|NCT04516746|50617143|FG001|Overall Study|Withdrawal by Subject|408|||
25301881|NCT04516746|50617142|FG000|Overall Study|Lost to Follow-up|157|||
25301882|NCT04516746|50617143|FG001|Overall Study|Lost to Follow-up|86|||
25301883|NCT04516746|50617142|FG000|Overall Study|Protocol deviation|18|||
25301884|NCT04516746|50617143|FG001|Overall Study|Protocol deviation|7|||
25301885|NCT04516746|50617142|FG000|Overall Study|Death|8|||
25301886|NCT04516746|50617143|FG001|Overall Study|Death|7|||
25301887|NCT04516746|50617142|FG000|Overall Study|Physician Decision|0|||
25301888|NCT04516746|50617143|FG001|Overall Study|Physician Decision|2|||
25301889|NCT04516746|50617142|FG000|Overall Study|Other|0|||
25301890|NCT04516746|50617143|FG001|Overall Study|Other|1|||
25301891|NCT04413617|50617173|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
25301892|NCT04413617|50617174|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
25301893|NCT04413617|50617175|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
25301894|NCT04413617|50617176|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
25301895|NCT04413617|50617177|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
25301896|NCT04413617|50617173|FG000|Overall Study|Protocol Violation|0|||
25301897|NCT04413617|50617174|FG001|Overall Study|Protocol Violation|1|||
25301898|NCT04413617|50617175|FG002|Overall Study|Protocol Violation|0|||
25301899|NCT04413617|50617176|FG003|Overall Study|Protocol Violation|0|||
25301900|NCT04413617|50617177|FG004|Overall Study|Protocol Violation|1|||
25301901|NCT04413617|50617173|FG000|Overall Study|Lack of Efficacy|2|||
25301902|NCT04413617|50617174|FG001|Overall Study|Lack of Efficacy|0|||
25301903|NCT04413617|50617175|FG002|Overall Study|Lack of Efficacy|2|||
25301904|NCT04413617|50617176|FG003|Overall Study|Lack of Efficacy|1|||
25301905|NCT04413617|50617177|FG004|Overall Study|Lack of Efficacy|0|||
25301906|NCT04413617|50617173|FG000|Overall Study|Withdrawal by Subject|3|||
25301907|NCT04413617|50617174|FG001|Overall Study|Withdrawal by Subject|4|||
25301908|NCT04413617|50617175|FG002|Overall Study|Withdrawal by Subject|2|||
25301909|NCT04413617|50617176|FG003|Overall Study|Withdrawal by Subject|5|||
25301910|NCT04413617|50617177|FG004|Overall Study|Withdrawal by Subject|3|||
25301911|NCT04413617|50617173|FG000|Overall Study|Death|1|||
25301912|NCT04413617|50617174|FG001|Overall Study|Death|0|||
25301913|NCT04413617|50617175|FG002|Overall Study|Death|0|||
25301914|NCT04413617|50617176|FG003|Overall Study|Death|0|||
25301915|NCT04413617|50617177|FG004|Overall Study|Death|0|||
25301916|NCT04413617|50617173|FG000|Overall Study|Adverse Event|1|||
25301917|NCT04413617|50617174|FG001|Overall Study|Adverse Event|0|||
25301918|NCT04413617|50617175|FG002|Overall Study|Adverse Event|0|||
25301919|NCT04413617|50617176|FG003|Overall Study|Adverse Event|1|||
25301920|NCT04413617|50617177|FG004|Overall Study|Adverse Event|1|||
25301921|NCT04413617|50617173|FG000|Overall Study|COVID-19|0|||
25301922|NCT04413617|50617174|FG001|Overall Study|COVID-19|1|||
25301923|NCT04413617|50617175|FG002|Overall Study|COVID-19|0|||
25301924|NCT04413617|50617176|FG003|Overall Study|COVID-19|0|||
25301925|NCT04413617|50617177|FG004|Overall Study|COVID-19|0|||
25301926|NCT04055116|50617213|FG000|First Intervention|Physician Decision|2|||
25301927|NCT04055116|50617214|FG001|First Intervention|Physician Decision|7|||
25301928|NCT03512262|50617264|FG000|Overall Study|Adverse Event|8|||
25301929|NCT03512262|50617265|FG001|Overall Study|Adverse Event|3|||
25301930|NCT03512262|50617264|FG000|Overall Study|Death (non-treatment emergent)|1|||
25301931|NCT03512262|50617265|FG001|Overall Study|Death (non-treatment emergent)|0|||
25301932|NCT03512262|50617264|FG000|Overall Study|Withdrawal by Subject|17|||
25301933|NCT03512262|50617265|FG001|Overall Study|Withdrawal by Subject|9|||
25301934|NCT03512262|50617264|FG000|Overall Study|Lost to Follow-up|7|||
25301935|NCT03512262|50617265|FG001|Overall Study|Lost to Follow-up|1|||
25301936|NCT03512262|50617264|FG000|Overall Study|Other than Specified|2|||
25301937|NCT03512262|50617265|FG001|Overall Study|Other than Specified|2|||
25301938|NCT03499600|50617273|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
25301939|NCT03499600|50617274|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
25301940|NCT03007979|50617288|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
25301941|NCT02960893|50617294|FG000|Randomization Phase (8-week)|Adverse Event|5|||
25301942|NCT02960893|50617295|FG001|Randomization Phase (8-week)|Adverse Event|0|||
25301943|NCT02960893|50617294|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
25301944|NCT02960893|50617295|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
25301945|NCT02960893|50617294|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
25301946|NCT02960893|50617295|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
25301947|NCT02960893|50617294|FG000|Extension Phase (48-week)|Adverse Event|2|||
25301948|NCT02960893|50617295|FG001|Extension Phase (48-week)|Adverse Event|3|||
25301949|NCT02960893|50617294|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
25301950|NCT02960893|50617295|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
25301951|NCT02960893|50617294|FG000|Extension Phase (48-week)|Other Reason|2|||
25301952|NCT02960893|50617295|FG001|Extension Phase (48-week)|Other Reason|1|||
25301953|NCT02960893|50617294|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
25301954|NCT02960893|50617295|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
25301955|NCT02960893|50617294|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
25301956|NCT02960893|50617295|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
25301957|NCT02867813|50617310|FG000|Overall Study|Withdrawal by Subject|57|||
25301958|NCT02867813|50617311|FG001|Overall Study|Withdrawal by Subject|56|||
25301959|NCT02867813|50617310|FG000|Overall Study|Decision by Sponsor|7|||
25301960|NCT02867813|50617311|FG001|Overall Study|Decision by Sponsor|7|||
25301961|NCT02867813|50617310|FG000|Overall Study|Lost to Follow-up|91|||
25301962|NCT02867813|50617311|FG001|Overall Study|Lost to Follow-up|78|||
25301963|NCT02867813|50617310|FG000|Overall Study|Missing|2|||
25301964|NCT02867813|50617311|FG001|Overall Study|Missing|1|||
25301965|NCT02867813|50617310|FG000|Overall Study|Death|294|||
25301966|NCT02867813|50617311|FG001|Overall Study|Death|268|||
25301967|NCT02278055|50617323|FG000|Overall Study|Adverse Event|1|||
25301968|NCT02278055|50617323|FG000|Overall Study|Lost to Follow-up|1|||
25301969|NCT02278055|50617323|FG000|Overall Study|Withdrawal by Subject|2|||
25301970|NCT02278055|50617323|FG000|Overall Study|Progressive Disease|4|||
25301971|NCT02231879|50617329|FG000|Overall Study|Adverse Event|2|||
25301972|NCT02231879|50617330|FG001|Overall Study|Adverse Event|1|||
25301973|NCT02231879|50617329|FG000|Overall Study|Lack of Efficacy|0|||
25301974|NCT02231879|50617330|FG001|Overall Study|Lack of Efficacy|1|||
25301975|NCT01833806|50617351|FG000|Overall Study|Alternative treatment|2|||
25301976|NCT01833806|50617351|FG000|Overall Study|Death|5|||
25301977|NCT01833806|50617351|FG000|Overall Study|Physician Decision|1|||
25301978|NCT01833806|50617351|FG000|Overall Study|Lost to Follow-up|1|||
25301979|NCT01712490|50617357|FG000|Overall Study|Ongoing|601|||
25301980|NCT01712490|50617358|FG001|Overall Study|Ongoing|586|||
25301981|NCT01712490|50617357|FG000|Overall Study|Other|11|||
25301982|NCT01712490|50617358|FG001|Overall Study|Other|11|||
25301983|NCT01712490|50617357|FG000|Overall Study|Withdrawal by Subject|36|||
25301984|NCT01712490|50617358|FG001|Overall Study|Withdrawal by Subject|44|||
25301985|NCT01712490|50617357|FG000|Overall Study|Lost to Follow-up|16|||
25301986|NCT01712490|50617358|FG001|Overall Study|Lost to Follow-up|29|||
25301987|NCT01439802|50617364|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
25301988|NCT01439802|50617364|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
25301989|NCT00816556|50617375|FG000|Overall Study|Adverse Event|1|||
25301990|NCT00816556|50617376|FG001|Overall Study|Adverse Event|1|||
25301991|NCT00816556|50617377|FG002|Overall Study|Adverse Event|1|||
25301992|NCT00816556|50617375|FG000|Overall Study|Withdrawal by Subject|1|||
25301993|NCT00816556|50617376|FG001|Overall Study|Withdrawal by Subject|1|||
25301994|NCT00816556|50617377|FG002|Overall Study|Withdrawal by Subject|1|||
25301995|NCT00816556|50617375|FG000|Overall Study|Lost to Follow-up|0|||
25301996|NCT00816556|50617376|FG001|Overall Study|Lost to Follow-up|0|||
25301997|NCT00816556|50617377|FG002|Overall Study|Lost to Follow-up|1|||
25301998|NCT00760747|50617387|FG000|Study Period II|Adverse Event|3|||
25301999|NCT00760747|50617388|FG001|Study Period II|Adverse Event|4|||
25302000|NCT00760747|50617387|FG000|Study Period II|Lack of Efficacy|0|||
25302001|NCT00760747|50617388|FG001|Study Period II|Lack of Efficacy|6|||
25302002|NCT00760747|50617387|FG000|Study Period II|Parent/Caregiver Decision|3|||
25302003|NCT00760747|50617388|FG001|Study Period II|Parent/Caregiver Decision|0|||
25302004|NCT00760747|50617387|FG000|Study Period II|Protocol Violation|6|||
25302005|NCT00760747|50617388|FG001|Study Period II|Protocol Violation|3|||
25302006|NCT00760747|50617387|FG000|Study Period II|Withdrawal by Subject|1|||
25302007|NCT00760747|50617388|FG001|Study Period II|Withdrawal by Subject|0|||
25302008|NCT00760747|50617387|FG000|Study Period II|No drug administered|0|||
25302009|NCT00760747|50617388|FG001|Study Period II|No drug administered|1|||
25302010|NCT00760747|50617387|FG000|Study Period III|Adverse Event|1|||
25302011|NCT00760747|50617388|FG001|Study Period III|Adverse Event|0|||
25302012|NCT00760747|50617387|FG000|Study Period III|Lack of Efficacy|1|||
25302013|NCT00760747|50617388|FG001|Study Period III|Lack of Efficacy|0|||
25302014|NCT00760747|50617387|FG000|Study Period III|Parent/Caregiver Decision|0|||
25302015|NCT00760747|50617388|FG001|Study Period III|Parent/Caregiver Decision|1|||
25302016|NCT00760747|50617387|FG000|Study Period III|Protocol Violation|1|||
25302017|NCT00760747|50617388|FG001|Study Period III|Protocol Violation|1|||
25302018|NCT00760747|50617387|FG000|Study Period III|Physician Decision|0|||
25302019|NCT00760747|50617388|FG001|Study Period III|Physician Decision|1|||
24969904|NCT00116688|50059371|FG000|Overall Study|Protocol-specified criteria|3|||
25302020|NCT00760669|50617394|FG000|Overall Study|Not assessed for overall improvement|18|||
25070965|NCT02760433|50177022|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
25070966|NCT02760433|50177023|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
25302021|NCT00760669|50617394|FG000|Overall Study|Participants missing efficacy assessment|6|||
25302022|NCT00760669|50617394|FG000|Overall Study|Participants with overlapping cases|1|||
25302023|NCT00760669|50617394|FG000|Overall Study|Took drug before entering in contract|5|||
25302024|NCT00769483|50617404|FG000|Overall Study|Withdrawal by Subject|0|||
25302025|NCT00769483|50617405|FG001|Overall Study|Withdrawal by Subject|1|||
25302026|NCT00769483|50617406|FG002|Overall Study|Withdrawal by Subject|0|||
25302027|NCT00769483|50617407|FG003|Overall Study|Withdrawal by Subject|0|||
25302028|NCT00769483|50617408|FG004|Overall Study|Withdrawal by Subject|1|||
25302029|NCT00769483|50617409|FG005|Overall Study|Withdrawal by Subject|0|||
25302030|NCT00760513|50617427|FG000|Overall Study|Withdrawal by Subject|5|||
25302031|NCT00760513|50617428|FG001|Overall Study|Withdrawal by Subject|7|||
25302032|NCT00907296|50617446|FG000|Overall Study|Ineligibility Determined|1|||
25302033|NCT00907296|50617447|FG001|Overall Study|Ineligibility Determined|0|||
25302034|NCT00907296|50617448|FG002|Overall Study|Ineligibility Determined|0|||
25302035|NCT00907296|50617449|FG003|Overall Study|Ineligibility Determined|1|||
25302036|NCT00907296|50617450|FG004|Overall Study|Ineligibility Determined|0|||
25302037|NCT00907296|50617451|FG005|Overall Study|Ineligibility Determined|0|||
25302038|NCT00907296|50617452|FG006|Overall Study|Ineligibility Determined|0|||
25302039|NCT00907296|50617453|FG007|Overall Study|Ineligibility Determined|1|||
25302040|NCT00907296|50617454|FG008|Overall Study|Ineligibility Determined|0|||
25302041|NCT00907296|50617455|FG009|Overall Study|Ineligibility Determined|0|||
25302042|NCT00907296|50617446|FG000|Overall Study|Protocol Deviation|0|||
25302043|NCT00907296|50617447|FG001|Overall Study|Protocol Deviation|1|||
25302044|NCT00907296|50617448|FG002|Overall Study|Protocol Deviation|0|||
25302045|NCT00907296|50617449|FG003|Overall Study|Protocol Deviation|0|||
25302046|NCT00907296|50617450|FG004|Overall Study|Protocol Deviation|0|||
25302047|NCT00907296|50617451|FG005|Overall Study|Protocol Deviation|0|||
25302048|NCT00907296|50617452|FG006|Overall Study|Protocol Deviation|0|||
25302049|NCT00907296|50617453|FG007|Overall Study|Protocol Deviation|0|||
25302050|NCT00907296|50617454|FG008|Overall Study|Protocol Deviation|0|||
25302051|NCT00907296|50617455|FG009|Overall Study|Protocol Deviation|0|||
25302052|NCT00907296|50617446|FG000|Overall Study|Noncompliance|1|||
25302053|NCT00907296|50617447|FG001|Overall Study|Noncompliance|1|||
25302054|NCT00907296|50617448|FG002|Overall Study|Noncompliance|1|||
25302055|NCT00907296|50617449|FG003|Overall Study|Noncompliance|0|||
25302056|NCT00907296|50617450|FG004|Overall Study|Noncompliance|0|||
25302057|NCT00907296|50617451|FG005|Overall Study|Noncompliance|1|||
25302058|NCT00907296|50617452|FG006|Overall Study|Noncompliance|0|||
25302059|NCT00907296|50617453|FG007|Overall Study|Noncompliance|2|||
25302060|NCT00907296|50617454|FG008|Overall Study|Noncompliance|0|||
25302061|NCT00907296|50617455|FG009|Overall Study|Noncompliance|0|||
25302062|NCT00907296|50617446|FG000|Overall Study|Adverse Event|2|||
25302063|NCT00907296|50617447|FG001|Overall Study|Adverse Event|0|||
25302064|NCT00907296|50617448|FG002|Overall Study|Adverse Event|0|||
25302065|NCT00907296|50617449|FG003|Overall Study|Adverse Event|0|||
25302066|NCT00907296|50617450|FG004|Overall Study|Adverse Event|0|||
24969905|NCT00116688|50059372|FG001|Overall Study|Protocol-specified criteria|0|||
24969906|NCT00116688|50059371|FG000|Overall Study|Pregnancy|1|||
25302067|NCT00907296|50617451|FG005|Overall Study|Adverse Event|0|||
25302068|NCT00907296|50617452|FG006|Overall Study|Adverse Event|1|||
25302069|NCT00907296|50617453|FG007|Overall Study|Adverse Event|0|||
25302070|NCT00907296|50617454|FG008|Overall Study|Adverse Event|0|||
25302071|NCT00907296|50617455|FG009|Overall Study|Adverse Event|1|||
25302072|NCT00907296|50617446|FG000|Overall Study|Withdrawal by Subject|7|||
25302073|NCT00907296|50617447|FG001|Overall Study|Withdrawal by Subject|2|||
25302074|NCT00907296|50617448|FG002|Overall Study|Withdrawal by Subject|1|||
25302075|NCT00907296|50617449|FG003|Overall Study|Withdrawal by Subject|1|||
25302076|NCT00907296|50617450|FG004|Overall Study|Withdrawal by Subject|1|||
25302077|NCT00907296|50617451|FG005|Overall Study|Withdrawal by Subject|5|||
25302078|NCT00907296|50617452|FG006|Overall Study|Withdrawal by Subject|3|||
25302079|NCT00907296|50617453|FG007|Overall Study|Withdrawal by Subject|2|||
25302080|NCT00907296|50617454|FG008|Overall Study|Withdrawal by Subject|4|||
25302081|NCT00907296|50617455|FG009|Overall Study|Withdrawal by Subject|2|||
25302082|NCT00907296|50617446|FG000|Overall Study|Lost to Follow-up|9|||
25302083|NCT00907296|50617447|FG001|Overall Study|Lost to Follow-up|1|||
25302084|NCT00907296|50617448|FG002|Overall Study|Lost to Follow-up|0|||
25302085|NCT00907296|50617449|FG003|Overall Study|Lost to Follow-up|2|||
25302086|NCT00907296|50617450|FG004|Overall Study|Lost to Follow-up|0|||
25302087|NCT00907296|50617451|FG005|Overall Study|Lost to Follow-up|3|||
25302088|NCT00907296|50617452|FG006|Overall Study|Lost to Follow-up|2|||
25302089|NCT00907296|50617453|FG007|Overall Study|Lost to Follow-up|2|||
25302090|NCT00907296|50617454|FG008|Overall Study|Lost to Follow-up|0|||
25302091|NCT00907296|50617455|FG009|Overall Study|Lost to Follow-up|4|||
25302092|NCT00816400|50617486|FG000|Overall Study|Death|2|||
25302093|NCT00816400|50617487|FG001|Overall Study|Death|3|||
25302094|NCT00816400|50617488|FG002|Overall Study|Death|3|||
25302095|NCT00816400|50617489|FG003|Overall Study|Death|3|||
25302096|NCT00816400|50617490|FG004|Overall Study|Death|2|||
25302097|NCT00816400|50617491|FG005|Overall Study|Death|3|||
25302098|NCT00816400|50617492|FG006|Overall Study|Death|2|||
25302099|NCT00816400|50617493|FG007|Overall Study|Death|5|||
25302100|NCT00816400|50617494|FG008|Overall Study|Death|6|||
25302101|NCT00816400|50617486|FG000|Overall Study|In hospice care at the end of the study|0|||
25302102|NCT00816400|50617487|FG001|Overall Study|In hospice care at the end of the study|0|||
25302103|NCT00816400|50617488|FG002|Overall Study|In hospice care at the end of the study|2|||
25070967|NCT02760433|50177024|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
25070968|NCT02760433|50177025|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
25070969|NCT02760433|50177021|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
25070970|NCT02760433|50177022|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
25070971|NCT02760433|50177023|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
25070972|NCT02760433|50177024|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
25070973|NCT02760433|50177025|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
25070974|NCT02699463|50177044|FG000|Overall Study|Lost to Follow-up|11|||
25070975|NCT02699463|50177045|FG001|Overall Study|Lost to Follow-up|8|||
25070976|NCT02699463|50177044|FG000|Overall Study|Withdrawal by Subject|4|||
25070977|NCT02699463|50177045|FG001|Overall Study|Withdrawal by Subject|1|||
25070978|NCT00100789|50177051|FG000|Overall Study|Adverse Event|10|||
25070979|NCT00100789|50177051|FG000|Overall Study|Withdrawal by Subject|1|||
25070980|NCT00100789|50177051|FG000|Overall Study|Progression/relapse|42|||
25191896|NCT01666782|50354449|FG000|Overall Study|Received 2 doses of vaccine|0|||
25191897|NCT01666782|50354450|FG001|Overall Study|Received 2 doses of vaccine|1|||
25191898|NCT01666782|50354449|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
25302104|NCT00816400|50617489|FG003|Overall Study|In hospice care at the end of the study|0|||
25302105|NCT00816400|50617490|FG004|Overall Study|In hospice care at the end of the study|0|||
25302106|NCT00816400|50617491|FG005|Overall Study|In hospice care at the end of the study|0|||
25302107|NCT00816400|50617492|FG006|Overall Study|In hospice care at the end of the study|0|||
25302108|NCT00816400|50617493|FG007|Overall Study|In hospice care at the end of the study|0|||
25302109|NCT00816400|50617494|FG008|Overall Study|In hospice care at the end of the study|0|||
25302110|NCT00906204|50617517|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
25302111|NCT00906204|50617518|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
25302112|NCT00906204|50617517|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
25302113|NCT00906204|50617518|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
25302114|NCT00906204|50617517|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
25302115|NCT00906204|50617518|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
25302116|NCT00906204|50617517|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
25302117|NCT00906204|50617518|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
25302118|NCT00906204|50617517|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
25302119|NCT00906204|50617518|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
25302120|NCT00905424|50617555|FG000|Overall Study|Lost to Follow-up|3|||
25302121|NCT00905424|50617556|FG001|Overall Study|Lost to Follow-up|3|||
25302122|NCT00905424|50617555|FG000|Overall Study|Withdrawal by Subject|1|||
25302123|NCT00905424|50617556|FG001|Overall Study|Withdrawal by Subject|2|||
25302124|NCT00905424|50617555|FG000|Overall Study|Adverse Event|4|||
25302125|NCT00905424|50617556|FG001|Overall Study|Adverse Event|2|||
25302126|NCT00905424|50617555|FG000|Overall Study|Non-compliance with study medication|2|||
25302127|NCT00905424|50617556|FG001|Overall Study|Non-compliance with study medication|0|||
25302128|NCT00905424|50617555|FG000|Overall Study|Sponsor decision|1|||
25302129|NCT00905424|50617556|FG001|Overall Study|Sponsor decision|0|||
25302130|NCT00905424|50617555|FG000|Overall Study|Positive urine drug screen|0|||
25302131|NCT00905424|50617556|FG001|Overall Study|Positive urine drug screen|1|||
25302132|NCT00905424|50617555|FG000|Overall Study|Non-adherence to visit schedule|0|||
25302133|NCT00905424|50617556|FG001|Overall Study|Non-adherence to visit schedule|1|||
25302134|NCT00816166|50617566|FG000|Overall Study|Lost to Follow-up|6|||
25302135|NCT00816166|50617567|FG001|Overall Study|Lost to Follow-up|10|||
25302136|NCT00816166|50617566|FG000|Overall Study|Death|4|||
25302137|NCT00816166|50617567|FG001|Overall Study|Death|2|||
25302138|NCT00815308|50617573|FG000|Overall Study|Adverse Event|4|||
25302139|NCT00815308|50617573|FG000|Overall Study|Withdrawal by Subject|0|||
25302140|NCT00815308|50617573|FG000|Overall Study|Protocol Violation|6|||
25302141|NCT01039376|50617579|FG000|Overall Study|Lost to Follow-up|5|||
25302142|NCT01039376|50617580|FG001|Overall Study|Lost to Follow-up|12|||
25302143|NCT01039376|50617579|FG000|Overall Study|Physician Decision|15|||
25302144|NCT01039376|50617580|FG001|Overall Study|Physician Decision|10|||
25302145|NCT01039376|50617579|FG000|Overall Study|Withdrawal by Subject|20|||
25302146|NCT01039376|50617580|FG001|Overall Study|Withdrawal by Subject|32|||
25302147|NCT01039376|50617579|FG000|Overall Study|Study terminated by Sponsor|90|||
25302148|NCT01039376|50617580|FG001|Overall Study|Study terminated by Sponsor|72|||
25191899|NCT01666782|50354450|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
25191900|NCT01439360|50354466|FG000|Overall Study|Adverse Event|4|||
25191901|NCT01439360|50354467|FG001|Overall Study|Adverse Event|16|||
25191902|NCT01439360|50354466|FG000|Overall Study|Lost to Follow-up|43|||
25191903|NCT01439360|50354467|FG001|Overall Study|Lost to Follow-up|58|||
25191904|NCT01439360|50354466|FG000|Overall Study|Others|10|||
25191905|NCT01439360|50354467|FG001|Overall Study|Others|5|||
25191906|NCT01439360|50354466|FG000|Overall Study|Protocol Violation|1|||
25191907|NCT01439360|50354467|FG001|Overall Study|Protocol Violation|0|||
25191908|NCT01439360|50354466|FG000|Overall Study|Withdrawal by Subject|140|||
25191909|NCT01439360|50354467|FG001|Overall Study|Withdrawal by Subject|129|||
25191910|NCT01439204|50354644|FG000|Overall Study|Withdrawal by Subject|0|||
25191911|NCT01439204|50354645|FG001|Overall Study|Withdrawal by Subject|1|||
25191912|NCT01439204|50354644|FG000|Overall Study|Lost to Follow-up|0|||
25191913|NCT01439204|50354645|FG001|Overall Study|Lost to Follow-up|2|||
25191914|NCT01439204|50354644|FG000|Overall Study|No longer meets study criteria|1|||
25191915|NCT01439204|50354645|FG001|Overall Study|No longer meets study criteria|0|||
25191916|NCT01439204|50354644|FG000|Overall Study|poor/non-compliance|3|||
25191917|NCT01439204|50354645|FG001|Overall Study|poor/non-compliance|0|||
25191918|NCT01439126|50354691|FG000|Overall Study|Adverse Event|2|||
25191919|NCT01439126|50354692|FG001|Overall Study|Adverse Event|0|||
25191920|NCT01439126|50354691|FG000|Overall Study|Withdrawal by Subject|5|||
25191921|NCT01439126|50354692|FG001|Overall Study|Withdrawal by Subject|21|||
25191922|NCT01439126|50354691|FG000|Overall Study|Protocol Violation|6|||
25191923|NCT01439126|50354692|FG001|Overall Study|Protocol Violation|4|||
25191924|NCT01439126|50354691|FG000|Overall Study|Lost to Follow-up|6|||
25191925|NCT01439126|50354692|FG001|Overall Study|Lost to Follow-up|3|||
25191926|NCT01439126|50354691|FG000|Overall Study|Other-Use of prohibited treatment|0|||
25191927|NCT01439126|50354692|FG001|Overall Study|Other-Use of prohibited treatment|2|||
25191928|NCT01439126|50354691|FG000|Overall Study|Other-Miscellaneous|12|||
25191929|NCT01439126|50354692|FG001|Overall Study|Other-Miscellaneous|12|||
25191930|NCT01449812|50354718|FG000|Overall Study|Migrated/moved from study area|1|||
25191931|NCT01449812|50354719|FG001|Overall Study|Migrated/moved from study area|0|||
25191932|NCT01449812|50354720|FG002|Overall Study|Migrated/moved from study area|0|||
25191933|NCT01449812|50354718|FG000|Overall Study|Withdrawal by Subject|0|||
25191934|NCT01449812|50354719|FG001|Overall Study|Withdrawal by Subject|0|||
25191935|NCT01449812|50354720|FG002|Overall Study|Withdrawal by Subject|1|||
25191936|NCT01449812|50354718|FG000|Overall Study|Lost to Follow-up|1|||
25191937|NCT01449812|50354719|FG001|Overall Study|Lost to Follow-up|0|||
25191938|NCT01449812|50354720|FG002|Overall Study|Lost to Follow-up|0|||
25191939|NCT01665144|50354773|FG000|Overall Study|New therapy for study indication|2|||
25191940|NCT01665144|50354774|FG001|Overall Study|New therapy for study indication|1|||
25191941|NCT01665144|50354773|FG000|Overall Study|Technical problems|2|||
25302149|NCT00905034|50617587|FG000|Overall Study|Withdrawal by Subject|1|||
25302150|NCT00828568|50617594|FG000|Randomized|Withdrawal by Subject|1|||
25302151|NCT00828568|50617595|FG001|Randomized|Withdrawal by Subject|0|||
25302152|NCT00828568|50617596|FG002|Randomized|Withdrawal by Subject|2|||
25302153|NCT00828568|50617594|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
25191942|NCT01665144|50354774|FG001|Overall Study|Technical problems|0|||
25191943|NCT01665144|50354773|FG000|Overall Study|Death|3|||
25191944|NCT01665144|50354774|FG001|Overall Study|Death|1|||
25191945|NCT01665144|50354773|FG000|Overall Study|Protocol deviation|3|||
25191946|NCT01665144|50354774|FG001|Overall Study|Protocol deviation|1|||
25191947|NCT01665144|50354773|FG000|Overall Study|Non-compliance w/study treatment|5|||
25191948|NCT01665144|50354774|FG001|Overall Study|Non-compliance w/study treatment|0|||
25191949|NCT01665144|50354773|FG000|Overall Study|Progressive disease|8|||
25191950|NCT01665144|50354774|FG001|Overall Study|Progressive disease|4|||
25302154|NCT00828568|50617595|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
25302155|NCT00828568|50617596|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
25302156|NCT00828568|50617594|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
25302157|NCT00828568|50617595|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
25302158|NCT00828568|50617596|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
25302159|NCT00828568|50617594|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
25302160|NCT00828568|50617595|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
25302161|NCT00828568|50617596|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
25302162|NCT00828568|50617594|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
25302163|NCT00828568|50617595|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
25302164|NCT00828568|50617596|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
25302165|NCT01038752|50617607|FG000|Overall Study|Tumor Progression|2|||
25302166|NCT01038752|50617608|FG001|Overall Study|Tumor Progression|2|||
25302167|NCT01038752|50617607|FG000|Overall Study|Lost to Follow-up|3|||
25302168|NCT01038752|50617608|FG001|Overall Study|Lost to Follow-up|3|||
25302169|NCT00903630|50617617|FG000|Phase 2|Adverse Event|0|||
25302170|NCT00903630|50617618|FG001|Phase 2|Adverse Event|0|||
25302171|NCT00903630|50617619|FG002|Phase 2|Adverse Event|1|||
25302172|NCT01037114|50617629|FG000|Year 20|Others|1|||
25302173|NCT00840970|50617633|FG000|Overall Study|Adverse Event|0|||
25302174|NCT00840970|50617634|FG001|Overall Study|Adverse Event|0|||
25302175|NCT00840970|50617635|FG002|Overall Study|Adverse Event|1|||
25302176|NCT01054820|50617645|FG000|Overall Study|Withdrawal by Subject|2|||
25302177|NCT00840658|50617653|FG000|Overall Study|Death|2|||
25302178|NCT00840658|50617654|FG001|Overall Study|Death|2|||
25302179|NCT00840658|50617655|FG002|Overall Study|Death|3|||
25302180|NCT00840658|50617656|FG003|Overall Study|Death|3|||
25302181|NCT00840658|50617653|FG000|Overall Study|Lost to Follow-up|3|||
25302182|NCT00840658|50617654|FG001|Overall Study|Lost to Follow-up|1|||
25302183|NCT00840658|50617655|FG002|Overall Study|Lost to Follow-up|2|||
25302184|NCT00840658|50617656|FG003|Overall Study|Lost to Follow-up|1|||
25302185|NCT01036724|50617672|FG000|Overall Study|Adverse Event|1|||
25302186|NCT01036724|50617673|FG001|Overall Study|Adverse Event|2|||
25302187|NCT01036724|50617672|FG000|Overall Study|Lack of Efficacy|1|||
25302188|NCT01036724|50617673|FG001|Overall Study|Lack of Efficacy|1|||
25302189|NCT01036724|50617672|FG000|Overall Study|Protocol Violation|4|||
25302190|NCT01036724|50617673|FG001|Overall Study|Protocol Violation|5|||
25302191|NCT01052714|50617681|FG000|Overall Study|Adverse Event|6|||
25302192|NCT01052714|50617682|FG001|Overall Study|Adverse Event|3|||
25302193|NCT01052714|50617683|FG002|Overall Study|Adverse Event|0|||
25302194|NCT01052714|50617681|FG000|Overall Study|Death|1|||
25302195|NCT01052714|50617682|FG001|Overall Study|Death|2|||
25302196|NCT01052714|50617683|FG002|Overall Study|Death|0|||
25302197|NCT01052714|50617681|FG000|Overall Study|Lost to Follow-up|2|||
25302198|NCT01052714|50617682|FG001|Overall Study|Lost to Follow-up|3|||
25302199|NCT01052714|50617683|FG002|Overall Study|Lost to Follow-up|0|||
25302200|NCT01052714|50617681|FG000|Overall Study|Physician Decision|9|||
25302201|NCT01052714|50617682|FG001|Overall Study|Physician Decision|9|||
25302202|NCT01052714|50617683|FG002|Overall Study|Physician Decision|1|||
25302203|NCT01052714|50617681|FG000|Overall Study|Withdrawal by Subject|7|||
25302204|NCT01052714|50617682|FG001|Overall Study|Withdrawal by Subject|12|||
25302205|NCT01052714|50617683|FG002|Overall Study|Withdrawal by Subject|1|||
25302206|NCT01052480|50617700|FG000|Overall Study|Lost to Follow-up|3|||
25302207|NCT01052480|50617701|FG001|Overall Study|Lost to Follow-up|3|||
25302208|NCT01052480|50617700|FG000|Overall Study|Protocol Violation|1|||
25302209|NCT01052480|50617701|FG001|Overall Study|Protocol Violation|0|||
25302210|NCT01052480|50617700|FG000|Overall Study|Withdrawal by Subject|3|||
25302211|NCT01052480|50617701|FG001|Overall Study|Withdrawal by Subject|7|||
25302212|NCT01052480|50617700|FG000|Overall Study|Physician Decision|0|||
25302213|NCT01052480|50617701|FG001|Overall Study|Physician Decision|2|||
25302214|NCT01052480|50617700|FG000|Overall Study|Death|1|||
25302215|NCT01052480|50617701|FG001|Overall Study|Death|5|||
25302216|NCT00904722|50617707|FG000|Overall Study|Physician Decision|1|||
25302217|NCT01029782|50617713|FG000|Overall Study|Lost to Follow-up|2|||
25302218|NCT01029782|50617714|FG001|Overall Study|Lost to Follow-up|2|||
25302219|NCT01029782|50617713|FG000|Overall Study|Diagnosis changed|1|||
25302220|NCT01029782|50617714|FG001|Overall Study|Diagnosis changed|1|||
25302221|NCT01029782|50617713|FG000|Overall Study|Adverse Event|0|||
25302222|NCT01029782|50617714|FG001|Overall Study|Adverse Event|1|||
25302223|NCT01029782|50617713|FG000|Overall Study|Physician Decision|0|||
25302224|NCT01029782|50617714|FG001|Overall Study|Physician Decision|1|||
25302225|NCT01029782|50617713|FG000|Overall Study|Protocol Violation|0|||
25302226|NCT01029782|50617714|FG001|Overall Study|Protocol Violation|2|||
25302227|NCT01029782|50617713|FG000|Overall Study|Withdrawal by Subject|0|||
25302228|NCT01029782|50617714|FG001|Overall Study|Withdrawal by Subject|1|||
25302229|NCT01029704|50617729|FG000|Overall Study|Adverse Event|0|||
25302230|NCT01029704|50617730|FG001|Overall Study|Adverse Event|0|||
25302231|NCT01029704|50617731|FG002|Overall Study|Adverse Event|0|||
25302232|NCT01029704|50617732|FG003|Overall Study|Adverse Event|0|||
25302233|NCT01029704|50617733|FG004|Overall Study|Adverse Event|0|||
25302234|NCT01029704|50617734|FG005|Overall Study|Adverse Event|0|||
25302235|NCT01029704|50617735|FG006|Overall Study|Adverse Event|1|||
25302236|NCT01029704|50617736|FG007|Overall Study|Adverse Event|1|||
25302237|NCT01029704|50617737|FG008|Overall Study|Adverse Event|0|||
25302238|NCT01029704|50617729|FG000|Overall Study|Withdrawal by Subject|0|||
25302239|NCT01029704|50617730|FG001|Overall Study|Withdrawal by Subject|0|||
25302240|NCT01029704|50617731|FG002|Overall Study|Withdrawal by Subject|0|||
25302241|NCT01029704|50617732|FG003|Overall Study|Withdrawal by Subject|0|||
25302242|NCT01029704|50617733|FG004|Overall Study|Withdrawal by Subject|2|||
25302243|NCT01029704|50617734|FG005|Overall Study|Withdrawal by Subject|1|||
25302244|NCT01029704|50617735|FG006|Overall Study|Withdrawal by Subject|1|||
25302245|NCT01029704|50617736|FG007|Overall Study|Withdrawal by Subject|1|||
25302246|NCT01029704|50617737|FG008|Overall Study|Withdrawal by Subject|0|||
25302247|NCT01029704|50617729|FG000|Overall Study|Lost to Follow-up|0|||
25302248|NCT01029704|50617730|FG001|Overall Study|Lost to Follow-up|0|||
25302249|NCT01029704|50617731|FG002|Overall Study|Lost to Follow-up|0|||
25302250|NCT01029704|50617732|FG003|Overall Study|Lost to Follow-up|0|||
25302251|NCT01029704|50617733|FG004|Overall Study|Lost to Follow-up|0|||
25302252|NCT01029704|50617734|FG005|Overall Study|Lost to Follow-up|0|||
25302253|NCT01029704|50617735|FG006|Overall Study|Lost to Follow-up|1|||
25302254|NCT01029704|50617736|FG007|Overall Study|Lost to Follow-up|1|||
25302255|NCT01029704|50617737|FG008|Overall Study|Lost to Follow-up|1|||
25302256|NCT01029704|50617729|FG000|Overall Study|Lack of Efficacy|0|||
25302257|NCT01029704|50617730|FG001|Overall Study|Lack of Efficacy|0|||
25302258|NCT01029704|50617731|FG002|Overall Study|Lack of Efficacy|0|||
25302259|NCT01029704|50617732|FG003|Overall Study|Lack of Efficacy|0|||
25302260|NCT01029704|50617733|FG004|Overall Study|Lack of Efficacy|2|||
25302261|NCT01029704|50617734|FG005|Overall Study|Lack of Efficacy|3|||
25302262|NCT01029704|50617735|FG006|Overall Study|Lack of Efficacy|1|||
25302263|NCT01029704|50617736|FG007|Overall Study|Lack of Efficacy|2|||
25302264|NCT01029704|50617737|FG008|Overall Study|Lack of Efficacy|0|||
25302265|NCT01029704|50617729|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
25302266|NCT01029704|50617730|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
25302267|NCT01029704|50617731|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
25302268|NCT01029704|50617732|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
25302269|NCT01029704|50617733|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
25302270|NCT01029704|50617734|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
25302271|NCT01029704|50617735|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
25302272|NCT01029704|50617736|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
25302273|NCT01029704|50617737|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
25302274|NCT00840034|50617759|FG000|Acute Treatment Phase|Adverse Event|6|||
25302275|NCT00840034|50617760|FG001|Acute Treatment Phase|Adverse Event|8|||
25302276|NCT00840034|50617759|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
25302277|NCT00840034|50617760|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
25302278|NCT00840034|50617759|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
25302279|NCT00840034|50617760|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
25302280|NCT00840034|50617759|FG000|Acute Treatment Phase|Physician Decision|0|||
25302281|NCT00840034|50617760|FG001|Acute Treatment Phase|Physician Decision|1|||
25302282|NCT00840034|50617759|FG000|Acute Treatment Phase|Protocol Violation|2|||
25302283|NCT00840034|50617760|FG001|Acute Treatment Phase|Protocol Violation|4|||
25302284|NCT00840034|50617759|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
25302285|NCT00840034|50617760|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
25302286|NCT00840034|50617759|FG000|Taper Phase|Adverse Event|1|||
25302287|NCT00840034|50617760|FG001|Taper Phase|Adverse Event|0|||
25302288|NCT00840034|50617759|FG000|Taper Phase|Lost to Follow-up|1|||
25302289|NCT00840034|50617760|FG001|Taper Phase|Lost to Follow-up|1|||
25302290|NCT00840034|50617759|FG000|Taper Phase|Withdrawal by Subject|1|||
25302291|NCT00840034|50617760|FG001|Taper Phase|Withdrawal by Subject|1|||
25302292|NCT00813904|50617768|FG000|Overall Study|Death|1|||
25302293|NCT00839956|50617772|FG000|Overall Study|Adverse Event|2|||
25302294|NCT00839956|50617772|FG000|Overall Study|Lack of Efficacy|6|||
25302295|NCT00839956|50617772|FG000|Overall Study|Physician Decision|1|||
25302296|NCT00839956|50617772|FG000|Overall Study|Withdrawal by Subject|3|||
25302297|NCT00839800|50617778|FG000|Overall Study|Adverse Event|8|||
25302298|NCT00839800|50617779|FG001|Overall Study|Adverse Event|12|||
25302299|NCT00839800|50617778|FG000|Overall Study|Lost to Follow-up|31|||
25302300|NCT00839800|50617779|FG001|Overall Study|Lost to Follow-up|26|||
25302301|NCT00839800|50617778|FG000|Overall Study|Withdrawal by Subject|28|||
25302302|NCT00839800|50617779|FG001|Overall Study|Withdrawal by Subject|34|||
25302303|NCT00839800|50617778|FG000|Overall Study|Incorrect Enrolment|3|||
25302304|NCT00839800|50617779|FG001|Overall Study|Incorrect Enrolment|3|||
25302305|NCT00839800|50617778|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
25302306|NCT00839800|50617779|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
25302307|NCT00839800|50617778|FG000|Overall Study|Safety Reasons|2|||
25302308|NCT00839800|50617779|FG001|Overall Study|Safety Reasons|1|||
25302309|NCT00839800|50617778|FG000|Overall Study|Other|8|||
25302310|NCT00839800|50617779|FG001|Overall Study|Other|14|||
25302311|NCT00839800|50617778|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
25302312|NCT00839800|50617779|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
25302313|NCT00753415|50617813|FG000|Part A|Disease progression|1|||
25302314|NCT00753415|50617814|FG001|Part A|Disease progression|0|||
25302315|NCT00753415|50617815|FG002|Part A|Disease progression|1|||
25302316|NCT00753415|50617816|FG003|Part A|Disease progression|2|||
25302317|NCT00753415|50617817|FG004|Part A|Disease progression|0|||
25302318|NCT00753415|50617818|FG005|Part A|Disease progression|0|||
25302319|NCT00753415|50617819|FG006|Part A|Disease progression|0|||
25302320|NCT00753415|50617820|FG007|Part A|Disease progression|0|||
25302321|NCT00753415|50617821|FG008|Part A|Disease progression|0|||
25302322|NCT00753415|50617822|FG009|Part A|Disease progression|0|||
25302323|NCT00753415|50617813|FG000|Part A|Withdrawal by Subject|0|||
25302324|NCT00753415|50617814|FG001|Part A|Withdrawal by Subject|0|||
25302325|NCT00753415|50617815|FG002|Part A|Withdrawal by Subject|1|||
25302326|NCT00753415|50617816|FG003|Part A|Withdrawal by Subject|0|||
25302327|NCT00753415|50617817|FG004|Part A|Withdrawal by Subject|0|||
25302328|NCT00753415|50617818|FG005|Part A|Withdrawal by Subject|0|||
25302329|NCT00753415|50617819|FG006|Part A|Withdrawal by Subject|0|||
25302330|NCT00753415|50617820|FG007|Part A|Withdrawal by Subject|0|||
25302331|NCT00753415|50617821|FG008|Part A|Withdrawal by Subject|0|||
25302332|NCT00753415|50617822|FG009|Part A|Withdrawal by Subject|0|||
25302333|NCT00753415|50617813|FG000|Part B|Lost to Follow-up|0|||
25302334|NCT00753415|50617814|FG001|Part B|Lost to Follow-up|0|||
25302335|NCT00753415|50617815|FG002|Part B|Lost to Follow-up|0|||
25191951|NCT01665144|50354773|FG000|Overall Study|Lost to Follow-up|9|||
25302336|NCT00753415|50617816|FG003|Part B|Lost to Follow-up|0|||
25302337|NCT00753415|50617817|FG004|Part B|Lost to Follow-up|0|||
25302338|NCT00753415|50617818|FG005|Part B|Lost to Follow-up|0|||
25302339|NCT00753415|50617819|FG006|Part B|Lost to Follow-up|0|||
25302340|NCT00753415|50617820|FG007|Part B|Lost to Follow-up|1|||
25302341|NCT00753415|50617821|FG008|Part B|Lost to Follow-up|1|||
25302342|NCT00753415|50617822|FG009|Part B|Lost to Follow-up|0|||
25302343|NCT00753415|50617813|FG000|Part B|Disease progression|0|||
25302344|NCT00753415|50617814|FG001|Part B|Disease progression|0|||
25302345|NCT00753415|50617815|FG002|Part B|Disease progression|0|||
25302346|NCT00753415|50617816|FG003|Part B|Disease progression|0|||
25302347|NCT00753415|50617817|FG004|Part B|Disease progression|0|||
25302348|NCT00753415|50617818|FG005|Part B|Disease progression|0|||
25302349|NCT00753415|50617819|FG006|Part B|Disease progression|0|||
25302350|NCT00753415|50617820|FG007|Part B|Disease progression|0|||
25302351|NCT00753415|50617821|FG008|Part B|Disease progression|2|||
25302352|NCT00753415|50617822|FG009|Part B|Disease progression|1|||
25302353|NCT00754741|50617849|FG000|Overall Study|Died or disenrolled|57|||
25302354|NCT00754741|50617850|FG001|Overall Study|Died or disenrolled|69|||
25302355|NCT00754741|50617851|FG002|Overall Study|Died or disenrolled|54|||
25302356|NCT00752791|50617859|FG000|Overall Study|Adverse Event|7|||
25302357|NCT00752791|50617859|FG000|Overall Study|Withdrawal by Subject|1|||
25302358|NCT00752791|50617859|FG000|Overall Study|Physician Decision|1|||
25302359|NCT00752791|50617859|FG000|Overall Study|Death|1|||
25302360|NCT00752791|50617859|FG000|Overall Study|Renal transplant|3|||
25302361|NCT00752791|50617859|FG000|Overall Study|Switched to hemodialysis|2|||
25302362|NCT00752791|50617859|FG000|Overall Study|Protocol deviation|1|||
25302363|NCT00902304|50617870|FG000|Overall Study|Adverse Event|4|||
25302364|NCT00902304|50617871|FG001|Overall Study|Adverse Event|10|||
25302365|NCT00902304|50617872|FG002|Overall Study|Adverse Event|25|||
25302366|NCT00902304|50617870|FG000|Overall Study|Investigator discretion|3|||
25302367|NCT00902304|50617871|FG001|Overall Study|Investigator discretion|5|||
25302368|NCT00902304|50617872|FG002|Overall Study|Investigator discretion|13|||
25302369|NCT00902304|50617870|FG000|Overall Study|Lost to Follow-up|7|||
25302370|NCT00902304|50617871|FG001|Overall Study|Lost to Follow-up|7|||
25302371|NCT00902304|50617872|FG002|Overall Study|Lost to Follow-up|7|||
25302372|NCT00902304|50617870|FG000|Overall Study|Protocol Violation|9|||
25302373|NCT00902304|50617871|FG001|Overall Study|Protocol Violation|18|||
25302374|NCT00902304|50617872|FG002|Overall Study|Protocol Violation|20|||
25302375|NCT00902304|50617870|FG000|Overall Study|Withdrawal by Subject|32|||
25302376|NCT00902304|50617871|FG001|Overall Study|Withdrawal by Subject|22|||
25302377|NCT00902304|50617872|FG002|Overall Study|Withdrawal by Subject|43|||
25302378|NCT00902304|50617870|FG000|Overall Study|includes pregnancy|3|||
25302379|NCT00902304|50617871|FG001|Overall Study|includes pregnancy|9|||
25302380|NCT00902304|50617872|FG002|Overall Study|includes pregnancy|2|||
25302381|NCT00759109|50617883|FG000|Overall Study|Adverse Event|17|||
25302382|NCT00759109|50617884|FG001|Overall Study|Adverse Event|12|||
25302383|NCT00759109|50617883|FG000|Overall Study|Inability to comply|1|||
25302384|NCT00759109|50617884|FG001|Overall Study|Inability to comply|1|||
25302385|NCT00759109|50617883|FG000|Overall Study|Withdrawal by Subject|9|||
25302386|NCT00759109|50617884|FG001|Overall Study|Withdrawal by Subject|5|||
25302387|NCT00759109|50617883|FG000|Overall Study|Death|4|||
25302388|NCT00759109|50617884|FG001|Overall Study|Death|3|||
25302389|NCT00759109|50617883|FG000|Overall Study|Lost to Follow-up|4|||
25302390|NCT00759109|50617884|FG001|Overall Study|Lost to Follow-up|6|||
25302391|NCT00759109|50617883|FG000|Overall Study|Started new therapy|2|||
25302392|NCT00759109|50617884|FG001|Overall Study|Started new therapy|6|||
25302393|NCT00759109|50617883|FG000|Overall Study|HCV RNA negative|1|||
25302394|NCT00759109|50617884|FG001|Overall Study|HCV RNA negative|0|||
25302395|NCT00759109|50617883|FG000|Overall Study|Participant moved to a different city|0|||
25302396|NCT00759109|50617884|FG001|Overall Study|Participant moved to a different city|1|||
25302397|NCT00759109|50617883|FG000|Overall Study|Participant had a liver transplant|0|||
25302398|NCT00759109|50617884|FG001|Overall Study|Participant had a liver transplant|1|||
25302399|NCT00759109|50617883|FG000|Overall Study|Lost during study|1|||
25302400|NCT00759109|50617884|FG001|Overall Study|Lost during study|0|||
25302401|NCT00759031|50617892|FG000|First Intervention (1 Day)|Physician Decision|1|||
25302402|NCT00759031|50617893|FG001|First Intervention (1 Day)|Physician Decision|0|||
25302403|NCT00759031|50617892|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
25302404|NCT00759031|50617893|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
25302405|NCT00759031|50617892|FG000|First Intervention (1 Day)|Screening failure|1|||
25302406|NCT00759031|50617893|FG001|First Intervention (1 Day)|Screening failure|0|||
25302407|NCT00758485|50617901|FG000|Overall Study|Lost to Follow-up|0|||
25302408|NCT00758485|50617902|FG001|Overall Study|Lost to Follow-up|1|||
25302409|NCT00758485|50617901|FG000|Overall Study|Not Treated|1|||
25302410|NCT00758485|50617902|FG001|Overall Study|Not Treated|2|||
25302411|NCT00757783|50617911|FG000|Overall Study|Adverse Event|0|||
25302412|NCT00757783|50617912|FG001|Overall Study|Adverse Event|2|||
25302413|NCT00757783|50617911|FG000|Overall Study|Lost to Follow-up|1|||
25302414|NCT00757783|50617912|FG001|Overall Study|Lost to Follow-up|1|||
25302415|NCT00757783|50617911|FG000|Overall Study|Protocol Violation|1|||
25302416|NCT00757783|50617912|FG001|Overall Study|Protocol Violation|0|||
25302417|NCT00757783|50617911|FG000|Overall Study|Withdrawal by Subject|2|||
25302418|NCT00757783|50617912|FG001|Overall Study|Withdrawal by Subject|1|||
25302419|NCT00757783|50617911|FG000|Overall Study|Other|1|||
25302420|NCT00757783|50617912|FG001|Overall Study|Other|2|||
25070981|NCT00100789|50177051|FG000|Overall Study|Death|2|||
25070982|NCT00100789|50177051|FG000|Overall Study|Not protocol specified|5|||
25070983|NCT00100789|50177051|FG000|Overall Study|Ineligible|3|||
25302421|NCT00757705|50617918|FG000|Overall Study|Adverse Event|19|||
25302422|NCT00757705|50617918|FG000|Overall Study|Lost to Follow-up|16|||
25302423|NCT00757705|50617918|FG000|Overall Study|Withdrawal by Subject|25|||
25302424|NCT00757705|50617918|FG000|Overall Study|Insufficient Response|26|||
25302425|NCT00757705|50617918|FG000|Overall Study|Ineligible to continue|8|||
25302426|NCT00757705|50617918|FG000|Overall Study|Non-compliant|9|||
25302427|NCT00757705|50617918|FG000|Overall Study|Other|18|||
25302428|NCT00757627|50617922|FG000|Overall Study|Adverse Event|15|||
25302429|NCT00757627|50617922|FG000|Overall Study|Lack of Efficacy|10|||
25302430|NCT00757627|50617922|FG000|Overall Study|Lost to Follow-up|28|||
25302431|NCT00757627|50617922|FG000|Overall Study|Withdrawal by Subject|27|||
25302432|NCT00757627|50617922|FG000|Overall Study|Other|1|||
25302433|NCT01023308|50617933|FG000|Overall Study|Abnormal test proceedure results|3|||
25302434|NCT01023308|50617934|FG001|Overall Study|Abnormal test proceedure results|8|||
25302435|NCT01023308|50617933|FG000|Overall Study|Administrative problems|2|||
25302436|NCT01023308|50617934|FG001|Overall Study|Administrative problems|1|||
25302437|NCT01023308|50617933|FG000|Overall Study|Adverse Event|130|||
25302438|NCT01023308|50617934|FG001|Overall Study|Adverse Event|66|||
25302439|NCT01023308|50617933|FG000|Overall Study|Death|21|||
25302440|NCT01023308|50617934|FG001|Overall Study|Death|17|||
25302441|NCT01023308|50617933|FG000|Overall Study|Disease progression|82|||
25302442|NCT01023308|50617934|FG001|Overall Study|Disease progression|153|||
25302443|NCT01023308|50617933|FG000|Overall Study|New Cancer therapy|4|||
25302444|NCT01023308|50617934|FG001|Overall Study|New Cancer therapy|7|||
25302445|NCT01023308|50617933|FG000|Overall Study|Protocol Violation|3|||
25302446|NCT01023308|50617934|FG001|Overall Study|Protocol Violation|4|||
25302447|NCT01023308|50617933|FG000|Overall Study|Untreated|5|||
25302448|NCT01023308|50617934|FG001|Overall Study|Untreated|5|||
25302449|NCT01023308|50617933|FG000|Overall Study|Lost to Follow-up|1|||
25302450|NCT01023308|50617934|FG001|Overall Study|Lost to Follow-up|0|||
25302451|NCT01023308|50617933|FG000|Overall Study|Withdrawal by Subject|34|||
25302452|NCT01023308|50617934|FG001|Overall Study|Withdrawal by Subject|18|||
25302453|NCT01022996|50617940|FG000|Overall Study|Adverse Event|14|||
25302454|NCT01022996|50617940|FG000|Overall Study|Withdrawal by Subject|3|||
25302455|NCT01022996|50617940|FG000|Overall Study|Lost to Follow-up|1|||
25302456|NCT01022996|50617940|FG000|Overall Study|Administrative problems|6|||
25302457|NCT01022996|50617940|FG000|Overall Study|Disease Progression|32|||
25302458|NCT01022996|50617940|FG000|Overall Study|Protocol Violation|1|||
25302459|NCT00757237|50617946|FG000|Overall Study|Lost to Follow-up|0|||
25302460|NCT00757237|50617947|FG001|Overall Study|Lost to Follow-up|1|||
25302461|NCT00757237|50617946|FG000|Overall Study|Protocol Violation|0|||
25302462|NCT00757237|50617947|FG001|Overall Study|Protocol Violation|2|||
25302463|NCT00757237|50617946|FG000|Overall Study|Physician Decision|2|||
25302464|NCT00757237|50617947|FG001|Overall Study|Physician Decision|3|||
25302465|NCT00757237|50617946|FG000|Overall Study|Withdrawal by Subject|8|||
25302466|NCT00757237|50617947|FG001|Overall Study|Withdrawal by Subject|12|||
25302467|NCT00757237|50617946|FG000|Overall Study|Safety or Tolerability|3|||
25302468|NCT00757237|50617947|FG001|Overall Study|Safety or Tolerability|5|||
25302469|NCT00757237|50617946|FG000|Overall Study|Other|0|||
25302470|NCT00757237|50617947|FG001|Overall Study|Other|2|||
25302471|NCT01029392|50617955|FG000|Overall Study|Withdrawal by Subject|18|||
25302472|NCT01029392|50617956|FG001|Overall Study|Withdrawal by Subject|11|||
25302473|NCT01029392|50617955|FG000|Overall Study|Physician Decision|2|||
25302474|NCT01029392|50617956|FG001|Overall Study|Physician Decision|0|||
25191952|NCT01665144|50354774|FG001|Overall Study|Lost to Follow-up|8|||
25302475|NCT00903006|50617968|FG000|Overall Study|Withdrawal by Subject|2|||
25302476|NCT00903006|50617969|FG001|Overall Study|Withdrawal by Subject|0|||
25302477|NCT00903006|50617970|FG002|Overall Study|Withdrawal by Subject|0|||
25191953|NCT01665144|50354773|FG000|Overall Study|Physician Decision|13|||
25302478|NCT00903006|50617971|FG003|Overall Study|Withdrawal by Subject|0|||
25302479|NCT00903006|50617968|FG000|Overall Study|Progressive Disease|0|||
25302480|NCT00903006|50617969|FG001|Overall Study|Progressive Disease|3|||
25302481|NCT00903006|50617970|FG002|Overall Study|Progressive Disease|1|||
25302482|NCT00903006|50617971|FG003|Overall Study|Progressive Disease|0|||
25302483|NCT00839332|50617984|FG000|Phase 1|Disease Progression|38|||
25302484|NCT00839332|50617985|FG001|Phase 1|Disease Progression|0|||
25302485|NCT00839332|50617986|FG002|Phase 1|Disease Progression|0|||
25302486|NCT00839332|50617984|FG000|Phase 1|Adverse Event|6|||
25302487|NCT00839332|50617985|FG001|Phase 1|Adverse Event|0|||
25302488|NCT00839332|50617986|FG002|Phase 1|Adverse Event|0|||
25302489|NCT00839332|50617984|FG000|Phase 1|Withdrawal by Subject|4|||
25302490|NCT00839332|50617985|FG001|Phase 1|Withdrawal by Subject|0|||
25302491|NCT00839332|50617986|FG002|Phase 1|Withdrawal by Subject|0|||
25302492|NCT00839332|50617984|FG000|Phase 1|Physician Decision|2|||
25302493|NCT00839332|50617985|FG001|Phase 1|Physician Decision|0|||
25302494|NCT00839332|50617986|FG002|Phase 1|Physician Decision|0|||
25302495|NCT00839332|50617984|FG000|Phase 2|Protocol Violation|0|||
25302496|NCT00839332|50617985|FG001|Phase 2|Protocol Violation|1|||
25302497|NCT00839332|50617986|FG002|Phase 2|Protocol Violation|0|||
25302498|NCT00839332|50617984|FG000|Phase 2|Disease Progression|0|||
25302499|NCT00839332|50617985|FG001|Phase 2|Disease Progression|46|||
25302500|NCT00839332|50617986|FG002|Phase 2|Disease Progression|21|||
25302501|NCT00839332|50617984|FG000|Phase 2|Adverse Event|0|||
25302502|NCT00839332|50617985|FG001|Phase 2|Adverse Event|8|||
25302503|NCT00839332|50617986|FG002|Phase 2|Adverse Event|6|||
25302504|NCT00839332|50617984|FG000|Phase 2|Death|0|||
25302505|NCT00839332|50617985|FG001|Phase 2|Death|4|||
25302506|NCT00839332|50617986|FG002|Phase 2|Death|2|||
25302507|NCT00839332|50617984|FG000|Phase 2|Withdrawal by Subject|0|||
25302508|NCT00839332|50617985|FG001|Phase 2|Withdrawal by Subject|5|||
25302509|NCT00839332|50617986|FG002|Phase 2|Withdrawal by Subject|8|||
25302510|NCT00839332|50617984|FG000|Phase 2|Physician Decision|0|||
25302511|NCT00839332|50617985|FG001|Phase 2|Physician Decision|4|||
25302512|NCT00839332|50617986|FG002|Phase 2|Physician Decision|1|||
25302513|NCT00839332|50617984|FG000|Phase 2|Lost to Follow-up|0|||
25302514|NCT00839332|50617985|FG001|Phase 2|Lost to Follow-up|0|||
25302515|NCT00839332|50617986|FG002|Phase 2|Lost to Follow-up|1|||
25302516|NCT00902850|50617997|FG000|Overall Study|Physician Decision|2|||
25302517|NCT00902850|50617998|FG001|Overall Study|Physician Decision|2|||
25302518|NCT00902538|50618007|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
25302519|NCT00902538|50618008|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
25302520|NCT00902538|50618009|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
25302521|NCT00902538|50618010|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
25302522|NCT00902538|50618011|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
25302523|NCT00902538|50618012|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
25302524|NCT00902538|50618007|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
25302525|NCT00902538|50618008|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
25302526|NCT00902538|50618009|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
25302527|NCT00902538|50618010|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
24969907|NCT00116688|50059372|FG001|Overall Study|Pregnancy|0|||
24969908|NCT00116688|50059371|FG000|Overall Study|Other|11|||
24969909|NCT00116688|50059372|FG001|Overall Study|Other|0|||
24969910|NCT04531540|50059378|FG000|Overall Study|Adverse Event|1|||
24969911|NCT04531540|50059378|FG000|Overall Study|Protocol Violation|3|||
24969912|NCT04531540|50059378|FG000|Overall Study|Withdrawal by Subject|4|||
24969913|NCT04531540|50059378|FG000|Overall Study|Found to be Ineligible|1|||
24969914|NCT04799782|50059382|FG000|Washout|Physician Decision|2|||
24969915|NCT04799782|50059383|FG001|Washout|Physician Decision|0|||
24969916|NCT04799782|50059382|FG000|Washout|Withdrawal by Subject|0|||
25191954|NCT01665144|50354774|FG001|Overall Study|Physician Decision|1|||
25302528|NCT00902538|50618011|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
25302529|NCT00902538|50618012|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
25302530|NCT00902538|50618007|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
25302531|NCT00902538|50618008|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
25302532|NCT00902538|50618009|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
25302533|NCT00902538|50618010|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
25302534|NCT00902538|50618011|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
25302535|NCT00902538|50618012|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
25302536|NCT00902538|50618007|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
25302537|NCT00902538|50618008|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
25302538|NCT00902538|50618009|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
25302539|NCT00902538|50618010|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
25302540|NCT00902538|50618011|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
25302541|NCT00902538|50618012|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
25302542|NCT00902538|50618007|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
24969917|NCT04799782|50059383|FG001|Washout|Withdrawal by Subject|2|||
24969918|NCT04799782|50059382|FG000|Washout|Lost to Follow-up|0|||
25302543|NCT00902538|50618008|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
25302544|NCT00902538|50618009|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
25302545|NCT00902538|50618010|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
25302546|NCT00902538|50618011|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
25302547|NCT00902538|50618012|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
25302548|NCT00902538|50618007|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
25302549|NCT00902538|50618008|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
24969919|NCT04799782|50059383|FG001|Washout|Lost to Follow-up|1|||
25191955|NCT01665144|50354773|FG000|Overall Study|Lack of Efficacy|16|||
24969920|NCT03697252|50059391|FG000|Overall Study|Adverse Event|3|||
25302550|NCT00902538|50618009|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
25302551|NCT00902538|50618010|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
25302552|NCT00902538|50618011|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
25302553|NCT00902538|50618012|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
25302554|NCT00902538|50618007|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
25302555|NCT00902538|50618008|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
25302556|NCT00902538|50618009|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
25302557|NCT00902538|50618010|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
25302558|NCT00902538|50618011|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
25302559|NCT00902538|50618012|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
25302560|NCT00902538|50618007|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
25302561|NCT00902538|50618008|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
25302562|NCT00902538|50618009|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
25302563|NCT00902538|50618010|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
25302564|NCT00902538|50618011|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
25302565|NCT00902538|50618012|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
25302566|NCT00902538|50618007|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
25302567|NCT00902538|50618008|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
25302568|NCT00902538|50618009|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
25302569|NCT00902538|50618010|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
25302570|NCT00902538|50618011|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
25302571|NCT00902538|50618012|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
25302572|NCT00902538|50618007|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
25302573|NCT00902538|50618008|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
25302574|NCT00902538|50618009|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
25302575|NCT00902538|50618010|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
25302576|NCT00902538|50618011|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
25302577|NCT00902538|50618012|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
25302578|NCT00902538|50618007|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
25302579|NCT00902538|50618008|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
25302580|NCT00902538|50618009|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
25302581|NCT00902538|50618010|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
25302582|NCT00902538|50618011|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
25302583|NCT00902538|50618012|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
25302584|NCT00902538|50618007|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
25302585|NCT00902538|50618008|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
25302586|NCT00902538|50618009|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
25302587|NCT00902538|50618010|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
25302588|NCT00902538|50618011|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
25302589|NCT00902538|50618012|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
25302590|NCT00902538|50618007|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
25302591|NCT00902538|50618008|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
25302592|NCT00902538|50618009|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
25302593|NCT00902538|50618010|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
25302594|NCT00902538|50618011|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
25302595|NCT00902538|50618012|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
25302596|NCT00902538|50618007|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
25302597|NCT00902538|50618008|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
25302598|NCT00902538|50618009|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
25302599|NCT00902538|50618010|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
25302600|NCT00902538|50618011|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
25302601|NCT00902538|50618012|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
25302602|NCT00902538|50618007|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
25302603|NCT00902538|50618008|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
25302604|NCT00902538|50618009|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
25302605|NCT00902538|50618010|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
25302606|NCT00902538|50618011|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
25302607|NCT00902538|50618012|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
25302608|NCT00902538|50618007|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
25302609|NCT00902538|50618008|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
25302610|NCT00902538|50618009|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
25302611|NCT00902538|50618010|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
25302612|NCT00902538|50618011|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
25302613|NCT00902538|50618012|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
25302614|NCT00902538|50618007|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
25302615|NCT00902538|50618008|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
25302616|NCT00902538|50618009|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
25302617|NCT00902538|50618010|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
25169379|NCT01830881|50301108|FG000|Overall Study|Changed decision to have an abortion|0|||
25169380|NCT01830881|50301109|FG001|Overall Study|Changed decision to have an abortion|1|||
25169381|NCT01838681|50301145|FG000|Period A|Adverse Event|39|||
25302618|NCT00902538|50618011|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
25302619|NCT00902538|50618012|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
25302620|NCT01036022|50618034|FG000|Overall Study|Adverse Event|1|||
25302621|NCT01036022|50618035|FG001|Overall Study|Adverse Event|3|||
24969921|NCT03697252|50059392|FG001|Overall Study|Adverse Event|2|||
24969922|NCT03697252|50059391|FG000|Overall Study|Withdrawal by Subject|14|||
24969923|NCT03697252|50059392|FG001|Overall Study|Withdrawal by Subject|14|||
25302622|NCT01036022|50618036|FG002|Overall Study|Adverse Event|2|||
25302623|NCT01036022|50618037|FG003|Overall Study|Adverse Event|1|||
25302624|NCT01036022|50618038|FG004|Overall Study|Adverse Event|0|||
25302625|NCT01036022|50618039|FG005|Overall Study|Adverse Event|2|||
25302626|NCT01036022|50618034|FG000|Overall Study|Lack of Efficacy|1|||
25302627|NCT01036022|50618035|FG001|Overall Study|Lack of Efficacy|1|||
25302628|NCT01036022|50618036|FG002|Overall Study|Lack of Efficacy|1|||
25302629|NCT01036022|50618037|FG003|Overall Study|Lack of Efficacy|0|||
25302630|NCT01036022|50618038|FG004|Overall Study|Lack of Efficacy|1|||
25302631|NCT01036022|50618039|FG005|Overall Study|Lack of Efficacy|1|||
25302632|NCT01036022|50618034|FG000|Overall Study|Physician Decision|0|||
25302633|NCT01036022|50618035|FG001|Overall Study|Physician Decision|0|||
25302634|NCT01036022|50618036|FG002|Overall Study|Physician Decision|1|||
25302635|NCT01036022|50618037|FG003|Overall Study|Physician Decision|0|||
25302636|NCT01036022|50618038|FG004|Overall Study|Physician Decision|0|||
25302637|NCT01036022|50618039|FG005|Overall Study|Physician Decision|0|||
25302638|NCT01036022|50618034|FG000|Overall Study|Withdrawal by Subject|0|||
25302639|NCT01036022|50618035|FG001|Overall Study|Withdrawal by Subject|0|||
25302640|NCT01036022|50618036|FG002|Overall Study|Withdrawal by Subject|0|||
25302641|NCT01036022|50618037|FG003|Overall Study|Withdrawal by Subject|1|||
25302642|NCT01036022|50618038|FG004|Overall Study|Withdrawal by Subject|2|||
25302643|NCT01036022|50618039|FG005|Overall Study|Withdrawal by Subject|0|||
25302644|NCT00752557|50618064|FG000|Overall Study|Withdrawal by Subject|4|||
25302645|NCT00752557|50618065|FG001|Overall Study|Withdrawal by Subject|3|||
25302646|NCT00752557|50618066|FG002|Overall Study|Withdrawal by Subject|3|||
25302647|NCT00752557|50618064|FG000|Overall Study|Unspecified resaons|0|||
25302648|NCT00752557|50618065|FG001|Overall Study|Unspecified resaons|2|||
25302649|NCT00752557|50618066|FG002|Overall Study|Unspecified resaons|2|||
25302650|NCT00752557|50618064|FG000|Overall Study|Lost to Follow-up|1|||
25302651|NCT00752557|50618065|FG001|Overall Study|Lost to Follow-up|0|||
25302652|NCT00752557|50618066|FG002|Overall Study|Lost to Follow-up|1|||
25302653|NCT00747643|50618078|FG000|Overall Study|Withdrawal by Subject|36|||
25302654|NCT00747643|50618079|FG001|Overall Study|Withdrawal by Subject|27|||
25302655|NCT01022762|50618087|FG000|Overall Study|Adverse Event|3|||
25302656|NCT01022762|50618088|FG001|Overall Study|Adverse Event|1|||
25302657|NCT01022762|50618087|FG000|Overall Study|Lack of Efficacy|0|||
25302658|NCT01022762|50618088|FG001|Overall Study|Lack of Efficacy|1|||
25302659|NCT01022762|50618087|FG000|Overall Study|Protocol Violation|7|||
25302660|NCT01022762|50618088|FG001|Overall Study|Protocol Violation|6|||
25302661|NCT01022762|50618087|FG000|Overall Study|Unclassified|12|||
25302662|NCT01022762|50618088|FG001|Overall Study|Unclassified|20|||
25302663|NCT01028378|50618094|FG000|Overall Study|Lost to Follow-up|12|||
25302664|NCT01028378|50618094|FG000|Overall Study|Withdrawal by Subject|1|||
25302665|NCT01028378|50618094|FG000|Overall Study|Adminstrative Reasons|4|||
25302666|NCT00747565|50618100|FG000|Overall Study|Withdrawal by Subject|10|||
25302667|NCT00747565|50618101|FG001|Overall Study|Withdrawal by Subject|6|||
25302668|NCT00747565|50618100|FG000|Overall Study|Lost to Follow-up|4|||
25302669|NCT00747565|50618101|FG001|Overall Study|Lost to Follow-up|1|||
25302670|NCT01028300|50618107|FG000|Overall Study|Study Terminated|4|||
25302671|NCT00752089|50618111|FG000|Overall Study|Adverse Event|1|||
25302672|NCT00752089|50618111|FG000|Overall Study|Protocol Deviation|2|||
25302673|NCT00752089|50618111|FG000|Overall Study|Could not attend visit 9|1|||
25302674|NCT00752089|50618111|FG000|Overall Study|Not capable of wearing partial denture|1|||
25302675|NCT00752089|50618111|FG000|Overall Study|Cannot continue the study|1|||
25302676|NCT00751933|50618122|FG000|Overall Study|Withdrawal by Subject|0|||
25302677|NCT00751933|50618123|FG001|Overall Study|Withdrawal by Subject|1|||
25302678|NCT00751933|50618124|FG002|Overall Study|Withdrawal by Subject|0|||
25302679|NCT00751933|50618125|FG003|Overall Study|Withdrawal by Subject|0|||
25302680|NCT00751933|50618122|FG000|Overall Study|Physician Decision|0|||
25302681|NCT00751933|50618123|FG001|Overall Study|Physician Decision|0|||
25302682|NCT00751933|50618124|FG002|Overall Study|Physician Decision|1|||
25302683|NCT00751933|50618125|FG003|Overall Study|Physician Decision|1|||
25302684|NCT00751621|50618129|FG000|Overall Study|Adverse Event|1|||
25302685|NCT00751621|50618129|FG000|Overall Study|Withdrawal by Subject|1|||
25302686|NCT00751621|50618129|FG000|Overall Study|Subject moved to another country|1|||
25302687|NCT00751621|50618129|FG000|Overall Study|Poor adherence to asthma treatment|1|||
25302688|NCT01028222|50618137|FG000|Overall Study|Protocol deviation|1|||
25302689|NCT01028222|50618138|FG001|Overall Study|Protocol deviation|0|||
25302690|NCT01028222|50618137|FG000|Overall Study|Disease progression|33|||
25302691|NCT01028222|50618138|FG001|Overall Study|Disease progression|9|||
25302692|NCT01028222|50618137|FG000|Overall Study|Administrative problems|1|||
25302693|NCT01028222|50618138|FG001|Overall Study|Administrative problems|1|||
25302694|NCT01028222|50618137|FG000|Overall Study|Lost to Follow-up|0|||
25302695|NCT01028222|50618138|FG001|Overall Study|Lost to Follow-up|1|||
25302696|NCT01028222|50618137|FG000|Overall Study|Withdrawal by Subject|1|||
25302697|NCT01028222|50618138|FG001|Overall Study|Withdrawal by Subject|0|||
25302698|NCT01028222|50618137|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
25302699|NCT01028222|50618138|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
25302700|NCT01028222|50618137|FG000|Overall Study|Adverse Event|2|||
25302701|NCT01028222|50618138|FG001|Overall Study|Adverse Event|0|||
25302702|NCT00586495|50618145|FG000|Treatment Period|Adverse Event|11|||
25302703|NCT00586495|50618145|FG000|Treatment Period|Death|1|||
25302704|NCT00586495|50618145|FG000|Treatment Period|Protocol Violation|1|||
25302705|NCT00586495|50618145|FG000|Treatment Period|Withdrawal by Subject|1|||
25302706|NCT00586495|50618145|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
25302707|NCT00586495|50618145|FG000|Treatment Period|Switch to commercial drug|10|||
25302708|NCT00586495|50618145|FG000|Follow-up|Death|40|||
25302709|NCT00586495|50618145|FG000|Follow-up|Lost to Follow-up|1|||
25302710|NCT00586495|50618145|FG000|Follow-up|Withdrawal by Subject|4|||
25302711|NCT00586495|50618145|FG000|Follow-up|Protocol driven decision point|37|||
25302712|NCT00586495|50618145|FG000|Follow-up|Switch to commercial drug|10|||
24969924|NCT03697252|50059391|FG000|Overall Study|Lost to Follow-up|0|||
24969925|NCT03697252|50059392|FG001|Overall Study|Lost to Follow-up|1|||
24969926|NCT03697252|50059391|FG000|Overall Study|Physician Decision|1|||
24969927|NCT03697252|50059392|FG001|Overall Study|Physician Decision|1|||
25070984|NCT00100789|50177051|FG000|Overall Study|Never received treatment|1|||
25302713|NCT01027754|50618151|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
25302714|NCT01027754|50618152|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
25302715|NCT01027754|50618151|FG000|Overall Study|Withdrawal by Subject|0|||
25302716|NCT01027754|50618152|FG001|Overall Study|Withdrawal by Subject|5|||
25302717|NCT01034540|50618164|FG000|Overall Study|Adverse Event|0|||
25302718|NCT01034540|50618165|FG001|Overall Study|Adverse Event|1|||
25302719|NCT00774930|50618175|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
25302720|NCT00774930|50618176|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
25302721|NCT00774930|50618175|FG000|DB Phase|Adverse Event|1|||
25302722|NCT00774930|50618176|FG001|DB Phase|Adverse Event|2|||
25302723|NCT00774930|50618175|FG000|DB Phase|Subject Decision|1|||
25302724|NCT00774930|50618176|FG001|DB Phase|Subject Decision|5|||
25302725|NCT00774930|50618175|FG000|DB Phase|Sponsor Decision|0|||
25302726|NCT00774930|50618176|FG001|DB Phase|Sponsor Decision|1|||
25302727|NCT00774930|50618175|FG000|DB Phase|Disease Progression|1|||
25302728|NCT00774930|50618176|FG001|DB Phase|Disease Progression|1|||
25302729|NCT00774930|50618175|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
25302730|NCT00774930|50618176|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
25302731|NCT00774930|50618175|FG000|IOL Phase|Adverse Event|1|||
25302732|NCT00774930|50618176|FG001|IOL Phase|Adverse Event|1|||
25302733|NCT00774930|50618175|FG000|IOL Phase|Subject Decision|4|||
25302734|NCT00774930|50618176|FG001|IOL Phase|Subject Decision|3|||
25302735|NCT00774930|50618175|FG000|IOL Phase|Physician Decision|3|||
25302736|NCT00774930|50618176|FG001|IOL Phase|Physician Decision|2|||
25302737|NCT00774930|50618175|FG000|IOL Phase|Sponsor Decision|1|||
25302738|NCT00774930|50618176|FG001|IOL Phase|Sponsor Decision|0|||
25302739|NCT00774930|50618175|FG000|IOL Phase|Disease Progression|2|||
25302740|NCT00774930|50618176|FG001|IOL Phase|Disease Progression|1|||
25302741|NCT00774930|50618175|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
25302742|NCT00774930|50618176|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
25302743|NCT00774930|50618175|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
25302744|NCT00774930|50618176|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
25302745|NCT00774930|50618175|FG000|IOL Phase|Other|1|||
25302746|NCT00774930|50618176|FG001|IOL Phase|Other|0|||
25302747|NCT00774930|50618175|FG000|IOL Phase|Brain radiation|0|||
25302748|NCT00774930|50618176|FG001|IOL Phase|Brain radiation|1|||
25302749|NCT00774930|50618175|FG000|LTOLE Phase|Adverse Event|7|||
25302750|NCT00774930|50618176|FG001|LTOLE Phase|Adverse Event|3|||
25302751|NCT00774930|50618175|FG000|LTOLE Phase|Subject decision|0|||
25302752|NCT00774930|50618176|FG001|LTOLE Phase|Subject decision|5|||
25302753|NCT00774930|50618175|FG000|LTOLE Phase|Physician Decision|4|||
25302754|NCT00774930|50618176|FG001|LTOLE Phase|Physician Decision|1|||
25302755|NCT00774930|50618175|FG000|LTOLE Phase|Sponsor decision|2|||
25302756|NCT00774930|50618176|FG001|LTOLE Phase|Sponsor decision|1|||
25302757|NCT00774930|50618175|FG000|LTOLE Phase|Disease Progression|2|||
25302758|NCT00774930|50618176|FG001|LTOLE Phase|Disease Progression|5|||
25302759|NCT00774930|50618175|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
25302760|NCT00774930|50618176|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
25302761|NCT00774930|50618175|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
25302762|NCT00774930|50618176|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
25302763|NCT01027364|50618197|FG000|Overall Study|Adverse Event|1|||
25302764|NCT01027364|50618198|FG001|Overall Study|Adverse Event|0|||
25302765|NCT01027364|50618199|FG002|Overall Study|Adverse Event|1|||
25302766|NCT01027364|50618200|FG003|Overall Study|Adverse Event|0|||
25302767|NCT01027364|50618197|FG000|Overall Study|Lost to Follow-up|1|||
25302768|NCT01027364|50618198|FG001|Overall Study|Lost to Follow-up|0|||
25302769|NCT01027364|50618199|FG002|Overall Study|Lost to Follow-up|0|||
25302770|NCT01027364|50618200|FG003|Overall Study|Lost to Follow-up|0|||
25302771|NCT01027364|50618197|FG000|Overall Study|Protocol Violation|1|||
25302772|NCT01027364|50618198|FG001|Overall Study|Protocol Violation|0|||
25302773|NCT01027364|50618199|FG002|Overall Study|Protocol Violation|0|||
25302774|NCT01027364|50618200|FG003|Overall Study|Protocol Violation|1|||
25302775|NCT01027364|50618197|FG000|Overall Study|Withdrawal by Subject|1|||
25302776|NCT01027364|50618198|FG001|Overall Study|Withdrawal by Subject|2|||
25302777|NCT01027364|50618199|FG002|Overall Study|Withdrawal by Subject|0|||
25302778|NCT01027364|50618200|FG003|Overall Study|Withdrawal by Subject|0|||
25302779|NCT01027286|50618228|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
25302780|NCT01027286|50618229|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
25302781|NCT01027286|50618228|FG000|Overall Study|Lost to Follow-up|0|||
25302782|NCT01027286|50618229|FG001|Overall Study|Lost to Follow-up|1|||
25302783|NCT01026974|50618239|FG000|Overall Study|Withdrawal by Subject|0|||
25302784|NCT01026974|50618240|FG001|Overall Study|Withdrawal by Subject|1|||
25302785|NCT01026974|50618241|FG002|Overall Study|Withdrawal by Subject|7|||
25302786|NCT01026974|50618242|FG003|Overall Study|Withdrawal by Subject|2|||
25302787|NCT01026974|50618239|FG000|Overall Study|Lost to Follow-up|1|||
25302788|NCT01026974|50618240|FG001|Overall Study|Lost to Follow-up|1|||
25302789|NCT01026974|50618241|FG002|Overall Study|Lost to Follow-up|4|||
25302790|NCT01026974|50618242|FG003|Overall Study|Lost to Follow-up|0|||
25302791|NCT01026974|50618239|FG000|Overall Study|Adverse Event|0|||
25302792|NCT01026974|50618240|FG001|Overall Study|Adverse Event|0|||
25302793|NCT01026974|50618241|FG002|Overall Study|Adverse Event|0|||
25302794|NCT01026974|50618242|FG003|Overall Study|Adverse Event|1|||
25302795|NCT01026974|50618239|FG000|Overall Study|Inappropriate enrollment|0|||
24969928|NCT03697252|50059391|FG000|Overall Study|Other|0|||
25302796|NCT01026974|50618240|FG001|Overall Study|Inappropriate enrollment|0|||
25302797|NCT01026974|50618241|FG002|Overall Study|Inappropriate enrollment|1|||
25302798|NCT01026974|50618242|FG003|Overall Study|Inappropriate enrollment|0|||
25302799|NCT00897390|50618257|FG000|Overall Study|Adverse Event|2|||
25302800|NCT00897390|50618257|FG000|Overall Study|No Longer Met Study Criteria|1|||
25302801|NCT00897390|50618257|FG000|Overall Study|Personal Reasons|1|||
25169382|NCT01838681|50301146|FG001|Period A|Adverse Event|0|||
25302802|NCT00897390|50618257|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
25302803|NCT01034462|50618270|FG000|Overall Study|Adverse Event|7|||
25302804|NCT01034462|50618271|FG001|Overall Study|Adverse Event|17|||
25302805|NCT01034462|50618270|FG000|Overall Study|Lack of Efficacy|4|||
25302806|NCT01034462|50618271|FG001|Overall Study|Lack of Efficacy|4|||
25302807|NCT01034462|50618270|FG000|Overall Study|Protocol Violation|10|||
25302808|NCT01034462|50618271|FG001|Overall Study|Protocol Violation|7|||
25302809|NCT01034462|50618270|FG000|Overall Study|Withdrawal by Subject|9|||
25302810|NCT01034462|50618271|FG001|Overall Study|Withdrawal by Subject|8|||
25302811|NCT01034462|50618270|FG000|Overall Study|Lost to Follow-up|14|||
25302812|NCT01034462|50618271|FG001|Overall Study|Lost to Follow-up|16|||
25302813|NCT01034462|50618270|FG000|Overall Study|Other reasons|1|||
25302814|NCT01034462|50618271|FG001|Overall Study|Other reasons|2|||
25302815|NCT01033448|50618279|FG000|Overall Study|Withdrawal by Subject|4|||
25302816|NCT01033448|50618279|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
25302817|NCT01033448|50618279|FG000|Overall Study|Lost to Follow-up|3|||
25302818|NCT01033448|50618279|FG000|Overall Study|Withdrew due to other reasons|3|||
25302819|NCT01033448|50618279|FG000|Overall Study|Unknown disposition|1|||
25302820|NCT00746941|50618289|FG000|Overall Study|Death|2|||
25302821|NCT00746941|50618290|FG001|Overall Study|Death|0|||
25302822|NCT00746941|50618291|FG002|Overall Study|Death|0|||
25302823|NCT00746941|50618292|FG003|Overall Study|Death|6|||
25302824|NCT00746941|50618289|FG000|Overall Study|Physician Decision|0|||
25302825|NCT00746941|50618290|FG001|Overall Study|Physician Decision|0|||
25302826|NCT00746941|50618291|FG002|Overall Study|Physician Decision|2|||
25302827|NCT00746941|50618292|FG003|Overall Study|Physician Decision|0|||
25302828|NCT00746941|50618289|FG000|Overall Study|Withdrawal by Subject|3|||
25302829|NCT00746941|50618290|FG001|Overall Study|Withdrawal by Subject|0|||
25302830|NCT00746941|50618291|FG002|Overall Study|Withdrawal by Subject|0|||
25302831|NCT00746941|50618292|FG003|Overall Study|Withdrawal by Subject|2|||
25302832|NCT00746941|50618289|FG000|Overall Study|Other, reason not provided|2|||
25302833|NCT00746941|50618290|FG001|Overall Study|Other, reason not provided|4|||
25302834|NCT00746941|50618291|FG002|Overall Study|Other, reason not provided|0|||
25302835|NCT00746941|50618292|FG003|Overall Study|Other, reason not provided|4|||
25302836|NCT00746941|50618289|FG000|Overall Study|Adverse Event|0|||
25302837|NCT00746941|50618290|FG001|Overall Study|Adverse Event|0|||
25302838|NCT00746941|50618291|FG002|Overall Study|Adverse Event|0|||
25302839|NCT00746941|50618292|FG003|Overall Study|Adverse Event|1|||
25302840|NCT00746785|50618304|FG000|Overall Study|Lost to Follow-up|29|||
25302841|NCT00746785|50618305|FG001|Overall Study|Lost to Follow-up|25|||
25302842|NCT00746785|50618306|FG002|Overall Study|Lost to Follow-up|27|||
25302843|NCT00750919|50618314|FG000|Overall Study|Adverse Event|9|||
25302844|NCT00750919|50618314|FG000|Overall Study|Withdrawal by Subject|1|||
25302845|NCT00750919|50618314|FG000|Overall Study|Lack of Efficacy|8|||
25302846|NCT00750919|50618314|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
25302847|NCT00750919|50618314|FG000|Overall Study|Other|36|||
25302848|NCT00746551|50618320|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
25302849|NCT00746551|50618321|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
25302850|NCT00746551|50618320|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
25302851|NCT00746551|50618321|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
25302852|NCT00746551|50618320|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
25302853|NCT00746551|50618321|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
25302854|NCT00753649|50618329|FG000|Overall Study|Migrated/moved from study area|1|||
25302855|NCT00753649|50618330|FG001|Overall Study|Migrated/moved from study area|0|||
25302856|NCT00753649|50618329|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
25302857|NCT00753649|50618330|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
25302858|NCT00753649|50618329|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
25302859|NCT00753649|50618330|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
25302860|NCT00753649|50618329|FG000|Overall Study|Protocol Violation|2|||
25302861|NCT00753649|50618330|FG001|Overall Study|Protocol Violation|0|||
25302862|NCT00750139|50618340|FG000|Overall Study|Adverse Event|1|||
25302863|NCT00750139|50618341|FG001|Overall Study|Adverse Event|2|||
25302864|NCT00750139|50618342|FG002|Overall Study|Adverse Event|0|||
25302865|NCT00750139|50618343|FG003|Overall Study|Adverse Event|1|||
25302866|NCT00750139|50618340|FG000|Overall Study|Lost to Follow-up|17|||
25302867|NCT00750139|50618341|FG001|Overall Study|Lost to Follow-up|12|||
25302868|NCT00750139|50618342|FG002|Overall Study|Lost to Follow-up|15|||
25302869|NCT00750139|50618343|FG003|Overall Study|Lost to Follow-up|6|||
25302870|NCT00750139|50618340|FG000|Overall Study|Withdrawal by Subject|3|||
25302871|NCT00750139|50618341|FG001|Overall Study|Withdrawal by Subject|2|||
25302872|NCT00750139|50618342|FG002|Overall Study|Withdrawal by Subject|6|||
25302873|NCT00750139|50618343|FG003|Overall Study|Withdrawal by Subject|2|||
25302874|NCT00750139|50618340|FG000|Overall Study|Physician Decision|1|||
25302875|NCT00750139|50618341|FG001|Overall Study|Physician Decision|1|||
25302876|NCT00750139|50618342|FG002|Overall Study|Physician Decision|0|||
25302877|NCT00750139|50618343|FG003|Overall Study|Physician Decision|0|||
25302878|NCT00750139|50618340|FG000|Overall Study|Non-compliance|1|||
25302879|NCT00750139|50618341|FG001|Overall Study|Non-compliance|0|||
25302880|NCT00750139|50618342|FG002|Overall Study|Non-compliance|1|||
25302881|NCT00750139|50618343|FG003|Overall Study|Non-compliance|3|||
25302882|NCT00750139|50618340|FG000|Overall Study|Termination by sponsor|4|||
25302883|NCT00750139|50618341|FG001|Overall Study|Termination by sponsor|0|||
25302884|NCT00750139|50618342|FG002|Overall Study|Termination by sponsor|0|||
25302885|NCT00750139|50618343|FG003|Overall Study|Termination by sponsor|1|||
25302886|NCT00750139|50618340|FG000|Overall Study|Non-specific|62|||
25302887|NCT00750139|50618341|FG001|Overall Study|Non-specific|42|||
25302888|NCT00750139|50618342|FG002|Overall Study|Non-specific|79|||
25302889|NCT00750139|50618343|FG003|Overall Study|Non-specific|33|||
25302890|NCT00750061|50618357|FG000|Overall Study|Adverse Event|2|||
25302891|NCT00750061|50618358|FG001|Overall Study|Adverse Event|0|||
25302892|NCT00750061|50618357|FG000|Overall Study|Withdrawal by Subject|0|||
25302893|NCT00750061|50618358|FG001|Overall Study|Withdrawal by Subject|1|||
25302894|NCT00750061|50618357|FG000|Overall Study|Physician Decision|0|||
25302895|NCT00750061|50618358|FG001|Overall Study|Physician Decision|1|||
25302896|NCT00744757|50618364|FG000|Overall Study|Objective disease progression|7|||
25302897|NCT00744757|50618364|FG000|Overall Study|Physician Decision|5|||
25302898|NCT00744757|50618364|FG000|Overall Study|Withdrawal by Subject|1|||
25302899|NCT00744757|50618364|FG000|Overall Study|Death|6|||
25302900|NCT00744757|50618364|FG000|Overall Study|Adverse Event|2|||
24969929|NCT03697252|50059392|FG001|Overall Study|Other|1|||
25191956|NCT01665144|50354774|FG001|Overall Study|Lack of Efficacy|11|||
25302901|NCT00745849|50618368|FG000|First Intervention|Withdrawal by Subject|0|||
25302902|NCT00745849|50618369|FG001|First Intervention|Withdrawal by Subject|1|||
25302903|NCT00745849|50618368|FG000|First Intervention|Lost to Follow-up|1|||
25302904|NCT00745849|50618369|FG001|First Intervention|Lost to Follow-up|1|||
25302905|NCT00745849|50618368|FG000|Second Intervention|Lost to Follow-up|2|||
25302906|NCT00745849|50618369|FG001|Second Intervention|Lost to Follow-up|1|||
25302907|NCT00749203|50618377|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
25302908|NCT00749203|50618378|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
25302909|NCT00749203|50618377|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
25302910|NCT00749203|50618378|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
25302911|NCT00749203|50618377|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
25302912|NCT00749203|50618378|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
25302913|NCT00749203|50618377|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
25302914|NCT00749203|50618378|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
25191957|NCT01665144|50354773|FG000|Overall Study|Adverse Event|45|||
25191958|NCT01665144|50354774|FG001|Overall Study|Adverse Event|18|||
25191959|NCT01665144|50354773|FG000|Overall Study|Withdrawal by Subject|96|||
25191960|NCT01665144|50354774|FG001|Overall Study|Withdrawal by Subject|77|||
25191961|NCT01466660|50354913|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
25191962|NCT01466660|50354914|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
25191963|NCT01466660|50354913|FG000|Overall Study|Worsening of underlying cancer disease|5|||
25191964|NCT01466660|50354914|FG001|Overall Study|Worsening of underlying cancer disease|2|||
25191965|NCT01466660|50354913|FG000|Overall Study|Other adverse event|19|||
25191966|NCT01466660|50354914|FG001|Overall Study|Other adverse event|18|||
25191967|NCT01466660|50354913|FG000|Overall Study|Protocol Violation|2|||
25191968|NCT01466660|50354914|FG001|Overall Study|Protocol Violation|1|||
25191969|NCT01466660|50354913|FG000|Overall Study|Refused continuation of trial medication|4|||
25191970|NCT01466660|50354914|FG001|Overall Study|Refused continuation of trial medication|3|||
25191971|NCT01466660|50354913|FG000|Overall Study|Other reason not defined above|10|||
25302915|NCT00749203|50618377|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
25302916|NCT00749203|50618378|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
25302917|NCT00749203|50618377|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
25302918|NCT00749203|50618378|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
25302919|NCT00748969|50618386|FG000|Overall Study|Withdrawal by Subject|1|||
25302920|NCT00748969|50618387|FG001|Overall Study|Withdrawal by Subject|0|||
25302921|NCT00748969|50618386|FG000|Overall Study|Withdrawal by Subject|0|||
25302922|NCT00748969|50618387|FG001|Overall Study|Withdrawal by Subject|1|||
25302923|NCT00745615|50618397|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
25302924|NCT00745615|50618398|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
25302925|NCT00745615|50618399|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
25302926|NCT00745615|50618400|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
25302927|NCT00745615|50618401|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
25302928|NCT00745615|50618402|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
25302929|NCT00745615|50618397|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
25302930|NCT00745615|50618398|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
25302931|NCT00745615|50618399|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
25302932|NCT00745615|50618400|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
25302933|NCT00745615|50618401|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
25302934|NCT00745615|50618402|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
25302935|NCT00745615|50618397|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
25302936|NCT00745615|50618398|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
25302937|NCT00745615|50618399|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
24969930|NCT03701074|50059400|FG000|Overall Study|Physician Decision|1|||
24969931|NCT03701074|50059401|FG001|Overall Study|Physician Decision|0|||
25070985|NCT00708123|50177056|FG000|Period 1|Protocol Violation|0|||
25070986|NCT00708123|50177057|FG001|Period 1|Protocol Violation|1|||
25302938|NCT00745615|50618400|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
25302939|NCT00745615|50618401|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
25302940|NCT00745615|50618402|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
25302941|NCT00745615|50618397|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
25302942|NCT00745615|50618398|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
25302943|NCT00745615|50618399|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
25302944|NCT00745615|50618400|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
25302945|NCT00745615|50618401|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
25302946|NCT00745615|50618402|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
25302947|NCT00745615|50618397|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
25302948|NCT00745615|50618398|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
25302949|NCT00745615|50618399|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
25302950|NCT00745615|50618400|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
25302951|NCT00745615|50618401|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
25302952|NCT00745615|50618402|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
25302953|NCT00745615|50618397|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
25302954|NCT00745615|50618398|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
25302955|NCT00745615|50618399|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
25302956|NCT00745615|50618400|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
25302957|NCT00745615|50618401|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
25302958|NCT00745615|50618402|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
25302959|NCT00745615|50618397|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
25302960|NCT00745615|50618398|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
25302961|NCT00745615|50618399|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
25302962|NCT00745615|50618400|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
25070987|NCT00708123|50177058|FG002|Period 1|Protocol Violation|0|||
25302963|NCT00745615|50618401|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
25302964|NCT00745615|50618402|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
25302965|NCT00745615|50618397|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
25302966|NCT00745615|50618398|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
25302967|NCT00745615|50618399|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
25302968|NCT00745615|50618400|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
25302969|NCT00745615|50618401|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
25302970|NCT00745615|50618402|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
25302971|NCT00745615|50618397|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
25302972|NCT00745615|50618398|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
25302973|NCT00745615|50618399|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
25302974|NCT00745615|50618400|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
25302975|NCT00745615|50618401|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
25302976|NCT00745615|50618402|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
25302977|NCT00745615|50618397|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
25302978|NCT00745615|50618398|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
25302979|NCT00745615|50618399|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
25302980|NCT00745615|50618400|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
25302981|NCT00745615|50618401|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
25302982|NCT00745615|50618402|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
25302983|NCT00745615|50618397|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
25302984|NCT00745615|50618398|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
25302985|NCT00745615|50618399|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
25302986|NCT00745615|50618400|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
25302987|NCT00745615|50618401|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
25302988|NCT00745615|50618402|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
25302989|NCT00745615|50618397|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
25302990|NCT00745615|50618398|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
25302991|NCT00745615|50618399|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
25302992|NCT00745615|50618400|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
25302993|NCT00745615|50618401|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
25302994|NCT00745615|50618402|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
25302995|NCT00745615|50618397|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
25302996|NCT00745615|50618398|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
25302997|NCT00745615|50618399|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
25302998|NCT00745615|50618400|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
25302999|NCT00745615|50618401|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
25303000|NCT00745615|50618402|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
25303001|NCT00745615|50618397|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
25303002|NCT00745615|50618398|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
25303003|NCT00745615|50618399|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
25303004|NCT00745615|50618400|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
25303005|NCT00745615|50618401|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
25303006|NCT00745615|50618402|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
25303007|NCT00744523|50618416|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
25303008|NCT00744523|50618417|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
25303009|NCT04517253|50618428|FG000|Overall Study|Adverse Event|1|||
25303010|NCT04517253|50618429|FG001|Overall Study|Adverse Event|0|||
25303011|NCT04517253|50618430|FG002|Overall Study|Adverse Event|0|||
25303012|NCT04517253|50618428|FG000|Overall Study|Death|0|||
25303013|NCT04517253|50618429|FG001|Overall Study|Death|1|||
25303014|NCT04517253|50618430|FG002|Overall Study|Death|0|||
25303015|NCT00744991|50618440|FG000|Overall Study|Progressive Disease|11|||
25303016|NCT00744991|50618440|FG000|Overall Study|Withdrawal by Subject|8|||
25303017|NCT00744991|50618440|FG000|Overall Study|Physician Decision|3|||
25303018|NCT00744991|50618440|FG000|Overall Study|Adverse Event|2|||
25191972|NCT01466660|50354914|FG001|Overall Study|Other reason not defined above|8|||
25191973|NCT01466348|50354939|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
25191974|NCT01466348|50354940|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
25191975|NCT01466270|50354963|FG000|Overall Study|Withdrawal by Subject|4|||
25191976|NCT01466270|50354964|FG001|Overall Study|Withdrawal by Subject|1|||
25191977|NCT01466270|50354963|FG000|Overall Study|Physician Decision|1|||
25191978|NCT01466270|50354964|FG001|Overall Study|Physician Decision|0|||
25191979|NCT01466270|50354963|FG000|Overall Study|Lost to Follow-up|1|||
25191980|NCT01466270|50354964|FG001|Overall Study|Lost to Follow-up|3|||
25191981|NCT01466270|50354963|FG000|Overall Study|Progression|1|||
25191982|NCT01466270|50354964|FG001|Overall Study|Progression|0|||
25191983|NCT01466270|50354963|FG000|Overall Study|Toxicity|4|||
25191984|NCT01466270|50354964|FG001|Overall Study|Toxicity|1|||
25191985|NCT01466270|50354963|FG000|Overall Study|Multiple|1|||
25191986|NCT01466270|50354964|FG001|Overall Study|Multiple|1|||
25191987|NCT01466192|50354997|FG000|Overall Study|Physician Decision|1|||
25191988|NCT01466192|50354997|FG000|Overall Study|Withdrawal by Subject|3|||
25303019|NCT00744991|50618440|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
25303020|NCT00839254|50618464|FG000|Overall Study|Protocol Violation|0|||
25303021|NCT00839254|50618465|FG001|Overall Study|Protocol Violation|1|||
25303022|NCT00839254|50618466|FG002|Overall Study|Protocol Violation|1|||
25303023|NCT00839254|50618467|FG003|Overall Study|Protocol Violation|1|||
25303024|NCT00839254|50618468|FG004|Overall Study|Protocol Violation|0|||
25303025|NCT00839254|50618469|FG005|Overall Study|Protocol Violation|0|||
25303026|NCT00839254|50618470|FG006|Overall Study|Protocol Violation|1|||
25303027|NCT00839254|50618471|FG007|Overall Study|Protocol Violation|2|||
25303028|NCT00839254|50618464|FG000|Overall Study|Physician Decision|0|||
25303029|NCT00839254|50618465|FG001|Overall Study|Physician Decision|1|||
25303030|NCT00839254|50618466|FG002|Overall Study|Physician Decision|0|||
25303031|NCT00839254|50618467|FG003|Overall Study|Physician Decision|0|||
25303032|NCT00839254|50618468|FG004|Overall Study|Physician Decision|0|||
25303033|NCT00839254|50618469|FG005|Overall Study|Physician Decision|0|||
25303034|NCT00839254|50618470|FG006|Overall Study|Physician Decision|0|||
25303035|NCT00839254|50618471|FG007|Overall Study|Physician Decision|1|||
25303036|NCT00839254|50618464|FG000|Overall Study|Wrong treatment number allocation|0|||
25303037|NCT00839254|50618465|FG001|Overall Study|Wrong treatment number allocation|1|||
25303038|NCT00839254|50618466|FG002|Overall Study|Wrong treatment number allocation|0|||
25303039|NCT00839254|50618467|FG003|Overall Study|Wrong treatment number allocation|0|||
25303040|NCT00839254|50618468|FG004|Overall Study|Wrong treatment number allocation|0|||
25303041|NCT00839254|50618469|FG005|Overall Study|Wrong treatment number allocation|1|||
25303042|NCT00839254|50618470|FG006|Overall Study|Wrong treatment number allocation|0|||
25303043|NCT00839254|50618471|FG007|Overall Study|Wrong treatment number allocation|0|||
25303044|NCT00839254|50618464|FG000|Overall Study|Adverse Event|12|||
25303045|NCT00839254|50618465|FG001|Overall Study|Adverse Event|6|||
25303046|NCT00839254|50618466|FG002|Overall Study|Adverse Event|3|||
25303047|NCT00839254|50618467|FG003|Overall Study|Adverse Event|5|||
25070988|NCT00708123|50177059|FG003|Period 1|Protocol Violation|1|||
25191989|NCT01438814|50355017|FG000|Overall Study|Adverse Event|3|||
25191990|NCT01438814|50355018|FG001|Overall Study|Adverse Event|3|||
25191991|NCT01438814|50355017|FG000|Overall Study|Protocol Violation|1|||
25303048|NCT00839254|50618468|FG004|Overall Study|Adverse Event|2|||
25303049|NCT00839254|50618469|FG005|Overall Study|Adverse Event|1|||
25303050|NCT00839254|50618470|FG006|Overall Study|Adverse Event|0|||
25303051|NCT00839254|50618471|FG007|Overall Study|Adverse Event|1|||
25303052|NCT00839254|50618464|FG000|Overall Study|Withdrawal by Subject|87|||
25303053|NCT00839254|50618465|FG001|Overall Study|Withdrawal by Subject|53|||
25303054|NCT00839254|50618466|FG002|Overall Study|Withdrawal by Subject|54|||
25303055|NCT00839254|50618467|FG003|Overall Study|Withdrawal by Subject|32|||
25303056|NCT00839254|50618468|FG004|Overall Study|Withdrawal by Subject|27|||
25303057|NCT00839254|50618469|FG005|Overall Study|Withdrawal by Subject|15|||
25303058|NCT00839254|50618470|FG006|Overall Study|Withdrawal by Subject|22|||
25303059|NCT00839254|50618471|FG007|Overall Study|Withdrawal by Subject|9|||
25303060|NCT00839254|50618464|FG000|Overall Study|Wrong group allocation|0|||
25303061|NCT00839254|50618465|FG001|Overall Study|Wrong group allocation|0|||
25303062|NCT00839254|50618466|FG002|Overall Study|Wrong group allocation|0|||
25303063|NCT00839254|50618467|FG003|Overall Study|Wrong group allocation|0|||
25303064|NCT00839254|50618468|FG004|Overall Study|Wrong group allocation|0|||
25303065|NCT00839254|50618469|FG005|Overall Study|Wrong group allocation|0|||
25303066|NCT00839254|50618470|FG006|Overall Study|Wrong group allocation|1|||
25303067|NCT00839254|50618471|FG007|Overall Study|Wrong group allocation|0|||
25303068|NCT00839254|50618464|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
25303069|NCT00839254|50618465|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
25303070|NCT00839254|50618466|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
25303071|NCT00839254|50618467|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
25303072|NCT00839254|50618468|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
25303073|NCT00839254|50618469|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
25303074|NCT00839254|50618470|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
25303075|NCT00839254|50618471|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
25303076|NCT00839254|50618464|FG000|Overall Study|Withdrawn due to non-compliance|2|||
25303077|NCT00839254|50618465|FG001|Overall Study|Withdrawn due to non-compliance|0|||
25303078|NCT00839254|50618466|FG002|Overall Study|Withdrawn due to non-compliance|0|||
25303079|NCT00839254|50618467|FG003|Overall Study|Withdrawn due to non-compliance|0|||
25303080|NCT00839254|50618468|FG004|Overall Study|Withdrawn due to non-compliance|0|||
25303081|NCT00839254|50618469|FG005|Overall Study|Withdrawn due to non-compliance|0|||
25303082|NCT00839254|50618470|FG006|Overall Study|Withdrawn due to non-compliance|0|||
25303083|NCT00839254|50618471|FG007|Overall Study|Withdrawn due to non-compliance|0|||
25303084|NCT00839254|50618464|FG000|Overall Study|Lost to Follow-up|51|||
25303085|NCT00839254|50618465|FG001|Overall Study|Lost to Follow-up|30|||
25303086|NCT00839254|50618466|FG002|Overall Study|Lost to Follow-up|32|||
25303087|NCT00839254|50618467|FG003|Overall Study|Lost to Follow-up|24|||
25303088|NCT00839254|50618468|FG004|Overall Study|Lost to Follow-up|8|||
25303089|NCT00839254|50618469|FG005|Overall Study|Lost to Follow-up|8|||
25303090|NCT00839254|50618470|FG006|Overall Study|Lost to Follow-up|4|||
25303091|NCT00839254|50618471|FG007|Overall Study|Lost to Follow-up|2|||
25303092|NCT00586339|50618523|FG000|Overall Study|Withdrawal by Subject|1|||
25303093|NCT00586339|50618524|FG001|Overall Study|Withdrawal by Subject|3|||
25303094|NCT00586339|50618525|FG002|Overall Study|Withdrawal by Subject|1|||
25303095|NCT00586339|50618523|FG000|Overall Study|Migrated/moved from study area|3|||
25303096|NCT00586339|50618524|FG001|Overall Study|Migrated/moved from study area|2|||
25303097|NCT00586339|50618525|FG002|Overall Study|Migrated/moved from study area|4|||
25303098|NCT00586339|50618523|FG000|Overall Study|Lost to Follow-up|3|||
25303099|NCT00586339|50618524|FG001|Overall Study|Lost to Follow-up|2|||
25303100|NCT00586339|50618525|FG002|Overall Study|Lost to Follow-up|1|||
25303101|NCT00812968|50618533|FG000|Overall Study|Relapse after erythroid response|6|||
24969932|NCT04728802|50059409|FG000|Overall Study|Withdrawal by Subject|4|||
24969933|NCT04728802|50059410|FG001|Overall Study|Withdrawal by Subject|20|||
25070989|NCT00708123|50177060|FG004|Period 1|Protocol Violation|0|||
25070990|NCT00708123|50177056|FG000|Period 1|Adverse Event|0|||
25303102|NCT00812968|50618533|FG000|Overall Study|Disease progression|1|||
25303103|NCT00812968|50618533|FG000|Overall Study|No further treatment required|1|||
25303104|NCT00812968|50618533|FG000|Overall Study|Study closed due to marketing approval|3|||
25303105|NCT00839098|50618542|FG000|Overall Study|Withdrawal by Subject|2|||
25303106|NCT00839098|50618543|FG001|Overall Study|Withdrawal by Subject|1|||
25303107|NCT00839098|50618544|FG002|Overall Study|Withdrawal by Subject|7|||
25303108|NCT00813748|50618554|FG000|Skin Test Substudy|Physician Decision|0|||
25303109|NCT00813748|50618555|FG001|Skin Test Substudy|Physician Decision|1|||
25303110|NCT00813592|50618563|FG000|Overall Study|Disease assessment was not completed per|2|||
25303111|NCT00813358|50618568|FG000|Overall Study|Death|32|||
25303112|NCT00813358|50618568|FG000|Overall Study|Lost to Follow-up|12|||
25303113|NCT00813358|50618568|FG000|Overall Study|other endpoints|5|||
25303114|NCT00813358|50618568|FG000|Overall Study|Withdrawal by Subject|20|||
25303115|NCT00812812|50618574|FG000|Overall Study|Adverse Event|2|||
25303116|NCT00812812|50618575|FG001|Overall Study|Adverse Event|1|||
25303117|NCT00812812|50618574|FG000|Overall Study|Lack of Efficacy|1|||
25303118|NCT00812812|50618575|FG001|Overall Study|Lack of Efficacy|0|||
25303119|NCT00812812|50618574|FG000|Overall Study|Lost to Follow-up|0|||
25303120|NCT00812812|50618575|FG001|Overall Study|Lost to Follow-up|1|||
25303121|NCT00812812|50618574|FG000|Overall Study|Withdrawal by Subject|0|||
25303122|NCT00812812|50618575|FG001|Overall Study|Withdrawal by Subject|2|||
25303123|NCT00810082|50618585|FG000|Overall Study|Lost to Follow-up|0|||
25303124|NCT00810082|50618586|FG001|Overall Study|Lost to Follow-up|4|||
25303125|NCT00748189|50618594|FG000|Overall Study|Death|99|||
25303126|NCT00748189|50618595|FG001|Overall Study|Death|84|||
25303127|NCT00748189|50618594|FG000|Overall Study|Withdrawal by Subject|23|||
25303128|NCT00748189|50618595|FG001|Overall Study|Withdrawal by Subject|29|||
25303129|NCT00748189|50618594|FG000|Overall Study|Physician Decision|16|||
25303130|NCT00748189|50618595|FG001|Overall Study|Physician Decision|5|||
25303131|NCT00748189|50618594|FG000|Overall Study|Lost to Follow-up|8|||
25303132|NCT00748189|50618595|FG001|Overall Study|Lost to Follow-up|15|||
25303133|NCT00748189|50618594|FG000|Overall Study|Study terminated by Sponsor|70|||
25303134|NCT00748189|50618595|FG001|Overall Study|Study terminated by Sponsor|79|||
25303135|NCT00744055|50618608|FG000|Overall Study|Withdrawal by Subject|6|||
25303136|NCT00744055|50618609|FG001|Overall Study|Withdrawal by Subject|9|||
25303137|NCT00744055|50618608|FG000|Overall Study|Lack of Efficacy|0|||
25303138|NCT00744055|50618609|FG001|Overall Study|Lack of Efficacy|1|||
25303139|NCT00744055|50618608|FG000|Overall Study|Physician Decision|0|||
25303140|NCT00744055|50618609|FG001|Overall Study|Physician Decision|2|||
25303141|NCT00744055|50618608|FG000|Overall Study|Protocol Violation|1|||
25303142|NCT00744055|50618609|FG001|Overall Study|Protocol Violation|1|||
25303143|NCT00744055|50618608|FG000|Overall Study|Lost to Follow-up|0|||
25303144|NCT00744055|50618609|FG001|Overall Study|Lost to Follow-up|1|||
25303145|NCT00748033|50618617|FG000|Overall Study|Adverse Event|0|||
25303146|NCT00748033|50618618|FG001|Overall Study|Adverse Event|1|||
25303147|NCT00735553|50618635|FG000|Overall Study|Study prematurely terminated|77|||
25303148|NCT00740779|50618646|FG000|Overall Study|Adverse Event|4|||
25303149|NCT00740779|50618647|FG001|Overall Study|Adverse Event|6|||
25303150|NCT00740779|50618648|FG002|Overall Study|Adverse Event|3|||
25303151|NCT00740779|50618646|FG000|Overall Study|Protocol Violation|1|||
25303152|NCT00740779|50618647|FG001|Overall Study|Protocol Violation|1|||
25303153|NCT00740779|50618648|FG002|Overall Study|Protocol Violation|1|||
25303154|NCT00740779|50618646|FG000|Overall Study|Lack of Efficacy|0|||
25303155|NCT00740779|50618647|FG001|Overall Study|Lack of Efficacy|0|||
25303156|NCT00740779|50618648|FG002|Overall Study|Lack of Efficacy|2|||
25303157|NCT00740779|50618646|FG000|Overall Study|Withdrawal by Subject|2|||
25303158|NCT00740779|50618647|FG001|Overall Study|Withdrawal by Subject|4|||
25303159|NCT00740779|50618648|FG002|Overall Study|Withdrawal by Subject|2|||
25303160|NCT00740779|50618646|FG000|Overall Study|Lost to Follow-up|2|||
25303161|NCT00740779|50618647|FG001|Overall Study|Lost to Follow-up|3|||
25303162|NCT00740779|50618648|FG002|Overall Study|Lost to Follow-up|5|||
25303163|NCT00735475|50618658|FG000|Overall Study|Adverse Event|0|||
25303164|NCT00735475|50618659|FG001|Overall Study|Adverse Event|1|||
25303165|NCT00735475|50618658|FG000|Overall Study|Death|1|||
25303166|NCT00735475|50618659|FG001|Overall Study|Death|1|||
25303167|NCT00735475|50618658|FG000|Overall Study|Lost to Follow-up|3|||
25303168|NCT00735475|50618659|FG001|Overall Study|Lost to Follow-up|3|||
25303169|NCT00735475|50618658|FG000|Overall Study|Physician Decision|0|||
25303170|NCT00735475|50618659|FG001|Overall Study|Physician Decision|1|||
25303171|NCT00735475|50618658|FG000|Overall Study|Withdrawal by Subject|4|||
25303172|NCT00735475|50618659|FG001|Overall Study|Withdrawal by Subject|5|||
25303173|NCT01026818|50618668|FG000|Screening Period|Entry Criteria Not Met|105|||
25303174|NCT01026818|50618669|FG001|Screening Period|Entry Criteria Not Met|0|||
25303175|NCT01026818|50618670|FG002|Screening Period|Entry Criteria Not Met|0|||
25191992|NCT01438814|50355018|FG001|Overall Study|Protocol Violation|2|||
25191993|NCT01438814|50355017|FG000|Overall Study|Lost to Follow-up|4|||
25303176|NCT01026818|50618671|FG003|Screening Period|Entry Criteria Not Met|0|||
25303177|NCT01026818|50618668|FG000|Screening Period|Withdrawal by Subject|49|||
25303178|NCT01026818|50618669|FG001|Screening Period|Withdrawal by Subject|0|||
25303179|NCT01026818|50618670|FG002|Screening Period|Withdrawal by Subject|0|||
25303180|NCT01026818|50618671|FG003|Screening Period|Withdrawal by Subject|0|||
25303181|NCT01026818|50618668|FG000|Screening Period|Protocol Deviation|3|||
25303182|NCT01026818|50618669|FG001|Screening Period|Protocol Deviation|0|||
25303183|NCT01026818|50618670|FG002|Screening Period|Protocol Deviation|0|||
25303184|NCT01026818|50618671|FG003|Screening Period|Protocol Deviation|0|||
25303185|NCT01026818|50618668|FG000|Screening Period|Adverse Event|2|||
25303186|NCT01026818|50618669|FG001|Screening Period|Adverse Event|0|||
25303187|NCT01026818|50618670|FG002|Screening Period|Adverse Event|0|||
25303188|NCT01026818|50618671|FG003|Screening Period|Adverse Event|0|||
25303189|NCT01026818|50618668|FG000|Screening Period|Physician Decision|1|||
25303190|NCT01026818|50618669|FG001|Screening Period|Physician Decision|0|||
25303191|NCT01026818|50618670|FG002|Screening Period|Physician Decision|0|||
25303192|NCT01026818|50618671|FG003|Screening Period|Physician Decision|0|||
25303193|NCT01026818|50618668|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
25303194|NCT01026818|50618669|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
25303195|NCT01026818|50618670|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
25303196|NCT01026818|50618671|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
25303197|NCT01026818|50618668|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
25303198|NCT01026818|50618669|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
25303199|NCT01026818|50618670|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
25303200|NCT01026818|50618671|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
25303201|NCT01026818|50618668|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
25303202|NCT01026818|50618669|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
25303203|NCT01026818|50618670|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
25303204|NCT01026818|50618671|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
25303205|NCT01026818|50618668|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
25303206|NCT01026818|50618669|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
25303207|NCT01026818|50618670|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
25303208|NCT01026818|50618671|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
25303209|NCT01026818|50618668|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
25303210|NCT01026818|50618669|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
25303211|NCT01026818|50618670|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
25303212|NCT01026818|50618671|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
25303213|NCT01026818|50618668|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
25303214|NCT01026818|50618669|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
25303215|NCT01026818|50618670|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
25303216|NCT01026818|50618671|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
25303217|NCT01026818|50618668|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
25303218|NCT01026818|50618669|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
25303219|NCT01026818|50618670|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
25303220|NCT01026818|50618671|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
25303221|NCT01026818|50618668|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
25303222|NCT01026818|50618669|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
25303223|NCT01026818|50618670|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
25303224|NCT01026818|50618671|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
25303225|NCT01026818|50618668|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
25303226|NCT01026818|50618669|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
25303227|NCT01026818|50618670|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
25303228|NCT01026818|50618671|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
25303229|NCT01026818|50618668|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
25303230|NCT01026818|50618669|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
25303231|NCT01026818|50618670|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
25303232|NCT01026818|50618671|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
25303233|NCT01026818|50618668|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
25303234|NCT01026818|50618669|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
25303235|NCT01026818|50618670|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
25303236|NCT01026818|50618671|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
25303237|NCT01026818|50618668|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
25303238|NCT01026818|50618669|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
25303239|NCT01026818|50618670|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
25303240|NCT01026818|50618671|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
25303241|NCT01026818|50618668|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
25303242|NCT01026818|50618669|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
25303243|NCT01026818|50618670|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
25303244|NCT01026818|50618671|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
25303245|NCT01026818|50618668|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
25303246|NCT01026818|50618669|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
25303247|NCT01026818|50618670|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
25303248|NCT01026818|50618671|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
25303249|NCT01026818|50618668|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
25070991|NCT00708123|50177057|FG001|Period 1|Adverse Event|0|||
25303250|NCT01026818|50618669|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
25303251|NCT01026818|50618670|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
25303252|NCT01026818|50618671|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
25303253|NCT01026818|50618668|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
25303254|NCT01026818|50618669|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
25303255|NCT01026818|50618670|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
25303256|NCT01026818|50618671|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
25303257|NCT01026818|50618668|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
25303258|NCT01026818|50618669|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
25303259|NCT01026818|50618670|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
25303260|NCT01026818|50618671|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
25303261|NCT01026818|50618668|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
25303262|NCT01026818|50618669|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
25303263|NCT01026818|50618670|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
25303264|NCT01026818|50618671|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
25303265|NCT01026818|50618668|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
25303266|NCT01026818|50618669|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
25303267|NCT01026818|50618670|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
25303268|NCT01026818|50618671|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
25303269|NCT00735397|50618683|FG000|Overall Study|Adverse Event|194|||
25303270|NCT00735397|50618683|FG000|Overall Study|Lost to Follow-up|33|||
25303271|NCT00735397|50618683|FG000|Overall Study|Participant choice|252|||
25303272|NCT00735397|50618683|FG000|Overall Study|Inadequate therapeutic effect|202|||
25303273|NCT00735397|50618683|FG000|Overall Study|Administrative/Other|502|||
25303274|NCT00735007|50618690|FG000|Overall Study|Adverse Event|4|||
25303275|NCT00735007|50618690|FG000|Overall Study|Protocol Violation|1|||
25303276|NCT00743509|50618694|FG000|Overall Study|Withdrawal by Subject|2|||
25303277|NCT00734929|50618700|FG000|Overall Study|Lost to Follow-up|1|||
25303278|NCT00734929|50618701|FG001|Overall Study|Lost to Follow-up|2|||
25303279|NCT00734929|50618700|FG000|Overall Study|No intervention/ screen fail|5|||
25303280|NCT00734929|50618701|FG001|Overall Study|No intervention/ screen fail|3|||
25303281|NCT00734851|50618709|FG000|Overall Study|Withdrawal by Subject|2|||
25303282|NCT00734851|50618709|FG000|Overall Study|Lost to Follow-up|1|||
25303283|NCT00734851|50618709|FG000|Overall Study|Physician Decision|18|||
25303284|NCT00734617|50618715|FG000|Overall Study|Adverse Event|4|||
25303285|NCT00734617|50618716|FG001|Overall Study|Adverse Event|7|||
25303286|NCT00734617|50618715|FG000|Overall Study|Withdrawal by Subject|103|||
25303287|NCT00734617|50618716|FG001|Overall Study|Withdrawal by Subject|95|||
25303288|NCT00743431|50618722|FG000|Overall Study|Toxicity|6|||
25303289|NCT00743431|50618722|FG000|Overall Study|Tumor progression|56|||
25303290|NCT00743431|50618722|FG000|Overall Study|Withdrawal by Subject|13|||
25303291|NCT00743431|50618722|FG000|Overall Study|Death|9|||
25303292|NCT00743431|50618722|FG000|Overall Study|Reason for discontinuation not specified|29|||
25303293|NCT00743431|50618722|FG000|Overall Study|No documentation available|13|||
25303294|NCT00734539|50618728|FG000|Main Study|Death|33|||
25303295|NCT00734539|50618729|FG001|Main Study|Death|32|||
25303296|NCT00734539|50618728|FG000|Main Study|Physician Decision|2|||
25303297|NCT00734539|50618729|FG001|Main Study|Physician Decision|0|||
25070992|NCT00708123|50177058|FG002|Period 1|Adverse Event|1|||
25303298|NCT00734539|50618728|FG000|Main Study|Withdrawal by Subject|1|||
25303299|NCT00734539|50618729|FG001|Main Study|Withdrawal by Subject|3|||
25303300|NCT00734539|50618728|FG000|Main Study|Enrolled in error; ineligible|1|||
25303301|NCT00734539|50618729|FG001|Main Study|Enrolled in error; ineligible|0|||
25303302|NCT00743275|50618740|FG000|Overall Study|Protocol Violation|0|||
25303303|NCT00743275|50618741|FG001|Overall Study|Protocol Violation|1|||
25303304|NCT00734149|50618747|FG000|Overall Study|Withdrawal by Subject|1|||
25070993|NCT00708123|50177059|FG003|Period 1|Adverse Event|0|||
25303305|NCT00743197|50618755|FG000|Overall Study|Study terminated due to departure of PI.|1|||
25303306|NCT00743197|50618756|FG001|Overall Study|Study terminated due to departure of PI.|2|||
25303307|NCT00734071|50618764|FG000|Overall Study|Adverse Event|4|||
25303308|NCT00734071|50618765|FG001|Overall Study|Adverse Event|3|||
25303309|NCT00734071|50618764|FG000|Overall Study|Lack of Efficacy|3|||
25303310|NCT00734071|50618765|FG001|Overall Study|Lack of Efficacy|1|||
25303311|NCT00734071|50618764|FG000|Overall Study|Noncompliance|2|||
25303312|NCT00734071|50618765|FG001|Overall Study|Noncompliance|2|||
25303313|NCT00734071|50618764|FG000|Overall Study|Protocol Deviations|3|||
25303314|NCT00734071|50618765|FG001|Overall Study|Protocol Deviations|4|||
25303315|NCT00734071|50618764|FG000|Overall Study|Voluntary Withdrawal|9|||
25303316|NCT00734071|50618765|FG001|Overall Study|Voluntary Withdrawal|7|||
25303317|NCT00734071|50618764|FG000|Overall Study|Lost to Follow-up|16|||
25303318|NCT00734071|50618765|FG001|Overall Study|Lost to Follow-up|8|||
25303319|NCT00734071|50618764|FG000|Overall Study|Other|1|||
25303320|NCT00734071|50618765|FG001|Overall Study|Other|2|||
25303321|NCT00739297|50618771|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
25303322|NCT00739297|50618772|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
25303323|NCT00739297|50618773|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
25303324|NCT00739297|50618774|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
25303325|NCT00739297|50618775|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
25303326|NCT00739297|50618776|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
25303327|NCT00739297|50618777|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
25303328|NCT00739297|50618771|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
25303329|NCT00739297|50618772|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
25303330|NCT00739297|50618773|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
25303331|NCT00739297|50618774|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
25303332|NCT00739297|50618775|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
25303333|NCT00739297|50618776|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
25303334|NCT00739297|50618777|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
25303335|NCT00739063|50618793|FG000|Overall Study|Screen failures|8|||
25303336|NCT01026194|50618799|FG000|Period 1：Double Blind Period|Adverse Event|2|||
25303337|NCT01026194|50618800|FG001|Period 1：Double Blind Period|Adverse Event|1|||
25303338|NCT01026194|50618799|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
25303339|NCT01026194|50618800|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
25303340|NCT01026194|50618799|FG000|Period 1：Double Blind Period|Physician Decision|0|||
25303341|NCT01026194|50618800|FG001|Period 1：Double Blind Period|Physician Decision|4|||
25303342|NCT01026194|50618799|FG000|Period 2：Open-label Period|Adverse Event|4|||
25303343|NCT01026194|50618800|FG001|Period 2：Open-label Period|Adverse Event|5|||
25303344|NCT01026194|50618799|FG000|Period 2：Open-label Period|Physician Decision|3|||
25303345|NCT01026194|50618800|FG001|Period 2：Open-label Period|Physician Decision|1|||
25303346|NCT01026194|50618799|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
25303347|NCT01026194|50618800|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
25303348|NCT01033136|50618810|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
25303349|NCT01033136|50618811|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
25303350|NCT00738673|50618821|FG000|Overall Study|Adverse Event|1|||
25303351|NCT00738673|50618822|FG001|Overall Study|Adverse Event|0|||
25303352|NCT00738673|50618821|FG000|Overall Study|Lack of Efficacy|19|||
25303353|NCT00738673|50618822|FG001|Overall Study|Lack of Efficacy|8|||
25303354|NCT00738673|50618821|FG000|Overall Study|Protocol Violation|1|||
25303355|NCT00738673|50618822|FG001|Overall Study|Protocol Violation|2|||
25303356|NCT00738673|50618821|FG000|Overall Study|Withdrawal by Subject|3|||
25303357|NCT00738673|50618822|FG001|Overall Study|Withdrawal by Subject|1|||
25303358|NCT00811954|50618831|FG000|Overall Study|Death|10|||
25303359|NCT00811954|50618832|FG001|Overall Study|Death|6|||
25303360|NCT00811954|50618833|FG002|Overall Study|Death|13|||
25303361|NCT00811954|50618831|FG000|Overall Study|Lost to Follow-up|29|||
25303362|NCT00811954|50618832|FG001|Overall Study|Lost to Follow-up|23|||
25303363|NCT00811954|50618833|FG002|Overall Study|Lost to Follow-up|34|||
25303364|NCT00811954|50618831|FG000|Overall Study|Not able to get to clinic|28|||
25303365|NCT00811954|50618832|FG001|Overall Study|Not able to get to clinic|35|||
25303366|NCT00811954|50618833|FG002|Overall Study|Not able to get to clinic|30|||
25303367|NCT00811954|50618831|FG000|Overall Study|Not willing to adhere to requirements|12|||
25303368|NCT00811954|50618832|FG001|Overall Study|Not willing to adhere to requirements|2|||
25303369|NCT00811954|50618833|FG002|Overall Study|Not willing to adhere to requirements|16|||
25191994|NCT01438814|50355018|FG001|Overall Study|Lost to Follow-up|3|||
25303370|NCT00811954|50618831|FG000|Overall Study|Withdraw consent prior study completion|4|||
25303371|NCT00811954|50618832|FG001|Overall Study|Withdraw consent prior study completion|6|||
25303372|NCT00811954|50618833|FG002|Overall Study|Withdraw consent prior study completion|5|||
25191995|NCT01438814|50355017|FG000|Overall Study|Withdrawal by Subject|4|||
25303373|NCT00811954|50618831|FG000|Overall Study|Site Closure|4|||
25303374|NCT00811954|50618832|FG001|Overall Study|Site Closure|0|||
25303375|NCT00811954|50618833|FG002|Overall Study|Site Closure|1|||
25303376|NCT00811954|50618831|FG000|Overall Study|Severe Debilitation|2|||
25303377|NCT00811954|50618832|FG001|Overall Study|Severe Debilitation|0|||
25303378|NCT00811954|50618833|FG002|Overall Study|Severe Debilitation|1|||
25303379|NCT00811954|50618831|FG000|Overall Study|Complete Protocol: No follow-up|0|||
25303380|NCT00811954|50618832|FG001|Overall Study|Complete Protocol: No follow-up|0|||
25303381|NCT00811954|50618833|FG002|Overall Study|Complete Protocol: No follow-up|1|||
25303382|NCT01032200|50618843|FG000|Overall Study|Death|1|||
25303383|NCT01032200|50618844|FG001|Overall Study|Death|1|||
25303384|NCT01032200|50618843|FG000|Overall Study|Withdrawal by Subject|1|||
25303385|NCT01032200|50618844|FG001|Overall Study|Withdrawal by Subject|3|||
25303386|NCT01032200|50618843|FG000|Overall Study|Toxicity|0|||
25303387|NCT01032200|50618844|FG001|Overall Study|Toxicity|2|||
25303388|NCT01032200|50618843|FG000|Overall Study|Progression|1|||
25303389|NCT01032200|50618844|FG001|Overall Study|Progression|0|||
25303390|NCT01032200|50618843|FG000|Overall Study|Multiple|1|||
25303391|NCT01032200|50618844|FG001|Overall Study|Multiple|1|||
25303392|NCT00738283|50618850|FG000|Overall Study|Death|1|||
25303393|NCT00738283|50618850|FG000|Overall Study|Transfer to another facility|2|||
25303394|NCT00738283|50618850|FG000|Overall Study|Discharge home prior to end of study|1|||
25303395|NCT00586105|50618863|FG000|Overall Study|Adverse Event|4|||
25303396|NCT00586105|50618863|FG000|Overall Study|Death|2|||
25303397|NCT00586105|50618863|FG000|Overall Study|Protocol Violation|1|||
25303398|NCT00586105|50618863|FG000|Overall Study|Withdrawal by Subject|3|||
25303399|NCT00586105|50618863|FG000|Overall Study|Disease progression|19|||
25303400|NCT00586105|50618863|FG000|Overall Study|Switched to commercial drug|9|||
25303401|NCT00586105|50618863|FG000|Overall Study|Reason not reported|1|||
25303402|NCT00743119|50618867|FG000|Overall Study|unreliable|3|||
25303403|NCT00743119|50618867|FG000|Overall Study|Withdrawal by Subject|1|||
25303404|NCT00733369|50618881|FG000|Overall Study|Lost to Follow-up|2|||
25303405|NCT00733369|50618882|FG001|Overall Study|Lost to Follow-up|1|||
25303406|NCT00733369|50618881|FG000|Overall Study|Adverse Event|4|||
25303407|NCT00733369|50618882|FG001|Overall Study|Adverse Event|4|||
25303408|NCT00733369|50618881|FG000|Overall Study|Protocol Violation|4|||
25303409|NCT00733369|50618882|FG001|Overall Study|Protocol Violation|4|||
25303410|NCT00813124|50618888|FG000|Overall Study|Death|2|||
25303411|NCT00813124|50618888|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
25303412|NCT00813124|50618888|FG000|Overall Study|Withdrawal by Subject|1|||
25303413|NCT00733291|50618894|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
25303414|NCT00733291|50618895|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
25303415|NCT00733291|50618896|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
25303416|NCT00733291|50618897|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
25303417|NCT00732199|50618910|FG000|Overall Study|Withdrawal by Subject|25|||
25303418|NCT00732199|50618911|FG001|Overall Study|Withdrawal by Subject|18|||
25303419|NCT00732199|50618910|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
25303420|NCT00732199|50618911|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
25303421|NCT00807040|50618922|FG000|Overall Study|Death|24|||
25303422|NCT00807040|50618923|FG001|Overall Study|Death|29|||
25303423|NCT00807040|50618922|FG000|Overall Study|Withdrawal by Subject|8|||
25191996|NCT01438814|50355018|FG001|Overall Study|Withdrawal by Subject|2|||
25303424|NCT00807040|50618923|FG001|Overall Study|Withdrawal by Subject|6|||
25070994|NCT00708123|50177060|FG004|Period 1|Adverse Event|0|||
25191997|NCT01438814|50355017|FG000|Overall Study|Other|2|||
25191998|NCT01438814|50355018|FG001|Overall Study|Other|4|||
25191999|NCT02926833|50355599|FG000|Overall Study|Full Consent Withdrawal|0|||
25192000|NCT02926833|50355600|FG001|Overall Study|Full Consent Withdrawal|0|||
25192001|NCT02926833|50355601|FG002|Overall Study|Full Consent Withdrawal|0|||
25192002|NCT02926833|50355602|FG003|Overall Study|Full Consent Withdrawal|2|||
25192003|NCT02926833|50355599|FG000|Overall Study|Death|1|||
25192004|NCT02926833|50355600|FG001|Overall Study|Death|1|||
25192005|NCT02926833|50355601|FG002|Overall Study|Death|1|||
25192006|NCT02926833|50355602|FG003|Overall Study|Death|7|||
25303425|NCT00807040|50618922|FG000|Overall Study|Lost to Follow-up|4|||
25303426|NCT00807040|50618923|FG001|Overall Study|Lost to Follow-up|6|||
25303427|NCT00811720|50618931|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
25303428|NCT00811720|50618932|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
25192007|NCT02926833|50355599|FG000|Overall Study|Still on study|2|||
25303429|NCT00811720|50618931|FG000|All Treated Patients|Adverse Event|20|||
25192008|NCT02926833|50355600|FG001|Overall Study|Still on study|3|||
25192009|NCT02926833|50355601|FG002|Overall Study|Still on study|5|||
25192010|NCT02926833|50355602|FG003|Overall Study|Still on study|14|||
25192011|NCT02926833|50355599|FG000|Overall Study|Adverse Event|0|||
25192012|NCT02926833|50355600|FG001|Overall Study|Adverse Event|0|||
25192013|NCT02926833|50355601|FG002|Overall Study|Adverse Event|1|||
25192014|NCT02926833|50355602|FG003|Overall Study|Adverse Event|0|||
25192015|NCT02851797|50355649|FG000|Overall Study|Withdrawal by Subject|4|||
25192016|NCT02851797|50355650|FG001|Overall Study|Withdrawal by Subject|2|||
25192017|NCT02851797|50355649|FG000|Overall Study|Adverse Event|3|||
25192018|NCT02851797|50355650|FG001|Overall Study|Adverse Event|0|||
25192019|NCT01666314|50355874|FG000|Overall Study|Adverse Event|3|||
25192020|NCT01666314|50355875|FG001|Overall Study|Adverse Event|13|||
25192021|NCT01666314|50355876|FG002|Overall Study|Adverse Event|7|||
25192022|NCT01666314|50355877|FG003|Overall Study|Adverse Event|7|||
25192023|NCT01666314|50355874|FG000|Overall Study|Progressive Disease|11|||
25192024|NCT01666314|50355875|FG001|Overall Study|Progressive Disease|9|||
25192025|NCT01666314|50355876|FG002|Overall Study|Progressive Disease|19|||
25192026|NCT01666314|50355877|FG003|Overall Study|Progressive Disease|20|||
25192027|NCT01666314|50355874|FG000|Overall Study|Symptomatic Deterioration|1|||
25192028|NCT01666314|50355875|FG001|Overall Study|Symptomatic Deterioration|0|||
25192029|NCT01666314|50355876|FG002|Overall Study|Symptomatic Deterioration|2|||
25192030|NCT01666314|50355877|FG003|Overall Study|Symptomatic Deterioration|0|||
25192031|NCT01666314|50355874|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
25192032|NCT01666314|50355875|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
25192033|NCT01666314|50355876|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
25192034|NCT01666314|50355877|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
25192035|NCT01666314|50355874|FG000|Overall Study|Withdrawal by Subject|1|||
25192036|NCT01666314|50355875|FG001|Overall Study|Withdrawal by Subject|1|||
25192037|NCT01666314|50355876|FG002|Overall Study|Withdrawal by Subject|2|||
25192038|NCT01666314|50355877|FG003|Overall Study|Withdrawal by Subject|3|||
25192039|NCT01666314|50355874|FG000|Overall Study|Reason not Specified|10|||
25192040|NCT01666314|50355875|FG001|Overall Study|Reason not Specified|7|||
25192041|NCT01666314|50355876|FG002|Overall Study|Reason not Specified|5|||
25192042|NCT01666314|50355877|FG003|Overall Study|Reason not Specified|5|||
25192043|NCT01666002|50355908|FG000|Overall Study|Lost to Follow-up|5|||
25192044|NCT01666002|50355909|FG001|Overall Study|Lost to Follow-up|0|||
25192045|NCT01665768|50355981|FG000|Overall Study|Adverse Event|3|||
25192046|NCT01665768|50355981|FG000|Overall Study|Lack of Efficacy|19|||
25303430|NCT00811720|50618932|FG001|All Treated Patients|Adverse Event|62|||
25303431|NCT00811720|50618931|FG000|All Treated Patients|Lack of Efficacy|22|||
25303432|NCT00811720|50618932|FG001|All Treated Patients|Lack of Efficacy|18|||
25303433|NCT00811720|50618931|FG000|All Treated Patients|Non-compliance|0|||
25303434|NCT00811720|50618932|FG001|All Treated Patients|Non-compliance|14|||
25303435|NCT00811720|50618931|FG000|All Treated Patients|Protocol Violation|9|||
25192047|NCT01665768|50355981|FG000|Overall Study|Withdrawal by Subject|1|||
25303436|NCT00811720|50618932|FG001|All Treated Patients|Protocol Violation|16|||
25303437|NCT00811720|50618931|FG000|All Treated Patients|Withdrawal by Subject|28|||
25303438|NCT00811720|50618932|FG001|All Treated Patients|Withdrawal by Subject|34|||
25303439|NCT00811720|50618931|FG000|All Treated Patients|Lost to Follow-up|10|||
25303440|NCT00811720|50618932|FG001|All Treated Patients|Lost to Follow-up|16|||
25303441|NCT00811720|50618931|FG000|All Treated Patients|Other Reason|7|||
25303442|NCT00811720|50618932|FG001|All Treated Patients|Other Reason|4|||
25303443|NCT04202679|50618940|FG000|Overall Study|Adverse Event|2|||
25303444|NCT04202679|50618941|FG001|Overall Study|Adverse Event|0|||
25303445|NCT04202679|50618940|FG000|Overall Study|Poor compliance to protocol|1|||
25303446|NCT04202679|50618941|FG001|Overall Study|Poor compliance to protocol|0|||
25303447|NCT04202679|50618940|FG000|Overall Study|Withdrawal by Subject|23|||
25303448|NCT04202679|50618941|FG001|Overall Study|Withdrawal by Subject|6|||
25303449|NCT00811642|50618948|FG000|Overall Study|Adverse Event|3|||
25192048|NCT02584452|50356189|FG000|Overall Study|Physician Decision|1|||
25192049|NCT02584452|50356190|FG001|Overall Study|Physician Decision|1|||
25192050|NCT02584452|50356189|FG000|Overall Study|Lost to Follow-up|1|||
25192051|NCT02584452|50356190|FG001|Overall Study|Lost to Follow-up|1|||
25192052|NCT02586012|50356237|FG000|Overall Study|Withdrawal by Subject|1|||
25303450|NCT00811642|50618948|FG000|Overall Study|Protocol Violation|1|||
25303451|NCT00811642|50618948|FG000|Overall Study|Death|2|||
25303452|NCT00811642|50618948|FG000|Overall Study|Withdrawal by Subject|7|||
25303453|NCT00811642|50618948|FG000|Overall Study|Cumulative use of antifungal agent|2|||
25192053|NCT02586012|50356238|FG001|Overall Study|Withdrawal by Subject|1|||
25192054|NCT02586012|50356239|FG002|Overall Study|Withdrawal by Subject|0|||
25303454|NCT00809926|50618954|FG000|Overall Study|Adverse Event|18|||
25192055|NCT02586012|50356240|FG003|Overall Study|Withdrawal by Subject|1|||
25192056|NCT02586012|50356241|FG004|Overall Study|Withdrawal by Subject|0|||
25192057|NCT02586012|50356242|FG005|Overall Study|Withdrawal by Subject|2|||
25303455|NCT00809926|50618955|FG001|Overall Study|Adverse Event|10|||
25303456|NCT00809926|50618954|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
25303457|NCT00809926|50618955|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
25303458|NCT00809926|50618954|FG000|Overall Study|Patient withdrew consent|8|||
25303459|NCT00809926|50618955|FG001|Overall Study|Patient withdrew consent|6|||
25303460|NCT00809926|50618954|FG000|Overall Study|Lost to Follow-up|2|||
25303461|NCT00809926|50618955|FG001|Overall Study|Lost to Follow-up|1|||
25303462|NCT00809926|50618954|FG000|Overall Study|Administrative Problems|0|||
25303463|NCT00809926|50618955|FG001|Overall Study|Administrative Problems|1|||
25303464|NCT00809926|50618954|FG000|Overall Study|Protocol deviation|0|||
25303465|NCT00809926|50618955|FG001|Overall Study|Protocol deviation|2|||
25303466|NCT00590980|50618961|FG000|Overall Study|Did not meet all inclusion criteria|10|||
25303467|NCT00590902|50618965|FG000|Overall Study|Death|1|||
25303468|NCT00590824|50618973|FG000|Overall Study|Disease could not be resected|0|||
25303469|NCT00590824|50618974|FG001|Overall Study|Disease could not be resected|2|||
25303470|NCT00590824|50618975|FG002|Overall Study|Disease could not be resected|1|||
25303471|NCT00590824|50618976|FG003|Overall Study|Disease could not be resected|0|||
25303472|NCT00590824|50618973|FG000|Overall Study|Adverse Event|0|||
25303473|NCT00590824|50618974|FG001|Overall Study|Adverse Event|0|||
25303474|NCT00590824|50618975|FG002|Overall Study|Adverse Event|0|||
25303475|NCT00590824|50618976|FG003|Overall Study|Adverse Event|1|||
25303476|NCT00590590|50618989|FG000|Overall Study|Lack of Efficacy|1|||
25303477|NCT00590590|50618990|FG001|Overall Study|Lack of Efficacy|2|||
25303478|NCT00590590|50618991|FG002|Overall Study|Lack of Efficacy|0|||
25303479|NCT00590590|50618989|FG000|Overall Study|Adverse Event|1|||
25303480|NCT00590590|50618990|FG001|Overall Study|Adverse Event|0|||
25303481|NCT00590590|50618991|FG002|Overall Study|Adverse Event|0|||
25303482|NCT00590590|50618989|FG000|Overall Study|Protocol Violation|0|||
25303483|NCT00590590|50618990|FG001|Overall Study|Protocol Violation|0|||
25303484|NCT00590590|50618991|FG002|Overall Study|Protocol Violation|2|||
25303485|NCT00590590|50618989|FG000|Overall Study|Lost to Follow-up|4|||
25303486|NCT00590590|50618990|FG001|Overall Study|Lost to Follow-up|1|||
25303487|NCT00590590|50618991|FG002|Overall Study|Lost to Follow-up|2|||
25303488|NCT00590590|50618989|FG000|Overall Study|Withdrawal by Subject|0|||
25303489|NCT00590590|50618990|FG001|Overall Study|Withdrawal by Subject|1|||
25303490|NCT00590590|50618991|FG002|Overall Study|Withdrawal by Subject|1|||
25303491|NCT00590590|50618989|FG000|Overall Study|Did not complete due to study closure|1|||
25303492|NCT00590590|50618990|FG001|Overall Study|Did not complete due to study closure|1|||
25303493|NCT00590590|50618991|FG002|Overall Study|Did not complete due to study closure|1|||
25303494|NCT00590590|50618989|FG000|Overall Study|Did not complete study|0|||
25303495|NCT00590590|50618990|FG001|Overall Study|Did not complete study|1|||
25303496|NCT00590590|50618991|FG002|Overall Study|Did not complete study|0|||
25303497|NCT00809614|50619001|FG000|Overall Study|Lack of Efficacy|2|||
25303498|NCT00809614|50619002|FG001|Overall Study|Lack of Efficacy|3|||
25303499|NCT00809614|50619001|FG000|Overall Study|Withdrawal by Subject|1|||
25303500|NCT00809614|50619002|FG001|Overall Study|Withdrawal by Subject|1|||
25303501|NCT00731731|50619011|FG000|Overall Study|Protocol Violation|0|||
25303502|NCT00731731|50619012|FG001|Overall Study|Protocol Violation|0|||
25303503|NCT00731731|50619013|FG002|Overall Study|Protocol Violation|1|||
25303504|NCT00731731|50619011|FG000|Overall Study|Cancel prior to treatment|0|||
24969934|NCT04728802|50059409|FG000|Overall Study|Physician Decision|7|||
24969935|NCT04728802|50059410|FG001|Overall Study|Physician Decision|7|||
24969936|NCT04728802|50059409|FG000|Overall Study|Protocol Violation|10|||
24969937|NCT04728802|50059410|FG001|Overall Study|Protocol Violation|4|||
24969938|NCT04728802|50059409|FG000|Overall Study|Transfer|1|||
24969939|NCT04728802|50059410|FG001|Overall Study|Transfer|0|||
24969940|NCT04728802|50059409|FG000|Overall Study|Death|4|||
25070995|NCT00708123|50177056|FG000|Period 2|Protocol Violation|0|||
24969941|NCT04728802|50059410|FG001|Overall Study|Death|5|||
24969942|NCT04728802|50059409|FG000|Overall Study|Other|3|||
25303505|NCT00731731|50619012|FG001|Overall Study|Cancel prior to treatment|0|||
25303506|NCT00731731|50619013|FG002|Overall Study|Cancel prior to treatment|2|||
25192058|NCT02586012|50356237|FG000|Overall Study|Protocol Violation|0|||
25192059|NCT02586012|50356238|FG001|Overall Study|Protocol Violation|0|||
25192060|NCT02586012|50356239|FG002|Overall Study|Protocol Violation|0|||
25192061|NCT02586012|50356240|FG003|Overall Study|Protocol Violation|0|||
25192062|NCT02586012|50356241|FG004|Overall Study|Protocol Violation|0|||
25192063|NCT02586012|50356242|FG005|Overall Study|Protocol Violation|1|||
25192064|NCT02586012|50356237|FG000|Overall Study|study terminated|0|||
25192065|NCT02586012|50356238|FG001|Overall Study|study terminated|2|||
25192066|NCT02586012|50356239|FG002|Overall Study|study terminated|1|||
25192067|NCT02586012|50356240|FG003|Overall Study|study terminated|1|||
25192068|NCT02586012|50356241|FG004|Overall Study|study terminated|1|||
25192069|NCT02586012|50356242|FG005|Overall Study|study terminated|0|||
25192070|NCT02582814|50356253|FG000|Overall Study|Study-specific withdrawal criteria|1|||
25303507|NCT00806494|50619026|FG000|Overall Study|Adverse Event|29|||
25303508|NCT00806494|50619026|FG000|Overall Study|Lack of Efficacy|6|||
25303509|NCT00806494|50619026|FG000|Overall Study|Lost to Follow-up|10|||
25303510|NCT00806494|50619026|FG000|Overall Study|Other|30|||
25303511|NCT00806494|50619026|FG000|Overall Study|Withdrawal by Subject|5|||
25303512|NCT00806416|50619033|FG000|Period 1 - Part I|Adverse Event|0|||
25303513|NCT00806416|50619034|FG001|Period 1 - Part I|Adverse Event|1|||
25303514|NCT00806416|50619035|FG002|Period 1 - Part I|Adverse Event|0|||
25303515|NCT00806416|50619036|FG003|Period 1 - Part I|Adverse Event|0|||
25303516|NCT00806416|50619033|FG000|Period 1 - Part I|Lost to Follow-up|0|||
25303517|NCT00806416|50619034|FG001|Period 1 - Part I|Lost to Follow-up|2|||
25303518|NCT00806416|50619035|FG002|Period 1 - Part I|Lost to Follow-up|0|||
25303519|NCT00806416|50619036|FG003|Period 1 - Part I|Lost to Follow-up|0|||
25303520|NCT00806416|50619033|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
25303521|NCT00806416|50619034|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
25303522|NCT00806416|50619035|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
25303523|NCT00806416|50619036|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
25303524|NCT00806416|50619033|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
25303525|NCT00806416|50619034|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
25303526|NCT00806416|50619035|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
25303527|NCT00806416|50619036|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
25303528|NCT02724969|50619046|FG000|Overall Study|Lost to Follow-up|12|||
25303529|NCT02724969|50619047|FG001|Overall Study|Lost to Follow-up|6|||
25303530|NCT02724969|50619046|FG000|Overall Study|Withdrawal by Subject|3|||
25303531|NCT02724969|50619047|FG001|Overall Study|Withdrawal by Subject|3|||
25303532|NCT02724969|50619046|FG000|Overall Study|Infant demise|0|||
25303533|NCT02724969|50619047|FG001|Overall Study|Infant demise|2|||
25303534|NCT00811252|50619056|FG000|Overall Study|Adverse Event|6|||
25303535|NCT00811252|50619057|FG001|Overall Study|Adverse Event|10|||
25303536|NCT00811252|50619058|FG002|Overall Study|Adverse Event|15|||
25303537|NCT00811252|50619056|FG000|Overall Study|Lack of Efficacy|7|||
25303538|NCT00811252|50619057|FG001|Overall Study|Lack of Efficacy|2|||
25303539|NCT00811252|50619058|FG002|Overall Study|Lack of Efficacy|0|||
25303540|NCT00811252|50619056|FG000|Overall Study|Protocol Violation|3|||
25303541|NCT00811252|50619057|FG001|Overall Study|Protocol Violation|3|||
25303542|NCT00811252|50619058|FG002|Overall Study|Protocol Violation|2|||
25303543|NCT00811252|50619056|FG000|Overall Study|Withdrawal of Consent|1|||
25303544|NCT00811252|50619057|FG001|Overall Study|Withdrawal of Consent|2|||
25303545|NCT00811252|50619058|FG002|Overall Study|Withdrawal of Consent|2|||
25303546|NCT00811252|50619056|FG000|Overall Study|Lost to Follow-up|0|||
25303547|NCT00811252|50619057|FG001|Overall Study|Lost to Follow-up|0|||
25303548|NCT00811252|50619058|FG002|Overall Study|Lost to Follow-up|2|||
25303549|NCT00811252|50619056|FG000|Overall Study|Administrative or Other Reasons|0|||
25303550|NCT00811252|50619057|FG001|Overall Study|Administrative or Other Reasons|3|||
25303551|NCT00811252|50619058|FG002|Overall Study|Administrative or Other Reasons|2|||
25303552|NCT00736957|50619075|FG000|Overall Study|Adverse Event|43|||
25303553|NCT00736957|50619075|FG000|Overall Study|Withdrawal by Subject|49|||
25303554|NCT00736957|50619075|FG000|Overall Study|violation of eligibility criteria|2|||
25303555|NCT00736957|50619075|FG000|Overall Study|did not attend hospital appointments|1|||
25070996|NCT00708123|50177057|FG001|Period 2|Protocol Violation|0|||
25303556|NCT00736957|50619075|FG000|Overall Study|not eligible for Treatment Period I|22|||
25303557|NCT00736957|50619075|FG000|Overall Study|Physician Decision|5|||
25303558|NCT00736879|50619083|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
25303559|NCT00736879|50619084|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
25192071|NCT02582814|50356254|FG001|Overall Study|Study-specific withdrawal criteria|0|||
25192072|NCT02582814|50356253|FG000|Overall Study|Withdrawal by Subject|4|||
25192073|NCT02582814|50356254|FG001|Overall Study|Withdrawal by Subject|3|||
25192074|NCT02582814|50356253|FG000|Overall Study|Adverse Event|4|||
25192075|NCT02582814|50356254|FG001|Overall Study|Adverse Event|4|||
25303560|NCT00736879|50619085|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
25303561|NCT00736879|50619086|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
25303562|NCT00736879|50619083|FG000|Double Blind Treatment Period|Adverse Event|0|||
25303563|NCT00736879|50619084|FG001|Double Blind Treatment Period|Adverse Event|1|||
25303564|NCT00736879|50619085|FG002|Double Blind Treatment Period|Adverse Event|1|||
25303565|NCT00736879|50619086|FG003|Double Blind Treatment Period|Adverse Event|0|||
25303566|NCT00736879|50619083|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
25303567|NCT00736879|50619084|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
25303568|NCT00736879|50619085|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
25303569|NCT00736879|50619086|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
25303570|NCT00736879|50619083|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
25303571|NCT00736879|50619084|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
25303572|NCT00736879|50619085|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
25303573|NCT00736879|50619086|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
25303574|NCT00736879|50619083|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
25303575|NCT00736879|50619084|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
25303576|NCT00736879|50619085|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
25303577|NCT00736879|50619086|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
25303578|NCT00736879|50619083|FG000|Double Blind Treatment Period|No longer met criteria|0|||
25303579|NCT00736879|50619084|FG001|Double Blind Treatment Period|No longer met criteria|1|||
25303580|NCT00736879|50619085|FG002|Double Blind Treatment Period|No longer met criteria|0|||
25303581|NCT00736879|50619086|FG003|Double Blind Treatment Period|No longer met criteria|0|||
25303582|NCT00736879|50619083|FG000|Double Blind Treatment Period|non-specified|0|||
25303583|NCT00736879|50619084|FG001|Double Blind Treatment Period|non-specified|1|||
25303584|NCT00736879|50619085|FG002|Double Blind Treatment Period|non-specified|0|||
25303585|NCT00736879|50619086|FG003|Double Blind Treatment Period|non-specified|0|||
25303586|NCT00736879|50619083|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
25303587|NCT00736879|50619084|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
25303588|NCT00736879|50619085|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
25303589|NCT00736879|50619086|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
25303590|NCT00736879|50619083|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
25303591|NCT00736879|50619084|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
25303592|NCT00736879|50619085|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
25303593|NCT00736879|50619086|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
25303594|NCT00806260|50619105|FG000|Period 1 (1 Day)|Adverse Event|0|||
25303595|NCT00806260|50619106|FG001|Period 1 (1 Day)|Adverse Event|0|||
25303596|NCT00806260|50619107|FG002|Period 1 (1 Day)|Adverse Event|0|||
25303597|NCT00806260|50619108|FG003|Period 1 (1 Day)|Adverse Event|0|||
25303598|NCT00806260|50619109|FG004|Period 1 (1 Day)|Adverse Event|3|||
25303599|NCT00806260|50619110|FG005|Period 1 (1 Day)|Adverse Event|0|||
25303600|NCT00806260|50619105|FG000|Period 2|Adverse Event|0|||
25303601|NCT00806260|50619106|FG001|Period 2|Adverse Event|0|||
25303602|NCT00806260|50619107|FG002|Period 2|Adverse Event|0|||
25303603|NCT00806260|50619108|FG003|Period 2|Adverse Event|1|||
25303604|NCT00806260|50619109|FG004|Period 2|Adverse Event|0|||
25303605|NCT00806260|50619110|FG005|Period 2|Adverse Event|0|||
25303606|NCT00806260|50619105|FG000|Period 2|Protocol Violation|1|||
25303607|NCT00806260|50619106|FG001|Period 2|Protocol Violation|0|||
25303608|NCT00806260|50619107|FG002|Period 2|Protocol Violation|1|||
25303609|NCT00806260|50619108|FG003|Period 2|Protocol Violation|0|||
25303610|NCT00806260|50619109|FG004|Period 2|Protocol Violation|0|||
25303611|NCT00806260|50619110|FG005|Period 2|Protocol Violation|0|||
25303612|NCT00806260|50619105|FG000|Period 2|Need to take concomitant medication|1|||
25303613|NCT00806260|50619106|FG001|Period 2|Need to take concomitant medication|0|||
25303614|NCT00806260|50619107|FG002|Period 2|Need to take concomitant medication|0|||
25303615|NCT00806260|50619108|FG003|Period 2|Need to take concomitant medication|0|||
25303616|NCT00806260|50619109|FG004|Period 2|Need to take concomitant medication|0|||
25303617|NCT00806260|50619110|FG005|Period 2|Need to take concomitant medication|0|||
25303618|NCT00806260|50619105|FG000|Period 2|sponsor request|0|||
25303619|NCT00806260|50619106|FG001|Period 2|sponsor request|0|||
25303620|NCT00806260|50619107|FG002|Period 2|sponsor request|1|||
25303621|NCT00806260|50619108|FG003|Period 2|sponsor request|1|||
25303622|NCT00806260|50619109|FG004|Period 2|sponsor request|0|||
25303623|NCT00806260|50619110|FG005|Period 2|sponsor request|0|||
25303624|NCT00806260|50619105|FG000|Period 3|Protocol Violation|0|||
25303625|NCT00806260|50619106|FG001|Period 3|Protocol Violation|1|||
25303626|NCT00806260|50619107|FG002|Period 3|Protocol Violation|1|||
25303627|NCT00806260|50619108|FG003|Period 3|Protocol Violation|0|||
25303628|NCT00806260|50619109|FG004|Period 3|Protocol Violation|0|||
25303629|NCT00806260|50619110|FG005|Period 3|Protocol Violation|0|||
25303630|NCT00806260|50619105|FG000|Period 3|Pregnancy|1|||
25303631|NCT00806260|50619106|FG001|Period 3|Pregnancy|0|||
25303632|NCT00806260|50619107|FG002|Period 3|Pregnancy|0|||
25303633|NCT00806260|50619108|FG003|Period 3|Pregnancy|0|||
25303634|NCT00806260|50619109|FG004|Period 3|Pregnancy|0|||
25303635|NCT00806260|50619110|FG005|Period 3|Pregnancy|0|||
25303636|NCT00742885|50619124|FG000|Overall Study|Lost to Follow-up|1|||
25303637|NCT00742885|50619125|FG001|Overall Study|Lost to Follow-up|0|||
25303638|NCT00811174|50619134|FG000|Overall Study|Protocol Violation|2|||
25303639|NCT00811174|50619134|FG000|Overall Study|Sponsors Decision|1|||
25303640|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
25303641|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
25303642|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
25303643|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
25303644|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
25303645|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
25303646|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
25303647|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
25303648|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
25303649|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
25303650|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
25303651|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
25303652|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
25303653|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
25303654|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
25303655|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
25303656|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
25303657|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
25303658|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
25303659|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
25303660|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
25303661|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
25303662|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
25303663|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
25303664|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
25303665|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
25303666|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
25303667|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
25303668|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
25303669|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
25303670|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
25303671|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
25303672|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
25303673|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
25303674|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
25303675|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
25303676|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
25303677|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
25303678|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
25303679|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
25303680|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
25303681|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
25303682|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
25303683|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
25303684|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
25303685|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
25303686|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
25303687|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
25303688|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
25303689|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
25303690|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
25303691|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
25303692|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
25303693|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
25303694|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
25303695|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
25303696|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
25303697|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
25303698|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
25303699|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
25303700|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
25303701|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
25303702|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
25303703|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
25303704|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
25303705|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
25303706|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
25303707|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
25303708|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
25303709|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
25303710|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|Change of location|0|||
25303711|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|Change of location|0|||
25303712|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|Change of location|0|||
25303713|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|Change of location|1|||
25303714|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|Change of location|0|||
25303715|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
25303716|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
25303717|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
25303718|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
25303719|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
25303720|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
25303721|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
25303722|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
25303723|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
25303724|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
25303725|NCT00730405|50619143|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
25303726|NCT00730405|50619144|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
25303727|NCT00730405|50619145|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
25303728|NCT00730405|50619146|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
25303729|NCT00730405|50619147|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
25303730|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
25303731|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
25303732|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
25303733|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
25303734|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
25303735|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
25303736|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
25303737|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
25303738|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
25303739|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
25303740|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
25303741|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
25303742|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
25303743|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
25303744|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
25303745|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Death|0|||
25303746|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Death|1|||
25303747|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Death|0|||
25303748|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Death|1|||
25303749|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Death|0|||
25303750|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Change of location|1|||
25303751|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Change of location|1|||
25070997|NCT00708123|50177058|FG002|Period 2|Protocol Violation|0|||
25070998|NCT00708123|50177059|FG003|Period 2|Protocol Violation|1|||
25070999|NCT00708123|50177060|FG004|Period 2|Protocol Violation|0|||
25071000|NCT00708123|50177056|FG000|Period 2|Other Reason|1|||
25071001|NCT00708123|50177057|FG001|Period 2|Other Reason|0|||
25071002|NCT00708123|50177058|FG002|Period 2|Other Reason|0|||
25071003|NCT00708123|50177059|FG003|Period 2|Other Reason|0|||
25303752|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Change of location|0|||
25303753|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Change of location|1|||
25303754|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Change of location|0|||
25303755|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
25303756|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
25303757|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
25303758|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
25303759|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
25303760|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
25303761|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
25303762|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
25303763|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
25303764|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
25303765|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
25303766|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
25303767|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
25303768|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
25303769|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
25303770|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
25303771|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
25303772|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
25303773|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
25303774|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
25303775|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
25303776|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
25303777|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
25303778|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
25303779|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
25303780|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
25303781|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
25303782|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
25303783|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
25303784|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
25303785|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
25303786|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
25303787|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
25303788|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
25303789|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
25303790|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
25303791|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
25303792|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
25303793|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
25303794|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
25303795|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
25303796|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
25303797|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
25303798|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
25303799|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
25303800|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
25303801|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
25303802|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
25303803|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
25303804|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
25303805|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Missing|0|||
25303806|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Missing|0|||
25303807|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Missing|2|||
25303808|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Missing|0|||
25303809|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Missing|0|||
25303810|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
25303811|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
25303812|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
25303813|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
25303814|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
25303815|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
25303816|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
25303817|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
25303818|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
25303819|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
25303820|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
25303821|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
25303822|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
25303823|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
25303824|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
25303825|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
25303826|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
25303827|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
25303828|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
25303829|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
25303830|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
25303831|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
25303832|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
25303833|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
25303834|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
25303835|NCT00730405|50619143|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
25303836|NCT00730405|50619144|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
25303837|NCT00730405|50619145|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
25303838|NCT00730405|50619146|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
25303839|NCT00730405|50619147|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
25303840|NCT00736723|50619163|FG000|Overall Study|Withdrawal by Subject|4|||
25303841|NCT00736723|50619164|FG001|Overall Study|Withdrawal by Subject|3|||
25303842|NCT00736645|50619174|FG000|Overall Study|Adverse Event|0|||
25303843|NCT00736645|50619175|FG001|Overall Study|Adverse Event|2|||
25303844|NCT00736645|50619176|FG002|Overall Study|Adverse Event|0|||
25303845|NCT00736645|50619177|FG003|Overall Study|Adverse Event|0|||
25303846|NCT00736489|50619187|FG000|Period 1|Lost to Follow-up|1|||
25303847|NCT00736489|50619188|FG001|Period 1|Lost to Follow-up|0|||
25303848|NCT00736489|50619189|FG002|Period 1|Lost to Follow-up|0|||
25303849|NCT00736489|50619190|FG003|Period 1|Lost to Follow-up|0|||
25303850|NCT00736489|50619191|FG004|Period 1|Lost to Follow-up|0|||
25303851|NCT00736489|50619192|FG005|Period 1|Lost to Follow-up|0|||
25303852|NCT00736489|50619187|FG000|Period 1|Withdrawal by Subject|0|||
25303853|NCT00736489|50619188|FG001|Period 1|Withdrawal by Subject|0|||
25303854|NCT00736489|50619189|FG002|Period 1|Withdrawal by Subject|0|||
25303855|NCT00736489|50619190|FG003|Period 1|Withdrawal by Subject|0|||
25303856|NCT00736489|50619191|FG004|Period 1|Withdrawal by Subject|0|||
25303857|NCT00736489|50619192|FG005|Period 1|Withdrawal by Subject|1|||
25303858|NCT00730327|50619224|FG000|Overall Study|Lost to Follow-up|14|||
25303859|NCT00730327|50619225|FG001|Overall Study|Lost to Follow-up|16|||
25303860|NCT00730327|50619224|FG000|Overall Study|Adverse Event|8|||
25303861|NCT00730327|50619225|FG001|Overall Study|Adverse Event|1|||
25303862|NCT00730327|50619224|FG000|Overall Study|Withdrawal by Subject|3|||
25303863|NCT00730327|50619225|FG001|Overall Study|Withdrawal by Subject|13|||
25303864|NCT00730327|50619224|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
25303865|NCT00730327|50619225|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
25303866|NCT00742417|50619240|FG000|Randomized|Withdrawal by legal representative|0|||
25303867|NCT00742417|50619241|FG001|Randomized|Withdrawal by legal representative|1|||
25303868|NCT00742417|50619240|FG000|Randomized|Withdrawal by Subject|1|||
25303869|NCT00742417|50619241|FG001|Randomized|Withdrawal by Subject|0|||
25303870|NCT00742417|50619240|FG000|Randomized|Physician Decision|1|||
25303871|NCT00742417|50619241|FG001|Randomized|Physician Decision|0|||
25303872|NCT00742417|50619240|FG000|Intensive Period|Withdrawal by Subject|1|||
25303873|NCT00742417|50619241|FG001|Intensive Period|Withdrawal by Subject|1|||
25303874|NCT00742417|50619240|FG000|Intensive Period|Adverse Event|2|||
25303875|NCT00742417|50619241|FG001|Intensive Period|Adverse Event|0|||
25303876|NCT00811018|50619249|FG000|Overall Study|Additional Chronic Treatment|31|||
25303877|NCT00811018|50619249|FG000|Overall Study|Adverse Event|79|||
25303878|NCT00811018|50619249|FG000|Overall Study|Death|147|||
25303879|NCT00811018|50619249|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
25303880|NCT00811018|50619249|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
25303881|NCT00811018|50619249|FG000|Overall Study|Investigator Decision|57|||
25303882|NCT00811018|50619249|FG000|Overall Study|Lost to Follow-up|19|||
25303883|NCT00811018|50619249|FG000|Overall Study|Pregnancy|6|||
25303884|NCT00811018|50619249|FG000|Overall Study|Sponsor Decision|450|||
25303885|NCT00811018|50619249|FG000|Overall Study|Withdrawal by Subject|70|||
25303886|NCT00811018|50619249|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
25303887|NCT00811018|50619249|FG000|Overall Study|Other|26|||
25303888|NCT00730171|50619258|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
25303889|NCT00730171|50619258|FG000|Overall Study|Adverse Event|193|||
25303890|NCT00730171|50619258|FG000|Overall Study|Protocol Violation|48|||
25303891|NCT00730171|50619258|FG000|Overall Study|Withdrawal by Subject|202|||
25303892|NCT00730171|50619258|FG000|Overall Study|Lost to Follow-up|121|||
25303893|NCT00730171|50619258|FG000|Overall Study|Insufficient Therapeutic Response|141|||
25303894|NCT00730171|50619258|FG000|Overall Study|Other|61|||
25303895|NCT00730015|50619269|FG000|Overall Study|Adverse Event|11|||
25303896|NCT00730015|50619270|FG001|Overall Study|Adverse Event|10|||
25303897|NCT00730015|50619271|FG002|Overall Study|Adverse Event|8|||
25303898|NCT00730015|50619269|FG000|Overall Study|Protocol Violation|2|||
25303899|NCT00730015|50619270|FG001|Overall Study|Protocol Violation|6|||
25303900|NCT00730015|50619271|FG002|Overall Study|Protocol Violation|4|||
25303901|NCT00730015|50619269|FG000|Overall Study|Withdrawal by Subject|12|||
25303902|NCT00730015|50619270|FG001|Overall Study|Withdrawal by Subject|12|||
25303903|NCT00730015|50619271|FG002|Overall Study|Withdrawal by Subject|8|||
25303904|NCT00730015|50619269|FG000|Overall Study|Lost to Follow-up|4|||
25303905|NCT00730015|50619270|FG001|Overall Study|Lost to Follow-up|10|||
25303906|NCT00730015|50619271|FG002|Overall Study|Lost to Follow-up|3|||
25303907|NCT00730015|50619269|FG000|Overall Study|Lack of Efficacy|1|||
25303908|NCT00730015|50619270|FG001|Overall Study|Lack of Efficacy|2|||
25303909|NCT00730015|50619271|FG002|Overall Study|Lack of Efficacy|8|||
25303910|NCT00730015|50619269|FG000|Overall Study|Other Reason|1|||
25303911|NCT00730015|50619270|FG001|Overall Study|Other Reason|0|||
25303912|NCT00730015|50619271|FG002|Overall Study|Other Reason|1|||
25303913|NCT00806026|50619290|FG000|Overall Study|Death|0|||
25303914|NCT00806026|50619291|FG001|Overall Study|Death|0|||
25303915|NCT00806026|50619292|FG002|Overall Study|Death|0|||
25303916|NCT00806026|50619293|FG003|Overall Study|Death|1|||
25303917|NCT00806026|50619294|FG004|Overall Study|Death|0|||
25303918|NCT00806026|50619295|FG005|Overall Study|Death|0|||
25303919|NCT00806026|50619290|FG000|Overall Study|Did not meet entrance criteria|4|||
25303920|NCT00806026|50619291|FG001|Overall Study|Did not meet entrance criteria|1|||
25303921|NCT00806026|50619292|FG002|Overall Study|Did not meet entrance criteria|2|||
25303922|NCT00806026|50619293|FG003|Overall Study|Did not meet entrance criteria|1|||
25303923|NCT00806026|50619294|FG004|Overall Study|Did not meet entrance criteria|0|||
25303924|NCT00806026|50619295|FG005|Overall Study|Did not meet entrance criteria|0|||
25303925|NCT00806026|50619290|FG000|Overall Study|Lack of Efficacy|5|||
25303926|NCT00806026|50619291|FG001|Overall Study|Lack of Efficacy|18|||
25303927|NCT00806026|50619292|FG002|Overall Study|Lack of Efficacy|13|||
25303928|NCT00806026|50619293|FG003|Overall Study|Lack of Efficacy|4|||
25303929|NCT00806026|50619294|FG004|Overall Study|Lack of Efficacy|8|||
25303930|NCT00806026|50619295|FG005|Overall Study|Lack of Efficacy|7|||
25303931|NCT00806026|50619290|FG000|Overall Study|Lost to Follow-up|8|||
25303932|NCT00806026|50619291|FG001|Overall Study|Lost to Follow-up|15|||
25303933|NCT00806026|50619292|FG002|Overall Study|Lost to Follow-up|8|||
25303934|NCT00806026|50619293|FG003|Overall Study|Lost to Follow-up|2|||
25303935|NCT00806026|50619294|FG004|Overall Study|Lost to Follow-up|6|||
25303936|NCT00806026|50619295|FG005|Overall Study|Lost to Follow-up|6|||
25071004|NCT00708123|50177060|FG004|Period 2|Other Reason|0|||
25071005|NCT00708123|50177056|FG000|Period 3|Lost to Follow-up|0|||
25071006|NCT00708123|50177057|FG001|Period 3|Lost to Follow-up|0|||
25192076|NCT02585934|50356402|FG000|Overall Study|Lost to Follow-up|2|||
25192077|NCT02585934|50356403|FG001|Overall Study|Lost to Follow-up|2|||
25192078|NCT02585934|50356402|FG000|Overall Study|Protocol Violation|14|||
25303937|NCT00806026|50619290|FG000|Overall Study|Withdrawal by Subject|14|||
25303938|NCT00806026|50619291|FG001|Overall Study|Withdrawal by Subject|17|||
25303939|NCT00806026|50619292|FG002|Overall Study|Withdrawal by Subject|9|||
25303940|NCT00806026|50619293|FG003|Overall Study|Withdrawal by Subject|2|||
25303941|NCT00806026|50619294|FG004|Overall Study|Withdrawal by Subject|5|||
25303942|NCT00806026|50619295|FG005|Overall Study|Withdrawal by Subject|3|||
25303943|NCT00806026|50619290|FG000|Overall Study|Other|3|||
25303944|NCT00806026|50619291|FG001|Overall Study|Other|6|||
25303945|NCT00806026|50619292|FG002|Overall Study|Other|8|||
25303946|NCT00806026|50619293|FG003|Overall Study|Other|2|||
25303947|NCT00806026|50619294|FG004|Overall Study|Other|0|||
25303948|NCT00806026|50619295|FG005|Overall Study|Other|4|||
25303949|NCT00806026|50619290|FG000|Overall Study|Protocol Violation|6|||
25303950|NCT00806026|50619291|FG001|Overall Study|Protocol Violation|9|||
25303951|NCT00806026|50619292|FG002|Overall Study|Protocol Violation|9|||
25303952|NCT00806026|50619293|FG003|Overall Study|Protocol Violation|0|||
25071007|NCT00708123|50177058|FG002|Period 3|Lost to Follow-up|1|||
25192079|NCT02585934|50356403|FG001|Overall Study|Protocol Violation|11|||
25303953|NCT00806026|50619294|FG004|Overall Study|Protocol Violation|2|||
25071008|NCT00708123|50177059|FG003|Period 3|Lost to Follow-up|1|||
25071009|NCT00708123|50177060|FG004|Period 3|Lost to Follow-up|0|||
25071010|NCT00708123|50177056|FG000|Period 4|Protocol Violation|0|||
25071011|NCT00708123|50177057|FG001|Period 4|Protocol Violation|1|||
25071012|NCT00708123|50177058|FG002|Period 4|Protocol Violation|0|||
25071013|NCT00708123|50177059|FG003|Period 4|Protocol Violation|0|||
25071014|NCT00708123|50177060|FG004|Period 4|Protocol Violation|0|||
25071015|NCT02165215|50177079|FG000|Induction Phase|Adverse Event|1|||
25071016|NCT02165215|50177080|FG001|Induction Phase|Adverse Event|0|||
25071017|NCT02165215|50177081|FG002|Induction Phase|Adverse Event|0|||
25071018|NCT02165215|50177079|FG000|Induction Phase|Withdrawal by Subject|10|||
25071019|NCT02165215|50177080|FG001|Induction Phase|Withdrawal by Subject|0|||
25071020|NCT02165215|50177081|FG002|Induction Phase|Withdrawal by Subject|0|||
25071021|NCT02165215|50177079|FG000|Induction Phase|Protocol Violation|1|||
25071022|NCT02165215|50177080|FG001|Induction Phase|Protocol Violation|0|||
25071023|NCT02165215|50177081|FG002|Induction Phase|Protocol Violation|0|||
25071024|NCT02165215|50177079|FG000|Induction Phase|Physician Decision|1|||
25071025|NCT02165215|50177080|FG001|Induction Phase|Physician Decision|0|||
25071026|NCT02165215|50177081|FG002|Induction Phase|Physician Decision|0|||
25071027|NCT02165215|50177079|FG000|Induction Phase|Lack of Efficacy|2|||
25071028|NCT02165215|50177080|FG001|Induction Phase|Lack of Efficacy|0|||
25169383|NCT01838681|50301147|FG002|Period A|Adverse Event|0|||
25169384|NCT01838681|50301148|FG003|Period A|Adverse Event|0|||
25169385|NCT01838681|50301145|FG000|Period A|Lack of Efficacy|21|||
25169386|NCT01838681|50301146|FG001|Period A|Lack of Efficacy|0|||
25169387|NCT01838681|50301147|FG002|Period A|Lack of Efficacy|0|||
25169388|NCT01838681|50301148|FG003|Period A|Lack of Efficacy|0|||
25169389|NCT01838681|50301145|FG000|Period A|Early response|148|||
25169390|NCT01838681|50301146|FG001|Period A|Early response|0|||
25169391|NCT01838681|50301147|FG002|Period A|Early response|0|||
25169392|NCT01838681|50301148|FG003|Period A|Early response|0|||
25169393|NCT01838681|50301145|FG000|Period A|Withdrawal by Subject|70|||
25169394|NCT01838681|50301146|FG001|Period A|Withdrawal by Subject|0|||
25303954|NCT00806026|50619295|FG005|Overall Study|Protocol Violation|3|||
25303955|NCT00806026|50619290|FG000|Overall Study|Adverse Event|52|||
25303956|NCT00806026|50619291|FG001|Overall Study|Adverse Event|35|||
25303957|NCT00806026|50619292|FG002|Overall Study|Adverse Event|44|||
25071029|NCT02165215|50177081|FG002|Induction Phase|Lack of Efficacy|0|||
25071030|NCT02165215|50177079|FG000|Induction Phase|Non-Compliance|2|||
25071031|NCT02165215|50177080|FG001|Induction Phase|Non-Compliance|0|||
25169395|NCT01838681|50301147|FG002|Period A|Withdrawal by Subject|0|||
25169396|NCT01838681|50301148|FG003|Period A|Withdrawal by Subject|0|||
25192080|NCT02585934|50356402|FG000|Overall Study|Adverse Event|21|||
25303958|NCT00806026|50619293|FG003|Overall Study|Adverse Event|17|||
25071032|NCT02165215|50177081|FG002|Induction Phase|Non-Compliance|0|||
25071033|NCT02165215|50177079|FG000|Induction Phase|Lost to Follow-up|6|||
25071034|NCT02165215|50177080|FG001|Induction Phase|Lost to Follow-up|0|||
25169397|NCT01838681|50301145|FG000|Period A|Protocol Violation|16|||
25192081|NCT02585934|50356403|FG001|Overall Study|Adverse Event|22|||
25192082|NCT02585934|50356402|FG000|Overall Study|Physician Decision|3|||
25303959|NCT00806026|50619294|FG004|Overall Study|Adverse Event|9|||
25303960|NCT00806026|50619295|FG005|Overall Study|Adverse Event|9|||
25303961|NCT04026165|50619310|FG000|Run-in Placebo Period|Enrollment Error|13|||
25303962|NCT04026165|50619311|FG001|Run-in Placebo Period|Enrollment Error|0|||
25303963|NCT04026165|50619312|FG002|Run-in Placebo Period|Enrollment Error|0|||
25303964|NCT04026165|50619313|FG003|Run-in Placebo Period|Enrollment Error|0|||
25303965|NCT04026165|50619310|FG000|Run-in Placebo Period|Run-in Failure|4|||
25303966|NCT04026165|50619311|FG001|Run-in Placebo Period|Run-in Failure|0|||
25303967|NCT04026165|50619312|FG002|Run-in Placebo Period|Run-in Failure|0|||
25303968|NCT04026165|50619313|FG003|Run-in Placebo Period|Run-in Failure|0|||
25303969|NCT04026165|50619310|FG000|Run-in Placebo Period|Protocol Violation|2|||
25303970|NCT04026165|50619311|FG001|Run-in Placebo Period|Protocol Violation|0|||
25303971|NCT04026165|50619312|FG002|Run-in Placebo Period|Protocol Violation|0|||
25303972|NCT04026165|50619313|FG003|Run-in Placebo Period|Protocol Violation|0|||
25303973|NCT04026165|50619310|FG000|Run-in Placebo Period|Withdrew Consent|2|||
25303974|NCT04026165|50619311|FG001|Run-in Placebo Period|Withdrew Consent|0|||
25303975|NCT04026165|50619312|FG002|Run-in Placebo Period|Withdrew Consent|0|||
25303976|NCT04026165|50619313|FG003|Run-in Placebo Period|Withdrew Consent|0|||
25303977|NCT04026165|50619310|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
25303978|NCT04026165|50619311|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
25303979|NCT04026165|50619312|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
25303980|NCT04026165|50619313|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
25071035|NCT02165215|50177081|FG002|Induction Phase|Lost to Follow-up|0|||
25071036|NCT02165215|50177079|FG000|Maintenance Phase|Withdrawal by Subject|0|||
25071037|NCT02165215|50177080|FG001|Maintenance Phase|Withdrawal by Subject|7|||
25071038|NCT02165215|50177081|FG002|Maintenance Phase|Withdrawal by Subject|3|||
25071039|NCT02165215|50177079|FG000|Maintenance Phase|Multiple reasons|0|||
25071040|NCT02165215|50177080|FG001|Maintenance Phase|Multiple reasons|2|||
25192083|NCT02585934|50356403|FG001|Overall Study|Physician Decision|2|||
25192084|NCT02585934|50356402|FG000|Overall Study|Withdrawal by Subject|7|||
25192085|NCT02585934|50356403|FG001|Overall Study|Withdrawal by Subject|21|||
25303981|NCT04026165|50619310|FG000|Run-in SEL Period|Run-in Failure|0|||
25303982|NCT04026165|50619311|FG001|Run-in SEL Period|Run-in Failure|26|||
25192086|NCT02585934|50356402|FG000|Overall Study|Lack of Efficacy|2|||
25303983|NCT04026165|50619312|FG002|Run-in SEL Period|Run-in Failure|0|||
25303984|NCT04026165|50619313|FG003|Run-in SEL Period|Run-in Failure|0|||
25192087|NCT02585934|50356403|FG001|Overall Study|Lack of Efficacy|1|||
25169398|NCT01838681|50301146|FG001|Period A|Protocol Violation|0|||
24969943|NCT04728802|50059410|FG001|Overall Study|Other|0|||
24969944|NCT04715932|50059418|FG000|Overall Study|Lost to Follow-up|1|||
25071041|NCT02165215|50177081|FG002|Maintenance Phase|Multiple reasons|1|||
25071042|NCT02165215|50177079|FG000|Maintenance Phase|Lost to Follow-up|0|||
25303985|NCT04026165|50619310|FG000|Run-in SEL Period|Withdrew Consent|0|||
25303986|NCT04026165|50619311|FG001|Run-in SEL Period|Withdrew Consent|10|||
25303987|NCT04026165|50619312|FG002|Run-in SEL Period|Withdrew Consent|0|||
25303988|NCT04026165|50619313|FG003|Run-in SEL Period|Withdrew Consent|0|||
25303989|NCT04026165|50619310|FG000|Run-in SEL Period|Enrollment Error|0|||
25303990|NCT04026165|50619311|FG001|Run-in SEL Period|Enrollment Error|4|||
25303991|NCT04026165|50619312|FG002|Run-in SEL Period|Enrollment Error|0|||
25303992|NCT04026165|50619313|FG003|Run-in SEL Period|Enrollment Error|0|||
25303993|NCT04026165|50619310|FG000|Run-in SEL Period|Protocol Violation|0|||
25303994|NCT04026165|50619311|FG001|Run-in SEL Period|Protocol Violation|3|||
25303995|NCT04026165|50619312|FG002|Run-in SEL Period|Protocol Violation|0|||
25303996|NCT04026165|50619313|FG003|Run-in SEL Period|Protocol Violation|0|||
25303997|NCT04026165|50619310|FG000|Run-in SEL Period|Investigator's Discretion|0|||
25303998|NCT04026165|50619311|FG001|Run-in SEL Period|Investigator's Discretion|2|||
25303999|NCT04026165|50619312|FG002|Run-in SEL Period|Investigator's Discretion|0|||
25304000|NCT04026165|50619313|FG003|Run-in SEL Period|Investigator's Discretion|0|||
25304001|NCT04026165|50619310|FG000|Run-in SEL Period|Death|0|||
25304002|NCT04026165|50619311|FG001|Run-in SEL Period|Death|1|||
25304003|NCT04026165|50619312|FG002|Run-in SEL Period|Death|0|||
25304004|NCT04026165|50619313|FG003|Run-in SEL Period|Death|0|||
25304005|NCT04026165|50619310|FG000|Randomized Period|Withdrew Consent|0|||
25304006|NCT04026165|50619311|FG001|Randomized Period|Withdrew Consent|0|||
25304007|NCT04026165|50619312|FG002|Randomized Period|Withdrew Consent|5|||
25304008|NCT04026165|50619313|FG003|Randomized Period|Withdrew Consent|8|||
25304009|NCT04026165|50619310|FG000|Randomized Period|Death|0|||
25071043|NCT02165215|50177080|FG001|Maintenance Phase|Lost to Follow-up|2|||
25071044|NCT02165215|50177081|FG002|Maintenance Phase|Lost to Follow-up|0|||
25071045|NCT02165215|50177079|FG000|Maintenance Phase|Adverse Event|0|||
25071046|NCT02165215|50177080|FG001|Maintenance Phase|Adverse Event|1|||
25071047|NCT02165215|50177081|FG002|Maintenance Phase|Adverse Event|1|||
25071048|NCT02757625|50177096|FG000|Overall Study|Investigator's discretion|0|||
25071049|NCT02757625|50177097|FG001|Overall Study|Investigator's discretion|0|||
25071050|NCT02757625|50177098|FG002|Overall Study|Investigator's discretion|1|||
25071051|NCT02757625|50177099|FG003|Overall Study|Investigator's discretion|0|||
25071052|NCT02757625|50177096|FG000|Overall Study|Adverse Event|0|||
25071053|NCT02757625|50177097|FG001|Overall Study|Adverse Event|0|||
25071054|NCT02757625|50177098|FG002|Overall Study|Adverse Event|1|||
25071055|NCT02757625|50177099|FG003|Overall Study|Adverse Event|0|||
25071056|NCT02581202|50177111|FG000|Overall Study|Lack of Efficacy|2|||
25071057|NCT02581202|50177111|FG000|Overall Study|Withdrawal by Subject|4|||
25071058|NCT02581202|50177111|FG000|Overall Study|Lost to Follow-up|5|||
25071059|NCT02581202|50177111|FG000|Overall Study|Pregnancy|3|||
25071060|NCT02758171|50177118|FG000|Wash-out|Withdrawal by Subject|1|||
25071061|NCT02758171|50177119|FG001|Wash-out|Withdrawal by Subject|0|||
25071062|NCT02758171|50177118|FG000|Wash-out|Other reason|1|||
25071063|NCT02758171|50177119|FG001|Wash-out|Other reason|0|||
25071064|NCT00101101|50177125|FG000|Overall Study|never received vaccine|20|||
25071065|NCT01664078|50177152|FG000|Overall Study|Death|9|||
25169399|NCT01838681|50301147|FG002|Period A|Protocol Violation|0|||
25071066|NCT01664078|50177152|FG000|Overall Study|Withdrawal by Subject|4|||
25071067|NCT01664078|50177152|FG000|Overall Study|Lost to Follow-up|2|||
25304010|NCT04026165|50619311|FG001|Randomized Period|Death|0|||
25304011|NCT04026165|50619312|FG002|Randomized Period|Death|5|||
25304012|NCT04026165|50619313|FG003|Randomized Period|Death|7|||
25304013|NCT04026165|50619310|FG000|Randomized Period|Investigator's Discretion|0|||
25304014|NCT04026165|50619311|FG001|Randomized Period|Investigator's Discretion|0|||
25304015|NCT04026165|50619312|FG002|Randomized Period|Investigator's Discretion|2|||
25304016|NCT04026165|50619313|FG003|Randomized Period|Investigator's Discretion|2|||
25304017|NCT04026165|50619310|FG000|Randomized Period|Lost to Follow-up|0|||
25304018|NCT04026165|50619311|FG001|Randomized Period|Lost to Follow-up|0|||
25304019|NCT04026165|50619312|FG002|Randomized Period|Lost to Follow-up|2|||
25304020|NCT04026165|50619313|FG003|Randomized Period|Lost to Follow-up|2|||
25304021|NCT00805792|50619321|FG000|Overall Study|Death|3|||
25304022|NCT00805792|50619321|FG000|Overall Study|Lost to Follow-up|2|||
25304023|NCT00590044|50619327|FG000|Overall Study|Withdrawal by Subject|2|||
25304024|NCT00590044|50619328|FG001|Overall Study|Withdrawal by Subject|2|||
25304025|NCT00590044|50619327|FG000|Overall Study|wrong insulin arm assigned|1|||
24969945|NCT04715932|50059419|FG001|Overall Study|Lost to Follow-up|0|||
25304026|NCT00590044|50619328|FG001|Overall Study|wrong insulin arm assigned|0|||
25304027|NCT00590044|50619327|FG000|Overall Study|Protocol Violation|1|||
25304028|NCT00590044|50619328|FG001|Overall Study|Protocol Violation|0|||
25304029|NCT00805480|50619341|FG000|Overall Study|Withdrawal by Subject|13|||
25304030|NCT00805480|50619342|FG001|Overall Study|Withdrawal by Subject|5|||
25304031|NCT00805480|50619343|FG002|Overall Study|Withdrawal by Subject|11|||
25304032|NCT00805480|50619344|FG003|Overall Study|Withdrawal by Subject|5|||
25304033|NCT00805480|50619341|FG000|Overall Study|Lost to Follow-up|1|||
25304034|NCT00805480|50619342|FG001|Overall Study|Lost to Follow-up|2|||
25304035|NCT00805480|50619343|FG002|Overall Study|Lost to Follow-up|0|||
25304036|NCT00805480|50619344|FG003|Overall Study|Lost to Follow-up|0|||
25304037|NCT00805480|50619341|FG000|Overall Study|Adverse Event|0|||
25304038|NCT00805480|50619342|FG001|Overall Study|Adverse Event|0|||
24969946|NCT00130832|50059427|FG000|Overall Study|Adverse Event|1|||
25304039|NCT00805480|50619343|FG002|Overall Study|Adverse Event|1|||
24969947|NCT00130832|50059428|FG001|Overall Study|Adverse Event|1|||
24969948|NCT00130832|50059427|FG000|Overall Study|Lost to Follow-up|1|||
25192088|NCT02585934|50356402|FG000|Overall Study|Death|2|||
25304040|NCT00805480|50619344|FG003|Overall Study|Adverse Event|0|||
25304041|NCT00729937|50619360|FG000|Overall Study|Lost to Follow-up|49|||
25304042|NCT00729937|50619361|FG001|Overall Study|Lost to Follow-up|58|||
24969949|NCT00130832|50059428|FG001|Overall Study|Lost to Follow-up|2|||
25304043|NCT00729937|50619362|FG002|Overall Study|Lost to Follow-up|18|||
25304044|NCT00729937|50619363|FG003|Overall Study|Lost to Follow-up|33|||
25304045|NCT00729937|50619364|FG004|Overall Study|Lost to Follow-up|18|||
25304046|NCT00729937|50619365|FG005|Overall Study|Lost to Follow-up|23|||
25304047|NCT00729937|50619360|FG000|Overall Study|Physician Decision|7|||
25304048|NCT00729937|50619361|FG001|Overall Study|Physician Decision|16|||
25304049|NCT00729937|50619362|FG002|Overall Study|Physician Decision|2|||
25304050|NCT00729937|50619363|FG003|Overall Study|Physician Decision|0|||
25304051|NCT00729937|50619364|FG004|Overall Study|Physician Decision|5|||
25304052|NCT00729937|50619365|FG005|Overall Study|Physician Decision|8|||
25304053|NCT00729937|50619360|FG000|Overall Study|Death|1|||
25304054|NCT00729937|50619361|FG001|Overall Study|Death|0|||
25304055|NCT00729937|50619362|FG002|Overall Study|Death|1|||
25304056|NCT00729937|50619363|FG003|Overall Study|Death|0|||
25304057|NCT00729937|50619364|FG004|Overall Study|Death|0|||
25304058|NCT00729937|50619365|FG005|Overall Study|Death|1|||
25304059|NCT00729937|50619360|FG000|Overall Study|Withdrawal by Subject|3|||
25304060|NCT00729937|50619361|FG001|Overall Study|Withdrawal by Subject|5|||
25304061|NCT00729937|50619362|FG002|Overall Study|Withdrawal by Subject|6|||
25304062|NCT00729937|50619363|FG003|Overall Study|Withdrawal by Subject|0|||
25304063|NCT00729937|50619364|FG004|Overall Study|Withdrawal by Subject|4|||
25304064|NCT00729937|50619365|FG005|Overall Study|Withdrawal by Subject|2|||
25304065|NCT00729937|50619360|FG000|Overall Study|Randomized but not treated|12|||
25304066|NCT00729937|50619361|FG001|Overall Study|Randomized but not treated|6|||
25304067|NCT00729937|50619362|FG002|Overall Study|Randomized but not treated|1|||
25304068|NCT00729937|50619363|FG003|Overall Study|Randomized but not treated|0|||
25304069|NCT00729937|50619364|FG004|Overall Study|Randomized but not treated|1|||
25304070|NCT00729937|50619365|FG005|Overall Study|Randomized but not treated|3|||
25304071|NCT00729937|50619360|FG000|Overall Study|Did not meet eligibility criteria|2|||
25304072|NCT00729937|50619361|FG001|Overall Study|Did not meet eligibility criteria|1|||
25304073|NCT00729937|50619362|FG002|Overall Study|Did not meet eligibility criteria|0|||
25304074|NCT00729937|50619363|FG003|Overall Study|Did not meet eligibility criteria|0|||
25304075|NCT00729937|50619364|FG004|Overall Study|Did not meet eligibility criteria|0|||
25304076|NCT00729937|50619365|FG005|Overall Study|Did not meet eligibility criteria|0|||
25192089|NCT02585934|50356403|FG001|Overall Study|Death|0|||
25304077|NCT00729937|50619360|FG000|Overall Study|Incarcerated|0|||
25304078|NCT00729937|50619361|FG001|Overall Study|Incarcerated|2|||
25304079|NCT00729937|50619362|FG002|Overall Study|Incarcerated|1|||
25304080|NCT00729937|50619363|FG003|Overall Study|Incarcerated|1|||
25304081|NCT00729937|50619364|FG004|Overall Study|Incarcerated|0|||
25304082|NCT00729937|50619365|FG005|Overall Study|Incarcerated|0|||
25304083|NCT00729859|50619382|FG000|Overall Study|Adverse Event|0|||
25304084|NCT00729859|50619383|FG001|Overall Study|Adverse Event|1|||
25304085|NCT00729859|50619384|FG002|Overall Study|Adverse Event|0|||
24969950|NCT00130832|50059427|FG000|Overall Study|Protocol Violation|6|||
25304086|NCT00729859|50619382|FG000|Overall Study|Withdrawal by Subject|0|||
25304087|NCT00729859|50619383|FG001|Overall Study|Withdrawal by Subject|1|||
25304088|NCT00729859|50619384|FG002|Overall Study|Withdrawal by Subject|0|||
25304089|NCT00810394|50619400|FG000|Overall Study|Withdrawal by Subject|3|||
25304090|NCT00736333|50619404|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
25304091|NCT00736333|50619404|FG000|Overall Study|Data Missing|2|||
25304092|NCT00736333|50619404|FG000|Overall Study|Tumor Progression|75|||
25304093|NCT00736333|50619404|FG000|Overall Study|Toxicity|6|||
25304094|NCT00736333|50619404|FG000|Overall Study|Withdrawal by Subject|10|||
25304095|NCT00736333|50619404|FG000|Overall Study|Death|7|||
25304096|NCT00736333|50619404|FG000|Overall Study|Other|4|||
25304097|NCT00736255|50619410|FG000|Overall Study|Adverse Event|1|||
25304098|NCT00736255|50619411|FG001|Overall Study|Adverse Event|0|||
25304099|NCT00736255|50619410|FG000|Overall Study|Physician Decision|1|||
25304100|NCT00736255|50619411|FG001|Overall Study|Physician Decision|0|||
25304101|NCT00736255|50619410|FG000|Overall Study|Non-compliance|1|||
25304102|NCT00736255|50619411|FG001|Overall Study|Non-compliance|1|||
25304103|NCT03920254|50619420|FG000|Overall Study|Adverse Event|1|||
25304104|NCT03920254|50619421|FG001|Overall Study|Adverse Event|0|||
25304105|NCT03920254|50619422|FG002|Overall Study|Adverse Event|0|||
25304106|NCT03920254|50619420|FG000|Overall Study|Physician Decision|0|||
25304107|NCT03920254|50619421|FG001|Overall Study|Physician Decision|1|||
25304108|NCT03920254|50619422|FG002|Overall Study|Physician Decision|2|||
25304109|NCT03920254|50619420|FG000|Overall Study|Study Terminated By Sponsor|12|||
25304110|NCT03920254|50619421|FG001|Overall Study|Study Terminated By Sponsor|17|||
25304111|NCT03920254|50619422|FG002|Overall Study|Study Terminated By Sponsor|12|||
25304112|NCT03920254|50619420|FG000|Overall Study|Withdrawal by Subject|0|||
25304113|NCT03920254|50619421|FG001|Overall Study|Withdrawal by Subject|0|||
25192090|NCT02585934|50356402|FG000|Overall Study|Caregiver Withdrew Consent|7|||
25192091|NCT02585934|50356403|FG001|Overall Study|Caregiver Withdrew Consent|7|||
25192092|NCT02585934|50356402|FG000|Overall Study|Sponsor Termination|1|||
25192093|NCT02585934|50356403|FG001|Overall Study|Sponsor Termination|2|||
25192094|NCT02585934|50356402|FG000|Overall Study|Another Reason|10|||
25192095|NCT02585934|50356403|FG001|Overall Study|Another Reason|5|||
25192096|NCT02582658|50356432|FG000|Overall Study|Failure to Return|10|||
25192097|NCT02582658|50356432|FG000|Overall Study|Insufficient Virological Response|2|||
25192098|NCT02582658|50356432|FG000|Overall Study|Withdrawn Consent|1|||
25192099|NCT02582658|50356432|FG000|Overall Study|Death|1|||
25192100|NCT02582658|50356432|FG000|Overall Study|Not further specified|11|||
25192101|NCT02585778|50356534|FG000|Overall Study|Adverse Event|17|||
25192102|NCT02585778|50356535|FG001|Overall Study|Adverse Event|4|||
25304114|NCT03920254|50619422|FG002|Overall Study|Withdrawal by Subject|1|||
25304115|NCT00729469|50619432|FG000|Overall Study|Adverse Event|14|||
25304116|NCT00729469|50619433|FG001|Overall Study|Adverse Event|25|||
25304117|NCT00729469|50619432|FG000|Overall Study|Lost to Follow-up|9|||
25304118|NCT00729469|50619433|FG001|Overall Study|Lost to Follow-up|9|||
25304119|NCT00729469|50619432|FG000|Overall Study|Protocol Violation|2|||
25304120|NCT00729469|50619433|FG001|Overall Study|Protocol Violation|1|||
25304121|NCT00729469|50619432|FG000|Overall Study|Withdrawal by Subject|19|||
25304122|NCT00729469|50619433|FG001|Overall Study|Withdrawal by Subject|8|||
25304123|NCT00729469|50619432|FG000|Overall Study|Other-Not mentioned|9|||
25304124|NCT00729469|50619433|FG001|Overall Study|Other-Not mentioned|4|||
25304125|NCT00742183|50619441|FG000|Overall Study|Adverse Event|2|||
25304126|NCT00742183|50619442|FG001|Overall Study|Adverse Event|2|||
25304127|NCT00742183|50619441|FG000|Overall Study|Death|1|||
25304128|NCT00742183|50619442|FG001|Overall Study|Death|0|||
25304129|NCT00742183|50619441|FG000|Overall Study|Physician Decision|0|||
25304130|NCT00742183|50619442|FG001|Overall Study|Physician Decision|2|||
25304131|NCT00742183|50619441|FG000|Overall Study|Lost to Follow-up|4|||
25304132|NCT00742183|50619442|FG001|Overall Study|Lost to Follow-up|4|||
25304133|NCT00742183|50619441|FG000|Overall Study|Required skin-graft|1|||
25304134|NCT00742183|50619442|FG001|Overall Study|Required skin-graft|1|||
25304135|NCT00742183|50619441|FG000|Overall Study|Withdrawal by Subject|1|||
25304136|NCT00742183|50619442|FG001|Overall Study|Withdrawal by Subject|0|||
25304137|NCT00742183|50619441|FG000|Overall Study|Lack of Efficacy|0|||
25304138|NCT00742183|50619442|FG001|Overall Study|Lack of Efficacy|3|||
25304139|NCT00808444|50619450|FG000|Overall Study|Withdrawal by Subject|1|||
25304140|NCT00808444|50619451|FG001|Overall Study|Withdrawal by Subject|0|||
25304141|NCT00808444|50619450|FG000|Overall Study|Lost to Follow-up|0|||
25304142|NCT00808444|50619451|FG001|Overall Study|Lost to Follow-up|1|||
25304143|NCT00742027|50619457|FG000|Overall Study|Disease Progression|76|||
25304144|NCT00742027|50619457|FG000|Overall Study|New Cancer Therapy|19|||
25304145|NCT00742027|50619457|FG000|Overall Study|Withdrawal by Subject|18|||
25304146|NCT00742027|50619457|FG000|Overall Study|Death|7|||
25304147|NCT00742027|50619457|FG000|Overall Study|Lost to Follow-up|4|||
25304148|NCT00742027|50619457|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
25304149|NCT00742027|50619457|FG000|Overall Study|Missing|2|||
25304150|NCT00742027|50619457|FG000|Overall Study|Administrative Problems|1|||
25304151|NCT03996369|50619463|FG000|Overall Study|Protocol deviation|1|||
25304152|NCT03996369|50619464|FG001|Overall Study|Protocol deviation|1|||
25304153|NCT03996369|50619463|FG000|Overall Study|Physician Decision|4|||
25304154|NCT03996369|50619464|FG001|Overall Study|Physician Decision|2|||
25304155|NCT03996369|50619463|FG000|Overall Study|Participant decision|0|||
25304156|NCT03996369|50619464|FG001|Overall Study|Participant decision|1|||
25304157|NCT03996369|50619463|FG000|Overall Study|Lack of Efficacy|4|||
25304158|NCT03996369|50619464|FG001|Overall Study|Lack of Efficacy|0|||
25304159|NCT03996369|50619463|FG000|Overall Study|Adverse Event|9|||
25304160|NCT03996369|50619464|FG001|Overall Study|Adverse Event|0|||
25304161|NCT03996369|50619463|FG000|Overall Study|Withdrawal by Subject|6|||
25304162|NCT03996369|50619464|FG001|Overall Study|Withdrawal by Subject|8|||
25304163|NCT03996369|50619463|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
25304164|NCT03996369|50619464|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
25304165|NCT03996369|50619463|FG000|Overall Study|Lost to Follow-up|0|||
25304166|NCT03996369|50619464|FG001|Overall Study|Lost to Follow-up|1|||
25304167|NCT00808210|50619472|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
25304168|NCT00808210|50619473|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
25304169|NCT00808210|50619472|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
25304170|NCT00808210|50619473|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
25304171|NCT00808210|50619472|FG000|Double-Blind TX Period|Adverse Event|0|||
25304172|NCT00808210|50619473|FG001|Double-Blind TX Period|Adverse Event|1|||
25304173|NCT00808210|50619472|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
25304174|NCT00808210|50619473|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
25304175|NCT00808210|50619472|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
25304176|NCT00808210|50619473|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
25304177|NCT00808210|50619472|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
25304178|NCT00808210|50619473|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
25192103|NCT02585778|50356534|FG000|Overall Study|Participant did not wish to continue|9|||
25192104|NCT02585778|50356535|FG001|Overall Study|Participant did not wish to continue|4|||
25192105|NCT02585778|50356534|FG000|Overall Study|Poor compliance to study protocol|0|||
25192106|NCT02585778|50356535|FG001|Overall Study|Poor compliance to study protocol|2|||
25192107|NCT02585778|50356534|FG000|Overall Study|Death|0|||
25192108|NCT02585778|50356535|FG001|Overall Study|Death|1|||
25192109|NCT02585778|50356534|FG000|Overall Study|Randomized but not treated|1|||
25192110|NCT02585778|50356535|FG001|Overall Study|Randomized but not treated|2|||
25192111|NCT02585778|50356534|FG000|Overall Study|Other than specified above|6|||
25192112|NCT02585778|50356535|FG001|Overall Study|Other than specified above|2|||
25304179|NCT00736099|50619481|FG000|Overall Study|Adverse Event|61|||
25304180|NCT00736099|50619482|FG001|Overall Study|Adverse Event|18|||
25304181|NCT00736099|50619481|FG000|Overall Study|Protocol Violation|10|||
25304182|NCT00736099|50619482|FG001|Overall Study|Protocol Violation|4|||
25304183|NCT00736099|50619481|FG000|Overall Study|Lost to Follow-up|12|||
25304184|NCT00736099|50619482|FG001|Overall Study|Lost to Follow-up|5|||
25304185|NCT00736099|50619481|FG000|Overall Study|Withdrawal by Subject|42|||
25304186|NCT00736099|50619482|FG001|Overall Study|Withdrawal by Subject|13|||
25304187|NCT00736099|50619481|FG000|Overall Study|Lack of Efficacy|15|||
25304188|NCT00736099|50619482|FG001|Overall Study|Lack of Efficacy|8|||
25304189|NCT00736099|50619481|FG000|Overall Study|Other reason|43|||
25304190|NCT00736099|50619482|FG001|Overall Study|Other reason|10|||
25304191|NCT00735943|50619488|FG000|Overall Study|Lost to Follow-up|1|||
25304192|NCT00735943|50619488|FG000|Overall Study|Adverse Event|1|||
25304193|NCT00735709|50619496|FG000|Overall Study|Adverse Event|2|||
25304194|NCT00735709|50619497|FG001|Overall Study|Adverse Event|3|||
25304195|NCT00735709|50619498|FG002|Overall Study|Adverse Event|1|||
25304196|NCT00735709|50619499|FG003|Overall Study|Adverse Event|5|||
25304197|NCT00735709|50619496|FG000|Overall Study|Lack of Efficacy|8|||
25304198|NCT00735709|50619497|FG001|Overall Study|Lack of Efficacy|4|||
25304199|NCT00735709|50619498|FG002|Overall Study|Lack of Efficacy|2|||
25304200|NCT00735709|50619499|FG003|Overall Study|Lack of Efficacy|3|||
25304201|NCT00735709|50619496|FG000|Overall Study|Noncompliance|0|||
25304202|NCT00735709|50619497|FG001|Overall Study|Noncompliance|0|||
25304203|NCT00735709|50619498|FG002|Overall Study|Noncompliance|1|||
25304204|NCT00735709|50619499|FG003|Overall Study|Noncompliance|0|||
25304205|NCT00735709|50619496|FG000|Overall Study|Protocol deviations|1|||
25304206|NCT00735709|50619497|FG001|Overall Study|Protocol deviations|2|||
25304207|NCT00735709|50619498|FG002|Overall Study|Protocol deviations|1|||
25304208|NCT00735709|50619499|FG003|Overall Study|Protocol deviations|1|||
25304209|NCT00735709|50619496|FG000|Overall Study|Voluntary Withdrawal|1|||
25304210|NCT00735709|50619497|FG001|Overall Study|Voluntary Withdrawal|3|||
25304211|NCT00735709|50619498|FG002|Overall Study|Voluntary Withdrawal|5|||
25304212|NCT00735709|50619499|FG003|Overall Study|Voluntary Withdrawal|7|||
25304213|NCT00735709|50619496|FG000|Overall Study|Lost to Follow-up|0|||
25304214|NCT00735709|50619497|FG001|Overall Study|Lost to Follow-up|1|||
25304215|NCT00735709|50619498|FG002|Overall Study|Lost to Follow-up|1|||
25304216|NCT00735709|50619499|FG003|Overall Study|Lost to Follow-up|1|||
25304217|NCT00735709|50619496|FG000|Overall Study|Excluded medication|1|||
25304218|NCT00735709|50619497|FG001|Overall Study|Excluded medication|0|||
25304219|NCT00735709|50619498|FG002|Overall Study|Excluded medication|0|||
25304220|NCT00735709|50619499|FG003|Overall Study|Excluded medication|1|||
25304221|NCT00729157|50619509|FG000|Overall Study|Withdrawal by Subject|1|||
25304222|NCT00728689|50619515|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
25304223|NCT00728689|50619516|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
25304224|NCT00727909|50619524|FG000|Overall Study|Withdrawal by Subject|5|||
25304225|NCT00727909|50619525|FG001|Overall Study|Withdrawal by Subject|11|||
25304226|NCT00727909|50619526|FG002|Overall Study|Withdrawal by Subject|8|||
25304227|NCT00727909|50619527|FG003|Overall Study|Withdrawal by Subject|5|||
25304228|NCT00727909|50619524|FG000|Overall Study|Death|0|||
25304229|NCT00727909|50619525|FG001|Overall Study|Death|0|||
25304230|NCT00727909|50619526|FG002|Overall Study|Death|1|||
25304231|NCT00727909|50619527|FG003|Overall Study|Death|0|||
25304232|NCT00726895|50619531|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
25304233|NCT00726895|50619532|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
25304234|NCT00585325|50619541|FG000|Overall Study|Withdrawal by Subject|1|||
25304235|NCT00585325|50619542|FG001|Overall Study|Withdrawal by Subject|1|||
25304236|NCT00726661|50619550|FG000|Overall Study|Lost to Follow-up|36|||
25304237|NCT00726661|50619551|FG001|Overall Study|Lost to Follow-up|11|||
25304238|NCT00726661|50619550|FG000|Overall Study|Withdrawal by Subject|17|||
25304239|NCT00726661|50619551|FG001|Overall Study|Withdrawal by Subject|13|||
25304240|NCT00726661|50619550|FG000|Overall Study|Trial terminated by sponsor|214|||
25304241|NCT00726661|50619551|FG001|Overall Study|Trial terminated by sponsor|187|||
25304242|NCT00726661|50619550|FG000|Overall Study|Death|475|||
25304243|NCT00726661|50619551|FG001|Overall Study|Death|159|||
25304244|NCT00726661|50619550|FG000|Overall Study|Physician Decision|25|||
25304245|NCT00726661|50619551|FG001|Overall Study|Physician Decision|13|||
25304246|NCT00726661|50619550|FG000|Overall Study|Other|47|||
25304247|NCT00726661|50619551|FG001|Overall Study|Other|35|||
24969951|NCT00130832|50059428|FG001|Overall Study|Protocol Violation|8|||
25304248|NCT00741091|50619567|FG000|Overall Study|Death|13|||
25304249|NCT00741091|50619567|FG000|Overall Study|Lost to Follow-up|16|||
25304250|NCT00741091|50619567|FG000|Overall Study|Withdrawal by Subject|6|||
25304251|NCT00741091|50619567|FG000|Overall Study|Missed Visit|22|||
25304252|NCT00741013|50619574|FG000|Overall Study|Adverse Event|1|||
25304253|NCT00741013|50619575|FG001|Overall Study|Adverse Event|0|||
25304254|NCT00741013|50619576|FG002|Overall Study|Adverse Event|0|||
25304255|NCT00741013|50619574|FG000|Overall Study|Withdrawal by Subject|0|||
25304256|NCT00741013|50619575|FG001|Overall Study|Withdrawal by Subject|0|||
25304257|NCT00741013|50619576|FG002|Overall Study|Withdrawal by Subject|1|||
25304258|NCT00741013|50619574|FG000|Overall Study|Discovered failed screen after enrolled|0|||
25304259|NCT00741013|50619575|FG001|Overall Study|Discovered failed screen after enrolled|2|||
25304260|NCT00741013|50619576|FG002|Overall Study|Discovered failed screen after enrolled|0|||
25304261|NCT00740857|50619587|FG000|Overall Study|Withdrawal by Subject|1|||
25304262|NCT00740857|50619588|FG001|Overall Study|Withdrawal by Subject|0|||
25304263|NCT00740857|50619589|FG002|Overall Study|Withdrawal by Subject|0|||
25304264|NCT00808132|50619602|FG000|Overall Study|Adverse Event|34|||
25304265|NCT00808132|50619603|FG001|Overall Study|Adverse Event|33|||
25304266|NCT00808132|50619604|FG002|Overall Study|Adverse Event|16|||
25304267|NCT00808132|50619605|FG003|Overall Study|Adverse Event|31|||
25304268|NCT00808132|50619606|FG004|Overall Study|Adverse Event|33|||
25304269|NCT00808132|50619602|FG000|Overall Study|Death|0|||
25304270|NCT00808132|50619603|FG001|Overall Study|Death|0|||
25304271|NCT00808132|50619604|FG002|Overall Study|Death|0|||
25304272|NCT00808132|50619605|FG003|Overall Study|Death|0|||
25304273|NCT00808132|50619606|FG004|Overall Study|Death|1|||
25304274|NCT00808132|50619602|FG000|Overall Study|Physician Decision|0|||
25304275|NCT00808132|50619603|FG001|Overall Study|Physician Decision|1|||
25304276|NCT00808132|50619604|FG002|Overall Study|Physician Decision|0|||
25304277|NCT00808132|50619605|FG003|Overall Study|Physician Decision|0|||
25304278|NCT00808132|50619606|FG004|Overall Study|Physician Decision|0|||
25304279|NCT00808132|50619602|FG000|Overall Study|Lost to Follow-up|8|||
25304280|NCT00808132|50619603|FG001|Overall Study|Lost to Follow-up|10|||
25304281|NCT00808132|50619604|FG002|Overall Study|Lost to Follow-up|11|||
25304282|NCT00808132|50619605|FG003|Overall Study|Lost to Follow-up|8|||
25304283|NCT00808132|50619606|FG004|Overall Study|Lost to Follow-up|9|||
25304284|NCT00808132|50619602|FG000|Overall Study|Protocol Violation|8|||
25304285|NCT00808132|50619603|FG001|Overall Study|Protocol Violation|9|||
25304286|NCT00808132|50619604|FG002|Overall Study|Protocol Violation|4|||
25304287|NCT00808132|50619605|FG003|Overall Study|Protocol Violation|9|||
25304288|NCT00808132|50619606|FG004|Overall Study|Protocol Violation|5|||
25304289|NCT00808132|50619602|FG000|Overall Study|Withdrawal by Subject|27|||
25304290|NCT00808132|50619603|FG001|Overall Study|Withdrawal by Subject|18|||
25304291|NCT00808132|50619604|FG002|Overall Study|Withdrawal by Subject|2|||
25304292|NCT00808132|50619605|FG003|Overall Study|Withdrawal by Subject|7|||
25304293|NCT00808132|50619606|FG004|Overall Study|Withdrawal by Subject|16|||
25304294|NCT00808132|50619602|FG000|Overall Study|Other|6|||
24969952|NCT00130832|50059427|FG000|Overall Study|Withdrawal by Subject|6|||
25304295|NCT00808132|50619603|FG001|Overall Study|Other|4|||
25304296|NCT00808132|50619604|FG002|Overall Study|Other|6|||
25304297|NCT00808132|50619605|FG003|Overall Study|Other|2|||
25304298|NCT00808132|50619606|FG004|Overall Study|Other|15|||
25304299|NCT00808132|50619602|FG000|Overall Study|Randomized, but not treated|10|||
25304300|NCT00808132|50619603|FG001|Overall Study|Randomized, but not treated|7|||
25304301|NCT00808132|50619604|FG002|Overall Study|Randomized, but not treated|9|||
25304302|NCT00808132|50619605|FG003|Overall Study|Randomized, but not treated|8|||
25304303|NCT00808132|50619606|FG004|Overall Study|Randomized, but not treated|9|||
25304304|NCT00808132|50619602|FG000|Overall Study|Unsatisfactory response|5|||
25304305|NCT00808132|50619603|FG001|Overall Study|Unsatisfactory response|6|||
25304306|NCT00808132|50619604|FG002|Overall Study|Unsatisfactory response|6|||
25304307|NCT00808132|50619605|FG003|Overall Study|Unsatisfactory response|4|||
25304308|NCT00808132|50619606|FG004|Overall Study|Unsatisfactory response|12|||
25304309|NCT00727441|50619621|FG000|Overall Study|Disease Progression|11|||
25304310|NCT00727441|50619622|FG001|Overall Study|Disease Progression|14|||
25304311|NCT00727441|50619623|FG002|Overall Study|Disease Progression|17|||
25304312|NCT00727441|50619621|FG000|Overall Study|Eligibility|7|||
25304313|NCT00727441|50619622|FG001|Overall Study|Eligibility|5|||
25304314|NCT00727441|50619623|FG002|Overall Study|Eligibility|7|||
25304315|NCT00727441|50619621|FG000|Overall Study|Death|0|||
25304316|NCT00727441|50619622|FG001|Overall Study|Death|1|||
25304317|NCT00727441|50619623|FG002|Overall Study|Death|1|||
25304318|NCT00727441|50619621|FG000|Overall Study|Physician Decision|0|||
25304319|NCT00727441|50619622|FG001|Overall Study|Physician Decision|1|||
25304320|NCT00727441|50619623|FG002|Overall Study|Physician Decision|0|||
25304321|NCT00727441|50619621|FG000|Overall Study|Withdrawal by Subject|0|||
25304322|NCT00727441|50619622|FG001|Overall Study|Withdrawal by Subject|1|||
25304323|NCT00727441|50619623|FG002|Overall Study|Withdrawal by Subject|0|||
25304324|NCT00717769|50619637|FG000|Overall Study|Adverse Event|9|||
25304325|NCT00717769|50619638|FG001|Overall Study|Adverse Event|6|||
25304326|NCT00717769|50619639|FG002|Overall Study|Adverse Event|1|||
24969953|NCT00130832|50059428|FG001|Overall Study|Withdrawal by Subject|1|||
24969954|NCT00130832|50059427|FG000|Overall Study|Moved|2|||
24969955|NCT00130832|50059428|FG001|Overall Study|Moved|2|||
24969956|NCT00130832|50059427|FG000|Overall Study|Other|0|||
24969957|NCT00130832|50059428|FG001|Overall Study|Other|3|||
24969958|NCT00096018|50059436|FG000|Overall Study|Became Ineligible (not treated)|0|||
24969959|NCT00096018|50059437|FG001|Overall Study|Became Ineligible (not treated)|3|||
24969960|NCT00096018|50059436|FG000|Overall Study|Miscellaneous (not treated)|0|||
24969961|NCT00096018|50059437|FG001|Overall Study|Miscellaneous (not treated)|2|||
24969962|NCT00096018|50059436|FG000|Overall Study|Adverse Event|0|||
24969963|NCT00096018|50059437|FG001|Overall Study|Adverse Event|5|||
25071068|NCT01664078|50177152|FG000|Overall Study|missed 5 year visit|1|||
25304327|NCT00717769|50619637|FG000|Overall Study|Lack of compliance|0|||
25304328|NCT00717769|50619638|FG001|Overall Study|Lack of compliance|2|||
25304329|NCT00717769|50619639|FG002|Overall Study|Lack of compliance|0|||
25304330|NCT00717769|50619637|FG000|Overall Study|Lost to Follow-up|3|||
25304331|NCT00717769|50619638|FG001|Overall Study|Lost to Follow-up|4|||
25304332|NCT00717769|50619639|FG002|Overall Study|Lost to Follow-up|0|||
25304333|NCT00717769|50619637|FG000|Overall Study|Lack of Efficacy|1|||
25304334|NCT00717769|50619638|FG001|Overall Study|Lack of Efficacy|2|||
25304335|NCT00717769|50619639|FG002|Overall Study|Lack of Efficacy|0|||
25304336|NCT00717769|50619637|FG000|Overall Study|Protocol Violation|0|||
25304337|NCT00717769|50619638|FG001|Overall Study|Protocol Violation|2|||
25304338|NCT00717769|50619639|FG002|Overall Study|Protocol Violation|0|||
25304339|NCT00717769|50619637|FG000|Overall Study|Sponsor decision|1|||
25304340|NCT00717769|50619638|FG001|Overall Study|Sponsor decision|0|||
25304341|NCT00717769|50619639|FG002|Overall Study|Sponsor decision|10|||
25304342|NCT00717769|50619637|FG000|Overall Study|Withdrew consent|2|||
25304343|NCT00717769|50619638|FG001|Overall Study|Withdrew consent|2|||
25304344|NCT00717769|50619639|FG002|Overall Study|Withdrew consent|0|||
24969964|NCT00096018|50059436|FG000|Overall Study|Death|0|||
25071069|NCT01664078|50177152|FG000|Overall Study|Other|53|||
25304345|NCT04153929|50619657|FG000|Overall Study|Other than listed|2|||
25304346|NCT04153929|50619658|FG001|Overall Study|Other than listed|2|||
25304347|NCT04153929|50619659|FG002|Overall Study|Other than listed|0|||
25304348|NCT04153929|50619660|FG003|Overall Study|Other than listed|1|||
25304349|NCT04153929|50619661|FG004|Overall Study|Other than listed|0|||
25304350|NCT04153929|50619662|FG005|Overall Study|Other than listed|2|||
25304351|NCT04153929|50619663|FG006|Overall Study|Other than listed|2|||
25304352|NCT04153929|50619664|FG007|Overall Study|Other than listed|1|||
25304353|NCT04153929|50619657|FG000|Overall Study|Lost to Follow-up|2|||
25304354|NCT04153929|50619658|FG001|Overall Study|Lost to Follow-up|1|||
25304355|NCT04153929|50619659|FG002|Overall Study|Lost to Follow-up|0|||
25304356|NCT04153929|50619660|FG003|Overall Study|Lost to Follow-up|1|||
25304357|NCT04153929|50619661|FG004|Overall Study|Lost to Follow-up|1|||
25304358|NCT04153929|50619662|FG005|Overall Study|Lost to Follow-up|0|||
25304359|NCT04153929|50619663|FG006|Overall Study|Lost to Follow-up|0|||
25304360|NCT04153929|50619664|FG007|Overall Study|Lost to Follow-up|0|||
25304361|NCT04153929|50619657|FG000|Overall Study|Withdrawal by Subject|3|||
25304362|NCT04153929|50619658|FG001|Overall Study|Withdrawal by Subject|1|||
25304363|NCT04153929|50619659|FG002|Overall Study|Withdrawal by Subject|0|||
25304364|NCT04153929|50619660|FG003|Overall Study|Withdrawal by Subject|3|||
25304365|NCT04153929|50619661|FG004|Overall Study|Withdrawal by Subject|1|||
25304366|NCT04153929|50619662|FG005|Overall Study|Withdrawal by Subject|0|||
25304367|NCT04153929|50619663|FG006|Overall Study|Withdrawal by Subject|1|||
25304368|NCT04153929|50619664|FG007|Overall Study|Withdrawal by Subject|0|||
25304369|NCT04153929|50619657|FG000|Overall Study|Protocol Violation|0|||
25304370|NCT04153929|50619658|FG001|Overall Study|Protocol Violation|0|||
25304371|NCT04153929|50619659|FG002|Overall Study|Protocol Violation|0|||
25304372|NCT04153929|50619660|FG003|Overall Study|Protocol Violation|0|||
25304373|NCT04153929|50619661|FG004|Overall Study|Protocol Violation|0|||
25304374|NCT04153929|50619662|FG005|Overall Study|Protocol Violation|0|||
25304375|NCT04153929|50619663|FG006|Overall Study|Protocol Violation|1|||
25304376|NCT04153929|50619664|FG007|Overall Study|Protocol Violation|2|||
25304377|NCT04153929|50619657|FG000|Overall Study|Adverse Event|3|||
25304378|NCT04153929|50619658|FG001|Overall Study|Adverse Event|5|||
25304379|NCT04153929|50619659|FG002|Overall Study|Adverse Event|5|||
25304380|NCT04153929|50619660|FG003|Overall Study|Adverse Event|11|||
25304381|NCT04153929|50619661|FG004|Overall Study|Adverse Event|15|||
25304382|NCT04153929|50619662|FG005|Overall Study|Adverse Event|4|||
25304383|NCT04153929|50619663|FG006|Overall Study|Adverse Event|8|||
25304384|NCT04153929|50619664|FG007|Overall Study|Adverse Event|2|||
25304385|NCT04153929|50619657|FG000|Overall Study|Not treated|1|||
25304386|NCT04153929|50619658|FG001|Overall Study|Not treated|0|||
25304387|NCT04153929|50619659|FG002|Overall Study|Not treated|0|||
25304388|NCT04153929|50619660|FG003|Overall Study|Not treated|0|||
25304389|NCT04153929|50619661|FG004|Overall Study|Not treated|0|||
25304390|NCT04153929|50619662|FG005|Overall Study|Not treated|0|||
25304391|NCT04153929|50619663|FG006|Overall Study|Not treated|1|||
25304392|NCT04153929|50619664|FG007|Overall Study|Not treated|0|||
25304393|NCT00591214|50619682|FG000|Overall Study|Physician Decision|7|||
25304394|NCT00591214|50619682|FG000|Overall Study|Withdrawal by Subject|1|||
25304395|NCT00725725|50619689|FG000|Overall Study|Adverse Event|1|||
25304396|NCT00725725|50619690|FG001|Overall Study|Adverse Event|3|||
25304397|NCT00725725|50619691|FG002|Overall Study|Adverse Event|2|||
25304398|NCT00725725|50619689|FG000|Overall Study|Lost to Follow-up|2|||
25304399|NCT00725725|50619690|FG001|Overall Study|Lost to Follow-up|0|||
25304400|NCT00725725|50619691|FG002|Overall Study|Lost to Follow-up|2|||
25304401|NCT00725725|50619689|FG000|Overall Study|Withdrawal by Subject|1|||
25304402|NCT00725725|50619690|FG001|Overall Study|Withdrawal by Subject|0|||
25304403|NCT00725725|50619691|FG002|Overall Study|Withdrawal by Subject|1|||
25304404|NCT00725725|50619689|FG000|Overall Study|Protocol Violation|0|||
25304405|NCT00725725|50619690|FG001|Overall Study|Protocol Violation|1|||
25304406|NCT00725725|50619691|FG002|Overall Study|Protocol Violation|0|||
25304407|NCT00725101|50619699|FG000|Overall Study|Death|3|||
25304408|NCT00725101|50619699|FG000|Overall Study|Lost to Follow-up|353|||
25304409|NCT00725101|50619699|FG000|Overall Study|Protocol Violation|1|||
25304410|NCT00725101|50619699|FG000|Overall Study|Withdrawal by Subject|127|||
24969965|NCT00096018|50059437|FG001|Overall Study|Death|1|||
24969966|NCT00096018|50059436|FG000|Overall Study|Withdrawal by Subject|0|||
24969967|NCT00096018|50059437|FG001|Overall Study|Withdrawal by Subject|2|||
24969968|NCT00096018|50059436|FG000|Overall Study|Miscellaneous|2|||
24969969|NCT00096018|50059437|FG001|Overall Study|Miscellaneous|1|||
24969970|NCT04713748|50059443|FG000|Overall Study|Not enough kits allocated|35|||
25304411|NCT00725101|50619699|FG000|Overall Study|not specified/no reason given|11|||
25304412|NCT00585169|50619703|FG000|Overall Study|Withdrawal by Subject|1|||
25304413|NCT00807742|50619711|FG000|Overall Study|Death|9|||
25304414|NCT00807742|50619712|FG001|Overall Study|Death|2|||
25304415|NCT00807742|50619711|FG000|Overall Study|Withdrawal by Subject|2|||
25304416|NCT00807742|50619712|FG001|Overall Study|Withdrawal by Subject|1|||
25304417|NCT00807742|50619711|FG000|Overall Study|Lost to Follow-up|35|||
25304418|NCT00807742|50619712|FG001|Overall Study|Lost to Follow-up|51|||
25304419|NCT00724945|50619718|FG000|Period 1|non-compliance|1|||
25304420|NCT00724945|50619719|FG001|Period 1|non-compliance|0|||
25304421|NCT00724945|50619718|FG000|Period 1|Adverse Event|1|||
25304422|NCT00724945|50619719|FG001|Period 1|Adverse Event|1|||
25304423|NCT00724945|50619718|FG000|Period 1|Lost to Follow-up|1|||
25304424|NCT00724945|50619719|FG001|Period 1|Lost to Follow-up|0|||
25304425|NCT00724945|50619718|FG000|Period 2|lens comfort issue|3|||
25304426|NCT00724945|50619719|FG001|Period 2|lens comfort issue|0|||
25304427|NCT00724945|50619718|FG000|Period 2|lens physiology issue|1|||
25304428|NCT00724945|50619719|FG001|Period 2|lens physiology issue|0|||
25304429|NCT00803452|50619727|FG000|Overall Study|Adverse Event|0|||
25304430|NCT00803452|50619728|FG001|Overall Study|Adverse Event|2|||
25304431|NCT00803452|50619727|FG000|Overall Study|Lost to Follow-up|0|||
25304432|NCT00803452|50619728|FG001|Overall Study|Lost to Follow-up|3|||
25304433|NCT00589108|50619737|FG000|Overall Study|Lost to Follow-up|1|||
25304434|NCT00589108|50619738|FG001|Overall Study|Lost to Follow-up|1|||
25304435|NCT00589108|50619739|FG002|Overall Study|Lost to Follow-up|1|||
25304436|NCT00589108|50619737|FG000|Overall Study|Death|3|||
25304437|NCT00589108|50619738|FG001|Overall Study|Death|3|||
25304438|NCT00589108|50619739|FG002|Overall Study|Death|4|||
25304439|NCT00717067|50619752|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
25304440|NCT00717067|50619753|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
25304441|NCT00717067|50619754|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
25304442|NCT00717067|50619755|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
25304443|NCT00717067|50619756|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
25304444|NCT00802438|50619778|FG000|Overall Study|Screen Failure|20|||
25304445|NCT00802438|50619778|FG000|Overall Study|Withdrawal by Subject|7|||
25304446|NCT00802438|50619778|FG000|Overall Study|Physician Decision|1|||
25304447|NCT00588952|50619788|FG000|Overall Study|Adverse Event|0|||
25304448|NCT00588952|50619789|FG001|Overall Study|Adverse Event|2|||
25304449|NCT00588952|50619788|FG000|Overall Study|Withdrawal by Subject|3|||
25304450|NCT00588952|50619789|FG001|Overall Study|Withdrawal by Subject|5|||
25304451|NCT01021748|50619804|FG000|Overall Study|Adverse Event|2|||
25304452|NCT01021748|50619805|FG001|Overall Study|Adverse Event|1|||
25304453|NCT01021748|50619806|FG002|Overall Study|Adverse Event|2|||
25304454|NCT01021748|50619807|FG003|Overall Study|Adverse Event|0|||
25304455|NCT01021748|50619808|FG004|Overall Study|Adverse Event|2|||
25304456|NCT01021748|50619809|FG005|Overall Study|Adverse Event|0|||
25304457|NCT01021748|50619810|FG006|Overall Study|Adverse Event|1|||
25304458|NCT01021748|50619811|FG007|Overall Study|Adverse Event|0|||
25304459|NCT01021748|50619812|FG008|Overall Study|Adverse Event|7|||
25304460|NCT01021748|50619804|FG000|Overall Study|Physician Decision|1|||
25304461|NCT01021748|50619805|FG001|Overall Study|Physician Decision|0|||
25304462|NCT01021748|50619806|FG002|Overall Study|Physician Decision|1|||
25304463|NCT01021748|50619807|FG003|Overall Study|Physician Decision|1|||
25304464|NCT01021748|50619808|FG004|Overall Study|Physician Decision|0|||
25304465|NCT01021748|50619809|FG005|Overall Study|Physician Decision|0|||
25304466|NCT01021748|50619810|FG006|Overall Study|Physician Decision|1|||
25304467|NCT01021748|50619811|FG007|Overall Study|Physician Decision|1|||
25304468|NCT01021748|50619812|FG008|Overall Study|Physician Decision|2|||
25304469|NCT01021748|50619804|FG000|Overall Study|Progressive Disease|3|||
25304470|NCT01021748|50619805|FG001|Overall Study|Progressive Disease|3|||
25304471|NCT01021748|50619806|FG002|Overall Study|Progressive Disease|4|||
25304472|NCT01021748|50619807|FG003|Overall Study|Progressive Disease|6|||
25304473|NCT01021748|50619808|FG004|Overall Study|Progressive Disease|7|||
25304474|NCT01021748|50619809|FG005|Overall Study|Progressive Disease|3|||
25304475|NCT01021748|50619810|FG006|Overall Study|Progressive Disease|0|||
25304476|NCT01021748|50619811|FG007|Overall Study|Progressive Disease|5|||
25304477|NCT01021748|50619812|FG008|Overall Study|Progressive Disease|6|||
25304478|NCT01021748|50619804|FG000|Overall Study|Withdrawal by Subject|0|||
25304479|NCT01021748|50619805|FG001|Overall Study|Withdrawal by Subject|0|||
25304480|NCT01021748|50619806|FG002|Overall Study|Withdrawal by Subject|0|||
25304481|NCT01021748|50619807|FG003|Overall Study|Withdrawal by Subject|0|||
25304482|NCT01021748|50619808|FG004|Overall Study|Withdrawal by Subject|0|||
25304483|NCT01021748|50619809|FG005|Overall Study|Withdrawal by Subject|0|||
25304484|NCT01021748|50619810|FG006|Overall Study|Withdrawal by Subject|1|||
25304485|NCT01021748|50619811|FG007|Overall Study|Withdrawal by Subject|0|||
25304486|NCT01021748|50619812|FG008|Overall Study|Withdrawal by Subject|1|||
25304487|NCT01021748|50619804|FG000|Overall Study|Not Treated|0|||
25304488|NCT01021748|50619805|FG001|Overall Study|Not Treated|1|||
25304489|NCT01021748|50619806|FG002|Overall Study|Not Treated|0|||
25304490|NCT01021748|50619807|FG003|Overall Study|Not Treated|0|||
25304491|NCT01021748|50619808|FG004|Overall Study|Not Treated|0|||
25304492|NCT01021748|50619809|FG005|Overall Study|Not Treated|0|||
25304493|NCT01021748|50619810|FG006|Overall Study|Not Treated|0|||
25304494|NCT01021748|50619811|FG007|Overall Study|Not Treated|0|||
25304495|NCT01021748|50619812|FG008|Overall Study|Not Treated|0|||
25304496|NCT00802360|50619836|FG000|Overall Study|Stimulation failure|4|||
25304497|NCT00802360|50619837|FG001|Overall Study|Stimulation failure|0|||
25304498|NCT00802360|50619838|FG002|Overall Study|Stimulation failure|3|||
25304499|NCT00802360|50619839|FG003|Overall Study|Stimulation failure|3|||
25304500|NCT00802360|50619836|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
25304501|NCT00802360|50619837|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
25304502|NCT00802360|50619838|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
25304503|NCT00802360|50619839|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
25304504|NCT00802360|50619836|FG000|Overall Study|Cycle cancelled|0|||
25304505|NCT00802360|50619837|FG001|Overall Study|Cycle cancelled|1|||
25304506|NCT00802360|50619838|FG002|Overall Study|Cycle cancelled|1|||
25304507|NCT00802360|50619839|FG003|Overall Study|Cycle cancelled|1|||
25304508|NCT00802360|50619836|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
24969971|NCT04702984|50059447|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
25304509|NCT00802360|50619837|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
25304510|NCT00802360|50619838|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
25304511|NCT00802360|50619839|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
25304512|NCT00802360|50619836|FG000|Overall Study|No positive serum pregnancy|17|||
25304513|NCT00802360|50619837|FG001|Overall Study|No positive serum pregnancy|20|||
25304514|NCT00802360|50619838|FG002|Overall Study|No positive serum pregnancy|14|||
25304515|NCT00802360|50619839|FG003|Overall Study|No positive serum pregnancy|10|||
25304516|NCT00802360|50619836|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
25304517|NCT00802360|50619837|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
24969972|NCT04701658|50059453|FG000|Overall Study|Lost to Follow-up|6|||
24969973|NCT00128102|50059459|FG000|Overall Study|Site Discontinued|3|||
24969974|NCT00128102|50059460|FG001|Overall Study|Site Discontinued|6|||
25304518|NCT00802360|50619838|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
25304519|NCT00802360|50619839|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
25304520|NCT00802360|50619836|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
25304521|NCT00802360|50619837|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
25304522|NCT00802360|50619838|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
25304523|NCT00802360|50619839|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
25304524|NCT00802360|50619836|FG000|Overall Study|Other|2|||
25304525|NCT00802360|50619837|FG001|Overall Study|Other|3|||
25304526|NCT00802360|50619838|FG002|Overall Study|Other|6|||
25304527|NCT00802360|50619839|FG003|Overall Study|Other|3|||
25304528|NCT01026038|50619854|FG000|Overall Study|Lost to Follow-up|1|||
25304529|NCT01026038|50619855|FG001|Overall Study|Lost to Follow-up|1|||
25304530|NCT01026038|50619856|FG002|Overall Study|Lost to Follow-up|0|||
25304531|NCT00801892|50619875|FG000|Main Study Period|Withdrawal by Subject|0|||
25304532|NCT00801892|50619876|FG001|Main Study Period|Withdrawal by Subject|1|||
25304533|NCT00801892|50619875|FG000|Sham Crossover Period|Lost to Follow-up|0|||
25304534|NCT00801892|50619876|FG001|Sham Crossover Period|Lost to Follow-up|2|||
25304535|NCT02680587|50619890|FG000|Overall Study|Withdrawal by Subject|1|||
25304536|NCT02680587|50619891|FG001|Overall Study|Withdrawal by Subject|0|||
25304537|NCT00589420|50619901|FG000|Overall Study|screen failure|1|||
25304538|NCT01025336|50619910|FG000|Overall Study|Protocol Violation|0|||
25304539|NCT01025336|50619911|FG001|Overall Study|Protocol Violation|0|||
25304540|NCT01025336|50619912|FG002|Overall Study|Protocol Violation|0|||
25304541|NCT01025336|50619913|FG003|Overall Study|Protocol Violation|2|||
25304542|NCT01025336|50619914|FG004|Overall Study|Protocol Violation|0|||
25304543|NCT00796978|50619948|FG000|Overall Study|Cardiac adverse event|5|||
25304544|NCT00796978|50619948|FG000|Overall Study|Adverse Event|4|||
25304545|NCT00796978|50619948|FG000|Overall Study|Withdrawal by Subject|3|||
25304546|NCT00796822|50619954|FG000|Overall Study|Lost to Follow-up|2|||
25304547|NCT00796822|50619955|FG001|Overall Study|Lost to Follow-up|0|||
25304548|NCT00796822|50619954|FG000|Overall Study|Adverse Event|1|||
25304549|NCT00796822|50619955|FG001|Overall Study|Adverse Event|0|||
25304550|NCT01020812|50619961|FG000|Overall Study|Physician Decision|1|||
25304551|NCT01020812|50619961|FG000|Overall Study|Withdrawal by Subject|1|||
25304552|NCT01020812|50619961|FG000|Overall Study|Protocol Violation|1|||
25304553|NCT01032044|50619967|FG000|Overall Study|Protocol Violation|14|||
25304554|NCT01032044|50619968|FG001|Overall Study|Protocol Violation|8|||
25304555|NCT01032044|50619967|FG000|Overall Study|Adverse Event|0|||
25304556|NCT01032044|50619968|FG001|Overall Study|Adverse Event|1|||
25304557|NCT01032044|50619967|FG000|Overall Study|Lost to Follow-up|11|||
25304558|NCT01032044|50619968|FG001|Overall Study|Lost to Follow-up|11|||
25304559|NCT01024946|50619974|FG000|Overall Study|Screen Failure|3|||
25304560|NCT01024946|50619974|FG000|Overall Study|Withdrawal by Subject|1|||
25304561|NCT01024946|50619974|FG000|Overall Study|Adverse Event|1|||
25304562|NCT00724867|50619978|FG000|Overall Study|Adverse Event|25|||
25304563|NCT00724867|50619978|FG000|Overall Study|Lack of Efficacy|14|||
25304564|NCT00724867|50619978|FG000|Overall Study|Lost to Follow-up|12|||
25304565|NCT00724867|50619978|FG000|Overall Study|Non-compliance with study drug|6|||
24969975|NCT00128102|50059459|FG000|Overall Study|Other|0|||
24969976|NCT00128102|50059460|FG001|Overall Study|Other|1|||
25304566|NCT00724867|50619978|FG000|Overall Study|Physician Decision|17|||
25304567|NCT00724867|50619978|FG000|Overall Study|Protocol Violation|1|||
25304568|NCT00724867|50619978|FG000|Overall Study|Withdrawal by Subject|31|||
25304569|NCT00724867|50619978|FG000|Overall Study|Sponsor decision to end study|14|||
25304570|NCT00724867|50619978|FG000|Overall Study|Subject incarcerated|1|||
25304571|NCT00724867|50619978|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
25304572|NCT00724867|50619978|FG000|Overall Study|Subject moved out of state|1|||
25304573|NCT00724867|50619978|FG000|Overall Study|Elected to exit due to site closure|2|||
25304574|NCT00724711|50619987|FG000|Overall Study|Adverse Event|7|||
25304575|NCT00724711|50619988|FG001|Overall Study|Adverse Event|3|||
25304576|NCT00724711|50619987|FG000|Overall Study|Pregnancy|0|||
25304577|NCT00724711|50619988|FG001|Overall Study|Pregnancy|1|||
25304578|NCT00724711|50619987|FG000|Overall Study|Lack of Efficacy|0|||
25304579|NCT00724711|50619988|FG001|Overall Study|Lack of Efficacy|1|||
25304580|NCT00724711|50619987|FG000|Overall Study|Physician Decision|0|||
25304581|NCT00724711|50619988|FG001|Overall Study|Physician Decision|3|||
25304582|NCT00724711|50619987|FG000|Overall Study|Withdrawal by Subject|5|||
25304583|NCT00724711|50619988|FG001|Overall Study|Withdrawal by Subject|4|||
25304584|NCT00724711|50619987|FG000|Overall Study|Lost to Follow-up|4|||
25304585|NCT00724711|50619988|FG001|Overall Study|Lost to Follow-up|5|||
25304586|NCT00724711|50619987|FG000|Overall Study|Protocol Violation|1|||
25304587|NCT00724711|50619988|FG001|Overall Study|Protocol Violation|0|||
25304588|NCT01024244|50619999|FG000|Overall Study|Adverse Event|1|||
25304589|NCT01024244|50620000|FG001|Overall Study|Adverse Event|2|||
25304590|NCT01024244|50620001|FG002|Overall Study|Adverse Event|0|||
25304591|NCT01024244|50620002|FG003|Overall Study|Adverse Event|1|||
25304592|NCT01024244|50620003|FG004|Overall Study|Adverse Event|2|||
25304593|NCT01024244|50619999|FG000|Overall Study|Entry Criteria Not Met|0|||
25304594|NCT01024244|50620000|FG001|Overall Study|Entry Criteria Not Met|1|||
25304595|NCT01024244|50620001|FG002|Overall Study|Entry Criteria Not Met|0|||
25304596|NCT01024244|50620002|FG003|Overall Study|Entry Criteria Not Met|0|||
25304597|NCT01024244|50620003|FG004|Overall Study|Entry Criteria Not Met|0|||
25304598|NCT01024244|50619999|FG000|Overall Study|Lack of Efficacy|1|||
25304599|NCT01024244|50620000|FG001|Overall Study|Lack of Efficacy|0|||
25304600|NCT01024244|50620001|FG002|Overall Study|Lack of Efficacy|0|||
25304601|NCT01024244|50620002|FG003|Overall Study|Lack of Efficacy|0|||
25304602|NCT01024244|50620003|FG004|Overall Study|Lack of Efficacy|0|||
25304603|NCT01024244|50619999|FG000|Overall Study|Protocol Violation|1|||
25304604|NCT01024244|50620000|FG001|Overall Study|Protocol Violation|0|||
25304605|NCT01024244|50620001|FG002|Overall Study|Protocol Violation|0|||
25304606|NCT01024244|50620002|FG003|Overall Study|Protocol Violation|0|||
25304607|NCT01024244|50620003|FG004|Overall Study|Protocol Violation|2|||
25304608|NCT01024244|50619999|FG000|Overall Study|Sponsor Decision|14|||
25304609|NCT01024244|50620000|FG001|Overall Study|Sponsor Decision|7|||
25304610|NCT01024244|50620001|FG002|Overall Study|Sponsor Decision|14|||
25304611|NCT01024244|50620002|FG003|Overall Study|Sponsor Decision|12|||
25304612|NCT01024244|50620003|FG004|Overall Study|Sponsor Decision|10|||
25304613|NCT01024244|50619999|FG000|Overall Study|Withdrawal by Subject|0|||
25304614|NCT01024244|50620000|FG001|Overall Study|Withdrawal by Subject|1|||
25304615|NCT01024244|50620001|FG002|Overall Study|Withdrawal by Subject|0|||
25304616|NCT01024244|50620002|FG003|Overall Study|Withdrawal by Subject|0|||
25304617|NCT01024244|50620003|FG004|Overall Study|Withdrawal by Subject|0|||
25304618|NCT00721279|50620017|FG000|Overall Study|Lack of Efficacy|6|||
25304619|NCT00721279|50620018|FG001|Overall Study|Lack of Efficacy|3|||
25304620|NCT00721279|50620017|FG000|Overall Study|Tolerability insufficient|5|||
25304621|NCT00721279|50620018|FG001|Overall Study|Tolerability insufficient|2|||
25304622|NCT00721279|50620017|FG000|Overall Study|Withdrawal by Subject|13|||
25304623|NCT00721279|50620018|FG001|Overall Study|Withdrawal by Subject|3|||
25304624|NCT00721279|50620017|FG000|Overall Study|Other|12|||
25304625|NCT00721279|50620018|FG001|Overall Study|Other|16|||
24969977|NCT00128102|50059459|FG000|Overall Study|Progressive Disease|255|||
25304626|NCT01030952|50620027|FG000|Overall Study|Protocol Violation|0|||
25304627|NCT01030952|50620028|FG001|Overall Study|Protocol Violation|1|||
25304628|NCT01030952|50620027|FG000|Overall Study|Informed consent withdrawal|1|||
25304629|NCT01030952|50620028|FG001|Overall Study|Informed consent withdrawal|0|||
25304630|NCT01030952|50620027|FG000|Overall Study|Lost to Follow-up|0|||
25304631|NCT01030952|50620028|FG001|Overall Study|Lost to Follow-up|1|||
25304632|NCT01030952|50620027|FG000|Overall Study|Unexplained|1|||
25304633|NCT01030952|50620028|FG001|Overall Study|Unexplained|1|||
25304634|NCT01030874|50620038|FG000|Overall Study|Withdrawal by Subject|1|||
25304635|NCT01030874|50620039|FG001|Overall Study|Withdrawal by Subject|0|||
25304636|NCT01030874|50620038|FG000|Overall Study|Discharged in first 2 weeks|17|||
25304637|NCT01030874|50620039|FG001|Overall Study|Discharged in first 2 weeks|16|||
25304638|NCT03611751|50620048|FG000|Pre-treatment|Randomized but not treated|1|||
25304639|NCT03611751|50620049|FG001|Pre-treatment|Randomized but not treated|1|||
25304640|NCT03611751|50620050|FG002|Pre-treatment|Randomized but not treated|0|||
25304641|NCT03611751|50620048|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
25304642|NCT03611751|50620049|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
25304643|NCT03611751|50620050|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
25304644|NCT03611751|50620048|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
25304645|NCT03611751|50620049|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
25304646|NCT03611751|50620050|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
25304647|NCT03611751|50620048|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
25304648|NCT03611751|50620049|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
25304649|NCT03611751|50620050|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
25304650|NCT03611751|50620048|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
25304651|NCT03611751|50620049|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
25304652|NCT03611751|50620050|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
25304653|NCT03611751|50620048|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
25304654|NCT03611751|50620049|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
25304655|NCT03611751|50620050|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
25304656|NCT03611751|50620048|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
25304657|NCT03611751|50620049|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
25304658|NCT03611751|50620050|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
25304659|NCT03611751|50620048|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
25304660|NCT03611751|50620049|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
25304661|NCT03611751|50620050|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
25304662|NCT03611751|50620048|FG000|Treatment Week 0 - Week 16|Death|0|||
25304663|NCT03611751|50620049|FG001|Treatment Week 0 - Week 16|Death|0|||
25304664|NCT03611751|50620050|FG002|Treatment Week 0 - Week 16|Death|1|||
25304665|NCT03611751|50620048|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
25304666|NCT03611751|50620049|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
25304667|NCT03611751|50620050|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
25304668|NCT03611751|50620048|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
25304669|NCT03611751|50620049|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
25304670|NCT03611751|50620050|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
25304671|NCT03611751|50620048|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
25304672|NCT03611751|50620049|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
25304673|NCT03611751|50620050|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
25304674|NCT03611751|50620048|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
25304675|NCT03611751|50620049|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
25304676|NCT03611751|50620050|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
25304677|NCT03611751|50620048|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
25304678|NCT03611751|50620049|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
25304679|NCT03611751|50620050|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
25304680|NCT03611751|50620048|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
25304681|NCT03611751|50620049|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
25304682|NCT03611751|50620050|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
25304683|NCT03611751|50620048|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
25304684|NCT03611751|50620049|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
25304685|NCT03611751|50620050|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
25304686|NCT03611751|50620048|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
25304687|NCT03611751|50620049|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
25304688|NCT03611751|50620050|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
25304689|NCT03611751|50620048|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
25304690|NCT03611751|50620049|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
25304691|NCT03611751|50620050|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
25304692|NCT03611751|50620048|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
25304693|NCT03611751|50620049|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
25304694|NCT03611751|50620050|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
25304695|NCT03611751|50620048|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
25304696|NCT03611751|50620049|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
25304697|NCT03611751|50620050|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
25304698|NCT03611751|50620048|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
25304699|NCT03611751|50620049|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
25304700|NCT03611751|50620050|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
25304701|NCT03611751|50620048|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
25304702|NCT03611751|50620049|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
25304703|NCT03611751|50620050|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
25304704|NCT03611751|50620048|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
25304705|NCT03611751|50620049|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
25304706|NCT03611751|50620050|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
25304707|NCT00721123|50620067|FG000|Overall Study|Adverse Event|96|||
25304708|NCT00721123|50620067|FG000|Overall Study|Death|10|||
25304709|NCT00721123|50620067|FG000|Overall Study|Insufficient Therapeutic Response|21|||
25304710|NCT00721123|50620067|FG000|Overall Study|Protocol Violation|1|||
25304711|NCT00721123|50620067|FG000|Overall Study|Refused Treatment|41|||
25304712|NCT00721123|50620067|FG000|Overall Study|Failure to Return|9|||
25304713|NCT00721123|50620067|FG000|Overall Study|Withdrawal by Subject|5|||
25304714|NCT00720499|50620087|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
25304715|NCT00720499|50620088|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
25304716|NCT00720499|50620087|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
25304717|NCT00720499|50620088|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
25304718|NCT00720499|50620087|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
25304719|NCT00720499|50620088|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
25304720|NCT00724243|50620095|FG000|Overall Study|Lack of Efficacy|10|||
25304721|NCT00724243|50620095|FG000|Overall Study|Adverse Event|5|||
25304722|NCT00720343|50620099|FG000|Overall Study|Physician Decision|3|||
25304723|NCT00720343|50620099|FG000|Overall Study|No data|3|||
25304724|NCT00720109|50620105|FG000|Induction Period|Did not meet eligibility criteria|3|||
25304725|NCT00720109|50620106|FG001|Induction Period|Did not meet eligibility criteria|0|||
25304726|NCT00720109|50620107|FG002|Induction Period|Did not meet eligibility criteria|0|||
25304727|NCT00720109|50620105|FG000|Induction Period|Bone Marrow Transplant|2|||
25304728|NCT00720109|50620106|FG001|Induction Period|Bone Marrow Transplant|0|||
25304729|NCT00720109|50620107|FG002|Induction Period|Bone Marrow Transplant|0|||
25304730|NCT00720109|50620105|FG000|Induction Period|Physician Decision|1|||
25304731|NCT00720109|50620106|FG001|Induction Period|Physician Decision|0|||
25304732|NCT00720109|50620107|FG002|Induction Period|Physician Decision|0|||
25304733|NCT00720109|50620105|FG000|Risk Stratification Period|Adverse Event|0|||
25071070|NCT03367403|50177205|FG000|Overall Study|Adverse Event|20|||
25304734|NCT00720109|50620106|FG001|Risk Stratification Period|Adverse Event|1|||
25304735|NCT00720109|50620107|FG002|Risk Stratification Period|Adverse Event|0|||
25304736|NCT00720109|50620105|FG000|Risk Stratification Period|Physician Decision|0|||
25304737|NCT00720109|50620106|FG001|Risk Stratification Period|Physician Decision|2|||
25304738|NCT00720109|50620107|FG002|Risk Stratification Period|Physician Decision|1|||
25304739|NCT00720109|50620105|FG000|Risk Stratification Period|Bone marrow transplant|0|||
25304740|NCT00720109|50620106|FG001|Risk Stratification Period|Bone marrow transplant|9|||
25304741|NCT00720109|50620107|FG002|Risk Stratification Period|Bone marrow transplant|7|||
25304742|NCT00720109|50620105|FG000|Risk Stratification Period|Disease progression or relapse|0|||
25304743|NCT00720109|50620106|FG001|Risk Stratification Period|Disease progression or relapse|2|||
25304744|NCT00720109|50620107|FG002|Risk Stratification Period|Disease progression or relapse|0|||
25304745|NCT00720109|50620105|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
25304746|NCT00720109|50620106|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
25304747|NCT00720109|50620107|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
25304748|NCT01705977|50620118|FG000|Overall Study|Withdrawal by Subject|128|||
25304749|NCT01705977|50620119|FG001|Overall Study|Withdrawal by Subject|128|||
25304750|NCT01705977|50620118|FG000|Overall Study|Adverse Event|57|||
25304751|NCT01705977|50620119|FG001|Overall Study|Adverse Event|49|||
25304752|NCT01705977|50620118|FG000|Overall Study|Protocol Violation|2|||
25304753|NCT01705977|50620119|FG001|Overall Study|Protocol Violation|4|||
25304754|NCT01705977|50620118|FG000|Overall Study|Site closure|3|||
25304755|NCT01705977|50620119|FG001|Overall Study|Site closure|2|||
25304756|NCT01705977|50620118|FG000|Overall Study|Lost to Follow-up|33|||
25304757|NCT01705977|50620119|FG001|Overall Study|Lost to Follow-up|37|||
25304758|NCT01705977|50620118|FG000|Overall Study|Physician Decision|48|||
25304759|NCT01705977|50620119|FG001|Overall Study|Physician Decision|38|||
25304760|NCT01705977|50620118|FG000|Overall Study|Missing study conclusion form|2|||
25304761|NCT01705977|50620119|FG001|Overall Study|Missing study conclusion form|2|||
25304762|NCT01015118|50620127|FG000|Overall Study|Protocol Violation|5|||
25304763|NCT01015118|50620128|FG001|Overall Study|Protocol Violation|6|||
25304764|NCT01015118|50620127|FG000|Overall Study|Withdrawal by Subject|103|||
25304765|NCT01015118|50620128|FG001|Overall Study|Withdrawal by Subject|27|||
25304766|NCT01015118|50620127|FG000|Overall Study|Other Adverse Event (AE)|141|||
25304767|NCT01015118|50620128|FG001|Overall Study|Other Adverse Event (AE)|33|||
25304768|NCT01015118|50620127|FG000|Overall Study|Worsening or AE of underlying disease|5|||
25304769|NCT01015118|50620128|FG001|Overall Study|Worsening or AE of underlying disease|4|||
25304770|NCT01015118|50620127|FG000|Overall Study|Progressive disease|364|||
25304771|NCT01015118|50620128|FG001|Overall Study|Progressive disease|229|||
25304772|NCT01015118|50620127|FG000|Overall Study|Not treated|9|||
25304773|NCT01015118|50620128|FG001|Overall Study|Not treated|5|||
25304774|NCT01015118|50620127|FG000|Overall Study|Other than stated above|42|||
25304775|NCT01015118|50620128|FG001|Overall Study|Other than stated above|23|||
25304776|NCT00800176|50620140|FG000|Overall Study|Adverse Event|2|||
25304777|NCT00800176|50620141|FG001|Overall Study|Adverse Event|1|||
25304778|NCT00800176|50620142|FG002|Overall Study|Adverse Event|0|||
25304779|NCT00800176|50620143|FG003|Overall Study|Adverse Event|2|||
25304780|NCT00800176|50620144|FG004|Overall Study|Adverse Event|1|||
25304781|NCT00800176|50620145|FG005|Overall Study|Adverse Event|1|||
25304782|NCT00800176|50620140|FG000|Overall Study|Refused treatment|3|||
25304783|NCT00800176|50620141|FG001|Overall Study|Refused treatment|2|||
25304784|NCT00800176|50620142|FG002|Overall Study|Refused treatment|0|||
25304785|NCT00800176|50620143|FG003|Overall Study|Refused treatment|0|||
25071071|NCT03367403|50177206|FG001|Overall Study|Adverse Event|6|||
25071072|NCT03367403|50177207|FG002|Overall Study|Adverse Event|2|||
25071073|NCT03367403|50177205|FG000|Overall Study|Withdrawal by Subject|12|||
25071074|NCT03367403|50177206|FG001|Overall Study|Withdrawal by Subject|13|||
25071075|NCT03367403|50177207|FG002|Overall Study|Withdrawal by Subject|1|||
25071076|NCT03367403|50177205|FG000|Overall Study|Death|1|||
25071077|NCT03367403|50177206|FG001|Overall Study|Death|2|||
25071078|NCT03367403|50177207|FG002|Overall Study|Death|0|||
25071079|NCT03367403|50177205|FG000|Overall Study|Physician Decision|0|||
25071080|NCT03367403|50177206|FG001|Overall Study|Physician Decision|1|||
25071081|NCT03367403|50177207|FG002|Overall Study|Physician Decision|0|||
25071082|NCT03367403|50177205|FG000|Overall Study|Protocol Violation|1|||
25071083|NCT03367403|50177206|FG001|Overall Study|Protocol Violation|1|||
25071084|NCT03367403|50177207|FG002|Overall Study|Protocol Violation|0|||
25071085|NCT03367403|50177205|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
25071086|NCT03367403|50177206|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
25071087|NCT03367403|50177207|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
25071088|NCT03367403|50177205|FG000|Overall Study|COVID-19|3|||
25071089|NCT03367403|50177206|FG001|Overall Study|COVID-19|6|||
25071090|NCT03367403|50177207|FG002|Overall Study|COVID-19|0|||
25071091|NCT03367403|50177205|FG000|Overall Study|Abuse of Alcohol Intake|0|||
25071092|NCT03367403|50177206|FG001|Overall Study|Abuse of Alcohol Intake|1|||
25192113|NCT01438424|50356558|FG000|Overall Study|Continuing treatment|29|||
25304786|NCT00800176|50620144|FG004|Overall Study|Refused treatment|1|||
25071093|NCT03367403|50177207|FG002|Overall Study|Abuse of Alcohol Intake|0|||
25192114|NCT01438424|50356558|FG000|Overall Study|Minimal virologic response|95|||
25304787|NCT00800176|50620145|FG005|Overall Study|Refused treatment|4|||
25169400|NCT01838681|50301148|FG003|Period A|Protocol Violation|0|||
25169401|NCT01838681|50301145|FG000|Period A|Non-compliance with IMP|6|||
25169402|NCT01838681|50301146|FG001|Period A|Non-compliance with IMP|0|||
25169403|NCT01838681|50301147|FG002|Period A|Non-compliance with IMP|0|||
25169404|NCT01838681|50301148|FG003|Period A|Non-compliance with IMP|0|||
25169405|NCT01838681|50301145|FG000|Period A|Lost to Follow-up|4|||
25169406|NCT01838681|50301146|FG001|Period A|Lost to Follow-up|0|||
25169407|NCT01838681|50301147|FG002|Period A|Lost to Follow-up|0|||
25169408|NCT01838681|50301148|FG003|Period A|Lost to Follow-up|0|||
25169409|NCT01838681|50301145|FG000|Period A|Withdrawal before treatment|4|||
25169410|NCT01838681|50301146|FG001|Period A|Withdrawal before treatment|0|||
25169411|NCT01838681|50301147|FG002|Period A|Withdrawal before treatment|0|||
25169412|NCT01838681|50301148|FG003|Period A|Withdrawal before treatment|0|||
25169413|NCT01838681|50301145|FG000|Period A|Administrative or other reasons|17|||
25169414|NCT01838681|50301146|FG001|Period A|Administrative or other reasons|0|||
25169415|NCT01838681|50301147|FG002|Period A|Administrative or other reasons|0|||
25169416|NCT01838681|50301148|FG003|Period A|Administrative or other reasons|0|||
25169417|NCT01838681|50301145|FG000|Period B/A+|Adverse Event|0|||
25169418|NCT01838681|50301146|FG001|Period B/A+|Adverse Event|13|||
25169419|NCT01838681|50301147|FG002|Period B/A+|Adverse Event|27|||
25169420|NCT01838681|50301148|FG003|Period B/A+|Adverse Event|16|||
25169421|NCT01838681|50301145|FG000|Period B/A+|Lack of Efficacy|0|||
25169422|NCT01838681|50301146|FG001|Period B/A+|Lack of Efficacy|9|||
25169423|NCT01838681|50301147|FG002|Period B/A+|Lack of Efficacy|11|||
25169424|NCT01838681|50301148|FG003|Period B/A+|Lack of Efficacy|6|||
25169425|NCT01838681|50301145|FG000|Period B/A+|Withdrawal by Subject|0|||
25169426|NCT01838681|50301146|FG001|Period B/A+|Withdrawal by Subject|28|||
25169427|NCT01838681|50301147|FG002|Period B/A+|Withdrawal by Subject|35|||
25169428|NCT01838681|50301148|FG003|Period B/A+|Withdrawal by Subject|47|||
25169429|NCT01838681|50301145|FG000|Period B/A+|Protocol Violation|0|||
25169430|NCT01838681|50301146|FG001|Period B/A+|Protocol Violation|1|||
25169431|NCT01838681|50301147|FG002|Period B/A+|Protocol Violation|4|||
25169432|NCT01838681|50301148|FG003|Period B/A+|Protocol Violation|6|||
25169433|NCT01838681|50301145|FG000|Period B/A+|Non-compliance with IMP|0|||
25169434|NCT01838681|50301146|FG001|Period B/A+|Non-compliance with IMP|2|||
25169435|NCT01838681|50301147|FG002|Period B/A+|Non-compliance with IMP|3|||
25169436|NCT01838681|50301148|FG003|Period B/A+|Non-compliance with IMP|3|||
24969978|NCT00128102|50059460|FG001|Overall Study|Progressive Disease|285|||
25169437|NCT01838681|50301145|FG000|Period B/A+|Lost to Follow-up|0|||
25169438|NCT01838681|50301146|FG001|Period B/A+|Lost to Follow-up|2|||
25169439|NCT01838681|50301147|FG002|Period B/A+|Lost to Follow-up|5|||
25169440|NCT01838681|50301148|FG003|Period B/A+|Lost to Follow-up|11|||
25169441|NCT01838681|50301145|FG000|Period B/A+|Withdrawal before treatment|0|||
25169442|NCT01838681|50301146|FG001|Period B/A+|Withdrawal before treatment|1|||
25169443|NCT01838681|50301147|FG002|Period B/A+|Withdrawal before treatment|0|||
25304788|NCT00800176|50620140|FG000|Overall Study|Failure to return|3|||
25304789|NCT00800176|50620141|FG001|Overall Study|Failure to return|3|||
25304790|NCT00800176|50620142|FG002|Overall Study|Failure to return|0|||
25304791|NCT00800176|50620143|FG003|Overall Study|Failure to return|2|||
25304792|NCT00800176|50620144|FG004|Overall Study|Failure to return|0|||
25304793|NCT00800176|50620145|FG005|Overall Study|Failure to return|0|||
25304794|NCT00800176|50620140|FG000|Overall Study|Other|1|||
25304795|NCT00800176|50620141|FG001|Overall Study|Other|0|||
25304796|NCT00800176|50620142|FG002|Overall Study|Other|0|||
25304797|NCT00800176|50620143|FG003|Overall Study|Other|0|||
25304798|NCT00800176|50620144|FG004|Overall Study|Other|2|||
25304799|NCT00800176|50620145|FG005|Overall Study|Other|0|||
25304800|NCT00715429|50620161|FG000|Overall Study|Did not complete the study diary|0|||
25304801|NCT00715429|50620162|FG001|Overall Study|Did not complete the study diary|1|||
25304802|NCT00715117|50620184|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
25304803|NCT00715117|50620185|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
25304804|NCT00723229|50620198|FG000|First Intervention|Lost to Follow-up|7|||
25304805|NCT00723229|50620199|FG001|First Intervention|Lost to Follow-up|3|||
25304806|NCT01030718|50620214|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
25304807|NCT01030718|50620215|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
25304808|NCT01030718|50620216|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
25304809|NCT01030718|50620214|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
25304810|NCT01030718|50620215|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
25304811|NCT01030718|50620216|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
25304812|NCT01030718|50620214|FG000|Studies CA180-031 and -036 Combined|Death|0|||
25304813|NCT01030718|50620215|FG001|Studies CA180-031 and -036 Combined|Death|1|||
25304814|NCT01030718|50620216|FG002|Studies CA180-031 and -036 Combined|Death|0|||
25304815|NCT01030718|50620214|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
25304816|NCT01030718|50620215|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
25304817|NCT01030718|50620216|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
25304818|NCT01030718|50620214|FG000|Study CA180-036 Only|insufficient effect|1|||
25304819|NCT01030718|50620215|FG001|Study CA180-036 Only|insufficient effect|1|||
25304820|NCT01030718|50620216|FG002|Study CA180-036 Only|insufficient effect|5|||
25304821|NCT01030718|50620214|FG000|Study CA180-036 Only|Adverse Event|2|||
25304822|NCT01030718|50620215|FG001|Study CA180-036 Only|Adverse Event|3|||
25304823|NCT01030718|50620216|FG002|Study CA180-036 Only|Adverse Event|0|||
25304824|NCT01030718|50620214|FG000|Study CA180-036 Only|Death|0|||
25304825|NCT01030718|50620215|FG001|Study CA180-036 Only|Death|1|||
25304826|NCT01030718|50620216|FG002|Study CA180-036 Only|Death|0|||
25304827|NCT01030718|50620214|FG000|Study CA180-036 Only|Other Reasons|0|||
25304828|NCT01030718|50620215|FG001|Study CA180-036 Only|Other Reasons|2|||
25304829|NCT01030718|50620216|FG002|Study CA180-036 Only|Other Reasons|0|||
25304830|NCT00722761|50620236|FG000|Overall Study|Lost to Follow-up|1|||
25304831|NCT00722761|50620237|FG001|Overall Study|Lost to Follow-up|4|||
25304832|NCT00722761|50620236|FG000|Overall Study|Withdrawal by Subject|5|||
25304833|NCT00722761|50620237|FG001|Overall Study|Withdrawal by Subject|2|||
25304834|NCT00719953|50620243|FG000|Overall Study|Adverse Event|4|||
25304835|NCT01019486|50620250|FG000|Overall Study|Withdrawal by Subject|1|||
25304836|NCT01019486|50620251|FG001|Overall Study|Withdrawal by Subject|1|||
25304837|NCT01019486|50620252|FG002|Overall Study|Withdrawal by Subject|1|||
25304838|NCT00714493|50620261|FG000|Overall Study|Adverse Event|11|||
25304839|NCT00714493|50620261|FG000|Overall Study|Death|3|||
25304840|NCT00714493|50620261|FG000|Overall Study|Lack of Efficacy|10|||
25304841|NCT00714493|50620261|FG000|Overall Study|Lost to Follow-up|3|||
25304842|NCT00714493|50620261|FG000|Overall Study|Protocol Violation|12|||
25304843|NCT00714493|50620261|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
25304844|NCT00714493|50620261|FG000|Overall Study|OTHER|2|||
25304845|NCT01019252|50620267|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
25304846|NCT01019252|50620268|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
25304847|NCT01019252|50620267|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
25304848|NCT01019252|50620268|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
25304849|NCT01019252|50620267|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
25304850|NCT01019252|50620268|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
25304851|NCT01019252|50620267|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
25304852|NCT01019252|50620268|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
25304853|NCT01013870|50620276|FG000|Overall Study|Lost to Follow-up|1|||
25304854|NCT01013870|50620277|FG001|Overall Study|Lost to Follow-up|3|||
25304855|NCT01013792|50620285|FG000|Overall Study|Study suspended|2|||
25304856|NCT01013792|50620286|FG001|Overall Study|Study suspended|1|||
25304857|NCT01013792|50620285|FG000|Overall Study|Adverse Event|0|||
25304858|NCT01013792|50620286|FG001|Overall Study|Adverse Event|3|||
25304859|NCT01013792|50620285|FG000|Overall Study|Lost to Follow-up|0|||
25304860|NCT01013792|50620286|FG001|Overall Study|Lost to Follow-up|1|||
25304861|NCT01018862|50620295|FG000|Overall Study|Adverse Event|2|||
25304862|NCT01018862|50620296|FG001|Overall Study|Adverse Event|0|||
25304863|NCT01018862|50620297|FG002|Overall Study|Adverse Event|6|||
25304864|NCT01018862|50620295|FG000|Overall Study|Lack of Efficacy|1|||
25304865|NCT01018862|50620296|FG001|Overall Study|Lack of Efficacy|0|||
25304866|NCT01018862|50620297|FG002|Overall Study|Lack of Efficacy|2|||
25304867|NCT01018862|50620295|FG000|Overall Study|Lost to Follow-up|3|||
25304868|NCT01018862|50620296|FG001|Overall Study|Lost to Follow-up|1|||
25304869|NCT01018862|50620297|FG002|Overall Study|Lost to Follow-up|0|||
25304870|NCT01018862|50620295|FG000|Overall Study|Protocol Violation|1|||
25304871|NCT01018862|50620296|FG001|Overall Study|Protocol Violation|3|||
25304872|NCT01018862|50620297|FG002|Overall Study|Protocol Violation|3|||
25304873|NCT01018862|50620295|FG000|Overall Study|Withdrawal by Subject|1|||
25304874|NCT01018862|50620296|FG001|Overall Study|Withdrawal by Subject|2|||
25304875|NCT01018862|50620297|FG002|Overall Study|Withdrawal by Subject|1|||
25304876|NCT01018862|50620295|FG000|Overall Study|administrative problems|5|||
25304877|NCT01018862|50620296|FG001|Overall Study|administrative problems|4|||
25304878|NCT01018862|50620297|FG002|Overall Study|administrative problems|4|||
25304879|NCT01018394|50620307|FG000|Overall Study|Withdrawal by Subject|5|||
25304880|NCT01018394|50620308|FG001|Overall Study|Withdrawal by Subject|5|||
25304881|NCT01018394|50620307|FG000|Overall Study|Lost to Follow-up|4|||
25304882|NCT01018394|50620308|FG001|Overall Study|Lost to Follow-up|3|||
25304883|NCT01017146|50620316|FG000|Overall Study|Adverse Event|11|||
25304884|NCT01017146|50620317|FG001|Overall Study|Adverse Event|1|||
25304885|NCT01017146|50620316|FG000|Overall Study|Lost to Follow-up|14|||
25304886|NCT01017146|50620317|FG001|Overall Study|Lost to Follow-up|14|||
25304887|NCT01017146|50620316|FG000|Overall Study|Noncompliance with Study Product|1|||
25304888|NCT01017146|50620317|FG001|Overall Study|Noncompliance with Study Product|1|||
25304889|NCT01017146|50620316|FG000|Overall Study|Withdrawal by Subject|32|||
25304890|NCT01017146|50620317|FG001|Overall Study|Withdrawal by Subject|16|||
25304891|NCT01017146|50620316|FG000|Overall Study|Relocation|0|||
25304892|NCT01017146|50620317|FG001|Overall Study|Relocation|4|||
25304893|NCT01017146|50620316|FG000|Overall Study|Pregnancy|2|||
25304894|NCT01017146|50620317|FG001|Overall Study|Pregnancy|1|||
25304895|NCT01017146|50620316|FG000|Overall Study|Protocol Violation|2|||
25304896|NCT01017146|50620317|FG001|Overall Study|Protocol Violation|0|||
25304897|NCT01017146|50620316|FG000|Overall Study|Took Excluded Medication|2|||
25304898|NCT01017146|50620317|FG001|Overall Study|Took Excluded Medication|0|||
25304899|NCT01017146|50620316|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
25304900|NCT01017146|50620317|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
25304901|NCT01017146|50620316|FG000|Overall Study|Change in Work Situation|1|||
25304902|NCT01017146|50620317|FG001|Overall Study|Change in Work Situation|0|||
25304903|NCT01010750|50620329|FG000|Second Intervention|Adverse Event|0|||
25304904|NCT01010750|50620330|FG001|Second Intervention|Adverse Event|1|||
25304905|NCT01010750|50620331|FG002|Second Intervention|Adverse Event|0|||
25304906|NCT01010750|50620332|FG003|Second Intervention|Adverse Event|0|||
25304907|NCT01010750|50620333|FG004|Second Intervention|Adverse Event|0|||
25304908|NCT01010750|50620334|FG005|Second Intervention|Adverse Event|0|||
25304909|NCT01012622|50620342|FG000|Overall Study|Withdrawal by Subject|6|||
25304910|NCT01012622|50620342|FG000|Overall Study|Lost to Follow-up|5|||
25304911|NCT01012622|50620342|FG000|Overall Study|Adverse Event|7|||
25304912|NCT01012622|50620342|FG000|Overall Study|non-compliance with the drug|9|||
25304913|NCT01012622|50620342|FG000|Overall Study|Other|1|||
25304914|NCT01012622|50620342|FG000|Overall Study|screening failure|1|||
25304915|NCT01012622|50620342|FG000|Overall Study|withdrawal of consent by a parent|2|||
25304916|NCT00722371|50620353|FG000|Overall Study|Adverse Event|6|||
25304917|NCT00722371|50620354|FG001|Overall Study|Adverse Event|13|||
25304918|NCT00722371|50620355|FG002|Overall Study|Adverse Event|9|||
25304919|NCT00722371|50620356|FG003|Overall Study|Adverse Event|10|||
25071094|NCT03367403|50177205|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
25304920|NCT00722371|50620357|FG004|Overall Study|Adverse Event|6|||
25304921|NCT00722371|50620358|FG005|Overall Study|Adverse Event|8|||
25304922|NCT00722371|50620359|FG006|Overall Study|Adverse Event|4|||
25304923|NCT00722371|50620353|FG000|Overall Study|Contraindication|0|||
25304924|NCT00722371|50620354|FG001|Overall Study|Contraindication|0|||
25304925|NCT00722371|50620355|FG002|Overall Study|Contraindication|1|||
25304926|NCT00722371|50620356|FG003|Overall Study|Contraindication|0|||
25304927|NCT00722371|50620357|FG004|Overall Study|Contraindication|0|||
25304928|NCT00722371|50620358|FG005|Overall Study|Contraindication|0|||
25304929|NCT00722371|50620359|FG006|Overall Study|Contraindication|0|||
25304930|NCT00722371|50620353|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
25304931|NCT00722371|50620354|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
25304932|NCT00722371|50620355|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
25304933|NCT00722371|50620356|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
25071095|NCT03367403|50177206|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
25071096|NCT03367403|50177207|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
25071097|NCT02577146|50177215|FG000|Overall Study|Lost to Follow-up|8|||
25071098|NCT02577146|50177215|FG000|Overall Study|Physician Decision|3|||
25071099|NCT02577146|50177215|FG000|Overall Study|Screen Failure|17|||
25071100|NCT00109967|50177221|FG000|Overall Study|Cancel Prior to Treatment|2|||
25071101|NCT00109967|50177222|FG001|Overall Study|Cancel Prior to Treatment|0|||
25304934|NCT00722371|50620357|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
25304935|NCT00722371|50620358|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
25304936|NCT00722371|50620359|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
25304937|NCT00722371|50620353|FG000|Overall Study|Excluded medication|0|||
25304938|NCT00722371|50620354|FG001|Overall Study|Excluded medication|1|||
25304939|NCT00722371|50620355|FG002|Overall Study|Excluded medication|1|||
25304940|NCT00722371|50620356|FG003|Overall Study|Excluded medication|0|||
25071102|NCT00109967|50177221|FG000|Overall Study|Adverse Event|12|||
25304941|NCT00722371|50620357|FG004|Overall Study|Excluded medication|0|||
25304942|NCT00722371|50620358|FG005|Overall Study|Excluded medication|0|||
24969979|NCT00128102|50059459|FG000|Overall Study|Adverse Event|34|||
24969980|NCT00128102|50059460|FG001|Overall Study|Adverse Event|11|||
24969981|NCT00128102|50059459|FG000|Overall Study|Death|12|||
24969982|NCT00128102|50059460|FG001|Overall Study|Death|13|||
24969983|NCT00128102|50059459|FG000|Overall Study|Physician Decision|3|||
24969984|NCT00128102|50059460|FG001|Overall Study|Physician Decision|3|||
25304943|NCT00722371|50620359|FG006|Overall Study|Excluded medication|1|||
25304944|NCT00722371|50620353|FG000|Overall Study|Hyperglycemia|2|||
25304945|NCT00722371|50620354|FG001|Overall Study|Hyperglycemia|6|||
25304946|NCT00722371|50620355|FG002|Overall Study|Hyperglycemia|4|||
25304947|NCT00722371|50620356|FG003|Overall Study|Hyperglycemia|2|||
25304948|NCT00722371|50620357|FG004|Overall Study|Hyperglycemia|5|||
25304949|NCT00722371|50620358|FG005|Overall Study|Hyperglycemia|1|||
25304950|NCT00722371|50620359|FG006|Overall Study|Hyperglycemia|1|||
25304951|NCT00722371|50620353|FG000|Overall Study|Hypoglycemia|1|||
25304952|NCT00722371|50620354|FG001|Overall Study|Hypoglycemia|0|||
25304953|NCT00722371|50620355|FG002|Overall Study|Hypoglycemia|0|||
25304954|NCT00722371|50620356|FG003|Overall Study|Hypoglycemia|0|||
25304955|NCT00722371|50620357|FG004|Overall Study|Hypoglycemia|0|||
25304956|NCT00722371|50620358|FG005|Overall Study|Hypoglycemia|0|||
25304957|NCT00722371|50620359|FG006|Overall Study|Hypoglycemia|0|||
25304958|NCT00722371|50620353|FG000|Overall Study|Lack of Efficacy|4|||
25304959|NCT00722371|50620354|FG001|Overall Study|Lack of Efficacy|6|||
25304960|NCT00722371|50620355|FG002|Overall Study|Lack of Efficacy|6|||
25304961|NCT00722371|50620356|FG003|Overall Study|Lack of Efficacy|6|||
25304962|NCT00722371|50620357|FG004|Overall Study|Lack of Efficacy|2|||
25304963|NCT00722371|50620358|FG005|Overall Study|Lack of Efficacy|3|||
25304964|NCT00722371|50620359|FG006|Overall Study|Lack of Efficacy|0|||
25304965|NCT00722371|50620353|FG000|Overall Study|Lost to Follow-up|11|||
25304966|NCT00722371|50620354|FG001|Overall Study|Lost to Follow-up|14|||
25304967|NCT00722371|50620355|FG002|Overall Study|Lost to Follow-up|21|||
25304968|NCT00722371|50620356|FG003|Overall Study|Lost to Follow-up|13|||
25304969|NCT00722371|50620357|FG004|Overall Study|Lost to Follow-up|8|||
25304970|NCT00722371|50620358|FG005|Overall Study|Lost to Follow-up|16|||
25304971|NCT00722371|50620359|FG006|Overall Study|Lost to Follow-up|13|||
25304972|NCT00722371|50620353|FG000|Overall Study|Physician Decision|5|||
25304973|NCT00722371|50620354|FG001|Overall Study|Physician Decision|2|||
25304974|NCT00722371|50620355|FG002|Overall Study|Physician Decision|2|||
25304975|NCT00722371|50620356|FG003|Overall Study|Physician Decision|5|||
25304976|NCT00722371|50620357|FG004|Overall Study|Physician Decision|2|||
25304977|NCT00722371|50620358|FG005|Overall Study|Physician Decision|3|||
25304978|NCT00722371|50620359|FG006|Overall Study|Physician Decision|4|||
25304979|NCT00722371|50620353|FG000|Overall Study|Pregnancy|1|||
25304980|NCT00722371|50620354|FG001|Overall Study|Pregnancy|1|||
25304981|NCT00722371|50620355|FG002|Overall Study|Pregnancy|0|||
25304982|NCT00722371|50620356|FG003|Overall Study|Pregnancy|0|||
25304983|NCT00722371|50620357|FG004|Overall Study|Pregnancy|0|||
25304984|NCT00722371|50620358|FG005|Overall Study|Pregnancy|1|||
25304985|NCT00722371|50620359|FG006|Overall Study|Pregnancy|0|||
25304986|NCT00722371|50620353|FG000|Overall Study|Protocol Violation|6|||
25304987|NCT00722371|50620354|FG001|Overall Study|Protocol Violation|1|||
25304988|NCT00722371|50620355|FG002|Overall Study|Protocol Violation|0|||
25304989|NCT00722371|50620356|FG003|Overall Study|Protocol Violation|1|||
25304990|NCT00722371|50620357|FG004|Overall Study|Protocol Violation|4|||
25304991|NCT00722371|50620358|FG005|Overall Study|Protocol Violation|2|||
25304992|NCT00722371|50620359|FG006|Overall Study|Protocol Violation|1|||
25304993|NCT00722371|50620353|FG000|Overall Study|Withdrawal by Subject|18|||
25304994|NCT00722371|50620354|FG001|Overall Study|Withdrawal by Subject|27|||
25304995|NCT00722371|50620355|FG002|Overall Study|Withdrawal by Subject|19|||
25304996|NCT00722371|50620356|FG003|Overall Study|Withdrawal by Subject|23|||
25304997|NCT00722371|50620357|FG004|Overall Study|Withdrawal by Subject|19|||
25304998|NCT00722371|50620358|FG005|Overall Study|Withdrawal by Subject|18|||
25304999|NCT00722371|50620359|FG006|Overall Study|Withdrawal by Subject|26|||
25305000|NCT00722137|50620377|FG000|Overall Study|Overt Disease Progression|5|||
25305001|NCT00722137|50620378|FG001|Overall Study|Overt Disease Progression|4|||
25305002|NCT00722137|50620377|FG000|Overall Study|Adverse Event|17|||
25305003|NCT00722137|50620378|FG001|Overall Study|Adverse Event|21|||
25305004|NCT00722137|50620377|FG000|Overall Study|Death|12|||
25305005|NCT00722137|50620378|FG001|Overall Study|Death|7|||
25305006|NCT00722137|50620377|FG000|Overall Study|Withdrawal by Subject|6|||
25305007|NCT00722137|50620378|FG001|Overall Study|Withdrawal by Subject|9|||
25305008|NCT00722137|50620377|FG000|Overall Study|Other Reason Unknown|3|||
25305009|NCT00722137|50620378|FG001|Overall Study|Other Reason Unknown|4|||
25305010|NCT00722137|50620377|FG000|Overall Study|Randomized But Not Treated|2|||
25305011|NCT00722137|50620378|FG001|Overall Study|Randomized But Not Treated|3|||
25071103|NCT00109967|50177222|FG001|Overall Study|Adverse Event|1|||
25305012|NCT00796666|50620392|FG000|Overall Study|Death|2|||
25305013|NCT00796666|50620393|FG001|Overall Study|Death|4|||
25305014|NCT00796666|50620392|FG000|Overall Study|Withdrawal by Subject|2|||
25305015|NCT00796666|50620393|FG001|Overall Study|Withdrawal by Subject|0|||
25305016|NCT00796666|50620392|FG000|Overall Study|Adverse Event|7|||
25305017|NCT00796666|50620393|FG001|Overall Study|Adverse Event|5|||
25305018|NCT00796666|50620392|FG000|Overall Study|Protocol Violation|1|||
25305019|NCT00796666|50620393|FG001|Overall Study|Protocol Violation|0|||
25305020|NCT00796666|50620392|FG000|Overall Study|Other|1|||
25305021|NCT00796666|50620393|FG001|Overall Study|Other|0|||
25305022|NCT00796666|50620392|FG000|Overall Study|Terminated by sponsor|53|||
25305023|NCT00796666|50620393|FG001|Overall Study|Terminated by sponsor|55|||
25305024|NCT00796666|50620392|FG000|Overall Study|Randomized and not treated|1|||
25305025|NCT00796666|50620393|FG001|Overall Study|Randomized and not treated|0|||
25305026|NCT00799708|50620402|FG000|Overall Study|non-compliance|1|||
25305027|NCT00799708|50620403|FG001|Overall Study|non-compliance|0|||
25305028|NCT00799708|50620404|FG002|Overall Study|non-compliance|0|||
25305029|NCT00796510|50620416|FG000|Overall Study|Death|1|||
25305030|NCT00796510|50620417|FG001|Overall Study|Death|0|||
25305031|NCT00796510|50620416|FG000|Overall Study|Study Terminated|2|||
25305032|NCT00796510|50620417|FG001|Overall Study|Study Terminated|0|||
25305033|NCT00588640|50620423|FG000|Overall Study|Physician Decision|1|||
25305034|NCT00588640|50620423|FG000|Overall Study|Ineligible Patient|1|||
25305035|NCT01016912|50620432|FG000|End of Treatment Period|Lack of Efficacy|0|||
25305036|NCT01016912|50620433|FG001|End of Treatment Period|Lack of Efficacy|1|||
25305037|NCT01016912|50620434|FG002|End of Treatment Period|Lack of Efficacy|0|||
25305038|NCT01016912|50620435|FG003|End of Treatment Period|Lack of Efficacy|4|||
25305039|NCT01016912|50620436|FG004|End of Treatment Period|Lack of Efficacy|4|||
25305040|NCT01016912|50620432|FG000|End of Treatment Period|Adverse Event|0|||
25305041|NCT01016912|50620433|FG001|End of Treatment Period|Adverse Event|1|||
25305042|NCT01016912|50620434|FG002|End of Treatment Period|Adverse Event|1|||
25305043|NCT01016912|50620435|FG003|End of Treatment Period|Adverse Event|0|||
25305044|NCT01016912|50620436|FG004|End of Treatment Period|Adverse Event|0|||
25305045|NCT01016912|50620432|FG000|End of Treatment Period|Completed double-blind period only|0|||
25305046|NCT01016912|50620433|FG001|End of Treatment Period|Completed double-blind period only|1|||
25305047|NCT01016912|50620434|FG002|End of Treatment Period|Completed double-blind period only|0|||
25305048|NCT01016912|50620435|FG003|End of Treatment Period|Completed double-blind period only|0|||
25305049|NCT01016912|50620436|FG004|End of Treatment Period|Completed double-blind period only|0|||
25305050|NCT01016912|50620432|FG000|Follow-up Period|Other reason|0|||
25305051|NCT01016912|50620433|FG001|Follow-up Period|Other reason|0|||
25305052|NCT01016912|50620434|FG002|Follow-up Period|Other reason|1|||
25305053|NCT01016912|50620435|FG003|Follow-up Period|Other reason|1|||
25305054|NCT01016912|50620436|FG004|Follow-up Period|Other reason|0|||
25305055|NCT00802672|50620471|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
25305056|NCT00802672|50620472|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
25305057|NCT00802672|50620473|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
25305058|NCT00802672|50620471|FG000|Overall Study|Adverse Event|1|||
25305059|NCT00802672|50620472|FG001|Overall Study|Adverse Event|1|||
25305060|NCT00802672|50620473|FG002|Overall Study|Adverse Event|1|||
25305061|NCT00802672|50620471|FG000|Overall Study|Protocol Violation|2|||
25305062|NCT00802672|50620472|FG001|Overall Study|Protocol Violation|1|||
25169444|NCT01838681|50301148|FG003|Period B/A+|Withdrawal before treatment|0|||
25169445|NCT01838681|50301145|FG000|Period B/A+|Administrative or other reasons|0|||
25305063|NCT00802672|50620473|FG002|Overall Study|Protocol Violation|1|||
25305064|NCT00802672|50620471|FG000|Overall Study|Lost to Follow-up|5|||
25305065|NCT00802672|50620472|FG001|Overall Study|Lost to Follow-up|5|||
25305066|NCT00802672|50620473|FG002|Overall Study|Lost to Follow-up|3|||
25305067|NCT00802672|50620471|FG000|Overall Study|Withdrawal by Subject|1|||
25305068|NCT00802672|50620472|FG001|Overall Study|Withdrawal by Subject|1|||
25169446|NCT01838681|50301146|FG001|Period B/A+|Administrative or other reasons|6|||
25305069|NCT00802672|50620473|FG002|Overall Study|Withdrawal by Subject|2|||
25305070|NCT00802672|50620471|FG000|Overall Study|other|3|||
25305071|NCT00802672|50620472|FG001|Overall Study|other|1|||
25305072|NCT00802672|50620473|FG002|Overall Study|other|2|||
25305073|NCT00714415|50620483|FG000|Overall Study|Lack of Efficacy|1|||
25305074|NCT00714415|50620484|FG001|Overall Study|Lack of Efficacy|0|||
25305075|NCT00714415|50620483|FG000|Overall Study|Death|1|||
25305076|NCT00714415|50620484|FG001|Overall Study|Death|0|||
25305077|NCT00714259|50620490|FG000|Overall Study|Death|2|||
25305078|NCT00796120|50620496|FG000|Overall Study|Death|3|||
25305079|NCT00796120|50620497|FG001|Overall Study|Death|0|||
25305080|NCT00796120|50620496|FG000|Overall Study|Adverse Event|11|||
25305081|NCT00796120|50620497|FG001|Overall Study|Adverse Event|6|||
25305082|NCT00796120|50620496|FG000|Overall Study|Progressive disease|22|||
25305083|NCT00796120|50620497|FG001|Overall Study|Progressive disease|13|||
25305084|NCT00796120|50620496|FG000|Overall Study|Participant refusal|3|||
25305085|NCT00796120|50620497|FG001|Overall Study|Participant refusal|4|||
25305086|NCT00796120|50620496|FG000|Overall Study|Other|6|||
25305087|NCT00796120|50620497|FG001|Overall Study|Other|17|||
25305088|NCT00796120|50620496|FG000|Overall Study|Physician Decision|16|||
25305089|NCT00796120|50620497|FG001|Overall Study|Physician Decision|17|||
25305090|NCT00796120|50620496|FG000|Overall Study|Randomized but not treated|0|||
25305091|NCT00796120|50620497|FG001|Overall Study|Randomized but not treated|3|||
25305092|NCT00795886|50620503|FG000|Overall Study|Death|10|||
25305093|NCT00719563|50620510|FG000|Overall Study|Adverse Event|16|||
25305094|NCT00719563|50620511|FG001|Overall Study|Adverse Event|13|||
25305095|NCT00719563|50620510|FG000|Overall Study|Medical condition changed|3|||
25305096|NCT00719563|50620511|FG001|Overall Study|Medical condition changed|5|||
25305097|NCT00719563|50620510|FG000|Overall Study|Lack of Efficacy|3|||
25305098|NCT00719563|50620511|FG001|Overall Study|Lack of Efficacy|7|||
25305099|NCT00719563|50620510|FG000|Overall Study|Personal reasons|6|||
25305100|NCT00719563|50620511|FG001|Overall Study|Personal reasons|7|||
25305101|NCT00719563|50620510|FG000|Overall Study|Unknown reasons|4|||
25305102|NCT00719563|50620511|FG001|Overall Study|Unknown reasons|6|||
25305103|NCT00719563|50620510|FG000|Overall Study|Noncompliant|1|||
25305104|NCT00719563|50620511|FG001|Overall Study|Noncompliant|1|||
25169447|NCT01838681|50301147|FG002|Period B/A+|Administrative or other reasons|10|||
25169448|NCT01838681|50301148|FG003|Period B/A+|Administrative or other reasons|28|||
25169449|NCT01611857|50301206|FG000|Overall Study|Withdrawal by Subject|0|||
25169450|NCT01611857|50301207|FG001|Overall Study|Withdrawal by Subject|2|||
25169451|NCT01829477|50301230|FG000|Overall Study|Study Terminated by Sponsor|15|||
25169452|NCT01829477|50301231|FG001|Overall Study|Study Terminated by Sponsor|15|||
25169453|NCT01829477|50301230|FG000|Overall Study|Withdrawal by Subject|1|||
25169454|NCT01829477|50301231|FG001|Overall Study|Withdrawal by Subject|0|||
25169455|NCT01611155|50301247|FG000|Overall Study|Adverse Event|1|||
25169456|NCT01611155|50301248|FG001|Overall Study|Adverse Event|1|||
25305105|NCT00719563|50620510|FG000|Overall Study|Lost to Follow-up|5|||
25305106|NCT00719563|50620511|FG001|Overall Study|Lost to Follow-up|3|||
25305107|NCT00795184|50620518|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
25305108|NCT00795184|50620519|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
25169457|NCT01611155|50301247|FG000|Overall Study|Refused further treatment|6|||
25169458|NCT01611155|50301248|FG001|Overall Study|Refused further treatment|4|||
25169459|NCT01611155|50301247|FG000|Overall Study|Disease progression|1|||
25169460|NCT01611155|50301248|FG001|Overall Study|Disease progression|0|||
25169461|NCT01611155|50301247|FG000|Overall Study|Withdrawal by Subject|1|||
25169462|NCT01611155|50301248|FG001|Overall Study|Withdrawal by Subject|0|||
25169463|NCT01611155|50301247|FG000|Overall Study|Alternative treatment|0|||
25169464|NCT01611155|50301248|FG001|Overall Study|Alternative treatment|1|||
25169465|NCT01611155|50301247|FG000|Overall Study|Ineligible patient|0|||
25169466|NCT01611155|50301248|FG001|Overall Study|Ineligible patient|1|||
25169467|NCT01829243|50301263|FG000|First Intervention|Screen Failure|4|||
25169468|NCT01829243|50301264|FG001|First Intervention|Screen Failure|2|||
25169469|NCT01838447|50301274|FG000|Overall Study|Change in surgical plan|1|||
25169470|NCT01838447|50301275|FG001|Overall Study|Change in surgical plan|2|||
25169471|NCT01838447|50301274|FG000|Overall Study|Withdrawal by Subject|1|||
25169472|NCT01838447|50301275|FG001|Overall Study|Withdrawal by Subject|1|||
25169473|NCT01829165|50301283|FG000|Overall Study|Did not complete intervention|2|||
25169474|NCT01829165|50301284|FG001|Overall Study|Did not complete intervention|0|||
25169475|NCT01838213|50301292|FG000|Overall Study|Ineligible|166|||
25305109|NCT00718861|50620530|FG000|Overall Study|Withdrawal by Subject|15|||
25305110|NCT00718861|50620531|FG001|Overall Study|Withdrawal by Subject|10|||
25305111|NCT00718861|50620530|FG000|Overall Study|Adverse Event|2|||
25305112|NCT00718861|50620531|FG001|Overall Study|Adverse Event|1|||
25305113|NCT00718861|50620530|FG000|Overall Study|Lost to Follow-up|2|||
25305114|NCT00718861|50620531|FG001|Overall Study|Lost to Follow-up|1|||
25305115|NCT00718861|50620530|FG000|Overall Study|Administrative Problems|1|||
25305116|NCT00718861|50620531|FG001|Overall Study|Administrative Problems|1|||
25305117|NCT00718861|50620530|FG000|Overall Study|Death|1|||
25305118|NCT00718861|50620531|FG001|Overall Study|Death|5|||
25305119|NCT01016600|50620541|FG000|Overall Study|Did not start treatment|1|||
25305120|NCT01016600|50620542|FG001|Overall Study|Did not start treatment|0|||
25305121|NCT01016600|50620543|FG002|Overall Study|Did not start treatment|0|||
25305122|NCT01016600|50620544|FG003|Overall Study|Did not start treatment|0|||
25305123|NCT01016132|50620555|FG000|Overall Study|Discomfort|1|||
25305124|NCT01015820|50620561|FG000|Overall Study|Suboptimal measurements|1|||
25305125|NCT01015820|50620562|FG001|Overall Study|Suboptimal measurements|0|||
25305126|NCT01010204|50620585|FG000|Overall Study|Lost to Follow-up|2|||
25305127|NCT01010204|50620586|FG001|Overall Study|Lost to Follow-up|2|||
25305128|NCT01010204|50620585|FG000|Overall Study|Adverse Event|1|||
25305129|NCT01010204|50620586|FG001|Overall Study|Adverse Event|3|||
25305130|NCT01010204|50620585|FG000|Overall Study|Withdrawal by Subject|2|||
25305131|NCT01010204|50620586|FG001|Overall Study|Withdrawal by Subject|3|||
25305132|NCT01010204|50620585|FG000|Overall Study|psychiatric hospitalization|2|||
25305133|NCT01010204|50620586|FG001|Overall Study|psychiatric hospitalization|1|||
25305134|NCT00718549|50620592|FG000|Induction Phase|Disease Progression|1|||
25305135|NCT00718549|50620593|FG001|Induction Phase|Disease Progression|0|||
25305136|NCT00718549|50620594|FG002|Induction Phase|Disease Progression|0|||
25305137|NCT00718549|50620592|FG000|Induction Phase|Eligibility Criteria Violation|2|||
25305138|NCT00718549|50620593|FG001|Induction Phase|Eligibility Criteria Violation|0|||
25305139|NCT00718549|50620594|FG002|Induction Phase|Eligibility Criteria Violation|0|||
25305140|NCT00718549|50620592|FG000|Induction Phase|Early Termination - No Additional Info|59|||
25305141|NCT00718549|50620593|FG001|Induction Phase|Early Termination - No Additional Info|0|||
25305142|NCT00718549|50620594|FG002|Induction Phase|Early Termination - No Additional Info|0|||
25305143|NCT00718549|50620592|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
25169476|NCT01838213|50301293|FG001|Overall Study|Ineligible|191|||
25305144|NCT00718549|50620593|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
25305145|NCT00718549|50620594|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
25305146|NCT00718549|50620592|FG000|Maintenance/ Observation Phase|Death|0|||
25305147|NCT00718549|50620593|FG001|Maintenance/ Observation Phase|Death|1|||
25305148|NCT00718549|50620594|FG002|Maintenance/ Observation Phase|Death|2|||
25169477|NCT01837823|50301299|FG000|Overall Study|Lost to Follow-up|6|||
25169478|NCT01828073|50301309|FG000|Overall Study|Lost to Follow-up|1|||
25305149|NCT00718549|50620592|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
25305150|NCT00718549|50620593|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
25305151|NCT00718549|50620594|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
25305152|NCT00718549|50620592|FG000|Maintenance/ Observation Phase|Progression|0|||
25305153|NCT00718549|50620593|FG001|Maintenance/ Observation Phase|Progression|5|||
25305154|NCT00718549|50620594|FG002|Maintenance/ Observation Phase|Progression|14|||
25305155|NCT00718549|50620592|FG000|Maintenance/ Observation Phase|Relapse|0|||
25305156|NCT00718549|50620593|FG001|Maintenance/ Observation Phase|Relapse|3|||
25305157|NCT00718549|50620594|FG002|Maintenance/ Observation Phase|Relapse|2|||
25305158|NCT00793624|50620611|FG000|Overall Study|Adverse Event|18|||
25305159|NCT00793624|50620612|FG001|Overall Study|Adverse Event|16|||
25305160|NCT00793624|50620613|FG002|Overall Study|Adverse Event|15|||
25305161|NCT00793624|50620614|FG003|Overall Study|Adverse Event|20|||
25305162|NCT00793624|50620611|FG000|Overall Study|Lost to Follow-up|2|||
25305163|NCT00793624|50620612|FG001|Overall Study|Lost to Follow-up|2|||
25305164|NCT00793624|50620613|FG002|Overall Study|Lost to Follow-up|4|||
25305165|NCT00793624|50620614|FG003|Overall Study|Lost to Follow-up|0|||
25305166|NCT00793624|50620611|FG000|Overall Study|Withdrawal by Subject|20|||
25305167|NCT00793624|50620612|FG001|Overall Study|Withdrawal by Subject|9|||
25305168|NCT00793624|50620613|FG002|Overall Study|Withdrawal by Subject|11|||
25305169|NCT00793624|50620614|FG003|Overall Study|Withdrawal by Subject|14|||
25305170|NCT00793624|50620611|FG000|Overall Study|Lack of Efficacy|9|||
25305171|NCT00793624|50620612|FG001|Overall Study|Lack of Efficacy|2|||
25305172|NCT00793624|50620613|FG002|Overall Study|Lack of Efficacy|1|||
25305173|NCT00793624|50620614|FG003|Overall Study|Lack of Efficacy|3|||
25305174|NCT00793624|50620611|FG000|Overall Study|Non compliance with protocol|2|||
25305175|NCT00793624|50620612|FG001|Overall Study|Non compliance with protocol|3|||
25305176|NCT00793624|50620613|FG002|Overall Study|Non compliance with protocol|2|||
25305177|NCT00793624|50620614|FG003|Overall Study|Non compliance with protocol|3|||
25305178|NCT00793624|50620611|FG000|Overall Study|Other reason not described above|6|||
25305179|NCT00793624|50620612|FG001|Overall Study|Other reason not described above|4|||
25305180|NCT00793624|50620613|FG002|Overall Study|Other reason not described above|6|||
25305181|NCT00793624|50620614|FG003|Overall Study|Other reason not described above|3|||
25305182|NCT00794950|50620632|FG000|BCG Induction|Withdrawal by Subject|2|||
25305183|NCT00794950|50620632|FG000|BCG Induction|ineligible|3|||
25305184|NCT00794950|50620632|FG000|BCG Induction|noncompliant w. BCG|1|||
25305185|NCT00794950|50620632|FG000|BCG Induction|Adverse Event|1|||
25305186|NCT00794950|50620632|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
25305187|NCT00794950|50620632|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
25305188|NCT00794950|50620632|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
25305189|NCT00794950|50620632|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
25305190|NCT00793546|50620639|FG000|Overall Study|Death|3|||
25305191|NCT00793546|50620640|FG001|Overall Study|Death|0|||
25305192|NCT00793546|50620639|FG000|Overall Study|Lost to Follow-up|1|||
25305193|NCT00793546|50620640|FG001|Overall Study|Lost to Follow-up|0|||
25305194|NCT00793546|50620639|FG000|Overall Study|Withdrawal by Subject|1|||
25305195|NCT00793546|50620640|FG001|Overall Study|Withdrawal by Subject|1|||
25305196|NCT00793546|50620639|FG000|Overall Study|Study Terminated by Sponsor|8|||
25305197|NCT00793546|50620640|FG001|Overall Study|Study Terminated by Sponsor|27|||
25305198|NCT00793546|50620639|FG000|Overall Study|Other|1|||
25305199|NCT00793546|50620640|FG001|Overall Study|Other|0|||
25305200|NCT00798694|50620650|FG000|Overall Study|Lost to Follow-up|1|||
25169479|NCT01828073|50301310|FG001|Overall Study|Lost to Follow-up|2|||
25305201|NCT00798694|50620651|FG001|Overall Study|Lost to Follow-up|1|||
25305202|NCT00798694|50620650|FG000|Overall Study|Physician Decision|1|||
25305203|NCT00798694|50620651|FG001|Overall Study|Physician Decision|0|||
25305204|NCT00718315|50620666|FG000|Overall Study|Adverse Event|1|||
25305205|NCT00718315|50620667|FG001|Overall Study|Adverse Event|2|||
25305206|NCT00718315|50620668|FG002|Overall Study|Adverse Event|3|||
25305207|NCT00718315|50620666|FG000|Overall Study|Death|6|||
25169480|NCT03819114|50301330|FG000|Overall Study|Protocol Violation|0|||
25169481|NCT03819114|50301331|FG001|Overall Study|Protocol Violation|1|||
25305208|NCT00718315|50620667|FG001|Overall Study|Death|6|||
25305209|NCT00718315|50620668|FG002|Overall Study|Death|5|||
25305210|NCT00718315|50620666|FG000|Overall Study|Lost to Follow-up|2|||
25305211|NCT00718315|50620667|FG001|Overall Study|Lost to Follow-up|3|||
25305212|NCT00718315|50620668|FG002|Overall Study|Lost to Follow-up|4|||
25305213|NCT00718315|50620666|FG000|Overall Study|Protocol Violation|5|||
25305214|NCT00718315|50620667|FG001|Overall Study|Protocol Violation|5|||
25305215|NCT00718315|50620668|FG002|Overall Study|Protocol Violation|3|||
25305216|NCT00718315|50620666|FG000|Overall Study|Erlotinib dose decreased|4|||
25305217|NCT00718315|50620667|FG001|Overall Study|Erlotinib dose decreased|3|||
25305218|NCT00718315|50620668|FG002|Overall Study|Erlotinib dose decreased|1|||
25305219|NCT00718315|50620666|FG000|Overall Study|Use of Minocyclin|1|||
25305220|NCT00718315|50620667|FG001|Overall Study|Use of Minocyclin|1|||
25305221|NCT00718315|50620668|FG002|Overall Study|Use of Minocyclin|1|||
25305222|NCT00718315|50620666|FG000|Overall Study|Disease progression|0|||
25305223|NCT00718315|50620667|FG001|Overall Study|Disease progression|1|||
25305224|NCT00718315|50620668|FG002|Overall Study|Disease progression|1|||
25305225|NCT00718315|50620666|FG000|Overall Study|Other|0|||
25305226|NCT00718315|50620667|FG001|Overall Study|Other|0|||
25305227|NCT00718315|50620668|FG002|Overall Study|Other|1|||
25305228|NCT00718315|50620666|FG000|Overall Study|Use of ATB and Corticoids|0|||
25305229|NCT00718315|50620667|FG001|Overall Study|Use of ATB and Corticoids|1|||
25305230|NCT00718315|50620668|FG002|Overall Study|Use of ATB and Corticoids|2|||
25305231|NCT00798304|50620679|FG000|Overall Study|Adverse Event|0|||
25305232|NCT00798304|50620680|FG001|Overall Study|Adverse Event|1|||
25305233|NCT00798304|50620681|FG002|Overall Study|Adverse Event|1|||
25305234|NCT00798304|50620679|FG000|Overall Study|Discontinuation by Sponsor|14|||
25305235|NCT00798304|50620680|FG001|Overall Study|Discontinuation by Sponsor|21|||
25305236|NCT00798304|50620681|FG002|Overall Study|Discontinuation by Sponsor|9|||
25305237|NCT00718237|50620691|FG000|Overall Study|Adverse Event|1|||
25305238|NCT00718237|50620692|FG001|Overall Study|Adverse Event|3|||
25305239|NCT00718237|50620691|FG000|Overall Study|Lost to Follow-up|2|||
25305240|NCT00718237|50620692|FG001|Overall Study|Lost to Follow-up|2|||
25305241|NCT00718237|50620691|FG000|Overall Study|Physician Decision|1|||
25305242|NCT00718237|50620692|FG001|Overall Study|Physician Decision|0|||
25305243|NCT00718237|50620691|FG000|Overall Study|Withdrawal by Subject|9|||
25305244|NCT00718237|50620692|FG001|Overall Study|Withdrawal by Subject|10|||
25305245|NCT00793780|50620702|FG000|Overall Study|Withdrawal by Subject|2|||
25305246|NCT00793780|50620703|FG001|Overall Study|Withdrawal by Subject|1|||
25305247|NCT02643303|50620718|FG000|Overall Study|Progressive Disease|4|||
25305248|NCT02643303|50620719|FG001|Overall Study|Progressive Disease|4|||
25305249|NCT02643303|50620720|FG002|Overall Study|Progressive Disease|1|||
25305250|NCT02643303|50620721|FG003|Overall Study|Progressive Disease|12|||
25305251|NCT02643303|50620722|FG004|Overall Study|Progressive Disease|6|||
25305252|NCT02643303|50620723|FG005|Overall Study|Progressive Disease|4|||
25305253|NCT02643303|50620724|FG006|Overall Study|Progressive Disease|8|||
25305254|NCT02643303|50620725|FG007|Overall Study|Progressive Disease|2|||
25305255|NCT02643303|50620726|FG008|Overall Study|Progressive Disease|6|||
25305256|NCT02643303|50620718|FG000|Overall Study|Adverse Event|0|||
25305257|NCT02643303|50620719|FG001|Overall Study|Adverse Event|1|||
25305258|NCT02643303|50620720|FG002|Overall Study|Adverse Event|0|||
25305259|NCT02643303|50620721|FG003|Overall Study|Adverse Event|0|||
25305260|NCT02643303|50620722|FG004|Overall Study|Adverse Event|1|||
25305261|NCT02643303|50620723|FG005|Overall Study|Adverse Event|0|||
25305262|NCT02643303|50620724|FG006|Overall Study|Adverse Event|0|||
25305263|NCT02643303|50620725|FG007|Overall Study|Adverse Event|0|||
25305264|NCT02643303|50620726|FG008|Overall Study|Adverse Event|0|||
25305265|NCT02643303|50620718|FG000|Overall Study|Withdrawal by Subject|0|||
25305266|NCT02643303|50620719|FG001|Overall Study|Withdrawal by Subject|0|||
25305267|NCT02643303|50620720|FG002|Overall Study|Withdrawal by Subject|0|||
25305268|NCT02643303|50620721|FG003|Overall Study|Withdrawal by Subject|1|||
25169482|NCT03819114|50301332|FG002|Overall Study|Protocol Violation|1|||
25305269|NCT02643303|50620722|FG004|Overall Study|Withdrawal by Subject|0|||
25305270|NCT02643303|50620723|FG005|Overall Study|Withdrawal by Subject|0|||
25305271|NCT02643303|50620724|FG006|Overall Study|Withdrawal by Subject|1|||
25305272|NCT02643303|50620725|FG007|Overall Study|Withdrawal by Subject|1|||
25305273|NCT02643303|50620726|FG008|Overall Study|Withdrawal by Subject|1|||
25305274|NCT00790036|50620748|FG000|Overall Study|Abnormal lab values|3|||
25305275|NCT00790036|50620749|FG001|Overall Study|Abnormal lab values|2|||
25305276|NCT00790036|50620748|FG000|Overall Study|Administrative problems|5|||
25305277|NCT00790036|50620749|FG001|Overall Study|Administrative problems|9|||
25305278|NCT00790036|50620748|FG000|Overall Study|Adverse Event|113|||
25305279|NCT00790036|50620749|FG001|Overall Study|Adverse Event|44|||
25305280|NCT00790036|50620748|FG000|Overall Study|Death|1|||
25305281|NCT00790036|50620749|FG001|Overall Study|Death|0|||
25305282|NCT00790036|50620748|FG000|Overall Study|Disease progression|24|||
25305283|NCT00790036|50620749|FG001|Overall Study|Disease progression|48|||
25305284|NCT00790036|50620748|FG000|Overall Study|Lost to Follow-up|1|||
25305285|NCT00790036|50620749|FG001|Overall Study|Lost to Follow-up|2|||
25305286|NCT00790036|50620748|FG000|Overall Study|Protocol Violation|10|||
25305287|NCT00790036|50620749|FG001|Overall Study|Protocol Violation|2|||
25305288|NCT00790036|50620748|FG000|Overall Study|Withdrawal by Subject|18|||
25305289|NCT00790036|50620749|FG001|Overall Study|Withdrawal by Subject|7|||
25305290|NCT00790036|50620748|FG000|Overall Study|Subject/guardian decision|20|||
25305291|NCT00790036|50620749|FG001|Overall Study|Subject/guardian decision|7|||
25305292|NCT00789958|50620756|FG000|Overall Study|Adverse Event|3|||
25305293|NCT00789958|50620756|FG000|Overall Study|Withdrawal by Subject|4|||
25305294|NCT00789958|50620756|FG000|Overall Study|Progression|3|||
25305295|NCT00789958|50620756|FG000|Overall Study|not protocol specified|1|||
25305296|NCT00789958|50620756|FG000|Overall Study|Not eligible/not analyzable|26|||
25305297|NCT00789880|50620768|FG000|Overall Study|Adverse Event|0|||
25305298|NCT00789880|50620769|FG001|Overall Study|Adverse Event|0|||
25305299|NCT00789880|50620770|FG002|Overall Study|Adverse Event|0|||
25305300|NCT00789880|50620771|FG003|Overall Study|Adverse Event|0|||
25305301|NCT00789880|50620772|FG004|Overall Study|Adverse Event|1|||
25305302|NCT00789880|50620773|FG005|Overall Study|Adverse Event|0|||
25305303|NCT00789880|50620768|FG000|Overall Study|Protocol Violation|0|||
25305304|NCT00789880|50620769|FG001|Overall Study|Protocol Violation|1|||
25305305|NCT00789880|50620770|FG002|Overall Study|Protocol Violation|0|||
25305306|NCT00789880|50620771|FG003|Overall Study|Protocol Violation|1|||
25305307|NCT00789880|50620772|FG004|Overall Study|Protocol Violation|0|||
25305308|NCT00789880|50620773|FG005|Overall Study|Protocol Violation|0|||
25305309|NCT00789880|50620768|FG000|Overall Study|Withdrawal by Subject|1|||
25305310|NCT00789880|50620769|FG001|Overall Study|Withdrawal by Subject|0|||
25305311|NCT00789880|50620770|FG002|Overall Study|Withdrawal by Subject|0|||
25305312|NCT00789880|50620771|FG003|Overall Study|Withdrawal by Subject|0|||
25071104|NCT00109967|50177221|FG000|Overall Study|Withdrawal by Subject|5|||
25071105|NCT00109967|50177222|FG001|Overall Study|Withdrawal by Subject|0|||
25305313|NCT00789880|50620772|FG004|Overall Study|Withdrawal by Subject|2|||
25305314|NCT00789880|50620773|FG005|Overall Study|Withdrawal by Subject|0|||
25305315|NCT00792298|50620787|FG000|Treatment Period 1|Adverse Event|0|||
25305316|NCT00792298|50620788|FG001|Treatment Period 1|Adverse Event|1|||
25305317|NCT00792298|50620789|FG002|Treatment Period 1|Adverse Event|0|||
25305318|NCT00792298|50620790|FG003|Treatment Period 1|Adverse Event|1|||
25305319|NCT00792298|50620791|FG004|Treatment Period 1|Adverse Event|0|||
25305320|NCT00792298|50620792|FG005|Treatment Period 1|Adverse Event|1|||
25305321|NCT00792298|50620793|FG006|Treatment Period 1|Adverse Event|1|||
25305322|NCT00792298|50620794|FG007|Treatment Period 1|Adverse Event|0|||
25305323|NCT00792298|50620787|FG000|Treatment Period 1|Lack of Efficacy|0|||
25305324|NCT00792298|50620788|FG001|Treatment Period 1|Lack of Efficacy|0|||
25305325|NCT00792298|50620789|FG002|Treatment Period 1|Lack of Efficacy|1|||
25305326|NCT00792298|50620790|FG003|Treatment Period 1|Lack of Efficacy|0|||
25305327|NCT00792298|50620791|FG004|Treatment Period 1|Lack of Efficacy|0|||
25305328|NCT00792298|50620792|FG005|Treatment Period 1|Lack of Efficacy|0|||
25305329|NCT00792298|50620793|FG006|Treatment Period 1|Lack of Efficacy|0|||
25305330|NCT00792298|50620794|FG007|Treatment Period 1|Lack of Efficacy|0|||
25305331|NCT00792298|50620787|FG000|Treatment Period 1|Withdrawal by Subject|1|||
25305332|NCT00792298|50620788|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25305333|NCT00792298|50620789|FG002|Treatment Period 1|Withdrawal by Subject|1|||
25305334|NCT00792298|50620790|FG003|Treatment Period 1|Withdrawal by Subject|2|||
25305335|NCT00792298|50620791|FG004|Treatment Period 1|Withdrawal by Subject|0|||
25305336|NCT00792298|50620792|FG005|Treatment Period 1|Withdrawal by Subject|2|||
25305337|NCT00792298|50620793|FG006|Treatment Period 1|Withdrawal by Subject|1|||
25305338|NCT00792298|50620794|FG007|Treatment Period 1|Withdrawal by Subject|0|||
25305339|NCT00792298|50620787|FG000|Treatment Period 1|Lost to Follow-up|0|||
25305340|NCT00792298|50620788|FG001|Treatment Period 1|Lost to Follow-up|0|||
25305341|NCT00792298|50620789|FG002|Treatment Period 1|Lost to Follow-up|0|||
25305342|NCT00792298|50620790|FG003|Treatment Period 1|Lost to Follow-up|0|||
25305343|NCT00792298|50620791|FG004|Treatment Period 1|Lost to Follow-up|0|||
25305344|NCT00792298|50620792|FG005|Treatment Period 1|Lost to Follow-up|0|||
25305345|NCT00792298|50620793|FG006|Treatment Period 1|Lost to Follow-up|1|||
25305346|NCT00792298|50620794|FG007|Treatment Period 1|Lost to Follow-up|0|||
25305347|NCT00792298|50620787|FG000|Treatment Period 1|Physician Decision|0|||
25305348|NCT00792298|50620788|FG001|Treatment Period 1|Physician Decision|0|||
25305349|NCT00792298|50620789|FG002|Treatment Period 1|Physician Decision|0|||
25305350|NCT00792298|50620790|FG003|Treatment Period 1|Physician Decision|1|||
25305351|NCT00792298|50620791|FG004|Treatment Period 1|Physician Decision|0|||
25305352|NCT00792298|50620792|FG005|Treatment Period 1|Physician Decision|0|||
25071106|NCT00109967|50177221|FG000|Overall Study|Physician Decision|1|||
25192115|NCT01438424|50356558|FG000|Overall Study|Not identified|55|||
25192116|NCT01438424|50356558|FG000|Overall Study|Withdrawal by Subject|104|||
25192117|NCT01438424|50356558|FG000|Overall Study|Progression of chronic hepatitis B|22|||
25192118|NCT01438424|50356558|FG000|Overall Study|Death|22|||
25305353|NCT00792298|50620793|FG006|Treatment Period 1|Physician Decision|1|||
25305354|NCT00792298|50620794|FG007|Treatment Period 1|Physician Decision|0|||
25305355|NCT00792298|50620787|FG000|Treatment Period 1|Protocol Violation|0|||
25305356|NCT00792298|50620788|FG001|Treatment Period 1|Protocol Violation|0|||
25305357|NCT00792298|50620789|FG002|Treatment Period 1|Protocol Violation|0|||
25305358|NCT00792298|50620790|FG003|Treatment Period 1|Protocol Violation|0|||
25305359|NCT00792298|50620791|FG004|Treatment Period 1|Protocol Violation|0|||
25305360|NCT00792298|50620792|FG005|Treatment Period 1|Protocol Violation|0|||
25305361|NCT00792298|50620793|FG006|Treatment Period 1|Protocol Violation|0|||
25305362|NCT00792298|50620794|FG007|Treatment Period 1|Protocol Violation|1|||
25305363|NCT00792298|50620787|FG000|Washout|Adverse Event|0|||
25305364|NCT00792298|50620788|FG001|Washout|Adverse Event|0|||
25305365|NCT00792298|50620789|FG002|Washout|Adverse Event|0|||
25305366|NCT00792298|50620790|FG003|Washout|Adverse Event|0|||
25305367|NCT00792298|50620791|FG004|Washout|Adverse Event|0|||
25305368|NCT00792298|50620792|FG005|Washout|Adverse Event|1|||
25305369|NCT00792298|50620793|FG006|Washout|Adverse Event|0|||
25305370|NCT00792298|50620794|FG007|Washout|Adverse Event|0|||
25305371|NCT00792298|50620787|FG000|Washout|Withdrawal by Subject|0|||
25305372|NCT00792298|50620788|FG001|Washout|Withdrawal by Subject|0|||
25305373|NCT00792298|50620789|FG002|Washout|Withdrawal by Subject|1|||
25305374|NCT00792298|50620790|FG003|Washout|Withdrawal by Subject|0|||
25305375|NCT00792298|50620791|FG004|Washout|Withdrawal by Subject|0|||
25305376|NCT00792298|50620792|FG005|Washout|Withdrawal by Subject|1|||
25192119|NCT01438424|50356558|FG000|Overall Study|Adverse Event|17|||
25192120|NCT01438424|50356558|FG000|Overall Study|Lost to Follow-up|17|||
25192121|NCT01438424|50356558|FG000|Overall Study|Abnormal laboratory test result|14|||
25305377|NCT00792298|50620793|FG006|Washout|Withdrawal by Subject|0|||
25305378|NCT00792298|50620794|FG007|Washout|Withdrawal by Subject|0|||
25305379|NCT00792298|50620787|FG000|Treatment Period 2|Lack of Efficacy|0|||
25305380|NCT00792298|50620788|FG001|Treatment Period 2|Lack of Efficacy|0|||
25305381|NCT00792298|50620789|FG002|Treatment Period 2|Lack of Efficacy|0|||
25305382|NCT00792298|50620790|FG003|Treatment Period 2|Lack of Efficacy|0|||
25071107|NCT00109967|50177222|FG001|Overall Study|Physician Decision|3|||
25305383|NCT00792298|50620791|FG004|Treatment Period 2|Lack of Efficacy|1|||
25305384|NCT00792298|50620792|FG005|Treatment Period 2|Lack of Efficacy|0|||
25071108|NCT00109967|50177221|FG000|Overall Study|Death|0|||
25192122|NCT01438424|50356558|FG000|Overall Study|Need for drug prohibited by protocol|14|||
25305385|NCT00792298|50620793|FG006|Treatment Period 2|Lack of Efficacy|0|||
25305386|NCT00792298|50620794|FG007|Treatment Period 2|Lack of Efficacy|0|||
25305387|NCT00792298|50620787|FG000|Treatment Period 2|Physician Decision|0|||
25305388|NCT00792298|50620788|FG001|Treatment Period 2|Physician Decision|0|||
25305389|NCT00792298|50620789|FG002|Treatment Period 2|Physician Decision|0|||
25305390|NCT00792298|50620790|FG003|Treatment Period 2|Physician Decision|0|||
25305391|NCT00792298|50620791|FG004|Treatment Period 2|Physician Decision|0|||
25305392|NCT00792298|50620792|FG005|Treatment Period 2|Physician Decision|0|||
25305393|NCT00792298|50620793|FG006|Treatment Period 2|Physician Decision|1|||
25305394|NCT00792298|50620794|FG007|Treatment Period 2|Physician Decision|0|||
25305395|NCT00792298|50620787|FG000|Treatment Period 2|Pregnancy|0|||
25305396|NCT00792298|50620788|FG001|Treatment Period 2|Pregnancy|0|||
25305397|NCT00792298|50620789|FG002|Treatment Period 2|Pregnancy|1|||
25305398|NCT00792298|50620790|FG003|Treatment Period 2|Pregnancy|0|||
25305399|NCT00792298|50620791|FG004|Treatment Period 2|Pregnancy|0|||
25305400|NCT00792298|50620792|FG005|Treatment Period 2|Pregnancy|0|||
25305401|NCT00792298|50620793|FG006|Treatment Period 2|Pregnancy|0|||
25305402|NCT00792298|50620794|FG007|Treatment Period 2|Pregnancy|0|||
25305403|NCT00792298|50620787|FG000|Treatment Period 2|Withdrawal by Subject|1|||
25305404|NCT00792298|50620788|FG001|Treatment Period 2|Withdrawal by Subject|1|||
25071109|NCT00109967|50177222|FG001|Overall Study|Death|2|||
25305405|NCT00792298|50620789|FG002|Treatment Period 2|Withdrawal by Subject|0|||
25305406|NCT00792298|50620790|FG003|Treatment Period 2|Withdrawal by Subject|2|||
25305407|NCT00792298|50620791|FG004|Treatment Period 2|Withdrawal by Subject|1|||
25305408|NCT00792298|50620792|FG005|Treatment Period 2|Withdrawal by Subject|0|||
25305409|NCT00792298|50620793|FG006|Treatment Period 2|Withdrawal by Subject|0|||
25305410|NCT00792298|50620794|FG007|Treatment Period 2|Withdrawal by Subject|2|||
25305411|NCT00718159|50620818|FG000|Overall Study|Progressive Disease|3|||
25305412|NCT00718159|50620819|FG001|Overall Study|Progressive Disease|3|||
25305413|NCT00718159|50620820|FG002|Overall Study|Progressive Disease|2|||
25305414|NCT00718159|50620821|FG003|Overall Study|Progressive Disease|0|||
25305415|NCT00718159|50620822|FG004|Overall Study|Progressive Disease|6|||
25305416|NCT00718159|50620823|FG005|Overall Study|Progressive Disease|0|||
25305417|NCT00718159|50620824|FG006|Overall Study|Progressive Disease|0|||
25305418|NCT00718159|50620818|FG000|Overall Study|Death due to Adverse Event|0|||
25305419|NCT00718159|50620819|FG001|Overall Study|Death due to Adverse Event|0|||
25305420|NCT00718159|50620820|FG002|Overall Study|Death due to Adverse Event|0|||
25305421|NCT00718159|50620821|FG003|Overall Study|Death due to Adverse Event|2|||
25305422|NCT00718159|50620822|FG004|Overall Study|Death due to Adverse Event|2|||
25305423|NCT00718159|50620823|FG005|Overall Study|Death due to Adverse Event|0|||
25305424|NCT00718159|50620824|FG006|Overall Study|Death due to Adverse Event|0|||
25305425|NCT00718159|50620818|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
25305426|NCT00718159|50620819|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
25305427|NCT00718159|50620820|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
25305428|NCT00718159|50620821|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
25305429|NCT00718159|50620822|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
25305430|NCT00718159|50620823|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
25305431|NCT00718159|50620824|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
25305432|NCT00718159|50620818|FG000|Overall Study|Investigator Decision|0|||
25305433|NCT00718159|50620819|FG001|Overall Study|Investigator Decision|0|||
25305434|NCT00718159|50620820|FG002|Overall Study|Investigator Decision|0|||
25305435|NCT00718159|50620821|FG003|Overall Study|Investigator Decision|0|||
25305436|NCT00718159|50620822|FG004|Overall Study|Investigator Decision|0|||
25305437|NCT00718159|50620823|FG005|Overall Study|Investigator Decision|1|||
25305438|NCT00718159|50620824|FG006|Overall Study|Investigator Decision|1|||
25305439|NCT00718081|50620843|FG000|Overall Study|Adverse Event|0|||
25305440|NCT00718081|50620844|FG001|Overall Study|Adverse Event|1|||
25305441|NCT00718081|50620845|FG002|Overall Study|Adverse Event|0|||
25305442|NCT00718081|50620843|FG000|Overall Study|Lack of Efficacy|7|||
25305443|NCT00718081|50620844|FG001|Overall Study|Lack of Efficacy|3|||
25305444|NCT00718081|50620845|FG002|Overall Study|Lack of Efficacy|21|||
25305445|NCT00788710|50620856|FG000|Overall Study|Adverse Event|1|||
25305446|NCT00788710|50620857|FG001|Overall Study|Adverse Event|3|||
25305447|NCT00788710|50620858|FG002|Overall Study|Adverse Event|4|||
25305448|NCT00788710|50620856|FG000|Overall Study|Lack of Efficacy|0|||
25305449|NCT00788710|50620857|FG001|Overall Study|Lack of Efficacy|0|||
25305450|NCT00788710|50620858|FG002|Overall Study|Lack of Efficacy|1|||
25305451|NCT00788710|50620856|FG000|Overall Study|Lost to Follow-up|0|||
25305452|NCT00788710|50620857|FG001|Overall Study|Lost to Follow-up|1|||
25305453|NCT00788710|50620858|FG002|Overall Study|Lost to Follow-up|0|||
25305454|NCT00788710|50620856|FG000|Overall Study|Physician Decision|2|||
25305455|NCT00788710|50620857|FG001|Overall Study|Physician Decision|1|||
25305456|NCT00788710|50620858|FG002|Overall Study|Physician Decision|0|||
24969985|NCT00128102|50059459|FG000|Overall Study|Withdrawal by Subject|19|||
25192123|NCT01438424|50356558|FG000|Overall Study|Pregnancy|7|||
25305457|NCT00788710|50620856|FG000|Overall Study|Protocol Violation|0|||
25305458|NCT00788710|50620857|FG001|Overall Study|Protocol Violation|1|||
25305459|NCT00788710|50620858|FG002|Overall Study|Protocol Violation|1|||
25305460|NCT00788710|50620856|FG000|Overall Study|Withdrawal by Subject|2|||
25169483|NCT03819114|50301333|FG003|Overall Study|Protocol Violation|0|||
25305461|NCT00788710|50620857|FG001|Overall Study|Withdrawal by Subject|2|||
25305462|NCT00788710|50620858|FG002|Overall Study|Withdrawal by Subject|0|||
25305463|NCT00787930|50620866|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
25305464|NCT00588094|50620876|FG000|Overall Study|Adverse Event|3|||
25305465|NCT00588094|50620876|FG000|Overall Study|Progression of Disease|2|||
25305466|NCT03373383|50620885|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
25305467|NCT03373383|50620886|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
25305468|NCT03373383|50620887|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
25305469|NCT03373383|50620888|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
25305470|NCT03373383|50620889|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
25305471|NCT03373383|50620885|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
25305472|NCT03373383|50620886|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
25305473|NCT03373383|50620887|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
25305474|NCT03373383|50620888|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
25305475|NCT03373383|50620889|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
25305476|NCT03373383|50620885|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
25305477|NCT03373383|50620886|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
25305478|NCT03373383|50620887|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
25305479|NCT03373383|50620888|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
25305480|NCT03373383|50620889|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
25305481|NCT03373383|50620885|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
25305482|NCT03373383|50620886|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
25305483|NCT03373383|50620887|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
25305484|NCT03373383|50620888|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
25305485|NCT03373383|50620889|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
25305486|NCT03373383|50620885|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
25305487|NCT03373383|50620886|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
25305488|NCT03373383|50620887|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
25305489|NCT03373383|50620888|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
25305490|NCT03373383|50620889|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
25305491|NCT03373383|50620885|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
25305492|NCT03373383|50620886|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
25305493|NCT03373383|50620887|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
25305494|NCT03373383|50620888|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
25305495|NCT03373383|50620889|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
25305496|NCT03373383|50620885|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
25305497|NCT03373383|50620886|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
25305498|NCT03373383|50620887|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
25305499|NCT03373383|50620888|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
25305500|NCT03373383|50620889|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
25305501|NCT03373383|50620885|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
25305502|NCT03373383|50620886|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
25305503|NCT03373383|50620887|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
25305504|NCT03373383|50620888|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
25305505|NCT03373383|50620889|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
25305506|NCT03373383|50620885|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
25305507|NCT03373383|50620886|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
25305508|NCT03373383|50620887|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
25305509|NCT03373383|50620888|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
25305510|NCT03373383|50620889|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
25305511|NCT00784654|50620916|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
25305512|NCT00784654|50620917|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
25305513|NCT00784654|50620918|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
25305514|NCT00784654|50620916|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
25305515|NCT00784654|50620917|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
25305516|NCT00784654|50620918|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
25305517|NCT00784654|50620916|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
25305518|NCT00784654|50620917|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
25305519|NCT00784654|50620918|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
25305520|NCT00784654|50620916|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
25305521|NCT00784654|50620917|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
25305522|NCT00784654|50620918|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
25305523|NCT00784654|50620916|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
25305524|NCT00784654|50620917|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
25305525|NCT00784654|50620918|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
25071110|NCT02579096|50177230|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
25305526|NCT00784654|50620916|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
25305527|NCT00784654|50620917|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
25305528|NCT00784654|50620918|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
25305529|NCT00784654|50620916|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
25305530|NCT00784654|50620917|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
25305531|NCT00784654|50620918|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
25305532|NCT00784654|50620916|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
25305533|NCT00784654|50620917|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
25305534|NCT00784654|50620918|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
25305535|NCT00784654|50620916|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
25305536|NCT00784654|50620917|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
25305537|NCT00784654|50620918|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
25305538|NCT00784654|50620916|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
25305539|NCT00784654|50620917|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
25305540|NCT00784654|50620918|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
25305541|NCT00784654|50620916|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
25305542|NCT00784654|50620917|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
25305543|NCT00784654|50620918|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
25305544|NCT00784654|50620916|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
25305545|NCT00784654|50620917|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
25305546|NCT00784654|50620918|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
25305547|NCT00784654|50620916|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
25305548|NCT00784654|50620917|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
25305549|NCT00784654|50620918|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
25305550|NCT00784654|50620916|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
25305551|NCT00784654|50620917|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
25305552|NCT00784654|50620918|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
25305553|NCT00784654|50620916|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
25305554|NCT00784654|50620917|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
25305555|NCT00784654|50620918|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
25305556|NCT00784654|50620916|FG000|Randomized Withdrawal Period|Adverse Event|0|||
25305557|NCT00784654|50620917|FG001|Randomized Withdrawal Period|Adverse Event|1|||
25192124|NCT01438424|50356558|FG000|Overall Study|No longer met inclusion criteria|1|||
25192125|NCT01438424|50356558|FG000|Overall Study|Participant noncompliance|20|||
25305558|NCT00784654|50620918|FG002|Randomized Withdrawal Period|Adverse Event|1|||
25305559|NCT00784654|50620916|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
25305560|NCT00784654|50620917|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
25305561|NCT00784654|50620918|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
25305562|NCT00784654|50620916|FG000|Randomized Withdrawal Period|Family reasons|0|||
25305563|NCT00784654|50620917|FG001|Randomized Withdrawal Period|Family reasons|0|||
25305564|NCT00784654|50620918|FG002|Randomized Withdrawal Period|Family reasons|1|||
25305565|NCT00787150|50620932|FG000|Overall Study|Adverse Event|4|||
25305566|NCT00787150|50620933|FG001|Overall Study|Adverse Event|4|||
25305567|NCT00787150|50620934|FG002|Overall Study|Adverse Event|4|||
25305568|NCT00787150|50620932|FG000|Overall Study|Physician Decision|1|||
25305569|NCT00787150|50620933|FG001|Overall Study|Physician Decision|2|||
25305570|NCT00787150|50620934|FG002|Overall Study|Physician Decision|1|||
25305571|NCT00787150|50620932|FG000|Overall Study|Withdrawal by Subject|2|||
25305572|NCT00787150|50620933|FG001|Overall Study|Withdrawal by Subject|1|||
25305573|NCT00787150|50620934|FG002|Overall Study|Withdrawal by Subject|0|||
25305574|NCT00787150|50620932|FG000|Overall Study|Dosing incorrect study durg|2|||
25305575|NCT00787150|50620933|FG001|Overall Study|Dosing incorrect study durg|0|||
25305576|NCT00787150|50620934|FG002|Overall Study|Dosing incorrect study durg|0|||
25305577|NCT00786838|50620944|FG000|Overall Study|Physician Decision|4|||
25305578|NCT00786838|50620944|FG000|Overall Study|Death|4|||
25305579|NCT00786838|50620944|FG000|Overall Study|Adverse Event|6|||
25305580|NCT00786838|50620944|FG000|Overall Study|Progressive disease|31|||
25305581|NCT00786838|50620944|FG000|Overall Study|Withdrawal by Subject|4|||
25305582|NCT00785980|50620953|FG000|7 Day Washout Period|Protocol Violation|3|||
25305583|NCT00791518|50620960|FG000|Overall Study|Protocol Violation|93|||
25305584|NCT00785512|50620981|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
25305585|NCT00785512|50620982|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
24969986|NCT00128102|50059460|FG001|Overall Study|Withdrawal by Subject|11|||
25305586|NCT00785512|50620981|FG000|Overall Study|Adverse Event|0|||
25305587|NCT00785512|50620982|FG001|Overall Study|Adverse Event|0|||
25305588|NCT00785512|50620981|FG000|Overall Study|Lack of Efficacy|0|||
25305589|NCT00785512|50620982|FG001|Overall Study|Lack of Efficacy|2|||
25305590|NCT00785512|50620981|FG000|Overall Study|Withdrawal by Subject|0|||
25305591|NCT00785512|50620982|FG001|Overall Study|Withdrawal by Subject|1|||
25305592|NCT00785512|50620981|FG000|Overall Study|Lost to Follow-up|3|||
25305593|NCT00785512|50620982|FG001|Overall Study|Lost to Follow-up|0|||
25305594|NCT00785512|50620981|FG000|Overall Study|Precedure Refused|0|||
25305595|NCT00785512|50620982|FG001|Overall Study|Precedure Refused|0|||
25305596|NCT00785512|50620981|FG000|Overall Study|IVRS Programing Error|0|||
25305597|NCT00785512|50620982|FG001|Overall Study|IVRS Programing Error|0|||
25305598|NCT00785512|50620981|FG000|Overall Study|Physician Decision|0|||
25305599|NCT00785512|50620982|FG001|Overall Study|Physician Decision|0|||
25305600|NCT00785512|50620981|FG000|Overall Study|Lack of compliance|0|||
25305601|NCT00785512|50620982|FG001|Overall Study|Lack of compliance|1|||
25305602|NCT00785356|50620992|FG000|Overall Study|Study prematurely terminated|8|||
25305603|NCT00785044|50621000|FG000|Overall Study|Dosed at non-participating sites|152|||
25305604|NCT00785044|50621000|FG000|Overall Study|Death|77|||
25305605|NCT00785044|50621000|FG000|Overall Study|Lost to Follow-up|266|||
25305606|NCT00785044|50621000|FG000|Overall Study|Withdrawal by Subject|1|||
25305607|NCT00784810|50621007|FG000|Overall Study|Adverse Event|32|||
25305608|NCT00784810|50621008|FG001|Overall Study|Adverse Event|20|||
25305609|NCT00784810|50621007|FG000|Overall Study|Lack of Efficacy|14|||
25305610|NCT00784810|50621008|FG001|Overall Study|Lack of Efficacy|11|||
25305611|NCT00784810|50621007|FG000|Overall Study|Withdrawal by Subject|11|||
25305612|NCT00784810|50621008|FG001|Overall Study|Withdrawal by Subject|9|||
25305613|NCT00784810|50621007|FG000|Overall Study|Administrative|5|||
25305614|NCT00784810|50621008|FG001|Overall Study|Administrative|8|||
25305615|NCT00784810|50621007|FG000|Overall Study|Lost to Follow-up|1|||
25305616|NCT00784810|50621008|FG001|Overall Study|Lost to Follow-up|1|||
25305617|NCT00791128|50621014|FG000|Overall Study|Adverse Event|4|||
25305618|NCT00791128|50621014|FG000|Overall Study|Device migration|2|||
25305619|NCT00791128|50621014|FG000|Overall Study|non-compliance by subject|2|||
25305620|NCT00791128|50621014|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
25305621|NCT00776230|50621034|FG000|Overall Study|Lost to Follow-up|2|||
25305622|NCT00776230|50621035|FG001|Overall Study|Lost to Follow-up|1|||
25305623|NCT00776230|50621036|FG002|Overall Study|Lost to Follow-up|5|||
25305624|NCT00776230|50621034|FG000|Overall Study|Not vaccinated at Day 0|1|||
25305625|NCT00776230|50621035|FG001|Overall Study|Not vaccinated at Day 0|0|||
25305626|NCT00776230|50621036|FG002|Overall Study|Not vaccinated at Day 0|0|||
25305627|NCT00776230|50621034|FG000|Overall Study|Withdrawal by Subject|0|||
25305628|NCT00776230|50621035|FG001|Overall Study|Withdrawal by Subject|1|||
25305629|NCT00776230|50621036|FG002|Overall Study|Withdrawal by Subject|0|||
25305630|NCT00776230|50621034|FG000|Overall Study|Subject missed Visit 4|0|||
25305631|NCT00776230|50621035|FG001|Overall Study|Subject missed Visit 4|1|||
25305632|NCT00776230|50621036|FG002|Overall Study|Subject missed Visit 4|0|||
25305633|NCT00775606|50621046|FG000|Overall Study|Study sponsor terminated funding|3|||
25305634|NCT00775606|50621047|FG001|Overall Study|Study sponsor terminated funding|0|||
25305635|NCT02960763|50621066|FG000|Step 1|Withdrawal by Subject|10|||
25305636|NCT02960763|50621067|FG001|Step 1|Withdrawal by Subject|8|||
25305637|NCT02960763|50621068|FG002|Step 1|Withdrawal by Subject|13|||
25305638|NCT02960763|50621069|FG003|Step 1|Withdrawal by Subject|0|||
25305639|NCT02960763|50621070|FG004|Step 1|Withdrawal by Subject|0|||
25305640|NCT02960763|50621066|FG000|Step 1|Lost to Follow-up|7|||
25305641|NCT02960763|50621067|FG001|Step 1|Lost to Follow-up|9|||
25305642|NCT02960763|50621068|FG002|Step 1|Lost to Follow-up|12|||
25305643|NCT02960763|50621069|FG003|Step 1|Lost to Follow-up|0|||
25305644|NCT02960763|50621070|FG004|Step 1|Lost to Follow-up|0|||
25305645|NCT02960763|50621066|FG000|Step 1|Death|1|||
25305646|NCT02960763|50621067|FG001|Step 1|Death|1|||
25305647|NCT02960763|50621068|FG002|Step 1|Death|1|||
25305648|NCT02960763|50621069|FG003|Step 1|Death|0|||
25305649|NCT02960763|50621070|FG004|Step 1|Death|0|||
25305650|NCT02960763|50621066|FG000|Step 1|Investigator discretion|1|||
25305651|NCT02960763|50621067|FG001|Step 1|Investigator discretion|0|||
25305652|NCT02960763|50621068|FG002|Step 1|Investigator discretion|1|||
25305653|NCT02960763|50621069|FG003|Step 1|Investigator discretion|0|||
25305654|NCT02960763|50621070|FG004|Step 1|Investigator discretion|0|||
25305655|NCT02960763|50621066|FG000|Step 1|Other|0|||
25305656|NCT02960763|50621067|FG001|Step 1|Other|0|||
25305657|NCT02960763|50621068|FG002|Step 1|Other|1|||
25305658|NCT02960763|50621069|FG003|Step 1|Other|0|||
25305659|NCT02960763|50621070|FG004|Step 1|Other|0|||
25305660|NCT02960763|50621066|FG000|Step 2|Withdrawal by Subject|0|||
25305661|NCT02960763|50621067|FG001|Step 2|Withdrawal by Subject|0|||
25305662|NCT02960763|50621068|FG002|Step 2|Withdrawal by Subject|0|||
25305663|NCT02960763|50621069|FG003|Step 2|Withdrawal by Subject|7|||
25305664|NCT02960763|50621070|FG004|Step 2|Withdrawal by Subject|3|||
25305665|NCT02960763|50621066|FG000|Step 2|Lost to Follow-up|0|||
25305666|NCT02960763|50621067|FG001|Step 2|Lost to Follow-up|0|||
25305667|NCT02960763|50621068|FG002|Step 2|Lost to Follow-up|0|||
25305668|NCT02960763|50621069|FG003|Step 2|Lost to Follow-up|4|||
25305669|NCT02960763|50621070|FG004|Step 2|Lost to Follow-up|1|||
25305670|NCT02960763|50621066|FG000|Step 2|Investigator discretion|0|||
25305671|NCT02960763|50621067|FG001|Step 2|Investigator discretion|0|||
25305672|NCT02960763|50621068|FG002|Step 2|Investigator discretion|0|||
25305673|NCT02960763|50621069|FG003|Step 2|Investigator discretion|0|||
25305674|NCT02960763|50621070|FG004|Step 2|Investigator discretion|1|||
25305675|NCT00775528|50621082|FG000|Overall Study|Protocol Violation|1|||
25305676|NCT00775450|50621091|FG000|Overall Study|Serious Adverse Event|2|||
25305677|NCT00775450|50621092|FG001|Overall Study|Serious Adverse Event|0|||
25305678|NCT00775450|50621093|FG002|Overall Study|Serious Adverse Event|0|||
25305679|NCT00775450|50621094|FG003|Overall Study|Serious Adverse Event|0|||
25305680|NCT00775450|50621095|FG004|Overall Study|Serious Adverse Event|0|||
25305681|NCT00775450|50621091|FG000|Overall Study|Protocol Violation|0|||
25305682|NCT00775450|50621092|FG001|Overall Study|Protocol Violation|0|||
25305683|NCT00775450|50621093|FG002|Overall Study|Protocol Violation|0|||
25305684|NCT00775450|50621094|FG003|Overall Study|Protocol Violation|0|||
25071111|NCT02579096|50177231|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
25071112|NCT02579096|50177230|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
25071113|NCT02579096|50177231|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
25071114|NCT02579096|50177230|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
25071115|NCT02579096|50177231|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
25071116|NCT02579096|50177230|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
25071117|NCT02579096|50177231|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
25071118|NCT02579096|50177230|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
25071119|NCT02579096|50177231|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
25071120|NCT02579096|50177230|FG000|Phase 2, Weeks 25 - 48|Death|2|||
25071121|NCT02579096|50177231|FG001|Phase 2, Weeks 25 - 48|Death|4|||
25071122|NCT02579096|50177230|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
25071123|NCT02579096|50177231|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
25071124|NCT02579096|50177230|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
25071125|NCT02579096|50177231|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
25071126|NCT02579096|50177230|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
25071127|NCT02579096|50177231|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
25071128|NCT02579096|50177230|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
25071129|NCT02579096|50177231|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
25071130|NCT02579096|50177230|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
25071131|NCT02579096|50177231|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
25071132|NCT02579096|50177230|FG000|Phase 3, Weeks 49 - 72|Death|3|||
25071133|NCT02579096|50177231|FG001|Phase 3, Weeks 49 - 72|Death|2|||
25071134|NCT02579096|50177230|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
25071135|NCT02579096|50177231|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
25071136|NCT02579096|50177230|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
25071137|NCT02579096|50177231|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
25071138|NCT02579096|50177230|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
25071139|NCT02579096|50177231|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
25071140|NCT02579096|50177230|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
25071141|NCT02579096|50177231|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
25071142|NCT02579096|50177230|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
25071143|NCT02579096|50177231|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
25071144|NCT02579096|50177230|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
25071145|NCT02579096|50177231|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
25169484|NCT03819114|50301330|FG000|Overall Study|Lost to Follow-up|0|||
25305685|NCT00775450|50621095|FG004|Overall Study|Protocol Violation|1|||
25305686|NCT00775450|50621091|FG000|Overall Study|Withdrawal by Subject|1|||
25305687|NCT00775450|50621092|FG001|Overall Study|Withdrawal by Subject|0|||
25305688|NCT00775450|50621093|FG002|Overall Study|Withdrawal by Subject|0|||
25305689|NCT00775450|50621094|FG003|Overall Study|Withdrawal by Subject|0|||
25305690|NCT00775450|50621095|FG004|Overall Study|Withdrawal by Subject|1|||
25305691|NCT00775138|50621111|FG000|Overall Study|Withdrawal by Subject|0|||
25305692|NCT00775138|50621112|FG001|Overall Study|Withdrawal by Subject|0|||
25305693|NCT00775138|50621113|FG002|Overall Study|Withdrawal by Subject|2|||
25305694|NCT00775138|50621114|FG003|Overall Study|Withdrawal by Subject|2|||
25305695|NCT00775138|50621111|FG000|Overall Study|Adverse Event|0|||
25305696|NCT00775138|50621112|FG001|Overall Study|Adverse Event|0|||
25305697|NCT00775138|50621113|FG002|Overall Study|Adverse Event|1|||
25305698|NCT00775138|50621114|FG003|Overall Study|Adverse Event|0|||
25305699|NCT04605991|50621126|FG000|Overall Study|Adverse Event|5|||
25305700|NCT04605991|50621126|FG000|Overall Study|Lack of Efficacy|1|||
25305701|NCT04605991|50621126|FG000|Overall Study|Lost to Follow-up|8|||
25305702|NCT04605991|50621126|FG000|Overall Study|Physician Decision|4|||
25305703|NCT04605991|50621126|FG000|Overall Study|Withdrawal by Subject|14|||
25305704|NCT04605991|50621126|FG000|Overall Study|Non-compliance with study|1|||
25305705|NCT00783796|50621130|FG000|Overall Study|Did not receive any stent|4|||
25305706|NCT00783796|50621130|FG000|Overall Study|Received non-XIENCE V stent|1|||
25305707|NCT00783796|50621130|FG000|Overall Study|Received commercial XIENCE V stent|1|||
25305708|NCT00783718|50621139|FG000|Induction Phase|Adverse Event|4|||
25305709|NCT00783718|50621140|FG001|Induction Phase|Adverse Event|0|||
25305710|NCT00783718|50621141|FG002|Induction Phase|Adverse Event|7|||
25305711|NCT00783718|50621142|FG003|Induction Phase|Adverse Event|0|||
25305712|NCT00783718|50621143|FG004|Induction Phase|Adverse Event|0|||
25305713|NCT00783718|50621144|FG005|Induction Phase|Adverse Event|0|||
25305714|NCT00783718|50621145|FG006|Induction Phase|Adverse Event|0|||
25305715|NCT00783718|50621139|FG000|Induction Phase|Protocol Violation|1|||
25305716|NCT00783718|50621140|FG001|Induction Phase|Protocol Violation|1|||
25305717|NCT00783718|50621141|FG002|Induction Phase|Protocol Violation|6|||
25305718|NCT00783718|50621142|FG003|Induction Phase|Protocol Violation|0|||
25305719|NCT00783718|50621143|FG004|Induction Phase|Protocol Violation|0|||
25305720|NCT00783718|50621144|FG005|Induction Phase|Protocol Violation|0|||
25305721|NCT00783718|50621145|FG006|Induction Phase|Protocol Violation|0|||
25305722|NCT00783718|50621139|FG000|Induction Phase|Lack of Efficacy|5|||
25305723|NCT00783718|50621140|FG001|Induction Phase|Lack of Efficacy|2|||
25305724|NCT00783718|50621141|FG002|Induction Phase|Lack of Efficacy|14|||
25305725|NCT00783718|50621142|FG003|Induction Phase|Lack of Efficacy|0|||
25305726|NCT00783718|50621143|FG004|Induction Phase|Lack of Efficacy|0|||
25305727|NCT00783718|50621144|FG005|Induction Phase|Lack of Efficacy|0|||
25305728|NCT00783718|50621145|FG006|Induction Phase|Lack of Efficacy|0|||
25305729|NCT00783718|50621139|FG000|Induction Phase|Withdrawal by Subject|3|||
25305730|NCT00783718|50621140|FG001|Induction Phase|Withdrawal by Subject|4|||
25305731|NCT00783718|50621141|FG002|Induction Phase|Withdrawal by Subject|8|||
25305732|NCT00783718|50621142|FG003|Induction Phase|Withdrawal by Subject|0|||
25305733|NCT00783718|50621143|FG004|Induction Phase|Withdrawal by Subject|0|||
25305734|NCT00783718|50621144|FG005|Induction Phase|Withdrawal by Subject|0|||
25305735|NCT00783718|50621145|FG006|Induction Phase|Withdrawal by Subject|0|||
25305736|NCT00783718|50621139|FG000|Induction Phase|Lost to Follow-up|1|||
25305737|NCT00783718|50621140|FG001|Induction Phase|Lost to Follow-up|0|||
25305738|NCT00783718|50621141|FG002|Induction Phase|Lost to Follow-up|1|||
25305739|NCT00783718|50621142|FG003|Induction Phase|Lost to Follow-up|0|||
25305740|NCT00783718|50621143|FG004|Induction Phase|Lost to Follow-up|0|||
25305741|NCT00783718|50621144|FG005|Induction Phase|Lost to Follow-up|0|||
25305742|NCT00783718|50621145|FG006|Induction Phase|Lost to Follow-up|0|||
25305743|NCT00783718|50621139|FG000|Maintenance Phase|Adverse Event|12|||
25305744|NCT00783718|50621140|FG001|Maintenance Phase|Adverse Event|0|||
25305745|NCT00783718|50621141|FG002|Maintenance Phase|Adverse Event|0|||
25305746|NCT00783718|50621142|FG003|Maintenance Phase|Adverse Event|15|||
25305747|NCT00783718|50621143|FG004|Maintenance Phase|Adverse Event|7|||
25305748|NCT00783718|50621144|FG005|Maintenance Phase|Adverse Event|6|||
25305749|NCT00783718|50621145|FG006|Maintenance Phase|Adverse Event|16|||
25305750|NCT00783718|50621139|FG000|Maintenance Phase|Protocol Violation|1|||
25305751|NCT00783718|50621140|FG001|Maintenance Phase|Protocol Violation|0|||
25305752|NCT00783718|50621141|FG002|Maintenance Phase|Protocol Violation|0|||
25305753|NCT00783718|50621142|FG003|Maintenance Phase|Protocol Violation|0|||
25305754|NCT00783718|50621143|FG004|Maintenance Phase|Protocol Violation|0|||
25305755|NCT00783718|50621144|FG005|Maintenance Phase|Protocol Violation|0|||
25305756|NCT00783718|50621145|FG006|Maintenance Phase|Protocol Violation|2|||
25305757|NCT00783718|50621139|FG000|Maintenance Phase|Lack of Efficacy|83|||
25305758|NCT00783718|50621140|FG001|Maintenance Phase|Lack of Efficacy|0|||
25305759|NCT00783718|50621141|FG002|Maintenance Phase|Lack of Efficacy|0|||
24969987|NCT00128102|50059459|FG000|Overall Study|Protocol Violation|2|||
25305760|NCT00783718|50621142|FG003|Maintenance Phase|Lack of Efficacy|61|||
25305761|NCT00783718|50621143|FG004|Maintenance Phase|Lack of Efficacy|31|||
25305762|NCT00783718|50621144|FG005|Maintenance Phase|Lack of Efficacy|33|||
25305763|NCT00783718|50621145|FG006|Maintenance Phase|Lack of Efficacy|155|||
25305764|NCT00783718|50621139|FG000|Maintenance Phase|Withdrawal by Subject|6|||
25305765|NCT00783718|50621140|FG001|Maintenance Phase|Withdrawal by Subject|0|||
24969988|NCT00128102|50059460|FG001|Overall Study|Protocol Violation|2|||
25305766|NCT00783718|50621141|FG002|Maintenance Phase|Withdrawal by Subject|0|||
25305767|NCT00783718|50621142|FG003|Maintenance Phase|Withdrawal by Subject|2|||
25305768|NCT00783718|50621143|FG004|Maintenance Phase|Withdrawal by Subject|5|||
25305769|NCT00783718|50621144|FG005|Maintenance Phase|Withdrawal by Subject|2|||
25305770|NCT00783718|50621145|FG006|Maintenance Phase|Withdrawal by Subject|20|||
25305771|NCT00783718|50621139|FG000|Maintenance Phase|Lost to Follow-up|3|||
25305772|NCT00783718|50621140|FG001|Maintenance Phase|Lost to Follow-up|0|||
25305773|NCT00783718|50621141|FG002|Maintenance Phase|Lost to Follow-up|0|||
25305774|NCT00783718|50621142|FG003|Maintenance Phase|Lost to Follow-up|0|||
25305775|NCT00783718|50621143|FG004|Maintenance Phase|Lost to Follow-up|2|||
25305776|NCT00783718|50621144|FG005|Maintenance Phase|Lost to Follow-up|0|||
25305777|NCT00783718|50621145|FG006|Maintenance Phase|Lost to Follow-up|2|||
25305778|NCT00774748|50621164|FG000|Overall Study|Lost to Follow-up|3|||
25305779|NCT00587860|50621174|FG000|Overall Study|Lost to Follow-up|2|||
25305780|NCT00587860|50621175|FG001|Overall Study|Lost to Follow-up|2|||
25305781|NCT00587860|50621174|FG000|Overall Study|Withdrawal by Subject|3|||
25305782|NCT00587860|50621175|FG001|Overall Study|Withdrawal by Subject|3|||
25305783|NCT00583453|50621183|FG000|Overall Study|discontinued intervention|0|||
25305784|NCT00583453|50621184|FG001|Overall Study|discontinued intervention|2|||
25305785|NCT00583219|50621192|FG000|Phase 2|Withdrawal by Subject|1|||
25305786|NCT01072175|50621212|FG000|Part A (Drug-Drug Interaction)|Death|1|||
25305787|NCT01072175|50621213|FG001|Part A (Drug-Drug Interaction)|Death|0|||
25305788|NCT01072175|50621214|FG002|Part A (Drug-Drug Interaction)|Death|0|||
25305789|NCT01072175|50621215|FG003|Part A (Drug-Drug Interaction)|Death|0|||
25305790|NCT01072175|50621216|FG004|Part A (Drug-Drug Interaction)|Death|0|||
25305791|NCT01072175|50621217|FG005|Part A (Drug-Drug Interaction)|Death|0|||
25305792|NCT01072175|50621218|FG006|Part A (Drug-Drug Interaction)|Death|0|||
25305793|NCT01072175|50621219|FG007|Part A (Drug-Drug Interaction)|Death|0|||
25305794|NCT01072175|50621220|FG008|Part A (Drug-Drug Interaction)|Death|0|||
25305795|NCT01072175|50621221|FG009|Part A (Drug-Drug Interaction)|Death|0|||
25305796|NCT01072175|50621222|FG010|Part A (Drug-Drug Interaction)|Death|0|||
25305797|NCT01072175|50621223|FG011|Part A (Drug-Drug Interaction)|Death|0|||
25305798|NCT01072175|50621224|FG012|Part A (Drug-Drug Interaction)|Death|0|||
25305799|NCT01072175|50621212|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
25305800|NCT01072175|50621213|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
25305801|NCT01072175|50621214|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
25305802|NCT01072175|50621215|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
25305803|NCT01072175|50621216|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
25305804|NCT01072175|50621217|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
25305805|NCT01072175|50621218|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
25305806|NCT01072175|50621219|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
25305807|NCT01072175|50621220|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
25305808|NCT01072175|50621221|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
25305809|NCT01072175|50621222|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
25305810|NCT01072175|50621223|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
25305811|NCT01072175|50621224|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
25305812|NCT01072175|50621212|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
25305813|NCT01072175|50621213|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
25305814|NCT01072175|50621214|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
25305815|NCT01072175|50621215|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
25305816|NCT01072175|50621216|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
25305817|NCT01072175|50621217|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
25305818|NCT01072175|50621218|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
25305819|NCT01072175|50621219|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
25305820|NCT01072175|50621220|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
25305821|NCT01072175|50621221|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
24969989|NCT04668274|50059466|FG000|Part 1 Study Period 1|Adverse Event|3|||
25305822|NCT01072175|50621222|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
25305823|NCT01072175|50621223|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
25305824|NCT01072175|50621224|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
25305825|NCT01072175|50621212|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
25305826|NCT01072175|50621213|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
25305827|NCT01072175|50621214|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
25305828|NCT01072175|50621215|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
25305829|NCT01072175|50621216|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
25305830|NCT01072175|50621217|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
25305831|NCT01072175|50621218|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
25305832|NCT01072175|50621219|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
25305833|NCT01072175|50621220|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
25305834|NCT01072175|50621221|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
25305835|NCT01072175|50621222|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
25305836|NCT01072175|50621223|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
25305837|NCT01072175|50621224|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
25305838|NCT01072175|50621212|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
25305839|NCT01072175|50621213|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
25305840|NCT01072175|50621214|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
25305841|NCT01072175|50621215|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
25305842|NCT01072175|50621216|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
25305843|NCT01072175|50621217|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
25305844|NCT01072175|50621218|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
25305845|NCT01072175|50621219|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
25305846|NCT01072175|50621220|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
25305847|NCT01072175|50621221|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
25305848|NCT01072175|50621222|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
25305849|NCT01072175|50621223|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
25305850|NCT01072175|50621224|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
25305851|NCT01072175|50621212|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
25305852|NCT01072175|50621213|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
25305853|NCT01072175|50621214|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
25305854|NCT01072175|50621215|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
25305855|NCT01072175|50621216|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
25305856|NCT01072175|50621217|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
25305857|NCT01072175|50621218|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
25305858|NCT01072175|50621219|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
25305859|NCT01072175|50621220|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
25305860|NCT01072175|50621221|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
25305861|NCT01072175|50621222|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
25305862|NCT01072175|50621223|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
25305863|NCT01072175|50621224|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
25305864|NCT01072175|50621212|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
25305865|NCT01072175|50621213|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
25305866|NCT01072175|50621214|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
25305867|NCT01072175|50621215|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
25305868|NCT01072175|50621216|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
25305869|NCT01072175|50621217|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
25305870|NCT01072175|50621218|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
25305871|NCT01072175|50621219|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
25305872|NCT01072175|50621220|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
25305873|NCT01072175|50621221|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
25305874|NCT01072175|50621222|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
25305875|NCT01072175|50621223|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
25305876|NCT01072175|50621224|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
25305877|NCT01072175|50621212|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
25305878|NCT01072175|50621213|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
25305879|NCT01072175|50621214|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
25305880|NCT01072175|50621215|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
25305881|NCT01072175|50621216|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
25305882|NCT01072175|50621217|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
25305883|NCT01072175|50621218|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
25305884|NCT01072175|50621219|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
25305885|NCT01072175|50621220|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
25305886|NCT01072175|50621221|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
25305887|NCT01072175|50621222|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
25305888|NCT01072175|50621223|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
25305889|NCT01072175|50621224|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
25305890|NCT01072175|50621212|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
25305891|NCT01072175|50621213|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
25305892|NCT01072175|50621214|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
25305893|NCT01072175|50621215|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
25305894|NCT01072175|50621216|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
25305895|NCT01072175|50621217|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
25305896|NCT01072175|50621218|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
25305897|NCT01072175|50621219|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
25305898|NCT01072175|50621220|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
25305899|NCT01072175|50621221|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
25305900|NCT01072175|50621222|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
25305901|NCT01072175|50621223|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
24969990|NCT04668274|50059467|FG001|Part 1 Study Period 1|Adverse Event|0|||
25305902|NCT01072175|50621224|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
25305903|NCT01072175|50621212|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
25305904|NCT01072175|50621213|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
25305905|NCT01072175|50621214|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
25305906|NCT01072175|50621215|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
25305907|NCT01072175|50621216|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
25305908|NCT01072175|50621217|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
25305909|NCT01072175|50621218|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
25305910|NCT01072175|50621219|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
25305911|NCT01072175|50621220|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
25305912|NCT01072175|50621221|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
25305913|NCT01072175|50621222|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
25305914|NCT01072175|50621223|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
25305915|NCT01072175|50621224|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
25305916|NCT01072175|50621212|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
25305917|NCT01072175|50621213|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
25305918|NCT01072175|50621214|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
25305919|NCT01072175|50621215|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
25305920|NCT01072175|50621216|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
25305921|NCT01072175|50621217|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
25305922|NCT01072175|50621218|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
25305923|NCT01072175|50621219|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
25305924|NCT01072175|50621220|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
25305925|NCT01072175|50621221|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
25305926|NCT01072175|50621222|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
25305927|NCT01072175|50621223|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
25305928|NCT01072175|50621224|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
25305929|NCT01072175|50621212|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
25305930|NCT01072175|50621213|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
25305931|NCT01072175|50621214|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
25305932|NCT01072175|50621215|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
25305933|NCT01072175|50621216|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
25305934|NCT01072175|50621217|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
25305935|NCT01072175|50621218|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
25305936|NCT01072175|50621219|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
25305937|NCT01072175|50621220|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
25305938|NCT01072175|50621221|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
25305939|NCT01072175|50621222|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
25305940|NCT01072175|50621223|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
25305941|NCT01072175|50621224|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
25305942|NCT01072175|50621212|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
25305943|NCT01072175|50621213|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
25305944|NCT01072175|50621214|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
25305945|NCT01072175|50621215|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
25305946|NCT01072175|50621216|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
25305947|NCT01072175|50621217|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
25305948|NCT01072175|50621218|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
25305949|NCT01072175|50621219|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
25305950|NCT01072175|50621220|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
25305951|NCT01072175|50621221|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
25305952|NCT01072175|50621222|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
25305953|NCT01072175|50621223|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
25305954|NCT01072175|50621224|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
25305955|NCT01072175|50621212|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
25305956|NCT01072175|50621213|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
25305957|NCT01072175|50621214|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
25305958|NCT01072175|50621215|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
25305959|NCT01072175|50621216|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
25305960|NCT01072175|50621217|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
25305961|NCT01072175|50621218|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
25305962|NCT01072175|50621219|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
25305963|NCT01072175|50621220|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
25305964|NCT01072175|50621221|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
25305965|NCT01072175|50621222|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
25305966|NCT01072175|50621223|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
25305967|NCT01072175|50621224|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
25305968|NCT01072175|50621212|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
25305969|NCT01072175|50621213|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
25305970|NCT01072175|50621214|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
25305971|NCT01072175|50621215|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
25305972|NCT01072175|50621216|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
25305973|NCT01072175|50621217|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
25305974|NCT01072175|50621218|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
25305975|NCT01072175|50621219|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
25305976|NCT01072175|50621220|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
25305977|NCT01072175|50621221|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
25305978|NCT01072175|50621222|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
25305979|NCT01072175|50621223|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
25305980|NCT01072175|50621224|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
25305981|NCT01072175|50621212|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
25305982|NCT01072175|50621213|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
25305983|NCT01072175|50621214|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
25305984|NCT01072175|50621215|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
25305985|NCT01072175|50621216|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
25305986|NCT01072175|50621217|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
25305987|NCT01072175|50621218|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
25305988|NCT01072175|50621219|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
25305989|NCT01072175|50621220|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
25305990|NCT01072175|50621221|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
25305991|NCT01072175|50621222|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
25305992|NCT01072175|50621223|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
25305993|NCT01072175|50621224|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
25305994|NCT01072175|50621212|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
25305995|NCT01072175|50621213|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
25305996|NCT01072175|50621214|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
25305997|NCT01072175|50621215|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
25305998|NCT01072175|50621216|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
25305999|NCT01072175|50621217|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
25306000|NCT01072175|50621218|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
25306001|NCT01072175|50621219|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
25306002|NCT01072175|50621220|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
25306003|NCT01072175|50621221|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
25306004|NCT01072175|50621222|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
25306005|NCT01072175|50621223|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
25306006|NCT01072175|50621224|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
25306007|NCT01072175|50621212|FG000|Part D (HPMC Capsules)|Death|0|||
25306008|NCT01072175|50621213|FG001|Part D (HPMC Capsules)|Death|0|||
25306009|NCT01072175|50621214|FG002|Part D (HPMC Capsules)|Death|0|||
25306010|NCT01072175|50621215|FG003|Part D (HPMC Capsules)|Death|0|||
25306011|NCT01072175|50621216|FG004|Part D (HPMC Capsules)|Death|0|||
25306012|NCT01072175|50621217|FG005|Part D (HPMC Capsules)|Death|0|||
25306013|NCT01072175|50621218|FG006|Part D (HPMC Capsules)|Death|0|||
25306014|NCT01072175|50621219|FG007|Part D (HPMC Capsules)|Death|0|||
25306015|NCT01072175|50621220|FG008|Part D (HPMC Capsules)|Death|0|||
25306016|NCT01072175|50621221|FG009|Part D (HPMC Capsules)|Death|10|||
25306017|NCT01072175|50621222|FG010|Part D (HPMC Capsules)|Death|12|||
25306018|NCT01072175|50621223|FG011|Part D (HPMC Capsules)|Death|28|||
25306019|NCT01072175|50621224|FG012|Part D (HPMC Capsules)|Death|26|||
25306020|NCT01072175|50621212|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
25306021|NCT01072175|50621213|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
25306022|NCT01072175|50621214|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
25306023|NCT01072175|50621215|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
25306024|NCT01072175|50621216|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
25306025|NCT01072175|50621217|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
25306026|NCT01072175|50621218|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
25306027|NCT01072175|50621219|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
25306028|NCT01072175|50621220|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
25306029|NCT01072175|50621221|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
25306030|NCT01072175|50621222|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
25306031|NCT01072175|50621223|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
25306032|NCT01072175|50621224|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
25306033|NCT01072175|50621212|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
25306034|NCT01072175|50621213|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
25306035|NCT01072175|50621214|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
25306036|NCT01072175|50621215|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
25306037|NCT01072175|50621216|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
25306038|NCT01072175|50621217|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
25306039|NCT01072175|50621218|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
25306040|NCT01072175|50621219|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
25306041|NCT01072175|50621220|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
25306042|NCT01072175|50621221|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
25306043|NCT01072175|50621222|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
25306044|NCT01072175|50621223|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
25306045|NCT01072175|50621224|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
25306046|NCT01072175|50621212|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
25306047|NCT01072175|50621213|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
25306048|NCT01072175|50621214|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
25306049|NCT01072175|50621215|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
25306050|NCT01072175|50621216|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
25306051|NCT01072175|50621217|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
25306052|NCT01072175|50621218|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
25306053|NCT01072175|50621219|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
25306054|NCT01072175|50621220|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
25306055|NCT01072175|50621221|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
25306056|NCT01072175|50621222|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
25306057|NCT01072175|50621223|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
25306058|NCT01072175|50621224|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
25306059|NCT01072175|50621212|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
25306060|NCT01072175|50621213|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
25306061|NCT01072175|50621214|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
25306062|NCT01072175|50621215|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
25306063|NCT01072175|50621216|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
25306064|NCT01072175|50621217|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
25306065|NCT01072175|50621218|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
25306066|NCT01072175|50621219|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
25306067|NCT01072175|50621220|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
25306068|NCT01072175|50621221|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
25306069|NCT01072175|50621222|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
25306070|NCT01072175|50621223|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
25306071|NCT01072175|50621224|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
25306072|NCT01071317|50621258|FG000|Overall Study|Lost to Follow-up|2|||
25306073|NCT01071317|50621259|FG001|Overall Study|Lost to Follow-up|2|||
25306074|NCT00783094|50621276|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
25306075|NCT00783094|50621277|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
25306076|NCT00783094|50621278|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
25306077|NCT00783094|50621276|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
25306078|NCT00783094|50621277|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
25306079|NCT00783094|50621278|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
25306080|NCT00783094|50621276|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
25306081|NCT00783094|50621277|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
25306082|NCT00783094|50621278|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
25306083|NCT00783094|50621276|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
25306084|NCT00783094|50621277|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
25306085|NCT00783094|50621278|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
25306086|NCT00783094|50621276|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
25306087|NCT00783094|50621277|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
25306088|NCT00783094|50621278|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
25306089|NCT00783094|50621276|FG000|Open-Label Extension Period|Adverse Event|12|||
25306090|NCT00783094|50621277|FG001|Open-Label Extension Period|Adverse Event|7|||
25306091|NCT00783094|50621278|FG002|Open-Label Extension Period|Adverse Event|16|||
25306092|NCT00783094|50621276|FG000|Open-Label Extension Period|Death|0|||
25306093|NCT00783094|50621277|FG001|Open-Label Extension Period|Death|0|||
25306094|NCT00783094|50621278|FG002|Open-Label Extension Period|Death|1|||
25306095|NCT00783094|50621276|FG000|Open-Label Extension Period|Protocol Violation|4|||
25306096|NCT00783094|50621277|FG001|Open-Label Extension Period|Protocol Violation|5|||
25306097|NCT00783094|50621278|FG002|Open-Label Extension Period|Protocol Violation|7|||
25306098|NCT00783094|50621276|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
25306099|NCT00783094|50621277|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
25306100|NCT00783094|50621278|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
25306101|NCT00783094|50621276|FG000|Open-Label Extension Period|Physician Decision|4|||
25306102|NCT00783094|50621277|FG001|Open-Label Extension Period|Physician Decision|2|||
25306103|NCT00783094|50621278|FG002|Open-Label Extension Period|Physician Decision|3|||
25306104|NCT00783094|50621276|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
25306105|NCT00783094|50621277|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
25306106|NCT00783094|50621278|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
25306107|NCT00790582|50621291|FG000|Overall Study|Death|14|||
25306108|NCT00790582|50621292|FG001|Overall Study|Death|32|||
25306109|NCT00790582|50621291|FG000|Overall Study|Physician Decision|7|||
25306110|NCT00790582|50621292|FG001|Overall Study|Physician Decision|1|||
25306111|NCT00790582|50621291|FG000|Overall Study|Lost to Follow-up|3|||
25306112|NCT00790582|50621292|FG001|Overall Study|Lost to Follow-up|3|||
25306113|NCT00790582|50621291|FG000|Overall Study|Withdrawal by Subject|7|||
25306114|NCT00790582|50621292|FG001|Overall Study|Withdrawal by Subject|51|||
25306115|NCT01048541|50621300|FG000|Overall Study|Withdrawal by Subject|1|||
25306116|NCT01048541|50621301|FG001|Overall Study|Withdrawal by Subject|0|||
25306117|NCT00774046|50621307|FG000|Screening|Not eligible|56|||
25306118|NCT00774046|50621307|FG000|Enrollment|Desired other therapy/refused|28|||
25306119|NCT00774046|50621307|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
25306120|NCT01046903|50621311|FG000|Overall Study|Lost to Follow-up|16|||
25306121|NCT01046903|50621311|FG000|Overall Study|Adverse Event|4|||
25306122|NCT01046903|50621311|FG000|Overall Study|Withdrawal by Subject|3|||
25306123|NCT01046903|50621311|FG000|Overall Study|Other|5|||
25306124|NCT00773968|50621315|FG000|Overall Study|Adverse Event|2|||
25306125|NCT00773968|50621315|FG000|Overall Study|Death|1|||
25306126|NCT00773968|50621315|FG000|Overall Study|Failure to Return|2|||
25306127|NCT00773968|50621315|FG000|Overall Study|Lack of Efficacy|3|||
25306128|NCT00773968|50621315|FG000|Overall Study|Protocol Violation|1|||
25306129|NCT00773968|50621315|FG000|Overall Study|Withdrawal by Subject|11|||
25306130|NCT00773968|50621315|FG000|Overall Study|Screen Failure|17|||
25306131|NCT00773968|50621315|FG000|Overall Study|Other|8|||
25306132|NCT00782626|50621319|FG000|Overall Study|Adverse Event|1|||
25306133|NCT00782626|50621319|FG000|Overall Study|Progressive Disease|5|||
25306134|NCT00782626|50621319|FG000|Overall Study|Other Complicating Disease|1|||
25306135|NCT01071083|50621328|FG000|Overall Study|Adverse Event|1|||
25306136|NCT01071083|50621329|FG001|Overall Study|Adverse Event|0|||
25306137|NCT01071083|50621330|FG002|Overall Study|Adverse Event|1|||
25306138|NCT01071083|50621331|FG003|Overall Study|Adverse Event|0|||
25306139|NCT01071083|50621332|FG004|Overall Study|Adverse Event|1|||
25306140|NCT01071083|50621328|FG000|Overall Study|Withdrawal by Subject|3|||
25306141|NCT01071083|50621329|FG001|Overall Study|Withdrawal by Subject|0|||
25306142|NCT01071083|50621330|FG002|Overall Study|Withdrawal by Subject|2|||
25306143|NCT01071083|50621331|FG003|Overall Study|Withdrawal by Subject|0|||
25306144|NCT01071083|50621332|FG004|Overall Study|Withdrawal by Subject|3|||
25306145|NCT01071083|50621328|FG000|Overall Study|Physician Decision|1|||
25306146|NCT01071083|50621329|FG001|Overall Study|Physician Decision|0|||
25306147|NCT01071083|50621330|FG002|Overall Study|Physician Decision|0|||
25306148|NCT01071083|50621331|FG003|Overall Study|Physician Decision|1|||
25306149|NCT01071083|50621332|FG004|Overall Study|Physician Decision|1|||
25306150|NCT01071083|50621328|FG000|Overall Study|Early Rescue|1|||
25306151|NCT01071083|50621329|FG001|Overall Study|Early Rescue|0|||
25306152|NCT01071083|50621330|FG002|Overall Study|Early Rescue|0|||
25306153|NCT01071083|50621331|FG003|Overall Study|Early Rescue|0|||
25306154|NCT01071083|50621332|FG004|Overall Study|Early Rescue|1|||
25306155|NCT01071083|50621328|FG000|Overall Study|Subject Moved|0|||
25306156|NCT01071083|50621329|FG001|Overall Study|Subject Moved|1|||
25306157|NCT01071083|50621330|FG002|Overall Study|Subject Moved|0|||
25306158|NCT01071083|50621331|FG003|Overall Study|Subject Moved|0|||
25306159|NCT01071083|50621332|FG004|Overall Study|Subject Moved|0|||
25306160|NCT01071083|50621328|FG000|Overall Study|Images Not Usable (Motion)|0|||
25306161|NCT01071083|50621329|FG001|Overall Study|Images Not Usable (Motion)|1|||
25306162|NCT01071083|50621330|FG002|Overall Study|Images Not Usable (Motion)|0|||
25306163|NCT01071083|50621331|FG003|Overall Study|Images Not Usable (Motion)|0|||
25306164|NCT01071083|50621332|FG004|Overall Study|Images Not Usable (Motion)|0|||
25306165|NCT01071083|50621328|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
25306166|NCT01071083|50621329|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
25306167|NCT01071083|50621330|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
25306168|NCT01071083|50621331|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
25306169|NCT01071083|50621332|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
25306170|NCT01071083|50621328|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
25306171|NCT01071083|50621329|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
25306172|NCT01071083|50621330|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
25306173|NCT01071083|50621331|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
25306174|NCT01071083|50621332|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
25306175|NCT01071083|50621328|FG000|Overall Study|Subject Refused to Continue|1|||
25306176|NCT01071083|50621329|FG001|Overall Study|Subject Refused to Continue|0|||
25306177|NCT01071083|50621330|FG002|Overall Study|Subject Refused to Continue|0|||
25306178|NCT01071083|50621331|FG003|Overall Study|Subject Refused to Continue|0|||
25306179|NCT01071083|50621332|FG004|Overall Study|Subject Refused to Continue|0|||
25306180|NCT01070771|50621344|FG000|Overall Study|Adverse Event|2|||
25306181|NCT01070771|50621344|FG000|Overall Study|Protocol Violation|1|||
25306182|NCT01070381|50621349|FG000|Period 2, 1 Week of Wear|Handling|0|||
25306183|NCT01070381|50621350|FG001|Period 2, 1 Week of Wear|Handling|1|||
25306184|NCT01070381|50621349|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
25306185|NCT01070381|50621350|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
25306186|NCT01010126|50621371|FG000|Overall Study|Withdrawal by Subject|1|||
25306187|NCT01010126|50621372|FG001|Overall Study|Withdrawal by Subject|0|||
25306188|NCT01010126|50621373|FG002|Overall Study|Withdrawal by Subject|1|||
25306189|NCT01010126|50621374|FG003|Overall Study|Withdrawal by Subject|0|||
25306190|NCT01010126|50621375|FG004|Overall Study|Withdrawal by Subject|3|||
25306191|NCT01010126|50621376|FG005|Overall Study|Withdrawal by Subject|0|||
25306192|NCT01043705|50621393|FG000|Overall Study|Death|28|||
25306193|NCT01043705|50621394|FG001|Overall Study|Death|60|||
25306194|NCT01043705|50621395|FG002|Overall Study|Death|26|||
25306195|NCT01043705|50621393|FG000|Overall Study|Lost to Follow-up|27|||
25306196|NCT01043705|50621394|FG001|Overall Study|Lost to Follow-up|12|||
25306197|NCT01043705|50621395|FG002|Overall Study|Lost to Follow-up|0|||
25306198|NCT01043705|50621393|FG000|Overall Study|Multiple Reasons|4|||
25306199|NCT01043705|50621394|FG001|Overall Study|Multiple Reasons|7|||
25306200|NCT01043705|50621395|FG002|Overall Study|Multiple Reasons|0|||
25306201|NCT01043705|50621393|FG000|Overall Study|Protocol Violation|2|||
25306202|NCT01043705|50621394|FG001|Overall Study|Protocol Violation|1|||
25306203|NCT01043705|50621395|FG002|Overall Study|Protocol Violation|0|||
25306204|NCT01043705|50621393|FG000|Overall Study|Withdrawal by Subject|8|||
25306205|NCT01043705|50621394|FG001|Overall Study|Withdrawal by Subject|6|||
25306206|NCT01043705|50621395|FG002|Overall Study|Withdrawal by Subject|0|||
25306207|NCT01043705|50621393|FG000|Overall Study|Site Closure|8|||
24969991|NCT04668274|50059468|FG002|Part 1 Study Period 1|Adverse Event|0|||
24969992|NCT04668274|50059469|FG003|Part 1 Study Period 1|Adverse Event|0|||
25306208|NCT01043705|50621394|FG001|Overall Study|Site Closure|0|||
25306209|NCT01043705|50621395|FG002|Overall Study|Site Closure|0|||
25306210|NCT01043705|50621393|FG000|Overall Study|Subsequent Procedure|9|||
25306211|NCT01043705|50621394|FG001|Overall Study|Subsequent Procedure|24|||
25306212|NCT01043705|50621395|FG002|Overall Study|Subsequent Procedure|29|||
25306213|NCT01043705|50621393|FG000|Overall Study|Adverse Event|0|||
25071146|NCT02578940|50177237|FG000|Overall Study|Screening failure|5|||
25306214|NCT01043705|50621394|FG001|Overall Study|Adverse Event|2|||
25306215|NCT01043705|50621395|FG002|Overall Study|Adverse Event|0|||
25306216|NCT01043705|50621393|FG000|Overall Study|Screen Fail|21|||
25306217|NCT01043705|50621394|FG001|Overall Study|Screen Fail|0|||
25306218|NCT01043705|50621395|FG002|Overall Study|Screen Fail|0|||
25306219|NCT01043705|50621393|FG000|Overall Study|Other|0|||
25306220|NCT01043705|50621394|FG001|Overall Study|Other|19|||
25306221|NCT01043705|50621395|FG002|Overall Study|Other|25|||
25306222|NCT03141177|50621406|FG000|Overall Study|Death|62|||
25306223|NCT03141177|50621407|FG001|Overall Study|Death|13|||
25306224|NCT03141177|50621408|FG002|Overall Study|Death|84|||
25306225|NCT03141177|50621406|FG000|Overall Study|Participant withdrew consent|9|||
25306226|NCT03141177|50621407|FG001|Overall Study|Participant withdrew consent|2|||
25306227|NCT03141177|50621408|FG002|Overall Study|Participant withdrew consent|13|||
25306228|NCT03141177|50621406|FG000|Overall Study|Not reported|1|||
25306229|NCT03141177|50621407|FG001|Overall Study|Not reported|0|||
25306230|NCT03141177|50621408|FG002|Overall Study|Not reported|1|||
25306231|NCT03141177|50621406|FG000|Overall Study|Lost to Follow-up|2|||
25306232|NCT03141177|50621407|FG001|Overall Study|Lost to Follow-up|1|||
25306233|NCT03141177|50621408|FG002|Overall Study|Lost to Follow-up|1|||
25306234|NCT03141177|50621406|FG000|Overall Study|Other reasons|4|||
25306235|NCT03141177|50621407|FG001|Overall Study|Other reasons|0|||
25306236|NCT03141177|50621408|FG002|Overall Study|Other reasons|11|||
25306237|NCT03141177|50621406|FG000|Overall Study|Participants did not start treatment period|3|||
25306238|NCT03141177|50621407|FG001|Overall Study|Participants did not start treatment period|0|||
25306239|NCT03141177|50621408|FG002|Overall Study|Participants did not start treatment period|8|||
25306240|NCT01070303|50621428|FG000|Overall Study|Adverse Event|39|||
25306241|NCT01070303|50621428|FG000|Overall Study|Withdrawal by Subject|20|||
25306242|NCT01070303|50621428|FG000|Overall Study|Lost to Follow-up|9|||
25306243|NCT01070303|50621428|FG000|Overall Study|Protocol Violation|0|||
25306244|NCT01070303|50621428|FG000|Overall Study|Lack of Efficacy|2|||
25306245|NCT01070303|50621428|FG000|Overall Study|Administrative Reason|1|||
25306246|NCT01070303|50621428|FG000|Overall Study|Other|18|||
25306247|NCT01009814|50621443|FG000|Overall Study|No longer met study criteria|1|||
25306248|NCT01009814|50621444|FG001|Overall Study|No longer met study criteria|1|||
25306249|NCT01009814|50621445|FG002|Overall Study|No longer met study criteria|0|||
25306250|NCT01009814|50621446|FG003|Overall Study|No longer met study criteria|0|||
25306251|NCT01009814|50621447|FG004|Overall Study|No longer met study criteria|0|||
25306252|NCT03824587|50621465|FG000|Run-in Period|Screen Failure|0|||
25306253|NCT03824587|50621466|FG001|Run-in Period|Screen Failure|275|||
25306254|NCT03824587|50621465|FG000|Treatment Period|Adverse Event|4|||
25306255|NCT03824587|50621466|FG001|Treatment Period|Adverse Event|1|||
25306256|NCT03824587|50621465|FG000|Treatment Period|Withdrawal by Subject|0|||
25306257|NCT03824587|50621466|FG001|Treatment Period|Withdrawal by Subject|1|||
25306258|NCT03824587|50621465|FG000|Treatment Period|Kidney Transplant|1|||
25306259|NCT03824587|50621466|FG001|Treatment Period|Kidney Transplant|1|||
25306260|NCT00773734|50621476|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
25306261|NCT00773734|50621477|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
25306262|NCT00773734|50621478|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
25306263|NCT00773734|50621479|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
25306264|NCT00773734|50621480|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
25306265|NCT00773734|50621481|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
25306266|NCT00773734|50621476|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
25306267|NCT00773734|50621477|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
25306268|NCT00773734|50621478|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
25306269|NCT00773734|50621479|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
25306270|NCT00773734|50621480|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
25306271|NCT00773734|50621481|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
25306272|NCT00773734|50621476|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
25306273|NCT00773734|50621477|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
25306274|NCT00773734|50621478|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
25306275|NCT00773734|50621479|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
25306276|NCT00773734|50621480|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
25306277|NCT00773734|50621481|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
25306278|NCT00773734|50621476|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
25306279|NCT00773734|50621477|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
25306280|NCT00773734|50621478|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
25306281|NCT00773734|50621479|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
25306282|NCT00773734|50621480|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
25306283|NCT00773734|50621481|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
25306284|NCT00773734|50621476|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
25306285|NCT00773734|50621477|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
25306286|NCT00773734|50621478|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
25306287|NCT00773734|50621479|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
25306288|NCT00773734|50621480|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
25306289|NCT00773734|50621481|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
25306290|NCT00773734|50621476|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
25306291|NCT00773734|50621477|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
25306292|NCT00773734|50621478|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
25306293|NCT00773734|50621479|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
25306294|NCT00773734|50621480|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
25306295|NCT00773734|50621481|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
25306296|NCT00773734|50621476|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
25306297|NCT00773734|50621477|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
25306298|NCT00773734|50621478|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
25306299|NCT00773734|50621479|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
25306300|NCT00773734|50621480|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
25306301|NCT00773734|50621481|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
25306302|NCT00773734|50621476|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
25306303|NCT00773734|50621477|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
25306304|NCT00773734|50621478|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
25306305|NCT00773734|50621479|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
25306306|NCT00773734|50621480|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
25306307|NCT00773734|50621481|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
25306308|NCT00773734|50621476|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
25306309|NCT00773734|50621477|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
25306310|NCT00773734|50621478|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
24969993|NCT04668274|50059466|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
24969994|NCT04668274|50059467|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
24969995|NCT04668274|50059468|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
25071147|NCT02578940|50177237|FG000|Overall Study|Lost to Follow-up|1|||
25306311|NCT00773734|50621479|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
25306312|NCT00773734|50621480|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
25306313|NCT00773734|50621481|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
25306314|NCT00773734|50621476|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
25306315|NCT00773734|50621477|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
25306316|NCT00773734|50621478|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
25306317|NCT00773734|50621479|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
25306318|NCT00773734|50621480|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
25306319|NCT00773734|50621481|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
25306320|NCT00773734|50621476|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
25306321|NCT00773734|50621477|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
25306322|NCT00773734|50621478|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
25306323|NCT00773734|50621479|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
25306324|NCT00773734|50621480|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
25306325|NCT00773734|50621481|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
25306326|NCT00773734|50621476|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
25306327|NCT00773734|50621477|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
25306328|NCT00773734|50621478|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
25306329|NCT00773734|50621479|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
25306330|NCT00773734|50621480|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
25306331|NCT00773734|50621481|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
25306332|NCT00773734|50621476|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
25306333|NCT00773734|50621477|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
25306334|NCT00773734|50621478|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
25306335|NCT00773734|50621479|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
25306336|NCT00773734|50621480|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
25306337|NCT00773734|50621481|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
25306338|NCT00773734|50621476|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
25306339|NCT00773734|50621477|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
25306340|NCT00773734|50621478|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
25306341|NCT00773734|50621479|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
25306342|NCT00773734|50621480|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
25306343|NCT00773734|50621481|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
25306344|NCT00773734|50621476|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
25306345|NCT00773734|50621477|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
25306346|NCT00773734|50621478|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
25306347|NCT00773734|50621479|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
25306348|NCT00773734|50621480|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
25306349|NCT00773734|50621481|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
25306350|NCT00773734|50621476|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
25306351|NCT00773734|50621477|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
25306352|NCT00773734|50621478|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
25306353|NCT00773734|50621479|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
25306354|NCT00773734|50621480|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
25306355|NCT00773734|50621481|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
25306356|NCT00773734|50621476|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
25306357|NCT00773734|50621477|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
25306358|NCT00773734|50621478|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
25306359|NCT00773734|50621479|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
25306360|NCT00773734|50621480|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
25306361|NCT00773734|50621481|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
25306362|NCT00773734|50621476|FG000|Extension: Active Treatment Week 24-52|Other|0|||
25306363|NCT00773734|50621477|FG001|Extension: Active Treatment Week 24-52|Other|0|||
25306364|NCT00773734|50621478|FG002|Extension: Active Treatment Week 24-52|Other|1|||
25306365|NCT00773734|50621479|FG003|Extension: Active Treatment Week 24-52|Other|2|||
25306366|NCT00773734|50621480|FG004|Extension: Active Treatment Week 24-52|Other|0|||
25306367|NCT00773734|50621481|FG005|Extension: Active Treatment Week 24-52|Other|1|||
25306368|NCT00773734|50621476|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
25306369|NCT00773734|50621477|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
25306370|NCT00773734|50621478|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
25306371|NCT00773734|50621479|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
25306372|NCT00773734|50621480|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
25306373|NCT00773734|50621481|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
25306374|NCT00773734|50621476|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
25306375|NCT00773734|50621477|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
25306376|NCT00773734|50621478|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
25306377|NCT00773734|50621479|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
25306378|NCT00773734|50621480|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
25306379|NCT00773734|50621481|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
25306380|NCT00773734|50621476|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
25306381|NCT00773734|50621477|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
25306382|NCT00773734|50621478|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
25306383|NCT00773734|50621479|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
25306384|NCT00773734|50621480|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
25306385|NCT00773734|50621481|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
25306386|NCT00773734|50621476|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
25306387|NCT00773734|50621477|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
25306388|NCT00773734|50621478|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
25306389|NCT00773734|50621479|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
25306390|NCT00773734|50621480|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
25306391|NCT00773734|50621481|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
25306392|NCT01009580|50621540|FG000|Overall Study|Adverse Event|4|||
25306393|NCT01009580|50621541|FG001|Overall Study|Adverse Event|4|||
25306394|NCT01009580|50621540|FG000|Overall Study|Lack of Efficacy|0|||
25306395|NCT01009580|50621541|FG001|Overall Study|Lack of Efficacy|1|||
25306396|NCT01009580|50621540|FG000|Overall Study|Protocol Violation|2|||
25306397|NCT01009580|50621541|FG001|Overall Study|Protocol Violation|3|||
25306398|NCT01009580|50621540|FG000|Overall Study|Withdrawal Criteria|4|||
25306399|NCT01009580|50621541|FG001|Overall Study|Withdrawal Criteria|6|||
25306400|NCT01009580|50621540|FG000|Overall Study|Unclassified|17|||
25306401|NCT01009580|50621541|FG001|Overall Study|Unclassified|21|||
25306402|NCT01009346|50621547|FG000|Overall Study|Adverse Event|4|||
25306403|NCT01001702|50621552|FG000|Overall Study|Lost to Follow-up|7|||
25306404|NCT01001702|50621552|FG000|Overall Study|Adverse Event|7|||
25306405|NCT01001702|50621552|FG000|Overall Study|Sponsor Discontinued Study|4|||
25306406|NCT01001702|50621552|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
25306407|NCT01001702|50621552|FG000|Overall Study|Investigator withdrew Subject|10|||
25306408|NCT01001702|50621552|FG000|Overall Study|Withdrawal by Subject|19|||
25306409|NCT01001702|50621552|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
25306410|NCT01070069|50621561|FG000|Overall Study|Death|1|||
25306411|NCT01070069|50621562|FG001|Overall Study|Death|0|||
25306412|NCT01070069|50621563|FG002|Overall Study|Death|2|||
25306413|NCT01070069|50621564|FG003|Overall Study|Death|0|||
25306414|NCT01070069|50621565|FG004|Overall Study|Death|1|||
25306415|NCT01070069|50621561|FG000|Overall Study|Withdrawal by Subject|1|||
25306416|NCT01070069|50621562|FG001|Overall Study|Withdrawal by Subject|1|||
25306417|NCT01070069|50621563|FG002|Overall Study|Withdrawal by Subject|4|||
25306418|NCT01070069|50621564|FG003|Overall Study|Withdrawal by Subject|0|||
25306419|NCT01070069|50621565|FG004|Overall Study|Withdrawal by Subject|0|||
25306420|NCT01070069|50621561|FG000|Overall Study|Lost to Follow-up|4|||
25306421|NCT01070069|50621562|FG001|Overall Study|Lost to Follow-up|1|||
25306422|NCT01070069|50621563|FG002|Overall Study|Lost to Follow-up|0|||
25306423|NCT01070069|50621564|FG003|Overall Study|Lost to Follow-up|0|||
25306424|NCT01070069|50621565|FG004|Overall Study|Lost to Follow-up|3|||
25306425|NCT01068665|50621582|FG000|Overall Study|Adverse Event|5|||
25306426|NCT01068665|50621583|FG001|Overall Study|Adverse Event|4|||
25306427|NCT01068665|50621582|FG000|Overall Study|Lack of Efficacy|0|||
25306428|NCT01068665|50621583|FG001|Overall Study|Lack of Efficacy|2|||
25306429|NCT01068665|50621582|FG000|Overall Study|Protocol Violation|5|||
25306430|NCT01068665|50621583|FG001|Overall Study|Protocol Violation|2|||
25306431|NCT01068665|50621582|FG000|Overall Study|Withdrawal Criteria|3|||
25306432|NCT01068665|50621583|FG001|Overall Study|Withdrawal Criteria|9|||
25306433|NCT01068665|50621582|FG000|Overall Study|Other|17|||
25306434|NCT01068665|50621583|FG001|Overall Study|Other|12|||
25306435|NCT01001390|50621589|FG000|Overall Study|Failure to wear AFO device|2|||
25306436|NCT01001390|50621590|FG001|Overall Study|Failure to wear AFO device|0|||
25306437|NCT00772954|50621598|FG000|Overall Study|Adverse Event|0|||
25306438|NCT00772954|50621599|FG001|Overall Study|Adverse Event|0|||
25306439|NCT00772954|50621600|FG002|Overall Study|Adverse Event|1|||
25306440|NCT00781768|50621610|FG000|Overall Study|Not transplanted.|0|||
25306441|NCT00781768|50621611|FG001|Overall Study|Not transplanted.|2|||
25306442|NCT01005680|50621619|FG000|Overall Study|Lost to Follow-up|4|||
25306443|NCT01005680|50621620|FG001|Overall Study|Lost to Follow-up|6|||
25306444|NCT01005680|50621619|FG000|Overall Study|Withdrawal by Subject|1|||
25306445|NCT01005680|50621620|FG001|Overall Study|Withdrawal by Subject|4|||
25306446|NCT01005680|50621619|FG000|Overall Study|Physician Decision|1|||
25306447|NCT01005680|50621620|FG001|Overall Study|Physician Decision|1|||
25306448|NCT01005602|50621629|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
25306449|NCT01005602|50621630|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
25306450|NCT01068509|50621646|FG000|Overall Study|Death|0|||
25071148|NCT02578862|50177245|FG000|Overall Study|Withdrawal by Subject|0|||
25071149|NCT02578862|50177246|FG001|Overall Study|Withdrawal by Subject|1|||
25071150|NCT02578862|50177245|FG000|Overall Study|Unplanned unilateral procedure|0|||
25071151|NCT02578862|50177246|FG001|Overall Study|Unplanned unilateral procedure|1|||
25071152|NCT02578706|50177255|FG000|Overall Study|Withdrawal by Subject|1|||
25071153|NCT02578706|50177256|FG001|Overall Study|Withdrawal by Subject|0|||
25071154|NCT02578706|50177257|FG002|Overall Study|Withdrawal by Subject|0|||
25071155|NCT02578706|50177255|FG000|Overall Study|Lost to Follow-up|0|||
25071156|NCT02578706|50177256|FG001|Overall Study|Lost to Follow-up|4|||
25071157|NCT02578706|50177257|FG002|Overall Study|Lost to Follow-up|0|||
25192126|NCT02580240|50356574|FG000|Overall Study|Physician Decision|2|||
25192127|NCT02580240|50356575|FG001|Overall Study|Physician Decision|0|||
25192128|NCT01465958|50356581|FG000|Run-in Phase|Protocol Violation|1|||
25192129|NCT01465958|50356582|FG001|Run-in Phase|Protocol Violation|0|||
25192130|NCT01465958|50356581|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
25192131|NCT01465958|50356582|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
25192132|NCT02581488|50356795|FG000|Overall Study|Adverse Event|6|||
25192133|NCT02581488|50356796|FG001|Overall Study|Adverse Event|7|||
25192134|NCT02581488|50356795|FG000|Overall Study|Lost to Follow-up|1|||
25192135|NCT02581488|50356796|FG001|Overall Study|Lost to Follow-up|0|||
25192136|NCT02581488|50356795|FG000|Overall Study|Withdrawal by Subject|1|||
25192137|NCT02581488|50356796|FG001|Overall Study|Withdrawal by Subject|0|||
25192138|NCT02581488|50356795|FG000|Overall Study|Non-Compliance|1|||
25192139|NCT02581488|50356796|FG001|Overall Study|Non-Compliance|0|||
25306451|NCT01068509|50621647|FG001|Overall Study|Death|0|||
25306452|NCT01068509|50621648|FG002|Overall Study|Death|1|||
25306453|NCT01068509|50621646|FG000|Overall Study|Disease Progression|5|||
25306454|NCT01068509|50621647|FG001|Overall Study|Disease Progression|20|||
25306455|NCT01068509|50621648|FG002|Overall Study|Disease Progression|18|||
25306456|NCT01068509|50621646|FG000|Overall Study|Lost to Follow-up|1|||
25192140|NCT02581488|50356795|FG000|Overall Study|Protocol Violation|0|||
25192141|NCT02581488|50356796|FG001|Overall Study|Protocol Violation|4|||
25306457|NCT01068509|50621647|FG001|Overall Study|Lost to Follow-up|0|||
25306458|NCT01068509|50621648|FG002|Overall Study|Lost to Follow-up|0|||
25306459|NCT01068509|50621646|FG000|Overall Study|Withdrew Consent|0|||
25306460|NCT01068509|50621647|FG001|Overall Study|Withdrew Consent|1|||
25306461|NCT01068509|50621648|FG002|Overall Study|Withdrew Consent|2|||
25306462|NCT01068509|50621646|FG000|Overall Study|Reason Not Specified|0|||
25306463|NCT01068509|50621647|FG001|Overall Study|Reason Not Specified|1|||
25306464|NCT01068509|50621648|FG002|Overall Study|Reason Not Specified|0|||
24969996|NCT04668274|50059469|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
24969997|NCT04668274|50059466|FG000|Part 1 Study Period 2|Other|0|||
24969998|NCT04668274|50059467|FG001|Part 1 Study Period 2|Other|1|||
24969999|NCT04668274|50059468|FG002|Part 1 Study Period 2|Other|0|||
24970000|NCT04668274|50059469|FG003|Part 1 Study Period 2|Other|0|||
24970001|NCT04668274|50059466|FG000|Part 1 Study Period 3|Adverse Event|0|||
24970002|NCT04668274|50059467|FG001|Part 1 Study Period 3|Adverse Event|0|||
24970003|NCT04668274|50059468|FG002|Part 1 Study Period 3|Adverse Event|1|||
24970004|NCT04668274|50059469|FG003|Part 1 Study Period 3|Adverse Event|0|||
24970005|NCT04668274|50059466|FG000|Part 1 Study Period 3|Other|0|||
24970006|NCT04668274|50059467|FG001|Part 1 Study Period 3|Other|0|||
24970007|NCT04668274|50059468|FG002|Part 1 Study Period 3|Other|2|||
24970008|NCT04668274|50059469|FG003|Part 1 Study Period 3|Other|0|||
24970009|NCT04668274|50059466|FG000|Part 2 Study Period 4|Other|0|||
24970010|NCT04668274|50059467|FG001|Part 2 Study Period 4|Other|0|||
24970011|NCT04668274|50059468|FG002|Part 2 Study Period 4|Other|0|||
24970012|NCT04668274|50059469|FG003|Part 2 Study Period 4|Other|1|||
24970013|NCT04406194|50059484|FG000|Period 1|Withdrawal by Subject|0|||
24970014|NCT04406194|50059485|FG001|Period 1|Withdrawal by Subject|1|||
24970015|NCT03822884|50059500|FG000|Overall Study|Withdrawal by Subject|0|||
25306465|NCT01009034|50621655|FG000|Overall Study|Lost to Follow-up|2|||
25306466|NCT01009034|50621655|FG000|Overall Study|Withdrawal by Subject|2|||
25306467|NCT00768430|50621661|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
25306468|NCT00768430|50621662|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
24970016|NCT03822884|50059501|FG001|Overall Study|Withdrawal by Subject|0|||
24970017|NCT03822884|50059502|FG002|Overall Study|Withdrawal by Subject|0|||
24970018|NCT03822884|50059503|FG003|Overall Study|Withdrawal by Subject|0|||
24970019|NCT03822884|50059504|FG004|Overall Study|Withdrawal by Subject|1|||
24970020|NCT03822884|50059505|FG005|Overall Study|Withdrawal by Subject|0|||
24970021|NCT03822416|50059515|FG000|Overall Study|Lost to Follow-up|1|||
25306469|NCT01064297|50621671|FG000|Overall Study|Lost to Follow-up|791|||
25306470|NCT01064297|50621672|FG001|Overall Study|Lost to Follow-up|48|||
25306471|NCT01064297|50621673|FG002|Overall Study|Lost to Follow-up|133|||
25306472|NCT00781456|50621690|FG000|Overall Study|Adverse Event|3|||
25306473|NCT00781456|50621691|FG001|Overall Study|Adverse Event|3|||
25306474|NCT00781456|50621690|FG000|Overall Study|Withdrawal by Subject|3|||
25306475|NCT00781456|50621691|FG001|Overall Study|Withdrawal by Subject|5|||
25306476|NCT00781456|50621690|FG000|Overall Study|Protocol Violation|4|||
25306477|NCT00781456|50621691|FG001|Overall Study|Protocol Violation|1|||
25306478|NCT00781456|50621690|FG000|Overall Study|Noncompliance With Protocol|1|||
25306479|NCT00781456|50621691|FG001|Overall Study|Noncompliance With Protocol|1|||
25306480|NCT00781456|50621690|FG000|Overall Study|Lost to Follow-up|10|||
25306481|NCT00781456|50621691|FG001|Overall Study|Lost to Follow-up|5|||
25306482|NCT00781456|50621690|FG000|Overall Study|Other Reason, Unknown|0|||
25306483|NCT00781456|50621691|FG001|Overall Study|Other Reason, Unknown|1|||
25306484|NCT00587158|50621699|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
25306485|NCT00587158|50621700|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
25306486|NCT00587158|50621699|FG000|Overall Study|Physician Decision|0|||
25306487|NCT00587158|50621700|FG001|Overall Study|Physician Decision|1|||
25306488|NCT00587158|50621699|FG000|Overall Study|Lost to Follow-up|1|||
25306489|NCT00587158|50621700|FG001|Overall Study|Lost to Follow-up|2|||
24970022|NCT03822416|50059516|FG001|Overall Study|Lost to Follow-up|0|||
24970023|NCT03822416|50059515|FG000|Overall Study|Withdrawal by Subject|0|||
24970024|NCT03822416|50059516|FG001|Overall Study|Withdrawal by Subject|1|||
24970025|NCT04405570|50059526|FG000|Overall Study|Adverse Event|0|||
24970026|NCT04405570|50059527|FG001|Overall Study|Adverse Event|1|||
25306490|NCT00587158|50621699|FG000|Overall Study|Death|0|||
25306491|NCT00587158|50621700|FG001|Overall Study|Death|1|||
25306492|NCT00587158|50621699|FG000|Overall Study|Subject did not want to take study med|0|||
25306493|NCT00587158|50621700|FG001|Overall Study|Subject did not want to take study med|1|||
25306494|NCT00582907|50621706|FG000|1st Course|Withdrawal by Subject|1|||
25306495|NCT00582907|50621707|FG001|1st Course|Withdrawal by Subject|0|||
25306496|NCT00582907|50621708|FG002|1st Course|Withdrawal by Subject|0|||
25306497|NCT00582907|50621709|FG003|1st Course|Withdrawal by Subject|0|||
25306498|NCT00582907|50621706|FG000|1st Course|Lost to Follow-up|0|||
25306499|NCT00582907|50621707|FG001|1st Course|Lost to Follow-up|0|||
25306500|NCT00582907|50621708|FG002|1st Course|Lost to Follow-up|0|||
25306501|NCT00582907|50621709|FG003|1st Course|Lost to Follow-up|1|||
25306502|NCT00582907|50621706|FG000|2nd Course|Lack of Efficacy|1|||
25306503|NCT00582907|50621707|FG001|2nd Course|Lack of Efficacy|0|||
25306504|NCT00582907|50621708|FG002|2nd Course|Lack of Efficacy|0|||
25306505|NCT00582907|50621709|FG003|2nd Course|Lack of Efficacy|0|||
25306506|NCT01062113|50621718|FG000|Overall Study|Adverse Event|1|||
25306507|NCT01062113|50621719|FG001|Overall Study|Adverse Event|0|||
24970027|NCT04405570|50059528|FG002|Overall Study|Adverse Event|1|||
25306508|NCT01062113|50621720|FG002|Overall Study|Adverse Event|0|||
25306509|NCT01062113|50621718|FG000|Overall Study|Lack of Efficacy|38|||
25306510|NCT01062113|50621719|FG001|Overall Study|Lack of Efficacy|22|||
25306511|NCT01062113|50621720|FG002|Overall Study|Lack of Efficacy|31|||
25306512|NCT01062113|50621718|FG000|Overall Study|Withdrawal by Subject|1|||
25306513|NCT01062113|50621719|FG001|Overall Study|Withdrawal by Subject|0|||
25306514|NCT01062113|50621720|FG002|Overall Study|Withdrawal by Subject|0|||
25306515|NCT00772330|50621728|FG000|Overall Study|Lost to Follow-up|3|||
25306516|NCT01038869|50621735|FG000|Overall Study|Withdrawal by Subject|1|||
25306517|NCT01038869|50621735|FG000|Overall Study|Lost to Follow-up|6|||
25306518|NCT01038713|50621746|FG000|Overall Study|Patient to hospice|1|||
25306519|NCT01038713|50621747|FG001|Overall Study|Patient to hospice|1|||
25306520|NCT01038713|50621748|FG002|Overall Study|Patient to hospice|1|||
25306521|NCT01038713|50621746|FG000|Overall Study|Lost to Follow-up|3|||
25306522|NCT01038713|50621747|FG001|Overall Study|Lost to Follow-up|0|||
25306523|NCT01038713|50621748|FG002|Overall Study|Lost to Follow-up|0|||
25306524|NCT01038713|50621746|FG000|Overall Study|Neuroendocrine Tumor|0|||
25306525|NCT01038713|50621747|FG001|Overall Study|Neuroendocrine Tumor|1|||
25306526|NCT01038713|50621748|FG002|Overall Study|Neuroendocrine Tumor|0|||
25306527|NCT01038713|50621746|FG000|Overall Study|died from PEP|0|||
25306528|NCT01038713|50621747|FG001|Overall Study|died from PEP|1|||
25306529|NCT01038713|50621748|FG002|Overall Study|died from PEP|0|||
25306530|NCT01038713|50621746|FG000|Overall Study|Autoimmune Pancreatitis|1|||
25306531|NCT01038713|50621747|FG001|Overall Study|Autoimmune Pancreatitis|0|||
25306532|NCT01038713|50621748|FG002|Overall Study|Autoimmune Pancreatitis|0|||
25306533|NCT00768040|50621758|FG000|Overall Study|Adverse Event|3|||
25306534|NCT00768040|50621759|FG001|Overall Study|Adverse Event|2|||
25306535|NCT00768040|50621758|FG000|Overall Study|Abnormal laboratory value|1|||
25306536|NCT00768040|50621759|FG001|Overall Study|Abnormal laboratory value|1|||
25306537|NCT00767806|50621767|FG000|Overall Study|Adverse Event|30|||
25306538|NCT00767806|50621768|FG001|Overall Study|Adverse Event|11|||
24970028|NCT04405570|50059529|FG003|Overall Study|Adverse Event|1|||
25169485|NCT03819114|50301331|FG001|Overall Study|Lost to Follow-up|0|||
24970029|NCT04405570|50059526|FG000|Overall Study|Lost to Follow-up|0|||
25306539|NCT00767806|50621767|FG000|Overall Study|Withdrawal by Subject|8|||
25306540|NCT00767806|50621768|FG001|Overall Study|Withdrawal by Subject|13|||
25306541|NCT00767806|50621767|FG000|Overall Study|Protocol Violation|6|||
25306542|NCT00767806|50621768|FG001|Overall Study|Protocol Violation|5|||
25306543|NCT00767806|50621767|FG000|Overall Study|Lack of Efficacy|1|||
25306544|NCT00767806|50621768|FG001|Overall Study|Lack of Efficacy|9|||
25306545|NCT00767806|50621767|FG000|Overall Study|Physician Decision|4|||
25306546|NCT00767806|50621768|FG001|Overall Study|Physician Decision|3|||
25306547|NCT00767806|50621767|FG000|Overall Study|Lost to Follow-up|1|||
25306548|NCT00767806|50621768|FG001|Overall Study|Lost to Follow-up|4|||
25306549|NCT00767806|50621767|FG000|Overall Study|Entry Criteria Not Met|1|||
25306550|NCT00767806|50621768|FG001|Overall Study|Entry Criteria Not Met|1|||
25306551|NCT00767806|50621767|FG000|Overall Study|Sponsor Decision|0|||
25306552|NCT00767806|50621768|FG001|Overall Study|Sponsor Decision|1|||
25306553|NCT00780910|50621774|FG000|Overall Study|Adverse Event|2|||
25306554|NCT00767104|50621780|FG000|Overall Study|Lost to Follow-up|1|||
25306555|NCT00767104|50621781|FG001|Overall Study|Lost to Follow-up|2|||
25306556|NCT00771472|50621789|FG000|Overall Study|Physician Decision|2|||
25306557|NCT00771472|50621790|FG001|Overall Study|Physician Decision|3|||
25306558|NCT00771472|50621789|FG000|Overall Study|Progressive Disease|3|||
25306559|NCT00771472|50621790|FG001|Overall Study|Progressive Disease|1|||
25306560|NCT00771472|50621789|FG000|Overall Study|Protocol Violation|1|||
25306561|NCT00771472|50621790|FG001|Overall Study|Protocol Violation|0|||
25306562|NCT00771316|50621797|FG000|Overall Study|Adverse Event|0|||
25306563|NCT00771316|50621798|FG001|Overall Study|Adverse Event|1|||
25306564|NCT00771316|50621797|FG000|Overall Study|Patient withdrew consent|1|||
25306565|NCT00771316|50621798|FG001|Overall Study|Patient withdrew consent|0|||
25306566|NCT00771316|50621797|FG000|Overall Study|Discontinued due to early termination|1|||
25306567|NCT00771316|50621798|FG001|Overall Study|Discontinued due to early termination|0|||
25306568|NCT00770770|50621806|FG000|Overall Study|Lost to Follow-up|1|||
25306569|NCT00770770|50621807|FG001|Overall Study|Lost to Follow-up|0|||
25306570|NCT00770770|50621806|FG000|Overall Study|Withdrawal by Subject|1|||
25306571|NCT00770770|50621807|FG001|Overall Study|Withdrawal by Subject|0|||
25306572|NCT00770770|50621806|FG000|Overall Study|Death|0|||
25306573|NCT00770770|50621807|FG001|Overall Study|Death|1|||
25306574|NCT00770770|50621806|FG000|Overall Study|Study Terminated|8|||
25306575|NCT00770770|50621807|FG001|Overall Study|Study Terminated|0|||
25306576|NCT00766636|50621815|FG000|Overall Study|Withdrawal by Subject|1|||
25306577|NCT00766636|50621816|FG001|Overall Study|Withdrawal by Subject|1|||
25306578|NCT00766636|50621815|FG000|Overall Study|Incomplete Treatment|0|||
25306579|NCT00766636|50621816|FG001|Overall Study|Incomplete Treatment|1|||
25306580|NCT00766636|50621815|FG000|Overall Study|Adverse Event|1|||
25306581|NCT00766636|50621816|FG001|Overall Study|Adverse Event|0|||
25306582|NCT00766636|50621815|FG000|Overall Study|Disease Progression|1|||
25306583|NCT00766636|50621816|FG001|Overall Study|Disease Progression|0|||
25306584|NCT00770692|50621826|FG000|Overall Study|Withdrawal by Subject|7|||
25306585|NCT00770692|50621827|FG001|Overall Study|Withdrawal by Subject|9|||
25306586|NCT00770692|50621828|FG002|Overall Study|Withdrawal by Subject|9|||
25306587|NCT00770692|50621829|FG003|Overall Study|Withdrawal by Subject|6|||
25306588|NCT00770692|50621826|FG000|Overall Study|Adverse Event|3|||
25306589|NCT00770692|50621827|FG001|Overall Study|Adverse Event|0|||
25306590|NCT00770692|50621828|FG002|Overall Study|Adverse Event|4|||
25306591|NCT00770692|50621829|FG003|Overall Study|Adverse Event|4|||
25306592|NCT00770692|50621826|FG000|Overall Study|Investigator judgment|2|||
25306593|NCT00770692|50621827|FG001|Overall Study|Investigator judgment|0|||
25306594|NCT00770692|50621828|FG002|Overall Study|Investigator judgment|1|||
25306595|NCT00770692|50621829|FG003|Overall Study|Investigator judgment|1|||
25306596|NCT03213691|50621839|FG000|Overall Study|Adverse Event|2|||
25306597|NCT03213691|50621839|FG000|Overall Study|Death|3|||
25306598|NCT03213691|50621839|FG000|Overall Study|Physician Decision|1|||
25306599|NCT03213691|50621839|FG000|Overall Study|Progressive Disease|14|||
25306600|NCT03213691|50621839|FG000|Overall Study|Ineligible|1|||
25306601|NCT02743819|50621847|FG000|Overall Study|Lack of Efficacy|5|||
25306602|NCT02743819|50621847|FG000|Overall Study|Death|2|||
25306603|NCT02743819|50621847|FG000|Overall Study|Adverse Event|1|||
25306604|NCT01004822|50621859|FG000|Overall Study|Objective progression or relapse|3|||
25306605|NCT01004822|50621860|FG001|Overall Study|Objective progression or relapse|3|||
24970030|NCT04405570|50059527|FG001|Overall Study|Lost to Follow-up|1|||
25306606|NCT01004822|50621861|FG002|Overall Study|Objective progression or relapse|0|||
25306607|NCT01004822|50621862|FG003|Overall Study|Objective progression or relapse|1|||
25306608|NCT01004822|50621863|FG004|Overall Study|Objective progression or relapse|2|||
25306609|NCT01004822|50621864|FG005|Overall Study|Objective progression or relapse|2|||
25306610|NCT01004822|50621865|FG006|Overall Study|Objective progression or relapse|1|||
25306611|NCT01004822|50621866|FG007|Overall Study|Objective progression or relapse|4|||
25306612|NCT01004822|50621859|FG000|Overall Study|Global deterioration of health status|0|||
25306613|NCT01004822|50621860|FG001|Overall Study|Global deterioration of health status|0|||
25306614|NCT01004822|50621861|FG002|Overall Study|Global deterioration of health status|0|||
25306615|NCT01004822|50621862|FG003|Overall Study|Global deterioration of health status|1|||
25306616|NCT01004822|50621863|FG004|Overall Study|Global deterioration of health status|0|||
25306617|NCT01004822|50621864|FG005|Overall Study|Global deterioration of health status|0|||
25306618|NCT01004822|50621865|FG006|Overall Study|Global deterioration of health status|1|||
25306619|NCT01004822|50621866|FG007|Overall Study|Global deterioration of health status|0|||
25306620|NCT01004822|50621859|FG000|Overall Study|No longer willing to continue|0|||
25306621|NCT01004822|50621860|FG001|Overall Study|No longer willing to continue|0|||
25306622|NCT01004822|50621861|FG002|Overall Study|No longer willing to continue|0|||
25306623|NCT01004822|50621862|FG003|Overall Study|No longer willing to continue|1|||
25306624|NCT01004822|50621863|FG004|Overall Study|No longer willing to continue|2|||
25306625|NCT01004822|50621864|FG005|Overall Study|No longer willing to continue|1|||
25306626|NCT01004822|50621865|FG006|Overall Study|No longer willing to continue|1|||
25306627|NCT01004822|50621866|FG007|Overall Study|No longer willing to continue|0|||
25306628|NCT01004822|50621859|FG000|Overall Study|Adverse Event|0|||
25306629|NCT01004822|50621860|FG001|Overall Study|Adverse Event|0|||
25306630|NCT01004822|50621861|FG002|Overall Study|Adverse Event|0|||
25306631|NCT01004822|50621862|FG003|Overall Study|Adverse Event|0|||
25306632|NCT01004822|50621863|FG004|Overall Study|Adverse Event|0|||
25306633|NCT01004822|50621864|FG005|Overall Study|Adverse Event|0|||
25306634|NCT01004822|50621865|FG006|Overall Study|Adverse Event|1|||
25306635|NCT01004822|50621866|FG007|Overall Study|Adverse Event|1|||
25306636|NCT01004822|50621859|FG000|Overall Study|Other|0|||
25306637|NCT01004822|50621860|FG001|Overall Study|Other|0|||
25306638|NCT01004822|50621861|FG002|Overall Study|Other|4|||
25306639|NCT01004822|50621862|FG003|Overall Study|Other|1|||
25306640|NCT01004822|50621863|FG004|Overall Study|Other|0|||
25306641|NCT01004822|50621864|FG005|Overall Study|Other|1|||
25306642|NCT01004822|50621865|FG006|Overall Study|Other|0|||
25306643|NCT01004822|50621866|FG007|Overall Study|Other|0|||
25306644|NCT01001234|50621891|FG000|Overall Study|Withdrawal by Subject|2|||
25306645|NCT01001234|50621892|FG001|Overall Study|Withdrawal by Subject|0|||
25306646|NCT01001234|50621893|FG002|Overall Study|Withdrawal by Subject|3|||
25306647|NCT01001234|50621894|FG003|Overall Study|Withdrawal by Subject|0|||
25306648|NCT01001234|50621895|FG004|Overall Study|Withdrawal by Subject|0|||
25306649|NCT01001234|50621891|FG000|Overall Study|Protocol Violation|34|||
25306650|NCT01001234|50621892|FG001|Overall Study|Protocol Violation|3|||
25306651|NCT01001234|50621893|FG002|Overall Study|Protocol Violation|19|||
25306652|NCT01001234|50621894|FG003|Overall Study|Protocol Violation|18|||
25306653|NCT01001234|50621895|FG004|Overall Study|Protocol Violation|0|||
25306654|NCT01001234|50621891|FG000|Overall Study|Lost to Follow-up|0|||
25306655|NCT01001234|50621892|FG001|Overall Study|Lost to Follow-up|0|||
25306656|NCT01001234|50621893|FG002|Overall Study|Lost to Follow-up|1|||
25306657|NCT01001234|50621894|FG003|Overall Study|Lost to Follow-up|2|||
25306658|NCT01001234|50621895|FG004|Overall Study|Lost to Follow-up|0|||
25306659|NCT01001234|50621891|FG000|Overall Study|Physician Decision|1|||
25306660|NCT01001234|50621892|FG001|Overall Study|Physician Decision|0|||
25306661|NCT01001234|50621893|FG002|Overall Study|Physician Decision|0|||
25306662|NCT01001234|50621894|FG003|Overall Study|Physician Decision|0|||
25306663|NCT01001234|50621895|FG004|Overall Study|Physician Decision|0|||
25306664|NCT01001234|50621891|FG000|Overall Study|Not Treated: Adverse Event|1|||
25306665|NCT01001234|50621892|FG001|Overall Study|Not Treated: Adverse Event|0|||
25306666|NCT01001234|50621893|FG002|Overall Study|Not Treated: Adverse Event|0|||
25306667|NCT01001234|50621894|FG003|Overall Study|Not Treated: Adverse Event|0|||
25306668|NCT01001234|50621895|FG004|Overall Study|Not Treated: Adverse Event|0|||
25306669|NCT01001234|50621891|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
25306670|NCT01001234|50621892|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
25306671|NCT01001234|50621893|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
25306672|NCT01001234|50621894|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
25306673|NCT01001234|50621895|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
25306674|NCT01001234|50621891|FG000|Overall Study|Not Treated: Protocol Violation|3|||
25306675|NCT01001234|50621892|FG001|Overall Study|Not Treated: Protocol Violation|0|||
25306676|NCT01001234|50621893|FG002|Overall Study|Not Treated: Protocol Violation|0|||
25306677|NCT01001234|50621894|FG003|Overall Study|Not Treated: Protocol Violation|0|||
25306678|NCT01001234|50621895|FG004|Overall Study|Not Treated: Protocol Violation|0|||
25306679|NCT01001234|50621891|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
25306680|NCT01001234|50621892|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
25306681|NCT01001234|50621893|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
25306682|NCT01001234|50621894|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
25306683|NCT01001234|50621895|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
25306684|NCT01001234|50621891|FG000|Overall Study|Not Treated: Pregnancy|3|||
25169486|NCT03819114|50301332|FG002|Overall Study|Lost to Follow-up|1|||
25306685|NCT01001234|50621892|FG001|Overall Study|Not Treated: Pregnancy|0|||
25306686|NCT01001234|50621893|FG002|Overall Study|Not Treated: Pregnancy|0|||
25306687|NCT01001234|50621894|FG003|Overall Study|Not Treated: Pregnancy|0|||
25306688|NCT01001234|50621895|FG004|Overall Study|Not Treated: Pregnancy|0|||
25306689|NCT01001234|50621891|FG000|Overall Study|Not Treated: Physician Decision|37|||
25306690|NCT01001234|50621892|FG001|Overall Study|Not Treated: Physician Decision|4|||
25306691|NCT01001234|50621893|FG002|Overall Study|Not Treated: Physician Decision|0|||
25306692|NCT01001234|50621894|FG003|Overall Study|Not Treated: Physician Decision|0|||
25306693|NCT01001234|50621895|FG004|Overall Study|Not Treated: Physician Decision|0|||
25306694|NCT01001234|50621891|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
25306695|NCT01001234|50621892|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
25306696|NCT01001234|50621893|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
25306697|NCT01001234|50621894|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
25306698|NCT01001234|50621895|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
25306699|NCT01004510|50621901|FG000|Overall Study|Adverse Event|1|||
25306700|NCT02609503|50621905|FG000|Overall Study|Adverse Event|1|||
25306701|NCT02609503|50621905|FG000|Overall Study|Death|1|||
25306702|NCT02609503|50621905|FG000|Overall Study|Withdrawal by Subject|1|||
25306703|NCT02609503|50621905|FG000|Overall Study|Disease progression|1|||
25306704|NCT01004432|50621912|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
25306705|NCT01004432|50621913|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
25306706|NCT01004432|50621914|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
25306707|NCT01004432|50621915|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
25306708|NCT01004432|50621916|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
25306709|NCT01004432|50621912|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
25306710|NCT01004432|50621913|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
25306711|NCT01004432|50621914|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
25306712|NCT01004432|50621915|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
25306713|NCT01004432|50621916|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
25306714|NCT01004432|50621912|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
25306715|NCT01004432|50621913|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
25071158|NCT02578706|50177255|FG000|Overall Study|Physician Decision|0|||
25071159|NCT02578706|50177256|FG001|Overall Study|Physician Decision|1|||
25071160|NCT02578706|50177257|FG002|Overall Study|Physician Decision|0|||
25071161|NCT00108953|50177267|FG000|Follow-up|Death|18|||
25071162|NCT00108953|50177268|FG001|Follow-up|Death|26|||
25071163|NCT00108953|50177267|FG000|Follow-up|Lost to Follow-up|1|||
25071164|NCT00108953|50177268|FG001|Follow-up|Lost to Follow-up|1|||
25071165|NCT00108953|50177267|FG000|Follow-up|Study terminated by sponsor|10|||
25071166|NCT00108953|50177268|FG001|Follow-up|Study terminated by sponsor|6|||
25071167|NCT02578316|50177276|FG000|Extension Phase|Progression of disease|6|||
25071168|NCT02576678|50177287|FG000|Overall Study|Adverse Event|0|||
25071169|NCT02576678|50177288|FG001|Overall Study|Adverse Event|0|||
25071170|NCT02576678|50177289|FG002|Overall Study|Adverse Event|2|||
25071171|NCT02576678|50177287|FG000|Overall Study|Withdrawal by Subject|3|||
25071172|NCT02576678|50177288|FG001|Overall Study|Withdrawal by Subject|1|||
25071173|NCT02576678|50177289|FG002|Overall Study|Withdrawal by Subject|2|||
25071174|NCT02576678|50177287|FG000|Overall Study|Lost to Follow-up|0|||
25071175|NCT02576678|50177288|FG001|Overall Study|Lost to Follow-up|0|||
25071176|NCT02576678|50177289|FG002|Overall Study|Lost to Follow-up|1|||
25071177|NCT02576678|50177287|FG000|Overall Study|Miscellaneous|2|||
25071178|NCT02576678|50177288|FG001|Overall Study|Miscellaneous|0|||
25071179|NCT02576678|50177289|FG002|Overall Study|Miscellaneous|0|||
25071180|NCT00108745|50177300|FG000|Overall Study|Withdrawal by Subject|19|||
25071181|NCT00108745|50177301|FG001|Overall Study|Withdrawal by Subject|12|||
25071182|NCT00108745|50177302|FG002|Overall Study|Withdrawal by Subject|12|||
25071183|NCT00108745|50177300|FG000|Overall Study|Never Treated|8|||
25071184|NCT00108745|50177301|FG001|Overall Study|Never Treated|10|||
25071185|NCT00108745|50177302|FG002|Overall Study|Never Treated|12|||
25071186|NCT00108745|50177300|FG000|Overall Study|Ineligible|7|||
25071187|NCT00108745|50177301|FG001|Overall Study|Ineligible|13|||
25071188|NCT00108745|50177302|FG002|Overall Study|Ineligible|13|||
25071189|NCT02716805|50177332|FG000|Overall Study|Progressive disease|2|||
25071190|NCT02716805|50177333|FG001|Overall Study|Progressive disease|0|||
25071191|NCT02716805|50177334|FG002|Overall Study|Progressive disease|0|||
25071192|NCT02716805|50177335|FG003|Overall Study|Progressive disease|0|||
25071193|NCT02581982|50177339|FG000|Overall Study|Lack of Efficacy|12|||
25071194|NCT02581982|50177339|FG000|Overall Study|Adverse Event|3|||
25071195|NCT02581982|50177339|FG000|Overall Study|Physician Decision|1|||
25071196|NCT02576990|50177345|FG000|Overall Study|Death|29|||
25071197|NCT02576990|50177346|FG001|Overall Study|Death|18|||
25071198|NCT02576990|50177345|FG000|Overall Study|Physician Decision|1|||
25306716|NCT01004432|50621914|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
25306717|NCT01004432|50621915|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
25071199|NCT02576990|50177346|FG001|Overall Study|Physician Decision|0|||
25071200|NCT02576990|50177345|FG000|Overall Study|Screen failure|2|||
25071201|NCT02576990|50177346|FG001|Overall Study|Screen failure|0|||
25071202|NCT02576990|50177345|FG000|Overall Study|Sponsor's decision|24|||
25071203|NCT02576990|50177346|FG001|Overall Study|Sponsor's decision|4|||
25071204|NCT02576990|50177345|FG000|Overall Study|Withdrawal by Subject|0|||
25071205|NCT02576990|50177346|FG001|Overall Study|Withdrawal by Subject|2|||
25306718|NCT01004432|50621916|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
25306719|NCT01004432|50621912|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
25306720|NCT01004432|50621913|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
25306721|NCT01004432|50621914|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
25306722|NCT01004432|50621915|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
25306723|NCT01004432|50621916|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
25306724|NCT01004432|50621912|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
25306725|NCT01004432|50621913|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
25306726|NCT01004432|50621914|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
25306727|NCT01004432|50621915|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
25306728|NCT01004432|50621916|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
25306729|NCT01004432|50621912|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
25306730|NCT01004432|50621913|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
25306731|NCT01004432|50621914|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
25306732|NCT01004432|50621915|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
25306733|NCT01004432|50621916|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
25306734|NCT01004432|50621912|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
25306735|NCT01004432|50621913|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
25306736|NCT01004432|50621914|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
25306737|NCT01004432|50621915|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
25306738|NCT01004432|50621916|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
25306739|NCT01004432|50621912|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
25306740|NCT01004432|50621913|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
25306741|NCT01004432|50621914|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
25306742|NCT01004432|50621915|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
25306743|NCT01004432|50621916|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
25306744|NCT01004432|50621912|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
25306745|NCT01004432|50621913|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
25306746|NCT01004432|50621914|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
25306747|NCT01004432|50621915|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
25306748|NCT01004432|50621916|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
25306749|NCT01004432|50621912|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
25306750|NCT01004432|50621913|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
25306751|NCT01004432|50621914|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
25306752|NCT01004432|50621915|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
25306753|NCT01004432|50621916|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
25306754|NCT01004432|50621912|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
25306755|NCT01004432|50621913|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
25306756|NCT01004432|50621914|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
25306757|NCT01004432|50621915|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
25306758|NCT01004432|50621916|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
25306759|NCT01004432|50621912|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
25306760|NCT01004432|50621913|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
25306761|NCT01004432|50621914|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
25306762|NCT01004432|50621915|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
25306763|NCT01004432|50621916|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
25306764|NCT01004432|50621912|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
25306765|NCT01004432|50621913|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
25306766|NCT01004432|50621914|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
25306767|NCT01004432|50621915|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
25306768|NCT01004432|50621916|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
25306769|NCT01004432|50621912|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
25306770|NCT01004432|50621913|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
25306771|NCT01004432|50621914|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
25306772|NCT01004432|50621915|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
25071206|NCT04510285|50177352|FG000|Overall Study|Death|1|||
25071207|NCT02576054|50177356|FG000|Overall Study|Withdrawal by Subject|1|||
25071208|NCT01606202|50177364|FG000|Overall Study|Adverse Event|5|||
25071209|NCT01606202|50177365|FG001|Overall Study|Adverse Event|0|||
25071210|NCT01606202|50177364|FG000|Overall Study|Withdrawal by Subject|2|||
25071211|NCT01606202|50177365|FG001|Overall Study|Withdrawal by Subject|1|||
25071212|NCT01606202|50177364|FG000|Overall Study|Personal problems|0|||
25169487|NCT03819114|50301333|FG003|Overall Study|Lost to Follow-up|0|||
25071213|NCT01606202|50177365|FG001|Overall Study|Personal problems|1|||
25169488|NCT01827839|50301345|FG000|Overall Study|Adverse Event|1|||
25169489|NCT01827839|50301345|FG000|Overall Study|Consent Withdrawal|2|||
25169490|NCT01827371|50301360|FG000|Overall Study|Adverse Event|0|||
25306773|NCT01004432|50621916|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
25306774|NCT01004432|50621912|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
25306775|NCT01004432|50621913|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
25306776|NCT01004432|50621914|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
25306777|NCT01004432|50621915|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
25306778|NCT01004432|50621916|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
25306779|NCT01000610|50621930|FG000|Overall Study|Adverse Event|1|||
25306780|NCT01000610|50621930|FG000|Overall Study|Lost to Follow-up|4|||
25306781|NCT01000610|50621930|FG000|Overall Study|Treatment failure|1|||
25306782|NCT01877655|50621936|FG000|Overall Study|Death|57|||
25306783|NCT01877655|50621937|FG001|Overall Study|Death|52|||
25306784|NCT01877655|50621936|FG000|Overall Study|Withdrawal by Subject|18|||
25306785|NCT01877655|50621937|FG001|Overall Study|Withdrawal by Subject|26|||
25306786|NCT01877655|50621936|FG000|Overall Study|Physician Decision|11|||
25306787|NCT01877655|50621937|FG001|Overall Study|Physician Decision|10|||
25306788|NCT01877655|50621936|FG000|Overall Study|Miscellaneous|4|||
25306789|NCT01877655|50621937|FG001|Overall Study|Miscellaneous|4|||
25306790|NCT01877655|50621936|FG000|Overall Study|Randomized but Never Received Drug|8|||
25306791|NCT01877655|50621937|FG001|Overall Study|Randomized but Never Received Drug|5|||
25306792|NCT00586924|50621949|FG000|Overall Study|Adverse event/serious adverse event|0|||
25306793|NCT00586924|50621950|FG001|Overall Study|Adverse event/serious adverse event|0|||
25306794|NCT00586924|50621951|FG002|Overall Study|Adverse event/serious adverse event|0|||
25306795|NCT00586924|50621952|FG003|Overall Study|Adverse event/serious adverse event|1|||
25306796|NCT00586924|50621953|FG004|Overall Study|Adverse event/serious adverse event|0|||
25192142|NCT02581410|50356839|FG000|Vaccination Phase|Adverse Event|2|||
25192143|NCT02581410|50356840|FG001|Vaccination Phase|Adverse Event|1|||
25192144|NCT02581410|50356839|FG000|Vaccination Phase|Withdrawal by Subject|0|||
25192145|NCT02581410|50356840|FG001|Vaccination Phase|Withdrawal by Subject|1|||
25192146|NCT02581410|50356839|FG000|Vaccination Phase|Migrated/moved from study area|0|||
25192147|NCT02581410|50356840|FG001|Vaccination Phase|Migrated/moved from study area|1|||
25192148|NCT02581410|50356839|FG000|End of Study Phase|Adverse Event|4|||
25192149|NCT02581410|50356840|FG001|End of Study Phase|Adverse Event|3|||
25192150|NCT02581410|50356839|FG000|End of Study Phase|Withdrawal by Subject|1|||
25192151|NCT02581410|50356840|FG001|End of Study Phase|Withdrawal by Subject|2|||
25192152|NCT02581410|50356839|FG000|End of Study Phase|Migrated/moved from study area|0|||
25192153|NCT02581410|50356840|FG001|End of Study Phase|Migrated/moved from study area|3|||
25192154|NCT02581410|50356839|FG000|End of Study Phase|Lost to Follow-up|0|||
25192155|NCT02581410|50356840|FG001|End of Study Phase|Lost to Follow-up|2|||
25192156|NCT02581410|50356839|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
25192157|NCT02581410|50356840|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
25306797|NCT00586924|50621954|FG005|Overall Study|Adverse event/serious adverse event|2|||
25306798|NCT00586924|50621949|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
25071214|NCT01606202|50177364|FG000|Overall Study|Problems with administration|0|||
25071215|NCT01606202|50177365|FG001|Overall Study|Problems with administration|1|||
25071216|NCT01493960|50177373|FG000|Overall Study|Adverse Event|0|||
25071217|NCT01493960|50177374|FG001|Overall Study|Adverse Event|1|||
25071218|NCT01493960|50177373|FG000|Overall Study|Lack of Efficacy|15|||
25071219|NCT01493960|50177374|FG001|Overall Study|Lack of Efficacy|9|||
25071220|NCT01493960|50177373|FG000|Overall Study|Protocol Violation|3|||
25306799|NCT00586924|50621950|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
25306800|NCT00586924|50621951|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
25306801|NCT00586924|50621952|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
25306802|NCT00586924|50621953|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
25306803|NCT00586924|50621954|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
25306804|NCT00586924|50621949|FG000|Overall Study|Disease progression|0|||
25306805|NCT00586924|50621950|FG001|Overall Study|Disease progression|0|||
25306806|NCT00586924|50621951|FG002|Overall Study|Disease progression|0|||
25306807|NCT00586924|50621952|FG003|Overall Study|Disease progression|1|||
25306808|NCT00586924|50621953|FG004|Overall Study|Disease progression|1|||
25306809|NCT00586924|50621954|FG005|Overall Study|Disease progression|0|||
25306810|NCT00586924|50621949|FG000|Overall Study|Development of neutralizing antibodies|2|||
25306811|NCT00586924|50621950|FG001|Overall Study|Development of neutralizing antibodies|2|||
25306812|NCT00586924|50621951|FG002|Overall Study|Development of neutralizing antibodies|2|||
25306813|NCT00586924|50621952|FG003|Overall Study|Development of neutralizing antibodies|0|||
25306814|NCT00586924|50621953|FG004|Overall Study|Development of neutralizing antibodies|0|||
25306815|NCT00586924|50621954|FG005|Overall Study|Development of neutralizing antibodies|22|||
25306816|NCT00586924|50621949|FG000|Overall Study|Complete response|0|||
25306817|NCT00586924|50621950|FG001|Overall Study|Complete response|1|||
25306818|NCT00586924|50621951|FG002|Overall Study|Complete response|0|||
25306819|NCT00586924|50621952|FG003|Overall Study|Complete response|0|||
25306820|NCT00586924|50621953|FG004|Overall Study|Complete response|2|||
25306821|NCT00586924|50621954|FG005|Overall Study|Complete response|2|||
25306822|NCT00586924|50621949|FG000|Overall Study|Other|1|||
25306823|NCT00586924|50621950|FG001|Overall Study|Other|0|||
25306824|NCT00586924|50621951|FG002|Overall Study|Other|1|||
25306825|NCT00586924|50621952|FG003|Overall Study|Other|1|||
25306826|NCT00586924|50621953|FG004|Overall Study|Other|1|||
25306827|NCT00586924|50621954|FG005|Overall Study|Other|6|||
25306828|NCT01000376|50621970|FG000|Cycle 1 Day 1|Adverse Event|1|||
25306829|NCT01000376|50621971|FG001|Cycle 1 Day 1|Adverse Event|0|||
25306830|NCT01000376|50621970|FG000|Cycle 1 Day 1|Progressive Disease|1|||
25306831|NCT01000376|50621971|FG001|Cycle 1 Day 1|Progressive Disease|0|||
25306832|NCT01038635|50621986|FG000|Overall Study|Disease Progression|2|||
25071221|NCT01493960|50177374|FG001|Overall Study|Protocol Violation|0|||
25306833|NCT01038635|50621987|FG001|Overall Study|Disease Progression|0|||
25071222|NCT01493960|50177373|FG000|Overall Study|Withdrawal by Subject|10|||
25071223|NCT01493960|50177374|FG001|Overall Study|Withdrawal by Subject|4|||
25192158|NCT01664130|50356899|FG000|Overall Study|competing secondary disease|2|||
25192159|NCT02579928|50356930|FG000|Overall Study|Withdrawal by Subject|1|||
24970031|NCT04405570|50059528|FG002|Overall Study|Lost to Follow-up|0|||
25192160|NCT02579928|50356931|FG001|Overall Study|Withdrawal by Subject|0|||
25192161|NCT00551460|50357025|FG000|Overall Study|Adverse Event|1|||
25306834|NCT01038635|50621988|FG002|Overall Study|Disease Progression|0|||
25306835|NCT01038635|50621989|FG003|Overall Study|Disease Progression|0|||
25306836|NCT01038635|50621990|FG004|Overall Study|Disease Progression|0|||
25306837|NCT01038635|50621991|FG005|Overall Study|Disease Progression|0|||
25306838|NCT01038635|50621992|FG006|Overall Study|Disease Progression|1|||
25306839|NCT01038635|50621993|FG007|Overall Study|Disease Progression|4|||
25306840|NCT01038635|50621994|FG008|Overall Study|Disease Progression|0|||
25306841|NCT01038635|50621986|FG000|Overall Study|Death|0|||
25306842|NCT01038635|50621987|FG001|Overall Study|Death|0|||
25306843|NCT01038635|50621988|FG002|Overall Study|Death|0|||
25306844|NCT01038635|50621989|FG003|Overall Study|Death|0|||
25306845|NCT01038635|50621990|FG004|Overall Study|Death|1|||
25306846|NCT01038635|50621991|FG005|Overall Study|Death|0|||
25306847|NCT01038635|50621992|FG006|Overall Study|Death|1|||
25306848|NCT01038635|50621993|FG007|Overall Study|Death|1|||
25306849|NCT01038635|50621994|FG008|Overall Study|Death|2|||
25306850|NCT01000064|50622015|FG000|Overall Study|Withdrawal by Subject|1|||
25306851|NCT01000064|50622016|FG001|Overall Study|Withdrawal by Subject|1|||
25306852|NCT00766090|50622027|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25306853|NCT00766090|50622028|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25306854|NCT00766090|50622029|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25306855|NCT00766090|50622030|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25306856|NCT00766090|50622031|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25306857|NCT00766090|50622032|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25306858|NCT00766090|50622033|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25306859|NCT00766090|50622034|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25306860|NCT00766090|50622035|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
25306861|NCT00766090|50622036|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25306862|NCT00766090|50622037|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25306863|NCT00766090|50622038|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
25306864|NCT00766090|50622027|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
25306865|NCT00766090|50622028|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
25306866|NCT00766090|50622029|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
25306867|NCT00766090|50622030|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
25306868|NCT00766090|50622031|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
25306869|NCT00766090|50622032|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
25306870|NCT00766090|50622033|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
25306871|NCT00766090|50622034|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
25306872|NCT00766090|50622035|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
25306873|NCT00766090|50622036|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
25306874|NCT00766090|50622037|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
25306875|NCT00766090|50622038|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
25306876|NCT00766090|50622027|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
25306877|NCT00766090|50622028|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25306878|NCT00766090|50622029|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25306879|NCT00766090|50622030|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
25306880|NCT00766090|50622031|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25306881|NCT00766090|50622032|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25306882|NCT00766090|50622033|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25306883|NCT00766090|50622034|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25306884|NCT00766090|50622035|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25306885|NCT00766090|50622036|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25306886|NCT00766090|50622037|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25306887|NCT00766090|50622038|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
25306888|NCT00766090|50622027|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
25306889|NCT00766090|50622028|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
25306890|NCT00766090|50622029|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
25306891|NCT00766090|50622030|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
25306892|NCT00766090|50622031|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
25071224|NCT01493960|50177373|FG000|Overall Study|Non-specified|4|||
25192162|NCT00551460|50357025|FG000|Overall Study|Withdrawal by Subject|1|||
25306893|NCT00766090|50622032|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
25306894|NCT00766090|50622033|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
25306895|NCT00766090|50622034|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
25306896|NCT00766090|50622035|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
25306897|NCT00766090|50622036|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
25306898|NCT00766090|50622037|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
25306899|NCT00766090|50622038|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
25306900|NCT00766090|50622027|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25306901|NCT00766090|50622028|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25306902|NCT00766090|50622029|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25192163|NCT00551460|50357025|FG000|Overall Study|Physician Decision|1|||
25306903|NCT00766090|50622030|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25306904|NCT00766090|50622031|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
25306905|NCT00766090|50622032|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25306906|NCT00766090|50622033|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25306907|NCT00766090|50622034|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25306908|NCT00766090|50622035|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25306909|NCT00766090|50622036|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25306910|NCT00766090|50622037|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25306911|NCT00766090|50622038|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
25306912|NCT00766090|50622027|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
25306913|NCT00766090|50622028|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
25306914|NCT00766090|50622029|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
25306915|NCT00766090|50622030|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
25306916|NCT00766090|50622031|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
25306917|NCT00766090|50622032|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
25306918|NCT00766090|50622033|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
25306919|NCT00766090|50622034|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
25306920|NCT00766090|50622035|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
25306921|NCT00766090|50622036|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
25306922|NCT00766090|50622037|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
25306923|NCT00766090|50622038|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
25306924|NCT00766090|50622027|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
25306925|NCT00766090|50622028|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
25306926|NCT00766090|50622029|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
25306927|NCT00766090|50622030|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
25306928|NCT00766090|50622031|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
25306929|NCT00766090|50622032|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
25306930|NCT00766090|50622033|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
25306931|NCT00766090|50622034|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
25306932|NCT00766090|50622035|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
25306933|NCT00766090|50622036|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
25306934|NCT00766090|50622037|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
25306935|NCT00766090|50622038|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
25306936|NCT00766090|50622027|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
25306937|NCT00766090|50622028|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
25306938|NCT00766090|50622029|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
25306939|NCT00766090|50622030|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
25306940|NCT00766090|50622031|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
25306941|NCT00766090|50622032|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
25306942|NCT00766090|50622033|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
25306943|NCT00766090|50622034|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
25306944|NCT00766090|50622035|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
25306945|NCT00766090|50622036|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
25306946|NCT00766090|50622037|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
25306947|NCT00766090|50622038|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
25306948|NCT00766090|50622027|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
25306949|NCT00766090|50622028|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
25192164|NCT00551460|50357025|FG000|Overall Study|Death|7|||
25192165|NCT00551460|50357025|FG000|Overall Study|Ineligible|4|||
25192166|NCT00551460|50357025|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
25192167|NCT02579772|50357086|FG000|Overall Study|Withdrawal by Subject|0|||
25192168|NCT02579772|50357087|FG001|Overall Study|Withdrawal by Subject|1|||
25192169|NCT02579772|50357086|FG000|Overall Study|Usage of additional antioxidants|1|||
25192170|NCT02579772|50357087|FG001|Overall Study|Usage of additional antioxidants|0|||
25192171|NCT02579772|50357086|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
25192172|NCT02579772|50357087|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
25192173|NCT02579616|50357160|FG000|Overall Study|Participants did not receive treatment|3|||
25192174|NCT04027608|50357237|FG000|Overall Study|Withdrawal by Subject|13|||
25192175|NCT04027608|50357238|FG001|Overall Study|Withdrawal by Subject|2|||
25192176|NCT04027608|50357237|FG000|Overall Study|Protocol Violation|2|||
25306950|NCT00766090|50622029|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
25306951|NCT00766090|50622030|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
25169491|NCT01827371|50301361|FG001|Overall Study|Adverse Event|0|||
24970032|NCT04405570|50059529|FG003|Overall Study|Lost to Follow-up|0|||
25169492|NCT01827371|50301362|FG002|Overall Study|Adverse Event|4|||
25169493|NCT01827371|50301363|FG003|Overall Study|Adverse Event|2|||
25169494|NCT01827371|50301360|FG000|Overall Study|Lost to Follow-up|0|||
25169495|NCT01827371|50301361|FG001|Overall Study|Lost to Follow-up|2|||
25169496|NCT01827371|50301362|FG002|Overall Study|Lost to Follow-up|0|||
25169497|NCT01827371|50301363|FG003|Overall Study|Lost to Follow-up|4|||
25169498|NCT01827371|50301360|FG000|Overall Study|Protocol Violation|1|||
25306952|NCT00766090|50622031|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
25306953|NCT00766090|50622032|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
25306954|NCT00766090|50622033|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
25306955|NCT00766090|50622034|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
25306956|NCT00766090|50622035|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
25306957|NCT00766090|50622036|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
25306958|NCT00766090|50622037|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
25306959|NCT00766090|50622038|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
25306960|NCT00766090|50622027|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
25306961|NCT00766090|50622028|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
25306962|NCT00766090|50622029|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
25306963|NCT00766090|50622030|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
25306964|NCT00766090|50622031|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
25306965|NCT00766090|50622032|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
25306966|NCT00766090|50622033|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
25306967|NCT00766090|50622034|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
25306968|NCT00766090|50622035|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
25306969|NCT00766090|50622036|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
25306970|NCT00766090|50622037|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
25306971|NCT00766090|50622038|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
25306972|NCT00580801|50622055|FG000|Overall Study|Physician Decision|1|||
25306973|NCT00580801|50622056|FG001|Overall Study|Physician Decision|0|||
25306974|NCT00580801|50622057|FG002|Overall Study|Physician Decision|0|||
25306975|NCT00580801|50622055|FG000|Overall Study|Adverse Event|2|||
25306976|NCT00580801|50622056|FG001|Overall Study|Adverse Event|0|||
25306977|NCT00580801|50622057|FG002|Overall Study|Adverse Event|0|||
25306978|NCT00580801|50622055|FG000|Overall Study|Lost to Follow-up|2|||
25306979|NCT00580801|50622056|FG001|Overall Study|Lost to Follow-up|0|||
25306980|NCT00580801|50622057|FG002|Overall Study|Lost to Follow-up|0|||
25306981|NCT00580801|50622055|FG000|Overall Study|Reached a virologic endpoint|0|||
25306982|NCT00580801|50622056|FG001|Overall Study|Reached a virologic endpoint|1|||
25306983|NCT00580801|50622057|FG002|Overall Study|Reached a virologic endpoint|2|||
25306984|NCT00580801|50622055|FG000|Overall Study|Participant non-compliant|0|||
25306985|NCT00580801|50622056|FG001|Overall Study|Participant non-compliant|0|||
25306986|NCT00580801|50622057|FG002|Overall Study|Participant non-compliant|1|||
25306987|NCT00580801|50622055|FG000|Overall Study|Travel|1|||
25306988|NCT00580801|50622056|FG001|Overall Study|Travel|0|||
25306989|NCT00580801|50622057|FG002|Overall Study|Travel|0|||
25306990|NCT01059539|50622065|FG000|Overall Study|Adverse Event|66|||
25306991|NCT01059539|50622065|FG000|Overall Study|Insufficient Therapeutic Response|26|||
25306992|NCT01059539|50622065|FG000|Overall Study|Protocol Violation|55|||
25306993|NCT01059539|50622065|FG000|Overall Study|Withdrawal of Consent|80|||
25306994|NCT01059539|50622065|FG000|Overall Study|Lost to Follow-up|42|||
25306995|NCT01059539|50622065|FG000|Overall Study|Reason Not Specified|2|||
25306996|NCT00999908|50622069|FG000|Treatment Period 1|Subject withdrew consent|2|||
25306997|NCT00999908|50622070|FG001|Treatment Period 1|Subject withdrew consent|0|||
25306998|NCT00999908|50622071|FG002|Treatment Period 1|Subject withdrew consent|0|||
25306999|NCT00999908|50622069|FG000|Treatment Period 2|Protocol Violation|1|||
25307000|NCT00999908|50622070|FG001|Treatment Period 2|Protocol Violation|0|||
25307001|NCT00999908|50622071|FG002|Treatment Period 2|Protocol Violation|0|||
25307002|NCT00580723|50622079|FG000|Overall Study|Did not want to participate in extension|3|||
25307003|NCT00580723|50622079|FG000|Overall Study|Lost to Follow-up|5|||
25307004|NCT00999596|50622083|FG000|Overall Study|Statistical population not required|101|||
25307005|NCT04676867|50622092|FG000|Overall Study|Screen failure|0|||
25307006|NCT04676867|50622093|FG001|Overall Study|Screen failure|0|||
25307007|NCT04676867|50622094|FG002|Overall Study|Screen failure|6|||
25307008|NCT04676867|50622095|FG003|Overall Study|Screen failure|2|||
25307009|NCT04676867|50622092|FG000|Overall Study|Death|0|||
25307010|NCT04676867|50622093|FG001|Overall Study|Death|0|||
25307011|NCT04676867|50622094|FG002|Overall Study|Death|1|||
25307012|NCT04676867|50622095|FG003|Overall Study|Death|0|||
25307013|NCT04676867|50622092|FG000|Overall Study|Withdrawal by Subject|2|||
25307014|NCT04676867|50622093|FG001|Overall Study|Withdrawal by Subject|2|||
25307015|NCT04676867|50622094|FG002|Overall Study|Withdrawal by Subject|4|||
25307016|NCT04676867|50622095|FG003|Overall Study|Withdrawal by Subject|4|||
25307017|NCT04676867|50622092|FG000|Overall Study|Lost to Follow-up|1|||
25307018|NCT04676867|50622093|FG001|Overall Study|Lost to Follow-up|0|||
25307019|NCT04676867|50622094|FG002|Overall Study|Lost to Follow-up|0|||
25307020|NCT04676867|50622095|FG003|Overall Study|Lost to Follow-up|0|||
25307021|NCT00770224|50622105|FG000|Step 1: Induction|Adverse Event|3|||
25307022|NCT00770224|50622106|FG001|Step 1: Induction|Adverse Event|0|||
25307023|NCT00770224|50622105|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
25307024|NCT00770224|50622106|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
25307025|NCT00770224|50622105|FG000|Step 1: Induction|Other reason not protocol specified|2|||
25307026|NCT00770224|50622106|FG001|Step 1: Induction|Other reason not protocol specified|0|||
25071225|NCT01493960|50177374|FG001|Overall Study|Non-specified|4|||
25071226|NCT02630459|50177384|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
25071227|NCT02630459|50177385|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
25071228|NCT02630459|50177386|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
25071229|NCT02630459|50177387|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
25071230|NCT02630459|50177388|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
25071231|NCT02630459|50177389|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
25071232|NCT02630459|50177390|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
25071233|NCT02630459|50177391|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
25071234|NCT02630459|50177384|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
25071235|NCT02630459|50177385|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
25071236|NCT02630459|50177386|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
25071237|NCT02630459|50177387|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
25071238|NCT02630459|50177388|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
25307027|NCT00770224|50622105|FG000|Step 1: Induction|Ineligible|2|||
25307028|NCT00770224|50622106|FG001|Step 1: Induction|Ineligible|0|||
25307029|NCT00770224|50622105|FG000|Step 1: Induction|No protocol treatment given|1|||
25307030|NCT00770224|50622106|FG001|Step 1: Induction|No protocol treatment given|0|||
25307031|NCT00770224|50622105|FG000|Step 2: Maintenance|Adverse Event|0|||
25307032|NCT00770224|50622106|FG001|Step 2: Maintenance|Adverse Event|10|||
25307033|NCT00770224|50622105|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
25307034|NCT00770224|50622106|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
25307035|NCT00770224|50622105|FG000|Step 2: Maintenance|Progression/relapse|0|||
25307036|NCT00770224|50622106|FG001|Step 2: Maintenance|Progression/relapse|1|||
25307037|NCT00770224|50622105|FG000|Step 2: Maintenance|Death|0|||
25307038|NCT00770224|50622106|FG001|Step 2: Maintenance|Death|2|||
25307039|NCT00770224|50622105|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
25307040|NCT00770224|50622106|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
25307041|NCT00770224|50622105|FG000|Step 2: Maintenance|Ineligible|0|||
25307042|NCT00770224|50622106|FG001|Step 2: Maintenance|Ineligible|2|||
25307043|NCT02399215|50622113|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
25307044|NCT02399215|50622113|FG000|Overall Study|Withdrawal by Subject|1|||
25307045|NCT01057589|50622117|FG000|Overall Study|Disease Progression|35|||
25307046|NCT01057589|50622117|FG000|Overall Study|Adverse Event|10|||
25307047|NCT01057589|50622117|FG000|Overall Study|Physician Decision|8|||
25307048|NCT01057589|50622117|FG000|Overall Study|Withdrawal by Subject|3|||
25307049|NCT01057589|50622117|FG000|Overall Study|Sponsor Decision|1|||
25307050|NCT01057589|50622117|FG000|Overall Study|Death|8|||
25307051|NCT01057589|50622117|FG000|Overall Study|Lost to Follow-up|1|||
25307052|NCT01716117|50622123|FG000|Overall Study|Death|5|||
25307053|NCT01716117|50622124|FG001|Overall Study|Death|2|||
25307054|NCT01716117|50622123|FG000|Overall Study|Withdrawal by Subject|2|||
25307055|NCT01716117|50622124|FG001|Overall Study|Withdrawal by Subject|0|||
25307056|NCT00579553|50622140|FG000|Overall Study|Lost to Follow-up|16|||
25307057|NCT00579553|50622141|FG001|Overall Study|Lost to Follow-up|13|||
25307058|NCT01650831|50622147|FG000|Overall Study|Screen failure|1|||
25307059|NCT00581893|50622155|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
25307060|NCT00581893|50622156|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
25307061|NCT00770146|50622164|FG000|Treatment Period|Withdrawal by Subject|6|||
25307062|NCT00770146|50622165|FG001|Treatment Period|Withdrawal by Subject|13|||
25307063|NCT00770146|50622164|FG000|Treatment Period|Adverse Event|2|||
25307064|NCT00770146|50622165|FG001|Treatment Period|Adverse Event|26|||
25307065|NCT00770146|50622164|FG000|Treatment Period|Other|1|||
25307066|NCT00770146|50622165|FG001|Treatment Period|Other|5|||
25307067|NCT00770146|50622164|FG000|Treatment Period|Protocol non-compliance|0|||
25307068|NCT00770146|50622165|FG001|Treatment Period|Protocol non-compliance|1|||
25307069|NCT00770146|50622164|FG000|Follow-up Period|Withdrawal by Subject|7|||
25307070|NCT00770146|50622165|FG001|Follow-up Period|Withdrawal by Subject|13|||
25307071|NCT00770146|50622164|FG000|Follow-up Period|Adverse Event|0|||
25307072|NCT00770146|50622165|FG001|Follow-up Period|Adverse Event|2|||
25307073|NCT00770146|50622164|FG000|Follow-up Period|Other|4|||
25307074|NCT00770146|50622165|FG001|Follow-up Period|Other|5|||
25307075|NCT01056341|50622176|FG000|Overall Study|Treatment Intolerance|0|||
25307076|NCT01056341|50622177|FG001|Overall Study|Treatment Intolerance|2|||
25307077|NCT01056341|50622178|FG002|Overall Study|Treatment Intolerance|0|||
25307078|NCT01056341|50622179|FG003|Overall Study|Treatment Intolerance|2|||
25307079|NCT01056341|50622180|FG004|Overall Study|Treatment Intolerance|0|||
25307080|NCT01056341|50622176|FG000|Overall Study|Lack of Efficacy|32|||
25307081|NCT01056341|50622177|FG001|Overall Study|Lack of Efficacy|30|||
25307082|NCT01056341|50622178|FG002|Overall Study|Lack of Efficacy|7|||
25307083|NCT01056341|50622179|FG003|Overall Study|Lack of Efficacy|25|||
25307084|NCT01056341|50622180|FG004|Overall Study|Lack of Efficacy|9|||
25307085|NCT01056341|50622176|FG000|Overall Study|Other reasons|4|||
25307086|NCT01056341|50622177|FG001|Overall Study|Other reasons|4|||
25307087|NCT01056341|50622178|FG002|Overall Study|Other reasons|8|||
25307088|NCT01056341|50622179|FG003|Overall Study|Other reasons|9|||
25307089|NCT01056341|50622180|FG004|Overall Study|Other reasons|5|||
25307090|NCT00999518|50622203|FG000|Overall Study|Adverse Event|1|||
25307091|NCT00999518|50622204|FG001|Overall Study|Adverse Event|6|||
25307092|NCT00999518|50622205|FG002|Overall Study|Adverse Event|3|||
25307093|NCT00999518|50622206|FG003|Overall Study|Adverse Event|1|||
25307094|NCT00999518|50622207|FG004|Overall Study|Adverse Event|2|||
25307095|NCT00999518|50622203|FG000|Overall Study|Lack of Efficacy|2|||
25307096|NCT00999518|50622204|FG001|Overall Study|Lack of Efficacy|0|||
25307097|NCT00999518|50622205|FG002|Overall Study|Lack of Efficacy|0|||
25307098|NCT00999518|50622206|FG003|Overall Study|Lack of Efficacy|2|||
25307099|NCT00999518|50622207|FG004|Overall Study|Lack of Efficacy|2|||
25307100|NCT00999518|50622203|FG000|Overall Study|Lost to Follow-up|0|||
25307101|NCT00999518|50622204|FG001|Overall Study|Lost to Follow-up|0|||
25307102|NCT00999518|50622205|FG002|Overall Study|Lost to Follow-up|0|||
25307103|NCT00999518|50622206|FG003|Overall Study|Lost to Follow-up|4|||
25307104|NCT00999518|50622207|FG004|Overall Study|Lost to Follow-up|1|||
25307105|NCT00999518|50622203|FG000|Overall Study|Did not meet entrance criteria|0|||
25307106|NCT00999518|50622204|FG001|Overall Study|Did not meet entrance criteria|0|||
24970033|NCT04405570|50059526|FG000|Overall Study|Physician Decision|0|||
25169499|NCT01827371|50301361|FG001|Overall Study|Protocol Violation|0|||
25307107|NCT00999518|50622205|FG002|Overall Study|Did not meet entrance criteria|0|||
25307108|NCT00999518|50622206|FG003|Overall Study|Did not meet entrance criteria|0|||
25307109|NCT00999518|50622207|FG004|Overall Study|Did not meet entrance criteria|1|||
25307110|NCT00999518|50622203|FG000|Overall Study|Study terminated by sponsor|10|||
25307111|NCT00999518|50622204|FG001|Overall Study|Study terminated by sponsor|6|||
25307112|NCT00999518|50622205|FG002|Overall Study|Study terminated by sponsor|5|||
25307113|NCT00999518|50622206|FG003|Overall Study|Study terminated by sponsor|5|||
25307114|NCT00999518|50622207|FG004|Overall Study|Study terminated by sponsor|9|||
25307115|NCT00999518|50622203|FG000|Overall Study|Pregnancy|0|||
25307116|NCT00999518|50622204|FG001|Overall Study|Pregnancy|0|||
25307117|NCT00999518|50622205|FG002|Overall Study|Pregnancy|1|||
25307118|NCT00999518|50622206|FG003|Overall Study|Pregnancy|0|||
25307119|NCT00999518|50622207|FG004|Overall Study|Pregnancy|0|||
25307120|NCT00999518|50622203|FG000|Overall Study|Protocol Violation|0|||
25307121|NCT00999518|50622204|FG001|Overall Study|Protocol Violation|1|||
25307122|NCT00999518|50622205|FG002|Overall Study|Protocol Violation|0|||
25307123|NCT00999518|50622206|FG003|Overall Study|Protocol Violation|0|||
25307124|NCT00999518|50622207|FG004|Overall Study|Protocol Violation|2|||
25307125|NCT00999518|50622203|FG000|Overall Study|Withdrawal by Subject|5|||
25307126|NCT00999518|50622204|FG001|Overall Study|Withdrawal by Subject|4|||
25307127|NCT00999518|50622205|FG002|Overall Study|Withdrawal by Subject|10|||
25307128|NCT00999518|50622206|FG003|Overall Study|Withdrawal by Subject|6|||
25307129|NCT00999518|50622207|FG004|Overall Study|Withdrawal by Subject|1|||
25307130|NCT00999518|50622203|FG000|Overall Study|Other|5|||
25307131|NCT00999518|50622204|FG001|Overall Study|Other|7|||
25307132|NCT00999518|50622205|FG002|Overall Study|Other|1|||
25307133|NCT00999518|50622206|FG003|Overall Study|Other|4|||
25307134|NCT00999518|50622207|FG004|Overall Study|Other|5|||
25307135|NCT00999518|50622203|FG000|Overall Study|Randomized but not Treated|1|||
25307136|NCT00999518|50622204|FG001|Overall Study|Randomized but not Treated|1|||
25307137|NCT00999518|50622205|FG002|Overall Study|Randomized but not Treated|2|||
25307138|NCT00999518|50622206|FG003|Overall Study|Randomized but not Treated|0|||
25307139|NCT00999518|50622207|FG004|Overall Study|Randomized but not Treated|1|||
25307140|NCT01056263|50622223|FG000|Overall Study|Adverse Event|12|||
25307141|NCT01056263|50622223|FG000|Overall Study|Death|1|||
25307142|NCT01056263|50622223|FG000|Overall Study|Withdrawal by Subject|1|||
25307143|NCT01056263|50622223|FG000|Overall Study|Lack of Efficacy|29|||
25307144|NCT01056263|50622223|FG000|Overall Study|Progressive disease|2|||
25307145|NCT01056263|50622223|FG000|Overall Study|Neoplasm progression|1|||
25307146|NCT01056263|50622223|FG000|Overall Study|Objective progression or relapse|1|||
25307147|NCT01056263|50622223|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
25307148|NCT01056107|50622231|FG000|Overall Study|Withdrawal by Subject|0|||
25307149|NCT01056107|50622232|FG001|Overall Study|Withdrawal by Subject|1|||
25307150|NCT01056107|50622233|FG002|Overall Study|Withdrawal by Subject|3|||
25307151|NCT01056107|50622234|FG003|Overall Study|Withdrawal by Subject|0|||
25307152|NCT01003886|50622244|FG000|Overall Study|Lack of Efficacy|5|||
25307153|NCT01003886|50622244|FG000|Overall Study|Lost to Follow-up|169|||
25307154|NCT01003886|50622244|FG000|Overall Study|Withdrawal by Subject|39|||
25169500|NCT01827371|50301362|FG002|Overall Study|Protocol Violation|0|||
25169501|NCT01827371|50301363|FG003|Overall Study|Protocol Violation|0|||
25169502|NCT01827371|50301360|FG000|Overall Study|Withdrawal by Subject|1|||
25307155|NCT01003886|50622244|FG000|Overall Study|Other|14|||
25169503|NCT01827371|50301361|FG001|Overall Study|Withdrawal by Subject|2|||
25307156|NCT01003886|50622244|FG000|Overall Study|Adverse Event|3|||
25307157|NCT01003184|50622250|FG000|Overall Study|Adverse Event|12|||
25169504|NCT01827371|50301362|FG002|Overall Study|Withdrawal by Subject|2|||
25307158|NCT01003184|50622251|FG001|Overall Study|Adverse Event|5|||
25307159|NCT01003184|50622250|FG000|Overall Study|Lost to Follow-up|1|||
25307160|NCT01003184|50622251|FG001|Overall Study|Lost to Follow-up|0|||
25307161|NCT01003184|50622250|FG000|Overall Study|Loss of glucose control|1|||
25307162|NCT01003184|50622251|FG001|Overall Study|Loss of glucose control|1|||
25307163|NCT01003184|50622250|FG000|Overall Study|Protocol Violation|3|||
25169505|NCT01827371|50301363|FG003|Overall Study|Withdrawal by Subject|3|||
25169506|NCT01827371|50301360|FG000|Overall Study|Physician Decision|0|||
25169507|NCT01827371|50301361|FG001|Overall Study|Physician Decision|1|||
25169508|NCT01827371|50301362|FG002|Overall Study|Physician Decision|0|||
25169509|NCT01827371|50301363|FG003|Overall Study|Physician Decision|1|||
25169510|NCT01827371|50301360|FG000|Overall Study|Temporary study halt to vaccinations|11|||
25307164|NCT01003184|50622251|FG001|Overall Study|Protocol Violation|0|||
25307165|NCT01003184|50622250|FG000|Overall Study|Withdrawal by Subject|1|||
25307166|NCT01003184|50622251|FG001|Overall Study|Withdrawal by Subject|6|||
25307167|NCT01003184|50622250|FG000|Overall Study|Physician Decision|1|||
25307168|NCT01003184|50622251|FG001|Overall Study|Physician Decision|0|||
25307169|NCT01029353|50622261|FG000|Overall Study|Lost to Follow-up|4|||
25307170|NCT01029353|50622262|FG001|Overall Study|Lost to Follow-up|5|||
25307171|NCT01029353|50622263|FG002|Overall Study|Lost to Follow-up|5|||
25307172|NCT01029353|50622264|FG003|Overall Study|Lost to Follow-up|4|||
25307173|NCT01029353|50622261|FG000|Overall Study|Consent Withdrawn|2|||
25307174|NCT01029353|50622262|FG001|Overall Study|Consent Withdrawn|0|||
25307175|NCT01029353|50622263|FG002|Overall Study|Consent Withdrawn|0|||
25307176|NCT01029353|50622264|FG003|Overall Study|Consent Withdrawn|0|||
25307177|NCT01029353|50622261|FG000|Overall Study|Primary Outcome Indeterminate|1|||
25307178|NCT01029353|50622262|FG001|Overall Study|Primary Outcome Indeterminate|3|||
25307179|NCT01029353|50622263|FG002|Overall Study|Primary Outcome Indeterminate|2|||
25307180|NCT01029353|50622264|FG003|Overall Study|Primary Outcome Indeterminate|0|||
25307181|NCT01008410|50622276|FG000|Overall Study|Adverse Event|13|||
25307182|NCT01008410|50622277|FG001|Overall Study|Adverse Event|7|||
25307183|NCT01008410|50622276|FG000|Overall Study|Withdrawal by Subject|6|||
25307184|NCT01008410|50622277|FG001|Overall Study|Withdrawal by Subject|2|||
25307185|NCT01008410|50622276|FG000|Overall Study|Lost to Follow-up|1|||
25307186|NCT01008410|50622277|FG001|Overall Study|Lost to Follow-up|0|||
25307187|NCT01008410|50622276|FG000|Overall Study|Noncompliance|1|||
25307188|NCT01008410|50622277|FG001|Overall Study|Noncompliance|0|||
25307189|NCT01008410|50622276|FG000|Overall Study|Low Cortisol|2|||
25307190|NCT01008410|50622277|FG001|Overall Study|Low Cortisol|0|||
25307191|NCT01008410|50622276|FG000|Overall Study|Lack of Efficacy|2|||
25307192|NCT01008410|50622277|FG001|Overall Study|Lack of Efficacy|6|||
25307193|NCT01008410|50622276|FG000|Overall Study|Met Exclusion Criterion|0|||
25307194|NCT01008410|50622277|FG001|Overall Study|Met Exclusion Criterion|1|||
25307195|NCT01023269|50622283|FG000|Overall Study|early termination of the study|2|||
25307196|NCT01023269|50622284|FG001|Overall Study|early termination of the study|0|||
25307197|NCT01007942|50622316|FG000|Overall Study|Adverse Event|29|||
25307198|NCT01007942|50622317|FG001|Overall Study|Adverse Event|14|||
25307199|NCT01007942|50622316|FG000|Overall Study|Abnormal test procedure|0|||
25307200|NCT01007942|50622317|FG001|Overall Study|Abnormal test procedure|1|||
25307201|NCT01007942|50622316|FG000|Overall Study|Disease progression|217|||
25307202|NCT01007942|50622317|FG001|Overall Study|Disease progression|242|||
25307203|NCT01007942|50622316|FG000|Overall Study|New cancer therapy|5|||
25307204|NCT01007942|50622317|FG001|Overall Study|New cancer therapy|1|||
25307205|NCT01007942|50622316|FG000|Overall Study|Protocol Violation|1|||
25307206|NCT01007942|50622317|FG001|Overall Study|Protocol Violation|1|||
25307207|NCT01007942|50622316|FG000|Overall Study|Withdrawal by Subject|19|||
25307208|NCT01007942|50622317|FG001|Overall Study|Withdrawal by Subject|14|||
25307209|NCT01007942|50622316|FG000|Overall Study|Lost to Follow-up|1|||
25307210|NCT01007942|50622317|FG001|Overall Study|Lost to Follow-up|0|||
25307211|NCT01007942|50622316|FG000|Overall Study|Administrative problems|2|||
25307212|NCT01007942|50622317|FG001|Overall Study|Administrative problems|0|||
25307213|NCT01007942|50622316|FG000|Overall Study|Death|3|||
25307214|NCT01007942|50622317|FG001|Overall Study|Death|2|||
25307215|NCT01007942|50622316|FG000|Overall Study|Patients untreated|4|||
25307216|NCT01007942|50622317|FG001|Overall Study|Patients untreated|3|||
25307217|NCT01023035|50622330|FG000|Treatment Period|Adverse Event|27|||
25307218|NCT01023035|50622331|FG001|Treatment Period|Adverse Event|32|||
25307219|NCT01023035|50622332|FG002|Treatment Period|Adverse Event|50|||
25307220|NCT01023035|50622330|FG000|Treatment Period|Non-Medical Reasons|19|||
25307221|NCT01023035|50622331|FG001|Treatment Period|Non-Medical Reasons|22|||
25307222|NCT01023035|50622332|FG002|Treatment Period|Non-Medical Reasons|44|||
25307223|NCT01023035|50622330|FG000|Treatment Period|Treatment Failure|26|||
25307224|NCT01023035|50622331|FG001|Treatment Period|Treatment Failure|31|||
25307225|NCT01023035|50622332|FG002|Treatment Period|Treatment Failure|24|||
25169511|NCT01827371|50301361|FG001|Overall Study|Temporary study halt to vaccinations|2|||
25307226|NCT01023035|50622330|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
25307227|NCT01023035|50622331|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
25307228|NCT01023035|50622332|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
25307229|NCT01023035|50622330|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
25307230|NCT01023035|50622331|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
25307231|NCT01023035|50622332|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
25307232|NCT01028651|50622342|FG000|Overall Study|Death|2|||
25307233|NCT01028651|50622342|FG000|Overall Study|Adverse Event|1|||
25307234|NCT01028027|50622350|FG000|Overall Study|Lost to Follow-up|4|||
25307235|NCT01028027|50622351|FG001|Overall Study|Lost to Follow-up|1|||
25307236|NCT01028027|50622350|FG000|Overall Study|Withdrawal by Subject|5|||
25307237|NCT01028027|50622351|FG001|Overall Study|Withdrawal by Subject|3|||
25307238|NCT01028027|50622350|FG000|Overall Study|Adverse Event|4|||
25307239|NCT01028027|50622351|FG001|Overall Study|Adverse Event|7|||
25307240|NCT01028027|50622350|FG000|Overall Study|Protocol Violation|3|||
25307241|NCT01028027|50622351|FG001|Overall Study|Protocol Violation|1|||
25307242|NCT01028027|50622350|FG000|Overall Study|Lack of Efficacy|0|||
25307243|NCT01028027|50622351|FG001|Overall Study|Lack of Efficacy|1|||
25307244|NCT01007552|50622357|FG000|Overall Study|Withdrawal by Subject|1|||
25307245|NCT01007396|50622361|FG000|Overall Study|Lost to Follow-up|47|||
25307246|NCT00998738|50622365|FG000|Overall Study|Uknown|1|||
25307247|NCT00997334|50622369|FG000|Overall Study|still on therapy|12|||
25307248|NCT00997334|50622369|FG000|Overall Study|Adverse Event|3|||
25307249|NCT00997334|50622369|FG000|Overall Study|Patient non-compliance|1|||
25307250|NCT00997334|50622369|FG000|Overall Study|Withdrawal by Subject|3|||
25307251|NCT00997334|50622369|FG000|Overall Study|Death|2|||
25307252|NCT00997334|50622369|FG000|Overall Study|Urgent Palliative Care|2|||
25307253|NCT00997334|50622369|FG000|Overall Study|No lesion amenable|1|||
25307254|NCT00997334|50622369|FG000|Overall Study|Ineligible|1|||
25307255|NCT00996944|50622375|FG000|Double-blind Treatment Period|Adverse Event|2|||
25307256|NCT00996944|50622376|FG001|Double-blind Treatment Period|Adverse Event|1|||
25307257|NCT00996944|50622375|FG000|Double-blind Treatment Period|Protocol Violation|1|||
25307258|NCT00996944|50622376|FG001|Double-blind Treatment Period|Protocol Violation|0|||
25307259|NCT00996944|50622375|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
25307260|NCT00996944|50622376|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
25307261|NCT00996944|50622375|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
25307262|NCT00996944|50622376|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
25307263|NCT00996944|50622375|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
25307264|NCT00996944|50622376|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
25307265|NCT01002482|50622386|FG000|Overall Study|Withdrawal by Subject|14|||
25307266|NCT01002482|50622387|FG001|Overall Study|Withdrawal by Subject|21|||
25307267|NCT01002482|50622386|FG000|Overall Study|Included twice|1|||
25307268|NCT01002482|50622387|FG001|Overall Study|Included twice|0|||
25307269|NCT01027949|50622393|FG000|Overall Study|Death|174|||
25307270|NCT01027949|50622393|FG000|Overall Study|Progressive Disease|163|||
25307271|NCT01027949|50622393|FG000|Overall Study|Adverse Event|172|||
25307272|NCT01027949|50622393|FG000|Overall Study|Withdrawal by Subject|113|||
25307273|NCT01027949|50622393|FG000|Overall Study|Lost to Follow-up|17|||
25307274|NCT01027949|50622393|FG000|Overall Study|Protocol Violation|13|||
25307275|NCT01027949|50622393|FG000|Overall Study|PI Decision|8|||
25307276|NCT01027949|50622393|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
25307277|NCT01027949|50622393|FG000|Overall Study|Non-compliance with Study Procedures|7|||
25307278|NCT01027949|50622393|FG000|Overall Study|Lung Transplant|5|||
25307279|NCT01027949|50622393|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
25307280|NCT01027949|50622393|FG000|Overall Study|Use of Excluded Medication|2|||
25307281|NCT01027949|50622393|FG000|Overall Study|Patient Self-discontinuation|1|||
25307282|NCT01027949|50622393|FG000|Overall Study|Pregnancy|1|||
25307283|NCT01027949|50622393|FG000|Overall Study|Surgery|1|||
25307284|NCT01038323|50622400|FG000|Overall Study|Withdrawal by Subject|3|||
25307285|NCT01038323|50622401|FG001|Overall Study|Withdrawal by Subject|2|||
25307286|NCT01038323|50622402|FG002|Overall Study|Withdrawal by Subject|4|||
25307287|NCT01027871|50622413|FG000|Overall Study|Physician Decision|1|||
25307288|NCT01027871|50622414|FG001|Overall Study|Physician Decision|5|||
25307289|NCT01027871|50622415|FG002|Overall Study|Physician Decision|0|||
25307290|NCT01027871|50622413|FG000|Overall Study|Protocol Violation|0|||
25307291|NCT01027871|50622414|FG001|Overall Study|Protocol Violation|2|||
25307292|NCT01027871|50622415|FG002|Overall Study|Protocol Violation|2|||
25307293|NCT01027871|50622413|FG000|Overall Study|Withdrawal by Subject|1|||
25307294|NCT01027871|50622414|FG001|Overall Study|Withdrawal by Subject|2|||
25307295|NCT01027871|50622415|FG002|Overall Study|Withdrawal by Subject|2|||
25307296|NCT01027871|50622413|FG000|Overall Study|Adverse Event|0|||
25307297|NCT01027871|50622414|FG001|Overall Study|Adverse Event|2|||
25307298|NCT01027871|50622415|FG002|Overall Study|Adverse Event|2|||
25307299|NCT01027871|50622413|FG000|Overall Study|Sponsor Decision|0|||
25307300|NCT01027871|50622414|FG001|Overall Study|Sponsor Decision|2|||
25307301|NCT01027871|50622415|FG002|Overall Study|Sponsor Decision|0|||
25307302|NCT01027871|50622413|FG000|Overall Study|Discontinued Prior to Treatment|0|||
25307303|NCT01027871|50622414|FG001|Overall Study|Discontinued Prior to Treatment|0|||
25307304|NCT01027871|50622415|FG002|Overall Study|Discontinued Prior to Treatment|1|||
25307305|NCT01021553|50622431|FG000|Overall Study|Adverse Event|1|||
25307306|NCT01021553|50622432|FG001|Overall Study|Adverse Event|0|||
25307307|NCT01021553|50622433|FG002|Overall Study|Adverse Event|0|||
25307308|NCT01021553|50622431|FG000|Overall Study|Lack of Efficacy|2|||
25307309|NCT01021553|50622432|FG001|Overall Study|Lack of Efficacy|2|||
25307310|NCT01021553|50622433|FG002|Overall Study|Lack of Efficacy|0|||
25307311|NCT01021553|50622431|FG000|Overall Study|Protocol Violation|0|||
25307312|NCT01021553|50622432|FG001|Overall Study|Protocol Violation|2|||
25307313|NCT01021553|50622433|FG002|Overall Study|Protocol Violation|2|||
25307314|NCT01021553|50622431|FG000|Overall Study|Lost to Follow-up|0|||
25307315|NCT01021553|50622432|FG001|Overall Study|Lost to Follow-up|0|||
25307316|NCT01021553|50622433|FG002|Overall Study|Lost to Follow-up|1|||
25307317|NCT01021553|50622431|FG000|Overall Study|Withdrawal by Subject|1|||
25307318|NCT01021553|50622432|FG001|Overall Study|Withdrawal by Subject|1|||
25307319|NCT01021553|50622433|FG002|Overall Study|Withdrawal by Subject|0|||
25307320|NCT01026389|50622448|FG000|Overall Study|Withdrawal by Subject|1|||
25307321|NCT01026389|50622449|FG001|Overall Study|Withdrawal by Subject|3|||
25307322|NCT01026389|50622448|FG000|Overall Study|change of treatment, patient moved|4|||
25307323|NCT01026389|50622449|FG001|Overall Study|change of treatment, patient moved|2|||
25307324|NCT01006616|50622459|FG000|Period 1 (6 Months)|Adverse Event|10|||
25307325|NCT01006616|50622460|FG001|Period 1 (6 Months)|Adverse Event|31|||
25307326|NCT01006616|50622461|FG002|Period 1 (6 Months)|Adverse Event|37|||
25307327|NCT01006616|50622462|FG003|Period 1 (6 Months)|Adverse Event|9|||
25307328|NCT01006616|50622459|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
25307329|NCT01006616|50622460|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
25307330|NCT01006616|50622461|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
25307331|NCT01006616|50622462|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
25307332|NCT01006616|50622459|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
25307333|NCT01006616|50622460|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
25307334|NCT01006616|50622461|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
25307335|NCT01006616|50622462|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
25307336|NCT01006616|50622459|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
25307337|NCT01006616|50622460|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
25307338|NCT01006616|50622461|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
24970034|NCT04405570|50059527|FG001|Overall Study|Physician Decision|0|||
25307339|NCT01006616|50622462|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
25307340|NCT01006616|50622459|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
25307341|NCT01006616|50622460|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
25307342|NCT01006616|50622461|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
25307343|NCT01006616|50622462|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
25307344|NCT01006616|50622459|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
25307345|NCT01006616|50622460|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
25307346|NCT01006616|50622461|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
25307347|NCT01006616|50622462|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
25307348|NCT01006616|50622459|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
25307349|NCT01006616|50622460|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
25307350|NCT01006616|50622461|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
25307351|NCT01006616|50622462|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
25307352|NCT01006616|50622459|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
25307353|NCT01006616|50622460|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
25307354|NCT01006616|50622461|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
25307355|NCT01006616|50622462|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
25307356|NCT01006616|50622459|FG000|Period 1 (6 Months)|Not Treated|0|||
25307357|NCT01006616|50622460|FG001|Period 1 (6 Months)|Not Treated|0|||
25307358|NCT01006616|50622461|FG002|Period 1 (6 Months)|Not Treated|1|||
25307359|NCT01006616|50622462|FG003|Period 1 (6 Months)|Not Treated|1|||
25307360|NCT01006616|50622459|FG000|Period 2 (18 Months)|Adverse Event|6|||
25307361|NCT01006616|50622460|FG001|Period 2 (18 Months)|Adverse Event|6|||
25307362|NCT01006616|50622461|FG002|Period 2 (18 Months)|Adverse Event|6|||
25307363|NCT01006616|50622462|FG003|Period 2 (18 Months)|Adverse Event|4|||
25307364|NCT01006616|50622459|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
25307365|NCT01006616|50622460|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
25307366|NCT01006616|50622461|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
25307367|NCT01006616|50622462|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
25307368|NCT01006616|50622459|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
25307369|NCT01006616|50622460|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
25307370|NCT01006616|50622461|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
25307371|NCT01006616|50622462|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
25307372|NCT01006616|50622459|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
25307373|NCT01006616|50622460|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
25307374|NCT01006616|50622461|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
25307375|NCT01006616|50622462|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
25307376|NCT01006616|50622459|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
25307377|NCT01006616|50622460|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
25307378|NCT01006616|50622461|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
25307379|NCT01006616|50622462|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
25307380|NCT01006616|50622459|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
25307381|NCT01006616|50622460|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
25307382|NCT01006616|50622461|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
25307383|NCT01006616|50622462|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
25307384|NCT01006616|50622459|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
25307385|NCT01006616|50622460|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
25307386|NCT01006616|50622461|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
25307387|NCT01006616|50622462|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
25307388|NCT01006616|50622459|FG000|Period 2 (18 Months)|Study Terminated|63|||
24970035|NCT04405570|50059528|FG002|Overall Study|Physician Decision|1|||
24970036|NCT04405570|50059529|FG003|Overall Study|Physician Decision|0|||
25071239|NCT02630459|50177389|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
24970037|NCT04405570|50059526|FG000|Overall Study|Withdrawal by Subject|0|||
24970038|NCT04405570|50059527|FG001|Overall Study|Withdrawal by Subject|1|||
24970039|NCT04405570|50059528|FG002|Overall Study|Withdrawal by Subject|1|||
24970040|NCT04405570|50059529|FG003|Overall Study|Withdrawal by Subject|0|||
24970041|NCT04405570|50059526|FG000|Overall Study|Randomized not dosed|0|||
24970042|NCT04405570|50059527|FG001|Overall Study|Randomized not dosed|2|||
24970043|NCT04405570|50059528|FG002|Overall Study|Randomized not dosed|0|||
24970044|NCT04405570|50059529|FG003|Overall Study|Randomized not dosed|0|||
24970045|NCT00127712|50059544|FG000|Overall Study|Adverse Event|3|||
24970046|NCT00127712|50059545|FG001|Overall Study|Adverse Event|0|||
24970047|NCT00127712|50059544|FG000|Overall Study|Lack of GI access to continue|2|||
24970048|NCT00127712|50059545|FG001|Overall Study|Lack of GI access to continue|0|||
24970049|NCT04404010|50059553|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
24970050|NCT04404010|50059554|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
24970051|NCT04401202|50059564|FG000|Overall Study|Lost to Follow-up|2|||
25169512|NCT01827371|50301362|FG002|Overall Study|Temporary study halt to vaccinations|5|||
25192177|NCT04027608|50357238|FG001|Overall Study|Protocol Violation|1|||
24970052|NCT04401202|50059565|FG001|Overall Study|Lost to Follow-up|2|||
24970053|NCT04401202|50059564|FG000|Overall Study|Adverse Event|0|||
24970054|NCT04401202|50059565|FG001|Overall Study|Adverse Event|1|||
24970055|NCT04401202|50059564|FG000|Overall Study|Hospitalized|4|||
24970056|NCT04401202|50059565|FG001|Overall Study|Hospitalized|1|||
24970057|NCT00096356|50059574|FG000|Overall Study|Adverse Event|11|||
24970058|NCT00096356|50059575|FG001|Overall Study|Adverse Event|9|||
24970059|NCT00096356|50059574|FG000|Overall Study|Physician Decision|5|||
25307389|NCT01006616|50622460|FG001|Period 2 (18 Months)|Study Terminated|46|||
25307390|NCT01006616|50622461|FG002|Period 2 (18 Months)|Study Terminated|44|||
25307391|NCT01006616|50622462|FG003|Period 2 (18 Months)|Study Terminated|70|||
25307392|NCT00996632|50622474|FG000|Overall Study|Physician Decision|0|||
25307393|NCT00996632|50622475|FG001|Overall Study|Physician Decision|0|||
25307394|NCT01025843|50622491|FG000|Washout 4|Withdrawal by Subject|0|||
25307395|NCT01025843|50622492|FG001|Washout 4|Withdrawal by Subject|0|||
25307396|NCT01025843|50622493|FG002|Washout 4|Withdrawal by Subject|1|||
25307397|NCT01025843|50622494|FG003|Washout 4|Withdrawal by Subject|1|||
25307398|NCT01025843|50622495|FG004|Washout 4|Withdrawal by Subject|0|||
25307399|NCT01025843|50622496|FG005|Washout 4|Withdrawal by Subject|0|||
25307400|NCT01025843|50622497|FG006|Washout 4|Withdrawal by Subject|0|||
25307401|NCT01025843|50622498|FG007|Washout 4|Withdrawal by Subject|0|||
25307402|NCT01025843|50622499|FG008|Washout 4|Withdrawal by Subject|0|||
25307403|NCT01025843|50622500|FG009|Washout 4|Withdrawal by Subject|0|||
25307404|NCT01036763|50622528|FG000|Overall Study|Adverse Event|25|||
25307405|NCT01036763|50622528|FG000|Overall Study|Lost to Follow-up|28|||
25307406|NCT01036763|50622528|FG000|Overall Study|Other reason (not specified)|40|||
25307407|NCT01021007|50622534|FG000|Overall Study|Lost to Follow-up|1|||
25307408|NCT01021007|50622535|FG001|Overall Study|Lost to Follow-up|1|||
25307409|NCT01021007|50622534|FG000|Overall Study|Adverse Event|1|||
25307410|NCT01021007|50622535|FG001|Overall Study|Adverse Event|3|||
25307411|NCT01020773|50622543|FG000|Overall Study|Withdrawal by Subject|4|||
25307412|NCT01020773|50622544|FG001|Overall Study|Withdrawal by Subject|3|||
25307413|NCT01020305|50622550|FG000|Overall Study|Adverse Event|2|||
25307414|NCT01036529|50622556|FG000|Overall Study|Adverse Event|0|||
25307415|NCT01036529|50622557|FG001|Overall Study|Adverse Event|1|||
25307416|NCT01036529|50622556|FG000|Overall Study|Lost to Follow-up|0|||
25307417|NCT01036529|50622557|FG001|Overall Study|Lost to Follow-up|1|||
25307418|NCT01036529|50622556|FG000|Overall Study|Physician Decision|1|||
25307419|NCT01036529|50622557|FG001|Overall Study|Physician Decision|0|||
25307420|NCT01036529|50622556|FG000|Overall Study|Withdrawal by Subject|1|||
25307421|NCT01036529|50622557|FG001|Overall Study|Withdrawal by Subject|1|||
25307422|NCT01036529|50622556|FG000|Overall Study|Sponsor study termination|11|||
25307423|NCT01036529|50622557|FG001|Overall Study|Sponsor study termination|12|||
25307424|NCT01024751|50622565|FG000|Enrolled Participants|Ineligible at baseline|3|||
25307425|NCT01024751|50622566|FG001|Enrolled Participants|Ineligible at baseline|4|||
25307426|NCT01024751|50622565|FG000|Eligible Participants|Withdrawal by Subject|0|||
25307427|NCT01024751|50622566|FG001|Eligible Participants|Withdrawal by Subject|1|||
25307428|NCT01024751|50622565|FG000|Eligible Participants|Lost to Follow-up|0|||
25307429|NCT01024751|50622566|FG001|Eligible Participants|Lost to Follow-up|1|||
25307430|NCT01024751|50622565|FG000|Eligible Participants|Ineligible|0|||
25307431|NCT01024751|50622566|FG001|Eligible Participants|Ineligible|1|||
25307432|NCT01019369|50622574|FG000|Overall Study|Lost to Follow-up|10|||
25307433|NCT01019369|50622575|FG001|Overall Study|Lost to Follow-up|6|||
25307434|NCT01019369|50622574|FG000|Overall Study|Withdrawal by Subject|0|||
25307435|NCT01019369|50622575|FG001|Overall Study|Withdrawal by Subject|1|||
25307436|NCT01019135|50622585|FG000|Overall Study|Did not receive allocated intervention|12|||
25307437|NCT01019135|50622586|FG001|Overall Study|Did not receive allocated intervention|6|||
25307438|NCT01019135|50622587|FG002|Overall Study|Did not receive allocated intervention|25|||
25307439|NCT01019135|50622585|FG000|Overall Study|Did not attend CR|8|||
25307440|NCT01019135|50622586|FG001|Overall Study|Did not attend CR|13|||
25307441|NCT01019135|50622587|FG002|Overall Study|Did not attend CR|6|||
25307442|NCT01018979|50622597|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
25307443|NCT01018979|50622598|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
24970060|NCT00096356|50059575|FG001|Overall Study|Physician Decision|3|||
24970061|NCT00096356|50059574|FG000|Overall Study|Withdrawal by Subject|17|||
24970062|NCT00096356|50059575|FG001|Overall Study|Withdrawal by Subject|23|||
25307444|NCT01018979|50622597|FG000|Overall Study|Not received at least one dose|0|||
25307445|NCT01018979|50622598|FG001|Overall Study|Not received at least one dose|1|||
25307446|NCT01572493|50622616|FG000|Overall Study|Physician Decision|1|||
25307447|NCT01572493|50622617|FG001|Overall Study|Physician Decision|0|||
25307448|NCT01572493|50622618|FG002|Overall Study|Physician Decision|0|||
25307449|NCT01572493|50622619|FG003|Overall Study|Physician Decision|0|||
25307450|NCT01572493|50622620|FG004|Overall Study|Physician Decision|0|||
25307451|NCT01572493|50622621|FG005|Overall Study|Physician Decision|0|||
25307452|NCT01572493|50622622|FG006|Overall Study|Physician Decision|0|||
25307453|NCT01572493|50622623|FG007|Overall Study|Physician Decision|0|||
25307454|NCT01572493|50622624|FG008|Overall Study|Physician Decision|0|||
25307455|NCT01572493|50622616|FG000|Overall Study|Switched to alternative treatment|0|||
25307456|NCT01572493|50622617|FG001|Overall Study|Switched to alternative treatment|1|||
25307457|NCT01572493|50622618|FG002|Overall Study|Switched to alternative treatment|2|||
25307458|NCT01572493|50622619|FG003|Overall Study|Switched to alternative treatment|1|||
25307459|NCT01572493|50622620|FG004|Overall Study|Switched to alternative treatment|2|||
25307460|NCT01572493|50622621|FG005|Overall Study|Switched to alternative treatment|0|||
25307461|NCT01572493|50622622|FG006|Overall Study|Switched to alternative treatment|2|||
25307462|NCT01572493|50622623|FG007|Overall Study|Switched to alternative treatment|0|||
25307463|NCT01572493|50622624|FG008|Overall Study|Switched to alternative treatment|2|||
25307464|NCT01572493|50622616|FG000|Overall Study|Death|0|||
25307465|NCT01572493|50622617|FG001|Overall Study|Death|0|||
25307466|NCT01572493|50622618|FG002|Overall Study|Death|0|||
25307467|NCT01572493|50622619|FG003|Overall Study|Death|1|||
25307468|NCT01572493|50622620|FG004|Overall Study|Death|0|||
25307469|NCT01572493|50622621|FG005|Overall Study|Death|1|||
25307470|NCT01572493|50622622|FG006|Overall Study|Death|0|||
25307471|NCT01572493|50622623|FG007|Overall Study|Death|0|||
25307472|NCT01572493|50622624|FG008|Overall Study|Death|0|||
25307473|NCT01572493|50622616|FG000|Overall Study|Adverse Event|0|||
25307474|NCT01572493|50622617|FG001|Overall Study|Adverse Event|0|||
25307475|NCT01572493|50622618|FG002|Overall Study|Adverse Event|0|||
25307476|NCT01572493|50622619|FG003|Overall Study|Adverse Event|0|||
25307477|NCT01572493|50622620|FG004|Overall Study|Adverse Event|0|||
25307478|NCT01572493|50622621|FG005|Overall Study|Adverse Event|0|||
25307479|NCT01572493|50622622|FG006|Overall Study|Adverse Event|1|||
25307480|NCT01572493|50622623|FG007|Overall Study|Adverse Event|0|||
25307481|NCT01572493|50622624|FG008|Overall Study|Adverse Event|0|||
25307482|NCT01018511|50622651|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
25307483|NCT01018511|50622652|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
25307484|NCT01018511|50622653|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
25307485|NCT01018511|50622654|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
25307486|NCT01018511|50622651|FG000|Overall Study|Adverse Event|5|||
25307487|NCT01018511|50622652|FG001|Overall Study|Adverse Event|9|||
25307488|NCT01018511|50622653|FG002|Overall Study|Adverse Event|13|||
25307489|NCT01018511|50622654|FG003|Overall Study|Adverse Event|10|||
25307490|NCT01018511|50622651|FG000|Overall Study|Lack of Efficacy|4|||
25307491|NCT01018511|50622652|FG001|Overall Study|Lack of Efficacy|1|||
25307492|NCT01018511|50622653|FG002|Overall Study|Lack of Efficacy|1|||
25307493|NCT01018511|50622654|FG003|Overall Study|Lack of Efficacy|2|||
25307494|NCT01018511|50622651|FG000|Overall Study|Withdrawal by Subject|6|||
25307495|NCT01018511|50622652|FG001|Overall Study|Withdrawal by Subject|5|||
25307496|NCT01018511|50622653|FG002|Overall Study|Withdrawal by Subject|11|||
25307497|NCT01018511|50622654|FG003|Overall Study|Withdrawal by Subject|9|||
25307498|NCT01018511|50622651|FG000|Overall Study|Lost to Follow-up|0|||
25307499|NCT01018511|50622652|FG001|Overall Study|Lost to Follow-up|0|||
25307500|NCT01018511|50622653|FG002|Overall Study|Lost to Follow-up|1|||
25307501|NCT01018511|50622654|FG003|Overall Study|Lost to Follow-up|0|||
25307502|NCT01018511|50622651|FG000|Overall Study|Protocol Violation|5|||
25307503|NCT01018511|50622652|FG001|Overall Study|Protocol Violation|8|||
25307504|NCT01018511|50622653|FG002|Overall Study|Protocol Violation|7|||
25307505|NCT01018511|50622654|FG003|Overall Study|Protocol Violation|9|||
25307506|NCT01018511|50622651|FG000|Overall Study|Miscellaneous|0|||
25307507|NCT01018511|50622652|FG001|Overall Study|Miscellaneous|2|||
25307508|NCT01018511|50622653|FG002|Overall Study|Miscellaneous|0|||
24970063|NCT00096356|50059574|FG000|Overall Study|Lack of Efficacy|1|||
25307509|NCT01018511|50622654|FG003|Overall Study|Miscellaneous|0|||
25307510|NCT00996476|50622675|FG000|Overall Study|Withdrawal by Subject|1|||
25307511|NCT00996476|50622676|FG001|Overall Study|Withdrawal by Subject|2|||
25307512|NCT00996476|50622677|FG002|Overall Study|Withdrawal by Subject|1|||
25307513|NCT00996476|50622678|FG003|Overall Study|Withdrawal by Subject|0|||
25307514|NCT00996476|50622679|FG004|Overall Study|Withdrawal by Subject|1|||
25307515|NCT00996476|50622675|FG000|Overall Study|Adverse Event|0|||
25307516|NCT00996476|50622676|FG001|Overall Study|Adverse Event|1|||
25307517|NCT00996476|50622677|FG002|Overall Study|Adverse Event|0|||
25307518|NCT00996476|50622678|FG003|Overall Study|Adverse Event|0|||
25307519|NCT00996476|50622679|FG004|Overall Study|Adverse Event|1|||
25307520|NCT02269267|50622696|FG000|Overall Study|Death|5|||
25307521|NCT01017731|50622700|FG000|Overall Study|Lost to Follow-up|2|||
25307522|NCT01017731|50622700|FG000|Overall Study|Withdrawal by Subject|3|||
25307523|NCT01017731|50622700|FG000|Overall Study|Physician Decision|2|||
25307524|NCT01017731|50622700|FG000|Overall Study|Adverse Event|1|||
25307525|NCT01035905|50622707|FG000|Overall Study|Lack of Efficacy|1|||
25307526|NCT01035905|50622708|FG001|Overall Study|Lack of Efficacy|1|||
25307527|NCT00779584|50622732|FG000|Overall Study|Protocol Violation|0|||
25307528|NCT00779584|50622733|FG001|Overall Study|Protocol Violation|0|||
25307529|NCT00779584|50622734|FG002|Overall Study|Protocol Violation|0|||
25307530|NCT00779584|50622735|FG003|Overall Study|Protocol Violation|0|||
25307531|NCT00779584|50622736|FG004|Overall Study|Protocol Violation|0|||
25307532|NCT00779584|50622737|FG005|Overall Study|Protocol Violation|1|||
25307533|NCT00779584|50622738|FG006|Overall Study|Protocol Violation|0|||
25307534|NCT00779584|50622739|FG007|Overall Study|Protocol Violation|0|||
25307535|NCT00779584|50622740|FG008|Overall Study|Protocol Violation|0|||
25307536|NCT00779584|50622732|FG000|Overall Study|Withdrawal by Subject|1|||
25307537|NCT00779584|50622733|FG001|Overall Study|Withdrawal by Subject|1|||
25307538|NCT00779584|50622734|FG002|Overall Study|Withdrawal by Subject|2|||
25307539|NCT00779584|50622735|FG003|Overall Study|Withdrawal by Subject|0|||
25307540|NCT00779584|50622736|FG004|Overall Study|Withdrawal by Subject|0|||
25307541|NCT00779584|50622737|FG005|Overall Study|Withdrawal by Subject|2|||
25307542|NCT00779584|50622738|FG006|Overall Study|Withdrawal by Subject|1|||
25307543|NCT00779584|50622739|FG007|Overall Study|Withdrawal by Subject|0|||
25307544|NCT00779584|50622740|FG008|Overall Study|Withdrawal by Subject|0|||
25307545|NCT00779584|50622732|FG000|Overall Study|Lost to Follow-up|0|||
25307546|NCT00779584|50622733|FG001|Overall Study|Lost to Follow-up|0|||
25307547|NCT00779584|50622734|FG002|Overall Study|Lost to Follow-up|0|||
25307548|NCT00779584|50622735|FG003|Overall Study|Lost to Follow-up|0|||
25307549|NCT00779584|50622736|FG004|Overall Study|Lost to Follow-up|1|||
25307550|NCT00779584|50622737|FG005|Overall Study|Lost to Follow-up|0|||
25307551|NCT00779584|50622738|FG006|Overall Study|Lost to Follow-up|0|||
25307552|NCT00779584|50622739|FG007|Overall Study|Lost to Follow-up|0|||
25307553|NCT00779584|50622740|FG008|Overall Study|Lost to Follow-up|0|||
25307554|NCT00779584|50622732|FG000|Overall Study|Progression of Disease|0|||
25307555|NCT00779584|50622733|FG001|Overall Study|Progression of Disease|1|||
25307556|NCT00779584|50622734|FG002|Overall Study|Progression of Disease|2|||
25307557|NCT00779584|50622735|FG003|Overall Study|Progression of Disease|6|||
25307558|NCT00779584|50622736|FG004|Overall Study|Progression of Disease|5|||
25307559|NCT00779584|50622737|FG005|Overall Study|Progression of Disease|1|||
25307560|NCT00779584|50622738|FG006|Overall Study|Progression of Disease|4|||
25307561|NCT00779584|50622739|FG007|Overall Study|Progression of Disease|2|||
25307562|NCT00779584|50622740|FG008|Overall Study|Progression of Disease|1|||
25307563|NCT00779584|50622732|FG000|Overall Study|Adverse Event|1|||
25307564|NCT00779584|50622733|FG001|Overall Study|Adverse Event|0|||
25307565|NCT00779584|50622734|FG002|Overall Study|Adverse Event|2|||
25307566|NCT00779584|50622735|FG003|Overall Study|Adverse Event|0|||
25307567|NCT00779584|50622736|FG004|Overall Study|Adverse Event|0|||
25307568|NCT00779584|50622737|FG005|Overall Study|Adverse Event|0|||
25307569|NCT00779584|50622738|FG006|Overall Study|Adverse Event|2|||
25307570|NCT00779584|50622739|FG007|Overall Study|Adverse Event|1|||
25307571|NCT00779584|50622740|FG008|Overall Study|Adverse Event|1|||
25307572|NCT00779584|50622732|FG000|Overall Study|Symptomatic Deterioration|1|||
25307573|NCT00779584|50622733|FG001|Overall Study|Symptomatic Deterioration|1|||
25307574|NCT00779584|50622734|FG002|Overall Study|Symptomatic Deterioration|1|||
25307575|NCT00779584|50622735|FG003|Overall Study|Symptomatic Deterioration|0|||
25307576|NCT00779584|50622736|FG004|Overall Study|Symptomatic Deterioration|0|||
25307577|NCT00779584|50622737|FG005|Overall Study|Symptomatic Deterioration|1|||
25307578|NCT00779584|50622738|FG006|Overall Study|Symptomatic Deterioration|1|||
25307579|NCT00779584|50622739|FG007|Overall Study|Symptomatic Deterioration|0|||
24970064|NCT00096356|50059575|FG001|Overall Study|Lack of Efficacy|0|||
25307580|NCT00779584|50622740|FG008|Overall Study|Symptomatic Deterioration|0|||
25307581|NCT00779584|50622732|FG000|Overall Study|Ongoing in Study|0|||
25307582|NCT00779584|50622733|FG001|Overall Study|Ongoing in Study|0|||
25307583|NCT00779584|50622734|FG002|Overall Study|Ongoing in Study|0|||
25307584|NCT00779584|50622735|FG003|Overall Study|Ongoing in Study|0|||
25307585|NCT00779584|50622736|FG004|Overall Study|Ongoing in Study|1|||
25307586|NCT00779584|50622737|FG005|Overall Study|Ongoing in Study|1|||
25307587|NCT00779584|50622738|FG006|Overall Study|Ongoing in Study|0|||
24970065|NCT00096356|50059574|FG000|Overall Study|multiple reasons|10|||
25307588|NCT00779584|50622739|FG007|Overall Study|Ongoing in Study|0|||
25307589|NCT00779584|50622740|FG008|Overall Study|Ongoing in Study|0|||
25307590|NCT00995930|50622762|FG000|Overall Study|Protocol deviation|2|||
25307591|NCT00995930|50622763|FG001|Overall Study|Protocol deviation|5|||
25307592|NCT00995930|50622762|FG000|Overall Study|Death|0|||
25307593|NCT00995930|50622763|FG001|Overall Study|Death|1|||
25307594|NCT00995930|50622762|FG000|Overall Study|Administrative problems|4|||
25307595|NCT00995930|50622763|FG001|Overall Study|Administrative problems|2|||
25307596|NCT00995930|50622762|FG000|Overall Study|Lost to Follow-up|1|||
25307597|NCT00995930|50622763|FG001|Overall Study|Lost to Follow-up|2|||
25307598|NCT00995930|50622762|FG000|Overall Study|Withdrawal by Subject|3|||
25307599|NCT00995930|50622763|FG001|Overall Study|Withdrawal by Subject|4|||
25307600|NCT00995930|50622762|FG000|Overall Study|Adverse Event|11|||
25307601|NCT00995930|50622763|FG001|Overall Study|Adverse Event|14|||
25307602|NCT00779506|50622770|FG000|Overall Study|Screening Failed|2|||
25307603|NCT00779506|50622770|FG000|Overall Study|Adverse Event|4|||
25307604|NCT00779506|50622770|FG000|Overall Study|Lack of Efficacy|11|||
25307605|NCT00779506|50622770|FG000|Overall Study|Protocol Violation|5|||
25307606|NCT00779506|50622770|FG000|Overall Study|Withdrawal by Subject|6|||
25307607|NCT00779506|50622770|FG000|Overall Study|Lost to Follow-up|1|||
25307608|NCT00995774|50622776|FG000|Training Period 2|Withdrawal by Subject|2|||
25307609|NCT00995774|50622777|FG001|Training Period 2|Withdrawal by Subject|0|||
25307610|NCT00765388|50622783|FG000|Period 1|Lack of Efficacy|1|||
25307611|NCT00765388|50622784|FG001|Period 1|Lack of Efficacy|2|||
25307612|NCT00765388|50622783|FG000|Period 1|Lost to Follow-up|0|||
25307613|NCT00765388|50622784|FG001|Period 1|Lost to Follow-up|1|||
25307614|NCT00765388|50622783|FG000|Period 1|Herpes Zoster|0|||
25307615|NCT00765388|50622784|FG001|Period 1|Herpes Zoster|1|||
25307616|NCT00765388|50622783|FG000|Period 1|Hip operation|0|||
25307617|NCT00765388|50622784|FG001|Period 1|Hip operation|1|||
25307618|NCT00769132|50622799|FG000|Period 1|Adverse Event|1|||
25307619|NCT00769132|50622800|FG001|Period 1|Adverse Event|0|||
25307620|NCT00769132|50622801|FG002|Period 1|Adverse Event|0|||
25307621|NCT00769132|50622802|FG003|Period 1|Adverse Event|1|||
25307622|NCT00769132|50622799|FG000|Period 2|Withdrawal by Subject|0|||
25307623|NCT00769132|50622800|FG001|Period 2|Withdrawal by Subject|0|||
25307624|NCT00769132|50622801|FG002|Period 2|Withdrawal by Subject|0|||
25307625|NCT00769132|50622802|FG003|Period 2|Withdrawal by Subject|1|||
25307626|NCT00769132|50622799|FG000|Period 3|Withdrawal by Subject|1|||
25307627|NCT00769132|50622800|FG001|Period 3|Withdrawal by Subject|0|||
25307628|NCT00769132|50622801|FG002|Period 3|Withdrawal by Subject|0|||
25307629|NCT00769132|50622802|FG003|Period 3|Withdrawal by Subject|0|||
25307630|NCT00769132|50622799|FG000|Period 4|Withdrawal by Subject|0|||
25307631|NCT00769132|50622800|FG001|Period 4|Withdrawal by Subject|1|||
25307632|NCT00769132|50622801|FG002|Period 4|Withdrawal by Subject|0|||
25307633|NCT00769132|50622802|FG003|Period 4|Withdrawal by Subject|0|||
25192178|NCT04027608|50357237|FG000|Overall Study|Physician Decision|1|||
25192179|NCT04027608|50357238|FG001|Overall Study|Physician Decision|0|||
25192180|NCT04027608|50357237|FG000|Overall Study|Lost to Follow-up|20|||
25192181|NCT04027608|50357238|FG001|Overall Study|Lost to Follow-up|4|||
25192182|NCT01664052|50357329|FG000|Phase 1|No device placement|6|||
25192183|NCT01664052|50357330|FG001|Phase 1|No device placement|0|||
25192184|NCT01664052|50357329|FG000|Phase 1|No HSG 1 hr post placement|1|||
25192185|NCT01664052|50357330|FG001|Phase 1|No HSG 1 hr post placement|0|||
25192186|NCT01664052|50357329|FG000|Phase 2|No device placement|0|||
25307634|NCT00991952|50622814|FG000|Overall Study|Adverse Event|0|||
25307635|NCT00991952|50622815|FG001|Overall Study|Adverse Event|1|||
25307636|NCT00779038|50622821|FG000|Overall Study|Study Prematurely Terminated|13|||
25307637|NCT00765076|50622828|FG000|Overall Study|Adverse Event|1|||
25307638|NCT00765076|50622829|FG001|Overall Study|Adverse Event|0|||
25192187|NCT01664052|50357330|FG001|Phase 2|No device placement|4|||
25192188|NCT01465802|50357377|FG000|Overall Study|Study terminated by sponsor|1|||
25192189|NCT01465802|50357378|FG001|Overall Study|Study terminated by sponsor|0|||
25307639|NCT00765076|50622830|FG002|Overall Study|Adverse Event|0|||
25307640|NCT00765076|50622828|FG000|Overall Study|Withdrawal by Subject|0|||
25307641|NCT00765076|50622829|FG001|Overall Study|Withdrawal by Subject|0|||
25307642|NCT00765076|50622830|FG002|Overall Study|Withdrawal by Subject|1|||
25307643|NCT00994682|50622840|FG000|Double Bilnd|Withdrawal by Subject|5|||
25307644|NCT00994682|50622841|FG001|Double Bilnd|Withdrawal by Subject|6|||
25307645|NCT00994682|50622840|FG000|Double Bilnd|Lost to Follow-up|3|||
25307646|NCT00994682|50622841|FG001|Double Bilnd|Lost to Follow-up|3|||
25307647|NCT00994682|50622840|FG000|Double Bilnd|Adverse Event|1|||
25307648|NCT00994682|50622841|FG001|Double Bilnd|Adverse Event|0|||
25307649|NCT00994682|50622840|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
25307650|NCT00994682|50622841|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
25307651|NCT00994682|50622840|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
25307652|NCT00994682|50622841|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
25307653|NCT00994682|50622840|FG000|Pioglitazone Open Label|Physician Decision|6|||
25307654|NCT00994682|50622841|FG001|Pioglitazone Open Label|Physician Decision|1|||
25307655|NCT00768898|50622851|FG000|Overall Study|Unrelated injury|1|||
25307656|NCT00768898|50622851|FG000|Overall Study|Headache|1|||
25307657|NCT00994448|50622862|FG000|Overall Study|Adverse Event|1|||
25307658|NCT00994448|50622863|FG001|Overall Study|Adverse Event|0|||
25307659|NCT00994448|50622862|FG000|Overall Study|Lost to Follow-up|5|||
25307660|NCT00994448|50622863|FG001|Overall Study|Lost to Follow-up|1|||
25307661|NCT00994448|50622862|FG000|Overall Study|Withdrawal by Subject|1|||
25307662|NCT00994448|50622863|FG001|Overall Study|Withdrawal by Subject|1|||
25307663|NCT00994448|50622862|FG000|Overall Study|Physician Decision|1|||
25307664|NCT00994448|50622863|FG001|Overall Study|Physician Decision|0|||
25307665|NCT00991406|50622869|FG000|Overall Study|One participant did not respond to FES.|1|||
25307666|NCT01017575|50622878|FG000|Overall Study|Lack of Efficacy|0|||
25307667|NCT01017575|50622879|FG001|Overall Study|Lack of Efficacy|1|||
25307668|NCT01017575|50622880|FG002|Overall Study|Lack of Efficacy|0|||
25307669|NCT01017575|50622881|FG003|Overall Study|Lack of Efficacy|1|||
25307670|NCT01017575|50622882|FG004|Overall Study|Lack of Efficacy|1|||
25307671|NCT01017575|50622878|FG000|Overall Study|Adverse Event|0|||
25307672|NCT01017575|50622879|FG001|Overall Study|Adverse Event|1|||
25307673|NCT01017575|50622880|FG002|Overall Study|Adverse Event|0|||
25307674|NCT01017575|50622881|FG003|Overall Study|Adverse Event|0|||
25307675|NCT01017575|50622882|FG004|Overall Study|Adverse Event|2|||
25307676|NCT01017575|50622878|FG000|Overall Study|Withdrawal by Subject|1|||
25307677|NCT01017575|50622879|FG001|Overall Study|Withdrawal by Subject|0|||
25307678|NCT01017575|50622880|FG002|Overall Study|Withdrawal by Subject|0|||
25307679|NCT01017575|50622881|FG003|Overall Study|Withdrawal by Subject|0|||
25307680|NCT01017575|50622882|FG004|Overall Study|Withdrawal by Subject|0|||
25307681|NCT01017263|50622894|FG000|Overall Study|not eligible|12|||
25307682|NCT00768664|50622898|FG000|Overall Study|Death|57|||
25307683|NCT00768664|50622898|FG000|Overall Study|Lost to Follow-up|2|||
25307684|NCT00768664|50622898|FG000|Overall Study|Other|9|||
25307685|NCT00768664|50622898|FG000|Overall Study|Participant refused|1|||
25307686|NCT00778336|50622906|FG000|Index Procedure-Discharge|Death|6|||
25307687|NCT00778336|50622907|FG001|Index Procedure-Discharge|Death|3|||
25307688|NCT00778336|50622908|FG002|Index Procedure-Discharge|Death|2|||
25307689|NCT00778336|50622909|FG003|Index Procedure-Discharge|Death|0|||
25307690|NCT00778336|50622906|FG000|3 Month Follow Up|Lost to Follow-up|15|||
25307691|NCT00778336|50622907|FG001|3 Month Follow Up|Lost to Follow-up|20|||
25307692|NCT00778336|50622908|FG002|3 Month Follow Up|Lost to Follow-up|3|||
25307693|NCT00778336|50622909|FG003|3 Month Follow Up|Lost to Follow-up|0|||
25307694|NCT00778336|50622906|FG000|3 Month Follow Up|Death|8|||
25307695|NCT00778336|50622907|FG001|3 Month Follow Up|Death|3|||
25307696|NCT00778336|50622908|FG002|3 Month Follow Up|Death|2|||
25307697|NCT00778336|50622909|FG003|3 Month Follow Up|Death|0|||
25307698|NCT01253161|50622919|FG000|Overall Study|Adverse Event|1|||
25307699|NCT00581113|50622925|FG000|Overall Study|Withdrawal by Subject|0|||
25307700|NCT00581113|50622926|FG001|Overall Study|Withdrawal by Subject|1|||
25307701|NCT01016015|50622932|FG000|Overall Study|Not Treated|3|||
25307702|NCT01016015|50622932|FG000|Overall Study|Withdrawal by Subject|1|||
24970066|NCT00096356|50059575|FG001|Overall Study|multiple reasons|18|||
25307703|NCT01016015|50622932|FG000|Overall Study|Adverse Event|15|||
25307704|NCT01015703|50622941|FG000|Overall Study|Withdrawal by Subject|0|||
25307705|NCT01015703|50622942|FG001|Overall Study|Withdrawal by Subject|1|||
25307706|NCT01015703|50622943|FG002|Overall Study|Withdrawal by Subject|0|||
25307707|NCT01015703|50622944|FG003|Overall Study|Withdrawal by Subject|0|||
25307708|NCT01015703|50622945|FG004|Overall Study|Withdrawal by Subject|0|||
25307709|NCT01015703|50622941|FG000|Overall Study|Adverse Event|1|||
25307710|NCT01015703|50622942|FG001|Overall Study|Adverse Event|0|||
25307711|NCT01015703|50622943|FG002|Overall Study|Adverse Event|0|||
25307712|NCT01015703|50622944|FG003|Overall Study|Adverse Event|0|||
25307713|NCT01015703|50622945|FG004|Overall Study|Adverse Event|0|||
25307714|NCT01015703|50622941|FG000|Overall Study|Protocol Violation|1|||
25307715|NCT01015703|50622942|FG001|Overall Study|Protocol Violation|0|||
25307716|NCT01015703|50622943|FG002|Overall Study|Protocol Violation|0|||
25307717|NCT01015703|50622944|FG003|Overall Study|Protocol Violation|0|||
25307718|NCT01015703|50622945|FG004|Overall Study|Protocol Violation|0|||
25307719|NCT04439071|50622959|FG000|Overall Study|Lost to Follow-up|0|||
25307720|NCT04439071|50622960|FG001|Overall Study|Lost to Follow-up|3|||
25307721|NCT04439071|50622959|FG000|Overall Study|Withdrawal by Subject|3|||
25307722|NCT04439071|50622960|FG001|Overall Study|Withdrawal by Subject|8|||
25307723|NCT04439071|50622959|FG000|Overall Study|Death|6|||
25307724|NCT04439071|50622960|FG001|Overall Study|Death|4|||
25307725|NCT04439071|50622959|FG000|Overall Study|Other than specified|3|||
25307726|NCT04439071|50622960|FG001|Overall Study|Other than specified|3|||
25307727|NCT04439071|50622959|FG000|Overall Study|Randomized but not treated|2|||
25307728|NCT04439071|50622960|FG001|Overall Study|Randomized but not treated|0|||
25307729|NCT01017029|50622968|FG000|Overall Study|Lost to Follow-up|1|||
25307730|NCT01017029|50622969|FG001|Overall Study|Lost to Follow-up|0|||
25307731|NCT01017029|50622968|FG000|Overall Study|Administrative problem|0|||
25307732|NCT01017029|50622969|FG001|Overall Study|Administrative problem|1|||
25307733|NCT01017029|50622968|FG000|Overall Study|Death|3|||
25307734|NCT01017029|50622969|FG001|Overall Study|Death|1|||
25307735|NCT00994214|50622979|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
25307736|NCT00994214|50622980|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
25307737|NCT00994214|50622981|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
25307738|NCT00994214|50622982|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
25307739|NCT00994214|50622979|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
25307740|NCT00994214|50622980|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
25307741|NCT00994214|50622981|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
25307742|NCT00994214|50622982|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
25307743|NCT00994214|50622979|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
25307744|NCT00994214|50622980|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
25307745|NCT00994214|50622981|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
25307746|NCT00994214|50622982|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
25307747|NCT00994214|50622979|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
25307748|NCT00994214|50622980|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
25307749|NCT00994214|50622981|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
25307750|NCT00994214|50622982|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
25307751|NCT00994214|50622979|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
25307752|NCT00994214|50622980|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
25307753|NCT00994214|50622981|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
25307754|NCT00994214|50622982|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
25307755|NCT00994214|50622979|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
25307756|NCT00994214|50622980|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
25307757|NCT00994214|50622981|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
25307758|NCT00994214|50622982|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
25307759|NCT01034657|50623010|FG000|Core Phase|Withdrawal by Subject|1|||
25307760|NCT01034657|50623011|FG001|Core Phase|Withdrawal by Subject|0|||
25307761|NCT01034657|50623012|FG002|Core Phase|Withdrawal by Subject|0|||
25307762|NCT01034657|50623010|FG000|Core Phase|Lack of Efficacy|2|||
25307763|NCT01034657|50623011|FG001|Core Phase|Lack of Efficacy|0|||
25307764|NCT01034657|50623012|FG002|Core Phase|Lack of Efficacy|0|||
25307765|NCT01034657|50623010|FG000|Core Phase|Abnormal laboratory value|1|||
25307766|NCT01034657|50623011|FG001|Core Phase|Abnormal laboratory value|0|||
25307767|NCT01034657|50623012|FG002|Core Phase|Abnormal laboratory value|0|||
25307768|NCT01034657|50623010|FG000|Core Phase|Adverse Event|8|||
25307769|NCT01034657|50623011|FG001|Core Phase|Adverse Event|0|||
25307770|NCT01034657|50623012|FG002|Core Phase|Adverse Event|0|||
25307771|NCT01034657|50623010|FG000|Core Phase|Protocol Violation|2|||
25307772|NCT01034657|50623011|FG001|Core Phase|Protocol Violation|0|||
24970068|NCT04358068|50059588|FG000|Overall Study|Did not initiate study treatment|2|||
25307773|NCT01034657|50623012|FG002|Core Phase|Protocol Violation|0|||
25307774|NCT01034657|50623010|FG000|Randomized Phase|Withdrawal by Subject|0|||
25307775|NCT01034657|50623011|FG001|Randomized Phase|Withdrawal by Subject|2|||
25307776|NCT01034657|50623012|FG002|Randomized Phase|Withdrawal by Subject|0|||
25307777|NCT01034657|50623010|FG000|Randomized Phase|Lack of Efficacy|5|||
25307778|NCT01034657|50623011|FG001|Randomized Phase|Lack of Efficacy|1|||
25307779|NCT01034657|50623012|FG002|Randomized Phase|Lack of Efficacy|0|||
25307780|NCT01034657|50623010|FG000|Randomized Phase|Abnormal laboratory value|0|||
25307781|NCT01034657|50623011|FG001|Randomized Phase|Abnormal laboratory value|1|||
25307782|NCT01034657|50623012|FG002|Randomized Phase|Abnormal laboratory value|0|||
25307783|NCT01034657|50623010|FG000|Randomized Phase|Adverse Event|0|||
25307784|NCT01034657|50623011|FG001|Randomized Phase|Adverse Event|2|||
25307785|NCT01034657|50623012|FG002|Randomized Phase|Adverse Event|1|||
25307786|NCT01014767|50623026|FG000|Overall Study|PI left institution, data unavailable|12|||
25307787|NCT01014767|50623027|FG001|Overall Study|PI left institution, data unavailable|1|||
25307788|NCT01014767|50623028|FG002|Overall Study|PI left institution, data unavailable|4|||
25307789|NCT01014767|50623029|FG003|Overall Study|PI left institution, data unavailable|1|||
25307790|NCT02016781|50623041|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
25307791|NCT02016781|50623042|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
25307792|NCT02016781|50623041|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
25307793|NCT02016781|50623042|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
25307794|NCT02016781|50623041|FG000|Final Database Lock|Withdrawal by Subject|2|||
25307795|NCT02016781|50623042|FG001|Final Database Lock|Withdrawal by Subject|1|||
25307796|NCT02016781|50623041|FG000|Final Database Lock|Lost to Follow-up|11|||
25307797|NCT02016781|50623042|FG001|Final Database Lock|Lost to Follow-up|4|||
25307798|NCT02016781|50623041|FG000|Final Database Lock|Missing data|0|||
25307799|NCT02016781|50623042|FG001|Final Database Lock|Missing data|3|||
25307800|NCT01014689|50623050|FG000|Overall Study|Lack of Efficacy|0|||
25307801|NCT01014689|50623051|FG001|Overall Study|Lack of Efficacy|1|||
25307802|NCT01014689|50623050|FG000|Overall Study|Adverse Event|3|||
25307803|NCT01014689|50623051|FG001|Overall Study|Adverse Event|0|||
25307804|NCT01014689|50623050|FG000|Overall Study|Withdrawal by Subject|5|||
25307805|NCT01014689|50623051|FG001|Overall Study|Withdrawal by Subject|4|||
25307806|NCT01014689|50623050|FG000|Overall Study|Protocol Violation|1|||
25307807|NCT01014689|50623051|FG001|Overall Study|Protocol Violation|1|||
25307808|NCT01014689|50623050|FG000|Overall Study|Lost to Follow-up|3|||
25307809|NCT01014689|50623051|FG001|Overall Study|Lost to Follow-up|7|||
25307810|NCT01014689|50623050|FG000|Overall Study|Pregnancy|1|||
25307811|NCT01014689|50623051|FG001|Overall Study|Pregnancy|0|||
25307812|NCT01014533|50623059|FG000|Overall Study|Protocol Violation|3|||
25307813|NCT01014533|50623060|FG001|Overall Study|Protocol Violation|2|||
25307814|NCT01014533|50623059|FG000|Overall Study|Withdrawal by Subject|2|||
25307815|NCT01014533|50623060|FG001|Overall Study|Withdrawal by Subject|0|||
25307816|NCT01014533|50623059|FG000|Overall Study|unable to come to appointment|0|||
25307817|NCT01014533|50623060|FG001|Overall Study|unable to come to appointment|3|||
25307818|NCT01014143|50623083|FG000|Second Intervention|Lost to Follow-up|2|||
25307819|NCT01014143|50623084|FG001|Second Intervention|Lost to Follow-up|0|||
25307820|NCT01014143|50623085|FG002|Second Intervention|Lost to Follow-up|0|||
25307821|NCT01013753|50623093|FG000|Overall Study|Adverse Event|8|||
25307822|NCT01013753|50623093|FG000|Overall Study|Protocol Violation|3|||
25307823|NCT01013753|50623093|FG000|Overall Study|Lost to Follow-up|1|||
25307824|NCT01013753|50623093|FG000|Overall Study|Withdrawal by Subject|2|||
25307825|NCT01013753|50623093|FG000|Overall Study|Other|2|||
25307826|NCT00757042|50623118|FG000|Overall Study|Lost to Follow-up|0|||
25307827|NCT00757042|50623119|FG001|Overall Study|Lost to Follow-up|0|||
25307828|NCT00757042|50623120|FG002|Overall Study|Lost to Follow-up|0|||
25307829|NCT00757042|50623121|FG003|Overall Study|Lost to Follow-up|0|||
25307830|NCT00757042|50623122|FG004|Overall Study|Lost to Follow-up|0|||
25307831|NCT00757042|50623123|FG005|Overall Study|Lost to Follow-up|0|||
25071240|NCT02630459|50177390|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
25071241|NCT02630459|50177391|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
25071242|NCT02630459|50177384|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
25071243|NCT02630459|50177385|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
25071244|NCT02630459|50177386|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
25071245|NCT02630459|50177387|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
25071246|NCT02630459|50177388|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
25071247|NCT02630459|50177389|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
25071248|NCT02630459|50177390|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
25071249|NCT02630459|50177391|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
25071250|NCT02630459|50177384|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
25071251|NCT02630459|50177385|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
25071252|NCT02630459|50177386|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
25071253|NCT02630459|50177387|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
25071254|NCT02630459|50177388|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
25071255|NCT02630459|50177389|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
25071256|NCT02630459|50177390|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
25071257|NCT02630459|50177391|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
25071258|NCT02630459|50177384|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
25071259|NCT02630459|50177385|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
25192190|NCT01465802|50357379|FG002|Overall Study|Study terminated by sponsor|0|||
25192191|NCT01465802|50357380|FG003|Overall Study|Study terminated by sponsor|1|||
25192192|NCT01465802|50357381|FG004|Overall Study|Study terminated by sponsor|7|||
25192193|NCT01465802|50357377|FG000|Overall Study|Withdrawal by Subject|7|||
25071260|NCT02630459|50177386|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
25071261|NCT02630459|50177387|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
25071262|NCT02630459|50177388|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
25071263|NCT02630459|50177389|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
25071264|NCT02630459|50177390|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
25071265|NCT02630459|50177391|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
25071266|NCT02630459|50177384|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
25071267|NCT02630459|50177385|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
25071268|NCT02630459|50177386|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
25071269|NCT02630459|50177387|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
25071270|NCT02630459|50177388|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
25071271|NCT02630459|50177389|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
25071272|NCT02630459|50177390|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
25071273|NCT02630459|50177391|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
25071274|NCT02630459|50177384|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
25071275|NCT02630459|50177385|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
25071276|NCT02630459|50177386|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
25071277|NCT02630459|50177387|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
25071278|NCT02630459|50177388|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
25071279|NCT02630459|50177389|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
25192194|NCT01465802|50357378|FG001|Overall Study|Withdrawal by Subject|7|||
25307832|NCT00757042|50623124|FG006|Overall Study|Lost to Follow-up|0|||
25307833|NCT00757042|50623125|FG007|Overall Study|Lost to Follow-up|0|||
25307834|NCT00757042|50623126|FG008|Overall Study|Lost to Follow-up|1|||
25307835|NCT00757042|50623127|FG009|Overall Study|Lost to Follow-up|0|||
25307836|NCT00757042|50623128|FG010|Overall Study|Lost to Follow-up|0|||
25307837|NCT00757042|50623118|FG000|Overall Study|Ineligibility Determined|0|||
25307838|NCT00757042|50623119|FG001|Overall Study|Ineligibility Determined|0|||
25307839|NCT00757042|50623120|FG002|Overall Study|Ineligibility Determined|0|||
25307840|NCT00757042|50623121|FG003|Overall Study|Ineligibility Determined|0|||
25307841|NCT00757042|50623122|FG004|Overall Study|Ineligibility Determined|0|||
25307842|NCT00757042|50623123|FG005|Overall Study|Ineligibility Determined|0|||
25307843|NCT00757042|50623124|FG006|Overall Study|Ineligibility Determined|0|||
25307844|NCT00757042|50623125|FG007|Overall Study|Ineligibility Determined|0|||
25307845|NCT00757042|50623126|FG008|Overall Study|Ineligibility Determined|0|||
25307846|NCT00757042|50623127|FG009|Overall Study|Ineligibility Determined|0|||
25307847|NCT00757042|50623128|FG010|Overall Study|Ineligibility Determined|1|||
25307848|NCT00757042|50623118|FG000|Overall Study|Withdrawal by Subject|0|||
25307849|NCT00757042|50623119|FG001|Overall Study|Withdrawal by Subject|0|||
25307850|NCT00757042|50623120|FG002|Overall Study|Withdrawal by Subject|0|||
25307851|NCT00757042|50623121|FG003|Overall Study|Withdrawal by Subject|0|||
25307852|NCT00757042|50623122|FG004|Overall Study|Withdrawal by Subject|0|||
25307853|NCT00757042|50623123|FG005|Overall Study|Withdrawal by Subject|0|||
25307854|NCT00757042|50623124|FG006|Overall Study|Withdrawal by Subject|0|||
25307855|NCT00757042|50623125|FG007|Overall Study|Withdrawal by Subject|0|||
25307856|NCT00757042|50623126|FG008|Overall Study|Withdrawal by Subject|0|||
25307857|NCT00757042|50623127|FG009|Overall Study|Withdrawal by Subject|1|||
25307858|NCT00757042|50623128|FG010|Overall Study|Withdrawal by Subject|0|||
25307859|NCT01013597|50623159|FG000|Overall Study|Withdrawal by Subject|1|||
25307860|NCT01013285|50623178|FG000|Overall Study|Death|48|||
25307861|NCT01013285|50623179|FG001|Overall Study|Death|89|||
25307862|NCT01033643|50623189|FG000|Overall Study|Withdrew Consent|0|||
25307863|NCT01033643|50623190|FG001|Overall Study|Withdrew Consent|3|||
25307864|NCT01033643|50623191|FG002|Overall Study|Withdrew Consent|0|||
25307865|NCT01033643|50623192|FG003|Overall Study|Withdrew Consent|0|||
25307866|NCT01033643|50623193|FG004|Overall Study|Withdrew Consent|0|||
25307867|NCT01033643|50623194|FG005|Overall Study|Withdrew Consent|1|||
25307868|NCT01013207|50623208|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
25307869|NCT01033487|50623212|FG000|Fourth Intervention Period|Adverse Event|0|||
25307870|NCT01033487|50623213|FG001|Fourth Intervention Period|Adverse Event|0|||
25307871|NCT01033487|50623214|FG002|Fourth Intervention Period|Adverse Event|0|||
25307872|NCT01033487|50623215|FG003|Fourth Intervention Period|Adverse Event|0|||
25307873|NCT01033487|50623216|FG004|Fourth Intervention Period|Adverse Event|0|||
25307874|NCT01033487|50623217|FG005|Fourth Intervention Period|Adverse Event|0|||
25307875|NCT01033487|50623218|FG006|Fourth Intervention Period|Adverse Event|0|||
25307876|NCT01033487|50623219|FG007|Fourth Intervention Period|Adverse Event|0|||
25307877|NCT01033487|50623220|FG008|Fourth Intervention Period|Adverse Event|1|||
25307878|NCT01033487|50623221|FG009|Fourth Intervention Period|Adverse Event|0|||
25307879|NCT01033019|50623237|FG000|Overall Study|Withdrawal by Subject|1|||
25307880|NCT01033019|50623238|FG001|Overall Study|Withdrawal by Subject|0|||
25307881|NCT00603447|50623252|FG000|Overall Study|Adverse Event|0|||
25307882|NCT00603447|50623253|FG001|Overall Study|Adverse Event|1|||
25307883|NCT00603447|50623254|FG002|Overall Study|Adverse Event|1|||
25307884|NCT00603447|50623255|FG003|Overall Study|Adverse Event|2|||
25307885|NCT00603447|50623256|FG004|Overall Study|Adverse Event|1|||
25307886|NCT00603447|50623257|FG005|Overall Study|Adverse Event|2|||
25307887|NCT00603447|50623258|FG006|Overall Study|Adverse Event|10|||
25169513|NCT01827371|50301363|FG003|Overall Study|Temporary study halt to vaccinations|13|||
25307888|NCT00603447|50623252|FG000|Overall Study|Other|0|||
25307889|NCT00603447|50623253|FG001|Overall Study|Other|0|||
25307890|NCT00603447|50623254|FG002|Overall Study|Other|1|||
25307891|NCT00603447|50623255|FG003|Overall Study|Other|0|||
25307892|NCT00603447|50623256|FG004|Overall Study|Other|3|||
25307893|NCT00603447|50623257|FG005|Overall Study|Other|0|||
25307894|NCT00603447|50623258|FG006|Overall Study|Other|13|||
25307895|NCT00603447|50623252|FG000|Overall Study|Withdrew Consent|0|||
25307896|NCT00603447|50623253|FG001|Overall Study|Withdrew Consent|2|||
25307897|NCT00603447|50623254|FG002|Overall Study|Withdrew Consent|0|||
25307898|NCT00603447|50623255|FG003|Overall Study|Withdrew Consent|0|||
25307899|NCT00603447|50623256|FG004|Overall Study|Withdrew Consent|1|||
25307900|NCT00603447|50623257|FG005|Overall Study|Withdrew Consent|0|||
25307901|NCT00603447|50623258|FG006|Overall Study|Withdrew Consent|1|||
25307902|NCT00778258|50623283|FG000|Overall Study|Adverse Event|1|||
25071280|NCT02630459|50177390|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
25071281|NCT02630459|50177391|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
25071282|NCT02573948|50177416|FG000|Longitudinal Cohort|Death|9|||
25071283|NCT02573948|50177416|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
25071284|NCT02573948|50177416|FG000|Longitudinal Cohort|Incarcerated|25|||
25071285|NCT01464593|50177423|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
25071286|NCT01361711|50177427|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
25071287|NCT01361711|50177427|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
25071288|NCT01361711|50177427|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
25071289|NCT01361711|50177427|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
25071290|NCT01361711|50177427|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
25071291|NCT01361711|50177427|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
25071292|NCT01361711|50177427|FG000|Completed Week 18 of Treatment|Other|9|||
25071293|NCT01361711|50177427|FG000|10 Year Follow-up|Still in follow-up|22|||
25071294|NCT01361711|50177427|FG000|10 Year Follow-up|Death|7|||
25071295|NCT01361711|50177427|FG000|10 Year Follow-up|Developed new cancer|1|||
25071296|NCT01361711|50177427|FG000|10 Year Follow-up|Lost to Follow-up|2|||
25071297|NCT01361711|50177427|FG000|10 Year Follow-up|New treatment started|6|||
25071298|NCT01361711|50177427|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
25307903|NCT00778258|50623284|FG001|Overall Study|Adverse Event|0|||
25307904|NCT00778258|50623285|FG002|Overall Study|Adverse Event|0|||
25307905|NCT00778258|50623286|FG003|Overall Study|Adverse Event|0|||
25307906|NCT00778258|50623287|FG004|Overall Study|Adverse Event|0|||
25307907|NCT00778258|50623288|FG005|Overall Study|Adverse Event|1|||
25307908|NCT00778258|50623289|FG006|Overall Study|Adverse Event|0|||
25307909|NCT00778258|50623290|FG007|Overall Study|Adverse Event|0|||
25307910|NCT00778258|50623291|FG008|Overall Study|Adverse Event|0|||
25307911|NCT00778258|50623283|FG000|Overall Study|Lost to Follow-up|0|||
25307912|NCT00778258|50623284|FG001|Overall Study|Lost to Follow-up|0|||
25307913|NCT00778258|50623285|FG002|Overall Study|Lost to Follow-up|2|||
25307914|NCT00778258|50623286|FG003|Overall Study|Lost to Follow-up|0|||
25307915|NCT00778258|50623287|FG004|Overall Study|Lost to Follow-up|0|||
25307916|NCT00778258|50623288|FG005|Overall Study|Lost to Follow-up|3|||
25307917|NCT00778258|50623289|FG006|Overall Study|Lost to Follow-up|2|||
25307918|NCT00778258|50623290|FG007|Overall Study|Lost to Follow-up|2|||
25307919|NCT00778258|50623291|FG008|Overall Study|Lost to Follow-up|0|||
25307920|NCT00778258|50623283|FG000|Overall Study|Withdrawal by Subject|6|||
25071299|NCT01361711|50177427|FG000|10 Year Follow-up|Progressive Disease|1|||
25307921|NCT00778258|50623284|FG001|Overall Study|Withdrawal by Subject|2|||
25307922|NCT00778258|50623285|FG002|Overall Study|Withdrawal by Subject|8|||
25307923|NCT00778258|50623286|FG003|Overall Study|Withdrawal by Subject|2|||
25307924|NCT00778258|50623287|FG004|Overall Study|Withdrawal by Subject|0|||
25307925|NCT00778258|50623288|FG005|Overall Study|Withdrawal by Subject|6|||
25307926|NCT00778258|50623289|FG006|Overall Study|Withdrawal by Subject|12|||
25307927|NCT00778258|50623290|FG007|Overall Study|Withdrawal by Subject|12|||
25307928|NCT00778258|50623291|FG008|Overall Study|Withdrawal by Subject|4|||
25307929|NCT00778258|50623283|FG000|Overall Study|New Contraindication|0|||
25307930|NCT00778258|50623284|FG001|Overall Study|New Contraindication|0|||
25307931|NCT00778258|50623285|FG002|Overall Study|New Contraindication|0|||
25307932|NCT00778258|50623286|FG003|Overall Study|New Contraindication|0|||
25307933|NCT00778258|50623287|FG004|Overall Study|New Contraindication|0|||
25307934|NCT00778258|50623288|FG005|Overall Study|New Contraindication|0|||
25307935|NCT00778258|50623289|FG006|Overall Study|New Contraindication|0|||
25307936|NCT00778258|50623290|FG007|Overall Study|New Contraindication|1|||
25307937|NCT00778258|50623291|FG008|Overall Study|New Contraindication|0|||
25307938|NCT00778258|50623283|FG000|Overall Study|Non-compliance|0|||
25307939|NCT00778258|50623284|FG001|Overall Study|Non-compliance|0|||
25307940|NCT00778258|50623285|FG002|Overall Study|Non-compliance|0|||
25307941|NCT00778258|50623286|FG003|Overall Study|Non-compliance|1|||
25307942|NCT00778258|50623287|FG004|Overall Study|Non-compliance|0|||
25307943|NCT00778258|50623288|FG005|Overall Study|Non-compliance|0|||
25307944|NCT00778258|50623289|FG006|Overall Study|Non-compliance|0|||
25307945|NCT00778258|50623290|FG007|Overall Study|Non-compliance|0|||
25307946|NCT00778258|50623291|FG008|Overall Study|Non-compliance|0|||
25307947|NCT00778258|50623283|FG000|Overall Study|Other|0|||
25307948|NCT00778258|50623284|FG001|Overall Study|Other|0|||
25307949|NCT00778258|50623285|FG002|Overall Study|Other|0|||
25307950|NCT00778258|50623286|FG003|Overall Study|Other|0|||
25307951|NCT00778258|50623287|FG004|Overall Study|Other|0|||
25307952|NCT00778258|50623288|FG005|Overall Study|Other|0|||
25307953|NCT00778258|50623289|FG006|Overall Study|Other|1|||
25307954|NCT00778258|50623290|FG007|Overall Study|Other|0|||
25307955|NCT00778258|50623291|FG008|Overall Study|Other|0|||
25307956|NCT00988208|50623319|FG000|Overall Study|Adverse Event|71|||
25307957|NCT00988208|50623320|FG001|Overall Study|Adverse Event|122|||
25307958|NCT00988208|50623319|FG000|Overall Study|Disease Progression|103|||
25307959|NCT00988208|50623320|FG001|Overall Study|Disease Progression|89|||
25307960|NCT00988208|50623319|FG000|Overall Study|Withdrawal by Subject|50|||
25307961|NCT00988208|50623320|FG001|Overall Study|Withdrawal by Subject|57|||
25307962|NCT00988208|50623319|FG000|Overall Study|Death|9|||
25307963|NCT00988208|50623320|FG001|Overall Study|Death|15|||
25307964|NCT00988208|50623319|FG000|Overall Study|Lost to Follow-up|2|||
25307965|NCT00988208|50623320|FG001|Overall Study|Lost to Follow-up|3|||
25307966|NCT00988208|50623319|FG000|Overall Study|Protocol Violation|9|||
25307967|NCT00988208|50623320|FG001|Overall Study|Protocol Violation|2|||
25307968|NCT00988208|50623319|FG000|Overall Study|Sponsor Decision|102|||
25307969|NCT00988208|50623320|FG001|Overall Study|Sponsor Decision|78|||
25307970|NCT00988208|50623319|FG000|Overall Study|Clinical Progression|17|||
25307971|NCT00988208|50623320|FG001|Overall Study|Clinical Progression|16|||
25307972|NCT00988208|50623319|FG000|Overall Study|Biochemical Progression|21|||
25307973|NCT00988208|50623320|FG001|Overall Study|Biochemical Progression|7|||
25307974|NCT00988208|50623319|FG000|Overall Study|Clinical Deterioration|7|||
25307975|NCT00988208|50623320|FG001|Overall Study|Clinical Deterioration|14|||
25307976|NCT00988208|50623319|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
25307977|NCT00988208|50623320|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
25307978|NCT00988208|50623319|FG000|Overall Study|Other|8|||
25307979|NCT00988208|50623320|FG001|Overall Study|Other|3|||
25307980|NCT00990704|50623328|FG000|Overall Study|Adverse Event|1|||
25307981|NCT00990704|50623329|FG001|Overall Study|Adverse Event|1|||
25307982|NCT00990704|50623328|FG000|Overall Study|Physician Decision|0|||
25307983|NCT00990704|50623329|FG001|Overall Study|Physician Decision|1|||
25307984|NCT04089553|50623337|FG000|Overall Study|Death|12|||
25307985|NCT04089553|50623338|FG001|Overall Study|Death|11|||
25307986|NCT04089553|50623337|FG000|Overall Study|Lost to Follow-up|2|||
25307987|NCT04089553|50623338|FG001|Overall Study|Lost to Follow-up|2|||
25307988|NCT04089553|50623337|FG000|Overall Study|Progressive disease|0|||
25307989|NCT04089553|50623338|FG001|Overall Study|Progressive disease|1|||
25307990|NCT04089553|50623337|FG000|Overall Study|Withdrawal by Subject|5|||
25307991|NCT04089553|50623338|FG001|Overall Study|Withdrawal by Subject|2|||
25307992|NCT04089553|50623337|FG000|Overall Study|Other|6|||
25307993|NCT04089553|50623338|FG001|Overall Study|Other|2|||
25307994|NCT00993668|50623347|FG000|Single-Blind Period|Adverse Event|1|||
25307995|NCT00993668|50623348|FG001|Single-Blind Period|Adverse Event|1|||
25307996|NCT00993668|50623347|FG000|Single-Blind Period|Lack of Efficacy|0|||
24970069|NCT04358068|50059589|FG001|Overall Study|Did not initiate study treatment|2|||
25307997|NCT00993668|50623348|FG001|Single-Blind Period|Lack of Efficacy|1|||
25307998|NCT00993668|50623347|FG000|Single-Blind Period|Lost to Follow-up|3|||
25307999|NCT00993668|50623348|FG001|Single-Blind Period|Lost to Follow-up|1|||
25308000|NCT00993668|50623347|FG000|Open-Label Period|Adverse Event|9|||
25308001|NCT00993668|50623348|FG001|Open-Label Period|Adverse Event|8|||
25308002|NCT00993668|50623347|FG000|Open-Label Period|Lack of Efficacy|4|||
25308003|NCT00993668|50623348|FG001|Open-Label Period|Lack of Efficacy|3|||
25308004|NCT00993668|50623347|FG000|Open-Label Period|Withdrawal by Subject|4|||
25308005|NCT00993668|50623348|FG001|Open-Label Period|Withdrawal by Subject|3|||
25308006|NCT00993668|50623347|FG000|Open-Label Period|Lost to Follow-up|6|||
25308007|NCT00993668|50623348|FG001|Open-Label Period|Lost to Follow-up|1|||
25308008|NCT00778102|50623357|FG000|Overall Study|Adverse Event|8|||
25308009|NCT00778102|50623358|FG001|Overall Study|Adverse Event|5|||
25308010|NCT00778102|50623357|FG000|Overall Study|Death|1|||
25308011|NCT00778102|50623358|FG001|Overall Study|Death|1|||
25308012|NCT00778102|50623357|FG000|Overall Study|Lost to Follow-up|1|||
25308013|NCT00778102|50623358|FG001|Overall Study|Lost to Follow-up|0|||
25308014|NCT00778102|50623357|FG000|Overall Study|Violation of Selection Criteria|1|||
25308015|NCT00778102|50623358|FG001|Overall Study|Violation of Selection Criteria|1|||
25308016|NCT00778102|50623357|FG000|Overall Study|Protocol Violation|0|||
25308017|NCT00778102|50623358|FG001|Overall Study|Protocol Violation|1|||
25308018|NCT00778102|50623357|FG000|Overall Study|Refused Treatment|2|||
25308019|NCT00778102|50623358|FG001|Overall Study|Refused Treatment|3|||
25308020|NCT00778102|50623357|FG000|Overall Study|Withdrawal by Subject|1|||
25308021|NCT00778102|50623358|FG001|Overall Study|Withdrawal by Subject|1|||
25308022|NCT00778102|50623357|FG000|Overall Study|Administrative Reason|7|||
25308023|NCT00778102|50623358|FG001|Overall Study|Administrative Reason|10|||
25308024|NCT00756886|50623366|FG000|Overall Study|Lost to Follow-up|1|||
25308025|NCT00756886|50623367|FG001|Overall Study|Lost to Follow-up|0|||
25308026|NCT00756886|50623366|FG000|Overall Study|Adverse Event|0|||
25308027|NCT00756886|50623367|FG001|Overall Study|Adverse Event|3|||
25308028|NCT00756886|50623366|FG000|Overall Study|Lack of Efficacy|1|||
25308029|NCT00756886|50623367|FG001|Overall Study|Lack of Efficacy|0|||
25308030|NCT00756886|50623366|FG000|Overall Study|Ineligible|9|||
25308031|NCT00756886|50623367|FG001|Overall Study|Ineligible|4|||
25308032|NCT00756730|50623375|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
25308033|NCT00756730|50623376|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
25308034|NCT00756730|50623375|FG000|Overall Study|persistent low-level viremmia|0|||
25308035|NCT00756730|50623376|FG001|Overall Study|persistent low-level viremmia|1|||
25308036|NCT00984620|50623384|FG000|Overall Study|Adverse Event|5|||
25308037|NCT00984620|50623385|FG001|Overall Study|Adverse Event|5|||
25308038|NCT00984620|50623384|FG000|Overall Study|Lost to Follow-up|1|||
25308039|NCT00984620|50623385|FG001|Overall Study|Lost to Follow-up|1|||
25308040|NCT00984620|50623384|FG000|Overall Study|Withdrawal by Subject|0|||
25308041|NCT00984620|50623385|FG001|Overall Study|Withdrawal by Subject|2|||
25308042|NCT00984620|50623384|FG000|Overall Study|reason other than listed above|0|||
25308043|NCT00984620|50623385|FG001|Overall Study|reason other than listed above|4|||
25308044|NCT00777946|50623396|FG000|Overall Study|Adverse Event|11|||
25308045|NCT00777946|50623397|FG001|Overall Study|Adverse Event|1|||
25308046|NCT00777946|50623398|FG002|Overall Study|Adverse Event|3|||
25308047|NCT00777946|50623396|FG000|Overall Study|Lack of Efficacy|0|||
25308048|NCT00777946|50623397|FG001|Overall Study|Lack of Efficacy|0|||
25308049|NCT00777946|50623398|FG002|Overall Study|Lack of Efficacy|9|||
25308050|NCT00777946|50623396|FG000|Overall Study|Condition no longer required study drug|1|||
25308051|NCT00777946|50623397|FG001|Overall Study|Condition no longer required study drug|0|||
25308052|NCT00777946|50623398|FG002|Overall Study|Condition no longer required study drug|0|||
25308053|NCT00777946|50623396|FG000|Overall Study|Patient withdrew consent|3|||
25308054|NCT00777946|50623397|FG001|Overall Study|Patient withdrew consent|2|||
25308055|NCT00777946|50623398|FG002|Overall Study|Patient withdrew consent|3|||
25308056|NCT00777946|50623396|FG000|Overall Study|Lost to Follow-up|3|||
25308057|NCT00777946|50623397|FG001|Overall Study|Lost to Follow-up|1|||
25308058|NCT00777946|50623398|FG002|Overall Study|Lost to Follow-up|0|||
25308059|NCT00777946|50623396|FG000|Overall Study|Protocol deviation|2|||
25308060|NCT00777946|50623397|FG001|Overall Study|Protocol deviation|1|||
24970070|NCT03694210|50059595|FG000|Overall Study|Death|1|||
24970071|NCT03694210|50059595|FG000|Overall Study|Screen Failure|7|||
25308061|NCT00777946|50623398|FG002|Overall Study|Protocol deviation|1|||
25308062|NCT00777946|50623396|FG000|Overall Study|Randomized in error|1|||
25308063|NCT00777946|50623397|FG001|Overall Study|Randomized in error|1|||
25308064|NCT00777946|50623398|FG002|Overall Study|Randomized in error|0|||
25308065|NCT00990314|50623406|FG000|Overall Study|Death|2|||
25308066|NCT00990314|50623406|FG000|Overall Study|Adverse Event|2|||
25308067|NCT00990314|50623406|FG000|Overall Study|Withdrawal by Subject|3|||
25308068|NCT00990314|50623406|FG000|Overall Study|Non-Compliance|1|||
25308069|NCT00990314|50623406|FG000|Overall Study|Physician Decision|3|||
25308070|NCT00990314|50623406|FG000|Overall Study|Lack of Efficacy|1|||
25308071|NCT00756652|50623412|FG000|Original Phase|Withdrawal by Subject|864|||
25308072|NCT00756652|50623413|FG001|Original Phase|Withdrawal by Subject|23|||
25308073|NCT00756652|50623412|FG000|Original Phase|Lost to Follow-up|601|||
25308074|NCT00756652|50623413|FG001|Original Phase|Lost to Follow-up|0|||
25308075|NCT00756652|50623412|FG000|Original Phase|Other Discontinuation|797|||
25308076|NCT00756652|50623413|FG001|Original Phase|Other Discontinuation|5|||
25308077|NCT00756652|50623412|FG000|Original Phase|Participant Noncompliance|18622|||
25308078|NCT00756652|50623413|FG001|Original Phase|Participant Noncompliance|424|||
25308079|NCT00756652|50623412|FG000|Original Phase|Unknown Discontinuation Reason|2|||
25308080|NCT00756652|50623413|FG001|Original Phase|Unknown Discontinuation Reason|0|||
25308081|NCT00756652|50623412|FG000|Original Phase|Participants without data|3259|||
25308082|NCT00756652|50623413|FG001|Original Phase|Participants without data|466|||
25308083|NCT00756652|50623412|FG000|Original Phase|Death|168|||
25308084|NCT00756652|50623413|FG001|Original Phase|Death|1|||
25308085|NCT00756652|50623412|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
25308086|NCT00756652|50623413|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
25308087|NCT00756652|50623412|FG000|Re-Op Phase|Withdrawal by Subject|62|||
25308088|NCT00756652|50623413|FG001|Re-Op Phase|Withdrawal by Subject|0|||
25308089|NCT00756652|50623412|FG000|Re-Op Phase|Death|6|||
25308090|NCT00756652|50623413|FG001|Re-Op Phase|Death|0|||
25308091|NCT00756652|50623412|FG000|Re-Op Phase|Lost to Follow-up|340|||
25308092|NCT00756652|50623413|FG001|Re-Op Phase|Lost to Follow-up|0|||
25308093|NCT00756652|50623412|FG000|Re-Op Phase|Site Closed|2454|||
25308094|NCT00756652|50623413|FG001|Re-Op Phase|Site Closed|0|||
25308095|NCT00756652|50623412|FG000|Re-Op Phase|Withdrawn after explant|14|||
25308096|NCT00756652|50623413|FG001|Re-Op Phase|Withdrawn after explant|0|||
25308097|NCT00777556|50623417|FG000|Overall Study|Inappropriate self-selection|34|||
25308098|NCT00777556|50623417|FG000|Overall Study|Dispensed but did not use product|12|||
25308099|NCT00777556|50623417|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
25308100|NCT00602979|50623426|FG000|Overall Study|Lost to Follow-up|3|||
25308101|NCT00602979|50623427|FG001|Overall Study|Lost to Follow-up|2|||
25308102|NCT00602979|50623428|FG002|Overall Study|Lost to Follow-up|3|||
25308103|NCT00602979|50623429|FG003|Overall Study|Lost to Follow-up|2|||
25308104|NCT00602979|50623430|FG004|Overall Study|Lost to Follow-up|3|||
25308105|NCT00602979|50623426|FG000|Overall Study|Failed Intubation|0|||
25308106|NCT00602979|50623427|FG001|Overall Study|Failed Intubation|1|||
25308107|NCT00602979|50623428|FG002|Overall Study|Failed Intubation|0|||
25308108|NCT00602979|50623429|FG003|Overall Study|Failed Intubation|1|||
25308109|NCT00602979|50623430|FG004|Overall Study|Failed Intubation|0|||
25308110|NCT04081363|50623444|FG000|Overall Study|Withdrawal by Subject|1|||
25308111|NCT04081363|50623445|FG001|Overall Study|Withdrawal by Subject|0|||
25308112|NCT00993044|50623451|FG000|Irinotecan 50 mg|Physician Decision|1|||
25308113|NCT00777088|50623465|FG000|Overall Study|PED Treatment not attempted|1|||
25308114|NCT00763282|50623481|FG000|Overall Study|Withdrawal by Subject|6|||
25308115|NCT00763282|50623482|FG001|Overall Study|Withdrawal by Subject|5|||
25308116|NCT00763282|50623481|FG000|Overall Study|Death|4|||
25308117|NCT00763282|50623482|FG001|Overall Study|Death|3|||
25308118|NCT00763282|50623481|FG000|Overall Study|Lost to Follow-up|22|||
25308119|NCT00763282|50623482|FG001|Overall Study|Lost to Follow-up|26|||
25308120|NCT00988598|50623492|FG000|Overall Study|Withdrawal by Subject|2|||
25308121|NCT00988598|50623493|FG001|Overall Study|Withdrawal by Subject|0|||
25308122|NCT00979628|50623502|FG000|Overall Study|received regimen < 24 hours|7|||
25308123|NCT00979628|50623503|FG001|Overall Study|received regimen < 24 hours|6|||
25308124|NCT00979628|50623504|FG002|Overall Study|received regimen < 24 hours|5|||
25308125|NCT00979628|50623502|FG000|Overall Study|received steroids|1|||
25308126|NCT00979628|50623503|FG001|Overall Study|received steroids|1|||
25308127|NCT00979628|50623504|FG002|Overall Study|received steroids|0|||
25308128|NCT00979628|50623502|FG000|Overall Study|transferred to ICU|1|||
25308129|NCT00979628|50623503|FG001|Overall Study|transferred to ICU|2|||
25308130|NCT00979628|50623504|FG002|Overall Study|transferred to ICU|1|||
25308131|NCT00762970|50623518|FG000|Overall Study|Withdrawal by Subject|7|||
24970072|NCT04339972|50059603|FG000|Overall Study|Scheduling Issues|3|||
25308132|NCT00762970|50623519|FG001|Overall Study|Withdrawal by Subject|4|||
25308133|NCT00762970|50623520|FG002|Overall Study|Withdrawal by Subject|0|||
25308134|NCT00762970|50623518|FG000|Overall Study|Protocol Violation|3|||
25308135|NCT00762970|50623519|FG001|Overall Study|Protocol Violation|1|||
25308136|NCT00762970|50623520|FG002|Overall Study|Protocol Violation|1|||
24970073|NCT04339972|50059604|FG001|Overall Study|Scheduling Issues|3|||
25308137|NCT00762970|50623518|FG000|Overall Study|Lost to Follow-up|1|||
25308138|NCT00762970|50623519|FG001|Overall Study|Lost to Follow-up|2|||
25308139|NCT00762970|50623520|FG002|Overall Study|Lost to Follow-up|0|||
25308140|NCT00762970|50623518|FG000|Overall Study|Difficulty of handling lens|1|||
25308141|NCT00762970|50623519|FG001|Overall Study|Difficulty of handling lens|2|||
25308142|NCT00762970|50623520|FG002|Overall Study|Difficulty of handling lens|0|||
25308143|NCT00988442|50623530|FG000|Overall Study|Death|1|||
25308144|NCT00988442|50623531|FG001|Overall Study|Death|2|||
25308145|NCT00988442|50623530|FG000|Overall Study|Lost to Follow-up|0|||
25308146|NCT00988442|50623531|FG001|Overall Study|Lost to Follow-up|1|||
25308147|NCT00988442|50623530|FG000|Overall Study|Early Study Closure|29|||
25308148|NCT00988442|50623531|FG001|Overall Study|Early Study Closure|25|||
25308149|NCT03258723|50623540|FG000|Overall Study|COVID Interruption of study|54|||
25308150|NCT03258723|50623540|FG000|Overall Study|Lost to Follow-up|8|||
25308151|NCT00992186|50623544|FG000|Overall Study|Withdrawal by Subject|2|||
25308152|NCT00992186|50623544|FG000|Overall Study|Protocol Violation|1|||
25308153|NCT00992186|50623544|FG000|Overall Study|Physician Decision|1|||
25308154|NCT00992186|50623544|FG000|Overall Study|Adverse Event|9|||
25308155|NCT00992186|50623544|FG000|Overall Study|Progressive Disease|30|||
25308156|NCT00992186|50623544|FG000|Overall Study|Refusal To Receive Study Agent|3|||
25308157|NCT00992108|50623551|FG000|Overall Study|Lost to Follow-up|0|||
25308158|NCT00992108|50623552|FG001|Overall Study|Lost to Follow-up|1|||
25308159|NCT00752986|50623561|FG000|Overall Study|Withdrawal by Subject|2|||
24970074|NCT04339972|50059603|FG000|Overall Study|dropout|1|||
25308160|NCT00752986|50623562|FG001|Overall Study|Withdrawal by Subject|1|||
25308161|NCT00752986|50623563|FG002|Overall Study|Withdrawal by Subject|2|||
25308162|NCT00752986|50623561|FG000|Overall Study|Protocol Violation|3|||
25308163|NCT00752986|50623562|FG001|Overall Study|Protocol Violation|0|||
25308164|NCT00752986|50623563|FG002|Overall Study|Protocol Violation|0|||
25308165|NCT03483103|50623571|FG000|Pre-Treatment Phase|Other reasons|1|||
25308166|NCT03483103|50623571|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
25308167|NCT03483103|50623571|FG000|Pre-Treatment Phase|Disease-related complications|1|||
25308168|NCT03483103|50623571|FG000|Pre-Treatment Phase|Death|5|||
25308169|NCT03483103|50623571|FG000|Treatment Phase|Withdrawal by Subject|6|||
25308170|NCT03483103|50623571|FG000|Treatment Phase|Other reasons|2|||
25308171|NCT03483103|50623571|FG000|Treatment Phase|Death|20|||
25308172|NCT03483103|50623571|FG000|Treatment Phase|Ongoing in study|26|||
25308173|NCT03483103|50623571|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
25308174|NCT03483103|50623571|FG000|Treatment Phase|Received nonconforming product|1|||
25308175|NCT00762892|50623577|FG000|Overall Study|Lost to Follow-up|2|||
25308176|NCT00762892|50623578|FG001|Overall Study|Lost to Follow-up|5|||
25308177|NCT00762892|50623577|FG000|Overall Study|Withdrawal by Subject|0|||
25308178|NCT00762892|50623578|FG001|Overall Study|Withdrawal by Subject|1|||
25308179|NCT00762892|50623577|FG000|Overall Study|Death|1|||
25308180|NCT00762892|50623578|FG001|Overall Study|Death|0|||
25308181|NCT00762892|50623577|FG000|Overall Study|Pregnancy|1|||
25308182|NCT00762892|50623578|FG001|Overall Study|Pregnancy|0|||
25308183|NCT00762892|50623577|FG000|Overall Study|Incarceration|1|||
25308184|NCT00762892|50623578|FG001|Overall Study|Incarceration|0|||
25308185|NCT00755716|50623587|FG000|Overall Study|Adverse Event|1|||
25308186|NCT00755716|50623588|FG001|Overall Study|Adverse Event|4|||
25308187|NCT00755716|50623589|FG002|Overall Study|Adverse Event|1|||
25308188|NCT00755716|50623587|FG000|Overall Study|Lack of Efficacy|2|||
25308189|NCT00755716|50623588|FG001|Overall Study|Lack of Efficacy|0|||
25308190|NCT00755716|50623589|FG002|Overall Study|Lack of Efficacy|0|||
25308191|NCT00755716|50623587|FG000|Overall Study|Lost to Follow-up|5|||
25308192|NCT00755716|50623588|FG001|Overall Study|Lost to Follow-up|3|||
25308193|NCT00755716|50623589|FG002|Overall Study|Lost to Follow-up|1|||
25308194|NCT00755716|50623587|FG000|Overall Study|work schedule issues|0|||
25308195|NCT00755716|50623588|FG001|Overall Study|work schedule issues|1|||
25308196|NCT00755716|50623589|FG002|Overall Study|work schedule issues|1|||
25308197|NCT00755326|50623599|FG000|Overall Study|Lost to Follow-up|2|||
25308198|NCT00755326|50623600|FG001|Overall Study|Lost to Follow-up|3|||
25308199|NCT03084471|50623607|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
25308200|NCT03084471|50623607|FG000|Overall Study|Condition under investigation worsened|84|||
25308201|NCT03084471|50623607|FG000|Overall Study|Lack of therapeutic response|2|||
25308202|NCT03084471|50623607|FG000|Overall Study|Protocol Violation|1|||
25308203|NCT03084471|50623607|FG000|Overall Study|Adverse Event|73|||
25308204|NCT03084471|50623607|FG000|Overall Study|Withdrawal by Subject|12|||
25308205|NCT03084471|50623607|FG000|Overall Study|Disease relapse|181|||
25308206|NCT03084471|50623607|FG000|Overall Study|Subjective disease progression|359|||
25308207|NCT03084471|50623607|FG000|Overall Study|Other (as recorded)|33|||
25308208|NCT03084471|50623607|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
25308209|NCT00754936|50623614|FG000|Overall Study|Lost to Follow-up|3|||
25308210|NCT00754936|50623614|FG000|Overall Study|Physician Decision|1|||
25308211|NCT00754936|50623614|FG000|Overall Study|Withdrawal by Subject|2|||
25308212|NCT00754936|50623614|FG000|Overall Study|Side Effects|3|||
25308213|NCT00754936|50623614|FG000|Overall Study|Inter-current medical events|3|||
25308214|NCT00762502|50623621|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
25308215|NCT00762502|50623622|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
25308216|NCT00762502|50623623|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
25308217|NCT00762502|50623621|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
25308218|NCT00762502|50623622|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
25308219|NCT00762502|50623623|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
25308220|NCT00762502|50623621|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
25308221|NCT00762502|50623622|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
25308222|NCT00762502|50623623|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
25308223|NCT00762268|50623631|FG000|Overall Study|Withdrawal by Subject|3|||
25308224|NCT00762268|50623632|FG001|Overall Study|Withdrawal by Subject|3|||
25308225|NCT00975884|50623640|FG000|Overall Study|Adverse Event|1|||
25308226|NCT00975884|50623641|FG001|Overall Study|Adverse Event|0|||
25308227|NCT00975884|50623640|FG000|Overall Study|Lost to Follow-up|5|||
25308228|NCT00975884|50623641|FG001|Overall Study|Lost to Follow-up|3|||
25308229|NCT00975884|50623640|FG000|Overall Study|Withdrawal by Subject|9|||
25308230|NCT00975884|50623641|FG001|Overall Study|Withdrawal by Subject|9|||
25308231|NCT00975884|50623640|FG000|Overall Study|Other|1|||
25308232|NCT00975884|50623641|FG001|Overall Study|Other|3|||
25308233|NCT00578227|50623660|FG000|Overall Study|Lost to Follow-up|0|||
25308234|NCT00578227|50623661|FG001|Overall Study|Lost to Follow-up|1|||
25308235|NCT00578227|50623662|FG002|Overall Study|Lost to Follow-up|1|||
25308236|NCT00578227|50623660|FG000|Overall Study|Withdrawal by Subject|5|||
25308237|NCT00578227|50623661|FG001|Overall Study|Withdrawal by Subject|1|||
25308238|NCT00578227|50623662|FG002|Overall Study|Withdrawal by Subject|3|||
25308239|NCT00978380|50623672|FG000|Overall Study|Protocol Violation|2|||
25308240|NCT00978380|50623672|FG000|Overall Study|Withdrawal criteria|9|||
25308241|NCT00978380|50623672|FG000|Overall Study|Unclassified|8|||
25308242|NCT00577993|50623680|FG000|Overall Study|Adverse Event|1|||
25308243|NCT00577993|50623681|FG001|Overall Study|Adverse Event|0|||
25308244|NCT00577993|50623682|FG002|Overall Study|Adverse Event|0|||
25308245|NCT00577993|50623680|FG000|Overall Study|Death|0|||
25308246|NCT00577993|50623681|FG001|Overall Study|Death|1|||
25308247|NCT00577993|50623682|FG002|Overall Study|Death|1|||
25308248|NCT00577993|50623680|FG000|Overall Study|Lack of Efficacy|0|||
25308249|NCT00577993|50623681|FG001|Overall Study|Lack of Efficacy|1|||
25308250|NCT00577993|50623682|FG002|Overall Study|Lack of Efficacy|0|||
25308251|NCT00577993|50623680|FG000|Overall Study|Protocol Violation|2|||
25308252|NCT00577993|50623681|FG001|Overall Study|Protocol Violation|3|||
25308253|NCT00577993|50623682|FG002|Overall Study|Protocol Violation|0|||
25308254|NCT00577993|50623680|FG000|Overall Study|Withdrawal by Subject|1|||
25308255|NCT00577993|50623681|FG001|Overall Study|Withdrawal by Subject|0|||
25308256|NCT00577993|50623682|FG002|Overall Study|Withdrawal by Subject|2|||
25308257|NCT00577993|50623680|FG000|Overall Study|Conversion|2|||
25308258|NCT00577993|50623681|FG001|Overall Study|Conversion|5|||
25308259|NCT00577993|50623682|FG002|Overall Study|Conversion|0|||
25308260|NCT00577993|50623680|FG000|Overall Study|Uninsured|1|||
25308261|NCT00577993|50623681|FG001|Overall Study|Uninsured|0|||
25308262|NCT00577993|50623682|FG002|Overall Study|Uninsured|0|||
25308263|NCT00975806|50623691|FG000|Overall Study|Adverse Event|2|||
25308264|NCT00975806|50623692|FG001|Overall Study|Adverse Event|1|||
25308265|NCT00975806|50623693|FG002|Overall Study|Adverse Event|2|||
25308266|NCT00975806|50623691|FG000|Overall Study|Disease Progression|1|||
25308267|NCT00975806|50623692|FG001|Overall Study|Disease Progression|5|||
25308268|NCT00975806|50623693|FG002|Overall Study|Disease Progression|1|||
25308269|NCT00975806|50623691|FG000|Overall Study|Withdrawal by Subject|1|||
25308270|NCT00975806|50623692|FG001|Overall Study|Withdrawal by Subject|0|||
25308271|NCT00975806|50623693|FG002|Overall Study|Withdrawal by Subject|0|||
25308272|NCT00975806|50623691|FG000|Overall Study|Death|0|||
25308273|NCT00975806|50623692|FG001|Overall Study|Death|1|||
25308274|NCT00975806|50623693|FG002|Overall Study|Death|0|||
25308275|NCT00975806|50623691|FG000|Overall Study|Physician decision and disease related|1|||
25308276|NCT00975806|50623692|FG001|Overall Study|Physician decision and disease related|0|||
25308277|NCT00975806|50623693|FG002|Overall Study|Physician decision and disease related|1|||
25308278|NCT00978068|50623705|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
25308279|NCT00978068|50623706|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
25308280|NCT00978068|50623705|FG000|Overall Study|Death|1|||
25308281|NCT00978068|50623706|FG001|Overall Study|Death|2|||
25308282|NCT00978068|50623705|FG000|Overall Study|Lost to Follow-up|1|||
25308283|NCT00978068|50623706|FG001|Overall Study|Lost to Follow-up|2|||
25308284|NCT00978068|50623705|FG000|Overall Study|Physician Decision|0|||
25308285|NCT00978068|50623706|FG001|Overall Study|Physician Decision|1|||
25308286|NCT00978068|50623705|FG000|Overall Study|Unable to Comply with Study|0|||
25308287|NCT00978068|50623706|FG001|Overall Study|Unable to Comply with Study|2|||
25308288|NCT00603525|50623718|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
24970075|NCT04339972|50059604|FG001|Overall Study|dropout|1|||
25308289|NCT00603525|50623719|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
25308290|NCT00603525|50623720|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
25308291|NCT00603525|50623718|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
25308292|NCT00603525|50623719|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
25308293|NCT00603525|50623720|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
25308294|NCT00603525|50623718|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
25308295|NCT00603525|50623719|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
25308296|NCT00603525|50623720|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
25308297|NCT00603525|50623718|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
25308298|NCT00603525|50623719|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
25308299|NCT00603525|50623720|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
25308300|NCT00603525|50623718|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
25308301|NCT00603525|50623719|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
25308302|NCT00603525|50623720|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
25308303|NCT00603525|50623718|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
25308304|NCT00603525|50623719|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
25308305|NCT00603525|50623720|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
25308306|NCT00603525|50623718|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
25308307|NCT00603525|50623719|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
25308308|NCT00603525|50623720|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
25308309|NCT00603525|50623718|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
25071300|NCT02572388|50177435|FG000|Overall Study|Withdrawal by Subject|1|||
25071301|NCT02572388|50177436|FG001|Overall Study|Withdrawal by Subject|1|||
25071302|NCT02572388|50177437|FG002|Overall Study|Withdrawal by Subject|2|||
25071303|NCT02572388|50177438|FG003|Overall Study|Withdrawal by Subject|2|||
25071304|NCT02573870|50177450|FG000|Overall Study|Adverse Event|0|||
25071305|NCT02573870|50177451|FG001|Overall Study|Adverse Event|2|||
25308310|NCT00603525|50623719|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
25308311|NCT00603525|50623720|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
25308312|NCT00603525|50623718|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
25308313|NCT00603525|50623719|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
25308314|NCT00603525|50623720|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
25308315|NCT00603525|50623718|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
25308316|NCT00603525|50623719|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
25308317|NCT00603525|50623720|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
25308318|NCT00603525|50623718|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
25308319|NCT00603525|50623719|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
25308320|NCT00603525|50623720|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
25308321|NCT00603525|50623718|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
25308322|NCT00603525|50623719|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
25308323|NCT00603525|50623720|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
25308324|NCT00603525|50623718|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
25308325|NCT00603525|50623719|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
25308326|NCT00603525|50623720|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
25308327|NCT00603525|50623718|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
25308328|NCT00603525|50623719|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
25308329|NCT00603525|50623720|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
25308330|NCT00603525|50623718|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
25308331|NCT00603525|50623719|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
25308332|NCT00603525|50623720|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
25308333|NCT00762034|50623733|FG000|Induction Period|Protocol Violation|1|||
25308334|NCT00762034|50623734|FG001|Induction Period|Protocol Violation|2|||
25308335|NCT00762034|50623733|FG000|Induction Period|Entry Criterion Not Met|12|||
25308336|NCT00762034|50623734|FG001|Induction Period|Entry Criterion Not Met|11|||
25308337|NCT00762034|50623733|FG000|Induction Period|Adverse Event|27|||
25308338|NCT00762034|50623734|FG001|Induction Period|Adverse Event|38|||
25308339|NCT00762034|50623733|FG000|Induction Period|Lost to Follow-up|1|||
25308340|NCT00762034|50623734|FG001|Induction Period|Lost to Follow-up|1|||
25308341|NCT00762034|50623733|FG000|Induction Period|Progressive Disease|73|||
25308342|NCT00762034|50623734|FG001|Induction Period|Progressive Disease|55|||
25308343|NCT00762034|50623733|FG000|Induction Period|Physician Decision|21|||
25308344|NCT00762034|50623734|FG001|Induction Period|Physician Decision|20|||
25308345|NCT00762034|50623733|FG000|Induction Period|Withdrawal by Subject|15|||
25308346|NCT00762034|50623734|FG001|Induction Period|Withdrawal by Subject|19|||
25308347|NCT00762034|50623733|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
25308348|NCT00762034|50623734|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
25308349|NCT00762034|50623733|FG000|Induction Period|Deaths Due to Study Disease|9|||
25308350|NCT00762034|50623734|FG001|Induction Period|Deaths Due to Study Disease|9|||
25308351|NCT00762034|50623733|FG000|Maintenance Period|Protocol Violation|1|||
25308352|NCT00762034|50623734|FG001|Maintenance Period|Protocol Violation|3|||
25308353|NCT00762034|50623733|FG000|Maintenance Period|Entry Criterion Not Met|0|||
25308354|NCT00762034|50623734|FG001|Maintenance Period|Entry Criterion Not Met|2|||
25308355|NCT00762034|50623733|FG000|Maintenance Period|Adverse Event|42|||
25308356|NCT00762034|50623734|FG001|Maintenance Period|Adverse Event|26|||
25308357|NCT00762034|50623733|FG000|Maintenance Period|Progressive Disease|186|||
25308358|NCT00762034|50623734|FG001|Maintenance Period|Progressive Disease|224|||
25308359|NCT00762034|50623733|FG000|Maintenance Period|Physician Decision|25|||
25308360|NCT00762034|50623734|FG001|Maintenance Period|Physician Decision|20|||
25308361|NCT00762034|50623733|FG000|Maintenance Period|Withdrawal by Subject|34|||
25308362|NCT00762034|50623734|FG001|Maintenance Period|Withdrawal by Subject|14|||
25308363|NCT00762034|50623733|FG000|Maintenance Period|Death not due to study disease|2|||
25308364|NCT00762034|50623734|FG001|Maintenance Period|Death not due to study disease|5|||
25308365|NCT00762034|50623733|FG000|Maintenance Period|Death due to study disease|3|||
25308366|NCT00762034|50623734|FG001|Maintenance Period|Death due to study disease|3|||
25308367|NCT00762034|50623733|FG000|Maintenance Period|Other|1|||
25308368|NCT00762034|50623734|FG001|Maintenance Period|Other|1|||
25308369|NCT00761956|50623766|FG000|Overall Study|Lost to Follow-up|6|||
25308370|NCT00761956|50623767|FG001|Overall Study|Lost to Follow-up|11|||
25308371|NCT00761956|50623766|FG000|Overall Study|Withdrawal by Subject|3|||
25308372|NCT00761956|50623767|FG001|Overall Study|Withdrawal by Subject|8|||
25308373|NCT00761956|50623766|FG000|Overall Study|Death|0|||
25308374|NCT00761956|50623767|FG001|Overall Study|Death|1|||
25308375|NCT00761956|50623766|FG000|Overall Study|Adverse Event|26|||
25308376|NCT00761956|50623767|FG001|Overall Study|Adverse Event|34|||
25308377|NCT00754624|50623773|FG000|Overall Study|Adverse Event|16|||
25308378|NCT00754624|50623773|FG000|Overall Study|Death|1|||
25308379|NCT00754624|50623773|FG000|Overall Study|Physician Decision|8|||
25308380|NCT00754624|50623773|FG000|Overall Study|Protocol Violation|1|||
25308381|NCT00754624|50623773|FG000|Overall Study|Withdrawal by Subject|28|||
25308382|NCT00754624|50623773|FG000|Overall Study|Various|12|||
25308383|NCT00754624|50623773|FG000|Overall Study|Lost to Follow-up|3|||
25308384|NCT00586846|50623786|FG000|Overall Study|Physician Decision|1|||
25308385|NCT00586846|50623786|FG000|Overall Study|Death|1|||
25308386|NCT00586846|50623786|FG000|Overall Study|Evaluable for Toxicity Only|4|||
25308387|NCT00973700|50623795|FG000|Overall Study|Withdrawal by Subject|2|||
25308388|NCT00973700|50623796|FG001|Overall Study|Withdrawal by Subject|2|||
25308389|NCT00973700|50623797|FG002|Overall Study|Withdrawal by Subject|8|||
25308390|NCT00973700|50623798|FG003|Overall Study|Withdrawal by Subject|4|||
25308391|NCT00973700|50623799|FG004|Overall Study|Withdrawal by Subject|4|||
25308392|NCT00973700|50623795|FG000|Overall Study|Lost to Follow-up|5|||
25308393|NCT00973700|50623796|FG001|Overall Study|Lost to Follow-up|0|||
25308394|NCT00973700|50623797|FG002|Overall Study|Lost to Follow-up|1|||
25308395|NCT00973700|50623798|FG003|Overall Study|Lost to Follow-up|8|||
25308396|NCT00973700|50623799|FG004|Overall Study|Lost to Follow-up|5|||
25308397|NCT00973700|50623795|FG000|Overall Study|Inappropriate enrolment|0|||
25308398|NCT00973700|50623796|FG001|Overall Study|Inappropriate enrolment|0|||
25308399|NCT00973700|50623797|FG002|Overall Study|Inappropriate enrolment|0|||
25308400|NCT00973700|50623798|FG003|Overall Study|Inappropriate enrolment|4|||
25308401|NCT00973700|50623799|FG004|Overall Study|Inappropriate enrolment|0|||
25308402|NCT00973700|50623795|FG000|Overall Study|Unable to Classify|0|||
25308403|NCT00973700|50623796|FG001|Overall Study|Unable to Classify|0|||
25308404|NCT00973700|50623797|FG002|Overall Study|Unable to Classify|1|||
25308405|NCT00973700|50623798|FG003|Overall Study|Unable to Classify|2|||
25308406|NCT00973700|50623799|FG004|Overall Study|Unable to Classify|1|||
25308407|NCT00754390|50623826|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
25308408|NCT00754390|50623826|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
25308409|NCT00754390|50623826|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
25308410|NCT00754390|50623826|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
25308411|NCT00754234|50623833|FG000|Overall Study|Withdrawal by Subject|3|||
25308412|NCT00753922|50623841|FG000|Overall Study|Lost to Follow-up|155|||
25308413|NCT00753922|50623842|FG001|Overall Study|Lost to Follow-up|24|||
25308414|NCT00753922|50623843|FG002|Overall Study|Lost to Follow-up|28|||
25308415|NCT00753922|50623844|FG003|Overall Study|Lost to Follow-up|5|||
25308416|NCT00753922|50623841|FG000|Overall Study|Withdrawal by Subject|9|||
25308417|NCT00753922|50623842|FG001|Overall Study|Withdrawal by Subject|11|||
25308418|NCT00753922|50623843|FG002|Overall Study|Withdrawal by Subject|4|||
25308419|NCT00753922|50623844|FG003|Overall Study|Withdrawal by Subject|2|||
25308420|NCT00753922|50623841|FG000|Overall Study|Patient Non-compliance|55|||
25308421|NCT00753922|50623842|FG001|Overall Study|Patient Non-compliance|22|||
25308422|NCT00753922|50623843|FG002|Overall Study|Patient Non-compliance|14|||
25308423|NCT00753922|50623844|FG003|Overall Study|Patient Non-compliance|11|||
25308424|NCT00753922|50623841|FG000|Overall Study|Patients Not Completing Visit|11|||
25308425|NCT00753922|50623842|FG001|Overall Study|Patients Not Completing Visit|0|||
25308426|NCT00753922|50623843|FG002|Overall Study|Patients Not Completing Visit|1|||
25308427|NCT00753922|50623844|FG003|Overall Study|Patients Not Completing Visit|0|||
25308428|NCT00753922|50623841|FG000|Overall Study|Death|2|||
25308429|NCT00753922|50623842|FG001|Overall Study|Death|23|||
25308430|NCT00753922|50623843|FG002|Overall Study|Death|2|||
25308431|NCT00753922|50623844|FG003|Overall Study|Death|1|||
25308432|NCT00753922|50623841|FG000|Overall Study|Discontinuation Due to Explantation|14|||
25308433|NCT00753922|50623842|FG001|Overall Study|Discontinuation Due to Explantation|14|||
25308434|NCT00753922|50623843|FG002|Overall Study|Discontinuation Due to Explantation|14|||
25308435|NCT00753922|50623844|FG003|Overall Study|Discontinuation Due to Explantation|4|||
25308436|NCT00761176|50623856|FG000|Overall Study|Death|1|||
25308437|NCT00761176|50623857|FG001|Overall Study|Death|0|||
25308438|NCT00761176|50623856|FG000|Overall Study|Withdrawal by Subject|1|||
25308439|NCT00761176|50623857|FG001|Overall Study|Withdrawal by Subject|1|||
25308440|NCT00760552|50623865|FG000|Overall Study|Death|2|||
25308441|NCT00760552|50623866|FG001|Overall Study|Death|0|||
25308442|NCT00760552|50623865|FG000|Overall Study|Lost to Follow-up|11|||
25308443|NCT00760552|50623866|FG001|Overall Study|Lost to Follow-up|10|||
25308444|NCT00753766|50623874|FG000|Overall Study|Physician Decision|1|||
25308445|NCT00753766|50623875|FG001|Overall Study|Physician Decision|0|||
25308446|NCT00976898|50623882|FG000|Overall Study|Protocol Violation|1|||
25308447|NCT00976898|50623882|FG000|Overall Study|Adverse Event|1|||
25308448|NCT00976898|50623882|FG000|Overall Study|Physician Decision|1|||
25308449|NCT00976898|50623882|FG000|Overall Study|Liver Transplant|1|||
25308450|NCT00976898|50623882|FG000|Overall Study|Progressive Disease|1|||
25308451|NCT02620579|50623894|FG000|Overall Study|Physician Decision|0|||
25192195|NCT01465802|50357379|FG002|Overall Study|Withdrawal by Subject|0|||
25308452|NCT02620579|50623895|FG001|Overall Study|Physician Decision|0|||
25308453|NCT02620579|50623896|FG002|Overall Study|Physician Decision|0|||
25308454|NCT02620579|50623897|FG003|Overall Study|Physician Decision|1|||
25308455|NCT02620579|50623894|FG000|Overall Study|Withdrawal by Subject|0|||
25308456|NCT02620579|50623895|FG001|Overall Study|Withdrawal by Subject|1|||
25308457|NCT02620579|50623896|FG002|Overall Study|Withdrawal by Subject|1|||
25308458|NCT02620579|50623897|FG003|Overall Study|Withdrawal by Subject|0|||
25308459|NCT00753688|50623913|FG000|Overall Study|Death|102|||
25308460|NCT00753688|50623914|FG001|Overall Study|Death|203|||
25308461|NCT00753688|50623913|FG000|Overall Study|Missing|4|||
25308462|NCT00753688|50623914|FG001|Overall Study|Missing|9|||
25308463|NCT00753688|50623913|FG000|Overall Study|Participant Withdrew Consent|2|||
25308464|NCT00753688|50623914|FG001|Overall Study|Participant Withdrew Consent|2|||
25308465|NCT00753688|50623913|FG000|Overall Study|Ongoing - in Follow-up|15|||
25308466|NCT00753688|50623914|FG001|Overall Study|Ongoing - in Follow-up|31|||
25308467|NCT00753688|50623913|FG000|Overall Study|Adverse Event|0|||
25308468|NCT00753688|50623914|FG001|Overall Study|Adverse Event|1|||
25308469|NCT00586612|50623922|FG000|Primary Phase|Protocol Violation|1|||
25308470|NCT00586612|50623923|FG001|Primary Phase|Protocol Violation|0|||
25308471|NCT00586612|50623922|FG000|Primary Phase|Lost to Follow-up|0|||
25308472|NCT00586612|50623923|FG001|Primary Phase|Lost to Follow-up|1|||
25308473|NCT00586612|50623922|FG000|Primary Phase|Withdrawal by Subject|0|||
25308474|NCT00586612|50623923|FG001|Primary Phase|Withdrawal by Subject|2|||
25308475|NCT00586612|50623922|FG000|Booster Phase|Lost to Follow-up|3|||
25308476|NCT00586612|50623923|FG001|Booster Phase|Lost to Follow-up|1|||
25071306|NCT02573870|50177450|FG000|Overall Study|Lack of Efficacy|0|||
25308477|NCT00586690|50623931|FG000|Overall Study|Death|2|||
25308478|NCT00586690|50623932|FG001|Overall Study|Death|0|||
25308479|NCT00586690|50623931|FG000|Overall Study|Disease Progression|10|||
25308480|NCT00586690|50623932|FG001|Overall Study|Disease Progression|0|||
25308481|NCT00586690|50623931|FG000|Overall Study|Adverse Event|1|||
25308482|NCT00586690|50623932|FG001|Overall Study|Adverse Event|0|||
25308483|NCT00586690|50623931|FG000|Overall Study|Lack of Efficacy|2|||
25308484|NCT00586690|50623932|FG001|Overall Study|Lack of Efficacy|0|||
25308485|NCT00586690|50623931|FG000|Overall Study|Lab can't accommodate|1|||
25308486|NCT00586690|50623932|FG001|Overall Study|Lab can't accommodate|0|||
25308487|NCT00976820|50623941|FG000|Overall Study|Lost to Follow-up|5|||
25308488|NCT00976820|50623942|FG001|Overall Study|Lost to Follow-up|16|||
25308489|NCT00976820|50623943|FG002|Overall Study|Lost to Follow-up|2|||
25308490|NCT00976820|50623944|FG003|Overall Study|Lost to Follow-up|3|||
25308491|NCT00976820|50623941|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
25308492|NCT00976820|50623942|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
25308493|NCT00976820|50623943|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
25308494|NCT00976820|50623944|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
25308495|NCT00976820|50623941|FG000|Overall Study|Withdrawal by Subject|2|||
25308496|NCT00976820|50623942|FG001|Overall Study|Withdrawal by Subject|4|||
25308497|NCT00976820|50623943|FG002|Overall Study|Withdrawal by Subject|1|||
25308498|NCT00976820|50623944|FG003|Overall Study|Withdrawal by Subject|4|||
25308499|NCT00760474|50623995|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
25308500|NCT00760474|50623996|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
25308501|NCT00760474|50623995|FG000|Placebo Washout Period|Other|0|||
25308502|NCT00760474|50623996|FG001|Placebo Washout Period|Other|1|||
25308503|NCT00760474|50623995|FG000|Period 2 (P2)|Lost to Follow-up|1|||
25308504|NCT00760474|50623996|FG001|Period 2 (P2)|Lost to Follow-up|0|||
25308505|NCT00760474|50623995|FG000|Period 2 (P2)|Adverse Event|0|||
25308506|NCT00760474|50623996|FG001|Period 2 (P2)|Adverse Event|1|||
25308507|NCT00975416|50624005|FG000|Overall Study|early discharge from tx|3|||
25308508|NCT00975416|50624006|FG001|Overall Study|early discharge from tx|5|||
25308509|NCT00760084|50624013|FG000|Overall Study|Physician Decision|5|||
25308510|NCT00760084|50624013|FG000|Overall Study|Withdrawal by Subject|2|||
25308511|NCT00760084|50624013|FG000|Overall Study|Progressive Disease|3|||
25308512|NCT00752206|50624019|FG000|Overall Study|Disease progression|8|||
25308513|NCT00752206|50624020|FG001|Overall Study|Disease progression|11|||
25308514|NCT00752206|50624019|FG000|Overall Study|Pregnancy|1|||
25308515|NCT00752206|50624020|FG001|Overall Study|Pregnancy|0|||
25308516|NCT00752128|50624026|FG000|Overall Study|Withdrawal by Subject|4|||
25308517|NCT00976508|50624033|FG000|Overall Study|Death|7|||
25308518|NCT00976508|50624034|FG001|Overall Study|Death|1|||
25308519|NCT00976508|50624033|FG000|Overall Study|Lost to Follow-up|1|||
25308520|NCT00976508|50624034|FG001|Overall Study|Lost to Follow-up|0|||
25308521|NCT00976508|50624033|FG000|Overall Study|Withdrawal by Subject|1|||
25308522|NCT00976508|50624034|FG001|Overall Study|Withdrawal by Subject|0|||
25308523|NCT00976508|50624033|FG000|Overall Study|Disease Progression|4|||
25308524|NCT00976508|50624034|FG001|Overall Study|Disease Progression|4|||
25308525|NCT00976508|50624033|FG000|Overall Study|Subject Enrolled in Hospice|1|||
25308526|NCT00976508|50624034|FG001|Overall Study|Subject Enrolled in Hospice|0|||
25308527|NCT00976508|50624033|FG000|Overall Study|Terminated by the Sponsor|0|||
25308528|NCT00976508|50624034|FG001|Overall Study|Terminated by the Sponsor|1|||
25308529|NCT00973622|50624045|FG000|Overall Study|did not attend MRI|14|||
25308530|NCT00973622|50624046|FG001|Overall Study|did not attend MRI|3|||
25308531|NCT00973622|50624045|FG000|Overall Study|did not pass MRI screen|6|||
25308532|NCT00973622|50624046|FG001|Overall Study|did not pass MRI screen|0|||
25308533|NCT00973622|50624045|FG000|Overall Study|did not complete rTMS sessions|11|||
25308534|NCT00973622|50624046|FG001|Overall Study|did not complete rTMS sessions|2|||
25308535|NCT04044716|50624054|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
25308536|NCT04044716|50624055|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
25308537|NCT04044716|50624056|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
25308538|NCT04044716|50624054|FG000|Overall Study|Lost to Follow-up|2|||
25308539|NCT04044716|50624055|FG001|Overall Study|Lost to Follow-up|3|||
25308540|NCT04044716|50624056|FG002|Overall Study|Lost to Follow-up|0|||
25308541|NCT00753454|50624063|FG000|Overall Study|Adverse Event|4|||
25308542|NCT00753454|50624063|FG000|Overall Study|Lack of Efficacy|1|||
25308543|NCT00753454|50624063|FG000|Overall Study|Lost to Follow-up|3|||
25308544|NCT00753454|50624063|FG000|Overall Study|Withdrawal by Subject|5|||
25308545|NCT00753454|50624063|FG000|Overall Study|Investigator Decision|1|||
25308546|NCT00976274|50624069|FG000|Overall Study|Lost to Follow-up|5|||
25308547|NCT00976274|50624070|FG001|Overall Study|Lost to Follow-up|5|||
25308548|NCT00976274|50624069|FG000|Overall Study|Withdrawal by Subject|1|||
25308549|NCT00976274|50624070|FG001|Overall Study|Withdrawal by Subject|1|||
25308550|NCT00976274|50624069|FG000|Overall Study|Physician Decision|1|||
25308551|NCT00976274|50624070|FG001|Overall Study|Physician Decision|2|||
25308552|NCT00759148|50624078|FG000|Overall Study|Adverse Event|1|||
25308553|NCT00759148|50624079|FG001|Overall Study|Adverse Event|6|||
25308554|NCT00759148|50624078|FG000|Overall Study|Withdrawal by Subject|3|||
25308555|NCT00759148|50624079|FG001|Overall Study|Withdrawal by Subject|7|||
25308556|NCT00759148|50624078|FG000|Overall Study|Lost to Follow-up|3|||
25308557|NCT00759148|50624079|FG001|Overall Study|Lost to Follow-up|9|||
25308558|NCT00759148|50624078|FG000|Overall Study|Treatment Failure|6|||
25308559|NCT00759148|50624079|FG001|Overall Study|Treatment Failure|10|||
25308560|NCT00759148|50624078|FG000|Overall Study|Reason not given|1|||
25308561|NCT00759148|50624079|FG001|Overall Study|Reason not given|0|||
25308562|NCT02794285|50624089|FG000|Overall Study|Adverse Event|11|||
25308563|NCT02794285|50624090|FG001|Overall Study|Adverse Event|4|||
25308564|NCT02794285|50624091|FG002|Overall Study|Adverse Event|5|||
25308565|NCT02794285|50624092|FG003|Overall Study|Adverse Event|8|||
25308566|NCT02794285|50624089|FG000|Overall Study|Condition Under Investigation Improved|1|||
25308567|NCT02794285|50624090|FG001|Overall Study|Condition Under Investigation Improved|0|||
25308568|NCT02794285|50624091|FG002|Overall Study|Condition Under Investigation Improved|0|||
25308569|NCT02794285|50624092|FG003|Overall Study|Condition Under Investigation Improved|0|||
25308570|NCT02794285|50624089|FG000|Overall Study|Condition Under Investigation Worsened|0|||
24970076|NCT04339972|50059603|FG000|Overall Study|Technical issues|1|||
24970077|NCT04339972|50059604|FG001|Overall Study|Technical issues|0|||
25308571|NCT02794285|50624090|FG001|Overall Study|Condition Under Investigation Worsened|2|||
25308572|NCT02794285|50624091|FG002|Overall Study|Condition Under Investigation Worsened|1|||
25308573|NCT02794285|50624092|FG003|Overall Study|Condition Under Investigation Worsened|0|||
25308574|NCT02794285|50624089|FG000|Overall Study|Death|2|||
25308575|NCT02794285|50624090|FG001|Overall Study|Death|1|||
25308576|NCT02794285|50624091|FG002|Overall Study|Death|2|||
25308577|NCT02794285|50624092|FG003|Overall Study|Death|0|||
25308578|NCT02794285|50624089|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
25308579|NCT02794285|50624090|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
25308580|NCT02794285|50624091|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
25308581|NCT02794285|50624092|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
25308582|NCT02794285|50624089|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
25308583|NCT02794285|50624090|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
25308584|NCT02794285|50624091|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
25308585|NCT02794285|50624092|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
25308586|NCT02794285|50624089|FG000|Overall Study|Lack of Efficacy|10|||
25308587|NCT02794285|50624090|FG001|Overall Study|Lack of Efficacy|6|||
25308588|NCT02794285|50624091|FG002|Overall Study|Lack of Efficacy|3|||
25308589|NCT02794285|50624092|FG003|Overall Study|Lack of Efficacy|3|||
25308590|NCT02794285|50624089|FG000|Overall Study|Lost to Follow-up|5|||
25308591|NCT02794285|50624090|FG001|Overall Study|Lost to Follow-up|6|||
25308592|NCT02794285|50624091|FG002|Overall Study|Lost to Follow-up|3|||
25308593|NCT02794285|50624092|FG003|Overall Study|Lost to Follow-up|1|||
25308594|NCT02794285|50624089|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
25308595|NCT02794285|50624090|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
25308596|NCT02794285|50624091|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
25308597|NCT02794285|50624092|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
25308598|NCT02794285|50624089|FG000|Overall Study|Withdrawal by Subject|38|||
25308599|NCT02794285|50624090|FG001|Overall Study|Withdrawal by Subject|29|||
25308600|NCT02794285|50624091|FG002|Overall Study|Withdrawal by Subject|20|||
25308601|NCT02794285|50624092|FG003|Overall Study|Withdrawal by Subject|12|||
25308602|NCT02794285|50624089|FG000|Overall Study|Missing|1|||
25308603|NCT02794285|50624090|FG001|Overall Study|Missing|0|||
25308604|NCT02794285|50624091|FG002|Overall Study|Missing|0|||
25308605|NCT02794285|50624092|FG003|Overall Study|Missing|0|||
25308606|NCT02794285|50624089|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
25308607|NCT02794285|50624090|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
25308608|NCT02794285|50624091|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
25308609|NCT02794285|50624092|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
25308610|NCT02794285|50624089|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
25308611|NCT02794285|50624090|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
25308612|NCT02794285|50624091|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
25308613|NCT02794285|50624092|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
25308614|NCT00970268|50624104|FG000|Overall Study|Withdrawal by Subject|12|||
25308615|NCT00970268|50624105|FG001|Overall Study|Withdrawal by Subject|19|||
25308616|NCT00970268|50624104|FG000|Overall Study|Adverse Event|15|||
25308617|NCT00970268|50624105|FG001|Overall Study|Adverse Event|12|||
25308618|NCT00970268|50624104|FG000|Overall Study|Lack of Efficacy|3|||
25308619|NCT00970268|50624105|FG001|Overall Study|Lack of Efficacy|6|||
25308620|NCT00970268|50624104|FG000|Overall Study|Protocol Violation|4|||
25308621|NCT00970268|50624105|FG001|Overall Study|Protocol Violation|7|||
25308622|NCT00970268|50624104|FG000|Overall Study|Other Reason|3|||
25308623|NCT00970268|50624105|FG001|Overall Study|Other Reason|1|||
25308624|NCT00970268|50624104|FG000|Overall Study|COPD Exacerbation|4|||
25308625|NCT00970268|50624105|FG001|Overall Study|COPD Exacerbation|2|||
25308626|NCT00970268|50624104|FG000|Overall Study|Lost to Follow-up|1|||
25308627|NCT00970268|50624105|FG001|Overall Study|Lost to Follow-up|2|||
25308628|NCT00970268|50624104|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
25071307|NCT02573870|50177451|FG001|Overall Study|Lack of Efficacy|1|||
25308629|NCT00970268|50624105|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
25308630|NCT00969332|50624117|FG000|Overall Study|Physician Decision|8|||
25308631|NCT00969332|50624117|FG000|Overall Study|Withdrawal by Subject|3|||
25308632|NCT00968864|50624122|FG000|Overall Study|Protocol exception/ not evaluable|1|||
25308633|NCT00758680|50624140|FG000|Overall Study|Adverse Event|0|||
25308634|NCT00758680|50624141|FG001|Overall Study|Adverse Event|0|||
25308635|NCT00758680|50624142|FG002|Overall Study|Adverse Event|0|||
25308636|NCT00758680|50624143|FG003|Overall Study|Adverse Event|0|||
25308637|NCT00758680|50624144|FG004|Overall Study|Adverse Event|0|||
25308638|NCT00758680|50624145|FG005|Overall Study|Adverse Event|0|||
25071308|NCT02573870|50177450|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
25308639|NCT00758680|50624146|FG006|Overall Study|Adverse Event|0|||
25308640|NCT00758680|50624147|FG007|Overall Study|Adverse Event|1|||
25308641|NCT00758680|50624148|FG008|Overall Study|Adverse Event|0|||
25308642|NCT00758680|50624149|FG009|Overall Study|Adverse Event|1|||
25308643|NCT00758680|50624140|FG000|Overall Study|Laboratory Adverse Event|0|||
25308644|NCT00758680|50624141|FG001|Overall Study|Laboratory Adverse Event|0|||
25308645|NCT00758680|50624142|FG002|Overall Study|Laboratory Adverse Event|0|||
25308646|NCT00758680|50624143|FG003|Overall Study|Laboratory Adverse Event|0|||
25308647|NCT00758680|50624144|FG004|Overall Study|Laboratory Adverse Event|0|||
25308648|NCT00758680|50624145|FG005|Overall Study|Laboratory Adverse Event|0|||
25308649|NCT00758680|50624146|FG006|Overall Study|Laboratory Adverse Event|0|||
24970078|NCT04339972|50059603|FG000|Overall Study|Claustraphobia|0|||
24970079|NCT04339972|50059604|FG001|Overall Study|Claustraphobia|1|||
24970080|NCT00096278|50059612|FG000|Overall Study|No follow-up data|15|||
24970081|NCT00096278|50059613|FG001|Overall Study|No follow-up data|18|||
24970082|NCT00096278|50059612|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
24970083|NCT00096278|50059613|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
24970084|NCT00095940|50059628|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
24970085|NCT00095940|50059629|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
25308650|NCT00758680|50624147|FG007|Overall Study|Laboratory Adverse Event|0|||
25308651|NCT00758680|50624148|FG008|Overall Study|Laboratory Adverse Event|1|||
25308652|NCT00758680|50624149|FG009|Overall Study|Laboratory Adverse Event|0|||
25308653|NCT00758680|50624140|FG000|Overall Study|Withdrawal by Subject|0|||
25308654|NCT00758680|50624141|FG001|Overall Study|Withdrawal by Subject|0|||
25308655|NCT00758680|50624142|FG002|Overall Study|Withdrawal by Subject|0|||
25308656|NCT00758680|50624143|FG003|Overall Study|Withdrawal by Subject|0|||
25308657|NCT00758680|50624144|FG004|Overall Study|Withdrawal by Subject|0|||
25308658|NCT00758680|50624145|FG005|Overall Study|Withdrawal by Subject|0|||
25308659|NCT00758680|50624146|FG006|Overall Study|Withdrawal by Subject|1|||
25308660|NCT00758680|50624147|FG007|Overall Study|Withdrawal by Subject|0|||
25308661|NCT00758680|50624148|FG008|Overall Study|Withdrawal by Subject|1|||
25308662|NCT00758680|50624149|FG009|Overall Study|Withdrawal by Subject|0|||
25308663|NCT00758602|50624174|FG000|Overall Study|Adverse Event|11|||
25308664|NCT00758602|50624175|FG001|Overall Study|Adverse Event|10|||
25308665|NCT00758602|50624174|FG000|Overall Study|Lost to Follow-up|4|||
25308666|NCT00758602|50624175|FG001|Overall Study|Lost to Follow-up|3|||
25308667|NCT00758602|50624174|FG000|Overall Study|Withdrawal by Subject|1|||
25308668|NCT00758602|50624175|FG001|Overall Study|Withdrawal by Subject|3|||
25308669|NCT00758602|50624174|FG000|Overall Study|Protocol Violation|0|||
25308670|NCT00758602|50624175|FG001|Overall Study|Protocol Violation|2|||
25308671|NCT00758602|50624174|FG000|Overall Study|Death|0|||
25308672|NCT00758602|50624175|FG001|Overall Study|Death|1|||
25308673|NCT00758602|50624174|FG000|Overall Study|Reason not specified|3|||
25308674|NCT00758602|50624175|FG001|Overall Study|Reason not specified|3|||
25308675|NCT00711529|50624184|FG000|Overall Study|Protocol Violation|2|||
25308676|NCT00711529|50624185|FG001|Overall Study|Protocol Violation|0|||
25308677|NCT00711529|50624184|FG000|Overall Study|Withdrawal by Subject|2|||
25308678|NCT00711529|50624185|FG001|Overall Study|Withdrawal by Subject|6|||
25308679|NCT00601419|50624191|FG000|Overall Study|Lost to Follow-up|3|||
25308680|NCT00601419|50624191|FG000|Overall Study|Missed Visits|1|||
25308681|NCT00712933|50624211|FG000|Overall Study|Adverse Event|69|||
25308682|NCT00712933|50624211|FG000|Overall Study|Lack of Efficacy|6|||
25308683|NCT00712933|50624211|FG000|Overall Study|Lost to Follow-up|22|||
25308684|NCT00712933|50624211|FG000|Overall Study|Non-compliance with study drug|13|||
25308685|NCT00712933|50624211|FG000|Overall Study|Other Pregnancy|37|||
25308686|NCT00712933|50624211|FG000|Overall Study|Sponsor decision|14|||
25308687|NCT00712933|50624211|FG000|Overall Study|Withdrew consent|4|||
25308688|NCT00712933|50624211|FG000|Overall Study|Hip replacement surgery|1|||
25308689|NCT00712933|50624211|FG000|Overall Study|Involved in Clinical research|3|||
25308690|NCT00712933|50624211|FG000|Overall Study|Participant hospitalized|1|||
25308691|NCT00712933|50624211|FG000|Overall Study|Participant travelled overseas|2|||
25308692|NCT00712933|50624211|FG000|Overall Study|Death of patient|1|||
25308693|NCT00712933|50624211|FG000|Overall Study|Other Physician decision|1|||
25308694|NCT00712933|50624211|FG000|Overall Study|Not committed to contraception|1|||
25308695|NCT00712933|50624211|FG000|Overall Study|Participant received medication|1|||
25308696|NCT00712933|50624211|FG000|Overall Study|Physician Decision|36|||
25308697|NCT00712933|50624211|FG000|Overall Study|Protocol Violation|4|||
25308698|NCT00712933|50624211|FG000|Overall Study|Withdrawal by Subject|151|||
25308699|NCT00712543|50624221|FG000|Day 8-14|Lost to Follow-up|0|||
25308700|NCT00712543|50624222|FG001|Day 8-14|Lost to Follow-up|2|||
25308701|NCT00709111|50624228|FG000|Overall Study|Withdrawal by Subject|1|||
25308702|NCT00709111|50624228|FG000|Overall Study|Unable to attend clinic visits|1|||
25308703|NCT00710749|50624232|FG000|First Intervention|Withdrawal by Subject|1|||
25308704|NCT00710749|50624233|FG001|First Intervention|Withdrawal by Subject|0|||
24970086|NCT00095940|50059630|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
25308705|NCT00699907|50624253|FG000|Overall Study|Withdrawal by Subject|2|||
25308706|NCT00699907|50624254|FG001|Overall Study|Withdrawal by Subject|1|||
25308707|NCT00699907|50624255|FG002|Overall Study|Withdrawal by Subject|0|||
25308708|NCT00699907|50624253|FG000|Overall Study|No usable sample|0|||
25308709|NCT00699907|50624254|FG001|Overall Study|No usable sample|9|||
24970087|NCT00095940|50059631|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
24970088|NCT00095940|50059632|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
24970089|NCT00095940|50059633|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
24970090|NCT00095940|50059634|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
24970091|NCT00095940|50059635|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
24970092|NCT00095940|50059636|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
24970093|NCT00095940|50059628|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
24970094|NCT00095940|50059629|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
24970095|NCT00095940|50059630|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
24970096|NCT00095940|50059631|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
24970097|NCT00095940|50059632|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
24970098|NCT00095940|50059633|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
25308710|NCT00699907|50624255|FG002|Overall Study|No usable sample|8|||
25308711|NCT00710593|50624265|FG000|Overall Study|Incarceration|1|||
25308712|NCT00710593|50624266|FG001|Overall Study|Incarceration|0|||
25308713|NCT00710593|50624265|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
25308714|NCT00710593|50624266|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
25308715|NCT00710593|50624265|FG000|Overall Study|Lost to Follow-up|3|||
25308716|NCT00710593|50624266|FG001|Overall Study|Lost to Follow-up|1|||
25308717|NCT00710593|50624265|FG000|Overall Study|Moved out of area|1|||
25308718|NCT00710593|50624266|FG001|Overall Study|Moved out of area|0|||
25308719|NCT00710593|50624265|FG000|Overall Study|Failure to adhere or complete study eval|1|||
25308720|NCT00710593|50624266|FG001|Overall Study|Failure to adhere or complete study eval|1|||
25308721|NCT00710593|50624265|FG000|Overall Study|Protocol Violation|1|||
25308722|NCT00710593|50624266|FG001|Overall Study|Protocol Violation|1|||
25308723|NCT00710593|50624265|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
25308724|NCT00710593|50624266|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
25308725|NCT00599313|50624288|FG000|Overall Study|Adverse Event|19|||
25308726|NCT00599313|50624288|FG000|Overall Study|Disease Progression|12|||
25308727|NCT00599313|50624288|FG000|Overall Study|Patient Request|4|||
25308728|NCT00599313|50624288|FG000|Overall Study|Ineligible|1|||
25308729|NCT00708175|50624294|FG000|Overall Study|Adverse Event|4|||
25308730|NCT00708175|50624295|FG001|Overall Study|Adverse Event|5|||
25308731|NCT00708175|50624294|FG000|Overall Study|Protocol Violation|2|||
25308732|NCT00708175|50624295|FG001|Overall Study|Protocol Violation|3|||
25308733|NCT00708175|50624294|FG000|Overall Study|Lost to Follow-up|5|||
25308734|NCT00708175|50624295|FG001|Overall Study|Lost to Follow-up|3|||
25308735|NCT00708175|50624294|FG000|Overall Study|Withdrawal by Subject|5|||
25308736|NCT00708175|50624295|FG001|Overall Study|Withdrawal by Subject|7|||
25308737|NCT00708175|50624294|FG000|Overall Study|BMD loss >7%|2|||
25308738|NCT00708175|50624295|FG001|Overall Study|BMD loss >7%|3|||
25308739|NCT00707239|50624304|FG000|Overall Study|Adverse Event|5|||
25308740|NCT00707239|50624305|FG001|Overall Study|Adverse Event|3|||
25308741|NCT00707239|50624306|FG002|Overall Study|Adverse Event|2|||
25308742|NCT00707239|50624304|FG000|Overall Study|Death|3|||
25308743|NCT00707239|50624305|FG001|Overall Study|Death|1|||
25308744|NCT00707239|50624306|FG002|Overall Study|Death|3|||
25308745|NCT00707239|50624304|FG000|Overall Study|Physician Decision|1|||
25308746|NCT00707239|50624305|FG001|Overall Study|Physician Decision|1|||
25308747|NCT00707239|50624306|FG002|Overall Study|Physician Decision|2|||
25308748|NCT00707239|50624304|FG000|Overall Study|Protocol Violation|0|||
25308749|NCT00707239|50624305|FG001|Overall Study|Protocol Violation|0|||
25308750|NCT00707239|50624306|FG002|Overall Study|Protocol Violation|1|||
24970099|NCT00095940|50059634|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
25308751|NCT00707239|50624304|FG000|Overall Study|Lack of Efficacy|1|||
25308752|NCT00707239|50624305|FG001|Overall Study|Lack of Efficacy|2|||
25308753|NCT00707239|50624306|FG002|Overall Study|Lack of Efficacy|0|||
25308754|NCT00707239|50624304|FG000|Overall Study|Randomized, but not treated|1|||
25308755|NCT00707239|50624305|FG001|Overall Study|Randomized, but not treated|1|||
25308756|NCT00707239|50624306|FG002|Overall Study|Randomized, but not treated|1|||
25308757|NCT00707239|50624304|FG000|Overall Study|Other|8|||
25308758|NCT00707239|50624305|FG001|Overall Study|Other|3|||
25308759|NCT00707239|50624306|FG002|Overall Study|Other|5|||
25308760|NCT00968708|50624319|FG000|Overall Study|Adverse Event|169|||
25308761|NCT00968708|50624320|FG001|Overall Study|Adverse Event|150|||
25308762|NCT00968708|50624319|FG000|Overall Study|Major Protocol Deviation|0|||
25308763|NCT00968708|50624320|FG001|Overall Study|Major Protocol Deviation|1|||
25308764|NCT00968708|50624319|FG000|Overall Study|Lost to Follow-up|19|||
25308765|NCT00968708|50624320|FG001|Overall Study|Lost to Follow-up|11|||
25308766|NCT00968708|50624319|FG000|Overall Study|Voluntary Withdrawal|104|||
25308767|NCT00968708|50624320|FG001|Overall Study|Voluntary Withdrawal|101|||
25308768|NCT00968708|50624319|FG000|Overall Study|Investigator Discretion|0|||
25308769|NCT00968708|50624320|FG001|Overall Study|Investigator Discretion|1|||
25308770|NCT00968708|50624319|FG000|Overall Study|Other|26|||
25308771|NCT00968708|50624320|FG001|Overall Study|Other|34|||
25308772|NCT00967694|50624326|FG000|Overall Study|Withdrawal by Subject|6|||
25071309|NCT02573870|50177451|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
25071310|NCT02573870|50177450|FG000|Overall Study|Lost to Follow-up|0|||
25071311|NCT02573870|50177451|FG001|Overall Study|Lost to Follow-up|1|||
25071312|NCT02573870|50177450|FG000|Overall Study|Other: Fail to Meet Visit|0|||
25071313|NCT02573870|50177451|FG001|Overall Study|Other: Fail to Meet Visit|2|||
25071314|NCT02572076|50177457|FG000|Overall Study|Protocol Violation|1|||
25071315|NCT02571452|50177463|FG000|Overall Study Treatment|Protocol Violation|0|||
25071316|NCT02571452|50177464|FG001|Overall Study Treatment|Protocol Violation|1|||
25071317|NCT02571452|50177463|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
25071318|NCT02571452|50177464|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
25071319|NCT02571452|50177463|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
25071320|NCT02571452|50177464|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
25071321|NCT02574260|50177470|FG000|Overall Study|Disease Progression|1|||
25071322|NCT02570126|50177476|FG000|Overall Study|Lost to Follow-up|2|||
25071323|NCT02570126|50177477|FG001|Overall Study|Lost to Follow-up|0|||
25071324|NCT02570126|50177476|FG000|Overall Study|Unable To Arrange Visit 3|1|||
25071325|NCT02570126|50177477|FG001|Overall Study|Unable To Arrange Visit 3|0|||
25071326|NCT02570126|50177476|FG000|Overall Study|Violation Of Procedures GSK|0|||
25071327|NCT02570126|50177477|FG001|Overall Study|Violation Of Procedures GSK|1|||
25071328|NCT02570126|50177476|FG000|Overall Study|Protocol Violation|0|||
25071329|NCT02570126|50177477|FG001|Overall Study|Protocol Violation|1|||
25071330|NCT02570126|50177476|FG000|Overall Study|Withdrawal by Subject|3|||
25071331|NCT02570126|50177477|FG001|Overall Study|Withdrawal by Subject|7|||
25071332|NCT04424641|50177491|FG000|Overall Study|Death|1|||
25071333|NCT04424641|50177492|FG001|Overall Study|Death|2|||
25071334|NCT04424641|50177493|FG002|Overall Study|Death|3|||
25071335|NCT04424641|50177494|FG003|Overall Study|Death|0|||
25071336|NCT04424641|50177495|FG004|Overall Study|Death|3|||
25071337|NCT04424641|50177496|FG005|Overall Study|Death|0|||
25071338|NCT04424641|50177497|FG006|Overall Study|Death|1|||
25071339|NCT04424641|50177498|FG007|Overall Study|Death|2|||
25071340|NCT04424641|50177491|FG000|Overall Study|Sponsor decision|0|||
25071341|NCT04424641|50177492|FG001|Overall Study|Sponsor decision|2|||
25071342|NCT04424641|50177493|FG002|Overall Study|Sponsor decision|3|||
25071343|NCT04424641|50177494|FG003|Overall Study|Sponsor decision|7|||
25071344|NCT04424641|50177495|FG004|Overall Study|Sponsor decision|2|||
25071345|NCT04424641|50177496|FG005|Overall Study|Sponsor decision|2|||
25071346|NCT04424641|50177497|FG006|Overall Study|Sponsor decision|3|||
25071347|NCT04424641|50177498|FG007|Overall Study|Sponsor decision|4|||
25071348|NCT04424641|50177491|FG000|Overall Study|Withdrawal by Subject|0|||
25071349|NCT04424641|50177492|FG001|Overall Study|Withdrawal by Subject|0|||
25308773|NCT00967616|50624332|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
25308774|NCT00967616|50624333|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
25071350|NCT04424641|50177493|FG002|Overall Study|Withdrawal by Subject|0|||
25071351|NCT04424641|50177494|FG003|Overall Study|Withdrawal by Subject|0|||
25071352|NCT04424641|50177495|FG004|Overall Study|Withdrawal by Subject|1|||
25071353|NCT04424641|50177496|FG005|Overall Study|Withdrawal by Subject|0|||
25071354|NCT04424641|50177497|FG006|Overall Study|Withdrawal by Subject|0|||
25071355|NCT04424641|50177498|FG007|Overall Study|Withdrawal by Subject|0|||
25071356|NCT04424641|50177491|FG000|Overall Study|Other|0|||
25071357|NCT04424641|50177492|FG001|Overall Study|Other|0|||
25308775|NCT00967616|50624332|FG000|Overall Study|Death|0|||
25308776|NCT00967616|50624333|FG001|Overall Study|Death|3|||
25308777|NCT00967616|50624332|FG000|Overall Study|Withdrawal by Subject|8|||
25308778|NCT00967616|50624333|FG001|Overall Study|Withdrawal by Subject|4|||
25308779|NCT00967616|50624332|FG000|Overall Study|Progressive Disease|31|||
25308780|NCT00967616|50624333|FG001|Overall Study|Progressive Disease|18|||
25308781|NCT00967616|50624332|FG000|Overall Study|Other|8|||
25308782|NCT00967616|50624333|FG001|Overall Study|Other|8|||
25308783|NCT00967616|50624332|FG000|Overall Study|Protocol Violation|1|||
25308784|NCT00967616|50624333|FG001|Overall Study|Protocol Violation|0|||
25308785|NCT00971204|50624343|FG000|Overall Study|Did not meet all criteria-not treated|14|||
25308786|NCT00971204|50624343|FG000|Overall Study|Lost to Follow-up|10|||
25308787|NCT03107793|50624347|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
25308788|NCT03107793|50624348|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
25308789|NCT03107793|50624349|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
25308790|NCT03107793|50624350|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
25308791|NCT03107793|50624351|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
25308792|NCT03107793|50624347|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
25308793|NCT03107793|50624348|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
25308794|NCT03107793|50624349|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
25308795|NCT03107793|50624350|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
25308796|NCT03107793|50624351|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
25308797|NCT03107793|50624347|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
25308798|NCT03107793|50624348|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
25308799|NCT03107793|50624349|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
25308800|NCT03107793|50624350|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
25308801|NCT03107793|50624351|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
25308802|NCT03107793|50624347|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
25308803|NCT03107793|50624348|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
25308804|NCT03107793|50624349|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
25308805|NCT03107793|50624350|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
25308806|NCT03107793|50624351|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
25308807|NCT03107793|50624347|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
25308808|NCT03107793|50624348|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
25308809|NCT03107793|50624349|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
25308810|NCT03107793|50624350|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
25308811|NCT03107793|50624351|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
25308812|NCT03107793|50624347|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
25308813|NCT03107793|50624348|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
25308814|NCT03107793|50624349|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
25308815|NCT03107793|50624350|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
25308816|NCT03107793|50624351|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
25308817|NCT03107793|50624347|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
25308818|NCT03107793|50624348|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
25308819|NCT03107793|50624349|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
25308820|NCT03107793|50624350|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
25308821|NCT03107793|50624351|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
25308822|NCT03107793|50624347|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
25308823|NCT03107793|50624348|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
25308824|NCT03107793|50624349|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
25308825|NCT03107793|50624350|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
25308826|NCT03107793|50624351|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
25308827|NCT03107793|50624347|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
25308828|NCT03107793|50624348|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
25308829|NCT03107793|50624349|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
25308830|NCT03107793|50624350|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
25308831|NCT03107793|50624351|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
25308832|NCT03107793|50624347|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
25308833|NCT03107793|50624348|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
25308834|NCT03107793|50624349|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
25308835|NCT03107793|50624350|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
25308836|NCT03107793|50624351|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
25308837|NCT03107793|50624347|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
25308838|NCT03107793|50624348|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
25308839|NCT03107793|50624349|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
24970100|NCT00095940|50059635|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
25308840|NCT03107793|50624350|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
25308841|NCT03107793|50624351|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
25308842|NCT03107793|50624347|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
25308843|NCT03107793|50624348|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
25308844|NCT03107793|50624349|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
25308845|NCT03107793|50624350|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
25308846|NCT03107793|50624351|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
25308847|NCT03107793|50624347|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
25308848|NCT03107793|50624348|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
25308849|NCT03107793|50624349|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
25308850|NCT03107793|50624350|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
25308851|NCT03107793|50624351|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
25308852|NCT03107793|50624347|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
25308853|NCT03107793|50624348|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
25308854|NCT03107793|50624349|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
25308855|NCT03107793|50624350|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
25308856|NCT03107793|50624351|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
25308857|NCT03107793|50624347|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
25308858|NCT03107793|50624348|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
25308859|NCT03107793|50624349|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
25308860|NCT03107793|50624350|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
25308861|NCT03107793|50624351|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
25308862|NCT03107793|50624347|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
25308863|NCT03107793|50624348|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
25308864|NCT03107793|50624349|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
25308865|NCT03107793|50624350|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
25308866|NCT03107793|50624351|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
25308867|NCT03107793|50624347|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
25308868|NCT03107793|50624348|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
25308869|NCT03107793|50624349|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
25308870|NCT03107793|50624350|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
25308871|NCT03107793|50624351|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
25308872|NCT03107793|50624347|FG000|Extension Period (Week 48- Week 104)|Death|0|||
25308873|NCT03107793|50624348|FG001|Extension Period (Week 48- Week 104)|Death|0|||
25308874|NCT03107793|50624349|FG002|Extension Period (Week 48- Week 104)|Death|0|||
25308875|NCT03107793|50624350|FG003|Extension Period (Week 48- Week 104)|Death|0|||
25308876|NCT03107793|50624351|FG004|Extension Period (Week 48- Week 104)|Death|1|||
25308877|NCT03107793|50624347|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
25308878|NCT03107793|50624348|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
25308879|NCT03107793|50624349|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
25308880|NCT03107793|50624350|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
25308881|NCT03107793|50624351|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
25308882|NCT03107793|50624347|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
25308883|NCT03107793|50624348|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
25308884|NCT03107793|50624349|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
25192196|NCT01465802|50357380|FG003|Overall Study|Withdrawal by Subject|8|||
25192197|NCT01465802|50357381|FG004|Overall Study|Withdrawal by Subject|1|||
25308885|NCT03107793|50624350|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
25308886|NCT03107793|50624351|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
25308887|NCT03107793|50624347|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
25308888|NCT03107793|50624348|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
25308889|NCT03107793|50624349|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
25308890|NCT03107793|50624350|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
25308891|NCT03107793|50624351|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
25308892|NCT03107793|50624347|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
25308893|NCT03107793|50624348|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
25308894|NCT03107793|50624349|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
25308895|NCT03107793|50624350|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
25308896|NCT03107793|50624351|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
25308897|NCT03107793|50624347|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
25308898|NCT03107793|50624348|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
25308899|NCT03107793|50624349|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
25308900|NCT03107793|50624350|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
25308901|NCT03107793|50624351|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
25308902|NCT03107793|50624347|FG000|Extension Period (Week 48- Week 104)|Other|0|||
25192198|NCT01465802|50357377|FG000|Overall Study|Lost to Follow-up|1|||
25308903|NCT03107793|50624348|FG001|Extension Period (Week 48- Week 104)|Other|0|||
25308904|NCT03107793|50624349|FG002|Extension Period (Week 48- Week 104)|Other|0|||
25308905|NCT03107793|50624350|FG003|Extension Period (Week 48- Week 104)|Other|1|||
25308906|NCT03107793|50624351|FG004|Extension Period (Week 48- Week 104)|Other|3|||
25308907|NCT03107793|50624347|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
25308908|NCT03107793|50624348|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
25308909|NCT03107793|50624349|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
25308910|NCT03107793|50624350|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
25308911|NCT03107793|50624351|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
25308912|NCT00974090|50624362|FG000|Period 1: Double Blind Period|Adverse Event|2|||
25308913|NCT00974090|50624363|FG001|Period 1: Double Blind Period|Adverse Event|1|||
25308914|NCT00974090|50624362|FG000|Period 1: Double Blind Period|Physician Decision|1|||
25308915|NCT00974090|50624363|FG001|Period 1: Double Blind Period|Physician Decision|0|||
25308916|NCT00974090|50624362|FG000|Period 2: Open-label Period|Adverse Event|4|||
25308917|NCT00974090|50624363|FG001|Period 2: Open-label Period|Adverse Event|6|||
25308918|NCT00974090|50624362|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
25308919|NCT00974090|50624363|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
25308920|NCT00974090|50624362|FG000|Period 2: Open-label Period|Physician Decision|0|||
25308921|NCT00974090|50624363|FG001|Period 2: Open-label Period|Physician Decision|3|||
25308922|NCT00974090|50624362|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
25308923|NCT00974090|50624363|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
25308924|NCT00971048|50624375|FG000|Overall Study|Protocol Violation|1|||
25308925|NCT00971048|50624376|FG001|Overall Study|Protocol Violation|2|||
25308926|NCT00971048|50624377|FG002|Overall Study|Protocol Violation|0|||
25308927|NCT00971048|50624378|FG003|Overall Study|Protocol Violation|1|||
25308928|NCT00971048|50624375|FG000|Overall Study|Adverse Event|0|||
25308929|NCT00971048|50624376|FG001|Overall Study|Adverse Event|0|||
25308930|NCT00971048|50624377|FG002|Overall Study|Adverse Event|1|||
25308931|NCT00971048|50624378|FG003|Overall Study|Adverse Event|0|||
25308932|NCT00971048|50624375|FG000|Overall Study|Physician Decision|0|||
25308933|NCT00971048|50624376|FG001|Overall Study|Physician Decision|0|||
25308934|NCT00971048|50624377|FG002|Overall Study|Physician Decision|0|||
25308935|NCT00971048|50624378|FG003|Overall Study|Physician Decision|1|||
25308936|NCT00699751|50624392|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
25308937|NCT00699751|50624393|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
25308938|NCT00699751|50624392|FG000|Period 1: Without/Before Drug Switch|Death|28|||
25308939|NCT00699751|50624393|FG001|Period 1: Without/Before Drug Switch|Death|29|||
25308940|NCT00699751|50624392|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
25308941|NCT00699751|50624393|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
25308942|NCT00699751|50624392|FG000|Period 1: Without/Before Drug Switch|Other|30|||
25308943|NCT00699751|50624393|FG001|Period 1: Without/Before Drug Switch|Other|20|||
25308944|NCT00699751|50624392|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
24970101|NCT00095940|50059636|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
24970102|NCT00095940|50059628|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
24970103|NCT00095940|50059629|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
24970104|NCT00095940|50059630|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
24970105|NCT00095940|50059631|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
24970106|NCT00095940|50059632|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
24970107|NCT00095940|50059633|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
24970108|NCT00095940|50059634|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
24970109|NCT00095940|50059635|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
24970110|NCT00095940|50059636|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
24970111|NCT00114218|50059654|FG000|Overall Study|Wrong Cell Type|2|||
24970112|NCT00114218|50059654|FG000|Overall Study|Wrong Primary|1|||
25308945|NCT00699751|50624393|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
25308946|NCT00699751|50624392|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
25308947|NCT00699751|50624393|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
25308948|NCT00699751|50624392|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
25308949|NCT00699751|50624393|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
25308950|NCT00699751|50624392|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
24970113|NCT00114218|50059654|FG000|Overall Study|Never Treated|1|||
25308951|NCT00699751|50624393|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
25308952|NCT00970502|50624400|FG000|Overall Study|Withdrawal by Subject|1|||
25308953|NCT00967226|50624410|FG000|Overall Study|Adverse Event|0|||
25308954|NCT00967226|50624411|FG001|Overall Study|Adverse Event|5|||
25308955|NCT00967226|50624410|FG000|Overall Study|Protocol Violation|2|||
25308956|NCT00967226|50624411|FG001|Overall Study|Protocol Violation|0|||
25308957|NCT00967226|50624410|FG000|Overall Study|Physician Decision|0|||
25308958|NCT00967226|50624411|FG001|Overall Study|Physician Decision|1|||
25308959|NCT00706381|50624445|FG000|Overall Study|Lost to Follow-up|0|||
25308960|NCT00706381|50624446|FG001|Overall Study|Lost to Follow-up|1|||
25308961|NCT00706381|50624447|FG002|Overall Study|Lost to Follow-up|1|||
25308962|NCT00706381|50624448|FG003|Overall Study|Lost to Follow-up|0|||
25308963|NCT00964886|50624465|FG000|Overall Study|Lost to Follow-up|2|||
25308964|NCT00964886|50624466|FG001|Overall Study|Lost to Follow-up|2|||
25308965|NCT00964886|50624467|FG002|Overall Study|Lost to Follow-up|6|||
25308966|NCT00964886|50624468|FG003|Overall Study|Lost to Follow-up|4|||
25308967|NCT00964886|50624465|FG000|Overall Study|Withdrawal by Subject|6|||
25308968|NCT00964886|50624466|FG001|Overall Study|Withdrawal by Subject|2|||
25308969|NCT00964886|50624467|FG002|Overall Study|Withdrawal by Subject|5|||
25308970|NCT00964886|50624468|FG003|Overall Study|Withdrawal by Subject|3|||
25308971|NCT00964886|50624465|FG000|Overall Study|Adverse Event|3|||
25308972|NCT00964886|50624466|FG001|Overall Study|Adverse Event|1|||
25308973|NCT00964886|50624467|FG002|Overall Study|Adverse Event|5|||
25308974|NCT00964886|50624468|FG003|Overall Study|Adverse Event|2|||
25308975|NCT00964886|50624465|FG000|Overall Study|Protocol Violation|0|||
25308976|NCT00964886|50624466|FG001|Overall Study|Protocol Violation|2|||
25308977|NCT00964886|50624467|FG002|Overall Study|Protocol Violation|0|||
25308978|NCT00964886|50624468|FG003|Overall Study|Protocol Violation|0|||
25308979|NCT00705757|50624485|FG000|Overall Study|Lack of Efficacy|5|||
25308980|NCT00705757|50624486|FG001|Overall Study|Lack of Efficacy|1|||
25308981|NCT00705757|50624487|FG002|Overall Study|Lack of Efficacy|3|||
25308982|NCT00705757|50624485|FG000|Overall Study|Lost to Follow-up|7|||
25308983|NCT00705757|50624486|FG001|Overall Study|Lost to Follow-up|6|||
25308984|NCT00705757|50624487|FG002|Overall Study|Lost to Follow-up|6|||
25308985|NCT00705757|50624485|FG000|Overall Study|Withdrawal by Subject|1|||
25308986|NCT00705757|50624486|FG001|Overall Study|Withdrawal by Subject|1|||
25308987|NCT00705757|50624487|FG002|Overall Study|Withdrawal by Subject|2|||
25308988|NCT00960752|50624515|FG000|Overall Study|Adverse Event|0|||
25308989|NCT00960752|50624516|FG001|Overall Study|Adverse Event|0|||
25308990|NCT00960752|50624517|FG002|Overall Study|Adverse Event|1|||
25308991|NCT00960752|50624515|FG000|Overall Study|Progression|0|||
24970114|NCT00095628|50059658|FG000|Overall Study|Disease progression prior to treatment|1|||
24970115|NCT04380142|50059664|FG000|LD/CD Stabilization Period|Adverse Event|3|||
24970116|NCT04380142|50059665|FG001|LD/CD Stabilization Period|Adverse Event|0|||
24970117|NCT04380142|50059666|FG002|LD/CD Stabilization Period|Adverse Event|0|||
24970118|NCT04380142|50059664|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
24970119|NCT04380142|50059665|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
24970120|NCT04380142|50059666|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
24970121|NCT04380142|50059664|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
24970122|NCT04380142|50059665|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
24970123|NCT04380142|50059666|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
25308992|NCT00960752|50624516|FG001|Overall Study|Progression|0|||
25308993|NCT00960752|50624517|FG002|Overall Study|Progression|1|||
25308994|NCT00758524|50624531|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
25308995|NCT00758524|50624532|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
25308996|NCT00758524|50624533|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
25308997|NCT00758524|50624534|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
25308998|NCT00758524|50624535|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
25308999|NCT00758524|50624536|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
25309000|NCT00758524|50624537|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
25309001|NCT00758524|50624538|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
25309002|NCT00758524|50624539|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
25309003|NCT00758524|50624540|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
25309004|NCT00758524|50624541|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
25309005|NCT00758524|50624542|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
25309006|NCT00758524|50624543|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
25309007|NCT00758524|50624544|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
25309008|NCT00758524|50624545|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
25309009|NCT00758524|50624546|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
25309010|NCT00758524|50624547|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
25309011|NCT00758524|50624531|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
25309012|NCT00758524|50624532|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
25309013|NCT00758524|50624533|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
25309014|NCT00758524|50624534|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
25309015|NCT00758524|50624535|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
25309016|NCT00758524|50624536|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
25309017|NCT00758524|50624537|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
25309018|NCT00758524|50624538|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
25309019|NCT00758524|50624539|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
25309020|NCT00758524|50624540|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
25309021|NCT00758524|50624541|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
25309022|NCT00758524|50624542|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
25309023|NCT00758524|50624543|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
25309024|NCT00758524|50624544|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
25309025|NCT00758524|50624545|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
25309026|NCT00758524|50624546|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
25309027|NCT00758524|50624547|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
24970124|NCT04380142|50059664|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
24970125|NCT04380142|50059665|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
24970126|NCT04380142|50059666|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
24970127|NCT04380142|50059664|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
24970128|NCT04380142|50059665|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
24970129|NCT04380142|50059666|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
25309028|NCT00758524|50624531|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
24970130|NCT04380142|50059664|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
24970131|NCT04380142|50059665|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
24970132|NCT04380142|50059666|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
25309029|NCT00758524|50624532|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
25309030|NCT00758524|50624533|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
24970133|NCT04380142|50059664|FG000|Double-Blind Treatment Period|Adverse Event|0|||
24970134|NCT04380142|50059665|FG001|Double-Blind Treatment Period|Adverse Event|1|||
24970135|NCT04380142|50059666|FG002|Double-Blind Treatment Period|Adverse Event|14|||
24970136|NCT04380142|50059664|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
24970137|NCT04380142|50059665|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
24970138|NCT04380142|50059666|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
24970139|NCT04380142|50059664|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
24970140|NCT04380142|50059665|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
24970141|NCT04380142|50059666|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
24970142|NCT04380142|50059664|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
24970143|NCT04380142|50059665|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
24970144|NCT04380142|50059666|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
24970145|NCT04380142|50059664|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
24970146|NCT04380142|50059665|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
24970147|NCT04380142|50059666|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
24970148|NCT04380142|50059664|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
24970149|NCT04380142|50059665|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
24970150|NCT04380142|50059666|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
24970151|NCT04045132|50059676|FG000|Overall Study|Lost to Follow-up|3|||
24970152|NCT04045132|50059677|FG001|Overall Study|Lost to Follow-up|6|||
24970153|NCT04335136|50059687|FG000|Overall Study|Death|8|||
24970154|NCT04335136|50059688|FG001|Overall Study|Death|4|||
24970155|NCT04335136|50059687|FG000|Overall Study|Lost to Follow-up|2|||
24970156|NCT04335136|50059688|FG001|Overall Study|Lost to Follow-up|0|||
24970157|NCT04335136|50059687|FG000|Overall Study|Protocol Violation|1|||
24970158|NCT04335136|50059688|FG001|Overall Study|Protocol Violation|0|||
24970159|NCT04335136|50059687|FG000|Overall Study|Withdrawal by Subject|1|||
24970160|NCT04335136|50059688|FG001|Overall Study|Withdrawal by Subject|1|||
24970161|NCT04335136|50059687|FG000|Overall Study|Health-threatening condition|0|||
24970162|NCT04335136|50059688|FG001|Overall Study|Health-threatening condition|1|||
24970163|NCT04335136|50059687|FG000|Overall Study|Adverse Event|0|||
24970164|NCT04335136|50059688|FG001|Overall Study|Adverse Event|1|||
24970165|NCT04335136|50059687|FG000|Overall Study|Erroneously randomized|2|||
24970166|NCT04335136|50059688|FG001|Overall Study|Erroneously randomized|0|||
24970167|NCT04171414|50059694|FG000|Overall Study|Death|1|||
24970168|NCT04171414|50059694|FG000|Overall Study|Withdrawal by Subject|1|||
24970169|NCT04167670|50059701|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
24970170|NCT04167670|50059702|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
24970171|NCT04167670|50059703|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
24970172|NCT04167670|50059701|FG000|Overall Study|Significant protocol deviation|3|||
24970173|NCT04167670|50059702|FG001|Overall Study|Significant protocol deviation|1|||
24970174|NCT04167670|50059703|FG002|Overall Study|Significant protocol deviation|0|||
24970175|NCT04167670|50059701|FG000|Overall Study|Lost to Follow-up|0|||
24970176|NCT04167670|50059702|FG001|Overall Study|Lost to Follow-up|3|||
24970177|NCT04167670|50059703|FG002|Overall Study|Lost to Follow-up|3|||
24970178|NCT04167670|50059701|FG000|Overall Study|Voluntary Withdrawal|0|||
24970179|NCT04167670|50059702|FG001|Overall Study|Voluntary Withdrawal|1|||
24970180|NCT04167670|50059703|FG002|Overall Study|Voluntary Withdrawal|1|||
24970181|NCT04167670|50059701|FG000|Overall Study|Withdrawal of Consent|4|||
25071358|NCT04424641|50177493|FG002|Overall Study|Other|1|||
25309031|NCT00758524|50624534|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
25309032|NCT00758524|50624535|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
25309033|NCT00758524|50624536|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
25309034|NCT00758524|50624537|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
25309035|NCT00758524|50624538|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
25309036|NCT00758524|50624539|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
25309037|NCT00758524|50624540|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
25309038|NCT00758524|50624541|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
25309039|NCT00758524|50624542|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
25309040|NCT00758524|50624543|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
25309041|NCT00758524|50624544|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
25309042|NCT00758524|50624545|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
25309043|NCT00758524|50624546|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
25309044|NCT00758524|50624547|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
25309045|NCT00758524|50624531|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
25309046|NCT00758524|50624532|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
25309047|NCT00758524|50624533|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
25309048|NCT00758524|50624534|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
25309049|NCT00758524|50624535|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
25309050|NCT00758524|50624536|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
25309051|NCT00758524|50624537|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
25309052|NCT00758524|50624538|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
25309053|NCT00758524|50624539|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
25309054|NCT00758524|50624540|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
25309055|NCT00758524|50624541|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
25309056|NCT00758524|50624542|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
25309057|NCT00758524|50624543|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
25309058|NCT00758524|50624544|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
25309059|NCT00758524|50624545|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
25309060|NCT00758524|50624546|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
25309061|NCT00758524|50624547|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
25309062|NCT00758524|50624531|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
25309063|NCT00758524|50624532|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
25309064|NCT00758524|50624533|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
25309065|NCT00758524|50624534|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
25309066|NCT00758524|50624535|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
25309067|NCT00758524|50624536|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
25309068|NCT00758524|50624537|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
25309069|NCT00758524|50624538|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
25309070|NCT00758524|50624539|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
25309071|NCT00758524|50624540|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
25309072|NCT00758524|50624541|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
25309073|NCT00758524|50624542|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
25309074|NCT00758524|50624543|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
25309075|NCT00758524|50624544|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
25309076|NCT00758524|50624545|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
25309077|NCT00758524|50624546|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
25309078|NCT00758524|50624547|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
25309079|NCT00758524|50624531|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
25309080|NCT00758524|50624532|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
25309081|NCT00758524|50624533|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
25309082|NCT00758524|50624534|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
25309083|NCT00758524|50624535|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
25309084|NCT00758524|50624536|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
25309085|NCT00758524|50624537|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
25309086|NCT00758524|50624538|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
25309087|NCT00758524|50624539|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
25309088|NCT00758524|50624540|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
25309089|NCT00758524|50624541|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
25309090|NCT00758524|50624542|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
25309091|NCT00758524|50624543|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
25309092|NCT00758524|50624544|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
25309093|NCT00758524|50624545|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
25309094|NCT00758524|50624546|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
25309095|NCT00758524|50624547|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
25309096|NCT00758524|50624531|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
25309097|NCT00758524|50624532|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
25309098|NCT00758524|50624533|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
25309099|NCT00758524|50624534|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
25309100|NCT00758524|50624535|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
25309101|NCT00758524|50624536|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
25309102|NCT00758524|50624537|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
25309103|NCT00758524|50624538|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
25309104|NCT00758524|50624539|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
25309105|NCT00758524|50624540|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
25309106|NCT00758524|50624541|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
25309107|NCT00758524|50624542|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
25309108|NCT00758524|50624543|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
25309109|NCT00758524|50624544|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
25309110|NCT00758524|50624545|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
25309111|NCT00758524|50624546|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
25309112|NCT00758524|50624547|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
25309113|NCT00758524|50624531|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
25309114|NCT00758524|50624532|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
25309115|NCT00758524|50624533|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
25309116|NCT00758524|50624534|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
25309117|NCT00758524|50624535|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
25309118|NCT00758524|50624536|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
25309119|NCT00758524|50624537|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
25309120|NCT00758524|50624538|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
25309121|NCT00758524|50624539|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
25309122|NCT00758524|50624540|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
25309123|NCT00758524|50624541|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
25309124|NCT00758524|50624542|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
25309125|NCT00758524|50624543|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
25309126|NCT00758524|50624544|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
25309127|NCT00758524|50624545|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
25309128|NCT00758524|50624546|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
25309129|NCT00758524|50624547|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
25309130|NCT00758524|50624531|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
25309131|NCT00758524|50624532|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
25309132|NCT00758524|50624533|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
25309133|NCT00758524|50624534|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
25309134|NCT00758524|50624535|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
25309135|NCT00758524|50624536|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
25309136|NCT00758524|50624537|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
25309137|NCT00758524|50624538|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
25309138|NCT00758524|50624539|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
25309139|NCT00758524|50624540|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
25309140|NCT00758524|50624541|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
25309141|NCT00758524|50624542|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
25309142|NCT00758524|50624543|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
25309143|NCT00758524|50624544|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
25309144|NCT00758524|50624545|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
25309145|NCT00758524|50624546|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
25309146|NCT00758524|50624547|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
25309147|NCT00758524|50624531|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
25309148|NCT00758524|50624532|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
25309149|NCT00758524|50624533|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
25309150|NCT00758524|50624534|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
25309151|NCT00758524|50624535|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
25309152|NCT00758524|50624536|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
25309153|NCT00758524|50624537|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
25309154|NCT00758524|50624538|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
25309155|NCT00758524|50624539|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
25309156|NCT00758524|50624540|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
25309157|NCT00758524|50624541|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
25309158|NCT00758524|50624542|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
25309159|NCT00758524|50624543|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
25309160|NCT00758524|50624544|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
25309161|NCT00758524|50624545|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
25309162|NCT00758524|50624546|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
25309163|NCT00758524|50624547|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
25309164|NCT00757588|50624587|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
25309165|NCT00757588|50624588|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
25309166|NCT00757588|50624587|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
25309167|NCT00757588|50624588|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
25309168|NCT00757588|50624587|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
25309169|NCT00757588|50624588|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
25309170|NCT00757588|50624587|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
25309171|NCT00757588|50624588|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
25309172|NCT00757588|50624587|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
25309173|NCT00757588|50624588|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
25309174|NCT00757588|50624587|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
25309175|NCT00757588|50624588|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
25309176|NCT00757588|50624587|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
25309177|NCT00757588|50624588|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
25309178|NCT00757588|50624587|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
25309179|NCT00757588|50624588|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
25309180|NCT00757588|50624587|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
25309181|NCT00757588|50624588|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
25309182|NCT00757588|50624587|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
25309183|NCT00757588|50624588|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
25309184|NCT00757588|50624587|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
25309185|NCT00757588|50624588|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
25309186|NCT00757588|50624587|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
25309187|NCT00757588|50624588|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
25309188|NCT00757588|50624587|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
25309189|NCT00757588|50624588|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
25309190|NCT00757588|50624587|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
25309191|NCT00757588|50624588|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
25309192|NCT00757588|50624587|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
25309193|NCT00757588|50624588|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
25309194|NCT00757588|50624587|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
25309195|NCT00757588|50624588|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
25309196|NCT00744796|50624594|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
25309197|NCT00705679|50624603|FG000|Overall Study|Adverse Event|1|||
25309198|NCT00705679|50624604|FG001|Overall Study|Adverse Event|1|||
25309199|NCT00705679|50624605|FG002|Overall Study|Adverse Event|0|||
25309200|NCT00705679|50624606|FG003|Overall Study|Adverse Event|0|||
25309201|NCT00705679|50624607|FG004|Overall Study|Adverse Event|0|||
25309202|NCT00705679|50624603|FG000|Overall Study|Death|0|||
25309203|NCT00705679|50624604|FG001|Overall Study|Death|0|||
25309204|NCT00705679|50624605|FG002|Overall Study|Death|3|||
25309205|NCT00705679|50624606|FG003|Overall Study|Death|2|||
25309206|NCT00705679|50624607|FG004|Overall Study|Death|1|||
25309207|NCT00705679|50624603|FG000|Overall Study|Lost to Follow-up|32|||
25309208|NCT00705679|50624604|FG001|Overall Study|Lost to Follow-up|60|||
25309209|NCT00705679|50624605|FG002|Overall Study|Lost to Follow-up|44|||
25309210|NCT00705679|50624606|FG003|Overall Study|Lost to Follow-up|30|||
25309211|NCT00705679|50624607|FG004|Overall Study|Lost to Follow-up|35|||
25309212|NCT00705679|50624603|FG000|Overall Study|Physician Decision|0|||
25309213|NCT00705679|50624604|FG001|Overall Study|Physician Decision|1|||
25309214|NCT00705679|50624605|FG002|Overall Study|Physician Decision|0|||
25309215|NCT00705679|50624606|FG003|Overall Study|Physician Decision|1|||
25309216|NCT00705679|50624607|FG004|Overall Study|Physician Decision|0|||
25309217|NCT00705679|50624603|FG000|Overall Study|Withdrawal by Subject|32|||
25309218|NCT00705679|50624604|FG001|Overall Study|Withdrawal by Subject|77|||
25309219|NCT00705679|50624605|FG002|Overall Study|Withdrawal by Subject|68|||
25309220|NCT00705679|50624606|FG003|Overall Study|Withdrawal by Subject|47|||
25309221|NCT00705679|50624607|FG004|Overall Study|Withdrawal by Subject|33|||
25309222|NCT00751348|50624630|FG000|Overall Study|Withdrawal by Subject|5|||
25309223|NCT00751348|50624631|FG001|Overall Study|Withdrawal by Subject|2|||
25309224|NCT00751348|50624630|FG000|Overall Study|Migration from study area|1|||
24970182|NCT04167670|50059702|FG001|Overall Study|Withdrawal of Consent|1|||
25309225|NCT00751348|50624631|FG001|Overall Study|Migration from study area|0|||
25309226|NCT00751114|50624639|FG000|Overall Study|Adverse Event|2|||
25309227|NCT00751114|50624640|FG001|Overall Study|Adverse Event|4|||
25309228|NCT00751114|50624639|FG000|Overall Study|Protocol Violation|8|||
25309229|NCT00751114|50624640|FG001|Overall Study|Protocol Violation|9|||
25309230|NCT00751114|50624639|FG000|Overall Study|Withdrawal by Subject|9|||
25309231|NCT00751114|50624640|FG001|Overall Study|Withdrawal by Subject|4|||
25309232|NCT00751114|50624639|FG000|Overall Study|Lost to Follow-up|4|||
25309233|NCT00751114|50624640|FG001|Overall Study|Lost to Follow-up|7|||
25309234|NCT00751114|50624639|FG000|Overall Study|Lack of Efficacy|0|||
25309235|NCT00751114|50624640|FG001|Overall Study|Lack of Efficacy|7|||
25309236|NCT00751114|50624639|FG000|Overall Study|Not Treated|13|||
25309237|NCT00751114|50624640|FG001|Overall Study|Not Treated|1|||
25309238|NCT00751114|50624639|FG000|Overall Study|Out of country for 2 months|1|||
25309239|NCT00751114|50624640|FG001|Overall Study|Out of country for 2 months|0|||
25309240|NCT00751114|50624639|FG000|Overall Study|Move to another city|1|||
25309241|NCT00751114|50624640|FG001|Overall Study|Move to another city|0|||
25309242|NCT00960440|50624650|FG000|Overall Study|Death|0|||
25309243|NCT00960440|50624651|FG001|Overall Study|Death|0|||
25309244|NCT00960440|50624652|FG002|Overall Study|Death|0|||
25309245|NCT00960440|50624653|FG003|Overall Study|Death|1|||
25309246|NCT00960440|50624650|FG000|Overall Study|Adverse Event|12|||
25309247|NCT00960440|50624651|FG001|Overall Study|Adverse Event|12|||
25309248|NCT00960440|50624652|FG002|Overall Study|Adverse Event|4|||
25309249|NCT00960440|50624653|FG003|Overall Study|Adverse Event|4|||
25309250|NCT00960440|50624650|FG000|Overall Study|Lack of Efficacy|2|||
25309251|NCT00960440|50624651|FG001|Overall Study|Lack of Efficacy|5|||
25309252|NCT00960440|50624652|FG002|Overall Study|Lack of Efficacy|3|||
25309253|NCT00960440|50624653|FG003|Overall Study|Lack of Efficacy|8|||
25309254|NCT00960440|50624650|FG000|Overall Study|Protocol Violation|2|||
25309255|NCT00960440|50624651|FG001|Overall Study|Protocol Violation|8|||
25309256|NCT00960440|50624652|FG002|Overall Study|Protocol Violation|3|||
25309257|NCT00960440|50624653|FG003|Overall Study|Protocol Violation|4|||
25309258|NCT00960440|50624650|FG000|Overall Study|Withdrawal by Subject|9|||
25309259|NCT00960440|50624651|FG001|Overall Study|Withdrawal by Subject|5|||
25309260|NCT00960440|50624652|FG002|Overall Study|Withdrawal by Subject|2|||
25309261|NCT00960440|50624653|FG003|Overall Study|Withdrawal by Subject|1|||
25309262|NCT00960440|50624650|FG000|Overall Study|Other|1|||
25309263|NCT00960440|50624651|FG001|Overall Study|Other|1|||
25309264|NCT00960440|50624652|FG002|Overall Study|Other|1|||
25309265|NCT00960440|50624653|FG003|Overall Study|Other|0|||
25309266|NCT00964028|50624667|FG000|Overall Study|Withdrawal by Subject|0|||
25309267|NCT00964028|50624668|FG001|Overall Study|Withdrawal by Subject|1|||
25309268|NCT00960206|50624677|FG000|Overall Study|Death|7|||
25309269|NCT00960206|50624678|FG001|Overall Study|Death|4|||
25309270|NCT00960206|50624679|FG002|Overall Study|Death|1|||
25309271|NCT00960206|50624677|FG000|Overall Study|Unwilling/Unable to return|1|||
25309272|NCT00960206|50624678|FG001|Overall Study|Unwilling/Unable to return|2|||
25309273|NCT00960206|50624679|FG002|Overall Study|Unwilling/Unable to return|0|||
25309274|NCT00960206|50624677|FG000|Overall Study|Lost to Follow-up|8|||
25309275|NCT00960206|50624678|FG001|Overall Study|Lost to Follow-up|14|||
25309276|NCT00960206|50624679|FG002|Overall Study|Lost to Follow-up|8|||
25309277|NCT00960206|50624677|FG000|Overall Study|Withdrawal by Subject|2|||
25309278|NCT00960206|50624678|FG001|Overall Study|Withdrawal by Subject|4|||
25309279|NCT00960206|50624679|FG002|Overall Study|Withdrawal by Subject|0|||
25309280|NCT00960206|50624677|FG000|Overall Study|Revision of study component|2|||
25309281|NCT00960206|50624678|FG001|Overall Study|Revision of study component|2|||
25309282|NCT00960206|50624679|FG002|Overall Study|Revision of study component|2|||
25309283|NCT00960206|50624677|FG000|Overall Study|Missing 10 year data|20|||
25309284|NCT00960206|50624678|FG001|Overall Study|Missing 10 year data|1|||
25309285|NCT00960206|50624679|FG002|Overall Study|Missing 10 year data|1|||
25309286|NCT00751036|50624690|FG000|Overall Study|Disease Progression|28|||
25309287|NCT00751036|50624691|FG001|Overall Study|Disease Progression|29|||
25309288|NCT00751036|50624690|FG000|Overall Study|Adverse Event|6|||
25309289|NCT00751036|50624691|FG001|Overall Study|Adverse Event|4|||
25309290|NCT00751036|50624690|FG000|Overall Study|Administrative Problems|3|||
25309291|NCT00751036|50624691|FG001|Overall Study|Administrative Problems|4|||
25309292|NCT00751036|50624690|FG000|Overall Study|Withdrawal by Subject|5|||
25309293|NCT00751036|50624691|FG001|Overall Study|Withdrawal by Subject|2|||
25309294|NCT00751036|50624690|FG000|Overall Study|Death|3|||
25309295|NCT00751036|50624691|FG001|Overall Study|Death|3|||
25309296|NCT00751036|50624690|FG000|Overall Study|Lost to Follow-up|0|||
25309297|NCT00751036|50624691|FG001|Overall Study|Lost to Follow-up|1|||
25309298|NCT00751036|50624690|FG000|Overall Study|Protocol Violation|1|||
25309299|NCT00751036|50624691|FG001|Overall Study|Protocol Violation|0|||
25309300|NCT00751036|50624690|FG000|Overall Study|Missing end of Treatment Page|2|||
25309301|NCT00751036|50624691|FG001|Overall Study|Missing end of Treatment Page|3|||
25309302|NCT00961298|50624697|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
25309303|NCT00961298|50624697|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
25309304|NCT00961298|50624697|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
25309305|NCT00744328|50624704|FG000|Overall Study|Lost to Follow-up|2|||
25309306|NCT00744328|50624705|FG001|Overall Study|Lost to Follow-up|5|||
25309307|NCT00744328|50624706|FG002|Overall Study|Lost to Follow-up|3|||
25309308|NCT00744328|50624704|FG000|Overall Study|Withdrawal by Subject|5|||
25309309|NCT00744328|50624705|FG001|Overall Study|Withdrawal by Subject|3|||
25309310|NCT00744328|50624706|FG002|Overall Study|Withdrawal by Subject|4|||
25309311|NCT00744328|50624704|FG000|Overall Study|Found ineligible after randomization|0|||
25309312|NCT00744328|50624705|FG001|Overall Study|Found ineligible after randomization|0|||
25309313|NCT00744328|50624706|FG002|Overall Study|Found ineligible after randomization|1|||
25309314|NCT03245840|50624716|FG000|Overall Study|Adverse Event|6|||
25309315|NCT03245840|50624717|FG001|Overall Study|Adverse Event|0|||
25309316|NCT03245840|50624716|FG000|Overall Study|Death|2|||
25309317|NCT03245840|50624717|FG001|Overall Study|Death|0|||
25309318|NCT03245840|50624716|FG000|Overall Study|Withdrawal by Subject|31|||
25309319|NCT03245840|50624717|FG001|Overall Study|Withdrawal by Subject|1|||
25309320|NCT03245840|50624716|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
25309321|NCT03245840|50624717|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
25309322|NCT03245840|50624716|FG000|Overall Study|Physician Decision|4|||
25309323|NCT03245840|50624717|FG001|Overall Study|Physician Decision|1|||
25309324|NCT03245840|50624716|FG000|Overall Study|Study Terminated by Sponsor|56|||
25309325|NCT03245840|50624717|FG001|Overall Study|Study Terminated by Sponsor|6|||
25309326|NCT03245840|50624716|FG000|Overall Study|Site Terminated by Sponsor|4|||
25309327|NCT03245840|50624717|FG001|Overall Study|Site Terminated by Sponsor|0|||
25309328|NCT03245840|50624716|FG000|Overall Study|Lost to Follow-up|12|||
25309329|NCT03245840|50624717|FG001|Overall Study|Lost to Follow-up|2|||
25309330|NCT03245840|50624716|FG000|Overall Study|Pregnancy|2|||
25309331|NCT03245840|50624717|FG001|Overall Study|Pregnancy|0|||
25309332|NCT03245840|50624716|FG000|Overall Study|Non-Compliance with Study Drug|2|||
25309333|NCT03245840|50624717|FG001|Overall Study|Non-Compliance with Study Drug|0|||
25309334|NCT03245840|50624716|FG000|Overall Study|Not treated|1|||
25309335|NCT03245840|50624717|FG001|Overall Study|Not treated|1|||
25309336|NCT00959894|50624723|FG000|Overall Study|Lost to Follow-up|10|||
25309337|NCT00959894|50624723|FG000|Overall Study|Adverse Event|3|||
25309338|NCT00959894|50624723|FG000|Overall Study|Withdrawal by Subject|1|||
25309339|NCT00959894|50624723|FG000|Overall Study|Need for contraindicated medication|1|||
25309340|NCT00959894|50624723|FG000|Overall Study|Subject moved out of town|1|||
25309341|NCT00750880|50624728|FG000|Overall Study|Adverse Event|76|||
25309342|NCT00750880|50624728|FG000|Overall Study|Death|4|||
25309343|NCT00750880|50624728|FG000|Overall Study|Lack of Efficacy|46|||
25309344|NCT00750880|50624728|FG000|Overall Study|Lost to Follow-up|10|||
25309345|NCT00750880|50624728|FG000|Overall Study|Protocol Violation|15|||
25309346|NCT00750880|50624728|FG000|Overall Study|Withdrawal by Subject|33|||
25309347|NCT00750880|50624728|FG000|Overall Study|Physician Decision|20|||
25309348|NCT00750880|50624728|FG000|Overall Study|Administrative|11|||
25309349|NCT00746590|50624733|FG000|Overall Study|Death|1|||
25309350|NCT01032629|50624740|FG000|Overall Study|Closed Site|21|||
25309351|NCT01032629|50624741|FG001|Overall Study|Closed Site|18|||
25309352|NCT01032629|50624742|FG002|Overall Study|Closed Site|16|||
25309353|NCT01032629|50624740|FG000|Overall Study|Withdrawal by Subject|50|||
25309354|NCT01032629|50624741|FG001|Overall Study|Withdrawal by Subject|36|||
25309355|NCT01032629|50624742|FG002|Overall Study|Withdrawal by Subject|35|||
25309356|NCT01032629|50624740|FG000|Overall Study|Lost to Follow-up|74|||
25309357|NCT01032629|50624741|FG001|Overall Study|Lost to Follow-up|47|||
25309358|NCT01032629|50624742|FG002|Overall Study|Lost to Follow-up|37|||
25309359|NCT00749944|50624753|FG000|Overall Study|Lost to Follow-up|2|||
25309360|NCT00749944|50624754|FG001|Overall Study|Lost to Follow-up|1|||
25309361|NCT00749944|50624753|FG000|Overall Study|Other|1|||
25309362|NCT00749944|50624754|FG001|Overall Study|Other|0|||
25309363|NCT00749944|50624753|FG000|Overall Study|Withdrawal by Subject|2|||
25309364|NCT00749944|50624754|FG001|Overall Study|Withdrawal by Subject|0|||
25309365|NCT00749398|50624760|FG000|Overall Study|Lack of Efficacy|7|||
25309366|NCT00749398|50624760|FG000|Overall Study|Adverse Event|4|||
25309367|NCT00749398|50624760|FG000|Overall Study|Serious adverse event|11|||
25309368|NCT00749398|50624760|FG000|Overall Study|Withdrawal by Subject|17|||
25309369|NCT00749398|50624760|FG000|Overall Study|Lost to Follow-up|11|||
25309370|NCT00749398|50624760|FG000|Overall Study|Reason not specified|2|||
25309371|NCT00749398|50624760|FG000|Overall Study|Unknown reason|1|||
25309372|NCT00746356|50624764|FG000|Overall Study|Withdrawal by Subject|2|||
25309373|NCT00746356|50624765|FG001|Overall Study|Withdrawal by Subject|3|||
25309374|NCT00746356|50624764|FG000|Overall Study|Death|7|||
25309375|NCT00746356|50624765|FG001|Overall Study|Death|3|||
25309376|NCT00746356|50624764|FG000|Overall Study|Lost to Follow-up|1|||
25309377|NCT00746356|50624765|FG001|Overall Study|Lost to Follow-up|0|||
25309378|NCT00746356|50624764|FG000|Overall Study|Removal of Device|0|||
25309379|NCT00746356|50624765|FG001|Overall Study|Removal of Device|1|||
25309380|NCT00746356|50624764|FG000|Overall Study|Patient relocated|1|||
25309381|NCT00746356|50624765|FG001|Overall Study|Patient relocated|0|||
25309382|NCT01012973|50624775|FG000|Overall Study|Adverse Event|5|||
25309383|NCT01012973|50624776|FG001|Overall Study|Adverse Event|5|||
25309384|NCT01012973|50624775|FG000|Overall Study|Lack of Efficacy|0|||
25309385|NCT01012973|50624776|FG001|Overall Study|Lack of Efficacy|5|||
25309386|NCT01012973|50624775|FG000|Overall Study|Lost to Follow-up|1|||
25309387|NCT01012973|50624776|FG001|Overall Study|Lost to Follow-up|0|||
25309388|NCT01012973|50624775|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
25309389|NCT01012973|50624776|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
24970183|NCT04167670|50059703|FG002|Overall Study|Withdrawal of Consent|3|||
25071359|NCT04424641|50177494|FG003|Overall Study|Other|0|||
25309390|NCT01012973|50624775|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
25309391|NCT01012973|50624776|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
25309392|NCT01012973|50624775|FG000|Overall Study|Protocol Violation|5|||
25309393|NCT01012973|50624776|FG001|Overall Study|Protocol Violation|2|||
25309394|NCT01012973|50624775|FG000|Overall Study|Withdrawal by Subject|4|||
25309395|NCT01012973|50624776|FG001|Overall Study|Withdrawal by Subject|6|||
25309396|NCT00748540|50624786|FG000|Overall Study|Physician Decision|1|||
25309397|NCT01012739|50624790|FG000|Treatment Period 1|Adverse Event|0|||
25309398|NCT01012739|50624791|FG001|Treatment Period 1|Adverse Event|0|||
25309399|NCT01012739|50624792|FG002|Treatment Period 1|Adverse Event|0|||
25309400|NCT01012739|50624793|FG003|Treatment Period 1|Adverse Event|1|||
25309401|NCT01012739|50624790|FG000|Treatment Period 2|Abnormal test procedure results|0|||
25309402|NCT01012739|50624791|FG001|Treatment Period 2|Abnormal test procedure results|0|||
25309403|NCT01012739|50624792|FG002|Treatment Period 2|Abnormal test procedure results|0|||
25309404|NCT01012739|50624793|FG003|Treatment Period 2|Abnormal test procedure results|1|||
25309405|NCT00742924|50624808|FG000|Overall Study|Adverse Event|0|||
25309406|NCT00742924|50624809|FG001|Overall Study|Adverse Event|0|||
25309407|NCT00742924|50624810|FG002|Overall Study|Adverse Event|1|||
25309408|NCT00742924|50624811|FG003|Overall Study|Adverse Event|1|||
25309409|NCT00742924|50624808|FG000|Overall Study|Lack of Efficacy|5|||
25309410|NCT00742924|50624809|FG001|Overall Study|Lack of Efficacy|1|||
25309411|NCT00742924|50624810|FG002|Overall Study|Lack of Efficacy|2|||
25309412|NCT00742924|50624811|FG003|Overall Study|Lack of Efficacy|4|||
25309413|NCT00742924|50624808|FG000|Overall Study|Physician Decision|0|||
25309414|NCT00742924|50624809|FG001|Overall Study|Physician Decision|0|||
25309415|NCT00742924|50624810|FG002|Overall Study|Physician Decision|0|||
25309416|NCT00742924|50624811|FG003|Overall Study|Physician Decision|1|||
25309417|NCT00742924|50624808|FG000|Overall Study|Withdrawal by Subject|0|||
25309418|NCT00742924|50624809|FG001|Overall Study|Withdrawal by Subject|1|||
25309419|NCT00742924|50624810|FG002|Overall Study|Withdrawal by Subject|1|||
25309420|NCT00742924|50624811|FG003|Overall Study|Withdrawal by Subject|0|||
25309421|NCT00698815|50624824|FG000|Overall Study|Death|1|||
25309422|NCT00698815|50624825|FG001|Overall Study|Death|2|||
25309423|NCT00698815|50624826|FG002|Overall Study|Death|4|||
25309424|NCT00698815|50624824|FG000|Overall Study|Withdrawal by Subject|6|||
25309425|NCT00698815|50624825|FG001|Overall Study|Withdrawal by Subject|3|||
25309426|NCT00698815|50624826|FG002|Overall Study|Withdrawal by Subject|2|||
25309427|NCT00698815|50624824|FG000|Overall Study|MD discretion|2|||
25309428|NCT00698815|50624825|FG001|Overall Study|MD discretion|7|||
25309429|NCT00698815|50624826|FG002|Overall Study|MD discretion|2|||
25309430|NCT00698815|50624824|FG000|Overall Study|Did not receive protocol treatment|1|||
25309431|NCT00698815|50624825|FG001|Overall Study|Did not receive protocol treatment|2|||
25309432|NCT00698815|50624826|FG002|Overall Study|Did not receive protocol treatment|2|||
25309433|NCT00745498|50624837|FG000|Overall Study|Lost to Follow-up|1|||
25309434|NCT00745498|50624838|FG001|Overall Study|Lost to Follow-up|1|||
25309435|NCT00745498|50624839|FG002|Overall Study|Lost to Follow-up|3|||
25309436|NCT00745498|50624837|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
25309437|NCT00745498|50624838|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
25309438|NCT00745498|50624839|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
25309439|NCT00745498|50624837|FG000|Overall Study|Non-PDR related VH|0|||
25309440|NCT00745498|50624838|FG001|Overall Study|Non-PDR related VH|1|||
25071360|NCT04424641|50177495|FG004|Overall Study|Other|0|||
25071361|NCT04424641|50177496|FG005|Overall Study|Other|0|||
25309441|NCT00745498|50624839|FG002|Overall Study|Non-PDR related VH|1|||
25309442|NCT00745498|50624837|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
25309443|NCT00745498|50624838|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
25309444|NCT00745498|50624839|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
25071362|NCT04424641|50177497|FG006|Overall Study|Other|0|||
25309445|NCT00744874|50624847|FG000|Overall Study|Lost to Follow-up|1|||
25309446|NCT00744874|50624847|FG000|Overall Study|Withdrawal by Subject|1|||
25309447|NCT00744874|50624847|FG000|Overall Study|Study Device not available at procedure|1|||
25309448|NCT00744874|50624847|FG000|Overall Study|Unable to accomodate schedule|1|||
25309449|NCT00576901|50624858|FG000|Overall Study|Withdrawal by Subject|1|||
25309450|NCT00576901|50624858|FG000|Overall Study|Disease course|1|||
25309451|NCT00576901|50624858|FG000|Overall Study|Protocol Violation|1|||
25309452|NCT00699283|50624864|FG000|Overall Study|Lack of Efficacy|15|||
25309453|NCT00699283|50624865|FG001|Overall Study|Lack of Efficacy|5|||
25309454|NCT00699283|50624864|FG000|Overall Study|Lost to Follow-up|2|||
25309455|NCT00699283|50624865|FG001|Overall Study|Lost to Follow-up|0|||
25309456|NCT00699283|50624864|FG000|Overall Study|Withdrawal by Subject|1|||
25309457|NCT00699283|50624865|FG001|Overall Study|Withdrawal by Subject|0|||
25309458|NCT00699283|50624864|FG000|Overall Study|Other Reason|5|||
25309459|NCT00699283|50624865|FG001|Overall Study|Other Reason|1|||
25309460|NCT00699283|50624864|FG000|Overall Study|SAE, non-fatal|1|||
25309461|NCT00699283|50624865|FG001|Overall Study|SAE, non-fatal|1|||
25309462|NCT00699283|50624864|FG000|Overall Study|AE, non-serious non-fatal|8|||
25309463|NCT00699283|50624865|FG001|Overall Study|AE, non-serious non-fatal|1|||
25309464|NCT00699283|50624864|FG000|Overall Study|AE of unknown type|1|||
25309465|NCT00699283|50624865|FG001|Overall Study|AE of unknown type|0|||
25309466|NCT00740584|50624870|FG000|Overall Study|Withdrawal by Subject|1|||
25309467|NCT01023815|50624879|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
25309468|NCT01023815|50624880|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
25309469|NCT01023815|50624881|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
24970184|NCT04167670|50059701|FG000|Overall Study|Miscellaneous|7|||
24970185|NCT04167670|50059702|FG001|Overall Study|Miscellaneous|5|||
24970186|NCT04167670|50059703|FG002|Overall Study|Miscellaneous|3|||
24970187|NCT00113516|50059711|FG000|Part 1|Adverse Event|6|||
24970188|NCT00113516|50059712|FG001|Part 1|Adverse Event|0|||
24970189|NCT00113516|50059711|FG000|Part 1|Death|3|||
24970190|NCT00113516|50059712|FG001|Part 1|Death|0|||
24970191|NCT00113516|50059711|FG000|Part 1|Other|3|||
24970192|NCT00113516|50059712|FG001|Part 1|Other|0|||
25309470|NCT01023815|50624882|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
25309471|NCT01023815|50624879|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
25309472|NCT01023815|50624880|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
25309473|NCT01023815|50624881|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
25309474|NCT01023815|50624882|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
25309475|NCT01023815|50624879|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
24970193|NCT00113516|50059711|FG000|Part 1|Withdrawal by Subject|2|||
25309476|NCT01023815|50624880|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
25309477|NCT01023815|50624881|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
25309478|NCT01023815|50624882|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
25309479|NCT01023815|50624879|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
25309480|NCT01023815|50624880|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
25309481|NCT01023815|50624881|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
25309482|NCT01023815|50624882|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
25309483|NCT01023815|50624879|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
25309484|NCT01023815|50624880|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
25309485|NCT01023815|50624881|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
25309486|NCT01023815|50624882|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
25309487|NCT01023659|50624896|FG000|Overall Study|Lost to Follow-up|73|||
25309488|NCT01023659|50624897|FG001|Overall Study|Lost to Follow-up|228|||
25309489|NCT01023659|50624898|FG002|Overall Study|Lost to Follow-up|99|||
25309490|NCT00740116|50624909|FG000|Overall Study|Withdrawal by Subject|1|||
25309491|NCT00740116|50624910|FG001|Overall Study|Withdrawal by Subject|1|||
25309492|NCT00740116|50624909|FG000|Overall Study|Protocol Violation|1|||
25309493|NCT00740116|50624910|FG001|Overall Study|Protocol Violation|4|||
25309494|NCT00698581|50624920|FG000|Overall Study|Lack of Efficacy|23|||
25309495|NCT00698581|50624921|FG001|Overall Study|Lack of Efficacy|11|||
25309496|NCT00698581|50624920|FG000|Overall Study|Withdrawal by Subject|6|||
25309497|NCT00698581|50624921|FG001|Overall Study|Withdrawal by Subject|0|||
25309498|NCT00698581|50624920|FG000|Overall Study|Other reason|9|||
25309499|NCT00698581|50624921|FG001|Overall Study|Other reason|1|||
25309500|NCT00698581|50624920|FG000|Overall Study|SAE, non-fatal|1|||
25309501|NCT00698581|50624921|FG001|Overall Study|SAE, non-fatal|0|||
25309502|NCT00698581|50624920|FG000|Overall Study|AE, non-serious non-fatal|4|||
25309503|NCT00698581|50624921|FG001|Overall Study|AE, non-serious non-fatal|0|||
25309504|NCT00698581|50624920|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
25309505|NCT00698581|50624921|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
25309506|NCT00698581|50624920|FG000|Overall Study|AE of unknown type|1|||
25309507|NCT00698581|50624921|FG001|Overall Study|AE of unknown type|0|||
25309508|NCT01023581|50624935|FG000|Overall Study|Adverse Event|4|||
25309509|NCT01023581|50624936|FG001|Overall Study|Adverse Event|4|||
25309510|NCT01023581|50624937|FG002|Overall Study|Adverse Event|7|||
25309511|NCT01023581|50624938|FG003|Overall Study|Adverse Event|3|||
25309512|NCT01023581|50624939|FG004|Overall Study|Adverse Event|2|||
25309513|NCT01023581|50624940|FG005|Overall Study|Adverse Event|5|||
25309514|NCT01023581|50624941|FG006|Overall Study|Adverse Event|11|||
25309515|NCT01023581|50624935|FG000|Overall Study|Major protocol deviation|2|||
25309516|NCT01023581|50624936|FG001|Overall Study|Major protocol deviation|0|||
25309517|NCT01023581|50624937|FG002|Overall Study|Major protocol deviation|3|||
25309518|NCT01023581|50624938|FG003|Overall Study|Major protocol deviation|0|||
25309519|NCT01023581|50624939|FG004|Overall Study|Major protocol deviation|0|||
25309520|NCT01023581|50624940|FG005|Overall Study|Major protocol deviation|0|||
25309521|NCT01023581|50624941|FG006|Overall Study|Major protocol deviation|0|||
25309522|NCT01023581|50624935|FG000|Overall Study|Lost to Follow-up|4|||
25309523|NCT01023581|50624936|FG001|Overall Study|Lost to Follow-up|8|||
25309524|NCT01023581|50624937|FG002|Overall Study|Lost to Follow-up|7|||
25309525|NCT01023581|50624938|FG003|Overall Study|Lost to Follow-up|2|||
25309526|NCT01023581|50624939|FG004|Overall Study|Lost to Follow-up|5|||
25309527|NCT01023581|50624940|FG005|Overall Study|Lost to Follow-up|2|||
25309528|NCT01023581|50624941|FG006|Overall Study|Lost to Follow-up|2|||
25309529|NCT01023581|50624935|FG000|Overall Study|Withdrawal by Subject|13|||
25309530|NCT01023581|50624936|FG001|Overall Study|Withdrawal by Subject|8|||
25309531|NCT01023581|50624937|FG002|Overall Study|Withdrawal by Subject|16|||
25309532|NCT01023581|50624938|FG003|Overall Study|Withdrawal by Subject|10|||
25309533|NCT01023581|50624939|FG004|Overall Study|Withdrawal by Subject|6|||
25309534|NCT01023581|50624940|FG005|Overall Study|Withdrawal by Subject|8|||
25309535|NCT01023581|50624941|FG006|Overall Study|Withdrawal by Subject|5|||
25309536|NCT01023581|50624935|FG000|Overall Study|Pregnancy|0|||
25309537|NCT01023581|50624936|FG001|Overall Study|Pregnancy|0|||
25309538|NCT01023581|50624937|FG002|Overall Study|Pregnancy|0|||
25309539|NCT01023581|50624938|FG003|Overall Study|Pregnancy|2|||
25309540|NCT01023581|50624939|FG004|Overall Study|Pregnancy|0|||
25309541|NCT01023581|50624940|FG005|Overall Study|Pregnancy|1|||
25309542|NCT01023581|50624941|FG006|Overall Study|Pregnancy|0|||
25309543|NCT01023581|50624935|FG000|Overall Study|Lack of Efficacy|9|||
25309544|NCT01023581|50624936|FG001|Overall Study|Lack of Efficacy|3|||
25309545|NCT01023581|50624937|FG002|Overall Study|Lack of Efficacy|6|||
25309546|NCT01023581|50624938|FG003|Overall Study|Lack of Efficacy|2|||
25309547|NCT01023581|50624939|FG004|Overall Study|Lack of Efficacy|1|||
25309548|NCT01023581|50624940|FG005|Overall Study|Lack of Efficacy|2|||
25309549|NCT01023581|50624941|FG006|Overall Study|Lack of Efficacy|1|||
25309550|NCT01023581|50624935|FG000|Overall Study|Physician Decision|2|||
25309551|NCT01023581|50624936|FG001|Overall Study|Physician Decision|0|||
25309552|NCT01023581|50624937|FG002|Overall Study|Physician Decision|2|||
25309553|NCT01023581|50624938|FG003|Overall Study|Physician Decision|1|||
25309554|NCT01023581|50624939|FG004|Overall Study|Physician Decision|1|||
25309555|NCT01023581|50624940|FG005|Overall Study|Physician Decision|1|||
25309556|NCT01023581|50624941|FG006|Overall Study|Physician Decision|1|||
25309557|NCT01023581|50624935|FG000|Overall Study|Other|1|||
25309558|NCT01023581|50624936|FG001|Overall Study|Other|0|||
25309559|NCT01023581|50624937|FG002|Overall Study|Other|1|||
25309560|NCT01023581|50624938|FG003|Overall Study|Other|0|||
25309561|NCT01023581|50624939|FG004|Overall Study|Other|1|||
25309562|NCT01023581|50624940|FG005|Overall Study|Other|0|||
25309563|NCT01023581|50624941|FG006|Overall Study|Other|0|||
25309564|NCT00962780|50624959|FG000|Overall Study|Death|0|||
25309565|NCT00962780|50624960|FG001|Overall Study|Death|1|||
25309566|NCT00962780|50624959|FG000|Overall Study|Protocol Violation|9|||
25309567|NCT00962780|50624960|FG001|Overall Study|Protocol Violation|4|||
25309568|NCT00962780|50624959|FG000|Overall Study|Withdrawal by Subject|1|||
25309569|NCT00962780|50624960|FG001|Overall Study|Withdrawal by Subject|8|||
25309570|NCT00962780|50624959|FG000|Overall Study|Other|0|||
25309571|NCT00962780|50624960|FG001|Overall Study|Other|1|||
25309572|NCT00739882|50624974|FG000|Double-blind Period|Adverse Event|1|||
25309573|NCT00739882|50624975|FG001|Double-blind Period|Adverse Event|2|||
25309574|NCT00739882|50624974|FG000|Double-blind Period|Protocol Violation|1|||
25309575|NCT00739882|50624975|FG001|Double-blind Period|Protocol Violation|0|||
25309576|NCT00739882|50624974|FG000|Double-blind Period|Lack of Efficacy|1|||
25309577|NCT00739882|50624975|FG001|Double-blind Period|Lack of Efficacy|1|||
25309578|NCT00739882|50624974|FG000|Double-blind Period|Other|16|||
25309579|NCT00739882|50624975|FG001|Double-blind Period|Other|8|||
25309580|NCT00739882|50624974|FG000|Open-label Period|Adverse Event|1|||
25309581|NCT00739882|50624975|FG001|Open-label Period|Adverse Event|0|||
25309582|NCT00739882|50624974|FG000|Open-label Period|Other|9|||
25309583|NCT00739882|50624975|FG001|Open-label Period|Other|5|||
25309584|NCT00961220|50624983|FG000|Overall Study|Adverse Event|3|||
25309585|NCT00961220|50624983|FG000|Overall Study|Lack of Efficacy|1|||
25309586|NCT00961220|50624983|FG000|Overall Study|No IV access for O6BG|1|||
25309587|NCT00961220|50624983|FG000|Overall Study|O6BG no longer supplied|1|||
25309588|NCT00961220|50624983|FG000|Overall Study|Complete Response prior to 12 courses|1|||
25309589|NCT00734656|50624989|FG000|Lab Session 1|Withdrawal by Subject|2|||
25309590|NCT00734656|50624990|FG001|Lab Session 1|Withdrawal by Subject|0|||
25309591|NCT00734656|50624991|FG002|Lab Session 1|Withdrawal by Subject|0|||
25309592|NCT00734656|50624992|FG003|Lab Session 1|Withdrawal by Subject|0|||
25309593|NCT00734656|50624989|FG000|Washout 1|Withdrawal by Subject|1|||
25309594|NCT00734656|50624990|FG001|Washout 1|Withdrawal by Subject|5|||
25309595|NCT00734656|50624991|FG002|Washout 1|Withdrawal by Subject|2|||
25309596|NCT00734656|50624992|FG003|Washout 1|Withdrawal by Subject|3|||
25309597|NCT00734656|50624989|FG000|Lab Session 2|Withdrawal by Subject|1|||
25309598|NCT00734656|50624990|FG001|Lab Session 2|Withdrawal by Subject|0|||
25309599|NCT00734656|50624991|FG002|Lab Session 2|Withdrawal by Subject|0|||
25309600|NCT00734656|50624992|FG003|Lab Session 2|Withdrawal by Subject|1|||
25309601|NCT00734656|50624989|FG000|Washout 2|Withdrawal by Subject|1|||
25309602|NCT00734656|50624990|FG001|Washout 2|Withdrawal by Subject|1|||
25309603|NCT00734656|50624991|FG002|Washout 2|Withdrawal by Subject|1|||
25309604|NCT00734656|50624992|FG003|Washout 2|Withdrawal by Subject|0|||
25309605|NCT00734656|50624989|FG000|Washout 3|Withdrawal by Subject|1|||
25309606|NCT00734656|50624990|FG001|Washout 3|Withdrawal by Subject|0|||
25309607|NCT00734656|50624991|FG002|Washout 3|Withdrawal by Subject|0|||
25309608|NCT00734656|50624992|FG003|Washout 3|Withdrawal by Subject|1|||
25309609|NCT00734656|50624989|FG000|Lab Session 4|Withdrawal by Subject|0|||
25309610|NCT00734656|50624990|FG001|Lab Session 4|Withdrawal by Subject|0|||
25309611|NCT00734656|50624991|FG002|Lab Session 4|Withdrawal by Subject|0|||
25309612|NCT00734656|50624992|FG003|Lab Session 4|Withdrawal by Subject|1|||
25309613|NCT00961064|50625002|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
25309614|NCT00961064|50625002|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
25309615|NCT00961064|50625002|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
25309616|NCT00961064|50625002|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
25309617|NCT00961064|50625002|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
25309618|NCT00961064|50625002|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
25309619|NCT00961064|50625002|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
25309620|NCT00961064|50625002|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
25309621|NCT00739648|50625009|FG000|Overall Study|Adverse Event|3|||
25309622|NCT00739648|50625010|FG001|Overall Study|Adverse Event|15|||
25309623|NCT00739648|50625009|FG000|Overall Study|Withdrawal by Subject|13|||
25309624|NCT00739648|50625010|FG001|Overall Study|Withdrawal by Subject|25|||
25309625|NCT00739648|50625009|FG000|Overall Study|Lost to Follow-up|4|||
25309626|NCT00739648|50625010|FG001|Overall Study|Lost to Follow-up|7|||
25309627|NCT00739648|50625009|FG000|Overall Study|Death|2|||
25309628|NCT00739648|50625010|FG001|Overall Study|Death|0|||
25309629|NCT00739648|50625009|FG000|Overall Study|Do not know|4|||
25309630|NCT00739648|50625010|FG001|Overall Study|Do not know|6|||
25309631|NCT01032239|50625022|FG000|Overall Study|Lost to Follow-up|3|||
25309632|NCT01032239|50625023|FG001|Overall Study|Lost to Follow-up|2|||
25309633|NCT01032239|50625022|FG000|Overall Study|Withdrawal by Subject|2|||
25309634|NCT01032239|50625023|FG001|Overall Study|Withdrawal by Subject|3|||
25309635|NCT01032239|50625022|FG000|Overall Study|Death|1|||
25309636|NCT01032239|50625023|FG001|Overall Study|Death|0|||
25309637|NCT01032239|50625022|FG000|Overall Study|Protocol Violation|1|||
25309638|NCT01032239|50625023|FG001|Overall Study|Protocol Violation|0|||
25309639|NCT00734578|50625032|FG000|Overall Study|Adverse Event|4|||
25309640|NCT00734578|50625033|FG001|Overall Study|Adverse Event|6|||
25309641|NCT00734578|50625034|FG002|Overall Study|Adverse Event|1|||
25309642|NCT00734578|50625032|FG000|Overall Study|Protocol Violation|8|||
25309643|NCT00734578|50625033|FG001|Overall Study|Protocol Violation|6|||
25309644|NCT00734578|50625034|FG002|Overall Study|Protocol Violation|3|||
25309645|NCT00734578|50625032|FG000|Overall Study|Withdrawal by Subject|7|||
25309646|NCT00734578|50625033|FG001|Overall Study|Withdrawal by Subject|8|||
25309647|NCT00734578|50625034|FG002|Overall Study|Withdrawal by Subject|11|||
25309648|NCT00734578|50625032|FG000|Overall Study|Lost to Follow-up|9|||
25309649|NCT00734578|50625033|FG001|Overall Study|Lost to Follow-up|3|||
25309650|NCT00734578|50625034|FG002|Overall Study|Lost to Follow-up|5|||
25309651|NCT00734578|50625032|FG000|Overall Study|Lack of Efficacy|3|||
25309652|NCT00734578|50625033|FG001|Overall Study|Lack of Efficacy|2|||
25309653|NCT00734578|50625034|FG002|Overall Study|Lack of Efficacy|5|||
25309654|NCT00734578|50625032|FG000|Overall Study|Randomized in error|1|||
25309655|NCT00734578|50625033|FG001|Overall Study|Randomized in error|0|||
25309656|NCT00734578|50625034|FG002|Overall Study|Randomized in error|0|||
25309657|NCT00734578|50625032|FG000|Overall Study|Exclusion criteria|1|||
25309658|NCT00734578|50625033|FG001|Overall Study|Exclusion criteria|0|||
25309659|NCT00734578|50625034|FG002|Overall Study|Exclusion criteria|0|||
25309660|NCT00739102|50625042|FG000|Overall Study|Death|5|||
25309661|NCT00739102|50625042|FG000|Overall Study|Withdrawal by Subject|10|||
25309662|NCT00959192|50625050|FG000|Overall Study|Adverse Event|1|||
25309663|NCT00959192|50625051|FG001|Overall Study|Adverse Event|1|||
25309664|NCT00959192|50625052|FG002|Overall Study|Adverse Event|1|||
25309665|NCT00959192|50625053|FG003|Overall Study|Adverse Event|0|||
25309666|NCT00959192|50625050|FG000|Overall Study|Investigator Request|1|||
25309667|NCT00959192|50625051|FG001|Overall Study|Investigator Request|0|||
25309668|NCT00959192|50625052|FG002|Overall Study|Investigator Request|0|||
25309669|NCT00959192|50625053|FG003|Overall Study|Investigator Request|0|||
25309670|NCT00959192|50625050|FG000|Overall Study|Caregiver Request|0|||
25309671|NCT00959192|50625051|FG001|Overall Study|Caregiver Request|0|||
25309672|NCT00959192|50625052|FG002|Overall Study|Caregiver Request|2|||
25309673|NCT00959192|50625053|FG003|Overall Study|Caregiver Request|1|||
25309674|NCT00696787|50625067|FG000|Overall Study|Adverse Event|1|||
25309675|NCT00696787|50625068|FG001|Overall Study|Adverse Event|0|||
25309676|NCT00696787|50625069|FG002|Overall Study|Adverse Event|6|||
25309677|NCT00696787|50625067|FG000|Overall Study|Discontinuation by Sponsor|9|||
25309678|NCT00696787|50625068|FG001|Overall Study|Discontinuation by Sponsor|13|||
25309679|NCT00696787|50625069|FG002|Overall Study|Discontinuation by Sponsor|14|||
25309680|NCT00696787|50625067|FG000|Overall Study|Lack of Efficacy|0|||
25309681|NCT00696787|50625068|FG001|Overall Study|Lack of Efficacy|1|||
25309682|NCT00696787|50625069|FG002|Overall Study|Lack of Efficacy|0|||
25309683|NCT00696787|50625067|FG000|Overall Study|Lost to Follow-up|4|||
25309684|NCT00696787|50625068|FG001|Overall Study|Lost to Follow-up|0|||
25309685|NCT00696787|50625069|FG002|Overall Study|Lost to Follow-up|3|||
25309686|NCT00696787|50625067|FG000|Overall Study|Withdrawal by Subject|0|||
25309687|NCT00696787|50625068|FG001|Overall Study|Withdrawal by Subject|3|||
25309688|NCT00696787|50625069|FG002|Overall Study|Withdrawal by Subject|2|||
25309689|NCT00696787|50625067|FG000|Overall Study|Failed to return|1|||
25309690|NCT00696787|50625068|FG001|Overall Study|Failed to return|3|||
25309691|NCT00696787|50625069|FG002|Overall Study|Failed to return|1|||
25309692|NCT01012037|50625080|FG000|Overall Study|Adverse Event|0|||
25309693|NCT01012037|50625081|FG001|Overall Study|Adverse Event|8|||
25309694|NCT01012037|50625082|FG002|Overall Study|Adverse Event|3|||
25309695|NCT01012037|50625080|FG000|Overall Study|Protocol Violation|0|||
25309696|NCT01012037|50625081|FG001|Overall Study|Protocol Violation|3|||
25309697|NCT01012037|50625082|FG002|Overall Study|Protocol Violation|5|||
25309698|NCT01012037|50625080|FG000|Overall Study|Withdrawal by Subject|0|||
25309699|NCT01012037|50625081|FG001|Overall Study|Withdrawal by Subject|4|||
25309700|NCT01012037|50625082|FG002|Overall Study|Withdrawal by Subject|1|||
25309701|NCT01012037|50625080|FG000|Overall Study|Other reason (not specified)|1|||
25309702|NCT01012037|50625081|FG001|Overall Study|Other reason (not specified)|1|||
25309703|NCT01012037|50625082|FG002|Overall Study|Other reason (not specified)|1|||
25309704|NCT00734032|50625094|FG000|Overall Study|Adverse Event|0|||
25309705|NCT00734032|50625095|FG001|Overall Study|Adverse Event|1|||
25309706|NCT00734032|50625096|FG002|Overall Study|Adverse Event|0|||
25309707|NCT00734032|50625097|FG003|Overall Study|Adverse Event|0|||
25309708|NCT01010633|50625109|FG000|Overall Study|Adverse Event|1|||
25309709|NCT01010633|50625110|FG001|Overall Study|Adverse Event|1|||
25309710|NCT01010633|50625109|FG000|Overall Study|Protocol Violation|1|||
25309711|NCT01010633|50625110|FG001|Overall Study|Protocol Violation|2|||
25309712|NCT01010633|50625109|FG000|Overall Study|Withdrawal by Subject|2|||
25309713|NCT01010633|50625110|FG001|Overall Study|Withdrawal by Subject|1|||
25309714|NCT01010633|50625109|FG000|Overall Study|Investigator decision|0|||
25309715|NCT01010633|50625110|FG001|Overall Study|Investigator decision|1|||
25309716|NCT00733954|50625118|FG000|Overall Study|Lost to Follow-up|5|||
25309717|NCT00733954|50625119|FG001|Overall Study|Lost to Follow-up|2|||
25309718|NCT00733954|50625118|FG000|Overall Study|Protocol Violation|1|||
25309719|NCT00733954|50625119|FG001|Overall Study|Protocol Violation|0|||
25309720|NCT00733954|50625118|FG000|Overall Study|Withdrawal by Subject|2|||
25309721|NCT00733954|50625119|FG001|Overall Study|Withdrawal by Subject|0|||
25309722|NCT00733408|50625125|FG000|Overall Study|Adverse Event|4|||
25309723|NCT01010867|50625129|FG000|Overall Study|< 50% adherence to probiotic|1|||
25309724|NCT00576823|50625136|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
25309725|NCT00576823|50625137|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
25309726|NCT00576823|50625138|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
25309727|NCT00576823|50625136|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
25309728|NCT00576823|50625137|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
25309729|NCT00576823|50625138|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
25309730|NCT00732940|50625151|FG000|Overall Study|Withdrawal by Subject|1|||
25309731|NCT00732940|50625152|FG001|Overall Study|Withdrawal by Subject|2|||
25309732|NCT00732940|50625151|FG000|Overall Study|Adverse Event|0|||
25309733|NCT00732940|50625152|FG001|Overall Study|Adverse Event|1|||
25309734|NCT00732940|50625151|FG000|Overall Study|Lost to Follow-up|1|||
25309735|NCT00732940|50625152|FG001|Overall Study|Lost to Follow-up|0|||
25309736|NCT00962390|50625162|FG000|Overall Study|Adverse Event|0|||
25309737|NCT00962390|50625163|FG001|Overall Study|Adverse Event|0|||
25309738|NCT00962390|50625164|FG002|Overall Study|Adverse Event|3|||
25309739|NCT00962390|50625165|FG003|Overall Study|Adverse Event|1|||
25309740|NCT00962390|50625162|FG000|Overall Study|Lost to Follow-up|2|||
25309741|NCT00962390|50625163|FG001|Overall Study|Lost to Follow-up|2|||
25309742|NCT00962390|50625164|FG002|Overall Study|Lost to Follow-up|0|||
25309743|NCT00962390|50625165|FG003|Overall Study|Lost to Follow-up|0|||
25309744|NCT00962390|50625162|FG000|Overall Study|Protocol Violation|1|||
25309745|NCT00962390|50625163|FG001|Overall Study|Protocol Violation|0|||
25309746|NCT00962390|50625164|FG002|Overall Study|Protocol Violation|0|||
25309747|NCT00962390|50625165|FG003|Overall Study|Protocol Violation|0|||
25309748|NCT00962390|50625162|FG000|Overall Study|Withdrawal by Subject|1|||
25309749|NCT00962390|50625163|FG001|Overall Study|Withdrawal by Subject|1|||
25309750|NCT00962390|50625164|FG002|Overall Study|Withdrawal by Subject|1|||
25309751|NCT00962390|50625165|FG003|Overall Study|Withdrawal by Subject|0|||
25309752|NCT00732472|50625179|FG000|Overall Study|Adverse Event|0|||
25309753|NCT00732472|50625180|FG001|Overall Study|Adverse Event|1|||
25309754|NCT00732472|50625181|FG002|Overall Study|Adverse Event|1|||
25309755|NCT00732472|50625182|FG003|Overall Study|Adverse Event|1|||
25309756|NCT00732472|50625179|FG000|Overall Study|Protocol Violation|0|||
25309757|NCT00732472|50625180|FG001|Overall Study|Protocol Violation|0|||
25309758|NCT00732472|50625181|FG002|Overall Study|Protocol Violation|0|||
25309759|NCT00732472|50625182|FG003|Overall Study|Protocol Violation|1|||
25309760|NCT00732472|50625179|FG000|Overall Study|Withdrawal by Subject|0|||
25309761|NCT00732472|50625180|FG001|Overall Study|Withdrawal by Subject|2|||
25309762|NCT00732472|50625181|FG002|Overall Study|Withdrawal by Subject|0|||
25309763|NCT00732472|50625182|FG003|Overall Study|Withdrawal by Subject|1|||
25309764|NCT00960986|50625197|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
25309765|NCT00960986|50625198|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
25309766|NCT00960986|50625199|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
25309767|NCT00960986|50625200|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
25309768|NCT00960986|50625197|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
25309769|NCT00960986|50625198|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
25309770|NCT00960986|50625199|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
25309771|NCT00960986|50625200|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
25309772|NCT00960986|50625197|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
25309773|NCT00960986|50625198|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
24970194|NCT00113516|50059712|FG001|Part 1|Withdrawal by Subject|0|||
25309774|NCT00960986|50625199|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
25309775|NCT00960986|50625200|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
25309776|NCT00960986|50625197|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
25309777|NCT00960986|50625198|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
25309778|NCT00960986|50625199|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
25309779|NCT00960986|50625200|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
25309780|NCT00960986|50625197|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
25309781|NCT00960986|50625198|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
25309782|NCT00960986|50625199|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
25309783|NCT00960986|50625200|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
25309784|NCT00960986|50625197|FG000|Period 3 (7-week Therapy Period)|Death|0|||
25309785|NCT00960986|50625198|FG001|Period 3 (7-week Therapy Period)|Death|0|||
25309786|NCT00960986|50625199|FG002|Period 3 (7-week Therapy Period)|Death|1|||
25309787|NCT00960986|50625200|FG003|Period 3 (7-week Therapy Period)|Death|0|||
25309788|NCT00960986|50625197|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
25309789|NCT00960986|50625198|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
25309790|NCT00960986|50625199|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
25309791|NCT00960986|50625200|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
25309792|NCT00960986|50625197|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
25309793|NCT00960986|50625198|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
25309794|NCT00960986|50625199|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
25309795|NCT00960986|50625200|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
25309796|NCT00960986|50625197|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
25309797|NCT00960986|50625198|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
25309798|NCT00960986|50625199|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
25309799|NCT00960986|50625200|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
25309800|NCT00960986|50625197|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
25309801|NCT00960986|50625198|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
25309802|NCT00960986|50625199|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
25309803|NCT00960986|50625200|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
25309804|NCT00732238|50625212|FG000|Overall Study|Bacteremia|4|||
25309805|NCT00732238|50625213|FG001|Overall Study|Bacteremia|1|||
25309806|NCT00732238|50625212|FG000|Overall Study|Asymptomatic bacteriuria|1|||
25309807|NCT00732238|50625213|FG001|Overall Study|Asymptomatic bacteriuria|0|||
25309808|NCT00958880|50625223|FG000|Overall Study|Lost to Follow-up|2|||
25309809|NCT00958880|50625224|FG001|Overall Study|Lost to Follow-up|2|||
25309810|NCT00732160|50625234|FG000|Overall Study|Adverse Event|1|||
25309811|NCT00732160|50625235|FG001|Overall Study|Adverse Event|0|||
25309812|NCT00732160|50625236|FG002|Overall Study|Adverse Event|1|||
25309813|NCT00732160|50625237|FG003|Overall Study|Adverse Event|1|||
25309814|NCT00732160|50625234|FG000|Overall Study|scheduling|4|||
25309815|NCT00732160|50625235|FG001|Overall Study|scheduling|4|||
25309816|NCT00732160|50625236|FG002|Overall Study|scheduling|2|||
25309817|NCT00732160|50625237|FG003|Overall Study|scheduling|1|||
25309818|NCT00958724|50625247|FG000|Overall Study|Disease Progression|6|||
25309819|NCT00738400|50625253|FG000|Overall Study|Adverse Event|3|||
25309820|NCT00738400|50625254|FG001|Overall Study|Adverse Event|1|||
25309821|NCT00738400|50625253|FG000|Overall Study|Withdrawal by Subject|0|||
25309822|NCT00738400|50625254|FG001|Overall Study|Withdrawal by Subject|1|||
25309823|NCT00738400|50625253|FG000|Overall Study|Lack of Efficacy|0|||
25309824|NCT00738400|50625254|FG001|Overall Study|Lack of Efficacy|1|||
25309825|NCT00738400|50625253|FG000|Overall Study|Lost to Follow-up|0|||
25309826|NCT00738400|50625254|FG001|Overall Study|Lost to Follow-up|3|||
25309827|NCT00738400|50625253|FG000|Overall Study|Protocol Violation|1|||
25309828|NCT00738400|50625254|FG001|Overall Study|Protocol Violation|0|||
25309829|NCT00738400|50625253|FG000|Overall Study|Non-compliant with study medication|0|||
25309830|NCT00738400|50625254|FG001|Overall Study|Non-compliant with study medication|1|||
25309831|NCT01009463|50625264|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
25309832|NCT01009463|50625265|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
25309833|NCT01009463|50625266|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
25309834|NCT01009463|50625267|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
25309835|NCT01009463|50625268|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
25309836|NCT01009463|50625264|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
25309837|NCT01009463|50625265|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
25309838|NCT01009463|50625266|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
25309839|NCT01009463|50625267|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
25309840|NCT01009463|50625268|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
25309841|NCT01009463|50625264|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
25192199|NCT01465802|50357378|FG001|Overall Study|Lost to Follow-up|1|||
25192200|NCT01465802|50357379|FG002|Overall Study|Lost to Follow-up|0|||
25192201|NCT01465802|50357380|FG003|Overall Study|Lost to Follow-up|0|||
25309842|NCT01009463|50625265|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
25309843|NCT01009463|50625266|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
25309844|NCT01009463|50625267|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
25192202|NCT01465802|50357381|FG004|Overall Study|Lost to Follow-up|0|||
25192203|NCT01465802|50357377|FG000|Overall Study|Reason not specified|9|||
25309845|NCT01009463|50625268|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
25309846|NCT01009463|50625264|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
25309847|NCT01009463|50625265|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
25309848|NCT01009463|50625266|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
25309849|NCT01009463|50625267|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
25309850|NCT01009463|50625268|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
25309851|NCT01009463|50625264|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
25309852|NCT01009463|50625265|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
25309853|NCT01009463|50625266|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
25309854|NCT01009463|50625267|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
25309855|NCT01009463|50625268|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
25309856|NCT01009463|50625264|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
25309857|NCT01009463|50625265|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
25309858|NCT01009463|50625266|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
25309859|NCT01009463|50625267|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
25309860|NCT01009463|50625268|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
25309861|NCT01009463|50625264|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
25309862|NCT01009463|50625265|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
25309863|NCT01009463|50625266|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
25309864|NCT01009463|50625267|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
24970195|NCT00113516|50059711|FG000|Part 1|Lack of Efficacy|2|||
24970196|NCT00113516|50059712|FG001|Part 1|Lack of Efficacy|0|||
24970197|NCT00113516|50059711|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
24970198|NCT00113516|50059712|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
25071363|NCT04424641|50177498|FG007|Overall Study|Other|0|||
25071364|NCT02755831|50177518|FG000|Overall Study|Lost to Follow-up|3|||
25071365|NCT02755831|50177519|FG001|Overall Study|Lost to Follow-up|3|||
25071366|NCT02573246|50177530|FG000|Overall Study|Lost to Follow-up|2|||
25071367|NCT02573246|50177531|FG001|Overall Study|Lost to Follow-up|0|||
25071368|NCT02573246|50177532|FG002|Overall Study|Lost to Follow-up|0|||
25071369|NCT02573246|50177533|FG003|Overall Study|Lost to Follow-up|0|||
25071370|NCT02573246|50177534|FG004|Overall Study|Lost to Follow-up|1|||
25071371|NCT02573246|50177530|FG000|Overall Study|Withdrawal by Subject|0|||
25071372|NCT02573246|50177531|FG001|Overall Study|Withdrawal by Subject|0|||
25071373|NCT02573246|50177532|FG002|Overall Study|Withdrawal by Subject|0|||
25071374|NCT02573246|50177533|FG003|Overall Study|Withdrawal by Subject|0|||
25071375|NCT02573246|50177534|FG004|Overall Study|Withdrawal by Subject|1|||
25071376|NCT02573246|50177530|FG000|Overall Study|Physician Decision|1|||
25071377|NCT02573246|50177531|FG001|Overall Study|Physician Decision|1|||
25071378|NCT02573246|50177532|FG002|Overall Study|Physician Decision|3|||
25071379|NCT02573246|50177533|FG003|Overall Study|Physician Decision|2|||
25071380|NCT02573246|50177534|FG004|Overall Study|Physician Decision|2|||
25071381|NCT02570750|50177553|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
25071382|NCT02570750|50177554|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
25071383|NCT02570750|50177553|FG000|Overall Study|Protocol deviation|4|||
24970199|NCT00113516|50059711|FG000|Part 1|Laboratory Abnormality|1|||
24970200|NCT00113516|50059712|FG001|Part 1|Laboratory Abnormality|0|||
24970201|NCT00113516|50059711|FG000|Part 1|Ongoing|1|||
24970202|NCT00113516|50059712|FG001|Part 1|Ongoing|0|||
24970203|NCT00113516|50059711|FG000|Part 1|Missing|65|||
24970204|NCT00113516|50059712|FG001|Part 1|Missing|0|||
24970205|NCT00113516|50059711|FG000|Part 2|Adverse Event|0|||
24970206|NCT00113516|50059712|FG001|Part 2|Adverse Event|16|||
24970207|NCT00113516|50059711|FG000|Part 2|Death|0|||
24970208|NCT00113516|50059712|FG001|Part 2|Death|5|||
24970209|NCT00113516|50059711|FG000|Part 2|Lack of Efficacy|0|||
24970210|NCT00113516|50059712|FG001|Part 2|Lack of Efficacy|37|||
24970211|NCT00113516|50059711|FG000|Part 2|Withdrawal by Subject|0|||
24970212|NCT00113516|50059712|FG001|Part 2|Withdrawal by Subject|3|||
24970213|NCT00113516|50059711|FG000|Part 2|Other|0|||
24970214|NCT00113516|50059712|FG001|Part 2|Other|3|||
24970215|NCT00113516|50059711|FG000|Part 2|Laboratory Abnormality|0|||
24970216|NCT00113516|50059712|FG001|Part 2|Laboratory Abnormality|1|||
24970217|NCT00113516|50059711|FG000|Part 2|Ongoing|0|||
25071384|NCT02570750|50177554|FG001|Overall Study|Protocol deviation|2|||
25071385|NCT02570750|50177553|FG000|Overall Study|Withdrawal by Subject|5|||
25071386|NCT02570750|50177554|FG001|Overall Study|Withdrawal by Subject|0|||
25309865|NCT01009463|50625268|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
25309866|NCT01009463|50625264|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
25309867|NCT01009463|50625265|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
25309868|NCT01009463|50625266|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
25309869|NCT01009463|50625267|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
25309870|NCT01009463|50625268|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
25309871|NCT01009463|50625264|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
25309872|NCT01009463|50625265|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
25309873|NCT01009463|50625266|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
25309874|NCT01009463|50625267|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
25309875|NCT01009463|50625268|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
25309876|NCT01009463|50625264|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
25309877|NCT01009463|50625265|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
25309878|NCT01009463|50625266|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
25309879|NCT01009463|50625267|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
25309880|NCT01009463|50625268|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
25309881|NCT01009463|50625264|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
25309882|NCT01009463|50625265|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
25309883|NCT01009463|50625266|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
25309884|NCT01009463|50625267|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
25309885|NCT01009463|50625268|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
25309886|NCT01009463|50625264|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
25309887|NCT01009463|50625265|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
25309888|NCT01009463|50625266|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
25309889|NCT01009463|50625267|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
25309890|NCT01009463|50625268|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
25309891|NCT01009463|50625264|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
25309892|NCT01009463|50625265|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
25309893|NCT01009463|50625266|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
25309894|NCT01009463|50625267|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
25309895|NCT01009463|50625268|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
25309896|NCT00958568|50625279|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
25309897|NCT00958568|50625280|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
25309898|NCT00958568|50625281|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
25309899|NCT00958568|50625282|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
25309900|NCT00958568|50625279|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
25309901|NCT00958568|50625280|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
25309902|NCT00958568|50625281|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
25309903|NCT00958568|50625282|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
25309904|NCT00958568|50625279|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
25309905|NCT00958568|50625280|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
25309906|NCT00958568|50625281|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
25309907|NCT00958568|50625282|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
25309908|NCT00958568|50625279|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
25309909|NCT00958568|50625280|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
25309910|NCT00958568|50625281|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
25309911|NCT00958568|50625282|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
25309912|NCT00958568|50625279|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
25309913|NCT00958568|50625280|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
25309914|NCT00958568|50625281|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
25309915|NCT00958568|50625282|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
25309916|NCT00958568|50625279|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
25309917|NCT00958568|50625280|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
25309918|NCT00958568|50625281|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
25309919|NCT00958568|50625282|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
25309920|NCT00958568|50625279|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
25309921|NCT00958568|50625280|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
25309922|NCT00958568|50625281|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
25309923|NCT00958568|50625282|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
25309924|NCT00958568|50625279|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
25309925|NCT00958568|50625280|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
25309926|NCT00958568|50625281|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
25309927|NCT00958568|50625282|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
25309928|NCT00958568|50625279|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
25309929|NCT00958568|50625280|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
25309930|NCT00958568|50625281|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
25309931|NCT00958568|50625282|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
25309932|NCT00958568|50625279|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
25309933|NCT00958568|50625280|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
25309934|NCT00958568|50625281|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
25309935|NCT00958568|50625282|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
25309936|NCT00958568|50625279|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
25309937|NCT00958568|50625280|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
25309938|NCT00958568|50625281|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
25309939|NCT00958568|50625282|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
25309940|NCT00958568|50625279|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
25309941|NCT00958568|50625280|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
25309942|NCT00958568|50625281|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
25309943|NCT00958568|50625282|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
25309944|NCT00958568|50625279|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
25309945|NCT00958568|50625280|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
25309946|NCT00958568|50625281|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
25309947|NCT00958568|50625282|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
25309948|NCT00958568|50625279|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
25309949|NCT00958568|50625280|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
25309950|NCT00958568|50625281|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
25309951|NCT00958568|50625282|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
25309952|NCT00958568|50625279|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
25309953|NCT00958568|50625280|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
25309954|NCT00958568|50625281|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
25309955|NCT00958568|50625282|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
25309956|NCT00958568|50625279|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
25309957|NCT00958568|50625280|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
25309958|NCT00958568|50625281|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
25309959|NCT00958568|50625282|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
25309960|NCT00958568|50625279|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
25309961|NCT00958568|50625280|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
25309962|NCT00958568|50625281|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
25309963|NCT00958568|50625282|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
25309964|NCT00958568|50625279|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
25309965|NCT00958568|50625280|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
25309966|NCT00958568|50625281|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
25309967|NCT00958568|50625282|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
25309968|NCT00958568|50625279|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
25309969|NCT00958568|50625280|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
25309970|NCT00958568|50625281|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
25309971|NCT00958568|50625282|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
25309972|NCT00958568|50625279|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
25309973|NCT00958568|50625280|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
25309974|NCT00958568|50625281|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
25309975|NCT00958568|50625282|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
25309976|NCT00958568|50625279|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
25309977|NCT00958568|50625280|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
25309978|NCT00958568|50625281|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
25309979|NCT00958568|50625282|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
25309980|NCT00958568|50625279|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
25309981|NCT00958568|50625280|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
25309982|NCT00958568|50625281|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
25309983|NCT00958568|50625282|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
25309984|NCT00958568|50625279|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
24970218|NCT00113516|50059712|FG001|Part 2|Ongoing|1|||
25071387|NCT02570750|50177553|FG000|Overall Study|Lost to Follow-up|2|||
25309985|NCT00958568|50625280|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
25309986|NCT00958568|50625281|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
25309987|NCT00958568|50625282|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
25309988|NCT00958568|50625279|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
25309989|NCT00958568|50625280|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
25309990|NCT00958568|50625281|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
25309991|NCT00958568|50625282|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
25309992|NCT00958568|50625279|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
25309993|NCT00958568|50625280|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
25309994|NCT00958568|50625281|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
25309995|NCT00958568|50625282|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
25309996|NCT00958568|50625279|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
25309997|NCT00958568|50625280|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
25309998|NCT00958568|50625281|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
25309999|NCT00958568|50625282|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
25310000|NCT00958568|50625279|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
25310001|NCT00958568|50625280|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
25310002|NCT00958568|50625281|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
25310003|NCT00958568|50625282|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
25310004|NCT00958568|50625279|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
25310005|NCT00958568|50625280|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
25310006|NCT00958568|50625281|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
25310007|NCT00958568|50625282|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
25310008|NCT00958568|50625279|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
25310009|NCT00958568|50625280|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
25310010|NCT00958568|50625281|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
25310011|NCT00958568|50625282|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
25310012|NCT00958412|50625293|FG000|Overall Study|Study prematurely terminated|18|||
25310013|NCT00958256|50625297|FG000|Overall Study|Adverse Event|3|||
25310014|NCT00696709|50625306|FG000|Overall Study|Withdrawal by Subject|1|||
25310015|NCT00696709|50625307|FG001|Overall Study|Withdrawal by Subject|2|||
25310016|NCT00696709|50625308|FG002|Overall Study|Withdrawal by Subject|1|||
25310017|NCT00696709|50625309|FG003|Overall Study|Withdrawal by Subject|4|||
25310018|NCT00696709|50625310|FG004|Overall Study|Withdrawal by Subject|3|||
25310019|NCT00696709|50625306|FG000|Overall Study|Protocol Violation|1|||
25310020|NCT00696709|50625307|FG001|Overall Study|Protocol Violation|0|||
25310021|NCT00696709|50625308|FG002|Overall Study|Protocol Violation|0|||
25310022|NCT00696709|50625309|FG003|Overall Study|Protocol Violation|0|||
25310023|NCT00696709|50625310|FG004|Overall Study|Protocol Violation|0|||
25310024|NCT00696709|50625306|FG000|Overall Study|Lost to Follow-up|1|||
25310025|NCT00696709|50625307|FG001|Overall Study|Lost to Follow-up|1|||
25310026|NCT00696709|50625308|FG002|Overall Study|Lost to Follow-up|0|||
25310027|NCT00696709|50625309|FG003|Overall Study|Lost to Follow-up|0|||
25192204|NCT01465802|50357378|FG001|Overall Study|Reason not specified|4|||
25310028|NCT00696709|50625310|FG004|Overall Study|Lost to Follow-up|0|||
25310029|NCT00696709|50625306|FG000|Overall Study|Adverse Event|0|||
25310030|NCT00696709|50625307|FG001|Overall Study|Adverse Event|0|||
25310031|NCT00696709|50625308|FG002|Overall Study|Adverse Event|0|||
25310032|NCT00696709|50625309|FG003|Overall Study|Adverse Event|1|||
25310033|NCT00696709|50625310|FG004|Overall Study|Adverse Event|0|||
25310034|NCT01006265|50625330|FG000|Overall Study|Lost to Follow-up|1|||
25310035|NCT01006265|50625331|FG001|Overall Study|Lost to Follow-up|0|||
25310036|NCT01006265|50625332|FG002|Overall Study|Lost to Follow-up|1|||
25310037|NCT01006265|50625333|FG003|Overall Study|Lost to Follow-up|0|||
25310038|NCT01006265|50625330|FG000|Overall Study|Withdrawal by Subject|4|||
25310039|NCT01006265|50625331|FG001|Overall Study|Withdrawal by Subject|7|||
25310040|NCT01006265|50625332|FG002|Overall Study|Withdrawal by Subject|5|||
25310041|NCT01006265|50625333|FG003|Overall Study|Withdrawal by Subject|5|||
25310042|NCT01006265|50625330|FG000|Overall Study|Administrative reason|1|||
25310043|NCT01006265|50625331|FG001|Overall Study|Administrative reason|2|||
25310044|NCT01006265|50625332|FG002|Overall Study|Administrative reason|3|||
25310045|NCT01006265|50625333|FG003|Overall Study|Administrative reason|0|||
25310046|NCT01008995|50625345|FG000|Controlled Period|Adverse Event|1|||
25310047|NCT01008995|50625346|FG001|Controlled Period|Adverse Event|2|||
25310048|NCT01008995|50625347|FG002|Controlled Period|Adverse Event|0|||
25310049|NCT01008995|50625348|FG003|Controlled Period|Adverse Event|0|||
25310050|NCT01008995|50625345|FG000|Controlled Period|Other|2|||
25310051|NCT01008995|50625346|FG001|Controlled Period|Other|1|||
25310052|NCT01008995|50625347|FG002|Controlled Period|Other|0|||
25310053|NCT01008995|50625348|FG003|Controlled Period|Other|0|||
25310054|NCT01008995|50625345|FG000|After Controlled Period|Adverse Event|0|||
25310055|NCT01008995|50625346|FG001|After Controlled Period|Adverse Event|0|||
25310056|NCT01008995|50625347|FG002|After Controlled Period|Adverse Event|1|||
25310057|NCT01008995|50625348|FG003|After Controlled Period|Adverse Event|1|||
25310058|NCT01008995|50625345|FG000|After Controlled Period|Other|0|||
25310059|NCT01008995|50625346|FG001|After Controlled Period|Other|0|||
25310060|NCT01008995|50625347|FG002|After Controlled Period|Other|1|||
25310061|NCT01008995|50625348|FG003|After Controlled Period|Other|0|||
25310062|NCT00957944|50625358|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
25310063|NCT00957944|50625359|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
25310064|NCT01005875|50625365|FG000|Overall Study|Death|3|||
25310065|NCT01005719|50625369|FG000|Period 1|Adverse Event|0|||
25310066|NCT01005719|50625370|FG001|Period 1|Adverse Event|0|||
25310067|NCT01005719|50625371|FG002|Period 1|Adverse Event|0|||
25310068|NCT01005719|50625372|FG003|Period 1|Adverse Event|1|||
25310069|NCT01005719|50625373|FG004|Period 1|Adverse Event|0|||
25310070|NCT01005719|50625374|FG005|Period 1|Adverse Event|0|||
25310071|NCT01005719|50625369|FG000|Period 1|Delay in completing study procedures|0|||
25310072|NCT01005719|50625370|FG001|Period 1|Delay in completing study procedures|0|||
25310073|NCT01005719|50625371|FG002|Period 1|Delay in completing study procedures|0|||
25310074|NCT01005719|50625372|FG003|Period 1|Delay in completing study procedures|0|||
25310075|NCT01005719|50625373|FG004|Period 1|Delay in completing study procedures|0|||
25310076|NCT01005719|50625374|FG005|Period 1|Delay in completing study procedures|1|||
25310077|NCT01005719|50625369|FG000|Period 2|Adverse Event|0|||
25310078|NCT01005719|50625370|FG001|Period 2|Adverse Event|0|||
25310079|NCT01005719|50625371|FG002|Period 2|Adverse Event|0|||
25310080|NCT01005719|50625372|FG003|Period 2|Adverse Event|0|||
25310081|NCT01005719|50625373|FG004|Period 2|Adverse Event|1|||
25310082|NCT01005719|50625374|FG005|Period 2|Adverse Event|1|||
25310083|NCT00953576|50625385|FG000|Overall Study|Adverse Event|0|||
25310084|NCT00953576|50625386|FG001|Overall Study|Adverse Event|1|||
25310085|NCT00953576|50625385|FG000|Overall Study|Ineligible after Consent|2|||
25310086|NCT00953576|50625386|FG001|Overall Study|Ineligible after Consent|0|||
25310087|NCT01005329|50625401|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
25310088|NCT01005251|50625411|FG000|Overall Study|Withdrawal by Subject|2|||
25310089|NCT01005251|50625412|FG001|Overall Study|Withdrawal by Subject|5|||
25310090|NCT01005251|50625413|FG002|Overall Study|Withdrawal by Subject|3|||
25310091|NCT01005251|50625414|FG003|Overall Study|Withdrawal by Subject|4|||
25310092|NCT01005251|50625415|FG004|Overall Study|Withdrawal by Subject|9|||
25310093|NCT01005251|50625411|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
25310094|NCT01005251|50625412|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
25310095|NCT01005251|50625413|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
25310096|NCT01005251|50625414|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
25310097|NCT01005251|50625415|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
25310098|NCT01005251|50625411|FG000|Overall Study|Adverse Event|2|||
25310099|NCT01005251|50625412|FG001|Overall Study|Adverse Event|6|||
25310100|NCT01005251|50625413|FG002|Overall Study|Adverse Event|8|||
25310101|NCT01005251|50625414|FG003|Overall Study|Adverse Event|5|||
25310102|NCT01005251|50625415|FG004|Overall Study|Adverse Event|4|||
25310103|NCT01005251|50625411|FG000|Overall Study|Protocol Violation|1|||
25310104|NCT01005251|50625412|FG001|Overall Study|Protocol Violation|0|||
25310105|NCT01005251|50625413|FG002|Overall Study|Protocol Violation|0|||
25310106|NCT01005251|50625414|FG003|Overall Study|Protocol Violation|0|||
25310107|NCT01005251|50625415|FG004|Overall Study|Protocol Violation|2|||
25310108|NCT01005251|50625411|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
25310109|NCT01005251|50625412|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
25310110|NCT01005251|50625413|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
25310111|NCT01005251|50625414|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
25310112|NCT01005251|50625415|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
25310113|NCT01005251|50625411|FG000|Overall Study|Lost to Follow-up|1|||
25310114|NCT01005251|50625412|FG001|Overall Study|Lost to Follow-up|4|||
25310115|NCT01005251|50625413|FG002|Overall Study|Lost to Follow-up|2|||
25310116|NCT01005251|50625414|FG003|Overall Study|Lost to Follow-up|0|||
25310117|NCT01005251|50625415|FG004|Overall Study|Lost to Follow-up|0|||
25310118|NCT01005251|50625411|FG000|Overall Study|Physician Decision|0|||
25310119|NCT01005251|50625412|FG001|Overall Study|Physician Decision|0|||
25310120|NCT01005251|50625413|FG002|Overall Study|Physician Decision|0|||
25310121|NCT01005251|50625414|FG003|Overall Study|Physician Decision|0|||
25310122|NCT01005251|50625415|FG004|Overall Study|Physician Decision|2|||
25310123|NCT01005251|50625411|FG000|Overall Study|Patient moved|1|||
25310124|NCT01005251|50625412|FG001|Overall Study|Patient moved|0|||
25310125|NCT01005251|50625413|FG002|Overall Study|Patient moved|0|||
25310126|NCT01005251|50625414|FG003|Overall Study|Patient moved|0|||
25310127|NCT01005251|50625415|FG004|Overall Study|Patient moved|0|||
25310128|NCT01005251|50625411|FG000|Overall Study|Wrong drug dispensed|0|||
25310129|NCT01005251|50625412|FG001|Overall Study|Wrong drug dispensed|1|||
25310130|NCT01005251|50625413|FG002|Overall Study|Wrong drug dispensed|0|||
25310131|NCT01005251|50625414|FG003|Overall Study|Wrong drug dispensed|0|||
25310132|NCT01005251|50625415|FG004|Overall Study|Wrong drug dispensed|0|||
25310133|NCT01005251|50625411|FG000|Overall Study|Randomized in error|0|||
25310134|NCT01005251|50625412|FG001|Overall Study|Randomized in error|0|||
25310135|NCT01005251|50625413|FG002|Overall Study|Randomized in error|1|||
25310136|NCT01005251|50625414|FG003|Overall Study|Randomized in error|1|||
25310137|NCT01005251|50625415|FG004|Overall Study|Randomized in error|0|||
25310138|NCT01005251|50625411|FG000|Overall Study|Lack of Efficacy|0|||
25310139|NCT01005251|50625412|FG001|Overall Study|Lack of Efficacy|0|||
25310140|NCT01005251|50625413|FG002|Overall Study|Lack of Efficacy|1|||
25310141|NCT01005251|50625414|FG003|Overall Study|Lack of Efficacy|1|||
25310142|NCT01005251|50625415|FG004|Overall Study|Lack of Efficacy|0|||
25310143|NCT03048578|50625429|FG000|Overall Study|Withdrawal by Subject|5|||
25310144|NCT03048578|50625430|FG001|Overall Study|Withdrawal by Subject|6|||
25310145|NCT03048578|50625429|FG000|Overall Study|Lost to Follow-up|22|||
25310146|NCT03048578|50625430|FG001|Overall Study|Lost to Follow-up|10|||
25310147|NCT03048578|50625429|FG000|Overall Study|Adverse Event|1|||
25310148|NCT03048578|50625430|FG001|Overall Study|Adverse Event|2|||
25310149|NCT03048578|50625429|FG000|Overall Study|Terminated|3|||
25310150|NCT03048578|50625430|FG001|Overall Study|Terminated|2|||
25310151|NCT01008449|50625438|FG000|Overall Study|Lost to Follow-up|29|||
25310152|NCT01008449|50625439|FG001|Overall Study|Lost to Follow-up|19|||
25310153|NCT00696241|50625450|FG000|Overall Study|Adverse Event|11|||
25310154|NCT00696241|50625451|FG001|Overall Study|Adverse Event|3|||
24970219|NCT04142242|50059724|FG000|Overall Study|Non-compliance with the protocol|1|||
25310155|NCT00696241|50625452|FG002|Overall Study|Adverse Event|6|||
25310156|NCT00696241|50625453|FG003|Overall Study|Adverse Event|4|||
25310157|NCT00696241|50625454|FG004|Overall Study|Adverse Event|5|||
25310158|NCT00696241|50625450|FG000|Overall Study|Protocol Violation|1|||
25310159|NCT00696241|50625451|FG001|Overall Study|Protocol Violation|1|||
25310160|NCT00696241|50625452|FG002|Overall Study|Protocol Violation|2|||
25310161|NCT00696241|50625453|FG003|Overall Study|Protocol Violation|0|||
25310162|NCT00696241|50625454|FG004|Overall Study|Protocol Violation|3|||
25310163|NCT00696241|50625450|FG000|Overall Study|Lost to Follow-up|1|||
25310164|NCT00696241|50625451|FG001|Overall Study|Lost to Follow-up|4|||
25310165|NCT00696241|50625452|FG002|Overall Study|Lost to Follow-up|1|||
25310166|NCT00696241|50625453|FG003|Overall Study|Lost to Follow-up|2|||
25310167|NCT00696241|50625454|FG004|Overall Study|Lost to Follow-up|0|||
25310168|NCT00696241|50625450|FG000|Overall Study|Withdrawal by Subject|4|||
25310169|NCT00696241|50625451|FG001|Overall Study|Withdrawal by Subject|8|||
25310170|NCT00696241|50625452|FG002|Overall Study|Withdrawal by Subject|6|||
25310171|NCT00696241|50625453|FG003|Overall Study|Withdrawal by Subject|1|||
25310172|NCT00696241|50625454|FG004|Overall Study|Withdrawal by Subject|0|||
25310173|NCT00696241|50625450|FG000|Overall Study|Lack of Efficacy|1|||
25310174|NCT00696241|50625451|FG001|Overall Study|Lack of Efficacy|5|||
25310175|NCT00696241|50625452|FG002|Overall Study|Lack of Efficacy|4|||
25310176|NCT00696241|50625453|FG003|Overall Study|Lack of Efficacy|5|||
25310177|NCT00696241|50625454|FG004|Overall Study|Lack of Efficacy|3|||
25310178|NCT00696241|50625450|FG000|Overall Study|Other|6|||
25310179|NCT00696241|50625451|FG001|Overall Study|Other|1|||
25310180|NCT00696241|50625452|FG002|Overall Study|Other|5|||
25310181|NCT00696241|50625453|FG003|Overall Study|Other|2|||
25310182|NCT00696241|50625454|FG004|Overall Study|Other|1|||
25310183|NCT00957008|50625470|FG000|Overall Study|Withdrawal by Subject|13|||
25310184|NCT00957008|50625471|FG001|Overall Study|Withdrawal by Subject|10|||
25310185|NCT00957008|50625472|FG002|Overall Study|Withdrawal by Subject|12|||
25310186|NCT00957008|50625473|FG003|Overall Study|Withdrawal by Subject|16|||
25310187|NCT00957008|50625470|FG000|Overall Study|Lost to Follow-up|3|||
25310188|NCT00957008|50625471|FG001|Overall Study|Lost to Follow-up|1|||
25310189|NCT00957008|50625472|FG002|Overall Study|Lost to Follow-up|3|||
25310190|NCT00957008|50625473|FG003|Overall Study|Lost to Follow-up|4|||
25310191|NCT00957008|50625470|FG000|Overall Study|Physician Decision|1|||
25310192|NCT00957008|50625471|FG001|Overall Study|Physician Decision|0|||
25310193|NCT00957008|50625472|FG002|Overall Study|Physician Decision|1|||
25310194|NCT00957008|50625473|FG003|Overall Study|Physician Decision|1|||
25310195|NCT00957008|50625470|FG000|Overall Study|Relocated; Family conflict|4|||
25310196|NCT00957008|50625471|FG001|Overall Study|Relocated; Family conflict|1|||
25310197|NCT00957008|50625472|FG002|Overall Study|Relocated; Family conflict|1|||
25310198|NCT00957008|50625473|FG003|Overall Study|Relocated; Family conflict|3|||
25071388|NCT02570750|50177554|FG001|Overall Study|Lost to Follow-up|2|||
25310199|NCT00952484|50625490|FG000|Overall Study|Withdrawal by Subject|0|||
25310200|NCT00952484|50625491|FG001|Overall Study|Withdrawal by Subject|1|||
25310201|NCT00952484|50625492|FG002|Overall Study|Withdrawal by Subject|0|||
25310202|NCT00689611|50625503|FG000|Overall Study|Death|6|||
25310203|NCT00689611|50625504|FG001|Overall Study|Death|9|||
25310204|NCT00689611|50625503|FG000|Overall Study|Withdrawal by Subject|8|||
25310205|NCT00689611|50625504|FG001|Overall Study|Withdrawal by Subject|9|||
25310206|NCT00689611|50625503|FG000|Overall Study|Lost to Follow-up|27|||
25310207|NCT00689611|50625504|FG001|Overall Study|Lost to Follow-up|28|||
25310208|NCT00689299|50625513|FG000|Overall Study|Adverse Event|2|||
25310209|NCT00689299|50625514|FG001|Overall Study|Adverse Event|1|||
25310210|NCT00689299|50625515|FG002|Overall Study|Adverse Event|1|||
25310211|NCT00689299|50625513|FG000|Overall Study|Lost to Follow-up|0|||
25310212|NCT00689299|50625514|FG001|Overall Study|Lost to Follow-up|1|||
25310213|NCT00689299|50625515|FG002|Overall Study|Lost to Follow-up|1|||
25310214|NCT00689299|50625513|FG000|Overall Study|Withdrawal by Subject|4|||
25310215|NCT00689299|50625514|FG001|Overall Study|Withdrawal by Subject|1|||
25310216|NCT00689299|50625515|FG002|Overall Study|Withdrawal by Subject|3|||
25310217|NCT00689299|50625513|FG000|Overall Study|Protocol Violation|1|||
25071389|NCT02570750|50177553|FG000|Overall Study|Adverse Event|2|||
25071390|NCT02570750|50177554|FG001|Overall Study|Adverse Event|1|||
25071391|NCT02573012|50177562|FG000|Overall Study|Adverse Event|5|||
25071392|NCT02573012|50177563|FG001|Overall Study|Adverse Event|5|||
25310218|NCT00689299|50625514|FG001|Overall Study|Protocol Violation|0|||
25310219|NCT00689299|50625515|FG002|Overall Study|Protocol Violation|0|||
25310220|NCT02506244|50625526|FG000|Overall Study|Did not undergo active monitoring|458|||
25310221|NCT02506244|50625527|FG001|Overall Study|Did not undergo active monitoring|459|||
25310222|NCT02506244|50625528|FG002|Overall Study|Did not undergo active monitoring|0|||
25310223|NCT00948974|50625538|FG000|Overall Study|Lost to Follow-up|23|||
25310224|NCT00948974|50625539|FG001|Overall Study|Lost to Follow-up|20|||
25310225|NCT01007435|50625549|FG000|Overall Study|Adverse Event|16|||
25310226|NCT01007435|50625550|FG001|Overall Study|Adverse Event|25|||
25310227|NCT01007435|50625551|FG002|Overall Study|Adverse Event|47|||
25310228|NCT01007435|50625552|FG003|Overall Study|Adverse Event|31|||
25310229|NCT01007435|50625549|FG000|Overall Study|Death|2|||
25310230|NCT01007435|50625550|FG001|Overall Study|Death|4|||
25310231|NCT01007435|50625551|FG002|Overall Study|Death|2|||
25310232|NCT01007435|50625552|FG003|Overall Study|Death|1|||
25310233|NCT01007435|50625549|FG000|Overall Study|Insufficient Therapeutic Response|21|||
25310234|NCT01007435|50625550|FG001|Overall Study|Insufficient Therapeutic Response|7|||
25310235|NCT01007435|50625551|FG002|Overall Study|Insufficient Therapeutic Response|2|||
25310236|NCT01007435|50625552|FG003|Overall Study|Insufficient Therapeutic Response|9|||
25310237|NCT01007435|50625549|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
25310238|NCT01007435|50625550|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
25310239|NCT01007435|50625551|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
24970220|NCT04142242|50059725|FG001|Overall Study|Non-compliance with the protocol|0|||
24970221|NCT04142242|50059726|FG002|Overall Study|Non-compliance with the protocol|0|||
25310240|NCT01007435|50625552|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
25310241|NCT01007435|50625549|FG000|Overall Study|Other Protocol Violation|2|||
25310242|NCT01007435|50625550|FG001|Overall Study|Other Protocol Violation|0|||
25310243|NCT01007435|50625551|FG002|Overall Study|Other Protocol Violation|1|||
25071393|NCT02573012|50177562|FG000|Overall Study|Lack of Efficacy|5|||
25310244|NCT01007435|50625552|FG003|Overall Study|Other Protocol Violation|0|||
25310245|NCT01007435|50625549|FG000|Overall Study|Refused Treatment|13|||
25310246|NCT01007435|50625550|FG001|Overall Study|Refused Treatment|13|||
25310247|NCT01007435|50625551|FG002|Overall Study|Refused Treatment|5|||
25310248|NCT01007435|50625552|FG003|Overall Study|Refused Treatment|8|||
25310249|NCT01007435|50625549|FG000|Overall Study|Failure to Return|5|||
25310250|NCT01007435|50625550|FG001|Overall Study|Failure to Return|4|||
25310251|NCT01007435|50625551|FG002|Overall Study|Failure to Return|3|||
25310252|NCT01007435|50625552|FG003|Overall Study|Failure to Return|6|||
25310253|NCT01007435|50625549|FG000|Overall Study|Reason not Specified|1|||
25310254|NCT01007435|50625550|FG001|Overall Study|Reason not Specified|1|||
25310255|NCT01007435|50625551|FG002|Overall Study|Reason not Specified|2|||
25310256|NCT01007435|50625552|FG003|Overall Study|Reason not Specified|1|||
25310257|NCT00948896|50625570|FG000|Randomization to 24 Months of Age|Death|1|||
25310258|NCT00948896|50625571|FG001|Randomization to 24 Months of Age|Death|0|||
25310259|NCT00948896|50625572|FG002|Randomization to 24 Months of Age|Death|0|||
25310260|NCT00948896|50625573|FG003|Randomization to 24 Months of Age|Death|0|||
25310261|NCT00948896|50625574|FG004|Randomization to 24 Months of Age|Death|2|||
25310262|NCT00948896|50625575|FG005|Randomization to 24 Months of Age|Death|1|||
25310263|NCT00948896|50625576|FG006|Randomization to 24 Months of Age|Death|2|||
25310264|NCT00948896|50625577|FG007|Randomization to 24 Months of Age|Death|1|||
25310265|NCT00948896|50625570|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
25310266|NCT00948896|50625571|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
25310267|NCT00948896|50625572|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
25310268|NCT00948896|50625573|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
25310269|NCT00948896|50625574|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
25310270|NCT00948896|50625575|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
25310271|NCT00948896|50625576|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
25310272|NCT00948896|50625577|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
25310273|NCT00948896|50625570|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
25310274|NCT00948896|50625571|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
25310275|NCT00948896|50625572|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
25310276|NCT00948896|50625573|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
25310277|NCT00948896|50625574|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
25310278|NCT00948896|50625575|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
25310279|NCT00948896|50625576|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
25310280|NCT00948896|50625577|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
25310281|NCT00948896|50625570|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
25310282|NCT00948896|50625571|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
25310283|NCT00948896|50625572|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
25310284|NCT00948896|50625573|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
25310285|NCT00948896|50625574|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
25310286|NCT00948896|50625575|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
25310287|NCT00948896|50625576|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
25310288|NCT00948896|50625577|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
25310289|NCT00948896|50625570|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
25310290|NCT00948896|50625571|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
25310291|NCT00948896|50625572|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
25310292|NCT00948896|50625573|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
25310293|NCT00948896|50625574|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
25310294|NCT00948896|50625575|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
25310295|NCT00948896|50625576|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
25310296|NCT00948896|50625577|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
25310297|NCT00948896|50625570|FG000|24 Months of Age to 36 Months of Age|Death|0|||
25310298|NCT00948896|50625571|FG001|24 Months of Age to 36 Months of Age|Death|2|||
25310299|NCT00948896|50625572|FG002|24 Months of Age to 36 Months of Age|Death|2|||
25310300|NCT00948896|50625573|FG003|24 Months of Age to 36 Months of Age|Death|0|||
25310301|NCT00948896|50625574|FG004|24 Months of Age to 36 Months of Age|Death|0|||
25310302|NCT00948896|50625575|FG005|24 Months of Age to 36 Months of Age|Death|1|||
25310303|NCT00948896|50625576|FG006|24 Months of Age to 36 Months of Age|Death|0|||
25310304|NCT00948896|50625577|FG007|24 Months of Age to 36 Months of Age|Death|0|||
25310305|NCT00948896|50625570|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
25310306|NCT00948896|50625571|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
25310307|NCT00948896|50625572|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
25310308|NCT00948896|50625573|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
25310309|NCT00948896|50625574|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
25310310|NCT00948896|50625575|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
25310311|NCT00948896|50625576|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
25310312|NCT00948896|50625577|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
25310313|NCT00948896|50625570|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
25310314|NCT00948896|50625571|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
25310315|NCT00948896|50625572|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
25310316|NCT00948896|50625573|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
25310317|NCT00948896|50625574|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
25310318|NCT00948896|50625575|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
25310319|NCT00948896|50625576|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
25310320|NCT00948896|50625577|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
25310321|NCT00948896|50625570|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
25310322|NCT00948896|50625571|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
25310323|NCT00948896|50625572|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
25310324|NCT00948896|50625573|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
25310325|NCT00948896|50625574|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
25310326|NCT00948896|50625575|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
25310327|NCT00948896|50625576|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
25310328|NCT00948896|50625577|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
25310329|NCT00948896|50625570|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
25310330|NCT00948896|50625571|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
25310331|NCT00948896|50625572|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
25310332|NCT00948896|50625573|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
25310333|NCT00948896|50625574|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
25310334|NCT00948896|50625575|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
25310335|NCT00948896|50625576|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
25310336|NCT00948896|50625577|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
25310337|NCT01004159|50625599|FG000|Overall Study|Adverse Event|2|||
25310338|NCT01004159|50625599|FG000|Overall Study|Disease Progression|18|||
25310339|NCT00948818|50625605|FG000|Overall Study|Adverse Event|10|||
25310340|NCT00948818|50625606|FG001|Overall Study|Adverse Event|32|||
25310341|NCT00948818|50625605|FG000|Overall Study|Protocol Violation|9|||
25310342|NCT00948818|50625606|FG001|Overall Study|Protocol Violation|10|||
25310343|NCT00948818|50625605|FG000|Overall Study|Withdrawal by Subject|25|||
25310344|NCT00948818|50625606|FG001|Overall Study|Withdrawal by Subject|25|||
25310345|NCT00948818|50625605|FG000|Overall Study|Lost to Follow-up|10|||
25310346|NCT00948818|50625606|FG001|Overall Study|Lost to Follow-up|17|||
25310347|NCT00948818|50625605|FG000|Overall Study|Lack of Efficacy|4|||
25310348|NCT00948818|50625606|FG001|Overall Study|Lack of Efficacy|5|||
25310349|NCT00948818|50625605|FG000|Overall Study|Other Reason|4|||
25310350|NCT00948818|50625606|FG001|Overall Study|Other Reason|5|||
25310351|NCT00948506|50625617|FG000|Overall Study|Withdrawal by Subject|3|||
25310352|NCT00948506|50625618|FG001|Overall Study|Withdrawal by Subject|1|||
25310353|NCT00955682|50625629|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
25310354|NCT00955682|50625630|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
25310355|NCT00689221|50625646|FG000|Overall Study|Ongoing at cut-off date|39|||
25310356|NCT00689221|50625647|FG001|Overall Study|Ongoing at cut-off date|36|||
25310357|NCT01875445|50625655|FG000|Overall Study|Lost to Follow-up|5|||
25310358|NCT01875445|50625656|FG001|Overall Study|Lost to Follow-up|0|||
25310359|NCT01875445|50625655|FG000|Overall Study|Withdrawal by Subject|2|||
25310360|NCT01875445|50625656|FG001|Overall Study|Withdrawal by Subject|0|||
25310361|NCT00688909|50625662|FG000|Overall Study|Adverse Event|28|||
25310362|NCT00688909|50625662|FG000|Overall Study|Patient withdrew consent|2|||
25310363|NCT00688909|50625662|FG000|Overall Study|Administrative problems|1|||
25310364|NCT00688909|50625662|FG000|Overall Study|Protocol Violation|2|||
25310365|NCT00948428|50625670|FG000|Overall Study|Withdrawal by Subject|6|||
25310366|NCT00948428|50625671|FG001|Overall Study|Withdrawal by Subject|12|||
25310367|NCT00948428|50625672|FG002|Overall Study|Withdrawal by Subject|7|||
25310368|NCT00948428|50625670|FG000|Overall Study|Adverse Event|6|||
25310369|NCT00948428|50625671|FG001|Overall Study|Adverse Event|3|||
25310370|NCT00948428|50625672|FG002|Overall Study|Adverse Event|0|||
25310371|NCT00948428|50625670|FG000|Overall Study|Lost to Follow-up|2|||
25310372|NCT00948428|50625671|FG001|Overall Study|Lost to Follow-up|1|||
25310373|NCT00948428|50625672|FG002|Overall Study|Lost to Follow-up|1|||
25310374|NCT00948428|50625670|FG000|Overall Study|Death|2|||
25192205|NCT01465802|50357379|FG002|Overall Study|Reason not specified|0|||
25310375|NCT00948428|50625671|FG001|Overall Study|Death|0|||
25310376|NCT00948428|50625672|FG002|Overall Study|Death|0|||
25310377|NCT00948428|50625670|FG000|Overall Study|Intercurrent Illness|1|||
25310378|NCT00948428|50625671|FG001|Overall Study|Intercurrent Illness|0|||
25310379|NCT00948428|50625672|FG002|Overall Study|Intercurrent Illness|0|||
25310380|NCT00948428|50625670|FG000|Overall Study|Non-compliance|1|||
25310381|NCT00948428|50625671|FG001|Overall Study|Non-compliance|2|||
25310382|NCT00948428|50625672|FG002|Overall Study|Non-compliance|0|||
25310383|NCT00948194|50625682|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
25310384|NCT00948194|50625683|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
25310385|NCT00691483|50625691|FG000|Overall Study|Adverse Event|14|||
25310386|NCT00691483|50625692|FG001|Overall Study|Adverse Event|6|||
25310387|NCT00691483|50625691|FG000|Overall Study|Lost to Follow-up|17|||
25310388|NCT00691483|50625692|FG001|Overall Study|Lost to Follow-up|10|||
25310389|NCT00691483|50625691|FG000|Overall Study|Withdrawal by Subject|24|||
25310390|NCT00691483|50625692|FG001|Overall Study|Withdrawal by Subject|7|||
25310391|NCT00691483|50625691|FG000|Overall Study|Other known cause|6|||
25310392|NCT00691483|50625692|FG001|Overall Study|Other known cause|1|||
25310393|NCT00691483|50625691|FG000|Overall Study|Randomized by not treated|7|||
25310394|NCT00691483|50625692|FG001|Overall Study|Randomized by not treated|1|||
25310395|NCT00691093|50625698|FG000|Overall Study|Adverse Event|1|||
25310396|NCT00691093|50625698|FG000|Overall Study|Lost to Follow-up|1|||
25310397|NCT00691093|50625698|FG000|Overall Study|Lack of Efficacy|1|||
25310398|NCT00691093|50625698|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
25310399|NCT00947882|50625711|FG000|Overall Study|Adverse Event|0|||
25310400|NCT00947882|50625712|FG001|Overall Study|Adverse Event|1|||
25310401|NCT00947882|50625713|FG002|Overall Study|Adverse Event|4|||
25310402|NCT00947882|50625714|FG003|Overall Study|Adverse Event|4|||
25310403|NCT00947882|50625711|FG000|Overall Study|Withdrawal by Subject|2|||
25310404|NCT00947882|50625712|FG001|Overall Study|Withdrawal by Subject|0|||
25310405|NCT00947882|50625713|FG002|Overall Study|Withdrawal by Subject|8|||
25310406|NCT00947882|50625714|FG003|Overall Study|Withdrawal by Subject|2|||
25310407|NCT00947882|50625711|FG000|Overall Study|Protocol Violation|0|||
25310408|NCT00947882|50625712|FG001|Overall Study|Protocol Violation|0|||
25310409|NCT00947882|50625713|FG002|Overall Study|Protocol Violation|1|||
25310410|NCT00947882|50625714|FG003|Overall Study|Protocol Violation|0|||
25310411|NCT00947882|50625711|FG000|Overall Study|Lost to Follow-up|0|||
25310412|NCT00947882|50625712|FG001|Overall Study|Lost to Follow-up|2|||
25310413|NCT00947882|50625713|FG002|Overall Study|Lost to Follow-up|1|||
25310414|NCT00947882|50625714|FG003|Overall Study|Lost to Follow-up|0|||
25310415|NCT00947882|50625711|FG000|Overall Study|Other/Unknown|10|||
25310416|NCT00947882|50625712|FG001|Overall Study|Other/Unknown|13|||
25310417|NCT00947882|50625713|FG002|Overall Study|Other/Unknown|3|||
25310418|NCT00947882|50625714|FG003|Overall Study|Other/Unknown|6|||
25310419|NCT00947882|50625711|FG000|Overall Study|Trial Terminated by Sponsor|62|||
25310420|NCT00947882|50625712|FG001|Overall Study|Trial Terminated by Sponsor|61|||
25310421|NCT00947882|50625713|FG002|Overall Study|Trial Terminated by Sponsor|62|||
25310422|NCT00947882|50625714|FG003|Overall Study|Trial Terminated by Sponsor|70|||
25310423|NCT00688753|50625725|FG000|Overall Study|Disease progression|55|||
25310424|NCT00688753|50625725|FG000|Overall Study|Missing|1|||
25310425|NCT00688753|50625725|FG000|Overall Study|Death|9|||
25310426|NCT00688753|50625725|FG000|Overall Study|Withdrawal by Subject|3|||
25310427|NCT00688753|50625725|FG000|Overall Study|Adverse Event|20|||
25310428|NCT00688753|50625725|FG000|Overall Study|Protocol Violation|1|||
25310429|NCT00688753|50625725|FG000|Overall Study|Lost to Follow-up|3|||
25310430|NCT00951080|50625731|FG000|Overall Study|Adverse Event|3|||
25310431|NCT00951080|50625732|FG001|Overall Study|Adverse Event|3|||
25310432|NCT00951080|50625731|FG000|Overall Study|Lost to Follow-up|0|||
25310433|NCT00951080|50625732|FG001|Overall Study|Lost to Follow-up|1|||
25310434|NCT00951080|50625731|FG000|Overall Study|Physician Decision|4|||
25310435|NCT00951080|50625732|FG001|Overall Study|Physician Decision|1|||
25310436|NCT00951080|50625731|FG000|Overall Study|Other|19|||
25310437|NCT00951080|50625732|FG001|Overall Study|Other|22|||
25310438|NCT00946322|50625738|FG000|Pre-treatment|participant failure to follow up|1|||
25310439|NCT00946322|50625738|FG000|Post-treatment|participant failure to follow up|2|||
25310440|NCT00950690|50625742|FG000|Overall Study|Death|4|||
25310441|NCT00950690|50625742|FG000|Overall Study|Adverse Event|15|||
25310442|NCT00950690|50625742|FG000|Overall Study|Lack of Efficacy|22|||
25310443|NCT00950690|50625742|FG000|Overall Study|Lost to Follow-up|40|||
25310444|NCT00950690|50625742|FG000|Overall Study|Other|163|||
25310445|NCT00694369|50625751|FG000|Overall Study|Adverse Event|0|||
25310446|NCT00694369|50625752|FG001|Overall Study|Adverse Event|1|||
24970222|NCT04142242|50059727|FG003|Overall Study|Non-compliance with the protocol|0|||
25310447|NCT00694369|50625753|FG002|Overall Study|Adverse Event|0|||
25310448|NCT00694369|50625754|FG003|Overall Study|Adverse Event|1|||
25310449|NCT00694369|50625755|FG004|Overall Study|Adverse Event|3|||
25310450|NCT00694369|50625751|FG000|Overall Study|Lost to Follow-up|0|||
25310451|NCT00694369|50625752|FG001|Overall Study|Lost to Follow-up|0|||
25310452|NCT00694369|50625753|FG002|Overall Study|Lost to Follow-up|1|||
25310453|NCT00694369|50625754|FG003|Overall Study|Lost to Follow-up|1|||
25310454|NCT00694369|50625755|FG004|Overall Study|Lost to Follow-up|0|||
25310455|NCT00694369|50625751|FG000|Overall Study|Physician Decision|0|||
25310456|NCT00694369|50625752|FG001|Overall Study|Physician Decision|0|||
25310457|NCT00694369|50625753|FG002|Overall Study|Physician Decision|0|||
25310458|NCT00694369|50625754|FG003|Overall Study|Physician Decision|0|||
25310459|NCT00694369|50625755|FG004|Overall Study|Physician Decision|1|||
25310460|NCT00694369|50625751|FG000|Overall Study|Protocol Violation|0|||
25310461|NCT00694369|50625752|FG001|Overall Study|Protocol Violation|1|||
25310462|NCT00694369|50625753|FG002|Overall Study|Protocol Violation|0|||
25310463|NCT00694369|50625754|FG003|Overall Study|Protocol Violation|0|||
25310464|NCT00694369|50625755|FG004|Overall Study|Protocol Violation|0|||
25310465|NCT00694369|50625751|FG000|Overall Study|Withdrawal by Subject|1|||
25310466|NCT00694369|50625752|FG001|Overall Study|Withdrawal by Subject|1|||
25310467|NCT00694369|50625753|FG002|Overall Study|Withdrawal by Subject|1|||
25310468|NCT00694369|50625754|FG003|Overall Study|Withdrawal by Subject|1|||
25310469|NCT00694369|50625755|FG004|Overall Study|Withdrawal by Subject|2|||
24970223|NCT04142242|50059728|FG004|Overall Study|Non-compliance with the protocol|0|||
25310470|NCT03412747|50625770|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
25310471|NCT03412747|50625771|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
25310472|NCT03412747|50625772|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
25310473|NCT03412747|50625770|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
25310474|NCT03412747|50625771|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
25310475|NCT03412747|50625772|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
25310476|NCT03412747|50625770|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
25310477|NCT03412747|50625771|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
25310478|NCT03412747|50625772|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
25310479|NCT03412747|50625770|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
25310480|NCT03412747|50625771|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
25310481|NCT03412747|50625772|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
25310482|NCT03412747|50625770|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
25310483|NCT03412747|50625771|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
25310484|NCT03412747|50625772|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
25310485|NCT03412747|50625770|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
25310486|NCT03412747|50625771|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
25310487|NCT03412747|50625772|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
25310488|NCT03412747|50625770|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
25310489|NCT03412747|50625771|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
25310490|NCT03412747|50625772|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
25310491|NCT03412747|50625770|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
25310492|NCT03412747|50625771|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
25310493|NCT03412747|50625772|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
25310494|NCT03412747|50625770|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
25310495|NCT03412747|50625771|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
25310496|NCT03412747|50625772|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
25310497|NCT03412747|50625770|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
25310498|NCT03412747|50625771|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
25310499|NCT03412747|50625772|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
25310500|NCT03412747|50625770|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
25310501|NCT03412747|50625771|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
25310502|NCT03412747|50625772|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
25310503|NCT03412747|50625770|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
25310504|NCT03412747|50625771|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
25310505|NCT03412747|50625772|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
25310506|NCT03412747|50625770|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
25310507|NCT03412747|50625771|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
24970224|NCT04142242|50059729|FG005|Overall Study|Non-compliance with the protocol|1|||
25310508|NCT03412747|50625772|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
25310509|NCT03412747|50625770|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
25310510|NCT03412747|50625771|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
25310511|NCT03412747|50625772|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
25310512|NCT03412747|50625770|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
25310513|NCT03412747|50625771|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
25310514|NCT03412747|50625772|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
25310515|NCT03412747|50625770|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
25310516|NCT03412747|50625771|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
25310517|NCT03412747|50625772|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
25310518|NCT00513019|50625792|FG000|Overall Study|Adverse Event|1|||
25310519|NCT00513019|50625793|FG001|Overall Study|Adverse Event|0|||
25310520|NCT00513019|50625792|FG000|Overall Study|Withdrawal by Subject|4|||
25310521|NCT00513019|50625793|FG001|Overall Study|Withdrawal by Subject|5|||
25310522|NCT00954512|50625814|FG000|Overall Study|Withdrawal by Subject|0|||
25310523|NCT00954512|50625815|FG001|Overall Study|Withdrawal by Subject|0|||
25310524|NCT00954512|50625816|FG002|Overall Study|Withdrawal by Subject|0|||
25310525|NCT00954512|50625817|FG003|Overall Study|Withdrawal by Subject|0|||
25310526|NCT00954512|50625818|FG004|Overall Study|Withdrawal by Subject|0|||
25310527|NCT00954512|50625819|FG005|Overall Study|Withdrawal by Subject|1|||
25310528|NCT00954512|50625814|FG000|Overall Study|Adverse Event|0|||
25310529|NCT00954512|50625815|FG001|Overall Study|Adverse Event|0|||
25310530|NCT00954512|50625816|FG002|Overall Study|Adverse Event|0|||
25310531|NCT00954512|50625817|FG003|Overall Study|Adverse Event|0|||
25310532|NCT00954512|50625818|FG004|Overall Study|Adverse Event|1|||
25310533|NCT00954512|50625819|FG005|Overall Study|Adverse Event|2|||
25310534|NCT00954512|50625814|FG000|Overall Study|Physician Decision|0|||
25310535|NCT00954512|50625815|FG001|Overall Study|Physician Decision|1|||
25310536|NCT00954512|50625816|FG002|Overall Study|Physician Decision|0|||
25310537|NCT00954512|50625817|FG003|Overall Study|Physician Decision|1|||
25310538|NCT00954512|50625818|FG004|Overall Study|Physician Decision|0|||
25310539|NCT00954512|50625819|FG005|Overall Study|Physician Decision|0|||
25310540|NCT00954512|50625814|FG000|Overall Study|Symptomatic Deterioration|0|||
25310541|NCT00954512|50625815|FG001|Overall Study|Symptomatic Deterioration|1|||
25310542|NCT00954512|50625816|FG002|Overall Study|Symptomatic Deterioration|0|||
25310543|NCT00954512|50625817|FG003|Overall Study|Symptomatic Deterioration|0|||
25310544|NCT00954512|50625818|FG004|Overall Study|Symptomatic Deterioration|2|||
25310545|NCT00954512|50625819|FG005|Overall Study|Symptomatic Deterioration|0|||
25310546|NCT00954512|50625814|FG000|Overall Study|Progression of Disease|2|||
25310547|NCT00954512|50625815|FG001|Overall Study|Progression of Disease|1|||
25310548|NCT00954512|50625816|FG002|Overall Study|Progression of Disease|0|||
25310549|NCT00954512|50625817|FG003|Overall Study|Progression of Disease|1|||
25310550|NCT00954512|50625818|FG004|Overall Study|Progression of Disease|1|||
25310551|NCT00954512|50625819|FG005|Overall Study|Progression of Disease|1|||
25310552|NCT00691015|50625832|FG000|Overall Study|Refused further treatment|1|||
25310553|NCT00950300|50625838|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
25310554|NCT00950300|50625839|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
25310555|NCT00950300|50625838|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
25310556|NCT00950300|50625839|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
25310557|NCT00950300|50625838|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
25310558|NCT00950300|50625839|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
25310559|NCT00950300|50625838|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
25310560|NCT00950300|50625839|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
25310561|NCT00950300|50625838|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
25310562|NCT00950300|50625839|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
25310563|NCT00950300|50625838|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
25310564|NCT00950300|50625839|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
25310565|NCT00950300|50625838|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
25310566|NCT00950300|50625839|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
25310567|NCT00950300|50625838|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
25310568|NCT00950300|50625839|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
25310569|NCT00950300|50625838|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
25310570|NCT00950300|50625839|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
25310571|NCT00950300|50625838|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
25310572|NCT00950300|50625839|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
25310573|NCT00950300|50625838|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
25310574|NCT00950300|50625839|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
25310575|NCT00950300|50625838|FG000|TFFU Period|Death|4|||
25310576|NCT00950300|50625839|FG001|TFFU Period|Death|1|||
25310577|NCT00950300|50625838|FG000|TFFU Period|Refused Treatment|10|||
25310578|NCT00950300|50625839|FG001|TFFU Period|Refused Treatment|11|||
25310579|NCT00950300|50625838|FG000|TFFU Period|Failure to Return|16|||
25310580|NCT00950300|50625839|FG001|TFFU Period|Failure to Return|16|||
25310581|NCT00950300|50625838|FG000|TFFU Period|Recurrence of Disease|63|||
25310582|NCT00950300|50625839|FG001|TFFU Period|Recurrence of Disease|72|||
25310583|NCT00950300|50625838|FG000|TFFU Period|Other|4|||
25310584|NCT00950300|50625839|FG001|TFFU Period|Other|3|||
25310585|NCT00950300|50625838|FG000|SFU Period|Death|44|||
25310586|NCT00950300|50625839|FG001|SFU Period|Death|42|||
25310587|NCT00950300|50625838|FG000|SFU Period|Lost to Follow-up|30|||
25310588|NCT00950300|50625839|FG001|SFU Period|Lost to Follow-up|28|||
25310589|NCT00950300|50625838|FG000|SFU Period|Withdrawal by Subject|4|||
25310590|NCT00950300|50625839|FG001|SFU Period|Withdrawal by Subject|8|||
25310591|NCT00949988|50625846|FG000|Overall Study|Withdrawal by Subject|3|||
25310592|NCT00731692|50625853|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
25310593|NCT00731692|50625854|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
25310594|NCT00731692|50625855|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
25310595|NCT00731692|50625853|FG000|Core Study (36 Months)|Physician Decision|1|||
25310596|NCT00731692|50625854|FG001|Core Study (36 Months)|Physician Decision|0|||
25310597|NCT00731692|50625855|FG002|Core Study (36 Months)|Physician Decision|2|||
25310598|NCT00731692|50625853|FG000|Core Study (36 Months)|Death|2|||
25310599|NCT00731692|50625854|FG001|Core Study (36 Months)|Death|1|||
25310600|NCT00731692|50625855|FG002|Core Study (36 Months)|Death|2|||
25310601|NCT00731692|50625853|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
25310602|NCT00731692|50625854|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
25310603|NCT00731692|50625855|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
25310604|NCT00731692|50625853|FG000|Core Study (36 Months)|Administrative|2|||
25310605|NCT00731692|50625854|FG001|Core Study (36 Months)|Administrative|2|||
25310606|NCT00731692|50625855|FG002|Core Study (36 Months)|Administrative|6|||
25310607|NCT00731692|50625853|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
25310608|NCT00731692|50625854|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
25310609|NCT00731692|50625855|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
25310610|NCT00731692|50625853|FG000|Core Study (36 Months)|Protocol Violation|4|||
25310611|NCT00731692|50625854|FG001|Core Study (36 Months)|Protocol Violation|5|||
25310612|NCT00731692|50625855|FG002|Core Study (36 Months)|Protocol Violation|8|||
25310613|NCT00731692|50625853|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
25310614|NCT00731692|50625854|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
25310615|NCT00731692|50625855|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
25310616|NCT00731692|50625853|FG000|Core Study (36 Months)|Adverse Event|25|||
25310617|NCT00731692|50625854|FG001|Core Study (36 Months)|Adverse Event|28|||
25310618|NCT00731692|50625855|FG002|Core Study (36 Months)|Adverse Event|29|||
25071394|NCT02573012|50177563|FG001|Overall Study|Lack of Efficacy|4|||
25310619|NCT00731692|50625853|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
25310620|NCT00731692|50625854|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
25310621|NCT00731692|50625855|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
25310622|NCT00731692|50625853|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
25310623|NCT00731692|50625854|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
25310624|NCT00731692|50625855|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
25310625|NCT00731692|50625853|FG000|Extension Phase|Abnormal test procedure|0|||
25310626|NCT00731692|50625854|FG001|Extension Phase|Abnormal test procedure|0|||
25310627|NCT00731692|50625855|FG002|Extension Phase|Abnormal test procedure|1|||
25310628|NCT00731692|50625853|FG000|Extension Phase|Abnormal lab values|0|||
25310629|NCT00731692|50625854|FG001|Extension Phase|Abnormal lab values|0|||
25310630|NCT00731692|50625855|FG002|Extension Phase|Abnormal lab values|1|||
25310631|NCT00731692|50625853|FG000|Extension Phase|Lost to Follow-up|0|||
25310632|NCT00731692|50625854|FG001|Extension Phase|Lost to Follow-up|1|||
25310633|NCT00731692|50625855|FG002|Extension Phase|Lost to Follow-up|4|||
25310634|NCT00731692|50625853|FG000|Extension Phase|Withdrawal by Subject|4|||
25310635|NCT00731692|50625854|FG001|Extension Phase|Withdrawal by Subject|5|||
25310636|NCT00731692|50625855|FG002|Extension Phase|Withdrawal by Subject|3|||
25310637|NCT00731692|50625853|FG000|Extension Phase|Adverse Event|1|||
25310638|NCT00731692|50625854|FG001|Extension Phase|Adverse Event|1|||
25310639|NCT00731692|50625855|FG002|Extension Phase|Adverse Event|15|||
25310640|NCT00687193|50625877|FG000|Overall Study|Adverse Event|0|||
25310641|NCT00687193|50625878|FG001|Overall Study|Adverse Event|1|||
25310642|NCT00687193|50625879|FG002|Overall Study|Adverse Event|2|||
25310643|NCT00687193|50625880|FG003|Overall Study|Adverse Event|3|||
25310644|NCT00687193|50625881|FG004|Overall Study|Adverse Event|0|||
25310645|NCT00687193|50625882|FG005|Overall Study|Adverse Event|2|||
25310646|NCT00687193|50625877|FG000|Overall Study|Lack of Efficacy|1|||
25310647|NCT00687193|50625878|FG001|Overall Study|Lack of Efficacy|1|||
25310648|NCT00687193|50625879|FG002|Overall Study|Lack of Efficacy|0|||
25310649|NCT00687193|50625880|FG003|Overall Study|Lack of Efficacy|0|||
25310650|NCT00687193|50625881|FG004|Overall Study|Lack of Efficacy|0|||
25310651|NCT00687193|50625882|FG005|Overall Study|Lack of Efficacy|2|||
25310652|NCT00687193|50625877|FG000|Overall Study|Protocol Violation|1|||
25310653|NCT00687193|50625878|FG001|Overall Study|Protocol Violation|2|||
25310654|NCT00687193|50625879|FG002|Overall Study|Protocol Violation|0|||
25310655|NCT00687193|50625880|FG003|Overall Study|Protocol Violation|1|||
25310656|NCT00687193|50625881|FG004|Overall Study|Protocol Violation|2|||
25310657|NCT00687193|50625882|FG005|Overall Study|Protocol Violation|0|||
25310658|NCT00730912|50625902|FG000|Overall Study|Discontinued|0|||
25310659|NCT00730912|50625903|FG001|Overall Study|Discontinued|0|||
25310660|NCT00730912|50625904|FG002|Overall Study|Discontinued|1|||
25310661|NCT00737698|50625915|FG000|Overall Study|Withdrawal by Subject|6|||
25310662|NCT00737698|50625916|FG001|Overall Study|Withdrawal by Subject|5|||
25310663|NCT00737698|50625917|FG002|Overall Study|Withdrawal by Subject|3|||
25310664|NCT00737698|50625915|FG000|Overall Study|Death|0|||
25310665|NCT00737698|50625916|FG001|Overall Study|Death|0|||
25310666|NCT00737698|50625917|FG002|Overall Study|Death|1|||
25310667|NCT00730756|50625927|FG000|Overall Study|Adverse Event|2|||
25310668|NCT00730756|50625928|FG001|Overall Study|Adverse Event|0|||
25310669|NCT00730756|50625927|FG000|Overall Study|Lack of Efficacy|1|||
25310670|NCT00730756|50625928|FG001|Overall Study|Lack of Efficacy|1|||
25310671|NCT00730756|50625927|FG000|Overall Study|Protocol Deviation|1|||
25310672|NCT00730756|50625928|FG001|Overall Study|Protocol Deviation|2|||
25310673|NCT00730756|50625927|FG000|Overall Study|Lost to Follow-up|0|||
25192206|NCT01465802|50357380|FG003|Overall Study|Reason not specified|10|||
25192207|NCT01465802|50357381|FG004|Overall Study|Reason not specified|2|||
25192208|NCT01465802|50357377|FG000|Overall Study|Death|15|||
25192209|NCT01465802|50357378|FG001|Overall Study|Death|12|||
25192210|NCT01465802|50357379|FG002|Overall Study|Death|0|||
25192211|NCT01465802|50357380|FG003|Overall Study|Death|10|||
25192212|NCT01465802|50357381|FG004|Overall Study|Death|2|||
25192213|NCT01437878|50357426|FG000|Overall Study|Withdrawal by Subject|1|||
25310674|NCT00730756|50625928|FG001|Overall Study|Lost to Follow-up|1|||
25310675|NCT00730756|50625927|FG000|Overall Study|Withdrew Consent|0|||
25071395|NCT02573012|50177562|FG000|Overall Study|Non-compliance|1|||
25310676|NCT00730756|50625928|FG001|Overall Study|Withdrew Consent|1|||
25310677|NCT00730132|50625934|FG000|Overall Study|Protocol Violation|154|||
25310678|NCT00730132|50625934|FG000|Overall Study|Death|1|||
25310679|NCT00737464|50625941|FG000|Overall Study|Adverse Event|1|||
25310680|NCT00737464|50625941|FG000|Overall Study|Death|6|||
25310681|NCT00737464|50625941|FG000|Overall Study|Other - Failure to Return|1|||
25310682|NCT00737464|50625941|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
25310683|NCT00737464|50625941|FG000|Overall Study|Other reasons|4|||
25310684|NCT00729586|50625947|FG000|Overall Study|Ineligible|0|||
25310685|NCT00729586|50625948|FG001|Overall Study|Ineligible|1|||
25310686|NCT00729586|50625947|FG000|Overall Study|never treated|1|||
25310687|NCT00729586|50625948|FG001|Overall Study|never treated|0|||
25192214|NCT01437878|50357427|FG001|Overall Study|Withdrawal by Subject|0|||
25310688|NCT00949910|50625955|FG000|Overall Study|Progressive Disease|3750|||
25310689|NCT00949910|50625955|FG000|Overall Study|Symptomatic Deterioration|1088|||
25310690|NCT00949910|50625955|FG000|Overall Study|Lost to Follow-up|100|||
25310691|NCT00949910|50625955|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
25310692|NCT00949910|50625955|FG000|Overall Study|Participant Refusal|390|||
25310693|NCT00949910|50625955|FG000|Overall Study|Death Due to Malignant Disease|456|||
25310694|NCT00949910|50625955|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
25310695|NCT00949910|50625955|FG000|Overall Study|Death Due to Adverse Event|115|||
25310696|NCT00949910|50625955|FG000|Overall Study|Death Due to Toxicity|3|||
25310697|NCT00949910|50625955|FG000|Overall Study|Death from Unknown Cause|5|||
25310698|NCT00949910|50625955|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
25310699|NCT00949910|50625955|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
25310700|NCT00949910|50625955|FG000|Overall Study|Switched to Commercial Treatment|4|||
25310701|NCT00949910|50625955|FG000|Overall Study|Violation of Eligibility|23|||
25310702|NCT00949910|50625955|FG000|Overall Study|Logistical Reasons|13|||
25310703|NCT00949910|50625955|FG000|Overall Study|Non-Compliance|10|||
25310704|NCT00949910|50625955|FG000|Overall Study|Prolonged Dosing Interruption|4|||
25310705|NCT00949910|50625955|FG000|Overall Study|Adverse Event|83|||
25310706|NCT00949910|50625955|FG000|Overall Study|Serious Adverse Event|6|||
25310707|NCT00949910|50625955|FG000|Overall Study|Physician/Participant Decision|7|||
25310708|NCT00949910|50625955|FG000|Overall Study|Other|4|||
25310709|NCT00949910|50625955|FG000|Overall Study|No Data|9|||
25310710|NCT00686959|50625961|FG000|Overall Study|Participants censored (no death events)|124|||
25310711|NCT00686959|50625962|FG001|Overall Study|Participants censored (no death events)|117|||
25310712|NCT00946088|50625970|FG000|Overall Study|Withdrawal by Subject|0|||
25310713|NCT00946088|50625971|FG001|Overall Study|Withdrawal by Subject|1|||
25310714|NCT00736996|50625982|FG000|Overall Study|Lost to Follow-up|1|||
25310715|NCT00736996|50625983|FG001|Overall Study|Lost to Follow-up|9|||
25310716|NCT00736996|50625984|FG002|Overall Study|Lost to Follow-up|2|||
25310717|NCT00728962|50625998|FG000|Implant Placement Surgery|Adverse Event|8|||
25310718|NCT00728962|50625998|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
25310719|NCT00728962|50625998|FG000|Implant Placement Surgery|Protocol Violation|1|||
25310720|NCT00728962|50625998|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
25310721|NCT00728962|50625998|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
25310722|NCT00954122|50626002|FG000|Overall Study|Withdrawal by Subject|5|||
25310723|NCT00954122|50626002|FG000|Overall Study|Adverse Event|1|||
25310724|NCT00954122|50626002|FG000|Overall Study|Safety Reason|1|||
25310725|NCT00586066|50626009|FG000|Overall Study|Lost to Follow-up|6|||
25310726|NCT00586066|50626010|FG001|Overall Study|Lost to Follow-up|3|||
25310727|NCT00586066|50626009|FG000|Overall Study|Lack of Efficacy|5|||
25310728|NCT00586066|50626010|FG001|Overall Study|Lack of Efficacy|3|||
25310729|NCT00586066|50626009|FG000|Overall Study|Adverse Event|2|||
25310730|NCT00586066|50626010|FG001|Overall Study|Adverse Event|2|||
25310731|NCT00586066|50626009|FG000|Overall Study|Physician Decision|1|||
25310732|NCT00586066|50626010|FG001|Overall Study|Physician Decision|0|||
25310733|NCT00586066|50626009|FG000|Overall Study|Withdrawal of consent|4|||
25310734|NCT00586066|50626010|FG001|Overall Study|Withdrawal of consent|2|||
25310735|NCT01186016|50626018|FG000|Overall Study|Withdrawal by Subject|46|||
25310736|NCT01186016|50626019|FG001|Overall Study|Withdrawal by Subject|29|||
25310737|NCT00728884|50626025|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
25310738|NCT00728884|50626025|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
25310739|NCT00728494|50626031|FG000|Overall Study|Adverse Event|7|||
25310740|NCT00728494|50626032|FG001|Overall Study|Adverse Event|0|||
25310741|NCT00728494|50626031|FG000|Overall Study|Withdrawal by Subject|0|||
25310742|NCT00728494|50626032|FG001|Overall Study|Withdrawal by Subject|2|||
25310743|NCT00728494|50626031|FG000|Overall Study|Lack of Efficacy|2|||
25310744|NCT00728494|50626032|FG001|Overall Study|Lack of Efficacy|4|||
25310745|NCT00728494|50626031|FG000|Overall Study|No data available|0|||
25310746|NCT00728494|50626032|FG001|Overall Study|No data available|1|||
25310747|NCT00728416|50626040|FG000|Overall Study|Adverse Event|1|||
25310748|NCT00728416|50626041|FG001|Overall Study|Adverse Event|1|||
25310749|NCT00728416|50626040|FG000|Overall Study|Treatment Failure|0|||
25310750|NCT00728416|50626041|FG001|Overall Study|Treatment Failure|1|||
25310751|NCT00728416|50626040|FG000|Overall Study|Withdrawal by Subject|1|||
25310752|NCT00728416|50626041|FG001|Overall Study|Withdrawal by Subject|0|||
25310753|NCT00728182|50626049|FG000|Overall Study|Adverse Event|1|||
25310754|NCT00728182|50626050|FG001|Overall Study|Adverse Event|0|||
25310755|NCT00728182|50626049|FG000|Overall Study|Lost to Follow-up|2|||
25310756|NCT00728182|50626050|FG001|Overall Study|Lost to Follow-up|0|||
25310757|NCT00728182|50626049|FG000|Overall Study|Death|0|||
25310758|NCT00728182|50626050|FG001|Overall Study|Death|2|||
25310759|NCT00728182|50626049|FG000|Overall Study|Protocol Noncompliance|0|||
25310760|NCT00728182|50626050|FG001|Overall Study|Protocol Noncompliance|1|||
25310761|NCT00941330|50626060|FG000|Overall Study|Other|1|||
25310762|NCT00941330|50626061|FG001|Overall Study|Other|0|||
25310763|NCT00941330|50626060|FG000|Overall Study|Physician Decision|0|||
25310764|NCT00941330|50626061|FG001|Overall Study|Physician Decision|2|||
25310765|NCT00736450|50626067|FG000|Overall Study|Not ABC gene eligible|19|||
25310766|NCT00736450|50626067|FG000|Overall Study|Withdrawal by Subject|5|||
25310767|NCT00736450|50626067|FG000|Overall Study|Physician Decision|1|||
25310768|NCT00686881|50626073|FG000|Overall Study|Withdrawal by Subject|11|||
25310769|NCT00686881|50626074|FG001|Overall Study|Withdrawal by Subject|18|||
25310770|NCT00686881|50626073|FG000|Overall Study|Lost to Follow-up|0|||
25310771|NCT00686881|50626074|FG001|Overall Study|Lost to Follow-up|1|||
25310772|NCT00686881|50626073|FG000|Overall Study|Treatment-related adverse event|10|||
25310773|NCT00686881|50626074|FG001|Overall Study|Treatment-related adverse event|9|||
25310774|NCT00686881|50626073|FG000|Overall Study|Met discontinuation criteria|5|||
25310775|NCT00686881|50626074|FG001|Overall Study|Met discontinuation criteria|0|||
25310776|NCT00686881|50626073|FG000|Overall Study|Onset of malignant tumor|11|||
25310777|NCT00686881|50626074|FG001|Overall Study|Onset of malignant tumor|11|||
25310778|NCT00686881|50626073|FG000|Overall Study|Lack of Efficacy|4|||
25310779|NCT00686881|50626074|FG001|Overall Study|Lack of Efficacy|3|||
25310780|NCT00686881|50626073|FG000|Overall Study|Physician Decision|1|||
25310781|NCT00686881|50626074|FG001|Overall Study|Physician Decision|0|||
25310782|NCT00686881|50626073|FG000|Overall Study|Circumstances of site|1|||
25310783|NCT00686881|50626074|FG001|Overall Study|Circumstances of site|1|||
25310784|NCT00686881|50626073|FG000|Overall Study|Did not meet protocol eligibility|1|||
25310785|NCT00686881|50626074|FG001|Overall Study|Did not meet protocol eligibility|0|||
25310786|NCT00686881|50626073|FG000|Overall Study|Irregular visits|1|||
25310787|NCT00686881|50626074|FG001|Overall Study|Irregular visits|0|||
25310788|NCT00686881|50626073|FG000|Overall Study|Study discontinuation|35|||
25310789|NCT00686881|50626074|FG001|Overall Study|Study discontinuation|32|||
25310790|NCT00686881|50626073|FG000|Overall Study|Never received study drug|2|||
25310791|NCT00686881|50626074|FG001|Overall Study|Never received study drug|6|||
25310792|NCT00727714|50626082|FG000|Overall Study|Lost to Follow-up|2|||
25310793|NCT00727558|50626088|FG000|Overall Study|Lens issue|0|||
25310794|NCT00727558|50626089|FG001|Overall Study|Lens issue|1|||
25310795|NCT00727558|50626088|FG000|Overall Study|Adverse Event|0|||
25310796|NCT00727558|50626089|FG001|Overall Study|Adverse Event|1|||
25310797|NCT00727558|50626088|FG000|Overall Study|Subject unable to return for follow-up|1|||
25310798|NCT00727558|50626089|FG001|Overall Study|Subject unable to return for follow-up|1|||
25310799|NCT00727558|50626088|FG000|Overall Study|Lost to Follow-up|1|||
25310800|NCT00727558|50626089|FG001|Overall Study|Lost to Follow-up|0|||
25310801|NCT00688597|50626098|FG000|Overall Study|Adverse Event|2|||
25310802|NCT00688597|50626099|FG001|Overall Study|Adverse Event|0|||
25310803|NCT00688597|50626100|FG002|Overall Study|Adverse Event|0|||
25310804|NCT00688597|50626098|FG000|Overall Study|Physician Decision|1|||
25310805|NCT00688597|50626099|FG001|Overall Study|Physician Decision|0|||
25310806|NCT00688597|50626100|FG002|Overall Study|Physician Decision|0|||
25310807|NCT00735904|50626108|FG000|Overall Study|Adverse Event|3|||
25310808|NCT00735904|50626108|FG000|Overall Study|Death|20|||
25310809|NCT00735904|50626108|FG000|Overall Study|Protocol Violation|1|||
25310810|NCT00735904|50626108|FG000|Overall Study|Withdrawal by Subject|1|||
25310811|NCT00735904|50626108|FG000|Overall Study|Study Terminated by Sponsor|5|||
25310812|NCT00735904|50626108|FG000|Overall Study|Other|8|||
25310813|NCT00688519|50626114|FG000|Overall Study|Adverse Event|2|||
25310814|NCT00688519|50626115|FG001|Overall Study|Adverse Event|3|||
25310815|NCT00688519|50626114|FG000|Overall Study|Lost to Follow-up|3|||
25310816|NCT00688519|50626115|FG001|Overall Study|Lost to Follow-up|3|||
25310817|NCT00688519|50626114|FG000|Overall Study|Lack of Efficacy|3|||
25310818|NCT00688519|50626115|FG001|Overall Study|Lack of Efficacy|1|||
25310819|NCT00688519|50626114|FG000|Overall Study|Withdrawal by Subject|7|||
25310820|NCT00688519|50626115|FG001|Overall Study|Withdrawal by Subject|6|||
25310821|NCT00688519|50626114|FG000|Overall Study|Prohibited medication|1|||
25310822|NCT00688519|50626115|FG001|Overall Study|Prohibited medication|0|||
25310823|NCT00688519|50626114|FG000|Overall Study|Non-compliance|0|||
25310824|NCT00688519|50626115|FG001|Overall Study|Non-compliance|1|||
25310825|NCT00688519|50626114|FG000|Overall Study|Subject moved out of state|1|||
25310826|NCT00688519|50626115|FG001|Overall Study|Subject moved out of state|0|||
25310827|NCT00688519|50626114|FG000|Overall Study|Investigator decision|1|||
25310828|NCT00688519|50626115|FG001|Overall Study|Investigator decision|0|||
25310829|NCT00688519|50626114|FG000|Overall Study|Subject moved out of area|1|||
25310830|NCT00688519|50626115|FG001|Overall Study|Subject moved out of area|0|||
25310831|NCT00688519|50626114|FG000|Overall Study|Pregnancy|0|||
25310832|NCT00688519|50626115|FG001|Overall Study|Pregnancy|1|||
25310833|NCT00721630|50626121|FG000|Overall Study|Participant found to be ineligible|1|||
25310834|NCT00686725|50626127|FG000|Overall Study|Adverse Event|1|||
25310835|NCT00686725|50626128|FG001|Overall Study|Adverse Event|1|||
25310836|NCT00686725|50626127|FG000|Overall Study|Progressive Disease|17|||
25310837|NCT00686725|50626128|FG001|Overall Study|Progressive Disease|23|||
25310838|NCT00686725|50626127|FG000|Overall Study|Lost to Follow-up|7|||
25310839|NCT00686725|50626128|FG001|Overall Study|Lost to Follow-up|5|||
25310840|NCT00686725|50626127|FG000|Overall Study|Death|6|||
25310841|NCT00686725|50626128|FG001|Overall Study|Death|3|||
25310842|NCT00686725|50626127|FG000|Overall Study|Withdrawal by Subject|13|||
25310843|NCT00686725|50626128|FG001|Overall Study|Withdrawal by Subject|4|||
25310844|NCT00686725|50626127|FG000|Overall Study|Protocol Violation|1|||
25310845|NCT00686725|50626128|FG001|Overall Study|Protocol Violation|3|||
25310846|NCT00686725|50626127|FG000|Overall Study|Other|1|||
25310847|NCT00686725|50626128|FG001|Overall Study|Other|3|||
25310848|NCT00727402|50626134|FG000|Overall Study|Physician Decision|116|||
25310849|NCT00727246|50626142|FG000|Overall Study|could not complete MRI|0|||
25310850|NCT00727246|50626143|FG001|Overall Study|could not complete MRI|1|||
25310851|NCT00727246|50626144|FG002|Overall Study|could not complete MRI|0|||
25310852|NCT00727246|50626145|FG003|Overall Study|could not complete MRI|1|||
25310853|NCT00727246|50626142|FG000|Overall Study|incidental finding|0|||
25310854|NCT00727246|50626143|FG001|Overall Study|incidental finding|0|||
25310855|NCT00727246|50626144|FG002|Overall Study|incidental finding|0|||
25310856|NCT00727246|50626145|FG003|Overall Study|incidental finding|1|||
25310857|NCT00727246|50626142|FG000|Overall Study|withdrawn|0|||
25310858|NCT00727246|50626143|FG001|Overall Study|withdrawn|0|||
25310859|NCT00727246|50626144|FG002|Overall Study|withdrawn|1|||
25310860|NCT00727246|50626145|FG003|Overall Study|withdrawn|0|||
25310861|NCT00686647|50626155|FG000|Overall Study|Lost to Follow-up|1|||
25310862|NCT00686647|50626155|FG000|Overall Study|Death|1|||
25310863|NCT00687973|50626162|FG000|Overall Study|Adverse Event|18|||
24970225|NCT04142242|50059724|FG000|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
24970226|NCT04142242|50059725|FG001|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|1|||
24970227|NCT04142242|50059726|FG002|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
24970228|NCT04142242|50059727|FG003|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
24970229|NCT04142242|50059728|FG004|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
25192215|NCT01465178|50357453|FG000|Overall Study|Withdrawal by Subject|1|||
25310864|NCT00687973|50626163|FG001|Overall Study|Adverse Event|28|||
25310865|NCT00687973|50626162|FG000|Overall Study|Lack of Efficacy|2|||
25310866|NCT00687973|50626163|FG001|Overall Study|Lack of Efficacy|3|||
25310867|NCT00687973|50626162|FG000|Overall Study|Protocol Violation|1|||
25310868|NCT00687973|50626163|FG001|Overall Study|Protocol Violation|2|||
25310869|NCT00687973|50626162|FG000|Overall Study|Administrative Reasons|0|||
25310870|NCT00687973|50626163|FG001|Overall Study|Administrative Reasons|2|||
25310871|NCT00687973|50626162|FG000|Overall Study|Withdrawal by Subject|3|||
25310872|NCT00687973|50626163|FG001|Overall Study|Withdrawal by Subject|3|||
25310873|NCT00721396|50626174|FG000|Overall Study|Adverse Event|4|||
25310874|NCT00721396|50626175|FG001|Overall Study|Adverse Event|7|||
25310875|NCT00721396|50626176|FG002|Overall Study|Adverse Event|2|||
25310876|NCT00721396|50626177|FG003|Overall Study|Adverse Event|0|||
25310877|NCT00721396|50626174|FG000|Overall Study|Withdrawal by Subject|12|||
25310878|NCT00721396|50626175|FG001|Overall Study|Withdrawal by Subject|15|||
25310879|NCT00721396|50626176|FG002|Overall Study|Withdrawal by Subject|3|||
25310880|NCT00721396|50626177|FG003|Overall Study|Withdrawal by Subject|7|||
25310881|NCT00721396|50626174|FG000|Overall Study|Lost to Follow-up|7|||
25310882|NCT00721396|50626175|FG001|Overall Study|Lost to Follow-up|9|||
25310883|NCT00721396|50626176|FG002|Overall Study|Lost to Follow-up|3|||
25310884|NCT00721396|50626177|FG003|Overall Study|Lost to Follow-up|3|||
25310885|NCT00721396|50626174|FG000|Overall Study|Protocol Violation|4|||
25310886|NCT00721396|50626175|FG001|Overall Study|Protocol Violation|3|||
25310887|NCT00721396|50626176|FG002|Overall Study|Protocol Violation|1|||
25310888|NCT00721396|50626177|FG003|Overall Study|Protocol Violation|0|||
25310889|NCT00721396|50626174|FG000|Overall Study|Inappropriate enrollment|0|||
25310890|NCT00721396|50626175|FG001|Overall Study|Inappropriate enrollment|2|||
25310891|NCT00721396|50626176|FG002|Overall Study|Inappropriate enrollment|0|||
25310892|NCT00721396|50626177|FG003|Overall Study|Inappropriate enrollment|0|||
25310893|NCT00721396|50626174|FG000|Overall Study|Administrative reason|3|||
25310894|NCT00721396|50626175|FG001|Overall Study|Administrative reason|0|||
25310895|NCT00721396|50626176|FG002|Overall Study|Administrative reason|1|||
25310896|NCT00721396|50626177|FG003|Overall Study|Administrative reason|0|||
25310897|NCT00943826|50626194|FG000|Concurrent Phase|Adverse Event|50|||
25310898|NCT00943826|50626195|FG001|Concurrent Phase|Adverse Event|27|||
25310899|NCT00943826|50626194|FG000|Concurrent Phase|Withdrew consent|3|||
25310900|NCT00943826|50626195|FG001|Concurrent Phase|Withdrew consent|7|||
25310901|NCT00943826|50626194|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
25310902|NCT00943826|50626195|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
25310903|NCT00943826|50626194|FG000|Concurrent Phase|Administrative reasons|2|||
25310904|NCT00943826|50626195|FG001|Concurrent Phase|Administrative reasons|1|||
25310905|NCT00943826|50626194|FG000|Concurrent Phase|Protocol Violation|1|||
25310906|NCT00943826|50626195|FG001|Concurrent Phase|Protocol Violation|0|||
25310907|NCT00943826|50626194|FG000|Maintenance Phase|Adverse Event|31|||
25310908|NCT00943826|50626195|FG001|Maintenance Phase|Adverse Event|30|||
25310909|NCT00943826|50626194|FG000|Maintenance Phase|Withdrew consent|2|||
25310910|NCT00943826|50626195|FG001|Maintenance Phase|Withdrew consent|4|||
25310911|NCT00943826|50626194|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
25310912|NCT00943826|50626195|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
25310913|NCT00943826|50626194|FG000|Maintenance Phase|Administrative reasons|4|||
25310914|NCT00943826|50626195|FG001|Maintenance Phase|Administrative reasons|1|||
25310915|NCT00943826|50626194|FG000|Maintenance Phase|Failure to return|0|||
25310916|NCT00943826|50626195|FG001|Maintenance Phase|Failure to return|1|||
25310917|NCT00943826|50626194|FG000|Monotherapy Phase|Adverse Event|42|||
25310918|NCT00943826|50626195|FG001|Monotherapy Phase|Adverse Event|5|||
25310919|NCT00943826|50626194|FG000|Monotherapy Phase|Administrative reasons|11|||
25310920|NCT00943826|50626195|FG001|Monotherapy Phase|Administrative reasons|5|||
25310921|NCT00943826|50626194|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
25310922|NCT00943826|50626195|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
25310923|NCT00943826|50626194|FG000|Monotherapy Phase|Withdrew Consent|2|||
25310924|NCT00943826|50626195|FG001|Monotherapy Phase|Withdrew Consent|3|||
25310925|NCT00943826|50626194|FG000|Monotherapy Phase|Failure to return|2|||
25310926|NCT00943826|50626195|FG001|Monotherapy Phase|Failure to return|1|||
25310927|NCT00943826|50626194|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
25310928|NCT00943826|50626195|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
25310929|NCT00943826|50626194|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
25310930|NCT00943826|50626195|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
25310931|NCT00943826|50626194|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
25310932|NCT00943826|50626195|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
25310933|NCT00943826|50626194|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
25310934|NCT00943826|50626195|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
25310935|NCT01004003|50626211|FG000|Overall Study|Progressive disease|2|||
25310936|NCT01004003|50626212|FG001|Overall Study|Progressive disease|1|||
25310937|NCT01004003|50626213|FG002|Overall Study|Progressive disease|1|||
25310938|NCT01004003|50626214|FG003|Overall Study|Progressive disease|0|||
25310939|NCT01004003|50626215|FG004|Overall Study|Progressive disease|2|||
25310940|NCT01004003|50626216|FG005|Overall Study|Progressive disease|1|||
25310941|NCT01004003|50626217|FG006|Overall Study|Progressive disease|1|||
25310942|NCT01004003|50626218|FG007|Overall Study|Progressive disease|39|||
25310943|NCT01004003|50626219|FG008|Overall Study|Progressive disease|22|||
25310944|NCT01004003|50626211|FG000|Overall Study|Adverse Event|4|||
25310945|NCT01004003|50626212|FG001|Overall Study|Adverse Event|2|||
25310946|NCT01004003|50626213|FG002|Overall Study|Adverse Event|3|||
25310947|NCT01004003|50626214|FG003|Overall Study|Adverse Event|3|||
25310948|NCT01004003|50626215|FG004|Overall Study|Adverse Event|2|||
25310949|NCT01004003|50626216|FG005|Overall Study|Adverse Event|2|||
25310950|NCT01004003|50626217|FG006|Overall Study|Adverse Event|7|||
25310951|NCT01004003|50626218|FG007|Overall Study|Adverse Event|21|||
25310952|NCT01004003|50626219|FG008|Overall Study|Adverse Event|6|||
25310953|NCT01004003|50626211|FG000|Overall Study|Refused to continue taking trial med.|0|||
25310954|NCT01004003|50626212|FG001|Overall Study|Refused to continue taking trial med.|0|||
25310955|NCT01004003|50626213|FG002|Overall Study|Refused to continue taking trial med.|0|||
25310956|NCT01004003|50626214|FG003|Overall Study|Refused to continue taking trial med.|0|||
25310957|NCT01004003|50626215|FG004|Overall Study|Refused to continue taking trial med.|0|||
25310958|NCT01004003|50626216|FG005|Overall Study|Refused to continue taking trial med.|0|||
25310959|NCT01004003|50626217|FG006|Overall Study|Refused to continue taking trial med.|0|||
25310960|NCT01004003|50626218|FG007|Overall Study|Refused to continue taking trial med.|0|||
25310961|NCT01004003|50626219|FG008|Overall Study|Refused to continue taking trial med.|2|||
25310962|NCT01004003|50626211|FG000|Overall Study|Other|0|||
25310963|NCT01004003|50626212|FG001|Overall Study|Other|0|||
25310964|NCT01004003|50626213|FG002|Overall Study|Other|0|||
25310965|NCT01004003|50626214|FG003|Overall Study|Other|0|||
25310966|NCT01004003|50626215|FG004|Overall Study|Other|0|||
25310967|NCT01004003|50626216|FG005|Overall Study|Other|1|||
25310968|NCT01004003|50626217|FG006|Overall Study|Other|0|||
25310969|NCT01004003|50626218|FG007|Overall Study|Other|0|||
25310970|NCT01004003|50626219|FG008|Overall Study|Other|0|||
25310971|NCT00943670|50626241|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
25310972|NCT00943670|50626241|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
25310973|NCT00943670|50626241|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
25310974|NCT00943670|50626241|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
25310975|NCT00943670|50626241|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
25310976|NCT00943670|50626241|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
25310977|NCT00943670|50626241|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
25310978|NCT00943670|50626241|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
25310979|NCT00943670|50626241|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
25310980|NCT00943670|50626241|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
25310981|NCT00938366|50626258|FG000|Overall Study|Withdrawal by Subject|1|||
25310982|NCT00938366|50626259|FG001|Overall Study|Withdrawal by Subject|0|||
25310983|NCT00943592|50626265|FG000|Overall Study|Death|3|||
25310984|NCT00943124|50626269|FG000|Period 1|Withdrawal by Subject|1|||
25310985|NCT00943124|50626270|FG001|Period 1|Withdrawal by Subject|1|||
25310986|NCT00943124|50626269|FG000|Period 1|Did Not Follow Study Procedures|1|||
25310987|NCT00943124|50626270|FG001|Period 1|Did Not Follow Study Procedures|0|||
25310988|NCT00943124|50626269|FG000|Period 1|Personal Reasons|0|||
25310989|NCT00943124|50626270|FG001|Period 1|Personal Reasons|1|||
25310990|NCT00492050|50626276|FG000|Overall Study|Adverse Event|1|||
25310991|NCT00492050|50626276|FG000|Overall Study|Lack of Efficacy|1|||
25310992|NCT00492050|50626276|FG000|Overall Study|Withdrawal by Subject|3|||
25310993|NCT00492050|50626276|FG000|Overall Study|Unable to collect SCT|2|||
25310994|NCT00492050|50626276|FG000|Overall Study|Progressive Disease|2|||
25310995|NCT00726622|50626282|FG000|Overall Study|Withdrawal by Subject|16|||
25310996|NCT00726622|50626283|FG001|Overall Study|Withdrawal by Subject|2|||
25310997|NCT00726622|50626282|FG000|Overall Study|Physician Decision|0|||
25310998|NCT00726622|50626283|FG001|Overall Study|Physician Decision|1|||
25310999|NCT00726622|50626282|FG000|Overall Study|Metastasis|2|||
25311000|NCT00726622|50626283|FG001|Overall Study|Metastasis|0|||
25311001|NCT00940316|50626292|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
25311002|NCT00940316|50626293|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
25311003|NCT00940316|50626294|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
25311004|NCT00940316|50626292|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
25311005|NCT00940316|50626293|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
25311006|NCT00940316|50626294|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
25311007|NCT00940316|50626292|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
25311008|NCT00940316|50626293|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
25311009|NCT00940316|50626294|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
25311010|NCT00940316|50626292|FG000|Treated After Cycle 5|Adverse Event|0|||
25311011|NCT00940316|50626293|FG001|Treated After Cycle 5|Adverse Event|0|||
25311012|NCT00940316|50626294|FG002|Treated After Cycle 5|Adverse Event|1|||
25311013|NCT00940316|50626292|FG000|Treated After Cycle 5|Progressive disease|0|||
25311014|NCT00940316|50626293|FG001|Treated After Cycle 5|Progressive disease|1|||
25311015|NCT00940316|50626294|FG002|Treated After Cycle 5|Progressive disease|0|||
25311016|NCT00726388|50626310|FG000|Overall Study|Withdrawal by Subject|5|||
25311017|NCT00726388|50626310|FG000|Overall Study|Adverse Event|3|||
24970230|NCT04142242|50059729|FG005|Overall Study|Voluntary withdrawal not due to an adverse event (AE)|0|||
24970231|NCT04142242|50059724|FG000|Overall Study|Ongoing|0|||
25311018|NCT00726388|50626310|FG000|Overall Study|Lost to Follow-up|10|||
24970232|NCT04142242|50059725|FG001|Overall Study|Ongoing|0|||
24970233|NCT04142242|50059726|FG002|Overall Study|Ongoing|31|||
24970234|NCT04142242|50059727|FG003|Overall Study|Ongoing|39|||
25311019|NCT00726388|50626310|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
25311020|NCT00726388|50626310|FG000|Overall Study|Other|5|||
25311021|NCT00726388|50626310|FG000|Overall Study|Enrolled, Not Treated|79|||
25311022|NCT00572455|50626328|FG000|Stage I (14 Days)|Adverse Event|0|||
25311023|NCT00572455|50626329|FG001|Stage I (14 Days)|Adverse Event|0|||
25311024|NCT00572455|50626330|FG002|Stage I (14 Days)|Adverse Event|0|||
25311025|NCT00572455|50626331|FG003|Stage I (14 Days)|Adverse Event|0|||
25311026|NCT00572455|50626332|FG004|Stage I (14 Days)|Adverse Event|0|||
25311027|NCT00572455|50626333|FG005|Stage I (14 Days)|Adverse Event|3|||
25311028|NCT00572455|50626334|FG006|Stage I (14 Days)|Adverse Event|0|||
25311029|NCT00572455|50626335|FG007|Stage I (14 Days)|Adverse Event|0|||
25311030|NCT00572455|50626336|FG008|Stage I (14 Days)|Adverse Event|0|||
25311031|NCT00572455|50626337|FG009|Stage I (14 Days)|Adverse Event|0|||
25311032|NCT00572455|50626338|FG010|Stage I (14 Days)|Adverse Event|0|||
25311033|NCT00572455|50626339|FG011|Stage I (14 Days)|Adverse Event|0|||
25311034|NCT00572455|50626340|FG012|Stage I (14 Days)|Adverse Event|0|||
25311035|NCT00572455|50626341|FG013|Stage I (14 Days)|Adverse Event|0|||
25311036|NCT00572455|50626328|FG000|Stage I (14 Days)|Other|0|||
25311037|NCT00572455|50626329|FG001|Stage I (14 Days)|Other|0|||
25311038|NCT00572455|50626330|FG002|Stage I (14 Days)|Other|0|||
25311039|NCT00572455|50626331|FG003|Stage I (14 Days)|Other|0|||
25311040|NCT00572455|50626332|FG004|Stage I (14 Days)|Other|1|||
25311041|NCT00572455|50626333|FG005|Stage I (14 Days)|Other|0|||
25311042|NCT00572455|50626334|FG006|Stage I (14 Days)|Other|0|||
25311043|NCT00572455|50626335|FG007|Stage I (14 Days)|Other|0|||
25311044|NCT00572455|50626336|FG008|Stage I (14 Days)|Other|0|||
25311045|NCT00572455|50626337|FG009|Stage I (14 Days)|Other|0|||
25311046|NCT00572455|50626338|FG010|Stage I (14 Days)|Other|0|||
25311047|NCT00572455|50626339|FG011|Stage I (14 Days)|Other|0|||
25311048|NCT00572455|50626340|FG012|Stage I (14 Days)|Other|0|||
25311049|NCT00572455|50626341|FG013|Stage I (14 Days)|Other|0|||
25311050|NCT00572455|50626328|FG000|Stage II (28 Days)|Adverse Event|0|||
25311051|NCT00572455|50626329|FG001|Stage II (28 Days)|Adverse Event|0|||
25311052|NCT00572455|50626330|FG002|Stage II (28 Days)|Adverse Event|0|||
25311053|NCT00572455|50626331|FG003|Stage II (28 Days)|Adverse Event|0|||
25311054|NCT00572455|50626332|FG004|Stage II (28 Days)|Adverse Event|0|||
25311055|NCT00572455|50626333|FG005|Stage II (28 Days)|Adverse Event|0|||
25311056|NCT00572455|50626334|FG006|Stage II (28 Days)|Adverse Event|0|||
25311057|NCT00572455|50626335|FG007|Stage II (28 Days)|Adverse Event|0|||
25311058|NCT00572455|50626336|FG008|Stage II (28 Days)|Adverse Event|1|||
25311059|NCT00572455|50626337|FG009|Stage II (28 Days)|Adverse Event|3|||
25311060|NCT00572455|50626338|FG010|Stage II (28 Days)|Adverse Event|3|||
25311061|NCT00572455|50626339|FG011|Stage II (28 Days)|Adverse Event|4|||
25311062|NCT00572455|50626340|FG012|Stage II (28 Days)|Adverse Event|5|||
25311063|NCT00572455|50626341|FG013|Stage II (28 Days)|Adverse Event|1|||
25311064|NCT00572455|50626328|FG000|Stage II (28 Days)|Death|0|||
25311065|NCT00572455|50626329|FG001|Stage II (28 Days)|Death|0|||
25311066|NCT00572455|50626330|FG002|Stage II (28 Days)|Death|0|||
25311067|NCT00572455|50626331|FG003|Stage II (28 Days)|Death|0|||
25311068|NCT00572455|50626332|FG004|Stage II (28 Days)|Death|0|||
25311069|NCT00572455|50626333|FG005|Stage II (28 Days)|Death|0|||
25311070|NCT00572455|50626334|FG006|Stage II (28 Days)|Death|0|||
25311071|NCT00572455|50626335|FG007|Stage II (28 Days)|Death|0|||
25311072|NCT00572455|50626336|FG008|Stage II (28 Days)|Death|1|||
25311073|NCT00572455|50626337|FG009|Stage II (28 Days)|Death|0|||
25311074|NCT00572455|50626338|FG010|Stage II (28 Days)|Death|0|||
25311075|NCT00572455|50626339|FG011|Stage II (28 Days)|Death|0|||
25311076|NCT00572455|50626340|FG012|Stage II (28 Days)|Death|0|||
25311077|NCT00572455|50626341|FG013|Stage II (28 Days)|Death|0|||
25311078|NCT00572455|50626328|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
25311079|NCT00572455|50626329|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
25311080|NCT00572455|50626330|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
25311081|NCT00572455|50626331|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
25311082|NCT00572455|50626332|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
25311083|NCT00572455|50626333|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
25311084|NCT00572455|50626334|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
25311085|NCT00572455|50626335|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
24970235|NCT04142242|50059728|FG004|Overall Study|Ongoing|0|||
25311086|NCT00572455|50626336|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
25311087|NCT00572455|50626337|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
25311088|NCT00572455|50626338|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
25311089|NCT00572455|50626339|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
25311090|NCT00572455|50626340|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
25311091|NCT00572455|50626341|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
25311092|NCT00572455|50626328|FG000|Stage II (28 Days)|Other|0|||
25311093|NCT00572455|50626329|FG001|Stage II (28 Days)|Other|0|||
25311094|NCT00572455|50626330|FG002|Stage II (28 Days)|Other|0|||
25311095|NCT00572455|50626331|FG003|Stage II (28 Days)|Other|0|||
24970236|NCT04142242|50059729|FG005|Overall Study|Ongoing|0|||
25311096|NCT00572455|50626332|FG004|Stage II (28 Days)|Other|0|||
25311097|NCT00572455|50626333|FG005|Stage II (28 Days)|Other|0|||
25311098|NCT00572455|50626334|FG006|Stage II (28 Days)|Other|0|||
25311099|NCT00572455|50626335|FG007|Stage II (28 Days)|Other|0|||
25311100|NCT00572455|50626336|FG008|Stage II (28 Days)|Other|1|||
25311101|NCT00572455|50626337|FG009|Stage II (28 Days)|Other|0|||
25311102|NCT00572455|50626338|FG010|Stage II (28 Days)|Other|0|||
25311103|NCT00572455|50626339|FG011|Stage II (28 Days)|Other|0|||
25311104|NCT00572455|50626340|FG012|Stage II (28 Days)|Other|0|||
25311105|NCT00572455|50626341|FG013|Stage II (28 Days)|Other|0|||
25311106|NCT00572455|50626328|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
25311107|NCT00572455|50626329|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
25311108|NCT00572455|50626330|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
25311109|NCT00572455|50626331|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
25311110|NCT00572455|50626332|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
25311111|NCT00572455|50626333|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
25311112|NCT00572455|50626334|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
25311113|NCT00572455|50626335|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
25311114|NCT00572455|50626336|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
25311115|NCT00572455|50626337|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
25311116|NCT00572455|50626338|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
25311117|NCT00572455|50626339|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
25311118|NCT00572455|50626340|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
25311119|NCT00572455|50626341|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
25311120|NCT01003691|50626375|FG000|Overall Study|Adverse Event|0|||
25311121|NCT01003691|50626376|FG001|Overall Study|Adverse Event|0|||
25311122|NCT01003691|50626377|FG002|Overall Study|Adverse Event|0|||
25311123|NCT01003691|50626378|FG003|Overall Study|Adverse Event|1|||
25311124|NCT00686335|50626389|FG000|Run-in Period|Adverse Event|1|||
25311125|NCT00686335|50626389|FG000|Run-in Period|asthma exacerbation|1|||
25311126|NCT00686335|50626389|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
25311127|NCT01002989|50626395|FG000|Overall Study|exclusion criteria, no consent|5|||
25311128|NCT00685945|50626399|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
25311129|NCT01007123|50626413|FG000|Overall Study|Adverse Event|3|||
25311130|NCT01007123|50626414|FG001|Overall Study|Adverse Event|4|||
25311131|NCT01007123|50626415|FG002|Overall Study|Adverse Event|7|||
25311132|NCT01007123|50626416|FG003|Overall Study|Adverse Event|1|||
25311133|NCT01007123|50626413|FG000|Overall Study|Lack of Efficacy|1|||
25311134|NCT01007123|50626414|FG001|Overall Study|Lack of Efficacy|0|||
25311135|NCT01007123|50626415|FG002|Overall Study|Lack of Efficacy|1|||
25311136|NCT01007123|50626416|FG003|Overall Study|Lack of Efficacy|4|||
25311137|NCT01007123|50626413|FG000|Overall Study|Protocol Violation|1|||
25311138|NCT01007123|50626414|FG001|Overall Study|Protocol Violation|1|||
25311139|NCT01007123|50626415|FG002|Overall Study|Protocol Violation|2|||
25311140|NCT01007123|50626416|FG003|Overall Study|Protocol Violation|1|||
25311141|NCT01007123|50626413|FG000|Overall Study|Withdrawal by Subject|1|||
25311142|NCT01007123|50626414|FG001|Overall Study|Withdrawal by Subject|0|||
25311143|NCT01007123|50626415|FG002|Overall Study|Withdrawal by Subject|1|||
25311144|NCT01007123|50626416|FG003|Overall Study|Withdrawal by Subject|0|||
25311145|NCT01007123|50626413|FG000|Overall Study|Lost to Follow-up|0|||
25311146|NCT01007123|50626414|FG001|Overall Study|Lost to Follow-up|1|||
25311147|NCT01007123|50626415|FG002|Overall Study|Lost to Follow-up|0|||
25311148|NCT01007123|50626416|FG003|Overall Study|Lost to Follow-up|0|||
25311149|NCT00687739|50626431|FG000|Overall Study|Lost to Follow-up|2|||
25311150|NCT00687739|50626432|FG001|Overall Study|Lost to Follow-up|2|||
25311151|NCT00687739|50626433|FG002|Overall Study|Lost to Follow-up|1|||
25311152|NCT00687739|50626434|FG003|Overall Study|Lost to Follow-up|2|||
25311153|NCT00687739|50626431|FG000|Overall Study|Adverse Event|0|||
25311154|NCT00687739|50626432|FG001|Overall Study|Adverse Event|1|||
25311155|NCT00687739|50626433|FG002|Overall Study|Adverse Event|1|||
25311156|NCT00687739|50626434|FG003|Overall Study|Adverse Event|0|||
25311157|NCT01006889|50626446|FG000|Overall Study|Withdrawal by Subject|3|||
25311158|NCT01001429|50626453|FG000|Overall Study|surgery cancelled|0|||
25311159|NCT01001429|50626454|FG001|Overall Study|surgery cancelled|1|||
25311160|NCT01000961|50626484|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
25311161|NCT01000961|50626485|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
25311162|NCT01000961|50626484|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
25311163|NCT01000961|50626485|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
25311164|NCT01000805|50626495|FG000|Overall Study|Adverse Event|21|||
25311165|NCT01000805|50626496|FG001|Overall Study|Adverse Event|9|||
25311166|NCT01000805|50626495|FG000|Overall Study|Lack of Efficacy|5|||
25311167|NCT01000805|50626496|FG001|Overall Study|Lack of Efficacy|16|||
25311168|NCT01000805|50626495|FG000|Overall Study|Lost to Follow-up|16|||
25311169|NCT01000805|50626496|FG001|Overall Study|Lost to Follow-up|21|||
25311170|NCT01000805|50626495|FG000|Overall Study|Physician Decision|0|||
25311171|NCT01000805|50626496|FG001|Overall Study|Physician Decision|1|||
25311172|NCT01000805|50626495|FG000|Overall Study|Protocol Violation|12|||
25311173|NCT01000805|50626496|FG001|Overall Study|Protocol Violation|8|||
25311174|NCT01000805|50626495|FG000|Overall Study|Withdrawal by Subject|16|||
25311175|NCT01000805|50626496|FG001|Overall Study|Withdrawal by Subject|6|||
25311176|NCT01000805|50626495|FG000|Overall Study|Sponsor Decision|0|||
25311177|NCT01000805|50626496|FG001|Overall Study|Sponsor Decision|1|||
25311178|NCT00684307|50626508|FG000|Overall Study|Adverse Event|11|||
25311179|NCT00684307|50626509|FG001|Overall Study|Adverse Event|6|||
25311180|NCT00684307|50626510|FG002|Overall Study|Adverse Event|15|||
25311181|NCT00684307|50626511|FG003|Overall Study|Adverse Event|16|||
25311182|NCT00684307|50626512|FG004|Overall Study|Adverse Event|8|||
25311183|NCT00684307|50626508|FG000|Overall Study|Development of increasing Liver Function|0|||
25311184|NCT00684307|50626509|FG001|Overall Study|Development of increasing Liver Function|2|||
25311185|NCT00684307|50626510|FG002|Overall Study|Development of increasing Liver Function|0|||
25311186|NCT00684307|50626511|FG003|Overall Study|Development of increasing Liver Function|1|||
25311187|NCT00684307|50626512|FG004|Overall Study|Development of increasing Liver Function|0|||
25311188|NCT00684307|50626508|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
25311189|NCT00684307|50626509|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
25311190|NCT00684307|50626510|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
25311191|NCT00684307|50626511|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
25311192|NCT00684307|50626512|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
25311193|NCT00684307|50626508|FG000|Overall Study|Incorrect enrolment or randomization|4|||
25311194|NCT00684307|50626509|FG001|Overall Study|Incorrect enrolment or randomization|0|||
25311195|NCT00684307|50626510|FG002|Overall Study|Incorrect enrolment or randomization|0|||
25311196|NCT00684307|50626511|FG003|Overall Study|Incorrect enrolment or randomization|0|||
25311197|NCT00684307|50626512|FG004|Overall Study|Incorrect enrolment or randomization|0|||
25311198|NCT00684307|50626508|FG000|Overall Study|Interupted IP for more than 7 days|0|||
25311199|NCT00684307|50626509|FG001|Overall Study|Interupted IP for more than 7 days|4|||
25311200|NCT00684307|50626510|FG002|Overall Study|Interupted IP for more than 7 days|1|||
25311201|NCT00684307|50626511|FG003|Overall Study|Interupted IP for more than 7 days|3|||
25311202|NCT00684307|50626512|FG004|Overall Study|Interupted IP for more than 7 days|3|||
25311203|NCT00684307|50626508|FG000|Overall Study|Severe non compliance to protocol|1|||
25311204|NCT00684307|50626509|FG001|Overall Study|Severe non compliance to protocol|0|||
25311205|NCT00684307|50626510|FG002|Overall Study|Severe non compliance to protocol|0|||
25311206|NCT00684307|50626511|FG003|Overall Study|Severe non compliance to protocol|1|||
25311207|NCT00684307|50626512|FG004|Overall Study|Severe non compliance to protocol|2|||
25311208|NCT00684307|50626508|FG000|Overall Study|Participant not willing to continue|7|||
25311209|NCT00684307|50626509|FG001|Overall Study|Participant not willing to continue|10|||
25311210|NCT00684307|50626510|FG002|Overall Study|Participant not willing to continue|11|||
25311211|NCT00684307|50626511|FG003|Overall Study|Participant not willing to continue|5|||
25311212|NCT00684307|50626512|FG004|Overall Study|Participant not willing to continue|8|||
25311213|NCT00684307|50626508|FG000|Overall Study|Criteria from the CSR|0|||
25311214|NCT00684307|50626509|FG001|Overall Study|Criteria from the CSR|0|||
25311215|NCT00684307|50626510|FG002|Overall Study|Criteria from the CSR|1|||
25311216|NCT00684307|50626511|FG003|Overall Study|Criteria from the CSR|3|||
25311217|NCT00684307|50626512|FG004|Overall Study|Criteria from the CSR|3|||
25311218|NCT00683917|50626527|FG000|Overall Study|Study prematurely terminated|10|||
25311219|NCT00687271|50626539|FG000|Overall Study|Adverse Event|1|||
25311220|NCT00687271|50626540|FG001|Overall Study|Adverse Event|3|||
25311221|NCT00687271|50626541|FG002|Overall Study|Adverse Event|1|||
25311222|NCT00687271|50626542|FG003|Overall Study|Adverse Event|0|||
25311223|NCT00687271|50626539|FG000|Overall Study|Lost to Follow-up|0|||
25311224|NCT00687271|50626540|FG001|Overall Study|Lost to Follow-up|1|||
25311225|NCT00687271|50626541|FG002|Overall Study|Lost to Follow-up|0|||
25311226|NCT00687271|50626542|FG003|Overall Study|Lost to Follow-up|0|||
25311227|NCT00687271|50626539|FG000|Overall Study|Protocol Violation|2|||
25311228|NCT00687271|50626540|FG001|Overall Study|Protocol Violation|1|||
25311229|NCT00687271|50626541|FG002|Overall Study|Protocol Violation|1|||
25311230|NCT00687271|50626542|FG003|Overall Study|Protocol Violation|0|||
25311231|NCT00687271|50626539|FG000|Overall Study|Withdrawal by Subject|0|||
25311232|NCT00687271|50626540|FG001|Overall Study|Withdrawal by Subject|1|||
25311233|NCT00687271|50626541|FG002|Overall Study|Withdrawal by Subject|3|||
25311234|NCT00687271|50626542|FG003|Overall Study|Withdrawal by Subject|0|||
25311235|NCT04617275|50626560|FG000|Treatment Period|Adverse Event|1|||
25311236|NCT04617275|50626561|FG001|Treatment Period|Adverse Event|6|||
25311237|NCT04617275|50626562|FG002|Treatment Period|Adverse Event|4|||
25311238|NCT04617275|50626563|FG003|Treatment Period|Adverse Event|6|||
25311239|NCT04617275|50626564|FG004|Treatment Period|Adverse Event|7|||
25311240|NCT04617275|50626565|FG005|Treatment Period|Adverse Event|8|||
25311241|NCT04617275|50626566|FG006|Treatment Period|Adverse Event|0|||
25311242|NCT04617275|50626567|FG007|Treatment Period|Adverse Event|12|||
25311243|NCT04617275|50626560|FG000|Treatment Period|Lost to Follow-up|0|||
25311244|NCT04617275|50626561|FG001|Treatment Period|Lost to Follow-up|0|||
25311245|NCT04617275|50626562|FG002|Treatment Period|Lost to Follow-up|2|||
25311246|NCT04617275|50626563|FG003|Treatment Period|Lost to Follow-up|0|||
25311247|NCT04617275|50626564|FG004|Treatment Period|Lost to Follow-up|0|||
25311248|NCT04617275|50626565|FG005|Treatment Period|Lost to Follow-up|3|||
25311249|NCT04617275|50626566|FG006|Treatment Period|Lost to Follow-up|0|||
25311250|NCT04617275|50626567|FG007|Treatment Period|Lost to Follow-up|2|||
25311251|NCT04617275|50626560|FG000|Treatment Period|No longer meets eligibility criteria|0|||
25311252|NCT04617275|50626561|FG001|Treatment Period|No longer meets eligibility criteria|0|||
25311253|NCT04617275|50626562|FG002|Treatment Period|No longer meets eligibility criteria|0|||
25311254|NCT04617275|50626563|FG003|Treatment Period|No longer meets eligibility criteria|1|||
25311255|NCT04617275|50626564|FG004|Treatment Period|No longer meets eligibility criteria|0|||
25311256|NCT04617275|50626565|FG005|Treatment Period|No longer meets eligibility criteria|0|||
25311257|NCT04617275|50626566|FG006|Treatment Period|No longer meets eligibility criteria|0|||
25311258|NCT04617275|50626567|FG007|Treatment Period|No longer meets eligibility criteria|0|||
25311259|NCT04617275|50626560|FG000|Treatment Period|Other|0|||
25311260|NCT04617275|50626561|FG001|Treatment Period|Other|1|||
25311261|NCT04617275|50626562|FG002|Treatment Period|Other|0|||
25311262|NCT04617275|50626563|FG003|Treatment Period|Other|0|||
25311263|NCT04617275|50626564|FG004|Treatment Period|Other|0|||
25311264|NCT04617275|50626565|FG005|Treatment Period|Other|0|||
25311265|NCT04617275|50626566|FG006|Treatment Period|Other|0|||
25311266|NCT04617275|50626567|FG007|Treatment Period|Other|0|||
25311267|NCT04617275|50626560|FG000|Treatment Period|Withdrawal by Subject|2|||
25311268|NCT04617275|50626561|FG001|Treatment Period|Withdrawal by Subject|0|||
25311269|NCT04617275|50626562|FG002|Treatment Period|Withdrawal by Subject|0|||
25311270|NCT04617275|50626563|FG003|Treatment Period|Withdrawal by Subject|2|||
25311271|NCT04617275|50626564|FG004|Treatment Period|Withdrawal by Subject|2|||
25311272|NCT04617275|50626565|FG005|Treatment Period|Withdrawal by Subject|0|||
25311273|NCT04617275|50626566|FG006|Treatment Period|Withdrawal by Subject|1|||
25311274|NCT04617275|50626567|FG007|Treatment Period|Withdrawal by Subject|2|||
25311275|NCT04617275|50626560|FG000|Follow-up Period|Adverse Event|1|||
25311276|NCT04617275|50626561|FG001|Follow-up Period|Adverse Event|1|||
25311277|NCT04617275|50626562|FG002|Follow-up Period|Adverse Event|2|||
25311278|NCT04617275|50626563|FG003|Follow-up Period|Adverse Event|3|||
25311279|NCT04617275|50626564|FG004|Follow-up Period|Adverse Event|4|||
25311280|NCT04617275|50626565|FG005|Follow-up Period|Adverse Event|3|||
25311281|NCT04617275|50626566|FG006|Follow-up Period|Adverse Event|0|||
25311282|NCT04617275|50626567|FG007|Follow-up Period|Adverse Event|3|||
25311283|NCT04617275|50626560|FG000|Follow-up Period|Lost to Follow-up|0|||
25311284|NCT04617275|50626561|FG001|Follow-up Period|Lost to Follow-up|1|||
25311285|NCT04617275|50626562|FG002|Follow-up Period|Lost to Follow-up|2|||
25311286|NCT04617275|50626563|FG003|Follow-up Period|Lost to Follow-up|0|||
25311287|NCT04617275|50626564|FG004|Follow-up Period|Lost to Follow-up|0|||
25311288|NCT04617275|50626565|FG005|Follow-up Period|Lost to Follow-up|4|||
25311289|NCT04617275|50626566|FG006|Follow-up Period|Lost to Follow-up|0|||
25311290|NCT04617275|50626567|FG007|Follow-up Period|Lost to Follow-up|3|||
25311291|NCT04617275|50626560|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
25311292|NCT04617275|50626561|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
25311293|NCT04617275|50626562|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
25311294|NCT04617275|50626563|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
25311295|NCT04617275|50626564|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
25311296|NCT04617275|50626565|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
25311297|NCT04617275|50626566|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
25311298|NCT04617275|50626567|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
25311299|NCT04617275|50626560|FG000|Follow-up Period|Other|0|||
25311300|NCT04617275|50626561|FG001|Follow-up Period|Other|1|||
25311301|NCT04617275|50626562|FG002|Follow-up Period|Other|0|||
25311302|NCT04617275|50626563|FG003|Follow-up Period|Other|0|||
25311303|NCT04617275|50626564|FG004|Follow-up Period|Other|0|||
25311304|NCT04617275|50626565|FG005|Follow-up Period|Other|0|||
25311305|NCT04617275|50626566|FG006|Follow-up Period|Other|0|||
25311306|NCT04617275|50626567|FG007|Follow-up Period|Other|0|||
25311307|NCT04617275|50626560|FG000|Follow-up Period|Withdrawal by Subject|2|||
25311308|NCT04617275|50626561|FG001|Follow-up Period|Withdrawal by Subject|0|||
25071396|NCT02573012|50177563|FG001|Overall Study|Non-compliance|2|||
25071397|NCT02573012|50177562|FG000|Overall Study|Withdrawal by Subject|2|||
25071398|NCT02573012|50177563|FG001|Overall Study|Withdrawal by Subject|2|||
25311309|NCT04617275|50626562|FG002|Follow-up Period|Withdrawal by Subject|0|||
25311310|NCT04617275|50626563|FG003|Follow-up Period|Withdrawal by Subject|2|||
25311311|NCT04617275|50626564|FG004|Follow-up Period|Withdrawal by Subject|2|||
25311312|NCT04617275|50626565|FG005|Follow-up Period|Withdrawal by Subject|0|||
25311313|NCT04617275|50626566|FG006|Follow-up Period|Withdrawal by Subject|1|||
25311314|NCT04617275|50626567|FG007|Follow-up Period|Withdrawal by Subject|2|||
25311315|NCT01031537|50626602|FG000|Overall Study|medical reasons not related to study|3|||
25311316|NCT01031537|50626602|FG000|Overall Study|Lack of Efficacy|1|||
25311317|NCT01031537|50626602|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
25311318|NCT01031537|50626602|FG000|Overall Study|moved, met exclusion criteria|10|||
25311319|NCT01031537|50626602|FG000|Overall Study|Withdrawal by Subject|5|||
25311320|NCT01031537|50626602|FG000|Overall Study|PI removal, no longer met eligibility|12|||
25311321|NCT01031381|50626606|FG000|Overall Study|Physician Decision|3|||
25311322|NCT01031381|50626606|FG000|Overall Study|Withdrawal by Subject|6|||
25311323|NCT00685399|50626618|FG000|Treatment Period 1|Withdrawal by Subject|2|||
25311324|NCT00685399|50626619|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25311325|NCT00685399|50626620|FG002|Treatment Period 1|Withdrawal by Subject|0|||
25311326|NCT00685399|50626621|FG003|Treatment Period 1|Withdrawal by Subject|0|||
25311327|NCT00685399|50626622|FG004|Treatment Period 1|Withdrawal by Subject|0|||
25311328|NCT00685399|50626623|FG005|Treatment Period 1|Withdrawal by Subject|0|||
25311329|NCT00685399|50626624|FG006|Treatment Period 1|Withdrawal by Subject|0|||
25311330|NCT00685399|50626625|FG007|Treatment Period 1|Withdrawal by Subject|0|||
25311331|NCT00685399|50626618|FG000|Treatment Period 1|Protocol Violation|1|||
25311332|NCT00685399|50626619|FG001|Treatment Period 1|Protocol Violation|0|||
25311333|NCT00685399|50626620|FG002|Treatment Period 1|Protocol Violation|0|||
25311334|NCT00685399|50626621|FG003|Treatment Period 1|Protocol Violation|0|||
25311335|NCT00685399|50626622|FG004|Treatment Period 1|Protocol Violation|0|||
25311336|NCT00685399|50626623|FG005|Treatment Period 1|Protocol Violation|0|||
25311337|NCT00685399|50626624|FG006|Treatment Period 1|Protocol Violation|0|||
25311338|NCT00685399|50626625|FG007|Treatment Period 1|Protocol Violation|0|||
25311339|NCT00685399|50626618|FG000|Treatment Period 1|Administrative|2|||
25311340|NCT00685399|50626619|FG001|Treatment Period 1|Administrative|0|||
25311341|NCT00685399|50626620|FG002|Treatment Period 1|Administrative|0|||
25311342|NCT00685399|50626621|FG003|Treatment Period 1|Administrative|0|||
25311343|NCT00685399|50626622|FG004|Treatment Period 1|Administrative|0|||
25311344|NCT00685399|50626623|FG005|Treatment Period 1|Administrative|0|||
25311345|NCT00685399|50626624|FG006|Treatment Period 1|Administrative|0|||
25311346|NCT00685399|50626625|FG007|Treatment Period 1|Administrative|0|||
25311347|NCT00685399|50626618|FG000|Treatment Period 1|Lack of Efficacy|1|||
25311348|NCT00685399|50626619|FG001|Treatment Period 1|Lack of Efficacy|0|||
25311349|NCT00685399|50626620|FG002|Treatment Period 1|Lack of Efficacy|0|||
25311350|NCT00685399|50626621|FG003|Treatment Period 1|Lack of Efficacy|0|||
25311351|NCT00685399|50626622|FG004|Treatment Period 1|Lack of Efficacy|0|||
25071399|NCT02573012|50177562|FG000|Overall Study|Study Ended per Protocol|1|||
25071400|NCT02573012|50177563|FG001|Overall Study|Study Ended per Protocol|0|||
25071401|NCT02573012|50177562|FG000|Overall Study|Physician Decision|1|||
25071402|NCT02573012|50177563|FG001|Overall Study|Physician Decision|2|||
25071403|NCT02752633|50177569|FG000|Overall Study|Withdrawal by Subject|1|||
25071404|NCT02752087|50177573|FG000|Washout|Physician Decision|1|||
25071405|NCT02752087|50177574|FG001|Washout|Physician Decision|0|||
25071406|NCT04766996|50177583|FG000|Overall Study|Withdrawal by Subject|1|||
25071407|NCT04766996|50177584|FG001|Overall Study|Withdrawal by Subject|0|||
25071408|NCT04766996|50177585|FG002|Overall Study|Withdrawal by Subject|13|||
25071409|NCT02563028|50177591|FG000|Overall Study|Lack of equipment|1|||
25071410|NCT02563028|50177591|FG000|Overall Study|Unable to elicit VEP post induction|1|||
25071411|NCT02192827|50177597|FG000|Overall Study|Lost to Follow-up|25|||
25071412|NCT02192827|50177598|FG001|Overall Study|Lost to Follow-up|27|||
25071413|NCT02192827|50177597|FG000|Overall Study|Given additional steroids with admission|13|||
25311352|NCT00685399|50626623|FG005|Treatment Period 1|Lack of Efficacy|0|||
25311353|NCT00685399|50626624|FG006|Treatment Period 1|Lack of Efficacy|0|||
25311354|NCT00685399|50626625|FG007|Treatment Period 1|Lack of Efficacy|0|||
25311355|NCT00685399|50626618|FG000|Treatment Period 2|Administrative Problems|0|||
25311356|NCT00685399|50626619|FG001|Treatment Period 2|Administrative Problems|2|||
25311357|NCT00685399|50626620|FG002|Treatment Period 2|Administrative Problems|1|||
25311358|NCT00685399|50626621|FG003|Treatment Period 2|Administrative Problems|0|||
25071414|NCT02192827|50177598|FG001|Overall Study|Given additional steroids with admission|11|||
25071415|NCT02562482|50177606|FG000|Overall Study|Enrolled, but did not receive product|4|||
25071416|NCT02562482|50177607|FG001|Overall Study|Enrolled, but did not receive product|0|||
25071417|NCT02562482|50177606|FG000|Overall Study|Lost to Follow-up|9|||
25071418|NCT02562482|50177607|FG001|Overall Study|Lost to Follow-up|6|||
25311359|NCT00685399|50626622|FG004|Treatment Period 2|Administrative Problems|0|||
25311360|NCT00685399|50626623|FG005|Treatment Period 2|Administrative Problems|0|||
25311361|NCT00685399|50626624|FG006|Treatment Period 2|Administrative Problems|0|||
25311362|NCT00685399|50626625|FG007|Treatment Period 2|Administrative Problems|0|||
25311363|NCT00685399|50626618|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25311364|NCT00685399|50626619|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25311365|NCT00685399|50626620|FG002|Treatment Period 2|Withdrawal by Subject|0|||
25311366|NCT00685399|50626621|FG003|Treatment Period 2|Withdrawal by Subject|0|||
25311367|NCT00685399|50626622|FG004|Treatment Period 2|Withdrawal by Subject|0|||
25311368|NCT00685399|50626623|FG005|Treatment Period 2|Withdrawal by Subject|0|||
25311369|NCT00685399|50626624|FG006|Treatment Period 2|Withdrawal by Subject|0|||
25311370|NCT00685399|50626625|FG007|Treatment Period 2|Withdrawal by Subject|2|||
25311371|NCT00685399|50626618|FG000|Treatment Period 2|Adverse Event|0|||
25311372|NCT00685399|50626619|FG001|Treatment Period 2|Adverse Event|0|||
25311373|NCT00685399|50626620|FG002|Treatment Period 2|Adverse Event|0|||
25311374|NCT00685399|50626621|FG003|Treatment Period 2|Adverse Event|0|||
25311375|NCT00685399|50626622|FG004|Treatment Period 2|Adverse Event|0|||
25311376|NCT00685399|50626623|FG005|Treatment Period 2|Adverse Event|1|||
25311377|NCT00685399|50626624|FG006|Treatment Period 2|Adverse Event|0|||
25311378|NCT00685399|50626625|FG007|Treatment Period 2|Adverse Event|0|||
25311379|NCT00685399|50626618|FG000|Treatment Period 2|Lack of Efficacy|0|||
25311380|NCT00685399|50626619|FG001|Treatment Period 2|Lack of Efficacy|10|||
25311381|NCT00685399|50626620|FG002|Treatment Period 2|Lack of Efficacy|2|||
25311382|NCT00685399|50626621|FG003|Treatment Period 2|Lack of Efficacy|0|||
25311383|NCT00685399|50626622|FG004|Treatment Period 2|Lack of Efficacy|0|||
25311384|NCT00685399|50626623|FG005|Treatment Period 2|Lack of Efficacy|1|||
25311385|NCT00685399|50626624|FG006|Treatment Period 2|Lack of Efficacy|0|||
25311386|NCT00685399|50626625|FG007|Treatment Period 2|Lack of Efficacy|0|||
25311387|NCT00685399|50626618|FG000|Extension|Administrative Issues|0|||
25311388|NCT00685399|50626619|FG001|Extension|Administrative Issues|0|||
25311389|NCT00685399|50626620|FG002|Extension|Administrative Issues|0|||
25311390|NCT00685399|50626621|FG003|Extension|Administrative Issues|1|||
25311391|NCT00685399|50626622|FG004|Extension|Administrative Issues|0|||
25311392|NCT00685399|50626623|FG005|Extension|Administrative Issues|0|||
25311393|NCT00685399|50626624|FG006|Extension|Administrative Issues|0|||
25311394|NCT00685399|50626625|FG007|Extension|Administrative Issues|0|||
25311395|NCT00685399|50626618|FG000|Extension|Withdrawal by Subject|0|||
25311396|NCT00685399|50626619|FG001|Extension|Withdrawal by Subject|0|||
25311397|NCT00685399|50626620|FG002|Extension|Withdrawal by Subject|0|||
25311398|NCT00685399|50626621|FG003|Extension|Withdrawal by Subject|1|||
25311399|NCT00685399|50626622|FG004|Extension|Withdrawal by Subject|0|||
25311400|NCT00685399|50626623|FG005|Extension|Withdrawal by Subject|0|||
25311401|NCT00685399|50626624|FG006|Extension|Withdrawal by Subject|0|||
25311402|NCT00685399|50626625|FG007|Extension|Withdrawal by Subject|0|||
25311403|NCT00685399|50626618|FG000|Extension|Protocol Violation|0|||
25311404|NCT00685399|50626619|FG001|Extension|Protocol Violation|0|||
25311405|NCT00685399|50626620|FG002|Extension|Protocol Violation|0|||
25311406|NCT00685399|50626621|FG003|Extension|Protocol Violation|1|||
25311407|NCT00685399|50626622|FG004|Extension|Protocol Violation|0|||
25311408|NCT00685399|50626623|FG005|Extension|Protocol Violation|0|||
25311409|NCT00685399|50626624|FG006|Extension|Protocol Violation|0|||
25311410|NCT00685399|50626625|FG007|Extension|Protocol Violation|0|||
25311411|NCT00685399|50626618|FG000|Extension|Lack of Efficacy|0|||
25311412|NCT00685399|50626619|FG001|Extension|Lack of Efficacy|0|||
25311413|NCT00685399|50626620|FG002|Extension|Lack of Efficacy|0|||
25311414|NCT00685399|50626621|FG003|Extension|Lack of Efficacy|2|||
25311415|NCT00685399|50626622|FG004|Extension|Lack of Efficacy|0|||
25311416|NCT00685399|50626623|FG005|Extension|Lack of Efficacy|0|||
25311417|NCT00685399|50626624|FG006|Extension|Lack of Efficacy|0|||
25311418|NCT00685399|50626625|FG007|Extension|Lack of Efficacy|0|||
25311419|NCT00685399|50626618|FG000|Extension|Adverse Event|0|||
25311420|NCT00685399|50626619|FG001|Extension|Adverse Event|0|||
25311421|NCT00685399|50626620|FG002|Extension|Adverse Event|0|||
25311422|NCT00685399|50626621|FG003|Extension|Adverse Event|2|||
25311423|NCT00685399|50626622|FG004|Extension|Adverse Event|0|||
25311424|NCT00685399|50626623|FG005|Extension|Adverse Event|0|||
25311425|NCT00685399|50626624|FG006|Extension|Adverse Event|0|||
25311426|NCT00685399|50626625|FG007|Extension|Adverse Event|0|||
25311427|NCT00685165|50626652|FG000|Washout Period of 14 Days|Adverse Event|1|||
25311428|NCT00685165|50626653|FG001|Washout Period of 14 Days|Adverse Event|0|||
25311429|NCT00683449|50626664|FG000|Overall Study|Lost to Follow-up|0|||
25311430|NCT00683449|50626665|FG001|Overall Study|Lost to Follow-up|1|||
25311431|NCT00683449|50626666|FG002|Overall Study|Lost to Follow-up|0|||
25311432|NCT00683449|50626667|FG003|Overall Study|Lost to Follow-up|0|||
25311433|NCT00683449|50626668|FG004|Overall Study|Lost to Follow-up|0|||
25311434|NCT00683293|50626687|FG000|Overall Study|Withdrawal by Subject|2|||
25311435|NCT00683293|50626688|FG001|Overall Study|Withdrawal by Subject|3|||
25311436|NCT00726232|50626700|FG000|Initial Phase (Dose-finding)|Death|0|||
25311437|NCT00726232|50626701|FG001|Initial Phase (Dose-finding)|Death|0|||
25311438|NCT00726232|50626702|FG002|Initial Phase (Dose-finding)|Death|0|||
25311439|NCT00726232|50626703|FG003|Initial Phase (Dose-finding)|Death|0|||
25311440|NCT00726232|50626704|FG004|Initial Phase (Dose-finding)|Death|1|||
25311441|NCT00726232|50626705|FG005|Initial Phase (Dose-finding)|Death|0|||
25311442|NCT00726232|50626706|FG006|Initial Phase (Dose-finding)|Death|0|||
25311443|NCT00726232|50626707|FG007|Initial Phase (Dose-finding)|Death|0|||
25311444|NCT00726232|50626700|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
25311445|NCT00726232|50626701|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
25311446|NCT00726232|50626702|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
25311447|NCT00726232|50626703|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
25311448|NCT00726232|50626704|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
25311449|NCT00726232|50626705|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
25311450|NCT00726232|50626706|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
25311451|NCT00726232|50626707|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
25311452|NCT00726232|50626700|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
25311453|NCT00726232|50626701|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
25311454|NCT00726232|50626702|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
25311455|NCT00726232|50626703|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
25311456|NCT00726232|50626704|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
25311457|NCT00726232|50626705|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
25311458|NCT00726232|50626706|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
25311459|NCT00726232|50626707|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
25311460|NCT00726232|50626700|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
25311461|NCT00726232|50626701|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
25311462|NCT00726232|50626702|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
25311463|NCT00726232|50626703|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
25311464|NCT00726232|50626704|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
25311465|NCT00726232|50626705|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
25311466|NCT00726232|50626706|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
25311467|NCT00726232|50626707|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
25311468|NCT00726232|50626700|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
25311469|NCT00726232|50626701|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
25311470|NCT00726232|50626702|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
25311471|NCT00726232|50626703|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
25311472|NCT00726232|50626704|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
25311473|NCT00726232|50626705|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
25311474|NCT00726232|50626706|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
25311475|NCT00726232|50626707|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
25311476|NCT00726232|50626700|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
25311477|NCT00726232|50626701|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
25311478|NCT00726232|50626702|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
25311479|NCT00726232|50626703|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
25311480|NCT00726232|50626704|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
25311481|NCT00726232|50626705|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
25311482|NCT00726232|50626706|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
24970237|NCT04140292|50059757|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
25311483|NCT00726232|50626707|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
25311484|NCT00726232|50626700|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
25311485|NCT00726232|50626701|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
25311486|NCT00726232|50626702|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
25311487|NCT00726232|50626703|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
25311488|NCT00726232|50626704|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
25311489|NCT00726232|50626705|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
25311490|NCT00726232|50626706|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
25311491|NCT00726232|50626707|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
25311492|NCT00726232|50626700|FG000|Expansion Phase|Death|0|||
25311493|NCT00726232|50626701|FG001|Expansion Phase|Death|0|||
25311494|NCT00726232|50626702|FG002|Expansion Phase|Death|0|||
25311495|NCT00726232|50626703|FG003|Expansion Phase|Death|0|||
25311496|NCT00726232|50626704|FG004|Expansion Phase|Death|0|||
25311497|NCT00726232|50626705|FG005|Expansion Phase|Death|0|||
25311498|NCT00726232|50626706|FG006|Expansion Phase|Death|0|||
25311499|NCT00726232|50626707|FG007|Expansion Phase|Death|1|||
25311500|NCT00726232|50626700|FG000|Expansion Phase|Adverse Event|0|||
25311501|NCT00726232|50626701|FG001|Expansion Phase|Adverse Event|0|||
25311502|NCT00726232|50626702|FG002|Expansion Phase|Adverse Event|0|||
25311503|NCT00726232|50626703|FG003|Expansion Phase|Adverse Event|0|||
25071419|NCT02562482|50177606|FG000|Overall Study|Moved from area|2|||
25071420|NCT02562482|50177607|FG001|Overall Study|Moved from area|3|||
25071421|NCT02562482|50177606|FG000|Overall Study|Withdrawal by Subject|5|||
25311504|NCT00726232|50626704|FG004|Expansion Phase|Adverse Event|0|||
25311505|NCT00726232|50626705|FG005|Expansion Phase|Adverse Event|0|||
25311506|NCT00726232|50626706|FG006|Expansion Phase|Adverse Event|6|||
25311507|NCT00726232|50626707|FG007|Expansion Phase|Adverse Event|11|||
25311508|NCT00726232|50626700|FG000|Expansion Phase|Withdrawal by Subject|0|||
25311509|NCT00726232|50626701|FG001|Expansion Phase|Withdrawal by Subject|0|||
25311510|NCT00726232|50626702|FG002|Expansion Phase|Withdrawal by Subject|0|||
25311511|NCT00726232|50626703|FG003|Expansion Phase|Withdrawal by Subject|0|||
25311512|NCT00726232|50626704|FG004|Expansion Phase|Withdrawal by Subject|0|||
25311513|NCT00726232|50626705|FG005|Expansion Phase|Withdrawal by Subject|0|||
25311514|NCT00726232|50626706|FG006|Expansion Phase|Withdrawal by Subject|2|||
25311515|NCT00726232|50626707|FG007|Expansion Phase|Withdrawal by Subject|3|||
25311516|NCT00726232|50626700|FG000|Expansion Phase|Disease progression|0|||
25311517|NCT00726232|50626701|FG001|Expansion Phase|Disease progression|0|||
25311518|NCT00726232|50626702|FG002|Expansion Phase|Disease progression|0|||
25311519|NCT00726232|50626703|FG003|Expansion Phase|Disease progression|0|||
25311520|NCT00726232|50626704|FG004|Expansion Phase|Disease progression|0|||
25311521|NCT00726232|50626705|FG005|Expansion Phase|Disease progression|0|||
25311522|NCT00726232|50626706|FG006|Expansion Phase|Disease progression|4|||
25311523|NCT00726232|50626707|FG007|Expansion Phase|Disease progression|0|||
25311524|NCT00726232|50626700|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
25311525|NCT00726232|50626701|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
25311526|NCT00726232|50626702|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
25311527|NCT00726232|50626703|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
25311528|NCT00726232|50626704|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
25311529|NCT00726232|50626705|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
25311530|NCT00726232|50626706|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
25311531|NCT00726232|50626707|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
25311532|NCT00726232|50626700|FG000|Expansion Phase|Per Investigator: lack of response|0|||
25311533|NCT00726232|50626701|FG001|Expansion Phase|Per Investigator: lack of response|0|||
25311534|NCT00726232|50626702|FG002|Expansion Phase|Per Investigator: lack of response|0|||
25311535|NCT00726232|50626703|FG003|Expansion Phase|Per Investigator: lack of response|0|||
25311536|NCT00726232|50626704|FG004|Expansion Phase|Per Investigator: lack of response|0|||
25311537|NCT00726232|50626705|FG005|Expansion Phase|Per Investigator: lack of response|0|||
25311538|NCT00726232|50626706|FG006|Expansion Phase|Per Investigator: lack of response|1|||
25311539|NCT00726232|50626707|FG007|Expansion Phase|Per Investigator: lack of response|7|||
25311540|NCT00726232|50626700|FG000|Expansion Phase|Unspecified reason|0|||
25311541|NCT00726232|50626701|FG001|Expansion Phase|Unspecified reason|0|||
25071422|NCT02562482|50177607|FG001|Overall Study|Withdrawal by Subject|3|||
25311542|NCT00726232|50626702|FG002|Expansion Phase|Unspecified reason|0|||
25311543|NCT00726232|50626703|FG003|Expansion Phase|Unspecified reason|0|||
25311544|NCT00726232|50626704|FG004|Expansion Phase|Unspecified reason|0|||
25311545|NCT00726232|50626705|FG005|Expansion Phase|Unspecified reason|0|||
25311546|NCT00726232|50626706|FG006|Expansion Phase|Unspecified reason|1|||
25311547|NCT00726232|50626707|FG007|Expansion Phase|Unspecified reason|0|||
25311548|NCT00720382|50626728|FG000|Overall Study|Adverse Event|54|||
25311549|NCT00720382|50626729|FG001|Overall Study|Adverse Event|17|||
25311550|NCT00720382|50626728|FG000|Overall Study|Lack of Efficacy|18|||
25311551|NCT00720382|50626729|FG001|Overall Study|Lack of Efficacy|7|||
25311552|NCT00720382|50626728|FG000|Overall Study|Non-Compliance|15|||
25311553|NCT00720382|50626729|FG001|Overall Study|Non-Compliance|5|||
25311554|NCT00720382|50626728|FG000|Overall Study|Withdrawal by Subject|47|||
25311555|NCT00720382|50626729|FG001|Overall Study|Withdrawal by Subject|11|||
25311556|NCT00720382|50626728|FG000|Overall Study|Lost to Follow-up|28|||
25311557|NCT00720382|50626729|FG001|Overall Study|Lost to Follow-up|14|||
25311558|NCT00720382|50626728|FG000|Overall Study|administrative|14|||
25311559|NCT00720382|50626729|FG001|Overall Study|administrative|5|||
25311560|NCT00720226|50626737|FG000|Overall Study|Withdrawal by Subject|7|||
25311561|NCT00720226|50626738|FG001|Overall Study|Withdrawal by Subject|4|||
25311562|NCT00725920|50626746|FG000|Overall Study|Lack of Efficacy|3|||
25311563|NCT00725920|50626747|FG001|Overall Study|Lack of Efficacy|6|||
25311564|NCT00725842|50626753|FG000|Overall Study|Lost to Follow-up|19|||
25311565|NCT00725842|50626753|FG000|Overall Study|Death|1|||
25311566|NCT00725842|50626753|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
25311567|NCT00725842|50626753|FG000|Overall Study|Consent date prior to study start date|5|||
25311568|NCT00725842|50626753|FG000|Overall Study|Inclusion criterion not met|1|||
25311569|NCT00725842|50626753|FG000|Overall Study|No Visit 1 data|1|||
25311570|NCT00725764|50626757|FG000|Overall Study|Withdrawal by Subject|2|||
25311571|NCT00725764|50626757|FG000|Overall Study|Physician Decision|1|||
25311572|NCT00725764|50626757|FG000|Overall Study|Progressive Disease|7|||
25311573|NCT00725764|50626757|FG000|Overall Study|Lost to Follow-up|1|||
25311574|NCT00725764|50626757|FG000|Overall Study|Death|1|||
25311575|NCT00725764|50626757|FG000|Overall Study|Participant non compliant with protocol|1|||
25311576|NCT00725764|50626757|FG000|Overall Study|Decline in performance status|1|||
25311577|NCT00725608|50626762|FG000|Overall Study|Lost to Follow-up|60|||
25311578|NCT00725608|50626762|FG000|Overall Study|Adverse Event|14|||
25311579|NCT00725608|50626762|FG000|Overall Study|Individual reasons|86|||
25311580|NCT00725608|50626762|FG000|Overall Study|Other|7|||
25311581|NCT00725452|50626766|FG000|Overall Study|Adverse Event|3|||
25311582|NCT00725452|50626766|FG000|Overall Study|Lack of Efficacy|2|||
25311583|NCT00725452|50626766|FG000|Overall Study|Reason not specified|1|||
25311584|NCT00725452|50626766|FG000|Overall Study|Physician Decision|1|||
25311585|NCT00725452|50626766|FG000|Overall Study|Withdrawal by Subject|3|||
25311586|NCT00725452|50626766|FG000|Overall Study|Lost to Follow-up|1|||
25311587|NCT00725296|50626770|FG000|Overall Study|Adverse Event|11|||
25311588|NCT00725296|50626770|FG000|Overall Study|Lack of Efficacy|7|||
25311589|NCT00725296|50626770|FG000|Overall Study|Withdrawal by Subject|3|||
25311590|NCT00725296|50626770|FG000|Overall Study|Non-Compliance|2|||
25311591|NCT00725296|50626770|FG000|Overall Study|Lost to Follow-up|1|||
25311592|NCT00725296|50626770|FG000|Overall Study|Other|38|||
25311593|NCT00719680|50626775|FG000|Overall Study|Adverse Event|1|||
25311594|NCT00719680|50626775|FG000|Overall Study|Lost to Follow-up|1|||
25311595|NCT00719680|50626775|FG000|Overall Study|Withdrawal by Subject|3|||
25311596|NCT00719212|50626779|FG000|Overall Study|Death|41|||
25311597|NCT00719212|50626779|FG000|Overall Study|Lost to Follow-up|2|||
25311598|NCT00719212|50626779|FG000|Overall Study|Withdrawal by Subject|1|||
25311599|NCT00585052|50626783|FG000|Overall Study|Withdrawal by Subject|1|||
25311600|NCT00724282|50626787|FG000|Overall Study|Withdrawal by Subject|3|||
25311601|NCT00724282|50626787|FG000|Overall Study|Physician Decision|1|||
25311602|NCT00724126|50626793|FG000|Overall Study|Adverse Event|2|||
25311603|NCT00724126|50626794|FG001|Overall Study|Adverse Event|0|||
25311604|NCT00724126|50626793|FG000|Overall Study|Withdrawal by Subject|8|||
25311605|NCT00724126|50626794|FG001|Overall Study|Withdrawal by Subject|6|||
25311606|NCT00724126|50626793|FG000|Overall Study|Lost to Follow-up|6|||
25311607|NCT00724126|50626794|FG001|Overall Study|Lost to Follow-up|6|||
25311608|NCT00724126|50626793|FG000|Overall Study|Noncompliance|2|||
25311609|NCT00724126|50626794|FG001|Overall Study|Noncompliance|1|||
25311610|NCT00724126|50626793|FG000|Overall Study|Subject randomized although ineligible|1|||
25311611|NCT00724126|50626794|FG001|Overall Study|Subject randomized although ineligible|1|||
25311612|NCT00724126|50626793|FG000|Overall Study|Subject had to leave vicinity of site|0|||
25311613|NCT00724126|50626794|FG001|Overall Study|Subject had to leave vicinity of site|1|||
25311614|NCT00723892|50626802|FG000|Overall Study|Participant not tracked|33|||
25311615|NCT00723892|50626803|FG001|Overall Study|Participant not tracked|35|||
25311616|NCT00723892|50626802|FG000|Overall Study|Virological criterion|24|||
25311617|NCT00723892|50626803|FG001|Overall Study|Virological criterion|9|||
25311618|NCT00723892|50626802|FG000|Overall Study|Withdrawal by Subject|6|||
25311619|NCT00723892|50626803|FG001|Overall Study|Withdrawal by Subject|9|||
25311620|NCT00723892|50626802|FG000|Overall Study|End planned|11|||
25311621|NCT00723892|50626803|FG001|Overall Study|End planned|7|||
25311622|NCT00723892|50626802|FG000|Overall Study|Bad tolerance|5|||
25311623|NCT00723892|50626803|FG001|Overall Study|Bad tolerance|5|||
25311624|NCT00723892|50626802|FG000|Overall Study|Multiple reasons|17|||
25311625|NCT00723892|50626803|FG001|Overall Study|Multiple reasons|12|||
25311626|NCT00723892|50626802|FG000|Overall Study|Other|6|||
25311627|NCT00723892|50626803|FG001|Overall Study|Other|3|||
25311628|NCT00723892|50626802|FG000|Overall Study|Study end|1|||
25311629|NCT00723892|50626803|FG001|Overall Study|Study end|3|||
25311630|NCT00723892|50626802|FG000|Overall Study|Weight loss|1|||
25311631|NCT00723892|50626803|FG001|Overall Study|Weight loss|3|||
25311632|NCT00723892|50626802|FG000|Overall Study|Alcohol abuse|0|||
25311633|NCT00723892|50626803|FG001|Overall Study|Alcohol abuse|1|||
25311634|NCT00723892|50626802|FG000|Overall Study|Intercurrent infection|2|||
25311635|NCT00723892|50626803|FG001|Overall Study|Intercurrent infection|0|||
25311636|NCT00723892|50626802|FG000|Overall Study|Drug addiction|1|||
25311637|NCT00723892|50626803|FG001|Overall Study|Drug addiction|0|||
25311638|NCT00718666|50626812|FG000|Booster Phase Year 5|No active participation request|0|||
25311639|NCT00718666|50626813|FG001|Booster Phase Year 5|No active participation request|0|||
25311640|NCT00718666|50626814|FG002|Booster Phase Year 5|No active participation request|1|||
25311641|NCT00718666|50626812|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
25311642|NCT00718666|50626813|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
25311643|NCT00718666|50626814|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
25311644|NCT00718666|50626812|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
25311645|NCT00718666|50626813|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
25311646|NCT00718666|50626814|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
25311647|NCT00718666|50626812|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
25311648|NCT00718666|50626813|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
25311649|NCT00718666|50626814|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
25311650|NCT03950440|50626835|FG000|Overall Study|Death|8|||
25311651|NCT03950440|50626836|FG001|Overall Study|Death|2|||
25311652|NCT03950440|50626837|FG002|Overall Study|Death|1|||
25311653|NCT00718510|50626847|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
25311654|NCT00718510|50626848|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
25311655|NCT00718510|50626847|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
25311656|NCT00718510|50626848|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
25311657|NCT00585286|50626854|FG000|Overall Study|Lost to Follow-up|1|||
25311658|NCT00723190|50626858|FG000|Overall Study|Withdrawal by Subject|45|||
25311659|NCT00723190|50626858|FG000|Overall Study|Lost to Follow-up|37|||
25311660|NCT00723190|50626858|FG000|Overall Study|Adverse Event|18|||
25311661|NCT00723190|50626858|FG000|Overall Study|Lack of Efficacy|16|||
25311662|NCT00723190|50626858|FG000|Overall Study|Protocol Violation|15|||
25311663|NCT00723190|50626858|FG000|Overall Study|Other-Premature Discontinuation|9|||
25311664|NCT00723190|50626858|FG000|Overall Study|Other-Not included in safety population|2|||
25311665|NCT00722800|50626864|FG000|Overall Study|Withdrawal by Subject|1|||
25311666|NCT00722800|50626865|FG001|Overall Study|Withdrawal by Subject|0|||
25311667|NCT00722800|50626864|FG000|Overall Study|Physician Decision|1|||
25311668|NCT00722800|50626865|FG001|Overall Study|Physician Decision|0|||
25311669|NCT00718042|50626877|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
25311670|NCT00718042|50626878|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
25311671|NCT00718042|50626879|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
25311672|NCT00718042|50626880|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
25311673|NCT00718042|50626881|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
25311674|NCT00718042|50626882|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
25311675|NCT00718042|50626877|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
25311676|NCT00718042|50626878|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
25311677|NCT00718042|50626879|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
25311678|NCT00718042|50626880|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
25311679|NCT00718042|50626881|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
25311680|NCT00718042|50626882|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
25311681|NCT00718042|50626877|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
25311682|NCT00718042|50626878|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
25311683|NCT00718042|50626879|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
25311684|NCT00718042|50626880|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
25311685|NCT00718042|50626881|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
25311686|NCT00718042|50626882|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
25311687|NCT00718042|50626877|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
25311688|NCT00718042|50626878|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
25311689|NCT00718042|50626879|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
25311690|NCT00718042|50626880|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
25311691|NCT00718042|50626881|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
25311692|NCT00718042|50626882|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
25311693|NCT00718042|50626877|FG000|Donor Follow-up|Lost to Follow-up|13|||
25311694|NCT00718042|50626878|FG001|Donor Follow-up|Lost to Follow-up|0|||
25311695|NCT00718042|50626879|FG002|Donor Follow-up|Lost to Follow-up|0|||
25311696|NCT00718042|50626880|FG003|Donor Follow-up|Lost to Follow-up|0|||
25311697|NCT00718042|50626881|FG004|Donor Follow-up|Lost to Follow-up|19|||
25311698|NCT00718042|50626882|FG005|Donor Follow-up|Lost to Follow-up|0|||
25311699|NCT00741598|50626896|FG000|Overall Study|Lost to Follow-up|3|||
25311700|NCT00741598|50626897|FG001|Overall Study|Lost to Follow-up|4|||
25311701|NCT00741598|50626896|FG000|Overall Study|Lack of Efficacy|1|||
25311702|NCT00741598|50626897|FG001|Overall Study|Lack of Efficacy|2|||
25311703|NCT00741598|50626896|FG000|Overall Study|Physician Decision|1|||
25311704|NCT00741598|50626897|FG001|Overall Study|Physician Decision|1|||
25311705|NCT00741598|50626896|FG000|Overall Study|Pregnancy|1|||
25311706|NCT00741598|50626897|FG001|Overall Study|Pregnancy|0|||
25311707|NCT00741598|50626896|FG000|Overall Study|Withdrawal by Subject|3|||
25311708|NCT00741598|50626897|FG001|Overall Study|Withdrawal by Subject|2|||
25311709|NCT00717886|50626904|FG000|Overall Study|Withdrawal by Subject|3|||
25311710|NCT00717886|50626904|FG000|Overall Study|Treatment Failure|1|||
25311711|NCT00741286|50626910|FG000|Overall Study|Lost to Follow-up|15|||
25311712|NCT00741286|50626911|FG001|Overall Study|Lost to Follow-up|10|||
25311713|NCT00741286|50626910|FG000|Overall Study|Adverse Event|1|||
25311714|NCT00741286|50626911|FG001|Overall Study|Adverse Event|6|||
25311715|NCT00741286|50626910|FG000|Overall Study|Protocol Violation|3|||
25311716|NCT00741286|50626911|FG001|Overall Study|Protocol Violation|2|||
25311717|NCT00741286|50626910|FG000|Overall Study|Primary Outcome|1|||
25311718|NCT00741286|50626911|FG001|Overall Study|Primary Outcome|1|||
25311719|NCT00716482|50626917|FG000|Overall Study|Lost to Follow-up|6|||
25311720|NCT00716482|50626917|FG000|Overall Study|Inadequate acquisition or analysis|50|||
25311721|NCT00716482|50626917|FG000|Overall Study|no pathology obtained|10|||
25311722|NCT00716482|50626917|FG000|Overall Study|technical/machine error|28|||
25311723|NCT00716482|50626917|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
25311724|NCT00716092|50626930|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
25311725|NCT00716092|50626931|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
25311726|NCT00716092|50626932|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
25311727|NCT00715624|50626942|FG000|Overall Study|Adverse Event|12|||
25311728|NCT00715624|50626943|FG001|Overall Study|Adverse Event|37|||
25311729|NCT00715624|50626942|FG000|Overall Study|Lack of Efficacy|11|||
25311730|NCT00715624|50626943|FG001|Overall Study|Lack of Efficacy|11|||
25311731|NCT00715624|50626942|FG000|Overall Study|Lost to Follow-up|1|||
25311732|NCT00715624|50626943|FG001|Overall Study|Lost to Follow-up|2|||
25311733|NCT00715624|50626942|FG000|Overall Study|Protocol Violation|1|||
25311734|NCT00715624|50626943|FG001|Overall Study|Protocol Violation|0|||
25311735|NCT00715624|50626942|FG000|Overall Study|Withdrawal by Subject|11|||
25311736|NCT00715624|50626943|FG001|Overall Study|Withdrawal by Subject|25|||
25311737|NCT00715624|50626942|FG000|Overall Study|Familial and personal reasons|10|||
25311738|NCT00715624|50626943|FG001|Overall Study|Familial and personal reasons|22|||
25311739|NCT00715624|50626942|FG000|Overall Study|Poor compliance|6|||
25311740|NCT00715624|50626943|FG001|Overall Study|Poor compliance|13|||
25311741|NCT00715624|50626942|FG000|Overall Study|Sponsor decision|0|||
25311742|NCT00715624|50626943|FG001|Overall Study|Sponsor decision|4|||
25311743|NCT00715624|50626942|FG000|Overall Study|Incorrect randomization (not treated)|0|||
25311744|NCT00715624|50626943|FG001|Overall Study|Incorrect randomization (not treated)|1|||
25311745|NCT00715624|50626942|FG000|Overall Study|Other|0|||
25311746|NCT00715624|50626943|FG001|Overall Study|Other|1|||
25311747|NCT00679783|50626956|FG000|Overall Study|Adverse Event|0|||
25311748|NCT00679783|50626957|FG001|Overall Study|Adverse Event|0|||
25192216|NCT01465178|50357454|FG001|Overall Study|Withdrawal by Subject|0|||
25192217|NCT01445678|50357560|FG000|Overall Study|Adverse Event|12|||
25192218|NCT01445678|50357561|FG001|Overall Study|Adverse Event|8|||
25192219|NCT01445678|50357560|FG000|Overall Study|Lack of Efficacy|0|||
25192220|NCT01445678|50357561|FG001|Overall Study|Lack of Efficacy|2|||
25311749|NCT00679783|50626958|FG002|Overall Study|Adverse Event|0|||
25311750|NCT00679783|50626959|FG003|Overall Study|Adverse Event|3|||
25311751|NCT00679783|50626960|FG004|Overall Study|Adverse Event|0|||
25311752|NCT00679783|50626961|FG005|Overall Study|Adverse Event|0|||
25311753|NCT00679783|50626962|FG006|Overall Study|Adverse Event|1|||
25311754|NCT00679783|50626956|FG000|Overall Study|Lack of Efficacy|0|||
25311755|NCT00679783|50626957|FG001|Overall Study|Lack of Efficacy|1|||
25311756|NCT00679783|50626958|FG002|Overall Study|Lack of Efficacy|0|||
25311757|NCT00679783|50626959|FG003|Overall Study|Lack of Efficacy|2|||
25311758|NCT00679783|50626960|FG004|Overall Study|Lack of Efficacy|0|||
25311759|NCT00679783|50626961|FG005|Overall Study|Lack of Efficacy|0|||
25311760|NCT00679783|50626962|FG006|Overall Study|Lack of Efficacy|0|||
25311761|NCT00679783|50626956|FG000|Overall Study|Withdrawal by Subject|0|||
25311762|NCT00679783|50626957|FG001|Overall Study|Withdrawal by Subject|0|||
25311763|NCT00679783|50626958|FG002|Overall Study|Withdrawal by Subject|1|||
25311764|NCT00679783|50626959|FG003|Overall Study|Withdrawal by Subject|1|||
25311765|NCT00679783|50626960|FG004|Overall Study|Withdrawal by Subject|0|||
25311766|NCT00679783|50626961|FG005|Overall Study|Withdrawal by Subject|0|||
25311767|NCT00679783|50626962|FG006|Overall Study|Withdrawal by Subject|0|||
25311768|NCT00679783|50626956|FG000|Overall Study|Not Captured|0|||
25311769|NCT00679783|50626957|FG001|Overall Study|Not Captured|0|||
25311770|NCT00679783|50626958|FG002|Overall Study|Not Captured|0|||
25311771|NCT00679783|50626959|FG003|Overall Study|Not Captured|5|||
25192221|NCT01445678|50357560|FG000|Overall Study|Lost to Follow-up|8|||
25192222|NCT01445678|50357561|FG001|Overall Study|Lost to Follow-up|5|||
25192223|NCT01445678|50357560|FG000|Overall Study|Protocol Violation|1|||
25192224|NCT01445678|50357561|FG001|Overall Study|Protocol Violation|1|||
25192225|NCT01445678|50357560|FG000|Overall Study|Withdrawal by Subject|9|||
25192226|NCT01445678|50357561|FG001|Overall Study|Withdrawal by Subject|5|||
25192227|NCT03769194|50357580|FG000|Overall Study|Withdrawal by Subject|0|||
25192228|NCT03769194|50357581|FG001|Overall Study|Withdrawal by Subject|7|||
25192229|NCT03769194|50357582|FG002|Overall Study|Withdrawal by Subject|4|||
25192230|NCT03769194|50357583|FG003|Overall Study|Withdrawal by Subject|1|||
25192231|NCT03769194|50357580|FG000|Overall Study|moved from study area|0|||
25192232|NCT03769194|50357581|FG001|Overall Study|moved from study area|2|||
25192233|NCT03769194|50357582|FG002|Overall Study|moved from study area|1|||
25311772|NCT00679783|50626960|FG004|Overall Study|Not Captured|0|||
25311773|NCT00679783|50626961|FG005|Overall Study|Not Captured|0|||
25311774|NCT00679783|50626962|FG006|Overall Study|Not Captured|0|||
25311775|NCT00679783|50626956|FG000|Overall Study|Ongoing at data cut-off|2|||
25311776|NCT00679783|50626957|FG001|Overall Study|Ongoing at data cut-off|2|||
25311777|NCT00679783|50626958|FG002|Overall Study|Ongoing at data cut-off|0|||
25311778|NCT00679783|50626959|FG003|Overall Study|Ongoing at data cut-off|9|||
25311779|NCT00679783|50626960|FG004|Overall Study|Ongoing at data cut-off|1|||
25311780|NCT00679783|50626961|FG005|Overall Study|Ongoing at data cut-off|0|||
25311781|NCT00679783|50626962|FG006|Overall Study|Ongoing at data cut-off|0|||
25311782|NCT00576199|50626978|FG000|Overall Study|Adverse Event|12|||
25311783|NCT00576199|50626978|FG000|Overall Study|Insufficient Therapeutic Response|14|||
25311784|NCT00576199|50626978|FG000|Overall Study|Refused Treatment|2|||
25311785|NCT00576199|50626978|FG000|Overall Study|Reason Unspecified|2|||
25311786|NCT00715078|50626985|FG000|Overall Study|Death|29|||
25311787|NCT00715078|50626986|FG001|Overall Study|Death|36|||
25311788|NCT00715078|50626987|FG002|Overall Study|Death|36|||
25311789|NCT00715078|50626985|FG000|Overall Study|Withdrawal by Subject|1|||
25311790|NCT00715078|50626986|FG001|Overall Study|Withdrawal by Subject|0|||
25311791|NCT00715078|50626987|FG002|Overall Study|Withdrawal by Subject|1|||
25311792|NCT00715078|50626985|FG000|Overall Study|Unable to start due to disease prog.|0|||
25311793|NCT00715078|50626986|FG001|Overall Study|Unable to start due to disease prog.|0|||
25311794|NCT00715078|50626987|FG002|Overall Study|Unable to start due to disease prog.|1|||
25311795|NCT00679627|50626997|FG000|Overall Study|Death|41|||
25311796|NCT00679627|50626998|FG001|Overall Study|Death|29|||
25311797|NCT00679627|50626997|FG000|Overall Study|Adverse Event|43|||
25311798|NCT00679627|50626998|FG001|Overall Study|Adverse Event|53|||
25192234|NCT03769194|50357583|FG003|Overall Study|moved from study area|1|||
25192235|NCT03769194|50357580|FG000|Overall Study|Lost to Follow-up|3|||
25192236|NCT03769194|50357581|FG001|Overall Study|Lost to Follow-up|6|||
25192237|NCT03769194|50357582|FG002|Overall Study|Lost to Follow-up|3|||
25192238|NCT03769194|50357583|FG003|Overall Study|Lost to Follow-up|6|||
25192239|NCT03769194|50357580|FG000|Overall Study|other|1|||
25311799|NCT00679627|50626997|FG000|Overall Study|Withdrawal by Subject|168|||
25311800|NCT00679627|50626998|FG001|Overall Study|Withdrawal by Subject|172|||
25311801|NCT00679627|50626997|FG000|Overall Study|Lost to Follow-up|22|||
25311802|NCT00679627|50626998|FG001|Overall Study|Lost to Follow-up|26|||
25311803|NCT00679627|50626997|FG000|Overall Study|Early Study Closure|425|||
25311804|NCT00679627|50626998|FG001|Overall Study|Early Study Closure|405|||
25311805|NCT00714688|50627007|FG000|Overall Study|Lack of Efficacy|14|||
25311806|NCT00714688|50627008|FG001|Overall Study|Lack of Efficacy|1|||
25311807|NCT00714688|50627009|FG002|Overall Study|Lack of Efficacy|4|||
25311808|NCT00714688|50627007|FG000|Overall Study|Withdrawal by Subject|4|||
25311809|NCT00714688|50627008|FG001|Overall Study|Withdrawal by Subject|3|||
25311810|NCT00714688|50627009|FG002|Overall Study|Withdrawal by Subject|3|||
25311811|NCT00714688|50627007|FG000|Overall Study|Lost to Follow-up|5|||
25311812|NCT00714688|50627008|FG001|Overall Study|Lost to Follow-up|2|||
25311813|NCT00714688|50627009|FG002|Overall Study|Lost to Follow-up|0|||
25311814|NCT00714688|50627007|FG000|Overall Study|Adverse Event|2|||
25311815|NCT00714688|50627008|FG001|Overall Study|Adverse Event|15|||
25311816|NCT00714688|50627009|FG002|Overall Study|Adverse Event|19|||
25311817|NCT00714688|50627007|FG000|Overall Study|Subject Non-compliant|3|||
25311818|NCT00714688|50627008|FG001|Overall Study|Subject Non-compliant|5|||
25311819|NCT00714688|50627009|FG002|Overall Study|Subject Non-compliant|5|||
25311820|NCT00714688|50627007|FG000|Overall Study|Ineligible to Continue the Study|0|||
25311821|NCT00714688|50627008|FG001|Overall Study|Ineligible to Continue the Study|1|||
25311822|NCT00714688|50627009|FG002|Overall Study|Ineligible to Continue the Study|1|||
25311823|NCT00714688|50627007|FG000|Overall Study|Sponsor's Decision|0|||
25311824|NCT00714688|50627008|FG001|Overall Study|Sponsor's Decision|2|||
25311825|NCT00714688|50627009|FG002|Overall Study|Sponsor's Decision|0|||
25311826|NCT00714688|50627007|FG000|Overall Study|Other|1|||
25311827|NCT00714688|50627008|FG001|Overall Study|Other|6|||
25311828|NCT00714688|50627009|FG002|Overall Study|Other|5|||
25311829|NCT00679549|50627019|FG000|Overall Study|dropout|2|||
25311830|NCT00679549|50627020|FG001|Overall Study|dropout|4|||
25311831|NCT00679549|50627019|FG000|Overall Study|missing outcome echocardiograms|4|||
25311832|NCT00679549|50627020|FG001|Overall Study|missing outcome echocardiograms|5|||
25311833|NCT01031069|50627030|FG000|Overall Study|Serious Adverse Event|0|||
25311834|NCT01031069|50627031|FG001|Overall Study|Serious Adverse Event|1|||
25311835|NCT01031069|50627032|FG002|Overall Study|Serious Adverse Event|0|||
25311836|NCT01031069|50627033|FG003|Overall Study|Serious Adverse Event|0|||
25311837|NCT01031069|50627030|FG000|Overall Study|Withdrawal by Subject|2|||
25311838|NCT01031069|50627031|FG001|Overall Study|Withdrawal by Subject|3|||
25311839|NCT01031069|50627032|FG002|Overall Study|Withdrawal by Subject|18|||
25311840|NCT01031069|50627033|FG003|Overall Study|Withdrawal by Subject|18|||
25311841|NCT01031069|50627030|FG000|Overall Study|Migrated/moved from study area|1|||
25311842|NCT01031069|50627031|FG001|Overall Study|Migrated/moved from study area|2|||
25311843|NCT01031069|50627032|FG002|Overall Study|Migrated/moved from study area|1|||
25311844|NCT01031069|50627033|FG003|Overall Study|Migrated/moved from study area|1|||
25311845|NCT01031069|50627030|FG000|Overall Study|Lost to Follow-up|9|||
25192240|NCT03769194|50357581|FG001|Overall Study|other|3|||
25192241|NCT03769194|50357582|FG002|Overall Study|other|0|||
25192242|NCT03769194|50357583|FG003|Overall Study|other|1|||
25192243|NCT01465022|50357609|FG000|Overall Study|Lost to Follow-up|15|||
25192244|NCT01465022|50357610|FG001|Overall Study|Lost to Follow-up|14|||
25192245|NCT01465022|50357611|FG002|Overall Study|Lost to Follow-up|0|||
25192246|NCT01465022|50357609|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
25192247|NCT01465022|50357610|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
25192248|NCT01465022|50357611|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
25192249|NCT01465022|50357609|FG000|Overall Study|Not Randomized|0|||
25192250|NCT01465022|50357610|FG001|Overall Study|Not Randomized|0|||
25192251|NCT01465022|50357611|FG002|Overall Study|Not Randomized|70|||
25192252|NCT01464788|50357655|FG000|Overall Study|Lost to Follow-up|0|||
25192253|NCT01464788|50357656|FG001|Overall Study|Lost to Follow-up|1|||
25192254|NCT01464788|50357657|FG002|Overall Study|Lost to Follow-up|0|||
25192255|NCT01464788|50357655|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
25192256|NCT01464788|50357656|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
25192257|NCT01464788|50357657|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
25192258|NCT01444898|50357667|FG000|Overall Study|Withdrawal by Subject|1|||
25192259|NCT01419626|50357689|FG000|Overall Study|Protocol Violation|3|||
25192260|NCT01419626|50357690|FG001|Overall Study|Protocol Violation|2|||
25192261|NCT01419626|50357691|FG002|Overall Study|Protocol Violation|2|||
25192262|NCT01419626|50357689|FG000|Overall Study|Withdrawal by Subject|1|||
25192263|NCT01419626|50357690|FG001|Overall Study|Withdrawal by Subject|0|||
25311846|NCT01031069|50627031|FG001|Overall Study|Lost to Follow-up|5|||
25192264|NCT01419626|50357691|FG002|Overall Study|Withdrawal by Subject|0|||
25192265|NCT01419626|50357689|FG000|Overall Study|Lost to Follow-up|0|||
25192266|NCT01419626|50357690|FG001|Overall Study|Lost to Follow-up|1|||
25192267|NCT01419626|50357691|FG002|Overall Study|Lost to Follow-up|1|||
25192268|NCT01444742|50357730|FG000|Overall Study|Death|1|||
25192269|NCT01444430|50357930|FG000|Overall Study|Withdrawal by Subject|53|||
25311847|NCT01031069|50627032|FG002|Overall Study|Lost to Follow-up|21|||
25311848|NCT01031069|50627033|FG003|Overall Study|Lost to Follow-up|15|||
25311849|NCT01031069|50627030|FG000|Overall Study|Other|0|||
25311850|NCT01031069|50627031|FG001|Overall Study|Other|0|||
25311851|NCT01031069|50627032|FG002|Overall Study|Other|1|||
25311852|NCT01031069|50627033|FG003|Overall Study|Other|0|||
25311853|NCT00679081|50627045|FG000|Overall Study|Lost to Follow-up|1|||
25311854|NCT00682435|50627053|FG000|Overall Study|Insufficient data|5|||
25311855|NCT00682435|50627053|FG000|Overall Study|Erroneously enrolled twice|2|||
25311856|NCT00713830|50627059|FG000|Overall Study|Adverse Event|23|||
25311857|NCT00713830|50627060|FG001|Overall Study|Adverse Event|71|||
25311858|NCT00713830|50627059|FG000|Overall Study|Lack of Efficacy|24|||
25311859|NCT00713830|50627060|FG001|Overall Study|Lack of Efficacy|16|||
25311860|NCT00713830|50627059|FG000|Overall Study|Lost to Follow-up|2|||
25311861|NCT00713830|50627060|FG001|Overall Study|Lost to Follow-up|9|||
25311862|NCT00713830|50627059|FG000|Overall Study|Withdrawal by Subject|13|||
25311863|NCT00713830|50627060|FG001|Overall Study|Withdrawal by Subject|23|||
25311864|NCT00713830|50627059|FG000|Overall Study|Poor Compliance to Protocol|7|||
25311865|NCT00713830|50627060|FG001|Overall Study|Poor Compliance to Protocol|14|||
25311866|NCT00713830|50627059|FG000|Overall Study|Familial and Personal Reasons|9|||
25311867|NCT00713830|50627060|FG001|Overall Study|Familial and Personal Reasons|34|||
25311868|NCT00713830|50627059|FG000|Overall Study|Sponsor Decision|4|||
25311869|NCT00713830|50627060|FG001|Overall Study|Sponsor Decision|10|||
25311870|NCT00681811|50627068|FG000|Overall Study|Adverse Event|1|||
25311871|NCT00681811|50627069|FG001|Overall Study|Adverse Event|1|||
25311872|NCT00681811|50627068|FG000|Overall Study|Withdrawal by Subject|2|||
25311873|NCT00681811|50627069|FG001|Overall Study|Withdrawal by Subject|2|||
25311874|NCT00681811|50627068|FG000|Overall Study|Non-compliance|0|||
25311875|NCT00681811|50627069|FG001|Overall Study|Non-compliance|1|||
25311876|NCT00681187|50627088|FG000|Overall Study|Withdrawal by Subject|1|||
25311877|NCT00681187|50627089|FG001|Overall Study|Withdrawal by Subject|0|||
25311878|NCT00681187|50627088|FG000|Overall Study|Death|0|||
25311879|NCT00681187|50627089|FG001|Overall Study|Death|1|||
25311880|NCT00681187|50627088|FG000|Overall Study|Adverse Event|0|||
25311881|NCT00681187|50627089|FG001|Overall Study|Adverse Event|1|||
25311882|NCT00681109|50627111|FG000|Overall Study|Lost to Follow-up|2|||
25311883|NCT00681109|50627112|FG001|Overall Study|Lost to Follow-up|6|||
25311884|NCT00681109|50627113|FG002|Overall Study|Lost to Follow-up|0|||
25311885|NCT00680407|50627127|FG000|Overall Study|Lost to Follow-up|3|||
25311886|NCT00680407|50627128|FG001|Overall Study|Lost to Follow-up|3|||
25311887|NCT00680407|50627129|FG002|Overall Study|Lost to Follow-up|1|||
25311888|NCT00680407|50627127|FG000|Overall Study|Withdrawal by Subject|5|||
25311889|NCT00680407|50627128|FG001|Overall Study|Withdrawal by Subject|2|||
25311890|NCT00680407|50627129|FG002|Overall Study|Withdrawal by Subject|2|||
25311891|NCT00677365|50627141|FG000|Overall Study|Adverse Event|2|||
25192270|NCT01444430|50357931|FG001|Overall Study|Withdrawal by Subject|72|||
25192271|NCT01444430|50357930|FG000|Overall Study|Death|6|||
25192272|NCT01444430|50357931|FG001|Overall Study|Death|8|||
25192273|NCT01444430|50357930|FG000|Overall Study|Lost to Follow-up|2|||
25192274|NCT01444430|50357931|FG001|Overall Study|Lost to Follow-up|0|||
24970238|NCT04140292|50059758|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
25311892|NCT00677365|50627142|FG001|Overall Study|Adverse Event|1|||
25311893|NCT00677365|50627143|FG002|Overall Study|Adverse Event|1|||
25311894|NCT00677365|50627144|FG003|Overall Study|Adverse Event|2|||
25311895|NCT00677365|50627141|FG000|Overall Study|Withdrawal by Subject|0|||
25311896|NCT00677365|50627142|FG001|Overall Study|Withdrawal by Subject|0|||
25311897|NCT00677365|50627143|FG002|Overall Study|Withdrawal by Subject|1|||
25311898|NCT00677365|50627144|FG003|Overall Study|Withdrawal by Subject|0|||
25311899|NCT00677365|50627141|FG000|Overall Study|Other reason|0|||
25311900|NCT00677365|50627142|FG001|Overall Study|Other reason|0|||
25311901|NCT00677365|50627143|FG002|Overall Study|Other reason|0|||
25311902|NCT00677365|50627144|FG003|Overall Study|Other reason|1|||
25311903|NCT00680017|50627156|FG000|Overall Study|Adverse Event|13|||
25311904|NCT00680017|50627157|FG001|Overall Study|Adverse Event|7|||
25311905|NCT00680017|50627156|FG000|Overall Study|Withdrawal by Subject|2|||
25311906|NCT00680017|50627157|FG001|Overall Study|Withdrawal by Subject|5|||
25311907|NCT00680017|50627156|FG000|Overall Study|Lost to Follow-up|2|||
25311908|NCT00680017|50627157|FG001|Overall Study|Lost to Follow-up|0|||
25311909|NCT00676663|50627165|FG000|Overall Study|Death|43|||
25311910|NCT00676663|50627166|FG001|Overall Study|Death|27|||
25311911|NCT00676663|50627165|FG000|Overall Study|Withdrew Consent|1|||
25311912|NCT00676663|50627166|FG001|Overall Study|Withdrew Consent|8|||
25311913|NCT00676663|50627165|FG000|Overall Study|Lost to Follow-up|1|||
25311914|NCT00676663|50627166|FG001|Overall Study|Lost to Follow-up|3|||
24970239|NCT04138810|50059767|FG000|Overall Study|Withdrawal by Subject|0|||
24970240|NCT04138810|50059768|FG001|Overall Study|Withdrawal by Subject|1|||
24970241|NCT04138810|50059767|FG000|Overall Study|Subject cancelled surgery|1|||
25311915|NCT00678691|50627176|FG000|Overall Study|Adverse Event|6|||
25311916|NCT00678691|50627177|FG001|Overall Study|Adverse Event|4|||
25311917|NCT00679939|50627185|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
25311918|NCT00679939|50627186|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
25311919|NCT00679939|50627185|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
25311920|NCT00679939|50627186|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
25311921|NCT00679939|50627185|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
25311922|NCT00679939|50627186|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
25311923|NCT00679939|50627185|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
25311924|NCT00679939|50627186|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
25311925|NCT00679939|50627185|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
25311926|NCT00679939|50627186|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
25311927|NCT00679939|50627185|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
25311928|NCT00679939|50627186|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
25311929|NCT00679939|50627185|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
25311930|NCT00679939|50627186|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
25311931|NCT00679939|50627185|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
25311932|NCT00679939|50627186|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
25311933|NCT00679939|50627185|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
25311934|NCT00679939|50627186|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
25311935|NCT00679939|50627185|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
25311936|NCT00679939|50627186|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
25311937|NCT00673933|50627196|FG000|Overall Study|Withdrawal by Subject|2|||
25311938|NCT00673933|50627196|FG000|Overall Study|Lost to Follow-up|1|||
25311939|NCT00571519|50627209|FG000|Overall Study|Subject withdrew consent|0|||
25311940|NCT00571519|50627210|FG001|Overall Study|Subject withdrew consent|1|||
25311941|NCT00571519|50627211|FG002|Overall Study|Subject withdrew consent|0|||
25311942|NCT00571519|50627212|FG003|Overall Study|Subject withdrew consent|2|||
25311943|NCT00571519|50627213|FG004|Overall Study|Subject withdrew consent|1|||
25311944|NCT00571519|50627214|FG005|Overall Study|Subject withdrew consent|1|||
25311945|NCT00571519|50627215|FG006|Overall Study|Subject withdrew consent|2|||
25311946|NCT00571519|50627209|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
25311947|NCT00571519|50627210|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
25311948|NCT00571519|50627211|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
25311949|NCT00571519|50627212|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
25311950|NCT00571519|50627213|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
25311951|NCT00571519|50627214|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
25311952|NCT00571519|50627215|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
25311953|NCT00571519|50627209|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
25311954|NCT00571519|50627210|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
25311955|NCT00571519|50627211|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
25311956|NCT00571519|50627212|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
25311957|NCT00571519|50627213|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
25311958|NCT00571519|50627214|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
25311959|NCT00571519|50627215|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
25311960|NCT00571519|50627209|FG000|Overall Study|Termination of study by Sponsor|2|||
25311961|NCT00571519|50627210|FG001|Overall Study|Termination of study by Sponsor|7|||
25311962|NCT00571519|50627211|FG002|Overall Study|Termination of study by Sponsor|10|||
25311963|NCT00571519|50627212|FG003|Overall Study|Termination of study by Sponsor|24|||
25311964|NCT00571519|50627213|FG004|Overall Study|Termination of study by Sponsor|8|||
25311965|NCT00571519|50627214|FG005|Overall Study|Termination of study by Sponsor|9|||
25311966|NCT00571519|50627215|FG006|Overall Study|Termination of study by Sponsor|22|||
25311967|NCT00571519|50627209|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
25311968|NCT00571519|50627210|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
25311969|NCT00571519|50627211|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
25311970|NCT00571519|50627212|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
25311971|NCT00571519|50627213|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
25311972|NCT00571519|50627214|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
25311973|NCT00571519|50627215|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
25311974|NCT00676195|50627231|FG000|Overall Study|Lost to Follow-up|1|||
25311975|NCT00676195|50627231|FG000|Overall Study|Adverse Event|1|||
25311976|NCT00676195|50627231|FG000|Overall Study|Physician Decision|1|||
25311977|NCT00675103|50627236|FG000|Overall Study|Lack of Efficacy|2|||
25311978|NCT00675103|50627236|FG000|Overall Study|Adverse Event|1|||
25311979|NCT00675025|50627242|FG000|Overall Study|Study Terminated by Sponsor|38|||
25311980|NCT00675025|50627243|FG001|Overall Study|Study Terminated by Sponsor|42|||
25311981|NCT00675025|50627242|FG000|Overall Study|Adverse Event|6|||
25311982|NCT00675025|50627243|FG001|Overall Study|Adverse Event|11|||
25311983|NCT00675025|50627242|FG000|Overall Study|Lost to Follow-up|6|||
25311984|NCT00675025|50627243|FG001|Overall Study|Lost to Follow-up|4|||
25311985|NCT00675025|50627242|FG000|Overall Study|Withdrawal by Subject|4|||
25311986|NCT00675025|50627243|FG001|Overall Study|Withdrawal by Subject|6|||
25311987|NCT00678379|50627261|FG000|Overall Study|Injection performed after tonsillectomy|2|||
25311988|NCT00678379|50627262|FG001|Overall Study|Injection performed after tonsillectomy|0|||
25311989|NCT00678379|50627263|FG002|Overall Study|Injection performed after tonsillectomy|1|||
25311990|NCT00678379|50627261|FG000|Overall Study|Incomplete Data|4|||
25311991|NCT00678379|50627262|FG001|Overall Study|Incomplete Data|3|||
25311992|NCT00678379|50627263|FG002|Overall Study|Incomplete Data|3|||
25311993|NCT00674323|50627274|FG000|Overall Study|Adverse Event|0|||
25311994|NCT00674323|50627275|FG001|Overall Study|Adverse Event|1|||
25311995|NCT00674323|50627276|FG002|Overall Study|Adverse Event|0|||
25311996|NCT00674323|50627274|FG000|Overall Study|Protocol Violation|1|||
25311997|NCT00674323|50627275|FG001|Overall Study|Protocol Violation|0|||
25311998|NCT00674323|50627276|FG002|Overall Study|Protocol Violation|0|||
25311999|NCT00678301|50627286|FG000|Overall Study|Non-compliance with study procedures|0|||
25312000|NCT00678301|50627287|FG001|Overall Study|Non-compliance with study procedures|1|||
25312001|NCT00678301|50627286|FG000|Overall Study|Adverse Event|1|||
25312002|NCT00678301|50627287|FG001|Overall Study|Adverse Event|0|||
25312003|NCT00678301|50627286|FG000|Overall Study|Withdrawal by Subject|4|||
25312004|NCT00678301|50627287|FG001|Overall Study|Withdrawal by Subject|0|||
25312005|NCT00678301|50627286|FG000|Overall Study|Lost to Follow-up|3|||
25312006|NCT00678301|50627287|FG001|Overall Study|Lost to Follow-up|1|||
25312007|NCT00939770|50627301|FG000|Overall Study|Adverse Event|1|||
25312008|NCT00939770|50627302|FG001|Overall Study|Adverse Event|1|||
25312009|NCT00939770|50627303|FG002|Overall Study|Adverse Event|0|||
25312010|NCT00939770|50627304|FG003|Overall Study|Adverse Event|0|||
25312011|NCT00939770|50627305|FG004|Overall Study|Adverse Event|6|||
25312012|NCT00939770|50627306|FG005|Overall Study|Adverse Event|2|||
25312013|NCT00939770|50627307|FG006|Overall Study|Adverse Event|1|||
25312014|NCT00939770|50627308|FG007|Overall Study|Adverse Event|1|||
25312015|NCT00939770|50627301|FG000|Overall Study|Lack of Efficacy|4|||
25312016|NCT00939770|50627302|FG001|Overall Study|Lack of Efficacy|6|||
25312017|NCT00939770|50627303|FG002|Overall Study|Lack of Efficacy|13|||
25312018|NCT00939770|50627304|FG003|Overall Study|Lack of Efficacy|9|||
25312019|NCT00939770|50627305|FG004|Overall Study|Lack of Efficacy|16|||
25312020|NCT00939770|50627306|FG005|Overall Study|Lack of Efficacy|8|||
25312021|NCT00939770|50627307|FG006|Overall Study|Lack of Efficacy|11|||
25312022|NCT00939770|50627308|FG007|Overall Study|Lack of Efficacy|1|||
25312023|NCT00939770|50627301|FG000|Overall Study|Lost to Follow-up|0|||
25312024|NCT00939770|50627302|FG001|Overall Study|Lost to Follow-up|0|||
25312025|NCT00939770|50627303|FG002|Overall Study|Lost to Follow-up|0|||
25312026|NCT00939770|50627304|FG003|Overall Study|Lost to Follow-up|0|||
25312027|NCT00939770|50627305|FG004|Overall Study|Lost to Follow-up|1|||
24970242|NCT04138810|50059768|FG001|Overall Study|Subject cancelled surgery|0|||
25312028|NCT00939770|50627306|FG005|Overall Study|Lost to Follow-up|0|||
25312029|NCT00939770|50627307|FG006|Overall Study|Lost to Follow-up|0|||
24970243|NCT00127166|50059776|FG000|Period I|Protocol Violation|0|||
25312030|NCT00939770|50627308|FG007|Overall Study|Lost to Follow-up|0|||
25312031|NCT00939770|50627301|FG000|Overall Study|Physician Decision|0|||
25312032|NCT00939770|50627302|FG001|Overall Study|Physician Decision|0|||
25312033|NCT00939770|50627303|FG002|Overall Study|Physician Decision|2|||
25312034|NCT00939770|50627304|FG003|Overall Study|Physician Decision|0|||
25312035|NCT00939770|50627305|FG004|Overall Study|Physician Decision|7|||
25312036|NCT00939770|50627306|FG005|Overall Study|Physician Decision|1|||
25312037|NCT00939770|50627307|FG006|Overall Study|Physician Decision|0|||
25312038|NCT00939770|50627308|FG007|Overall Study|Physician Decision|6|||
25312039|NCT00939770|50627301|FG000|Overall Study|Protocol Violation|0|||
25312040|NCT00939770|50627302|FG001|Overall Study|Protocol Violation|0|||
25312041|NCT00939770|50627303|FG002|Overall Study|Protocol Violation|0|||
25312042|NCT00939770|50627304|FG003|Overall Study|Protocol Violation|0|||
25312043|NCT00939770|50627305|FG004|Overall Study|Protocol Violation|1|||
25312044|NCT00939770|50627306|FG005|Overall Study|Protocol Violation|0|||
24970244|NCT00127166|50059777|FG001|Period I|Protocol Violation|2|||
24970245|NCT00127166|50059776|FG000|Period I|Withdrawal by Subject|2|||
24970246|NCT00127166|50059777|FG001|Period I|Withdrawal by Subject|0|||
24970247|NCT00127166|50059776|FG000|Period I|Patient did not meet inclusion criteria|1|||
24970248|NCT00127166|50059777|FG001|Period I|Patient did not meet inclusion criteria|0|||
24970249|NCT00127166|50059776|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
24970250|NCT00127166|50059777|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
24970251|NCT00127166|50059776|FG000|Period II|Withdrawal by Subject|2|||
24970252|NCT00127166|50059777|FG001|Period II|Withdrawal by Subject|0|||
24970253|NCT00127166|50059776|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
24970254|NCT00127166|50059777|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
24970255|NCT00125138|50059787|FG000|Overall Study|Adverse Event|1|||
24970256|NCT00125138|50059788|FG001|Overall Study|Adverse Event|0|||
24970257|NCT00125138|50059789|FG002|Overall Study|Adverse Event|3|||
25071423|NCT02562482|50177606|FG000|Overall Study|Physician Decision|1|||
24970258|NCT00125138|50059790|FG003|Overall Study|Adverse Event|2|||
25312045|NCT00939770|50627307|FG006|Overall Study|Protocol Violation|0|||
25312046|NCT00939770|50627308|FG007|Overall Study|Protocol Violation|0|||
25312047|NCT00939770|50627301|FG000|Overall Study|Withdrawal by Subject|0|||
25312048|NCT00939770|50627302|FG001|Overall Study|Withdrawal by Subject|1|||
24970259|NCT00125138|50059787|FG000|Overall Study|Withdrawal by Subject|2|||
24970260|NCT00125138|50059788|FG001|Overall Study|Withdrawal by Subject|3|||
24970261|NCT00125138|50059789|FG002|Overall Study|Withdrawal by Subject|1|||
24970262|NCT00125138|50059790|FG003|Overall Study|Withdrawal by Subject|1|||
24970263|NCT00125138|50059787|FG000|Overall Study|Lack of Efficacy|0|||
25312049|NCT00939770|50627303|FG002|Overall Study|Withdrawal by Subject|5|||
25312050|NCT00939770|50627304|FG003|Overall Study|Withdrawal by Subject|2|||
25312051|NCT00939770|50627305|FG004|Overall Study|Withdrawal by Subject|6|||
25312052|NCT00939770|50627306|FG005|Overall Study|Withdrawal by Subject|0|||
25312053|NCT00939770|50627307|FG006|Overall Study|Withdrawal by Subject|2|||
25312054|NCT00939770|50627308|FG007|Overall Study|Withdrawal by Subject|2|||
25312055|NCT00939692|50627341|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
25312056|NCT00939692|50627342|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
25312057|NCT00939692|50627341|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
25312058|NCT00939692|50627342|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
25312059|NCT04672252|50627350|FG000|Overall Study|Protocol Violation|1|||
25312060|NCT04672252|50627351|FG001|Overall Study|Protocol Violation|0|||
25312061|NCT00584740|50627359|FG000|Overall Study|Adverse Event|1|||
25312062|NCT00584740|50627360|FG001|Overall Study|Adverse Event|1|||
25312063|NCT00584740|50627359|FG000|Overall Study|Lack of Efficacy|8|||
25312064|NCT00584740|50627360|FG001|Overall Study|Lack of Efficacy|2|||
25312065|NCT00584740|50627359|FG000|Overall Study|Withdrawal by Subject|3|||
25312066|NCT00584740|50627360|FG001|Overall Study|Withdrawal by Subject|2|||
25312067|NCT00584740|50627359|FG000|Overall Study|Lost to Follow-up|0|||
25312068|NCT00584740|50627360|FG001|Overall Study|Lost to Follow-up|1|||
25312069|NCT00942968|50627366|FG000|Overall Study|Adverse Event|60|||
25312070|NCT00942968|50627366|FG000|Overall Study|Death|76|||
25312071|NCT00942968|50627366|FG000|Overall Study|Protocol Violation|9|||
25312072|NCT00942968|50627366|FG000|Overall Study|Lost to Follow-up|4|||
25312073|NCT00942968|50627366|FG000|Overall Study|Withdrawal by Subject|44|||
25312074|NCT00942968|50627366|FG000|Overall Study|Sponsor request|5|||
25312075|NCT00942968|50627366|FG000|Overall Study|Physician Decision|11|||
25312076|NCT00942968|50627366|FG000|Overall Study|Progression of disease|12|||
25312077|NCT00942968|50627366|FG000|Overall Study|Inferior vena cava filter placement|4|||
25312078|NCT00942968|50627366|FG000|Overall Study|Pulmonary embolism (PE)|1|||
25312079|NCT00942968|50627366|FG000|Overall Study|Participant required pancreatic biopsy|1|||
25312080|NCT00942968|50627366|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
25312081|NCT00942734|50627370|FG000|Overall Study|Adverse Event|2|||
25312082|NCT00942734|50627370|FG000|Overall Study|Protocol Violation|3|||
25312083|NCT00942734|50627370|FG000|Overall Study|Disease Progression|2|||
25312084|NCT00942734|50627370|FG000|Overall Study|Physician Decision|1|||
25312085|NCT00584194|50627374|FG000|Overall Study|Other|135|||
25312086|NCT00942422|50627378|FG000|Overall Study|Withdrawal by Subject|1|||
25312087|NCT00942422|50627378|FG000|Overall Study|Death|1|||
25312088|NCT00942422|50627378|FG000|Overall Study|Progressive diease|1|||
25312089|NCT00677833|50627386|FG000|Overall Study|Withdrawal by Subject|4|||
25312090|NCT00677833|50627387|FG001|Overall Study|Withdrawal by Subject|0|||
24970264|NCT00125138|50059788|FG001|Overall Study|Lack of Efficacy|0|||
25071424|NCT02562482|50177607|FG001|Overall Study|Physician Decision|3|||
25312091|NCT00677833|50627388|FG002|Overall Study|Withdrawal by Subject|1|||
25312092|NCT00677833|50627389|FG003|Overall Study|Withdrawal by Subject|3|||
25312093|NCT00677833|50627386|FG000|Overall Study|Lost to Follow-up|0|||
25312094|NCT00677833|50627387|FG001|Overall Study|Lost to Follow-up|0|||
25312095|NCT00677833|50627388|FG002|Overall Study|Lost to Follow-up|1|||
25312096|NCT00677833|50627389|FG003|Overall Study|Lost to Follow-up|0|||
25312097|NCT00942266|50627399|FG000|Overall Study|Withdrawal by Subject|1|||
25312098|NCT00942266|50627400|FG001|Overall Study|Withdrawal by Subject|0|||
25312099|NCT00942266|50627399|FG000|Overall Study|Adverse Event|2|||
25312100|NCT00942266|50627400|FG001|Overall Study|Adverse Event|1|||
25312101|NCT00942266|50627399|FG000|Overall Study|Disease Progression|38|||
25312102|NCT00942266|50627400|FG001|Overall Study|Disease Progression|11|||
25312103|NCT00942266|50627399|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
25312104|NCT00942266|50627400|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
25312105|NCT00942266|50627399|FG000|Overall Study|Intercurrent illness|0|||
25312106|NCT00942266|50627400|FG001|Overall Study|Intercurrent illness|1|||
25312107|NCT00942266|50627399|FG000|Overall Study|Physician Decision|2|||
25312108|NCT00942266|50627400|FG001|Overall Study|Physician Decision|0|||
25312109|NCT00942266|50627399|FG000|Overall Study|medical deterioration (pneumonia)|0|||
25312110|NCT00942266|50627400|FG001|Overall Study|medical deterioration (pneumonia)|1|||
25312111|NCT00942188|50627410|FG000|Overall Study|Adverse Event|0|||
25312112|NCT00942188|50627411|FG001|Overall Study|Adverse Event|3|||
25312113|NCT00942188|50627412|FG002|Overall Study|Adverse Event|2|||
25312114|NCT00942188|50627413|FG003|Overall Study|Adverse Event|0|||
25312115|NCT00942188|50627410|FG000|Overall Study|Lack of Efficacy|0|||
25312116|NCT00942188|50627411|FG001|Overall Study|Lack of Efficacy|0|||
25312117|NCT00942188|50627412|FG002|Overall Study|Lack of Efficacy|0|||
25312118|NCT00942188|50627413|FG003|Overall Study|Lack of Efficacy|1|||
25312119|NCT00942188|50627410|FG000|Overall Study|Protocol Violation|1|||
25312120|NCT00942188|50627411|FG001|Overall Study|Protocol Violation|1|||
25312121|NCT00942188|50627412|FG002|Overall Study|Protocol Violation|0|||
25312122|NCT00942188|50627413|FG003|Overall Study|Protocol Violation|0|||
25312123|NCT00942188|50627410|FG000|Overall Study|Lost to Follow-up|2|||
25312124|NCT00942188|50627411|FG001|Overall Study|Lost to Follow-up|1|||
25312125|NCT00942188|50627412|FG002|Overall Study|Lost to Follow-up|2|||
25312126|NCT00942188|50627413|FG003|Overall Study|Lost to Follow-up|0|||
25312127|NCT00942188|50627410|FG000|Overall Study|Withdrawal by Subject|1|||
25312128|NCT00942188|50627411|FG001|Overall Study|Withdrawal by Subject|3|||
25312129|NCT00942188|50627412|FG002|Overall Study|Withdrawal by Subject|4|||
25312130|NCT00942188|50627413|FG003|Overall Study|Withdrawal by Subject|2|||
25312131|NCT00942188|50627410|FG000|Overall Study|Physician Decision|0|||
25312132|NCT00942188|50627411|FG001|Overall Study|Physician Decision|0|||
25312133|NCT00942188|50627412|FG002|Overall Study|Physician Decision|1|||
25312134|NCT00942188|50627413|FG003|Overall Study|Physician Decision|0|||
25312135|NCT00942188|50627410|FG000|Overall Study|Sponsor Decision|0|||
25312136|NCT00942188|50627411|FG001|Overall Study|Sponsor Decision|2|||
25312137|NCT00942188|50627412|FG002|Overall Study|Sponsor Decision|0|||
25312138|NCT00942188|50627413|FG003|Overall Study|Sponsor Decision|1|||
25312139|NCT00673231|50627427|FG000|Overall Study|Withdrawal by Subject|14|||
25312140|NCT00673231|50627428|FG001|Overall Study|Withdrawal by Subject|10|||
25312141|NCT00673231|50627429|FG002|Overall Study|Withdrawal by Subject|8|||
25312142|NCT00673231|50627430|FG003|Overall Study|Withdrawal by Subject|6|||
25312143|NCT00673231|50627427|FG000|Overall Study|Adverse Event|6|||
25312144|NCT00673231|50627428|FG001|Overall Study|Adverse Event|5|||
25312145|NCT00673231|50627429|FG002|Overall Study|Adverse Event|9|||
25312146|NCT00673231|50627430|FG003|Overall Study|Adverse Event|6|||
25312147|NCT00673231|50627427|FG000|Overall Study|Lost to Follow-up|1|||
25312148|NCT00673231|50627428|FG001|Overall Study|Lost to Follow-up|2|||
25312149|NCT00673231|50627429|FG002|Overall Study|Lost to Follow-up|1|||
25312150|NCT00673231|50627430|FG003|Overall Study|Lost to Follow-up|2|||
25312151|NCT00673231|50627427|FG000|Overall Study|Death|0|||
25312152|NCT00673231|50627428|FG001|Overall Study|Death|0|||
25312153|NCT00673231|50627429|FG002|Overall Study|Death|1|||
25312154|NCT00673231|50627430|FG003|Overall Study|Death|0|||
25312155|NCT00673231|50627427|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
25312156|NCT00673231|50627428|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
25312157|NCT00673231|50627429|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
25312158|NCT00673231|50627430|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
25312159|NCT00672841|50627442|FG000|Overall Study|Comfort care|1|||
25312160|NCT00672841|50627443|FG001|Overall Study|Comfort care|4|||
25312161|NCT00672841|50627442|FG000|Overall Study|icteric specimens|0|||
25312162|NCT00672841|50627443|FG001|Overall Study|icteric specimens|3|||
25312163|NCT00672841|50627442|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
25312164|NCT00672841|50627443|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
25312165|NCT00672841|50627442|FG000|Overall Study|Adverse Event|0|||
25312166|NCT00672841|50627443|FG001|Overall Study|Adverse Event|3|||
25312167|NCT00672841|50627442|FG000|Overall Study|Pregnancy|0|||
24970265|NCT00125138|50059789|FG002|Overall Study|Lack of Efficacy|0|||
25312168|NCT00672841|50627443|FG001|Overall Study|Pregnancy|1|||
25312169|NCT00673465|50627452|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
25312170|NCT00673465|50627453|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
25312171|NCT00673465|50627454|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
25312172|NCT00673465|50627455|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
25312173|NCT00673465|50627456|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
25312174|NCT00673465|50627457|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
25312175|NCT00673465|50627458|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
25312176|NCT00673465|50627459|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
25312177|NCT00673465|50627460|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
25312178|NCT00673465|50627461|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
25312179|NCT00673465|50627462|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
25312180|NCT00673465|50627463|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
25312181|NCT00673465|50627452|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
25312182|NCT00673465|50627453|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
25312183|NCT00673465|50627454|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
25312184|NCT00673465|50627455|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
25312185|NCT00673465|50627456|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
25312186|NCT00673465|50627457|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
25312187|NCT00673465|50627458|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
25312188|NCT00673465|50627459|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
25312189|NCT00673465|50627460|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
25312190|NCT00673465|50627461|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
25312191|NCT00673465|50627462|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
25312192|NCT00673465|50627463|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
25312193|NCT00941798|50627473|FG000|Overall Study|Withdrawal by Subject|72|||
25312194|NCT00941798|50627474|FG001|Overall Study|Withdrawal by Subject|74|||
25312195|NCT00941798|50627473|FG000|Overall Study|Adverse Event|43|||
25312196|NCT00941798|50627474|FG001|Overall Study|Adverse Event|23|||
25312197|NCT00941798|50627473|FG000|Overall Study|Lost to Follow-up|29|||
25312198|NCT00941798|50627474|FG001|Overall Study|Lost to Follow-up|23|||
25312199|NCT00941798|50627473|FG000|Overall Study|Protocol Violation|17|||
25312200|NCT00941798|50627474|FG001|Overall Study|Protocol Violation|20|||
25312201|NCT00941798|50627473|FG000|Overall Study|Administrative problems|13|||
25312202|NCT00941798|50627474|FG001|Overall Study|Administrative problems|23|||
25312203|NCT00941798|50627473|FG000|Overall Study|Lack of Efficacy|10|||
25312204|NCT00941798|50627474|FG001|Overall Study|Lack of Efficacy|17|||
25312205|NCT00941798|50627473|FG000|Overall Study|Patient's inability to use device|6|||
25312206|NCT00941798|50627474|FG001|Overall Study|Patient's inability to use device|1|||
25312207|NCT00941798|50627473|FG000|Overall Study|Abnormal test procedure results|3|||
25312208|NCT00941798|50627474|FG001|Overall Study|Abnormal test procedure results|1|||
25312209|NCT00941798|50627473|FG000|Overall Study|Abnormal laboratory values|1|||
25312210|NCT00941798|50627474|FG001|Overall Study|Abnormal laboratory values|2|||
25312211|NCT00941798|50627473|FG000|Overall Study|Death|0|||
25312212|NCT00941798|50627474|FG001|Overall Study|Death|1|||
25312213|NCT00583102|50627480|FG000|Overall Study|Adverse Event|3|||
25312214|NCT05208866|50627488|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
25312215|NCT04745351|50627503|FG000|Overall Study|Death|51|||
25312216|NCT04745351|50627504|FG001|Overall Study|Death|25|||
25312217|NCT04745351|50627503|FG000|Overall Study|Lost to Follow-up|9|||
25312218|NCT04745351|50627504|FG001|Overall Study|Lost to Follow-up|3|||
25312219|NCT04745351|50627503|FG000|Overall Study|Randomized but Never Treated|3|||
25312220|NCT04745351|50627504|FG001|Overall Study|Randomized but Never Treated|3|||
25312221|NCT04745351|50627503|FG000|Overall Study|Adverse Event|4|||
25312222|NCT04745351|50627504|FG001|Overall Study|Adverse Event|0|||
25312223|NCT04745351|50627503|FG000|Overall Study|Withdrew Consent|1|||
25312224|NCT04745351|50627504|FG001|Overall Study|Withdrew Consent|2|||
25312225|NCT04745351|50627503|FG000|Overall Study|Investigator's Discretion|2|||
25312226|NCT04745351|50627504|FG001|Overall Study|Investigator's Discretion|0|||
25312227|NCT04745351|50627503|FG000|Overall Study|Protocol Violation|1|||
25312228|NCT04745351|50627504|FG001|Overall Study|Protocol Violation|0|||
25312229|NCT04576455|50627521|FG000|Overall Study|Ongoing in the Study|122|||
25312230|NCT04576455|50627522|FG001|Overall Study|Ongoing in the Study|135|||
25312231|NCT04576455|50627521|FG000|Overall Study|Death|18|||
25312232|NCT04576455|50627522|FG001|Overall Study|Death|12|||
25312233|NCT04576455|50627521|FG000|Overall Study|Lost to Follow-up|1|||
25312234|NCT04576455|50627522|FG001|Overall Study|Lost to Follow-up|0|||
25312235|NCT04576455|50627521|FG000|Overall Study|Withdrawal by Subject|10|||
25312236|NCT04576455|50627522|FG001|Overall Study|Withdrawal by Subject|5|||
25312237|NCT04427501|50627539|FG000|Overall Study|Death|0|||
25312238|NCT04427501|50627540|FG001|Overall Study|Death|0|||
25312239|NCT04427501|50627541|FG002|Overall Study|Death|0|||
25312240|NCT04427501|50627542|FG003|Overall Study|Death|0|||
25312241|NCT04427501|50627543|FG004|Overall Study|Death|0|||
25312242|NCT04427501|50627544|FG005|Overall Study|Death|15|||
25312243|NCT04427501|50627545|FG006|Overall Study|Death|0|||
25312244|NCT04427501|50627546|FG007|Overall Study|Death|0|||
25312245|NCT04427501|50627547|FG008|Overall Study|Death|0|||
25312246|NCT04427501|50627548|FG009|Overall Study|Death|0|||
25312247|NCT04427501|50627539|FG000|Overall Study|Lost to Follow-up|5|||
25312248|NCT04427501|50627540|FG001|Overall Study|Lost to Follow-up|1|||
25312249|NCT04427501|50627541|FG002|Overall Study|Lost to Follow-up|2|||
25312250|NCT04427501|50627542|FG003|Overall Study|Lost to Follow-up|0|||
24970266|NCT00125138|50059790|FG003|Overall Study|Lack of Efficacy|1|||
25071425|NCT02562482|50177606|FG000|Overall Study|Illness/Injury unrelated to product|0|||
25071426|NCT02562482|50177607|FG001|Overall Study|Illness/Injury unrelated to product|1|||
25071427|NCT02568254|50177622|FG000|Period 2|Adverse Event|0|||
25071428|NCT02568254|50177623|FG001|Period 2|Adverse Event|0|||
25071429|NCT02568254|50177624|FG002|Period 2|Adverse Event|1|||
25312251|NCT04427501|50627543|FG004|Overall Study|Lost to Follow-up|2|||
25312252|NCT04427501|50627544|FG005|Overall Study|Lost to Follow-up|11|||
25312253|NCT04427501|50627545|FG006|Overall Study|Lost to Follow-up|10|||
25312254|NCT04427501|50627546|FG007|Overall Study|Lost to Follow-up|10|||
25312255|NCT04427501|50627547|FG008|Overall Study|Lost to Follow-up|2|||
25312256|NCT04427501|50627548|FG009|Overall Study|Lost to Follow-up|5|||
25312257|NCT04427501|50627539|FG000|Overall Study|Physician Decision|0|||
25312258|NCT04427501|50627540|FG001|Overall Study|Physician Decision|3|||
25312259|NCT04427501|50627541|FG002|Overall Study|Physician Decision|0|||
25312260|NCT04427501|50627542|FG003|Overall Study|Physician Decision|0|||
25312261|NCT04427501|50627543|FG004|Overall Study|Physician Decision|0|||
25312262|NCT04427501|50627544|FG005|Overall Study|Physician Decision|0|||
25312263|NCT04427501|50627545|FG006|Overall Study|Physician Decision|2|||
25312264|NCT04427501|50627546|FG007|Overall Study|Physician Decision|0|||
25312265|NCT04427501|50627547|FG008|Overall Study|Physician Decision|0|||
25312266|NCT04427501|50627548|FG009|Overall Study|Physician Decision|0|||
25312267|NCT04427501|50627539|FG000|Overall Study|Withdrawal by Subject|9|||
25312268|NCT04427501|50627540|FG001|Overall Study|Withdrawal by Subject|2|||
25312269|NCT04427501|50627541|FG002|Overall Study|Withdrawal by Subject|2|||
25312270|NCT04427501|50627542|FG003|Overall Study|Withdrawal by Subject|3|||
25312271|NCT04427501|50627543|FG004|Overall Study|Withdrawal by Subject|7|||
25312272|NCT04427501|50627544|FG005|Overall Study|Withdrawal by Subject|25|||
25312273|NCT04427501|50627545|FG006|Overall Study|Withdrawal by Subject|15|||
25312274|NCT04427501|50627546|FG007|Overall Study|Withdrawal by Subject|7|||
25312275|NCT04427501|50627547|FG008|Overall Study|Withdrawal by Subject|4|||
25312276|NCT04427501|50627548|FG009|Overall Study|Withdrawal by Subject|1|||
25312277|NCT04427501|50627539|FG000|Overall Study|Other - as reported by the investigator|1|||
25312278|NCT04427501|50627540|FG001|Overall Study|Other - as reported by the investigator|0|||
25312279|NCT04427501|50627541|FG002|Overall Study|Other - as reported by the investigator|0|||
25312280|NCT04427501|50627542|FG003|Overall Study|Other - as reported by the investigator|0|||
25312281|NCT04427501|50627543|FG004|Overall Study|Other - as reported by the investigator|0|||
25312282|NCT04427501|50627544|FG005|Overall Study|Other - as reported by the investigator|6|||
25312283|NCT04427501|50627545|FG006|Overall Study|Other - as reported by the investigator|6|||
25312284|NCT04427501|50627546|FG007|Overall Study|Other - as reported by the investigator|0|||
25312285|NCT04427501|50627547|FG008|Overall Study|Other - as reported by the investigator|0|||
25312286|NCT04427501|50627548|FG009|Overall Study|Other - as reported by the investigator|0|||
25312287|NCT03981614|50627601|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
25312288|NCT03981614|50627602|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
25312289|NCT03981614|50627603|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
25312290|NCT03439124|50627616|FG000|Overall Study|Adverse Event|2|||
25312291|NCT03439124|50627617|FG001|Overall Study|Adverse Event|0|||
25312292|NCT03439124|50627616|FG000|Overall Study|Lost to Follow-up|1|||
25312293|NCT03439124|50627617|FG001|Overall Study|Lost to Follow-up|0|||
25312294|NCT03439124|50627616|FG000|Overall Study|Other reasons|1|||
25312295|NCT03439124|50627617|FG001|Overall Study|Other reasons|0|||
25312296|NCT03212989|50627636|FG000|Overall Study|Physician Decision|8|||
25312297|NCT03200548|50627644|FG000|Overall Study|Withdrawal by Subject|5|||
25312298|NCT03200548|50627645|FG001|Overall Study|Withdrawal by Subject|11|||
25312299|NCT03200548|50627646|FG002|Overall Study|Withdrawal by Subject|7|||
25312300|NCT03200548|50627647|FG003|Overall Study|Withdrawal by Subject|6|||
25312301|NCT03158688|50627659|FG000|Overall Study|Withdrawal by Subject|14|||
25312302|NCT03158688|50627660|FG001|Overall Study|Withdrawal by Subject|28|||
25312303|NCT03158688|50627659|FG000|Overall Study|Decision by sponsor|13|||
25312304|NCT03158688|50627660|FG001|Overall Study|Decision by sponsor|37|||
25312305|NCT03158688|50627659|FG000|Overall Study|Lost to Follow-up|4|||
25312306|NCT03158688|50627660|FG001|Overall Study|Lost to Follow-up|3|||
25312307|NCT03158688|50627659|FG000|Overall Study|Death|74|||
25312308|NCT03158688|50627660|FG001|Overall Study|Death|142|||
25312309|NCT03138733|50627668|FG000|Overall Study|Death|17|||
25312310|NCT03138733|50627669|FG001|Overall Study|Death|18|||
25312311|NCT03138733|50627668|FG000|Overall Study|Withdrawal by Subject|11|||
25312312|NCT03138733|50627669|FG001|Overall Study|Withdrawal by Subject|6|||
25312313|NCT03138733|50627668|FG000|Overall Study|Lost to Follow-up|3|||
25312314|NCT03138733|50627669|FG001|Overall Study|Lost to Follow-up|2|||
25312315|NCT03138733|50627668|FG000|Overall Study|Adverse Event|1|||
25312316|NCT03138733|50627669|FG001|Overall Study|Adverse Event|0|||
25312317|NCT03138733|50627668|FG000|Overall Study|Protocol Violation|1|||
25312318|NCT03138733|50627669|FG001|Overall Study|Protocol Violation|3|||
25312319|NCT03138733|50627668|FG000|Overall Study|Administrative or logistical reason|1|||
25312320|NCT03138733|50627669|FG001|Overall Study|Administrative or logistical reason|0|||
25312321|NCT03138733|50627668|FG000|Overall Study|The patient was transferred to another hospital|1|||
25312322|NCT03138733|50627669|FG001|Overall Study|The patient was transferred to another hospital|0|||
25312323|NCT03137173|50627677|FG000|Overall Study|Withdrawal by Subject|8|||
25312324|NCT03137173|50627678|FG001|Overall Study|Withdrawal by Subject|13|||
25312325|NCT03137173|50627677|FG000|Overall Study|Death|1|||
25071430|NCT02568254|50177625|FG003|Period 2|Adverse Event|0|||
25312326|NCT03137173|50627678|FG001|Overall Study|Death|3|||
25312327|NCT03137173|50627677|FG000|Overall Study|Physician Decision|1|||
25312328|NCT03137173|50627678|FG001|Overall Study|Physician Decision|0|||
25312329|NCT03137173|50627677|FG000|Overall Study|Lost to Follow-up|13|||
25312330|NCT03137173|50627678|FG001|Overall Study|Lost to Follow-up|18|||
25312331|NCT03137173|50627677|FG000|Overall Study|Other reasons|3|||
25312332|NCT03137173|50627678|FG001|Overall Study|Other reasons|2|||
25312333|NCT02949219|50627685|FG000|Overall Study|Withdrawal by Subject|1|||
25312334|NCT02838420|50627691|FG000|Overall Study|Ongoing in Study|113|||
25312335|NCT02838420|50627692|FG001|Overall Study|Ongoing in Study|45|||
25312336|NCT02838420|50627691|FG000|Overall Study|Lost to Follow-up|1|||
25312337|NCT02838420|50627692|FG001|Overall Study|Lost to Follow-up|0|||
25312338|NCT02838420|50627691|FG000|Overall Study|Withdrawal by Subject|3|||
25312339|NCT02838420|50627692|FG001|Overall Study|Withdrawal by Subject|4|||
25312340|NCT02838420|50627691|FG000|Overall Study|Death|8|||
25312341|NCT02838420|50627692|FG001|Overall Study|Death|13|||
25312342|NCT02437318|50627716|FG000|Overall Study|Progressive disease|173|||
25312343|NCT02437318|50627717|FG001|Overall Study|Progressive disease|208|||
25312344|NCT02437318|50627716|FG000|Overall Study|Subject/guardian decision|22|||
25312345|NCT02437318|50627717|FG001|Overall Study|Subject/guardian decision|10|||
25312346|NCT02437318|50627716|FG000|Overall Study|Physician Decision|11|||
25312347|NCT02437318|50627717|FG001|Overall Study|Physician Decision|10|||
25312348|NCT02437318|50627716|FG000|Overall Study|Adverse Event|14|||
25312349|NCT02437318|50627717|FG001|Overall Study|Adverse Event|3|||
25312350|NCT02437318|50627716|FG000|Overall Study|Death|4|||
25312351|NCT02437318|50627717|FG001|Overall Study|Death|4|||
25312352|NCT02437318|50627716|FG000|Overall Study|Protocol Violation|5|||
25312353|NCT02437318|50627717|FG001|Overall Study|Protocol Violation|6|||
25312354|NCT02437318|50627716|FG000|Overall Study|Untreated|0|||
25312355|NCT02437318|50627717|FG001|Overall Study|Untreated|1|||
25312356|NCT02087423|50627726|FG000|Overall Study|Withdrawal by Subject|20|||
25312357|NCT02087423|50627727|FG001|Overall Study|Withdrawal by Subject|20|||
25312358|NCT02087423|50627728|FG002|Overall Study|Withdrawal by Subject|3|||
25312359|NCT02087423|50627726|FG000|Overall Study|Death|68|||
25312360|NCT02087423|50627727|FG001|Overall Study|Death|207|||
25312361|NCT02087423|50627728|FG002|Overall Study|Death|40|||
25312362|NCT02087423|50627726|FG000|Overall Study|Lost to Follow-up|0|||
25312363|NCT02087423|50627727|FG001|Overall Study|Lost to Follow-up|2|||
25312364|NCT02087423|50627728|FG002|Overall Study|Lost to Follow-up|0|||
25312365|NCT02087423|50627726|FG000|Overall Study|Terminated from study at final DCO|23|||
25312366|NCT02087423|50627727|FG001|Overall Study|Terminated from study at final DCO|36|||
25312367|NCT02087423|50627728|FG002|Overall Study|Terminated from study at final DCO|25|||
25312368|NCT01575808|50627762|FG000|Overall Study|Death|2|||
25312369|NCT01575808|50627763|FG001|Overall Study|Death|0|||
25312370|NCT01575808|50627762|FG000|Overall Study|Withdrawal by Subject|1|||
25312371|NCT01575808|50627763|FG001|Overall Study|Withdrawal by Subject|0|||
25312372|NCT01546753|50627773|FG000|Overall Study|anxiety|1|||
25312373|NCT01546753|50627774|FG001|Overall Study|anxiety|1|||
25312374|NCT01546753|50627773|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
25312375|NCT01546753|50627774|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
25312376|NCT00680901|50627789|FG000|Overall Study|Lost to Follow-up|8|||
25312377|NCT00680901|50627790|FG001|Overall Study|Lost to Follow-up|8|||
25312378|NCT00680901|50627789|FG000|Overall Study|Withdrawal by Subject|4|||
25312379|NCT00680901|50627790|FG001|Overall Study|Withdrawal by Subject|13|||
25312380|NCT00680901|50627789|FG000|Overall Study|Physician Decision|0|||
25312381|NCT00680901|50627790|FG001|Overall Study|Physician Decision|1|||
25312382|NCT00680901|50627789|FG000|Overall Study|Ongoing: On Study Treatment|16|||
25312383|NCT00680901|50627790|FG001|Overall Study|Ongoing: On Study Treatment|13|||
25312384|NCT00680901|50627789|FG000|Overall Study|Ongoing: In Follow Up|45|||
25312385|NCT00680901|50627790|FG001|Overall Study|Ongoing: In Follow Up|41|||
25312386|NCT00941720|50627796|FG000|Overall Study|Withdrawal by Subject|1|||
25312387|NCT00941720|50627796|FG000|Overall Study|Insurance denied participation|11|||
25312388|NCT00941720|50627796|FG000|Overall Study|ineligible|2|||
25312389|NCT00933686|50627802|FG000|Overall Study|Protocol Violation|0|||
25312390|NCT00933686|50627803|FG001|Overall Study|Protocol Violation|1|||
25312391|NCT00933686|50627802|FG000|Overall Study|Lost to Follow-up|2|||
25312392|NCT00933686|50627803|FG001|Overall Study|Lost to Follow-up|2|||
25312393|NCT00933686|50627802|FG000|Overall Study|Withdrawal by Subject|6|||
25312394|NCT00933686|50627803|FG001|Overall Study|Withdrawal by Subject|5|||
25312395|NCT00933686|50627802|FG000|Overall Study|Adverse Event|1|||
25312396|NCT00933686|50627803|FG001|Overall Study|Adverse Event|1|||
25312397|NCT00933686|50627802|FG000|Overall Study|Physician Decision|1|||
25312398|NCT00933686|50627803|FG001|Overall Study|Physician Decision|0|||
25312399|NCT00933686|50627802|FG000|Overall Study|Failure to show up at endpoint visits|0|||
25312400|NCT00933686|50627803|FG001|Overall Study|Failure to show up at endpoint visits|2|||
25312401|NCT00937040|50627811|FG000|Overall Study|Adverse Event|5|||
25312402|NCT00937040|50627812|FG001|Overall Study|Adverse Event|8|||
25312403|NCT00937040|50627811|FG000|Overall Study|Lost to Follow-up|12|||
25312404|NCT00937040|50627812|FG001|Overall Study|Lost to Follow-up|12|||
25312405|NCT00937040|50627811|FG000|Overall Study|Protocol Violation|3|||
25312406|NCT00937040|50627812|FG001|Overall Study|Protocol Violation|0|||
25312407|NCT00937040|50627811|FG000|Overall Study|Withdrawal by Subject|13|||
25312408|NCT00937040|50627812|FG001|Overall Study|Withdrawal by Subject|7|||
25312409|NCT00937040|50627811|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
25312410|NCT00937040|50627812|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
25312411|NCT00937040|50627811|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
25312412|NCT00937040|50627812|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
25312413|NCT00673387|50627826|FG000|Overall Study|Withdrawal by Subject|15|||
25312414|NCT00673387|50627827|FG001|Overall Study|Withdrawal by Subject|16|||
25312415|NCT00673387|50627828|FG002|Overall Study|Withdrawal by Subject|20|||
25312416|NCT00673387|50627829|FG003|Overall Study|Withdrawal by Subject|16|||
25312417|NCT00673387|50627830|FG004|Overall Study|Withdrawal by Subject|18|||
25312418|NCT00673387|50627831|FG005|Overall Study|Withdrawal by Subject|21|||
25312419|NCT00673387|50627832|FG006|Overall Study|Withdrawal by Subject|15|||
25312420|NCT00673387|50627833|FG007|Overall Study|Withdrawal by Subject|21|||
25312421|NCT00673387|50627826|FG000|Overall Study|Adverse Event|3|||
25312422|NCT00673387|50627827|FG001|Overall Study|Adverse Event|1|||
25312423|NCT00673387|50627828|FG002|Overall Study|Adverse Event|5|||
25312424|NCT00673387|50627829|FG003|Overall Study|Adverse Event|2|||
25312425|NCT00673387|50627830|FG004|Overall Study|Adverse Event|6|||
25312426|NCT00673387|50627831|FG005|Overall Study|Adverse Event|2|||
25312427|NCT00673387|50627832|FG006|Overall Study|Adverse Event|5|||
25312428|NCT00673387|50627833|FG007|Overall Study|Adverse Event|5|||
25312429|NCT00673387|50627826|FG000|Overall Study|Physician Decision|0|||
25312430|NCT00673387|50627827|FG001|Overall Study|Physician Decision|0|||
25312431|NCT00673387|50627828|FG002|Overall Study|Physician Decision|0|||
25312432|NCT00673387|50627829|FG003|Overall Study|Physician Decision|0|||
25312433|NCT00673387|50627830|FG004|Overall Study|Physician Decision|0|||
25312434|NCT00673387|50627831|FG005|Overall Study|Physician Decision|5|||
25312435|NCT00673387|50627832|FG006|Overall Study|Physician Decision|1|||
25312436|NCT00673387|50627833|FG007|Overall Study|Physician Decision|1|||
25312437|NCT00673387|50627826|FG000|Overall Study|Protocol Violation|3|||
25312438|NCT00673387|50627827|FG001|Overall Study|Protocol Violation|0|||
25312439|NCT00673387|50627828|FG002|Overall Study|Protocol Violation|1|||
25312440|NCT00673387|50627829|FG003|Overall Study|Protocol Violation|2|||
25312441|NCT00673387|50627830|FG004|Overall Study|Protocol Violation|0|||
25312442|NCT00673387|50627831|FG005|Overall Study|Protocol Violation|1|||
25312443|NCT00673387|50627832|FG006|Overall Study|Protocol Violation|1|||
25312444|NCT00673387|50627833|FG007|Overall Study|Protocol Violation|3|||
25312445|NCT00673387|50627826|FG000|Overall Study|Lost to Follow-up|8|||
25312446|NCT00673387|50627827|FG001|Overall Study|Lost to Follow-up|6|||
25071431|NCT02568254|50177626|FG004|Period 2|Adverse Event|0|||
25071432|NCT02568254|50177627|FG005|Period 2|Adverse Event|0|||
25071433|NCT02568254|50177622|FG000|Period 3|Unstatisfactory Lens fitting|0|||
25071434|NCT02568254|50177623|FG001|Period 3|Unstatisfactory Lens fitting|0|||
25071435|NCT02568254|50177624|FG002|Period 3|Unstatisfactory Lens fitting|0|||
25071436|NCT02568254|50177625|FG003|Period 3|Unstatisfactory Lens fitting|0|||
25071437|NCT02568254|50177626|FG004|Period 3|Unstatisfactory Lens fitting|1|||
25071438|NCT02568254|50177627|FG005|Period 3|Unstatisfactory Lens fitting|0|||
25071439|NCT02567708|50177635|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
25071440|NCT02567708|50177636|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
25071441|NCT02567708|50177635|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
25071442|NCT02567708|50177636|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
25071443|NCT02567708|50177635|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
25071444|NCT02567708|50177636|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
25071445|NCT02567708|50177635|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
25071446|NCT02567708|50177636|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
25071447|NCT02562716|50177645|FG000|Overall Study|Adverse Event|7|||
25071448|NCT02562716|50177646|FG001|Overall Study|Adverse Event|14|||
25071449|NCT02562716|50177645|FG000|Overall Study|Withdrawal unrelated to AE|7|||
25071450|NCT02562716|50177646|FG001|Overall Study|Withdrawal unrelated to AE|1|||
25071451|NCT02562716|50177645|FG000|Overall Study|Progression|8|||
25071452|NCT02562716|50177646|FG001|Overall Study|Progression|10|||
25071453|NCT02562716|50177645|FG000|Overall Study|Death|2|||
25071454|NCT02562716|50177646|FG001|Overall Study|Death|1|||
25071455|NCT02562716|50177645|FG000|Overall Study|Not protocol specified|4|||
25071456|NCT02562716|50177646|FG001|Overall Study|Not protocol specified|2|||
25071457|NCT02751931|50177656|FG000|Overall Study|Adverse Event|3|||
25071458|NCT02751931|50177657|FG001|Overall Study|Adverse Event|0|||
25071459|NCT02751931|50177656|FG000|Overall Study|Other: Miscelleneous|10|||
25071460|NCT02751931|50177657|FG001|Overall Study|Other: Miscelleneous|8|||
25071461|NCT02561156|50177682|FG000|Part 2|Adverse Event|0|||
25071462|NCT02561156|50177683|FG001|Part 2|Adverse Event|0|||
25071463|NCT02561156|50177684|FG002|Part 2|Adverse Event|0|||
25071464|NCT02561156|50177685|FG003|Part 2|Adverse Event|0|||
25071465|NCT02561156|50177686|FG004|Part 2|Adverse Event|0|||
25071466|NCT02561156|50177687|FG005|Part 2|Adverse Event|0|||
25071467|NCT02561156|50177688|FG006|Part 2|Adverse Event|0|||
25071468|NCT02561156|50177689|FG007|Part 2|Adverse Event|0|||
25071469|NCT02561156|50177690|FG008|Part 2|Adverse Event|0|||
25071470|NCT02561156|50177691|FG009|Part 2|Adverse Event|0|||
25071471|NCT02561156|50177692|FG010|Part 2|Adverse Event|0|||
25071472|NCT02561156|50177693|FG011|Part 2|Adverse Event|1|||
25071473|NCT02561156|50177694|FG012|Part 2|Adverse Event|0|||
25071474|NCT02561078|50177740|FG000|Overall Study|Adverse Event|5|||
25071475|NCT02561078|50177741|FG001|Overall Study|Adverse Event|2|||
25071476|NCT02561078|50177740|FG000|Overall Study|Death|2|||
25071477|NCT02561078|50177741|FG001|Overall Study|Death|1|||
25071478|NCT02561078|50177740|FG000|Overall Study|Lost to Follow-up|2|||
25071479|NCT02561078|50177741|FG001|Overall Study|Lost to Follow-up|6|||
25071480|NCT02561078|50177740|FG000|Overall Study|Non-Compliance with Study Drug|6|||
25071481|NCT02561078|50177741|FG001|Overall Study|Non-Compliance with Study Drug|3|||
25071482|NCT02561078|50177740|FG000|Overall Study|Physician Decision|2|||
25071483|NCT02561078|50177741|FG001|Overall Study|Physician Decision|3|||
25071484|NCT02561078|50177740|FG000|Overall Study|Withdrawal by Subject|13|||
25071485|NCT02561078|50177741|FG001|Overall Study|Withdrawal by Subject|10|||
25071486|NCT02567552|50177749|FG000|Overall Study|Adverse Event|0|||
25071487|NCT02567552|50177750|FG001|Overall Study|Adverse Event|1|||
25071488|NCT02561000|50177764|FG000|Overall Study|Withdrawal by Subject|2|||
25071489|NCT02561000|50177765|FG001|Overall Study|Withdrawal by Subject|3|||
25071490|NCT02561000|50177766|FG002|Overall Study|Withdrawal by Subject|0|||
25071491|NCT02561000|50177764|FG000|Overall Study|Adverse Event|0|||
25071492|NCT02561000|50177765|FG001|Overall Study|Adverse Event|1|||
25071493|NCT02561000|50177766|FG002|Overall Study|Adverse Event|0|||
25169514|NCT04409262|50301552|FG000|Overall Study|Adverse Event|0|||
25169515|NCT04409262|50301553|FG001|Overall Study|Adverse Event|2|||
25071494|NCT01663532|50177776|FG000|Overall Study|Lost to Follow-up|9|||
25071495|NCT01663532|50177777|FG001|Overall Study|Lost to Follow-up|10|||
25071496|NCT01663532|50177776|FG000|Overall Study|Adverse Event|7|||
25071497|NCT01663532|50177777|FG001|Overall Study|Adverse Event|13|||
25071498|NCT01663532|50177776|FG000|Overall Study|Met Withdrawal Criteria|7|||
25071499|NCT01663532|50177777|FG001|Overall Study|Met Withdrawal Criteria|6|||
25071500|NCT01663532|50177776|FG000|Overall Study|Physician Decision|1|||
25071501|NCT01663532|50177777|FG001|Overall Study|Physician Decision|1|||
24970267|NCT00125138|50059787|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
24970268|NCT00125138|50059788|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
24970269|NCT00125138|50059789|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
24970270|NCT00125138|50059790|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
24970271|NCT04132336|50059807|FG000|Overall Study|Investigator Decision|0|||
24970272|NCT04132336|50059808|FG001|Overall Study|Investigator Decision|1|||
24970273|NCT04132336|50059809|FG002|Overall Study|Investigator Decision|0|||
24970274|NCT04132336|50059810|FG003|Overall Study|Investigator Decision|0|||
24970275|NCT04132336|50059811|FG004|Overall Study|Investigator Decision|0|||
24970276|NCT04132336|50059812|FG005|Overall Study|Investigator Decision|0|||
25312447|NCT00673387|50627828|FG002|Overall Study|Lost to Follow-up|5|||
25312448|NCT00673387|50627829|FG003|Overall Study|Lost to Follow-up|6|||
25312449|NCT00673387|50627830|FG004|Overall Study|Lost to Follow-up|6|||
25312450|NCT00673387|50627831|FG005|Overall Study|Lost to Follow-up|5|||
25312451|NCT00673387|50627832|FG006|Overall Study|Lost to Follow-up|8|||
25312452|NCT00673387|50627833|FG007|Overall Study|Lost to Follow-up|5|||
25312453|NCT00933608|50627863|FG000|Overall Study|Adverse Event|4|||
25312454|NCT00933608|50627864|FG001|Overall Study|Adverse Event|2|||
25312455|NCT00933608|50627863|FG000|Overall Study|Physician Decision|1|||
25312456|NCT00933608|50627864|FG001|Overall Study|Physician Decision|0|||
25312457|NCT00574951|50627870|FG000|Overall Study|Ineligible - improper prior treatment|1|||
25312458|NCT01557751|50627874|FG000|Overall Study|Physician Decision|3|||
25312459|NCT00936884|50627880|FG000|Double-blind|Withdrawal by Subject|6|||
25312460|NCT00936884|50627881|FG001|Double-blind|Withdrawal by Subject|4|||
25312461|NCT00936884|50627882|FG002|Double-blind|Withdrawal by Subject|0|||
25312462|NCT00936884|50627880|FG000|Double-blind|Death|2|||
25312463|NCT00936884|50627881|FG001|Double-blind|Death|1|||
25312464|NCT00936884|50627882|FG002|Double-blind|Death|0|||
25312465|NCT00936884|50627880|FG000|Double-blind|Lack of Efficacy|1|||
25312466|NCT00936884|50627881|FG001|Double-blind|Lack of Efficacy|1|||
25312467|NCT00936884|50627882|FG002|Double-blind|Lack of Efficacy|0|||
25312468|NCT00936884|50627880|FG000|Double-blind|Adverse Event|1|||
25312469|NCT00936884|50627881|FG001|Double-blind|Adverse Event|0|||
25312470|NCT00936884|50627882|FG002|Double-blind|Adverse Event|0|||
25312471|NCT00936884|50627880|FG000|Double-blind|Physician Decision|1|||
25312472|NCT00936884|50627881|FG001|Double-blind|Physician Decision|0|||
25312473|NCT00936884|50627882|FG002|Double-blind|Physician Decision|0|||
25312474|NCT00936884|50627880|FG000|Double-blind|No post baseline diary entry|1|||
25312475|NCT00936884|50627881|FG001|Double-blind|No post baseline diary entry|0|||
25312476|NCT00936884|50627882|FG002|Double-blind|No post baseline diary entry|0|||
25312477|NCT00936884|50627880|FG000|Double-blind|Did not receive study drug|0|||
25312478|NCT00936884|50627881|FG001|Double-blind|Did not receive study drug|1|||
25312479|NCT00936884|50627882|FG002|Double-blind|Did not receive study drug|0|||
24970277|NCT04132336|50059813|FG006|Overall Study|Investigator Decision|0|||
25312480|NCT00668863|50627898|FG000|Overall Study|Objective Progression or Relapse|42|||
25312481|NCT00668863|50627898|FG000|Overall Study|Adverse Event|13|||
25312482|NCT00668863|50627898|FG000|Overall Study|Study Terminated by Sponsor|8|||
25312483|NCT00668863|50627898|FG000|Overall Study|Global Deterioration of Health Status|4|||
25312484|NCT00668863|50627898|FG000|Overall Study|Withdrawal by Subject|1|||
25312485|NCT00668863|50627898|FG000|Overall Study|Surgery|1|||
25312486|NCT00668863|50627898|FG000|Overall Study|Subject's work scheduling problem|1|||
25312487|NCT00668863|50627898|FG000|Overall Study|Physician Decision|1|||
25312488|NCT00935012|50627902|FG000|Overall Study|Death|19|||
25312489|NCT00935012|50627902|FG000|Overall Study|Withdrawal by Subject|3|||
25312490|NCT00935012|50627902|FG000|Overall Study|Other|5|||
25312491|NCT00935012|50627902|FG000|Overall Study|Adverse Event|2|||
25312492|NCT00932360|50627906|FG000|Washout (One Week)|Withdrawal by Subject|0|||
25312493|NCT00932360|50627907|FG001|Washout (One Week)|Withdrawal by Subject|0|||
25312494|NCT00932360|50627908|FG002|Washout (One Week)|Withdrawal by Subject|0|||
25312495|NCT00932360|50627909|FG003|Washout (One Week)|Withdrawal by Subject|0|||
25312496|NCT00932360|50627910|FG004|Washout (One Week)|Withdrawal by Subject|2|||
25312497|NCT00932360|50627911|FG005|Washout (One Week)|Withdrawal by Subject|0|||
25312498|NCT00668707|50627927|FG000|Overall Study|Cancer Recurrence|58|||
25312499|NCT00668707|50627928|FG001|Overall Study|Cancer Recurrence|58|||
25312500|NCT00668707|50627927|FG000|Overall Study|Withdrawal by Subject|117|||
25312501|NCT00668707|50627928|FG001|Overall Study|Withdrawal by Subject|100|||
25312502|NCT00668707|50627927|FG000|Overall Study|Lost to Follow-up|3|||
25312503|NCT00668707|50627928|FG001|Overall Study|Lost to Follow-up|6|||
25312504|NCT00668707|50627927|FG000|Overall Study|Protocol Violation|10|||
25312505|NCT00668707|50627928|FG001|Overall Study|Protocol Violation|12|||
25312506|NCT00668707|50627927|FG000|Overall Study|Death|11|||
25312507|NCT00668707|50627928|FG001|Overall Study|Death|4|||
25312508|NCT00668395|50627942|FG000|Overall Study|Withdrawal by Subject|4|||
25312509|NCT00668395|50627943|FG001|Overall Study|Withdrawal by Subject|4|||
25312510|NCT00668395|50627944|FG002|Overall Study|Withdrawal by Subject|1|||
25312511|NCT00668395|50627942|FG000|Overall Study|Adverse Event|1|||
25312512|NCT00668395|50627943|FG001|Overall Study|Adverse Event|1|||
25312513|NCT00668395|50627944|FG002|Overall Study|Adverse Event|0|||
25312514|NCT00668395|50627942|FG000|Overall Study|Physician Decision|1|||
25312515|NCT00668395|50627943|FG001|Overall Study|Physician Decision|1|||
25312516|NCT00668395|50627944|FG002|Overall Study|Physician Decision|0|||
25312517|NCT00668317|50627952|FG000|Overall Study|Adverse Event|2|||
25312518|NCT00670111|50627973|FG000|Enrollment to One Month|Testing Failure|0|||
25312519|NCT00670111|50627974|FG001|Enrollment to One Month|Testing Failure|0|||
25312520|NCT00670111|50627975|FG002|Enrollment to One Month|Testing Failure|13|||
25312521|NCT00670111|50627973|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
25312522|NCT00670111|50627974|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
25312523|NCT00670111|50627975|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
25312524|NCT00670111|50627973|FG000|Enrollment to One Month|Physician Decision|1|||
25312525|NCT00670111|50627974|FG001|Enrollment to One Month|Physician Decision|0|||
25312526|NCT00670111|50627975|FG002|Enrollment to One Month|Physician Decision|0|||
25312527|NCT00672139|50627985|FG000|Overall Study|Death|14|||
25312528|NCT00672139|50627986|FG001|Overall Study|Death|23|||
25312529|NCT00672139|50627985|FG000|Overall Study|Withdrawal by Subject|2|||
25312530|NCT00672139|50627986|FG001|Overall Study|Withdrawal by Subject|11|||
25312531|NCT00672139|50627985|FG000|Overall Study|Adverse Event|4|||
25312532|NCT00672139|50627986|FG001|Overall Study|Adverse Event|7|||
25312533|NCT00672139|50627985|FG000|Overall Study|Physician Decision|2|||
25312534|NCT00672139|50627986|FG001|Overall Study|Physician Decision|0|||
25312535|NCT00672139|50627985|FG000|Overall Study|Lack of Efficacy|4|||
25312536|NCT00672139|50627986|FG001|Overall Study|Lack of Efficacy|1|||
25312537|NCT00672139|50627985|FG000|Overall Study|Protocol Violation|1|||
25312538|NCT00672139|50627986|FG001|Overall Study|Protocol Violation|1|||
25312539|NCT00672139|50627985|FG000|Overall Study|hospice discharge, caregiver requests|3|||
25312540|NCT00672139|50627986|FG001|Overall Study|hospice discharge, caregiver requests|2|||
25312541|NCT00570739|50627996|FG000|Overall Study|Adverse Event|8|||
25312542|NCT00570739|50627997|FG001|Overall Study|Adverse Event|6|||
25312543|NCT00570739|50627998|FG002|Overall Study|Adverse Event|2|||
25312544|NCT00570739|50627999|FG003|Overall Study|Adverse Event|2|||
25312545|NCT00570739|50627996|FG000|Overall Study|Lost to Follow-up|4|||
25312546|NCT00570739|50627997|FG001|Overall Study|Lost to Follow-up|5|||
25312547|NCT00570739|50627998|FG002|Overall Study|Lost to Follow-up|4|||
25312548|NCT00570739|50627999|FG003|Overall Study|Lost to Follow-up|1|||
25312549|NCT00570739|50627996|FG000|Overall Study|Physician Decision|1|||
25312550|NCT00570739|50627997|FG001|Overall Study|Physician Decision|1|||
25312551|NCT00570739|50627998|FG002|Overall Study|Physician Decision|0|||
25312552|NCT00570739|50627999|FG003|Overall Study|Physician Decision|0|||
25312553|NCT00570739|50627996|FG000|Overall Study|Withdrawal by Subject|7|||
25312554|NCT00570739|50627997|FG001|Overall Study|Withdrawal by Subject|7|||
25312555|NCT00570739|50627998|FG002|Overall Study|Withdrawal by Subject|3|||
25312556|NCT00570739|50627999|FG003|Overall Study|Withdrawal by Subject|5|||
25312557|NCT00570739|50627996|FG000|Overall Study|Required restricted medication|0|||
25312558|NCT00570739|50627997|FG001|Overall Study|Required restricted medication|0|||
25312559|NCT00570739|50627998|FG002|Overall Study|Required restricted medication|1|||
25312560|NCT00570739|50627999|FG003|Overall Study|Required restricted medication|0|||
25312561|NCT00570739|50627996|FG000|Overall Study|Met discontinuation criteria|1|||
25312562|NCT00570739|50627997|FG001|Overall Study|Met discontinuation criteria|0|||
25312563|NCT00570739|50627998|FG002|Overall Study|Met discontinuation criteria|1|||
25312564|NCT00570739|50627999|FG003|Overall Study|Met discontinuation criteria|1|||
25312565|NCT00570739|50627996|FG000|Overall Study|Other|0|||
25312566|NCT00570739|50627997|FG001|Overall Study|Other|2|||
25312567|NCT00570739|50627998|FG002|Overall Study|Other|5|||
25312568|NCT00570739|50627999|FG003|Overall Study|Other|3|||
25312569|NCT03689530|50628031|FG000|Overall Study|Withdrawal by Subject|53|||
25312570|NCT03689530|50628032|FG001|Overall Study|Withdrawal by Subject|16|||
25312571|NCT04188106|50628038|FG000|Overall Study|Lost to Follow-up|5|||
25312572|NCT04188106|50628038|FG000|Overall Study|Non-Compliance|1|||
25312573|NCT00669955|50628046|FG000|Overall Study|Adverse Event|3|||
25312574|NCT00669955|50628047|FG001|Overall Study|Adverse Event|5|||
25312575|NCT00669955|50628046|FG000|Overall Study|Death|0|||
25312576|NCT00669955|50628047|FG001|Overall Study|Death|1|||
25312577|NCT00669955|50628046|FG000|Overall Study|Withdrawal by Subject|2|||
25312578|NCT00669955|50628047|FG001|Overall Study|Withdrawal by Subject|3|||
25312579|NCT00669955|50628046|FG000|Overall Study|Lost to Follow-up|5|||
25312580|NCT00669955|50628047|FG001|Overall Study|Lost to Follow-up|7|||
25312581|NCT00669955|50628046|FG000|Overall Study|Protocol Violation|2|||
25312582|NCT00669955|50628047|FG001|Overall Study|Protocol Violation|7|||
25312583|NCT00669955|50628046|FG000|Overall Study|Investigator Sponsor Judgement|0|||
25312584|NCT00669955|50628047|FG001|Overall Study|Investigator Sponsor Judgement|1|||
25312585|NCT00669955|50628046|FG000|Overall Study|not compliant with study drug/visit|2|||
25312586|NCT00669955|50628047|FG001|Overall Study|not compliant with study drug/visit|3|||
25312587|NCT00671749|50628053|FG000|Overall Study|Adverse Event|2|||
25312588|NCT00671749|50628053|FG000|Overall Study|Withdrawal by Subject|4|||
25312589|NCT00671749|50628053|FG000|Overall Study|Protocol Violation|1|||
25312590|NCT00671749|50628053|FG000|Overall Study|Lost to Follow-up|1|||
25312591|NCT00669877|50628057|FG000|Overall Study|Disease Progression/Death|4|||
25312592|NCT00882999|50628068|FG000|Overall Study|Adverse Event|0|||
25312593|NCT00882999|50628069|FG001|Overall Study|Adverse Event|0|||
25312594|NCT00882999|50628070|FG002|Overall Study|Adverse Event|0|||
25312595|NCT00882999|50628071|FG003|Overall Study|Adverse Event|0|||
25312596|NCT00882999|50628072|FG004|Overall Study|Adverse Event|1|||
25312597|NCT00882999|50628073|FG005|Overall Study|Adverse Event|0|||
25312598|NCT00882999|50628074|FG006|Overall Study|Adverse Event|0|||
25312599|NCT00882999|50628068|FG000|Overall Study|Death|0|||
25312600|NCT00882999|50628069|FG001|Overall Study|Death|1|||
25312601|NCT00882999|50628070|FG002|Overall Study|Death|0|||
25312602|NCT00882999|50628071|FG003|Overall Study|Death|0|||
25312603|NCT00882999|50628072|FG004|Overall Study|Death|0|||
25312604|NCT00882999|50628073|FG005|Overall Study|Death|0|||
25312605|NCT00882999|50628074|FG006|Overall Study|Death|0|||
25312606|NCT00882999|50628068|FG000|Overall Study|Withdrawal by Subject|7|||
25169516|NCT04409262|50301552|FG000|Overall Study|Death|55|||
25312607|NCT00882999|50628069|FG001|Overall Study|Withdrawal by Subject|6|||
25312608|NCT00882999|50628070|FG002|Overall Study|Withdrawal by Subject|3|||
25312609|NCT00882999|50628071|FG003|Overall Study|Withdrawal by Subject|3|||
25312610|NCT00882999|50628072|FG004|Overall Study|Withdrawal by Subject|6|||
25312611|NCT00882999|50628073|FG005|Overall Study|Withdrawal by Subject|5|||
25312612|NCT00882999|50628074|FG006|Overall Study|Withdrawal by Subject|5|||
25312613|NCT00882999|50628068|FG000|Overall Study|Lost to Follow-up|0|||
25312614|NCT00882999|50628069|FG001|Overall Study|Lost to Follow-up|1|||
25312615|NCT00882999|50628070|FG002|Overall Study|Lost to Follow-up|1|||
25312616|NCT00882999|50628071|FG003|Overall Study|Lost to Follow-up|2|||
25312617|NCT00882999|50628072|FG004|Overall Study|Lost to Follow-up|1|||
25312618|NCT00882999|50628073|FG005|Overall Study|Lost to Follow-up|1|||
25312619|NCT00882999|50628074|FG006|Overall Study|Lost to Follow-up|2|||
25312620|NCT00882999|50628068|FG000|Overall Study|Physician Decision|1|||
25312621|NCT00882999|50628069|FG001|Overall Study|Physician Decision|0|||
25312622|NCT00882999|50628070|FG002|Overall Study|Physician Decision|0|||
25312623|NCT00882999|50628071|FG003|Overall Study|Physician Decision|0|||
25312624|NCT00882999|50628072|FG004|Overall Study|Physician Decision|0|||
25312625|NCT00882999|50628073|FG005|Overall Study|Physician Decision|1|||
25312626|NCT00882999|50628074|FG006|Overall Study|Physician Decision|1|||
25312627|NCT00671437|50628097|FG000|Overall Study|Progressive disease before C1 week 8|8|||
25312628|NCT00671437|50628097|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
25312629|NCT00671437|50628097|FG000|Overall Study|Adverse Event|3|||
25312630|NCT00671437|50628097|FG000|Overall Study|Ineligible post-hoc|1|||
25312631|NCT00882921|50628109|FG000|Overall Study|Death|2|||
25312632|NCT00882921|50628109|FG000|Overall Study|Other|3|||
25312633|NCT00882921|50628109|FG000|Overall Study|Lost to Follow-up|2|||
25312634|NCT00882921|50628109|FG000|Overall Study|Termination By Investigator|3|||
25312635|NCT00882921|50628109|FG000|Overall Study|Withdrawal Of Consent|1|||
25312636|NCT00582712|50628114|FG000|Overall Study|Adverse Event|1|||
25312637|NCT00582712|50628114|FG000|Overall Study|Lack of Efficacy|1|||
25312638|NCT00582712|50628114|FG000|Overall Study|Withdrawal by Subject|1|||
25312639|NCT00582712|50628114|FG000|Overall Study|Complicating disease requiring treatment|1|||
25312640|NCT00582790|50628118|FG000|Overall Study|Rapid progression of disease|1|||
25312641|NCT00881751|50628125|FG000|Overall Study|Physician Decision|0|||
25312642|NCT00881751|50628126|FG001|Overall Study|Physician Decision|1|||
25312643|NCT00881751|50628125|FG000|Overall Study|Adverse Event|0|||
25312644|NCT00881751|50628126|FG001|Overall Study|Adverse Event|2|||
25312645|NCT00881751|50628125|FG000|Overall Study|Withdrawal by Subject|0|||
25312646|NCT00881751|50628126|FG001|Overall Study|Withdrawal by Subject|2|||
25312647|NCT00934856|50628138|FG000|Feasibility Part|Progressive disease|4|||
25312648|NCT00934856|50628139|FG001|Feasibility Part|Progressive disease|4|||
25312649|NCT00934856|50628140|FG002|Feasibility Part|Progressive disease|2|||
25312650|NCT00934856|50628141|FG003|Feasibility Part|Progressive disease|3|||
25312651|NCT00934856|50628142|FG004|Feasibility Part|Progressive disease|0|||
25312652|NCT00934856|50628143|FG005|Feasibility Part|Progressive disease|0|||
25312653|NCT00934856|50628138|FG000|Feasibility Part|Physician Decision|0|||
25312654|NCT00934856|50628139|FG001|Feasibility Part|Physician Decision|0|||
25312655|NCT00934856|50628140|FG002|Feasibility Part|Physician Decision|1|||
25312656|NCT00934856|50628141|FG003|Feasibility Part|Physician Decision|0|||
25312657|NCT00934856|50628142|FG004|Feasibility Part|Physician Decision|0|||
25312658|NCT00934856|50628143|FG005|Feasibility Part|Physician Decision|0|||
25312659|NCT00934856|50628138|FG000|Feasibility Part|Adverse Event|1|||
25312660|NCT00934856|50628139|FG001|Feasibility Part|Adverse Event|1|||
25312661|NCT00934856|50628140|FG002|Feasibility Part|Adverse Event|0|||
25312662|NCT00934856|50628141|FG003|Feasibility Part|Adverse Event|1|||
25312663|NCT00934856|50628142|FG004|Feasibility Part|Adverse Event|0|||
25312664|NCT00934856|50628143|FG005|Feasibility Part|Adverse Event|2|||
25312665|NCT00934856|50628138|FG000|Feasibility Part|Withdrawal by Subject|0|||
25312666|NCT00934856|50628139|FG001|Feasibility Part|Withdrawal by Subject|0|||
25312667|NCT00934856|50628140|FG002|Feasibility Part|Withdrawal by Subject|0|||
25312668|NCT00934856|50628141|FG003|Feasibility Part|Withdrawal by Subject|1|||
25312669|NCT00934856|50628142|FG004|Feasibility Part|Withdrawal by Subject|0|||
25312670|NCT00934856|50628143|FG005|Feasibility Part|Withdrawal by Subject|1|||
25312671|NCT00934856|50628138|FG000|Extension Part|Adverse Event|0|||
25312672|NCT00934856|50628139|FG001|Extension Part|Adverse Event|0|||
25312673|NCT00934856|50628140|FG002|Extension Part|Adverse Event|0|||
25312674|NCT00934856|50628141|FG003|Extension Part|Adverse Event|1|||
25312675|NCT00934856|50628142|FG004|Extension Part|Adverse Event|4|||
25312676|NCT00934856|50628143|FG005|Extension Part|Adverse Event|4|||
25312677|NCT00934856|50628138|FG000|Extension Part|Progressive disease|0|||
25312678|NCT00934856|50628139|FG001|Extension Part|Progressive disease|0|||
25312679|NCT00934856|50628140|FG002|Extension Part|Progressive disease|0|||
25312680|NCT00934856|50628141|FG003|Extension Part|Progressive disease|1|||
25312681|NCT00934856|50628142|FG004|Extension Part|Progressive disease|0|||
25312682|NCT00934856|50628143|FG005|Extension Part|Progressive disease|0|||
25312683|NCT00934856|50628138|FG000|Extension Part|Non-compliance with drug|0|||
25312684|NCT00934856|50628139|FG001|Extension Part|Non-compliance with drug|0|||
25312685|NCT00934856|50628140|FG002|Extension Part|Non-compliance with drug|0|||
25312686|NCT00934856|50628141|FG003|Extension Part|Non-compliance with drug|0|||
25312687|NCT00934856|50628142|FG004|Extension Part|Non-compliance with drug|0|||
25312688|NCT00934856|50628143|FG005|Extension Part|Non-compliance with drug|1|||
25312689|NCT00934700|50628177|FG000|Overall Study|missing scan|5|||
25312690|NCT00934700|50628178|FG001|Overall Study|missing scan|9|||
25312691|NCT00934700|50628177|FG000|Overall Study|Death|8|||
25312692|NCT00934700|50628178|FG001|Overall Study|Death|3|||
25312693|NCT00930176|50628185|FG000|Overall Study|Death|1|||
25312694|NCT00669409|50628195|FG000|Part 2|Withdrawal by Subject|0|||
25312695|NCT00669409|50628196|FG001|Part 2|Withdrawal by Subject|0|||
25312696|NCT00669409|50628197|FG002|Part 2|Withdrawal by Subject|0|||
25312697|NCT00669409|50628198|FG003|Part 2|Withdrawal by Subject|0|||
25312698|NCT00669409|50628199|FG004|Part 2|Withdrawal by Subject|0|||
25312699|NCT00669409|50628200|FG005|Part 2|Withdrawal by Subject|0|||
25312700|NCT00669409|50628201|FG006|Part 2|Withdrawal by Subject|0|||
25312701|NCT00669409|50628202|FG007|Part 2|Withdrawal by Subject|0|||
25312702|NCT00669409|50628203|FG008|Part 2|Withdrawal by Subject|0|||
25312703|NCT00669409|50628204|FG009|Part 2|Withdrawal by Subject|1|||
25312704|NCT00669409|50628205|FG010|Part 2|Withdrawal by Subject|0|||
25312705|NCT00669331|50628234|FG000|Randomisation to First Dose|Adverse Event|1|||
25312706|NCT00669331|50628235|FG001|Randomisation to First Dose|Adverse Event|0|||
25312707|NCT00669331|50628234|FG000|Randomisation to First Dose|Protocol Violation|1|||
25312708|NCT00669331|50628235|FG001|Randomisation to First Dose|Protocol Violation|0|||
25312709|NCT00669331|50628234|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
25312710|NCT00669331|50628235|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
25312711|NCT00669331|50628234|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
25312712|NCT00669331|50628235|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
25312713|NCT00669331|50628234|FG000|Randomisation to First Dose|Death|1|||
25312714|NCT00669331|50628235|FG001|Randomisation to First Dose|Death|0|||
24970278|NCT04131556|50059829|FG000|Overall Study|Adverse Event|1|||
24970279|NCT04131556|50059829|FG000|Overall Study|Withdrawal by Subject|1|||
24970280|NCT04295356|50059838|FG000|Overall Study|Physician Decision|1|||
24970281|NCT04295356|50059839|FG001|Overall Study|Physician Decision|0|||
24970282|NCT04295356|50059838|FG000|Overall Study|Lost to Follow-up|0|||
24970283|NCT04295356|50059839|FG001|Overall Study|Lost to Follow-up|3|||
24970284|NCT04295356|50059838|FG000|Overall Study|Protocol Violation|0|||
24970285|NCT04295356|50059839|FG001|Overall Study|Protocol Violation|1|||
24970286|NCT03691948|50059847|FG000|Overall Study|Lost to Follow-up|1|||
24970287|NCT03691948|50059848|FG001|Overall Study|Lost to Follow-up|3|||
24970288|NCT04126174|50059855|FG000|Overall Study|Lost to Follow-up|3|||
25312715|NCT00669331|50628234|FG000|Randomisation to First Dose|Sponsor decision|0|||
25312716|NCT00669331|50628235|FG001|Randomisation to First Dose|Sponsor decision|1|||
25312717|NCT00669331|50628234|FG000|Randomisation to First Dose|Randomised in error|3|||
25312718|NCT00669331|50628235|FG001|Randomisation to First Dose|Randomised in error|10|||
25312719|NCT00669331|50628234|FG000|Blinded Treatment Period|Adverse Event|16|||
25312720|NCT00669331|50628235|FG001|Blinded Treatment Period|Adverse Event|10|||
25312721|NCT00669331|50628234|FG000|Blinded Treatment Period|Protocol Violation|1|||
25312722|NCT00669331|50628235|FG001|Blinded Treatment Period|Protocol Violation|1|||
25312723|NCT00669331|50628234|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
25312724|NCT00669331|50628235|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
25312725|NCT00669331|50628234|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
25312726|NCT00669331|50628235|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
25312727|NCT00669331|50628234|FG000|Blinded Treatment Period|Death|0|||
25312728|NCT00669331|50628235|FG001|Blinded Treatment Period|Death|2|||
25312729|NCT00669331|50628234|FG000|Blinded Treatment Period|Physician Decision|3|||
25312730|NCT00669331|50628235|FG001|Blinded Treatment Period|Physician Decision|3|||
25312731|NCT00669331|50628234|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
25312732|NCT00669331|50628235|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
25312733|NCT00932126|50628243|FG000|Overall Study|Adverse Event|0|||
25312734|NCT00932126|50628244|FG001|Overall Study|Adverse Event|0|||
25312735|NCT00932126|50628245|FG002|Overall Study|Adverse Event|0|||
25312736|NCT00932126|50628246|FG003|Overall Study|Adverse Event|0|||
25312737|NCT00932126|50628247|FG004|Overall Study|Adverse Event|0|||
25312738|NCT00932126|50628248|FG005|Overall Study|Adverse Event|0|||
25312739|NCT00932126|50628249|FG006|Overall Study|Adverse Event|1|||
24970289|NCT04126174|50059856|FG001|Overall Study|Lost to Follow-up|3|||
24970290|NCT04124926|50059864|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
24970291|NCT04124926|50059865|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
25312740|NCT00932126|50628250|FG007|Overall Study|Adverse Event|2|||
25312741|NCT00932126|50628243|FG000|Overall Study|Protocol Violation|0|||
25312742|NCT00932126|50628244|FG001|Overall Study|Protocol Violation|0|||
25312743|NCT00932126|50628245|FG002|Overall Study|Protocol Violation|0|||
25312744|NCT00932126|50628246|FG003|Overall Study|Protocol Violation|0|||
25312745|NCT00932126|50628247|FG004|Overall Study|Protocol Violation|1|||
25312746|NCT00932126|50628248|FG005|Overall Study|Protocol Violation|0|||
25312747|NCT00932126|50628249|FG006|Overall Study|Protocol Violation|0|||
25312748|NCT00932126|50628250|FG007|Overall Study|Protocol Violation|0|||
25312749|NCT00932126|50628243|FG000|Overall Study|Withdrawal by Subject|0|||
25312750|NCT00932126|50628244|FG001|Overall Study|Withdrawal by Subject|0|||
25312751|NCT00932126|50628245|FG002|Overall Study|Withdrawal by Subject|1|||
25312752|NCT00932126|50628246|FG003|Overall Study|Withdrawal by Subject|0|||
25312753|NCT00932126|50628247|FG004|Overall Study|Withdrawal by Subject|0|||
25312754|NCT00932126|50628248|FG005|Overall Study|Withdrawal by Subject|0|||
25312755|NCT00932126|50628249|FG006|Overall Study|Withdrawal by Subject|0|||
25312756|NCT00932126|50628250|FG007|Overall Study|Withdrawal by Subject|1|||
25312757|NCT00932126|50628243|FG000|Overall Study|Objective progression or relapse|3|||
25312758|NCT00932126|50628244|FG001|Overall Study|Objective progression or relapse|3|||
25312759|NCT00932126|50628245|FG002|Overall Study|Objective progression or relapse|2|||
25312760|NCT00932126|50628246|FG003|Overall Study|Objective progression or relapse|3|||
25312761|NCT00932126|50628247|FG004|Overall Study|Objective progression or relapse|3|||
25312762|NCT00932126|50628248|FG005|Overall Study|Objective progression or relapse|3|||
25312763|NCT00932126|50628249|FG006|Overall Study|Objective progression or relapse|3|||
25312764|NCT00932126|50628250|FG007|Overall Study|Objective progression or relapse|5|||
25312765|NCT00932126|50628243|FG000|Overall Study|Other|0|||
25312766|NCT00932126|50628244|FG001|Overall Study|Other|0|||
25312767|NCT00932126|50628245|FG002|Overall Study|Other|0|||
25312768|NCT00932126|50628246|FG003|Overall Study|Other|0|||
25312769|NCT00932126|50628247|FG004|Overall Study|Other|1|||
25312770|NCT00932126|50628248|FG005|Overall Study|Other|0|||
25312771|NCT00932126|50628249|FG006|Overall Study|Other|1|||
25312772|NCT00932126|50628250|FG007|Overall Study|Other|2|||
25312773|NCT00667225|50628272|FG000|Overall Study|Subject had no more lesions to treat.|1|||
25312774|NCT00667225|50628273|FG001|Overall Study|Subject had no more lesions to treat.|0|||
25312775|NCT00667225|50628272|FG000|Overall Study|Lost to Follow-up|0|||
25312776|NCT00667225|50628273|FG001|Overall Study|Lost to Follow-up|1|||
25312777|NCT00929864|50628281|FG000|Overall Study|Death|1|||
25312778|NCT00929864|50628282|FG001|Overall Study|Death|1|||
25312779|NCT00929864|50628281|FG000|Overall Study|Adverse Event|11|||
25312780|NCT00929864|50628282|FG001|Overall Study|Adverse Event|30|||
25312781|NCT00929864|50628281|FG000|Overall Study|Lack of Efficacy|19|||
25312782|NCT00929864|50628282|FG001|Overall Study|Lack of Efficacy|16|||
25312783|NCT00929864|50628281|FG000|Overall Study|Lost to Follow-up|7|||
25312784|NCT00929864|50628282|FG001|Overall Study|Lost to Follow-up|12|||
25312785|NCT00929864|50628281|FG000|Overall Study|Withdrawal by Subject|20|||
25312786|NCT00929864|50628282|FG001|Overall Study|Withdrawal by Subject|9|||
25312787|NCT00929864|50628281|FG000|Overall Study|No longer met criteria|2|||
25312788|NCT00929864|50628282|FG001|Overall Study|No longer met criteria|1|||
25312789|NCT00929864|50628281|FG000|Overall Study|Poor or non-compliance|3|||
25312790|NCT00929864|50628282|FG001|Overall Study|Poor or non-compliance|3|||
25312791|NCT00929864|50628281|FG000|Overall Study|Pregnancy|0|||
25312792|NCT00929864|50628282|FG001|Overall Study|Pregnancy|3|||
25312793|NCT00929864|50628281|FG000|Overall Study|Administrative reason by Sponsor|1|||
25312794|NCT00929864|50628282|FG001|Overall Study|Administrative reason by Sponsor|1|||
25312795|NCT00929864|50628281|FG000|Overall Study|Non-specified|2|||
25312796|NCT00929864|50628282|FG001|Overall Study|Non-specified|7|||
25312797|NCT00597753|50628290|FG000|Overall Study|Adverse Event|6|||
25312798|NCT00597753|50628291|FG001|Overall Study|Adverse Event|2|||
25312799|NCT00597753|50628290|FG000|Overall Study|Death|55|||
24970292|NCT04124926|50059866|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
25312800|NCT00597753|50628291|FG001|Overall Study|Death|29|||
25312801|NCT00597753|50628290|FG000|Overall Study|Lack of Efficacy|2|||
25312802|NCT00597753|50628291|FG001|Overall Study|Lack of Efficacy|0|||
25312803|NCT00597753|50628290|FG000|Overall Study|Lost to Follow-up|10|||
25312804|NCT00597753|50628291|FG001|Overall Study|Lost to Follow-up|3|||
25312805|NCT00597753|50628290|FG000|Overall Study|Physician Decision|5|||
25312806|NCT00597753|50628291|FG001|Overall Study|Physician Decision|1|||
25071502|NCT01663532|50177776|FG000|Overall Study|Withdrawal by Subject|35|||
25312807|NCT00597753|50628290|FG000|Overall Study|Pregnancy|1|||
25312808|NCT00597753|50628291|FG001|Overall Study|Pregnancy|0|||
25312809|NCT00597753|50628290|FG000|Overall Study|Withdrawal by Subject|35|||
25312810|NCT00597753|50628291|FG001|Overall Study|Withdrawal by Subject|12|||
25312811|NCT00597753|50628290|FG000|Overall Study|Discontinued Dialysis|0|||
25312812|NCT00597753|50628291|FG001|Overall Study|Discontinued Dialysis|1|||
25312813|NCT00597753|50628290|FG000|Overall Study|Never dosed|2|||
25312814|NCT00597753|50628291|FG001|Overall Study|Never dosed|0|||
25312815|NCT00597753|50628290|FG000|Overall Study|Noncompliance|2|||
25312816|NCT00597753|50628291|FG001|Overall Study|Noncompliance|1|||
25312817|NCT00597753|50628290|FG000|Overall Study|Relocation|17|||
25312818|NCT00597753|50628291|FG001|Overall Study|Relocation|6|||
25312819|NCT00597753|50628290|FG000|Overall Study|Renal transplant|10|||
25312820|NCT00597753|50628291|FG001|Overall Study|Renal transplant|3|||
25312821|NCT00597753|50628290|FG000|Overall Study|Site closed by sponsor|19|||
25312822|NCT00597753|50628291|FG001|Overall Study|Site closed by sponsor|7|||
25312823|NCT00597753|50628290|FG000|Overall Study|Site elected to close|2|||
25312824|NCT00597753|50628291|FG001|Overall Study|Site elected to close|4|||
25312825|NCT00665431|50628300|FG000|Overall Study|Adverse Event|16|||
25312826|NCT00665431|50628301|FG001|Overall Study|Adverse Event|22|||
25312827|NCT00665431|50628302|FG002|Overall Study|Adverse Event|6|||
25312828|NCT00665431|50628300|FG000|Overall Study|Withdrawal by Subject|17|||
25312829|NCT00665431|50628301|FG001|Overall Study|Withdrawal by Subject|25|||
25312830|NCT00665431|50628302|FG002|Overall Study|Withdrawal by Subject|15|||
25312831|NCT00665431|50628300|FG000|Overall Study|Lost to Follow-up|3|||
25312832|NCT00665431|50628301|FG001|Overall Study|Lost to Follow-up|3|||
25312833|NCT00665431|50628302|FG002|Overall Study|Lost to Follow-up|1|||
25312834|NCT00665431|50628300|FG000|Overall Study|Other|4|||
25312835|NCT00665431|50628301|FG001|Overall Study|Other|7|||
25312836|NCT00665431|50628302|FG002|Overall Study|Other|2|||
25312837|NCT00934622|50628310|FG000|Overall Study|Lost to Follow-up|7|||
25312838|NCT00934622|50628310|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
25312839|NCT00881361|50628316|FG000|Overall Study|Terminated prior to surgery|27|||
25312840|NCT00881361|50628317|FG001|Overall Study|Terminated prior to surgery|7|||
25312841|NCT00881361|50628318|FG002|Overall Study|Terminated prior to surgery|0|||
25312842|NCT00881361|50628316|FG000|Overall Study|Ineligible|17|||
25312843|NCT00881361|50628317|FG001|Overall Study|Ineligible|2|||
25312844|NCT00881361|50628318|FG002|Overall Study|Ineligible|2|||
25312845|NCT01000727|50628329|FG000|Overall Study|Lost to Follow-up|41|||
25312846|NCT01000727|50628330|FG001|Overall Study|Lost to Follow-up|43|||
25312847|NCT01000727|50628329|FG000|Overall Study|Withdrawal by Subject|111|||
25312848|NCT01000727|50628330|FG001|Overall Study|Withdrawal by Subject|109|||
25312849|NCT01000727|50628329|FG000|Overall Study|Study closed/terminated|23|||
25312850|NCT01000727|50628330|FG001|Overall Study|Study closed/terminated|24|||
25312851|NCT00881205|50628340|FG000|Overall Study|Adverse Event|8|||
25312852|NCT00881205|50628341|FG001|Overall Study|Adverse Event|3|||
25312853|NCT00881205|50628340|FG000|Overall Study|Withdrawal by Subject|1|||
25312854|NCT00881205|50628341|FG001|Overall Study|Withdrawal by Subject|2|||
25312855|NCT00881205|50628340|FG000|Overall Study|Lost to Follow-up|0|||
25312856|NCT00881205|50628341|FG001|Overall Study|Lost to Follow-up|1|||
25312857|NCT00881205|50628340|FG000|Overall Study|Administrative problems|1|||
25312858|NCT00881205|50628341|FG001|Overall Study|Administrative problems|1|||
25312859|NCT00881205|50628340|FG000|Overall Study|Condition no longer requires drug|1|||
25312860|NCT00881205|50628341|FG001|Overall Study|Condition no longer requires drug|0|||
25312861|NCT00879879|50628348|FG000|Overall Study|Death|1|||
25312862|NCT00879879|50628348|FG000|Overall Study|Withdrawal by Subject|1|||
25312863|NCT00879879|50628348|FG000|Overall Study|Physician Decision|1|||
25312864|NCT00661999|50628357|FG000|Overall Study|Adverse Event|11|||
25312865|NCT00661999|50628358|FG001|Overall Study|Adverse Event|5|||
25312866|NCT00661999|50628359|FG002|Overall Study|Adverse Event|8|||
25312867|NCT00661999|50628357|FG000|Overall Study|Death|8|||
25312868|NCT00661999|50628358|FG001|Overall Study|Death|6|||
25312869|NCT00661999|50628359|FG002|Overall Study|Death|3|||
25312870|NCT00661999|50628357|FG000|Overall Study|Other Reasons|5|||
25312871|NCT00661999|50628358|FG001|Overall Study|Other Reasons|12|||
25312872|NCT00661999|50628359|FG002|Overall Study|Other Reasons|23|||
25312873|NCT00661999|50628357|FG000|Overall Study|Withdrawal by Subject|30|||
25312874|NCT00661999|50628358|FG001|Overall Study|Withdrawal by Subject|23|||
25312875|NCT00661999|50628359|FG002|Overall Study|Withdrawal by Subject|14|||
25312876|NCT00661999|50628357|FG000|Overall Study|Alternative Treatment|1|||
25312877|NCT00661999|50628358|FG001|Overall Study|Alternative Treatment|0|||
25312878|NCT00661999|50628359|FG002|Overall Study|Alternative Treatment|0|||
25312879|NCT00661999|50628357|FG000|Overall Study|Other Medical Problems|4|||
25312880|NCT00661999|50628358|FG001|Overall Study|Other Medical Problems|4|||
25312881|NCT00661999|50628359|FG002|Overall Study|Other Medical Problems|9|||
25312882|NCT00665353|50628367|FG000|Study Step 1|Adverse Event|1|||
25312883|NCT00665353|50628367|FG000|Study Step 1|Withdrawal by Subject|2|||
25312884|NCT00665353|50628367|FG000|Study Step 2|Lost to Follow-up|2|||
25312885|NCT00665353|50628367|FG000|Study Step 2|Lack of Efficacy|12|||
25312886|NCT00597207|50628373|FG000|Overall Study|Lost to Follow-up|5|||
25312887|NCT00597207|50628374|FG001|Overall Study|Lost to Follow-up|7|||
25312888|NCT00879645|50628384|FG000|Overall Study|Adverse Event|1|||
25312889|NCT00879645|50628385|FG001|Overall Study|Adverse Event|0|||
25312890|NCT00879645|50628386|FG002|Overall Study|Adverse Event|0|||
25312891|NCT00879645|50628387|FG003|Overall Study|Adverse Event|0|||
25312892|NCT00664105|50628397|FG000|Overall Study|Death|3|||
25312893|NCT00664105|50628397|FG000|Overall Study|Withdrawal by Subject|5|||
25312894|NCT00664105|50628397|FG000|Overall Study|Adverse Event|9|||
25312895|NCT00664105|50628397|FG000|Overall Study|Disease progression|7|||
25312896|NCT00661687|50628402|FG000|Overall Study|Study related symptoms and complaints|5|||
25312897|NCT00661687|50628402|FG000|Overall Study|Positive slit lamp findings|4|||
25312898|NCT00661687|50628402|FG000|Overall Study|Inability to maintain wearing schedule|3|||
25312899|NCT00661687|50628402|FG000|Overall Study|Physician Decision|1|||
25312900|NCT00661687|50628402|FG000|Overall Study|Adverse Event|2|||
25312901|NCT00596817|50628411|FG000|Open-label Period|Adverse Event|0|||
25312902|NCT00596817|50628412|FG001|Open-label Period|Adverse Event|49|||
25312903|NCT00596817|50628411|FG000|Open-label Period|Lack of Efficacy|0|||
25312904|NCT00596817|50628412|FG001|Open-label Period|Lack of Efficacy|33|||
25312905|NCT00596817|50628411|FG000|Open-label Period|Other Reasons|0|||
25312906|NCT00596817|50628412|FG001|Open-label Period|Other Reasons|65|||
25312907|NCT00596817|50628411|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
25312908|NCT00596817|50628412|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
25312909|NCT00596817|50628411|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
25312910|NCT00596817|50628412|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
25312911|NCT00596817|50628411|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
25312912|NCT00596817|50628412|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
25312913|NCT00596817|50628411|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
25312914|NCT00596817|50628412|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
25312915|NCT00596817|50628411|FG000|Double-blind Period|Adverse Event|5|||
25312916|NCT00596817|50628412|FG001|Double-blind Period|Adverse Event|16|||
25312917|NCT00596817|50628411|FG000|Double-blind Period|Lack of Efficacy|52|||
25312918|NCT00596817|50628412|FG001|Double-blind Period|Lack of Efficacy|28|||
25312919|NCT00596817|50628411|FG000|Double-blind Period|Non-compliance With Study Product|3|||
25312920|NCT00596817|50628412|FG001|Double-blind Period|Non-compliance With Study Product|4|||
25312921|NCT00596817|50628411|FG000|Double-blind Period|Protocol Violation|11|||
25312922|NCT00596817|50628412|FG001|Double-blind Period|Protocol Violation|8|||
25312923|NCT00596817|50628411|FG000|Double-blind Period|Withdrawal of Consent|7|||
25312924|NCT00596817|50628412|FG001|Double-blind Period|Withdrawal of Consent|3|||
25312925|NCT00596817|50628411|FG000|Double-blind Period|Lost to Follow-up|0|||
25312926|NCT00596817|50628412|FG001|Double-blind Period|Lost to Follow-up|2|||
25312927|NCT00596817|50628411|FG000|Double-blind Period|Other Reasons|10|||
25312928|NCT00596817|50628412|FG001|Double-blind Period|Other Reasons|18|||
25312929|NCT01000649|50628423|FG000|Overall Study|Adverse Event|5|||
25312930|NCT01000649|50628424|FG001|Overall Study|Adverse Event|1|||
25312931|NCT01000649|50628425|FG002|Overall Study|Adverse Event|2|||
25312932|NCT01000649|50628426|FG003|Overall Study|Adverse Event|4|||
25312933|NCT01000649|50628423|FG000|Overall Study|Lost to Follow-up|0|||
25312934|NCT01000649|50628424|FG001|Overall Study|Lost to Follow-up|2|||
25312935|NCT01000649|50628425|FG002|Overall Study|Lost to Follow-up|0|||
25312936|NCT01000649|50628426|FG003|Overall Study|Lost to Follow-up|2|||
25312937|NCT00666835|50628437|FG000|Overall Study|Withdrawal by Subject|5|||
25312938|NCT00666835|50628438|FG001|Overall Study|Withdrawal by Subject|2|||
25312939|NCT00666835|50628437|FG000|Overall Study|Lack of Efficacy|0|||
25312940|NCT00666835|50628438|FG001|Overall Study|Lack of Efficacy|1|||
24970293|NCT04124926|50059867|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
24970294|NCT04124926|50059868|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
24970295|NCT04124926|50059864|FG000|Healing Phase|Protocol Violation|0|||
24970296|NCT04124926|50059865|FG001|Healing Phase|Protocol Violation|1|||
24970297|NCT04124926|50059866|FG002|Healing Phase|Protocol Violation|0|||
24970298|NCT04124926|50059867|FG003|Healing Phase|Protocol Violation|0|||
24970299|NCT04124926|50059868|FG004|Healing Phase|Protocol Violation|0|||
24970300|NCT04124926|50059864|FG000|Healing Phase|Lost to Follow-up|5|||
25312941|NCT00666835|50628437|FG000|Overall Study|Incl./excl. not fulfilled|7|||
25312942|NCT00666835|50628438|FG001|Overall Study|Incl./excl. not fulfilled|2|||
24970301|NCT04124926|50059865|FG001|Healing Phase|Lost to Follow-up|4|||
25312943|NCT00666835|50628437|FG000|Overall Study|Adverse Event|7|||
25312944|NCT00666835|50628438|FG001|Overall Study|Adverse Event|6|||
25312945|NCT00666835|50628437|FG000|Overall Study|Protocol Violation|2|||
25312946|NCT00666835|50628438|FG001|Overall Study|Protocol Violation|0|||
25312947|NCT00666835|50628437|FG000|Overall Study|Death|15|||
25312948|NCT00666835|50628438|FG001|Overall Study|Death|4|||
25312949|NCT00666835|50628437|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
25312950|NCT00666835|50628438|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
25312951|NCT00666835|50628437|FG000|Overall Study|Hemoglobulin concentration|4|||
25312952|NCT00666835|50628438|FG001|Overall Study|Hemoglobulin concentration|3|||
25312953|NCT00666835|50628437|FG000|Overall Study|Planned operation|2|||
25312954|NCT00666835|50628438|FG001|Overall Study|Planned operation|0|||
25312955|NCT00666835|50628437|FG000|Overall Study|Physician Decision|1|||
25312956|NCT00666835|50628438|FG001|Overall Study|Physician Decision|2|||
25312957|NCT00879411|50628445|FG000|Overall Study|lost to follow-up (non-AE)|162|||
25312958|NCT01000493|50628451|FG000|Overall Study|Adverse Event|3|||
25312959|NCT01000493|50628452|FG001|Overall Study|Adverse Event|6|||
25192275|NCT01444430|50357930|FG000|Overall Study|CRF termination module not completed.|0|||
25192276|NCT01444430|50357931|FG001|Overall Study|CRF termination module not completed.|1|||
25192277|NCT01436162|50358007|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
25192278|NCT01436162|50358008|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
25192279|NCT01436162|50358009|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
25192280|NCT01436162|50358007|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
25192281|NCT01436162|50358008|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
25192282|NCT01436162|50358009|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
25192283|NCT01436162|50358007|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
25192284|NCT01436162|50358008|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
25192285|NCT01436162|50358009|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
25192286|NCT01436162|50358007|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
25192287|NCT01436162|50358008|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
25192288|NCT01436162|50358009|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
25192289|NCT01436162|50358007|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
25192290|NCT01436162|50358008|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
25192291|NCT01436162|50358009|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
25192292|NCT01436162|50358007|FG000|Single-blind Lead-in Phase|Other|107|||
25192293|NCT01436162|50358008|FG001|Single-blind Lead-in Phase|Other|0|||
25192294|NCT01436162|50358009|FG002|Single-blind Lead-in Phase|Other|0|||
25312960|NCT01000493|50628451|FG000|Overall Study|Lack of Efficacy|1|||
25312961|NCT01000493|50628452|FG001|Overall Study|Lack of Efficacy|1|||
25312962|NCT01000493|50628451|FG000|Overall Study|Protocol Violation|1|||
25312963|NCT01000493|50628452|FG001|Overall Study|Protocol Violation|8|||
25312964|NCT01000493|50628451|FG000|Overall Study|Study closed/terminated|25|||
25312965|NCT01000493|50628452|FG001|Overall Study|Study closed/terminated|23|||
25312966|NCT01000493|50628451|FG000|Overall Study|Lost to Follow-up|5|||
25312967|NCT01000493|50628452|FG001|Overall Study|Lost to Follow-up|9|||
25312968|NCT01000493|50628451|FG000|Overall Study|Physician Decision|1|||
25312969|NCT01000493|50628452|FG001|Overall Study|Physician Decision|1|||
25312970|NCT01000493|50628451|FG000|Overall Study|Withdrawal by Subject|3|||
25312971|NCT01000493|50628452|FG001|Overall Study|Withdrawal by Subject|7|||
25312972|NCT00666757|50628460|FG000|Overall Study|Lost to Follow-up|39|||
25312973|NCT00666757|50628461|FG001|Overall Study|Lost to Follow-up|35|||
25312974|NCT00666757|50628460|FG000|Overall Study|Protocol Violation|23|||
25312975|NCT00666757|50628461|FG001|Overall Study|Protocol Violation|24|||
25312976|NCT00666757|50628460|FG000|Overall Study|Adverse Event|22|||
25312977|NCT00666757|50628461|FG001|Overall Study|Adverse Event|12|||
25312978|NCT00666757|50628460|FG000|Overall Study|Withdrawal by Subject|13|||
25312979|NCT00666757|50628461|FG001|Overall Study|Withdrawal by Subject|17|||
25312980|NCT00666757|50628460|FG000|Overall Study|Lack of Efficacy|3|||
25312981|NCT00666757|50628461|FG001|Overall Study|Lack of Efficacy|6|||
25312982|NCT00666757|50628460|FG000|Overall Study|Physician Decision|0|||
25312983|NCT00666757|50628461|FG001|Overall Study|Physician Decision|2|||
25312984|NCT00666757|50628460|FG000|Overall Study|Sponsor decision|0|||
25312985|NCT00666757|50628461|FG001|Overall Study|Sponsor decision|1|||
25312986|NCT01000337|50628472|FG000|Overall Study|Lost to Follow-up|4|||
25312987|NCT01000337|50628473|FG001|Overall Study|Lost to Follow-up|3|||
25312988|NCT00666679|50628481|FG000|First Intervention|Lost to Follow-up|1|||
25312989|NCT00666679|50628482|FG001|First Intervention|Lost to Follow-up|0|||
25312990|NCT00666679|50628481|FG000|First Intervention|Protocol Violation|1|||
25312991|NCT00666679|50628482|FG001|First Intervention|Protocol Violation|0|||
25312992|NCT00666679|50628481|FG000|First Intervention|Withdrawal by Subject|1|||
25192295|NCT01436162|50358007|FG000|Randomized Phase|Adverse Event|1|||
25192296|NCT01436162|50358008|FG001|Randomized Phase|Adverse Event|5|||
25192297|NCT01436162|50358009|FG002|Randomized Phase|Adverse Event|6|||
25192298|NCT01436162|50358007|FG000|Randomized Phase|Protocol Violation|4|||
25192299|NCT01436162|50358008|FG001|Randomized Phase|Protocol Violation|4|||
25192300|NCT01436162|50358009|FG002|Randomized Phase|Protocol Violation|2|||
25312993|NCT00666679|50628482|FG001|First Intervention|Withdrawal by Subject|0|||
25312994|NCT00666679|50628481|FG000|First Intervention|Randomized did not start treatment|1|||
25312995|NCT00666679|50628482|FG001|First Intervention|Randomized did not start treatment|1|||
25312996|NCT00666679|50628481|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
25312997|NCT00666679|50628482|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
25312998|NCT00666679|50628481|FG000|Washout Period of 1 Week|Protocol Violation|0|||
25312999|NCT00666679|50628482|FG001|Washout Period of 1 Week|Protocol Violation|1|||
25313000|NCT00666679|50628481|FG000|Second Intervention|Adverse Event|1|||
25313001|NCT00666679|50628482|FG001|Second Intervention|Adverse Event|0|||
25313002|NCT00666679|50628481|FG000|Second Intervention|Death|0|||
25313003|NCT00666679|50628482|FG001|Second Intervention|Death|1|||
25313004|NCT00595413|50628492|FG000|Overall Study|Adverse Event|0|||
25313005|NCT00595413|50628493|FG001|Overall Study|Adverse Event|2|||
25313006|NCT00595413|50628494|FG002|Overall Study|Adverse Event|1|||
25313007|NCT00595413|50628495|FG003|Overall Study|Adverse Event|1|||
25313008|NCT00595413|50628492|FG000|Overall Study|Lost to Follow-up|2|||
25313009|NCT00595413|50628493|FG001|Overall Study|Lost to Follow-up|2|||
25313010|NCT00595413|50628494|FG002|Overall Study|Lost to Follow-up|1|||
25313011|NCT00595413|50628495|FG003|Overall Study|Lost to Follow-up|3|||
25313012|NCT00595413|50628492|FG000|Overall Study|Death|0|||
25313013|NCT00595413|50628493|FG001|Overall Study|Death|0|||
25313014|NCT00595413|50628494|FG002|Overall Study|Death|1|||
25313015|NCT00595413|50628495|FG003|Overall Study|Death|0|||
25313016|NCT00595413|50628492|FG000|Overall Study|Other|5|||
25313017|NCT00595413|50628493|FG001|Overall Study|Other|1|||
25313018|NCT00595413|50628494|FG002|Overall Study|Other|5|||
25313019|NCT00595413|50628495|FG003|Overall Study|Other|0|||
25313020|NCT01000025|50628507|FG000|Overall Study|Adverse Event|43|||
25313021|NCT01000025|50628508|FG001|Overall Study|Adverse Event|2|||
24970302|NCT04124926|50059866|FG002|Healing Phase|Lost to Follow-up|0|||
24970303|NCT04124926|50059867|FG003|Healing Phase|Lost to Follow-up|0|||
24970304|NCT04124926|50059868|FG004|Healing Phase|Lost to Follow-up|0|||
24970305|NCT04124926|50059864|FG000|Healing Phase|Voluntary Withdrawal|10|||
24970306|NCT04124926|50059865|FG001|Healing Phase|Voluntary Withdrawal|7|||
24970307|NCT04124926|50059866|FG002|Healing Phase|Voluntary Withdrawal|0|||
24970308|NCT04124926|50059867|FG003|Healing Phase|Voluntary Withdrawal|0|||
24970309|NCT04124926|50059868|FG004|Healing Phase|Voluntary Withdrawal|0|||
24970310|NCT04124926|50059864|FG000|Healing Phase|Withdrawal of Consent|5|||
24970311|NCT04124926|50059865|FG001|Healing Phase|Withdrawal of Consent|3|||
24970312|NCT04124926|50059866|FG002|Healing Phase|Withdrawal of Consent|0|||
24970313|NCT04124926|50059867|FG003|Healing Phase|Withdrawal of Consent|0|||
24970314|NCT04124926|50059868|FG004|Healing Phase|Withdrawal of Consent|0|||
24970315|NCT04124926|50059864|FG000|Healing Phase|Miscellaneous|8|||
24970316|NCT04124926|50059865|FG001|Healing Phase|Miscellaneous|7|||
24970317|NCT04124926|50059866|FG002|Healing Phase|Miscellaneous|0|||
24970318|NCT04124926|50059867|FG003|Healing Phase|Miscellaneous|0|||
24970319|NCT04124926|50059868|FG004|Healing Phase|Miscellaneous|0|||
24970320|NCT04124926|50059864|FG000|Healing Phase|Randomized but not Treated|0|||
24970321|NCT04124926|50059865|FG001|Healing Phase|Randomized but not Treated|3|||
24970322|NCT04124926|50059866|FG002|Healing Phase|Randomized but not Treated|0|||
24970323|NCT04124926|50059867|FG003|Healing Phase|Randomized but not Treated|0|||
24970324|NCT04124926|50059868|FG004|Healing Phase|Randomized but not Treated|0|||
25071503|NCT01663532|50177777|FG001|Overall Study|Withdrawal by Subject|17|||
24970325|NCT04124926|50059864|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
24970326|NCT04124926|50059865|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
24970327|NCT04124926|50059866|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
24970328|NCT04124926|50059867|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
24970329|NCT04124926|50059868|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
25313022|NCT01000025|50628507|FG000|Overall Study|Withdrawal by Subject|13|||
25313023|NCT01000025|50628508|FG001|Overall Study|Withdrawal by Subject|8|||
25313024|NCT01000025|50628507|FG000|Overall Study|Death|23|||
25313025|NCT01000025|50628508|FG001|Overall Study|Death|13|||
25313026|NCT01000025|50628507|FG000|Overall Study|Lack of Efficacy|363|||
25313027|NCT01000025|50628508|FG001|Overall Study|Lack of Efficacy|208|||
25313028|NCT01000025|50628507|FG000|Overall Study|Intercurrent Illness|26|||
25313029|NCT01000025|50628508|FG001|Overall Study|Intercurrent Illness|7|||
25313030|NCT00595335|50628516|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
25313031|NCT00595335|50628517|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
25313032|NCT00595335|50628516|FG000|Baseline to Six Months|Disease Progression|1|||
25313033|NCT00595335|50628517|FG001|Baseline to Six Months|Disease Progression|1|||
25313034|NCT00595335|50628516|FG000|Baseline to Six Months|Adverse Event|1|||
25313035|NCT00595335|50628517|FG001|Baseline to Six Months|Adverse Event|0|||
25313036|NCT00595335|50628516|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
25313037|NCT00595335|50628517|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
25313038|NCT00595335|50628516|FG000|Six Months to Twelve Months|Disease Progression|1|||
25313039|NCT00595335|50628517|FG001|Six Months to Twelve Months|Disease Progression|0|||
25313040|NCT00661609|50628527|FG000|Overall Study|Adverse Event|4|||
25313041|NCT00661609|50628527|FG000|Overall Study|Death|20|||
25313042|NCT00661609|50628527|FG000|Overall Study|Withdrawal by Subject|2|||
25313043|NCT00661609|50628527|FG000|Overall Study|PI Decision|1|||
25313044|NCT00661609|50628527|FG000|Overall Study|Survival follow up stage discontinued|11|||
25313045|NCT00661609|50628527|FG000|Overall Study|Disease progression|3|||
25313046|NCT00661531|50628531|FG000|Overall Study|Withdrawal by Subject|3|||
25313047|NCT00998309|50628535|FG000|Overall Study|Protocol Violation|4|||
25313048|NCT00999713|50628589|FG000|Overall Study|Physician Decision|2|||
25313049|NCT00999713|50628590|FG001|Overall Study|Physician Decision|0|||
25313050|NCT00997373|50628598|FG000|Overall Study|Withdrawal by Subject|5|||
25313051|NCT00997373|50628599|FG001|Overall Study|Withdrawal by Subject|0|||
25313052|NCT00997373|50628598|FG000|Overall Study|wrong tumor type|4|||
25313053|NCT00997373|50628599|FG001|Overall Study|wrong tumor type|0|||
25313054|NCT00997373|50628598|FG000|Overall Study|could not have hysterectomy|6|||
25313055|NCT00997373|50628599|FG001|Overall Study|could not have hysterectomy|0|||
25313056|NCT00663871|50628607|FG000|Overall Study|Lost to Follow-up|5|||
25313057|NCT00663871|50628608|FG001|Overall Study|Lost to Follow-up|5|||
25313058|NCT00663871|50628607|FG000|Overall Study|Withdrawal by Subject|5|||
25192301|NCT01436162|50358007|FG000|Randomized Phase|Withdrawal by Subject|16|||
25192302|NCT01436162|50358008|FG001|Randomized Phase|Withdrawal by Subject|9|||
25192303|NCT01436162|50358009|FG002|Randomized Phase|Withdrawal by Subject|8|||
25192304|NCT01436162|50358007|FG000|Randomized Phase|Lost to Follow-up|17|||
25313059|NCT00663871|50628608|FG001|Overall Study|Withdrawal by Subject|2|||
25313060|NCT04152447|50628618|FG000|Overall Study|Lost to Follow-up|1|||
25313061|NCT04152447|50628619|FG001|Overall Study|Lost to Follow-up|0|||
25313062|NCT04152447|50628618|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
25313063|NCT04152447|50628619|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
25313064|NCT04152447|50628618|FG000|Overall Study|Withdrawal by Subject|0|||
25313065|NCT04152447|50628619|FG001|Overall Study|Withdrawal by Subject|1|||
25313066|NCT04152447|50628618|FG000|Overall Study|Found ineligible after enrolling|1|||
25313067|NCT04152447|50628619|FG001|Overall Study|Found ineligible after enrolling|1|||
25192305|NCT01436162|50358008|FG001|Randomized Phase|Lost to Follow-up|5|||
25192306|NCT01436162|50358009|FG002|Randomized Phase|Lost to Follow-up|4|||
25313068|NCT04152447|50628618|FG000|Overall Study|Did not receive VR headset in time.|0|||
25313069|NCT04152447|50628619|FG001|Overall Study|Did not receive VR headset in time.|2|||
25313070|NCT00996593|50628625|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
25313071|NCT00996593|50628625|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
25313072|NCT00996593|50628625|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
25313073|NCT00996593|50628625|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
25313074|NCT00996593|50628625|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
25313075|NCT00996593|50628625|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
25313076|NCT00996593|50628625|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
25313077|NCT00996593|50628625|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
25313078|NCT00996593|50628625|FG000|Long-Term Follow-Up|Site Closed|1|||
25313079|NCT00570661|50628629|FG000|Overall Study|Disease worsening|5|||
25313080|NCT00570661|50628629|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
25313081|NCT00570661|50628629|FG000|Overall Study|Adverse Event|1|||
25313082|NCT00934544|50628636|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
25313083|NCT00934544|50628637|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
25313084|NCT00934544|50628638|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
25313085|NCT00934544|50628636|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
25313086|NCT00934544|50628637|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
25313087|NCT00934544|50628638|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
25313088|NCT00934544|50628636|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
25313089|NCT00934544|50628637|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
25313090|NCT00934544|50628638|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
25313091|NCT00934544|50628636|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
25313092|NCT00934544|50628637|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
25313093|NCT00934544|50628638|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
25313094|NCT00934544|50628636|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
25313095|NCT00934544|50628637|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
25313096|NCT00934544|50628638|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
25313097|NCT00934544|50628636|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
25313098|NCT00934544|50628637|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
25313099|NCT00934544|50628638|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
25313100|NCT00934544|50628636|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
25313101|NCT00934544|50628637|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
25313102|NCT00934544|50628638|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
25313103|NCT00934544|50628636|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
25313104|NCT00934544|50628637|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
25313105|NCT00934544|50628638|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
25313106|NCT00934544|50628636|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
25313107|NCT00934544|50628637|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
25313108|NCT00934544|50628638|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
25313109|NCT00934544|50628636|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
25313110|NCT00934544|50628637|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
25313111|NCT00934544|50628638|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
25313112|NCT00934544|50628636|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
25313113|NCT00934544|50628637|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
25313114|NCT00934544|50628638|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
25313115|NCT00934544|50628636|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
25313116|NCT00934544|50628637|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
25071504|NCT01663532|50177776|FG000|Overall Study|Lack of Efficacy|15|||
25071505|NCT01663532|50177777|FG001|Overall Study|Lack of Efficacy|60|||
25313117|NCT00934544|50628638|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
25071506|NCT02525939|50177785|FG000|Overall Study|Lost to Follow-up|27|||
25071507|NCT02525939|50177786|FG001|Overall Study|Lost to Follow-up|24|||
25313118|NCT00934544|50628636|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
25313119|NCT00934544|50628637|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
25313120|NCT00934544|50628638|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
25313121|NCT00934544|50628636|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
25313122|NCT00934544|50628637|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
25313123|NCT00934544|50628638|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
25313124|NCT00934544|50628636|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
25313125|NCT00934544|50628637|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
25313126|NCT00934544|50628638|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
25313127|NCT00934544|50628636|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
25313128|NCT00934544|50628637|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
25313129|NCT00934544|50628638|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
25313130|NCT00999167|50628657|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
25313131|NCT00999167|50628658|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
25313132|NCT00999167|50628659|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
25313133|NCT00999167|50628657|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
25071508|NCT02525939|50177785|FG000|Overall Study|Physician Decision|0|||
25071509|NCT02525939|50177786|FG001|Overall Study|Physician Decision|1|||
25313134|NCT00999167|50628658|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
25313135|NCT00999167|50628659|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
25313136|NCT00999167|50628657|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
25313137|NCT00999167|50628658|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
25313138|NCT00999167|50628659|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
25313139|NCT00999167|50628657|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
25313140|NCT00999167|50628658|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
25313141|NCT00999167|50628659|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
25313142|NCT00999167|50628657|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
25313143|NCT00999167|50628658|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
25313144|NCT00999167|50628659|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
25313145|NCT00999167|50628657|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
25313146|NCT00999167|50628658|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
25313147|NCT00999167|50628659|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
25313148|NCT00999167|50628657|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
25313149|NCT00999167|50628658|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
25313150|NCT00999167|50628659|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
25313151|NCT00999167|50628657|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
25313152|NCT00999167|50628658|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
25313153|NCT00999167|50628659|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
25313154|NCT00570505|50628669|FG000|Overall Study|Adverse Event|7|||
25313155|NCT00570505|50628669|FG000|Overall Study|Withdrawal by Subject|7|||
25313156|NCT00570505|50628669|FG000|Overall Study|Lost to Follow-up|23|||
25313157|NCT00570505|50628669|FG000|Overall Study|Other loss to follow-up|4|||
25313158|NCT00931892|50628675|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
25313159|NCT00931892|50628676|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
25313160|NCT00666211|50628724|FG000|Overall Study|Withdrawal by Subject|10|||
25313161|NCT00666211|50628725|FG001|Overall Study|Withdrawal by Subject|13|||
25313162|NCT00666211|50628724|FG000|Overall Study|went off medication, no more pain|1|||
25313163|NCT00666211|50628725|FG001|Overall Study|went off medication, no more pain|0|||
25313164|NCT00666211|50628724|FG000|Overall Study|patient non-compliant|6|||
25313165|NCT00666211|50628725|FG001|Overall Study|patient non-compliant|6|||
25313166|NCT00666211|50628724|FG000|Overall Study|disease progression|1|||
25313167|NCT00666211|50628725|FG001|Overall Study|disease progression|8|||
25313168|NCT00666211|50628724|FG000|Overall Study|Lost to Follow-up|2|||
25313169|NCT00666211|50628725|FG001|Overall Study|Lost to Follow-up|0|||
25313170|NCT00666211|50628724|FG000|Overall Study|toxicity|0|||
25313171|NCT00666211|50628725|FG001|Overall Study|toxicity|2|||
25313172|NCT00666211|50628724|FG000|Overall Study|hospital admission|0|||
25313173|NCT00666211|50628725|FG001|Overall Study|hospital admission|5|||
25313174|NCT00666211|50628724|FG000|Overall Study|Death|0|||
25313175|NCT00666211|50628725|FG001|Overall Study|Death|2|||
25313176|NCT00666211|50628724|FG000|Overall Study|off tx for other complicating disease|0|||
25313177|NCT00666211|50628725|FG001|Overall Study|off tx for other complicating disease|1|||
25313178|NCT00666211|50628724|FG000|Overall Study|Physician Decision|0|||
25313179|NCT00666211|50628725|FG001|Overall Study|Physician Decision|1|||
25313180|NCT00878709|50628733|FG000|Overall Study|Withdrawal by Subject|197|||
25313181|NCT00878709|50628734|FG001|Overall Study|Withdrawal by Subject|120|||
25313182|NCT00878709|50628733|FG000|Overall Study|Lost to Follow-up|35|||
25313183|NCT00878709|50628734|FG001|Overall Study|Lost to Follow-up|33|||
25313184|NCT00878709|50628733|FG000|Overall Study|Other Reasons|93|||
25313185|NCT00878709|50628734|FG001|Overall Study|Other Reasons|84|||
25313186|NCT00927758|50628741|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
25313187|NCT00927758|50628742|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
25313188|NCT00927758|50628743|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
25313189|NCT00927758|50628744|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
25313190|NCT00927758|50628745|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
25313191|NCT00927758|50628746|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
25313192|NCT00927758|50628741|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
25313193|NCT00927758|50628742|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
25313194|NCT00927758|50628743|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
25313195|NCT00927758|50628744|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
25313196|NCT00927758|50628745|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
25313197|NCT00927758|50628746|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
25313198|NCT00927368|50628757|FG000|Overall Study|enrollment in another study|1|||
25313199|NCT00927368|50628758|FG001|Overall Study|enrollment in another study|1|||
25313200|NCT00927368|50628759|FG002|Overall Study|enrollment in another study|2|||
25313201|NCT00927368|50628757|FG000|Overall Study|Lost to Follow-up|4|||
25313202|NCT00927368|50628758|FG001|Overall Study|Lost to Follow-up|0|||
25313203|NCT00927368|50628759|FG002|Overall Study|Lost to Follow-up|0|||
25313204|NCT00927368|50628757|FG000|Overall Study|equipment failure|1|||
25313205|NCT00927368|50628758|FG001|Overall Study|equipment failure|0|||
25313206|NCT00927368|50628759|FG002|Overall Study|equipment failure|0|||
25313207|NCT00927368|50628757|FG000|Overall Study|ineligible post randomization|0|||
25313208|NCT00927368|50628758|FG001|Overall Study|ineligible post randomization|3|||
25313209|NCT00927368|50628759|FG002|Overall Study|ineligible post randomization|1|||
25313210|NCT00927368|50628757|FG000|Overall Study|cancellation of surgery|0|||
25313211|NCT00927368|50628758|FG001|Overall Study|cancellation of surgery|1|||
25313212|NCT00927368|50628759|FG002|Overall Study|cancellation of surgery|2|||
25313213|NCT00662857|50628767|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
25313214|NCT00662857|50628768|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
25313215|NCT00662857|50628767|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
25313216|NCT00662857|50628768|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
25313217|NCT00662857|50628767|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
25313218|NCT00662857|50628768|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
25313219|NCT00878553|50628781|FG000|Sleep Study|Withdrawal by Subject|2|||
25313220|NCT00878553|50628782|FG001|Sleep Study|Withdrawal by Subject|0|||
25313221|NCT00878553|50628783|FG002|Sleep Study|Withdrawal by Subject|0|||
25313222|NCT00878553|50628784|FG003|Sleep Study|Withdrawal by Subject|0|||
25313223|NCT00878553|50628785|FG004|Sleep Study|Withdrawal by Subject|0|||
25313224|NCT00878553|50628781|FG000|Sleep Study|Lost to Follow-up|1|||
25313225|NCT00878553|50628782|FG001|Sleep Study|Lost to Follow-up|0|||
25313226|NCT00878553|50628783|FG002|Sleep Study|Lost to Follow-up|0|||
25313227|NCT00878553|50628784|FG003|Sleep Study|Lost to Follow-up|0|||
25313228|NCT00878553|50628785|FG004|Sleep Study|Lost to Follow-up|0|||
25313229|NCT00878553|50628781|FG000|Sleep Study|car accident|1|||
25313230|NCT00878553|50628782|FG001|Sleep Study|car accident|0|||
25313231|NCT00878553|50628783|FG002|Sleep Study|car accident|0|||
25313232|NCT00878553|50628784|FG003|Sleep Study|car accident|0|||
25313233|NCT00878553|50628785|FG004|Sleep Study|car accident|0|||
25313234|NCT00878553|50628781|FG000|Sleep Study|family emergency|1|||
25313235|NCT00878553|50628782|FG001|Sleep Study|family emergency|0|||
25313236|NCT00878553|50628783|FG002|Sleep Study|family emergency|0|||
25313237|NCT00878553|50628784|FG003|Sleep Study|family emergency|0|||
25313238|NCT00878553|50628785|FG004|Sleep Study|family emergency|0|||
25313239|NCT00878553|50628781|FG000|PK Study|Withdrawal by Subject|0|||
25313240|NCT00878553|50628782|FG001|PK Study|Withdrawal by Subject|0|||
25313241|NCT00878553|50628783|FG002|PK Study|Withdrawal by Subject|0|||
25313242|NCT00878553|50628784|FG003|PK Study|Withdrawal by Subject|1|||
25313243|NCT00878553|50628785|FG004|PK Study|Withdrawal by Subject|0|||
25313244|NCT00996437|50628804|FG000|Overall Study|Death|1|||
25313245|NCT00996437|50628805|FG001|Overall Study|Death|0|||
25313246|NCT00996437|50628804|FG000|Overall Study|Dropped|2|||
25313247|NCT00996437|50628805|FG001|Overall Study|Dropped|2|||
25313248|NCT00996437|50628804|FG000|Overall Study|Missed|2|||
25313249|NCT00996437|50628805|FG001|Overall Study|Missed|5|||
25313250|NCT00662311|50628814|FG000|Overall Study|Respiratory Infection|1|||
25313251|NCT00662311|50628815|FG001|Overall Study|Respiratory Infection|0|||
25313252|NCT00662311|50628816|FG002|Overall Study|Respiratory Infection|0|||
25313253|NCT00929708|50628829|FG000|Overall Study|Protocol Violation|2|||
25313254|NCT00929708|50628830|FG001|Overall Study|Protocol Violation|1|||
25313255|NCT00929708|50628831|FG002|Overall Study|Protocol Violation|1|||
25313256|NCT00929708|50628832|FG003|Overall Study|Protocol Violation|1|||
25313257|NCT00929708|50628833|FG004|Overall Study|Protocol Violation|1|||
25313258|NCT00929708|50628829|FG000|Overall Study|Withdrawal by Subject|2|||
25313259|NCT00929708|50628830|FG001|Overall Study|Withdrawal by Subject|0|||
25313260|NCT00929708|50628831|FG002|Overall Study|Withdrawal by Subject|0|||
25313261|NCT00929708|50628832|FG003|Overall Study|Withdrawal by Subject|2|||
25313262|NCT00929708|50628833|FG004|Overall Study|Withdrawal by Subject|1|||
25313263|NCT00929708|50628829|FG000|Overall Study|Adverse Event|0|||
25313264|NCT00929708|50628830|FG001|Overall Study|Adverse Event|0|||
25313265|NCT00929708|50628831|FG002|Overall Study|Adverse Event|0|||
25313266|NCT00929708|50628832|FG003|Overall Study|Adverse Event|0|||
25313267|NCT00929708|50628833|FG004|Overall Study|Adverse Event|3|||
25313268|NCT00929708|50628829|FG000|Overall Study|Physician Decision|0|||
25313269|NCT00929708|50628830|FG001|Overall Study|Physician Decision|2|||
25313270|NCT00929708|50628831|FG002|Overall Study|Physician Decision|2|||
25313271|NCT00929708|50628832|FG003|Overall Study|Physician Decision|2|||
25313272|NCT00929708|50628833|FG004|Overall Study|Physician Decision|1|||
25313273|NCT00929708|50628829|FG000|Overall Study|Lost to Follow-up|0|||
25313274|NCT00929708|50628830|FG001|Overall Study|Lost to Follow-up|0|||
25313275|NCT00929708|50628831|FG002|Overall Study|Lost to Follow-up|0|||
25313276|NCT00929708|50628832|FG003|Overall Study|Lost to Follow-up|1|||
25313277|NCT00929708|50628833|FG004|Overall Study|Lost to Follow-up|0|||
25313278|NCT00996281|50628847|FG000|Overall Study|Adverse Event|75|||
25313279|NCT00996281|50628848|FG001|Overall Study|Adverse Event|37|||
25313280|NCT00996281|50628847|FG000|Overall Study|Major Protocol Deviation|6|||
25313281|NCT00996281|50628848|FG001|Overall Study|Major Protocol Deviation|7|||
25313282|NCT00996281|50628847|FG000|Overall Study|Lost to Follow-up|14|||
25313283|NCT00996281|50628848|FG001|Overall Study|Lost to Follow-up|16|||
25313284|NCT00996281|50628847|FG000|Overall Study|Withdrawal by Subject|31|||
25313285|NCT00996281|50628848|FG001|Overall Study|Withdrawal by Subject|20|||
25313286|NCT00996281|50628847|FG000|Overall Study|Lack of Efficacy|0|||
25313287|NCT00996281|50628848|FG001|Overall Study|Lack of Efficacy|2|||
25313288|NCT00996281|50628847|FG000|Overall Study|Other|5|||
25313289|NCT00996281|50628848|FG001|Overall Study|Other|7|||
25313290|NCT00996203|50628854|FG000|Overall Study|Adverse Event|3|||
25313291|NCT00996203|50628854|FG000|Overall Study|Lost to Follow-up|1|||
25313292|NCT00996203|50628854|FG000|Overall Study|Lack of Efficacy|1|||
25313293|NCT00996203|50628854|FG000|Overall Study|Protocol Violation|2|||
25313294|NCT00877929|50628861|FG000|Overall Study|Adverse Event|11|||
25313295|NCT00877929|50628862|FG001|Overall Study|Adverse Event|20|||
25313296|NCT00877929|50628861|FG000|Overall Study|Protocol Violation|3|||
25313297|NCT00877929|50628862|FG001|Overall Study|Protocol Violation|3|||
25313298|NCT00877929|50628861|FG000|Overall Study|Lost to Follow-up|0|||
25313299|NCT00877929|50628862|FG001|Overall Study|Lost to Follow-up|1|||
25313300|NCT00877929|50628861|FG000|Overall Study|Withdrawal by Subject|4|||
25313301|NCT00877929|50628862|FG001|Overall Study|Withdrawal by Subject|4|||
25313302|NCT00877929|50628861|FG000|Overall Study|Lack of Efficacy|0|||
25313303|NCT00877929|50628862|FG001|Overall Study|Lack of Efficacy|1|||
25313304|NCT00877929|50628861|FG000|Overall Study|Other reason (not specified)|2|||
25313305|NCT00877929|50628862|FG001|Overall Study|Other reason (not specified)|6|||
25313306|NCT00931268|50628872|FG000|Overall Study|Lost to Follow-up|6|||
25313307|NCT00996125|50628878|FG000|Overall Study|Adverse Event|0|||
25313308|NCT00996125|50628879|FG001|Overall Study|Adverse Event|2|||
25313309|NCT00996125|50628878|FG000|Overall Study|Lost to Follow-up|1|||
25313310|NCT00996125|50628879|FG001|Overall Study|Lost to Follow-up|6|||
25313311|NCT00996125|50628878|FG000|Overall Study|Withdrawal by Subject|4|||
25313312|NCT00996125|50628879|FG001|Overall Study|Withdrawal by Subject|3|||
25313313|NCT04211363|50628887|FG000|Overall Study|Adverse Event|5|||
25313314|NCT04211363|50628888|FG001|Overall Study|Adverse Event|2|||
25313315|NCT04211363|50628887|FG000|Overall Study|Physician Decision|0|||
25313316|NCT04211363|50628888|FG001|Overall Study|Physician Decision|1|||
25313317|NCT04211363|50628887|FG000|Overall Study|Protocol Violation|1|||
25313318|NCT04211363|50628888|FG001|Overall Study|Protocol Violation|0|||
25313319|NCT04211363|50628887|FG000|Overall Study|Pregnancy|1|||
25313320|NCT04211363|50628888|FG001|Overall Study|Pregnancy|0|||
25313321|NCT04211363|50628887|FG000|Overall Study|Lost to Follow-up|12|||
25313322|NCT04211363|50628888|FG001|Overall Study|Lost to Follow-up|4|||
25313323|NCT04211363|50628887|FG000|Overall Study|Withdrawal by Subject|11|||
25313324|NCT04211363|50628888|FG001|Overall Study|Withdrawal by Subject|11|||
25313325|NCT04211363|50628887|FG000|Overall Study|Other|1|||
25313326|NCT04211363|50628888|FG001|Overall Study|Other|2|||
25313327|NCT00995345|50628899|FG000|Overall Study|Withdrawal by Subject|4|||
25313328|NCT00995345|50628900|FG001|Overall Study|Withdrawal by Subject|2|||
25313329|NCT00995345|50628901|FG002|Overall Study|Withdrawal by Subject|1|||
25313330|NCT00995345|50628902|FG003|Overall Study|Withdrawal by Subject|3|||
25313331|NCT00995345|50628903|FG004|Overall Study|Withdrawal by Subject|1|||
25313332|NCT00995345|50628899|FG000|Overall Study|Adverse Event|3|||
25313333|NCT00995345|50628900|FG001|Overall Study|Adverse Event|1|||
25313334|NCT00995345|50628901|FG002|Overall Study|Adverse Event|2|||
25313335|NCT00995345|50628902|FG003|Overall Study|Adverse Event|0|||
25313336|NCT00995345|50628903|FG004|Overall Study|Adverse Event|1|||
25313337|NCT00995345|50628899|FG000|Overall Study|Lost to Follow-up|2|||
25313338|NCT00995345|50628900|FG001|Overall Study|Lost to Follow-up|2|||
25313339|NCT00995345|50628901|FG002|Overall Study|Lost to Follow-up|2|||
25313340|NCT00995345|50628902|FG003|Overall Study|Lost to Follow-up|1|||
25313341|NCT00995345|50628903|FG004|Overall Study|Lost to Follow-up|0|||
25313342|NCT00995345|50628899|FG000|Overall Study|all other reasons combined|2|||
25313343|NCT00995345|50628900|FG001|Overall Study|all other reasons combined|2|||
25313344|NCT00995345|50628901|FG002|Overall Study|all other reasons combined|2|||
25313345|NCT00995345|50628902|FG003|Overall Study|all other reasons combined|1|||
25313346|NCT00995345|50628903|FG004|Overall Study|all other reasons combined|3|||
25313347|NCT00660907|50628917|FG000|Overall Study|Incorrect Enrollment|1|||
25313348|NCT00660907|50628918|FG001|Overall Study|Incorrect Enrollment|1|||
25313349|NCT00660907|50628917|FG000|Overall Study|Adverse Event|33|||
25313350|NCT00660907|50628918|FG001|Overall Study|Adverse Event|19|||
25313351|NCT00660907|50628917|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
25313352|NCT00660907|50628918|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
25313353|NCT00660907|50628917|FG000|Overall Study|Withdrawal by Subject|23|||
25313354|NCT00660907|50628918|FG001|Overall Study|Withdrawal by Subject|32|||
25313355|NCT00660907|50628917|FG000|Overall Study|Lost to Follow-up|3|||
25313356|NCT00660907|50628918|FG001|Overall Study|Lost to Follow-up|3|||
25313357|NCT00660907|50628917|FG000|Overall Study|Poor/Non-Compliance|5|||
25313358|NCT00660907|50628918|FG001|Overall Study|Poor/Non-Compliance|1|||
25313359|NCT00660907|50628917|FG000|Overall Study|Safety|1|||
25313360|NCT00660907|50628918|FG001|Overall Study|Safety|0|||
24970330|NCT04124926|50059864|FG000|Maintenance Phase|Protocol Violation|0|||
25169517|NCT04409262|50301553|FG001|Overall Study|Death|97|||
24970331|NCT04124926|50059865|FG001|Maintenance Phase|Protocol Violation|0|||
25313361|NCT00660907|50628917|FG000|Overall Study|Death|1|||
25313362|NCT00660907|50628918|FG001|Overall Study|Death|3|||
25313363|NCT00660907|50628917|FG000|Overall Study|Various|11|||
25313364|NCT00660907|50628918|FG001|Overall Study|Various|8|||
25313365|NCT00877773|50628924|FG000|Overall Study|Disease Progression|44|||
25313366|NCT00659815|50628930|FG000|Overall Study|Study related symptoms and complaints|2|||
25313367|NCT00659815|50628931|FG001|Overall Study|Study related symptoms and complaints|1|||
25313368|NCT00659815|50628930|FG000|Overall Study|Inability to maintain wearing schedule|1|||
25313369|NCT00659815|50628931|FG001|Overall Study|Inability to maintain wearing schedule|2|||
25313370|NCT00659815|50628930|FG000|Overall Study|Withdrawal by Subject|1|||
25313371|NCT00659815|50628931|FG001|Overall Study|Withdrawal by Subject|1|||
25313372|NCT00994643|50628937|FG000|Overall Study|Withdrawal by Subject|1|||
25313373|NCT00660829|50628943|FG000|Overall Study|Adverse Event|3|||
25313374|NCT00660829|50628944|FG001|Overall Study|Adverse Event|4|||
25313375|NCT00660829|50628943|FG000|Overall Study|Lack of Efficacy|2|||
25313376|NCT00660829|50628944|FG001|Overall Study|Lack of Efficacy|3|||
25313377|NCT00660829|50628943|FG000|Overall Study|Non-Compliance|0|||
25313378|NCT00660829|50628944|FG001|Overall Study|Non-Compliance|4|||
25313379|NCT00660829|50628943|FG000|Overall Study|Withdrawal by Subject|1|||
25313380|NCT00660829|50628944|FG001|Overall Study|Withdrawal by Subject|2|||
25313381|NCT00660829|50628943|FG000|Overall Study|Lost to Follow-up|3|||
25313382|NCT00660829|50628944|FG001|Overall Study|Lost to Follow-up|2|||
25313383|NCT00660829|50628943|FG000|Overall Study|Other|9|||
25313384|NCT00660829|50628944|FG001|Overall Study|Other|4|||
25313385|NCT00877383|50628952|FG000|Overall Study|Adverse Event|13|||
25313386|NCT00877383|50628953|FG001|Overall Study|Adverse Event|14|||
25313387|NCT00877383|50628952|FG000|Overall Study|Lost to Follow-up|5|||
25313388|NCT00877383|50628953|FG001|Overall Study|Lost to Follow-up|3|||
25313389|NCT00877383|50628952|FG000|Overall Study|Subject withdrew consent|3|||
25313390|NCT00877383|50628953|FG001|Overall Study|Subject withdrew consent|12|||
25313391|NCT00877383|50628952|FG000|Overall Study|Subject no longer requires study drug|2|||
25313392|NCT00877383|50628953|FG001|Overall Study|Subject no longer requires study drug|0|||
25313393|NCT00877383|50628952|FG000|Overall Study|Administrative problems|2|||
25313394|NCT00877383|50628953|FG001|Overall Study|Administrative problems|0|||
25313395|NCT00877383|50628952|FG000|Overall Study|Protocol deviation|2|||
25313396|NCT00877383|50628953|FG001|Overall Study|Protocol deviation|6|||
25313397|NCT00877383|50628952|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25313398|NCT00877383|50628953|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
25313399|NCT00877383|50628952|FG000|Overall Study|Death|1|||
25313400|NCT00877383|50628953|FG001|Overall Study|Death|2|||
25313401|NCT00993473|50628961|FG000|Overall Study|Adverse Event|0|||
25313402|NCT00993473|50628962|FG001|Overall Study|Adverse Event|2|||
25313403|NCT00993473|50628961|FG000|Overall Study|Protocol Violation|1|||
25313404|NCT00993473|50628962|FG001|Overall Study|Protocol Violation|2|||
25313405|NCT00993473|50628961|FG000|Overall Study|Lost to Follow-up|1|||
25313406|NCT00993473|50628962|FG001|Overall Study|Lost to Follow-up|0|||
25313407|NCT00993473|50628961|FG000|Overall Study|Withdrawal by Subject|1|||
25313408|NCT00993473|50628962|FG001|Overall Study|Withdrawal by Subject|5|||
25313409|NCT00993473|50628961|FG000|Overall Study|Technical problem with CGM device|0|||
25313410|NCT00993473|50628962|FG001|Overall Study|Technical problem with CGM device|1|||
25313411|NCT00993473|50628961|FG000|Overall Study|Family event|1|||
25313412|NCT00993473|50628962|FG001|Overall Study|Family event|0|||
25313413|NCT00660595|50628970|FG000|Overall Study|Lost to Follow-up|0|||
25313414|NCT00660595|50628971|FG001|Overall Study|Lost to Follow-up|1|||
25313415|NCT00660595|50628970|FG000|Overall Study|Did not consent to participate in study|12|||
25313416|NCT00660595|50628971|FG001|Overall Study|Did not consent to participate in study|8|||
25313417|NCT00660595|50628970|FG000|Overall Study|Participant left hospital|1|||
25313418|NCT00660595|50628971|FG001|Overall Study|Participant left hospital|0|||
25313419|NCT00660595|50628970|FG000|Overall Study|Non Specified reasons|5|||
25313420|NCT00660595|50628971|FG001|Overall Study|Non Specified reasons|0|||
25313421|NCT00929240|50628977|FG000|Initial Treatment Phase|Adverse Event|31|||
25313422|NCT00929240|50628978|FG001|Initial Treatment Phase|Adverse Event|0|||
25313423|NCT00929240|50628979|FG002|Initial Treatment Phase|Adverse Event|0|||
25313424|NCT00929240|50628977|FG000|Initial Treatment Phase|Disease progression|41|||
25313425|NCT00929240|50628978|FG001|Initial Treatment Phase|Disease progression|0|||
25313426|NCT00929240|50628979|FG002|Initial Treatment Phase|Disease progression|0|||
25313427|NCT00929240|50628977|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
25313428|NCT00929240|50628978|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
25313429|NCT00929240|50628979|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
25313430|NCT00929240|50628977|FG000|Initial Treatment Phase|Protocol Violation|5|||
25313431|NCT00929240|50628978|FG001|Initial Treatment Phase|Protocol Violation|0|||
25313432|NCT00929240|50628979|FG002|Initial Treatment Phase|Protocol Violation|0|||
25313433|NCT00929240|50628977|FG000|Initial Treatment Phase|Death|2|||
25313434|NCT00929240|50628978|FG001|Initial Treatment Phase|Death|0|||
25313435|NCT00929240|50628979|FG002|Initial Treatment Phase|Death|0|||
24970332|NCT04124926|50059866|FG002|Maintenance Phase|Protocol Violation|3|||
25313436|NCT00929240|50628977|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
25313437|NCT00929240|50628978|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
24970333|NCT04124926|50059867|FG003|Maintenance Phase|Protocol Violation|0|||
25169518|NCT04409262|50301552|FG000|Overall Study|Lost to Follow-up|12|||
25313438|NCT00929240|50628979|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
24970334|NCT04124926|50059868|FG004|Maintenance Phase|Protocol Violation|0|||
25313439|NCT00929240|50628977|FG000|Initial Treatment Phase|Physician Decision|4|||
25313440|NCT00929240|50628978|FG001|Initial Treatment Phase|Physician Decision|0|||
25313441|NCT00929240|50628979|FG002|Initial Treatment Phase|Physician Decision|0|||
25313442|NCT00929240|50628977|FG000|Maintenance Phase|Disease progression|0|||
25313443|NCT00929240|50628978|FG001|Maintenance Phase|Disease progression|73|||
25313444|NCT00929240|50628979|FG002|Maintenance Phase|Disease progression|60|||
25313445|NCT00929240|50628977|FG000|Maintenance Phase|Adverse Event|0|||
25313446|NCT00929240|50628978|FG001|Maintenance Phase|Adverse Event|9|||
25313447|NCT00929240|50628979|FG002|Maintenance Phase|Adverse Event|12|||
25313448|NCT00929240|50628977|FG000|Maintenance Phase|Withdrawal by Subject|0|||
25313449|NCT00929240|50628978|FG001|Maintenance Phase|Withdrawal by Subject|2|||
25313450|NCT00929240|50628979|FG002|Maintenance Phase|Withdrawal by Subject|6|||
25313451|NCT00929240|50628977|FG000|Maintenance Phase|Protocol Violation|0|||
25313452|NCT00929240|50628978|FG001|Maintenance Phase|Protocol Violation|1|||
25313453|NCT00929240|50628979|FG002|Maintenance Phase|Protocol Violation|0|||
25313454|NCT00929240|50628977|FG000|Maintenance Phase|Health authority/Study termination|0|||
25313455|NCT00929240|50628978|FG001|Maintenance Phase|Health authority/Study termination|1|||
25313456|NCT00929240|50628979|FG002|Maintenance Phase|Health authority/Study termination|2|||
25313457|NCT00929240|50628977|FG000|Maintenance Phase|Physician Decision|0|||
25313458|NCT00929240|50628978|FG001|Maintenance Phase|Physician Decision|2|||
25313459|NCT00929240|50628979|FG002|Maintenance Phase|Physician Decision|1|||
25313460|NCT00929240|50628977|FG000|Maintenance Phase|Change of treatment|0|||
25313461|NCT00929240|50628978|FG001|Maintenance Phase|Change of treatment|4|||
25313462|NCT00929240|50628979|FG002|Maintenance Phase|Change of treatment|0|||
25313463|NCT00929240|50628977|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
25313464|NCT00929240|50628978|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
25313465|NCT00929240|50628979|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
25313466|NCT00929240|50628977|FG000|Maintenance Phase|Participant not treated|0|||
25313467|NCT00929240|50628978|FG001|Maintenance Phase|Participant not treated|2|||
25313468|NCT00929240|50628979|FG002|Maintenance Phase|Participant not treated|0|||
25313469|NCT00993317|50628990|FG000|Overall Study|Adverse Event|2|||
25313470|NCT00993317|50628991|FG001|Overall Study|Adverse Event|4|||
25313471|NCT00993317|50628990|FG000|Overall Study|Lack of Efficacy|18|||
25313472|NCT00993317|50628991|FG001|Overall Study|Lack of Efficacy|18|||
25313473|NCT00993317|50628990|FG000|Overall Study|Withdrawal by Subject|0|||
25313474|NCT00993317|50628991|FG001|Overall Study|Withdrawal by Subject|2|||
25313475|NCT00993317|50628990|FG000|Overall Study|Investigator's opinion|0|||
25313476|NCT00993317|50628991|FG001|Overall Study|Investigator's opinion|1|||
25313477|NCT00993317|50628990|FG000|Overall Study|Early study termination at the site|1|||
25313478|NCT00993317|50628991|FG001|Overall Study|Early study termination at the site|0|||
25313479|NCT01030133|50628999|FG000|Overall Study|failed to experience pain at level 7/10|2|||
25313480|NCT01030133|50629000|FG001|Overall Study|failed to experience pain at level 7/10|2|||
25313481|NCT00877071|50629010|FG000|Overall Study|disease progression|2|||
25313482|NCT00987389|50629016|FG000|Overall Study|Ineligible|0|||
25313483|NCT00987389|50629017|FG001|Overall Study|Ineligible|3|||
25313484|NCT00987389|50629018|FG002|Overall Study|Ineligible|0|||
25313485|NCT00987389|50629019|FG003|Overall Study|Ineligible|0|||
25313486|NCT00987389|50629016|FG000|Overall Study|Lost to Follow-up|4|||
25313487|NCT00987389|50629017|FG001|Overall Study|Lost to Follow-up|1|||
25313488|NCT00987389|50629018|FG002|Overall Study|Lost to Follow-up|3|||
25313489|NCT00987389|50629019|FG003|Overall Study|Lost to Follow-up|1|||
25313490|NCT00987389|50629016|FG000|Overall Study|Withdrawal by Subject|4|||
25313491|NCT00987389|50629017|FG001|Overall Study|Withdrawal by Subject|3|||
25313492|NCT00987389|50629018|FG002|Overall Study|Withdrawal by Subject|2|||
25313493|NCT00987389|50629019|FG003|Overall Study|Withdrawal by Subject|1|||
25313494|NCT00987389|50629016|FG000|Overall Study|Withdrawn from Treatment|0|||
25313495|NCT00987389|50629017|FG001|Overall Study|Withdrawn from Treatment|1|||
25313496|NCT00987389|50629018|FG002|Overall Study|Withdrawn from Treatment|0|||
25313497|NCT00987389|50629019|FG003|Overall Study|Withdrawn from Treatment|0|||
25313498|NCT00987389|50629016|FG000|Overall Study|Multiple different reasons|1|||
25313499|NCT00987389|50629017|FG001|Overall Study|Multiple different reasons|0|||
25313500|NCT00987389|50629018|FG002|Overall Study|Multiple different reasons|3|||
25313501|NCT00987389|50629019|FG003|Overall Study|Multiple different reasons|1|||
25313502|NCT00929162|50629029|FG000|Overall Study|Adverse Event|8|||
25313503|NCT00929162|50629030|FG001|Overall Study|Adverse Event|5|||
25313504|NCT00929162|50629029|FG000|Overall Study|Withdrawal by Subject|3|||
25313505|NCT00929162|50629030|FG001|Overall Study|Withdrawal by Subject|1|||
25313506|NCT00929162|50629029|FG000|Overall Study|Protocol Violation|32|||
25313507|NCT00929162|50629030|FG001|Overall Study|Protocol Violation|30|||
25313508|NCT00929162|50629029|FG000|Overall Study|Other termination reason|5|||
25313509|NCT00929162|50629030|FG001|Overall Study|Other termination reason|6|||
25313510|NCT00992459|50629038|FG000|Overall Study|Withdrawal by Subject|0|||
25313511|NCT00992459|50629039|FG001|Overall Study|Withdrawal by Subject|1|||
25313512|NCT00992459|50629038|FG000|Overall Study|Adverse Event|1|||
25313513|NCT00992459|50629039|FG001|Overall Study|Adverse Event|0|||
25313514|NCT00930722|50629045|FG000|Overall Study|Lost to Follow-up|16|||
25313515|NCT00930722|50629045|FG000|Overall Study|No longer willing to participate|9|||
25313516|NCT00930722|50629045|FG000|Overall Study|Study terminated by sponsor|2|||
25313517|NCT00992225|50629049|FG000|Overall Study|Entry Criteria Not Met|8|||
25313518|NCT00992225|50629049|FG000|Overall Study|Adverse Event|2|||
25313519|NCT00659581|50629053|FG000|Overall Study|Adverse Event|1006|||
25313520|NCT00659581|50629053|FG000|Overall Study|Lack of Efficacy|1183|||
25313521|NCT00659581|50629053|FG000|Overall Study|Other|6393|||
25313522|NCT00991289|50629057|FG000|Overall Study|Adverse Event|1|||
25313523|NCT00991289|50629057|FG000|Overall Study|Physician Decision|2|||
25313524|NCT00991289|50629057|FG000|Overall Study|Withdrawal by Subject|3|||
25313525|NCT00991289|50629057|FG000|Overall Study|Lost to Follow-up|4|||
25313526|NCT00991289|50629057|FG000|Overall Study|Protocol Violation|2|||
25313527|NCT00930644|50629061|FG000|Overall Study|Withdrawal by Subject|4|||
25313528|NCT00930644|50629061|FG000|Overall Study|Physician Decision|2|||
25313529|NCT00930644|50629061|FG000|Overall Study|Death|1|||
25313530|NCT00930644|50629061|FG000|Overall Study|Adverse Event|16|||
25313531|NCT00990821|50629082|FG000|Overall Study|Withdrawal by Subject|0|||
25313532|NCT00990821|50629083|FG001|Overall Study|Withdrawal by Subject|2|||
25313533|NCT00990821|50629084|FG002|Overall Study|Withdrawal by Subject|0|||
25313534|NCT00990821|50629085|FG003|Overall Study|Withdrawal by Subject|0|||
25313535|NCT00990821|50629086|FG004|Overall Study|Withdrawal by Subject|3|||
25313536|NCT00990821|50629087|FG005|Overall Study|Withdrawal by Subject|3|||
25313537|NCT00990821|50629088|FG006|Overall Study|Withdrawal by Subject|1|||
25313538|NCT00990821|50629089|FG007|Overall Study|Withdrawal by Subject|0|||
25313539|NCT00990821|50629090|FG008|Overall Study|Withdrawal by Subject|0|||
25313540|NCT00990821|50629091|FG009|Overall Study|Withdrawal by Subject|1|||
25313541|NCT00990821|50629092|FG010|Overall Study|Withdrawal by Subject|3|||
25313542|NCT00990821|50629093|FG011|Overall Study|Withdrawal by Subject|5|||
25313543|NCT00990821|50629094|FG012|Overall Study|Withdrawal by Subject|2|||
25313544|NCT00990821|50629095|FG013|Overall Study|Withdrawal by Subject|1|||
25313545|NCT00990665|50629112|FG000|Overall Study|Unsuccessful Implant|8|||
25313546|NCT00990665|50629112|FG000|Overall Study|Death|29|||
25313547|NCT00990665|50629112|FG000|Overall Study|Heart Transplant|1|||
25313548|NCT00990665|50629112|FG000|Overall Study|Withdrawal by Subject|6|||
25313549|NCT00990665|50629112|FG000|Overall Study|Lost to Follow-up|1|||
25313550|NCT00990665|50629112|FG000|Overall Study|System Explant|3|||
25313551|NCT00658567|50629121|FG000|Overall Study|Adverse Event|5|||
25313552|NCT00658567|50629122|FG001|Overall Study|Adverse Event|2|||
25313553|NCT00658567|50629123|FG002|Overall Study|Adverse Event|3|||
25313554|NCT00658567|50629121|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
25313555|NCT00658567|50629122|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
25313556|NCT00658567|50629123|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
25313557|NCT00658567|50629121|FG000|Overall Study|Physician Decision|0|||
25313558|NCT00658567|50629122|FG001|Overall Study|Physician Decision|1|||
25313559|NCT00658567|50629123|FG002|Overall Study|Physician Decision|0|||
25313560|NCT00658567|50629121|FG000|Overall Study|At Discretion of Sponsor|1|||
25313561|NCT00658567|50629122|FG001|Overall Study|At Discretion of Sponsor|1|||
25313562|NCT00658567|50629123|FG002|Overall Study|At Discretion of Sponsor|1|||
25313563|NCT00875433|50629131|FG000|Overall Study|Progressive disease|41|||
25313564|NCT00875433|50629131|FG000|Overall Study|Other Adverse Event|14|||
25313565|NCT00875433|50629131|FG000|Overall Study|Withdrawal by Subject|2|||
25313566|NCT00875433|50629131|FG000|Overall Study|Other|3|||
25313567|NCT00985985|50629139|FG000|Overall Study|Adverse Event|4|||
25313568|NCT00985985|50629140|FG001|Overall Study|Adverse Event|2|||
25313569|NCT00985985|50629141|FG002|Overall Study|Adverse Event|2|||
25313570|NCT00985985|50629142|FG003|Overall Study|Adverse Event|2|||
25313571|NCT00985985|50629139|FG000|Overall Study|Lost to Follow-up|4|||
25313572|NCT00985985|50629140|FG001|Overall Study|Lost to Follow-up|11|||
25313573|NCT00985985|50629141|FG002|Overall Study|Lost to Follow-up|2|||
25313574|NCT00985985|50629142|FG003|Overall Study|Lost to Follow-up|3|||
25313575|NCT00985985|50629139|FG000|Overall Study|Protocol Violation|1|||
25313576|NCT00985985|50629140|FG001|Overall Study|Protocol Violation|2|||
25071510|NCT02525939|50177785|FG000|Overall Study|Withdrawal by Subject|24|||
25071511|NCT02525939|50177786|FG001|Overall Study|Withdrawal by Subject|39|||
25071512|NCT02525939|50177785|FG000|Overall Study|Death|180|||
25313577|NCT00985985|50629141|FG002|Overall Study|Protocol Violation|0|||
25313578|NCT00985985|50629142|FG003|Overall Study|Protocol Violation|1|||
25313579|NCT00985985|50629139|FG000|Overall Study|Lack of Efficacy|5|||
25313580|NCT00985985|50629140|FG001|Overall Study|Lack of Efficacy|6|||
25313581|NCT00985985|50629141|FG002|Overall Study|Lack of Efficacy|1|||
25313582|NCT00985985|50629142|FG003|Overall Study|Lack of Efficacy|3|||
25313583|NCT00985985|50629139|FG000|Overall Study|Withdrawal by Subject|4|||
25313584|NCT00985985|50629140|FG001|Overall Study|Withdrawal by Subject|2|||
25313585|NCT00985985|50629141|FG002|Overall Study|Withdrawal by Subject|2|||
25313586|NCT00985985|50629142|FG003|Overall Study|Withdrawal by Subject|2|||
25313587|NCT00985985|50629139|FG000|Overall Study|Other Reason|6|||
25313588|NCT00985985|50629140|FG001|Overall Study|Other Reason|1|||
25313589|NCT00985985|50629141|FG002|Overall Study|Other Reason|4|||
25313590|NCT00985985|50629142|FG003|Overall Study|Other Reason|2|||
25313591|NCT00923936|50629159|FG000|Overall Study|progressive disease on study|2|||
25313592|NCT00923936|50629160|FG001|Overall Study|progressive disease on study|1|||
25313593|NCT00923936|50629159|FG000|Overall Study|Adverse Event|2|||
25313594|NCT00923936|50629160|FG001|Overall Study|Adverse Event|1|||
25313595|NCT00923936|50629159|FG000|Overall Study|Lost to follow up|2|||
25313596|NCT00923936|50629160|FG001|Overall Study|Lost to follow up|0|||
25313597|NCT00923936|50629159|FG000|Overall Study|Continuing in follow up period|2|||
25313598|NCT00923936|50629160|FG001|Overall Study|Continuing in follow up period|1|||
25313599|NCT00924950|50629168|FG000|Overall Study|Lost to Follow-up|2|||
25313600|NCT00988637|50629177|FG000|Overall Study|Lost to Follow-up|2|||
25313601|NCT00988637|50629178|FG001|Overall Study|Lost to Follow-up|1|||
25313602|NCT00988637|50629177|FG000|Overall Study|Withdrawal by Subject|1|||
25313603|NCT00988637|50629178|FG001|Overall Study|Withdrawal by Subject|1|||
25313604|NCT00988637|50629177|FG000|Overall Study|non-compliance with study drug|0|||
25313605|NCT00988637|50629178|FG001|Overall Study|non-compliance with study drug|1|||
25313606|NCT00923702|50629189|FG000|Overall Study|Ongoing enrollment|0|||
25313607|NCT00923702|50629190|FG001|Overall Study|Ongoing enrollment|0|||
25313608|NCT00923702|50629191|FG002|Overall Study|Ongoing enrollment|0|||
25313609|NCT00923702|50629192|FG003|Overall Study|Ongoing enrollment|0|||
25313610|NCT00923702|50629193|FG004|Overall Study|Ongoing enrollment|354|||
25313611|NCT00923156|50629208|FG000|Overall Study|Adverse Event|0|||
25313612|NCT00923156|50629209|FG001|Overall Study|Adverse Event|2|||
25313613|NCT00923156|50629210|FG002|Overall Study|Adverse Event|1|||
25313614|NCT00923156|50629208|FG000|Overall Study|Abnormal laboratory values|0|||
25313615|NCT00923156|50629209|FG001|Overall Study|Abnormal laboratory values|0|||
25313616|NCT00923156|50629210|FG002|Overall Study|Abnormal laboratory values|1|||
25313617|NCT00923156|50629208|FG000|Overall Study|Withdrawal by Subject|0|||
25313618|NCT00923156|50629209|FG001|Overall Study|Withdrawal by Subject|1|||
25313619|NCT00923156|50629210|FG002|Overall Study|Withdrawal by Subject|0|||
25313620|NCT00923156|50629208|FG000|Overall Study|Death|0|||
25313621|NCT00923156|50629209|FG001|Overall Study|Death|1|||
25313622|NCT00923156|50629210|FG002|Overall Study|Death|0|||
25313623|NCT00923156|50629208|FG000|Overall Study|Lack of Efficacy|0|||
25313624|NCT00923156|50629209|FG001|Overall Study|Lack of Efficacy|0|||
25313625|NCT00923156|50629210|FG002|Overall Study|Lack of Efficacy|1|||
25313626|NCT00874731|50629218|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
25313627|NCT00874731|50629219|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
25313628|NCT00874731|50629220|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
25313629|NCT00874731|50629218|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
25313630|NCT00874731|50629219|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
25313631|NCT00874731|50629220|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
25313632|NCT00874731|50629218|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
25313633|NCT00874731|50629219|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
25313634|NCT00874731|50629220|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
25313635|NCT00924638|50629230|FG000|Overall Study|Death|3|||
25313636|NCT00924638|50629231|FG001|Overall Study|Death|2|||
25313637|NCT00924638|50629230|FG000|Overall Study|Lost to Follow-up|1|||
25313638|NCT00924638|50629231|FG001|Overall Study|Lost to Follow-up|1|||
25313639|NCT00924638|50629230|FG000|Overall Study|Withdrawal by Subject|5|||
25313640|NCT00924638|50629231|FG001|Overall Study|Withdrawal by Subject|7|||
24970335|NCT04124926|50059864|FG000|Maintenance Phase|Lost to Follow-up|0|||
24970336|NCT04124926|50059865|FG001|Maintenance Phase|Lost to Follow-up|0|||
25071513|NCT02525939|50177786|FG001|Overall Study|Death|179|||
25313641|NCT00924638|50629230|FG000|Overall Study|Physician Decision|3|||
25313642|NCT00924638|50629231|FG001|Overall Study|Physician Decision|3|||
25313643|NCT00874497|50629239|FG000|Overall Study|Lost to Follow-up|2|||
25313644|NCT00874497|50629240|FG001|Overall Study|Lost to Follow-up|4|||
25313645|NCT00874497|50629239|FG000|Overall Study|Adverse Event|9|||
25313646|NCT00874497|50629240|FG001|Overall Study|Adverse Event|4|||
25313647|NCT00874497|50629239|FG000|Overall Study|Sponsor Discontinued Trial|7|||
25313648|NCT00874497|50629240|FG001|Overall Study|Sponsor Discontinued Trial|3|||
25313649|NCT00874497|50629239|FG000|Overall Study|Met Withdrawal Criteria|4|||
25169519|NCT04409262|50301553|FG001|Overall Study|Lost to Follow-up|23|||
25169520|NCT04409262|50301552|FG000|Overall Study|Lack of Staff|0|||
25169521|NCT04409262|50301553|FG001|Overall Study|Lack of Staff|1|||
25169522|NCT04409262|50301552|FG000|Overall Study|Protocol Violation|3|||
25169523|NCT04409262|50301553|FG001|Overall Study|Protocol Violation|1|||
25169524|NCT04409262|50301552|FG000|Overall Study|Withdrawal by Subject|5|||
25169525|NCT04409262|50301553|FG001|Overall Study|Withdrawal by Subject|10|||
25169526|NCT04305912|50301597|FG000|First Intervention|COVID-19 Suspension|2|||
25169527|NCT04305912|50301598|FG001|First Intervention|COVID-19 Suspension|0|||
25169528|NCT04305912|50301597|FG000|First Intervention|Withdrawal by Subject|0|||
25169529|NCT04305912|50301598|FG001|First Intervention|Withdrawal by Subject|1|||
25169530|NCT04305912|50301597|FG000|Second Intervention|Adverse Event|0|||
25169531|NCT04305912|50301598|FG001|Second Intervention|Adverse Event|1|||
25169532|NCT00782184|50301827|FG000|Overall Study|Adverse Event|1|||
25169533|NCT00782184|50301828|FG001|Overall Study|Adverse Event|2|||
25169534|NCT00782184|50301827|FG000|Overall Study|Protocol Violation|0|||
25169535|NCT00782184|50301828|FG001|Overall Study|Protocol Violation|1|||
25169536|NCT00782184|50301827|FG000|Overall Study|Withdrawal by Subject|3|||
25169537|NCT00782184|50301828|FG001|Overall Study|Withdrawal by Subject|2|||
25169538|NCT02731638|50301864|FG000|Overall Study|Lost to Follow-up|6|||
25169539|NCT02731638|50301865|FG001|Overall Study|Lost to Follow-up|9|||
25169540|NCT03730662|50302312|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
25169541|NCT03730662|50302313|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
25169542|NCT03730662|50302314|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
25169543|NCT03730662|50302315|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
25169544|NCT03730662|50302312|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
25169545|NCT03730662|50302313|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
25169546|NCT03730662|50302314|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
25169547|NCT03730662|50302315|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
25169548|NCT03730662|50302312|FG000|Treatment Period (52 Weeks)|Death|6|||
25169549|NCT03730662|50302313|FG001|Treatment Period (52 Weeks)|Death|2|||
25169550|NCT03730662|50302314|FG002|Treatment Period (52 Weeks)|Death|2|||
25169551|NCT03730662|50302315|FG003|Treatment Period (52 Weeks)|Death|9|||
25169552|NCT03730662|50302312|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
25169553|NCT03730662|50302313|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
25169554|NCT03730662|50302314|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
25169555|NCT03730662|50302315|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
25169556|NCT03730662|50302312|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
25169557|NCT03730662|50302313|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
25169558|NCT03730662|50302314|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
25169559|NCT03730662|50302315|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
25169560|NCT03730662|50302312|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
25169561|NCT03730662|50302313|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
25169562|NCT03730662|50302314|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
25169563|NCT03730662|50302315|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
25169564|NCT03730662|50302312|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
25169565|NCT03730662|50302313|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
25169566|NCT03730662|50302314|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
25169567|NCT03730662|50302315|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
25169568|NCT03730662|50302312|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
25169569|NCT03730662|50302313|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
25169570|NCT03730662|50302314|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
25169571|NCT03730662|50302315|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
25169572|NCT03730662|50302312|FG000|Variable Treatment Period|Adverse Event|1|||
25169573|NCT03730662|50302313|FG001|Variable Treatment Period|Adverse Event|2|||
25169574|NCT03730662|50302314|FG002|Variable Treatment Period|Adverse Event|0|||
25169575|NCT03730662|50302315|FG003|Variable Treatment Period|Adverse Event|7|||
25169576|NCT03730662|50302312|FG000|Variable Treatment Period|Death|9|||
25169577|NCT03730662|50302313|FG001|Variable Treatment Period|Death|0|||
25169578|NCT03730662|50302314|FG002|Variable Treatment Period|Death|6|||
25313650|NCT00874497|50629240|FG001|Overall Study|Met Withdrawal Criteria|2|||
25313651|NCT00874497|50629239|FG000|Overall Study|Physician Decision|1|||
25313652|NCT00874497|50629240|FG001|Overall Study|Physician Decision|1|||
25313653|NCT00874497|50629239|FG000|Overall Study|Withdrawal by Subject|5|||
25313654|NCT00874497|50629240|FG001|Overall Study|Withdrawal by Subject|4|||
25313655|NCT00924560|50629249|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
25313656|NCT00924560|50629250|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
25313657|NCT00924560|50629251|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
25313658|NCT00924560|50629249|FG000|Overall Study|Non Compliance with the Protocol|20|||
25313659|NCT00924560|50629250|FG001|Overall Study|Non Compliance with the Protocol|15|||
25313660|NCT00924560|50629251|FG002|Overall Study|Non Compliance with the Protocol|4|||
25313661|NCT00924560|50629249|FG000|Overall Study|Physician Decision|2|||
25313662|NCT00924560|50629250|FG001|Overall Study|Physician Decision|3|||
25313663|NCT00924560|50629251|FG002|Overall Study|Physician Decision|4|||
25313664|NCT00924560|50629249|FG000|Overall Study|Withdrawal by Subject|50|||
25313665|NCT00924560|50629250|FG001|Overall Study|Withdrawal by Subject|44|||
25313666|NCT00924560|50629251|FG002|Overall Study|Withdrawal by Subject|18|||
25313667|NCT00924560|50629249|FG000|Overall Study|Adverse Event|39|||
25313668|NCT00924560|50629250|FG001|Overall Study|Adverse Event|33|||
25313669|NCT00924560|50629251|FG002|Overall Study|Adverse Event|0|||
25313670|NCT00924560|50629249|FG000|Overall Study|Pregnancy|5|||
25313671|NCT00924560|50629250|FG001|Overall Study|Pregnancy|7|||
25313672|NCT00924560|50629251|FG002|Overall Study|Pregnancy|1|||
25313673|NCT00924560|50629249|FG000|Overall Study|Lost to Follow-up|78|||
25313674|NCT00924560|50629250|FG001|Overall Study|Lost to Follow-up|94|||
25313675|NCT00924560|50629251|FG002|Overall Study|Lost to Follow-up|45|||
25313676|NCT00924560|50629249|FG000|Overall Study|Miscellaneous Reasons|13|||
25313677|NCT00924560|50629250|FG001|Overall Study|Miscellaneous Reasons|10|||
25313678|NCT00924560|50629251|FG002|Overall Study|Miscellaneous Reasons|10|||
25313679|NCT00923078|50629264|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
25313680|NCT00923078|50629265|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
25313681|NCT00923078|50629266|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
25313682|NCT00923078|50629264|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
25313683|NCT00923078|50629265|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
25313684|NCT00923078|50629266|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
25313685|NCT00978731|50629277|FG000|Overall Study|Death|4|||
25313686|NCT00978731|50629278|FG001|Overall Study|Death|1|||
25313687|NCT00978731|50629279|FG002|Overall Study|Death|1|||
25313688|NCT00978731|50629280|FG003|Overall Study|Death|0|||
25313689|NCT00978731|50629277|FG000|Overall Study|Lost to Follow-up|0|||
25313690|NCT00978731|50629278|FG001|Overall Study|Lost to Follow-up|0|||
25313691|NCT00978731|50629279|FG002|Overall Study|Lost to Follow-up|0|||
25313692|NCT00978731|50629280|FG003|Overall Study|Lost to Follow-up|1|||
25313693|NCT00978731|50629277|FG000|Overall Study|Adverse Event|5|||
25313694|NCT00978731|50629278|FG001|Overall Study|Adverse Event|2|||
25313695|NCT00978731|50629279|FG002|Overall Study|Adverse Event|0|||
25313696|NCT00978731|50629280|FG003|Overall Study|Adverse Event|0|||
25313697|NCT00978731|50629277|FG000|Overall Study|Participant's request|1|||
25313698|NCT00978731|50629278|FG001|Overall Study|Participant's request|0|||
25313699|NCT00978731|50629279|FG002|Overall Study|Participant's request|0|||
25313700|NCT00978731|50629280|FG003|Overall Study|Participant's request|0|||
25313701|NCT00978731|50629277|FG000|Overall Study|Administrative reason|3|||
25313702|NCT00978731|50629278|FG001|Overall Study|Administrative reason|3|||
25313703|NCT00978731|50629279|FG002|Overall Study|Administrative reason|1|||
25313704|NCT00978731|50629280|FG003|Overall Study|Administrative reason|0|||
25313705|NCT00978731|50629277|FG000|Overall Study|Deterioration without progression|0|||
25313706|NCT00978731|50629278|FG001|Overall Study|Deterioration without progression|1|||
25313707|NCT00978731|50629279|FG002|Overall Study|Deterioration without progression|0|||
25313708|NCT00978731|50629280|FG003|Overall Study|Deterioration without progression|0|||
25313709|NCT00978731|50629277|FG000|Overall Study|Disease progression/relapse|5|||
25313710|NCT00978731|50629278|FG001|Overall Study|Disease progression/relapse|4|||
25313711|NCT00978731|50629279|FG002|Overall Study|Disease progression/relapse|2|||
25313712|NCT00978731|50629280|FG003|Overall Study|Disease progression/relapse|2|||
25313713|NCT00978731|50629277|FG000|Overall Study|Study closure|3|||
25313714|NCT00978731|50629278|FG001|Overall Study|Study closure|4|||
25313715|NCT00978731|50629279|FG002|Overall Study|Study closure|1|||
25313716|NCT00978731|50629280|FG003|Overall Study|Study closure|1|||
25313717|NCT00978731|50629277|FG000|Overall Study|No response|1|||
25313718|NCT00978731|50629278|FG001|Overall Study|No response|0|||
25169579|NCT03730662|50302315|FG003|Variable Treatment Period|Death|26|||
25313719|NCT00978731|50629279|FG002|Overall Study|No response|0|||
25313720|NCT00978731|50629280|FG003|Overall Study|No response|0|||
25313721|NCT05056870|50629294|FG000|Period 1|Site COVID-19 Related|3|||
25313722|NCT05056870|50629295|FG001|Period 1|Site COVID-19 Related|3|||
25313723|NCT05056870|50629294|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
25313724|NCT05056870|50629295|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
25313725|NCT05056870|50629294|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
25313726|NCT05056870|50629295|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
25313727|NCT05056870|50629294|FG000|Period 2|COVID-19 Related|1|||
25313728|NCT05056870|50629295|FG001|Period 2|COVID-19 Related|0|||
25313729|NCT05056870|50629294|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
25313730|NCT05056870|50629295|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
25313731|NCT04488822|50629319|FG000|Overall Study|Adverse Event|8|||
25313732|NCT04488822|50629319|FG000|Overall Study|Withdrawal by Subject|1|||
25313733|NCT04396626|50629332|FG000|Overall Study|Premature termination of study|975|||
25313734|NCT04242186|50629336|FG000|Overall Study|Death|5|||
25313735|NCT03934216|50629343|FG000|Randomization|Randomized in Error|1|||
25313736|NCT03934216|50629344|FG001|Randomization|Randomized in Error|1|||
25313737|NCT03934216|50629343|FG000|Treatment Period|Adverse Event|10|||
25313738|NCT03934216|50629344|FG001|Treatment Period|Adverse Event|3|||
25313739|NCT03934216|50629343|FG000|Treatment Period|Withdrawal by Participant|6|||
25313740|NCT03934216|50629344|FG001|Treatment Period|Withdrawal by Participant|2|||
25313741|NCT03934216|50629343|FG000|Treatment Period|Other Reasons|2|||
25313742|NCT03934216|50629344|FG001|Treatment Period|Other Reasons|2|||
25313743|NCT03183128|50629390|FG000|Overall Study|Adverse Event|1|||
25313744|NCT03183128|50629391|FG001|Overall Study|Adverse Event|2|||
25313745|NCT03183128|50629390|FG000|Overall Study|Withdrawal by Subject|1|||
25313746|NCT03183128|50629391|FG001|Overall Study|Withdrawal by Subject|8|||
25313747|NCT03183128|50629390|FG000|Overall Study|Protocol Violation|2|||
25313748|NCT03183128|50629391|FG001|Overall Study|Protocol Violation|0|||
25313749|NCT03183128|50629390|FG000|Overall Study|Lack of Efficacy|4|||
25313750|NCT03183128|50629391|FG001|Overall Study|Lack of Efficacy|27|||
25313751|NCT03183128|50629390|FG000|Overall Study|Lost to Follow-up|1|||
25313752|NCT03183128|50629391|FG001|Overall Study|Lost to Follow-up|0|||
25313753|NCT03183128|50629390|FG000|Overall Study|Death|2|||
25313754|NCT03183128|50629391|FG001|Overall Study|Death|0|||
25313755|NCT03183128|50629390|FG000|Overall Study|Physician Decision|1|||
25313756|NCT03183128|50629391|FG001|Overall Study|Physician Decision|0|||
25313757|NCT02308488|50629433|FG000|Overall Study|Withdrawal by Subject|2|||
25313758|NCT02159950|50629439|FG000|Overall Study|Adverse Event|0|||
24970337|NCT04124926|50059866|FG002|Maintenance Phase|Lost to Follow-up|7|||
25313759|NCT02159950|50629440|FG001|Overall Study|Adverse Event|1|||
25313760|NCT02159950|50629439|FG000|Overall Study|Progression|0|||
25313761|NCT02159950|50629440|FG001|Overall Study|Progression|1|||
25313762|NCT02152137|50629446|FG000|Overall Study|Withdrawal by Subject|1|||
25313763|NCT02152137|50629446|FG000|Overall Study|Originally assigned to Arm B|3|||
25313764|NCT02007512|50629454|FG000|Double Blind Treatment Period|Adverse Event|4|||
25313765|NCT02007512|50629455|FG001|Double Blind Treatment Period|Adverse Event|2|||
25313766|NCT02007512|50629456|FG002|Double Blind Treatment Period|Adverse Event|6|||
25313767|NCT02007512|50629457|FG003|Double Blind Treatment Period|Adverse Event|2|||
25313768|NCT02007512|50629454|FG000|Double Blind Treatment Period|Death|1|||
25313769|NCT02007512|50629455|FG001|Double Blind Treatment Period|Death|0|||
25313770|NCT02007512|50629456|FG002|Double Blind Treatment Period|Death|0|||
25313771|NCT02007512|50629457|FG003|Double Blind Treatment Period|Death|0|||
25313772|NCT02007512|50629454|FG000|Double Blind Treatment Period|Disease progression|44|||
25313773|NCT02007512|50629455|FG001|Double Blind Treatment Period|Disease progression|49|||
25313774|NCT02007512|50629456|FG002|Double Blind Treatment Period|Disease progression|45|||
25313775|NCT02007512|50629457|FG003|Double Blind Treatment Period|Disease progression|51|||
25313776|NCT02007512|50629454|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
25313777|NCT02007512|50629455|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
25313778|NCT02007512|50629456|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
25313779|NCT02007512|50629457|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
25313780|NCT02007512|50629454|FG000|Double Blind Treatment Period|Protocol Violation|0|||
25313781|NCT02007512|50629455|FG001|Double Blind Treatment Period|Protocol Violation|0|||
25313782|NCT02007512|50629456|FG002|Double Blind Treatment Period|Protocol Violation|0|||
25313783|NCT02007512|50629457|FG003|Double Blind Treatment Period|Protocol Violation|1|||
25313784|NCT02007512|50629454|FG000|Double Blind Treatment Period|Other|0|||
25313785|NCT02007512|50629455|FG001|Double Blind Treatment Period|Other|0|||
25313786|NCT02007512|50629456|FG002|Double Blind Treatment Period|Other|1|||
25313787|NCT02007512|50629457|FG003|Double Blind Treatment Period|Other|2|||
25313788|NCT02007512|50629454|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
25313789|NCT02007512|50629455|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
25313790|NCT02007512|50629456|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
25313791|NCT02007512|50629457|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
25313792|NCT02007512|50629454|FG000|Open Label Treatment Period|Adverse Event|0|||
25313793|NCT02007512|50629455|FG001|Open Label Treatment Period|Adverse Event|1|||
25313794|NCT02007512|50629456|FG002|Open Label Treatment Period|Adverse Event|0|||
25313795|NCT02007512|50629457|FG003|Open Label Treatment Period|Adverse Event|0|||
25313796|NCT02007512|50629454|FG000|Open Label Treatment Period|Other|0|||
25313797|NCT02007512|50629455|FG001|Open Label Treatment Period|Other|0|||
25313798|NCT02007512|50629456|FG002|Open Label Treatment Period|Other|0|||
25313799|NCT02007512|50629457|FG003|Open Label Treatment Period|Other|1|||
25313800|NCT02007512|50629454|FG000|Open Label Treatment Period|Disease progression|0|||
25313801|NCT02007512|50629455|FG001|Open Label Treatment Period|Disease progression|17|||
25313802|NCT02007512|50629456|FG002|Open Label Treatment Period|Disease progression|0|||
25313803|NCT02007512|50629457|FG003|Open Label Treatment Period|Disease progression|11|||
25313804|NCT02007512|50629454|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
25313805|NCT02007512|50629455|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
25313806|NCT02007512|50629456|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
25313807|NCT02007512|50629457|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
25313808|NCT01984346|50629472|FG000|Overall Study|Physician Decision|4|||
25313809|NCT01984346|50629473|FG001|Overall Study|Physician Decision|2|||
25313810|NCT01984346|50629472|FG000|Overall Study|Withdrawal by Subject|2|||
25313811|NCT01984346|50629473|FG001|Overall Study|Withdrawal by Subject|2|||
25313812|NCT01984346|50629472|FG000|Overall Study|Enrollment Closed|8|||
25313813|NCT01984346|50629473|FG001|Overall Study|Enrollment Closed|1|||
25313814|NCT01984346|50629472|FG000|Overall Study|Insurance Coverage|1|||
25313815|NCT01984346|50629473|FG001|Overall Study|Insurance Coverage|0|||
25313816|NCT01984346|50629472|FG000|Overall Study|Intra-operative Exclusion|2|||
25313817|NCT01984346|50629473|FG001|Overall Study|Intra-operative Exclusion|0|||
25313818|NCT01942135|50629481|FG000|Overall Study|Adverse Event|9|||
25313819|NCT01942135|50629482|FG001|Overall Study|Adverse Event|3|||
25313820|NCT01942135|50629481|FG000|Overall Study|Global deterioration of health status|8|||
25313821|NCT01942135|50629482|FG001|Overall Study|Global deterioration of health status|3|||
25313822|NCT01942135|50629481|FG000|Overall Study|Randomized Not Treated|2|||
25313823|NCT01942135|50629482|FG001|Overall Study|Randomized Not Treated|2|||
25313824|NCT01942135|50629481|FG000|Overall Study|Death|0|||
25313825|NCT01942135|50629482|FG001|Overall Study|Death|1|||
25313826|NCT01942135|50629481|FG000|Overall Study|ObjectiveProgression+Progressive Disease|85|||
25071514|NCT02697591|50177823|FG000|Overall Study|Lost to Follow-up|0|||
25071515|NCT02697591|50177824|FG001|Overall Study|Lost to Follow-up|0|||
25071516|NCT02697591|50177825|FG002|Overall Study|Lost to Follow-up|0|||
25071517|NCT02697591|50177826|FG003|Overall Study|Lost to Follow-up|0|||
25071518|NCT02697591|50177827|FG004|Overall Study|Lost to Follow-up|0|||
25071519|NCT02697591|50177828|FG005|Overall Study|Lost to Follow-up|1|||
25071520|NCT02697591|50177829|FG006|Overall Study|Lost to Follow-up|1|||
25313827|NCT01942135|50629482|FG001|Overall Study|ObjectiveProgression+Progressive Disease|87|||
25313828|NCT01942135|50629481|FG000|Overall Study|Participant Refused toContinue Treatment|1|||
25313829|NCT01942135|50629482|FG001|Overall Study|Participant Refused toContinue Treatment|1|||
25313830|NCT01942135|50629481|FG000|Overall Study|Withdrawal by Subject|4|||
25313831|NCT01942135|50629482|FG001|Overall Study|Withdrawal by Subject|2|||
25313832|NCT01942135|50629481|FG000|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238|||
25313833|NCT01942135|50629482|FG001|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75|||
25313834|NCT01889238|50629488|FG000|Overall Study|Treatment ongoing|9|||
25071521|NCT02697591|50177830|FG007|Overall Study|Lost to Follow-up|0|||
25313835|NCT01696968|50629511|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
25313836|NCT01696968|50629512|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
25313837|NCT01696968|50629511|FG000|Overall Study|Died Before Randomization|3|||
25313838|NCT01696968|50629512|FG001|Overall Study|Died Before Randomization|8|||
25313839|NCT01696968|50629511|FG000|Overall Study|Died Before ASU (Control)|278|||
25313840|NCT01696968|50629512|FG001|Overall Study|Died Before ASU (Control)|0|||
25313841|NCT01696968|50629511|FG000|Overall Study|Refused ASU (Control)|920|||
25313842|NCT01696968|50629512|FG001|Overall Study|Refused ASU (Control)|0|||
25313843|NCT01696968|50629511|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
25313844|NCT01696968|50629512|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
25313845|NCT00539591|50629527|FG000|Overall Study|Toxicity|3|||
25313846|NCT00539591|50629528|FG001|Overall Study|Toxicity|0|||
25313847|NCT00539591|50629529|FG002|Overall Study|Toxicity|0|||
25313848|NCT00539591|50629527|FG000|Overall Study|Disease progression|2|||
25313849|NCT00539591|50629528|FG001|Overall Study|Disease progression|2|||
25313850|NCT00539591|50629529|FG002|Overall Study|Disease progression|3|||
25313851|NCT00978341|50629565|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
25313852|NCT00978341|50629566|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
25313853|NCT00978029|50629576|FG000|Overall Study|Adverse Event|1|||
25313854|NCT00978029|50629577|FG001|Overall Study|Adverse Event|2|||
25313855|NCT00978029|50629578|FG002|Overall Study|Adverse Event|5|||
25313856|NCT00978029|50629576|FG000|Overall Study|Withdrawal by Subject|0|||
25313857|NCT00978029|50629577|FG001|Overall Study|Withdrawal by Subject|0|||
25313858|NCT00978029|50629578|FG002|Overall Study|Withdrawal by Subject|1|||
25313859|NCT00978029|50629576|FG000|Overall Study|Protocol Violation|0|||
25313860|NCT00978029|50629577|FG001|Overall Study|Protocol Violation|1|||
25313861|NCT00978029|50629578|FG002|Overall Study|Protocol Violation|0|||
25313862|NCT00871377|50629586|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
25313863|NCT00871377|50629587|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
25313864|NCT00871377|50629588|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
25313865|NCT00871377|50629589|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
25313866|NCT00871377|50629590|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
25313867|NCT00871377|50629591|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
25313868|NCT00871377|50629586|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
25313869|NCT00871377|50629587|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
25313870|NCT00871377|50629588|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
25313871|NCT00871377|50629589|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
25313872|NCT00871377|50629590|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
25313873|NCT00871377|50629591|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
25313874|NCT00871377|50629586|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
25313875|NCT00871377|50629587|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
25313876|NCT00871377|50629588|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
25313877|NCT00871377|50629589|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
25313878|NCT00871377|50629590|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
25313879|NCT00871377|50629591|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
25313880|NCT00871377|50629586|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
25313881|NCT00871377|50629587|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
25313882|NCT00871377|50629588|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
25313883|NCT00871377|50629589|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
25071522|NCT02697591|50177831|FG008|Overall Study|Lost to Follow-up|0|||
25313884|NCT00871377|50629590|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
25313885|NCT00871377|50629591|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
25313886|NCT00871377|50629586|FG000|Third Intervention (10 Weeks)|Death|0|||
25313887|NCT00871377|50629587|FG001|Third Intervention (10 Weeks)|Death|0|||
25313888|NCT00871377|50629588|FG002|Third Intervention (10 Weeks)|Death|0|||
25313889|NCT00871377|50629589|FG003|Third Intervention (10 Weeks)|Death|1|||
25313890|NCT00871377|50629590|FG004|Third Intervention (10 Weeks)|Death|0|||
25313891|NCT00871377|50629591|FG005|Third Intervention (10 Weeks)|Death|0|||
25313892|NCT00977561|50629601|FG000|Overall Study|Death|3|||
25313893|NCT00977561|50629602|FG001|Overall Study|Death|2|||
25313894|NCT00977561|50629601|FG000|Overall Study|Study terminated|0|||
25313895|NCT00977561|50629602|FG001|Overall Study|Study terminated|2|||
25071523|NCT02697591|50177832|FG009|Overall Study|Lost to Follow-up|1|||
25313896|NCT00977561|50629601|FG000|Overall Study|Other|2|||
25313897|NCT00977561|50629602|FG001|Overall Study|Other|0|||
25313898|NCT00594165|50629610|FG000|Overall Study|Major protocol violation|1|||
25313899|NCT00594165|50629610|FG000|Overall Study|Lack of Efficacy|12|||
25313900|NCT00594165|50629610|FG000|Overall Study|Adverse Event|52|||
25313901|NCT00594165|50629610|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
25313902|NCT00594165|50629610|FG000|Overall Study|Subject withdrew consent|27|||
25313903|NCT00594165|50629610|FG000|Overall Study|Study ended per sponsor|102|||
25313904|NCT00594165|50629610|FG000|Overall Study|Lost to Follow-up|4|||
25313905|NCT00594165|50629610|FG000|Overall Study|Other: PI discretion|5|||
25313906|NCT00594165|50629610|FG000|Overall Study|Other: Subject moving|3|||
25313907|NCT00594165|50629610|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
24970338|NCT04124926|50059867|FG003|Maintenance Phase|Lost to Follow-up|8|||
24970339|NCT04124926|50059868|FG004|Maintenance Phase|Lost to Follow-up|9|||
24970340|NCT04124926|50059864|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
24970341|NCT04124926|50059865|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
24970342|NCT04124926|50059866|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
24970343|NCT04124926|50059867|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
24970344|NCT04124926|50059868|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
24970345|NCT04124926|50059864|FG000|Maintenance Phase|Pregnancy|0|||
24970346|NCT04124926|50059865|FG001|Maintenance Phase|Pregnancy|0|||
24970347|NCT04124926|50059866|FG002|Maintenance Phase|Pregnancy|0|||
24970348|NCT04124926|50059867|FG003|Maintenance Phase|Pregnancy|1|||
24970349|NCT04124926|50059868|FG004|Maintenance Phase|Pregnancy|0|||
24970350|NCT04124926|50059864|FG000|Maintenance Phase|Lack of Efficacy|0|||
24970351|NCT04124926|50059865|FG001|Maintenance Phase|Lack of Efficacy|0|||
24970352|NCT04124926|50059866|FG002|Maintenance Phase|Lack of Efficacy|0|||
24970353|NCT04124926|50059867|FG003|Maintenance Phase|Lack of Efficacy|0|||
24970354|NCT04124926|50059868|FG004|Maintenance Phase|Lack of Efficacy|1|||
24970355|NCT04124926|50059864|FG000|Maintenance Phase|Withdrawal of Consent|0|||
24970356|NCT04124926|50059865|FG001|Maintenance Phase|Withdrawal of Consent|0|||
24970357|NCT04124926|50059866|FG002|Maintenance Phase|Withdrawal of Consent|5|||
24970358|NCT04124926|50059867|FG003|Maintenance Phase|Withdrawal of Consent|5|||
24970359|NCT04124926|50059868|FG004|Maintenance Phase|Withdrawal of Consent|5|||
24970360|NCT04124926|50059864|FG000|Maintenance Phase|Miscellaneous|0|||
24970361|NCT04124926|50059865|FG001|Maintenance Phase|Miscellaneous|0|||
24970362|NCT04124926|50059866|FG002|Maintenance Phase|Miscellaneous|1|||
24970363|NCT04124926|50059867|FG003|Maintenance Phase|Miscellaneous|2|||
24970364|NCT04124926|50059868|FG004|Maintenance Phase|Miscellaneous|4|||
24970365|NCT04124926|50059864|FG000|Maintenance Phase|Randomized but not Treated|0|||
24970366|NCT04124926|50059865|FG001|Maintenance Phase|Randomized but not Treated|0|||
25071524|NCT02697591|50177823|FG000|Overall Study|Withdrawal by Subject|1|||
25071525|NCT02697591|50177824|FG001|Overall Study|Withdrawal by Subject|1|||
25313908|NCT00594165|50629610|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
25313909|NCT00594165|50629610|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
24970367|NCT04124926|50059866|FG002|Maintenance Phase|Randomized but not Treated|2|||
24970368|NCT04124926|50059867|FG003|Maintenance Phase|Randomized but not Treated|2|||
25313910|NCT00594165|50629610|FG000|Overall Study|Other: Site terminated participation|2|||
25313911|NCT00975923|50629616|FG000|Overall Study|Withdrawal by Subject|0|||
25313912|NCT00975923|50629617|FG001|Overall Study|Withdrawal by Subject|1|||
25313913|NCT00928070|50629626|FG000|Overall Study|Lost to Follow-up|1|||
25313914|NCT00928070|50629627|FG001|Overall Study|Lost to Follow-up|2|||
25313915|NCT00928070|50629626|FG000|Overall Study|Withdrawal by Subject|10|||
25313916|NCT00928070|50629627|FG001|Overall Study|Withdrawal by Subject|3|||
25313917|NCT00928070|50629626|FG000|Overall Study|Adverse Event|14|||
25313918|NCT00928070|50629627|FG001|Overall Study|Adverse Event|26|||
25313919|NCT00928070|50629626|FG000|Overall Study|Lack of Efficacy|9|||
25313920|NCT00928070|50629627|FG001|Overall Study|Lack of Efficacy|5|||
25313921|NCT00928070|50629626|FG000|Overall Study|Did not meet entrance criteria|16|||
25313922|NCT00928070|50629627|FG001|Overall Study|Did not meet entrance criteria|9|||
25313923|NCT00928070|50629626|FG000|Overall Study|Protocol Violation|6|||
25313924|NCT00928070|50629627|FG001|Overall Study|Protocol Violation|5|||
25313925|NCT00928070|50629626|FG000|Overall Study|Randomized but not treated|2|||
25313926|NCT00928070|50629627|FG001|Overall Study|Randomized but not treated|2|||
25313927|NCT00928070|50629626|FG000|Overall Study|Other|5|||
25313928|NCT00928070|50629627|FG001|Overall Study|Other|5|||
25313929|NCT00924404|50629635|FG000|Overall Study|Lost to Follow-up|6|||
25313930|NCT00924404|50629636|FG001|Overall Study|Lost to Follow-up|4|||
25313931|NCT00976937|50629644|FG000|Overall Study|Adverse Event|4|||
25313932|NCT00976937|50629645|FG001|Overall Study|Adverse Event|5|||
25313933|NCT00976937|50629644|FG000|Overall Study|Lost to Follow-up|2|||
25313934|NCT00976937|50629645|FG001|Overall Study|Lost to Follow-up|1|||
25313935|NCT00976937|50629644|FG000|Overall Study|Withdrawal by Subject|5|||
25313936|NCT00976937|50629645|FG001|Overall Study|Withdrawal by Subject|3|||
25313937|NCT00976937|50629644|FG000|Overall Study|Poor compliance to protocol|3|||
25313938|NCT00976937|50629645|FG001|Overall Study|Poor compliance to protocol|0|||
25313939|NCT00976937|50629644|FG000|Overall Study|Personal and Familial Reason|2|||
25313940|NCT00976937|50629645|FG001|Overall Study|Personal and Familial Reason|2|||
25313941|NCT00976703|50629653|FG000|Overall Study|Physician Decision|1|||
25313942|NCT00976703|50629654|FG001|Overall Study|Physician Decision|1|||
25313943|NCT00976703|50629653|FG000|Overall Study|ineligible for study|2|||
25313944|NCT00976703|50629654|FG001|Overall Study|ineligible for study|2|||
25313945|NCT00975689|50629662|FG000|Overall Study|Adverse Event|0|||
25313946|NCT00975689|50629663|FG001|Overall Study|Adverse Event|3|||
25313947|NCT00975689|50629662|FG000|Overall Study|Withdrawal by Subject|1|||
25313948|NCT00975689|50629663|FG001|Overall Study|Withdrawal by Subject|0|||
25313949|NCT00975689|50629662|FG000|Overall Study|Physician Decision|1|||
25313950|NCT00975689|50629663|FG001|Overall Study|Physician Decision|0|||
25313951|NCT00922766|50629669|FG000|Overall Study|Death|3|||
25313952|NCT00922766|50629669|FG000|Overall Study|Withdrawal by Subject|2|||
25313953|NCT00922766|50629669|FG000|Overall Study|Other|1|||
25313954|NCT00922766|50629669|FG000|Overall Study|Adverse Event|1|||
25313955|NCT00917852|50629673|FG000|Overall Study|Death|6|||
25313956|NCT00976391|50629680|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
25313957|NCT00976391|50629681|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
25313958|NCT00976391|50629680|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
25313959|NCT00976391|50629681|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
25313960|NCT00976391|50629680|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
25313961|NCT00976391|50629681|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
25313962|NCT00976391|50629680|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
25313963|NCT00976391|50629681|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
25313964|NCT00976391|50629680|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
25313965|NCT00976391|50629681|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
25313966|NCT00976391|50629680|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
25313967|NCT00976391|50629681|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
25313968|NCT00976391|50629680|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
25313969|NCT00976391|50629681|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
25313970|NCT00976391|50629680|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
25313971|NCT00976391|50629681|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
25313972|NCT00976391|50629680|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
25313973|NCT00976391|50629681|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
25313974|NCT00976391|50629680|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
25313975|NCT00976391|50629681|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
25313976|NCT00976391|50629680|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
25313977|NCT00976391|50629681|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
25313978|NCT00976391|50629680|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
25313979|NCT00976391|50629681|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
25313980|NCT00976391|50629680|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
25313981|NCT00976391|50629681|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
25313982|NCT00976391|50629680|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
25313983|NCT00976391|50629681|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
25313984|NCT00917462|50629687|FG000|Overall Study|Clinical Deterioration|1|||
25313985|NCT00979901|50629695|FG000|Overall Study|Adverse Event|1|||
25313986|NCT00979901|50629696|FG001|Overall Study|Adverse Event|3|||
25313987|NCT00979901|50629697|FG002|Overall Study|Adverse Event|9|||
25313988|NCT00979901|50629698|FG003|Overall Study|Adverse Event|2|||
25313989|NCT00979901|50629695|FG000|Overall Study|Lack of Efficacy|8|||
25313990|NCT00979901|50629696|FG001|Overall Study|Lack of Efficacy|4|||
25313991|NCT00979901|50629697|FG002|Overall Study|Lack of Efficacy|9|||
25313992|NCT00979901|50629698|FG003|Overall Study|Lack of Efficacy|0|||
25313993|NCT00979901|50629695|FG000|Overall Study|Lost to Follow-up|1|||
25313994|NCT00979901|50629696|FG001|Overall Study|Lost to Follow-up|1|||
25313995|NCT00979901|50629697|FG002|Overall Study|Lost to Follow-up|2|||
25313996|NCT00979901|50629698|FG003|Overall Study|Lost to Follow-up|0|||
25313997|NCT00979901|50629695|FG000|Overall Study|Protocol Violation|2|||
25313998|NCT00979901|50629696|FG001|Overall Study|Protocol Violation|2|||
25313999|NCT00979901|50629697|FG002|Overall Study|Protocol Violation|7|||
25314000|NCT00979901|50629698|FG003|Overall Study|Protocol Violation|1|||
25314001|NCT00979901|50629695|FG000|Overall Study|Withdrawal by Subject|2|||
25314002|NCT00979901|50629696|FG001|Overall Study|Withdrawal by Subject|1|||
25314003|NCT00979901|50629697|FG002|Overall Study|Withdrawal by Subject|1|||
25314004|NCT00979901|50629698|FG003|Overall Study|Withdrawal by Subject|1|||
25314005|NCT00979901|50629695|FG000|Overall Study|Noncompliance|1|||
25314006|NCT00979901|50629696|FG001|Overall Study|Noncompliance|0|||
25314007|NCT00979901|50629697|FG002|Overall Study|Noncompliance|0|||
25314008|NCT00979901|50629698|FG003|Overall Study|Noncompliance|0|||
25314009|NCT00979901|50629695|FG000|Overall Study|out-of-state|1|||
25314010|NCT00979901|50629696|FG001|Overall Study|out-of-state|0|||
25314011|NCT00979901|50629697|FG002|Overall Study|out-of-state|0|||
25314012|NCT00979901|50629698|FG003|Overall Study|out-of-state|0|||
25314013|NCT00979901|50629695|FG000|Overall Study|vacation|1|||
25314014|NCT00979901|50629696|FG001|Overall Study|vacation|0|||
25314015|NCT00979901|50629697|FG002|Overall Study|vacation|0|||
25314016|NCT00979901|50629698|FG003|Overall Study|vacation|0|||
25314017|NCT00979901|50629695|FG000|Overall Study|elevated lab values pre-randomization|1|||
25314018|NCT00979901|50629696|FG001|Overall Study|elevated lab values pre-randomization|0|||
25314019|NCT00979901|50629697|FG002|Overall Study|elevated lab values pre-randomization|0|||
25314020|NCT00979901|50629698|FG003|Overall Study|elevated lab values pre-randomization|0|||
25314021|NCT00979901|50629695|FG000|Overall Study|Discontinued in Error|0|||
25314022|NCT00979901|50629696|FG001|Overall Study|Discontinued in Error|1|||
25314023|NCT00979901|50629697|FG002|Overall Study|Discontinued in Error|0|||
25314024|NCT00979901|50629698|FG003|Overall Study|Discontinued in Error|0|||
25314025|NCT00979901|50629695|FG000|Overall Study|Left Country|0|||
25314026|NCT00979901|50629696|FG001|Overall Study|Left Country|0|||
25314027|NCT00979901|50629697|FG002|Overall Study|Left Country|1|||
25314028|NCT00979901|50629698|FG003|Overall Study|Left Country|0|||
25314029|NCT00979901|50629695|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
25314030|NCT00979901|50629696|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
25314031|NCT00979901|50629697|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
25314032|NCT00979901|50629698|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
25314033|NCT00975611|50629707|FG000|Overall Study|Screen Fail|16|||
25314034|NCT00975611|50629707|FG000|Overall Study|Physician Decision|1|||
25314035|NCT00970307|50629714|FG000|Overall Study|Serious Adverse Event|1|||
25314036|NCT00970307|50629715|FG001|Overall Study|Serious Adverse Event|0|||
25314037|NCT00970307|50629716|FG002|Overall Study|Serious Adverse Event|0|||
25314038|NCT00970307|50629714|FG000|Overall Study|Withdrawal by Subject|2|||
25314039|NCT00970307|50629715|FG001|Overall Study|Withdrawal by Subject|3|||
25314040|NCT00970307|50629716|FG002|Overall Study|Withdrawal by Subject|2|||
25314041|NCT00917384|50629726|FG000|Overall Study|Lost to Follow-up|4|||
25314042|NCT00917384|50629727|FG001|Overall Study|Lost to Follow-up|2|||
25314043|NCT00917384|50629726|FG000|Overall Study|Withdrawal by Subject|10|||
25314044|NCT00917384|50629727|FG001|Overall Study|Withdrawal by Subject|2|||
25314045|NCT00864513|50629733|FG000|Overall Study|Withdrawal by Subject|3|||
25314046|NCT00917150|50629741|FG000|Overall Study|Adverse Event|12|||
25314047|NCT00917150|50629742|FG001|Overall Study|Adverse Event|7|||
25314048|NCT00917150|50629743|FG002|Overall Study|Adverse Event|12|||
25314049|NCT00917150|50629744|FG003|Overall Study|Adverse Event|11|||
25314050|NCT00917150|50629741|FG000|Overall Study|Death|1|||
25314051|NCT00917150|50629742|FG001|Overall Study|Death|4|||
25314052|NCT00917150|50629743|FG002|Overall Study|Death|3|||
25314053|NCT00917150|50629744|FG003|Overall Study|Death|2|||
25314054|NCT00917150|50629741|FG000|Overall Study|Lost to Follow-up|1|||
25314055|NCT00917150|50629742|FG001|Overall Study|Lost to Follow-up|0|||
25314056|NCT00917150|50629743|FG002|Overall Study|Lost to Follow-up|4|||
25314057|NCT00917150|50629744|FG003|Overall Study|Lost to Follow-up|2|||
25314058|NCT00917150|50629741|FG000|Overall Study|Physician Decision|0|||
25314059|NCT00917150|50629742|FG001|Overall Study|Physician Decision|2|||
25314060|NCT00917150|50629743|FG002|Overall Study|Physician Decision|0|||
25314061|NCT00917150|50629744|FG003|Overall Study|Physician Decision|1|||
25314062|NCT00917150|50629741|FG000|Overall Study|Protocol Violation|5|||
25314063|NCT00917150|50629742|FG001|Overall Study|Protocol Violation|5|||
25314064|NCT00917150|50629743|FG002|Overall Study|Protocol Violation|3|||
25314065|NCT00917150|50629744|FG003|Overall Study|Protocol Violation|5|||
25314066|NCT00917150|50629741|FG000|Overall Study|Withdrawal by Subject|15|||
25314067|NCT00917150|50629742|FG001|Overall Study|Withdrawal by Subject|16|||
25314068|NCT00917150|50629743|FG002|Overall Study|Withdrawal by Subject|18|||
25314069|NCT00917150|50629744|FG003|Overall Study|Withdrawal by Subject|11|||
25314070|NCT00917150|50629741|FG000|Overall Study|Other than specified|3|||
25314071|NCT00917150|50629742|FG001|Overall Study|Other than specified|3|||
25314072|NCT00917150|50629743|FG002|Overall Study|Other than specified|2|||
25314073|NCT00917150|50629744|FG003|Overall Study|Other than specified|2|||
25314074|NCT00659425|50629764|FG000|Overall Study|Disease progression|1|||
25314075|NCT00659425|50629765|FG001|Overall Study|Disease progression|0|||
25314076|NCT00659425|50629766|FG002|Overall Study|Disease progression|0|||
25314077|NCT00659425|50629767|FG003|Overall Study|Disease progression|1|||
25314078|NCT00659425|50629768|FG004|Overall Study|Disease progression|0|||
25314079|NCT00659425|50629769|FG005|Overall Study|Disease progression|2|||
25314080|NCT00659425|50629770|FG006|Overall Study|Disease progression|4|||
25314081|NCT00659425|50629771|FG007|Overall Study|Disease progression|3|||
25314082|NCT00659425|50629772|FG008|Overall Study|Disease progression|5|||
25314083|NCT00659425|50629773|FG009|Overall Study|Disease progression|3|||
25314084|NCT00659425|50629764|FG000|Overall Study|Death|0|||
25314085|NCT00659425|50629765|FG001|Overall Study|Death|0|||
25314086|NCT00659425|50629766|FG002|Overall Study|Death|0|||
25314087|NCT00659425|50629767|FG003|Overall Study|Death|1|||
25314088|NCT00659425|50629768|FG004|Overall Study|Death|0|||
25314089|NCT00659425|50629769|FG005|Overall Study|Death|0|||
25314090|NCT00659425|50629770|FG006|Overall Study|Death|1|||
25314091|NCT00659425|50629771|FG007|Overall Study|Death|0|||
25314092|NCT00659425|50629772|FG008|Overall Study|Death|0|||
25314093|NCT00659425|50629773|FG009|Overall Study|Death|0|||
25314094|NCT00659425|50629764|FG000|Overall Study|Adverse Event|0|||
25314095|NCT00659425|50629765|FG001|Overall Study|Adverse Event|0|||
25314096|NCT00659425|50629766|FG002|Overall Study|Adverse Event|0|||
25314097|NCT00659425|50629767|FG003|Overall Study|Adverse Event|0|||
25314098|NCT00659425|50629768|FG004|Overall Study|Adverse Event|0|||
25314099|NCT00659425|50629769|FG005|Overall Study|Adverse Event|1|||
25314100|NCT00659425|50629770|FG006|Overall Study|Adverse Event|0|||
25314101|NCT00659425|50629771|FG007|Overall Study|Adverse Event|3|||
24970369|NCT04124926|50059868|FG004|Maintenance Phase|Randomized but not Treated|0|||
24970370|NCT04274686|50059880|FG000|Overall Study|Physician Decision|1|||
24970371|NCT04274686|50059881|FG001|Overall Study|Physician Decision|0|||
24970372|NCT04113694|50059889|FG000|Overall Study|Adverse Event|2|||
24970373|NCT04113694|50059889|FG000|Overall Study|Lost to Follow-up|2|||
25314102|NCT00659425|50629772|FG008|Overall Study|Adverse Event|1|||
25314103|NCT00659425|50629773|FG009|Overall Study|Adverse Event|4|||
25314104|NCT00659425|50629764|FG000|Overall Study|Investigator Discretion|0|||
25314105|NCT00659425|50629765|FG001|Overall Study|Investigator Discretion|0|||
25314106|NCT00659425|50629766|FG002|Overall Study|Investigator Discretion|0|||
25314107|NCT00659425|50629767|FG003|Overall Study|Investigator Discretion|0|||
25314108|NCT00659425|50629768|FG004|Overall Study|Investigator Discretion|0|||
25314109|NCT00659425|50629769|FG005|Overall Study|Investigator Discretion|1|||
25314110|NCT00659425|50629770|FG006|Overall Study|Investigator Discretion|0|||
25314111|NCT00659425|50629771|FG007|Overall Study|Investigator Discretion|3|||
24970374|NCT04113694|50059889|FG000|Overall Study|Withdrawal by Subject|6|||
24970375|NCT04113694|50059889|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
24970376|NCT04105972|50059898|FG000|Overall Study|Adverse Event|2|||
24970377|NCT04105972|50059899|FG001|Overall Study|Adverse Event|1|||
24970378|NCT04102540|50059905|FG000|Overall Study|Withdrawn by PI|2|||
24970379|NCT04102540|50059905|FG000|Overall Study|Lost to Follow-up|6|||
24970380|NCT00124982|50059911|FG000|Short-term Period|Death|1|||
24970381|NCT00124982|50059912|FG001|Short-term Period|Death|1|||
24970382|NCT00124982|50059913|FG002|Short-term Period|Death|0|||
24970383|NCT00124982|50059911|FG000|Short-term Period|Adverse Event|17|||
24970384|NCT00124982|50059912|FG001|Short-term Period|Adverse Event|22|||
24970385|NCT00124982|50059913|FG002|Short-term Period|Adverse Event|0|||
24970386|NCT00124982|50059911|FG000|Short-term Period|Lack of Efficacy|32|||
24970387|NCT00124982|50059912|FG001|Short-term Period|Lack of Efficacy|73|||
24970388|NCT00124982|50059913|FG002|Short-term Period|Lack of Efficacy|0|||
24970389|NCT00124982|50059911|FG000|Short-term Period|Lost to Follow-up|8|||
24970390|NCT00124982|50059912|FG001|Short-term Period|Lost to Follow-up|5|||
24970391|NCT00124982|50059913|FG002|Short-term Period|Lost to Follow-up|0|||
24970392|NCT00124982|50059911|FG000|Short-term Period|Withdrawal of Consent|7|||
24970393|NCT00124982|50059912|FG001|Short-term Period|Withdrawal of Consent|9|||
24970394|NCT00124982|50059913|FG002|Short-term Period|Withdrawal of Consent|0|||
24970395|NCT00124982|50059911|FG000|Short-term Period|Poor/Non-compliance|3|||
24970396|NCT00124982|50059912|FG001|Short-term Period|Poor/Non-compliance|1|||
24970397|NCT00124982|50059913|FG002|Short-term Period|Poor/Non-compliance|0|||
25192307|NCT01436162|50358007|FG000|Randomized Phase|Lack of Efficacy|0|||
24970398|NCT00124982|50059911|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
24970399|NCT00124982|50059912|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
24970400|NCT00124982|50059913|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
24970401|NCT00124982|50059911|FG000|Short-term Period|Participant Decision|1|||
24970402|NCT00124982|50059912|FG001|Short-term Period|Participant Decision|0|||
24970403|NCT00124982|50059913|FG002|Short-term Period|Participant Decision|0|||
24970404|NCT00124982|50059911|FG000|Short-term Period|Participant Chose Own Doctor|0|||
24970405|NCT00124982|50059912|FG001|Short-term Period|Participant Chose Own Doctor|1|||
24970406|NCT00124982|50059913|FG002|Short-term Period|Participant Chose Own Doctor|0|||
24970407|NCT00124982|50059911|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
24970408|NCT00124982|50059912|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
24970409|NCT00124982|50059913|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
24970410|NCT00124982|50059911|FG000|Short-term Period|Participant Had Lymphopenia|1|||
24970411|NCT00124982|50059912|FG001|Short-term Period|Participant Had Lymphopenia|0|||
24970412|NCT00124982|50059913|FG002|Short-term Period|Participant Had Lymphopenia|0|||
24970413|NCT00124982|50059911|FG000|Long-term Period|Death|0|||
24970414|NCT00124982|50059912|FG001|Long-term Period|Death|0|||
24970415|NCT00124982|50059913|FG002|Long-term Period|Death|1|||
24970416|NCT00124982|50059911|FG000|Long-term Period|Adverse Event|0|||
24970417|NCT00124982|50059912|FG001|Long-term Period|Adverse Event|0|||
24970418|NCT00124982|50059913|FG002|Long-term Period|Adverse Event|17|||
24970419|NCT00124982|50059911|FG000|Long-term Period|Lack of Efficacy|0|||
24970420|NCT00124982|50059912|FG001|Long-term Period|Lack of Efficacy|0|||
24970421|NCT00124982|50059913|FG002|Long-term Period|Lack of Efficacy|46|||
24970422|NCT00124982|50059911|FG000|Long-term Period|Lost to Follow-up|0|||
24970423|NCT00124982|50059912|FG001|Long-term Period|Lost to Follow-up|0|||
24970424|NCT00124982|50059913|FG002|Long-term Period|Lost to Follow-up|4|||
24970425|NCT00124982|50059911|FG000|Long-term Period|Withdrawal by Subject|0|||
24970426|NCT00124982|50059912|FG001|Long-term Period|Withdrawal by Subject|0|||
24970427|NCT00124982|50059913|FG002|Long-term Period|Withdrawal by Subject|16|||
24970428|NCT00124982|50059911|FG000|Long-term Period|Pregnancy|0|||
24970429|NCT00124982|50059912|FG001|Long-term Period|Pregnancy|0|||
24970430|NCT00124982|50059913|FG002|Long-term Period|Pregnancy|1|||
24970431|NCT00124982|50059911|FG000|Long-term Period|Poor/Non-compliance|0|||
24970432|NCT00124982|50059912|FG001|Long-term Period|Poor/Non-compliance|0|||
24970433|NCT00124982|50059913|FG002|Long-term Period|Poor/Non-compliance|2|||
24970434|NCT00124982|50059911|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
24970435|NCT00124982|50059912|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
24970436|NCT00124982|50059913|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
24970437|NCT00124982|50059911|FG000|Long-term Period|Neurologist Recommendation|0|||
24970438|NCT00124982|50059912|FG001|Long-term Period|Neurologist Recommendation|0|||
24970439|NCT00124982|50059913|FG002|Long-term Period|Neurologist Recommendation|1|||
24970440|NCT04263142|50059927|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
24970441|NCT04263142|50059928|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
24970442|NCT04263142|50059929|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
25071526|NCT02697591|50177825|FG002|Overall Study|Withdrawal by Subject|2|||
25071527|NCT02697591|50177826|FG003|Overall Study|Withdrawal by Subject|1|||
24970443|NCT04263142|50059930|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
24970444|NCT04263142|50059931|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
24970445|NCT04263142|50059927|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
24970446|NCT04263142|50059928|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
24970447|NCT04263142|50059929|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
24970448|NCT04263142|50059930|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
24970449|NCT04263142|50059931|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
24970450|NCT04095286|50059944|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
24970451|NCT04095286|50059945|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
24970452|NCT04095286|50059946|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
24970453|NCT04095286|50059947|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
24970454|NCT04095286|50059948|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
24970455|NCT04095286|50059949|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
24970456|NCT04095286|50059944|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
24970457|NCT04095286|50059945|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
24970458|NCT04095286|50059946|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
24970459|NCT04095286|50059947|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
24970460|NCT04095286|50059948|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
24970461|NCT04095286|50059949|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
24970462|NCT04095286|50059944|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
24970463|NCT04095286|50059945|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
24970464|NCT04095286|50059946|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
24970465|NCT04095286|50059947|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
24970466|NCT04095286|50059948|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
24970467|NCT04095286|50059949|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
24970468|NCT04095286|50059944|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
25071528|NCT02697591|50177827|FG004|Overall Study|Withdrawal by Subject|7|||
25071529|NCT02697591|50177828|FG005|Overall Study|Withdrawal by Subject|6|||
24995116|NCT03015532|50085971|FG005|Overall Study|Withdrawal by Subject|0|||
25314112|NCT00659425|50629772|FG008|Overall Study|Investigator Discretion|0|||
24970469|NCT04095286|50059945|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
25071530|NCT02697591|50177829|FG006|Overall Study|Withdrawal by Subject|9|||
24970470|NCT04095286|50059946|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
24970471|NCT04095286|50059947|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
24970472|NCT04095286|50059948|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
24970473|NCT04095286|50059949|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
24970474|NCT04095286|50059944|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
24970475|NCT04095286|50059945|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
25071531|NCT02697591|50177830|FG007|Overall Study|Withdrawal by Subject|1|||
25071532|NCT02697591|50177831|FG008|Overall Study|Withdrawal by Subject|6|||
25071533|NCT02697591|50177832|FG009|Overall Study|Withdrawal by Subject|10|||
25071534|NCT02697591|50177823|FG000|Overall Study|Physician Decision|1|||
25071535|NCT02697591|50177824|FG001|Overall Study|Physician Decision|0|||
25071536|NCT02697591|50177825|FG002|Overall Study|Physician Decision|0|||
25071537|NCT02697591|50177826|FG003|Overall Study|Physician Decision|0|||
25071538|NCT02697591|50177827|FG004|Overall Study|Physician Decision|1|||
25071539|NCT02697591|50177828|FG005|Overall Study|Physician Decision|2|||
25071540|NCT02697591|50177829|FG006|Overall Study|Physician Decision|0|||
25071541|NCT02697591|50177830|FG007|Overall Study|Physician Decision|0|||
25071542|NCT02697591|50177831|FG008|Overall Study|Physician Decision|1|||
25071543|NCT02697591|50177832|FG009|Overall Study|Physician Decision|1|||
25071544|NCT02697591|50177823|FG000|Overall Study|Death|2|||
25071545|NCT02697591|50177824|FG001|Overall Study|Death|3|||
25071546|NCT02697591|50177825|FG002|Overall Study|Death|1|||
25071547|NCT02697591|50177826|FG003|Overall Study|Death|1|||
25071548|NCT02697591|50177827|FG004|Overall Study|Death|4|||
25071549|NCT02697591|50177828|FG005|Overall Study|Death|5|||
25071550|NCT02697591|50177829|FG006|Overall Study|Death|3|||
25071551|NCT02697591|50177830|FG007|Overall Study|Death|1|||
25071552|NCT02697591|50177831|FG008|Overall Study|Death|1|||
25071553|NCT02697591|50177832|FG009|Overall Study|Death|5|||
25071554|NCT02697591|50177823|FG000|Overall Study|Reason not Specified|0|||
25071555|NCT02697591|50177824|FG001|Overall Study|Reason not Specified|0|||
25071556|NCT02697591|50177825|FG002|Overall Study|Reason not Specified|0|||
25071557|NCT02697591|50177826|FG003|Overall Study|Reason not Specified|1|||
25071558|NCT02697591|50177827|FG004|Overall Study|Reason not Specified|1|||
25071559|NCT02697591|50177828|FG005|Overall Study|Reason not Specified|2|||
25071560|NCT02697591|50177829|FG006|Overall Study|Reason not Specified|3|||
25071561|NCT02697591|50177830|FG007|Overall Study|Reason not Specified|1|||
25071562|NCT02697591|50177831|FG008|Overall Study|Reason not Specified|1|||
25071563|NCT02697591|50177832|FG009|Overall Study|Reason not Specified|3|||
25071564|NCT02697435|50177857|FG000|Overall Study|Withdrawal by Subject|1|||
25071565|NCT02697435|50177858|FG001|Overall Study|Withdrawal by Subject|0|||
25071566|NCT02697435|50177857|FG000|Overall Study|Physician Decision|0|||
25071567|NCT02697435|50177858|FG001|Overall Study|Physician Decision|4|||
24970476|NCT04095286|50059946|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
24970477|NCT04095286|50059947|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
24970478|NCT04095286|50059948|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
24970479|NCT04095286|50059949|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
24970480|NCT04093414|50059959|FG000|3 Month Follow up|Physician Decision|0|||
24970481|NCT04093414|50059960|FG001|3 Month Follow up|Physician Decision|1|||
25071568|NCT02174861|50177865|FG000|Overall Study|Decision by sponsor|8|||
25071569|NCT02174861|50177865|FG000|Overall Study|Withdrawal by Subject|124|||
25071570|NCT02174861|50177865|FG000|Overall Study|Lost to Follow-up|26|||
25071571|NCT00140855|50177871|FG000|Overall Study|Progressive disease|2|||
25192308|NCT01436162|50358008|FG001|Randomized Phase|Lack of Efficacy|1|||
25071572|NCT00700635|50177878|FG000|Overall Study|Adverse Event|1|||
25192309|NCT01436162|50358009|FG002|Randomized Phase|Lack of Efficacy|1|||
24970482|NCT04093414|50059959|FG000|6month Follow up|Physician Decision|1|||
24970483|NCT04093414|50059960|FG001|6month Follow up|Physician Decision|3|||
25071573|NCT00700635|50177879|FG001|Overall Study|Adverse Event|0|||
25071574|NCT00700635|50177880|FG002|Overall Study|Adverse Event|0|||
25071575|NCT00700635|50177878|FG000|Overall Study|Lost to Follow-up|1|||
25071576|NCT00700635|50177879|FG001|Overall Study|Lost to Follow-up|3|||
25071577|NCT00700635|50177880|FG002|Overall Study|Lost to Follow-up|0|||
25071578|NCT00700635|50177878|FG000|Overall Study|Protocol Violation|2|||
25071579|NCT00700635|50177879|FG001|Overall Study|Protocol Violation|2|||
25314113|NCT00659425|50629773|FG009|Overall Study|Investigator Discretion|0|||
25314114|NCT00659425|50629764|FG000|Overall Study|Other|0|||
25314115|NCT00659425|50629765|FG001|Overall Study|Other|1|||
25314116|NCT00659425|50629766|FG002|Overall Study|Other|1|||
25314117|NCT00659425|50629767|FG003|Overall Study|Other|2|||
25314118|NCT00659425|50629768|FG004|Overall Study|Other|4|||
25314119|NCT00659425|50629769|FG005|Overall Study|Other|0|||
25314120|NCT00659425|50629770|FG006|Overall Study|Other|3|||
25314121|NCT00659425|50629771|FG007|Overall Study|Other|2|||
25314122|NCT00659425|50629772|FG008|Overall Study|Other|0|||
25314123|NCT00659425|50629773|FG009|Overall Study|Other|6|||
25314124|NCT00656851|50629810|FG000|Overall Study|Withdrawal by Subject|0|||
25314125|NCT00656851|50629811|FG001|Overall Study|Withdrawal by Subject|4|||
25314126|NCT00656617|50629817|FG000|Overall Study|Adverse Event|1|||
25314127|NCT00656617|50629817|FG000|Overall Study|Death|2|||
25314128|NCT00656617|50629817|FG000|Overall Study|Insurance Issues|2|||
25314129|NCT00656617|50629817|FG000|Overall Study|Move to different clinical trial|2|||
25314130|NCT04797637|50629824|FG000|Overall Study|Lost to Follow-up|23|||
25314131|NCT04797637|50629825|FG001|Overall Study|Lost to Follow-up|32|||
25314132|NCT04797637|50629824|FG000|Overall Study|Withdrawal by Subject|0|||
25314133|NCT04797637|50629825|FG001|Overall Study|Withdrawal by Subject|1|||
25314134|NCT00659269|50629833|FG000|Overall Study|Physician Decision|1|||
25314135|NCT00659269|50629834|FG001|Overall Study|Physician Decision|1|||
25314136|NCT00658333|50629851|FG000|Overall Study|Adverse Event|2|||
25314137|NCT00658333|50629852|FG001|Overall Study|Adverse Event|1|||
25314138|NCT00658879|50629858|FG000|Overall Study|Protocol Violation|1|||
25314139|NCT00570037|50629864|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
25314140|NCT00570037|50629865|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
25314141|NCT00863655|50629873|FG000|Overall Study|Protocol Violation|4|||
25314142|NCT00863655|50629874|FG001|Overall Study|Protocol Violation|0|||
25314143|NCT00863655|50629873|FG000|Overall Study|Adverse Event|52|||
25314144|NCT00863655|50629874|FG001|Overall Study|Adverse Event|8|||
25314145|NCT00863655|50629873|FG000|Overall Study|Withdrawal by Subject|47|||
25314146|NCT00863655|50629874|FG001|Overall Study|Withdrawal by Subject|7|||
25314147|NCT00863655|50629873|FG000|Overall Study|Administrative problems|1|||
25314148|NCT00863655|50629874|FG001|Overall Study|Administrative problems|0|||
25314149|NCT00863655|50629873|FG000|Overall Study|Death|7|||
25314150|NCT00863655|50629874|FG001|Overall Study|Death|1|||
25314151|NCT00863655|50629873|FG000|Overall Study|New cancer therapy|5|||
25314152|NCT00863655|50629874|FG001|Overall Study|New cancer therapy|1|||
24970484|NCT04093258|50059966|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
24970485|NCT04093258|50059967|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
24970486|NCT04253236|50059975|FG000|Overall Study|Adverse Event|1|||
24970487|NCT04253236|50059976|FG001|Overall Study|Adverse Event|0|||
24970488|NCT04253236|50059975|FG000|Overall Study|Safety Concerns|1|||
24970489|NCT04253236|50059976|FG001|Overall Study|Safety Concerns|0|||
24970490|NCT04253236|50059975|FG000|Overall Study|Study Terminated by Sponsor|1|||
24970491|NCT04253236|50059976|FG001|Overall Study|Study Terminated by Sponsor|0|||
24970492|NCT04087720|50059982|FG000|Overall Study|Withdrawal by Subject|2|||
24970493|NCT04087720|50059982|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
24970494|NCT04086472|50059991|FG000|Overall Study|Lost to Follow-up|1|||
24970495|NCT04086472|50059992|FG001|Overall Study|Lost to Follow-up|0|||
24970496|NCT04086472|50059993|FG002|Overall Study|Lost to Follow-up|0|||
24970497|NCT04086472|50059994|FG003|Overall Study|Lost to Follow-up|0|||
24970498|NCT04086472|50059995|FG004|Overall Study|Lost to Follow-up|1|||
24970499|NCT04086472|50059991|FG000|Overall Study|Physician Decision|0|||
24970500|NCT04086472|50059992|FG001|Overall Study|Physician Decision|1|||
24970501|NCT04086472|50059993|FG002|Overall Study|Physician Decision|1|||
24970502|NCT04086472|50059994|FG003|Overall Study|Physician Decision|0|||
24970503|NCT04086472|50059995|FG004|Overall Study|Physician Decision|0|||
24970504|NCT04086472|50059991|FG000|Overall Study|Withdrawal by Subject|1|||
24970505|NCT04086472|50059992|FG001|Overall Study|Withdrawal by Subject|1|||
24970506|NCT04086472|50059993|FG002|Overall Study|Withdrawal by Subject|1|||
24970507|NCT04086472|50059994|FG003|Overall Study|Withdrawal by Subject|0|||
24970508|NCT04086472|50059995|FG004|Overall Study|Withdrawal by Subject|0|||
25314153|NCT00863655|50629873|FG000|Overall Study|Disease progression|364|||
25314154|NCT00863655|50629874|FG001|Overall Study|Disease progression|221|||
25314155|NCT00863655|50629873|FG000|Overall Study|Treatment completed as per protocol|5|||
24970509|NCT04086472|50059991|FG000|Overall Study|Various reasons|2|||
24970510|NCT04086472|50059992|FG001|Overall Study|Various reasons|0|||
24970511|NCT04086472|50059993|FG002|Overall Study|Various reasons|0|||
24970512|NCT04086472|50059994|FG003|Overall Study|Various reasons|3|||
24970513|NCT04086472|50059995|FG004|Overall Study|Various reasons|1|||
24970514|NCT04249336|50060011|FG000|Overall Study|Lost to Follow-up|3|||
25314156|NCT00863655|50629874|FG001|Overall Study|Treatment completed as per protocol|1|||
25314157|NCT00658723|50629882|FG000|Overall Study|Lost to Follow-up|0|||
25314158|NCT00658723|50629883|FG001|Overall Study|Lost to Follow-up|2|||
25314159|NCT00658723|50629884|FG002|Overall Study|Lost to Follow-up|2|||
24970515|NCT04249336|50060012|FG001|Overall Study|Lost to Follow-up|3|||
24970516|NCT04249336|50060013|FG002|Overall Study|Lost to Follow-up|3|||
24970517|NCT04249336|50060014|FG003|Overall Study|Lost to Follow-up|3|||
24970518|NCT04245202|50060026|FG000|Overall Study|Lack of Efficacy|10|||
24970519|NCT04245202|50060027|FG001|Overall Study|Lack of Efficacy|1|||
24970520|NCT04079842|50060034|FG000|Overall Study|Request of subject|2|||
24970521|NCT04079842|50060034|FG000|Overall Study|Unable to draw Arterial samples|1|||
24970522|NCT04078126|50060038|FG000|Washout|Study put on hold due to COVID-19|0|||
24970523|NCT04078126|50060039|FG001|Washout|Study put on hold due to COVID-19|2|||
24970524|NCT04078126|50060038|FG000|Period 2|Study put on hold due to COVID-19|1|||
24970525|NCT04078126|50060039|FG001|Period 2|Study put on hold due to COVID-19|1|||
24970526|NCT04073368|50060049|FG000|Overall Study|Adverse Event|2|||
24970527|NCT04073368|50060050|FG001|Overall Study|Adverse Event|0|||
24970528|NCT04073368|50060051|FG002|Overall Study|Adverse Event|1|||
24970529|NCT04073368|50060052|FG003|Overall Study|Adverse Event|1|||
24970530|NCT04073368|50060049|FG000|Overall Study|Withdrawal by Subject|2|||
24970531|NCT04073368|50060050|FG001|Overall Study|Withdrawal by Subject|2|||
24970532|NCT04073368|50060051|FG002|Overall Study|Withdrawal by Subject|1|||
24970533|NCT04073368|50060052|FG003|Overall Study|Withdrawal by Subject|1|||
24970534|NCT04073368|50060049|FG000|Overall Study|Lost to Follow-up|1|||
24970535|NCT04073368|50060050|FG001|Overall Study|Lost to Follow-up|1|||
24970536|NCT04073368|50060051|FG002|Overall Study|Lost to Follow-up|1|||
24970537|NCT04073368|50060052|FG003|Overall Study|Lost to Follow-up|0|||
24970538|NCT04073368|50060049|FG000|Overall Study|Protocol Violation|0|||
24970539|NCT04073368|50060050|FG001|Overall Study|Protocol Violation|1|||
24970540|NCT04073368|50060051|FG002|Overall Study|Protocol Violation|0|||
24970541|NCT04073368|50060052|FG003|Overall Study|Protocol Violation|0|||
24970542|NCT04073368|50060049|FG000|Overall Study|Subject noncompliance|7|||
24970543|NCT04073368|50060050|FG001|Overall Study|Subject noncompliance|4|||
24970544|NCT04073368|50060051|FG002|Overall Study|Subject noncompliance|0|||
24970545|NCT04073368|50060052|FG003|Overall Study|Subject noncompliance|0|||
24970546|NCT04380688|50060064|FG000|Overall Study|Death|2|||
24970547|NCT04380688|50060065|FG001|Overall Study|Death|2|||
24970548|NCT04380688|50060064|FG000|Overall Study|Lost to Follow-up|2|||
24970549|NCT04380688|50060065|FG001|Overall Study|Lost to Follow-up|4|||
25192310|NCT01436162|50358007|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
25192311|NCT01436162|50358008|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
25192312|NCT01436162|50358009|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
25192313|NCT01436162|50358007|FG000|Randomized Phase|Other|2|||
25192314|NCT01436162|50358008|FG001|Randomized Phase|Other|5|||
25314160|NCT00658723|50629882|FG000|Overall Study|Death|2|||
25314161|NCT00658723|50629883|FG001|Overall Study|Death|1|||
25314162|NCT00658723|50629884|FG002|Overall Study|Death|4|||
25314163|NCT00658723|50629882|FG000|Overall Study|Scheduling Issue|1|||
25314164|NCT00658723|50629883|FG001|Overall Study|Scheduling Issue|1|||
25314165|NCT00658723|50629884|FG002|Overall Study|Scheduling Issue|0|||
25314166|NCT00658723|50629882|FG000|Overall Study|Withdrawal by Subject|1|||
25314167|NCT00658723|50629883|FG001|Overall Study|Withdrawal by Subject|0|||
25314168|NCT00658723|50629884|FG002|Overall Study|Withdrawal by Subject|1|||
25314169|NCT00593385|50629895|FG000|Overall Study|Death|14|||
25314170|NCT00593385|50629895|FG000|Overall Study|Lost to Follow-up|17|||
25314171|NCT00593385|50629895|FG000|Overall Study|Withdrawal by Subject|9|||
25314172|NCT00658021|50629904|FG000|28-Week Treatment Period|Adverse Event|3|||
25314173|NCT00658021|50629905|FG001|28-Week Treatment Period|Adverse Event|1|||
25314174|NCT00658021|50629906|FG002|28-Week Treatment Period|Adverse Event|0|||
25314175|NCT00658021|50629904|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
25314176|NCT00658021|50629905|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
25314177|NCT00658021|50629906|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
24970550|NCT04380688|50060064|FG000|Overall Study|Withdrawal by Subject|3|||
25314178|NCT00658021|50629904|FG000|28-Week Treatment Period|Protocol Violation|0|||
25314179|NCT00658021|50629905|FG001|28-Week Treatment Period|Protocol Violation|2|||
25314180|NCT00658021|50629906|FG002|28-Week Treatment Period|Protocol Violation|1|||
25314181|NCT00658021|50629904|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
25314182|NCT00658021|50629905|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
25314183|NCT00658021|50629906|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
25314184|NCT00658021|50629904|FG000|28-Week Treatment Period|Physician Decision|1|||
25314185|NCT00658021|50629905|FG001|28-Week Treatment Period|Physician Decision|2|||
25314186|NCT00658021|50629906|FG002|28-Week Treatment Period|Physician Decision|1|||
24970551|NCT04380688|50060065|FG001|Overall Study|Withdrawal by Subject|3|||
24970552|NCT00124748|50060073|FG000|Overall Study|Adverse Event|8|||
24970553|NCT00124748|50060074|FG001|Overall Study|Adverse Event|39|||
24970554|NCT00124748|50060073|FG000|Overall Study|Abnormal laboratory Value|2|||
24970555|NCT00124748|50060074|FG001|Overall Study|Abnormal laboratory Value|2|||
24970556|NCT00124748|50060073|FG000|Overall Study|Abnormal Procedure|0|||
24970557|NCT00124748|50060074|FG001|Overall Study|Abnormal Procedure|1|||
25192315|NCT01436162|50358009|FG002|Randomized Phase|Other|4|||
24970558|NCT00124748|50060073|FG000|Overall Study|Lack of Efficacy|20|||
24970559|NCT00124748|50060074|FG001|Overall Study|Lack of Efficacy|41|||
24970560|NCT00124748|50060073|FG000|Overall Study|No longer requires study drug|1|||
24970561|NCT00124748|50060074|FG001|Overall Study|No longer requires study drug|1|||
24970562|NCT00124748|50060073|FG000|Overall Study|Protocol Violation|3|||
24970563|NCT00124748|50060074|FG001|Overall Study|Protocol Violation|1|||
24970564|NCT00124748|50060073|FG000|Overall Study|Withdrawal by Subject|5|||
24970565|NCT00124748|50060074|FG001|Overall Study|Withdrawal by Subject|15|||
24970566|NCT00124748|50060073|FG000|Overall Study|Lost to Follow-up|2|||
24970567|NCT00124748|50060074|FG001|Overall Study|Lost to Follow-up|7|||
24970568|NCT00124748|50060073|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
24970569|NCT00124748|50060074|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
24970570|NCT00124748|50060073|FG000|Overall Study|Death|1|||
24970571|NCT00124748|50060074|FG001|Overall Study|Death|3|||
24970572|NCT04070326|50060082|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
24970573|NCT04070326|50060083|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
24970574|NCT03689452|50060093|FG000|Overall Study|Lost to Follow-up|1|||
24970575|NCT03689452|50060094|FG001|Overall Study|Lost to Follow-up|1|||
24970576|NCT04067050|50060102|FG000|One Month|Lost to Follow-up|4|||
24970577|NCT04067050|50060103|FG001|One Month|Lost to Follow-up|0|||
24970578|NCT04067050|50060102|FG000|Two Month|Lost to Follow-up|1|||
24970579|NCT04067050|50060103|FG001|Two Month|Lost to Follow-up|0|||
24970580|NCT04067050|50060102|FG000|Two Month|Adverse Event|1|||
24970581|NCT04067050|50060103|FG001|Two Month|Adverse Event|0|||
24970582|NCT04060654|50060109|FG000|Overall Study|Withdrawal by Subject|1|||
24970583|NCT04060654|50060109|FG000|Overall Study|Lost to Follow-up|5|||
24970584|NCT00096200|50060116|FG000|Overall Study|Adverse Event|0|||
24970585|NCT00096200|50060117|FG001|Overall Study|Adverse Event|4|||
24970586|NCT00096200|50060118|FG002|Overall Study|Adverse Event|0|||
24970587|NCT00096200|50060116|FG000|Overall Study|Withdrawal by Subject|1|||
24970588|NCT00096200|50060117|FG001|Overall Study|Withdrawal by Subject|2|||
24970589|NCT00096200|50060118|FG002|Overall Study|Withdrawal by Subject|0|||
24970590|NCT00096200|50060116|FG000|Overall Study|Ineligible pathology|0|||
24970591|NCT00096200|50060117|FG001|Overall Study|Ineligible pathology|1|||
24970592|NCT00096200|50060118|FG002|Overall Study|Ineligible pathology|0|||
24970593|NCT04059094|50060131|FG000|Overall Study|Adverse Event|0|||
24970594|NCT04059094|50060132|FG001|Overall Study|Adverse Event|0|||
24970595|NCT04059094|50060133|FG002|Overall Study|Adverse Event|0|||
24970596|NCT04059094|50060134|FG003|Overall Study|Adverse Event|0|||
24970597|NCT04059094|50060135|FG004|Overall Study|Adverse Event|1|||
24970598|NCT04059094|50060131|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
24970599|NCT04059094|50060132|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
24970600|NCT04059094|50060133|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
25192316|NCT02579382|50358021|FG000|Main Study Phase|Lost to Follow-up|0|||
25314187|NCT00658021|50629904|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
25314188|NCT00658021|50629905|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
25314189|NCT00658021|50629906|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
25314190|NCT00658021|50629904|FG000|28-Week Treatment Period|Loss of glucose control|1|||
25314191|NCT00658021|50629905|FG001|28-Week Treatment Period|Loss of glucose control|1|||
25314192|NCT00658021|50629906|FG002|28-Week Treatment Period|Loss of glucose control|10|||
25314193|NCT00658021|50629904|FG000|28-Week Treatment Period|Other|2|||
25314194|NCT00658021|50629905|FG001|28-Week Treatment Period|Other|3|||
25314195|NCT00658021|50629906|FG002|28-Week Treatment Period|Other|1|||
25314196|NCT00658021|50629904|FG000|28-Week Treatment Period|Did not receive treatment|2|||
25314197|NCT00658021|50629905|FG001|28-Week Treatment Period|Did not receive treatment|0|||
25314198|NCT00658021|50629906|FG002|28-Week Treatment Period|Did not receive treatment|0|||
25314199|NCT00658021|50629904|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
25314200|NCT00658021|50629905|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
25314201|NCT00658021|50629906|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
25314202|NCT00658021|50629904|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
25314203|NCT00658021|50629905|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
24970601|NCT04059094|50060134|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
24970602|NCT04059094|50060135|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
24970603|NCT00096044|50060151|FG000|Overall Study|Withdrawal by Subject|9|||
24970604|NCT00096044|50060151|FG000|Overall Study|Adverse Event|21|||
24970605|NCT00096044|50060151|FG000|Overall Study|Disease Progression|4|||
24970606|NCT03689374|50060157|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
24970607|NCT03689374|50060158|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
24970608|NCT03689374|50060159|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
24970609|NCT03689374|50060157|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
24970610|NCT03689374|50060158|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
24970611|NCT03689374|50060159|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
24970612|NCT03689374|50060157|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
24970613|NCT03689374|50060158|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
24970614|NCT03689374|50060159|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
24970615|NCT03689374|50060157|FG000|Treatment Period (Week 0 to 52)|Death|0|||
24970616|NCT03689374|50060158|FG001|Treatment Period (Week 0 to 52)|Death|11|||
24970617|NCT03689374|50060159|FG002|Treatment Period (Week 0 to 52)|Death|1|||
24970618|NCT00113360|50060165|FG000|Overall Study|Adverse Event|3|||
24970619|NCT00113360|50060165|FG000|Overall Study|Subject required surgery|1|||
24970620|NCT00113360|50060165|FG000|Overall Study|Did not meet eligibility criteria|3|||
24970621|NCT00123734|50060169|FG000|Overall Study|Death|3|||
24970622|NCT00123734|50060169|FG000|Overall Study|Lost to Follow-up|3|||
24970623|NCT00123734|50060169|FG000|Overall Study|Dropout|1|||
24970624|NCT00123734|50060169|FG000|Overall Study|Withdrawal by Subject|1|||
24970625|NCT00112736|50060179|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
24970626|NCT00112736|50060180|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
24970627|NCT00123422|50060195|FG000|Overall Study|Physician Decision|2|||
24970628|NCT00123422|50060196|FG001|Overall Study|Physician Decision|2|||
24970629|NCT00123422|50060197|FG002|Overall Study|Physician Decision|6|||
24970630|NCT00123422|50060195|FG000|Overall Study|Withdrawal by Subject|1|||
24970631|NCT00123422|50060196|FG001|Overall Study|Withdrawal by Subject|2|||
24970632|NCT00123422|50060197|FG002|Overall Study|Withdrawal by Subject|2|||
24970633|NCT00123422|50060195|FG000|Overall Study|Lost to Follow-up|1|||
24970634|NCT00123422|50060196|FG001|Overall Study|Lost to Follow-up|2|||
24970635|NCT00123422|50060197|FG002|Overall Study|Lost to Follow-up|2|||
24970636|NCT04052620|50060207|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
24970637|NCT04052620|50060208|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
24970638|NCT04052620|50060207|FG000|Overall Study|Withdrawal by Subject|1|||
24970639|NCT04052620|50060208|FG001|Overall Study|Withdrawal by Subject|0|||
24970640|NCT04052620|50060207|FG000|Overall Study|Lost to Follow-up|1|||
24970641|NCT04052620|50060208|FG001|Overall Study|Lost to Follow-up|1|||
24970642|NCT04052620|50060207|FG000|Overall Study|Adverse Event|1|||
24970643|NCT04052620|50060208|FG001|Overall Study|Adverse Event|0|||
24970644|NCT04052620|50060207|FG000|Overall Study|Subject did not meet study Criteria|0|||
24970645|NCT04052620|50060208|FG001|Overall Study|Subject did not meet study Criteria|1|||
24970646|NCT04052620|50060207|FG000|Overall Study|Screened failure, randomized by mistake|0|||
24970647|NCT04052620|50060208|FG001|Overall Study|Screened failure, randomized by mistake|1|||
24970648|NCT04052620|50060207|FG000|Overall Study|Personal reasons|2|||
24970649|NCT04052620|50060208|FG001|Overall Study|Personal reasons|4|||
24970650|NCT04052620|50060207|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
24970651|NCT04052620|50060208|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
24970652|NCT00112580|50060216|FG000|Overall Study|Adverse Event|1|||
24970653|NCT00112580|50060217|FG001|Overall Study|Adverse Event|2|||
24970654|NCT00112580|50060216|FG000|Overall Study|Disease progression|5|||
24970655|NCT00112580|50060217|FG001|Overall Study|Disease progression|16|||
24970656|NCT00112580|50060216|FG000|Overall Study|Participant withdrew consent|2|||
24970657|NCT00112580|50060217|FG001|Overall Study|Participant withdrew consent|1|||
24970658|NCT04238650|50060224|FG000|Overall Study|Withdrawal by Subject|0|||
24970659|NCT04238650|50060225|FG001|Overall Study|Withdrawal by Subject|1|||
24970660|NCT00095576|50060233|FG000|Overall Study|Adverse Event|5|||
24970661|NCT00095576|50060234|FG001|Overall Study|Adverse Event|3|||
24970662|NCT00095576|50060233|FG000|Overall Study|Lost to Follow-up|233|||
24970663|NCT00095576|50060234|FG001|Overall Study|Lost to Follow-up|229|||
24970664|NCT00095576|50060233|FG000|Overall Study|Protocol Violation|1|||
24970665|NCT00095576|50060234|FG001|Overall Study|Protocol Violation|0|||
24970666|NCT00095576|50060233|FG000|Overall Study|Withdrawal by Subject|34|||
24970667|NCT00095576|50060234|FG001|Overall Study|Withdrawal by Subject|47|||
24970668|NCT00095576|50060233|FG000|Overall Study|Option to switch to a rollover study|1097|||
24970669|NCT00095576|50060234|FG001|Overall Study|Option to switch to a rollover study|1099|||
24970670|NCT00095576|50060233|FG000|Overall Study|Site terminated|75|||
24970671|NCT00095576|50060234|FG001|Overall Study|Site terminated|67|||
24970672|NCT00095576|50060233|FG000|Overall Study|Subject moved|30|||
24970673|NCT00095576|50060234|FG001|Overall Study|Subject moved|36|||
24970674|NCT04049578|50060240|FG000|Overall Study|Physician Decision|1|||
24970675|NCT04044352|50060244|FG000|Overall Study|Lost to Follow-up|9|||
24970676|NCT04044352|50060244|FG000|Overall Study|Withdrawal by Subject|2|||
24970677|NCT04043962|50060249|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
24970678|NCT04043962|50060249|FG000|Post-Treatment|Withdrawal by Subject|5|||
24970679|NCT04043962|50060249|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
24970680|NCT04043728|50060256|FG000|Overall Study|Lost to Follow-up|1|||
25071580|NCT00700635|50177880|FG002|Overall Study|Protocol Violation|0|||
24970681|NCT04043728|50060257|FG001|Overall Study|Lost to Follow-up|2|||
24970682|NCT04043728|50060258|FG002|Overall Study|Lost to Follow-up|0|||
24970683|NCT04043416|50060268|FG000|Washout|Change in health condition|0|||
24970684|NCT04043416|50060269|FG001|Washout|Change in health condition|1|||
24970685|NCT00095498|50060281|FG000|Overall Study|Physician Decision|9|||
25071581|NCT00700635|50177878|FG000|Overall Study|Withdrawal by Subject|7|||
24970686|NCT00095498|50060282|FG001|Overall Study|Physician Decision|10|||
24970687|NCT00095498|50060283|FG002|Overall Study|Physician Decision|8|||
24970688|NCT00095498|50060281|FG000|Overall Study|Adverse Event|1|||
24970689|NCT00095498|50060282|FG001|Overall Study|Adverse Event|0|||
24970690|NCT00095498|50060283|FG002|Overall Study|Adverse Event|1|||
24970691|NCT00095498|50060281|FG000|Overall Study|Withdrawal by Subject|15|||
24970692|NCT00095498|50060282|FG001|Overall Study|Withdrawal by Subject|16|||
24970693|NCT00095498|50060283|FG002|Overall Study|Withdrawal by Subject|15|||
24970694|NCT00095498|50060281|FG000|Overall Study|Disease progression|0|||
24970695|NCT00095498|50060282|FG001|Overall Study|Disease progression|1|||
24970696|NCT00095498|50060283|FG002|Overall Study|Disease progression|1|||
24970697|NCT00095498|50060281|FG000|Overall Study|Ineligibility determined|3|||
24970698|NCT00095498|50060282|FG001|Overall Study|Ineligibility determined|0|||
24970699|NCT00095498|50060283|FG002|Overall Study|Ineligibility determined|2|||
24970700|NCT00095498|50060281|FG000|Overall Study|Lost to Follow-up|1|||
24970701|NCT00095498|50060282|FG001|Overall Study|Lost to Follow-up|1|||
24970702|NCT00095498|50060283|FG002|Overall Study|Lost to Follow-up|2|||
24970703|NCT00095498|50060281|FG000|Overall Study|Noncompliance|1|||
24970704|NCT00095498|50060282|FG001|Overall Study|Noncompliance|0|||
24970705|NCT00095498|50060283|FG002|Overall Study|Noncompliance|1|||
24970706|NCT00095498|50060281|FG000|Overall Study|Other|6|||
24970707|NCT00095498|50060282|FG001|Overall Study|Other|7|||
24970708|NCT00095498|50060283|FG002|Overall Study|Other|6|||
24970709|NCT00095498|50060281|FG000|Overall Study|Protocol Violation|0|||
24970710|NCT00095498|50060282|FG001|Overall Study|Protocol Violation|0|||
24970711|NCT00095498|50060283|FG002|Overall Study|Protocol Violation|1|||
24970712|NCT00095498|50060281|FG000|Overall Study|Requirement for alternative therapy|1|||
24970713|NCT00095498|50060282|FG001|Overall Study|Requirement for alternative therapy|0|||
24970714|NCT00095498|50060283|FG002|Overall Study|Requirement for alternative therapy|2|||
24970715|NCT04237792|50060297|FG000|Treatment (Day 1)|Adverse Event|1|||
24970716|NCT04237792|50060298|FG001|Treatment (Day 1)|Adverse Event|0|||
24970717|NCT04237792|50060299|FG002|Treatment (Day 1)|Adverse Event|0|||
24970718|NCT04237792|50060300|FG003|Treatment (Day 1)|Adverse Event|0|||
24970719|NCT04237792|50060301|FG004|Treatment (Day 1)|Adverse Event|1|||
24970720|NCT04237792|50060302|FG005|Treatment (Day 1)|Adverse Event|1|||
24970721|NCT04237792|50060297|FG000|Treatment (Day 1)|Other|0|||
24970722|NCT04237792|50060298|FG001|Treatment (Day 1)|Other|0|||
24970723|NCT04237792|50060299|FG002|Treatment (Day 1)|Other|1|||
24970724|NCT04237792|50060300|FG003|Treatment (Day 1)|Other|0|||
24970725|NCT04237792|50060301|FG004|Treatment (Day 1)|Other|0|||
24970726|NCT04237792|50060302|FG005|Treatment (Day 1)|Other|1|||
24970727|NCT04237792|50060297|FG000|Treatment (Day 1)|Not treated|1|||
24970728|NCT04237792|50060298|FG001|Treatment (Day 1)|Not treated|1|||
24970729|NCT04237792|50060299|FG002|Treatment (Day 1)|Not treated|2|||
24970730|NCT04237792|50060300|FG003|Treatment (Day 1)|Not treated|1|||
24970731|NCT04237792|50060301|FG004|Treatment (Day 1)|Not treated|0|||
24970732|NCT04237792|50060302|FG005|Treatment (Day 1)|Not treated|1|||
24970733|NCT04233580|50060333|FG000|Overall Study|Adverse Event|3|||
24970734|NCT04233580|50060334|FG001|Overall Study|Adverse Event|3|||
24970735|NCT04233580|50060333|FG000|Overall Study|Withdrawal by Subject|2|||
24970736|NCT04233580|50060334|FG001|Overall Study|Withdrawal by Subject|1|||
24970737|NCT00122954|50060342|FG000|Overall Study|Withdrawal by Subject|2|||
24970738|NCT00122954|50060343|FG001|Overall Study|Withdrawal by Subject|2|||
24970739|NCT00122954|50060342|FG000|Overall Study|Protocol Violation|0|||
24970740|NCT00122954|50060343|FG001|Overall Study|Protocol Violation|1|||
24970741|NCT04491994|50060351|FG000|Overall Study|Withdrawal by Subject|10|||
24970742|NCT04491994|50060352|FG001|Overall Study|Withdrawal by Subject|5|||
24970743|NCT04491994|50060351|FG000|Overall Study|developed fever > 3 days|4|||
24970744|NCT04491994|50060352|FG001|Overall Study|developed fever > 3 days|1|||
24970745|NCT04491994|50060351|FG000|Overall Study|Protocol Violation|11|||
24970746|NCT04491994|50060352|FG001|Overall Study|Protocol Violation|2|||
24970747|NCT04491994|50060351|FG000|Overall Study|Lost to Follow-up|4|||
24970748|NCT04491994|50060352|FG001|Overall Study|Lost to Follow-up|3|||
24970749|NCT04041700|50060358|FG000|Overall Study|Pregnancy|1|||
24970750|NCT04041700|50060358|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
25192317|NCT02579382|50358022|FG001|Main Study Phase|Lost to Follow-up|0|||
24970751|NCT04227340|50060364|FG000|Overall Study|Withdrawal by Subject|3|||
24970752|NCT04033432|50060371|FG000|Overall Study|Progressive Disease|8|||
24970753|NCT04033432|50060371|FG000|Overall Study|Adverse Event|4|||
25192318|NCT02579382|50358023|FG002|Main Study Phase|Lost to Follow-up|2|||
24970754|NCT04033432|50060371|FG000|Overall Study|Death|1|||
24970755|NCT04223830|50060376|FG000|Overall Study|Lost to Follow-up|9|||
24970756|NCT04223830|50060376|FG000|Overall Study|Adverse Event|1|||
25192319|NCT02579382|50358024|FG003|Main Study Phase|Lost to Follow-up|0|||
24970757|NCT04032652|50060383|FG000|Overall Study|The study was terminated and the PI has|1|||
24970758|NCT04032652|50060384|FG001|Overall Study|The study was terminated and the PI has|1|||
25192320|NCT02579382|50358021|FG000|Main Study Phase|Withdrew Consent|0|||
24970759|NCT04031404|50060390|FG000|Baseline|Lost to Follow-up|0|||
24970760|NCT04031404|50060391|FG001|Baseline|Lost to Follow-up|1|||
24970761|NCT04031404|50060390|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
24970762|NCT04031404|50060391|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
24970763|NCT04031404|50060390|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
24970764|NCT04031404|50060391|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
24970765|NCT04031404|50060390|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
24970766|NCT04031404|50060391|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
24970767|NCT04031404|50060390|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
24970768|NCT04031404|50060391|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
24970769|NCT04476784|50060407|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
24970770|NCT04476784|50060408|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
24970771|NCT04026568|50060419|FG000|Overall Study|study terminated|0|||
24970772|NCT04026568|50060420|FG001|Overall Study|study terminated|1|||
24970773|NCT04025632|50060428|FG000|Overall Study|Adverse Event|1|||
24970774|NCT04025632|50060429|FG001|Overall Study|Adverse Event|1|||
24970775|NCT04025632|50060428|FG000|Overall Study|Withdrawal by Subject|1|||
24970776|NCT04025632|50060429|FG001|Overall Study|Withdrawal by Subject|1|||
25314204|NCT00658021|50629906|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
25314205|NCT00920816|50629920|FG000|Overall Study|Death|116|||
25314206|NCT00920816|50629921|FG001|Overall Study|Death|63|||
25314207|NCT00920816|50629922|FG002|Overall Study|Death|8|||
25314208|NCT00920816|50629923|FG003|Overall Study|Death|3|||
25314209|NCT00920816|50629920|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
25314210|NCT00920816|50629921|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
25314211|NCT00920816|50629922|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
25314212|NCT00920816|50629923|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
25314213|NCT00920816|50629920|FG000|Overall Study|Global deterioration of health status|2|||
24970777|NCT04025632|50060428|FG000|Overall Study|Study Terminated by Sponsor|10|||
24970778|NCT04025632|50060429|FG001|Overall Study|Study Terminated by Sponsor|9|||
24970779|NCT04025632|50060428|FG000|Overall Study|Physician Decision|3|||
24970780|NCT04025632|50060429|FG001|Overall Study|Physician Decision|1|||
25314214|NCT00920816|50629921|FG001|Overall Study|Global deterioration of health status|0|||
25314215|NCT00920816|50629922|FG002|Overall Study|Global deterioration of health status|0|||
25314216|NCT00920816|50629923|FG003|Overall Study|Global deterioration of health status|0|||
25314217|NCT00920816|50629920|FG000|Overall Study|Objective progression or relapse|6|||
25314218|NCT00920816|50629921|FG001|Overall Study|Objective progression or relapse|2|||
25314219|NCT00920816|50629922|FG002|Overall Study|Objective progression or relapse|0|||
25314220|NCT00920816|50629923|FG003|Overall Study|Objective progression or relapse|0|||
25314221|NCT00920816|50629920|FG000|Overall Study|Other|26|||
25314222|NCT00920816|50629921|FG001|Overall Study|Other|15|||
25314223|NCT00920816|50629922|FG002|Overall Study|Other|1|||
24970781|NCT04024228|50060440|FG000|Overall Study|Adverse Event|1|||
25071582|NCT00700635|50177879|FG001|Overall Study|Withdrawal by Subject|3|||
25071583|NCT00700635|50177880|FG002|Overall Study|Withdrawal by Subject|1|||
25071584|NCT02780687|50177890|FG000|Overall Study|Adverse Event|1|||
25071585|NCT02780687|50177891|FG001|Overall Study|Adverse Event|1|||
25071586|NCT02780687|50177890|FG000|Overall Study|Withdrawal by Subject|2|||
25071587|NCT02780687|50177891|FG001|Overall Study|Withdrawal by Subject|1|||
25071588|NCT02780687|50177890|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
25071589|NCT02780687|50177891|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
25071590|NCT02780687|50177890|FG000|Overall Study|progressive disease|29|||
25071591|NCT02780687|50177891|FG001|Overall Study|progressive disease|6|||
25071592|NCT02698371|50177896|FG000|All Participants Flow|Lost to Follow-up|3|||
25071593|NCT02698371|50177896|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
25071594|NCT02698371|50177896|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
25071595|NCT02698371|50177896|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
25071596|NCT02698371|50177896|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
25071597|NCT02698371|50177896|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
25071598|NCT02698371|50177896|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
25071599|NCT02781311|50177915|FG000|Overall Study|Adverse Event|2|||
25071600|NCT02781311|50177916|FG001|Overall Study|Adverse Event|6|||
25192321|NCT02579382|50358022|FG001|Main Study Phase|Withdrew Consent|0|||
25314224|NCT00920816|50629923|FG003|Overall Study|Other|2|||
25314225|NCT00920816|50629920|FG000|Overall Study|Lost to Follow-up|11|||
25314226|NCT00920816|50629921|FG001|Overall Study|Lost to Follow-up|2|||
24970782|NCT04024228|50060441|FG001|Overall Study|Adverse Event|0|||
24970783|NCT04024228|50060440|FG000|Overall Study|Protocol Deviation|0|||
24970784|NCT04024228|50060441|FG001|Overall Study|Protocol Deviation|2|||
24970785|NCT04024228|50060440|FG000|Overall Study|Withdrawal by Subject|3|||
25071601|NCT02781311|50177917|FG002|Overall Study|Adverse Event|1|||
25071602|NCT02781311|50177915|FG000|Overall Study|Withdrawal of Consent|11|||
25071603|NCT02781311|50177916|FG001|Overall Study|Withdrawal of Consent|12|||
25314227|NCT00920816|50629922|FG002|Overall Study|Lost to Follow-up|0|||
25314228|NCT00920816|50629923|FG003|Overall Study|Lost to Follow-up|0|||
25314229|NCT00920816|50629920|FG000|Overall Study|Adverse Event|1|||
25314230|NCT00920816|50629921|FG001|Overall Study|Adverse Event|1|||
25314231|NCT00920816|50629922|FG002|Overall Study|Adverse Event|1|||
25314232|NCT00920816|50629923|FG003|Overall Study|Adverse Event|0|||
25314233|NCT00920816|50629920|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
25314234|NCT00920816|50629921|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
25314235|NCT00920816|50629922|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
25314236|NCT00920816|50629923|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
25314237|NCT00920816|50629920|FG000|Overall Study|Randomized but not treated|3|||
24970786|NCT04024228|50060441|FG001|Overall Study|Withdrawal by Subject|4|||
24970787|NCT04023994|50060455|FG000|Overall Study|Lost to Follow-up|0|||
24970788|NCT04023994|50060456|FG001|Overall Study|Lost to Follow-up|1|||
24970789|NCT04023994|50060457|FG002|Overall Study|Lost to Follow-up|2|||
24970790|NCT04023994|50060458|FG003|Overall Study|Lost to Follow-up|0|||
24970791|NCT04023994|50060459|FG004|Overall Study|Lost to Follow-up|0|||
24970792|NCT04023994|50060460|FG005|Overall Study|Lost to Follow-up|0|||
24970793|NCT04023994|50060455|FG000|Overall Study|Withdrawal by Subject|0|||
24970794|NCT04023994|50060456|FG001|Overall Study|Withdrawal by Subject|0|||
24970795|NCT04023994|50060457|FG002|Overall Study|Withdrawal by Subject|0|||
24970796|NCT04023994|50060458|FG003|Overall Study|Withdrawal by Subject|1|||
24970797|NCT04023994|50060459|FG004|Overall Study|Withdrawal by Subject|0|||
24970798|NCT04023994|50060460|FG005|Overall Study|Withdrawal by Subject|0|||
24970799|NCT04023682|50060479|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
25314238|NCT00920816|50629921|FG001|Overall Study|Randomized but not treated|0|||
25314239|NCT00920816|50629922|FG002|Overall Study|Randomized but not treated|0|||
25314240|NCT00920816|50629923|FG003|Overall Study|Randomized but not treated|0|||
25314241|NCT00657709|50629938|FG000|Overall Study|AE or Death|7|||
25314242|NCT00657709|50629939|FG001|Overall Study|AE or Death|7|||
25314243|NCT00657709|50629940|FG002|Overall Study|AE or Death|6|||
25314244|NCT00657709|50629941|FG003|Overall Study|AE or Death|7|||
25314245|NCT00657709|50629942|FG004|Overall Study|AE or Death|1|||
25314246|NCT00657709|50629938|FG000|Overall Study|Withdrawal by Subject|7|||
25314247|NCT00657709|50629939|FG001|Overall Study|Withdrawal by Subject|15|||
25314248|NCT00657709|50629940|FG002|Overall Study|Withdrawal by Subject|15|||
25314249|NCT00657709|50629941|FG003|Overall Study|Withdrawal by Subject|5|||
25314250|NCT00657709|50629942|FG004|Overall Study|Withdrawal by Subject|9|||
25314251|NCT00657709|50629938|FG000|Overall Study|Lost to Follow-up|9|||
25314252|NCT00657709|50629939|FG001|Overall Study|Lost to Follow-up|9|||
25314253|NCT00657709|50629940|FG002|Overall Study|Lost to Follow-up|7|||
25314254|NCT00657709|50629941|FG003|Overall Study|Lost to Follow-up|1|||
25314255|NCT00657709|50629942|FG004|Overall Study|Lost to Follow-up|21|||
25314256|NCT00657709|50629938|FG000|Overall Study|Protocol Violation|0|||
25314257|NCT00657709|50629939|FG001|Overall Study|Protocol Violation|2|||
25314258|NCT00657709|50629940|FG002|Overall Study|Protocol Violation|0|||
25314259|NCT00657709|50629941|FG003|Overall Study|Protocol Violation|1|||
25314260|NCT00657709|50629942|FG004|Overall Study|Protocol Violation|2|||
25314261|NCT00915356|50629969|FG000|Overall Study|Withdrawal by Subject|1|||
25314262|NCT00915356|50629970|FG001|Overall Study|Withdrawal by Subject|0|||
25314263|NCT00915356|50629971|FG002|Overall Study|Withdrawal by Subject|0|||
25314264|NCT00915356|50629972|FG003|Overall Study|Withdrawal by Subject|0|||
25314265|NCT00915356|50629973|FG004|Overall Study|Withdrawal by Subject|0|||
25314266|NCT00657553|50629987|FG000|Overall Study|low accrual, no analysis run|5|||
25314267|NCT00657553|50629988|FG001|Overall Study|low accrual, no analysis run|5|||
25314268|NCT00862719|50629998|FG000|Overall Study|Disease Progression|5|||
25314269|NCT00862719|50629999|FG001|Overall Study|Disease Progression|0|||
25314270|NCT00862719|50630000|FG002|Overall Study|Disease Progression|1|||
25314271|NCT00862719|50630001|FG003|Overall Study|Disease Progression|0|||
25314272|NCT00862719|50629998|FG000|Overall Study|Death|5|||
25314273|NCT00862719|50629999|FG001|Overall Study|Death|6|||
25314274|NCT00862719|50630000|FG002|Overall Study|Death|1|||
25314275|NCT00862719|50630001|FG003|Overall Study|Death|1|||
25314276|NCT00862719|50629998|FG000|Overall Study|Engraftment failure|0|||
25314277|NCT00862719|50629999|FG001|Overall Study|Engraftment failure|0|||
24970800|NCT04018612|50060490|FG000|Overall Study|Withdrawal by Subject|1|||
24970801|NCT04018612|50060491|FG001|Overall Study|Withdrawal by Subject|0|||
25314278|NCT00862719|50630000|FG002|Overall Study|Engraftment failure|1|||
25314279|NCT00862719|50630001|FG003|Overall Study|Engraftment failure|0|||
24970802|NCT04018612|50060492|FG002|Overall Study|Withdrawal by Subject|1|||
24970803|NCT04018066|50060500|FG000|Overall Study|participants started taking medications during the study period|3|||
25314280|NCT00862719|50629998|FG000|Overall Study|Veno-Occlusive Disease|0|||
25314281|NCT00862719|50629999|FG001|Overall Study|Veno-Occlusive Disease|0|||
25314282|NCT00862719|50630000|FG002|Overall Study|Veno-Occlusive Disease|1|||
25314283|NCT00862719|50630001|FG003|Overall Study|Veno-Occlusive Disease|0|||
25314284|NCT00862641|50630015|FG000|Overall Study|Randomized, but drug not received|1|||
25314285|NCT00862641|50630016|FG001|Overall Study|Randomized, but drug not received|4|||
25314286|NCT00862641|50630017|FG002|Overall Study|Randomized, but drug not received|1|||
25314287|NCT00862641|50630018|FG003|Overall Study|Randomized, but drug not received|4|||
25314288|NCT00861471|50630028|FG000|Overall Study|Withdrawal by Subject|1|||
25314289|NCT00861471|50630028|FG000|Overall Study|Adverse Event|2|||
25314290|NCT00861471|50630028|FG000|Overall Study|Lack of Efficacy|3|||
25314291|NCT00861471|50630028|FG000|Overall Study|treatment for lumbar laminectomy|1|||
25314292|NCT00861471|50630028|FG000|Overall Study|Physician Decision|2|||
25314293|NCT00860067|50630035|FG000|Overall Study|Lost to Follow-up|46|||
25314294|NCT00860067|50630036|FG001|Overall Study|Lost to Follow-up|9|||
25314295|NCT00860067|50630037|FG002|Overall Study|Lost to Follow-up|9|||
25314296|NCT00860067|50630035|FG000|Overall Study|Withdrawal by Subject|4|||
25314297|NCT00860067|50630036|FG001|Overall Study|Withdrawal by Subject|0|||
25314298|NCT00860067|50630037|FG002|Overall Study|Withdrawal by Subject|0|||
25314299|NCT00860067|50630035|FG000|Overall Study|Pregnancy|1|||
25314300|NCT00860067|50630036|FG001|Overall Study|Pregnancy|0|||
25314301|NCT00860067|50630037|FG002|Overall Study|Pregnancy|0|||
25314302|NCT00858117|50630048|FG000|Treatment on Study|Adverse Event|2|||
25314303|NCT00858117|50630048|FG000|Follow up for 5 Years|Death|4|||
25314304|NCT00858117|50630048|FG000|Follow up for 5 Years|No further data collected for study|9|||
25314305|NCT00652951|50630055|FG000|Booster Phase|Adverse event, non-fatal|0|||
25314306|NCT00652951|50630056|FG001|Booster Phase|Adverse event, non-fatal|1|||
25314307|NCT00652951|50630057|FG002|Booster Phase|Adverse event, non-fatal|0|||
25314308|NCT00652951|50630055|FG000|Booster Phase|Other|1|||
25314309|NCT00652951|50630056|FG001|Booster Phase|Other|0|||
25314310|NCT00652951|50630057|FG002|Booster Phase|Other|0|||
25314311|NCT00848211|50630069|FG000|Overall Study|Protocol Violation|0|||
25314312|NCT00848211|50630070|FG001|Overall Study|Protocol Violation|1|||
25314313|NCT00848211|50630071|FG002|Overall Study|Protocol Violation|1|||
25314314|NCT00848211|50630072|FG003|Overall Study|Protocol Violation|0|||
25314315|NCT00848211|50630069|FG000|Overall Study|Adverse Event|0|||
25314316|NCT00848211|50630070|FG001|Overall Study|Adverse Event|0|||
25314317|NCT00848211|50630071|FG002|Overall Study|Adverse Event|0|||
25314318|NCT00848211|50630072|FG003|Overall Study|Adverse Event|0|||
25314319|NCT00592683|50630084|FG000|Overall Study|Found ineligible|0|||
25314320|NCT00592683|50630085|FG001|Overall Study|Found ineligible|1|||
25314321|NCT00592683|50630084|FG000|Overall Study|Withdrawal by Subject|1|||
25314322|NCT00592683|50630085|FG001|Overall Study|Withdrawal by Subject|0|||
25314323|NCT00592683|50630084|FG000|Overall Study|Adverse Event|0|||
25314324|NCT00592683|50630085|FG001|Overall Study|Adverse Event|2|||
25314325|NCT00592683|50630084|FG000|Overall Study|Protocol Violation|1|||
25314326|NCT00592683|50630085|FG001|Overall Study|Protocol Violation|0|||
25314327|NCT00592683|50630084|FG000|Overall Study|Study drug expired|1|||
25314328|NCT00592683|50630085|FG001|Overall Study|Study drug expired|0|||
25314329|NCT00592683|50630084|FG000|Overall Study|Other|1|||
25314330|NCT00592683|50630085|FG001|Overall Study|Other|0|||
25314331|NCT00592683|50630084|FG000|Overall Study|Lost to Follow-up|0|||
25314332|NCT00592683|50630085|FG001|Overall Study|Lost to Follow-up|1|||
25314333|NCT00847665|50630093|FG000|Overall Study|Withdrawal by Subject|1|||
25314334|NCT00847665|50630094|FG001|Overall Study|Withdrawal by Subject|0|||
25314335|NCT00916370|50630102|FG000|Overall Study|Death|3|||
25314336|NCT00916370|50630103|FG001|Overall Study|Death|1|||
25314337|NCT00916370|50630102|FG000|Overall Study|Withdrawal by Subject|2|||
25314338|NCT00916370|50630103|FG001|Overall Study|Withdrawal by Subject|0|||
25314339|NCT00916370|50630102|FG000|Overall Study|Physician Decision|0|||
25314340|NCT00916370|50630103|FG001|Overall Study|Physician Decision|1|||
25314341|NCT00847197|50630112|FG000|Overall Study|Adverse Event|21|||
25314342|NCT00847197|50630113|FG001|Overall Study|Adverse Event|3|||
25314343|NCT00847197|50630112|FG000|Overall Study|Protocol Violation|0|||
25314344|NCT00847197|50630113|FG001|Overall Study|Protocol Violation|1|||
25314345|NCT00847197|50630112|FG000|Overall Study|Withdrawal by Subject|3|||
25314346|NCT00847197|50630113|FG001|Overall Study|Withdrawal by Subject|1|||
24970804|NCT04018066|50060500|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
24970805|NCT04209400|50060507|FG000|Overall Study|Withdrawal by Subject|0|||
24970806|NCT04209400|50060508|FG001|Overall Study|Withdrawal by Subject|1|||
25314347|NCT00654901|50630123|FG000|Overall Study|Lost to Follow-up|1|||
25314348|NCT00654901|50630124|FG001|Overall Study|Lost to Follow-up|0|||
25314349|NCT00654901|50630125|FG002|Overall Study|Lost to Follow-up|1|||
25314350|NCT00654901|50630126|FG003|Overall Study|Lost to Follow-up|0|||
25314351|NCT00654901|50630123|FG000|Overall Study|Withdrawal by Subject|3|||
25192322|NCT02579382|50358023|FG002|Main Study Phase|Withdrew Consent|0|||
25192323|NCT02579382|50358024|FG003|Main Study Phase|Withdrew Consent|2|||
25314352|NCT00654901|50630124|FG001|Overall Study|Withdrawal by Subject|0|||
24970807|NCT04207840|50060514|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
24970808|NCT04207840|50060515|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
24970809|NCT04207840|50060516|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
25071604|NCT02781311|50177917|FG002|Overall Study|Withdrawal of Consent|2|||
25071605|NCT02781311|50177915|FG000|Overall Study|Lost to Follow-up|11|||
25071606|NCT02781311|50177916|FG001|Overall Study|Lost to Follow-up|8|||
25071607|NCT02781311|50177917|FG002|Overall Study|Lost to Follow-up|1|||
25071608|NCT02781311|50177915|FG000|Overall Study|Non-Compliance with Study Drug|2|||
25071609|NCT02781311|50177916|FG001|Overall Study|Non-Compliance with Study Drug|0|||
25071610|NCT02781311|50177917|FG002|Overall Study|Non-Compliance with Study Drug|0|||
25071611|NCT02564198|50177927|FG000|Overall Study|Withdrawal by Subject|2|||
25071612|NCT02564198|50177928|FG001|Overall Study|Withdrawal by Subject|4|||
25071613|NCT02564198|50177929|FG002|Overall Study|Withdrawal by Subject|0|||
25071614|NCT02564198|50177927|FG000|Overall Study|Adverse Event|0|||
25071615|NCT02564198|50177928|FG001|Overall Study|Adverse Event|1|||
25071616|NCT02564198|50177929|FG002|Overall Study|Adverse Event|0|||
25071617|NCT02564120|50177944|FG000|Overall Study|Did not return release forms|160|||
25071618|NCT02564120|50177944|FG000|Overall Study|Death|58|||
24970810|NCT04207840|50060514|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
24970811|NCT04207840|50060515|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
24970812|NCT04207840|50060516|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
24970813|NCT04006366|50060524|FG000|Overall Study|Withdrawal by Subject|1|||
24970814|NCT04191148|50060530|FG000|Overall Study|Withdrawal by Subject|1|||
24970815|NCT04191148|50060531|FG001|Overall Study|Withdrawal by Subject|0|||
24970816|NCT04191148|50060530|FG000|Overall Study|Adverse Event|1|||
24970817|NCT04191148|50060531|FG001|Overall Study|Adverse Event|0|||
24970818|NCT04004260|50060541|FG000|Overall Study|Withdrawal by Subject|7|||
24970819|NCT04004260|50060542|FG001|Overall Study|Withdrawal by Subject|3|||
24970820|NCT04004260|50060541|FG000|Overall Study|Lost to Follow-up|22|||
24970821|NCT04004260|50060542|FG001|Overall Study|Lost to Follow-up|12|||
24970822|NCT04004260|50060541|FG000|Overall Study|Did not engage in intervention|13|||
24970823|NCT04004260|50060542|FG001|Overall Study|Did not engage in intervention|17|||
24970824|NCT04470622|50060550|FG000|Overall Study|Withdrawal by Subject|0|||
24970825|NCT04470622|50060551|FG001|Overall Study|Withdrawal by Subject|1|||
24970826|NCT04470622|50060550|FG000|Overall Study|Screen Failure|0|||
24970827|NCT04470622|50060551|FG001|Overall Study|Screen Failure|1|||
25314353|NCT00654901|50630125|FG002|Overall Study|Withdrawal by Subject|1|||
24970828|NCT04470622|50060550|FG000|Overall Study|Death|0|||
25314354|NCT00654901|50630126|FG003|Overall Study|Withdrawal by Subject|0|||
24970829|NCT04470622|50060551|FG001|Overall Study|Death|1|||
24970830|NCT04465630|50060557|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
24970831|NCT04465630|50060557|FG000|Overall Study|Screen failure|8|||
25071619|NCT02564120|50177944|FG000|Overall Study|Withdrawal by Subject|204|||
25071620|NCT02564120|50177944|FG000|Overall Study|Other medical condition|24|||
25192324|NCT02579382|50358021|FG000|Main Study Phase|Lack of Efficacy|0|||
25192325|NCT02579382|50358022|FG001|Main Study Phase|Lack of Efficacy|0|||
25192326|NCT02579382|50358023|FG002|Main Study Phase|Lack of Efficacy|0|||
25192327|NCT02579382|50358024|FG003|Main Study Phase|Lack of Efficacy|1|||
25192328|NCT02579382|50358021|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
25192329|NCT02579382|50358022|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
25192330|NCT02579382|50358023|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
25192331|NCT02579382|50358024|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
25192332|NCT02579382|50358021|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
25192333|NCT02579382|50358022|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
25314355|NCT00846807|50630136|FG000|Overall Study|Adverse Event|270|||
24970832|NCT04465630|50060557|FG000|Overall Study|Baseline failure|16|||
25314356|NCT00846807|50630136|FG000|Overall Study|Lost to Follow-up|94|||
25314357|NCT00846807|50630136|FG000|Overall Study|Withdrawal by Subject|56|||
25314358|NCT00846807|50630136|FG000|Overall Study|Non compliant with European label|7|||
25314359|NCT00846807|50630136|FG000|Overall Study|Switch to other anticoagulants|89|||
25314360|NCT00846807|50630136|FG000|Overall Study|No prescription after hospital discharge|56|||
25314361|NCT00846807|50630136|FG000|Overall Study|Other|60|||
25314362|NCT00846495|50630142|FG000|Overall Study|Lost to Follow-up|1|||
25314363|NCT00846495|50630143|FG001|Overall Study|Lost to Follow-up|0|||
25314364|NCT00846495|50630142|FG000|Overall Study|Adverse Event|5|||
25314365|NCT00846495|50630143|FG001|Overall Study|Adverse Event|1|||
25314366|NCT00846495|50630142|FG000|Overall Study|Lack of Efficacy|1|||
25314367|NCT00846495|50630143|FG001|Overall Study|Lack of Efficacy|2|||
25314368|NCT00846495|50630142|FG000|Overall Study|Physician Decision|1|||
25314369|NCT00846495|50630143|FG001|Overall Study|Physician Decision|0|||
25314370|NCT00654745|50630149|FG000|Overall Study|Adverse Event|12|||
25314371|NCT00654745|50630149|FG000|Overall Study|Lost to Follow-up|7|||
25314372|NCT00654745|50630149|FG000|Overall Study|Protocol Violation|11|||
25314373|NCT00654745|50630149|FG000|Overall Study|Withdrawal by Subject|10|||
24970833|NCT04182880|50060564|FG000|Overall Study|Pregnancy|1|||
24970834|NCT04182880|50060565|FG001|Overall Study|Pregnancy|0|||
25169580|NCT03730662|50302312|FG000|Variable Treatment Period|Lost to Follow-up|2|||
25314374|NCT00654745|50630149|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
25314375|NCT00846027|50630159|FG000|Overall Study|Death|3|||
25314376|NCT00846027|50630159|FG000|Overall Study|Disease Progression|30|||
25314377|NCT00846027|50630159|FG000|Overall Study|Toxicity|12|||
25071621|NCT00705783|50177960|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
25071622|NCT00705783|50177961|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
25071623|NCT00705783|50177962|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
25071624|NCT00705783|50177960|FG000|Conversion Phase|Lost to Follow-up|13|||
25071625|NCT00705783|50177961|FG001|Conversion Phase|Lost to Follow-up|0|||
25071626|NCT00705783|50177962|FG002|Conversion Phase|Lost to Follow-up|0|||
25071627|NCT00705783|50177960|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
25071628|NCT00705783|50177961|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
25071629|NCT00705783|50177962|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
25071630|NCT00705783|50177960|FG000|Conversion Phase|Withdrawn by Investigator|4|||
25071631|NCT00705783|50177961|FG001|Conversion Phase|Withdrawn by Investigator|0|||
25071632|NCT00705783|50177962|FG002|Conversion Phase|Withdrawn by Investigator|0|||
25071633|NCT00705783|50177960|FG000|Conversion Phase|Withdrew Consent|24|||
25071634|NCT00705783|50177961|FG001|Conversion Phase|Withdrew Consent|0|||
25071635|NCT00705783|50177962|FG002|Conversion Phase|Withdrew Consent|0|||
25071636|NCT00705783|50177960|FG000|Conversion Phase|Protocol Deviation|2|||
25071637|NCT00705783|50177961|FG001|Conversion Phase|Protocol Deviation|0|||
25071638|NCT00705783|50177962|FG002|Conversion Phase|Protocol Deviation|0|||
25071639|NCT00705783|50177960|FG000|Conversion Phase|Adverse Event|11|||
25314378|NCT00846027|50630159|FG000|Overall Study|Patient Decision|7|||
25314379|NCT00846027|50630159|FG000|Overall Study|Investigator Discretion|29|||
25314380|NCT00846027|50630159|FG000|Overall Study|Protocol Violation|2|||
25314381|NCT00846027|50630159|FG000|Overall Study|Subject Not Treated|7|||
25314382|NCT00646399|50630165|FG000|Overall Study|Death|63|||
25314383|NCT00646399|50630166|FG001|Overall Study|Death|53|||
25314384|NCT00646399|50630165|FG000|Overall Study|Withdrawal by Subject|9|||
25314385|NCT00646399|50630166|FG001|Overall Study|Withdrawal by Subject|10|||
25314386|NCT00646399|50630165|FG000|Overall Study|Other Reason|11|||
25314387|NCT00646399|50630166|FG001|Overall Study|Other Reason|11|||
25314388|NCT00652327|50630174|FG000|Overall Study|Adverse Event|0|||
25314389|NCT00652327|50630175|FG001|Overall Study|Adverse Event|2|||
25314390|NCT00652327|50630174|FG000|Overall Study|Lost to Follow-up|0|||
25071640|NCT00705783|50177961|FG001|Conversion Phase|Adverse Event|0|||
25071641|NCT00705783|50177962|FG002|Conversion Phase|Adverse Event|0|||
25071642|NCT00705783|50177960|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
25071643|NCT00705783|50177961|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
25071644|NCT00705783|50177962|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
25314391|NCT00652327|50630175|FG001|Overall Study|Lost to Follow-up|3|||
25314392|NCT00645853|50630183|FG000|Overall Study|Adverse Event|18|||
25314393|NCT00645853|50630184|FG001|Overall Study|Adverse Event|7|||
25314394|NCT00645853|50630183|FG000|Overall Study|AZ study closure in Hungary|60|||
25314395|NCT00645853|50630184|FG001|Overall Study|AZ study closure in Hungary|40|||
25314396|NCT00645853|50630183|FG000|Overall Study|Withdrawal by Subject|5|||
25314397|NCT00645853|50630184|FG001|Overall Study|Withdrawal by Subject|2|||
25314398|NCT00645853|50630183|FG000|Overall Study|Protocol Violation|0|||
25314399|NCT00645853|50630184|FG001|Overall Study|Protocol Violation|2|||
25314400|NCT00645853|50630183|FG000|Overall Study|Discontinuation criteria|2|||
25314401|NCT00645853|50630184|FG001|Overall Study|Discontinuation criteria|2|||
25314402|NCT00645853|50630183|FG000|Overall Study|recall of ICF, planned operation, death|7|||
25314403|NCT00645853|50630184|FG001|Overall Study|recall of ICF, planned operation, death|4|||
25314404|NCT00652093|50630196|FG000|Overall Study|Withdrawal by Subject|0|||
25314405|NCT00652093|50630197|FG001|Overall Study|Withdrawal by Subject|0|||
25314406|NCT00652093|50630198|FG002|Overall Study|Withdrawal by Subject|1|||
25314407|NCT00652093|50630199|FG003|Overall Study|Withdrawal by Subject|0|||
25314408|NCT00652093|50630200|FG004|Overall Study|Withdrawal by Subject|1|||
25314409|NCT00652093|50630201|FG005|Overall Study|Withdrawal by Subject|0|||
25314410|NCT00652093|50630196|FG000|Overall Study|Physician Decision|0|||
25314411|NCT00652093|50630197|FG001|Overall Study|Physician Decision|0|||
25314412|NCT00652093|50630198|FG002|Overall Study|Physician Decision|0|||
25314413|NCT00652093|50630199|FG003|Overall Study|Physician Decision|0|||
25314414|NCT00652093|50630200|FG004|Overall Study|Physician Decision|1|||
25314415|NCT00652093|50630201|FG005|Overall Study|Physician Decision|0|||
25314416|NCT00651937|50630217|FG000|Overall Study|Withdrawal by Subject|4|||
25314417|NCT00651937|50630218|FG001|Overall Study|Withdrawal by Subject|1|||
25314418|NCT00654355|50630226|FG000|Overall Study|Lost to Follow-up|2|||
25314419|NCT00654355|50630227|FG001|Overall Study|Lost to Follow-up|2|||
25314420|NCT00651313|50630235|FG000|Overall Study|Adverse Event|0|||
25071645|NCT00705783|50177960|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
25314421|NCT00651313|50630236|FG001|Overall Study|Adverse Event|1|||
25314422|NCT00651313|50630235|FG000|Overall Study|Withdrawal by Subject|3|||
25314423|NCT00651313|50630236|FG001|Overall Study|Withdrawal by Subject|1|||
25314424|NCT00651313|50630235|FG000|Overall Study|Lost to Follow-up|1|||
25314425|NCT00651313|50630236|FG001|Overall Study|Lost to Follow-up|1|||
25314426|NCT00651313|50630235|FG000|Overall Study|Adminstrative Discontinuation|2|||
25314427|NCT00651313|50630236|FG001|Overall Study|Adminstrative Discontinuation|3|||
25314428|NCT00969761|50630254|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
25314429|NCT00969761|50630255|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
25314430|NCT00969761|50630256|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
25314431|NCT00969761|50630257|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
25314432|NCT00969761|50630258|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
25314433|NCT00969761|50630259|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
25314434|NCT00969761|50630260|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
25314435|NCT00969761|50630261|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
25169581|NCT03730662|50302313|FG001|Variable Treatment Period|Lost to Follow-up|1|||
25169582|NCT03730662|50302314|FG002|Variable Treatment Period|Lost to Follow-up|4|||
25169583|NCT03730662|50302315|FG003|Variable Treatment Period|Lost to Follow-up|11|||
25169584|NCT03730662|50302312|FG000|Variable Treatment Period|Personal Reason|0|||
25169585|NCT03730662|50302313|FG001|Variable Treatment Period|Personal Reason|2|||
25169586|NCT03730662|50302314|FG002|Variable Treatment Period|Personal Reason|1|||
25169587|NCT03730662|50302315|FG003|Variable Treatment Period|Personal Reason|6|||
25169588|NCT03730662|50302312|FG000|Variable Treatment Period|Physician Decision|0|||
25169589|NCT03730662|50302313|FG001|Variable Treatment Period|Physician Decision|0|||
25169590|NCT03730662|50302314|FG002|Variable Treatment Period|Physician Decision|0|||
25169591|NCT03730662|50302315|FG003|Variable Treatment Period|Physician Decision|3|||
25314436|NCT00969761|50630262|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
25169592|NCT03730662|50302312|FG000|Variable Treatment Period|Protocol Violation|0|||
25169593|NCT03730662|50302313|FG001|Variable Treatment Period|Protocol Violation|1|||
25169594|NCT03730662|50302314|FG002|Variable Treatment Period|Protocol Violation|1|||
25169595|NCT03730662|50302315|FG003|Variable Treatment Period|Protocol Violation|1|||
25169596|NCT03730662|50302312|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
25169597|NCT03730662|50302313|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
25169598|NCT03730662|50302314|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
25169599|NCT03730662|50302315|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
25169600|NCT03185832|50302430|FG000|Overall Study|Death|9|||
25169601|NCT03185832|50302431|FG001|Overall Study|Death|14|||
25169602|NCT03185832|50302432|FG002|Overall Study|Death|9|||
25169603|NCT03185832|50302433|FG003|Overall Study|Death|7|||
25169604|NCT03185832|50302430|FG000|Overall Study|Withdrawn - vital status available|0|||
25169605|NCT03185832|50302431|FG001|Overall Study|Withdrawn - vital status available|1|||
25169606|NCT03185832|50302432|FG002|Overall Study|Withdrawn - vital status available|1|||
25169607|NCT03185832|50302433|FG003|Overall Study|Withdrawn - vital status available|4|||
25169608|NCT04569786|50302485|FG000|Overall Study|Lost to Follow-up|1|||
25169609|NCT04569786|50302486|FG001|Overall Study|Lost to Follow-up|0|||
25169610|NCT04569786|50302487|FG002|Overall Study|Lost to Follow-up|4|||
25169611|NCT04569786|50302488|FG003|Overall Study|Lost to Follow-up|1|||
25169612|NCT04569786|50302489|FG004|Overall Study|Lost to Follow-up|0|||
25169613|NCT04569786|50302485|FG000|Overall Study|Withdrawal by Subject|0|||
25169614|NCT04569786|50302486|FG001|Overall Study|Withdrawal by Subject|0|||
25169615|NCT04569786|50302487|FG002|Overall Study|Withdrawal by Subject|0|||
25169616|NCT04569786|50302488|FG003|Overall Study|Withdrawal by Subject|5|||
25169617|NCT04569786|50302489|FG004|Overall Study|Withdrawal by Subject|1|||
25169618|NCT04569786|50302485|FG000|Overall Study|Physician Decision|0|||
25169619|NCT04569786|50302486|FG001|Overall Study|Physician Decision|0|||
25169620|NCT04569786|50302487|FG002|Overall Study|Physician Decision|0|||
25169621|NCT04569786|50302488|FG003|Overall Study|Physician Decision|1|||
25169622|NCT04569786|50302489|FG004|Overall Study|Physician Decision|0|||
25169623|NCT01826981|50302665|FG000|Overall Study|Lack of Efficacy|0|||
25169624|NCT01826981|50302666|FG001|Overall Study|Lack of Efficacy|1|||
25169625|NCT01826981|50302667|FG002|Overall Study|Lack of Efficacy|0|||
25314437|NCT00969761|50630263|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
25314438|NCT00969761|50630264|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
25314439|NCT00969761|50630265|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
25314440|NCT00969761|50630254|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
25314441|NCT00969761|50630255|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
25314442|NCT00969761|50630256|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
25314443|NCT00969761|50630257|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
25314444|NCT00969761|50630258|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
25314445|NCT00969761|50630259|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
25314446|NCT00969761|50630260|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
25314447|NCT00969761|50630261|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
25314448|NCT00969761|50630262|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
25314449|NCT00969761|50630263|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
25314450|NCT00969761|50630264|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
25314451|NCT00969761|50630265|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
25314452|NCT00969761|50630254|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
25314453|NCT00969761|50630255|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
25169626|NCT01826981|50302668|FG003|Overall Study|Lack of Efficacy|0|||
25169627|NCT01826981|50302669|FG004|Overall Study|Lack of Efficacy|5|||
25169628|NCT01826981|50302670|FG005|Overall Study|Lack of Efficacy|0|||
25169629|NCT01826981|50302671|FG006|Overall Study|Lack of Efficacy|0|||
25169630|NCT01826981|50302672|FG007|Overall Study|Lack of Efficacy|8|||
25169631|NCT01826981|50302673|FG008|Overall Study|Lack of Efficacy|7|||
25169632|NCT01826981|50302674|FG009|Overall Study|Lack of Efficacy|0|||
25169633|NCT01826981|50302675|FG010|Overall Study|Lack of Efficacy|1|||
25169634|NCT01826981|50302676|FG011|Overall Study|Lack of Efficacy|0|||
25169635|NCT01826981|50302677|FG012|Overall Study|Lack of Efficacy|0|||
25169636|NCT01826981|50302678|FG013|Overall Study|Lack of Efficacy|3|||
25169637|NCT01826981|50302679|FG014|Overall Study|Lack of Efficacy|0|||
25169638|NCT01826981|50302665|FG000|Overall Study|Lost to Follow-up|0|||
25169639|NCT01826981|50302666|FG001|Overall Study|Lost to Follow-up|0|||
25169640|NCT01826981|50302667|FG002|Overall Study|Lost to Follow-up|0|||
25169641|NCT01826981|50302668|FG003|Overall Study|Lost to Follow-up|0|||
25169642|NCT01826981|50302669|FG004|Overall Study|Lost to Follow-up|1|||
25169643|NCT01826981|50302670|FG005|Overall Study|Lost to Follow-up|1|||
25169644|NCT01826981|50302671|FG006|Overall Study|Lost to Follow-up|0|||
25169645|NCT01826981|50302672|FG007|Overall Study|Lost to Follow-up|1|||
25169646|NCT01826981|50302673|FG008|Overall Study|Lost to Follow-up|0|||
25169647|NCT01826981|50302674|FG009|Overall Study|Lost to Follow-up|1|||
25169648|NCT01826981|50302675|FG010|Overall Study|Lost to Follow-up|1|||
25169649|NCT01826981|50302676|FG011|Overall Study|Lost to Follow-up|1|||
25169650|NCT01826981|50302677|FG012|Overall Study|Lost to Follow-up|1|||
25169651|NCT01826981|50302678|FG013|Overall Study|Lost to Follow-up|0|||
25169652|NCT01826981|50302679|FG014|Overall Study|Lost to Follow-up|0|||
25169653|NCT01826981|50302665|FG000|Overall Study|Withdrew Consent|0|||
25169654|NCT01826981|50302666|FG001|Overall Study|Withdrew Consent|0|||
25169655|NCT01826981|50302667|FG002|Overall Study|Withdrew Consent|0|||
25169656|NCT01826981|50302668|FG003|Overall Study|Withdrew Consent|0|||
25169657|NCT01826981|50302669|FG004|Overall Study|Withdrew Consent|0|||
25169658|NCT01826981|50302670|FG005|Overall Study|Withdrew Consent|0|||
25169659|NCT01826981|50302671|FG006|Overall Study|Withdrew Consent|1|||
25169660|NCT01826981|50302672|FG007|Overall Study|Withdrew Consent|1|||
25169661|NCT01826981|50302673|FG008|Overall Study|Withdrew Consent|0|||
25169662|NCT01826981|50302674|FG009|Overall Study|Withdrew Consent|0|||
25169663|NCT01826981|50302675|FG010|Overall Study|Withdrew Consent|0|||
25169664|NCT01826981|50302676|FG011|Overall Study|Withdrew Consent|1|||
25169665|NCT01826981|50302677|FG012|Overall Study|Withdrew Consent|0|||
25169666|NCT01826981|50302678|FG013|Overall Study|Withdrew Consent|1|||
25169667|NCT01826981|50302679|FG014|Overall Study|Withdrew Consent|0|||
25169668|NCT01826981|50302665|FG000|Overall Study|Adverse Event|0|||
25169669|NCT01826981|50302666|FG001|Overall Study|Adverse Event|0|||
25169670|NCT01826981|50302667|FG002|Overall Study|Adverse Event|0|||
25169671|NCT01826981|50302668|FG003|Overall Study|Adverse Event|0|||
25169672|NCT01826981|50302669|FG004|Overall Study|Adverse Event|1|||
25169673|NCT01826981|50302670|FG005|Overall Study|Adverse Event|0|||
25169674|NCT01826981|50302671|FG006|Overall Study|Adverse Event|0|||
25169675|NCT01826981|50302672|FG007|Overall Study|Adverse Event|0|||
25169676|NCT01826981|50302673|FG008|Overall Study|Adverse Event|0|||
25169677|NCT01826981|50302674|FG009|Overall Study|Adverse Event|0|||
25169678|NCT01826981|50302675|FG010|Overall Study|Adverse Event|0|||
25169679|NCT01826981|50302676|FG011|Overall Study|Adverse Event|0|||
25169680|NCT01826981|50302677|FG012|Overall Study|Adverse Event|0|||
25169681|NCT01826981|50302678|FG013|Overall Study|Adverse Event|0|||
25169682|NCT01826981|50302679|FG014|Overall Study|Adverse Event|0|||
25169683|NCT01826981|50302665|FG000|Overall Study|Upper G-I Haemorrhage|0|||
25169684|NCT01826981|50302666|FG001|Overall Study|Upper G-I Haemorrhage|0|||
25169685|NCT01826981|50302667|FG002|Overall Study|Upper G-I Haemorrhage|0|||
25169686|NCT01826981|50302668|FG003|Overall Study|Upper G-I Haemorrhage|0|||
25169687|NCT01826981|50302669|FG004|Overall Study|Upper G-I Haemorrhage|0|||
25169688|NCT01826981|50302670|FG005|Overall Study|Upper G-I Haemorrhage|0|||
25169689|NCT01826981|50302671|FG006|Overall Study|Upper G-I Haemorrhage|0|||
25169690|NCT01826981|50302672|FG007|Overall Study|Upper G-I Haemorrhage|0|||
25169691|NCT01826981|50302673|FG008|Overall Study|Upper G-I Haemorrhage|0|||
25169692|NCT01826981|50302674|FG009|Overall Study|Upper G-I Haemorrhage|0|||
25169693|NCT01826981|50302675|FG010|Overall Study|Upper G-I Haemorrhage|0|||
25169694|NCT01826981|50302676|FG011|Overall Study|Upper G-I Haemorrhage|0|||
25169695|NCT01826981|50302677|FG012|Overall Study|Upper G-I Haemorrhage|0|||
25169696|NCT01826981|50302678|FG013|Overall Study|Upper G-I Haemorrhage|1|||
25169697|NCT01826981|50302679|FG014|Overall Study|Upper G-I Haemorrhage|0|||
25169698|NCT01826981|50302665|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
25169699|NCT01826981|50302666|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
25169700|NCT01826981|50302667|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
25071646|NCT00705783|50177961|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
25169701|NCT01826981|50302668|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
25169702|NCT01826981|50302669|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
25169703|NCT01826981|50302670|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
25169704|NCT01826981|50302671|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
25169705|NCT01826981|50302672|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
25169706|NCT01826981|50302673|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
25169707|NCT01826981|50302674|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
25169708|NCT01826981|50302675|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
25169709|NCT01826981|50302676|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
25169710|NCT01826981|50302677|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
25169711|NCT01826981|50302678|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
25169712|NCT01826981|50302679|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
25169713|NCT01804049|50302751|FG000|Overall Study|Adverse Event|2|||
25169714|NCT01804049|50302752|FG001|Overall Study|Adverse Event|10|||
25169715|NCT01804049|50302751|FG000|Overall Study|Lost to Follow-up|2|||
25169716|NCT01804049|50302752|FG001|Overall Study|Lost to Follow-up|1|||
25169717|NCT01804049|50302751|FG000|Overall Study|Decreased interest/personal|4|||
25169718|NCT01804049|50302752|FG001|Overall Study|Decreased interest/personal|5|||
25169719|NCT01804049|50302751|FG000|Overall Study|Other health concerns|2|||
25169720|NCT01804049|50302752|FG001|Overall Study|Other health concerns|7|||
25169721|NCT01804049|50302751|FG000|Overall Study|Moved out of area|0|||
25169722|NCT01804049|50302752|FG001|Overall Study|Moved out of area|7|||
25169723|NCT01804049|50302751|FG000|Overall Study|other MD recommended|1|||
25169724|NCT01804049|50302752|FG001|Overall Study|other MD recommended|1|||
25169725|NCT01804049|50302751|FG000|Overall Study|Enrollment in dual studies|0|||
25169726|NCT01804049|50302752|FG001|Overall Study|Enrollment in dual studies|1|||
25169727|NCT01826825|50302762|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
25169728|NCT01826825|50302763|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
25169729|NCT01803737|50302773|FG000|Overall Study|Lack of Time|1|||
25169730|NCT01803737|50302774|FG001|Overall Study|Lack of Time|0|||
25169731|NCT01803737|50302773|FG000|Overall Study|Medical Reason|0|||
25169732|NCT01803737|50302774|FG001|Overall Study|Medical Reason|1|||
25169733|NCT01803737|50302773|FG000|Overall Study|Lost to Follow-up|0|||
25169734|NCT01803737|50302774|FG001|Overall Study|Lost to Follow-up|2|||
25169735|NCT01826201|50302780|FG000|Overall Study|Non compliance with protocol|4|||
25169736|NCT01803269|50302811|FG000|Overall Study|Withdrawal by Subject|3|||
25169737|NCT01803269|50302812|FG001|Overall Study|Withdrawal by Subject|0|||
25169738|NCT01803269|50302813|FG002|Overall Study|Withdrawal by Subject|0|||
25169739|NCT01802879|50302821|FG000|Overall Study|Administrative problems|2|||
25169740|NCT01802879|50302821|FG000|Overall Study|Disease progression|6|||
25169741|NCT01825577|50302825|FG000|Overall Study|Physician Decision|2|||
25169742|NCT01825577|50302825|FG000|Overall Study|Withdrawal by Subject|1|||
25169743|NCT01825577|50302825|FG000|Overall Study|Withdrawn by family members|2|||
25169744|NCT01825577|50302825|FG000|Overall Study|Lack of Efficacy|3|||
25169745|NCT01802411|50302831|FG000|Overall Study|Death|2|||
25169746|NCT01802411|50302832|FG001|Overall Study|Death|1|||
25169747|NCT01802411|50302831|FG000|Overall Study|Adverse Event|2|||
25169748|NCT01802411|50302832|FG001|Overall Study|Adverse Event|7|||
25169749|NCT01802411|50302831|FG000|Overall Study|Lack of Efficacy|8|||
25169750|NCT01802411|50302832|FG001|Overall Study|Lack of Efficacy|10|||
25169751|NCT01802411|50302831|FG000|Overall Study|Withdrawal by Subject|0|||
25169752|NCT01802411|50302832|FG001|Overall Study|Withdrawal by Subject|2|||
25169753|NCT01802411|50302831|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
25169754|NCT01802411|50302832|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
25169755|NCT01802411|50302831|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
25169756|NCT01802411|50302832|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
25169757|NCT01802411|50302831|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
25169758|NCT01802411|50302832|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
25169759|NCT02963610|50302873|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
25169760|NCT02606136|50302955|FG000|Overall Study|Participant/Legal Guardian Decision|5|||
25169761|NCT02606136|50302955|FG000|Overall Study|Withdrawal by Subject|1|||
25169762|NCT01802333|50303098|FG000|Overall Study|Ineligible|2|||
25169763|NCT01802333|50303099|FG001|Overall Study|Ineligible|6|||
25169764|NCT01802333|50303100|FG002|Overall Study|Ineligible|8|||
25169765|NCT01802333|50303098|FG000|Overall Study|Adverse Event|1|||
25169766|NCT01802333|50303099|FG001|Overall Study|Adverse Event|8|||
25169767|NCT01802333|50303100|FG002|Overall Study|Adverse Event|8|||
25169768|NCT01802333|50303098|FG000|Overall Study|Withdrawal by Subject|6|||
25169769|NCT01802333|50303099|FG001|Overall Study|Withdrawal by Subject|6|||
25169770|NCT01802333|50303100|FG002|Overall Study|Withdrawal by Subject|5|||
25169771|NCT01802333|50303098|FG000|Overall Study|Progression/relapse|1|||
25192334|NCT02579382|50358023|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
25314454|NCT00969761|50630256|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
25169772|NCT01802333|50303099|FG001|Overall Study|Progression/relapse|3|||
25169773|NCT01802333|50303100|FG002|Overall Study|Progression/relapse|0|||
25169774|NCT01802333|50303098|FG000|Overall Study|Death|7|||
25192335|NCT02579382|50358024|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
25169775|NCT01802333|50303099|FG001|Overall Study|Death|14|||
25169776|NCT01802333|50303100|FG002|Overall Study|Death|13|||
25169777|NCT01802333|50303098|FG000|Overall Study|Other - not protocol specified|32|||
25169778|NCT01802333|50303099|FG001|Overall Study|Other - not protocol specified|22|||
25169779|NCT01802333|50303100|FG002|Overall Study|Other - not protocol specified|24|||
25169780|NCT01802333|50303098|FG000|Overall Study|Did not start treatment|0|||
25169781|NCT01802333|50303099|FG001|Overall Study|Did not start treatment|2|||
25169782|NCT01802333|50303100|FG002|Overall Study|Did not start treatment|5|||
25169783|NCT00980655|50303145|FG000|Overall Study|Adverse Event|13|||
25169784|NCT00980655|50303146|FG001|Overall Study|Adverse Event|31|||
25169785|NCT00980655|50303145|FG000|Overall Study|Death|0|||
25169786|NCT00980655|50303146|FG001|Overall Study|Death|7|||
25169787|NCT00980655|50303145|FG000|Overall Study|Protocol Violation|2|||
25169788|NCT00980655|50303146|FG001|Overall Study|Protocol Violation|7|||
25169789|NCT00980655|50303145|FG000|Overall Study|Withdrawal by Subject|0|||
25169790|NCT00980655|50303146|FG001|Overall Study|Withdrawal by Subject|4|||
25169791|NCT00980655|50303145|FG000|Overall Study|Lost to Follow-up|0|||
25169792|NCT00980655|50303146|FG001|Overall Study|Lost to Follow-up|1|||
25169793|NCT00980655|50303145|FG000|Overall Study|Parent/legal guardian request|1|||
25169794|NCT00980655|50303146|FG001|Overall Study|Parent/legal guardian request|0|||
25169795|NCT00980655|50303145|FG000|Overall Study|Other|0|||
25169796|NCT00980655|50303146|FG001|Overall Study|Other|1|||
25314455|NCT00969761|50630257|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
24970835|NCT04465396|50060575|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
24970836|NCT04465396|50060576|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
24970837|NCT04465396|50060577|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
25071647|NCT00705783|50177962|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
25071648|NCT00705783|50177960|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
25071649|NCT00705783|50177961|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
25071650|NCT00705783|50177962|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
25071651|NCT00705783|50177960|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
25071652|NCT00705783|50177961|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
25071653|NCT00705783|50177962|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
25071654|NCT00705783|50177960|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
25071655|NCT00705783|50177961|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
25071656|NCT00705783|50177962|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
25071657|NCT00705783|50177960|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
25071658|NCT00705783|50177961|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
25071659|NCT00705783|50177962|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
25071660|NCT00705783|50177960|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
25071661|NCT00705783|50177961|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
25071662|NCT00705783|50177962|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
25071663|NCT00705783|50177960|FG000|Oral Stabilization Phase|Adverse Event|14|||
25071664|NCT00705783|50177961|FG001|Oral Stabilization Phase|Adverse Event|0|||
25071665|NCT00705783|50177962|FG002|Oral Stabilization Phase|Adverse Event|0|||
25071666|NCT00705783|50177960|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
25071667|NCT00705783|50177961|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
25071668|NCT00705783|50177962|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
25071669|NCT00705783|50177960|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
25071670|NCT00705783|50177961|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
25071671|NCT00705783|50177962|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
25071672|NCT00705783|50177960|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
25071673|NCT00705783|50177961|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
25071674|NCT00705783|50177962|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
25071675|NCT00705783|50177960|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
25071676|NCT00705783|50177961|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
25071677|NCT00705783|50177962|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
25071678|NCT00705783|50177960|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
25071679|NCT00705783|50177961|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
25071680|NCT00705783|50177962|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
25071681|NCT00705783|50177960|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
25071682|NCT00705783|50177961|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
24970838|NCT04465396|50060578|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
24970839|NCT03999892|50060603|FG000|Overall Study|Lost to Follow-up|1|||
24970840|NCT03996694|50060607|FG000|First Washout (7 Days)|positive urine drug screen|0|||
24970841|NCT03996694|50060608|FG001|First Washout (7 Days)|positive urine drug screen|0|||
24970842|NCT03996694|50060609|FG002|First Washout (7 Days)|positive urine drug screen|1|||
24970843|NCT03996694|50060610|FG003|First Washout (7 Days)|positive urine drug screen|0|||
25071683|NCT00705783|50177962|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
25071684|NCT00705783|50177960|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
25071685|NCT00705783|50177961|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
25071686|NCT00705783|50177962|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
25314456|NCT00969761|50630258|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
25192336|NCT02579382|50358021|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
25314457|NCT00969761|50630259|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
25192337|NCT02579382|50358022|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
24970844|NCT03996694|50060611|FG004|First Washout (7 Days)|positive urine drug screen|0|||
24970845|NCT03996694|50060612|FG005|First Washout (7 Days)|positive urine drug screen|0|||
24970846|NCT03996694|50060607|FG000|First Washout (7 Days)|Adverse Event|0|||
24970847|NCT03996694|50060608|FG001|First Washout (7 Days)|Adverse Event|1|||
24970848|NCT03996694|50060609|FG002|First Washout (7 Days)|Adverse Event|0|||
24970849|NCT03996694|50060610|FG003|First Washout (7 Days)|Adverse Event|0|||
24970850|NCT03996694|50060611|FG004|First Washout (7 Days)|Adverse Event|0|||
24970851|NCT03996694|50060612|FG005|First Washout (7 Days)|Adverse Event|0|||
25071687|NCT00705783|50177960|FG000|Depot Stabilization Phase|Adverse Event|17|||
25071688|NCT00705783|50177961|FG001|Depot Stabilization Phase|Adverse Event|0|||
25071689|NCT00705783|50177962|FG002|Depot Stabilization Phase|Adverse Event|0|||
25071690|NCT00705783|50177960|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
25071691|NCT00705783|50177961|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
25071692|NCT00705783|50177962|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
25071693|NCT00705783|50177960|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
25071694|NCT00705783|50177961|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
25071695|NCT00705783|50177962|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
25071696|NCT00705783|50177960|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
25071697|NCT00705783|50177961|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
25071698|NCT00705783|50177962|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
25071699|NCT00705783|50177960|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
25071700|NCT00705783|50177961|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
25071701|NCT00705783|50177962|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
25071702|NCT00705783|50177960|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
25071703|NCT00705783|50177961|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
25071704|NCT00705783|50177962|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
25071705|NCT00705783|50177960|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
25071706|NCT00705783|50177961|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
25071707|NCT00705783|50177962|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
25071708|NCT00705783|50177960|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
25071709|NCT00705783|50177961|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
25071710|NCT00705783|50177962|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
25071711|NCT00705783|50177960|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
25071712|NCT00705783|50177961|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
25071713|NCT00705783|50177962|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
25071714|NCT00705783|50177960|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
25071715|NCT00705783|50177961|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
25071716|NCT00705783|50177962|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
25071717|NCT00705783|50177960|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
25071718|NCT00705783|50177961|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
25071719|NCT00705783|50177962|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
25071720|NCT00705783|50177960|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
25071721|NCT00705783|50177961|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
25071722|NCT00705783|50177962|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
25071723|NCT02694549|50177971|FG000|Overall Study|screen failures|2|||
25071724|NCT02782325|50177977|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
25071725|NCT02782325|50177978|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
25071726|NCT02782325|50177979|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
25071727|NCT02782325|50177977|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
25071728|NCT02782325|50177978|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
25071729|NCT02782325|50177979|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
25071730|NCT02693691|50177987|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
25071731|NCT02693691|50177987|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
25071732|NCT02693691|50177987|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
25071733|NCT02693691|50177987|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
25071734|NCT02693691|50177987|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
25071735|NCT02693691|50177987|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
24970852|NCT03996694|50060607|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
25314458|NCT00969761|50630260|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
24970853|NCT03996694|50060608|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
24970854|NCT03996694|50060609|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
24970855|NCT03996694|50060610|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
24970856|NCT03996694|50060611|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
25314459|NCT00969761|50630261|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
25314460|NCT00969761|50630262|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
24970857|NCT03996694|50060612|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
24970858|NCT03996694|50060607|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
24970859|NCT03996694|50060608|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
25071736|NCT02693691|50177987|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
25314461|NCT00969761|50630263|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
25071737|NCT04203667|50177991|FG000|Overall Study|Withdrawal by Subject|1|||
25071738|NCT04203667|50177991|FG000|Overall Study|Lost to Follow-up|1|||
24970860|NCT03996694|50060609|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
24970861|NCT03996694|50060610|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
24970862|NCT03996694|50060611|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
24970863|NCT03996694|50060612|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
24970864|NCT04179838|50060628|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
24970865|NCT04179838|50060629|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
24970866|NCT04179838|50060628|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
24970867|NCT04179838|50060629|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
24970868|NCT03994120|50060637|FG000|Overall Study|Lost to Follow-up|3|||
24970869|NCT03994120|50060638|FG001|Overall Study|Lost to Follow-up|1|||
24970870|NCT04178590|50060644|FG000|Overall Study|Pregnancy|1|||
24970871|NCT04178590|50060644|FG000|Overall Study|Lost to Follow-up|1|||
24970872|NCT04175392|50060672|FG000|Overall Study|Withdrawal by Subject|3|||
24970873|NCT04175392|50060673|FG001|Overall Study|Withdrawal by Subject|2|||
24970874|NCT03986866|50060681|FG000|Overall Study|Withdrawal by Subject|0|||
24970875|NCT03986866|50060682|FG001|Overall Study|Withdrawal by Subject|3|||
24970876|NCT03986866|50060681|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
25071739|NCT04203667|50177991|FG000|Overall Study|Death|1|||
24970877|NCT03986866|50060682|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
24970878|NCT03980938|50060690|FG000|Treatment Period 1|Study Terminated|1|||
24970879|NCT03980938|50060691|FG001|Treatment Period 1|Study Terminated|1|||
24970880|NCT03980938|50060690|FG000|Treatment Period 2|Study Terminated|2|||
24970881|NCT03980938|50060691|FG001|Treatment Period 2|Study Terminated|2|||
24970882|NCT03656692|50060697|FG000|Overall Study|Worsening of disease activity|2|||
24970883|NCT03656692|50060697|FG000|Overall Study|Physician Decision|1|||
24970884|NCT04439266|50060701|FG000|Overall Study|Ineligible|1|||
24970885|NCT04439266|50060701|FG000|Overall Study|Adverse Event|1|||
24970886|NCT04439266|50060701|FG000|Overall Study|Death|1|||
24970887|NCT04439266|50060701|FG000|Overall Study|Disease progression|1|||
24970888|NCT04439266|50060701|FG000|Overall Study|Still on treatment|1|||
24970889|NCT03682120|50060709|FG000|Overall Study|Lost to Follow-up|11|||
24970890|NCT03682120|50060710|FG001|Overall Study|Lost to Follow-up|4|||
24970891|NCT03682120|50060711|FG002|Overall Study|Lost to Follow-up|5|||
24970892|NCT03682120|50060712|FG003|Overall Study|Lost to Follow-up|2|||
24970893|NCT03682120|50060709|FG000|Overall Study|Physician Decision|1|||
24970894|NCT03682120|50060710|FG001|Overall Study|Physician Decision|0|||
24970895|NCT03682120|50060711|FG002|Overall Study|Physician Decision|0|||
24970896|NCT03682120|50060712|FG003|Overall Study|Physician Decision|0|||
24970897|NCT03682120|50060709|FG000|Overall Study|Withdrawal by Subject|1|||
24970898|NCT03682120|50060710|FG001|Overall Study|Withdrawal by Subject|2|||
24970899|NCT03682120|50060711|FG002|Overall Study|Withdrawal by Subject|3|||
24970900|NCT03682120|50060712|FG003|Overall Study|Withdrawal by Subject|0|||
24970901|NCT03682120|50060709|FG000|Overall Study|Death|0|||
24970902|NCT03682120|50060710|FG001|Overall Study|Death|1|||
24970903|NCT03682120|50060711|FG002|Overall Study|Death|0|||
24970904|NCT03682120|50060712|FG003|Overall Study|Death|0|||
24970905|NCT03682120|50060709|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
24970906|NCT03682120|50060710|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
24970907|NCT03682120|50060711|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
24970908|NCT03682120|50060712|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
24970909|NCT04428502|50060724|FG000|Overall Study|Did not meet entrance criteria|14|||
24970910|NCT04428424|50060729|FG000|Overall Study|Does not meet entrance criteria|132|||
24970911|NCT04428424|50060729|FG000|Overall Study|Lost to Follow-up|115|||
24970912|NCT03655756|50060733|FG000|Overall Study|Death|1|||
24970913|NCT00095238|50060739|FG000|Overall Study|Lack of Efficacy|9|||
24970914|NCT00095238|50060740|FG001|Overall Study|Lack of Efficacy|9|||
24970915|NCT00095238|50060739|FG000|Overall Study|Adverse Event|331|||
25314462|NCT00969761|50630264|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
25314463|NCT00969761|50630265|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
25314464|NCT00969761|50630254|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
25314465|NCT00969761|50630255|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
25314466|NCT00969761|50630256|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
25314467|NCT00969761|50630257|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
24970916|NCT00095238|50060740|FG001|Overall Study|Adverse Event|287|||
24970917|NCT00095238|50060739|FG000|Overall Study|Subject Withdrew Consent|208|||
24970918|NCT00095238|50060740|FG001|Overall Study|Subject Withdrew Consent|223|||
24970919|NCT00095238|50060739|FG000|Overall Study|Death|154|||
24970920|NCT00095238|50060740|FG001|Overall Study|Death|170|||
24970921|NCT00095238|50060739|FG000|Overall Study|Lost to Follow-up|19|||
24970922|NCT00095238|50060740|FG001|Overall Study|Lost to Follow-up|24|||
24970923|NCT00095238|50060739|FG000|Overall Study|Noncompliance|44|||
24970924|NCT00095238|50060740|FG001|Overall Study|Noncompliance|45|||
24970925|NCT00095238|50060739|FG000|Overall Study|No longer met study criteria|4|||
24970926|NCT00095238|50060740|FG001|Overall Study|No longer met study criteria|5|||
24970927|NCT00095238|50060739|FG000|Overall Study|Study terminated by sponsor|0|||
24970928|NCT00095238|50060740|FG001|Overall Study|Study terminated by sponsor|1|||
24970929|NCT00095238|50060739|FG000|Overall Study|Missing|1|||
24970930|NCT00095238|50060740|FG001|Overall Study|Missing|0|||
24970931|NCT00095238|50060739|FG000|Overall Study|Other Reasons|87|||
24970932|NCT00095238|50060740|FG001|Overall Study|Other Reasons|88|||
24970933|NCT00082368|50060778|FG000|Overall Study|Not treated-pt had poor IV access|1|||
24970934|NCT00094770|50060784|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
24970935|NCT00094770|50060785|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
24970936|NCT00094770|50060784|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
24970937|NCT00094770|50060785|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
24970938|NCT00094770|50060784|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
25314468|NCT00969761|50630258|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
25314469|NCT00969761|50630259|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
25314470|NCT00969761|50630260|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
25314471|NCT00969761|50630261|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
25314472|NCT00969761|50630262|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
25314473|NCT00969761|50630263|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
25314474|NCT00969761|50630264|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
25314475|NCT00969761|50630265|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
25314476|NCT00969761|50630254|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
25314477|NCT00969761|50630255|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
25314478|NCT00969761|50630256|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
25314479|NCT00969761|50630257|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
25314480|NCT00969761|50630258|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
25071740|NCT04203667|50177991|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
25314481|NCT00969761|50630259|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
25071741|NCT02782169|50177998|FG000|Overall Study|Lost to Follow-up|1|||
25071742|NCT02782169|50177999|FG001|Overall Study|Lost to Follow-up|2|||
25071743|NCT02564042|50178011|FG000|Overall Study|Adverse Event|4|||
25071744|NCT02564042|50178012|FG001|Overall Study|Adverse Event|4|||
25071745|NCT02564042|50178013|FG002|Overall Study|Adverse Event|3|||
25071746|NCT02564042|50178014|FG003|Overall Study|Adverse Event|0|||
25071747|NCT02564042|50178015|FG004|Overall Study|Adverse Event|0|||
25071748|NCT02564042|50178016|FG005|Overall Study|Adverse Event|1|||
25071749|NCT02564042|50178011|FG000|Overall Study|Lost to Follow-up|1|||
25071750|NCT02564042|50178012|FG001|Overall Study|Lost to Follow-up|1|||
25071751|NCT02564042|50178013|FG002|Overall Study|Lost to Follow-up|1|||
25071752|NCT02564042|50178014|FG003|Overall Study|Lost to Follow-up|0|||
25071753|NCT02564042|50178015|FG004|Overall Study|Lost to Follow-up|1|||
25071754|NCT02564042|50178016|FG005|Overall Study|Lost to Follow-up|1|||
25071755|NCT02564042|50178011|FG000|Overall Study|Physician Decision|1|||
25071756|NCT02564042|50178012|FG001|Overall Study|Physician Decision|0|||
25071757|NCT02564042|50178013|FG002|Overall Study|Physician Decision|0|||
25071758|NCT02564042|50178014|FG003|Overall Study|Physician Decision|1|||
25071759|NCT02564042|50178015|FG004|Overall Study|Physician Decision|0|||
25071760|NCT02564042|50178016|FG005|Overall Study|Physician Decision|0|||
25071761|NCT02564042|50178011|FG000|Overall Study|Withdrawal by Subject|5|||
25071762|NCT02564042|50178012|FG001|Overall Study|Withdrawal by Subject|3|||
25071763|NCT02564042|50178013|FG002|Overall Study|Withdrawal by Subject|2|||
25314482|NCT00969761|50630260|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
25314483|NCT00969761|50630261|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
25314484|NCT00969761|50630262|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
25314485|NCT00969761|50630263|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
25314486|NCT00969761|50630264|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
25314487|NCT00969761|50630265|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
25314488|NCT00969761|50630254|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
25314489|NCT00969761|50630255|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
25314490|NCT00969761|50630256|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
25314491|NCT00969761|50630257|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
25314492|NCT00969761|50630258|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
25314493|NCT00969761|50630259|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
25314494|NCT00969761|50630260|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
25314495|NCT00969761|50630261|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
25314496|NCT00969761|50630262|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
25314497|NCT00969761|50630263|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
25314498|NCT00969761|50630264|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
25314499|NCT00969761|50630265|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
25314500|NCT00845871|50630291|FG000|Assessment Period|Adverse Event|2|||
25314501|NCT00845871|50630291|FG000|Assessment Period|Abnormal laboratory values|1|||
25071764|NCT02564042|50178014|FG003|Overall Study|Withdrawal by Subject|2|||
25071765|NCT02564042|50178015|FG004|Overall Study|Withdrawal by Subject|10|||
25314502|NCT00845871|50630291|FG000|Assessment Period|Abnormal test procedure results|1|||
25071766|NCT02564042|50178016|FG005|Overall Study|Withdrawal by Subject|12|||
25071767|NCT02695719|50178049|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
25071768|NCT02695719|50178050|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
25071769|NCT02695719|50178049|FG000|Overall Study|Significant Protocol Deviation|0|||
25071770|NCT02695719|50178050|FG001|Overall Study|Significant Protocol Deviation|1|||
25071771|NCT02695719|50178049|FG000|Overall Study|Voluntary Withdrawal|1|||
25071772|NCT02695719|50178050|FG001|Overall Study|Voluntary Withdrawal|0|||
25071773|NCT02563106|50178067|FG000|Overall Study|Withdrawal by Subject|7|||
25071774|NCT02563106|50178068|FG001|Overall Study|Withdrawal by Subject|8|||
25071775|NCT02563106|50178067|FG000|Overall Study|Adverse Event|17|||
25071776|NCT02563106|50178068|FG001|Overall Study|Adverse Event|15|||
25071777|NCT02563106|50178067|FG000|Overall Study|Protocol Violation|1|||
24970939|NCT00094770|50060785|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
24970940|NCT00094770|50060784|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
24970941|NCT00094770|50060785|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
24970942|NCT00094770|50060784|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
24970943|NCT00094770|50060785|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
24970944|NCT00094770|50060784|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
24970945|NCT00094770|50060785|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
24970946|NCT00094770|50060784|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
24970947|NCT00094770|50060785|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
25071778|NCT02563106|50178068|FG001|Overall Study|Protocol Violation|0|||
25071779|NCT02563106|50178067|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
25071780|NCT02563106|50178068|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
25071781|NCT02563106|50178067|FG000|Overall Study|Lost to Follow-up|3|||
25071782|NCT02563106|50178068|FG001|Overall Study|Lost to Follow-up|2|||
25071783|NCT02563106|50178067|FG000|Overall Study|Physician Decision|3|||
25071784|NCT02563106|50178068|FG001|Overall Study|Physician Decision|1|||
24970948|NCT00094770|50060784|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
24970949|NCT00094770|50060785|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
24970950|NCT00094770|50060784|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
24970951|NCT00094770|50060785|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
24970952|NCT00094770|50060784|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
24970953|NCT00094770|50060785|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
24970954|NCT00094770|50060784|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
24970955|NCT00094770|50060785|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
24970956|NCT00094770|50060784|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
24970957|NCT00094770|50060785|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
24970958|NCT00094770|50060784|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
24970959|NCT00094770|50060785|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
24970960|NCT00094770|50060784|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
24970961|NCT00094770|50060785|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
24970962|NCT00094770|50060784|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
24970963|NCT00094770|50060785|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
24970964|NCT00094770|50060784|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
24970965|NCT00094770|50060785|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
24970966|NCT00094770|50060784|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
24970967|NCT00094770|50060785|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
24970968|NCT00094770|50060784|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
24970969|NCT00094770|50060785|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
24970970|NCT00069576|50060793|FG000|Original Trial|Lost to Follow-up|25|||
24970971|NCT00069576|50060794|FG001|Original Trial|Lost to Follow-up|33|||
24970972|NCT00069576|50060793|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
24970973|NCT00069576|50060794|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
24970974|NCT00069264|50060800|FG000|Overall Study|Adverse Event|3|||
24970975|NCT00069264|50060800|FG000|Overall Study|Progressive Disease|23|||
24970976|NCT00069264|50060800|FG000|Overall Study|Withdrawal by Subject|3|||
24970977|NCT00069264|50060800|FG000|Overall Study|Discon Therapy|3|||
24970978|NCT00069108|50060806|FG000|Overall Study|Withdrawal by Subject|5|||
24970979|NCT00069108|50060807|FG001|Overall Study|Withdrawal by Subject|9|||
24970980|NCT00069108|50060806|FG000|Overall Study|Adverse Event|64|||
24970981|NCT00069108|50060807|FG001|Overall Study|Adverse Event|42|||
24970982|NCT00069108|50060806|FG000|Overall Study|Death|6|||
24970983|NCT00069108|50060807|FG001|Overall Study|Death|6|||
24970984|NCT00069108|50060806|FG000|Overall Study|Administration|15|||
24970985|NCT00069108|50060807|FG001|Overall Study|Administration|4|||
25314503|NCT00845871|50630291|FG000|Assessment Period|Patient withdrew consent|3|||
25314504|NCT00915278|50630321|FG000|Overall Study|Death|1|||
25314505|NCT00915278|50630322|FG001|Overall Study|Death|0|||
25314506|NCT00915278|50630323|FG002|Overall Study|Death|0|||
25314507|NCT00915278|50630324|FG003|Overall Study|Death|0|||
25314508|NCT00915278|50630325|FG004|Overall Study|Death|0|||
25314509|NCT00915278|50630326|FG005|Overall Study|Death|0|||
25314510|NCT00915278|50630321|FG000|Overall Study|Lost to Follow-up|0|||
25314511|NCT00915278|50630322|FG001|Overall Study|Lost to Follow-up|1|||
25314512|NCT00915278|50630323|FG002|Overall Study|Lost to Follow-up|0|||
25314513|NCT00915278|50630324|FG003|Overall Study|Lost to Follow-up|0|||
25314514|NCT00915278|50630325|FG004|Overall Study|Lost to Follow-up|0|||
25314515|NCT00915278|50630326|FG005|Overall Study|Lost to Follow-up|0|||
24970986|NCT00069108|50060806|FG000|Overall Study|Insufficient therapy|117|||
25071785|NCT02563106|50178067|FG000|Overall Study|Other reason - not specified|2|||
25071786|NCT02563106|50178068|FG001|Overall Study|Other reason - not specified|1|||
24970987|NCT00069108|50060807|FG001|Overall Study|Insufficient therapy|144|||
25314516|NCT00915278|50630321|FG000|Overall Study|Withdrawal by Subject|0|||
25314517|NCT00915278|50630322|FG001|Overall Study|Withdrawal by Subject|1|||
25314518|NCT00915278|50630323|FG002|Overall Study|Withdrawal by Subject|0|||
25314519|NCT00915278|50630324|FG003|Overall Study|Withdrawal by Subject|0|||
24970988|NCT00069108|50060806|FG000|Overall Study|Violation criteria|1|||
24970989|NCT00069108|50060807|FG001|Overall Study|Violation criteria|4|||
24970990|NCT00069108|50060806|FG000|Overall Study|Refused treatment|5|||
24970991|NCT00069108|50060807|FG001|Overall Study|Refused treatment|10|||
24970992|NCT00094536|50060814|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
24970993|NCT00094536|50060814|FG000|Treatment and Follow-up|Adverse Event|4|||
24970994|NCT00094536|50060814|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
24970995|NCT00094536|50060814|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
24970996|NCT00094536|50060814|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
24970997|NCT00094536|50060814|FG000|Treatment and Follow-up|Subject non-compliance|9|||
24970998|NCT00094536|50060814|FG000|Treatment and Follow-up|Unable to attend visits|1|||
24970999|NCT00405587|50060822|FG000|Overall Study|Death|0|||
24971000|NCT00405587|50060823|FG001|Overall Study|Death|0|||
24971001|NCT00405587|50060824|FG002|Overall Study|Death|0|||
24971002|NCT00405587|50060825|FG003|Overall Study|Death|1|||
24971003|NCT00405587|50060822|FG000|Overall Study|Disease Progression|22|||
24971004|NCT00405587|50060823|FG001|Overall Study|Disease Progression|23|||
24971005|NCT00405587|50060824|FG002|Overall Study|Disease Progression|21|||
24971006|NCT00405587|50060825|FG003|Overall Study|Disease Progression|17|||
24971007|NCT00405587|50060822|FG000|Overall Study|Physician Decision|3|||
24971008|NCT00405587|50060823|FG001|Overall Study|Physician Decision|2|||
24971009|NCT00405587|50060824|FG002|Overall Study|Physician Decision|0|||
24971010|NCT00405587|50060825|FG003|Overall Study|Physician Decision|0|||
24971011|NCT00405587|50060822|FG000|Overall Study|Adverse Event|1|||
24971012|NCT00405587|50060823|FG001|Overall Study|Adverse Event|0|||
24971013|NCT00405587|50060824|FG002|Overall Study|Adverse Event|0|||
24971014|NCT00405587|50060825|FG003|Overall Study|Adverse Event|0|||
24971015|NCT00405587|50060822|FG000|Overall Study|Lost to Follow-up|0|||
24971016|NCT00405587|50060823|FG001|Overall Study|Lost to Follow-up|1|||
24971017|NCT00405587|50060824|FG002|Overall Study|Lost to Follow-up|1|||
24971018|NCT00405587|50060825|FG003|Overall Study|Lost to Follow-up|0|||
24971019|NCT00405587|50060822|FG000|Overall Study|Radiation induced necrosis|0|||
25071787|NCT02691741|50178076|FG000|Overall Study|Adverse Event|0|||
24971020|NCT00405587|50060823|FG001|Overall Study|Radiation induced necrosis|1|||
24971021|NCT00405587|50060824|FG002|Overall Study|Radiation induced necrosis|0|||
24971022|NCT00405587|50060825|FG003|Overall Study|Radiation induced necrosis|0|||
24971023|NCT00405587|50060822|FG000|Overall Study|Withdrawal by Subject|0|||
24971024|NCT00405587|50060823|FG001|Overall Study|Withdrawal by Subject|0|||
24971025|NCT00405587|50060824|FG002|Overall Study|Withdrawal by Subject|0|||
24971026|NCT00405587|50060825|FG003|Overall Study|Withdrawal by Subject|2|||
24971027|NCT00405587|50060822|FG000|Overall Study|Participant not dosed|0|||
24971028|NCT00405587|50060823|FG001|Overall Study|Participant not dosed|1|||
24971029|NCT00405587|50060824|FG002|Overall Study|Participant not dosed|0|||
24971030|NCT00405587|50060825|FG003|Overall Study|Participant not dosed|0|||
24971031|NCT00405275|50060863|FG000|Overall Study|Death|1|||
24971032|NCT00405275|50060864|FG001|Overall Study|Death|0|||
24971033|NCT00405275|50060863|FG000|Overall Study|Lost to Follow-up|5|||
24971034|NCT00405275|50060864|FG001|Overall Study|Lost to Follow-up|1|||
24971035|NCT00405275|50060863|FG000|Overall Study|Withdrawal by Subject|7|||
24971036|NCT00405275|50060864|FG001|Overall Study|Withdrawal by Subject|9|||
24971037|NCT00405275|50060863|FG000|Overall Study|Unwilling to continue|10|||
24971038|NCT00405275|50060864|FG001|Overall Study|Unwilling to continue|9|||
24971039|NCT00404651|50060874|FG000|Overall Study|Serious Adverse Event|0|||
24971040|NCT00404651|50060875|FG001|Overall Study|Serious Adverse Event|0|||
24971041|NCT00404651|50060876|FG002|Overall Study|Serious Adverse Event|2|||
24971042|NCT00404651|50060877|FG003|Overall Study|Serious Adverse Event|0|||
24971043|NCT00404651|50060874|FG000|Overall Study|Protocol Violation|10|||
24971044|NCT00404651|50060875|FG001|Overall Study|Protocol Violation|5|||
24971045|NCT00404651|50060876|FG002|Overall Study|Protocol Violation|14|||
24971046|NCT00404651|50060877|FG003|Overall Study|Protocol Violation|5|||
24971047|NCT00404651|50060874|FG000|Overall Study|Lost to Follow-up|15|||
24971048|NCT00404651|50060875|FG001|Overall Study|Lost to Follow-up|11|||
24971049|NCT00404651|50060876|FG002|Overall Study|Lost to Follow-up|13|||
24971050|NCT00404651|50060877|FG003|Overall Study|Lost to Follow-up|10|||
24971051|NCT00404651|50060874|FG000|Overall Study|Withdrawal by Subject|14|||
24971052|NCT00404651|50060875|FG001|Overall Study|Withdrawal by Subject|12|||
24971053|NCT00404651|50060876|FG002|Overall Study|Withdrawal by Subject|16|||
24971054|NCT00404651|50060877|FG003|Overall Study|Withdrawal by Subject|6|||
24971055|NCT00404495|50060889|FG000|Overall Study|Death|37|||
24971056|NCT00404495|50060890|FG001|Overall Study|Death|11|||
24971057|NCT00404495|50060889|FG000|Overall Study|Lost to Follow-up|5|||
24971058|NCT00404495|50060890|FG001|Overall Study|Lost to Follow-up|0|||
24971059|NCT00404495|50060889|FG000|Overall Study|Other|1|||
24971060|NCT00404495|50060890|FG001|Overall Study|Other|0|||
24971061|NCT00404495|50060889|FG000|Overall Study|Withdrawal by Subject|1|||
24971062|NCT00404495|50060890|FG001|Overall Study|Withdrawal by Subject|0|||
25071788|NCT02691741|50178077|FG001|Overall Study|Adverse Event|2|||
25071789|NCT02691741|50178076|FG000|Overall Study|Lost to Follow-up|1|||
25071790|NCT02691741|50178077|FG001|Overall Study|Lost to Follow-up|0|||
25071791|NCT02691741|50178076|FG000|Overall Study|Physician Decision|0|||
24971063|NCT00409409|50060898|FG000|Overall Study|Adverse Event|7|||
24971064|NCT00409409|50060899|FG001|Overall Study|Adverse Event|2|||
24971065|NCT00409409|50060898|FG000|Overall Study|Withdrawal by Subject|1|||
24971066|NCT00409409|50060899|FG001|Overall Study|Withdrawal by Subject|1|||
24971067|NCT00409409|50060898|FG000|Overall Study|Any other reason not above-mentioned|0|||
24971068|NCT00409409|50060899|FG001|Overall Study|Any other reason not above-mentioned|1|||
24971069|NCT00409331|50060905|FG000|Overall Study|Physician Decision|1|||
24971070|NCT00409175|50060911|FG000|Overall Study|Adverse Event|4|||
24971071|NCT00409175|50060912|FG001|Overall Study|Adverse Event|3|||
24971072|NCT00409175|50060911|FG000|Overall Study|Withdrawal by Subject|1|||
24971073|NCT00409175|50060912|FG001|Overall Study|Withdrawal by Subject|2|||
24971074|NCT00409175|50060911|FG000|Overall Study|Negative genotype|0|||
24971075|NCT00409175|50060912|FG001|Overall Study|Negative genotype|1|||
24971076|NCT00409175|50060911|FG000|Overall Study|Liver transplantation|13|||
24971077|NCT00409175|50060912|FG001|Overall Study|Liver transplantation|13|||
24971078|NCT00408629|50060920|FG000|Overall Study|Adverse Event|13|||
24971079|NCT00408629|50060921|FG001|Overall Study|Adverse Event|27|||
24971080|NCT00408629|50060920|FG000|Overall Study|Withdrawal by Subject|8|||
24971081|NCT00408629|50060921|FG001|Overall Study|Withdrawal by Subject|4|||
24971082|NCT00408629|50060920|FG000|Overall Study|Lost to Follow-up|1|||
24971083|NCT00408629|50060921|FG001|Overall Study|Lost to Follow-up|1|||
24971084|NCT00408629|50060920|FG000|Overall Study|Lack of Efficacy|63|||
24971085|NCT00408629|50060921|FG001|Overall Study|Lack of Efficacy|73|||
24971086|NCT00408629|50060920|FG000|Overall Study|Protocol Violation|1|||
24971087|NCT00408629|50060921|FG001|Overall Study|Protocol Violation|5|||
24971088|NCT00408629|50060920|FG000|Overall Study|Miscellaneous|11|||
24971089|NCT00408629|50060921|FG001|Overall Study|Miscellaneous|15|||
24971090|NCT00408317|50060928|FG000|First Intervention Period|Adverse Event|0|||
24971091|NCT00408317|50060929|FG001|First Intervention Period|Adverse Event|1|||
24971092|NCT00408317|50060928|FG000|Second Intervention Period|Adverse Event|2|||
24971093|NCT00408317|50060929|FG001|Second Intervention Period|Adverse Event|0|||
24971094|NCT00408317|50060928|FG000|Second Intervention Period|Protocol Violation|0|||
24971095|NCT00408317|50060929|FG001|Second Intervention Period|Protocol Violation|1|||
24971096|NCT00408317|50060928|FG000|Second Intervention Period|Withdrawal of consent|0|||
24971097|NCT00408317|50060929|FG001|Second Intervention Period|Withdrawal of consent|1|||
24971098|NCT00112502|50060943|FG000|Overall Study|Withdrawal by Subject|0|||
24971099|NCT00112502|50060944|FG001|Overall Study|Withdrawal by Subject|1|||
24971100|NCT00112502|50060945|FG002|Overall Study|Withdrawal by Subject|1|||
24971101|NCT00112502|50060946|FG003|Overall Study|Withdrawal by Subject|4|||
24971102|NCT00112502|50060947|FG004|Overall Study|Withdrawal by Subject|2|||
24971103|NCT00112502|50060948|FG005|Overall Study|Withdrawal by Subject|5|||
24971104|NCT00112502|50060949|FG006|Overall Study|Withdrawal by Subject|3|||
24971105|NCT00112502|50060950|FG007|Overall Study|Withdrawal by Subject|7|||
24971106|NCT03822182|50060981|FG000|Overall Study|Protocol Violation|0|||
24971107|NCT03822182|50060982|FG001|Overall Study|Protocol Violation|1|||
24971108|NCT03822182|50060983|FG002|Overall Study|Protocol Violation|1|||
24971109|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
24971110|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
24971111|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
24971112|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
24971113|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
24971114|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
24971115|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
24971116|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
24971117|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
24971118|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
24971119|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
24971120|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
24971121|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
24971122|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
24971123|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
24971124|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
24971125|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
25071792|NCT02691741|50178077|FG001|Overall Study|Physician Decision|1|||
24971126|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
24971127|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
24971128|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
25192338|NCT02579382|50358023|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
24971129|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
24971130|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
24971131|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
24971132|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
24971133|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
25192339|NCT02579382|50358024|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
25192340|NCT02579382|50358021|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
25192341|NCT02579382|50358022|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
25192342|NCT02579382|50358023|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
25192343|NCT02579382|50358024|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
25192344|NCT02579382|50358021|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
25192345|NCT02579382|50358022|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
25192346|NCT02579382|50358023|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
24971134|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
25071793|NCT02691741|50178076|FG000|Overall Study|Withdrawal by Subject|0|||
25192347|NCT02579382|50358024|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
25192348|NCT02579382|50358021|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
25192349|NCT02579382|50358022|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
25192350|NCT02579382|50358023|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
25192351|NCT02579382|50358024|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
24971135|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
24971136|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
24971137|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
24971138|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
24971139|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
24971140|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
24971141|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
24971142|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
24971143|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
24971144|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
24971145|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
25314520|NCT00915278|50630325|FG004|Overall Study|Withdrawal by Subject|1|||
25314521|NCT00915278|50630326|FG005|Overall Study|Withdrawal by Subject|4|||
25314522|NCT00915278|50630321|FG000|Overall Study|Adverse Event|4|||
25314523|NCT00915278|50630322|FG001|Overall Study|Adverse Event|1|||
24971146|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
24971147|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
24971148|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
24971149|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
24971150|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
24971151|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
24971152|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
24971153|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
24971154|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
24971155|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
24971156|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
24971157|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
24971158|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
24971159|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
24971160|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
24971161|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
25071794|NCT02691741|50178077|FG001|Overall Study|Withdrawal by Subject|4|||
25071795|NCT02691507|50178090|FG000|Overall Study|Missed Visit 3|0|||
25071796|NCT02691507|50178091|FG001|Overall Study|Missed Visit 3|1|||
25071797|NCT04579393|50178099|FG000|Overall Study|Withdrawal by Subject|2|||
25071798|NCT04579393|50178100|FG001|Overall Study|Withdrawal by Subject|2|||
25071799|NCT04579393|50178099|FG000|Overall Study|Death|1|||
25071800|NCT04579393|50178100|FG001|Overall Study|Death|3|||
25071801|NCT02776553|50178109|FG000|Overall Study|Lost to Follow-up|1|||
25071802|NCT02776553|50178110|FG001|Overall Study|Lost to Follow-up|0|||
25071803|NCT02776553|50178109|FG000|Overall Study|got liver transplant|1|||
25071804|NCT02776553|50178110|FG001|Overall Study|got liver transplant|2|||
25071805|NCT02776553|50178109|FG000|Overall Study|had other surgery|1|||
25071806|NCT02776553|50178110|FG001|Overall Study|had other surgery|0|||
25071807|NCT02776553|50178109|FG000|Overall Study|Protocol Violation|0|||
25071808|NCT02776553|50178110|FG001|Overall Study|Protocol Violation|1|||
25071809|NCT02690727|50178116|FG000|Overall Study|Adverse Event|2|||
25071810|NCT02690727|50178117|FG001|Overall Study|Adverse Event|2|||
25071811|NCT02777333|50178127|FG000|Overall Study|Withdrawal by Subject|0|||
25071812|NCT02777333|50178128|FG001|Overall Study|Withdrawal by Subject|1|||
25071813|NCT02777333|50178127|FG000|Overall Study|Lost to Follow-up|0|||
25071814|NCT02777333|50178128|FG001|Overall Study|Lost to Follow-up|1|||
25071815|NCT02695329|50178136|FG000|Overall Study|Adverse Event|1|||
24971162|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
24971163|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
25071816|NCT02695329|50178137|FG001|Overall Study|Adverse Event|0|||
25071817|NCT02695329|50178136|FG000|Overall Study|Poor X-ray quality for measurement|4|||
25071818|NCT02695329|50178137|FG001|Overall Study|Poor X-ray quality for measurement|5|||
25071819|NCT02690649|50178145|FG000|Overall Study|Withdrawal by Subject|1|||
25071820|NCT02690649|50178146|FG001|Overall Study|Withdrawal by Subject|1|||
25314524|NCT00915278|50630323|FG002|Overall Study|Adverse Event|0|||
24971164|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
24971165|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
24971166|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
24971167|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
24971168|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
24971169|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
24971170|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
24971171|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
24971172|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
24971173|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
24971174|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
24971175|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
24971176|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
24971177|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
24971178|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
25314525|NCT00915278|50630324|FG003|Overall Study|Adverse Event|0|||
25314526|NCT00915278|50630325|FG004|Overall Study|Adverse Event|0|||
25314527|NCT00915278|50630326|FG005|Overall Study|Adverse Event|0|||
25314528|NCT00915278|50630321|FG000|Overall Study|Progressive disease/clinical progression|0|||
24971179|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
24971180|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
25314529|NCT00915278|50630322|FG001|Overall Study|Progressive disease/clinical progression|0|||
25314530|NCT00915278|50630323|FG002|Overall Study|Progressive disease/clinical progression|0|||
24971181|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
24971182|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
24971183|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
24971184|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
24971185|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
24971186|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
24971187|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
24971188|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
24971189|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
24971190|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
24971191|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
24971192|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
24971193|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
24971194|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
24971195|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
24971196|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
24971197|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
24971198|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
24971199|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
24971200|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
24971201|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
24971202|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
24971203|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
24971204|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
24971205|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
24971206|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
24971207|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
24971208|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
24971209|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
24971210|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
24971211|NCT00111800|50060998|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
24971212|NCT00111800|50060999|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
24971213|NCT00111800|50061000|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
24971214|NCT00111800|50061001|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
24971215|NCT00111800|50061002|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
24971216|NCT00111800|50061003|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
24971217|NCT00111800|50060998|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
24971218|NCT00111800|50060999|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
24971219|NCT00111800|50061000|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
24971220|NCT00111800|50061001|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
24971221|NCT00111800|50061002|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
24971222|NCT00111800|50061003|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
24971223|NCT00111800|50060998|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
24971224|NCT00111800|50060999|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
24971225|NCT00111800|50061000|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
24971226|NCT00111800|50061001|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
24971227|NCT00111800|50061002|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
24971228|NCT00111800|50061003|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
24971229|NCT00111800|50060998|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
25071821|NCT02690649|50178145|FG000|Overall Study|Protocol Violation|0|||
24971230|NCT00111800|50060999|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
24971231|NCT00111800|50061000|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
24971232|NCT00111800|50061001|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
24971233|NCT00111800|50061002|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
24971234|NCT00111800|50061003|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
24971235|NCT00111800|50060998|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
24971236|NCT00111800|50060999|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
24971237|NCT00111800|50061000|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
24971238|NCT00111800|50061001|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
24971239|NCT00111800|50061002|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
24971240|NCT00111800|50061003|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
24971241|NCT00111800|50060998|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
24971242|NCT00111800|50060999|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
24971243|NCT00111800|50061000|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
24971244|NCT00111800|50061001|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
24971245|NCT00111800|50061002|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
24971246|NCT00111800|50061003|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
25071822|NCT02690649|50178146|FG001|Overall Study|Protocol Violation|3|||
25071823|NCT01358864|50178162|FG000|Overall Study|Adverse Event|0|||
25071824|NCT01358864|50178163|FG001|Overall Study|Adverse Event|6|||
25314531|NCT00915278|50630324|FG003|Overall Study|Progressive disease/clinical progression|3|||
25314532|NCT00915278|50630325|FG004|Overall Study|Progressive disease/clinical progression|1|||
25314533|NCT00915278|50630326|FG005|Overall Study|Progressive disease/clinical progression|2|||
25314534|NCT00915278|50630321|FG000|Overall Study|Infusion related AEs|0|||
25314535|NCT00915278|50630322|FG001|Overall Study|Infusion related AEs|0|||
25314536|NCT00915278|50630323|FG002|Overall Study|Infusion related AEs|0|||
25314537|NCT00915278|50630324|FG003|Overall Study|Infusion related AEs|0|||
25314538|NCT00915278|50630325|FG004|Overall Study|Infusion related AEs|0|||
25314539|NCT00915278|50630326|FG005|Overall Study|Infusion related AEs|2|||
25314540|NCT00915278|50630321|FG000|Overall Study|Admission to hospice|0|||
25314541|NCT00915278|50630322|FG001|Overall Study|Admission to hospice|0|||
25314542|NCT00915278|50630323|FG002|Overall Study|Admission to hospice|1|||
25314543|NCT00915278|50630324|FG003|Overall Study|Admission to hospice|0|||
25314544|NCT00915278|50630325|FG004|Overall Study|Admission to hospice|0|||
25314545|NCT00915278|50630326|FG005|Overall Study|Admission to hospice|0|||
24971247|NCT00111800|50060998|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
24971248|NCT00111800|50060999|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
24971249|NCT00111800|50061000|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
24971250|NCT00111800|50061001|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
24971251|NCT00111800|50061002|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
24971252|NCT00111800|50061003|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
24971253|NCT00111800|50060998|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
24971254|NCT00111800|50060999|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
24971255|NCT00111800|50061000|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
24971256|NCT00111800|50061001|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
24971257|NCT00111800|50061002|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
24971258|NCT00111800|50061003|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
24971259|NCT00111800|50060998|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
24971260|NCT00111800|50060999|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
24971261|NCT00111800|50061000|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
24971262|NCT00111800|50061001|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
24971263|NCT00111800|50061002|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
24971264|NCT00111800|50061003|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
24971265|NCT00094328|50061026|FG000|Overall Study|Lost to Follow-up|1|||
24971266|NCT00094172|50061032|FG000|Overall Study|Adverse Event|0|||
24971267|NCT00094172|50061033|FG001|Overall Study|Adverse Event|1|||
24971268|NCT00094172|50061032|FG000|Overall Study|Lost to Follow-up|2|||
24971269|NCT00094172|50061033|FG001|Overall Study|Lost to Follow-up|0|||
24971270|NCT00094172|50061032|FG000|Overall Study|Protocol Violation|0|||
24971271|NCT00094172|50061033|FG001|Overall Study|Protocol Violation|1|||
24971272|NCT00094172|50061032|FG000|Overall Study|Withdrawal by Subject|10|||
24971273|NCT00094172|50061033|FG001|Overall Study|Withdrawal by Subject|5|||
24971274|NCT00094172|50061032|FG000|Overall Study|Primary endpoint met.|1|||
24971275|NCT00094172|50061033|FG001|Overall Study|Primary endpoint met.|0|||
24971276|NCT00094172|50061032|FG000|Overall Study|Started other MS therapy due to disease|1|||
24971277|NCT00094172|50061033|FG001|Overall Study|Started other MS therapy due to disease|0|||
24971278|NCT00094094|50061039|FG000|Overall Study|Death|2|||
24971279|NCT00094094|50061039|FG000|Overall Study|Lack of Efficacy|23|||
24971280|NCT00094094|50061039|FG000|Overall Study|Adverse Event|7|||
24971281|NCT00110396|50061043|FG000|Overall Study|Adverse Event|15|||
24971282|NCT00110396|50061043|FG000|Overall Study|Lost to Follow-up|1|||
24971283|NCT00110396|50061043|FG000|Overall Study|Administration of plasmapheresis|1|||
24971284|NCT00110396|50061043|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
24971285|NCT00110396|50061043|FG000|Overall Study|Lack of Efficacy|1|||
24971286|NCT00110396|50061043|FG000|Overall Study|Decided not to continue treatment|1|||
24971287|NCT00110396|50061043|FG000|Overall Study|Patient non-compliance|1|||
24971288|NCT00110396|50061043|FG000|Overall Study|Patient refused to continue|1|||
25314546|NCT00844857|50630342|FG000|Overall Study|Adverse Event|24|||
25314547|NCT00844857|50630343|FG001|Overall Study|Adverse Event|5|||
25314548|NCT00844857|50630342|FG000|Overall Study|Sponsor Decision|1|||
25192352|NCT01436084|50358060|FG000|Overall Study|Disease Progression|2|||
25192353|NCT01436084|50358060|FG000|Overall Study|Withdrawal by Subject|1|||
25192354|NCT01436084|50358060|FG000|Overall Study|Early Closure of Study|1|||
25192355|NCT01419314|50358075|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
24971289|NCT00110396|50061043|FG000|Overall Study|Patient refused to participate|1|||
25192356|NCT01419314|50358076|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
24971290|NCT00110396|50061043|FG000|Overall Study|Patient will|1|||
24971291|NCT00110396|50061043|FG000|Overall Study|Patient's decision|1|||
24971292|NCT00110396|50061043|FG000|Overall Study|Participation in MS vaccine study|1|||
24971293|NCT00110396|50061043|FG000|Overall Study|Pregnancy|1|||
24971294|NCT00110396|50061043|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
24971295|NCT00110396|50061043|FG000|Overall Study|Protocol Violation|2|||
24971296|NCT00110396|50061043|FG000|Overall Study|Patient refused to come back|1|||
24971297|NCT00110396|50061043|FG000|Overall Study|The patient has refused|2|||
24971298|NCT00110396|50061043|FG000|Overall Study|The patient has refused to visit site|1|||
24971299|NCT00110396|50061043|FG000|Overall Study|Patient is to be administered copaxone|1|||
24971300|NCT03819218|50061047|FG000|Overall Study|Protocol Violation|1|||
24971301|NCT00093470|50061053|FG000|Overall Study|Disease progression|39|||
24971302|NCT00093470|50061054|FG001|Overall Study|Disease progression|0|||
24971303|NCT00093470|50061053|FG000|Overall Study|Adverse Event|15|||
24971304|NCT00093470|50061054|FG001|Overall Study|Adverse Event|0|||
24971305|NCT00093470|50061053|FG000|Overall Study|Death|2|||
24971306|NCT00093470|50061054|FG001|Overall Study|Death|0|||
24971307|NCT00093470|50061053|FG000|Overall Study|Withdrawal by Subject|8|||
24971308|NCT00093470|50061054|FG001|Overall Study|Withdrawal by Subject|0|||
24971309|NCT00093470|50061053|FG000|Overall Study|Alternative therapy|2|||
24971310|NCT00093470|50061054|FG001|Overall Study|Alternative therapy|0|||
25071825|NCT01358864|50178164|FG002|Overall Study|Adverse Event|9|||
25071826|NCT01358864|50178165|FG003|Overall Study|Adverse Event|0|||
25071827|NCT01358864|50178166|FG004|Overall Study|Adverse Event|4|||
25071828|NCT01358864|50178167|FG005|Overall Study|Adverse Event|8|||
25071829|NCT01358864|50178168|FG006|Overall Study|Adverse Event|12|||
25071830|NCT01358864|50178169|FG007|Overall Study|Adverse Event|7|||
25071831|NCT01358864|50178162|FG000|Overall Study|Lack of Efficacy|26|||
25071832|NCT01358864|50178163|FG001|Overall Study|Lack of Efficacy|3|||
25071833|NCT01358864|50178164|FG002|Overall Study|Lack of Efficacy|4|||
25071834|NCT01358864|50178165|FG003|Overall Study|Lack of Efficacy|19|||
25071835|NCT01358864|50178166|FG004|Overall Study|Lack of Efficacy|7|||
25071836|NCT01358864|50178167|FG005|Overall Study|Lack of Efficacy|4|||
25071837|NCT01358864|50178168|FG006|Overall Study|Lack of Efficacy|49|||
25071838|NCT01358864|50178169|FG007|Overall Study|Lack of Efficacy|44|||
25071839|NCT01358864|50178162|FG000|Overall Study|Lost to Follow-up|0|||
25071840|NCT01358864|50178163|FG001|Overall Study|Lost to Follow-up|0|||
25071841|NCT01358864|50178164|FG002|Overall Study|Lost to Follow-up|1|||
25071842|NCT01358864|50178165|FG003|Overall Study|Lost to Follow-up|0|||
25071843|NCT01358864|50178166|FG004|Overall Study|Lost to Follow-up|0|||
25071844|NCT01358864|50178167|FG005|Overall Study|Lost to Follow-up|0|||
25071845|NCT01358864|50178168|FG006|Overall Study|Lost to Follow-up|0|||
25071846|NCT01358864|50178169|FG007|Overall Study|Lost to Follow-up|1|||
25071847|NCT01358864|50178162|FG000|Overall Study|Withdrawal by Subject|3|||
25071848|NCT01358864|50178163|FG001|Overall Study|Withdrawal by Subject|4|||
25071849|NCT01358864|50178164|FG002|Overall Study|Withdrawal by Subject|2|||
25071850|NCT01358864|50178165|FG003|Overall Study|Withdrawal by Subject|0|||
25071851|NCT01358864|50178166|FG004|Overall Study|Withdrawal by Subject|0|||
25071852|NCT01358864|50178167|FG005|Overall Study|Withdrawal by Subject|1|||
25314549|NCT00844857|50630343|FG001|Overall Study|Sponsor Decision|1|||
24971311|NCT00093470|50061053|FG000|Overall Study|Other complicating disease|3|||
24971312|NCT00093470|50061054|FG001|Overall Study|Other complicating disease|0|||
24971313|NCT00093470|50061053|FG000|Overall Study|Physician Decision|2|||
24971314|NCT00093470|50061054|FG001|Overall Study|Physician Decision|0|||
24971315|NCT00093470|50061053|FG000|Overall Study|Never started treatment|1|||
25071853|NCT01358864|50178168|FG006|Overall Study|Withdrawal by Subject|1|||
25071854|NCT01358864|50178169|FG007|Overall Study|Withdrawal by Subject|3|||
24971316|NCT00093470|50061054|FG001|Overall Study|Never started treatment|0|||
24971317|NCT00093470|50061053|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
24971318|NCT00093470|50061054|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
25071855|NCT01358864|50178162|FG000|Overall Study|Other reason not defined above|2|||
25071856|NCT01358864|50178163|FG001|Overall Study|Other reason not defined above|0|||
25071857|NCT01358864|50178164|FG002|Overall Study|Other reason not defined above|0|||
25071858|NCT01358864|50178165|FG003|Overall Study|Other reason not defined above|0|||
24971319|NCT00407537|50061062|FG000|Overall Study|Death|5|||
25192357|NCT01419314|50358075|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
25192358|NCT01419314|50358076|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
24971320|NCT00407537|50061063|FG001|Overall Study|Death|2|||
25192359|NCT01419314|50358075|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
25314550|NCT00844857|50630342|FG000|Overall Study|Physician Decision|2|||
25314551|NCT00844857|50630343|FG001|Overall Study|Physician Decision|0|||
25071859|NCT01358864|50178166|FG004|Overall Study|Other reason not defined above|0|||
24971321|NCT00407537|50061062|FG000|Overall Study|Adverse Event|36|||
24971322|NCT00407537|50061063|FG001|Overall Study|Adverse Event|0|||
24971323|NCT00407537|50061062|FG000|Overall Study|Lost to Follow-up|12|||
24971324|NCT00407537|50061063|FG001|Overall Study|Lost to Follow-up|19|||
24971325|NCT00407537|50061062|FG000|Overall Study|Other|6|||
24971326|NCT00407537|50061063|FG001|Overall Study|Other|7|||
24971327|NCT00407537|50061062|FG000|Overall Study|Withdrawal by Subject|34|||
24971328|NCT00407537|50061063|FG001|Overall Study|Withdrawal by Subject|16|||
24971329|NCT00094458|50061072|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
24971330|NCT00094458|50061073|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
24971331|NCT00094458|50061074|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
24971332|NCT00094458|50061075|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
24971333|NCT00094458|50061076|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
24971334|NCT00094458|50061077|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
24971335|NCT00094458|50061072|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
24971336|NCT00094458|50061073|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
24971337|NCT00094458|50061074|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
25071860|NCT01358864|50178167|FG005|Overall Study|Other reason not defined above|0|||
25314552|NCT00844857|50630342|FG000|Overall Study|Parent/Caregiver Decision|6|||
25314553|NCT00844857|50630343|FG001|Overall Study|Parent/Caregiver Decision|2|||
25314554|NCT00844857|50630342|FG000|Overall Study|Withdrawal by Subject|8|||
25314555|NCT00844857|50630343|FG001|Overall Study|Withdrawal by Subject|7|||
25314556|NCT00844857|50630342|FG000|Overall Study|Protocol Violation|6|||
25314557|NCT00844857|50630343|FG001|Overall Study|Protocol Violation|0|||
25169819|NCT01801865|50303201|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
25169820|NCT01801865|50303201|FG000|Overall Study|Physician Decision|7|||
25071861|NCT01358864|50178168|FG006|Overall Study|Other reason not defined above|2|||
25071862|NCT01358864|50178169|FG007|Overall Study|Other reason not defined above|0|||
25071863|NCT01358864|50178162|FG000|Overall Study|Not treated|0|||
25071864|NCT01358864|50178163|FG001|Overall Study|Not treated|0|||
25071865|NCT01358864|50178164|FG002|Overall Study|Not treated|0|||
25071866|NCT01358864|50178165|FG003|Overall Study|Not treated|0|||
25071867|NCT01358864|50178166|FG004|Overall Study|Not treated|0|||
25071868|NCT01358864|50178167|FG005|Overall Study|Not treated|0|||
25071869|NCT01358864|50178168|FG006|Overall Study|Not treated|1|||
25169821|NCT00980343|50303211|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
25169822|NCT00980343|50303212|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
24971338|NCT00094458|50061075|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
25071870|NCT01358864|50178169|FG007|Overall Study|Not treated|0|||
25071871|NCT02750761|50178195|FG000|Overall Study|Lost to Follow-up|0|||
25071872|NCT02750761|50178196|FG001|Overall Study|Lost to Follow-up|0|||
24971339|NCT00094458|50061076|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
24971340|NCT00094458|50061077|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
24971341|NCT00094458|50061072|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
24971342|NCT00094458|50061073|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
24971343|NCT00094458|50061074|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
24971344|NCT00094458|50061075|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
24971345|NCT00094458|50061076|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
24971346|NCT00094458|50061077|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
24971347|NCT00094458|50061072|FG000|Main Study: Through Week 30|Adverse Event|38|||
24971348|NCT00094458|50061073|FG001|Main Study: Through Week 30|Adverse Event|20|||
24971349|NCT00094458|50061074|FG002|Main Study: Through Week 30|Adverse Event|28|||
24971350|NCT00094458|50061075|FG003|Main Study: Through Week 30|Adverse Event|0|||
24971351|NCT00094458|50061076|FG004|Main Study: Through Week 30|Adverse Event|0|||
24971352|NCT00094458|50061077|FG005|Main Study: Through Week 30|Adverse Event|0|||
24971353|NCT00094458|50061072|FG000|Main Study: Through Week 30|Death|1|||
24971354|NCT00094458|50061073|FG001|Main Study: Through Week 30|Death|0|||
24971355|NCT00094458|50061074|FG002|Main Study: Through Week 30|Death|0|||
24971356|NCT00094458|50061075|FG003|Main Study: Through Week 30|Death|0|||
24971357|NCT00094458|50061076|FG004|Main Study: Through Week 30|Death|0|||
24971358|NCT00094458|50061077|FG005|Main Study: Through Week 30|Death|0|||
24971359|NCT00094458|50061072|FG000|Main Study: Through Week 30|Other|19|||
24971360|NCT00094458|50061073|FG001|Main Study: Through Week 30|Other|16|||
24971361|NCT00094458|50061074|FG002|Main Study: Through Week 30|Other|9|||
24971362|NCT00094458|50061075|FG003|Main Study: Through Week 30|Other|0|||
24971363|NCT00094458|50061076|FG004|Main Study: Through Week 30|Other|0|||
24971364|NCT00094458|50061077|FG005|Main Study: Through Week 30|Other|0|||
25071873|NCT02750761|50178197|FG002|Overall Study|Lost to Follow-up|1|||
24971365|NCT00094458|50061072|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
25071874|NCT02750761|50178198|FG003|Overall Study|Lost to Follow-up|0|||
25071875|NCT02750761|50178199|FG004|Overall Study|Lost to Follow-up|0|||
25071876|NCT02750761|50178200|FG005|Overall Study|Lost to Follow-up|0|||
25071877|NCT02688933|50178243|FG000|Overall Study|Adverse Event|3|||
25071878|NCT02688933|50178244|FG001|Overall Study|Adverse Event|1|||
25071879|NCT02688933|50178243|FG000|Overall Study|Lack of Efficacy|2|||
25071880|NCT02688933|50178244|FG001|Overall Study|Lack of Efficacy|2|||
25071881|NCT02688933|50178243|FG000|Overall Study|Poor compliance to protocol|7|||
25071882|NCT02688933|50178244|FG001|Overall Study|Poor compliance to protocol|4|||
25169823|NCT01801475|50303222|FG000|Overall Study|Withdrawal by Subject|0|||
25071883|NCT02688933|50178243|FG000|Overall Study|Hypoglycemia|2|||
24971366|NCT00094458|50061073|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
24971367|NCT00094458|50061074|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
24971368|NCT00094458|50061075|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
24971369|NCT00094458|50061076|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
24971370|NCT00094458|50061077|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
24971371|NCT00094458|50061072|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
24971372|NCT00094458|50061073|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
24971373|NCT00094458|50061074|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
24971374|NCT00094458|50061075|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
24971375|NCT00094458|50061076|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
24971376|NCT00094458|50061077|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
24971377|NCT00094458|50061072|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
24971378|NCT00094458|50061073|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
24971379|NCT00094458|50061074|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
24971380|NCT00094458|50061075|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
24971381|NCT00094458|50061076|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
24971382|NCT00094458|50061077|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
24971383|NCT00094458|50061072|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
24971384|NCT00094458|50061073|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
24971385|NCT00094458|50061074|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
24971386|NCT00094458|50061075|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
24971387|NCT00094458|50061076|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
24971388|NCT00094458|50061077|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
24971389|NCT00094458|50061072|FG000|OLE: Open-Label Extension|Adverse Event|0|||
24971390|NCT00094458|50061073|FG001|OLE: Open-Label Extension|Adverse Event|0|||
24971391|NCT00094458|50061074|FG002|OLE: Open-Label Extension|Adverse Event|0|||
24971392|NCT00094458|50061075|FG003|OLE: Open-Label Extension|Adverse Event|0|||
24971393|NCT00094458|50061076|FG004|OLE: Open-Label Extension|Adverse Event|3|||
24971394|NCT00094458|50061077|FG005|OLE: Open-Label Extension|Adverse Event|4|||
24971395|NCT00094458|50061072|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
24971396|NCT00094458|50061073|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
24971397|NCT00094458|50061074|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
24971398|NCT00094458|50061075|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
24971399|NCT00094458|50061076|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
24971400|NCT00094458|50061077|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
25071884|NCT02688933|50178244|FG001|Overall Study|Hypoglycemia|0|||
24971401|NCT00094458|50061072|FG000|OLE: Open-Label Extension|Patient decision|0|||
24971402|NCT00094458|50061073|FG001|OLE: Open-Label Extension|Patient decision|0|||
25071885|NCT02688933|50178243|FG000|Overall Study|Other than Specified|14|||
25071886|NCT02688933|50178244|FG001|Overall Study|Other than Specified|25|||
24971403|NCT00094458|50061074|FG002|OLE: Open-Label Extension|Patient decision|0|||
24971404|NCT00094458|50061075|FG003|OLE: Open-Label Extension|Patient decision|0|||
24971405|NCT00094458|50061076|FG004|OLE: Open-Label Extension|Patient decision|1|||
24971406|NCT00094458|50061077|FG005|OLE: Open-Label Extension|Patient decision|0|||
24971407|NCT00406367|50061093|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
24971408|NCT00406367|50061094|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
24971409|NCT00406367|50061093|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
24971410|NCT00406367|50061094|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
24971411|NCT00406367|50061093|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
24971412|NCT00406367|50061094|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
25071887|NCT02688933|50178243|FG000|Overall Study|Lost to Follow-up|1|||
25071888|NCT02688933|50178244|FG001|Overall Study|Lost to Follow-up|5|||
25071889|NCT03626545|50178265|FG000|Overall Study|Progressive disease|3|||
25071890|NCT03626545|50178266|FG001|Overall Study|Progressive disease|82|||
25071891|NCT03626545|50178267|FG002|Overall Study|Progressive disease|85|||
25071892|NCT03626545|50178265|FG000|Overall Study|Adverse Event|3|||
25071893|NCT03626545|50178266|FG001|Overall Study|Adverse Event|13|||
25071894|NCT03626545|50178267|FG002|Overall Study|Adverse Event|10|||
25071895|NCT03626545|50178265|FG000|Overall Study|Physician Decision|1|||
25071896|NCT03626545|50178266|FG001|Overall Study|Physician Decision|18|||
25071897|NCT03626545|50178267|FG002|Overall Study|Physician Decision|14|||
25071898|NCT03626545|50178265|FG000|Overall Study|Subject Decision|0|||
24971413|NCT00406367|50061093|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
25071899|NCT03626545|50178266|FG001|Overall Study|Subject Decision|5|||
25314558|NCT00844857|50630342|FG000|Overall Study|Lack of Efficacy|5|||
25314559|NCT00844857|50630343|FG001|Overall Study|Lack of Efficacy|5|||
25314560|NCT00844857|50630342|FG000|Overall Study|Clinical Relapse|0|||
25314561|NCT00844857|50630343|FG001|Overall Study|Clinical Relapse|1|||
25314562|NCT00844857|50630342|FG000|Overall Study|Entry Criteria Not Met|0|||
25314563|NCT00844857|50630343|FG001|Overall Study|Entry Criteria Not Met|1|||
24971414|NCT00406367|50061094|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
24971415|NCT00406367|50061093|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
24971416|NCT00406367|50061094|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
24971417|NCT00406367|50061093|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
24971418|NCT00406367|50061094|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
24971419|NCT00406367|50061093|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
24971420|NCT00406367|50061094|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
24971421|NCT00406367|50061093|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
24971422|NCT00406367|50061094|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
24971423|NCT00406367|50061093|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
24971424|NCT00406367|50061094|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
24971425|NCT00406367|50061093|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
24971426|NCT00406367|50061094|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
24971427|NCT00406367|50061093|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
24971428|NCT00406367|50061094|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
24971429|NCT00406367|50061093|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
24971430|NCT00406367|50061094|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
24971431|NCT00394589|50061103|FG000|Overall Study|Adverse Event|2|||
24971432|NCT00394589|50061104|FG001|Overall Study|Adverse Event|1|||
24971433|NCT00394589|50061105|FG002|Overall Study|Adverse Event|2|||
24971434|NCT00394589|50061103|FG000|Overall Study|Lack of Efficacy|2|||
24971435|NCT00394589|50061104|FG001|Overall Study|Lack of Efficacy|2|||
24971436|NCT00394589|50061105|FG002|Overall Study|Lack of Efficacy|3|||
24971437|NCT00394589|50061103|FG000|Overall Study|Protocol Violation|4|||
24971438|NCT00394589|50061104|FG001|Overall Study|Protocol Violation|0|||
24971439|NCT00394589|50061105|FG002|Overall Study|Protocol Violation|2|||
24971440|NCT00068406|50061113|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
24971441|NCT00068406|50061113|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
24971442|NCT00403559|50061119|FG000|Overall Study|Adverse Event|0|||
24971443|NCT00403559|50061120|FG001|Overall Study|Adverse Event|1|||
24971444|NCT00403559|50061119|FG000|Overall Study|Lost to Follow-up|3|||
24971445|NCT00403559|50061120|FG001|Overall Study|Lost to Follow-up|3|||
24971446|NCT00403559|50061119|FG000|Overall Study|Withdrawal by Subject|1|||
24971447|NCT00403559|50061120|FG001|Overall Study|Withdrawal by Subject|0|||
24971448|NCT00403481|50061128|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
24971449|NCT00403481|50061128|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
24971450|NCT00403481|50061128|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
24971451|NCT00403481|50061128|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
24971452|NCT00403481|50061128|FG000|Olm 40 mg|Adverse Event|2|||
24971453|NCT00403481|50061128|FG000|Olm 40 mg|Protocol Violation|1|||
24971454|NCT00403481|50061128|FG000|Olm 40 mg|Withdrawal by Subject|1|||
24971455|NCT00403481|50061128|FG000|Olm 40 mg|Other|1|||
24971456|NCT00403481|50061128|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
24971457|NCT00403481|50061128|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
24971458|NCT00403481|50061128|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
24971459|NCT00403481|50061128|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
24971460|NCT00403481|50061128|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
24971461|NCT00403481|50061128|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
25169824|NCT01801475|50303223|FG001|Overall Study|Withdrawal by Subject|0|||
25314564|NCT00844857|50630342|FG000|Overall Study|Lost to Follow-up|2|||
25314565|NCT00844857|50630343|FG001|Overall Study|Lost to Follow-up|3|||
24971462|NCT00402779|50061137|FG000|Overall Study|Screen Failure|77|||
24971463|NCT00402779|50061138|FG001|Overall Study|Screen Failure|76|||
24971464|NCT00394433|50061144|FG000|Overall Study|Adverse Event|2|||
24971465|NCT00394433|50061144|FG000|Overall Study|Alternative Therapy|1|||
24971466|NCT00092534|50061150|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
24971467|NCT00092534|50061151|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
24971468|NCT00092534|50061152|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
24971469|NCT00092534|50061153|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
24971470|NCT00092534|50061154|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
24971471|NCT00092534|50061150|FG000|Base Study Vaccination Period|Adverse Event|3|||
24971472|NCT00092534|50061151|FG001|Base Study Vaccination Period|Adverse Event|1|||
24971473|NCT00092534|50061152|FG002|Base Study Vaccination Period|Adverse Event|0|||
24971474|NCT00092534|50061153|FG003|Base Study Vaccination Period|Adverse Event|0|||
24971475|NCT00092534|50061154|FG004|Base Study Vaccination Period|Adverse Event|0|||
24971476|NCT00092534|50061150|FG000|Base Study Vaccination Period|Death|5|||
24971477|NCT00092534|50061151|FG001|Base Study Vaccination Period|Death|4|||
24971478|NCT00092534|50061152|FG002|Base Study Vaccination Period|Death|0|||
24971479|NCT00092534|50061153|FG003|Base Study Vaccination Period|Death|0|||
24971480|NCT00092534|50061154|FG004|Base Study Vaccination Period|Death|0|||
24971481|NCT00092534|50061150|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
24971482|NCT00092534|50061151|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
24971483|NCT00092534|50061152|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
24971484|NCT00092534|50061153|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
24971485|NCT00092534|50061154|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
24971486|NCT00092534|50061150|FG000|Base Study Vaccination Period|Physician Decision|1|||
24971487|NCT00092534|50061151|FG001|Base Study Vaccination Period|Physician Decision|0|||
24971488|NCT00092534|50061152|FG002|Base Study Vaccination Period|Physician Decision|0|||
24971489|NCT00092534|50061153|FG003|Base Study Vaccination Period|Physician Decision|0|||
24971490|NCT00092534|50061154|FG004|Base Study Vaccination Period|Physician Decision|0|||
24971491|NCT00092534|50061150|FG000|Base Study Vaccination Period|Pregnancy|9|||
24971492|NCT00092534|50061151|FG001|Base Study Vaccination Period|Pregnancy|7|||
24971493|NCT00092534|50061152|FG002|Base Study Vaccination Period|Pregnancy|0|||
24971494|NCT00092534|50061153|FG003|Base Study Vaccination Period|Pregnancy|0|||
24971495|NCT00092534|50061154|FG004|Base Study Vaccination Period|Pregnancy|0|||
24971496|NCT00092534|50061150|FG000|Base Study Vaccination Period|Protocol Violation|2|||
24971497|NCT00092534|50061151|FG001|Base Study Vaccination Period|Protocol Violation|1|||
24971498|NCT00092534|50061152|FG002|Base Study Vaccination Period|Protocol Violation|0|||
25169825|NCT01801475|50303224|FG002|Overall Study|Withdrawal by Subject|0|||
24971499|NCT00092534|50061153|FG003|Base Study Vaccination Period|Protocol Violation|0|||
24971500|NCT00092534|50061154|FG004|Base Study Vaccination Period|Protocol Violation|0|||
24971501|NCT00092534|50061150|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
24971502|NCT00092534|50061151|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
24971503|NCT00092534|50061152|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
24971504|NCT00092534|50061153|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
24971505|NCT00092534|50061154|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
24971506|NCT00092534|50061150|FG000|Base Study Vaccination Period|Moved|14|||
24971507|NCT00092534|50061151|FG001|Base Study Vaccination Period|Moved|12|||
24971508|NCT00092534|50061152|FG002|Base Study Vaccination Period|Moved|0|||
24971509|NCT00092534|50061153|FG003|Base Study Vaccination Period|Moved|0|||
24971510|NCT00092534|50061154|FG004|Base Study Vaccination Period|Moved|0|||
24971511|NCT00092534|50061150|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
24971512|NCT00092534|50061151|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
24971513|NCT00092534|50061152|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
24971514|NCT00092534|50061153|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
24971515|NCT00092534|50061154|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
24971516|NCT00092534|50061150|FG000|Base Study Vaccination Period|Travel|1|||
24971517|NCT00092534|50061151|FG001|Base Study Vaccination Period|Travel|0|||
24971518|NCT00092534|50061152|FG002|Base Study Vaccination Period|Travel|0|||
24971519|NCT00092534|50061153|FG003|Base Study Vaccination Period|Travel|0|||
24971520|NCT00092534|50061154|FG004|Base Study Vaccination Period|Travel|0|||
24971521|NCT00092534|50061150|FG000|Base Study Vaccination Period|Site Closed|0|||
25169826|NCT01801475|50303225|FG003|Overall Study|Withdrawal by Subject|0|||
24971522|NCT00092534|50061151|FG001|Base Study Vaccination Period|Site Closed|1|||
24971523|NCT00092534|50061152|FG002|Base Study Vaccination Period|Site Closed|0|||
24971524|NCT00092534|50061153|FG003|Base Study Vaccination Period|Site Closed|0|||
24971525|NCT00092534|50061154|FG004|Base Study Vaccination Period|Site Closed|0|||
24971526|NCT00092534|50061150|FG000|Base Study Follow-Up Period|Adverse Event|2|||
24971527|NCT00092534|50061151|FG001|Base Study Follow-Up Period|Adverse Event|4|||
24971528|NCT00092534|50061152|FG002|Base Study Follow-Up Period|Adverse Event|0|||
24971529|NCT00092534|50061153|FG003|Base Study Follow-Up Period|Adverse Event|0|||
25169827|NCT01801475|50303226|FG004|Overall Study|Withdrawal by Subject|1|||
24971530|NCT00092534|50061154|FG004|Base Study Follow-Up Period|Adverse Event|0|||
24971531|NCT00092534|50061150|FG000|Base Study Follow-Up Period|Death|2|||
24971532|NCT00092534|50061151|FG001|Base Study Follow-Up Period|Death|1|||
24971533|NCT00092534|50061152|FG002|Base Study Follow-Up Period|Death|0|||
24971534|NCT00092534|50061153|FG003|Base Study Follow-Up Period|Death|0|||
24971535|NCT00092534|50061154|FG004|Base Study Follow-Up Period|Death|0|||
24971536|NCT00092534|50061150|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
24971537|NCT00092534|50061151|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
24971538|NCT00092534|50061152|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
24971539|NCT00092534|50061153|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
24971540|NCT00092534|50061154|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
24971541|NCT00092534|50061150|FG000|Base Study Follow-Up Period|Pregnancy|6|||
24971542|NCT00092534|50061151|FG001|Base Study Follow-Up Period|Pregnancy|10|||
24971543|NCT00092534|50061152|FG002|Base Study Follow-Up Period|Pregnancy|0|||
24971544|NCT00092534|50061153|FG003|Base Study Follow-Up Period|Pregnancy|0|||
24971545|NCT00092534|50061154|FG004|Base Study Follow-Up Period|Pregnancy|0|||
24971546|NCT00092534|50061150|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
24971547|NCT00092534|50061151|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
24971548|NCT00092534|50061152|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
24971549|NCT00092534|50061153|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
24971550|NCT00092534|50061154|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
24971551|NCT00092534|50061150|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
24971552|NCT00092534|50061151|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
24971553|NCT00092534|50061152|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
24971554|NCT00092534|50061153|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
24971555|NCT00092534|50061154|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
24971556|NCT00092534|50061150|FG000|Base Study Follow-Up Period|Moved|62|||
24971557|NCT00092534|50061151|FG001|Base Study Follow-Up Period|Moved|58|||
24971558|NCT00092534|50061152|FG002|Base Study Follow-Up Period|Moved|0|||
24971559|NCT00092534|50061153|FG003|Base Study Follow-Up Period|Moved|0|||
24971560|NCT00092534|50061154|FG004|Base Study Follow-Up Period|Moved|0|||
24971561|NCT00092534|50061150|FG000|Base Study Follow-Up Period|Travel|10|||
24971562|NCT00092534|50061151|FG001|Base Study Follow-Up Period|Travel|7|||
24971563|NCT00092534|50061152|FG002|Base Study Follow-Up Period|Travel|0|||
24971564|NCT00092534|50061153|FG003|Base Study Follow-Up Period|Travel|0|||
24971565|NCT00092534|50061154|FG004|Base Study Follow-Up Period|Travel|0|||
24971566|NCT00092534|50061150|FG000|Base Study Follow-Up Period|Site Closed|0|||
24971567|NCT00092534|50061151|FG001|Base Study Follow-Up Period|Site Closed|2|||
24971568|NCT00092534|50061152|FG002|Base Study Follow-Up Period|Site Closed|0|||
24971569|NCT00092534|50061153|FG003|Base Study Follow-Up Period|Site Closed|0|||
24971570|NCT00092534|50061154|FG004|Base Study Follow-Up Period|Site Closed|0|||
24971571|NCT00092534|50061150|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
24971572|NCT00092534|50061151|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
24971573|NCT00092534|50061152|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
24971574|NCT00092534|50061153|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
24971575|NCT00092534|50061154|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
24971576|NCT00092534|50061150|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
24971577|NCT00092534|50061151|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
24971578|NCT00092534|50061152|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
24971579|NCT00092534|50061153|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
24971580|NCT00092534|50061154|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
24971581|NCT00092534|50061150|FG000|Base Study EXT|Lost to Follow-up|0|||
24971582|NCT00092534|50061151|FG001|Base Study EXT|Lost to Follow-up|0|||
24971583|NCT00092534|50061152|FG002|Base Study EXT|Lost to Follow-up|41|||
24971584|NCT00092534|50061153|FG003|Base Study EXT|Lost to Follow-up|0|||
24971585|NCT00092534|50061154|FG004|Base Study EXT|Lost to Follow-up|0|||
24971586|NCT00092534|50061150|FG000|Base Study EXT|Physician Decision|0|||
24971587|NCT00092534|50061151|FG001|Base Study EXT|Physician Decision|0|||
24971588|NCT00092534|50061152|FG002|Base Study EXT|Physician Decision|1|||
24971589|NCT00092534|50061153|FG003|Base Study EXT|Physician Decision|0|||
24971590|NCT00092534|50061154|FG004|Base Study EXT|Physician Decision|0|||
24971591|NCT00092534|50061150|FG000|Base Study EXT|Pregnancy|0|||
24971592|NCT00092534|50061151|FG001|Base Study EXT|Pregnancy|0|||
24971593|NCT00092534|50061152|FG002|Base Study EXT|Pregnancy|12|||
24971594|NCT00092534|50061153|FG003|Base Study EXT|Pregnancy|0|||
24971595|NCT00092534|50061154|FG004|Base Study EXT|Pregnancy|0|||
24971596|NCT00092534|50061150|FG000|Base Study EXT|Withdrawal by Subject|0|||
24971597|NCT00092534|50061151|FG001|Base Study EXT|Withdrawal by Subject|0|||
24971598|NCT00092534|50061152|FG002|Base Study EXT|Withdrawal by Subject|18|||
24971599|NCT00092534|50061153|FG003|Base Study EXT|Withdrawal by Subject|0|||
24971600|NCT00092534|50061154|FG004|Base Study EXT|Withdrawal by Subject|0|||
24971601|NCT00092534|50061150|FG000|Base Study EXT|Participant moved|0|||
24971602|NCT00092534|50061151|FG001|Base Study EXT|Participant moved|0|||
24971603|NCT00092534|50061152|FG002|Base Study EXT|Participant moved|6|||
24971604|NCT00092534|50061153|FG003|Base Study EXT|Participant moved|0|||
24971605|NCT00092534|50061154|FG004|Base Study EXT|Participant moved|0|||
24971606|NCT00092534|50061150|FG000|Base Study EXT|Travel|0|||
24971607|NCT00092534|50061151|FG001|Base Study EXT|Travel|0|||
24971608|NCT00092534|50061152|FG002|Base Study EXT|Travel|2|||
24971609|NCT00092534|50061153|FG003|Base Study EXT|Travel|0|||
24971610|NCT00092534|50061154|FG004|Base Study EXT|Travel|0|||
24971611|NCT00092534|50061150|FG000|Base Study EXT|Site closed|0|||
24971612|NCT00092534|50061151|FG001|Base Study EXT|Site closed|0|||
24971613|NCT00092534|50061152|FG002|Base Study EXT|Site closed|21|||
24971614|NCT00092534|50061153|FG003|Base Study EXT|Site closed|0|||
24971615|NCT00092534|50061154|FG004|Base Study EXT|Site closed|0|||
24971616|NCT00092534|50061150|FG000|Base Study EXT|Study ended|0|||
24971617|NCT00092534|50061151|FG001|Base Study EXT|Study ended|0|||
24971618|NCT00092534|50061152|FG002|Base Study EXT|Study ended|29|||
24971619|NCT00092534|50061153|FG003|Base Study EXT|Study ended|0|||
24971620|NCT00092534|50061154|FG004|Base Study EXT|Study ended|0|||
24971621|NCT00092534|50061150|FG000|Base Study EXT|Protocol Violation|0|||
24971622|NCT00092534|50061151|FG001|Base Study EXT|Protocol Violation|0|||
24971623|NCT00092534|50061152|FG002|Base Study EXT|Protocol Violation|15|||
24971624|NCT00092534|50061153|FG003|Base Study EXT|Protocol Violation|0|||
24971625|NCT00092534|50061154|FG004|Base Study EXT|Protocol Violation|0|||
24971626|NCT00092534|50061150|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
24971627|NCT00092534|50061151|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
24971628|NCT00092534|50061152|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
24971629|NCT00092534|50061153|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
24971630|NCT00092534|50061154|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
24971631|NCT00068250|50061167|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
24971632|NCT00068250|50061168|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
24971633|NCT00068250|50061169|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
24971634|NCT00068250|50061170|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
24971635|NCT00393887|50061180|FG000|Overall Study|Physician Decision|5|||
24971636|NCT00393887|50061181|FG001|Overall Study|Physician Decision|0|||
24971637|NCT00393887|50061180|FG000|Overall Study|Lost to Follow-up|11|||
24971638|NCT00393887|50061181|FG001|Overall Study|Lost to Follow-up|9|||
24971639|NCT00393029|50061189|FG000|Overall Study|Not treated|0|||
24971640|NCT00393029|50061190|FG001|Overall Study|Not treated|1|||
24971641|NCT00402233|50061201|FG000|Overall Study|Adverse Event|1|||
24971642|NCT00402233|50061202|FG001|Overall Study|Adverse Event|7|||
24971643|NCT00402233|50061203|FG002|Overall Study|Adverse Event|9|||
24971644|NCT00402233|50061204|FG003|Overall Study|Adverse Event|9|||
24971645|NCT00402233|50061201|FG000|Overall Study|Protocol Violation|0|||
24971646|NCT00402233|50061202|FG001|Overall Study|Protocol Violation|1|||
24971647|NCT00402233|50061203|FG002|Overall Study|Protocol Violation|0|||
24971648|NCT00402233|50061204|FG003|Overall Study|Protocol Violation|0|||
24971649|NCT00402233|50061201|FG000|Overall Study|Withdrawal by Subject|2|||
24971650|NCT00402233|50061202|FG001|Overall Study|Withdrawal by Subject|1|||
24971651|NCT00402233|50061203|FG002|Overall Study|Withdrawal by Subject|2|||
24971652|NCT00402233|50061204|FG003|Overall Study|Withdrawal by Subject|2|||
24971653|NCT00402233|50061201|FG000|Overall Study|Worsening of disease under study|2|||
24971654|NCT00402233|50061202|FG001|Overall Study|Worsening of disease under study|0|||
24971655|NCT00402233|50061203|FG002|Overall Study|Worsening of disease under study|0|||
24971656|NCT00402233|50061204|FG003|Overall Study|Worsening of disease under study|0|||
24971657|NCT00402233|50061201|FG000|Overall Study|Worsening of other pre-existing disease|0|||
24971658|NCT00402233|50061202|FG001|Overall Study|Worsening of other pre-existing disease|1|||
24971659|NCT00402233|50061203|FG002|Overall Study|Worsening of other pre-existing disease|0|||
24971660|NCT00402233|50061204|FG003|Overall Study|Worsening of other pre-existing disease|0|||
25169828|NCT01822925|50303285|FG000|Overall Study|Adverse Event|1|||
24971661|NCT00092456|50061218|FG000|Overall Study|Adverse Event|0|||
24971662|NCT00092456|50061219|FG001|Overall Study|Adverse Event|0|||
24971663|NCT00092456|50061220|FG002|Overall Study|Adverse Event|1|||
24971664|NCT00092456|50061221|FG003|Overall Study|Adverse Event|1|||
24971665|NCT00092456|50061218|FG000|Overall Study|Lost to Follow-up|2|||
24971666|NCT00092456|50061219|FG001|Overall Study|Lost to Follow-up|2|||
24971667|NCT00092456|50061220|FG002|Overall Study|Lost to Follow-up|1|||
24971668|NCT00092456|50061221|FG003|Overall Study|Lost to Follow-up|2|||
24971669|NCT00092456|50061218|FG000|Overall Study|Protocol Violation|5|||
24971670|NCT00092456|50061219|FG001|Overall Study|Protocol Violation|7|||
24971671|NCT00092456|50061220|FG002|Overall Study|Protocol Violation|8|||
24971672|NCT00092456|50061221|FG003|Overall Study|Protocol Violation|6|||
24971673|NCT00092456|50061218|FG000|Overall Study|Withdrawal by Subject|13|||
24971674|NCT00092456|50061219|FG001|Overall Study|Withdrawal by Subject|5|||
24971675|NCT00092456|50061220|FG002|Overall Study|Withdrawal by Subject|16|||
24971676|NCT00092456|50061221|FG003|Overall Study|Withdrawal by Subject|6|||
24971677|NCT00092456|50061218|FG000|Overall Study|Moved|1|||
24971678|NCT00092456|50061219|FG001|Overall Study|Moved|1|||
24971679|NCT00092456|50061220|FG002|Overall Study|Moved|0|||
24971680|NCT00092456|50061221|FG003|Overall Study|Moved|1|||
24971681|NCT00092456|50061218|FG000|Overall Study|Other|4|||
24971682|NCT00092456|50061219|FG001|Overall Study|Other|2|||
24971683|NCT00092456|50061220|FG002|Overall Study|Other|3|||
24971684|NCT00092456|50061221|FG003|Overall Study|Other|0|||
24971685|NCT00067470|50061233|FG000|Overall Study|Withdrawal by Subject|0|||
24971686|NCT00067470|50061234|FG001|Overall Study|Withdrawal by Subject|1|||
24971687|NCT00401843|50061243|FG000|Overall Study|Achieved Complete Response|1|||
24971688|NCT00401843|50061244|FG001|Overall Study|Achieved Complete Response|5|||
24971689|NCT00401843|50061245|FG002|Overall Study|Achieved Complete Response|11|||
24971690|NCT00401843|50061243|FG000|Overall Study|Adverse Event|7|||
24971691|NCT00401843|50061244|FG001|Overall Study|Adverse Event|26|||
24971692|NCT00401843|50061245|FG002|Overall Study|Adverse Event|27|||
24971693|NCT00401843|50061243|FG000|Overall Study|Death|0|||
24971694|NCT00401843|50061244|FG001|Overall Study|Death|8|||
24971695|NCT00401843|50061245|FG002|Overall Study|Death|10|||
24971696|NCT00401843|50061243|FG000|Overall Study|Disease progression|10|||
25169829|NCT01822925|50303286|FG001|Overall Study|Adverse Event|1|||
24971697|NCT00401843|50061244|FG001|Overall Study|Disease progression|60|||
24971698|NCT00401843|50061245|FG002|Overall Study|Disease progression|49|||
25314566|NCT00844857|50630342|FG000|Overall Study|Did Not Take Study Drug|3|||
25314567|NCT00844857|50630343|FG001|Overall Study|Did Not Take Study Drug|1|||
25314568|NCT00844857|50630342|FG000|Overall Study|Good Clinical Practice Violations|21|||
25314569|NCT00844857|50630343|FG001|Overall Study|Good Clinical Practice Violations|11|||
25314570|NCT00569803|50630360|FG000|Overall Study|Lost to Follow-up|1|||
25314571|NCT00569803|50630361|FG001|Overall Study|Lost to Follow-up|0|||
25314572|NCT00569803|50630362|FG002|Overall Study|Lost to Follow-up|0|||
25314573|NCT00569803|50630363|FG003|Overall Study|Lost to Follow-up|0|||
25314574|NCT00569803|50630364|FG004|Overall Study|Lost to Follow-up|0|||
25314575|NCT00569803|50630365|FG005|Overall Study|Lost to Follow-up|0|||
25314576|NCT00569803|50630366|FG006|Overall Study|Lost to Follow-up|0|||
25314577|NCT00569803|50630367|FG007|Overall Study|Lost to Follow-up|0|||
25314578|NCT00569803|50630360|FG000|Overall Study|injection syringe leaked during dosing|0|||
25314579|NCT00569803|50630361|FG001|Overall Study|injection syringe leaked during dosing|0|||
25314580|NCT00569803|50630362|FG002|Overall Study|injection syringe leaked during dosing|0|||
25314581|NCT00569803|50630363|FG003|Overall Study|injection syringe leaked during dosing|1|||
25314582|NCT00569803|50630364|FG004|Overall Study|injection syringe leaked during dosing|0|||
24971699|NCT00401843|50061243|FG000|Overall Study|End of Study|1|||
24971700|NCT00401843|50061244|FG001|Overall Study|End of Study|1|||
24971701|NCT00401843|50061245|FG002|Overall Study|End of Study|2|||
24971702|NCT00401843|50061243|FG000|Overall Study|Lost to Follow-up|0|||
24971703|NCT00401843|50061244|FG001|Overall Study|Lost to Follow-up|0|||
24971704|NCT00401843|50061245|FG002|Overall Study|Lost to Follow-up|2|||
24971705|NCT00401843|50061243|FG000|Overall Study|Other Unspecified|0|||
24971706|NCT00401843|50061244|FG001|Overall Study|Other Unspecified|3|||
24971707|NCT00401843|50061245|FG002|Overall Study|Other Unspecified|5|||
24971708|NCT00401843|50061243|FG000|Overall Study|Physician Decision|0|||
24971709|NCT00401843|50061244|FG001|Overall Study|Physician Decision|16|||
24971710|NCT00401843|50061245|FG002|Overall Study|Physician Decision|10|||
24971711|NCT00401843|50061243|FG000|Overall Study|Protocol Violation|0|||
24971712|NCT00401843|50061244|FG001|Overall Study|Protocol Violation|0|||
24971713|NCT00401843|50061245|FG002|Overall Study|Protocol Violation|1|||
24971714|NCT00401843|50061243|FG000|Overall Study|Withdrawal by Subject|1|||
24971715|NCT00401843|50061244|FG001|Overall Study|Withdrawal by Subject|5|||
24971716|NCT00401843|50061245|FG002|Overall Study|Withdrawal by Subject|5|||
24971717|NCT00401843|50061243|FG000|Overall Study|Withdrawal of consent to study agent|1|||
24971718|NCT00401843|50061244|FG001|Overall Study|Withdrawal of consent to study agent|15|||
24971719|NCT00401843|50061245|FG002|Overall Study|Withdrawal of consent to study agent|17|||
24971720|NCT00401843|50061243|FG000|Overall Study|Randomized but not Treated|0|||
24971721|NCT00401843|50061244|FG001|Overall Study|Randomized but not Treated|2|||
24971722|NCT00401843|50061245|FG002|Overall Study|Randomized but not Treated|3|||
24971723|NCT00401843|50061243|FG000|Overall Study|Received incorrect treatment|0|||
24971724|NCT00401843|50061244|FG001|Overall Study|Received incorrect treatment|3|||
24971725|NCT00401843|50061245|FG002|Overall Study|Received incorrect treatment|0|||
24971726|NCT00401531|50061257|FG000|Overall Study|Adverse Event|2|||
24971727|NCT00401531|50061258|FG001|Overall Study|Adverse Event|0|||
24971728|NCT00401531|50061257|FG000|Overall Study|Protocol Violation|3|||
24971729|NCT00401531|50061258|FG001|Overall Study|Protocol Violation|7|||
24971730|NCT00401531|50061257|FG000|Overall Study|Lost to Follow-up|1|||
24971731|NCT00401531|50061258|FG001|Overall Study|Lost to Follow-up|1|||
24971732|NCT00401531|50061257|FG000|Overall Study|Withdrawal by Subject|3|||
24971733|NCT00401531|50061258|FG001|Overall Study|Withdrawal by Subject|2|||
24971734|NCT00401375|50061267|FG000|Overall Study|Protocol Violation|2|||
24971735|NCT00401375|50061268|FG001|Overall Study|Protocol Violation|2|||
24971736|NCT00401375|50061269|FG002|Overall Study|Protocol Violation|1|||
24971737|NCT00401375|50061267|FG000|Overall Study|Adverse Event|6|||
24971738|NCT00401375|50061268|FG001|Overall Study|Adverse Event|11|||
24971739|NCT00401375|50061269|FG002|Overall Study|Adverse Event|10|||
24971740|NCT00401375|50061267|FG000|Overall Study|Withdrawal by Subject|9|||
24971741|NCT00401375|50061268|FG001|Overall Study|Withdrawal by Subject|7|||
24971742|NCT00401375|50061269|FG002|Overall Study|Withdrawal by Subject|7|||
24971743|NCT00401375|50061267|FG000|Overall Study|Lost to Follow-up|0|||
24971744|NCT00401375|50061268|FG001|Overall Study|Lost to Follow-up|1|||
24971745|NCT00401375|50061269|FG002|Overall Study|Lost to Follow-up|1|||
24971746|NCT00401375|50061267|FG000|Overall Study|Other than specified|2|||
24971747|NCT00401375|50061268|FG001|Overall Study|Other than specified|1|||
24971748|NCT00401375|50061269|FG002|Overall Study|Other than specified|3|||
24971749|NCT00401375|50061267|FG000|Overall Study|Randomized but not treated|3|||
24971750|NCT00401375|50061268|FG001|Overall Study|Randomized but not treated|3|||
24971751|NCT00401375|50061269|FG002|Overall Study|Randomized but not treated|3|||
24971752|NCT00400985|50061277|FG000|Overall Study|Withdrawal by Subject|5|||
24971753|NCT00400985|50061277|FG000|Overall Study|system modification|8|||
24971754|NCT00400985|50061277|FG000|Overall Study|Death|30|||
24971755|NCT00400985|50061277|FG000|Overall Study|Lost to Follow-up|9|||
24971756|NCT00400517|50061281|FG000|Overall Study|Withdrawal by Subject|1|||
24971757|NCT00400517|50061281|FG000|Overall Study|Physician Decision|1|||
24971758|NCT00392171|50061285|FG000|Overall Study|Did not meet inclusion criteria|4|||
24971759|NCT00392171|50061285|FG000|Overall Study|Disease progression|101|||
24971760|NCT00392015|50061295|FG000|Overall Study|Lost to Follow-up|2|||
24971761|NCT00392015|50061296|FG001|Overall Study|Lost to Follow-up|0|||
24971762|NCT00392015|50061297|FG002|Overall Study|Lost to Follow-up|2|||
24971763|NCT00392015|50061298|FG003|Overall Study|Lost to Follow-up|1|||
24971764|NCT00392015|50061299|FG004|Overall Study|Lost to Follow-up|1|||
24971765|NCT00392015|50061300|FG005|Overall Study|Lost to Follow-up|0|||
24971766|NCT00392015|50061295|FG000|Overall Study|Withdrawal by Subject|0|||
24971767|NCT00392015|50061296|FG001|Overall Study|Withdrawal by Subject|0|||
24971768|NCT00392015|50061297|FG002|Overall Study|Withdrawal by Subject|2|||
24971769|NCT00392015|50061298|FG003|Overall Study|Withdrawal by Subject|0|||
24971770|NCT00392015|50061299|FG004|Overall Study|Withdrawal by Subject|0|||
24971771|NCT00392015|50061300|FG005|Overall Study|Withdrawal by Subject|0|||
24971772|NCT00392015|50061295|FG000|Overall Study|Adverse Event|0|||
24971773|NCT00392015|50061296|FG001|Overall Study|Adverse Event|0|||
24971774|NCT00392015|50061297|FG002|Overall Study|Adverse Event|0|||
24971775|NCT00392015|50061298|FG003|Overall Study|Adverse Event|0|||
24971776|NCT00392015|50061299|FG004|Overall Study|Adverse Event|1|||
24971777|NCT00392015|50061300|FG005|Overall Study|Adverse Event|0|||
24971778|NCT00392015|50061295|FG000|Overall Study|Previous trial recipient|0|||
24971779|NCT00392015|50061296|FG001|Overall Study|Previous trial recipient|0|||
24971780|NCT00392015|50061297|FG002|Overall Study|Previous trial recipient|0|||
24971781|NCT00392015|50061298|FG003|Overall Study|Previous trial recipient|0|||
24971782|NCT00392015|50061299|FG004|Overall Study|Previous trial recipient|1|||
24971783|NCT00392015|50061300|FG005|Overall Study|Previous trial recipient|0|||
25192360|NCT01419314|50358076|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
24971784|NCT00391625|50061319|FG000|Month 14|Withdrawal by Subject|1|||
24971785|NCT00391625|50061319|FG000|Month 50|Physician Decision|1|||
24971786|NCT00091832|50061352|FG000|Overall Study|Physician Decision|1|||
24971787|NCT00091832|50061353|FG001|Overall Study|Physician Decision|0|||
24971788|NCT00091832|50061354|FG002|Overall Study|Physician Decision|0|||
24971789|NCT00091832|50061355|FG003|Overall Study|Physician Decision|0|||
24971790|NCT00091832|50061356|FG004|Overall Study|Physician Decision|0|||
24971791|NCT00091832|50061357|FG005|Overall Study|Physician Decision|0|||
24971792|NCT00091832|50061352|FG000|Overall Study|Adverse Event|0|||
24971793|NCT00091832|50061353|FG001|Overall Study|Adverse Event|0|||
24971794|NCT00091832|50061354|FG002|Overall Study|Adverse Event|0|||
25192361|NCT01419236|50358133|FG000|Overall Study|Adverse Event|1|||
25192362|NCT01419236|50358134|FG001|Overall Study|Adverse Event|0|||
24971795|NCT00091832|50061355|FG003|Overall Study|Adverse Event|1|||
24971796|NCT00091832|50061356|FG004|Overall Study|Adverse Event|3|||
25169830|NCT01822925|50303287|FG002|Overall Study|Adverse Event|1|||
24971797|NCT00091832|50061357|FG005|Overall Study|Adverse Event|0|||
24971798|NCT00091832|50061352|FG000|Overall Study|Withdrawal by Subject|4|||
24971799|NCT00091832|50061353|FG001|Overall Study|Withdrawal by Subject|5|||
24971800|NCT00091832|50061354|FG002|Overall Study|Withdrawal by Subject|0|||
24971801|NCT00091832|50061355|FG003|Overall Study|Withdrawal by Subject|1|||
24971802|NCT00091832|50061356|FG004|Overall Study|Withdrawal by Subject|3|||
24971803|NCT00091832|50061357|FG005|Overall Study|Withdrawal by Subject|1|||
24971804|NCT00091832|50061352|FG000|Overall Study|Death|6|||
24971805|NCT00091832|50061353|FG001|Overall Study|Death|4|||
24971806|NCT00091832|50061354|FG002|Overall Study|Death|5|||
24971807|NCT00091832|50061355|FG003|Overall Study|Death|8|||
24971808|NCT00091832|50061356|FG004|Overall Study|Death|5|||
24971809|NCT00091832|50061357|FG005|Overall Study|Death|6|||
24971810|NCT00091832|50061352|FG000|Overall Study|Disease Progression|2|||
24971811|NCT00091832|50061353|FG001|Overall Study|Disease Progression|0|||
24971812|NCT00091832|50061354|FG002|Overall Study|Disease Progression|0|||
24971813|NCT00091832|50061355|FG003|Overall Study|Disease Progression|1|||
24971814|NCT00091832|50061356|FG004|Overall Study|Disease Progression|1|||
24971815|NCT00091832|50061357|FG005|Overall Study|Disease Progression|2|||
24971816|NCT00091832|50061352|FG000|Overall Study|Ineligibility Determined|0|||
24971817|NCT00091832|50061353|FG001|Overall Study|Ineligibility Determined|0|||
24971818|NCT00091832|50061354|FG002|Overall Study|Ineligibility Determined|1|||
24971819|NCT00091832|50061355|FG003|Overall Study|Ineligibility Determined|0|||
24971820|NCT00091832|50061356|FG004|Overall Study|Ineligibility Determined|1|||
24971821|NCT00091832|50061357|FG005|Overall Study|Ineligibility Determined|0|||
24971822|NCT00091832|50061352|FG000|Overall Study|Lost to Follow-up|1|||
24971823|NCT00091832|50061353|FG001|Overall Study|Lost to Follow-up|0|||
24971824|NCT00091832|50061354|FG002|Overall Study|Lost to Follow-up|3|||
24971825|NCT00091832|50061355|FG003|Overall Study|Lost to Follow-up|3|||
24971826|NCT00091832|50061356|FG004|Overall Study|Lost to Follow-up|2|||
24971827|NCT00091832|50061357|FG005|Overall Study|Lost to Follow-up|1|||
24971828|NCT00091832|50061352|FG000|Overall Study|Noncompliance|0|||
24971829|NCT00091832|50061353|FG001|Overall Study|Noncompliance|1|||
24971830|NCT00091832|50061354|FG002|Overall Study|Noncompliance|0|||
24971831|NCT00091832|50061355|FG003|Overall Study|Noncompliance|0|||
24971832|NCT00091832|50061356|FG004|Overall Study|Noncompliance|0|||
24971833|NCT00091832|50061357|FG005|Overall Study|Noncompliance|0|||
24971834|NCT00091832|50061352|FG000|Overall Study|Other|0|||
24971835|NCT00091832|50061353|FG001|Overall Study|Other|1|||
24971836|NCT00091832|50061354|FG002|Overall Study|Other|2|||
24971837|NCT00091832|50061355|FG003|Overall Study|Other|0|||
24971838|NCT00091832|50061356|FG004|Overall Study|Other|0|||
24971839|NCT00091832|50061357|FG005|Overall Study|Other|0|||
24971840|NCT00091832|50061352|FG000|Overall Study|Protocol Violation|0|||
24971841|NCT00091832|50061353|FG001|Overall Study|Protocol Violation|0|||
24971842|NCT00091832|50061354|FG002|Overall Study|Protocol Violation|1|||
24971843|NCT00091832|50061355|FG003|Overall Study|Protocol Violation|0|||
24971844|NCT00091832|50061356|FG004|Overall Study|Protocol Violation|0|||
24971845|NCT00091832|50061357|FG005|Overall Study|Protocol Violation|1|||
24971846|NCT00391391|50061375|FG000|Overall Study|Adverse Event|0|||
24971847|NCT00391391|50061376|FG001|Overall Study|Adverse Event|0|||
24971848|NCT00391391|50061377|FG002|Overall Study|Adverse Event|0|||
24971849|NCT00391391|50061378|FG003|Overall Study|Adverse Event|1|||
24971850|NCT00391391|50061375|FG000|Overall Study|Lost to Follow-up|1|||
24971851|NCT00391391|50061376|FG001|Overall Study|Lost to Follow-up|3|||
24971852|NCT00391391|50061377|FG002|Overall Study|Lost to Follow-up|7|||
25314583|NCT00569803|50630365|FG005|Overall Study|injection syringe leaked during dosing|0|||
25314584|NCT00569803|50630366|FG006|Overall Study|injection syringe leaked during dosing|0|||
25314585|NCT00569803|50630367|FG007|Overall Study|injection syringe leaked during dosing|0|||
25314586|NCT00569803|50630360|FG000|Overall Study|Withdrawal by Subject|0|||
25314587|NCT00569803|50630361|FG001|Overall Study|Withdrawal by Subject|0|||
25314588|NCT00569803|50630362|FG002|Overall Study|Withdrawal by Subject|0|||
25314589|NCT00569803|50630363|FG003|Overall Study|Withdrawal by Subject|0|||
25314590|NCT00569803|50630364|FG004|Overall Study|Withdrawal by Subject|0|||
25314591|NCT00569803|50630365|FG005|Overall Study|Withdrawal by Subject|0|||
25314592|NCT00569803|50630366|FG006|Overall Study|Withdrawal by Subject|0|||
25314593|NCT00569803|50630367|FG007|Overall Study|Withdrawal by Subject|1|||
25314594|NCT00920426|50630392|FG000|ITZ111451|Adverse Event|1|||
25071900|NCT03626545|50178267|FG002|Overall Study|Subject Decision|5|||
25071901|NCT03626545|50178265|FG000|Overall Study|Death|1|||
25071902|NCT03626545|50178266|FG001|Overall Study|Death|1|||
25071903|NCT03626545|50178267|FG002|Overall Study|Death|1|||
25071904|NCT03626545|50178265|FG000|Overall Study|Protocol Deviation|0|||
25071905|NCT03626545|50178266|FG001|Overall Study|Protocol Deviation|1|||
25071906|NCT03626545|50178267|FG002|Overall Study|Protocol Deviation|1|||
25071907|NCT03626545|50178265|FG000|Overall Study|Guardian Decision|0|||
25071908|NCT03626545|50178266|FG001|Overall Study|Guardian Decision|0|||
25071909|NCT03626545|50178267|FG002|Overall Study|Guardian Decision|1|||
25169831|NCT01822925|50303288|FG003|Overall Study|Adverse Event|1|||
25169832|NCT01822925|50303285|FG000|Overall Study|Lost to Follow-up|0|||
25169833|NCT01822925|50303286|FG001|Overall Study|Lost to Follow-up|1|||
25169834|NCT01822925|50303287|FG002|Overall Study|Lost to Follow-up|0|||
25169835|NCT01822925|50303288|FG003|Overall Study|Lost to Follow-up|0|||
25169836|NCT01822925|50303285|FG000|Overall Study|Protocol Violation|1|||
25169837|NCT01822925|50303286|FG001|Overall Study|Protocol Violation|0|||
25169838|NCT01822925|50303287|FG002|Overall Study|Protocol Violation|0|||
25169839|NCT01822925|50303288|FG003|Overall Study|Protocol Violation|1|||
25169840|NCT01822925|50303285|FG000|Overall Study|Withdrawal by Subject|2|||
24971853|NCT00391391|50061378|FG003|Overall Study|Lost to Follow-up|4|||
24971854|NCT00391391|50061375|FG000|Overall Study|Protocol Violation|2|||
24971855|NCT00391391|50061376|FG001|Overall Study|Protocol Violation|3|||
24971856|NCT00391391|50061377|FG002|Overall Study|Protocol Violation|6|||
24971857|NCT00391391|50061378|FG003|Overall Study|Protocol Violation|7|||
24971858|NCT00391391|50061375|FG000|Overall Study|Withdrawal by Subject|6|||
24971859|NCT00391391|50061376|FG001|Overall Study|Withdrawal by Subject|4|||
24971860|NCT00391391|50061377|FG002|Overall Study|Withdrawal by Subject|10|||
24971861|NCT00391391|50061378|FG003|Overall Study|Withdrawal by Subject|7|||
24971862|NCT00091442|50061390|FG000|Overall Study|Progressive Disease|220|||
25071910|NCT02688621|50178283|FG000|Overall Study|Pregnancy|1|||
25169841|NCT01822925|50303286|FG001|Overall Study|Withdrawal by Subject|0|||
25169842|NCT01822925|50303287|FG002|Overall Study|Withdrawal by Subject|2|||
25169843|NCT01822925|50303288|FG003|Overall Study|Withdrawal by Subject|2|||
25169844|NCT01822925|50303285|FG000|Overall Study|Taking prohibited medication|2|||
25314595|NCT00920426|50630393|FG001|ITZ111451|Adverse Event|0|||
25314596|NCT00920426|50630394|FG002|ITZ111451|Adverse Event|0|||
25314597|NCT00920426|50630395|FG003|ITZ111451|Adverse Event|0|||
25314598|NCT00644995|50630409|FG000|Overall Study|Lost to Follow-up|1|||
24971863|NCT00091442|50061391|FG001|Overall Study|Progressive Disease|189|||
25071911|NCT02688621|50178284|FG001|Overall Study|Pregnancy|3|||
24971864|NCT00091442|50061390|FG000|Overall Study|Physician Decision|61|||
24971865|NCT00091442|50061391|FG001|Overall Study|Physician Decision|58|||
24971866|NCT00091442|50061390|FG000|Overall Study|Withdrawal by Subject|38|||
24971867|NCT00091442|50061391|FG001|Overall Study|Withdrawal by Subject|46|||
24971868|NCT00091442|50061390|FG000|Overall Study|Adverse Event|29|||
24971869|NCT00091442|50061391|FG001|Overall Study|Adverse Event|48|||
24971870|NCT00091442|50061390|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
24971871|NCT00091442|50061391|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
24971872|NCT00091442|50061390|FG000|Overall Study|Death|9|||
24971873|NCT00091442|50061391|FG001|Overall Study|Death|7|||
24971874|NCT00091442|50061390|FG000|Overall Study|Lost to Follow-up|1|||
24971875|NCT00091442|50061391|FG001|Overall Study|Lost to Follow-up|3|||
24971876|NCT00091442|50061390|FG000|Overall Study|Other|2|||
24971877|NCT00091442|50061391|FG001|Overall Study|Other|6|||
24971878|NCT00390689|50061400|FG000|Overall Study|Adverse Event|2|||
24971879|NCT00390689|50061401|FG001|Overall Study|Adverse Event|5|||
24971880|NCT00390689|50061402|FG002|Overall Study|Adverse Event|2|||
24971881|NCT00390689|50061400|FG000|Overall Study|Lack of Efficacy|0|||
24971882|NCT00390689|50061401|FG001|Overall Study|Lack of Efficacy|0|||
24971883|NCT00390689|50061402|FG002|Overall Study|Lack of Efficacy|1|||
24971884|NCT00390689|50061400|FG000|Overall Study|Protocol Violation|1|||
24971885|NCT00390689|50061401|FG001|Overall Study|Protocol Violation|0|||
24971886|NCT00390689|50061402|FG002|Overall Study|Protocol Violation|0|||
24971887|NCT00390689|50061400|FG000|Overall Study|Investigator's judgement|2|||
24971888|NCT00390689|50061401|FG001|Overall Study|Investigator's judgement|0|||
24971889|NCT00390689|50061402|FG002|Overall Study|Investigator's judgement|0|||
24971890|NCT00121238|50061419|FG000|Overall Study|disease progression before intervention|1|||
24971891|NCT00121238|50061419|FG000|Overall Study|Protocol Violation|2|||
24971892|NCT00390455|50061425|FG000|Overall Study|Adverse Event|17|||
24971893|NCT00390455|50061426|FG001|Overall Study|Adverse Event|3|||
24971894|NCT00390455|50061425|FG000|Overall Study|Withdrawal by Subject|8|||
24971895|NCT00390455|50061426|FG001|Overall Study|Withdrawal by Subject|8|||
24971896|NCT00390455|50061425|FG000|Overall Study|Alternate Treatment|0|||
24971897|NCT00390455|50061426|FG001|Overall Study|Alternate Treatment|1|||
24971898|NCT00390455|50061425|FG000|Overall Study|Other Medical Reasons|7|||
24971899|NCT00390455|50061426|FG001|Overall Study|Other Medical Reasons|11|||
24971900|NCT03812510|50061432|FG000|Overall Study|Lost to Follow-up|39|||
24971901|NCT03812510|50061432|FG000|Overall Study|Withdrawal by Subject|42|||
24971902|NCT03812510|50061432|FG000|Overall Study|Physician Decision|2|||
24971903|NCT03812510|50061432|FG000|Overall Study|Study Terminated by Sponsor|9|||
24971904|NCT03812510|50061432|FG000|Overall Study|Did Not Start Study Medication|55|||
24971905|NCT03812510|50061432|FG000|Overall Study|Adverse Event|5|||
24971906|NCT00390299|50061442|FG000|Overall Study|Cancellation|1|||
24971907|NCT00390299|50061443|FG001|Overall Study|Cancellation|0|||
24971908|NCT00390299|50061444|FG002|Overall Study|Cancellation|0|||
24971909|NCT00390299|50061445|FG003|Overall Study|Cancellation|0|||
25071912|NCT02688621|50178283|FG000|Overall Study|Lost to Follow-up|38|||
25071913|NCT02688621|50178284|FG001|Overall Study|Lost to Follow-up|15|||
24971910|NCT00390299|50061446|FG004|Overall Study|Cancellation|0|||
24971911|NCT00119678|50061462|FG000|Double-blind Treatment Period|Death|1|||
24971912|NCT00119678|50061463|FG001|Double-blind Treatment Period|Death|0|||
25192363|NCT01419236|50358133|FG000|Overall Study|Lack of Efficacy|0|||
24971913|NCT00119678|50061462|FG000|Double-blind Treatment Period|Adverse Event|7|||
25071914|NCT02688621|50178283|FG000|Overall Study|Withdrawal by Subject|1|||
25071915|NCT02688621|50178284|FG001|Overall Study|Withdrawal by Subject|0|||
24971914|NCT00119678|50061463|FG001|Double-blind Treatment Period|Adverse Event|1|||
24971915|NCT00119678|50061462|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
24971916|NCT00119678|50061463|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
24971917|NCT00119678|50061462|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
24971918|NCT00119678|50061463|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
24971919|NCT00119678|50061462|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
24971920|NCT00119678|50061463|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
24971921|NCT00119678|50061462|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
24971922|NCT00119678|50061463|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
24971923|NCT00119678|50061462|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
24971924|NCT00119678|50061463|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
24971925|NCT00119678|50061462|FG000|Double-blind Treatment Period|Pregnancy|0|||
24971926|NCT00119678|50061463|FG001|Double-blind Treatment Period|Pregnancy|2|||
24971927|NCT00119678|50061462|FG000|Double-blind Treatment Period|Not treated|1|||
24971928|NCT00119678|50061463|FG001|Double-blind Treatment Period|Not treated|2|||
24971929|NCT00119678|50061462|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
24971930|NCT00119678|50061463|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
24971931|NCT00119678|50061462|FG000|Open-label Treatment Period|Death|1|||
24971932|NCT00119678|50061463|FG001|Open-label Treatment Period|Death|0|||
24971933|NCT00119678|50061462|FG000|Open-label Treatment Period|Adverse Event|3|||
24971934|NCT00119678|50061463|FG001|Open-label Treatment Period|Adverse Event|0|||
24971935|NCT00119678|50061462|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
24971936|NCT00119678|50061463|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
25192364|NCT01419236|50358134|FG001|Overall Study|Lack of Efficacy|1|||
24971937|NCT00119678|50061462|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
24971938|NCT00119678|50061463|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
24971939|NCT00119678|50061462|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
24971940|NCT00119678|50061463|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
24971941|NCT00119678|50061462|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
24971942|NCT00119678|50061463|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
24971943|NCT00119678|50061462|FG000|Open-label Treatment Period|Pregnancy|1|||
24971944|NCT00119678|50061463|FG001|Open-label Treatment Period|Pregnancy|0|||
24971945|NCT00119678|50061462|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
24971946|NCT00119678|50061463|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
24971947|NCT00110084|50061471|FG000|Overall Study|Adverse Event|9|||
24971948|NCT00110084|50061471|FG000|Overall Study|Death|1|||
24971949|NCT00110084|50061471|FG000|Overall Study|Patient Refusal|10|||
24971950|NCT00110084|50061471|FG000|Overall Study|Alternate Therapy|5|||
24971951|NCT00110084|50061471|FG000|Overall Study|Intercurrent Illness|1|||
24971952|NCT00110084|50061471|FG000|Overall Study|Other|2|||
24971953|NCT00390221|50061478|FG000|Overall Study|Lost to Follow-up|0|||
24971954|NCT00390221|50061479|FG001|Overall Study|Lost to Follow-up|3|||
24971955|NCT00390221|50061480|FG002|Overall Study|Lost to Follow-up|0|||
24971956|NCT00390221|50061478|FG000|Overall Study|Adverse Event|1|||
24971957|NCT00390221|50061479|FG001|Overall Study|Adverse Event|4|||
24971958|NCT00390221|50061480|FG002|Overall Study|Adverse Event|3|||
24971959|NCT00390221|50061478|FG000|Overall Study|Investigator Decision|0|||
24971960|NCT00390221|50061479|FG001|Overall Study|Investigator Decision|0|||
24971961|NCT00390221|50061480|FG002|Overall Study|Investigator Decision|1|||
24971962|NCT00390221|50061478|FG000|Overall Study|Withdrawal by Subject|13|||
24971963|NCT00390221|50061479|FG001|Overall Study|Withdrawal by Subject|9|||
24971964|NCT00390221|50061480|FG002|Overall Study|Withdrawal by Subject|7|||
25082667|NCT02714569|50191355|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
24971965|NCT00390221|50061478|FG000|Overall Study|Subject Non-compliance|1|||
24971966|NCT00390221|50061479|FG001|Overall Study|Subject Non-compliance|0|||
24971967|NCT00390221|50061480|FG002|Overall Study|Subject Non-compliance|2|||
24971968|NCT00390221|50061478|FG000|Overall Study|Other|3|||
24971969|NCT00390221|50061479|FG001|Overall Study|Other|4|||
24971970|NCT00390221|50061480|FG002|Overall Study|Other|2|||
25192365|NCT01419236|50358133|FG000|Overall Study|Lost to Follow-up|1|||
25192366|NCT01419236|50358134|FG001|Overall Study|Lost to Follow-up|0|||
24971971|NCT00389831|50061491|FG000|Overall Study|Lack of Efficacy|0|||
24971972|NCT00389831|50061492|FG001|Overall Study|Lack of Efficacy|2|||
24971973|NCT00389831|50061491|FG000|Overall Study|Did not receive treatment.|0|||
24971974|NCT00389831|50061492|FG001|Overall Study|Did not receive treatment.|2|||
24971975|NCT00389831|50061491|FG000|Overall Study|Other reasons|0|||
24971976|NCT00389831|50061492|FG001|Overall Study|Other reasons|2|||
24971977|NCT00389831|50061491|FG000|Overall Study|Lost to Follow-up|0|||
24971978|NCT00389831|50061492|FG001|Overall Study|Lost to Follow-up|1|||
24971979|NCT00389597|50061514|FG000|Overall Study|Lost to Follow-up|8|||
24971980|NCT00389597|50061515|FG001|Overall Study|Lost to Follow-up|6|||
24971981|NCT00389597|50061516|FG002|Overall Study|Lost to Follow-up|4|||
24971982|NCT00389597|50061517|FG003|Overall Study|Lost to Follow-up|6|||
24971983|NCT00389519|50061531|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
24971984|NCT00389519|50061532|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
24971985|NCT00389519|50061533|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
24971986|NCT00389519|50061534|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
24971987|NCT00389519|50061531|FG000|Placebo Run-In|Withdrawal by Subject|19|||
24971988|NCT00389519|50061532|FG001|Placebo Run-In|Withdrawal by Subject|0|||
24971989|NCT00389519|50061533|FG002|Placebo Run-In|Withdrawal by Subject|0|||
24971990|NCT00389519|50061534|FG003|Placebo Run-In|Withdrawal by Subject|0|||
24971991|NCT00389519|50061531|FG000|Placebo Run-In|Reason not specified|40|||
24971992|NCT00389519|50061532|FG001|Placebo Run-In|Reason not specified|0|||
24971993|NCT00389519|50061533|FG002|Placebo Run-In|Reason not specified|0|||
24971994|NCT00389519|50061534|FG003|Placebo Run-In|Reason not specified|0|||
24971995|NCT00389519|50061531|FG000|Randomized|Did not receive study drug|2|||
24971996|NCT00389519|50061532|FG001|Randomized|Did not receive study drug|0|||
24971997|NCT00389519|50061533|FG002|Randomized|Did not receive study drug|0|||
24971998|NCT00389519|50061534|FG003|Randomized|Did not receive study drug|0|||
24971999|NCT00389519|50061531|FG000|Treated|Adverse Event|1|||
24972000|NCT00389519|50061532|FG001|Treated|Adverse Event|0|||
24972001|NCT00389519|50061533|FG002|Treated|Adverse Event|0|||
24972002|NCT00389519|50061534|FG003|Treated|Adverse Event|2|||
25071916|NCT04227704|50178296|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
25071917|NCT04227704|50178297|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
25071918|NCT04227704|50178298|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
25071919|NCT04227704|50178296|FG000|Overall Study|due to C/S being cancelled|1|||
25071920|NCT04227704|50178297|FG001|Overall Study|due to C/S being cancelled|0|||
25071921|NCT04227704|50178298|FG002|Overall Study|due to C/S being cancelled|0|||
25071922|NCT03530293|50178308|FG000|Pre-randomization|Adverse Event|12|||
25071923|NCT03530293|50178309|FG001|Pre-randomization|Adverse Event|0|||
25071924|NCT03530293|50178310|FG002|Pre-randomization|Adverse Event|0|||
25071925|NCT03530293|50178308|FG000|Pre-randomization|Protocol Violation|2|||
25071926|NCT03530293|50178309|FG001|Pre-randomization|Protocol Violation|0|||
25071927|NCT03530293|50178310|FG002|Pre-randomization|Protocol Violation|0|||
25071928|NCT03530293|50178308|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
25071929|NCT03530293|50178309|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
25071930|NCT03530293|50178310|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
25071931|NCT03530293|50178308|FG000|Pre-randomization|Withdrawal by Subject|5|||
25071932|NCT03530293|50178309|FG001|Pre-randomization|Withdrawal by Subject|0|||
25071933|NCT03530293|50178310|FG002|Pre-randomization|Withdrawal by Subject|0|||
25071934|NCT03530293|50178308|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
25071935|NCT03530293|50178309|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
25071936|NCT03530293|50178310|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
25071937|NCT03530293|50178308|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
25071938|NCT03530293|50178309|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
25071939|NCT03530293|50178310|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
25071940|NCT03530293|50178308|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
25071941|NCT03530293|50178309|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
25071942|NCT03530293|50178310|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
25071943|NCT03530293|50178308|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
25071944|NCT03530293|50178309|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
25071945|NCT03530293|50178310|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
25071946|NCT03530293|50178308|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
25071947|NCT03530293|50178309|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
25071948|NCT03530293|50178310|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
25071949|NCT01662986|50178345|FG000|Overall Study|Adverse Event|5|||
25071950|NCT01662986|50178346|FG001|Overall Study|Adverse Event|4|||
25071951|NCT01662986|50178345|FG000|Overall Study|Protocol Violation|2|||
25071952|NCT01662986|50178346|FG001|Overall Study|Protocol Violation|3|||
25071953|NCT01662986|50178345|FG000|Overall Study|Lost to Follow-up|5|||
25071954|NCT01662986|50178346|FG001|Overall Study|Lost to Follow-up|4|||
25071955|NCT01662986|50178345|FG000|Overall Study|Withdrawal by Subject|2|||
25071956|NCT01662986|50178346|FG001|Overall Study|Withdrawal by Subject|2|||
24972003|NCT00389519|50061531|FG000|Treated|Reason not specified|1|||
24972004|NCT00389519|50061532|FG001|Treated|Reason not specified|1|||
24972005|NCT00389519|50061533|FG002|Treated|Reason not specified|0|||
24972006|NCT00389519|50061534|FG003|Treated|Reason not specified|2|||
24972007|NCT00389441|50061544|FG000|Overall Study|Adverse Event|7|||
24972008|NCT00389441|50061544|FG000|Overall Study|Death|4|||
24972009|NCT00389441|50061544|FG000|Overall Study|Lost to Follow-up|2|||
25071957|NCT01662986|50178345|FG000|Overall Study|Not Treated|1|||
25071958|NCT01662986|50178346|FG001|Overall Study|Not Treated|0|||
25071959|NCT01662986|50178345|FG000|Overall Study|Other than stated above|3|||
25071960|NCT01662986|50178346|FG001|Overall Study|Other than stated above|0|||
25071961|NCT01337167|50178354|FG000|Infant Series|Adverse Event|1|||
25071962|NCT01337167|50178355|FG001|Infant Series|Adverse Event|1|||
25071963|NCT01337167|50178354|FG000|Infant Series|Death|1|||
25071964|NCT01337167|50178355|FG001|Infant Series|Death|1|||
25071965|NCT01337167|50178354|FG000|Infant Series|Lost to Follow-up|13|||
25071966|NCT01337167|50178355|FG001|Infant Series|Lost to Follow-up|7|||
25071967|NCT01337167|50178354|FG000|Infant Series|Non-compliance with study drug|2|||
25071968|NCT01337167|50178355|FG001|Infant Series|Non-compliance with study drug|1|||
25071969|NCT01337167|50178354|FG000|Infant Series|Physician Decision|3|||
25071970|NCT01337167|50178355|FG001|Infant Series|Physician Decision|1|||
25071971|NCT01337167|50178354|FG000|Infant Series|Protocol Violation|22|||
25071972|NCT01337167|50178355|FG001|Infant Series|Protocol Violation|9|||
25071973|NCT01337167|50178354|FG000|Infant Series|Withdrawal by Subject|15|||
25071974|NCT01337167|50178355|FG001|Infant Series|Withdrawal by Subject|4|||
25071975|NCT01337167|50178354|FG000|Infant Series|Randomized but not vaccinated|5|||
25071976|NCT01337167|50178355|FG001|Infant Series|Randomized but not vaccinated|3|||
25071977|NCT01337167|50178354|FG000|Interim Period|Lost to Follow-up|51|||
25071978|NCT01337167|50178355|FG001|Interim Period|Lost to Follow-up|23|||
25071979|NCT01337167|50178354|FG000|Interim Period|Non-compliance with study drug|1|||
25071980|NCT01337167|50178355|FG001|Interim Period|Non-compliance with study drug|0|||
25071981|NCT01337167|50178354|FG000|Interim Period|Physician Decision|6|||
25071982|NCT01337167|50178355|FG001|Interim Period|Physician Decision|3|||
25071983|NCT01337167|50178354|FG000|Interim Period|Protocol Violation|5|||
25071984|NCT01337167|50178355|FG001|Interim Period|Protocol Violation|3|||
25071985|NCT01337167|50178354|FG000|Interim Period|Withdrawal by Subject|18|||
25071986|NCT01337167|50178355|FG001|Interim Period|Withdrawal by Subject|10|||
25071987|NCT01337167|50178354|FG000|Interim Period|Other protocol criterion not met|0|||
25071988|NCT01337167|50178355|FG001|Interim Period|Other protocol criterion not met|1|||
25071989|NCT01337167|50178354|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
25071990|NCT01337167|50178355|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
25071991|NCT01337167|50178354|FG000|Toddler Vaccinations|Protocol Violation|0|||
25071992|NCT01337167|50178355|FG001|Toddler Vaccinations|Protocol Violation|1|||
25071993|NCT01337167|50178354|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
25071994|NCT01337167|50178355|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
25071995|NCT01338025|50178363|FG000|Overall Study|Unexpected closure of study|10|||
25071996|NCT01338025|50178364|FG001|Overall Study|Unexpected closure of study|9|||
25071997|NCT01338025|50178363|FG000|Overall Study|Withdrawal by Subject|0|||
25071998|NCT01338025|50178364|FG001|Overall Study|Withdrawal by Subject|2|||
25071999|NCT01338025|50178363|FG000|Overall Study|Found ineligible after starting|1|||
25072000|NCT01338025|50178364|FG001|Overall Study|Found ineligible after starting|0|||
25072001|NCT02559206|50178408|FG000|Overall Study|Adverse Event|0|||
25072002|NCT02559206|50178409|FG001|Overall Study|Adverse Event|4|||
25072003|NCT02559206|50178410|FG002|Overall Study|Adverse Event|1|||
25072004|NCT02559206|50178411|FG003|Overall Study|Adverse Event|5|||
25072005|NCT02559206|50178412|FG004|Overall Study|Adverse Event|3|||
25072006|NCT02559206|50178413|FG005|Overall Study|Adverse Event|0|||
25072007|NCT02559206|50178414|FG006|Overall Study|Adverse Event|1|||
25072008|NCT02559206|50178415|FG007|Overall Study|Adverse Event|0|||
25072009|NCT02559206|50178408|FG000|Overall Study|Protocol Violation|1|||
25072010|NCT02559206|50178409|FG001|Overall Study|Protocol Violation|0|||
25072011|NCT02559206|50178410|FG002|Overall Study|Protocol Violation|1|||
25072012|NCT02559206|50178411|FG003|Overall Study|Protocol Violation|0|||
25072013|NCT02559206|50178412|FG004|Overall Study|Protocol Violation|0|||
25072014|NCT02559206|50178413|FG005|Overall Study|Protocol Violation|2|||
25072015|NCT02559206|50178414|FG006|Overall Study|Protocol Violation|0|||
25072016|NCT02559206|50178415|FG007|Overall Study|Protocol Violation|0|||
25072017|NCT02559206|50178408|FG000|Overall Study|Withdrawal by Subject|3|||
25072018|NCT02559206|50178409|FG001|Overall Study|Withdrawal by Subject|3|||
25072019|NCT02559206|50178410|FG002|Overall Study|Withdrawal by Subject|1|||
25072020|NCT02559206|50178411|FG003|Overall Study|Withdrawal by Subject|3|||
25072021|NCT02559206|50178412|FG004|Overall Study|Withdrawal by Subject|5|||
25072022|NCT02559206|50178413|FG005|Overall Study|Withdrawal by Subject|4|||
25072023|NCT02559206|50178414|FG006|Overall Study|Withdrawal by Subject|1|||
24972010|NCT00389441|50061544|FG000|Overall Study|Withdrawal by Subject|4|||
24972011|NCT00389441|50061544|FG000|Overall Study|Physician Decision|1|||
24972012|NCT00389441|50061544|FG000|Overall Study|Protocol Violation|1|||
24972013|NCT00389441|50061544|FG000|Overall Study|Global deterioration of health status|4|||
24972014|NCT00389441|50061544|FG000|Overall Study|Objective progression or relapse|26|||
24972015|NCT00389441|50061544|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
24972016|NCT00389441|50061544|FG000|Overall Study|Clinical progression|1|||
24972017|NCT00118898|50061552|FG000|Overall Study|Death|6|||
24972018|NCT00118898|50061553|FG001|Overall Study|Death|11|||
24972019|NCT00118898|50061554|FG002|Overall Study|Death|6|||
25072024|NCT02559206|50178415|FG007|Overall Study|Withdrawal by Subject|2|||
25072025|NCT02559206|50178408|FG000|Overall Study|Lost to Follow-up|3|||
25072026|NCT02559206|50178409|FG001|Overall Study|Lost to Follow-up|5|||
25072027|NCT02559206|50178410|FG002|Overall Study|Lost to Follow-up|3|||
25072028|NCT02559206|50178411|FG003|Overall Study|Lost to Follow-up|3|||
25072029|NCT02559206|50178412|FG004|Overall Study|Lost to Follow-up|2|||
24972020|NCT00118898|50061555|FG003|Overall Study|Death|8|||
25072030|NCT02559206|50178413|FG005|Overall Study|Lost to Follow-up|5|||
25072031|NCT02559206|50178414|FG006|Overall Study|Lost to Follow-up|1|||
25072032|NCT02559206|50178415|FG007|Overall Study|Lost to Follow-up|4|||
25169845|NCT01822925|50303286|FG001|Overall Study|Taking prohibited medication|0|||
24972021|NCT00118898|50061552|FG000|Overall Study|Lost to Follow-up|26|||
24972022|NCT00118898|50061553|FG001|Overall Study|Lost to Follow-up|34|||
24972023|NCT00118898|50061554|FG002|Overall Study|Lost to Follow-up|33|||
25169846|NCT01822925|50303287|FG002|Overall Study|Taking prohibited medication|0|||
24972024|NCT00118898|50061555|FG003|Overall Study|Lost to Follow-up|33|||
24972025|NCT00118898|50061552|FG000|Overall Study|Withdrawal by Subject|10|||
24972026|NCT00118898|50061553|FG001|Overall Study|Withdrawal by Subject|5|||
24972027|NCT00118898|50061554|FG002|Overall Study|Withdrawal by Subject|8|||
25072033|NCT02559206|50178408|FG000|Overall Study|Lack of Efficacy|1|||
25072034|NCT02559206|50178409|FG001|Overall Study|Lack of Efficacy|0|||
25072035|NCT02559206|50178410|FG002|Overall Study|Lack of Efficacy|3|||
25072036|NCT02559206|50178411|FG003|Overall Study|Lack of Efficacy|2|||
24972028|NCT00118898|50061555|FG003|Overall Study|Withdrawal by Subject|8|||
24972029|NCT00118898|50061552|FG000|Overall Study|Site Closure|33|||
24972030|NCT00118898|50061553|FG001|Overall Study|Site Closure|31|||
24972031|NCT00118898|50061554|FG002|Overall Study|Site Closure|28|||
24972032|NCT00118898|50061555|FG003|Overall Study|Site Closure|37|||
24972033|NCT00118898|50061552|FG000|Overall Study|Severe debilitation|1|||
24972034|NCT00118898|50061553|FG001|Overall Study|Severe debilitation|4|||
24972035|NCT00118898|50061554|FG002|Overall Study|Severe debilitation|6|||
24972036|NCT00118898|50061555|FG003|Overall Study|Severe debilitation|4|||
24972037|NCT00118898|50061552|FG000|Overall Study|Not compliant with requirements|11|||
24972038|NCT00118898|50061553|FG001|Overall Study|Not compliant with requirements|13|||
24972039|NCT00118898|50061554|FG002|Overall Study|Not compliant with requirements|11|||
24972040|NCT00118898|50061555|FG003|Overall Study|Not compliant with requirements|11|||
24972041|NCT00118898|50061552|FG000|Overall Study|Not able to get to clinic|34|||
24972042|NCT00118898|50061553|FG001|Overall Study|Not able to get to clinic|43|||
24972043|NCT00118898|50061554|FG002|Overall Study|Not able to get to clinic|31|||
24972044|NCT00118898|50061555|FG003|Overall Study|Not able to get to clinic|40|||
24972045|NCT00118430|50061568|FG000|Overall Study|Withdrawal by Subject|6|||
25072037|NCT02559206|50178412|FG004|Overall Study|Lack of Efficacy|2|||
25072038|NCT02559206|50178413|FG005|Overall Study|Lack of Efficacy|3|||
25072039|NCT02559206|50178414|FG006|Overall Study|Lack of Efficacy|3|||
25072040|NCT02559206|50178415|FG007|Overall Study|Lack of Efficacy|3|||
25072041|NCT02559206|50178408|FG000|Overall Study|Other Not Specified|0|||
25072042|NCT02559206|50178409|FG001|Overall Study|Other Not Specified|0|||
25072043|NCT02559206|50178410|FG002|Overall Study|Other Not Specified|0|||
25072044|NCT02559206|50178411|FG003|Overall Study|Other Not Specified|1|||
25072045|NCT02559206|50178412|FG004|Overall Study|Other Not Specified|0|||
25072046|NCT02559206|50178413|FG005|Overall Study|Other Not Specified|0|||
25072047|NCT02559206|50178414|FG006|Overall Study|Other Not Specified|0|||
25072048|NCT02559206|50178415|FG007|Overall Study|Other Not Specified|0|||
25072049|NCT02558894|50178435|FG000|Overall Study|Death; any cause, entire study duration|28|||
25072050|NCT02558894|50178436|FG001|Overall Study|Death; any cause, entire study duration|31|||
25072051|NCT02558894|50178435|FG000|Overall Study|Withdrawal by Subject|2|||
25072052|NCT02558894|50178436|FG001|Overall Study|Withdrawal by Subject|1|||
25072053|NCT02558894|50178435|FG000|Overall Study|Closure of Part A|2|||
25072054|NCT02558894|50178436|FG001|Overall Study|Closure of Part A|1|||
25072055|NCT02688387|50178446|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072056|NCT02688387|50178447|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072057|NCT02688387|50178448|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
25072058|NCT02688387|50178449|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072059|NCT02688387|50178450|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072060|NCT02688387|50178451|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072061|NCT02688387|50178452|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072062|NCT02688387|50178453|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072063|NCT02688387|50178454|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072064|NCT02688387|50178455|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072065|NCT02688387|50178456|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072066|NCT02688387|50178457|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072067|NCT02688387|50178458|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072068|NCT02688387|50178459|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072069|NCT02688387|50178460|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072070|NCT02688387|50178461|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25169847|NCT01822925|50303288|FG003|Overall Study|Taking prohibited medication|1|||
25169848|NCT01801007|50303321|FG000|Overall Study|Adverse Event|2|||
25169849|NCT01801007|50303321|FG000|Overall Study|Lost to Follow-up|4|||
24972046|NCT00118430|50061569|FG001|Overall Study|Withdrawal by Subject|2|||
24972047|NCT00118430|50061570|FG002|Overall Study|Withdrawal by Subject|0|||
24972048|NCT00118430|50061568|FG000|Overall Study|Lost to Follow-up|15|||
24972049|NCT00118430|50061569|FG001|Overall Study|Lost to Follow-up|22|||
24972050|NCT00118430|50061570|FG002|Overall Study|Lost to Follow-up|28|||
24972051|NCT00090584|50061579|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
24972052|NCT00090584|50061580|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
25072071|NCT02688387|50178462|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072072|NCT02688387|50178463|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072073|NCT02688387|50178464|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072074|NCT02688387|50178465|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072075|NCT02688387|50178466|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072076|NCT02688387|50178467|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
25072077|NCT02688387|50178446|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072078|NCT02688387|50178447|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072079|NCT02688387|50178448|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072080|NCT02688387|50178449|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
25072081|NCT02688387|50178450|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072082|NCT02688387|50178451|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072083|NCT02688387|50178452|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072084|NCT02688387|50178453|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072085|NCT02688387|50178454|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072086|NCT02688387|50178455|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072087|NCT02688387|50178456|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072088|NCT02688387|50178457|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072089|NCT02688387|50178458|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072090|NCT02688387|50178459|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072091|NCT02688387|50178460|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072092|NCT02688387|50178461|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072093|NCT02688387|50178462|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072094|NCT02688387|50178463|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
24972053|NCT00090584|50061579|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
24972054|NCT00090584|50061580|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
24972055|NCT03670810|50061600|FG000|Main Study|Adverse Event|37|||
24972056|NCT03670810|50061601|FG001|Main Study|Adverse Event|38|||
24972057|NCT03670810|50061602|FG002|Main Study|Adverse Event|3|||
24972058|NCT03670810|50061603|FG003|Main Study|Adverse Event|4|||
25072095|NCT02688387|50178464|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072096|NCT02688387|50178465|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072097|NCT02688387|50178466|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072098|NCT02688387|50178467|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
24972059|NCT03670810|50061604|FG004|Main Study|Adverse Event|4|||
24972060|NCT03670810|50061605|FG005|Main Study|Adverse Event|5|||
24972061|NCT03670810|50061606|FG006|Main Study|Adverse Event|0|||
24972062|NCT03670810|50061607|FG007|Main Study|Adverse Event|0|||
24972063|NCT03670810|50061608|FG008|Main Study|Adverse Event|0|||
24972064|NCT03670810|50061600|FG000|Main Study|Lack of Efficacy|8|||
24972065|NCT03670810|50061601|FG001|Main Study|Lack of Efficacy|9|||
24972066|NCT03670810|50061602|FG002|Main Study|Lack of Efficacy|3|||
24972067|NCT03670810|50061603|FG003|Main Study|Lack of Efficacy|4|||
24972068|NCT03670810|50061604|FG004|Main Study|Lack of Efficacy|0|||
24972069|NCT03670810|50061605|FG005|Main Study|Lack of Efficacy|0|||
24972070|NCT03670810|50061606|FG006|Main Study|Lack of Efficacy|0|||
24972071|NCT03670810|50061607|FG007|Main Study|Lack of Efficacy|0|||
24972072|NCT03670810|50061608|FG008|Main Study|Lack of Efficacy|0|||
25072099|NCT02688387|50178446|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25072100|NCT02688387|50178447|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
25072101|NCT02688387|50178448|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25072102|NCT02688387|50178449|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25072103|NCT02688387|50178450|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25192367|NCT01419236|50358133|FG000|Overall Study|Physician Decision|1|||
24972073|NCT03670810|50061600|FG000|Main Study|Lost to Follow-up|9|||
24972074|NCT03670810|50061601|FG001|Main Study|Lost to Follow-up|7|||
24972075|NCT03670810|50061602|FG002|Main Study|Lost to Follow-up|4|||
24972076|NCT03670810|50061603|FG003|Main Study|Lost to Follow-up|6|||
24972077|NCT03670810|50061604|FG004|Main Study|Lost to Follow-up|1|||
24972078|NCT03670810|50061605|FG005|Main Study|Lost to Follow-up|0|||
25082668|NCT02714569|50191356|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
24972079|NCT03670810|50061606|FG006|Main Study|Lost to Follow-up|0|||
24972080|NCT03670810|50061607|FG007|Main Study|Lost to Follow-up|0|||
24972081|NCT03670810|50061608|FG008|Main Study|Lost to Follow-up|0|||
24972082|NCT03670810|50061600|FG000|Main Study|Non-compliance with Study Drug|0|||
24972083|NCT03670810|50061601|FG001|Main Study|Non-compliance with Study Drug|2|||
24972084|NCT03670810|50061602|FG002|Main Study|Non-compliance with Study Drug|3|||
24972085|NCT03670810|50061603|FG003|Main Study|Non-compliance with Study Drug|0|||
24972086|NCT03670810|50061604|FG004|Main Study|Non-compliance with Study Drug|0|||
24972087|NCT03670810|50061605|FG005|Main Study|Non-compliance with Study Drug|0|||
24972088|NCT03670810|50061606|FG006|Main Study|Non-compliance with Study Drug|0|||
24972089|NCT03670810|50061607|FG007|Main Study|Non-compliance with Study Drug|1|||
24972090|NCT03670810|50061608|FG008|Main Study|Non-compliance with Study Drug|0|||
24972091|NCT03670810|50061600|FG000|Main Study|Physician Decision|3|||
24972092|NCT03670810|50061601|FG001|Main Study|Physician Decision|0|||
24972093|NCT03670810|50061602|FG002|Main Study|Physician Decision|1|||
24972094|NCT03670810|50061603|FG003|Main Study|Physician Decision|0|||
24972095|NCT03670810|50061604|FG004|Main Study|Physician Decision|0|||
24972096|NCT03670810|50061605|FG005|Main Study|Physician Decision|0|||
24972097|NCT03670810|50061606|FG006|Main Study|Physician Decision|1|||
24972098|NCT03670810|50061607|FG007|Main Study|Physician Decision|1|||
24972099|NCT03670810|50061608|FG008|Main Study|Physician Decision|0|||
24972100|NCT03670810|50061600|FG000|Main Study|Pregnancy|1|||
24972101|NCT03670810|50061601|FG001|Main Study|Pregnancy|2|||
24972102|NCT03670810|50061602|FG002|Main Study|Pregnancy|0|||
24972103|NCT03670810|50061603|FG003|Main Study|Pregnancy|0|||
24972104|NCT03670810|50061604|FG004|Main Study|Pregnancy|0|||
24972105|NCT03670810|50061605|FG005|Main Study|Pregnancy|0|||
24972106|NCT03670810|50061606|FG006|Main Study|Pregnancy|0|||
24972107|NCT03670810|50061607|FG007|Main Study|Pregnancy|0|||
24972108|NCT03670810|50061608|FG008|Main Study|Pregnancy|0|||
24972109|NCT03670810|50061600|FG000|Main Study|Protocol Deviation|2|||
24972110|NCT03670810|50061601|FG001|Main Study|Protocol Deviation|12|||
24972111|NCT03670810|50061602|FG002|Main Study|Protocol Deviation|8|||
24972112|NCT03670810|50061603|FG003|Main Study|Protocol Deviation|4|||
24972113|NCT03670810|50061604|FG004|Main Study|Protocol Deviation|0|||
24972114|NCT03670810|50061605|FG005|Main Study|Protocol Deviation|0|||
24972115|NCT03670810|50061606|FG006|Main Study|Protocol Deviation|0|||
24972116|NCT03670810|50061607|FG007|Main Study|Protocol Deviation|0|||
24972117|NCT03670810|50061608|FG008|Main Study|Protocol Deviation|0|||
24972118|NCT03670810|50061600|FG000|Main Study|Withdrawal by Subject|21|||
24972119|NCT03670810|50061601|FG001|Main Study|Withdrawal by Subject|21|||
24972120|NCT03670810|50061602|FG002|Main Study|Withdrawal by Subject|8|||
24972121|NCT03670810|50061603|FG003|Main Study|Withdrawal by Subject|9|||
24972122|NCT03670810|50061604|FG004|Main Study|Withdrawal by Subject|5|||
24972123|NCT03670810|50061605|FG005|Main Study|Withdrawal by Subject|2|||
24972124|NCT03670810|50061606|FG006|Main Study|Withdrawal by Subject|1|||
24972125|NCT03670810|50061607|FG007|Main Study|Withdrawal by Subject|1|||
24972126|NCT03670810|50061608|FG008|Main Study|Withdrawal by Subject|0|||
24972127|NCT03670810|50061600|FG000|Main Study|Participant did not want to take the three other treatments|1|||
24972128|NCT03670810|50061601|FG001|Main Study|Participant did not want to take the three other treatments|0|||
24972129|NCT03670810|50061602|FG002|Main Study|Participant did not want to take the three other treatments|0|||
24972130|NCT03670810|50061603|FG003|Main Study|Participant did not want to take the three other treatments|0|||
24972131|NCT03670810|50061604|FG004|Main Study|Participant did not want to take the three other treatments|0|||
24972132|NCT03670810|50061605|FG005|Main Study|Participant did not want to take the three other treatments|0|||
24972133|NCT03670810|50061606|FG006|Main Study|Participant did not want to take the three other treatments|0|||
24972134|NCT03670810|50061607|FG007|Main Study|Participant did not want to take the three other treatments|0|||
24972135|NCT03670810|50061608|FG008|Main Study|Participant did not want to take the three other treatments|0|||
24972136|NCT03670810|50061600|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
24972137|NCT03670810|50061601|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
24972138|NCT03670810|50061602|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
24972139|NCT03670810|50061603|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
24972140|NCT03670810|50061604|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
25169850|NCT01801007|50303321|FG000|Overall Study|Withdrawal by Subject|5|||
25169851|NCT01822691|50303325|FG000|Overall Study|Withdrawal by Subject|2|||
25169852|NCT01822535|50303331|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
25192368|NCT01419236|50358134|FG001|Overall Study|Physician Decision|0|||
24972141|NCT03670810|50061605|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
24972142|NCT03670810|50061606|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
24972143|NCT03670810|50061607|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
24972144|NCT03670810|50061608|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
24972145|NCT03670810|50061600|FG000|Main Study|Travel and Coronavirus issues|0|||
25192369|NCT01419236|50358133|FG000|Overall Study|Withdrawal by Subject|1|||
25192370|NCT01419236|50358134|FG001|Overall Study|Withdrawal by Subject|4|||
25192371|NCT01419236|50358133|FG000|Overall Study|Entry Criteria Not Met|1|||
25192372|NCT01419236|50358134|FG001|Overall Study|Entry Criteria Not Met|0|||
25192373|NCT03323658|50358147|FG000|Overall Study|Adverse Event|0|||
25192374|NCT03323658|50358148|FG001|Overall Study|Adverse Event|1|||
25192375|NCT03323658|50358149|FG002|Overall Study|Adverse Event|0|||
25192376|NCT01443026|50358174|FG000|Overall Study|Physician Decision|1|||
25192377|NCT01443026|50358175|FG001|Overall Study|Physician Decision|0|||
25192378|NCT01443026|50358174|FG000|Overall Study|Death|0|||
25192379|NCT01443026|50358175|FG001|Overall Study|Death|1|||
25192380|NCT01443026|50358174|FG000|Overall Study|Withdrawal by Subject|0|||
24972146|NCT03670810|50061601|FG001|Main Study|Travel and Coronavirus issues|0|||
24972147|NCT03670810|50061602|FG002|Main Study|Travel and Coronavirus issues|0|||
24972148|NCT03670810|50061603|FG003|Main Study|Travel and Coronavirus issues|1|||
25192381|NCT01443026|50358175|FG001|Overall Study|Withdrawal by Subject|3|||
25192382|NCT01443026|50358174|FG000|Overall Study|Lost to Follow-up|2|||
24972149|NCT03670810|50061604|FG004|Main Study|Travel and Coronavirus issues|0|||
25192383|NCT01443026|50358175|FG001|Overall Study|Lost to Follow-up|1|||
25192384|NCT01442714|50358209|FG000|Overall Study|Death|11|||
25169853|NCT01822535|50303332|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
25314599|NCT00644995|50630410|FG001|Overall Study|Lost to Follow-up|4|||
24972150|NCT03670810|50061605|FG005|Main Study|Travel and Coronavirus issues|0|||
24972151|NCT03670810|50061606|FG006|Main Study|Travel and Coronavirus issues|0|||
24972152|NCT03670810|50061607|FG007|Main Study|Travel and Coronavirus issues|0|||
24972153|NCT03670810|50061608|FG008|Main Study|Travel and Coronavirus issues|0|||
24972154|NCT03670810|50061600|FG000|Open Label Extension|Protocol Deviation|0|||
24972155|NCT03670810|50061601|FG001|Open Label Extension|Protocol Deviation|0|||
24972156|NCT03670810|50061602|FG002|Open Label Extension|Protocol Deviation|0|||
24972157|NCT03670810|50061603|FG003|Open Label Extension|Protocol Deviation|0|||
24972158|NCT03670810|50061604|FG004|Open Label Extension|Protocol Deviation|0|||
24972159|NCT03670810|50061605|FG005|Open Label Extension|Protocol Deviation|0|||
24972160|NCT03670810|50061606|FG006|Open Label Extension|Protocol Deviation|0|||
24972161|NCT03670810|50061607|FG007|Open Label Extension|Protocol Deviation|0|||
24972162|NCT03670810|50061608|FG008|Open Label Extension|Protocol Deviation|5|||
24972163|NCT03670810|50061600|FG000|Open Label Extension|Death|0|||
24972164|NCT03670810|50061601|FG001|Open Label Extension|Death|0|||
24972165|NCT03670810|50061602|FG002|Open Label Extension|Death|0|||
24972166|NCT03670810|50061603|FG003|Open Label Extension|Death|0|||
24972167|NCT03670810|50061604|FG004|Open Label Extension|Death|0|||
24972168|NCT03670810|50061605|FG005|Open Label Extension|Death|0|||
24972169|NCT03670810|50061606|FG006|Open Label Extension|Death|0|||
24972170|NCT03670810|50061607|FG007|Open Label Extension|Death|0|||
24972171|NCT03670810|50061608|FG008|Open Label Extension|Death|1|||
24972172|NCT03670810|50061600|FG000|Open Label Extension|COVID-19|0|||
24972173|NCT03670810|50061601|FG001|Open Label Extension|COVID-19|0|||
24972174|NCT03670810|50061602|FG002|Open Label Extension|COVID-19|0|||
24972175|NCT03670810|50061603|FG003|Open Label Extension|COVID-19|0|||
24972176|NCT03670810|50061604|FG004|Open Label Extension|COVID-19|0|||
24972177|NCT03670810|50061605|FG005|Open Label Extension|COVID-19|0|||
24972178|NCT03670810|50061606|FG006|Open Label Extension|COVID-19|0|||
24972179|NCT03670810|50061607|FG007|Open Label Extension|COVID-19|0|||
24972180|NCT03670810|50061608|FG008|Open Label Extension|COVID-19|1|||
24972181|NCT03670810|50061600|FG000|Open Label Extension|Lack of Efficacy|0|||
24972182|NCT03670810|50061601|FG001|Open Label Extension|Lack of Efficacy|0|||
24972183|NCT03670810|50061602|FG002|Open Label Extension|Lack of Efficacy|0|||
24972184|NCT03670810|50061603|FG003|Open Label Extension|Lack of Efficacy|0|||
24972185|NCT03670810|50061604|FG004|Open Label Extension|Lack of Efficacy|0|||
24972186|NCT03670810|50061605|FG005|Open Label Extension|Lack of Efficacy|0|||
24972187|NCT03670810|50061606|FG006|Open Label Extension|Lack of Efficacy|0|||
24972188|NCT03670810|50061607|FG007|Open Label Extension|Lack of Efficacy|0|||
24972189|NCT03670810|50061608|FG008|Open Label Extension|Lack of Efficacy|39|||
24972190|NCT03670810|50061600|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
24972191|NCT03670810|50061601|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
24972192|NCT03670810|50061602|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
24972193|NCT03670810|50061603|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
24972194|NCT03670810|50061604|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
24972195|NCT03670810|50061605|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
24972196|NCT03670810|50061606|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
24972197|NCT03670810|50061607|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
24972198|NCT03670810|50061608|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
24972199|NCT03670810|50061600|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
24972200|NCT03670810|50061601|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
24972201|NCT03670810|50061602|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
24972202|NCT03670810|50061603|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
25169854|NCT01822535|50303331|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
25314600|NCT00644995|50630409|FG000|Overall Study|Refused|1|||
25314601|NCT00644995|50630410|FG001|Overall Study|Refused|0|||
24972203|NCT03670810|50061604|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
24972204|NCT03670810|50061605|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
24972205|NCT03670810|50061606|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
24972206|NCT03670810|50061607|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
24972207|NCT03670810|50061608|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
25314602|NCT00914966|50630418|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
25314603|NCT00914966|50630418|FG000|Step 1: 1500 Units|Physician Decision|1|||
25314604|NCT00914966|50630418|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
25314605|NCT00914810|50630429|FG000|Overall Study|Withdrawal by Subject|1|||
25314606|NCT00914810|50630430|FG001|Overall Study|Withdrawal by Subject|0|||
25314607|NCT00914810|50630429|FG000|Overall Study|Relocated out of state|1|||
25314608|NCT00914810|50630430|FG001|Overall Study|Relocated out of state|0|||
25314609|NCT00914810|50630429|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
25314610|NCT00914810|50630430|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
25314611|NCT00644917|50630436|FG000|Overall Study|Withdrawal by Subject|2|||
25314612|NCT00914732|50630447|FG000|Overall Study|Lost to Follow-up|6|||
24972208|NCT03670810|50061600|FG000|Open Label Extension|Withdrawal by Subject|0|||
24972209|NCT03670810|50061601|FG001|Open Label Extension|Withdrawal by Subject|0|||
24972210|NCT03670810|50061602|FG002|Open Label Extension|Withdrawal by Subject|0|||
24972211|NCT03670810|50061603|FG003|Open Label Extension|Withdrawal by Subject|0|||
24972212|NCT03670810|50061604|FG004|Open Label Extension|Withdrawal by Subject|0|||
24972213|NCT03670810|50061605|FG005|Open Label Extension|Withdrawal by Subject|0|||
24972214|NCT03670810|50061606|FG006|Open Label Extension|Withdrawal by Subject|0|||
24972215|NCT03670810|50061607|FG007|Open Label Extension|Withdrawal by Subject|0|||
24972216|NCT03670810|50061608|FG008|Open Label Extension|Withdrawal by Subject|46|||
24972217|NCT03670810|50061600|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
24972218|NCT03670810|50061601|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
24972219|NCT03670810|50061602|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
24972220|NCT03670810|50061603|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
24972221|NCT03670810|50061604|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
24972222|NCT03670810|50061605|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
24972223|NCT03670810|50061606|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
25072104|NCT02688387|50178451|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25072105|NCT02688387|50178452|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25072106|NCT02688387|50178453|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25072107|NCT02688387|50178454|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25169855|NCT01822535|50303332|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
24972224|NCT03670810|50061607|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
24972225|NCT03670810|50061608|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
24972226|NCT03670810|50061600|FG000|Open Label Extension|Physician Decision|0|||
24972227|NCT03670810|50061601|FG001|Open Label Extension|Physician Decision|0|||
24972228|NCT03670810|50061602|FG002|Open Label Extension|Physician Decision|0|||
24972229|NCT03670810|50061603|FG003|Open Label Extension|Physician Decision|0|||
24972230|NCT03670810|50061604|FG004|Open Label Extension|Physician Decision|0|||
24972231|NCT03670810|50061605|FG005|Open Label Extension|Physician Decision|0|||
24972232|NCT03670810|50061606|FG006|Open Label Extension|Physician Decision|0|||
24972233|NCT03670810|50061607|FG007|Open Label Extension|Physician Decision|0|||
24972234|NCT03670810|50061608|FG008|Open Label Extension|Physician Decision|2|||
24972235|NCT03670810|50061600|FG000|Open Label Extension|Non-compliance with study drug|0|||
24972236|NCT03670810|50061601|FG001|Open Label Extension|Non-compliance with study drug|0|||
24972237|NCT03670810|50061602|FG002|Open Label Extension|Non-compliance with study drug|0|||
24972238|NCT03670810|50061603|FG003|Open Label Extension|Non-compliance with study drug|0|||
24972239|NCT03670810|50061604|FG004|Open Label Extension|Non-compliance with study drug|0|||
24972240|NCT03670810|50061605|FG005|Open Label Extension|Non-compliance with study drug|0|||
24972241|NCT03670810|50061606|FG006|Open Label Extension|Non-compliance with study drug|0|||
24972242|NCT03670810|50061607|FG007|Open Label Extension|Non-compliance with study drug|0|||
24972243|NCT03670810|50061608|FG008|Open Label Extension|Non-compliance with study drug|5|||
24972244|NCT03670810|50061600|FG000|Open Label Extension|Pregnancy|0|||
24972245|NCT03670810|50061601|FG001|Open Label Extension|Pregnancy|0|||
24972246|NCT03670810|50061602|FG002|Open Label Extension|Pregnancy|0|||
24972247|NCT03670810|50061603|FG003|Open Label Extension|Pregnancy|0|||
24972248|NCT03670810|50061604|FG004|Open Label Extension|Pregnancy|0|||
24972249|NCT03670810|50061605|FG005|Open Label Extension|Pregnancy|0|||
24972250|NCT03670810|50061606|FG006|Open Label Extension|Pregnancy|0|||
24972251|NCT03670810|50061607|FG007|Open Label Extension|Pregnancy|0|||
24972252|NCT03670810|50061608|FG008|Open Label Extension|Pregnancy|3|||
24972253|NCT03670810|50061600|FG000|Open Label Extension|Adverse Event|0|||
24972254|NCT03670810|50061601|FG001|Open Label Extension|Adverse Event|0|||
24972255|NCT03670810|50061602|FG002|Open Label Extension|Adverse Event|0|||
24972256|NCT03670810|50061603|FG003|Open Label Extension|Adverse Event|0|||
24972257|NCT03670810|50061604|FG004|Open Label Extension|Adverse Event|0|||
24972258|NCT03670810|50061605|FG005|Open Label Extension|Adverse Event|0|||
24972259|NCT03670810|50061606|FG006|Open Label Extension|Adverse Event|0|||
24972260|NCT03670810|50061607|FG007|Open Label Extension|Adverse Event|0|||
24972261|NCT03670810|50061608|FG008|Open Label Extension|Adverse Event|24|||
24972262|NCT03670810|50061600|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
24972263|NCT03670810|50061601|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
24972264|NCT03670810|50061602|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
24972265|NCT03670810|50061603|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
24972266|NCT03670810|50061604|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
24972267|NCT03670810|50061605|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
24972268|NCT03670810|50061606|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
24972269|NCT03670810|50061607|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
24972270|NCT03670810|50061608|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
25072108|NCT02688387|50178455|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25072109|NCT02688387|50178456|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
24972271|NCT03670810|50061600|FG000|Open Label Extension|Lost to Follow-up|0|||
24972272|NCT03670810|50061601|FG001|Open Label Extension|Lost to Follow-up|0|||
24972273|NCT03670810|50061602|FG002|Open Label Extension|Lost to Follow-up|0|||
24972274|NCT03670810|50061603|FG003|Open Label Extension|Lost to Follow-up|0|||
24972275|NCT03670810|50061604|FG004|Open Label Extension|Lost to Follow-up|0|||
24972276|NCT03670810|50061605|FG005|Open Label Extension|Lost to Follow-up|0|||
24972277|NCT03670810|50061606|FG006|Open Label Extension|Lost to Follow-up|0|||
24972278|NCT03670810|50061607|FG007|Open Label Extension|Lost to Follow-up|0|||
24972279|NCT03670810|50061608|FG008|Open Label Extension|Lost to Follow-up|23|||
24972280|NCT00089648|50061622|FG000|Overall Study|Adverse Event|7|||
24972281|NCT00089648|50061622|FG000|Overall Study|Withdrawal by Subject|1|||
24972282|NCT00089648|50061622|FG000|Overall Study|Lack of Efficacy|33|||
24972283|NCT00118040|50061629|FG000|Overall Study|Adverse Event|0|||
24972284|NCT00118040|50061630|FG001|Overall Study|Adverse Event|1|||
24972285|NCT00118040|50061631|FG002|Overall Study|Adverse Event|0|||
24972286|NCT00118040|50061629|FG000|Overall Study|Withdrawal by Subject|0|||
24972287|NCT00118040|50061630|FG001|Overall Study|Withdrawal by Subject|0|||
24972288|NCT00118040|50061631|FG002|Overall Study|Withdrawal by Subject|2|||
24972289|NCT00118040|50061629|FG000|Overall Study|Medical Contraindication|0|||
24972290|NCT00118040|50061630|FG001|Overall Study|Medical Contraindication|0|||
24972291|NCT00118040|50061631|FG002|Overall Study|Medical Contraindication|1|||
24972292|NCT00118040|50061629|FG000|Overall Study|Non-Compliant Participant|1|||
24972293|NCT00118040|50061630|FG001|Overall Study|Non-Compliant Participant|1|||
24972294|NCT00118040|50061631|FG002|Overall Study|Non-Compliant Participant|2|||
24972295|NCT00118040|50061629|FG000|Overall Study|Other|0|||
24972296|NCT00118040|50061630|FG001|Overall Study|Other|0|||
24972297|NCT00118040|50061631|FG002|Overall Study|Other|1|||
24972298|NCT00389207|50061647|FG000|Overall Study|Adverse Event|26|||
24972299|NCT00389207|50061648|FG001|Overall Study|Adverse Event|32|||
24972300|NCT00389207|50061649|FG002|Overall Study|Adverse Event|10|||
24972301|NCT00389207|50061647|FG000|Overall Study|Protocol Violation|3|||
24972302|NCT00389207|50061648|FG001|Overall Study|Protocol Violation|1|||
24972303|NCT00389207|50061649|FG002|Overall Study|Protocol Violation|4|||
24972304|NCT00389207|50061647|FG000|Overall Study|Lost to Follow-up|12|||
24972305|NCT00389207|50061648|FG001|Overall Study|Lost to Follow-up|9|||
24972306|NCT00389207|50061649|FG002|Overall Study|Lost to Follow-up|7|||
24972307|NCT00389207|50061647|FG000|Overall Study|Withdrawal by Subject|5|||
24972308|NCT00389207|50061648|FG001|Overall Study|Withdrawal by Subject|7|||
24972309|NCT00389207|50061649|FG002|Overall Study|Withdrawal by Subject|11|||
24972310|NCT00389207|50061647|FG000|Overall Study|Other|17|||
24972311|NCT00389207|50061648|FG001|Overall Study|Other|23|||
24972312|NCT00389207|50061649|FG002|Overall Study|Other|9|||
24972313|NCT00388973|50061664|FG000|Overall Study|Adverse Event|16|||
24972314|NCT00388973|50061665|FG001|Overall Study|Adverse Event|6|||
24972315|NCT00388973|50061664|FG000|Overall Study|Lack of Efficacy|1|||
25072110|NCT02688387|50178457|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25072111|NCT02688387|50178458|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25072112|NCT02688387|50178459|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25072113|NCT02688387|50178460|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25072114|NCT02688387|50178461|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
24972316|NCT00388973|50061665|FG001|Overall Study|Lack of Efficacy|12|||
24972317|NCT00388973|50061664|FG000|Overall Study|Protocol Violation|3|||
25072115|NCT02688387|50178462|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25072116|NCT02688387|50178463|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25072117|NCT02688387|50178464|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25072118|NCT02688387|50178465|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25072119|NCT02688387|50178466|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25072120|NCT02688387|50178467|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
25072121|NCT02688387|50178446|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072122|NCT02688387|50178447|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072123|NCT02688387|50178448|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
25072124|NCT02688387|50178449|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072125|NCT02688387|50178450|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
25072126|NCT02688387|50178451|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072127|NCT02688387|50178452|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072128|NCT02688387|50178453|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072129|NCT02688387|50178454|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072130|NCT02688387|50178455|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072131|NCT02688387|50178456|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072132|NCT02688387|50178457|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072133|NCT02688387|50178458|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072134|NCT02688387|50178459|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072135|NCT02688387|50178460|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072136|NCT02688387|50178461|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072137|NCT02688387|50178462|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072138|NCT02688387|50178463|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
24972318|NCT00388973|50061665|FG001|Overall Study|Protocol Violation|0|||
24972319|NCT00388973|50061664|FG000|Overall Study|Withdrawal by Subject|14|||
24972320|NCT00388973|50061665|FG001|Overall Study|Withdrawal by Subject|17|||
24972321|NCT00388973|50061664|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
25072139|NCT02688387|50178464|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072140|NCT02688387|50178465|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072141|NCT02688387|50178466|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072142|NCT02688387|50178467|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
25072143|NCT02688387|50178446|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
25072144|NCT02688387|50178447|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072145|NCT02688387|50178448|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072146|NCT02688387|50178449|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072147|NCT02688387|50178450|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072148|NCT02688387|50178451|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072149|NCT02688387|50178452|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072150|NCT02688387|50178453|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072151|NCT02688387|50178454|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072152|NCT02688387|50178455|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25314613|NCT00914732|50630448|FG001|Overall Study|Lost to Follow-up|7|||
24972322|NCT00388973|50061665|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
24972323|NCT00388973|50061664|FG000|Overall Study|Did not complete 61 days of treatment|5|||
24972324|NCT00388973|50061665|FG001|Overall Study|Did not complete 61 days of treatment|4|||
24972325|NCT00388973|50061664|FG000|Overall Study|Left region|0|||
24972326|NCT00388973|50061665|FG001|Overall Study|Left region|1|||
24972327|NCT00388973|50061664|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
24972328|NCT00388973|50061665|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
24972329|NCT00085202|50061673|FG000|Overall Study|Still on therapy|2|||
24972330|NCT00085202|50061674|FG001|Overall Study|Still on therapy|0|||
24972331|NCT00085202|50061673|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
24972332|NCT00085202|50061674|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
24972333|NCT00085202|50061673|FG000|Overall Study|Excessive toxicity|6|||
24972334|NCT00085202|50061674|FG001|Overall Study|Excessive toxicity|5|||
24972335|NCT00085202|50061673|FG000|Overall Study|Non-specified|3|||
24972336|NCT00085202|50061674|FG001|Overall Study|Non-specified|5|||
24972337|NCT00085202|50061673|FG000|Overall Study|Withdrawal by Subject|2|||
24972338|NCT00085202|50061674|FG001|Overall Study|Withdrawal by Subject|1|||
24972339|NCT00085202|50061673|FG000|Overall Study|Physician Decision|4|||
24972340|NCT00085202|50061674|FG001|Overall Study|Physician Decision|1|||
24972341|NCT00085202|50061673|FG000|Overall Study|Progressive disease|1|||
24972342|NCT00085202|50061674|FG001|Overall Study|Progressive disease|11|||
24972343|NCT00388583|50061700|FG000|Overall Study|Protocol Violation|1|||
24972344|NCT00388583|50061701|FG001|Overall Study|Protocol Violation|0|||
24972345|NCT00388583|50061700|FG000|Overall Study|Withdrawal by Subject|3|||
24972346|NCT00388583|50061701|FG001|Overall Study|Withdrawal by Subject|3|||
24972347|NCT00388583|50061700|FG000|Overall Study|Serious Adverse Event|2|||
24972348|NCT00388583|50061701|FG001|Overall Study|Serious Adverse Event|0|||
24972349|NCT00388583|50061700|FG000|Overall Study|Did not receive vaccine|0|||
24972350|NCT00388583|50061701|FG001|Overall Study|Did not receive vaccine|1|||
24972351|NCT00117572|50061709|FG000|Overall Study|Site withdrew before starting treatment|2|||
24972352|NCT00117572|50061710|FG001|Overall Study|Site withdrew before starting treatment|3|||
24972353|NCT00117572|50061709|FG000|Overall Study|Withdrawal by Subject|3|||
24972354|NCT00117572|50061710|FG001|Overall Study|Withdrawal by Subject|3|||
24972355|NCT00117572|50061709|FG000|Overall Study|Protocol Violation|1|||
24972356|NCT00117572|50061710|FG001|Overall Study|Protocol Violation|0|||
24972357|NCT00388505|50061718|FG000|Overall Study|Adverse Event or Death|43|||
24972358|NCT00388505|50061719|FG001|Overall Study|Adverse Event or Death|17|||
24972359|NCT00388505|50061718|FG000|Overall Study|Withdrawal by Subject|24|||
24972360|NCT00388505|50061719|FG001|Overall Study|Withdrawal by Subject|9|||
24972361|NCT00388505|50061718|FG000|Overall Study|Lost to Follow-up|5|||
24972362|NCT00388505|50061719|FG001|Overall Study|Lost to Follow-up|3|||
24972363|NCT00388505|50061718|FG000|Overall Study|Inappropriate Enrollment|0|||
24972364|NCT00388505|50061719|FG001|Overall Study|Inappropriate Enrollment|1|||
24972365|NCT00388505|50061718|FG000|Overall Study|Administrative Reason|1|||
25072153|NCT02688387|50178456|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072154|NCT02688387|50178457|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072155|NCT02688387|50178458|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072156|NCT02688387|50178459|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072157|NCT02688387|50178460|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072158|NCT02688387|50178461|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072159|NCT02688387|50178462|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072160|NCT02688387|50178463|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072161|NCT02688387|50178464|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072162|NCT02688387|50178465|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072163|NCT02688387|50178466|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072164|NCT02688387|50178467|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
25072165|NCT02688387|50178446|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072166|NCT02688387|50178447|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072167|NCT02688387|50178448|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072168|NCT02688387|50178449|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072169|NCT02688387|50178450|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072170|NCT02688387|50178451|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072171|NCT02688387|50178452|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072172|NCT02688387|50178453|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072173|NCT02688387|50178454|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25192385|NCT01442714|50358209|FG000|Overall Study|Withdrawal by Subject|1|||
25314614|NCT00914732|50630449|FG002|Overall Study|Lost to Follow-up|9|||
25314615|NCT00914732|50630447|FG000|Overall Study|Withdrawal by Subject|3|||
25314616|NCT00914732|50630448|FG001|Overall Study|Withdrawal by Subject|0|||
24972366|NCT00388505|50061719|FG001|Overall Study|Administrative Reason|0|||
24972367|NCT00388505|50061718|FG000|Overall Study|Protocol Violation|6|||
24972368|NCT00388505|50061719|FG001|Overall Study|Protocol Violation|5|||
24972369|NCT00388505|50061718|FG000|Overall Study|Unable to classify|4|||
24972370|NCT00388505|50061719|FG001|Overall Study|Unable to classify|3|||
24972371|NCT00388349|50061725|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
24972372|NCT00388349|50061726|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
24972373|NCT00117338|50061736|FG000|Overall Study|Adverse Event|0|||
24972374|NCT00117338|50061737|FG001|Overall Study|Adverse Event|1|||
24972375|NCT00117338|50061736|FG000|Overall Study|Protocol Violation|3|||
24972376|NCT00117338|50061737|FG001|Overall Study|Protocol Violation|2|||
24972377|NCT00117338|50061736|FG000|Overall Study|Withdrawal by Subject|1|||
24972378|NCT00117338|50061737|FG001|Overall Study|Withdrawal by Subject|0|||
24972379|NCT00117338|50061736|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
24972380|NCT00117338|50061737|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
25072174|NCT02688387|50178455|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25314617|NCT00914732|50630449|FG002|Overall Study|Withdrawal by Subject|2|||
24972381|NCT00117338|50061736|FG000|Overall Study|Lack of Efficacy|0|||
24972382|NCT00117338|50061737|FG001|Overall Study|Lack of Efficacy|1|||
24972383|NCT00388037|50061743|FG000|Overall Study|Protocol Violation|1|||
24972384|NCT00387881|50061749|FG000|Overall Study|Lost to Follow-up|23|||
24972385|NCT00387881|50061750|FG001|Overall Study|Lost to Follow-up|23|||
24972386|NCT00387881|50061749|FG000|Overall Study|Protocol Violation|2|||
24972387|NCT00387881|50061750|FG001|Overall Study|Protocol Violation|12|||
24972388|NCT00387881|50061749|FG000|Overall Study|Withdrawal by Subject|15|||
24972389|NCT00387881|50061750|FG001|Overall Study|Withdrawal by Subject|18|||
24972390|NCT00387881|50061749|FG000|Overall Study|Sponsor terminated Study|0|||
24972391|NCT00387881|50061750|FG001|Overall Study|Sponsor terminated Study|1|||
24972392|NCT00387881|50061749|FG000|Overall Study|Not eligible|6|||
24972393|NCT00387881|50061750|FG001|Overall Study|Not eligible|7|||
24972394|NCT00387881|50061749|FG000|Overall Study|No opportunity to treat headache|32|||
24972395|NCT00387881|50061750|FG001|Overall Study|No opportunity to treat headache|34|||
24972396|NCT00387881|50061749|FG000|Overall Study|Not otherwise specified|11|||
24972397|NCT00387881|50061750|FG001|Overall Study|Not otherwise specified|7|||
24972398|NCT00084656|50061759|FG000|Overall Study|Other reasons|0|||
25072175|NCT02688387|50178456|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
25072176|NCT02688387|50178457|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072177|NCT02688387|50178458|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072178|NCT02688387|50178459|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072179|NCT02688387|50178460|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
24972399|NCT00084656|50061760|FG001|Overall Study|Other reasons|12|||
24972400|NCT00084656|50061761|FG002|Overall Study|Other reasons|11|||
24972401|NCT00084656|50061759|FG000|Overall Study|Withdrawal by Subject|15|||
24972402|NCT00084656|50061760|FG001|Overall Study|Withdrawal by Subject|4|||
24972403|NCT00084656|50061761|FG002|Overall Study|Withdrawal by Subject|4|||
24972404|NCT00084656|50061759|FG000|Overall Study|Disease relapse|0|||
25072180|NCT02688387|50178461|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072181|NCT02688387|50178462|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072182|NCT02688387|50178463|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072183|NCT02688387|50178464|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072184|NCT02688387|50178465|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072185|NCT02688387|50178466|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072186|NCT02688387|50178467|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
25072187|NCT02688387|50178446|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072188|NCT02688387|50178447|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072189|NCT02688387|50178448|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072190|NCT02688387|50178449|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072191|NCT02688387|50178450|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072192|NCT02688387|50178451|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072193|NCT02688387|50178452|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072194|NCT02688387|50178453|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072195|NCT02688387|50178454|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072196|NCT02688387|50178455|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072197|NCT02688387|50178456|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072198|NCT02688387|50178457|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072199|NCT02688387|50178458|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072200|NCT02688387|50178459|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
24972405|NCT00084656|50061760|FG001|Overall Study|Disease relapse|9|||
24972406|NCT00084656|50061761|FG002|Overall Study|Disease relapse|10|||
24972407|NCT00084656|50061759|FG000|Overall Study|Disease progression|9|||
24972408|NCT00084656|50061760|FG001|Overall Study|Disease progression|0|||
24972409|NCT00084656|50061761|FG002|Overall Study|Disease progression|0|||
24972410|NCT00084656|50061759|FG000|Overall Study|Lost to Follow-up|1|||
24972411|NCT00084656|50061760|FG001|Overall Study|Lost to Follow-up|0|||
24972412|NCT00084656|50061761|FG002|Overall Study|Lost to Follow-up|1|||
24972413|NCT00387725|50061775|FG000|Overall Study|Adverse Event|0|||
24972414|NCT00387725|50061776|FG001|Overall Study|Adverse Event|0|||
24972415|NCT00387725|50061777|FG002|Overall Study|Adverse Event|0|||
24972416|NCT00387725|50061778|FG003|Overall Study|Adverse Event|1|||
25192386|NCT01418378|50358222|FG000|Overall Study|Death|1|||
24972417|NCT00387725|50061775|FG000|Overall Study|Protocol Violation|0|||
24972418|NCT00387725|50061776|FG001|Overall Study|Protocol Violation|1|||
24972419|NCT00387725|50061777|FG002|Overall Study|Protocol Violation|0|||
25192387|NCT01418378|50358223|FG001|Overall Study|Death|2|||
24972420|NCT00387725|50061778|FG003|Overall Study|Protocol Violation|0|||
24972421|NCT00387725|50061775|FG000|Overall Study|Withdrawal by Subject|1|||
24972422|NCT00387725|50061776|FG001|Overall Study|Withdrawal by Subject|0|||
24972423|NCT00387725|50061777|FG002|Overall Study|Withdrawal by Subject|1|||
24972424|NCT00387725|50061778|FG003|Overall Study|Withdrawal by Subject|0|||
24972425|NCT00387725|50061775|FG000|Overall Study|Parent/legal guardian request|0|||
24972426|NCT00387725|50061776|FG001|Overall Study|Parent/legal guardian request|0|||
24972427|NCT00387725|50061777|FG002|Overall Study|Parent/legal guardian request|1|||
24972428|NCT00387725|50061778|FG003|Overall Study|Parent/legal guardian request|1|||
24972429|NCT00102596|50061788|FG000|Part A|Screen failures|6|||
24972430|NCT00102596|50061789|FG001|Part A|Screen failures|0|||
24972431|NCT00102596|50061788|FG000|Part A|Adverse Event|1|||
24972432|NCT00102596|50061789|FG001|Part A|Adverse Event|0|||
24972433|NCT00387647|50061796|FG000|Overall Study|Death|18|||
24972434|NCT00386009|50061802|FG000|Overall Study|Adverse Event|0|||
24972435|NCT00386009|50061803|FG001|Overall Study|Adverse Event|2|||
24972436|NCT00386009|50061802|FG000|Overall Study|Death|1|||
24972437|NCT00386009|50061803|FG001|Overall Study|Death|0|||
24972438|NCT00386009|50061802|FG000|Overall Study|Entry Criteria Not Met|0|||
24972439|NCT00386009|50061803|FG001|Overall Study|Entry Criteria Not Met|2|||
24972440|NCT00386009|50061802|FG000|Overall Study|Lost to Follow-up|1|||
24972441|NCT00386009|50061803|FG001|Overall Study|Lost to Follow-up|1|||
24972442|NCT00386009|50061802|FG000|Overall Study|Protocol Violation|1|||
24972443|NCT00386009|50061803|FG001|Overall Study|Protocol Violation|0|||
24972444|NCT00386009|50061802|FG000|Overall Study|Sponsor Decision|1|||
24972445|NCT00386009|50061803|FG001|Overall Study|Sponsor Decision|1|||
24972446|NCT00386009|50061802|FG000|Overall Study|Withdrawal by Subject|5|||
24972447|NCT00386009|50061803|FG001|Overall Study|Withdrawal by Subject|4|||
24972448|NCT00373685|50061811|FG000|Overall Study|Death|2|||
24972449|NCT00373685|50061812|FG001|Overall Study|Death|1|||
24972450|NCT00373685|50061811|FG000|Overall Study|Adverse Event|278|||
24972451|NCT00373685|50061812|FG001|Overall Study|Adverse Event|253|||
24972452|NCT00373685|50061811|FG000|Overall Study|Insufficient clinical response|169|||
24972453|NCT00373685|50061812|FG001|Overall Study|Insufficient clinical response|119|||
24972454|NCT00373685|50061811|FG000|Overall Study|Did not meet entrance criteria|167|||
24972455|NCT00373685|50061812|FG001|Overall Study|Did not meet entrance criteria|184|||
24972456|NCT00373685|50061811|FG000|Overall Study|Lost to follow up|83|||
24972457|NCT00373685|50061812|FG001|Overall Study|Lost to follow up|103|||
24972458|NCT00373685|50061811|FG000|Overall Study|No longer willing to participate|337|||
24972459|NCT00373685|50061812|FG001|Overall Study|No longer willing to participate|352|||
24972460|NCT00373685|50061811|FG000|Overall Study|Other|149|||
24972461|NCT00373685|50061812|FG001|Overall Study|Other|146|||
24972462|NCT00373685|50061811|FG000|Overall Study|Protocol Violation|191|||
24972463|NCT00373685|50061812|FG001|Overall Study|Protocol Violation|182|||
24972464|NCT00373685|50061811|FG000|Overall Study|Final Status Unknown|12|||
24972465|NCT00373685|50061812|FG001|Overall Study|Final Status Unknown|4|||
24972466|NCT00373685|50061811|FG000|Overall Study|Randomized, not treated|51|||
24972467|NCT00373685|50061812|FG001|Overall Study|Randomized, not treated|77|||
24972468|NCT00373529|50061818|FG000|Overall Study|Physician Decision|19|||
24972469|NCT00373529|50061818|FG000|Overall Study|Withdrawal by Subject|7|||
24972470|NCT00373529|50061818|FG000|Overall Study|Adverse Event|7|||
24972471|NCT00373529|50061818|FG000|Overall Study|Treatment failure|36|||
24972472|NCT00373529|50061818|FG000|Overall Study|Disease recurrence|10|||
24972473|NCT00373529|50061818|FG000|Overall Study|Death|16|||
24972474|NCT00373529|50061818|FG000|Overall Study|Need for treatment prohibited by study|1|||
24972475|NCT00373529|50061818|FG000|Overall Study|Other|8|||
24972476|NCT00373529|50061818|FG000|Overall Study|Failed independent confirmation of AML|3|||
24972477|NCT00373529|50061818|FG000|Overall Study|Consent violation|1|||
24972478|NCT00373295|50061822|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
25072201|NCT02688387|50178460|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
25072202|NCT02688387|50178461|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072203|NCT02688387|50178462|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072204|NCT02688387|50178463|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072205|NCT02688387|50178464|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072206|NCT02688387|50178465|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072207|NCT02688387|50178466|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072208|NCT02688387|50178467|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
25072209|NCT02688387|50178446|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072210|NCT02688387|50178447|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072211|NCT02688387|50178448|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
24972479|NCT00373295|50061823|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
25072212|NCT02688387|50178449|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072213|NCT02688387|50178450|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072214|NCT02688387|50178451|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072215|NCT02688387|50178452|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072216|NCT02688387|50178453|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072217|NCT02688387|50178454|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072218|NCT02688387|50178455|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072219|NCT02688387|50178456|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072220|NCT02688387|50178457|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072221|NCT02688387|50178458|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072222|NCT02688387|50178459|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072223|NCT02688387|50178460|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072224|NCT02688387|50178461|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072225|NCT02688387|50178462|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072226|NCT02688387|50178463|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072227|NCT02688387|50178464|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072228|NCT02688387|50178465|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072229|NCT02688387|50178466|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
25072230|NCT02688387|50178467|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
25072231|NCT02688387|50178446|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
25072232|NCT02688387|50178447|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
25072233|NCT02688387|50178448|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
25072234|NCT02688387|50178449|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
25072235|NCT02688387|50178450|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
24972480|NCT00373295|50061824|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
24972481|NCT00373295|50061825|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
24972482|NCT00373295|50061826|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
24972483|NCT00373295|50061827|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
24972484|NCT00385541|50061837|FG000|Overall Study|severe pain, clinician requested unblind|0|||
24972485|NCT00385541|50061838|FG001|Overall Study|severe pain, clinician requested unblind|1|||
24972486|NCT00094302|50061846|FG000|Overall Study|Lost to Follow-up|43|||
24972487|NCT00094302|50061847|FG001|Overall Study|Lost to Follow-up|41|||
24972488|NCT00094302|50061846|FG000|Overall Study|Physician Decision|5|||
24972489|NCT00094302|50061847|FG001|Overall Study|Physician Decision|8|||
24972490|NCT00094302|50061846|FG000|Overall Study|Withdrawal by Subject|103|||
24972491|NCT00094302|50061847|FG001|Overall Study|Withdrawal by Subject|111|||
25072236|NCT02688387|50178451|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
24972492|NCT00094302|50061846|FG000|Overall Study|Death|266|||
24972493|NCT00094302|50061847|FG001|Overall Study|Death|246|||
24972494|NCT00372905|50061853|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
24972495|NCT00372905|50061854|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
24972496|NCT00372905|50061855|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
24972497|NCT00372905|50061856|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
24972498|NCT00372905|50061853|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
24972499|NCT00372905|50061854|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
24972500|NCT00372905|50061855|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
24972501|NCT00372905|50061856|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
24972502|NCT00372905|50061853|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
24972503|NCT00372905|50061854|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
24972504|NCT00372905|50061855|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
24972505|NCT00372905|50061856|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
24972506|NCT00372905|50061853|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
24972507|NCT00372905|50061854|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
24972508|NCT00372905|50061855|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
24972509|NCT00372905|50061856|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
24972510|NCT00372905|50061853|FG000|Follow up Until Relapse or Progression|Study closed|0|||
25314618|NCT00914732|50630447|FG000|Overall Study|Adverse Event|1|||
25314619|NCT00914732|50630448|FG001|Overall Study|Adverse Event|0|||
24972511|NCT00372905|50061854|FG001|Follow up Until Relapse or Progression|Study closed|0|||
25192388|NCT01418378|50358222|FG000|Overall Study|Physician Decision|0|||
25314620|NCT00914732|50630449|FG002|Overall Study|Adverse Event|0|||
25314621|NCT00844545|50630458|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
25314622|NCT00844545|50630458|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
25314623|NCT00844545|50630458|FG000|Extension Treatment Period|Adverse Event|2|||
24972512|NCT00372905|50061855|FG002|Follow up Until Relapse or Progression|Study closed|0|||
24972513|NCT00372905|50061856|FG003|Follow up Until Relapse or Progression|Study closed|3|||
24972514|NCT00372905|50061853|FG000|Follow up Until Relapse or Progression|Other|0|||
24972515|NCT00372905|50061854|FG001|Follow up Until Relapse or Progression|Other|1|||
24972516|NCT00372905|50061855|FG002|Follow up Until Relapse or Progression|Other|0|||
24972517|NCT00372905|50061856|FG003|Follow up Until Relapse or Progression|Other|0|||
24972518|NCT00384839|50061866|FG000|Overall Study|Adverse Event|4|||
24972519|NCT00384839|50061866|FG000|Overall Study|Investigator Request|1|||
24972520|NCT00384839|50061866|FG000|Overall Study|Patient Request|1|||
24972521|NCT00384839|50061866|FG000|Overall Study|Ineligible|2|||
24972522|NCT00384293|50061872|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
24972523|NCT00384293|50061873|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
24972524|NCT00384293|50061874|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
24972525|NCT00384293|50061872|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
24972526|NCT00384293|50061873|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
24972527|NCT00384293|50061874|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
24972528|NCT00384293|50061872|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
24972529|NCT00384293|50061873|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
24972530|NCT00384293|50061874|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
25169856|NCT01822535|50303331|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
25169857|NCT01822535|50303332|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
24972531|NCT00384293|50061872|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
24972532|NCT00384293|50061873|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
24972533|NCT00384293|50061874|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
24972534|NCT00384293|50061872|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
24972535|NCT00384293|50061873|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
24972536|NCT00384293|50061874|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
25169858|NCT01799993|50303418|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
25169859|NCT01799993|50303419|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
25169860|NCT01799993|50303418|FG000|Overall Study|Death|61|||
25169861|NCT01799993|50303419|FG001|Overall Study|Death|45|||
25169862|NCT01799993|50303418|FG000|Overall Study|Withdrawal by Subject|23|||
25169863|NCT01799993|50303419|FG001|Overall Study|Withdrawal by Subject|24|||
25169864|NCT01799993|50303418|FG000|Overall Study|Lost to Follow-up|5|||
25169865|NCT01799993|50303419|FG001|Overall Study|Lost to Follow-up|8|||
25169866|NCT01799993|50303418|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
25169867|NCT01799993|50303419|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
24972537|NCT00384293|50061872|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
24972538|NCT00384293|50061873|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
24972539|NCT00384293|50061874|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
24972540|NCT00384293|50061872|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
24972541|NCT00384293|50061873|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
24972542|NCT00384293|50061874|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
24972543|NCT00384293|50061872|FG000|Post-randomization Period|Adverse Event|0|||
24972544|NCT00384293|50061873|FG001|Post-randomization Period|Adverse Event|23|||
24972545|NCT00384293|50061874|FG002|Post-randomization Period|Adverse Event|7|||
24972546|NCT00384293|50061872|FG000|Post-randomization Period|Lost to Follow-up|0|||
24972547|NCT00384293|50061873|FG001|Post-randomization Period|Lost to Follow-up|2|||
24972548|NCT00384293|50061874|FG002|Post-randomization Period|Lost to Follow-up|1|||
24972549|NCT00384293|50061872|FG000|Post-randomization Period|Protocol Violation|0|||
24972550|NCT00384293|50061873|FG001|Post-randomization Period|Protocol Violation|1|||
24972551|NCT00384293|50061874|FG002|Post-randomization Period|Protocol Violation|0|||
24972552|NCT00384293|50061872|FG000|Post-randomization Period|Withdrawal by Subject|0|||
24972553|NCT00384293|50061873|FG001|Post-randomization Period|Withdrawal by Subject|8|||
24972554|NCT00384293|50061874|FG002|Post-randomization Period|Withdrawal by Subject|6|||
24972555|NCT00384293|50061872|FG000|Post-randomization Period|Trial Termination|0|||
24972556|NCT00384293|50061873|FG001|Post-randomization Period|Trial Termination|180|||
24972557|NCT00384293|50061874|FG002|Post-randomization Period|Trial Termination|204|||
24972558|NCT00384293|50061872|FG000|Post-randomization Period|Patient Randomized in Error|0|||
24972559|NCT00384293|50061873|FG001|Post-randomization Period|Patient Randomized in Error|0|||
24972560|NCT00384293|50061874|FG002|Post-randomization Period|Patient Randomized in Error|1|||
24972561|NCT00067002|50061884|FG000|Overall Study|Early Death|1|||
24972562|NCT00067002|50061885|FG001|Overall Study|Early Death|2|||
24972563|NCT00067002|50061884|FG000|Overall Study|Delayed|1|||
24972564|NCT00067002|50061885|FG001|Overall Study|Delayed|1|||
24972565|NCT00067002|50061884|FG000|Overall Study|Graft Failure|5|||
24972566|NCT00067002|50061885|FG001|Overall Study|Graft Failure|6|||
24972567|NCT00091572|50061893|FG000|Overall Study|Lost to Follow-up|1|||
24972568|NCT00091572|50061894|FG001|Overall Study|Lost to Follow-up|1|||
24972569|NCT00091572|50061893|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
24972570|NCT00091572|50061894|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
24972571|NCT00091572|50061893|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
24972572|NCT00091572|50061894|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
24972573|NCT00091572|50061893|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
24972574|NCT00091572|50061894|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
24972575|NCT00091572|50061893|FG000|Overall Study|Other Reason|6|||
24972576|NCT00091572|50061894|FG001|Overall Study|Other Reason|13|||
24972577|NCT00091572|50061893|FG000|Overall Study|Ongoing (still on treatment)|8|||
24972578|NCT00091572|50061894|FG001|Overall Study|Ongoing (still on treatment)|12|||
24972579|NCT00091572|50061893|FG000|Overall Study|Major Protocol Violation|2|||
24972580|NCT00091572|50061894|FG001|Overall Study|Major Protocol Violation|0|||
24972581|NCT00091572|50061893|FG000|Overall Study|Toxicity (Related AE)|53|||
24972582|NCT00091572|50061894|FG001|Overall Study|Toxicity (Related AE)|9|||
24972583|NCT00084266|50061902|FG000|Overall Study|Death|42|||
24972584|NCT00084266|50061903|FG001|Overall Study|Death|39|||
24972585|NCT00084266|50061902|FG000|Overall Study|Adverse Event|8|||
24972586|NCT00084266|50061903|FG001|Overall Study|Adverse Event|5|||
24972587|NCT00084266|50061902|FG000|Overall Study|Lack of Efficacy|2|||
24972588|NCT00084266|50061903|FG001|Overall Study|Lack of Efficacy|4|||
24972589|NCT00084266|50061902|FG000|Overall Study|Lost to Follow-up|5|||
24972590|NCT00084266|50061903|FG001|Overall Study|Lost to Follow-up|3|||
24972591|NCT00084266|50061902|FG000|Overall Study|Participant not willing to participate|3|||
25192389|NCT01418378|50358223|FG001|Overall Study|Physician Decision|1|||
24972592|NCT00084266|50061903|FG001|Overall Study|Participant not willing to participate|8|||
24972593|NCT00084266|50061902|FG000|Overall Study|Other|360|||
24972594|NCT00084266|50061903|FG001|Overall Study|Other|344|||
24972595|NCT00084266|50061902|FG000|Overall Study|Randomized not treated|21|||
24972596|NCT00084266|50061903|FG001|Overall Study|Randomized not treated|20|||
24972597|NCT00091026|50061911|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
24972598|NCT00091026|50061912|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
24972599|NCT00091026|50061911|FG000|Overall Study|Patient withdrew and never received trea|0|||
24972600|NCT00091026|50061912|FG001|Overall Study|Patient withdrew and never received trea|2|||
24972601|NCT00091026|50061911|FG000|Overall Study|Unknown-never received treatment|0|||
24972602|NCT00091026|50061912|FG001|Overall Study|Unknown-never received treatment|1|||
24972603|NCT00116558|50061921|FG000|Overall Study|Death|11|||
24972604|NCT00116558|50061922|FG001|Overall Study|Death|5|||
24972605|NCT00116558|50061923|FG002|Overall Study|Death|3|||
24972606|NCT00116558|50061921|FG000|Overall Study|Withdrawal by Subject|17|||
24972607|NCT00116558|50061922|FG001|Overall Study|Withdrawal by Subject|3|||
24972608|NCT00116558|50061923|FG002|Overall Study|Withdrawal by Subject|12|||
24972609|NCT00116558|50061921|FG000|Overall Study|disease progression|3|||
24972610|NCT00116558|50061922|FG001|Overall Study|disease progression|7|||
24972611|NCT00116558|50061923|FG002|Overall Study|disease progression|18|||
24972612|NCT00116168|50061934|FG000|Overall Study|Lost to Follow-up|6|||
24972613|NCT00116168|50061935|FG001|Overall Study|Lost to Follow-up|5|||
24972614|NCT00116168|50061936|FG002|Overall Study|Lost to Follow-up|0|||
24972615|NCT00116168|50061937|FG003|Overall Study|Lost to Follow-up|0|||
24972616|NCT00115934|50061949|FG000|Overall Study|Lost to Follow-up|1|||
24972617|NCT00115934|50061950|FG001|Overall Study|Lost to Follow-up|0|||
24972618|NCT00115934|50061949|FG000|Overall Study|Did not receive intervention|3|||
24972619|NCT00115934|50061950|FG001|Overall Study|Did not receive intervention|2|||
24972620|NCT00115778|50061956|FG000|Overall Study|Withdrawal by Subject|0|||
24972621|NCT00115778|50061957|FG001|Overall Study|Withdrawal by Subject|1|||
24972622|NCT00100178|50061966|FG000|Overall Study|Lost to Follow-up|0|||
24972623|NCT00100178|50061967|FG001|Overall Study|Lost to Follow-up|6|||
24972624|NCT00100178|50061968|FG002|Overall Study|Lost to Follow-up|5|||
24972625|NCT00100178|50061966|FG000|Overall Study|Adverse Event|2|||
24972626|NCT00100178|50061967|FG001|Overall Study|Adverse Event|2|||
24972627|NCT00100178|50061968|FG002|Overall Study|Adverse Event|1|||
24972628|NCT00100178|50061966|FG000|Overall Study|Withdrawal by Subject|1|||
24972629|NCT00100178|50061967|FG001|Overall Study|Withdrawal by Subject|1|||
24972630|NCT00100178|50061968|FG002|Overall Study|Withdrawal by Subject|1|||
24972631|NCT00100178|50061966|FG000|Overall Study|Physician Decision|6|||
24972632|NCT00100178|50061967|FG001|Overall Study|Physician Decision|1|||
24972633|NCT00100178|50061968|FG002|Overall Study|Physician Decision|3|||
24972634|NCT00099632|50061982|FG000|Overall Study|Lost to Follow-up|1|||
24972635|NCT00099632|50061983|FG001|Overall Study|Lost to Follow-up|0|||
24972636|NCT00099632|50061984|FG002|Overall Study|Lost to Follow-up|3|||
24972637|NCT00099632|50061985|FG003|Overall Study|Lost to Follow-up|1|||
24972638|NCT00099632|50061986|FG004|Overall Study|Lost to Follow-up|1|||
24972639|NCT00099632|50061987|FG005|Overall Study|Lost to Follow-up|0|||
24972640|NCT00099632|50061982|FG000|Overall Study|Withdrawal by Subject|0|||
24972641|NCT00099632|50061983|FG001|Overall Study|Withdrawal by Subject|1|||
24972642|NCT00099632|50061984|FG002|Overall Study|Withdrawal by Subject|0|||
24972643|NCT00099632|50061985|FG003|Overall Study|Withdrawal by Subject|0|||
24972644|NCT00099632|50061986|FG004|Overall Study|Withdrawal by Subject|0|||
24972645|NCT00099632|50061987|FG005|Overall Study|Withdrawal by Subject|1|||
24972646|NCT00099632|50061982|FG000|Overall Study|Protocol Violation|0|||
24972647|NCT00099632|50061983|FG001|Overall Study|Protocol Violation|0|||
24972648|NCT00099632|50061984|FG002|Overall Study|Protocol Violation|0|||
24972649|NCT00099632|50061985|FG003|Overall Study|Protocol Violation|0|||
24972650|NCT00099632|50061986|FG004|Overall Study|Protocol Violation|0|||
24972651|NCT00099632|50061987|FG005|Overall Study|Protocol Violation|1|||
25072237|NCT02688387|50178452|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
25169868|NCT01799993|50303418|FG000|Overall Study|Protocol driven decision point|0|||
25169869|NCT01799993|50303419|FG001|Overall Study|Protocol driven decision point|3|||
24972652|NCT00098774|50062001|FG000|Overall Study|Adverse Event|2|||
24972653|NCT00098774|50062001|FG000|Overall Study|Disease Progression|9|||
24972654|NCT00098774|50062001|FG000|Overall Study|Withdrawal by Subject|1|||
24972655|NCT00098774|50062001|FG000|Overall Study|Failed (to respond) during induction|4|||
24972656|NCT00098774|50062001|FG000|Overall Study|Physician Decision|2|||
24972657|NCT00384059|50062007|FG000|Infant Series|Not consented|2|||
25072238|NCT02688387|50178453|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
24972658|NCT00384059|50062008|FG001|Infant Series|Not consented|6|||
25169870|NCT01799993|50303418|FG000|Overall Study|Protocol Violation|1|||
24972659|NCT00384059|50062007|FG000|Infant Series|Withdrawal by Subject|2|||
24972660|NCT00384059|50062008|FG001|Infant Series|Withdrawal by Subject|2|||
24972661|NCT00384059|50062007|FG000|Infant Series|Adverse Event|1|||
24972662|NCT00384059|50062008|FG001|Infant Series|Adverse Event|2|||
24972663|NCT00384059|50062007|FG000|Infant Series|Protocol Violation|1|||
24972664|NCT00384059|50062008|FG001|Infant Series|Protocol Violation|2|||
24972665|NCT00384059|50062007|FG000|Infant Series|Lost to Follow-up|0|||
24972666|NCT00384059|50062008|FG001|Infant Series|Lost to Follow-up|1|||
24972667|NCT00384059|50062007|FG000|After Infant Series|Protocol Violation|2|||
24972668|NCT00384059|50062008|FG001|After Infant Series|Protocol Violation|3|||
24972669|NCT00384059|50062007|FG000|After Infant Series|Withdrawal by Subject|2|||
24972670|NCT00384059|50062008|FG001|After Infant Series|Withdrawal by Subject|2|||
24972671|NCT00384059|50062007|FG000|After Infant Series|Failed to Return|0|||
24972672|NCT00384059|50062008|FG001|After Infant Series|Failed to Return|2|||
24972673|NCT00384059|50062007|FG000|After Infant Series|Adverse Event|0|||
24972674|NCT00384059|50062008|FG001|After Infant Series|Adverse Event|1|||
24972675|NCT00384059|50062007|FG000|After Infant Series|Physician Decision|0|||
24972676|NCT00384059|50062008|FG001|After Infant Series|Physician Decision|1|||
24972677|NCT00384059|50062007|FG000|After Infant Series|Lost to Follow-up|0|||
24972678|NCT00384059|50062008|FG001|After Infant Series|Lost to Follow-up|1|||
24972679|NCT00384059|50062007|FG000|Toddler Dose|Lost to Follow-up|1|||
24972680|NCT00384059|50062008|FG001|Toddler Dose|Lost to Follow-up|1|||
24972681|NCT00384059|50062007|FG000|Toddler Dose|Failed to return|0|||
24972682|NCT00384059|50062008|FG001|Toddler Dose|Failed to return|1|||
24972683|NCT00383123|50062037|FG000|Overall Study|Adverse Event|1|||
24972684|NCT00383123|50062038|FG001|Overall Study|Adverse Event|0|||
24972685|NCT00383123|50062037|FG000|Overall Study|Lost to Follow-up|68|||
24972686|NCT00383123|50062038|FG001|Overall Study|Lost to Follow-up|61|||
24972687|NCT00383123|50062037|FG000|Overall Study|Protocol Violation|5|||
24972688|NCT00383123|50062038|FG001|Overall Study|Protocol Violation|1|||
24972689|NCT00383123|50062037|FG000|Overall Study|Withdrawal by Subject|27|||
24972690|NCT00383123|50062038|FG001|Overall Study|Withdrawal by Subject|18|||
24972691|NCT00383123|50062037|FG000|Overall Study|Other reason|10|||
24972692|NCT00383123|50062038|FG001|Overall Study|Other reason|6|||
24972693|NCT00382967|50062046|FG000|Overall Study|Protocol Violation|1|||
24972694|NCT00382967|50062047|FG001|Overall Study|Protocol Violation|1|||
24972695|NCT00858364|50062055|FG000|Overall Study|Administrative Decision|3|||
24972696|NCT00858364|50062056|FG001|Overall Study|Administrative Decision|2|||
24972697|NCT00858364|50062055|FG000|Overall Study|Adverse Event|5|||
24972698|NCT00858364|50062056|FG001|Overall Study|Adverse Event|2|||
24972699|NCT00858364|50062055|FG000|Overall Study|Withdrawal by Subject|44|||
24972700|NCT00858364|50062056|FG001|Overall Study|Withdrawal by Subject|118|||
25072239|NCT02688387|50178454|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
25072240|NCT02688387|50178455|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
25072241|NCT02688387|50178456|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
25072242|NCT02688387|50178457|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
25072243|NCT02688387|50178458|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
25072244|NCT02688387|50178459|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
25072245|NCT02688387|50178460|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
25072246|NCT02688387|50178461|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
25072247|NCT02688387|50178462|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
25072248|NCT02688387|50178463|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
25072249|NCT02688387|50178464|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
25072250|NCT02688387|50178465|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
25072251|NCT02688387|50178466|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
25072252|NCT02688387|50178467|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
25072253|NCT02688387|50178446|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072254|NCT02688387|50178447|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072255|NCT02688387|50178448|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072256|NCT02688387|50178449|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072257|NCT02688387|50178450|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072258|NCT02688387|50178451|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072259|NCT02688387|50178452|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072260|NCT02688387|50178453|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072261|NCT02688387|50178454|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072262|NCT02688387|50178455|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072263|NCT02688387|50178456|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072264|NCT02688387|50178457|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072265|NCT02688387|50178458|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072266|NCT02688387|50178459|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072267|NCT02688387|50178460|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072268|NCT02688387|50178461|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
24972701|NCT00858364|50062055|FG000|Overall Study|Ineligibility Determined|1|||
24972702|NCT00858364|50062056|FG001|Overall Study|Ineligibility Determined|10|||
24972703|NCT00858364|50062055|FG000|Overall Study|Lost to Follow-up|24|||
25072269|NCT02688387|50178462|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072270|NCT02688387|50178463|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
24972704|NCT00858364|50062056|FG001|Overall Study|Lost to Follow-up|54|||
24972705|NCT00858364|50062055|FG000|Overall Study|Noncompliance|3|||
24972706|NCT00858364|50062056|FG001|Overall Study|Noncompliance|4|||
24972707|NCT00858364|50062055|FG000|Overall Study|Protocol Deviation|0|||
24972708|NCT00858364|50062056|FG001|Overall Study|Protocol Deviation|2|||
24972709|NCT00858364|50062055|FG000|Overall Study|Other|9|||
24972710|NCT00858364|50062056|FG001|Overall Study|Other|17|||
24972711|NCT00858364|50062055|FG000|Overall Study|Missing|1|||
24972712|NCT00858364|50062056|FG001|Overall Study|Missing|1|||
24972713|NCT00858364|50062055|FG000|Overall Study|Still on-study|114|||
24972714|NCT00858364|50062056|FG001|Overall Study|Still on-study|247|||
25072271|NCT02688387|50178464|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072272|NCT02688387|50178465|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
25072273|NCT02688387|50178466|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072274|NCT02688387|50178467|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
25072275|NCT02476201|50178513|FG000|Overall Study|Unable to program MPP|9|||
25072276|NCT02476201|50178513|FG000|Overall Study|Study echo not performed|5|||
25072277|NCT02476201|50178513|FG000|Overall Study|Adverse Event|4|||
25072278|NCT02476201|50178513|FG000|Overall Study|Death|2|||
25072279|NCT02476201|50178513|FG000|Overall Study|Lost to Follow-up|2|||
25072280|NCT02476201|50178513|FG000|Overall Study|MPP programmed to OFF|2|||
25072281|NCT02476201|50178513|FG000|Overall Study|Withdrawal by Subject|1|||
25072282|NCT02476201|50178513|FG000|Overall Study|Unsuccessful implant|1|||
25072283|NCT04112173|50178518|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
24972715|NCT00382733|50062062|FG000|Overall Study|Withdrawal by Subject|0|||
24972716|NCT00382733|50062063|FG001|Overall Study|Withdrawal by Subject|1|||
24972717|NCT00382733|50062064|FG002|Overall Study|Withdrawal by Subject|0|||
24972718|NCT00382733|50062065|FG003|Overall Study|Withdrawal by Subject|0|||
24972719|NCT00382733|50062066|FG004|Overall Study|Withdrawal by Subject|0|||
25072284|NCT02688153|50178524|FG000|Overall Study|Death|7|||
25072285|NCT02688153|50178525|FG001|Overall Study|Death|5|||
25072286|NCT02688153|50178524|FG000|Overall Study|Withdrawal by Subject|4|||
25072287|NCT02688153|50178525|FG001|Overall Study|Withdrawal by Subject|2|||
24972720|NCT03631732|50062081|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
25072288|NCT02688153|50178524|FG000|Overall Study|Valve Explant|1|||
25072289|NCT02688153|50178525|FG001|Overall Study|Valve Explant|0|||
25072290|NCT02688153|50178524|FG000|Overall Study|Conversion to Commercial Valve|3|||
25072291|NCT02688153|50178525|FG001|Overall Study|Conversion to Commercial Valve|0|||
25072292|NCT02687919|50178534|FG000|Overall Study|Withdrawal by Subject|6|||
25072293|NCT02687919|50178535|FG001|Overall Study|Withdrawal by Subject|6|||
25072294|NCT02687919|50178534|FG000|Overall Study|Protocol Violation|2|||
25072295|NCT02687919|50178535|FG001|Overall Study|Protocol Violation|0|||
25072296|NCT02687451|50178547|FG000|Overall Study|Withdrawal by Subject|1|||
25072297|NCT02687451|50178548|FG001|Overall Study|Withdrawal by Subject|0|||
25072298|NCT02687451|50178549|FG002|Overall Study|Withdrawal by Subject|0|||
25072299|NCT02687451|50178550|FG003|Overall Study|Withdrawal by Subject|0|||
24972721|NCT03631732|50062082|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
24972722|NCT03631732|50062081|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
25072300|NCT02687451|50178551|FG004|Overall Study|Withdrawal by Subject|0|||
25072301|NCT02687451|50178552|FG005|Overall Study|Withdrawal by Subject|1|||
25072302|NCT02557646|50178568|FG000|Overall Study|Adverse Event|40|||
25072303|NCT02557646|50178568|FG000|Overall Study|Death|1|||
25072304|NCT02557646|50178568|FG000|Overall Study|Lack of Efficacy|186|||
25072305|NCT02557646|50178568|FG000|Overall Study|Withdrawal by Subject|18|||
25072306|NCT02557646|50178568|FG000|Overall Study|Lost to Follow-up|17|||
25072307|NCT02557646|50178568|FG000|Overall Study|Other|14|||
25072308|NCT02679573|50178574|FG000|Overall Study|Adverse Event|13|||
25072309|NCT02679573|50178575|FG001|Overall Study|Adverse Event|6|||
25072310|NCT02679573|50178574|FG000|Overall Study|Lack of Efficacy|12|||
25072311|NCT02679573|50178575|FG001|Overall Study|Lack of Efficacy|15|||
25072312|NCT02679573|50178574|FG000|Overall Study|Could not complete required study visits|6|||
25072313|NCT02679573|50178575|FG001|Overall Study|Could not complete required study visits|2|||
25072314|NCT02679573|50178574|FG000|Overall Study|Withdrawal by Subject|2|||
25072315|NCT02679573|50178575|FG001|Overall Study|Withdrawal by Subject|9|||
25072316|NCT02679573|50178574|FG000|Overall Study|Death|2|||
25072317|NCT02679573|50178575|FG001|Overall Study|Death|0|||
25072318|NCT02679573|50178574|FG000|Overall Study|Physician Decision|2|||
25072319|NCT02679573|50178575|FG001|Overall Study|Physician Decision|4|||
25072320|NCT02679573|50178574|FG000|Overall Study|Lost to Follow-up|0|||
25072321|NCT02679573|50178575|FG001|Overall Study|Lost to Follow-up|3|||
25072322|NCT02685033|50178583|FG000|Overall Study|Withdrawal of Consent|0|||
25072323|NCT02685033|50178584|FG001|Overall Study|Withdrawal of Consent|1|||
25072324|NCT02685033|50178583|FG000|Overall Study|Lost to Follow-up|2|||
25072325|NCT02685033|50178584|FG001|Overall Study|Lost to Follow-up|1|||
25072326|NCT02685033|50178583|FG000|Overall Study|Adverse Event|1|||
25072327|NCT02685033|50178584|FG001|Overall Study|Adverse Event|0|||
25072328|NCT02684097|50178592|FG000|Overall Study|Lack of Efficacy|13|||
25072329|NCT02684097|50178593|FG001|Overall Study|Lack of Efficacy|6|||
25072330|NCT02555618|50178601|FG000|Overall Study|Sponsor's Circumstances|1|||
25072331|NCT02555618|50178602|FG001|Overall Study|Sponsor's Circumstances|0|||
25072332|NCT02557100|50178628|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
25072333|NCT02557100|50178629|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
24972723|NCT03631732|50062082|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
24972724|NCT03631732|50062081|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
24972725|NCT03631732|50062082|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
24972726|NCT03631732|50062081|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
24972727|NCT03631732|50062082|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
24972728|NCT03631732|50062081|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
24972729|NCT03631732|50062082|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
25072334|NCT02557100|50178630|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
25072335|NCT02557100|50178628|FG000|Single Blind Treatment Period|Death|0|||
25072336|NCT02557100|50178629|FG001|Single Blind Treatment Period|Death|1|||
25072337|NCT02557100|50178630|FG002|Single Blind Treatment Period|Death|0|||
25072338|NCT02557100|50178628|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
25072339|NCT02557100|50178629|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
24972730|NCT03631732|50062081|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
24972731|NCT03631732|50062082|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
24972732|NCT03631732|50062081|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
24972733|NCT03631732|50062082|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
24972734|NCT03631732|50062081|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
24972735|NCT03631732|50062082|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
24972736|NCT03631732|50062081|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
24972737|NCT03631732|50062082|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
24972738|NCT03631732|50062081|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
24972739|NCT03631732|50062082|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
24972740|NCT03630016|50062092|FG000|Overall Study|Poor Sensor Placement|1|||
25169871|NCT01799993|50303419|FG001|Overall Study|Protocol Violation|1|||
24972741|NCT03628924|50062099|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
25192390|NCT01418378|50358222|FG000|Overall Study|ligament imbalance|0|||
24972742|NCT03628924|50062100|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
25072340|NCT02557100|50178630|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
25072341|NCT02557100|50178628|FG000|Single Blind Treatment Period|Adverse Event|0|||
25072342|NCT02557100|50178629|FG001|Single Blind Treatment Period|Adverse Event|1|||
25072343|NCT02557100|50178630|FG002|Single Blind Treatment Period|Adverse Event|0|||
25072344|NCT02557100|50178628|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
25072345|NCT02557100|50178629|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
25072346|NCT02557100|50178630|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
25072347|NCT02557100|50178628|FG000|Cumulative Abatacept Period|Other Reasons|0|||
25072348|NCT02557100|50178629|FG001|Cumulative Abatacept Period|Other Reasons|0|||
25072349|NCT02557100|50178630|FG002|Cumulative Abatacept Period|Other Reasons|1|||
25072350|NCT02557100|50178628|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
25072351|NCT02557100|50178629|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
25072352|NCT02557100|50178630|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
25072353|NCT02557100|50178628|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
25072354|NCT02557100|50178629|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
25072355|NCT02557100|50178630|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
25072356|NCT01337635|50178640|FG000|Overall Study|Lost to Follow-up|0|||
25072357|NCT01337635|50178641|FG001|Overall Study|Lost to Follow-up|1|||
25072358|NCT02556710|50178649|FG000|Overall Study|Surgical treatment|3|||
25072359|NCT02556710|50178650|FG001|Overall Study|Surgical treatment|0|||
25072360|NCT02556710|50178649|FG000|Overall Study|Required proscribed pain medication|2|||
25072361|NCT02556710|50178650|FG001|Overall Study|Required proscribed pain medication|1|||
25072362|NCT02556710|50178649|FG000|Overall Study|Lack of Efficacy|1|||
25072363|NCT02556710|50178650|FG001|Overall Study|Lack of Efficacy|0|||
25072364|NCT02556710|50178649|FG000|Overall Study|Worsening osteoarthritis|1|||
25072365|NCT02556710|50178650|FG001|Overall Study|Worsening osteoarthritis|0|||
25072366|NCT02556710|50178649|FG000|Overall Study|Moved out of state|1|||
25072367|NCT02556710|50178650|FG001|Overall Study|Moved out of state|0|||
25072368|NCT02556710|50178649|FG000|Overall Study|Missing reason|3|||
25072369|NCT02556710|50178650|FG001|Overall Study|Missing reason|1|||
25072370|NCT02556710|50178649|FG000|Overall Study|Pain as lack of efficacy|0|||
25072371|NCT02556710|50178650|FG001|Overall Study|Pain as lack of efficacy|4|||
25072372|NCT02556632|50178661|FG000|Overall Study|Lost to Follow-up|1|||
25072373|NCT02556632|50178662|FG001|Overall Study|Lost to Follow-up|0|||
25072374|NCT02556632|50178663|FG002|Overall Study|Lost to Follow-up|0|||
25072375|NCT02556632|50178661|FG000|Overall Study|Disliked Intervention|1|||
25072376|NCT02556632|50178662|FG001|Overall Study|Disliked Intervention|1|||
25072377|NCT02556632|50178663|FG002|Overall Study|Disliked Intervention|1|||
25072378|NCT02556632|50178661|FG000|Overall Study|No Reason|1|||
25072379|NCT02556632|50178662|FG001|Overall Study|No Reason|0|||
25072380|NCT02556632|50178663|FG002|Overall Study|No Reason|1|||
25072381|NCT02556632|50178661|FG000|Overall Study|Personal Issues|0|||
25072382|NCT02556632|50178662|FG001|Overall Study|Personal Issues|1|||
25072383|NCT02556632|50178663|FG002|Overall Study|Personal Issues|1|||
25072384|NCT02556632|50178661|FG000|Overall Study|Changed Mind|0|||
25072385|NCT02556632|50178662|FG001|Overall Study|Changed Mind|1|||
25072386|NCT02556632|50178663|FG002|Overall Study|Changed Mind|0|||
25072387|NCT02556632|50178661|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
25072388|NCT02556632|50178662|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
25072389|NCT02556632|50178663|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
25072390|NCT02556632|50178661|FG000|Overall Study|Unrelated Adverse Event|1|||
25072391|NCT02556632|50178662|FG001|Overall Study|Unrelated Adverse Event|0|||
25072392|NCT02556632|50178663|FG002|Overall Study|Unrelated Adverse Event|3|||
25072393|NCT02556632|50178661|FG000|Overall Study|Related Adverse Event|0|||
25072394|NCT02556632|50178662|FG001|Overall Study|Related Adverse Event|1|||
25072395|NCT02556632|50178663|FG002|Overall Study|Related Adverse Event|0|||
25072396|NCT02556632|50178661|FG000|Overall Study|Possibly Related Adverse Event|0|||
25072397|NCT02556632|50178662|FG001|Overall Study|Possibly Related Adverse Event|0|||
25072398|NCT02556632|50178663|FG002|Overall Study|Possibly Related Adverse Event|1|||
25072399|NCT02556632|50178661|FG000|Overall Study|Did Not Start RT|0|||
25072400|NCT02556632|50178662|FG001|Overall Study|Did Not Start RT|1|||
25072401|NCT02556632|50178663|FG002|Overall Study|Did Not Start RT|0|||
25072402|NCT02556632|50178661|FG000|Overall Study|Ineligible|0|||
25072403|NCT02556632|50178662|FG001|Overall Study|Ineligible|1|||
25072404|NCT02556632|50178663|FG002|Overall Study|Ineligible|0|||
25072405|NCT02556632|50178661|FG000|Overall Study|Disliked Study Procedures|0|||
25072406|NCT02556632|50178662|FG001|Overall Study|Disliked Study Procedures|0|||
25072407|NCT02556632|50178663|FG002|Overall Study|Disliked Study Procedures|1|||
25072408|NCT02556632|50178661|FG000|Overall Study|Treatment or Change Delay|0|||
25072409|NCT02556632|50178662|FG001|Overall Study|Treatment or Change Delay|0|||
25072410|NCT02556632|50178663|FG002|Overall Study|Treatment or Change Delay|1|||
25072411|NCT01662440|50178675|FG000|Overall Study|Adverse Event|1|||
25072412|NCT01662440|50178676|FG001|Overall Study|Adverse Event|0|||
25192391|NCT01418378|50358223|FG001|Overall Study|ligament imbalance|1|||
25072413|NCT01662440|50178677|FG002|Overall Study|Adverse Event|0|||
25072414|NCT01662440|50178678|FG003|Overall Study|Adverse Event|1|||
24972743|NCT03628924|50062101|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
24972744|NCT03628924|50062102|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
24972745|NCT03628924|50062103|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
24972746|NCT03628924|50062104|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
24972747|NCT03628924|50062105|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
24972748|NCT03628924|50062099|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
24972749|NCT03628924|50062100|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
24972750|NCT03628924|50062101|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
24972751|NCT03628924|50062102|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
24972752|NCT03628924|50062103|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
24972753|NCT03628924|50062104|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
24972754|NCT03628924|50062105|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
24972755|NCT03628924|50062099|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
24972756|NCT03628924|50062100|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
24972757|NCT03628924|50062101|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
24972758|NCT03628924|50062102|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
24972759|NCT03628924|50062103|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
24972760|NCT03628924|50062104|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
24972761|NCT03628924|50062105|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
25072415|NCT01662440|50178675|FG000|Overall Study|Death|0|||
25072416|NCT01662440|50178676|FG001|Overall Study|Death|1|||
25072417|NCT01662440|50178677|FG002|Overall Study|Death|0|||
25072418|NCT01662440|50178678|FG003|Overall Study|Death|0|||
25072419|NCT01662440|50178675|FG000|Overall Study|Lost to Follow-up|2|||
25072420|NCT01662440|50178676|FG001|Overall Study|Lost to Follow-up|2|||
25072421|NCT01662440|50178677|FG002|Overall Study|Lost to Follow-up|4|||
25072422|NCT01662440|50178678|FG003|Overall Study|Lost to Follow-up|1|||
25072423|NCT01662440|50178675|FG000|Overall Study|Subject moved to another country.|0|||
25072424|NCT01662440|50178676|FG001|Overall Study|Subject moved to another country.|1|||
25072425|NCT01662440|50178677|FG002|Overall Study|Subject moved to another country.|0|||
25072426|NCT01662440|50178678|FG003|Overall Study|Subject moved to another country.|0|||
25072427|NCT01662440|50178675|FG000|Overall Study|Protocol Violation|1|||
25072428|NCT01662440|50178676|FG001|Overall Study|Protocol Violation|0|||
25072429|NCT01662440|50178677|FG002|Overall Study|Protocol Violation|0|||
25072430|NCT01662440|50178678|FG003|Overall Study|Protocol Violation|0|||
25072431|NCT01662440|50178675|FG000|Overall Study|Withdrawal by Subject|5|||
25072432|NCT01662440|50178676|FG001|Overall Study|Withdrawal by Subject|2|||
25072433|NCT01662440|50178677|FG002|Overall Study|Withdrawal by Subject|2|||
25072434|NCT01662440|50178678|FG003|Overall Study|Withdrawal by Subject|2|||
25072435|NCT01662362|50178698|FG000|Overall Study|Lost to Follow-up|38|||
25072436|NCT02554682|50178713|FG000|Overall Study|Lost to Follow-up|11|||
25072437|NCT02554682|50178714|FG001|Overall Study|Lost to Follow-up|9|||
24972762|NCT03628924|50062099|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
24972763|NCT03628924|50062100|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
24972764|NCT03628924|50062101|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
24972765|NCT03628924|50062102|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
24972766|NCT03628924|50062103|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
24972767|NCT03628924|50062104|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
24972768|NCT03628924|50062105|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
24972769|NCT03628924|50062099|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
24972770|NCT03628924|50062100|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
24972771|NCT03628924|50062101|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
24972772|NCT03628924|50062102|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
24972773|NCT03628924|50062103|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
24972774|NCT03628924|50062104|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
24972775|NCT03628924|50062105|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
24972776|NCT03628924|50062099|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
24972777|NCT03628924|50062100|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
24972778|NCT03628924|50062101|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
24972779|NCT03628924|50062102|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
24972780|NCT03628924|50062103|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
24972781|NCT03628924|50062104|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
24972782|NCT03628924|50062105|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
24972783|NCT03628924|50062099|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
24972784|NCT03628924|50062100|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
24972785|NCT03628924|50062101|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
24972786|NCT03628924|50062102|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
25072438|NCT02554682|50178715|FG002|Overall Study|Lost to Follow-up|4|||
24972787|NCT03628924|50062103|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
25072439|NCT02554682|50178716|FG003|Overall Study|Lost to Follow-up|3|||
25072440|NCT02554682|50178717|FG004|Overall Study|Lost to Follow-up|2|||
25072441|NCT02554682|50178718|FG005|Overall Study|Lost to Follow-up|1|||
25072442|NCT02554682|50178719|FG006|Overall Study|Lost to Follow-up|6|||
25072443|NCT02554682|50178720|FG007|Overall Study|Lost to Follow-up|6|||
25072444|NCT02554682|50178721|FG008|Overall Study|Lost to Follow-up|2|||
25072445|NCT02554682|50178722|FG009|Overall Study|Lost to Follow-up|2|||
25072446|NCT02554682|50178713|FG000|Overall Study|Withdrawal by Subject|2|||
25072447|NCT02554682|50178714|FG001|Overall Study|Withdrawal by Subject|1|||
25072448|NCT02554682|50178715|FG002|Overall Study|Withdrawal by Subject|0|||
25072449|NCT02554682|50178716|FG003|Overall Study|Withdrawal by Subject|0|||
25072450|NCT02554682|50178717|FG004|Overall Study|Withdrawal by Subject|0|||
25072451|NCT02554682|50178718|FG005|Overall Study|Withdrawal by Subject|0|||
25072452|NCT02554682|50178719|FG006|Overall Study|Withdrawal by Subject|0|||
25072453|NCT02554682|50178720|FG007|Overall Study|Withdrawal by Subject|0|||
25072454|NCT02554682|50178721|FG008|Overall Study|Withdrawal by Subject|0|||
25072455|NCT02554682|50178722|FG009|Overall Study|Withdrawal by Subject|0|||
25072456|NCT02554682|50178713|FG000|Overall Study|Physician Decision|2|||
25072457|NCT02554682|50178714|FG001|Overall Study|Physician Decision|2|||
25072458|NCT02554682|50178715|FG002|Overall Study|Physician Decision|0|||
25072459|NCT02554682|50178716|FG003|Overall Study|Physician Decision|0|||
25072460|NCT02554682|50178717|FG004|Overall Study|Physician Decision|0|||
25072461|NCT02554682|50178718|FG005|Overall Study|Physician Decision|0|||
25072462|NCT02554682|50178719|FG006|Overall Study|Physician Decision|0|||
25072463|NCT02554682|50178720|FG007|Overall Study|Physician Decision|0|||
24972788|NCT03628924|50062104|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
24972789|NCT03628924|50062105|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
24972790|NCT03628924|50062099|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
25072464|NCT02554682|50178721|FG008|Overall Study|Physician Decision|0|||
25072465|NCT02554682|50178722|FG009|Overall Study|Physician Decision|0|||
25072466|NCT00154063|50178758|FG000|Overall Study|Adverse Event|4|||
25072467|NCT00154063|50178759|FG001|Overall Study|Adverse Event|8|||
25072468|NCT00154063|50178758|FG000|Overall Study|Protocol Violation|1|||
25072469|NCT00154063|50178759|FG001|Overall Study|Protocol Violation|1|||
25072470|NCT00154063|50178758|FG000|Overall Study|Investigator or Sponsor Request|0|||
25072471|NCT00154063|50178759|FG001|Overall Study|Investigator or Sponsor Request|1|||
25072472|NCT00154063|50178758|FG000|Overall Study|Withdrawal by Subject|4|||
25072473|NCT00154063|50178759|FG001|Overall Study|Withdrawal by Subject|9|||
25072474|NCT00154063|50178758|FG000|Overall Study|Other|3|||
25072475|NCT00154063|50178759|FG001|Overall Study|Other|3|||
25072476|NCT02683941|50178771|FG000|Double-blind Phase|Adverse Event|0|||
25072477|NCT02683941|50178772|FG001|Double-blind Phase|Adverse Event|1|||
25072478|NCT02683941|50178771|FG000|Double-blind Phase|Withdrawal by Subject|4|||
25072479|NCT02683941|50178772|FG001|Double-blind Phase|Withdrawal by Subject|2|||
25072480|NCT02683941|50178771|FG000|Double-blind Phase|Lost to Follow-up|1|||
25072481|NCT02683941|50178772|FG001|Double-blind Phase|Lost to Follow-up|0|||
25072482|NCT02683941|50178771|FG000|Double-blind Phase|Disease Progression|5|||
25072483|NCT02683941|50178772|FG001|Double-blind Phase|Disease Progression|2|||
25072484|NCT02683941|50178771|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
25072485|NCT02683941|50178772|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
25072486|NCT02683941|50178771|FG000|Open-label Treatment Phase|Disease Progression|1|||
25072487|NCT02683941|50178772|FG001|Open-label Treatment Phase|Disease Progression|2|||
25072488|NCT02683941|50178771|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
25072489|NCT02683941|50178772|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
25072490|NCT02683941|50178771|FG000|Open-label Treatment Phase|Other|1|||
25072491|NCT02683941|50178772|FG001|Open-label Treatment Phase|Other|0|||
25072492|NCT02683941|50178771|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
25072493|NCT02683941|50178772|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
25072494|NCT02683941|50178771|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
25072495|NCT02683941|50178772|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
25072496|NCT02683941|50178771|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
25072497|NCT02683941|50178772|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
25072498|NCT02683941|50178771|FG000|Open-label Follow-up Phase|Other|8|||
25072499|NCT02683941|50178772|FG001|Open-label Follow-up Phase|Other|1|||
25072500|NCT02678247|50178784|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
25072501|NCT02678247|50178785|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
25072502|NCT02678247|50178784|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
25072503|NCT02678247|50178785|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
25072504|NCT02678247|50178784|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
25072505|NCT02678247|50178785|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
25072506|NCT02678247|50178784|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
25072507|NCT02678247|50178785|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
25072508|NCT02678247|50178784|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
25072509|NCT02678247|50178785|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
25072510|NCT02678247|50178784|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
25072511|NCT02678247|50178785|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
25072512|NCT02683785|50178798|FG000|Overall Study|Withdrawal by Subject|1|||
25072513|NCT02683785|50178799|FG001|Overall Study|Withdrawal by Subject|1|||
25072514|NCT02683785|50178798|FG000|Overall Study|Lost to Follow-up|0|||
25072515|NCT02683785|50178799|FG001|Overall Study|Lost to Follow-up|1|||
25072516|NCT02683785|50178798|FG000|Overall Study|Adverse Event|0|||
25072517|NCT02683785|50178799|FG001|Overall Study|Adverse Event|2|||
25072518|NCT02543294|50178807|FG000|Overall Study|Lost to Follow-up|3|||
25072519|NCT02543294|50178807|FG000|Overall Study|Physician Decision|2|||
25072520|NCT02543294|50178807|FG000|Overall Study|Withdrawal by Subject|7|||
25072521|NCT02728076|50178812|FG000|Overall Study|Physician Decision|4|||
25072522|NCT02551874|50178818|FG000|Overall Study|Lost to Follow-up|0|||
25072523|NCT02551874|50178819|FG001|Overall Study|Lost to Follow-up|2|||
25072524|NCT02551874|50178818|FG000|Overall Study|Pregnancy|0|||
25072525|NCT02551874|50178819|FG001|Overall Study|Pregnancy|1|||
25072526|NCT02551874|50178818|FG000|Overall Study|Reason not reported|10|||
25072527|NCT02551874|50178819|FG001|Overall Study|Reason not reported|4|||
25072528|NCT02551874|50178818|FG000|Overall Study|Did not receive randomized treatment|0|||
25072529|NCT02551874|50178819|FG001|Overall Study|Did not receive randomized treatment|7|||
25072530|NCT02551874|50178818|FG000|Overall Study|Did not enter long-term study|18|||
24972791|NCT03628924|50062100|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
24972792|NCT03628924|50062101|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
24972793|NCT03628924|50062102|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
24972794|NCT03628924|50062103|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
24972795|NCT03628924|50062104|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
24972796|NCT03628924|50062105|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
24972797|NCT03628924|50062099|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
24972798|NCT03628924|50062100|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
25169872|NCT01799993|50303418|FG000|Overall Study|Deterioration of general conditions|2|||
25169873|NCT01799993|50303419|FG001|Overall Study|Deterioration of general conditions|0|||
25169874|NCT01799993|50303418|FG000|Overall Study|Screen failure|0|||
25169875|NCT01799993|50303419|FG001|Overall Study|Screen failure|1|||
25169876|NCT01799993|50303418|FG000|Overall Study|Adverse Event|1|||
25169877|NCT01799993|50303419|FG001|Overall Study|Adverse Event|0|||
25169878|NCT01799993|50303418|FG000|Overall Study|Lack of Efficacy|1|||
25169879|NCT01799993|50303419|FG001|Overall Study|Lack of Efficacy|0|||
24972799|NCT03628924|50062101|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
25072531|NCT02551874|50178819|FG001|Overall Study|Did not enter long-term study|25|||
25072532|NCT02682927|50178844|FG000|Overall Study|Adverse Event|0|||
25072533|NCT02682927|50178845|FG001|Overall Study|Adverse Event|0|||
25072534|NCT02682927|50178846|FG002|Overall Study|Adverse Event|5|||
25072535|NCT02682927|50178847|FG003|Overall Study|Adverse Event|1|||
25072536|NCT02682927|50178848|FG004|Overall Study|Adverse Event|0|||
25072537|NCT02682927|50178849|FG005|Overall Study|Adverse Event|2|||
25072538|NCT02682927|50178844|FG000|Overall Study|Death|0|||
25072539|NCT02682927|50178845|FG001|Overall Study|Death|0|||
25072540|NCT02682927|50178846|FG002|Overall Study|Death|0|||
25072541|NCT02682927|50178847|FG003|Overall Study|Death|1|||
25072542|NCT02682927|50178848|FG004|Overall Study|Death|0|||
25072543|NCT02682927|50178849|FG005|Overall Study|Death|0|||
25072544|NCT02682927|50178844|FG000|Overall Study|Lack of Efficacy|1|||
25072545|NCT02682927|50178845|FG001|Overall Study|Lack of Efficacy|0|||
25072546|NCT02682927|50178846|FG002|Overall Study|Lack of Efficacy|0|||
25072547|NCT02682927|50178847|FG003|Overall Study|Lack of Efficacy|1|||
25072548|NCT02682927|50178848|FG004|Overall Study|Lack of Efficacy|0|||
25072549|NCT02682927|50178849|FG005|Overall Study|Lack of Efficacy|0|||
25072550|NCT02682927|50178844|FG000|Overall Study|Other|0|||
25072551|NCT02682927|50178845|FG001|Overall Study|Other|0|||
25072552|NCT02682927|50178846|FG002|Overall Study|Other|0|||
25072553|NCT02682927|50178847|FG003|Overall Study|Other|2|||
25072554|NCT02682927|50178848|FG004|Overall Study|Other|0|||
25072555|NCT02682927|50178849|FG005|Overall Study|Other|0|||
25072556|NCT02682927|50178844|FG000|Overall Study|Withdrawal by Subject|2|||
25072557|NCT02682927|50178845|FG001|Overall Study|Withdrawal by Subject|0|||
25072558|NCT02682927|50178846|FG002|Overall Study|Withdrawal by Subject|1|||
25072559|NCT02682927|50178847|FG003|Overall Study|Withdrawal by Subject|0|||
25072560|NCT02682927|50178848|FG004|Overall Study|Withdrawal by Subject|1|||
25072561|NCT02682927|50178849|FG005|Overall Study|Withdrawal by Subject|1|||
25072562|NCT02550938|50178873|FG000|Overall Study|Lost to Follow-up|8|||
25072563|NCT02550938|50178874|FG001|Overall Study|Lost to Follow-up|7|||
25072564|NCT02550938|50178875|FG002|Overall Study|Lost to Follow-up|12|||
25072565|NCT02550938|50178876|FG003|Overall Study|Lost to Follow-up|11|||
25072566|NCT02769065|50178916|FG000|Overall Study|Voluntary Withdrawal|1|||
25072567|NCT02769065|50178917|FG001|Overall Study|Voluntary Withdrawal|0|||
25072568|NCT02769065|50178918|FG002|Overall Study|Voluntary Withdrawal|0|||
25072569|NCT02769065|50178919|FG003|Overall Study|Voluntary Withdrawal|0|||
25072570|NCT02769065|50178920|FG004|Overall Study|Voluntary Withdrawal|0|||
25072571|NCT02769065|50178921|FG005|Overall Study|Voluntary Withdrawal|0|||
25072572|NCT02769065|50178922|FG006|Overall Study|Voluntary Withdrawal|0|||
25072573|NCT02769065|50178923|FG007|Overall Study|Voluntary Withdrawal|0|||
25072574|NCT02769065|50178924|FG008|Overall Study|Voluntary Withdrawal|0|||
25072575|NCT02769065|50178925|FG009|Overall Study|Voluntary Withdrawal|0|||
25072576|NCT02769065|50178926|FG010|Overall Study|Voluntary Withdrawal|0|||
25072577|NCT02769065|50178927|FG011|Overall Study|Voluntary Withdrawal|0|||
24972800|NCT03628924|50062102|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
24972801|NCT03628924|50062103|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
24972802|NCT03628924|50062104|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
25072578|NCT02769065|50178928|FG012|Overall Study|Voluntary Withdrawal|0|||
25072579|NCT02769065|50178929|FG013|Overall Study|Voluntary Withdrawal|0|||
25072580|NCT02769065|50178930|FG014|Overall Study|Voluntary Withdrawal|0|||
25072581|NCT02769065|50178931|FG015|Overall Study|Voluntary Withdrawal|0|||
25072582|NCT02769065|50178932|FG016|Overall Study|Voluntary Withdrawal|0|||
25072583|NCT02769065|50178933|FG017|Overall Study|Voluntary Withdrawal|0|||
25072584|NCT02769065|50178934|FG018|Overall Study|Voluntary Withdrawal|0|||
25072585|NCT02769065|50178935|FG019|Overall Study|Voluntary Withdrawal|0|||
25072586|NCT02769065|50178936|FG020|Overall Study|Voluntary Withdrawal|0|||
25072587|NCT02769065|50178937|FG021|Overall Study|Voluntary Withdrawal|0|||
24972803|NCT03628924|50062105|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
24972804|NCT03628924|50062099|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
24972805|NCT03628924|50062100|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
24972806|NCT03628924|50062101|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
24972807|NCT03628924|50062102|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
24972808|NCT03628924|50062103|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
24972809|NCT03628924|50062104|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
24972810|NCT03628924|50062105|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
25072588|NCT02769065|50178938|FG022|Overall Study|Voluntary Withdrawal|0|||
25072589|NCT02769065|50178939|FG023|Overall Study|Voluntary Withdrawal|0|||
25072590|NCT02769065|50178940|FG024|Overall Study|Voluntary Withdrawal|0|||
25072591|NCT02769065|50178941|FG025|Overall Study|Voluntary Withdrawal|0|||
25072592|NCT02769065|50178942|FG026|Overall Study|Voluntary Withdrawal|0|||
25072593|NCT02769065|50178943|FG027|Overall Study|Voluntary Withdrawal|0|||
25072594|NCT02769065|50178944|FG028|Overall Study|Voluntary Withdrawal|0|||
25072595|NCT02769065|50178945|FG029|Overall Study|Voluntary Withdrawal|0|||
25072596|NCT02769065|50178916|FG000|Overall Study|Reason Not Specified|0|||
25072597|NCT02769065|50178917|FG001|Overall Study|Reason Not Specified|0|||
25072598|NCT02769065|50178918|FG002|Overall Study|Reason Not Specified|0|||
25072599|NCT02769065|50178919|FG003|Overall Study|Reason Not Specified|0|||
25072600|NCT02769065|50178920|FG004|Overall Study|Reason Not Specified|0|||
25072601|NCT02769065|50178921|FG005|Overall Study|Reason Not Specified|0|||
25072602|NCT02769065|50178922|FG006|Overall Study|Reason Not Specified|1|||
25072603|NCT02769065|50178923|FG007|Overall Study|Reason Not Specified|0|||
25072604|NCT02769065|50178924|FG008|Overall Study|Reason Not Specified|0|||
25072605|NCT02769065|50178925|FG009|Overall Study|Reason Not Specified|0|||
25072606|NCT02769065|50178926|FG010|Overall Study|Reason Not Specified|0|||
25072607|NCT02769065|50178927|FG011|Overall Study|Reason Not Specified|0|||
25072608|NCT02769065|50178928|FG012|Overall Study|Reason Not Specified|0|||
25072609|NCT02769065|50178929|FG013|Overall Study|Reason Not Specified|0|||
25072610|NCT02769065|50178930|FG014|Overall Study|Reason Not Specified|0|||
25072611|NCT02769065|50178931|FG015|Overall Study|Reason Not Specified|0|||
25072612|NCT02769065|50178932|FG016|Overall Study|Reason Not Specified|0|||
25072613|NCT02769065|50178933|FG017|Overall Study|Reason Not Specified|0|||
25072614|NCT02769065|50178934|FG018|Overall Study|Reason Not Specified|0|||
25072615|NCT02769065|50178935|FG019|Overall Study|Reason Not Specified|0|||
25072616|NCT02769065|50178936|FG020|Overall Study|Reason Not Specified|0|||
25072617|NCT02769065|50178937|FG021|Overall Study|Reason Not Specified|0|||
25072618|NCT02769065|50178938|FG022|Overall Study|Reason Not Specified|0|||
25072619|NCT02769065|50178939|FG023|Overall Study|Reason Not Specified|0|||
25072620|NCT02769065|50178940|FG024|Overall Study|Reason Not Specified|0|||
25072621|NCT02769065|50178941|FG025|Overall Study|Reason Not Specified|0|||
24972811|NCT03627832|50062119|FG000|Overall Study|Withdrawal by Subject|10|||
24972812|NCT03627832|50062120|FG001|Overall Study|Withdrawal by Subject|1|||
24972813|NCT00112437|50062131|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
25072622|NCT02769065|50178942|FG026|Overall Study|Reason Not Specified|0|||
25072623|NCT02769065|50178943|FG027|Overall Study|Reason Not Specified|0|||
25072624|NCT02769065|50178944|FG028|Overall Study|Reason Not Specified|0|||
25072625|NCT02769065|50178945|FG029|Overall Study|Reason Not Specified|0|||
25072626|NCT02769065|50178916|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072627|NCT02769065|50178917|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072628|NCT02769065|50178918|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
24972814|NCT00112437|50062132|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
24972815|NCT00112437|50062133|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
24972816|NCT00112437|50062134|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
24972817|NCT00112437|50062135|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
24972818|NCT00112437|50062136|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972819|NCT00112437|50062137|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972820|NCT00112437|50062138|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972821|NCT00112437|50062139|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972822|NCT00112437|50062140|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972823|NCT00112437|50062141|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972824|NCT00112437|50062142|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972825|NCT00112437|50062143|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972826|NCT00112437|50062144|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972827|NCT00112437|50062145|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972828|NCT00112437|50062146|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972829|NCT00112437|50062147|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972830|NCT00112437|50062148|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972831|NCT00112437|50062149|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972832|NCT00112437|50062150|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972833|NCT00112437|50062151|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972834|NCT00112437|50062152|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972835|NCT00112437|50062153|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972836|NCT00112437|50062154|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972837|NCT00112437|50062155|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972838|NCT00112437|50062156|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
24972839|NCT00112437|50062131|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972840|NCT00112437|50062132|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
24972841|NCT00112437|50062133|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972842|NCT00112437|50062134|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972843|NCT00112437|50062135|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972844|NCT00112437|50062136|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972845|NCT00112437|50062137|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972846|NCT00112437|50062138|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972847|NCT00112437|50062139|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972848|NCT00112437|50062140|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972849|NCT00112437|50062141|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
25072629|NCT02769065|50178919|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072630|NCT02769065|50178920|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072631|NCT02769065|50178921|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072632|NCT02769065|50178922|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072633|NCT02769065|50178923|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072634|NCT02769065|50178924|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072635|NCT02769065|50178925|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072636|NCT02769065|50178926|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
25072637|NCT02769065|50178927|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072638|NCT02769065|50178928|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072639|NCT02769065|50178929|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072640|NCT02769065|50178930|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072641|NCT02769065|50178931|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072642|NCT02769065|50178932|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072643|NCT02769065|50178933|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072644|NCT02769065|50178934|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072645|NCT02769065|50178935|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072646|NCT02769065|50178936|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072647|NCT02769065|50178937|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072648|NCT02769065|50178938|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072649|NCT02769065|50178939|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072650|NCT02769065|50178940|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072651|NCT02769065|50178941|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072652|NCT02769065|50178942|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072653|NCT02769065|50178943|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072654|NCT02769065|50178944|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072655|NCT02769065|50178945|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
25072656|NCT02681523|50179038|FG000|Overall Study|Adverse Event|1|||
25072657|NCT02681523|50179038|FG000|Overall Study|Patient Non-compliance|1|||
25072658|NCT02540954|50179044|FG000|Overall Study|Physician Decision|3|||
25072659|NCT02540954|50179045|FG001|Overall Study|Physician Decision|1|||
25072660|NCT02540954|50179044|FG000|Overall Study|Withdrawal by Subject|6|||
25072661|NCT02540954|50179045|FG001|Overall Study|Withdrawal by Subject|5|||
25072662|NCT02540954|50179044|FG000|Overall Study|Lost to Follow-up|1|||
25169880|NCT01799993|50303418|FG000|Overall Study|Recovery|0|||
25314624|NCT00844545|50630458|FG000|Post Treatment Period|Withdrawal by Subject|1|||
24972850|NCT00112437|50062142|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972851|NCT00112437|50062143|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972852|NCT00112437|50062144|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
25072663|NCT02540954|50179045|FG001|Overall Study|Lost to Follow-up|1|||
25072664|NCT02540954|50179044|FG000|Overall Study|Adverse Event|4|||
25072665|NCT02540954|50179045|FG001|Overall Study|Adverse Event|2|||
25072666|NCT02540954|50179044|FG000|Overall Study|Death|0|||
25072667|NCT02540954|50179045|FG001|Overall Study|Death|3|||
25072668|NCT02540954|50179044|FG000|Overall Study|Treatment failure|1|||
24972853|NCT00112437|50062145|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972854|NCT00112437|50062146|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972855|NCT00112437|50062147|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972856|NCT00112437|50062148|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972857|NCT00112437|50062149|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972858|NCT00112437|50062150|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972859|NCT00112437|50062151|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972860|NCT00112437|50062152|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972861|NCT00112437|50062153|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972862|NCT00112437|50062154|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972863|NCT00112437|50062155|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972864|NCT00112437|50062156|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
24972865|NCT00112437|50062131|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972866|NCT00112437|50062132|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
24972867|NCT00112437|50062133|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972868|NCT00112437|50062134|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972869|NCT00112437|50062135|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972870|NCT00112437|50062136|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972871|NCT00112437|50062137|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972872|NCT00112437|50062138|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972873|NCT00112437|50062139|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972874|NCT00112437|50062140|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972875|NCT00112437|50062141|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972876|NCT00112437|50062142|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972877|NCT00112437|50062143|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972878|NCT00112437|50062144|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972879|NCT00112437|50062145|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972880|NCT00112437|50062146|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972881|NCT00112437|50062147|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972882|NCT00112437|50062148|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972883|NCT00112437|50062149|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972884|NCT00112437|50062150|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972885|NCT00112437|50062151|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972886|NCT00112437|50062152|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
25072669|NCT02540954|50179045|FG001|Overall Study|Treatment failure|0|||
25072670|NCT02540954|50179044|FG000|Overall Study|Other reason|4|||
25072671|NCT02540954|50179045|FG001|Overall Study|Other reason|2|||
25072672|NCT02658812|50179051|FG000|Overall Study|Disease Progression|7|||
25072673|NCT02658812|50179051|FG000|Overall Study|Unrelated to study treatment|1|||
25072674|NCT02658812|50179051|FG000|Overall Study|Adverse Event|1|||
25072675|NCT02680665|50179055|FG000|Overall Study|No visit after the first prescription|5|||
25072676|NCT00154375|50179061|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
25072677|NCT00154375|50179062|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
25072678|NCT00154375|50179061|FG000|Overall Study|Adverse Event|18|||
25072679|NCT00154375|50179062|FG001|Overall Study|Adverse Event|20|||
25072680|NCT00154375|50179061|FG000|Overall Study|Withdrawal by Subject|14|||
25072681|NCT00154375|50179062|FG001|Overall Study|Withdrawal by Subject|10|||
25072682|NCT00154375|50179061|FG000|Overall Study|Death|5|||
25072683|NCT00154375|50179062|FG001|Overall Study|Death|13|||
25072684|NCT00154375|50179061|FG000|Overall Study|Study drug no longer required|5|||
25072685|NCT00154375|50179062|FG001|Overall Study|Study drug no longer required|3|||
25072686|NCT00154375|50179061|FG000|Overall Study|Lost to Follow-up|2|||
25072687|NCT00154375|50179062|FG001|Overall Study|Lost to Follow-up|1|||
25072688|NCT00154375|50179061|FG000|Overall Study|Abnormal laboratory value(s)|0|||
25072689|NCT00154375|50179062|FG001|Overall Study|Abnormal laboratory value(s)|2|||
25072690|NCT00154375|50179061|FG000|Overall Study|Protocol Violation|0|||
25072691|NCT00154375|50179062|FG001|Overall Study|Protocol Violation|1|||
25072692|NCT00154375|50179061|FG000|Overall Study|Suspected progression of disease|44|||
25072693|NCT00154375|50179062|FG001|Overall Study|Suspected progression of disease|30|||
25072694|NCT02765399|50179071|FG000|Overall Study|Nausea|1|||
25072695|NCT02765399|50179072|FG001|Overall Study|Nausea|0|||
25072696|NCT02676765|50179080|FG000|Overall Study|Lost to Follow-up|0|||
25072697|NCT02676765|50179081|FG001|Overall Study|Lost to Follow-up|1|||
25072698|NCT02680041|50179087|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
25072699|NCT02680041|50179087|FG000|Overall Study|Lost to Follow-up|2|||
25072700|NCT02547974|50179096|FG000|Overall Study|Withdrawal by Subject|1|||
25072701|NCT02547974|50179097|FG001|Overall Study|Withdrawal by Subject|0|||
25072702|NCT02547974|50179098|FG002|Overall Study|Withdrawal by Subject|0|||
25072703|NCT02547974|50179099|FG003|Overall Study|Withdrawal by Subject|0|||
25072704|NCT00154297|50179114|FG000|Overall Study|Death|5|||
25072705|NCT00154297|50179115|FG001|Overall Study|Death|2|||
25072706|NCT00154297|50179114|FG000|Overall Study|Withdrawal by Subject|0|||
25072707|NCT00154297|50179115|FG001|Overall Study|Withdrawal by Subject|5|||
25072708|NCT00154297|50179114|FG000|Overall Study|Lost to Follow-up|3|||
25072709|NCT00154297|50179115|FG001|Overall Study|Lost to Follow-up|0|||
25072710|NCT02679729|50179130|FG000|Overall Study|Lost to Follow-up|0|||
25072711|NCT02679729|50179131|FG001|Overall Study|Lost to Follow-up|1|||
25072712|NCT02679729|50179132|FG002|Overall Study|Lost to Follow-up|0|||
25072713|NCT02679729|50179133|FG003|Overall Study|Lost to Follow-up|0|||
25072714|NCT02679729|50179134|FG004|Overall Study|Lost to Follow-up|1|||
25072715|NCT02679729|50179135|FG005|Overall Study|Lost to Follow-up|0|||
25072716|NCT02679729|50179136|FG006|Overall Study|Lost to Follow-up|0|||
25072717|NCT02679729|50179137|FG007|Overall Study|Lost to Follow-up|0|||
25072718|NCT02679729|50179138|FG008|Overall Study|Lost to Follow-up|0|||
25072719|NCT02679729|50179130|FG000|Overall Study|Participant decision|0|||
25072720|NCT02679729|50179131|FG001|Overall Study|Participant decision|1|||
25072721|NCT02679729|50179132|FG002|Overall Study|Participant decision|0|||
25072722|NCT02679729|50179133|FG003|Overall Study|Participant decision|0|||
25072723|NCT02679729|50179134|FG004|Overall Study|Participant decision|0|||
25192392|NCT01418378|50358222|FG000|Overall Study|developed chronic myopathy|0|||
25314625|NCT00651157|50630463|FG000|Overall Study|Death|1|||
24972887|NCT00112437|50062153|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972888|NCT00112437|50062154|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972889|NCT00112437|50062155|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972890|NCT00112437|50062156|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
24972891|NCT00112437|50062131|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
24972892|NCT00112437|50062132|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972893|NCT00112437|50062133|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
24972894|NCT00112437|50062134|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
24972895|NCT00112437|50062135|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
25072724|NCT02679729|50179135|FG005|Overall Study|Participant decision|0|||
25072725|NCT02679729|50179136|FG006|Overall Study|Participant decision|1|||
25192393|NCT01418378|50358223|FG001|Overall Study|developed chronic myopathy|1|||
25192394|NCT01435928|50358244|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
24972896|NCT00112437|50062136|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972897|NCT00112437|50062137|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972898|NCT00112437|50062138|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
25072726|NCT02679729|50179137|FG007|Overall Study|Participant decision|0|||
25072727|NCT02679729|50179138|FG008|Overall Study|Participant decision|0|||
25072728|NCT02765165|50179177|FG000|Treatment Period|Progressive disease|3|||
24972899|NCT00112437|50062139|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972900|NCT00112437|50062140|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972901|NCT00112437|50062141|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972902|NCT00112437|50062142|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972903|NCT00112437|50062143|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972904|NCT00112437|50062144|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972905|NCT00112437|50062145|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972906|NCT00112437|50062146|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972907|NCT00112437|50062147|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972908|NCT00112437|50062148|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972909|NCT00112437|50062149|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972910|NCT00112437|50062150|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972911|NCT00112437|50062151|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972912|NCT00112437|50062152|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972913|NCT00112437|50062153|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972914|NCT00112437|50062154|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972915|NCT00112437|50062155|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972916|NCT00112437|50062156|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
24972917|NCT00112437|50062131|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
24972918|NCT00112437|50062132|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
24972919|NCT00112437|50062133|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
24972920|NCT00112437|50062134|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
24972921|NCT00112437|50062135|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
24972922|NCT00112437|50062136|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972923|NCT00112437|50062137|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972924|NCT00112437|50062138|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972925|NCT00112437|50062139|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972926|NCT00112437|50062140|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972927|NCT00112437|50062141|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972928|NCT00112437|50062142|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972929|NCT00112437|50062143|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972930|NCT00112437|50062144|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972931|NCT00112437|50062145|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972932|NCT00112437|50062146|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972933|NCT00112437|50062147|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972934|NCT00112437|50062148|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972935|NCT00112437|50062149|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972936|NCT00112437|50062150|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972937|NCT00112437|50062151|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972938|NCT00112437|50062152|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972939|NCT00112437|50062153|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972940|NCT00112437|50062154|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972941|NCT00112437|50062155|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972942|NCT00112437|50062156|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
24972943|NCT00112437|50062131|FG000|Year 1 (12-Month Base Study)|moved|0|||
24972944|NCT00112437|50062132|FG001|Year 1 (12-Month Base Study)|moved|1|||
25072729|NCT02765165|50179178|FG001|Treatment Period|Progressive disease|2|||
25072730|NCT02765165|50179179|FG002|Treatment Period|Progressive disease|3|||
25072731|NCT02765165|50179180|FG003|Treatment Period|Progressive disease|3|||
25169881|NCT01799993|50303419|FG001|Overall Study|Recovery|1|||
25169882|NCT01799993|50303418|FG000|Overall Study|Logistical difficulties|1|||
25169883|NCT01799993|50303419|FG001|Overall Study|Logistical difficulties|0|||
24972945|NCT00112437|50062133|FG002|Year 1 (12-Month Base Study)|moved|1|||
25072732|NCT02765165|50179181|FG004|Treatment Period|Progressive disease|4|||
25072733|NCT02765165|50179182|FG005|Treatment Period|Progressive disease|2|||
25072734|NCT02765165|50179183|FG006|Treatment Period|Progressive disease|2|||
25072735|NCT02765165|50179177|FG000|Treatment Period|Physician Decision|0|||
25072736|NCT02765165|50179178|FG001|Treatment Period|Physician Decision|1|||
25072737|NCT02765165|50179179|FG002|Treatment Period|Physician Decision|0|||
25072738|NCT02765165|50179180|FG003|Treatment Period|Physician Decision|0|||
25072739|NCT02765165|50179181|FG004|Treatment Period|Physician Decision|0|||
25072740|NCT02765165|50179182|FG005|Treatment Period|Physician Decision|0|||
25072741|NCT02765165|50179183|FG006|Treatment Period|Physician Decision|0|||
25072742|NCT02765165|50179177|FG000|Treatment Period|Adverse Event|0|||
25072743|NCT02765165|50179178|FG001|Treatment Period|Adverse Event|1|||
25072744|NCT02765165|50179179|FG002|Treatment Period|Adverse Event|0|||
25072745|NCT02765165|50179180|FG003|Treatment Period|Adverse Event|0|||
25072746|NCT02765165|50179181|FG004|Treatment Period|Adverse Event|0|||
25072747|NCT02765165|50179182|FG005|Treatment Period|Adverse Event|0|||
25072748|NCT02765165|50179183|FG006|Treatment Period|Adverse Event|0|||
25072749|NCT02765165|50179177|FG000|Treatment Period|Withdrawal by Subject|0|||
25072750|NCT02765165|50179178|FG001|Treatment Period|Withdrawal by Subject|0|||
25072751|NCT02765165|50179179|FG002|Treatment Period|Withdrawal by Subject|0|||
25072752|NCT02765165|50179180|FG003|Treatment Period|Withdrawal by Subject|0|||
25072753|NCT02765165|50179181|FG004|Treatment Period|Withdrawal by Subject|2|||
25072754|NCT02765165|50179182|FG005|Treatment Period|Withdrawal by Subject|0|||
24972946|NCT00112437|50062134|FG003|Year 1 (12-Month Base Study)|moved|0|||
24972947|NCT00112437|50062135|FG004|Year 1 (12-Month Base Study)|moved|0|||
24972948|NCT00112437|50062136|FG005|Year 1 (12-Month Base Study)|moved|0|||
24972949|NCT00112437|50062137|FG006|Year 1 (12-Month Base Study)|moved|0|||
24972950|NCT00112437|50062138|FG007|Year 1 (12-Month Base Study)|moved|0|||
24972951|NCT00112437|50062139|FG008|Year 1 (12-Month Base Study)|moved|0|||
24972952|NCT00112437|50062140|FG009|Year 1 (12-Month Base Study)|moved|0|||
24972953|NCT00112437|50062141|FG010|Year 1 (12-Month Base Study)|moved|0|||
24972954|NCT00112437|50062142|FG011|Year 1 (12-Month Base Study)|moved|0|||
25072755|NCT02765165|50179183|FG006|Treatment Period|Withdrawal by Subject|0|||
25072756|NCT02765165|50179177|FG000|Treatment Period|Study terminated|0|||
24972955|NCT00112437|50062143|FG012|Year 1 (12-Month Base Study)|moved|0|||
25072757|NCT02765165|50179178|FG001|Treatment Period|Study terminated|0|||
25072758|NCT02765165|50179179|FG002|Treatment Period|Study terminated|0|||
25072759|NCT02765165|50179180|FG003|Treatment Period|Study terminated|0|||
24972956|NCT00112437|50062144|FG013|Year 1 (12-Month Base Study)|moved|0|||
24972957|NCT00112437|50062145|FG014|Year 1 (12-Month Base Study)|moved|0|||
24972958|NCT00112437|50062146|FG015|Year 1 (12-Month Base Study)|moved|0|||
25072760|NCT02765165|50179181|FG004|Treatment Period|Study terminated|0|||
25072761|NCT02765165|50179182|FG005|Treatment Period|Study terminated|1|||
25072762|NCT02765165|50179183|FG006|Treatment Period|Study terminated|2|||
25072763|NCT02765165|50179177|FG000|Post-treatment Follow-up|Death|1|||
25072764|NCT02765165|50179178|FG001|Post-treatment Follow-up|Death|2|||
25072765|NCT02765165|50179179|FG002|Post-treatment Follow-up|Death|1|||
25072766|NCT02765165|50179180|FG003|Post-treatment Follow-up|Death|1|||
25072767|NCT02765165|50179181|FG004|Post-treatment Follow-up|Death|1|||
25072768|NCT02765165|50179182|FG005|Post-treatment Follow-up|Death|1|||
25072769|NCT02765165|50179183|FG006|Post-treatment Follow-up|Death|0|||
25072770|NCT02765165|50179177|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
25072771|NCT02765165|50179178|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
25072772|NCT02765165|50179179|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
25072773|NCT02765165|50179180|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
25072774|NCT02765165|50179181|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
25072775|NCT02765165|50179182|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
25072776|NCT02765165|50179183|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
25072777|NCT02765165|50179177|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
25072778|NCT02765165|50179178|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
25072779|NCT02765165|50179179|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
25072780|NCT02765165|50179180|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
25072781|NCT02765165|50179181|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
25072782|NCT02765165|50179182|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
25072783|NCT02765165|50179183|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
25072784|NCT02765165|50179177|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
25072785|NCT02765165|50179178|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
25072786|NCT02765165|50179179|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
25072787|NCT02765165|50179180|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
25072788|NCT02765165|50179181|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
25072789|NCT02765165|50179182|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
25072790|NCT02765165|50179183|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
25072791|NCT02765165|50179177|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
25072792|NCT02765165|50179178|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
25072793|NCT02765165|50179179|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
25072794|NCT02765165|50179180|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
25072795|NCT02765165|50179181|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
25072796|NCT02765165|50179182|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
25072797|NCT02765165|50179183|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
25072798|NCT02765165|50179177|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
25072799|NCT02765165|50179178|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
25072800|NCT02765165|50179179|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
25072801|NCT02765165|50179180|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
25072802|NCT02765165|50179181|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
25072803|NCT02765165|50179182|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
25072804|NCT02765165|50179183|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
25072805|NCT02675907|50179205|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
25072806|NCT02675907|50179206|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
25072807|NCT02675907|50179205|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
25072808|NCT02675907|50179206|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
24972959|NCT00112437|50062147|FG016|Year 1 (12-Month Base Study)|moved|0|||
24972960|NCT00112437|50062148|FG017|Year 1 (12-Month Base Study)|moved|0|||
24972961|NCT00112437|50062149|FG018|Year 1 (12-Month Base Study)|moved|0|||
24972962|NCT00112437|50062150|FG019|Year 1 (12-Month Base Study)|moved|0|||
24972963|NCT00112437|50062151|FG020|Year 1 (12-Month Base Study)|moved|0|||
24972964|NCT00112437|50062152|FG021|Year 1 (12-Month Base Study)|moved|0|||
24972965|NCT00112437|50062153|FG022|Year 1 (12-Month Base Study)|moved|0|||
24972966|NCT00112437|50062154|FG023|Year 1 (12-Month Base Study)|moved|0|||
24972967|NCT00112437|50062155|FG024|Year 1 (12-Month Base Study)|moved|0|||
24972968|NCT00112437|50062156|FG025|Year 1 (12-Month Base Study)|moved|0|||
24972969|NCT00112437|50062131|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972970|NCT00112437|50062132|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972971|NCT00112437|50062133|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
25072809|NCT02675907|50179205|FG000|Study Overall|Lack of Efficacy|1|||
25072810|NCT02675907|50179206|FG001|Study Overall|Lack of Efficacy|0|||
25072811|NCT02675907|50179205|FG000|Study Overall|Withdrawal by Subject|2|||
25072812|NCT02675907|50179206|FG001|Study Overall|Withdrawal by Subject|2|||
25072813|NCT02675907|50179205|FG000|Study Overall|Lost to Follow-up|0|||
25072814|NCT02675907|50179206|FG001|Study Overall|Lost to Follow-up|2|||
25072815|NCT02675517|50179212|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
25072816|NCT02675517|50179212|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
25072817|NCT02764775|50179216|FG000|Overall Study|Death|1|||
25072818|NCT02764775|50179216|FG000|Overall Study|Lost to Follow-up|2|||
25072819|NCT02764775|50179216|FG000|Overall Study|Withdrawal by Subject|3|||
25072820|NCT02774681|50179220|FG000|Treatment on Study|Progressive Disease|7|||
25072821|NCT02774681|50179220|FG000|Follow-Up for 3 Years|Death|11|||
25072822|NCT02774681|50179220|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
25072823|NCT02547428|50179226|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
25072824|NCT02547428|50179227|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
25072825|NCT02547428|50179226|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
25072826|NCT02547428|50179227|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
25072827|NCT02547428|50179226|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
25072828|NCT02547428|50179227|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
25072829|NCT02547428|50179226|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
25072830|NCT02547428|50179227|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
25072831|NCT02547428|50179226|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
25072832|NCT02547428|50179227|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
25072833|NCT02547428|50179226|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
25072834|NCT02547428|50179227|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
25072835|NCT02547428|50179226|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
25072836|NCT02547428|50179227|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
25072837|NCT02547428|50179226|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
25072838|NCT02547428|50179227|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
25072839|NCT01374087|50179242|FG000|Overall Study|Adverse Event|1|||
25072840|NCT01374087|50179243|FG001|Overall Study|Adverse Event|0|||
25072841|NCT01374087|50179242|FG000|Overall Study|Disease progression|2|||
25072842|NCT01374087|50179243|FG001|Overall Study|Disease progression|2|||
25072843|NCT01374087|50179242|FG000|Overall Study|Study discontinued|13|||
25072844|NCT01374087|50179243|FG001|Overall Study|Study discontinued|13|||
25072845|NCT00152971|50179252|FG000|Overall Study|Adverse Event|12|||
25072846|NCT00152971|50179253|FG001|Overall Study|Adverse Event|10|||
25072847|NCT00152971|50179254|FG002|Overall Study|Adverse Event|9|||
25072848|NCT00152971|50179252|FG000|Overall Study|Protocol Violation|10|||
25072849|NCT00152971|50179253|FG001|Overall Study|Protocol Violation|11|||
25072850|NCT00152971|50179254|FG002|Overall Study|Protocol Violation|8|||
25072851|NCT00152971|50179252|FG000|Overall Study|Lost to Follow-up|17|||
25072852|NCT00152971|50179253|FG001|Overall Study|Lost to Follow-up|14|||
25072853|NCT00152971|50179254|FG002|Overall Study|Lost to Follow-up|13|||
25072854|NCT00152971|50179252|FG000|Overall Study|Withdrawal by Subject|9|||
25072855|NCT00152971|50179253|FG001|Overall Study|Withdrawal by Subject|8|||
24972972|NCT00112437|50062134|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
24972973|NCT00112437|50062135|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972974|NCT00112437|50062136|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972975|NCT00112437|50062137|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972976|NCT00112437|50062138|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972977|NCT00112437|50062139|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972978|NCT00112437|50062140|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972979|NCT00112437|50062141|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972980|NCT00112437|50062142|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
25314626|NCT00651157|50630463|FG000|Overall Study|Protocol Violation|1|||
25314627|NCT00843843|50630469|FG000|Overall Study|Physician Decision|1|||
25314628|NCT00843843|50630470|FG001|Overall Study|Physician Decision|1|||
25314629|NCT00843843|50630469|FG000|Overall Study|Protocol Violation|1|||
25314630|NCT00843843|50630470|FG001|Overall Study|Protocol Violation|1|||
25314631|NCT00650845|50630478|FG000|Overall Study|Withdrawal by Subject|5|||
25314632|NCT00650845|50630479|FG001|Overall Study|Withdrawal by Subject|0|||
25314633|NCT00650845|50630478|FG000|Overall Study|Protocol Violation|0|||
25314634|NCT00650845|50630479|FG001|Overall Study|Protocol Violation|13|||
25314635|NCT00842985|50630486|FG000|Screening|Did not meet entrance requirements|27|||
25314636|NCT00842985|50630486|FG000|First Intervention|Withdrawal by Subject|3|||
25314637|NCT00842985|50630486|FG000|First Intervention|Protocol Violation|3|||
25314638|NCT00842985|50630486|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
24972981|NCT00112437|50062143|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972982|NCT00112437|50062144|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972983|NCT00112437|50062145|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972984|NCT00112437|50062146|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972985|NCT00112437|50062147|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972986|NCT00112437|50062148|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972987|NCT00112437|50062149|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972988|NCT00112437|50062150|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972989|NCT00112437|50062151|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972990|NCT00112437|50062152|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972991|NCT00112437|50062153|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972992|NCT00112437|50062154|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972993|NCT00112437|50062155|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972994|NCT00112437|50062156|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
24972995|NCT00112437|50062131|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24972996|NCT00112437|50062132|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24972997|NCT00112437|50062133|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24972998|NCT00112437|50062134|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24972999|NCT00112437|50062135|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
24973000|NCT00112437|50062136|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973001|NCT00112437|50062137|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973002|NCT00112437|50062138|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973003|NCT00112437|50062139|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973004|NCT00112437|50062140|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973005|NCT00112437|50062141|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973006|NCT00112437|50062142|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
25072856|NCT00152971|50179254|FG002|Overall Study|Withdrawal by Subject|14|||
25072857|NCT00152971|50179252|FG000|Overall Study|Other|3|||
25072858|NCT00152971|50179253|FG001|Overall Study|Other|5|||
25072859|NCT00152971|50179254|FG002|Overall Study|Other|5|||
25072860|NCT00152971|50179252|FG000|Treatment|Adverse Event|49|||
25072861|NCT00152971|50179253|FG001|Treatment|Adverse Event|40|||
25072862|NCT00152971|50179254|FG002|Treatment|Adverse Event|54|||
25072863|NCT00152971|50179252|FG000|Treatment|Protocol Violation|8|||
25072864|NCT00152971|50179253|FG001|Treatment|Protocol Violation|6|||
25072865|NCT00152971|50179254|FG002|Treatment|Protocol Violation|10|||
25072866|NCT00152971|50179252|FG000|Treatment|Lost to Follow-up|1|||
25072867|NCT00152971|50179253|FG001|Treatment|Lost to Follow-up|2|||
25072868|NCT00152971|50179254|FG002|Treatment|Lost to Follow-up|1|||
25072869|NCT00152971|50179252|FG000|Treatment|Withdrawal by Subject|4|||
25072870|NCT00152971|50179253|FG001|Treatment|Withdrawal by Subject|4|||
25072871|NCT00152971|50179254|FG002|Treatment|Withdrawal by Subject|5|||
25072872|NCT00152971|50179252|FG000|Treatment|Other|9|||
25072873|NCT00152971|50179253|FG001|Treatment|Other|11|||
25072874|NCT00152971|50179254|FG002|Treatment|Other|10|||
25072875|NCT02538614|50179262|FG000|Overall Study|Progressive Disease|2|||
25072876|NCT04620135|50179270|FG000|Study Completion|Adverse Event|2|||
25192395|NCT01435928|50358245|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
24973007|NCT00112437|50062143|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973008|NCT00112437|50062144|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973009|NCT00112437|50062145|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973010|NCT00112437|50062146|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973011|NCT00112437|50062147|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973012|NCT00112437|50062148|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973013|NCT00112437|50062149|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973014|NCT00112437|50062150|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973015|NCT00112437|50062151|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973016|NCT00112437|50062152|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973017|NCT00112437|50062153|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973018|NCT00112437|50062154|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973019|NCT00112437|50062155|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
24973020|NCT00112437|50062156|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
25072877|NCT04620135|50179271|FG001|Study Completion|Adverse Event|3|||
25072878|NCT04620135|50179270|FG000|Study Completion|Withdrawal by Subject|2|||
25072879|NCT04620135|50179271|FG001|Study Completion|Withdrawal by Subject|0|||
25072880|NCT02552966|50179277|FG000|Overall Study|Lost to Follow-up|2|||
25072881|NCT02552966|50179277|FG000|Overall Study|Withdrawal by Subject|3|||
25072882|NCT02552888|50179283|FG000|Overall Study|Lost to Follow-up|1|||
25072883|NCT02552888|50179284|FG001|Overall Study|Lost to Follow-up|1|||
25072884|NCT01373931|50179303|FG000|Lead-in Period|Adverse Event|2|||
25072885|NCT01373931|50179304|FG001|Lead-in Period|Adverse Event|0|||
25072886|NCT01373931|50179303|FG000|Period 1|Adverse Event|2|||
25072887|NCT01373931|50179304|FG001|Period 1|Adverse Event|0|||
25072888|NCT01373931|50179303|FG000|Period 1|Withdrawal by Subject|0|||
25072889|NCT01373931|50179304|FG001|Period 1|Withdrawal by Subject|2|||
25072890|NCT02552732|50179311|FG000|Overall Study|Lost to Follow-up|2|||
25072891|NCT02552732|50179311|FG000|Overall Study|Physician Decision|1|||
25072892|NCT02552732|50179311|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
25072893|NCT02552732|50179311|FG000|Overall Study|Withdrawal by Subject|6|||
25072894|NCT02547038|50179318|FG000|Overall Study|Lost to Follow-up|3|||
25072895|NCT02547038|50179319|FG001|Overall Study|Lost to Follow-up|2|||
25072896|NCT02764697|50179325|FG000|Overall Study|Lack of Efficacy|3|||
25072897|NCT02673489|50179331|FG000|Treatment Period|Lost to Follow-up|3|||
25072898|NCT02673489|50179332|FG001|Treatment Period|Lost to Follow-up|0|||
25072899|NCT02673489|50179331|FG000|Treatment Period|Participant request to discontinue|1|||
25072900|NCT02673489|50179332|FG001|Treatment Period|Participant request to discontinue|1|||
25072901|NCT02673489|50179331|FG000|Treatment Period|Participant moved to another province|1|||
25072902|NCT02673489|50179332|FG001|Treatment Period|Participant moved to another province|0|||
25072903|NCT02673489|50179331|FG000|Treatment Period|Participant was incarcerated|0|||
25072904|NCT02673489|50179332|FG001|Treatment Period|Participant was incarcerated|1|||
25072905|NCT02673489|50179331|FG000|Treatment Period|Adverse Event|0|||
25072906|NCT02673489|50179332|FG001|Treatment Period|Adverse Event|1|||
24973021|NCT00112437|50062131|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
24973022|NCT00112437|50062132|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
24973023|NCT00112437|50062133|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
24973024|NCT00112437|50062134|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
24973025|NCT00112437|50062135|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
24973026|NCT00112437|50062136|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
24973027|NCT00112437|50062137|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
24973028|NCT00112437|50062138|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
24973029|NCT00112437|50062139|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
24973030|NCT00112437|50062140|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
24973031|NCT00112437|50062141|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
24973032|NCT00112437|50062142|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
25072907|NCT02673489|50179331|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
25072908|NCT02673489|50179332|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
25072909|NCT02673489|50179331|FG000|Follow Up Period|Unable to return for follow-up|0|||
25072910|NCT02673489|50179332|FG001|Follow Up Period|Unable to return for follow-up|1|||
25072911|NCT02772809|50179339|FG000|Overall Study|not completed some tasks|6|||
25072912|NCT02537678|50179350|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
25072913|NCT02537678|50179351|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
25072914|NCT02537678|50179350|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
25072915|NCT02537678|50179351|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
25072916|NCT02537678|50179350|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
25072917|NCT02537678|50179351|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
25072918|NCT02537678|50179350|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
25072919|NCT02537678|50179351|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
25072920|NCT02537678|50179350|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
25072921|NCT02537678|50179351|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
25072922|NCT02537678|50179350|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
25072923|NCT02537678|50179351|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
25072924|NCT02537678|50179350|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
25072925|NCT02537678|50179351|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
24973033|NCT00112437|50062143|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
24973034|NCT00112437|50062144|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
24973035|NCT00112437|50062145|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
25072926|NCT02766023|50179363|FG000|Overall Study|Lost to Follow-up|23|||
25072927|NCT02766023|50179364|FG001|Overall Study|Lost to Follow-up|11|||
25072928|NCT02766023|50179363|FG000|Overall Study|Pregnancy|1|||
24973036|NCT00112437|50062146|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
24973037|NCT00112437|50062147|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
24973038|NCT00112437|50062148|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
24973039|NCT00112437|50062149|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
24973040|NCT00112437|50062150|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
24973041|NCT00112437|50062151|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
24973042|NCT00112437|50062152|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
24973043|NCT00112437|50062153|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
24973044|NCT00112437|50062154|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
25072929|NCT02766023|50179364|FG001|Overall Study|Pregnancy|0|||
25072930|NCT02766023|50179363|FG000|Overall Study|Adverse Event|1|||
25072931|NCT02766023|50179364|FG001|Overall Study|Adverse Event|0|||
25072932|NCT02766023|50179363|FG000|Overall Study|Withdrawal by Subject|4|||
25072933|NCT02766023|50179364|FG001|Overall Study|Withdrawal by Subject|5|||
25072934|NCT02766023|50179363|FG000|Overall Study|Physician Decision|1|||
25072935|NCT02766023|50179364|FG001|Overall Study|Physician Decision|0|||
25072936|NCT02766023|50179363|FG000|Overall Study|Not Eligible at Enrollment|0|||
25072937|NCT02766023|50179364|FG001|Overall Study|Not Eligible at Enrollment|1|||
25072938|NCT02764229|50179370|FG000|Overall Study|Withdrawal by Subject|15|||
25072939|NCT02764229|50179370|FG000|Overall Study|Adverse Event|9|||
24973045|NCT00112437|50062155|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
24973046|NCT00112437|50062156|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
24973047|NCT00112437|50062131|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973048|NCT00112437|50062132|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973049|NCT00112437|50062133|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973050|NCT00112437|50062134|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973051|NCT00112437|50062135|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973052|NCT00112437|50062136|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
24973053|NCT00112437|50062137|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
24973054|NCT00112437|50062138|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973055|NCT00112437|50062139|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973056|NCT00112437|50062140|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
24973057|NCT00112437|50062141|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973058|NCT00112437|50062142|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973059|NCT00112437|50062143|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973060|NCT00112437|50062144|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973061|NCT00112437|50062145|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973062|NCT00112437|50062146|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973063|NCT00112437|50062147|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973064|NCT00112437|50062148|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973065|NCT00112437|50062149|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973066|NCT00112437|50062150|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973067|NCT00112437|50062151|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973068|NCT00112437|50062152|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973069|NCT00112437|50062153|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973070|NCT00112437|50062154|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973071|NCT00112437|50062155|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973072|NCT00112437|50062156|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
24973073|NCT00112437|50062131|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973074|NCT00112437|50062132|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973075|NCT00112437|50062133|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973076|NCT00112437|50062134|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973077|NCT00112437|50062135|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973078|NCT00112437|50062136|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973079|NCT00112437|50062137|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973080|NCT00112437|50062138|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973081|NCT00112437|50062139|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
24973082|NCT00112437|50062140|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973083|NCT00112437|50062141|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973084|NCT00112437|50062142|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973085|NCT00112437|50062143|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973086|NCT00112437|50062144|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973087|NCT00112437|50062145|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973088|NCT00112437|50062146|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973089|NCT00112437|50062147|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
25072940|NCT02764229|50179370|FG000|Overall Study|Physician Decision|5|||
25072941|NCT02764229|50179370|FG000|Overall Study|Lost to Follow-up|3|||
25072942|NCT02764229|50179370|FG000|Overall Study|Lack of Efficacy|1|||
25072943|NCT02764229|50179370|FG000|Overall Study|Study Stopped by Sponsor|69|||
25072944|NCT02537522|50179374|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
25072945|NCT02537522|50179375|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
25072946|NCT02537522|50179376|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
25072947|NCT02537522|50179377|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
25072948|NCT02537522|50179374|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
25072949|NCT02537522|50179375|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
25072950|NCT02537522|50179376|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
25072951|NCT02537522|50179377|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
25072952|NCT02537522|50179374|FG000|Phase I - Contralateral|incorrect randomization|0|||
25072953|NCT02537522|50179375|FG001|Phase I - Contralateral|incorrect randomization|1|||
25072954|NCT02537522|50179376|FG002|Phase I - Contralateral|incorrect randomization|0|||
25072955|NCT02537522|50179377|FG003|Phase I - Contralateral|incorrect randomization|0|||
25072956|NCT02537522|50179374|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
25072957|NCT02537522|50179375|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
25072958|NCT02537522|50179376|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
25072959|NCT02537522|50179377|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
25072960|NCT02537522|50179374|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
25072961|NCT02537522|50179375|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
25072962|NCT02537522|50179376|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
25072963|NCT02537522|50179377|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
25072964|NCT02536976|50179385|FG000|Overall Study|Physician Decision|0|||
25072965|NCT02536976|50179386|FG001|Overall Study|Physician Decision|1|||
25072966|NCT02672553|50179396|FG000|Overall Study|Death|3|||
25072967|NCT02672553|50179397|FG001|Overall Study|Death|5|||
25072968|NCT02672553|50179396|FG000|Overall Study|Valve Explant|1|||
25072969|NCT02672553|50179397|FG001|Overall Study|Valve Explant|0|||
25072970|NCT02672553|50179396|FG000|Overall Study|Conversion to Commercial Valve|3|||
25072971|NCT02672553|50179397|FG001|Overall Study|Conversion to Commercial Valve|0|||
25072972|NCT02672553|50179396|FG000|Overall Study|Withdrawal by Subject|3|||
25072973|NCT02672553|50179397|FG001|Overall Study|Withdrawal by Subject|3|||
25072974|NCT02672553|50179396|FG000|Overall Study|Intraoperative screen failure|2|||
25072975|NCT02672553|50179397|FG001|Overall Study|Intraoperative screen failure|0|||
25072976|NCT01373229|50179404|FG000|Overall Study|Death|3|||
25072977|NCT01373229|50179404|FG000|Overall Study|Physician Decision|3|||
25072978|NCT02671461|50179411|FG000|Treatment|Adverse Event|0|||
25072979|NCT02671461|50179412|FG001|Treatment|Adverse Event|0|||
25072980|NCT02671461|50179413|FG002|Treatment|Adverse Event|1|||
25072981|NCT02671461|50179411|FG000|Treatment|Administrative Reason by Sponsor|1|||
25072982|NCT02671461|50179412|FG001|Treatment|Administrative Reason by Sponsor|3|||
25072983|NCT02671461|50179413|FG002|Treatment|Administrative Reason by Sponsor|4|||
25072984|NCT02671461|50179411|FG000|Treatment|Randomized, not treated|1|||
25072985|NCT02671461|50179412|FG001|Treatment|Randomized, not treated|0|||
25072986|NCT02671461|50179413|FG002|Treatment|Randomized, not treated|0|||
25072987|NCT02671461|50179411|FG000|Follow-up|Withdrawal by Subject|1|||
25072988|NCT02671461|50179412|FG001|Follow-up|Withdrawal by Subject|0|||
25072989|NCT02671461|50179413|FG002|Follow-up|Withdrawal by Subject|0|||
25072990|NCT02671461|50179411|FG000|Follow-up|Lost to Follow-up|0|||
25072991|NCT02671461|50179412|FG001|Follow-up|Lost to Follow-up|0|||
25072992|NCT02671461|50179413|FG002|Follow-up|Lost to Follow-up|1|||
25072993|NCT02671461|50179411|FG000|Follow-up|Administrative Reason by Sponsor|0|||
25072994|NCT02671461|50179412|FG001|Follow-up|Administrative Reason by Sponsor|1|||
24973090|NCT00112437|50062148|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
25072995|NCT02671461|50179413|FG002|Follow-up|Administrative Reason by Sponsor|0|||
25072996|NCT02535416|50179430|FG000|Overall Study|Family bereavement overseas|1|||
25072997|NCT02535416|50179431|FG001|Overall Study|Family bereavement overseas|0|||
25072998|NCT02535416|50179432|FG002|Overall Study|Family bereavement overseas|0|||
25072999|NCT02535416|50179433|FG003|Overall Study|Family bereavement overseas|0|||
25073000|NCT02535416|50179434|FG004|Overall Study|Family bereavement overseas|0|||
24973091|NCT00112437|50062149|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973092|NCT00112437|50062150|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973093|NCT00112437|50062151|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973094|NCT00112437|50062152|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973095|NCT00112437|50062153|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973096|NCT00112437|50062154|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973097|NCT00112437|50062155|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973098|NCT00112437|50062156|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
24973099|NCT00112437|50062131|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973100|NCT00112437|50062132|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973101|NCT00112437|50062133|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973102|NCT00112437|50062134|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
25073001|NCT02535416|50179435|FG005|Overall Study|Family bereavement overseas|0|||
24973103|NCT00112437|50062135|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973104|NCT00112437|50062136|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973105|NCT00112437|50062137|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973106|NCT00112437|50062138|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973107|NCT00112437|50062139|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
24973108|NCT00112437|50062140|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
25073002|NCT02535416|50179436|FG006|Overall Study|Family bereavement overseas|0|||
25073003|NCT02535416|50179437|FG007|Overall Study|Family bereavement overseas|0|||
25073004|NCT02535416|50179438|FG008|Overall Study|Family bereavement overseas|0|||
25073005|NCT02670915|50179488|FG000|Overall Study|Withdrawal by Subject|0|||
25073006|NCT02670915|50179489|FG001|Overall Study|Withdrawal by Subject|1|||
25073007|NCT02670915|50179490|FG002|Overall Study|Withdrawal by Subject|4|||
25192396|NCT01435928|50358246|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
24973109|NCT00112437|50062141|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
25192397|NCT01435928|50358244|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
24973110|NCT00112437|50062142|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973111|NCT00112437|50062143|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973112|NCT00112437|50062144|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973113|NCT00112437|50062145|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973114|NCT00112437|50062146|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973115|NCT00112437|50062147|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973116|NCT00112437|50062148|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973117|NCT00112437|50062149|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973118|NCT00112437|50062150|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973119|NCT00112437|50062151|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
25169884|NCT01799993|50303418|FG000|Overall Study|Protocol deviation|1|||
24973120|NCT00112437|50062152|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973121|NCT00112437|50062153|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973122|NCT00112437|50062154|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973123|NCT00112437|50062155|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
25073008|NCT02670915|50179488|FG000|Overall Study|Withdrawal by parent/guardian|4|||
25073009|NCT02670915|50179489|FG001|Overall Study|Withdrawal by parent/guardian|4|||
25073010|NCT02670915|50179490|FG002|Overall Study|Withdrawal by parent/guardian|1|||
25073011|NCT02670915|50179488|FG000|Overall Study|Unclassified|0|||
25073012|NCT02670915|50179489|FG001|Overall Study|Unclassified|3|||
25073013|NCT02670915|50179490|FG002|Overall Study|Unclassified|0|||
25073014|NCT02545868|50179501|FG000|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33|||
24973124|NCT00112437|50062156|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
24973125|NCT00112437|50062131|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973126|NCT00112437|50062132|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973127|NCT00112437|50062133|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973128|NCT00112437|50062134|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973129|NCT00112437|50062135|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973130|NCT00112437|50062136|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
24973131|NCT00112437|50062137|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
24973132|NCT00112437|50062138|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
24973133|NCT00112437|50062139|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
24973134|NCT00112437|50062140|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
24973135|NCT00112437|50062141|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973136|NCT00112437|50062142|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973137|NCT00112437|50062143|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973138|NCT00112437|50062144|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973139|NCT00112437|50062145|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973140|NCT00112437|50062146|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
25073015|NCT02545868|50179502|FG001|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35|||
25073016|NCT02545868|50179503|FG002|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34|||
25073017|NCT02764151|50179520|FG000|Overall Study|Subject refused further follow-up|0|||
25073018|NCT02764151|50179521|FG001|Overall Study|Subject refused further follow-up|0|||
25073019|NCT02764151|50179522|FG002|Overall Study|Subject refused further follow-up|0|||
25073020|NCT02764151|50179523|FG003|Overall Study|Subject refused further follow-up|1|||
25073021|NCT02764151|50179520|FG000|Overall Study|Other|0|||
25073022|NCT02764151|50179521|FG001|Overall Study|Other|0|||
25073023|NCT02764151|50179522|FG002|Overall Study|Other|0|||
25073024|NCT02764151|50179523|FG003|Overall Study|Other|2|||
25073025|NCT02545322|50179533|FG000|Overall Study|Withdrawal by Subject|3|||
25073026|NCT02763215|50179537|FG000|Overall Study|Participants withdrew from study|3|||
25073027|NCT02763215|50179537|FG000|Overall Study|Missed visit|1|||
25073028|NCT02763215|50179537|FG000|Overall Study|Visit outside visit-window|1|||
25192398|NCT01435928|50358245|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
25073029|NCT02763215|50179537|FG000|Overall Study|Death|1|||
25073030|NCT02763215|50179537|FG000|Overall Study|Lost to Follow-up|1|||
25073031|NCT02770547|50179556|FG000|Overall Study|Patient non-compliant|1|||
25073032|NCT02770547|50179557|FG001|Overall Study|Patient non-compliant|0|||
25073033|NCT02770547|50179556|FG000|Overall Study|Adverse Event|0|||
24973141|NCT00112437|50062147|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973142|NCT00112437|50062148|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973143|NCT00112437|50062149|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973144|NCT00112437|50062150|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973145|NCT00112437|50062151|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973146|NCT00112437|50062152|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973147|NCT00112437|50062153|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973148|NCT00112437|50062154|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973149|NCT00112437|50062155|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973150|NCT00112437|50062156|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
24973151|NCT00112437|50062131|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973152|NCT00112437|50062132|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973153|NCT00112437|50062133|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973154|NCT00112437|50062134|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973155|NCT00112437|50062135|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973156|NCT00112437|50062136|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973157|NCT00112437|50062137|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973158|NCT00112437|50062138|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973159|NCT00112437|50062139|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973160|NCT00112437|50062140|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
24973161|NCT00112437|50062141|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973162|NCT00112437|50062142|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973163|NCT00112437|50062143|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973164|NCT00112437|50062144|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973165|NCT00112437|50062145|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973166|NCT00112437|50062146|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973167|NCT00112437|50062147|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973168|NCT00112437|50062148|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973169|NCT00112437|50062149|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973170|NCT00112437|50062150|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973171|NCT00112437|50062151|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973172|NCT00112437|50062152|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973173|NCT00112437|50062153|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973174|NCT00112437|50062154|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973175|NCT00112437|50062155|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973176|NCT00112437|50062156|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
24973177|NCT00112437|50062131|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973178|NCT00112437|50062132|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973179|NCT00112437|50062133|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973180|NCT00112437|50062134|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973181|NCT00112437|50062135|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973182|NCT00112437|50062136|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973183|NCT00112437|50062137|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
25169885|NCT01799993|50303419|FG001|Overall Study|Protocol deviation|0|||
25169886|NCT01799993|50303418|FG000|Overall Study|Non-compliance with medical device|1|||
25169887|NCT01799993|50303419|FG001|Overall Study|Non-compliance with medical device|0|||
25169888|NCT01799993|50303418|FG000|Overall Study|Withdrawal by parent/guardian|0|||
25169889|NCT01799993|50303419|FG001|Overall Study|Withdrawal by parent/guardian|1|||
25169890|NCT01799993|50303418|FG000|Overall Study|Other|1|||
25169891|NCT01799993|50303419|FG001|Overall Study|Other|0|||
25169892|NCT01799993|50303418|FG000|Overall Study|Subject didn't return for follow-up|0|||
25169893|NCT01799993|50303419|FG001|Overall Study|Subject didn't return for follow-up|1|||
25169894|NCT01822223|50303436|FG000|Overall Study|Death|0|||
25169895|NCT01822223|50303437|FG001|Overall Study|Death|1|||
25169896|NCT02228382|50303523|FG000|Overall Study|Death|5|||
25169897|NCT02228382|50303524|FG001|Overall Study|Death|7|||
25169898|NCT02228382|50303525|FG002|Overall Study|Death|5|||
25169899|NCT02228382|50303526|FG003|Overall Study|Death|0|||
25169900|NCT02228382|50303527|FG004|Overall Study|Death|2|||
25073034|NCT02770547|50179557|FG001|Overall Study|Adverse Event|1|||
25073035|NCT01661972|50179565|FG000|Overall Study|Adverse Event|1|||
25073036|NCT01661972|50179566|FG001|Overall Study|Adverse Event|2|||
25073037|NCT01661972|50179565|FG000|Overall Study|Death during Treatment period|1|||
25073038|NCT01661972|50179566|FG001|Overall Study|Death during Treatment period|1|||
25073039|NCT01661972|50179565|FG000|Overall Study|Withdrawal by Subject|0|||
25073040|NCT01661972|50179566|FG001|Overall Study|Withdrawal by Subject|1|||
25073041|NCT00888355|50179578|FG000|Overall Study|Adverse Event|10|||
25073042|NCT00888355|50179579|FG001|Overall Study|Adverse Event|0|||
25073043|NCT00888355|50179580|FG002|Overall Study|Adverse Event|3|||
25073044|NCT00888355|50179581|FG003|Overall Study|Adverse Event|3|||
25073045|NCT00888355|50179578|FG000|Overall Study|Lack of Efficacy|9|||
25073046|NCT00888355|50179579|FG001|Overall Study|Lack of Efficacy|2|||
25073047|NCT00888355|50179580|FG002|Overall Study|Lack of Efficacy|5|||
25073048|NCT00888355|50179581|FG003|Overall Study|Lack of Efficacy|2|||
24973184|NCT00112437|50062138|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973185|NCT00112437|50062139|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973186|NCT00112437|50062140|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
24973187|NCT00112437|50062141|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973188|NCT00112437|50062142|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973189|NCT00112437|50062143|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973190|NCT00112437|50062144|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973191|NCT00112437|50062145|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973192|NCT00112437|50062146|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973193|NCT00112437|50062147|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973194|NCT00112437|50062148|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973195|NCT00112437|50062149|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
25073049|NCT00888355|50179578|FG000|Overall Study|Lost to Follow-up|0|||
25073050|NCT00888355|50179579|FG001|Overall Study|Lost to Follow-up|2|||
25169901|NCT02228382|50303523|FG000|Overall Study|Participant refused further follow-up|0|||
24973196|NCT00112437|50062150|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973197|NCT00112437|50062151|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973198|NCT00112437|50062152|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973199|NCT00112437|50062153|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973200|NCT00112437|50062154|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973201|NCT00112437|50062155|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973202|NCT00112437|50062156|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
24973203|NCT00112437|50062131|FG000|Year 2 (12-Month Extension)|Moved|0|||
24973204|NCT00112437|50062132|FG001|Year 2 (12-Month Extension)|Moved|0|||
24973205|NCT00112437|50062133|FG002|Year 2 (12-Month Extension)|Moved|0|||
24973206|NCT00112437|50062134|FG003|Year 2 (12-Month Extension)|Moved|0|||
24973207|NCT00112437|50062135|FG004|Year 2 (12-Month Extension)|Moved|0|||
24973208|NCT00112437|50062136|FG005|Year 2 (12-Month Extension)|Moved|0|||
24973209|NCT00112437|50062137|FG006|Year 2 (12-Month Extension)|Moved|0|||
24973210|NCT00112437|50062138|FG007|Year 2 (12-Month Extension)|Moved|0|||
24973211|NCT00112437|50062139|FG008|Year 2 (12-Month Extension)|Moved|0|||
24973212|NCT00112437|50062140|FG009|Year 2 (12-Month Extension)|Moved|1|||
24973213|NCT00112437|50062141|FG010|Year 2 (12-Month Extension)|Moved|0|||
24973214|NCT00112437|50062142|FG011|Year 2 (12-Month Extension)|Moved|0|||
24973215|NCT00112437|50062143|FG012|Year 2 (12-Month Extension)|Moved|0|||
24973216|NCT00112437|50062144|FG013|Year 2 (12-Month Extension)|Moved|0|||
24973217|NCT00112437|50062145|FG014|Year 2 (12-Month Extension)|Moved|0|||
24973218|NCT00112437|50062146|FG015|Year 2 (12-Month Extension)|Moved|0|||
24973219|NCT00112437|50062147|FG016|Year 2 (12-Month Extension)|Moved|0|||
24973220|NCT00112437|50062148|FG017|Year 2 (12-Month Extension)|Moved|0|||
24973221|NCT00112437|50062149|FG018|Year 2 (12-Month Extension)|Moved|0|||
25169902|NCT02228382|50303524|FG001|Overall Study|Participant refused further follow-up|0|||
25169903|NCT02228382|50303525|FG002|Overall Study|Participant refused further follow-up|1|||
25073051|NCT00888355|50179580|FG002|Overall Study|Lost to Follow-up|2|||
25073052|NCT00888355|50179581|FG003|Overall Study|Lost to Follow-up|0|||
25073053|NCT00888355|50179578|FG000|Overall Study|Protocol Violation|3|||
25169904|NCT02228382|50303526|FG003|Overall Study|Participant refused further follow-up|0|||
25169905|NCT02228382|50303527|FG004|Overall Study|Participant refused further follow-up|0|||
25169906|NCT02228382|50303523|FG000|Overall Study|Study terminated by sponsor|3|||
25169907|NCT02228382|50303524|FG001|Overall Study|Study terminated by sponsor|5|||
25169908|NCT02228382|50303525|FG002|Overall Study|Study terminated by sponsor|7|||
25169909|NCT02228382|50303526|FG003|Overall Study|Study terminated by sponsor|0|||
25169910|NCT02228382|50303527|FG004|Overall Study|Study terminated by sponsor|0|||
25169911|NCT02228382|50303523|FG000|Overall Study|Lost to Follow-up|0|||
25169912|NCT02228382|50303524|FG001|Overall Study|Lost to Follow-up|0|||
25169913|NCT02228382|50303525|FG002|Overall Study|Lost to Follow-up|3|||
25169914|NCT02228382|50303526|FG003|Overall Study|Lost to Follow-up|1|||
25169915|NCT02228382|50303527|FG004|Overall Study|Lost to Follow-up|0|||
25169916|NCT02228382|50303523|FG000|Overall Study|Withdrawal by Subject|0|||
25169917|NCT02228382|50303524|FG001|Overall Study|Withdrawal by Subject|3|||
25169918|NCT02228382|50303525|FG002|Overall Study|Withdrawal by Subject|2|||
25169919|NCT02228382|50303526|FG003|Overall Study|Withdrawal by Subject|1|||
25169920|NCT02228382|50303527|FG004|Overall Study|Withdrawal by Subject|0|||
25169921|NCT02228382|50303523|FG000|Overall Study|Other|2|||
25192399|NCT01435928|50358246|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
25192400|NCT01435928|50358244|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
25192401|NCT01435928|50358245|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
24973222|NCT00112437|50062150|FG019|Year 2 (12-Month Extension)|Moved|0|||
24973223|NCT00112437|50062151|FG020|Year 2 (12-Month Extension)|Moved|0|||
24973224|NCT00112437|50062152|FG021|Year 2 (12-Month Extension)|Moved|0|||
24973225|NCT00112437|50062153|FG022|Year 2 (12-Month Extension)|Moved|0|||
24973226|NCT00112437|50062154|FG023|Year 2 (12-Month Extension)|Moved|0|||
24973227|NCT00112437|50062155|FG024|Year 2 (12-Month Extension)|Moved|0|||
24973228|NCT00112437|50062156|FG025|Year 2 (12-Month Extension)|Moved|0|||
24973229|NCT00112437|50062131|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
24973230|NCT00112437|50062132|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
24973231|NCT00112437|50062133|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
24973232|NCT00112437|50062134|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
24973233|NCT00112437|50062135|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
25192402|NCT01435928|50358246|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
25192403|NCT01435928|50358244|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
25192404|NCT01435928|50358245|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
25192405|NCT01435928|50358246|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
25192406|NCT01435928|50358244|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
25192407|NCT01435928|50358245|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
25192408|NCT01435928|50358246|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
25192409|NCT01435928|50358244|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
25192410|NCT01435928|50358245|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
25192411|NCT01435928|50358246|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
25192412|NCT01435928|50358244|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
25192413|NCT01435928|50358245|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
25192414|NCT01435928|50358246|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
25192415|NCT01435928|50358244|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
25192416|NCT01435928|50358245|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
25192417|NCT01435928|50358246|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
25192418|NCT01435928|50358244|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
25192419|NCT01435928|50358245|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
25192420|NCT01435928|50358246|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
24973234|NCT00112437|50062136|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
25169922|NCT02228382|50303524|FG001|Overall Study|Other|3|||
25169923|NCT02228382|50303525|FG002|Overall Study|Other|3|||
25169924|NCT02228382|50303526|FG003|Overall Study|Other|0|||
25169925|NCT02228382|50303527|FG004|Overall Study|Other|0|||
24973235|NCT00112437|50062137|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
24973236|NCT00112437|50062138|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
24973237|NCT00112437|50062139|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
24973238|NCT00112437|50062140|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
24973239|NCT00112437|50062141|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
24973240|NCT00112437|50062142|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
24973241|NCT00112437|50062143|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
24973242|NCT00112437|50062144|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
24973243|NCT00112437|50062145|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
24973244|NCT00112437|50062146|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
24973245|NCT00112437|50062147|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
24973246|NCT00112437|50062148|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
24973247|NCT00112437|50062149|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
24973248|NCT00112437|50062150|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
24973249|NCT00112437|50062151|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
24973250|NCT00112437|50062152|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
25073054|NCT00888355|50179579|FG001|Overall Study|Protocol Violation|2|||
25073055|NCT00888355|50179580|FG002|Overall Study|Protocol Violation|1|||
25073056|NCT00888355|50179581|FG003|Overall Study|Protocol Violation|2|||
25073057|NCT00888355|50179578|FG000|Overall Study|Withdrawal by Subject|0|||
25073058|NCT00888355|50179579|FG001|Overall Study|Withdrawal by Subject|3|||
25073059|NCT00888355|50179580|FG002|Overall Study|Withdrawal by Subject|1|||
25073060|NCT00888355|50179581|FG003|Overall Study|Withdrawal by Subject|3|||
25073061|NCT00794677|50179589|FG000|First Intervention|Withdrawal by Subject|2|||
25073062|NCT00794677|50179590|FG001|First Intervention|Withdrawal by Subject|0|||
25073063|NCT02770391|50179594|FG000|Overall Study|Lost to Follow-up|2|||
25073064|NCT02770391|50179594|FG000|Overall Study|Withdrawal by Subject|1|||
25073065|NCT02770391|50179594|FG000|Overall Study|Surgery delayed unevaluable|2|||
25073066|NCT02770391|50179594|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
25073067|NCT02536508|50179601|FG000|Overall Study|Withdrawal by Subject|18|||
25073068|NCT02536508|50179602|FG001|Overall Study|Withdrawal by Subject|13|||
25073069|NCT02536508|50179603|FG002|Overall Study|Withdrawal by Subject|7|||
25073070|NCT02536508|50179601|FG000|Overall Study|Adverse Event|14|||
25073071|NCT02536508|50179602|FG001|Overall Study|Adverse Event|13|||
25073072|NCT02536508|50179603|FG002|Overall Study|Adverse Event|6|||
25073073|NCT02536508|50179601|FG000|Overall Study|Lost to Follow-up|12|||
25073074|NCT02536508|50179602|FG001|Overall Study|Lost to Follow-up|4|||
25073075|NCT02536508|50179603|FG002|Overall Study|Lost to Follow-up|0|||
25073076|NCT02536508|50179601|FG000|Overall Study|Lack of Efficacy|3|||
25073077|NCT02536508|50179602|FG001|Overall Study|Lack of Efficacy|5|||
25073078|NCT02536508|50179603|FG002|Overall Study|Lack of Efficacy|4|||
25073079|NCT02536508|50179601|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
25073080|NCT02536508|50179602|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
25073081|NCT02536508|50179603|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
25073082|NCT02536508|50179601|FG000|Overall Study|Physician Decision|0|||
25169926|NCT01900002|50303571|FG000|Overall Study|Withdrawal by Subject|2|||
25169927|NCT01900002|50303571|FG000|Overall Study|ineligible for Y-90|4|||
25169928|NCT01377012|50303601|FG000|Core Study|Study terminated by Sponsor|47|||
25169929|NCT01377012|50303602|FG001|Core Study|Study terminated by Sponsor|54|||
25169930|NCT01377012|50303603|FG002|Core Study|Study terminated by Sponsor|46|||
25169931|NCT01377012|50303601|FG000|Core Study|Technical problems|1|||
25169932|NCT01377012|50303602|FG001|Core Study|Technical problems|0|||
25169933|NCT01377012|50303603|FG002|Core Study|Technical problems|0|||
24973251|NCT00112437|50062153|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
25073083|NCT02536508|50179602|FG001|Overall Study|Physician Decision|4|||
24973252|NCT00112437|50062154|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
24973253|NCT00112437|50062155|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
24973254|NCT00112437|50062156|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
24973255|NCT00112437|50062131|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973256|NCT00112437|50062132|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973257|NCT00112437|50062133|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973258|NCT00112437|50062134|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973259|NCT00112437|50062135|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973260|NCT00112437|50062136|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973261|NCT00112437|50062137|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973262|NCT00112437|50062138|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973263|NCT00112437|50062139|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973264|NCT00112437|50062140|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973265|NCT00112437|50062141|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973266|NCT00112437|50062142|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
24973267|NCT00112437|50062143|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973268|NCT00112437|50062144|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
24973269|NCT00112437|50062145|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973270|NCT00112437|50062146|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
24973271|NCT00112437|50062147|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973272|NCT00112437|50062148|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973273|NCT00112437|50062149|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
24973274|NCT00112437|50062150|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973275|NCT00112437|50062151|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973276|NCT00112437|50062152|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973277|NCT00112437|50062153|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973278|NCT00112437|50062154|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973279|NCT00112437|50062155|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973280|NCT00112437|50062156|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
24973281|NCT00112437|50062131|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973282|NCT00112437|50062132|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973283|NCT00112437|50062133|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973284|NCT00112437|50062134|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973285|NCT00112437|50062135|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973286|NCT00112437|50062136|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973287|NCT00112437|50062137|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973288|NCT00112437|50062138|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973289|NCT00112437|50062139|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973290|NCT00112437|50062140|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973291|NCT00112437|50062141|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973292|NCT00112437|50062142|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973293|NCT00112437|50062143|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973294|NCT00112437|50062144|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973295|NCT00112437|50062145|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973296|NCT00112437|50062146|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
24973297|NCT00112437|50062147|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973298|NCT00112437|50062148|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973299|NCT00112437|50062149|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973300|NCT00112437|50062150|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973301|NCT00112437|50062151|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973302|NCT00112437|50062152|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973303|NCT00112437|50062153|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973304|NCT00112437|50062154|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973305|NCT00112437|50062155|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973306|NCT00112437|50062156|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
24973307|NCT00112437|50062131|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973308|NCT00112437|50062132|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
25192421|NCT01435928|50358244|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
25192422|NCT01435928|50358245|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
25192423|NCT01435928|50358246|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
24973309|NCT00112437|50062133|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973310|NCT00112437|50062134|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973311|NCT00112437|50062135|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973312|NCT00112437|50062136|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973313|NCT00112437|50062137|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973314|NCT00112437|50062138|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973315|NCT00112437|50062139|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973316|NCT00112437|50062140|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973317|NCT00112437|50062141|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973318|NCT00112437|50062142|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973319|NCT00112437|50062143|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973320|NCT00112437|50062144|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973321|NCT00112437|50062145|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973322|NCT00112437|50062146|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
24973323|NCT00112437|50062147|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973324|NCT00112437|50062148|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973325|NCT00112437|50062149|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973326|NCT00112437|50062150|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973327|NCT00112437|50062151|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
25073084|NCT02536508|50179603|FG002|Overall Study|Physician Decision|2|||
24973328|NCT00112437|50062152|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
25073085|NCT02536508|50179601|FG000|Overall Study|Major Protocol Deviation|2|||
25073086|NCT02536508|50179602|FG001|Overall Study|Major Protocol Deviation|2|||
25073087|NCT02536508|50179603|FG002|Overall Study|Major Protocol Deviation|2|||
25073088|NCT02536508|50179601|FG000|Overall Study|Administrative Reasons|0|||
25073089|NCT02536508|50179602|FG001|Overall Study|Administrative Reasons|1|||
25073090|NCT02536508|50179603|FG002|Overall Study|Administrative Reasons|0|||
25073091|NCT00103259|50179620|FG000|Overall Study|Death|3|||
25073092|NCT00103259|50179621|FG001|Overall Study|Death|2|||
25073093|NCT00103259|50179620|FG000|Overall Study|Withdrawal by Subject|2|||
25073094|NCT00103259|50179621|FG001|Overall Study|Withdrawal by Subject|3|||
25073095|NCT00103259|50179620|FG000|Overall Study|alternative therapy|1|||
25073096|NCT00103259|50179621|FG001|Overall Study|alternative therapy|0|||
25073097|NCT00103259|50179620|FG000|Overall Study|other (reasons were not specified)|2|||
25073098|NCT00103259|50179621|FG001|Overall Study|other (reasons were not specified)|1|||
25073099|NCT00103259|50179620|FG000|Overall Study|ineligible/no protocol therapy|4|||
25169934|NCT01377012|50303601|FG000|Core Study|Withdrawal by Subject|15|||
24973329|NCT00112437|50062153|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973330|NCT00112437|50062154|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
25073100|NCT00103259|50179621|FG001|Overall Study|ineligible/no protocol therapy|6|||
25073101|NCT02544152|50179631|FG000|Overall Study|Adverse Event|0|||
25073102|NCT02544152|50179632|FG001|Overall Study|Adverse Event|4|||
25073103|NCT02544152|50179631|FG000|Overall Study|Withdrawal by Subject|0|||
25073104|NCT02544152|50179632|FG001|Overall Study|Withdrawal by Subject|3|||
25073105|NCT02544152|50179631|FG000|Overall Study|Other|1|||
25073106|NCT02544152|50179632|FG001|Overall Study|Other|0|||
25073107|NCT02534324|50179640|FG000|Overall Study|Protocol Violation|4|||
25073108|NCT02534324|50179641|FG001|Overall Study|Protocol Violation|1|||
25073109|NCT02534324|50179640|FG000|Overall Study|Lost to Follow-up|20|||
25073110|NCT02534324|50179641|FG001|Overall Study|Lost to Follow-up|7|||
25073111|NCT02534324|50179640|FG000|Overall Study|Adverse Event|1|||
25073112|NCT02534324|50179641|FG001|Overall Study|Adverse Event|0|||
25073113|NCT02761733|50179651|FG000|Overall Study|Death|3|||
25073114|NCT02761733|50179652|FG001|Overall Study|Death|5|||
25073115|NCT02761733|50179653|FG002|Overall Study|Death|1|||
25073116|NCT02761733|50179654|FG003|Overall Study|Death|1|||
25073117|NCT02761733|50179651|FG000|Overall Study|Lost to Follow-up|6|||
25073118|NCT02761733|50179652|FG001|Overall Study|Lost to Follow-up|7|||
25073119|NCT02761733|50179653|FG002|Overall Study|Lost to Follow-up|0|||
25073120|NCT02761733|50179654|FG003|Overall Study|Lost to Follow-up|3|||
25073121|NCT02761733|50179651|FG000|Overall Study|Physician Decision|4|||
25073122|NCT02761733|50179652|FG001|Overall Study|Physician Decision|0|||
25073123|NCT02761733|50179653|FG002|Overall Study|Physician Decision|0|||
25073124|NCT02761733|50179654|FG003|Overall Study|Physician Decision|0|||
25073125|NCT02761733|50179651|FG000|Overall Study|Withdrawal by Subject|2|||
25073126|NCT02761733|50179652|FG001|Overall Study|Withdrawal by Subject|0|||
25073127|NCT02761733|50179653|FG002|Overall Study|Withdrawal by Subject|0|||
25073128|NCT02761733|50179654|FG003|Overall Study|Withdrawal by Subject|0|||
25073129|NCT02761733|50179651|FG000|Overall Study|Discharged from Study Site|10|||
25073130|NCT02761733|50179652|FG001|Overall Study|Discharged from Study Site|9|||
25073131|NCT02761733|50179653|FG002|Overall Study|Discharged from Study Site|25|||
25073132|NCT02761733|50179654|FG003|Overall Study|Discharged from Study Site|11|||
25073133|NCT02761733|50179651|FG000|Overall Study|Cognitive Impairment|5|||
25073134|NCT02761733|50179652|FG001|Overall Study|Cognitive Impairment|0|||
25073135|NCT02761733|50179653|FG002|Overall Study|Cognitive Impairment|1|||
25073136|NCT02761733|50179654|FG003|Overall Study|Cognitive Impairment|0|||
25073137|NCT03715465|50179666|FG000|Overall Study|Withdrawal by Subject|1|||
25073138|NCT03715465|50179667|FG001|Overall Study|Withdrawal by Subject|2|||
25073139|NCT00840073|50179675|FG000|Second Intervention|Missed 72 hour blood draw|1|||
25073140|NCT00840073|50179676|FG001|Second Intervention|Missed 72 hour blood draw|1|||
25073141|NCT00838279|50179682|FG000|Washout|Protocol Violation|1|||
25073142|NCT00838279|50179683|FG001|Washout|Protocol Violation|0|||
25073143|NCT00838279|50179682|FG000|Washout|Withdrawal by Subject|0|||
25073144|NCT00838279|50179683|FG001|Washout|Withdrawal by Subject|1|||
25073145|NCT02759939|50179691|FG000|Overall Study|Missing data on first outcome assessed|11|||
25073146|NCT02759939|50179692|FG001|Overall Study|Missing data on first outcome assessed|2|||
25073147|NCT02759939|50179693|FG002|Overall Study|Missing data on first outcome assessed|5|||
24973331|NCT00112437|50062155|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973332|NCT00112437|50062156|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
24973333|NCT00112437|50062131|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973334|NCT00112437|50062132|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973335|NCT00112437|50062133|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973336|NCT00112437|50062134|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973337|NCT00112437|50062135|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973338|NCT00112437|50062136|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973339|NCT00112437|50062137|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973340|NCT00112437|50062138|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973341|NCT00112437|50062139|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973342|NCT00112437|50062140|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973343|NCT00112437|50062141|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
25073148|NCT02759939|50179694|FG003|Overall Study|Missing data on first outcome assessed|2|||
25073149|NCT02759939|50179691|FG000|Overall Study|Ineligible for T2 and T3|310|||
25073150|NCT02759939|50179692|FG001|Overall Study|Ineligible for T2 and T3|179|||
25073151|NCT02759939|50179693|FG002|Overall Study|Ineligible for T2 and T3|366|||
25073152|NCT02759939|50179694|FG003|Overall Study|Ineligible for T2 and T3|391|||
24973344|NCT00112437|50062142|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
24973345|NCT00112437|50062143|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973346|NCT00112437|50062144|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
25073153|NCT02759939|50179691|FG000|Overall Study|Lost to Follow-up|735|||
25073154|NCT02759939|50179692|FG001|Overall Study|Lost to Follow-up|791|||
25073155|NCT02759939|50179693|FG002|Overall Study|Lost to Follow-up|783|||
25073156|NCT02759939|50179694|FG003|Overall Study|Lost to Follow-up|650|||
25073157|NCT00835705|50179713|FG000|First Intervention|Difficulty with vein|1|||
25073158|NCT00835705|50179714|FG001|First Intervention|Difficulty with vein|0|||
25073159|NCT00835705|50179713|FG000|Second Intervention|Difficulty with vein|1|||
25073160|NCT00835705|50179714|FG001|Second Intervention|Difficulty with vein|0|||
25073161|NCT02938520|50179720|FG000|Overall Study|On-going at the time of analysis|258|||
25073162|NCT02938520|50179721|FG001|Overall Study|On-going at the time of analysis|261|||
25073163|NCT02938520|50179720|FG000|Overall Study|Physician Decision|2|||
25073164|NCT02938520|50179721|FG001|Overall Study|Physician Decision|5|||
25073165|NCT02938520|50179720|FG000|Overall Study|Lost to Follow-up|2|||
25073166|NCT02938520|50179721|FG001|Overall Study|Lost to Follow-up|2|||
24973347|NCT00112437|50062145|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
24973348|NCT00112437|50062146|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973349|NCT00112437|50062147|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973350|NCT00112437|50062148|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973351|NCT00112437|50062149|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973352|NCT00112437|50062150|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973353|NCT00112437|50062151|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973354|NCT00112437|50062152|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973355|NCT00112437|50062153|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973356|NCT00112437|50062154|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973357|NCT00112437|50062155|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973358|NCT00112437|50062156|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
24973359|NCT00112437|50062131|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973360|NCT00112437|50062132|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973361|NCT00112437|50062133|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973362|NCT00112437|50062134|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973363|NCT00112437|50062135|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973364|NCT00112437|50062136|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973365|NCT00112437|50062137|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973366|NCT00112437|50062138|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973367|NCT00112437|50062139|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973368|NCT00112437|50062140|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973369|NCT00112437|50062141|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
24973370|NCT00112437|50062142|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
24973371|NCT00112437|50062143|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973372|NCT00112437|50062144|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973373|NCT00112437|50062145|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973374|NCT00112437|50062146|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973375|NCT00112437|50062147|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973376|NCT00112437|50062148|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
25073167|NCT02938520|50179720|FG000|Overall Study|Withdrawal by Subject|7|||
25073168|NCT02938520|50179721|FG001|Overall Study|Withdrawal by Subject|7|||
25073169|NCT02938520|50179720|FG000|Overall Study|Protocol Violation|0|||
25073170|NCT02938520|50179721|FG001|Overall Study|Protocol Violation|1|||
25192424|NCT01435928|50358244|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
25192425|NCT01435928|50358245|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
25073171|NCT02938520|50179720|FG000|Overall Study|Lack of Efficacy|5|||
25073172|NCT02938520|50179721|FG001|Overall Study|Lack of Efficacy|3|||
25073173|NCT02938520|50179720|FG000|Overall Study|Adverse Event|9|||
25073174|NCT02938520|50179721|FG001|Overall Study|Adverse Event|4|||
25073175|NCT02759471|50179730|FG000|Overall Study|discomfort|2|||
25073176|NCT00835549|50179738|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
25073177|NCT00835549|50179739|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
25073178|NCT03945825|50179749|FG000|Overall Study|Enrolled but treatment not administered|0|||
25073179|NCT03945825|50179750|FG001|Overall Study|Enrolled but treatment not administered|0|||
25073180|NCT03945825|50179751|FG002|Overall Study|Enrolled but treatment not administered|0|||
25073181|NCT03945825|50179752|FG003|Overall Study|Enrolled but treatment not administered|0|||
25073182|NCT03945825|50179753|FG004|Overall Study|Enrolled but treatment not administered|1|||
25073183|NCT03945825|50179754|FG005|Overall Study|Enrolled but treatment not administered|0|||
25073184|NCT03945825|50179749|FG000|Overall Study|Lost to Follow-up|1|||
25073185|NCT03945825|50179750|FG001|Overall Study|Lost to Follow-up|5|||
25073186|NCT03945825|50179751|FG002|Overall Study|Lost to Follow-up|0|||
25073187|NCT03945825|50179752|FG003|Overall Study|Lost to Follow-up|1|||
25073188|NCT03945825|50179753|FG004|Overall Study|Lost to Follow-up|2|||
25073189|NCT03945825|50179754|FG005|Overall Study|Lost to Follow-up|2|||
25073190|NCT03945825|50179749|FG000|Overall Study|Withdrawal by Subject|1|||
25073191|NCT03945825|50179750|FG001|Overall Study|Withdrawal by Subject|0|||
25073192|NCT03945825|50179751|FG002|Overall Study|Withdrawal by Subject|1|||
25073193|NCT03945825|50179752|FG003|Overall Study|Withdrawal by Subject|1|||
25073194|NCT03945825|50179753|FG004|Overall Study|Withdrawal by Subject|0|||
25073195|NCT03945825|50179754|FG005|Overall Study|Withdrawal by Subject|1|||
25073196|NCT02759315|50179782|FG000|Overall Study|Adverse Event|0|||
25073197|NCT02759315|50179783|FG001|Overall Study|Adverse Event|0|||
25073198|NCT02759315|50179784|FG002|Overall Study|Adverse Event|0|||
25073199|NCT02759315|50179785|FG003|Overall Study|Adverse Event|1|||
25073200|NCT02759315|50179786|FG004|Overall Study|Adverse Event|0|||
25073201|NCT02759315|50179782|FG000|Overall Study|Death|0|||
25073202|NCT02759315|50179783|FG001|Overall Study|Death|0|||
25073203|NCT02759315|50179784|FG002|Overall Study|Death|1|||
25073204|NCT02759315|50179785|FG003|Overall Study|Death|0|||
25073205|NCT02759315|50179786|FG004|Overall Study|Death|0|||
25073206|NCT02759315|50179782|FG000|Overall Study|Lost to Follow-up|2|||
25073207|NCT02759315|50179783|FG001|Overall Study|Lost to Follow-up|0|||
25073208|NCT02759315|50179784|FG002|Overall Study|Lost to Follow-up|4|||
25073209|NCT02759315|50179785|FG003|Overall Study|Lost to Follow-up|0|||
25073210|NCT02759315|50179786|FG004|Overall Study|Lost to Follow-up|0|||
25073211|NCT02759315|50179782|FG000|Overall Study|Protocol Violation|0|||
25073212|NCT02759315|50179783|FG001|Overall Study|Protocol Violation|1|||
25073213|NCT02759315|50179784|FG002|Overall Study|Protocol Violation|0|||
25073214|NCT02759315|50179785|FG003|Overall Study|Protocol Violation|0|||
25073215|NCT02759315|50179786|FG004|Overall Study|Protocol Violation|0|||
25073216|NCT02759315|50179782|FG000|Overall Study|Study terminated prior to completion|2|||
25073217|NCT02759315|50179783|FG001|Overall Study|Study terminated prior to completion|0|||
25073218|NCT02759315|50179784|FG002|Overall Study|Study terminated prior to completion|5|||
25073219|NCT02759315|50179785|FG003|Overall Study|Study terminated prior to completion|0|||
25073220|NCT02759315|50179786|FG004|Overall Study|Study terminated prior to completion|1|||
25073221|NCT00835081|50179802|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
25073222|NCT00835081|50179803|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
25073223|NCT02543918|50179809|FG000|Overall Study|Never treated|0|||
25192426|NCT01435928|50358246|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
25073224|NCT02543918|50179810|FG001|Overall Study|Never treated|1|||
25073225|NCT02543918|50179809|FG000|Overall Study|Lost to Follow-up|1|||
25073226|NCT02543918|50179810|FG001|Overall Study|Lost to Follow-up|1|||
25073227|NCT02543918|50179809|FG000|Overall Study|Withdrawal by Subject|1|||
25073228|NCT02543918|50179810|FG001|Overall Study|Withdrawal by Subject|1|||
25073229|NCT02543918|50179809|FG000|Overall Study|Adverse Event|1|||
25073230|NCT02543918|50179810|FG001|Overall Study|Adverse Event|1|||
25073231|NCT01372995|50179819|FG000|Overall Study|Spouse withdrew participant from study|0|||
25073232|NCT01372995|50179820|FG001|Overall Study|Spouse withdrew participant from study|1|||
25073233|NCT01372995|50179821|FG002|Overall Study|Spouse withdrew participant from study|0|||
25192427|NCT01435928|50358244|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
25192428|NCT01435928|50358245|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
25192429|NCT01435928|50358246|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
25192430|NCT01435928|50358244|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
25192431|NCT01435928|50358245|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
25192432|NCT01435928|50358246|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
25192433|NCT01435928|50358244|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
25192434|NCT01435928|50358245|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
25192435|NCT01435928|50358246|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
25192436|NCT01435928|50358244|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
25192437|NCT01435928|50358245|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
25192438|NCT01435928|50358246|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
25192439|NCT01435928|50358244|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
25192440|NCT01435928|50358245|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
25192441|NCT01435928|50358246|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
25192442|NCT01416272|50358258|FG000|Overall Study|Unacceptable distance visual acuity|2|||
25192443|NCT01416272|50358258|FG000|Overall Study|Lost to Follow-up|1|||
25192444|NCT01416272|50358258|FG000|Overall Study|Study related complaints|1|||
25192445|NCT01435772|50358757|FG000|Overall Study|Adverse Event|1|||
25192446|NCT01435772|50358758|FG001|Overall Study|Adverse Event|0|||
25192447|NCT01435772|50358759|FG002|Overall Study|Adverse Event|2|||
25192448|NCT01435772|50358757|FG000|Overall Study|Withdrawal by Subject|0|||
25192449|NCT01435772|50358758|FG001|Overall Study|Withdrawal by Subject|1|||
25192450|NCT01435772|50358759|FG002|Overall Study|Withdrawal by Subject|3|||
25192451|NCT01435772|50358757|FG000|Overall Study|Other - study termination|2|||
25192452|NCT01435772|50358758|FG001|Overall Study|Other - study termination|2|||
25192453|NCT01435772|50358759|FG002|Overall Study|Other - study termination|10|||
24973377|NCT00112437|50062149|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973378|NCT00112437|50062150|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973379|NCT00112437|50062151|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973380|NCT00112437|50062152|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973381|NCT00112437|50062153|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973382|NCT00112437|50062154|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973383|NCT00112437|50062155|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973384|NCT00112437|50062156|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
24973385|NCT00112437|50062131|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973386|NCT00112437|50062132|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973387|NCT00112437|50062133|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973388|NCT00112437|50062134|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
25192454|NCT01435616|50358978|FG000|Overall Study|Adverse Event|39|||
25192455|NCT01435616|50358979|FG001|Overall Study|Adverse Event|21|||
24973389|NCT00112437|50062135|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973390|NCT00112437|50062136|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973391|NCT00112437|50062137|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973392|NCT00112437|50062138|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973393|NCT00112437|50062139|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973394|NCT00112437|50062140|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973395|NCT00112437|50062141|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
25073234|NCT01372995|50179819|FG000|Overall Study|Physician Decision|0|||
25192456|NCT01435616|50358978|FG000|Overall Study|Death|7|||
25192457|NCT01435616|50358979|FG001|Overall Study|Death|2|||
25192458|NCT01435616|50358978|FG000|Overall Study|Lost to Follow-up|22|||
25192459|NCT01435616|50358979|FG001|Overall Study|Lost to Follow-up|13|||
25192460|NCT01435616|50358978|FG000|Overall Study|Protocol Violation|16|||
25192461|NCT01435616|50358979|FG001|Overall Study|Protocol Violation|13|||
25192462|NCT01435616|50358978|FG000|Overall Study|Withdrawal by Subject|66|||
25192463|NCT01435616|50358979|FG001|Overall Study|Withdrawal by Subject|24|||
25192464|NCT01435616|50358978|FG000|Overall Study|Physician Decision|20|||
25192465|NCT01435616|50358979|FG001|Overall Study|Physician Decision|7|||
25192466|NCT01435616|50358978|FG000|Overall Study|Sponsor Decision|1|||
25192467|NCT01435616|50358979|FG001|Overall Study|Sponsor Decision|0|||
25314639|NCT00842985|50630486|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
24973396|NCT00112437|50062142|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
25073235|NCT01372995|50179820|FG001|Overall Study|Physician Decision|0|||
25073236|NCT01372995|50179821|FG002|Overall Study|Physician Decision|1|||
24973397|NCT00112437|50062143|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
25192468|NCT01435460|50359029|FG000|Overall Study|Adverse Event|2|||
25192469|NCT01435460|50359030|FG001|Overall Study|Adverse Event|1|||
25192470|NCT01435460|50359029|FG000|Overall Study|Lost to Follow-up|6|||
25192471|NCT01435460|50359030|FG001|Overall Study|Lost to Follow-up|1|||
25192472|NCT01435460|50359029|FG000|Overall Study|Withdrawal by Subject|1|||
25192473|NCT01435460|50359030|FG001|Overall Study|Withdrawal by Subject|3|||
25192474|NCT01435460|50359029|FG000|Overall Study|Protocol Violation|0|||
25192475|NCT01435460|50359030|FG001|Overall Study|Protocol Violation|1|||
25192476|NCT01435460|50359029|FG000|Overall Study|Did not meet eligibility criteria|2|||
25192477|NCT01435460|50359030|FG001|Overall Study|Did not meet eligibility criteria|0|||
25192478|NCT01435382|50359116|FG000|Overall Study|Lost to Follow-up|1|||
25192479|NCT01435382|50359117|FG001|Overall Study|Lost to Follow-up|0|||
25192480|NCT01435382|50359118|FG002|Overall Study|Lost to Follow-up|1|||
25192481|NCT01435382|50359119|FG003|Overall Study|Lost to Follow-up|0|||
25192482|NCT01435382|50359116|FG000|Overall Study|Withdrawal by Subject|0|||
25192483|NCT01435382|50359117|FG001|Overall Study|Withdrawal by Subject|2|||
25073237|NCT02757521|50179831|FG000|Overall Study|Adverse Event|1|||
25073238|NCT02757521|50179832|FG001|Overall Study|Adverse Event|0|||
25073239|NCT00834613|50179840|FG000|First Intervention|Protocol Violation|1|||
25073240|NCT00834613|50179841|FG001|First Intervention|Protocol Violation|0|||
25073241|NCT00834067|50179858|FG000|Washout of 21 Days|Protocol Violation|0|||
25073242|NCT00834067|50179859|FG001|Washout of 21 Days|Protocol Violation|1|||
25073243|NCT02758613|50179867|FG000|Treatment|Physician and Sponsor Decision|1|||
25073244|NCT02758613|50179868|FG001|Treatment|Physician and Sponsor Decision|0|||
25073245|NCT02758613|50179869|FG002|Treatment|Physician and Sponsor Decision|0|||
25073246|NCT02758613|50179870|FG003|Treatment|Physician and Sponsor Decision|0|||
25073247|NCT02758613|50179867|FG000|Treatment|Withdrawal by Subject|1|||
25073248|NCT02758613|50179868|FG001|Treatment|Withdrawal by Subject|0|||
25073249|NCT02758613|50179869|FG002|Treatment|Withdrawal by Subject|1|||
25073250|NCT02758613|50179870|FG003|Treatment|Withdrawal by Subject|0|||
25073251|NCT02758301|50179885|FG000|Overall Study|Death|12|||
25073252|NCT02758301|50179886|FG001|Overall Study|Death|0|||
25073253|NCT02758301|50179885|FG000|Overall Study|Physician Decision|10|||
25073254|NCT02758301|50179886|FG001|Overall Study|Physician Decision|1|||
25073255|NCT02758301|50179885|FG000|Overall Study|Withdrawal by Subject|5|||
25073256|NCT02758301|50179886|FG001|Overall Study|Withdrawal by Subject|6|||
25073257|NCT02758301|50179885|FG000|Overall Study|Lost to Follow-up|7|||
25073258|NCT02758301|50179886|FG001|Overall Study|Lost to Follow-up|0|||
25073259|NCT02758301|50179885|FG000|Overall Study|Protocol Violation|0|||
25073260|NCT02758301|50179886|FG001|Overall Study|Protocol Violation|1|||
25073261|NCT02669667|50179906|FG000|Overall Study|Lost to Follow-up|0|||
25073262|NCT02669667|50179907|FG001|Overall Study|Lost to Follow-up|0|||
25073263|NCT02669667|50179908|FG002|Overall Study|Lost to Follow-up|0|||
25073264|NCT02669667|50179909|FG003|Overall Study|Lost to Follow-up|0|||
25073265|NCT02669667|50179910|FG004|Overall Study|Lost to Follow-up|0|||
25073266|NCT02669667|50179911|FG005|Overall Study|Lost to Follow-up|1|||
25073267|NCT02669667|50179912|FG006|Overall Study|Lost to Follow-up|0|||
25169935|NCT01377012|50303602|FG001|Core Study|Withdrawal by Subject|23|||
25169936|NCT01377012|50303603|FG002|Core Study|Withdrawal by Subject|18|||
25169937|NCT01377012|50303601|FG000|Core Study|Protocol Violation|7|||
25169938|NCT01377012|50303602|FG001|Core Study|Protocol Violation|3|||
25169939|NCT01377012|50303603|FG002|Core Study|Protocol Violation|2|||
25169940|NCT01377012|50303601|FG000|Core Study|Pregnancy|0|||
25169941|NCT01377012|50303602|FG001|Core Study|Pregnancy|0|||
25169942|NCT01377012|50303603|FG002|Core Study|Pregnancy|1|||
25169943|NCT01377012|50303601|FG000|Core Study|Physician Decision|5|||
25169944|NCT01377012|50303602|FG001|Core Study|Physician Decision|4|||
25169945|NCT01377012|50303603|FG002|Core Study|Physician Decision|10|||
25169946|NCT01377012|50303601|FG000|Core Study|Non-Compliant with study treatment|0|||
25192484|NCT01435382|50359118|FG002|Overall Study|Withdrawal by Subject|0|||
25192485|NCT01435382|50359119|FG003|Overall Study|Withdrawal by Subject|1|||
25192486|NCT01414166|50359184|FG000|Overall Study|Adverse Event|10|||
25073268|NCT02669433|50179937|FG000|Overall Study|Protocol Violation|0|||
25073269|NCT02669433|50179938|FG001|Overall Study|Protocol Violation|4|||
25073270|NCT02669433|50179939|FG002|Overall Study|Protocol Violation|1|||
25169947|NCT01377012|50303602|FG001|Core Study|Non-Compliant with study treatment|0|||
25073271|NCT02669433|50179937|FG000|Overall Study|Disease Progression|1|||
25073272|NCT02669433|50179938|FG001|Overall Study|Disease Progression|0|||
25073273|NCT02669433|50179939|FG002|Overall Study|Disease Progression|0|||
25073274|NCT02669433|50179937|FG000|Overall Study|Physician Decision|1|||
25073275|NCT02669433|50179938|FG001|Overall Study|Physician Decision|1|||
24973398|NCT00112437|50062144|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973399|NCT00112437|50062145|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973400|NCT00112437|50062146|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
25073276|NCT02669433|50179939|FG002|Overall Study|Physician Decision|0|||
25073277|NCT02669433|50179937|FG000|Overall Study|Adverse Event|6|||
25073278|NCT02669433|50179938|FG001|Overall Study|Adverse Event|7|||
25073279|NCT02669433|50179939|FG002|Overall Study|Adverse Event|10|||
24973401|NCT00112437|50062147|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973402|NCT00112437|50062148|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973403|NCT00112437|50062149|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973404|NCT00112437|50062150|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973405|NCT00112437|50062151|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
24973406|NCT00112437|50062152|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
25073280|NCT02669433|50179937|FG000|Overall Study|Sponsor Termination|1|||
25073281|NCT02669433|50179938|FG001|Overall Study|Sponsor Termination|0|||
25073282|NCT02669433|50179939|FG002|Overall Study|Sponsor Termination|1|||
25073283|NCT02669433|50179937|FG000|Overall Study|Withdrawal by Subject|5|||
25073284|NCT02669433|50179938|FG001|Overall Study|Withdrawal by Subject|1|||
25073285|NCT02669433|50179939|FG002|Overall Study|Withdrawal by Subject|0|||
25073286|NCT02669433|50179937|FG000|Overall Study|Withdrawal by Caregiver|1|||
25073287|NCT02669433|50179938|FG001|Overall Study|Withdrawal by Caregiver|0|||
25073288|NCT02669433|50179939|FG002|Overall Study|Withdrawal by Caregiver|2|||
25073289|NCT02669433|50179937|FG000|Overall Study|Death|0|||
25073290|NCT02669433|50179938|FG001|Overall Study|Death|1|||
25073291|NCT02669433|50179939|FG002|Overall Study|Death|1|||
25073292|NCT02756819|50179947|FG000|Overall Study|Lost for observation|23|||
25073293|NCT02756819|50179947|FG000|Overall Study|Patient's unwillingness|16|||
25073294|NCT02756819|50179947|FG000|Overall Study|Insufficient efficacy|2|||
25073295|NCT02756819|50179947|FG000|Overall Study|Adverse Event|2|||
25073296|NCT02756819|50179947|FG000|Overall Study|Reason not Specified|9|||
25073297|NCT00829309|50179953|FG000|Washout: 7 Days|Protocol Violation|1|||
25073298|NCT00829309|50179954|FG001|Washout: 7 Days|Protocol Violation|0|||
25073299|NCT02669121|50179960|FG000|Overall Study|Adverse Event|4|||
25073300|NCT02669121|50179961|FG001|Overall Study|Adverse Event|5|||
25073301|NCT02669121|50179960|FG000|Overall Study|Lost to Follow-up|15|||
25073302|NCT02669121|50179961|FG001|Overall Study|Lost to Follow-up|27|||
25073303|NCT02669121|50179960|FG000|Overall Study|Withdrawal by Subject|132|||
25073304|NCT02669121|50179961|FG001|Overall Study|Withdrawal by Subject|140|||
25073305|NCT02669121|50179960|FG000|Overall Study|Pregnancy|0|||
25073306|NCT02669121|50179961|FG001|Overall Study|Pregnancy|1|||
25073307|NCT02669121|50179960|FG000|Overall Study|Discharged from US Military Active Service|117|||
25073308|NCT02669121|50179961|FG001|Overall Study|Discharged from US Military Active Service|91|||
25073309|NCT02669121|50179960|FG000|Overall Study|Reason not Specified|22|||
25073310|NCT02669121|50179961|FG001|Overall Study|Reason not Specified|18|||
25073311|NCT02743117|50179969|FG000|Overall Study|Lost to Follow-up|0|||
25073312|NCT02743117|50179970|FG001|Overall Study|Lost to Follow-up|1|||
25073313|NCT02743117|50179969|FG000|Overall Study|Other|1|||
25073314|NCT02743117|50179970|FG001|Overall Study|Other|0|||
25073315|NCT02669043|50179985|FG000|Overall Study|Didn't meet I/E criteria|4|||
25073316|NCT02760407|50179993|FG000|Overall Study|Death|2|||
25073317|NCT02760407|50179994|FG001|Overall Study|Death|3|||
25073318|NCT02760407|50179995|FG002|Overall Study|Death|1|||
25073319|NCT02760407|50179996|FG003|Overall Study|Death|1|||
25073320|NCT02760407|50179993|FG000|Overall Study|Lost to Follow-up|1|||
25073321|NCT02760407|50179994|FG001|Overall Study|Lost to Follow-up|7|||
25073322|NCT02760407|50179995|FG002|Overall Study|Lost to Follow-up|4|||
25073323|NCT02760407|50179996|FG003|Overall Study|Lost to Follow-up|6|||
25073324|NCT02760407|50179993|FG000|Overall Study|Withdrawal by Subject|25|||
25073325|NCT02760407|50179994|FG001|Overall Study|Withdrawal by Subject|31|||
24973407|NCT00112437|50062153|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973408|NCT00112437|50062154|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
25073326|NCT02760407|50179995|FG002|Overall Study|Withdrawal by Subject|37|||
25073327|NCT02760407|50179996|FG003|Overall Study|Withdrawal by Subject|25|||
25073328|NCT02760407|50179993|FG000|Overall Study|Violation of Eligibility criteria|0|||
25073329|NCT02760407|50179994|FG001|Overall Study|Violation of Eligibility criteria|0|||
25073330|NCT02760407|50179995|FG002|Overall Study|Violation of Eligibility criteria|1|||
25073331|NCT02760407|50179996|FG003|Overall Study|Violation of Eligibility criteria|1|||
25073332|NCT02760407|50179993|FG000|Overall Study|Personal reasons|0|||
25073333|NCT02760407|50179994|FG001|Overall Study|Personal reasons|0|||
25073334|NCT02760407|50179995|FG002|Overall Study|Personal reasons|0|||
25073335|NCT02760407|50179996|FG003|Overall Study|Personal reasons|1|||
25073336|NCT02760407|50179993|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
25073337|NCT02760407|50179994|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
25073338|NCT02760407|50179995|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
25073339|NCT02760407|50179996|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
25073340|NCT02760407|50179993|FG000|Overall Study|Use of prohibited Medication|0|||
25073341|NCT02760407|50179994|FG001|Overall Study|Use of prohibited Medication|0|||
25073342|NCT02760407|50179995|FG002|Overall Study|Use of prohibited Medication|1|||
25073343|NCT02760407|50179996|FG003|Overall Study|Use of prohibited Medication|0|||
25169948|NCT01377012|50303603|FG002|Core Study|Non-Compliant with study treatment|1|||
25314640|NCT00842829|50630495|FG000|Dose Titration Period|Adverse Event|11|||
24973409|NCT00112437|50062155|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973410|NCT00112437|50062156|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
24973411|NCT00112437|50062131|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973412|NCT00112437|50062132|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973413|NCT00112437|50062133|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973414|NCT00112437|50062134|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973415|NCT00112437|50062135|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973416|NCT00112437|50062136|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973417|NCT00112437|50062137|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973418|NCT00112437|50062138|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973419|NCT00112437|50062139|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973420|NCT00112437|50062140|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973421|NCT00112437|50062141|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973422|NCT00112437|50062142|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973423|NCT00112437|50062143|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973424|NCT00112437|50062144|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973425|NCT00112437|50062145|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973426|NCT00112437|50062146|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973427|NCT00112437|50062147|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973428|NCT00112437|50062148|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973429|NCT00112437|50062149|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973430|NCT00112437|50062150|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973431|NCT00112437|50062151|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
24973432|NCT00112437|50062152|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973433|NCT00112437|50062153|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973434|NCT00112437|50062154|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973435|NCT00112437|50062155|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973436|NCT00112437|50062156|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
24973437|NCT00112437|50062131|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973438|NCT00112437|50062132|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973439|NCT00112437|50062133|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973440|NCT00112437|50062134|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
25169949|NCT01377012|50303601|FG000|Core Study|No Longer require treatment|0|||
25169950|NCT01377012|50303602|FG001|Core Study|No Longer require treatment|0|||
25169951|NCT01377012|50303603|FG002|Core Study|No Longer require treatment|1|||
25169952|NCT01377012|50303601|FG000|Core Study|Lost to Follow-up|7|||
25169953|NCT01377012|50303602|FG001|Core Study|Lost to Follow-up|5|||
25169954|NCT01377012|50303603|FG002|Core Study|Lost to Follow-up|4|||
25169955|NCT01377012|50303601|FG000|Core Study|Lack of Efficacy|41|||
25314641|NCT00842829|50630496|FG001|Dose Titration Period|Adverse Event|10|||
25314642|NCT00842829|50630497|FG002|Dose Titration Period|Adverse Event|0|||
25314643|NCT00842829|50630495|FG000|Dose Titration Period|Lack of Efficacy|4|||
25073344|NCT02760407|50179993|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
25073345|NCT02760407|50179994|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
25073346|NCT02760407|50179995|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
25073347|NCT02760407|50179996|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
25073348|NCT02760407|50179993|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
25073349|NCT02760407|50179994|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
25073350|NCT02760407|50179995|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
25073351|NCT02760407|50179996|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
25073352|NCT02760407|50179993|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
25073353|NCT02760407|50179994|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
25073354|NCT02760407|50179995|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
25073355|NCT02760407|50179996|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
25073356|NCT02760407|50179993|FG000|Overall Study|Inadequately Enrolled|0|||
25073357|NCT02760407|50179994|FG001|Overall Study|Inadequately Enrolled|0|||
25073358|NCT02760407|50179995|FG002|Overall Study|Inadequately Enrolled|0|||
25073359|NCT02760407|50179996|FG003|Overall Study|Inadequately Enrolled|1|||
25073360|NCT02760407|50179993|FG000|Overall Study|Withdrawal By PI's Decision|0|||
25073361|NCT02760407|50179994|FG001|Overall Study|Withdrawal By PI's Decision|1|||
25073362|NCT02760407|50179995|FG002|Overall Study|Withdrawal By PI's Decision|0|||
25073363|NCT02760407|50179996|FG003|Overall Study|Withdrawal By PI's Decision|0|||
25073364|NCT02760407|50179993|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
25073365|NCT02760407|50179994|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
25073366|NCT02760407|50179995|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
25073367|NCT02760407|50179996|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
25073368|NCT02760407|50179993|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
25073369|NCT02760407|50179994|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
25073370|NCT02760407|50179995|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
25073371|NCT02760407|50179996|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
25073372|NCT02760407|50179993|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
24973441|NCT00112437|50062135|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973442|NCT00112437|50062136|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973443|NCT00112437|50062137|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973444|NCT00112437|50062138|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973445|NCT00112437|50062139|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973446|NCT00112437|50062140|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973447|NCT00112437|50062141|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973448|NCT00112437|50062142|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973449|NCT00112437|50062143|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973450|NCT00112437|50062144|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973451|NCT00112437|50062145|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973452|NCT00112437|50062146|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973453|NCT00112437|50062147|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973454|NCT00112437|50062148|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973455|NCT00112437|50062149|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973456|NCT00112437|50062150|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973457|NCT00112437|50062151|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973458|NCT00112437|50062152|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
24973459|NCT00112437|50062153|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973460|NCT00112437|50062154|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973461|NCT00112437|50062155|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973462|NCT00112437|50062156|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
24973463|NCT00112437|50062131|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973464|NCT00112437|50062132|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973465|NCT00112437|50062133|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973466|NCT00112437|50062134|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973467|NCT00112437|50062135|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973468|NCT00112437|50062136|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973469|NCT00112437|50062137|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973470|NCT00112437|50062138|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973471|NCT00112437|50062139|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973472|NCT00112437|50062140|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973473|NCT00112437|50062141|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973474|NCT00112437|50062142|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
25073373|NCT02760407|50179994|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
25073374|NCT02760407|50179995|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
25073375|NCT02760407|50179996|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
25073376|NCT02760407|50179993|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
25073377|NCT02760407|50179994|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
25073378|NCT02760407|50179995|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
25073379|NCT02760407|50179996|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
25073380|NCT02760407|50179993|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
25073381|NCT02760407|50179994|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
25073382|NCT02760407|50179995|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
25073383|NCT02760407|50179996|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
25073384|NCT02760407|50179993|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
25073385|NCT02760407|50179994|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
25073386|NCT02760407|50179995|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
25073387|NCT02760407|50179996|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
25073388|NCT02760407|50179993|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
25073389|NCT02760407|50179994|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
25073390|NCT02760407|50179995|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
25073391|NCT02760407|50179996|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
25073392|NCT02760407|50179993|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
25073393|NCT02760407|50179994|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
25073394|NCT02760407|50179995|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
25073395|NCT02760407|50179996|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
25073396|NCT02760407|50179993|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
24973475|NCT00112437|50062143|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973476|NCT00112437|50062144|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973477|NCT00112437|50062145|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973478|NCT00112437|50062146|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973479|NCT00112437|50062147|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973480|NCT00112437|50062148|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973481|NCT00112437|50062149|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973482|NCT00112437|50062150|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973483|NCT00112437|50062151|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973484|NCT00112437|50062152|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
25073397|NCT02760407|50179994|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
25073398|NCT02760407|50179995|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
25073399|NCT02760407|50179996|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
25073400|NCT00805129|50180007|FG000|Overall Study|Not treated|1|||
25073401|NCT02668185|50180011|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
25073402|NCT02668185|50180012|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
25073403|NCT02668185|50180011|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
25073404|NCT02668185|50180012|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
25073405|NCT02668185|50180011|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
25073406|NCT02668185|50180012|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
25073407|NCT02668185|50180011|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
25073408|NCT02668185|50180012|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
25073409|NCT02742181|50180023|FG000|Overall Study|Physician Decision|1|||
25073410|NCT02742181|50180024|FG001|Overall Study|Physician Decision|0|||
25073411|NCT02742103|50180032|FG000|Overall Study|Protocol Violation|1|||
25073412|NCT02742103|50180033|FG001|Overall Study|Protocol Violation|0|||
25073413|NCT02742103|50180032|FG000|Overall Study|Death|2|||
25073414|NCT02742103|50180033|FG001|Overall Study|Death|2|||
25073415|NCT02742103|50180032|FG000|Overall Study|Adverse Event|1|||
25073416|NCT02742103|50180033|FG001|Overall Study|Adverse Event|0|||
25073417|NCT02742103|50180032|FG000|Overall Study|Moved to another town|0|||
25073418|NCT02742103|50180033|FG001|Overall Study|Moved to another town|1|||
25073419|NCT02742103|50180032|FG000|Overall Study|Withdrawal by Subject|5|||
25073420|NCT02742103|50180033|FG001|Overall Study|Withdrawal by Subject|2|||
25073421|NCT02741713|50180041|FG000|Overall Study|Surgery type changed intra-operatively|2|||
25073422|NCT02741713|50180042|FG001|Overall Study|Surgery type changed intra-operatively|1|||
25073423|NCT02663271|50180049|FG000|Overall Study|Withdrawal by Subject|5|||
25073424|NCT02663271|50180049|FG000|Overall Study|Lack of Efficacy|1|||
25073425|NCT02742649|50180056|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
25073426|NCT02742649|50180057|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
25073427|NCT02742649|50180058|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
25073428|NCT02742649|50180059|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
25073429|NCT02742649|50180060|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
25073430|NCT02742649|50180056|FG000|Double-Blind Treatment Period|Adverse Event|0|||
25073431|NCT02742649|50180057|FG001|Double-Blind Treatment Period|Adverse Event|1|||
25073432|NCT02742649|50180058|FG002|Double-Blind Treatment Period|Adverse Event|0|||
25073433|NCT02742649|50180059|FG003|Double-Blind Treatment Period|Adverse Event|0|||
25073434|NCT02742649|50180060|FG004|Double-Blind Treatment Period|Adverse Event|0|||
25073435|NCT02742649|50180056|FG000|Open-Label Period|Lost to Follow-up|0|||
25073436|NCT02742649|50180057|FG001|Open-Label Period|Lost to Follow-up|0|||
25073437|NCT02742649|50180058|FG002|Open-Label Period|Lost to Follow-up|0|||
25073438|NCT02742649|50180059|FG003|Open-Label Period|Lost to Follow-up|0|||
25073439|NCT02742649|50180060|FG004|Open-Label Period|Lost to Follow-up|1|||
25073440|NCT02665689|50180073|FG000|Overall Study|Adverse Event|1|||
25073441|NCT02665689|50180074|FG001|Overall Study|Adverse Event|0|||
25073442|NCT02665689|50180073|FG000|Overall Study|Trial termination|1|||
25073443|NCT02665689|50180074|FG001|Overall Study|Trial termination|1|||
25073444|NCT02665689|50180073|FG000|Overall Study|Lost to Follow-up|0|||
25073445|NCT02665689|50180074|FG001|Overall Study|Lost to Follow-up|1|||
25073446|NCT02665455|50180080|FG000|Overall Study|Withdrawal by Subject|6|||
25073447|NCT02665455|50180080|FG000|Overall Study|Lost to Follow-up|1|||
25073448|NCT02665455|50180080|FG000|Overall Study|Adverse Event|1|||
25073449|NCT02665455|50180080|FG000|Overall Study|Protocol Violation|1|||
25073450|NCT02755805|50180086|FG000|Overall Study|Lost to Follow-up|1|||
25073451|NCT02755805|50180087|FG001|Overall Study|Lost to Follow-up|2|||
25073452|NCT02755805|50180086|FG000|Overall Study|Refused assessments|1|||
25073453|NCT02755805|50180087|FG001|Overall Study|Refused assessments|0|||
25073454|NCT02755805|50180086|FG000|Overall Study|Withdrawal by Subject|0|||
25073455|NCT02755805|50180087|FG001|Overall Study|Withdrawal by Subject|2|||
25073456|NCT02755649|50180096|FG000|Overall Study|Transitioned into OLE study|99|||
25073457|NCT02755649|50180097|FG001|Overall Study|Transitioned into OLE study|98|||
25073458|NCT02755649|50180098|FG002|Overall Study|Transitioned into OLE study|100|||
25073459|NCT02755649|50180096|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
25073460|NCT02755649|50180097|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
25073461|NCT02755649|50180098|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
25073462|NCT02755649|50180096|FG000|Overall Study|Physician Decision|0|||
25073463|NCT02755649|50180097|FG001|Overall Study|Physician Decision|0|||
25073464|NCT02755649|50180098|FG002|Overall Study|Physician Decision|2|||
24973485|NCT00112437|50062153|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973486|NCT00112437|50062154|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973487|NCT00112437|50062155|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973488|NCT00112437|50062156|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
24973489|NCT00112437|50062131|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973490|NCT00112437|50062132|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973491|NCT00112437|50062133|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973492|NCT00112437|50062134|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973493|NCT00112437|50062135|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973494|NCT00112437|50062136|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973495|NCT00112437|50062137|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
25073465|NCT02755649|50180096|FG000|Overall Study|Withdrawal by Subject|0|||
25073466|NCT02755649|50180097|FG001|Overall Study|Withdrawal by Subject|1|||
25073467|NCT02755649|50180098|FG002|Overall Study|Withdrawal by Subject|0|||
25073468|NCT02755649|50180096|FG000|Overall Study|Undecided|1|||
25073469|NCT02755649|50180097|FG001|Overall Study|Undecided|0|||
25073470|NCT02755649|50180098|FG002|Overall Study|Undecided|0|||
25073471|NCT00151411|50180108|FG000|Overall Study|Lost to Follow-up|15|||
25073472|NCT00151411|50180109|FG001|Overall Study|Lost to Follow-up|19|||
25073473|NCT00151411|50180108|FG000|Overall Study|Withdrawal by Subject|12|||
25073474|NCT00151411|50180109|FG001|Overall Study|Withdrawal by Subject|20|||
25073475|NCT00151411|50180108|FG000|Overall Study|Adverse Event|6|||
25073476|NCT00151411|50180109|FG001|Overall Study|Adverse Event|0|||
25073477|NCT00151411|50180108|FG000|Overall Study|Pregnancy|0|||
25073478|NCT00151411|50180109|FG001|Overall Study|Pregnancy|4|||
25073479|NCT02662569|50180119|FG000|Overall Study|Withdrawal by Subject|6|||
25073480|NCT02662569|50180120|FG001|Overall Study|Withdrawal by Subject|1|||
25073481|NCT02662569|50180121|FG002|Overall Study|Withdrawal by Subject|6|||
25073482|NCT02662569|50180122|FG003|Overall Study|Withdrawal by Subject|4|||
25073483|NCT02662569|50180119|FG000|Overall Study|Lost to Follow-up|1|||
25073484|NCT02662569|50180120|FG001|Overall Study|Lost to Follow-up|0|||
24973496|NCT00112437|50062138|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
25073485|NCT02662569|50180121|FG002|Overall Study|Lost to Follow-up|0|||
25073486|NCT02662569|50180122|FG003|Overall Study|Lost to Follow-up|0|||
25073487|NCT02741635|50180132|FG000|Overall Study|Withdrawal by Subject|1|||
25073488|NCT02753075|50180140|FG000|Overall Study|Adverse Event|2|||
25073489|NCT02753075|50180141|FG001|Overall Study|Adverse Event|1|||
25073490|NCT02753075|50180142|FG002|Overall Study|Adverse Event|0|||
25073491|NCT02753075|50180140|FG000|Overall Study|Lost to Follow-up|2|||
25073492|NCT02753075|50180141|FG001|Overall Study|Lost to Follow-up|0|||
25073493|NCT02753075|50180142|FG002|Overall Study|Lost to Follow-up|0|||
25073494|NCT02753075|50180140|FG000|Overall Study|Withdrawal of Consent|1|||
25073495|NCT02753075|50180141|FG001|Overall Study|Withdrawal of Consent|1|||
25073496|NCT02753075|50180142|FG002|Overall Study|Withdrawal of Consent|3|||
25073497|NCT02753075|50180140|FG000|Overall Study|Physician Decision|3|||
25073498|NCT02753075|50180141|FG001|Overall Study|Physician Decision|1|||
25073499|NCT02753075|50180142|FG002|Overall Study|Physician Decision|0|||
25073500|NCT02332720|50180174|FG000|Part A and Part B|Lost to Follow-up|1|||
25073501|NCT02332720|50180175|FG001|Part A and Part B|Lost to Follow-up|0|||
25073502|NCT02332720|50180176|FG002|Part A and Part B|Lost to Follow-up|0|||
25073503|NCT02332720|50180177|FG003|Part A and Part B|Lost to Follow-up|0|||
25073504|NCT02332720|50180178|FG004|Part A and Part B|Lost to Follow-up|0|||
25073505|NCT02332720|50180179|FG005|Part A and Part B|Lost to Follow-up|2|||
25073506|NCT02332720|50180180|FG006|Part A and Part B|Lost to Follow-up|1|||
25073507|NCT02332720|50180181|FG007|Part A and Part B|Lost to Follow-up|1|||
25073508|NCT02332720|50180182|FG008|Part A and Part B|Lost to Follow-up|0|||
25073509|NCT02332720|50180183|FG009|Part A and Part B|Lost to Follow-up|0|||
25073510|NCT02332720|50180184|FG010|Part A and Part B|Lost to Follow-up|0|||
25073511|NCT02332720|50180185|FG011|Part A and Part B|Lost to Follow-up|0|||
25073512|NCT02332720|50180186|FG012|Part A and Part B|Lost to Follow-up|0|||
24973497|NCT00112437|50062139|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973498|NCT00112437|50062140|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973499|NCT00112437|50062141|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973500|NCT00112437|50062142|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973501|NCT00112437|50062143|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973502|NCT00112437|50062144|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973503|NCT00112437|50062145|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973504|NCT00112437|50062146|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973505|NCT00112437|50062147|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973506|NCT00112437|50062148|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973507|NCT00112437|50062149|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973508|NCT00112437|50062150|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973509|NCT00112437|50062151|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
24973510|NCT00112437|50062152|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
24973511|NCT00112437|50062153|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973512|NCT00112437|50062154|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973513|NCT00112437|50062155|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973514|NCT00112437|50062156|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
24973515|NCT00112437|50062131|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973516|NCT00112437|50062132|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973517|NCT00112437|50062133|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973518|NCT00112437|50062134|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973519|NCT00112437|50062135|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973520|NCT00112437|50062136|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973521|NCT00112437|50062137|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973522|NCT00112437|50062138|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973523|NCT00112437|50062139|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973524|NCT00112437|50062140|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973525|NCT00112437|50062141|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973526|NCT00112437|50062142|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973527|NCT00112437|50062143|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973528|NCT00112437|50062144|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973529|NCT00112437|50062145|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973530|NCT00112437|50062146|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973531|NCT00112437|50062147|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973532|NCT00112437|50062148|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973533|NCT00112437|50062149|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973534|NCT00112437|50062150|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973535|NCT00112437|50062151|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973536|NCT00112437|50062152|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
24973537|NCT00112437|50062153|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
24973538|NCT00112437|50062154|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
24973539|NCT00112437|50062155|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
25073513|NCT02332720|50180187|FG013|Part A and Part B|Lost to Follow-up|0|||
25073514|NCT02332720|50180188|FG014|Part A and Part B|Lost to Follow-up|0|||
25073515|NCT02332720|50180189|FG015|Part A and Part B|Lost to Follow-up|1|||
25073516|NCT02332720|50180190|FG016|Part A and Part B|Lost to Follow-up|0|||
25073517|NCT02332720|50180191|FG017|Part A and Part B|Lost to Follow-up|0|||
25073518|NCT02332720|50180192|FG018|Part A and Part B|Lost to Follow-up|0|||
25073519|NCT02332720|50180193|FG019|Part A and Part B|Lost to Follow-up|0|||
25169956|NCT01377012|50303602|FG001|Core Study|Lack of Efficacy|28|||
25073520|NCT02332720|50180194|FG020|Part A and Part B|Lost to Follow-up|0|||
25073521|NCT02332720|50180195|FG021|Part A and Part B|Lost to Follow-up|0|||
25073522|NCT02332720|50180196|FG022|Part A and Part B|Lost to Follow-up|0|||
25073523|NCT02332720|50180174|FG000|Part A and Part B|Adverse Event|0|||
25073524|NCT02332720|50180175|FG001|Part A and Part B|Adverse Event|0|||
25073525|NCT02332720|50180176|FG002|Part A and Part B|Adverse Event|0|||
25073526|NCT02332720|50180177|FG003|Part A and Part B|Adverse Event|0|||
25073527|NCT02332720|50180178|FG004|Part A and Part B|Adverse Event|0|||
25073528|NCT02332720|50180179|FG005|Part A and Part B|Adverse Event|0|||
25073529|NCT02332720|50180180|FG006|Part A and Part B|Adverse Event|0|||
25073530|NCT02332720|50180181|FG007|Part A and Part B|Adverse Event|0|||
25073531|NCT02332720|50180182|FG008|Part A and Part B|Adverse Event|0|||
25073532|NCT02332720|50180183|FG009|Part A and Part B|Adverse Event|0|||
25073533|NCT02332720|50180184|FG010|Part A and Part B|Adverse Event|0|||
25073534|NCT02332720|50180185|FG011|Part A and Part B|Adverse Event|0|||
25073535|NCT02332720|50180186|FG012|Part A and Part B|Adverse Event|0|||
25073536|NCT02332720|50180187|FG013|Part A and Part B|Adverse Event|0|||
25073537|NCT02332720|50180188|FG014|Part A and Part B|Adverse Event|0|||
25073538|NCT02332720|50180189|FG015|Part A and Part B|Adverse Event|0|||
25073539|NCT02332720|50180190|FG016|Part A and Part B|Adverse Event|0|||
25073540|NCT02332720|50180191|FG017|Part A and Part B|Adverse Event|1|||
25073541|NCT02332720|50180192|FG018|Part A and Part B|Adverse Event|0|||
25073542|NCT02332720|50180193|FG019|Part A and Part B|Adverse Event|0|||
25073543|NCT02332720|50180194|FG020|Part A and Part B|Adverse Event|0|||
25073544|NCT02332720|50180195|FG021|Part A and Part B|Adverse Event|0|||
25073545|NCT02332720|50180196|FG022|Part A and Part B|Adverse Event|0|||
25073546|NCT02332720|50180174|FG000|Part A and Part B|Physician Decision|0|||
25073547|NCT02332720|50180175|FG001|Part A and Part B|Physician Decision|0|||
25073548|NCT02332720|50180176|FG002|Part A and Part B|Physician Decision|0|||
25073549|NCT02332720|50180177|FG003|Part A and Part B|Physician Decision|0|||
25073550|NCT02332720|50180178|FG004|Part A and Part B|Physician Decision|0|||
25073551|NCT02332720|50180179|FG005|Part A and Part B|Physician Decision|0|||
25073552|NCT02332720|50180180|FG006|Part A and Part B|Physician Decision|0|||
25073553|NCT02332720|50180181|FG007|Part A and Part B|Physician Decision|0|||
25073554|NCT02332720|50180182|FG008|Part A and Part B|Physician Decision|0|||
25073555|NCT02332720|50180183|FG009|Part A and Part B|Physician Decision|0|||
25073556|NCT02332720|50180184|FG010|Part A and Part B|Physician Decision|0|||
25073557|NCT02332720|50180185|FG011|Part A and Part B|Physician Decision|0|||
25073558|NCT02332720|50180186|FG012|Part A and Part B|Physician Decision|0|||
25073559|NCT02332720|50180187|FG013|Part A and Part B|Physician Decision|0|||
25073560|NCT02332720|50180188|FG014|Part A and Part B|Physician Decision|0|||
25073561|NCT02332720|50180189|FG015|Part A and Part B|Physician Decision|0|||
25073562|NCT02332720|50180190|FG016|Part A and Part B|Physician Decision|0|||
25073563|NCT02332720|50180191|FG017|Part A and Part B|Physician Decision|0|||
25073564|NCT02332720|50180192|FG018|Part A and Part B|Physician Decision|1|||
25073565|NCT02332720|50180193|FG019|Part A and Part B|Physician Decision|0|||
25073566|NCT02332720|50180194|FG020|Part A and Part B|Physician Decision|0|||
25073567|NCT02332720|50180195|FG021|Part A and Part B|Physician Decision|0|||
25073568|NCT02332720|50180196|FG022|Part A and Part B|Physician Decision|0|||
25073569|NCT02332720|50180174|FG000|Part A and Part B|Withdrawal by Subject|0|||
25073570|NCT02332720|50180175|FG001|Part A and Part B|Withdrawal by Subject|0|||
25073571|NCT02332720|50180176|FG002|Part A and Part B|Withdrawal by Subject|0|||
25073572|NCT02332720|50180177|FG003|Part A and Part B|Withdrawal by Subject|0|||
25073573|NCT02332720|50180178|FG004|Part A and Part B|Withdrawal by Subject|0|||
25073574|NCT02332720|50180179|FG005|Part A and Part B|Withdrawal by Subject|1|||
25073575|NCT02332720|50180180|FG006|Part A and Part B|Withdrawal by Subject|0|||
25073576|NCT02332720|50180181|FG007|Part A and Part B|Withdrawal by Subject|0|||
25073577|NCT02332720|50180182|FG008|Part A and Part B|Withdrawal by Subject|0|||
25073578|NCT02332720|50180183|FG009|Part A and Part B|Withdrawal by Subject|0|||
25073579|NCT02332720|50180184|FG010|Part A and Part B|Withdrawal by Subject|0|||
25073580|NCT02332720|50180185|FG011|Part A and Part B|Withdrawal by Subject|0|||
25169957|NCT01377012|50303603|FG002|Core Study|Lack of Efficacy|37|||
25073581|NCT02332720|50180186|FG012|Part A and Part B|Withdrawal by Subject|0|||
25073582|NCT02332720|50180187|FG013|Part A and Part B|Withdrawal by Subject|0|||
25073583|NCT02332720|50180188|FG014|Part A and Part B|Withdrawal by Subject|0|||
25073584|NCT02332720|50180189|FG015|Part A and Part B|Withdrawal by Subject|0|||
25073585|NCT02332720|50180190|FG016|Part A and Part B|Withdrawal by Subject|0|||
25073586|NCT02332720|50180191|FG017|Part A and Part B|Withdrawal by Subject|0|||
25073587|NCT02332720|50180192|FG018|Part A and Part B|Withdrawal by Subject|0|||
25073588|NCT02332720|50180193|FG019|Part A and Part B|Withdrawal by Subject|1|||
25073589|NCT02332720|50180194|FG020|Part A and Part B|Withdrawal by Subject|0|||
25073590|NCT02332720|50180195|FG021|Part A and Part B|Withdrawal by Subject|0|||
25073591|NCT02332720|50180196|FG022|Part A and Part B|Withdrawal by Subject|0|||
25073592|NCT02331394|50180268|FG000|Overall Study|Disease progression|1|||
25073593|NCT01645930|50180279|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
25073594|NCT01645930|50180279|FG000|Overall Study|Progressive Disease|12|||
25073595|NCT01645930|50180279|FG000|Overall Study|Adverse Event|4|||
25073596|NCT01645930|50180279|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
25073597|NCT01645930|50180279|FG000|Overall Study|Withdrawal by Participant|2|||
25073598|NCT01645930|50180279|FG000|Overall Study|Reason not Defined|1|||
25073599|NCT02299336|50180283|FG000|Overall Study|Withdrawal by Subject|11|||
25073600|NCT02299336|50180283|FG000|Overall Study|Adverse Event|1|||
25073601|NCT02299336|50180283|FG000|Overall Study|Death|1|||
25073602|NCT02299336|50180283|FG000|Overall Study|Lost to Follow-up|1|||
25073603|NCT02664441|50180289|FG000|Randomization|Withdrawal by Subject|0|||
25073604|NCT02664441|50180290|FG001|Randomization|Withdrawal by Subject|1|||
25073605|NCT02664441|50180289|FG000|36-week Randomized Trial|Adverse Event|2|||
25073606|NCT02664441|50180290|FG001|36-week Randomized Trial|Adverse Event|0|||
25073607|NCT02664441|50180289|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
25073608|NCT02664441|50180290|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
25073609|NCT02664441|50180289|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
25073610|NCT02664441|50180290|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
25073611|NCT02664441|50180289|FG000|18-week Open Label Extension|Adverse Event|1|||
25073612|NCT02664441|50180290|FG001|18-week Open Label Extension|Adverse Event|0|||
25073613|NCT02664441|50180289|FG000|18-week Open Label Extension|Physician Decision|1|||
25073614|NCT02664441|50180290|FG001|18-week Open Label Extension|Physician Decision|0|||
25073615|NCT02664441|50180289|FG000|18-week Open Label Extension|Death|1|||
25073616|NCT02664441|50180290|FG001|18-week Open Label Extension|Death|0|||
25073617|NCT02664441|50180289|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
25073618|NCT02664441|50180290|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
25073619|NCT02298946|50180299|FG000|Overall Study|Did not receive treatment|2|||
25073620|NCT02298946|50180300|FG001|Overall Study|Did not receive treatment|0|||
25073621|NCT02298946|50180299|FG000|Overall Study|Unevaluable|2|||
25073622|NCT02298946|50180300|FG001|Overall Study|Unevaluable|1|||
25073623|NCT02328040|50180307|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
25073624|NCT02328040|50180308|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
25073625|NCT01647958|50180316|FG000|Initial Study|Lost to Follow-up|2|||
25073626|NCT01647958|50180317|FG001|Initial Study|Lost to Follow-up|3|||
25073627|NCT01647958|50180316|FG000|Continuation Phase|treatment received during Overall Study|39|||
25073628|NCT01647958|50180317|FG001|Continuation Phase|treatment received during Overall Study|0|||
25073629|NCT01647958|50180316|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
25073630|NCT01647958|50180317|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
25073631|NCT02298868|50180332|FG000|Overall Study|Adverse Event|1|||
25073632|NCT02298868|50180332|FG000|Overall Study|Death|1|||
25073633|NCT02298868|50180332|FG000|Overall Study|Patient underwent transplant|1|||
25073634|NCT02327260|50180339|FG000|Overall Study|Lost to Follow-up|2|||
25073635|NCT02327260|50180340|FG001|Overall Study|Lost to Follow-up|3|||
25073636|NCT02327260|50180341|FG002|Overall Study|Lost to Follow-up|2|||
25073637|NCT02327260|50180339|FG000|Overall Study|invalid phone number|1|||
25073638|NCT02327260|50180340|FG001|Overall Study|invalid phone number|1|||
25073639|NCT02327260|50180341|FG002|Overall Study|invalid phone number|0|||
25073640|NCT02327260|50180339|FG000|Overall Study|non-adherence to protocol|2|||
25073641|NCT02327260|50180340|FG001|Overall Study|non-adherence to protocol|0|||
25073642|NCT02327260|50180341|FG002|Overall Study|non-adherence to protocol|0|||
25073643|NCT02327260|50180339|FG000|Overall Study|cognitive concerns|1|||
25073644|NCT02327260|50180340|FG001|Overall Study|cognitive concerns|0|||
25073645|NCT02327260|50180341|FG002|Overall Study|cognitive concerns|0|||
25073646|NCT02296840|50180352|FG000|Overall Study|Adverse Event|1|||
25073647|NCT02296840|50180353|FG001|Overall Study|Adverse Event|1|||
25073648|NCT02296840|50180352|FG000|Overall Study|Protocol Violation|2|||
25073649|NCT02296840|50180353|FG001|Overall Study|Protocol Violation|1|||
25073650|NCT02296840|50180352|FG000|Overall Study|Lost to Follow-up|6|||
25073651|NCT02296840|50180353|FG001|Overall Study|Lost to Follow-up|17|||
25073652|NCT02663895|50180362|FG000|Overall Study|Adverse Event|3|||
25073653|NCT02663895|50180362|FG000|Overall Study|Physician Decision|2|||
25073654|NCT02663895|50180362|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
25073655|NCT02663895|50180362|FG000|Overall Study|Withdrawal by Subject|1|||
25073656|NCT02663817|50180367|FG000|Overall Study|Screen failure|2|||
25073657|NCT01372605|50180375|FG000|Overall Study|Death|1|||
25073658|NCT01372605|50180376|FG001|Overall Study|Death|2|||
25073659|NCT01372605|50180375|FG000|Overall Study|Lost to Follow-up|2|||
25073660|NCT01372605|50180376|FG001|Overall Study|Lost to Follow-up|1|||
25073661|NCT01372605|50180375|FG000|Overall Study|Withdrawal by Subject|4|||
25073662|NCT01372605|50180376|FG001|Overall Study|Withdrawal by Subject|7|||
25073663|NCT01372605|50180375|FG000|Overall Study|Moved|3|||
25073664|NCT01372605|50180376|FG001|Overall Study|Moved|0|||
25073665|NCT01372605|50180375|FG000|Overall Study|Changed medical home|2|||
25073666|NCT01372605|50180376|FG001|Overall Study|Changed medical home|0|||
25073667|NCT02751983|50180384|FG000|Treatment|Stopped ACT, but Remained in study|2|||
25073668|NCT02751983|50180385|FG001|Treatment|Stopped ACT, but Remained in study|0|||
25073669|NCT02751983|50180384|FG000|Treatment|Discharged prior to beginning ACT|2|||
25073670|NCT02751983|50180385|FG001|Treatment|Discharged prior to beginning ACT|0|||
25073671|NCT02751983|50180384|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
25073672|NCT02751983|50180385|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
25073673|NCT02751983|50180384|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
25073674|NCT02751983|50180385|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
25073675|NCT02751983|50180384|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
25073676|NCT02751983|50180385|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
25073677|NCT00232141|50180405|FG000|Overall Study|Adverse Event|9|||
25073678|NCT00232141|50180406|FG001|Overall Study|Adverse Event|4|||
25073679|NCT00232141|50180405|FG000|Overall Study|Lack of Efficacy|0|||
25073680|NCT00232141|50180406|FG001|Overall Study|Lack of Efficacy|3|||
25073681|NCT00232141|50180405|FG000|Overall Study|Lost to Follow-up|9|||
25073682|NCT00232141|50180406|FG001|Overall Study|Lost to Follow-up|6|||
25073683|NCT00232141|50180405|FG000|Overall Study|Other|8|||
25073684|NCT00232141|50180406|FG001|Overall Study|Other|10|||
25073685|NCT00232141|50180405|FG000|Overall Study|Withdrawal by Subject|5|||
25073686|NCT00232141|50180406|FG001|Overall Study|Withdrawal by Subject|3|||
25073687|NCT02741245|50180435|FG000|Overall Study|Adverse Event|0|||
25073688|NCT02741245|50180436|FG001|Overall Study|Adverse Event|0|||
25073689|NCT02741245|50180437|FG002|Overall Study|Adverse Event|0|||
25073690|NCT02741245|50180438|FG003|Overall Study|Adverse Event|2|||
25073691|NCT02741245|50180439|FG004|Overall Study|Adverse Event|2|||
25073692|NCT02741245|50180435|FG000|Overall Study|Protocol Violation|0|||
25073693|NCT02741245|50180436|FG001|Overall Study|Protocol Violation|1|||
25073694|NCT02741245|50180437|FG002|Overall Study|Protocol Violation|0|||
25073695|NCT02741245|50180438|FG003|Overall Study|Protocol Violation|1|||
24973540|NCT00112437|50062156|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
24973541|NCT00112437|50062131|FG000|Years 6-10 (60-Month Extension)|Death|0|||
25073696|NCT02741245|50180439|FG004|Overall Study|Protocol Violation|0|||
25073697|NCT02741245|50180435|FG000|Overall Study|Withdrawal by Subject|0|||
25073698|NCT02741245|50180436|FG001|Overall Study|Withdrawal by Subject|0|||
25073699|NCT02741245|50180437|FG002|Overall Study|Withdrawal by Subject|0|||
25073700|NCT02741245|50180438|FG003|Overall Study|Withdrawal by Subject|1|||
25073701|NCT02741245|50180439|FG004|Overall Study|Withdrawal by Subject|0|||
25073702|NCT03227757|50180451|FG000|Overall Study|Death|7|||
24973542|NCT00112437|50062132|FG001|Years 6-10 (60-Month Extension)|Death|0|||
24973543|NCT00112437|50062133|FG002|Years 6-10 (60-Month Extension)|Death|0|||
24973544|NCT00112437|50062134|FG003|Years 6-10 (60-Month Extension)|Death|0|||
24973545|NCT00112437|50062135|FG004|Years 6-10 (60-Month Extension)|Death|0|||
24973546|NCT00112437|50062136|FG005|Years 6-10 (60-Month Extension)|Death|0|||
24973547|NCT00112437|50062137|FG006|Years 6-10 (60-Month Extension)|Death|0|||
24973548|NCT00112437|50062138|FG007|Years 6-10 (60-Month Extension)|Death|0|||
24973549|NCT00112437|50062139|FG008|Years 6-10 (60-Month Extension)|Death|0|||
24973550|NCT00112437|50062140|FG009|Years 6-10 (60-Month Extension)|Death|0|||
24973551|NCT00112437|50062141|FG010|Years 6-10 (60-Month Extension)|Death|0|||
24973552|NCT00112437|50062142|FG011|Years 6-10 (60-Month Extension)|Death|0|||
24973553|NCT00112437|50062143|FG012|Years 6-10 (60-Month Extension)|Death|0|||
24973554|NCT00112437|50062144|FG013|Years 6-10 (60-Month Extension)|Death|0|||
24973555|NCT00112437|50062145|FG014|Years 6-10 (60-Month Extension)|Death|0|||
24973556|NCT00112437|50062146|FG015|Years 6-10 (60-Month Extension)|Death|0|||
24973557|NCT00112437|50062147|FG016|Years 6-10 (60-Month Extension)|Death|0|||
24973558|NCT00112437|50062148|FG017|Years 6-10 (60-Month Extension)|Death|0|||
25073703|NCT03227757|50180451|FG000|Overall Study|Withdrawal|5|||
25073704|NCT03227757|50180451|FG000|Overall Study|Missed visits|4|||
25073705|NCT02751827|50180458|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
25073706|NCT02751827|50180459|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
25073707|NCT02751827|50180460|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
25073708|NCT04896593|50180477|FG000|Overall Study|Withdrawal by Subject|2|||
25073709|NCT04896593|50180477|FG000|Overall Study|Lost to Follow-up|1|||
25073710|NCT04896593|50180477|FG000|Overall Study|Did not complete onboarding|2|||
25073711|NCT04601272|50180493|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
25073712|NCT04601272|50180494|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
24973559|NCT00112437|50062149|FG018|Years 6-10 (60-Month Extension)|Death|0|||
24973560|NCT00112437|50062150|FG019|Years 6-10 (60-Month Extension)|Death|0|||
24973561|NCT00112437|50062151|FG020|Years 6-10 (60-Month Extension)|Death|0|||
25073713|NCT04601272|50180495|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
25073714|NCT04059484|50180514|FG000|Overall Study|Adverse Event|2|||
25073715|NCT04059484|50180515|FG001|Overall Study|Adverse Event|5|||
25073716|NCT04059484|50180514|FG000|Overall Study|Withdrawal by Subject|5|||
25073717|NCT04059484|50180515|FG001|Overall Study|Withdrawal by Subject|3|||
25073718|NCT04059484|50180514|FG000|Overall Study|Progressive disease|112|||
25073719|NCT04059484|50180515|FG001|Overall Study|Progressive disease|112|||
25073720|NCT04059484|50180514|FG000|Overall Study|Other|8|||
25073721|NCT04059484|50180515|FG001|Overall Study|Other|3|||
25073722|NCT04059484|50180514|FG000|Overall Study|Ongoing|20|||
25073723|NCT04059484|50180515|FG001|Overall Study|Ongoing|20|||
25073724|NCT03965091|50180527|FG000|Overall Study|Adverse Event|0|||
25073725|NCT03965091|50180528|FG001|Overall Study|Adverse Event|2|||
25073726|NCT03965091|50180529|FG002|Overall Study|Adverse Event|3|||
25073727|NCT03965091|50180527|FG000|Overall Study|Withdrawal by Subject|11|||
25073728|NCT03965091|50180528|FG001|Overall Study|Withdrawal by Subject|3|||
25073729|NCT03965091|50180529|FG002|Overall Study|Withdrawal by Subject|5|||
25073730|NCT03965091|50180527|FG000|Overall Study|Non-compliance with study drug|0|||
25073731|NCT03965091|50180528|FG001|Overall Study|Non-compliance with study drug|0|||
25073732|NCT03965091|50180529|FG002|Overall Study|Non-compliance with study drug|1|||
25073733|NCT03965091|50180527|FG000|Overall Study|Lost to Follow-up|1|||
25073734|NCT03965091|50180528|FG001|Overall Study|Lost to Follow-up|1|||
25073735|NCT03965091|50180529|FG002|Overall Study|Lost to Follow-up|1|||
25073736|NCT03965091|50180527|FG000|Overall Study|Lack of Efficacy|2|||
25073737|NCT03965091|50180528|FG001|Overall Study|Lack of Efficacy|0|||
25073738|NCT03965091|50180529|FG002|Overall Study|Lack of Efficacy|0|||
25073739|NCT03965091|50180527|FG000|Overall Study|Other than specified|9|||
25073740|NCT03965091|50180528|FG001|Overall Study|Other than specified|11|||
25073741|NCT03965091|50180529|FG002|Overall Study|Other than specified|8|||
25073742|NCT03359096|50180556|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
25073743|NCT03359096|50180557|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
25073744|NCT03359096|50180556|FG000|First Intervention (4 Weeks)|Death|1|||
25073745|NCT03359096|50180557|FG001|First Intervention (4 Weeks)|Death|0|||
25073746|NCT03359096|50180556|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
25073747|NCT03359096|50180557|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
25073748|NCT03261700|50180565|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
25073749|NCT03261700|50180566|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
25073750|NCT03019588|50180595|FG000|Overall Study|Death|44|||
25073751|NCT03019588|50180596|FG001|Overall Study|Death|46|||
25073752|NCT03019588|50180595|FG000|Overall Study|Study terminated by Sponsor|3|||
25073753|NCT03019588|50180596|FG001|Overall Study|Study terminated by Sponsor|1|||
25073754|NCT02455557|50180628|FG000|Overall Study|Withdrawal by Subject|2|||
25073755|NCT02270450|50180636|FG000|Overall Study|Refusal unrelated to adverse event|3|||
25073756|NCT02270450|50180637|FG001|Overall Study|Refusal unrelated to adverse event|1|||
25073757|NCT02270450|50180638|FG002|Overall Study|Refusal unrelated to adverse event|5|||
25073758|NCT02270450|50180639|FG003|Overall Study|Refusal unrelated to adverse event|14|||
25073759|NCT02270450|50180636|FG000|Overall Study|Progression/relapse|1|||
25073760|NCT02270450|50180637|FG001|Overall Study|Progression/relapse|2|||
25073761|NCT02270450|50180638|FG002|Overall Study|Progression/relapse|4|||
25073762|NCT02270450|50180639|FG003|Overall Study|Progression/relapse|9|||
25073763|NCT02270450|50180636|FG000|Overall Study|Death|19|||
25073764|NCT02270450|50180637|FG001|Overall Study|Death|19|||
25073765|NCT02270450|50180638|FG002|Overall Study|Death|31|||
25073766|NCT02270450|50180639|FG003|Overall Study|Death|59|||
25073767|NCT01570868|50180662|FG000|Overall Study|Adverse Event|8|||
25073768|NCT01570868|50180663|FG001|Overall Study|Adverse Event|1|||
25073769|NCT01570868|50180662|FG000|Overall Study|FDA Recommendation|23|||
25073770|NCT01570868|50180663|FG001|Overall Study|FDA Recommendation|3|||
25073771|NCT01570868|50180662|FG000|Overall Study|Physician Decision|10|||
25073772|NCT01570868|50180663|FG001|Overall Study|Physician Decision|4|||
24973562|NCT00112437|50062152|FG021|Years 6-10 (60-Month Extension)|Death|0|||
25073773|NCT01570868|50180662|FG000|Overall Study|Lost to Follow-up|1|||
25192487|NCT01414166|50359185|FG001|Overall Study|Adverse Event|2|||
25192488|NCT01414166|50359184|FG000|Overall Study|Lost to Follow-up|4|||
25192489|NCT01414166|50359185|FG001|Overall Study|Lost to Follow-up|1|||
25192490|NCT01414166|50359184|FG000|Overall Study|Non-compliance with study drug|2|||
25192491|NCT01414166|50359185|FG001|Overall Study|Non-compliance with study drug|0|||
25073774|NCT01570868|50180663|FG001|Overall Study|Lost to Follow-up|0|||
25314644|NCT00842829|50630496|FG001|Dose Titration Period|Lack of Efficacy|1|||
25073775|NCT01570868|50180662|FG000|Overall Study|Withdrawal by Subject|1|||
25073776|NCT01570868|50180663|FG001|Overall Study|Withdrawal by Subject|0|||
25073777|NCT01565499|50180673|FG000|Overall Study|Physician Decision|1|||
25192492|NCT01414166|50359184|FG000|Overall Study|Physician Decision|2|||
25073778|NCT01565499|50180673|FG000|Overall Study|Adverse Event|5|||
25073779|NCT01565499|50180673|FG000|Overall Study|Withdrawal by Subject|2|||
25073780|NCT01036087|50180677|FG000|Overall Study|Adverse Event|2|||
25073781|NCT01036087|50180677|FG000|Overall Study|Lack of Efficacy|1|||
25073782|NCT00572156|50180694|FG000|Overall Study|Adverse Event|3|||
25073783|NCT00572156|50180695|FG001|Overall Study|Adverse Event|1|||
25073784|NCT00572156|50180696|FG002|Overall Study|Adverse Event|5|||
25073785|NCT00572156|50180697|FG003|Overall Study|Adverse Event|1|||
25073786|NCT00572156|50180694|FG000|Overall Study|Lost to Follow-up|1|||
24973563|NCT00112437|50062153|FG022|Years 6-10 (60-Month Extension)|Death|0|||
24973564|NCT00112437|50062154|FG023|Years 6-10 (60-Month Extension)|Death|2|||
24973565|NCT00112437|50062155|FG024|Years 6-10 (60-Month Extension)|Death|0|||
24973566|NCT00112437|50062156|FG025|Years 6-10 (60-Month Extension)|Death|0|||
25073787|NCT00572156|50180695|FG001|Overall Study|Lost to Follow-up|1|||
25073788|NCT00572156|50180696|FG002|Overall Study|Lost to Follow-up|1|||
25073789|NCT00572156|50180697|FG003|Overall Study|Lost to Follow-up|0|||
25073790|NCT00572156|50180694|FG000|Overall Study|Protocol Violation|1|||
24973567|NCT00112437|50062131|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973568|NCT00112437|50062132|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973569|NCT00112437|50062133|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973570|NCT00112437|50062134|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973571|NCT00112437|50062135|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973572|NCT00112437|50062136|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
25073791|NCT00572156|50180695|FG001|Overall Study|Protocol Violation|2|||
25073792|NCT00572156|50180696|FG002|Overall Study|Protocol Violation|0|||
25073793|NCT00572156|50180697|FG003|Overall Study|Protocol Violation|2|||
25073794|NCT00572156|50180694|FG000|Overall Study|Patient/Parent Decision|1|||
25073795|NCT00572156|50180695|FG001|Overall Study|Patient/Parent Decision|6|||
25073796|NCT00572156|50180696|FG002|Overall Study|Patient/Parent Decision|4|||
25073797|NCT00572156|50180697|FG003|Overall Study|Patient/Parent Decision|3|||
25073798|NCT00572156|50180694|FG000|Overall Study|Sponsor Decision|20|||
25073799|NCT00572156|50180695|FG001|Overall Study|Sponsor Decision|16|||
25073800|NCT00572156|50180696|FG002|Overall Study|Sponsor Decision|17|||
25073801|NCT00572156|50180697|FG003|Overall Study|Sponsor Decision|19|||
25073802|NCT00447772|50180707|FG000|Overall Study|Lack of Efficacy|3|||
25073803|NCT00447772|50180707|FG000|Overall Study|Insufficient compliance|6|||
25073804|NCT00447772|50180707|FG000|Overall Study|Discontinuation of drug therapy|1|||
25073805|NCT00447772|50180707|FG000|Overall Study|Lost to Follow-up|9|||
25073806|NCT00447772|50180707|FG000|Overall Study|Withdrawal by Subject|1|||
25073807|NCT00447772|50180707|FG000|Overall Study|Unable to attend all study visits|2|||
25073808|NCT00447772|50180707|FG000|Overall Study|Adverse Event|1|||
25073809|NCT00447772|50180707|FG000|Overall Study|Patient relocated|1|||
24973573|NCT00112437|50062137|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
25073810|NCT00447772|50180707|FG000|Overall Study|Incomplete documentation at visit 1|1|||
25073811|NCT00447772|50180707|FG000|Overall Study|Chemotherapy for lung cancer|1|||
25073812|NCT00447772|50180707|FG000|Overall Study|Premature re-injection required|1|||
25073813|NCT02296138|50180716|FG000|Overall Study|Adverse Event|348|||
25073814|NCT02296138|50180717|FG001|Overall Study|Adverse Event|259|||
25073815|NCT02296138|50180716|FG000|Overall Study|Lack of Efficacy|59|||
25073816|NCT02296138|50180717|FG001|Overall Study|Lack of Efficacy|37|||
25073817|NCT02296138|50180716|FG000|Overall Study|Protocol Violation|35|||
25073818|NCT02296138|50180717|FG001|Overall Study|Protocol Violation|36|||
25073819|NCT02296138|50180716|FG000|Overall Study|Lost to Follow-up|9|||
25073820|NCT02296138|50180717|FG001|Overall Study|Lost to Follow-up|12|||
25073821|NCT02296138|50180716|FG000|Overall Study|Withdrawal by Subject|184|||
25073822|NCT02296138|50180717|FG001|Overall Study|Withdrawal by Subject|131|||
25073823|NCT02296138|50180716|FG000|Overall Study|Not Treated|1|||
25073824|NCT02296138|50180717|FG001|Overall Study|Not Treated|1|||
25073825|NCT02296138|50180716|FG000|Overall Study|Patients with data irregularities|10|||
25073826|NCT02296138|50180717|FG001|Overall Study|Patients with data irregularities|11|||
25073827|NCT02296138|50180716|FG000|Overall Study|Other than specified|15|||
25073828|NCT02296138|50180717|FG001|Overall Study|Other than specified|13|||
25073829|NCT01306942|50180726|FG000|Phase I|Adverse Event|2|||
25073830|NCT01306942|50180727|FG001|Phase I|Adverse Event|2|||
25073831|NCT01306942|50180728|FG002|Phase I|Adverse Event|0|||
25314645|NCT00842829|50630497|FG002|Dose Titration Period|Lack of Efficacy|0|||
24973574|NCT00112437|50062138|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973575|NCT00112437|50062139|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
25073832|NCT01306942|50180729|FG003|Phase I|Adverse Event|0|||
25073833|NCT01306942|50180726|FG000|Phase I|Physician Decision|3|||
25073834|NCT01306942|50180727|FG001|Phase I|Physician Decision|1|||
25073835|NCT01306942|50180728|FG002|Phase I|Physician Decision|0|||
25073836|NCT01306942|50180729|FG003|Phase I|Physician Decision|0|||
25073837|NCT01306942|50180726|FG000|Phase II|Adverse Event|0|||
25073838|NCT01306942|50180727|FG001|Phase II|Adverse Event|0|||
25073839|NCT01306942|50180728|FG002|Phase II|Adverse Event|0|||
25073840|NCT01306942|50180729|FG003|Phase II|Adverse Event|6|||
25073841|NCT01306942|50180726|FG000|Phase II|Physician Decision|2|||
25073842|NCT01306942|50180727|FG001|Phase II|Physician Decision|0|||
25073843|NCT01306942|50180728|FG002|Phase II|Physician Decision|0|||
25073844|NCT01306942|50180729|FG003|Phase II|Physician Decision|5|||
25073845|NCT01306942|50180726|FG000|Phase II|Withdrawal by Subject|0|||
25073846|NCT01306942|50180727|FG001|Phase II|Withdrawal by Subject|0|||
25073847|NCT01306942|50180728|FG002|Phase II|Withdrawal by Subject|0|||
25073848|NCT01306942|50180729|FG003|Phase II|Withdrawal by Subject|2|||
25073849|NCT01306942|50180726|FG000|Phase II|Death|0|||
25192493|NCT01414166|50359185|FG001|Overall Study|Physician Decision|0|||
25192494|NCT01414166|50359184|FG000|Overall Study|Protocol Violation|2|||
24973576|NCT00112437|50062140|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973577|NCT00112437|50062141|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973578|NCT00112437|50062142|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973579|NCT00112437|50062143|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973580|NCT00112437|50062144|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973581|NCT00112437|50062145|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973582|NCT00112437|50062146|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973583|NCT00112437|50062147|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973584|NCT00112437|50062148|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973585|NCT00112437|50062149|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973586|NCT00112437|50062150|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973587|NCT00112437|50062151|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973588|NCT00112437|50062152|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973589|NCT00112437|50062153|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973590|NCT00112437|50062154|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973591|NCT00112437|50062155|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
24973592|NCT00112437|50062156|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
24973593|NCT00112437|50062131|FG000|Years 6-10 (60-Month Extension)|Other|0|||
24973594|NCT00112437|50062132|FG001|Years 6-10 (60-Month Extension)|Other|0|||
24973595|NCT00112437|50062133|FG002|Years 6-10 (60-Month Extension)|Other|0|||
24973596|NCT00112437|50062134|FG003|Years 6-10 (60-Month Extension)|Other|0|||
24973597|NCT00112437|50062135|FG004|Years 6-10 (60-Month Extension)|Other|0|||
24973598|NCT00112437|50062136|FG005|Years 6-10 (60-Month Extension)|Other|0|||
24973599|NCT00112437|50062137|FG006|Years 6-10 (60-Month Extension)|Other|0|||
24973600|NCT00112437|50062138|FG007|Years 6-10 (60-Month Extension)|Other|0|||
24973601|NCT00112437|50062139|FG008|Years 6-10 (60-Month Extension)|Other|0|||
24973602|NCT00112437|50062140|FG009|Years 6-10 (60-Month Extension)|Other|0|||
24973603|NCT00112437|50062141|FG010|Years 6-10 (60-Month Extension)|Other|0|||
24973604|NCT00112437|50062142|FG011|Years 6-10 (60-Month Extension)|Other|0|||
24973605|NCT00112437|50062143|FG012|Years 6-10 (60-Month Extension)|Other|0|||
24973606|NCT00112437|50062144|FG013|Years 6-10 (60-Month Extension)|Other|0|||
24973607|NCT00112437|50062145|FG014|Years 6-10 (60-Month Extension)|Other|0|||
24973608|NCT00112437|50062146|FG015|Years 6-10 (60-Month Extension)|Other|0|||
24973609|NCT00112437|50062147|FG016|Years 6-10 (60-Month Extension)|Other|0|||
24973610|NCT00112437|50062148|FG017|Years 6-10 (60-Month Extension)|Other|0|||
24973611|NCT00112437|50062149|FG018|Years 6-10 (60-Month Extension)|Other|0|||
24973612|NCT00112437|50062150|FG019|Years 6-10 (60-Month Extension)|Other|0|||
24973613|NCT00112437|50062151|FG020|Years 6-10 (60-Month Extension)|Other|0|||
24973614|NCT00112437|50062152|FG021|Years 6-10 (60-Month Extension)|Other|0|||
24973615|NCT00112437|50062153|FG022|Years 6-10 (60-Month Extension)|Other|0|||
24973616|NCT00112437|50062154|FG023|Years 6-10 (60-Month Extension)|Other|0|||
24973617|NCT00112437|50062155|FG024|Years 6-10 (60-Month Extension)|Other|1|||
24973618|NCT00112437|50062156|FG025|Years 6-10 (60-Month Extension)|Other|0|||
24973619|NCT00112437|50062131|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973620|NCT00112437|50062132|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
25192495|NCT01414166|50359185|FG001|Overall Study|Protocol Violation|0|||
24973621|NCT00112437|50062133|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973622|NCT00112437|50062134|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973623|NCT00112437|50062135|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
25192496|NCT01414166|50359184|FG000|Overall Study|Study terminated by Sponsor|68|||
25192497|NCT01414166|50359185|FG001|Overall Study|Study terminated by Sponsor|75|||
25192498|NCT01414166|50359184|FG000|Overall Study|Withdrawal by Subject|3|||
24973624|NCT00112437|50062136|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973625|NCT00112437|50062137|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
25073850|NCT01306942|50180727|FG001|Phase II|Death|0|||
24973626|NCT00112437|50062138|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973627|NCT00112437|50062139|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973628|NCT00112437|50062140|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973629|NCT00112437|50062141|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973630|NCT00112437|50062142|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973631|NCT00112437|50062143|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973632|NCT00112437|50062144|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973633|NCT00112437|50062145|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973634|NCT00112437|50062146|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973635|NCT00112437|50062147|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973636|NCT00112437|50062148|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973637|NCT00112437|50062149|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973638|NCT00112437|50062150|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973639|NCT00112437|50062151|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973640|NCT00112437|50062152|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973641|NCT00112437|50062153|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973642|NCT00112437|50062154|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
24973643|NCT00112437|50062155|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973644|NCT00112437|50062156|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
24973645|NCT00112437|50062131|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
25073851|NCT01306942|50180728|FG002|Phase II|Death|0|||
25073852|NCT01306942|50180729|FG003|Phase II|Death|1|||
25073853|NCT01306942|50180726|FG000|Phase II|Not finished treatment|0|||
25073854|NCT01306942|50180727|FG001|Phase II|Not finished treatment|0|||
25073855|NCT01306942|50180728|FG002|Phase II|Not finished treatment|0|||
25073856|NCT01306942|50180729|FG003|Phase II|Not finished treatment|1|||
25073857|NCT01306942|50180726|FG000|Phase II|Protocol Violation|0|||
25073858|NCT01306942|50180727|FG001|Phase II|Protocol Violation|0|||
25073859|NCT01306942|50180728|FG002|Phase II|Protocol Violation|0|||
25073860|NCT01306942|50180729|FG003|Phase II|Protocol Violation|1|||
25073861|NCT02324842|50180744|FG000|Overall Study|Lost to Follow-up|1|||
25073862|NCT02324842|50180745|FG001|Overall Study|Lost to Follow-up|1|||
25073863|NCT02324842|50180746|FG002|Overall Study|Lost to Follow-up|2|||
25073864|NCT02295280|50180756|FG000|Overall Study|Adverse Event|0|||
25073865|NCT02295280|50180757|FG001|Overall Study|Adverse Event|1|||
25073866|NCT02294734|50180765|FG000|Overall Study|Adverse Event|5|||
25073867|NCT02294734|50180766|FG001|Overall Study|Adverse Event|5|||
25073868|NCT02294734|50180765|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
25073869|NCT02294734|50180766|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
25073870|NCT02294734|50180765|FG000|Overall Study|Lost to Follow-up|2|||
25073871|NCT02294734|50180766|FG001|Overall Study|Lost to Follow-up|0|||
25073872|NCT02294734|50180765|FG000|Overall Study|Physician Decision|2|||
25073873|NCT02294734|50180766|FG001|Overall Study|Physician Decision|1|||
25073874|NCT02294734|50180765|FG000|Overall Study|Withdrawal by Subject|4|||
25073875|NCT02294734|50180766|FG001|Overall Study|Withdrawal by Subject|2|||
25073876|NCT02323204|50180787|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
25073877|NCT02323204|50180788|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
25073878|NCT02323204|50180789|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
25073879|NCT02323204|50180790|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
25073880|NCT02323204|50180787|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
25073881|NCT02323204|50180788|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
25073882|NCT02323204|50180789|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
25073883|NCT02323204|50180790|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
25073884|NCT02323204|50180787|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
25073885|NCT02323204|50180788|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
24973646|NCT00112437|50062132|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973647|NCT00112437|50062133|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973648|NCT00112437|50062134|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973649|NCT00112437|50062135|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973650|NCT00112437|50062136|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973651|NCT00112437|50062137|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973652|NCT00112437|50062138|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973653|NCT00112437|50062139|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
25073886|NCT02323204|50180789|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
25073887|NCT02323204|50180790|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
25073888|NCT02323204|50180787|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
25073889|NCT02323204|50180788|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
25073890|NCT02323204|50180789|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
25073891|NCT02323204|50180790|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
25073892|NCT02323204|50180787|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
24973654|NCT00112437|50062140|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973655|NCT00112437|50062141|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973656|NCT00112437|50062142|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973657|NCT00112437|50062143|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
25073893|NCT02323204|50180788|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
25073894|NCT02323204|50180789|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
25073895|NCT02323204|50180790|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
25073896|NCT02323204|50180787|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
25073897|NCT02323204|50180788|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
25073898|NCT02323204|50180789|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
25073899|NCT02323204|50180790|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
25073900|NCT02323204|50180787|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
25073901|NCT02323204|50180788|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
25073902|NCT02323204|50180789|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
25073903|NCT02323204|50180790|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
25073904|NCT02323204|50180787|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
25073905|NCT02323204|50180788|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
25073906|NCT02323204|50180789|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
25073907|NCT02323204|50180790|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
25073908|NCT02323204|50180787|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
25073909|NCT02323204|50180788|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
25073910|NCT02323204|50180789|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
25073911|NCT02323204|50180790|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
25073912|NCT02322892|50180802|FG000|Overall Study|Surgery cancelled|1|||
24973658|NCT00112437|50062144|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973659|NCT00112437|50062145|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973660|NCT00112437|50062146|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
25073913|NCT02322892|50180803|FG001|Overall Study|Surgery cancelled|2|||
25073914|NCT02322892|50180802|FG000|Overall Study|Met exclusion criteria|0|||
24973661|NCT00112437|50062147|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
25073915|NCT02322892|50180803|FG001|Overall Study|Met exclusion criteria|1|||
25073916|NCT02322892|50180802|FG000|Overall Study|Protocol Violation|1|||
25073917|NCT02322892|50180803|FG001|Overall Study|Protocol Violation|0|||
25073918|NCT03916081|50180812|FG000|Overall Study|Adverse Event|1|||
25073919|NCT03916081|50180813|FG001|Overall Study|Adverse Event|0|||
25073920|NCT03916081|50180814|FG002|Overall Study|Adverse Event|0|||
25073921|NCT03916081|50180812|FG000|Overall Study|Physician Decision|0|||
25073922|NCT03916081|50180813|FG001|Overall Study|Physician Decision|0|||
25073923|NCT03916081|50180814|FG002|Overall Study|Physician Decision|1|||
25073924|NCT03916081|50180812|FG000|Overall Study|Lost to Follow-up|0|||
25073925|NCT03916081|50180813|FG001|Overall Study|Lost to Follow-up|1|||
25073926|NCT03916081|50180814|FG002|Overall Study|Lost to Follow-up|0|||
25073927|NCT03916081|50180812|FG000|Overall Study|Withdrawal by Subject|3|||
25073928|NCT03916081|50180813|FG001|Overall Study|Withdrawal by Subject|0|||
25073929|NCT03916081|50180814|FG002|Overall Study|Withdrawal by Subject|1|||
25073930|NCT03916081|50180812|FG000|Overall Study|Worsening of AD|0|||
25073931|NCT03916081|50180813|FG001|Overall Study|Worsening of AD|0|||
25073932|NCT03916081|50180814|FG002|Overall Study|Worsening of AD|1|||
25073933|NCT02739997|50180822|FG000|Overall Study|Death|1|||
25073934|NCT02739997|50180822|FG000|Overall Study|Withdrawal by Subject|1|||
25073935|NCT02221037|50180830|FG000|Overall Study|Physician Decision|0|||
25073936|NCT02221037|50180831|FG001|Overall Study|Physician Decision|0|||
25073937|NCT02221037|50180832|FG002|Overall Study|Physician Decision|1|||
25073938|NCT02221037|50180833|FG003|Overall Study|Physician Decision|0|||
25192499|NCT01414166|50359185|FG001|Overall Study|Withdrawal by Subject|5|||
25192500|NCT01434680|50359195|FG000|Overall Study|Withdrawal by Subject|1|||
25073939|NCT02704429|50180849|FG000|Part A: 24 Weeks|Adverse Event|3|||
25073940|NCT02704429|50180850|FG001|Part A: 24 Weeks|Adverse Event|0|||
25073941|NCT02704429|50180849|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
25073942|NCT02704429|50180850|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
25073943|NCT02751359|50180857|FG000|Overall Study|Lost to Follow-up|1|||
24973662|NCT00112437|50062148|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973663|NCT00112437|50062149|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973664|NCT00112437|50062150|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973665|NCT00112437|50062151|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973666|NCT00112437|50062152|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973667|NCT00112437|50062153|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
24973668|NCT00112437|50062154|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
24973669|NCT00112437|50062155|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
24973670|NCT00112437|50062156|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
24973671|NCT03653416|50062212|FG000|Overall Study|Protocol Violation|6|||
24973672|NCT03653416|50062213|FG001|Overall Study|Protocol Violation|1|||
24973673|NCT00112359|50062221|FG000|Overall Study|Unrelated adverse event|16|||
24973674|NCT00112359|50062222|FG001|Overall Study|Unrelated adverse event|8|||
24973675|NCT00112359|50062221|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
24973676|NCT00112359|50062222|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
24973677|NCT00112359|50062221|FG000|Overall Study|Related adverse event|5|||
24973678|NCT00112359|50062222|FG001|Overall Study|Related adverse event|3|||
24973679|NCT00112359|50062221|FG000|Overall Study|Lost to Follow-up|0|||
24973680|NCT00112359|50062222|FG001|Overall Study|Lost to Follow-up|1|||
24973681|NCT00112359|50062221|FG000|Overall Study|Personal/administrative|1|||
24973682|NCT00112359|50062222|FG001|Overall Study|Personal/administrative|1|||
24973683|NCT00112359|50062221|FG000|Overall Study|Other|3|||
24973684|NCT00112359|50062222|FG001|Overall Study|Other|0|||
24973685|NCT00119379|50062230|FG000|Overall Study|Adverse Event|4|||
24973686|NCT00119379|50062231|FG001|Overall Study|Adverse Event|1|||
24973687|NCT00118911|50062239|FG000|Overall Study|Withdrawal by Subject|2|||
24973688|NCT00118911|50062240|FG001|Overall Study|Withdrawal by Subject|5|||
24973689|NCT00131937|50062246|FG000|Overall Study|Adverse Event|3|||
24973690|NCT00131937|50062246|FG000|Overall Study|Withdrawal by Subject|2|||
24973691|NCT00131937|50062246|FG000|Overall Study|Physician Decision|1|||
24973692|NCT00131937|50062246|FG000|Overall Study|Disease Progression|7|||
24973693|NCT00131937|50062246|FG000|Overall Study|Alternative therapy|1|||
24973694|NCT00131469|50062252|FG000|Overall Study|Withdrawal by Subject|3|||
24973695|NCT00131469|50062253|FG001|Overall Study|Withdrawal by Subject|4|||
24973696|NCT00131469|50062252|FG000|Overall Study|Protocol Violation|3|||
24973697|NCT00131469|50062253|FG001|Overall Study|Protocol Violation|1|||
24973698|NCT00131469|50062252|FG000|Overall Study|Death|0|||
24973699|NCT00131469|50062253|FG001|Overall Study|Death|1|||
24973700|NCT00131469|50062252|FG000|Overall Study|Lost to Follow-up|0|||
24973701|NCT00131469|50062253|FG001|Overall Study|Lost to Follow-up|1|||
24973702|NCT00131469|50062252|FG000|Overall Study|scan not analyzable|3|||
24973703|NCT00131469|50062253|FG001|Overall Study|scan not analyzable|6|||
24973704|NCT00372593|50062262|FG000|Overall Study|Adverse Event|43|||
24973705|NCT00372593|50062263|FG001|Overall Study|Adverse Event|45|||
24973706|NCT00372593|50062264|FG002|Overall Study|Adverse Event|0|||
24973707|NCT00372593|50062262|FG000|Overall Study|Death|16|||
24973708|NCT00372593|50062263|FG001|Overall Study|Death|20|||
24973709|NCT00372593|50062264|FG002|Overall Study|Death|1|||
24973710|NCT00372593|50062262|FG000|Overall Study|Lack of Efficacy|82|||
24973711|NCT00372593|50062263|FG001|Overall Study|Lack of Efficacy|71|||
24973712|NCT00372593|50062264|FG002|Overall Study|Lack of Efficacy|2|||
24973713|NCT00372593|50062262|FG000|Overall Study|Lost to Follow-up|1|||
24973714|NCT00372593|50062263|FG001|Overall Study|Lost to Follow-up|0|||
24973715|NCT00372593|50062264|FG002|Overall Study|Lost to Follow-up|0|||
24973716|NCT00372593|50062262|FG000|Overall Study|Physician Decision|42|||
24973717|NCT00372593|50062263|FG001|Overall Study|Physician Decision|41|||
25073944|NCT02750813|50180876|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
25073945|NCT02750813|50180877|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
25073946|NCT02750813|50180876|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
25073947|NCT02750813|50180877|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
25073948|NCT00503035|50180893|FG000|Overall Study|Lost to Follow-up|2|||
25073949|NCT00503035|50180893|FG000|Overall Study|Physician Decision|3|||
25073950|NCT00503035|50180893|FG000|Overall Study|Ineligible|15|||
25073951|NCT03137381|50180902|FG000|Overall Study|Adverse Event|3|||
25073952|NCT03137381|50180903|FG001|Overall Study|Adverse Event|0|||
25073953|NCT03137381|50180904|FG002|Overall Study|Adverse Event|2|||
25073954|NCT03137381|50180905|FG003|Overall Study|Adverse Event|0|||
25073955|NCT03137381|50180902|FG000|Overall Study|Lost to Follow-up|2|||
25073956|NCT03137381|50180903|FG001|Overall Study|Lost to Follow-up|1|||
25073957|NCT03137381|50180904|FG002|Overall Study|Lost to Follow-up|1|||
25073958|NCT03137381|50180905|FG003|Overall Study|Lost to Follow-up|0|||
25073959|NCT03137381|50180902|FG000|Overall Study|Protocol deviation|1|||
25073960|NCT03137381|50180903|FG001|Overall Study|Protocol deviation|1|||
25073961|NCT03137381|50180904|FG002|Overall Study|Protocol deviation|0|||
25073962|NCT03137381|50180905|FG003|Overall Study|Protocol deviation|1|||
25073963|NCT03137381|50180902|FG000|Overall Study|Withdrawal by Investigator|0|||
25073964|NCT03137381|50180903|FG001|Overall Study|Withdrawal by Investigator|1|||
25073965|NCT03137381|50180904|FG002|Overall Study|Withdrawal by Investigator|1|||
25073966|NCT03137381|50180905|FG003|Overall Study|Withdrawal by Investigator|0|||
25073967|NCT03137381|50180902|FG000|Overall Study|Withdrawal by Subject|3|||
25073968|NCT03137381|50180903|FG001|Overall Study|Withdrawal by Subject|4|||
24973718|NCT00372593|50062264|FG002|Overall Study|Physician Decision|0|||
24973719|NCT00372593|50062262|FG000|Overall Study|Ineligible|20|||
24973720|NCT00372593|50062263|FG001|Overall Study|Ineligible|21|||
24973721|NCT00372593|50062264|FG002|Overall Study|Ineligible|1|||
25073969|NCT03137381|50180904|FG002|Overall Study|Withdrawal by Subject|3|||
25073970|NCT03137381|50180905|FG003|Overall Study|Withdrawal by Subject|0|||
25073971|NCT03137381|50180902|FG000|Overall Study|Pregnancy|0|||
25073972|NCT03137381|50180903|FG001|Overall Study|Pregnancy|0|||
25073973|NCT03137381|50180904|FG002|Overall Study|Pregnancy|1|||
25073974|NCT03137381|50180905|FG003|Overall Study|Pregnancy|0|||
25073975|NCT02750501|50180932|FG000|Overall Study|Adverse Event|4|||
25073976|NCT02750501|50180932|FG000|Overall Study|Physician Decision|1|||
25073977|NCT02750501|50180932|FG000|Overall Study|Protocol Violation|1|||
25073978|NCT02750501|50180932|FG000|Overall Study|G-tube came out|1|||
25073979|NCT02750501|50180932|FG000|Overall Study|Non-compliant use of PERT|1|||
25073980|NCT01337297|50180946|FG000|Overall Study|They entered to single anodal tDCS|4|||
25073981|NCT01337297|50180947|FG001|Overall Study|They entered to single anodal tDCS|3|||
25073982|NCT01337297|50180946|FG000|Overall Study|Lost to Follow-up|1|||
25073983|NCT01337297|50180947|FG001|Overall Study|Lost to Follow-up|3|||
25073984|NCT02302963|50180955|FG000|Overall Study|Withdrawal by Subject|2|||
25073985|NCT02302963|50180956|FG001|Overall Study|Withdrawal by Subject|1|||
25073986|NCT02302963|50180955|FG000|Overall Study|Steroid injection|0|||
25169958|NCT01377012|50303601|FG000|Core Study|Death|1|||
25169959|NCT01377012|50303602|FG001|Core Study|Death|1|||
25169960|NCT01377012|50303603|FG002|Core Study|Death|1|||
25169961|NCT01377012|50303601|FG000|Core Study|Adverse Event|10|||
24973722|NCT03666988|50062279|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
24973723|NCT03666988|50062280|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
24973724|NCT03666988|50062281|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
24973725|NCT03666988|50062282|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
24973726|NCT03666988|50062283|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
24973727|NCT03666988|50062284|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
24973728|NCT03666988|50062279|FG000|Part 1 (Up to 28 Months)|Other|0|||
24973729|NCT03666988|50062280|FG001|Part 1 (Up to 28 Months)|Other|1|||
24973730|NCT03666988|50062281|FG002|Part 1 (Up to 28 Months)|Other|1|||
24973731|NCT03666988|50062282|FG003|Part 1 (Up to 28 Months)|Other|0|||
24973732|NCT03666988|50062283|FG004|Part 1 (Up to 28 Months)|Other|0|||
24973733|NCT03666988|50062284|FG005|Part 1 (Up to 28 Months)|Other|0|||
24973734|NCT03666988|50062279|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
25073987|NCT02302963|50180956|FG001|Overall Study|Steroid injection|1|||
25073988|NCT02302963|50180955|FG000|Overall Study|Physician Decision|1|||
25169962|NCT01377012|50303602|FG001|Core Study|Adverse Event|14|||
25073989|NCT02302963|50180956|FG001|Overall Study|Physician Decision|0|||
25073990|NCT04702997|50180964|FG000|Overall Study|Withdrawal by Subject|1|||
25073991|NCT04702997|50180965|FG001|Overall Study|Withdrawal by Subject|1|||
25073992|NCT03507127|50180986|FG000|Overall Study|Withdrawal by Subject|1|||
25073993|NCT03507127|50180987|FG001|Overall Study|Withdrawal by Subject|0|||
25073994|NCT03507127|50180986|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
25073995|NCT03507127|50180987|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
25169963|NCT01377012|50303603|FG002|Core Study|Adverse Event|13|||
24973735|NCT03666988|50062280|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
24973736|NCT03666988|50062281|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
25073996|NCT02322190|50181010|FG000|Overall Study|Death on study|1|||
25169964|NCT01377012|50303601|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
25073997|NCT02322190|50181011|FG001|Overall Study|Death on study|0|||
25073998|NCT02321800|50181027|FG000|Overall Study|Withdrawal by Subject|3|||
25073999|NCT02321800|50181028|FG001|Overall Study|Withdrawal by Subject|3|||
25074000|NCT02321800|50181027|FG000|Overall Study|Death|1|||
25074001|NCT02321800|50181028|FG001|Overall Study|Death|0|||
25074002|NCT02321800|50181027|FG000|Overall Study|Protocol Violation|1|||
25074003|NCT02321800|50181028|FG001|Overall Study|Protocol Violation|0|||
25074004|NCT02321800|50181027|FG000|Overall Study|Lost to Follow-up|10|||
25074005|NCT02321800|50181028|FG001|Overall Study|Lost to Follow-up|4|||
25074006|NCT02321800|50181027|FG000|Overall Study|Adverse Event|2|||
25074007|NCT02321800|50181028|FG001|Overall Study|Adverse Event|3|||
25074008|NCT02321800|50181027|FG000|Overall Study|Other, Miscellaneous|3|||
25074009|NCT02321800|50181028|FG001|Overall Study|Other, Miscellaneous|1|||
25074010|NCT02292784|50181074|FG000|Overall Study|Lost to Follow-up|1|||
25074011|NCT02292784|50181075|FG001|Overall Study|Lost to Follow-up|17|||
25074012|NCT02292784|50181076|FG002|Overall Study|Lost to Follow-up|18|||
25074013|NCT02292784|50181074|FG000|Overall Study|Withdrawal by Subject|0|||
25074014|NCT02292784|50181075|FG001|Overall Study|Withdrawal by Subject|3|||
25074015|NCT02292784|50181076|FG002|Overall Study|Withdrawal by Subject|3|||
25074016|NCT02320396|50181086|FG000|Overall Study|Adverse Event|2|||
25074017|NCT02320396|50181087|FG001|Overall Study|Adverse Event|2|||
25074018|NCT02320396|50181086|FG000|Overall Study|Pregnancy|0|||
25074019|NCT02320396|50181087|FG001|Overall Study|Pregnancy|1|||
25074020|NCT02320396|50181086|FG000|Overall Study|Protocol Violation|0|||
25074021|NCT02320396|50181087|FG001|Overall Study|Protocol Violation|1|||
25074022|NCT02320396|50181086|FG000|Overall Study|Withdrawal by Subject|2|||
25074023|NCT02320396|50181087|FG001|Overall Study|Withdrawal by Subject|0|||
25074024|NCT02292238|50181095|FG000|Overall Study|Protocol Violation|1|||
25074025|NCT02292238|50181096|FG001|Overall Study|Protocol Violation|2|||
25074026|NCT02292238|50181095|FG000|Overall Study|Withdrawal by Subject|2|||
25074027|NCT02292238|50181096|FG001|Overall Study|Withdrawal by Subject|1|||
25074028|NCT02292238|50181095|FG000|Overall Study|Lost to Follow-up|1|||
25074029|NCT02292238|50181096|FG001|Overall Study|Lost to Follow-up|0|||
25074030|NCT02292238|50181095|FG000|Overall Study|Physician Decision|0|||
25074031|NCT02292238|50181096|FG001|Overall Study|Physician Decision|1|||
25074032|NCT02234843|50181133|FG000|Overall Study|Death|1|||
25074033|NCT02234843|50181134|FG001|Overall Study|Death|0|||
25074034|NCT02234843|50181135|FG002|Overall Study|Death|0|||
25074035|NCT02234843|50181136|FG003|Overall Study|Death|0|||
25074036|NCT02234843|50181137|FG004|Overall Study|Death|0|||
25074037|NCT02234843|50181138|FG005|Overall Study|Death|0|||
25074038|NCT02234843|50181139|FG006|Overall Study|Death|0|||
25074039|NCT02234843|50181140|FG007|Overall Study|Death|0|||
25074040|NCT02234843|50181141|FG008|Overall Study|Death|0|||
25074041|NCT02234843|50181142|FG009|Overall Study|Death|0|||
25074042|NCT02234843|50181133|FG000|Overall Study|Protocol Violation|1|||
25074043|NCT02234843|50181134|FG001|Overall Study|Protocol Violation|0|||
25074044|NCT02234843|50181135|FG002|Overall Study|Protocol Violation|1|||
25074045|NCT02234843|50181136|FG003|Overall Study|Protocol Violation|0|||
25074046|NCT02234843|50181137|FG004|Overall Study|Protocol Violation|0|||
25074047|NCT02234843|50181138|FG005|Overall Study|Protocol Violation|0|||
25074048|NCT02234843|50181139|FG006|Overall Study|Protocol Violation|0|||
25074049|NCT02234843|50181140|FG007|Overall Study|Protocol Violation|0|||
25074050|NCT02234843|50181141|FG008|Overall Study|Protocol Violation|0|||
25074051|NCT02234843|50181142|FG009|Overall Study|Protocol Violation|0|||
25074052|NCT02234843|50181133|FG000|Overall Study|Efficacy outcome reached|2|||
25074053|NCT02234843|50181134|FG001|Overall Study|Efficacy outcome reached|0|||
25074054|NCT02234843|50181135|FG002|Overall Study|Efficacy outcome reached|0|||
25074055|NCT02234843|50181136|FG003|Overall Study|Efficacy outcome reached|0|||
25074056|NCT02234843|50181137|FG004|Overall Study|Efficacy outcome reached|0|||
25074057|NCT02234843|50181138|FG005|Overall Study|Efficacy outcome reached|2|||
25074058|NCT02234843|50181139|FG006|Overall Study|Efficacy outcome reached|0|||
25074059|NCT02234843|50181140|FG007|Overall Study|Efficacy outcome reached|0|||
25074060|NCT02234843|50181141|FG008|Overall Study|Efficacy outcome reached|0|||
25074061|NCT02234843|50181142|FG009|Overall Study|Efficacy outcome reached|0|||
25074062|NCT02234843|50181133|FG000|Overall Study|Patient convenience|2|||
25074063|NCT02234843|50181134|FG001|Overall Study|Patient convenience|0|||
25074064|NCT02234843|50181135|FG002|Overall Study|Patient convenience|0|||
25074065|NCT02234843|50181136|FG003|Overall Study|Patient convenience|0|||
25074066|NCT02234843|50181137|FG004|Overall Study|Patient convenience|0|||
25074067|NCT02234843|50181138|FG005|Overall Study|Patient convenience|1|||
25074068|NCT02234843|50181139|FG006|Overall Study|Patient convenience|0|||
25074069|NCT02234843|50181140|FG007|Overall Study|Patient convenience|0|||
25074070|NCT02234843|50181141|FG008|Overall Study|Patient convenience|0|||
25074071|NCT02234843|50181142|FG009|Overall Study|Patient convenience|0|||
25074072|NCT02234843|50181133|FG000|Overall Study|Withdrawal by Subject|5|||
25074073|NCT02234843|50181134|FG001|Overall Study|Withdrawal by Subject|1|||
25074074|NCT02234843|50181135|FG002|Overall Study|Withdrawal by Subject|1|||
25074075|NCT02234843|50181136|FG003|Overall Study|Withdrawal by Subject|0|||
25074076|NCT02234843|50181137|FG004|Overall Study|Withdrawal by Subject|0|||
25074077|NCT02234843|50181138|FG005|Overall Study|Withdrawal by Subject|7|||
25074078|NCT02234843|50181139|FG006|Overall Study|Withdrawal by Subject|0|||
25074079|NCT02234843|50181140|FG007|Overall Study|Withdrawal by Subject|0|||
25074080|NCT02234843|50181141|FG008|Overall Study|Withdrawal by Subject|0|||
25074081|NCT02234843|50181142|FG009|Overall Study|Withdrawal by Subject|0|||
25074082|NCT02234843|50181133|FG000|Overall Study|Recovery|1|||
25074083|NCT02234843|50181134|FG001|Overall Study|Recovery|0|||
25074084|NCT02234843|50181135|FG002|Overall Study|Recovery|0|||
25074085|NCT02234843|50181136|FG003|Overall Study|Recovery|0|||
25074086|NCT02234843|50181137|FG004|Overall Study|Recovery|0|||
25074087|NCT02234843|50181138|FG005|Overall Study|Recovery|0|||
25074088|NCT02234843|50181139|FG006|Overall Study|Recovery|0|||
25074089|NCT02234843|50181140|FG007|Overall Study|Recovery|0|||
25074090|NCT02234843|50181141|FG008|Overall Study|Recovery|0|||
25074091|NCT02234843|50181142|FG009|Overall Study|Recovery|0|||
25074092|NCT02234843|50181133|FG000|Overall Study|Other|0|||
25074093|NCT02234843|50181134|FG001|Overall Study|Other|2|||
25074094|NCT02234843|50181135|FG002|Overall Study|Other|0|||
25074095|NCT02234843|50181136|FG003|Overall Study|Other|1|||
25074096|NCT02234843|50181137|FG004|Overall Study|Other|0|||
25074097|NCT02234843|50181138|FG005|Overall Study|Other|1|||
25074098|NCT02234843|50181139|FG006|Overall Study|Other|0|||
25074099|NCT02234843|50181140|FG007|Overall Study|Other|1|||
25074100|NCT02234843|50181141|FG008|Overall Study|Other|0|||
25074101|NCT02234843|50181142|FG009|Overall Study|Other|0|||
25074102|NCT02234843|50181133|FG000|Overall Study|Physician Decision|4|||
25074103|NCT02234843|50181134|FG001|Overall Study|Physician Decision|1|||
25074104|NCT02234843|50181135|FG002|Overall Study|Physician Decision|0|||
25074105|NCT02234843|50181136|FG003|Overall Study|Physician Decision|1|||
25074106|NCT02234843|50181137|FG004|Overall Study|Physician Decision|0|||
25074107|NCT02234843|50181138|FG005|Overall Study|Physician Decision|0|||
25074108|NCT02234843|50181139|FG006|Overall Study|Physician Decision|0|||
25074109|NCT02234843|50181140|FG007|Overall Study|Physician Decision|1|||
25074110|NCT02234843|50181141|FG008|Overall Study|Physician Decision|0|||
25074111|NCT02234843|50181142|FG009|Overall Study|Physician Decision|0|||
25074112|NCT02234843|50181133|FG000|Overall Study|Adverse Event|5|||
25074113|NCT02234843|50181134|FG001|Overall Study|Adverse Event|1|||
25074114|NCT02234843|50181135|FG002|Overall Study|Adverse Event|1|||
25074115|NCT02234843|50181136|FG003|Overall Study|Adverse Event|3|||
25074116|NCT02234843|50181137|FG004|Overall Study|Adverse Event|2|||
25074117|NCT02234843|50181138|FG005|Overall Study|Adverse Event|1|||
25074118|NCT02234843|50181139|FG006|Overall Study|Adverse Event|0|||
25074119|NCT02234843|50181140|FG007|Overall Study|Adverse Event|0|||
25074120|NCT02234843|50181141|FG008|Overall Study|Adverse Event|1|||
25074121|NCT02234843|50181142|FG009|Overall Study|Adverse Event|0|||
25074122|NCT02234843|50181133|FG000|Overall Study|Non-compliance with study drug|1|||
25192501|NCT01434680|50359196|FG001|Overall Study|Withdrawal by Subject|0|||
25192502|NCT01434680|50359197|FG002|Overall Study|Withdrawal by Subject|2|||
25192503|NCT01434680|50359198|FG003|Overall Study|Withdrawal by Subject|0|||
25192504|NCT01434680|50359195|FG000|Overall Study|Lost to Follow-up|1|||
25192505|NCT01434680|50359196|FG001|Overall Study|Lost to Follow-up|1|||
25192506|NCT01434680|50359197|FG002|Overall Study|Lost to Follow-up|0|||
25192507|NCT01434680|50359198|FG003|Overall Study|Lost to Follow-up|0|||
25192508|NCT01434680|50359195|FG000|Overall Study|Protocol Violation|1|||
25192509|NCT01434680|50359196|FG001|Overall Study|Protocol Violation|1|||
25192510|NCT01434680|50359197|FG002|Overall Study|Protocol Violation|0|||
25192511|NCT01434680|50359198|FG003|Overall Study|Protocol Violation|0|||
25192512|NCT01433978|50359331|FG000|Core Study|Adverse Event, Non-Fatal|0|||
25192513|NCT01433978|50359332|FG001|Core Study|Adverse Event, Non-Fatal|1|||
25192514|NCT01433978|50359333|FG002|Core Study|Adverse Event, Non-Fatal|0|||
25192515|NCT01433978|50359331|FG000|Core Study|Lack of Efficacy|5|||
25192516|NCT01433978|50359332|FG001|Core Study|Lack of Efficacy|1|||
25192517|NCT01433978|50359333|FG002|Core Study|Lack of Efficacy|0|||
25074123|NCT02234843|50181134|FG001|Overall Study|Non-compliance with study drug|0|||
25074124|NCT02234843|50181135|FG002|Overall Study|Non-compliance with study drug|0|||
25192518|NCT01433978|50359331|FG000|Core Study|Study Terminated by Sponsor|6|||
25074125|NCT02234843|50181136|FG003|Overall Study|Non-compliance with study drug|0|||
25074126|NCT02234843|50181137|FG004|Overall Study|Non-compliance with study drug|0|||
25074127|NCT02234843|50181138|FG005|Overall Study|Non-compliance with study drug|1|||
25074128|NCT02234843|50181139|FG006|Overall Study|Non-compliance with study drug|1|||
25074129|NCT02234843|50181140|FG007|Overall Study|Non-compliance with study drug|0|||
25074130|NCT02234843|50181141|FG008|Overall Study|Non-compliance with study drug|0|||
25074131|NCT02234843|50181142|FG009|Overall Study|Non-compliance with study drug|0|||
25074132|NCT02234843|50181133|FG000|Overall Study|Lost to Follow-up|0|||
25074133|NCT02234843|50181134|FG001|Overall Study|Lost to Follow-up|1|||
25314646|NCT00842829|50630495|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
25074134|NCT02234843|50181135|FG002|Overall Study|Lost to Follow-up|0|||
25192519|NCT01433978|50359332|FG001|Core Study|Study Terminated by Sponsor|9|||
25192520|NCT01433978|50359333|FG002|Core Study|Study Terminated by Sponsor|0|||
25192521|NCT01433978|50359331|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
25074135|NCT02234843|50181136|FG003|Overall Study|Lost to Follow-up|0|||
25074136|NCT02234843|50181137|FG004|Overall Study|Lost to Follow-up|0|||
25074137|NCT02234843|50181138|FG005|Overall Study|Lost to Follow-up|0|||
25074138|NCT02234843|50181139|FG006|Overall Study|Lost to Follow-up|1|||
25074139|NCT02234843|50181140|FG007|Overall Study|Lost to Follow-up|0|||
25074140|NCT02234843|50181141|FG008|Overall Study|Lost to Follow-up|0|||
25074141|NCT02234843|50181142|FG009|Overall Study|Lost to Follow-up|0|||
25074142|NCT02740231|50181179|FG000|Overall Study|Withdrawal by Subject|1|||
25074143|NCT02740231|50181180|FG001|Overall Study|Withdrawal by Subject|1|||
25074144|NCT02740231|50181181|FG002|Overall Study|Withdrawal by Subject|1|||
25074145|NCT02740231|50181182|FG003|Overall Study|Withdrawal by Subject|0|||
25074146|NCT02740231|50181179|FG000|Overall Study|Lack of Efficacy|0|||
25074147|NCT02740231|50181180|FG001|Overall Study|Lack of Efficacy|1|||
25074148|NCT02740231|50181181|FG002|Overall Study|Lack of Efficacy|0|||
25074149|NCT02740231|50181182|FG003|Overall Study|Lack of Efficacy|4|||
25074150|NCT02740231|50181179|FG000|Overall Study|Lost to Follow-up|1|||
25074151|NCT02740231|50181180|FG001|Overall Study|Lost to Follow-up|3|||
25074152|NCT02740231|50181181|FG002|Overall Study|Lost to Follow-up|0|||
25074153|NCT02740231|50181182|FG003|Overall Study|Lost to Follow-up|3|||
25074154|NCT02740231|50181179|FG000|Overall Study|Adverse Event|0|||
25074155|NCT02740231|50181180|FG001|Overall Study|Adverse Event|1|||
25074156|NCT02740231|50181181|FG002|Overall Study|Adverse Event|0|||
25074157|NCT02740231|50181182|FG003|Overall Study|Adverse Event|1|||
25074158|NCT02750345|50181192|FG000|Intervention 1|Adverse Event|0|||
25074159|NCT02750345|50181193|FG001|Intervention 1|Adverse Event|0|||
25074160|NCT02750345|50181194|FG002|Intervention 1|Adverse Event|0|||
25074161|NCT02750345|50181195|FG003|Intervention 1|Adverse Event|0|||
25074162|NCT02750345|50181196|FG004|Intervention 1|Adverse Event|1|||
25074163|NCT02750345|50181197|FG005|Intervention 1|Adverse Event|0|||
25074164|NCT02640625|50181207|FG000|Overall Study|Adverse Event|1|||
25074165|NCT01329263|50181214|FG000|Overall Study|Lost to Follow-up|4|||
25074166|NCT01329263|50181215|FG001|Overall Study|Lost to Follow-up|21|||
25074167|NCT01329263|50181214|FG000|Overall Study|Withdrawal by Subject|1|||
25074168|NCT01329263|50181215|FG001|Overall Study|Withdrawal by Subject|2|||
25074169|NCT02474329|50181223|FG000|Overall Study|Withdraw or did not contribute data.|13|||
25074170|NCT01388491|50181230|FG000|Overall Study|Adverse Event|10|||
25074171|NCT01388491|50181231|FG001|Overall Study|Adverse Event|9|||
25074172|NCT01388491|50181230|FG000|Overall Study|Sponsor Request|9|||
25074173|NCT01388491|50181231|FG001|Overall Study|Sponsor Request|7|||
25074174|NCT01388491|50181230|FG000|Overall Study|Withdrawal by Subject|6|||
24973737|NCT03666988|50062282|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
24973738|NCT03666988|50062283|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
24973739|NCT03666988|50062284|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
24973740|NCT03666988|50062279|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
24973741|NCT03666988|50062280|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
24973742|NCT03666988|50062281|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
24973743|NCT03666988|50062282|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
24973744|NCT03666988|50062283|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
24973745|NCT03666988|50062284|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
24973746|NCT03666988|50062279|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
24973747|NCT03666988|50062280|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
24973748|NCT03666988|50062281|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
24973749|NCT03666988|50062282|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
24973750|NCT03666988|50062283|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
24973751|NCT03666988|50062284|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
24973752|NCT00382109|50062304|FG000|Overall Study|Adverse Event|3|||
24973753|NCT00382109|50062305|FG001|Overall Study|Adverse Event|0|||
24973754|NCT00382109|50062304|FG000|Overall Study|Physician Decision|6|||
24973755|NCT00382109|50062305|FG001|Overall Study|Physician Decision|1|||
24973756|NCT00382109|50062304|FG000|Overall Study|Withdrawal by Subject|1|||
25074175|NCT01388491|50181231|FG001|Overall Study|Withdrawal by Subject|10|||
25074176|NCT01388491|50181230|FG000|Overall Study|Lost to Follow-up|4|||
25074177|NCT01388491|50181231|FG001|Overall Study|Lost to Follow-up|3|||
25074178|NCT01388491|50181230|FG000|Overall Study|Protocol Violation|2|||
25074179|NCT01388491|50181231|FG001|Overall Study|Protocol Violation|0|||
25074180|NCT01388491|50181230|FG000|Overall Study|Noncompliance|2|||
25074181|NCT01388491|50181231|FG001|Overall Study|Noncompliance|0|||
24973757|NCT00382109|50062305|FG001|Overall Study|Withdrawal by Subject|0|||
24973758|NCT00382109|50062304|FG000|Overall Study|ineligible|2|||
24973759|NCT00382109|50062305|FG001|Overall Study|ineligible|0|||
25074182|NCT01388491|50181230|FG000|Overall Study|Pregnancy|1|||
25074183|NCT01388491|50181231|FG001|Overall Study|Pregnancy|0|||
25074184|NCT02749799|50181237|FG000|Overall Study|Adverse Event|2|||
25192522|NCT01433978|50359332|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
25074185|NCT02749799|50181237|FG000|Overall Study|Lost to Follow-up|4|||
25074186|NCT02749799|50181237|FG000|Overall Study|Protocol Violation|1|||
25074187|NCT02749799|50181237|FG000|Overall Study|Withdrawal by Subject|1|||
25192523|NCT01433978|50359333|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
24973760|NCT00382109|50062304|FG000|Overall Study|Other|0|||
24973761|NCT00382109|50062305|FG001|Overall Study|Other|2|||
24973762|NCT00382109|50062304|FG000|Overall Study|consent withdrawal|0|||
24973763|NCT00382109|50062305|FG001|Overall Study|consent withdrawal|1|||
24973764|NCT03651622|50062317|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
24973765|NCT03651622|50062318|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
24973766|NCT03651622|50062319|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
24973767|NCT03651622|50062317|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
24973768|NCT03651622|50062318|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
25169965|NCT01377012|50303602|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
25192524|NCT01433978|50359331|FG000|Extension Phase|Lack of Efficacy|0|||
24973769|NCT03651622|50062319|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
24973770|NCT03651622|50062317|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
24973771|NCT03651622|50062318|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
24973772|NCT03651622|50062319|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
24973773|NCT03651622|50062317|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
24973774|NCT03651622|50062318|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
25169966|NCT01377012|50303603|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
25192525|NCT01433978|50359332|FG001|Extension Phase|Lack of Efficacy|0|||
25192526|NCT01433978|50359333|FG002|Extension Phase|Lack of Efficacy|1|||
25192527|NCT01433978|50359331|FG000|Extension Phase|Study Terminated by Sponsor|0|||
25192528|NCT01433978|50359332|FG001|Extension Phase|Study Terminated by Sponsor|0|||
25192529|NCT01433978|50359333|FG002|Extension Phase|Study Terminated by Sponsor|4|||
25192530|NCT01433354|50359382|FG000|Overall Study|Adverse Event|6|||
25192531|NCT01433354|50359382|FG000|Overall Study|Lost to Follow-up|1|||
25192532|NCT01433354|50359382|FG000|Overall Study|Administrative problems|90|||
25192533|NCT01433354|50359382|FG000|Overall Study|Protocol Violation|2|||
25192534|NCT01433354|50359382|FG000|Overall Study|Lack of Efficacy|17|||
25192535|NCT01433354|50359382|FG000|Overall Study|Subject Withdrew Consent|3|||
25192536|NCT00559845|50359950|FG000|Overall Study|Withdrew Consent|1|||
25192537|NCT00559845|50359950|FG000|Overall Study|Disease Progression|1|||
25192538|NCT00559845|50359950|FG000|Overall Study|Adverse Event|3|||
25192539|NCT00559845|50359950|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
25192540|NCT00559845|50359950|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
25192541|NCT01393964|50360053|FG000|Overall Study|Disease Progression|4|||
25192542|NCT01393964|50360054|FG001|Overall Study|Disease Progression|3|||
25192543|NCT01393964|50360055|FG002|Overall Study|Disease Progression|5|||
25192544|NCT01393964|50360053|FG000|Overall Study|Study drug toxicity|1|||
25192545|NCT01393964|50360054|FG001|Overall Study|Study drug toxicity|0|||
25192546|NCT01393964|50360055|FG002|Overall Study|Study drug toxicity|0|||
25192547|NCT01393964|50360053|FG000|Overall Study|Withdrawal by Subject|0|||
25192548|NCT01393964|50360054|FG001|Overall Study|Withdrawal by Subject|0|||
25192549|NCT01393964|50360055|FG002|Overall Study|Withdrawal by Subject|1|||
25192550|NCT01393964|50360053|FG000|Overall Study|Adverse event unrelated to study drug|0|||
25192551|NCT01393964|50360054|FG001|Overall Study|Adverse event unrelated to study drug|3|||
25192552|NCT01393964|50360055|FG002|Overall Study|Adverse event unrelated to study drug|0|||
25192553|NCT01393964|50360053|FG000|Overall Study|Subject request stop study treatment|0|||
25192554|NCT01393964|50360054|FG001|Overall Study|Subject request stop study treatment|1|||
25192555|NCT01393964|50360055|FG002|Overall Study|Subject request stop study treatment|0|||
25192556|NCT01393964|50360053|FG000|Overall Study|Subject decided to move to transplant|1|||
25192557|NCT01393964|50360054|FG001|Overall Study|Subject decided to move to transplant|0|||
25192558|NCT01393964|50360055|FG002|Overall Study|Subject decided to move to transplant|0|||
25192559|NCT01393964|50360053|FG000|Overall Study|Subject switched to commercial supply|1|||
25192560|NCT01393964|50360054|FG001|Overall Study|Subject switched to commercial supply|0|||
25192561|NCT01393964|50360055|FG002|Overall Study|Subject switched to commercial supply|2|||
25192562|NCT01393964|50360053|FG000|Overall Study|Subject plateaued in terms of effect|1|||
25192563|NCT01393964|50360054|FG001|Overall Study|Subject plateaued in terms of effect|0|||
25192564|NCT01393964|50360055|FG002|Overall Study|Subject plateaued in terms of effect|0|||
25192565|NCT01393964|50360053|FG000|Overall Study|Investigator removed subject from study|0|||
24973775|NCT03651622|50062319|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
24973776|NCT03651622|50062317|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
24973777|NCT03651622|50062318|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
25169967|NCT01377012|50303601|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
25169968|NCT01377012|50303602|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
25169969|NCT01377012|50303603|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
25169970|NCT01377012|50303601|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
25169971|NCT01377012|50303602|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
25169972|NCT01377012|50303603|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
25192566|NCT01393964|50360054|FG001|Overall Study|Investigator removed subject from study|1|||
25192567|NCT01393964|50360055|FG002|Overall Study|Investigator removed subject from study|0|||
25192568|NCT01393964|50360053|FG000|Overall Study|Subject converted to roll-over study|0|||
24973778|NCT03651622|50062319|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
24973779|NCT00381797|50062332|FG000|Overall Study|Withdrawal by Subject|1|||
24973780|NCT00381797|50062333|FG001|Overall Study|Withdrawal by Subject|1|||
24973781|NCT00381797|50062334|FG002|Overall Study|Withdrawal by Subject|0|||
24973782|NCT00381797|50062335|FG003|Overall Study|Withdrawal by Subject|0|||
24973783|NCT00381797|50062336|FG004|Overall Study|Withdrawal by Subject|2|||
24973784|NCT00381797|50062332|FG000|Overall Study|Ineligible|0|||
24973785|NCT00381797|50062333|FG001|Overall Study|Ineligible|0|||
24973786|NCT00381797|50062334|FG002|Overall Study|Ineligible|0|||
24973787|NCT00381797|50062335|FG003|Overall Study|Ineligible|1|||
24973788|NCT00381797|50062336|FG004|Overall Study|Ineligible|0|||
24973789|NCT03665038|50062372|FG000|Overall Study|Lost to Follow-up|0|||
24973790|NCT03665038|50062373|FG001|Overall Study|Lost to Follow-up|0|||
24973791|NCT03665038|50062374|FG002|Overall Study|Lost to Follow-up|1|||
24973792|NCT03664024|50062384|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
24973793|NCT03664024|50062384|FG000|Overall Study|Lost to Follow-up|2|||
24973794|NCT03664024|50062384|FG000|Overall Study|Withdrawal by Subject|2|||
24973795|NCT03664024|50062384|FG000|Overall Study|Death|80|||
24973796|NCT00381641|50062393|FG000|Overall Study|Withdrawal by Subject|0|||
24973797|NCT00381641|50062394|FG001|Overall Study|Withdrawal by Subject|2|||
24973798|NCT00381563|50062402|FG000|Overall Study|Withdrawal by Subject|5|||
24973799|NCT00381563|50062403|FG001|Overall Study|Withdrawal by Subject|5|||
25074188|NCT03253393|50181244|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
25074189|NCT03253393|50181245|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
25074190|NCT03253393|50181246|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
25074191|NCT03128671|50181262|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
25074192|NCT03128671|50181263|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
25074193|NCT03128671|50181262|FG000|Allocation|Death|1|||
25074194|NCT03128671|50181263|FG001|Allocation|Death|0|||
25074195|NCT03128671|50181262|FG000|Allocation|Withdrawal by Subject|4|||
25074196|NCT03128671|50181263|FG001|Allocation|Withdrawal by Subject|0|||
25074197|NCT03128671|50181262|FG000|Intervention|Withdrawal by Subject|11|||
25074198|NCT03128671|50181263|FG001|Intervention|Withdrawal by Subject|10|||
25074199|NCT03128671|50181262|FG000|Intervention|Palliative/hospice care initiated|9|||
25074200|NCT03128671|50181263|FG001|Intervention|Palliative/hospice care initiated|10|||
25074201|NCT03128671|50181262|FG000|Intervention|Death|13|||
25074202|NCT03128671|50181263|FG001|Intervention|Death|11|||
25074203|NCT03128671|50181262|FG000|Intervention|Interrupted by hurricane|1|||
25074204|NCT03128671|50181263|FG001|Intervention|Interrupted by hurricane|0|||
25074205|NCT03128671|50181262|FG000|Intervention|Physician Decision|2|||
25074206|NCT03128671|50181263|FG001|Intervention|Physician Decision|3|||
25074207|NCT02925338|50181274|FG000|Overall Study|Death|0|||
25074208|NCT02925338|50181275|FG001|Overall Study|Death|2|||
25192569|NCT01393964|50360054|FG001|Overall Study|Subject converted to roll-over study|1|||
25192570|NCT01393964|50360055|FG002|Overall Study|Subject converted to roll-over study|0|||
25192571|NCT01393964|50360053|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
25192572|NCT01393964|50360054|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
25192573|NCT01393964|50360055|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
25192574|NCT01393730|50360143|FG000|Overall Study|Withdrawal by Subject|3|||
25192575|NCT01393730|50360143|FG000|Overall Study|Other|2|||
24973800|NCT00381563|50062402|FG000|Overall Study|Lost to Follow-up|2|||
25074209|NCT02925338|50181276|FG002|Overall Study|Death|1|||
25074210|NCT02925338|50181277|FG003|Overall Study|Death|0|||
25074211|NCT02925338|50181278|FG004|Overall Study|Death|0|||
25074212|NCT02925338|50181274|FG000|Overall Study|Lost to Follow-up|30|||
25074213|NCT02925338|50181275|FG001|Overall Study|Lost to Follow-up|10|||
25074214|NCT02925338|50181276|FG002|Overall Study|Lost to Follow-up|1|||
25074215|NCT02925338|50181277|FG003|Overall Study|Lost to Follow-up|16|||
25074216|NCT02925338|50181278|FG004|Overall Study|Lost to Follow-up|3|||
25074217|NCT02925338|50181274|FG000|Overall Study|Withdrawal by Subject|3|||
25074218|NCT02925338|50181275|FG001|Overall Study|Withdrawal by Subject|0|||
25074219|NCT02925338|50181276|FG002|Overall Study|Withdrawal by Subject|3|||
25074220|NCT02925338|50181277|FG003|Overall Study|Withdrawal by Subject|2|||
25074221|NCT02925338|50181278|FG004|Overall Study|Withdrawal by Subject|2|||
24973801|NCT00381563|50062403|FG001|Overall Study|Lost to Follow-up|0|||
24973802|NCT00381563|50062402|FG000|Overall Study|Protocol Violation|0|||
24973803|NCT00381563|50062403|FG001|Overall Study|Protocol Violation|1|||
24973804|NCT03624946|50062410|FG000|Overall Study|Lost to Follow-up|0|||
24973805|NCT03624946|50062411|FG001|Overall Study|Lost to Follow-up|1|||
24973806|NCT00381095|50062423|FG000|Overall Study|Death|3|||
24973807|NCT00381095|50062424|FG001|Overall Study|Death|4|||
24973808|NCT00381095|50062423|FG000|Overall Study|Lack of Efficacy|2|||
24973809|NCT00381095|50062424|FG001|Overall Study|Lack of Efficacy|4|||
25074222|NCT02925338|50181274|FG000|Overall Study|Missing|38|||
25074223|NCT02925338|50181275|FG001|Overall Study|Missing|27|||
25074224|NCT02925338|50181276|FG002|Overall Study|Missing|0|||
25074225|NCT02925338|50181277|FG003|Overall Study|Missing|3|||
25192576|NCT01393730|50360143|FG000|Overall Study|Adverse Event|1|||
25192577|NCT01393106|50360162|FG000|Overall Study|Adverse Event|3|||
25192578|NCT01393106|50360162|FG000|Overall Study|Withdrawal by Subject|1|||
24973810|NCT00381095|50062423|FG000|Overall Study|Other|2|||
24973811|NCT00381095|50062424|FG001|Overall Study|Other|2|||
24973812|NCT00381095|50062423|FG000|Overall Study|Protocol Violation|1|||
24973813|NCT00381095|50062424|FG001|Overall Study|Protocol Violation|1|||
24973814|NCT00381095|50062423|FG000|Overall Study|Withdrawal by Subject|3|||
24973815|NCT00381095|50062424|FG001|Overall Study|Withdrawal by Subject|3|||
25192579|NCT01393106|50360162|FG000|Overall Study|Lack of Efficacy|1|||
25192580|NCT00553059|50360168|FG000|Overall Study|Deemed ineligible|1|||
25192581|NCT00553059|50360169|FG001|Overall Study|Deemed ineligible|1|||
25192582|NCT00553059|50360168|FG000|Overall Study|Drug supply not available|0|||
25192583|NCT00553059|50360169|FG001|Overall Study|Drug supply not available|1|||
25192584|NCT01413542|50360202|FG000|Overall Study|Physician Decision|1|||
25192585|NCT01413542|50360203|FG001|Overall Study|Physician Decision|0|||
25192586|NCT01413542|50360204|FG002|Overall Study|Physician Decision|3|||
25192587|NCT01413542|50360205|FG003|Overall Study|Physician Decision|0|||
25192588|NCT01413542|50360202|FG000|Overall Study|Adverse Event|0|||
25192589|NCT01413542|50360203|FG001|Overall Study|Adverse Event|0|||
25192590|NCT01413542|50360204|FG002|Overall Study|Adverse Event|0|||
25192591|NCT01413542|50360205|FG003|Overall Study|Adverse Event|1|||
25192592|NCT01432730|50360237|FG000|Period 1|Adverse Event|2|||
25192593|NCT01432730|50360238|FG001|Period 1|Adverse Event|0|||
25192594|NCT01432730|50360237|FG000|Period 2|Adverse Event|0|||
25192595|NCT01432730|50360238|FG001|Period 2|Adverse Event|4|||
25192596|NCT01432574|50360253|FG000|Overall Study|Moved|2|||
25192597|NCT01432574|50360253|FG000|Overall Study|Not interested|1|||
25192598|NCT01392560|50360286|FG000|Overall Study|Adverse Event|2|||
25192599|NCT01392560|50360286|FG000|Overall Study|not entered|8|||
25192600|NCT01392560|50360286|FG000|Overall Study|discontinued during placebo run-in|2|||
25192601|NCT00552279|50360347|FG000|Overall Study|Adverse Event|0|||
25192602|NCT00552279|50360348|FG001|Overall Study|Adverse Event|1|||
25192603|NCT00552279|50360347|FG000|Overall Study|Withdrawal by Subject|12|||
25192604|NCT00552279|50360348|FG001|Overall Study|Withdrawal by Subject|1|||
25192605|NCT00552279|50360347|FG000|Overall Study|Lost to Follow-up|1|||
25192606|NCT00552279|50360348|FG001|Overall Study|Lost to Follow-up|0|||
25192607|NCT00552279|50360347|FG000|Overall Study|Other|1|||
25192608|NCT00552279|50360348|FG001|Overall Study|Other|1|||
25192609|NCT00559377|50360389|FG000|Overall Study|Withdrawal by Subject|9|||
25192610|NCT01412060|50360396|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
25192611|NCT01412060|50360397|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
25192612|NCT01412060|50360398|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
25192613|NCT01412060|50360396|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
25192614|NCT01412060|50360397|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
25192615|NCT01412060|50360398|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
25192616|NCT01412060|50360396|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
25192617|NCT01412060|50360397|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
25192618|NCT01412060|50360398|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
25192619|NCT01412060|50360396|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
25192620|NCT01412060|50360397|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
25192621|NCT01412060|50360398|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
24973816|NCT00381095|50062423|FG000|Overall Study|Adverse Event|2|||
24973817|NCT00381095|50062424|FG001|Overall Study|Adverse Event|7|||
24973818|NCT03619174|50062432|FG000|Overall Study|Lost to Follow-up|3|||
24973819|NCT03619174|50062433|FG001|Overall Study|Lost to Follow-up|0|||
24973820|NCT03619174|50062432|FG000|Overall Study|Withdrawal by Subject|4|||
24973821|NCT03619174|50062433|FG001|Overall Study|Withdrawal by Subject|3|||
24973822|NCT03619174|50062432|FG000|Overall Study|Pregnancy|1|||
24973823|NCT03619174|50062433|FG001|Overall Study|Pregnancy|1|||
24973824|NCT03619174|50062432|FG000|Overall Study|Discomfort during treatment|1|||
24973825|NCT03619174|50062433|FG001|Overall Study|Discomfort during treatment|0|||
24973826|NCT00112047|50062441|FG000|Randomized Phase|Lost to Follow-up|26|||
24973827|NCT00112047|50062442|FG001|Randomized Phase|Lost to Follow-up|33|||
24973828|NCT00112047|50062441|FG000|Randomized Phase|Adverse Event|10|||
24973829|NCT00112047|50062442|FG001|Randomized Phase|Adverse Event|10|||
24973830|NCT00112047|50062441|FG000|Randomized Phase|Withrawal of consent|10|||
24973831|NCT00112047|50062442|FG001|Randomized Phase|Withrawal of consent|18|||
24973832|NCT00112047|50062441|FG000|Randomized Phase|Sub-optimal virological response|3|||
24973833|NCT00112047|50062442|FG001|Randomized Phase|Sub-optimal virological response|13|||
24973834|NCT00112047|50062441|FG000|Randomized Phase|Noncompliance|8|||
24973835|NCT00112047|50062442|FG001|Randomized Phase|Noncompliance|4|||
25192622|NCT01412060|50360396|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
25192623|NCT01412060|50360397|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
25192624|NCT01412060|50360398|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
25192625|NCT01412060|50360396|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
25192626|NCT01412060|50360397|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
24973836|NCT00112047|50062441|FG000|Randomized Phase|Protocol Violation|2|||
25074226|NCT02925338|50181278|FG004|Overall Study|Missing|2|||
25074227|NCT02925338|50181274|FG000|Overall Study|Participant's Decision|11|||
25074228|NCT02925338|50181275|FG001|Overall Study|Participant's Decision|7|||
25074229|NCT02925338|50181276|FG002|Overall Study|Participant's Decision|3|||
25074230|NCT02925338|50181277|FG003|Overall Study|Participant's Decision|8|||
25074231|NCT02925338|50181278|FG004|Overall Study|Participant's Decision|1|||
25074232|NCT02925338|50181274|FG000|Overall Study|Treatment Discontinuation|144|||
25074233|NCT02925338|50181275|FG001|Overall Study|Treatment Discontinuation|65|||
25074234|NCT02925338|50181276|FG002|Overall Study|Treatment Discontinuation|56|||
25074235|NCT02925338|50181277|FG003|Overall Study|Treatment Discontinuation|131|||
25074236|NCT02925338|50181278|FG004|Overall Study|Treatment Discontinuation|22|||
25074237|NCT02543528|50181296|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
25074238|NCT02543528|50181297|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
25074239|NCT02543528|50181298|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
25074240|NCT02543528|50181299|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
25074241|NCT02543528|50181300|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
25074242|NCT02543528|50181296|FG000|Adaptation Period|Lens Handling Difficultes|0|||
25074243|NCT02543528|50181297|FG001|Adaptation Period|Lens Handling Difficultes|0|||
25074244|NCT02543528|50181298|FG002|Adaptation Period|Lens Handling Difficultes|0|||
25074245|NCT02543528|50181299|FG003|Adaptation Period|Lens Handling Difficultes|0|||
25074246|NCT02543528|50181300|FG004|Adaptation Period|Lens Handling Difficultes|8|||
25074247|NCT02543528|50181296|FG000|Adaptation Period|Lost to Follow-up|0|||
25074248|NCT02543528|50181297|FG001|Adaptation Period|Lost to Follow-up|0|||
25074249|NCT02543528|50181298|FG002|Adaptation Period|Lost to Follow-up|0|||
25074250|NCT02543528|50181299|FG003|Adaptation Period|Lost to Follow-up|0|||
25074251|NCT02543528|50181300|FG004|Adaptation Period|Lost to Follow-up|14|||
25074252|NCT02543528|50181296|FG000|Adaptation Period|Adverse Event|0|||
25074253|NCT02543528|50181297|FG001|Adaptation Period|Adverse Event|0|||
25074254|NCT02543528|50181298|FG002|Adaptation Period|Adverse Event|0|||
25074255|NCT02543528|50181299|FG003|Adaptation Period|Adverse Event|0|||
25074256|NCT02543528|50181300|FG004|Adaptation Period|Adverse Event|2|||
25074257|NCT02543528|50181296|FG000|Extended Wear Period|Adverse Event|17|||
25074258|NCT02543528|50181297|FG001|Extended Wear Period|Adverse Event|11|||
25074259|NCT02543528|50181298|FG002|Extended Wear Period|Adverse Event|16|||
25074260|NCT02543528|50181299|FG003|Extended Wear Period|Adverse Event|3|||
25074261|NCT02543528|50181300|FG004|Extended Wear Period|Adverse Event|0|||
25074262|NCT02543528|50181296|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
25192627|NCT01412060|50360398|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
25192628|NCT01412060|50360396|FG000|Period Between RIP and SP|Adverse Event|4|||
25192629|NCT01412060|50360397|FG001|Period Between RIP and SP|Adverse Event|0|||
25192630|NCT01412060|50360398|FG002|Period Between RIP and SP|Adverse Event|0|||
25192631|NCT01412060|50360396|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
25192632|NCT01412060|50360397|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
25192633|NCT01412060|50360398|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
25192634|NCT01412060|50360396|FG000|Period Between RIP and SP|Protocol Violation|2|||
25192635|NCT01412060|50360397|FG001|Period Between RIP and SP|Protocol Violation|0|||
25192636|NCT01412060|50360398|FG002|Period Between RIP and SP|Protocol Violation|0|||
25192637|NCT01412060|50360396|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
25192638|NCT01412060|50360397|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
25192639|NCT01412060|50360398|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
25192640|NCT01412060|50360396|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
25192641|NCT01412060|50360397|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
25192642|NCT01412060|50360398|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
25192643|NCT01412060|50360396|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
25192644|NCT01412060|50360397|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
25192645|NCT01412060|50360398|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
25192646|NCT01412060|50360396|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
25192647|NCT01412060|50360397|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
25074263|NCT02543528|50181297|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
25074264|NCT02543528|50181298|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
25192648|NCT01412060|50360398|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
25192649|NCT01412060|50360396|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
25192650|NCT01412060|50360397|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
25192651|NCT01412060|50360398|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
25192652|NCT01412060|50360396|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
25192653|NCT01412060|50360397|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
25192654|NCT01412060|50360398|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
25074265|NCT02543528|50181299|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
25074266|NCT02543528|50181300|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
25192655|NCT01412060|50360396|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
25192656|NCT01412060|50360397|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
25192657|NCT01412060|50360398|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
25192658|NCT01412060|50360396|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
25192659|NCT01412060|50360397|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
25192660|NCT01412060|50360398|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
24973837|NCT00112047|50062442|FG001|Randomized Phase|Protocol Violation|0|||
24973838|NCT00112047|50062441|FG000|Randomized Phase|Pregnancy|3|||
24973839|NCT00112047|50062442|FG001|Randomized Phase|Pregnancy|1|||
24973840|NCT00112047|50062441|FG000|Randomized Phase|Death|1|||
24973841|NCT00112047|50062442|FG001|Randomized Phase|Death|3|||
24973842|NCT00112047|50062441|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
24973843|NCT00112047|50062442|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
24973844|NCT00112047|50062441|FG000|Randomized Phase|Inability to swallow pills|0|||
24973845|NCT00112047|50062442|FG001|Randomized Phase|Inability to swallow pills|1|||
24973846|NCT00112047|50062441|FG000|Randomized Phase|Incarceration|3|||
24973847|NCT00112047|50062442|FG001|Randomized Phase|Incarceration|2|||
24973848|NCT00112047|50062441|FG000|Randomized Phase|Moved out of State|0|||
24973849|NCT00112047|50062442|FG001|Randomized Phase|Moved out of State|1|||
24973850|NCT00112047|50062441|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
24973851|NCT00112047|50062442|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
24973852|NCT00112047|50062441|FG000|Randomized Phase|High Hepatitis B DNA|0|||
24973853|NCT00112047|50062442|FG001|Randomized Phase|High Hepatitis B DNA|1|||
24973854|NCT00112047|50062441|FG000|Atripla Phase|Adverse Event|2|||
24973855|NCT00112047|50062442|FG001|Atripla Phase|Adverse Event|1|||
24973856|NCT00112047|50062441|FG000|Atripla Phase|Lost to Follow-up|5|||
24973857|NCT00112047|50062442|FG001|Atripla Phase|Lost to Follow-up|7|||
24973858|NCT00112047|50062441|FG000|Atripla Phase|Pregnancy|0|||
24973859|NCT00112047|50062442|FG001|Atripla Phase|Pregnancy|1|||
24973860|NCT00112047|50062441|FG000|Atripla Phase|Death|0|||
24973861|NCT00112047|50062442|FG001|Atripla Phase|Death|2|||
24973862|NCT00112047|50062441|FG000|Atripla Phase|Withdrew consent|7|||
24973863|NCT00112047|50062442|FG001|Atripla Phase|Withdrew consent|7|||
24973864|NCT00112047|50062441|FG000|Atripla Phase|Sub-optimal virological response|0|||
24973865|NCT00112047|50062442|FG001|Atripla Phase|Sub-optimal virological response|1|||
24973866|NCT00112047|50062441|FG000|Atripla Phase|Non-compliance|1|||
24973867|NCT00112047|50062442|FG001|Atripla Phase|Non-compliance|0|||
24973868|NCT00112047|50062441|FG000|Atripla Phase|Other|3|||
24973869|NCT00112047|50062442|FG001|Atripla Phase|Other|1|||
24973870|NCT03658876|50062455|FG000|Overall Study|Protocol Violation|3|||
24973871|NCT03658876|50062456|FG001|Overall Study|Protocol Violation|2|||
24973872|NCT03658876|50062455|FG000|Overall Study|Withdrawal by Subject|2|||
24973873|NCT03658876|50062456|FG001|Overall Study|Withdrawal by Subject|0|||
24973874|NCT03658876|50062455|FG000|Overall Study|Death|0|||
24973875|NCT03658876|50062456|FG001|Overall Study|Death|1|||
24973876|NCT03658876|50062455|FG000|Overall Study|Intercurrent illness|6|||
24973877|NCT03658876|50062456|FG001|Overall Study|Intercurrent illness|4|||
24973878|NCT03658876|50062455|FG000|Overall Study|Transplantation/other operation|1|||
24973879|NCT03658876|50062456|FG001|Overall Study|Transplantation/other operation|5|||
24973880|NCT03618628|50062462|FG000|Overall Study|Death|1|||
24973881|NCT03618628|50062462|FG000|Overall Study|Lost to Follow-up|1|||
24973882|NCT03617770|50062468|FG000|Overall Study|Lost to Follow-up|1|||
24973883|NCT03617770|50062469|FG001|Overall Study|Lost to Follow-up|0|||
24973884|NCT03616600|50062477|FG000|Overall Study|Withdrawal by Subject|1|||
24973885|NCT03616600|50062478|FG001|Overall Study|Withdrawal by Subject|0|||
24973886|NCT00380393|50062487|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
24973887|NCT00380393|50062488|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
24973888|NCT00380393|50062487|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
24973889|NCT00380393|50062488|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
24973890|NCT00380393|50062487|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
24973891|NCT00380393|50062488|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
24973892|NCT00380393|50062487|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
24973893|NCT00380393|50062488|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
24973894|NCT00380393|50062487|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
24973895|NCT00380393|50062488|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
24973896|NCT00380393|50062487|FG000|Month 14|Withdrawal by Subject|9|||
25074267|NCT02543528|50181296|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
25074268|NCT02543528|50181297|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
25074269|NCT02543528|50181298|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
25074270|NCT02543528|50181299|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
25074271|NCT02543528|50181300|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
25074272|NCT02543528|50181296|FG000|Extended Wear Period|Lost to Follow-up|0|||
25074273|NCT02543528|50181297|FG001|Extended Wear Period|Lost to Follow-up|1|||
25074274|NCT02543528|50181298|FG002|Extended Wear Period|Lost to Follow-up|2|||
25169973|NCT01377012|50303601|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
25169974|NCT01377012|50303602|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
25169975|NCT01377012|50303603|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
25169976|NCT01377012|50303601|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
25169977|NCT01377012|50303602|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
25169978|NCT01377012|50303603|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
25169979|NCT01377012|50303601|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
25169980|NCT01377012|50303602|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
25169981|NCT01377012|50303603|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
25169982|NCT01376310|50303852|FG000|Overall Study|Study closed/terminated|1|||
25169983|NCT01376310|50303853|FG001|Overall Study|Study closed/terminated|2|||
25169984|NCT01376310|50303852|FG000|Overall Study|Withdrawal by Subject|8|||
25169985|NCT01376310|50303853|FG001|Overall Study|Withdrawal by Subject|2|||
25169986|NCT01376310|50303852|FG000|Overall Study|Physician Decision|26|||
25169987|NCT01376310|50303853|FG001|Overall Study|Physician Decision|7|||
25169988|NCT01376310|50303852|FG000|Overall Study|Lost to Follow-up|1|||
25169989|NCT01376310|50303853|FG001|Overall Study|Lost to Follow-up|0|||
25169990|NCT01949506|50303859|FG000|Overall Study|Physician Decision|1|||
25169991|NCT00709098|50303956|FG000|Double-blind Period|Withdrawal of consent|3|||
25169992|NCT00709098|50303957|FG001|Double-blind Period|Withdrawal of consent|3|||
25169993|NCT00709098|50303958|FG002|Double-blind Period|Withdrawal of consent|0|||
25169994|NCT00709098|50303956|FG000|Double-blind Period|Administrative reason|1|||
25169995|NCT00709098|50303957|FG001|Double-blind Period|Administrative reason|3|||
25169996|NCT00709098|50303958|FG002|Double-blind Period|Administrative reason|0|||
25169997|NCT00709098|50303956|FG000|Double-blind Period|Death|1|||
25169998|NCT00709098|50303957|FG001|Double-blind Period|Death|1|||
25169999|NCT00709098|50303958|FG002|Double-blind Period|Death|0|||
25170000|NCT00709098|50303956|FG000|Double-blind Period|Lost to Follow-up|1|||
25170001|NCT00709098|50303957|FG001|Double-blind Period|Lost to Follow-up|1|||
25170002|NCT00709098|50303958|FG002|Double-blind Period|Lost to Follow-up|0|||
25170003|NCT00709098|50303956|FG000|Open-label Period|Withdrawal of consent|0|||
25170004|NCT00709098|50303957|FG001|Open-label Period|Withdrawal of consent|0|||
25170005|NCT00709098|50303958|FG002|Open-label Period|Withdrawal of consent|7|||
25170006|NCT00709098|50303956|FG000|Open-label Period|Administrative reason|0|||
25170007|NCT00709098|50303957|FG001|Open-label Period|Administrative reason|0|||
25170008|NCT00709098|50303958|FG002|Open-label Period|Administrative reason|5|||
25170009|NCT00709098|50303956|FG000|Open-label Period|Death|0|||
25170010|NCT00709098|50303957|FG001|Open-label Period|Death|0|||
25170011|NCT00709098|50303958|FG002|Open-label Period|Death|1|||
25170012|NCT00709098|50303956|FG000|Open-label Period|Lost to Follow-up|0|||
25170013|NCT00709098|50303957|FG001|Open-label Period|Lost to Follow-up|0|||
25074275|NCT02543528|50181299|FG003|Extended Wear Period|Lost to Follow-up|1|||
25074276|NCT02543528|50181300|FG004|Extended Wear Period|Lost to Follow-up|0|||
25074277|NCT02543528|50181296|FG000|Extended Wear Period|Withdrawal by Subject|10|||
25074278|NCT02543528|50181297|FG001|Extended Wear Period|Withdrawal by Subject|9|||
25074279|NCT02543528|50181298|FG002|Extended Wear Period|Withdrawal by Subject|4|||
25074280|NCT02543528|50181299|FG003|Extended Wear Period|Withdrawal by Subject|5|||
25074281|NCT02543528|50181300|FG004|Extended Wear Period|Withdrawal by Subject|0|||
25074282|NCT00156533|50181318|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
25074283|NCT00156533|50181319|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
25074284|NCT00156533|50181320|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
25074285|NCT00156533|50181321|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
25074286|NCT00156533|50181318|FG000|Overall Study|Withdrawal by Subject|1|||
25074287|NCT00156533|50181319|FG001|Overall Study|Withdrawal by Subject|0|||
25074288|NCT00156533|50181320|FG002|Overall Study|Withdrawal by Subject|0|||
25170014|NCT00709098|50303958|FG002|Open-label Period|Lost to Follow-up|1|||
25170015|NCT01376700|50303967|FG000|Overall Study|Sponsor terminated study early|8|||
25170016|NCT01376700|50303967|FG000|Overall Study|Low or high titer inhibitor|8|||
25170017|NCT01797965|50303978|FG000|Overall Study|Adverse Event|104|||
25170018|NCT01797965|50303979|FG001|Overall Study|Adverse Event|129|||
25170019|NCT01797965|50303980|FG002|Overall Study|Adverse Event|4|||
25192661|NCT01412060|50360396|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
25170020|NCT01797965|50303981|FG003|Overall Study|Adverse Event|21|||
25074289|NCT00156533|50181321|FG003|Overall Study|Withdrawal by Subject|1|||
25074290|NCT00156533|50181318|FG000|Overall Study|Failed Screening|1|||
25074291|NCT00156533|50181319|FG001|Overall Study|Failed Screening|0|||
25074292|NCT00156533|50181320|FG002|Overall Study|Failed Screening|1|||
25074293|NCT00156533|50181321|FG003|Overall Study|Failed Screening|1|||
25074294|NCT01660022|50181339|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
25074295|NCT01660022|50181340|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
25074296|NCT01660022|50181341|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
25074297|NCT01660022|50181342|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
25074298|NCT01660022|50181343|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
25074299|NCT01660022|50181344|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
25074300|NCT01660022|50181339|FG000|First Sequence (7 Days)|Adverse Event|0|||
25074301|NCT01660022|50181340|FG001|First Sequence (7 Days)|Adverse Event|0|||
25074302|NCT01660022|50181341|FG002|First Sequence (7 Days)|Adverse Event|0|||
25074303|NCT01660022|50181342|FG003|First Sequence (7 Days)|Adverse Event|0|||
25074304|NCT01660022|50181343|FG004|First Sequence (7 Days)|Adverse Event|1|||
25074305|NCT01660022|50181344|FG005|First Sequence (7 Days)|Adverse Event|3|||
25074306|NCT01660022|50181339|FG000|First Sequence (7 Days)|Protocol Violation|0|||
25074307|NCT01660022|50181340|FG001|First Sequence (7 Days)|Protocol Violation|0|||
25074308|NCT01660022|50181341|FG002|First Sequence (7 Days)|Protocol Violation|0|||
25074309|NCT01660022|50181342|FG003|First Sequence (7 Days)|Protocol Violation|0|||
25074310|NCT01660022|50181343|FG004|First Sequence (7 Days)|Protocol Violation|0|||
25074311|NCT01660022|50181344|FG005|First Sequence (7 Days)|Protocol Violation|1|||
25074312|NCT00156065|50181373|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
25074313|NCT00156065|50181374|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
25074314|NCT00156065|50181375|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
25074315|NCT00156065|50181373|FG000|Overall Study|Adverse Event|8|||
25074316|NCT00156065|50181374|FG001|Overall Study|Adverse Event|11|||
25074317|NCT00156065|50181375|FG002|Overall Study|Adverse Event|4|||
25074318|NCT00156065|50181373|FG000|Overall Study|Lack of Efficacy|2|||
25074319|NCT00156065|50181374|FG001|Overall Study|Lack of Efficacy|9|||
25074320|NCT00156065|50181375|FG002|Overall Study|Lack of Efficacy|3|||
25074321|NCT00156065|50181373|FG000|Overall Study|Withdrawal by Subject|13|||
25192662|NCT01412060|50360397|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
25192663|NCT01412060|50360398|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
25192664|NCT01412060|50360396|FG000|Period Between SP and DBP|Protocol Violation|2|||
25192665|NCT01412060|50360397|FG001|Period Between SP and DBP|Protocol Violation|0|||
25074322|NCT00156065|50181374|FG001|Overall Study|Withdrawal by Subject|26|||
25074323|NCT00156065|50181375|FG002|Overall Study|Withdrawal by Subject|16|||
25074324|NCT00156065|50181373|FG000|Overall Study|Lost to Follow-up|5|||
25074325|NCT00156065|50181374|FG001|Overall Study|Lost to Follow-up|7|||
25074326|NCT00156065|50181375|FG002|Overall Study|Lost to Follow-up|1|||
25074327|NCT00156065|50181373|FG000|Overall Study|Other|2|||
25074328|NCT00156065|50181374|FG001|Overall Study|Other|9|||
25074329|NCT00156065|50181375|FG002|Overall Study|Other|3|||
25074330|NCT01554956|50181386|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
25074331|NCT01554956|50181387|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
25314647|NCT00842829|50630496|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
24973897|NCT00380393|50062488|FG001|Month 14|Withdrawal by Subject|7|||
24973898|NCT00380393|50062487|FG000|Month 14|Death|1|||
24973899|NCT00380393|50062488|FG001|Month 14|Death|0|||
24973900|NCT00380393|50062487|FG000|Month 14|Lost to Follow-up|0|||
24973901|NCT00380393|50062488|FG001|Month 14|Lost to Follow-up|1|||
24973902|NCT00380393|50062487|FG000|Month 14|Migrated/moved from study area|39|||
24973903|NCT00380393|50062488|FG001|Month 14|Migrated/moved from study area|42|||
24973904|NCT00380393|50062487|FG000|Month 14|Protocol Violation|2|||
24973905|NCT00380393|50062488|FG001|Month 14|Protocol Violation|0|||
24973906|NCT00380393|50062487|FG000|Month 14|Others|6|||
24973907|NCT00380393|50062488|FG001|Month 14|Others|6|||
24973908|NCT00380081|50062500|FG000|Overall Study|Withdrawal by Subject|0|||
24973909|NCT00380081|50062501|FG001|Overall Study|Withdrawal by Subject|0|||
24973910|NCT00380081|50062502|FG002|Overall Study|Withdrawal by Subject|0|||
24973911|NCT00380081|50062503|FG003|Overall Study|Withdrawal by Subject|0|||
24973912|NCT00380081|50062504|FG004|Overall Study|Withdrawal by Subject|1|||
24973913|NCT00380081|50062505|FG005|Overall Study|Withdrawal by Subject|0|||
24973914|NCT00380081|50062500|FG000|Overall Study|Family Emergency|0|||
25074332|NCT01554956|50181388|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
25074333|NCT01554956|50181386|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
25074334|NCT01554956|50181387|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
25074335|NCT01554956|50181388|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
24973915|NCT00380081|50062501|FG001|Overall Study|Family Emergency|0|||
24973916|NCT00380081|50062502|FG002|Overall Study|Family Emergency|0|||
24973917|NCT00380081|50062503|FG003|Overall Study|Family Emergency|0|||
24973918|NCT00380081|50062504|FG004|Overall Study|Family Emergency|0|||
25074336|NCT01554956|50181386|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
25074337|NCT01554956|50181387|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
25082669|NCT02714569|50191357|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
25074338|NCT01554956|50181388|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
25074339|NCT02138786|50181409|FG000|Overall Study|Adverse Event|0|||
25074340|NCT02138786|50181410|FG001|Overall Study|Adverse Event|2|||
25074341|NCT02138786|50181411|FG002|Overall Study|Adverse Event|1|||
25074342|NCT02138786|50181409|FG000|Overall Study|Death|1|||
25074343|NCT02138786|50181410|FG001|Overall Study|Death|7|||
25074344|NCT02138786|50181411|FG002|Overall Study|Death|2|||
25074345|NCT02138786|50181409|FG000|Overall Study|Disease Progression|1|||
25074346|NCT02138786|50181410|FG001|Overall Study|Disease Progression|1|||
25074347|NCT02138786|50181411|FG002|Overall Study|Disease Progression|3|||
25074348|NCT02138786|50181409|FG000|Overall Study|Withdrawal by Subject|1|||
25074349|NCT02138786|50181410|FG001|Overall Study|Withdrawal by Subject|2|||
25074350|NCT02138786|50181411|FG002|Overall Study|Withdrawal by Subject|0|||
25074351|NCT02138786|50181409|FG000|Overall Study|Patient's Wish|0|||
25074352|NCT02138786|50181410|FG001|Overall Study|Patient's Wish|2|||
25074353|NCT02138786|50181411|FG002|Overall Study|Patient's Wish|0|||
25074354|NCT02138786|50181409|FG000|Overall Study|Sponsor Terminated Study|0|||
25074355|NCT02138786|50181410|FG001|Overall Study|Sponsor Terminated Study|1|||
25074356|NCT02138786|50181411|FG002|Overall Study|Sponsor Terminated Study|1|||
25074357|NCT02138786|50181409|FG000|Overall Study|Non-Compliance|0|||
25074358|NCT02138786|50181410|FG001|Overall Study|Non-Compliance|0|||
25074359|NCT02138786|50181411|FG002|Overall Study|Non-Compliance|1|||
25074360|NCT02529488|50181417|FG000|Overall Study|Adverse Event|1|||
25074361|NCT02529488|50181417|FG000|Overall Study|Death|3|||
25074362|NCT01329419|50181425|FG000|Overall Study|Protocol Violation|235|||
25074363|NCT01329341|50181430|FG000|Overall Study|Withdrawal by Subject|44|||
25074364|NCT02532764|50181444|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
25074365|NCT02532764|50181445|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
25074366|NCT02532764|50181446|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
25074367|NCT02532764|50181447|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
25074368|NCT02532764|50181448|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
25074369|NCT02532764|50181449|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
25074370|NCT02532764|50181450|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
25074371|NCT02532764|50181451|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
25074372|NCT02532764|50181452|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
25074373|NCT02532764|50181453|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
25074374|NCT02528942|50181480|FG000|Overall Study|Did not meet imaging criteria|9|||
25074375|NCT02528942|50181480|FG000|Overall Study|Lost to Follow-up|25|||
25074376|NCT02527148|50181486|FG000|Overall Study|Did not receive study intervention|1|||
25074377|NCT02527148|50181487|FG001|Overall Study|Did not receive study intervention|0|||
25074378|NCT02291614|50181506|FG000|Overall Study|Lost to Follow-up|0|||
25074379|NCT02291614|50181507|FG001|Overall Study|Lost to Follow-up|0|||
25074380|NCT02291614|50181508|FG002|Overall Study|Lost to Follow-up|0|||
25074381|NCT02291614|50181509|FG003|Overall Study|Lost to Follow-up|0|||
25074382|NCT02291614|50181510|FG004|Overall Study|Lost to Follow-up|0|||
25074383|NCT02291614|50181511|FG005|Overall Study|Lost to Follow-up|0|||
25074384|NCT02291614|50181512|FG006|Overall Study|Lost to Follow-up|0|||
25074385|NCT02291614|50181513|FG007|Overall Study|Lost to Follow-up|1|||
25074386|NCT02291614|50181514|FG008|Overall Study|Lost to Follow-up|0|||
25074387|NCT02291614|50181515|FG009|Overall Study|Lost to Follow-up|0|||
25192666|NCT01412060|50360398|FG002|Period Between SP and DBP|Protocol Violation|0|||
24973919|NCT00380081|50062505|FG005|Overall Study|Family Emergency|1|||
24973920|NCT03579940|50062524|FG000|Period 2|Withdrawal by Subject|0|||
24973921|NCT03579940|50062525|FG001|Period 2|Withdrawal by Subject|0|||
24973922|NCT03579940|50062526|FG002|Period 2|Withdrawal by Subject|1|||
24973923|NCT03579940|50062527|FG003|Period 2|Withdrawal by Subject|0|||
25074388|NCT02291614|50181516|FG010|Overall Study|Lost to Follow-up|0|||
25074389|NCT02291614|50181506|FG000|Overall Study|Withdrawal by Subject|0|||
25074390|NCT02291614|50181507|FG001|Overall Study|Withdrawal by Subject|1|||
25192667|NCT01412060|50360396|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
25192668|NCT01412060|50360397|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
25192669|NCT01412060|50360398|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
25192670|NCT01412060|50360396|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
25192671|NCT01412060|50360397|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
25192672|NCT01412060|50360398|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
24973924|NCT03579940|50062528|FG004|Period 2|Withdrawal by Subject|0|||
24973925|NCT03579940|50062529|FG005|Period 2|Withdrawal by Subject|0|||
25074391|NCT02291614|50181508|FG002|Overall Study|Withdrawal by Subject|0|||
25074392|NCT02291614|50181509|FG003|Overall Study|Withdrawal by Subject|0|||
25074393|NCT02291614|50181510|FG004|Overall Study|Withdrawal by Subject|0|||
25074394|NCT02291614|50181511|FG005|Overall Study|Withdrawal by Subject|0|||
25074395|NCT02291614|50181512|FG006|Overall Study|Withdrawal by Subject|0|||
25074396|NCT02291614|50181513|FG007|Overall Study|Withdrawal by Subject|0|||
25074397|NCT02291614|50181514|FG008|Overall Study|Withdrawal by Subject|0|||
25074398|NCT02291614|50181515|FG009|Overall Study|Withdrawal by Subject|2|||
25074399|NCT02291614|50181516|FG010|Overall Study|Withdrawal by Subject|2|||
25074400|NCT02291614|50181506|FG000|Overall Study|Decision by sponsor|0|||
25074401|NCT02291614|50181507|FG001|Overall Study|Decision by sponsor|0|||
25074402|NCT02291614|50181508|FG002|Overall Study|Decision by sponsor|0|||
25074403|NCT02291614|50181509|FG003|Overall Study|Decision by sponsor|1|||
25074404|NCT02291614|50181510|FG004|Overall Study|Decision by sponsor|0|||
25074405|NCT02291614|50181511|FG005|Overall Study|Decision by sponsor|0|||
25074406|NCT02291614|50181512|FG006|Overall Study|Decision by sponsor|0|||
25074407|NCT02291614|50181513|FG007|Overall Study|Decision by sponsor|0|||
25074408|NCT02291614|50181514|FG008|Overall Study|Decision by sponsor|0|||
25074409|NCT02291614|50181515|FG009|Overall Study|Decision by sponsor|0|||
25074410|NCT02291614|50181516|FG010|Overall Study|Decision by sponsor|0|||
25074411|NCT02291614|50181506|FG000|Overall Study|Death|0|||
25074412|NCT02291614|50181507|FG001|Overall Study|Death|0|||
25074413|NCT02291614|50181508|FG002|Overall Study|Death|1|||
25074414|NCT02291614|50181509|FG003|Overall Study|Death|0|||
24973926|NCT03579940|50062530|FG006|Period 2|Withdrawal by Subject|0|||
24973927|NCT03579940|50062531|FG007|Period 2|Withdrawal by Subject|0|||
24973928|NCT03579940|50062532|FG008|Period 2|Withdrawal by Subject|0|||
24973929|NCT03579940|50062533|FG009|Period 2|Withdrawal by Subject|0|||
24973930|NCT03579940|50062534|FG010|Period 2|Withdrawal by Subject|0|||
25074415|NCT02291614|50181510|FG004|Overall Study|Death|1|||
25074416|NCT02291614|50181511|FG005|Overall Study|Death|1|||
25074417|NCT02291614|50181512|FG006|Overall Study|Death|1|||
25074418|NCT02291614|50181513|FG007|Overall Study|Death|0|||
25074419|NCT02291614|50181514|FG008|Overall Study|Death|0|||
25074420|NCT02291614|50181515|FG009|Overall Study|Death|0|||
25074421|NCT02291614|50181516|FG010|Overall Study|Death|0|||
25074422|NCT02526524|50181552|FG000|Overall Study|Withdrawal by Subject|3|||
25074423|NCT02526524|50181553|FG001|Overall Study|Withdrawal by Subject|3|||
25074424|NCT02526524|50181554|FG002|Overall Study|Withdrawal by Subject|6|||
25074425|NCT02526524|50181555|FG003|Overall Study|Withdrawal by Subject|1|||
25074426|NCT02526524|50181556|FG004|Overall Study|Withdrawal by Subject|9|||
25074427|NCT02526524|50181557|FG005|Overall Study|Withdrawal by Subject|5|||
25074428|NCT02526524|50181552|FG000|Overall Study|Adverse Event|3|||
25074429|NCT02526524|50181553|FG001|Overall Study|Adverse Event|2|||
25074430|NCT02526524|50181554|FG002|Overall Study|Adverse Event|4|||
25074431|NCT02526524|50181555|FG003|Overall Study|Adverse Event|2|||
25074432|NCT02526524|50181556|FG004|Overall Study|Adverse Event|6|||
24973931|NCT00098306|50062569|FG000|Double Blind|Randomized, not treated|9|||
24973932|NCT00098306|50062570|FG001|Double Blind|Randomized, not treated|5|||
24973933|NCT00098306|50062571|FG002|Double Blind|Randomized, not treated|2|||
24973934|NCT00098306|50062572|FG003|Double Blind|Randomized, not treated|0|||
24973935|NCT00098306|50062573|FG004|Double Blind|Randomized, not treated|0|||
24973936|NCT00098306|50062574|FG005|Double Blind|Randomized, not treated|0|||
24973937|NCT00098306|50062575|FG006|Double Blind|Randomized, not treated|0|||
24973938|NCT00098306|50062569|FG000|Double Blind|Ongoing at cut-off date|151|||
24973939|NCT00098306|50062570|FG001|Double Blind|Ongoing at cut-off date|166|||
24973940|NCT00098306|50062571|FG002|Double Blind|Ongoing at cut-off date|72|||
24973941|NCT00098306|50062572|FG003|Double Blind|Ongoing at cut-off date|0|||
24973942|NCT00098306|50062573|FG004|Double Blind|Ongoing at cut-off date|0|||
24973943|NCT00098306|50062574|FG005|Double Blind|Ongoing at cut-off date|0|||
24973944|NCT00098306|50062575|FG006|Double Blind|Ongoing at cut-off date|0|||
24973945|NCT00098306|50062569|FG000|Double Blind|Adverse Event|11|||
24973946|NCT00098306|50062570|FG001|Double Blind|Adverse Event|10|||
24973947|NCT00098306|50062571|FG002|Double Blind|Adverse Event|6|||
24973948|NCT00098306|50062572|FG003|Double Blind|Adverse Event|0|||
24973949|NCT00098306|50062573|FG004|Double Blind|Adverse Event|0|||
24973950|NCT00098306|50062574|FG005|Double Blind|Adverse Event|0|||
24973951|NCT00098306|50062575|FG006|Double Blind|Adverse Event|0|||
24973952|NCT00098306|50062569|FG000|Double Blind|Lack of Efficacy|43|||
24973953|NCT00098306|50062570|FG001|Double Blind|Lack of Efficacy|34|||
24973954|NCT00098306|50062571|FG002|Double Blind|Lack of Efficacy|17|||
25074433|NCT02526524|50181557|FG005|Overall Study|Adverse Event|8|||
25074434|NCT02526524|50181552|FG000|Overall Study|Lost to Follow-up|2|||
25074435|NCT02526524|50181553|FG001|Overall Study|Lost to Follow-up|3|||
25074436|NCT02526524|50181554|FG002|Overall Study|Lost to Follow-up|8|||
25074437|NCT02526524|50181555|FG003|Overall Study|Lost to Follow-up|1|||
25074438|NCT02526524|50181556|FG004|Overall Study|Lost to Follow-up|2|||
25074439|NCT02526524|50181557|FG005|Overall Study|Lost to Follow-up|5|||
25074440|NCT02526524|50181552|FG000|Overall Study|Protocol Violation|3|||
25074441|NCT02526524|50181553|FG001|Overall Study|Protocol Violation|1|||
25074442|NCT02526524|50181554|FG002|Overall Study|Protocol Violation|5|||
25074443|NCT02526524|50181555|FG003|Overall Study|Protocol Violation|3|||
25074444|NCT02526524|50181556|FG004|Overall Study|Protocol Violation|4|||
24973955|NCT00098306|50062572|FG003|Double Blind|Lack of Efficacy|0|||
24973956|NCT00098306|50062573|FG004|Double Blind|Lack of Efficacy|0|||
24973957|NCT00098306|50062574|FG005|Double Blind|Lack of Efficacy|0|||
24973958|NCT00098306|50062575|FG006|Double Blind|Lack of Efficacy|0|||
24973959|NCT00098306|50062569|FG000|Double Blind|Death|1|||
24973960|NCT00098306|50062570|FG001|Double Blind|Death|4|||
24973961|NCT00098306|50062571|FG002|Double Blind|Death|1|||
24973962|NCT00098306|50062572|FG003|Double Blind|Death|0|||
24973963|NCT00098306|50062573|FG004|Double Blind|Death|0|||
24973964|NCT00098306|50062574|FG005|Double Blind|Death|0|||
24973965|NCT00098306|50062575|FG006|Double Blind|Death|0|||
24973966|NCT00098306|50062569|FG000|Double Blind|Participant defaulted|19|||
24973967|NCT00098306|50062570|FG001|Double Blind|Participant defaulted|18|||
24973968|NCT00098306|50062571|FG002|Double Blind|Participant defaulted|11|||
24973969|NCT00098306|50062572|FG003|Double Blind|Participant defaulted|0|||
24973970|NCT00098306|50062573|FG004|Double Blind|Participant defaulted|0|||
24973971|NCT00098306|50062574|FG005|Double Blind|Participant defaulted|0|||
24973972|NCT00098306|50062575|FG006|Double Blind|Participant defaulted|0|||
24973973|NCT00098306|50062569|FG000|Double Blind|Un-specified|7|||
24973974|NCT00098306|50062570|FG001|Double Blind|Un-specified|3|||
24973975|NCT00098306|50062571|FG002|Double Blind|Un-specified|11|||
24973976|NCT00098306|50062572|FG003|Double Blind|Un-specified|0|||
24973977|NCT00098306|50062573|FG004|Double Blind|Un-specified|0|||
24973978|NCT00098306|50062574|FG005|Double Blind|Un-specified|0|||
24973979|NCT00098306|50062575|FG006|Double Blind|Un-specified|0|||
25074445|NCT02526524|50181557|FG005|Overall Study|Protocol Violation|3|||
25074446|NCT02526524|50181552|FG000|Overall Study|Loss of Glucose Control|0|||
25074447|NCT02526524|50181553|FG001|Overall Study|Loss of Glucose Control|0|||
25074448|NCT02526524|50181554|FG002|Overall Study|Loss of Glucose Control|3|||
25074449|NCT02526524|50181555|FG003|Overall Study|Loss of Glucose Control|0|||
25074450|NCT02526524|50181556|FG004|Overall Study|Loss of Glucose Control|2|||
25074451|NCT02526524|50181557|FG005|Overall Study|Loss of Glucose Control|0|||
25074452|NCT02526524|50181552|FG000|Overall Study|Physician Decision|0|||
25074453|NCT02526524|50181553|FG001|Overall Study|Physician Decision|0|||
25074454|NCT02526524|50181554|FG002|Overall Study|Physician Decision|0|||
25074455|NCT02526524|50181555|FG003|Overall Study|Physician Decision|0|||
25074456|NCT02526524|50181556|FG004|Overall Study|Physician Decision|1|||
25074457|NCT02526524|50181557|FG005|Overall Study|Physician Decision|0|||
25074458|NCT02526524|50181552|FG000|Overall Study|Sponsor Decision|1|||
25074459|NCT02526524|50181553|FG001|Overall Study|Sponsor Decision|0|||
25074460|NCT02526524|50181554|FG002|Overall Study|Sponsor Decision|0|||
25074461|NCT02526524|50181555|FG003|Overall Study|Sponsor Decision|0|||
25074462|NCT02526524|50181556|FG004|Overall Study|Sponsor Decision|0|||
25074463|NCT02526524|50181557|FG005|Overall Study|Sponsor Decision|0|||
25074464|NCT02526290|50181571|FG000|Overall Study|Adverse Event|3|||
25074465|NCT02526290|50181571|FG000|Overall Study|Withdrawal by Subject|4|||
25074466|NCT02526290|50181571|FG000|Overall Study|Physician Decision|1|||
25170021|NCT01797965|50303978|FG000|Overall Study|Lost to Follow-up|9|||
25170022|NCT01797965|50303979|FG001|Overall Study|Lost to Follow-up|8|||
25170023|NCT01797965|50303980|FG002|Overall Study|Lost to Follow-up|1|||
25170024|NCT01797965|50303981|FG003|Overall Study|Lost to Follow-up|2|||
25170025|NCT01797965|50303978|FG000|Overall Study|Consent withdrawn|130|||
25170026|NCT01797965|50303979|FG001|Overall Study|Consent withdrawn|117|||
25170027|NCT01797965|50303980|FG002|Overall Study|Consent withdrawn|3|||
25170028|NCT01797965|50303981|FG003|Overall Study|Consent withdrawn|35|||
25170029|NCT01797965|50303978|FG000|Overall Study|Investigator decision|21|||
25170030|NCT01797965|50303979|FG001|Overall Study|Investigator decision|15|||
25170031|NCT01797965|50303980|FG002|Overall Study|Investigator decision|0|||
25170032|NCT01797965|50303981|FG003|Overall Study|Investigator decision|0|||
25170033|NCT01797965|50303978|FG000|Overall Study|Death|2|||
25192673|NCT01412060|50360396|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
24973980|NCT00098306|50062569|FG000|Open Label|Lack of Efficacy|0|||
25074467|NCT02319148|50181578|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
25074468|NCT02319148|50181579|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
24973981|NCT00098306|50062570|FG001|Open Label|Lack of Efficacy|0|||
24973982|NCT00098306|50062571|FG002|Open Label|Lack of Efficacy|0|||
24973983|NCT00098306|50062572|FG003|Open Label|Lack of Efficacy|13|||
24973984|NCT00098306|50062573|FG004|Open Label|Lack of Efficacy|0|||
24973985|NCT00098306|50062574|FG005|Open Label|Lack of Efficacy|0|||
25314648|NCT00842829|50630497|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
24973986|NCT00098306|50062575|FG006|Open Label|Lack of Efficacy|0|||
25170034|NCT01797965|50303979|FG001|Overall Study|Death|4|||
24973987|NCT00098306|50062569|FG000|Open Label|Adverse Event|0|||
25170035|NCT01797965|50303980|FG002|Overall Study|Death|0|||
25074469|NCT02319148|50181580|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
25074470|NCT02319148|50181581|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
25074471|NCT02319148|50181578|FG000|Second Intervention Period|No longer willing to participate|0|||
25074472|NCT02319148|50181579|FG001|Second Intervention Period|No longer willing to participate|1|||
25074473|NCT02319148|50181580|FG002|Second Intervention Period|No longer willing to participate|0|||
25074474|NCT02319148|50181581|FG003|Second Intervention Period|No longer willing to participate|0|||
25074475|NCT02319148|50181578|FG000|Second Intervention Period|Other|0|||
25074476|NCT02319148|50181579|FG001|Second Intervention Period|Other|0|||
25074477|NCT02319148|50181580|FG002|Second Intervention Period|Other|0|||
25074478|NCT02319148|50181581|FG003|Second Intervention Period|Other|1|||
25074479|NCT02526212|50181602|FG000|Overall Study|Incarceration|1|||
25074480|NCT02526212|50181603|FG001|Overall Study|Incarceration|0|||
25074481|NCT02526212|50181602|FG000|Overall Study|Lost to Follow-up|1|||
24973988|NCT00098306|50062570|FG001|Open Label|Adverse Event|0|||
24973989|NCT00098306|50062571|FG002|Open Label|Adverse Event|0|||
25074482|NCT02526212|50181603|FG001|Overall Study|Lost to Follow-up|0|||
25074483|NCT02526212|50181602|FG000|Overall Study|Death|0|||
25074484|NCT02526212|50181603|FG001|Overall Study|Death|1|||
24973990|NCT00098306|50062572|FG003|Open Label|Adverse Event|2|||
24973991|NCT00098306|50062573|FG004|Open Label|Adverse Event|0|||
24973992|NCT00098306|50062574|FG005|Open Label|Adverse Event|0|||
24973993|NCT00098306|50062575|FG006|Open Label|Adverse Event|0|||
24973994|NCT00098306|50062569|FG000|Open Label|Death|0|||
24973995|NCT00098306|50062570|FG001|Open Label|Death|0|||
24973996|NCT00098306|50062571|FG002|Open Label|Death|0|||
24973997|NCT00098306|50062572|FG003|Open Label|Death|4|||
24973998|NCT00098306|50062573|FG004|Open Label|Death|0|||
24973999|NCT00098306|50062574|FG005|Open Label|Death|0|||
24974000|NCT00098306|50062575|FG006|Open Label|Death|0|||
24974001|NCT00098306|50062569|FG000|Open Label|Participant defaulted|0|||
24974002|NCT00098306|50062570|FG001|Open Label|Participant defaulted|0|||
24974003|NCT00098306|50062571|FG002|Open Label|Participant defaulted|0|||
24974004|NCT00098306|50062572|FG003|Open Label|Participant defaulted|24|||
24974005|NCT00098306|50062573|FG004|Open Label|Participant defaulted|0|||
24974006|NCT00098306|50062574|FG005|Open Label|Participant defaulted|0|||
24974007|NCT00098306|50062575|FG006|Open Label|Participant defaulted|0|||
24974008|NCT00098306|50062569|FG000|Open Label|Un-specified|0|||
24974009|NCT00098306|50062570|FG001|Open Label|Un-specified|0|||
24974010|NCT00098306|50062571|FG002|Open Label|Un-specified|0|||
24974011|NCT00098306|50062572|FG003|Open Label|Un-specified|15|||
24974012|NCT00098306|50062573|FG004|Open Label|Un-specified|0|||
24974013|NCT00098306|50062574|FG005|Open Label|Un-specified|0|||
24974014|NCT00098306|50062575|FG006|Open Label|Un-specified|0|||
24974015|NCT00098306|50062569|FG000|Open Label|Ongoing at cut-off date|0|||
24974016|NCT00098306|50062570|FG001|Open Label|Ongoing at cut-off date|0|||
24974017|NCT00098306|50062571|FG002|Open Label|Ongoing at cut-off date|0|||
24974018|NCT00098306|50062572|FG003|Open Label|Ongoing at cut-off date|269|||
24974019|NCT00098306|50062573|FG004|Open Label|Ongoing at cut-off date|62|||
24974020|NCT00098306|50062574|FG005|Open Label|Ongoing at cut-off date|0|||
24974021|NCT00098306|50062575|FG006|Open Label|Ongoing at cut-off date|0|||
24974022|NCT00098306|50062569|FG000|Observational Phase|Death|0|||
24974023|NCT00098306|50062570|FG001|Observational Phase|Death|0|||
24974024|NCT00098306|50062571|FG002|Observational Phase|Death|0|||
24974025|NCT00098306|50062572|FG003|Observational Phase|Death|0|||
24974026|NCT00098306|50062573|FG004|Observational Phase|Death|0|||
24974027|NCT00098306|50062574|FG005|Observational Phase|Death|5|||
24974028|NCT00098306|50062575|FG006|Observational Phase|Death|4|||
24974029|NCT00098306|50062569|FG000|Observational Phase|Participant defaulted|0|||
24974030|NCT00098306|50062570|FG001|Observational Phase|Participant defaulted|0|||
24974031|NCT00098306|50062571|FG002|Observational Phase|Participant defaulted|0|||
24974032|NCT00098306|50062572|FG003|Observational Phase|Participant defaulted|0|||
24974033|NCT00098306|50062573|FG004|Observational Phase|Participant defaulted|0|||
24974034|NCT00098306|50062574|FG005|Observational Phase|Participant defaulted|34|||
24974035|NCT00098306|50062575|FG006|Observational Phase|Participant defaulted|18|||
24974036|NCT00098306|50062569|FG000|Observational Phase|Un-specified|0|||
24974037|NCT00098306|50062570|FG001|Observational Phase|Un-specified|0|||
24974038|NCT00098306|50062571|FG002|Observational Phase|Un-specified|0|||
24974039|NCT00098306|50062572|FG003|Observational Phase|Un-specified|0|||
24974040|NCT00098306|50062573|FG004|Observational Phase|Un-specified|0|||
24974041|NCT00098306|50062574|FG005|Observational Phase|Un-specified|7|||
24974042|NCT00098306|50062575|FG006|Observational Phase|Un-specified|4|||
24974043|NCT03615040|50062590|FG000|Overall Study|Withdrawal by Subject|2|||
24974044|NCT03615040|50062591|FG001|Overall Study|Withdrawal by Subject|1|||
24974045|NCT03615040|50062590|FG000|Overall Study|Physician Decision|2|||
24974046|NCT03615040|50062591|FG001|Overall Study|Physician Decision|2|||
24974047|NCT03615040|50062590|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
24974048|NCT03615040|50062591|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
24974049|NCT03615040|50062590|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
24974050|NCT03615040|50062591|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
24974051|NCT03615040|50062590|FG000|Overall Study|Death|0|||
24974052|NCT03615040|50062591|FG001|Overall Study|Death|2|||
24974053|NCT00068822|50062599|FG000|First Randomized Intervention|Lost to Follow-up|1|||
24974054|NCT00068822|50062600|FG001|First Randomized Intervention|Lost to Follow-up|2|||
24974055|NCT00068588|50062609|FG000|Overall Study|Adverse Event|0|||
24974056|NCT00068588|50062610|FG001|Overall Study|Adverse Event|0|||
24974057|NCT00068588|50062611|FG002|Overall Study|Adverse Event|2|||
24974058|NCT00068588|50062609|FG000|Overall Study|Withdrawal by Subject|0|||
25074485|NCT02532374|50181609|FG000|Overall Study|Withdrawal by Subject|1|||
25074486|NCT02532374|50181609|FG000|Overall Study|Physician Decision|1|||
25074487|NCT02525744|50181621|FG000|Period 1|Physician Decision|0|||
25074488|NCT02525744|50181622|FG001|Period 1|Physician Decision|0|||
25074489|NCT02525744|50181623|FG002|Period 1|Physician Decision|1|||
25074490|NCT02525744|50181624|FG003|Period 1|Physician Decision|0|||
25074491|NCT02525744|50181621|FG000|Period 3|Adverse Event|0|||
25074492|NCT02525744|50181622|FG001|Period 3|Adverse Event|1|||
24974059|NCT00068588|50062610|FG001|Overall Study|Withdrawal by Subject|0|||
24974060|NCT00068588|50062611|FG002|Overall Study|Withdrawal by Subject|1|||
24974061|NCT00068588|50062609|FG000|Overall Study|Poor KPS|0|||
24974062|NCT00068588|50062610|FG001|Overall Study|Poor KPS|0|||
24974063|NCT00068588|50062611|FG002|Overall Study|Poor KPS|1|||
24974064|NCT03650452|50062620|FG000|Overall Study|Physician Decision|1|||
24974065|NCT03650452|50062621|FG001|Overall Study|Physician Decision|0|||
24974066|NCT03650452|50062620|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
24974067|NCT03650452|50062621|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
24974068|NCT03650452|50062620|FG000|Overall Study|Adverse Event|3|||
25074493|NCT02525744|50181623|FG002|Period 3|Adverse Event|0|||
25074494|NCT02525744|50181624|FG003|Period 3|Adverse Event|0|||
25074495|NCT02525744|50181621|FG000|Period 4|Withdrawal by Subject|1|||
25074496|NCT02525744|50181622|FG001|Period 4|Withdrawal by Subject|0|||
24974069|NCT03650452|50062621|FG001|Overall Study|Adverse Event|4|||
24974070|NCT03650452|50062620|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
25074497|NCT02525744|50181623|FG002|Period 4|Withdrawal by Subject|0|||
25074498|NCT02525744|50181624|FG003|Period 4|Withdrawal by Subject|0|||
25074499|NCT02525744|50181621|FG000|Period 5|Physician Decision|1|||
25074500|NCT02525744|50181622|FG001|Period 5|Physician Decision|0|||
24974071|NCT03650452|50062621|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
24974072|NCT03575806|50062629|FG000|Overall Study|Withdrawal by Subject|0|||
24974073|NCT03575806|50062630|FG001|Overall Study|Withdrawal by Subject|2|||
24974074|NCT03575806|50062629|FG000|Overall Study|Protocol Violation|0|||
24974075|NCT03575806|50062630|FG001|Overall Study|Protocol Violation|2|||
24974076|NCT03610048|50062636|FG000|Overall Study|Study terminated by sponsor|84|||
24974077|NCT03610048|50062636|FG000|Overall Study|Adverse Event|32|||
24974078|NCT03610048|50062636|FG000|Overall Study|Withdrawal by Subject|31|||
24974079|NCT03610048|50062636|FG000|Overall Study|Lost to Follow-up|8|||
24974080|NCT03610048|50062636|FG000|Overall Study|Other|4|||
24974081|NCT03610048|50062636|FG000|Overall Study|Physician Decision|1|||
24974082|NCT03610048|50062636|FG000|Overall Study|Pregnancy|1|||
24974083|NCT03608254|50062640|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
24974084|NCT03608254|50062640|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
24974085|NCT03606460|50062646|FG000|Overall Study|Lost to Follow-up|1|||
24974086|NCT03606460|50062647|FG001|Overall Study|Lost to Follow-up|8|||
25074501|NCT02525744|50181623|FG002|Period 5|Physician Decision|0|||
25074502|NCT02525744|50181624|FG003|Period 5|Physician Decision|0|||
24974087|NCT03605836|50062658|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
24974088|NCT03605836|50062659|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
24974089|NCT03605836|50062660|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
25074503|NCT00152477|50181637|FG000|Chemotherapy Period|Adverse Event|9|||
25074504|NCT00152477|50181638|FG001|Chemotherapy Period|Adverse Event|4|||
25074505|NCT00152477|50181639|FG002|Chemotherapy Period|Adverse Event|5|||
25074506|NCT00152477|50181637|FG000|Chemotherapy Period|Death|1|||
24974090|NCT03605836|50062661|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
24974091|NCT03605836|50062658|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
24974092|NCT03605836|50062659|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
25074507|NCT00152477|50181638|FG001|Chemotherapy Period|Death|3|||
25074508|NCT00152477|50181639|FG002|Chemotherapy Period|Death|3|||
25074509|NCT00152477|50181637|FG000|Chemotherapy Period|Lack of Efficacy|4|||
25074510|NCT00152477|50181638|FG001|Chemotherapy Period|Lack of Efficacy|5|||
24974093|NCT03605836|50062660|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
24974094|NCT03605836|50062661|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
24974095|NCT03605836|50062658|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
24974096|NCT03605836|50062659|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
24974097|NCT03605836|50062660|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
24974098|NCT03605836|50062661|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
25074511|NCT00152477|50181639|FG002|Chemotherapy Period|Lack of Efficacy|6|||
25074512|NCT00152477|50181637|FG000|Chemotherapy Period|Lost to Follow-up|1|||
25170036|NCT01797965|50303981|FG003|Overall Study|Death|0|||
25074513|NCT00152477|50181638|FG001|Chemotherapy Period|Lost to Follow-up|0|||
25074514|NCT00152477|50181639|FG002|Chemotherapy Period|Lost to Follow-up|1|||
25074515|NCT00152477|50181637|FG000|Chemotherapy Period|Protocol Violation|1|||
25074516|NCT00152477|50181638|FG001|Chemotherapy Period|Protocol Violation|1|||
25074517|NCT00152477|50181639|FG002|Chemotherapy Period|Protocol Violation|0|||
24974099|NCT03605836|50062658|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
24974100|NCT03605836|50062659|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
24974101|NCT03605836|50062660|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
24974102|NCT03605836|50062661|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
24974103|NCT03605836|50062658|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
24974104|NCT03605836|50062659|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
24974105|NCT03605836|50062660|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
24974106|NCT03605836|50062661|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
24974107|NCT03605836|50062658|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
24974108|NCT03605836|50062659|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
24974109|NCT03605836|50062660|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
24974110|NCT03605836|50062661|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
24974111|NCT03605836|50062658|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
24974112|NCT03605836|50062659|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
24974113|NCT03605836|50062660|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
24974114|NCT03605836|50062661|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
24974115|NCT03605836|50062658|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
24974116|NCT03605836|50062659|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
24974117|NCT03605836|50062660|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
24974118|NCT03605836|50062661|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
25074518|NCT00152477|50181637|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
25074519|NCT00152477|50181638|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
25074520|NCT00152477|50181639|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
25074521|NCT00152477|50181637|FG000|Chemotherapy Period|Progression of Disease|6|||
25074522|NCT00152477|50181638|FG001|Chemotherapy Period|Progression of Disease|8|||
25074523|NCT00152477|50181639|FG002|Chemotherapy Period|Progression of Disease|4|||
24974119|NCT03605836|50062658|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
24974120|NCT03605836|50062659|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
24974121|NCT03605836|50062660|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
24974122|NCT03605836|50062661|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
24974123|NCT03605836|50062658|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
24974124|NCT03605836|50062659|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
24974125|NCT03605836|50062660|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
25074524|NCT00152477|50181637|FG000|Chemotherapy Period|Investigator decision|0|||
25074525|NCT00152477|50181638|FG001|Chemotherapy Period|Investigator decision|0|||
25074526|NCT00152477|50181639|FG002|Chemotherapy Period|Investigator decision|1|||
25170037|NCT01797965|50303978|FG000|Overall Study|Disease progression, defined by protocol|3|||
25170038|NCT01797965|50303979|FG001|Overall Study|Disease progression, defined by protocol|1|||
25170039|NCT01797965|50303980|FG002|Overall Study|Disease progression, defined by protocol|0|||
25170040|NCT01797965|50303981|FG003|Overall Study|Disease progression, defined by protocol|0|||
25170041|NCT01797965|50303978|FG000|Overall Study|Reason Not Specified|280|||
25170042|NCT01797965|50303979|FG001|Overall Study|Reason Not Specified|295|||
25170043|NCT01797965|50303980|FG002|Overall Study|Reason Not Specified|0|||
25170044|NCT01797965|50303981|FG003|Overall Study|Reason Not Specified|15|||
25170045|NCT01376388|50304026|FG000|Overall Study|Adverse Event|13|||
25170046|NCT01376388|50304026|FG000|Overall Study|Lack of Efficacy|2|||
25170047|NCT01376388|50304026|FG000|Overall Study|Withdrawal by Subject|3|||
25170048|NCT01821677|50304047|FG000|Overall Study|Adverse Event|4|||
25170049|NCT01821677|50304048|FG001|Overall Study|Adverse Event|6|||
25170050|NCT01821677|50304049|FG002|Overall Study|Adverse Event|5|||
25170051|NCT01821677|50304047|FG000|Overall Study|Physician Decision|1|||
25170052|NCT01821677|50304048|FG001|Overall Study|Physician Decision|4|||
25170053|NCT01821677|50304049|FG002|Overall Study|Physician Decision|1|||
25170054|NCT01821677|50304047|FG000|Overall Study|Non-compliance|0|||
25170055|NCT01821677|50304048|FG001|Overall Study|Non-compliance|1|||
25074527|NCT00152477|50181637|FG000|Chemotherapy Period|Patient condition worsened|1|||
25074528|NCT00152477|50181638|FG001|Chemotherapy Period|Patient condition worsened|0|||
25074529|NCT00152477|50181639|FG002|Chemotherapy Period|Patient condition worsened|0|||
25074530|NCT00152477|50181637|FG000|Monotherapy Period|Adverse Event|1|||
25074531|NCT00152477|50181638|FG001|Monotherapy Period|Adverse Event|0|||
25074532|NCT00152477|50181639|FG002|Monotherapy Period|Adverse Event|5|||
25074533|NCT00152477|50181637|FG000|Monotherapy Period|Death|2|||
25074534|NCT00152477|50181638|FG001|Monotherapy Period|Death|0|||
25074535|NCT00152477|50181639|FG002|Monotherapy Period|Death|1|||
25074536|NCT00152477|50181637|FG000|Monotherapy Period|Lack of Efficacy|7|||
25074537|NCT00152477|50181638|FG001|Monotherapy Period|Lack of Efficacy|16|||
25074538|NCT00152477|50181639|FG002|Monotherapy Period|Lack of Efficacy|10|||
25074539|NCT00152477|50181637|FG000|Monotherapy Period|Protocol Violation|0|||
24974126|NCT03605836|50062661|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
24974127|NCT03605836|50062658|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
24974128|NCT03605836|50062659|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
24974129|NCT03605836|50062660|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
25074540|NCT00152477|50181638|FG001|Monotherapy Period|Protocol Violation|1|||
25074541|NCT00152477|50181639|FG002|Monotherapy Period|Protocol Violation|0|||
25074542|NCT00152477|50181637|FG000|Monotherapy Period|Withdrawal by Subject|0|||
25074543|NCT00152477|50181638|FG001|Monotherapy Period|Withdrawal by Subject|0|||
25074544|NCT00152477|50181639|FG002|Monotherapy Period|Withdrawal by Subject|4|||
25074545|NCT00152477|50181637|FG000|Monotherapy Period|Progression of Disease|5|||
25074546|NCT00152477|50181638|FG001|Monotherapy Period|Progression of Disease|11|||
25074547|NCT00152477|50181639|FG002|Monotherapy Period|Progression of Disease|12|||
25074548|NCT00152477|50181637|FG000|Monotherapy Period|Patient decision|0|||
25074549|NCT00152477|50181638|FG001|Monotherapy Period|Patient decision|1|||
25074550|NCT00152477|50181639|FG002|Monotherapy Period|Patient decision|1|||
25074551|NCT00152477|50181637|FG000|Monotherapy Period|Study personel decision|0|||
25074552|NCT00152477|50181638|FG001|Monotherapy Period|Study personel decision|0|||
25074553|NCT00152477|50181639|FG002|Monotherapy Period|Study personel decision|1|||
25074554|NCT02525588|50181652|FG000|Overall Study|Death|3|||
25074555|NCT02525588|50181653|FG001|Overall Study|Death|1|||
25074556|NCT02525588|50181652|FG000|Overall Study|Lost to Follow-up|2|||
25074557|NCT02525588|50181653|FG001|Overall Study|Lost to Follow-up|0|||
25074558|NCT02525588|50181652|FG000|Overall Study|Withdrawal by Subject|1|||
24974130|NCT03605836|50062661|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
24974131|NCT03605836|50062658|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
24974132|NCT03605836|50062659|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
24974133|NCT03605836|50062660|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
24974134|NCT03605836|50062661|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
24974135|NCT03605836|50062658|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
25074559|NCT02525588|50181653|FG001|Overall Study|Withdrawal by Subject|1|||
25074560|NCT02525588|50181652|FG000|Overall Study|Adverse Event|0|||
25074561|NCT02525588|50181653|FG001|Overall Study|Adverse Event|1|||
25074562|NCT00153179|50181661|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
25074563|NCT00153179|50181662|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
24974136|NCT03605836|50062659|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
24974137|NCT03605836|50062660|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
24974138|NCT03605836|50062661|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
24974139|NCT03605836|50062658|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
25074564|NCT00153179|50181663|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
25074565|NCT00153179|50181664|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
25170056|NCT01821677|50304049|FG002|Overall Study|Non-compliance|2|||
25170057|NCT01821677|50304047|FG000|Overall Study|Lost to Follow-up|2|||
24974140|NCT03605836|50062659|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
24974141|NCT03605836|50062660|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
24974142|NCT03605836|50062661|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
24974143|NCT03605836|50062658|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
25074566|NCT02531594|50181674|FG000|Overall Study|Withdrawal by Subject|7|||
25074567|NCT02531594|50181675|FG001|Overall Study|Withdrawal by Subject|8|||
25074568|NCT02743949|50181684|FG000|Overall Study|Adverse Event|0|||
25074569|NCT02743949|50181685|FG001|Overall Study|Adverse Event|0|||
25074570|NCT02743949|50181686|FG002|Overall Study|Adverse Event|2|||
25074571|NCT02743949|50181684|FG000|Overall Study|Significant Protocol Deviation|2|||
25170058|NCT01821677|50304048|FG001|Overall Study|Lost to Follow-up|1|||
25074572|NCT02743949|50181685|FG001|Overall Study|Significant Protocol Deviation|0|||
25074573|NCT02743949|50181686|FG002|Overall Study|Significant Protocol Deviation|1|||
25074574|NCT02743949|50181684|FG000|Overall Study|Voluntary Withdrawal|2|||
25074575|NCT02743949|50181685|FG001|Overall Study|Voluntary Withdrawal|1|||
25170059|NCT01821677|50304049|FG002|Overall Study|Lost to Follow-up|3|||
24974144|NCT03605836|50062659|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
25074576|NCT02743949|50181686|FG002|Overall Study|Voluntary Withdrawal|0|||
25074577|NCT02531438|50181696|FG000|Overall Study|Adverse Event|7|||
25170060|NCT01821677|50304047|FG000|Overall Study|Protocol Violation|0|||
25170061|NCT01821677|50304048|FG001|Overall Study|Protocol Violation|0|||
25170062|NCT01821677|50304049|FG002|Overall Study|Protocol Violation|2|||
25170063|NCT01821677|50304047|FG000|Overall Study|Withdrawal by Subject|7|||
25170064|NCT01821677|50304048|FG001|Overall Study|Withdrawal by Subject|3|||
25170065|NCT01821677|50304049|FG002|Overall Study|Withdrawal by Subject|2|||
25170066|NCT01821677|50304047|FG000|Overall Study|Other|9|||
25170067|NCT01821677|50304048|FG001|Overall Study|Other|0|||
25170068|NCT01821677|50304049|FG002|Overall Study|Other|0|||
25192674|NCT01412060|50360397|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
25192675|NCT01412060|50360398|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
25192676|NCT01412060|50360396|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
25192677|NCT01412060|50360397|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
25192678|NCT01412060|50360398|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
25192679|NCT01412060|50360396|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
25192680|NCT01412060|50360397|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
25192681|NCT01412060|50360398|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
25192682|NCT01412060|50360396|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
25192683|NCT01412060|50360397|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
25192684|NCT01412060|50360398|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
25192685|NCT01412060|50360396|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
25192686|NCT01412060|50360397|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
25192687|NCT01412060|50360398|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
25192688|NCT01412060|50360396|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
25192689|NCT01412060|50360397|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
25192690|NCT01412060|50360398|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
25192691|NCT01412060|50360396|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
25192692|NCT01412060|50360397|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
25192693|NCT01412060|50360398|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
25192694|NCT01412060|50360396|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
24974145|NCT03605836|50062660|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
24974146|NCT03605836|50062661|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
24974147|NCT03605836|50062658|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
24974148|NCT03605836|50062659|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
24974149|NCT03605836|50062660|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
24974150|NCT03605836|50062661|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
24974151|NCT03605836|50062658|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
24974152|NCT03605836|50062659|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
24974153|NCT03605836|50062660|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
24974154|NCT03605836|50062661|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
24974155|NCT03605836|50062658|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
24974156|NCT03605836|50062659|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
24974157|NCT03605836|50062660|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
24974158|NCT03605836|50062661|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
24974159|NCT03605836|50062658|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
24974160|NCT03605836|50062659|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
24974161|NCT03605836|50062660|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
24974162|NCT03605836|50062661|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
24974163|NCT03605836|50062658|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
24974164|NCT03605836|50062659|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
24974165|NCT03605836|50062660|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
24974166|NCT03605836|50062661|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
24974167|NCT03605836|50062658|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
24974168|NCT03605836|50062659|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
24974169|NCT03605836|50062660|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
24974170|NCT03605836|50062661|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
24974171|NCT03605836|50062658|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
24974172|NCT03605836|50062659|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
25074578|NCT02531438|50181697|FG001|Overall Study|Adverse Event|9|||
25074579|NCT02531438|50181696|FG000|Overall Study|Lost to Follow-up|0|||
25170069|NCT01797731|50304060|FG000|Overall Study|Didn't have proper radiographs required|3|||
25170070|NCT01797731|50304061|FG001|Overall Study|Didn't have proper radiographs required|3|||
25170071|NCT00709722|50304067|FG000|Overall Study|Adverse Event|1|||
25170072|NCT01820585|50304088|FG000|Overall Study|Adverse Event|9|||
25074580|NCT02531438|50181697|FG001|Overall Study|Lost to Follow-up|3|||
25074581|NCT02531438|50181696|FG000|Overall Study|Withdrawal by Subject|7|||
25074582|NCT02531438|50181697|FG001|Overall Study|Withdrawal by Subject|8|||
25074583|NCT02531438|50181696|FG000|Overall Study|Physician Decision|0|||
25074584|NCT02531438|50181697|FG001|Overall Study|Physician Decision|1|||
25074585|NCT02531438|50181696|FG000|Overall Study|Death|6|||
25074586|NCT02531438|50181697|FG001|Overall Study|Death|3|||
25074587|NCT02531438|50181696|FG000|Overall Study|Randomized, but Not Treated|4|||
25074588|NCT02531438|50181697|FG001|Overall Study|Randomized, but Not Treated|0|||
25074589|NCT02531438|50181696|FG000|Overall Study|Missed EOT/PTE Visit|5|||
25074590|NCT02531438|50181697|FG001|Overall Study|Missed EOT/PTE Visit|2|||
25074591|NCT02531438|50181696|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
25074592|NCT02531438|50181697|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
25074593|NCT02289898|50181706|FG000|Overall Study|Death|5|||
25074594|NCT02289898|50181707|FG001|Overall Study|Death|4|||
25074595|NCT02289898|50181708|FG002|Overall Study|Death|3|||
25074596|NCT02289898|50181706|FG000|Overall Study|Physician Decision|2|||
25074597|NCT02289898|50181707|FG001|Overall Study|Physician Decision|5|||
25074598|NCT02289898|50181708|FG002|Overall Study|Physician Decision|2|||
25074599|NCT02289898|50181706|FG000|Overall Study|Withdrawal by Subject|0|||
25074600|NCT02289898|50181707|FG001|Overall Study|Withdrawal by Subject|4|||
25074601|NCT02289898|50181708|FG002|Overall Study|Withdrawal by Subject|1|||
25074602|NCT02289898|50181706|FG000|Overall Study|Adverse Event|3|||
25074603|NCT02289898|50181707|FG001|Overall Study|Adverse Event|5|||
25074604|NCT02289898|50181708|FG002|Overall Study|Adverse Event|5|||
25074605|NCT02289898|50181706|FG000|Overall Study|Disease progression|34|||
25074606|NCT02289898|50181707|FG001|Overall Study|Disease progression|28|||
25074607|NCT02289898|50181708|FG002|Overall Study|Disease progression|34|||
25074608|NCT02289898|50181706|FG000|Overall Study|Use of another anticancer therapy|0|||
25074609|NCT02289898|50181707|FG001|Overall Study|Use of another anticancer therapy|0|||
25074610|NCT02289898|50181708|FG002|Overall Study|Use of another anticancer therapy|1|||
25074611|NCT02289898|50181706|FG000|Overall Study|Other|8|||
25074612|NCT02289898|50181707|FG001|Overall Study|Other|7|||
25074613|NCT02289898|50181708|FG002|Overall Study|Other|10|||
25074614|NCT01660412|50181715|FG000|Overall Study|Protocol Violation|0|||
25074615|NCT01660412|50181716|FG001|Overall Study|Protocol Violation|3|||
25074616|NCT01659554|50181722|FG000|Overall Study|Study Termination|4|||
24974173|NCT03605836|50062660|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
24974174|NCT03605836|50062661|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
25074617|NCT01659320|50181726|FG000|Overall Study|Withdrawal by Subject|2|||
25074618|NCT01659320|50181726|FG000|Overall Study|Physician Decision|1|||
25074619|NCT01660334|50181730|FG000|Overall Study|Lost to Follow-up|1|||
25074620|NCT01660256|50181737|FG000|Overall Study|Adverse Event|4|||
25074621|NCT01660256|50181738|FG001|Overall Study|Adverse Event|0|||
25074622|NCT01660256|50181739|FG002|Overall Study|Adverse Event|2|||
24974175|NCT03605680|50062674|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
25074623|NCT01660256|50181737|FG000|Overall Study|Withdrawal by Subject|1|||
25074624|NCT01660256|50181738|FG001|Overall Study|Withdrawal by Subject|0|||
25074625|NCT01660256|50181739|FG002|Overall Study|Withdrawal by Subject|2|||
25074626|NCT02034123|50181765|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
25074627|NCT02034123|50181766|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
25074628|NCT02034123|50181767|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
25074629|NCT02034123|50181768|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
25074630|NCT02034123|50181769|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
25192695|NCT01412060|50360397|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
25192696|NCT01412060|50360398|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
25192697|NCT00551421|50360429|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
25074631|NCT02034123|50181770|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
25074632|NCT02034123|50181771|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
25074633|NCT02034123|50181772|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
25314649|NCT00842829|50630495|FG000|Dose Titration Period|Withdrawal by Subject|2|||
25074634|NCT02034123|50181773|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
25074635|NCT02034123|50181774|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
25074636|NCT02034123|50181775|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
25074637|NCT02034123|50181776|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
25074638|NCT02034123|50181777|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
25192698|NCT01891643|50360449|FG000|Overall Study|Adverse event unrelated to study drug|2|||
25192699|NCT01891643|50360450|FG001|Overall Study|Adverse event unrelated to study drug|5|||
25192700|NCT01891643|50360449|FG000|Overall Study|Disease Progression|4|||
25192701|NCT01891643|50360450|FG001|Overall Study|Disease Progression|3|||
25192702|NCT01891643|50360449|FG000|Overall Study|Study Drug Toxicity|3|||
25192703|NCT01891643|50360450|FG001|Overall Study|Study Drug Toxicity|0|||
25192704|NCT01891643|50360449|FG000|Overall Study|Maximum Clinical Benefit|0|||
25192705|NCT01891643|50360450|FG001|Overall Study|Maximum Clinical Benefit|1|||
25192706|NCT01891643|50360449|FG000|Overall Study|Poor/Non-compliance|0|||
25192707|NCT01891643|50360450|FG001|Overall Study|Poor/Non-compliance|1|||
24974176|NCT03605680|50062675|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
24974177|NCT03605680|50062676|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
24974178|NCT03605680|50062677|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
24974179|NCT03605680|50062674|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
24974180|NCT03605680|50062675|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
24974181|NCT03605680|50062676|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
24974182|NCT03605680|50062677|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
24974183|NCT03605680|50062674|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
24974184|NCT03605680|50062675|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
24974185|NCT03605680|50062676|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
24974186|NCT03605680|50062677|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
24974187|NCT03605680|50062674|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
24974188|NCT03605680|50062675|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
24974189|NCT03605680|50062676|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
24974190|NCT03605680|50062677|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
24974191|NCT03605680|50062674|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
24974192|NCT03605680|50062675|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
25074639|NCT02034123|50181778|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
25074640|NCT02034123|50181779|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
25074641|NCT02034123|50181780|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
25074642|NCT02034123|50181781|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
25074643|NCT02034123|50181782|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
25074644|NCT02034123|50181765|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
25074645|NCT02034123|50181766|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
25074646|NCT02034123|50181767|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
25074647|NCT02034123|50181768|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
25074648|NCT02034123|50181769|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
25074649|NCT02034123|50181770|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
25074650|NCT02034123|50181771|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
25074651|NCT02034123|50181772|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
25074652|NCT02034123|50181773|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
25074653|NCT02034123|50181774|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
25074654|NCT02034123|50181775|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
25074655|NCT02034123|50181776|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
25074656|NCT02034123|50181777|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
25074657|NCT02034123|50181778|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
25074658|NCT02034123|50181779|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
25074659|NCT02034123|50181780|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
25074660|NCT02034123|50181781|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
25074661|NCT02034123|50181782|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
25074662|NCT02034123|50181765|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
25074663|NCT02034123|50181766|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
25074664|NCT02034123|50181767|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
25074665|NCT02034123|50181768|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
25170073|NCT01820585|50304089|FG001|Overall Study|Adverse Event|13|||
25192708|NCT01891643|50360449|FG000|Overall Study|Participant request to discontinue|1|||
25192709|NCT01891643|50360450|FG001|Overall Study|Participant request to discontinue|0|||
24974193|NCT03605680|50062676|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
24974194|NCT03605680|50062677|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
24974195|NCT03605680|50062674|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
24974196|NCT03605680|50062675|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
24974197|NCT03605680|50062676|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
24974198|NCT03605680|50062677|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
24974199|NCT03605680|50062674|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
24974200|NCT03605680|50062675|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
25074666|NCT02034123|50181769|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
25074667|NCT02034123|50181770|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
25074668|NCT02034123|50181771|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
25074669|NCT02034123|50181772|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
25074670|NCT02034123|50181773|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
25074671|NCT02034123|50181774|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
25074672|NCT02034123|50181775|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
25074673|NCT02034123|50181776|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
25074674|NCT02034123|50181777|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
25074675|NCT02034123|50181778|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
25074676|NCT02034123|50181779|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
25074677|NCT02034123|50181780|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
25074678|NCT02034123|50181781|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
25074679|NCT02034123|50181782|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
25074680|NCT02034123|50181765|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
25074681|NCT02034123|50181766|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
25074682|NCT02034123|50181767|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
25074683|NCT02034123|50181768|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
25074684|NCT02034123|50181769|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
25074685|NCT02034123|50181770|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
25074686|NCT02034123|50181771|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
25074687|NCT02034123|50181772|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
25074688|NCT02034123|50181773|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
25074689|NCT02034123|50181774|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
25074690|NCT02034123|50181775|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
25074691|NCT02034123|50181776|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
25074692|NCT02034123|50181777|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
25074693|NCT02034123|50181778|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
25074694|NCT02034123|50181779|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
25074695|NCT02034123|50181780|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
25074696|NCT02034123|50181781|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
25170074|NCT01820585|50304090|FG002|Overall Study|Adverse Event|23|||
25170075|NCT01820585|50304091|FG003|Overall Study|Adverse Event|34|||
25170076|NCT01820585|50304088|FG000|Overall Study|Lack of Efficacy|9|||
25192710|NCT01392326|50360584|FG000|Overall Study|Death|2|||
25192711|NCT01392326|50360585|FG001|Overall Study|Death|0|||
25192712|NCT01392326|50360586|FG002|Overall Study|Death|0|||
25192713|NCT01392326|50360584|FG000|Overall Study|Withdrawal by Subject|12|||
25192714|NCT01392326|50360585|FG001|Overall Study|Withdrawal by Subject|11|||
25192715|NCT01392326|50360586|FG002|Overall Study|Withdrawal by Subject|15|||
25192716|NCT01392326|50360584|FG000|Overall Study|Protocol Violation|2|||
25192717|NCT01392326|50360585|FG001|Overall Study|Protocol Violation|0|||
25192718|NCT01392326|50360586|FG002|Overall Study|Protocol Violation|0|||
25192719|NCT01392326|50360584|FG000|Overall Study|Pregnancy|0|||
25192720|NCT01392326|50360585|FG001|Overall Study|Pregnancy|0|||
25192721|NCT01392326|50360586|FG002|Overall Study|Pregnancy|1|||
25192722|NCT01392326|50360584|FG000|Overall Study|Physician Decision|7|||
25192723|NCT01392326|50360585|FG001|Overall Study|Physician Decision|5|||
25192724|NCT01392326|50360586|FG002|Overall Study|Physician Decision|2|||
25192725|NCT01392326|50360584|FG000|Overall Study|Lost to Follow-up|1|||
25192726|NCT01392326|50360585|FG001|Overall Study|Lost to Follow-up|3|||
25192727|NCT01392326|50360586|FG002|Overall Study|Lost to Follow-up|4|||
25192728|NCT01392326|50360584|FG000|Overall Study|Lack of Efficacy|14|||
25192729|NCT01392326|50360585|FG001|Overall Study|Lack of Efficacy|10|||
25314650|NCT00842829|50630496|FG001|Dose Titration Period|Withdrawal by Subject|6|||
25314651|NCT00842829|50630497|FG002|Dose Titration Period|Withdrawal by Subject|0|||
24974201|NCT03605680|50062676|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
25170077|NCT01820585|50304089|FG001|Overall Study|Lack of Efficacy|7|||
25170078|NCT01820585|50304090|FG002|Overall Study|Lack of Efficacy|5|||
25170079|NCT01820585|50304091|FG003|Overall Study|Lack of Efficacy|1|||
25170080|NCT01820585|50304088|FG000|Overall Study|Withdrawal by Subject|3|||
25074697|NCT02034123|50181782|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
25074698|NCT02530970|50181825|FG000|Overall Study|Adverse Event|8|||
25074699|NCT02530970|50181825|FG000|Overall Study|Lost to Follow-up|88|||
25074700|NCT02530970|50181825|FG000|Overall Study|Physician Decision|5|||
25074701|NCT02530970|50181825|FG000|Overall Study|Withdrawal by Subject|14|||
25074702|NCT02530970|50181825|FG000|Overall Study|Death|6|||
25074703|NCT02530970|50181825|FG000|Overall Study|Hospitalization|1|||
25074704|NCT02530970|50181825|FG000|Overall Study|Insurance|2|||
25074705|NCT02530970|50181825|FG000|Overall Study|Explant|2|||
25074706|NCT02530970|50181825|FG000|Overall Study|Change in Provider|5|||
25074707|NCT02530970|50181825|FG000|Overall Study|Relocation|3|||
25074708|NCT02318602|50181832|FG000|Overall Study|Adverse Event|0|||
25074709|NCT02318602|50181833|FG001|Overall Study|Adverse Event|1|||
25074710|NCT02318602|50181834|FG002|Overall Study|Adverse Event|1|||
25074711|NCT02318602|50181832|FG000|Overall Study|Withdrawal by Subject|0|||
25074712|NCT02318602|50181833|FG001|Overall Study|Withdrawal by Subject|3|||
25074713|NCT02318602|50181834|FG002|Overall Study|Withdrawal by Subject|0|||
25074714|NCT02318602|50181832|FG000|Overall Study|Death|1|||
25074715|NCT02318602|50181833|FG001|Overall Study|Death|0|||
25074716|NCT02318602|50181834|FG002|Overall Study|Death|0|||
25074717|NCT02318602|50181832|FG000|Overall Study|Guardian decision to withdraw|0|||
25074718|NCT02318602|50181833|FG001|Overall Study|Guardian decision to withdraw|0|||
25074719|NCT02318602|50181834|FG002|Overall Study|Guardian decision to withdraw|1|||
25074720|NCT02318368|50181850|FG000|Overall Study|Withdrawal by Subject|2|||
25074721|NCT02318368|50181851|FG001|Overall Study|Withdrawal by Subject|0|||
25074722|NCT02318368|50181850|FG000|Overall Study|Study terminated by the sponsor|5|||
25074723|NCT02318368|50181851|FG001|Overall Study|Study terminated by the sponsor|2|||
25074724|NCT02318368|50181850|FG000|Overall Study|Death|0|||
25074725|NCT02318368|50181851|FG001|Overall Study|Death|1|||
25074726|NCT02318134|50181859|FG000|Overall Study|Withdrawal by Subject|2|||
25074727|NCT02318134|50181860|FG001|Overall Study|Withdrawal by Subject|1|||
25074728|NCT02317510|50181870|FG000|Overall Study|Adverse Event|0|||
25074729|NCT02317510|50181871|FG001|Overall Study|Adverse Event|1|||
25074730|NCT02317432|50181882|FG000|Overall Study|Death|4|||
25074731|NCT02317432|50181883|FG001|Overall Study|Death|1|||
25074732|NCT02317432|50181882|FG000|Overall Study|Lost to Follow-up|0|||
25074733|NCT02317432|50181883|FG001|Overall Study|Lost to Follow-up|5|||
25074734|NCT02317432|50181882|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
25074735|NCT02317432|50181883|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
25074736|NCT00494234|50181891|FG000|Overall Study|Lack of Efficacy|12|||
25074737|NCT00494234|50181892|FG001|Overall Study|Lack of Efficacy|9|||
25074738|NCT00494234|50181891|FG000|Overall Study|Withdrawal by Subject|1|||
25074739|NCT00494234|50181892|FG001|Overall Study|Withdrawal by Subject|0|||
25074740|NCT00494234|50181891|FG000|Overall Study|Death|2|||
25074741|NCT00494234|50181892|FG001|Overall Study|Death|1|||
25074742|NCT02289820|50181909|FG000|Overall Study|Withdrawal by Subject|2|||
25074743|NCT02289820|50181910|FG001|Overall Study|Withdrawal by Subject|1|||
25074744|NCT02289820|50181911|FG002|Overall Study|Withdrawal by Subject|2|||
25074745|NCT02289820|50181912|FG003|Overall Study|Withdrawal by Subject|1|||
25074746|NCT02289820|50181913|FG004|Overall Study|Withdrawal by Subject|0|||
25074747|NCT02289820|50181914|FG005|Overall Study|Withdrawal by Subject|0|||
24974202|NCT03605680|50062677|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
24974203|NCT03605680|50062674|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
25074748|NCT02289820|50181915|FG006|Overall Study|Withdrawal by Subject|1|||
25074749|NCT02289820|50181909|FG000|Overall Study|Death|0|||
25074750|NCT02289820|50181910|FG001|Overall Study|Death|0|||
25074751|NCT02289820|50181911|FG002|Overall Study|Death|1|||
25074752|NCT02289820|50181912|FG003|Overall Study|Death|0|||
25074753|NCT02289820|50181913|FG004|Overall Study|Death|0|||
25074754|NCT02289820|50181914|FG005|Overall Study|Death|0|||
25074755|NCT02289820|50181915|FG006|Overall Study|Death|0|||
25074756|NCT02289820|50181909|FG000|Overall Study|Lost to Follow-up|0|||
25074757|NCT02289820|50181910|FG001|Overall Study|Lost to Follow-up|0|||
25074758|NCT02289820|50181911|FG002|Overall Study|Lost to Follow-up|3|||
25074759|NCT02289820|50181912|FG003|Overall Study|Lost to Follow-up|1|||
25074760|NCT02289820|50181913|FG004|Overall Study|Lost to Follow-up|0|||
25074761|NCT02289820|50181914|FG005|Overall Study|Lost to Follow-up|1|||
25074762|NCT02289820|50181915|FG006|Overall Study|Lost to Follow-up|1|||
25074763|NCT02289820|50181909|FG000|Overall Study|withdrawal of consent|0|||
25074764|NCT02289820|50181910|FG001|Overall Study|withdrawal of consent|1|||
25074765|NCT02289820|50181911|FG002|Overall Study|withdrawal of consent|0|||
24974204|NCT03605680|50062675|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
24974205|NCT03605680|50062676|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
25074766|NCT02289820|50181912|FG003|Overall Study|withdrawal of consent|0|||
25192730|NCT01392326|50360586|FG002|Overall Study|Lack of Efficacy|15|||
25192731|NCT01392326|50360584|FG000|Overall Study|Adverse Event|9|||
25192732|NCT01392326|50360585|FG001|Overall Study|Adverse Event|6|||
25192733|NCT01392326|50360586|FG002|Overall Study|Adverse Event|11|||
25192734|NCT01432262|50360629|FG000|Overall Study|Withdrawal by Subject|2|||
25192735|NCT01432262|50360630|FG001|Overall Study|Withdrawal by Subject|1|||
25192736|NCT01410890|50360650|FG000|Overall Study|Withdrawal by Subject|0|||
25192737|NCT01410890|50360651|FG001|Overall Study|Withdrawal by Subject|1|||
25192738|NCT01431950|50360661|FG000|Overall Study|Study Site Closed/Terminated|7|||
25192739|NCT01431950|50360662|FG001|Overall Study|Study Site Closed/Terminated|3|||
25192740|NCT01431950|50360661|FG000|Overall Study|Withdrawal by Subject|4|||
25192741|NCT01431950|50360662|FG001|Overall Study|Withdrawal by Subject|3|||
25192742|NCT01431950|50360661|FG000|Overall Study|Protocol Violation|2|||
25192743|NCT01431950|50360662|FG001|Overall Study|Protocol Violation|3|||
25192744|NCT01431950|50360661|FG000|Overall Study|Adverse Event|2|||
25192745|NCT01431950|50360662|FG001|Overall Study|Adverse Event|2|||
25192746|NCT01431950|50360661|FG000|Overall Study|Physician Decision|2|||
25192747|NCT01431950|50360662|FG001|Overall Study|Physician Decision|1|||
25192748|NCT01431950|50360661|FG000|Overall Study|Lack of Efficacy|2|||
25192749|NCT01431950|50360662|FG001|Overall Study|Lack of Efficacy|1|||
25192750|NCT01431950|50360661|FG000|Overall Study|Lost to Follow-up|0|||
25192751|NCT01431950|50360662|FG001|Overall Study|Lost to Follow-up|1|||
25192752|NCT01431950|50360661|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
25192753|NCT01431950|50360662|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
25192754|NCT00551031|50360673|FG000|Overall Study|Adverse Event|0|||
25192755|NCT00551031|50360674|FG001|Overall Study|Adverse Event|1|||
25192756|NCT00551031|50360675|FG002|Overall Study|Adverse Event|0|||
25192757|NCT00551031|50360676|FG003|Overall Study|Adverse Event|0|||
25192758|NCT00551031|50360677|FG004|Overall Study|Adverse Event|0|||
25192759|NCT00551031|50360673|FG000|Overall Study|Protocol Violation|1|||
25192760|NCT00551031|50360674|FG001|Overall Study|Protocol Violation|1|||
25192761|NCT00551031|50360675|FG002|Overall Study|Protocol Violation|0|||
25192762|NCT00551031|50360676|FG003|Overall Study|Protocol Violation|0|||
25192763|NCT00551031|50360677|FG004|Overall Study|Protocol Violation|0|||
25192764|NCT00551031|50360673|FG000|Overall Study|Lost to Follow-up|0|||
25192765|NCT00551031|50360674|FG001|Overall Study|Lost to Follow-up|1|||
25192766|NCT00551031|50360675|FG002|Overall Study|Lost to Follow-up|0|||
25192767|NCT00551031|50360676|FG003|Overall Study|Lost to Follow-up|1|||
25192768|NCT00551031|50360677|FG004|Overall Study|Lost to Follow-up|1|||
25192769|NCT00551031|50360673|FG000|Overall Study|Withdrawal by Subject|0|||
25192770|NCT00551031|50360674|FG001|Overall Study|Withdrawal by Subject|4|||
25192771|NCT00551031|50360675|FG002|Overall Study|Withdrawal by Subject|1|||
25192772|NCT00551031|50360676|FG003|Overall Study|Withdrawal by Subject|2|||
25192773|NCT00551031|50360677|FG004|Overall Study|Withdrawal by Subject|0|||
25192774|NCT00551031|50360673|FG000|Overall Study|Serious Adverse Event|0|||
25192775|NCT00551031|50360674|FG001|Overall Study|Serious Adverse Event|2|||
25192776|NCT00551031|50360675|FG002|Overall Study|Serious Adverse Event|1|||
25192777|NCT00551031|50360676|FG003|Overall Study|Serious Adverse Event|0|||
25192778|NCT00551031|50360677|FG004|Overall Study|Serious Adverse Event|0|||
25192779|NCT00551031|50360673|FG000|Overall Study|Did not receive vaccine|1|||
25192780|NCT00551031|50360674|FG001|Overall Study|Did not receive vaccine|2|||
25192781|NCT00551031|50360675|FG002|Overall Study|Did not receive vaccine|0|||
25192782|NCT00551031|50360676|FG003|Overall Study|Did not receive vaccine|0|||
25074767|NCT02289820|50181913|FG004|Overall Study|withdrawal of consent|0|||
25192783|NCT00551031|50360677|FG004|Overall Study|Did not receive vaccine|0|||
25192784|NCT01431716|50360689|FG000|Overall Study|Withdrawal of consent|1|||
25192785|NCT00550953|50360695|FG000|Overall Study|Adverse Event|4|||
25192786|NCT00550953|50360696|FG001|Overall Study|Adverse Event|3|||
25192787|NCT00550953|50360695|FG000|Overall Study|Not able to visit the site|2|||
25074768|NCT02289820|50181914|FG005|Overall Study|withdrawal of consent|0|||
25074769|NCT02289820|50181915|FG006|Overall Study|withdrawal of consent|0|||
25074770|NCT02289742|50181937|FG000|First Wear Period|Adverse event prior to treatment|0|||
25074771|NCT02289742|50181938|FG001|First Wear Period|Adverse event prior to treatment|1|||
25074772|NCT02289742|50181939|FG002|First Wear Period|Adverse event prior to treatment|0|||
25074773|NCT02289742|50181940|FG003|First Wear Period|Adverse event prior to treatment|0|||
24974206|NCT03605680|50062677|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
24974207|NCT03605680|50062674|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
24974208|NCT03605680|50062675|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
24974209|NCT03605680|50062676|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
24974210|NCT03605680|50062677|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
24974211|NCT03605680|50062674|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
24974212|NCT03605680|50062675|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
24974213|NCT03605680|50062676|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
24974214|NCT03605680|50062677|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
24974215|NCT03605680|50062674|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
24974216|NCT03605680|50062675|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
24974217|NCT03605680|50062676|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
24974218|NCT03605680|50062677|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
24974219|NCT03605680|50062674|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
25074774|NCT02289742|50181937|FG000|First Wear Period|Adverse Event|0|||
24974220|NCT03605680|50062675|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
24974221|NCT03605680|50062676|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
24974222|NCT03605680|50062677|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
24974223|NCT03605680|50062674|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
24974224|NCT03605680|50062675|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
24974225|NCT03605680|50062676|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
24974226|NCT03605680|50062677|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
24974227|NCT03605680|50062674|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
24974228|NCT03605680|50062675|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
24974229|NCT03605680|50062676|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
24974230|NCT03605680|50062677|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
24974231|NCT03605680|50062674|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
24974232|NCT03605680|50062675|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
24974233|NCT03605680|50062676|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
24974234|NCT03605680|50062677|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
24974235|NCT03605680|50062674|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
24974236|NCT03605680|50062675|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
24974237|NCT03605680|50062676|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
24974238|NCT03605680|50062677|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
24974239|NCT03605680|50062674|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
24974240|NCT03605680|50062675|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
24974241|NCT03605680|50062676|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
25074775|NCT02289742|50181938|FG001|First Wear Period|Adverse Event|0|||
25074776|NCT02289742|50181939|FG002|First Wear Period|Adverse Event|1|||
25074777|NCT02289742|50181940|FG003|First Wear Period|Adverse Event|0|||
25074778|NCT02289742|50181937|FG000|First Wear Period|Other prior to treatment|0|||
25074779|NCT02289742|50181938|FG001|First Wear Period|Other prior to treatment|0|||
25074780|NCT02289742|50181939|FG002|First Wear Period|Other prior to treatment|0|||
24974242|NCT03605680|50062677|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
24974243|NCT03605680|50062674|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
24974244|NCT03605680|50062675|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
25314652|NCT00842829|50630495|FG000|Dose Titration Period|Other|5|||
25074781|NCT02289742|50181940|FG003|First Wear Period|Other prior to treatment|1|||
25074782|NCT02289742|50181937|FG000|Third Wear Period|Adverse Event|0|||
24974245|NCT03605680|50062676|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
24974246|NCT03605680|50062677|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
24974247|NCT03605680|50062674|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
24974248|NCT03605680|50062675|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
24974249|NCT03605680|50062676|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
24974250|NCT03605680|50062677|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
24974251|NCT03572218|50062688|FG000|Overall Study|Lost to Follow-up|3|||
24974252|NCT03572218|50062689|FG001|Overall Study|Lost to Follow-up|2|||
24974253|NCT03572218|50062688|FG000|Overall Study|No longer available for study visits|2|||
24974254|NCT03572218|50062689|FG001|Overall Study|No longer available for study visits|1|||
24974255|NCT03572218|50062688|FG000|Overall Study|No longer interested|1|||
24974256|NCT03572218|50062689|FG001|Overall Study|No longer interested|2|||
24974257|NCT00111813|50062695|FG000|Overall Study|Adverse Event|1|||
24974258|NCT00111813|50062696|FG001|Overall Study|Adverse Event|2|||
24974259|NCT00111813|50062697|FG002|Overall Study|Adverse Event|4|||
24974260|NCT00111813|50062698|FG003|Overall Study|Adverse Event|2|||
24974261|NCT00111813|50062699|FG004|Overall Study|Adverse Event|2|||
24974262|NCT00111813|50062700|FG005|Overall Study|Adverse Event|2|||
24974263|NCT00111813|50062695|FG000|Overall Study|Progressive disease|2|||
24974264|NCT00111813|50062696|FG001|Overall Study|Progressive disease|1|||
24974265|NCT00111813|50062697|FG002|Overall Study|Progressive disease|5|||
25074783|NCT02289742|50181938|FG001|Third Wear Period|Adverse Event|1|||
25074784|NCT02289742|50181939|FG002|Third Wear Period|Adverse Event|0|||
25074785|NCT02289742|50181940|FG003|Third Wear Period|Adverse Event|0|||
25074786|NCT02289742|50181937|FG000|Third Wear Period|Reason not given|0|||
25074787|NCT02289742|50181938|FG001|Third Wear Period|Reason not given|0|||
25074788|NCT02289742|50181939|FG002|Third Wear Period|Reason not given|0|||
25074789|NCT02289742|50181940|FG003|Third Wear Period|Reason not given|1|||
24974266|NCT00111813|50062698|FG003|Overall Study|Progressive disease|3|||
24974267|NCT00111813|50062699|FG004|Overall Study|Progressive disease|4|||
24974268|NCT00111813|50062700|FG005|Overall Study|Progressive disease|3|||
24974269|NCT00111813|50062695|FG000|Overall Study|Lack of Efficacy|0|||
24974270|NCT00111813|50062696|FG001|Overall Study|Lack of Efficacy|0|||
24974271|NCT00111813|50062697|FG002|Overall Study|Lack of Efficacy|0|||
24974272|NCT00111813|50062698|FG003|Overall Study|Lack of Efficacy|0|||
24974273|NCT00111813|50062699|FG004|Overall Study|Lack of Efficacy|0|||
24974274|NCT00111813|50062700|FG005|Overall Study|Lack of Efficacy|1|||
24974275|NCT00111813|50062695|FG000|Overall Study|Other|0|||
24974276|NCT00111813|50062696|FG001|Overall Study|Other|0|||
24974277|NCT00111813|50062697|FG002|Overall Study|Other|1|||
24974278|NCT00111813|50062698|FG003|Overall Study|Other|0|||
24974279|NCT00111813|50062699|FG004|Overall Study|Other|0|||
25074790|NCT02289352|50181957|FG000|Overall Study|Withdrawal by Subject|1|||
25074791|NCT02289352|50181958|FG001|Overall Study|Withdrawal by Subject|1|||
25074792|NCT02289352|50181959|FG002|Overall Study|Withdrawal by Subject|0|||
25074793|NCT02315560|50181968|FG000|Overall Study|noncompliance by subjects|3|||
25074794|NCT02522624|50181974|FG000|Overall Study|Technical failure|1|||
24974280|NCT00111813|50062700|FG005|Overall Study|Other|0|||
24974281|NCT00118287|50062715|FG000|Overall Study|Intracranial haemorrhage|1|||
24974282|NCT00118287|50062715|FG000|Overall Study|Muscle pain|1|||
24974283|NCT00130689|50062719|FG000|Overall Study|Progressive Disease|29|||
24974284|NCT00130689|50062719|FG000|Overall Study|Death|1|||
24974285|NCT00130689|50062719|FG000|Overall Study|Clinical Deterioration|4|||
25074795|NCT02522624|50181975|FG001|Overall Study|Technical failure|0|||
24974286|NCT00130689|50062719|FG000|Overall Study|Withdrawal by Subject|3|||
24974287|NCT00130689|50062719|FG000|Overall Study|Ineligible|6|||
25074796|NCT02287402|50181981|FG000|Treatment Period|Adverse Event|17|||
25074797|NCT02287402|50181981|FG000|Treatment Period|Voluntary Withdrawal|10|||
25074798|NCT02287402|50181981|FG000|Follow-up|Lost to Follow-up|1|||
25074799|NCT02287402|50181981|FG000|Follow-up|Voluntary Withdrawal|2|||
25074800|NCT02314780|50181988|FG000|Overall Study|organizational reasons|0|||
25074801|NCT02314780|50181989|FG001|Overall Study|organizational reasons|2|||
25074802|NCT02314780|50181990|FG002|Overall Study|organizational reasons|0|||
25074803|NCT02314780|50181988|FG000|Overall Study|Adverse Event|0|||
25074804|NCT02314780|50181989|FG001|Overall Study|Adverse Event|1|||
24974288|NCT03605212|50062728|FG000|Treatment Period|Adverse Event|1|||
24974289|NCT03605212|50062729|FG001|Treatment Period|Adverse Event|0|||
24974290|NCT03605212|50062730|FG002|Treatment Period|Adverse Event|0|||
24974291|NCT03605212|50062731|FG003|Treatment Period|Adverse Event|0|||
24974292|NCT03605212|50062732|FG004|Treatment Period|Adverse Event|0|||
24974293|NCT03605212|50062728|FG000|Treatment Period|Physician Decision|0|||
24974294|NCT03605212|50062729|FG001|Treatment Period|Physician Decision|0|||
24974295|NCT03605212|50062730|FG002|Treatment Period|Physician Decision|0|||
24974296|NCT03605212|50062731|FG003|Treatment Period|Physician Decision|0|||
24974297|NCT03605212|50062732|FG004|Treatment Period|Physician Decision|1|||
24974298|NCT03603652|50062745|FG000|Overall Study|Death|2|||
24974299|NCT00117507|50062749|FG000|Overall Study|Adverse Event|4|||
24974300|NCT00117507|50062749|FG000|Overall Study|Abnormal laboratory values|3|||
24974301|NCT00117507|50062749|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
24974302|NCT00117507|50062749|FG000|Overall Study|Patient withdrew consent|4|||
24974303|NCT00117507|50062749|FG000|Overall Study|Death|3|||
24974304|NCT03603496|50062756|FG000|Overall Study|Death|19|||
24974305|NCT03603496|50062757|FG001|Overall Study|Death|24|||
25074805|NCT02314780|50181990|FG002|Overall Study|Adverse Event|0|||
25074806|NCT02288182|50182000|FG000|Overall Study|Adverse Event|0|||
25074807|NCT02288182|50182001|FG001|Overall Study|Adverse Event|1|||
25074808|NCT02288182|50182000|FG000|Overall Study|Lost to Follow-up|0|||
25074809|NCT02288182|50182001|FG001|Overall Study|Lost to Follow-up|1|||
25074810|NCT02286466|50182011|FG000|Overall Study|Death|1|||
25074811|NCT02286466|50182012|FG001|Overall Study|Death|3|||
25074812|NCT02286466|50182011|FG000|Overall Study|Withdrawal by Subject|5|||
25074813|NCT02286466|50182012|FG001|Overall Study|Withdrawal by Subject|2|||
25074814|NCT02286466|50182011|FG000|Overall Study|Lost to Follow-up|1|||
25074815|NCT02286466|50182012|FG001|Overall Study|Lost to Follow-up|4|||
25074816|NCT02286466|50182011|FG000|Overall Study|Declined Clinician Assessment|0|||
25074817|NCT02286466|50182012|FG001|Overall Study|Declined Clinician Assessment|1|||
25074818|NCT02313766|50182021|FG000|Overall Study|surgery cancelled|1|||
25074819|NCT02313766|50182022|FG001|Overall Study|surgery cancelled|0|||
25074820|NCT02313766|50182023|FG002|Overall Study|surgery cancelled|0|||
25074821|NCT02313766|50182021|FG000|Overall Study|Lost to Follow-up|0|||
25074822|NCT02313766|50182022|FG001|Overall Study|Lost to Follow-up|2|||
25074823|NCT02313766|50182023|FG002|Overall Study|Lost to Follow-up|0|||
25074824|NCT02313766|50182021|FG000|Overall Study|Adverse Event|0|||
25074825|NCT02313766|50182022|FG001|Overall Study|Adverse Event|1|||
25074826|NCT02313766|50182023|FG002|Overall Study|Adverse Event|0|||
25074827|NCT01646398|50182033|FG000|Overall Study|Withdrawal by Subject|1|||
25074828|NCT01646398|50182034|FG001|Overall Study|Withdrawal by Subject|0|||
25074829|NCT01646320|50182042|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
25074830|NCT01646320|50182043|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
25074831|NCT01646320|50182042|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
25074832|NCT01646320|50182043|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
25074833|NCT01646320|50182042|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
25074834|NCT01646320|50182043|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
25074835|NCT01646320|50182042|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
24974306|NCT03603496|50062756|FG000|Overall Study|Lost to Follow-up|141|||
24974307|NCT03603496|50062757|FG001|Overall Study|Lost to Follow-up|141|||
25074836|NCT01646320|50182043|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
25074837|NCT01646320|50182042|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
25074838|NCT01646320|50182043|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
25074839|NCT01646320|50182042|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
25074840|NCT01646320|50182043|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
25074841|NCT01646320|50182042|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
24974308|NCT03603496|50062756|FG000|Overall Study|Withdrawal by Subject|26|||
24974309|NCT03603496|50062757|FG001|Overall Study|Withdrawal by Subject|20|||
24974310|NCT03603028|50062763|FG000|Overall Study|Withdrawal by Subject|1|||
25074842|NCT01646320|50182043|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
25074843|NCT01646320|50182042|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
25074844|NCT01646320|50182043|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
25074845|NCT01646320|50182042|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
25074846|NCT01646320|50182043|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
25074847|NCT01646320|50182042|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
25074848|NCT01646320|50182043|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
25074849|NCT01646320|50182042|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
25074850|NCT01646320|50182043|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
25074851|NCT02524730|50182049|FG000|Overall Study|Lost to Follow-up|5|||
25074852|NCT02524730|50182049|FG000|Overall Study|Withdrawal by Subject|18|||
25074853|NCT02524730|50182049|FG000|Overall Study|Death|10|||
25074854|NCT02524730|50182049|FG000|Overall Study|Adverse Event|8|||
25074855|NCT02524730|50182049|FG000|Overall Study|Protocol Violation|1|||
25074856|NCT02524730|50182049|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
25074857|NCT01658150|50182053|FG000|Overall Study|Withdrawal by Subject|1|||
25074858|NCT02285998|50182060|FG000|Overall Study|Adverse Event|9|||
25074859|NCT02285998|50182061|FG001|Overall Study|Adverse Event|8|||
25074860|NCT02285998|50182060|FG000|Overall Study|Physician Decision|1|||
25074861|NCT02285998|50182061|FG001|Overall Study|Physician Decision|2|||
25074862|NCT02285998|50182060|FG000|Overall Study|Lost to Follow-up|176|||
25074863|NCT02285998|50182061|FG001|Overall Study|Lost to Follow-up|172|||
25074864|NCT02285998|50182060|FG000|Overall Study|Withdrawal by Subject|53|||
25074865|NCT02285998|50182061|FG001|Overall Study|Withdrawal by Subject|61|||
25074866|NCT02285998|50182060|FG000|Overall Study|Other Reasons|7|||
25074867|NCT02285998|50182061|FG001|Overall Study|Other Reasons|10|||
25074868|NCT01658072|50182069|FG000|Overall Study|Protocol Violation|4|||
25074869|NCT01658072|50182070|FG001|Overall Study|Protocol Violation|2|||
25074870|NCT02285920|50182080|FG000|Overall Study|Kidney transplantation|2|||
25074871|NCT02285920|50182081|FG001|Overall Study|Kidney transplantation|2|||
25074872|NCT02285920|50182082|FG002|Overall Study|Kidney transplantation|2|||
25170081|NCT01820585|50304089|FG001|Overall Study|Withdrawal by Subject|7|||
25170082|NCT01820585|50304090|FG002|Overall Study|Withdrawal by Subject|3|||
25170083|NCT01820585|50304091|FG003|Overall Study|Withdrawal by Subject|8|||
25074873|NCT02285920|50182083|FG003|Overall Study|Kidney transplantation|0|||
25074874|NCT02285920|50182080|FG000|Overall Study|Change to peritoneal dialysis|0|||
25170084|NCT01820585|50304088|FG000|Overall Study|Lost to Follow-up|3|||
25170085|NCT01820585|50304089|FG001|Overall Study|Lost to Follow-up|3|||
25170086|NCT01820585|50304090|FG002|Overall Study|Lost to Follow-up|0|||
25074875|NCT02285920|50182081|FG001|Overall Study|Change to peritoneal dialysis|0|||
25170087|NCT01820585|50304091|FG003|Overall Study|Lost to Follow-up|3|||
25170088|NCT01820585|50304088|FG000|Overall Study|Protocol Violation|3|||
25170089|NCT01820585|50304089|FG001|Overall Study|Protocol Violation|1|||
25170090|NCT01820585|50304090|FG002|Overall Study|Protocol Violation|1|||
25074876|NCT02285920|50182082|FG002|Overall Study|Change to peritoneal dialysis|1|||
25074877|NCT02285920|50182083|FG003|Overall Study|Change to peritoneal dialysis|0|||
25074878|NCT02285920|50182080|FG000|Overall Study|Transfer to non-participating unit|0|||
25074879|NCT02285920|50182081|FG001|Overall Study|Transfer to non-participating unit|1|||
25074880|NCT02285920|50182082|FG002|Overall Study|Transfer to non-participating unit|0|||
25074881|NCT02285920|50182083|FG003|Overall Study|Transfer to non-participating unit|0|||
25074882|NCT02285920|50182080|FG000|Overall Study|Dialysis discontinuation|0|||
25074883|NCT02285920|50182081|FG001|Overall Study|Dialysis discontinuation|1|||
25074884|NCT02285920|50182082|FG002|Overall Study|Dialysis discontinuation|0|||
25074885|NCT02285920|50182083|FG003|Overall Study|Dialysis discontinuation|0|||
25074886|NCT02285920|50182080|FG000|Overall Study|Death|2|||
25074887|NCT02285920|50182081|FG001|Overall Study|Death|0|||
25074888|NCT02285920|50182082|FG002|Overall Study|Death|2|||
25074889|NCT02285920|50182083|FG003|Overall Study|Death|1|||
24974311|NCT03602482|50062769|FG000|Overall Study|Withdrawal by Subject|6|||
24974312|NCT03602482|50062770|FG001|Overall Study|Withdrawal by Subject|7|||
24974313|NCT03602482|50062771|FG002|Overall Study|Withdrawal by Subject|0|||
25074890|NCT02035137|50182096|FG000|Overall Study|Physician Decision|0|||
25074891|NCT02035137|50182097|FG001|Overall Study|Physician Decision|0|||
25074892|NCT02035137|50182098|FG002|Overall Study|Physician Decision|1|||
25074893|NCT02035137|50182096|FG000|Overall Study|Withdrawal by Subject|0|||
25074894|NCT02035137|50182097|FG001|Overall Study|Withdrawal by Subject|1|||
25074895|NCT02035137|50182098|FG002|Overall Study|Withdrawal by Subject|2|||
25074896|NCT02035137|50182096|FG000|Overall Study|Ineligible|0|||
25074897|NCT02035137|50182097|FG001|Overall Study|Ineligible|1|||
24974314|NCT03602482|50062772|FG003|Overall Study|Withdrawal by Subject|0|||
24974315|NCT00096135|50062787|FG000|Overall Study|Physician Decision|20|||
24974316|NCT00096135|50062788|FG001|Overall Study|Physician Decision|4|||
24974317|NCT00096135|50062787|FG000|Overall Study|Refusal of further protocol therapy|4|||
25074898|NCT02035137|50182098|FG002|Overall Study|Ineligible|2|||
25074899|NCT02035137|50182096|FG000|Overall Study|Disease progression prior to treatment start|2|||
25074900|NCT02035137|50182097|FG001|Overall Study|Disease progression prior to treatment start|0|||
25074901|NCT02035137|50182098|FG002|Overall Study|Disease progression prior to treatment start|0|||
25074902|NCT02522780|50182108|FG000|Overall Study|Consent withdrawn by subject|5|||
25074903|NCT02522780|50182109|FG001|Overall Study|Consent withdrawn by subject|7|||
25074904|NCT02522780|50182108|FG000|Overall Study|Protocol deviation|1|||
25074905|NCT02522780|50182109|FG001|Overall Study|Protocol deviation|3|||
25074906|NCT02522780|50182108|FG000|Overall Study|Subject refused endoscopic procedure|0|||
25074907|NCT02522780|50182109|FG001|Overall Study|Subject refused endoscopic procedure|1|||
25074908|NCT02522780|50182108|FG000|Overall Study|Adverse event, non-fatal|11|||
25074909|NCT02522780|50182109|FG001|Overall Study|Adverse event, non-fatal|16|||
25074910|NCT02285062|50182129|FG000|Pre-Treatment Period|Protocol Violation|0|||
25074911|NCT02285062|50182130|FG001|Pre-Treatment Period|Protocol Violation|2|||
25074912|NCT02285062|50182129|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
25074913|NCT02285062|50182130|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
25074914|NCT01352741|50182136|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
25074915|NCT01352741|50182137|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
25074916|NCT01352741|50182136|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
25074917|NCT01352741|50182137|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
25074918|NCT01352741|50182136|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
25074919|NCT01352741|50182137|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
25074920|NCT01352741|50182136|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
25074921|NCT01352741|50182137|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
25074922|NCT01352741|50182136|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
25074923|NCT01352741|50182137|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
25074924|NCT01352741|50182136|FG000|Open-label Tapentadol Titration Period|Other|4|||
25074925|NCT01352741|50182137|FG001|Open-label Tapentadol Titration Period|Other|0|||
25074926|NCT01352741|50182136|FG000|Double-blind Comparative Period|Protocol Violation|2|||
25074927|NCT01352741|50182137|FG001|Double-blind Comparative Period|Protocol Violation|0|||
25074928|NCT01352741|50182136|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
25074929|NCT01352741|50182137|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
25074930|NCT01352741|50182136|FG000|Double-blind Comparative Period|Adverse Event|16|||
25074931|NCT01352741|50182137|FG001|Double-blind Comparative Period|Adverse Event|17|||
25074932|NCT01352741|50182136|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
25074933|NCT01352741|50182137|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
25074934|NCT01352741|50182136|FG000|Double-blind Comparative Period|Death|0|||
25074935|NCT01352741|50182137|FG001|Double-blind Comparative Period|Death|1|||
25192788|NCT00550953|50360696|FG001|Overall Study|Not able to visit the site|3|||
24974318|NCT00096135|50062788|FG001|Overall Study|Refusal of further protocol therapy|1|||
25170091|NCT01820585|50304091|FG003|Overall Study|Protocol Violation|1|||
25192789|NCT00558831|50360731|FG000|Overall Study|Lost to Follow-up|1|||
24974319|NCT00096135|50062787|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
25074936|NCT01352741|50182136|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
24974320|NCT00096135|50062788|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
25074937|NCT01352741|50182137|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
25074938|NCT01352741|50182136|FG000|Double-blind Comparative Period|Other|1|||
24974321|NCT00096135|50062787|FG000|Overall Study|Other, specify|15|||
24974322|NCT00096135|50062788|FG001|Overall Study|Other, specify|3|||
24974323|NCT00096135|50062787|FG000|Overall Study|Ineligible|2|||
24974324|NCT00096135|50062788|FG001|Overall Study|Ineligible|0|||
24974325|NCT00116805|50062796|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
24974326|NCT00116805|50062797|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
24974327|NCT00116805|50062796|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
24974328|NCT00116805|50062797|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
24974329|NCT00116805|50062796|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
24974330|NCT00116805|50062797|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
24974331|NCT00116805|50062796|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
24974332|NCT00116805|50062797|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
24974333|NCT00116805|50062796|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
24974334|NCT00116805|50062797|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
24974335|NCT00116805|50062796|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
24974336|NCT00116805|50062797|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
24974337|NCT00116805|50062796|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
24974338|NCT00116805|50062797|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
24974339|NCT00116805|50062796|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
24974340|NCT00116805|50062797|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
24974341|NCT00116805|50062796|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
24974342|NCT00116805|50062797|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
24974343|NCT00116805|50062796|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
24974344|NCT00116805|50062797|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
24974345|NCT00116805|50062796|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
24974346|NCT00116805|50062797|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
24974347|NCT00116805|50062796|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
24974348|NCT00116805|50062797|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
24974349|NCT00116805|50062796|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
24974350|NCT00116805|50062797|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
24974351|NCT00116805|50062796|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
24974352|NCT00116805|50062797|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
24974353|NCT00116805|50062796|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
24974354|NCT00116805|50062797|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
24974355|NCT00116805|50062796|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
24974356|NCT00116805|50062797|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
24974357|NCT00116805|50062796|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
25074939|NCT01352741|50182137|FG001|Double-blind Comparative Period|Other|2|||
25074940|NCT01352741|50182136|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
25074941|NCT01352741|50182137|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
25074942|NCT01352741|50182136|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
25074943|NCT01352741|50182137|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
25074944|NCT01352741|50182136|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
25074945|NCT01352741|50182137|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
25074946|NCT01352741|50182136|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
25074947|NCT01352741|50182137|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
25074948|NCT01657292|50182157|FG000|Overall Study|Adverse Event|6|||
25074949|NCT01657292|50182157|FG000|Overall Study|Withdrawal by Subject|2|||
25074950|NCT01657292|50182157|FG000|Overall Study|Violation of eligibility criteria|1|||
25192790|NCT01431638|50360740|FG000|Overall Study|Adverse Event|1|||
25192791|NCT01431638|50360741|FG001|Overall Study|Adverse Event|3|||
25192792|NCT01431638|50360742|FG002|Overall Study|Adverse Event|1|||
25192793|NCT01431638|50360740|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
25192794|NCT01431638|50360741|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
25192795|NCT01431638|50360742|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
25192796|NCT01431638|50360740|FG000|Overall Study|Participants condition no longer requires study drug|0|||
25192797|NCT01431638|50360741|FG001|Overall Study|Participants condition no longer requires study drug|1|||
25192798|NCT01431638|50360742|FG002|Overall Study|Participants condition no longer requires study drug|0|||
25192799|NCT01431638|50360740|FG000|Overall Study|Participant withdrew consent|14|||
24974358|NCT00116805|50062797|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
24974359|NCT00116805|50062796|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
24974360|NCT00116805|50062797|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
25192800|NCT01431638|50360741|FG001|Overall Study|Participant withdrew consent|5|||
25192801|NCT01431638|50360742|FG002|Overall Study|Participant withdrew consent|8|||
24974361|NCT00116805|50062796|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
24974362|NCT00116805|50062797|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
24974363|NCT00116805|50062796|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
24974364|NCT00116805|50062797|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
24974365|NCT00116805|50062796|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
24974366|NCT00116805|50062797|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
24974367|NCT00116805|50062796|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
24974368|NCT00116805|50062797|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
24974369|NCT00116805|50062796|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
24974370|NCT00116805|50062797|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
24974371|NCT00116805|50062796|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
24974372|NCT00116805|50062797|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
24974373|NCT00116805|50062796|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
24974374|NCT00116805|50062797|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
24974375|NCT00116805|50062796|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
24974376|NCT00116805|50062797|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
24974377|NCT00116805|50062796|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
25074951|NCT01657292|50182157|FG000|Overall Study|Change of therapy|1|||
25074952|NCT00905567|50182173|FG000|Washout|Withdrawal by Subject|0|||
25074953|NCT00905567|50182174|FG001|Washout|Withdrawal by Subject|1|||
25074954|NCT02282020|50182180|FG000|Overall Study|Objective Disease Progression|128|||
25074955|NCT02282020|50182181|FG001|Overall Study|Objective Disease Progression|30|||
25074956|NCT02282020|50182180|FG000|Overall Study|Adverse Event|18|||
25074957|NCT02282020|50182181|FG001|Overall Study|Adverse Event|15|||
25074958|NCT02282020|50182180|FG000|Overall Study|Withdrawal by Subject|7|||
25074959|NCT02282020|50182181|FG001|Overall Study|Withdrawal by Subject|10|||
25074960|NCT02282020|50182180|FG000|Overall Study|Miscellaneous|5|||
25074961|NCT02282020|50182181|FG001|Overall Study|Miscellaneous|19|||
24974378|NCT00116805|50062797|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
24974379|NCT00116805|50062796|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
24974380|NCT00116805|50062797|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
24974381|NCT00116805|50062796|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
24974382|NCT00116805|50062797|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
24974383|NCT00116805|50062796|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
24974384|NCT00116805|50062797|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
24974385|NCT00116805|50062796|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
24974386|NCT00116805|50062797|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
24974387|NCT00116805|50062796|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
24974388|NCT00116805|50062797|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
24974389|NCT00116805|50062796|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
24974390|NCT00116805|50062797|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
24974391|NCT00116805|50062796|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
24974392|NCT00116805|50062797|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
24974393|NCT00116805|50062796|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
24974394|NCT00116805|50062797|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
24974395|NCT00116805|50062796|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
24974396|NCT00116805|50062797|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
24974397|NCT00116805|50062796|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
24974398|NCT00116805|50062797|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
24974399|NCT00116805|50062796|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
24974400|NCT00116805|50062797|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
24974401|NCT00116805|50062796|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
24974402|NCT00116805|50062797|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
24974403|NCT00116805|50062796|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
24974404|NCT00116805|50062797|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
24974405|NCT00116805|50062796|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
24974406|NCT00116805|50062797|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
24974407|NCT00116805|50062796|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
24974408|NCT00116805|50062797|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
24974409|NCT00116805|50062796|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
24974410|NCT00116805|50062797|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
24974411|NCT00116805|50062796|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
25074962|NCT02282020|50182180|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
25074963|NCT02282020|50182181|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
25074964|NCT02282020|50182180|FG000|Overall Study|Developed Discontinuation Criteria|0|||
25074965|NCT02282020|50182181|FG001|Overall Study|Developed Discontinuation Criteria|2|||
25074966|NCT02282020|50182180|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
25074967|NCT02282020|50182181|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
25074968|NCT02281552|50182197|FG000|Overall Study|Medication error|1|||
25074969|NCT02281552|50182198|FG001|Overall Study|Medication error|0|||
25074970|NCT02281552|50182197|FG000|Overall Study|Insufficient clinical response|0|||
25074971|NCT02281552|50182198|FG001|Overall Study|Insufficient clinical response|1|||
25074972|NCT02281552|50182197|FG000|Overall Study|Adverse Event|3|||
25074973|NCT02281552|50182198|FG001|Overall Study|Adverse Event|9|||
25074974|NCT00890591|50182204|FG000|Overall Study|Lack of Efficacy|20|||
25074975|NCT02284906|50182213|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
25074976|NCT02284906|50182214|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
25074977|NCT02284906|50182215|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
25074978|NCT02284906|50182213|FG000|Overall Study|Major Protocol Deviation|0|||
25074979|NCT02284906|50182214|FG001|Overall Study|Major Protocol Deviation|1|||
25074980|NCT02284906|50182215|FG002|Overall Study|Major Protocol Deviation|0|||
25074981|NCT02284906|50182213|FG000|Overall Study|Voluntary Withdrawal|2|||
25074982|NCT02284906|50182214|FG001|Overall Study|Voluntary Withdrawal|4|||
25074983|NCT02284906|50182215|FG002|Overall Study|Voluntary Withdrawal|5|||
25074984|NCT02284906|50182213|FG000|Overall Study|Study Termination|0|||
25074985|NCT02284906|50182214|FG001|Overall Study|Study Termination|11|||
25074986|NCT02284906|50182215|FG002|Overall Study|Study Termination|14|||
25074987|NCT02284906|50182213|FG000|Overall Study|Reason not Specified|1|||
25074988|NCT02284906|50182214|FG001|Overall Study|Reason not Specified|1|||
25074989|NCT02284906|50182215|FG002|Overall Study|Reason not Specified|0|||
25074990|NCT02879305|50182225|FG000|Overall Study|Investigator Site Closed|55|||
25074991|NCT02879305|50182226|FG001|Overall Study|Investigator Site Closed|57|||
25074992|NCT02879305|50182225|FG000|Overall Study|Withdrawal by Subject|44|||
25074993|NCT02879305|50182226|FG001|Overall Study|Withdrawal by Subject|42|||
25074994|NCT02879305|50182225|FG000|Overall Study|Lost to Follow-up|17|||
25074995|NCT02879305|50182226|FG001|Overall Study|Lost to Follow-up|12|||
25074996|NCT02879305|50182225|FG000|Overall Study|Other|1|||
25074997|NCT02879305|50182226|FG001|Overall Study|Other|0|||
25074998|NCT02281318|50182234|FG000|Overall Study|Adverse Event|2|||
25074999|NCT02281318|50182235|FG001|Overall Study|Adverse Event|2|||
25075000|NCT02281318|50182234|FG000|Overall Study|Lack of Efficacy|2|||
25075001|NCT02281318|50182235|FG001|Overall Study|Lack of Efficacy|0|||
25075002|NCT02281318|50182234|FG000|Overall Study|Lost to Follow-up|2|||
25075003|NCT02281318|50182235|FG001|Overall Study|Lost to Follow-up|1|||
25075004|NCT02281318|50182234|FG000|Overall Study|Physician Decision|2|||
25075005|NCT02281318|50182235|FG001|Overall Study|Physician Decision|0|||
25075006|NCT02281318|50182234|FG000|Overall Study|Withdrawal by Subject|6|||
25075007|NCT02281318|50182235|FG001|Overall Study|Withdrawal by Subject|2|||
25075008|NCT01657760|50182243|FG000|Overall Study|Withdrawal by Subject|0|||
25075009|NCT01657760|50182244|FG001|Overall Study|Withdrawal by Subject|0|||
25170092|NCT01820585|50304088|FG000|Overall Study|Subject non-compliance|0|||
25170093|NCT01820585|50304089|FG001|Overall Study|Subject non-compliance|0|||
25170094|NCT01820585|50304090|FG002|Overall Study|Subject non-compliance|1|||
25170095|NCT01820585|50304091|FG003|Overall Study|Subject non-compliance|2|||
25170096|NCT01820585|50304088|FG000|Overall Study|at sponsor request|0|||
25170097|NCT01820585|50304089|FG001|Overall Study|at sponsor request|0|||
25170098|NCT01820585|50304090|FG002|Overall Study|at sponsor request|1|||
25170099|NCT01820585|50304091|FG003|Overall Study|at sponsor request|0|||
25170100|NCT01820585|50304088|FG000|Overall Study|Pregnancy|0|||
25170101|NCT01820585|50304089|FG001|Overall Study|Pregnancy|1|||
25192802|NCT01431638|50360740|FG000|Overall Study|Lost to Follow-up|7|||
25075010|NCT01657760|50182245|FG002|Overall Study|Withdrawal by Subject|0|||
25170102|NCT01820585|50304090|FG002|Overall Study|Pregnancy|0|||
25170103|NCT01820585|50304091|FG003|Overall Study|Pregnancy|0|||
25170104|NCT01797263|50304103|FG000|Overall Study|Withdrawal by Subject|21|||
25075011|NCT01657760|50182246|FG003|Overall Study|Withdrawal by Subject|1|||
25075012|NCT01657760|50182243|FG000|Overall Study|Physician Decision|1|||
25075013|NCT01657760|50182244|FG001|Overall Study|Physician Decision|1|||
25075014|NCT01657760|50182245|FG002|Overall Study|Physician Decision|1|||
25075015|NCT01657760|50182246|FG003|Overall Study|Physician Decision|2|||
25075016|NCT02280304|50182273|FG000|Overall Study|Lost to Follow-up|7|||
25314653|NCT00842829|50630496|FG001|Dose Titration Period|Other|4|||
25314654|NCT00842829|50630497|FG002|Dose Titration Period|Other|0|||
24974412|NCT00116805|50062797|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
25314655|NCT00842829|50630495|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
25314656|NCT00842829|50630496|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
25314657|NCT00842829|50630497|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
25314658|NCT00842829|50630495|FG000|Dose Titration Period|Non-compliance to study drug|2|||
25314659|NCT00842829|50630496|FG001|Dose Titration Period|Non-compliance to study drug|1|||
25314660|NCT00842829|50630497|FG002|Dose Titration Period|Non-compliance to study drug|0|||
25314661|NCT00842829|50630495|FG000|Treatment Period|Adverse Event|0|||
25314662|NCT00842829|50630496|FG001|Treatment Period|Adverse Event|0|||
25314663|NCT00842829|50630497|FG002|Treatment Period|Adverse Event|15|||
25314664|NCT00842829|50630495|FG000|Treatment Period|Lack of Efficacy|0|||
25314665|NCT00842829|50630496|FG001|Treatment Period|Lack of Efficacy|0|||
25314666|NCT00842829|50630497|FG002|Treatment Period|Lack of Efficacy|6|||
25314667|NCT00842829|50630495|FG000|Treatment Period|Unstable persistent cancer pain|0|||
25314668|NCT00842829|50630496|FG001|Treatment Period|Unstable persistent cancer pain|0|||
25314669|NCT00842829|50630497|FG002|Treatment Period|Unstable persistent cancer pain|5|||
25314670|NCT00842829|50630495|FG000|Treatment Period|Withdrawal by Subject|0|||
25314671|NCT00842829|50630496|FG001|Treatment Period|Withdrawal by Subject|0|||
25314672|NCT00842829|50630497|FG002|Treatment Period|Withdrawal by Subject|11|||
25314673|NCT00842829|50630495|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
25314674|NCT00842829|50630496|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
25314675|NCT00842829|50630497|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
25314676|NCT00842829|50630495|FG000|Treatment Period|Protocol Violation|0|||
25314677|NCT00842829|50630496|FG001|Treatment Period|Protocol Violation|0|||
25314678|NCT00842829|50630497|FG002|Treatment Period|Protocol Violation|2|||
25314679|NCT00842829|50630495|FG000|Treatment Period|Other|0|||
25314680|NCT00842829|50630496|FG001|Treatment Period|Other|0|||
25314681|NCT00842829|50630497|FG002|Treatment Period|Other|18|||
25314682|NCT00842829|50630495|FG000|Treatment Period|Non-compliance to study procedures|0|||
25314683|NCT00842829|50630496|FG001|Treatment Period|Non-compliance to study procedures|0|||
25314684|NCT00842829|50630497|FG002|Treatment Period|Non-compliance to study procedures|4|||
25314685|NCT00842829|50630495|FG000|Treatment Period|Unclear completion status|0|||
25314686|NCT00842829|50630496|FG001|Treatment Period|Unclear completion status|0|||
25314687|NCT00842829|50630497|FG002|Treatment Period|Unclear completion status|1|||
25314688|NCT00842829|50630495|FG000|Continuation Period|Adverse Event|0|||
25314689|NCT00842829|50630496|FG001|Continuation Period|Adverse Event|0|||
25314690|NCT00842829|50630497|FG002|Continuation Period|Adverse Event|32|||
25314691|NCT00842829|50630495|FG000|Continuation Period|Lack of Efficacy|0|||
25314692|NCT00842829|50630496|FG001|Continuation Period|Lack of Efficacy|0|||
25314693|NCT00842829|50630497|FG002|Continuation Period|Lack of Efficacy|6|||
25314694|NCT00842829|50630495|FG000|Continuation Period|Unstable persistent cancer pain|0|||
25314695|NCT00842829|50630496|FG001|Continuation Period|Unstable persistent cancer pain|0|||
25314696|NCT00842829|50630497|FG002|Continuation Period|Unstable persistent cancer pain|3|||
25314697|NCT00842829|50630495|FG000|Continuation Period|Withdrawal by Subject|0|||
25314698|NCT00842829|50630496|FG001|Continuation Period|Withdrawal by Subject|0|||
25314699|NCT00842829|50630497|FG002|Continuation Period|Withdrawal by Subject|10|||
25314700|NCT00842829|50630495|FG000|Continuation Period|Other|0|||
25314701|NCT00842829|50630496|FG001|Continuation Period|Other|0|||
25314702|NCT00842829|50630497|FG002|Continuation Period|Other|7|||
25075017|NCT02280304|50182274|FG001|Overall Study|Lost to Follow-up|8|||
25075018|NCT02283658|50182294|FG000|Overall Study|Withdrawal by Subject|1|||
25075019|NCT02279524|50182321|FG000|Overall Study|Withdrawal by Subject|3|||
25075020|NCT02279524|50182322|FG001|Overall Study|Withdrawal by Subject|6|||
25075021|NCT02279524|50182323|FG002|Overall Study|Withdrawal by Subject|3|||
25075022|NCT02279524|50182321|FG000|Overall Study|Adverse Event|4|||
25075023|NCT02279524|50182322|FG001|Overall Study|Adverse Event|3|||
25075024|NCT02279524|50182323|FG002|Overall Study|Adverse Event|2|||
25075025|NCT02279524|50182321|FG000|Overall Study|Lost to Follow-up|1|||
25075026|NCT02279524|50182322|FG001|Overall Study|Lost to Follow-up|1|||
25075027|NCT02279524|50182323|FG002|Overall Study|Lost to Follow-up|0|||
25075028|NCT02279524|50182321|FG000|Overall Study|Disallowed medication|1|||
25075029|NCT02279524|50182322|FG001|Overall Study|Disallowed medication|1|||
25075030|NCT02279524|50182323|FG002|Overall Study|Disallowed medication|2|||
25075031|NCT02279524|50182321|FG000|Overall Study|Bariatric surgery|1|||
25075032|NCT02279524|50182322|FG001|Overall Study|Bariatric surgery|0|||
25075033|NCT02279524|50182323|FG002|Overall Study|Bariatric surgery|0|||
25075034|NCT02283268|50182331|FG000|Overall Study|Withdrawal by Subject|1|||
25075035|NCT00857285|50182345|FG000|Overall Study|Adverse Event|4|||
25075036|NCT00857285|50182346|FG001|Overall Study|Adverse Event|2|||
25075037|NCT00857285|50182345|FG000|Overall Study|Lack of Efficacy|0|||
25075038|NCT00857285|50182346|FG001|Overall Study|Lack of Efficacy|2|||
25075039|NCT00857285|50182345|FG000|Overall Study|Protocol Violation|3|||
25075040|NCT00857285|50182346|FG001|Overall Study|Protocol Violation|1|||
25075041|NCT00857285|50182345|FG000|Overall Study|Withdrawal by Subject|4|||
25075042|NCT00857285|50182346|FG001|Overall Study|Withdrawal by Subject|0|||
25075043|NCT00857285|50182345|FG000|Overall Study|Randomization criteria not met|1|||
25075044|NCT00857285|50182346|FG001|Overall Study|Randomization criteria not met|1|||
25075045|NCT02278354|50182352|FG000|Overall Study|Lost to Follow-up|2|||
25075046|NCT02278354|50182353|FG001|Overall Study|Lost to Follow-up|2|||
25075047|NCT02278354|50182352|FG000|Overall Study|Withdrawal by Subject|0|||
25075048|NCT02278354|50182353|FG001|Overall Study|Withdrawal by Subject|1|||
25075049|NCT02278354|50182352|FG000|Overall Study|<10 professional fights|2|||
25075050|NCT02278354|50182353|FG001|Overall Study|<10 professional fights|0|||
25075051|NCT01657370|50182372|FG000|Overall Study|Withdrawal by Subject|0|||
25075052|NCT01657370|50182373|FG001|Overall Study|Withdrawal by Subject|0|||
25075053|NCT01657370|50182374|FG002|Overall Study|Withdrawal by Subject|1|||
25075054|NCT01657370|50182375|FG003|Overall Study|Withdrawal by Subject|0|||
25075055|NCT01657370|50182376|FG004|Overall Study|Withdrawal by Subject|0|||
25075056|NCT01657370|50182377|FG005|Overall Study|Withdrawal by Subject|1|||
25075057|NCT01657370|50182372|FG000|Overall Study|Physician Decision|2|||
25075058|NCT01657370|50182373|FG001|Overall Study|Physician Decision|3|||
25075059|NCT01657370|50182374|FG002|Overall Study|Physician Decision|1|||
25075060|NCT01657370|50182375|FG003|Overall Study|Physician Decision|2|||
25075061|NCT01657370|50182376|FG004|Overall Study|Physician Decision|5|||
25075062|NCT01657370|50182377|FG005|Overall Study|Physician Decision|0|||
25075063|NCT01657370|50182372|FG000|Overall Study|Lack of Qualifying Event|1|||
25075064|NCT01657370|50182373|FG001|Overall Study|Lack of Qualifying Event|0|||
25075065|NCT01657370|50182374|FG002|Overall Study|Lack of Qualifying Event|3|||
25075066|NCT01657370|50182375|FG003|Overall Study|Lack of Qualifying Event|2|||
25075067|NCT01657370|50182376|FG004|Overall Study|Lack of Qualifying Event|1|||
25075068|NCT01657370|50182377|FG005|Overall Study|Lack of Qualifying Event|2|||
25075069|NCT01657370|50182372|FG000|Overall Study|Adverse Event|0|||
25075070|NCT01657370|50182373|FG001|Overall Study|Adverse Event|0|||
25075071|NCT01657370|50182374|FG002|Overall Study|Adverse Event|0|||
25075072|NCT01657370|50182375|FG003|Overall Study|Adverse Event|0|||
25075073|NCT01657370|50182376|FG004|Overall Study|Adverse Event|1|||
25075074|NCT01657370|50182377|FG005|Overall Study|Adverse Event|0|||
25075075|NCT01657370|50182372|FG000|Overall Study|Protocol Violation|1|||
25075076|NCT01657370|50182373|FG001|Overall Study|Protocol Violation|1|||
25075077|NCT01657370|50182374|FG002|Overall Study|Protocol Violation|1|||
25075078|NCT01657370|50182375|FG003|Overall Study|Protocol Violation|1|||
25075079|NCT01657370|50182376|FG004|Overall Study|Protocol Violation|0|||
25075080|NCT01657370|50182377|FG005|Overall Study|Protocol Violation|0|||
25075081|NCT01657370|50182372|FG000|Overall Study|Lost to Follow-up|2|||
25075082|NCT01657370|50182373|FG001|Overall Study|Lost to Follow-up|0|||
25075083|NCT01657370|50182374|FG002|Overall Study|Lost to Follow-up|1|||
25075084|NCT01657370|50182375|FG003|Overall Study|Lost to Follow-up|0|||
25075085|NCT01657370|50182376|FG004|Overall Study|Lost to Follow-up|0|||
25075086|NCT01657370|50182377|FG005|Overall Study|Lost to Follow-up|1|||
25075087|NCT00849797|50182419|FG000|First Intervention|bad veins|1|||
25075088|NCT00849797|50182420|FG001|First Intervention|bad veins|0|||
25192803|NCT01431638|50360741|FG001|Overall Study|Lost to Follow-up|9|||
25075089|NCT00849797|50182419|FG000|First Intervention|Adverse Event|0|||
25075090|NCT00849797|50182420|FG001|First Intervention|Adverse Event|1|||
25075091|NCT00849797|50182419|FG000|Washout: One Week|Withdrawal by Subject|0|||
25075092|NCT00849797|50182420|FG001|Washout: One Week|Withdrawal by Subject|2|||
25075093|NCT00840203|50182441|FG000|First Intervention|Protocol Violation|1|||
25075094|NCT00840203|50182442|FG001|First Intervention|Protocol Violation|1|||
25075095|NCT00840203|50182441|FG000|Washout|Protocol Violation|1|||
25075096|NCT00840203|50182442|FG001|Washout|Protocol Violation|0|||
25075097|NCT00835991|50182448|FG000|First Intervention|Adverse Event|0|||
25075098|NCT00835991|50182449|FG001|First Intervention|Adverse Event|1|||
25075099|NCT00835991|50182448|FG000|Washout|Protocol Violation|0|||
25075100|NCT00835991|50182449|FG001|Washout|Protocol Violation|2|||
25075101|NCT00835991|50182448|FG000|Washout|Withdrawal by Subject|3|||
25075102|NCT00835991|50182449|FG001|Washout|Withdrawal by Subject|1|||
25075103|NCT02276872|50182456|FG000|Overall Study|Adverse Event|1|||
25075104|NCT02276872|50182457|FG001|Overall Study|Adverse Event|0|||
25075105|NCT02276872|50182458|FG002|Overall Study|Adverse Event|0|||
25075106|NCT00835367|50182473|FG000|Washout|Adverse Event|2|||
25075107|NCT00835367|50182474|FG001|Washout|Adverse Event|0|||
25075108|NCT00835367|50182473|FG000|Washout|Withdrawal by Subject|1|||
25075109|NCT00835367|50182474|FG001|Washout|Withdrawal by Subject|0|||
25075110|NCT00835367|50182473|FG000|Second Intervention|Adverse Event|1|||
24974413|NCT00116805|50062796|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
24974414|NCT00116805|50062797|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
24974415|NCT00116649|50062812|FG000|Overall Study|Adverse Event|20|||
24974416|NCT00116649|50062812|FG000|Overall Study|Lack of Efficacy|1|||
24974417|NCT00116649|50062812|FG000|Overall Study|Lost to Follow-up|32|||
24974418|NCT00116649|50062812|FG000|Overall Study|Withdrawal by Subject|68|||
24974419|NCT00116649|50062812|FG000|Overall Study|Local Skin Reaction|9|||
24974420|NCT00116649|50062812|FG000|Overall Study|Various Reasons|18|||
24974421|NCT00116649|50062812|FG000|Overall Study|Protocol Specified|7|||
24974422|NCT00083889|50062818|FG000|Overall Study|Adverse Event|76|||
24974423|NCT00083889|50062819|FG001|Overall Study|Adverse Event|86|||
24974424|NCT00083889|50062818|FG000|Overall Study|Protocol Violation|2|||
24974425|NCT00083889|50062819|FG001|Overall Study|Protocol Violation|2|||
24974426|NCT00083889|50062818|FG000|Overall Study|Withdrawal by Subject|22|||
24974427|NCT00083889|50062819|FG001|Overall Study|Withdrawal by Subject|24|||
24974428|NCT00083889|50062818|FG000|Overall Study|Lack of Efficacy|240|||
24974429|NCT00083889|50062819|FG001|Overall Study|Lack of Efficacy|219|||
24974430|NCT00083889|50062818|FG000|Overall Study|Decision of sponsor|32|||
24974431|NCT00083889|50062819|FG001|Overall Study|Decision of sponsor|4|||
24974432|NCT00083889|50062818|FG000|Overall Study|Randomized: did not take study drug|0|||
24974433|NCT00083889|50062819|FG001|Overall Study|Randomized: did not take study drug|15|||
24974434|NCT00083889|50062818|FG000|Overall Study|Completed on marketed sunitinub|3|||
24974435|NCT00083889|50062819|FG001|Overall Study|Completed on marketed sunitinub|0|||
24974436|NCT00083889|50062818|FG000|Overall Study|Crossover to SU011248|0|||
24974437|NCT00083889|50062819|FG001|Overall Study|Crossover to SU011248|25|||
24974438|NCT03572062|50062838|FG000|Overall Study|Adverse Event|0|||
24974439|NCT03572062|50062839|FG001|Overall Study|Adverse Event|0|||
24974440|NCT03572062|50062840|FG002|Overall Study|Adverse Event|0|||
24974441|NCT03572062|50062841|FG003|Overall Study|Adverse Event|0|||
24974442|NCT03572062|50062842|FG004|Overall Study|Adverse Event|0|||
24974443|NCT03572062|50062843|FG005|Overall Study|Adverse Event|0|||
24974444|NCT03572062|50062844|FG006|Overall Study|Adverse Event|0|||
24974445|NCT03572062|50062845|FG007|Overall Study|Adverse Event|0|||
24974446|NCT03572062|50062846|FG008|Overall Study|Adverse Event|1|||
24974447|NCT03572062|50062847|FG009|Overall Study|Adverse Event|3|||
24974448|NCT03572062|50062838|FG000|Overall Study|Death|0|||
24974449|NCT03572062|50062839|FG001|Overall Study|Death|0|||
24974450|NCT03572062|50062840|FG002|Overall Study|Death|0|||
24974451|NCT03572062|50062841|FG003|Overall Study|Death|0|||
24974452|NCT03572062|50062842|FG004|Overall Study|Death|0|||
24974453|NCT03572062|50062843|FG005|Overall Study|Death|1|||
24974454|NCT03572062|50062844|FG006|Overall Study|Death|0|||
24974455|NCT03572062|50062845|FG007|Overall Study|Death|0|||
24974456|NCT03572062|50062846|FG008|Overall Study|Death|0|||
24974457|NCT03572062|50062847|FG009|Overall Study|Death|0|||
24974458|NCT03572062|50062838|FG000|Overall Study|Lost to Follow-up|0|||
24974459|NCT03572062|50062839|FG001|Overall Study|Lost to Follow-up|0|||
25075111|NCT00835367|50182474|FG001|Second Intervention|Adverse Event|1|||
25075112|NCT02276560|50182481|FG000|Overall Study|Adverse Event|1|||
25075113|NCT02276560|50182482|FG001|Overall Study|Adverse Event|0|||
25075114|NCT02276560|50182483|FG002|Overall Study|Adverse Event|0|||
24974460|NCT03572062|50062840|FG002|Overall Study|Lost to Follow-up|0|||
24974461|NCT03572062|50062841|FG003|Overall Study|Lost to Follow-up|0|||
24974462|NCT03572062|50062842|FG004|Overall Study|Lost to Follow-up|0|||
24974463|NCT03572062|50062843|FG005|Overall Study|Lost to Follow-up|1|||
24974464|NCT03572062|50062844|FG006|Overall Study|Lost to Follow-up|1|||
24974465|NCT03572062|50062845|FG007|Overall Study|Lost to Follow-up|0|||
24974466|NCT03572062|50062846|FG008|Overall Study|Lost to Follow-up|0|||
24974467|NCT03572062|50062847|FG009|Overall Study|Lost to Follow-up|0|||
24974468|NCT03572062|50062838|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
24974469|NCT03572062|50062839|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
24974470|NCT03572062|50062840|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
24974471|NCT03572062|50062841|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
24974472|NCT03572062|50062842|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
24974473|NCT03572062|50062843|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
24974474|NCT03572062|50062844|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
24974475|NCT03572062|50062845|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
24974476|NCT03572062|50062846|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
24974477|NCT03572062|50062847|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
24974478|NCT03572062|50062838|FG000|Overall Study|Study Terminated By Sponsor|0|||
24974479|NCT03572062|50062839|FG001|Overall Study|Study Terminated By Sponsor|0|||
24974480|NCT03572062|50062840|FG002|Overall Study|Study Terminated By Sponsor|0|||
24974481|NCT03572062|50062841|FG003|Overall Study|Study Terminated By Sponsor|0|||
24974482|NCT03572062|50062842|FG004|Overall Study|Study Terminated By Sponsor|0|||
24974483|NCT03572062|50062843|FG005|Overall Study|Study Terminated By Sponsor|0|||
24974484|NCT03572062|50062844|FG006|Overall Study|Study Terminated By Sponsor|0|||
24974485|NCT03572062|50062845|FG007|Overall Study|Study Terminated By Sponsor|0|||
24974486|NCT03572062|50062846|FG008|Overall Study|Study Terminated By Sponsor|29|||
24974487|NCT03572062|50062847|FG009|Overall Study|Study Terminated By Sponsor|27|||
24974488|NCT03572062|50062838|FG000|Overall Study|Physician Decision|0|||
24974489|NCT03572062|50062839|FG001|Overall Study|Physician Decision|0|||
24974490|NCT03572062|50062840|FG002|Overall Study|Physician Decision|0|||
24974491|NCT03572062|50062841|FG003|Overall Study|Physician Decision|0|||
24974492|NCT03572062|50062842|FG004|Overall Study|Physician Decision|0|||
24974493|NCT03572062|50062843|FG005|Overall Study|Physician Decision|0|||
24974494|NCT03572062|50062844|FG006|Overall Study|Physician Decision|0|||
24974495|NCT03572062|50062845|FG007|Overall Study|Physician Decision|0|||
24974496|NCT03572062|50062846|FG008|Overall Study|Physician Decision|1|||
24974497|NCT03572062|50062847|FG009|Overall Study|Physician Decision|0|||
24974498|NCT03572062|50062838|FG000|Overall Study|Withdrawal by Subject|0|||
24974499|NCT03572062|50062839|FG001|Overall Study|Withdrawal by Subject|0|||
24974500|NCT03572062|50062840|FG002|Overall Study|Withdrawal by Subject|0|||
24974501|NCT03572062|50062841|FG003|Overall Study|Withdrawal by Subject|0|||
24974502|NCT03572062|50062842|FG004|Overall Study|Withdrawal by Subject|0|||
24974503|NCT03572062|50062843|FG005|Overall Study|Withdrawal by Subject|0|||
24974504|NCT03572062|50062844|FG006|Overall Study|Withdrawal by Subject|0|||
24974505|NCT03572062|50062845|FG007|Overall Study|Withdrawal by Subject|0|||
24974506|NCT03572062|50062846|FG008|Overall Study|Withdrawal by Subject|0|||
24974507|NCT03572062|50062847|FG009|Overall Study|Withdrawal by Subject|1|||
24974508|NCT03572062|50062838|FG000|Overall Study|Randomized But Not Treated|0|||
24974509|NCT03572062|50062839|FG001|Overall Study|Randomized But Not Treated|0|||
24974510|NCT03572062|50062840|FG002|Overall Study|Randomized But Not Treated|0|||
24974511|NCT03572062|50062841|FG003|Overall Study|Randomized But Not Treated|0|||
24974512|NCT03572062|50062842|FG004|Overall Study|Randomized But Not Treated|1|||
24974513|NCT03572062|50062843|FG005|Overall Study|Randomized But Not Treated|2|||
24974514|NCT03572062|50062844|FG006|Overall Study|Randomized But Not Treated|0|||
24974515|NCT03572062|50062845|FG007|Overall Study|Randomized But Not Treated|1|||
24974516|NCT03572062|50062846|FG008|Overall Study|Randomized But Not Treated|0|||
24974517|NCT03572062|50062847|FG009|Overall Study|Randomized But Not Treated|0|||
24974518|NCT03571516|50062869|FG000|Overall Study|Severe diarrhea|1|||
24974519|NCT03571516|50062870|FG001|Overall Study|Severe diarrhea|0|||
24974520|NCT03571516|50062869|FG000|Overall Study|Withdrawal by Subject|0|||
24974521|NCT03571516|50062870|FG001|Overall Study|Withdrawal by Subject|1|||
25075115|NCT02276482|50182493|FG000|Overall Study|Adverse Event|1|||
25192804|NCT01431638|50360742|FG002|Overall Study|Lost to Follow-up|7|||
24974522|NCT03600376|50062878|FG000|Overall Study|Adverse Event|1|||
24974523|NCT03600376|50062879|FG001|Overall Study|Adverse Event|1|||
24974524|NCT03600376|50062878|FG000|Overall Study|Transferred to other facility|1|||
24974525|NCT03600376|50062879|FG001|Overall Study|Transferred to other facility|0|||
24974526|NCT03600376|50062878|FG000|Overall Study|Investigator Decision|0|||
24974527|NCT03600376|50062879|FG001|Overall Study|Investigator Decision|4|||
24974528|NCT03600376|50062878|FG000|Overall Study|Determined to be ineligible for study|0|||
24974529|NCT03600376|50062879|FG001|Overall Study|Determined to be ineligible for study|1|||
24974530|NCT03599362|50062885|FG000|Overall Study|Screen Failure|3|||
25075116|NCT02276482|50182494|FG001|Overall Study|Adverse Event|0|||
25075117|NCT02276482|50182493|FG000|Overall Study|Withdrawal by Subject|1|||
25075118|NCT02276482|50182494|FG001|Overall Study|Withdrawal by Subject|0|||
25075119|NCT02276482|50182493|FG000|Overall Study|Gram-negative infection|1|||
25075120|NCT02276482|50182494|FG001|Overall Study|Gram-negative infection|0|||
25075121|NCT02276482|50182493|FG000|Overall Study|Reason not specified|0|||
25075122|NCT02276482|50182494|FG001|Overall Study|Reason not specified|1|||
25075123|NCT00835211|50182512|FG000|First Intervention|Withdrawal by Subject|0|||
25075124|NCT00835211|50182513|FG001|First Intervention|Withdrawal by Subject|1|||
25075125|NCT00835211|50182512|FG000|Washout: 7 Days|Adverse Event|2|||
25075126|NCT00835211|50182513|FG001|Washout: 7 Days|Adverse Event|1|||
25075127|NCT00835211|50182512|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
25075128|NCT00835211|50182513|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
25075129|NCT00834743|50182526|FG000|Second Intervention|Withdrawal by Subject|1|||
25075130|NCT00834743|50182527|FG001|Second Intervention|Withdrawal by Subject|0|||
25192805|NCT01431638|50360740|FG000|Overall Study|Administrative problems|1|||
25192806|NCT01431638|50360741|FG001|Overall Study|Administrative problems|4|||
25192807|NCT01431638|50360742|FG002|Overall Study|Administrative problems|6|||
25192808|NCT01431638|50360740|FG000|Overall Study|Death|1|||
25192809|NCT01431638|50360741|FG001|Overall Study|Death|0|||
25192810|NCT01431638|50360742|FG002|Overall Study|Death|0|||
25192811|NCT01431638|50360740|FG000|Overall Study|Protocol deviation|1|||
25192812|NCT01431638|50360741|FG001|Overall Study|Protocol deviation|1|||
25192813|NCT01431638|50360742|FG002|Overall Study|Protocol deviation|4|||
25192814|NCT01431638|50360740|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
25192815|NCT01431638|50360741|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
25192816|NCT01431638|50360742|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
25192817|NCT01392170|50360750|FG000|Overall Study|Withdrawal by Subject|1|||
25192818|NCT01392170|50360750|FG000|Overall Study|Ineligible|1|||
25192819|NCT00558753|50360756|FG000|Overall Study|Lost to Follow-up|5|||
25192820|NCT00558753|50360757|FG001|Overall Study|Lost to Follow-up|7|||
24974531|NCT03598036|50062891|FG000|Overall Study|Withdrawal by Subject|1|||
25075131|NCT00834587|50182533|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
25075132|NCT00834587|50182534|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
25075133|NCT00834431|50182540|FG000|First Intervention|Adverse Event|0|||
25075134|NCT00834431|50182541|FG001|First Intervention|Adverse Event|1|||
25075135|NCT00834431|50182540|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
25075136|NCT00834431|50182541|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
25075137|NCT00830219|50182561|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
25075138|NCT00830219|50182562|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
25075139|NCT02274766|50182568|FG000|Overall Study|Withdrawal by Subject|3|||
25075140|NCT02274766|50182569|FG001|Overall Study|Withdrawal by Subject|6|||
25075141|NCT02274766|50182568|FG000|Overall Study|Did Not Receive Study Drug|1|||
25075142|NCT02274766|50182569|FG001|Overall Study|Did Not Receive Study Drug|1|||
25075143|NCT02274766|50182568|FG000|Overall Study|Subject Unwilling to Proceed|0|||
25075144|NCT02274766|50182569|FG001|Overall Study|Subject Unwilling to Proceed|1|||
25075145|NCT02274766|50182568|FG000|Overall Study|Adverse Event|0|||
24974532|NCT03598036|50062892|FG001|Overall Study|Withdrawal by Subject|0|||
24974533|NCT00082407|50062902|FG000|Overall Study|Adverse Event|20|||
24974534|NCT00082407|50062903|FG001|Overall Study|Adverse Event|0|||
24974535|NCT00082407|50062902|FG000|Overall Study|Protocol Violation|14|||
24974536|NCT00082407|50062903|FG001|Overall Study|Protocol Violation|12|||
24974537|NCT00082407|50062902|FG000|Overall Study|Patient Decision|13|||
24974538|NCT00082407|50062903|FG001|Overall Study|Patient Decision|6|||
24974539|NCT00082407|50062902|FG000|Overall Study|Physician Decision|5|||
24974540|NCT00082407|50062903|FG001|Overall Study|Physician Decision|3|||
24974541|NCT00082407|50062902|FG000|Overall Study|Loss of Glucose Control|2|||
24974542|NCT00082407|50062903|FG001|Overall Study|Loss of Glucose Control|2|||
24974543|NCT00082407|50062902|FG000|Overall Study|Death|2|||
24974544|NCT00082407|50062903|FG001|Overall Study|Death|1|||
24974545|NCT00082407|50062902|FG000|Overall Study|Lost to Follow-up|0|||
24974546|NCT00082407|50062903|FG001|Overall Study|Lost to Follow-up|3|||
24974547|NCT03643432|50062911|FG000|Overall Study|Lost to Follow-up|1|||
24974548|NCT03643432|50062912|FG001|Overall Study|Lost to Follow-up|0|||
24974549|NCT03810183|50062920|FG000|Overall Study|Study terminated by Sponsor|2|||
24974550|NCT03810183|50062921|FG001|Overall Study|Study terminated by Sponsor|1|||
24974551|NCT03597022|50062931|FG000|Overall Study|Premature termination of the study|7|||
24974552|NCT03597022|50062932|FG001|Overall Study|Premature termination of the study|7|||
24974553|NCT03597022|50062933|FG002|Overall Study|Premature termination of the study|8|||
24974554|NCT03597022|50062931|FG000|Overall Study|Serious adverse event|1|||
24974555|NCT03597022|50062932|FG001|Overall Study|Serious adverse event|1|||
24974556|NCT03597022|50062933|FG002|Overall Study|Serious adverse event|0|||
24974557|NCT03571204|50062944|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
24974558|NCT03571204|50062945|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
25075146|NCT02274766|50182569|FG001|Overall Study|Adverse Event|1|||
25075147|NCT00829673|50182577|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
25170105|NCT01797263|50304104|FG001|Overall Study|Withdrawal by Subject|25|||
25170106|NCT01797263|50304103|FG000|Overall Study|Death|1|||
25170107|NCT01797263|50304104|FG001|Overall Study|Death|0|||
25170108|NCT01797263|50304103|FG000|Overall Study|Lost to Follow-up|15|||
25170109|NCT01797263|50304104|FG001|Overall Study|Lost to Follow-up|15|||
25170110|NCT01797185|50304159|FG000|Overall Study|Adverse Event|5|||
25170111|NCT01797185|50304160|FG001|Overall Study|Adverse Event|15|||
25170112|NCT01797185|50304161|FG002|Overall Study|Adverse Event|6|||
25170113|NCT01797185|50304159|FG000|Overall Study|Withdrawal by Subject|6|||
25170114|NCT01797185|50304160|FG001|Overall Study|Withdrawal by Subject|9|||
25170115|NCT01797185|50304161|FG002|Overall Study|Withdrawal by Subject|5|||
25170116|NCT01797185|50304159|FG000|Overall Study|Site terminated|8|||
25192821|NCT01391546|50360765|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
25192822|NCT01391546|50360766|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
25192823|NCT01410110|50360775|FG000|Overall Study|Withdrawal by Subject|4|||
25192824|NCT01410110|50360776|FG001|Overall Study|Withdrawal by Subject|2|||
25192825|NCT01391000|50360784|FG000|Overall Study|Lost to Follow-up|2|||
25192826|NCT01391000|50360785|FG001|Overall Study|Lost to Follow-up|0|||
25314703|NCT00842829|50630495|FG000|Continuation Period|Non-compliance to study procedures|0|||
25314704|NCT00842829|50630496|FG001|Continuation Period|Non-compliance to study procedures|0|||
24974559|NCT03571204|50062946|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
24974560|NCT03571204|50062944|FG000|Overall Study|Physician Decision|0|||
25170117|NCT01797185|50304160|FG001|Overall Study|Site terminated|4|||
25170118|NCT01797185|50304161|FG002|Overall Study|Site terminated|0|||
24974561|NCT03571204|50062945|FG001|Overall Study|Physician Decision|1|||
24974562|NCT03571204|50062946|FG002|Overall Study|Physician Decision|0|||
24974563|NCT03569098|50062958|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
24974564|NCT03569098|50062959|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
24974565|NCT03569098|50062960|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
25075148|NCT00829673|50182578|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
25075149|NCT02370238|50182584|FG000|Overall Study|Death|42|||
25075150|NCT02370238|50182585|FG001|Overall Study|Death|35|||
25075151|NCT02370238|50182584|FG000|Overall Study|Lost to Follow-up|1|||
25170119|NCT01797185|50304159|FG000|Overall Study|Lost to Follow-up|2|||
25170120|NCT01797185|50304160|FG001|Overall Study|Lost to Follow-up|6|||
24974566|NCT03569098|50062958|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
25075152|NCT02370238|50182585|FG001|Overall Study|Lost to Follow-up|3|||
25075153|NCT02370238|50182584|FG000|Overall Study|Withdrawal by Subject|2|||
25075154|NCT02370238|50182585|FG001|Overall Study|Withdrawal by Subject|6|||
25075155|NCT02370238|50182584|FG000|Overall Study|Other|2|||
25075156|NCT02370238|50182585|FG001|Overall Study|Other|1|||
25075157|NCT02370160|50182595|FG000|Overall Study|Death|3|||
25075158|NCT02370160|50182596|FG001|Overall Study|Death|4|||
25075159|NCT02370160|50182597|FG002|Overall Study|Death|1|||
25075160|NCT02273908|50182612|FG000|Overall Study|Adverse Event|16|||
25075161|NCT02273908|50182613|FG001|Overall Study|Adverse Event|0|||
25075162|NCT02273908|50182612|FG000|Overall Study|Lost to Follow-up|10|||
25075163|NCT02273908|50182613|FG001|Overall Study|Lost to Follow-up|1|||
25075164|NCT02273908|50182612|FG000|Overall Study|Did not meet entrance criteria|3|||
25075165|NCT02273908|50182613|FG001|Overall Study|Did not meet entrance criteria|2|||
25075166|NCT02273908|50182612|FG000|Overall Study|Withdrawal by Subject|4|||
25075167|NCT02273908|50182613|FG001|Overall Study|Withdrawal by Subject|2|||
25075168|NCT02273752|50182623|FG000|Overall Study|Trial was terminated early|2|||
25075169|NCT05180630|50182627|FG000|First Intervention|Physician Decision|0|||
24974567|NCT03569098|50062959|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
24974568|NCT03569098|50062960|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
24974569|NCT03569098|50062958|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
24974570|NCT03569098|50062959|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
24974571|NCT03569098|50062960|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
24974572|NCT03569098|50062958|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
24974573|NCT03569098|50062959|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
24974574|NCT03569098|50062960|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
24974575|NCT03569098|50062958|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
24974576|NCT03569098|50062959|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
24974577|NCT03569098|50062960|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
24974578|NCT03569098|50062958|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
24974579|NCT03569098|50062959|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
24974580|NCT03569098|50062960|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
24974581|NCT03569098|50062958|FG000|Double-Blind Treatment Cycle 1|Other|1|||
24974582|NCT03569098|50062959|FG001|Double-Blind Treatment Cycle 1|Other|0|||
24974583|NCT03569098|50062960|FG002|Double-Blind Treatment Cycle 1|Other|1|||
24974584|NCT03569098|50062958|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
24974585|NCT03569098|50062959|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
24974586|NCT03569098|50062960|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
24974587|NCT03569098|50062958|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
25075170|NCT05180630|50182628|FG001|First Intervention|Physician Decision|0|||
25075171|NCT05180630|50182629|FG002|First Intervention|Physician Decision|3|||
25075172|NCT02273596|50182638|FG000|24-Week Treatment Period|Adverse Event|3|||
25075173|NCT02273596|50182638|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
25075174|NCT02273596|50182638|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
25075175|NCT02273596|50182638|FG000|24-Week Treatment Period|Physician Decision|1|||
25075176|NCT02273596|50182638|FG000|24-Week Treatment Period|Protocol Deviation|1|||
25075177|NCT02273596|50182638|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
25075178|NCT02273596|50182638|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
25075179|NCT02273596|50182638|FG000|Extension Period|Lost to Follow-up|1|||
25075180|NCT02273596|50182638|FG000|Extension Period|Protocol Deviation|1|||
25075181|NCT01656200|50182648|FG000|Overall Study|Withdrawal by Subject|1|||
24974588|NCT03569098|50062959|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
24974589|NCT03569098|50062960|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
24974590|NCT03569098|50062958|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
24974591|NCT03569098|50062959|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
24974592|NCT03569098|50062960|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
24974593|NCT03569098|50062958|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
24974594|NCT03569098|50062959|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
24974595|NCT03569098|50062960|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
25075182|NCT02369848|50182652|FG000|Overall Study|Death|1|||
25075183|NCT02369848|50182652|FG000|Overall Study|Withdrawal by Subject|2|||
25075184|NCT02369848|50182652|FG000|Overall Study|Lost to Follow-up|1|||
25075185|NCT02368210|50182658|FG000|Overall Study|Withdrawal by Subject|1|||
25075186|NCT02368210|50182659|FG001|Overall Study|Withdrawal by Subject|0|||
25075187|NCT02368210|50182658|FG000|Overall Study|Adverse Event|0|||
25075188|NCT02368210|50182659|FG001|Overall Study|Adverse Event|1|||
25170121|NCT01797185|50304161|FG002|Overall Study|Lost to Follow-up|1|||
25170122|NCT01797185|50304159|FG000|Overall Study|Withdrawn per sponsor|5|||
25170123|NCT01797185|50304160|FG001|Overall Study|Withdrawn per sponsor|0|||
25075189|NCT02273050|50182668|FG000|Overall Study|Adverse Event|4|||
25075190|NCT02273050|50182669|FG001|Overall Study|Adverse Event|3|||
25075191|NCT02273050|50182670|FG002|Overall Study|Adverse Event|3|||
25170124|NCT01797185|50304161|FG002|Overall Study|Withdrawn per sponsor|0|||
25075192|NCT02273050|50182668|FG000|Overall Study|Death|0|||
25075193|NCT02273050|50182669|FG001|Overall Study|Death|0|||
25075194|NCT02273050|50182670|FG002|Overall Study|Death|1|||
25075195|NCT02273050|50182668|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
25075196|NCT02273050|50182669|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
25075197|NCT02273050|50182670|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
24974596|NCT03569098|50062958|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
24974597|NCT03569098|50062959|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
24974598|NCT03569098|50062960|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
24974599|NCT03569098|50062958|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
24974600|NCT03569098|50062959|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
24974601|NCT03569098|50062960|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
24974602|NCT03568942|50062971|FG000|Overall Study|Family emergency|1|||
24974603|NCT03568942|50062971|FG000|Overall Study|Lost to Follow-up|1|||
24974604|NCT00110019|50062977|FG000|Overall Study|Lack of Efficacy|253|||
24974605|NCT00110019|50062978|FG001|Overall Study|Lack of Efficacy|285|||
24974606|NCT00110019|50062977|FG000|Overall Study|Adverse Event|61|||
25075198|NCT02273050|50182668|FG000|Overall Study|Lack of Efficacy|0|||
25075199|NCT02273050|50182669|FG001|Overall Study|Lack of Efficacy|1|||
25075200|NCT02273050|50182670|FG002|Overall Study|Lack of Efficacy|1|||
25075201|NCT02273050|50182668|FG000|Overall Study|Withdrawal by Subject|17|||
25075202|NCT02273050|50182669|FG001|Overall Study|Withdrawal by Subject|14|||
25075203|NCT02273050|50182670|FG002|Overall Study|Withdrawal by Subject|16|||
25075204|NCT02273050|50182668|FG000|Overall Study|Lost to Follow-up|0|||
25075205|NCT02273050|50182669|FG001|Overall Study|Lost to Follow-up|2|||
25075206|NCT02273050|50182670|FG002|Overall Study|Lost to Follow-up|3|||
25075207|NCT02273050|50182668|FG000|Overall Study|Protocol Violation|3|||
25075208|NCT02273050|50182669|FG001|Overall Study|Protocol Violation|1|||
25075209|NCT02273050|50182670|FG002|Overall Study|Protocol Violation|4|||
25075210|NCT02272816|50182678|FG000|Overall Study|Adverse Event|1|||
25075211|NCT02271880|50182684|FG000|Overall Study|Premature discontinuation of study|3|||
25075212|NCT02271880|50182685|FG001|Overall Study|Premature discontinuation of study|4|||
25075213|NCT02367352|50182693|FG000|Overall Study|Progressive disease|7|||
25075214|NCT02367352|50182694|FG001|Overall Study|Progressive disease|0|||
25075215|NCT02367352|50182695|FG002|Overall Study|Progressive disease|0|||
25075216|NCT02367352|50182693|FG000|Overall Study|Participant Received Alternative Therapy|1|||
25075217|NCT02367352|50182694|FG001|Overall Study|Participant Received Alternative Therapy|0|||
25075218|NCT02367352|50182695|FG002|Overall Study|Participant Received Alternative Therapy|0|||
25075219|NCT02367352|50182693|FG000|Overall Study|Adverse Event|1|||
25075220|NCT02367352|50182694|FG001|Overall Study|Adverse Event|0|||
25075221|NCT02367352|50182695|FG002|Overall Study|Adverse Event|0|||
25075222|NCT02365636|50182704|FG000|Overall Study|Adverse Event|3|||
25075223|NCT02365636|50182705|FG001|Overall Study|Adverse Event|3|||
25075224|NCT02365636|50182706|FG002|Overall Study|Adverse Event|2|||
25075225|NCT02365636|50182704|FG000|Overall Study|Protocol Violation|1|||
25075226|NCT02365636|50182705|FG001|Overall Study|Protocol Violation|4|||
25075227|NCT02365636|50182706|FG002|Overall Study|Protocol Violation|0|||
25075228|NCT02365636|50182704|FG000|Overall Study|Lost to Follow-up|0|||
25075229|NCT02365636|50182705|FG001|Overall Study|Lost to Follow-up|0|||
25075230|NCT02365636|50182706|FG002|Overall Study|Lost to Follow-up|1|||
25075231|NCT02365636|50182704|FG000|Overall Study|Other|2|||
25075232|NCT02365636|50182705|FG001|Overall Study|Other|0|||
25075233|NCT02365636|50182706|FG002|Overall Study|Other|0|||
25075234|NCT01655498|50182714|FG000|Overall Study|Unrelated health issue|2|||
25075235|NCT01655498|50182714|FG000|Overall Study|Protocol Violation|2|||
25075236|NCT01655498|50182714|FG000|Overall Study|Withdrawal by Subject|1|||
25075237|NCT02270944|50182723|FG000|Overall Study|Lost to Follow-up|9|||
25075238|NCT02270944|50182724|FG001|Overall Study|Lost to Follow-up|4|||
25075239|NCT02270944|50182723|FG000|Overall Study|Withdrawal by Subject|2|||
25075240|NCT02270944|50182724|FG001|Overall Study|Withdrawal by Subject|1|||
25075241|NCT02365558|50182731|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
25075242|NCT02365558|50182732|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
25075243|NCT02365558|50182731|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
24974607|NCT00110019|50062978|FG001|Overall Study|Adverse Event|40|||
24974608|NCT00110019|50062977|FG000|Overall Study|Death|13|||
24974609|NCT00110019|50062978|FG001|Overall Study|Death|15|||
24974610|NCT00110019|50062977|FG000|Overall Study|Withdrawal by Subject|21|||
24974611|NCT00110019|50062978|FG001|Overall Study|Withdrawal by Subject|9|||
24974612|NCT00110019|50062977|FG000|Overall Study|alternative therapy|5|||
24974613|NCT00110019|50062978|FG001|Overall Study|alternative therapy|1|||
24974614|NCT00110019|50062977|FG000|Overall Study|complicating disease|1|||
24974615|NCT00110019|50062978|FG001|Overall Study|complicating disease|1|||
24974616|NCT00110019|50062977|FG000|Overall Study|symptom deterioration|13|||
24974617|NCT00110019|50062978|FG001|Overall Study|symptom deterioration|16|||
24974618|NCT00110019|50062977|FG000|Overall Study|Not start protocol therapy|17|||
24974619|NCT00110019|50062978|FG001|Overall Study|Not start protocol therapy|16|||
24974620|NCT00110019|50062977|FG000|Overall Study|other reasons|22|||
24974621|NCT00110019|50062978|FG001|Overall Study|other reasons|30|||
24974622|NCT03595618|50062988|FG000|Overall Study|Adverse Event|16|||
24974623|NCT03595618|50062989|FG001|Overall Study|Adverse Event|17|||
24974624|NCT03595618|50062990|FG002|Overall Study|Adverse Event|20|||
24974625|NCT03595618|50062991|FG003|Overall Study|Adverse Event|8|||
24974626|NCT03595618|50062988|FG000|Overall Study|Withdrawal by Subject|12|||
24974627|NCT03595618|50062989|FG001|Overall Study|Withdrawal by Subject|14|||
24974628|NCT03595618|50062990|FG002|Overall Study|Withdrawal by Subject|14|||
24974629|NCT03595618|50062991|FG003|Overall Study|Withdrawal by Subject|10|||
24974630|NCT03595618|50062988|FG000|Overall Study|Lost to Follow-up|6|||
24974631|NCT03595618|50062989|FG001|Overall Study|Lost to Follow-up|4|||
24974632|NCT03595618|50062990|FG002|Overall Study|Lost to Follow-up|5|||
24974633|NCT03595618|50062991|FG003|Overall Study|Lost to Follow-up|6|||
24974634|NCT03595618|50062988|FG000|Overall Study|Protocol Violation|2|||
24974635|NCT03595618|50062989|FG001|Overall Study|Protocol Violation|0|||
24974636|NCT03595618|50062990|FG002|Overall Study|Protocol Violation|6|||
24974637|NCT03595618|50062991|FG003|Overall Study|Protocol Violation|2|||
24974638|NCT03595618|50062988|FG000|Overall Study|Physician Decision|0|||
24974639|NCT03595618|50062989|FG001|Overall Study|Physician Decision|0|||
24974640|NCT03595618|50062990|FG002|Overall Study|Physician Decision|1|||
24974641|NCT03595618|50062991|FG003|Overall Study|Physician Decision|2|||
24974642|NCT03595618|50062988|FG000|Overall Study|Miscellaneous|7|||
24974643|NCT03595618|50062989|FG001|Overall Study|Miscellaneous|5|||
24974644|NCT03595618|50062990|FG002|Overall Study|Miscellaneous|10|||
24974645|NCT03595618|50062991|FG003|Overall Study|Miscellaneous|6|||
24974646|NCT02954848|50063003|FG000|Overall Study|Randomized but Not Treated|0|||
24974647|NCT02954848|50063004|FG001|Overall Study|Randomized but Not Treated|1|||
24974648|NCT02954848|50063003|FG000|Overall Study|Adverse Event|2|||
24974649|NCT02954848|50063004|FG001|Overall Study|Adverse Event|3|||
24974650|NCT02954848|50063003|FG000|Overall Study|Withdrawal by Participant|0|||
24974651|NCT02954848|50063004|FG001|Overall Study|Withdrawal by Participant|1|||
24974652|NCT03642262|50063010|FG000|Period 1|Withdrawal by Subject|1|||
24974653|NCT03642262|50063011|FG001|Period 1|Withdrawal by Subject|1|||
24974654|NCT03642262|50063010|FG000|Period 1|Adverse Event|0|||
24974655|NCT03642262|50063011|FG001|Period 1|Adverse Event|1|||
24974656|NCT00109707|50063021|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
24974657|NCT00109707|50063022|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
25314705|NCT00842829|50630497|FG002|Continuation Period|Non-compliance to study procedures|2|||
25314706|NCT00842829|50630495|FG000|Continuation Period|Non-compliance to study drug|0|||
25314707|NCT00842829|50630496|FG001|Continuation Period|Non-compliance to study drug|0|||
25314708|NCT00842829|50630497|FG002|Continuation Period|Non-compliance to study drug|1|||
24974658|NCT00109707|50063023|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
24974659|NCT00109707|50063021|FG000|Overall Study|Abnormal laboratory values|1|||
24974660|NCT00109707|50063022|FG001|Overall Study|Abnormal laboratory values|0|||
24974661|NCT00109707|50063023|FG002|Overall Study|Abnormal laboratory values|0|||
24974662|NCT00109707|50063021|FG000|Overall Study|Administrative problems|2|||
24974663|NCT00109707|50063022|FG001|Overall Study|Administrative problems|0|||
24974664|NCT00109707|50063023|FG002|Overall Study|Administrative problems|1|||
24974665|NCT00109707|50063021|FG000|Overall Study|Adverse Event|10|||
24974666|NCT00109707|50063022|FG001|Overall Study|Adverse Event|2|||
24974667|NCT00109707|50063023|FG002|Overall Study|Adverse Event|3|||
24974668|NCT00109707|50063021|FG000|Overall Study|Death|4|||
25075244|NCT02365558|50182732|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
25075245|NCT02365480|50182743|FG000|Overall Study|Withdrawal by Subject|2|||
25075246|NCT02365480|50182744|FG001|Overall Study|Withdrawal by Subject|0|||
25075247|NCT02270242|50182752|FG000|Overall Study|Withdrawal by Subject|18|||
25075248|NCT02270242|50182753|FG001|Overall Study|Withdrawal by Subject|25|||
25075249|NCT02270242|50182752|FG000|Overall Study|Lost to Follow-up|41|||
25075250|NCT02270242|50182753|FG001|Overall Study|Lost to Follow-up|27|||
25075251|NCT02270242|50182752|FG000|Overall Study|Physician Decision|0|||
25075252|NCT02270242|50182753|FG001|Overall Study|Physician Decision|1|||
25075253|NCT02364388|50182759|FG000|Overall Study|Protocol Violation|1|||
25075254|NCT02364388|50182759|FG000|Overall Study|Technical Failure|3|||
25075255|NCT02364388|50182759|FG000|Overall Study|No OA/US data|2|||
25075256|NCT02364388|50182759|FG000|Overall Study|No Biopsy|2|||
25075257|NCT02363686|50182763|FG000|Overall Study|Withdrawal by Subject|22|||
25075258|NCT02363686|50182763|FG000|Overall Study|incomplete FEES examinations|13|||
25075259|NCT02268916|50182769|FG000|Overall Study|Lost to Follow-up|1|||
25075260|NCT02268916|50182770|FG001|Overall Study|Lost to Follow-up|1|||
25075261|NCT02268916|50182769|FG000|Overall Study|Withdrawal by Subject|6|||
25075262|NCT02268916|50182770|FG001|Overall Study|Withdrawal by Subject|5|||
25075263|NCT02268916|50182769|FG000|Overall Study|Participant did not have diabetes|1|||
25075264|NCT02268916|50182770|FG001|Overall Study|Participant did not have diabetes|0|||
25075265|NCT02268916|50182769|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
25075266|NCT02268916|50182770|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
25075267|NCT02518490|50182777|FG000|Overall Study|Withdrawal by Subject|1|||
25075268|NCT02518490|50182778|FG001|Overall Study|Withdrawal by Subject|1|||
25075269|NCT01364870|50182788|FG000|Overall Study|Withdrawal by Subject|13|||
25075270|NCT01364870|50182789|FG001|Overall Study|Withdrawal by Subject|24|||
25075271|NCT01364870|50182790|FG002|Overall Study|Withdrawal by Subject|10|||
25075272|NCT01364870|50182788|FG000|Overall Study|Adverse Event|8|||
25075273|NCT01364870|50182789|FG001|Overall Study|Adverse Event|6|||
25075274|NCT01364870|50182790|FG002|Overall Study|Adverse Event|4|||
25075275|NCT01364870|50182788|FG000|Overall Study|Protocol Violation|1|||
25075276|NCT01364870|50182789|FG001|Overall Study|Protocol Violation|0|||
25075277|NCT01364870|50182790|FG002|Overall Study|Protocol Violation|0|||
25075278|NCT02268526|50182801|FG000|Overall Study|Adverse Event|0|||
25075279|NCT02268526|50182802|FG001|Overall Study|Adverse Event|2|||
25075280|NCT02268526|50182803|FG002|Overall Study|Adverse Event|1|||
25075281|NCT02268526|50182801|FG000|Overall Study|Death|1|||
25075282|NCT02268526|50182802|FG001|Overall Study|Death|11|||
25075283|NCT02268526|50182803|FG002|Overall Study|Death|0|||
25075284|NCT02268526|50182801|FG000|Overall Study|protocol deviation|0|||
25075285|NCT02268526|50182802|FG001|Overall Study|protocol deviation|1|||
25075286|NCT02268526|50182803|FG002|Overall Study|protocol deviation|0|||
25075287|NCT02268526|50182801|FG000|Overall Study|Physician Decision|0|||
25075288|NCT02268526|50182802|FG001|Overall Study|Physician Decision|0|||
25075289|NCT02268526|50182803|FG002|Overall Study|Physician Decision|1|||
25075290|NCT02268526|50182801|FG000|Overall Study|Subject/guardian decision|0|||
25075291|NCT02268526|50182802|FG001|Overall Study|Subject/guardian decision|7|||
25075292|NCT02268526|50182803|FG002|Overall Study|Subject/guardian decision|3|||
25075293|NCT02268214|50182816|FG000|Overall Study|Subject no longer meets study criteria|0|||
25075294|NCT02268214|50182817|FG001|Overall Study|Subject no longer meets study criteria|2|||
25075295|NCT02268214|50182818|FG002|Overall Study|Subject no longer meets study criteria|0|||
25075296|NCT02268214|50182816|FG000|Overall Study|Pregnancy|2|||
25075297|NCT02268214|50182817|FG001|Overall Study|Pregnancy|2|||
25075298|NCT02268214|50182818|FG002|Overall Study|Pregnancy|1|||
25075299|NCT02268214|50182816|FG000|Overall Study|Lost to Follow-up|3|||
25075300|NCT02268214|50182817|FG001|Overall Study|Lost to Follow-up|3|||
25075301|NCT02268214|50182818|FG002|Overall Study|Lost to Follow-up|4|||
25075302|NCT02268214|50182816|FG000|Overall Study|Lack of Efficacy|1|||
25075303|NCT02268214|50182817|FG001|Overall Study|Lack of Efficacy|0|||
25075304|NCT02268214|50182818|FG002|Overall Study|Lack of Efficacy|2|||
25075305|NCT02268214|50182816|FG000|Overall Study|Adverse Event|11|||
25075306|NCT02268214|50182817|FG001|Overall Study|Adverse Event|14|||
25075307|NCT02268214|50182818|FG002|Overall Study|Adverse Event|9|||
25075308|NCT02268214|50182816|FG000|Overall Study|Withdrawal by Subject|4|||
25075309|NCT02268214|50182817|FG001|Overall Study|Withdrawal by Subject|5|||
25170125|NCT01797185|50304159|FG000|Overall Study|Physician Decision|1|||
25170126|NCT01797185|50304160|FG001|Overall Study|Physician Decision|3|||
25075310|NCT02268214|50182818|FG002|Overall Study|Withdrawal by Subject|10|||
25075311|NCT02268214|50182816|FG000|Overall Study|Subject request to discontinue treatment|10|||
25075312|NCT02268214|50182817|FG001|Overall Study|Subject request to discontinue treatment|8|||
25075313|NCT02268214|50182818|FG002|Overall Study|Subject request to discontinue treatment|6|||
25075314|NCT02268214|50182816|FG000|Overall Study|Poor/non-compliance|2|||
25075315|NCT02268214|50182817|FG001|Overall Study|Poor/non-compliance|1|||
25075316|NCT02268214|50182818|FG002|Overall Study|Poor/non-compliance|2|||
25075317|NCT02268214|50182816|FG000|Overall Study|Other reasons|7|||
25075318|NCT02268214|50182817|FG001|Overall Study|Other reasons|3|||
25075319|NCT02268214|50182818|FG002|Overall Study|Other reasons|3|||
25075320|NCT02268214|50182816|FG000|Overall Study|Not entering long-term period|2|||
25075321|NCT02268214|50182817|FG001|Overall Study|Not entering long-term period|3|||
25075322|NCT02268214|50182818|FG002|Overall Study|Not entering long-term period|5|||
25075323|NCT02521376|50182830|FG000|Overall Study|Enrolled, But Not Treated|1|||
25192827|NCT01390844|50360860|FG000|Treatment Phase|Adverse Event|12|||
25192828|NCT01390844|50360861|FG001|Treatment Phase|Adverse Event|2|||
25075324|NCT02521376|50182831|FG001|Overall Study|Enrolled, But Not Treated|0|||
25075325|NCT02521376|50182832|FG002|Overall Study|Enrolled, But Not Treated|0|||
25075326|NCT02521376|50182833|FG003|Overall Study|Enrolled, But Not Treated|0|||
25075327|NCT02268058|50182855|FG000|Overall Study|Protocol Violation|1|||
25075328|NCT02268058|50182856|FG001|Overall Study|Protocol Violation|0|||
25075329|NCT02268058|50182857|FG002|Overall Study|Protocol Violation|0|||
25075330|NCT02268058|50182858|FG003|Overall Study|Protocol Violation|0|||
25075331|NCT02267824|50182870|FG000|Overall Study|Pregnancy|1|||
25075332|NCT02267824|50182871|FG001|Overall Study|Pregnancy|1|||
25075333|NCT02267824|50182870|FG000|Overall Study|Lost to Follow-up|4|||
25075334|NCT02267824|50182871|FG001|Overall Study|Lost to Follow-up|0|||
25075335|NCT02267824|50182870|FG000|Overall Study|Protocol Violation|3|||
25075336|NCT02267824|50182871|FG001|Overall Study|Protocol Violation|0|||
25075337|NCT02267824|50182870|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
25075338|NCT02267824|50182871|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
25075339|NCT02267746|50182880|FG000|Overall Study|Adverse Event|0|||
25075340|NCT02267746|50182881|FG001|Overall Study|Adverse Event|2|||
25075341|NCT02267746|50182882|FG002|Overall Study|Adverse Event|1|||
25075342|NCT02267746|50182880|FG000|Overall Study|Protocol Violation|8|||
25075343|NCT02267746|50182881|FG001|Overall Study|Protocol Violation|7|||
25075344|NCT02267746|50182882|FG002|Overall Study|Protocol Violation|3|||
25075345|NCT02267746|50182880|FG000|Overall Study|Lack of Efficacy|11|||
25075346|NCT02267746|50182881|FG001|Overall Study|Lack of Efficacy|11|||
25075347|NCT02267746|50182882|FG002|Overall Study|Lack of Efficacy|15|||
25075348|NCT02267746|50182880|FG000|Overall Study|Protocol Violation|1|||
25075349|NCT02267746|50182881|FG001|Overall Study|Protocol Violation|2|||
25075350|NCT02267746|50182882|FG002|Overall Study|Protocol Violation|1|||
25075351|NCT02267746|50182880|FG000|Overall Study|Miscellaneous|1|||
25075352|NCT02267746|50182881|FG001|Overall Study|Miscellaneous|0|||
25075353|NCT02267746|50182882|FG002|Overall Study|Miscellaneous|1|||
25075354|NCT02362360|50182892|FG000|Period 1|Lack of Efficacy|1|||
25075355|NCT02362360|50182893|FG001|Period 1|Lack of Efficacy|0|||
25192829|NCT01390844|50360862|FG002|Treatment Phase|Adverse Event|3|||
25192830|NCT01390844|50360863|FG003|Treatment Phase|Adverse Event|2|||
25192831|NCT01390844|50360860|FG000|Treatment Phase|Treatment Failure|23|||
25192832|NCT01390844|50360861|FG001|Treatment Phase|Treatment Failure|25|||
25192833|NCT01390844|50360862|FG002|Treatment Phase|Treatment Failure|10|||
25192834|NCT01390844|50360863|FG003|Treatment Phase|Treatment Failure|13|||
25192835|NCT01390844|50360860|FG000|Treatment Phase|Non-Medical Reasons|5|||
25192836|NCT01390844|50360861|FG001|Treatment Phase|Non-Medical Reasons|1|||
25075356|NCT02362360|50182892|FG000|Period 1|Withdrawal by Subject|2|||
25075357|NCT02362360|50182893|FG001|Period 1|Withdrawal by Subject|1|||
25075358|NCT02362282|50182901|FG000|Overall Study|Withdrawal by Subject|1|||
25075359|NCT02362282|50182902|FG001|Overall Study|Withdrawal by Subject|0|||
25075360|NCT02361580|50182910|FG000|Overall Study|Lost to Follow-up|6|||
25075361|NCT02361580|50182911|FG001|Overall Study|Lost to Follow-up|3|||
25075362|NCT02520284|50182920|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
25075363|NCT02520284|50182921|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
25075364|NCT02520284|50182922|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
25075365|NCT02520284|50182920|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
25075366|NCT02520284|50182921|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
25075367|NCT02520284|50182922|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
25075368|NCT02520284|50182920|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
25075369|NCT02520284|50182921|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
25075370|NCT02520284|50182922|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
25075371|NCT02520284|50182920|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
25075372|NCT02520284|50182921|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
25075373|NCT02520284|50182922|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
25075374|NCT02520284|50182920|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
25075375|NCT02520284|50182921|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
25075376|NCT02520284|50182922|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
25075377|NCT02520284|50182920|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
25075378|NCT02520284|50182921|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
25075379|NCT02520284|50182922|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
25075380|NCT02520284|50182920|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
25075381|NCT02520284|50182921|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
25075382|NCT02520284|50182922|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
25075383|NCT02520284|50182920|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
25192837|NCT01390844|50360862|FG002|Treatment Phase|Non-Medical Reasons|8|||
25192838|NCT01390844|50360863|FG003|Treatment Phase|Non-Medical Reasons|1|||
25192839|NCT01390844|50360860|FG000|Treatment Phase|Non-GCP Compliant|0|||
25192840|NCT01390844|50360861|FG001|Treatment Phase|Non-GCP Compliant|0|||
25192841|NCT01390844|50360862|FG002|Treatment Phase|Non-GCP Compliant|10|||
25192842|NCT01390844|50360863|FG003|Treatment Phase|Non-GCP Compliant|3|||
25192843|NCT01390844|50360860|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
25192844|NCT01390844|50360861|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
25192845|NCT01390844|50360862|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
25192846|NCT01390844|50360863|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
25192847|NCT01430624|50360876|FG000|Overall Study|Lost to Follow-up|23|||
25192848|NCT01430624|50360877|FG001|Overall Study|Lost to Follow-up|29|||
25192849|NCT01430624|50360878|FG002|Overall Study|Lost to Follow-up|27|||
25192850|NCT01430624|50360876|FG000|Overall Study|technical or eligibility|5|||
25192851|NCT01430624|50360877|FG001|Overall Study|technical or eligibility|5|||
25192852|NCT01430624|50360878|FG002|Overall Study|technical or eligibility|2|||
25192853|NCT01430468|50360903|FG000|Overall Study|Physician Decision|2|||
25192854|NCT01430468|50360904|FG001|Overall Study|Physician Decision|1|||
25192855|NCT01430468|50360903|FG000|Overall Study|Withdrawal by Subject|5|||
25192856|NCT01430468|50360904|FG001|Overall Study|Withdrawal by Subject|5|||
25192857|NCT01409564|50360925|FG000|Overall Study|low medication compliance|4|||
25192858|NCT01409564|50360926|FG001|Overall Study|low medication compliance|3|||
25192859|NCT01409564|50360925|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
25192860|NCT01409564|50360926|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
25192861|NCT01390298|50360936|FG000|Overall Study|Death|1|||
25192862|NCT01390298|50360936|FG000|Overall Study|long term ICU admission|1|||
25192863|NCT01390298|50360936|FG000|Overall Study|Withdrawal by Subject|14|||
25192864|NCT01390298|50360936|FG000|Overall Study|Lost to Follow-up|7|||
25192865|NCT01390298|50360936|FG000|Overall Study|Surgery cancelled|1|||
25192866|NCT01390220|50360954|FG000|Test Dose Phase|Adverse Event|17|||
25192867|NCT01390220|50360955|FG001|Test Dose Phase|Adverse Event|0|||
25192868|NCT01390220|50360956|FG002|Test Dose Phase|Adverse Event|0|||
25192869|NCT01390220|50360954|FG000|Test Dose Phase|Withdrawal by Subject|8|||
25192870|NCT01390220|50360955|FG001|Test Dose Phase|Withdrawal by Subject|0|||
25192871|NCT01390220|50360956|FG002|Test Dose Phase|Withdrawal by Subject|0|||
25192872|NCT01390220|50360954|FG000|Test Dose Phase|Lost to Follow-up|2|||
25192873|NCT01390220|50360955|FG001|Test Dose Phase|Lost to Follow-up|0|||
25192874|NCT01390220|50360956|FG002|Test Dose Phase|Lost to Follow-up|0|||
25192875|NCT01390220|50360954|FG000|Test Dose Phase|Protocol Violation|8|||
25192876|NCT01390220|50360955|FG001|Test Dose Phase|Protocol Violation|0|||
25192877|NCT01390220|50360956|FG002|Test Dose Phase|Protocol Violation|0|||
25192878|NCT01390220|50360954|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
25192879|NCT01390220|50360955|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
25192880|NCT01390220|50360956|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
25192881|NCT01390220|50360954|FG000|Test Dose Phase|Study/Site closure|6|||
25192882|NCT01390220|50360955|FG001|Test Dose Phase|Study/Site closure|0|||
25192883|NCT01390220|50360956|FG002|Test Dose Phase|Study/Site closure|0|||
25192884|NCT01390220|50360954|FG000|Test Dose Phase|Caregiver no longer available|5|||
25192885|NCT01390220|50360955|FG001|Test Dose Phase|Caregiver no longer available|0|||
25192886|NCT01390220|50360956|FG002|Test Dose Phase|Caregiver no longer available|0|||
25075384|NCT02520284|50182921|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
25192887|NCT01390220|50360954|FG000|Test Dose Phase|Noncompliance|2|||
25192888|NCT01390220|50360955|FG001|Test Dose Phase|Noncompliance|0|||
25192889|NCT01390220|50360956|FG002|Test Dose Phase|Noncompliance|0|||
25192890|NCT01390220|50360954|FG000|Test Dose Phase|Logistical|6|||
25192891|NCT01390220|50360955|FG001|Test Dose Phase|Logistical|0|||
25192892|NCT01390220|50360956|FG002|Test Dose Phase|Logistical|0|||
25192893|NCT01390220|50360954|FG000|Comparative Phase|Withdrawal by Subject|0|||
25075385|NCT02520284|50182922|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
25075386|NCT02520284|50182920|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
25075387|NCT02520284|50182921|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
25075388|NCT02520284|50182922|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
25075389|NCT02520284|50182920|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
25075390|NCT02520284|50182921|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
25075391|NCT02520284|50182922|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
25075392|NCT02520284|50182920|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
25075393|NCT02520284|50182921|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
25075394|NCT02520284|50182922|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
25170127|NCT01797185|50304161|FG002|Overall Study|Physician Decision|0|||
25170128|NCT01797185|50304159|FG000|Overall Study|Protocol Violation|1|||
25170129|NCT01797185|50304160|FG001|Overall Study|Protocol Violation|1|||
25170130|NCT01797185|50304161|FG002|Overall Study|Protocol Violation|0|||
25170131|NCT01819727|50304217|FG000|Overall Study|Adverse Event|8|||
25170132|NCT01819727|50304218|FG001|Overall Study|Adverse Event|9|||
25170133|NCT01819727|50304217|FG000|Overall Study|Death|1|||
25170134|NCT01819727|50304218|FG001|Overall Study|Death|0|||
25170135|NCT01819727|50304217|FG000|Overall Study|Lost to Follow-up|1|||
25170136|NCT01819727|50304218|FG001|Overall Study|Lost to Follow-up|1|||
25170137|NCT01819727|50304217|FG000|Overall Study|Physician Decision|3|||
25170138|NCT01819727|50304218|FG001|Overall Study|Physician Decision|2|||
25170139|NCT01819727|50304217|FG000|Overall Study|Pregnancy|1|||
25075395|NCT02517866|50182936|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
25075396|NCT02517866|50182937|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
25075397|NCT02517866|50182938|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
25075398|NCT02517866|50182936|FG000|Overall Study|Significant Protocol Deviation|4|||
25075399|NCT02517866|50182937|FG001|Overall Study|Significant Protocol Deviation|1|||
25075400|NCT02517866|50182938|FG002|Overall Study|Significant Protocol Deviation|0|||
25075401|NCT02517866|50182936|FG000|Overall Study|Lost to Follow-up|1|||
25075402|NCT02517866|50182937|FG001|Overall Study|Lost to Follow-up|0|||
25075403|NCT02517866|50182938|FG002|Overall Study|Lost to Follow-up|0|||
25075404|NCT02517866|50182936|FG000|Overall Study|Voluntary Withdrawal|2|||
25075405|NCT02517866|50182937|FG001|Overall Study|Voluntary Withdrawal|2|||
25075406|NCT02517866|50182938|FG002|Overall Study|Voluntary Withdrawal|0|||
25075407|NCT02517866|50182936|FG000|Overall Study|Investigator Decision|2|||
25075408|NCT02517866|50182937|FG001|Overall Study|Investigator Decision|1|||
25075409|NCT02517866|50182938|FG002|Overall Study|Investigator Decision|0|||
25075410|NCT02517866|50182936|FG000|Overall Study|Reason not specified|2|||
25075411|NCT02517866|50182937|FG001|Overall Study|Reason not specified|0|||
25075412|NCT02517866|50182938|FG002|Overall Study|Reason not specified|0|||
25075413|NCT02515994|50182950|FG000|Overall Study|Protocol Violation|3|||
25075414|NCT02515994|50182951|FG001|Overall Study|Protocol Violation|5|||
25075415|NCT02515994|50182950|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
25075416|NCT02515994|50182951|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
25075417|NCT02515994|50182950|FG000|Overall Study|Adverse Event|3|||
25075418|NCT02515994|50182951|FG001|Overall Study|Adverse Event|1|||
25075419|NCT02515994|50182950|FG000|Overall Study|Withdrawal by Subject|2|||
25075420|NCT02515994|50182951|FG001|Overall Study|Withdrawal by Subject|0|||
25075421|NCT02516306|50182959|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
25075422|NCT02516306|50182960|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
25075423|NCT02516228|50182966|FG000|Overall Study|Lost to Follow-up|1|||
25075424|NCT02516228|50182966|FG000|Overall Study|Withdrawal by Subject|1|||
25075425|NCT02516228|50182966|FG000|Overall Study|Physician Decision|1|||
25075426|NCT02519504|50182972|FG000|Overall Study|Protocol Violation|6|||
25075427|NCT02519504|50182973|FG001|Overall Study|Protocol Violation|5|||
25075428|NCT02519504|50182972|FG000|Overall Study|Ineligible for direct testing|12|||
25075429|NCT02519504|50182973|FG001|Overall Study|Ineligible for direct testing|12|||
25075430|NCT02519504|50182972|FG000|Overall Study|Did not participate in direct testing|95|||
24974669|NCT00109707|50063022|FG001|Overall Study|Death|0|||
24974670|NCT00109707|50063023|FG002|Overall Study|Death|0|||
24974671|NCT00109707|50063021|FG000|Overall Study|Disease progression|12|||
25075431|NCT02519504|50182973|FG001|Overall Study|Did not participate in direct testing|86|||
25075432|NCT02514824|50182981|FG000|Overall Study|Withdrawal by Subject|1|||
25075433|NCT02514824|50182982|FG001|Overall Study|Withdrawal by Subject|0|||
25075434|NCT02514824|50182983|FG002|Overall Study|Withdrawal by Subject|0|||
25075435|NCT02514824|50182984|FG003|Overall Study|Withdrawal by Subject|0|||
25075436|NCT02514824|50182981|FG000|Overall Study|Dose-Limiting Toxicity|0|||
25075437|NCT02514824|50182982|FG001|Overall Study|Dose-Limiting Toxicity|1|||
25075438|NCT02514824|50182983|FG002|Overall Study|Dose-Limiting Toxicity|0|||
25075439|NCT02514824|50182984|FG003|Overall Study|Dose-Limiting Toxicity|0|||
25192894|NCT01390220|50360955|FG001|Comparative Phase|Withdrawal by Subject|1|||
25192895|NCT01390220|50360956|FG002|Comparative Phase|Withdrawal by Subject|0|||
25192896|NCT00550173|50360986|FG000|Overall Study|Death|45|||
25192897|NCT00550173|50360987|FG001|Overall Study|Death|38|||
25192898|NCT00550173|50360988|FG002|Overall Study|Death|50|||
25192899|NCT00550173|50360986|FG000|Overall Study|Physician Decision|1|||
25192900|NCT00550173|50360987|FG001|Overall Study|Physician Decision|2|||
25192901|NCT00550173|50360988|FG002|Overall Study|Physician Decision|2|||
25192902|NCT00550173|50360986|FG000|Overall Study|Withdrawal by Subject|9|||
25192903|NCT00550173|50360987|FG001|Overall Study|Withdrawal by Subject|12|||
25192904|NCT00550173|50360988|FG002|Overall Study|Withdrawal by Subject|17|||
25075440|NCT02514746|50182993|FG000|Overall Study|Chronically Ill|1|||
25075441|NCT02514746|50182994|FG001|Overall Study|Chronically Ill|2|||
25075442|NCT02514746|50182993|FG000|Overall Study|Physician Decision|4|||
25075443|NCT02514746|50182994|FG001|Overall Study|Physician Decision|2|||
25192905|NCT00550173|50360986|FG000|Overall Study|Sponsor Decision|13|||
25192906|NCT00550173|50360987|FG001|Overall Study|Sponsor Decision|7|||
25192907|NCT00550173|50360988|FG002|Overall Study|Sponsor Decision|1|||
25192908|NCT00550173|50360986|FG000|Overall Study|Lost to Follow-up|4|||
25192909|NCT00550173|50360987|FG001|Overall Study|Lost to Follow-up|4|||
24974672|NCT00109707|50063022|FG001|Overall Study|Disease progression|4|||
25192910|NCT00550173|50360988|FG002|Overall Study|Lost to Follow-up|3|||
25192911|NCT01429298|50360999|FG000|Overall Study|Protocol Violation|4|||
25192912|NCT01429298|50361000|FG001|Overall Study|Protocol Violation|6|||
25192913|NCT01408706|50361012|FG000|Overall Study|Physician Decision|1|||
25192914|NCT01408706|50361013|FG001|Overall Study|Physician Decision|0|||
24974673|NCT00109707|50063023|FG002|Overall Study|Disease progression|3|||
24974674|NCT00109707|50063021|FG000|Overall Study|Lost to Follow-up|3|||
24974675|NCT00109707|50063022|FG001|Overall Study|Lost to Follow-up|0|||
24974676|NCT00109707|50063023|FG002|Overall Study|Lost to Follow-up|0|||
24974677|NCT00109707|50063021|FG000|Overall Study|Protocol Violation|1|||
24974678|NCT00109707|50063022|FG001|Overall Study|Protocol Violation|0|||
24974679|NCT00109707|50063023|FG002|Overall Study|Protocol Violation|0|||
24974680|NCT00109707|50063021|FG000|Overall Study|Patient withdrew consent|6|||
24974681|NCT00109707|50063022|FG001|Overall Study|Patient withdrew consent|1|||
25192915|NCT01408628|50361021|FG000|Consented|Withdrawal by Subject|12|||
24974682|NCT00109707|50063023|FG002|Overall Study|Patient withdrew consent|0|||
24974683|NCT00095979|50063035|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
25075444|NCT02514746|50182993|FG000|Overall Study|Withdrawal by Subject|12|||
25075445|NCT02514746|50182994|FG001|Overall Study|Withdrawal by Subject|10|||
25075446|NCT02514746|50182993|FG000|Overall Study|Other|5|||
25192916|NCT01408628|50361021|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
24974684|NCT00082173|50063046|FG000|Overall Study|Withdrawal by Subject|3|||
24974685|NCT00082173|50063047|FG001|Overall Study|Withdrawal by Subject|5|||
24974686|NCT00082173|50063046|FG000|Overall Study|Lost to Follow-up|1|||
24974687|NCT00082173|50063047|FG001|Overall Study|Lost to Follow-up|0|||
24974688|NCT00082173|50063046|FG000|Overall Study|Adverse Event|1|||
24974689|NCT00082173|50063047|FG001|Overall Study|Adverse Event|0|||
24974690|NCT00082173|50063046|FG000|Overall Study|Culture negative or resistant at baselin|5|||
24974691|NCT00082173|50063047|FG001|Overall Study|Culture negative or resistant at baselin|6|||
25075447|NCT02514746|50182994|FG001|Overall Study|Other|1|||
25075448|NCT02483078|50183004|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
25075449|NCT02483078|50183005|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
25075450|NCT02483078|50183004|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
25075451|NCT02483078|50183005|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
25075452|NCT02483078|50183004|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
25075453|NCT02483078|50183005|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
25075454|NCT02483078|50183004|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
25075455|NCT02483078|50183005|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
25075456|NCT02483078|50183004|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
25314709|NCT00653263|50630509|FG000|Overall Study|Withdrawal by Subject|1|||
25314710|NCT00653263|50630509|FG000|Overall Study|Physician Decision|1|||
25075457|NCT02483078|50183005|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
25075458|NCT02483078|50183004|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
25075459|NCT02483078|50183005|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
25075460|NCT02452190|50183019|FG000|Overall Study|Withdrawal by Sponsor|1|||
25075461|NCT02452190|50183020|FG001|Overall Study|Withdrawal by Sponsor|3|||
25075462|NCT02452190|50183019|FG000|Overall Study|Pregnancy|1|||
25075463|NCT02452190|50183020|FG001|Overall Study|Pregnancy|0|||
25075464|NCT02452190|50183019|FG000|Overall Study|Investigator's Decision|2|||
25075465|NCT02452190|50183020|FG001|Overall Study|Investigator's Decision|0|||
25075466|NCT02452190|50183019|FG000|Overall Study|Lack of Efficacy|3|||
25075467|NCT02452190|50183020|FG001|Overall Study|Lack of Efficacy|1|||
25075468|NCT02452190|50183019|FG000|Overall Study|Lost to Follow-up|4|||
25075469|NCT02452190|50183020|FG001|Overall Study|Lost to Follow-up|3|||
25075470|NCT02452190|50183019|FG000|Overall Study|Adverse Event|2|||
25075471|NCT02452190|50183020|FG001|Overall Study|Adverse Event|5|||
25075472|NCT02452190|50183019|FG000|Overall Study|Withdrawal by Subject|20|||
25075473|NCT02452190|50183020|FG001|Overall Study|Withdrawal by Subject|11|||
25075474|NCT02452190|50183019|FG000|Overall Study|Noncompliance with study drug|1|||
25314711|NCT00842361|50630515|FG000|Overall Study|Protocol Violation|1|||
25314712|NCT00842361|50630516|FG001|Overall Study|Protocol Violation|0|||
25314713|NCT00842361|50630515|FG000|Overall Study|Unclassified|0|||
25314714|NCT00842361|50630516|FG001|Overall Study|Unclassified|2|||
25075475|NCT02452190|50183020|FG001|Overall Study|Noncompliance with study drug|0|||
25075476|NCT02452190|50183019|FG000|Overall Study|Participant traveled abroad|1|||
25075477|NCT02452190|50183020|FG001|Overall Study|Participant traveled abroad|0|||
25075478|NCT02452190|50183019|FG000|Overall Study|Death|0|||
25075479|NCT02452190|50183020|FG001|Overall Study|Death|1|||
25075480|NCT02514122|50183028|FG000|Overall Study|Withdrawal by Subject|2|||
25075481|NCT02514122|50183029|FG001|Overall Study|Withdrawal by Subject|0|||
25075482|NCT00730639|50183040|FG000|Overall Study|Adverse Event|3|||
25075483|NCT00730639|50183041|FG001|Overall Study|Adverse Event|0|||
25314715|NCT00841035|50630522|FG000|Phase 1 Overall Study|Physician Decision|13|||
25314716|NCT00642811|50630533|FG000|Overall Study|Adverse Event|2|||
25314717|NCT00642811|50630534|FG001|Overall Study|Adverse Event|3|||
25314718|NCT00642811|50630535|FG002|Overall Study|Adverse Event|0|||
25075484|NCT00730639|50183042|FG002|Overall Study|Adverse Event|9|||
25075485|NCT00730639|50183043|FG003|Overall Study|Adverse Event|8|||
25075486|NCT00730639|50183044|FG004|Overall Study|Adverse Event|23|||
25075487|NCT00730639|50183040|FG000|Overall Study|Complete Response|0|||
25075488|NCT00730639|50183041|FG001|Overall Study|Complete Response|0|||
25075489|NCT00730639|50183042|FG002|Overall Study|Complete Response|2|||
25075490|NCT00730639|50183043|FG003|Overall Study|Complete Response|2|||
25075491|NCT00730639|50183044|FG004|Overall Study|Complete Response|1|||
25075492|NCT00730639|50183040|FG000|Overall Study|Completed Maximum Cycles|0|||
25314719|NCT00642811|50630536|FG003|Overall Study|Adverse Event|0|||
25314720|NCT00642811|50630537|FG004|Overall Study|Adverse Event|0|||
25314721|NCT00642811|50630538|FG005|Overall Study|Adverse Event|1|||
25075493|NCT00730639|50183041|FG001|Overall Study|Completed Maximum Cycles|0|||
25075494|NCT00730639|50183042|FG002|Overall Study|Completed Maximum Cycles|11|||
25075495|NCT00730639|50183043|FG003|Overall Study|Completed Maximum Cycles|3|||
25075496|NCT00730639|50183044|FG004|Overall Study|Completed Maximum Cycles|6|||
25075497|NCT00730639|50183040|FG000|Overall Study|Death|0|||
25314722|NCT00642811|50630533|FG000|Overall Study|Developement of discontinuation criteria|0|||
25075498|NCT00730639|50183041|FG001|Overall Study|Death|0|||
25075499|NCT00730639|50183042|FG002|Overall Study|Death|0|||
25075500|NCT00730639|50183043|FG003|Overall Study|Death|0|||
25075501|NCT00730639|50183044|FG004|Overall Study|Death|2|||
25314723|NCT00642811|50630534|FG001|Overall Study|Developement of discontinuation criteria|0|||
25314724|NCT00642811|50630535|FG002|Overall Study|Developement of discontinuation criteria|0|||
25314725|NCT00642811|50630536|FG003|Overall Study|Developement of discontinuation criteria|0|||
25314726|NCT00642811|50630537|FG004|Overall Study|Developement of discontinuation criteria|1|||
25314727|NCT00642811|50630538|FG005|Overall Study|Developement of discontinuation criteria|0|||
25314728|NCT00642811|50630533|FG000|Overall Study|Severe Non-compliance to protocol|1|||
25314729|NCT00642811|50630534|FG001|Overall Study|Severe Non-compliance to protocol|0|||
25314730|NCT00642811|50630535|FG002|Overall Study|Severe Non-compliance to protocol|0|||
25314731|NCT00642811|50630536|FG003|Overall Study|Severe Non-compliance to protocol|0|||
25314732|NCT00642811|50630537|FG004|Overall Study|Severe Non-compliance to protocol|0|||
25314733|NCT00642811|50630538|FG005|Overall Study|Severe Non-compliance to protocol|0|||
25314734|NCT00642811|50630533|FG000|Overall Study|Other|0|||
25314735|NCT00642811|50630534|FG001|Overall Study|Other|1|||
25314736|NCT00642811|50630535|FG002|Overall Study|Other|0|||
25075502|NCT00730639|50183040|FG000|Overall Study|Disease Progression|12|||
25075503|NCT00730639|50183041|FG001|Overall Study|Disease Progression|13|||
25075504|NCT00730639|50183042|FG002|Overall Study|Disease Progression|48|||
25075505|NCT00730639|50183043|FG003|Overall Study|Disease Progression|32|||
25075506|NCT00730639|50183044|FG004|Overall Study|Disease Progression|88|||
25075507|NCT00730639|50183040|FG000|Overall Study|non-specified|0|||
25075508|NCT00730639|50183041|FG001|Overall Study|non-specified|0|||
25075509|NCT00730639|50183042|FG002|Overall Study|non-specified|4|||
25075510|NCT00730639|50183043|FG003|Overall Study|non-specified|2|||
25075511|NCT00730639|50183044|FG004|Overall Study|non-specified|3|||
25075512|NCT00730639|50183040|FG000|Overall Study|Protocol Violation|0|||
25075513|NCT00730639|50183041|FG001|Overall Study|Protocol Violation|0|||
25075514|NCT00730639|50183042|FG002|Overall Study|Protocol Violation|1|||
25075515|NCT00730639|50183043|FG003|Overall Study|Protocol Violation|0|||
25075516|NCT00730639|50183044|FG004|Overall Study|Protocol Violation|0|||
25075517|NCT00730639|50183040|FG000|Overall Study|Withdrawal by Subject|0|||
25075518|NCT00730639|50183041|FG001|Overall Study|Withdrawal by Subject|0|||
25075519|NCT00730639|50183042|FG002|Overall Study|Withdrawal by Subject|6|||
25075520|NCT00730639|50183043|FG003|Overall Study|Withdrawal by Subject|3|||
25075521|NCT00730639|50183044|FG004|Overall Study|Withdrawal by Subject|4|||
25075522|NCT00730639|50183040|FG000|Overall Study|Treatment on-going|2|||
25075523|NCT00730639|50183041|FG001|Overall Study|Treatment on-going|5|||
25075524|NCT00730639|50183042|FG002|Overall Study|Treatment on-going|5|||
25314737|NCT00642811|50630536|FG003|Overall Study|Other|1|||
25314738|NCT00642811|50630537|FG004|Overall Study|Other|0|||
25314739|NCT00642811|50630538|FG005|Overall Study|Other|0|||
25314740|NCT00838929|50630555|FG000|Overall Study|Protocol Violation|0|||
24974722|NCT00108069|50063080|FG000|Overall Study|Never rec'd study drug|0|||
24974723|NCT00108069|50063081|FG001|Overall Study|Never rec'd study drug|1|||
25075525|NCT00730639|50183043|FG003|Overall Study|Treatment on-going|4|||
25075526|NCT00730639|50183044|FG004|Overall Study|Treatment on-going|4|||
25075527|NCT02536339|50183067|FG000|Overall Study|Death|20|||
25075528|NCT02536339|50183067|FG000|Overall Study|Withdrawal by Subject|3|||
25075529|NCT02536339|50183067|FG000|Overall Study|Lost to Follow-up|2|||
25075530|NCT02536339|50183067|FG000|Overall Study|Treatment discontinued|2|||
25075531|NCT02536339|50183067|FG000|Overall Study|Physician Decision|1|||
25075532|NCT02743871|50183101|FG000|Overall Study|Lost to Follow-up|0|||
24974724|NCT00108069|50063080|FG000|Overall Study|Adverse Event|1|||
24974725|NCT00108069|50063081|FG001|Overall Study|Adverse Event|1|||
25075533|NCT02743871|50183102|FG001|Overall Study|Lost to Follow-up|0|||
25075534|NCT02743871|50183103|FG002|Overall Study|Lost to Follow-up|0|||
25075535|NCT02743871|50183104|FG003|Overall Study|Lost to Follow-up|1|||
25075536|NCT02743871|50183105|FG004|Overall Study|Lost to Follow-up|0|||
25075537|NCT02743871|50183106|FG005|Overall Study|Lost to Follow-up|0|||
25075538|NCT02743871|50183107|FG006|Overall Study|Lost to Follow-up|1|||
24974726|NCT00108069|50063080|FG000|Overall Study|Withdrawal by Subject|1|||
24974727|NCT00108069|50063081|FG001|Overall Study|Withdrawal by Subject|0|||
24974728|NCT00108069|50063080|FG000|Overall Study|Death|1|||
24974729|NCT00108069|50063081|FG001|Overall Study|Death|0|||
24974730|NCT00108069|50063080|FG000|Overall Study|Progessive disease|27|||
25075539|NCT02743871|50183108|FG007|Overall Study|Lost to Follow-up|0|||
25075540|NCT02743871|50183109|FG008|Overall Study|Lost to Follow-up|0|||
25075541|NCT02743871|50183110|FG009|Overall Study|Lost to Follow-up|0|||
25075542|NCT02743871|50183111|FG010|Overall Study|Lost to Follow-up|0|||
25075543|NCT02743871|50183112|FG011|Overall Study|Lost to Follow-up|2|||
25075544|NCT02743871|50183113|FG012|Overall Study|Lost to Follow-up|0|||
24974731|NCT00108069|50063081|FG001|Overall Study|Progessive disease|11|||
24974732|NCT00079274|50063100|FG000|Overall Study|Withdrawal by Subject|111|||
24974733|NCT00079274|50063101|FG001|Overall Study|Withdrawal by Subject|10|||
24974734|NCT00079274|50063102|FG002|Overall Study|Withdrawal by Subject|12|||
24974735|NCT00079274|50063103|FG003|Overall Study|Withdrawal by Subject|163|||
24974736|NCT00079274|50063104|FG004|Overall Study|Withdrawal by Subject|7|||
24974737|NCT00079274|50063105|FG005|Overall Study|Withdrawal by Subject|8|||
24974738|NCT00079274|50063106|FG006|Overall Study|Withdrawal by Subject|0|||
24974739|NCT00079274|50063100|FG000|Overall Study|Adverse Event|130|||
24974740|NCT00079274|50063101|FG001|Overall Study|Adverse Event|8|||
24974741|NCT00079274|50063102|FG002|Overall Study|Adverse Event|8|||
24974742|NCT00079274|50063103|FG003|Overall Study|Adverse Event|184|||
24974743|NCT00079274|50063104|FG004|Overall Study|Adverse Event|7|||
24974744|NCT00079274|50063105|FG005|Overall Study|Adverse Event|8|||
24974745|NCT00079274|50063106|FG006|Overall Study|Adverse Event|0|||
24974746|NCT00079274|50063100|FG000|Overall Study|Recurrence|21|||
24974747|NCT00079274|50063101|FG001|Overall Study|Recurrence|0|||
24974748|NCT00079274|50063102|FG002|Overall Study|Recurrence|1|||
25075545|NCT02743871|50183114|FG013|Overall Study|Lost to Follow-up|0|||
25075546|NCT02743871|50183101|FG000|Overall Study|Withdrawal by Subject|0|||
25075547|NCT02743871|50183102|FG001|Overall Study|Withdrawal by Subject|0|||
25075548|NCT02743871|50183103|FG002|Overall Study|Withdrawal by Subject|0|||
25075549|NCT02743871|50183104|FG003|Overall Study|Withdrawal by Subject|0|||
25075550|NCT02743871|50183105|FG004|Overall Study|Withdrawal by Subject|0|||
25075551|NCT02743871|50183106|FG005|Overall Study|Withdrawal by Subject|0|||
25075552|NCT02743871|50183107|FG006|Overall Study|Withdrawal by Subject|0|||
25075553|NCT02743871|50183108|FG007|Overall Study|Withdrawal by Subject|0|||
25075554|NCT02743871|50183109|FG008|Overall Study|Withdrawal by Subject|0|||
25075555|NCT02743871|50183110|FG009|Overall Study|Withdrawal by Subject|0|||
25075556|NCT02743871|50183111|FG010|Overall Study|Withdrawal by Subject|1|||
25075557|NCT02743871|50183112|FG011|Overall Study|Withdrawal by Subject|0|||
25075558|NCT02743871|50183113|FG012|Overall Study|Withdrawal by Subject|12|||
25075559|NCT02743871|50183114|FG013|Overall Study|Withdrawal by Subject|6|||
25075560|NCT02743871|50183101|FG000|Overall Study|Adverse Event|1|||
25075561|NCT02743871|50183102|FG001|Overall Study|Adverse Event|0|||
25075562|NCT02743871|50183103|FG002|Overall Study|Adverse Event|0|||
25075563|NCT02743871|50183104|FG003|Overall Study|Adverse Event|0|||
25075564|NCT02743871|50183105|FG004|Overall Study|Adverse Event|0|||
25075565|NCT02743871|50183106|FG005|Overall Study|Adverse Event|0|||
25075566|NCT02743871|50183107|FG006|Overall Study|Adverse Event|0|||
25075567|NCT02743871|50183108|FG007|Overall Study|Adverse Event|0|||
24974749|NCT00079274|50063103|FG003|Overall Study|Recurrence|15|||
24974750|NCT00079274|50063104|FG004|Overall Study|Recurrence|0|||
24974751|NCT00079274|50063105|FG005|Overall Study|Recurrence|2|||
24974752|NCT00079274|50063106|FG006|Overall Study|Recurrence|0|||
24974753|NCT00079274|50063100|FG000|Overall Study|Alternate Treatment|6|||
24974754|NCT00079274|50063101|FG001|Overall Study|Alternate Treatment|1|||
24974755|NCT00079274|50063102|FG002|Overall Study|Alternate Treatment|0|||
24974756|NCT00079274|50063103|FG003|Overall Study|Alternate Treatment|3|||
24974757|NCT00079274|50063104|FG004|Overall Study|Alternate Treatment|0|||
24974758|NCT00079274|50063105|FG005|Overall Study|Alternate Treatment|0|||
24974759|NCT00079274|50063106|FG006|Overall Study|Alternate Treatment|0|||
24974760|NCT00079274|50063100|FG000|Overall Study|Other Medical Problems|6|||
24974761|NCT00079274|50063101|FG001|Overall Study|Other Medical Problems|1|||
24974762|NCT00079274|50063102|FG002|Overall Study|Other Medical Problems|0|||
24974763|NCT00079274|50063103|FG003|Overall Study|Other Medical Problems|7|||
25075568|NCT02743871|50183109|FG008|Overall Study|Adverse Event|0|||
24974764|NCT00079274|50063104|FG004|Overall Study|Other Medical Problems|0|||
24974765|NCT00079274|50063105|FG005|Overall Study|Other Medical Problems|0|||
24974766|NCT00079274|50063106|FG006|Overall Study|Other Medical Problems|0|||
24974767|NCT00079274|50063100|FG000|Overall Study|Death|4|||
24974768|NCT00079274|50063101|FG001|Overall Study|Death|0|||
24974769|NCT00079274|50063102|FG002|Overall Study|Death|1|||
24974770|NCT00079274|50063103|FG003|Overall Study|Death|15|||
24974771|NCT00079274|50063104|FG004|Overall Study|Death|0|||
24974772|NCT00079274|50063105|FG005|Overall Study|Death|0|||
24974773|NCT00079274|50063106|FG006|Overall Study|Death|0|||
24974774|NCT00079274|50063100|FG000|Overall Study|Cytogenetic resistance|0|||
24974775|NCT00079274|50063101|FG001|Overall Study|Cytogenetic resistance|0|||
24974776|NCT00079274|50063102|FG002|Overall Study|Cytogenetic resistance|0|||
24974777|NCT00079274|50063103|FG003|Overall Study|Cytogenetic resistance|2|||
24974778|NCT00079274|50063104|FG004|Overall Study|Cytogenetic resistance|0|||
25075569|NCT02743871|50183110|FG009|Overall Study|Adverse Event|0|||
25075570|NCT02743871|50183111|FG010|Overall Study|Adverse Event|0|||
25075571|NCT02743871|50183112|FG011|Overall Study|Adverse Event|0|||
25075572|NCT02743871|50183113|FG012|Overall Study|Adverse Event|0|||
25075573|NCT02743871|50183114|FG013|Overall Study|Adverse Event|0|||
25075574|NCT02743871|50183101|FG000|Overall Study|Other|0|||
25075575|NCT02743871|50183102|FG001|Overall Study|Other|0|||
25075576|NCT02743871|50183103|FG002|Overall Study|Other|0|||
25075577|NCT02743871|50183104|FG003|Overall Study|Other|0|||
25075578|NCT02743871|50183105|FG004|Overall Study|Other|0|||
25075579|NCT02743871|50183106|FG005|Overall Study|Other|0|||
24974779|NCT00079274|50063105|FG005|Overall Study|Cytogenetic resistance|0|||
24974780|NCT00079274|50063106|FG006|Overall Study|Cytogenetic resistance|0|||
24974781|NCT00079274|50063100|FG000|Overall Study|Other|43|||
24974782|NCT00079274|50063101|FG001|Overall Study|Other|7|||
25075580|NCT02743871|50183107|FG006|Overall Study|Other|0|||
25075581|NCT02743871|50183108|FG007|Overall Study|Other|0|||
25075582|NCT02743871|50183109|FG008|Overall Study|Other|0|||
25075583|NCT02743871|50183110|FG009|Overall Study|Other|0|||
25075584|NCT02743871|50183111|FG010|Overall Study|Other|0|||
25075585|NCT02743871|50183112|FG011|Overall Study|Other|1|||
24974783|NCT00079274|50063102|FG002|Overall Study|Other|5|||
24974784|NCT00079274|50063103|FG003|Overall Study|Other|55|||
24974785|NCT00079274|50063104|FG004|Overall Study|Other|1|||
24974786|NCT00079274|50063105|FG005|Overall Study|Other|2|||
24974787|NCT00079274|50063106|FG006|Overall Study|Other|0|||
24974788|NCT00079040|50063119|FG000|Overall Study|Withdrew before treatment|1|||
24974789|NCT00079040|50063119|FG000|Overall Study|Ineligible|1|||
24974790|NCT00078806|50063123|FG000|Part 1A|Adverse Event|2|||
24974791|NCT00078806|50063124|FG001|Part 1A|Adverse Event|0|||
24974792|NCT00078806|50063125|FG002|Part 1A|Adverse Event|0|||
24974793|NCT00078806|50063126|FG003|Part 1A|Adverse Event|0|||
24974794|NCT00078806|50063123|FG000|Part 1A|Lack of Efficacy|7|||
25192917|NCT01408628|50361021|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
25192918|NCT01408628|50361021|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
25192919|NCT01389752|50361026|FG000|Study Period 1|Sponsor decision|0|||
25192920|NCT01389752|50361027|FG001|Study Period 1|Sponsor decision|2|||
24974795|NCT00078806|50063124|FG001|Part 1A|Lack of Efficacy|0|||
25075586|NCT02743871|50183113|FG012|Overall Study|Other|1|||
25192921|NCT01389752|50361026|FG000|Study Period 2|Sponsor decision|1|||
25192922|NCT01389752|50361027|FG001|Study Period 2|Sponsor decision|0|||
24974796|NCT00078806|50063125|FG002|Part 1A|Lack of Efficacy|0|||
24974797|NCT00078806|50063126|FG003|Part 1A|Lack of Efficacy|0|||
24974798|NCT00078806|50063123|FG000|Part 1A|Other|1|||
24974799|NCT00078806|50063124|FG001|Part 1A|Other|0|||
24974800|NCT00078806|50063125|FG002|Part 1A|Other|0|||
24974801|NCT00078806|50063126|FG003|Part 1A|Other|0|||
25075587|NCT02743871|50183114|FG013|Overall Study|Other|1|||
25192923|NCT01428128|50361034|FG000|Overall Study|Withdrawal by Subject|4|||
25075588|NCT02743871|50183101|FG000|Overall Study|Protocol Violation|0|||
25075589|NCT02743871|50183102|FG001|Overall Study|Protocol Violation|0|||
25075590|NCT02743871|50183103|FG002|Overall Study|Protocol Violation|0|||
25075591|NCT02743871|50183104|FG003|Overall Study|Protocol Violation|0|||
25075592|NCT02743871|50183105|FG004|Overall Study|Protocol Violation|0|||
25075593|NCT02743871|50183106|FG005|Overall Study|Protocol Violation|0|||
25075594|NCT02743871|50183107|FG006|Overall Study|Protocol Violation|0|||
25075595|NCT02743871|50183108|FG007|Overall Study|Protocol Violation|0|||
25075596|NCT02743871|50183109|FG008|Overall Study|Protocol Violation|0|||
25170140|NCT01819727|50304218|FG001|Overall Study|Pregnancy|0|||
25170141|NCT01819727|50304217|FG000|Overall Study|Protocol Violation|0|||
25170142|NCT01819727|50304218|FG001|Overall Study|Protocol Violation|2|||
25314741|NCT00838929|50630556|FG001|Overall Study|Protocol Violation|1|||
25314742|NCT00838929|50630557|FG002|Overall Study|Protocol Violation|0|||
25314743|NCT00838929|50630555|FG000|Overall Study|Disease progression|0|||
25314744|NCT00838929|50630556|FG001|Overall Study|Disease progression|2|||
25314745|NCT00838929|50630557|FG002|Overall Study|Disease progression|1|||
24974802|NCT00078806|50063123|FG000|Part 1B|Adverse Event|1|||
24974803|NCT00078806|50063124|FG001|Part 1B|Adverse Event|0|||
24974804|NCT00078806|50063125|FG002|Part 1B|Adverse Event|0|||
24974805|NCT00078806|50063126|FG003|Part 1B|Adverse Event|0|||
24974806|NCT00078806|50063123|FG000|Part 1B|Lack of Efficacy|7|||
24974807|NCT00078806|50063124|FG001|Part 1B|Lack of Efficacy|0|||
24974808|NCT00078806|50063125|FG002|Part 1B|Lack of Efficacy|0|||
24974809|NCT00078806|50063126|FG003|Part 1B|Lack of Efficacy|0|||
24974810|NCT00078806|50063123|FG000|Part 2|Adverse Event|0|||
24974811|NCT00078806|50063124|FG001|Part 2|Adverse Event|1|||
24974812|NCT00078806|50063125|FG002|Part 2|Adverse Event|0|||
25314746|NCT00916058|50630570|FG000|Phase 1|Screen Failure|0|||
24974813|NCT00078806|50063126|FG003|Part 2|Adverse Event|0|||
24974814|NCT00078338|50063143|FG000|Overall Study|Adverse Event|31|||
24974815|NCT00078338|50063144|FG001|Overall Study|Adverse Event|24|||
24974816|NCT00078338|50063143|FG000|Overall Study|Lost to Follow-up|17|||
24974817|NCT00078338|50063144|FG001|Overall Study|Lost to Follow-up|2|||
24974818|NCT00078338|50063143|FG000|Overall Study|Protocol Violation|2|||
25314747|NCT00916058|50630571|FG001|Phase 1|Screen Failure|0|||
25314748|NCT00916058|50630572|FG002|Phase 1|Screen Failure|0|||
25314749|NCT00916058|50630573|FG003|Phase 1|Screen Failure|0|||
25314750|NCT00916058|50630574|FG004|Phase 1|Screen Failure|0|||
25314751|NCT00916058|50630575|FG005|Phase 1|Screen Failure|1|||
25314752|NCT00916058|50630576|FG006|Phase 1|Screen Failure|0|||
25314753|NCT00916058|50630570|FG000|Phase 2|Screen Failure|0|||
25314754|NCT00916058|50630571|FG001|Phase 2|Screen Failure|0|||
25314755|NCT00916058|50630572|FG002|Phase 2|Screen Failure|0|||
25314756|NCT00916058|50630573|FG003|Phase 2|Screen Failure|0|||
25314757|NCT00916058|50630574|FG004|Phase 2|Screen Failure|0|||
25314758|NCT00916058|50630575|FG005|Phase 2|Screen Failure|0|||
25314759|NCT00916058|50630576|FG006|Phase 2|Screen Failure|3|||
25314760|NCT00912782|50630596|FG000|Overall Study|Death|2|||
25314761|NCT00912782|50630597|FG001|Overall Study|Death|1|||
25314762|NCT00912782|50630596|FG000|Overall Study|Lost to Follow-up|0|||
25314763|NCT00912782|50630597|FG001|Overall Study|Lost to Follow-up|1|||
25314764|NCT00912782|50630596|FG000|Overall Study|Did not receive vascular access type|1|||
25314765|NCT00912782|50630597|FG001|Overall Study|Did not receive vascular access type|2|||
25314766|NCT00912782|50630596|FG000|Overall Study|Relocated before study completion|0|||
25314767|NCT00912782|50630597|FG001|Overall Study|Relocated before study completion|1|||
25314768|NCT03444038|50630603|FG000|Overall Study|Adverse Event|12|||
25314769|NCT03444038|50630603|FG000|Overall Study|Withdrawal by Subject|7|||
24974819|NCT00078338|50063144|FG001|Overall Study|Protocol Violation|2|||
24974820|NCT00078338|50063143|FG000|Overall Study|Disease Progression|4|||
24974821|NCT00078338|50063144|FG001|Overall Study|Disease Progression|7|||
24974822|NCT00078338|50063143|FG000|Overall Study|Other|28|||
24974823|NCT00078338|50063144|FG001|Overall Study|Other|16|||
24974824|NCT00078338|50063143|FG000|Overall Study|Subjects randomized, but not treated|3|||
24974825|NCT00078338|50063144|FG001|Overall Study|Subjects randomized, but not treated|3|||
24974826|NCT03808688|50063152|FG000|Overall Study|Adverse Event|13|||
24974827|NCT03808688|50063153|FG001|Overall Study|Adverse Event|17|||
24974828|NCT03808688|50063152|FG000|Overall Study|Lack of Efficacy|2|||
24974829|NCT03808688|50063153|FG001|Overall Study|Lack of Efficacy|0|||
24974830|NCT03808688|50063152|FG000|Overall Study|Lost to Follow-up|0|||
24974831|NCT03808688|50063153|FG001|Overall Study|Lost to Follow-up|2|||
24974832|NCT03808688|50063152|FG000|Overall Study|Withdrawal by Subject|1|||
24974833|NCT03808688|50063153|FG001|Overall Study|Withdrawal by Subject|0|||
25170143|NCT01819727|50304217|FG000|Overall Study|Study Terminated by Sponsor|0|||
25314770|NCT03444038|50630603|FG000|Overall Study|Lost to Follow-up|1|||
25314771|NCT03444038|50630603|FG000|Overall Study|Physician Decision|2|||
25314772|NCT03444038|50630603|FG000|Overall Study|Lack of Efficacy|7|||
25314773|NCT00911534|50630609|FG000|Overall Study|Adverse Event|4|||
25314774|NCT00911534|50630610|FG001|Overall Study|Adverse Event|4|||
25314775|NCT00911534|50630609|FG000|Overall Study|Lost to Follow-up|2|||
25314776|NCT00911534|50630610|FG001|Overall Study|Lost to Follow-up|4|||
25314777|NCT00911534|50630609|FG000|Overall Study|Withdrawal by Subject|2|||
24974834|NCT03808688|50063152|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
24974835|NCT03808688|50063153|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
24974836|NCT03808688|50063152|FG000|Overall Study|IOP Too High|1|||
24974837|NCT03808688|50063153|FG001|Overall Study|IOP Too High|1|||
24974838|NCT03808688|50063152|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
24974839|NCT03808688|50063153|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
24974840|NCT03808688|50063152|FG000|Overall Study|Visit Out of Window|0|||
24974841|NCT03808688|50063153|FG001|Overall Study|Visit Out of Window|1|||
24974842|NCT03808688|50063152|FG000|Overall Study|Medication Non-Compliance|0|||
24974843|NCT03808688|50063153|FG001|Overall Study|Medication Non-Compliance|1|||
24974844|NCT03808298|50063161|FG000|Overall Study|Adverse Event|3|||
24974845|NCT03808298|50063161|FG000|Overall Study|Physician Decision|1|||
24974846|NCT03808298|50063161|FG000|Overall Study|Withdrawal by Subject|1|||
24974847|NCT03808298|50063161|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
24974848|NCT00077636|50063192|FG000|Overall Study|Refused Treatment|9|||
24974849|NCT00077636|50063193|FG001|Overall Study|Refused Treatment|31|||
24974850|NCT00077636|50063192|FG000|Overall Study|Admin|3|||
24974851|NCT00077636|50063193|FG001|Overall Study|Admin|3|||
24974852|NCT00077636|50063192|FG000|Overall Study|Withdrawal by Subject|2|||
24974853|NCT00077636|50063193|FG001|Overall Study|Withdrawal by Subject|2|||
24974854|NCT00077636|50063192|FG000|Overall Study|Adverse Event|17|||
24974855|NCT00077636|50063193|FG001|Overall Study|Adverse Event|34|||
24974856|NCT00077636|50063192|FG000|Overall Study|Protocol Violation|0|||
24974857|NCT00077636|50063193|FG001|Overall Study|Protocol Violation|2|||
24974858|NCT00077636|50063192|FG000|Overall Study|Lost to Follow-up|10|||
24974859|NCT00077636|50063193|FG001|Overall Study|Lost to Follow-up|18|||
24974860|NCT00077636|50063192|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
24974861|NCT00077636|50063193|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
24974862|NCT00095199|50063204|FG000|Overall Study|Adverse Event|40|||
24974863|NCT00095199|50063205|FG001|Overall Study|Adverse Event|22|||
24974864|NCT00095199|50063206|FG002|Overall Study|Adverse Event|26|||
24974865|NCT00095199|50063207|FG003|Overall Study|Adverse Event|11|||
24974866|NCT00095199|50063204|FG000|Overall Study|Progressive disease|213|||
24974867|NCT00095199|50063205|FG001|Overall Study|Progressive disease|179|||
24974868|NCT00095199|50063206|FG002|Overall Study|Progressive disease|105|||
24974869|NCT00095199|50063207|FG003|Overall Study|Progressive disease|98|||
24974870|NCT00095199|50063204|FG000|Overall Study|Death|10|||
24974871|NCT00095199|50063205|FG001|Overall Study|Death|6|||
24974872|NCT00095199|50063206|FG002|Overall Study|Death|11|||
24974873|NCT00095199|50063207|FG003|Overall Study|Death|9|||
24974874|NCT00095199|50063204|FG000|Overall Study|Withdrawal by Subject|21|||
24974875|NCT00095199|50063205|FG001|Overall Study|Withdrawal by Subject|16|||
24974876|NCT00095199|50063206|FG002|Overall Study|Withdrawal by Subject|13|||
25075597|NCT02743871|50183110|FG009|Overall Study|Protocol Violation|0|||
25075598|NCT02743871|50183111|FG010|Overall Study|Protocol Violation|0|||
25075599|NCT02743871|50183112|FG011|Overall Study|Protocol Violation|0|||
25075600|NCT02743871|50183113|FG012|Overall Study|Protocol Violation|2|||
25075601|NCT02743871|50183114|FG013|Overall Study|Protocol Violation|0|||
25075602|NCT01704547|50183156|FG000|Overall Study|Physician Decision|4|||
25192924|NCT01428128|50361034|FG000|Overall Study|Screen failure by p53|10|||
24974877|NCT00095199|50063207|FG003|Overall Study|Withdrawal by Subject|22|||
24974878|NCT00095199|50063204|FG000|Overall Study|Protocol Violation|4|||
24974879|NCT00095199|50063205|FG001|Overall Study|Protocol Violation|4|||
24974880|NCT00095199|50063206|FG002|Overall Study|Protocol Violation|2|||
24974881|NCT00095199|50063207|FG003|Overall Study|Protocol Violation|0|||
24974882|NCT00095199|50063204|FG000|Overall Study|Liver function test results elevated|0|||
25075603|NCT01704547|50183156|FG000|Overall Study|Withdrawal by Subject|1|||
25075604|NCT00796523|50183176|FG000|Overall Study|Lost to Follow-up|9|||
24974883|NCT00095199|50063205|FG001|Overall Study|Liver function test results elevated|0|||
24974884|NCT00095199|50063206|FG002|Overall Study|Liver function test results elevated|1|||
24974885|NCT00095199|50063207|FG003|Overall Study|Liver function test results elevated|1|||
24974886|NCT00095199|50063204|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
25075605|NCT00796523|50183177|FG001|Overall Study|Lost to Follow-up|7|||
25075606|NCT01352585|50183192|FG000|Overall Study|Adverse Event|2|||
25075607|NCT01352585|50183193|FG001|Overall Study|Adverse Event|1|||
25075608|NCT01352585|50183192|FG000|Overall Study|Lost to Follow-up|1|||
25075609|NCT01352585|50183193|FG001|Overall Study|Lost to Follow-up|0|||
25075610|NCT01352585|50183192|FG000|Overall Study|Other|5|||
25075611|NCT01352585|50183193|FG001|Overall Study|Other|2|||
25075612|NCT01352507|50183202|FG000|Treatment Period 1|Adverse Event|3|||
25075613|NCT01352507|50183203|FG001|Treatment Period 1|Adverse Event|0|||
25075614|NCT01352507|50183202|FG000|Treatment Period 1|Lost to Follow-up|3|||
25075615|NCT01352507|50183203|FG001|Treatment Period 1|Lost to Follow-up|4|||
25075616|NCT01352507|50183202|FG000|Treatment Period 1|Withdrawal by Subject|7|||
25075617|NCT01352507|50183203|FG001|Treatment Period 1|Withdrawal by Subject|5|||
25075618|NCT01352507|50183202|FG000|Treatment Period 1|Physician Decision|1|||
25075619|NCT01352507|50183203|FG001|Treatment Period 1|Physician Decision|0|||
25075620|NCT01352507|50183202|FG000|Washout Period|Withdrawal by Subject|0|||
25075621|NCT01352507|50183203|FG001|Washout Period|Withdrawal by Subject|1|||
25075622|NCT01352507|50183202|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
25075623|NCT01352507|50183203|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
25075624|NCT01352507|50183202|FG000|Treatment Period 2|Withdrawal by Subject|4|||
25075625|NCT01352507|50183203|FG001|Treatment Period 2|Withdrawal by Subject|3|||
25075626|NCT01352507|50183202|FG000|Treatment Period 2|Lack of Efficacy|1|||
25075627|NCT01352507|50183203|FG001|Treatment Period 2|Lack of Efficacy|0|||
25075628|NCT02361346|50183224|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
25075629|NCT02361346|50183225|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
25075630|NCT02361346|50183226|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
25075631|NCT02361346|50183227|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
25075632|NCT02361346|50183228|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
25075633|NCT02361346|50183229|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
25075634|NCT02361346|50183230|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
25075635|NCT02361346|50183231|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
25075636|NCT02361346|50183232|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
25075637|NCT02361346|50183224|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
25314778|NCT00911534|50630610|FG001|Overall Study|Withdrawal by Subject|1|||
25314779|NCT00911534|50630609|FG000|Overall Study|Lack of Efficacy|4|||
25314780|NCT00911534|50630610|FG001|Overall Study|Lack of Efficacy|1|||
25075638|NCT02361346|50183225|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
25075639|NCT02361346|50183226|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
25075640|NCT02361346|50183227|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
25075641|NCT02361346|50183228|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
25075642|NCT02361346|50183229|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
25075643|NCT02361346|50183230|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
25075644|NCT02361346|50183231|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
25075645|NCT02361346|50183232|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
25075646|NCT02361346|50183224|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
25075647|NCT02361346|50183225|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
25075648|NCT02361346|50183226|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
25075649|NCT02361346|50183227|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
25075650|NCT02361346|50183228|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
25075651|NCT02361346|50183229|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
25075652|NCT02361346|50183230|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
25075653|NCT02361346|50183231|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
24974887|NCT00095199|50063205|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
25075654|NCT02361346|50183232|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
25075655|NCT02361346|50183224|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
25075656|NCT02361346|50183225|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
25075657|NCT02361346|50183226|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
25075658|NCT02361346|50183227|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
25314781|NCT00911534|50630609|FG000|Overall Study|Withdrawal of consent|1|||
24974888|NCT00095199|50063206|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
24974889|NCT00095199|50063207|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
24974890|NCT00095199|50063204|FG000|Overall Study|Physician Decision|5|||
24974891|NCT00095199|50063205|FG001|Overall Study|Physician Decision|6|||
24974892|NCT00095199|50063206|FG002|Overall Study|Physician Decision|1|||
24974893|NCT00095199|50063207|FG003|Overall Study|Physician Decision|1|||
24974894|NCT00095199|50063204|FG000|Overall Study|Not eligible|1|||
24974895|NCT00095199|50063205|FG001|Overall Study|Not eligible|7|||
25192925|NCT01428128|50361034|FG000|Overall Study|Received Neulasta in one cycle|2|||
25192926|NCT01428128|50361034|FG000|Overall Study|Adverse Event|1|||
25192927|NCT01407926|50361039|FG000|Overall Study|Lost to Follow-up|55|||
25192928|NCT01427972|50361066|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
25192929|NCT01427972|50361067|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
25192930|NCT01427972|50361068|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
25192931|NCT01427972|50361069|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
25192932|NCT01427972|50361070|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
25192933|NCT01427972|50361071|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
25192934|NCT01427972|50361072|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
25192935|NCT01427972|50361073|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
25192936|NCT01427972|50361074|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
25192937|NCT01427972|50361075|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
25192938|NCT01427972|50361076|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
25192939|NCT01427972|50361077|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
25192940|NCT01427972|50361066|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
25192941|NCT01427972|50361067|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
25192942|NCT01427972|50361068|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
25192943|NCT01427972|50361069|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
25192944|NCT01427972|50361070|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
25192945|NCT01427972|50361071|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
25192946|NCT01427972|50361072|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
25192947|NCT01427972|50361073|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
25192948|NCT01427972|50361074|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
25192949|NCT01427972|50361075|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
25192950|NCT01427972|50361076|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
25192951|NCT01427972|50361077|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
25192952|NCT01427972|50361066|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
25192953|NCT01427972|50361067|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
25192954|NCT01427972|50361068|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
25192955|NCT01427972|50361069|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
25192956|NCT01427972|50361070|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
25192957|NCT01427972|50361071|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
25192958|NCT01427972|50361072|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
25192959|NCT01427972|50361073|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
25192960|NCT01427972|50361074|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
25192961|NCT01427972|50361075|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
25192962|NCT01427972|50361076|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
24974896|NCT00095199|50063206|FG002|Overall Study|Not eligible|0|||
24974897|NCT00095199|50063207|FG003|Overall Study|Not eligible|1|||
24974898|NCT00095199|50063204|FG000|Overall Study|Started Palliative Radiotherapy|1|||
25075659|NCT02361346|50183228|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
24974899|NCT00095199|50063205|FG001|Overall Study|Started Palliative Radiotherapy|0|||
24974900|NCT00095199|50063206|FG002|Overall Study|Started Palliative Radiotherapy|0|||
24974901|NCT00095199|50063207|FG003|Overall Study|Started Palliative Radiotherapy|0|||
24974902|NCT00095199|50063204|FG000|Overall Study|Started radiotherapy regimen|0|||
24974903|NCT00095199|50063205|FG001|Overall Study|Started radiotherapy regimen|1|||
24974904|NCT00095199|50063206|FG002|Overall Study|Started radiotherapy regimen|0|||
24974905|NCT00095199|50063207|FG003|Overall Study|Started radiotherapy regimen|0|||
24974906|NCT00095199|50063204|FG000|Overall Study|Primary tumor removed in other surgery|0|||
24974907|NCT00095199|50063205|FG001|Overall Study|Primary tumor removed in other surgery|1|||
24974908|NCT00095199|50063206|FG002|Overall Study|Primary tumor removed in other surgery|0|||
24974909|NCT00095199|50063207|FG003|Overall Study|Primary tumor removed in other surgery|0|||
24974910|NCT00095199|50063204|FG000|Overall Study|Data inadvertently lost by site|1|||
24974911|NCT00095199|50063205|FG001|Overall Study|Data inadvertently lost by site|0|||
24974912|NCT00095199|50063206|FG002|Overall Study|Data inadvertently lost by site|0|||
24974913|NCT00095199|50063207|FG003|Overall Study|Data inadvertently lost by site|0|||
24974914|NCT00075764|50063224|FG000|Overall Study|Adverse Event|5|||
24974915|NCT00075764|50063225|FG001|Overall Study|Adverse Event|12|||
24974916|NCT00075764|50063224|FG000|Overall Study|Death|4|||
24974917|NCT00075764|50063225|FG001|Overall Study|Death|8|||
24974918|NCT00075764|50063224|FG000|Overall Study|Withdrawal by Subject|28|||
25075660|NCT02361346|50183229|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
25075661|NCT02361346|50183230|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
25075662|NCT02361346|50183231|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
25075663|NCT02361346|50183232|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
25075664|NCT02361346|50183224|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
25075665|NCT02361346|50183225|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
25075666|NCT02361346|50183226|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
25075667|NCT02361346|50183227|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
25075668|NCT02361346|50183228|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
25075669|NCT02361346|50183229|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
25075670|NCT02361346|50183230|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
25075671|NCT02361346|50183231|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
25075672|NCT02361346|50183232|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
25075673|NCT02361346|50183224|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
25192963|NCT01427972|50361077|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
24974919|NCT00075764|50063225|FG001|Overall Study|Withdrawal by Subject|18|||
24974920|NCT00075764|50063224|FG000|Overall Study|Progression|269|||
24974921|NCT00075764|50063225|FG001|Overall Study|Progression|274|||
24974922|NCT00075764|50063224|FG000|Overall Study|Still on treatment|8|||
24974923|NCT00075764|50063225|FG001|Overall Study|Still on treatment|15|||
25192964|NCT01427738|50361114|FG000|Overall Study|Death|12|||
25192965|NCT01427738|50361115|FG001|Overall Study|Death|9|||
25192966|NCT01427738|50361114|FG000|Overall Study|Severe debilitation, unable to continue|0|||
25192967|NCT01427738|50361115|FG001|Overall Study|Severe debilitation, unable to continue|1|||
25192968|NCT01427738|50361114|FG000|Overall Study|Subject unable to get to clinic|5|||
25192969|NCT01427738|50361115|FG001|Overall Study|Subject unable to get to clinic|2|||
25192970|NCT01427738|50361114|FG000|Overall Study|Withdrawal by Subject|0|||
25192971|NCT01427738|50361115|FG001|Overall Study|Withdrawal by Subject|2|||
25192972|NCT01427738|50361114|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
25192973|NCT01427738|50361115|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
25192974|NCT01427738|50361114|FG000|Overall Study|Lost to Follow-up|1|||
24974924|NCT00075764|50063224|FG000|Overall Study|Delinquent|4|||
24974925|NCT00075764|50063225|FG001|Overall Study|Delinquent|2|||
24974926|NCT00075764|50063224|FG000|Overall Study|Not protocol specified|27|||
24974927|NCT00075764|50063225|FG001|Overall Study|Not protocol specified|19|||
25075674|NCT02361346|50183225|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
24974928|NCT00075764|50063224|FG000|Overall Study|Under review|0|||
25075675|NCT02361346|50183226|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
25075676|NCT02361346|50183227|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
25075677|NCT02361346|50183228|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
25075678|NCT02361346|50183229|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
25075679|NCT02361346|50183230|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
25075680|NCT02361346|50183231|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
25075681|NCT02361346|50183232|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
25075682|NCT02267278|50183274|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
25075683|NCT02267278|50183274|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
25075684|NCT02267278|50183274|FG000|Overall Study|Developed new cancer diagnoses|2|||
25075685|NCT02267278|50183274|FG000|Overall Study|prescribed prohibited medication|1|||
25075686|NCT02360098|50183280|FG000|Overall Study|Physician Decision|7|||
25075687|NCT02266888|50183291|FG000|Overall Study|Death|2|||
25075688|NCT02266888|50183292|FG001|Overall Study|Death|2|||
25075689|NCT02266888|50183293|FG002|Overall Study|Death|4|||
25075690|NCT02266888|50183294|FG003|Overall Study|Death|2|||
25075691|NCT02266888|50183291|FG000|Overall Study|Physician Decision|0|||
25075692|NCT02266888|50183292|FG001|Overall Study|Physician Decision|1|||
25075693|NCT02266888|50183293|FG002|Overall Study|Physician Decision|2|||
25075694|NCT02266888|50183294|FG003|Overall Study|Physician Decision|2|||
25075695|NCT02266888|50183291|FG000|Overall Study|Study Terminated|5|||
25075696|NCT02266888|50183292|FG001|Overall Study|Study Terminated|1|||
25075697|NCT02266888|50183293|FG002|Overall Study|Study Terminated|0|||
25075698|NCT02266888|50183294|FG003|Overall Study|Study Terminated|0|||
25075699|NCT02266888|50183291|FG000|Overall Study|No Longer Eligible|0|||
25075700|NCT02266888|50183292|FG001|Overall Study|No Longer Eligible|0|||
25075701|NCT02266888|50183293|FG002|Overall Study|No Longer Eligible|0|||
25075702|NCT02266888|50183294|FG003|Overall Study|No Longer Eligible|2|||
25075703|NCT02266888|50183291|FG000|Overall Study|Randomization Closed|0|||
25075704|NCT02266888|50183292|FG001|Overall Study|Randomization Closed|0|||
25075705|NCT02266888|50183293|FG002|Overall Study|Randomization Closed|4|||
25075706|NCT02266888|50183294|FG003|Overall Study|Randomization Closed|0|||
25075707|NCT02266888|50183291|FG000|Overall Study|Personnel unavailable at transplant|0|||
25075708|NCT02266888|50183292|FG001|Overall Study|Personnel unavailable at transplant|0|||
25075709|NCT02266888|50183293|FG002|Overall Study|Personnel unavailable at transplant|0|||
25075710|NCT02266888|50183294|FG003|Overall Study|Personnel unavailable at transplant|1|||
25075711|NCT02266888|50183291|FG000|Overall Study|Transfer of care|0|||
25075712|NCT02266888|50183292|FG001|Overall Study|Transfer of care|0|||
25075713|NCT02266888|50183293|FG002|Overall Study|Transfer of care|1|||
25075714|NCT02266888|50183294|FG003|Overall Study|Transfer of care|0|||
25075715|NCT01641952|50183302|FG000|Overall Study|Lost to Follow-up|28|||
25075716|NCT01641952|50183302|FG000|Overall Study|Adverse Event|6|||
25075717|NCT02359552|50183308|FG000|Overall Study|Lost to Follow-up|3|||
25075718|NCT02359552|50183309|FG001|Overall Study|Lost to Follow-up|4|||
25075719|NCT02743793|50183317|FG000|Overall Study|Death|1|||
25075720|NCT02743793|50183318|FG001|Overall Study|Death|1|||
25075721|NCT02743793|50183317|FG000|Overall Study|Withdrawal by Subject|0|||
25075722|NCT02743793|50183318|FG001|Overall Study|Withdrawal by Subject|1|||
25075723|NCT02743793|50183317|FG000|Overall Study|Screen Failure|4|||
25075724|NCT02743793|50183318|FG001|Overall Study|Screen Failure|0|||
25075725|NCT02743793|50183317|FG000|Overall Study|No Primary Care Physician|0|||
25075726|NCT02743793|50183318|FG001|Overall Study|No Primary Care Physician|1|||
25075727|NCT02743793|50183317|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
25075728|NCT02743793|50183318|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
25075729|NCT02743793|50183317|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
25075730|NCT02743793|50183318|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
25314782|NCT00911534|50630610|FG001|Overall Study|Withdrawal of consent|4|||
24974929|NCT00075764|50063225|FG001|Overall Study|Under review|1|||
24974930|NCT03568162|50063239|FG000|Overall Study|Adverse Event|0|||
24974931|NCT03568162|50063240|FG001|Overall Study|Adverse Event|1|||
25075731|NCT00152009|50183327|FG000|Overall Study|Adverse Event|9|||
25075732|NCT00152009|50183328|FG001|Overall Study|Adverse Event|13|||
25075733|NCT00152009|50183329|FG002|Overall Study|Adverse Event|20|||
25075734|NCT00152009|50183330|FG003|Overall Study|Adverse Event|1|||
25075735|NCT00152009|50183327|FG000|Overall Study|Protocol Violation|3|||
25075736|NCT00152009|50183328|FG001|Overall Study|Protocol Violation|0|||
25075737|NCT00152009|50183329|FG002|Overall Study|Protocol Violation|0|||
25075738|NCT00152009|50183330|FG003|Overall Study|Protocol Violation|1|||
25075739|NCT00152009|50183327|FG000|Overall Study|Withdrawal by Subject|2|||
25075740|NCT00152009|50183328|FG001|Overall Study|Withdrawal by Subject|3|||
25075741|NCT00152009|50183329|FG002|Overall Study|Withdrawal by Subject|4|||
25075742|NCT00152009|50183330|FG003|Overall Study|Withdrawal by Subject|9|||
25075743|NCT00152009|50183327|FG000|Overall Study|Lost to Follow-up|2|||
25075744|NCT00152009|50183328|FG001|Overall Study|Lost to Follow-up|4|||
25075745|NCT00152009|50183329|FG002|Overall Study|Lost to Follow-up|3|||
25075746|NCT00152009|50183330|FG003|Overall Study|Lost to Follow-up|3|||
25314783|NCT00911534|50630609|FG000|Overall Study|Other|2|||
24974932|NCT03568162|50063241|FG002|Overall Study|Adverse Event|2|||
25075747|NCT00152009|50183327|FG000|Overall Study|Lack of Efficacy|8|||
25075748|NCT00152009|50183328|FG001|Overall Study|Lack of Efficacy|6|||
25075749|NCT00152009|50183329|FG002|Overall Study|Lack of Efficacy|7|||
25075750|NCT00152009|50183330|FG003|Overall Study|Lack of Efficacy|15|||
25075751|NCT00152009|50183327|FG000|Overall Study|ECG abnormalities|2|||
25075752|NCT00152009|50183328|FG001|Overall Study|ECG abnormalities|2|||
25075753|NCT00152009|50183329|FG002|Overall Study|ECG abnormalities|2|||
25075754|NCT00152009|50183330|FG003|Overall Study|ECG abnormalities|1|||
25075755|NCT00152009|50183327|FG000|Overall Study|Sponsor's decision|3|||
25075756|NCT00152009|50183328|FG001|Overall Study|Sponsor's decision|3|||
25075757|NCT00152009|50183329|FG002|Overall Study|Sponsor's decision|1|||
25075758|NCT00152009|50183330|FG003|Overall Study|Sponsor's decision|3|||
25075759|NCT02265952|50183340|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
25075760|NCT02265952|50183341|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
25075761|NCT02265952|50183340|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
25075762|NCT02265952|50183341|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
25075763|NCT02265796|50183349|FG000|Overall Study|Death|1|||
25075764|NCT02265796|50183350|FG001|Overall Study|Death|0|||
25075765|NCT02265796|50183349|FG000|Overall Study|started on excluded medication|1|||
25075766|NCT02265796|50183350|FG001|Overall Study|started on excluded medication|0|||
25075767|NCT02265796|50183349|FG000|Overall Study|Withdrawal by Subject|1|||
25075768|NCT02265796|50183350|FG001|Overall Study|Withdrawal by Subject|1|||
25075769|NCT02357368|50183360|FG000|Overall Study|Lost to Follow-up|0|||
25075770|NCT02357368|50183361|FG001|Overall Study|Lost to Follow-up|0|||
25075771|NCT02357368|50183362|FG002|Overall Study|Lost to Follow-up|0|||
25075772|NCT02357368|50183363|FG003|Overall Study|Lost to Follow-up|1|||
25075773|NCT02357368|50183360|FG000|Overall Study|Pregnancy|3|||
25075774|NCT02357368|50183361|FG001|Overall Study|Pregnancy|2|||
25075775|NCT02357368|50183362|FG002|Overall Study|Pregnancy|0|||
25075776|NCT02357368|50183363|FG003|Overall Study|Pregnancy|0|||
25075777|NCT02357368|50183360|FG000|Overall Study|Withdrawal by Subject|3|||
25075778|NCT02357368|50183361|FG001|Overall Study|Withdrawal by Subject|1|||
25075779|NCT02357368|50183362|FG002|Overall Study|Withdrawal by Subject|1|||
25075780|NCT02357368|50183363|FG003|Overall Study|Withdrawal by Subject|2|||
25075781|NCT03287245|50183377|FG000|Overall Study|Study terminated by sponsor|3|||
25075782|NCT03287245|50183378|FG001|Overall Study|Study terminated by sponsor|0|||
25075783|NCT03287245|50183379|FG002|Overall Study|Study terminated by sponsor|3|||
25075784|NCT03287245|50183380|FG003|Overall Study|Study terminated by sponsor|1|||
25075785|NCT03287245|50183377|FG000|Overall Study|Adverse Event|1|||
25075786|NCT03287245|50183378|FG001|Overall Study|Adverse Event|0|||
25075787|NCT03287245|50183379|FG002|Overall Study|Adverse Event|0|||
25075788|NCT03287245|50183380|FG003|Overall Study|Adverse Event|0|||
25075789|NCT03287245|50183377|FG000|Overall Study|Withdrawal by Subject|8|||
25075790|NCT03287245|50183378|FG001|Overall Study|Withdrawal by Subject|3|||
25075791|NCT03287245|50183379|FG002|Overall Study|Withdrawal by Subject|3|||
25075792|NCT03287245|50183380|FG003|Overall Study|Withdrawal by Subject|0|||
25075793|NCT03287245|50183377|FG000|Overall Study|Physician Decision|3|||
25075794|NCT03287245|50183378|FG001|Overall Study|Physician Decision|2|||
25075795|NCT03287245|50183379|FG002|Overall Study|Physician Decision|0|||
25075796|NCT03287245|50183380|FG003|Overall Study|Physician Decision|0|||
25075797|NCT02262754|50183413|FG000|Overall Study|Adverse Event|3|||
25075798|NCT02262754|50183414|FG001|Overall Study|Adverse Event|4|||
25075799|NCT02262754|50183415|FG002|Overall Study|Adverse Event|0|||
25075800|NCT02262754|50183413|FG000|Overall Study|Lack of Efficacy|2|||
25075801|NCT02262754|50183414|FG001|Overall Study|Lack of Efficacy|0|||
25075802|NCT02262754|50183415|FG002|Overall Study|Lack of Efficacy|1|||
25075803|NCT02262754|50183413|FG000|Overall Study|Lost to Follow-up|0|||
25075804|NCT02262754|50183414|FG001|Overall Study|Lost to Follow-up|0|||
25075805|NCT02262754|50183415|FG002|Overall Study|Lost to Follow-up|1|||
25075806|NCT02262754|50183413|FG000|Overall Study|No longer meets eligibility criteria|0|||
25075807|NCT02262754|50183414|FG001|Overall Study|No longer meets eligibility criteria|1|||
25075808|NCT02262754|50183415|FG002|Overall Study|No longer meets eligibility criteria|0|||
25075809|NCT02262754|50183413|FG000|Overall Study|Study terminated by sponsor|5|||
25075810|NCT02262754|50183414|FG001|Overall Study|Study terminated by sponsor|4|||
25075811|NCT02262754|50183415|FG002|Overall Study|Study terminated by sponsor|4|||
25075812|NCT02262754|50183413|FG000|Overall Study|Protocol Violation|1|||
25075813|NCT02262754|50183414|FG001|Overall Study|Protocol Violation|0|||
25075814|NCT02262754|50183415|FG002|Overall Study|Protocol Violation|0|||
25075815|NCT02262754|50183413|FG000|Overall Study|Withdrawal by Subject|1|||
25075816|NCT02262754|50183414|FG001|Overall Study|Withdrawal by Subject|0|||
25075817|NCT02262754|50183415|FG002|Overall Study|Withdrawal by Subject|1|||
25075818|NCT02262754|50183413|FG000|Overall Study|Other|4|||
25075819|NCT02262754|50183414|FG001|Overall Study|Other|0|||
25075820|NCT02262754|50183415|FG002|Overall Study|Other|2|||
25075821|NCT02262364|50183425|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
25075822|NCT00309985|50183431|FG000|Overall Study|Disease progression|12|||
25075823|NCT00309985|50183432|FG001|Overall Study|Disease progression|0|||
25075824|NCT00309985|50183431|FG000|Overall Study|Adverse Event|30|||
25192975|NCT01427738|50361115|FG001|Overall Study|Lost to Follow-up|5|||
25075825|NCT00309985|50183432|FG001|Overall Study|Adverse Event|0|||
24974933|NCT03568162|50063242|FG003|Overall Study|Adverse Event|0|||
25075826|NCT00309985|50183431|FG000|Overall Study|Death|2|||
25075827|NCT00309985|50183432|FG001|Overall Study|Death|0|||
25075828|NCT00309985|50183431|FG000|Overall Study|Withdrawal by Subject|5|||
25075829|NCT00309985|50183432|FG001|Overall Study|Withdrawal by Subject|1|||
25075830|NCT00309985|50183431|FG000|Overall Study|Physician Decision|3|||
25075831|NCT00309985|50183432|FG001|Overall Study|Physician Decision|0|||
25075832|NCT00309985|50183431|FG000|Overall Study|Never started treatment|7|||
24974934|NCT03568162|50063243|FG004|Overall Study|Adverse Event|0|||
24974935|NCT03568162|50063244|FG005|Overall Study|Adverse Event|1|||
24974936|NCT03568162|50063239|FG000|Overall Study|Death|0|||
24974937|NCT03568162|50063240|FG001|Overall Study|Death|0|||
24974938|NCT03568162|50063241|FG002|Overall Study|Death|0|||
24974939|NCT03568162|50063242|FG003|Overall Study|Death|0|||
24974940|NCT03568162|50063243|FG004|Overall Study|Death|1|||
24974941|NCT03568162|50063244|FG005|Overall Study|Death|0|||
24974942|NCT03568162|50063239|FG000|Overall Study|Lost to Follow-up|3|||
24974943|NCT03568162|50063240|FG001|Overall Study|Lost to Follow-up|2|||
24974944|NCT03568162|50063241|FG002|Overall Study|Lost to Follow-up|4|||
24974945|NCT03568162|50063242|FG003|Overall Study|Lost to Follow-up|2|||
24974946|NCT03568162|50063243|FG004|Overall Study|Lost to Follow-up|3|||
24974947|NCT03568162|50063244|FG005|Overall Study|Lost to Follow-up|2|||
24974948|NCT03568162|50063239|FG000|Overall Study|Physician Decision|0|||
24974949|NCT03568162|50063240|FG001|Overall Study|Physician Decision|1|||
24974950|NCT03568162|50063241|FG002|Overall Study|Physician Decision|1|||
24974951|NCT03568162|50063242|FG003|Overall Study|Physician Decision|0|||
24974952|NCT03568162|50063243|FG004|Overall Study|Physician Decision|1|||
24974953|NCT03568162|50063244|FG005|Overall Study|Physician Decision|0|||
24974954|NCT03568162|50063239|FG000|Overall Study|Pregnancy|0|||
24974955|NCT03568162|50063240|FG001|Overall Study|Pregnancy|0|||
24974956|NCT03568162|50063241|FG002|Overall Study|Pregnancy|0|||
24974957|NCT03568162|50063242|FG003|Overall Study|Pregnancy|1|||
24974958|NCT03568162|50063243|FG004|Overall Study|Pregnancy|0|||
24974959|NCT03568162|50063244|FG005|Overall Study|Pregnancy|0|||
24974960|NCT03568162|50063239|FG000|Overall Study|Protocol Violation|1|||
24974961|NCT03568162|50063240|FG001|Overall Study|Protocol Violation|0|||
24974962|NCT03568162|50063241|FG002|Overall Study|Protocol Violation|1|||
25075833|NCT00309985|50183432|FG001|Overall Study|Never started treatment|0|||
24974963|NCT03568162|50063242|FG003|Overall Study|Protocol Violation|1|||
24974964|NCT03568162|50063243|FG004|Overall Study|Protocol Violation|1|||
24974965|NCT03568162|50063244|FG005|Overall Study|Protocol Violation|1|||
24974966|NCT03568162|50063239|FG000|Overall Study|Withdrawal by Subject|15|||
24974967|NCT03568162|50063240|FG001|Overall Study|Withdrawal by Subject|15|||
24974968|NCT03568162|50063241|FG002|Overall Study|Withdrawal by Subject|26|||
24974969|NCT03568162|50063242|FG003|Overall Study|Withdrawal by Subject|22|||
24974970|NCT03568162|50063243|FG004|Overall Study|Withdrawal by Subject|6|||
25075834|NCT00309985|50183431|FG000|Overall Study|Complicating disease|1|||
25075835|NCT00309985|50183432|FG001|Overall Study|Complicating disease|0|||
25075836|NCT00309985|50183431|FG000|Overall Study|Non-compliance|1|||
24974971|NCT03568162|50063244|FG005|Overall Study|Withdrawal by Subject|9|||
24974972|NCT03568162|50063239|FG000|Overall Study|Others|3|||
25075837|NCT00309985|50183432|FG001|Overall Study|Non-compliance|0|||
24974973|NCT03568162|50063240|FG001|Overall Study|Others|4|||
24974974|NCT03568162|50063241|FG002|Overall Study|Others|1|||
24974975|NCT03568162|50063242|FG003|Overall Study|Others|4|||
24974976|NCT03568162|50063243|FG004|Overall Study|Others|2|||
24974977|NCT03568162|50063244|FG005|Overall Study|Others|1|||
24974978|NCT03567616|50063263|FG000|Overall Study|Disease progression|4|||
24974979|NCT03567616|50063263|FG000|Overall Study|Withdrawal by Subject|1|||
24974980|NCT03567616|50063263|FG000|Overall Study|Physician Decision|1|||
25075838|NCT00309985|50183431|FG000|Overall Study|Chemotherapy discontinued only|1|||
25075839|NCT00309985|50183432|FG001|Overall Study|Chemotherapy discontinued only|0|||
24974981|NCT03567616|50063263|FG000|Overall Study|Death|1|||
24974982|NCT03567616|50063263|FG000|Overall Study|Adverse Event|1|||
24974983|NCT03567382|50063272|FG000|Overall Study|Lost to Follow-up|1|||
24974984|NCT03567382|50063273|FG001|Overall Study|Lost to Follow-up|21|||
24974985|NCT03567382|50063274|FG002|Overall Study|Lost to Follow-up|1|||
24974986|NCT03567382|50063275|FG003|Overall Study|Lost to Follow-up|21|||
25075840|NCT02261974|50183440|FG000|Overall Study|Withdrawal by Subject|3|||
25075841|NCT02261974|50183441|FG001|Overall Study|Withdrawal by Subject|2|||
25075842|NCT02261974|50183440|FG000|Overall Study|Pregnancy|0|||
25075843|NCT02261974|50183441|FG001|Overall Study|Pregnancy|1|||
25075844|NCT02261974|50183440|FG000|Overall Study|Missed treatment cut-off date|6|||
25075845|NCT02261974|50183441|FG001|Overall Study|Missed treatment cut-off date|3|||
25075846|NCT02261974|50183440|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
25075847|NCT02261974|50183441|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
25075848|NCT02261974|50183440|FG000|Overall Study|Lost to Follow-up|2|||
25075849|NCT02261974|50183441|FG001|Overall Study|Lost to Follow-up|0|||
25075850|NCT02261974|50183440|FG000|Overall Study|Adverse Event|1|||
25075851|NCT02261974|50183441|FG001|Overall Study|Adverse Event|0|||
25075852|NCT02356588|50183449|FG000|Overall Study|Lack of Efficacy|4|||
25075853|NCT02356588|50183450|FG001|Overall Study|Lack of Efficacy|10|||
24974987|NCT03567382|50063272|FG000|Overall Study|Withdrawal by Subject|2|||
24974988|NCT03567382|50063273|FG001|Overall Study|Withdrawal by Subject|14|||
24974989|NCT03567382|50063274|FG002|Overall Study|Withdrawal by Subject|1|||
24974990|NCT03567382|50063275|FG003|Overall Study|Withdrawal by Subject|12|||
24974991|NCT03595384|50063286|FG000|Overall Study|Other time commitments|8|||
24974992|NCT03595384|50063286|FG000|Overall Study|Changes to session time|7|||
25075854|NCT02356588|50183449|FG000|Overall Study|Adverse Event|0|||
25075855|NCT02356588|50183450|FG001|Overall Study|Adverse Event|2|||
25075856|NCT02356588|50183449|FG000|Overall Study|Withdrawal by Subject|1|||
25075857|NCT02356588|50183450|FG001|Overall Study|Withdrawal by Subject|0|||
24974993|NCT03595384|50063286|FG000|Overall Study|Relocation out of country|1|||
24974994|NCT03591874|50063292|FG000|Overall Study|Adverse Event|4|||
25075858|NCT02356588|50183449|FG000|Overall Study|Protocol Violation|0|||
25075859|NCT02356588|50183450|FG001|Overall Study|Protocol Violation|1|||
25075860|NCT02355028|50183458|FG000|Overall Study|Adverse Event|2|||
25075861|NCT02355028|50183459|FG001|Overall Study|Adverse Event|0|||
25075862|NCT02355028|50183458|FG000|Overall Study|Withdrawal by Subject|1|||
25075863|NCT02355028|50183459|FG001|Overall Study|Withdrawal by Subject|1|||
25075864|NCT02355028|50183458|FG000|Overall Study|Deemed ineligible after randomization|8|||
25075865|NCT02355028|50183459|FG001|Overall Study|Deemed ineligible after randomization|4|||
25075866|NCT01643668|50183474|FG000|Overall Study|Death|1|||
24974995|NCT03591874|50063293|FG001|Overall Study|Adverse Event|0|||
25075867|NCT02260882|50183480|FG000|Overall Study|Protocol Violation|0|||
25075868|NCT02260882|50183481|FG001|Overall Study|Protocol Violation|1|||
24974996|NCT03591874|50063292|FG000|Overall Study|Withdrawal by Subject|2|||
24974997|NCT03591874|50063293|FG001|Overall Study|Withdrawal by Subject|1|||
25075869|NCT02260804|50183490|FG000|Induction Study Period|Protocol Violation|2|||
25075870|NCT02260804|50183491|FG001|Induction Study Period|Protocol Violation|0|||
25075871|NCT02260804|50183490|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
25075872|NCT02260804|50183491|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
24974998|NCT03591874|50063292|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
24974999|NCT03591874|50063293|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
24975000|NCT03591874|50063292|FG000|Overall Study|On Study at Time of Study Termination|12|||
24975001|NCT03591874|50063293|FG001|Overall Study|On Study at Time of Study Termination|6|||
24975002|NCT03566680|50063299|FG000|Overall Study|Pregnancy|1|||
24975003|NCT03566680|50063299|FG000|Overall Study|Lost to Follow-up|13|||
25075873|NCT02260804|50183490|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
25075874|NCT02260804|50183491|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
25075875|NCT02260804|50183490|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
25075876|NCT02260804|50183491|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
25075877|NCT02260804|50183490|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
25075878|NCT02260804|50183491|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
25075879|NCT02260804|50183490|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
25075880|NCT02260804|50183491|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
25075881|NCT02260804|50183490|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
25075882|NCT02260804|50183491|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
25075883|NCT02260804|50183490|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
25075884|NCT02260804|50183491|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
25075885|NCT02260804|50183490|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
25075886|NCT02260804|50183491|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
25075887|NCT02260804|50183490|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
25075888|NCT02260804|50183491|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
25075889|NCT02260804|50183490|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
25075890|NCT02260804|50183491|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
25075891|NCT02260648|50183500|FG000|Overall Study|Adverse Event|3|||
25075892|NCT02260648|50183501|FG001|Overall Study|Adverse Event|0|||
25075893|NCT02260648|50183502|FG002|Overall Study|Adverse Event|1|||
25075894|NCT02260648|50183500|FG000|Overall Study|Withdrawal by Subject|1|||
25075895|NCT02260648|50183501|FG001|Overall Study|Withdrawal by Subject|1|||
25075896|NCT02260648|50183502|FG002|Overall Study|Withdrawal by Subject|0|||
25075897|NCT02260648|50183500|FG000|Overall Study|Protocol Violation|1|||
25075898|NCT02260648|50183501|FG001|Overall Study|Protocol Violation|0|||
25075899|NCT02260648|50183502|FG002|Overall Study|Protocol Violation|0|||
25075900|NCT02260648|50183500|FG000|Overall Study|Discontinue Due to Study Termination|13|||
25075901|NCT02260648|50183501|FG001|Overall Study|Discontinue Due to Study Termination|12|||
25075902|NCT02260648|50183502|FG002|Overall Study|Discontinue Due to Study Termination|7|||
25075903|NCT02260492|50183513|FG000|Overall Study|Adverse Event|6|||
25170144|NCT01819727|50304218|FG001|Overall Study|Study Terminated by Sponsor|1|||
25170145|NCT01819727|50304217|FG000|Overall Study|Withdrawal by Subject|6|||
25170146|NCT01819727|50304218|FG001|Overall Study|Withdrawal by Subject|11|||
24975004|NCT03566680|50063299|FG000|Overall Study|Withdrawal by Subject|3|||
24975005|NCT00106353|50063305|FG000|Part 1|Disease progression|3|||
24975006|NCT00106353|50063306|FG001|Part 1|Disease progression|4|||
24975007|NCT00106353|50063307|FG002|Part 1|Disease progression|1|||
24975008|NCT00106353|50063308|FG003|Part 1|Disease progression|3|||
24975009|NCT00106353|50063309|FG004|Part 1|Disease progression|0|||
24975010|NCT00106353|50063310|FG005|Part 1|Disease progression|0|||
24975011|NCT00106353|50063311|FG006|Part 1|Disease progression|0|||
24975012|NCT00106353|50063305|FG000|Part 1|Withdrawal by Subject|0|||
24975013|NCT00106353|50063306|FG001|Part 1|Withdrawal by Subject|0|||
24975014|NCT00106353|50063307|FG002|Part 1|Withdrawal by Subject|1|||
24975015|NCT00106353|50063308|FG003|Part 1|Withdrawal by Subject|2|||
24975016|NCT00106353|50063309|FG004|Part 1|Withdrawal by Subject|0|||
24975017|NCT00106353|50063310|FG005|Part 1|Withdrawal by Subject|0|||
24975018|NCT00106353|50063311|FG006|Part 1|Withdrawal by Subject|0|||
24975019|NCT00106353|50063305|FG000|Part 1|Symptomatic deterioration|0|||
24975020|NCT00106353|50063306|FG001|Part 1|Symptomatic deterioration|0|||
24975021|NCT00106353|50063307|FG002|Part 1|Symptomatic deterioration|1|||
24975022|NCT00106353|50063308|FG003|Part 1|Symptomatic deterioration|0|||
24975023|NCT00106353|50063309|FG004|Part 1|Symptomatic deterioration|0|||
24975024|NCT00106353|50063310|FG005|Part 1|Symptomatic deterioration|0|||
24975025|NCT00106353|50063311|FG006|Part 1|Symptomatic deterioration|0|||
24975026|NCT00106353|50063305|FG000|Part 1|Entered follow-up phase|1|||
24975027|NCT00106353|50063306|FG001|Part 1|Entered follow-up phase|1|||
24975028|NCT00106353|50063307|FG002|Part 1|Entered follow-up phase|0|||
24975029|NCT00106353|50063308|FG003|Part 1|Entered follow-up phase|1|||
24975030|NCT00106353|50063309|FG004|Part 1|Entered follow-up phase|0|||
24975031|NCT00106353|50063310|FG005|Part 1|Entered follow-up phase|0|||
24975032|NCT00106353|50063311|FG006|Part 1|Entered follow-up phase|0|||
24975033|NCT00106353|50063305|FG000|Part 1|Adverse Event|0|||
25075904|NCT02260492|50183514|FG001|Overall Study|Adverse Event|1|||
25075905|NCT02260492|50183515|FG002|Overall Study|Adverse Event|2|||
25075906|NCT02260492|50183513|FG000|Overall Study|Death|0|||
25075907|NCT02260492|50183514|FG001|Overall Study|Death|1|||
25075908|NCT02260492|50183515|FG002|Overall Study|Death|0|||
25075909|NCT02260492|50183513|FG000|Overall Study|Lost to Follow-up|12|||
25075910|NCT02260492|50183514|FG001|Overall Study|Lost to Follow-up|9|||
25075911|NCT02260492|50183515|FG002|Overall Study|Lost to Follow-up|0|||
25075912|NCT02260492|50183513|FG000|Overall Study|Physician Decision|2|||
25075913|NCT02260492|50183514|FG001|Overall Study|Physician Decision|0|||
25075914|NCT02260492|50183515|FG002|Overall Study|Physician Decision|1|||
25075915|NCT02260492|50183513|FG000|Overall Study|Withdrawal by Subject|3|||
25075916|NCT02260492|50183514|FG001|Overall Study|Withdrawal by Subject|2|||
25075917|NCT02260492|50183515|FG002|Overall Study|Withdrawal by Subject|2|||
25192976|NCT01426958|50361121|FG000|Overall Study|Adverse Event|2|||
25192977|NCT02578992|50361299|FG000|Overall Study|equipment not available or malfunction|3|||
25192978|NCT02578992|50361300|FG001|Overall Study|equipment not available or malfunction|3|||
25192979|NCT00558519|50361364|FG000|Overall Study|Ph+|20|||
25192980|NCT00558519|50361364|FG000|Overall Study|Ineligible|1|||
25192981|NCT00558519|50361364|FG000|Overall Study|Insufficient data|1|||
25192982|NCT00558519|50361364|FG000|Overall Study|Never received treatment|1|||
25192983|NCT00558285|50361408|FG000|Overall Study|Adverse Event|1|||
25314784|NCT00911534|50630610|FG001|Overall Study|Other|2|||
25314785|NCT00911300|50630618|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
25314786|NCT00911300|50630619|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
25314787|NCT00911300|50630618|FG000|Overall Study|Death|1|||
25314788|NCT00911300|50630619|FG001|Overall Study|Death|0|||
25314789|NCT00911300|50630618|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
25192984|NCT00558285|50361409|FG001|Overall Study|Adverse Event|1|||
25192985|NCT00558285|50361410|FG002|Overall Study|Adverse Event|4|||
25192986|NCT00558285|50361411|FG003|Overall Study|Adverse Event|1|||
25192987|NCT00558285|50361412|FG004|Overall Study|Adverse Event|2|||
25192988|NCT00558285|50361408|FG000|Overall Study|Abnormal test procedure result(s)|1|||
25192989|NCT00558285|50361409|FG001|Overall Study|Abnormal test procedure result(s)|0|||
25192990|NCT00558285|50361410|FG002|Overall Study|Abnormal test procedure result(s)|0|||
25192991|NCT00558285|50361411|FG003|Overall Study|Abnormal test procedure result(s)|0|||
25192992|NCT00558285|50361412|FG004|Overall Study|Abnormal test procedure result(s)|0|||
25192993|NCT00558285|50361408|FG000|Overall Study|Subject withdrew consent|2|||
25192994|NCT00558285|50361409|FG001|Overall Study|Subject withdrew consent|0|||
25192995|NCT00558285|50361410|FG002|Overall Study|Subject withdrew consent|1|||
25192996|NCT00558285|50361411|FG003|Overall Study|Subject withdrew consent|1|||
25192997|NCT00558285|50361412|FG004|Overall Study|Subject withdrew consent|1|||
25192998|NCT00558285|50361408|FG000|Overall Study|Lost to Follow-up|1|||
25192999|NCT00558285|50361409|FG001|Overall Study|Lost to Follow-up|1|||
25193000|NCT00558285|50361410|FG002|Overall Study|Lost to Follow-up|0|||
25193001|NCT00558285|50361411|FG003|Overall Study|Lost to Follow-up|0|||
25193002|NCT00558285|50361412|FG004|Overall Study|Lost to Follow-up|0|||
25193003|NCT00558285|50361408|FG000|Overall Study|Administrative problems|0|||
25193004|NCT00558285|50361409|FG001|Overall Study|Administrative problems|0|||
25193005|NCT00558285|50361410|FG002|Overall Study|Administrative problems|0|||
25193006|NCT00558285|50361411|FG003|Overall Study|Administrative problems|1|||
25193007|NCT00558285|50361412|FG004|Overall Study|Administrative problems|1|||
25193008|NCT00558285|50361408|FG000|Overall Study|Protocol deviation|1|||
25193009|NCT00558285|50361409|FG001|Overall Study|Protocol deviation|1|||
25193010|NCT00558285|50361410|FG002|Overall Study|Protocol deviation|0|||
25193011|NCT00558285|50361411|FG003|Overall Study|Protocol deviation|1|||
25193012|NCT00558285|50361412|FG004|Overall Study|Protocol deviation|0|||
25193013|NCT01389596|50361427|FG000|Overall Study|Protocol Violation|3|||
25075918|NCT02260258|50183525|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
25193014|NCT01389596|50361428|FG001|Overall Study|Protocol Violation|4|||
25193015|NCT01389596|50361429|FG002|Overall Study|Protocol Violation|3|||
25314790|NCT00911300|50630619|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
25314791|NCT00911300|50630618|FG000|Overall Study|Adverse Event|14|||
25193016|NCT01389596|50361427|FG000|Overall Study|Withdrawal by Subject|1|||
25314792|NCT00911300|50630619|FG001|Overall Study|Adverse Event|6|||
25314793|NCT00911300|50630618|FG000|Overall Study|Protocol Violation|3|||
25075919|NCT02260258|50183526|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
25075920|NCT02260180|50183536|FG000|Overall Study|Adverse Event|2|||
25075921|NCT02260180|50183537|FG001|Overall Study|Adverse Event|0|||
25075922|NCT02260180|50183538|FG002|Overall Study|Adverse Event|1|||
25193017|NCT01389596|50361428|FG001|Overall Study|Withdrawal by Subject|2|||
24975034|NCT00106353|50063306|FG001|Part 1|Adverse Event|0|||
24975035|NCT00106353|50063307|FG002|Part 1|Adverse Event|0|||
24975036|NCT00106353|50063308|FG003|Part 1|Adverse Event|1|||
24975037|NCT00106353|50063309|FG004|Part 1|Adverse Event|0|||
24975038|NCT00106353|50063310|FG005|Part 1|Adverse Event|0|||
24975039|NCT00106353|50063311|FG006|Part 1|Adverse Event|0|||
24975040|NCT00106353|50063305|FG000|Part 2|Disease progression|0|||
25193018|NCT01389596|50361429|FG002|Overall Study|Withdrawal by Subject|2|||
25193019|NCT01389596|50361427|FG000|Overall Study|Insufficient Clinical Response|3|||
25193020|NCT01389596|50361428|FG001|Overall Study|Insufficient Clinical Response|4|||
25193021|NCT01389596|50361429|FG002|Overall Study|Insufficient Clinical Response|5|||
25193022|NCT01389596|50361427|FG000|Overall Study|Adverse Event|1|||
25193023|NCT01389596|50361428|FG001|Overall Study|Adverse Event|4|||
25193024|NCT01389596|50361429|FG002|Overall Study|Adverse Event|0|||
25193025|NCT01389596|50361427|FG000|Overall Study|Death|0|||
24975041|NCT00106353|50063306|FG001|Part 2|Disease progression|0|||
24975042|NCT00106353|50063307|FG002|Part 2|Disease progression|0|||
24975043|NCT00106353|50063308|FG003|Part 2|Disease progression|0|||
24975044|NCT00106353|50063309|FG004|Part 2|Disease progression|8|||
24975045|NCT00106353|50063310|FG005|Part 2|Disease progression|14|||
24975046|NCT00106353|50063311|FG006|Part 2|Disease progression|13|||
24975047|NCT00106353|50063305|FG000|Part 2|Death|0|||
24975048|NCT00106353|50063306|FG001|Part 2|Death|0|||
25075923|NCT02353468|50183546|FG000|Overall Study|Study terminated|3|||
25075924|NCT02349412|50183552|FG000|Overall Study|Withdrawal by Subject|7|||
24975049|NCT00106353|50063307|FG002|Part 2|Death|0|||
24975050|NCT00106353|50063308|FG003|Part 2|Death|0|||
24975051|NCT00106353|50063309|FG004|Part 2|Death|3|||
24975052|NCT00106353|50063310|FG005|Part 2|Death|0|||
24975053|NCT00106353|50063311|FG006|Part 2|Death|1|||
24975054|NCT00106353|50063305|FG000|Part 2|Symptomatic deterioration|0|||
24975055|NCT00106353|50063306|FG001|Part 2|Symptomatic deterioration|0|||
24975056|NCT00106353|50063307|FG002|Part 2|Symptomatic deterioration|0|||
24975057|NCT00106353|50063308|FG003|Part 2|Symptomatic deterioration|0|||
24975058|NCT00106353|50063309|FG004|Part 2|Symptomatic deterioration|3|||
24975059|NCT00106353|50063310|FG005|Part 2|Symptomatic deterioration|0|||
24975060|NCT00106353|50063311|FG006|Part 2|Symptomatic deterioration|0|||
24975061|NCT00106353|50063305|FG000|Part 2|Adverse Event|0|||
24975062|NCT00106353|50063306|FG001|Part 2|Adverse Event|0|||
24975063|NCT00106353|50063307|FG002|Part 2|Adverse Event|0|||
24975064|NCT00106353|50063308|FG003|Part 2|Adverse Event|0|||
24975065|NCT00106353|50063309|FG004|Part 2|Adverse Event|0|||
24975066|NCT00106353|50063310|FG005|Part 2|Adverse Event|2|||
24975067|NCT00106353|50063311|FG006|Part 2|Adverse Event|1|||
24975068|NCT00106353|50063305|FG000|Part 2|Other|0|||
24975069|NCT00106353|50063306|FG001|Part 2|Other|0|||
24975070|NCT00106353|50063307|FG002|Part 2|Other|0|||
24975071|NCT00106353|50063308|FG003|Part 2|Other|0|||
24975072|NCT00106353|50063309|FG004|Part 2|Other|1|||
24975073|NCT00106353|50063310|FG005|Part 2|Other|1|||
24975074|NCT00106353|50063311|FG006|Part 2|Other|1|||
24975075|NCT00106353|50063305|FG000|Part 2|Withdrawal by Subject|0|||
24975076|NCT00106353|50063306|FG001|Part 2|Withdrawal by Subject|0|||
24975077|NCT00106353|50063307|FG002|Part 2|Withdrawal by Subject|0|||
24975078|NCT00106353|50063308|FG003|Part 2|Withdrawal by Subject|0|||
24975079|NCT00106353|50063309|FG004|Part 2|Withdrawal by Subject|1|||
24975080|NCT00106353|50063310|FG005|Part 2|Withdrawal by Subject|0|||
24975081|NCT00106353|50063311|FG006|Part 2|Withdrawal by Subject|0|||
24975082|NCT00106353|50063305|FG000|Part 2|Physician Decision|0|||
24975083|NCT00106353|50063306|FG001|Part 2|Physician Decision|0|||
24975084|NCT00106353|50063307|FG002|Part 2|Physician Decision|0|||
24975085|NCT00106353|50063308|FG003|Part 2|Physician Decision|0|||
24975086|NCT00106353|50063309|FG004|Part 2|Physician Decision|0|||
24975087|NCT00106353|50063310|FG005|Part 2|Physician Decision|1|||
24975088|NCT00106353|50063311|FG006|Part 2|Physician Decision|0|||
24975089|NCT00080301|50063334|FG000|Overall Study|Randomized but Never Treated|5|||
24975090|NCT00080301|50063335|FG001|Overall Study|Randomized but Never Treated|10|||
24975091|NCT00080301|50063334|FG000|Overall Study|Still on Treatment as of CSR date|0|||
24975092|NCT00080301|50063335|FG001|Overall Study|Still on Treatment as of CSR date|1|||
24975093|NCT00079677|50063344|FG000|Overall Study|Adverse Event|5|||
24975094|NCT00079677|50063345|FG001|Overall Study|Adverse Event|6|||
24975095|NCT00079677|50063344|FG000|Overall Study|Lack of Efficacy|1|||
25075925|NCT02349412|50183553|FG001|Overall Study|Withdrawal by Subject|7|||
25075926|NCT02259400|50183561|FG000|Overall Study|Death|0|||
25075927|NCT02259400|50183562|FG001|Overall Study|Death|2|||
25075928|NCT01530997|50183568|FG000|Overall Study|Physician Decision|1|||
25075929|NCT01530997|50183568|FG000|Overall Study|Withdrawal by Subject|1|||
25075930|NCT02259088|50183581|FG000|Overall Study|Adverse Event|6|||
25075931|NCT02259088|50183582|FG001|Overall Study|Adverse Event|4|||
24975096|NCT00079677|50063345|FG001|Overall Study|Lack of Efficacy|0|||
24975097|NCT00079677|50063344|FG000|Overall Study|Lost to Follow-up|2|||
24975098|NCT00079677|50063345|FG001|Overall Study|Lost to Follow-up|2|||
24975099|NCT00079677|50063344|FG000|Overall Study|Physician Decision|3|||
24975100|NCT00079677|50063345|FG001|Overall Study|Physician Decision|0|||
24975101|NCT00079677|50063344|FG000|Overall Study|Protocol Violation|2|||
24975102|NCT00079677|50063345|FG001|Overall Study|Protocol Violation|3|||
24975103|NCT00079677|50063344|FG000|Overall Study|Withdrawal by Subject|5|||
24975104|NCT00079677|50063345|FG001|Overall Study|Withdrawal by Subject|3|||
25075932|NCT02259088|50183581|FG000|Overall Study|Lost to Follow-up|2|||
24975105|NCT00079677|50063344|FG000|Overall Study|Miscellaneous|2|||
24975106|NCT00079677|50063345|FG001|Overall Study|Miscellaneous|0|||
24975107|NCT00095121|50063353|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
24975108|NCT00095121|50063354|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
24975109|NCT00095121|50063353|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
24975110|NCT00095121|50063354|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
25075933|NCT02259088|50183582|FG001|Overall Study|Lost to Follow-up|0|||
25075934|NCT02259088|50183581|FG000|Overall Study|Death|2|||
25075935|NCT02259088|50183582|FG001|Overall Study|Death|0|||
25075936|NCT02259088|50183581|FG000|Overall Study|Physician Decision|5|||
25075937|NCT02259088|50183582|FG001|Overall Study|Physician Decision|2|||
25075938|NCT02259088|50183581|FG000|Overall Study|Protocol deviation|5|||
24975111|NCT00094809|50063372|FG000|Overall Study|Protocol deviation|2|||
24975112|NCT00094809|50063373|FG001|Overall Study|Protocol deviation|2|||
24975113|NCT00094809|50063372|FG000|Overall Study|Noncompliance|1|||
24975114|NCT00094809|50063373|FG001|Overall Study|Noncompliance|0|||
24975115|NCT00094809|50063372|FG000|Overall Study|Adverse Event|3|||
24975116|NCT00094809|50063373|FG001|Overall Study|Adverse Event|1|||
24975117|NCT00094809|50063372|FG000|Overall Study|Withdrawal by Subject|8|||
24975118|NCT00094809|50063373|FG001|Overall Study|Withdrawal by Subject|9|||
24975119|NCT00094809|50063372|FG000|Overall Study|Disease progression|3|||
24975120|NCT00094809|50063373|FG001|Overall Study|Disease progression|3|||
24975121|NCT00094809|50063372|FG000|Overall Study|Physician Decision|3|||
24975122|NCT00094809|50063373|FG001|Overall Study|Physician Decision|5|||
24975123|NCT00094809|50063372|FG000|Overall Study|Lost to Follow-up|6|||
25075939|NCT02259088|50183582|FG001|Overall Study|Protocol deviation|0|||
25075940|NCT02259088|50183581|FG000|Overall Study|Subject/guardian decision|8|||
25075941|NCT02259088|50183582|FG001|Overall Study|Subject/guardian decision|8|||
25075942|NCT02880241|50183594|FG000|Overall Study|Lack of Efficacy|1|||
25075943|NCT02880241|50183595|FG001|Overall Study|Lack of Efficacy|0|||
25075944|NCT02880241|50183596|FG002|Overall Study|Lack of Efficacy|0|||
25075945|NCT02880241|50183597|FG003|Overall Study|Lack of Efficacy|0|||
24975124|NCT00094809|50063373|FG001|Overall Study|Lost to Follow-up|6|||
24975125|NCT00094809|50063372|FG000|Overall Study|Death|19|||
25075946|NCT02880241|50183598|FG004|Overall Study|Lack of Efficacy|0|||
25075947|NCT02880241|50183599|FG005|Overall Study|Lack of Efficacy|0|||
25075948|NCT02259010|50183615|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
25075949|NCT02021773|50183624|FG000|Overall Study|Adverse Event|1|||
25075950|NCT02021773|50183625|FG001|Overall Study|Adverse Event|4|||
25075951|NCT02021773|50183626|FG002|Overall Study|Adverse Event|3|||
25075952|NCT02021773|50183624|FG000|Overall Study|Lack of Efficacy|2|||
25075953|NCT02021773|50183625|FG001|Overall Study|Lack of Efficacy|2|||
25075954|NCT02021773|50183626|FG002|Overall Study|Lack of Efficacy|2|||
25075955|NCT02021773|50183624|FG000|Overall Study|Protocol Violation|2|||
25075956|NCT02021773|50183625|FG001|Overall Study|Protocol Violation|3|||
25075957|NCT02021773|50183626|FG002|Overall Study|Protocol Violation|1|||
25075958|NCT02021773|50183624|FG000|Overall Study|Withdrawal by Subject|3|||
25075959|NCT02021773|50183625|FG001|Overall Study|Withdrawal by Subject|4|||
25075960|NCT02021773|50183626|FG002|Overall Study|Withdrawal by Subject|5|||
25075961|NCT02021773|50183624|FG000|Overall Study|Lost to Follow-up|1|||
25075962|NCT02021773|50183625|FG001|Overall Study|Lost to Follow-up|3|||
25075963|NCT02021773|50183626|FG002|Overall Study|Lost to Follow-up|0|||
25075964|NCT02021773|50183624|FG000|Overall Study|Reason not specified|3|||
25075965|NCT02021773|50183625|FG001|Overall Study|Reason not specified|0|||
25075966|NCT02021773|50183626|FG002|Overall Study|Reason not specified|0|||
25075967|NCT00151775|50183639|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
25075968|NCT00151775|50183640|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
25075969|NCT00151775|50183641|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
25075970|NCT00151775|50183642|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
25075971|NCT00151775|50183643|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
25075972|NCT00151775|50183644|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
25075973|NCT00151775|50183645|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
25075974|NCT00151775|50183646|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
25075975|NCT00151775|50183647|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
25075976|NCT00151775|50183648|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
25075977|NCT00151775|50183649|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
25075978|NCT00151775|50183650|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
25075979|NCT00151775|50183639|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
25075980|NCT00151775|50183640|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
24975126|NCT00094809|50063373|FG001|Overall Study|Death|25|||
24975127|NCT00094809|50063372|FG000|Overall Study|Protocol-specified criteria|1|||
24975128|NCT00094809|50063373|FG001|Overall Study|Protocol-specified criteria|1|||
25075981|NCT00151775|50183641|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
25075982|NCT00151775|50183642|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
25075983|NCT00151775|50183643|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
25075984|NCT00151775|50183644|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
25075985|NCT00151775|50183645|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
25075986|NCT00151775|50183646|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
25075987|NCT00151775|50183647|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
25075988|NCT00151775|50183648|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
25075989|NCT00151775|50183649|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
25075990|NCT00151775|50183650|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
25075991|NCT00151775|50183639|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
25075992|NCT00151775|50183640|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
25075993|NCT00151775|50183641|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
25075994|NCT00151775|50183642|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
25075995|NCT00151775|50183643|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
25075996|NCT00151775|50183644|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
25075997|NCT00151775|50183645|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
25075998|NCT00151775|50183646|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
25075999|NCT00151775|50183647|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
25076000|NCT00151775|50183648|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
25076001|NCT00151775|50183649|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
25076002|NCT00151775|50183650|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
25076003|NCT00151775|50183639|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
25076004|NCT00151775|50183640|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
25076005|NCT00151775|50183641|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
25076006|NCT00151775|50183642|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
25076007|NCT00151775|50183643|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
24975129|NCT00094809|50063372|FG000|Overall Study|Other|2|||
24975130|NCT00094809|50063373|FG001|Overall Study|Other|4|||
24975131|NCT00094809|50063372|FG000|Overall Study|Informed consent signed after treatment|1|||
24975132|NCT00094809|50063373|FG001|Overall Study|Informed consent signed after treatment|0|||
25076008|NCT00151775|50183644|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
25076009|NCT00151775|50183645|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
25076010|NCT00151775|50183646|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
25076011|NCT00151775|50183647|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
25076012|NCT00151775|50183648|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
25076013|NCT00151775|50183649|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
25076014|NCT00151775|50183650|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
25076015|NCT00151775|50183639|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
25076016|NCT00151775|50183640|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
25076017|NCT00151775|50183641|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
25076018|NCT00151775|50183642|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
24975133|NCT00094809|50063372|FG000|Overall Study|Study drug not received|2|||
24975134|NCT00094809|50063373|FG001|Overall Study|Study drug not received|8|||
24975135|NCT00094809|50063372|FG000|Overall Study|Other|1|||
24975136|NCT00094809|50063373|FG001|Overall Study|Other|1|||
24975137|NCT00075218|50063381|FG000|Double-Blind Treatment|Adverse Event|23|||
24975138|NCT00075218|50063382|FG001|Double-Blind Treatment|Adverse Event|4|||
24975139|NCT00075218|50063383|FG002|Double-Blind Treatment|Adverse Event|0|||
24975140|NCT00075218|50063381|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
24975141|NCT00075218|50063382|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
24975142|NCT00075218|50063383|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
24975143|NCT00075218|50063381|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
24975144|NCT00075218|50063382|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
25076019|NCT00151775|50183643|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
25076020|NCT00151775|50183644|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
25076021|NCT00151775|50183645|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
25076022|NCT00151775|50183646|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
25076023|NCT00151775|50183647|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
25193026|NCT01389596|50361428|FG001|Overall Study|Death|1|||
24975145|NCT00075218|50063383|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
24975146|NCT00075218|50063381|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
24975147|NCT00075218|50063382|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
24975148|NCT00075218|50063383|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
24975149|NCT00075218|50063381|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
24975150|NCT00075218|50063382|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
24975151|NCT00075218|50063383|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
24975152|NCT00075218|50063381|FG000|Double-Blind Treatment|No study medication taken|2|||
24975153|NCT00075218|50063382|FG001|Double-Blind Treatment|No study medication taken|0|||
24975154|NCT00075218|50063383|FG002|Double-Blind Treatment|No study medication taken|0|||
24975155|NCT00075218|50063381|FG000|Open-Label Treatment|Lack of Efficacy|0|||
24975156|NCT00075218|50063382|FG001|Open-Label Treatment|Lack of Efficacy|0|||
24975157|NCT00075218|50063383|FG002|Open-Label Treatment|Lack of Efficacy|174|||
24975158|NCT00075218|50063381|FG000|Open-Label Treatment|Adverse Event|0|||
24975159|NCT00075218|50063382|FG001|Open-Label Treatment|Adverse Event|0|||
24975160|NCT00075218|50063383|FG002|Open-Label Treatment|Adverse Event|51|||
24975161|NCT00075218|50063381|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
24975162|NCT00075218|50063382|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
24975163|NCT00075218|50063383|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
24975164|NCT00075218|50063381|FG000|Open-Label Treatment|Decision of Sponsor|0|||
24975165|NCT00075218|50063382|FG001|Open-Label Treatment|Decision of Sponsor|0|||
24975166|NCT00075218|50063383|FG002|Open-Label Treatment|Decision of Sponsor|8|||
24975167|NCT00075218|50063381|FG000|Open-Label Treatment|Protocol Violation|0|||
24975168|NCT00075218|50063382|FG001|Open-Label Treatment|Protocol Violation|0|||
24975169|NCT00075218|50063383|FG002|Open-Label Treatment|Protocol Violation|1|||
24975170|NCT00075218|50063381|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
24975171|NCT00075218|50063382|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
24975172|NCT00075218|50063383|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
24975173|NCT00094653|50063393|FG000|Overall Study|Death|306|||
24975174|NCT00094653|50063394|FG001|Overall Study|Death|100|||
24975175|NCT00094653|50063395|FG002|Overall Study|Death|119|||
25314794|NCT00911300|50630619|FG001|Overall Study|Protocol Violation|2|||
25314795|NCT00911300|50630618|FG000|Overall Study|Consent Withdrawn|4|||
24975176|NCT00094653|50063393|FG000|Overall Study|Subject Withdrew Consent|10|||
24975177|NCT00094653|50063394|FG001|Overall Study|Subject Withdrew Consent|2|||
24975178|NCT00094653|50063395|FG002|Overall Study|Subject Withdrew Consent|3|||
24975179|NCT00094653|50063393|FG000|Overall Study|Other|2|||
24975180|NCT00094653|50063394|FG001|Overall Study|Other|2|||
24975181|NCT00094653|50063395|FG002|Overall Study|Other|2|||
24975182|NCT00094653|50063393|FG000|Overall Study|Lost to Follow-up|3|||
24975183|NCT00094653|50063394|FG001|Overall Study|Lost to Follow-up|2|||
24975184|NCT00094653|50063395|FG002|Overall Study|Lost to Follow-up|1|||
24975185|NCT00094653|50063393|FG000|Overall Study|Protocol Violation|0|||
24975186|NCT00094653|50063394|FG001|Overall Study|Protocol Violation|0|||
24975187|NCT00094653|50063395|FG002|Overall Study|Protocol Violation|1|||
24975188|NCT00104247|50063406|FG000|Overall Study|Withdrawal by Subject|1|||
24975189|NCT00104247|50063407|FG001|Overall Study|Withdrawal by Subject|0|||
24975190|NCT00104247|50063406|FG000|Overall Study|Noncompliant with dosing|0|||
24975191|NCT00104247|50063407|FG001|Overall Study|Noncompliant with dosing|1|||
24975192|NCT03565900|50063415|FG000|Overall Study|Disposition Unknown|4|||
24975193|NCT03565900|50063416|FG001|Overall Study|Disposition Unknown|1|||
24975194|NCT03565900|50063415|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
24975195|NCT03565900|50063416|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
24975196|NCT03565900|50063415|FG000|Overall Study|Withdrawal by Subject|4|||
24975197|NCT03565900|50063416|FG001|Overall Study|Withdrawal by Subject|5|||
24975198|NCT03565900|50063415|FG000|Overall Study|Randomized By Mistake|0|||
24975199|NCT03565900|50063416|FG001|Overall Study|Randomized By Mistake|2|||
24975200|NCT03565900|50063415|FG000|Overall Study|Physician Decision|7|||
24975201|NCT03565900|50063416|FG001|Overall Study|Physician Decision|11|||
24975202|NCT03565900|50063415|FG000|Overall Study|Death|9|||
24975203|NCT03565900|50063416|FG001|Overall Study|Death|7|||
24975204|NCT03591406|50063440|FG000|Overall Study|Adverse Event|5|||
24975205|NCT03591406|50063441|FG001|Overall Study|Adverse Event|3|||
24975206|NCT03591406|50063440|FG000|Overall Study|Protocol Violation|2|||
24975207|NCT03591406|50063441|FG001|Overall Study|Protocol Violation|1|||
24975208|NCT03591406|50063440|FG000|Overall Study|Withdrawal by Subject|0|||
24975209|NCT03591406|50063441|FG001|Overall Study|Withdrawal by Subject|5|||
24975210|NCT03560986|50063449|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
24975211|NCT03560986|50063450|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
24975212|NCT03560986|50063449|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
24975213|NCT03560986|50063450|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
24975214|NCT03560986|50063449|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
24975215|NCT03560986|50063450|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
24975216|NCT03560986|50063449|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
24975217|NCT03560986|50063450|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
24975218|NCT03560986|50063449|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
24975219|NCT03560986|50063450|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
24975220|NCT03560986|50063449|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
24975221|NCT03560986|50063450|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
24975222|NCT03560986|50063449|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
24975223|NCT03560986|50063450|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
24975224|NCT03560518|50063465|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
24975225|NCT03560518|50063466|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
24975226|NCT03560518|50063467|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
24975227|NCT03560518|50063465|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
24975228|NCT03560518|50063466|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
24975229|NCT03560518|50063467|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
24975230|NCT03560518|50063465|FG000|Double Blind Treatment Period|Protocol Violation|1|||
25170147|NCT01819727|50304217|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
25170148|NCT01819727|50304218|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
24975231|NCT03560518|50063466|FG001|Double Blind Treatment Period|Protocol Violation|2|||
24975232|NCT03560518|50063467|FG002|Double Blind Treatment Period|Protocol Violation|0|||
24975233|NCT03560518|50063465|FG000|Double Blind Treatment Period|Pregnancy|0|||
25076024|NCT00151775|50183648|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
24975234|NCT03560518|50063466|FG001|Double Blind Treatment Period|Pregnancy|2|||
24975235|NCT03560518|50063467|FG002|Double Blind Treatment Period|Pregnancy|0|||
24975236|NCT03560518|50063465|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
24975237|NCT03560518|50063466|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
24975238|NCT03560518|50063467|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
24975239|NCT03560518|50063465|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
24975240|NCT03560518|50063466|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
24975241|NCT03560518|50063467|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
24975242|NCT03560518|50063465|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
24975243|NCT03560518|50063466|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
25076025|NCT00151775|50183649|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
25076026|NCT00151775|50183650|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
24975244|NCT03560518|50063467|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
24975245|NCT03560518|50063465|FG000|Double Blind Treatment Period|Adverse Event|0|||
24975246|NCT03560518|50063466|FG001|Double Blind Treatment Period|Adverse Event|3|||
24975247|NCT03560518|50063467|FG002|Double Blind Treatment Period|Adverse Event|1|||
24975248|NCT03560206|50063477|FG000|Overall Study|Lost to Follow-up|19|||
25314796|NCT00911300|50630619|FG001|Overall Study|Consent Withdrawn|12|||
25314797|NCT00911300|50630618|FG000|Overall Study|Coronary Angiography Performed|1|||
25314798|NCT00911300|50630619|FG001|Overall Study|Coronary Angiography Performed|0|||
25076027|NCT00151775|50183639|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
25076028|NCT00151775|50183640|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
25076029|NCT00151775|50183641|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
25076030|NCT00151775|50183642|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
25076031|NCT00151775|50183643|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
25076032|NCT00151775|50183644|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
25076033|NCT00151775|50183645|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
25076034|NCT00151775|50183646|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
25076035|NCT00151775|50183647|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
25076036|NCT00151775|50183648|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
25076037|NCT00151775|50183649|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
24975249|NCT03560206|50063478|FG001|Overall Study|Lost to Follow-up|11|||
25076038|NCT00151775|50183650|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
25076039|NCT00151775|50183639|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
25076040|NCT00151775|50183640|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
25076041|NCT00151775|50183641|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
25076042|NCT00151775|50183642|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
25076043|NCT00151775|50183643|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
25076044|NCT00151775|50183644|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
25076045|NCT00151775|50183645|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
24975250|NCT03560206|50063477|FG000|Overall Study|Withdrawal by Subject|2|||
24975251|NCT03560206|50063478|FG001|Overall Study|Withdrawal by Subject|4|||
24975252|NCT03560206|50063477|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
24975253|NCT03560206|50063478|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
24975254|NCT03560206|50063477|FG000|Overall Study|Busy schedule|14|||
24975255|NCT03560206|50063478|FG001|Overall Study|Busy schedule|2|||
24975256|NCT03560206|50063477|FG000|Overall Study|patients' new health condition such as cancer|10|||
24975257|NCT03560206|50063478|FG001|Overall Study|patients' new health condition such as cancer|1|||
24975258|NCT02892760|50063484|FG000|Overall Study|Withdrawal by Subject|3|||
25076046|NCT00151775|50183646|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
25314799|NCT00911300|50630618|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
25314800|NCT00911300|50630619|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
25076047|NCT00151775|50183647|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
25076048|NCT00151775|50183648|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
25076049|NCT00151775|50183649|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
25076050|NCT00151775|50183650|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
25076051|NCT00151775|50183639|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
25076052|NCT00151775|50183640|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
25076053|NCT00151775|50183641|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
25076054|NCT00151775|50183642|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
25076055|NCT00151775|50183643|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
25314801|NCT00911300|50630618|FG000|Overall Study|Received Commercial Treatment|1|||
25314802|NCT00911300|50630619|FG001|Overall Study|Received Commercial Treatment|0|||
25314803|NCT00911300|50630618|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
25314804|NCT00911300|50630619|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
25076056|NCT00151775|50183644|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
25076057|NCT00151775|50183645|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
25076058|NCT00151775|50183646|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
25076059|NCT00151775|50183647|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
25076060|NCT00151775|50183648|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
25076061|NCT00151775|50183649|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
25076062|NCT00151775|50183650|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
25076063|NCT00151775|50183639|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
25076064|NCT00151775|50183640|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
25076065|NCT00151775|50183641|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
25076066|NCT00151775|50183642|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
25076067|NCT00151775|50183643|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
25076068|NCT00151775|50183644|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
25076069|NCT00151775|50183645|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
25076070|NCT00151775|50183646|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
25076071|NCT00151775|50183647|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
25076072|NCT00151775|50183648|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
25076073|NCT00151775|50183649|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
25076074|NCT00151775|50183650|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
25076075|NCT00151775|50183639|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
25076076|NCT00151775|50183640|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
25076077|NCT00151775|50183641|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
25076078|NCT00151775|50183642|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
25076079|NCT00151775|50183643|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
25076080|NCT00151775|50183644|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
25076081|NCT00151775|50183645|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
25076082|NCT00151775|50183646|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
25076083|NCT00151775|50183647|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
25076084|NCT00151775|50183648|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
25076085|NCT00151775|50183649|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
25076086|NCT00151775|50183650|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
25076087|NCT00151775|50183639|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
25076088|NCT00151775|50183640|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
25076089|NCT00151775|50183641|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
25076090|NCT00151775|50183642|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
25076091|NCT00151775|50183643|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
25076092|NCT00151775|50183644|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
25076093|NCT00151775|50183645|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
25076094|NCT00151775|50183646|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
25076095|NCT00151775|50183647|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
25076096|NCT00151775|50183648|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
25076097|NCT00151775|50183649|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
25076098|NCT00151775|50183650|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
25076099|NCT00151775|50183639|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
25170149|NCT01819727|50304217|FG000|Overall Study|Quit due to lack of health benifits|0|||
25170150|NCT01819727|50304218|FG001|Overall Study|Quit due to lack of health benifits|1|||
25170151|NCT01795937|50304277|FG000|Overall Study|Withdrawal by Subject|1|||
25170152|NCT01795937|50304278|FG001|Overall Study|Withdrawal by Subject|0|||
25170153|NCT01795937|50304279|FG002|Overall Study|Withdrawal by Subject|0|||
25170154|NCT01795937|50304277|FG000|Overall Study|Physician Decision|0|||
24975259|NCT03635086|50063493|FG000|Overall Study|Withdrawal of consent|0|||
25314805|NCT00911300|50630618|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
25314806|NCT00911300|50630619|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
24975260|NCT03635086|50063494|FG001|Overall Study|Withdrawal of consent|0|||
24975261|NCT03635086|50063495|FG002|Overall Study|Withdrawal of consent|1|||
24975262|NCT03635086|50063496|FG003|Overall Study|Withdrawal of consent|0|||
24975263|NCT03635086|50063497|FG004|Overall Study|Withdrawal of consent|0|||
24975264|NCT03635086|50063493|FG000|Overall Study|Adverse Event|0|||
24975265|NCT03635086|50063494|FG001|Overall Study|Adverse Event|1|||
24975266|NCT03635086|50063495|FG002|Overall Study|Adverse Event|0|||
24975267|NCT03635086|50063496|FG003|Overall Study|Adverse Event|0|||
25076100|NCT00151775|50183640|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
25076101|NCT00151775|50183641|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
25076102|NCT00151775|50183642|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
25076103|NCT00151775|50183643|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
25170155|NCT01795937|50304278|FG001|Overall Study|Physician Decision|1|||
25170156|NCT01795937|50304279|FG002|Overall Study|Physician Decision|0|||
25170157|NCT01817777|50304321|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
25170158|NCT01817777|50304322|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
25170159|NCT01817777|50304323|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
25170160|NCT01817777|50304321|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
25314807|NCT00911300|50630618|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
24975268|NCT03635086|50063497|FG004|Overall Study|Adverse Event|0|||
24975269|NCT03635086|50063493|FG000|Overall Study|Lost to Follow-up|1|||
25076104|NCT00151775|50183644|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
25076105|NCT00151775|50183645|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
25076106|NCT00151775|50183646|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
25076107|NCT00151775|50183647|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
25076108|NCT00151775|50183648|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
25076109|NCT00151775|50183649|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
25076110|NCT00151775|50183650|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
25076111|NCT00151775|50183639|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
25076112|NCT00151775|50183640|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
25076113|NCT00151775|50183641|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
25076114|NCT00151775|50183642|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
25076115|NCT00151775|50183643|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
25076116|NCT00151775|50183644|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
25076117|NCT00151775|50183645|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
25076118|NCT00151775|50183646|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
25076119|NCT00151775|50183647|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
25076120|NCT00151775|50183648|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
25076121|NCT00151775|50183649|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
25076122|NCT00151775|50183650|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
25076123|NCT00151775|50183639|FG000|Period 4: Open Label|Increased blood pressure|0|||
25076124|NCT00151775|50183640|FG001|Period 4: Open Label|Increased blood pressure|0|||
25076125|NCT00151775|50183641|FG002|Period 4: Open Label|Increased blood pressure|0|||
25076126|NCT00151775|50183642|FG003|Period 4: Open Label|Increased blood pressure|0|||
25076127|NCT00151775|50183643|FG004|Period 4: Open Label|Increased blood pressure|1|||
25076128|NCT00151775|50183644|FG005|Period 4: Open Label|Increased blood pressure|0|||
25076129|NCT00151775|50183645|FG006|Period 4: Open Label|Increased blood pressure|0|||
25076130|NCT00151775|50183646|FG007|Period 4: Open Label|Increased blood pressure|0|||
25076131|NCT00151775|50183647|FG008|Period 4: Open Label|Increased blood pressure|0|||
25076132|NCT00151775|50183648|FG009|Period 4: Open Label|Increased blood pressure|1|||
25076133|NCT00151775|50183649|FG010|Period 4: Open Label|Increased blood pressure|0|||
25076134|NCT00151775|50183650|FG011|Period 4: Open Label|Increased blood pressure|0|||
25076135|NCT00151775|50183639|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
25076136|NCT00151775|50183640|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
25076137|NCT00151775|50183641|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
25076138|NCT00151775|50183642|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
25076139|NCT00151775|50183643|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
25076140|NCT00151775|50183644|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
25076141|NCT00151775|50183645|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
25076142|NCT00151775|50183646|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
25076143|NCT00151775|50183647|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
25076144|NCT00151775|50183648|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
25076145|NCT00151775|50183649|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
25076146|NCT00151775|50183650|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
25076147|NCT00151775|50183639|FG000|Period 4: Open Label|Adverse Event|0|||
25076148|NCT00151775|50183640|FG001|Period 4: Open Label|Adverse Event|0|||
25076149|NCT00151775|50183641|FG002|Period 4: Open Label|Adverse Event|0|||
25076150|NCT00151775|50183642|FG003|Period 4: Open Label|Adverse Event|0|||
25076151|NCT00151775|50183643|FG004|Period 4: Open Label|Adverse Event|1|||
25076152|NCT00151775|50183644|FG005|Period 4: Open Label|Adverse Event|0|||
25076153|NCT00151775|50183645|FG006|Period 4: Open Label|Adverse Event|0|||
25076154|NCT00151775|50183646|FG007|Period 4: Open Label|Adverse Event|0|||
25076155|NCT00151775|50183647|FG008|Period 4: Open Label|Adverse Event|0|||
25076156|NCT00151775|50183648|FG009|Period 4: Open Label|Adverse Event|2|||
25076157|NCT00151775|50183649|FG010|Period 4: Open Label|Adverse Event|0|||
25076158|NCT00151775|50183650|FG011|Period 4: Open Label|Adverse Event|0|||
25076159|NCT00151775|50183639|FG000|Period 4: Open Label|Lost to Follow-up|0|||
25076160|NCT00151775|50183640|FG001|Period 4: Open Label|Lost to Follow-up|0|||
25076161|NCT00151775|50183641|FG002|Period 4: Open Label|Lost to Follow-up|0|||
25076162|NCT00151775|50183642|FG003|Period 4: Open Label|Lost to Follow-up|0|||
24975270|NCT03635086|50063494|FG001|Overall Study|Lost to Follow-up|0|||
24975271|NCT03635086|50063495|FG002|Overall Study|Lost to Follow-up|0|||
24975272|NCT03635086|50063496|FG003|Overall Study|Lost to Follow-up|0|||
24975273|NCT03635086|50063497|FG004|Overall Study|Lost to Follow-up|0|||
24975274|NCT03588910|50063512|FG000|Overall Study|Withdrawal by Subject|1|||
24975275|NCT03588910|50063513|FG001|Overall Study|Withdrawal by Subject|0|||
24975276|NCT03588910|50063512|FG000|Overall Study|Allergy|2|||
24975277|NCT03588910|50063513|FG001|Overall Study|Allergy|0|||
24975278|NCT03588910|50063512|FG000|Overall Study|Protocol Violation|0|||
25076163|NCT00151775|50183643|FG004|Period 4: Open Label|Lost to Follow-up|17|||
24975279|NCT03588910|50063513|FG001|Overall Study|Protocol Violation|3|||
24975280|NCT03588910|50063512|FG000|Overall Study|Did not complete Day 1 Survey|5|||
25076164|NCT00151775|50183644|FG005|Period 4: Open Label|Lost to Follow-up|0|||
25076165|NCT00151775|50183645|FG006|Period 4: Open Label|Lost to Follow-up|0|||
25076166|NCT00151775|50183646|FG007|Period 4: Open Label|Lost to Follow-up|0|||
25076167|NCT00151775|50183647|FG008|Period 4: Open Label|Lost to Follow-up|0|||
25076168|NCT00151775|50183648|FG009|Period 4: Open Label|Lost to Follow-up|7|||
25076169|NCT00151775|50183649|FG010|Period 4: Open Label|Lost to Follow-up|0|||
25076170|NCT00151775|50183650|FG011|Period 4: Open Label|Lost to Follow-up|0|||
25076171|NCT00151775|50183639|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
25076172|NCT00151775|50183640|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
25076173|NCT00151775|50183641|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
25076174|NCT00151775|50183642|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
25076175|NCT00151775|50183643|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
25076176|NCT00151775|50183644|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
25076177|NCT00151775|50183645|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
25076178|NCT00151775|50183646|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
25076179|NCT00151775|50183647|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
25170161|NCT01817777|50304322|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
25170162|NCT01817777|50304323|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
25170163|NCT01817777|50304321|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
25170164|NCT01817777|50304322|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
24975281|NCT03588910|50063513|FG001|Overall Study|Did not complete Day 1 Survey|10|||
25170165|NCT01817777|50304323|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
25170166|NCT01817777|50304321|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
25170167|NCT01817777|50304322|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
25170168|NCT01817777|50304323|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
25170169|NCT01817777|50304321|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
25170170|NCT01817777|50304322|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
25170171|NCT01817777|50304323|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
25170172|NCT01795547|50304349|FG000|Overall Study|Adverse Event|16|||
25170173|NCT01795547|50304350|FG001|Overall Study|Adverse Event|27|||
25170174|NCT01795547|50304349|FG000|Overall Study|Lack of Efficacy|8|||
25170175|NCT01795547|50304350|FG001|Overall Study|Lack of Efficacy|3|||
25170176|NCT01795547|50304349|FG000|Overall Study|Protocol Violation|6|||
25170177|NCT01795547|50304350|FG001|Overall Study|Protocol Violation|4|||
25170178|NCT01795547|50304349|FG000|Overall Study|Lost to Follow-up|2|||
25170179|NCT01795547|50304350|FG001|Overall Study|Lost to Follow-up|5|||
25170180|NCT01795547|50304349|FG000|Overall Study|Withdrawal of consent|7|||
25170181|NCT01795547|50304350|FG001|Overall Study|Withdrawal of consent|12|||
25170182|NCT01795547|50304349|FG000|Overall Study|Not Treated|4|||
25170183|NCT01795547|50304350|FG001|Overall Study|Not Treated|10|||
25170184|NCT01795547|50304349|FG000|Overall Study|Non-compliance with IMP|1|||
25170185|NCT01795547|50304350|FG001|Overall Study|Non-compliance with IMP|1|||
25170186|NCT01795547|50304349|FG000|Overall Study|Others|4|||
25170187|NCT01795547|50304350|FG001|Overall Study|Others|1|||
25170188|NCT01795547|50304349|FG000|Overall Study|Not stated|0|||
25170189|NCT01795547|50304350|FG001|Overall Study|Not stated|1|||
25170190|NCT01794923|50304376|FG000|Overall Study|Adverse Event|0|||
25170191|NCT01794923|50304377|FG001|Overall Study|Adverse Event|0|||
25170192|NCT01794923|50304378|FG002|Overall Study|Adverse Event|1|||
25170193|NCT01794845|50304386|FG000|Overall Study|Withdrawal by Subject|1|||
25170194|NCT01794689|50304394|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
25170195|NCT01794689|50304395|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
25170196|NCT01794689|50304396|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
25170197|NCT01794689|50304397|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
25170198|NCT01794689|50304394|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
25170199|NCT01794689|50304395|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
25170200|NCT01794689|50304396|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
25170201|NCT01794689|50304397|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
25170202|NCT01794689|50304394|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
25170203|NCT01794689|50304395|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
25170204|NCT01794689|50304396|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
25170205|NCT01794689|50304397|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
25170206|NCT01794689|50304394|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
25076180|NCT00151775|50183648|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
25076181|NCT00151775|50183649|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
25170207|NCT01794689|50304395|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
25170208|NCT01794689|50304396|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
25170209|NCT01794689|50304397|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
25170210|NCT01794299|50304413|FG000|Overall Study|ATIR manufacturing not possible|1|||
25170211|NCT01794299|50304413|FG000|Overall Study|Death|14|||
25170212|NCT01794299|50304413|FG000|Overall Study|Graft failure|1|||
25170213|NCT01794299|50304413|FG000|Overall Study|ATIR batch rejected|2|||
25170214|NCT01794299|50304413|FG000|Overall Study|Relapse|2|||
24975282|NCT03588910|50063512|FG000|Overall Study|Did not complete Day 7 Survey|5|||
24975283|NCT03588910|50063513|FG001|Overall Study|Did not complete Day 7 Survey|2|||
24975284|NCT03587974|50063521|FG000|Overall Study|caregiver demented, care recipient died|3|||
24975285|NCT03587974|50063522|FG001|Overall Study|caregiver demented, care recipient died|3|||
24975286|NCT03587974|50063521|FG000|Overall Study|Withdrawal by Subject|2|||
24975287|NCT03587974|50063522|FG001|Overall Study|Withdrawal by Subject|1|||
24975288|NCT00103857|50063535|FG000|54-Week Base Study|Adverse Event|12|||
24975289|NCT00103857|50063536|FG001|54-Week Base Study|Adverse Event|9|||
25170215|NCT01794299|50304413|FG000|Overall Study|Discontinued from active follow-up|1|||
25170216|NCT01794299|50304413|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
25170217|NCT01817075|50304419|FG000|Overall Study|Adverse Event|7|||
25170218|NCT01817075|50304420|FG001|Overall Study|Adverse Event|5|||
25170219|NCT01817075|50304419|FG000|Overall Study|Physician Decision|9|||
25170220|NCT01817075|50304420|FG001|Overall Study|Physician Decision|12|||
25170221|NCT01817075|50304419|FG000|Overall Study|Withdrawal by Subject|31|||
25170222|NCT01817075|50304420|FG001|Overall Study|Withdrawal by Subject|15|||
25170223|NCT01817075|50304419|FG000|Overall Study|Received Sorafenib after enrollment|0|||
25170224|NCT01817075|50304420|FG001|Overall Study|Received Sorafenib after enrollment|1|||
25170225|NCT01817075|50304419|FG000|Overall Study|Ineligible|0|||
25170226|NCT01817075|50304420|FG001|Overall Study|Ineligible|2|||
25170227|NCT01816763|50304429|FG000|Overall Study|The main reason for an incomplete survey|4|||
25170228|NCT01816763|50304430|FG001|Overall Study|The main reason for an incomplete survey|15|||
25170229|NCT01816763|50304431|FG002|Overall Study|The main reason for an incomplete survey|11|||
25170230|NCT01816685|50304444|FG000|Overall Study|Lost to Follow-up|7|||
25170231|NCT01816685|50304445|FG001|Overall Study|Lost to Follow-up|9|||
25170232|NCT01816685|50304444|FG000|Overall Study|Surgery Cancelled|3|||
25170233|NCT01816685|50304445|FG001|Overall Study|Surgery Cancelled|2|||
25170234|NCT00708552|50304476|FG000|Overall Study|Adverse Event|10|||
25170235|NCT00708552|50304477|FG001|Overall Study|Adverse Event|3|||
25170236|NCT00708552|50304478|FG002|Overall Study|Adverse Event|4|||
25170237|NCT00708552|50304479|FG003|Overall Study|Adverse Event|6|||
25170238|NCT00708552|50304476|FG000|Overall Study|Lack of Efficacy|0|||
25170239|NCT00708552|50304477|FG001|Overall Study|Lack of Efficacy|4|||
25170240|NCT00708552|50304478|FG002|Overall Study|Lack of Efficacy|1|||
25170241|NCT00708552|50304479|FG003|Overall Study|Lack of Efficacy|0|||
25170242|NCT00708552|50304476|FG000|Overall Study|Protocol Violation|0|||
25170243|NCT00708552|50304477|FG001|Overall Study|Protocol Violation|0|||
25170244|NCT00708552|50304478|FG002|Overall Study|Protocol Violation|2|||
25170245|NCT00708552|50304479|FG003|Overall Study|Protocol Violation|4|||
25170246|NCT00708552|50304476|FG000|Overall Study|Lost to Follow-up|4|||
25170247|NCT00708552|50304477|FG001|Overall Study|Lost to Follow-up|2|||
25170248|NCT00708552|50304478|FG002|Overall Study|Lost to Follow-up|0|||
25170249|NCT00708552|50304479|FG003|Overall Study|Lost to Follow-up|1|||
25170250|NCT00708552|50304476|FG000|Overall Study|Physician Decision|1|||
25193027|NCT01389596|50361429|FG002|Overall Study|Death|0|||
25193028|NCT01389596|50361427|FG000|Overall Study|Other Unspecified|2|||
25193029|NCT01389596|50361428|FG001|Overall Study|Other Unspecified|1|||
24975290|NCT00103857|50063537|FG002|54-Week Base Study|Adverse Event|11|||
24975291|NCT00103857|50063538|FG003|54-Week Base Study|Adverse Event|6|||
24975292|NCT00103857|50063539|FG004|54-Week Base Study|Adverse Event|5|||
24975293|NCT00103857|50063540|FG005|54-Week Base Study|Adverse Event|11|||
24975294|NCT00103857|50063541|FG006|54-Week Base Study|Adverse Event|3|||
24975295|NCT00103857|50063535|FG000|54-Week Base Study|Death|0|||
24975296|NCT00103857|50063536|FG001|54-Week Base Study|Death|0|||
24975297|NCT00103857|50063537|FG002|54-Week Base Study|Death|0|||
24975298|NCT00103857|50063538|FG003|54-Week Base Study|Death|0|||
24975299|NCT00103857|50063539|FG004|54-Week Base Study|Death|1|||
24975300|NCT00103857|50063540|FG005|54-Week Base Study|Death|1|||
24975301|NCT00103857|50063541|FG006|54-Week Base Study|Death|0|||
24975302|NCT00103857|50063535|FG000|54-Week Base Study|Lack of Efficacy|11|||
24975303|NCT00103857|50063536|FG001|54-Week Base Study|Lack of Efficacy|14|||
25170251|NCT00708552|50304477|FG001|Overall Study|Physician Decision|2|||
25170252|NCT00708552|50304478|FG002|Overall Study|Physician Decision|0|||
25170253|NCT00708552|50304479|FG003|Overall Study|Physician Decision|0|||
25170254|NCT00708552|50304476|FG000|Overall Study|Withdrawal by Subject|12|||
25193030|NCT01389596|50361429|FG002|Overall Study|Other Unspecified|0|||
24975304|NCT00103857|50063537|FG002|54-Week Base Study|Lack of Efficacy|8|||
24975305|NCT00103857|50063538|FG003|54-Week Base Study|Lack of Efficacy|4|||
25076182|NCT00151775|50183650|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
25076183|NCT00151775|50183639|FG000|Period 4: Open Label|Other|0|||
25076184|NCT00151775|50183640|FG001|Period 4: Open Label|Other|0|||
25076185|NCT00151775|50183641|FG002|Period 4: Open Label|Other|0|||
25076186|NCT00151775|50183642|FG003|Period 4: Open Label|Other|0|||
25076187|NCT00151775|50183643|FG004|Period 4: Open Label|Other|1|||
25076188|NCT00151775|50183644|FG005|Period 4: Open Label|Other|0|||
25076189|NCT00151775|50183645|FG006|Period 4: Open Label|Other|0|||
25076190|NCT00151775|50183646|FG007|Period 4: Open Label|Other|0|||
25076191|NCT00151775|50183647|FG008|Period 4: Open Label|Other|0|||
25076192|NCT00151775|50183648|FG009|Period 4: Open Label|Other|3|||
25076193|NCT00151775|50183649|FG010|Period 4: Open Label|Other|0|||
25076194|NCT00151775|50183650|FG011|Period 4: Open Label|Other|0|||
24975306|NCT00103857|50063539|FG004|54-Week Base Study|Lack of Efficacy|3|||
24975307|NCT00103857|50063540|FG005|54-Week Base Study|Lack of Efficacy|14|||
24975308|NCT00103857|50063541|FG006|54-Week Base Study|Lack of Efficacy|19|||
24975309|NCT00103857|50063535|FG000|54-Week Base Study|Lost to Follow-up|5|||
24975310|NCT00103857|50063536|FG001|54-Week Base Study|Lost to Follow-up|4|||
24975311|NCT00103857|50063537|FG002|54-Week Base Study|Lost to Follow-up|7|||
24975312|NCT00103857|50063538|FG003|54-Week Base Study|Lost to Follow-up|5|||
24975313|NCT00103857|50063539|FG004|54-Week Base Study|Lost to Follow-up|10|||
24975314|NCT00103857|50063540|FG005|54-Week Base Study|Lost to Follow-up|9|||
24975315|NCT00103857|50063541|FG006|54-Week Base Study|Lost to Follow-up|3|||
24975316|NCT00103857|50063535|FG000|54-Week Base Study|Physician Decision|1|||
24975317|NCT00103857|50063536|FG001|54-Week Base Study|Physician Decision|1|||
24975318|NCT00103857|50063537|FG002|54-Week Base Study|Physician Decision|0|||
24975319|NCT00103857|50063538|FG003|54-Week Base Study|Physician Decision|0|||
24975320|NCT00103857|50063539|FG004|54-Week Base Study|Physician Decision|1|||
24975321|NCT00103857|50063540|FG005|54-Week Base Study|Physician Decision|0|||
24975322|NCT00103857|50063541|FG006|54-Week Base Study|Physician Decision|0|||
24975323|NCT00103857|50063535|FG000|54-Week Base Study|Pregnancy|1|||
24975324|NCT00103857|50063536|FG001|54-Week Base Study|Pregnancy|0|||
24975325|NCT00103857|50063537|FG002|54-Week Base Study|Pregnancy|0|||
24975326|NCT00103857|50063538|FG003|54-Week Base Study|Pregnancy|0|||
24975327|NCT00103857|50063539|FG004|54-Week Base Study|Pregnancy|1|||
24975328|NCT00103857|50063540|FG005|54-Week Base Study|Pregnancy|0|||
24975329|NCT00103857|50063541|FG006|54-Week Base Study|Pregnancy|1|||
24975330|NCT00103857|50063535|FG000|54-Week Base Study|Protocol Violation|6|||
24975331|NCT00103857|50063536|FG001|54-Week Base Study|Protocol Violation|4|||
24975332|NCT00103857|50063537|FG002|54-Week Base Study|Protocol Violation|2|||
24975333|NCT00103857|50063538|FG003|54-Week Base Study|Protocol Violation|4|||
24975334|NCT00103857|50063539|FG004|54-Week Base Study|Protocol Violation|0|||
24975335|NCT00103857|50063540|FG005|54-Week Base Study|Protocol Violation|3|||
24975336|NCT00103857|50063541|FG006|54-Week Base Study|Protocol Violation|3|||
24975337|NCT00103857|50063535|FG000|54-Week Base Study|Withdrawal by Subject|17|||
24975338|NCT00103857|50063536|FG001|54-Week Base Study|Withdrawal by Subject|16|||
24975339|NCT00103857|50063537|FG002|54-Week Base Study|Withdrawal by Subject|16|||
24975340|NCT00103857|50063538|FG003|54-Week Base Study|Withdrawal by Subject|15|||
24975341|NCT00103857|50063539|FG004|54-Week Base Study|Withdrawal by Subject|10|||
24975342|NCT00103857|50063540|FG005|54-Week Base Study|Withdrawal by Subject|15|||
24975343|NCT00103857|50063541|FG006|54-Week Base Study|Withdrawal by Subject|4|||
24975344|NCT00103857|50063535|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
24975345|NCT00103857|50063536|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
24975346|NCT00103857|50063537|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
24975347|NCT00103857|50063538|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
24975348|NCT00103857|50063539|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
25076195|NCT00151775|50183639|FG000|Period 4: Open Label|Physician Decision|0|||
24975349|NCT00103857|50063540|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
24975350|NCT00103857|50063541|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
24975351|NCT00103857|50063535|FG000|54-Week Base Study|patient moved|0|||
24975352|NCT00103857|50063536|FG001|54-Week Base Study|patient moved|1|||
24975353|NCT00103857|50063537|FG002|54-Week Base Study|patient moved|1|||
24975354|NCT00103857|50063538|FG003|54-Week Base Study|patient moved|2|||
24975355|NCT00103857|50063539|FG004|54-Week Base Study|patient moved|3|||
25076196|NCT00151775|50183640|FG001|Period 4: Open Label|Physician Decision|0|||
25076197|NCT00151775|50183641|FG002|Period 4: Open Label|Physician Decision|0|||
24975356|NCT00103857|50063540|FG005|54-Week Base Study|patient moved|1|||
24975357|NCT00103857|50063541|FG006|54-Week Base Study|patient moved|0|||
24975358|NCT00103857|50063535|FG000|54-Week Base Study|non-compliance with study procedures|1|||
24975359|NCT00103857|50063536|FG001|54-Week Base Study|non-compliance with study procedures|2|||
24975360|NCT00103857|50063537|FG002|54-Week Base Study|non-compliance with study procedures|0|||
24975361|NCT00103857|50063538|FG003|54-Week Base Study|non-compliance with study procedures|0|||
24975362|NCT00103857|50063539|FG004|54-Week Base Study|non-compliance with study procedures|0|||
24975363|NCT00103857|50063540|FG005|54-Week Base Study|non-compliance with study procedures|2|||
25076198|NCT00151775|50183642|FG003|Period 4: Open Label|Physician Decision|0|||
24975364|NCT00103857|50063541|FG006|54-Week Base Study|non-compliance with study procedures|0|||
24975365|NCT00103857|50063535|FG000|54-Week Base Study|patient incarcerated|0|||
25076199|NCT00151775|50183643|FG004|Period 4: Open Label|Physician Decision|0|||
25076200|NCT00151775|50183644|FG005|Period 4: Open Label|Physician Decision|0|||
25076201|NCT00151775|50183645|FG006|Period 4: Open Label|Physician Decision|0|||
25076202|NCT00151775|50183646|FG007|Period 4: Open Label|Physician Decision|0|||
25076203|NCT00151775|50183647|FG008|Period 4: Open Label|Physician Decision|0|||
25076204|NCT00151775|50183648|FG009|Period 4: Open Label|Physician Decision|2|||
25076205|NCT00151775|50183649|FG010|Period 4: Open Label|Physician Decision|0|||
25076206|NCT00151775|50183650|FG011|Period 4: Open Label|Physician Decision|0|||
25076207|NCT00151775|50183639|FG000|Period 4: Open Label|Protocol Violation|0|||
25076208|NCT00151775|50183640|FG001|Period 4: Open Label|Protocol Violation|0|||
25076209|NCT00151775|50183641|FG002|Period 4: Open Label|Protocol Violation|0|||
25076210|NCT00151775|50183642|FG003|Period 4: Open Label|Protocol Violation|0|||
25076211|NCT00151775|50183643|FG004|Period 4: Open Label|Protocol Violation|1|||
25076212|NCT00151775|50183644|FG005|Period 4: Open Label|Protocol Violation|0|||
25076213|NCT00151775|50183645|FG006|Period 4: Open Label|Protocol Violation|0|||
25076214|NCT00151775|50183646|FG007|Period 4: Open Label|Protocol Violation|0|||
25076215|NCT00151775|50183647|FG008|Period 4: Open Label|Protocol Violation|0|||
25076216|NCT00151775|50183648|FG009|Period 4: Open Label|Protocol Violation|0|||
25076217|NCT00151775|50183649|FG010|Period 4: Open Label|Protocol Violation|0|||
25076218|NCT00151775|50183650|FG011|Period 4: Open Label|Protocol Violation|0|||
25076219|NCT02258464|50183693|FG000|Overall Study|Progressive disease (PD)|9|||
25076220|NCT02258464|50183694|FG001|Overall Study|Progressive disease (PD)|17|||
25076221|NCT02258464|50183693|FG000|Overall Study|Study drug never administered|1|||
25076222|NCT02258464|50183694|FG001|Overall Study|Study drug never administered|1|||
25076223|NCT02258464|50183693|FG000|Overall Study|AE not related to clinical PD|1|||
25076224|NCT02258464|50183694|FG001|Overall Study|AE not related to clinical PD|3|||
25076225|NCT02258464|50183693|FG000|Overall Study|Withdrawal by Subject|5|||
25076226|NCT02258464|50183694|FG001|Overall Study|Withdrawal by Subject|4|||
25076227|NCT02258464|50183693|FG000|Overall Study|AE related to clinical PD|1|||
25076228|NCT02258464|50183694|FG001|Overall Study|AE related to clinical PD|0|||
25076229|NCT02682901|50183702|FG000|Overall Study|Adverse Event|10|||
25076230|NCT02682901|50183703|FG001|Overall Study|Adverse Event|3|||
25076231|NCT02682901|50183702|FG000|Overall Study|Lack of Efficacy|0|||
25076232|NCT02682901|50183703|FG001|Overall Study|Lack of Efficacy|1|||
25076233|NCT02258074|50183713|FG000|Overall Study|Withdrawal by Subject|1|||
25076234|NCT02258074|50183714|FG001|Overall Study|Withdrawal by Subject|0|||
25076235|NCT02258074|50183715|FG002|Overall Study|Withdrawal by Subject|0|||
25076236|NCT02258074|50183716|FG003|Overall Study|Withdrawal by Subject|0|||
25076237|NCT01643044|50183728|FG000|Overall Study|Lost to Follow-up|1|||
25076238|NCT01643044|50183729|FG001|Overall Study|Lost to Follow-up|1|||
25076239|NCT01643044|50183728|FG000|Overall Study|Miscarried baby|2|||
25193031|NCT01405898|50361465|FG000|Overall Study|Withdrawal by Subject|2|||
25193032|NCT01405898|50361466|FG001|Overall Study|Withdrawal by Subject|2|||
24975366|NCT00103857|50063536|FG001|54-Week Base Study|patient incarcerated|0|||
24975367|NCT00103857|50063537|FG002|54-Week Base Study|patient incarcerated|0|||
24975368|NCT00103857|50063538|FG003|54-Week Base Study|patient incarcerated|0|||
24975369|NCT00103857|50063539|FG004|54-Week Base Study|patient incarcerated|1|||
24975370|NCT00103857|50063540|FG005|54-Week Base Study|patient incarcerated|1|||
24975371|NCT00103857|50063541|FG006|54-Week Base Study|patient incarcerated|0|||
24975372|NCT00103857|50063535|FG000|54-Week Base Study|laboratory reporting error|0|||
24975373|NCT00103857|50063536|FG001|54-Week Base Study|laboratory reporting error|0|||
24975374|NCT00103857|50063537|FG002|54-Week Base Study|laboratory reporting error|0|||
24975375|NCT00103857|50063538|FG003|54-Week Base Study|laboratory reporting error|0|||
24975376|NCT00103857|50063539|FG004|54-Week Base Study|laboratory reporting error|1|||
24975377|NCT00103857|50063540|FG005|54-Week Base Study|laboratory reporting error|0|||
24975378|NCT00103857|50063541|FG006|54-Week Base Study|laboratory reporting error|0|||
24975379|NCT00103857|50063535|FG000|54-Week Base Study|site error|0|||
24975380|NCT00103857|50063536|FG001|54-Week Base Study|site error|0|||
24975381|NCT00103857|50063537|FG002|54-Week Base Study|site error|0|||
24975382|NCT00103857|50063538|FG003|54-Week Base Study|site error|0|||
24975383|NCT00103857|50063539|FG004|54-Week Base Study|site error|0|||
24975384|NCT00103857|50063540|FG005|54-Week Base Study|site error|1|||
24975385|NCT00103857|50063541|FG006|54-Week Base Study|site error|0|||
24975386|NCT00103857|50063535|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
25193033|NCT01389128|50361492|FG000|Overall Study|Fetal distress|1|||
24975387|NCT00103857|50063536|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
24975388|NCT00103857|50063537|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
25076240|NCT01643044|50183729|FG001|Overall Study|Miscarried baby|2|||
25076241|NCT01643044|50183728|FG000|Overall Study|Delivered outside of hospital|1|||
25193034|NCT01389128|50361493|FG001|Overall Study|Fetal distress|0|||
24975389|NCT00103857|50063538|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
25076242|NCT01643044|50183729|FG001|Overall Study|Delivered outside of hospital|2|||
25193035|NCT01389128|50361492|FG000|Overall Study|Cervix dilation stop|1|||
25076243|NCT01642732|50183735|FG000|Overall Study|Withdrawal by Subject|1|||
25076244|NCT02257684|50183739|FG000|Overall Study|Adverse Event|2|||
25076245|NCT02257684|50183739|FG000|Overall Study|Lack of Efficacy|1|||
25076246|NCT02257684|50183739|FG000|Overall Study|Sponsor's Decision|1|||
25076247|NCT02190721|50183746|FG000|Overall Study|Patient was out of the city|0|||
25193036|NCT01389128|50361493|FG001|Overall Study|Cervix dilation stop|2|||
25193037|NCT01389128|50361492|FG000|Overall Study|Rapid labor evolution|3|||
25193038|NCT01389128|50361493|FG001|Overall Study|Rapid labor evolution|2|||
25193039|NCT01389128|50361492|FG000|Overall Study|Intolerance to procedure|0|||
25193040|NCT01389128|50361493|FG001|Overall Study|Intolerance to procedure|2|||
24975390|NCT00103857|50063539|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
24975391|NCT00103857|50063540|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
24975392|NCT00103857|50063541|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
24975393|NCT00103857|50063535|FG000|50-Week Extension Study|Adverse Event|2|||
24975394|NCT00103857|50063536|FG001|50-Week Extension Study|Adverse Event|3|||
24975395|NCT00103857|50063537|FG002|50-Week Extension Study|Adverse Event|2|||
24975396|NCT00103857|50063538|FG003|50-Week Extension Study|Adverse Event|0|||
25076248|NCT02190721|50183747|FG001|Overall Study|Patient was out of the city|1|||
25076249|NCT02190721|50183748|FG002|Overall Study|Patient was out of the city|0|||
25076250|NCT00581477|50183756|FG000|Overall Study|Physician Decision|2|||
25076251|NCT02348008|50183772|FG000|Overall Study|Adverse Event|2|||
25076252|NCT02348008|50183773|FG001|Overall Study|Adverse Event|3|||
25076253|NCT02348008|50183774|FG002|Overall Study|Adverse Event|3|||
25076254|NCT02348008|50183772|FG000|Overall Study|Disease Progression|1|||
25076255|NCT02348008|50183773|FG001|Overall Study|Disease Progression|5|||
25076256|NCT02348008|50183774|FG002|Overall Study|Disease Progression|16|||
25076257|NCT02348008|50183772|FG000|Overall Study|Withdrawal by Subject|0|||
25076258|NCT02348008|50183773|FG001|Overall Study|Withdrawal by Subject|1|||
25076259|NCT02348008|50183774|FG002|Overall Study|Withdrawal by Subject|0|||
25076260|NCT02348008|50183772|FG000|Overall Study|Symptomatic Deterioration|0|||
25076261|NCT02348008|50183773|FG001|Overall Study|Symptomatic Deterioration|1|||
25076262|NCT02348008|50183774|FG002|Overall Study|Symptomatic Deterioration|0|||
25076263|NCT00495131|50183782|FG000|Overall Study|Adverse Event|6|||
25076264|NCT00495131|50183783|FG001|Overall Study|Adverse Event|2|||
25076265|NCT00495131|50183782|FG000|Overall Study|Lack of Efficacy|0|||
25076266|NCT00495131|50183783|FG001|Overall Study|Lack of Efficacy|2|||
25076267|NCT00495131|50183782|FG000|Overall Study|Lost to Follow-up|0|||
25076268|NCT00495131|50183783|FG001|Overall Study|Lost to Follow-up|2|||
25076269|NCT00495131|50183782|FG000|Overall Study|Withdrawal by Subject|1|||
25076270|NCT00495131|50183783|FG001|Overall Study|Withdrawal by Subject|0|||
25076271|NCT02257372|50183789|FG000|Overall Study|Adverse Event|3|||
25076272|NCT02257372|50183790|FG001|Overall Study|Adverse Event|7|||
25076273|NCT02257372|50183789|FG000|Overall Study|Lack of Efficacy|2|||
25076274|NCT02257372|50183790|FG001|Overall Study|Lack of Efficacy|1|||
25076275|NCT02257372|50183789|FG000|Overall Study|Protocol Violation|1|||
25076276|NCT02257372|50183790|FG001|Overall Study|Protocol Violation|1|||
25076277|NCT02257372|50183789|FG000|Overall Study|Lost to Follow-up|0|||
25076278|NCT02257372|50183790|FG001|Overall Study|Lost to Follow-up|1|||
25076279|NCT02257372|50183789|FG000|Overall Study|Withdrew consent|1|||
25076280|NCT02257372|50183790|FG001|Overall Study|Withdrew consent|0|||
25076281|NCT02256982|50183798|FG000|Overall Study|Disease Progression|0|||
25076282|NCT02256982|50183799|FG001|Overall Study|Disease Progression|1|||
25076283|NCT02736721|50183805|FG000|Overall Study|Adverse Event|8|||
25076284|NCT02736721|50183805|FG000|Overall Study|Lost to Follow-up|3|||
25076285|NCT02736721|50183805|FG000|Overall Study|Other|5|||
25076286|NCT04176445|50183809|FG000|Overall Study|Adverse Event|0|||
25076287|NCT04176445|50183810|FG001|Overall Study|Adverse Event|1|||
25076288|NCT04176445|50183809|FG000|Overall Study|change plans weaning after first intervention|0|||
25076289|NCT04176445|50183810|FG001|Overall Study|change plans weaning after first intervention|1|||
25076290|NCT02738203|50183818|FG000|Overall Study|Failed IUD Insertion|2|||
25076291|NCT02738203|50183819|FG001|Overall Study|Failed IUD Insertion|2|||
25076292|NCT02738203|50183818|FG000|Overall Study|Protocol Violation|0|||
25076293|NCT02738203|50183819|FG001|Overall Study|Protocol Violation|1|||
25076294|NCT02452034|50183831|FG000|Overall Study|Adverse Event|0|||
25170255|NCT00708552|50304477|FG001|Overall Study|Withdrawal by Subject|7|||
25170256|NCT00708552|50304478|FG002|Overall Study|Withdrawal by Subject|8|||
25170257|NCT00708552|50304479|FG003|Overall Study|Withdrawal by Subject|10|||
25170258|NCT01816295|50304609|FG000|Double Blind Phase|Adverse Event|11|||
25170259|NCT01816295|50304610|FG001|Double Blind Phase|Adverse Event|8|||
25170260|NCT01816295|50304609|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
25170261|NCT01816295|50304610|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
25170262|NCT01816295|50304609|FG000|Double Blind Phase|Lost to Follow-up|3|||
25170263|NCT01816295|50304610|FG001|Double Blind Phase|Lost to Follow-up|5|||
25170264|NCT01816295|50304609|FG000|Double Blind Phase|Physician Decision|2|||
25076295|NCT02452034|50183832|FG001|Overall Study|Adverse Event|0|||
25076296|NCT02452034|50183833|FG002|Overall Study|Adverse Event|0|||
25076297|NCT02452034|50183834|FG003|Overall Study|Adverse Event|0|||
25076298|NCT02452034|50183835|FG004|Overall Study|Adverse Event|0|||
25076299|NCT02452034|50183836|FG005|Overall Study|Adverse Event|1|||
25076300|NCT02452034|50183831|FG000|Overall Study|Death|0|||
25076301|NCT02452034|50183832|FG001|Overall Study|Death|0|||
25076302|NCT02452034|50183833|FG002|Overall Study|Death|0|||
25076303|NCT02452034|50183834|FG003|Overall Study|Death|0|||
25076304|NCT02452034|50183835|FG004|Overall Study|Death|1|||
25076305|NCT02452034|50183836|FG005|Overall Study|Death|1|||
25076306|NCT02452034|50183831|FG000|Overall Study|Physician Decision|0|||
25076307|NCT02452034|50183832|FG001|Overall Study|Physician Decision|1|||
25076308|NCT02452034|50183833|FG002|Overall Study|Physician Decision|1|||
25076309|NCT02452034|50183834|FG003|Overall Study|Physician Decision|0|||
25076310|NCT02452034|50183835|FG004|Overall Study|Physician Decision|0|||
25076311|NCT02452034|50183836|FG005|Overall Study|Physician Decision|0|||
25076312|NCT02452034|50183831|FG000|Overall Study|Protocol Violation|0|||
25076313|NCT02452034|50183832|FG001|Overall Study|Protocol Violation|0|||
25076314|NCT02452034|50183833|FG002|Overall Study|Protocol Violation|0|||
25076315|NCT02452034|50183834|FG003|Overall Study|Protocol Violation|0|||
25076316|NCT02452034|50183835|FG004|Overall Study|Protocol Violation|0|||
25076317|NCT02452034|50183836|FG005|Overall Study|Protocol Violation|1|||
25076318|NCT02452034|50183831|FG000|Overall Study|Screen Failure|1|||
25076319|NCT02452034|50183832|FG001|Overall Study|Screen Failure|0|||
25076320|NCT02452034|50183833|FG002|Overall Study|Screen Failure|0|||
25076321|NCT02452034|50183834|FG003|Overall Study|Screen Failure|1|||
25076322|NCT02452034|50183835|FG004|Overall Study|Screen Failure|0|||
25076323|NCT02452034|50183836|FG005|Overall Study|Screen Failure|0|||
25076324|NCT02452034|50183831|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
25076325|NCT02452034|50183832|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
25076326|NCT02452034|50183833|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
25076327|NCT02452034|50183834|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
25076328|NCT02452034|50183835|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
25076329|NCT02452034|50183836|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
25076330|NCT02482298|50183863|FG000|Overall Study|Withdrawal by Subject|2|||
25076331|NCT02482298|50183864|FG001|Overall Study|Withdrawal by Subject|1|||
25076332|NCT02482298|50183865|FG002|Overall Study|Withdrawal by Subject|2|||
25076333|NCT02482298|50183863|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
25193041|NCT01388816|50361524|FG000|Overall Study|Adverse Event|0|||
25193042|NCT01388816|50361525|FG001|Overall Study|Adverse Event|2|||
25193043|NCT01388816|50361526|FG002|Overall Study|Adverse Event|0|||
25193044|NCT01388816|50361527|FG003|Overall Study|Adverse Event|0|||
25193045|NCT01388816|50361524|FG000|Overall Study|Lost to Follow-up|0|||
25193046|NCT01388816|50361525|FG001|Overall Study|Lost to Follow-up|1|||
25193047|NCT01388816|50361526|FG002|Overall Study|Lost to Follow-up|0|||
25193048|NCT01388816|50361527|FG003|Overall Study|Lost to Follow-up|0|||
25193049|NCT01388816|50361524|FG000|Overall Study|Withdrawal by Subject|2|||
25193050|NCT01388816|50361525|FG001|Overall Study|Withdrawal by Subject|1|||
25193051|NCT01388816|50361526|FG002|Overall Study|Withdrawal by Subject|1|||
25193052|NCT01388816|50361527|FG003|Overall Study|Withdrawal by Subject|0|||
25193053|NCT01388816|50361524|FG000|Overall Study|Protocol Violation|0|||
25193054|NCT01388816|50361525|FG001|Overall Study|Protocol Violation|0|||
25193055|NCT01388816|50361526|FG002|Overall Study|Protocol Violation|2|||
25193056|NCT01388816|50361527|FG003|Overall Study|Protocol Violation|0|||
25193057|NCT00555477|50361681|FG000|Overall Study|Adverse Event|0|||
25193058|NCT00555477|50361682|FG001|Overall Study|Adverse Event|9|||
25193059|NCT00555477|50361681|FG000|Overall Study|Withdrawal by Subject|1|||
25193060|NCT00555477|50361682|FG001|Overall Study|Withdrawal by Subject|2|||
25193061|NCT00555477|50361681|FG000|Overall Study|Physician Decision|1|||
25193062|NCT00555477|50361682|FG001|Overall Study|Physician Decision|2|||
25193063|NCT00554619|50361699|FG000|Overall Study|Adverse Event|1|||
25193064|NCT00554619|50361699|FG000|Overall Study|Physician Decision|1|||
25193065|NCT00554619|50361699|FG000|Overall Study|Liver Function Test Abnormality|1|||
25193066|NCT01426412|50361759|FG000|Overall Study|Withdrawal by Subject|1|||
25193067|NCT01426412|50361760|FG001|Overall Study|Withdrawal by Subject|0|||
25193068|NCT01426412|50361761|FG002|Overall Study|Withdrawal by Subject|0|||
25193069|NCT01426412|50361762|FG003|Overall Study|Withdrawal by Subject|0|||
25076334|NCT02482298|50183864|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
25193070|NCT01426412|50361763|FG004|Overall Study|Withdrawal by Subject|1|||
25076335|NCT02482298|50183865|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
25076336|NCT02482298|50183863|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
25076337|NCT02482298|50183864|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
25076338|NCT02482298|50183865|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
25076339|NCT02482298|50183863|FG000|Overall Study|Lost to Follow-up|0|||
25076340|NCT02482298|50183864|FG001|Overall Study|Lost to Follow-up|1|||
25076341|NCT02482298|50183865|FG002|Overall Study|Lost to Follow-up|0|||
25076342|NCT00440531|50183876|FG000|Overall Study|Adverse Event|1|||
25193071|NCT01426412|50361764|FG005|Overall Study|Withdrawal by Subject|0|||
25193072|NCT01426412|50361765|FG006|Overall Study|Withdrawal by Subject|0|||
25193073|NCT01426412|50361766|FG007|Overall Study|Withdrawal by Subject|3|||
25076343|NCT00440531|50183877|FG001|Overall Study|Adverse Event|0|||
25076344|NCT00440531|50183878|FG002|Overall Study|Adverse Event|2|||
25076345|NCT00440531|50183876|FG000|Overall Study|Withdrawal by Subject|2|||
25076346|NCT00440531|50183877|FG001|Overall Study|Withdrawal by Subject|0|||
25076347|NCT00440531|50183878|FG002|Overall Study|Withdrawal by Subject|0|||
25076348|NCT00440531|50183876|FG000|Overall Study|Protocol Violation|1|||
25193074|NCT01426412|50361767|FG008|Overall Study|Withdrawal by Subject|1|||
25193075|NCT00554229|50361971|FG000|Overall Study|Lost to Follow-up|3|||
25193076|NCT00554229|50361972|FG001|Overall Study|Lost to Follow-up|6|||
25193077|NCT00554229|50361971|FG000|Overall Study|Withdrawal by Subject|29|||
25193078|NCT00554229|50361972|FG001|Overall Study|Withdrawal by Subject|37|||
25193079|NCT00554229|50361971|FG000|Overall Study|Adverse Event|71|||
25193080|NCT00554229|50361972|FG001|Overall Study|Adverse Event|39|||
25193081|NCT00554229|50361971|FG000|Overall Study|Protocol Violation|3|||
25193082|NCT00554229|50361972|FG001|Overall Study|Protocol Violation|3|||
25193083|NCT00554229|50361971|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
25193084|NCT00554229|50361972|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
25193085|NCT00554229|50361971|FG000|Overall Study|Randomised but no treatment received|1|||
25193086|NCT00554229|50361972|FG001|Overall Study|Randomised but no treatment received|0|||
25193087|NCT05065983|50362052|FG000|Overall Study|Lost to Follow-up|2|||
25193088|NCT01405820|50362086|FG000|Randomized Treatment Period|Adverse Event|3|||
25193089|NCT01405820|50362087|FG001|Randomized Treatment Period|Adverse Event|3|||
25193090|NCT01405820|50362088|FG002|Randomized Treatment Period|Adverse Event|3|||
25193091|NCT01405820|50362089|FG003|Randomized Treatment Period|Adverse Event|0|||
25193092|NCT01405820|50362090|FG004|Randomized Treatment Period|Adverse Event|2|||
25193093|NCT01405820|50362091|FG005|Randomized Treatment Period|Adverse Event|1|||
25193094|NCT01405820|50362086|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
25193095|NCT01405820|50362087|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
25193096|NCT01405820|50362088|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
25193097|NCT01405820|50362089|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
25193098|NCT01405820|50362090|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
25193099|NCT01405820|50362091|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
25193100|NCT01405820|50362086|FG000|Randomized Treatment Period|Other|2|||
25193101|NCT01405820|50362087|FG001|Randomized Treatment Period|Other|2|||
25193102|NCT01405820|50362088|FG002|Randomized Treatment Period|Other|1|||
25193103|NCT01405820|50362089|FG003|Randomized Treatment Period|Other|1|||
25193104|NCT01405820|50362090|FG004|Randomized Treatment Period|Other|0|||
25193105|NCT01405820|50362091|FG005|Randomized Treatment Period|Other|0|||
25193106|NCT01405820|50362086|FG000|Randomized Treatment Period|Physician Decision|0|||
25193107|NCT01405820|50362087|FG001|Randomized Treatment Period|Physician Decision|2|||
25193108|NCT01405820|50362088|FG002|Randomized Treatment Period|Physician Decision|1|||
25193109|NCT01405820|50362089|FG003|Randomized Treatment Period|Physician Decision|0|||
25193110|NCT01405820|50362090|FG004|Randomized Treatment Period|Physician Decision|0|||
25193111|NCT01405820|50362091|FG005|Randomized Treatment Period|Physician Decision|0|||
25193112|NCT01405820|50362086|FG000|Randomized Treatment Period|Rescue|0|||
25193113|NCT01405820|50362087|FG001|Randomized Treatment Period|Rescue|1|||
25193114|NCT01405820|50362088|FG002|Randomized Treatment Period|Rescue|13|||
25193115|NCT01405820|50362089|FG003|Randomized Treatment Period|Rescue|10|||
25193116|NCT01405820|50362090|FG004|Randomized Treatment Period|Rescue|8|||
25193117|NCT01405820|50362091|FG005|Randomized Treatment Period|Rescue|8|||
25193118|NCT01405820|50362086|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
25193119|NCT01405820|50362087|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
25193120|NCT01405820|50362088|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
25193121|NCT01405820|50362089|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
25193122|NCT01405820|50362090|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
25193123|NCT01405820|50362091|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
25193124|NCT01405820|50362086|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
25193125|NCT01405820|50362087|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
25193126|NCT01405820|50362088|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
25193127|NCT01405820|50362089|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
25076349|NCT00440531|50183877|FG001|Overall Study|Protocol Violation|2|||
25076350|NCT00440531|50183878|FG002|Overall Study|Protocol Violation|0|||
25076351|NCT00440531|50183876|FG000|Overall Study|Lost to Follow-up|4|||
25076352|NCT00440531|50183877|FG001|Overall Study|Lost to Follow-up|3|||
25076353|NCT00440531|50183878|FG002|Overall Study|Lost to Follow-up|5|||
25076354|NCT00440531|50183876|FG000|Overall Study|see pre-assignment details|2|||
25076355|NCT00440531|50183877|FG001|Overall Study|see pre-assignment details|0|||
25076356|NCT00440531|50183878|FG002|Overall Study|see pre-assignment details|0|||
25076357|NCT02513732|50183884|FG000|Overall Study|Lost to Follow-up|11|||
25076358|NCT02513732|50183884|FG000|Overall Study|Death|9|||
25076359|NCT02513732|50183884|FG000|Overall Study|Changing hospital|2|||
25193128|NCT01405820|50362090|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
25076360|NCT00429923|50183891|FG000|Overall Study|Adverse Event|0|||
25076361|NCT00429923|50183892|FG001|Overall Study|Adverse Event|2|||
25076362|NCT00429923|50183893|FG002|Overall Study|Adverse Event|3|||
24975397|NCT00103857|50063539|FG004|50-Week Extension Study|Adverse Event|1|||
24975398|NCT00103857|50063540|FG005|50-Week Extension Study|Adverse Event|1|||
24975399|NCT00103857|50063541|FG006|50-Week Extension Study|Adverse Event|0|||
24975400|NCT00103857|50063535|FG000|50-Week Extension Study|Death|0|||
24975401|NCT00103857|50063536|FG001|50-Week Extension Study|Death|0|||
24975402|NCT00103857|50063537|FG002|50-Week Extension Study|Death|0|||
24975403|NCT00103857|50063538|FG003|50-Week Extension Study|Death|1|||
24975404|NCT00103857|50063539|FG004|50-Week Extension Study|Death|0|||
24975405|NCT00103857|50063540|FG005|50-Week Extension Study|Death|1|||
24975406|NCT00103857|50063541|FG006|50-Week Extension Study|Death|0|||
24975407|NCT00103857|50063535|FG000|50-Week Extension Study|Lack of Efficacy|26|||
24975408|NCT00103857|50063536|FG001|50-Week Extension Study|Lack of Efficacy|15|||
25076363|NCT00429923|50183891|FG000|Overall Study|Lack of Efficacy|4|||
25076364|NCT00429923|50183892|FG001|Overall Study|Lack of Efficacy|1|||
25076365|NCT00429923|50183893|FG002|Overall Study|Lack of Efficacy|33|||
25076366|NCT00429923|50183891|FG000|Overall Study|Lost to Follow-up|0|||
25076367|NCT00429923|50183892|FG001|Overall Study|Lost to Follow-up|0|||
25076368|NCT00429923|50183893|FG002|Overall Study|Lost to Follow-up|2|||
25076369|NCT00429923|50183891|FG000|Overall Study|Withdrew Consent|1|||
25076370|NCT00429923|50183892|FG001|Overall Study|Withdrew Consent|0|||
25076371|NCT00429923|50183893|FG002|Overall Study|Withdrew Consent|1|||
25076372|NCT00429923|50183891|FG000|Overall Study|Early Termination|0|||
25076373|NCT00429923|50183892|FG001|Overall Study|Early Termination|1|||
25076374|NCT00429923|50183893|FG002|Overall Study|Early Termination|0|||
25076375|NCT02256436|50183900|FG000|Overall Study|Adverse Event|9|||
25076376|NCT02256436|50183901|FG001|Overall Study|Adverse Event|14|||
25076377|NCT02256436|50183900|FG000|Overall Study|Death|216|||
25076378|NCT02256436|50183901|FG001|Overall Study|Death|208|||
25076379|NCT02256436|50183900|FG000|Overall Study|Lost to Follow-up|1|||
25076380|NCT02256436|50183901|FG001|Overall Study|Lost to Follow-up|2|||
25076381|NCT02256436|50183900|FG000|Overall Study|Physician Decision|1|||
25076382|NCT02256436|50183901|FG001|Overall Study|Physician Decision|0|||
25076383|NCT02256436|50183900|FG000|Overall Study|Protocol Violation|0|||
25076384|NCT02256436|50183901|FG001|Overall Study|Protocol Violation|1|||
25076385|NCT02256436|50183900|FG000|Overall Study|Withdrawal by Subject|26|||
25076386|NCT02256436|50183901|FG001|Overall Study|Withdrawal by Subject|10|||
25076387|NCT02256436|50183900|FG000|Overall Study|Transferred to Extension Study|11|||
25076388|NCT02256436|50183901|FG001|Overall Study|Transferred to Extension Study|23|||
25076389|NCT02256436|50183900|FG000|Overall Study|Did Not Continue on Extension Study|8|||
25076390|NCT02256436|50183901|FG001|Overall Study|Did Not Continue on Extension Study|12|||
25076391|NCT02481830|50183910|FG000|Overall Study|No longer meets Study Criteria|1|||
25076392|NCT02481830|50183911|FG001|Overall Study|No longer meets Study Criteria|4|||
25076393|NCT02481830|50183910|FG000|Overall Study|Withdrawal by Subject|0|||
25076394|NCT02481830|50183911|FG001|Overall Study|Withdrawal by Subject|14|||
25076395|NCT02481830|50183910|FG000|Overall Study|Disease Progression|1|||
25076396|NCT02481830|50183911|FG001|Overall Study|Disease Progression|1|||
25076397|NCT02481830|50183910|FG000|Overall Study|Participant not eligible for trial|0|||
25076398|NCT02481830|50183911|FG001|Overall Study|Participant not eligible for trial|1|||
25076399|NCT00326183|50183919|FG000|Overall Study|Lost to Follow-up|104|||
25076400|NCT00326183|50183920|FG001|Overall Study|Lost to Follow-up|56|||
25076401|NCT00326183|50183919|FG000|Overall Study|Protocol Violation|6|||
25076402|NCT00326183|50183920|FG001|Overall Study|Protocol Violation|3|||
25076403|NCT00326183|50183919|FG000|Overall Study|Withdrawal by Subject|35|||
25076404|NCT00326183|50183920|FG001|Overall Study|Withdrawal by Subject|7|||
25193129|NCT01405820|50362091|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
24975409|NCT00103857|50063537|FG002|50-Week Extension Study|Lack of Efficacy|13|||
24975410|NCT00103857|50063538|FG003|50-Week Extension Study|Lack of Efficacy|16|||
24975411|NCT00103857|50063539|FG004|50-Week Extension Study|Lack of Efficacy|8|||
25076405|NCT00326183|50183919|FG000|Overall Study|Subject Moved|7|||
24975412|NCT00103857|50063540|FG005|50-Week Extension Study|Lack of Efficacy|8|||
25076406|NCT00326183|50183920|FG001|Overall Study|Subject Moved|4|||
25076407|NCT00326183|50183919|FG000|Overall Study|Other|47|||
25076408|NCT00326183|50183920|FG001|Overall Study|Other|13|||
25076409|NCT00326183|50183919|FG000|Overall Study|Adverse Event|1|||
25076410|NCT00326183|50183920|FG001|Overall Study|Adverse Event|0|||
25076411|NCT02481050|50183924|FG000|Overall Study|Adverse Event|1|||
25076412|NCT02481050|50183924|FG000|Overall Study|Disease Progression|47|||
25076413|NCT02481050|50183924|FG000|Overall Study|Withdrawal by Subject|7|||
25076414|NCT02481050|50183924|FG000|Overall Study|Other|3|||
25076415|NCT02511782|50183931|FG000|Overall Study|Withdrawal by Subject|1|||
25076416|NCT02511782|50183932|FG001|Overall Study|Withdrawal by Subject|0|||
25076417|NCT02511782|50183933|FG002|Overall Study|Withdrawal by Subject|0|||
25076418|NCT02480114|50183943|FG000|Overall Study|Not completing surveys|3|||
25076419|NCT02480114|50183944|FG001|Overall Study|Not completing surveys|2|||
25076420|NCT02480114|50183943|FG000|Overall Study|Withdrawal by Subject|2|||
25076421|NCT02480114|50183944|FG001|Overall Study|Withdrawal by Subject|4|||
25076422|NCT02480114|50183943|FG000|Overall Study|Disease progression|3|||
25076423|NCT02480114|50183944|FG001|Overall Study|Disease progression|0|||
25076424|NCT02480114|50183943|FG000|Overall Study|Improper completion of survey|1|||
25076425|NCT02480114|50183944|FG001|Overall Study|Improper completion of survey|1|||
25076426|NCT02480114|50183943|FG000|Overall Study|Not eligible|0|||
25076427|NCT02480114|50183944|FG001|Overall Study|Not eligible|1|||
25076428|NCT02479880|50183952|FG000|Overall Study|Study Terminated by Sponsor|13|||
25076429|NCT02479880|50183953|FG001|Overall Study|Study Terminated by Sponsor|12|||
25076430|NCT02479880|50183952|FG000|Overall Study|Pregnancy|0|||
25076431|NCT02479880|50183953|FG001|Overall Study|Pregnancy|1|||
25076432|NCT02479802|50183959|FG000|Overall Study|Lost to Follow-up|1|||
25076433|NCT02479802|50183959|FG000|Overall Study|Adverse Event|1|||
25076434|NCT02479412|50183972|FG000|Overall Study|Adverse Event|0|||
25076435|NCT02479412|50183973|FG001|Overall Study|Adverse Event|0|||
25076436|NCT02479412|50183974|FG002|Overall Study|Adverse Event|1|||
25076437|NCT02479412|50183975|FG003|Overall Study|Adverse Event|0|||
25076438|NCT02479412|50183976|FG004|Overall Study|Adverse Event|0|||
25076439|NCT02479412|50183977|FG005|Overall Study|Adverse Event|0|||
25076440|NCT02479412|50183978|FG006|Overall Study|Adverse Event|0|||
25076441|NCT02479412|50183979|FG007|Overall Study|Adverse Event|0|||
25076442|NCT02479412|50183980|FG008|Overall Study|Adverse Event|0|||
25170265|NCT01816295|50304610|FG001|Double Blind Phase|Physician Decision|2|||
25170266|NCT01816295|50304609|FG000|Double Blind Phase|Protocol Violation|17|||
25170267|NCT01816295|50304610|FG001|Double Blind Phase|Protocol Violation|11|||
25170268|NCT01816295|50304609|FG000|Double Blind Phase|Sponsor Decision|8|||
25170269|NCT01816295|50304610|FG001|Double Blind Phase|Sponsor Decision|8|||
25170270|NCT01816295|50304609|FG000|Double Blind Phase|Withdrawal by Subject|22|||
25193130|NCT01405820|50362086|FG000|Randomized Treatment Period|Death|0|||
25193131|NCT01405820|50362087|FG001|Randomized Treatment Period|Death|0|||
25193132|NCT01405820|50362088|FG002|Randomized Treatment Period|Death|0|||
25193133|NCT01405820|50362089|FG003|Randomized Treatment Period|Death|1|||
25193134|NCT01405820|50362090|FG004|Randomized Treatment Period|Death|0|||
25193135|NCT01405820|50362091|FG005|Randomized Treatment Period|Death|0|||
25193136|NCT01405820|50362086|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
25193137|NCT01405820|50362087|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
25193138|NCT01405820|50362088|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
25193139|NCT01405820|50362089|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
25193140|NCT01405820|50362090|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
25193141|NCT01405820|50362091|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
25193142|NCT01405820|50362086|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
25193143|NCT01405820|50362087|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
25193144|NCT01405820|50362088|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
25193145|NCT01405820|50362089|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
25193146|NCT01405820|50362090|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
25193147|NCT01405820|50362091|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
24975413|NCT00103857|50063541|FG006|50-Week Extension Study|Lack of Efficacy|0|||
25076443|NCT02479412|50183972|FG000|Overall Study|Study-specific withdrawal criteria|0|||
25076444|NCT02479412|50183973|FG001|Overall Study|Study-specific withdrawal criteria|0|||
25076445|NCT02479412|50183974|FG002|Overall Study|Study-specific withdrawal criteria|1|||
25170271|NCT01816295|50304610|FG001|Double Blind Phase|Withdrawal by Subject|20|||
25170272|NCT01816295|50304609|FG000|OLE Phase|Adverse Event|17|||
25170273|NCT01816295|50304610|FG001|OLE Phase|Adverse Event|15|||
25170274|NCT01816295|50304609|FG000|OLE Phase|Death|1|||
25170275|NCT01816295|50304610|FG001|OLE Phase|Death|0|||
25170276|NCT01816295|50304609|FG000|OLE Phase|Entry Criteria Not Met|3|||
25170277|NCT01816295|50304610|FG001|OLE Phase|Entry Criteria Not Met|5|||
25170278|NCT01816295|50304609|FG000|OLE Phase|Lost to Follow-up|5|||
25170279|NCT01816295|50304610|FG001|OLE Phase|Lost to Follow-up|5|||
25076446|NCT02479412|50183975|FG003|Overall Study|Study-specific withdrawal criteria|1|||
25076447|NCT02479412|50183976|FG004|Overall Study|Study-specific withdrawal criteria|0|||
25076448|NCT02479412|50183977|FG005|Overall Study|Study-specific withdrawal criteria|0|||
25170280|NCT01816295|50304609|FG000|OLE Phase|Physician Decision|3|||
25170281|NCT01816295|50304610|FG001|OLE Phase|Physician Decision|1|||
25170282|NCT01816295|50304609|FG000|OLE Phase|Protocol Violation|4|||
25170283|NCT01816295|50304610|FG001|OLE Phase|Protocol Violation|4|||
25193148|NCT01405820|50362086|FG000|Open-Label Treatment Period|Other|1|||
25076449|NCT02479412|50183978|FG006|Overall Study|Study-specific withdrawal criteria|0|||
25076450|NCT02479412|50183979|FG007|Overall Study|Study-specific withdrawal criteria|1|||
25170284|NCT01816295|50304609|FG000|OLE Phase|Sponsor Decision|7|||
25076451|NCT02479412|50183980|FG008|Overall Study|Study-specific withdrawal criteria|1|||
25076452|NCT02479412|50183972|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
25193149|NCT01405820|50362087|FG001|Open-Label Treatment Period|Other|1|||
25193150|NCT01405820|50362088|FG002|Open-Label Treatment Period|Other|1|||
25193151|NCT01405820|50362089|FG003|Open-Label Treatment Period|Other|1|||
25193152|NCT01405820|50362090|FG004|Open-Label Treatment Period|Other|1|||
25193153|NCT01405820|50362091|FG005|Open-Label Treatment Period|Other|1|||
25193154|NCT01405820|50362086|FG000|Open-Label Treatment Period|Physician Decision|0|||
25193155|NCT01405820|50362087|FG001|Open-Label Treatment Period|Physician Decision|0|||
25193156|NCT01405820|50362088|FG002|Open-Label Treatment Period|Physician Decision|1|||
25193157|NCT01405820|50362089|FG003|Open-Label Treatment Period|Physician Decision|2|||
25193158|NCT01405820|50362090|FG004|Open-Label Treatment Period|Physician Decision|1|||
25193159|NCT01405820|50362091|FG005|Open-Label Treatment Period|Physician Decision|0|||
25193160|NCT01405820|50362086|FG000|Open-Label Treatment Period|Adverse Event|0|||
25193161|NCT01405820|50362087|FG001|Open-Label Treatment Period|Adverse Event|0|||
25193162|NCT01405820|50362088|FG002|Open-Label Treatment Period|Adverse Event|0|||
25193163|NCT01405820|50362089|FG003|Open-Label Treatment Period|Adverse Event|1|||
25193164|NCT01405820|50362090|FG004|Open-Label Treatment Period|Adverse Event|0|||
25193165|NCT01405820|50362091|FG005|Open-Label Treatment Period|Adverse Event|0|||
25193166|NCT01405742|50362120|FG000|Overall Study|Lost to Follow-up|1|||
25193167|NCT01405742|50362121|FG001|Overall Study|Lost to Follow-up|0|||
25170285|NCT01816295|50304610|FG001|OLE Phase|Sponsor Decision|9|||
25170286|NCT01816295|50304609|FG000|OLE Phase|Withdrawal by Subject|10|||
25170287|NCT01816295|50304610|FG001|OLE Phase|Withdrawal by Subject|10|||
25170288|NCT01816295|50304609|FG000|OLE Phase|Lack of Efficacy|3|||
25193168|NCT01425632|50362150|FG000|Overall Study|Adverse Event|0|||
25193169|NCT01425632|50362151|FG001|Overall Study|Adverse Event|1|||
25193170|NCT01425632|50362152|FG002|Overall Study|Adverse Event|1|||
25193171|NCT01425632|50362150|FG000|Overall Study|Physician Decision|1|||
25193172|NCT01425632|50362151|FG001|Overall Study|Physician Decision|0|||
25193173|NCT01425632|50362152|FG002|Overall Study|Physician Decision|0|||
25193174|NCT01425632|50362150|FG000|Overall Study|Protocol Violation|0|||
25193175|NCT01425632|50362151|FG001|Overall Study|Protocol Violation|0|||
25193176|NCT01425632|50362152|FG002|Overall Study|Protocol Violation|2|||
25193177|NCT01425632|50362150|FG000|Overall Study|Withdrawal by Subject|0|||
25193178|NCT01425632|50362151|FG001|Overall Study|Withdrawal by Subject|0|||
25193179|NCT01425632|50362152|FG002|Overall Study|Withdrawal by Subject|1|||
25193180|NCT01405508|50362189|FG000|Overall Study|AE, non-serious non-fatal|1|||
25193181|NCT01405508|50362190|FG001|Overall Study|AE, non-serious non-fatal|1|||
25193182|NCT01405508|50362191|FG002|Overall Study|AE, non-serious non-fatal|0|||
25170289|NCT01816295|50304610|FG001|OLE Phase|Lack of Efficacy|7|||
25170290|NCT01610297|50304635|FG000|Overall Study|Lost to Follow-up|1|||
25170291|NCT01793051|50304646|FG000|Overall Study|Withdrawal by Subject|6|||
25170292|NCT01793051|50304647|FG001|Overall Study|Withdrawal by Subject|4|||
25170293|NCT01793051|50304646|FG000|Overall Study|Adverse Event|0|||
24975414|NCT00103857|50063535|FG000|50-Week Extension Study|Lost to Follow-up|4|||
25193183|NCT01405508|50362192|FG003|Overall Study|AE, non-serious non-fatal|0|||
25193184|NCT01405196|50362328|FG000|Overall Study|Study Terminated by Sponsor|0|||
25170294|NCT01793051|50304647|FG001|Overall Study|Adverse Event|2|||
25170295|NCT01793051|50304646|FG000|Overall Study|Too ill to continue|1|||
25193185|NCT01405196|50362329|FG001|Overall Study|Study Terminated by Sponsor|0|||
25193186|NCT01405196|50362330|FG002|Overall Study|Study Terminated by Sponsor|9|||
25193187|NCT01405196|50362331|FG003|Overall Study|Study Terminated by Sponsor|0|||
25193188|NCT01405196|50362328|FG000|Overall Study|Other|2|||
25193189|NCT01405196|50362329|FG001|Overall Study|Other|2|||
25193190|NCT01405196|50362330|FG002|Overall Study|Other|5|||
25076453|NCT02479412|50183973|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
25076454|NCT02479412|50183974|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
25076455|NCT02479412|50183975|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
25076456|NCT02479412|50183976|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
25076457|NCT02479412|50183977|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
25076458|NCT02479412|50183978|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
25076459|NCT02479412|50183979|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
25076460|NCT02479412|50183980|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
25076461|NCT00224003|50183996|FG000|Overall Study|Adverse Event|1|||
25076462|NCT00224003|50183996|FG000|Overall Study|Protocol Violation|2|||
25076463|NCT00224003|50183996|FG000|Overall Study|Withdrawal by Subject|1|||
25076464|NCT00224003|50183996|FG000|Overall Study|unk|3|||
25076465|NCT02450552|50184002|FG000|Overall Study|Withdrawal by Subject|4|||
25076466|NCT02450552|50184003|FG001|Overall Study|Withdrawal by Subject|0|||
25076467|NCT02450552|50184004|FG002|Overall Study|Withdrawal by Subject|4|||
25076468|NCT02450552|50184002|FG000|Overall Study|Physician Decision|1|||
25076469|NCT02450552|50184003|FG001|Overall Study|Physician Decision|0|||
25076470|NCT02450552|50184004|FG002|Overall Study|Physician Decision|1|||
25076471|NCT02508428|50184014|FG000|Overall Study|Death|32|||
25076472|NCT02508428|50184015|FG001|Overall Study|Death|33|||
25076473|NCT02508428|50184014|FG000|Overall Study|Liner revised|3|||
25076474|NCT02508428|50184015|FG001|Overall Study|Liner revised|19|||
25076475|NCT02508428|50184014|FG000|Overall Study|Incomplete follow-up|17|||
25076476|NCT02508428|50184015|FG001|Overall Study|Incomplete follow-up|15|||
25076477|NCT02448680|50184023|FG000|Overall Study|Physician Decision|1|||
25076478|NCT02448680|50184024|FG001|Overall Study|Physician Decision|1|||
25076479|NCT02448680|50184023|FG000|Overall Study|Withdrawal by Subject|0|||
25076480|NCT02448680|50184024|FG001|Overall Study|Withdrawal by Subject|2|||
25076481|NCT02448446|50184034|FG000|Overall Study|Withdrawal by Subject|1|||
25076482|NCT02448446|50184035|FG001|Overall Study|Withdrawal by Subject|0|||
25076483|NCT02447744|50184043|FG000|Overall Study|Withdrawal by Subject|3|||
25076484|NCT02447744|50184044|FG001|Overall Study|Withdrawal by Subject|1|||
24975415|NCT00103857|50063536|FG001|50-Week Extension Study|Lost to Follow-up|0|||
24975416|NCT00103857|50063537|FG002|50-Week Extension Study|Lost to Follow-up|1|||
24975417|NCT00103857|50063538|FG003|50-Week Extension Study|Lost to Follow-up|4|||
24975418|NCT00103857|50063539|FG004|50-Week Extension Study|Lost to Follow-up|3|||
24975419|NCT00103857|50063540|FG005|50-Week Extension Study|Lost to Follow-up|3|||
24975420|NCT00103857|50063541|FG006|50-Week Extension Study|Lost to Follow-up|0|||
24975421|NCT00103857|50063535|FG000|50-Week Extension Study|Physician Decision|0|||
24975422|NCT00103857|50063536|FG001|50-Week Extension Study|Physician Decision|1|||
24975423|NCT00103857|50063537|FG002|50-Week Extension Study|Physician Decision|1|||
24975424|NCT00103857|50063538|FG003|50-Week Extension Study|Physician Decision|0|||
24975425|NCT00103857|50063539|FG004|50-Week Extension Study|Physician Decision|0|||
24975426|NCT00103857|50063540|FG005|50-Week Extension Study|Physician Decision|0|||
24975427|NCT00103857|50063541|FG006|50-Week Extension Study|Physician Decision|0|||
24975428|NCT00103857|50063535|FG000|50-Week Extension Study|Pregnancy|0|||
25076485|NCT02447744|50184043|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
25076486|NCT02447744|50184044|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
25076487|NCT02478632|50184052|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
25076488|NCT02478632|50184053|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
24975429|NCT00103857|50063536|FG001|50-Week Extension Study|Pregnancy|0|||
24975430|NCT00103857|50063537|FG002|50-Week Extension Study|Pregnancy|1|||
24975431|NCT00103857|50063538|FG003|50-Week Extension Study|Pregnancy|0|||
24975432|NCT00103857|50063539|FG004|50-Week Extension Study|Pregnancy|1|||
24975433|NCT00103857|50063540|FG005|50-Week Extension Study|Pregnancy|0|||
24975434|NCT00103857|50063541|FG006|50-Week Extension Study|Pregnancy|0|||
24975435|NCT00103857|50063535|FG000|50-Week Extension Study|Protocol Violation|1|||
24975436|NCT00103857|50063536|FG001|50-Week Extension Study|Protocol Violation|1|||
24975437|NCT00103857|50063537|FG002|50-Week Extension Study|Protocol Violation|1|||
24975438|NCT00103857|50063538|FG003|50-Week Extension Study|Protocol Violation|2|||
24975439|NCT00103857|50063539|FG004|50-Week Extension Study|Protocol Violation|0|||
24975440|NCT00103857|50063540|FG005|50-Week Extension Study|Protocol Violation|1|||
24975441|NCT00103857|50063541|FG006|50-Week Extension Study|Protocol Violation|0|||
24975442|NCT00103857|50063535|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
24975443|NCT00103857|50063536|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
24975444|NCT00103857|50063537|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
24975445|NCT00103857|50063538|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
24975446|NCT00103857|50063539|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
24975447|NCT00103857|50063540|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
24975448|NCT00103857|50063541|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
24975449|NCT00103857|50063535|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
24975450|NCT00103857|50063536|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
24975451|NCT00103857|50063537|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
24975452|NCT00103857|50063538|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
24975453|NCT00103857|50063539|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
24975454|NCT00103857|50063540|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
24975455|NCT00103857|50063541|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
24975456|NCT00103857|50063535|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
24975457|NCT00103857|50063536|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
24975458|NCT00103857|50063537|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
24975459|NCT00103857|50063538|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
24975460|NCT00103857|50063539|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
24975461|NCT00103857|50063540|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
24975462|NCT00103857|50063541|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
24975463|NCT00103857|50063535|FG000|50-Week Extension Study|patient moved|0|||
25076489|NCT02478632|50184052|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
25076490|NCT02478632|50184053|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
25076491|NCT02478632|50184052|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
24975464|NCT00103857|50063536|FG001|50-Week Extension Study|patient moved|0|||
25076492|NCT02478632|50184053|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
25076493|NCT02478398|50184064|FG000|Overall Study|Adverse Event|20|||
24975465|NCT00103857|50063537|FG002|50-Week Extension Study|patient moved|1|||
24975466|NCT00103857|50063538|FG003|50-Week Extension Study|patient moved|2|||
25076494|NCT02478398|50184065|FG001|Overall Study|Adverse Event|5|||
25076495|NCT02478398|50184064|FG000|Overall Study|Lost to Follow-up|5|||
25076496|NCT02478398|50184065|FG001|Overall Study|Lost to Follow-up|4|||
25076497|NCT02478398|50184064|FG000|Overall Study|Non-Compliance With Study Drug|5|||
25076498|NCT02478398|50184065|FG001|Overall Study|Non-Compliance With Study Drug|1|||
25076499|NCT02478398|50184064|FG000|Overall Study|Protocol Violation|3|||
25076500|NCT02478398|50184065|FG001|Overall Study|Protocol Violation|1|||
25076501|NCT02478398|50184064|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
25076502|NCT02478398|50184065|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
25076503|NCT02478398|50184064|FG000|Overall Study|Withdrawal By Participant|10|||
25076504|NCT02478398|50184065|FG001|Overall Study|Withdrawal By Participant|4|||
25076505|NCT02478164|50184072|FG000|Overall Study|Lack of Efficacy|13|||
25076506|NCT02478164|50184072|FG000|Overall Study|Adverse Event|1|||
25076507|NCT02478164|50184072|FG000|Overall Study|Withdrawal by Subject|1|||
25076508|NCT02476994|50184078|FG000|Overall Study|Based on feedback from FDA|1|||
25076509|NCT02476994|50184079|FG001|Overall Study|Based on feedback from FDA|0|||
25076510|NCT02508194|50184087|FG000|Overall Study|Death|5|||
25076511|NCT02508194|50184088|FG001|Overall Study|Death|3|||
25076512|NCT02508194|50184087|FG000|Overall Study|Lost to Follow-up|25|||
25076513|NCT02508194|50184088|FG001|Overall Study|Lost to Follow-up|18|||
25076514|NCT02508194|50184087|FG000|Overall Study|Withdrawal by Subject|20|||
25076515|NCT02508194|50184088|FG001|Overall Study|Withdrawal by Subject|18|||
25076516|NCT02508194|50184087|FG000|Overall Study|Error in Randomization|1|||
25076517|NCT02508194|50184088|FG001|Overall Study|Error in Randomization|3|||
25076518|NCT02508194|50184087|FG000|Overall Study|Principal Investigator Decision|1|||
25076519|NCT02508194|50184088|FG001|Overall Study|Principal Investigator Decision|2|||
25076520|NCT02508116|50184096|FG000|Overall Study|Lost to Follow-up|2|||
24975467|NCT00103857|50063539|FG004|50-Week Extension Study|patient moved|0|||
24975468|NCT00103857|50063540|FG005|50-Week Extension Study|patient moved|0|||
24975469|NCT00103857|50063541|FG006|50-Week Extension Study|patient moved|0|||
24975470|NCT00103857|50063535|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
24975471|NCT00103857|50063536|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
24975472|NCT00103857|50063537|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
24975473|NCT00103857|50063538|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
24975474|NCT00103857|50063539|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
24975475|NCT00103857|50063540|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
24975476|NCT00103857|50063541|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
24975477|NCT00103857|50063535|FG000|50-Week Extension Study|reason unspecified|0|||
24975478|NCT00103857|50063536|FG001|50-Week Extension Study|reason unspecified|0|||
24975479|NCT00103857|50063537|FG002|50-Week Extension Study|reason unspecified|0|||
24975480|NCT00103857|50063538|FG003|50-Week Extension Study|reason unspecified|0|||
24975481|NCT00103857|50063539|FG004|50-Week Extension Study|reason unspecified|1|||
24975482|NCT00103857|50063540|FG005|50-Week Extension Study|reason unspecified|0|||
24975483|NCT00103857|50063541|FG006|50-Week Extension Study|reason unspecified|0|||
24975484|NCT03587584|50063558|FG000|Overall Study|SOC deviations|4|||
24975485|NCT03587584|50063559|FG001|Overall Study|SOC deviations|6|||
24975486|NCT03587584|50063558|FG000|Overall Study|Incomplete data|0|||
24975487|NCT03587584|50063559|FG001|Overall Study|Incomplete data|3|||
24975488|NCT03586726|50063565|FG000|Overall Study|Withdrawal by Subject|1|||
25170296|NCT01793051|50304647|FG001|Overall Study|Too ill to continue|0|||
24975489|NCT03586648|50063569|FG000|Period 1|Withdrawal by Subject|0|||
24975490|NCT03586648|50063570|FG001|Period 1|Withdrawal by Subject|1|||
25076521|NCT02508116|50184097|FG001|Overall Study|Lost to Follow-up|3|||
25076522|NCT02508116|50184096|FG000|Overall Study|Withdrawal by Subject|3|||
25076523|NCT02508116|50184097|FG001|Overall Study|Withdrawal by Subject|2|||
25076524|NCT02508116|50184096|FG000|Overall Study|Protocol Violation|1|||
24975491|NCT03586648|50063569|FG000|Period 1|Lost to Follow-up|1|||
24975492|NCT03586648|50063570|FG001|Period 1|Lost to Follow-up|1|||
24975493|NCT03586648|50063569|FG000|Period 1|Adverse Event|1|||
24975494|NCT03586648|50063570|FG001|Period 1|Adverse Event|0|||
24975495|NCT03586648|50063569|FG000|Period 1|Study related symptoms or complaints|2|||
24975496|NCT03586648|50063570|FG001|Period 1|Study related symptoms or complaints|1|||
24975497|NCT03586648|50063569|FG000|Period 1|Physician Decision|0|||
24975498|NCT03586648|50063570|FG001|Period 1|Physician Decision|1|||
24975499|NCT03586648|50063569|FG000|Period 2|Adverse Event|1|||
24975500|NCT03586648|50063570|FG001|Period 2|Adverse Event|0|||
24975501|NCT02892448|50063579|FG000|Overall Study|Screening failure|2|||
24975502|NCT02892448|50063580|FG001|Overall Study|Screening failure|2|||
24975503|NCT02892448|50063581|FG002|Overall Study|Screening failure|1|||
24975504|NCT03585712|50063589|FG000|Treatment Period 1|Protocol Violation|1|||
24975505|NCT03585712|50063590|FG001|Treatment Period 1|Protocol Violation|0|||
24975506|NCT03585712|50063591|FG002|Treatment Period 1|Protocol Violation|0|||
24975507|NCT03585712|50063589|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
24975508|NCT03585712|50063590|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
24975509|NCT03585712|50063591|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
24975510|NCT03585712|50063589|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
24975511|NCT03585712|50063590|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
24975512|NCT03585712|50063591|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
24975513|NCT03585712|50063589|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
24975514|NCT03585712|50063590|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
24975515|NCT03585712|50063591|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
24975516|NCT03585244|50063608|FG000|Overall Study|Withdrawal by Subject|15|||
24975517|NCT00074984|50063614|FG000|Overall Study|Death|1|||
24975518|NCT00074984|50063615|FG001|Overall Study|Death|2|||
24975519|NCT00074984|50063614|FG000|Overall Study|Withdrawal by Subject|2|||
24975520|NCT00074984|50063615|FG001|Overall Study|Withdrawal by Subject|3|||
24975521|NCT00074984|50063614|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
24975522|NCT00074984|50063615|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
24975523|NCT03583606|50063625|FG000|Overall Study|Lost to Follow-up|0|||
24975524|NCT03583606|50063626|FG001|Overall Study|Lost to Follow-up|1|||
24975525|NCT03583606|50063627|FG002|Overall Study|Lost to Follow-up|0|||
24975526|NCT03583606|50063625|FG000|Overall Study|Ineligible at baseline|1|||
24975527|NCT03583606|50063626|FG001|Overall Study|Ineligible at baseline|0|||
24975528|NCT03583606|50063627|FG002|Overall Study|Ineligible at baseline|0|||
24975529|NCT03583450|50063638|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
25193191|NCT01405196|50362331|FG003|Overall Study|Other|0|||
25193192|NCT01405196|50362328|FG000|Overall Study|Withdrawal by Subject|4|||
25193193|NCT01405196|50362329|FG001|Overall Study|Withdrawal by Subject|6|||
25193194|NCT01405196|50362330|FG002|Overall Study|Withdrawal by Subject|3|||
24975530|NCT03583450|50063639|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
24975531|NCT03583372|50063651|FG000|Overall Study|Withdrawal by Subject|6|||
24975532|NCT03583372|50063652|FG001|Overall Study|Withdrawal by Subject|11|||
24975533|NCT03583372|50063653|FG002|Overall Study|Withdrawal by Subject|7|||
24975534|NCT03583372|50063654|FG003|Overall Study|Withdrawal by Subject|8|||
24975535|NCT03583372|50063651|FG000|Overall Study|Lost to Follow-up|4|||
24975536|NCT03583372|50063652|FG001|Overall Study|Lost to Follow-up|6|||
25193195|NCT01405196|50362331|FG003|Overall Study|Withdrawal by Subject|6|||
25193196|NCT01405196|50362328|FG000|Overall Study|Adverse Event|2|||
24975537|NCT03583372|50063653|FG002|Overall Study|Lost to Follow-up|3|||
24975538|NCT03583372|50063654|FG003|Overall Study|Lost to Follow-up|2|||
24975539|NCT03583372|50063651|FG000|Overall Study|Adverse Event|1|||
24975540|NCT03583372|50063652|FG001|Overall Study|Adverse Event|3|||
24975541|NCT03583372|50063653|FG002|Overall Study|Adverse Event|4|||
24975542|NCT03583372|50063654|FG003|Overall Study|Adverse Event|4|||
24975543|NCT03583372|50063651|FG000|Overall Study|Physician Decision|0|||
24975544|NCT03583372|50063652|FG001|Overall Study|Physician Decision|1|||
24975545|NCT03583372|50063653|FG002|Overall Study|Physician Decision|1|||
24975546|NCT03583372|50063654|FG003|Overall Study|Physician Decision|1|||
24975547|NCT03583372|50063651|FG000|Overall Study|Lack of Efficacy|0|||
24975548|NCT03583372|50063652|FG001|Overall Study|Lack of Efficacy|1|||
24975549|NCT03583372|50063653|FG002|Overall Study|Lack of Efficacy|0|||
24975550|NCT03583372|50063654|FG003|Overall Study|Lack of Efficacy|1|||
24975551|NCT03583372|50063651|FG000|Overall Study|Death|1|||
24975552|NCT03583372|50063652|FG001|Overall Study|Death|0|||
24975553|NCT03583372|50063653|FG002|Overall Study|Death|0|||
24975554|NCT03583372|50063654|FG003|Overall Study|Death|0|||
24975555|NCT03583372|50063651|FG000|Overall Study|Protocol Violation|0|||
24975556|NCT03583372|50063652|FG001|Overall Study|Protocol Violation|1|||
24975557|NCT03583372|50063653|FG002|Overall Study|Protocol Violation|0|||
24975558|NCT03583372|50063654|FG003|Overall Study|Protocol Violation|0|||
25193197|NCT01405196|50362329|FG001|Overall Study|Adverse Event|2|||
25314808|NCT00911300|50630619|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
25314809|NCT00911300|50630618|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
25314810|NCT00911300|50630619|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
25314811|NCT00911300|50630618|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
25314812|NCT00911300|50630619|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
25314813|NCT00911300|50630618|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
25314814|NCT00911300|50630619|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
25314815|NCT00911300|50630618|FG000|Overall Study|International Normalized Ratio Too High|0|||
25314816|NCT00911300|50630619|FG001|Overall Study|International Normalized Ratio Too High|1|||
25314817|NCT00911300|50630618|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
25314818|NCT00911300|50630619|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
25314819|NCT00911300|50630618|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
25314820|NCT00911300|50630619|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
25314821|NCT00911300|50630618|FG000|Overall Study|Physician Decision|0|||
25193198|NCT01405196|50362330|FG002|Overall Study|Adverse Event|0|||
25193199|NCT01405196|50362331|FG003|Overall Study|Adverse Event|2|||
25193200|NCT01405196|50362328|FG000|Overall Study|Death|1|||
25193201|NCT01405196|50362329|FG001|Overall Study|Death|0|||
25193202|NCT01405196|50362330|FG002|Overall Study|Death|3|||
25193203|NCT01405196|50362331|FG003|Overall Study|Death|0|||
25193204|NCT01405196|50362328|FG000|Overall Study|Lost to Follow-up|2|||
25193205|NCT01405196|50362329|FG001|Overall Study|Lost to Follow-up|2|||
25193206|NCT01405196|50362330|FG002|Overall Study|Lost to Follow-up|3|||
25193207|NCT01405196|50362331|FG003|Overall Study|Lost to Follow-up|1|||
25193208|NCT01402700|50362381|FG000|Overall Study|Death|3|||
25193209|NCT01402700|50362381|FG000|Overall Study|Withdrawal by Subject|3|||
25193210|NCT01402700|50362381|FG000|Overall Study|Missed Visit|1|||
25193211|NCT01424930|50362503|FG000|Overall Study|Adverse Event|0|||
25193212|NCT01424930|50362504|FG001|Overall Study|Adverse Event|1|||
24975559|NCT03583372|50063651|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
25314822|NCT00911300|50630619|FG001|Overall Study|Physician Decision|1|||
25314823|NCT00911300|50630618|FG000|Overall Study|Treatment Stopped by Mistake|0|||
25314824|NCT00911300|50630619|FG001|Overall Study|Treatment Stopped by Mistake|1|||
25314825|NCT00911300|50630618|FG000|Overall Study|Randomized; No Study Medication Received|0|||
25314826|NCT00911300|50630619|FG001|Overall Study|Randomized; No Study Medication Received|2|||
25314827|NCT00911144|50630628|FG000|Overall Study|Withdrawal by Subject|16|||
24975560|NCT03583372|50063652|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
25193213|NCT01424930|50362503|FG000|Overall Study|Death|1|||
24975561|NCT03583372|50063653|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
24975562|NCT03583372|50063654|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
25193214|NCT01424930|50362504|FG001|Overall Study|Death|0|||
25193215|NCT01424930|50362503|FG000|Overall Study|Progressive Disease|3|||
25193216|NCT01424930|50362504|FG001|Overall Study|Progressive Disease|6|||
25314828|NCT00911144|50630629|FG001|Overall Study|Withdrawal by Subject|5|||
25314829|NCT00910988|50630639|FG000|Overall Study|Lost to Follow-up|2|||
25314830|NCT00910988|50630640|FG001|Overall Study|Lost to Follow-up|4|||
25314831|NCT00910988|50630641|FG002|Overall Study|Lost to Follow-up|3|||
25314832|NCT00910988|50630642|FG003|Overall Study|Lost to Follow-up|0|||
25314833|NCT00644059|50630671|FG000|Overall Study|Lost to Follow-up|37|||
25314834|NCT00644059|50630672|FG001|Overall Study|Lost to Follow-up|34|||
24975563|NCT03583372|50063651|FG000|Overall Study|Did Not Receive Study Drug|0|||
24975564|NCT03583372|50063652|FG001|Overall Study|Did Not Receive Study Drug|1|||
24975565|NCT03583372|50063653|FG002|Overall Study|Did Not Receive Study Drug|0|||
24975566|NCT03583372|50063654|FG003|Overall Study|Did Not Receive Study Drug|0|||
24975567|NCT03583372|50063651|FG000|Overall Study|Captured as Other in the Database|1|||
24975568|NCT03583372|50063652|FG001|Overall Study|Captured as Other in the Database|2|||
24975569|NCT03583372|50063653|FG002|Overall Study|Captured as Other in the Database|4|||
24975570|NCT03583372|50063654|FG003|Overall Study|Captured as Other in the Database|1|||
24975571|NCT03582826|50063666|FG000|Overall Study|Lost to Follow-up|39|||
24975572|NCT03582826|50063667|FG001|Overall Study|Lost to Follow-up|0|||
24975573|NCT03582826|50063666|FG000|Overall Study|Withdrawal by Subject|2|||
24975574|NCT03582826|50063667|FG001|Overall Study|Withdrawal by Subject|0|||
24975575|NCT03518008|50063682|FG000|Period 2, Second Week of Wear|Family emergency|0|||
24975576|NCT03518008|50063683|FG001|Period 2, Second Week of Wear|Family emergency|1|||
24975577|NCT03810014|50063693|FG000|Overall Study|Pregnancy|2|||
24975578|NCT03810014|50063694|FG001|Overall Study|Pregnancy|2|||
24975579|NCT03810014|50063695|FG002|Overall Study|Pregnancy|0|||
24975580|NCT03810014|50063696|FG003|Overall Study|Pregnancy|2|||
25314835|NCT00644059|50630673|FG002|Overall Study|Lost to Follow-up|16|||
25314836|NCT00644059|50630671|FG000|Overall Study|Withdrawal by Subject|52|||
25314837|NCT00644059|50630672|FG001|Overall Study|Withdrawal by Subject|60|||
25314838|NCT00644059|50630673|FG002|Overall Study|Withdrawal by Subject|30|||
25314839|NCT00644059|50630671|FG000|Overall Study|Adverse Event|8|||
25314840|NCT00644059|50630672|FG001|Overall Study|Adverse Event|5|||
25314841|NCT00644059|50630673|FG002|Overall Study|Adverse Event|1|||
25314842|NCT00644059|50630671|FG000|Overall Study|Inappropriate Enrollment|1|||
24975589|NCT05012163|50063714|FG000|Overall Study|Protocol Violation|0|||
24975590|NCT05012163|50063715|FG001|Overall Study|Protocol Violation|0|||
25314843|NCT00644059|50630672|FG001|Overall Study|Inappropriate Enrollment|3|||
25314844|NCT00644059|50630673|FG002|Overall Study|Inappropriate Enrollment|0|||
24975591|NCT05012163|50063716|FG002|Overall Study|Protocol Violation|1|||
24975592|NCT05012163|50063717|FG003|Overall Study|Protocol Violation|1|||
24975593|NCT05009251|50063732|FG000|Overall Study|Protocol Violation|100|||
24975594|NCT05009251|50063733|FG001|Overall Study|Protocol Violation|105|||
24975595|NCT05009251|50063734|FG002|Overall Study|Protocol Violation|119|||
24975596|NCT05009251|50063735|FG003|Overall Study|Protocol Violation|120|||
24975597|NCT05009251|50063736|FG004|Overall Study|Protocol Violation|119|||
24975598|NCT05009251|50063732|FG000|Overall Study|Death|25|||
24975599|NCT05009251|50063733|FG001|Overall Study|Death|22|||
24975600|NCT05009251|50063734|FG002|Overall Study|Death|24|||
24975601|NCT05009251|50063735|FG003|Overall Study|Death|19|||
24975602|NCT05009251|50063736|FG004|Overall Study|Death|15|||
24975603|NCT04978363|50063759|FG000|Overall Study|Other medical issues unrelated to the study|0|||
24975604|NCT04978363|50063760|FG001|Overall Study|Other medical issues unrelated to the study|0|||
24975605|NCT04978363|50063761|FG002|Overall Study|Other medical issues unrelated to the study|0|||
24975606|NCT04978363|50063762|FG003|Overall Study|Other medical issues unrelated to the study|0|||
24975607|NCT04978363|50063763|FG004|Overall Study|Other medical issues unrelated to the study|1|||
24975608|NCT04978363|50063764|FG005|Overall Study|Other medical issues unrelated to the study|0|||
24975609|NCT04978363|50063765|FG006|Overall Study|Other medical issues unrelated to the study|0|||
24975610|NCT04978363|50063766|FG007|Overall Study|Other medical issues unrelated to the study|0|||
24975611|NCT04978363|50063767|FG008|Overall Study|Other medical issues unrelated to the study|0|||
24975612|NCT04978363|50063768|FG009|Overall Study|Other medical issues unrelated to the study|0|||
24975613|NCT04978363|50063769|FG010|Overall Study|Other medical issues unrelated to the study|0|||
24975614|NCT04978363|50063759|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
24975615|NCT04978363|50063760|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
24975616|NCT04978363|50063761|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
24975617|NCT04978363|50063762|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
24975618|NCT04978363|50063763|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
24975619|NCT04978363|50063764|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
24975620|NCT04978363|50063765|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
24975621|NCT04978363|50063766|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
24975622|NCT04978363|50063767|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
24975623|NCT04978363|50063768|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
24975624|NCT04978363|50063769|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
24975625|NCT04978363|50063759|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
24975626|NCT04978363|50063760|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
24975627|NCT04978363|50063761|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
24975628|NCT04978363|50063762|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
24975629|NCT04978363|50063763|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
24975630|NCT04978363|50063764|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
25076525|NCT02508116|50184097|FG001|Overall Study|Protocol Violation|2|||
25170297|NCT01793051|50304646|FG000|Overall Study|Switched chemo|1|||
24975631|NCT04978363|50063765|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
25076526|NCT02508116|50184096|FG000|Overall Study|Physician Decision|2|||
25076527|NCT02508116|50184097|FG001|Overall Study|Physician Decision|0|||
25076528|NCT01653782|50184106|FG000|Overall Study|Withdrawal by Subject|9|||
25076529|NCT01653782|50184107|FG001|Overall Study|Withdrawal by Subject|15|||
25076530|NCT01653782|50184108|FG002|Overall Study|Withdrawal by Subject|4|||
24975632|NCT04978363|50063766|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
24975633|NCT04978363|50063767|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
24975634|NCT04978363|50063768|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
24975635|NCT04978363|50063769|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
24975636|NCT04101422|50063849|FG000|Overall Study|Ineligible|1|||
24975637|NCT04101422|50063850|FG001|Overall Study|Ineligible|0|||
24975638|NCT04101422|50063851|FG002|Overall Study|Ineligible|9|||
24975639|NCT04101422|50063852|FG003|Overall Study|Ineligible|0|||
24975640|NCT04101422|50063849|FG000|Overall Study|Withdrawal by Subject|0|||
24975641|NCT04101422|50063850|FG001|Overall Study|Withdrawal by Subject|0|||
24975642|NCT04101422|50063851|FG002|Overall Study|Withdrawal by Subject|1|||
25076531|NCT01653782|50184106|FG000|Overall Study|Lost to Follow-up|7|||
25076532|NCT01653782|50184107|FG001|Overall Study|Lost to Follow-up|3|||
25076533|NCT01653782|50184108|FG002|Overall Study|Lost to Follow-up|2|||
24975643|NCT04101422|50063852|FG003|Overall Study|Withdrawal by Subject|0|||
25076534|NCT02318329|50184126|FG000|Overall Study|Progressive Disease|2|||
25076535|NCT02318329|50184127|FG001|Overall Study|Progressive Disease|3|||
25076536|NCT02318329|50184128|FG002|Overall Study|Progressive Disease|2|||
24975644|NCT04101422|50063849|FG000|Overall Study|Not attending to the stimuli|0|||
24975645|NCT04101422|50063850|FG001|Overall Study|Not attending to the stimuli|0|||
24975646|NCT04101422|50063851|FG002|Overall Study|Not attending to the stimuli|4|||
24975647|NCT04101422|50063852|FG003|Overall Study|Not attending to the stimuli|0|||
25076537|NCT02318329|50184129|FG003|Overall Study|Progressive Disease|3|||
25076538|NCT02318329|50184130|FG004|Overall Study|Progressive Disease|3|||
25076539|NCT02318329|50184131|FG005|Overall Study|Progressive Disease|3|||
25076540|NCT02318329|50184132|FG006|Overall Study|Progressive Disease|1|||
25076541|NCT02318329|50184133|FG007|Overall Study|Progressive Disease|1|||
25076542|NCT02318329|50184134|FG008|Overall Study|Progressive Disease|5|||
25076543|NCT02318329|50184135|FG009|Overall Study|Progressive Disease|39|||
25076544|NCT02318329|50184126|FG000|Overall Study|Death|0|||
25076545|NCT02318329|50184127|FG001|Overall Study|Death|0|||
24975648|NCT04101422|50063849|FG000|Overall Study|Did not download app|0|||
24975649|NCT04101422|50063850|FG001|Overall Study|Did not download app|0|||
24975650|NCT04101422|50063851|FG002|Overall Study|Did not download app|0|||
24975651|NCT04101422|50063852|FG003|Overall Study|Did not download app|17|||
24975652|NCT04101422|50063849|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
24975653|NCT04101422|50063850|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
25076546|NCT02318329|50184128|FG002|Overall Study|Death|0|||
25076547|NCT02318329|50184129|FG003|Overall Study|Death|0|||
25076548|NCT02318329|50184130|FG004|Overall Study|Death|0|||
24975654|NCT04101422|50063851|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
24975655|NCT04101422|50063852|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
24975656|NCT03841604|50063864|FG000|Overall Study|Withdrawal by Subject|3|||
24975657|NCT03841604|50063865|FG001|Overall Study|Withdrawal by Subject|1|||
24975658|NCT03841604|50063864|FG000|Overall Study|Adverse Event|4|||
24975659|NCT03841604|50063865|FG001|Overall Study|Adverse Event|2|||
24975660|NCT03841604|50063864|FG000|Overall Study|Physician Decision|1|||
24975661|NCT03841604|50063865|FG001|Overall Study|Physician Decision|0|||
24975662|NCT03541187|50063882|FG000|Overall Study|Lost to Follow-up|2|||
24975663|NCT03541187|50063883|FG001|Overall Study|Lost to Follow-up|6|||
24975664|NCT03541187|50063882|FG000|Overall Study|Pregnancy|0|||
25076549|NCT02318329|50184131|FG005|Overall Study|Death|0|||
25076550|NCT02318329|50184132|FG006|Overall Study|Death|0|||
25076551|NCT02318329|50184133|FG007|Overall Study|Death|0|||
25076552|NCT02318329|50184134|FG008|Overall Study|Death|0|||
25076553|NCT02318329|50184135|FG009|Overall Study|Death|5|||
25076554|NCT02318329|50184126|FG000|Overall Study|Lost to Follow-up|0|||
25076555|NCT02318329|50184127|FG001|Overall Study|Lost to Follow-up|0|||
25076556|NCT02318329|50184128|FG002|Overall Study|Lost to Follow-up|0|||
25076557|NCT02318329|50184129|FG003|Overall Study|Lost to Follow-up|0|||
25076558|NCT02318329|50184130|FG004|Overall Study|Lost to Follow-up|0|||
25076559|NCT02318329|50184131|FG005|Overall Study|Lost to Follow-up|0|||
25076560|NCT02318329|50184132|FG006|Overall Study|Lost to Follow-up|0|||
25076561|NCT02318329|50184133|FG007|Overall Study|Lost to Follow-up|0|||
25076562|NCT02318329|50184134|FG008|Overall Study|Lost to Follow-up|0|||
25076563|NCT02318329|50184135|FG009|Overall Study|Lost to Follow-up|1|||
25076564|NCT02318329|50184126|FG000|Overall Study|Withdrawal by Subject|0|||
25076565|NCT02318329|50184127|FG001|Overall Study|Withdrawal by Subject|0|||
25076566|NCT02318329|50184128|FG002|Overall Study|Withdrawal by Subject|0|||
25076567|NCT02318329|50184129|FG003|Overall Study|Withdrawal by Subject|0|||
25076568|NCT02318329|50184130|FG004|Overall Study|Withdrawal by Subject|0|||
25076569|NCT02318329|50184131|FG005|Overall Study|Withdrawal by Subject|0|||
24975665|NCT03541187|50063883|FG001|Overall Study|Pregnancy|1|||
24975666|NCT03541187|50063882|FG000|Overall Study|Withdrawal by Subject|6|||
24975667|NCT03541187|50063883|FG001|Overall Study|Withdrawal by Subject|2|||
25076570|NCT02318329|50184132|FG006|Overall Study|Withdrawal by Subject|0|||
25076571|NCT02318329|50184133|FG007|Overall Study|Withdrawal by Subject|0|||
24975668|NCT03541187|50063882|FG000|Overall Study|Moved out of town|1|||
24975669|NCT03541187|50063883|FG001|Overall Study|Moved out of town|0|||
25076572|NCT02318329|50184134|FG008|Overall Study|Withdrawal by Subject|0|||
25076573|NCT02318329|50184135|FG009|Overall Study|Withdrawal by Subject|6|||
25076574|NCT02318329|50184126|FG000|Overall Study|Other|1|||
25076575|NCT02318329|50184127|FG001|Overall Study|Other|1|||
25076576|NCT02318329|50184128|FG002|Overall Study|Other|1|||
25076577|NCT02318329|50184129|FG003|Overall Study|Other|0|||
24975670|NCT03541187|50063882|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
25076578|NCT02318329|50184130|FG004|Overall Study|Other|0|||
25076579|NCT02318329|50184131|FG005|Overall Study|Other|0|||
25076580|NCT02318329|50184132|FG006|Overall Study|Other|0|||
25076581|NCT02318329|50184133|FG007|Overall Study|Other|0|||
25076582|NCT02318329|50184134|FG008|Overall Study|Other|1|||
25076583|NCT02318329|50184135|FG009|Overall Study|Other|1|||
25076584|NCT02255656|50184176|FG000|Overall Study|Adverse Event|11|||
25076585|NCT02255656|50184176|FG000|Overall Study|Poor compliance to protocol|3|||
25076586|NCT02255656|50184176|FG000|Overall Study|Lost to Follow-up|30|||
25076587|NCT02255656|50184176|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
25076588|NCT02255656|50184176|FG000|Overall Study|Other|126|||
25076589|NCT02255500|50184189|FG000|Overall Study|Withdrawal by Subject|1|||
25076590|NCT02255500|50184190|FG001|Overall Study|Withdrawal by Subject|0|||
24975671|NCT03541187|50063883|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
24975672|NCT03541187|50063882|FG000|Overall Study|Did not meet randomization criteria|1|||
24975673|NCT03541187|50063883|FG001|Overall Study|Did not meet randomization criteria|1|||
24975674|NCT03541187|50063882|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
24975675|NCT03541187|50063883|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
24975676|NCT03541187|50063882|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
24975677|NCT03541187|50063883|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
24975678|NCT03240081|50063904|FG000|Overall Study|Withdrawal by Subject|0|||
24975679|NCT03240081|50063905|FG001|Overall Study|Withdrawal by Subject|2|||
24975680|NCT03240081|50063904|FG000|Overall Study|Lost to Follow-up|0|||
24975681|NCT03240081|50063905|FG001|Overall Study|Lost to Follow-up|1|||
24975682|NCT03003520|50063926|FG000|Overall Study|Adverse Event|9|||
24975683|NCT03003520|50063927|FG001|Overall Study|Adverse Event|0|||
24975684|NCT03003520|50063926|FG000|Overall Study|Death|1|||
24975685|NCT03003520|50063927|FG001|Overall Study|Death|0|||
24975686|NCT03003520|50063926|FG000|Overall Study|Other reasons|4|||
24975687|NCT03003520|50063927|FG001|Overall Study|Other reasons|0|||
25076591|NCT02505542|50184196|FG000|Part A: Open-Label Period|Adverse Event|31|||
24975688|NCT03003520|50063926|FG000|Overall Study|Withdrawal by Subject|6|||
24975689|NCT03003520|50063927|FG001|Overall Study|Withdrawal by Subject|0|||
24975690|NCT03003520|50063926|FG000|Overall Study|Progressive disease|9|||
25076592|NCT02505542|50184197|FG001|Part A: Open-Label Period|Adverse Event|0|||
25076593|NCT02505542|50184198|FG002|Part A: Open-Label Period|Adverse Event|0|||
24975691|NCT03003520|50063927|FG001|Overall Study|Progressive disease|1|||
24975692|NCT02958527|50063950|FG000|Overall Study|Not collected CRFs|12|||
24975693|NCT02586025|50063972|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
24975694|NCT02586025|50063973|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
24975695|NCT02586025|50063972|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
24975696|NCT02586025|50063973|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
24975697|NCT02586025|50063972|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
24975698|NCT02586025|50063973|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
24975699|NCT02586025|50063972|FG000|Neoadjuvant Treatment|Death|1|||
24975700|NCT02586025|50063973|FG001|Neoadjuvant Treatment|Death|0|||
24975701|NCT02586025|50063972|FG000|Neoadjuvant Treatment|Adverse Event|1|||
24975702|NCT02586025|50063973|FG001|Neoadjuvant Treatment|Adverse Event|0|||
24975703|NCT02586025|50063972|FG000|Neoadjuvant Treatment|Physician Decision|2|||
24975704|NCT02586025|50063973|FG001|Neoadjuvant Treatment|Physician Decision|1|||
24975705|NCT02586025|50063972|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
24975706|NCT02586025|50063973|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
24975707|NCT02586025|50063972|FG000|Adjuvant Treatment|Recurrent Disease|4|||
24975708|NCT02586025|50063973|FG001|Adjuvant Treatment|Recurrent Disease|5|||
24975709|NCT02586025|50063972|FG000|Adjuvant Treatment|Physician Decision|0|||
24975710|NCT02586025|50063973|FG001|Adjuvant Treatment|Physician Decision|1|||
25076594|NCT02505542|50184199|FG003|Part A: Open-Label Period|Adverse Event|0|||
25076595|NCT02505542|50184196|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
25076596|NCT02505542|50184197|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
25076597|NCT02505542|50184198|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
25076598|NCT02505542|50184199|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
25076599|NCT02505542|50184196|FG000|Part A: Open-Label Period|Protocol Violation|1|||
24975711|NCT02586025|50063972|FG000|Adjuvant Treatment|Pregnancy|1|||
24975712|NCT02586025|50063973|FG001|Adjuvant Treatment|Pregnancy|0|||
24975713|NCT02586025|50063972|FG000|Treatment-Free Follow-Up|Death|11|||
25076600|NCT02505542|50184197|FG001|Part A: Open-Label Period|Protocol Violation|0|||
25076601|NCT02505542|50184198|FG002|Part A: Open-Label Period|Protocol Violation|0|||
25076602|NCT02505542|50184199|FG003|Part A: Open-Label Period|Protocol Violation|0|||
25076603|NCT02505542|50184196|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
25076604|NCT02505542|50184197|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
25076605|NCT02505542|50184198|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
25076606|NCT02505542|50184199|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
25076607|NCT02505542|50184196|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
25076608|NCT02505542|50184197|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
25076609|NCT02505542|50184198|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
25076610|NCT02505542|50184199|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
25076611|NCT02505542|50184196|FG000|Part A: Open-Label Period|New medical history available|1|||
25076612|NCT02505542|50184197|FG001|Part A: Open-Label Period|New medical history available|0|||
25076613|NCT02505542|50184198|FG002|Part A: Open-Label Period|New medical history available|0|||
25076614|NCT02505542|50184199|FG003|Part A: Open-Label Period|New medical history available|0|||
25076615|NCT02505542|50184196|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
25076616|NCT02505542|50184197|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
25076617|NCT02505542|50184198|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
25076618|NCT02505542|50184199|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
25076619|NCT02505542|50184196|FG000|Part A: Open-Label Period|Pregnancy|2|||
25076620|NCT02505542|50184197|FG001|Part A: Open-Label Period|Pregnancy|0|||
25076621|NCT02505542|50184198|FG002|Part A: Open-Label Period|Pregnancy|0|||
25076622|NCT02505542|50184199|FG003|Part A: Open-Label Period|Pregnancy|0|||
25076623|NCT02505542|50184196|FG000|Part A: Open-Label Period|Sponsor directive|1|||
25076624|NCT02505542|50184197|FG001|Part A: Open-Label Period|Sponsor directive|0|||
25076625|NCT02505542|50184198|FG002|Part A: Open-Label Period|Sponsor directive|0|||
25076626|NCT02505542|50184199|FG003|Part A: Open-Label Period|Sponsor directive|0|||
25076627|NCT02505542|50184196|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
25076628|NCT02505542|50184197|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
25076629|NCT02505542|50184198|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
25076630|NCT02505542|50184199|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
25076631|NCT02505542|50184196|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
25076632|NCT02505542|50184197|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
25076633|NCT02505542|50184198|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
25076634|NCT02505542|50184199|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
25076635|NCT02505542|50184196|FG000|Part A: Open-Label Period|Non-compliance|1|||
25193217|NCT01424930|50362503|FG000|Overall Study|Screen Failure|0|||
24975714|NCT02586025|50063973|FG001|Treatment-Free Follow-Up|Death|11|||
24975715|NCT02586025|50063972|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
24975716|NCT02586025|50063973|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
24975717|NCT02586025|50063972|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
25076636|NCT02505542|50184197|FG001|Part A: Open-Label Period|Non-compliance|0|||
25076637|NCT02505542|50184198|FG002|Part A: Open-Label Period|Non-compliance|0|||
25076638|NCT02505542|50184199|FG003|Part A: Open-Label Period|Non-compliance|0|||
25076639|NCT02505542|50184196|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
25076640|NCT02505542|50184197|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
25076641|NCT02505542|50184198|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
25076642|NCT02505542|50184199|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
25076643|NCT02505542|50184196|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
25076644|NCT02505542|50184197|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
25076645|NCT02505542|50184198|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
25076646|NCT02505542|50184199|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
25076647|NCT02505542|50184196|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
25076648|NCT02505542|50184197|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
25076649|NCT02505542|50184198|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
25076650|NCT02505542|50184199|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
25076651|NCT02505542|50184196|FG000|Part B: Double-Blind Period|Adverse Event|0|||
25076652|NCT02505542|50184197|FG001|Part B: Double-Blind Period|Adverse Event|0|||
24975718|NCT02586025|50063973|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
24975719|NCT02586025|50063972|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
24975720|NCT02586025|50063973|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
24975721|NCT02586025|50063972|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
24975722|NCT02586025|50063973|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
24975723|NCT02446600|50063993|FG000|Overall Study|Never treated|20|||
24975724|NCT02446600|50063994|FG001|Overall Study|Never treated|2|||
24975725|NCT02446600|50063995|FG002|Overall Study|Never treated|6|||
24975726|NCT02446600|50063996|FG003|Overall Study|Never treated|0|||
24975727|NCT02446600|50063993|FG000|Overall Study|Withdrawal by Subject|19|||
24975728|NCT02446600|50063994|FG001|Overall Study|Withdrawal by Subject|5|||
24975729|NCT02446600|50063995|FG002|Overall Study|Withdrawal by Subject|17|||
24975730|NCT02446600|50063996|FG003|Overall Study|Withdrawal by Subject|0|||
24975731|NCT02446600|50063993|FG000|Overall Study|Ineligible|1|||
24975732|NCT02446600|50063994|FG001|Overall Study|Ineligible|4|||
24975733|NCT02446600|50063995|FG002|Overall Study|Ineligible|4|||
24975734|NCT02446600|50063996|FG003|Overall Study|Ineligible|1|||
24975735|NCT02446600|50063993|FG000|Overall Study|Duplicate Enrollment|0|||
25193218|NCT01424930|50362504|FG001|Overall Study|Screen Failure|1|||
25193219|NCT01424930|50362503|FG000|Overall Study|Reason not specified|0|||
25193220|NCT01424930|50362504|FG001|Overall Study|Reason not specified|6|||
25193221|NCT01424306|50362519|FG000|Overall Study|Protocol Violation|0|||
25193222|NCT01424306|50362520|FG001|Overall Study|Protocol Violation|0|||
25193223|NCT01424306|50362521|FG002|Overall Study|Protocol Violation|0|||
25193224|NCT01424306|50362522|FG003|Overall Study|Protocol Violation|0|||
25193225|NCT01424306|50362523|FG004|Overall Study|Protocol Violation|1|||
25193226|NCT01424306|50362524|FG005|Overall Study|Protocol Violation|0|||
24975736|NCT02446600|50063994|FG001|Overall Study|Duplicate Enrollment|1|||
24975737|NCT02446600|50063995|FG002|Overall Study|Duplicate Enrollment|0|||
24975738|NCT02446600|50063996|FG003|Overall Study|Duplicate Enrollment|0|||
24975739|NCT02285114|50064009|FG000|Overall Study|Investigator's Discretion|0|||
25076653|NCT02505542|50184198|FG002|Part B: Double-Blind Period|Adverse Event|1|||
25076654|NCT02505542|50184199|FG003|Part B: Double-Blind Period|Adverse Event|3|||
25076655|NCT02505542|50184196|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
25076656|NCT02505542|50184197|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
25076657|NCT02505542|50184198|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
25193227|NCT01424228|50362568|FG000|Overall Study|Withdrawal by Subject|27|||
25193228|NCT01424228|50362569|FG001|Overall Study|Withdrawal by Subject|11|||
25193229|NCT01424228|50362568|FG000|Overall Study|Adverse Event|10|||
25193230|NCT01424228|50362569|FG001|Overall Study|Adverse Event|14|||
25193231|NCT01424228|50362568|FG000|Overall Study|Sponsor's decision|9|||
25193232|NCT01424228|50362569|FG001|Overall Study|Sponsor's decision|12|||
25193233|NCT01424228|50362568|FG000|Overall Study|Lack of Efficacy|5|||
25193234|NCT01424228|50362569|FG001|Overall Study|Lack of Efficacy|7|||
25193235|NCT01424228|50362568|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
25193236|NCT01424228|50362569|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
25193237|NCT01424228|50362568|FG000|Overall Study|Non-compliance|2|||
25193238|NCT01424228|50362569|FG001|Overall Study|Non-compliance|0|||
25193239|NCT01424228|50362568|FG000|Overall Study|Worsening of symptoms|1|||
25193240|NCT01424228|50362569|FG001|Overall Study|Worsening of symptoms|0|||
25193241|NCT01424228|50362568|FG000|Overall Study|Unplanned journey|0|||
25193242|NCT01424228|50362569|FG001|Overall Study|Unplanned journey|1|||
25193243|NCT01423916|50362578|FG000|Overall Study|Adverse Event|5|||
25193244|NCT01423916|50362579|FG001|Overall Study|Adverse Event|9|||
25193245|NCT01423916|50362580|FG002|Overall Study|Adverse Event|2|||
25193246|NCT01423916|50362578|FG000|Overall Study|Met Withdrawal Criteria|1|||
25193247|NCT01423916|50362579|FG001|Overall Study|Met Withdrawal Criteria|1|||
25193248|NCT01423916|50362580|FG002|Overall Study|Met Withdrawal Criteria|1|||
25193249|NCT01423916|50362578|FG000|Overall Study|Physician Decision|1|||
25193250|NCT01423916|50362579|FG001|Overall Study|Physician Decision|0|||
25193251|NCT01423916|50362580|FG002|Overall Study|Physician Decision|1|||
25193252|NCT01423916|50362578|FG000|Overall Study|Withdrawal by Subject|3|||
25193253|NCT01423916|50362579|FG001|Overall Study|Withdrawal by Subject|10|||
25193254|NCT01423916|50362580|FG002|Overall Study|Withdrawal by Subject|3|||
25193255|NCT01423916|50362578|FG000|Overall Study|Protocol Deviation|1|||
25193256|NCT01423916|50362579|FG001|Overall Study|Protocol Deviation|0|||
25193257|NCT01423916|50362580|FG002|Overall Study|Protocol Deviation|0|||
25193258|NCT01423604|50362699|FG000|Safety Run-In|Adverse Event|3|||
25193259|NCT01423604|50362700|FG001|Safety Run-In|Adverse Event|0|||
25193260|NCT01423604|50362699|FG000|Safety Run-In|Death|1|||
25193261|NCT01423604|50362700|FG001|Safety Run-In|Death|0|||
25193262|NCT01423604|50362699|FG000|Safety Run-In|Physician Decision|1|||
25193263|NCT01423604|50362700|FG001|Safety Run-In|Physician Decision|0|||
25193264|NCT01423604|50362699|FG000|Safety Run-In|Disease progression|3|||
25193265|NCT01423604|50362700|FG001|Safety Run-In|Disease progression|0|||
25193266|NCT01423604|50362699|FG000|Safety Run-In|Patient decision|1|||
25193267|NCT01423604|50362700|FG001|Safety Run-In|Patient decision|0|||
25193268|NCT01423604|50362699|FG000|Randomized|Adverse Event|4|||
25193269|NCT01423604|50362700|FG001|Randomized|Adverse Event|10|||
25193270|NCT01423604|50362699|FG000|Randomized|Death|1|||
25193271|NCT01423604|50362700|FG001|Randomized|Death|0|||
25193272|NCT01423604|50362699|FG000|Randomized|Physician Decision|16|||
25193273|NCT01423604|50362700|FG001|Randomized|Physician Decision|13|||
25193274|NCT01423604|50362699|FG000|Randomized|Other - unspecified|37|||
25193275|NCT01423604|50362700|FG001|Randomized|Other - unspecified|31|||
25193276|NCT01423604|50362699|FG000|Randomized|Patient decision|5|||
25193277|NCT01423604|50362700|FG001|Randomized|Patient decision|9|||
25193278|NCT01402544|50362716|FG000|Overall Study|Withdrawal by Subject|6|||
25193279|NCT01401842|50362722|FG000|Overall Study|Withdrawal by Subject|3|||
25193280|NCT01401842|50362723|FG001|Overall Study|Withdrawal by Subject|2|||
25193281|NCT01401842|50362722|FG000|Overall Study|academic reason|4|||
25076658|NCT02505542|50184199|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
25193282|NCT01401842|50362723|FG001|Overall Study|academic reason|1|||
25193283|NCT01401842|50362722|FG000|Overall Study|changed companies|20|||
25193284|NCT01401842|50362723|FG001|Overall Study|changed companies|34|||
25076659|NCT02505542|50184196|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
25193285|NCT01401842|50362722|FG000|Overall Study|discharged from US Army|3|||
25193286|NCT01401842|50362723|FG001|Overall Study|discharged from US Army|4|||
25193287|NCT01401842|50362722|FG000|Overall Study|invalid follow-up strength data|1|||
25193288|NCT01401842|50362723|FG001|Overall Study|invalid follow-up strength data|4|||
25193289|NCT01401842|50362722|FG000|Overall Study|on profile|9|||
25193290|NCT01401842|50362723|FG001|Overall Study|on profile|5|||
25193291|NCT01401842|50362722|FG000|Overall Study|other/unknown|28|||
25193292|NCT01401842|50362723|FG001|Overall Study|other/unknown|17|||
25193293|NCT01422824|50362729|FG000|Overall Study|Case record form not evaluated|1|||
25193294|NCT01422824|50362729|FG000|Overall Study|Lost to Follow-up|37|||
25076660|NCT02505542|50184197|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
25193295|NCT01401530|50362792|FG000|Overall Study|Disease Progression|1|||
25193296|NCT01401530|50362793|FG001|Overall Study|Disease Progression|2|||
25076661|NCT02505542|50184198|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
25076662|NCT02505542|50184199|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
25076663|NCT02505542|50184196|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
25076664|NCT02505542|50184197|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
25076665|NCT02505542|50184198|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
25076666|NCT02505542|50184199|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
25076667|NCT02505542|50184196|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
25076668|NCT02505542|50184197|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
25076669|NCT02505542|50184198|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
25076670|NCT02505542|50184199|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
25076671|NCT02505542|50184196|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
25076672|NCT02505542|50184197|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
25076673|NCT02505542|50184198|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
25076674|NCT02505542|50184199|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
25193297|NCT01401530|50362794|FG002|Overall Study|Disease Progression|1|||
25193298|NCT01401530|50362792|FG000|Overall Study|Adverse Event|1|||
25193299|NCT01401530|50362793|FG001|Overall Study|Adverse Event|1|||
25193300|NCT01401530|50362794|FG002|Overall Study|Adverse Event|1|||
25193301|NCT01401530|50362792|FG000|Overall Study|Participant Choice|1|||
25193302|NCT01401530|50362793|FG001|Overall Study|Participant Choice|2|||
25193303|NCT01401530|50362794|FG002|Overall Study|Participant Choice|1|||
25193304|NCT01401530|50362792|FG000|Overall Study|Physician Decision|0|||
25193305|NCT01401530|50362793|FG001|Overall Study|Physician Decision|1|||
25076675|NCT02505542|50184196|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
25076676|NCT02505542|50184197|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
25076677|NCT02505542|50184198|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
25076678|NCT02505542|50184199|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
25076679|NCT02505542|50184196|FG000|Part B: Double-Blind Period|Miscalculation|0|||
25076680|NCT02505542|50184197|FG001|Part B: Double-Blind Period|Miscalculation|1|||
25076681|NCT02505542|50184198|FG002|Part B: Double-Blind Period|Miscalculation|0|||
25076682|NCT02505542|50184199|FG003|Part B: Double-Blind Period|Miscalculation|0|||
25076683|NCT02505542|50184196|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
25076684|NCT02505542|50184197|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
25076685|NCT02505542|50184198|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
25076686|NCT02505542|50184199|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
25076687|NCT02475980|50184248|FG000|Overall Study|Lost to Follow-up|4|||
25076688|NCT02475980|50184248|FG000|Overall Study|Withdrawal by Subject|1|||
25076689|NCT02447432|50184254|FG000|Epoch 001|Adverse Event|1|||
25076690|NCT02447432|50184255|FG001|Epoch 001|Adverse Event|1|||
25076691|NCT02447432|50184254|FG000|Epoch 001|Withdrawal by Subject|0|||
25076692|NCT02447432|50184255|FG001|Epoch 001|Withdrawal by Subject|4|||
25076693|NCT02447432|50184254|FG000|Epoch 001|Migrated/moved from study area|3|||
25076694|NCT02447432|50184255|FG001|Epoch 001|Migrated/moved from study area|5|||
25076695|NCT02447432|50184254|FG000|Epoch 001|Lost to Follow-up|1|||
25076696|NCT02447432|50184255|FG001|Epoch 001|Lost to Follow-up|3|||
25076697|NCT02446886|50184263|FG000|Overall Study|Adverse Event|1|||
25076698|NCT02446886|50184264|FG001|Overall Study|Adverse Event|3|||
25076699|NCT02446886|50184263|FG000|Overall Study|Withdrawal by Subject|1|||
25076700|NCT02446886|50184264|FG001|Overall Study|Withdrawal by Subject|1|||
25076701|NCT03448939|50184282|FG000|Overall Study|Adverse Event|5|||
25076702|NCT03448939|50184283|FG001|Overall Study|Adverse Event|1|||
25076703|NCT03448939|50184282|FG000|Overall Study|Lost to Follow-up|6|||
25076704|NCT03448939|50184283|FG001|Overall Study|Lost to Follow-up|6|||
25076705|NCT03448939|50184282|FG000|Overall Study|Pregnancy|1|||
25170298|NCT01793051|50304647|FG001|Overall Study|Switched chemo|1|||
25170299|NCT01793051|50304646|FG000|Overall Study|Lack of compliance|1|||
25170300|NCT01793051|50304647|FG001|Overall Study|Lack of compliance|0|||
25193306|NCT01401530|50362794|FG002|Overall Study|Physician Decision|0|||
25193307|NCT01387022|50362806|FG000|Overall Study|Death|1|||
24975740|NCT02285114|50064010|FG001|Overall Study|Investigator's Discretion|2|||
24975741|NCT02285114|50064011|FG002|Overall Study|Investigator's Discretion|0|||
24975742|NCT02285114|50064009|FG000|Overall Study|Withdrew Consent|0|||
24975743|NCT02285114|50064010|FG001|Overall Study|Withdrew Consent|0|||
24975744|NCT02285114|50064011|FG002|Overall Study|Withdrew Consent|1|||
24975745|NCT02285114|50064009|FG000|Overall Study|Enrolled but not treated|1|||
24975746|NCT02285114|50064010|FG001|Overall Study|Enrolled but not treated|0|||
24975747|NCT02285114|50064011|FG002|Overall Study|Enrolled but not treated|0|||
24975748|NCT02285114|50064009|FG000|Overall Study|Still on study|21|||
25076706|NCT03448939|50184283|FG001|Overall Study|Pregnancy|1|||
25076707|NCT03448939|50184282|FG000|Overall Study|Withdrawal by Subject|9|||
25076708|NCT03448939|50184283|FG001|Overall Study|Withdrawal by Subject|3|||
25076709|NCT02504294|50184301|FG000|Overall Study|Adverse Event|15|||
25076710|NCT02504294|50184302|FG001|Overall Study|Adverse Event|12|||
25170301|NCT01793051|50304646|FG000|Overall Study|Requested to be removed from the study|1|||
25193308|NCT01387022|50362807|FG001|Overall Study|Death|1|||
24975749|NCT02285114|50064010|FG001|Overall Study|Still on study|5|||
24975750|NCT02285114|50064011|FG002|Overall Study|Still on study|2|||
24975751|NCT02094261|50064025|FG000|Overall Study|Death|24|||
24975752|NCT02094261|50064025|FG000|Overall Study|Lost to Follow-up|1|||
24975753|NCT02094261|50064025|FG000|Overall Study|Withdrawal by Subject|4|||
24975754|NCT02094261|50064025|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
24975755|NCT01721577|50064031|FG000|Overall Study|Lack of Efficacy|1|||
24975756|NCT01721577|50064032|FG001|Overall Study|Lack of Efficacy|0|||
25076711|NCT02504294|50184301|FG000|Overall Study|Withdrawal by Subject|7|||
25193309|NCT01387022|50362806|FG000|Overall Study|Lost to Follow-up|0|||
25193310|NCT01387022|50362807|FG001|Overall Study|Lost to Follow-up|3|||
25193311|NCT01386944|50362833|FG000|Overall Study|Adverse Event|26|||
25193312|NCT01386944|50362833|FG000|Overall Study|Lack of Efficacy|14|||
25193313|NCT01386944|50362833|FG000|Overall Study|Lost to Follow-up|8|||
25193314|NCT01386944|50362833|FG000|Overall Study|Unspecified reason|8|||
25193315|NCT01386788|50362844|FG000|Overall Study|Lost to Follow-up|2|||
25193316|NCT01386554|50362909|FG000|Overall Study|Lost to Follow-up|0|||
25193317|NCT01386554|50362910|FG001|Overall Study|Lost to Follow-up|0|||
25193318|NCT01386554|50362911|FG002|Overall Study|Lost to Follow-up|1|||
25193319|NCT01386554|50362909|FG000|Overall Study|Adverse Event|2|||
25193320|NCT01386554|50362910|FG001|Overall Study|Adverse Event|5|||
25193321|NCT01386554|50362911|FG002|Overall Study|Adverse Event|2|||
25193322|NCT01386554|50362909|FG000|Overall Study|Progressive disease|1|||
25193323|NCT01386554|50362910|FG001|Overall Study|Progressive disease|2|||
25193324|NCT01386554|50362911|FG002|Overall Study|Progressive disease|2|||
25193325|NCT01386554|50362909|FG000|Overall Study|Administration of live vaccines|0|||
25193326|NCT01386554|50362910|FG001|Overall Study|Administration of live vaccines|1|||
25193327|NCT01386554|50362911|FG002|Overall Study|Administration of live vaccines|0|||
25193328|NCT01386554|50362909|FG000|Overall Study|Investigator discretion|0|||
25193329|NCT01386554|50362910|FG001|Overall Study|Investigator discretion|0|||
25193330|NCT01386554|50362911|FG002|Overall Study|Investigator discretion|1|||
25193331|NCT01386554|50362909|FG000|Overall Study|Reason not collected|0|||
25193332|NCT01386554|50362910|FG001|Overall Study|Reason not collected|1|||
25193333|NCT01386554|50362911|FG002|Overall Study|Reason not collected|0|||
25193334|NCT01386008|50362936|FG000|Overall Study|exited w/o incident /study discontinued|17|||
25193335|NCT01386008|50362936|FG000|Overall Study|Adverse Event|3|||
25193336|NCT01421342|50363093|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
25193337|NCT01421342|50363094|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
25193338|NCT01421342|50363095|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
25193339|NCT01421342|50363093|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
25193340|NCT01421342|50363094|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
25193341|NCT01421342|50363095|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
25193342|NCT01421342|50363093|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
25193343|NCT01421342|50363094|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
25193344|NCT01421342|50363095|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
25193345|NCT01421342|50363093|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
25193346|NCT01421342|50363094|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
25193347|NCT01421342|50363095|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
25193348|NCT01421342|50363093|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
25193349|NCT01421342|50363094|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
25193350|NCT01421342|50363095|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
25193351|NCT01421342|50363093|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
25193352|NCT01421342|50363094|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
25193353|NCT01421342|50363095|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
24975757|NCT01721577|50064031|FG000|Overall Study|Death|1|||
24975758|NCT01721577|50064032|FG001|Overall Study|Death|0|||
24975759|NCT01721577|50064031|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
24975760|NCT01721577|50064032|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
24975761|NCT01721577|50064031|FG000|Overall Study|Adverse Event|0|||
24975762|NCT01721577|50064032|FG001|Overall Study|Adverse Event|2|||
24975763|NCT01411332|50064049|FG000|Enrollment|Protocol Violation|0|||
24975764|NCT01411332|50064050|FG001|Enrollment|Protocol Violation|1|||
24975765|NCT01411332|50064049|FG000|Enrollment|Withdrawal by Subject|0|||
24975766|NCT01411332|50064050|FG001|Enrollment|Withdrawal by Subject|1|||
24975767|NCT01411332|50064049|FG000|Treatment|Lost to Follow-up|1|||
24975768|NCT01411332|50064050|FG001|Treatment|Lost to Follow-up|0|||
25076712|NCT02504294|50184302|FG001|Overall Study|Withdrawal by Subject|1|||
25193354|NCT01421342|50363093|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
25193355|NCT01421342|50363094|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
24975769|NCT01194570|50064059|FG000|Overall Study|Death|1|||
24975770|NCT01194570|50064060|FG001|Overall Study|Death|3|||
24975771|NCT01194570|50064059|FG000|Overall Study|Ongoing at CCOD|162|||
24975772|NCT01194570|50064060|FG001|Overall Study|Ongoing at CCOD|387|||
24975773|NCT01194570|50064059|FG000|Overall Study|Physician Decision|2|||
24975774|NCT01194570|50064060|FG001|Overall Study|Physician Decision|6|||
24975775|NCT01194570|50064059|FG000|Overall Study|Reason not specified|13|||
25076713|NCT02504294|50184301|FG000|Overall Study|Protocol Violation|27|||
25076714|NCT02504294|50184302|FG001|Overall Study|Protocol Violation|26|||
25076715|NCT02504294|50184301|FG000|Overall Study|Physician Decision|1|||
25076716|NCT02504294|50184302|FG001|Overall Study|Physician Decision|2|||
25076717|NCT02504294|50184301|FG000|Overall Study|Lost to Follow-up|6|||
25076718|NCT02504294|50184302|FG001|Overall Study|Lost to Follow-up|7|||
25076719|NCT02446418|50184310|FG000|Overall Study|Adverse Event|4|||
25076720|NCT02446418|50184311|FG001|Overall Study|Adverse Event|8|||
25076721|NCT02446418|50184310|FG000|Overall Study|Physician Decision|5|||
25076722|NCT02446418|50184311|FG001|Overall Study|Physician Decision|1|||
25076723|NCT02446418|50184310|FG000|Overall Study|Withdrawal by Subject|3|||
25076724|NCT02446418|50184311|FG001|Overall Study|Withdrawal by Subject|3|||
25076725|NCT02446418|50184310|FG000|Overall Study|Lost to Follow-up|2|||
25076726|NCT02446418|50184311|FG001|Overall Study|Lost to Follow-up|2|||
25076727|NCT02446418|50184310|FG000|Overall Study|Protocol Violation|1|||
25076728|NCT02446418|50184311|FG001|Overall Study|Protocol Violation|2|||
25076729|NCT02446418|50184310|FG000|Overall Study|Lack of Efficacy|2|||
25076730|NCT02446418|50184311|FG001|Overall Study|Lack of Efficacy|0|||
25076731|NCT02446418|50184310|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
25076732|NCT02446418|50184311|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
25076733|NCT02255422|50184324|FG000|Overall Study|Withdrawal by Subject|0|||
25076734|NCT02255422|50184325|FG001|Overall Study|Withdrawal by Subject|0|||
25076735|NCT02255422|50184326|FG002|Overall Study|Withdrawal by Subject|0|||
25076736|NCT02255422|50184327|FG003|Overall Study|Withdrawal by Subject|0|||
24975776|NCT01194570|50064060|FG001|Overall Study|Reason not specified|20|||
24975777|NCT01194570|50064059|FG000|Overall Study|Protocol Violation|0|||
25076737|NCT02255422|50184328|FG004|Overall Study|Withdrawal by Subject|0|||
25076738|NCT02255422|50184329|FG005|Overall Study|Withdrawal by Subject|0|||
25076739|NCT02255422|50184330|FG006|Overall Study|Withdrawal by Subject|2|||
25076740|NCT02255422|50184324|FG000|Overall Study|Lost to Follow-up|0|||
25076741|NCT02255422|50184325|FG001|Overall Study|Lost to Follow-up|0|||
25076742|NCT02255422|50184326|FG002|Overall Study|Lost to Follow-up|1|||
25076743|NCT02255422|50184327|FG003|Overall Study|Lost to Follow-up|0|||
25076744|NCT02255422|50184328|FG004|Overall Study|Lost to Follow-up|0|||
25076745|NCT02255422|50184329|FG005|Overall Study|Lost to Follow-up|0|||
25076746|NCT02255422|50184330|FG006|Overall Study|Lost to Follow-up|0|||
25076747|NCT02445794|50184350|FG000|Overall Study|Adverse Event|0|||
25076748|NCT02445794|50184351|FG001|Overall Study|Adverse Event|0|||
25076749|NCT02445794|50184352|FG002|Overall Study|Adverse Event|2|||
25076750|NCT02445794|50184353|FG003|Overall Study|Adverse Event|0|||
25076751|NCT02475278|50184368|FG000|Overall Study|Lost to Follow-up|1|||
25076752|NCT02475278|50184368|FG000|Overall Study|Reason Not Specified|1|||
25076753|NCT02254486|50184374|FG000|Overall Study|Adverse Event|1|||
25076754|NCT02254486|50184375|FG001|Overall Study|Adverse Event|1|||
25076755|NCT02254486|50184374|FG000|Overall Study|Lack of Efficacy|1|||
25076756|NCT02254486|50184375|FG001|Overall Study|Lack of Efficacy|0|||
25076757|NCT02254486|50184374|FG000|Overall Study|Lost to Follow-up|2|||
24975778|NCT01194570|50064060|FG001|Overall Study|Protocol Violation|2|||
24975779|NCT01194570|50064059|FG000|Overall Study|Non-compliance with study drug|2|||
25076758|NCT02254486|50184375|FG001|Overall Study|Lost to Follow-up|4|||
25076759|NCT02254486|50184374|FG000|Overall Study|Protocol Violation|1|||
25076760|NCT02254486|50184375|FG001|Overall Study|Protocol Violation|2|||
24975780|NCT01194570|50064060|FG001|Overall Study|Non-compliance with study drug|2|||
24975781|NCT01194570|50064059|FG000|Overall Study|Adverse Event|12|||
24975782|NCT01194570|50064060|FG001|Overall Study|Adverse Event|18|||
25076761|NCT02254486|50184374|FG000|Overall Study|Withdrawal by Subject|17|||
25076762|NCT02254486|50184375|FG001|Overall Study|Withdrawal by Subject|15|||
25076763|NCT02254486|50184374|FG000|Overall Study|GFR<60mL/min|16|||
25170302|NCT01793051|50304647|FG001|Overall Study|Requested to be removed from the study|1|||
24975783|NCT01194570|50064059|FG000|Overall Study|Non-compliance|2|||
24975784|NCT01194570|50064060|FG001|Overall Study|Non-compliance|2|||
24975785|NCT01194570|50064059|FG000|Overall Study|Lack of Efficacy|27|||
24975786|NCT01194570|50064060|FG001|Overall Study|Lack of Efficacy|21|||
24975787|NCT01194570|50064059|FG000|Overall Study|Withdrawal by Subject|21|||
25076764|NCT02254486|50184375|FG001|Overall Study|GFR<60mL/min|21|||
25076765|NCT02254486|50184374|FG000|Overall Study|Various|12|||
25076766|NCT02254486|50184375|FG001|Overall Study|Various|12|||
25076767|NCT01641640|50184381|FG000|Overall Study|Enrolled but not treated|1|||
25076768|NCT01641640|50184381|FG000|Overall Study|Efficacy failure|29|||
25076769|NCT01641640|50184381|FG000|Overall Study|Lost to Follow-up|3|||
25076770|NCT01641640|50184381|FG000|Overall Study|Withdrawal by Subject|2|||
25076771|NCT01641640|50184381|FG000|Overall Study|Adverse Event|1|||
25076772|NCT01639144|50184387|FG000|Overall Study|Withdrawal by Subject|4|||
25076773|NCT01639144|50184388|FG001|Overall Study|Withdrawal by Subject|2|||
25076774|NCT01639144|50184387|FG000|Overall Study|Physician Decision|2|||
25076775|NCT01639144|50184388|FG001|Overall Study|Physician Decision|0|||
25076776|NCT01639144|50184387|FG000|Overall Study|Met postoperative exclusion criteria|4|||
25076777|NCT01639144|50184388|FG001|Overall Study|Met postoperative exclusion criteria|3|||
24975788|NCT01194570|50064060|FG001|Overall Study|Withdrawal by Subject|22|||
24975789|NCT01194570|50064059|FG000|Overall Study|Pregnancy|1|||
24975790|NCT01194570|50064060|FG001|Overall Study|Pregnancy|1|||
24975791|NCT01194570|50064059|FG000|Overall Study|Lost to Follow-up|1|||
25076778|NCT01601626|50184397|FG000|Overall Study|Death|1|||
25076779|NCT01601626|50184398|FG001|Overall Study|Death|1|||
25076780|NCT01601626|50184399|FG002|Overall Study|Death|1|||
25076781|NCT01601626|50184397|FG000|Overall Study|Lost to Follow-up|1|||
25193356|NCT01421342|50363095|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
25193357|NCT01421342|50363093|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
25193358|NCT01421342|50363094|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
25193359|NCT01421342|50363095|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
25193360|NCT01421342|50363093|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
25193361|NCT01421342|50363094|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
25193362|NCT01421342|50363095|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
25193363|NCT01421342|50363093|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
25193364|NCT01421342|50363094|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
25193365|NCT01421342|50363095|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
25193366|NCT01421342|50363093|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
25193367|NCT01421342|50363094|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
25193368|NCT01421342|50363095|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
25193369|NCT01421342|50363093|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
25193370|NCT01421342|50363094|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
25193371|NCT01421342|50363095|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
25193372|NCT01421342|50363093|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
25193373|NCT01421342|50363094|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
25193374|NCT01421342|50363095|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
25193375|NCT01421342|50363093|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
25193376|NCT01421342|50363094|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
25193377|NCT01421342|50363095|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
25193378|NCT01421342|50363093|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
25193379|NCT01421342|50363094|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
25193380|NCT01421342|50363095|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
25193381|NCT01421342|50363093|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
25193382|NCT01421342|50363094|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
25193383|NCT01421342|50363095|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
25314845|NCT00644059|50630671|FG000|Overall Study|Protocol Deviation/violation|20|||
25076782|NCT01601626|50184398|FG001|Overall Study|Lost to Follow-up|2|||
25076783|NCT01601626|50184399|FG002|Overall Study|Lost to Follow-up|0|||
25076784|NCT01601626|50184397|FG000|Overall Study|Unable to Get to Clinic|0|||
25170303|NCT01816061|50304680|FG000|Overall Study|Lost to Follow-up|13|||
25170304|NCT01816061|50304681|FG001|Overall Study|Lost to Follow-up|24|||
25170305|NCT01792115|50304707|FG000|Overall Study|Lost to Follow-up|0|||
25170306|NCT01792115|50304708|FG001|Overall Study|Lost to Follow-up|1|||
25170307|NCT01792115|50304709|FG002|Overall Study|Lost to Follow-up|0|||
25170308|NCT01791803|50304721|FG000|Overall Study|Withdrawal by Subject|0|||
25170309|NCT01791803|50304722|FG001|Overall Study|Withdrawal by Subject|0|||
25170310|NCT01791803|50304723|FG002|Overall Study|Withdrawal by Subject|0|||
25170311|NCT01791803|50304724|FG003|Overall Study|Withdrawal by Subject|2|||
25170312|NCT01791803|50304721|FG000|Overall Study|Physician Decision|0|||
25170313|NCT01791803|50304722|FG001|Overall Study|Physician Decision|2|||
25170314|NCT01791803|50304723|FG002|Overall Study|Physician Decision|0|||
25170315|NCT01791803|50304724|FG003|Overall Study|Physician Decision|1|||
25170316|NCT01791803|50304721|FG000|Overall Study|Death|0|||
25170317|NCT01791803|50304722|FG001|Overall Study|Death|0|||
25170318|NCT01791803|50304723|FG002|Overall Study|Death|2|||
24975792|NCT01194570|50064060|FG001|Overall Study|Lost to Follow-up|4|||
24975793|NCT04881747|50064086|FG000|Period 2 Washout|Adverse Event|1|||
25076785|NCT01601626|50184398|FG001|Overall Study|Unable to Get to Clinic|1|||
25076786|NCT01601626|50184399|FG002|Overall Study|Unable to Get to Clinic|0|||
25170319|NCT01791803|50304724|FG003|Overall Study|Death|2|||
25076787|NCT01601626|50184397|FG000|Overall Study|Withdrawal by Subject|0|||
25076788|NCT01601626|50184398|FG001|Overall Study|Withdrawal by Subject|1|||
25076789|NCT01601626|50184399|FG002|Overall Study|Withdrawal by Subject|1|||
25076790|NCT01601626|50184397|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
25076791|NCT01601626|50184398|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
25076792|NCT01601626|50184399|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
25076793|NCT02737501|50184409|FG000|Randomized Phase|Died|41|||
25076794|NCT02737501|50184410|FG001|Randomized Phase|Died|29|||
25076795|NCT02737501|50184411|FG002|Randomized Phase|Died|0|||
25076796|NCT02737501|50184409|FG000|Randomized Phase|Withdrawal by Subject|16|||
25076797|NCT02737501|50184410|FG001|Randomized Phase|Withdrawal by Subject|6|||
25076798|NCT02737501|50184411|FG002|Randomized Phase|Withdrawal by Subject|0|||
25076799|NCT02737501|50184409|FG000|Randomized Phase|Lost to Follow-up|0|||
25076800|NCT02737501|50184410|FG001|Randomized Phase|Lost to Follow-up|1|||
25076801|NCT02737501|50184411|FG002|Randomized Phase|Lost to Follow-up|0|||
25076802|NCT02737501|50184409|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
25076803|NCT02737501|50184410|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
25076804|NCT02737501|50184411|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
25076805|NCT02737501|50184409|FG000|Randomized Phase|Reason not Specified|1|||
25076806|NCT02737501|50184410|FG001|Randomized Phase|Reason not Specified|1|||
25076807|NCT02737501|50184411|FG002|Randomized Phase|Reason not Specified|0|||
25076808|NCT02737501|50184409|FG000|Randomized Phase|Never Treated|1|||
25076809|NCT02737501|50184410|FG001|Randomized Phase|Never Treated|1|||
25076810|NCT02737501|50184411|FG002|Randomized Phase|Never Treated|0|||
25076811|NCT02737501|50184409|FG000|Crossover Phase|Died|0|||
25076812|NCT02737501|50184410|FG001|Crossover Phase|Died|0|||
25076813|NCT02737501|50184411|FG002|Crossover Phase|Died|22|||
25076814|NCT02737501|50184409|FG000|Crossover Phase|Withdrew Consent|0|||
25076815|NCT02737501|50184410|FG001|Crossover Phase|Withdrew Consent|0|||
25076816|NCT02737501|50184411|FG002|Crossover Phase|Withdrew Consent|9|||
25076817|NCT02737501|50184409|FG000|Crossover Phase|Physician Decision|0|||
25076818|NCT02737501|50184410|FG001|Crossover Phase|Physician Decision|0|||
25076819|NCT02737501|50184411|FG002|Crossover Phase|Physician Decision|1|||
24975794|NCT04881747|50064087|FG001|Period 2 Washout|Adverse Event|0|||
24975795|NCT04881747|50064088|FG002|Period 2 Washout|Adverse Event|0|||
24975796|NCT04881747|50064089|FG003|Period 2 Washout|Adverse Event|0|||
24975797|NCT04881747|50064090|FG004|Period 2 Washout|Adverse Event|1|||
24975798|NCT04881747|50064091|FG005|Period 2 Washout|Adverse Event|0|||
24975799|NCT04881747|50064086|FG000|Period 2 Washout|Withdrawal by Subject|1|||
24975800|NCT04881747|50064087|FG001|Period 2 Washout|Withdrawal by Subject|0|||
24975801|NCT04881747|50064088|FG002|Period 2 Washout|Withdrawal by Subject|0|||
24975802|NCT04881747|50064089|FG003|Period 2 Washout|Withdrawal by Subject|1|||
24975803|NCT04881747|50064090|FG004|Period 2 Washout|Withdrawal by Subject|0|||
24975804|NCT04881747|50064091|FG005|Period 2 Washout|Withdrawal by Subject|0|||
24975805|NCT04795622|50064101|FG000|Overall Study|Adverse Event|1|||
24975806|NCT04795622|50064102|FG001|Overall Study|Adverse Event|0|||
25076820|NCT02737501|50184409|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
25076821|NCT02737501|50184410|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
25076822|NCT02737501|50184411|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
25076823|NCT01640314|50184421|FG000|Overall Study|Protocol Violation|0|||
25076824|NCT01640314|50184422|FG001|Overall Study|Protocol Violation|1|||
25076825|NCT02740049|50184504|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
25076826|NCT01601704|50184510|FG000|Overall Study|Randomized but not dispensed study med|1|||
25076827|NCT01601704|50184511|FG001|Overall Study|Randomized but not dispensed study med|4|||
25076828|NCT04969276|50184520|FG000|Overall Study|Protocol Deviation|0|||
25076829|NCT04969276|50184521|FG001|Overall Study|Protocol Deviation|1|||
25076830|NCT04969276|50184522|FG002|Overall Study|Protocol Deviation|0|||
25076831|NCT04969276|50184520|FG000|Overall Study|Withdrawal by Subject|1|||
25076832|NCT04969276|50184521|FG001|Overall Study|Withdrawal by Subject|10|||
25076833|NCT04969276|50184522|FG002|Overall Study|Withdrawal by Subject|0|||
25076834|NCT04969276|50184520|FG000|Overall Study|Lost to Follow-up|0|||
25076835|NCT04969276|50184521|FG001|Overall Study|Lost to Follow-up|1|||
25076836|NCT04969276|50184522|FG002|Overall Study|Lost to Follow-up|0|||
25076837|NCT01601470|50184530|FG000|Period 2 - LCZ696|Physician Decision|1|||
25076838|NCT03248375|50184554|FG000|Overall Study|Lost to Follow-up|5|||
25076839|NCT01637272|50184558|FG000|Overall Study|Adverse Event|6|||
25076840|NCT01637272|50184558|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
25076841|NCT01637272|50184558|FG000|Overall Study|Withdrawal by Subject|3|||
25076842|NCT01637272|50184558|FG000|Overall Study|Lost to Follow-up|2|||
25076843|NCT01637272|50184558|FG000|Overall Study|completed core, did not enter ext. phase|4|||
25076844|NCT01637272|50184558|FG000|Overall Study|Administrative problems|1|||
25076845|NCT01637272|50184558|FG000|Overall Study|Protocol Violation|2|||
25076846|NCT01636960|50184577|FG000|Induction Phase|Adverse Event|2|||
25193384|NCT01421342|50363093|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
25193385|NCT01421342|50363094|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
25193386|NCT01421342|50363095|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
25193387|NCT01421342|50363093|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
25193388|NCT01421342|50363094|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
25193389|NCT01421342|50363095|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
25193390|NCT01421342|50363093|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
25193391|NCT01421342|50363094|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
25193392|NCT01421342|50363095|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
25193393|NCT01421342|50363093|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
25193394|NCT01421342|50363094|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
25193395|NCT01421342|50363095|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
25193396|NCT01421342|50363093|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
25193397|NCT01421342|50363094|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
25193398|NCT01421342|50363095|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
25193399|NCT01421342|50363093|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
25193400|NCT01421342|50363094|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
25193401|NCT01421342|50363095|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
25193402|NCT01421342|50363093|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
25193403|NCT01421342|50363094|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
25193404|NCT01421342|50363095|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
24975807|NCT04795622|50064101|FG000|Overall Study|Withdrawal by Subject|3|||
24975808|NCT04795622|50064102|FG001|Overall Study|Withdrawal by Subject|3|||
24975809|NCT04795622|50064101|FG000|Overall Study|Protocol Violation|0|||
24975810|NCT04795622|50064102|FG001|Overall Study|Protocol Violation|2|||
24975811|NCT04795622|50064101|FG000|Overall Study|Lost to Follow-up|2|||
24975812|NCT04795622|50064102|FG001|Overall Study|Lost to Follow-up|3|||
24975813|NCT04795622|50064101|FG000|Overall Study|Other|7|||
24975814|NCT04795622|50064102|FG001|Overall Study|Other|8|||
24975815|NCT04652245|50064123|FG000|Wash-Out Period|Adverse Event|0|||
24975816|NCT04652245|50064124|FG001|Wash-Out Period|Adverse Event|2|||
24975817|NCT04652245|50064123|FG000|Wash-Out Period|Withdrawal by Subject|0|||
24975818|NCT04652245|50064124|FG001|Wash-Out Period|Withdrawal by Subject|2|||
24975819|NCT04405739|50064141|FG000|Overall Study|Adverse Event|0|||
24975820|NCT04405739|50064142|FG001|Overall Study|Adverse Event|1|||
24975821|NCT04405739|50064143|FG002|Overall Study|Adverse Event|0|||
24975822|NCT04405739|50064144|FG003|Overall Study|Adverse Event|0|||
24975823|NCT04405739|50064141|FG000|Overall Study|Lost to Follow-up|0|||
24975824|NCT04405739|50064142|FG001|Overall Study|Lost to Follow-up|2|||
24975825|NCT04405739|50064143|FG002|Overall Study|Lost to Follow-up|1|||
24975826|NCT04405739|50064144|FG003|Overall Study|Lost to Follow-up|3|||
24975827|NCT04405739|50064141|FG000|Overall Study|Withdrawal by Subject|0|||
24975828|NCT04405739|50064142|FG001|Overall Study|Withdrawal by Subject|2|||
24975829|NCT04405739|50064143|FG002|Overall Study|Withdrawal by Subject|1|||
24975830|NCT04405739|50064144|FG003|Overall Study|Withdrawal by Subject|1|||
24975831|NCT04405739|50064141|FG000|Overall Study|Death|0|||
24975832|NCT04405739|50064142|FG001|Overall Study|Death|0|||
24975833|NCT04405739|50064143|FG002|Overall Study|Death|1|||
25076847|NCT01636960|50184577|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
25076848|NCT01636960|50184577|FG000|Maintenance Phase|Adverse Event|3|||
25076849|NCT01636960|50184577|FG000|Maintenance Phase|Progressive disease|1|||
25076850|NCT01636258|50184583|FG000|Overall Study|Lost to Follow-up|1|||
25076851|NCT01636258|50184584|FG001|Overall Study|Lost to Follow-up|0|||
25193405|NCT01421342|50363093|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
25193406|NCT01421342|50363094|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
25193407|NCT01421342|50363095|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
25193408|NCT01421342|50363093|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
25193409|NCT01421342|50363094|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
25193410|NCT01421342|50363095|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
25193411|NCT01421342|50363093|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
25193412|NCT01421342|50363094|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
24975834|NCT04405739|50064144|FG003|Overall Study|Death|0|||
24975835|NCT04405739|50064141|FG000|Overall Study|Transferred to rehab|0|||
24975836|NCT04405739|50064142|FG001|Overall Study|Transferred to rehab|0|||
24975837|NCT04405739|50064143|FG002|Overall Study|Transferred to rehab|0|||
24975838|NCT04405739|50064144|FG003|Overall Study|Transferred to rehab|1|||
24975839|NCT04405739|50064141|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
24975840|NCT04405739|50064142|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
25076852|NCT02504216|50184593|FG000|Overall Study|Lost to Follow-up|3|||
25076853|NCT02504216|50184594|FG001|Overall Study|Lost to Follow-up|3|||
25076854|NCT02504216|50184593|FG000|Overall Study|Withdrawal by Subject|8|||
25076855|NCT02504216|50184594|FG001|Overall Study|Withdrawal by Subject|12|||
25076856|NCT04354870|50184602|FG000|Overall Study|Lost to Follow-up|32|||
25076857|NCT04354870|50184603|FG001|Overall Study|Lost to Follow-up|12|||
25076858|NCT04354870|50184602|FG000|Overall Study|Withdrawal by Subject|10|||
25076859|NCT04354870|50184603|FG001|Overall Study|Withdrawal by Subject|16|||
25076860|NCT04354870|50184602|FG000|Overall Study|Did not complete all study visits|6|||
25076861|NCT04354870|50184603|FG001|Overall Study|Did not complete all study visits|5|||
25076862|NCT02473952|50184611|FG000|Overall Study|Adverse Event|2|||
25076863|NCT02473952|50184612|FG001|Overall Study|Adverse Event|2|||
25076864|NCT02473952|50184611|FG000|Overall Study|Withdrawal by Subject|0|||
25076865|NCT02473952|50184612|FG001|Overall Study|Withdrawal by Subject|6|||
25076866|NCT02473640|50184618|FG000|Treatment Period 1|Adverse Event|1|||
25076867|NCT01637584|50184627|FG000|Overall Study|Withdrawal by Subject|1|||
25076868|NCT01637584|50184628|FG001|Overall Study|Withdrawal by Subject|3|||
25076869|NCT03883906|50184635|FG000|Overall Study|Withdrawal by Subject|2|||
25076870|NCT03883906|50184635|FG000|Overall Study|Physician Decision|5|||
25076871|NCT03875092|50184641|FG000|Overall Study|Adverse Event|2|||
25076872|NCT03875092|50184642|FG001|Overall Study|Adverse Event|5|||
25076873|NCT03875092|50184641|FG000|Overall Study|Death|28|||
25076874|NCT03875092|50184642|FG001|Overall Study|Death|41|||
25076875|NCT03875092|50184641|FG000|Overall Study|Ongoing in Study|35|||
25076876|NCT03875092|50184642|FG001|Overall Study|Ongoing in Study|14|||
25076877|NCT02503202|50184653|FG000|Base Study: Up to Month 6|Death|1|||
25076878|NCT02503202|50184654|FG001|Base Study: Up to Month 6|Death|1|||
25076879|NCT02503202|50184655|FG002|Base Study: Up to Month 6|Death|0|||
25076880|NCT02503202|50184656|FG003|Base Study: Up to Month 6|Death|0|||
25076881|NCT02503202|50184657|FG004|Base Study: Up to Month 6|Death|0|||
25076882|NCT02503202|50184653|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
25076883|NCT02503202|50184654|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
25076884|NCT02503202|50184655|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
25076885|NCT02503202|50184656|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
25193413|NCT01421342|50363095|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
25314846|NCT00644059|50630672|FG001|Overall Study|Protocol Deviation/violation|19|||
24975841|NCT04405739|50064143|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
24975842|NCT04405739|50064144|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
25076886|NCT02503202|50184657|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
25076887|NCT02503202|50184653|FG000|Base Study: Up to Month 6|Physician Decision|0|||
25076888|NCT02503202|50184654|FG001|Base Study: Up to Month 6|Physician Decision|0|||
25076889|NCT02503202|50184655|FG002|Base Study: Up to Month 6|Physician Decision|0|||
25076890|NCT02503202|50184656|FG003|Base Study: Up to Month 6|Physician Decision|0|||
25076891|NCT02503202|50184657|FG004|Base Study: Up to Month 6|Physician Decision|1|||
25076892|NCT02503202|50184653|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
25314847|NCT00644059|50630673|FG002|Overall Study|Protocol Deviation/violation|15|||
25314848|NCT00644059|50630671|FG000|Overall Study|Unable to classify|6|||
25314849|NCT00644059|50630672|FG001|Overall Study|Unable to classify|2|||
25314850|NCT00644059|50630673|FG002|Overall Study|Unable to classify|3|||
25314851|NCT00643279|50630724|FG000|Overall Study|Death|13|||
25314852|NCT00643279|50630725|FG001|Overall Study|Death|11|||
25314853|NCT00643279|50630724|FG000|Overall Study|Withdrawal by Subject|3|||
24975843|NCT04241315|50064156|FG000|Overall Study|Withdrawal by Subject|0|||
24975844|NCT04241315|50064157|FG001|Overall Study|Withdrawal by Subject|1|||
24975845|NCT04225026|50064163|FG000|Overall Study|Withdrawal by Subject|4|||
24975846|NCT04225026|50064163|FG000|Overall Study|Adverse Event|1|||
24975847|NCT04225026|50064163|FG000|Overall Study|Other|1|||
24975848|NCT04225026|50064163|FG000|Overall Study|Death|11|||
24975849|NCT04225026|50064163|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
24975850|NCT03493958|50064569|FG000|Overall Study|Withdrawal by Subject|6|||
24975851|NCT03493958|50064569|FG000|Overall Study|Lost to Follow-up|7|||
24975852|NCT03493958|50064569|FG000|Overall Study|Did not complete all required study procedures|2|||
24975853|NCT03486223|50064575|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
24975854|NCT03486223|50064576|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
24975855|NCT03482024|50064587|FG000|Overall Study|Physician Decision|1|||
24975856|NCT03482024|50064588|FG001|Overall Study|Physician Decision|0|||
24975857|NCT03482024|50064589|FG002|Overall Study|Physician Decision|0|||
24975858|NCT03482024|50064590|FG003|Overall Study|Physician Decision|0|||
24975859|NCT03482024|50064591|FG004|Overall Study|Physician Decision|0|||
24975860|NCT03468309|50064603|FG000|Overall Study|Lost to Follow-up|4|||
24975861|NCT03468309|50064603|FG000|Overall Study|Withdrawal by Subject|2|||
24975862|NCT03423147|50064609|FG000|Overall Study|Lost to Follow-up|5|||
24975863|NCT03423147|50064610|FG001|Overall Study|Lost to Follow-up|8|||
24975864|NCT03423147|50064609|FG000|Overall Study|Withdrawal by Subject|1|||
24975865|NCT03423147|50064610|FG001|Overall Study|Withdrawal by Subject|0|||
24975866|NCT03423147|50064609|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
24975867|NCT03423147|50064610|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
24975868|NCT03423147|50064609|FG000|Overall Study|Age < 18|1|||
24975869|NCT03423147|50064610|FG001|Overall Study|Age < 18|0|||
24975870|NCT03423147|50064609|FG000|Overall Study|No Trial of Labor|0|||
24975871|NCT03423147|50064610|FG001|Overall Study|No Trial of Labor|1|||
24975872|NCT03322631|50064620|FG000|Overall Study|Withdrawal by Subject|0|||
24975873|NCT03322631|50064621|FG001|Overall Study|Withdrawal by Subject|1|||
24975874|NCT03322631|50064622|FG002|Overall Study|Withdrawal by Subject|0|||
24975875|NCT03322631|50064623|FG003|Overall Study|Withdrawal by Subject|0|||
24975876|NCT03322631|50064620|FG000|Overall Study|Adverse Event|0|||
24975877|NCT03322631|50064621|FG001|Overall Study|Adverse Event|0|||
24975878|NCT03322631|50064622|FG002|Overall Study|Adverse Event|1|||
24975879|NCT03322631|50064623|FG003|Overall Study|Adverse Event|0|||
24975880|NCT03018704|50064642|FG000|Overall Study|Lost to Follow-up|1|||
24975881|NCT03018704|50064643|FG001|Overall Study|Lost to Follow-up|1|||
24975882|NCT02663349|50064649|FG000|Overall Study|Withdrawal by Subject|6|||
24975883|NCT02558491|50064653|FG000|First Invention|Withdrawal by Subject|3|||
24975884|NCT02558491|50064654|FG001|First Invention|Withdrawal by Subject|1|||
24975885|NCT02558491|50064653|FG000|First Invention|Data collection issues|1|||
24975886|NCT02558491|50064654|FG001|First Invention|Data collection issues|0|||
24975887|NCT02558491|50064653|FG000|First Invention|Stopping criteria|0|||
24975888|NCT02558491|50064654|FG001|First Invention|Stopping criteria|1|||
24975889|NCT02558491|50064653|FG000|First Invention|Changed parameters during trial|1|||
24975890|NCT02558491|50064654|FG001|First Invention|Changed parameters during trial|0|||
24975891|NCT02558491|50064653|FG000|Second Intervention|Withdrawal by Subject|1|||
24975892|NCT02558491|50064654|FG001|Second Intervention|Withdrawal by Subject|0|||
25076893|NCT02503202|50184654|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
25076894|NCT02503202|50184655|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
24975893|NCT02558491|50064653|FG000|Second Intervention|Stopping Criteria|1|||
24975894|NCT02558491|50064654|FG001|Second Intervention|Stopping Criteria|0|||
24975895|NCT02490878|50064663|FG000|Overall Study|deemed ineligible|0|||
24975896|NCT02490878|50064664|FG001|Overall Study|deemed ineligible|1|||
24975897|NCT02490878|50064663|FG000|Overall Study|progression prior to treatment|0|||
24975898|NCT02490878|50064664|FG001|Overall Study|progression prior to treatment|1|||
24975899|NCT02490878|50064663|FG000|Overall Study|only submitted baseline QOL|0|||
24975900|NCT02490878|50064664|FG001|Overall Study|only submitted baseline QOL|1|||
24975901|NCT02421601|50064670|FG000|Overall Study|Adverse Event|4|||
24975902|NCT02421601|50064670|FG000|Overall Study|Lack of Efficacy|5|||
24975903|NCT02421601|50064670|FG000|Overall Study|Physician Decision|1|||
24975904|NCT02421601|50064670|FG000|Overall Study|Withdrawal by Subject|31|||
24975905|NCT02421601|50064670|FG000|Overall Study|Others|41|||
24975906|NCT01934218|50064676|FG000|Double-blind Phase|Adverse Event|8|||
24975907|NCT01934218|50064677|FG001|Double-blind Phase|Adverse Event|8|||
24975908|NCT01934218|50064676|FG000|Double-blind Phase|Lack of Efficacy|6|||
24975909|NCT01934218|50064677|FG001|Double-blind Phase|Lack of Efficacy|7|||
24975910|NCT01934218|50064676|FG000|Double-blind Phase|Lost to Follow-up|7|||
24975911|NCT01934218|50064677|FG001|Double-blind Phase|Lost to Follow-up|14|||
24975912|NCT01934218|50064676|FG000|Double-blind Phase|Physician Decision|1|||
24975913|NCT01934218|50064677|FG001|Double-blind Phase|Physician Decision|2|||
24975914|NCT01934218|50064676|FG000|Double-blind Phase|Protocol Violation|4|||
24975915|NCT01934218|50064677|FG001|Double-blind Phase|Protocol Violation|0|||
24975916|NCT01934218|50064676|FG000|Double-blind Phase|Withdrawal by Subject|16|||
24975917|NCT01934218|50064677|FG001|Double-blind Phase|Withdrawal by Subject|13|||
24975918|NCT01934218|50064676|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
24975919|NCT01934218|50064677|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
24975920|NCT01934218|50064676|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
24975921|NCT01934218|50064677|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
24975922|NCT01934218|50064676|FG000|Open-Label Phase|Adverse Event|2|||
24975923|NCT01934218|50064677|FG001|Open-Label Phase|Adverse Event|4|||
24975924|NCT01934218|50064676|FG000|Open-Label Phase|Lack of Efficacy|1|||
24975925|NCT01934218|50064677|FG001|Open-Label Phase|Lack of Efficacy|4|||
24975926|NCT01934218|50064676|FG000|Open-Label Phase|Lost to Follow-up|4|||
24975927|NCT01934218|50064677|FG001|Open-Label Phase|Lost to Follow-up|2|||
24975928|NCT01934218|50064676|FG000|Open-Label Phase|Physician Decision|1|||
24975929|NCT01934218|50064677|FG001|Open-Label Phase|Physician Decision|0|||
24975930|NCT01934218|50064676|FG000|Open-Label Phase|Protocol Violation|1|||
24975931|NCT01934218|50064677|FG001|Open-Label Phase|Protocol Violation|0|||
24975932|NCT01934218|50064676|FG000|Open-Label Phase|Withdrawal by Subject|13|||
24975933|NCT01934218|50064677|FG001|Open-Label Phase|Withdrawal by Subject|11|||
24975934|NCT01934218|50064676|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
24975935|NCT01934218|50064677|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
24975936|NCT01934218|50064676|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
25193414|NCT01421342|50363093|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
25193415|NCT01421342|50363094|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
25193416|NCT01421342|50363095|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
25193417|NCT01421342|50363093|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
25193418|NCT01421342|50363094|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
25193419|NCT01421342|50363095|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
25193420|NCT01384760|50363118|FG000|Overall Study|Lost to Follow-up|0|||
25193421|NCT01384760|50363119|FG001|Overall Study|Lost to Follow-up|6|||
25193422|NCT01384760|50363118|FG000|Overall Study|Protocol Violation|16|||
25193423|NCT01384760|50363119|FG001|Overall Study|Protocol Violation|0|||
25193424|NCT01384292|50363159|FG000|Part B|Severe non-compliance to protocol|1|||
25193425|NCT01384292|50363160|FG001|Part B|Severe non-compliance to protocol|0|||
25193426|NCT01384292|50363161|FG002|Part B|Severe non-compliance to protocol|0|||
25193427|NCT01401452|50363171|FG000|Overall Study|Adverse reaction|9|||
25193428|NCT01401452|50363171|FG000|Overall Study|Lost to Follow-up|12|||
24975937|NCT01934218|50064677|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
24975938|NCT01702805|50064685|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
24975939|NCT01702805|50064686|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
24975940|NCT01702805|50064685|FG000|Overall Study|Incomplete Follow-up|18|||
25076895|NCT02503202|50184656|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
25314854|NCT00643279|50630725|FG001|Overall Study|Withdrawal by Subject|0|||
24975941|NCT01702805|50064686|FG001|Overall Study|Incomplete Follow-up|15|||
25076896|NCT02503202|50184657|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
24975942|NCT01702805|50064685|FG000|Overall Study|Vital Status Assessment Only|40|||
24975943|NCT01702805|50064686|FG001|Overall Study|Vital Status Assessment Only|39|||
24975944|NCT01702805|50064685|FG000|Overall Study|Lost to Follow-up|5|||
25170320|NCT01791725|50304749|FG000|Overall Study|Withdrawal by Subject|0|||
25193429|NCT01401452|50363171|FG000|Overall Study|Lack of Efficacy|30|||
25193430|NCT01401452|50363171|FG000|Overall Study|Participant developed breast cancer|1|||
25193431|NCT01401452|50363171|FG000|Overall Study|Tx stopped due to financial reasons|1|||
25193432|NCT01401452|50363171|FG000|Overall Study|Tx stopped by psychiatrist|1|||
25193433|NCT01401452|50363171|FG000|Overall Study|No more visits within the 36 wk followup|4|||
25193434|NCT01401452|50363171|FG000|Overall Study|Subject did not come to follow up visits|2|||
25193435|NCT01401452|50363171|FG000|Overall Study|Subject didn't return for routine visits|1|||
25193436|NCT01401452|50363171|FG000|Overall Study|Subject moved to another city|1|||
25193437|NCT01401452|50363171|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
25193438|NCT01401452|50363171|FG000|Overall Study|Psoriatic arthritis|1|||
25193439|NCT01401452|50363171|FG000|Overall Study|Participant stopped Tx|2|||
25193440|NCT01401452|50363171|FG000|Overall Study|Discontinuation for personal reasons|1|||
25193441|NCT01401452|50363171|FG000|Overall Study|Treatment failure|1|||
25193442|NCT01401452|50363171|FG000|Overall Study|Unsatisfactory output|1|||
25193443|NCT01401452|50363171|FG000|Overall Study|Subject withdrew because of Tx success|1|||
25193444|NCT01401452|50363171|FG000|Overall Study|Subject chose to discontinue treatment|1|||
25193445|NCT01401452|50363171|FG000|Overall Study|Participant withdrew consent|1|||
25193446|NCT01401062|50363206|FG000|Overall Study|Death|9|||
25193447|NCT01401062|50363207|FG001|Overall Study|Death|7|||
25193448|NCT01401062|50363206|FG000|Overall Study|Physician Decision|1|||
25193449|NCT01401062|50363207|FG001|Overall Study|Physician Decision|0|||
25193450|NCT01401062|50363206|FG000|Overall Study|Withdrawal by Subject|1|||
25193451|NCT01401062|50363207|FG001|Overall Study|Withdrawal by Subject|1|||
25193452|NCT01400516|50363240|FG000|Primary Trial|Withdrawal by Subject|0|||
25193453|NCT01400516|50363241|FG001|Primary Trial|Withdrawal by Subject|2|||
25193454|NCT01383356|50363247|FG000|Period 1|Adverse Event|5|||
25193455|NCT01383356|50363248|FG001|Period 1|Adverse Event|3|||
25193456|NCT01383356|50363247|FG000|Period 1|Non-compliance|3|||
25193457|NCT01383356|50363248|FG001|Period 1|Non-compliance|0|||
25193458|NCT01383356|50363247|FG000|Period 1|Out of Range Mid-study-Test|0|||
25193459|NCT01383356|50363248|FG001|Period 1|Out of Range Mid-study-Test|1|||
25193460|NCT01383356|50363247|FG000|Period 1|Personal|0|||
25193461|NCT01383356|50363248|FG001|Period 1|Personal|2|||
25193462|NCT01399736|50363299|FG000|Overall Study|Withdrawal by Subject|4|||
25193463|NCT01399736|50363300|FG001|Overall Study|Withdrawal by Subject|2|||
25193464|NCT01399736|50363299|FG000|Overall Study|Lost to Follow-up|0|||
25193465|NCT01399736|50363300|FG001|Overall Study|Lost to Follow-up|2|||
25193466|NCT04372927|50363430|FG000|Overall Study|Death|1|||
25193467|NCT01381874|50363437|FG000|Overall Study|Lost to Follow-up|1|||
25193468|NCT01381874|50363438|FG001|Overall Study|Lost to Follow-up|1|||
25193469|NCT01381874|50363439|FG002|Overall Study|Lost to Follow-up|0|||
25193470|NCT01381874|50363437|FG000|Overall Study|Withdrawal by Subject|9|||
25193471|NCT01381874|50363438|FG001|Overall Study|Withdrawal by Subject|10|||
25170321|NCT01791725|50304750|FG001|Overall Study|Withdrawal by Subject|1|||
25170322|NCT01791725|50304751|FG002|Overall Study|Withdrawal by Subject|0|||
25170323|NCT01791413|50304761|FG000|Overall Study|Lost to Follow-up|5|||
25170324|NCT01791413|50304762|FG001|Overall Study|Lost to Follow-up|1|||
25170325|NCT01610063|50304775|FG000|Overall Study|Lost to Follow-up|42|||
25170326|NCT01610063|50304776|FG001|Overall Study|Lost to Follow-up|20|||
25170327|NCT01813721|50304782|FG000|Overall Study|Ineligibility determined|63|||
25170328|NCT01813721|50304782|FG000|Overall Study|Withdrawal by Subject|1|||
25193472|NCT01381874|50363439|FG002|Overall Study|Withdrawal by Subject|9|||
25193473|NCT01381874|50363437|FG000|Overall Study|Other|67|||
25193474|NCT01381874|50363438|FG001|Overall Study|Other|52|||
25193475|NCT01381874|50363439|FG002|Overall Study|Other|67|||
25193476|NCT01399190|50363447|FG000|Overall Study|Not Eligible for Final Analysis|5|||
25193477|NCT01399190|50363447|FG000|Overall Study|Adverse Event|8|||
25170329|NCT01790633|50304806|FG000|Overall Study|Protocol Violation|1|||
25170330|NCT01790633|50304807|FG001|Overall Study|Protocol Violation|2|||
24975945|NCT01702805|50064686|FG001|Overall Study|Lost to Follow-up|5|||
24975946|NCT00097370|50064763|FG000|Stage 1|Adverse Event|3|||
24975947|NCT00097370|50064763|FG000|Stage 1|Withdrawal by Subject|1|||
24975948|NCT00097370|50064763|FG000|Stage 1|Lack of Efficacy|2|||
24975949|NCT00097370|50064763|FG000|Stage 2|Adverse Event|5|||
24975950|NCT00097370|50064763|FG000|Stage 2|Withdrawal by Subject|1|||
24975951|NCT00097370|50064763|FG000|Stage 2|Lack of Efficacy|3|||
24975952|NCT00097370|50064763|FG000|Stage 2|Pregnancy|1|||
24975953|NCT00097370|50064763|FG000|Stage 2|Sponsor Terminated Study|2|||
24975954|NCT00097370|50064763|FG000|Stage 2|Lost to Follow-up|1|||
24975955|NCT00097370|50064763|FG000|Stage 3|Adverse Event|2|||
24975956|NCT00097370|50064763|FG000|Stage 3|Withdrawal by Subject|3|||
24975957|NCT00097370|50064763|FG000|Stage 3|Lack of Efficacy|1|||
24975958|NCT00097370|50064763|FG000|Stage 3|Sponsor Terminated Study|52|||
24975959|NCT00097370|50064763|FG000|Stage 3|Lost to Follow-up|1|||
24975960|NCT03515824|50064770|FG000|Overall Study|Death|3|||
24975961|NCT03515824|50064771|FG001|Overall Study|Death|2|||
24975962|NCT03515824|50064772|FG002|Overall Study|Death|6|||
24975963|NCT03515824|50064773|FG003|Overall Study|Death|0|||
24975964|NCT03515824|50064770|FG000|Overall Study|Lost to Follow-up|0|||
24975965|NCT03515824|50064771|FG001|Overall Study|Lost to Follow-up|1|||
24975966|NCT03515824|50064772|FG002|Overall Study|Lost to Follow-up|1|||
24975967|NCT03515824|50064773|FG003|Overall Study|Lost to Follow-up|0|||
24975968|NCT03515824|50064770|FG000|Overall Study|Study terminated by sponsor|0|||
24975969|NCT03515824|50064771|FG001|Overall Study|Study terminated by sponsor|1|||
24975970|NCT03515824|50064772|FG002|Overall Study|Study terminated by sponsor|6|||
24975971|NCT03515824|50064773|FG003|Overall Study|Study terminated by sponsor|0|||
24975972|NCT03515824|50064770|FG000|Overall Study|Status not recorded|0|||
24975973|NCT03515824|50064771|FG001|Overall Study|Status not recorded|0|||
24975974|NCT03515824|50064772|FG002|Overall Study|Status not recorded|2|||
24975975|NCT03515824|50064773|FG003|Overall Study|Status not recorded|0|||
24975976|NCT03511378|50064783|FG000|Overall Study|Withdrawal by Subject|2|||
24975977|NCT03511378|50064784|FG001|Overall Study|Withdrawal by Subject|2|||
24975978|NCT03511378|50064783|FG000|Overall Study|Patient not coming or schedule visit|1|||
24975979|NCT03511378|50064784|FG001|Overall Study|Patient not coming or schedule visit|0|||
24975980|NCT03511066|50064793|FG000|Overall Study|Withdrawal by Subject|1|||
24975981|NCT03511066|50064794|FG001|Overall Study|Withdrawal by Subject|2|||
24975982|NCT03511066|50064795|FG002|Overall Study|Withdrawal by Subject|3|||
25076897|NCT02503202|50184653|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
25076898|NCT02503202|50184654|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
25076899|NCT02503202|50184655|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
25076900|NCT02503202|50184656|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
25076901|NCT02503202|50184657|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
25076902|NCT02503202|50184653|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
25076903|NCT02503202|50184654|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
25076904|NCT02503202|50184655|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
25076905|NCT02503202|50184656|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
25193478|NCT01399190|50363447|FG000|Overall Study|Participant's Request|5|||
24975983|NCT03511066|50064793|FG000|Overall Study|Lost to Follow-up|2|||
25193479|NCT01399190|50363447|FG000|Overall Study|Physician Decision|2|||
25170331|NCT01790633|50304806|FG000|Overall Study|Did not have serology performed|47|||
25170332|NCT01790633|50304807|FG001|Overall Study|Did not have serology performed|0|||
25170333|NCT01790633|50304806|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
25170334|NCT01790633|50304807|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
25170335|NCT01788215|50304816|FG000|Overall Study|Withdrawal by Subject|0|||
25170336|NCT01788215|50304817|FG001|Overall Study|Withdrawal by Subject|1|||
25170337|NCT01788215|50304816|FG000|Overall Study|Lost to Follow-up|2|||
25193480|NCT01381718|50363465|FG000|Overall Study|Withdrawal by Subject|2|||
25193481|NCT01381718|50363466|FG001|Overall Study|Withdrawal by Subject|5|||
25193482|NCT01381718|50363465|FG000|Overall Study|Lost to Follow-up|3|||
25193483|NCT01381718|50363466|FG001|Overall Study|Lost to Follow-up|5|||
25193484|NCT01381718|50363465|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
25193485|NCT01381718|50363466|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
25193486|NCT01398956|50363485|FG000|Overall Study|Withdrawal by Subject|4|||
25193487|NCT01398956|50363485|FG000|Overall Study|AE, non-serious non-fatal|4|||
25193488|NCT01398956|50363485|FG000|Overall Study|Withdrawal Criteria No.3|1|||
25193489|NCT01398956|50363485|FG000|Overall Study|Subject moved a long distance|1|||
25193490|NCT01381562|50363511|FG000|Overall Study|Adverse Event|0|||
25193491|NCT01381562|50363512|FG001|Overall Study|Adverse Event|1|||
25193492|NCT01381562|50363513|FG002|Overall Study|Adverse Event|0|||
25193493|NCT01381016|50363536|FG000|Overall Study|Lost to Follow-up|1|||
25193494|NCT01381016|50363537|FG001|Overall Study|Lost to Follow-up|1|||
25193495|NCT01381016|50363536|FG000|Overall Study|Screen Failure|2|||
25193496|NCT01381016|50363537|FG001|Overall Study|Screen Failure|2|||
25193497|NCT01381016|50363536|FG000|Overall Study|Withdrawal by Subject|0|||
25193498|NCT01381016|50363537|FG001|Overall Study|Withdrawal by Subject|1|||
25193499|NCT01381016|50363536|FG000|Overall Study|Physician Decision|0|||
25193500|NCT01381016|50363537|FG001|Overall Study|Physician Decision|2|||
25193501|NCT01398410|50363564|FG000|Overall Study|Adverse Event|12|||
25193502|NCT01398410|50363565|FG001|Overall Study|Adverse Event|16|||
25193503|NCT01398410|50363564|FG000|Overall Study|Participants Choice|8|||
25193504|NCT01398410|50363565|FG001|Overall Study|Participants Choice|11|||
25193505|NCT01398410|50363564|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
25193506|NCT01398410|50363565|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
25193507|NCT01398410|50363564|FG000|Overall Study|Other|36|||
25193508|NCT01398410|50363565|FG001|Overall Study|Other|29|||
25193509|NCT01380782|50363631|FG000|Overall Study|Adverse Event|0|||
25193510|NCT01380782|50363632|FG001|Overall Study|Adverse Event|1|||
25193511|NCT01380782|50363633|FG002|Overall Study|Adverse Event|0|||
25193512|NCT01380782|50363634|FG003|Overall Study|Adverse Event|0|||
25193513|NCT01380782|50363631|FG000|Overall Study|Death|1|||
25193514|NCT01380782|50363632|FG001|Overall Study|Death|0|||
25193515|NCT01380782|50363633|FG002|Overall Study|Death|0|||
25193516|NCT01380782|50363634|FG003|Overall Study|Death|0|||
25193517|NCT01380782|50363631|FG000|Overall Study|Lack of Efficacy|10|||
25170338|NCT01788215|50304817|FG001|Overall Study|Lost to Follow-up|0|||
25170339|NCT01787825|50304823|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
25170340|NCT01787825|50304824|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
25170341|NCT01787825|50304823|FG000|Overall Study|Data Not Analyzable|5|||
25170342|NCT01787825|50304824|FG001|Overall Study|Data Not Analyzable|1|||
25170343|NCT01813019|50304833|FG000|Overall Study|Adverse Event|0|||
25170344|NCT01813019|50304834|FG001|Overall Study|Adverse Event|3|||
25170345|NCT01813019|50304833|FG000|Overall Study|Withdrawal by Subject|3|||
25170346|NCT01813019|50304834|FG001|Overall Study|Withdrawal by Subject|2|||
25170347|NCT01813019|50304833|FG000|Overall Study|administrative problems|2|||
25170348|NCT01813019|50304834|FG001|Overall Study|administrative problems|0|||
25193518|NCT01380782|50363632|FG001|Overall Study|Lack of Efficacy|9|||
25193519|NCT01380782|50363633|FG002|Overall Study|Lack of Efficacy|10|||
25193520|NCT01380782|50363634|FG003|Overall Study|Lack of Efficacy|3|||
25193521|NCT01380782|50363631|FG000|Overall Study|Physician Decision|1|||
25193522|NCT01380782|50363632|FG001|Overall Study|Physician Decision|0|||
25193523|NCT01380782|50363633|FG002|Overall Study|Physician Decision|0|||
25193524|NCT01380782|50363634|FG003|Overall Study|Physician Decision|0|||
25193525|NCT01380782|50363631|FG000|Overall Study|Withdrawal by Subject|0|||
25170349|NCT01813019|50304833|FG000|Overall Study|Protocol Deviation|2|||
25170350|NCT01813019|50304834|FG001|Overall Study|Protocol Deviation|1|||
25193526|NCT01380782|50363632|FG001|Overall Study|Withdrawal by Subject|0|||
25193527|NCT01380782|50363633|FG002|Overall Study|Withdrawal by Subject|1|||
25193528|NCT01380782|50363634|FG003|Overall Study|Withdrawal by Subject|1|||
25076906|NCT02503202|50184657|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
25076907|NCT02503202|50184653|FG000|Extension: Month 6 to 24|Death|1|||
25076908|NCT02503202|50184654|FG001|Extension: Month 6 to 24|Death|0|||
25076909|NCT02503202|50184655|FG002|Extension: Month 6 to 24|Death|0|||
25076910|NCT02503202|50184656|FG003|Extension: Month 6 to 24|Death|0|||
25076911|NCT02503202|50184657|FG004|Extension: Month 6 to 24|Death|0|||
25076912|NCT02503202|50184653|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
25076913|NCT02503202|50184654|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
25076914|NCT02503202|50184655|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
25076915|NCT02503202|50184656|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
25076916|NCT02503202|50184657|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
25076917|NCT02503202|50184653|FG000|Extension: Month 6 to 24|Physician Decision|1|||
25076918|NCT02503202|50184654|FG001|Extension: Month 6 to 24|Physician Decision|0|||
25076919|NCT02503202|50184655|FG002|Extension: Month 6 to 24|Physician Decision|1|||
25076920|NCT02503202|50184656|FG003|Extension: Month 6 to 24|Physician Decision|3|||
25076921|NCT02503202|50184657|FG004|Extension: Month 6 to 24|Physician Decision|0|||
25076922|NCT02503202|50184653|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
25076923|NCT02503202|50184654|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
25076924|NCT02503202|50184655|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
25076925|NCT02503202|50184656|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
25076926|NCT02503202|50184657|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
25076927|NCT02728102|50184672|FG000|Overall Study|Death|3|||
25076928|NCT02728102|50184673|FG001|Overall Study|Death|0|||
25193529|NCT01398176|50363648|FG000|Overall Study|Lost to Follow-up|1|||
25193530|NCT01398176|50363649|FG001|Overall Study|Lost to Follow-up|3|||
25193531|NCT01398176|50363648|FG000|Overall Study|Physician Decision|2|||
25193532|NCT01398176|50363649|FG001|Overall Study|Physician Decision|3|||
25193533|NCT01397786|50363702|FG000|Phase A|Lost to Follow-up|0|||
25193534|NCT01397786|50363703|FG001|Phase A|Lost to Follow-up|0|||
25193535|NCT01397786|50363704|FG002|Phase A|Lost to Follow-up|6|||
25193536|NCT01397786|50363702|FG000|Phase A|Adverse Event|0|||
25193537|NCT01397786|50363703|FG001|Phase A|Adverse Event|0|||
25193538|NCT01397786|50363704|FG002|Phase A|Adverse Event|8|||
25193539|NCT01397786|50363702|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
25193540|NCT01397786|50363703|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
25193541|NCT01397786|50363704|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
25193542|NCT01397786|50363702|FG000|Phase A|Physician Decision|0|||
25314855|NCT00643279|50630724|FG000|Overall Study|Lost to Follow-up|0|||
25314856|NCT00643279|50630725|FG001|Overall Study|Lost to Follow-up|1|||
25193543|NCT01397786|50363703|FG001|Phase A|Physician Decision|0|||
25193544|NCT01397786|50363704|FG002|Phase A|Physician Decision|1|||
25193545|NCT01397786|50363702|FG000|Phase A|Withdrawal by Subject|0|||
25193546|NCT01397786|50363703|FG001|Phase A|Withdrawal by Subject|0|||
25193547|NCT01397786|50363704|FG002|Phase A|Withdrawal by Subject|5|||
25193548|NCT01397786|50363702|FG000|Phase A|Lack of Efficacy|0|||
25193549|NCT01397786|50363703|FG001|Phase A|Lack of Efficacy|0|||
25193550|NCT01397786|50363704|FG002|Phase A|Lack of Efficacy|1|||
25193551|NCT01397786|50363702|FG000|Phase B|Lost to Follow-up|22|||
25193552|NCT01397786|50363703|FG001|Phase B|Lost to Follow-up|12|||
25193553|NCT01397786|50363704|FG002|Phase B|Lost to Follow-up|22|||
25193554|NCT01397786|50363702|FG000|Phase B|Adverse Event|109|||
25193555|NCT01397786|50363703|FG001|Phase B|Adverse Event|23|||
25193556|NCT01397786|50363704|FG002|Phase B|Adverse Event|27|||
25193557|NCT01397786|50363702|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
25193558|NCT01397786|50363703|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
24975984|NCT03511066|50064794|FG001|Overall Study|Lost to Follow-up|3|||
25193559|NCT01397786|50363704|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
25193560|NCT01397786|50363702|FG000|Phase B|Physician Decision|9|||
25193561|NCT01397786|50363703|FG001|Phase B|Physician Decision|1|||
25193562|NCT01397786|50363704|FG002|Phase B|Physician Decision|3|||
25076929|NCT02728102|50184674|FG002|Overall Study|Death|1|||
25076930|NCT02728102|50184672|FG000|Overall Study|Withdrawal by Subject|0|||
25076931|NCT02728102|50184673|FG001|Overall Study|Withdrawal by Subject|2|||
25076932|NCT02728102|50184674|FG002|Overall Study|Withdrawal by Subject|3|||
25193563|NCT01397786|50363702|FG000|Phase B|Withdrawal by Subject|102|||
25193564|NCT01397786|50363703|FG001|Phase B|Withdrawal by Subject|45|||
25193565|NCT01397786|50363704|FG002|Phase B|Withdrawal by Subject|30|||
24975985|NCT03511066|50064795|FG002|Overall Study|Lost to Follow-up|0|||
24975986|NCT03510910|50064805|FG000|Overall Study|Incomplete Survey|2|||
24975987|NCT03510910|50064806|FG001|Overall Study|Incomplete Survey|3|||
24975988|NCT03509350|50064814|FG000|Overall Study|Withdrawal by Subject|0|||
24975989|NCT03509350|50064815|FG001|Overall Study|Withdrawal by Subject|2|||
24975990|NCT00072410|50064823|FG000|Overall Study|Progressive disease|0|||
24975991|NCT00072410|50064824|FG001|Overall Study|Progressive disease|3|||
24975992|NCT03478696|50064832|FG000|Overall Study|Adverse Event|1|||
25170351|NCT01787591|50304842|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
25170352|NCT01787591|50304843|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
25170353|NCT01787591|50304844|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
25170354|NCT01787591|50304845|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
25170355|NCT01812707|50304860|FG000|Overall Study|Adverse Event|0|||
25170356|NCT01812707|50304861|FG001|Overall Study|Adverse Event|0|||
25170357|NCT01812707|50304862|FG002|Overall Study|Adverse Event|0|||
25170358|NCT01812707|50304863|FG003|Overall Study|Adverse Event|2|||
25170359|NCT01812707|50304860|FG000|Overall Study|Poor compliance to protocol|1|||
25170360|NCT01812707|50304861|FG001|Overall Study|Poor compliance to protocol|0|||
25170361|NCT01812707|50304862|FG002|Overall Study|Poor compliance to protocol|0|||
25170362|NCT01812707|50304863|FG003|Overall Study|Poor compliance to protocol|0|||
25170363|NCT01812707|50304860|FG000|Overall Study|Consent withdrawn by participant|1|||
25170364|NCT01812707|50304861|FG001|Overall Study|Consent withdrawn by participant|0|||
25170365|NCT01812707|50304862|FG002|Overall Study|Consent withdrawn by participant|0|||
25170366|NCT01812707|50304863|FG003|Overall Study|Consent withdrawn by participant|0|||
25170367|NCT01787279|50304874|FG000|Overall Study|Lost to Follow-up|2|||
25170368|NCT01787279|50304874|FG000|Overall Study|Lack of Efficacy|1|||
25170369|NCT02728206|50304878|FG000|Overall Study|Death|1|||
25170370|NCT01811225|50304882|FG000|Treatment Period 1|Adverse Event|2|||
25170371|NCT01811225|50304883|FG001|Treatment Period 1|Adverse Event|3|||
25170372|NCT01811225|50304882|FG000|Treatment Period 1|Lost to Follow-up|12|||
25170373|NCT01811225|50304883|FG001|Treatment Period 1|Lost to Follow-up|8|||
25170374|NCT01811225|50304882|FG000|Treatment Period 1|transporation|1|||
25170375|NCT01811225|50304883|FG001|Treatment Period 1|transporation|0|||
25170376|NCT01811225|50304882|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
25170377|NCT01811225|50304883|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
25170378|NCT01811225|50304882|FG000|Treatment Period 2|Lost to Follow-up|1|||
25170379|NCT01811225|50304883|FG001|Treatment Period 2|Lost to Follow-up|2|||
25170380|NCT01811225|50304882|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
25170381|NCT01811225|50304883|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
25170382|NCT01809197|50304891|FG000|Overall Study|Lost to Follow-up|4|||
25170383|NCT01809197|50304892|FG001|Overall Study|Lost to Follow-up|2|||
25170384|NCT01809197|50304891|FG000|Overall Study|Adverse Event|2|||
25170385|NCT01809197|50304892|FG001|Overall Study|Adverse Event|3|||
25170386|NCT01809197|50304891|FG000|Overall Study|Failed slit lamp exam|1|||
25170387|NCT01809197|50304892|FG001|Overall Study|Failed slit lamp exam|0|||
25170388|NCT01809197|50304891|FG000|Overall Study|Non-Compliance|1|||
25170389|NCT01809197|50304892|FG001|Overall Study|Non-Compliance|1|||
25170390|NCT01809197|50304891|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
25170391|NCT01809197|50304892|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
25170392|NCT01809197|50304891|FG000|Overall Study|Withdrawal by Subject|1|||
25170393|NCT01809197|50304892|FG001|Overall Study|Withdrawal by Subject|1|||
25170394|NCT01809197|50304891|FG000|Overall Study|Product not available|0|||
25170395|NCT01809197|50304892|FG001|Overall Study|Product not available|1|||
25170396|NCT01786109|50304901|FG000|Overall Study|fail manometry barostat tube placement|1|||
25170397|NCT01786109|50304902|FG001|Overall Study|fail manometry barostat tube placement|0|||
25170398|NCT01786109|50304903|FG002|Overall Study|fail manometry barostat tube placement|0|||
25170399|NCT01786109|50304901|FG000|Overall Study|unrelated illness|0|||
25170400|NCT01786109|50304902|FG001|Overall Study|unrelated illness|0|||
25170401|NCT01786109|50304903|FG002|Overall Study|unrelated illness|1|||
25170402|NCT01786109|50304901|FG000|Overall Study|adverse effects colon preparation|0|||
25170403|NCT01786109|50304902|FG001|Overall Study|adverse effects colon preparation|0|||
25170404|NCT01786109|50304903|FG002|Overall Study|adverse effects colon preparation|1|||
25170405|NCT02728830|50304987|FG000|Overall Study|Exclusionary Surgery|9|||
25170406|NCT02728830|50304987|FG000|Overall Study|Exclusionary Pathology|6|||
24975993|NCT03478696|50064833|FG001|Overall Study|Adverse Event|5|||
24975994|NCT03478696|50064832|FG000|Overall Study|Lost to Follow-up|1|||
25170407|NCT02728830|50304987|FG000|Overall Study|Physician Decision|3|||
25170408|NCT02728830|50304987|FG000|Overall Study|Withdrawal by Subject|2|||
25170409|NCT02728830|50304987|FG000|Overall Study|Lost to Follow-up|1|||
25170410|NCT02728830|50304987|FG000|Overall Study|Exclusionary Lab Values|1|||
25170411|NCT02728830|50304987|FG000|Overall Study|Contraindicated Illness|1|||
25170412|NCT02728830|50304987|FG000|Overall Study|Language Barrier|1|||
25170413|NCT02728596|50305041|FG000|Overall Study|Refusal unrelated to adverse event|3|||
25170414|NCT02728596|50305042|FG001|Overall Study|Refusal unrelated to adverse event|6|||
25170415|NCT02728596|50305043|FG002|Overall Study|Refusal unrelated to adverse event|7|||
25193566|NCT01397786|50363702|FG000|Phase B|Protocol Deviation|1|||
25193567|NCT01397786|50363703|FG001|Phase B|Protocol Deviation|2|||
25193568|NCT01397786|50363704|FG002|Phase B|Protocol Deviation|4|||
25193569|NCT01397786|50363702|FG000|Phase B|Lack of Efficacy|22|||
25193570|NCT01397786|50363703|FG001|Phase B|Lack of Efficacy|7|||
25193571|NCT01397786|50363704|FG002|Phase B|Lack of Efficacy|14|||
25193572|NCT01397552|50363763|FG000|Overall Study|Adverse Event|1|||
25193573|NCT01397552|50363764|FG001|Overall Study|Adverse Event|0|||
25193574|NCT01397552|50363763|FG000|Overall Study|Withdrawal by Subject|2|||
25193575|NCT01397552|50363764|FG001|Overall Study|Withdrawal by Subject|1|||
25193576|NCT01397162|50363784|FG000|Overall Study|Adverse Event|4|||
25193577|NCT01397162|50363785|FG001|Overall Study|Adverse Event|0|||
25193578|NCT01397162|50363786|FG002|Overall Study|Adverse Event|0|||
25193579|NCT01397162|50363787|FG003|Overall Study|Adverse Event|0|||
25193580|NCT01397162|50363788|FG004|Overall Study|Adverse Event|0|||
25193581|NCT01397162|50363784|FG000|Overall Study|Not yet defined|3|||
25193582|NCT01397162|50363785|FG001|Overall Study|Not yet defined|4|||
25193583|NCT01397162|50363786|FG002|Overall Study|Not yet defined|3|||
25193584|NCT01397162|50363787|FG003|Overall Study|Not yet defined|5|||
25193585|NCT01397162|50363788|FG004|Overall Study|Not yet defined|3|||
25193586|NCT01397084|50363821|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
25193587|NCT01397084|50363821|FG000|Overall Study|Protocol Violation|2|||
25193588|NCT01397084|50363821|FG000|Overall Study|Adverse Event|2|||
25193589|NCT01397084|50363821|FG000|Overall Study|Withdrawal by Subject|1|||
25193590|NCT01397084|50363821|FG000|Overall Study|Lost to Follow-up|1|||
25193591|NCT01397084|50363821|FG000|Overall Study|Used other proton pump inhibitor|1|||
25193592|NCT01396148|50363861|FG000|Overall Study|Patient Decision|1|||
25193593|NCT01396070|50363894|FG000|Overall Study|Withdrawal by Subject|2|||
25193594|NCT01396070|50363894|FG000|Overall Study|Death|2|||
25193595|NCT01396070|50363894|FG000|Overall Study|Adverse Event|8|||
25170416|NCT02728596|50305044|FG003|Overall Study|Refusal unrelated to adverse event|7|||
25170417|NCT02728596|50305041|FG000|Overall Study|Death|44|||
25170418|NCT02728596|50305042|FG001|Overall Study|Death|42|||
25170419|NCT02728596|50305043|FG002|Overall Study|Death|123|||
25170420|NCT02728596|50305044|FG003|Overall Study|Death|68|||
25170421|NCT00708162|50305418|FG000|Randomized Phase|Randomized but Not Treated|7|||
25193596|NCT01396070|50363894|FG000|Overall Study|Physician Decision|3|||
25193597|NCT01396070|50363894|FG000|Overall Study|Lack of Efficacy|4|||
25193598|NCT01395914|50363911|FG000|Overall Study|Unrelated to study drug AE|6|||
25193599|NCT01395914|50363912|FG001|Overall Study|Unrelated to study drug AE|1|||
25193600|NCT01395914|50363911|FG000|Overall Study|Death|23|||
25193601|NCT01395914|50363912|FG001|Overall Study|Death|17|||
25193602|NCT01395914|50363911|FG000|Overall Study|Other|9|||
25193603|NCT01395914|50363912|FG001|Overall Study|Other|3|||
25193604|NCT01395914|50363911|FG000|Overall Study|Withdrawal by patient|27|||
25193605|NCT01395914|50363912|FG001|Overall Study|Withdrawal by patient|14|||
25193606|NCT01395914|50363911|FG000|Overall Study|Study drug-related AE|1|||
25193607|NCT01395914|50363912|FG001|Overall Study|Study drug-related AE|0|||
25193608|NCT01395914|50363911|FG000|Overall Study|Lost to Follow-up|6|||
25193609|NCT01395914|50363912|FG001|Overall Study|Lost to Follow-up|2|||
25193610|NCT01395758|50364174|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
25193611|NCT01395758|50364175|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
25193612|NCT01395758|50364176|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
25193613|NCT01395524|50364230|FG000|Overall Study|Non-compliance with study schedule|1|||
25193614|NCT01395524|50364231|FG001|Overall Study|Non-compliance with study schedule|0|||
25193615|NCT01395524|50364232|FG002|Overall Study|Non-compliance with study schedule|1|||
25193616|NCT01395524|50364230|FG000|Overall Study|Lost to Follow-up|3|||
25193617|NCT01395524|50364231|FG001|Overall Study|Lost to Follow-up|1|||
25193618|NCT01395524|50364232|FG002|Overall Study|Lost to Follow-up|1|||
25193619|NCT01395524|50364230|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
25193620|NCT01395524|50364231|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
25193621|NCT01395524|50364232|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
25170422|NCT00708162|50305419|FG001|Randomized Phase|Randomized but Not Treated|5|||
25170423|NCT00708162|50305418|FG000|Randomized Phase|Participant Noncompliance|40|||
25170424|NCT00708162|50305419|FG001|Randomized Phase|Participant Noncompliance|32|||
25170425|NCT00708162|50305418|FG000|Randomized Phase|Lost to Follow-up|34|||
25193622|NCT01395524|50364230|FG000|Overall Study|Severe noncompliance with protocol|1|||
25193623|NCT01395524|50364231|FG001|Overall Study|Severe noncompliance with protocol|0|||
25193624|NCT01395524|50364232|FG002|Overall Study|Severe noncompliance with protocol|0|||
25170426|NCT00708162|50305419|FG001|Randomized Phase|Lost to Follow-up|34|||
25170427|NCT00708162|50305418|FG000|Randomized Phase|Withdrew Consent|31|||
25193625|NCT01395524|50364230|FG000|Overall Study|Adverse Event|4|||
25193626|NCT01395524|50364231|FG001|Overall Study|Adverse Event|4|||
25193627|NCT01395524|50364232|FG002|Overall Study|Adverse Event|3|||
25193628|NCT01395524|50364230|FG000|Overall Study|Death|1|||
25193629|NCT01395524|50364231|FG001|Overall Study|Death|0|||
25193630|NCT01395524|50364232|FG002|Overall Study|Death|0|||
25193631|NCT01395524|50364230|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
25170428|NCT00708162|50305419|FG001|Randomized Phase|Withdrew Consent|22|||
25170429|NCT00708162|50305418|FG000|Randomized Phase|Lack of Efficacy|14|||
25170430|NCT00708162|50305419|FG001|Randomized Phase|Lack of Efficacy|19|||
25170431|NCT00708162|50305418|FG000|Randomized Phase|Protocol Violation|10|||
25170432|NCT00708162|50305419|FG001|Randomized Phase|Protocol Violation|11|||
25170433|NCT00708162|50305418|FG000|Randomized Phase|Adverse Event|8|||
25170434|NCT00708162|50305419|FG001|Randomized Phase|Adverse Event|12|||
24975995|NCT03478696|50064833|FG001|Overall Study|Lost to Follow-up|0|||
24975996|NCT03478696|50064832|FG000|Overall Study|Physician Decision|6|||
24975997|NCT03478696|50064833|FG001|Overall Study|Physician Decision|3|||
24975998|NCT03478696|50064832|FG000|Overall Study|Withdrawal by Subject|9|||
24975999|NCT03478696|50064833|FG001|Overall Study|Withdrawal by Subject|4|||
24976000|NCT03477838|50064839|FG000|Overall Study|Lost to Follow-up|14|||
24976001|NCT00072176|50064845|FG000|Overall Study|Withdrawal by Subject|1|||
24976002|NCT00072176|50064846|FG001|Overall Study|Withdrawal by Subject|0|||
24976003|NCT00072176|50064845|FG000|Overall Study|Protocol Violation|0|||
24976004|NCT00072176|50064846|FG001|Overall Study|Protocol Violation|1|||
24976005|NCT00071396|50064852|FG000|Overall Study|Withdrawal by Subject|1|||
24976006|NCT00071396|50064852|FG000|Overall Study|Physician Decision|2|||
24976007|NCT03473236|50064866|FG000|Overall Study|Withdrawal by Subject|0|||
24976008|NCT03473236|50064867|FG001|Overall Study|Withdrawal by Subject|0|||
24976009|NCT03473236|50064868|FG002|Overall Study|Withdrawal by Subject|0|||
24976010|NCT03473236|50064869|FG003|Overall Study|Withdrawal by Subject|0|||
24976011|NCT03473236|50064870|FG004|Overall Study|Withdrawal by Subject|0|||
24976012|NCT03473236|50064871|FG005|Overall Study|Withdrawal by Subject|1|||
24976013|NCT03473236|50064872|FG006|Overall Study|Withdrawal by Subject|0|||
24976014|NCT03473236|50064873|FG007|Overall Study|Withdrawal by Subject|0|||
24976015|NCT03473236|50064874|FG008|Overall Study|Withdrawal by Subject|1|||
24976016|NCT03473236|50064875|FG009|Overall Study|Withdrawal by Subject|0|||
24976017|NCT03550378|50064907|FG000|Overall Study|Death|0|||
24976018|NCT03550378|50064908|FG001|Overall Study|Death|1|||
24976019|NCT03472534|50064915|FG000|Overall Study|Withdrawal by Subject|9|||
24976020|NCT03472534|50064915|FG000|Overall Study|Adverse Event|2|||
24976021|NCT03549130|50064921|FG000|Overall Study|Adverse Event|0|||
24976022|NCT03549130|50064922|FG001|Overall Study|Adverse Event|1|||
24976023|NCT03549130|50064921|FG000|Overall Study|Lost to Follow-up|0|||
24976024|NCT03549130|50064922|FG001|Overall Study|Lost to Follow-up|1|||
24976025|NCT03470194|50064932|FG000|Overall Study|Lost to Follow-up|11|||
24976026|NCT03470194|50064933|FG001|Overall Study|Lost to Follow-up|17|||
25076933|NCT02728102|50184672|FG000|Overall Study|Physician Decision|1|||
25076934|NCT02728102|50184673|FG001|Overall Study|Physician Decision|1|||
25076935|NCT02728102|50184674|FG002|Overall Study|Physician Decision|0|||
25076936|NCT02728102|50184672|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
25076937|NCT02728102|50184673|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
25076938|NCT02728102|50184674|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
25076939|NCT02728102|50184672|FG000|Overall Study|Covid|0|||
25076940|NCT02728102|50184673|FG001|Overall Study|Covid|0|||
25076941|NCT02728102|50184674|FG002|Overall Study|Covid|1|||
25076942|NCT02502734|50184683|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
25076943|NCT02502734|50184684|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
25076944|NCT02502734|50184683|FG000|Washout Period|Adverse Event|1|||
25076945|NCT02502734|50184684|FG001|Washout Period|Adverse Event|0|||
25076946|NCT02473250|50184692|FG000|Overall Study|Lost to Follow-up|10|||
25076947|NCT02473250|50184692|FG000|Overall Study|Physician Decision|5|||
24976027|NCT03469336|50064939|FG000|Overall Study|Adverse Event|1|||
24976028|NCT03469258|50064949|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
24976029|NCT03503188|50064955|FG000|Overall Study|Non eligible in the sub study|0|||
24976030|NCT03503188|50064956|FG001|Overall Study|Non eligible in the sub study|1|||
24976031|NCT03502798|50064964|FG000|Overall Study|equipment failure|0|||
24976032|NCT03502798|50064965|FG001|Overall Study|equipment failure|7|||
24976033|NCT00066170|50064975|FG000|Overall Study|Adverse Event|2|||
24976034|NCT00066170|50064976|FG001|Overall Study|Adverse Event|4|||
24976035|NCT00066170|50064977|FG002|Overall Study|Adverse Event|1|||
25076948|NCT02473250|50184692|FG000|Overall Study|Did not tolerate medication washout|3|||
25076949|NCT02473250|50184692|FG000|Overall Study|Antidepressant effect of divalproex|2|||
25076950|NCT02501642|50184699|FG000|Overall Study|Lost to Follow-up|7|||
25314857|NCT00643279|50630724|FG000|Overall Study|Physician Decision|0|||
25170435|NCT00708162|50305418|FG000|Randomized Phase|Investigator's Discretion|7|||
25170436|NCT00708162|50305419|FG001|Randomized Phase|Investigator's Discretion|10|||
25170437|NCT00708162|50305418|FG000|Randomized Phase|Death|2|||
25170438|NCT00708162|50305419|FG001|Randomized Phase|Death|9|||
25170439|NCT00708162|50305418|FG000|Randomized Phase|Pregnancy|3|||
25170440|NCT00708162|50305419|FG001|Randomized Phase|Pregnancy|0|||
25170441|NCT00708162|50305418|FG000|Open-Label Phase|Lost to Follow-up|10|||
25170442|NCT00708162|50305419|FG001|Open-Label Phase|Lost to Follow-up|8|||
25170443|NCT00708162|50305418|FG000|Open-Label Phase|Withdrew Consent|12|||
25170444|NCT00708162|50305419|FG001|Open-Label Phase|Withdrew Consent|6|||
25170445|NCT00708162|50305418|FG000|Open-Label Phase|Participant Noncompliance|7|||
25170446|NCT00708162|50305419|FG001|Open-Label Phase|Participant Noncompliance|7|||
25170447|NCT00708162|50305418|FG000|Open-Label Phase|Lack of Efficacy|7|||
25170448|NCT00708162|50305419|FG001|Open-Label Phase|Lack of Efficacy|4|||
25170449|NCT00708162|50305418|FG000|Open-Label Phase|Investigator's Discretion|3|||
25170450|NCT00708162|50305419|FG001|Open-Label Phase|Investigator's Discretion|2|||
25170451|NCT00708162|50305418|FG000|Open-Label Phase|Death|3|||
25170452|NCT00708162|50305419|FG001|Open-Label Phase|Death|1|||
25170453|NCT00708162|50305418|FG000|Open-Label Phase|Adverse Event|1|||
25170454|NCT00708162|50305419|FG001|Open-Label Phase|Adverse Event|2|||
25170455|NCT00708162|50305418|FG000|Open-Label Phase|Other|1|||
25170456|NCT00708162|50305419|FG001|Open-Label Phase|Other|0|||
25170457|NCT02245672|50305504|FG000|Overall Study|Adverse Event|4|||
25193632|NCT01395524|50364231|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
25193633|NCT01395524|50364232|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
25193634|NCT01395524|50364230|FG000|Overall Study|Withdrawal by Subject|4|||
25193635|NCT01395524|50364231|FG001|Overall Study|Withdrawal by Subject|8|||
25193636|NCT01395524|50364232|FG002|Overall Study|Withdrawal by Subject|8|||
25193637|NCT01395524|50364230|FG000|Overall Study|Did not receive treatment|1|||
25170458|NCT02245672|50305505|FG001|Overall Study|Adverse Event|4|||
25170459|NCT02245672|50305506|FG002|Overall Study|Adverse Event|4|||
25170460|NCT02245672|50305504|FG000|Overall Study|Lost to Follow-up|3|||
25170461|NCT02245672|50305505|FG001|Overall Study|Lost to Follow-up|5|||
25193638|NCT01395524|50364231|FG001|Overall Study|Did not receive treatment|1|||
25193639|NCT01395524|50364232|FG002|Overall Study|Did not receive treatment|3|||
25193640|NCT01395524|50364230|FG000|Overall Study|Subject had spinal surgery|0|||
25193641|NCT01395524|50364231|FG001|Overall Study|Subject had spinal surgery|0|||
25193642|NCT01395524|50364232|FG002|Overall Study|Subject had spinal surgery|1|||
25193643|NCT01395368|50364240|FG000|Overall Study|Physician Decision|14|||
25193644|NCT01395368|50364240|FG000|Overall Study|Withdrawal by Subject|2|||
25193645|NCT01394978|50364247|FG000|Overall Study|Withdrawal by Subject|2|||
25193646|NCT01394978|50364248|FG001|Overall Study|Withdrawal by Subject|4|||
25193647|NCT01394978|50364247|FG000|Overall Study|Lost to Follow-up|13|||
25193648|NCT01394978|50364248|FG001|Overall Study|Lost to Follow-up|20|||
25193649|NCT01394978|50364247|FG000|Overall Study|Death|6|||
25170462|NCT02245672|50305506|FG002|Overall Study|Lost to Follow-up|1|||
25170463|NCT02245672|50305504|FG000|Overall Study|Withdrawal by Subject|6|||
25193650|NCT01394978|50364248|FG001|Overall Study|Death|7|||
25193651|NCT01394276|50364255|FG000|Overall Study|Related Adverse event (AEs)|15|||
25193652|NCT01394276|50364255|FG000|Overall Study|Not related AEs|9|||
25193653|NCT01394276|50364255|FG000|Overall Study|Remission of disease|2|||
25193654|NCT01394276|50364255|FG000|Overall Study|Insufficient therapeutic effect|17|||
25193655|NCT01394276|50364255|FG000|Overall Study|Insufficient compliance|9|||
25193656|NCT01394276|50364255|FG000|Overall Study|Lost to Follow-up|5|||
25193657|NCT01394276|50364255|FG000|Overall Study|Participant moved to another site|1|||
25193658|NCT01394276|50364255|FG000|Overall Study|Pregnancy|1|||
25193659|NCT01394276|50364255|FG000|Overall Study|unavailability of drug at the Hospital|2|||
25193660|NCT01394276|50364255|FG000|Overall Study|Symptoms of concurrent diseases|1|||
25193661|NCT00211172|50364355|FG000|Overall Study|Died or lost health plan eligibility|39|||
25170464|NCT02245672|50305505|FG001|Overall Study|Withdrawal by Subject|3|||
25193662|NCT00211172|50364356|FG001|Overall Study|Died or lost health plan eligibility|32|||
25193663|NCT00210626|50364407|FG000|Overall Study|Adverse Event|1|||
25193664|NCT00210626|50364408|FG001|Overall Study|Adverse Event|2|||
25193665|NCT00210626|50364407|FG000|Overall Study|Protocol Violation|1|||
25170465|NCT02245672|50305506|FG002|Overall Study|Withdrawal by Subject|0|||
25170466|NCT02245672|50305504|FG000|Overall Study|Randomized in error (not treated)|0|||
25170467|NCT02245672|50305505|FG001|Overall Study|Randomized in error (not treated)|1|||
25170468|NCT02245672|50305506|FG002|Overall Study|Randomized in error (not treated)|0|||
25193666|NCT00210626|50364408|FG001|Overall Study|Protocol Violation|5|||
25170469|NCT00706992|50305651|FG000|Overall Study|Study termination|5|||
25170470|NCT00706992|50305652|FG001|Overall Study|Study termination|5|||
25193667|NCT00210626|50364407|FG000|Overall Study|Lost to Follow-up|11|||
25170471|NCT00706992|50305653|FG002|Overall Study|Study termination|6|||
25170472|NCT00706992|50305654|FG003|Overall Study|Study termination|2|||
25170473|NCT00706992|50305655|FG004|Overall Study|Study termination|3|||
25170474|NCT00706992|50305656|FG005|Overall Study|Study termination|2|||
25170475|NCT00706992|50305657|FG006|Overall Study|Study termination|3|||
25170476|NCT00706992|50305651|FG000|Overall Study|Disease progression before treatment|0|||
25170477|NCT00706992|50305652|FG001|Overall Study|Disease progression before treatment|0|||
25170478|NCT00706992|50305653|FG002|Overall Study|Disease progression before treatment|0|||
25170479|NCT00706992|50305654|FG003|Overall Study|Disease progression before treatment|0|||
25170480|NCT00706992|50305655|FG004|Overall Study|Disease progression before treatment|1|||
25170481|NCT00706992|50305656|FG005|Overall Study|Disease progression before treatment|0|||
25170482|NCT00706992|50305657|FG006|Overall Study|Disease progression before treatment|0|||
25170483|NCT01785875|50305710|FG000|Overall Study|Withdrawal by Subject|41|||
25193668|NCT00210626|50364408|FG001|Overall Study|Lost to Follow-up|11|||
25193669|NCT00210626|50364407|FG000|Overall Study|Death|1|||
25193670|NCT00210626|50364408|FG001|Overall Study|Death|0|||
25193671|NCT00210626|50364407|FG000|Overall Study|Withdrawal by Subject|29|||
25193672|NCT00210626|50364408|FG001|Overall Study|Withdrawal by Subject|20|||
25193673|NCT00210626|50364407|FG000|Overall Study|Physician Decision|0|||
25193674|NCT00210626|50364408|FG001|Overall Study|Physician Decision|2|||
25193675|NCT00210626|50364407|FG000|Overall Study|Sponser Request|1|||
25193676|NCT00210626|50364408|FG001|Overall Study|Sponser Request|0|||
25193677|NCT00210626|50364407|FG000|Overall Study|Other|4|||
25193678|NCT00210626|50364408|FG001|Overall Study|Other|5|||
25193679|NCT00217022|50364430|FG000|Overall Study|Withdrawal by Subject|1|||
25193680|NCT00217022|50364431|FG001|Overall Study|Withdrawal by Subject|1|||
25193681|NCT00219284|50364778|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
25193682|NCT00219284|50364779|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
25193683|NCT00219284|50364778|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
25193684|NCT00219284|50364779|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
25193685|NCT00219284|50364778|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
25193686|NCT00219284|50364779|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
25193687|NCT00219284|50364778|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
25193688|NCT00219284|50364779|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
25193689|NCT00219284|50364778|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
25170484|NCT01785875|50305711|FG001|Overall Study|Withdrawal by Subject|34|||
25170485|NCT01785875|50305712|FG002|Overall Study|Withdrawal by Subject|36|||
25193690|NCT00219284|50364779|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
25193691|NCT00219284|50364778|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
24976036|NCT00066170|50064978|FG003|Overall Study|Adverse Event|7|||
24976037|NCT00066170|50064975|FG000|Overall Study|Serious Adverse Event|0|||
24976038|NCT00066170|50064976|FG001|Overall Study|Serious Adverse Event|0|||
24976039|NCT00066170|50064977|FG002|Overall Study|Serious Adverse Event|1|||
24976040|NCT00066170|50064978|FG003|Overall Study|Serious Adverse Event|1|||
24976041|NCT00066170|50064975|FG000|Overall Study|Lost to Follow-up|0|||
24976042|NCT00066170|50064976|FG001|Overall Study|Lost to Follow-up|1|||
24976043|NCT00066170|50064977|FG002|Overall Study|Lost to Follow-up|0|||
24976044|NCT00066170|50064978|FG003|Overall Study|Lost to Follow-up|0|||
24976045|NCT00066170|50064975|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
24976046|NCT00066170|50064976|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
24976047|NCT00066170|50064977|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
24976048|NCT00066170|50064978|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
24976049|NCT00066170|50064975|FG000|Overall Study|Protocol Violation|3|||
24976050|NCT00066170|50064976|FG001|Overall Study|Protocol Violation|0|||
24976051|NCT00066170|50064977|FG002|Overall Study|Protocol Violation|0|||
24976052|NCT00066170|50064978|FG003|Overall Study|Protocol Violation|0|||
24976053|NCT00066170|50064975|FG000|Overall Study|Other|1|||
24976054|NCT00066170|50064976|FG001|Overall Study|Other|5|||
24976055|NCT00066170|50064977|FG002|Overall Study|Other|2|||
24976056|NCT00066170|50064978|FG003|Overall Study|Other|0|||
24976057|NCT00065468|50064991|FG000|Overall Study|Death|172|||
24976058|NCT00065468|50064992|FG001|Overall Study|Death|169|||
24976059|NCT00065468|50064993|FG002|Overall Study|Death|171|||
24976060|NCT00065468|50064991|FG000|Overall Study|Withdrawal by Subject|3|||
24976061|NCT00065468|50064992|FG001|Overall Study|Withdrawal by Subject|4|||
24976062|NCT00065468|50064993|FG002|Overall Study|Withdrawal by Subject|5|||
24976063|NCT00065468|50064991|FG000|Overall Study|Lost to Follow-up|5|||
24976064|NCT00065468|50064992|FG001|Overall Study|Lost to Follow-up|3|||
24976065|NCT00065468|50064993|FG002|Overall Study|Lost to Follow-up|2|||
24976066|NCT00065468|50064991|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
24976067|NCT00065468|50064992|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
25076951|NCT02501642|50184700|FG001|Overall Study|Lost to Follow-up|11|||
25076952|NCT02706730|50184706|FG000|Overall Study|Adverse Event|3|||
25076953|NCT02706730|50184706|FG000|Overall Study|Lack of Efficacy|5|||
25076954|NCT02706730|50184706|FG000|Overall Study|Withdrawal by Subject|11|||
25170486|NCT01785875|50305710|FG000|Overall Study|Lost to Follow-up|19|||
24976068|NCT00065468|50064993|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
24976069|NCT00065468|50064991|FG000|Overall Study|Disease progression|0|||
25076955|NCT02706730|50184706|FG000|Overall Study|Study Terminated by Sponsor|11|||
24976070|NCT00065468|50064992|FG001|Overall Study|Disease progression|0|||
24976071|NCT00065468|50064993|FG002|Overall Study|Disease progression|1|||
24976072|NCT00065468|50064991|FG000|Overall Study|Other|14|||
24976073|NCT00065468|50064992|FG001|Overall Study|Other|24|||
24976074|NCT00065468|50064993|FG002|Overall Study|Other|18|||
24976075|NCT00071006|50065001|FG000|Overall Study|Lack of Efficacy|7|||
24976076|NCT00071006|50065001|FG000|Overall Study|Adverse Event|1|||
24976077|NCT00071006|50065001|FG000|Overall Study|Withdrawal by Subject|1|||
24976078|NCT00071006|50065001|FG000|Overall Study|Other|3|||
24976079|NCT00094575|50065007|FG000|Overall Study|Death|146|||
24976080|NCT00094575|50065008|FG001|Overall Study|Death|146|||
24976081|NCT00057746|50065019|FG000|Overall Study|Withdrawal by Subject|0|||
24976082|NCT00057746|50065020|FG001|Overall Study|Withdrawal by Subject|0|||
24976083|NCT00057746|50065021|FG002|Overall Study|Withdrawal by Subject|1|||
24976084|NCT00094107|50065029|FG000|Overall Study|Lack of Efficacy|23|||
24976085|NCT00094107|50065029|FG000|Overall Study|Death|5|||
24976086|NCT00094107|50065029|FG000|Overall Study|Adverse Event|3|||
25193692|NCT00219284|50364779|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
24976087|NCT00094107|50065029|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
24976088|NCT00102063|50065036|FG000|Overall Study|Lack of Efficacy|5|||
24976089|NCT00102063|50065037|FG001|Overall Study|Lack of Efficacy|1|||
24976090|NCT00102063|50065038|FG002|Overall Study|Lack of Efficacy|1|||
24976091|NCT00102063|50065036|FG000|Overall Study|Adverse Event|7|||
24976092|NCT00102063|50065037|FG001|Overall Study|Adverse Event|4|||
24976093|NCT00102063|50065038|FG002|Overall Study|Adverse Event|2|||
24976094|NCT00102063|50065036|FG000|Overall Study|Withdrawal by Subject|4|||
24976095|NCT00102063|50065037|FG001|Overall Study|Withdrawal by Subject|12|||
24976096|NCT00102063|50065038|FG002|Overall Study|Withdrawal by Subject|5|||
24976097|NCT00102063|50065036|FG000|Overall Study|Lost to Follow-up|0|||
24976098|NCT00102063|50065037|FG001|Overall Study|Lost to Follow-up|0|||
24976099|NCT00102063|50065038|FG002|Overall Study|Lost to Follow-up|1|||
24976100|NCT00102063|50065036|FG000|Overall Study|Protocol Violation|0|||
24976101|NCT00102063|50065037|FG001|Overall Study|Protocol Violation|1|||
24976102|NCT00102063|50065038|FG002|Overall Study|Protocol Violation|1|||
24976103|NCT00065156|50065046|FG000|Overall Study|Adverse Event|37|||
24976104|NCT00065156|50065046|FG000|Overall Study|Lack of Efficacy|52|||
24976105|NCT00065156|50065046|FG000|Overall Study|Withdrawal by Subject|8|||
24976106|NCT00065156|50065046|FG000|Overall Study|Lost to Follow-up|1|||
24976107|NCT00065156|50065046|FG000|Overall Study|Death|11|||
24976108|NCT00065156|50065046|FG000|Overall Study|Study Closed by Sponsor|2|||
24976109|NCT00065156|50065046|FG000|Overall Study|Disease Progression|7|||
24976110|NCT00065156|50065046|FG000|Overall Study|Investigator Decision|2|||
24976111|NCT00065156|50065046|FG000|Overall Study|Non-Compliance|2|||
24976112|NCT00065156|50065046|FG000|Overall Study|Loss of Response|1|||
24976113|NCT00065156|50065046|FG000|Overall Study|Secondary Malign Disease|1|||
24976114|NCT00064298|50065052|FG000|Overall Study|Withdrawal by Subject|2|||
24976115|NCT00064298|50065053|FG001|Overall Study|Withdrawal by Subject|1|||
24976116|NCT00064298|50065052|FG000|Overall Study|Lost to Follow-up|2|||
24976117|NCT00064298|50065053|FG001|Overall Study|Lost to Follow-up|2|||
24976118|NCT00064298|50065052|FG000|Overall Study|Death|0|||
24976119|NCT00064298|50065053|FG001|Overall Study|Death|1|||
24976120|NCT00064298|50065052|FG000|Overall Study|Disease Progression|2|||
25193693|NCT00219284|50364778|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
25193694|NCT00219284|50364779|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
25193695|NCT00219284|50364778|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
25193696|NCT00219284|50364779|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
25193697|NCT00219284|50364778|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
25193698|NCT00219284|50364779|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
25193699|NCT00216476|50364918|FG000|Overall Study|Withdrawal by Subject|59|||
25193700|NCT00216476|50364919|FG001|Overall Study|Withdrawal by Subject|72|||
25193701|NCT00216476|50364920|FG002|Overall Study|Withdrawal by Subject|9|||
25193702|NCT00216476|50364918|FG000|Overall Study|Lost to Follow-up|10|||
25193703|NCT00216476|50364919|FG001|Overall Study|Lost to Follow-up|9|||
25193704|NCT00216476|50364920|FG002|Overall Study|Lost to Follow-up|1|||
25193705|NCT00216476|50364918|FG000|Overall Study|Adverse Event|6|||
25193706|NCT00216476|50364919|FG001|Overall Study|Adverse Event|10|||
25193707|NCT00216476|50364920|FG002|Overall Study|Adverse Event|1|||
25193708|NCT00216476|50364918|FG000|Overall Study|Lack of Efficacy|4|||
25193709|NCT00216476|50364919|FG001|Overall Study|Lack of Efficacy|3|||
25193710|NCT00216476|50364920|FG002|Overall Study|Lack of Efficacy|0|||
25193711|NCT00216476|50364918|FG000|Overall Study|Death|2|||
25193712|NCT00216476|50364919|FG001|Overall Study|Death|0|||
25193713|NCT00216476|50364920|FG002|Overall Study|Death|0|||
25193714|NCT00216476|50364918|FG000|Overall Study|Pregnancy|0|||
25193715|NCT00216476|50364919|FG001|Overall Study|Pregnancy|1|||
25193716|NCT00216476|50364920|FG002|Overall Study|Pregnancy|1|||
25193717|NCT00216476|50364918|FG000|Overall Study|Other|0|||
25193718|NCT00216476|50364919|FG001|Overall Study|Other|0|||
25193719|NCT00216476|50364920|FG002|Overall Study|Other|1|||
24976121|NCT00064298|50065053|FG001|Overall Study|Disease Progression|1|||
24976122|NCT00078819|50065061|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
24976123|NCT00078819|50065062|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
24976124|NCT00078819|50065063|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
24976125|NCT00078819|50065064|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
24976126|NCT00078819|50065061|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
24976127|NCT00078819|50065062|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
24976128|NCT00078819|50065063|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
25076956|NCT02706730|50184706|FG000|Overall Study|Subject chose not to receive injection|3|||
25193720|NCT00216476|50364918|FG000|Overall Study|Refuses Injection|11|||
25193721|NCT00216476|50364919|FG001|Overall Study|Refuses Injection|0|||
25193722|NCT00216476|50364920|FG002|Overall Study|Refuses Injection|0|||
24976129|NCT00078819|50065064|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
25076957|NCT02443688|50184713|FG000|Overall Study|Adverse Event|2|||
25193723|NCT00216476|50364918|FG000|Overall Study|No Further Need for Treatment|3|||
25193724|NCT00216476|50364919|FG001|Overall Study|No Further Need for Treatment|4|||
25193725|NCT00216476|50364920|FG002|Overall Study|No Further Need for Treatment|1|||
25193726|NCT00216476|50364918|FG000|Overall Study|Non-compliance|0|||
25193727|NCT00216476|50364919|FG001|Overall Study|Non-compliance|4|||
25193728|NCT00216476|50364920|FG002|Overall Study|Non-compliance|1|||
25193729|NCT00216476|50364918|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
25193730|NCT00216476|50364919|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
25193731|NCT00216476|50364920|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
25193732|NCT00216476|50364918|FG000|Overall Study|Administrative Reasons|1|||
25193733|NCT00216476|50364919|FG001|Overall Study|Administrative Reasons|1|||
25193734|NCT00216476|50364920|FG002|Overall Study|Administrative Reasons|0|||
25193735|NCT00216476|50364918|FG000|Overall Study|Protocol Deviation|5|||
25193736|NCT00216476|50364919|FG001|Overall Study|Protocol Deviation|1|||
25193737|NCT00216476|50364920|FG002|Overall Study|Protocol Deviation|0|||
25193738|NCT00216476|50364918|FG000|Overall Study|Patient Moved|2|||
25193739|NCT00216476|50364919|FG001|Overall Study|Patient Moved|2|||
25193740|NCT00216476|50364920|FG002|Overall Study|Patient Moved|0|||
25193741|NCT00216086|50364971|FG000|Overall Study|Protocol Violation|1|||
25193742|NCT00216086|50364971|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
25193743|NCT00216086|50364971|FG000|Overall Study|Social Reasons|2|||
25193744|NCT00215150|50365002|FG000|Open Label Phase|Lost to Follow-up|7|||
25193745|NCT00215150|50365002|FG000|Open Label Phase|Withdrawal by Subject|1|||
25193746|NCT00215150|50365002|FG000|Open Label Phase|Did not complete a post base visit|13|||
25193747|NCT00215150|50365002|FG000|Open Label Phase|Did not meet randomization criteria|9|||
25193748|NCT00215150|50365002|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
25193749|NCT00215150|50365002|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
25193750|NCT00215150|50365002|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
25193751|NCT00214136|50365010|FG000|Overall Study|Death|5|||
25193752|NCT00213980|50365016|FG000|Overall Study|Withdrawal by Subject|3|||
25193753|NCT00213980|50365017|FG001|Overall Study|Withdrawal by Subject|1|||
25193754|NCT00213980|50365016|FG000|Overall Study|Adverse Event|1|||
25193755|NCT00213980|50365017|FG001|Overall Study|Adverse Event|1|||
25193756|NCT00213980|50365016|FG000|Overall Study|Disease progression|0|||
25193757|NCT00213980|50365017|FG001|Overall Study|Disease progression|2|||
25193758|NCT00213980|50365016|FG000|Overall Study|Developed ovarian cancer|1|||
25193759|NCT00213980|50365017|FG001|Overall Study|Developed ovarian cancer|0|||
25193760|NCT00213980|50365016|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
25193761|NCT00213980|50365017|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
25193762|NCT04388527|50365457|FG000|Overall Study|Death|14|||
25193763|NCT04388527|50365457|FG000|Overall Study|Withdrawal by Subject|2|||
25193764|NCT04388527|50365457|FG000|Overall Study|Lost to Follow-up|1|||
25193765|NCT04149002|50365709|FG000|Overall Study|Lost to Follow-up|1|||
25193766|NCT04149002|50365710|FG001|Overall Study|Lost to Follow-up|0|||
25193767|NCT04149002|50365709|FG000|Overall Study|Withdrawal by Subject|1|||
25193768|NCT04149002|50365710|FG001|Overall Study|Withdrawal by Subject|0|||
25193769|NCT00555321|50365793|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
25193770|NCT00555321|50365794|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
25193771|NCT00555321|50365795|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
25193772|NCT00555321|50365796|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
25193773|NCT00555321|50365797|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
25193774|NCT00555321|50365793|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
25193775|NCT00555321|50365794|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
25193776|NCT00555321|50365795|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
25193777|NCT00555321|50365796|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
25193778|NCT00555321|50365797|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
25170487|NCT01785875|50305711|FG001|Overall Study|Lost to Follow-up|22|||
25170488|NCT01785875|50305712|FG002|Overall Study|Lost to Follow-up|6|||
25170489|NCT01785875|50305710|FG000|Overall Study|Death|27|||
25170490|NCT01785875|50305711|FG001|Overall Study|Death|16|||
25170491|NCT01785875|50305712|FG002|Overall Study|Death|7|||
25170492|NCT01785875|50305710|FG000|Overall Study|Sponsor Decision|0|||
25170493|NCT01785875|50305711|FG001|Overall Study|Sponsor Decision|2|||
25170494|NCT01785875|50305712|FG002|Overall Study|Sponsor Decision|0|||
25170495|NCT01785875|50305710|FG000|Overall Study|Protocol Specified Criteria|207|||
25170496|NCT01785875|50305711|FG001|Overall Study|Protocol Specified Criteria|214|||
25170497|NCT01785875|50305712|FG002|Overall Study|Protocol Specified Criteria|55|||
25170498|NCT01785875|50305710|FG000|Overall Study|Missing|0|||
25170499|NCT01785875|50305711|FG001|Overall Study|Missing|1|||
25170500|NCT01785875|50305712|FG002|Overall Study|Missing|3|||
25170501|NCT00706914|50305765|FG000|Overall Study|Lack of Efficacy|0|||
25170502|NCT00706914|50305766|FG001|Overall Study|Lack of Efficacy|1|||
25193779|NCT00555321|50365793|FG000|Treatment Phase up to 12-months|Death|2|||
25193780|NCT00555321|50365794|FG001|Treatment Phase up to 12-months|Death|1|||
24976130|NCT00078819|50065061|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
24976131|NCT00078819|50065062|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
24976132|NCT00078819|50065063|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
24976133|NCT00078819|50065064|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
24976134|NCT00078819|50065061|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
24976135|NCT00078819|50065062|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
25076958|NCT02443688|50184714|FG001|Overall Study|Adverse Event|3|||
25076959|NCT02443688|50184715|FG002|Overall Study|Adverse Event|2|||
24976136|NCT00078819|50065063|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
24976137|NCT00078819|50065064|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
24976138|NCT00078819|50065061|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
24976139|NCT00078819|50065062|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
24976140|NCT00078819|50065063|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
24976141|NCT00078819|50065064|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
24976142|NCT00078819|50065061|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
24976143|NCT00078819|50065062|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
24976144|NCT00078819|50065063|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
24976145|NCT00078819|50065064|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
24976146|NCT00078819|50065061|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
25170503|NCT00706914|50305767|FG002|Overall Study|Lack of Efficacy|0|||
25170504|NCT00706914|50305765|FG000|Overall Study|Lost to Follow-up|1|||
25170505|NCT00706914|50305766|FG001|Overall Study|Lost to Follow-up|0|||
25170506|NCT00706914|50305767|FG002|Overall Study|Lost to Follow-up|0|||
25170507|NCT00706914|50305765|FG000|Overall Study|Adverse Event|2|||
25170508|NCT00706914|50305766|FG001|Overall Study|Adverse Event|2|||
25170509|NCT00706914|50305767|FG002|Overall Study|Adverse Event|0|||
25170510|NCT00706914|50305765|FG000|Overall Study|Protocol Violation|3|||
25170511|NCT00706914|50305766|FG001|Overall Study|Protocol Violation|1|||
25170512|NCT00706914|50305767|FG002|Overall Study|Protocol Violation|1|||
25170513|NCT01808651|50305874|FG000|Study Period 1|Lost to Follow-up|1|||
25170514|NCT01808651|50305875|FG001|Study Period 1|Lost to Follow-up|3|||
25170515|NCT01808651|50305876|FG002|Study Period 1|Lost to Follow-up|0|||
25170516|NCT01808651|50305874|FG000|Study Period 1|Protocol Violation|1|||
25170517|NCT01808651|50305875|FG001|Study Period 1|Protocol Violation|0|||
25170518|NCT01808651|50305876|FG002|Study Period 1|Protocol Violation|1|||
25170519|NCT01808651|50305874|FG000|Study Period 1|Physician Decision|3|||
25076960|NCT02443688|50184713|FG000|Overall Study|Lost to Follow-up|1|||
25076961|NCT02443688|50184714|FG001|Overall Study|Lost to Follow-up|0|||
25076962|NCT02443688|50184715|FG002|Overall Study|Lost to Follow-up|0|||
25076963|NCT02443688|50184713|FG000|Overall Study|Physician Decision|3|||
25076964|NCT02443688|50184714|FG001|Overall Study|Physician Decision|0|||
25076965|NCT02443688|50184715|FG002|Overall Study|Physician Decision|1|||
25076966|NCT02443688|50184713|FG000|Overall Study|Pregnancy|0|||
25076967|NCT02443688|50184714|FG001|Overall Study|Pregnancy|0|||
25076968|NCT02443688|50184715|FG002|Overall Study|Pregnancy|1|||
25076969|NCT02443688|50184713|FG000|Overall Study|Withdrawal by Subject|3|||
25076970|NCT02443688|50184714|FG001|Overall Study|Withdrawal by Subject|3|||
25076971|NCT02443688|50184715|FG002|Overall Study|Withdrawal by Subject|4|||
25076972|NCT02443688|50184713|FG000|Overall Study|Non-compliance with study drug|1|||
25076973|NCT02443688|50184714|FG001|Overall Study|Non-compliance with study drug|2|||
25076974|NCT02443688|50184715|FG002|Overall Study|Non-compliance with study drug|4|||
25076975|NCT02443688|50184713|FG000|Overall Study|Sponsor Request|2|||
25076976|NCT02443688|50184714|FG001|Overall Study|Sponsor Request|1|||
25076977|NCT02443688|50184715|FG002|Overall Study|Sponsor Request|0|||
25170520|NCT01808651|50305875|FG001|Study Period 1|Physician Decision|2|||
25170521|NCT01808651|50305876|FG002|Study Period 1|Physician Decision|0|||
25193781|NCT00555321|50365795|FG002|Treatment Phase up to 12-months|Death|4|||
25193782|NCT00555321|50365796|FG003|Treatment Phase up to 12-months|Death|0|||
25193783|NCT00555321|50365797|FG004|Treatment Phase up to 12-months|Death|0|||
25193784|NCT00555321|50365793|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
25193785|NCT00555321|50365794|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
25193786|NCT00555321|50365795|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
25193787|NCT00555321|50365796|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
25193788|NCT00555321|50365797|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
25193789|NCT00555321|50365793|FG000|Treatment Phase up to 12-months|Other Reason|1|||
25193790|NCT00555321|50365794|FG001|Treatment Phase up to 12-months|Other Reason|3|||
25193791|NCT00555321|50365795|FG002|Treatment Phase up to 12-months|Other Reason|2|||
25193792|NCT00555321|50365796|FG003|Treatment Phase up to 12-months|Other Reason|0|||
25193793|NCT00555321|50365797|FG004|Treatment Phase up to 12-months|Other Reason|0|||
25193794|NCT00555321|50365793|FG000|Treatment Phase up to 12-months|Never treated|2|||
25193795|NCT00555321|50365794|FG001|Treatment Phase up to 12-months|Never treated|3|||
25193796|NCT00555321|50365795|FG002|Treatment Phase up to 12-months|Never treated|1|||
25193797|NCT00555321|50365796|FG003|Treatment Phase up to 12-months|Never treated|0|||
25193798|NCT00555321|50365797|FG004|Treatment Phase up to 12-months|Never treated|4|||
25193799|NCT00555321|50365793|FG000|Long-term Extension Phase|Adverse Event|2|||
25193800|NCT00555321|50365794|FG001|Long-term Extension Phase|Adverse Event|5|||
25193801|NCT00555321|50365795|FG002|Long-term Extension Phase|Adverse Event|2|||
25193802|NCT00555321|50365796|FG003|Long-term Extension Phase|Adverse Event|1|||
25193803|NCT00555321|50365797|FG004|Long-term Extension Phase|Adverse Event|0|||
25193804|NCT00555321|50365793|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
25193805|NCT00555321|50365794|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
25193806|NCT00555321|50365795|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
25193807|NCT00555321|50365796|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
25193808|NCT00555321|50365797|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
25170522|NCT01808651|50305874|FG000|Study Period 1|Lack of Efficacy|2|||
25170523|NCT01808651|50305875|FG001|Study Period 1|Lack of Efficacy|1|||
25170524|NCT01808651|50305876|FG002|Study Period 1|Lack of Efficacy|0|||
25170525|NCT01808651|50305874|FG000|Study Period 1|Adverse Event|10|||
25170526|NCT01808651|50305875|FG001|Study Period 1|Adverse Event|4|||
25170527|NCT01808651|50305876|FG002|Study Period 1|Adverse Event|1|||
25170528|NCT01808651|50305874|FG000|Study Period 1|Participant Decision|9|||
25170529|NCT01808651|50305875|FG001|Study Period 1|Participant Decision|7|||
25170530|NCT01808651|50305876|FG002|Study Period 1|Participant Decision|3|||
25170531|NCT00706134|50305941|FG000|Overall Study|Adverse Event|8|||
25170532|NCT00706134|50305942|FG001|Overall Study|Adverse Event|7|||
25170533|NCT00706134|50305943|FG002|Overall Study|Adverse Event|2|||
25170534|NCT00706134|50305944|FG003|Overall Study|Adverse Event|3|||
25170535|NCT00706134|50305941|FG000|Overall Study|Lost to Follow-up|0|||
25170536|NCT00706134|50305942|FG001|Overall Study|Lost to Follow-up|1|||
25170537|NCT00706134|50305943|FG002|Overall Study|Lost to Follow-up|0|||
25170538|NCT00706134|50305944|FG003|Overall Study|Lost to Follow-up|0|||
25170539|NCT00706134|50305941|FG000|Overall Study|Protocol Violation|0|||
25170540|NCT00706134|50305942|FG001|Overall Study|Protocol Violation|6|||
25170541|NCT00706134|50305943|FG002|Overall Study|Protocol Violation|0|||
25170542|NCT00706134|50305944|FG003|Overall Study|Protocol Violation|3|||
25170543|NCT00706134|50305941|FG000|Overall Study|Withdrawal by Subject|1|||
25170544|NCT00706134|50305942|FG001|Overall Study|Withdrawal by Subject|2|||
25170545|NCT00706134|50305943|FG002|Overall Study|Withdrawal by Subject|1|||
25170546|NCT00706134|50305944|FG003|Overall Study|Withdrawal by Subject|0|||
25170547|NCT00706134|50305941|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
25170548|NCT00706134|50305942|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
25170549|NCT00706134|50305943|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
25170550|NCT00706134|50305944|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
25170551|NCT00706134|50305941|FG000|Overall Study|Did not meet study criteria|2|||
25170552|NCT00706134|50305942|FG001|Overall Study|Did not meet study criteria|0|||
25170553|NCT00706134|50305943|FG002|Overall Study|Did not meet study criteria|0|||
25170554|NCT00706134|50305944|FG003|Overall Study|Did not meet study criteria|0|||
25170555|NCT01808573|50305956|FG000|Overall Study|Death|212|||
25193809|NCT00555321|50365793|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
25193810|NCT00555321|50365794|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
25314858|NCT00643279|50630725|FG001|Overall Study|Physician Decision|1|||
25170556|NCT01808573|50305957|FG001|Overall Study|Death|240|||
25170557|NCT01808573|50305956|FG000|Overall Study|Withdrawal by Subject|12|||
25170558|NCT01808573|50305957|FG001|Overall Study|Withdrawal by Subject|10|||
25170559|NCT01808573|50305956|FG000|Overall Study|Lost to Follow-up|3|||
25170560|NCT01808573|50305957|FG001|Overall Study|Lost to Follow-up|0|||
25170561|NCT01808573|50305956|FG000|Overall Study|Discontinuation of study by sponsor|79|||
25170562|NCT01808573|50305957|FG001|Overall Study|Discontinuation of study by sponsor|64|||
25170563|NCT01808573|50305956|FG000|Overall Study|Randomized in Error|1|||
25314859|NCT00910910|50630735|FG000|Overall Study|Adverse Event|63|||
25193811|NCT00555321|50365795|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
25193812|NCT00555321|50365796|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
25193813|NCT00555321|50365797|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
25193814|NCT00555321|50365793|FG000|Long-term Extension Phase|Death|2|||
25193815|NCT00555321|50365794|FG001|Long-term Extension Phase|Death|0|||
25193816|NCT00555321|50365795|FG002|Long-term Extension Phase|Death|0|||
25193817|NCT00555321|50365796|FG003|Long-term Extension Phase|Death|3|||
25193818|NCT00555321|50365797|FG004|Long-term Extension Phase|Death|0|||
25193819|NCT00555321|50365793|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
25193820|NCT00555321|50365794|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
25193821|NCT00555321|50365795|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
25193822|NCT00555321|50365796|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
25193823|NCT00555321|50365797|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
25193824|NCT00555321|50365793|FG000|Long-term Extension Phase|Other Reason|1|||
25193825|NCT00555321|50365794|FG001|Long-term Extension Phase|Other Reason|0|||
25193826|NCT00555321|50365795|FG002|Long-term Extension Phase|Other Reason|2|||
25193827|NCT00555321|50365796|FG003|Long-term Extension Phase|Other Reason|0|||
25193828|NCT00555321|50365797|FG004|Long-term Extension Phase|Other Reason|0|||
25193829|NCT03589976|50366318|FG000|Overall Study|Death|5|||
25193830|NCT03589976|50366319|FG001|Overall Study|Death|1|||
25193831|NCT03589976|50366318|FG000|Overall Study|Adverse Event|5|||
25193832|NCT03589976|50366319|FG001|Overall Study|Adverse Event|1|||
25193833|NCT03589976|50366318|FG000|Overall Study|Withdrawal by Subject|4|||
25193834|NCT03589976|50366319|FG001|Overall Study|Withdrawal by Subject|1|||
25193835|NCT03589976|50366318|FG000|Overall Study|Lost to Follow-up|1|||
25193836|NCT03589976|50366319|FG001|Overall Study|Lost to Follow-up|0|||
25193837|NCT03589976|50366318|FG000|Overall Study|Other|4|||
25193838|NCT03589976|50366319|FG001|Overall Study|Other|3|||
25193839|NCT03029780|50366475|FG000|Overall Study|Disease Progression|20|||
25193840|NCT03029780|50366476|FG001|Overall Study|Disease Progression|22|||
25193841|NCT03029780|50366475|FG000|Overall Study|Study Drug Toxicity|15|||
25193842|NCT03029780|50366476|FG001|Overall Study|Study Drug Toxicity|11|||
25193843|NCT03029780|50366475|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
25193844|NCT03029780|50366476|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
25193845|NCT03029780|50366475|FG000|Overall Study|Participant request to discontinue study treatment|4|||
25193846|NCT03029780|50366476|FG001|Overall Study|Participant request to discontinue study treatment|1|||
25193847|NCT03029780|50366475|FG000|Overall Study|Maximum clinical benefit|1|||
25193848|NCT03029780|50366476|FG001|Overall Study|Maximum clinical benefit|0|||
25193849|NCT03029780|50366475|FG000|Overall Study|Participant no longer meets study criteria|0|||
25193850|NCT03029780|50366476|FG001|Overall Study|Participant no longer meets study criteria|1|||
25193851|NCT03029780|50366475|FG000|Overall Study|Other reasons|6|||
25193852|NCT03029780|50366476|FG001|Overall Study|Other reasons|6|||
25193853|NCT03029780|50366475|FG000|Overall Study|Not reported|1|||
25193854|NCT03029780|50366476|FG001|Overall Study|Not reported|1|||
25193855|NCT03029780|50366475|FG000|Overall Study|Death|2|||
25193856|NCT03029780|50366476|FG001|Overall Study|Death|6|||
25193857|NCT03029234|50366536|FG000|Overall Study|Sponsor Decision|1|||
25193858|NCT03029234|50366536|FG000|Overall Study|Withdrawal by Subject|5|||
25193859|NCT03029234|50366536|FG000|Overall Study|Death|91|||
25193860|NCT03029234|50366536|FG000|Overall Study|Lost to Follow-up|2|||
25193861|NCT03018080|50367134|FG000|Overall Study|Death|11|||
25193862|NCT03018080|50367135|FG001|Overall Study|Death|19|||
25193863|NCT03018080|50367134|FG000|Overall Study|Still On Study (in follow up)|10|||
25193864|NCT03018080|50367135|FG001|Overall Study|Still On Study (in follow up)|0|||
25193865|NCT00557193|50367189|FG000|Induction|Adverse Event|2|||
25193866|NCT00557193|50367190|FG001|Induction|Adverse Event|0|||
25193867|NCT00557193|50367191|FG002|Induction|Adverse Event|0|||
25193868|NCT00557193|50367192|FG003|Induction|Adverse Event|0|||
25193869|NCT00557193|50367193|FG004|Induction|Adverse Event|0|||
25193870|NCT00557193|50367194|FG005|Induction|Adverse Event|0|||
25193871|NCT00557193|50367189|FG000|Induction|Death|6|||
25193872|NCT00557193|50367190|FG001|Induction|Death|0|||
25193873|NCT00557193|50367191|FG002|Induction|Death|0|||
25193874|NCT00557193|50367192|FG003|Induction|Death|0|||
25193875|NCT00557193|50367193|FG004|Induction|Death|0|||
25170564|NCT01808573|50305957|FG001|Overall Study|Randomized in Error|0|||
25170565|NCT02246530|50305984|FG000|Overall Study|Lost to Follow-up|4|||
25170566|NCT02246530|50305985|FG001|Overall Study|Lost to Follow-up|0|||
25170567|NCT01808339|50305991|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
25170568|NCT01808339|50305992|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
25170569|NCT01808339|50305993|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
25170570|NCT01808339|50305994|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
25193876|NCT00557193|50367194|FG005|Induction|Death|0|||
25193877|NCT00557193|50367189|FG000|Induction|Physician Decision|3|||
25193878|NCT00557193|50367190|FG001|Induction|Physician Decision|0|||
25193879|NCT00557193|50367191|FG002|Induction|Physician Decision|0|||
25193880|NCT00557193|50367192|FG003|Induction|Physician Decision|0|||
25193881|NCT00557193|50367193|FG004|Induction|Physician Decision|0|||
25193882|NCT00557193|50367194|FG005|Induction|Physician Decision|0|||
25193883|NCT00557193|50367189|FG000|Induction|Withdrawal by Subject|1|||
25193884|NCT00557193|50367190|FG001|Induction|Withdrawal by Subject|0|||
25193885|NCT00557193|50367191|FG002|Induction|Withdrawal by Subject|0|||
25193886|NCT00557193|50367192|FG003|Induction|Withdrawal by Subject|0|||
25193887|NCT00557193|50367193|FG004|Induction|Withdrawal by Subject|0|||
25193888|NCT00557193|50367194|FG005|Induction|Withdrawal by Subject|0|||
25193889|NCT00557193|50367189|FG000|Induction|Refusal of Further Protocol Therapy|2|||
25193890|NCT00557193|50367190|FG001|Induction|Refusal of Further Protocol Therapy|0|||
25193891|NCT00557193|50367191|FG002|Induction|Refusal of Further Protocol Therapy|0|||
25193892|NCT00557193|50367192|FG003|Induction|Refusal of Further Protocol Therapy|0|||
25193893|NCT00557193|50367193|FG004|Induction|Refusal of Further Protocol Therapy|0|||
25193894|NCT00557193|50367194|FG005|Induction|Refusal of Further Protocol Therapy|0|||
25193895|NCT00557193|50367189|FG000|Induction|Ineligible|8|||
25193896|NCT00557193|50367190|FG001|Induction|Ineligible|0|||
25193897|NCT00557193|50367191|FG002|Induction|Ineligible|0|||
25193898|NCT00557193|50367192|FG003|Induction|Ineligible|0|||
25193899|NCT00557193|50367193|FG004|Induction|Ineligible|0|||
25193900|NCT00557193|50367194|FG005|Induction|Ineligible|0|||
25193901|NCT00557193|50367189|FG000|Induction|Inevaluable for post Induction|2|||
25193902|NCT00557193|50367190|FG001|Induction|Inevaluable for post Induction|0|||
25193903|NCT00557193|50367191|FG002|Induction|Inevaluable for post Induction|0|||
25193904|NCT00557193|50367192|FG003|Induction|Inevaluable for post Induction|0|||
25193905|NCT00557193|50367193|FG004|Induction|Inevaluable for post Induction|0|||
25193906|NCT00557193|50367194|FG005|Induction|Inevaluable for post Induction|0|||
25193907|NCT00557193|50367189|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
25193908|NCT00557193|50367190|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
25193909|NCT00557193|50367191|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
25193910|NCT00557193|50367192|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
25193911|NCT00557193|50367193|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
25193912|NCT00557193|50367194|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
25193913|NCT00557193|50367189|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
25193914|NCT00557193|50367190|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
25193915|NCT00557193|50367191|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
25193916|NCT00557193|50367192|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
25193917|NCT00557193|50367193|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
25193918|NCT00557193|50367194|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
25193919|NCT00557193|50367189|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
25193920|NCT00557193|50367190|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
25193921|NCT00557193|50367191|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
25193922|NCT00557193|50367192|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
25193923|NCT00557193|50367193|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
25193924|NCT00557193|50367194|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
25193925|NCT00557193|50367189|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
25193926|NCT00557193|50367190|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
25193927|NCT00557193|50367191|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
25193928|NCT00557193|50367192|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
25193929|NCT00557193|50367193|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
25193930|NCT00557193|50367194|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
25193931|NCT00557193|50367189|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
25193932|NCT00557193|50367190|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
25193933|NCT00557193|50367191|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
25193934|NCT00557193|50367192|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
25193935|NCT00557193|50367193|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
25193936|NCT00557193|50367194|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
25193937|NCT00557193|50367189|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
25193938|NCT00557193|50367190|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
25193939|NCT00557193|50367191|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
25193940|NCT00557193|50367192|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
25193941|NCT00557193|50367193|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
25193942|NCT00557193|50367194|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
25193943|NCT00557193|50367189|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
25314860|NCT00910910|50630736|FG001|Overall Study|Adverse Event|35|||
25314861|NCT00910910|50630735|FG000|Overall Study|PD without histologic change|27|||
24976147|NCT00078819|50065062|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
25193944|NCT00557193|50367190|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
25193945|NCT00557193|50367191|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
25193946|NCT00557193|50367192|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
25193947|NCT00557193|50367193|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
25193948|NCT00557193|50367194|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
25193949|NCT00557193|50367189|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
25193950|NCT00557193|50367190|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
25193951|NCT00557193|50367191|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
25193952|NCT00557193|50367192|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
25193953|NCT00557193|50367193|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
25193954|NCT00557193|50367194|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
25193955|NCT00557193|50367189|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
25193956|NCT00557193|50367190|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
25193957|NCT00557193|50367191|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
25193958|NCT00557193|50367192|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
25193959|NCT00557193|50367193|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
25193960|NCT00557193|50367194|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
25193961|NCT03991299|50367250|FG000|Overall Study|Study closed, sponsor decision|3|||
25193962|NCT03991299|50367250|FG000|Overall Study|Withdrawal by Subject|1|||
25193963|NCT03155373|50367268|FG000|Overall Study|No longer required surgery|1|||
25193964|NCT03155373|50367268|FG000|Overall Study|Protocol Violation|1|||
25193965|NCT03155373|50367268|FG000|Overall Study|Death|2|||
25193966|NCT03155373|50367268|FG000|Overall Study|Withdrawal by Subject|3|||
25193967|NCT02775903|50367973|FG000|Overall Study|Death|7|||
25193968|NCT02775903|50367974|FG001|Overall Study|Death|11|||
25193969|NCT02775903|50367975|FG002|Overall Study|Death|12|||
25193970|NCT02775903|50367976|FG003|Overall Study|Death|11|||
25193971|NCT02775903|50367973|FG000|Overall Study|Adverse Event|0|||
25193972|NCT02775903|50367974|FG001|Overall Study|Adverse Event|1|||
25193973|NCT02775903|50367975|FG002|Overall Study|Adverse Event|12|||
25193974|NCT02775903|50367976|FG003|Overall Study|Adverse Event|3|||
25193975|NCT02775903|50367973|FG000|Overall Study|Progressive disease|15|||
25193976|NCT02775903|50367974|FG001|Overall Study|Progressive disease|14|||
25193977|NCT02775903|50367975|FG002|Overall Study|Progressive disease|30|||
25193978|NCT02775903|50367976|FG003|Overall Study|Progressive disease|20|||
25193979|NCT02775903|50367973|FG000|Overall Study|Lack of Efficacy|2|||
25193980|NCT02775903|50367974|FG001|Overall Study|Lack of Efficacy|2|||
25193981|NCT02775903|50367975|FG002|Overall Study|Lack of Efficacy|2|||
25193982|NCT02775903|50367976|FG003|Overall Study|Lack of Efficacy|6|||
25193983|NCT02775903|50367973|FG000|Overall Study|Withdrawal by Subject|7|||
25193984|NCT02775903|50367974|FG001|Overall Study|Withdrawal by Subject|5|||
25193985|NCT02775903|50367975|FG002|Overall Study|Withdrawal by Subject|5|||
25193986|NCT02775903|50367976|FG003|Overall Study|Withdrawal by Subject|8|||
25193987|NCT02775903|50367973|FG000|Overall Study|Other reasons|7|||
25193988|NCT02775903|50367974|FG001|Overall Study|Other reasons|8|||
25193989|NCT02775903|50367975|FG002|Overall Study|Other reasons|2|||
25193990|NCT02775903|50367976|FG003|Overall Study|Other reasons|12|||
25193991|NCT02723019|50368049|FG000|Overall Study|Death|17|||
25193992|NCT02723019|50368050|FG001|Overall Study|Death|13|||
25193993|NCT02723019|50368049|FG000|Overall Study|Withdrawal by Subject|11|||
25193994|NCT02723019|50368050|FG001|Overall Study|Withdrawal by Subject|7|||
25193995|NCT02723019|50368049|FG000|Overall Study|Lost to Follow-up|57|||
25193996|NCT02723019|50368050|FG001|Overall Study|Lost to Follow-up|70|||
25193997|NCT00088166|50368305|FG000|Overall Study|Adverse Event|11|||
25314862|NCT00910910|50630736|FG001|Overall Study|PD without histologic change|23|||
25193998|NCT00088166|50368306|FG001|Overall Study|Adverse Event|9|||
25193999|NCT00088166|50368305|FG000|Overall Study|Death|3|||
25194000|NCT00088166|50368306|FG001|Overall Study|Death|1|||
25194001|NCT00088166|50368305|FG000|Overall Study|Lost to Follow-up|0|||
25194002|NCT00088166|50368306|FG001|Overall Study|Lost to Follow-up|1|||
25194003|NCT00088166|50368305|FG000|Overall Study|Physician Decision|4|||
25194004|NCT00088166|50368306|FG001|Overall Study|Physician Decision|1|||
25194005|NCT00088166|50368305|FG000|Overall Study|Protocol Violation|1|||
25194006|NCT00088166|50368306|FG001|Overall Study|Protocol Violation|5|||
25194007|NCT00088166|50368305|FG000|Overall Study|Patient deterioration|29|||
25194008|NCT00088166|50368306|FG001|Overall Study|Patient deterioration|39|||
25194009|NCT00088166|50368305|FG000|Overall Study|Withdrawal by Subject|5|||
25194010|NCT00088166|50368306|FG001|Overall Study|Withdrawal by Subject|5|||
25314863|NCT00910910|50630735|FG000|Overall Study|PD with histologic change|0|||
25194011|NCT00087698|50368350|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
25194012|NCT00087698|50368350|FG000|Overall Study|Death from Other Causes|3|||
25194013|NCT00087698|50368350|FG000|Overall Study|Adverse Event|4|||
25194014|NCT00087698|50368350|FG000|Overall Study|Withdrawal by Subject|4|||
25194015|NCT00087698|50368350|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
25194016|NCT00087698|50368350|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
25194017|NCT00087698|50368350|FG000|Overall Study|Clinical Relapse|1|||
25194018|NCT00087698|50368350|FG000|Overall Study|Death from Study Disease|2|||
25194019|NCT00087698|50368350|FG000|Overall Study|Death from Study Drug Toxicity|2|||
25194020|NCT00087698|50368350|FG000|Overall Study|Protocol Violation|1|||
25194021|NCT00087152|50368368|FG000|Overall Study|Ineligible|6|||
25194022|NCT00086996|50368420|FG000|Overall Study|Adverse Event|29|||
25194023|NCT00086996|50368420|FG000|Overall Study|Death|4|||
25194024|NCT00086996|50368420|FG000|Overall Study|progression/relapse|7|||
25194025|NCT00086996|50368420|FG000|Overall Study|Withdrawal by Subject|13|||
25076978|NCT02443298|50184729|FG000|Overall Study|Adverse Event|3|||
25076979|NCT02443298|50184730|FG001|Overall Study|Adverse Event|3|||
25076980|NCT02443298|50184729|FG000|Overall Study|Withdrawal by Subject|1|||
25076981|NCT02443298|50184730|FG001|Overall Study|Withdrawal by Subject|2|||
25076982|NCT02500706|50184739|FG000|Overall Study|Adverse Event|0|||
25076983|NCT02500706|50184740|FG001|Overall Study|Adverse Event|0|||
25076984|NCT02500706|50184741|FG002|Overall Study|Adverse Event|1|||
25076985|NCT02500706|50184739|FG000|Overall Study|Lost to Follow-up|0|||
25170571|NCT01808339|50305995|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
25170572|NCT01808339|50305996|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
25170573|NCT01808339|50305991|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
25170574|NCT01808339|50305992|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
25170575|NCT01808339|50305993|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
25170576|NCT01808339|50305994|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
25170577|NCT01808339|50305995|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
25170578|NCT01808339|50305996|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
25170579|NCT01808339|50305991|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
25170580|NCT01808339|50305992|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
25170581|NCT01808339|50305993|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
25170582|NCT01808339|50305994|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
25170583|NCT01808339|50305995|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
25170584|NCT01808339|50305996|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
25170585|NCT02727660|50306046|FG000|Overall Study|Lack of Efficacy|40|||
25170586|NCT02727660|50306047|FG001|Overall Study|Lack of Efficacy|40|||
25170587|NCT02727660|50306048|FG002|Overall Study|Lack of Efficacy|70|||
25170588|NCT02727660|50306046|FG000|Overall Study|Adverse Event|28|||
25170589|NCT02727660|50306047|FG001|Overall Study|Adverse Event|21|||
25170590|NCT02727660|50306048|FG002|Overall Study|Adverse Event|32|||
25170591|NCT02727660|50306046|FG000|Overall Study|Withdrawal by Subject|26|||
25170592|NCT02727660|50306047|FG001|Overall Study|Withdrawal by Subject|25|||
25170593|NCT02727660|50306048|FG002|Overall Study|Withdrawal by Subject|30|||
25170594|NCT02727660|50306046|FG000|Overall Study|Physician Decision|3|||
25170595|NCT02727660|50306047|FG001|Overall Study|Physician Decision|8|||
25170596|NCT02727660|50306048|FG002|Overall Study|Physician Decision|14|||
25170597|NCT02727660|50306046|FG000|Overall Study|Lost to Follow-up|5|||
25170598|NCT02727660|50306047|FG001|Overall Study|Lost to Follow-up|9|||
25170599|NCT02727660|50306048|FG002|Overall Study|Lost to Follow-up|8|||
25170600|NCT02727660|50306046|FG000|Overall Study|Protocol Violation|7|||
25170601|NCT02727660|50306047|FG001|Overall Study|Protocol Violation|5|||
25170602|NCT02727660|50306048|FG002|Overall Study|Protocol Violation|5|||
25170603|NCT02727660|50306046|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
25170604|NCT02727660|50306047|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
25170605|NCT02727660|50306048|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
25170606|NCT02727660|50306046|FG000|Overall Study|Administrative Reasons|2|||
25170607|NCT02727660|50306047|FG001|Overall Study|Administrative Reasons|3|||
25170608|NCT02727660|50306048|FG002|Overall Study|Administrative Reasons|4|||
25170609|NCT01784861|50306062|FG000|Overall Study|Adverse Event|0|||
25170610|NCT01784861|50306063|FG001|Overall Study|Adverse Event|0|||
25170611|NCT01784861|50306064|FG002|Overall Study|Adverse Event|1|||
25170612|NCT01784861|50306065|FG003|Overall Study|Adverse Event|2|||
25170613|NCT01784861|50306066|FG004|Overall Study|Adverse Event|1|||
25170614|NCT01784861|50306067|FG005|Overall Study|Adverse Event|0|||
25170615|NCT01784861|50306062|FG000|Overall Study|Withdrawal by Subject|0|||
25170616|NCT01784861|50306063|FG001|Overall Study|Withdrawal by Subject|0|||
25170617|NCT01784861|50306064|FG002|Overall Study|Withdrawal by Subject|0|||
25170618|NCT01784861|50306065|FG003|Overall Study|Withdrawal by Subject|1|||
25170619|NCT01784861|50306066|FG004|Overall Study|Withdrawal by Subject|0|||
25314864|NCT00910910|50630736|FG001|Overall Study|PD with histologic change|2|||
25076986|NCT02500706|50184740|FG001|Overall Study|Lost to Follow-up|1|||
25076987|NCT02500706|50184741|FG002|Overall Study|Lost to Follow-up|1|||
25194026|NCT00086996|50368420|FG000|Overall Study|Other|6|||
25194027|NCT00086996|50368420|FG000|Overall Study|not eligible|5|||
25194028|NCT00086684|50368722|FG000|Overall Study|Adverse Event|12|||
25194029|NCT00086684|50368723|FG001|Overall Study|Adverse Event|17|||
25194030|NCT00086684|50368724|FG002|Overall Study|Adverse Event|14|||
25194031|NCT00086684|50368722|FG000|Overall Study|Lack of Efficacy|6|||
25194032|NCT00086684|50368723|FG001|Overall Study|Lack of Efficacy|6|||
25194033|NCT00086684|50368724|FG002|Overall Study|Lack of Efficacy|5|||
25194034|NCT00086684|50368722|FG000|Overall Study|Lost to Follow-up|15|||
25194035|NCT00086684|50368723|FG001|Overall Study|Lost to Follow-up|8|||
25194036|NCT00086684|50368724|FG002|Overall Study|Lost to Follow-up|10|||
25194037|NCT00086684|50368722|FG000|Overall Study|Protocol Violation|8|||
25194038|NCT00086684|50368723|FG001|Overall Study|Protocol Violation|3|||
25194039|NCT00086684|50368724|FG002|Overall Study|Protocol Violation|0|||
25194040|NCT00086684|50368722|FG000|Overall Study|Withdrawal by Subject|0|||
25194041|NCT00086684|50368723|FG001|Overall Study|Withdrawal by Subject|4|||
25194042|NCT00086684|50368724|FG002|Overall Study|Withdrawal by Subject|10|||
25194043|NCT00086684|50368722|FG000|Overall Study|NONCOMPLIANCE|5|||
25194044|NCT00086684|50368723|FG001|Overall Study|NONCOMPLIANCE|7|||
25194045|NCT00086684|50368724|FG002|Overall Study|NONCOMPLIANCE|6|||
25194046|NCT00086684|50368722|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
25194047|NCT00086684|50368723|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
25194048|NCT00086684|50368724|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
25194049|NCT00086684|50368722|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
25194050|NCT00086684|50368723|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
25194051|NCT00086684|50368724|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
25194052|NCT00086684|50368722|FG000|Overall Study|Other|4|||
25194053|NCT00086684|50368723|FG001|Overall Study|Other|2|||
25194054|NCT00086684|50368724|FG002|Overall Study|Other|3|||
25194055|NCT00082628|50368788|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
25194056|NCT00082628|50368789|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
25194057|NCT00082628|50368790|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
25194058|NCT00082628|50368791|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
25194059|NCT00082628|50368792|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
25194060|NCT00082628|50368788|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
25194061|NCT00082628|50368789|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
25194062|NCT00082628|50368790|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
25194063|NCT00082628|50368791|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
25194064|NCT00082628|50368792|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
25194065|NCT00082628|50368788|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
25194066|NCT00082628|50368789|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
25194067|NCT00082628|50368790|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
25194068|NCT00082628|50368791|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
25194069|NCT00082628|50368792|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
25194070|NCT00082628|50368788|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
25194071|NCT00082628|50368789|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
25194072|NCT00082628|50368790|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
25194073|NCT00082628|50368791|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
25194074|NCT00082628|50368792|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
25194075|NCT00082628|50368788|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
25194076|NCT00082628|50368789|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
25194077|NCT00082628|50368790|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
25194078|NCT00082628|50368791|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
25194079|NCT00082628|50368792|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
25194080|NCT00082628|50368788|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
25194081|NCT00082628|50368789|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
25194082|NCT00082628|50368790|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
25194083|NCT00082628|50368791|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
25194084|NCT00082628|50368792|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
24976148|NCT00078819|50065063|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
25194085|NCT00082628|50368788|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
25194086|NCT00082628|50368789|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
25194087|NCT00082628|50368790|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
25194088|NCT00082628|50368791|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
25194089|NCT00082628|50368792|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
25194090|NCT02993263|50369148|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
25194091|NCT01274533|50369176|FG000|Overall Study|Withdrawal by Subject|1|||
25194092|NCT01274533|50369176|FG000|Overall Study|Non-compliance|1|||
25194093|NCT01274533|50369176|FG000|Overall Study|Disease progression|2|||
25194094|NCT01273597|50369180|FG000|Overall Study|Adverse Event|5|||
25194095|NCT01273597|50369180|FG000|Overall Study|Underwent Kidney Transplantation|2|||
25194096|NCT01273597|50369180|FG000|Overall Study|Reason Not Reported|1|||
25194097|NCT01273519|50369187|FG000|Overall Study|Adverse Event|3|||
25194098|NCT01273519|50369188|FG001|Overall Study|Adverse Event|0|||
25194099|NCT01273519|50369189|FG002|Overall Study|Adverse Event|0|||
25194100|NCT01273519|50369187|FG000|Overall Study|Lost to Follow-up|2|||
25194101|NCT01273519|50369188|FG001|Overall Study|Lost to Follow-up|1|||
25194102|NCT01273519|50369189|FG002|Overall Study|Lost to Follow-up|3|||
25194103|NCT01273519|50369187|FG000|Overall Study|Lack of Efficacy|8|||
25194104|NCT01273519|50369188|FG001|Overall Study|Lack of Efficacy|3|||
25194105|NCT01273519|50369189|FG002|Overall Study|Lack of Efficacy|4|||
25194106|NCT01273519|50369187|FG000|Overall Study|Other|6|||
25194107|NCT01273519|50369188|FG001|Overall Study|Other|1|||
25194108|NCT01273519|50369189|FG002|Overall Study|Other|1|||
25194109|NCT01272661|50369246|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
25194110|NCT01272661|50369247|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
25194111|NCT01272661|50369248|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
25194112|NCT04276051|50369414|FG000|Overall Study|Lost to Follow-up|0|||
25194113|NCT04276051|50369415|FG001|Overall Study|Lost to Follow-up|1|||
25194114|NCT04276051|50369414|FG000|Overall Study|Physician Decision|0|||
25194115|NCT04276051|50369415|FG001|Overall Study|Physician Decision|1|||
25194116|NCT04276051|50369414|FG000|Overall Study|Withdrawal by Subject|1|||
25194117|NCT04276051|50369415|FG001|Overall Study|Withdrawal by Subject|1|||
25194118|NCT00081770|50369675|FG000|Overall Study|Adverse Event|130|||
25194119|NCT00081770|50369676|FG001|Overall Study|Adverse Event|98|||
25194120|NCT00081770|50369677|FG002|Overall Study|Adverse Event|136|||
25194121|NCT00081770|50369675|FG000|Overall Study|Lack of Efficacy|262|||
25194122|NCT00081770|50369676|FG001|Overall Study|Lack of Efficacy|357|||
25194123|NCT00081770|50369677|FG002|Overall Study|Lack of Efficacy|211|||
25194124|NCT00081770|50369675|FG000|Overall Study|Lost to Follow-up|45|||
25194125|NCT00081770|50369676|FG001|Overall Study|Lost to Follow-up|34|||
25194126|NCT00081770|50369677|FG002|Overall Study|Lost to Follow-up|45|||
25194127|NCT00081770|50369675|FG000|Overall Study|Protocol Violation|15|||
25194128|NCT00081770|50369676|FG001|Overall Study|Protocol Violation|10|||
25194129|NCT00081770|50369677|FG002|Overall Study|Protocol Violation|10|||
25194130|NCT00081770|50369675|FG000|Overall Study|Withdrawal by Subject|45|||
25194131|NCT00081770|50369676|FG001|Overall Study|Withdrawal by Subject|40|||
25194132|NCT00081770|50369677|FG002|Overall Study|Withdrawal by Subject|42|||
25194133|NCT00081770|50369675|FG000|Overall Study|Did not meet protocol eligibility|2|||
25314865|NCT00910910|50630735|FG000|Overall Study|Withdrawal by Subject|7|||
25314866|NCT00910910|50630736|FG001|Overall Study|Withdrawal by Subject|5|||
25314867|NCT00910910|50630735|FG000|Overall Study|Lost to Follow-up|2|||
25314868|NCT00910910|50630736|FG001|Overall Study|Lost to Follow-up|2|||
25314869|NCT00910910|50630735|FG000|Overall Study|Death|9|||
25314870|NCT00910910|50630736|FG001|Overall Study|Death|3|||
25314871|NCT00910910|50630735|FG000|Overall Study|Protocol Violation|2|||
25314872|NCT00910910|50630736|FG001|Overall Study|Protocol Violation|2|||
25314873|NCT00910910|50630735|FG000|Overall Study|Completed 13 cycles of treatment|0|||
25314874|NCT00910910|50630736|FG001|Overall Study|Completed 13 cycles of treatment|118|||
25314875|NCT00910910|50630735|FG000|Overall Study|Other|114|||
25314876|NCT00910910|50630736|FG001|Overall Study|Other|32|||
25314877|NCT00910910|50630735|FG000|Overall Study|Untreated before cycle 1|1|||
25314878|NCT00910910|50630736|FG001|Overall Study|Untreated before cycle 1|2|||
25314879|NCT00911768|50630744|FG000|Overall Study|Protocol Violation|5|||
25314880|NCT00911768|50630745|FG001|Overall Study|Protocol Violation|4|||
25314881|NCT00911768|50630744|FG000|Overall Study|Withdrawal by Subject|1|||
25314882|NCT00911768|50630745|FG001|Overall Study|Withdrawal by Subject|0|||
25314883|NCT00909038|50630751|FG000|Overall Study|Protocol Violation|187|||
25314884|NCT00909038|50630751|FG000|Overall Study|Non-evaluable Subjects|230|||
25314885|NCT00909428|50630758|FG000|Overall Study|Lost to Follow-up|13|||
25314886|NCT00909428|50630759|FG001|Overall Study|Lost to Follow-up|10|||
25314887|NCT00909428|50630760|FG002|Overall Study|Lost to Follow-up|9|||
25076988|NCT02500706|50184739|FG000|Overall Study|Withdrawal by Subject|4|||
25076989|NCT02500706|50184740|FG001|Overall Study|Withdrawal by Subject|6|||
25076990|NCT02500706|50184741|FG002|Overall Study|Withdrawal by Subject|4|||
25194134|NCT00081770|50369676|FG001|Overall Study|Did not meet protocol eligibility|0|||
25194135|NCT00081770|50369677|FG002|Overall Study|Did not meet protocol eligibility|3|||
25194136|NCT00081770|50369675|FG000|Overall Study|Administrative|1|||
25194137|NCT00081770|50369676|FG001|Overall Study|Administrative|0|||
25194138|NCT00081770|50369677|FG002|Overall Study|Administrative|1|||
25194139|NCT00081770|50369675|FG000|Overall Study|Other|2|||
25194140|NCT00081770|50369676|FG001|Overall Study|Other|7|||
25194141|NCT00081770|50369677|FG002|Overall Study|Other|8|||
25194142|NCT00081458|50369777|FG000|Overall Study|Adverse Event|1|||
25194143|NCT00081458|50369778|FG001|Overall Study|Adverse Event|5|||
25194144|NCT00081458|50369779|FG002|Overall Study|Adverse Event|2|||
25194145|NCT00081458|50369777|FG000|Overall Study|Withdrawal by Subject|0|||
25194146|NCT00081458|50369778|FG001|Overall Study|Withdrawal by Subject|3|||
25194147|NCT00081458|50369779|FG002|Overall Study|Withdrawal by Subject|1|||
25194148|NCT00081458|50369777|FG000|Overall Study|Randomized but not dosed|0|||
25194149|NCT00081458|50369778|FG001|Overall Study|Randomized but not dosed|0|||
25194150|NCT00081458|50369779|FG002|Overall Study|Randomized but not dosed|1|||
25194151|NCT01271803|50369856|FG000|Overall Study|Progressive disease|0|||
25194152|NCT01271803|50369857|FG001|Overall Study|Progressive disease|0|||
25194153|NCT01271803|50369858|FG002|Overall Study|Progressive disease|2|||
25194154|NCT01271803|50369856|FG000|Overall Study|Death|53|||
25194155|NCT01271803|50369857|FG001|Overall Study|Death|34|||
25194156|NCT01271803|50369858|FG002|Overall Study|Death|0|||
25194157|NCT01271803|50369856|FG000|Overall Study|Withdrawal by Subject|1|||
25194158|NCT01271803|50369857|FG001|Overall Study|Withdrawal by Subject|5|||
25194159|NCT01271803|50369858|FG002|Overall Study|Withdrawal by Subject|0|||
25194160|NCT01271803|50369856|FG000|Overall Study|Lost to Follow-up|1|||
25194161|NCT01271803|50369857|FG001|Overall Study|Lost to Follow-up|0|||
25194162|NCT01271803|50369858|FG002|Overall Study|Lost to Follow-up|0|||
25194163|NCT00080288|50369909|FG000|Overall Study|Adverse Event|7|||
25194164|NCT00080288|50369910|FG001|Overall Study|Adverse Event|4|||
25194165|NCT00080288|50369909|FG000|Overall Study|Lost to Follow-up|3|||
25194166|NCT00080288|50369910|FG001|Overall Study|Lost to Follow-up|5|||
25194167|NCT00080288|50369909|FG000|Overall Study|Physician Decision|6|||
25194168|NCT00080288|50369910|FG001|Overall Study|Physician Decision|2|||
25194169|NCT00080288|50369909|FG000|Overall Study|Withdrawal by Subject|3|||
25194170|NCT00080288|50369910|FG001|Overall Study|Withdrawal by Subject|16|||
25194171|NCT00080288|50369909|FG000|Overall Study|Miscellaneous|11|||
25194172|NCT00080288|50369910|FG001|Overall Study|Miscellaneous|11|||
25194173|NCT01271725|50369984|FG000|Part A|Progressive disease according to RECIST|8|||
25194174|NCT01271725|50369985|FG001|Part A|Progressive disease according to RECIST|0|||
25194175|NCT01271725|50369984|FG000|Part A|Clinical signs/symptoms of progression|2|||
25194176|NCT01271725|50369985|FG001|Part A|Clinical signs/symptoms of progression|0|||
25194177|NCT01271725|50369984|FG000|Part A|Other Adverse Event|8|||
25194178|NCT01271725|50369985|FG001|Part A|Other Adverse Event|0|||
25194179|NCT01271725|50369984|FG000|Part A|Lost to Follow-up|1|||
25194180|NCT01271725|50369985|FG001|Part A|Lost to Follow-up|0|||
25194181|NCT01271725|50369984|FG000|Part A|Withdrawal by Subject|12|||
25194182|NCT01271725|50369985|FG001|Part A|Withdrawal by Subject|0|||
25194183|NCT01271725|50369984|FG000|Part A|Other than specified|3|||
25194184|NCT01271725|50369985|FG001|Part A|Other than specified|0|||
25194185|NCT01271725|50369984|FG000|Part A|Protocol Violation|1|||
25194186|NCT01271725|50369985|FG001|Part A|Protocol Violation|0|||
25194187|NCT01271725|50369984|FG000|Part B|Other than specified|0|||
25194188|NCT01271725|50369985|FG001|Part B|Other than specified|2|||
25194189|NCT01271725|50369984|FG000|Part B|Clinical signs/symptoms of progression|0|||
25194190|NCT01271725|50369985|FG001|Part B|Clinical signs/symptoms of progression|2|||
25194191|NCT01271725|50369984|FG000|Part B|Other Adverse Event|0|||
25194192|NCT01271725|50369985|FG001|Part B|Other Adverse Event|1|||
25194193|NCT01271725|50369984|FG000|Part B|Protocol Violation|0|||
25194194|NCT01271725|50369985|FG001|Part B|Protocol Violation|1|||
25314888|NCT00908960|50630770|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
24976149|NCT00078819|50065064|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
24976150|NCT00078819|50065061|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
24976151|NCT00078819|50065062|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
24976152|NCT00078819|50065063|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
24976153|NCT00078819|50065064|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
25314889|NCT00908960|50630771|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
25314890|NCT00908960|50630772|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
25194195|NCT01271725|50369984|FG000|Part B|Withdrawal by Subject|0|||
25194196|NCT01271725|50369985|FG001|Part B|Withdrawal by Subject|6|||
25194197|NCT01270321|50370010|FG000|Overall Study|Death|3|||
25194198|NCT01270321|50370011|FG001|Overall Study|Death|1|||
25194199|NCT01270321|50370012|FG002|Overall Study|Death|4|||
25194200|NCT01270321|50370010|FG000|Overall Study|Adverse Event|7|||
25194201|NCT01270321|50370011|FG001|Overall Study|Adverse Event|9|||
25194202|NCT01270321|50370012|FG002|Overall Study|Adverse Event|5|||
25194203|NCT00249769|50370106|FG000|Overall Study|Withdrawal by Subject|1|||
25194204|NCT00249769|50370107|FG001|Overall Study|Withdrawal by Subject|10|||
25194205|NCT00249769|50370108|FG002|Overall Study|Withdrawal by Subject|6|||
25194206|NCT00249769|50370106|FG000|Overall Study|Migration from Study Area|1|||
25194207|NCT00249769|50370107|FG001|Overall Study|Migration from Study Area|3|||
25194208|NCT00249769|50370108|FG002|Overall Study|Migration from Study Area|14|||
25194209|NCT00249769|50370106|FG000|Overall Study|Miscellaneous|0|||
25194210|NCT00249769|50370107|FG001|Overall Study|Miscellaneous|2|||
25194211|NCT00249769|50370108|FG002|Overall Study|Miscellaneous|2|||
25194212|NCT00249769|50370106|FG000|Overall Study|Adverse Event|0|||
25194213|NCT00249769|50370107|FG001|Overall Study|Adverse Event|0|||
25194214|NCT00249769|50370108|FG002|Overall Study|Adverse Event|1|||
25194215|NCT00249769|50370106|FG000|Overall Study|Physician Decision|0|||
25194216|NCT00249769|50370107|FG001|Overall Study|Physician Decision|0|||
25194217|NCT00249769|50370108|FG002|Overall Study|Physician Decision|2|||
25314891|NCT00650767|50630790|FG000|Overall Study|Adverse Event|0|||
24976157|NCT00098865|50065085|FG000|Overall Study|Progressive Disease|6|||
25194218|NCT00249769|50370106|FG000|Overall Study|Lost to Follow-up|0|||
25194219|NCT00249769|50370107|FG001|Overall Study|Lost to Follow-up|0|||
25194220|NCT00249769|50370108|FG002|Overall Study|Lost to Follow-up|3|||
25194221|NCT00249613|50370118|FG000|12 Month Follow-up|Death|1|||
25194222|NCT00249613|50370119|FG001|12 Month Follow-up|Death|1|||
25194223|NCT00249613|50370118|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
25194224|NCT00249613|50370119|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
25194225|NCT00249613|50370118|FG000|12 Month Follow-up|Lost to Follow-up|10|||
25194226|NCT00249613|50370119|FG001|12 Month Follow-up|Lost to Follow-up|8|||
25194227|NCT00248833|50370155|FG000|Overall Study|Adverse Event|2|||
25194228|NCT00248833|50370156|FG001|Overall Study|Adverse Event|0|||
25194229|NCT00248833|50370157|FG002|Overall Study|Adverse Event|0|||
25194230|NCT00248833|50370155|FG000|Overall Study|Withdrawal by Subject|0|||
25194231|NCT00248833|50370156|FG001|Overall Study|Withdrawal by Subject|1|||
25194232|NCT00248833|50370157|FG002|Overall Study|Withdrawal by Subject|1|||
25194233|NCT00248833|50370155|FG000|Overall Study|Lost to Follow-up|1|||
25194234|NCT00248833|50370156|FG001|Overall Study|Lost to Follow-up|1|||
25194235|NCT00248833|50370157|FG002|Overall Study|Lost to Follow-up|1|||
25194236|NCT00248833|50370155|FG000|Overall Study|Other|0|||
25194237|NCT00248833|50370156|FG001|Overall Study|Other|1|||
25194238|NCT00248833|50370157|FG002|Overall Study|Other|0|||
25194239|NCT00247273|50370337|FG000|Overall Study|Adverse Event|85|||
25194240|NCT00247273|50370338|FG001|Overall Study|Adverse Event|80|||
25194241|NCT00247273|50370337|FG000|Overall Study|Physician Decision|6|||
25194242|NCT00247273|50370338|FG001|Overall Study|Physician Decision|3|||
25194243|NCT00247273|50370337|FG000|Overall Study|Lost to Follow-up|7|||
25194244|NCT00247273|50370338|FG001|Overall Study|Lost to Follow-up|7|||
25194245|NCT00247273|50370337|FG000|Overall Study|Withdrawal by Subject|46|||
25194246|NCT00247273|50370338|FG001|Overall Study|Withdrawal by Subject|47|||
25194247|NCT00247273|50370337|FG000|Overall Study|Did not take any study drug|2|||
25194248|NCT00247273|50370338|FG001|Overall Study|Did not take any study drug|0|||
25194249|NCT00246259|50370426|FG000|Overall Study|Other|3|||
25194250|NCT00246259|50370427|FG001|Overall Study|Other|3|||
25194251|NCT00246259|50370426|FG000|Overall Study|Not stable by Week 18|2|||
25194252|NCT00246259|50370427|FG001|Overall Study|Not stable by Week 18|1|||
25194253|NCT00246259|50370426|FG000|Overall Study|Participant non-compliant|4|||
25194254|NCT00246259|50370427|FG001|Overall Study|Participant non-compliant|9|||
25194255|NCT00246259|50370426|FG000|Overall Study|Lack of Efficacy|2|||
25194256|NCT00246259|50370427|FG001|Overall Study|Lack of Efficacy|2|||
25194257|NCT00246259|50370426|FG000|Overall Study|Investigator withdrew participant|2|||
25194258|NCT00246259|50370427|FG001|Overall Study|Investigator withdrew participant|0|||
25194259|NCT00246259|50370426|FG000|Overall Study|Adverse Event|5|||
25194260|NCT00246259|50370427|FG001|Overall Study|Adverse Event|0|||
25194261|NCT00246259|50370426|FG000|Overall Study|Lost to Follow-up|3|||
25194262|NCT00246259|50370427|FG001|Overall Study|Lost to Follow-up|4|||
25194263|NCT00246259|50370426|FG000|Overall Study|Withdrawal by Subject|5|||
25194264|NCT00246259|50370427|FG001|Overall Study|Withdrawal by Subject|1|||
25194265|NCT00246259|50370426|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
25194266|NCT00246259|50370427|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
25194267|NCT00246025|50370479|FG000|Overall Study|Adverse Event|7|||
25194268|NCT00246025|50370480|FG001|Overall Study|Adverse Event|9|||
25194269|NCT00246025|50370481|FG002|Overall Study|Adverse Event|9|||
25194270|NCT00246025|50370482|FG003|Overall Study|Adverse Event|10|||
25194271|NCT00246025|50370479|FG000|Overall Study|Withdrawal by Subject|3|||
25194272|NCT00246025|50370480|FG001|Overall Study|Withdrawal by Subject|0|||
25194273|NCT00246025|50370481|FG002|Overall Study|Withdrawal by Subject|1|||
25194274|NCT00246025|50370482|FG003|Overall Study|Withdrawal by Subject|2|||
25194275|NCT00246025|50370479|FG000|Overall Study|unsuitable medical history was found|0|||
25194276|NCT00246025|50370480|FG001|Overall Study|unsuitable medical history was found|0|||
25194277|NCT00246025|50370481|FG002|Overall Study|unsuitable medical history was found|0|||
25194278|NCT00246025|50370482|FG003|Overall Study|unsuitable medical history was found|1|||
25194279|NCT00245011|50370612|FG000|Overall Study|Lack of Efficacy|1|||
25194280|NCT00244855|50370631|FG000|Overall Study|Withdrawal by Subject|0|||
24976158|NCT00098865|50065085|FG000|Overall Study|Adverse Event|2|||
25194281|NCT00244855|50370632|FG001|Overall Study|Withdrawal by Subject|1|||
25194282|NCT00244621|50370662|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
25194283|NCT00244621|50370663|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
25194284|NCT00244621|50370664|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
25194285|NCT00244621|50370662|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
25194286|NCT00244621|50370663|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
25194287|NCT00244621|50370664|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
25194288|NCT00244621|50370662|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
25194289|NCT00244621|50370663|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
24976159|NCT00098865|50065085|FG000|Overall Study|Alternative Therapy|1|||
25314892|NCT00650767|50630791|FG001|Overall Study|Adverse Event|3|||
25194290|NCT00244621|50370664|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
25194291|NCT00244621|50370662|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
25194292|NCT00244621|50370663|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
25194293|NCT00244621|50370664|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
25194294|NCT00244621|50370662|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
25194295|NCT00244621|50370663|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
25194296|NCT00244621|50370664|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
25194297|NCT00244621|50370662|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
25194298|NCT00244621|50370663|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
25194299|NCT00244621|50370664|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
25194300|NCT00244621|50370662|FG000|Open-label Treatment Period|Adverse Event|0|||
25194301|NCT00244621|50370663|FG001|Open-label Treatment Period|Adverse Event|0|||
25194302|NCT00244621|50370664|FG002|Open-label Treatment Period|Adverse Event|1|||
25194303|NCT00244621|50370662|FG000|Open-label Treatment Period|Moved abroad|0|||
25194304|NCT00244621|50370663|FG001|Open-label Treatment Period|Moved abroad|0|||
25194305|NCT00244621|50370664|FG002|Open-label Treatment Period|Moved abroad|1|||
25194306|NCT00243841|50370747|FG000|Overall Study|Physician Decision|0|||
25194307|NCT00243841|50370748|FG001|Overall Study|Physician Decision|0|||
25194308|NCT00243841|50370749|FG002|Overall Study|Physician Decision|1|||
25194309|NCT00243841|50370750|FG003|Overall Study|Physician Decision|0|||
25194310|NCT00243841|50370751|FG004|Overall Study|Physician Decision|0|||
25194311|NCT00243841|50370752|FG005|Overall Study|Physician Decision|2|||
25194312|NCT02980731|50370945|FG000|Overall Study|Death|63|||
25194313|NCT02980731|50370945|FG000|Overall Study|Withdrawal by Subject|6|||
25194314|NCT02980731|50370945|FG000|Overall Study|Lost to Follow-up|5|||
25194315|NCT02980731|50370945|FG000|Overall Study|Study terminated by Sponsor|4|||
25194316|NCT02980731|50370945|FG000|Overall Study|Completed survival follow-up period|65|||
25194317|NCT02980731|50370945|FG000|Overall Study|COVID-19 infection|1|||
25194318|NCT02980731|50370945|FG000|Overall Study|Other, not specified|66|||
25194319|NCT02641587|50370985|FG000|Confinement Period|Adverse Event|1|||
25194320|NCT02641587|50370986|FG001|Confinement Period|Adverse Event|0|||
25194321|NCT02641587|50370985|FG000|Confinement Period|Withdrawal by Subject|2|||
25194322|NCT02641587|50370986|FG001|Confinement Period|Withdrawal by Subject|1|||
25194323|NCT02641587|50370985|FG000|Ambulatory Period|Withdrawal by Subject|1|||
25194324|NCT02641587|50370986|FG001|Ambulatory Period|Withdrawal by Subject|0|||
25194325|NCT04672083|50371104|FG000|Overall Study|Lost to Follow-up|1|||
25194326|NCT04672083|50371105|FG001|Overall Study|Lost to Follow-up|0|||
25194327|NCT04672083|50371106|FG002|Overall Study|Lost to Follow-up|0|||
25194328|NCT04672083|50371107|FG003|Overall Study|Lost to Follow-up|0|||
25194329|NCT04672083|50371108|FG004|Overall Study|Lost to Follow-up|0|||
25194330|NCT01781637|50371211|FG000|Overall Study|Adverse Event|1|||
25194331|NCT01781637|50371212|FG001|Overall Study|Adverse Event|0|||
25194332|NCT01781637|50371211|FG000|Overall Study|Lack of Efficacy|2|||
25194333|NCT01781637|50371212|FG001|Overall Study|Lack of Efficacy|6|||
25194334|NCT01781637|50371211|FG000|Overall Study|Withdrawal by Subject|1|||
25194335|NCT01781637|50371212|FG001|Overall Study|Withdrawal by Subject|0|||
25194336|NCT01459497|50371260|FG000|Overall Study|Inability to meet trial constraints.|1|||
25194337|NCT01459497|50371261|FG001|Overall Study|Inability to meet trial constraints.|0|||
25194338|NCT01459497|50371260|FG000|Overall Study|Physician Decision|1|||
25194339|NCT01459497|50371261|FG001|Overall Study|Physician Decision|1|||
25194340|NCT01459497|50371260|FG000|Overall Study|Hospitalization.|0|||
25194341|NCT01459497|50371261|FG001|Overall Study|Hospitalization.|3|||
25194342|NCT01459497|50371260|FG000|Overall Study|Disease progression.|0|||
25194343|NCT01459497|50371261|FG001|Overall Study|Disease progression.|1|||
25194344|NCT04575584|50371610|FG000|Overall Study|Death|6|||
25194345|NCT04575584|50371611|FG001|Overall Study|Death|4|||
25194346|NCT04575584|50371612|FG002|Overall Study|Death|6|||
25194347|NCT04575584|50371613|FG003|Overall Study|Death|2|||
25194348|NCT04575584|50371614|FG004|Overall Study|Death|0|||
25194349|NCT04575584|50371615|FG005|Overall Study|Death|0|||
25194350|NCT04575584|50371610|FG000|Overall Study|Lost to Follow-up|1|||
25194351|NCT04575584|50371611|FG001|Overall Study|Lost to Follow-up|1|||
25194352|NCT04575584|50371612|FG002|Overall Study|Lost to Follow-up|1|||
25194353|NCT04575584|50371613|FG003|Overall Study|Lost to Follow-up|1|||
25194354|NCT04575584|50371614|FG004|Overall Study|Lost to Follow-up|0|||
25194355|NCT04575584|50371615|FG005|Overall Study|Lost to Follow-up|0|||
25194356|NCT04575584|50371610|FG000|Overall Study|Physician Decision|0|||
25194357|NCT04575584|50371611|FG001|Overall Study|Physician Decision|1|||
25194358|NCT04575584|50371612|FG002|Overall Study|Physician Decision|1|||
25194359|NCT04575584|50371613|FG003|Overall Study|Physician Decision|1|||
25194360|NCT04575584|50371614|FG004|Overall Study|Physician Decision|0|||
25194361|NCT04575584|50371615|FG005|Overall Study|Physician Decision|0|||
25194362|NCT04575584|50371610|FG000|Overall Study|Withdrawal by Subject|7|||
25194363|NCT04575584|50371611|FG001|Overall Study|Withdrawal by Subject|9|||
25194364|NCT04575584|50371612|FG002|Overall Study|Withdrawal by Subject|5|||
25194365|NCT04575584|50371613|FG003|Overall Study|Withdrawal by Subject|3|||
25314893|NCT00650767|50630792|FG002|Overall Study|Adverse Event|10|||
25194366|NCT04575584|50371614|FG004|Overall Study|Withdrawal by Subject|0|||
25194367|NCT04575584|50371615|FG005|Overall Study|Withdrawal by Subject|0|||
25194368|NCT04575584|50371610|FG000|Overall Study|Not recorded|0|||
25194369|NCT04575584|50371611|FG001|Overall Study|Not recorded|0|||
25194370|NCT04575584|50371612|FG002|Overall Study|Not recorded|0|||
25194371|NCT04575584|50371613|FG003|Overall Study|Not recorded|1|||
25194372|NCT04575584|50371614|FG004|Overall Study|Not recorded|0|||
25194373|NCT04575584|50371615|FG005|Overall Study|Not recorded|0|||
25194374|NCT03721965|50371654|FG000|Overall Study|Death|1|||
25194375|NCT03721965|50371654|FG000|Overall Study|Study Terminated by Sponsor|1|||
25194376|NCT03873116|50371710|FG000|Overall Study|Study drug discontinuation due to rash|0|||
25194377|NCT03873116|50371711|FG001|Overall Study|Study drug discontinuation due to rash|0|||
25194378|NCT03873116|50371712|FG002|Overall Study|Study drug discontinuation due to rash|1|||
25194379|NCT02312258|50371998|FG000|Overall Study|Adverse Event|15|||
25194380|NCT02312258|50371999|FG001|Overall Study|Adverse Event|47|||
25194381|NCT02312258|50371998|FG000|Overall Study|Lost to Follow-up|0|||
25194382|NCT02312258|50371999|FG001|Overall Study|Lost to Follow-up|1|||
25194383|NCT02312258|50371998|FG000|Overall Study|Progressive Disease|174|||
25194384|NCT02312258|50371999|FG001|Overall Study|Progressive Disease|188|||
25194385|NCT02312258|50371998|FG000|Overall Study|Withdrawal by Subject|8|||
25194386|NCT02312258|50371999|FG001|Overall Study|Withdrawal by Subject|9|||
25194387|NCT02312258|50371998|FG000|Overall Study|Reason not Specified|11|||
25194388|NCT02312258|50371999|FG001|Overall Study|Reason not Specified|31|||
25194389|NCT02312258|50371998|FG000|Overall Study|Participants Ongoing Treatment|43|||
25194390|NCT02312258|50371999|FG001|Overall Study|Participants Ongoing Treatment|83|||
25194391|NCT03686384|50372169|FG000|Overall Study|Lack of Efficacy|4|||
25194392|NCT03686384|50372170|FG001|Overall Study|Lack of Efficacy|13|||
25194393|NCT03686384|50372169|FG000|Overall Study|Lost to Follow-up|3|||
25194394|NCT03686384|50372170|FG001|Overall Study|Lost to Follow-up|0|||
25194395|NCT03686384|50372169|FG000|Overall Study|Physician Decision|0|||
25194396|NCT03686384|50372170|FG001|Overall Study|Physician Decision|1|||
25194397|NCT03686384|50372169|FG000|Overall Study|Took prohibited medication|0|||
25194398|NCT03686384|50372170|FG001|Overall Study|Took prohibited medication|1|||
25194399|NCT00240331|50372242|FG000|Overall Study|Withdrawal by Subject|125|||
25194400|NCT00240331|50372243|FG001|Overall Study|Withdrawal by Subject|132|||
25194401|NCT00240331|50372242|FG000|Overall Study|Option selected by investigator|1|||
25194402|NCT00240331|50372243|FG001|Overall Study|Option selected by investigator|2|||
25194403|NCT00240097|50372249|FG000|Part I|Adverse Event|1|||
25194404|NCT00240097|50372249|FG000|Part I|Death|1|||
25194405|NCT00240097|50372249|FG000|Part I|histology|1|||
25194406|NCT00240097|50372249|FG000|Part I|unevaluable|1|||
25194407|NCT00240097|50372249|FG000|Part II|did not continue from Part I|23|||
25194408|NCT03620162|50372340|FG000|Overall Study|Physician Decision|4|||
25194409|NCT03620162|50372341|FG001|Overall Study|Physician Decision|0|||
25194410|NCT03620162|50372342|FG002|Overall Study|Physician Decision|1|||
25194411|NCT03620162|50372343|FG003|Overall Study|Physician Decision|0|||
25194412|NCT03620162|50372344|FG004|Overall Study|Physician Decision|2|||
25194413|NCT03620162|50372340|FG000|Overall Study|Lost to Follow-up|2|||
25194414|NCT03620162|50372341|FG001|Overall Study|Lost to Follow-up|6|||
25194415|NCT03620162|50372342|FG002|Overall Study|Lost to Follow-up|7|||
25194416|NCT03620162|50372343|FG003|Overall Study|Lost to Follow-up|3|||
25194417|NCT03620162|50372344|FG004|Overall Study|Lost to Follow-up|2|||
25194418|NCT03620162|50372340|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
25194419|NCT03620162|50372341|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
25194420|NCT03620162|50372342|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
25194421|NCT03620162|50372343|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
25194422|NCT03620162|50372344|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
25194423|NCT03084302|50372485|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
25194424|NCT03084302|50372485|FG000|Overall Study|No valid objective monitor data|6|||
25194425|NCT01279681|50372618|FG000|Overall Study|Disease Progression|9|||
25194426|NCT01279681|50372619|FG001|Overall Study|Disease Progression|6|||
25194427|NCT01279681|50372618|FG000|Overall Study|Withdrawal by Subject|3|||
25194428|NCT01279681|50372619|FG001|Overall Study|Withdrawal by Subject|4|||
25194429|NCT01279681|50372618|FG000|Overall Study|Adverse Event|2|||
25194430|NCT01279681|50372619|FG001|Overall Study|Adverse Event|3|||
25194431|NCT01279681|50372618|FG000|Overall Study|Death|0|||
25194432|NCT01279681|50372619|FG001|Overall Study|Death|1|||
25194433|NCT01279681|50372618|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
25194434|NCT01279681|50372619|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
25194435|NCT01279681|50372618|FG000|Overall Study|Physician Decision|1|||
25194436|NCT01279681|50372619|FG001|Overall Study|Physician Decision|0|||
25194437|NCT01279681|50372618|FG000|Overall Study|Other Reason|0|||
25194438|NCT01279681|50372619|FG001|Overall Study|Other Reason|2|||
25194439|NCT01279057|50372637|FG000|Overall Study|Adverse Event|1|||
25194440|NCT01279057|50372638|FG001|Overall Study|Adverse Event|0|||
25194441|NCT01279057|50372639|FG002|Overall Study|Adverse Event|1|||
25194442|NCT01279057|50372637|FG000|Overall Study|Insufficient therapeutic response|0|||
25194443|NCT01279057|50372638|FG001|Overall Study|Insufficient therapeutic response|0|||
25194444|NCT01279057|50372639|FG002|Overall Study|Insufficient therapeutic response|1|||
25194445|NCT01279057|50372637|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
25194446|NCT01279057|50372638|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
25194447|NCT01279057|50372639|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
25194448|NCT01279057|50372637|FG000|Overall Study|Withdrew consent|2|||
25194449|NCT01279057|50372638|FG001|Overall Study|Withdrew consent|0|||
25194450|NCT01279057|50372639|FG002|Overall Study|Withdrew consent|1|||
25194451|NCT01279057|50372637|FG000|Overall Study|Pregnancy|0|||
25194452|NCT01279057|50372638|FG001|Overall Study|Pregnancy|1|||
25194453|NCT01279057|50372639|FG002|Overall Study|Pregnancy|0|||
25194454|NCT01279057|50372637|FG000|Overall Study|Other|3|||
25194455|NCT01279057|50372638|FG001|Overall Study|Other|3|||
25194456|NCT01279057|50372639|FG002|Overall Study|Other|0|||
25194457|NCT02999633|50372647|FG000|Overall Study|Adverse Event|2|||
25194458|NCT02999633|50372647|FG000|Overall Study|Progressive disease|12|||
25194459|NCT01278745|50372749|FG000|Overall Study|Death|2|||
25194460|NCT01278745|50372750|FG001|Overall Study|Death|5|||
25194461|NCT01278745|50372751|FG002|Overall Study|Death|7|||
25194462|NCT01278745|50372752|FG003|Overall Study|Death|0|||
25194463|NCT01278745|50372749|FG000|Overall Study|Physician Decision|1|||
25194464|NCT01278745|50372750|FG001|Overall Study|Physician Decision|0|||
25194465|NCT01278745|50372751|FG002|Overall Study|Physician Decision|0|||
25194466|NCT01278745|50372752|FG003|Overall Study|Physician Decision|9|||
25194467|NCT01278745|50372749|FG000|Overall Study|Withdrawal by Subject|1|||
25194468|NCT01278745|50372750|FG001|Overall Study|Withdrawal by Subject|1|||
25194469|NCT01278745|50372751|FG002|Overall Study|Withdrawal by Subject|5|||
25194470|NCT01278745|50372752|FG003|Overall Study|Withdrawal by Subject|1|||
25194471|NCT01278745|50372749|FG000|Overall Study|Sponsor Decision|1|||
25194472|NCT01278745|50372750|FG001|Overall Study|Sponsor Decision|0|||
25194473|NCT01278745|50372751|FG002|Overall Study|Sponsor Decision|62|||
25194474|NCT01278745|50372752|FG003|Overall Study|Sponsor Decision|6|||
25194475|NCT01278745|50372749|FG000|Overall Study|Ineligible|0|||
25194476|NCT01278745|50372750|FG001|Overall Study|Ineligible|0|||
25194477|NCT01278745|50372751|FG002|Overall Study|Ineligible|42|||
25194478|NCT01278745|50372752|FG003|Overall Study|Ineligible|61|||
25194479|NCT01278745|50372749|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
25194480|NCT01278745|50372750|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
25194481|NCT01278745|50372751|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
25194482|NCT01278745|50372752|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
25194483|NCT03006926|50372762|FG000|Overall Study|Death|0|||
25194484|NCT03006926|50372763|FG001|Overall Study|Death|33|||
25194485|NCT03006926|50372762|FG000|Overall Study|Ongoing Survival Follow-up|0|||
25194486|NCT03006926|50372763|FG001|Overall Study|Ongoing Survival Follow-up|26|||
25194487|NCT03006926|50372762|FG000|Overall Study|Ongoing-on Treatment|0|||
25194488|NCT03006926|50372763|FG001|Overall Study|Ongoing-on Treatment|36|||
25194489|NCT03006926|50372762|FG000|Overall Study|Lost to Follow-up|0|||
25194490|NCT03006926|50372763|FG001|Overall Study|Lost to Follow-up|1|||
25194491|NCT03006926|50372762|FG000|Overall Study|Withdrawal by Subject|0|||
25194492|NCT03006926|50372763|FG001|Overall Study|Withdrawal by Subject|2|||
25194493|NCT01277887|50372825|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
25194494|NCT01277887|50372826|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
25194495|NCT01277887|50372825|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
25194496|NCT01277887|50372826|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
25194497|NCT01277887|50372825|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
25194498|NCT01277887|50372826|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
25194499|NCT01276327|50372840|FG000|Overall Study|Adverse Event|1|||
25194500|NCT01276327|50372841|FG001|Overall Study|Adverse Event|3|||
25194501|NCT01276327|50372840|FG000|Overall Study|Withdrawal by Subject|1|||
25194502|NCT01276327|50372841|FG001|Overall Study|Withdrawal by Subject|0|||
25194503|NCT00639002|50372963|FG000|Overall Study|Death|1|||
25194504|NCT00639002|50372963|FG000|Overall Study|Adverse Event|1|||
25194505|NCT00639002|50372963|FG000|Overall Study|Protocol Violation|1|||
25194506|NCT00639002|50372963|FG000|Overall Study|Disease progression|3|||
25194507|NCT00639002|50372963|FG000|Overall Study|Physician Decision|6|||
25194508|NCT00639002|50372963|FG000|Overall Study|Lack of Efficacy|1|||
25194509|NCT00638846|50372999|FG000|Overall Study|Adverse Event|0|||
25194510|NCT00638846|50373000|FG001|Overall Study|Adverse Event|1|||
25194511|NCT00638846|50372999|FG000|Overall Study|Lost to Follow-up|3|||
25194512|NCT00638846|50373000|FG001|Overall Study|Lost to Follow-up|2|||
25194513|NCT00638846|50372999|FG000|Overall Study|lens issue|1|||
25194514|NCT00638846|50373000|FG001|Overall Study|lens issue|3|||
25194515|NCT00638456|50373008|FG000|Overall Study|Withdrawal by Subject|6|||
25194516|NCT00638456|50373009|FG001|Overall Study|Withdrawal by Subject|2|||
25194517|NCT00638378|50373038|FG000|Overall Study|Death|2|||
25194518|NCT00638378|50373038|FG000|Overall Study|Adverse Event|1|||
25194519|NCT00638378|50373038|FG000|Overall Study|Disease progression|15|||
25194520|NCT00638378|50373038|FG000|Overall Study|Physician Decision|4|||
25194521|NCT03807349|50373215|FG000|Overall Study|Early Study Termination|9|||
25194522|NCT03802825|50373225|FG000|Overall Study|Lost to follow-up for intervention|12|||
25194523|NCT03802825|50373226|FG001|Overall Study|Lost to follow-up for intervention|3|||
25194524|NCT03802825|50373225|FG000|Overall Study|Received only 1 component of intervention|0|||
25194525|NCT03802825|50373226|FG001|Overall Study|Received only 1 component of intervention|13|||
25194526|NCT03808909|50373245|FG000|Overall Study|Lost to Follow-up|3|||
25194527|NCT03808909|50373246|FG001|Overall Study|Lost to Follow-up|0|||
25194528|NCT03802513|50373267|FG000|Overall Study|Lost to Follow-up|1|||
25194529|NCT01276223|50373458|FG000|Overall Study|Adverse Event|7|||
25194530|NCT01276223|50373459|FG001|Overall Study|Adverse Event|4|||
25194531|NCT01276223|50373460|FG002|Overall Study|Adverse Event|1|||
25194532|NCT01276223|50373458|FG000|Overall Study|Lost to Follow-up|0|||
25194533|NCT01276223|50373459|FG001|Overall Study|Lost to Follow-up|0|||
25194534|NCT01276223|50373460|FG002|Overall Study|Lost to Follow-up|1|||
25194535|NCT01276223|50373458|FG000|Overall Study|Other|0|||
25194536|NCT01276223|50373459|FG001|Overall Study|Other|0|||
25194537|NCT01276223|50373460|FG002|Overall Study|Other|1|||
25194538|NCT01276223|50373458|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
25194539|NCT01276223|50373459|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
25194540|NCT01276223|50373460|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
25194541|NCT01276223|50373458|FG000|Overall Study|Protocol Violation|1|||
25194542|NCT01276223|50373459|FG001|Overall Study|Protocol Violation|0|||
25194543|NCT01276223|50373460|FG002|Overall Study|Protocol Violation|0|||
25194544|NCT01275833|50373469|FG000|Overall Study|Study terminated|1|||
25194545|NCT01275833|50373470|FG001|Overall Study|Study terminated|1|||
25194546|NCT01275755|50373478|FG000|Double-blind Treatment Period|Adverse Event|0|||
25194547|NCT01275755|50373479|FG001|Double-blind Treatment Period|Adverse Event|2|||
25194548|NCT01275755|50373478|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
25194549|NCT01275755|50373479|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
25194550|NCT01275755|50373478|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
25194551|NCT01275755|50373479|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
25194552|NCT01275755|50373478|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
25194553|NCT01275755|50373479|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
25194554|NCT01275131|50373510|FG000|Period 1|Withdrawal by Subject|1|||
25194555|NCT01275131|50373511|FG001|Period 1|Withdrawal by Subject|0|||
25194556|NCT01275131|50373512|FG002|Period 1|Withdrawal by Subject|3|||
25194557|NCT01275131|50373513|FG003|Period 1|Withdrawal by Subject|2|||
25194558|NCT01275131|50373510|FG000|Period 1|Physician Decision|1|||
25194559|NCT01275131|50373511|FG001|Period 1|Physician Decision|0|||
25194560|NCT01275131|50373512|FG002|Period 1|Physician Decision|0|||
25194561|NCT01275131|50373513|FG003|Period 1|Physician Decision|0|||
25194562|NCT01275131|50373510|FG000|Period 2 (Crossover)|Adverse Event|0|||
25194563|NCT01275131|50373511|FG001|Period 2 (Crossover)|Adverse Event|1|||
25194564|NCT01275131|50373512|FG002|Period 2 (Crossover)|Adverse Event|0|||
25194565|NCT01275131|50373513|FG003|Period 2 (Crossover)|Adverse Event|0|||
25194566|NCT01275131|50373510|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
25194567|NCT01275131|50373511|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
25194568|NCT01275131|50373512|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
25194569|NCT01275131|50373513|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
25194570|NCT01274429|50373542|FG000|Overall Study|Study closed do to lack of funding|5|||
25194571|NCT01273883|50373546|FG000|First Intervention|Adverse Event|2|||
25194572|NCT01273883|50373547|FG001|First Intervention|Adverse Event|1|||
25194573|NCT01273883|50373546|FG000|Second Intervention|Lost to Follow-up|1|||
25194574|NCT01273883|50373547|FG001|Second Intervention|Lost to Follow-up|1|||
25194575|NCT01273883|50373546|FG000|Second Intervention|Lack of Efficacy|1|||
25194576|NCT01273883|50373547|FG001|Second Intervention|Lack of Efficacy|0|||
25194577|NCT01273805|50373555|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
24976160|NCT00098787|50065092|FG000|Overall Study|Never started treatment|3|||
24976161|NCT00098787|50065093|FG001|Overall Study|Never started treatment|2|||
24976162|NCT00098787|50065094|FG002|Overall Study|Never started treatment|1|||
24976163|NCT00098787|50065092|FG000|Overall Study|Ineligible|9|||
24976164|NCT00098787|50065093|FG001|Overall Study|Ineligible|7|||
25194578|NCT01273805|50373556|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
25194579|NCT01273181|50373566|FG000|Phase I, Dose 1|Study termination|1|||
25194580|NCT01273181|50373567|FG001|Phase I, Dose 1|Study termination|0|||
25194581|NCT01273181|50373568|FG002|Phase I, Dose 1|Study termination|0|||
25194582|NCT01273181|50373569|FG003|Phase I, Dose 1|Study termination|0|||
25194583|NCT01273181|50373566|FG000|Phase I, Dose 2|Death during treatment|0|||
25194584|NCT01273181|50373567|FG001|Phase I, Dose 2|Death during treatment|1|||
24976165|NCT00098787|50065094|FG002|Overall Study|Ineligible|3|||
25194585|NCT01273181|50373568|FG002|Phase I, Dose 2|Death during treatment|0|||
25194586|NCT01273181|50373569|FG003|Phase I, Dose 2|Death during treatment|0|||
25194587|NCT01273181|50373566|FG000|Phase 2, Dose 1|Study termination|0|||
25194588|NCT01273181|50373567|FG001|Phase 2, Dose 1|Study termination|0|||
25194589|NCT01273181|50373568|FG002|Phase 2, Dose 1|Study termination|1|||
25194590|NCT01273181|50373569|FG003|Phase 2, Dose 1|Study termination|0|||
25194591|NCT01273181|50373566|FG000|Phase 2, Dose 2|Death during treatment|0|||
25194592|NCT01273181|50373567|FG001|Phase 2, Dose 2|Death during treatment|0|||
25194593|NCT01273181|50373568|FG002|Phase 2, Dose 2|Death during treatment|0|||
25194594|NCT01273181|50373569|FG003|Phase 2, Dose 2|Death during treatment|1|||
25194595|NCT01272947|50373585|FG000|Overall Study|Abnormal Laboratory Value|2|||
25194596|NCT01272947|50373586|FG001|Overall Study|Abnormal Laboratory Value|2|||
25194597|NCT01279343|50373594|FG000|Overall Study|Did not receive treatment|2|||
25194598|NCT01279343|50373595|FG001|Overall Study|Did not receive treatment|6|||
25194599|NCT01278797|50373601|FG000|Period 1|Adverse Event|0|||
25194600|NCT01278797|50373602|FG001|Period 1|Adverse Event|1|||
25194601|NCT01278797|50373601|FG000|Period 1|Protocol Violation|1|||
25194602|NCT01278797|50373602|FG001|Period 1|Protocol Violation|0|||
25194603|NCT01272869|50373610|FG000|Period 2 (14 Days)|Adverse Event|1|||
25194604|NCT01272869|50373611|FG001|Period 2 (14 Days)|Adverse Event|0|||
25194605|NCT01272635|50373619|FG000|Overall Study|Lost to Follow-up|31|||
25194606|NCT01272635|50373620|FG001|Overall Study|Lost to Follow-up|20|||
25194607|NCT01272635|50373621|FG002|Overall Study|Lost to Follow-up|31|||
25194608|NCT01272635|50373622|FG003|Overall Study|Lost to Follow-up|23|||
25194609|NCT01272011|50373633|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
25194610|NCT01272011|50373634|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
25194611|NCT01272011|50373635|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
25194612|NCT01270841|50373656|FG000|Overall Study|Adverse Event|0|||
25194613|NCT01270841|50373657|FG001|Overall Study|Adverse Event|1|||
25194614|NCT01270841|50373658|FG002|Overall Study|Adverse Event|0|||
25194615|NCT01270841|50373659|FG003|Overall Study|Adverse Event|3|||
25194616|NCT01270841|50373656|FG000|Overall Study|Withdrawal by Subject|3|||
25194617|NCT01270841|50373657|FG001|Overall Study|Withdrawal by Subject|2|||
25194618|NCT01270841|50373658|FG002|Overall Study|Withdrawal by Subject|3|||
25194619|NCT01270841|50373659|FG003|Overall Study|Withdrawal by Subject|3|||
25194620|NCT01270841|50373656|FG000|Overall Study|Lost to Follow-up|3|||
25194621|NCT01270841|50373657|FG001|Overall Study|Lost to Follow-up|1|||
25194622|NCT01270841|50373658|FG002|Overall Study|Lost to Follow-up|4|||
25194623|NCT01270841|50373659|FG003|Overall Study|Lost to Follow-up|2|||
25194624|NCT01270841|50373656|FG000|Overall Study|Physician Decision|0|||
25194625|NCT01270841|50373657|FG001|Overall Study|Physician Decision|1|||
25194626|NCT01270841|50373658|FG002|Overall Study|Physician Decision|0|||
25194627|NCT01270841|50373659|FG003|Overall Study|Physician Decision|0|||
25194628|NCT01270841|50373656|FG000|Overall Study|Did not qualify|6|||
25194629|NCT01270841|50373657|FG001|Overall Study|Did not qualify|3|||
25194630|NCT01270841|50373658|FG002|Overall Study|Did not qualify|4|||
25194631|NCT01270841|50373659|FG003|Overall Study|Did not qualify|5|||
25194632|NCT01270841|50373656|FG000|Overall Study|Protocol Violation|1|||
25194633|NCT01270841|50373657|FG001|Overall Study|Protocol Violation|5|||
25194634|NCT01270841|50373658|FG002|Overall Study|Protocol Violation|0|||
25194635|NCT01270841|50373659|FG003|Overall Study|Protocol Violation|0|||
25194636|NCT01270841|50373656|FG000|Overall Study|Enrolled in error|0|||
25194637|NCT01270841|50373657|FG001|Overall Study|Enrolled in error|1|||
25194638|NCT01270841|50373658|FG002|Overall Study|Enrolled in error|0|||
25194639|NCT01270841|50373659|FG003|Overall Study|Enrolled in error|0|||
25194640|NCT01270139|50373672|FG000|Overall Study|Adverse Event|8|||
25194641|NCT01270139|50373673|FG001|Overall Study|Adverse Event|17|||
25194642|NCT01270139|50373674|FG002|Overall Study|Adverse Event|18|||
25194643|NCT01270139|50373672|FG000|Overall Study|Lost to Follow-up|10|||
25194644|NCT01270139|50373673|FG001|Overall Study|Lost to Follow-up|9|||
25194645|NCT01270139|50373674|FG002|Overall Study|Lost to Follow-up|2|||
25194646|NCT01278407|50373692|FG000|Confirmatory Phase|Adverse Event|5|||
25194647|NCT01278407|50373693|FG001|Confirmatory Phase|Adverse Event|10|||
25194648|NCT01278407|50373694|FG002|Confirmatory Phase|Adverse Event|1|||
25194649|NCT01278407|50373695|FG003|Confirmatory Phase|Adverse Event|0|||
25194650|NCT01278407|50373696|FG004|Confirmatory Phase|Adverse Event|0|||
25194651|NCT01278407|50373692|FG000|Confirmatory Phase|Participant's Choice|3|||
25194652|NCT01278407|50373693|FG001|Confirmatory Phase|Participant's Choice|5|||
25194653|NCT01278407|50373694|FG002|Confirmatory Phase|Participant's Choice|3|||
25314894|NCT00650767|50630793|FG003|Overall Study|Adverse Event|8|||
25314895|NCT00650767|50630790|FG000|Overall Study|Death|1|||
25076991|NCT02500706|50184739|FG000|Overall Study|Unclassified|0|||
25194654|NCT01278407|50373695|FG003|Confirmatory Phase|Participant's Choice|0|||
25194655|NCT01278407|50373696|FG004|Confirmatory Phase|Participant's Choice|0|||
25194656|NCT01278407|50373692|FG000|Confirmatory Phase|Other|1|||
25194657|NCT01278407|50373693|FG001|Confirmatory Phase|Other|1|||
25194658|NCT01278407|50373694|FG002|Confirmatory Phase|Other|2|||
25194659|NCT01278407|50373695|FG003|Confirmatory Phase|Other|0|||
25314896|NCT00650767|50630791|FG001|Overall Study|Death|0|||
25194660|NCT01278407|50373696|FG004|Confirmatory Phase|Other|0|||
25194661|NCT01278407|50373692|FG000|Extension Phase|Adverse Event|0|||
25194662|NCT01278407|50373693|FG001|Extension Phase|Adverse Event|0|||
25194663|NCT01278407|50373694|FG002|Extension Phase|Adverse Event|0|||
25194664|NCT01278407|50373695|FG003|Extension Phase|Adverse Event|7|||
25194665|NCT01278407|50373696|FG004|Extension Phase|Adverse Event|16|||
25194666|NCT01278407|50373692|FG000|Extension Phase|Participant's Choice|0|||
25194667|NCT01278407|50373693|FG001|Extension Phase|Participant's Choice|0|||
25194668|NCT01278407|50373694|FG002|Extension Phase|Participant's Choice|0|||
25194669|NCT01278407|50373695|FG003|Extension Phase|Participant's Choice|4|||
25194670|NCT01278407|50373696|FG004|Extension Phase|Participant's Choice|11|||
25194671|NCT01278407|50373692|FG000|Extension Phase|Other|0|||
25194672|NCT01278407|50373693|FG001|Extension Phase|Other|0|||
25194673|NCT01278407|50373694|FG002|Extension Phase|Other|0|||
25194674|NCT01278407|50373695|FG003|Extension Phase|Other|1|||
25194675|NCT01278407|50373696|FG004|Extension Phase|Other|3|||
25194676|NCT01278173|50373706|FG000|Overall Study|Lack of Efficacy|13|||
25194677|NCT01278173|50373706|FG000|Overall Study|Adverse Event|8|||
25194678|NCT01278173|50373706|FG000|Overall Study|Administrative or other reason|4|||
25194679|NCT01278173|50373706|FG000|Overall Study|Protocol Violation|1|||
25194680|NCT01278173|50373706|FG000|Overall Study|Withdrawal by Subject|1|||
24976166|NCT00098787|50065092|FG000|Overall Study|Disease progression|28|||
24976167|NCT00098787|50065093|FG001|Overall Study|Disease progression|17|||
24976168|NCT00098787|50065094|FG002|Overall Study|Disease progression|23|||
24976169|NCT00098787|50065092|FG000|Overall Study|Adverse Event|8|||
24976170|NCT00098787|50065093|FG001|Overall Study|Adverse Event|17|||
24976171|NCT00098787|50065094|FG002|Overall Study|Adverse Event|8|||
24976172|NCT00098787|50065092|FG000|Overall Study|Death|6|||
24976173|NCT00098787|50065093|FG001|Overall Study|Death|1|||
24976174|NCT00098787|50065094|FG002|Overall Study|Death|0|||
24976175|NCT00098787|50065092|FG000|Overall Study|Withdrawal by Subject|4|||
24976176|NCT00098787|50065093|FG001|Overall Study|Withdrawal by Subject|12|||
24976177|NCT00098787|50065094|FG002|Overall Study|Withdrawal by Subject|6|||
24976178|NCT00098787|50065092|FG000|Overall Study|Alternative therapy|8|||
24976179|NCT00098787|50065093|FG001|Overall Study|Alternative therapy|13|||
24976180|NCT00098787|50065094|FG002|Overall Study|Alternative therapy|13|||
24976181|NCT00098787|50065092|FG000|Overall Study|Other|7|||
24976182|NCT00098787|50065093|FG001|Overall Study|Other|6|||
24976183|NCT00098787|50065094|FG002|Overall Study|Other|9|||
24976184|NCT02954458|50065106|FG000|Overall Study|Adverse Event|0|||
24976185|NCT02954458|50065107|FG001|Overall Study|Adverse Event|0|||
24976186|NCT02954458|50065108|FG002|Overall Study|Adverse Event|0|||
24976187|NCT02954458|50065109|FG003|Overall Study|Adverse Event|1|||
24976188|NCT02954458|50065106|FG000|Overall Study|Withdrawal by Subject|0|||
24976189|NCT02954458|50065107|FG001|Overall Study|Withdrawal by Subject|0|||
24976190|NCT02954458|50065108|FG002|Overall Study|Withdrawal by Subject|0|||
24976191|NCT02954458|50065109|FG003|Overall Study|Withdrawal by Subject|1|||
24976192|NCT02954458|50065106|FG000|Overall Study|Physician Decision|0|||
24976193|NCT02954458|50065107|FG001|Overall Study|Physician Decision|0|||
24976194|NCT02954458|50065108|FG002|Overall Study|Physician Decision|1|||
24976195|NCT02954458|50065109|FG003|Overall Study|Physician Decision|1|||
25194681|NCT01277861|50373750|FG000|Overall Study|Physician Decision|2|||
25194682|NCT01277861|50373751|FG001|Overall Study|Physician Decision|2|||
25194683|NCT01277549|50373778|FG000|Overall Study|Failed to meet eligibility criteria|13|||
25194684|NCT01277549|50373779|FG001|Overall Study|Failed to meet eligibility criteria|9|||
25194685|NCT01277549|50373778|FG000|Overall Study|Withdrawal by Subject|1|||
25194686|NCT01277549|50373779|FG001|Overall Study|Withdrawal by Subject|3|||
25194687|NCT01277549|50373778|FG000|Overall Study|Protocol Violation|10|||
25194688|NCT01277549|50373779|FG001|Overall Study|Protocol Violation|1|||
25194689|NCT01277549|50373778|FG000|Overall Study|Physician Decision|2|||
25194690|NCT01277549|50373779|FG001|Overall Study|Physician Decision|1|||
25194691|NCT01276847|50373791|FG000|Overall Study|Withdrawal by Subject|1|||
25076992|NCT02500706|50184740|FG001|Overall Study|Unclassified|0|||
25194692|NCT01276847|50373792|FG001|Overall Study|Withdrawal by Subject|0|||
25194693|NCT01276847|50373793|FG002|Overall Study|Withdrawal by Subject|0|||
25194694|NCT01276457|50373825|FG000|Core Study|Adverse Event|6|||
25194695|NCT01276457|50373826|FG001|Core Study|Adverse Event|3|||
24976196|NCT02954458|50065106|FG000|Overall Study|Lost to Follow-up|1|||
25194696|NCT01276457|50373825|FG000|Core Study|Lost to Follow-up|1|||
25194697|NCT01276457|50373826|FG001|Core Study|Lost to Follow-up|2|||
24976197|NCT02954458|50065107|FG001|Overall Study|Lost to Follow-up|0|||
24976198|NCT02954458|50065108|FG002|Overall Study|Lost to Follow-up|0|||
24976199|NCT02954458|50065109|FG003|Overall Study|Lost to Follow-up|1|||
24976200|NCT02954458|50065106|FG000|Overall Study|Death|0|||
24976201|NCT02954458|50065107|FG001|Overall Study|Death|0|||
24976202|NCT02954458|50065108|FG002|Overall Study|Death|0|||
24976203|NCT02954458|50065109|FG003|Overall Study|Death|1|||
24976204|NCT02954458|50065106|FG000|Overall Study|Other|0|||
24976205|NCT02954458|50065107|FG001|Overall Study|Other|0|||
25194698|NCT01276457|50373825|FG000|Core Study|Administrative problems|1|||
25194699|NCT01276457|50373826|FG001|Core Study|Administrative problems|1|||
25194700|NCT01276457|50373825|FG000|Core Study|Death|2|||
25194701|NCT01276457|50373826|FG001|Core Study|Death|2|||
25194702|NCT01276457|50373825|FG000|Core Study|Lack of Efficacy|3|||
25194703|NCT01276457|50373826|FG001|Core Study|Lack of Efficacy|12|||
25194704|NCT01276457|50373825|FG000|Extension Study|Lost to Follow-up|3|||
25194705|NCT01276457|50373826|FG001|Extension Study|Lost to Follow-up|0|||
25194706|NCT01276457|50373825|FG000|Extension Study|Death|0|||
25194707|NCT01276457|50373826|FG001|Extension Study|Death|1|||
25194708|NCT01276457|50373825|FG000|Extension Study|Lack of Efficacy|3|||
25194709|NCT01276457|50373826|FG001|Extension Study|Lack of Efficacy|1|||
25194710|NCT01276379|50373916|FG000|Overall Study|Screening failure|40|||
25194711|NCT03809663|50374212|FG000|Overall Study|Decision by sponsor|24|||
25194712|NCT03809663|50374213|FG001|Overall Study|Decision by sponsor|18|||
25194713|NCT03809663|50374214|FG002|Overall Study|Decision by sponsor|20|||
25194714|NCT03809663|50374215|FG003|Overall Study|Decision by sponsor|20|||
25194715|NCT03809663|50374216|FG004|Overall Study|Decision by sponsor|0|||
25194716|NCT03809663|50374217|FG005|Overall Study|Decision by sponsor|0|||
25194717|NCT03809663|50374212|FG000|Overall Study|Withdrawal by Subject|26|||
25194718|NCT03809663|50374213|FG001|Overall Study|Withdrawal by Subject|22|||
25194719|NCT03809663|50374214|FG002|Overall Study|Withdrawal by Subject|27|||
25194720|NCT03809663|50374215|FG003|Overall Study|Withdrawal by Subject|26|||
25194721|NCT03809663|50374216|FG004|Overall Study|Withdrawal by Subject|0|||
25194722|NCT03809663|50374217|FG005|Overall Study|Withdrawal by Subject|0|||
25194723|NCT03809663|50374212|FG000|Overall Study|Lost to Follow-up|1|||
25194724|NCT03809663|50374213|FG001|Overall Study|Lost to Follow-up|4|||
25194725|NCT03809663|50374214|FG002|Overall Study|Lost to Follow-up|1|||
25194726|NCT03809663|50374215|FG003|Overall Study|Lost to Follow-up|1|||
25194727|NCT03809663|50374216|FG004|Overall Study|Lost to Follow-up|0|||
25194728|NCT03809663|50374217|FG005|Overall Study|Lost to Follow-up|0|||
25194729|NCT00249821|50374279|FG000|Overall Study|Technical problem|0|||
25194730|NCT00249821|50374280|FG001|Overall Study|Technical problem|1|||
25194731|NCT00248651|50374355|FG000|Overall Study|Withdrawal by Subject|28|||
25194732|NCT00248651|50374356|FG001|Overall Study|Withdrawal by Subject|40|||
25194733|NCT00248651|50374357|FG002|Overall Study|Withdrawal by Subject|32|||
25194734|NCT00248495|50374394|FG000|Overall Study|Withdrawal by Subject|1|||
25194735|NCT03802565|50374491|FG000|Overall Study|Adverse Event|0|||
25194736|NCT03802565|50374492|FG001|Overall Study|Adverse Event|1|||
24976206|NCT02954458|50065108|FG002|Overall Study|Other|0|||
24976207|NCT02954458|50065109|FG003|Overall Study|Other|7|||
24976208|NCT03500692|50065123|FG000|Overall Study|Death|76|||
24976209|NCT03500692|50065123|FG000|Overall Study|Missed visit|30|||
24976210|NCT03500692|50065123|FG000|Overall Study|Termination Reasons|3|||
24976211|NCT03500224|50065127|FG000|Overall Study|Withdrawal by Subject|2|||
24976212|NCT03495154|50065131|FG000|Overall Study|Screen Failures Pre-Operatively|3|||
24976213|NCT03495154|50065131|FG000|Overall Study|Withdrawn Prior to Surgery|11|||
24976214|NCT03495154|50065131|FG000|Overall Study|Screen Failures During Surgery|6|||
24976215|NCT03495154|50065131|FG000|Overall Study|Death|2|||
24976216|NCT03495154|50065131|FG000|Overall Study|Lost to Follow-up|6|||
24976217|NCT03495154|50065131|FG000|Overall Study|Protocol Violation|1|||
24976218|NCT03495154|50065131|FG000|Overall Study|Withdrawal by Subject|1|||
24976219|NCT00077649|50065139|FG000|Overall Study|Adverse Event|5|||
24976220|NCT00077649|50065140|FG001|Overall Study|Adverse Event|1|||
24976221|NCT00077649|50065141|FG002|Overall Study|Adverse Event|7|||
24976222|NCT00077649|50065142|FG003|Overall Study|Adverse Event|9|||
24976223|NCT00077649|50065139|FG000|Overall Study|Lack of Efficacy|5|||
25194737|NCT03802565|50374493|FG002|Overall Study|Adverse Event|2|||
25194738|NCT03802565|50374494|FG003|Overall Study|Adverse Event|1|||
25194739|NCT03802565|50374495|FG004|Overall Study|Adverse Event|1|||
25194740|NCT03802565|50374491|FG000|Overall Study|Withdrawal by Subject|2|||
25194741|NCT03802565|50374492|FG001|Overall Study|Withdrawal by Subject|2|||
25194742|NCT03802565|50374493|FG002|Overall Study|Withdrawal by Subject|2|||
25314897|NCT00650767|50630792|FG002|Overall Study|Death|0|||
25314898|NCT00650767|50630793|FG003|Overall Study|Death|0|||
25194743|NCT03802565|50374494|FG003|Overall Study|Withdrawal by Subject|0|||
25194744|NCT03802565|50374495|FG004|Overall Study|Withdrawal by Subject|1|||
25194745|NCT03802565|50374491|FG000|Overall Study|Protocol Violation|2|||
25194746|NCT03802565|50374492|FG001|Overall Study|Protocol Violation|1|||
25194747|NCT03802565|50374493|FG002|Overall Study|Protocol Violation|4|||
25194748|NCT03802565|50374494|FG003|Overall Study|Protocol Violation|5|||
24976224|NCT00077649|50065140|FG001|Overall Study|Lack of Efficacy|3|||
24976225|NCT00077649|50065141|FG002|Overall Study|Lack of Efficacy|3|||
24976226|NCT00077649|50065142|FG003|Overall Study|Lack of Efficacy|2|||
25194749|NCT03802565|50374495|FG004|Overall Study|Protocol Violation|1|||
25194750|NCT03802565|50374491|FG000|Overall Study|Lost to Follow-up|0|||
25194751|NCT03802565|50374492|FG001|Overall Study|Lost to Follow-up|0|||
25194752|NCT03802565|50374493|FG002|Overall Study|Lost to Follow-up|1|||
25194753|NCT03802565|50374494|FG003|Overall Study|Lost to Follow-up|0|||
25194754|NCT03802565|50374495|FG004|Overall Study|Lost to Follow-up|0|||
25194755|NCT03802565|50374491|FG000|Overall Study|Subjects Related to Each Other|1|||
25194756|NCT03802565|50374492|FG001|Overall Study|Subjects Related to Each Other|0|||
25194757|NCT03802565|50374493|FG002|Overall Study|Subjects Related to Each Other|0|||
25194758|NCT03802565|50374494|FG003|Overall Study|Subjects Related to Each Other|2|||
25194759|NCT03802565|50374495|FG004|Overall Study|Subjects Related to Each Other|1|||
25194760|NCT03802565|50374491|FG000|Overall Study|Elevated Enzymes|0|||
25194761|NCT03802565|50374492|FG001|Overall Study|Elevated Enzymes|0|||
25194762|NCT03802565|50374493|FG002|Overall Study|Elevated Enzymes|0|||
25194763|NCT03802565|50374494|FG003|Overall Study|Elevated Enzymes|0|||
25194764|NCT03802565|50374495|FG004|Overall Study|Elevated Enzymes|2|||
25194765|NCT00245765|50374539|FG000|Overall Study|Adverse Event|1|||
25194766|NCT00245765|50374540|FG001|Overall Study|Adverse Event|1|||
25194767|NCT00245765|50374541|FG002|Overall Study|Adverse Event|0|||
25194768|NCT00245765|50374539|FG000|Overall Study|Lack of Efficacy|14|||
25194769|NCT00245765|50374540|FG001|Overall Study|Lack of Efficacy|7|||
25194770|NCT00245765|50374541|FG002|Overall Study|Lack of Efficacy|0|||
25194771|NCT00245765|50374539|FG000|Overall Study|Lost to Follow-up|1|||
25194772|NCT00245765|50374540|FG001|Overall Study|Lost to Follow-up|2|||
25194773|NCT00245765|50374541|FG002|Overall Study|Lost to Follow-up|0|||
25194774|NCT00245765|50374539|FG000|Overall Study|Withdrawal by Subject|1|||
25194775|NCT00245765|50374540|FG001|Overall Study|Withdrawal by Subject|0|||
25194776|NCT00245765|50374541|FG002|Overall Study|Withdrawal by Subject|3|||
25194777|NCT00245765|50374539|FG000|Overall Study|Other reason|2|||
25194778|NCT00245765|50374540|FG001|Overall Study|Other reason|0|||
25194779|NCT00245765|50374541|FG002|Overall Study|Other reason|1|||
25194780|NCT00245765|50374539|FG000|Overall Study|Other|13|||
25194781|NCT00245765|50374540|FG001|Overall Study|Other|4|||
25194782|NCT00245765|50374541|FG002|Overall Study|Other|4|||
25194783|NCT00245063|50374613|FG000|Overall Study|Adverse Event|6|||
25194784|NCT00245063|50374614|FG001|Overall Study|Adverse Event|5|||
25194785|NCT00245063|50374613|FG000|Overall Study|Death|1|||
25194786|NCT00245063|50374614|FG001|Overall Study|Death|0|||
25194787|NCT04329091|50374679|FG000|Overall Study|Physician Decision|5|||
25194788|NCT00244751|50374686|FG000|Overall Study|Adverse Event|7|||
25194789|NCT00244751|50374687|FG001|Overall Study|Adverse Event|7|||
25194790|NCT00244751|50374688|FG002|Overall Study|Adverse Event|5|||
25194791|NCT00244751|50374686|FG000|Overall Study|Lost to Follow-up|0|||
25194792|NCT00244751|50374687|FG001|Overall Study|Lost to Follow-up|1|||
25194793|NCT00244751|50374688|FG002|Overall Study|Lost to Follow-up|0|||
25194794|NCT00244751|50374686|FG000|Overall Study|Protocol Violation|1|||
25194795|NCT00244751|50374687|FG001|Overall Study|Protocol Violation|0|||
25194796|NCT00244751|50374688|FG002|Overall Study|Protocol Violation|1|||
25194797|NCT00244751|50374686|FG000|Overall Study|Withdrawal by Subject|7|||
25194798|NCT00244751|50374687|FG001|Overall Study|Withdrawal by Subject|5|||
25194799|NCT00244751|50374688|FG002|Overall Study|Withdrawal by Subject|3|||
25194800|NCT00244751|50374686|FG000|Overall Study|Elevated liver enzymes|1|||
25194801|NCT00244751|50374687|FG001|Overall Study|Elevated liver enzymes|0|||
25194802|NCT00244751|50374688|FG002|Overall Study|Elevated liver enzymes|0|||
25194803|NCT00244751|50374686|FG000|Overall Study|Lack of compliance with protocol|0|||
25194804|NCT00244751|50374687|FG001|Overall Study|Lack of compliance with protocol|1|||
25194805|NCT00244751|50374688|FG002|Overall Study|Lack of compliance with protocol|0|||
25194806|NCT00244751|50374686|FG000|Overall Study|Safety reasons|0|||
25194807|NCT00244751|50374687|FG001|Overall Study|Safety reasons|1|||
25194808|NCT00244751|50374688|FG002|Overall Study|Safety reasons|0|||
25170620|NCT01784861|50306067|FG005|Overall Study|Withdrawal by Subject|0|||
25170621|NCT01784861|50306062|FG000|Overall Study|Physician Decision|0|||
25170622|NCT01784861|50306063|FG001|Overall Study|Physician Decision|0|||
25170623|NCT01784861|50306064|FG002|Overall Study|Physician Decision|0|||
25170624|NCT01784861|50306065|FG003|Overall Study|Physician Decision|2|||
25170625|NCT01784861|50306066|FG004|Overall Study|Physician Decision|0|||
25170626|NCT01784861|50306067|FG005|Overall Study|Physician Decision|1|||
25170627|NCT02727192|50306141|FG000|Overall Study|Lost to Follow-up|1|||
25194809|NCT00244751|50374686|FG000|Overall Study|Participant randomized by mistake|0|||
25194810|NCT00244751|50374687|FG001|Overall Study|Participant randomized by mistake|0|||
25194811|NCT00244751|50374688|FG002|Overall Study|Participant randomized by mistake|1|||
25194812|NCT00243659|50374730|FG000|Overall Study|Withdrawal by Subject|1|||
25194813|NCT00243659|50374731|FG001|Overall Study|Withdrawal by Subject|1|||
25194814|NCT00243659|50374730|FG000|Overall Study|Protocol Violation|1|||
25194815|NCT00243659|50374731|FG001|Overall Study|Protocol Violation|2|||
25194816|NCT00243347|50374746|FG000|Overall Study|Lack of Efficacy|4|||
25170628|NCT02727192|50306142|FG001|Overall Study|Lost to Follow-up|0|||
25194817|NCT00243347|50374746|FG000|Overall Study|Adverse Event|2|||
25194818|NCT00243347|50374746|FG000|Overall Study|Death|1|||
25194819|NCT00243347|50374746|FG000|Overall Study|Withdrawal by Subject|5|||
25194820|NCT00243347|50374746|FG000|Overall Study|Condition worsened|7|||
25194821|NCT00243269|50374754|FG000|Overall Study|Protocol Violation|2|||
25194822|NCT00243269|50374755|FG001|Overall Study|Protocol Violation|1|||
25194823|NCT00243269|50374756|FG002|Overall Study|Protocol Violation|0|||
25194824|NCT00243269|50374757|FG003|Overall Study|Protocol Violation|1|||
25194825|NCT00243269|50374754|FG000|Overall Study|Lost to Follow-up|1|||
25194826|NCT00243269|50374755|FG001|Overall Study|Lost to Follow-up|0|||
25194827|NCT00243269|50374756|FG002|Overall Study|Lost to Follow-up|1|||
25194828|NCT00243269|50374757|FG003|Overall Study|Lost to Follow-up|3|||
25194829|NCT00242567|50375985|FG000|Overall Study|Adverse Event|70|||
25194830|NCT00242567|50375986|FG001|Overall Study|Adverse Event|43|||
25194831|NCT00242567|50375985|FG000|Overall Study|Disease Progression|17|||
25194832|NCT00242567|50375986|FG001|Overall Study|Disease Progression|22|||
25194833|NCT00242567|50375985|FG000|Overall Study|Symptomatic deterioration|9|||
25194834|NCT00242567|50375986|FG001|Overall Study|Symptomatic deterioration|3|||
25194835|NCT00242567|50375985|FG000|Overall Study|Lack of Efficacy|2|||
25194836|NCT00242567|50375986|FG001|Overall Study|Lack of Efficacy|2|||
25194837|NCT00242567|50375985|FG000|Overall Study|Lost to Follow-up|9|||
25194838|NCT00242567|50375986|FG001|Overall Study|Lost to Follow-up|19|||
25194839|NCT00242567|50375985|FG000|Overall Study|Withdrawal by Subject|33|||
25194840|NCT00242567|50375986|FG001|Overall Study|Withdrawal by Subject|28|||
25194841|NCT00242567|50375985|FG000|Overall Study|Protocol Violation|12|||
25194842|NCT00242567|50375986|FG001|Overall Study|Protocol Violation|12|||
25194843|NCT00242567|50375985|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
25194844|NCT00242567|50375986|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
25194845|NCT00242567|50375985|FG000|Overall Study|Other|14|||
25194846|NCT00242567|50375986|FG001|Overall Study|Other|9|||
25194847|NCT00241631|50375996|FG000|Run in (2 Weeks)|Physician Decision|3|||
25194848|NCT00241631|50375997|FG001|Run in (2 Weeks)|Physician Decision|3|||
25194849|NCT00241631|50375996|FG000|Phase 1 (4 Weeks)|sore throat|1|||
25194850|NCT00241631|50375997|FG001|Phase 1 (4 Weeks)|sore throat|0|||
25194851|NCT00241631|50375996|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
25194852|NCT00241631|50375997|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
25194853|NCT00241631|50375996|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
25194854|NCT00241631|50375997|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
25194855|NCT00241631|50375996|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
25194856|NCT00241631|50375997|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
25194857|NCT00240071|50376012|FG000|Overall Study|Withdrawal by Subject|3|||
25194858|NCT03761277|50377009|FG000|Enrollment to Implant|Screen Failure|17|||
25194859|NCT03761277|50377009|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
25194860|NCT03761277|50377009|FG000|Enrollment to Implant|Physician Decision|2|||
25194861|NCT03761277|50377009|FG000|Enrollment to Implant|Site Closure|3|||
25194862|NCT03761277|50377009|FG000|Enrollment to Implant|Sponsor Request|2|||
25194863|NCT03761277|50377009|FG000|Post-Implant to 6 Months|Adverse Event|2|||
25194864|NCT03761277|50377009|FG000|Post-Implant to 6 Months|Death|1|||
25194865|NCT03761277|50377009|FG000|Post-Implant to 6 Months|Site Closure|2|||
25194866|NCT03761277|50377009|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
25194867|NCT03761277|50377009|FG000|6 Months to 12 Months|Physician Decision|2|||
25194868|NCT03761277|50377009|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
25194869|NCT04099641|50377060|FG000|Overall Study|Death|46|||
25194870|NCT04099641|50377061|FG001|Overall Study|Death|12|||
25194871|NCT04099641|50377060|FG000|Overall Study|Lost to Follow-up|1|||
25194872|NCT04099641|50377061|FG001|Overall Study|Lost to Follow-up|0|||
25194873|NCT04099641|50377060|FG000|Overall Study|Withdrawal by Subject|2|||
25194874|NCT04099641|50377061|FG001|Overall Study|Withdrawal by Subject|0|||
25194875|NCT03123393|50377187|FG000|Overall Study|Study Terminated by Sponsor|6|||
25194876|NCT03123393|50377188|FG001|Overall Study|Study Terminated by Sponsor|9|||
25194877|NCT03123393|50377187|FG000|Overall Study|Withdrawal by Subject|2|||
25194878|NCT03123393|50377188|FG001|Overall Study|Withdrawal by Subject|1|||
25194879|NCT03123393|50377187|FG000|Overall Study|Reason not Specified|13|||
25194880|NCT03123393|50377188|FG001|Overall Study|Reason not Specified|13|||
25194881|NCT02834247|50377819|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
25194882|NCT02834247|50377820|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
25194883|NCT02834247|50377821|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
25194884|NCT02834247|50377822|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
25194885|NCT02834247|50377819|FG000|Dose Escalation Phase|Death|5|||
25194886|NCT02834247|50377820|FG001|Dose Escalation Phase|Death|6|||
25194887|NCT02834247|50377821|FG002|Dose Escalation Phase|Death|5|||
25194888|NCT02834247|50377822|FG003|Dose Escalation Phase|Death|0|||
25194889|NCT02834247|50377819|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
25194890|NCT02834247|50377820|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
25194891|NCT02834247|50377821|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
25194892|NCT02834247|50377822|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
25194893|NCT02834247|50377819|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
25194894|NCT02834247|50377820|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
25194895|NCT02834247|50377821|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
25194896|NCT02834247|50377822|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
25194897|NCT02834247|50377819|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
25194898|NCT02834247|50377820|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
25194899|NCT02834247|50377821|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
25194900|NCT02834247|50377822|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
25194901|NCT02834247|50377819|FG000|Dose Expansion Phase|Death|0|||
25194902|NCT02834247|50377820|FG001|Dose Expansion Phase|Death|0|||
25194903|NCT02834247|50377821|FG002|Dose Expansion Phase|Death|0|||
25194904|NCT02834247|50377822|FG003|Dose Expansion Phase|Death|8|||
25194905|NCT02834247|50377819|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
25194906|NCT02834247|50377820|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
25194907|NCT02834247|50377821|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
25194908|NCT02834247|50377822|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
25194909|NCT02834247|50377819|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
25194910|NCT02834247|50377820|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
25194911|NCT02834247|50377821|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
25194912|NCT02834247|50377822|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
25194913|NCT01839331|50379110|FG000|Overall Study|Early Termination|3|||
25194914|NCT01839331|50379111|FG001|Overall Study|Early Termination|0|||
25194915|NCT01839331|50379112|FG002|Overall Study|Early Termination|1|||
25194916|NCT01839331|50379113|FG003|Overall Study|Early Termination|2|||
25194917|NCT01839331|50379110|FG000|Overall Study|Protocol Violation|1|||
25194918|NCT01839331|50379111|FG001|Overall Study|Protocol Violation|6|||
25194919|NCT01839331|50379112|FG002|Overall Study|Protocol Violation|4|||
25194920|NCT01839331|50379113|FG003|Overall Study|Protocol Violation|3|||
25194921|NCT02733042|50379259|FG000|Treatment Period|Adverse Event|1|||
25194922|NCT02733042|50379260|FG001|Treatment Period|Adverse Event|0|||
25194923|NCT02733042|50379261|FG002|Treatment Period|Adverse Event|1|||
25194924|NCT02733042|50379262|FG003|Treatment Period|Adverse Event|1|||
25194925|NCT02733042|50379263|FG004|Treatment Period|Adverse Event|0|||
25194926|NCT02733042|50379264|FG005|Treatment Period|Adverse Event|0|||
25194927|NCT02733042|50379265|FG006|Treatment Period|Adverse Event|0|||
25194928|NCT02733042|50379266|FG007|Treatment Period|Adverse Event|0|||
25194929|NCT02733042|50379267|FG008|Treatment Period|Adverse Event|0|||
25194930|NCT02733042|50379268|FG009|Treatment Period|Adverse Event|0|||
25076993|NCT02500706|50184741|FG002|Overall Study|Unclassified|1|||
25076994|NCT02442830|50184751|FG000|Overall Study|Technical Failure|0|||
25076995|NCT02442830|50184752|FG001|Overall Study|Technical Failure|1|||
25076996|NCT02471612|50184759|FG000|Overall Study|Lost to Follow-up|2|||
25194931|NCT02733042|50379269|FG010|Treatment Period|Adverse Event|2|||
25194932|NCT02733042|50379270|FG011|Treatment Period|Adverse Event|2|||
25194933|NCT02733042|50379271|FG012|Treatment Period|Adverse Event|0|||
25194934|NCT02733042|50379272|FG013|Treatment Period|Adverse Event|2|||
25194935|NCT02733042|50379273|FG014|Treatment Period|Adverse Event|0|||
25194936|NCT02733042|50379274|FG015|Treatment Period|Adverse Event|0|||
25194937|NCT02733042|50379275|FG016|Treatment Period|Adverse Event|0|||
25194938|NCT02733042|50379276|FG017|Treatment Period|Adverse Event|1|||
25194939|NCT02733042|50379277|FG018|Treatment Period|Adverse Event|0|||
25194940|NCT02733042|50379259|FG000|Treatment Period|Progressive Disease|2|||
25194941|NCT02733042|50379260|FG001|Treatment Period|Progressive Disease|1|||
25194942|NCT02733042|50379261|FG002|Treatment Period|Progressive Disease|3|||
25194943|NCT02733042|50379262|FG003|Treatment Period|Progressive Disease|1|||
25194944|NCT02733042|50379263|FG004|Treatment Period|Progressive Disease|1|||
25194945|NCT02733042|50379264|FG005|Treatment Period|Progressive Disease|3|||
25194946|NCT02733042|50379265|FG006|Treatment Period|Progressive Disease|0|||
25194947|NCT02733042|50379266|FG007|Treatment Period|Progressive Disease|3|||
25194948|NCT02733042|50379267|FG008|Treatment Period|Progressive Disease|3|||
25194949|NCT02733042|50379268|FG009|Treatment Period|Progressive Disease|0|||
25194950|NCT02733042|50379269|FG010|Treatment Period|Progressive Disease|2|||
25194951|NCT02733042|50379270|FG011|Treatment Period|Progressive Disease|2|||
25194952|NCT02733042|50379271|FG012|Treatment Period|Progressive Disease|8|||
25194953|NCT02733042|50379272|FG013|Treatment Period|Progressive Disease|1|||
25194954|NCT02733042|50379273|FG014|Treatment Period|Progressive Disease|4|||
25194955|NCT02733042|50379274|FG015|Treatment Period|Progressive Disease|7|||
25194956|NCT02733042|50379275|FG016|Treatment Period|Progressive Disease|2|||
25194957|NCT02733042|50379276|FG017|Treatment Period|Progressive Disease|3|||
25194958|NCT02733042|50379277|FG018|Treatment Period|Progressive Disease|4|||
25194959|NCT02733042|50379259|FG000|Treatment Period|Withdrawal by Subject|0|||
25194960|NCT02733042|50379260|FG001|Treatment Period|Withdrawal by Subject|1|||
25194961|NCT02733042|50379261|FG002|Treatment Period|Withdrawal by Subject|2|||
25194962|NCT02733042|50379262|FG003|Treatment Period|Withdrawal by Subject|1|||
25194963|NCT02733042|50379263|FG004|Treatment Period|Withdrawal by Subject|0|||
25194964|NCT02733042|50379264|FG005|Treatment Period|Withdrawal by Subject|0|||
25194965|NCT02733042|50379265|FG006|Treatment Period|Withdrawal by Subject|0|||
25076997|NCT02500550|50184776|FG000|Overall Study|Death|7|||
25194966|NCT02733042|50379266|FG007|Treatment Period|Withdrawal by Subject|0|||
25194967|NCT02733042|50379267|FG008|Treatment Period|Withdrawal by Subject|1|||
25194968|NCT02733042|50379268|FG009|Treatment Period|Withdrawal by Subject|1|||
25194969|NCT02733042|50379269|FG010|Treatment Period|Withdrawal by Subject|0|||
25194970|NCT02733042|50379270|FG011|Treatment Period|Withdrawal by Subject|2|||
25194971|NCT02733042|50379271|FG012|Treatment Period|Withdrawal by Subject|1|||
25194972|NCT02733042|50379272|FG013|Treatment Period|Withdrawal by Subject|1|||
25194973|NCT02733042|50379273|FG014|Treatment Period|Withdrawal by Subject|0|||
25194974|NCT02733042|50379274|FG015|Treatment Period|Withdrawal by Subject|0|||
25194975|NCT02733042|50379275|FG016|Treatment Period|Withdrawal by Subject|0|||
25194976|NCT02733042|50379276|FG017|Treatment Period|Withdrawal by Subject|0|||
25194977|NCT02733042|50379277|FG018|Treatment Period|Withdrawal by Subject|0|||
25194978|NCT02733042|50379259|FG000|Treatment Period|Other|0|||
25194979|NCT02733042|50379260|FG001|Treatment Period|Other|0|||
25194980|NCT02733042|50379261|FG002|Treatment Period|Other|1|||
25194981|NCT02733042|50379262|FG003|Treatment Period|Other|0|||
25194982|NCT02733042|50379263|FG004|Treatment Period|Other|0|||
25194983|NCT02733042|50379264|FG005|Treatment Period|Other|0|||
25194984|NCT02733042|50379265|FG006|Treatment Period|Other|0|||
25194985|NCT02733042|50379266|FG007|Treatment Period|Other|0|||
25194986|NCT02733042|50379267|FG008|Treatment Period|Other|0|||
25194987|NCT02733042|50379268|FG009|Treatment Period|Other|1|||
25194988|NCT02733042|50379269|FG010|Treatment Period|Other|1|||
25194989|NCT02733042|50379270|FG011|Treatment Period|Other|0|||
25194990|NCT02733042|50379271|FG012|Treatment Period|Other|0|||
25194991|NCT02733042|50379272|FG013|Treatment Period|Other|0|||
25194992|NCT02733042|50379273|FG014|Treatment Period|Other|0|||
25194993|NCT02733042|50379274|FG015|Treatment Period|Other|1|||
25194994|NCT02733042|50379275|FG016|Treatment Period|Other|0|||
25194995|NCT02733042|50379276|FG017|Treatment Period|Other|1|||
25194996|NCT02733042|50379277|FG018|Treatment Period|Other|0|||
25194997|NCT02733042|50379259|FG000|Treatment Period|Ongoing on Assigned Treatment|0|||
25194998|NCT02733042|50379260|FG001|Treatment Period|Ongoing on Assigned Treatment|0|||
25194999|NCT02733042|50379261|FG002|Treatment Period|Ongoing on Assigned Treatment|0|||
25195000|NCT02733042|50379262|FG003|Treatment Period|Ongoing on Assigned Treatment|0|||
25195001|NCT02733042|50379263|FG004|Treatment Period|Ongoing on Assigned Treatment|3|||
25195002|NCT02733042|50379264|FG005|Treatment Period|Ongoing on Assigned Treatment|0|||
25195003|NCT02733042|50379265|FG006|Treatment Period|Ongoing on Assigned Treatment|0|||
25195004|NCT02733042|50379266|FG007|Treatment Period|Ongoing on Assigned Treatment|0|||
25195005|NCT02733042|50379267|FG008|Treatment Period|Ongoing on Assigned Treatment|0|||
25195006|NCT02733042|50379268|FG009|Treatment Period|Ongoing on Assigned Treatment|8|||
25195007|NCT02733042|50379269|FG010|Treatment Period|Ongoing on Assigned Treatment|4|||
25195008|NCT02733042|50379270|FG011|Treatment Period|Ongoing on Assigned Treatment|0|||
25195009|NCT02733042|50379271|FG012|Treatment Period|Ongoing on Assigned Treatment|0|||
25195010|NCT02733042|50379272|FG013|Treatment Period|Ongoing on Assigned Treatment|0|||
25195011|NCT02733042|50379273|FG014|Treatment Period|Ongoing on Assigned Treatment|0|||
25195012|NCT02733042|50379274|FG015|Treatment Period|Ongoing on Assigned Treatment|0|||
25195013|NCT02733042|50379275|FG016|Treatment Period|Ongoing on Assigned Treatment|0|||
25195014|NCT02733042|50379276|FG017|Treatment Period|Ongoing on Assigned Treatment|0|||
25195015|NCT02733042|50379277|FG018|Treatment Period|Ongoing on Assigned Treatment|1|||
25195016|NCT02733042|50379259|FG000|Treatment Period|Death|0|||
25195017|NCT02733042|50379260|FG001|Treatment Period|Death|0|||
25195018|NCT02733042|50379261|FG002|Treatment Period|Death|0|||
25195019|NCT02733042|50379262|FG003|Treatment Period|Death|0|||
25195020|NCT02733042|50379263|FG004|Treatment Period|Death|0|||
25195021|NCT02733042|50379264|FG005|Treatment Period|Death|0|||
25195022|NCT02733042|50379265|FG006|Treatment Period|Death|1|||
25195023|NCT02733042|50379266|FG007|Treatment Period|Death|0|||
25170629|NCT02727192|50306143|FG002|Overall Study|Lost to Follow-up|0|||
25170630|NCT00705666|50306163|FG000|Overall Study|No post-treatment questionnaire|279|||
25170631|NCT00705666|50306163|FG000|Overall Study|Withdrawal by Subject|21|||
25170632|NCT00705666|50306163|FG000|Overall Study|Physician Decision|7|||
25170633|NCT00705666|50306163|FG000|Overall Study|Lost to Follow-up|5|||
25170634|NCT00705666|50306163|FG000|Overall Study|Death|1|||
25170635|NCT00705666|50306163|FG000|Overall Study|Adverse Event|4|||
25170636|NCT00705666|50306163|FG000|Overall Study|Other|12|||
25170637|NCT00705666|50306163|FG000|Overall Study|Other|2|||
25195024|NCT02733042|50379267|FG008|Treatment Period|Death|1|||
25195025|NCT02733042|50379268|FG009|Treatment Period|Death|0|||
25195026|NCT02733042|50379269|FG010|Treatment Period|Death|1|||
25195027|NCT02733042|50379270|FG011|Treatment Period|Death|0|||
25195028|NCT02733042|50379271|FG012|Treatment Period|Death|0|||
25170638|NCT00705666|50306163|FG000|Overall Study|Lack of data|3|||
25195029|NCT02733042|50379272|FG013|Treatment Period|Death|0|||
25195030|NCT02733042|50379273|FG014|Treatment Period|Death|1|||
25195031|NCT02733042|50379274|FG015|Treatment Period|Death|2|||
25170639|NCT00705666|50306163|FG000|Overall Study|Untreated|5|||
25170640|NCT02725866|50306322|FG000|Overall Study|Failure to return|6|||
25195032|NCT02733042|50379275|FG016|Treatment Period|Death|0|||
25195033|NCT02733042|50379276|FG017|Treatment Period|Death|0|||
25195034|NCT02733042|50379277|FG018|Treatment Period|Death|0|||
25195035|NCT02733042|50379259|FG000|Follow-up Period|Ongoing on Follow-up|2|||
25195036|NCT02733042|50379260|FG001|Follow-up Period|Ongoing on Follow-up|2|||
25195037|NCT02733042|50379261|FG002|Follow-up Period|Ongoing on Follow-up|4|||
25195038|NCT02733042|50379262|FG003|Follow-up Period|Ongoing on Follow-up|2|||
25195039|NCT02733042|50379263|FG004|Follow-up Period|Ongoing on Follow-up|0|||
25195040|NCT02733042|50379264|FG005|Follow-up Period|Ongoing on Follow-up|0|||
25195041|NCT02733042|50379265|FG006|Follow-up Period|Ongoing on Follow-up|0|||
25195042|NCT02733042|50379266|FG007|Follow-up Period|Ongoing on Follow-up|1|||
25195043|NCT02733042|50379267|FG008|Follow-up Period|Ongoing on Follow-up|0|||
25195044|NCT02733042|50379268|FG009|Follow-up Period|Ongoing on Follow-up|2|||
25195045|NCT02733042|50379269|FG010|Follow-up Period|Ongoing on Follow-up|4|||
25195046|NCT02733042|50379270|FG011|Follow-up Period|Ongoing on Follow-up|9|||
25195047|NCT02733042|50379271|FG012|Follow-up Period|Ongoing on Follow-up|1|||
25195048|NCT02733042|50379272|FG013|Follow-up Period|Ongoing on Follow-up|3|||
25195049|NCT02733042|50379273|FG014|Follow-up Period|Ongoing on Follow-up|0|||
25195050|NCT02733042|50379274|FG015|Follow-up Period|Ongoing on Follow-up|0|||
25195051|NCT02733042|50379275|FG016|Follow-up Period|Ongoing on Follow-up|0|||
25195052|NCT02733042|50379276|FG017|Follow-up Period|Ongoing on Follow-up|1|||
25195053|NCT02733042|50379277|FG018|Follow-up Period|Ongoing on Follow-up|0|||
25195054|NCT02733042|50379259|FG000|Follow-up Period|Death|1|||
25195055|NCT02733042|50379260|FG001|Follow-up Period|Death|1|||
25195056|NCT02733042|50379261|FG002|Follow-up Period|Death|2|||
25195057|NCT02733042|50379262|FG003|Follow-up Period|Death|0|||
25195058|NCT02733042|50379263|FG004|Follow-up Period|Death|1|||
25195059|NCT02733042|50379264|FG005|Follow-up Period|Death|2|||
25195060|NCT02733042|50379265|FG006|Follow-up Period|Death|0|||
25195061|NCT02733042|50379266|FG007|Follow-up Period|Death|3|||
25195062|NCT02733042|50379267|FG008|Follow-up Period|Death|3|||
25195063|NCT02733042|50379268|FG009|Follow-up Period|Death|0|||
25195064|NCT02733042|50379269|FG010|Follow-up Period|Death|0|||
25195065|NCT02733042|50379270|FG011|Follow-up Period|Death|0|||
25195066|NCT02733042|50379271|FG012|Follow-up Period|Death|8|||
25195067|NCT02733042|50379272|FG013|Follow-up Period|Death|1|||
25195068|NCT02733042|50379273|FG014|Follow-up Period|Death|1|||
25195069|NCT02733042|50379274|FG015|Follow-up Period|Death|4|||
25195070|NCT02733042|50379275|FG016|Follow-up Period|Death|0|||
25195071|NCT02733042|50379276|FG017|Follow-up Period|Death|1|||
25314899|NCT00650767|50630790|FG000|Overall Study|Withdrawal by Subject|2|||
25314900|NCT00650767|50630791|FG001|Overall Study|Withdrawal by Subject|4|||
25314901|NCT00650767|50630792|FG002|Overall Study|Withdrawal by Subject|3|||
25314902|NCT00650767|50630793|FG003|Overall Study|Withdrawal by Subject|3|||
25314903|NCT00650767|50630790|FG000|Overall Study|Lost to Follow-up|1|||
25314904|NCT00650767|50630791|FG001|Overall Study|Lost to Follow-up|1|||
25314905|NCT00650767|50630792|FG002|Overall Study|Lost to Follow-up|1|||
25314906|NCT00650767|50630793|FG003|Overall Study|Lost to Follow-up|0|||
25314907|NCT00650767|50630790|FG000|Overall Study|Other|1|||
25314908|NCT00650767|50630791|FG001|Overall Study|Other|1|||
25314909|NCT00650767|50630792|FG002|Overall Study|Other|0|||
25314910|NCT00650767|50630793|FG003|Overall Study|Other|0|||
25314911|NCT00973349|50630819|FG000|Overall Study|Adverse Event|0|||
25314912|NCT00973349|50630820|FG001|Overall Study|Adverse Event|0|||
25314913|NCT00973349|50630821|FG002|Overall Study|Adverse Event|0|||
25314914|NCT00973349|50630822|FG003|Overall Study|Adverse Event|0|||
25314915|NCT00973349|50630823|FG004|Overall Study|Adverse Event|1|||
25314916|NCT00973349|50630824|FG005|Overall Study|Adverse Event|0|||
25314917|NCT00973349|50630825|FG006|Overall Study|Adverse Event|0|||
25314918|NCT00973349|50630826|FG007|Overall Study|Adverse Event|0|||
25314919|NCT00973349|50630827|FG008|Overall Study|Adverse Event|1|||
25314920|NCT00973349|50630828|FG009|Overall Study|Adverse Event|0|||
25314921|NCT00973349|50630829|FG010|Overall Study|Adverse Event|0|||
25314922|NCT00973349|50630830|FG011|Overall Study|Adverse Event|0|||
25314923|NCT00973349|50630831|FG012|Overall Study|Adverse Event|0|||
25314924|NCT00973349|50630832|FG013|Overall Study|Adverse Event|0|||
25314925|NCT00973349|50630833|FG014|Overall Study|Adverse Event|1|||
25314926|NCT00973349|50630834|FG015|Overall Study|Adverse Event|0|||
25314927|NCT00973349|50630819|FG000|Overall Study|Withdrawal by Subject|1|||
25314928|NCT00973349|50630820|FG001|Overall Study|Withdrawal by Subject|2|||
25314929|NCT00973349|50630821|FG002|Overall Study|Withdrawal by Subject|2|||
25314930|NCT00973349|50630822|FG003|Overall Study|Withdrawal by Subject|3|||
25195072|NCT02733042|50379277|FG018|Follow-up Period|Death|2|||
25314931|NCT00973349|50630823|FG004|Overall Study|Withdrawal by Subject|2|||
25195073|NCT02733042|50379259|FG000|Follow-up Period|Other|0|||
25195074|NCT02733042|50379260|FG001|Follow-up Period|Other|0|||
25195075|NCT02733042|50379261|FG002|Follow-up Period|Other|0|||
25195076|NCT02733042|50379262|FG003|Follow-up Period|Other|1|||
25195077|NCT02733042|50379263|FG004|Follow-up Period|Other|0|||
25314932|NCT00973349|50630824|FG005|Overall Study|Withdrawal by Subject|0|||
25314933|NCT00973349|50630825|FG006|Overall Study|Withdrawal by Subject|2|||
25195078|NCT02733042|50379264|FG005|Follow-up Period|Other|0|||
25195079|NCT02733042|50379265|FG006|Follow-up Period|Other|0|||
25195080|NCT02733042|50379266|FG007|Follow-up Period|Other|0|||
25195081|NCT02733042|50379267|FG008|Follow-up Period|Other|0|||
25195082|NCT02733042|50379268|FG009|Follow-up Period|Other|0|||
25195083|NCT02733042|50379269|FG010|Follow-up Period|Other|0|||
25195084|NCT02733042|50379270|FG011|Follow-up Period|Other|0|||
25195085|NCT02733042|50379271|FG012|Follow-up Period|Other|0|||
25195086|NCT02733042|50379272|FG013|Follow-up Period|Other|0|||
25195087|NCT02733042|50379273|FG014|Follow-up Period|Other|0|||
25195088|NCT02733042|50379274|FG015|Follow-up Period|Other|0|||
25195089|NCT02733042|50379275|FG016|Follow-up Period|Other|0|||
25195090|NCT02733042|50379276|FG017|Follow-up Period|Other|0|||
25195091|NCT02733042|50379277|FG018|Follow-up Period|Other|0|||
25195092|NCT02733042|50379259|FG000|Follow-up Period|Withdrawal by Subject|0|||
25195093|NCT02733042|50379260|FG001|Follow-up Period|Withdrawal by Subject|0|||
25195094|NCT02733042|50379261|FG002|Follow-up Period|Withdrawal by Subject|0|||
25195095|NCT02733042|50379262|FG003|Follow-up Period|Withdrawal by Subject|0|||
25195096|NCT02733042|50379263|FG004|Follow-up Period|Withdrawal by Subject|0|||
25195097|NCT02733042|50379264|FG005|Follow-up Period|Withdrawal by Subject|0|||
25195098|NCT02733042|50379265|FG006|Follow-up Period|Withdrawal by Subject|0|||
25195099|NCT02733042|50379266|FG007|Follow-up Period|Withdrawal by Subject|0|||
25195100|NCT02733042|50379267|FG008|Follow-up Period|Withdrawal by Subject|1|||
25195101|NCT02733042|50379268|FG009|Follow-up Period|Withdrawal by Subject|0|||
25195102|NCT02733042|50379269|FG010|Follow-up Period|Withdrawal by Subject|1|||
25195103|NCT02733042|50379270|FG011|Follow-up Period|Withdrawal by Subject|0|||
25195104|NCT02733042|50379271|FG012|Follow-up Period|Withdrawal by Subject|0|||
25195105|NCT02733042|50379272|FG013|Follow-up Period|Withdrawal by Subject|0|||
25195106|NCT02733042|50379273|FG014|Follow-up Period|Withdrawal by Subject|0|||
25195107|NCT02733042|50379274|FG015|Follow-up Period|Withdrawal by Subject|1|||
25195108|NCT02733042|50379275|FG016|Follow-up Period|Withdrawal by Subject|0|||
25195109|NCT02733042|50379276|FG017|Follow-up Period|Withdrawal by Subject|0|||
25195110|NCT02733042|50379277|FG018|Follow-up Period|Withdrawal by Subject|0|||
25195111|NCT01606176|50379545|FG000|Overall Study|Adverse Event|2|||
25195112|NCT01606176|50379546|FG001|Overall Study|Adverse Event|3|||
25195113|NCT01606176|50379545|FG000|Overall Study|Disease progression|1|||
25195114|NCT01606176|50379546|FG001|Overall Study|Disease progression|0|||
25195115|NCT01606176|50379545|FG000|Overall Study|Withdrawal by Subject|1|||
25195116|NCT01606176|50379546|FG001|Overall Study|Withdrawal by Subject|0|||
25195117|NCT01663896|50379612|FG000|Overall Study|Various reasons|43|||
25195118|NCT02576652|50379665|FG000|Overall Study|Withdrawal by Subject|2|||
25195119|NCT02575950|50379749|FG000|Overall Study|Withdrawal by Subject|0|||
25195120|NCT02575950|50379750|FG001|Overall Study|Withdrawal by Subject|0|||
25195121|NCT02575950|50379751|FG002|Overall Study|Withdrawal by Subject|0|||
25195122|NCT02575950|50379752|FG003|Overall Study|Withdrawal by Subject|2|||
25195123|NCT02575950|50379749|FG000|Overall Study|Lost to Follow-up|0|||
25195124|NCT02575950|50379750|FG001|Overall Study|Lost to Follow-up|1|||
25195125|NCT02575950|50379751|FG002|Overall Study|Lost to Follow-up|0|||
25195126|NCT02575950|50379752|FG003|Overall Study|Lost to Follow-up|3|||
25195127|NCT01049581|50379851|FG000|Overall Study|Lost to Follow-up|2|||
25195128|NCT01049581|50379852|FG001|Overall Study|Lost to Follow-up|1|||
25195129|NCT02571972|50379870|FG000|Overall Study|Protocol Violation|2|||
25195130|NCT02571972|50379870|FG000|Overall Study|Withdrawal by Subject|2|||
25195131|NCT02166905|50379968|FG000|Overall Study|Withdrawal by Subject|1|||
25195132|NCT02166905|50379969|FG001|Overall Study|Withdrawal by Subject|0|||
25195133|NCT02166905|50379970|FG002|Overall Study|Withdrawal by Subject|0|||
25195134|NCT02166905|50379971|FG003|Overall Study|Withdrawal by Subject|0|||
25195135|NCT01501955|50380018|FG000|Overall Study|Withdrawal by Subject|1|||
25195136|NCT01501955|50380019|FG001|Overall Study|Withdrawal by Subject|0|||
25195137|NCT01501955|50380018|FG000|Overall Study|Adverse Event|1|||
25195138|NCT01501955|50380019|FG001|Overall Study|Adverse Event|3|||
25195139|NCT02574312|50380147|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
25195140|NCT02574312|50380148|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
25195141|NCT01049035|50380170|FG000|Overall Study|Serious adverse event|0|||
25195142|NCT01049035|50380171|FG001|Overall Study|Serious adverse event|1|||
25195143|NCT01049035|50380172|FG002|Overall Study|Serious adverse event|1|||
25195144|NCT01049035|50380173|FG003|Overall Study|Serious adverse event|2|||
25195145|NCT01049035|50380174|FG004|Overall Study|Serious adverse event|0|||
25195146|NCT01049035|50380175|FG005|Overall Study|Serious adverse event|0|||
25195147|NCT01049035|50380176|FG006|Overall Study|Serious adverse event|0|||
25195148|NCT01049035|50380170|FG000|Overall Study|Other adverse event (AE)|0|||
25195149|NCT01049035|50380171|FG001|Overall Study|Other adverse event (AE)|0|||
25195150|NCT01049035|50380172|FG002|Overall Study|Other adverse event (AE)|0|||
25195151|NCT01049035|50380173|FG003|Overall Study|Other adverse event (AE)|1|||
25195152|NCT01049035|50380174|FG004|Overall Study|Other adverse event (AE)|0|||
25195153|NCT01049035|50380175|FG005|Overall Study|Other adverse event (AE)|0|||
25195154|NCT01049035|50380176|FG006|Overall Study|Other adverse event (AE)|0|||
25195155|NCT01049035|50380170|FG000|Overall Study|Non-compliance with the protocol|12|||
25195156|NCT01049035|50380171|FG001|Overall Study|Non-compliance with the protocol|6|||
25195157|NCT01049035|50380172|FG002|Overall Study|Non-compliance with the protocol|14|||
25195158|NCT01049035|50380173|FG003|Overall Study|Non-compliance with the protocol|5|||
25195159|NCT01049035|50380174|FG004|Overall Study|Non-compliance with the protocol|3|||
25195160|NCT01049035|50380175|FG005|Overall Study|Non-compliance with the protocol|4|||
25195161|NCT01049035|50380176|FG006|Overall Study|Non-compliance with the protocol|10|||
25195162|NCT01049035|50380170|FG000|Overall Study|Lost to Follow-up|5|||
25195163|NCT01049035|50380171|FG001|Overall Study|Lost to Follow-up|4|||
25195164|NCT01049035|50380172|FG002|Overall Study|Lost to Follow-up|4|||
25195165|NCT01049035|50380173|FG003|Overall Study|Lost to Follow-up|1|||
25195166|NCT01049035|50380174|FG004|Overall Study|Lost to Follow-up|0|||
25195167|NCT01049035|50380175|FG005|Overall Study|Lost to Follow-up|3|||
25195168|NCT01049035|50380176|FG006|Overall Study|Lost to Follow-up|3|||
25195169|NCT01049035|50380170|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
25195170|NCT01049035|50380171|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
25195171|NCT01049035|50380172|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
25195172|NCT01049035|50380173|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
25195173|NCT01049035|50380174|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
25195174|NCT01049035|50380175|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
25195175|NCT01049035|50380176|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
25195176|NCT01048333|50380202|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
25195177|NCT01048333|50380203|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
25195178|NCT01048333|50380204|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
25195179|NCT01048333|50380205|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
25195180|NCT01048333|50380206|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
25195181|NCT01048333|50380207|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
25195182|NCT02323113|50380222|FG000|Overall Study|Adverse Event|3|||
25195183|NCT02323113|50380223|FG001|Overall Study|Adverse Event|3|||
25195184|NCT02323113|50380224|FG002|Overall Study|Adverse Event|2|||
25195185|NCT02323113|50380225|FG003|Overall Study|Adverse Event|5|||
25195186|NCT02323113|50380226|FG004|Overall Study|Adverse Event|8|||
25195187|NCT02323113|50380227|FG005|Overall Study|Adverse Event|3|||
25195188|NCT02323113|50380228|FG006|Overall Study|Adverse Event|6|||
25195189|NCT02323113|50380229|FG007|Overall Study|Adverse Event|0|||
25195190|NCT02323113|50380222|FG000|Overall Study|Progressive Disease|0|||
25195191|NCT02323113|50380223|FG001|Overall Study|Progressive Disease|1|||
25195192|NCT02323113|50380224|FG002|Overall Study|Progressive Disease|1|||
25195193|NCT02323113|50380225|FG003|Overall Study|Progressive Disease|0|||
25195194|NCT02323113|50380226|FG004|Overall Study|Progressive Disease|0|||
25195195|NCT02323113|50380227|FG005|Overall Study|Progressive Disease|3|||
25195196|NCT02323113|50380228|FG006|Overall Study|Progressive Disease|0|||
25195197|NCT02323113|50380229|FG007|Overall Study|Progressive Disease|0|||
25195198|NCT02323113|50380222|FG000|Overall Study|Symptomatic Deterioration|0|||
25195199|NCT02323113|50380223|FG001|Overall Study|Symptomatic Deterioration|0|||
25195200|NCT02323113|50380224|FG002|Overall Study|Symptomatic Deterioration|1|||
25195201|NCT02323113|50380225|FG003|Overall Study|Symptomatic Deterioration|0|||
25195202|NCT02323113|50380226|FG004|Overall Study|Symptomatic Deterioration|1|||
25195203|NCT02323113|50380227|FG005|Overall Study|Symptomatic Deterioration|0|||
25195204|NCT02323113|50380228|FG006|Overall Study|Symptomatic Deterioration|0|||
25195205|NCT02323113|50380229|FG007|Overall Study|Symptomatic Deterioration|0|||
25195206|NCT02323113|50380222|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
25195207|NCT02323113|50380223|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
25195208|NCT02323113|50380224|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
25195209|NCT02323113|50380225|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
25195210|NCT02323113|50380226|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
25195211|NCT02323113|50380227|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
25195212|NCT02323113|50380228|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
25195213|NCT02323113|50380229|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
25195214|NCT02323113|50380222|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
25195215|NCT02323113|50380223|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
25195216|NCT02323113|50380224|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
25195217|NCT02323113|50380225|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
25195218|NCT02323113|50380226|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
25195219|NCT02323113|50380227|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
25195220|NCT02323113|50380228|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
25195221|NCT02323113|50380229|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
25195222|NCT02281383|50380276|FG000|Overall Study|Progressive Disease|1|||
25195223|NCT02281383|50380276|FG000|Overall Study|Withdrawal by Subject|6|||
25195224|NCT02281383|50380276|FG000|Overall Study|Protocol Violation|2|||
25195225|NCT02281383|50380276|FG000|Overall Study|Death|1|||
25195226|NCT02281383|50380276|FG000|Overall Study|Adverse Event|2|||
25195227|NCT01047553|50380282|FG000|Overall Study|Adverse Event|10|||
25195228|NCT01047553|50380283|FG001|Overall Study|Adverse Event|5|||
25195229|NCT01047553|50380282|FG000|Overall Study|Withdrawal by Subject|4|||
25195230|NCT01047553|50380283|FG001|Overall Study|Withdrawal by Subject|2|||
25195231|NCT01047553|50380282|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
25195232|NCT01047553|50380283|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
25195233|NCT01047553|50380282|FG000|Overall Study|Lost to Follow-up|1|||
25195234|NCT01047553|50380283|FG001|Overall Study|Lost to Follow-up|0|||
25195235|NCT01047553|50380282|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
25195236|NCT01047553|50380283|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
25195237|NCT01047553|50380282|FG000|Overall Study|PI's decision|0|||
25195238|NCT01047553|50380283|FG001|Overall Study|PI's decision|1|||
25195239|NCT01047007|50380317|FG000|Overall Study|Adverse Event|0|||
25195240|NCT01047007|50380318|FG001|Overall Study|Adverse Event|2|||
25195241|NCT01047007|50380319|FG002|Overall Study|Adverse Event|1|||
25195242|NCT01047007|50380320|FG003|Overall Study|Adverse Event|0|||
25195243|NCT01047007|50380317|FG000|Overall Study|Progressive Disease|2|||
25195244|NCT01047007|50380318|FG001|Overall Study|Progressive Disease|4|||
25195245|NCT01047007|50380319|FG002|Overall Study|Progressive Disease|1|||
25195246|NCT01047007|50380320|FG003|Overall Study|Progressive Disease|0|||
25195247|NCT01046695|50380332|FG000|Overall Study|Subject had a pacemaker|0|||
25195248|NCT01046695|50380333|FG001|Overall Study|Subject had a pacemaker|1|||
25195249|NCT01046695|50380332|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
24976227|NCT00077649|50065139|FG000|Overall Study|Withdrawal by Subject|0|||
24976228|NCT00077649|50065140|FG001|Overall Study|Withdrawal by Subject|1|||
24976229|NCT00077649|50065141|FG002|Overall Study|Withdrawal by Subject|1|||
24976230|NCT00077649|50065142|FG003|Overall Study|Withdrawal by Subject|2|||
25195250|NCT01046695|50380333|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
25195251|NCT03304379|50380348|FG000|Overall Study|Protocol Violation|8|||
25195252|NCT03304379|50380349|FG001|Overall Study|Protocol Violation|10|||
25195253|NCT03304379|50380350|FG002|Overall Study|Protocol Violation|5|||
25195254|NCT03304379|50380351|FG003|Overall Study|Protocol Violation|0|||
25195255|NCT03304379|50380352|FG004|Overall Study|Protocol Violation|2|||
25195256|NCT03304379|50380348|FG000|Overall Study|Adverse Event|4|||
25195257|NCT03304379|50380349|FG001|Overall Study|Adverse Event|20|||
25195258|NCT03304379|50380350|FG002|Overall Study|Adverse Event|17|||
25195259|NCT03304379|50380351|FG003|Overall Study|Adverse Event|1|||
25195260|NCT03304379|50380352|FG004|Overall Study|Adverse Event|0|||
25195261|NCT03304379|50380348|FG000|Overall Study|Lack of Efficacy|17|||
25195262|NCT03304379|50380349|FG001|Overall Study|Lack of Efficacy|16|||
25195263|NCT03304379|50380350|FG002|Overall Study|Lack of Efficacy|20|||
25195264|NCT03304379|50380351|FG003|Overall Study|Lack of Efficacy|0|||
25195265|NCT03304379|50380352|FG004|Overall Study|Lack of Efficacy|0|||
25195266|NCT03304379|50380348|FG000|Overall Study|Physician Decision|6|||
25195267|NCT03304379|50380349|FG001|Overall Study|Physician Decision|10|||
25195268|NCT03304379|50380350|FG002|Overall Study|Physician Decision|6|||
25195269|NCT03304379|50380351|FG003|Overall Study|Physician Decision|9|||
25195270|NCT03304379|50380352|FG004|Overall Study|Physician Decision|10|||
25195271|NCT03304379|50380348|FG000|Overall Study|Withdrawal by Subject|26|||
25195272|NCT03304379|50380349|FG001|Overall Study|Withdrawal by Subject|58|||
25195273|NCT03304379|50380350|FG002|Overall Study|Withdrawal by Subject|66|||
25195274|NCT03304379|50380351|FG003|Overall Study|Withdrawal by Subject|3|||
25195275|NCT03304379|50380352|FG004|Overall Study|Withdrawal by Subject|5|||
25195276|NCT03304379|50380348|FG000|Overall Study|Lost to Follow-up|8|||
25195277|NCT03304379|50380349|FG001|Overall Study|Lost to Follow-up|24|||
25195278|NCT03304379|50380350|FG002|Overall Study|Lost to Follow-up|35|||
25314934|NCT00973349|50630826|FG007|Overall Study|Withdrawal by Subject|2|||
25314935|NCT00973349|50630827|FG008|Overall Study|Withdrawal by Subject|0|||
25314936|NCT00973349|50630828|FG009|Overall Study|Withdrawal by Subject|2|||
25314937|NCT00973349|50630829|FG010|Overall Study|Withdrawal by Subject|0|||
24976231|NCT00077649|50065139|FG000|Overall Study|Lost to Follow-up|2|||
25195279|NCT03304379|50380351|FG003|Overall Study|Lost to Follow-up|4|||
25195280|NCT03304379|50380352|FG004|Overall Study|Lost to Follow-up|0|||
25195281|NCT03304379|50380348|FG000|Overall Study|Death|1|||
25195282|NCT03304379|50380349|FG001|Overall Study|Death|2|||
25195283|NCT03304379|50380350|FG002|Overall Study|Death|0|||
25195284|NCT03304379|50380351|FG003|Overall Study|Death|0|||
25195285|NCT03304379|50380352|FG004|Overall Study|Death|0|||
25195286|NCT03304379|50380348|FG000|Overall Study|Other|0|||
25195287|NCT03304379|50380349|FG001|Overall Study|Other|1|||
25195288|NCT03304379|50380350|FG002|Overall Study|Other|0|||
25195289|NCT03304379|50380351|FG003|Overall Study|Other|0|||
25195290|NCT03304379|50380352|FG004|Overall Study|Other|0|||
25195291|NCT01044745|50380407|FG000|Overall Study|Ineiligible|2|||
25195292|NCT01044433|50380430|FG000|Overall Study|Lost to Follow-up|3|||
25195293|NCT01044433|50380430|FG000|Overall Study|Withdrawal by Subject|3|||
25195294|NCT01043185|50380439|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
25195295|NCT01043185|50380440|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
25195296|NCT01043185|50380441|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
25195297|NCT01043185|50380442|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
25195298|NCT01043185|50380443|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
25195299|NCT01043185|50380444|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
25195300|NCT01043185|50380445|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
25195301|NCT01043185|50380446|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
25195302|NCT01043185|50380447|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
25195303|NCT01043185|50380448|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
25195304|NCT01042093|50380473|FG000|Overall Study|Protocol Violation|2|||
25195305|NCT01042093|50380474|FG001|Overall Study|Protocol Violation|2|||
25195306|NCT01042093|50380475|FG002|Overall Study|Protocol Violation|2|||
25195307|NCT01042093|50380476|FG003|Overall Study|Protocol Violation|3|||
25195308|NCT01042093|50380473|FG000|Overall Study|Withdrawal by Subject|0|||
25195309|NCT01042093|50380474|FG001|Overall Study|Withdrawal by Subject|0|||
25195310|NCT01042093|50380475|FG002|Overall Study|Withdrawal by Subject|0|||
25195311|NCT01042093|50380476|FG003|Overall Study|Withdrawal by Subject|1|||
25195312|NCT01041859|50380506|FG000|Open-Label Titration|Adverse Event|69|||
25195313|NCT01041859|50380507|FG001|Open-Label Titration|Adverse Event|0|||
25195314|NCT01041859|50380508|FG002|Open-Label Titration|Adverse Event|0|||
25195315|NCT01041859|50380506|FG000|Open-Label Titration|Lack of Efficacy|3|||
25195316|NCT01041859|50380507|FG001|Open-Label Titration|Lack of Efficacy|0|||
25195317|NCT01041859|50380508|FG002|Open-Label Titration|Lack of Efficacy|0|||
25195318|NCT01041859|50380506|FG000|Open-Label Titration|Lost to Follow-up|1|||
25195319|NCT01041859|50380507|FG001|Open-Label Titration|Lost to Follow-up|0|||
25195320|NCT01041859|50380508|FG002|Open-Label Titration|Lost to Follow-up|0|||
25195321|NCT01041859|50380506|FG000|Open-Label Titration|Physician Decision|1|||
25195322|NCT01041859|50380507|FG001|Open-Label Titration|Physician Decision|0|||
25195323|NCT01041859|50380508|FG002|Open-Label Titration|Physician Decision|0|||
25195324|NCT01041859|50380506|FG000|Open-Label Titration|Protocol Violation|1|||
25195325|NCT01041859|50380507|FG001|Open-Label Titration|Protocol Violation|0|||
25195326|NCT01041859|50380508|FG002|Open-Label Titration|Protocol Violation|0|||
25195327|NCT01041859|50380506|FG000|Open-Label Titration|Other|7|||
25195328|NCT01041859|50380507|FG001|Open-Label Titration|Other|0|||
25195329|NCT01041859|50380508|FG002|Open-Label Titration|Other|0|||
25195330|NCT01041859|50380506|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
25195331|NCT01041859|50380507|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
25195332|NCT01041859|50380508|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
25195333|NCT01041859|50380506|FG000|Open-Label Titration|Withdrawal by Subject|11|||
25195334|NCT01041859|50380507|FG001|Open-Label Titration|Withdrawal by Subject|0|||
25195335|NCT01041859|50380508|FG002|Open-Label Titration|Withdrawal by Subject|0|||
25195336|NCT01041859|50380506|FG000|Double-Blind Maintenance|Adverse Event|0|||
25195337|NCT01041859|50380507|FG001|Double-Blind Maintenance|Adverse Event|23|||
25195338|NCT01041859|50380508|FG002|Double-Blind Maintenance|Adverse Event|13|||
25195339|NCT01041859|50380506|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
25195340|NCT01041859|50380507|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
25195341|NCT01041859|50380508|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
25195342|NCT01041859|50380506|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
25195343|NCT01041859|50380507|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
25195344|NCT01041859|50380508|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
25195345|NCT01041859|50380506|FG000|Double-Blind Maintenance|Physician Decision|0|||
25195346|NCT01041859|50380507|FG001|Double-Blind Maintenance|Physician Decision|2|||
25195347|NCT01041859|50380508|FG002|Double-Blind Maintenance|Physician Decision|1|||
25195348|NCT01041859|50380506|FG000|Double-Blind Maintenance|Protocol Violation|0|||
25195349|NCT01041859|50380507|FG001|Double-Blind Maintenance|Protocol Violation|1|||
25195350|NCT01041859|50380508|FG002|Double-Blind Maintenance|Protocol Violation|3|||
25195351|NCT01041859|50380506|FG000|Double-Blind Maintenance|Other|0|||
25195352|NCT01041859|50380507|FG001|Double-Blind Maintenance|Other|6|||
25195353|NCT01041859|50380508|FG002|Double-Blind Maintenance|Other|2|||
25195354|NCT01041859|50380506|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
25195355|NCT01041859|50380507|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
25195356|NCT01041859|50380508|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
25195357|NCT01041859|50380506|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
24976232|NCT00077649|50065140|FG001|Overall Study|Lost to Follow-up|2|||
25195358|NCT01041859|50380507|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
25195359|NCT01041859|50380508|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
25195360|NCT01040845|50380517|FG000|Overall Study|Withdrawal by Subject|1|||
25195361|NCT01040845|50380518|FG001|Overall Study|Withdrawal by Subject|1|||
25195362|NCT01040845|50380517|FG000|Overall Study|Physician Decision|1|||
25195363|NCT01040845|50380518|FG001|Overall Study|Physician Decision|0|||
25195364|NCT01040689|50380526|FG000|Overall Study|Adverse Event|0|||
25195365|NCT01040689|50380527|FG001|Overall Study|Adverse Event|0|||
25195366|NCT01040689|50380528|FG002|Overall Study|Adverse Event|2|||
25195367|NCT01040689|50380529|FG003|Overall Study|Adverse Event|4|||
25195368|NCT01040689|50380526|FG000|Overall Study|Lack of Efficacy|0|||
25195369|NCT01040689|50380527|FG001|Overall Study|Lack of Efficacy|0|||
25195370|NCT01040689|50380528|FG002|Overall Study|Lack of Efficacy|1|||
25195371|NCT01040689|50380529|FG003|Overall Study|Lack of Efficacy|0|||
25195372|NCT01040689|50380526|FG000|Overall Study|Lost to Follow-up|1|||
25195373|NCT01040689|50380527|FG001|Overall Study|Lost to Follow-up|0|||
25195374|NCT01040689|50380528|FG002|Overall Study|Lost to Follow-up|0|||
25195375|NCT01040689|50380529|FG003|Overall Study|Lost to Follow-up|0|||
25195376|NCT01040689|50380526|FG000|Overall Study|Withdrawal by Subject|2|||
25195377|NCT01040689|50380527|FG001|Overall Study|Withdrawal by Subject|1|||
25195378|NCT01040689|50380528|FG002|Overall Study|Withdrawal by Subject|1|||
25195379|NCT01040689|50380529|FG003|Overall Study|Withdrawal by Subject|0|||
25195380|NCT01040689|50380526|FG000|Overall Study|Other reasons not listed above|0|||
25195381|NCT01040689|50380527|FG001|Overall Study|Other reasons not listed above|1|||
25195382|NCT01040689|50380528|FG002|Overall Study|Other reasons not listed above|0|||
25195383|NCT01040689|50380529|FG003|Overall Study|Other reasons not listed above|0|||
25195384|NCT01047319|50380578|FG000|Overall Study|Teva requested participant withdrawal|3|||
25195385|NCT01047319|50380579|FG001|Overall Study|Teva requested participant withdrawal|0|||
25195386|NCT01047319|50380580|FG002|Overall Study|Teva requested participant withdrawal|1|||
25195387|NCT01047319|50380578|FG000|Overall Study|Protocol Violation|3|||
25195388|NCT01047319|50380579|FG001|Overall Study|Protocol Violation|2|||
25195389|NCT01047319|50380580|FG002|Overall Study|Protocol Violation|4|||
25195390|NCT01047319|50380578|FG000|Overall Study|Lack of Efficacy|4|||
25195391|NCT01047319|50380579|FG001|Overall Study|Lack of Efficacy|3|||
25195392|NCT01047319|50380580|FG002|Overall Study|Lack of Efficacy|3|||
25195393|NCT01047319|50380578|FG000|Overall Study|Death|5|||
25195394|NCT01047319|50380579|FG001|Overall Study|Death|1|||
25195395|NCT01047319|50380580|FG002|Overall Study|Death|5|||
25195396|NCT01047319|50380578|FG000|Overall Study|Pregnancy|13|||
25195397|NCT01047319|50380579|FG001|Overall Study|Pregnancy|8|||
25195398|NCT01047319|50380580|FG002|Overall Study|Pregnancy|8|||
25195399|NCT01047319|50380578|FG000|Overall Study|Physician Decision|12|||
25195400|NCT01047319|50380579|FG001|Overall Study|Physician Decision|9|||
25195401|NCT01047319|50380580|FG002|Overall Study|Physician Decision|10|||
25195402|NCT01047319|50380578|FG000|Overall Study|Lost to Follow-up|14|||
25195403|NCT01047319|50380579|FG001|Overall Study|Lost to Follow-up|10|||
25195404|NCT01047319|50380580|FG002|Overall Study|Lost to Follow-up|10|||
25195405|NCT01047319|50380578|FG000|Overall Study|Adverse Event|16|||
25195406|NCT01047319|50380579|FG001|Overall Study|Adverse Event|27|||
25195407|NCT01047319|50380580|FG002|Overall Study|Adverse Event|21|||
25195408|NCT01047319|50380578|FG000|Overall Study|Withdrawal by Subject|77|||
25195409|NCT01047319|50380579|FG001|Overall Study|Withdrawal by Subject|75|||
25195410|NCT01047319|50380580|FG002|Overall Study|Withdrawal by Subject|87|||
25195411|NCT01047319|50380578|FG000|Overall Study|Study terminated by Sponsor|198|||
25170641|NCT02725866|50306322|FG000|Overall Study|Withdrew consent|3|||
25170642|NCT02725866|50306322|FG000|Overall Study|Insufficient virological response|1|||
25170643|NCT02725866|50306322|FG000|Overall Study|Other, not specified|4|||
25170644|NCT02726022|50306358|FG000|Overall Study|Adverse Event|14|||
25170645|NCT02726022|50306358|FG000|Overall Study|Treatment Failure|8|||
25170646|NCT02726022|50306358|FG000|Overall Study|Poor Compliance|13|||
25170647|NCT02726022|50306358|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
25170648|NCT02725788|50306373|FG000|Overall Study|Lost to Follow-up|1|||
25170649|NCT02725788|50306374|FG001|Overall Study|Lost to Follow-up|1|||
25170650|NCT02725788|50306373|FG000|Overall Study|Protocol Violation|0|||
25170651|NCT02725788|50306374|FG001|Overall Study|Protocol Violation|1|||
25170652|NCT02725710|50306513|FG000|Overall Study|Lost to Follow-up|1|||
25170653|NCT02725710|50306514|FG001|Overall Study|Lost to Follow-up|0|||
25170654|NCT02724462|50306545|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
25170655|NCT02724462|50306546|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
25170656|NCT02724462|50306545|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
25195412|NCT01047319|50380579|FG001|Overall Study|Study terminated by Sponsor|215|||
25195413|NCT01047319|50380580|FG002|Overall Study|Study terminated by Sponsor|203|||
25195414|NCT00014911|50380897|FG000|Overall Study|Adverse Event|1|||
25195415|NCT00014911|50380897|FG000|Overall Study|Lost to Follow-up|1|||
25195416|NCT00014911|50380897|FG000|Overall Study|Withdrawal by Subject|6|||
25195417|NCT00014911|50380897|FG000|Overall Study|Unknown Reasons|2|||
25195418|NCT00014911|50380897|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
25195419|NCT01049009|50381461|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
25195420|NCT01049009|50381462|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
25170657|NCT02724462|50306546|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
25170658|NCT02724462|50306545|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
25195421|NCT01049009|50381461|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
25195422|NCT01049009|50381462|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
25195423|NCT01049009|50381461|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
25195424|NCT01049009|50381462|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
25195425|NCT01049009|50381461|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
25195426|NCT01049009|50381462|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
25195427|NCT01047683|50381484|FG000|Overall Study|Adverse Event|3|||
25195428|NCT01047683|50381485|FG001|Overall Study|Adverse Event|1|||
25195429|NCT01047683|50381486|FG002|Overall Study|Adverse Event|0|||
25195430|NCT01047683|50381484|FG000|Overall Study|Withdrew Consent|1|||
25195431|NCT01047683|50381485|FG001|Overall Study|Withdrew Consent|4|||
25195432|NCT01047683|50381486|FG002|Overall Study|Withdrew Consent|2|||
25195433|NCT01047683|50381484|FG000|Overall Study|Lost to Follow-up|0|||
25195434|NCT01047683|50381485|FG001|Overall Study|Lost to Follow-up|1|||
25195435|NCT01047683|50381486|FG002|Overall Study|Lost to Follow-up|0|||
25195436|NCT01047683|50381484|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
25195437|NCT01047683|50381485|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
25195438|NCT01047683|50381486|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
25195439|NCT01047293|50381574|FG000|Overall Study|DLT criteria not fulfilled|1|||
25195440|NCT01047293|50381575|FG001|Overall Study|DLT criteria not fulfilled|1|||
25195441|NCT01047293|50381576|FG002|Overall Study|DLT criteria not fulfilled|0|||
25195442|NCT01047293|50381577|FG003|Overall Study|DLT criteria not fulfilled|0|||
25195443|NCT01045967|50381586|FG000|Second Intervention|Protocol Violation|0|||
25195444|NCT01045967|50381587|FG001|Second Intervention|Protocol Violation|1|||
25195445|NCT01045421|50382173|FG000|Phase 1|Progressive Disease|0|||
25195446|NCT01045421|50382174|FG001|Phase 1|Progressive Disease|0|||
25195447|NCT01045421|50382175|FG002|Phase 1|Progressive Disease|0|||
25195448|NCT01045421|50382176|FG003|Phase 1|Progressive Disease|0|||
25195449|NCT01045421|50382177|FG004|Phase 1|Progressive Disease|1|||
25195450|NCT01045421|50382178|FG005|Phase 1|Progressive Disease|0|||
25195451|NCT01045421|50382179|FG006|Phase 1|Progressive Disease|0|||
25195452|NCT01045421|50382180|FG007|Phase 1|Progressive Disease|0|||
25195453|NCT01045421|50382181|FG008|Phase 1|Progressive Disease|0|||
25195454|NCT01045421|50382182|FG009|Phase 1|Progressive Disease|0|||
25195455|NCT01045421|50382183|FG010|Phase 1|Progressive Disease|0|||
25195456|NCT01045421|50382173|FG000|Phase 1|Withdrawal by Subject|0|||
25195457|NCT01045421|50382174|FG001|Phase 1|Withdrawal by Subject|0|||
25195458|NCT01045421|50382175|FG002|Phase 1|Withdrawal by Subject|0|||
25195459|NCT01045421|50382176|FG003|Phase 1|Withdrawal by Subject|1|||
25195460|NCT01045421|50382177|FG004|Phase 1|Withdrawal by Subject|0|||
25195461|NCT01045421|50382178|FG005|Phase 1|Withdrawal by Subject|0|||
25195462|NCT01045421|50382179|FG006|Phase 1|Withdrawal by Subject|0|||
25195463|NCT01045421|50382180|FG007|Phase 1|Withdrawal by Subject|0|||
25195464|NCT01045421|50382181|FG008|Phase 1|Withdrawal by Subject|0|||
25195465|NCT01045421|50382182|FG009|Phase 1|Withdrawal by Subject|0|||
25195466|NCT01045421|50382183|FG010|Phase 1|Withdrawal by Subject|0|||
25195467|NCT01045421|50382173|FG000|Phase 2|Progressive Disease|0|||
25195468|NCT01045421|50382174|FG001|Phase 2|Progressive Disease|0|||
25195469|NCT01045421|50382175|FG002|Phase 2|Progressive Disease|0|||
25195470|NCT01045421|50382176|FG003|Phase 2|Progressive Disease|0|||
25195471|NCT01045421|50382177|FG004|Phase 2|Progressive Disease|0|||
25195472|NCT01045421|50382178|FG005|Phase 2|Progressive Disease|0|||
25195473|NCT01045421|50382179|FG006|Phase 2|Progressive Disease|0|||
25195474|NCT01045421|50382180|FG007|Phase 2|Progressive Disease|1|||
25195475|NCT01045421|50382181|FG008|Phase 2|Progressive Disease|1|||
25195476|NCT01045421|50382182|FG009|Phase 2|Progressive Disease|1|||
25195477|NCT01045421|50382183|FG010|Phase 2|Progressive Disease|1|||
25195478|NCT01045421|50382173|FG000|Phase 2|Death|0|||
25195479|NCT01045421|50382174|FG001|Phase 2|Death|0|||
25195480|NCT01045421|50382175|FG002|Phase 2|Death|0|||
25195481|NCT01045421|50382176|FG003|Phase 2|Death|0|||
25195482|NCT01045421|50382177|FG004|Phase 2|Death|0|||
25195483|NCT01045421|50382178|FG005|Phase 2|Death|0|||
25195484|NCT01045421|50382179|FG006|Phase 2|Death|0|||
25195485|NCT01045421|50382180|FG007|Phase 2|Death|1|||
25195486|NCT01045421|50382181|FG008|Phase 2|Death|1|||
25195487|NCT01045421|50382182|FG009|Phase 2|Death|2|||
25195488|NCT01045421|50382183|FG010|Phase 2|Death|0|||
25195489|NCT01045421|50382173|FG000|Phase 2|Other|0|||
25195490|NCT01045421|50382174|FG001|Phase 2|Other|0|||
25195491|NCT01045421|50382175|FG002|Phase 2|Other|0|||
25195492|NCT01045421|50382176|FG003|Phase 2|Other|0|||
25195493|NCT01045421|50382177|FG004|Phase 2|Other|0|||
25195494|NCT01045421|50382178|FG005|Phase 2|Other|0|||
25195495|NCT01045421|50382179|FG006|Phase 2|Other|0|||
25195496|NCT01045421|50382180|FG007|Phase 2|Other|3|||
24976233|NCT00077649|50065141|FG002|Overall Study|Lost to Follow-up|3|||
24976234|NCT00077649|50065142|FG003|Overall Study|Lost to Follow-up|2|||
25195497|NCT01045421|50382181|FG008|Phase 2|Other|0|||
25195498|NCT01045421|50382182|FG009|Phase 2|Other|0|||
25195499|NCT01045421|50382183|FG010|Phase 2|Other|1|||
25195500|NCT01042535|50382231|FG000|Overall Study|disease progression prior to treatment|3|||
25195501|NCT01042535|50382231|FG000|Overall Study|disease progression during treatment|3|||
25195502|NCT01042535|50382231|FG000|Overall Study|complications from other disease|2|||
25195503|NCT01041287|50382237|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
25195504|NCT01041287|50382238|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
25195505|NCT01041287|50382237|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
25195506|NCT01041287|50382238|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
25195507|NCT01040351|50382259|FG000|Overall Study|poor ovarian response|1|||
25195508|NCT01040351|50382260|FG001|Overall Study|poor ovarian response|2|||
25195509|NCT02049957|50382280|FG000|Overall Study|Progressive Disease|5|||
25195510|NCT02049957|50382281|FG001|Overall Study|Progressive Disease|4|||
25195511|NCT02049957|50382282|FG002|Overall Study|Progressive Disease|2|||
25195512|NCT02049957|50382283|FG003|Overall Study|Progressive Disease|2|||
25195513|NCT02049957|50382284|FG004|Overall Study|Progressive Disease|6|||
25195514|NCT02049957|50382285|FG005|Overall Study|Progressive Disease|35|||
25195515|NCT02049957|50382286|FG006|Overall Study|Progressive Disease|7|||
25195516|NCT02049957|50382287|FG007|Overall Study|Progressive Disease|26|||
25195517|NCT02049957|50382288|FG008|Overall Study|Progressive Disease|6|||
25195518|NCT02049957|50382280|FG000|Overall Study|Adverse Event|1|||
25195519|NCT02049957|50382281|FG001|Overall Study|Adverse Event|1|||
25195520|NCT02049957|50382282|FG002|Overall Study|Adverse Event|1|||
25195521|NCT02049957|50382283|FG003|Overall Study|Adverse Event|0|||
25195522|NCT02049957|50382284|FG004|Overall Study|Adverse Event|0|||
25195523|NCT02049957|50382285|FG005|Overall Study|Adverse Event|5|||
25195524|NCT02049957|50382286|FG006|Overall Study|Adverse Event|0|||
25195525|NCT02049957|50382287|FG007|Overall Study|Adverse Event|6|||
25195526|NCT02049957|50382288|FG008|Overall Study|Adverse Event|1|||
25195527|NCT02049957|50382280|FG000|Overall Study|Study Terminated by Sponsor|0|||
25195528|NCT02049957|50382281|FG001|Overall Study|Study Terminated by Sponsor|1|||
25195529|NCT02049957|50382282|FG002|Overall Study|Study Terminated by Sponsor|0|||
25195530|NCT02049957|50382283|FG003|Overall Study|Study Terminated by Sponsor|0|||
25195531|NCT02049957|50382284|FG004|Overall Study|Study Terminated by Sponsor|0|||
25195532|NCT02049957|50382285|FG005|Overall Study|Study Terminated by Sponsor|0|||
25195533|NCT02049957|50382286|FG006|Overall Study|Study Terminated by Sponsor|1|||
25195534|NCT02049957|50382287|FG007|Overall Study|Study Terminated by Sponsor|0|||
25195535|NCT02049957|50382288|FG008|Overall Study|Study Terminated by Sponsor|0|||
25195536|NCT02049957|50382280|FG000|Overall Study|Withdrawal by Subject|0|||
25195537|NCT02049957|50382281|FG001|Overall Study|Withdrawal by Subject|0|||
25195538|NCT02049957|50382282|FG002|Overall Study|Withdrawal by Subject|0|||
25195539|NCT02049957|50382283|FG003|Overall Study|Withdrawal by Subject|1|||
25195540|NCT02049957|50382284|FG004|Overall Study|Withdrawal by Subject|0|||
25195541|NCT02049957|50382285|FG005|Overall Study|Withdrawal by Subject|2|||
25195542|NCT02049957|50382286|FG006|Overall Study|Withdrawal by Subject|0|||
25195543|NCT02049957|50382287|FG007|Overall Study|Withdrawal by Subject|3|||
25195544|NCT02049957|50382288|FG008|Overall Study|Withdrawal by Subject|1|||
25195545|NCT02049957|50382280|FG000|Overall Study|Physician Decision|0|||
25195546|NCT02049957|50382281|FG001|Overall Study|Physician Decision|0|||
25195547|NCT02049957|50382282|FG002|Overall Study|Physician Decision|0|||
25195548|NCT02049957|50382283|FG003|Overall Study|Physician Decision|0|||
25195549|NCT02049957|50382284|FG004|Overall Study|Physician Decision|0|||
25195550|NCT02049957|50382285|FG005|Overall Study|Physician Decision|1|||
25195551|NCT02049957|50382286|FG006|Overall Study|Physician Decision|0|||
25195552|NCT02049957|50382287|FG007|Overall Study|Physician Decision|0|||
25195553|NCT02049957|50382288|FG008|Overall Study|Physician Decision|0|||
25195554|NCT00014495|50382551|FG000|Overall Study|Death|0|||
25195555|NCT00014495|50382552|FG001|Overall Study|Death|0|||
25195556|NCT00014495|50382553|FG002|Overall Study|Death|1|||
25195557|NCT00014495|50382554|FG003|Overall Study|Death|0|||
25195558|NCT00014495|50382551|FG000|Overall Study|Clinical deterioration|0|||
25195559|NCT00014495|50382552|FG001|Overall Study|Clinical deterioration|0|||
25195560|NCT00014495|50382553|FG002|Overall Study|Clinical deterioration|0|||
25195561|NCT00014495|50382554|FG003|Overall Study|Clinical deterioration|1|||
25195562|NCT01351623|50384589|FG000|Overall Study|Protocol Violation|2|||
25195563|NCT01351623|50384589|FG000|Overall Study|Adverse Event|4|||
25195564|NCT01351623|50384589|FG000|Overall Study|Withdrawal by Subject|1|||
25195565|NCT01351623|50384589|FG000|Overall Study|Death|2|||
25195566|NCT03670953|50384726|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
25195567|NCT03670953|50384727|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
25195568|NCT03670953|50384728|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
25195569|NCT03670953|50384729|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
25195570|NCT03670953|50384726|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
25195571|NCT03670953|50384727|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
25195572|NCT03670953|50384728|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
25195573|NCT03670953|50384729|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
25195574|NCT03670953|50384726|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
25195575|NCT03670953|50384727|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
25195576|NCT03670953|50384728|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
25195577|NCT03670953|50384729|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
25195578|NCT03670953|50384726|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
25195579|NCT03670953|50384727|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
25195580|NCT03670953|50384728|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
25195581|NCT03670953|50384729|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
25195582|NCT03670953|50384726|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
25195583|NCT03670953|50384727|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
25195584|NCT03670953|50384728|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
25195585|NCT03670953|50384729|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
25195586|NCT03670953|50384726|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
25195587|NCT03670953|50384727|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
25195588|NCT03670953|50384728|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
25195589|NCT03670953|50384729|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
25195590|NCT03670953|50384726|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
25195591|NCT03670953|50384727|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
25195592|NCT03670953|50384728|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
25195593|NCT03670953|50384729|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
25195594|NCT03670953|50384726|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
25195595|NCT03670953|50384727|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
25195596|NCT03670953|50384728|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
25195597|NCT03670953|50384729|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
25195598|NCT03670953|50384726|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
25195599|NCT03670953|50384727|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
25195600|NCT03670953|50384728|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
25195601|NCT03670953|50384729|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
25195602|NCT03670953|50384726|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
25195603|NCT03670953|50384727|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
25195604|NCT03670953|50384728|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
25195605|NCT03670953|50384729|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
25195606|NCT03670953|50384726|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
25195607|NCT03670953|50384727|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
25195608|NCT03670953|50384728|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
25195609|NCT03670953|50384729|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
25195610|NCT03670953|50384726|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
25195611|NCT03670953|50384727|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
25195612|NCT03670953|50384728|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
25195613|NCT03670953|50384729|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
25195614|NCT03670953|50384726|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
25195615|NCT03670953|50384727|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
25195616|NCT03670953|50384728|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
25195617|NCT03670953|50384729|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
25195618|NCT03670953|50384726|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
25195619|NCT03670953|50384727|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
25195620|NCT03670953|50384728|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
25195621|NCT03670953|50384729|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
25195622|NCT03670953|50384726|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
25195623|NCT03670953|50384727|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
25195624|NCT03670953|50384728|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
25195625|NCT03670953|50384729|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
25195626|NCT03670953|50384726|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
25195627|NCT03670953|50384727|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
25195628|NCT03670953|50384728|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
25195629|NCT03670953|50384729|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
25195630|NCT03670953|50384726|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
25195631|NCT03670953|50384727|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
25195632|NCT03670953|50384728|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
25195633|NCT03670953|50384729|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
25195634|NCT03670953|50384726|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
25195635|NCT03670953|50384727|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
25195636|NCT03670953|50384728|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
25195637|NCT03670953|50384729|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
25195638|NCT02519348|50384780|FG000|Overall Study|Death|31|||
25195639|NCT02519348|50384781|FG001|Overall Study|Death|74|||
25195640|NCT02519348|50384782|FG002|Overall Study|Death|47|||
25195641|NCT02519348|50384783|FG003|Overall Study|Death|54|||
25195642|NCT02519348|50384784|FG004|Overall Study|Death|63|||
25195643|NCT02519348|50384785|FG005|Overall Study|Death|18|||
25195644|NCT02519348|50384786|FG006|Overall Study|Death|2|||
25195645|NCT02519348|50384787|FG007|Overall Study|Death|5|||
25195646|NCT02519348|50384788|FG008|Overall Study|Death|5|||
25195647|NCT02519348|50384780|FG000|Overall Study|Withdrawal by Subject|4|||
25195648|NCT02519348|50384781|FG001|Overall Study|Withdrawal by Subject|7|||
25195649|NCT02519348|50384782|FG002|Overall Study|Withdrawal by Subject|4|||
25195650|NCT02519348|50384783|FG003|Overall Study|Withdrawal by Subject|3|||
25195651|NCT02519348|50384784|FG004|Overall Study|Withdrawal by Subject|3|||
25195652|NCT02519348|50384785|FG005|Overall Study|Withdrawal by Subject|2|||
25195653|NCT02519348|50384786|FG006|Overall Study|Withdrawal by Subject|0|||
25195654|NCT02519348|50384787|FG007|Overall Study|Withdrawal by Subject|0|||
25195655|NCT02519348|50384788|FG008|Overall Study|Withdrawal by Subject|1|||
25195656|NCT02519348|50384780|FG000|Overall Study|Lost to Follow-up|0|||
25195657|NCT02519348|50384781|FG001|Overall Study|Lost to Follow-up|0|||
25195658|NCT02519348|50384782|FG002|Overall Study|Lost to Follow-up|1|||
25195659|NCT02519348|50384783|FG003|Overall Study|Lost to Follow-up|0|||
25195660|NCT02519348|50384784|FG004|Overall Study|Lost to Follow-up|2|||
25195661|NCT02519348|50384785|FG005|Overall Study|Lost to Follow-up|1|||
25195662|NCT02519348|50384786|FG006|Overall Study|Lost to Follow-up|1|||
25195663|NCT02519348|50384787|FG007|Overall Study|Lost to Follow-up|0|||
25195664|NCT02519348|50384788|FG008|Overall Study|Lost to Follow-up|0|||
25195665|NCT02519348|50384780|FG000|Overall Study|Other|0|||
25195666|NCT02519348|50384781|FG001|Overall Study|Other|3|||
25195667|NCT02519348|50384782|FG002|Overall Study|Other|0|||
25195668|NCT02519348|50384783|FG003|Overall Study|Other|0|||
25195669|NCT02519348|50384784|FG004|Overall Study|Other|1|||
25195670|NCT02519348|50384785|FG005|Overall Study|Other|0|||
25195671|NCT02519348|50384786|FG006|Overall Study|Other|0|||
25195672|NCT02519348|50384787|FG007|Overall Study|Other|0|||
25195673|NCT02519348|50384788|FG008|Overall Study|Other|0|||
25195674|NCT02519348|50384780|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
25195675|NCT02519348|50384781|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
25195676|NCT02519348|50384782|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
25195677|NCT02519348|50384783|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
25195678|NCT02519348|50384784|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
25195679|NCT02519348|50384785|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
25195680|NCT02519348|50384786|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
25195681|NCT02519348|50384787|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
25195682|NCT02519348|50384788|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
25195683|NCT00636818|50384809|FG000|Overall Study|Adverse Event|1|||
25195684|NCT00636818|50384809|FG000|Overall Study|Lost to Follow-up|2|||
25195685|NCT00636818|50384809|FG000|Overall Study|Entry Criteria Exclusion|3|||
25195686|NCT00636818|50384809|FG000|Overall Study|Protocol Violation|1|||
25195687|NCT00636818|50384809|FG000|Overall Study|Withdrawal by Subject|4|||
25195688|NCT03127137|50384815|FG000|Overall Study|Requested sedation after consent|1|||
25195689|NCT03127137|50384816|FG001|Overall Study|Requested sedation after consent|0|||
25195690|NCT03127137|50384815|FG000|Overall Study|Malfunction in electronic data collection|1|||
25195691|NCT03127137|50384816|FG001|Overall Study|Malfunction in electronic data collection|0|||
25195692|NCT03127137|50384815|FG000|Overall Study|Post procedure testing could not be obtained|0|||
25195693|NCT03127137|50384816|FG001|Overall Study|Post procedure testing could not be obtained|1|||
25195694|NCT00636506|50384824|FG000|Overall Study|Lost to Follow-up|8|||
25170659|NCT02724462|50306546|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
25170660|NCT02724462|50306545|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
25170661|NCT02724462|50306546|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
25170662|NCT02724462|50306545|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
25170663|NCT02724462|50306546|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
25170664|NCT02724462|50306545|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
25170665|NCT02724462|50306546|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
25170666|NCT02725476|50306603|FG000|Overall Study|Physician Decision|2|||
25170667|NCT02725476|50306604|FG001|Overall Study|Physician Decision|0|||
25170668|NCT02725476|50306603|FG000|Overall Study|Adverse Event|1|||
25170669|NCT02725476|50306604|FG001|Overall Study|Adverse Event|1|||
25170670|NCT02725008|50306709|FG000|Overall Study|Lost to Follow-up|7|||
25170671|NCT02725008|50306710|FG001|Overall Study|Lost to Follow-up|9|||
25170672|NCT02725008|50306709|FG000|Overall Study|Withdrawal by Subject|2|||
25170673|NCT02725008|50306710|FG001|Overall Study|Withdrawal by Subject|2|||
25170674|NCT02725008|50306709|FG000|Overall Study|Admitted to hospital|0|||
25170675|NCT02725008|50306710|FG001|Overall Study|Admitted to hospital|1|||
25170676|NCT01807949|50306982|FG000|Overall Study|Adverse Event|1|||
25170677|NCT01807949|50306983|FG001|Overall Study|Adverse Event|2|||
25170678|NCT01807949|50306984|FG002|Overall Study|Adverse Event|2|||
25170679|NCT01807949|50306982|FG000|Overall Study|Withdrawal by Subject|1|||
25170680|NCT01807949|50306983|FG001|Overall Study|Withdrawal by Subject|2|||
25170681|NCT01807949|50306984|FG002|Overall Study|Withdrawal by Subject|2|||
25170682|NCT01807949|50306982|FG000|Overall Study|Non-Compliance|0|||
25170683|NCT01807949|50306983|FG001|Overall Study|Non-Compliance|0|||
25170684|NCT01807949|50306984|FG002|Overall Study|Non-Compliance|1|||
25170685|NCT01807949|50306982|FG000|Overall Study|Undefined|0|||
25170686|NCT01807949|50306983|FG001|Overall Study|Undefined|1|||
25170687|NCT01807949|50306984|FG002|Overall Study|Undefined|2|||
25195695|NCT00636506|50384824|FG000|Overall Study|Explanted|1|||
25195696|NCT00636506|50384824|FG000|Overall Study|Withdrawal by Subject|6|||
25195697|NCT00636506|50384824|FG000|Overall Study|Procedure aborted|1|||
25195698|NCT00636194|50384848|FG000|Overall Study|Study related symptoms and complaints|1|||
25195699|NCT00636194|50384849|FG001|Overall Study|Study related symptoms and complaints|0|||
25195700|NCT00636194|50384848|FG000|Overall Study|Protocol Violation|2|||
25195701|NCT00636194|50384849|FG001|Overall Study|Protocol Violation|0|||
25195702|NCT00635804|50384915|FG000|Overall Study|Adverse Event|0|||
25195703|NCT00635804|50384916|FG001|Overall Study|Adverse Event|0|||
25195704|NCT00635804|50384917|FG002|Overall Study|Adverse Event|0|||
25195705|NCT00635804|50384918|FG003|Overall Study|Adverse Event|0|||
25195706|NCT00635804|50384919|FG004|Overall Study|Adverse Event|0|||
25195707|NCT00635804|50384920|FG005|Overall Study|Adverse Event|1|||
25195708|NCT00635804|50384921|FG006|Overall Study|Adverse Event|0|||
25195709|NCT00635804|50384922|FG007|Overall Study|Adverse Event|0|||
25195710|NCT00635804|50384915|FG000|Overall Study|Withdrawal by Subject|1|||
25195711|NCT00635804|50384916|FG001|Overall Study|Withdrawal by Subject|0|||
25195712|NCT00635804|50384917|FG002|Overall Study|Withdrawal by Subject|0|||
25195713|NCT00635804|50384918|FG003|Overall Study|Withdrawal by Subject|0|||
25195714|NCT00635804|50384919|FG004|Overall Study|Withdrawal by Subject|0|||
25195715|NCT00635804|50384920|FG005|Overall Study|Withdrawal by Subject|0|||
25195716|NCT00635804|50384921|FG006|Overall Study|Withdrawal by Subject|0|||
25195717|NCT00635804|50384922|FG007|Overall Study|Withdrawal by Subject|0|||
25195718|NCT00635648|50384952|FG000|Overall Study|Adverse Event|12|||
25195719|NCT00635648|50384952|FG000|Overall Study|Withdrawal by Subject|9|||
25195720|NCT00635648|50384952|FG000|Overall Study|Physician Decision|4|||
25195721|NCT00635648|50384952|FG000|Overall Study|Rapid progression of baseline disease|4|||
25195722|NCT00635648|50384952|FG000|Overall Study|Use of other antifungal agent needed|1|||
25195723|NCT00635648|50384952|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
25195724|NCT00635648|50384952|FG000|Overall Study|Noncompliance with protocol|1|||
25195725|NCT00635648|50384952|FG000|Overall Study|Other reason|2|||
25195726|NCT00635102|50384977|FG000|Overall Study|Withdrawal by Subject|7|||
25195727|NCT00635102|50384978|FG001|Overall Study|Withdrawal by Subject|8|||
25195728|NCT00635024|50384993|FG000|Overall Study|Adverse Event|1|||
25195729|NCT00634244|50385042|FG000|Overall Study|Never started treatment|0|||
25195730|NCT00634244|50385043|FG001|Overall Study|Never started treatment|1|||
25195731|NCT00634244|50385044|FG002|Overall Study|Never started treatment|0|||
25195732|NCT00634244|50385042|FG000|Overall Study|Death|1|||
25195733|NCT00634244|50385043|FG001|Overall Study|Death|6|||
25195734|NCT00634244|50385044|FG002|Overall Study|Death|0|||
25195735|NCT00634244|50385042|FG000|Overall Study|Adverse Event|0|||
25195736|NCT00634244|50385043|FG001|Overall Study|Adverse Event|2|||
25195737|NCT00634244|50385044|FG002|Overall Study|Adverse Event|0|||
25195738|NCT00634244|50385042|FG000|Overall Study|Withdrawal by Subject|0|||
25195739|NCT00634244|50385043|FG001|Overall Study|Withdrawal by Subject|1|||
25195740|NCT00634244|50385044|FG002|Overall Study|Withdrawal by Subject|0|||
25195741|NCT00634244|50385042|FG000|Overall Study|Physician Decision|0|||
25195742|NCT00634244|50385043|FG001|Overall Study|Physician Decision|1|||
25195743|NCT00634244|50385044|FG002|Overall Study|Physician Decision|0|||
25195744|NCT00634244|50385042|FG000|Overall Study|Disease progression/relapse|0|||
25195745|NCT00634244|50385043|FG001|Overall Study|Disease progression/relapse|1|||
25195746|NCT00634244|50385044|FG002|Overall Study|Disease progression/relapse|0|||
25195747|NCT00634244|50385042|FG000|Overall Study|Other complicating disease|0|||
25195748|NCT00634244|50385043|FG001|Overall Study|Other complicating disease|1|||
25195749|NCT00634244|50385044|FG002|Overall Study|Other complicating disease|0|||
25195750|NCT00634088|50385228|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
25195751|NCT00634088|50385229|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
25195752|NCT00634088|50385230|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
25195753|NCT00634088|50385231|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
25195754|NCT00634088|50385228|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
25195755|NCT00634088|50385229|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
25195756|NCT00634088|50385230|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
25195757|NCT00634088|50385231|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
25195758|NCT00634088|50385228|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
25195759|NCT00634088|50385229|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
25195760|NCT00634088|50385230|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
25195761|NCT00634088|50385231|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
25195762|NCT00634088|50385228|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
25195763|NCT00634088|50385229|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
25195764|NCT00634088|50385230|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
25195765|NCT00634088|50385231|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
25195766|NCT00634088|50385228|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
25195767|NCT00634088|50385229|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
25195768|NCT00634088|50385230|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
25195769|NCT00634088|50385231|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
25195770|NCT00634088|50385228|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
25195771|NCT00634088|50385229|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
25195772|NCT00634088|50385230|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
25195773|NCT00634088|50385231|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
25195774|NCT00634010|50385331|FG000|Overall Study|Adverse Event|2|||
25195775|NCT00634010|50385332|FG001|Overall Study|Adverse Event|5|||
25195776|NCT00634010|50385331|FG000|Overall Study|Withdrawal by Subject|5|||
25195777|NCT00634010|50385332|FG001|Overall Study|Withdrawal by Subject|6|||
25195778|NCT00634010|50385331|FG000|Overall Study|Physician Decision|1|||
25195779|NCT00634010|50385332|FG001|Overall Study|Physician Decision|1|||
25195780|NCT00634010|50385331|FG000|Overall Study|Disease Progression|1|||
25195781|NCT00634010|50385332|FG001|Overall Study|Disease Progression|1|||
25195782|NCT00634010|50385331|FG000|Overall Study|Non-Compliant|1|||
25195783|NCT00634010|50385332|FG001|Overall Study|Non-Compliant|1|||
25195784|NCT00633932|50385345|FG000|Overall Study|Adverse Event|1|||
25195785|NCT00633932|50385346|FG001|Overall Study|Adverse Event|3|||
25195786|NCT00633932|50385347|FG002|Overall Study|Adverse Event|4|||
25195787|NCT00633932|50385345|FG000|Overall Study|Withdrawal by Subject|3|||
25195788|NCT00633932|50385346|FG001|Overall Study|Withdrawal by Subject|9|||
25195789|NCT00633932|50385347|FG002|Overall Study|Withdrawal by Subject|1|||
25195790|NCT00633932|50385345|FG000|Overall Study|Lost to Follow-up|1|||
25195791|NCT00633932|50385346|FG001|Overall Study|Lost to Follow-up|0|||
25195792|NCT00633932|50385347|FG002|Overall Study|Lost to Follow-up|2|||
25195793|NCT00633932|50385345|FG000|Overall Study|Protocol Violation|5|||
25195794|NCT00633932|50385346|FG001|Overall Study|Protocol Violation|2|||
25195795|NCT00633932|50385347|FG002|Overall Study|Protocol Violation|3|||
25195796|NCT00633932|50385345|FG000|Overall Study|Physician Decision|0|||
25195797|NCT00633932|50385346|FG001|Overall Study|Physician Decision|0|||
25195798|NCT00633932|50385347|FG002|Overall Study|Physician Decision|1|||
25195799|NCT00633932|50385345|FG000|Overall Study|Doctor's judgement|1|||
25195800|NCT00633932|50385346|FG001|Overall Study|Doctor's judgement|0|||
25195801|NCT00633932|50385347|FG002|Overall Study|Doctor's judgement|0|||
25195802|NCT00633932|50385345|FG000|Overall Study|Moved Away|1|||
25195803|NCT00633932|50385346|FG001|Overall Study|Moved Away|0|||
25195804|NCT00633932|50385347|FG002|Overall Study|Moved Away|0|||
25195805|NCT00633464|50385477|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
25195806|NCT00633464|50385478|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
25195807|NCT00633464|50385477|FG000|Overall Study|Never Treated (Randomized in error)|0|||
25195808|NCT00633464|50385478|FG001|Overall Study|Never Treated (Randomized in error)|1|||
25195809|NCT00633152|50385519|FG000|Overall Study|Adverse Event|1|||
25195810|NCT00633152|50385520|FG001|Overall Study|Adverse Event|0|||
25195811|NCT00633152|50385519|FG000|Overall Study|Randomized, did not receive study drug|5|||
25195812|NCT00633152|50385520|FG001|Overall Study|Randomized, did not receive study drug|2|||
25195813|NCT00633152|50385519|FG000|Overall Study|Withdrawal by Subject|1|||
25195814|NCT00633152|50385520|FG001|Overall Study|Withdrawal by Subject|1|||
25195815|NCT00633152|50385519|FG000|Overall Study|Lost to Follow-up|4|||
25195816|NCT00633152|50385520|FG001|Overall Study|Lost to Follow-up|1|||
25195817|NCT00633152|50385519|FG000|Overall Study|Miscellaneous Other|3|||
25195818|NCT00633152|50385520|FG001|Overall Study|Miscellaneous Other|2|||
25195819|NCT00633074|50385539|FG000|Overall Study|Adverse Event|1|||
25195820|NCT00633074|50385540|FG001|Overall Study|Adverse Event|0|||
25195821|NCT00630344|50385727|FG000|Overall Study|Adverse Event|5|||
25195822|NCT00630344|50385727|FG000|Overall Study|Progressive Disease|19|||
25195823|NCT00630344|50385727|FG000|Overall Study|Physician Decision|9|||
25195824|NCT00630344|50385727|FG000|Overall Study|Withdrawal by Subject|1|||
25195825|NCT00630344|50385727|FG000|Overall Study|Intercurrent Illness|1|||
25195826|NCT00630344|50385727|FG000|Overall Study|Other|1|||
25195827|NCT02913261|50385753|FG000|Overall Study|Technical problems|0|||
25195828|NCT02913261|50385754|FG001|Overall Study|Technical problems|1|||
25195829|NCT02913261|50385753|FG000|Overall Study|Lack of Efficacy|32|||
25195830|NCT02913261|50385754|FG001|Overall Study|Lack of Efficacy|69|||
25195831|NCT02913261|50385753|FG000|Overall Study|Adverse Event|27|||
25195832|NCT02913261|50385754|FG001|Overall Study|Adverse Event|5|||
25195833|NCT02913261|50385753|FG000|Overall Study|Death|25|||
25195834|NCT02913261|50385754|FG001|Overall Study|Death|22|||
25195835|NCT02913261|50385753|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
25195836|NCT02913261|50385754|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
25195837|NCT02913261|50385753|FG000|Overall Study|Disease relapse|8|||
25195838|NCT02913261|50385754|FG001|Overall Study|Disease relapse|13|||
25195839|NCT02913261|50385753|FG000|Overall Study|Physician Decision|8|||
25195840|NCT02913261|50385754|FG001|Overall Study|Physician Decision|9|||
25195841|NCT02913261|50385753|FG000|Overall Study|Subject/guardian decision|4|||
25195842|NCT02913261|50385754|FG001|Overall Study|Subject/guardian decision|6|||
25195843|NCT02913261|50385753|FG000|Overall Study|Graft loss|2|||
25195844|NCT02913261|50385754|FG001|Overall Study|Graft loss|0|||
25195845|NCT00635882|50385818|FG000|Overall Study|Protocol Violation|1|||
25195846|NCT00635882|50385819|FG001|Overall Study|Protocol Violation|0|||
25195847|NCT00635882|50385820|FG002|Overall Study|Protocol Violation|0|||
25195848|NCT00635882|50385821|FG003|Overall Study|Protocol Violation|0|||
25195849|NCT00635882|50385822|FG004|Overall Study|Protocol Violation|0|||
25195850|NCT00635882|50385823|FG005|Overall Study|Protocol Violation|0|||
25195851|NCT00986570|50386074|FG000|Overall Study|Lost to Follow-up|6|||
25195852|NCT00986570|50386074|FG000|Overall Study|Potential bias for objective assessment|1|||
25195853|NCT00986258|50386078|FG000|Observation Period|Not eligible to be dosed|11|||
25195854|NCT00986258|50386078|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
25195855|NCT00986258|50386078|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
25195856|NCT00986258|50386078|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
25195857|NCT00986258|50386078|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
25195858|NCT00986258|50386078|FG000|Titration and Optimal Dose Period|Other|1|||
25195859|NCT00986258|50386078|FG000|Maintenance Period|Adverse Event|5|||
25195860|NCT00986258|50386078|FG000|Maintenance Period|Lack of Efficacy|2|||
25195861|NCT00986258|50386078|FG000|Maintenance Period|Withdrawal by Subject|2|||
25195862|NCT00986180|50386094|FG000|Overall Study|Adverse Event|21|||
25195863|NCT00986180|50386095|FG001|Overall Study|Adverse Event|23|||
25195864|NCT00986180|50386094|FG000|Overall Study|Lack of Efficacy|4|||
25195865|NCT00986180|50386095|FG001|Overall Study|Lack of Efficacy|3|||
25195866|NCT00986180|50386094|FG000|Overall Study|Lost to Follow-up|5|||
25195867|NCT00986180|50386095|FG001|Overall Study|Lost to Follow-up|7|||
25195868|NCT00986180|50386094|FG000|Overall Study|Physician Decision|1|||
25195869|NCT00986180|50386095|FG001|Overall Study|Physician Decision|3|||
25195870|NCT00986180|50386094|FG000|Overall Study|Protocol Violation|2|||
25195871|NCT00986180|50386095|FG001|Overall Study|Protocol Violation|0|||
25195872|NCT00986180|50386094|FG000|Overall Study|Withdrawal by Subject|1|||
25195873|NCT00986180|50386095|FG001|Overall Study|Withdrawal by Subject|9|||
25195874|NCT00986180|50386094|FG000|Overall Study|Miscellanies|10|||
25195875|NCT00986180|50386095|FG001|Overall Study|Miscellanies|11|||
25195876|NCT00986102|50386277|FG000|Overall Study|Lost to Follow-up|0|||
25195877|NCT00986102|50386278|FG001|Overall Study|Lost to Follow-up|1|||
25195878|NCT00986102|50386279|FG002|Overall Study|Lost to Follow-up|0|||
25195879|NCT00986102|50386280|FG003|Overall Study|Lost to Follow-up|1|||
25195880|NCT00986102|50386277|FG000|Overall Study|Withdrawal by Subject|1|||
25195881|NCT00986102|50386278|FG001|Overall Study|Withdrawal by Subject|1|||
25195882|NCT00986102|50386279|FG002|Overall Study|Withdrawal by Subject|0|||
25195883|NCT00986102|50386280|FG003|Overall Study|Withdrawal by Subject|0|||
25195884|NCT00985946|50386303|FG000|Overall Study|Lost to Follow-up|6|||
25195885|NCT00985946|50386303|FG000|Overall Study|Withdrawal by Subject|1|||
25195886|NCT00985790|50386318|FG000|Overall Study|Withdrawal by Subject|1|||
25195887|NCT00985790|50386319|FG001|Overall Study|Withdrawal by Subject|1|||
25195888|NCT00985790|50386318|FG000|Overall Study|Lost to Follow-up|6|||
25314938|NCT00973349|50630830|FG011|Overall Study|Withdrawal by Subject|1|||
25314939|NCT00973349|50630831|FG012|Overall Study|Withdrawal by Subject|0|||
25314940|NCT00973349|50630832|FG013|Overall Study|Withdrawal by Subject|0|||
25314941|NCT00973349|50630833|FG014|Overall Study|Withdrawal by Subject|0|||
25314942|NCT00973349|50630834|FG015|Overall Study|Withdrawal by Subject|0|||
25314943|NCT00973349|50630819|FG000|Overall Study|Lost to Follow-up|3|||
25314944|NCT00973349|50630820|FG001|Overall Study|Lost to Follow-up|1|||
25314945|NCT00973349|50630821|FG002|Overall Study|Lost to Follow-up|2|||
25314946|NCT00973349|50630822|FG003|Overall Study|Lost to Follow-up|2|||
25314947|NCT00973349|50630823|FG004|Overall Study|Lost to Follow-up|1|||
25314948|NCT00973349|50630824|FG005|Overall Study|Lost to Follow-up|3|||
25314949|NCT00973349|50630825|FG006|Overall Study|Lost to Follow-up|0|||
25314950|NCT00973349|50630826|FG007|Overall Study|Lost to Follow-up|1|||
25314951|NCT00973349|50630827|FG008|Overall Study|Lost to Follow-up|2|||
25314952|NCT00973349|50630828|FG009|Overall Study|Lost to Follow-up|1|||
25314953|NCT00973349|50630829|FG010|Overall Study|Lost to Follow-up|0|||
25314954|NCT00973349|50630830|FG011|Overall Study|Lost to Follow-up|1|||
25314955|NCT00973349|50630831|FG012|Overall Study|Lost to Follow-up|0|||
25314956|NCT00973349|50630832|FG013|Overall Study|Lost to Follow-up|0|||
25314957|NCT00973349|50630833|FG014|Overall Study|Lost to Follow-up|0|||
25314958|NCT00973349|50630834|FG015|Overall Study|Lost to Follow-up|1|||
25314959|NCT00973349|50630819|FG000|Overall Study|Inappropriate enrolment|0|||
25314960|NCT00973349|50630820|FG001|Overall Study|Inappropriate enrolment|0|||
25314961|NCT00973349|50630821|FG002|Overall Study|Inappropriate enrolment|1|||
25314962|NCT00973349|50630822|FG003|Overall Study|Inappropriate enrolment|0|||
25314963|NCT00973349|50630823|FG004|Overall Study|Inappropriate enrolment|0|||
25076998|NCT02499770|50184782|FG000|Overall Study|Death|17|||
25314964|NCT00973349|50630824|FG005|Overall Study|Inappropriate enrolment|0|||
25076999|NCT02499770|50184783|FG001|Overall Study|Death|56|||
25195889|NCT00985790|50386319|FG001|Overall Study|Lost to Follow-up|7|||
25195890|NCT00985712|50386346|FG000|Overall Study|Adverse Event|0|||
25195891|NCT00985712|50386347|FG001|Overall Study|Adverse Event|1|||
25195892|NCT00985712|50386346|FG000|Overall Study|Lost to Follow-up|2|||
25195893|NCT00985712|50386347|FG001|Overall Study|Lost to Follow-up|2|||
25195894|NCT00985712|50386346|FG000|Overall Study|Protocol Violation|0|||
25195895|NCT00985712|50386347|FG001|Overall Study|Protocol Violation|1|||
25195896|NCT00985712|50386346|FG000|Overall Study|Withdrawal by Subject|4|||
25195897|NCT00985712|50386347|FG001|Overall Study|Withdrawal by Subject|1|||
25195898|NCT00985712|50386346|FG000|Overall Study|Sponsor decision|0|||
25195899|NCT00985712|50386347|FG001|Overall Study|Sponsor decision|2|||
25195900|NCT00985166|50386454|FG000|Overall Study|Lost to Follow-up|3|||
25195901|NCT00985166|50386455|FG001|Overall Study|Lost to Follow-up|2|||
25195902|NCT00985166|50386456|FG002|Overall Study|Lost to Follow-up|2|||
25195903|NCT00985166|50386454|FG000|Overall Study|Withdrawal by Subject|3|||
25195904|NCT00985166|50386455|FG001|Overall Study|Withdrawal by Subject|2|||
25195905|NCT00985166|50386456|FG002|Overall Study|Withdrawal by Subject|0|||
25195906|NCT00985166|50386454|FG000|Overall Study|Test not done|2|||
25195907|NCT00985166|50386455|FG001|Overall Study|Test not done|0|||
25195908|NCT00985166|50386456|FG002|Overall Study|Test not done|4|||
25195909|NCT00985166|50386454|FG000|Overall Study|Other|1|||
25195910|NCT00985166|50386455|FG001|Overall Study|Other|0|||
25195911|NCT00985166|50386456|FG002|Overall Study|Other|1|||
25195912|NCT02184195|50386618|FG000|Overall Study|Patients ongoing Study Treatment|19|||
25195913|NCT02184195|50386619|FG001|Overall Study|Patients ongoing Study Treatment|7|||
25195914|NCT01341405|50386711|FG000|Overall Study|Adverse Event|0|||
25195915|NCT01341405|50386712|FG001|Overall Study|Adverse Event|1|||
25195916|NCT01341405|50386713|FG002|Overall Study|Adverse Event|1|||
25195917|NCT01341405|50386711|FG000|Overall Study|Withdrawal by Subject|3|||
25195918|NCT01341405|50386712|FG001|Overall Study|Withdrawal by Subject|2|||
25195919|NCT01341405|50386713|FG002|Overall Study|Withdrawal by Subject|1|||
25195920|NCT00633945|50387986|FG000|Overall Study|Physician Decision|2|||
25195921|NCT02574078|50388250|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25195922|NCT02574078|50388251|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25195923|NCT02574078|50388252|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25195924|NCT02574078|50388253|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25195925|NCT02574078|50388254|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25195926|NCT02574078|50388255|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
25195927|NCT02574078|50388256|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
25195928|NCT02574078|50388257|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25195929|NCT02574078|50388258|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
25195930|NCT02574078|50388259|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25195931|NCT02574078|50388260|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25195932|NCT02574078|50388261|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25195933|NCT02574078|50388262|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25195934|NCT02574078|50388250|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
25195935|NCT02574078|50388251|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
25195936|NCT02574078|50388252|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
25195937|NCT02574078|50388253|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
25195938|NCT02574078|50388254|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
25195939|NCT02574078|50388255|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
25195940|NCT02574078|50388256|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
25195941|NCT02574078|50388257|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
25195942|NCT02574078|50388258|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
25195943|NCT02574078|50388259|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
25195944|NCT02574078|50388260|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
25195945|NCT02574078|50388261|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
25195946|NCT02574078|50388262|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
25195947|NCT02574078|50388250|FG000|Pre-Treatment Period|Other reasons|0|||
25195948|NCT02574078|50388251|FG001|Pre-Treatment Period|Other reasons|0|||
25195949|NCT02574078|50388252|FG002|Pre-Treatment Period|Other reasons|0|||
25195950|NCT02574078|50388253|FG003|Pre-Treatment Period|Other reasons|0|||
25195951|NCT02574078|50388254|FG004|Pre-Treatment Period|Other reasons|0|||
25195952|NCT02574078|50388255|FG005|Pre-Treatment Period|Other reasons|0|||
25195953|NCT02574078|50388256|FG006|Pre-Treatment Period|Other reasons|2|||
25195954|NCT02574078|50388257|FG007|Pre-Treatment Period|Other reasons|0|||
25195955|NCT02574078|50388258|FG008|Pre-Treatment Period|Other reasons|0|||
25195956|NCT02574078|50388259|FG009|Pre-Treatment Period|Other reasons|0|||
25195957|NCT02574078|50388260|FG010|Pre-Treatment Period|Other reasons|2|||
25195958|NCT02574078|50388261|FG011|Pre-Treatment Period|Other reasons|0|||
25195959|NCT02574078|50388262|FG012|Pre-Treatment Period|Other reasons|0|||
25195960|NCT02574078|50388250|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
25195961|NCT02574078|50388251|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
25195962|NCT02574078|50388252|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
25195963|NCT02574078|50388253|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
25314965|NCT00973349|50630825|FG006|Overall Study|Inappropriate enrolment|0|||
25195964|NCT02574078|50388254|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
25195965|NCT02574078|50388255|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
25195966|NCT02574078|50388256|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
25195967|NCT02574078|50388257|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
25195968|NCT02574078|50388258|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
25195969|NCT02574078|50388259|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
25195970|NCT02574078|50388260|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
25195971|NCT02574078|50388261|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
25195972|NCT02574078|50388262|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
25195973|NCT02574078|50388250|FG000|Treatment Period|Disease progression|6|||
25195974|NCT02574078|50388251|FG001|Treatment Period|Disease progression|4|||
25195975|NCT02574078|50388252|FG002|Treatment Period|Disease progression|7|||
25195976|NCT02574078|50388253|FG003|Treatment Period|Disease progression|18|||
25195977|NCT02574078|50388254|FG004|Treatment Period|Disease progression|16|||
25195978|NCT02574078|50388255|FG005|Treatment Period|Disease progression|26|||
25195979|NCT02574078|50388256|FG006|Treatment Period|Disease progression|5|||
25195980|NCT02574078|50388257|FG007|Treatment Period|Disease progression|9|||
25195981|NCT02574078|50388258|FG008|Treatment Period|Disease progression|8|||
25195982|NCT02574078|50388259|FG009|Treatment Period|Disease progression|5|||
25195983|NCT02574078|50388260|FG010|Treatment Period|Disease progression|20|||
25195984|NCT02574078|50388261|FG011|Treatment Period|Disease progression|29|||
25195985|NCT02574078|50388262|FG012|Treatment Period|Disease progression|2|||
25195986|NCT02574078|50388250|FG000|Treatment Period|Study drug toxicity|1|||
25195987|NCT02574078|50388251|FG001|Treatment Period|Study drug toxicity|1|||
25195988|NCT02574078|50388252|FG002|Treatment Period|Study drug toxicity|0|||
25195989|NCT02574078|50388253|FG003|Treatment Period|Study drug toxicity|5|||
25195990|NCT02574078|50388254|FG004|Treatment Period|Study drug toxicity|3|||
25195991|NCT02574078|50388255|FG005|Treatment Period|Study drug toxicity|1|||
25195992|NCT02574078|50388256|FG006|Treatment Period|Study drug toxicity|2|||
25195993|NCT02574078|50388257|FG007|Treatment Period|Study drug toxicity|0|||
25195994|NCT02574078|50388258|FG008|Treatment Period|Study drug toxicity|2|||
25195995|NCT02574078|50388259|FG009|Treatment Period|Study drug toxicity|1|||
25195996|NCT02574078|50388260|FG010|Treatment Period|Study drug toxicity|16|||
25195997|NCT02574078|50388261|FG011|Treatment Period|Study drug toxicity|2|||
25195998|NCT02574078|50388262|FG012|Treatment Period|Study drug toxicity|4|||
25195999|NCT02574078|50388250|FG000|Treatment Period|Death|2|||
25196000|NCT02574078|50388251|FG001|Treatment Period|Death|0|||
25196001|NCT02574078|50388252|FG002|Treatment Period|Death|0|||
25196002|NCT02574078|50388253|FG003|Treatment Period|Death|0|||
25314966|NCT00973349|50630826|FG007|Overall Study|Inappropriate enrolment|0|||
25314967|NCT00973349|50630827|FG008|Overall Study|Inappropriate enrolment|0|||
25314968|NCT00973349|50630828|FG009|Overall Study|Inappropriate enrolment|2|||
25314969|NCT00973349|50630829|FG010|Overall Study|Inappropriate enrolment|0|||
25314970|NCT00973349|50630830|FG011|Overall Study|Inappropriate enrolment|0|||
25314971|NCT00973349|50630831|FG012|Overall Study|Inappropriate enrolment|1|||
25314972|NCT00973349|50630832|FG013|Overall Study|Inappropriate enrolment|0|||
25314973|NCT00973349|50630833|FG014|Overall Study|Inappropriate enrolment|1|||
25314974|NCT00973349|50630834|FG015|Overall Study|Inappropriate enrolment|1|||
25314975|NCT00973349|50630819|FG000|Overall Study|Protocol Violation|0|||
25314976|NCT00973349|50630820|FG001|Overall Study|Protocol Violation|0|||
25314977|NCT00973349|50630821|FG002|Overall Study|Protocol Violation|0|||
25314978|NCT00973349|50630822|FG003|Overall Study|Protocol Violation|0|||
25314979|NCT00973349|50630823|FG004|Overall Study|Protocol Violation|0|||
25314980|NCT00973349|50630824|FG005|Overall Study|Protocol Violation|0|||
25314981|NCT00973349|50630825|FG006|Overall Study|Protocol Violation|0|||
25314982|NCT00973349|50630826|FG007|Overall Study|Protocol Violation|0|||
25314983|NCT00973349|50630827|FG008|Overall Study|Protocol Violation|1|||
25314984|NCT00973349|50630828|FG009|Overall Study|Protocol Violation|0|||
25314985|NCT00973349|50630829|FG010|Overall Study|Protocol Violation|0|||
25314986|NCT00973349|50630830|FG011|Overall Study|Protocol Violation|0|||
25314987|NCT00973349|50630831|FG012|Overall Study|Protocol Violation|0|||
25314988|NCT00973349|50630832|FG013|Overall Study|Protocol Violation|0|||
25314989|NCT00973349|50630833|FG014|Overall Study|Protocol Violation|0|||
25314990|NCT00973349|50630834|FG015|Overall Study|Protocol Violation|0|||
25314991|NCT00973349|50630819|FG000|Overall Study|Unable to classify|0|||
25314992|NCT00973349|50630820|FG001|Overall Study|Unable to classify|0|||
25077000|NCT02499770|50184782|FG000|Overall Study|Study completion|1|||
25077001|NCT02499770|50184783|FG001|Overall Study|Study completion|10|||
25314993|NCT00973349|50630821|FG002|Overall Study|Unable to classify|0|||
25314994|NCT00973349|50630822|FG003|Overall Study|Unable to classify|0|||
25314995|NCT00973349|50630823|FG004|Overall Study|Unable to classify|1|||
25077002|NCT02499770|50184782|FG000|Overall Study|Withdrawal by Subject|0|||
25196003|NCT02574078|50388254|FG004|Treatment Period|Death|1|||
25196004|NCT02574078|50388255|FG005|Treatment Period|Death|1|||
25196005|NCT02574078|50388256|FG006|Treatment Period|Death|1|||
25196006|NCT02574078|50388257|FG007|Treatment Period|Death|1|||
25196007|NCT02574078|50388258|FG008|Treatment Period|Death|7|||
25196008|NCT02574078|50388259|FG009|Treatment Period|Death|1|||
25196009|NCT02574078|50388260|FG010|Treatment Period|Death|0|||
25314996|NCT00973349|50630824|FG005|Overall Study|Unable to classify|1|||
25314997|NCT00973349|50630825|FG006|Overall Study|Unable to classify|0|||
25314998|NCT00973349|50630826|FG007|Overall Study|Unable to classify|0|||
25196010|NCT02574078|50388261|FG011|Treatment Period|Death|2|||
25196011|NCT02574078|50388262|FG012|Treatment Period|Death|1|||
25196012|NCT02574078|50388250|FG000|Treatment Period|Adverse event unrelated to drug|0|||
25196013|NCT02574078|50388251|FG001|Treatment Period|Adverse event unrelated to drug|0|||
25196014|NCT02574078|50388252|FG002|Treatment Period|Adverse event unrelated to drug|1|||
25196015|NCT02574078|50388253|FG003|Treatment Period|Adverse event unrelated to drug|0|||
25196016|NCT02574078|50388254|FG004|Treatment Period|Adverse event unrelated to drug|2|||
25196017|NCT02574078|50388255|FG005|Treatment Period|Adverse event unrelated to drug|3|||
25196018|NCT02574078|50388256|FG006|Treatment Period|Adverse event unrelated to drug|0|||
25196019|NCT02574078|50388257|FG007|Treatment Period|Adverse event unrelated to drug|0|||
25196020|NCT02574078|50388258|FG008|Treatment Period|Adverse event unrelated to drug|1|||
25196021|NCT02574078|50388259|FG009|Treatment Period|Adverse event unrelated to drug|2|||
25196022|NCT02574078|50388260|FG010|Treatment Period|Adverse event unrelated to drug|4|||
25196023|NCT02574078|50388261|FG011|Treatment Period|Adverse event unrelated to drug|1|||
25196024|NCT02574078|50388262|FG012|Treatment Period|Adverse event unrelated to drug|0|||
25170688|NCT01807949|50306982|FG000|Overall Study|Randomized But Not Treated|0|||
25170689|NCT01807949|50306983|FG001|Overall Study|Randomized But Not Treated|2|||
25170690|NCT01807949|50306984|FG002|Overall Study|Randomized But Not Treated|2|||
25170691|NCT01806779|50306996|FG000|Overall Study|Physician Decision|2|||
25170692|NCT01806779|50306997|FG001|Overall Study|Physician Decision|0|||
25170693|NCT01806779|50306998|FG002|Overall Study|Physician Decision|1|||
25170694|NCT01806779|50306996|FG000|Overall Study|Lack of Efficacy|1|||
25170695|NCT01806779|50306997|FG001|Overall Study|Lack of Efficacy|1|||
25170696|NCT01806779|50306998|FG002|Overall Study|Lack of Efficacy|0|||
25170697|NCT01806779|50306996|FG000|Overall Study|Lost to Follow-up|19|||
25170698|NCT01806779|50306997|FG001|Overall Study|Lost to Follow-up|20|||
25170699|NCT01806779|50306998|FG002|Overall Study|Lost to Follow-up|0|||
25170700|NCT01806779|50306996|FG000|Overall Study|Withdrawal by Subject|20|||
25170701|NCT01806779|50306997|FG001|Overall Study|Withdrawal by Subject|23|||
25170702|NCT01806779|50306998|FG002|Overall Study|Withdrawal by Subject|22|||
25170703|NCT01607957|50307072|FG000|Overall Study|Not treated|1|||
25170704|NCT01607957|50307073|FG001|Overall Study|Not treated|1|||
25170705|NCT01607957|50307072|FG000|Overall Study|Death|367|||
25170706|NCT01607957|50307073|FG001|Overall Study|Death|211|||
25170707|NCT01607957|50307072|FG000|Overall Study|Lost to Follow-up|3|||
25170708|NCT01607957|50307073|FG001|Overall Study|Lost to Follow-up|3|||
25170709|NCT01607957|50307072|FG000|Overall Study|Participant refusal|1|||
25170710|NCT01607957|50307073|FG001|Overall Study|Participant refusal|0|||
25170711|NCT01806623|50307093|FG000|Overall Study|Withdrawal by Subject|1|||
25170712|NCT01806623|50307093|FG000|Overall Study|Adverse Event|1|||
25170713|NCT01806623|50307093|FG000|Overall Study|Did not meet the inclusion criteria|56|||
25170714|NCT01806545|50307099|FG000|Overall Study|Adverse Event|2|||
25170715|NCT01806545|50307100|FG001|Overall Study|Adverse Event|3|||
25170716|NCT01806545|50307099|FG000|Overall Study|Lost to Follow-up|1|||
25170717|NCT01806545|50307100|FG001|Overall Study|Lost to Follow-up|0|||
25170718|NCT01806545|50307099|FG000|Overall Study|Withdrawal by Subject|3|||
25170719|NCT01806545|50307100|FG001|Overall Study|Withdrawal by Subject|2|||
25170720|NCT01806389|50307106|FG000|Overall Study|Withdrawal by Subject|4|||
25170721|NCT01782131|50307362|FG000|Overall Study|Death|93|||
25170722|NCT01782131|50307363|FG001|Overall Study|Death|96|||
25170723|NCT01782131|50307362|FG000|Overall Study|Lost to Follow-up|1|||
25170724|NCT01782131|50307363|FG001|Overall Study|Lost to Follow-up|3|||
25170725|NCT01782131|50307362|FG000|Overall Study|Withdrawal by Subject|10|||
25170726|NCT01782131|50307363|FG001|Overall Study|Withdrawal by Subject|10|||
25170727|NCT01782131|50307362|FG000|Overall Study|Randomized but not treated|5|||
25170728|NCT01782131|50307363|FG001|Overall Study|Randomized but not treated|5|||
25170729|NCT01782131|50307362|FG000|Overall Study|Reason not provided|0|||
25170730|NCT01782131|50307363|FG001|Overall Study|Reason not provided|1|||
25170731|NCT01781975|50307384|FG000|Overall Study|Death|1|||
25170732|NCT01781975|50307385|FG001|Overall Study|Death|0|||
25170733|NCT01781975|50307384|FG000|Overall Study|Withdrawal by Subject|1|||
25170734|NCT01781975|50307385|FG001|Overall Study|Withdrawal by Subject|1|||
25196025|NCT02574078|50388250|FG000|Treatment Period|Administrative reason by Sponsor|0|||
25196026|NCT02574078|50388251|FG001|Treatment Period|Administrative reason by Sponsor|1|||
25196027|NCT02574078|50388252|FG002|Treatment Period|Administrative reason by Sponsor|0|||
25314999|NCT00973349|50630827|FG008|Overall Study|Unable to classify|0|||
25170735|NCT01804673|50307406|FG000|Overall Study|Adverse Event|4|||
25170736|NCT01804673|50307406|FG000|Overall Study|Withdrawal by Subject|1|||
25170737|NCT01804673|50307406|FG000|Overall Study|Lack of Efficacy|9|||
25170738|NCT01804673|50307406|FG000|Overall Study|Change to Oral Therapy|37|||
25170739|NCT01804673|50307406|FG000|Overall Study|No Further Therapy Required|84|||
25170740|NCT01804673|50307406|FG000|Overall Study|Use of Prohibited Medication|1|||
25170741|NCT01804673|50307406|FG000|Overall Study|Other|4|||
25170742|NCT01774097|50307416|FG000|Overall Study|Withdrawal by Subject|1|||
25170743|NCT01774097|50307417|FG001|Overall Study|Withdrawal by Subject|1|||
25170744|NCT01774097|50307416|FG000|Overall Study|Adverse Event|1|||
25170745|NCT01774097|50307417|FG001|Overall Study|Adverse Event|1|||
25170746|NCT02859558|50307491|FG000|Step 1|Not Eligible|0|||
25196028|NCT02574078|50388253|FG003|Treatment Period|Administrative reason by Sponsor|0|||
25196029|NCT02574078|50388254|FG004|Treatment Period|Administrative reason by Sponsor|0|||
25196030|NCT02574078|50388255|FG005|Treatment Period|Administrative reason by Sponsor|0|||
25196031|NCT02574078|50388256|FG006|Treatment Period|Administrative reason by Sponsor|1|||
25196032|NCT02574078|50388257|FG007|Treatment Period|Administrative reason by Sponsor|0|||
25196033|NCT02574078|50388258|FG008|Treatment Period|Administrative reason by Sponsor|0|||
25196034|NCT02574078|50388259|FG009|Treatment Period|Administrative reason by Sponsor|0|||
25196035|NCT02574078|50388260|FG010|Treatment Period|Administrative reason by Sponsor|0|||
25196036|NCT02574078|50388261|FG011|Treatment Period|Administrative reason by Sponsor|0|||
25196037|NCT02574078|50388262|FG012|Treatment Period|Administrative reason by Sponsor|3|||
25196038|NCT02574078|50388250|FG000|Treatment Period|Other reasons|1|||
25196039|NCT02574078|50388251|FG001|Treatment Period|Other reasons|0|||
25196040|NCT02574078|50388252|FG002|Treatment Period|Other reasons|1|||
25196041|NCT02574078|50388253|FG003|Treatment Period|Other reasons|3|||
25196042|NCT02574078|50388254|FG004|Treatment Period|Other reasons|3|||
25196043|NCT02574078|50388255|FG005|Treatment Period|Other reasons|1|||
25196044|NCT02574078|50388256|FG006|Treatment Period|Other reasons|2|||
25196045|NCT02574078|50388257|FG007|Treatment Period|Other reasons|1|||
25196046|NCT02574078|50388258|FG008|Treatment Period|Other reasons|3|||
25196047|NCT02574078|50388259|FG009|Treatment Period|Other reasons|1|||
25196048|NCT02574078|50388260|FG010|Treatment Period|Other reasons|1|||
25196049|NCT02574078|50388261|FG011|Treatment Period|Other reasons|3|||
25196050|NCT02574078|50388262|FG012|Treatment Period|Other reasons|1|||
25196051|NCT02574078|50388250|FG000|Treatment Period|Participant request to stop drug|0|||
25196052|NCT02574078|50388251|FG001|Treatment Period|Participant request to stop drug|0|||
25196053|NCT02574078|50388252|FG002|Treatment Period|Participant request to stop drug|0|||
25196054|NCT02574078|50388253|FG003|Treatment Period|Participant request to stop drug|2|||
25196055|NCT02574078|50388254|FG004|Treatment Period|Participant request to stop drug|4|||
25196056|NCT02574078|50388255|FG005|Treatment Period|Participant request to stop drug|0|||
25196057|NCT02574078|50388256|FG006|Treatment Period|Participant request to stop drug|1|||
25196058|NCT02574078|50388257|FG007|Treatment Period|Participant request to stop drug|0|||
25196059|NCT02574078|50388258|FG008|Treatment Period|Participant request to stop drug|3|||
25196060|NCT02574078|50388259|FG009|Treatment Period|Participant request to stop drug|2|||
25196061|NCT02574078|50388260|FG010|Treatment Period|Participant request to stop drug|2|||
25196062|NCT02574078|50388261|FG011|Treatment Period|Participant request to stop drug|4|||
25196063|NCT02574078|50388262|FG012|Treatment Period|Participant request to stop drug|1|||
25196064|NCT02574078|50388250|FG000|Treatment Period|Participant withdrew consent|0|||
25196065|NCT02574078|50388251|FG001|Treatment Period|Participant withdrew consent|0|||
25196066|NCT02574078|50388252|FG002|Treatment Period|Participant withdrew consent|0|||
25196067|NCT02574078|50388253|FG003|Treatment Period|Participant withdrew consent|0|||
25196068|NCT02574078|50388254|FG004|Treatment Period|Participant withdrew consent|1|||
25196069|NCT02574078|50388255|FG005|Treatment Period|Participant withdrew consent|1|||
25196070|NCT02574078|50388256|FG006|Treatment Period|Participant withdrew consent|0|||
25196071|NCT02574078|50388257|FG007|Treatment Period|Participant withdrew consent|1|||
25196072|NCT02574078|50388258|FG008|Treatment Period|Participant withdrew consent|0|||
25196073|NCT02574078|50388259|FG009|Treatment Period|Participant withdrew consent|2|||
25196074|NCT02574078|50388260|FG010|Treatment Period|Participant withdrew consent|1|||
25196075|NCT02574078|50388261|FG011|Treatment Period|Participant withdrew consent|4|||
25196076|NCT02574078|50388262|FG012|Treatment Period|Participant withdrew consent|1|||
25196077|NCT02574078|50388250|FG000|Treatment Period|Participant no longer meets criteria|0|||
25196078|NCT02574078|50388251|FG001|Treatment Period|Participant no longer meets criteria|0|||
25196079|NCT02574078|50388252|FG002|Treatment Period|Participant no longer meets criteria|0|||
25196080|NCT02574078|50388253|FG003|Treatment Period|Participant no longer meets criteria|0|||
25196081|NCT02574078|50388254|FG004|Treatment Period|Participant no longer meets criteria|1|||
25170747|NCT02859558|50307492|FG001|Step 1|Not Eligible|0|||
25170748|NCT02859558|50307493|FG002|Step 1|Not Eligible|0|||
25170749|NCT02859558|50307494|FG003|Step 1|Not Eligible|0|||
25170750|NCT02859558|50307495|FG004|Step 1|Not Eligible|3|||
25170751|NCT02859558|50307491|FG000|Step 1|Lost to Follow-up|1|||
25170752|NCT02859558|50307492|FG001|Step 1|Lost to Follow-up|3|||
25170753|NCT02859558|50307493|FG002|Step 1|Lost to Follow-up|3|||
25170754|NCT02859558|50307494|FG003|Step 1|Lost to Follow-up|0|||
25170755|NCT02859558|50307495|FG004|Step 1|Lost to Follow-up|0|||
25170756|NCT02859558|50307491|FG000|Step 1|Did Not Return to Clinic|2|||
25170757|NCT02859558|50307492|FG001|Step 1|Did Not Return to Clinic|3|||
25170758|NCT02859558|50307493|FG002|Step 1|Did Not Return to Clinic|4|||
25170759|NCT02859558|50307494|FG003|Step 1|Did Not Return to Clinic|0|||
25170760|NCT02859558|50307495|FG004|Step 1|Did Not Return to Clinic|0|||
25170761|NCT02859558|50307491|FG000|Step 1|Moved|0|||
25170762|NCT02859558|50307492|FG001|Step 1|Moved|1|||
25170763|NCT02859558|50307493|FG002|Step 1|Moved|1|||
25170764|NCT02859558|50307494|FG003|Step 1|Moved|0|||
25170765|NCT02859558|50307495|FG004|Step 1|Moved|0|||
25170766|NCT02859558|50307491|FG000|Step 1|Withdrawal By Participant|1|||
25170767|NCT02859558|50307492|FG001|Step 1|Withdrawal By Participant|2|||
25170768|NCT02859558|50307493|FG002|Step 1|Withdrawal By Participant|1|||
25196082|NCT02574078|50388255|FG005|Treatment Period|Participant no longer meets criteria|0|||
25196083|NCT02574078|50388256|FG006|Treatment Period|Participant no longer meets criteria|0|||
25196084|NCT02574078|50388257|FG007|Treatment Period|Participant no longer meets criteria|0|||
25196085|NCT02574078|50388258|FG008|Treatment Period|Participant no longer meets criteria|0|||
25196086|NCT02574078|50388259|FG009|Treatment Period|Participant no longer meets criteria|1|||
25196087|NCT02574078|50388260|FG010|Treatment Period|Participant no longer meets criteria|1|||
25196088|NCT02574078|50388261|FG011|Treatment Period|Participant no longer meets criteria|1|||
25196089|NCT02574078|50388262|FG012|Treatment Period|Participant no longer meets criteria|0|||
25196090|NCT02574078|50388250|FG000|Treatment Period|Lost to Follow-up|0|||
25196091|NCT02574078|50388251|FG001|Treatment Period|Lost to Follow-up|0|||
25196092|NCT02574078|50388252|FG002|Treatment Period|Lost to Follow-up|0|||
25196093|NCT02574078|50388253|FG003|Treatment Period|Lost to Follow-up|0|||
25196094|NCT02574078|50388254|FG004|Treatment Period|Lost to Follow-up|0|||
25196095|NCT02574078|50388255|FG005|Treatment Period|Lost to Follow-up|0|||
25196096|NCT02574078|50388256|FG006|Treatment Period|Lost to Follow-up|0|||
25196097|NCT02574078|50388257|FG007|Treatment Period|Lost to Follow-up|0|||
25196098|NCT02574078|50388258|FG008|Treatment Period|Lost to Follow-up|0|||
25196099|NCT02574078|50388259|FG009|Treatment Period|Lost to Follow-up|1|||
25196100|NCT02574078|50388260|FG010|Treatment Period|Lost to Follow-up|0|||
25196101|NCT02574078|50388261|FG011|Treatment Period|Lost to Follow-up|1|||
25196102|NCT02574078|50388262|FG012|Treatment Period|Lost to Follow-up|0|||
25196103|NCT02574078|50388250|FG000|Treatment Period|Maximum clinical benefit|0|||
25196104|NCT02574078|50388251|FG001|Treatment Period|Maximum clinical benefit|0|||
25196105|NCT02574078|50388252|FG002|Treatment Period|Maximum clinical benefit|0|||
25196106|NCT02574078|50388253|FG003|Treatment Period|Maximum clinical benefit|0|||
25196107|NCT02574078|50388254|FG004|Treatment Period|Maximum clinical benefit|0|||
25196108|NCT02574078|50388255|FG005|Treatment Period|Maximum clinical benefit|0|||
25196109|NCT02574078|50388256|FG006|Treatment Period|Maximum clinical benefit|0|||
25196110|NCT02574078|50388257|FG007|Treatment Period|Maximum clinical benefit|0|||
25196111|NCT02574078|50388258|FG008|Treatment Period|Maximum clinical benefit|0|||
25196112|NCT02574078|50388259|FG009|Treatment Period|Maximum clinical benefit|1|||
25196113|NCT02574078|50388260|FG010|Treatment Period|Maximum clinical benefit|0|||
25196114|NCT02574078|50388261|FG011|Treatment Period|Maximum clinical benefit|0|||
25196115|NCT02574078|50388262|FG012|Treatment Period|Maximum clinical benefit|0|||
25196116|NCT02565810|50388380|FG000|Overall Study|Withdrawal by Subject|1|||
25196117|NCT02561832|50388545|FG000|Overall Study|Withdrawal by Subject|1|||
25196118|NCT02561832|50388546|FG001|Overall Study|Withdrawal by Subject|1|||
25196119|NCT02561832|50388545|FG000|Overall Study|Adverse Event|3|||
25196120|NCT02561832|50388546|FG001|Overall Study|Adverse Event|0|||
25196121|NCT02561832|50388545|FG000|Overall Study|Disease progression|3|||
25196122|NCT02561832|50388546|FG001|Overall Study|Disease progression|3|||
25196123|NCT00985088|50390194|FG000|Overall Study|Serious Adverse Event|1|||
25196124|NCT00985088|50390195|FG001|Overall Study|Serious Adverse Event|1|||
25196125|NCT00985088|50390196|FG002|Overall Study|Serious Adverse Event|0|||
25196126|NCT00985088|50390197|FG003|Overall Study|Serious Adverse Event|0|||
25196127|NCT00985088|50390198|FG004|Overall Study|Serious Adverse Event|0|||
25196128|NCT00985088|50390199|FG005|Overall Study|Serious Adverse Event|0|||
25196129|NCT00985088|50390200|FG006|Overall Study|Serious Adverse Event|0|||
25196130|NCT00985088|50390201|FG007|Overall Study|Serious Adverse Event|1|||
25196131|NCT00985088|50390194|FG000|Overall Study|Adverse Event|0|||
25196132|NCT00985088|50390195|FG001|Overall Study|Adverse Event|0|||
25196133|NCT00985088|50390196|FG002|Overall Study|Adverse Event|1|||
25196134|NCT00985088|50390197|FG003|Overall Study|Adverse Event|0|||
25196135|NCT00985088|50390198|FG004|Overall Study|Adverse Event|0|||
25196136|NCT00985088|50390199|FG005|Overall Study|Adverse Event|0|||
25196137|NCT00985088|50390200|FG006|Overall Study|Adverse Event|0|||
25196138|NCT00985088|50390201|FG007|Overall Study|Adverse Event|0|||
25196139|NCT00985088|50390194|FG000|Overall Study|Withdrawal by Subject|4|||
25196140|NCT00985088|50390195|FG001|Overall Study|Withdrawal by Subject|0|||
25196141|NCT00985088|50390196|FG002|Overall Study|Withdrawal by Subject|0|||
25196142|NCT00985088|50390197|FG003|Overall Study|Withdrawal by Subject|1|||
25196143|NCT00985088|50390198|FG004|Overall Study|Withdrawal by Subject|3|||
25196144|NCT00985088|50390199|FG005|Overall Study|Withdrawal by Subject|2|||
25196145|NCT00985088|50390200|FG006|Overall Study|Withdrawal by Subject|1|||
25196146|NCT00985088|50390201|FG007|Overall Study|Withdrawal by Subject|2|||
25196147|NCT00985088|50390194|FG000|Overall Study|Migrated/moved from study area|0|||
25196148|NCT00985088|50390195|FG001|Overall Study|Migrated/moved from study area|0|||
25196149|NCT00985088|50390196|FG002|Overall Study|Migrated/moved from study area|1|||
25196150|NCT00985088|50390197|FG003|Overall Study|Migrated/moved from study area|0|||
25196151|NCT00985088|50390198|FG004|Overall Study|Migrated/moved from study area|0|||
25196152|NCT00985088|50390199|FG005|Overall Study|Migrated/moved from study area|0|||
25196153|NCT00985088|50390200|FG006|Overall Study|Migrated/moved from study area|0|||
25196154|NCT00985088|50390201|FG007|Overall Study|Migrated/moved from study area|1|||
25196155|NCT00985088|50390194|FG000|Overall Study|Lost to Follow-up|6|||
25196156|NCT00985088|50390195|FG001|Overall Study|Lost to Follow-up|1|||
25196157|NCT00985088|50390196|FG002|Overall Study|Lost to Follow-up|2|||
25196158|NCT00985088|50390197|FG003|Overall Study|Lost to Follow-up|6|||
25196159|NCT00985088|50390198|FG004|Overall Study|Lost to Follow-up|6|||
25196160|NCT00985088|50390199|FG005|Overall Study|Lost to Follow-up|5|||
25196161|NCT00985088|50390200|FG006|Overall Study|Lost to Follow-up|3|||
25196162|NCT00985088|50390201|FG007|Overall Study|Lost to Follow-up|2|||
25196163|NCT00984542|50390247|FG000|Overall Study|disease progression|19|||
25196164|NCT00984542|50390247|FG000|Overall Study|toxicity|7|||
25196165|NCT00984542|50390247|FG000|Overall Study|Death|7|||
25196166|NCT00984542|50390247|FG000|Overall Study|complicating disease|3|||
25196167|NCT00984542|50390247|FG000|Overall Study|Withdrawal by Subject|3|||
25196168|NCT00984542|50390247|FG000|Overall Study|clinical deterioration|2|||
25196169|NCT00983918|50390256|FG000|Overall Study|conversion to open cholecystectomy|0|||
25196170|NCT00983918|50390257|FG001|Overall Study|conversion to open cholecystectomy|2|||
25196171|NCT00983918|50390258|FG002|Overall Study|conversion to open cholecystectomy|2|||
25196172|NCT00983918|50390259|FG003|Overall Study|conversion to open cholecystectomy|2|||
25196173|NCT00983528|50390269|FG000|Overall Study|Death|4|||
25196174|NCT00983528|50390269|FG000|Overall Study|Lost to Follow-up|1|||
25196175|NCT00983528|50390269|FG000|Overall Study|Study Terminated|1|||
25196176|NCT00983372|50390273|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
25196177|NCT00983372|50390273|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
25196178|NCT00983372|50390273|FG000|Diltiazem ER Alone|Adverse Event|1|||
25196179|NCT00983294|50390305|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
25196180|NCT00983294|50390305|FG000|Colchicine With Azithromycin|Adverse Event|1|||
25196181|NCT00982280|50390321|FG000|Observation Period|Not eligible to be dosed|19|||
25196182|NCT00982280|50390321|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
25196183|NCT00982280|50390321|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
25196184|NCT00982280|50390321|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
25196185|NCT00982280|50390321|FG000|Maintenance Period|Adverse Event|1|||
25196186|NCT00981578|50390339|FG000|Overall Study|Death|1|||
25196187|NCT00981578|50390339|FG000|Overall Study|Withdrawal by Subject|2|||
25196188|NCT00980798|50390362|FG000|Overall Study|Adverse Event|7|||
25196189|NCT00980798|50390363|FG001|Overall Study|Adverse Event|36|||
25196190|NCT00980798|50390362|FG000|Overall Study|Lack of Efficacy|16|||
25196191|NCT00980798|50390363|FG001|Overall Study|Lack of Efficacy|5|||
25196192|NCT00980798|50390362|FG000|Overall Study|Lost to Follow-up|0|||
25196193|NCT00980798|50390363|FG001|Overall Study|Lost to Follow-up|1|||
25196194|NCT00980798|50390362|FG000|Overall Study|Physician Decision|2|||
25196195|NCT00980798|50390363|FG001|Overall Study|Physician Decision|1|||
25196196|NCT00980798|50390362|FG000|Overall Study|Withdrawal by Subject|8|||
25196197|NCT00980798|50390363|FG001|Overall Study|Withdrawal by Subject|11|||
25196198|NCT00980798|50390362|FG000|Overall Study|Other|0|||
25196199|NCT00980798|50390363|FG001|Overall Study|Other|1|||
25196200|NCT00980330|50390508|FG000|Overall Study|Adverse Event|0|||
25196201|NCT00980330|50390509|FG001|Overall Study|Adverse Event|0|||
25196202|NCT00980330|50390510|FG002|Overall Study|Adverse Event|0|||
25196203|NCT00980330|50390511|FG003|Overall Study|Adverse Event|1|||
25196204|NCT00980330|50390512|FG004|Overall Study|Adverse Event|0|||
25196205|NCT00980330|50390513|FG005|Overall Study|Adverse Event|0|||
25196206|NCT00980330|50390514|FG006|Overall Study|Adverse Event|0|||
25196207|NCT00980330|50390508|FG000|Overall Study|Lost to Follow-up|1|||
25196208|NCT00980330|50390509|FG001|Overall Study|Lost to Follow-up|1|||
25196209|NCT00980330|50390510|FG002|Overall Study|Lost to Follow-up|4|||
25196210|NCT00980330|50390511|FG003|Overall Study|Lost to Follow-up|2|||
25196211|NCT00980330|50390512|FG004|Overall Study|Lost to Follow-up|1|||
25196212|NCT00980330|50390513|FG005|Overall Study|Lost to Follow-up|1|||
25196213|NCT00980330|50390514|FG006|Overall Study|Lost to Follow-up|2|||
25196214|NCT00980330|50390508|FG000|Overall Study|Withdrawal by Subject|2|||
25196215|NCT00980330|50390509|FG001|Overall Study|Withdrawal by Subject|4|||
25196216|NCT00980330|50390510|FG002|Overall Study|Withdrawal by Subject|4|||
25196217|NCT00980330|50390511|FG003|Overall Study|Withdrawal by Subject|1|||
25196218|NCT00980330|50390512|FG004|Overall Study|Withdrawal by Subject|3|||
25196219|NCT00980330|50390513|FG005|Overall Study|Withdrawal by Subject|2|||
25196220|NCT00980330|50390514|FG006|Overall Study|Withdrawal by Subject|5|||
25196221|NCT00980330|50390508|FG000|Overall Study|(not specified)|2|||
25196222|NCT00980330|50390509|FG001|Overall Study|(not specified)|0|||
25196223|NCT00980330|50390510|FG002|Overall Study|(not specified)|0|||
25196224|NCT00980330|50390511|FG003|Overall Study|(not specified)|1|||
25196225|NCT00980330|50390512|FG004|Overall Study|(not specified)|1|||
25196226|NCT00980330|50390513|FG005|Overall Study|(not specified)|1|||
25196227|NCT00980330|50390514|FG006|Overall Study|(not specified)|0|||
25196228|NCT00980174|50390558|FG000|Overall Study|Withdrawal by Subject|1|||
25196229|NCT00980174|50390559|FG001|Overall Study|Withdrawal by Subject|4|||
25196230|NCT00980174|50390558|FG000|Overall Study|Adverse Event|0|||
25196231|NCT00980174|50390559|FG001|Overall Study|Adverse Event|3|||
25196232|NCT00980174|50390558|FG000|Overall Study|Ineligibility determined|2|||
25196233|NCT00980174|50390559|FG001|Overall Study|Ineligibility determined|1|||
25196234|NCT00980174|50390558|FG000|Overall Study|Death|1|||
25196235|NCT00980174|50390559|FG001|Overall Study|Death|1|||
25196236|NCT00980174|50390558|FG000|Overall Study|Other|0|||
25196237|NCT00980174|50390559|FG001|Overall Study|Other|1|||
25196238|NCT00980018|50390587|FG000|Overall Study|Adverse Event|8|||
25196239|NCT00980018|50390587|FG000|Overall Study|Patient withdrew consent|3|||
25196240|NCT00980018|50390587|FG000|Overall Study|Lost to Follow-up|1|||
25196241|NCT00981656|50390608|FG000|Overall Study|Protocol Violation|1|||
25196242|NCT00981656|50390608|FG000|Overall Study|Did not start protocol treatment|2|||
25196243|NCT00988052|50390614|FG000|Overall Study|Missing|1|||
25196244|NCT00988052|50390615|FG001|Overall Study|Missing|0|||
25196245|NCT00988052|50390614|FG000|Overall Study|Teva requested subject withdrawal|3|||
25196246|NCT00988052|50390615|FG001|Overall Study|Teva requested subject withdrawal|1|||
25196247|NCT00988052|50390614|FG000|Overall Study|Death|1|||
25196248|NCT00988052|50390615|FG001|Overall Study|Death|3|||
25196249|NCT00988052|50390614|FG000|Overall Study|Protocol Violation|6|||
25196250|NCT00988052|50390615|FG001|Overall Study|Protocol Violation|5|||
25196251|NCT00988052|50390614|FG000|Overall Study|Pregnancy|6|||
25196252|NCT00988052|50390615|FG001|Overall Study|Pregnancy|6|||
25196253|NCT00988052|50390614|FG000|Overall Study|Lack of Efficacy|8|||
25196254|NCT00988052|50390615|FG001|Overall Study|Lack of Efficacy|7|||
25196255|NCT00988052|50390614|FG000|Overall Study|Lost to Follow-up|6|||
25196256|NCT00988052|50390615|FG001|Overall Study|Lost to Follow-up|11|||
25196257|NCT00988052|50390614|FG000|Overall Study|Physician Decision|27|||
25196258|NCT00988052|50390615|FG001|Overall Study|Physician Decision|28|||
25196259|NCT00988052|50390614|FG000|Overall Study|Adverse Event|35|||
25196260|NCT00988052|50390615|FG001|Overall Study|Adverse Event|28|||
25196261|NCT00988052|50390614|FG000|Overall Study|Withdrawal by Subject|90|||
25196262|NCT00988052|50390615|FG001|Overall Study|Withdrawal by Subject|91|||
25170769|NCT02859558|50307494|FG003|Step 1|Withdrawal By Participant|0|||
25170770|NCT02859558|50307495|FG004|Step 1|Withdrawal By Participant|0|||
25170771|NCT02859558|50307491|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
25170772|NCT02859558|50307492|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
25170773|NCT02859558|50307493|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
25170774|NCT02859558|50307494|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
25170775|NCT02859558|50307495|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
25170776|NCT02859558|50307491|FG000|Step 1|Incarceration|0|||
25170777|NCT02859558|50307492|FG001|Step 1|Incarceration|1|||
25170778|NCT02859558|50307493|FG002|Step 1|Incarceration|0|||
25170779|NCT02859558|50307494|FG003|Step 1|Incarceration|0|||
25170780|NCT02859558|50307495|FG004|Step 1|Incarceration|0|||
25170781|NCT02859558|50307491|FG000|Step 1|Non-Adherence to Study Drug|2|||
25170782|NCT02859558|50307492|FG001|Step 1|Non-Adherence to Study Drug|0|||
25170783|NCT02859558|50307493|FG002|Step 1|Non-Adherence to Study Drug|1|||
25170784|NCT02859558|50307494|FG003|Step 1|Non-Adherence to Study Drug|0|||
25170785|NCT02859558|50307495|FG004|Step 1|Non-Adherence to Study Drug|0|||
25170786|NCT02859558|50307491|FG000|Step 1|Non-Adherence to Study Requirements|3|||
25170787|NCT02859558|50307492|FG001|Step 1|Non-Adherence to Study Requirements|1|||
25170788|NCT02859558|50307493|FG002|Step 1|Non-Adherence to Study Requirements|0|||
25170789|NCT02859558|50307494|FG003|Step 1|Non-Adherence to Study Requirements|0|||
25170790|NCT02859558|50307495|FG004|Step 1|Non-Adherence to Study Requirements|0|||
25170791|NCT02859558|50307491|FG000|Step 1|Virologic Failure|2|||
25170792|NCT02859558|50307492|FG001|Step 1|Virologic Failure|1|||
25170793|NCT02859558|50307493|FG002|Step 1|Virologic Failure|1|||
25170794|NCT02859558|50307494|FG003|Step 1|Virologic Failure|0|||
25170795|NCT02859558|50307495|FG004|Step 1|Virologic Failure|0|||
25170796|NCT02859558|50307491|FG000|Step 2|Active On Study|23|||
25170797|NCT02859558|50307492|FG001|Step 2|Active On Study|38|||
25170798|NCT02859558|50307493|FG002|Step 2|Active On Study|20|||
25170799|NCT02859558|50307494|FG003|Step 2|Active On Study|0|||
25170800|NCT02859558|50307495|FG004|Step 2|Active On Study|0|||
25170801|NCT02859558|50307491|FG000|Step 2|Did Not Return to Clinic|2|||
25170802|NCT02859558|50307492|FG001|Step 2|Did Not Return to Clinic|0|||
25196263|NCT00988052|50390614|FG000|Overall Study|Study terminated by sponsor|240|||
25196264|NCT00988052|50390615|FG001|Overall Study|Study terminated by sponsor|236|||
25170803|NCT02859558|50307493|FG002|Step 2|Did Not Return to Clinic|0|||
25170804|NCT02859558|50307494|FG003|Step 2|Did Not Return to Clinic|0|||
25170805|NCT02859558|50307495|FG004|Step 2|Did Not Return to Clinic|0|||
25170806|NCT02859558|50307491|FG000|Step 2|Unexpected Closure of Site|0|||
25170807|NCT02859558|50307492|FG001|Step 2|Unexpected Closure of Site|1|||
25170808|NCT02859558|50307493|FG002|Step 2|Unexpected Closure of Site|1|||
25170809|NCT02859558|50307494|FG003|Step 2|Unexpected Closure of Site|0|||
25170810|NCT02859558|50307495|FG004|Step 2|Unexpected Closure of Site|0|||
25196265|NCT02569710|50390716|FG000|Overall Study|Adverse Event|1|||
25196266|NCT02569710|50390717|FG001|Overall Study|Adverse Event|0|||
25196267|NCT02569710|50390718|FG002|Overall Study|Adverse Event|0|||
25196268|NCT02569710|50390719|FG003|Overall Study|Adverse Event|0|||
25196269|NCT02569710|50390720|FG004|Overall Study|Adverse Event|0|||
25196270|NCT02569710|50390721|FG005|Overall Study|Adverse Event|0|||
25196271|NCT02569710|50390722|FG006|Overall Study|Adverse Event|0|||
25196272|NCT02569710|50390723|FG007|Overall Study|Adverse Event|0|||
25196273|NCT02569710|50390724|FG008|Overall Study|Adverse Event|0|||
25196274|NCT02569710|50390725|FG009|Overall Study|Adverse Event|0|||
25196275|NCT02569710|50390716|FG000|Overall Study|Lost to Follow-up|0|||
25196276|NCT02569710|50390717|FG001|Overall Study|Lost to Follow-up|0|||
25196277|NCT02569710|50390718|FG002|Overall Study|Lost to Follow-up|0|||
25196278|NCT02569710|50390719|FG003|Overall Study|Lost to Follow-up|0|||
25196279|NCT02569710|50390720|FG004|Overall Study|Lost to Follow-up|0|||
25196280|NCT02569710|50390721|FG005|Overall Study|Lost to Follow-up|0|||
25196281|NCT02569710|50390722|FG006|Overall Study|Lost to Follow-up|1|||
25196282|NCT02569710|50390723|FG007|Overall Study|Lost to Follow-up|0|||
25196283|NCT02569710|50390724|FG008|Overall Study|Lost to Follow-up|1|||
25196284|NCT02569710|50390725|FG009|Overall Study|Lost to Follow-up|0|||
25196285|NCT02569710|50390716|FG000|Overall Study|Virologic failure|0|||
25196286|NCT02569710|50390717|FG001|Overall Study|Virologic failure|0|||
25196287|NCT02569710|50390718|FG002|Overall Study|Virologic failure|0|||
25196288|NCT02569710|50390719|FG003|Overall Study|Virologic failure|0|||
25196289|NCT02569710|50390720|FG004|Overall Study|Virologic failure|1|||
25196290|NCT02569710|50390721|FG005|Overall Study|Virologic failure|0|||
25196291|NCT02569710|50390722|FG006|Overall Study|Virologic failure|1|||
25196292|NCT02569710|50390723|FG007|Overall Study|Virologic failure|0|||
25196293|NCT02569710|50390724|FG008|Overall Study|Virologic failure|0|||
25196294|NCT02569710|50390725|FG009|Overall Study|Virologic failure|0|||
25196295|NCT02569710|50390716|FG000|Overall Study|Withdrawal by Subject|0|||
25196296|NCT02569710|50390717|FG001|Overall Study|Withdrawal by Subject|0|||
25196297|NCT02569710|50390718|FG002|Overall Study|Withdrawal by Subject|0|||
25196298|NCT02569710|50390719|FG003|Overall Study|Withdrawal by Subject|0|||
25196299|NCT02569710|50390720|FG004|Overall Study|Withdrawal by Subject|0|||
25196300|NCT02569710|50390721|FG005|Overall Study|Withdrawal by Subject|1|||
25196301|NCT02569710|50390722|FG006|Overall Study|Withdrawal by Subject|0|||
25196302|NCT02569710|50390723|FG007|Overall Study|Withdrawal by Subject|0|||
25196303|NCT02569710|50390724|FG008|Overall Study|Withdrawal by Subject|0|||
25196304|NCT02569710|50390725|FG009|Overall Study|Withdrawal by Subject|0|||
25196305|NCT02569476|50390827|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
25196306|NCT02569476|50390827|FG000|Overall Study|Death|33|||
25196307|NCT02569476|50390827|FG000|Overall Study|Withdrawal by Subject|9|||
25196308|NCT02569476|50390827|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
25196309|NCT02569476|50390827|FG000|Overall Study|Palliative care|1|||
25196310|NCT02569476|50390827|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
25196311|NCT02569476|50390827|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
25196312|NCT02565576|50390899|FG000|Overall Study|abnormal lab value|2|||
25196313|NCT02565576|50390900|FG001|Overall Study|abnormal lab value|0|||
25196314|NCT02565576|50390899|FG000|Overall Study|subject / guardian decision|1|||
25196315|NCT02565576|50390900|FG001|Overall Study|subject / guardian decision|3|||
25196316|NCT02565576|50390899|FG000|Overall Study|Lost to Follow-up|1|||
25196317|NCT02565576|50390900|FG001|Overall Study|Lost to Follow-up|0|||
25196318|NCT02565576|50390899|FG000|Overall Study|Death|0|||
25196319|NCT02565576|50390900|FG001|Overall Study|Death|2|||
25196320|NCT02565576|50390899|FG000|Overall Study|Adverse Event|1|||
25196321|NCT02565576|50390900|FG001|Overall Study|Adverse Event|0|||
25196322|NCT02569398|50390931|FG000|Overall Study|Adverse Event|0|||
25196323|NCT02569398|50390932|FG001|Overall Study|Adverse Event|1|||
25196324|NCT02569398|50390933|FG002|Overall Study|Adverse Event|6|||
25196325|NCT02569398|50390931|FG000|Overall Study|Withdrawal by Subject|43|||
25196326|NCT02569398|50390932|FG001|Overall Study|Withdrawal by Subject|43|||
25196327|NCT02569398|50390933|FG002|Overall Study|Withdrawal by Subject|30|||
25196328|NCT02569398|50390931|FG000|Overall Study|Study terminated by sponsor|130|||
25196329|NCT02569398|50390932|FG001|Overall Study|Study terminated by sponsor|131|||
24976235|NCT00077649|50065139|FG000|Overall Study|Abnormality of Laboratory Test|1|||
25077003|NCT02499770|50184783|FG001|Overall Study|Withdrawal by Subject|7|||
25196330|NCT02569398|50390933|FG002|Overall Study|Study terminated by sponsor|134|||
25196331|NCT02569398|50390931|FG000|Overall Study|Other|12|||
25196332|NCT02569398|50390932|FG001|Overall Study|Other|14|||
25196333|NCT02569398|50390933|FG002|Overall Study|Other|13|||
25196334|NCT02569242|50390977|FG000|Overall Study|Death|1|||
25196335|NCT02569242|50390978|FG001|Overall Study|Death|0|||
25196336|NCT02569242|50390977|FG000|Overall Study|Withdrawal by Subject|0|||
25196337|NCT02569242|50390978|FG001|Overall Study|Withdrawal by Subject|1|||
25196338|NCT01663740|50391046|FG000|Overall Study|Lost to Follow-up|1|||
25196339|NCT01663740|50391047|FG001|Overall Study|Lost to Follow-up|4|||
25196340|NCT01663740|50391046|FG000|Overall Study|Other|9|||
25196341|NCT01663740|50391047|FG001|Overall Study|Other|2|||
25196342|NCT01663740|50391046|FG000|Overall Study|Inclusion/Exclusion not met|1|||
25196343|NCT01663740|50391047|FG001|Overall Study|Inclusion/Exclusion not met|0|||
25196344|NCT01663740|50391046|FG000|Overall Study|Death|0|||
25196345|NCT01663740|50391047|FG001|Overall Study|Death|1|||
25196346|NCT01663740|50391046|FG000|Overall Study|Withdrawal by Subject|2|||
25196347|NCT01663740|50391047|FG001|Overall Study|Withdrawal by Subject|1|||
25196348|NCT01663740|50391046|FG000|Overall Study|No end of study status|3|||
25196349|NCT01663740|50391047|FG001|Overall Study|No end of study status|0|||
25196350|NCT01663506|50391163|FG000|Overall Study|Lack of Efficacy|3|||
25196351|NCT01663506|50391163|FG000|Overall Study|Consent Withdrawal by Subject|1|||
25196352|NCT01663506|50391163|FG000|Overall Study|Lost to Follow-up|1|||
25315000|NCT00973349|50630828|FG009|Overall Study|Unable to classify|1|||
25315001|NCT00973349|50630829|FG010|Overall Study|Unable to classify|0|||
25315002|NCT00973349|50630830|FG011|Overall Study|Unable to classify|0|||
25315003|NCT00973349|50630831|FG012|Overall Study|Unable to classify|0|||
25077004|NCT02499770|50184782|FG000|Overall Study|Lost to Follow-up|0|||
25315004|NCT00973349|50630832|FG013|Overall Study|Unable to classify|0|||
25315005|NCT00973349|50630833|FG014|Overall Study|Unable to classify|0|||
25315006|NCT00973349|50630834|FG015|Overall Study|Unable to classify|0|||
25315007|NCT00643201|50630862|FG000|Randomized, Completed 6 Months of Study|Death|20|||
25315008|NCT00643201|50630863|FG001|Randomized, Completed 6 Months of Study|Death|26|||
25315009|NCT00643201|50630862|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
25315010|NCT00643201|50630863|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
25315011|NCT00643201|50630862|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
25315012|NCT00643201|50630863|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
25315013|NCT00643201|50630862|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
25315014|NCT00643201|50630863|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
25315015|NCT00643201|50630862|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
25315016|NCT00643201|50630863|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
25315017|NCT00643201|50630862|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
25315018|NCT00643201|50630863|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
25315019|NCT00643201|50630862|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
25315020|NCT00643201|50630863|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
25315021|NCT00643201|50630862|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
25315022|NCT00643201|50630863|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
25315023|NCT00643201|50630862|FG000|Randomized, Completed 6 Months of Study|Other|107|||
25315024|NCT00643201|50630863|FG001|Randomized, Completed 6 Months of Study|Other|107|||
25077005|NCT02499770|50184783|FG001|Overall Study|Lost to Follow-up|2|||
25196353|NCT01663506|50391163|FG000|Overall Study|Adverse Event|1|||
25196354|NCT01663506|50391163|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
25170811|NCT00705432|50307546|FG000|Treatment Period|Adverse Event|45|||
25170812|NCT00705432|50307547|FG001|Treatment Period|Adverse Event|37|||
25196355|NCT02568384|50391167|FG000|Overall Study|Mobile devices incompatible with App|2|||
25196356|NCT02965976|50391263|FG000|Overall Study|Withdrawal by Subject|2|||
25196357|NCT02965976|50391264|FG001|Overall Study|Withdrawal by Subject|0|||
25196358|NCT04125680|50391282|FG000|Overall Study|Lost to Follow-up|15|||
25196359|NCT02565186|50391306|FG000|Overall Study|Adverse Event|113|||
25196360|NCT02565186|50391307|FG001|Overall Study|Adverse Event|148|||
25196361|NCT02565186|50391306|FG000|Overall Study|Lost to Follow-up|102|||
25196362|NCT02565186|50391307|FG001|Overall Study|Lost to Follow-up|93|||
25196363|NCT02565186|50391306|FG000|Overall Study|Non-Compliance|57|||
25196364|NCT02565186|50391307|FG001|Overall Study|Non-Compliance|55|||
25196365|NCT02565186|50391306|FG000|Overall Study|Withdrawal by Subject|229|||
25196366|NCT02565186|50391307|FG001|Overall Study|Withdrawal by Subject|214|||
25196367|NCT02565186|50391306|FG000|Overall Study|Physician Decision|18|||
25196368|NCT02565186|50391307|FG001|Overall Study|Physician Decision|16|||
25196369|NCT02565186|50391306|FG000|Overall Study|Sponsor Request|5|||
25196370|NCT02565186|50391307|FG001|Overall Study|Sponsor Request|9|||
25196371|NCT02565186|50391306|FG000|Overall Study|Missing|1|||
25196372|NCT02565186|50391307|FG001|Overall Study|Missing|0|||
25196373|NCT02565186|50391306|FG000|Overall Study|Did Not Receive Study Drug|55|||
25196374|NCT02565186|50391307|FG001|Overall Study|Did Not Receive Study Drug|86|||
25196375|NCT02568072|50391313|FG000|Overall Study|Unavailable for appointment|23|||
25196376|NCT02568072|50391313|FG000|Overall Study|Unable to contact|3|||
25196377|NCT02568072|50391313|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
25196378|NCT02568072|50391313|FG000|Overall Study|Withdrawal by Subject|1|||
25196379|NCT02568072|50391313|FG000|Overall Study|Sustained injury, marathon not run|24|||
25196380|NCT02565108|50391320|FG000|Overall Study|Adverse Event|1|||
25196381|NCT02565108|50391321|FG001|Overall Study|Adverse Event|0|||
25196382|NCT02565108|50391320|FG000|Overall Study|Withdrew Consent|1|||
25196383|NCT02565108|50391321|FG001|Overall Study|Withdrew Consent|0|||
25196384|NCT02564952|50391327|FG000|Overall Study|Adverse Event|6|||
25196385|NCT02564952|50391327|FG000|Overall Study|Lost to Follow-up|1|||
25196386|NCT02564952|50391327|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
25196387|NCT02564952|50391327|FG000|Overall Study|Withdrawal by Subject|1|||
25196388|NCT02564952|50391327|FG000|Overall Study|Low Efficacy|1|||
25196389|NCT02564952|50391327|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
25196390|NCT02566902|50391333|FG000|Overall Study|Protocol Violation|2|||
25196391|NCT02566902|50391334|FG001|Overall Study|Protocol Violation|1|||
25196392|NCT02564796|50391342|FG000|Overall Study|Physician Decision|2|||
25196393|NCT02564796|50391343|FG001|Overall Study|Physician Decision|2|||
25196394|NCT02564718|50391351|FG000|Overall Study|Withdrew from treatment|0|||
25196395|NCT02564718|50391352|FG001|Overall Study|Withdrew from treatment|1|||
25196396|NCT01453946|50391358|FG000|Overall Study|Did not receive drug for the taper phase|1|||
25196397|NCT01453946|50391358|FG000|Overall Study|Protocol Violation|2|||
25196398|NCT01453946|50391358|FG000|Overall Study|Lack of Efficacy|3|||
25196399|NCT01453946|50391358|FG000|Overall Study|Adverse Event|3|||
25196400|NCT02563548|50391480|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
25196401|NCT02563548|50391481|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
24976236|NCT00077649|50065140|FG001|Overall Study|Abnormality of Laboratory Test|2|||
24976237|NCT00077649|50065141|FG002|Overall Study|Abnormality of Laboratory Test|1|||
24976238|NCT00077649|50065142|FG003|Overall Study|Abnormality of Laboratory Test|2|||
24976239|NCT00077649|50065139|FG000|Overall Study|Randomized but never dosed|1|||
25170813|NCT00705432|50307548|FG002|Treatment Period|Adverse Event|51|||
25170814|NCT00705432|50307549|FG003|Treatment Period|Adverse Event|12|||
25170815|NCT00705432|50307550|FG004|Treatment Period|Adverse Event|8|||
25170816|NCT00705432|50307551|FG005|Treatment Period|Adverse Event|9|||
25170817|NCT00705432|50307546|FG000|Treatment Period|Treatment failure|92|||
25170818|NCT00705432|50307547|FG001|Treatment Period|Treatment failure|42|||
25170819|NCT00705432|50307548|FG002|Treatment Period|Treatment failure|33|||
25170820|NCT00705432|50307549|FG003|Treatment Period|Treatment failure|25|||
25170821|NCT00705432|50307550|FG004|Treatment Period|Treatment failure|13|||
25170822|NCT00705432|50307551|FG005|Treatment Period|Treatment failure|14|||
25170823|NCT00705432|50307546|FG000|Treatment Period|Non medical reason|26|||
25170824|NCT00705432|50307547|FG001|Treatment Period|Non medical reason|32|||
25170825|NCT00705432|50307548|FG002|Treatment Period|Non medical reason|37|||
25170826|NCT00705432|50307549|FG003|Treatment Period|Non medical reason|4|||
25170827|NCT00705432|50307550|FG004|Treatment Period|Non medical reason|7|||
25170828|NCT00705432|50307551|FG005|Treatment Period|Non medical reason|7|||
25170829|NCT00705432|50307546|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
25196402|NCT02563548|50391482|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
25196403|NCT02563548|50391483|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
25196404|NCT02563548|50391484|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
25196405|NCT02563548|50391485|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
25196406|NCT02563548|50391480|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
25196407|NCT02563548|50391481|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
25196408|NCT02563548|50391482|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
25196409|NCT02563548|50391483|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
25196410|NCT02563548|50391484|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
25196411|NCT02563548|50391485|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
25196412|NCT02563548|50391480|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
25196413|NCT02563548|50391481|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
25196414|NCT02563548|50391482|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
25196415|NCT02563548|50391483|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
25196416|NCT02563548|50391484|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
25196417|NCT02563548|50391485|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
25196418|NCT02563548|50391480|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
25196419|NCT02563548|50391481|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
25196420|NCT02563548|50391482|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
25196421|NCT02563548|50391483|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
25196422|NCT02563548|50391484|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
25196423|NCT02563548|50391485|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
25196424|NCT02563548|50391480|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
25196425|NCT02563548|50391481|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
25196426|NCT02563548|50391482|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
25196427|NCT02563548|50391483|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
25196428|NCT02563548|50391484|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
25196429|NCT02563548|50391485|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
25196430|NCT02563548|50391480|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
25196431|NCT02563548|50391481|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
25196432|NCT02563548|50391482|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
25196433|NCT02563548|50391483|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
25196434|NCT02563548|50391484|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
25196435|NCT02563548|50391485|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
25196436|NCT02563548|50391480|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
25196437|NCT02563548|50391481|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
25196438|NCT02563548|50391482|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
25196439|NCT02563548|50391483|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
25196440|NCT02563548|50391484|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
25196441|NCT02563548|50391485|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
25196442|NCT02563548|50391480|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
25196443|NCT02563548|50391481|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
25196444|NCT02563548|50391482|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
25196445|NCT02563548|50391483|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
25196446|NCT02563548|50391484|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
25196447|NCT02563548|50391485|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
25196448|NCT02563548|50391480|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
25196449|NCT02563548|50391481|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
25196450|NCT02563548|50391482|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
25196451|NCT02563548|50391483|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
25170830|NCT00705432|50307547|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
25170831|NCT00705432|50307548|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
25170832|NCT00705432|50307549|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
25170833|NCT00705432|50307550|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
25170834|NCT00705432|50307551|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
25170835|NCT00705432|50307546|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
25170836|NCT00705432|50307547|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
25170837|NCT00705432|50307548|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
25170838|NCT00705432|50307549|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
25170839|NCT00705432|50307550|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
25170840|NCT00705432|50307551|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
25170841|NCT00704964|50307562|FG000|Overall Study|Not completed on time|328|||
25170842|NCT00704808|50307578|FG000|Overall Study|Discontinued prior to starting treatment|14|||
25170843|NCT00704808|50307578|FG000|Overall Study|Death|7|||
25170844|NCT00704808|50307578|FG000|Overall Study|Tumor progression|80|||
25170845|NCT00704808|50307578|FG000|Overall Study|Patient's decision|11|||
25315025|NCT00643201|50630862|FG000|Completed Study Follow Up|Death|28|||
25196452|NCT02563548|50391484|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
25196453|NCT02563548|50391485|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
25196454|NCT02563548|50391480|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
25196455|NCT02563548|50391481|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
25196456|NCT02563548|50391482|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
25196457|NCT02563548|50391483|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
25196458|NCT02563548|50391484|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
25196459|NCT02563548|50391485|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
25196460|NCT02563548|50391480|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
25196461|NCT02563548|50391481|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
25196462|NCT02563548|50391482|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
25196463|NCT02563548|50391483|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
25196464|NCT02563548|50391484|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
25196465|NCT02563548|50391485|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
25196466|NCT02563548|50391480|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
25196467|NCT02563548|50391481|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
25196468|NCT02563548|50391482|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
25196469|NCT02563548|50391483|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
25196470|NCT02563548|50391484|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
25196471|NCT02563548|50391485|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
25196472|NCT02559570|50391566|FG000|Overall Study|Adverse Event|0|||
25196473|NCT02559570|50391567|FG001|Overall Study|Adverse Event|2|||
25196474|NCT02559570|50391568|FG002|Overall Study|Adverse Event|0|||
25196475|NCT02559570|50391569|FG003|Overall Study|Adverse Event|1|||
25196476|NCT02559570|50391570|FG004|Overall Study|Adverse Event|0|||
25196477|NCT02559570|50391566|FG000|Overall Study|Withdrawal of Consent|0|||
25196478|NCT02559570|50391567|FG001|Overall Study|Withdrawal of Consent|0|||
25196479|NCT02559570|50391568|FG002|Overall Study|Withdrawal of Consent|1|||
25196480|NCT02559570|50391569|FG003|Overall Study|Withdrawal of Consent|2|||
25196481|NCT02559570|50391570|FG004|Overall Study|Withdrawal of Consent|1|||
25196482|NCT02559570|50391566|FG000|Overall Study|Lost to Follow-up|1|||
25196483|NCT02559570|50391567|FG001|Overall Study|Lost to Follow-up|0|||
25196484|NCT02559570|50391568|FG002|Overall Study|Lost to Follow-up|0|||
25196485|NCT02559570|50391569|FG003|Overall Study|Lost to Follow-up|0|||
25196486|NCT02559570|50391570|FG004|Overall Study|Lost to Follow-up|0|||
25196487|NCT02559570|50391566|FG000|Overall Study|Protocol Violation|1|||
25196488|NCT02559570|50391567|FG001|Overall Study|Protocol Violation|0|||
25196489|NCT02559570|50391568|FG002|Overall Study|Protocol Violation|0|||
25196490|NCT02559570|50391569|FG003|Overall Study|Protocol Violation|0|||
25196491|NCT02559570|50391570|FG004|Overall Study|Protocol Violation|1|||
25196492|NCT02559570|50391566|FG000|Overall Study|Other Miscellaneous Reasons|0|||
25196493|NCT02559570|50391567|FG001|Overall Study|Other Miscellaneous Reasons|0|||
25196494|NCT02559570|50391568|FG002|Overall Study|Other Miscellaneous Reasons|1|||
25196495|NCT02559570|50391569|FG003|Overall Study|Other Miscellaneous Reasons|0|||
25196496|NCT02559570|50391570|FG004|Overall Study|Other Miscellaneous Reasons|0|||
25196497|NCT02559414|50391925|FG000|Overall Study|Lost to Follow-up|0|||
25196498|NCT02559414|50391926|FG001|Overall Study|Lost to Follow-up|1|||
25196499|NCT02559414|50391927|FG002|Overall Study|Lost to Follow-up|0|||
25196500|NCT02559414|50391925|FG000|Overall Study|Withdrawal by Subject|1|||
25196501|NCT02559414|50391926|FG001|Overall Study|Withdrawal by Subject|0|||
25196502|NCT02559414|50391927|FG002|Overall Study|Withdrawal by Subject|1|||
25196503|NCT02559414|50391925|FG000|Overall Study|Other|0|||
25196504|NCT02559414|50391926|FG001|Overall Study|Other|1|||
25196505|NCT02559414|50391927|FG002|Overall Study|Other|1|||
25196506|NCT02558790|50392002|FG000|Overall Study|Lost to Follow-up|2|||
25196507|NCT02558790|50392002|FG000|Overall Study|Physician Decision|1|||
25196508|NCT02558790|50392002|FG000|Overall Study|Withdrawal by Subject|1|||
25196509|NCT02558790|50392002|FG000|Overall Study|Screen Fail|3|||
25196510|NCT02556138|50392028|FG000|Overall Study|Withdrawal by Subject|1|||
25196511|NCT02558400|50392111|FG000|Overall Study|Adverse Event|47|||
25196512|NCT02558400|50392112|FG001|Overall Study|Adverse Event|53|||
25196513|NCT02558400|50392113|FG002|Overall Study|Adverse Event|4|||
25196514|NCT02558400|50392111|FG000|Overall Study|Withdrawal by Subject|13|||
25196515|NCT02558400|50392112|FG001|Overall Study|Withdrawal by Subject|9|||
25196516|NCT02558400|50392113|FG002|Overall Study|Withdrawal by Subject|8|||
25196517|NCT02558400|50392111|FG000|Overall Study|Non-Compliant|0|||
25196518|NCT02558400|50392112|FG001|Overall Study|Non-Compliant|1|||
25196519|NCT02558400|50392113|FG002|Overall Study|Non-Compliant|3|||
25196520|NCT02558400|50392111|FG000|Overall Study|Lost to Follow-up|5|||
25196521|NCT02558400|50392112|FG001|Overall Study|Lost to Follow-up|5|||
25196522|NCT02558400|50392113|FG002|Overall Study|Lost to Follow-up|4|||
25196523|NCT02558400|50392111|FG000|Overall Study|Lack of Efficacy|0|||
25196524|NCT02558400|50392112|FG001|Overall Study|Lack of Efficacy|13|||
25196525|NCT02558400|50392113|FG002|Overall Study|Lack of Efficacy|1|||
25196526|NCT02558400|50392111|FG000|Overall Study|Disallowed Concurrent Medication|6|||
25196527|NCT02558400|50392112|FG001|Overall Study|Disallowed Concurrent Medication|7|||
25196528|NCT02558400|50392113|FG002|Overall Study|Disallowed Concurrent Medication|5|||
25196529|NCT02558400|50392111|FG000|Overall Study|Physician Decision|2|||
25196530|NCT02558400|50392112|FG001|Overall Study|Physician Decision|2|||
25196531|NCT02558400|50392113|FG002|Overall Study|Physician Decision|0|||
25196532|NCT02558400|50392111|FG000|Overall Study|Protocol Violation|6|||
25196533|NCT02558400|50392112|FG001|Overall Study|Protocol Violation|3|||
25196534|NCT02558400|50392113|FG002|Overall Study|Protocol Violation|8|||
25196535|NCT02558400|50392111|FG000|Overall Study|Death|0|||
25196536|NCT02558400|50392112|FG001|Overall Study|Death|1|||
25196537|NCT02558400|50392113|FG002|Overall Study|Death|0|||
25196538|NCT02558400|50392111|FG000|Overall Study|Ineligible for the study|0|||
25196539|NCT02558400|50392112|FG001|Overall Study|Ineligible for the study|2|||
25196540|NCT02558400|50392113|FG002|Overall Study|Ineligible for the study|0|||
25196541|NCT01662648|50392245|FG000|Overall Study|Death|1|||
25196542|NCT01662648|50392246|FG001|Overall Study|Death|3|||
25196543|NCT01662648|50392245|FG000|Overall Study|Adverse Event|40|||
25196544|NCT01662648|50392246|FG001|Overall Study|Adverse Event|37|||
25196545|NCT01662648|50392245|FG000|Overall Study|Lack of Efficacy|17|||
25196546|NCT01662648|50392246|FG001|Overall Study|Lack of Efficacy|16|||
25196547|NCT01662648|50392245|FG000|Overall Study|Participant ineligible to continue trial|1|||
25196548|NCT01662648|50392246|FG001|Overall Study|Participant ineligible to continue trial|1|||
25196549|NCT01662648|50392245|FG000|Overall Study|Lost to Follow-up|24|||
25196550|NCT01662648|50392246|FG001|Overall Study|Lost to Follow-up|36|||
25196551|NCT01662648|50392245|FG000|Overall Study|Withdrawal by Subject|36|||
25196552|NCT01662648|50392246|FG001|Overall Study|Withdrawal by Subject|53|||
25196553|NCT01662648|50392245|FG000|Overall Study|Participant non-compliant|16|||
25196554|NCT01662648|50392246|FG001|Overall Study|Participant non-compliant|20|||
25196555|NCT01662648|50392245|FG000|Overall Study|Other|8|||
25196556|NCT01662648|50392246|FG001|Overall Study|Other|11|||
25196557|NCT01662648|50392245|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
25196558|NCT01662648|50392246|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
25196559|NCT01662648|50392245|FG000|Overall Study|LOE and other reason unspecified|1|||
25196560|NCT01662648|50392246|FG001|Overall Study|LOE and other reason unspecified|0|||
25196561|NCT01662648|50392245|FG000|Overall Study|LOE and Participant non-compliant|0|||
25196562|NCT01662648|50392246|FG001|Overall Study|LOE and Participant non-compliant|1|||
25196563|NCT02556918|50392311|FG000|Overall Study|Protocol Violation|5|||
25196564|NCT02556918|50392312|FG001|Overall Study|Protocol Violation|6|||
25196565|NCT02556918|50392311|FG000|Overall Study|Withdrawal by Subject|4|||
25196566|NCT02556918|50392312|FG001|Overall Study|Withdrawal by Subject|4|||
25196567|NCT01662492|50392428|FG000|Overall Study|Other miscellaneous reasons.|1|||
25196568|NCT01662492|50392429|FG001|Overall Study|Other miscellaneous reasons.|0|||
25196569|NCT01662492|50392430|FG002|Overall Study|Other miscellaneous reasons.|1|||
25196570|NCT01662492|50392428|FG000|Overall Study|Withdrawal by Subject|0|||
25196571|NCT01662492|50392429|FG001|Overall Study|Withdrawal by Subject|0|||
25196572|NCT01662492|50392430|FG002|Overall Study|Withdrawal by Subject|1|||
25196573|NCT01662492|50392428|FG000|Overall Study|Protocol Violation|1|||
25196574|NCT01662492|50392429|FG001|Overall Study|Protocol Violation|0|||
25196575|NCT01662492|50392430|FG002|Overall Study|Protocol Violation|0|||
25196576|NCT01662492|50392428|FG000|Overall Study|Lost to Follow-up|0|||
25196577|NCT01662492|50392429|FG001|Overall Study|Lost to Follow-up|0|||
25196578|NCT01662492|50392430|FG002|Overall Study|Lost to Follow-up|2|||
25196579|NCT01662492|50392428|FG000|Overall Study|Lack of Efficacy|1|||
25196580|NCT01662492|50392429|FG001|Overall Study|Lack of Efficacy|1|||
25196581|NCT01662492|50392430|FG002|Overall Study|Lack of Efficacy|2|||
25196582|NCT02552238|50392600|FG000|Overall Study|Withdrawal by Subject|2|||
25196583|NCT02552238|50392600|FG000|Overall Study|Adverse Event|2|||
25315026|NCT00643201|50630863|FG001|Completed Study Follow Up|Death|34|||
25315027|NCT00643201|50630862|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
25315028|NCT00643201|50630863|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
25315029|NCT00643201|50630862|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
25315030|NCT00643201|50630863|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
25315031|NCT00643201|50630862|FG000|Completed Study Follow Up|non-specified|1|||
25315032|NCT00643201|50630863|FG001|Completed Study Follow Up|non-specified|0|||
25196584|NCT01662102|50392818|FG000|Overall Study|Sponsor's decision|1|||
25196585|NCT01662102|50392819|FG001|Overall Study|Sponsor's decision|0|||
25196586|NCT02554656|50392859|FG000|Overall Study|Protocol Violation|3|||
25315033|NCT00643123|50630873|FG000|Overall Study|Lost to Follow-up|4|||
25196587|NCT03414684|50393019|FG000|First-course Treatment|Complete response|0|||
25196588|NCT03414684|50393020|FG001|First-course Treatment|Complete response|1|||
25196589|NCT03414684|50393019|FG000|First-course Treatment|Intercurrent illness|1|||
25196590|NCT03414684|50393020|FG001|First-course Treatment|Intercurrent illness|0|||
25196591|NCT03414684|50393019|FG000|First-course Treatment|Progressive Disease|31|||
25196592|NCT03414684|50393020|FG001|First-course Treatment|Progressive Disease|32|||
25196593|NCT03414684|50393019|FG000|First-course Treatment|Adverse Event|1|||
25196594|NCT03414684|50393020|FG001|First-course Treatment|Adverse Event|2|||
25196595|NCT03414684|50393019|FG000|First-course Treatment|Physician Decision|0|||
25196596|NCT03414684|50393020|FG001|First-course Treatment|Physician Decision|1|||
25196597|NCT03414684|50393019|FG000|First-course Treatment|Withdrawal by Subject|0|||
25196598|NCT03414684|50393020|FG001|First-course Treatment|Withdrawal by Subject|1|||
25196599|NCT03414684|50393019|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
25196600|NCT03414684|50393020|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
25196601|NCT03414684|50393019|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
25196602|NCT03414684|50393020|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
25196603|NCT03414684|50393019|FG000|First-course Treatment|Still on treatment|3|||
25196604|NCT03414684|50393020|FG001|First-course Treatment|Still on treatment|0|||
25196605|NCT03414684|50393019|FG000|First-course Treatment|Never started protocol therapy|2|||
25196606|NCT03414684|50393020|FG001|First-course Treatment|Never started protocol therapy|1|||
25196607|NCT03414684|50393019|FG000|Crossover Treatment|Progressive disease|0|||
25196608|NCT03414684|50393020|FG001|Crossover Treatment|Progressive disease|12|||
25196609|NCT03414684|50393019|FG000|Crossover Treatment|Adverse Event|0|||
25196610|NCT03414684|50393020|FG001|Crossover Treatment|Adverse Event|3|||
25196611|NCT03414684|50393019|FG000|Crossover Treatment|Physician Decision|0|||
25196612|NCT03414684|50393020|FG001|Crossover Treatment|Physician Decision|1|||
25196613|NCT03414684|50393019|FG000|Crossover Treatment|Still on treatment|0|||
25196614|NCT03414684|50393020|FG001|Crossover Treatment|Still on treatment|2|||
25196615|NCT02551692|50393099|FG000|Overall Study|Lost to Follow-up|0|||
25196616|NCT02551692|50393100|FG001|Overall Study|Lost to Follow-up|1|||
25196617|NCT02551692|50393101|FG002|Overall Study|Lost to Follow-up|4|||
25196618|NCT02551692|50393099|FG000|Overall Study|Withdrawal by Subject|1|||
25196619|NCT02551692|50393100|FG001|Overall Study|Withdrawal by Subject|0|||
25196620|NCT02551692|50393101|FG002|Overall Study|Withdrawal by Subject|1|||
25196621|NCT02553330|50393188|FG000|Overall Study|Study Terminated by Sponsor|2|||
25196622|NCT02553330|50393189|FG001|Overall Study|Study Terminated by Sponsor|13|||
25196623|NCT02553330|50393190|FG002|Overall Study|Study Terminated by Sponsor|12|||
25196624|NCT02553330|50393188|FG000|Overall Study|Withdrawal by Subject|3|||
25196625|NCT02553330|50393189|FG001|Overall Study|Withdrawal by Subject|19|||
25196626|NCT02553330|50393190|FG002|Overall Study|Withdrawal by Subject|21|||
25196627|NCT02553330|50393188|FG000|Overall Study|Other|0|||
25196628|NCT02553330|50393189|FG001|Overall Study|Other|1|||
25196629|NCT02553330|50393190|FG002|Overall Study|Other|0|||
25196630|NCT02553330|50393188|FG000|Overall Study|Non compliance to study treatment|0|||
25196631|NCT02553330|50393189|FG001|Overall Study|Non compliance to study treatment|1|||
25196632|NCT02553330|50393190|FG002|Overall Study|Non compliance to study treatment|0|||
25196633|NCT02553330|50393188|FG000|Overall Study|Adverse Event|0|||
25196634|NCT02553330|50393189|FG001|Overall Study|Adverse Event|1|||
25196635|NCT02553330|50393190|FG002|Overall Study|Adverse Event|0|||
25196636|NCT02553330|50393188|FG000|Overall Study|Lost to Follow-up|0|||
25196637|NCT02553330|50393189|FG001|Overall Study|Lost to Follow-up|4|||
25196638|NCT02553330|50393190|FG002|Overall Study|Lost to Follow-up|4|||
25196639|NCT02550288|50393232|FG000|Overall Study|Adverse Event|0|||
25196640|NCT02550288|50393233|FG001|Overall Study|Adverse Event|1|||
25196641|NCT02550288|50393234|FG002|Overall Study|Adverse Event|0|||
25196642|NCT02550288|50393235|FG003|Overall Study|Adverse Event|0|||
25196643|NCT02550288|50393236|FG004|Overall Study|Adverse Event|0|||
25196644|NCT02550288|50393232|FG000|Overall Study|Physician Decision|0|||
25196645|NCT02550288|50393233|FG001|Overall Study|Physician Decision|0|||
25196646|NCT02550288|50393234|FG002|Overall Study|Physician Decision|0|||
25196647|NCT02550288|50393235|FG003|Overall Study|Physician Decision|1|||
25196648|NCT02550288|50393236|FG004|Overall Study|Physician Decision|0|||
25196649|NCT02550288|50393232|FG000|Overall Study|Protocol Violation|2|||
25196650|NCT02550288|50393233|FG001|Overall Study|Protocol Violation|2|||
25196651|NCT02550288|50393234|FG002|Overall Study|Protocol Violation|1|||
25196652|NCT02550288|50393235|FG003|Overall Study|Protocol Violation|0|||
25196653|NCT02550288|50393236|FG004|Overall Study|Protocol Violation|3|||
25315034|NCT00643123|50630874|FG001|Overall Study|Lost to Follow-up|0|||
25196654|NCT02550288|50393232|FG000|Overall Study|Participant moved|0|||
25196655|NCT02550288|50393233|FG001|Overall Study|Participant moved|0|||
25196656|NCT02550288|50393234|FG002|Overall Study|Participant moved|0|||
25196657|NCT02550288|50393235|FG003|Overall Study|Participant moved|1|||
25196658|NCT02550288|50393236|FG004|Overall Study|Participant moved|0|||
25196659|NCT02550288|50393232|FG000|Overall Study|Withdrawal by Subject|0|||
25196660|NCT02550288|50393233|FG001|Overall Study|Withdrawal by Subject|0|||
25315035|NCT00643123|50630873|FG000|Overall Study|Withdrawal by Subject|1|||
25315036|NCT00643123|50630874|FG001|Overall Study|Withdrawal by Subject|1|||
25315037|NCT00968981|50630883|FG000|Overall Study|Adverse Event|2|||
25196661|NCT02550288|50393234|FG002|Overall Study|Withdrawal by Subject|0|||
25196662|NCT02550288|50393235|FG003|Overall Study|Withdrawal by Subject|1|||
25315038|NCT00968981|50630884|FG001|Overall Study|Adverse Event|0|||
25196663|NCT02550288|50393236|FG004|Overall Study|Withdrawal by Subject|0|||
25196664|NCT01662336|50393301|FG000|Overall Study|Adverse Event|1|||
25196665|NCT01662336|50393301|FG000|Overall Study|No longer on LPV/r|30|||
25196666|NCT01662336|50393301|FG000|Overall Study|Other|29|||
25196667|NCT01662336|50393301|FG000|Overall Study|Withdrawal by Subject|6|||
25196668|NCT02549352|50393320|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
25196669|NCT02549352|50393321|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
25196670|NCT02549352|50393320|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
25196671|NCT02549352|50393321|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
25196672|NCT02549352|50393320|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
25196673|NCT02549352|50393321|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
25196674|NCT02549352|50393320|FG000|12-month Follow-up|Withdrawal by Subject|4|||
25196675|NCT02549352|50393321|FG001|12-month Follow-up|Withdrawal by Subject|5|||
25196676|NCT02549352|50393320|FG000|12-month Follow-up|Lost to Follow-up|3|||
25196677|NCT02549352|50393321|FG001|12-month Follow-up|Lost to Follow-up|2|||
25196678|NCT02549352|50393320|FG000|12-month Follow-up|Death|0|||
25196679|NCT02549352|50393321|FG001|12-month Follow-up|Death|1|||
25196680|NCT02549352|50393320|FG000|12-month Follow-up|Protocol Violation|0|||
25196681|NCT02549352|50393321|FG001|12-month Follow-up|Protocol Violation|1|||
25196682|NCT02549352|50393320|FG000|12-month Follow-up|Other|1|||
25196683|NCT02549352|50393321|FG001|12-month Follow-up|Other|3|||
25196684|NCT02554890|50393498|FG000|Double-blind|Adverse Event|45|||
25196685|NCT02554890|50393499|FG001|Double-blind|Adverse Event|51|||
25196686|NCT02554890|50393498|FG000|Double-blind|Death|6|||
25196687|NCT02554890|50393499|FG001|Double-blind|Death|4|||
25196688|NCT02554890|50393498|FG000|Double-blind|Protocol Violation|1|||
25196689|NCT02554890|50393499|FG001|Double-blind|Protocol Violation|1|||
25196690|NCT02554890|50393498|FG000|Double-blind|Physician Decision|4|||
25196691|NCT02554890|50393499|FG001|Double-blind|Physician Decision|3|||
25196692|NCT02554890|50393498|FG000|Double-blind|Subject/Guardian decision|21|||
25196693|NCT02554890|50393499|FG001|Double-blind|Subject/Guardian decision|16|||
25196694|NCT02554890|50393498|FG000|Double-blind|Lost to Follow-up|7|||
25196695|NCT02554890|50393499|FG001|Double-blind|Lost to Follow-up|5|||
25196696|NCT02554890|50393498|FG000|Double-blind|Technical problems|1|||
25196697|NCT02554890|50393499|FG001|Double-blind|Technical problems|0|||
25196698|NCT02554890|50393498|FG000|Double-blind|Withdrawal by Subject|5|||
25196699|NCT02554890|50393499|FG001|Double-blind|Withdrawal by Subject|6|||
25196700|NCT02554890|50393498|FG000|Double-blind|Noncompliance with study treatment|6|||
25196701|NCT02554890|50393499|FG001|Double-blind|Noncompliance with study treatment|5|||
25196702|NCT02554890|50393498|FG000|Open-label|Adverse Event|0|||
25196703|NCT02554890|50393499|FG001|Open-label|Adverse Event|30|||
25196704|NCT02554890|50393498|FG000|Open-label|Death|0|||
25196705|NCT02554890|50393499|FG001|Open-label|Death|1|||
25196706|NCT02554890|50393498|FG000|Open-label|Physician Decision|0|||
25196707|NCT02554890|50393499|FG001|Open-label|Physician Decision|1|||
25196708|NCT02554890|50393498|FG000|Open-label|Subject/Guardian decision|0|||
25196709|NCT02554890|50393499|FG001|Open-label|Subject/Guardian decision|11|||
25196710|NCT02554890|50393498|FG000|Open-label|Lost to Follow-up|0|||
25196711|NCT02554890|50393499|FG001|Open-label|Lost to Follow-up|7|||
25196712|NCT02554890|50393498|FG000|Open-label|Technical problems|0|||
25196713|NCT02554890|50393499|FG001|Open-label|Technical problems|1|||
25196714|NCT02554890|50393498|FG000|Open-label|Withdrawal by Subject|0|||
25196715|NCT02554890|50393499|FG001|Open-label|Withdrawal by Subject|1|||
25196716|NCT02552316|50393516|FG000|Overall Study|Withdrawal by Subject|1|||
25196717|NCT02552316|50393516|FG000|Overall Study|Withdrawal due to non-compliance|1|||
25196718|NCT02543346|50393564|FG000|Second Priming Visit|Withdrawal by Subject|0|||
25196719|NCT02543346|50393565|FG001|Second Priming Visit|Withdrawal by Subject|2|||
25196720|NCT02543346|50393566|FG002|Second Priming Visit|Withdrawal by Subject|2|||
25196721|NCT02543346|50393567|FG003|Second Priming Visit|Withdrawal by Subject|2|||
25196722|NCT02543346|50393564|FG000|Second Priming Visit|Adverse Event|1|||
25196723|NCT02543346|50393565|FG001|Second Priming Visit|Adverse Event|0|||
25196724|NCT02543346|50393566|FG002|Second Priming Visit|Adverse Event|0|||
25196725|NCT02543346|50393567|FG003|Second Priming Visit|Adverse Event|0|||
25196726|NCT02549196|50393581|FG000|Overall Study|Protocol Violation|0|||
25196727|NCT02549196|50393582|FG001|Overall Study|Protocol Violation|0|||
25196728|NCT02549196|50393583|FG002|Overall Study|Protocol Violation|0|||
25196729|NCT02549196|50393584|FG003|Overall Study|Protocol Violation|1|||
25196730|NCT02549196|50393581|FG000|Overall Study|Withdrawal by Subject|1|||
25196731|NCT02549196|50393582|FG001|Overall Study|Withdrawal by Subject|0|||
25196732|NCT02549196|50393583|FG002|Overall Study|Withdrawal by Subject|1|||
25196733|NCT02549196|50393584|FG003|Overall Study|Withdrawal by Subject|0|||
25196734|NCT02904954|50393596|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
25196735|NCT02904954|50393597|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
25196736|NCT02904954|50393596|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
25196737|NCT02904954|50393597|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
25196738|NCT02904954|50393596|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
25196739|NCT02904954|50393597|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
25196740|NCT02904954|50393596|FG000|Adjuvant Durvalumab|Recurrence|2|||
25196741|NCT02904954|50393597|FG001|Adjuvant Durvalumab|Recurrence|0|||
25196742|NCT02904954|50393596|FG000|Adjuvant Durvalumab|Adverse Event|2|||
25196743|NCT02904954|50393597|FG001|Adjuvant Durvalumab|Adverse Event|6|||
25196744|NCT02904954|50393596|FG000|Adjuvant Durvalumab|Participant wishes|12|||
25196745|NCT02904954|50393597|FG001|Adjuvant Durvalumab|Participant wishes|7|||
25196746|NCT02904954|50393596|FG000|Adjuvant Durvalumab|Physician Decision|2|||
25196747|NCT02904954|50393597|FG001|Adjuvant Durvalumab|Physician Decision|1|||
25196748|NCT02904954|50393596|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
25196749|NCT02904954|50393597|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
25196750|NCT02904954|50393596|FG000|Adjuvant Durvalumab|Death|0|||
25196751|NCT02904954|50393597|FG001|Adjuvant Durvalumab|Death|1|||
25196752|NCT02904954|50393596|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
25196753|NCT02904954|50393597|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
25196754|NCT02548962|50393713|FG000|Overall Study|Withdrawal by Subject|1|||
25196755|NCT02548962|50393714|FG001|Overall Study|Withdrawal by Subject|0|||
25196756|NCT02548650|50393741|FG000|Triple Therapy|Adverse Event|1|||
25196757|NCT02548650|50393742|FG001|Triple Therapy|Adverse Event|0|||
25196758|NCT02548650|50393741|FG000|Triple Therapy|Withdrawal by Subject|0|||
25196759|NCT02548650|50393742|FG001|Triple Therapy|Withdrawal by Subject|4|||
25196760|NCT02548650|50393741|FG000|Double Therapy|Adverse Event|1|||
25196761|NCT02548650|50393742|FG001|Double Therapy|Adverse Event|1|||
25196762|NCT02548650|50393741|FG000|Double Therapy|Withdrawal by Subject|0|||
25196763|NCT02548650|50393742|FG001|Double Therapy|Withdrawal by Subject|1|||
25196764|NCT02535000|50393837|FG000|Overall Study|Cancellation of surgery.|1|||
25196765|NCT02535000|50393838|FG001|Overall Study|Cancellation of surgery.|2|||
25196766|NCT03110562|50393967|FG000|Overall Study|Withdrawal by Subject|37|||
25196767|NCT03110562|50393968|FG001|Overall Study|Withdrawal by Subject|35|||
25196768|NCT03110562|50393967|FG000|Overall Study|Death|47|||
25196769|NCT03110562|50393968|FG001|Overall Study|Death|61|||
25196770|NCT03110562|50393967|FG000|Overall Study|Lost to Follow-up|7|||
25196771|NCT03110562|50393968|FG001|Overall Study|Lost to Follow-up|6|||
25196772|NCT03110562|50393967|FG000|Overall Study|Other|2|||
25196773|NCT03110562|50393968|FG001|Overall Study|Other|1|||
25196774|NCT03110562|50393967|FG000|Overall Study|Randomized but never treated|0|||
25196775|NCT03110562|50393968|FG001|Overall Study|Randomized but never treated|3|||
25196776|NCT03110562|50393967|FG000|Overall Study|Ongoing|102|||
25196777|NCT03110562|50393968|FG001|Overall Study|Ongoing|101|||
25196778|NCT02546856|50394011|FG000|4 Months Evaluation|Death|2|||
25196779|NCT02546856|50394012|FG001|4 Months Evaluation|Death|3|||
25196780|NCT02546856|50394011|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
25196781|NCT02546856|50394012|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
25196782|NCT02546856|50394011|FG000|4 Months Evaluation|Lost to Follow-up|3|||
25196783|NCT02546856|50394012|FG001|4 Months Evaluation|Lost to Follow-up|3|||
25196784|NCT02546856|50394011|FG000|4 Months Evaluation|Physician Decision|3|||
25196785|NCT02546856|50394012|FG001|4 Months Evaluation|Physician Decision|0|||
25196786|NCT02546856|50394011|FG000|4 Months Evaluation|Working or living abroad|5|||
25196787|NCT02546856|50394012|FG001|4 Months Evaluation|Working or living abroad|1|||
25196788|NCT02546856|50394011|FG000|4 Months Evaluation|reasons not due to titration|4|||
25196789|NCT02546856|50394012|FG001|4 Months Evaluation|reasons not due to titration|1|||
25196790|NCT02546856|50394011|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
25196791|NCT02546856|50394012|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
25196792|NCT02546856|50394011|FG000|6 Months Evaluation|Death|1|||
25196793|NCT02546856|50394012|FG001|6 Months Evaluation|Death|1|||
25196794|NCT02546856|50394011|FG000|6 Months Evaluation|Lost to Follow-up|1|||
25196795|NCT02546856|50394012|FG001|6 Months Evaluation|Lost to Follow-up|1|||
25196796|NCT02546856|50394011|FG000|6 Months Evaluation|Working or living abroad|6|||
25196797|NCT02546856|50394012|FG001|6 Months Evaluation|Working or living abroad|4|||
25196798|NCT02546856|50394011|FG000|6 Months Evaluation|reasons not due to titration|0|||
25196799|NCT02546856|50394012|FG001|6 Months Evaluation|reasons not due to titration|1|||
25196800|NCT02696616|50394137|FG000|Overall Study|Adverse Event|0|||
25196801|NCT02696616|50394138|FG001|Overall Study|Adverse Event|1|||
25196802|NCT02696616|50394139|FG002|Overall Study|Adverse Event|0|||
25196803|NCT02696616|50394140|FG003|Overall Study|Adverse Event|0|||
25196804|NCT02696616|50394141|FG004|Overall Study|Adverse Event|0|||
25196805|NCT02696616|50394142|FG005|Overall Study|Adverse Event|0|||
25196806|NCT02696616|50394143|FG006|Overall Study|Adverse Event|0|||
25196807|NCT01661790|50394194|FG000|Overall Study|Lost to Follow-up|0|||
25196808|NCT01661790|50394195|FG001|Overall Study|Lost to Follow-up|2|||
25196809|NCT02546544|50394215|FG000|Overall Study|Disease Progression|14|||
25196810|NCT02546544|50394215|FG000|Overall Study|Adverse Event|1|||
25196811|NCT02546544|50394215|FG000|Overall Study|Withdrawal by Subject|1|||
25196812|NCT05593211|50394510|FG000|Overall Study|Withdrawal by Subject|1|||
25196813|NCT02533674|50394849|FG000|Dose Level I|Progressive disease|1|||
25196814|NCT02533674|50394850|FG001|Dose Level I|Progressive disease|0|||
25196815|NCT02533674|50394851|FG002|Dose Level I|Progressive disease|0|||
25196816|NCT02533674|50394852|FG003|Dose Level I|Progressive disease|0|||
25196817|NCT02533674|50394853|FG004|Dose Level I|Progressive disease|0|||
25196818|NCT02533674|50394854|FG005|Dose Level I|Progressive disease|0|||
25196819|NCT02533674|50394855|FG006|Dose Level I|Progressive disease|0|||
25196820|NCT02533674|50394856|FG007|Dose Level I|Progressive disease|0|||
25196821|NCT02533674|50394849|FG000|Dose Level I|Withdrawal by Subject|1|||
25196822|NCT02533674|50394850|FG001|Dose Level I|Withdrawal by Subject|0|||
25196823|NCT02533674|50394851|FG002|Dose Level I|Withdrawal by Subject|0|||
25196824|NCT02533674|50394852|FG003|Dose Level I|Withdrawal by Subject|0|||
25196825|NCT02533674|50394853|FG004|Dose Level I|Withdrawal by Subject|0|||
25196826|NCT02533674|50394854|FG005|Dose Level I|Withdrawal by Subject|0|||
25196827|NCT02533674|50394855|FG006|Dose Level I|Withdrawal by Subject|0|||
25196828|NCT02533674|50394856|FG007|Dose Level I|Withdrawal by Subject|0|||
25196829|NCT02533674|50394849|FG000|Dose Level I|Physician Decision|1|||
25196830|NCT02533674|50394850|FG001|Dose Level I|Physician Decision|0|||
25196831|NCT02533674|50394851|FG002|Dose Level I|Physician Decision|0|||
25196832|NCT02533674|50394852|FG003|Dose Level I|Physician Decision|0|||
25196833|NCT02533674|50394853|FG004|Dose Level I|Physician Decision|0|||
25196834|NCT02533674|50394854|FG005|Dose Level I|Physician Decision|0|||
25196835|NCT02533674|50394855|FG006|Dose Level I|Physician Decision|0|||
25196836|NCT02533674|50394856|FG007|Dose Level I|Physician Decision|0|||
25196837|NCT02533674|50394849|FG000|Dose Level I|Death|1|||
25196838|NCT02533674|50394850|FG001|Dose Level I|Death|0|||
25196839|NCT02533674|50394851|FG002|Dose Level I|Death|0|||
25196840|NCT02533674|50394852|FG003|Dose Level I|Death|0|||
25196841|NCT02533674|50394853|FG004|Dose Level I|Death|0|||
25196842|NCT02533674|50394854|FG005|Dose Level I|Death|0|||
25196843|NCT02533674|50394855|FG006|Dose Level I|Death|0|||
25196844|NCT02533674|50394856|FG007|Dose Level I|Death|0|||
25315039|NCT00968981|50630885|FG002|Overall Study|Adverse Event|0|||
25315040|NCT00968981|50630883|FG000|Overall Study|Disease Progression|14|||
25170846|NCT00704808|50307578|FG000|Overall Study|Early therapy discontinuation|16|||
25170847|NCT00704808|50307578|FG000|Overall Study|Adverse Event|1|||
25170848|NCT00704808|50307578|FG000|Overall Study|Lost to Follow-up|1|||
25170849|NCT00704808|50307578|FG000|Overall Study|Treatment change|1|||
25170850|NCT05166876|50307612|FG000|Overall Study|Withdrawal by Subject|1|||
25170851|NCT05166876|50307613|FG001|Overall Study|Withdrawal by Subject|0|||
25170852|NCT05166876|50307614|FG002|Overall Study|Withdrawal by Subject|0|||
25170853|NCT01375608|50307626|FG000|Overall Study|Withdrawal by Subject|2|||
25170854|NCT00704418|50307641|FG000|Overall Study|Withdrawal by Subject|2|||
25170855|NCT00704418|50307642|FG001|Overall Study|Withdrawal by Subject|0|||
25170856|NCT00704418|50307641|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
25170857|NCT00704418|50307642|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
25170858|NCT00704340|50307711|FG000|Overall Study|Lost to Follow-up|2|||
25170859|NCT00704340|50307712|FG001|Overall Study|Lost to Follow-up|1|||
25170860|NCT00704340|50307711|FG000|Overall Study|Death|0|||
25170861|NCT00704340|50307712|FG001|Overall Study|Death|1|||
25170862|NCT00552058|50307720|FG000|Overall Study|Adverse Event|8|||
25170863|NCT00552058|50307721|FG001|Overall Study|Adverse Event|7|||
25170864|NCT00552058|50307720|FG000|Overall Study|Lack of Efficacy|1|||
25170865|NCT00552058|50307721|FG001|Overall Study|Lack of Efficacy|5|||
25170866|NCT00552058|50307720|FG000|Overall Study|Lost to Follow-up|1|||
25170867|NCT00552058|50307721|FG001|Overall Study|Lost to Follow-up|0|||
25170868|NCT00552058|50307720|FG000|Overall Study|Withdrawal by Subject|4|||
25170869|NCT00552058|50307721|FG001|Overall Study|Withdrawal by Subject|4|||
25170870|NCT00552058|50307720|FG000|Overall Study|Other: Protocol Violation|0|||
25170871|NCT00552058|50307721|FG001|Overall Study|Other: Protocol Violation|1|||
25170872|NCT00552058|50307720|FG000|Overall Study|Other: Non Compliance|1|||
25170873|NCT00552058|50307721|FG001|Overall Study|Other: Non Compliance|2|||
25170874|NCT00552058|50307720|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
25170875|NCT00552058|50307721|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
25170876|NCT00552058|50307720|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
25170877|NCT00552058|50307721|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
25170878|NCT00552058|50307720|FG000|Overall Study|Other: Positive Stool Result|0|||
25170879|NCT00552058|50307721|FG001|Overall Study|Other: Positive Stool Result|1|||
25196845|NCT02533674|50394849|FG000|Dose Level I|Never Treated|1|||
25196846|NCT02533674|50394850|FG001|Dose Level I|Never Treated|0|||
25196847|NCT02533674|50394851|FG002|Dose Level I|Never Treated|0|||
25196848|NCT02533674|50394852|FG003|Dose Level I|Never Treated|0|||
25196849|NCT02533674|50394853|FG004|Dose Level I|Never Treated|0|||
25170880|NCT00552058|50307720|FG000|Overall Study|Other: Randomized in error|0|||
25196850|NCT02533674|50394854|FG005|Dose Level I|Never Treated|0|||
25170881|NCT00552058|50307721|FG001|Overall Study|Other: Randomized in error|1|||
25196851|NCT02533674|50394855|FG006|Dose Level I|Never Treated|0|||
25170882|NCT00552058|50307720|FG000|Overall Study|Other: Sponsors Decision|0|||
25196852|NCT02533674|50394856|FG007|Dose Level I|Never Treated|0|||
25196853|NCT02533674|50394849|FG000|Dose Level II|Progressive disease|0|||
25196854|NCT02533674|50394850|FG001|Dose Level II|Progressive disease|3|||
25196855|NCT02533674|50394851|FG002|Dose Level II|Progressive disease|0|||
25196856|NCT02533674|50394852|FG003|Dose Level II|Progressive disease|0|||
25196857|NCT02533674|50394853|FG004|Dose Level II|Progressive disease|0|||
25196858|NCT02533674|50394854|FG005|Dose Level II|Progressive disease|0|||
25196859|NCT02533674|50394855|FG006|Dose Level II|Progressive disease|0|||
25196860|NCT02533674|50394856|FG007|Dose Level II|Progressive disease|0|||
25196861|NCT02533674|50394849|FG000|Dose Level II|Withdrawal by Subject|0|||
25196862|NCT02533674|50394850|FG001|Dose Level II|Withdrawal by Subject|1|||
25196863|NCT02533674|50394851|FG002|Dose Level II|Withdrawal by Subject|0|||
25196864|NCT02533674|50394852|FG003|Dose Level II|Withdrawal by Subject|0|||
25196865|NCT02533674|50394853|FG004|Dose Level II|Withdrawal by Subject|0|||
25196866|NCT02533674|50394854|FG005|Dose Level II|Withdrawal by Subject|0|||
25196867|NCT02533674|50394855|FG006|Dose Level II|Withdrawal by Subject|0|||
25196868|NCT02533674|50394856|FG007|Dose Level II|Withdrawal by Subject|0|||
25196869|NCT02533674|50394849|FG000|Dose Level II|Treatment-related AE|0|||
25196870|NCT02533674|50394850|FG001|Dose Level II|Treatment-related AE|1|||
25196871|NCT02533674|50394851|FG002|Dose Level II|Treatment-related AE|0|||
25196872|NCT02533674|50394852|FG003|Dose Level II|Treatment-related AE|0|||
25196873|NCT02533674|50394853|FG004|Dose Level II|Treatment-related AE|0|||
25196874|NCT02533674|50394854|FG005|Dose Level II|Treatment-related AE|0|||
25196875|NCT02533674|50394855|FG006|Dose Level II|Treatment-related AE|0|||
25196876|NCT02533674|50394856|FG007|Dose Level II|Treatment-related AE|0|||
25196877|NCT02533674|50394849|FG000|Dose Level II|Physician Decision|0|||
25196878|NCT02533674|50394850|FG001|Dose Level II|Physician Decision|1|||
25196879|NCT02533674|50394851|FG002|Dose Level II|Physician Decision|0|||
25196880|NCT02533674|50394852|FG003|Dose Level II|Physician Decision|0|||
25196881|NCT02533674|50394853|FG004|Dose Level II|Physician Decision|0|||
25196882|NCT02533674|50394854|FG005|Dose Level II|Physician Decision|0|||
25196883|NCT02533674|50394855|FG006|Dose Level II|Physician Decision|0|||
25196884|NCT02533674|50394856|FG007|Dose Level II|Physician Decision|0|||
25196885|NCT02533674|50394849|FG000|Dose Level II|Non-treatment-related AE|0|||
25196886|NCT02533674|50394850|FG001|Dose Level II|Non-treatment-related AE|1|||
25196887|NCT02533674|50394851|FG002|Dose Level II|Non-treatment-related AE|0|||
25196888|NCT02533674|50394852|FG003|Dose Level II|Non-treatment-related AE|0|||
25196889|NCT02533674|50394853|FG004|Dose Level II|Non-treatment-related AE|0|||
25196890|NCT02533674|50394854|FG005|Dose Level II|Non-treatment-related AE|0|||
25196891|NCT02533674|50394855|FG006|Dose Level II|Non-treatment-related AE|0|||
25196892|NCT02533674|50394856|FG007|Dose Level II|Non-treatment-related AE|0|||
25196893|NCT02533674|50394849|FG000|Dose Level III|Progressive disease|0|||
25196894|NCT02533674|50394850|FG001|Dose Level III|Progressive disease|0|||
25196895|NCT02533674|50394851|FG002|Dose Level III|Progressive disease|2|||
25196896|NCT02533674|50394852|FG003|Dose Level III|Progressive disease|0|||
25196897|NCT02533674|50394853|FG004|Dose Level III|Progressive disease|0|||
25196898|NCT02533674|50394854|FG005|Dose Level III|Progressive disease|0|||
25196899|NCT02533674|50394855|FG006|Dose Level III|Progressive disease|0|||
25196900|NCT02533674|50394856|FG007|Dose Level III|Progressive disease|0|||
25196901|NCT02533674|50394849|FG000|Dose Level III|Withdrawal by Subject|0|||
25196902|NCT02533674|50394850|FG001|Dose Level III|Withdrawal by Subject|0|||
25196903|NCT02533674|50394851|FG002|Dose Level III|Withdrawal by Subject|1|||
25196904|NCT02533674|50394852|FG003|Dose Level III|Withdrawal by Subject|0|||
25196905|NCT02533674|50394853|FG004|Dose Level III|Withdrawal by Subject|0|||
25196906|NCT02533674|50394854|FG005|Dose Level III|Withdrawal by Subject|0|||
25196907|NCT02533674|50394855|FG006|Dose Level III|Withdrawal by Subject|0|||
25196908|NCT02533674|50394856|FG007|Dose Level III|Withdrawal by Subject|0|||
25196909|NCT02533674|50394849|FG000|Dose Level III|Treatment-related AE|0|||
25196910|NCT02533674|50394850|FG001|Dose Level III|Treatment-related AE|0|||
25315041|NCT00968981|50630884|FG001|Overall Study|Disease Progression|16|||
25196911|NCT02533674|50394851|FG002|Dose Level III|Treatment-related AE|1|||
25196912|NCT02533674|50394852|FG003|Dose Level III|Treatment-related AE|0|||
25196913|NCT02533674|50394853|FG004|Dose Level III|Treatment-related AE|0|||
25196914|NCT02533674|50394854|FG005|Dose Level III|Treatment-related AE|0|||
25196915|NCT02533674|50394855|FG006|Dose Level III|Treatment-related AE|0|||
25196916|NCT02533674|50394856|FG007|Dose Level III|Treatment-related AE|0|||
25196917|NCT02533674|50394849|FG000|Dose Level IV|Progressive disease|0|||
25196918|NCT02533674|50394850|FG001|Dose Level IV|Progressive disease|0|||
25196919|NCT02533674|50394851|FG002|Dose Level IV|Progressive disease|0|||
25196920|NCT02533674|50394852|FG003|Dose Level IV|Progressive disease|3|||
25196921|NCT02533674|50394853|FG004|Dose Level IV|Progressive disease|0|||
25196922|NCT02533674|50394854|FG005|Dose Level IV|Progressive disease|0|||
25196923|NCT02533674|50394855|FG006|Dose Level IV|Progressive disease|0|||
25315042|NCT00968981|50630885|FG002|Overall Study|Disease Progression|13|||
25315043|NCT00968981|50630883|FG000|Overall Study|Lost to Follow-up|0|||
25315044|NCT00968981|50630884|FG001|Overall Study|Lost to Follow-up|0|||
25315045|NCT00968981|50630885|FG002|Overall Study|Lost to Follow-up|1|||
25315046|NCT00968981|50630883|FG000|Overall Study|Physician Decision|5|||
25315047|NCT00968981|50630884|FG001|Overall Study|Physician Decision|3|||
25315048|NCT00968981|50630885|FG002|Overall Study|Physician Decision|5|||
25315049|NCT00968981|50630883|FG000|Overall Study|Withdrawal by Subject|1|||
25315050|NCT00968981|50630884|FG001|Overall Study|Withdrawal by Subject|3|||
25315051|NCT00968981|50630885|FG002|Overall Study|Withdrawal by Subject|3|||
25315052|NCT00641719|50630896|FG000|Overall Study|Lack of Efficacy|1|||
25196924|NCT02533674|50394856|FG007|Dose Level IV|Progressive disease|0|||
25196925|NCT02533674|50394849|FG000|Dose Level IV|Withdrawal by Subject|0|||
25196926|NCT02533674|50394850|FG001|Dose Level IV|Withdrawal by Subject|0|||
25196927|NCT02533674|50394851|FG002|Dose Level IV|Withdrawal by Subject|0|||
25196928|NCT02533674|50394852|FG003|Dose Level IV|Withdrawal by Subject|1|||
25196929|NCT02533674|50394853|FG004|Dose Level IV|Withdrawal by Subject|0|||
25196930|NCT02533674|50394854|FG005|Dose Level IV|Withdrawal by Subject|0|||
25196931|NCT02533674|50394855|FG006|Dose Level IV|Withdrawal by Subject|0|||
25196932|NCT02533674|50394856|FG007|Dose Level IV|Withdrawal by Subject|0|||
25196933|NCT02533674|50394849|FG000|Dose Level IV|Physician Decision|0|||
25196934|NCT02533674|50394850|FG001|Dose Level IV|Physician Decision|0|||
25196935|NCT02533674|50394851|FG002|Dose Level IV|Physician Decision|0|||
25196936|NCT02533674|50394852|FG003|Dose Level IV|Physician Decision|1|||
25196937|NCT02533674|50394853|FG004|Dose Level IV|Physician Decision|0|||
25196938|NCT02533674|50394854|FG005|Dose Level IV|Physician Decision|0|||
25196939|NCT02533674|50394855|FG006|Dose Level IV|Physician Decision|0|||
25196940|NCT02533674|50394856|FG007|Dose Level IV|Physician Decision|0|||
25196941|NCT02533674|50394849|FG000|Dose Level V|Progressive disease|0|||
25196942|NCT02533674|50394850|FG001|Dose Level V|Progressive disease|0|||
25196943|NCT02533674|50394851|FG002|Dose Level V|Progressive disease|0|||
25196944|NCT02533674|50394852|FG003|Dose Level V|Progressive disease|0|||
25196945|NCT02533674|50394853|FG004|Dose Level V|Progressive disease|3|||
25196946|NCT02533674|50394854|FG005|Dose Level V|Progressive disease|0|||
25196947|NCT02533674|50394855|FG006|Dose Level V|Progressive disease|0|||
25196948|NCT02533674|50394856|FG007|Dose Level V|Progressive disease|0|||
25196949|NCT02533674|50394849|FG000|Dose Level V|Withdrawal by Subject|0|||
25196950|NCT02533674|50394850|FG001|Dose Level V|Withdrawal by Subject|0|||
25196951|NCT02533674|50394851|FG002|Dose Level V|Withdrawal by Subject|0|||
25196952|NCT02533674|50394852|FG003|Dose Level V|Withdrawal by Subject|0|||
25196953|NCT02533674|50394853|FG004|Dose Level V|Withdrawal by Subject|1|||
25196954|NCT02533674|50394854|FG005|Dose Level V|Withdrawal by Subject|0|||
25196955|NCT02533674|50394855|FG006|Dose Level V|Withdrawal by Subject|0|||
25196956|NCT02533674|50394856|FG007|Dose Level V|Withdrawal by Subject|0|||
25196957|NCT02533674|50394849|FG000|Dose Level V|Physician Decision|0|||
25196958|NCT02533674|50394850|FG001|Dose Level V|Physician Decision|0|||
25196959|NCT02533674|50394851|FG002|Dose Level V|Physician Decision|0|||
25196960|NCT02533674|50394852|FG003|Dose Level V|Physician Decision|0|||
25315053|NCT00641719|50630897|FG001|Overall Study|Lack of Efficacy|2|||
25315054|NCT00641719|50630896|FG000|Overall Study|Adverse Event|24|||
25315055|NCT00641719|50630897|FG001|Overall Study|Adverse Event|29|||
25196961|NCT02533674|50394853|FG004|Dose Level V|Physician Decision|1|||
25196962|NCT02533674|50394854|FG005|Dose Level V|Physician Decision|0|||
25196963|NCT02533674|50394855|FG006|Dose Level V|Physician Decision|0|||
25196964|NCT02533674|50394856|FG007|Dose Level V|Physician Decision|0|||
25196965|NCT02533674|50394849|FG000|Dose Level VI|Progressive disease|0|||
25196966|NCT02533674|50394850|FG001|Dose Level VI|Progressive disease|0|||
25196967|NCT02533674|50394851|FG002|Dose Level VI|Progressive disease|0|||
25196968|NCT02533674|50394852|FG003|Dose Level VI|Progressive disease|0|||
25196969|NCT02533674|50394853|FG004|Dose Level VI|Progressive disease|0|||
25196970|NCT02533674|50394854|FG005|Dose Level VI|Progressive disease|7|||
25196971|NCT02533674|50394855|FG006|Dose Level VI|Progressive disease|0|||
25315056|NCT00641719|50630896|FG000|Overall Study|Withdrawal by Subject|4|||
25196972|NCT02533674|50394856|FG007|Dose Level VI|Progressive disease|0|||
25196973|NCT02533674|50394849|FG000|Dose Level VI|Withdrawal by Subject|0|||
25196974|NCT02533674|50394850|FG001|Dose Level VI|Withdrawal by Subject|0|||
25196975|NCT02533674|50394851|FG002|Dose Level VI|Withdrawal by Subject|0|||
25196976|NCT02533674|50394852|FG003|Dose Level VI|Withdrawal by Subject|0|||
25196977|NCT02533674|50394853|FG004|Dose Level VI|Withdrawal by Subject|0|||
25196978|NCT02533674|50394854|FG005|Dose Level VI|Withdrawal by Subject|1|||
25196979|NCT02533674|50394855|FG006|Dose Level VI|Withdrawal by Subject|0|||
25196980|NCT02533674|50394856|FG007|Dose Level VI|Withdrawal by Subject|0|||
25196981|NCT02533674|50394849|FG000|Dose Level VI|Treatment-related AE|0|||
25196982|NCT02533674|50394850|FG001|Dose Level VI|Treatment-related AE|0|||
25196983|NCT02533674|50394851|FG002|Dose Level VI|Treatment-related AE|0|||
25196984|NCT02533674|50394852|FG003|Dose Level VI|Treatment-related AE|0|||
25196985|NCT02533674|50394853|FG004|Dose Level VI|Treatment-related AE|0|||
25196986|NCT02533674|50394854|FG005|Dose Level VI|Treatment-related AE|1|||
25196987|NCT02533674|50394855|FG006|Dose Level VI|Treatment-related AE|0|||
25196988|NCT02533674|50394856|FG007|Dose Level VI|Treatment-related AE|0|||
25196989|NCT02533674|50394849|FG000|Dose Level VII|Progressive disease|0|||
25196990|NCT02533674|50394850|FG001|Dose Level VII|Progressive disease|0|||
25196991|NCT02533674|50394851|FG002|Dose Level VII|Progressive disease|0|||
25196992|NCT02533674|50394852|FG003|Dose Level VII|Progressive disease|0|||
25196993|NCT02533674|50394853|FG004|Dose Level VII|Progressive disease|0|||
25196994|NCT02533674|50394854|FG005|Dose Level VII|Progressive disease|0|||
25196995|NCT02533674|50394855|FG006|Dose Level VII|Progressive disease|10|||
25196996|NCT02533674|50394856|FG007|Dose Level VII|Progressive disease|0|||
25196997|NCT02533674|50394849|FG000|Dose Level VII|Withdrawal by Subject|0|||
25196998|NCT02533674|50394850|FG001|Dose Level VII|Withdrawal by Subject|0|||
25196999|NCT02533674|50394851|FG002|Dose Level VII|Withdrawal by Subject|0|||
25197000|NCT02533674|50394852|FG003|Dose Level VII|Withdrawal by Subject|0|||
25197001|NCT02533674|50394853|FG004|Dose Level VII|Withdrawal by Subject|0|||
25197002|NCT02533674|50394854|FG005|Dose Level VII|Withdrawal by Subject|0|||
25197003|NCT02533674|50394855|FG006|Dose Level VII|Withdrawal by Subject|3|||
25197004|NCT02533674|50394856|FG007|Dose Level VII|Withdrawal by Subject|0|||
25197005|NCT02533674|50394849|FG000|Dose Level VII|Treatment-related AE|0|||
25197006|NCT02533674|50394850|FG001|Dose Level VII|Treatment-related AE|0|||
25197007|NCT02533674|50394851|FG002|Dose Level VII|Treatment-related AE|0|||
25197008|NCT02533674|50394852|FG003|Dose Level VII|Treatment-related AE|0|||
25197009|NCT02533674|50394853|FG004|Dose Level VII|Treatment-related AE|0|||
25197010|NCT02533674|50394854|FG005|Dose Level VII|Treatment-related AE|0|||
25197011|NCT02533674|50394855|FG006|Dose Level VII|Treatment-related AE|1|||
25197012|NCT02533674|50394856|FG007|Dose Level VII|Treatment-related AE|0|||
25197013|NCT02533674|50394849|FG000|Dose Level VII|Death|0|||
25197014|NCT02533674|50394850|FG001|Dose Level VII|Death|0|||
25197015|NCT02533674|50394851|FG002|Dose Level VII|Death|0|||
25197016|NCT02533674|50394852|FG003|Dose Level VII|Death|0|||
25197017|NCT02533674|50394853|FG004|Dose Level VII|Death|0|||
25197018|NCT02533674|50394854|FG005|Dose Level VII|Death|0|||
25197019|NCT02533674|50394855|FG006|Dose Level VII|Death|2|||
25197020|NCT02533674|50394856|FG007|Dose Level VII|Death|0|||
25077006|NCT02499770|50184782|FG000|Overall Study|Subject declined further treatment|1|||
25077007|NCT02499770|50184783|FG001|Overall Study|Subject declined further treatment|0|||
25077008|NCT02499770|50184782|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
25077009|NCT02499770|50184783|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
25077010|NCT02499770|50184782|FG000|Overall Study|Randomized but not enrolled|0|||
25077011|NCT02499770|50184783|FG001|Overall Study|Randomized but not enrolled|1|||
25077012|NCT02442284|50184795|FG000|Overall Study|Adverse Event|1|||
25077013|NCT02442284|50184795|FG000|Overall Study|Withdrew Consent|2|||
25197021|NCT02533674|50394849|FG000|Dose Level VIII|Progressive disease|0|||
25197022|NCT02533674|50394850|FG001|Dose Level VIII|Progressive disease|0|||
25197023|NCT02533674|50394851|FG002|Dose Level VIII|Progressive disease|0|||
25197024|NCT02533674|50394852|FG003|Dose Level VIII|Progressive disease|0|||
25197025|NCT02533674|50394853|FG004|Dose Level VIII|Progressive disease|0|||
25077014|NCT02442284|50184795|FG000|Overall Study|Lost to Follow-up|3|||
25170883|NCT00552058|50307721|FG001|Overall Study|Other: Sponsors Decision|1|||
25170884|NCT00552058|50307720|FG000|Overall Study|Other: Early Roll Over|1|||
25170885|NCT00552058|50307721|FG001|Overall Study|Other: Early Roll Over|0|||
25170886|NCT00550732|50307750|FG000|Overall Study|Death|4|||
25170887|NCT00550732|50307750|FG000|Overall Study|Withdrawal by Subject|2|||
25170888|NCT00550732|50307750|FG000|Overall Study|Physician Decision|2|||
25170889|NCT00550732|50307750|FG000|Overall Study|Lost to Follow-up|1|||
25170890|NCT00550732|50307750|FG000|Overall Study|Palliative care|1|||
25170891|NCT00550732|50307750|FG000|Overall Study|Adverse Event|1|||
25197026|NCT02533674|50394854|FG005|Dose Level VIII|Progressive disease|0|||
25197027|NCT02533674|50394855|FG006|Dose Level VIII|Progressive disease|0|||
25197028|NCT02533674|50394856|FG007|Dose Level VIII|Progressive disease|3|||
25197029|NCT02533674|50394849|FG000|Dose Level VIII|Withdrawal by Subject|0|||
25197030|NCT02533674|50394850|FG001|Dose Level VIII|Withdrawal by Subject|0|||
25197031|NCT02533674|50394851|FG002|Dose Level VIII|Withdrawal by Subject|0|||
25197032|NCT02533674|50394852|FG003|Dose Level VIII|Withdrawal by Subject|0|||
25197033|NCT02533674|50394853|FG004|Dose Level VIII|Withdrawal by Subject|0|||
25197034|NCT02533674|50394854|FG005|Dose Level VIII|Withdrawal by Subject|0|||
25197035|NCT02533674|50394855|FG006|Dose Level VIII|Withdrawal by Subject|0|||
25197036|NCT02533674|50394856|FG007|Dose Level VIII|Withdrawal by Subject|1|||
25197037|NCT02533674|50394849|FG000|Dose Level VIII|Treatment-related AE|0|||
25197038|NCT02533674|50394850|FG001|Dose Level VIII|Treatment-related AE|0|||
25197039|NCT02533674|50394851|FG002|Dose Level VIII|Treatment-related AE|0|||
25197040|NCT02533674|50394852|FG003|Dose Level VIII|Treatment-related AE|0|||
25197041|NCT02533674|50394853|FG004|Dose Level VIII|Treatment-related AE|0|||
25197042|NCT02533674|50394854|FG005|Dose Level VIII|Treatment-related AE|0|||
25197043|NCT02533674|50394855|FG006|Dose Level VIII|Treatment-related AE|0|||
25197044|NCT02533674|50394856|FG007|Dose Level VIII|Treatment-related AE|1|||
25197045|NCT02533674|50394849|FG000|Dose Level VIII|Never treated|0|||
25197046|NCT02533674|50394850|FG001|Dose Level VIII|Never treated|0|||
25197047|NCT02533674|50394851|FG002|Dose Level VIII|Never treated|0|||
25197048|NCT02533674|50394852|FG003|Dose Level VIII|Never treated|0|||
25197049|NCT02533674|50394853|FG004|Dose Level VIII|Never treated|0|||
25197050|NCT02533674|50394854|FG005|Dose Level VIII|Never treated|0|||
25197051|NCT02533674|50394855|FG006|Dose Level VIII|Never treated|0|||
25197052|NCT02533674|50394856|FG007|Dose Level VIII|Never treated|1|||
25197053|NCT02540850|50394877|FG000|Overall Study|Lost to Follow-up|69|||
25197054|NCT02540850|50394878|FG001|Overall Study|Lost to Follow-up|66|||
25197055|NCT02540850|50394879|FG002|Overall Study|Lost to Follow-up|34|||
25197056|NCT01662024|50394887|FG000|Overall Study|Pregnancy|2|||
25197057|NCT01662024|50394887|FG000|Overall Study|Withdrawal by Subject|3|||
25197058|NCT02544750|50394969|FG000|Overall Study|Physician Decision|3|||
25197059|NCT02544750|50394970|FG001|Overall Study|Physician Decision|1|||
25197060|NCT02544750|50394969|FG000|Overall Study|Other reasons|69|||
25197061|NCT02544750|50394970|FG001|Overall Study|Other reasons|39|||
25197062|NCT02544750|50394969|FG000|Overall Study|Met withdrawal criteria|2|||
25197063|NCT02544750|50394970|FG001|Overall Study|Met withdrawal criteria|2|||
25197064|NCT02544750|50394969|FG000|Overall Study|Transition To Commercial Product|1|||
25197065|NCT02544750|50394970|FG001|Overall Study|Transition To Commercial Product|0|||
25197066|NCT02544750|50394969|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
25197067|NCT02544750|50394970|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
25197068|NCT02544750|50394969|FG000|Overall Study|Adverse Event|8|||
25197069|NCT02544750|50394970|FG001|Overall Study|Adverse Event|10|||
25197070|NCT02544750|50394969|FG000|Overall Study|Withdrawal by Subject|10|||
25197071|NCT02544750|50394970|FG001|Overall Study|Withdrawal by Subject|4|||
25197072|NCT02544750|50394969|FG000|Overall Study|Lost to Follow-up|1|||
25197073|NCT02544750|50394970|FG001|Overall Study|Lost to Follow-up|0|||
25197074|NCT02540538|50395016|FG000|Overall Study|Pregnancy|0|||
25197075|NCT02540538|50395017|FG001|Overall Study|Pregnancy|1|||
25197076|NCT02540538|50395018|FG002|Overall Study|Pregnancy|0|||
25197077|NCT04697056|50395051|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
25197078|NCT04697056|50395052|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
25197079|NCT02181738|50395176|FG000|Overall Study|Death|1|||
25197080|NCT02181738|50395177|FG001|Overall Study|Death|1|||
25197081|NCT02181738|50395178|FG002|Overall Study|Death|6|||
25197082|NCT02181738|50395179|FG003|Overall Study|Death|1|||
25197083|NCT02181738|50395176|FG000|Overall Study|Subject Withdrew Consent|1|||
25197084|NCT02181738|50395177|FG001|Overall Study|Subject Withdrew Consent|3|||
25197085|NCT02181738|50395178|FG002|Overall Study|Subject Withdrew Consent|2|||
25197086|NCT02181738|50395179|FG003|Overall Study|Subject Withdrew Consent|1|||
25197087|NCT02181738|50395176|FG000|Overall Study|Lost to Follow-up|0|||
25197088|NCT02181738|50395177|FG001|Overall Study|Lost to Follow-up|4|||
25197089|NCT02181738|50395178|FG002|Overall Study|Lost to Follow-up|2|||
25197090|NCT02181738|50395179|FG003|Overall Study|Lost to Follow-up|0|||
25197091|NCT02181738|50395176|FG000|Overall Study|Patient Return to Home Country|0|||
25197092|NCT02181738|50395177|FG001|Overall Study|Patient Return to Home Country|1|||
25197093|NCT02181738|50395178|FG002|Overall Study|Patient Return to Home Country|0|||
25197094|NCT02181738|50395179|FG003|Overall Study|Patient Return to Home Country|0|||
25197095|NCT03493282|50395210|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
25197096|NCT03493282|50395211|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
25197097|NCT03493282|50395212|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
25197098|NCT03493282|50395210|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
25197099|NCT03493282|50395211|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
25315057|NCT00641719|50630897|FG001|Overall Study|Withdrawal by Subject|4|||
25197100|NCT03493282|50395212|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
25197101|NCT02532972|50395226|FG000|Overall Study|Withdrawal by Subject|1|||
25197102|NCT03187834|50395279|FG000|Overall Study|Lost to Follow-up|0|||
25315058|NCT00641719|50630896|FG000|Overall Study|Reason Not Specified|1|||
25197103|NCT03187834|50395280|FG001|Overall Study|Lost to Follow-up|1|||
25197104|NCT03187834|50395281|FG002|Overall Study|Lost to Follow-up|2|||
25197105|NCT03187834|50395282|FG003|Overall Study|Lost to Follow-up|2|||
25197106|NCT03187834|50395279|FG000|Overall Study|Had invalid anthropometric measurements|5|||
25197107|NCT03187834|50395280|FG001|Overall Study|Had invalid anthropometric measurements|3|||
25197108|NCT03187834|50395281|FG002|Overall Study|Had invalid anthropometric measurements|4|||
25197109|NCT03187834|50395282|FG003|Overall Study|Had invalid anthropometric measurements|2|||
25197110|NCT03713944|50395435|FG000|Study Treatment|Patient non-compliance|1|||
25197111|NCT03713944|50395435|FG000|Study Treatment|Alternative Cancer Therapy|3|||
25197112|NCT03713944|50395435|FG000|Study Treatment|Disease Progression|18|||
25197113|NCT03713944|50395435|FG000|Study Treatment|AE/Side Effects/Complications|2|||
25197114|NCT03713944|50395435|FG000|Study Treatment|Death|2|||
25197115|NCT03713944|50395435|FG000|Study Treatment|Withdrawal by Subject|1|||
25197116|NCT03713944|50395435|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
25197117|NCT03713944|50395435|FG000|Study Treatment|Symptomatic Deterioration|2|||
25197118|NCT03713944|50395435|FG000|Follow up|Withdrawal by Subject|2|||
25197119|NCT03713944|50395435|FG000|Follow up|Death|11|||
25197120|NCT03713944|50395435|FG000|Follow up|Study Terminated|3|||
25197121|NCT01572662|50395513|FG000|Overall Study|Withdrawal by Subject|1|||
25197122|NCT01572662|50395514|FG001|Overall Study|Withdrawal by Subject|0|||
25197123|NCT01572662|50395513|FG000|Overall Study|Physician Decision|0|||
25197124|NCT01572662|50395514|FG001|Overall Study|Physician Decision|1|||
25197125|NCT02325154|50395544|FG000|Overall Study|Physician Decision|1|||
25197126|NCT00493870|50395671|FG000|Overall Study|Lost to Follow-up|12|||
25197127|NCT00493870|50395672|FG001|Overall Study|Lost to Follow-up|15|||
25197128|NCT04439344|50395957|FG000|Overall Study|Never started threapy|3|||
25197129|NCT04439344|50395957|FG000|Overall Study|Ineligible|3|||
25197130|NCT04439344|50395957|FG000|Overall Study|Adverse Event|13|||
25197131|NCT04439344|50395957|FG000|Overall Study|Death|2|||
25197132|NCT04439344|50395957|FG000|Overall Study|Disease progression|29|||
25197133|NCT04439344|50395957|FG000|Overall Study|Withdrawal by Subject|2|||
25197134|NCT04439344|50395957|FG000|Overall Study|Alternative therapy|1|||
25197135|NCT04439279|50395961|FG000|Overall Study|Adverse Event|7|||
25197136|NCT04439279|50395961|FG000|Overall Study|Death|4|||
25197137|NCT04439279|50395961|FG000|Overall Study|Disease progression|17|||
25197138|NCT04439279|50395961|FG000|Overall Study|Complicating disease|3|||
25197139|NCT04439279|50395961|FG000|Overall Study|Withdrawal by Subject|2|||
25197140|NCT04439279|50395961|FG000|Overall Study|Ineligible|1|||
25197141|NCT04439279|50395961|FG000|Overall Study|Treatment still ongoing|1|||
25197142|NCT04439175|50395965|FG000|Overall Study|Never started treatment|4|||
25197143|NCT04439175|50395965|FG000|Overall Study|Ineligible|5|||
25197144|NCT04439175|50395965|FG000|Overall Study|Adverse Event|6|||
25197145|NCT04439175|50395965|FG000|Overall Study|Death|4|||
25197146|NCT04439175|50395965|FG000|Overall Study|Disease progression|44|||
25197147|NCT04439175|50395965|FG000|Overall Study|Withdrawal by Subject|4|||
25197148|NCT04439175|50395965|FG000|Overall Study|Alternative Therapy|1|||
25197149|NCT04439175|50395965|FG000|Overall Study|Other|2|||
25197150|NCT03951753|50395985|FG000|Overall Study|Adverse Event|1|||
25197151|NCT03951753|50395986|FG001|Overall Study|Adverse Event|0|||
25197152|NCT03951753|50395987|FG002|Overall Study|Adverse Event|3|||
25197153|NCT03951753|50395985|FG000|Overall Study|Withdrawal by Subject|3|||
25197154|NCT03951753|50395986|FG001|Overall Study|Withdrawal by Subject|1|||
25197155|NCT03951753|50395987|FG002|Overall Study|Withdrawal by Subject|0|||
25197156|NCT03951753|50395985|FG000|Overall Study|Lost to Follow-up|0|||
25197157|NCT03951753|50395986|FG001|Overall Study|Lost to Follow-up|0|||
25197158|NCT03951753|50395987|FG002|Overall Study|Lost to Follow-up|1|||
25197159|NCT03941964|50395997|FG000|Overall Study|Adverse Event|1|||
25197160|NCT03941964|50395998|FG001|Overall Study|Adverse Event|8|||
25197161|NCT03941964|50395997|FG000|Overall Study|Progressive disease|7|||
25197162|NCT03941964|50395998|FG001|Overall Study|Progressive disease|3|||
25197163|NCT03941964|50395997|FG000|Overall Study|Lack of Efficacy|0|||
25197164|NCT03941964|50395998|FG001|Overall Study|Lack of Efficacy|1|||
25197165|NCT03941964|50395997|FG000|Overall Study|Death|3|||
25197166|NCT03941964|50395998|FG001|Overall Study|Death|1|||
25197167|NCT03941964|50395997|FG000|Overall Study|Withdrew consent|1|||
25315059|NCT00641719|50630897|FG001|Overall Study|Reason Not Specified|2|||
25197168|NCT03941964|50395998|FG001|Overall Study|Withdrew consent|3|||
25197169|NCT03941964|50395997|FG000|Overall Study|Physician Decision|9|||
25197170|NCT03941964|50395998|FG001|Overall Study|Physician Decision|2|||
25197171|NCT03941964|50395997|FG000|Overall Study|Other, not specified|2|||
25197172|NCT03941964|50395998|FG001|Overall Study|Other, not specified|1|||
25197173|NCT03837509|50396028|FG000|Phase 1|Death|5|||
25197174|NCT03837509|50396029|FG001|Phase 1|Death|2|||
25315060|NCT00648895|50630905|FG000|Overall Study|Lack of Efficacy|0|||
25197175|NCT03837509|50396030|FG002|Phase 1|Death|0|||
25197176|NCT03837509|50396031|FG003|Phase 1|Death|0|||
25197177|NCT03837509|50396032|FG004|Phase 1|Death|0|||
25197178|NCT03837509|50396028|FG000|Phase 2|Death|0|||
25197179|NCT03837509|50396029|FG001|Phase 2|Death|0|||
25197180|NCT03837509|50396030|FG002|Phase 2|Death|0|||
25197181|NCT03837509|50396031|FG003|Phase 2|Death|1|||
25197182|NCT03837509|50396032|FG004|Phase 2|Death|1|||
25197183|NCT03822117|50396052|FG000|Overall Study|Death|18|||
25197184|NCT03822117|50396053|FG001|Overall Study|Death|17|||
25197185|NCT03822117|50396054|FG002|Overall Study|Death|12|||
25197186|NCT03822117|50396055|FG003|Overall Study|Death|4|||
25197187|NCT03822117|50396052|FG000|Overall Study|Lost to Follow-up|1|||
25197188|NCT03822117|50396053|FG001|Overall Study|Lost to Follow-up|2|||
25197189|NCT03822117|50396054|FG002|Overall Study|Lost to Follow-up|3|||
25197190|NCT03822117|50396055|FG003|Overall Study|Lost to Follow-up|0|||
25197191|NCT03822117|50396052|FG000|Overall Study|Study Terminated by Sponsor|25|||
25197192|NCT03822117|50396053|FG001|Overall Study|Study Terminated by Sponsor|11|||
25197193|NCT03822117|50396054|FG002|Overall Study|Study Terminated by Sponsor|6|||
25197194|NCT03822117|50396055|FG003|Overall Study|Study Terminated by Sponsor|0|||
25197195|NCT03822117|50396052|FG000|Overall Study|Withdrawal by Subject|4|||
25197196|NCT03822117|50396053|FG001|Overall Study|Withdrawal by Subject|0|||
25197197|NCT03822117|50396054|FG002|Overall Study|Withdrawal by Subject|3|||
25197198|NCT03822117|50396055|FG003|Overall Study|Withdrawal by Subject|0|||
25315061|NCT00648895|50630906|FG001|Overall Study|Lack of Efficacy|1|||
25315062|NCT00975221|50630914|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
25315063|NCT00975221|50630915|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
25315064|NCT00975221|50630914|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
25315065|NCT00975221|50630915|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
25315066|NCT00975221|50630914|FG000|Titration Phase (Weeks 1-12)|Other|0|||
25197199|NCT03822117|50396052|FG000|Overall Study|Disease Progression|1|||
25197200|NCT03822117|50396053|FG001|Overall Study|Disease Progression|2|||
25197201|NCT03822117|50396054|FG002|Overall Study|Disease Progression|1|||
25197202|NCT03822117|50396055|FG003|Overall Study|Disease Progression|0|||
25315067|NCT00975221|50630915|FG001|Titration Phase (Weeks 1-12)|Other|1|||
25315068|NCT00975221|50630914|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
25197203|NCT03822117|50396052|FG000|Overall Study|Never Returned to Hospital|0|||
25197204|NCT03822117|50396053|FG001|Overall Study|Never Returned to Hospital|0|||
25197205|NCT03822117|50396054|FG002|Overall Study|Never Returned to Hospital|1|||
25197206|NCT03822117|50396055|FG003|Overall Study|Never Returned to Hospital|0|||
25197207|NCT03497897|50396069|FG000|Overall Study|Adverse Event|1|||
25197208|NCT03497897|50396070|FG001|Overall Study|Adverse Event|1|||
25197209|NCT03497897|50396071|FG002|Overall Study|Adverse Event|1|||
25197210|NCT03497897|50396069|FG000|Overall Study|Lost to Follow-up|2|||
25197211|NCT03497897|50396070|FG001|Overall Study|Lost to Follow-up|0|||
25315069|NCT00975221|50630915|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
25315070|NCT00975221|50630914|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
25315071|NCT00975221|50630915|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
25315072|NCT00975221|50630914|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
25077015|NCT02442284|50184795|FG000|Overall Study|Other|1|||
25197212|NCT03497897|50396071|FG002|Overall Study|Lost to Follow-up|2|||
25197213|NCT03497897|50396069|FG000|Overall Study|Physician Decision|1|||
25197214|NCT03497897|50396070|FG001|Overall Study|Physician Decision|0|||
25197215|NCT03497897|50396071|FG002|Overall Study|Physician Decision|0|||
25197216|NCT03497897|50396069|FG000|Overall Study|Subject/Guardian Decision|2|||
25197217|NCT03497897|50396070|FG001|Overall Study|Subject/Guardian Decision|1|||
25197218|NCT03497897|50396071|FG002|Overall Study|Subject/Guardian Decision|3|||
25197219|NCT03428217|50396082|FG000|Overall Study|Death|89|||
25197220|NCT03428217|50396083|FG001|Overall Study|Death|93|||
25197221|NCT03428217|50396082|FG000|Overall Study|Withdrawal by Subject|8|||
25197222|NCT03428217|50396083|FG001|Overall Study|Withdrawal by Subject|7|||
25197223|NCT03428217|50396082|FG000|Overall Study|Lost to Follow-up|1|||
25197224|NCT03428217|50396083|FG001|Overall Study|Lost to Follow-up|3|||
25197225|NCT03428217|50396082|FG000|Overall Study|Study terminated by sponsor|124|||
25197226|NCT03428217|50396083|FG001|Overall Study|Study terminated by sponsor|118|||
25197227|NCT03428217|50396082|FG000|Overall Study|Other, Not Specified|1|||
25197228|NCT03428217|50396083|FG001|Overall Study|Other, Not Specified|0|||
25197229|NCT03189719|50396093|FG000|Overall Study|Death|260|||
25197230|NCT03189719|50396094|FG001|Overall Study|Death|308|||
25197231|NCT03189719|50396093|FG000|Overall Study|Withdrawal by Subject|5|||
25197232|NCT03189719|50396094|FG001|Overall Study|Withdrawal by Subject|3|||
25197233|NCT03189719|50396093|FG000|Overall Study|Ongoing in Study|108|||
25197234|NCT03189719|50396094|FG001|Overall Study|Ongoing in Study|65|||
25197235|NCT02969525|50396105|FG000|Double-Blind Period|Adverse Event|0|||
25197236|NCT02969525|50396106|FG001|Double-Blind Period|Adverse Event|0|||
25197237|NCT02969525|50396107|FG002|Double-Blind Period|Adverse Event|1|||
25197238|NCT02969525|50396108|FG003|Double-Blind Period|Adverse Event|1|||
25197239|NCT02969525|50396109|FG004|Double-Blind Period|Adverse Event|0|||
25197240|NCT02969525|50396110|FG005|Double-Blind Period|Adverse Event|0|||
25197241|NCT02969525|50396111|FG006|Double-Blind Period|Adverse Event|0|||
25197242|NCT02969525|50396112|FG007|Double-Blind Period|Adverse Event|0|||
25197243|NCT02969525|50396113|FG008|Double-Blind Period|Adverse Event|0|||
25197244|NCT02969525|50396114|FG009|Double-Blind Period|Adverse Event|0|||
25197245|NCT02969525|50396115|FG010|Double-Blind Period|Adverse Event|0|||
25197246|NCT02969525|50396116|FG011|Double-Blind Period|Adverse Event|0|||
25197247|NCT02969525|50396105|FG000|Double-Blind Period|LOW EGFR|0|||
25197248|NCT02969525|50396106|FG001|Double-Blind Period|LOW EGFR|0|||
25197249|NCT02969525|50396107|FG002|Double-Blind Period|LOW EGFR|0|||
25197250|NCT02969525|50396108|FG003|Double-Blind Period|LOW EGFR|1|||
25197251|NCT02969525|50396109|FG004|Double-Blind Period|LOW EGFR|0|||
25197252|NCT02969525|50396110|FG005|Double-Blind Period|LOW EGFR|0|||
25197253|NCT02969525|50396111|FG006|Double-Blind Period|LOW EGFR|0|||
25197254|NCT02969525|50396112|FG007|Double-Blind Period|LOW EGFR|0|||
25197255|NCT02969525|50396113|FG008|Double-Blind Period|LOW EGFR|0|||
25197256|NCT02969525|50396114|FG009|Double-Blind Period|LOW EGFR|0|||
25197257|NCT02969525|50396115|FG010|Double-Blind Period|LOW EGFR|0|||
25197258|NCT02969525|50396116|FG011|Double-Blind Period|LOW EGFR|0|||
25197259|NCT02969525|50396105|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
25197260|NCT02969525|50396106|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
25197261|NCT02969525|50396107|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
25197262|NCT02969525|50396108|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
25197263|NCT02969525|50396109|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
25197264|NCT02969525|50396110|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
25197265|NCT02969525|50396111|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
25197266|NCT02969525|50396112|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
25197267|NCT02969525|50396113|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
25197268|NCT02969525|50396114|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
25197269|NCT02969525|50396115|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
25197270|NCT02969525|50396116|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
25197271|NCT02969525|50396105|FG000|Dose-Blind Period|Adverse Event|0|||
25197272|NCT02969525|50396106|FG001|Dose-Blind Period|Adverse Event|0|||
25197273|NCT02969525|50396107|FG002|Dose-Blind Period|Adverse Event|0|||
25197274|NCT02969525|50396108|FG003|Dose-Blind Period|Adverse Event|0|||
25197275|NCT02969525|50396109|FG004|Dose-Blind Period|Adverse Event|0|||
25197276|NCT02969525|50396110|FG005|Dose-Blind Period|Adverse Event|0|||
25197277|NCT02969525|50396111|FG006|Dose-Blind Period|Adverse Event|0|||
25197278|NCT02969525|50396112|FG007|Dose-Blind Period|Adverse Event|0|||
25197279|NCT02969525|50396113|FG008|Dose-Blind Period|Adverse Event|0|||
25197280|NCT02969525|50396114|FG009|Dose-Blind Period|Adverse Event|1|||
25197281|NCT02969525|50396115|FG010|Dose-Blind Period|Adverse Event|1|||
25197282|NCT02969525|50396116|FG011|Dose-Blind Period|Adverse Event|1|||
25197283|NCT02969525|50396105|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
25197284|NCT02969525|50396106|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
25197285|NCT02969525|50396107|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
25197286|NCT02969525|50396108|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
25197287|NCT02969525|50396109|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
25197288|NCT02969525|50396110|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
25197289|NCT02969525|50396111|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
25197290|NCT02969525|50396112|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
25197291|NCT02969525|50396113|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
25197292|NCT02969525|50396114|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
25197293|NCT02969525|50396115|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
25197294|NCT02969525|50396116|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
25197295|NCT02969525|50396105|FG000|Dose-Blind Period|Non-cooperating patient|0|||
25197296|NCT02969525|50396106|FG001|Dose-Blind Period|Non-cooperating patient|0|||
25197297|NCT02969525|50396107|FG002|Dose-Blind Period|Non-cooperating patient|0|||
25197298|NCT02969525|50396108|FG003|Dose-Blind Period|Non-cooperating patient|0|||
25197299|NCT02969525|50396109|FG004|Dose-Blind Period|Non-cooperating patient|0|||
25197300|NCT02969525|50396110|FG005|Dose-Blind Period|Non-cooperating patient|0|||
25197301|NCT02969525|50396111|FG006|Dose-Blind Period|Non-cooperating patient|0|||
25197302|NCT02969525|50396112|FG007|Dose-Blind Period|Non-cooperating patient|0|||
25197303|NCT02969525|50396113|FG008|Dose-Blind Period|Non-cooperating patient|0|||
25197304|NCT02969525|50396114|FG009|Dose-Blind Period|Non-cooperating patient|0|||
25197305|NCT02969525|50396115|FG010|Dose-Blind Period|Non-cooperating patient|0|||
25197306|NCT02969525|50396116|FG011|Dose-Blind Period|Non-cooperating patient|1|||
25197307|NCT02969525|50396105|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
25197308|NCT02969525|50396106|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
25197309|NCT02969525|50396107|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
25197310|NCT02969525|50396108|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
25197311|NCT02969525|50396109|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
25197312|NCT02969525|50396110|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
25197313|NCT02969525|50396111|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
25197314|NCT02969525|50396112|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
25197315|NCT02969525|50396113|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
25197316|NCT02969525|50396114|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
25197317|NCT02969525|50396115|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
25197318|NCT02969525|50396116|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
25197319|NCT04232215|50396147|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
25197320|NCT04232215|50396148|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
25197321|NCT02399813|50396163|FG000|Overall Study|Progressive Disease-Radiographic|2|||
25197322|NCT02399813|50396163|FG000|Overall Study|Death|20|||
25197323|NCT02399813|50396163|FG000|Overall Study|Withdrawal by Subject|3|||
25197324|NCT02399813|50396163|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
25197325|NCT02399813|50396163|FG000|Overall Study|Lost to Follow-up|2|||
25197326|NCT02399813|50396163|FG000|Overall Study|Other than specified|5|||
25197327|NCT02291055|50396172|FG000|Overall Study|Death|2|||
25197328|NCT02291055|50396173|FG001|Overall Study|Death|2|||
25197329|NCT02291055|50396174|FG002|Overall Study|Death|5|||
25197330|NCT02291055|50396175|FG003|Overall Study|Death|8|||
25197331|NCT02291055|50396176|FG004|Overall Study|Death|12|||
25197332|NCT02291055|50396172|FG000|Overall Study|Lost to Follow-up|0|||
25197333|NCT02291055|50396173|FG001|Overall Study|Lost to Follow-up|0|||
25197334|NCT02291055|50396174|FG002|Overall Study|Lost to Follow-up|0|||
25197335|NCT02291055|50396175|FG003|Overall Study|Lost to Follow-up|1|||
25197336|NCT02291055|50396176|FG004|Overall Study|Lost to Follow-up|2|||
25197337|NCT02291055|50396172|FG000|Overall Study|Withdrawal by Subject|3|||
25197338|NCT02291055|50396173|FG001|Overall Study|Withdrawal by Subject|1|||
25197339|NCT02291055|50396174|FG002|Overall Study|Withdrawal by Subject|1|||
25197340|NCT02291055|50396175|FG003|Overall Study|Withdrawal by Subject|5|||
25197341|NCT02291055|50396176|FG004|Overall Study|Withdrawal by Subject|10|||
25197342|NCT02291055|50396172|FG000|Overall Study|Progressive Disease|0|||
25197343|NCT02291055|50396173|FG001|Overall Study|Progressive Disease|0|||
25197344|NCT02291055|50396174|FG002|Overall Study|Progressive Disease|1|||
25197345|NCT02291055|50396175|FG003|Overall Study|Progressive Disease|4|||
25197346|NCT02291055|50396176|FG004|Overall Study|Progressive Disease|2|||
25197347|NCT02291055|50396172|FG000|Overall Study|Study Terminated by Sponsor|0|||
25197348|NCT02291055|50396173|FG001|Overall Study|Study Terminated by Sponsor|0|||
25197349|NCT02291055|50396174|FG002|Overall Study|Study Terminated by Sponsor|0|||
25197350|NCT02291055|50396175|FG003|Overall Study|Study Terminated by Sponsor|5|||
25197351|NCT02291055|50396176|FG004|Overall Study|Study Terminated by Sponsor|1|||
25197352|NCT02291055|50396172|FG000|Overall Study|Other|0|||
24976240|NCT00077649|50065140|FG001|Overall Study|Randomized but never dosed|0|||
24976241|NCT00077649|50065141|FG002|Overall Study|Randomized but never dosed|0|||
24976242|NCT00077649|50065142|FG003|Overall Study|Randomized but never dosed|0|||
25197353|NCT02291055|50396173|FG001|Overall Study|Other|2|||
25197354|NCT02291055|50396174|FG002|Overall Study|Other|1|||
25197355|NCT02291055|50396175|FG003|Overall Study|Other|4|||
25197356|NCT02291055|50396176|FG004|Overall Study|Other|0|||
25197357|NCT00723697|50396192|FG000|Overall Study|Physician questionnaires not received|2|||
25197358|NCT00723697|50396192|FG000|Overall Study|Missing Informed Consent Form|10|||
25197359|NCT00723697|50396192|FG000|Overall Study|Other exclusion criteria applied|6|||
24976243|NCT00038948|50065158|FG000|Overall Study|Adverse Event|131|||
25197360|NCT00684073|50396199|FG000|Selection|Selection/non-selection criteria|3|||
25197361|NCT00684073|50396199|FG000|Selection|Death|1|||
25197362|NCT00684073|50396199|FG000|Selection|noncompliance|1|||
25197363|NCT00684073|50396199|FG000|Selection|Lost to Follow-up|1|||
25197364|NCT00684073|50396199|FG000|Selection|request of the sponsor|1|||
25197365|NCT00684073|50396199|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
25197366|NCT02539368|50398166|FG000|Overall Study|Death|4|||
25197367|NCT02539368|50398167|FG001|Overall Study|Death|2|||
25197368|NCT02539368|50398168|FG002|Overall Study|Death|1|||
25197369|NCT02539368|50398169|FG003|Overall Study|Death|0|||
25197370|NCT02539368|50398170|FG004|Overall Study|Death|0|||
25197371|NCT02539368|50398166|FG000|Overall Study|Withdrawal by Subject|44|||
25197372|NCT02539368|50398167|FG001|Overall Study|Withdrawal by Subject|35|||
25197373|NCT02539368|50398168|FG002|Overall Study|Withdrawal by Subject|9|||
25197374|NCT02539368|50398169|FG003|Overall Study|Withdrawal by Subject|1|||
25197375|NCT02539368|50398170|FG004|Overall Study|Withdrawal by Subject|3|||
25197376|NCT02539368|50398166|FG000|Overall Study|Physician Decision|49|||
25197377|NCT02539368|50398167|FG001|Overall Study|Physician Decision|15|||
25197378|NCT02539368|50398168|FG002|Overall Study|Physician Decision|7|||
25197379|NCT02539368|50398169|FG003|Overall Study|Physician Decision|0|||
25197380|NCT02539368|50398170|FG004|Overall Study|Physician Decision|2|||
25197381|NCT02539368|50398166|FG000|Overall Study|Lost to Follow-up|96|||
25197382|NCT02539368|50398167|FG001|Overall Study|Lost to Follow-up|21|||
25197383|NCT02539368|50398168|FG002|Overall Study|Lost to Follow-up|16|||
25197384|NCT02539368|50398169|FG003|Overall Study|Lost to Follow-up|4|||
25197385|NCT02539368|50398170|FG004|Overall Study|Lost to Follow-up|3|||
25197386|NCT02539368|50398166|FG000|Overall Study|Adverse Event|44|||
25197387|NCT02539368|50398167|FG001|Overall Study|Adverse Event|5|||
25197388|NCT02539368|50398168|FG002|Overall Study|Adverse Event|9|||
25197389|NCT02539368|50398169|FG003|Overall Study|Adverse Event|0|||
25197390|NCT02539368|50398170|FG004|Overall Study|Adverse Event|3|||
25197391|NCT02539368|50398166|FG000|Overall Study|Participant Non-compliant|13|||
25197392|NCT02539368|50398167|FG001|Overall Study|Participant Non-compliant|2|||
25197393|NCT02539368|50398168|FG002|Overall Study|Participant Non-compliant|1|||
25197394|NCT02539368|50398169|FG003|Overall Study|Participant Non-compliant|1|||
25197395|NCT02539368|50398170|FG004|Overall Study|Participant Non-compliant|0|||
25197396|NCT02539368|50398166|FG000|Overall Study|Other|145|||
25197397|NCT02539368|50398167|FG001|Overall Study|Other|18|||
25197398|NCT02539368|50398168|FG002|Overall Study|Other|24|||
25197399|NCT02539368|50398169|FG003|Overall Study|Other|1|||
25197400|NCT02539368|50398170|FG004|Overall Study|Other|3|||
25197401|NCT02539368|50398166|FG000|Overall Study|Missing|10|||
25197402|NCT02539368|50398167|FG001|Overall Study|Missing|3|||
25197403|NCT02539368|50398168|FG002|Overall Study|Missing|0|||
25197404|NCT02539368|50398169|FG003|Overall Study|Missing|0|||
25197405|NCT02539368|50398170|FG004|Overall Study|Missing|0|||
25197406|NCT02539134|50398323|FG000|Overall Study|Lost to Follow-up|1|||
25197407|NCT02539134|50398324|FG001|Overall Study|Lost to Follow-up|0|||
25197408|NCT02539134|50398325|FG002|Overall Study|Lost to Follow-up|0|||
25197409|NCT02539134|50398326|FG003|Overall Study|Lost to Follow-up|0|||
25197410|NCT02539134|50398327|FG004|Overall Study|Lost to Follow-up|0|||
25197411|NCT02539134|50398328|FG005|Overall Study|Lost to Follow-up|0|||
25197412|NCT02538900|50398432|FG000|Overall Study|Death|2|||
25197413|NCT02538900|50398433|FG001|Overall Study|Death|2|||
25197414|NCT02538900|50398434|FG002|Overall Study|Death|2|||
25197415|NCT02538900|50398432|FG000|Overall Study|Withdrawal by Subject|18|||
25197416|NCT02538900|50398433|FG001|Overall Study|Withdrawal by Subject|16|||
25197417|NCT02538900|50398434|FG002|Overall Study|Withdrawal by Subject|15|||
25197418|NCT01986348|50398923|FG000|Overall Study|Death|8|||
25197419|NCT01986348|50398924|FG001|Overall Study|Death|22|||
25197420|NCT01986348|50398925|FG002|Overall Study|Death|10|||
25197421|NCT01986348|50398926|FG003|Overall Study|Death|21|||
25197422|NCT01986348|50398923|FG000|Overall Study|Lost to Follow-up|0|||
25197423|NCT01986348|50398924|FG001|Overall Study|Lost to Follow-up|0|||
25197424|NCT01986348|50398925|FG002|Overall Study|Lost to Follow-up|0|||
25197425|NCT01986348|50398926|FG003|Overall Study|Lost to Follow-up|2|||
25197426|NCT01986348|50398923|FG000|Overall Study|Physician Decision|0|||
25197427|NCT01986348|50398924|FG001|Overall Study|Physician Decision|0|||
25197428|NCT01986348|50398925|FG002|Overall Study|Physician Decision|0|||
25197429|NCT01986348|50398926|FG003|Overall Study|Physician Decision|1|||
25197430|NCT01986348|50398923|FG000|Overall Study|Progressive Disease|0|||
25197431|NCT01986348|50398924|FG001|Overall Study|Progressive Disease|0|||
25197432|NCT01986348|50398925|FG002|Overall Study|Progressive Disease|2|||
25197433|NCT01986348|50398926|FG003|Overall Study|Progressive Disease|0|||
25197434|NCT01986348|50398923|FG000|Overall Study|Withdrawal by Participant|0|||
25197435|NCT01986348|50398924|FG001|Overall Study|Withdrawal by Participant|1|||
24976244|NCT00038948|50065159|FG001|Overall Study|Adverse Event|43|||
25197436|NCT01986348|50398925|FG002|Overall Study|Withdrawal by Participant|2|||
25197437|NCT01986348|50398926|FG003|Overall Study|Withdrawal by Participant|1|||
25197438|NCT01986348|50398923|FG000|Overall Study|Study Terminated by Sponsor|0|||
25197439|NCT01986348|50398924|FG001|Overall Study|Study Terminated by Sponsor|0|||
25197440|NCT01986348|50398925|FG002|Overall Study|Study Terminated by Sponsor|0|||
25197441|NCT01986348|50398926|FG003|Overall Study|Study Terminated by Sponsor|3|||
25197442|NCT01986348|50398923|FG000|Overall Study|Other-unspecified|0|||
25197443|NCT01986348|50398924|FG001|Overall Study|Other-unspecified|1|||
25197444|NCT01986348|50398925|FG002|Overall Study|Other-unspecified|0|||
25197445|NCT01986348|50398926|FG003|Overall Study|Other-unspecified|2|||
25197446|NCT02543892|50399504|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
25197447|NCT02543892|50399505|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
25197448|NCT02543892|50399506|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
25197449|NCT02543892|50399507|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
25197450|NCT02543892|50399508|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
25197451|NCT02543892|50399509|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
25197452|NCT02543892|50399510|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
25197453|NCT02543892|50399511|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
25197454|NCT02543892|50399504|FG000|Received Vaccination 2|Physician Decision|0|||
25197455|NCT02543892|50399505|FG001|Received Vaccination 2|Physician Decision|0|||
25197456|NCT02543892|50399506|FG002|Received Vaccination 2|Physician Decision|0|||
25197457|NCT02543892|50399507|FG003|Received Vaccination 2|Physician Decision|0|||
25197458|NCT02543892|50399508|FG004|Received Vaccination 2|Physician Decision|0|||
25197459|NCT02543892|50399509|FG005|Received Vaccination 2|Physician Decision|1|||
25197460|NCT02543892|50399510|FG006|Received Vaccination 2|Physician Decision|0|||
25197461|NCT02543892|50399511|FG007|Received Vaccination 2|Physician Decision|0|||
25197462|NCT02543892|50399504|FG000|Received Vaccination 2|Adverse Event|0|||
25197463|NCT02543892|50399505|FG001|Received Vaccination 2|Adverse Event|1|||
25197464|NCT02543892|50399506|FG002|Received Vaccination 2|Adverse Event|0|||
25197465|NCT02543892|50399507|FG003|Received Vaccination 2|Adverse Event|0|||
25197466|NCT02543892|50399508|FG004|Received Vaccination 2|Adverse Event|0|||
25197467|NCT02543892|50399509|FG005|Received Vaccination 2|Adverse Event|0|||
25197468|NCT02543892|50399510|FG006|Received Vaccination 2|Adverse Event|0|||
25197469|NCT02543892|50399511|FG007|Received Vaccination 2|Adverse Event|0|||
25197470|NCT02543892|50399504|FG000|Had Immunology Data|Withdrawal by Subject|0|||
25197471|NCT02543892|50399505|FG001|Had Immunology Data|Withdrawal by Subject|0|||
25197472|NCT02543892|50399506|FG002|Had Immunology Data|Withdrawal by Subject|0|||
25197473|NCT02543892|50399507|FG003|Had Immunology Data|Withdrawal by Subject|0|||
25197474|NCT02543892|50399508|FG004|Had Immunology Data|Withdrawal by Subject|0|||
25197475|NCT02543892|50399509|FG005|Had Immunology Data|Withdrawal by Subject|0|||
25197476|NCT02543892|50399510|FG006|Had Immunology Data|Withdrawal by Subject|1|||
25197477|NCT02543892|50399511|FG007|Had Immunology Data|Withdrawal by Subject|0|||
25197478|NCT02543658|50399592|FG000|Overall Study|Lack of Efficacy|0|||
24976245|NCT00038948|50065158|FG000|Overall Study|Lost to Follow-up|4|||
24976246|NCT00038948|50065159|FG001|Overall Study|Lost to Follow-up|4|||
25197479|NCT02543658|50399593|FG001|Overall Study|Lack of Efficacy|4|||
25197480|NCT01607892|50400348|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
25197481|NCT01607892|50400349|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
25197482|NCT01607892|50400350|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
25197483|NCT01607892|50400351|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
25197484|NCT01607892|50400352|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
25197485|NCT01607892|50400348|FG000|Overall Study|Death|4|||
25197486|NCT01607892|50400349|FG001|Overall Study|Death|2|||
25197487|NCT01607892|50400350|FG002|Overall Study|Death|8|||
25197488|NCT01607892|50400351|FG003|Overall Study|Death|10|||
25197489|NCT01607892|50400352|FG004|Overall Study|Death|3|||
25197490|NCT01607892|50400348|FG000|Overall Study|Investigator discretion|2|||
25197491|NCT01607892|50400349|FG001|Overall Study|Investigator discretion|4|||
25197492|NCT01607892|50400350|FG002|Overall Study|Investigator discretion|4|||
24976247|NCT00038948|50065158|FG000|Overall Study|Nonmedical event|5|||
25197493|NCT01607892|50400351|FG003|Overall Study|Investigator discretion|8|||
25197494|NCT01607892|50400352|FG004|Overall Study|Investigator discretion|0|||
25197495|NCT01607892|50400348|FG000|Overall Study|Other treatments became available|1|||
25197496|NCT01607892|50400349|FG001|Overall Study|Other treatments became available|1|||
25197497|NCT01607892|50400350|FG002|Overall Study|Other treatments became available|0|||
25197498|NCT01607892|50400351|FG003|Overall Study|Other treatments became available|0|||
25197499|NCT01607892|50400352|FG004|Overall Study|Other treatments became available|2|||
25197500|NCT01607892|50400348|FG000|Overall Study|Intercurrent illness|1|||
25197501|NCT01607892|50400349|FG001|Overall Study|Intercurrent illness|0|||
25197502|NCT01607892|50400350|FG002|Overall Study|Intercurrent illness|0|||
25197503|NCT01607892|50400351|FG003|Overall Study|Intercurrent illness|3|||
25197504|NCT01607892|50400352|FG004|Overall Study|Intercurrent illness|0|||
25197505|NCT01607892|50400348|FG000|Overall Study|Non-Compliance with study procedures|0|||
25197506|NCT01607892|50400349|FG001|Overall Study|Non-Compliance with study procedures|0|||
25197507|NCT01607892|50400350|FG002|Overall Study|Non-Compliance with study procedures|1|||
25197508|NCT01607892|50400351|FG003|Overall Study|Non-Compliance with study procedures|0|||
25197509|NCT01607892|50400352|FG004|Overall Study|Non-Compliance with study procedures|0|||
25197510|NCT01607892|50400348|FG000|Overall Study|Consent withdrawn by participant|9|||
25197511|NCT01607892|50400349|FG001|Overall Study|Consent withdrawn by participant|4|||
25197512|NCT01607892|50400350|FG002|Overall Study|Consent withdrawn by participant|24|||
25197513|NCT01607892|50400351|FG003|Overall Study|Consent withdrawn by participant|14|||
25197514|NCT01607892|50400352|FG004|Overall Study|Consent withdrawn by participant|4|||
25197515|NCT01607892|50400348|FG000|Overall Study|Disease progression|38|||
25197516|NCT01607892|50400349|FG001|Overall Study|Disease progression|13|||
25197517|NCT01607892|50400350|FG002|Overall Study|Disease progression|37|||
25197518|NCT01607892|50400351|FG003|Overall Study|Disease progression|57|||
25197519|NCT01607892|50400352|FG004|Overall Study|Disease progression|9|||
25197520|NCT01607892|50400348|FG000|Overall Study|Incidence or severity of Adverse events|3|||
25197521|NCT01607892|50400349|FG001|Overall Study|Incidence or severity of Adverse events|3|||
25197522|NCT01607892|50400350|FG002|Overall Study|Incidence or severity of Adverse events|7|||
25197523|NCT01607892|50400351|FG003|Overall Study|Incidence or severity of Adverse events|2|||
25197524|NCT01607892|50400352|FG004|Overall Study|Incidence or severity of Adverse events|6|||
25197525|NCT02530242|50400398|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
25197526|NCT02530242|50400399|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
25197527|NCT02537574|50400423|FG000|Overall Study|Adverse Event|1|||
25197528|NCT02537574|50400424|FG001|Overall Study|Adverse Event|3|||
25197529|NCT02537574|50400425|FG002|Overall Study|Adverse Event|2|||
25197530|NCT02537574|50400423|FG000|Overall Study|Lost to Follow-up|40|||
25197531|NCT02537574|50400424|FG001|Overall Study|Lost to Follow-up|51|||
25197532|NCT02537574|50400425|FG002|Overall Study|Lost to Follow-up|55|||
25197533|NCT02537574|50400423|FG000|Overall Study|Noncompliance with study drug|0|||
25197534|NCT02537574|50400424|FG001|Overall Study|Noncompliance with study drug|1|||
25197535|NCT02537574|50400425|FG002|Overall Study|Noncompliance with study drug|1|||
25197536|NCT02537574|50400423|FG000|Overall Study|Physician Decision|2|||
24976248|NCT00038948|50065159|FG001|Overall Study|Nonmedical event|7|||
25077016|NCT02442206|50184805|FG000|Period 1|Adverse Event|1|||
25077017|NCT02442206|50184806|FG001|Period 1|Adverse Event|1|||
25077018|NCT02442206|50184805|FG000|Period 1|withdrew consent|0|||
25077019|NCT02442206|50184806|FG001|Period 1|withdrew consent|1|||
25077020|NCT02442206|50184805|FG000|Period 1|COPD exacerbation|0|||
25077021|NCT02442206|50184806|FG001|Period 1|COPD exacerbation|1|||
25077022|NCT02442206|50184805|FG000|Period 2|Adverse Event|1|||
25170892|NCT00550420|50307764|FG000|Overall Study|Adverse Event|28|||
25170893|NCT00550420|50307764|FG000|Overall Study|Lost to Follow-up|8|||
24976249|NCT00038948|50065158|FG000|Overall Study|Withdrawal by Subject|23|||
25077023|NCT02442206|50184806|FG001|Period 2|Adverse Event|0|||
25077024|NCT02499146|50184813|FG000|Overall Study|Lost to Follow-up|1|||
25170894|NCT00550420|50307764|FG000|Overall Study|Protocol Violation|11|||
25077025|NCT02499146|50184813|FG000|Overall Study|Withdrawal by Subject|1|||
25170895|NCT00550420|50307764|FG000|Overall Study|Withdrawal by Subject|30|||
25170896|NCT00550420|50307764|FG000|Overall Study|Still in study at termination|206|||
25170897|NCT00550420|50307764|FG000|Overall Study|Missing|2|||
25170898|NCT00550420|50307764|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
25170899|NCT00550420|50307764|FG000|Overall Study|Investigators opinion|1|||
25170900|NCT00550420|50307764|FG000|Overall Study|Lack of curative effect|1|||
25197537|NCT02537574|50400424|FG001|Overall Study|Physician Decision|0|||
25197538|NCT02537574|50400425|FG002|Overall Study|Physician Decision|0|||
25197539|NCT02537574|50400423|FG000|Overall Study|Protocol Violation|4|||
25197540|NCT02537574|50400424|FG001|Overall Study|Protocol Violation|2|||
25197541|NCT02537574|50400425|FG002|Overall Study|Protocol Violation|3|||
25197542|NCT02537574|50400423|FG000|Overall Study|Withdrawal by Subject|37|||
25197543|NCT02537574|50400424|FG001|Overall Study|Withdrawal by Subject|27|||
25197544|NCT02537574|50400425|FG002|Overall Study|Withdrawal by Subject|29|||
25197545|NCT02537574|50400423|FG000|Overall Study|Lack of Efficacy|14|||
25197546|NCT02537574|50400424|FG001|Overall Study|Lack of Efficacy|16|||
25197547|NCT02537574|50400425|FG002|Overall Study|Lack of Efficacy|15|||
25197548|NCT02537574|50400423|FG000|Overall Study|Duplicate Patient|1|||
25197549|NCT02537574|50400424|FG001|Overall Study|Duplicate Patient|0|||
25197550|NCT02537574|50400425|FG002|Overall Study|Duplicate Patient|0|||
25197551|NCT02537574|50400423|FG000|Overall Study|Patient not Stable|0|||
25197552|NCT02537574|50400424|FG001|Overall Study|Patient not Stable|1|||
25197553|NCT02537574|50400425|FG002|Overall Study|Patient not Stable|0|||
25197554|NCT02537574|50400423|FG000|Overall Study|Incarceration|0|||
25197555|NCT02537574|50400424|FG001|Overall Study|Incarceration|1|||
25197556|NCT02537574|50400425|FG002|Overall Study|Incarceration|0|||
25197557|NCT02537574|50400423|FG000|Overall Study|Failed Naloxone Challenge|0|||
25197558|NCT02537574|50400424|FG001|Overall Study|Failed Naloxone Challenge|1|||
25197559|NCT02537574|50400425|FG002|Overall Study|Failed Naloxone Challenge|0|||
25197560|NCT02537574|50400423|FG000|Overall Study|Transportation Issues|0|||
25197561|NCT02537574|50400424|FG001|Overall Study|Transportation Issues|0|||
25197562|NCT02537574|50400425|FG002|Overall Study|Transportation Issues|1|||
25197563|NCT02537574|50400423|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
25197564|NCT02537574|50400424|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
25197565|NCT02537574|50400425|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
25197566|NCT02537574|50400423|FG000|Overall Study|Noncompliance with Protocol|0|||
25197567|NCT02537574|50400424|FG001|Overall Study|Noncompliance with Protocol|0|||
25197568|NCT02537574|50400425|FG002|Overall Study|Noncompliance with Protocol|1|||
25197569|NCT02531802|50401090|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
25197570|NCT02531802|50401091|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
25197571|NCT02531802|50401092|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
25197572|NCT02531802|50401093|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
25197573|NCT02531802|50401094|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
25197574|NCT02531802|50401095|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
25197575|NCT02531802|50401096|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
25197576|NCT02531802|50401097|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
25197577|NCT02531802|50401098|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
25197578|NCT02531802|50401099|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
25197579|NCT02531802|50401100|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
25197580|NCT02531802|50401101|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
25197581|NCT02531802|50401102|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
25197582|NCT02531802|50401103|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
25197583|NCT02531802|50401104|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
25197584|NCT02531802|50401105|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
25197585|NCT02531802|50401106|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
25197586|NCT02531802|50401107|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
25197587|NCT02531802|50401108|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
25197588|NCT02531802|50401109|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
25197589|NCT02531802|50401110|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
25197590|NCT02531802|50401090|FG000|Received Vaccination 2|Physician Decision|0|||
25197591|NCT02531802|50401091|FG001|Received Vaccination 2|Physician Decision|0|||
25197592|NCT02531802|50401092|FG002|Received Vaccination 2|Physician Decision|0|||
25197593|NCT02531802|50401093|FG003|Received Vaccination 2|Physician Decision|0|||
25197594|NCT02531802|50401094|FG004|Received Vaccination 2|Physician Decision|0|||
25197595|NCT02531802|50401095|FG005|Received Vaccination 2|Physician Decision|1|||
25197596|NCT02531802|50401096|FG006|Received Vaccination 2|Physician Decision|0|||
25197597|NCT02531802|50401097|FG007|Received Vaccination 2|Physician Decision|0|||
25197598|NCT02531802|50401098|FG008|Received Vaccination 2|Physician Decision|0|||
25315073|NCT00975221|50630915|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
25315074|NCT00972179|50630930|FG000|Overall Study|Noncompliance|1|||
25197599|NCT02531802|50401099|FG009|Received Vaccination 2|Physician Decision|2|||
25197600|NCT02531802|50401100|FG010|Received Vaccination 2|Physician Decision|0|||
25197601|NCT02531802|50401101|FG011|Received Vaccination 2|Physician Decision|0|||
25197602|NCT02531802|50401102|FG012|Received Vaccination 2|Physician Decision|0|||
25197603|NCT02531802|50401103|FG013|Received Vaccination 2|Physician Decision|1|||
25197604|NCT02531802|50401104|FG014|Received Vaccination 2|Physician Decision|0|||
25197605|NCT02531802|50401105|FG015|Received Vaccination 2|Physician Decision|0|||
25197606|NCT02531802|50401106|FG016|Received Vaccination 2|Physician Decision|0|||
25197607|NCT02531802|50401107|FG017|Received Vaccination 2|Physician Decision|1|||
25197608|NCT02531802|50401108|FG018|Received Vaccination 2|Physician Decision|0|||
25197609|NCT02531802|50401109|FG019|Received Vaccination 2|Physician Decision|0|||
25197610|NCT02531802|50401110|FG020|Received Vaccination 2|Physician Decision|0|||
25197611|NCT02531802|50401090|FG000|Received Vaccination 2|Adverse Event|0|||
25197612|NCT02531802|50401091|FG001|Received Vaccination 2|Adverse Event|0|||
25197613|NCT02531802|50401092|FG002|Received Vaccination 2|Adverse Event|0|||
25197614|NCT02531802|50401093|FG003|Received Vaccination 2|Adverse Event|0|||
25197615|NCT02531802|50401094|FG004|Received Vaccination 2|Adverse Event|0|||
25197616|NCT02531802|50401095|FG005|Received Vaccination 2|Adverse Event|2|||
25197617|NCT02531802|50401096|FG006|Received Vaccination 2|Adverse Event|0|||
25197618|NCT02531802|50401097|FG007|Received Vaccination 2|Adverse Event|0|||
25197619|NCT02531802|50401098|FG008|Received Vaccination 2|Adverse Event|0|||
25197620|NCT02531802|50401099|FG009|Received Vaccination 2|Adverse Event|0|||
25197621|NCT02531802|50401100|FG010|Received Vaccination 2|Adverse Event|0|||
25197622|NCT02531802|50401101|FG011|Received Vaccination 2|Adverse Event|0|||
25197623|NCT02531802|50401102|FG012|Received Vaccination 2|Adverse Event|0|||
25197624|NCT02531802|50401103|FG013|Received Vaccination 2|Adverse Event|0|||
25197625|NCT02531802|50401104|FG014|Received Vaccination 2|Adverse Event|0|||
25197626|NCT02531802|50401105|FG015|Received Vaccination 2|Adverse Event|0|||
25197627|NCT02531802|50401106|FG016|Received Vaccination 2|Adverse Event|0|||
25197628|NCT02531802|50401107|FG017|Received Vaccination 2|Adverse Event|2|||
25197629|NCT02531802|50401108|FG018|Received Vaccination 2|Adverse Event|1|||
25197630|NCT02531802|50401109|FG019|Received Vaccination 2|Adverse Event|0|||
25197631|NCT02531802|50401110|FG020|Received Vaccination 2|Adverse Event|1|||
25197632|NCT02531802|50401090|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
25197633|NCT02531802|50401091|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
25197634|NCT02531802|50401092|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
25197635|NCT02531802|50401093|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
25197636|NCT02531802|50401094|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
25197637|NCT02531802|50401095|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
25197638|NCT02531802|50401096|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
25197639|NCT02531802|50401097|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
25197640|NCT02531802|50401098|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
25197641|NCT02531802|50401099|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
25197642|NCT02531802|50401100|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
25197643|NCT02531802|50401101|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
25197644|NCT02531802|50401102|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
25197645|NCT02531802|50401103|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
25197646|NCT02531802|50401104|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
25197647|NCT02531802|50401105|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
25197648|NCT02531802|50401106|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
25197649|NCT02531802|50401107|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
25197650|NCT02531802|50401108|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
25197651|NCT02531802|50401109|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
25197652|NCT02531802|50401110|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
25197653|NCT01602666|50401213|FG000|Induction Chemotherapy|Death|2|||
25197654|NCT01602666|50401214|FG001|Induction Chemotherapy|Death|1|||
25197655|NCT01602666|50401213|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
25197656|NCT01602666|50401214|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
25197657|NCT01602666|50401213|FG000|Induction Chemotherapy|Physician Decision|12|||
25197658|NCT01602666|50401214|FG001|Induction Chemotherapy|Physician Decision|5|||
25197659|NCT01602666|50401213|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
25197660|NCT01602666|50401214|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
25197661|NCT01602666|50401213|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
25197662|NCT01602666|50401214|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
25197663|NCT01602666|50401213|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
25197664|NCT01602666|50401214|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
25197665|NCT01602666|50401213|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
25197666|NCT01602666|50401214|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
25197667|NCT01602666|50401213|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
25197668|NCT01602666|50401214|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
25197669|NCT01602666|50401213|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
25197670|NCT01602666|50401214|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
25197671|NCT01602666|50401213|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
25197672|NCT01602666|50401214|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
25197673|NCT01602666|50401213|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
25197674|NCT01602666|50401214|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
25197675|NCT02531646|50401225|FG000|Overall Study|equip. image processing issue|5|||
25197676|NCT02531646|50401226|FG001|Overall Study|equip. image processing issue|1|||
25197677|NCT02531646|50401227|FG002|Overall Study|equip. image processing issue|0|||
25197678|NCT02536404|50401292|FG000|Overall Study|Adverse Event|5|||
25197679|NCT02536404|50401293|FG001|Overall Study|Adverse Event|0|||
25197680|NCT02536404|50401292|FG000|Overall Study|Withdrawal by Subject|4|||
25197681|NCT02536404|50401293|FG001|Overall Study|Withdrawal by Subject|1|||
25197682|NCT02536404|50401292|FG000|Overall Study|Physician Decision|10|||
25197683|NCT02536404|50401293|FG001|Overall Study|Physician Decision|0|||
25197684|NCT02536404|50401292|FG000|Overall Study|Sponsor decision|1|||
25197685|NCT02536404|50401293|FG001|Overall Study|Sponsor decision|0|||
25197686|NCT02527200|50402224|FG000|Overall Study|Withdrawal by Subject|3|||
25197687|NCT02527200|50402225|FG001|Overall Study|Withdrawal by Subject|2|||
25197688|NCT02527200|50402226|FG002|Overall Study|Withdrawal by Subject|1|||
25197689|NCT02527200|50402227|FG003|Overall Study|Withdrawal by Subject|0|||
25197690|NCT02527200|50402224|FG000|Overall Study|Unclassified|0|||
25197691|NCT02527200|50402225|FG001|Overall Study|Unclassified|1|||
25197692|NCT02527200|50402226|FG002|Overall Study|Unclassified|0|||
25197693|NCT02527200|50402227|FG003|Overall Study|Unclassified|0|||
25197694|NCT02527200|50402224|FG000|Overall Study|Lost to Follow-up|0|||
25197695|NCT02527200|50402225|FG001|Overall Study|Lost to Follow-up|0|||
25197696|NCT02527200|50402226|FG002|Overall Study|Lost to Follow-up|1|||
25197697|NCT02527200|50402227|FG003|Overall Study|Lost to Follow-up|0|||
25197698|NCT01659996|50402274|FG000|Overall Study|Protocol Violation|3|||
25197699|NCT01659996|50402275|FG001|Overall Study|Protocol Violation|3|||
25197700|NCT01659996|50402276|FG002|Overall Study|Protocol Violation|3|||
25197701|NCT01659996|50402274|FG000|Overall Study|Lost to Follow-up|1|||
25197702|NCT01659996|50402275|FG001|Overall Study|Lost to Follow-up|3|||
25197703|NCT01659996|50402276|FG002|Overall Study|Lost to Follow-up|2|||
25197704|NCT01659996|50402274|FG000|Overall Study|Adverse Event|0|||
25197705|NCT01659996|50402275|FG001|Overall Study|Adverse Event|0|||
25197706|NCT01659996|50402276|FG002|Overall Study|Adverse Event|1|||
25197707|NCT01659996|50402274|FG000|Overall Study|Withdrawal by Subject|4|||
25197708|NCT01659996|50402275|FG001|Overall Study|Withdrawal by Subject|1|||
25197709|NCT01659996|50402276|FG002|Overall Study|Withdrawal by Subject|5|||
25197710|NCT00389610|50402573|FG000|Overall Study|Disease Progression|0|||
25197711|NCT00389610|50402574|FG001|Overall Study|Disease Progression|19|||
25197712|NCT00389610|50402573|FG000|Overall Study|Death|0|||
25197713|NCT00389610|50402574|FG001|Overall Study|Death|1|||
25197714|NCT00389610|50402573|FG000|Overall Study|Physician Decision|0|||
25197715|NCT00389610|50402574|FG001|Overall Study|Physician Decision|1|||
25197716|NCT00389610|50402573|FG000|Overall Study|Withdrawal by Subject|0|||
25197717|NCT00389610|50402574|FG001|Overall Study|Withdrawal by Subject|1|||
25197718|NCT02525874|50402649|FG000|Overall Study|Other|1|||
25197719|NCT02525874|50402649|FG000|Overall Study|Investigator Decision|1|||
25197720|NCT02525874|50402649|FG000|Overall Study|Consent withdrawn|22|||
25197721|NCT02525874|50402649|FG000|Overall Study|Non-compliance with study drug|3|||
25197722|NCT02525874|50402649|FG000|Overall Study|Adverse Event|17|||
25197723|NCT02525874|50402649|FG000|Overall Study|Lost to Follow-up|7|||
25197724|NCT02525874|50402649|FG000|Overall Study|Disease progression, defined by protocol|2|||
25197725|NCT02525874|50402649|FG000|Overall Study|Disease relapse|4|||
25197726|NCT02525874|50402649|FG000|Overall Study|Alternative Treatment for MS|2|||
25197727|NCT02525874|50402649|FG000|Overall Study|New lesions in Brain|1|||
25197728|NCT02528214|50402659|FG000|Overall Study|Protocol Violation|0|||
25197729|NCT02528214|50402660|FG001|Overall Study|Protocol Violation|1|||
25197730|NCT02528214|50402659|FG000|Overall Study|Adverse Event|0|||
25197731|NCT02528214|50402660|FG001|Overall Study|Adverse Event|1|||
25197732|NCT02528214|50402659|FG000|Overall Study|Other than specified above|0|||
25197733|NCT02528214|50402660|FG001|Overall Study|Other than specified above|1|||
25197734|NCT05348681|50402704|FG000|Overall Study|Study terminated by Sponsor|8|||
25197735|NCT05348681|50402705|FG001|Overall Study|Study terminated by Sponsor|3|||
25197736|NCT05348681|50402704|FG000|Overall Study|Withdrawal by Subject|1|||
25197737|NCT05348681|50402705|FG001|Overall Study|Withdrawal by Subject|1|||
25197738|NCT05348681|50402704|FG000|Overall Study|Lost to Follow-up|1|||
25197739|NCT05348681|50402705|FG001|Overall Study|Lost to Follow-up|1|||
25197740|NCT05348681|50402704|FG000|Overall Study|Adverse Event|1|||
25197741|NCT05348681|50402705|FG001|Overall Study|Adverse Event|0|||
25197742|NCT05348681|50402704|FG000|Overall Study|Other|2|||
25197743|NCT05348681|50402705|FG001|Overall Study|Other|1|||
25197744|NCT04423757|50402731|FG000|Overall Study|Adverse Event|2|||
25197745|NCT04423757|50402732|FG001|Overall Study|Adverse Event|0|||
25197746|NCT04423757|50402731|FG000|Overall Study|Not treated|1|||
25197747|NCT04423757|50402732|FG001|Overall Study|Not treated|1|||
25197748|NCT04379713|50402740|FG000|Overall Study|Adverse Event|2|||
25197749|NCT04379713|50402741|FG001|Overall Study|Adverse Event|0|||
25197750|NCT04379713|50402740|FG000|Overall Study|Physician Decision|2|||
25197751|NCT04379713|50402741|FG001|Overall Study|Physician Decision|1|||
25197752|NCT04379713|50402740|FG000|Overall Study|Protocol Violation|11|||
25197753|NCT04379713|50402741|FG001|Overall Study|Protocol Violation|6|||
25197754|NCT04379713|50402740|FG000|Overall Study|No longer met eligibility criteria|14|||
25197755|NCT04379713|50402741|FG001|Overall Study|No longer met eligibility criteria|11|||
25197756|NCT04379713|50402740|FG000|Overall Study|Withdrawal by parent/guardian|36|||
25197757|NCT04379713|50402741|FG001|Overall Study|Withdrawal by parent/guardian|15|||
25197758|NCT04379713|50402740|FG000|Overall Study|Lost to Follow-up|31|||
25197759|NCT04379713|50402741|FG001|Overall Study|Lost to Follow-up|21|||
25197760|NCT04085328|50402749|FG000|Overall Study|Witihdrew Consent|16|||
25197761|NCT04085328|50402750|FG001|Overall Study|Witihdrew Consent|16|||
25197762|NCT04085328|50402749|FG000|Overall Study|Adverse Event|8|||
25197763|NCT04085328|50402750|FG001|Overall Study|Adverse Event|7|||
25197764|NCT04085328|50402749|FG000|Overall Study|Lost to Follow-up|7|||
25197765|NCT04085328|50402750|FG001|Overall Study|Lost to Follow-up|2|||
25197766|NCT04085328|50402749|FG000|Overall Study|Physician Decision|0|||
25197767|NCT04085328|50402750|FG001|Overall Study|Physician Decision|1|||
25197768|NCT04085328|50402749|FG000|Overall Study|Pregnancy|0|||
25197769|NCT04085328|50402750|FG001|Overall Study|Pregnancy|1|||
25197770|NCT04085328|50402749|FG000|Overall Study|Reasons Related to COVID-19|5|||
25197771|NCT04085328|50402750|FG001|Overall Study|Reasons Related to COVID-19|8|||
25197772|NCT04085328|50402749|FG000|Overall Study|Did not meet inclusion criteria|1|||
25197773|NCT04085328|50402750|FG001|Overall Study|Did not meet inclusion criteria|1|||
25197774|NCT04085328|50402749|FG000|Overall Study|Early termination|1|||
25197775|NCT04085328|50402750|FG001|Overall Study|Early termination|0|||
25197776|NCT03789110|50402763|FG000|Overall Study|Adverse Event|2|||
25197777|NCT03789110|50402763|FG000|Overall Study|Physician Decision|1|||
25197778|NCT03789110|50402763|FG000|Overall Study|Withdrawal by Subject|2|||
25197779|NCT03789110|50402763|FG000|Overall Study|Lack of Efficacy|22|||
25197780|NCT03789110|50402763|FG000|Overall Study|still on treatment|3|||
25197781|NCT03735121|50402781|FG000|Overall Study|Death|3|||
25197782|NCT03735121|50402782|FG001|Overall Study|Death|6|||
25197783|NCT03735121|50402783|FG002|Overall Study|Death|8|||
25197784|NCT03735121|50402784|FG003|Overall Study|Death|37|||
25197785|NCT03735121|50402785|FG004|Overall Study|Death|86|||
25197786|NCT03735121|50402781|FG000|Overall Study|Withdrawal by Subject|1|||
25197787|NCT03735121|50402782|FG001|Overall Study|Withdrawal by Subject|1|||
25197788|NCT03735121|50402783|FG002|Overall Study|Withdrawal by Subject|3|||
25197789|NCT03735121|50402784|FG003|Overall Study|Withdrawal by Subject|4|||
25197790|NCT03735121|50402785|FG004|Overall Study|Withdrawal by Subject|2|||
25197791|NCT03735121|50402781|FG000|Overall Study|Progressive Disease|0|||
25197792|NCT03735121|50402782|FG001|Overall Study|Progressive Disease|0|||
25197793|NCT03735121|50402783|FG002|Overall Study|Progressive Disease|1|||
25197794|NCT03735121|50402784|FG003|Overall Study|Progressive Disease|0|||
25197795|NCT03735121|50402785|FG004|Overall Study|Progressive Disease|0|||
25197796|NCT03735121|50402781|FG000|Overall Study|Lost to Follow-up|0|||
25197797|NCT03735121|50402782|FG001|Overall Study|Lost to Follow-up|0|||
25197798|NCT03735121|50402783|FG002|Overall Study|Lost to Follow-up|0|||
25197799|NCT03735121|50402784|FG003|Overall Study|Lost to Follow-up|0|||
25197800|NCT03735121|50402785|FG004|Overall Study|Lost to Follow-up|1|||
25197801|NCT03735121|50402781|FG000|Overall Study|Ongoing|3|||
25197802|NCT03735121|50402782|FG001|Overall Study|Ongoing|3|||
25197803|NCT03735121|50402783|FG002|Overall Study|Ongoing|26|||
25197804|NCT03735121|50402784|FG003|Overall Study|Ongoing|83|||
25197805|NCT03735121|50402785|FG004|Overall Study|Ongoing|158|||
25197806|NCT03317405|50402821|FG000|Overall Study|Withdrawal by Subject|1|||
25197807|NCT03317405|50402822|FG001|Overall Study|Withdrawal by Subject|0|||
25197808|NCT03317405|50402823|FG002|Overall Study|Withdrawal by Subject|0|||
25197809|NCT03317405|50402821|FG000|Overall Study|Physician Decision|0|||
25197810|NCT03317405|50402822|FG001|Overall Study|Physician Decision|0|||
25197811|NCT03317405|50402823|FG002|Overall Study|Physician Decision|1|||
25197812|NCT03317405|50402821|FG000|Overall Study|Surgery Rescheduled|0|||
25197813|NCT03317405|50402822|FG001|Overall Study|Surgery Rescheduled|1|||
25197814|NCT03317405|50402823|FG002|Overall Study|Surgery Rescheduled|0|||
25197815|NCT03309878|50402839|FG000|Overall Study|Adverse Event|1|||
25197816|NCT03309878|50402840|FG001|Overall Study|Adverse Event|0|||
25197817|NCT03309878|50402841|FG002|Overall Study|Adverse Event|0|||
25197818|NCT03309878|50402842|FG003|Overall Study|Adverse Event|0|||
25077026|NCT02499146|50184813|FG000|Overall Study|Other|2|||
25077027|NCT02499146|50184813|FG000|Overall Study|Ongoing at date of cut-off|9|||
25197819|NCT03309878|50402839|FG000|Overall Study|Did not maintain eligibility|2|||
25197820|NCT03309878|50402840|FG001|Overall Study|Did not maintain eligibility|1|||
25197821|NCT03309878|50402841|FG002|Overall Study|Did not maintain eligibility|0|||
25197822|NCT03309878|50402842|FG003|Overall Study|Did not maintain eligibility|0|||
25197823|NCT03309878|50402839|FG000|Overall Study|Withdrawal by Subject|0|||
25197824|NCT03309878|50402840|FG001|Overall Study|Withdrawal by Subject|1|||
25197825|NCT03309878|50402841|FG002|Overall Study|Withdrawal by Subject|0|||
25197826|NCT03309878|50402842|FG003|Overall Study|Withdrawal by Subject|0|||
25197827|NCT03074474|50402852|FG000|Overall Study|Lost to Follow-up|10|||
25197828|NCT03074474|50402852|FG000|Overall Study|Withdrawal by Subject|10|||
25197829|NCT03074474|50402852|FG000|Overall Study|Death|4|||
25197830|NCT03074474|50402852|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
25197831|NCT03043313|50402860|FG000|Overall Study|Withdrawal by Subject|4|||
25197832|NCT03043313|50402861|FG001|Overall Study|Withdrawal by Subject|1|||
25197833|NCT03043313|50402862|FG002|Overall Study|Withdrawal by Subject|1|||
25197834|NCT03043313|50402860|FG000|Overall Study|Lost to Follow-up|1|||
25197835|NCT03043313|50402861|FG001|Overall Study|Lost to Follow-up|0|||
25197836|NCT03043313|50402862|FG002|Overall Study|Lost to Follow-up|0|||
25197837|NCT03043313|50402860|FG000|Overall Study|Death|26|||
25197838|NCT03043313|50402861|FG001|Overall Study|Death|13|||
25197839|NCT03043313|50402862|FG002|Overall Study|Death|8|||
25197840|NCT03043313|50402860|FG000|Overall Study|On Treatment|7|||
25197841|NCT03043313|50402861|FG001|Overall Study|On Treatment|12|||
25197842|NCT03043313|50402862|FG002|Overall Study|On Treatment|11|||
25197843|NCT03043313|50402860|FG000|Overall Study|In follow up|7|||
25197844|NCT03043313|50402861|FG001|Overall Study|In follow up|15|||
25197845|NCT03043313|50402862|FG002|Overall Study|In follow up|11|||
25197846|NCT02744391|50402873|FG000|Overall Study|Lost to Follow-up|9|||
25197847|NCT02744391|50402873|FG000|Overall Study|Physician Decision|2|||
25197848|NCT02744391|50402873|FG000|Overall Study|Withdrawal by Subject|3|||
25197849|NCT02634710|50402877|FG000|Overall Study|Death|4|||
25197850|NCT02462837|50402883|FG000|Overall Study|pt developed hives|1|||
25197851|NCT02462837|50402884|FG001|Overall Study|pt developed hives|0|||
25197852|NCT02462837|50402883|FG000|Overall Study|Withdrawal by Subject|1|||
25197853|NCT02462837|50402884|FG001|Overall Study|Withdrawal by Subject|0|||
25197854|NCT02346201|50402892|FG000|Overall Study|Adverse Event|3|||
25197855|NCT02346201|50402893|FG001|Overall Study|Adverse Event|2|||
25197856|NCT02346201|50402892|FG000|Overall Study|Lost to Follow-up|1|||
25197857|NCT02346201|50402893|FG001|Overall Study|Lost to Follow-up|0|||
25197858|NCT02346201|50402892|FG000|Overall Study|Withdrawal by Subject|6|||
25197859|NCT02346201|50402893|FG001|Overall Study|Withdrawal by Subject|3|||
25197860|NCT02346201|50402892|FG000|Overall Study|Unavailable for future follow-up|0|||
25197861|NCT02346201|50402893|FG001|Overall Study|Unavailable for future follow-up|1|||
25197862|NCT02346201|50402892|FG000|Overall Study|Physician Decision|0|||
25197863|NCT02346201|50402893|FG001|Overall Study|Physician Decision|1|||
25197864|NCT02346201|50402892|FG000|Overall Study|Missed final visit|0|||
25197865|NCT02346201|50402893|FG001|Overall Study|Missed final visit|2|||
25197866|NCT01866930|50402913|FG000|Treatment Period|Other|1|||
25197867|NCT01866930|50402914|FG001|Treatment Period|Other|0|||
25197868|NCT01866930|50402913|FG000|Treatment Period|Death|0|||
25197869|NCT01866930|50402914|FG001|Treatment Period|Death|2|||
25197870|NCT01866930|50402913|FG000|Treatment Period|Poor/non compliance|0|||
25197871|NCT01866930|50402914|FG001|Treatment Period|Poor/non compliance|2|||
25197872|NCT01866930|50402913|FG000|Treatment Period|No longer meets study criteria|0|||
25197873|NCT01866930|50402914|FG001|Treatment Period|No longer meets study criteria|1|||
25197874|NCT01866930|50402913|FG000|Treatment Period|Withdrawal by Subject|2|||
25197875|NCT01866930|50402914|FG001|Treatment Period|Withdrawal by Subject|8|||
25197876|NCT01866930|50402913|FG000|Treatment Period|Lack of Efficacy|1|||
25197877|NCT01866930|50402914|FG001|Treatment Period|Lack of Efficacy|9|||
25197878|NCT01866930|50402913|FG000|Treatment Period|Adverse Event|4|||
25197879|NCT01866930|50402914|FG001|Treatment Period|Adverse Event|12|||
25197880|NCT01866930|50402913|FG000|Treatment Period|Lost to Follow-up|1|||
25197881|NCT01866930|50402914|FG001|Treatment Period|Lost to Follow-up|1|||
25197882|NCT01866930|50402913|FG000|Follow-up Period|Lost to Follow-up|1|||
25197883|NCT01866930|50402914|FG001|Follow-up Period|Lost to Follow-up|1|||
25197884|NCT01866930|50402913|FG000|Follow-up Period|Other|1|||
25315075|NCT00972179|50630931|FG001|Overall Study|Noncompliance|0|||
25315076|NCT00972179|50630932|FG002|Overall Study|Noncompliance|0|||
25315077|NCT00972179|50630933|FG003|Overall Study|Noncompliance|0|||
25315078|NCT00972179|50630934|FG004|Overall Study|Noncompliance|1|||
25315079|NCT00972179|50630935|FG005|Overall Study|Noncompliance|0|||
25315080|NCT00972179|50630936|FG006|Overall Study|Noncompliance|1|||
25315081|NCT00972179|50630930|FG000|Overall Study|Withdrawal by Subject|0|||
25170901|NCT00550420|50307764|FG000|Overall Study|Unethical stop of enrollment|2|||
25315082|NCT00972179|50630931|FG001|Overall Study|Withdrawal by Subject|3|||
25315083|NCT00972179|50630932|FG002|Overall Study|Withdrawal by Subject|0|||
25170902|NCT00550420|50307764|FG000|Overall Study|Caregiver's decision to withdraw|1|||
25170903|NCT00550420|50307764|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
25170904|NCT00550420|50307764|FG000|Overall Study|Exclusion criteria|1|||
25170905|NCT00550420|50307764|FG000|Overall Study|Prohibited medicine|1|||
25170906|NCT00558064|50307776|FG000|Overall Study|Adverse Event|3|||
25170907|NCT00558064|50307777|FG001|Overall Study|Adverse Event|2|||
25170908|NCT00558064|50307776|FG000|Overall Study|Lack of Efficacy|0|||
25197885|NCT01866930|50402914|FG001|Follow-up Period|Other|5|||
25197886|NCT01866930|50402913|FG000|Follow-up Period|No longer required per protocol|1|||
25197887|NCT01866930|50402914|FG001|Follow-up Period|No longer required per protocol|0|||
25197888|NCT01866930|50402913|FG000|Follow-up Period|Withdrawal by Subject|3|||
25197889|NCT01866930|50402914|FG001|Follow-up Period|Withdrawal by Subject|3|||
25197890|NCT01621568|50402922|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
25315084|NCT00972179|50630933|FG003|Overall Study|Withdrawal by Subject|1|||
25170909|NCT00558064|50307777|FG001|Overall Study|Lack of Efficacy|1|||
25197891|NCT01621568|50402923|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
25197892|NCT01621568|50402922|FG000|Week 5-6 No Treatment|Death|1|||
25197893|NCT01621568|50402923|FG001|Week 5-6 No Treatment|Death|0|||
25197894|NCT01196390|50402952|FG000|Overall Study|Protocol Violation|4|||
25197895|NCT01196390|50402953|FG001|Overall Study|Protocol Violation|5|||
25197896|NCT00813293|50402963|FG000|Overall Study|Intercurrent illness|1|||
25197897|NCT00813293|50402964|FG001|Overall Study|Intercurrent illness|0|||
25197898|NCT00813293|50402963|FG000|Overall Study|Adverse Event|0|||
25197899|NCT00813293|50402964|FG001|Overall Study|Adverse Event|1|||
25197900|NCT00777036|50402973|FG000|On Treatment|Reason Not Specified|4|||
25197901|NCT00777036|50402974|FG001|On Treatment|Reason Not Specified|7|||
25197902|NCT00777036|50402975|FG002|On Treatment|Reason Not Specified|12|||
25197903|NCT00777036|50402973|FG000|On Treatment|Failure to Meet Study Criteria|0|||
25197904|NCT00777036|50402974|FG001|On Treatment|Failure to Meet Study Criteria|1|||
25197905|NCT00777036|50402975|FG002|On Treatment|Failure to Meet Study Criteria|0|||
25197906|NCT00777036|50402973|FG000|On Treatment|Non-compliance with Study Drug|1|||
25197907|NCT00777036|50402974|FG001|On Treatment|Non-compliance with Study Drug|0|||
25197908|NCT00777036|50402975|FG002|On Treatment|Non-compliance with Study Drug|0|||
25197909|NCT00777036|50402973|FG000|On Treatment|Maximum Clinical Benefit|2|||
25197910|NCT00777036|50402974|FG001|On Treatment|Maximum Clinical Benefit|0|||
25197911|NCT00777036|50402975|FG002|On Treatment|Maximum Clinical Benefit|1|||
25197912|NCT00777036|50402973|FG000|On Treatment|Withdrawal by Subject|3|||
25197913|NCT00777036|50402974|FG001|On Treatment|Withdrawal by Subject|2|||
25197914|NCT00777036|50402975|FG002|On Treatment|Withdrawal by Subject|3|||
25197915|NCT00777036|50402973|FG000|On Treatment|Death|0|||
25197916|NCT00777036|50402974|FG001|On Treatment|Death|2|||
25197917|NCT00777036|50402975|FG002|On Treatment|Death|0|||
25197918|NCT00777036|50402973|FG000|On Treatment|Study Drug Toxicity|0|||
25197919|NCT00777036|50402974|FG001|On Treatment|Study Drug Toxicity|0|||
25197920|NCT00777036|50402975|FG002|On Treatment|Study Drug Toxicity|1|||
25197921|NCT00777036|50402973|FG000|On Treatment|Progressive Disease|5|||
25197922|NCT00777036|50402974|FG001|On Treatment|Progressive Disease|4|||
25197923|NCT00777036|50402975|FG002|On Treatment|Progressive Disease|6|||
25197924|NCT00777036|50402973|FG000|Follow-Up|Lost to Follow-up|1|||
25197925|NCT00777036|50402974|FG001|Follow-Up|Lost to Follow-up|0|||
25197926|NCT00777036|50402975|FG002|Follow-Up|Lost to Follow-up|0|||
25197927|NCT00777036|50402973|FG000|Follow-Up|Reason Not Specified|2|||
25197928|NCT00777036|50402974|FG001|Follow-Up|Reason Not Specified|0|||
25197929|NCT00777036|50402975|FG002|Follow-Up|Reason Not Specified|0|||
25197930|NCT00777036|50402973|FG000|Follow-Up|Withdrawal by Subject|1|||
25197931|NCT00777036|50402974|FG001|Follow-Up|Withdrawal by Subject|0|||
25197932|NCT00777036|50402975|FG002|Follow-Up|Withdrawal by Subject|4|||
25197933|NCT00777036|50402973|FG000|Follow-Up|Death|1|||
25197934|NCT00777036|50402974|FG001|Follow-Up|Death|8|||
25197935|NCT00777036|50402975|FG002|Follow-Up|Death|0|||
25197936|NCT00481091|50403000|FG000|Overall Study|Withdrawal by Subject|0|||
25197937|NCT00481091|50403001|FG001|Overall Study|Withdrawal by Subject|1|||
25197938|NCT00481091|50403002|FG002|Overall Study|Withdrawal by Subject|1|||
25197939|NCT00481091|50403003|FG003|Overall Study|Withdrawal by Subject|0|||
25197940|NCT00481091|50403004|FG004|Overall Study|Withdrawal by Subject|0|||
25197941|NCT00481091|50403005|FG005|Overall Study|Withdrawal by Subject|0|||
25197942|NCT00481091|50403006|FG006|Overall Study|Withdrawal by Subject|0|||
25197943|NCT00481091|50403007|FG007|Overall Study|Withdrawal by Subject|0|||
25197944|NCT00481091|50403008|FG008|Overall Study|Withdrawal by Subject|1|||
25197945|NCT00481091|50403009|FG009|Overall Study|Withdrawal by Subject|6|||
25197946|NCT00481091|50403000|FG000|Overall Study|Other, Not Specified|0|||
25197947|NCT00481091|50403001|FG001|Overall Study|Other, Not Specified|1|||
25197948|NCT00481091|50403002|FG002|Overall Study|Other, Not Specified|1|||
25197949|NCT00481091|50403003|FG003|Overall Study|Other, Not Specified|0|||
25197950|NCT00481091|50403004|FG004|Overall Study|Other, Not Specified|0|||
25197951|NCT00481091|50403005|FG005|Overall Study|Other, Not Specified|1|||
25197952|NCT00481091|50403006|FG006|Overall Study|Other, Not Specified|0|||
25197953|NCT00481091|50403007|FG007|Overall Study|Other, Not Specified|0|||
25197954|NCT00481091|50403008|FG008|Overall Study|Other, Not Specified|0|||
25197955|NCT00481091|50403009|FG009|Overall Study|Other, Not Specified|4|||
25170910|NCT00558064|50307776|FG000|Overall Study|Protocol Violation|1|||
25197956|NCT00481091|50403000|FG000|Overall Study|Adverse Event|1|||
25197957|NCT00481091|50403001|FG001|Overall Study|Adverse Event|2|||
25170911|NCT00558064|50307777|FG001|Overall Study|Protocol Violation|0|||
25170912|NCT00558064|50307776|FG000|Overall Study|Lost to Follow-up|0|||
25170913|NCT00558064|50307777|FG001|Overall Study|Lost to Follow-up|1|||
25170914|NCT00558064|50307776|FG000|Overall Study|Withdrawal by Subject|0|||
25170915|NCT00558064|50307777|FG001|Overall Study|Withdrawal by Subject|1|||
25170916|NCT00558064|50307776|FG000|Overall Study|No visit within allowance period|1|||
25170917|NCT00558064|50307777|FG001|Overall Study|No visit within allowance period|0|||
25170918|NCT00557830|50307786|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
25170919|NCT00557830|50307787|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
25197958|NCT00481091|50403002|FG002|Overall Study|Adverse Event|0|||
25197959|NCT00481091|50403003|FG003|Overall Study|Adverse Event|1|||
25197960|NCT00481091|50403004|FG004|Overall Study|Adverse Event|1|||
25197961|NCT00481091|50403005|FG005|Overall Study|Adverse Event|1|||
25197962|NCT00481091|50403006|FG006|Overall Study|Adverse Event|2|||
25197963|NCT00481091|50403007|FG007|Overall Study|Adverse Event|1|||
25197964|NCT00481091|50403008|FG008|Overall Study|Adverse Event|1|||
25197965|NCT00481091|50403009|FG009|Overall Study|Adverse Event|6|||
25197966|NCT00481091|50403000|FG000|Overall Study|Progressive disease clinical|0|||
25197967|NCT00481091|50403001|FG001|Overall Study|Progressive disease clinical|0|||
25197968|NCT00481091|50403002|FG002|Overall Study|Progressive disease clinical|0|||
25197969|NCT00481091|50403003|FG003|Overall Study|Progressive disease clinical|0|||
25197970|NCT00481091|50403004|FG004|Overall Study|Progressive disease clinical|0|||
25197971|NCT00481091|50403005|FG005|Overall Study|Progressive disease clinical|0|||
25197972|NCT00481091|50403006|FG006|Overall Study|Progressive disease clinical|0|||
25197973|NCT00481091|50403007|FG007|Overall Study|Progressive disease clinical|0|||
25197974|NCT00481091|50403008|FG008|Overall Study|Progressive disease clinical|1|||
25197975|NCT00481091|50403009|FG009|Overall Study|Progressive disease clinical|7|||
25197976|NCT00481091|50403000|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
25197977|NCT00481091|50403001|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
25197978|NCT00481091|50403002|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
25197979|NCT00481091|50403003|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
25197980|NCT00481091|50403004|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
25197981|NCT00481091|50403005|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
25197982|NCT00481091|50403006|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
25197983|NCT00481091|50403007|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
25197984|NCT00481091|50403008|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
25197985|NCT00481091|50403009|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
25197986|NCT00481091|50403000|FG000|Overall Study|Progressive disease other|1|||
25197987|NCT00481091|50403001|FG001|Overall Study|Progressive disease other|1|||
25197988|NCT00481091|50403002|FG002|Overall Study|Progressive disease other|0|||
25197989|NCT00481091|50403003|FG003|Overall Study|Progressive disease other|1|||
25197990|NCT00481091|50403004|FG004|Overall Study|Progressive disease other|1|||
25197991|NCT00481091|50403005|FG005|Overall Study|Progressive disease other|1|||
25197992|NCT00481091|50403006|FG006|Overall Study|Progressive disease other|0|||
25197993|NCT00481091|50403007|FG007|Overall Study|Progressive disease other|2|||
25197994|NCT00481091|50403008|FG008|Overall Study|Progressive disease other|0|||
25197995|NCT00481091|50403009|FG009|Overall Study|Progressive disease other|0|||
25197996|NCT00481091|50403000|FG000|Overall Study|No reason given|0|||
25197997|NCT00481091|50403001|FG001|Overall Study|No reason given|0|||
25197998|NCT00481091|50403002|FG002|Overall Study|No reason given|1|||
25197999|NCT00481091|50403003|FG003|Overall Study|No reason given|1|||
25198000|NCT00481091|50403004|FG004|Overall Study|No reason given|1|||
25198001|NCT00481091|50403005|FG005|Overall Study|No reason given|0|||
25198002|NCT00481091|50403006|FG006|Overall Study|No reason given|1|||
25198003|NCT00481091|50403007|FG007|Overall Study|No reason given|1|||
25198004|NCT00481091|50403008|FG008|Overall Study|No reason given|1|||
25198005|NCT00481091|50403009|FG009|Overall Study|No reason given|4|||
25198006|NCT00075946|50403042|FG000|Overall Study|Path ineligible: undetermined histology|0|||
25198007|NCT00075946|50403043|FG001|Overall Study|Path ineligible: undetermined histology|0|||
25198008|NCT00075946|50403044|FG002|Overall Study|Path ineligible: undetermined histology|0|||
25198009|NCT00075946|50403045|FG003|Overall Study|Path ineligible: undetermined histology|0|||
25198010|NCT00075946|50403046|FG004|Overall Study|Path ineligible: undetermined histology|6|||
25198011|NCT00075946|50403042|FG000|Overall Study|Did not achieve response after induction|0|||
25198012|NCT00075946|50403043|FG001|Overall Study|Did not achieve response after induction|0|||
25198013|NCT00075946|50403044|FG002|Overall Study|Did not achieve response after induction|0|||
25198014|NCT00075946|50403045|FG003|Overall Study|Did not achieve response after induction|0|||
25198015|NCT00075946|50403046|FG004|Overall Study|Did not achieve response after induction|182|||
25198016|NCT00075946|50403042|FG000|Overall Study|Incorrectly randomized (no response)|5|||
25198017|NCT00075946|50403043|FG001|Overall Study|Incorrectly randomized (no response)|5|||
25198018|NCT00075946|50403044|FG002|Overall Study|Incorrectly randomized (no response)|5|||
25198019|NCT00075946|50403045|FG003|Overall Study|Incorrectly randomized (no response)|1|||
25198020|NCT00075946|50403046|FG004|Overall Study|Incorrectly randomized (no response)|0|||
25198021|NCT00075946|50403042|FG000|Overall Study|Still on treatment at time of analysis|52|||
25198022|NCT00075946|50403043|FG001|Overall Study|Still on treatment at time of analysis|19|||
25198023|NCT00075946|50403044|FG002|Overall Study|Still on treatment at time of analysis|3|||
25198024|NCT00075946|50403045|FG003|Overall Study|Still on treatment at time of analysis|9|||
25198025|NCT00075946|50403046|FG004|Overall Study|Still on treatment at time of analysis|0|||
25198026|NCT00075946|50403042|FG000|Overall Study|Adverse Event|2|||
25198027|NCT00075946|50403043|FG001|Overall Study|Adverse Event|10|||
25198028|NCT00075946|50403044|FG002|Overall Study|Adverse Event|0|||
25198029|NCT00075946|50403045|FG003|Overall Study|Adverse Event|2|||
25198030|NCT00075946|50403046|FG004|Overall Study|Adverse Event|0|||
25198031|NCT00075946|50403042|FG000|Overall Study|Death|0|||
25198032|NCT00075946|50403043|FG001|Overall Study|Death|1|||
25198033|NCT00075946|50403044|FG002|Overall Study|Death|0|||
25198034|NCT00075946|50403045|FG003|Overall Study|Death|0|||
25198035|NCT00075946|50403046|FG004|Overall Study|Death|0|||
25198036|NCT00075946|50403042|FG000|Overall Study|Withdrawal by Subject|23|||
25198037|NCT00075946|50403043|FG001|Overall Study|Withdrawal by Subject|58|||
25198038|NCT00075946|50403044|FG002|Overall Study|Withdrawal by Subject|4|||
25198039|NCT00075946|50403045|FG003|Overall Study|Withdrawal by Subject|9|||
25198040|NCT00075946|50403046|FG004|Overall Study|Withdrawal by Subject|0|||
25198041|NCT00075946|50403042|FG000|Overall Study|Alternative therapy|16|||
25198042|NCT00075946|50403043|FG001|Overall Study|Alternative therapy|2|||
25198043|NCT00075946|50403044|FG002|Overall Study|Alternative therapy|5|||
25198044|NCT00075946|50403045|FG003|Overall Study|Alternative therapy|0|||
25198045|NCT00075946|50403046|FG004|Overall Study|Alternative therapy|0|||
25198046|NCT00075946|50403042|FG000|Overall Study|Other complicating disease|7|||
25198047|NCT00075946|50403043|FG001|Overall Study|Other complicating disease|13|||
25198048|NCT00075946|50403044|FG002|Overall Study|Other complicating disease|1|||
25198049|NCT00075946|50403045|FG003|Overall Study|Other complicating disease|4|||
25198050|NCT00075946|50403046|FG004|Overall Study|Other complicating disease|0|||
25198051|NCT00075946|50403042|FG000|Overall Study|No response to retreatment|23|||
25198052|NCT00075946|50403043|FG001|Overall Study|No response to retreatment|0|||
25198053|NCT00075946|50403044|FG002|Overall Study|No response to retreatment|2|||
25198054|NCT00075946|50403045|FG003|Overall Study|No response to retreatment|0|||
25198055|NCT00075946|50403046|FG004|Overall Study|No response to retreatment|0|||
25198056|NCT00075946|50403042|FG000|Overall Study|Time to progression less than 6 months|15|||
25198057|NCT00075946|50403043|FG001|Overall Study|Time to progression less than 6 months|30|||
25198058|NCT00075946|50403044|FG002|Overall Study|Time to progression less than 6 months|8|||
25198059|NCT00075946|50403045|FG003|Overall Study|Time to progression less than 6 months|3|||
25198060|NCT00075946|50403046|FG004|Overall Study|Time to progression less than 6 months|0|||
25198061|NCT00075946|50403042|FG000|Overall Study|Other|5|||
25198062|NCT00075946|50403043|FG001|Overall Study|Other|13|||
25198063|NCT00075946|50403044|FG002|Overall Study|Other|0|||
25198064|NCT00075946|50403045|FG003|Overall Study|Other|2|||
25198065|NCT00075946|50403046|FG004|Overall Study|Other|0|||
25198066|NCT00003641|50403059|FG000|Overall Study|Withdrawal by Subject|0|||
25198067|NCT00003641|50403060|FG001|Overall Study|Withdrawal by Subject|100|||
25198068|NCT00003641|50403059|FG000|Overall Study|Adverse Event|0|||
25198069|NCT00003641|50403060|FG001|Overall Study|Adverse Event|38|||
25198070|NCT00003641|50403059|FG000|Overall Study|Disease progression|0|||
25198071|NCT00003641|50403060|FG001|Overall Study|Disease progression|2|||
25198072|NCT00003641|50403059|FG000|Overall Study|Unknown/missing|0|||
25198073|NCT00003641|50403060|FG001|Overall Study|Unknown/missing|22|||
25198074|NCT00003641|50403059|FG000|Overall Study|Should not receive interferon therapy|2|||
25198075|NCT00003641|50403060|FG001|Overall Study|Should not receive interferon therapy|0|||
25198076|NCT00003641|50403059|FG000|Overall Study|Never started interferon|567|||
25198077|NCT00003641|50403060|FG001|Overall Study|Never started interferon|12|||
25198078|NCT02524158|50403090|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
25198079|NCT02524158|50403091|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
25198080|NCT02524158|50403090|FG000|12-weeks Assessment|Lost to Follow-up|18|||
25198081|NCT02524158|50403091|FG001|12-weeks Assessment|Lost to Follow-up|12|||
25198082|NCT02524158|50403090|FG000|6-month Assessment|Withdrawal by Subject|1|||
25198083|NCT02524158|50403091|FG001|6-month Assessment|Withdrawal by Subject|1|||
25198084|NCT02524158|50403090|FG000|6-month Assessment|Lost to Follow-up|21|||
25198085|NCT02524158|50403091|FG001|6-month Assessment|Lost to Follow-up|20|||
25315085|NCT00972179|50630934|FG004|Overall Study|Withdrawal by Subject|0|||
25315086|NCT00972179|50630935|FG005|Overall Study|Withdrawal by Subject|0|||
25315087|NCT00972179|50630936|FG006|Overall Study|Withdrawal by Subject|2|||
25315088|NCT00972179|50630930|FG000|Overall Study|Administrative Decision|0|||
25315089|NCT00972179|50630931|FG001|Overall Study|Administrative Decision|0|||
25315090|NCT00972179|50630932|FG002|Overall Study|Administrative Decision|0|||
25315091|NCT00972179|50630933|FG003|Overall Study|Administrative Decision|0|||
25315092|NCT00972179|50630934|FG004|Overall Study|Administrative Decision|1|||
25315093|NCT00972179|50630935|FG005|Overall Study|Administrative Decision|0|||
25315094|NCT00972179|50630936|FG006|Overall Study|Administrative Decision|0|||
25315095|NCT00972179|50630930|FG000|Overall Study|Lost to Follow-up|0|||
25315096|NCT00972179|50630931|FG001|Overall Study|Lost to Follow-up|0|||
25315097|NCT00972179|50630932|FG002|Overall Study|Lost to Follow-up|1|||
25315098|NCT00972179|50630933|FG003|Overall Study|Lost to Follow-up|0|||
25198086|NCT02525094|50403111|FG000|Overall Study|Lost to Follow-up|2|||
25198087|NCT02525094|50403112|FG001|Overall Study|Lost to Follow-up|1|||
25198088|NCT02525094|50403111|FG000|Overall Study|Withdrawal by Subject|5|||
25198089|NCT02525094|50403112|FG001|Overall Study|Withdrawal by Subject|6|||
25315099|NCT00972179|50630934|FG004|Overall Study|Lost to Follow-up|0|||
25198090|NCT02525094|50403111|FG000|Overall Study|Not Treated|1|||
25198091|NCT02525094|50403112|FG001|Overall Study|Not Treated|1|||
25198092|NCT01657266|50403269|FG000|Overall Study|Lost to Follow-up|2|||
25198093|NCT01657266|50403270|FG001|Overall Study|Lost to Follow-up|2|||
25198094|NCT01657266|50403269|FG000|Overall Study|Adverse Event|2|||
25198095|NCT01657266|50403270|FG001|Overall Study|Adverse Event|3|||
25198096|NCT01657032|50403355|FG000|Overall Study|Lost to Follow-up|0|||
25198097|NCT01657032|50403356|FG001|Overall Study|Lost to Follow-up|7|||
25198098|NCT01657500|50403484|FG000|Overall Study|set impropperly matched|3|||
25198099|NCT01657500|50403485|FG001|Overall Study|set impropperly matched|3|||
25198100|NCT01657500|50403484|FG000|Overall Study|Lost to Follow-up|2|||
25198101|NCT01657500|50403485|FG001|Overall Study|Lost to Follow-up|2|||
25198102|NCT01658904|50403498|FG000|Overall Study|Principal Investigator discretion|2|||
25198103|NCT01658904|50403499|FG001|Overall Study|Principal Investigator discretion|0|||
25198104|NCT01658904|50403500|FG002|Overall Study|Principal Investigator discretion|0|||
25198105|NCT01658514|50403684|FG000|Overall Study|Protocol Violation|1|||
25198106|NCT01658514|50403685|FG001|Overall Study|Protocol Violation|0|||
25198107|NCT01658514|50403686|FG002|Overall Study|Protocol Violation|2|||
25198108|NCT01658436|50403707|FG000|Overall Study|Adverse Event|6|||
25198109|NCT01658436|50403708|FG001|Overall Study|Adverse Event|5|||
25198110|NCT01658436|50403707|FG000|Overall Study|Physician Decision|1|||
25198111|NCT01658436|50403708|FG001|Overall Study|Physician Decision|0|||
25198112|NCT01658436|50403707|FG000|Overall Study|Progressive disease|12|||
25198113|NCT01658436|50403708|FG001|Overall Study|Progressive disease|4|||
25198114|NCT01658436|50403707|FG000|Overall Study|Study terminated by sponsor|0|||
25198115|NCT01658436|50403708|FG001|Overall Study|Study terminated by sponsor|1|||
25198116|NCT01658436|50403707|FG000|Overall Study|Subject/guardian decision|0|||
25198117|NCT01658436|50403708|FG001|Overall Study|Subject/guardian decision|1|||
25198118|NCT01658436|50403707|FG000|Overall Study|Death|1|||
25198119|NCT01658436|50403708|FG001|Overall Study|Death|0|||
25198120|NCT01656408|50404276|FG000|Overall Study|Adverse Event|0|||
25198121|NCT01656408|50404277|FG001|Overall Study|Adverse Event|0|||
25198122|NCT01656408|50404278|FG002|Overall Study|Adverse Event|1|||
25198123|NCT01656408|50404279|FG003|Overall Study|Adverse Event|0|||
25198124|NCT01656408|50404280|FG004|Overall Study|Adverse Event|0|||
25198125|NCT01656408|50404281|FG005|Overall Study|Adverse Event|1|||
25198126|NCT01656408|50404282|FG006|Overall Study|Adverse Event|1|||
25198127|NCT01656408|50404283|FG007|Overall Study|Adverse Event|0|||
25198128|NCT01656408|50404284|FG008|Overall Study|Adverse Event|1|||
25198129|NCT01656408|50404285|FG009|Overall Study|Adverse Event|0|||
25198130|NCT01656408|50404276|FG000|Overall Study|Physician Decision|1|||
25198131|NCT01656408|50404277|FG001|Overall Study|Physician Decision|0|||
25198132|NCT01656408|50404278|FG002|Overall Study|Physician Decision|1|||
25198133|NCT01656408|50404279|FG003|Overall Study|Physician Decision|0|||
25198134|NCT01656408|50404280|FG004|Overall Study|Physician Decision|1|||
25198135|NCT01656408|50404281|FG005|Overall Study|Physician Decision|1|||
25198136|NCT01656408|50404282|FG006|Overall Study|Physician Decision|0|||
25198137|NCT01656408|50404283|FG007|Overall Study|Physician Decision|1|||
25198138|NCT01656408|50404284|FG008|Overall Study|Physician Decision|1|||
25198139|NCT01656408|50404285|FG009|Overall Study|Physician Decision|3|||
25198140|NCT01364298|50404728|FG000|Overall Study|Adverse Event|3|||
25198141|NCT01364298|50404729|FG001|Overall Study|Adverse Event|4|||
25198142|NCT01364298|50404728|FG000|Overall Study|Lack of adherence to treatment|1|||
25198143|NCT01364298|50404729|FG001|Overall Study|Lack of adherence to treatment|3|||
25198144|NCT01364298|50404728|FG000|Overall Study|Lack of Efficacy|1|||
25198145|NCT01364298|50404729|FG001|Overall Study|Lack of Efficacy|0|||
25198146|NCT01364298|50404728|FG000|Overall Study|Lost to Follow-up|5|||
25198147|NCT01364298|50404729|FG001|Overall Study|Lost to Follow-up|10|||
25198148|NCT01364298|50404728|FG000|Overall Study|Withdrawal by Subject|3|||
25198149|NCT01364298|50404729|FG001|Overall Study|Withdrawal by Subject|3|||
25198150|NCT01364298|50404728|FG000|Overall Study|Other|1|||
25198151|NCT01364298|50404729|FG001|Overall Study|Other|3|||
25198152|NCT01364922|50404788|FG000|Open-label (OL) Period|Adverse Event|7|||
25198153|NCT01364922|50404789|FG001|Open-label (OL) Period|Adverse Event|0|||
25198154|NCT01364922|50404790|FG002|Open-label (OL) Period|Adverse Event|0|||
25198155|NCT01364922|50404788|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
25198156|NCT01364922|50404789|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
25198157|NCT01364922|50404790|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
25198158|NCT01364922|50404788|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
25198159|NCT01364922|50404789|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
25198160|NCT01364922|50404790|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
25198161|NCT01364922|50404788|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
25198162|NCT01364922|50404789|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
25315100|NCT00972179|50630935|FG005|Overall Study|Lost to Follow-up|3|||
25198163|NCT01364922|50404790|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
25198164|NCT01364922|50404788|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
25198165|NCT01364922|50404789|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
25198166|NCT01364922|50404790|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
25198167|NCT01364922|50404788|FG000|Open-label (OL) Period|Other, Unspecified|1|||
25198168|NCT01364922|50404789|FG001|Open-label (OL) Period|Other, Unspecified|0|||
25198169|NCT01364922|50404790|FG002|Open-label (OL) Period|Other, Unspecified|0|||
25198170|NCT01364922|50404788|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
25198171|NCT01364922|50404789|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
25198172|NCT01364922|50404790|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
25198173|NCT01364922|50404788|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
25198174|NCT01364922|50404789|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
25198175|NCT01364922|50404790|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
25198176|NCT01364922|50404788|FG000|Double-Blind (DB) Period|Adverse Event|0|||
25198177|NCT01364922|50404789|FG001|Double-Blind (DB) Period|Adverse Event|0|||
25198178|NCT01364922|50404790|FG002|Double-Blind (DB) Period|Adverse Event|1|||
25198179|NCT01364922|50404788|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
25198180|NCT01364922|50404789|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
25198181|NCT01364922|50404790|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
25198182|NCT02522286|50404964|FG000|Overall Study|Withdrawal by Subject|3|||
25198183|NCT02522286|50404965|FG001|Overall Study|Withdrawal by Subject|0|||
25198184|NCT02522286|50404966|FG002|Overall Study|Withdrawal by Subject|0|||
25198185|NCT02522286|50404967|FG003|Overall Study|Withdrawal by Subject|3|||
25198186|NCT02520726|50404988|FG000|Overall Study|Lost to Follow-up|3|||
25198187|NCT02520726|50404989|FG001|Overall Study|Lost to Follow-up|2|||
25198188|NCT02519712|50405012|FG000|Overall Study|Disease Relapse|1|||
25198189|NCT02519712|50405012|FG000|Overall Study|Disease Progression|1|||
25198190|NCT02519712|50405012|FG000|Overall Study|Accruals are donors|2|||
25198191|NCT02516202|50405255|FG000|Overall Study|Withdrawal by Subject|1|||
25198192|NCT02516202|50405256|FG001|Overall Study|Withdrawal by Subject|0|||
25198193|NCT02516202|50405257|FG002|Overall Study|Withdrawal by Subject|1|||
25198194|NCT02516202|50405255|FG000|Overall Study|Lost to Follow-up|1|||
25198195|NCT02516202|50405256|FG001|Overall Study|Lost to Follow-up|1|||
25198196|NCT02516202|50405257|FG002|Overall Study|Lost to Follow-up|1|||
25198197|NCT02516202|50405255|FG000|Overall Study|Stopped Follow-up|0|||
25198198|NCT02516202|50405256|FG001|Overall Study|Stopped Follow-up|0|||
25198199|NCT02516202|50405257|FG002|Overall Study|Stopped Follow-up|1|||
25198200|NCT02518620|50405463|FG000|Overall Study|Adverse Event|23|||
25198201|NCT02518620|50405464|FG001|Overall Study|Adverse Event|11|||
25198202|NCT02518620|50405463|FG000|Overall Study|Lack of Efficacy|2|||
25198203|NCT02518620|50405464|FG001|Overall Study|Lack of Efficacy|0|||
25198204|NCT02518620|50405463|FG000|Overall Study|Non-Compliance with Study Drug|1|||
25198205|NCT02518620|50405464|FG001|Overall Study|Non-Compliance with Study Drug|0|||
25198206|NCT02518620|50405463|FG000|Overall Study|Physician Decision|1|||
25198207|NCT02518620|50405464|FG001|Overall Study|Physician Decision|1|||
25198208|NCT02518620|50405463|FG000|Overall Study|Sponsor's Decision|0|||
25198209|NCT02518620|50405464|FG001|Overall Study|Sponsor's Decision|3|||
25198210|NCT02518620|50405463|FG000|Overall Study|Lost to Follow-up|1|||
25198211|NCT02518620|50405464|FG001|Overall Study|Lost to Follow-up|1|||
25198212|NCT02518620|50405463|FG000|Overall Study|Withdrawal by Subject|17|||
25198213|NCT02518620|50405464|FG001|Overall Study|Withdrawal by Subject|9|||
25198214|NCT02518620|50405463|FG000|Overall Study|Death|1|||
25198215|NCT02518620|50405464|FG001|Overall Study|Death|0|||
25198216|NCT02518620|50405463|FG000|Overall Study|Pregnancy Wish|3|||
25198217|NCT02518620|50405464|FG001|Overall Study|Pregnancy Wish|0|||
25198218|NCT02518620|50405463|FG000|Overall Study|Pregnancy|1|||
25198219|NCT02518620|50405464|FG001|Overall Study|Pregnancy|0|||
25198220|NCT02518620|50405463|FG000|Overall Study|Relocation|2|||
25198221|NCT02518620|50405464|FG001|Overall Study|Relocation|1|||
25198222|NCT01653912|50405643|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
25198223|NCT01653912|50405644|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
25198224|NCT01653912|50405645|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
25198225|NCT01653912|50405646|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
25198226|NCT01653912|50405647|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
25198227|NCT01653912|50405648|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
25198228|NCT01653912|50405643|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
25198229|NCT01653912|50405644|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
25198230|NCT01653912|50405645|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
25198231|NCT01653912|50405646|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
25198232|NCT01653912|50405647|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
25198233|NCT01653912|50405648|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
25198234|NCT01653912|50405643|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
25198235|NCT01653912|50405644|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
25198236|NCT01653912|50405645|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
25315101|NCT00972179|50630936|FG006|Overall Study|Lost to Follow-up|1|||
25315102|NCT00906698|50630962|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
25198237|NCT01653912|50405646|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
25198238|NCT01653912|50405647|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
25198239|NCT01653912|50405648|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
25198240|NCT01653912|50405643|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
25198241|NCT01653912|50405644|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
25198242|NCT01653912|50405645|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
25198243|NCT01653912|50405646|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
25198244|NCT01653912|50405647|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
25198245|NCT01653912|50405648|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
25198246|NCT01653912|50405643|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
25198247|NCT01653912|50405644|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
25198248|NCT01653912|50405645|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
25198249|NCT01653912|50405646|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
25198250|NCT01653912|50405647|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
25198251|NCT01653912|50405648|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
25198252|NCT01653912|50405643|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
25198253|NCT01653912|50405644|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
25198254|NCT01653912|50405645|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
25198255|NCT01653912|50405646|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
25198256|NCT01653912|50405647|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
25198257|NCT01653912|50405648|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
25198258|NCT01653912|50405643|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
25198259|NCT01653912|50405644|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
25198260|NCT01653912|50405645|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
25198261|NCT01653912|50405646|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
25198262|NCT01653912|50405647|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
25198263|NCT01653912|50405648|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
25198264|NCT02483520|50405674|FG000|Overall Study|Lost to Follow-up|3|||
25198265|NCT02483520|50405675|FG001|Overall Study|Lost to Follow-up|4|||
25198266|NCT02483520|50405674|FG000|Overall Study|Withdrawal by Subject|4|||
25198267|NCT02483520|50405675|FG001|Overall Study|Withdrawal by Subject|14|||
25198268|NCT02483520|50405674|FG000|Overall Study|Hospitalized|2|||
25198269|NCT02483520|50405675|FG001|Overall Study|Hospitalized|3|||
25198270|NCT02483520|50405674|FG000|Overall Study|Moved to LTC|2|||
25198271|NCT02483520|50405675|FG001|Overall Study|Moved to LTC|3|||
25198272|NCT02514174|50405681|FG000|Overall Study|Patient refused to continue medication|1|||
25198273|NCT02514174|50405681|FG000|Overall Study|Adverse Event|2|||
25198274|NCT02514174|50405681|FG000|Overall Study|Study closed by sponsor|9|||
25198275|NCT02514174|50405681|FG000|Overall Study|Progressive disease|11|||
25198276|NCT02514174|50405681|FG000|Overall Study|Treatment change|1|||
25198277|NCT02514174|50405681|FG000|Overall Study|Treated off study with Afatinib.|1|||
25198278|NCT02482428|50405741|FG000|Overall Study|Lost to Follow-up|4|||
25198279|NCT02482428|50405742|FG001|Overall Study|Lost to Follow-up|9|||
25198280|NCT02482428|50405743|FG002|Overall Study|Lost to Follow-up|1|||
25198281|NCT02482428|50405744|FG003|Overall Study|Lost to Follow-up|2|||
25198282|NCT02482428|50405745|FG004|Overall Study|Lost to Follow-up|4|||
25198283|NCT02482428|50405741|FG000|Overall Study|Physician Decision|0|||
25198284|NCT02482428|50405742|FG001|Overall Study|Physician Decision|0|||
25198285|NCT02482428|50405743|FG002|Overall Study|Physician Decision|0|||
25198286|NCT02482428|50405744|FG003|Overall Study|Physician Decision|0|||
25198287|NCT02482428|50405745|FG004|Overall Study|Physician Decision|1|||
25198288|NCT02482428|50405741|FG000|Overall Study|protocol deviation|1|||
25198289|NCT02482428|50405742|FG001|Overall Study|protocol deviation|1|||
25198290|NCT02482428|50405743|FG002|Overall Study|protocol deviation|0|||
25198291|NCT02482428|50405744|FG003|Overall Study|protocol deviation|0|||
25198292|NCT02482428|50405745|FG004|Overall Study|protocol deviation|0|||
25198293|NCT02482428|50405741|FG000|Overall Study|subject/guardian decision|4|||
25198294|NCT02482428|50405742|FG001|Overall Study|subject/guardian decision|2|||
25198295|NCT02482428|50405743|FG002|Overall Study|subject/guardian decision|0|||
25198296|NCT02482428|50405744|FG003|Overall Study|subject/guardian decision|0|||
25315103|NCT00906698|50630963|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
25315104|NCT00906698|50630964|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
25315105|NCT00906698|50630965|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
25077028|NCT02499146|50184813|FG000|Overall Study|Began other treatment/therapy|13|||
25077029|NCT03544138|50184817|FG000|Overall Study|Lost to Follow-up|29|||
25077030|NCT01634854|50184823|FG000|Overall Study|Cesarean delivery|2|||
25077031|NCT01634854|50184824|FG001|Overall Study|Cesarean delivery|7|||
25077032|NCT02469896|50184832|FG000|Overall Study|Withdrawal by Subject|2|||
25077033|NCT02469896|50184833|FG001|Overall Study|Withdrawal by Subject|0|||
25077034|NCT02441114|50184843|FG000|Washout2|Withdrawal by Subject|4|||
25077035|NCT02498678|50184849|FG000|Overall Study|interference from the surgical team|0|||
25077036|NCT02498678|50184850|FG001|Overall Study|interference from the surgical team|2|||
25198297|NCT02482428|50405745|FG004|Overall Study|subject/guardian decision|2|||
25198298|NCT02480712|50405804|FG000|Overall Study|Enrolled but Never Treated|1|||
25198299|NCT02480712|50405804|FG000|Overall Study|Lost to Follow-up|5|||
25198300|NCT02480712|50405804|FG000|Overall Study|Withdrew Consent|3|||
25077037|NCT02441036|50184861|FG000|Overall Study|No tissue resected|0|||
25077038|NCT02441036|50184862|FG001|Overall Study|No tissue resected|1|||
25198301|NCT02480712|50405804|FG000|Overall Study|Death|1|||
25198302|NCT02480712|50405804|FG000|Overall Study|Lack of Efficacy|1|||
25198303|NCT02513550|50407122|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
25198304|NCT02513550|50407123|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
25198305|NCT02513550|50407124|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
25198306|NCT02513550|50407125|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
25198307|NCT02513550|50407126|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
25198308|NCT02513550|50407127|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
25198309|NCT02513550|50407122|FG000|Double Blind Treatment Period|Adverse Event|5|||
25198310|NCT02513550|50407123|FG001|Double Blind Treatment Period|Adverse Event|13|||
25198311|NCT02513550|50407124|FG002|Double Blind Treatment Period|Adverse Event|17|||
25198312|NCT02513550|50407125|FG003|Double Blind Treatment Period|Adverse Event|0|||
25198313|NCT02513550|50407126|FG004|Double Blind Treatment Period|Adverse Event|1|||
25198314|NCT02513550|50407127|FG005|Double Blind Treatment Period|Adverse Event|0|||
25198315|NCT02513550|50407122|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
25198316|NCT02513550|50407123|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
25198317|NCT02513550|50407124|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
25198318|NCT02513550|50407125|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
25198319|NCT02513550|50407126|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
25198320|NCT02513550|50407127|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
25198321|NCT02513550|50407122|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
25198322|NCT02513550|50407123|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
25198323|NCT02513550|50407124|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
25198324|NCT02513550|50407125|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
25198325|NCT02513550|50407126|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
25198326|NCT02513550|50407127|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
25198327|NCT02513550|50407122|FG000|Double Blind Treatment Period|Protocol Violation|1|||
25198328|NCT02513550|50407123|FG001|Double Blind Treatment Period|Protocol Violation|1|||
25198329|NCT02513550|50407124|FG002|Double Blind Treatment Period|Protocol Violation|4|||
25198330|NCT02513550|50407125|FG003|Double Blind Treatment Period|Protocol Violation|0|||
25198331|NCT02513550|50407126|FG004|Double Blind Treatment Period|Protocol Violation|0|||
25198332|NCT02513550|50407127|FG005|Double Blind Treatment Period|Protocol Violation|0|||
25198333|NCT02513550|50407122|FG000|Double Blind Treatment Period|Physician Decision|2|||
25198334|NCT02513550|50407123|FG001|Double Blind Treatment Period|Physician Decision|0|||
25198335|NCT02513550|50407124|FG002|Double Blind Treatment Period|Physician Decision|4|||
25198336|NCT02513550|50407125|FG003|Double Blind Treatment Period|Physician Decision|0|||
25198337|NCT02513550|50407126|FG004|Double Blind Treatment Period|Physician Decision|0|||
25198338|NCT02513550|50407127|FG005|Double Blind Treatment Period|Physician Decision|0|||
25198339|NCT02513550|50407122|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
25198340|NCT02513550|50407123|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
25198341|NCT02513550|50407124|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
25198342|NCT02513550|50407125|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
25198343|NCT02513550|50407126|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
25198344|NCT02513550|50407127|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
25198345|NCT02513550|50407122|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
25198346|NCT02513550|50407123|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
25198347|NCT02513550|50407124|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
25198348|NCT02513550|50407125|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
25198349|NCT02513550|50407126|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
25198350|NCT02513550|50407127|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
25198351|NCT02513550|50407122|FG000|Double Blind Treatment Period|Due to personal business|2|||
25198352|NCT02513550|50407123|FG001|Double Blind Treatment Period|Due to personal business|0|||
25198353|NCT02513550|50407124|FG002|Double Blind Treatment Period|Due to personal business|1|||
25198354|NCT02513550|50407125|FG003|Double Blind Treatment Period|Due to personal business|0|||
25198355|NCT02513550|50407126|FG004|Double Blind Treatment Period|Due to personal business|0|||
25198356|NCT02513550|50407127|FG005|Double Blind Treatment Period|Due to personal business|0|||
25198357|NCT02513550|50407122|FG000|Double Blind Treatment Period|Death|1|||
25198358|NCT02513550|50407123|FG001|Double Blind Treatment Period|Death|0|||
25198359|NCT02513550|50407124|FG002|Double Blind Treatment Period|Death|2|||
25198360|NCT02513550|50407125|FG003|Double Blind Treatment Period|Death|0|||
25198361|NCT02513550|50407126|FG004|Double Blind Treatment Period|Death|0|||
25198362|NCT02513550|50407127|FG005|Double Blind Treatment Period|Death|0|||
25198363|NCT02513550|50407122|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
25315106|NCT00906698|50630966|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
25315107|NCT00906698|50630967|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
25198364|NCT02513550|50407123|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
25198365|NCT02513550|50407124|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
25198366|NCT02513550|50407125|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
25198367|NCT02513550|50407126|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
25198368|NCT02513550|50407127|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
25198369|NCT02513550|50407122|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
25198370|NCT02513550|50407123|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
25198371|NCT02513550|50407124|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
25198372|NCT02513550|50407125|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
25198373|NCT02513550|50407126|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
25198374|NCT02513550|50407127|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
25198375|NCT02513550|50407122|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
25198376|NCT02513550|50407123|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
25198377|NCT02513550|50407124|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
25198378|NCT02513550|50407125|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
25198379|NCT02513550|50407126|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
25198380|NCT02513550|50407127|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
25198381|NCT02513550|50407122|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
25077039|NCT02441036|50184863|FG002|Overall Study|No tissue resected|0|||
25077040|NCT02441036|50184864|FG003|Overall Study|No tissue resected|1|||
25077041|NCT02441036|50184865|FG004|Overall Study|No tissue resected|0|||
25077042|NCT02498444|50184880|FG000|Overall Study|Withdrawal by Subject|3|||
25077043|NCT02498444|50184881|FG001|Overall Study|Withdrawal by Subject|0|||
25077044|NCT02498444|50184880|FG000|Overall Study|Physician Decision|1|||
25077045|NCT02498444|50184881|FG001|Overall Study|Physician Decision|0|||
25198382|NCT02513550|50407123|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
25198383|NCT02513550|50407124|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
25198384|NCT02513550|50407125|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
25198385|NCT02513550|50407126|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
25198386|NCT02513550|50407127|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
25198387|NCT02513550|50407122|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
25198388|NCT02513550|50407123|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
25198389|NCT02513550|50407124|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
25198390|NCT02513550|50407125|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
25198391|NCT02513550|50407126|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
25198392|NCT02513550|50407127|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
25198393|NCT02513550|50407122|FG000|Post-Treatment Follow-up Period|Death|0|||
25198394|NCT02513550|50407123|FG001|Post-Treatment Follow-up Period|Death|0|||
25198395|NCT02513550|50407124|FG002|Post-Treatment Follow-up Period|Death|1|||
25198396|NCT02513550|50407125|FG003|Post-Treatment Follow-up Period|Death|0|||
25198397|NCT02513550|50407126|FG004|Post-Treatment Follow-up Period|Death|0|||
25198398|NCT02513550|50407127|FG005|Post-Treatment Follow-up Period|Death|0|||
25198399|NCT02513550|50407122|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
25198400|NCT02513550|50407123|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
25198401|NCT02513550|50407124|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
25198402|NCT02513550|50407125|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
25198403|NCT02513550|50407126|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
25198404|NCT02513550|50407127|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
25198405|NCT02513550|50407122|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
25198406|NCT02513550|50407123|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
25198407|NCT02513550|50407124|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
25198408|NCT02513550|50407125|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
25198409|NCT02513550|50407126|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
25198410|NCT02513550|50407127|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
25198411|NCT02513550|50407122|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
25198412|NCT02513550|50407123|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
25198413|NCT02513550|50407124|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
25315108|NCT00906698|50630962|FG000|Overall Study|Adverse Event|0|||
25315109|NCT00906698|50630963|FG001|Overall Study|Adverse Event|0|||
25315110|NCT00906698|50630964|FG002|Overall Study|Adverse Event|2|||
25315111|NCT00906698|50630965|FG003|Overall Study|Adverse Event|0|||
25198414|NCT02513550|50407125|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
25198415|NCT02513550|50407126|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
25198416|NCT02513550|50407127|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
25198417|NCT02513472|50407453|FG000|Overall Study|Radiological Disease Progression|45|||
25198418|NCT02513472|50407454|FG001|Overall Study|Radiological Disease Progression|57|||
25198419|NCT02513472|50407453|FG000|Overall Study|Clinical Disease Progression|5|||
25198420|NCT02513472|50407454|FG001|Overall Study|Clinical Disease Progression|13|||
25315112|NCT00906698|50630966|FG004|Overall Study|Adverse Event|4|||
25315113|NCT00906698|50630967|FG005|Overall Study|Adverse Event|1|||
25077046|NCT02497976|50184889|FG000|Overall Study|Withdrawal by Subject|2|||
25077047|NCT02497976|50184890|FG001|Overall Study|Withdrawal by Subject|0|||
25198421|NCT02513472|50407453|FG000|Overall Study|Adverse Event|8|||
25198422|NCT02513472|50407454|FG001|Overall Study|Adverse Event|11|||
25198423|NCT02513472|50407453|FG000|Overall Study|Withdrawal by Subject|0|||
25198424|NCT02513472|50407454|FG001|Overall Study|Withdrawal by Subject|4|||
25198425|NCT02513472|50407453|FG000|Overall Study|Subject Choice|2|||
25198426|NCT02513472|50407454|FG001|Overall Study|Subject Choice|7|||
25198427|NCT02513472|50407453|FG000|Overall Study|Treatment Completed as per Protocol|3|||
25198428|NCT02513472|50407454|FG001|Overall Study|Treatment Completed as per Protocol|3|||
25198429|NCT02513472|50407453|FG000|Overall Study|Other|3|||
25198430|NCT02513472|50407454|FG001|Overall Study|Other|6|||
25198431|NCT04490395|50407683|FG000|Overall Study|Lost to Follow-up|0|||
25198432|NCT04490395|50407684|FG001|Overall Study|Lost to Follow-up|1|||
25198433|NCT03843541|50408127|FG000|Overall Study|Adverse Event|4|||
25198434|NCT03843541|50408128|FG001|Overall Study|Adverse Event|2|||
25198435|NCT03843541|50408129|FG002|Overall Study|Adverse Event|3|||
25198436|NCT03843541|50408127|FG000|Overall Study|Death|1|||
25198437|NCT03843541|50408128|FG001|Overall Study|Death|0|||
25198438|NCT03843541|50408129|FG002|Overall Study|Death|0|||
25198439|NCT03843541|50408127|FG000|Overall Study|Lack of adherence to study medication|0|||
25198440|NCT03843541|50408128|FG001|Overall Study|Lack of adherence to study medication|0|||
25198441|NCT03843541|50408129|FG002|Overall Study|Lack of adherence to study medication|1|||
25198442|NCT03843541|50408127|FG000|Overall Study|Physician Decision|1|||
25198443|NCT03843541|50408128|FG001|Overall Study|Physician Decision|2|||
25198444|NCT03843541|50408129|FG002|Overall Study|Physician Decision|2|||
25198445|NCT03843541|50408127|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
25198446|NCT03843541|50408128|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
25198447|NCT03843541|50408129|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
25198448|NCT03843541|50408127|FG000|Overall Study|Withdrawal by Subject|6|||
25198449|NCT03843541|50408128|FG001|Overall Study|Withdrawal by Subject|9|||
25198450|NCT03843541|50408129|FG002|Overall Study|Withdrawal by Subject|7|||
25198451|NCT03843541|50408127|FG000|Overall Study|Administration of rescue mucolytic|0|||
25198452|NCT03843541|50408128|FG001|Overall Study|Administration of rescue mucolytic|0|||
25198453|NCT03843541|50408129|FG002|Overall Study|Administration of rescue mucolytic|1|||
25198454|NCT03843541|50408127|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
25198455|NCT03843541|50408128|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
25198456|NCT03843541|50408129|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
25198457|NCT02992418|50409392|FG000|Overall Study|Withdrawal by Subject|11|||
25198458|NCT02992418|50409393|FG001|Overall Study|Withdrawal by Subject|12|||
25198459|NCT02992418|50409392|FG000|Overall Study|Non-compliance with the protocol|308|||
25198460|NCT02992418|50409393|FG001|Overall Study|Non-compliance with the protocol|308|||
25198461|NCT02992418|50409392|FG000|Overall Study|Lost to Follow-up|27|||
25198462|NCT02992418|50409393|FG001|Overall Study|Lost to Follow-up|22|||
25198463|NCT01276106|50409635|FG000|Overall Study|Adverse Event|3|||
25198464|NCT01276106|50409636|FG001|Overall Study|Adverse Event|3|||
25198465|NCT01276106|50409637|FG002|Overall Study|Adverse Event|11|||
25198466|NCT01276106|50409638|FG003|Overall Study|Adverse Event|3|||
25198467|NCT01276106|50409635|FG000|Overall Study|Withdrawal by Subject|6|||
25198468|NCT01276106|50409636|FG001|Overall Study|Withdrawal by Subject|3|||
25198469|NCT01276106|50409637|FG002|Overall Study|Withdrawal by Subject|1|||
25198470|NCT01276106|50409638|FG003|Overall Study|Withdrawal by Subject|6|||
25198471|NCT01276106|50409635|FG000|Overall Study|Lack of Efficacy|0|||
25198472|NCT01276106|50409636|FG001|Overall Study|Lack of Efficacy|1|||
25198473|NCT01276106|50409637|FG002|Overall Study|Lack of Efficacy|0|||
25198474|NCT01276106|50409638|FG003|Overall Study|Lack of Efficacy|1|||
25198475|NCT01276106|50409635|FG000|Overall Study|Lost to Follow-up|2|||
25198476|NCT01276106|50409636|FG001|Overall Study|Lost to Follow-up|1|||
25198477|NCT01276106|50409637|FG002|Overall Study|Lost to Follow-up|1|||
25198478|NCT01276106|50409638|FG003|Overall Study|Lost to Follow-up|0|||
25198479|NCT01276106|50409635|FG000|Overall Study|Physician Decision|0|||
25315114|NCT00906698|50630962|FG000|Overall Study|Disease progression|3|||
25315115|NCT00906698|50630963|FG001|Overall Study|Disease progression|12|||
25198480|NCT01276106|50409636|FG001|Overall Study|Physician Decision|0|||
25198481|NCT01276106|50409637|FG002|Overall Study|Physician Decision|1|||
25198482|NCT01276106|50409638|FG003|Overall Study|Physician Decision|1|||
25198483|NCT01276106|50409635|FG000|Overall Study|Protocol Violation|1|||
25198484|NCT01276106|50409636|FG001|Overall Study|Protocol Violation|1|||
25198485|NCT01276106|50409637|FG002|Overall Study|Protocol Violation|0|||
25198486|NCT01276106|50409638|FG003|Overall Study|Protocol Violation|2|||
25198487|NCT01276106|50409635|FG000|Overall Study|Insufficient therapeutic effects|0|||
25315116|NCT00906698|50630964|FG002|Overall Study|Disease progression|4|||
25198488|NCT01276106|50409636|FG001|Overall Study|Insufficient therapeutic effects|0|||
25198489|NCT01276106|50409637|FG002|Overall Study|Insufficient therapeutic effects|2|||
25198490|NCT01276106|50409638|FG003|Overall Study|Insufficient therapeutic effects|0|||
25198491|NCT01275170|50409656|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
25198492|NCT01275170|50409657|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
25198493|NCT01275170|50409658|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
25198494|NCT01275170|50409659|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
25198495|NCT01275170|50409660|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
25198496|NCT01275170|50409661|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
25198497|NCT01275170|50409662|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
25198498|NCT01275170|50409663|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
25198499|NCT01273064|50409710|FG000|Overall Study|Adverse Event|5|||
25198500|NCT01273064|50409711|FG001|Overall Study|Adverse Event|1|||
25198501|NCT01273064|50409712|FG002|Overall Study|Adverse Event|3|||
25198502|NCT01273064|50409713|FG003|Overall Study|Adverse Event|2|||
25198503|NCT01273064|50409714|FG004|Overall Study|Adverse Event|1|||
25198504|NCT01273064|50409710|FG000|Overall Study|Withdrawal by Subject|4|||
25198505|NCT01273064|50409711|FG001|Overall Study|Withdrawal by Subject|2|||
25198506|NCT01273064|50409712|FG002|Overall Study|Withdrawal by Subject|2|||
25198507|NCT01273064|50409713|FG003|Overall Study|Withdrawal by Subject|2|||
25198508|NCT01273064|50409714|FG004|Overall Study|Withdrawal by Subject|0|||
25198509|NCT01273064|50409710|FG000|Overall Study|Study Termination|13|||
25198510|NCT01273064|50409711|FG001|Overall Study|Study Termination|27|||
25198511|NCT01273064|50409712|FG002|Overall Study|Study Termination|26|||
25198512|NCT01273064|50409713|FG003|Overall Study|Study Termination|16|||
25198513|NCT01273064|50409714|FG004|Overall Study|Study Termination|8|||
25198514|NCT01273064|50409710|FG000|Overall Study|Lost to Follow-up|1|||
25198515|NCT01273064|50409711|FG001|Overall Study|Lost to Follow-up|0|||
25198516|NCT01273064|50409712|FG002|Overall Study|Lost to Follow-up|0|||
25198517|NCT01273064|50409713|FG003|Overall Study|Lost to Follow-up|0|||
25198518|NCT01273064|50409714|FG004|Overall Study|Lost to Follow-up|0|||
25198519|NCT01273064|50409710|FG000|Overall Study|Physician Decision|0|||
25198520|NCT01273064|50409711|FG001|Overall Study|Physician Decision|0|||
25198521|NCT01273064|50409712|FG002|Overall Study|Physician Decision|0|||
25198522|NCT01273064|50409713|FG003|Overall Study|Physician Decision|0|||
25198523|NCT01273064|50409714|FG004|Overall Study|Physician Decision|1|||
25198524|NCT01272908|50409726|FG000|Initial Treatment Period|Adverse Event|1|||
25198525|NCT01272908|50409726|FG000|Initial Treatment Period|Lack of Efficacy|5|||
25198526|NCT01272908|50409726|FG000|Initial Treatment Period|Protocol Violation|1|||
25198527|NCT01272908|50409726|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
25198528|NCT01272908|50409726|FG000|Re-Treatment Period|Adverse Event|2|||
25198529|NCT01272908|50409726|FG000|Re-Treatment Period|Lack of Efficacy|3|||
25198530|NCT01272908|50409726|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
25198531|NCT01271504|50409736|FG000|Overall Study|Death|7|||
25198532|NCT01271504|50409737|FG001|Overall Study|Death|6|||
25198533|NCT01271504|50409738|FG002|Overall Study|Death|32|||
25170920|NCT00557830|50307788|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
25170921|NCT00557830|50307786|FG000|Screening Treatment Phase|Adverse Event|2|||
25170922|NCT00557830|50307787|FG001|Screening Treatment Phase|Adverse Event|0|||
25170923|NCT00557830|50307788|FG002|Screening Treatment Phase|Adverse Event|0|||
25170924|NCT00557830|50307786|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
25170925|NCT00557830|50307787|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
25170926|NCT00557830|50307788|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
25170927|NCT00557440|50307799|FG000|Treatment Period 1|Adverse Event|0|||
25170928|NCT00557440|50307800|FG001|Treatment Period 1|Adverse Event|0|||
25170929|NCT00557440|50307801|FG002|Treatment Period 1|Adverse Event|1|||
25170930|NCT00556894|50307812|FG000|Overall Study|Adverse Event|2|||
25170931|NCT00556894|50307813|FG001|Overall Study|Adverse Event|3|||
25170932|NCT00556894|50307814|FG002|Overall Study|Adverse Event|3|||
25170933|NCT00556894|50307812|FG000|Overall Study|Death|1|||
25170934|NCT00556894|50307813|FG001|Overall Study|Death|0|||
25170935|NCT00556894|50307814|FG002|Overall Study|Death|0|||
25198534|NCT01271504|50409739|FG003|Overall Study|Death|32|||
25198535|NCT01271504|50409736|FG000|Overall Study|Lost to Follow-up|0|||
25198536|NCT01271504|50409737|FG001|Overall Study|Lost to Follow-up|1|||
25198537|NCT01271504|50409738|FG002|Overall Study|Lost to Follow-up|3|||
25198538|NCT01271504|50409739|FG003|Overall Study|Lost to Follow-up|1|||
25198539|NCT01271504|50409736|FG000|Overall Study|Protocol Violation|0|||
25198540|NCT01271504|50409737|FG001|Overall Study|Protocol Violation|0|||
25198541|NCT01271504|50409738|FG002|Overall Study|Protocol Violation|0|||
25198542|NCT01271504|50409739|FG003|Overall Study|Protocol Violation|2|||
25198543|NCT01271504|50409736|FG000|Overall Study|Administrative Reasons|0|||
25198544|NCT01271504|50409737|FG001|Overall Study|Administrative Reasons|0|||
25198545|NCT01271504|50409738|FG002|Overall Study|Administrative Reasons|6|||
25198546|NCT01271504|50409739|FG003|Overall Study|Administrative Reasons|5|||
25198547|NCT01271504|50409736|FG000|Overall Study|Withdrawal by Subject|0|||
25198548|NCT01271504|50409737|FG001|Overall Study|Withdrawal by Subject|0|||
25198549|NCT01271504|50409738|FG002|Overall Study|Withdrawal by Subject|1|||
25198550|NCT01271504|50409739|FG003|Overall Study|Withdrawal by Subject|3|||
25198551|NCT01271504|50409736|FG000|Overall Study|Other|0|||
25198552|NCT01271504|50409737|FG001|Overall Study|Other|1|||
25198553|NCT01271504|50409738|FG002|Overall Study|Other|2|||
25198554|NCT01271504|50409739|FG003|Overall Study|Other|0|||
25198555|NCT01270958|50409782|FG000|Overall Study|Lost to Follow-up|2|||
25198556|NCT01270958|50409782|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
25198557|NCT01270880|50409786|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
25198558|NCT01270802|50409792|FG000|Overall Study|Withdrawal by Subject|1|||
25198559|NCT01270802|50409793|FG001|Overall Study|Withdrawal by Subject|0|||
25198560|NCT01270802|50409792|FG000|Overall Study|Adverse Event|1|||
25198561|NCT01270802|50409793|FG001|Overall Study|Adverse Event|0|||
25198562|NCT01270802|50409792|FG000|Overall Study|Lost to Follow-up|0|||
25198563|NCT01270802|50409793|FG001|Overall Study|Lost to Follow-up|1|||
25198564|NCT01270256|50409802|FG000|Overall Study|Withdrawal by Subject|1|||
25198565|NCT01270256|50409803|FG001|Overall Study|Withdrawal by Subject|0|||
25198566|NCT01279616|50409873|FG000|Overall Study|donor could not be located|5|||
25198567|NCT01279616|50409873|FG000|Overall Study|no signs of sickle cell disease|2|||
25198568|NCT01279070|50409884|FG000|Overall Study|Withdrawal by Subject|2|||
25198569|NCT01279070|50409885|FG001|Overall Study|Withdrawal by Subject|3|||
25198570|NCT01279070|50409884|FG000|Overall Study|Acute exacerbation|3|||
25198571|NCT01279070|50409885|FG001|Overall Study|Acute exacerbation|1|||
25198572|NCT01277744|50409895|FG000|Overall Study|Physician Decision|2|||
25198573|NCT01277822|50409901|FG000|Overall Study|Adverse Event|2|||
25198574|NCT01277822|50409902|FG001|Overall Study|Adverse Event|1|||
25198575|NCT01277822|50409901|FG000|Overall Study|Withdrawal by Subject|6|||
25198576|NCT01277822|50409902|FG001|Overall Study|Withdrawal by Subject|7|||
25198577|NCT01277822|50409901|FG000|Overall Study|Physician Decision|1|||
25198578|NCT01277822|50409902|FG001|Overall Study|Physician Decision|1|||
25198579|NCT01277822|50409901|FG000|Overall Study|Protocol Violation|1|||
25198580|NCT01277822|50409902|FG001|Overall Study|Protocol Violation|0|||
25198581|NCT01277822|50409901|FG000|Overall Study|Lost to Follow-up|2|||
25198582|NCT01277822|50409902|FG001|Overall Study|Lost to Follow-up|1|||
25198583|NCT01277822|50409901|FG000|Overall Study|Contraindicated medication used|2|||
25198584|NCT01277822|50409902|FG001|Overall Study|Contraindicated medication used|1|||
25315117|NCT00906698|50630965|FG003|Overall Study|Disease progression|4|||
25315118|NCT00906698|50630966|FG004|Overall Study|Disease progression|12|||
25315119|NCT00906698|50630967|FG005|Overall Study|Disease progression|4|||
25315120|NCT00906698|50630962|FG000|Overall Study|Withdrawal by Subject|0|||
25315121|NCT00906698|50630963|FG001|Overall Study|Withdrawal by Subject|0|||
25315122|NCT00906698|50630964|FG002|Overall Study|Withdrawal by Subject|0|||
25315123|NCT00906698|50630965|FG003|Overall Study|Withdrawal by Subject|0|||
25315124|NCT00906698|50630966|FG004|Overall Study|Withdrawal by Subject|1|||
25315125|NCT00906698|50630967|FG005|Overall Study|Withdrawal by Subject|0|||
25315126|NCT00906698|50630962|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
25315127|NCT00906698|50630963|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
25315128|NCT00906698|50630964|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
25315129|NCT00906698|50630965|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
25315130|NCT00906698|50630966|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
25315131|NCT00906698|50630967|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
25315132|NCT00972023|50630999|FG000|Overall Study|Withdrawal by Subject|1|||
25315133|NCT00971945|50631005|FG000|Overall Study|Progressive Disease|3|||
25315134|NCT00971945|50631005|FG000|Overall Study|Change in treatment policy|1|||
25315135|NCT00971945|50631005|FG000|Overall Study|Other reasons|2|||
25315136|NCT00971867|50631009|FG000|Overall Study|Adverse Event|4|||
25315137|NCT00971867|50631009|FG000|Overall Study|Participant Withdrew Consent|1|||
25315138|NCT00971867|50631009|FG000|Overall Study|Disease Progression|6|||
25315139|NCT00971321|50631015|FG000|Up to Month 7|Withdrawal by Subject|1|||
25315140|NCT00971321|50631016|FG001|Up to Month 7|Withdrawal by Subject|0|||
25315141|NCT00971321|50631015|FG000|Up to Month 7|Migrated/moved from study area|3|||
25315142|NCT00971321|50631016|FG001|Up to Month 7|Migrated/moved from study area|2|||
25315143|NCT00971321|50631015|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
25315144|NCT00971321|50631016|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
25315145|NCT00971321|50631015|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
25198585|NCT01277822|50409901|FG000|Overall Study|Participant moved|1|||
25198586|NCT01277822|50409902|FG001|Overall Study|Participant moved|0|||
25198587|NCT01277666|50409911|FG000|Overall Study|Adverse Event|26|||
25198588|NCT01277666|50409912|FG001|Overall Study|Adverse Event|25|||
25198589|NCT01277666|50409913|FG002|Overall Study|Adverse Event|20|||
25198590|NCT01277666|50409911|FG000|Overall Study|Lack of Efficacy|8|||
25315146|NCT00971321|50631016|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
25315147|NCT00971321|50631015|FG000|Up to Month 11-12|Lost to Follow-up|1|||
25315148|NCT00971321|50631016|FG001|Up to Month 11-12|Lost to Follow-up|0|||
25315149|NCT00648739|50631022|FG000|Overall Study|Adverse Event|1|||
25315150|NCT00648739|50631023|FG001|Overall Study|Adverse Event|0|||
25198591|NCT01277666|50409912|FG001|Overall Study|Lack of Efficacy|20|||
25198592|NCT01277666|50409913|FG002|Overall Study|Lack of Efficacy|12|||
25198593|NCT01277666|50409911|FG000|Overall Study|Protocol Violation|2|||
25198594|NCT01277666|50409912|FG001|Overall Study|Protocol Violation|3|||
25198595|NCT01277666|50409913|FG002|Overall Study|Protocol Violation|2|||
25198596|NCT01277666|50409911|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
25198597|NCT01277666|50409912|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
25198598|NCT01277666|50409913|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
25198599|NCT01277666|50409911|FG000|Overall Study|Lost to Follow-up|1|||
25198600|NCT01277666|50409912|FG001|Overall Study|Lost to Follow-up|1|||
25198601|NCT01277666|50409913|FG002|Overall Study|Lost to Follow-up|2|||
25198602|NCT01277666|50409911|FG000|Overall Study|Withdrawal by Subject|7|||
25198603|NCT01277666|50409912|FG001|Overall Study|Withdrawal by Subject|8|||
25198604|NCT01277666|50409913|FG002|Overall Study|Withdrawal by Subject|6|||
25198605|NCT01277666|50409911|FG000|Overall Study|Death|0|||
25198606|NCT01277666|50409912|FG001|Overall Study|Death|0|||
25198607|NCT01277666|50409913|FG002|Overall Study|Death|1|||
25198608|NCT00249002|50409921|FG000|Overall Study|Adverse Event|2|||
25198609|NCT00249002|50409921|FG000|Overall Study|Study cancellation|3|||
25198610|NCT00249002|50409921|FG000|Overall Study|Other|2|||
25198611|NCT01277042|50409927|FG000|Overall Study|Adverse Event|4|||
25198612|NCT01277042|50409928|FG001|Overall Study|Adverse Event|3|||
25198613|NCT01277042|50409927|FG000|Overall Study|Lost to Follow-up|2|||
25198614|NCT01277042|50409928|FG001|Overall Study|Lost to Follow-up|2|||
25198615|NCT01277042|50409927|FG000|Overall Study|Withdrawal by Subject|2|||
25315151|NCT00648739|50631024|FG002|Overall Study|Adverse Event|1|||
25315152|NCT00648739|50631025|FG003|Overall Study|Adverse Event|2|||
25315153|NCT00648739|50631026|FG004|Overall Study|Adverse Event|1|||
25315154|NCT00648739|50631027|FG005|Overall Study|Adverse Event|0|||
25315155|NCT00648739|50631028|FG006|Overall Study|Adverse Event|0|||
25315156|NCT00648739|50631022|FG000|Overall Study|Withdrawal by Subject|1|||
25315157|NCT00648739|50631023|FG001|Overall Study|Withdrawal by Subject|0|||
25315158|NCT00648739|50631024|FG002|Overall Study|Withdrawal by Subject|1|||
25315159|NCT00648739|50631025|FG003|Overall Study|Withdrawal by Subject|0|||
25315160|NCT00648739|50631026|FG004|Overall Study|Withdrawal by Subject|0|||
25315161|NCT00648739|50631027|FG005|Overall Study|Withdrawal by Subject|2|||
25315162|NCT00648739|50631028|FG006|Overall Study|Withdrawal by Subject|0|||
25315163|NCT00648739|50631022|FG000|Overall Study|Lack of Efficacy|0|||
25315164|NCT00648739|50631023|FG001|Overall Study|Lack of Efficacy|0|||
25315165|NCT00648739|50631024|FG002|Overall Study|Lack of Efficacy|0|||
25315166|NCT00648739|50631025|FG003|Overall Study|Lack of Efficacy|0|||
25315167|NCT00648739|50631026|FG004|Overall Study|Lack of Efficacy|1|||
25315168|NCT00648739|50631027|FG005|Overall Study|Lack of Efficacy|2|||
25315169|NCT00648739|50631028|FG006|Overall Study|Lack of Efficacy|0|||
25315170|NCT00648739|50631022|FG000|Overall Study|Investigator Considered it Advisable|0|||
25315171|NCT00648739|50631023|FG001|Overall Study|Investigator Considered it Advisable|0|||
25315172|NCT00648739|50631024|FG002|Overall Study|Investigator Considered it Advisable|0|||
25315173|NCT00648739|50631025|FG003|Overall Study|Investigator Considered it Advisable|0|||
25315174|NCT00648739|50631026|FG004|Overall Study|Investigator Considered it Advisable|0|||
25315175|NCT00648739|50631027|FG005|Overall Study|Investigator Considered it Advisable|1|||
25315176|NCT00648739|50631028|FG006|Overall Study|Investigator Considered it Advisable|1|||
25315177|NCT00648739|50631022|FG000|Overall Study|Death|0|||
25315178|NCT00648739|50631023|FG001|Overall Study|Death|1|||
25315179|NCT00648739|50631024|FG002|Overall Study|Death|0|||
25315180|NCT00648739|50631025|FG003|Overall Study|Death|0|||
25315181|NCT00648739|50631026|FG004|Overall Study|Death|0|||
25315182|NCT00648739|50631027|FG005|Overall Study|Death|0|||
25315183|NCT00648739|50631028|FG006|Overall Study|Death|0|||
25315184|NCT00648739|50631022|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
25315185|NCT00648739|50631023|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
25315186|NCT00648739|50631024|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
25315187|NCT00648739|50631025|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
25315188|NCT00648739|50631026|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
25315189|NCT00648739|50631027|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
25315190|NCT00648739|50631028|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
25315191|NCT00648739|50631022|FG000|Overall Study|Follow-up Visits Not Completed|0|||
25315192|NCT00648739|50631023|FG001|Overall Study|Follow-up Visits Not Completed|1|||
25315193|NCT00648739|50631024|FG002|Overall Study|Follow-up Visits Not Completed|0|||
25315194|NCT00648739|50631025|FG003|Overall Study|Follow-up Visits Not Completed|0|||
25315195|NCT00648739|50631026|FG004|Overall Study|Follow-up Visits Not Completed|0|||
25315196|NCT00648739|50631027|FG005|Overall Study|Follow-up Visits Not Completed|0|||
25315197|NCT00648739|50631028|FG006|Overall Study|Follow-up Visits Not Completed|0|||
25198616|NCT01277042|50409928|FG001|Overall Study|Withdrawal by Subject|0|||
25198617|NCT00246740|50409968|FG000|Initial Enrollment|Death|1|||
25198618|NCT00246740|50409969|FG001|Initial Enrollment|Death|0|||
25198619|NCT00246740|50409968|FG000|Initial Enrollment|Additional surgery scheduled|0|||
25315198|NCT00648037|50631049|FG000|Overall Study|Not Treated|1|||
25315199|NCT00648037|50631049|FG000|Overall Study|Withdrawal by Subject|1|||
25198620|NCT00246740|50409969|FG001|Initial Enrollment|Additional surgery scheduled|2|||
25198621|NCT00246740|50409968|FG000|Initial Enrollment|Surgery schedule change|4|||
25198622|NCT00246740|50409969|FG001|Initial Enrollment|Surgery schedule change|4|||
25198623|NCT00246740|50409968|FG000|Initial Enrollment|Other|1|||
25198624|NCT00246740|50409969|FG001|Initial Enrollment|Other|2|||
25198625|NCT00245102|50410014|FG000|Overall Study|Not Treated|1|||
25198626|NCT00245102|50410015|FG001|Overall Study|Not Treated|0|||
25198627|NCT00245102|50410016|FG002|Overall Study|Not Treated|1|||
25198628|NCT00245102|50410017|FG003|Overall Study|Not Treated|0|||
25198629|NCT00245102|50410018|FG004|Overall Study|Not Treated|0|||
25198630|NCT00245102|50410019|FG005|Overall Study|Not Treated|0|||
25198631|NCT00245102|50410014|FG000|Overall Study|Protocol Violation|1|||
25198632|NCT00245102|50410015|FG001|Overall Study|Protocol Violation|0|||
25198633|NCT00245102|50410016|FG002|Overall Study|Protocol Violation|0|||
25198634|NCT00245102|50410017|FG003|Overall Study|Protocol Violation|0|||
25198635|NCT00245102|50410018|FG004|Overall Study|Protocol Violation|0|||
25198636|NCT00245102|50410019|FG005|Overall Study|Protocol Violation|0|||
25198637|NCT00245102|50410014|FG000|Overall Study|Death|0|||
25198638|NCT00245102|50410015|FG001|Overall Study|Death|0|||
25198639|NCT00245102|50410016|FG002|Overall Study|Death|0|||
25198640|NCT00245102|50410017|FG003|Overall Study|Death|1|||
25198641|NCT00245102|50410018|FG004|Overall Study|Death|0|||
25198642|NCT00245102|50410019|FG005|Overall Study|Death|0|||
25198643|NCT00245102|50410014|FG000|Overall Study|Adverse Event|4|||
25198644|NCT00245102|50410015|FG001|Overall Study|Adverse Event|2|||
25198645|NCT00245102|50410016|FG002|Overall Study|Adverse Event|5|||
25198646|NCT00245102|50410017|FG003|Overall Study|Adverse Event|1|||
25198647|NCT00245102|50410018|FG004|Overall Study|Adverse Event|0|||
25198648|NCT00245102|50410019|FG005|Overall Study|Adverse Event|2|||
25198649|NCT00245102|50410014|FG000|Overall Study|Decline in performance|0|||
25198650|NCT00245102|50410015|FG001|Overall Study|Decline in performance|2|||
25198651|NCT00245102|50410016|FG002|Overall Study|Decline in performance|0|||
25198652|NCT00245102|50410017|FG003|Overall Study|Decline in performance|1|||
25198653|NCT00245102|50410018|FG004|Overall Study|Decline in performance|0|||
25198654|NCT00245102|50410019|FG005|Overall Study|Decline in performance|2|||
25198655|NCT00245102|50410014|FG000|Overall Study|Participant needed surgery|0|||
25198656|NCT00245102|50410015|FG001|Overall Study|Participant needed surgery|0|||
25198657|NCT00245102|50410016|FG002|Overall Study|Participant needed surgery|1|||
25198658|NCT00245102|50410017|FG003|Overall Study|Participant needed surgery|0|||
25198659|NCT00245102|50410018|FG004|Overall Study|Participant needed surgery|0|||
25198660|NCT00245102|50410019|FG005|Overall Study|Participant needed surgery|0|||
25198661|NCT00245102|50410014|FG000|Overall Study|Clinical progression|1|||
25198662|NCT00245102|50410015|FG001|Overall Study|Clinical progression|0|||
25198663|NCT00245102|50410016|FG002|Overall Study|Clinical progression|0|||
25198664|NCT00245102|50410017|FG003|Overall Study|Clinical progression|0|||
25198665|NCT00245102|50410018|FG004|Overall Study|Clinical progression|0|||
25198666|NCT00245102|50410019|FG005|Overall Study|Clinical progression|0|||
25198667|NCT00244712|50410064|FG000|Overall Study|Adverse Event|20|||
25198668|NCT00244712|50410065|FG001|Overall Study|Adverse Event|21|||
25198669|NCT00244712|50410064|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
25198670|NCT00244712|50410065|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
25198671|NCT00244712|50410064|FG000|Overall Study|Lack of Compliance|10|||
25198672|NCT00244712|50410065|FG001|Overall Study|Lack of Compliance|11|||
25198673|NCT00244712|50410064|FG000|Overall Study|Lost to Follow-up|45|||
25198674|NCT00244712|50410065|FG001|Overall Study|Lost to Follow-up|52|||
25198675|NCT00244712|50410064|FG000|Overall Study|Withdrawal by Subject|13|||
25198676|NCT00244712|50410065|FG001|Overall Study|Withdrawal by Subject|23|||
25198677|NCT00244712|50410064|FG000|Overall Study|Protocol Violation, disease progression|13|||
25198678|NCT00244712|50410065|FG001|Overall Study|Protocol Violation, disease progression|11|||
25198679|NCT00243932|50410083|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
25198680|NCT00243932|50410084|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
25198681|NCT00243932|50410085|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
25077048|NCT02497976|50184889|FG000|Overall Study|Moved out of area|0|||
25077049|NCT02497976|50184890|FG001|Overall Study|Moved out of area|1|||
25198682|NCT00243386|50410093|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
25198683|NCT00243386|50410094|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
25198684|NCT00243386|50410095|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
25198685|NCT00243386|50410093|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
25077050|NCT03347188|50184898|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
25198686|NCT00243386|50410094|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
25198687|NCT00243386|50410095|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
25198688|NCT00243386|50410093|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
25198689|NCT00243386|50410094|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
25198690|NCT00243386|50410095|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
25198691|NCT00243386|50410093|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
25198692|NCT00243386|50410094|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
25198693|NCT00243386|50410095|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
25198694|NCT00243386|50410093|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
25198695|NCT00243386|50410094|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
25198696|NCT00243386|50410095|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
25198697|NCT00243386|50410093|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
25198698|NCT00243386|50410094|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
25198699|NCT00243386|50410095|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
25198700|NCT00243386|50410093|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
25198701|NCT00243386|50410094|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
25198702|NCT00243386|50410095|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
25198703|NCT00243386|50410093|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
25198704|NCT00243386|50410094|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
25198705|NCT00243386|50410095|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
25198706|NCT00243230|50410154|FG000|Double-Blind Period|Adverse Event|0|||
25198707|NCT00243230|50410155|FG001|Double-Blind Period|Adverse Event|2|||
25198708|NCT00243230|50410156|FG002|Double-Blind Period|Adverse Event|2|||
25198709|NCT00243230|50410157|FG003|Double-Blind Period|Adverse Event|0|||
25198710|NCT00243230|50410154|FG000|Double-Blind Period|Withdrawal by Subject|1|||
25198711|NCT00243230|50410155|FG001|Double-Blind Period|Withdrawal by Subject|0|||
25198712|NCT00243230|50410156|FG002|Double-Blind Period|Withdrawal by Subject|0|||
25198713|NCT00243230|50410157|FG003|Double-Blind Period|Withdrawal by Subject|0|||
25198714|NCT00243230|50410154|FG000|Double-Blind Period|Protocol Violation|0|||
25198715|NCT00243230|50410155|FG001|Double-Blind Period|Protocol Violation|0|||
25198716|NCT00243230|50410156|FG002|Double-Blind Period|Protocol Violation|1|||
25198717|NCT00243230|50410157|FG003|Double-Blind Period|Protocol Violation|0|||
25198718|NCT00243230|50410154|FG000|Double-Blind Period|Randomized but Not Treated|0|||
25198719|NCT00243230|50410155|FG001|Double-Blind Period|Randomized but Not Treated|0|||
25198720|NCT00243230|50410156|FG002|Double-Blind Period|Randomized but Not Treated|2|||
25198721|NCT00243230|50410157|FG003|Double-Blind Period|Randomized but Not Treated|0|||
25198722|NCT00243230|50410154|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
25198723|NCT00243230|50410155|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
25198724|NCT00243230|50410156|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
25198725|NCT00243230|50410157|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
25198726|NCT00243230|50410154|FG000|Open Label Period|Adverse Event|0|||
25198727|NCT00243230|50410155|FG001|Open Label Period|Adverse Event|0|||
25198728|NCT00243230|50410156|FG002|Open Label Period|Adverse Event|0|||
25198729|NCT00243230|50410157|FG003|Open Label Period|Adverse Event|2|||
25198730|NCT00243230|50410154|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
25198731|NCT00243230|50410155|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
25198732|NCT00243230|50410156|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
25198733|NCT00243230|50410157|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
25198734|NCT00243230|50410154|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
25198735|NCT00243230|50410155|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
25198736|NCT00243230|50410156|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
25198737|NCT00243230|50410157|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
25198738|NCT00243230|50410154|FG000|Open Label Period|Lost to Follow-up|0|||
25198739|NCT00243230|50410155|FG001|Open Label Period|Lost to Follow-up|0|||
25198740|NCT00243230|50410156|FG002|Open Label Period|Lost to Follow-up|0|||
25198741|NCT00243230|50410157|FG003|Open Label Period|Lost to Follow-up|2|||
25198742|NCT00243230|50410154|FG000|Open Label Period|Withdrawal by Subject|0|||
25198743|NCT00243230|50410155|FG001|Open Label Period|Withdrawal by Subject|0|||
25198744|NCT00243230|50410156|FG002|Open Label Period|Withdrawal by Subject|0|||
25198745|NCT00243230|50410157|FG003|Open Label Period|Withdrawal by Subject|2|||
25198746|NCT00243230|50410154|FG000|Open Label Period|Protocol Violation|0|||
25198747|NCT00243230|50410155|FG001|Open Label Period|Protocol Violation|0|||
25198748|NCT00243230|50410156|FG002|Open Label Period|Protocol Violation|0|||
25198749|NCT00243230|50410157|FG003|Open Label Period|Protocol Violation|2|||
25198750|NCT00243230|50410154|FG000|Open Label Period|Administrative Reason|0|||
25198751|NCT00243230|50410155|FG001|Open Label Period|Administrative Reason|0|||
25198752|NCT00243230|50410156|FG002|Open Label Period|Administrative Reason|0|||
25198753|NCT00243230|50410157|FG003|Open Label Period|Administrative Reason|63|||
25198754|NCT00243074|50410167|FG000|Overall Study|Ineligible|6|||
25198755|NCT00243074|50410167|FG000|Overall Study|Adverse Event|6|||
25198756|NCT00243074|50410167|FG000|Overall Study|Withdrawal by Subject|2|||
25198757|NCT00243074|50410167|FG000|Overall Study|Lack of Efficacy|36|||
25198758|NCT00243074|50410167|FG000|Overall Study|Death|2|||
25198759|NCT00243074|50410167|FG000|Overall Study|not protocol specified|1|||
25198760|NCT00243074|50410167|FG000|Overall Study|Did not receive any treatment|1|||
25315200|NCT00648037|50631049|FG000|Overall Study|Adverse Event|11|||
25315201|NCT00648037|50631049|FG000|Overall Study|Relapse|2|||
25198761|NCT00241358|50410175|FG000|Overall Study|Determined to be not ineligible|0|||
25198762|NCT00241358|50410176|FG001|Overall Study|Determined to be not ineligible|1|||
25198763|NCT00241358|50410177|FG002|Overall Study|Determined to be not ineligible|1|||
25198764|NCT00241280|50410186|FG000|Overall Study|Adverse Event|2|||
25198765|NCT00241280|50410187|FG001|Overall Study|Adverse Event|6|||
25198766|NCT00241280|50410186|FG000|Overall Study|Discomfort|11|||
25198767|NCT00241280|50410187|FG001|Overall Study|Discomfort|16|||
25198768|NCT00241280|50410186|FG000|Overall Study|Pregnancy|1|||
25198769|NCT00241280|50410187|FG001|Overall Study|Pregnancy|5|||
25198770|NCT00241280|50410186|FG000|Overall Study|Lost to Follow-up|5|||
25198771|NCT00241280|50410187|FG001|Overall Study|Lost to Follow-up|8|||
25198772|NCT00241280|50410186|FG000|Overall Study|Withdrawal by Subject|7|||
25198773|NCT00241280|50410187|FG001|Overall Study|Withdrawal by Subject|4|||
25198774|NCT00241280|50410186|FG000|Overall Study|Protocol Violation|4|||
25198775|NCT00241280|50410187|FG001|Overall Study|Protocol Violation|10|||
25198776|NCT00241280|50410186|FG000|Overall Study|Relocation|4|||
25198777|NCT00241280|50410187|FG001|Overall Study|Relocation|4|||
25198778|NCT00241280|50410186|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
25198779|NCT00241280|50410187|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
25198780|NCT00241280|50410186|FG000|Overall Study|Unsatisfactory Visual Response|1|||
25198781|NCT00241280|50410187|FG001|Overall Study|Unsatisfactory Visual Response|1|||
25198782|NCT00241280|50410186|FG000|Overall Study|Diabetic|1|||
25198783|NCT00241280|50410187|FG001|Overall Study|Diabetic|0|||
25198784|NCT00241280|50410186|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
25198785|NCT00241280|50410187|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
25198786|NCT00241280|50410186|FG000|Overall Study|Dispensed incorrect test article|1|||
25198787|NCT00241280|50410187|FG001|Overall Study|Dispensed incorrect test article|2|||
25198788|NCT00241280|50410186|FG000|Overall Study|Unacceptable Fit|0|||
25198789|NCT00241280|50410187|FG001|Overall Study|Unacceptable Fit|1|||
25198790|NCT00241280|50410186|FG000|Overall Study|Scheduling Conflict|0|||
25198791|NCT00241280|50410187|FG001|Overall Study|Scheduling Conflict|2|||
25198792|NCT00241280|50410186|FG000|Overall Study|History of Ocular Surgery|0|||
25315202|NCT00648037|50631049|FG000|Overall Study|Other|1|||
25315203|NCT00627523|50631055|FG000|Overall Study|Lack of Efficacy|1|||
25315204|NCT00627523|50631056|FG001|Overall Study|Lack of Efficacy|0|||
25315205|NCT00627523|50631055|FG000|Overall Study|Withdrawal by Subject|0|||
25315206|NCT00627523|50631056|FG001|Overall Study|Withdrawal by Subject|2|||
25315207|NCT00627523|50631055|FG000|Overall Study|Other|1|||
25315208|NCT00627523|50631056|FG001|Overall Study|Other|0|||
25315209|NCT00640393|50631062|FG000|Part 1|Lost to Follow-up|2|||
25315210|NCT00640393|50631063|FG001|Part 1|Lost to Follow-up|0|||
25315211|NCT00640393|50631064|FG002|Part 1|Lost to Follow-up|0|||
25315212|NCT00640393|50631062|FG000|Part 1|Withdrawal by Subject|3|||
25315213|NCT00640393|50631063|FG001|Part 1|Withdrawal by Subject|0|||
25315214|NCT00640393|50631064|FG002|Part 1|Withdrawal by Subject|0|||
25315215|NCT00640393|50631062|FG000|Randomization|Withdrawn per protocol|17|||
25315216|NCT00640393|50631063|FG001|Randomization|Withdrawn per protocol|0|||
25315217|NCT00640393|50631064|FG002|Randomization|Withdrawn per protocol|0|||
25315218|NCT00640393|50631062|FG000|Randomization|Never randomized by site|2|||
25315219|NCT00640393|50631063|FG001|Randomization|Never randomized by site|0|||
25315220|NCT00640393|50631064|FG002|Randomization|Never randomized by site|0|||
25315221|NCT00640393|50631062|FG000|Part 2|Lost to Follow-up|0|||
25315222|NCT00640393|50631063|FG001|Part 2|Lost to Follow-up|2|||
25315223|NCT00640393|50631064|FG002|Part 2|Lost to Follow-up|2|||
25315224|NCT00640393|50631062|FG000|Part 2|Withdrawal by Subject|0|||
25315225|NCT00640393|50631063|FG001|Part 2|Withdrawal by Subject|6|||
25315226|NCT00640393|50631064|FG002|Part 2|Withdrawal by Subject|1|||
25315227|NCT00640393|50631062|FG000|Part 2|Non-adherence|0|||
25315228|NCT00640393|50631063|FG001|Part 2|Non-adherence|1|||
25315229|NCT00640393|50631064|FG002|Part 2|Non-adherence|0|||
25315230|NCT00640393|50631062|FG000|Part 2|Adverse Event|0|||
25315231|NCT00640393|50631063|FG001|Part 2|Adverse Event|1|||
25315232|NCT00640393|50631064|FG002|Part 2|Adverse Event|0|||
25315233|NCT00907478|50631075|FG000|Overall Study|Ineligibility determined|0|||
25315234|NCT00907478|50631076|FG001|Overall Study|Ineligibility determined|0|||
25315235|NCT00907478|50631077|FG002|Overall Study|Ineligibility determined|1|||
25315236|NCT00907478|50631075|FG000|Overall Study|Noncompliance|0|||
25198793|NCT00241280|50410187|FG001|Overall Study|History of Ocular Surgery|1|||
25198794|NCT00241280|50410186|FG000|Overall Study|Coating on Lens|1|||
25198795|NCT00241280|50410187|FG001|Overall Study|Coating on Lens|0|||
25198796|NCT00241280|50410186|FG000|Overall Study|Excessive Dryness|0|||
25198797|NCT00241280|50410187|FG001|Overall Study|Excessive Dryness|1|||
25198798|NCT04278872|50410764|FG000|Overall Study|Adverse Event|1|||
25198799|NCT04278872|50410765|FG001|Overall Study|Adverse Event|0|||
25315237|NCT00907478|50631076|FG001|Overall Study|Noncompliance|0|||
25315238|NCT00907478|50631077|FG002|Overall Study|Noncompliance|1|||
25315239|NCT00907478|50631075|FG000|Overall Study|Adverse Event|3|||
25315240|NCT00907478|50631076|FG001|Overall Study|Adverse Event|1|||
25315241|NCT00907478|50631077|FG002|Overall Study|Adverse Event|2|||
25315242|NCT00907478|50631075|FG000|Overall Study|Withdrawal by Subject|8|||
25198800|NCT04278872|50410764|FG000|Overall Study|Protocol Violation|0|||
25198801|NCT04278872|50410765|FG001|Overall Study|Protocol Violation|1|||
25198802|NCT04278872|50410764|FG000|Overall Study|Study Termination|2|||
25198803|NCT04278872|50410765|FG001|Overall Study|Study Termination|0|||
25198804|NCT02513160|50413254|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
25198805|NCT02513160|50413255|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
25198806|NCT02513160|50413256|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
25198807|NCT02513160|50413257|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
25198808|NCT02513160|50413254|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
25198809|NCT02513160|50413255|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
25198810|NCT02513160|50413256|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
25198811|NCT02513160|50413257|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
25198812|NCT02513160|50413254|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
25198813|NCT02513160|50413255|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
25198814|NCT02513160|50413256|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
25315243|NCT00907478|50631076|FG001|Overall Study|Withdrawal by Subject|9|||
25315244|NCT00907478|50631077|FG002|Overall Study|Withdrawal by Subject|6|||
25315245|NCT00907478|50631075|FG000|Overall Study|Requirement for alternative therapy|1|||
25315246|NCT00907478|50631076|FG001|Overall Study|Requirement for alternative therapy|2|||
25315247|NCT00907478|50631077|FG002|Overall Study|Requirement for alternative therapy|3|||
25315248|NCT00907478|50631075|FG000|Overall Study|Physician Decision|2|||
25315249|NCT00907478|50631076|FG001|Overall Study|Physician Decision|0|||
25315250|NCT00907478|50631077|FG002|Overall Study|Physician Decision|3|||
25315251|NCT00907478|50631075|FG000|Overall Study|Death|4|||
25315252|NCT00907478|50631076|FG001|Overall Study|Death|2|||
25315253|NCT00907478|50631077|FG002|Overall Study|Death|1|||
25315254|NCT00907478|50631075|FG000|Overall Study|Protocol-specified criteria|5|||
25315255|NCT00907478|50631076|FG001|Overall Study|Protocol-specified criteria|2|||
25315256|NCT00907478|50631077|FG002|Overall Study|Protocol-specified criteria|3|||
25315257|NCT00907478|50631075|FG000|Overall Study|Pregnancy|0|||
25315258|NCT00907478|50631076|FG001|Overall Study|Pregnancy|1|||
25315259|NCT00907478|50631077|FG002|Overall Study|Pregnancy|1|||
25315260|NCT00907478|50631075|FG000|Overall Study|Lost to Follow-up|1|||
25315261|NCT00907478|50631076|FG001|Overall Study|Lost to Follow-up|0|||
25315262|NCT00907478|50631077|FG002|Overall Study|Lost to Follow-up|0|||
25315263|NCT00907478|50631075|FG000|Overall Study|Other|3|||
25315264|NCT00907478|50631076|FG001|Overall Study|Other|0|||
25315265|NCT00907478|50631077|FG002|Overall Study|Other|1|||
25315266|NCT00627445|50631089|FG000|Overall Study|Adverse Event|3|||
25315267|NCT00627445|50631090|FG001|Overall Study|Adverse Event|3|||
25315268|NCT00627445|50631089|FG000|Overall Study|Lack of Efficacy|0|||
25315269|NCT00627445|50631090|FG001|Overall Study|Lack of Efficacy|1|||
25315270|NCT00627445|50631089|FG000|Overall Study|Other|6|||
25315271|NCT00627445|50631090|FG001|Overall Study|Other|8|||
25315272|NCT00905840|50631098|FG000|Overall Study|Lost to Follow-up|11|||
25315273|NCT00905840|50631098|FG000|Overall Study|Death|3|||
25315274|NCT00905840|50631098|FG000|Overall Study|Withdrawal by Subject|1|||
25315275|NCT00905840|50631098|FG000|Overall Study|Adverse Event|1|||
25315276|NCT00626821|50631105|FG000|Overall Study|Adverse Event|44|||
25315277|NCT00626821|50631105|FG000|Overall Study|Protocol Violation|33|||
25315278|NCT00626821|50631105|FG000|Overall Study|Withdrawal by Subject|10|||
25315279|NCT00626821|50631105|FG000|Overall Study|Physician Decision|9|||
25315280|NCT00626821|50631105|FG000|Overall Study|Product dysfunction|21|||
25315281|NCT00626821|50631105|FG000|Overall Study|other/unknown reason|104|||
25170936|NCT00556894|50307812|FG000|Overall Study|regulatory decision in Bulgaria|10|||
25170937|NCT00556894|50307813|FG001|Overall Study|regulatory decision in Bulgaria|14|||
25170938|NCT00556894|50307814|FG002|Overall Study|regulatory decision in Bulgaria|13|||
25170939|NCT00556894|50307812|FG000|Overall Study|Change in therapy|2|||
25170940|NCT00556894|50307813|FG001|Overall Study|Change in therapy|1|||
25170941|NCT00556894|50307814|FG002|Overall Study|Change in therapy|2|||
25170942|NCT00556894|50307812|FG000|Overall Study|Withdrawal by Subject|1|||
25170943|NCT00556894|50307813|FG001|Overall Study|Withdrawal by Subject|1|||
25170944|NCT00556894|50307814|FG002|Overall Study|Withdrawal by Subject|1|||
25170945|NCT02722044|50307822|FG000|Overall Study|Adverse Event|2|||
25170946|NCT02722044|50307822|FG000|Overall Study|Physician Decision|1|||
25170947|NCT02722044|50307822|FG000|Overall Study|Withdrawal by Subject|1|||
25170948|NCT02722044|50307822|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
25198815|NCT02513160|50413257|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
25198816|NCT02513160|50413254|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
25315282|NCT00625183|50631109|FG000|Overall Study|Disease Progression|1|||
25315283|NCT00904982|50631119|FG000|Overall Study|Withdrawal by Subject|2|||
25315284|NCT00904982|50631120|FG001|Overall Study|Withdrawal by Subject|0|||
25315285|NCT00904982|50631121|FG002|Overall Study|Withdrawal by Subject|0|||
25315286|NCT00904982|50631122|FG003|Overall Study|Withdrawal by Subject|0|||
25315287|NCT00640315|50631134|FG000|Overall Study|Withdrawal by Subject|0|||
25315288|NCT00640315|50631135|FG001|Overall Study|Withdrawal by Subject|1|||
25198817|NCT02513160|50413255|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
25198818|NCT02513160|50413256|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
25198819|NCT02513160|50413257|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
25198820|NCT02513160|50413254|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
25198821|NCT02513160|50413255|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
25198822|NCT02513160|50413256|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
25198823|NCT02513160|50413257|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
25198824|NCT02513160|50413254|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
25198825|NCT02513160|50413255|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
25198826|NCT02513160|50413256|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
25198827|NCT02513160|50413257|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
25198828|NCT02513160|50413254|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
25198829|NCT02513160|50413255|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
25198830|NCT02513160|50413256|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
25198831|NCT02513160|50413257|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
25198832|NCT02513160|50413254|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
25198833|NCT02513160|50413255|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
25198834|NCT02513160|50413256|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
25198835|NCT02513160|50413257|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
25198836|NCT02513160|50413254|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
25198837|NCT02513160|50413255|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
25198838|NCT02513160|50413256|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
25198839|NCT02513160|50413257|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
25198840|NCT02513160|50413254|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
25198841|NCT02513160|50413255|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
25198842|NCT02513160|50413256|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
25198843|NCT02513160|50413257|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
25198844|NCT02513160|50413254|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
25198845|NCT02513160|50413255|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
25198846|NCT02513160|50413256|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
25198847|NCT02513160|50413257|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
25198848|NCT02513160|50413254|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
25198849|NCT02513160|50413255|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
25198850|NCT02513160|50413256|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
25198851|NCT02513160|50413257|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
25198852|NCT02480010|50413292|FG000|Overall Study|Adverse Event|3|||
25198853|NCT02480010|50413293|FG001|Overall Study|Adverse Event|1|||
25198854|NCT02480010|50413292|FG000|Overall Study|Death|1|||
25198855|NCT02480010|50413293|FG001|Overall Study|Death|0|||
25198856|NCT02480010|50413292|FG000|Overall Study|Insufficient therapeutic response|31|||
25198857|NCT02480010|50413293|FG001|Overall Study|Insufficient therapeutic response|29|||
25198858|NCT02480010|50413292|FG000|Overall Study|Refused Treatment|0|||
25198859|NCT02480010|50413293|FG001|Overall Study|Refused Treatment|3|||
25198860|NCT02512302|50413321|FG000|Period 1|Adverse Event|0|||
25198861|NCT02512302|50413322|FG001|Period 1|Adverse Event|1|||
25198862|NCT02512302|50413323|FG002|Period 1|Adverse Event|0|||
25198863|NCT02512302|50413324|FG003|Period 1|Adverse Event|0|||
25198864|NCT02512302|50413325|FG004|Period 1|Adverse Event|0|||
25198865|NCT02512302|50413326|FG005|Period 1|Adverse Event|0|||
25198866|NCT02512302|50413327|FG006|Period 1|Adverse Event|0|||
25198867|NCT02512302|50413328|FG007|Period 1|Adverse Event|0|||
25198868|NCT02512302|50413329|FG008|Period 1|Adverse Event|0|||
25198869|NCT02512302|50413330|FG009|Period 1|Adverse Event|0|||
25198870|NCT02512302|50413321|FG000|Period 2|Adverse Event|0|||
25198871|NCT02512302|50413322|FG001|Period 2|Adverse Event|0|||
25198872|NCT02512302|50413323|FG002|Period 2|Adverse Event|0|||
25198873|NCT02512302|50413324|FG003|Period 2|Adverse Event|0|||
25198874|NCT02512302|50413325|FG004|Period 2|Adverse Event|0|||
25198875|NCT02512302|50413326|FG005|Period 2|Adverse Event|0|||
25198876|NCT02512302|50413327|FG006|Period 2|Adverse Event|0|||
25198877|NCT02512302|50413328|FG007|Period 2|Adverse Event|0|||
25198878|NCT02512302|50413329|FG008|Period 2|Adverse Event|0|||
25198879|NCT02512302|50413330|FG009|Period 2|Adverse Event|1|||
25198880|NCT02512302|50413321|FG000|Period 3|Lost to Follow-up|0|||
25198881|NCT02512302|50413322|FG001|Period 3|Lost to Follow-up|0|||
25198882|NCT02512302|50413323|FG002|Period 3|Lost to Follow-up|1|||
25198883|NCT02512302|50413324|FG003|Period 3|Lost to Follow-up|0|||
25198884|NCT02512302|50413325|FG004|Period 3|Lost to Follow-up|0|||
25198885|NCT02512302|50413326|FG005|Period 3|Lost to Follow-up|0|||
25198886|NCT02512302|50413327|FG006|Period 3|Lost to Follow-up|0|||
25198887|NCT02512302|50413328|FG007|Period 3|Lost to Follow-up|0|||
25198888|NCT02512302|50413329|FG008|Period 3|Lost to Follow-up|0|||
25198889|NCT02512302|50413330|FG009|Period 3|Lost to Follow-up|0|||
25198890|NCT02512302|50413321|FG000|Period 4|Adverse Event|0|||
25198891|NCT02512302|50413322|FG001|Period 4|Adverse Event|0|||
25198892|NCT02512302|50413323|FG002|Period 4|Adverse Event|0|||
25315289|NCT00904748|50631141|FG000|Overall Study|Withdrawal by Subject|1|||
25315290|NCT00904748|50631142|FG001|Overall Study|Withdrawal by Subject|1|||
25315291|NCT00904748|50631143|FG002|Overall Study|Withdrawal by Subject|1|||
25315292|NCT00904748|50631144|FG003|Overall Study|Withdrawal by Subject|2|||
25315293|NCT00904748|50631145|FG004|Overall Study|Withdrawal by Subject|0|||
25315294|NCT00904748|50631146|FG005|Overall Study|Withdrawal by Subject|0|||
25315295|NCT00904748|50631141|FG000|Overall Study|Adverse Event|0|||
25315296|NCT00904748|50631142|FG001|Overall Study|Adverse Event|0|||
25315297|NCT00904748|50631143|FG002|Overall Study|Adverse Event|0|||
25315298|NCT00904748|50631144|FG003|Overall Study|Adverse Event|0|||
25315299|NCT00904748|50631145|FG004|Overall Study|Adverse Event|1|||
25198893|NCT02512302|50413324|FG003|Period 4|Adverse Event|0|||
25198894|NCT02512302|50413325|FG004|Period 4|Adverse Event|0|||
25198895|NCT02512302|50413326|FG005|Period 4|Adverse Event|0|||
25198896|NCT02512302|50413327|FG006|Period 4|Adverse Event|1|||
25198897|NCT02512302|50413328|FG007|Period 4|Adverse Event|0|||
25198898|NCT02512302|50413329|FG008|Period 4|Adverse Event|0|||
25198899|NCT02512302|50413330|FG009|Period 4|Adverse Event|0|||
25198900|NCT02512068|50413438|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
25198901|NCT02512068|50413439|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
25198902|NCT02512068|50413438|FG000|Overall Study|Major Protocol Deviation|1|||
25198903|NCT02512068|50413439|FG001|Overall Study|Major Protocol Deviation|0|||
25198904|NCT02512068|50413438|FG000|Overall Study|Voluntary Withdrawal|0|||
25198905|NCT02512068|50413439|FG001|Overall Study|Voluntary Withdrawal|1|||
25198906|NCT02512068|50413438|FG000|Overall Study|Lack of Efficacy|0|||
25198907|NCT02512068|50413439|FG001|Overall Study|Lack of Efficacy|1|||
25198908|NCT02512068|50413438|FG000|Overall Study|Reason Not Specified|3|||
25198909|NCT02512068|50413439|FG001|Overall Study|Reason Not Specified|5|||
25198910|NCT02511678|50413454|FG000|Overall Study|Withdrawal by Subject|2|||
25198911|NCT02511678|50413454|FG000|Overall Study|Lost to Follow-up|4|||
25198912|NCT02511678|50413454|FG000|Overall Study|Death|19|||
25198913|NCT02511678|50413454|FG000|Overall Study|Adverse Event|1|||
25198914|NCT02511678|50413454|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
25198915|NCT02511678|50413454|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
25198916|NCT02511678|50413454|FG000|Overall Study|Required Radiofrequency Ablation|1|||
25198917|NCT02511678|50413454|FG000|Overall Study|Biopsy was Negative|1|||
25198918|NCT02511678|50413454|FG000|Overall Study|Protocol Violation|1|||
25198919|NCT02511678|50413454|FG000|Overall Study|Received Radiation Treatment|1|||
25198920|NCT02518464|50413481|FG000|Overall Study|Adverse Event|2|||
25198921|NCT02510820|50413485|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
25198922|NCT02510820|50413486|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
25198923|NCT02510820|50413485|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
25198924|NCT02510820|50413486|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
25198925|NCT02510664|50413496|FG000|Overall Study|Transferred Care|9|||
25198926|NCT02510664|50413497|FG001|Overall Study|Transferred Care|9|||
25198927|NCT02510664|50413498|FG002|Overall Study|Transferred Care|0|||
25198928|NCT02510664|50413496|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
25198929|NCT02510664|50413497|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
25198930|NCT02510664|50413498|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
25198931|NCT02510664|50413496|FG000|Overall Study|Time Constraints|1|||
25198932|NCT02510664|50413497|FG001|Overall Study|Time Constraints|1|||
25198933|NCT02510664|50413498|FG002|Overall Study|Time Constraints|0|||
25198934|NCT02510040|50413523|FG000|Overall Study|Deemed no longer eligible|18|||
25198935|NCT02510040|50413524|FG001|Overall Study|Deemed no longer eligible|3|||
25198936|NCT02510040|50413525|FG002|Overall Study|Deemed no longer eligible|1|||
25198937|NCT01363986|50413543|FG000|Overall Study|Disease progression|1|||
25198938|NCT02478372|50413577|FG000|Overall Study|Protocol Violation|12|||
25198939|NCT02478372|50413578|FG001|Overall Study|Protocol Violation|8|||
25198940|NCT02478372|50413577|FG000|Overall Study|Lost to Follow-up|1|||
25198941|NCT02478372|50413578|FG001|Overall Study|Lost to Follow-up|4|||
25198942|NCT02478372|50413577|FG000|Overall Study|Death|0|||
25198943|NCT02478372|50413578|FG001|Overall Study|Death|2|||
25198944|NCT01654536|50413590|FG000|Overall Study|Lost to Follow-up|5|||
25198945|NCT01654536|50413591|FG001|Overall Study|Lost to Follow-up|5|||
25198946|NCT01654536|50413590|FG000|Overall Study|Physician Decision|12|||
25198947|NCT01654536|50413591|FG001|Overall Study|Physician Decision|8|||
25198948|NCT01654536|50413590|FG000|Overall Study|Withdrawal by Subject|27|||
25198949|NCT01654536|50413591|FG001|Overall Study|Withdrawal by Subject|25|||
25198950|NCT01654380|50413600|FG000|Part B, Period 1|Physician Decision|0|||
25198951|NCT01654380|50413601|FG001|Part B, Period 1|Physician Decision|0|||
25198952|NCT01654380|50413602|FG002|Part B, Period 1|Physician Decision|1|||
25198953|NCT01654380|50413603|FG003|Part B, Period 1|Physician Decision|0|||
25198954|NCT02477670|50413622|FG000|Stage 1|Adverse Event|2|||
25198955|NCT02477670|50413623|FG001|Stage 1|Adverse Event|7|||
25315300|NCT00904748|50631146|FG005|Overall Study|Adverse Event|0|||
25315301|NCT00574405|50631157|FG000|Overall Study|Withdrawal by Subject|3|||
25198956|NCT02477670|50413624|FG002|Stage 1|Adverse Event|0|||
25198957|NCT02477670|50413625|FG003|Stage 1|Adverse Event|0|||
25198958|NCT02477670|50413626|FG004|Stage 1|Adverse Event|0|||
25198959|NCT02477670|50413627|FG005|Stage 1|Adverse Event|0|||
25198960|NCT02477670|50413628|FG006|Stage 1|Adverse Event|0|||
25198961|NCT02477670|50413622|FG000|Stage 1|Lost to Follow-up|0|||
25198962|NCT02477670|50413623|FG001|Stage 1|Lost to Follow-up|2|||
25198963|NCT02477670|50413624|FG002|Stage 1|Lost to Follow-up|0|||
25198964|NCT02477670|50413625|FG003|Stage 1|Lost to Follow-up|0|||
25198965|NCT02477670|50413626|FG004|Stage 1|Lost to Follow-up|0|||
25198966|NCT02477670|50413627|FG005|Stage 1|Lost to Follow-up|0|||
25198967|NCT02477670|50413628|FG006|Stage 1|Lost to Follow-up|0|||
25198968|NCT02477670|50413622|FG000|Stage 1|Withdrawal by Subject|1|||
25198969|NCT02477670|50413623|FG001|Stage 1|Withdrawal by Subject|2|||
25198970|NCT02477670|50413624|FG002|Stage 1|Withdrawal by Subject|0|||
25198971|NCT02477670|50413625|FG003|Stage 1|Withdrawal by Subject|0|||
25198972|NCT02477670|50413626|FG004|Stage 1|Withdrawal by Subject|0|||
25198973|NCT02477670|50413627|FG005|Stage 1|Withdrawal by Subject|0|||
25198974|NCT02477670|50413628|FG006|Stage 1|Withdrawal by Subject|0|||
25198975|NCT02477670|50413622|FG000|Stage 1|Non-compliance with Study Drug|1|||
25198976|NCT02477670|50413623|FG001|Stage 1|Non-compliance with Study Drug|2|||
25198977|NCT02477670|50413624|FG002|Stage 1|Non-compliance with Study Drug|0|||
25198978|NCT02477670|50413625|FG003|Stage 1|Non-compliance with Study Drug|0|||
25198979|NCT02477670|50413626|FG004|Stage 1|Non-compliance with Study Drug|0|||
25198980|NCT02477670|50413627|FG005|Stage 1|Non-compliance with Study Drug|0|||
25198981|NCT02477670|50413628|FG006|Stage 1|Non-compliance with Study Drug|0|||
25198982|NCT02477670|50413622|FG000|Stage 2|Adverse Event|0|||
25198983|NCT02477670|50413623|FG001|Stage 2|Adverse Event|0|||
25198984|NCT02477670|50413624|FG002|Stage 2|Adverse Event|1|||
25198985|NCT02477670|50413625|FG003|Stage 2|Adverse Event|0|||
25198986|NCT02477670|50413626|FG004|Stage 2|Adverse Event|0|||
25198987|NCT02477670|50413627|FG005|Stage 2|Adverse Event|0|||
25198988|NCT02477670|50413628|FG006|Stage 2|Adverse Event|0|||
25198989|NCT02477670|50413622|FG000|Stage 2|Antipsychotic Medication Changed|0|||
25198990|NCT02477670|50413623|FG001|Stage 2|Antipsychotic Medication Changed|0|||
25198991|NCT02477670|50413624|FG002|Stage 2|Antipsychotic Medication Changed|1|||
25198992|NCT02477670|50413625|FG003|Stage 2|Antipsychotic Medication Changed|0|||
25198993|NCT02477670|50413626|FG004|Stage 2|Antipsychotic Medication Changed|0|||
25198994|NCT02477670|50413627|FG005|Stage 2|Antipsychotic Medication Changed|0|||
25198995|NCT02477670|50413628|FG006|Stage 2|Antipsychotic Medication Changed|0|||
25198996|NCT02477670|50413622|FG000|Stage 2|Withdrawal by Subject|0|||
25198997|NCT02477670|50413623|FG001|Stage 2|Withdrawal by Subject|0|||
25198998|NCT02477670|50413624|FG002|Stage 2|Withdrawal by Subject|0|||
25198999|NCT02477670|50413625|FG003|Stage 2|Withdrawal by Subject|1|||
25199000|NCT02477670|50413626|FG004|Stage 2|Withdrawal by Subject|0|||
25199001|NCT02477670|50413627|FG005|Stage 2|Withdrawal by Subject|0|||
25199002|NCT02477670|50413628|FG006|Stage 2|Withdrawal by Subject|0|||
25199003|NCT02509026|50413639|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
25199004|NCT02509026|50413639|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
25199005|NCT02509026|50413639|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
25199006|NCT02509026|50413639|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
25199007|NCT02509026|50413639|FG000|Induction Period (24 Weeks)|Other|2|||
25199008|NCT02509026|50413639|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
25199009|NCT02509026|50413639|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
25199010|NCT02509026|50413639|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
25199011|NCT02509026|50413639|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
25199012|NCT02509026|50413639|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
25199013|NCT02509026|50413639|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
25199014|NCT02509026|50413639|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
25199015|NCT02509026|50413639|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
25199016|NCT02476968|50414022|FG000|Overall Study|Other|0|||
25199017|NCT02476968|50414023|FG001|Overall Study|Other|2|||
25199018|NCT02476968|50414024|FG002|Overall Study|Other|0|||
25199019|NCT02476968|50414022|FG000|Overall Study|Lost to Follow-up|10|||
25199020|NCT02476968|50414023|FG001|Overall Study|Lost to Follow-up|0|||
25199021|NCT02476968|50414024|FG002|Overall Study|Lost to Follow-up|1|||
25199022|NCT02476968|50414022|FG000|Overall Study|Death|48|||
25199023|NCT02476968|50414023|FG001|Overall Study|Death|8|||
25199024|NCT02476968|50414024|FG002|Overall Study|Death|1|||
25199025|NCT02476968|50414022|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
25199026|NCT02476968|50414023|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
25199027|NCT02476968|50414024|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
25199028|NCT02476968|50414022|FG000|Overall Study|Patient decision|37|||
25199029|NCT02476968|50414023|FG001|Overall Study|Patient decision|8|||
25199030|NCT02476968|50414024|FG002|Overall Study|Patient decision|0|||
25199031|NCT02476578|50414045|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
25199032|NCT02476578|50414046|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
25199033|NCT02476578|50414045|FG000|Overall Study|Lost to Follow-up|6|||
25199034|NCT02476578|50414046|FG001|Overall Study|Lost to Follow-up|13|||
25199035|NCT02504892|50414064|FG000|Overall Study|Adverse event-pneumonitis|2|||
25199036|NCT02504502|50414070|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
25199037|NCT02504502|50414071|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
25199038|NCT02504502|50414070|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
25199039|NCT02504502|50414071|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
25199040|NCT02504424|50414099|FG000|Overall Study|Withdrawal by Subject|2|||
25199041|NCT02548832|50414429|FG000|Overall Study|Lost to Follow-up|2|||
25199042|NCT02548832|50414430|FG001|Overall Study|Lost to Follow-up|2|||
25199043|NCT02548832|50414431|FG002|Overall Study|Lost to Follow-up|2|||
25199044|NCT02504268|50414691|FG000|Overall Study|Adverse Event|18|||
25199045|NCT02504268|50414692|FG001|Overall Study|Adverse Event|8|||
25199046|NCT02504268|50414693|FG002|Overall Study|Adverse Event|14|||
25199047|NCT02504268|50414694|FG003|Overall Study|Adverse Event|0|||
25199048|NCT02504268|50414695|FG004|Overall Study|Adverse Event|0|||
25199049|NCT02504268|50414696|FG005|Overall Study|Adverse Event|0|||
25199050|NCT02504268|50414697|FG006|Overall Study|Adverse Event|0|||
25199051|NCT02504268|50414698|FG007|Overall Study|Adverse Event|0|||
25199052|NCT02504268|50414699|FG008|Overall Study|Adverse Event|0|||
25199053|NCT02504268|50414691|FG000|Overall Study|Withdrawal of Consent|11|||
25199054|NCT02504268|50414692|FG001|Overall Study|Withdrawal of Consent|10|||
25199055|NCT02504268|50414693|FG002|Overall Study|Withdrawal of Consent|3|||
25199056|NCT02504268|50414694|FG003|Overall Study|Withdrawal of Consent|0|||
25199057|NCT02504268|50414695|FG004|Overall Study|Withdrawal of Consent|0|||
25199058|NCT02504268|50414696|FG005|Overall Study|Withdrawal of Consent|0|||
25199059|NCT02504268|50414697|FG006|Overall Study|Withdrawal of Consent|0|||
25199060|NCT02504268|50414698|FG007|Overall Study|Withdrawal of Consent|0|||
25199061|NCT02504268|50414699|FG008|Overall Study|Withdrawal of Consent|0|||
25199062|NCT02504268|50414691|FG000|Overall Study|Pregnancy|2|||
25199063|NCT02504268|50414692|FG001|Overall Study|Pregnancy|0|||
25199064|NCT02504268|50414693|FG002|Overall Study|Pregnancy|0|||
25199065|NCT02504268|50414694|FG003|Overall Study|Pregnancy|0|||
25199066|NCT02504268|50414695|FG004|Overall Study|Pregnancy|0|||
25199067|NCT02504268|50414696|FG005|Overall Study|Pregnancy|0|||
25199068|NCT02504268|50414697|FG006|Overall Study|Pregnancy|0|||
25315302|NCT00574405|50631158|FG001|Overall Study|Withdrawal by Subject|2|||
25315303|NCT00971243|50631169|FG000|Double Blind Period|Adverse Event|2|||
25315304|NCT00971243|50631170|FG001|Double Blind Period|Adverse Event|3|||
25315305|NCT00971243|50631171|FG002|Double Blind Period|Adverse Event|2|||
25315306|NCT00971243|50631172|FG003|Double Blind Period|Adverse Event|2|||
25315307|NCT00971243|50631173|FG004|Double Blind Period|Adverse Event|3|||
25315308|NCT00971243|50631169|FG000|Double Blind Period|Lost to Follow-up|0|||
25315309|NCT00971243|50631170|FG001|Double Blind Period|Lost to Follow-up|1|||
25315310|NCT00971243|50631171|FG002|Double Blind Period|Lost to Follow-up|1|||
25315311|NCT00971243|50631172|FG003|Double Blind Period|Lost to Follow-up|0|||
25315312|NCT00971243|50631173|FG004|Double Blind Period|Lost to Follow-up|1|||
25315313|NCT00971243|50631169|FG000|Double Blind Period|Physician Decision|10|||
25315314|NCT00971243|50631170|FG001|Double Blind Period|Physician Decision|6|||
25315315|NCT00971243|50631171|FG002|Double Blind Period|Physician Decision|7|||
25315316|NCT00971243|50631172|FG003|Double Blind Period|Physician Decision|6|||
25315317|NCT00971243|50631173|FG004|Double Blind Period|Physician Decision|7|||
25315318|NCT00971243|50631169|FG000|Double Blind Period|Protocol Violation|2|||
25315319|NCT00971243|50631170|FG001|Double Blind Period|Protocol Violation|0|||
25315320|NCT00971243|50631171|FG002|Double Blind Period|Protocol Violation|3|||
25315321|NCT00971243|50631172|FG003|Double Blind Period|Protocol Violation|2|||
25315322|NCT00971243|50631173|FG004|Double Blind Period|Protocol Violation|2|||
25315323|NCT00971243|50631169|FG000|Double Blind Period|Withdrawal by Subject|4|||
25315324|NCT00971243|50631170|FG001|Double Blind Period|Withdrawal by Subject|1|||
25315325|NCT00971243|50631171|FG002|Double Blind Period|Withdrawal by Subject|4|||
25315326|NCT00971243|50631172|FG003|Double Blind Period|Withdrawal by Subject|4|||
25315327|NCT00971243|50631173|FG004|Double Blind Period|Withdrawal by Subject|4|||
25315328|NCT00971243|50631169|FG000|Double Blind Period|Other reasons|1|||
25315329|NCT00971243|50631170|FG001|Double Blind Period|Other reasons|0|||
25315330|NCT00971243|50631171|FG002|Double Blind Period|Other reasons|2|||
25315331|NCT00971243|50631172|FG003|Double Blind Period|Other reasons|0|||
25315332|NCT00971243|50631173|FG004|Double Blind Period|Other reasons|1|||
25315333|NCT00971243|50631169|FG000|Open-label Period|Adverse Event|1|||
25077051|NCT03347188|50184899|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
25199069|NCT02504268|50414698|FG007|Overall Study|Pregnancy|0|||
25199070|NCT02504268|50414699|FG008|Overall Study|Pregnancy|0|||
25315334|NCT00971243|50631170|FG001|Open-label Period|Adverse Event|0|||
25315335|NCT00971243|50631171|FG002|Open-label Period|Adverse Event|1|||
25199071|NCT02504268|50414691|FG000|Overall Study|Lost to Follow-up|3|||
25199072|NCT02504268|50414692|FG001|Overall Study|Lost to Follow-up|6|||
25199073|NCT02504268|50414693|FG002|Overall Study|Lost to Follow-up|4|||
25199074|NCT02504268|50414694|FG003|Overall Study|Lost to Follow-up|0|||
25199075|NCT02504268|50414695|FG004|Overall Study|Lost to Follow-up|0|||
25315336|NCT00971243|50631172|FG003|Open-label Period|Adverse Event|1|||
25315337|NCT00971243|50631173|FG004|Open-label Period|Adverse Event|0|||
25199076|NCT02504268|50414696|FG005|Overall Study|Lost to Follow-up|0|||
25199077|NCT02504268|50414697|FG006|Overall Study|Lost to Follow-up|0|||
25199078|NCT02504268|50414698|FG007|Overall Study|Lost to Follow-up|0|||
25199079|NCT02504268|50414699|FG008|Overall Study|Lost to Follow-up|0|||
25199080|NCT02504268|50414691|FG000|Overall Study|Death|1|||
25199081|NCT02504268|50414692|FG001|Overall Study|Death|1|||
25199082|NCT02504268|50414693|FG002|Overall Study|Death|0|||
25199083|NCT02504268|50414694|FG003|Overall Study|Death|0|||
25199084|NCT02504268|50414695|FG004|Overall Study|Death|0|||
25199085|NCT02504268|50414696|FG005|Overall Study|Death|0|||
25199086|NCT02504268|50414697|FG006|Overall Study|Death|0|||
25199087|NCT02504268|50414698|FG007|Overall Study|Death|0|||
25199088|NCT02504268|50414699|FG008|Overall Study|Death|0|||
25199089|NCT02504268|50414691|FG000|Overall Study|Subject Request to Discontinue|11|||
25199090|NCT02504268|50414692|FG001|Overall Study|Subject Request to Discontinue|3|||
25199091|NCT02504268|50414693|FG002|Overall Study|Subject Request to Discontinue|6|||
25199092|NCT02504268|50414694|FG003|Overall Study|Subject Request to Discontinue|0|||
25315338|NCT00971243|50631169|FG000|Open-label Period|Physician Decision|5|||
25315339|NCT00971243|50631170|FG001|Open-label Period|Physician Decision|9|||
25315340|NCT00971243|50631171|FG002|Open-label Period|Physician Decision|3|||
25315341|NCT00971243|50631172|FG003|Open-label Period|Physician Decision|7|||
25315342|NCT00971243|50631173|FG004|Open-label Period|Physician Decision|2|||
25315343|NCT00971243|50631169|FG000|Open-label Period|Protocol Violation|1|||
25315344|NCT00971243|50631170|FG001|Open-label Period|Protocol Violation|1|||
25315345|NCT00971243|50631171|FG002|Open-label Period|Protocol Violation|1|||
25315346|NCT00971243|50631172|FG003|Open-label Period|Protocol Violation|0|||
25315347|NCT00971243|50631173|FG004|Open-label Period|Protocol Violation|1|||
25315348|NCT00971243|50631169|FG000|Open-label Period|Withdrawal by Subject|1|||
25315349|NCT00971243|50631170|FG001|Open-label Period|Withdrawal by Subject|0|||
25315350|NCT00971243|50631171|FG002|Open-label Period|Withdrawal by Subject|0|||
25315351|NCT00971243|50631172|FG003|Open-label Period|Withdrawal by Subject|2|||
25315352|NCT00971243|50631173|FG004|Open-label Period|Withdrawal by Subject|1|||
25315353|NCT00971243|50631169|FG000|Open-label Period|Other reason|0|||
25315354|NCT00971243|50631170|FG001|Open-label Period|Other reason|0|||
25315355|NCT00971243|50631171|FG002|Open-label Period|Other reason|0|||
25315356|NCT00971243|50631172|FG003|Open-label Period|Other reason|0|||
25315357|NCT00971243|50631173|FG004|Open-label Period|Other reason|2|||
25315358|NCT00568555|50631187|FG000|Overall Study|Withdrawal by Subject|1|||
25315359|NCT00568555|50631188|FG001|Overall Study|Withdrawal by Subject|1|||
25315360|NCT00904670|50631196|FG000|Open Label Phase|Withdrawal by Subject|2|||
25315361|NCT00904670|50631197|FG001|Open Label Phase|Withdrawal by Subject|0|||
25315362|NCT00904670|50631196|FG000|Open Label Phase|Adverse Event|2|||
25315363|NCT00904670|50631197|FG001|Open Label Phase|Adverse Event|0|||
25315364|NCT00904670|50631196|FG000|Open Label Phase|Lack of Efficacy|1|||
25315365|NCT00904670|50631197|FG001|Open Label Phase|Lack of Efficacy|0|||
25315366|NCT00904670|50631196|FG000|Open Label Phase|Lost to Follow-up|1|||
25315367|NCT00904670|50631197|FG001|Open Label Phase|Lost to Follow-up|0|||
25315368|NCT00638443|50631205|FG000|First Intervention|Adverse Event|2|||
25315369|NCT00638443|50631206|FG001|First Intervention|Adverse Event|1|||
25315370|NCT00636181|50631217|FG000|Overall Study|Withdrawal by Subject|8|||
25315371|NCT00636181|50631218|FG001|Overall Study|Withdrawal by Subject|6|||
25315372|NCT00636181|50631219|FG002|Overall Study|Withdrawal by Subject|10|||
25315373|NCT00968669|50631231|FG000|Overall Study|Lost to Follow-up|5|||
25315374|NCT00968669|50631232|FG001|Overall Study|Lost to Follow-up|2|||
25315375|NCT00968669|50631233|FG002|Overall Study|Lost to Follow-up|1|||
25315376|NCT00968669|50631234|FG003|Overall Study|Lost to Follow-up|4|||
25315377|NCT00968669|50631231|FG000|Overall Study|Withdrawal by Subject|9|||
25315378|NCT00968669|50631232|FG001|Overall Study|Withdrawal by Subject|7|||
25077052|NCT03347188|50184898|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
25077053|NCT03347188|50184899|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
25199093|NCT02504268|50414695|FG004|Overall Study|Subject Request to Discontinue|0|||
25199094|NCT02504268|50414696|FG005|Overall Study|Subject Request to Discontinue|0|||
25199095|NCT02504268|50414697|FG006|Overall Study|Subject Request to Discontinue|0|||
25315379|NCT00968669|50631233|FG002|Overall Study|Withdrawal by Subject|5|||
25315380|NCT00968669|50631234|FG003|Overall Study|Withdrawal by Subject|3|||
25315381|NCT00968669|50631231|FG000|Overall Study|Pregnancy|0|||
25315382|NCT00968669|50631232|FG001|Overall Study|Pregnancy|0|||
25315383|NCT00968669|50631233|FG002|Overall Study|Pregnancy|2|||
25315384|NCT00968669|50631234|FG003|Overall Study|Pregnancy|0|||
25077054|NCT03347188|50184898|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
25077055|NCT03347188|50184899|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
25199096|NCT02504268|50414698|FG007|Overall Study|Subject Request to Discontinue|0|||
25199097|NCT02504268|50414699|FG008|Overall Study|Subject Request to Discontinue|0|||
25199098|NCT02504268|50414691|FG000|Overall Study|No Longer Meets Study Criteria|2|||
25199099|NCT02504268|50414692|FG001|Overall Study|No Longer Meets Study Criteria|3|||
25199100|NCT02504268|50414693|FG002|Overall Study|No Longer Meets Study Criteria|0|||
25199101|NCT02504268|50414694|FG003|Overall Study|No Longer Meets Study Criteria|0|||
25199102|NCT02504268|50414695|FG004|Overall Study|No Longer Meets Study Criteria|0|||
25199103|NCT02504268|50414696|FG005|Overall Study|No Longer Meets Study Criteria|0|||
25199104|NCT02504268|50414697|FG006|Overall Study|No Longer Meets Study Criteria|0|||
25199105|NCT02504268|50414698|FG007|Overall Study|No Longer Meets Study Criteria|0|||
25199106|NCT02504268|50414699|FG008|Overall Study|No Longer Meets Study Criteria|0|||
25199107|NCT02504268|50414691|FG000|Overall Study|Lack of Efficacy|11|||
25199108|NCT02504268|50414692|FG001|Overall Study|Lack of Efficacy|35|||
25199109|NCT02504268|50414693|FG002|Overall Study|Lack of Efficacy|9|||
25199110|NCT02504268|50414694|FG003|Overall Study|Lack of Efficacy|0|||
25199111|NCT02504268|50414695|FG004|Overall Study|Lack of Efficacy|0|||
25199112|NCT02504268|50414696|FG005|Overall Study|Lack of Efficacy|0|||
25199113|NCT02504268|50414697|FG006|Overall Study|Lack of Efficacy|0|||
25199114|NCT02504268|50414698|FG007|Overall Study|Lack of Efficacy|0|||
25199115|NCT02504268|50414699|FG008|Overall Study|Lack of Efficacy|0|||
25199116|NCT02504268|50414691|FG000|Overall Study|Poor/Non-Compliance|3|||
25199117|NCT02504268|50414692|FG001|Overall Study|Poor/Non-Compliance|2|||
25199118|NCT02504268|50414693|FG002|Overall Study|Poor/Non-Compliance|3|||
25199119|NCT02504268|50414694|FG003|Overall Study|Poor/Non-Compliance|0|||
25199120|NCT02504268|50414695|FG004|Overall Study|Poor/Non-Compliance|0|||
25199121|NCT02504268|50414696|FG005|Overall Study|Poor/Non-Compliance|0|||
25199122|NCT02504268|50414697|FG006|Overall Study|Poor/Non-Compliance|0|||
25199123|NCT02504268|50414698|FG007|Overall Study|Poor/Non-Compliance|0|||
25199124|NCT02504268|50414699|FG008|Overall Study|Poor/Non-Compliance|0|||
25199125|NCT02504268|50414691|FG000|Overall Study|Not Disclosed|1|||
25199126|NCT02504268|50414692|FG001|Overall Study|Not Disclosed|0|||
25199127|NCT02504268|50414693|FG002|Overall Study|Not Disclosed|2|||
25199128|NCT02504268|50414694|FG003|Overall Study|Not Disclosed|0|||
25199129|NCT02504268|50414695|FG004|Overall Study|Not Disclosed|0|||
25199130|NCT02504268|50414696|FG005|Overall Study|Not Disclosed|0|||
25199131|NCT02504268|50414697|FG006|Overall Study|Not Disclosed|0|||
25199132|NCT02504268|50414698|FG007|Overall Study|Not Disclosed|0|||
25199133|NCT02504268|50414699|FG008|Overall Study|Not Disclosed|0|||
25199134|NCT01654302|50414743|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
25199135|NCT01654302|50414744|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
25199136|NCT02476422|50414760|FG000|Overall Study|Subject/guardian decision|0|||
25199137|NCT02476422|50414761|FG001|Overall Study|Subject/guardian decision|1|||
25199138|NCT02475954|50414773|FG000|Overall Study|Withdrawal by Subject|2|||
25199139|NCT02475954|50414774|FG001|Overall Study|Withdrawal by Subject|2|||
25199140|NCT02475954|50414773|FG000|Overall Study|Lost to Follow-up|11|||
25199141|NCT02475954|50414774|FG001|Overall Study|Lost to Follow-up|9|||
25199142|NCT02475954|50414773|FG000|Overall Study|Death|1|||
25199143|NCT02475954|50414774|FG001|Overall Study|Death|1|||
25199144|NCT02475564|50414801|FG000|Overall Study|Withdrawal by Subject|1|||
25199145|NCT02475564|50414802|FG001|Overall Study|Withdrawal by Subject|0|||
25199146|NCT02475564|50414801|FG000|Overall Study|Lost to Follow-up|2|||
25199147|NCT02475564|50414802|FG001|Overall Study|Lost to Follow-up|1|||
25077056|NCT03347188|50184898|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
25077057|NCT03347188|50184899|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
25077058|NCT03347188|50184898|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
25077059|NCT03347188|50184899|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
25199148|NCT02475564|50414801|FG000|Overall Study|Intense Menstrual bleeding|1|||
25199149|NCT02475564|50414802|FG001|Overall Study|Intense Menstrual bleeding|0|||
25199150|NCT02503332|50415090|FG000|Overall Study|Adverse Event|17|||
25199151|NCT02503332|50415091|FG001|Overall Study|Adverse Event|5|||
25199152|NCT02503332|50415092|FG002|Overall Study|Adverse Event|3|||
25199153|NCT02503332|50415093|FG003|Overall Study|Adverse Event|1|||
25199154|NCT02503332|50415090|FG000|Overall Study|Investigator's Decision|5|||
25199155|NCT02503332|50415091|FG001|Overall Study|Investigator's Decision|1|||
25199156|NCT02503332|50415092|FG002|Overall Study|Investigator's Decision|0|||
25199157|NCT02503332|50415093|FG003|Overall Study|Investigator's Decision|0|||
25199158|NCT02503332|50415090|FG000|Overall Study|Sponsor's Decision|1|||
25199159|NCT02503332|50415091|FG001|Overall Study|Sponsor's Decision|0|||
25199160|NCT02503332|50415092|FG002|Overall Study|Sponsor's Decision|0|||
25199161|NCT02503332|50415093|FG003|Overall Study|Sponsor's Decision|1|||
25199162|NCT02503332|50415090|FG000|Overall Study|Subject Request|6|||
25199163|NCT02503332|50415091|FG001|Overall Study|Subject Request|5|||
25199164|NCT02503332|50415092|FG002|Overall Study|Subject Request|2|||
25199165|NCT02503332|50415093|FG003|Overall Study|Subject Request|1|||
25199166|NCT02503332|50415090|FG000|Overall Study|Death|0|||
25199167|NCT02503332|50415091|FG001|Overall Study|Death|2|||
25199168|NCT02503332|50415092|FG002|Overall Study|Death|2|||
25199169|NCT02503332|50415093|FG003|Overall Study|Death|0|||
25199170|NCT02503332|50415090|FG000|Overall Study|Other|5|||
25199171|NCT02503332|50415091|FG001|Overall Study|Other|6|||
25199172|NCT02503332|50415092|FG002|Overall Study|Other|1|||
25199173|NCT02503332|50415093|FG003|Overall Study|Other|1|||
25199174|NCT02502864|50415111|FG000|Overall Study|Withdrawal by Subject|1|||
25199175|NCT02474082|50415145|FG000|Overall Study|Adverse Event|2|||
25199176|NCT02474082|50415146|FG001|Overall Study|Adverse Event|32|||
25199177|NCT02474082|50415145|FG000|Overall Study|Withdrawal of informed consent|1|||
25199178|NCT02474082|50415146|FG001|Overall Study|Withdrawal of informed consent|11|||
25199179|NCT02474082|50415145|FG000|Overall Study|Lost to Follow-up|2|||
25199180|NCT02474082|50415146|FG001|Overall Study|Lost to Follow-up|2|||
25199181|NCT02474082|50415145|FG000|Overall Study|Dose tapering not achieved|0|||
25199182|NCT02474082|50415146|FG001|Overall Study|Dose tapering not achieved|4|||
25199183|NCT02474082|50415145|FG000|Overall Study|Participant/guardian decision|1|||
25199184|NCT02474082|50415146|FG001|Overall Study|Participant/guardian decision|2|||
25199185|NCT02474082|50415145|FG000|Overall Study|Non-compliance with study treatment|0|||
25199186|NCT02474082|50415146|FG001|Overall Study|Non-compliance with study treatment|2|||
25199187|NCT02474082|50415145|FG000|Overall Study|Protocol deviation|0|||
25199188|NCT02474082|50415146|FG001|Overall Study|Protocol deviation|1|||
25199189|NCT02501928|50415256|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
25199190|NCT02501928|50415257|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
25199191|NCT02501928|50415258|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
25199192|NCT02501928|50415259|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
25199193|NCT02501928|50415260|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
25199194|NCT02501928|50415261|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
25199195|NCT02473614|50415325|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
25199196|NCT02473614|50415326|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
25199197|NCT02500758|50415348|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
25199198|NCT02500758|50415349|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
25199199|NCT02500758|50415348|FG000|Washout (1 Week)|Lost to Follow-up|2|||
25199200|NCT02500758|50415349|FG001|Washout (1 Week)|Lost to Follow-up|2|||
25199201|NCT02500758|50415348|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
25199202|NCT02500758|50415349|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
25199203|NCT02500758|50415348|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
25199204|NCT02500758|50415349|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
25199205|NCT02500758|50415348|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
25199206|NCT02500758|50415349|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
25199207|NCT02500056|50415363|FG000|Overall Study|Lost to Follow-up|3|||
25199208|NCT02500056|50415364|FG001|Overall Study|Lost to Follow-up|7|||
25199209|NCT02500056|50415363|FG000|Overall Study|Recurrence|1|||
25199210|NCT02500056|50415364|FG001|Overall Study|Recurrence|0|||
25199211|NCT02500056|50415363|FG000|Overall Study|Death|3|||
25199212|NCT02500056|50415364|FG001|Overall Study|Death|1|||
25199213|NCT02472756|50415413|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
25199214|NCT02472756|50415413|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
25199215|NCT02472756|50415413|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
25199216|NCT02472756|50415413|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
25199217|NCT02472756|50415413|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
25199218|NCT02498652|50415423|FG000|Overall Study|Protocol Violation|0|||
25199219|NCT02498652|50415424|FG001|Overall Study|Protocol Violation|1|||
25199220|NCT03213158|50415448|FG000|Overall Study|Withdrawal by Subject|1|||
25199221|NCT03213158|50415448|FG000|Overall Study|Physician Decision|2|||
25199222|NCT02498418|50415455|FG000|Overall Study|Lack of Efficacy|0|||
25199223|NCT02498418|50415456|FG001|Overall Study|Lack of Efficacy|0|||
25199224|NCT02498418|50415457|FG002|Overall Study|Lack of Efficacy|1|||
25199225|NCT02498418|50415455|FG000|Overall Study|Withdrawal by Subject|2|||
25199226|NCT02498418|50415456|FG001|Overall Study|Withdrawal by Subject|0|||
25199227|NCT02498418|50415457|FG002|Overall Study|Withdrawal by Subject|3|||
25199228|NCT02498418|50415455|FG000|Overall Study|Lost to Follow-up|0|||
25199229|NCT02498418|50415456|FG001|Overall Study|Lost to Follow-up|1|||
25199230|NCT02498418|50415457|FG002|Overall Study|Lost to Follow-up|1|||
25199231|NCT02498418|50415455|FG000|Overall Study|Participant taken prohibited medication|0|||
25199232|NCT02498418|50415456|FG001|Overall Study|Participant taken prohibited medication|1|||
25199233|NCT02498418|50415457|FG002|Overall Study|Participant taken prohibited medication|1|||
25199234|NCT02472366|50415475|FG000|Overall Study|Lost to Follow-up|1|||
25199235|NCT02472366|50415476|FG001|Overall Study|Lost to Follow-up|0|||
25199236|NCT03219164|50415484|FG000|Overall Study|Study Terminated by Sponsor|16|||
25199237|NCT03219164|50415485|FG001|Overall Study|Study Terminated by Sponsor|12|||
25199238|NCT03219164|50415484|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
25199239|NCT03219164|50415485|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
25199240|NCT03219164|50415484|FG000|Overall Study|Lost to Follow-up|1|||
25199241|NCT03219164|50415485|FG001|Overall Study|Lost to Follow-up|1|||
25199242|NCT03219164|50415484|FG000|Overall Study|Adverse Event|1|||
25199243|NCT03219164|50415485|FG001|Overall Study|Adverse Event|0|||
25199244|NCT03219164|50415484|FG000|Overall Study|Non-Compliance with Study Drug|1|||
25199245|NCT03219164|50415485|FG001|Overall Study|Non-Compliance with Study Drug|0|||
25199246|NCT03219164|50415484|FG000|Overall Study|Protocol Violation|0|||
25199247|NCT03219164|50415485|FG001|Overall Study|Protocol Violation|1|||
25199248|NCT03219164|50415484|FG000|Overall Study|Withdrew Assent|1|||
25199249|NCT03219164|50415485|FG001|Overall Study|Withdrew Assent|0|||
25199250|NCT02471586|50415503|FG000|Overall Study|Lost to Follow-up|3|||
25199251|NCT02471586|50415504|FG001|Overall Study|Lost to Follow-up|8|||
25199252|NCT02471586|50415505|FG002|Overall Study|Lost to Follow-up|4|||
25199253|NCT02471586|50415503|FG000|Overall Study|Death|2|||
25199254|NCT02471586|50415504|FG001|Overall Study|Death|2|||
25199255|NCT02471586|50415505|FG002|Overall Study|Death|0|||
25199256|NCT02470806|50415656|FG000|Overall Study|Lost to Follow-up|1|||
25199257|NCT02470806|50415657|FG001|Overall Study|Lost to Follow-up|1|||
25199258|NCT02470806|50415656|FG000|Overall Study|Adverse Event|5|||
25199259|NCT02470806|50415657|FG001|Overall Study|Adverse Event|2|||
25199260|NCT02470806|50415656|FG000|Overall Study|Protocol Violation|4|||
25199261|NCT02470806|50415657|FG001|Overall Study|Protocol Violation|11|||
25199262|NCT02470806|50415656|FG000|Overall Study|Physician Decision|0|||
25199263|NCT02470806|50415657|FG001|Overall Study|Physician Decision|3|||
25199264|NCT02470806|50415656|FG000|Overall Study|Withdrawal by Subject|3|||
25199265|NCT02470806|50415657|FG001|Overall Study|Withdrawal by Subject|10|||
25199266|NCT02470806|50415656|FG000|Overall Study|Lack of Efficacy|5|||
25199267|NCT02470806|50415657|FG001|Overall Study|Lack of Efficacy|15|||
25199268|NCT01363908|50415699|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
25199269|NCT01363908|50415700|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
25199270|NCT01363908|50415699|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
25199271|NCT01363908|50415700|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
25199272|NCT01363908|50415699|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
25199273|NCT01363908|50415700|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
25199274|NCT01363908|50415699|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
25199275|NCT01363908|50415700|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
25199276|NCT02497404|50415738|FG000|Overall Study|Adverse Event|1|||
25199277|NCT02496702|50415771|FG000|Overall Study|Lost to Follow-up|8|||
25199278|NCT02496702|50415772|FG001|Overall Study|Lost to Follow-up|6|||
25199279|NCT02496702|50415771|FG000|Overall Study|Only partially tested|0|||
25199280|NCT02496702|50415772|FG001|Overall Study|Only partially tested|2|||
25199281|NCT02469246|50415848|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
25199282|NCT02469246|50415849|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
25199283|NCT02469246|50415848|FG000|Double-Blind Phase|Adverse Event|12|||
25199284|NCT02469246|50415849|FG001|Double-Blind Phase|Adverse Event|9|||
25199285|NCT02469246|50415848|FG000|Double-Blind Phase|Death|2|||
25199286|NCT02469246|50415849|FG001|Double-Blind Phase|Death|0|||
25199287|NCT02469246|50415848|FG000|Double-Blind Phase|Lack of Efficacy|2|||
25199288|NCT02469246|50415849|FG001|Double-Blind Phase|Lack of Efficacy|1|||
25199289|NCT02469246|50415848|FG000|Double-Blind Phase|Investigator's Discretion|8|||
25199290|NCT02469246|50415849|FG001|Double-Blind Phase|Investigator's Discretion|8|||
25199291|NCT02469246|50415848|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
25199292|NCT02469246|50415849|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
25199293|NCT02469246|50415848|FG000|Double-Blind Phase|Protocol Violation|1|||
25199294|NCT02469246|50415849|FG001|Double-Blind Phase|Protocol Violation|1|||
25199295|NCT02469246|50415848|FG000|Double-Blind Phase|Withdrew Consent|25|||
25199296|NCT02469246|50415849|FG001|Double-Blind Phase|Withdrew Consent|25|||
25199297|NCT02469246|50415848|FG000|Double-Blind Phase|Lost to Follow-up|9|||
25199298|NCT02469246|50415849|FG001|Double-Blind Phase|Lost to Follow-up|5|||
25199299|NCT02469168|50415868|FG000|Overall Study|Trial closed|1|||
25199300|NCT02469168|50415869|FG001|Overall Study|Trial closed|0|||
25199301|NCT02469090|50415877|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
25199302|NCT02469090|50415878|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
25199303|NCT02469090|50415879|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
25199304|NCT02469090|50415877|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
25199305|NCT02469090|50415878|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
25199306|NCT02469090|50415879|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
25199307|NCT02469090|50415877|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
25199308|NCT02469090|50415878|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
25199309|NCT02469090|50415879|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
25199310|NCT02469090|50415877|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
25199311|NCT02469090|50415878|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
25199312|NCT02469090|50415879|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
25199313|NCT02469090|50415877|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
25199314|NCT02469090|50415878|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
25199315|NCT02469090|50415879|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
25199316|NCT02469090|50415877|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
25199317|NCT02469090|50415878|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
25199318|NCT02469090|50415879|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
25199319|NCT02469090|50415877|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
25199320|NCT02469090|50415878|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
25199321|NCT02469090|50415879|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
25199322|NCT02469090|50415877|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
25199323|NCT02469090|50415878|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
25199324|NCT02469090|50415879|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
25199325|NCT02496000|50415889|FG000|Overall Study|Withdrawal by Subject|1|||
25199326|NCT02496000|50415890|FG001|Overall Study|Withdrawal by Subject|2|||
25199327|NCT02496000|50415891|FG002|Overall Study|Withdrawal by Subject|0|||
25199328|NCT02496000|50415889|FG000|Overall Study|Lost to Follow-up|1|||
25199329|NCT02496000|50415890|FG001|Overall Study|Lost to Follow-up|0|||
25199330|NCT02496000|50415891|FG002|Overall Study|Lost to Follow-up|1|||
25199331|NCT02496000|50415889|FG000|Overall Study|Protocol Violation|0|||
25199332|NCT02496000|50415890|FG001|Overall Study|Protocol Violation|0|||
25199333|NCT02496000|50415891|FG002|Overall Study|Protocol Violation|1|||
25199334|NCT02496000|50415889|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
25199335|NCT02496000|50415890|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
25199336|NCT02496000|50415891|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
25199337|NCT02496000|50415889|FG000|Overall Study|undetermined|0|||
25199338|NCT02496000|50415890|FG001|Overall Study|undetermined|1|||
25199339|NCT02496000|50415891|FG002|Overall Study|undetermined|0|||
25199340|NCT02468934|50415900|FG000|Overall Study|Withdrawal by Subject|4|||
25199341|NCT02468934|50415900|FG000|Overall Study|Screen Failure|3|||
25199342|NCT02517528|50415906|FG000|Overall Study|Withdrawal by Subject|1|||
25199343|NCT02495844|50415912|FG000|Overall Study|Lack of Efficacy|1|||
25199344|NCT02495844|50415913|FG001|Overall Study|Lack of Efficacy|2|||
25199345|NCT02495844|50415912|FG000|Overall Study|AE, non-fatal|0|||
25199346|NCT02495844|50415913|FG001|Overall Study|AE, non-fatal|1|||
25199347|NCT02495844|50415912|FG000|Overall Study|Hepatitis Positivity|0|||
25199348|NCT02495844|50415913|FG001|Overall Study|Hepatitis Positivity|1|||
25199349|NCT02468778|50415924|FG000|Overall Study|Death|2|||
25199350|NCT02468778|50415925|FG001|Overall Study|Death|1|||
25199351|NCT02468778|50415926|FG002|Overall Study|Death|0|||
25199352|NCT02468778|50415924|FG000|Overall Study|Lost to Follow-up|1|||
25199353|NCT02468778|50415925|FG001|Overall Study|Lost to Follow-up|2|||
25199354|NCT02468778|50415926|FG002|Overall Study|Lost to Follow-up|2|||
25199355|NCT02468778|50415924|FG000|Overall Study|Withdrawal by Subject|0|||
25199356|NCT02468778|50415925|FG001|Overall Study|Withdrawal by Subject|1|||
25199357|NCT02468778|50415926|FG002|Overall Study|Withdrawal by Subject|1|||
25199358|NCT01727336|50415940|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
25199359|NCT01727336|50415941|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
25199360|NCT01727336|50415942|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
25199361|NCT01727336|50415943|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
25199362|NCT01727336|50415944|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
25199363|NCT01727336|50415945|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
25199364|NCT01727336|50415940|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
25077060|NCT03347188|50184898|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
25199365|NCT01727336|50415941|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
25199366|NCT01727336|50415942|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
25199367|NCT01727336|50415943|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
25199368|NCT01727336|50415944|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
25199369|NCT01727336|50415945|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
25199370|NCT01727336|50415940|FG000|Part 2 Blinded|Death|0|||
25199371|NCT01727336|50415941|FG001|Part 2 Blinded|Death|0|||
25199372|NCT01727336|50415942|FG002|Part 2 Blinded|Death|0|||
25315385|NCT00968669|50631231|FG000|Overall Study|AE|1|||
25315386|NCT00968669|50631232|FG001|Overall Study|AE|0|||
25077061|NCT03347188|50184899|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
25077062|NCT03347188|50184898|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
25077063|NCT03347188|50184899|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
25077064|NCT03347188|50184898|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
25315387|NCT00968669|50631233|FG002|Overall Study|AE|0|||
25199373|NCT01727336|50415943|FG003|Part 2 Blinded|Death|0|||
25199374|NCT01727336|50415944|FG004|Part 2 Blinded|Death|20|||
25199375|NCT01727336|50415945|FG005|Part 2 Blinded|Death|16|||
25199376|NCT01727336|50415940|FG000|Part 2 Blinded|Lack of Efficacy|0|||
25199377|NCT01727336|50415941|FG001|Part 2 Blinded|Lack of Efficacy|0|||
25199378|NCT01727336|50415942|FG002|Part 2 Blinded|Lack of Efficacy|0|||
25199379|NCT01727336|50415943|FG003|Part 2 Blinded|Lack of Efficacy|0|||
25199380|NCT01727336|50415944|FG004|Part 2 Blinded|Lack of Efficacy|42|||
25199381|NCT01727336|50415945|FG005|Part 2 Blinded|Lack of Efficacy|44|||
25199382|NCT01727336|50415940|FG000|Part 2 Blinded|Lost to Follow-up|0|||
25199383|NCT01727336|50415941|FG001|Part 2 Blinded|Lost to Follow-up|0|||
25199384|NCT01727336|50415942|FG002|Part 2 Blinded|Lost to Follow-up|0|||
25199385|NCT01727336|50415943|FG003|Part 2 Blinded|Lost to Follow-up|0|||
25199386|NCT01727336|50415944|FG004|Part 2 Blinded|Lost to Follow-up|0|||
25199387|NCT01727336|50415945|FG005|Part 2 Blinded|Lost to Follow-up|1|||
25199388|NCT01727336|50415940|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
25199389|NCT01727336|50415941|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
25199390|NCT01727336|50415942|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
25199391|NCT01727336|50415943|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
25199392|NCT01727336|50415944|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
25199393|NCT01727336|50415945|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
25199394|NCT01727336|50415940|FG000|Part 2 Blinded|use of prohibited medications|0|||
25199395|NCT01727336|50415941|FG001|Part 2 Blinded|use of prohibited medications|0|||
25199396|NCT01727336|50415942|FG002|Part 2 Blinded|use of prohibited medications|0|||
25199397|NCT01727336|50415943|FG003|Part 2 Blinded|use of prohibited medications|0|||
25199398|NCT01727336|50415944|FG004|Part 2 Blinded|use of prohibited medications|1|||
25199399|NCT01727336|50415945|FG005|Part 2 Blinded|use of prohibited medications|3|||
25199400|NCT02466516|50415979|FG000|Overall Study|Adverse Event|1|||
25199401|NCT02466516|50415980|FG001|Overall Study|Adverse Event|1|||
25199402|NCT02466516|50415981|FG002|Overall Study|Adverse Event|0|||
25199403|NCT02466516|50415982|FG003|Overall Study|Adverse Event|0|||
25199404|NCT02466516|50415983|FG004|Overall Study|Adverse Event|0|||
25199405|NCT02466516|50415979|FG000|Overall Study|Withdrew Consent|1|||
25199406|NCT02466516|50415980|FG001|Overall Study|Withdrew Consent|0|||
25199407|NCT02466516|50415981|FG002|Overall Study|Withdrew Consent|0|||
25199408|NCT02466516|50415982|FG003|Overall Study|Withdrew Consent|0|||
25199409|NCT02466516|50415983|FG004|Overall Study|Withdrew Consent|0|||
25199410|NCT02466516|50415979|FG000|Overall Study|Lost to Follow-up|2|||
25199411|NCT02466516|50415980|FG001|Overall Study|Lost to Follow-up|0|||
25199412|NCT02466516|50415981|FG002|Overall Study|Lost to Follow-up|1|||
25199413|NCT02466516|50415982|FG003|Overall Study|Lost to Follow-up|0|||
25199414|NCT02466516|50415983|FG004|Overall Study|Lost to Follow-up|0|||
25199415|NCT01725152|50415997|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
25199416|NCT01725152|50415998|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
25199417|NCT01725152|50415997|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
25199418|NCT01725152|50415998|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
25199419|NCT01725152|50415997|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
25199420|NCT01725152|50415998|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
25199421|NCT01725152|50415997|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
25199422|NCT01725152|50415998|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
25199423|NCT01049984|50416014|FG000|Overall Study|Withdrawal by Subject|1|||
25199424|NCT01049984|50416015|FG001|Overall Study|Withdrawal by Subject|5|||
25199425|NCT01049984|50416014|FG000|Overall Study|Protocol Violation|3|||
25199426|NCT01049984|50416015|FG001|Overall Study|Protocol Violation|4|||
25199427|NCT01049984|50416014|FG000|Overall Study|Lost to Follow-up|2|||
25199428|NCT01049984|50416015|FG001|Overall Study|Lost to Follow-up|1|||
25199429|NCT01049984|50416014|FG000|Overall Study|Adverse Event|13|||
25199430|NCT01049984|50416015|FG001|Overall Study|Adverse Event|7|||
25199431|NCT01049984|50416014|FG000|Overall Study|Treatment failure|0|||
25199432|NCT01049984|50416015|FG001|Overall Study|Treatment failure|2|||
25199433|NCT01049360|50416021|FG000|Period 1|Adverse Event|0|||
25199434|NCT01049360|50416022|FG001|Period 1|Adverse Event|1|||
25199435|NCT01049360|50416023|FG002|Period 1|Adverse Event|0|||
25199436|NCT01049360|50416024|FG003|Period 1|Adverse Event|1|||
25199437|NCT01049360|50416025|FG004|Period 1|Adverse Event|0|||
25199438|NCT01049360|50416026|FG005|Period 1|Adverse Event|0|||
25199439|NCT01049360|50416027|FG006|Period 1|Adverse Event|0|||
25199440|NCT01049360|50416028|FG007|Period 1|Adverse Event|1|||
25199441|NCT01049360|50416029|FG008|Period 1|Adverse Event|0|||
25199442|NCT01049360|50416030|FG009|Period 1|Adverse Event|0|||
25199443|NCT01049360|50416031|FG010|Period 1|Adverse Event|0|||
25199444|NCT01049360|50416032|FG011|Period 1|Adverse Event|0|||
25199445|NCT01049360|50416033|FG012|Period 1|Adverse Event|1|||
25199446|NCT01049360|50416034|FG013|Period 1|Adverse Event|1|||
25199447|NCT01049360|50416035|FG014|Period 1|Adverse Event|0|||
25199448|NCT01049360|50416036|FG015|Period 1|Adverse Event|0|||
25199449|NCT01049360|50416037|FG016|Period 1|Adverse Event|1|||
25199450|NCT01049360|50416038|FG017|Period 1|Adverse Event|0|||
25199451|NCT01049360|50416039|FG018|Period 1|Adverse Event|1|||
25199452|NCT01049360|50416040|FG019|Period 1|Adverse Event|0|||
25199453|NCT01049360|50416021|FG000|Period 1|Did not meet inc/exc criteria|0|||
25199454|NCT01049360|50416022|FG001|Period 1|Did not meet inc/exc criteria|0|||
25199455|NCT01049360|50416023|FG002|Period 1|Did not meet inc/exc criteria|0|||
25199456|NCT01049360|50416024|FG003|Period 1|Did not meet inc/exc criteria|0|||
25199457|NCT01049360|50416025|FG004|Period 1|Did not meet inc/exc criteria|0|||
25199458|NCT01049360|50416026|FG005|Period 1|Did not meet inc/exc criteria|0|||
25199459|NCT01049360|50416027|FG006|Period 1|Did not meet inc/exc criteria|0|||
25199460|NCT01049360|50416028|FG007|Period 1|Did not meet inc/exc criteria|1|||
25199461|NCT01049360|50416029|FG008|Period 1|Did not meet inc/exc criteria|1|||
25199462|NCT01049360|50416030|FG009|Period 1|Did not meet inc/exc criteria|0|||
25199463|NCT01049360|50416031|FG010|Period 1|Did not meet inc/exc criteria|0|||
25199464|NCT01049360|50416032|FG011|Period 1|Did not meet inc/exc criteria|0|||
25199465|NCT01049360|50416033|FG012|Period 1|Did not meet inc/exc criteria|0|||
25199466|NCT01049360|50416034|FG013|Period 1|Did not meet inc/exc criteria|0|||
25199467|NCT01049360|50416035|FG014|Period 1|Did not meet inc/exc criteria|0|||
25199468|NCT01049360|50416036|FG015|Period 1|Did not meet inc/exc criteria|0|||
25199469|NCT01049360|50416037|FG016|Period 1|Did not meet inc/exc criteria|0|||
25199470|NCT01049360|50416038|FG017|Period 1|Did not meet inc/exc criteria|0|||
25199471|NCT01049360|50416039|FG018|Period 1|Did not meet inc/exc criteria|0|||
25199472|NCT01049360|50416040|FG019|Period 1|Did not meet inc/exc criteria|0|||
25199473|NCT01049360|50416021|FG000|Period 1|Withdrawal by Subject|0|||
25199474|NCT01049360|50416022|FG001|Period 1|Withdrawal by Subject|0|||
25199475|NCT01049360|50416023|FG002|Period 1|Withdrawal by Subject|0|||
25199476|NCT01049360|50416024|FG003|Period 1|Withdrawal by Subject|0|||
25199477|NCT01049360|50416025|FG004|Period 1|Withdrawal by Subject|0|||
25199478|NCT01049360|50416026|FG005|Period 1|Withdrawal by Subject|0|||
25199479|NCT01049360|50416027|FG006|Period 1|Withdrawal by Subject|0|||
25199480|NCT01049360|50416028|FG007|Period 1|Withdrawal by Subject|0|||
25199481|NCT01049360|50416029|FG008|Period 1|Withdrawal by Subject|1|||
25199482|NCT01049360|50416030|FG009|Period 1|Withdrawal by Subject|0|||
25199483|NCT01049360|50416031|FG010|Period 1|Withdrawal by Subject|1|||
25199484|NCT01049360|50416032|FG011|Period 1|Withdrawal by Subject|0|||
25199485|NCT01049360|50416033|FG012|Period 1|Withdrawal by Subject|1|||
25199486|NCT01049360|50416034|FG013|Period 1|Withdrawal by Subject|0|||
25199487|NCT01049360|50416035|FG014|Period 1|Withdrawal by Subject|0|||
25199488|NCT01049360|50416036|FG015|Period 1|Withdrawal by Subject|0|||
25199489|NCT01049360|50416037|FG016|Period 1|Withdrawal by Subject|0|||
25199490|NCT01049360|50416038|FG017|Period 1|Withdrawal by Subject|0|||
25199491|NCT01049360|50416039|FG018|Period 1|Withdrawal by Subject|0|||
25199492|NCT01049360|50416040|FG019|Period 1|Withdrawal by Subject|0|||
25199493|NCT01049360|50416021|FG000|Period 2|Protocol Violation|0|||
25199494|NCT01049360|50416022|FG001|Period 2|Protocol Violation|0|||
25199495|NCT01049360|50416023|FG002|Period 2|Protocol Violation|0|||
25199496|NCT01049360|50416024|FG003|Period 2|Protocol Violation|1|||
25199497|NCT01049360|50416025|FG004|Period 2|Protocol Violation|0|||
25315388|NCT00968669|50631234|FG003|Overall Study|AE|0|||
25315389|NCT00968669|50631231|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
25315390|NCT00968669|50631232|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
25315391|NCT00968669|50631233|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
25315392|NCT00968669|50631234|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
25315393|NCT00968669|50631231|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
25315394|NCT00968669|50631232|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
25315395|NCT00968669|50631233|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
25315396|NCT00968669|50631234|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
25315397|NCT00968669|50631231|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
25315398|NCT00968669|50631232|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
25315399|NCT00968669|50631233|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
25315400|NCT00968669|50631234|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
25315401|NCT00968669|50631231|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
25315402|NCT00968669|50631232|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
25315403|NCT00968669|50631233|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
25315404|NCT00968669|50631234|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
25315405|NCT00968669|50631231|FG000|Overall Study|EARLY WITHDRAWAL|0|||
25315406|NCT00968669|50631232|FG001|Overall Study|EARLY WITHDRAWAL|1|||
25315407|NCT00968669|50631233|FG002|Overall Study|EARLY WITHDRAWAL|0|||
25199498|NCT01049360|50416026|FG005|Period 2|Protocol Violation|0|||
25199499|NCT01049360|50416027|FG006|Period 2|Protocol Violation|0|||
25199500|NCT01049360|50416028|FG007|Period 2|Protocol Violation|0|||
25199501|NCT01049360|50416029|FG008|Period 2|Protocol Violation|0|||
25199502|NCT01049360|50416030|FG009|Period 2|Protocol Violation|0|||
25199503|NCT01049360|50416031|FG010|Period 2|Protocol Violation|0|||
25199504|NCT01049360|50416032|FG011|Period 2|Protocol Violation|0|||
25199505|NCT01049360|50416033|FG012|Period 2|Protocol Violation|0|||
25199506|NCT01049360|50416034|FG013|Period 2|Protocol Violation|0|||
25315408|NCT00968669|50631234|FG003|Overall Study|EARLY WITHDRAWAL|0|||
25199507|NCT01049360|50416035|FG014|Period 2|Protocol Violation|1|||
25199508|NCT01049360|50416036|FG015|Period 2|Protocol Violation|1|||
25199509|NCT01049360|50416037|FG016|Period 2|Protocol Violation|0|||
25199510|NCT01049360|50416038|FG017|Period 2|Protocol Violation|0|||
25199511|NCT01049360|50416039|FG018|Period 2|Protocol Violation|0|||
25199512|NCT01049360|50416040|FG019|Period 2|Protocol Violation|0|||
25199513|NCT01049360|50416021|FG000|Period 2|Adverse Event|0|||
25199514|NCT01049360|50416022|FG001|Period 2|Adverse Event|1|||
25199515|NCT01049360|50416023|FG002|Period 2|Adverse Event|0|||
25199516|NCT01049360|50416024|FG003|Period 2|Adverse Event|0|||
25199517|NCT01049360|50416025|FG004|Period 2|Adverse Event|0|||
25199518|NCT01049360|50416026|FG005|Period 2|Adverse Event|0|||
25199519|NCT01049360|50416027|FG006|Period 2|Adverse Event|0|||
25199520|NCT01049360|50416028|FG007|Period 2|Adverse Event|0|||
25199521|NCT01049360|50416029|FG008|Period 2|Adverse Event|1|||
25199522|NCT01049360|50416030|FG009|Period 2|Adverse Event|0|||
25199523|NCT01049360|50416031|FG010|Period 2|Adverse Event|0|||
25199524|NCT01049360|50416032|FG011|Period 2|Adverse Event|0|||
25315409|NCT00968669|50631231|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
25315410|NCT00968669|50631232|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
25315411|NCT00968669|50631233|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
25315412|NCT00968669|50631234|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
25315413|NCT00968669|50631231|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
25315414|NCT00968669|50631232|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
25315415|NCT00968669|50631233|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
25315416|NCT00968669|50631234|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
25315417|NCT00968669|50631231|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
25315418|NCT00968669|50631232|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
25315419|NCT00968669|50631233|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
25315420|NCT00968669|50631234|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
25315421|NCT00968669|50631231|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
25315422|NCT00968669|50631232|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
25315423|NCT00968669|50631233|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
25315424|NCT00968669|50631234|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
25315425|NCT00968669|50631231|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
25315426|NCT00968669|50631232|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
25315427|NCT00968669|50631233|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
25315428|NCT00968669|50631234|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
25315429|NCT00968669|50631231|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
25315430|NCT00968669|50631232|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
25315431|NCT00968669|50631233|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
25315432|NCT00968669|50631234|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
25315433|NCT00968669|50631231|FG000|Overall Study|SPONSOR DECISION|0|||
25315434|NCT00968669|50631232|FG001|Overall Study|SPONSOR DECISION|1|||
25315435|NCT00968669|50631233|FG002|Overall Study|SPONSOR DECISION|0|||
25315436|NCT00968669|50631234|FG003|Overall Study|SPONSOR DECISION|0|||
25315437|NCT00968669|50631231|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
25315438|NCT00968669|50631232|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
25315439|NCT00968669|50631233|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
25315440|NCT00968669|50631234|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
25315441|NCT00968669|50631231|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
25315442|NCT00968669|50631232|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
25315443|NCT00968669|50631233|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
25315444|NCT00968669|50631234|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
25315445|NCT00968669|50631231|FG000|Overall Study|SUBJECT INCARCERATED|0|||
25315446|NCT00968669|50631232|FG001|Overall Study|SUBJECT INCARCERATED|1|||
25315447|NCT00968669|50631233|FG002|Overall Study|SUBJECT INCARCERATED|0|||
25315448|NCT00968669|50631234|FG003|Overall Study|SUBJECT INCARCERATED|0|||
25315449|NCT00968669|50631231|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
25315450|NCT00968669|50631232|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
25315451|NCT00968669|50631233|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
25315452|NCT00968669|50631234|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
25315453|NCT00968669|50631231|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
25315454|NCT00968669|50631232|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
25315455|NCT00968669|50631233|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
25315456|NCT00968669|50631234|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
25315457|NCT00568399|50631244|FG000|Overall Study|Death|2|||
25315458|NCT00568399|50631244|FG000|Overall Study|Adverse Event|5|||
25315459|NCT00568399|50631244|FG000|Overall Study|Withdrawal by Subject|8|||
25199525|NCT01049360|50416033|FG012|Period 2|Adverse Event|0|||
25199526|NCT01049360|50416034|FG013|Period 2|Adverse Event|0|||
25199527|NCT01049360|50416035|FG014|Period 2|Adverse Event|0|||
25199528|NCT01049360|50416036|FG015|Period 2|Adverse Event|0|||
25199529|NCT01049360|50416037|FG016|Period 2|Adverse Event|0|||
25199530|NCT01049360|50416038|FG017|Period 2|Adverse Event|0|||
25199531|NCT01049360|50416039|FG018|Period 2|Adverse Event|0|||
25315460|NCT00975143|50631250|FG000|Overall Study|Adverse Event|19|||
25315461|NCT00975143|50631251|FG001|Overall Study|Adverse Event|15|||
25315462|NCT00975143|50631250|FG000|Overall Study|Withdrawal by Subject|15|||
25315463|NCT00975143|50631251|FG001|Overall Study|Withdrawal by Subject|15|||
25315464|NCT00975143|50631250|FG000|Overall Study|Lost to Follow-up|20|||
25315465|NCT00975143|50631251|FG001|Overall Study|Lost to Follow-up|16|||
25315466|NCT00975143|50631250|FG000|Overall Study|Non-compliance|5|||
25315467|NCT00975143|50631251|FG001|Overall Study|Non-compliance|8|||
25315468|NCT00975143|50631250|FG000|Overall Study|Physician Decision|1|||
25315469|NCT00975143|50631251|FG001|Overall Study|Physician Decision|2|||
25315470|NCT00975143|50631250|FG000|Overall Study|Details not available|10|||
25315471|NCT00975143|50631251|FG001|Overall Study|Details not available|4|||
25315472|NCT00974675|50631274|FG000|Overall Study|Adverse Event|2|||
25315473|NCT00974675|50631275|FG001|Overall Study|Adverse Event|1|||
25315474|NCT00974675|50631276|FG002|Overall Study|Adverse Event|1|||
25315475|NCT00974675|50631277|FG003|Overall Study|Adverse Event|1|||
25315476|NCT00974675|50631274|FG000|Overall Study|Physician Decision|0|||
25315477|NCT00974675|50631275|FG001|Overall Study|Physician Decision|0|||
25315478|NCT00974675|50631276|FG002|Overall Study|Physician Decision|1|||
25315479|NCT00974675|50631277|FG003|Overall Study|Physician Decision|0|||
24976250|NCT00038948|50065159|FG001|Overall Study|Withdrawal by Subject|10|||
24976251|NCT00038948|50065158|FG000|Overall Study|Protocol Violation|3|||
24976252|NCT00038948|50065159|FG001|Overall Study|Protocol Violation|7|||
24976253|NCT00038948|50065158|FG000|Overall Study|Lack of Efficacy|3|||
25077065|NCT03347188|50184899|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
25077066|NCT02440568|50184909|FG000|Overall Study|Death|1|||
25077067|NCT02440568|50184910|FG001|Overall Study|Death|3|||
25077068|NCT02440568|50184911|FG002|Overall Study|Death|4|||
25077069|NCT02440568|50184912|FG003|Overall Study|Death|2|||
25077070|NCT02440568|50184909|FG000|Overall Study|Lack of Efficacy|2|||
25077071|NCT02440568|50184910|FG001|Overall Study|Lack of Efficacy|0|||
25077072|NCT02440568|50184911|FG002|Overall Study|Lack of Efficacy|1|||
25077073|NCT02440568|50184912|FG003|Overall Study|Lack of Efficacy|0|||
25077074|NCT02440568|50184909|FG000|Overall Study|Lost to Follow-up|1|||
25077075|NCT02440568|50184910|FG001|Overall Study|Lost to Follow-up|0|||
25077076|NCT02440568|50184911|FG002|Overall Study|Lost to Follow-up|0|||
25077077|NCT02440568|50184912|FG003|Overall Study|Lost to Follow-up|0|||
25077078|NCT03090191|50184925|FG000|Overall Study|Adverse Event|90|||
25077079|NCT03090191|50184926|FG001|Overall Study|Adverse Event|72|||
25077080|NCT03090191|50184925|FG000|Overall Study|Death|365|||
25077081|NCT03090191|50184926|FG001|Overall Study|Death|358|||
25077082|NCT03090191|50184925|FG000|Overall Study|Lost to Follow-up|382|||
25077083|NCT03090191|50184926|FG001|Overall Study|Lost to Follow-up|394|||
25077084|NCT03090191|50184925|FG000|Overall Study|Physician Decision|77|||
25077085|NCT03090191|50184926|FG001|Overall Study|Physician Decision|66|||
25077086|NCT03090191|50184925|FG000|Overall Study|Protocol Violation|43|||
25315480|NCT00974675|50631274|FG000|Overall Study|Participant on holiday; unable to attend|0|||
25315481|NCT00974675|50631275|FG001|Overall Study|Participant on holiday; unable to attend|0|||
25315482|NCT00974675|50631276|FG002|Overall Study|Participant on holiday; unable to attend|0|||
25315483|NCT00974675|50631277|FG003|Overall Study|Participant on holiday; unable to attend|1|||
25315484|NCT00634933|50631290|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
25315485|NCT00634933|50631291|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
24976254|NCT00038948|50065159|FG001|Overall Study|Lack of Efficacy|6|||
24976255|NCT00054704|50065173|FG000|Overall Study|Lack of Efficacy|2|||
24976256|NCT00054704|50065174|FG001|Overall Study|Lack of Efficacy|3|||
24976257|NCT00054704|50065173|FG000|Overall Study|Adverse Event|3|||
24976258|NCT00054704|50065174|FG001|Overall Study|Adverse Event|1|||
24976259|NCT00054704|50065173|FG000|Overall Study|Lost to Follow-up|0|||
24976260|NCT00054704|50065174|FG001|Overall Study|Lost to Follow-up|1|||
24976261|NCT00031694|50065180|FG000|Overall Study|Adverse Event|12|||
25315486|NCT00634933|50631292|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
24976262|NCT00031694|50065180|FG000|Overall Study|Death|2|||
25077087|NCT03090191|50184926|FG001|Overall Study|Protocol Violation|52|||
25077088|NCT03090191|50184925|FG000|Overall Study|Withdrawal by Subject|2160|||
25077089|NCT03090191|50184926|FG001|Overall Study|Withdrawal by Subject|2133|||
25077090|NCT03090191|50184925|FG000|Overall Study|Site terminated|7|||
25315487|NCT00634933|50631293|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
25315488|NCT00634933|50631294|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
25315489|NCT00634933|50631290|FG000|Part A: Baseline to Week 24|Death|1|||
25315490|NCT00634933|50631291|FG001|Part A: Baseline to Week 24|Death|0|||
25315491|NCT00634933|50631292|FG002|Part A: Baseline to Week 24|Death|0|||
25315492|NCT00634933|50631293|FG003|Part A: Baseline to Week 24|Death|0|||
25315493|NCT00634933|50631294|FG004|Part A: Baseline to Week 24|Death|0|||
25315494|NCT00634933|50631290|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
25315495|NCT00634933|50631291|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
25315496|NCT00634933|50631292|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
25315497|NCT00634933|50631293|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
25315498|NCT00634933|50631294|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
25315499|NCT00634933|50631290|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
25315500|NCT00634933|50631291|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
25315501|NCT00634933|50631292|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
25315502|NCT00634933|50631293|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
25315503|NCT00634933|50631294|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
25315504|NCT00634933|50631290|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
25315505|NCT00634933|50631291|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
25315506|NCT00634933|50631292|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
25315507|NCT00634933|50631293|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
25315508|NCT00634933|50631294|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
25315509|NCT00634933|50631290|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
25315510|NCT00634933|50631291|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
25315511|NCT00634933|50631292|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
25315512|NCT00634933|50631293|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
25315513|NCT00634933|50631294|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
25315514|NCT00634933|50631290|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
25315515|NCT00634933|50631291|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
25315516|NCT00634933|50631292|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
25315517|NCT00634933|50631293|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
25315518|NCT00634933|50631294|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
25315519|NCT00634933|50631290|FG000|Part A: Baseline to Week 24|Other|1|||
25315520|NCT00634933|50631291|FG001|Part A: Baseline to Week 24|Other|8|||
25315521|NCT00634933|50631292|FG002|Part A: Baseline to Week 24|Other|5|||
25315522|NCT00634933|50631293|FG003|Part A: Baseline to Week 24|Other|0|||
25315523|NCT00634933|50631294|FG004|Part A: Baseline to Week 24|Other|0|||
25315524|NCT00634933|50631290|FG000|Between Part A and Part B|Physician Decision|0|||
25315525|NCT00634933|50631291|FG001|Between Part A and Part B|Physician Decision|1|||
25315526|NCT00634933|50631292|FG002|Between Part A and Part B|Physician Decision|0|||
25315527|NCT00634933|50631293|FG003|Between Part A and Part B|Physician Decision|0|||
25315528|NCT00634933|50631294|FG004|Between Part A and Part B|Physician Decision|0|||
25315529|NCT00634933|50631290|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
25315530|NCT00634933|50631291|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
25315531|NCT00634933|50631292|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
25315532|NCT00634933|50631293|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
25315533|NCT00634933|50631294|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
25315534|NCT00634933|50631290|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
25315535|NCT00634933|50631291|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
25315536|NCT00634933|50631292|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
25315537|NCT00634933|50631293|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
25315538|NCT00634933|50631294|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
25315539|NCT00634933|50631290|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
25315540|NCT00634933|50631291|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
25315541|NCT00634933|50631292|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
25315542|NCT00634933|50631293|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
25315543|NCT00634933|50631294|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
25315544|NCT00634933|50631290|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
25315545|NCT00634933|50631291|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
25315546|NCT00634933|50631292|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
25077091|NCT03090191|50184926|FG001|Overall Study|Site terminated|8|||
25170949|NCT00556426|50307827|FG000|Overall Study|Withdrawal by Subject|3|||
25170950|NCT00556426|50307827|FG000|Overall Study|Death|6|||
25170951|NCT00555568|50307835|FG000|Overall Study|Lost to Follow-up|26|||
25170952|NCT00555568|50307836|FG001|Overall Study|Lost to Follow-up|16|||
25170953|NCT00555568|50307837|FG002|Overall Study|Lost to Follow-up|16|||
25170954|NCT00702702|50307848|FG000|Overall Study|Study prematurely terminated|56|||
25170955|NCT02721966|50307859|FG000|Overall Study|Protocol Violation|1|||
25170956|NCT02721966|50307860|FG001|Overall Study|Protocol Violation|0|||
25170957|NCT02721966|50307861|FG002|Overall Study|Protocol Violation|0|||
25170958|NCT02721966|50307862|FG003|Overall Study|Protocol Violation|0|||
25170959|NCT02721966|50307863|FG004|Overall Study|Protocol Violation|0|||
25077092|NCT03090191|50184925|FG000|Overall Study|Other|66|||
25199532|NCT01049360|50416040|FG019|Period 2|Adverse Event|1|||
25199533|NCT01049360|50416021|FG000|Period 2|Withdrawal by Subject|0|||
25199534|NCT01049360|50416022|FG001|Period 2|Withdrawal by Subject|0|||
25199535|NCT01049360|50416023|FG002|Period 2|Withdrawal by Subject|0|||
25199536|NCT01049360|50416024|FG003|Period 2|Withdrawal by Subject|1|||
25199537|NCT01049360|50416025|FG004|Period 2|Withdrawal by Subject|0|||
25199538|NCT01049360|50416026|FG005|Period 2|Withdrawal by Subject|0|||
25199539|NCT01049360|50416027|FG006|Period 2|Withdrawal by Subject|0|||
25199540|NCT01049360|50416028|FG007|Period 2|Withdrawal by Subject|0|||
25199541|NCT01049360|50416029|FG008|Period 2|Withdrawal by Subject|0|||
25199542|NCT01049360|50416030|FG009|Period 2|Withdrawal by Subject|0|||
25199543|NCT01049360|50416031|FG010|Period 2|Withdrawal by Subject|0|||
25199544|NCT01049360|50416032|FG011|Period 2|Withdrawal by Subject|0|||
25199545|NCT01049360|50416033|FG012|Period 2|Withdrawal by Subject|0|||
25199546|NCT01049360|50416034|FG013|Period 2|Withdrawal by Subject|0|||
25199547|NCT01049360|50416035|FG014|Period 2|Withdrawal by Subject|1|||
25199548|NCT01049360|50416036|FG015|Period 2|Withdrawal by Subject|0|||
25199549|NCT01049360|50416037|FG016|Period 2|Withdrawal by Subject|0|||
25199550|NCT01049360|50416038|FG017|Period 2|Withdrawal by Subject|0|||
25199551|NCT01049360|50416039|FG018|Period 2|Withdrawal by Subject|0|||
25199552|NCT01049360|50416040|FG019|Period 2|Withdrawal by Subject|1|||
25199553|NCT01049360|50416021|FG000|Period 2|Lack of Efficacy|0|||
25199554|NCT01049360|50416022|FG001|Period 2|Lack of Efficacy|0|||
25199555|NCT01049360|50416023|FG002|Period 2|Lack of Efficacy|0|||
25199556|NCT01049360|50416024|FG003|Period 2|Lack of Efficacy|0|||
25199557|NCT01049360|50416025|FG004|Period 2|Lack of Efficacy|0|||
25199558|NCT01049360|50416026|FG005|Period 2|Lack of Efficacy|1|||
25199559|NCT01049360|50416027|FG006|Period 2|Lack of Efficacy|0|||
25199560|NCT01049360|50416028|FG007|Period 2|Lack of Efficacy|0|||
25199561|NCT01049360|50416029|FG008|Period 2|Lack of Efficacy|0|||
25199562|NCT01049360|50416030|FG009|Period 2|Lack of Efficacy|0|||
25199563|NCT01049360|50416031|FG010|Period 2|Lack of Efficacy|0|||
25199564|NCT01049360|50416032|FG011|Period 2|Lack of Efficacy|0|||
25199565|NCT01049360|50416033|FG012|Period 2|Lack of Efficacy|0|||
25199566|NCT01049360|50416034|FG013|Period 2|Lack of Efficacy|0|||
25199567|NCT01049360|50416035|FG014|Period 2|Lack of Efficacy|0|||
25199568|NCT01049360|50416036|FG015|Period 2|Lack of Efficacy|0|||
25199569|NCT01049360|50416037|FG016|Period 2|Lack of Efficacy|0|||
25199570|NCT01049360|50416038|FG017|Period 2|Lack of Efficacy|0|||
25199571|NCT01049360|50416039|FG018|Period 2|Lack of Efficacy|0|||
25199572|NCT01049360|50416040|FG019|Period 2|Lack of Efficacy|0|||
25199573|NCT01049360|50416021|FG000|Period 4|Protocol Violation|0|||
25199574|NCT01049360|50416022|FG001|Period 4|Protocol Violation|0|||
25199575|NCT01049360|50416023|FG002|Period 4|Protocol Violation|0|||
25199576|NCT01049360|50416024|FG003|Period 4|Protocol Violation|0|||
25199577|NCT01049360|50416025|FG004|Period 4|Protocol Violation|0|||
25199578|NCT01049360|50416026|FG005|Period 4|Protocol Violation|0|||
25199579|NCT01049360|50416027|FG006|Period 4|Protocol Violation|0|||
25199580|NCT01049360|50416028|FG007|Period 4|Protocol Violation|0|||
25199581|NCT01049360|50416029|FG008|Period 4|Protocol Violation|0|||
25199582|NCT01049360|50416030|FG009|Period 4|Protocol Violation|0|||
25199583|NCT01049360|50416031|FG010|Period 4|Protocol Violation|0|||
25199584|NCT01049360|50416032|FG011|Period 4|Protocol Violation|0|||
25199585|NCT01049360|50416033|FG012|Period 4|Protocol Violation|0|||
25199586|NCT01049360|50416034|FG013|Period 4|Protocol Violation|0|||
25199587|NCT01049360|50416035|FG014|Period 4|Protocol Violation|0|||
25199588|NCT01049360|50416036|FG015|Period 4|Protocol Violation|0|||
25199589|NCT01049360|50416037|FG016|Period 4|Protocol Violation|0|||
25199590|NCT01049360|50416038|FG017|Period 4|Protocol Violation|1|||
25199591|NCT01049360|50416039|FG018|Period 4|Protocol Violation|0|||
25199592|NCT01049360|50416040|FG019|Period 4|Protocol Violation|0|||
25199593|NCT01049360|50416021|FG000|Period 4|Withdrawal by Subject|0|||
25199594|NCT01049360|50416022|FG001|Period 4|Withdrawal by Subject|0|||
25199595|NCT01049360|50416023|FG002|Period 4|Withdrawal by Subject|0|||
25199596|NCT01049360|50416024|FG003|Period 4|Withdrawal by Subject|1|||
25199597|NCT01049360|50416025|FG004|Period 4|Withdrawal by Subject|0|||
25199598|NCT01049360|50416026|FG005|Period 4|Withdrawal by Subject|0|||
25199599|NCT01049360|50416027|FG006|Period 4|Withdrawal by Subject|0|||
25199600|NCT01049360|50416028|FG007|Period 4|Withdrawal by Subject|0|||
25199601|NCT01049360|50416029|FG008|Period 4|Withdrawal by Subject|0|||
25199602|NCT01049360|50416030|FG009|Period 4|Withdrawal by Subject|0|||
25199603|NCT01049360|50416031|FG010|Period 4|Withdrawal by Subject|0|||
25199604|NCT01049360|50416032|FG011|Period 4|Withdrawal by Subject|0|||
25199605|NCT01049360|50416033|FG012|Period 4|Withdrawal by Subject|0|||
25199606|NCT01049360|50416034|FG013|Period 4|Withdrawal by Subject|0|||
25199607|NCT01049360|50416035|FG014|Period 4|Withdrawal by Subject|0|||
25199608|NCT01049360|50416036|FG015|Period 4|Withdrawal by Subject|0|||
25199609|NCT01049360|50416037|FG016|Period 4|Withdrawal by Subject|0|||
25199610|NCT01049360|50416038|FG017|Period 4|Withdrawal by Subject|0|||
25199611|NCT01049360|50416039|FG018|Period 4|Withdrawal by Subject|0|||
25199612|NCT01049360|50416040|FG019|Period 4|Withdrawal by Subject|0|||
25199613|NCT02494596|50416052|FG000|Overall Study|Insufficient Therapeutic Response|3|||
25199614|NCT02494596|50416053|FG001|Overall Study|Insufficient Therapeutic Response|3|||
25199615|NCT02494596|50416054|FG002|Overall Study|Insufficient Therapeutic Response|1|||
25199616|NCT02494596|50416052|FG000|Overall Study|Adverse Event|0|||
25199617|NCT02494596|50416053|FG001|Overall Study|Adverse Event|1|||
25199618|NCT02494596|50416054|FG002|Overall Study|Adverse Event|0|||
25199619|NCT02494596|50416052|FG000|Overall Study|Refused Treatment|0|||
25199620|NCT02494596|50416053|FG001|Overall Study|Refused Treatment|1|||
25199621|NCT02494596|50416054|FG002|Overall Study|Refused Treatment|0|||
25199622|NCT02494206|50416073|FG000|Overall Study|Adverse Event|1|||
25199623|NCT02494206|50416073|FG000|Overall Study|Disease Progression|1|||
25199624|NCT01048502|50416090|FG000|Overall Study|Lost to Follow-up|2|||
25199625|NCT01048502|50416091|FG001|Overall Study|Lost to Follow-up|0|||
25199626|NCT01048502|50416092|FG002|Overall Study|Lost to Follow-up|0|||
25199627|NCT01048502|50416093|FG003|Overall Study|Lost to Follow-up|0|||
25199628|NCT01048502|50416090|FG000|Overall Study|Adverse Event|1|||
25199629|NCT01048502|50416091|FG001|Overall Study|Adverse Event|0|||
25199630|NCT01048502|50416092|FG002|Overall Study|Adverse Event|0|||
25199631|NCT01048502|50416093|FG003|Overall Study|Adverse Event|0|||
25199632|NCT01048502|50416090|FG000|Overall Study|Withdrawal by Subject|1|||
25199633|NCT01048502|50416091|FG001|Overall Study|Withdrawal by Subject|4|||
25199634|NCT01048502|50416092|FG002|Overall Study|Withdrawal by Subject|5|||
25199635|NCT01048502|50416093|FG003|Overall Study|Withdrawal by Subject|3|||
25199636|NCT01048502|50416090|FG000|Overall Study|Physician Decision|0|||
25199637|NCT01048502|50416091|FG001|Overall Study|Physician Decision|3|||
25199638|NCT01048502|50416092|FG002|Overall Study|Physician Decision|0|||
25199639|NCT01048502|50416093|FG003|Overall Study|Physician Decision|1|||
25199640|NCT02465034|50416106|FG000|Overall Study|Withdrawal by Subject|1|||
25199641|NCT02465034|50416107|FG001|Overall Study|Withdrawal by Subject|1|||
25199642|NCT02465034|50416106|FG000|Overall Study|Screen fail|2|||
25199643|NCT02465034|50416107|FG001|Overall Study|Screen fail|0|||
25199644|NCT02465034|50416106|FG000|Overall Study|Could not be scheduled for study visit|0|||
25199645|NCT02465034|50416107|FG001|Overall Study|Could not be scheduled for study visit|5|||
25199646|NCT02516982|50416134|FG000|Overall Study|Called in to antenatal appointment|32|||
25199647|NCT02516982|50416135|FG001|Overall Study|Called in to antenatal appointment|35|||
25199648|NCT02516982|50416136|FG002|Overall Study|Called in to antenatal appointment|0|||
25199649|NCT02516982|50416137|FG003|Overall Study|Called in to antenatal appointment|0|||
25199650|NCT02516982|50416134|FG000|Overall Study|Withdrawal by Subject|0|||
25199651|NCT02516982|50416135|FG001|Overall Study|Withdrawal by Subject|0|||
25199652|NCT02516982|50416136|FG002|Overall Study|Withdrawal by Subject|1|||
25199653|NCT02516982|50416137|FG003|Overall Study|Withdrawal by Subject|2|||
25199654|NCT02516982|50416134|FG000|Overall Study|Protocol Violation|0|||
25199655|NCT02516982|50416135|FG001|Overall Study|Protocol Violation|0|||
25199656|NCT02516982|50416136|FG002|Overall Study|Protocol Violation|1|||
25199657|NCT02516982|50416137|FG003|Overall Study|Protocol Violation|1|||
25199658|NCT02516982|50416134|FG000|Overall Study|Did not install the app|0|||
25199659|NCT02516982|50416135|FG001|Overall Study|Did not install the app|0|||
25199660|NCT02516982|50416136|FG002|Overall Study|Did not install the app|46|||
25199661|NCT02516982|50416137|FG003|Overall Study|Did not install the app|47|||
25199662|NCT02464410|50416182|FG000|Overall Study|Death|3|||
25199663|NCT02464410|50416183|FG001|Overall Study|Death|4|||
25199664|NCT02464410|50416182|FG000|Overall Study|Lost to Follow-up|7|||
25199665|NCT02464410|50416183|FG001|Overall Study|Lost to Follow-up|9|||
25199666|NCT02464410|50416182|FG000|Overall Study|Withdrawal by Subject|12|||
25199667|NCT02464410|50416183|FG001|Overall Study|Withdrawal by Subject|3|||
25199668|NCT01047332|50416191|FG000|Overall Study|SEMS Obstruction|11|||
25199669|NCT01047332|50416192|FG001|Overall Study|SEMS Obstruction|20|||
25199670|NCT01047332|50416191|FG000|Overall Study|Died Unobstructed|38|||
25199671|NCT01047332|50416192|FG001|Overall Study|Died Unobstructed|41|||
25199672|NCT01047332|50416191|FG000|Overall Study|Lost to Follow-up|8|||
25199673|NCT01047332|50416192|FG001|Overall Study|Lost to Follow-up|3|||
25199674|NCT01046396|50416198|FG000|Overall Study|Withdrawal by Subject|5|||
25199675|NCT01046084|50416224|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
25199676|NCT01046084|50416225|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
25199677|NCT01045694|50416244|FG000|Overall Study|Withdrawal by Subject|2|||
25199678|NCT01044290|50416304|FG000|Follow-up 1|Death|3|||
25199679|NCT01044290|50416305|FG001|Follow-up 1|Death|3|||
25199680|NCT01044290|50416306|FG002|Follow-up 1|Death|1|||
25199681|NCT01044290|50416304|FG000|Follow-up 1|Withdrawal by Subject|2|||
25199682|NCT01044290|50416305|FG001|Follow-up 1|Withdrawal by Subject|2|||
25199683|NCT01044290|50416306|FG002|Follow-up 1|Withdrawal by Subject|0|||
25199684|NCT01044290|50416304|FG000|Follow-Up 2|Death|0|||
25199685|NCT01044290|50416305|FG001|Follow-Up 2|Death|1|||
25315547|NCT00634933|50631293|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
25315548|NCT00634933|50631294|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
25199686|NCT01044290|50416306|FG002|Follow-Up 2|Death|1|||
25199687|NCT01044290|50416304|FG000|Follow-Up 2|Withdrawal by Subject|0|||
25077093|NCT03090191|50184926|FG001|Overall Study|Other|60|||
25199688|NCT01044290|50416305|FG001|Follow-Up 2|Withdrawal by Subject|1|||
25199689|NCT01044290|50416306|FG002|Follow-Up 2|Withdrawal by Subject|1|||
25199690|NCT01041638|50416387|FG000|Overall Study|Adverse Event|4|||
25199691|NCT01041638|50416387|FG000|Overall Study|Death|1|||
25199692|NCT01041638|50416387|FG000|Overall Study|Lack of Efficacy|7|||
25199693|NCT01041638|50416387|FG000|Overall Study|Physician Decision|4|||
25199694|NCT01041638|50416387|FG000|Overall Study|Withdrawal by Subject|11|||
25199695|NCT01045460|50416411|FG000|Overall Study|Physician Decision|3|||
25199696|NCT01045460|50416412|FG001|Overall Study|Physician Decision|2|||
25199697|NCT01045460|50416411|FG000|Overall Study|Lost to Follow-up|0|||
25199698|NCT01045460|50416412|FG001|Overall Study|Lost to Follow-up|1|||
25199699|NCT01045460|50416411|FG000|Overall Study|Lack of Efficacy|3|||
25199700|NCT01045460|50416412|FG001|Overall Study|Lack of Efficacy|0|||
25199701|NCT05014919|50416423|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
25199702|NCT05014919|50416424|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
25199703|NCT05014919|50416425|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
25199704|NCT05014919|50416423|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
25199705|NCT05014919|50416424|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
25199706|NCT05014919|50416425|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
25199707|NCT05014919|50416423|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
25199708|NCT05014919|50416424|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
25199709|NCT05014919|50416425|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
25199710|NCT05014919|50416423|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
25199711|NCT05014919|50416424|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
25199712|NCT05014919|50416425|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
25199713|NCT05014919|50416423|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
25199714|NCT05014919|50416424|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
25199715|NCT05014919|50416425|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
25199716|NCT05014919|50416423|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
25199717|NCT05014919|50416424|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
25199718|NCT05014919|50416425|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
25199719|NCT05014919|50416423|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
25199720|NCT05014919|50416424|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
25199721|NCT05014919|50416425|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
25199722|NCT05014919|50416423|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
25199723|NCT05014919|50416424|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
25199724|NCT05014919|50416425|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
25199725|NCT03409796|50416468|FG000|Overall Study|Adverse Event|2|||
25199726|NCT03409796|50416469|FG001|Overall Study|Adverse Event|0|||
25199727|NCT03409796|50416468|FG000|Overall Study|Other|0|||
25199728|NCT03409796|50416469|FG001|Overall Study|Other|1|||
25199729|NCT02462928|50416478|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
25199730|NCT02462928|50416479|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
25199731|NCT02462928|50416480|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
25199732|NCT02462928|50416478|FG000|Overall Study|Adverse Event|47|||
25199733|NCT02462928|50416479|FG001|Overall Study|Adverse Event|51|||
25199734|NCT02462928|50416480|FG002|Overall Study|Adverse Event|25|||
25199735|NCT02462928|50416478|FG000|Overall Study|Lack of Efficacy|3|||
25199736|NCT02462928|50416479|FG001|Overall Study|Lack of Efficacy|8|||
25199737|NCT02462928|50416480|FG002|Overall Study|Lack of Efficacy|3|||
25199738|NCT02462928|50416478|FG000|Overall Study|Lost to Follow-up|4|||
25199739|NCT02462928|50416479|FG001|Overall Study|Lost to Follow-up|4|||
25199740|NCT02462928|50416480|FG002|Overall Study|Lost to Follow-up|1|||
25199741|NCT02462928|50416478|FG000|Overall Study|Withdrawal by Patient|31|||
25199742|NCT02462928|50416479|FG001|Overall Study|Withdrawal by Patient|21|||
25199743|NCT02462928|50416480|FG002|Overall Study|Withdrawal by Patient|21|||
25199744|NCT02462928|50416478|FG000|Overall Study|Protocol Violation|0|||
25199745|NCT02462928|50416479|FG001|Overall Study|Protocol Violation|1|||
25199746|NCT02462928|50416480|FG002|Overall Study|Protocol Violation|0|||
25199747|NCT02462928|50416478|FG000|Overall Study|Reason not Specified|4|||
25199748|NCT02462928|50416479|FG001|Overall Study|Reason not Specified|6|||
25199749|NCT02462928|50416480|FG002|Overall Study|Reason not Specified|5|||
25199750|NCT00019604|50416497|FG000|Overall Study|Death|1|||
25199751|NCT00019604|50416497|FG000|Overall Study|Progressive disease|23|||
25199752|NCT00019604|50416497|FG000|Overall Study|Refused treatment|1|||
25199753|NCT00019604|50416497|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
25199754|NCT00019604|50416497|FG000|Overall Study|Going to have liver transplant|1|||
25199755|NCT00019604|50416497|FG000|Overall Study|Move to a different study|1|||
25199756|NCT00019604|50416497|FG000|Overall Study|Non compliant on systemic CH|1|||
25199757|NCT00019604|50416497|FG000|Overall Study|Non compliant|1|||
25199758|NCT00019604|50416497|FG000|Overall Study|Resectable disease|1|||
25199759|NCT00019604|50416497|FG000|Overall Study|Started new chemo regimen|1|||
25199760|NCT00019604|50416497|FG000|Overall Study|Pt going to immunotherapy study|1|||
25199761|NCT00019604|50416497|FG000|Overall Study|Too much disease|1|||
25199762|NCT00019604|50416497|FG000|Overall Study|Unable to evaluate|1|||
25199763|NCT00019604|50416497|FG000|Overall Study|Details for other not available|4|||
25199764|NCT02492958|50416513|FG000|Overall Study|Withdrawal by Subject|0|||
25199765|NCT02492958|50416514|FG001|Overall Study|Withdrawal by Subject|0|||
25199766|NCT02492958|50416515|FG002|Overall Study|Withdrawal by Subject|1|||
25199767|NCT02492958|50416516|FG003|Overall Study|Withdrawal by Subject|0|||
25199768|NCT02492958|50416513|FG000|Overall Study|Adverse Event|1|||
25199769|NCT02492958|50416514|FG001|Overall Study|Adverse Event|0|||
25199770|NCT02492958|50416515|FG002|Overall Study|Adverse Event|1|||
25199771|NCT02492958|50416516|FG003|Overall Study|Adverse Event|0|||
25199772|NCT02492880|50416526|FG000|Overall Study|Lost to Follow-up|1|||
25199773|NCT02492880|50416526|FG000|Overall Study|Protocol Violation|1|||
25199774|NCT02516592|50416532|FG000|Overall Study|Patient withdrew consent|5|||
25199775|NCT02516592|50416533|FG001|Overall Study|Patient withdrew consent|2|||
25199776|NCT02516592|50416532|FG000|Overall Study|Protocol deviation|4|||
25199777|NCT02516592|50416533|FG001|Overall Study|Protocol deviation|4|||
25199778|NCT02516592|50416532|FG000|Overall Study|Lost to Follow-up|2|||
25199779|NCT02516592|50416533|FG001|Overall Study|Lost to Follow-up|3|||
25199780|NCT02516592|50416532|FG000|Overall Study|Patient/guardian decision|2|||
25199781|NCT02516592|50416533|FG001|Overall Study|Patient/guardian decision|1|||
25199782|NCT02516592|50416532|FG000|Overall Study|Adverse Event|1|||
25199783|NCT02516592|50416533|FG001|Overall Study|Adverse Event|2|||
25199784|NCT02516592|50416532|FG000|Overall Study|Abnormal test procedure result|1|||
25199785|NCT02516592|50416533|FG001|Overall Study|Abnormal test procedure result|0|||
25199786|NCT02516592|50416532|FG000|Overall Study|Death|1|||
25199787|NCT02516592|50416533|FG001|Overall Study|Death|1|||
25199788|NCT02492100|50416561|FG000|Overall Study|Death|1|||
25199789|NCT02461758|50416584|FG000|Overall Study|Lost to Follow-up|0|||
25199790|NCT02461758|50416585|FG001|Overall Study|Lost to Follow-up|1|||
25199791|NCT02461758|50416586|FG002|Overall Study|Lost to Follow-up|1|||
25199792|NCT02461758|50416587|FG003|Overall Study|Lost to Follow-up|0|||
25199793|NCT02461290|50416609|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
25199794|NCT02461290|50416609|FG000|Overall Study|Lost to Follow-up|3|||
25199795|NCT02461134|50416613|FG000|Overall Study|Adverse Event|1|||
25199796|NCT02460978|50416642|FG000|Overall Study|Adverse Event|17|||
25199797|NCT02460978|50416643|FG001|Overall Study|Adverse Event|11|||
25199798|NCT02460978|50416644|FG002|Overall Study|Adverse Event|11|||
25199799|NCT02460978|50416642|FG000|Overall Study|Withdrawal by Subject|5|||
25199800|NCT02460978|50416643|FG001|Overall Study|Withdrawal by Subject|5|||
25199801|NCT02460978|50416644|FG002|Overall Study|Withdrawal by Subject|14|||
25199802|NCT02460978|50416642|FG000|Overall Study|Lost to Follow-up|2|||
25199803|NCT02460978|50416643|FG001|Overall Study|Lost to Follow-up|3|||
25199804|NCT02460978|50416644|FG002|Overall Study|Lost to Follow-up|1|||
25199805|NCT02460978|50416642|FG000|Overall Study|Protocol Violation|1|||
25199806|NCT02460978|50416643|FG001|Overall Study|Protocol Violation|1|||
25199807|NCT02460978|50416644|FG002|Overall Study|Protocol Violation|1|||
25199808|NCT02460978|50416642|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
25199809|NCT02460978|50416643|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
25199810|NCT02460978|50416644|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
25199811|NCT02460978|50416642|FG000|Overall Study|Pregnancy|0|||
25199812|NCT02460978|50416643|FG001|Overall Study|Pregnancy|0|||
25199813|NCT02460978|50416644|FG002|Overall Study|Pregnancy|2|||
25199814|NCT02489448|50416659|FG000|Overall Study|Death|3|||
25199815|NCT02489448|50416659|FG000|Overall Study|Withdrawal by Subject|2|||
25199816|NCT02488980|50416680|FG000|Overall Study|Protocol Violation|2|||
25199817|NCT02488980|50416681|FG001|Overall Study|Protocol Violation|2|||
25199818|NCT02488980|50416682|FG002|Overall Study|Protocol Violation|2|||
25199819|NCT02460822|50416694|FG000|Overall Study|Withdrawal by Subject|1|||
25199820|NCT02488824|50416700|FG000|Overall Study|Adverse Event|1|||
25199821|NCT02488824|50416701|FG001|Overall Study|Adverse Event|1|||
25199822|NCT02308241|50416804|FG000|Overall Study|Withdrawal by Subject|3|||
25199823|NCT02460198|50416843|FG000|Overall Study|Adverse Event|1|||
25199824|NCT02460198|50416844|FG001|Overall Study|Adverse Event|3|||
25199825|NCT02460198|50416843|FG000|Overall Study|Death|36|||
25199826|NCT02460198|50416844|FG001|Overall Study|Death|28|||
25199827|NCT02460198|50416843|FG000|Overall Study|Lost to Follow-up|1|||
25199828|NCT02460198|50416844|FG001|Overall Study|Lost to Follow-up|1|||
25199829|NCT02460198|50416843|FG000|Overall Study|Transferred to Extension Study|15|||
25199830|NCT02460198|50416844|FG001|Overall Study|Transferred to Extension Study|15|||
25199831|NCT02460198|50416843|FG000|Overall Study|Withdrawal by Subject|2|||
25199832|NCT02460198|50416844|FG001|Overall Study|Withdrawal by Subject|4|||
25199833|NCT02460198|50416843|FG000|Overall Study|Site Terminated By Sponsor|0|||
25315549|NCT00634933|50631290|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
25315550|NCT00634933|50631291|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
25199834|NCT02460198|50416844|FG001|Overall Study|Site Terminated By Sponsor|1|||
25199835|NCT02460198|50416843|FG000|Overall Study|Did Not Continue on Extension Study|6|||
25199836|NCT02460198|50416844|FG001|Overall Study|Did Not Continue on Extension Study|11|||
25199837|NCT02487810|50416864|FG000|Overall Study|Withdrawal by Subject|1|||
25199838|NCT02487810|50416865|FG001|Overall Study|Withdrawal by Subject|0|||
25199839|NCT02452320|50416873|FG000|Overall Study|Adverse Event|0|||
25199840|NCT02452320|50416874|FG001|Overall Study|Adverse Event|1|||
25199841|NCT02459964|50416883|FG000|Overall Study|Withdrawal by Subject|0|||
25199842|NCT02459964|50416884|FG001|Overall Study|Withdrawal by Subject|0|||
25199843|NCT02459964|50416885|FG002|Overall Study|Withdrawal by Subject|1|||
25199844|NCT02459964|50416883|FG000|Overall Study|Abnormal EKG changes|0|||
25199845|NCT02459964|50416884|FG001|Overall Study|Abnormal EKG changes|0|||
25199846|NCT02459964|50416885|FG002|Overall Study|Abnormal EKG changes|1|||
25199847|NCT02451930|50416962|FG000|Overall Study|Death|0|||
25199848|NCT02451930|50416963|FG001|Overall Study|Death|15|||
25199849|NCT02451930|50416962|FG000|Overall Study|Lost to Follow-up|0|||
25199850|NCT02451930|50416963|FG001|Overall Study|Lost to Follow-up|3|||
25199851|NCT02451930|50416962|FG000|Overall Study|Sponsor Decision|2|||
25199852|NCT02451930|50416963|FG001|Overall Study|Sponsor Decision|10|||
25199853|NCT02451930|50416962|FG000|Overall Study|Withdrawal by Subject|0|||
25199854|NCT02451930|50416963|FG001|Overall Study|Withdrawal by Subject|1|||
25199855|NCT02451930|50416962|FG000|Overall Study|Other|0|||
25199856|NCT02451930|50416963|FG001|Overall Study|Other|1|||
25199857|NCT02451696|50416999|FG000|Overall Study|Surgery postponed|1|||
25199858|NCT02451696|50417000|FG001|Overall Study|Surgery postponed|0|||
25199859|NCT02459418|50417023|FG000|Overall Study|Exclusion Criteria|4|||
25199860|NCT02459418|50417024|FG001|Overall Study|Exclusion Criteria|0|||
25199861|NCT02459418|50417023|FG000|Overall Study|Protocol Violation|0|||
25199862|NCT02459418|50417024|FG001|Overall Study|Protocol Violation|2|||
25199863|NCT02459418|50417023|FG000|Overall Study|Physician Decision|0|||
25199864|NCT02459418|50417024|FG001|Overall Study|Physician Decision|2|||
25199865|NCT02459418|50417023|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
25199866|NCT02459418|50417024|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
25199867|NCT02459418|50417023|FG000|Overall Study|Adverse Event|0|||
25199868|NCT02459418|50417024|FG001|Overall Study|Adverse Event|1|||
25199869|NCT02459418|50417023|FG000|Overall Study|Withdrawal by Subject|1|||
25199870|NCT02459418|50417024|FG001|Overall Study|Withdrawal by Subject|1|||
25199871|NCT02459418|50417023|FG000|Overall Study|Elevated Creatine Kinase|1|||
25199872|NCT02459418|50417024|FG001|Overall Study|Elevated Creatine Kinase|0|||
25199873|NCT02459418|50417023|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
25199874|NCT02459418|50417024|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
25199875|NCT02487498|50417054|FG000|Period: Period 1|Adverse Event|2|||
25199876|NCT02487498|50417055|FG001|Period: Period 1|Adverse Event|4|||
25199877|NCT02487498|50417054|FG000|Period: Period 1|Subject/guardian decision|2|||
25199878|NCT02487498|50417055|FG001|Period: Period 1|Subject/guardian decision|4|||
25199879|NCT02487498|50417054|FG000|Period: Period 1|Lost to Follow-up|0|||
25199880|NCT02487498|50417055|FG001|Period: Period 1|Lost to Follow-up|2|||
25199881|NCT02487498|50417054|FG000|Period: Period 1|Lack of Efficacy|1|||
25199882|NCT02487498|50417055|FG001|Period: Period 1|Lack of Efficacy|0|||
25199883|NCT02487498|50417054|FG000|Period: Period 1|Physician Decision|0|||
25199884|NCT02487498|50417055|FG001|Period: Period 1|Physician Decision|1|||
25199885|NCT02487498|50417054|FG000|Period: Period 1|Protocol deviation|1|||
25199886|NCT02487498|50417055|FG001|Period: Period 1|Protocol deviation|0|||
25199887|NCT02487498|50417054|FG000|Period: Washout|Subject/guardian decision|0|||
25199888|NCT02487498|50417055|FG001|Period: Washout|Subject/guardian decision|5|||
25199889|NCT02487498|50417054|FG000|Period: Washout|Lack of Efficacy|1|||
25199890|NCT02487498|50417055|FG001|Period: Washout|Lack of Efficacy|1|||
25199891|NCT02487498|50417054|FG000|Period: Washout|Physician Decision|1|||
25199892|NCT02487498|50417055|FG001|Period: Washout|Physician Decision|0|||
25199893|NCT02487498|50417054|FG000|Period: Washout|Non-compliance with study treatment|0|||
25199894|NCT02487498|50417055|FG001|Period: Washout|Non-compliance with study treatment|1|||
25199895|NCT02487498|50417054|FG000|Period: Period 2|Adverse Event|2|||
25199896|NCT02487498|50417055|FG001|Period: Period 2|Adverse Event|2|||
25199897|NCT02487498|50417054|FG000|Period: Period 2|Subject/guardian decision|2|||
25199898|NCT02487498|50417055|FG001|Period: Period 2|Subject/guardian decision|1|||
25199899|NCT02487498|50417054|FG000|Period: Period 2|Lost to Follow-up|1|||
25199900|NCT02487498|50417055|FG001|Period: Period 2|Lost to Follow-up|1|||
25199901|NCT02487498|50417054|FG000|Period: Period 2|Death|0|||
25199902|NCT02487498|50417055|FG001|Period: Period 2|Death|1|||
25199903|NCT02487498|50417054|FG000|Period: Period 2|Physician Decision|1|||
25199904|NCT02487498|50417055|FG001|Period: Period 2|Physician Decision|0|||
25199905|NCT02487108|50417066|FG000|Overall Study|Adverse Event|1|||
25199906|NCT02487108|50417067|FG001|Overall Study|Adverse Event|6|||
25199907|NCT02487108|50417068|FG002|Overall Study|Adverse Event|12|||
25199908|NCT02487108|50417069|FG003|Overall Study|Adverse Event|6|||
25199909|NCT02487108|50417066|FG000|Overall Study|Withdrawal by Subject|8|||
25199910|NCT02487108|50417067|FG001|Overall Study|Withdrawal by Subject|5|||
25199911|NCT02487108|50417068|FG002|Overall Study|Withdrawal by Subject|5|||
25199912|NCT02487108|50417069|FG003|Overall Study|Withdrawal by Subject|0|||
25199913|NCT02487108|50417066|FG000|Overall Study|Non-compliance to study medication|3|||
25199914|NCT02487108|50417067|FG001|Overall Study|Non-compliance to study medication|2|||
25199915|NCT02487108|50417068|FG002|Overall Study|Non-compliance to study medication|5|||
25199916|NCT02487108|50417069|FG003|Overall Study|Non-compliance to study medication|4|||
25199917|NCT02487108|50417066|FG000|Overall Study|Protocol Violation|1|||
25199918|NCT02487108|50417067|FG001|Overall Study|Protocol Violation|1|||
25199919|NCT02487108|50417068|FG002|Overall Study|Protocol Violation|2|||
25199920|NCT02487108|50417069|FG003|Overall Study|Protocol Violation|0|||
25199921|NCT02487108|50417066|FG000|Overall Study|Non-compliance to study procedures|0|||
25199922|NCT02487108|50417067|FG001|Overall Study|Non-compliance to study procedures|0|||
25199923|NCT02487108|50417068|FG002|Overall Study|Non-compliance to study procedures|0|||
25199924|NCT02487108|50417069|FG003|Overall Study|Non-compliance to study procedures|1|||
25199925|NCT02487108|50417066|FG000|Overall Study|Other than specified|3|||
25199926|NCT02487108|50417067|FG001|Overall Study|Other than specified|2|||
25199927|NCT02487108|50417068|FG002|Overall Study|Other than specified|2|||
25199928|NCT02487108|50417069|FG003|Overall Study|Other than specified|0|||
25199929|NCT02487030|50417086|FG000|Overall Study|Lack of Efficacy|2|||
25199930|NCT02487030|50417087|FG001|Overall Study|Lack of Efficacy|4|||
25199931|NCT02487030|50417088|FG002|Overall Study|Lack of Efficacy|1|||
25199932|NCT02487030|50417089|FG003|Overall Study|Lack of Efficacy|0|||
25199933|NCT02487030|50417090|FG004|Overall Study|Lack of Efficacy|1|||
25199934|NCT02487030|50417091|FG005|Overall Study|Lack of Efficacy|0|||
24976263|NCT00031694|50065180|FG000|Overall Study|Withdrawal by Subject|5|||
25199935|NCT02487030|50417092|FG006|Overall Study|Lack of Efficacy|0|||
25199936|NCT02487030|50417086|FG000|Overall Study|Lost to Follow-up|0|||
25199937|NCT02487030|50417087|FG001|Overall Study|Lost to Follow-up|0|||
25199938|NCT02487030|50417088|FG002|Overall Study|Lost to Follow-up|1|||
25199939|NCT02487030|50417089|FG003|Overall Study|Lost to Follow-up|1|||
25199940|NCT02487030|50417090|FG004|Overall Study|Lost to Follow-up|0|||
25199941|NCT02487030|50417091|FG005|Overall Study|Lost to Follow-up|1|||
25199942|NCT02487030|50417092|FG006|Overall Study|Lost to Follow-up|0|||
25199943|NCT02487030|50417086|FG000|Overall Study|Adverse Event|0|||
25199944|NCT02487030|50417087|FG001|Overall Study|Adverse Event|0|||
25199945|NCT02487030|50417088|FG002|Overall Study|Adverse Event|0|||
25199946|NCT02487030|50417089|FG003|Overall Study|Adverse Event|1|||
25199947|NCT02487030|50417090|FG004|Overall Study|Adverse Event|0|||
25199948|NCT02487030|50417091|FG005|Overall Study|Adverse Event|0|||
25199949|NCT02487030|50417092|FG006|Overall Study|Adverse Event|0|||
25199950|NCT02487030|50417086|FG000|Overall Study|Death|0|||
24976264|NCT00093795|50065188|FG000|Overall Study|No follow up data|20|||
24976265|NCT00093795|50065189|FG001|Overall Study|No follow up data|16|||
24976266|NCT00093795|50065190|FG002|Overall Study|No follow up data|17|||
24976267|NCT03467152|50065200|FG000|Overall Study|Adverse Event|4|||
25199951|NCT02487030|50417087|FG001|Overall Study|Death|0|||
25199952|NCT02487030|50417088|FG002|Overall Study|Death|0|||
25199953|NCT02487030|50417089|FG003|Overall Study|Death|0|||
25199954|NCT02487030|50417090|FG004|Overall Study|Death|1|||
25199955|NCT02487030|50417091|FG005|Overall Study|Death|0|||
25315551|NCT00634933|50631292|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
25315552|NCT00634933|50631293|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
24976268|NCT03467152|50065201|FG001|Overall Study|Adverse Event|5|||
24976269|NCT03467152|50065202|FG002|Overall Study|Adverse Event|0|||
24976270|NCT03467152|50065200|FG000|Overall Study|Subject Choice|1|||
25077094|NCT03090191|50184925|FG000|Overall Study|Withdrawn before any study vaccination|43|||
25199956|NCT02487030|50417092|FG006|Overall Study|Death|0|||
25199957|NCT02486952|50417109|FG000|Overall Study|Not Started Induction Therapy|3|||
25199958|NCT02486952|50417109|FG000|Overall Study|Adverse Event|1|||
25199959|NCT02486952|50417109|FG000|Overall Study|Death|15|||
25199960|NCT02486952|50417109|FG000|Overall Study|Lack of Efficacy|3|||
25199961|NCT02486952|50417109|FG000|Overall Study|Lost to Follow-up|26|||
25199962|NCT02486952|50417109|FG000|Overall Study|Other|2|||
25199963|NCT02486796|50417115|FG000|Overall Study|Withdrawal by Subject|1|||
24976271|NCT03467152|50065201|FG001|Overall Study|Subject Choice|3|||
25199964|NCT02486796|50417116|FG001|Overall Study|Withdrawal by Subject|1|||
25199965|NCT02486796|50417115|FG000|Overall Study|Physician Decision|1|||
25199966|NCT02486796|50417116|FG001|Overall Study|Physician Decision|0|||
25199967|NCT02459262|50417133|FG000|Overall Study|Withdrawal by Subject|0|||
25199968|NCT02459262|50417134|FG001|Overall Study|Withdrawal by Subject|0|||
25199969|NCT02459262|50417135|FG002|Overall Study|Withdrawal by Subject|0|||
25199970|NCT02459262|50417136|FG003|Overall Study|Withdrawal by Subject|0|||
25199971|NCT02459262|50417137|FG004|Overall Study|Withdrawal by Subject|0|||
25199972|NCT02459262|50417138|FG005|Overall Study|Withdrawal by Subject|0|||
25199973|NCT02459262|50417139|FG006|Overall Study|Withdrawal by Subject|0|||
25199974|NCT02459262|50417140|FG007|Overall Study|Withdrawal by Subject|0|||
25199975|NCT02459262|50417141|FG008|Overall Study|Withdrawal by Subject|0|||
25199976|NCT02459262|50417142|FG009|Overall Study|Withdrawal by Subject|1|||
25199977|NCT02459262|50417143|FG010|Overall Study|Withdrawal by Subject|0|||
25199978|NCT02450526|50417227|FG000|DB Period (Cycle 1)|Adverse Event|0|||
25199979|NCT02450526|50417228|FG001|DB Period (Cycle 1)|Adverse Event|0|||
25199980|NCT02450526|50417229|FG002|DB Period (Cycle 1)|Adverse Event|2|||
25199981|NCT02450526|50417230|FG003|DB Period (Cycle 1)|Adverse Event|0|||
25199982|NCT02450526|50417231|FG004|DB Period (Cycle 1)|Adverse Event|0|||
25199983|NCT02450526|50417227|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
25199984|NCT02450526|50417228|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
25199985|NCT02450526|50417229|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
25199986|NCT02450526|50417230|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
25199987|NCT02450526|50417231|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
25199988|NCT02450526|50417227|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
25199989|NCT02450526|50417228|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
25199990|NCT02450526|50417229|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
25199991|NCT02450526|50417230|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
25199992|NCT02450526|50417231|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
25199993|NCT02450526|50417227|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
25199994|NCT02450526|50417228|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
25199995|NCT02450526|50417229|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
25199996|NCT02450526|50417230|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
25199997|NCT02450526|50417231|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
25199998|NCT02450526|50417227|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
25199999|NCT02450526|50417228|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
25200000|NCT02450526|50417229|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
25200001|NCT02450526|50417230|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
25200002|NCT02450526|50417231|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
25200003|NCT02450526|50417227|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
25200004|NCT02450526|50417228|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
25200005|NCT02450526|50417229|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
25200006|NCT02450526|50417230|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
25200007|NCT02450526|50417231|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
25200008|NCT02450526|50417227|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
25200009|NCT02450526|50417228|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
25200010|NCT02450526|50417229|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
25200011|NCT02450526|50417230|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
25200012|NCT02450526|50417231|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
25200013|NCT02450526|50417227|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
25200014|NCT02450526|50417228|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
25200015|NCT02450526|50417229|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
25200016|NCT02450526|50417230|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
25200017|NCT02450526|50417231|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
25200018|NCT02458638|50417298|FG000|Overall Study|Death|309|||
25200019|NCT02458638|50417298|FG000|Overall Study|End of Cohort/End of Study|67|||
25200020|NCT02458638|50417298|FG000|Overall Study|Lost to Follow-up|31|||
25200021|NCT02458638|50417298|FG000|Overall Study|Other Reasons|4|||
25200022|NCT02458638|50417298|FG000|Overall Study|Physician Decision|1|||
25200023|NCT02458638|50417298|FG000|Overall Study|Withdrawal by Subject|47|||
25200024|NCT02458092|50417436|FG000|Overall Study|Withdrawal by Subject|1|||
25200025|NCT02458092|50417437|FG001|Overall Study|Withdrawal by Subject|0|||
25170960|NCT02721966|50307859|FG000|Overall Study|Withdrawal by Subject|9|||
25170961|NCT02721966|50307860|FG001|Overall Study|Withdrawal by Subject|2|||
25170962|NCT02721966|50307861|FG002|Overall Study|Withdrawal by Subject|3|||
25170963|NCT02721966|50307862|FG003|Overall Study|Withdrawal by Subject|7|||
25170964|NCT02721966|50307863|FG004|Overall Study|Withdrawal by Subject|0|||
25170965|NCT02721966|50307859|FG000|Overall Study|Adverse Event|4|||
25170966|NCT02721966|50307860|FG001|Overall Study|Adverse Event|4|||
25170967|NCT02721966|50307861|FG002|Overall Study|Adverse Event|3|||
25170968|NCT02721966|50307862|FG003|Overall Study|Adverse Event|0|||
25200026|NCT02449902|50417460|FG000|Overall Study|Adverse Event|0|||
25200027|NCT02449902|50417461|FG001|Overall Study|Adverse Event|1|||
25200028|NCT02449902|50417460|FG000|Overall Study|Withdrawal by Subject|0|||
25200029|NCT02449902|50417461|FG001|Overall Study|Withdrawal by Subject|1|||
25200030|NCT02449044|50417469|FG000|Overall Study|Lost to Follow-up|2|||
25200031|NCT02449044|50417469|FG000|Overall Study|Withdrawal by Subject|13|||
25200032|NCT02449044|50417469|FG000|Overall Study|Adverse Event|30|||
25200033|NCT02449044|50417469|FG000|Overall Study|Met Withdrawal Criteria|7|||
25200034|NCT02449044|50417469|FG000|Overall Study|Physician Decision|9|||
25200035|NCT02449044|50417469|FG000|Overall Study|Sponsor Discontinued Trial|3|||
25200036|NCT02448810|50418349|FG000|Overall Study|Adverse Event|0|||
25200037|NCT02448810|50418350|FG001|Overall Study|Adverse Event|0|||
25200038|NCT02448810|50418351|FG002|Overall Study|Adverse Event|1|||
25200039|NCT02448810|50418352|FG003|Overall Study|Adverse Event|0|||
25200040|NCT02448810|50418353|FG004|Overall Study|Adverse Event|0|||
25200041|NCT02448810|50418354|FG005|Overall Study|Adverse Event|0|||
25200042|NCT02448810|50418355|FG006|Overall Study|Adverse Event|0|||
25200043|NCT02448810|50418356|FG007|Overall Study|Adverse Event|0|||
25200044|NCT02448810|50418349|FG000|Overall Study|Withdrawal by Subject|0|||
25200045|NCT02448810|50418350|FG001|Overall Study|Withdrawal by Subject|0|||
25200046|NCT02448810|50418351|FG002|Overall Study|Withdrawal by Subject|1|||
24976272|NCT03467152|50065202|FG002|Overall Study|Subject Choice|0|||
25170969|NCT02721966|50307863|FG004|Overall Study|Adverse Event|0|||
25170970|NCT02721966|50307859|FG000|Overall Study|Death|1|||
25170971|NCT02721966|50307860|FG001|Overall Study|Death|0|||
25170972|NCT02721966|50307861|FG002|Overall Study|Death|0|||
25170973|NCT02721966|50307862|FG003|Overall Study|Death|0|||
25170974|NCT02721966|50307863|FG004|Overall Study|Death|0|||
25170975|NCT02721966|50307859|FG000|Overall Study|Lack of Efficacy|7|||
25170976|NCT02721966|50307860|FG001|Overall Study|Lack of Efficacy|4|||
25170977|NCT02721966|50307861|FG002|Overall Study|Lack of Efficacy|0|||
25170978|NCT02721966|50307862|FG003|Overall Study|Lack of Efficacy|0|||
25170979|NCT02721966|50307863|FG004|Overall Study|Lack of Efficacy|0|||
25170980|NCT02721966|50307859|FG000|Overall Study|Lost to Follow-up|0|||
25170981|NCT02721966|50307860|FG001|Overall Study|Lost to Follow-up|0|||
25170982|NCT02721966|50307861|FG002|Overall Study|Lost to Follow-up|3|||
25170983|NCT02721966|50307862|FG003|Overall Study|Lost to Follow-up|0|||
25170984|NCT02721966|50307863|FG004|Overall Study|Lost to Follow-up|0|||
25170985|NCT02721966|50307859|FG000|Overall Study|Physician Decision|1|||
25170986|NCT02721966|50307860|FG001|Overall Study|Physician Decision|1|||
25170987|NCT02721966|50307861|FG002|Overall Study|Physician Decision|0|||
25170988|NCT02721966|50307862|FG003|Overall Study|Physician Decision|0|||
25170989|NCT02721966|50307863|FG004|Overall Study|Physician Decision|0|||
25170990|NCT02721966|50307859|FG000|Overall Study|Pregnancy|1|||
25170991|NCT02721966|50307860|FG001|Overall Study|Pregnancy|0|||
25170992|NCT02721966|50307861|FG002|Overall Study|Pregnancy|0|||
25170993|NCT02721966|50307862|FG003|Overall Study|Pregnancy|0|||
25170994|NCT02721966|50307863|FG004|Overall Study|Pregnancy|0|||
25170995|NCT02721966|50307859|FG000|Overall Study|Did not continue to period 2|5|||
25170996|NCT02721966|50307860|FG001|Overall Study|Did not continue to period 2|12|||
25170997|NCT02721966|50307861|FG002|Overall Study|Did not continue to period 2|0|||
25170998|NCT02721966|50307862|FG003|Overall Study|Did not continue to period 2|0|||
25170999|NCT02721966|50307863|FG004|Overall Study|Did not continue to period 2|5|||
25171000|NCT00553462|50307871|FG000|Overall Study|Adverse Event|4|||
25171001|NCT00553462|50307871|FG000|Overall Study|Progression|4|||
25171002|NCT00553462|50307871|FG000|Overall Study|Withdrawal by Subject|5|||
25171003|NCT00553462|50307871|FG000|Overall Study|Physician Decision|1|||
25171004|NCT00553150|50307877|FG000|Overall Study|Withdrawal by Subject|0|||
25171005|NCT00553150|50307878|FG001|Overall Study|Withdrawal by Subject|0|||
25171006|NCT00553150|50307879|FG002|Overall Study|Withdrawal by Subject|0|||
25171007|NCT00553150|50307880|FG003|Overall Study|Withdrawal by Subject|2|||
25171008|NCT00553150|50307877|FG000|Overall Study|Protocol Violation|0|||
25171009|NCT00553150|50307878|FG001|Overall Study|Protocol Violation|0|||
25171010|NCT00553150|50307879|FG002|Overall Study|Protocol Violation|0|||
25171011|NCT00553150|50307880|FG003|Overall Study|Protocol Violation|1|||
25171012|NCT00553150|50307877|FG000|Overall Study|Ineligible|0|||
25171013|NCT00553150|50307878|FG001|Overall Study|Ineligible|0|||
25171014|NCT00553150|50307879|FG002|Overall Study|Ineligible|0|||
25171015|NCT00553150|50307880|FG003|Overall Study|Ineligible|1|||
25171016|NCT03301350|50307888|FG000|Overall Study|Withdrawal by Subject|4|||
25171017|NCT03301350|50307888|FG000|Overall Study|Adverse Event|1|||
25171018|NCT03301350|50307888|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
25171019|NCT03301350|50307888|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
25171020|NCT03301350|50307888|FG000|Overall Study|no detail provided|1|||
25171021|NCT04735432|50307895|FG000|Overall Study|Other - due to personal reason|1|||
25200047|NCT02448810|50418352|FG003|Overall Study|Withdrawal by Subject|0|||
25171022|NCT04735432|50307896|FG001|Overall Study|Other - due to personal reason|0|||
25171023|NCT04735432|50307895|FG000|Overall Study|Adverse Event|2|||
25171024|NCT04735432|50307896|FG001|Overall Study|Adverse Event|0|||
25171025|NCT02722278|50307905|FG000|Overall Study|Withdrawal by Subject|5|||
25171026|NCT02722278|50307906|FG001|Overall Study|Withdrawal by Subject|3|||
25171027|NCT02722278|50307905|FG000|Overall Study|Adverse Event|4|||
25200048|NCT02448810|50418353|FG004|Overall Study|Withdrawal by Subject|3|||
25200049|NCT02448810|50418354|FG005|Overall Study|Withdrawal by Subject|5|||
25200050|NCT02448810|50418355|FG006|Overall Study|Withdrawal by Subject|0|||
25200051|NCT02448810|50418356|FG007|Overall Study|Withdrawal by Subject|2|||
25200052|NCT02448810|50418349|FG000|Overall Study|Other (study terminated by sponsor)|0|||
25200053|NCT02448810|50418350|FG001|Overall Study|Other (study terminated by sponsor)|0|||
25200054|NCT02448810|50418351|FG002|Overall Study|Other (study terminated by sponsor)|0|||
25200055|NCT02448810|50418352|FG003|Overall Study|Other (study terminated by sponsor)|0|||
25200056|NCT02448810|50418353|FG004|Overall Study|Other (study terminated by sponsor)|4|||
25200057|NCT02448810|50418354|FG005|Overall Study|Other (study terminated by sponsor)|2|||
25200058|NCT02448810|50418355|FG006|Overall Study|Other (study terminated by sponsor)|2|||
25200059|NCT02448810|50418356|FG007|Overall Study|Other (study terminated by sponsor)|1|||
25200060|NCT02448810|50418349|FG000|Overall Study|Death|1|||
25200061|NCT02448810|50418350|FG001|Overall Study|Death|0|||
25200062|NCT02448810|50418351|FG002|Overall Study|Death|1|||
25200063|NCT02448810|50418352|FG003|Overall Study|Death|0|||
25200064|NCT02448810|50418353|FG004|Overall Study|Death|1|||
25200065|NCT02448810|50418354|FG005|Overall Study|Death|0|||
25200066|NCT02448810|50418355|FG006|Overall Study|Death|0|||
25200067|NCT02448810|50418356|FG007|Overall Study|Death|0|||
25200068|NCT02448810|50418349|FG000|Overall Study|Other (Progressive disease)|2|||
25200069|NCT02448810|50418350|FG001|Overall Study|Other (Progressive disease)|2|||
25200070|NCT02448810|50418351|FG002|Overall Study|Other (Progressive disease)|0|||
25200071|NCT02448810|50418352|FG003|Overall Study|Other (Progressive disease)|3|||
25200072|NCT02448810|50418353|FG004|Overall Study|Other (Progressive disease)|23|||
25200073|NCT02448810|50418354|FG005|Overall Study|Other (Progressive disease)|9|||
25200074|NCT02448810|50418355|FG006|Overall Study|Other (Progressive disease)|14|||
25200075|NCT02448810|50418356|FG007|Overall Study|Other (Progressive disease)|5|||
25200076|NCT02448810|50418349|FG000|Overall Study|Lost to Follow-up|0|||
25200077|NCT02448810|50418350|FG001|Overall Study|Lost to Follow-up|1|||
25200078|NCT02448810|50418351|FG002|Overall Study|Lost to Follow-up|0|||
25200079|NCT02448810|50418352|FG003|Overall Study|Lost to Follow-up|0|||
25200080|NCT02448810|50418353|FG004|Overall Study|Lost to Follow-up|0|||
25200081|NCT02448810|50418354|FG005|Overall Study|Lost to Follow-up|0|||
25200082|NCT02448810|50418355|FG006|Overall Study|Lost to Follow-up|0|||
25200083|NCT02448810|50418356|FG007|Overall Study|Lost to Follow-up|0|||
25171028|NCT02722278|50307906|FG001|Overall Study|Adverse Event|1|||
25200084|NCT02448810|50418349|FG000|Overall Study|Other (unspecified)|0|||
25315553|NCT00634933|50631294|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
25315554|NCT00634933|50631290|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
25315555|NCT00634933|50631291|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
25315556|NCT00634933|50631292|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
25315557|NCT00634933|50631293|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
25315558|NCT00634933|50631294|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
25315559|NCT00634933|50631290|FG000|Part B: Week 24 to Week 52|Other|0|||
25315560|NCT00634933|50631291|FG001|Part B: Week 24 to Week 52|Other|0|||
25315561|NCT00634933|50631292|FG002|Part B: Week 24 to Week 52|Other|5|||
25315562|NCT00634933|50631293|FG003|Part B: Week 24 to Week 52|Other|0|||
25315563|NCT00634933|50631294|FG004|Part B: Week 24 to Week 52|Other|1|||
25315564|NCT00967499|50631308|FG000|Overall Study|Adverse Event|0|||
25315565|NCT00967499|50631309|FG001|Overall Study|Adverse Event|1|||
25171029|NCT02722278|50307905|FG000|Overall Study|Lost to Follow-up|2|||
25171030|NCT02722278|50307906|FG001|Overall Study|Lost to Follow-up|0|||
25171031|NCT02722278|50307905|FG000|Overall Study|Protocol Violation|1|||
25171032|NCT02722278|50307906|FG001|Overall Study|Protocol Violation|0|||
25171033|NCT02722278|50307905|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
25171034|NCT02722278|50307906|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
25171035|NCT02722278|50307905|FG000|Overall Study|Subject declined after tx assignment|0|||
25171036|NCT02722278|50307906|FG001|Overall Study|Subject declined after tx assignment|1|||
25171037|NCT02722278|50307905|FG000|Overall Study|Site closure not study related|0|||
25171038|NCT02722278|50307906|FG001|Overall Study|Site closure not study related|1|||
25171039|NCT00703092|50307914|FG000|Overall Study|Withdrawal by Subject|2|||
25171040|NCT02720484|50307918|FG000|Treatment on Study|Adverse Event|1|||
25171041|NCT02720484|50307918|FG000|Treatment on Study|Withdrawal by Subject|1|||
25171042|NCT02720484|50307918|FG000|Treatment on Study|Progressive Disease|4|||
25171043|NCT02720484|50307918|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
25171044|NCT02720484|50307918|FG000|Follow Up for 2 Years|Death|3|||
25171045|NCT02720484|50307918|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
25200085|NCT02448810|50418350|FG001|Overall Study|Other (unspecified)|0|||
25200086|NCT02448810|50418351|FG002|Overall Study|Other (unspecified)|0|||
25200087|NCT02448810|50418352|FG003|Overall Study|Other (unspecified)|0|||
25200088|NCT02448810|50418353|FG004|Overall Study|Other (unspecified)|0|||
25200089|NCT02448810|50418354|FG005|Overall Study|Other (unspecified)|0|||
25200090|NCT02448810|50418355|FG006|Overall Study|Other (unspecified)|2|||
25200091|NCT02448810|50418356|FG007|Overall Study|Other (unspecified)|0|||
25315566|NCT00967499|50631308|FG000|Overall Study|Protocol Violation|1|||
25200092|NCT02457546|50418429|FG000|Overall Study|Other reasons|4|||
25200093|NCT02457546|50418430|FG001|Overall Study|Other reasons|1|||
25200094|NCT02457546|50418429|FG000|Overall Study|Refused to complete study/procedures|1|||
25200095|NCT02457546|50418430|FG001|Overall Study|Refused to complete study/procedures|1|||
25200096|NCT02457546|50418429|FG000|Overall Study|Lost to Follow-up|4|||
25200097|NCT02457546|50418430|FG001|Overall Study|Lost to Follow-up|1|||
25200098|NCT02457546|50418429|FG000|Overall Study|Adverse Event|0|||
25200099|NCT02457546|50418430|FG001|Overall Study|Adverse Event|1|||
25200100|NCT02447952|50418451|FG000|Overall Study|Adverse Event|2|||
25200101|NCT02447952|50418451|FG000|Overall Study|Physician Decision|1|||
25200102|NCT02447952|50418451|FG000|Overall Study|Withdrawal by Subject|4|||
25200103|NCT02447718|50418485|FG000|Overall Study|Lost to Follow-up|8|||
25200104|NCT02447718|50418486|FG001|Overall Study|Lost to Follow-up|0|||
25200105|NCT02447718|50418485|FG000|Overall Study|Withdrawal by Subject|3|||
25200106|NCT02447718|50418486|FG001|Overall Study|Withdrawal by Subject|0|||
25200107|NCT02447718|50418485|FG000|Overall Study|Screen Failure|1|||
25200108|NCT02447718|50418486|FG001|Overall Study|Screen Failure|0|||
25200109|NCT02486406|50418663|FG000|Overall Study|Withdrew consent|1|||
25200110|NCT02486406|50418664|FG001|Overall Study|Withdrew consent|0|||
25200111|NCT02486406|50418665|FG002|Overall Study|Withdrew consent|0|||
25200112|NCT02486406|50418666|FG003|Overall Study|Withdrew consent|1|||
25200113|NCT02486406|50418663|FG000|Overall Study|Lost to Follow-up|1|||
25200114|NCT02486406|50418664|FG001|Overall Study|Lost to Follow-up|3|||
25200115|NCT02486406|50418665|FG002|Overall Study|Lost to Follow-up|1|||
25200116|NCT02486406|50418666|FG003|Overall Study|Lost to Follow-up|3|||
25200117|NCT02486406|50418663|FG000|Overall Study|Other, not specified|0|||
25200118|NCT02486406|50418664|FG001|Overall Study|Other, not specified|0|||
25200119|NCT02486406|50418665|FG002|Overall Study|Other, not specified|1|||
25200120|NCT02486406|50418666|FG003|Overall Study|Other, not specified|0|||
25200121|NCT02485704|50418738|FG000|Overall Study|Lost to Follow-up|4|||
25200122|NCT02485704|50418739|FG001|Overall Study|Lost to Follow-up|5|||
25171046|NCT02715804|50307924|FG000|Overall Study|Death|222|||
25171047|NCT02715804|50307925|FG001|Overall Study|Death|106|||
25171048|NCT02715804|50307924|FG000|Overall Study|Withdrawal by Subject|5|||
25171049|NCT02715804|50307925|FG001|Overall Study|Withdrawal by Subject|4|||
25171050|NCT02715804|50307924|FG000|Overall Study|Other than specified|2|||
25171051|NCT02715804|50307925|FG001|Overall Study|Other than specified|3|||
25171052|NCT02717832|50307931|FG000|Overall Study|Inability to place IV|3|||
25171053|NCT02717754|50307942|FG000|Overall Study|Incorrect Infusion Duration|0|||
25171054|NCT02717754|50307943|FG001|Overall Study|Incorrect Infusion Duration|0|||
25171055|NCT02717754|50307944|FG002|Overall Study|Incorrect Infusion Duration|0|||
25171056|NCT02717754|50307945|FG003|Overall Study|Incorrect Infusion Duration|10|||
25171057|NCT02717754|50307946|FG004|Overall Study|Incorrect Infusion Duration|20|||
25171058|NCT02717754|50307947|FG005|Overall Study|Incorrect Infusion Duration|20|||
25171059|NCT02717130|50307957|FG000|Overall Study|Withdrawal by Subject|1|||
25171060|NCT02717130|50307957|FG000|Overall Study|Adverse Event|1|||
25171061|NCT02717130|50307957|FG000|Overall Study|Physician Decision|1|||
25171062|NCT02717130|50307957|FG000|Overall Study|Study Closure|4|||
25171063|NCT02192502|50307963|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
25171064|NCT02192502|50307964|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
25171065|NCT02192502|50307963|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
25171066|NCT02192502|50307964|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
25171067|NCT02192502|50307963|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
25171068|NCT02192502|50307964|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
25171069|NCT01781429|50307985|FG000|Overall Study|Death|0|||
25171070|NCT01781429|50307986|FG001|Overall Study|Death|0|||
25171071|NCT01781429|50307987|FG002|Overall Study|Death|0|||
25171072|NCT01781429|50307988|FG003|Overall Study|Death|0|||
25171073|NCT01781429|50307989|FG004|Overall Study|Death|0|||
25171074|NCT01781429|50307990|FG005|Overall Study|Death|0|||
25171075|NCT01781429|50307991|FG006|Overall Study|Death|0|||
25171076|NCT01781429|50307992|FG007|Overall Study|Death|0|||
25171077|NCT01781429|50307993|FG008|Overall Study|Death|0|||
25171078|NCT01781429|50307994|FG009|Overall Study|Death|1|||
25171079|NCT01781429|50307995|FG010|Overall Study|Death|0|||
25171080|NCT01781429|50307996|FG011|Overall Study|Death|0|||
25171081|NCT01781429|50307997|FG012|Overall Study|Death|1|||
25171082|NCT01781429|50307998|FG013|Overall Study|Death|0|||
25171083|NCT01781429|50307999|FG014|Overall Study|Death|1|||
25171084|NCT01781429|50308000|FG015|Overall Study|Death|0|||
25171085|NCT01781429|50307985|FG000|Overall Study|Withdrawal by Subject|0|||
25171086|NCT01781429|50307986|FG001|Overall Study|Withdrawal by Subject|0|||
25171087|NCT01781429|50307987|FG002|Overall Study|Withdrawal by Subject|0|||
25171088|NCT01781429|50307988|FG003|Overall Study|Withdrawal by Subject|0|||
25171089|NCT01781429|50307989|FG004|Overall Study|Withdrawal by Subject|0|||
25171090|NCT01781429|50307990|FG005|Overall Study|Withdrawal by Subject|0|||
25200123|NCT02485704|50418738|FG000|Overall Study|Withdrawal by Subject|0|||
25200124|NCT02485704|50418739|FG001|Overall Study|Withdrawal by Subject|3|||
25200125|NCT02485704|50418738|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
25200126|NCT02485704|50418739|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
25200127|NCT02485158|50418749|FG000|Overall Study|Withdrawal by Subject|3|||
25200128|NCT02485158|50418749|FG000|Overall Study|expected drug side effect|1|||
25200129|NCT02455518|50418768|FG000|Overall Study|Protocol Violation|0|||
25200130|NCT02455518|50418769|FG001|Overall Study|Protocol Violation|1|||
25200131|NCT02455518|50418770|FG002|Overall Study|Protocol Violation|1|||
25200132|NCT02455518|50418771|FG003|Overall Study|Protocol Violation|3|||
25200133|NCT02873195|50418919|FG000|Overall Study|Ineligible|5|||
25200134|NCT02873195|50418920|FG001|Overall Study|Ineligible|0|||
25200135|NCT02435849|50418955|FG000|Overall Study|Enrolled but not infused|18|||
25200136|NCT02435849|50418955|FG000|Overall Study|Death|16|||
25200137|NCT02435849|50418955|FG000|Overall Study|Lack of Efficacy|9|||
25200138|NCT02435849|50418955|FG000|Overall Study|New therapy for study indication|7|||
25200139|NCT02435849|50418955|FG000|Overall Study|Subject/guardian decision|2|||
25200140|NCT02435849|50418955|FG000|Overall Study|Study follow-up ongoing|45|||
25200141|NCT02240069|50419002|FG000|Overall Study|Withdrawal by Subject|5|||
25200142|NCT02240069|50419003|FG001|Overall Study|Withdrawal by Subject|5|||
25200143|NCT02240069|50419004|FG002|Overall Study|Withdrawal by Subject|2|||
25200144|NCT02484690|50419090|FG000|Overall Study|Adverse Event|1|||
25200145|NCT02484690|50419091|FG001|Overall Study|Adverse Event|3|||
25200146|NCT02484690|50419092|FG002|Overall Study|Adverse Event|0|||
25200147|NCT02484690|50419093|FG003|Overall Study|Adverse Event|0|||
25200148|NCT02484690|50419094|FG004|Overall Study|Adverse Event|5|||
25200149|NCT02484690|50419090|FG000|Overall Study|Death|0|||
25200150|NCT02484690|50419091|FG001|Overall Study|Death|0|||
25200151|NCT02484690|50419092|FG002|Overall Study|Death|0|||
25200152|NCT02484690|50419093|FG003|Overall Study|Death|0|||
25200153|NCT02484690|50419094|FG004|Overall Study|Death|1|||
25200154|NCT02484690|50419090|FG000|Overall Study|Withdrawal by Subject|1|||
25200155|NCT02484690|50419091|FG001|Overall Study|Withdrawal by Subject|3|||
25200156|NCT02484690|50419092|FG002|Overall Study|Withdrawal by Subject|1|||
25200157|NCT02484690|50419093|FG003|Overall Study|Withdrawal by Subject|2|||
25200158|NCT02484690|50419094|FG004|Overall Study|Withdrawal by Subject|0|||
25200159|NCT02484690|50419090|FG000|Overall Study|Physician Decision|2|||
25200160|NCT02484690|50419091|FG001|Overall Study|Physician Decision|0|||
25200161|NCT02484690|50419092|FG002|Overall Study|Physician Decision|1|||
25200162|NCT02484690|50419093|FG003|Overall Study|Physician Decision|0|||
25200163|NCT02484690|50419094|FG004|Overall Study|Physician Decision|0|||
25200164|NCT02484690|50419090|FG000|Overall Study|Lost to Follow-up|0|||
25200165|NCT02484690|50419091|FG001|Overall Study|Lost to Follow-up|0|||
25200166|NCT02484690|50419092|FG002|Overall Study|Lost to Follow-up|1|||
25200167|NCT02484690|50419093|FG003|Overall Study|Lost to Follow-up|0|||
25200168|NCT02484690|50419094|FG004|Overall Study|Lost to Follow-up|0|||
25200169|NCT01654224|50419118|FG000|Overall Study|Lost to Follow-up|2|||
25200170|NCT01654224|50419119|FG001|Overall Study|Lost to Follow-up|2|||
25200171|NCT01654224|50419118|FG000|Overall Study|Did not receive allocation|1|||
25200172|NCT01654224|50419119|FG001|Overall Study|Did not receive allocation|8|||
25200173|NCT01654224|50419118|FG000|Overall Study|Insufficient blood sample|3|||
25200174|NCT01654224|50419119|FG001|Overall Study|Insufficient blood sample|2|||
25200175|NCT02447328|50419125|FG000|Overall Study|Withdrawal by Subject|1|||
25200176|NCT02447250|50419129|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
25200177|NCT02447250|50419129|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
25200178|NCT02447250|50419129|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
25200179|NCT02447172|50419233|FG000|Overall Study|Adverse Event|11|||
25200180|NCT02447172|50419234|FG001|Overall Study|Adverse Event|8|||
25200181|NCT02447172|50419235|FG002|Overall Study|Adverse Event|7|||
25200182|NCT02447172|50419233|FG000|Overall Study|Death|3|||
25200183|NCT02447172|50419234|FG001|Overall Study|Death|1|||
25200184|NCT02447172|50419235|FG002|Overall Study|Death|0|||
25200185|NCT02447172|50419233|FG000|Overall Study|Protocol Violation|2|||
25200186|NCT02447172|50419234|FG001|Overall Study|Protocol Violation|1|||
25200187|NCT02447172|50419235|FG002|Overall Study|Protocol Violation|2|||
25200188|NCT02447172|50419233|FG000|Overall Study|Lost to Follow-up|7|||
25200189|NCT02447172|50419234|FG001|Overall Study|Lost to Follow-up|4|||
25200190|NCT02447172|50419235|FG002|Overall Study|Lost to Follow-up|4|||
25077095|NCT03090191|50184926|FG001|Overall Study|Withdrawn before any study vaccination|52|||
25200191|NCT02447172|50419233|FG000|Overall Study|Withdrawal by Subject|5|||
25077096|NCT02439320|50184948|FG000|Overall Study|Adverse Event|0|||
25200192|NCT02447172|50419234|FG001|Overall Study|Withdrawal by Subject|1|||
25200193|NCT02447172|50419235|FG002|Overall Study|Withdrawal by Subject|3|||
25200194|NCT02447172|50419233|FG000|Overall Study|protocol specific treatment unrelated|3|||
25200195|NCT02447172|50419234|FG001|Overall Study|protocol specific treatment unrelated|0|||
25200196|NCT02447172|50419235|FG002|Overall Study|protocol specific treatment unrelated|2|||
25200197|NCT02455050|50419268|FG000|Treatment Period 1|Lost to Follow-up|1|||
25200198|NCT02455050|50419269|FG001|Treatment Period 1|Lost to Follow-up|1|||
25200199|NCT02455050|50419270|FG002|Treatment Period 1|Lost to Follow-up|1|||
25200200|NCT02455050|50419271|FG003|Treatment Period 1|Lost to Follow-up|2|||
25200201|NCT02455050|50419268|FG000|Treatment Period 2|Lost to Follow-up|1|||
25200202|NCT02455050|50419269|FG001|Treatment Period 2|Lost to Follow-up|0|||
25200203|NCT02455050|50419270|FG002|Treatment Period 2|Lost to Follow-up|2|||
25200204|NCT02455050|50419271|FG003|Treatment Period 2|Lost to Follow-up|1|||
25200205|NCT02418468|50419311|FG000|Overall Study|Adverse Event|1|||
25200206|NCT02418468|50419312|FG001|Overall Study|Adverse Event|0|||
25200207|NCT02418468|50419311|FG000|Overall Study|Withdrawal of informed consent|1|||
25200208|NCT02418468|50419312|FG001|Overall Study|Withdrawal of informed consent|1|||
25200209|NCT02418156|50419318|FG000|Overall Study|Lost to Follow-up|12|||
25200210|NCT02418156|50419318|FG000|Overall Study|Death|2|||
25200211|NCT02418156|50419318|FG000|Overall Study|Physician Decision|1|||
25200212|NCT02418156|50419318|FG000|Overall Study|Withdrawal by Subject|1|||
25200213|NCT02418156|50419318|FG000|Overall Study|Subject refused to return|1|||
25200214|NCT02418000|50419447|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
25200215|NCT02418000|50419448|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
25200216|NCT02418000|50419449|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
25200217|NCT02418000|50419450|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
25200218|NCT02418000|50419451|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
25200219|NCT02418000|50419447|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
25200220|NCT02418000|50419448|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
25200221|NCT02418000|50419449|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
25200222|NCT02418000|50419450|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
25200223|NCT02418000|50419451|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
25200224|NCT02418000|50419447|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
25200225|NCT02418000|50419448|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
25200226|NCT02418000|50419449|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
25200227|NCT02418000|50419450|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
25200228|NCT02418000|50419451|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
25200229|NCT02418000|50419447|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
25200230|NCT02418000|50419448|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
25200231|NCT02418000|50419449|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
25200232|NCT02418000|50419450|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
25200233|NCT02418000|50419451|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
25200234|NCT02418000|50419447|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
25200235|NCT02418000|50419448|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
25200236|NCT02418000|50419449|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
25200237|NCT02418000|50419450|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
25200238|NCT02418000|50419451|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
25200239|NCT02418000|50419447|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
25200240|NCT02418000|50419448|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
25200241|NCT02418000|50419449|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
25200242|NCT02418000|50419450|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
25200243|NCT02418000|50419451|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
25200244|NCT02418000|50419447|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
25200245|NCT02418000|50419448|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
25200246|NCT02418000|50419449|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
25200247|NCT02418000|50419450|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
25200248|NCT02418000|50419451|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
25200249|NCT02418000|50419447|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
25200250|NCT02418000|50419448|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
25200251|NCT02418000|50419449|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
25200252|NCT02418000|50419450|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
25200253|NCT02418000|50419451|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
25200254|NCT02418000|50419447|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
25200255|NCT02418000|50419448|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
25200256|NCT02418000|50419449|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
25200257|NCT02418000|50419450|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
25200258|NCT02418000|50419451|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
25200259|NCT02417064|50419555|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
25200260|NCT02417064|50419556|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
25315567|NCT00967499|50631309|FG001|Overall Study|Protocol Violation|0|||
25315568|NCT00967499|50631308|FG000|Overall Study|Sponsor Decision|1|||
25315569|NCT00967499|50631309|FG001|Overall Study|Sponsor Decision|0|||
25315570|NCT00967499|50631308|FG000|Overall Study|Randomized but not treated|63|||
25315571|NCT00967499|50631309|FG001|Overall Study|Randomized but not treated|59|||
25077097|NCT02439320|50184949|FG001|Overall Study|Adverse Event|2|||
25077098|NCT02439320|50184950|FG002|Overall Study|Adverse Event|0|||
25200261|NCT02417064|50419557|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
25200262|NCT02417064|50419555|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
25200263|NCT02417064|50419556|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
25200264|NCT02417064|50419557|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
25200265|NCT02417064|50419555|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
25200266|NCT02417064|50419556|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
25200267|NCT02417064|50419557|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
25200268|NCT02417064|50419555|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
25200269|NCT02417064|50419556|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
25200270|NCT02417064|50419557|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
25200271|NCT02417064|50419555|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
25200272|NCT02417064|50419556|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
25200273|NCT02417064|50419557|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
25200274|NCT02417064|50419555|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
25200275|NCT02417064|50419556|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
25200276|NCT02417064|50419557|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
25200277|NCT02417064|50419555|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
25200278|NCT02417064|50419556|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
25200279|NCT02417064|50419557|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
25200280|NCT02417064|50419555|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
25200281|NCT02417064|50419556|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
25200282|NCT02417064|50419557|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
25200283|NCT02417064|50419555|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
25200284|NCT02417064|50419556|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
25200285|NCT02417064|50419557|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
25200286|NCT02417064|50419555|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
25200287|NCT02417064|50419556|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
25200288|NCT02417064|50419557|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
25200289|NCT02417064|50419555|FG000|Follow-up Phase (24 Weeks)|Other|2|||
25200290|NCT02417064|50419556|FG001|Follow-up Phase (24 Weeks)|Other|2|||
25200291|NCT02417064|50419557|FG002|Follow-up Phase (24 Weeks)|Other|3|||
25200292|NCT01653132|50419572|FG000|First Intervention|Protocol Violation|1|||
25200293|NCT01653132|50419573|FG001|First Intervention|Protocol Violation|0|||
25200294|NCT02453334|50419598|FG000|Overall Study|Death|15|||
25200295|NCT02453334|50419599|FG001|Overall Study|Death|13|||
25200296|NCT02453334|50419598|FG000|Overall Study|Adverse Event|2|||
25200297|NCT02453334|50419599|FG001|Overall Study|Adverse Event|1|||
25200298|NCT02453334|50419598|FG000|Overall Study|Lost to Follow-up|5|||
25200299|NCT02453334|50419599|FG001|Overall Study|Lost to Follow-up|9|||
25200300|NCT02453334|50419598|FG000|Overall Study|Physician Decision|1|||
25200301|NCT02453334|50419599|FG001|Overall Study|Physician Decision|0|||
25200302|NCT02453334|50419598|FG000|Overall Study|Withdrawal by Subject|17|||
25200303|NCT02453334|50419599|FG001|Overall Study|Withdrawal by Subject|13|||
25200304|NCT02453334|50419598|FG000|Overall Study|Other reason|1|||
25200305|NCT02453334|50419599|FG001|Overall Study|Other reason|4|||
25200306|NCT02443740|50419685|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
25200307|NCT02443740|50419686|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
25200308|NCT02443740|50419687|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
25200309|NCT02443740|50419688|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
25200310|NCT02443740|50419689|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
25200311|NCT02443740|50419690|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
25200312|NCT02443740|50419691|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
25200313|NCT02443740|50419692|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
25200314|NCT02443740|50419693|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
25200315|NCT02443740|50419694|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
25200316|NCT02443740|50419695|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
25200317|NCT02443740|50419685|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
25200318|NCT02443740|50419686|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
25200319|NCT02443740|50419687|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
25200320|NCT02443740|50419688|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
25200321|NCT02443740|50419689|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
25200322|NCT02443740|50419690|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
25200323|NCT02443740|50419691|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
25200324|NCT02443740|50419692|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
25200325|NCT02443740|50419693|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
25200326|NCT02443740|50419694|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
25200327|NCT02443740|50419695|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
25200328|NCT02443740|50419685|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
25200329|NCT02443740|50419686|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
25200330|NCT02443740|50419687|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
24976273|NCT03467152|50065200|FG000|Overall Study|Lost to Follow-up|1|||
25200331|NCT02443740|50419688|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
25200332|NCT02443740|50419689|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
25200333|NCT02443740|50419690|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
25200334|NCT02443740|50419691|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
25200335|NCT02443740|50419692|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
25200336|NCT02443740|50419693|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
25200337|NCT02443740|50419694|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
25200338|NCT02443740|50419695|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
25200339|NCT02416908|50419926|FG000|Dose Escalation Phase|Adverse Event|0|||
25200340|NCT02416908|50419927|FG001|Dose Escalation Phase|Adverse Event|0|||
25200341|NCT02416908|50419928|FG002|Dose Escalation Phase|Adverse Event|3|||
25200342|NCT02416908|50419929|FG003|Dose Escalation Phase|Adverse Event|0|||
25200343|NCT02416908|50419926|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
25200344|NCT02416908|50419927|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
25200345|NCT02416908|50419928|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
25200346|NCT02416908|50419929|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
25200347|NCT02453256|50420019|FG000|Double Blind Period|Death|1|||
25200348|NCT02453256|50420020|FG001|Double Blind Period|Death|1|||
25200349|NCT02453256|50420019|FG000|Double Blind Period|Adverse Event|3|||
25200350|NCT02453256|50420020|FG001|Double Blind Period|Adverse Event|2|||
25200351|NCT02453256|50420019|FG000|Double Blind Period|Withdrawal by Subject|9|||
25200352|NCT02453256|50420020|FG001|Double Blind Period|Withdrawal by Subject|5|||
25200353|NCT02453256|50420019|FG000|Double Blind Period|Other|0|||
25200354|NCT02453256|50420020|FG001|Double Blind Period|Other|1|||
25200355|NCT02453256|50420019|FG000|Open Label Period|Adverse Event|1|||
25200356|NCT02453256|50420020|FG001|Open Label Period|Adverse Event|3|||
25200357|NCT02453256|50420019|FG000|Open Label Period|Death|0|||
25200358|NCT02453256|50420020|FG001|Open Label Period|Death|1|||
25200359|NCT02453256|50420019|FG000|Open Label Period|Lost to Follow-up|1|||
25200360|NCT02453256|50420020|FG001|Open Label Period|Lost to Follow-up|0|||
25200361|NCT02453256|50420019|FG000|Open Label Period|Other|0|||
25200362|NCT02453256|50420020|FG001|Open Label Period|Other|2|||
25200363|NCT02453256|50420019|FG000|Open Label Period|Withdrawal by Subject|5|||
25200364|NCT02453256|50420020|FG001|Open Label Period|Withdrawal by Subject|1|||
25200365|NCT02442804|50420035|FG000|Overall Study|Withdrawal by Subject|0|||
25200366|NCT02442804|50420036|FG001|Overall Study|Withdrawal by Subject|1|||
25200367|NCT02442804|50420035|FG000|Overall Study|Adverse Event|1|||
25200368|NCT02442804|50420036|FG001|Overall Study|Adverse Event|0|||
25200369|NCT02414958|50420125|FG000|Overall Study|Adverse Event|6|||
25200370|NCT02414958|50420126|FG001|Overall Study|Adverse Event|6|||
25200371|NCT02414958|50420127|FG002|Overall Study|Adverse Event|3|||
25200372|NCT02414958|50420125|FG000|Overall Study|Protocol Violation|10|||
25200373|NCT02414958|50420126|FG001|Overall Study|Protocol Violation|3|||
25200374|NCT02414958|50420127|FG002|Overall Study|Protocol Violation|1|||
25200375|NCT02414958|50420125|FG000|Overall Study|Lost to Follow-up|7|||
25200376|NCT02414958|50420126|FG001|Overall Study|Lost to Follow-up|4|||
25200377|NCT02414958|50420127|FG002|Overall Study|Lost to Follow-up|0|||
25200378|NCT02414958|50420125|FG000|Overall Study|Withdrawal by Subject|5|||
25200379|NCT02414958|50420126|FG001|Overall Study|Withdrawal by Subject|3|||
25200380|NCT02414958|50420127|FG002|Overall Study|Withdrawal by Subject|5|||
25200381|NCT02414958|50420125|FG000|Overall Study|Other than specified|4|||
25200382|NCT02414958|50420126|FG001|Overall Study|Other than specified|4|||
25200383|NCT02414958|50420127|FG002|Overall Study|Other than specified|5|||
25200384|NCT02452476|50420200|FG000|Overall Study|Death|4|||
25200385|NCT02452476|50420201|FG001|Overall Study|Death|7|||
25200386|NCT02452476|50420200|FG000|Overall Study|Lost to Follow-up|1|||
25200387|NCT02452476|50420201|FG001|Overall Study|Lost to Follow-up|1|||
25200388|NCT02452476|50420200|FG000|Overall Study|Physician Decision|1|||
25200389|NCT02452476|50420201|FG001|Overall Study|Physician Decision|1|||
25200390|NCT02452476|50420200|FG000|Overall Study|Not treated|5|||
25200391|NCT02452476|50420201|FG001|Overall Study|Not treated|1|||
25200392|NCT02442336|50420216|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
25200393|NCT02442336|50420216|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
25200394|NCT02442336|50420216|FG000|Overall Study|Lost to Follow-up|11|||
25200395|NCT02452398|50420220|FG000|Overall Study|Adverse Event|1|||
25200396|NCT02452398|50420220|FG000|Overall Study|Lost to Follow-up|28|||
25200397|NCT02452398|50420220|FG000|Overall Study|Physician Decision|2|||
25200398|NCT02452398|50420220|FG000|Overall Study|Withdrawal by Subject|6|||
25200399|NCT02452398|50420220|FG000|Overall Study|Moved away|4|||
25200400|NCT02413398|50420226|FG000|Overall Study|Lost to Follow-up|2|||
25200401|NCT02413398|50420227|FG001|Overall Study|Lost to Follow-up|4|||
25200402|NCT02413398|50420226|FG000|Overall Study|Withdrawal by Subject|1|||
25200403|NCT02413398|50420227|FG001|Overall Study|Withdrawal by Subject|1|||
25200404|NCT02413398|50420226|FG000|Overall Study|Other Eligibility criteria|1|||
25200405|NCT02413398|50420227|FG001|Overall Study|Other Eligibility criteria|2|||
25200406|NCT02441946|50420236|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
25200407|NCT02441946|50420237|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
25200408|NCT02441946|50420238|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
25200409|NCT02441946|50420236|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
25200410|NCT02441946|50420237|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
25200411|NCT02441946|50420238|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
25200412|NCT02441946|50420236|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
25200413|NCT02441946|50420237|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
25200414|NCT02441946|50420238|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
25200415|NCT02441946|50420236|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
25200416|NCT02441946|50420237|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
25200417|NCT02441946|50420238|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
25200418|NCT02441946|50420236|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
25200419|NCT02441946|50420237|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
25200420|NCT02441946|50420238|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
25200421|NCT02441946|50420236|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
25200422|NCT02441946|50420237|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
25200423|NCT02441946|50420238|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
25200424|NCT02441946|50420236|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
25200425|NCT02441946|50420237|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
25200426|NCT02441946|50420238|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
25200427|NCT02441946|50420236|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
25200428|NCT02441946|50420237|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
25200429|NCT02441946|50420238|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
25200430|NCT02441946|50420236|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
25200431|NCT02441946|50420237|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
25200432|NCT02441946|50420238|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
25200433|NCT02441946|50420236|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
25200434|NCT02441946|50420237|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
25200435|NCT02441946|50420238|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
25200436|NCT02441946|50420236|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
25200437|NCT02441946|50420237|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
25200438|NCT02441946|50420238|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
25200439|NCT02387580|50420272|FG000|Overall Study|Withdrawal by Subject|0|||
25200440|NCT02387580|50420273|FG001|Overall Study|Withdrawal by Subject|0|||
25200441|NCT02387580|50420274|FG002|Overall Study|Withdrawal by Subject|0|||
25200442|NCT02387580|50420275|FG003|Overall Study|Withdrawal by Subject|1|||
25200443|NCT02387580|50420276|FG004|Overall Study|Withdrawal by Subject|0|||
25200444|NCT02387580|50420277|FG005|Overall Study|Withdrawal by Subject|0|||
25200445|NCT02440854|50420293|FG000|Overall Study|Relocation of patient|1|||
25200446|NCT02440854|50420293|FG000|Overall Study|Death|6|||
25200447|NCT02440854|50420293|FG000|Overall Study|Lost to Follow-up|10|||
25200448|NCT02440854|50420293|FG000|Overall Study|Afatinib discontinuation|46|||
25200449|NCT02440854|50420293|FG000|Overall Study|stopped study at earlier timepoint|14|||
25200450|NCT02440854|50420293|FG000|Overall Study|Study medication not received|1|||
25200451|NCT02440854|50420293|FG000|Overall Study|Violation of inclusion criteria|2|||
25200452|NCT02412852|50420348|FG000|Overall Study|Withdrawal by Subject|0|||
25200453|NCT02412852|50420349|FG001|Overall Study|Withdrawal by Subject|1|||
25200454|NCT02412852|50420350|FG002|Overall Study|Withdrawal by Subject|0|||
25200455|NCT02412852|50420351|FG003|Overall Study|Withdrawal by Subject|0|||
25200456|NCT02412852|50420348|FG000|Overall Study|Physician Decision|0|||
25200457|NCT02412852|50420349|FG001|Overall Study|Physician Decision|0|||
25200458|NCT02412852|50420350|FG002|Overall Study|Physician Decision|0|||
25200459|NCT02412852|50420351|FG003|Overall Study|Physician Decision|1|||
25200460|NCT02386098|50420407|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
25200461|NCT02386098|50420408|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
25200462|NCT02386098|50420409|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
25200463|NCT02386098|50420410|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
25200464|NCT02386098|50420411|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
25200465|NCT02386098|50420407|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
24976274|NCT03467152|50065201|FG001|Overall Study|Lost to Follow-up|0|||
24976275|NCT03467152|50065202|FG002|Overall Study|Lost to Follow-up|0|||
25200466|NCT02386098|50420408|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
25315572|NCT03909971|50631317|FG000|Overall Study|Other Reasons Not Specified|0|||
25200467|NCT02386098|50420409|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
25200468|NCT02386098|50420410|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
25200469|NCT02386098|50420411|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
25200470|NCT02386098|50420407|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
25200471|NCT02386098|50420408|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
25200472|NCT02386098|50420409|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
25200473|NCT02386098|50420410|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
25200474|NCT02386098|50420411|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
25200475|NCT02386098|50420407|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
25200476|NCT02386098|50420408|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
25200477|NCT02386098|50420409|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
25200478|NCT02386098|50420410|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
25200479|NCT02386098|50420411|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
25200480|NCT02386098|50420407|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
25200481|NCT02386098|50420408|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
25200482|NCT02386098|50420409|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
25200483|NCT02386098|50420410|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
25200484|NCT02386098|50420411|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
25200485|NCT02386098|50420407|FG000|Stage 1 (96 Weeks)|Other|1|||
25200486|NCT02386098|50420408|FG001|Stage 1 (96 Weeks)|Other|0|||
25200487|NCT02386098|50420409|FG002|Stage 1 (96 Weeks)|Other|0|||
25200488|NCT02386098|50420410|FG003|Stage 1 (96 Weeks)|Other|0|||
25200489|NCT02386098|50420411|FG004|Stage 1 (96 Weeks)|Other|0|||
25200490|NCT02386098|50420407|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
25200491|NCT02386098|50420408|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
25200492|NCT02386098|50420409|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
25200493|NCT02386098|50420410|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
25200494|NCT02386098|50420411|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
25200495|NCT02412618|50420454|FG000|Overall Study|Withdrawal by Subject|1|||
25200496|NCT02412618|50420455|FG001|Overall Study|Withdrawal by Subject|1|||
25200497|NCT02412618|50420454|FG000|Overall Study|Expulsion|1|||
25200498|NCT02412618|50420455|FG001|Overall Study|Expulsion|1|||
25200499|NCT00585195|50420652|FG000|Overall Study|Adverse Event|0|||
25200500|NCT00585195|50420653|FG001|Overall Study|Adverse Event|0|||
25200501|NCT00585195|50420654|FG002|Overall Study|Adverse Event|0|||
25200502|NCT00585195|50420655|FG003|Overall Study|Adverse Event|0|||
25200503|NCT00585195|50420656|FG004|Overall Study|Adverse Event|2|||
25200504|NCT00585195|50420657|FG005|Overall Study|Adverse Event|1|||
25200505|NCT00585195|50420658|FG006|Overall Study|Adverse Event|0|||
25200506|NCT00585195|50420659|FG007|Overall Study|Adverse Event|1|||
25200507|NCT00585195|50420660|FG008|Overall Study|Adverse Event|0|||
25200508|NCT00585195|50420661|FG009|Overall Study|Adverse Event|0|||
25200509|NCT00585195|50420662|FG010|Overall Study|Adverse Event|3|||
25200510|NCT00585195|50420663|FG011|Overall Study|Adverse Event|0|||
25200511|NCT00585195|50420664|FG012|Overall Study|Adverse Event|8|||
25200512|NCT00585195|50420665|FG013|Overall Study|Adverse Event|6|||
25200513|NCT00585195|50420666|FG014|Overall Study|Adverse Event|4|||
25200514|NCT00585195|50420667|FG015|Overall Study|Adverse Event|1|||
25200515|NCT00585195|50420668|FG016|Overall Study|Adverse Event|14|||
25200516|NCT00585195|50420669|FG017|Overall Study|Adverse Event|9|||
25200517|NCT00585195|50420670|FG018|Overall Study|Adverse Event|2|||
25200518|NCT00585195|50420671|FG019|Overall Study|Adverse Event|3|||
25200519|NCT00585195|50420672|FG020|Overall Study|Adverse Event|1|||
25200520|NCT00585195|50420652|FG000|Overall Study|Progressive Disease|2|||
25200521|NCT00585195|50420653|FG001|Overall Study|Progressive Disease|2|||
25200522|NCT00585195|50420654|FG002|Overall Study|Progressive Disease|5|||
25200523|NCT00585195|50420655|FG003|Overall Study|Progressive Disease|4|||
25200524|NCT00585195|50420656|FG004|Overall Study|Progressive Disease|6|||
25200525|NCT00585195|50420657|FG005|Overall Study|Progressive Disease|4|||
25200526|NCT00585195|50420658|FG006|Overall Study|Progressive Disease|6|||
25200527|NCT00585195|50420659|FG007|Overall Study|Progressive Disease|3|||
25200528|NCT00585195|50420660|FG008|Overall Study|Progressive Disease|0|||
25200529|NCT00585195|50420661|FG009|Overall Study|Progressive Disease|5|||
25200530|NCT00585195|50420662|FG010|Overall Study|Progressive Disease|2|||
25200531|NCT00585195|50420663|FG011|Overall Study|Progressive Disease|25|||
25200532|NCT00585195|50420664|FG012|Overall Study|Progressive Disease|29|||
25200533|NCT00585195|50420665|FG013|Overall Study|Progressive Disease|26|||
25200534|NCT00585195|50420666|FG014|Overall Study|Progressive Disease|21|||
25200535|NCT00585195|50420667|FG015|Overall Study|Progressive Disease|12|||
25200536|NCT00585195|50420668|FG016|Overall Study|Progressive Disease|94|||
25200537|NCT00585195|50420669|FG017|Overall Study|Progressive Disease|42|||
25200538|NCT00585195|50420670|FG018|Overall Study|Progressive Disease|4|||
25200539|NCT00585195|50420671|FG019|Overall Study|Progressive Disease|9|||
25200540|NCT00585195|50420672|FG020|Overall Study|Progressive Disease|8|||
25200541|NCT00585195|50420652|FG000|Overall Study|Withdrawal by Subject|1|||
25200542|NCT00585195|50420653|FG001|Overall Study|Withdrawal by Subject|1|||
25200543|NCT00585195|50420654|FG002|Overall Study|Withdrawal by Subject|2|||
25200544|NCT00585195|50420655|FG003|Overall Study|Withdrawal by Subject|2|||
25200545|NCT00585195|50420656|FG004|Overall Study|Withdrawal by Subject|0|||
25200546|NCT00585195|50420657|FG005|Overall Study|Withdrawal by Subject|0|||
25200547|NCT00585195|50420658|FG006|Overall Study|Withdrawal by Subject|0|||
25200548|NCT00585195|50420659|FG007|Overall Study|Withdrawal by Subject|1|||
25200549|NCT00585195|50420660|FG008|Overall Study|Withdrawal by Subject|0|||
25200550|NCT00585195|50420661|FG009|Overall Study|Withdrawal by Subject|0|||
25200551|NCT00585195|50420662|FG010|Overall Study|Withdrawal by Subject|3|||
25200552|NCT00585195|50420663|FG011|Overall Study|Withdrawal by Subject|8|||
25200553|NCT00585195|50420664|FG012|Overall Study|Withdrawal by Subject|15|||
25200554|NCT00585195|50420665|FG013|Overall Study|Withdrawal by Subject|0|||
25200555|NCT00585195|50420666|FG014|Overall Study|Withdrawal by Subject|3|||
25200556|NCT00585195|50420667|FG015|Overall Study|Withdrawal by Subject|0|||
25200557|NCT00585195|50420668|FG016|Overall Study|Withdrawal by Subject|7|||
25200558|NCT00585195|50420669|FG017|Overall Study|Withdrawal by Subject|1|||
25200559|NCT00585195|50420670|FG018|Overall Study|Withdrawal by Subject|2|||
25200560|NCT00585195|50420671|FG019|Overall Study|Withdrawal by Subject|2|||
25200561|NCT00585195|50420672|FG020|Overall Study|Withdrawal by Subject|0|||
25200562|NCT00585195|50420652|FG000|Overall Study|Other|0|||
25200563|NCT00585195|50420653|FG001|Overall Study|Other|1|||
25200564|NCT00585195|50420654|FG002|Overall Study|Other|1|||
25200565|NCT00585195|50420655|FG003|Overall Study|Other|1|||
25200566|NCT00585195|50420656|FG004|Overall Study|Other|0|||
25200567|NCT00585195|50420657|FG005|Overall Study|Other|1|||
25200568|NCT00585195|50420658|FG006|Overall Study|Other|0|||
25200569|NCT00585195|50420659|FG007|Overall Study|Other|0|||
25200570|NCT00585195|50420660|FG008|Overall Study|Other|2|||
25200571|NCT00585195|50420661|FG009|Overall Study|Other|1|||
25200572|NCT00585195|50420662|FG010|Overall Study|Other|0|||
25200573|NCT00585195|50420663|FG011|Overall Study|Other|19|||
25200574|NCT00585195|50420664|FG012|Overall Study|Other|24|||
25200575|NCT00585195|50420665|FG013|Overall Study|Other|7|||
25200576|NCT00585195|50420666|FG014|Overall Study|Other|11|||
25200577|NCT00585195|50420667|FG015|Overall Study|Other|3|||
25200578|NCT00585195|50420668|FG016|Overall Study|Other|28|||
25200579|NCT00585195|50420669|FG017|Overall Study|Other|12|||
25200580|NCT00585195|50420670|FG018|Overall Study|Other|10|||
25200581|NCT00585195|50420671|FG019|Overall Study|Other|4|||
25200582|NCT00585195|50420672|FG020|Overall Study|Other|2|||
25200583|NCT00585195|50420652|FG000|Overall Study|Randomized not treated|0|||
25200584|NCT00585195|50420653|FG001|Overall Study|Randomized not treated|0|||
25200585|NCT00585195|50420654|FG002|Overall Study|Randomized not treated|1|||
25200586|NCT00585195|50420655|FG003|Overall Study|Randomized not treated|0|||
25200587|NCT00585195|50420656|FG004|Overall Study|Randomized not treated|1|||
25200588|NCT00585195|50420657|FG005|Overall Study|Randomized not treated|0|||
25200589|NCT00585195|50420658|FG006|Overall Study|Randomized not treated|1|||
25200590|NCT00585195|50420659|FG007|Overall Study|Randomized not treated|0|||
25200591|NCT00585195|50420660|FG008|Overall Study|Randomized not treated|0|||
25200592|NCT00585195|50420661|FG009|Overall Study|Randomized not treated|0|||
25200593|NCT00585195|50420662|FG010|Overall Study|Randomized not treated|2|||
25200594|NCT00585195|50420663|FG011|Overall Study|Randomized not treated|0|||
25200595|NCT00585195|50420664|FG012|Overall Study|Randomized not treated|0|||
25200596|NCT00585195|50420665|FG013|Overall Study|Randomized not treated|0|||
25200597|NCT00585195|50420666|FG014|Overall Study|Randomized not treated|0|||
25200598|NCT00585195|50420667|FG015|Overall Study|Randomized not treated|1|||
25200599|NCT00585195|50420668|FG016|Overall Study|Randomized not treated|0|||
25200600|NCT00585195|50420669|FG017|Overall Study|Randomized not treated|1|||
25200601|NCT00585195|50420670|FG018|Overall Study|Randomized not treated|3|||
25200602|NCT00585195|50420671|FG019|Overall Study|Randomized not treated|0|||
25200603|NCT00585195|50420672|FG020|Overall Study|Randomized not treated|2|||
25200604|NCT00585195|50420652|FG000|Overall Study|Death|0|||
25200605|NCT00585195|50420653|FG001|Overall Study|Death|0|||
25200606|NCT00585195|50420654|FG002|Overall Study|Death|0|||
25200607|NCT00585195|50420655|FG003|Overall Study|Death|0|||
25200608|NCT00585195|50420656|FG004|Overall Study|Death|0|||
25200609|NCT00585195|50420657|FG005|Overall Study|Death|0|||
25200610|NCT00585195|50420658|FG006|Overall Study|Death|0|||
25200611|NCT00585195|50420659|FG007|Overall Study|Death|0|||
25200612|NCT00585195|50420660|FG008|Overall Study|Death|1|||
25200613|NCT00585195|50420661|FG009|Overall Study|Death|0|||
25200614|NCT00585195|50420662|FG010|Overall Study|Death|1|||
25200615|NCT00585195|50420663|FG011|Overall Study|Death|1|||
25200616|NCT00585195|50420664|FG012|Overall Study|Death|7|||
25200617|NCT00585195|50420665|FG013|Overall Study|Death|2|||
25200618|NCT00585195|50420666|FG014|Overall Study|Death|8|||
25200619|NCT00585195|50420667|FG015|Overall Study|Death|2|||
25200620|NCT00585195|50420668|FG016|Overall Study|Death|11|||
25200621|NCT00585195|50420669|FG017|Overall Study|Death|0|||
25200622|NCT00585195|50420670|FG018|Overall Study|Death|0|||
25200623|NCT00585195|50420671|FG019|Overall Study|Death|0|||
25200624|NCT00585195|50420672|FG020|Overall Study|Death|1|||
25200625|NCT00585195|50420652|FG000|Overall Study|Lost to Follow-up|0|||
25200626|NCT00585195|50420653|FG001|Overall Study|Lost to Follow-up|0|||
25200627|NCT00585195|50420654|FG002|Overall Study|Lost to Follow-up|0|||
25200628|NCT00585195|50420655|FG003|Overall Study|Lost to Follow-up|0|||
25200629|NCT00585195|50420656|FG004|Overall Study|Lost to Follow-up|0|||
25200630|NCT00585195|50420657|FG005|Overall Study|Lost to Follow-up|0|||
25200631|NCT00585195|50420658|FG006|Overall Study|Lost to Follow-up|0|||
25200632|NCT00585195|50420659|FG007|Overall Study|Lost to Follow-up|0|||
25200633|NCT00585195|50420660|FG008|Overall Study|Lost to Follow-up|0|||
25200634|NCT00585195|50420661|FG009|Overall Study|Lost to Follow-up|0|||
25200635|NCT00585195|50420662|FG010|Overall Study|Lost to Follow-up|0|||
25200636|NCT00585195|50420663|FG011|Overall Study|Lost to Follow-up|0|||
25200637|NCT00585195|50420664|FG012|Overall Study|Lost to Follow-up|1|||
25200638|NCT00585195|50420665|FG013|Overall Study|Lost to Follow-up|0|||
25200639|NCT00585195|50420666|FG014|Overall Study|Lost to Follow-up|0|||
25200640|NCT00585195|50420667|FG015|Overall Study|Lost to Follow-up|0|||
25200641|NCT00585195|50420668|FG016|Overall Study|Lost to Follow-up|0|||
25200642|NCT00585195|50420669|FG017|Overall Study|Lost to Follow-up|2|||
25200643|NCT00585195|50420670|FG018|Overall Study|Lost to Follow-up|0|||
25200644|NCT00585195|50420671|FG019|Overall Study|Lost to Follow-up|0|||
25200645|NCT00585195|50420672|FG020|Overall Study|Lost to Follow-up|0|||
25200646|NCT00585195|50420652|FG000|Overall Study|Site Terminated by Sponsor|0|||
25200647|NCT00585195|50420653|FG001|Overall Study|Site Terminated by Sponsor|0|||
25200648|NCT00585195|50420654|FG002|Overall Study|Site Terminated by Sponsor|0|||
25200649|NCT00585195|50420655|FG003|Overall Study|Site Terminated by Sponsor|0|||
25200650|NCT00585195|50420656|FG004|Overall Study|Site Terminated by Sponsor|0|||
25200651|NCT00585195|50420657|FG005|Overall Study|Site Terminated by Sponsor|0|||
25200652|NCT00585195|50420658|FG006|Overall Study|Site Terminated by Sponsor|0|||
25200653|NCT00585195|50420659|FG007|Overall Study|Site Terminated by Sponsor|0|||
25200654|NCT00585195|50420660|FG008|Overall Study|Site Terminated by Sponsor|0|||
25200655|NCT00585195|50420661|FG009|Overall Study|Site Terminated by Sponsor|0|||
25200656|NCT00585195|50420662|FG010|Overall Study|Site Terminated by Sponsor|0|||
25200657|NCT00585195|50420663|FG011|Overall Study|Site Terminated by Sponsor|0|||
25200658|NCT00585195|50420664|FG012|Overall Study|Site Terminated by Sponsor|1|||
25200659|NCT00585195|50420665|FG013|Overall Study|Site Terminated by Sponsor|0|||
25200660|NCT00585195|50420666|FG014|Overall Study|Site Terminated by Sponsor|0|||
25200661|NCT00585195|50420667|FG015|Overall Study|Site Terminated by Sponsor|0|||
25200662|NCT00585195|50420668|FG016|Overall Study|Site Terminated by Sponsor|0|||
25200663|NCT00585195|50420669|FG017|Overall Study|Site Terminated by Sponsor|0|||
25200664|NCT00585195|50420670|FG018|Overall Study|Site Terminated by Sponsor|0|||
25200665|NCT00585195|50420671|FG019|Overall Study|Site Terminated by Sponsor|0|||
25200666|NCT00585195|50420672|FG020|Overall Study|Site Terminated by Sponsor|0|||
25200667|NCT00585195|50420652|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
25200668|NCT00585195|50420653|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
25200669|NCT00585195|50420654|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
25200670|NCT00585195|50420655|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
25200671|NCT00585195|50420656|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
25200672|NCT00585195|50420657|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
25200673|NCT00585195|50420658|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
25200674|NCT00585195|50420659|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
25200675|NCT00585195|50420660|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
25200676|NCT00585195|50420661|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
25200677|NCT00585195|50420662|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
25200678|NCT00585195|50420663|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
25200679|NCT00585195|50420664|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
25200680|NCT00585195|50420665|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
25200681|NCT00585195|50420666|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
25200682|NCT00585195|50420667|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
25200683|NCT00585195|50420668|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
25200684|NCT00585195|50420669|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
25200685|NCT00585195|50420670|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
25200686|NCT00585195|50420671|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
25200687|NCT00585195|50420672|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
25200688|NCT02439216|50420844|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
25200689|NCT02439216|50420845|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
25200690|NCT02439216|50420846|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
25200691|NCT02439216|50420847|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
25200692|NCT02439216|50420848|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
25200693|NCT02439216|50420849|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
25200694|NCT02439216|50420850|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
25200695|NCT02439216|50420851|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
25200696|NCT02439216|50420852|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
25200697|NCT02439216|50420844|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
25200698|NCT02439216|50420845|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
25200699|NCT02439216|50420846|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
25200700|NCT02439216|50420847|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
25200701|NCT02439216|50420848|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
25200702|NCT02439216|50420849|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
25200703|NCT02439216|50420850|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
25200704|NCT02439216|50420851|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
25200705|NCT02439216|50420852|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
25200706|NCT02439216|50420844|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
25200707|NCT02439216|50420845|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
25200708|NCT02439216|50420846|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
25200709|NCT02439216|50420847|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
25200710|NCT02439216|50420848|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
25200711|NCT02439216|50420849|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
25200712|NCT02439216|50420850|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
25200713|NCT02439216|50420851|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
25200714|NCT02439216|50420852|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
25200715|NCT02439216|50420844|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
25200716|NCT02439216|50420845|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
25200717|NCT02439216|50420846|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
25200718|NCT02439216|50420847|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
25200719|NCT02439216|50420848|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
25200720|NCT02439216|50420849|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
25200721|NCT02439216|50420850|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
25200722|NCT02439216|50420851|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
25171091|NCT01781429|50307991|FG006|Overall Study|Withdrawal by Subject|0|||
25171092|NCT01781429|50307992|FG007|Overall Study|Withdrawal by Subject|0|||
25171093|NCT01781429|50307993|FG008|Overall Study|Withdrawal by Subject|1|||
25171094|NCT01781429|50307994|FG009|Overall Study|Withdrawal by Subject|3|||
25171095|NCT01781429|50307995|FG010|Overall Study|Withdrawal by Subject|1|||
25171096|NCT01781429|50307996|FG011|Overall Study|Withdrawal by Subject|1|||
25171097|NCT01781429|50307997|FG012|Overall Study|Withdrawal by Subject|5|||
25171098|NCT01781429|50307998|FG013|Overall Study|Withdrawal by Subject|2|||
25171099|NCT01781429|50307999|FG014|Overall Study|Withdrawal by Subject|3|||
25171100|NCT01781429|50308000|FG015|Overall Study|Withdrawal by Subject|0|||
25171101|NCT01781429|50307985|FG000|Overall Study|Disease Progression|1|||
25171102|NCT01781429|50307986|FG001|Overall Study|Disease Progression|0|||
25171103|NCT01781429|50307987|FG002|Overall Study|Disease Progression|1|||
25171104|NCT01781429|50307988|FG003|Overall Study|Disease Progression|1|||
25171105|NCT01781429|50307989|FG004|Overall Study|Disease Progression|1|||
25171106|NCT01781429|50307990|FG005|Overall Study|Disease Progression|4|||
25171107|NCT01781429|50307991|FG006|Overall Study|Disease Progression|7|||
25171108|NCT01781429|50307992|FG007|Overall Study|Disease Progression|4|||
25171109|NCT01781429|50307993|FG008|Overall Study|Disease Progression|6|||
25171110|NCT01781429|50307994|FG009|Overall Study|Disease Progression|15|||
25171111|NCT01781429|50307995|FG010|Overall Study|Disease Progression|15|||
25171112|NCT01781429|50307996|FG011|Overall Study|Disease Progression|15|||
25171113|NCT01781429|50307997|FG012|Overall Study|Disease Progression|15|||
25171114|NCT01781429|50307998|FG013|Overall Study|Disease Progression|4|||
25171115|NCT01781429|50307999|FG014|Overall Study|Disease Progression|11|||
25171116|NCT01781429|50308000|FG015|Overall Study|Disease Progression|0|||
25171117|NCT01781429|50307985|FG000|Overall Study|Unacceptable Toxicity|0|||
25171118|NCT01781429|50307986|FG001|Overall Study|Unacceptable Toxicity|0|||
25171119|NCT01781429|50307987|FG002|Overall Study|Unacceptable Toxicity|0|||
25171120|NCT01781429|50307988|FG003|Overall Study|Unacceptable Toxicity|0|||
25171121|NCT01781429|50307989|FG004|Overall Study|Unacceptable Toxicity|0|||
25171122|NCT01781429|50307990|FG005|Overall Study|Unacceptable Toxicity|0|||
25171123|NCT01781429|50307991|FG006|Overall Study|Unacceptable Toxicity|0|||
25171124|NCT01781429|50307992|FG007|Overall Study|Unacceptable Toxicity|0|||
25171125|NCT01781429|50307993|FG008|Overall Study|Unacceptable Toxicity|0|||
25171126|NCT01781429|50307994|FG009|Overall Study|Unacceptable Toxicity|0|||
25171127|NCT01781429|50307995|FG010|Overall Study|Unacceptable Toxicity|0|||
25171128|NCT01781429|50307996|FG011|Overall Study|Unacceptable Toxicity|2|||
25171129|NCT01781429|50307997|FG012|Overall Study|Unacceptable Toxicity|0|||
25171130|NCT01781429|50307998|FG013|Overall Study|Unacceptable Toxicity|0|||
25171131|NCT01781429|50307999|FG014|Overall Study|Unacceptable Toxicity|0|||
25171132|NCT01781429|50308000|FG015|Overall Study|Unacceptable Toxicity|0|||
25171133|NCT01781429|50307985|FG000|Overall Study|Patient Condition Changed|0|||
25171134|NCT01781429|50307986|FG001|Overall Study|Patient Condition Changed|0|||
25171135|NCT01781429|50307987|FG002|Overall Study|Patient Condition Changed|0|||
25171136|NCT01781429|50307988|FG003|Overall Study|Patient Condition Changed|0|||
25171137|NCT01781429|50307989|FG004|Overall Study|Patient Condition Changed|0|||
25171138|NCT01781429|50307990|FG005|Overall Study|Patient Condition Changed|0|||
25171139|NCT01781429|50307991|FG006|Overall Study|Patient Condition Changed|0|||
25171140|NCT01781429|50307992|FG007|Overall Study|Patient Condition Changed|0|||
25171141|NCT01781429|50307993|FG008|Overall Study|Patient Condition Changed|0|||
25171142|NCT01781429|50307994|FG009|Overall Study|Patient Condition Changed|4|||
25171143|NCT01781429|50307995|FG010|Overall Study|Patient Condition Changed|0|||
25171144|NCT01781429|50307996|FG011|Overall Study|Patient Condition Changed|1|||
25171145|NCT01781429|50307997|FG012|Overall Study|Patient Condition Changed|0|||
25171146|NCT01781429|50307998|FG013|Overall Study|Patient Condition Changed|1|||
25200723|NCT02439216|50420852|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
25200724|NCT02439216|50420844|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
25200725|NCT02439216|50420845|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
25200726|NCT02439216|50420846|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
25200727|NCT02439216|50420847|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
25200728|NCT02439216|50420848|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
25200729|NCT02439216|50420849|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
25200730|NCT02439216|50420850|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
25200731|NCT02439216|50420851|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
25200732|NCT02439216|50420852|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
25200733|NCT02439138|50420880|FG000|Overall Study|Adverse Event|1|||
25200734|NCT02439138|50420880|FG000|Overall Study|PI decision to terminate the study|2|||
25200735|NCT02438826|50421256|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
25200736|NCT02438826|50421257|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
25200737|NCT02438826|50421258|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
25200738|NCT02438826|50421259|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
25200739|NCT02438826|50421256|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
25200740|NCT02438826|50421257|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
25200741|NCT02438826|50421258|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
25200742|NCT02438826|50421259|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
25200743|NCT02438826|50421256|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
25200744|NCT02438826|50421257|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
25200745|NCT02438826|50421258|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
25200746|NCT02438826|50421259|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
25200747|NCT02438826|50421256|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
25200748|NCT02438826|50421257|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
25200749|NCT02438826|50421258|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
25200750|NCT02438826|50421259|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
25200751|NCT02438826|50421256|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
25200752|NCT02438826|50421257|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
25200753|NCT02438826|50421258|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
25200754|NCT02438826|50421259|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
25200755|NCT02438826|50421256|FG000|Open-Label Treatment Phase|Adverse Event|11|||
25200756|NCT02438826|50421257|FG001|Open-Label Treatment Phase|Adverse Event|6|||
25200757|NCT02438826|50421258|FG002|Open-Label Treatment Phase|Adverse Event|0|||
25200758|NCT02438826|50421259|FG003|Open-Label Treatment Phase|Adverse Event|0|||
25200759|NCT02438826|50421256|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
24976276|NCT03467152|50065200|FG000|Overall Study|Withdrawal by Subject|4|||
24976277|NCT03467152|50065201|FG001|Overall Study|Withdrawal by Subject|2|||
24976278|NCT03467152|50065202|FG002|Overall Study|Withdrawal by Subject|0|||
24976279|NCT03467152|50065200|FG000|Overall Study|Others|3|||
24976280|NCT03467152|50065201|FG001|Overall Study|Others|0|||
24976281|NCT03467152|50065202|FG002|Overall Study|Others|0|||
24976282|NCT03467152|50065200|FG000|Overall Study|Not treated|3|||
24976283|NCT03467152|50065201|FG001|Overall Study|Not treated|1|||
24976284|NCT03467152|50065202|FG002|Overall Study|Not treated|6|||
24976285|NCT03466060|50065211|FG000|Period 1|Test Lens Damage|0|||
24976286|NCT03466060|50065212|FG001|Period 1|Test Lens Damage|2|||
24976287|NCT03466060|50065213|FG002|Period 1|Test Lens Damage|0|||
24976288|NCT03466060|50065214|FG003|Period 1|Test Lens Damage|0|||
24976289|NCT03466060|50065215|FG004|Period 1|Test Lens Damage|0|||
24976290|NCT03466060|50065216|FG005|Period 1|Test Lens Damage|0|||
24976291|NCT03466060|50065211|FG000|Period 1|Withdrawal by Subject|0|||
24976292|NCT03466060|50065212|FG001|Period 1|Withdrawal by Subject|0|||
24976293|NCT03466060|50065213|FG002|Period 1|Withdrawal by Subject|2|||
25200760|NCT02438826|50421257|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
25200761|NCT02438826|50421258|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
25200762|NCT02438826|50421259|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
25200763|NCT02438826|50421256|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
25200764|NCT02438826|50421257|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
25200765|NCT02438826|50421258|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
25200766|NCT02438826|50421259|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
25200767|NCT02438826|50421256|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
25200768|NCT02438826|50421257|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
25200769|NCT02438826|50421258|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
25200770|NCT02438826|50421259|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
25315573|NCT03909971|50631318|FG001|Overall Study|Other Reasons Not Specified|1|||
25315574|NCT03909971|50631317|FG000|Overall Study|Global Deterioration of Health Status|2|||
24976294|NCT03466060|50065214|FG003|Period 1|Withdrawal by Subject|0|||
24976295|NCT03466060|50065215|FG004|Period 1|Withdrawal by Subject|0|||
24976296|NCT03466060|50065216|FG005|Period 1|Withdrawal by Subject|0|||
25200771|NCT02438826|50421256|FG000|Post-Treatment Phase|Adverse Event|3|||
25200772|NCT02438826|50421257|FG001|Post-Treatment Phase|Adverse Event|0|||
25200773|NCT02438826|50421258|FG002|Post-Treatment Phase|Adverse Event|0|||
25200774|NCT02438826|50421259|FG003|Post-Treatment Phase|Adverse Event|0|||
25200775|NCT02438826|50421256|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
25200776|NCT02438826|50421257|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
25200777|NCT02438826|50421258|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
25200778|NCT02438826|50421259|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
25200779|NCT02438826|50421256|FG000|Post-Treatment Phase|Physician Decision|1|||
25200780|NCT02438826|50421257|FG001|Post-Treatment Phase|Physician Decision|0|||
25200781|NCT02438826|50421258|FG002|Post-Treatment Phase|Physician Decision|0|||
25200782|NCT02438826|50421259|FG003|Post-Treatment Phase|Physician Decision|0|||
25200783|NCT02438826|50421256|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
25200784|NCT02438826|50421257|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
25200785|NCT02438826|50421258|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
25200786|NCT02438826|50421259|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
25200787|NCT02438280|50421276|FG000|Overall Study|Physician Decision|1|||
25200788|NCT02438280|50421277|FG001|Overall Study|Physician Decision|0|||
25200789|NCT02385708|50421295|FG000|Overall Study|Withdrawal by Subject|0|||
25200790|NCT02385708|50421296|FG001|Overall Study|Withdrawal by Subject|2|||
25200791|NCT02385708|50421295|FG000|Overall Study|Withdrawn - surgery canceled|2|||
25200792|NCT02385708|50421296|FG001|Overall Study|Withdrawn - surgery canceled|5|||
25200793|NCT02385708|50421295|FG000|Overall Study|Investigator decision|5|||
25200794|NCT02385708|50421296|FG001|Overall Study|Investigator decision|7|||
25200795|NCT02385708|50421295|FG000|Overall Study|Protocol Violation|1|||
25200796|NCT02385708|50421296|FG001|Overall Study|Protocol Violation|1|||
25200797|NCT02385084|50422035|FG000|Period 2|Protocol Violation|0|||
25200798|NCT02385084|50422036|FG001|Period 2|Protocol Violation|0|||
25200799|NCT02385084|50422037|FG002|Period 2|Protocol Violation|1|||
25200800|NCT02385084|50422038|FG003|Period 2|Protocol Violation|0|||
25200801|NCT02385084|50422039|FG004|Period 2|Protocol Violation|0|||
25200802|NCT02385084|50422040|FG005|Period 2|Protocol Violation|0|||
25200803|NCT02411292|50422049|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
25200804|NCT02411292|50422049|FG000|Overall Study|Death|2|||
25200805|NCT02411292|50422049|FG000|Overall Study|Lost to Follow-up|3|||
25200806|NCT02384850|50422112|FG000|Overall Study|Withdrawal by Subject|2|||
25200807|NCT02384850|50422113|FG001|Overall Study|Withdrawal by Subject|2|||
25200808|NCT02437890|50422335|FG000|Overall Study|Non-compliance to study drug|0|||
25200809|NCT02437890|50422336|FG001|Overall Study|Non-compliance to study drug|1|||
25200810|NCT02437890|50422337|FG002|Overall Study|Non-compliance to study drug|0|||
25200811|NCT02437890|50422338|FG003|Overall Study|Non-compliance to study drug|0|||
25200812|NCT02437890|50422339|FG004|Overall Study|Non-compliance to study drug|1|||
25200813|NCT02437890|50422335|FG000|Overall Study|Sponsor's decision|1|||
25200814|NCT02437890|50422336|FG001|Overall Study|Sponsor's decision|1|||
25200815|NCT02437890|50422337|FG002|Overall Study|Sponsor's decision|4|||
25200816|NCT02437890|50422338|FG003|Overall Study|Sponsor's decision|0|||
25200817|NCT02437890|50422339|FG004|Overall Study|Sponsor's decision|2|||
25200818|NCT02437890|50422335|FG000|Overall Study|Physician Decision|0|||
25200819|NCT02437890|50422336|FG001|Overall Study|Physician Decision|0|||
25200820|NCT02437890|50422337|FG002|Overall Study|Physician Decision|0|||
25200821|NCT02437890|50422338|FG003|Overall Study|Physician Decision|1|||
25200822|NCT02437890|50422339|FG004|Overall Study|Physician Decision|0|||
25200823|NCT02437890|50422335|FG000|Overall Study|Unable to attend visit(s)|1|||
25200824|NCT02437890|50422336|FG001|Overall Study|Unable to attend visit(s)|0|||
25200825|NCT02437890|50422337|FG002|Overall Study|Unable to attend visit(s)|0|||
25200826|NCT02437890|50422338|FG003|Overall Study|Unable to attend visit(s)|0|||
25200827|NCT02437890|50422339|FG004|Overall Study|Unable to attend visit(s)|0|||
25200828|NCT02437890|50422335|FG000|Overall Study|Lack of Efficacy|1|||
25200829|NCT02437890|50422336|FG001|Overall Study|Lack of Efficacy|3|||
25200830|NCT02437890|50422337|FG002|Overall Study|Lack of Efficacy|0|||
25200831|NCT02437890|50422338|FG003|Overall Study|Lack of Efficacy|3|||
25200832|NCT02437890|50422339|FG004|Overall Study|Lack of Efficacy|1|||
25200833|NCT02437890|50422335|FG000|Overall Study|Adverse Event|4|||
25200834|NCT02437890|50422336|FG001|Overall Study|Adverse Event|9|||
25200835|NCT02437890|50422337|FG002|Overall Study|Adverse Event|5|||
25200836|NCT02437890|50422338|FG003|Overall Study|Adverse Event|11|||
25200837|NCT02437890|50422339|FG004|Overall Study|Adverse Event|7|||
25200838|NCT02437890|50422335|FG000|Overall Study|Withdrawal by Subject|1|||
25200839|NCT02437890|50422336|FG001|Overall Study|Withdrawal by Subject|2|||
25200840|NCT02437890|50422337|FG002|Overall Study|Withdrawal by Subject|6|||
25077099|NCT02439320|50184948|FG000|Overall Study|Lost to Follow-up|37|||
25200841|NCT02437890|50422338|FG003|Overall Study|Withdrawal by Subject|5|||
25200842|NCT02437890|50422339|FG004|Overall Study|Withdrawal by Subject|5|||
25200843|NCT02437890|50422335|FG000|Overall Study|Death|0|||
25200844|NCT02437890|50422336|FG001|Overall Study|Death|0|||
25200845|NCT02437890|50422337|FG002|Overall Study|Death|0|||
25200846|NCT02437890|50422338|FG003|Overall Study|Death|2|||
25200847|NCT02437890|50422339|FG004|Overall Study|Death|0|||
25200848|NCT02384538|50422400|FG000|Overall Study|Adverse Event|1|||
25200849|NCT02384538|50422401|FG001|Overall Study|Adverse Event|4|||
25200850|NCT02384538|50422400|FG000|Overall Study|Lack of Efficacy|4|||
25200851|NCT02384538|50422401|FG001|Overall Study|Lack of Efficacy|4|||
25200852|NCT02384538|50422400|FG000|Overall Study|Withdrew Consent|0|||
25200853|NCT02384538|50422401|FG001|Overall Study|Withdrew Consent|4|||
25200854|NCT02384538|50422400|FG000|Overall Study|Other|1|||
25200855|NCT02384538|50422401|FG001|Overall Study|Other|3|||
25200856|NCT02410824|50422425|FG000|First Intervention (One Week)|Headache|0|||
25200857|NCT02410824|50422426|FG001|First Intervention (One Week)|Headache|1|||
25200858|NCT02384460|50422456|FG000|Overall Study|Protocol Violation|0|||
25200859|NCT02384460|50422457|FG001|Overall Study|Protocol Violation|1|||
25200860|NCT02384460|50422456|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
25200861|NCT02384460|50422457|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
25200862|NCT02384460|50422456|FG000|Overall Study|Adverse Event|5|||
25200863|NCT02384460|50422457|FG001|Overall Study|Adverse Event|2|||
25200864|NCT02384460|50422456|FG000|Overall Study|Withdrawal by Subject|0|||
25200865|NCT02384460|50422457|FG001|Overall Study|Withdrawal by Subject|3|||
25200866|NCT02384460|50422456|FG000|Overall Study|Elective medical treatment|1|||
25200867|NCT02384460|50422457|FG001|Overall Study|Elective medical treatment|0|||
25200868|NCT02384460|50422456|FG000|Overall Study|Non-compliance|1|||
25200869|NCT02384460|50422457|FG001|Overall Study|Non-compliance|0|||
25200870|NCT02384382|50422480|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
25200871|NCT02384382|50422480|FG000|Overall Study|Death|1|||
25200872|NCT02384382|50422480|FG000|Overall Study|Adverse Event|1|||
25200873|NCT02384382|50422480|FG000|Overall Study|Disease progression|16|||
25200874|NCT02437188|50422500|FG000|Overall Study|Randomized but did not receive surgery|4|||
25200875|NCT02437188|50422501|FG001|Overall Study|Randomized but did not receive surgery|8|||
25200876|NCT02437188|50422500|FG000|Overall Study|Adverse Event|0|||
25200877|NCT02437188|50422501|FG001|Overall Study|Adverse Event|1|||
25200878|NCT02383758|50422523|FG000|Overall Study|Withdrawal by Subject|0|||
25200879|NCT02383758|50422524|FG001|Overall Study|Withdrawal by Subject|2|||
25200880|NCT02410278|50422574|FG000|Run-in Period|Adverse Event|5|||
25200881|NCT02410278|50422575|FG001|Run-in Period|Adverse Event|0|||
25200882|NCT02410278|50422576|FG002|Run-in Period|Adverse Event|0|||
25200883|NCT02410278|50422574|FG000|Run-in Period|GSRS Threshold Not Met|30|||
25200884|NCT02410278|50422575|FG001|Run-in Period|GSRS Threshold Not Met|0|||
25200885|NCT02410278|50422576|FG002|Run-in Period|GSRS Threshold Not Met|0|||
25200886|NCT02410278|50422574|FG000|Run-in Period|Lost to Follow-up|1|||
25200887|NCT02410278|50422575|FG001|Run-in Period|Lost to Follow-up|0|||
25200888|NCT02410278|50422576|FG002|Run-in Period|Lost to Follow-up|0|||
25200889|NCT02410278|50422574|FG000|Run-in Period|Withdrawal by Subject|1|||
25200890|NCT02410278|50422575|FG001|Run-in Period|Withdrawal by Subject|0|||
25200891|NCT02410278|50422576|FG002|Run-in Period|Withdrawal by Subject|0|||
25200892|NCT02410278|50422574|FG000|Run-in Period|Pregnancy|1|||
25200893|NCT02410278|50422575|FG001|Run-in Period|Pregnancy|0|||
25200894|NCT02410278|50422576|FG002|Run-in Period|Pregnancy|0|||
25200895|NCT02410278|50422574|FG000|Study Treatment Period|Adverse Event|0|||
25200896|NCT02410278|50422575|FG001|Study Treatment Period|Adverse Event|6|||
25200897|NCT02410278|50422576|FG002|Study Treatment Period|Adverse Event|3|||
25200898|NCT02410278|50422574|FG000|Study Treatment Period|Physician Decision|0|||
25200899|NCT02410278|50422575|FG001|Study Treatment Period|Physician Decision|0|||
25200900|NCT02410278|50422576|FG002|Study Treatment Period|Physician Decision|1|||
25200901|NCT02410278|50422574|FG000|Study Treatment Period|Withdrawal by Subject|0|||
25200902|NCT02410278|50422575|FG001|Study Treatment Period|Withdrawal by Subject|1|||
25200903|NCT02410278|50422576|FG002|Study Treatment Period|Withdrawal by Subject|0|||
25200904|NCT02410278|50422574|FG000|Study Treatment Period|Other|0|||
25200905|NCT02410278|50422575|FG001|Study Treatment Period|Other|3|||
25200906|NCT02410278|50422576|FG002|Study Treatment Period|Other|0|||
25200907|NCT02410278|50422574|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
25200908|NCT02410278|50422575|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
25200909|NCT02410278|50422576|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
25200910|NCT02410200|50422609|FG000|Overall Study|Adverse Event|2|||
25200911|NCT02383056|50422628|FG000|Overall Study|Adverse Event|1|||
25200912|NCT02383056|50422629|FG001|Overall Study|Adverse Event|0|||
25200913|NCT02383056|50422628|FG000|Overall Study|Lost to Follow-up|0|||
25077100|NCT02439320|50184949|FG001|Overall Study|Lost to Follow-up|34|||
25200914|NCT02383056|50422629|FG001|Overall Study|Lost to Follow-up|2|||
25200915|NCT02409732|50422635|FG000|Overall Study|Withdrawal by Subject|4|||
25200916|NCT02409732|50422635|FG000|Overall Study|Lost to Follow-up|2|||
25200917|NCT01650636|50422646|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
25200918|NCT01650636|50422647|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
25200919|NCT01650636|50422646|FG000|Washout up to 5 Months|Physician Decision|2|||
25200920|NCT01650636|50422647|FG001|Washout up to 5 Months|Physician Decision|2|||
25200921|NCT01650636|50422646|FG000|Washout up to 5 Months|Death|1|||
25200922|NCT01650636|50422647|FG001|Washout up to 5 Months|Death|0|||
25200923|NCT01650636|50422646|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
25200924|NCT01650636|50422647|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
25200925|NCT01650636|50422646|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
25200926|NCT01650636|50422647|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
25200927|NCT01650636|50422646|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
25200928|NCT01650636|50422647|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
25200929|NCT02436876|50422657|FG000|Overall Study|Lost to Follow-up|0|||
25200930|NCT02436876|50422658|FG001|Overall Study|Lost to Follow-up|1|||
25200931|NCT02436876|50422659|FG002|Overall Study|Lost to Follow-up|1|||
25200932|NCT02436876|50422660|FG003|Overall Study|Lost to Follow-up|1|||
25200933|NCT02436876|50422657|FG000|Overall Study|Withdrawal by Subject|1|||
25200934|NCT02436876|50422658|FG001|Overall Study|Withdrawal by Subject|0|||
25200935|NCT02436876|50422659|FG002|Overall Study|Withdrawal by Subject|0|||
25200936|NCT02436876|50422660|FG003|Overall Study|Withdrawal by Subject|1|||
25200937|NCT02436876|50422657|FG000|Overall Study|Physician Decision|0|||
25200938|NCT02436876|50422658|FG001|Overall Study|Physician Decision|2|||
25200939|NCT02436876|50422659|FG002|Overall Study|Physician Decision|1|||
25200940|NCT02436876|50422660|FG003|Overall Study|Physician Decision|0|||
25200941|NCT02436876|50422657|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
25200942|NCT02436876|50422658|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
25200943|NCT02436876|50422659|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
25200944|NCT02436876|50422660|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
25200945|NCT02382276|50422689|FG000|Overall Study|Withdrawal by Subject|4|||
25200946|NCT02382276|50422690|FG001|Overall Study|Withdrawal by Subject|8|||
25200947|NCT02382276|50422691|FG002|Overall Study|Withdrawal by Subject|5|||
25200948|NCT02382276|50422689|FG000|Overall Study|Adverse Event|7|||
25200949|NCT02382276|50422690|FG001|Overall Study|Adverse Event|2|||
25200950|NCT02382276|50422691|FG002|Overall Study|Adverse Event|32|||
25200951|NCT02382276|50422689|FG000|Overall Study|Physician Decision|0|||
25200952|NCT02382276|50422690|FG001|Overall Study|Physician Decision|0|||
25200953|NCT02382276|50422691|FG002|Overall Study|Physician Decision|2|||
25200954|NCT02436408|50422732|FG000|Overall Study|Death|1|||
25200955|NCT02436330|50422755|FG000|Cohort 1|Lost to Follow-up|5|||
25200956|NCT02436330|50422756|FG001|Cohort 1|Lost to Follow-up|2|||
25200957|NCT02436330|50422755|FG000|Cohort 1|Withdrawal by Subject|0|||
25200958|NCT02436330|50422756|FG001|Cohort 1|Withdrawal by Subject|1|||
25200959|NCT02436330|50422755|FG000|Cohort 2|Lost to Follow-up|2|||
25200960|NCT02436330|50422756|FG001|Cohort 2|Lost to Follow-up|0|||
25200961|NCT02436330|50422755|FG000|Cohort 2|Withdrawal by Subject|2|||
25200962|NCT02436330|50422756|FG001|Cohort 2|Withdrawal by Subject|3|||
25200963|NCT02436330|50422755|FG000|Cohort 3|Lost to Follow-up|1|||
25200964|NCT02436330|50422756|FG001|Cohort 3|Lost to Follow-up|0|||
25200965|NCT02436330|50422755|FG000|Cohort 3|Withdrawal by Subject|4|||
25200966|NCT02436330|50422756|FG001|Cohort 3|Withdrawal by Subject|0|||
25200967|NCT02436330|50422755|FG000|Cohort 4|Lost to Follow-up|1|||
25200968|NCT02436330|50422756|FG001|Cohort 4|Lost to Follow-up|0|||
25200969|NCT02436330|50422755|FG000|Cohort 4|Withdrawal by Subject|1|||
25200970|NCT02436330|50422756|FG001|Cohort 4|Withdrawal by Subject|0|||
25200971|NCT02436330|50422755|FG000|Cohort 5|Lost to Follow-up|3|||
25200972|NCT02436330|50422756|FG001|Cohort 5|Lost to Follow-up|2|||
25200973|NCT02436330|50422755|FG000|Cohort 5|Withdrawal by Subject|3|||
25200974|NCT02436330|50422756|FG001|Cohort 5|Withdrawal by Subject|2|||
25200975|NCT02436330|50422755|FG000|Cohort 6|Lost to Follow-up|2|||
25200976|NCT02436330|50422756|FG001|Cohort 6|Lost to Follow-up|0|||
25200977|NCT02436330|50422755|FG000|Cohort 6|Withdrawal by Subject|1|||
25200978|NCT02436330|50422756|FG001|Cohort 6|Withdrawal by Subject|1|||
25200979|NCT01650558|50422793|FG000|Overall Study|Migration out of study area|61|||
25200980|NCT01650558|50422794|FG001|Overall Study|Migration out of study area|71|||
25200981|NCT01650558|50422795|FG002|Overall Study|Migration out of study area|56|||
25200982|NCT01650558|50422793|FG000|Overall Study|Lost to Follow-up|10|||
25200983|NCT01650558|50422794|FG001|Overall Study|Lost to Follow-up|13|||
25200984|NCT01650558|50422795|FG002|Overall Study|Lost to Follow-up|6|||
25200985|NCT01650558|50422793|FG000|Overall Study|Death|10|||
25200986|NCT01650558|50422794|FG001|Overall Study|Death|6|||
25200987|NCT01650558|50422795|FG002|Overall Study|Death|8|||
25200988|NCT01650558|50422793|FG000|Overall Study|Withdrawal by Subject|1|||
25200989|NCT01650558|50422794|FG001|Overall Study|Withdrawal by Subject|1|||
25200990|NCT01650558|50422795|FG002|Overall Study|Withdrawal by Subject|3|||
25200991|NCT01650558|50422793|FG000|Overall Study|Non-compliant participant|1|||
25200992|NCT01650558|50422794|FG001|Overall Study|Non-compliant participant|0|||
25200993|NCT01650558|50422795|FG002|Overall Study|Non-compliant participant|2|||
25200994|NCT01650558|50422793|FG000|Overall Study|Physician Decision|0|||
25200995|NCT01650558|50422794|FG001|Overall Study|Physician Decision|1|||
25200996|NCT01650558|50422795|FG002|Overall Study|Physician Decision|0|||
25200997|NCT02408484|50422834|FG000|Overall Study|Withdrawal by Subject|3|||
25200998|NCT02408484|50422834|FG000|Overall Study|Not treated during study period|1|||
25200999|NCT02380248|50422862|FG000|Overall Study|Lost to Follow-up|11|||
25201000|NCT02380248|50422862|FG000|Overall Study|Withdrawal by Subject|3|||
25201001|NCT02408016|50422909|FG000|Overall Study|Death|6|||
25201002|NCT02408016|50422910|FG001|Overall Study|Death|1|||
25201003|NCT02408016|50422911|FG002|Overall Study|Death|0|||
25201004|NCT02408016|50422909|FG000|Overall Study|Physician Decision|0|||
25201005|NCT02408016|50422910|FG001|Overall Study|Physician Decision|2|||
25201006|NCT02408016|50422911|FG002|Overall Study|Physician Decision|0|||
25201007|NCT02407704|50422975|FG000|Overall Study|Lost to Follow-up|0|||
25201008|NCT02407704|50422976|FG001|Overall Study|Lost to Follow-up|0|||
25201009|NCT02407704|50422977|FG002|Overall Study|Lost to Follow-up|0|||
25201010|NCT02407704|50422978|FG003|Overall Study|Lost to Follow-up|2|||
25201011|NCT02407704|50422975|FG000|Overall Study|Protocol Violation|0|||
25201012|NCT02407704|50422976|FG001|Overall Study|Protocol Violation|0|||
25201013|NCT02407704|50422977|FG002|Overall Study|Protocol Violation|0|||
25201014|NCT02407704|50422978|FG003|Overall Study|Protocol Violation|1|||
25201015|NCT02407704|50422975|FG000|Overall Study|Withdrawal by Subject|0|||
25201016|NCT02407704|50422976|FG001|Overall Study|Withdrawal by Subject|0|||
25201017|NCT02407704|50422977|FG002|Overall Study|Withdrawal by Subject|1|||
25201018|NCT02407704|50422978|FG003|Overall Study|Withdrawal by Subject|0|||
25201019|NCT02406612|50422999|FG000|Overall Study|Screening Failure|3|||
25201020|NCT02406612|50423000|FG001|Overall Study|Screening Failure|0|||
25201021|NCT02406612|50422999|FG000|Overall Study|Intra-procedural Exclusion|1|||
25201022|NCT02406612|50423000|FG001|Overall Study|Intra-procedural Exclusion|3|||
25201023|NCT02406612|50422999|FG000|Overall Study|Guidewire Failure|0|||
25201024|NCT02406612|50423000|FG001|Overall Study|Guidewire Failure|1|||
25201025|NCT02405442|50423144|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
25201026|NCT02405442|50423145|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
25201027|NCT02405442|50423146|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
25201028|NCT02405442|50423147|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
25201029|NCT02405442|50423144|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
25201030|NCT02405442|50423145|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
25201031|NCT02405442|50423146|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
25201032|NCT02405442|50423147|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
25201033|NCT02405442|50423144|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
25201034|NCT02405442|50423145|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
25201035|NCT02405442|50423146|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
25201036|NCT02405442|50423147|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
25201037|NCT02405442|50423144|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
25201038|NCT02405442|50423145|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
25201039|NCT02405442|50423146|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
25201040|NCT02405442|50423147|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
25201041|NCT02405442|50423144|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
25201042|NCT02405442|50423145|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
25201043|NCT02405442|50423146|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
25201044|NCT02405442|50423147|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
25201045|NCT02405442|50423144|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
25315575|NCT03909971|50631318|FG001|Overall Study|Global Deterioration of Health Status|1|||
25315576|NCT03909971|50631317|FG000|Overall Study|Progressive Disease|6|||
25315577|NCT03909971|50631318|FG001|Overall Study|Progressive Disease|14|||
25315578|NCT03909971|50631317|FG000|Overall Study|Death|2|||
25315579|NCT03909971|50631318|FG001|Overall Study|Death|6|||
25315580|NCT00967343|50631325|FG000|Overall Study|Study termination by sponsor|12|||
25315581|NCT00967343|50631325|FG000|Overall Study|Death|24|||
25315582|NCT00967343|50631325|FG000|Overall Study|Relapse|1|||
25315583|NCT00967343|50631325|FG000|Overall Study|Lost to Follow-up|1|||
25315584|NCT00973973|50631331|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
25315585|NCT00973973|50631332|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
25315586|NCT00973973|50631331|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
25315587|NCT00973973|50631332|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
25315588|NCT00973973|50631331|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
25315589|NCT00973973|50631332|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
25315590|NCT00973973|50631331|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
25315591|NCT00973973|50631332|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
25315592|NCT00973973|50631331|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
25315593|NCT00973973|50631332|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
25201046|NCT02405442|50423145|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
25315594|NCT00973973|50631331|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
25315595|NCT00973973|50631332|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
25315596|NCT00973973|50631331|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
25315597|NCT00973973|50631332|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
25201047|NCT02405442|50423146|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
25201048|NCT02405442|50423147|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
25201049|NCT02405442|50423144|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
25201050|NCT02405442|50423145|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
25201051|NCT02405442|50423146|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
25201052|NCT02405442|50423147|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
25201053|NCT02405442|50423144|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
25201054|NCT02405442|50423145|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
25201055|NCT02405442|50423146|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
25201056|NCT02405442|50423147|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
25201057|NCT02405442|50423144|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
25201058|NCT02405442|50423145|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
25201059|NCT02405442|50423146|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
25201060|NCT02405442|50423147|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
25201061|NCT02405442|50423144|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
25201062|NCT02405442|50423145|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
25201063|NCT02405442|50423146|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
25201064|NCT02405442|50423147|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
25201065|NCT02405442|50423144|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
25201066|NCT02405442|50423145|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
25171147|NCT01781429|50307999|FG014|Overall Study|Patient Condition Changed|0|||
25171148|NCT01781429|50308000|FG015|Overall Study|Patient Condition Changed|0|||
25171149|NCT01781429|50307985|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
25171150|NCT01781429|50307986|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
25171151|NCT01781429|50307987|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
25171152|NCT01781429|50307988|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
25171153|NCT01781429|50307989|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
25171154|NCT01781429|50307990|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
25201067|NCT02405442|50423146|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
25201068|NCT02405442|50423147|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
25201069|NCT02405442|50423144|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
25201070|NCT02405442|50423145|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
25201071|NCT02405442|50423146|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
25201072|NCT02405442|50423147|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
25201073|NCT02405442|50423144|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
25201074|NCT02405442|50423145|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
25201075|NCT02405442|50423146|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
25201076|NCT02405442|50423147|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
25201077|NCT02405442|50423144|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
25201078|NCT02405442|50423145|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
25201079|NCT02405442|50423146|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
25201080|NCT02405442|50423147|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
25201081|NCT02404350|50423263|FG000|Overall Study|Adverse Event|2|||
25201082|NCT02404350|50423264|FG001|Overall Study|Adverse Event|2|||
25201083|NCT02404350|50423265|FG002|Overall Study|Adverse Event|3|||
25201084|NCT02404350|50423266|FG003|Overall Study|Adverse Event|9|||
25201085|NCT02404350|50423263|FG000|Overall Study|Lack of Efficacy|3|||
25201086|NCT02404350|50423264|FG001|Overall Study|Lack of Efficacy|1|||
25201087|NCT02404350|50423265|FG002|Overall Study|Lack of Efficacy|0|||
25201088|NCT02404350|50423266|FG003|Overall Study|Lack of Efficacy|3|||
25201089|NCT02404350|50423263|FG000|Overall Study|Lost to Follow-up|2|||
25201090|NCT02404350|50423264|FG001|Overall Study|Lost to Follow-up|0|||
25201091|NCT02404350|50423265|FG002|Overall Study|Lost to Follow-up|0|||
25201092|NCT02404350|50423266|FG003|Overall Study|Lost to Follow-up|1|||
25201093|NCT02404350|50423263|FG000|Overall Study|Physician Decision|1|||
25201094|NCT02404350|50423264|FG001|Overall Study|Physician Decision|0|||
25201095|NCT02404350|50423265|FG002|Overall Study|Physician Decision|0|||
25201096|NCT02404350|50423266|FG003|Overall Study|Physician Decision|2|||
25201097|NCT02404350|50423263|FG000|Overall Study|Pregnancy|0|||
25201098|NCT02404350|50423264|FG001|Overall Study|Pregnancy|0|||
25201099|NCT02404350|50423265|FG002|Overall Study|Pregnancy|0|||
25171155|NCT01781429|50307991|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
25171156|NCT01781429|50307992|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
25171157|NCT01781429|50307993|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
25171158|NCT01781429|50307994|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
25171159|NCT01781429|50307995|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
25171160|NCT01781429|50307996|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
25201100|NCT02404350|50423266|FG003|Overall Study|Pregnancy|1|||
25201101|NCT02404350|50423263|FG000|Overall Study|Withdrawal by Subject|7|||
25201102|NCT02404350|50423264|FG001|Overall Study|Withdrawal by Subject|3|||
25201103|NCT02404350|50423265|FG002|Overall Study|Withdrawal by Subject|3|||
25201104|NCT02404350|50423266|FG003|Overall Study|Withdrawal by Subject|19|||
25201105|NCT02404350|50423263|FG000|Overall Study|Due to Non-compliance with treatment|0|||
25201106|NCT02404350|50423264|FG001|Overall Study|Due to Non-compliance with treatment|0|||
25201107|NCT02404350|50423265|FG002|Overall Study|Due to Non-compliance with treatment|0|||
25201108|NCT02404350|50423266|FG003|Overall Study|Due to Non-compliance with treatment|1|||
25201109|NCT02404350|50423263|FG000|Overall Study|Due to Technical problems|0|||
25201110|NCT02404350|50423264|FG001|Overall Study|Due to Technical problems|0|||
25201111|NCT02404350|50423265|FG002|Overall Study|Due to Technical problems|0|||
25201112|NCT02404350|50423266|FG003|Overall Study|Due to Technical problems|1|||
25201113|NCT02434770|50423565|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
25201114|NCT02434770|50423566|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
25201115|NCT02434770|50423567|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
25201116|NCT02434770|50423565|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
25201117|NCT02434770|50423566|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
25201118|NCT02434770|50423567|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
25201119|NCT02434770|50423565|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
25201120|NCT02434770|50423566|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
25201121|NCT02434770|50423567|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
25201122|NCT02434770|50423565|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
25201123|NCT02434770|50423566|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
25201124|NCT02434770|50423567|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
25201125|NCT02434770|50423565|FG000|Week 1 to Week 18|Death|1|||
25201126|NCT02434770|50423566|FG001|Week 1 to Week 18|Death|0|||
25201127|NCT02434770|50423567|FG002|Week 1 to Week 18|Death|0|||
25201128|NCT02434770|50423565|FG000|Week 18 to Week|Lost to Follow-up|2|||
25201129|NCT02434770|50423566|FG001|Week 18 to Week|Lost to Follow-up|2|||
25201130|NCT02434770|50423567|FG002|Week 18 to Week|Lost to Follow-up|1|||
25201131|NCT02434770|50423565|FG000|Week 18 to Week|Withdrawal by Subject|0|||
25201132|NCT02434770|50423566|FG001|Week 18 to Week|Withdrawal by Subject|0|||
25201133|NCT02434770|50423567|FG002|Week 18 to Week|Withdrawal by Subject|2|||
25201134|NCT02434770|50423565|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
25201135|NCT02434770|50423566|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
25201136|NCT02434770|50423567|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
25201137|NCT02433834|50423598|FG000|Overall Study|Protocol-specified criteria|7|||
25201138|NCT02433834|50423598|FG000|Overall Study|Protocol Violation|3|||
25201139|NCT02433834|50423598|FG000|Overall Study|Lost to Follow-up|6|||
25201140|NCT02433834|50423598|FG000|Overall Study|Withdrawal by Subject|14|||
25201141|NCT02433834|50423598|FG000|Overall Study|Adverse Event|6|||
25201142|NCT02433834|50423598|FG000|Overall Study|Physician Decision|1|||
25201143|NCT02433678|50423642|FG000|Overall Study|Lost to Follow-up|1|||
25201144|NCT02433678|50423643|FG001|Overall Study|Lost to Follow-up|2|||
25201145|NCT02433288|50423656|FG000|Overall Study|Severe non-compliance to protocol|13|||
25201146|NCT02433288|50423657|FG001|Overall Study|Severe non-compliance to protocol|7|||
25201147|NCT02433288|50423656|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
25201148|NCT02433288|50423657|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
25201149|NCT02433288|50423656|FG000|Overall Study|Withdrawal by Subject|101|||
25201150|NCT02433288|50423657|FG001|Overall Study|Withdrawal by Subject|99|||
25201151|NCT02433288|50423656|FG000|Overall Study|Lost to Follow-up|2|||
25201152|NCT02433288|50423657|FG001|Overall Study|Lost to Follow-up|14|||
25201153|NCT02433288|50423656|FG000|Overall Study|Death|0|||
25201154|NCT02433288|50423657|FG001|Overall Study|Death|3|||
25201155|NCT02433210|50423677|FG000|Overall Study|Physician Decision|1|||
25201156|NCT02433210|50423678|FG001|Overall Study|Physician Decision|0|||
25201157|NCT02433210|50423679|FG002|Overall Study|Physician Decision|0|||
25201158|NCT02432040|50423814|FG000|Overall Study|Lack of Efficacy|3|||
25201159|NCT02432040|50423815|FG001|Overall Study|Lack of Efficacy|0|||
25201160|NCT02432040|50423814|FG000|Overall Study|Lost to Follow-up|4|||
25201161|NCT02432040|50423815|FG001|Overall Study|Lost to Follow-up|5|||
25201162|NCT02432040|50423814|FG000|Overall Study|Physician Decision|1|||
25201163|NCT02432040|50423815|FG001|Overall Study|Physician Decision|1|||
25201164|NCT04418076|50423861|FG000|Overall Study|Death|1|||
25201165|NCT04418076|50423862|FG001|Overall Study|Death|0|||
25201166|NCT04418076|50423863|FG002|Overall Study|Death|0|||
25201167|NCT04418076|50423864|FG003|Overall Study|Death|0|||
25201168|NCT04418076|50423861|FG000|Overall Study|Lost to Follow-up|2|||
25201169|NCT04418076|50423862|FG001|Overall Study|Lost to Follow-up|5|||
25201170|NCT04418076|50423863|FG002|Overall Study|Lost to Follow-up|1|||
25201171|NCT04418076|50423864|FG003|Overall Study|Lost to Follow-up|2|||
25201172|NCT04418076|50423861|FG000|Overall Study|Withdrawal by Subject|1|||
25201173|NCT04418076|50423862|FG001|Overall Study|Withdrawal by Subject|0|||
25201174|NCT04418076|50423863|FG002|Overall Study|Withdrawal by Subject|1|||
25201175|NCT04418076|50423864|FG003|Overall Study|Withdrawal by Subject|1|||
25201176|NCT04418076|50423861|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
25201177|NCT04418076|50423862|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
25201178|NCT04418076|50423863|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
25201179|NCT04418076|50423864|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
25201180|NCT04165824|50423874|FG000|Overall Study|Adverse Event|23|||
25201181|NCT04165824|50423874|FG000|Overall Study|Physician Decision|1|||
25201182|NCT04165824|50423874|FG000|Overall Study|Withdrawal by Subject|17|||
25201183|NCT04165824|50423874|FG000|Overall Study|Other|5|||
25201184|NCT03809039|50423887|FG000|Part 1|Withdrawal by Subject|1|||
25201185|NCT03809039|50423888|FG001|Part 1|Withdrawal by Subject|0|||
25201186|NCT03809039|50423889|FG002|Part 1|Withdrawal by Subject|0|||
25201187|NCT03809039|50423890|FG003|Part 1|Withdrawal by Subject|1|||
25201188|NCT03809039|50423891|FG004|Part 1|Withdrawal by Subject|0|||
25201189|NCT03809039|50423892|FG005|Part 1|Withdrawal by Subject|0|||
25201190|NCT03809039|50423893|FG006|Part 1|Withdrawal by Subject|0|||
25201191|NCT03809039|50423894|FG007|Part 1|Withdrawal by Subject|0|||
25201192|NCT03809039|50423895|FG008|Part 1|Withdrawal by Subject|0|||
25201193|NCT03809039|50423887|FG000|Part 3|Withdrawn by study termination|0|||
25201194|NCT03809039|50423888|FG001|Part 3|Withdrawn by study termination|0|||
25201195|NCT03809039|50423889|FG002|Part 3|Withdrawn by study termination|0|||
25201196|NCT03809039|50423890|FG003|Part 3|Withdrawn by study termination|0|||
25201197|NCT03809039|50423891|FG004|Part 3|Withdrawn by study termination|0|||
25201198|NCT03809039|50423892|FG005|Part 3|Withdrawn by study termination|0|||
25201199|NCT03809039|50423893|FG006|Part 3|Withdrawn by study termination|0|||
25201200|NCT03809039|50423894|FG007|Part 3|Withdrawn by study termination|2|||
25201201|NCT03809039|50423895|FG008|Part 3|Withdrawn by study termination|6|||
25201202|NCT03541200|50423963|FG000|Overall Study|Adverse Event|19|||
25201203|NCT03541200|50423963|FG000|Overall Study|Death|1|||
25201204|NCT03541200|50423963|FG000|Overall Study|Lost to Follow-up|10|||
25201205|NCT03541200|50423963|FG000|Overall Study|Physician Decision|1|||
25201206|NCT03541200|50423963|FG000|Overall Study|Protocol Violation|51|||
25201207|NCT03541200|50423963|FG000|Overall Study|Withdrawal by Subject|23|||
25201208|NCT03541200|50423963|FG000|Overall Study|other|8|||
25201209|NCT03520036|50423970|FG000|Overall Study|Adverse Event|1|||
25201210|NCT03520036|50423971|FG001|Overall Study|Adverse Event|2|||
25201211|NCT03520036|50423972|FG002|Overall Study|Adverse Event|0|||
25201212|NCT03520036|50423970|FG000|Overall Study|Protocol Violation|1|||
25201213|NCT03520036|50423971|FG001|Overall Study|Protocol Violation|0|||
25201214|NCT03520036|50423972|FG002|Overall Study|Protocol Violation|0|||
25201215|NCT03520036|50423970|FG000|Overall Study|Withdrawal by Subject|0|||
25201216|NCT03520036|50423971|FG001|Overall Study|Withdrawal by Subject|1|||
25315598|NCT00973973|50631331|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
25077101|NCT02439320|50184950|FG002|Overall Study|Lost to Follow-up|42|||
25171161|NCT01781429|50307997|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
25171162|NCT01781429|50307998|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
25171163|NCT01781429|50307999|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
25171164|NCT01781429|50308000|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
25171165|NCT01781429|50307985|FG000|Overall Study|Enrolled, but not treated|0|||
25171166|NCT01781429|50307986|FG001|Overall Study|Enrolled, but not treated|0|||
25171167|NCT01781429|50307987|FG002|Overall Study|Enrolled, but not treated|0|||
25171168|NCT01781429|50307988|FG003|Overall Study|Enrolled, but not treated|0|||
25171169|NCT01781429|50307989|FG004|Overall Study|Enrolled, but not treated|0|||
25171170|NCT01781429|50307990|FG005|Overall Study|Enrolled, but not treated|0|||
25171171|NCT01781429|50307991|FG006|Overall Study|Enrolled, but not treated|0|||
25171172|NCT01781429|50307992|FG007|Overall Study|Enrolled, but not treated|0|||
25171173|NCT01781429|50307993|FG008|Overall Study|Enrolled, but not treated|0|||
25171174|NCT01781429|50307994|FG009|Overall Study|Enrolled, but not treated|0|||
25171175|NCT01781429|50307995|FG010|Overall Study|Enrolled, but not treated|1|||
25171176|NCT01781429|50307996|FG011|Overall Study|Enrolled, but not treated|0|||
25201217|NCT03520036|50423972|FG002|Overall Study|Withdrawal by Subject|4|||
25201218|NCT03520036|50423970|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
25201219|NCT03520036|50423971|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
25201220|NCT03520036|50423972|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
25201221|NCT03505710|50423983|FG000|Overall Study|Progressive Disease|22|||
25201222|NCT03505710|50423984|FG001|Overall Study|Progressive Disease|9|||
25201223|NCT03505710|50423985|FG002|Overall Study|Progressive Disease|34|||
25201224|NCT03505710|50423983|FG000|Overall Study|Clinical Progression|6|||
25201225|NCT03505710|50423984|FG001|Overall Study|Clinical Progression|6|||
25201226|NCT03505710|50423985|FG002|Overall Study|Clinical Progression|3|||
25201227|NCT03505710|50423983|FG000|Overall Study|Adverse Event|12|||
25201228|NCT03505710|50423984|FG001|Overall Study|Adverse Event|5|||
25201229|NCT03505710|50423985|FG002|Overall Study|Adverse Event|27|||
25201230|NCT03505710|50423983|FG000|Overall Study|Withdrawal by Subject|1|||
25201231|NCT03505710|50423984|FG001|Overall Study|Withdrawal by Subject|3|||
25201232|NCT03505710|50423985|FG002|Overall Study|Withdrawal by Subject|3|||
25201233|NCT03505710|50423983|FG000|Overall Study|Physician Decision|1|||
25201234|NCT03505710|50423984|FG001|Overall Study|Physician Decision|0|||
25201235|NCT03505710|50423985|FG002|Overall Study|Physician Decision|2|||
25201236|NCT03505710|50423983|FG000|Overall Study|Death|4|||
25201237|NCT03505710|50423984|FG001|Overall Study|Death|3|||
25201238|NCT03505710|50423985|FG002|Overall Study|Death|6|||
25201239|NCT03505710|50423983|FG000|Overall Study|Other Reasons|1|||
25201240|NCT03505710|50423984|FG001|Overall Study|Other Reasons|1|||
25201241|NCT03505710|50423985|FG002|Overall Study|Other Reasons|1|||
25201242|NCT03459729|50423993|FG000|Overall Study|Physician Decision|2|||
25201243|NCT03291067|50424001|FG000|Overall Study|Adverse Event|0|||
25201244|NCT03291067|50424002|FG001|Overall Study|Adverse Event|2|||
25201245|NCT03291067|50424003|FG002|Overall Study|Adverse Event|17|||
25201246|NCT03291067|50424004|FG003|Overall Study|Adverse Event|3|||
25201247|NCT03291067|50424001|FG000|Overall Study|Lost to Follow-up|2|||
25201248|NCT03291067|50424002|FG001|Overall Study|Lost to Follow-up|1|||
25201249|NCT03291067|50424003|FG002|Overall Study|Lost to Follow-up|0|||
25201250|NCT03291067|50424004|FG003|Overall Study|Lost to Follow-up|1|||
25201251|NCT03291067|50424001|FG000|Overall Study|Physician Decision|0|||
25201252|NCT03291067|50424002|FG001|Overall Study|Physician Decision|0|||
25201253|NCT03291067|50424003|FG002|Overall Study|Physician Decision|1|||
25201254|NCT03291067|50424004|FG003|Overall Study|Physician Decision|0|||
25201255|NCT03291067|50424001|FG000|Overall Study|Protocol Violation|5|||
25201256|NCT03291067|50424002|FG001|Overall Study|Protocol Violation|3|||
25201257|NCT03291067|50424003|FG002|Overall Study|Protocol Violation|4|||
25201258|NCT03291067|50424004|FG003|Overall Study|Protocol Violation|2|||
25201259|NCT03291067|50424001|FG000|Overall Study|Withdrawal by Subject|3|||
25201260|NCT03291067|50424002|FG001|Overall Study|Withdrawal by Subject|4|||
25201261|NCT03291067|50424003|FG002|Overall Study|Withdrawal by Subject|7|||
25201262|NCT03291067|50424004|FG003|Overall Study|Withdrawal by Subject|5|||
25201263|NCT03291067|50424001|FG000|Overall Study|Other|0|||
25201264|NCT03291067|50424002|FG001|Overall Study|Other|4|||
25201265|NCT03291067|50424003|FG002|Overall Study|Other|4|||
25201266|NCT03291067|50424004|FG003|Overall Study|Other|6|||
25201267|NCT03035409|50424014|FG000|Overall Study|Adverse Event|5|||
25201268|NCT03035409|50424014|FG000|Overall Study|Death|2|||
25201269|NCT03035409|50424014|FG000|Overall Study|Withdrawal by Subject|2|||
25201270|NCT03035409|50424014|FG000|Overall Study|Non compliance|4|||
25201271|NCT03035409|50424014|FG000|Overall Study|Patient was jittery|1|||
25201272|NCT03035409|50424014|FG000|Overall Study|Did not like Questionnaire|1|||
25201273|NCT03035409|50424014|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
25201274|NCT03035409|50424014|FG000|Overall Study|Did not like taking drugs|1|||
25201275|NCT02847598|50424026|FG000|Overall Study|Adverse Event|0|||
25201276|NCT02847598|50424027|FG001|Overall Study|Adverse Event|0|||
25201277|NCT02847598|50424028|FG002|Overall Study|Adverse Event|0|||
25201278|NCT02847598|50424029|FG003|Overall Study|Adverse Event|0|||
25201279|NCT02847598|50424030|FG004|Overall Study|Adverse Event|0|||
25201280|NCT02847598|50424031|FG005|Overall Study|Adverse Event|0|||
25201281|NCT02847598|50424032|FG006|Overall Study|Adverse Event|0|||
25201282|NCT02847598|50424033|FG007|Overall Study|Adverse Event|1|||
25201283|NCT02847598|50424026|FG000|Overall Study|Consent withdrawn|2|||
25201284|NCT02847598|50424027|FG001|Overall Study|Consent withdrawn|0|||
25201285|NCT02847598|50424028|FG002|Overall Study|Consent withdrawn|0|||
25201286|NCT02847598|50424029|FG003|Overall Study|Consent withdrawn|4|||
25201287|NCT02847598|50424030|FG004|Overall Study|Consent withdrawn|3|||
25201288|NCT02847598|50424031|FG005|Overall Study|Consent withdrawn|2|||
25201289|NCT02847598|50424032|FG006|Overall Study|Consent withdrawn|1|||
25201290|NCT02847598|50424033|FG007|Overall Study|Consent withdrawn|3|||
25201291|NCT02847598|50424026|FG000|Overall Study|Death|3|||
25201292|NCT02847598|50424027|FG001|Overall Study|Death|0|||
25201293|NCT02847598|50424028|FG002|Overall Study|Death|0|||
25201294|NCT02847598|50424029|FG003|Overall Study|Death|0|||
25201295|NCT02847598|50424030|FG004|Overall Study|Death|0|||
25201296|NCT02847598|50424031|FG005|Overall Study|Death|0|||
25201297|NCT02847598|50424032|FG006|Overall Study|Death|0|||
25201298|NCT02847598|50424033|FG007|Overall Study|Death|0|||
25201299|NCT02847598|50424026|FG000|Overall Study|Lost to Follow-up|0|||
25201300|NCT02847598|50424027|FG001|Overall Study|Lost to Follow-up|0|||
25201301|NCT02847598|50424028|FG002|Overall Study|Lost to Follow-up|0|||
25201302|NCT02847598|50424029|FG003|Overall Study|Lost to Follow-up|0|||
25201303|NCT02847598|50424030|FG004|Overall Study|Lost to Follow-up|0|||
25201304|NCT02847598|50424031|FG005|Overall Study|Lost to Follow-up|1|||
25201305|NCT02847598|50424032|FG006|Overall Study|Lost to Follow-up|1|||
25201306|NCT02847598|50424033|FG007|Overall Study|Lost to Follow-up|0|||
25201307|NCT02841280|50424059|FG000|Overall Study|Adverse Event|2|||
25201308|NCT02841280|50424060|FG001|Overall Study|Adverse Event|1|||
25201309|NCT02841280|50424059|FG000|Overall Study|Death|1|||
25201310|NCT02841280|50424060|FG001|Overall Study|Death|0|||
25201311|NCT02841280|50424059|FG000|Overall Study|Lost to Follow-up|2|||
25201312|NCT02841280|50424060|FG001|Overall Study|Lost to Follow-up|2|||
25201313|NCT02841280|50424059|FG000|Overall Study|Withdrawal by Subject|7|||
25201314|NCT02841280|50424060|FG001|Overall Study|Withdrawal by Subject|3|||
25201315|NCT02841280|50424059|FG000|Overall Study|Stop Point: BP above threshold|2|||
25201316|NCT02841280|50424060|FG001|Overall Study|Stop Point: BP above threshold|0|||
25201317|NCT02576574|50424073|FG000|Overall Study|still ongoing|65|||
25201318|NCT02576574|50424074|FG001|Overall Study|still ongoing|66|||
25201319|NCT02576574|50424075|FG002|Overall Study|still ongoing|73|||
25171177|NCT01781429|50307997|FG012|Overall Study|Enrolled, but not treated|0|||
25171178|NCT01781429|50307998|FG013|Overall Study|Enrolled, but not treated|0|||
25201320|NCT02576574|50424073|FG000|Overall Study|Randomized, not treated|5|||
25201321|NCT02576574|50424074|FG001|Overall Study|Randomized, not treated|4|||
25201322|NCT02576574|50424075|FG002|Overall Study|Randomized, not treated|26|||
25201323|NCT02550652|50424087|FG000|Overall Study|Death|1|||
25201324|NCT02550652|50424088|FG001|Overall Study|Death|4|||
25201325|NCT02550652|50424087|FG000|Overall Study|Lack of Efficacy|1|||
25201326|NCT02550652|50424088|FG001|Overall Study|Lack of Efficacy|0|||
25201327|NCT02550652|50424087|FG000|Overall Study|Withdrawal by Subject|3|||
25201328|NCT02550652|50424088|FG001|Overall Study|Withdrawal by Subject|7|||
25201329|NCT02550652|50424087|FG000|Overall Study|Post Trial Access|1|||
25201330|NCT02550652|50424088|FG001|Overall Study|Post Trial Access|0|||
25201331|NCT02550652|50424087|FG000|Overall Study|Lost to Follow-up|1|||
25201332|NCT02550652|50424088|FG001|Overall Study|Lost to Follow-up|3|||
25201333|NCT02550652|50424087|FG000|Overall Study|Physician Decision|0|||
25201334|NCT02550652|50424088|FG001|Overall Study|Physician Decision|2|||
25201335|NCT02550652|50424087|FG000|Overall Study|Ongoing in safety/B-cell follow-up period|14|||
25201336|NCT02550652|50424088|FG001|Overall Study|Ongoing in safety/B-cell follow-up period|5|||
25201337|NCT02345330|50424098|FG000|Overall Study|Death|1|||
25201338|NCT02345330|50424098|FG000|Overall Study|Progressive Disease|2|||
25201339|NCT02281084|50424106|FG000|Overall Study|Adverse Event|1|||
25201340|NCT02281084|50424107|FG001|Overall Study|Adverse Event|0|||
25201341|NCT02281084|50424108|FG002|Overall Study|Adverse Event|0|||
25201342|NCT02281084|50424109|FG003|Overall Study|Adverse Event|0|||
25201343|NCT02281084|50424106|FG000|Overall Study|Withdrawal by Subject|1|||
25201344|NCT02281084|50424107|FG001|Overall Study|Withdrawal by Subject|2|||
25201345|NCT02281084|50424108|FG002|Overall Study|Withdrawal by Subject|0|||
25315599|NCT00973973|50631332|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
25315600|NCT00973973|50631331|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
25315601|NCT00973973|50631332|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
25315602|NCT00973973|50631331|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
25315603|NCT00973973|50631332|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
25315604|NCT00973973|50631331|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
25315605|NCT00973973|50631332|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
25315606|NCT00973973|50631331|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
25171179|NCT01781429|50307999|FG014|Overall Study|Enrolled, but not treated|0|||
25171180|NCT01781429|50308000|FG015|Overall Study|Enrolled, but not treated|0|||
25171181|NCT01773473|50308035|FG000|Overall Study|Adverse Event|3|||
25171182|NCT01773473|50308036|FG001|Overall Study|Adverse Event|2|||
25171183|NCT01773473|50308035|FG000|Overall Study|Protocol Violation|0|||
25171184|NCT01773473|50308036|FG001|Overall Study|Protocol Violation|4|||
25171185|NCT01773473|50308035|FG000|Overall Study|Physician Decision|3|||
25171186|NCT01773473|50308036|FG001|Overall Study|Physician Decision|5|||
25171187|NCT01773473|50308035|FG000|Overall Study|Sponsor Decision|2|||
25171188|NCT01773473|50308036|FG001|Overall Study|Sponsor Decision|0|||
25171189|NCT01773473|50308035|FG000|Overall Study|Lack of Efficacy|0|||
25171190|NCT01773473|50308036|FG001|Overall Study|Lack of Efficacy|1|||
25171191|NCT01773473|50308035|FG000|Overall Study|Non-Compliance with study drug|1|||
25171192|NCT01773473|50308036|FG001|Overall Study|Non-Compliance with study drug|4|||
25171193|NCT01773473|50308035|FG000|Overall Study|Withdrawal by Subject|5|||
25171194|NCT01773473|50308036|FG001|Overall Study|Withdrawal by Subject|3|||
25171195|NCT01773473|50308035|FG000|Overall Study|Lost to Follow-up|2|||
25201346|NCT02281084|50424109|FG003|Overall Study|Withdrawal by Subject|0|||
25201347|NCT02281084|50424106|FG000|Overall Study|Death|20|||
25201348|NCT02281084|50424107|FG001|Overall Study|Death|16|||
25201349|NCT02281084|50424108|FG002|Overall Study|Death|3|||
25201350|NCT02281084|50424109|FG003|Overall Study|Death|5|||
25201351|NCT02281084|50424106|FG000|Overall Study|Physician Decision|0|||
25201352|NCT02281084|50424107|FG001|Overall Study|Physician Decision|0|||
25201353|NCT02281084|50424108|FG002|Overall Study|Physician Decision|1|||
25201354|NCT02281084|50424109|FG003|Overall Study|Physician Decision|0|||
25201355|NCT01513343|50424130|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
25201356|NCT01513343|50424131|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
25201357|NCT01513343|50424130|FG000|Post Data Collection|Dropped/withdrew from study|7|||
25201358|NCT01513343|50424131|FG001|Post Data Collection|Dropped/withdrew from study|1|||
25201359|NCT01513343|50424130|FG000|Post Data Collection|Lost to Follow-up|10|||
25201360|NCT01513343|50424131|FG001|Post Data Collection|Lost to Follow-up|23|||
25201361|NCT01513343|50424130|FG000|6-month Follow-up|Lost to Follow-up|28|||
25201362|NCT01513343|50424131|FG001|6-month Follow-up|Lost to Follow-up|17|||
25201363|NCT01513343|50424130|FG000|12-month Follow-up|Lost to Follow-up|10|||
25201364|NCT01513343|50424131|FG001|12-month Follow-up|Lost to Follow-up|3|||
25201365|NCT01440816|50424158|FG000|Overall Study|Disease Progression|0|||
25201366|NCT01440816|50424159|FG001|Overall Study|Disease Progression|9|||
25201367|NCT01440816|50424158|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
25201368|NCT01440816|50424159|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
25201369|NCT01348919|50424170|FG000|Overall Study|Adverse Event|3|||
25201370|NCT01348919|50424171|FG001|Overall Study|Adverse Event|1|||
25201371|NCT01348919|50424172|FG002|Overall Study|Adverse Event|0|||
25201372|NCT01348919|50424170|FG000|Overall Study|Withdrawal by Subject|0|||
25201373|NCT01348919|50424171|FG001|Overall Study|Withdrawal by Subject|1|||
25201374|NCT01348919|50424172|FG002|Overall Study|Withdrawal by Subject|0|||
25201375|NCT01348919|50424170|FG000|Overall Study|Disease progression|0|||
25201376|NCT01348919|50424171|FG001|Overall Study|Disease progression|1|||
25201377|NCT01348919|50424172|FG002|Overall Study|Disease progression|1|||
25201378|NCT00966381|50424184|FG000|Overall Study|Withdrawal by Subject|2|||
25201379|NCT00966381|50424185|FG001|Overall Study|Withdrawal by Subject|2|||
25201380|NCT02431806|50424197|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
25201381|NCT02431806|50424198|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
25201382|NCT02431806|50424199|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
25201383|NCT02431806|50424200|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
25201384|NCT02431806|50424197|FG000|Double-blind Treatment Period|Adverse Event|4|||
25201385|NCT02431806|50424198|FG001|Double-blind Treatment Period|Adverse Event|7|||
25201386|NCT02431806|50424199|FG002|Double-blind Treatment Period|Adverse Event|11|||
25201387|NCT02431806|50424200|FG003|Double-blind Treatment Period|Adverse Event|7|||
25201388|NCT02431806|50424197|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
25201389|NCT02431806|50424198|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
25201390|NCT02431806|50424199|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
25201391|NCT02431806|50424200|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
25201392|NCT02431806|50424197|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
25201393|NCT02431806|50424198|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
25201394|NCT02431806|50424199|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
25201395|NCT02431806|50424200|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
25201396|NCT02431806|50424197|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
25201397|NCT02431806|50424198|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
25201398|NCT02431806|50424199|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
25201399|NCT02431806|50424200|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
25201400|NCT02431806|50424197|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
25201401|NCT02431806|50424198|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
25201402|NCT02431806|50424199|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
25201403|NCT02431806|50424200|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
25201404|NCT02431806|50424197|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
25201405|NCT02431806|50424198|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
25201406|NCT02431806|50424199|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
25201407|NCT02431806|50424200|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
25201408|NCT01650246|50424241|FG000|Overall Study|Adverse Event|23|||
25201409|NCT01650246|50424241|FG000|Overall Study|Protocol Violation|5|||
25201410|NCT01650246|50424241|FG000|Overall Study|Sponsor terminated study|53|||
25201411|NCT01650246|50424241|FG000|Overall Study|Lost to Follow-up|5|||
25201412|NCT01650246|50424241|FG000|Overall Study|Withdrawal by Subject|26|||
25201413|NCT01650246|50424241|FG000|Overall Study|Death|1|||
25201414|NCT01650246|50424241|FG000|Overall Study|Lack of Efficacy|30|||
25201415|NCT01652664|50424260|FG000|Overall Study|Treatment Failure|5|||
25201416|NCT01652664|50424261|FG001|Overall Study|Treatment Failure|1|||
25201417|NCT01652664|50424260|FG000|Overall Study|Inadequate IOP control|1|||
25201418|NCT01652664|50424261|FG001|Overall Study|Inadequate IOP control|0|||
25201419|NCT02379390|50424301|FG000|Overall Study|Adverse Event|1|||
25201420|NCT02379390|50424302|FG001|Overall Study|Adverse Event|1|||
25201421|NCT02379390|50424301|FG000|Overall Study|Investigator's decision|1|||
25201422|NCT02379390|50424302|FG001|Overall Study|Investigator's decision|0|||
25201423|NCT02379390|50424301|FG000|Overall Study|Study Termination|0|||
25201424|NCT02379390|50424302|FG001|Overall Study|Study Termination|1|||
25201425|NCT02379078|50424313|FG000|Overall Study|Lost to Follow-up|33|||
25201426|NCT02379078|50424314|FG001|Overall Study|Lost to Follow-up|30|||
25201427|NCT02379078|50424313|FG000|Overall Study|Withdrawal by Subject|6|||
25201428|NCT02379078|50424314|FG001|Overall Study|Withdrawal by Subject|5|||
25201429|NCT01714739|50424407|FG000|Overall Study|Disease progression|3|||
25201430|NCT01714739|50424408|FG001|Overall Study|Disease progression|5|||
25201431|NCT01714739|50424409|FG002|Overall Study|Disease progression|5|||
25201432|NCT01714739|50424410|FG003|Overall Study|Disease progression|204|||
25201433|NCT01714739|50424411|FG004|Overall Study|Disease progression|1|||
25201434|NCT01714739|50424412|FG005|Overall Study|Disease progression|3|||
25201435|NCT01714739|50424413|FG006|Overall Study|Disease progression|5|||
25201436|NCT01714739|50424407|FG000|Overall Study|Study drug toxicity|1|||
25201437|NCT01714739|50424408|FG001|Overall Study|Study drug toxicity|1|||
25201438|NCT01714739|50424409|FG002|Overall Study|Study drug toxicity|1|||
25201439|NCT01714739|50424410|FG003|Overall Study|Study drug toxicity|15|||
25201440|NCT01714739|50424411|FG004|Overall Study|Study drug toxicity|0|||
25201441|NCT01714739|50424412|FG005|Overall Study|Study drug toxicity|0|||
25201442|NCT01714739|50424413|FG006|Overall Study|Study drug toxicity|5|||
25201443|NCT01714739|50424407|FG000|Overall Study|Death|0|||
25201444|NCT01714739|50424408|FG001|Overall Study|Death|0|||
25201445|NCT01714739|50424409|FG002|Overall Study|Death|0|||
25201446|NCT01714739|50424410|FG003|Overall Study|Death|1|||
25201447|NCT01714739|50424411|FG004|Overall Study|Death|0|||
25201448|NCT01714739|50424412|FG005|Overall Study|Death|0|||
25201449|NCT01714739|50424413|FG006|Overall Study|Death|0|||
25201450|NCT01714739|50424407|FG000|Overall Study|Adverse Event unrelated to drug|0|||
25201451|NCT01714739|50424408|FG001|Overall Study|Adverse Event unrelated to drug|0|||
25201452|NCT01714739|50424409|FG002|Overall Study|Adverse Event unrelated to drug|3|||
25201453|NCT01714739|50424410|FG003|Overall Study|Adverse Event unrelated to drug|21|||
24976297|NCT03466060|50065211|FG000|Period 1|Lost to Follow-up|0|||
24976298|NCT03466060|50065212|FG001|Period 1|Lost to Follow-up|0|||
24976299|NCT03466060|50065213|FG002|Period 1|Lost to Follow-up|0|||
24976300|NCT03466060|50065214|FG003|Period 1|Lost to Follow-up|1|||
24976301|NCT03466060|50065215|FG004|Period 1|Lost to Follow-up|0|||
24976302|NCT03466060|50065216|FG005|Period 1|Lost to Follow-up|0|||
24976303|NCT03466060|50065211|FG000|Period 1|Grade 2 Conjunctivitis|0|||
24976304|NCT03466060|50065212|FG001|Period 1|Grade 2 Conjunctivitis|0|||
25077102|NCT02439320|50184948|FG000|Overall Study|Death|0|||
25077103|NCT02439320|50184949|FG001|Overall Study|Death|1|||
25201454|NCT01714739|50424411|FG004|Overall Study|Adverse Event unrelated to drug|0|||
25201455|NCT01714739|50424412|FG005|Overall Study|Adverse Event unrelated to drug|0|||
25201456|NCT01714739|50424413|FG006|Overall Study|Adverse Event unrelated to drug|0|||
25201457|NCT01714739|50424407|FG000|Overall Study|Participant request to stop therapy|0|||
25201458|NCT01714739|50424408|FG001|Overall Study|Participant request to stop therapy|1|||
25201459|NCT01714739|50424409|FG002|Overall Study|Participant request to stop therapy|0|||
25201460|NCT01714739|50424410|FG003|Overall Study|Participant request to stop therapy|6|||
25315607|NCT00973973|50631332|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
25315608|NCT00633139|50631341|FG000|Overall Study|Non compliance|0|||
25315609|NCT00633139|50631342|FG001|Overall Study|Non compliance|0|||
25315610|NCT00633139|50631343|FG002|Overall Study|Non compliance|1|||
25315611|NCT00633139|50631341|FG000|Overall Study|Withdrawal by Subject|0|||
25315612|NCT00633139|50631342|FG001|Overall Study|Withdrawal by Subject|1|||
25315613|NCT00633139|50631343|FG002|Overall Study|Withdrawal by Subject|0|||
25315614|NCT00965081|50631353|FG000|Overall Study|Adverse Event|14|||
25315615|NCT00965081|50631354|FG001|Overall Study|Adverse Event|9|||
25315616|NCT00965081|50631353|FG000|Overall Study|Lack of Efficacy|2|||
25315617|NCT00965081|50631354|FG001|Overall Study|Lack of Efficacy|5|||
25315618|NCT00965081|50631353|FG000|Overall Study|Lost to Follow-up|4|||
25315619|NCT00965081|50631354|FG001|Overall Study|Lost to Follow-up|5|||
25315620|NCT00965081|50631353|FG000|Overall Study|Physician Decision|2|||
25315621|NCT00965081|50631354|FG001|Overall Study|Physician Decision|0|||
25315622|NCT00965081|50631353|FG000|Overall Study|Protocol Violation|2|||
25315623|NCT00965081|50631354|FG001|Overall Study|Protocol Violation|5|||
25315624|NCT00965081|50631353|FG000|Overall Study|Sponsor Decision|1|||
25315625|NCT00965081|50631354|FG001|Overall Study|Sponsor Decision|0|||
25315626|NCT00965081|50631353|FG000|Overall Study|Withdrawal by Subject|4|||
25315627|NCT00965081|50631354|FG001|Overall Study|Withdrawal by Subject|7|||
25315628|NCT00965081|50631353|FG000|Overall Study|Switched to Rescue Arm|5|||
25315629|NCT00965081|50631354|FG001|Overall Study|Switched to Rescue Arm|12|||
25315630|NCT00961649|50631365|FG000|Overall Study|Adverse Event|4|||
25315631|NCT00961649|50631366|FG001|Overall Study|Adverse Event|0|||
25315632|NCT00961649|50631367|FG002|Overall Study|Adverse Event|0|||
25315633|NCT00961649|50631368|FG003|Overall Study|Adverse Event|2|||
25315634|NCT00961649|50631365|FG000|Overall Study|Inadequate control of IOP|0|||
25315635|NCT00961649|50631366|FG001|Overall Study|Inadequate control of IOP|0|||
25315636|NCT00961649|50631367|FG002|Overall Study|Inadequate control of IOP|0|||
25315637|NCT00961649|50631368|FG003|Overall Study|Inadequate control of IOP|1|||
25315638|NCT00961649|50631365|FG000|Overall Study|Patient has travel plans during holidays|0|||
25315639|NCT00961649|50631366|FG001|Overall Study|Patient has travel plans during holidays|0|||
25315640|NCT00961649|50631367|FG002|Overall Study|Patient has travel plans during holidays|1|||
25315641|NCT00961649|50631368|FG003|Overall Study|Patient has travel plans during holidays|0|||
25315642|NCT00961649|50631365|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
25315643|NCT00961649|50631366|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
25315644|NCT00961649|50631367|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
25315645|NCT00961649|50631368|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
25315646|NCT00961649|50631365|FG000|Overall Study|Study terminated by sponsor|4|||
25315647|NCT00961649|50631366|FG001|Overall Study|Study terminated by sponsor|4|||
25315648|NCT00961649|50631367|FG002|Overall Study|Study terminated by sponsor|4|||
25315649|NCT00961649|50631368|FG003|Overall Study|Study terminated by sponsor|1|||
25315650|NCT00632125|50631378|FG000|Overall Study|Death|82|||
25315651|NCT00632125|50631378|FG000|Overall Study|Withdrawal by Subject|44|||
25315652|NCT00632125|50631378|FG000|Overall Study|Adverse Event|36|||
25315653|NCT00632125|50631378|FG000|Overall Study|Renal transplantation|17|||
25315654|NCT00632125|50631378|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
25315655|NCT00632125|50631378|FG000|Overall Study|Non-compliance|8|||
25315656|NCT00632125|50631378|FG000|Overall Study|Development of uncontrolled hypertension|5|||
25315657|NCT00632125|50631378|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
25315658|NCT00903968|50631384|FG000|Overall Study|Adverse Event|0|||
25315659|NCT00903968|50631385|FG001|Overall Study|Adverse Event|0|||
25315660|NCT00903968|50631386|FG002|Overall Study|Adverse Event|0|||
25315661|NCT00903968|50631387|FG003|Overall Study|Adverse Event|0|||
25315662|NCT00903968|50631388|FG004|Overall Study|Adverse Event|0|||
25315663|NCT00903968|50631389|FG005|Overall Study|Adverse Event|0|||
25315664|NCT00903968|50631390|FG006|Overall Study|Adverse Event|1|||
25315665|NCT00903968|50631391|FG007|Overall Study|Adverse Event|8|||
25315666|NCT00903968|50631384|FG000|Overall Study|DLT|0|||
25315667|NCT00903968|50631385|FG001|Overall Study|DLT|0|||
25315668|NCT00903968|50631386|FG002|Overall Study|DLT|0|||
25315669|NCT00903968|50631387|FG003|Overall Study|DLT|0|||
25315670|NCT00903968|50631388|FG004|Overall Study|DLT|0|||
25315671|NCT00903968|50631389|FG005|Overall Study|DLT|0|||
25315672|NCT00903968|50631390|FG006|Overall Study|DLT|2|||
25315673|NCT00903968|50631391|FG007|Overall Study|DLT|0|||
25201461|NCT01714739|50424411|FG004|Overall Study|Participant request to stop therapy|0|||
25201462|NCT01714739|50424412|FG005|Overall Study|Participant request to stop therapy|0|||
25201463|NCT01714739|50424413|FG006|Overall Study|Participant request to stop therapy|0|||
25201464|NCT01714739|50424407|FG000|Overall Study|Participant withdrew consent|0|||
25201465|NCT01714739|50424408|FG001|Overall Study|Participant withdrew consent|1|||
25201466|NCT01714739|50424409|FG002|Overall Study|Participant withdrew consent|0|||
25201467|NCT01714739|50424410|FG003|Overall Study|Participant withdrew consent|8|||
25201468|NCT01714739|50424411|FG004|Overall Study|Participant withdrew consent|0|||
25201469|NCT01714739|50424412|FG005|Overall Study|Participant withdrew consent|0|||
25201470|NCT01714739|50424413|FG006|Overall Study|Participant withdrew consent|0|||
25201471|NCT01714739|50424407|FG000|Overall Study|Lost to Follow-up|0|||
25201472|NCT01714739|50424408|FG001|Overall Study|Lost to Follow-up|0|||
25201473|NCT01714739|50424409|FG002|Overall Study|Lost to Follow-up|0|||
25201474|NCT01714739|50424410|FG003|Overall Study|Lost to Follow-up|1|||
25201475|NCT01714739|50424411|FG004|Overall Study|Lost to Follow-up|0|||
25201476|NCT01714739|50424412|FG005|Overall Study|Lost to Follow-up|0|||
25201477|NCT01714739|50424413|FG006|Overall Study|Lost to Follow-up|0|||
25201478|NCT01714739|50424407|FG000|Overall Study|Maximum clinical benefit|0|||
25201479|NCT01714739|50424408|FG001|Overall Study|Maximum clinical benefit|1|||
25201480|NCT01714739|50424409|FG002|Overall Study|Maximum clinical benefit|1|||
25201481|NCT01714739|50424410|FG003|Overall Study|Maximum clinical benefit|3|||
25201482|NCT01714739|50424411|FG004|Overall Study|Maximum clinical benefit|0|||
25201483|NCT01714739|50424412|FG005|Overall Study|Maximum clinical benefit|0|||
25201484|NCT01714739|50424413|FG006|Overall Study|Maximum clinical benefit|0|||
25201485|NCT01714739|50424407|FG000|Overall Study|Poor/non-comliance|0|||
25201486|NCT01714739|50424408|FG001|Overall Study|Poor/non-comliance|1|||
25201487|NCT01714739|50424409|FG002|Overall Study|Poor/non-comliance|0|||
25201488|NCT01714739|50424410|FG003|Overall Study|Poor/non-comliance|1|||
25201489|NCT01714739|50424411|FG004|Overall Study|Poor/non-comliance|0|||
25201490|NCT01714739|50424412|FG005|Overall Study|Poor/non-comliance|0|||
25201491|NCT01714739|50424413|FG006|Overall Study|Poor/non-comliance|0|||
25201492|NCT01714739|50424407|FG000|Overall Study|No longer meets study criteria|0|||
25201493|NCT01714739|50424408|FG001|Overall Study|No longer meets study criteria|0|||
25201494|NCT01714739|50424409|FG002|Overall Study|No longer meets study criteria|0|||
25201495|NCT01714739|50424410|FG003|Overall Study|No longer meets study criteria|1|||
25201496|NCT01714739|50424411|FG004|Overall Study|No longer meets study criteria|0|||
25201497|NCT01714739|50424412|FG005|Overall Study|No longer meets study criteria|0|||
25201498|NCT01714739|50424413|FG006|Overall Study|No longer meets study criteria|0|||
25201499|NCT01714739|50424407|FG000|Overall Study|Other reason|0|||
25201500|NCT01714739|50424408|FG001|Overall Study|Other reason|0|||
25201501|NCT01714739|50424409|FG002|Overall Study|Other reason|0|||
25201502|NCT01714739|50424410|FG003|Overall Study|Other reason|3|||
25201503|NCT01714739|50424411|FG004|Overall Study|Other reason|1|||
25201504|NCT01714739|50424412|FG005|Overall Study|Other reason|0|||
25201505|NCT01714739|50424413|FG006|Overall Study|Other reason|0|||
25201506|NCT00609791|50424481|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
25201507|NCT03823287|50426417|FG000|Overall Study|Withdrawal by Subject|25|||
25077104|NCT02439320|50184950|FG002|Overall Study|Death|0|||
25171196|NCT01773473|50308036|FG001|Overall Study|Lost to Follow-up|0|||
25171197|NCT01772693|50308044|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
25171198|NCT01772693|50308045|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
25171199|NCT01772693|50308044|FG000|Overall Study|Withdrawal by Subject|2|||
25171200|NCT01772693|50308045|FG001|Overall Study|Withdrawal by Subject|0|||
25171201|NCT01772693|50308044|FG000|Overall Study|Alternative Treatment|2|||
25171202|NCT01772693|50308045|FG001|Overall Study|Alternative Treatment|0|||
25171203|NCT01779869|50308051|FG000|Overall Study|Physician Decision|2|||
25171204|NCT01772537|50308058|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
25201508|NCT03823287|50426418|FG001|Overall Study|Withdrawal by Subject|17|||
25201509|NCT03823287|50426417|FG000|Overall Study|Death|13|||
25201510|NCT03823287|50426418|FG001|Overall Study|Death|7|||
25201511|NCT03823287|50426417|FG000|Overall Study|Lost to Follow-up|7|||
25201512|NCT03823287|50426418|FG001|Overall Study|Lost to Follow-up|8|||
25201513|NCT03823287|50426417|FG000|Overall Study|Adverse Event|6|||
25201514|NCT03823287|50426418|FG001|Overall Study|Adverse Event|8|||
25201515|NCT03823287|50426417|FG000|Overall Study|Physician Decision|5|||
25201516|NCT03823287|50426418|FG001|Overall Study|Physician Decision|2|||
25201517|NCT03823287|50426417|FG000|Overall Study|Lack of Efficacy|2|||
25201518|NCT03823287|50426418|FG001|Overall Study|Lack of Efficacy|0|||
25201519|NCT03823287|50426417|FG000|Overall Study|Other|2|||
25201520|NCT03823287|50426418|FG001|Overall Study|Other|4|||
25201521|NCT03707925|50426579|FG000|Overall Study|Inevaluable|1|||
25201522|NCT03461757|50426639|FG000|Overall Study|Adverse Event|1|||
25201523|NCT03461757|50426640|FG001|Overall Study|Adverse Event|0|||
25201524|NCT03461757|50426639|FG000|Overall Study|Lost to Follow-up|13|||
25201525|NCT03461757|50426640|FG001|Overall Study|Lost to Follow-up|7|||
25201526|NCT03461757|50426639|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
25201527|NCT03461757|50426640|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
25201528|NCT03461757|50426639|FG000|Overall Study|Non-compliance with study treatment|0|||
25201529|NCT03461757|50426640|FG001|Overall Study|Non-compliance with study treatment|1|||
25201530|NCT03461757|50426639|FG000|Overall Study|Pregnancy|2|||
25201531|NCT03461757|50426640|FG001|Overall Study|Pregnancy|0|||
25201532|NCT03461757|50426639|FG000|Overall Study|Protocol Violation|1|||
25201533|NCT03461757|50426640|FG001|Overall Study|Protocol Violation|1|||
25201534|NCT03461757|50426639|FG000|Overall Study|Withdrawal by Subject|7|||
25201535|NCT03461757|50426640|FG001|Overall Study|Withdrawal by Subject|7|||
25201536|NCT03461757|50426639|FG000|Overall Study|Other Reasons|1|||
25201537|NCT03461757|50426640|FG001|Overall Study|Other Reasons|4|||
25201538|NCT03235479|50427128|FG000|Overall Study|Lost to Follow-up|8|||
25201539|NCT03235479|50427129|FG001|Overall Study|Lost to Follow-up|11|||
25201540|NCT03235479|50427128|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
25201541|NCT03235479|50427129|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
25201542|NCT03235479|50427128|FG000|Overall Study|Pregnancy|1|||
25201543|NCT03235479|50427129|FG001|Overall Study|Pregnancy|0|||
25201544|NCT03235479|50427128|FG000|Overall Study|Protocol Deviation|1|||
25201545|NCT03235479|50427129|FG001|Overall Study|Protocol Deviation|3|||
25201546|NCT03235479|50427128|FG000|Overall Study|Technical Problems|3|||
25201547|NCT03235479|50427129|FG001|Overall Study|Technical Problems|2|||
25201548|NCT03235479|50427128|FG000|Overall Study|Withdrawal by Subject|2|||
25201549|NCT03235479|50427129|FG001|Overall Study|Withdrawal by Subject|2|||
25201550|NCT03235479|50427128|FG000|Overall Study|Other Reasons|3|||
25201551|NCT03235479|50427129|FG001|Overall Study|Other Reasons|5|||
25201552|NCT03193437|50427185|FG000|Overall Study|Adverse Event|4|||
25201553|NCT03193437|50427185|FG000|Overall Study|Withdrawal by Subject|2|||
25201554|NCT03193437|50427185|FG000|Overall Study|Disease Progression|2|||
25201555|NCT02906787|50427238|FG000|Overall Study|Withdrawal by Subject|12|||
25201556|NCT02906787|50427239|FG001|Overall Study|Withdrawal by Subject|10|||
25201557|NCT02906787|50427238|FG000|Overall Study|Missed|24|||
25201558|NCT02906787|50427239|FG001|Overall Study|Missed|22|||
25201559|NCT02107443|50427842|FG000|Overall Study|Death|42|||
25201560|NCT02107443|50427843|FG001|Overall Study|Death|30|||
25201561|NCT02107443|50427842|FG000|Overall Study|Study Protocol Violation|3|||
25201562|NCT02107443|50427843|FG001|Overall Study|Study Protocol Violation|1|||
25201563|NCT02107443|50427842|FG000|Overall Study|Registered but Not Eligible|0|||
25201564|NCT02107443|50427843|FG001|Overall Study|Registered but Not Eligible|1|||
25201565|NCT02107443|50427842|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
25201566|NCT02107443|50427843|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
25201567|NCT02107443|50427842|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
25201568|NCT02107443|50427843|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
25201569|NCT02107443|50427842|FG000|Overall Study|Withdrawal: Changed Mind|2|||
25201570|NCT02107443|50427843|FG001|Overall Study|Withdrawal: Changed Mind|0|||
25201571|NCT02107443|50427842|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
25201572|NCT02107443|50427843|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
25201573|NCT02107443|50427842|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
25201574|NCT02107443|50427843|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
25201575|NCT02107443|50427842|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
25201576|NCT02107443|50427843|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
25201577|NCT02107443|50427842|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
25201578|NCT02107443|50427843|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
25201579|NCT02107443|50427842|FG000|Overall Study|Withdrawal: Other Medical|9|||
25201580|NCT02107443|50427843|FG001|Overall Study|Withdrawal: Other Medical|5|||
25315674|NCT00903968|50631384|FG000|Overall Study|Withdrawal by Subject|1|||
25201581|NCT02107443|50427842|FG000|Overall Study|Withdrawal: Disease Progression|4|||
25201582|NCT02107443|50427843|FG001|Overall Study|Withdrawal: Disease Progression|2|||
25201583|NCT02107443|50427842|FG000|Overall Study|Withdrawal: Personal Issues|0|||
25201584|NCT02107443|50427843|FG001|Overall Study|Withdrawal: Personal Issues|3|||
25315675|NCT00903968|50631385|FG001|Overall Study|Withdrawal by Subject|0|||
25315676|NCT00903968|50631386|FG002|Overall Study|Withdrawal by Subject|1|||
25201585|NCT00559949|50428760|FG000|Overall Study|Progressive Disease during cycle 1|1|||
25315677|NCT00903968|50631387|FG003|Overall Study|Withdrawal by Subject|0|||
25201586|NCT00559949|50428760|FG000|Overall Study|Adverse Event|1|||
25201587|NCT00559949|50428760|FG000|Overall Study|Withdrawal by Subject|4|||
25201588|NCT00559949|50428760|FG000|Overall Study|No disease evaluation per protocol|1|||
25201589|NCT00559637|50428816|FG000|Overall Study|Adverse Event|22|||
25201590|NCT00559637|50428816|FG000|Overall Study|Withdrawal by Subject|4|||
25201591|NCT00559637|50428816|FG000|Overall Study|Protocol Violation|6|||
25201592|NCT00559637|50428816|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
25201593|NCT00559637|50428816|FG000|Overall Study|Failure to return|6|||
25201594|NCT00559637|50428816|FG000|Overall Study|Insufficient response|3|||
25201595|NCT00559637|50428816|FG000|Overall Study|Started requiring dialysis after month 7|2|||
25201596|NCT00559637|50428816|FG000|Overall Study|Suspected lung cancer|1|||
25201597|NCT00559637|50428816|FG000|Overall Study|Participation in another study|1|||
25201598|NCT00559637|50428816|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
25201599|NCT00559637|50428816|FG000|Overall Study|Change of center|1|||
25201600|NCT00559637|50428816|FG000|Overall Study|Change of home|1|||
25201601|NCT00559637|50428816|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
25201602|NCT02578641|50428889|FG000|Overall Study|Adverse Event|5|||
25201603|NCT02578641|50428890|FG001|Overall Study|Adverse Event|15|||
25201604|NCT02578641|50428889|FG000|Overall Study|Death|16|||
25201605|NCT02578641|50428890|FG001|Overall Study|Death|8|||
25201606|NCT02578641|50428889|FG000|Overall Study|Lost to Follow-up|0|||
25201607|NCT02578641|50428890|FG001|Overall Study|Lost to Follow-up|1|||
25201608|NCT02578641|50428889|FG000|Overall Study|Withdrawal by Subject|14|||
25201609|NCT02578641|50428890|FG001|Overall Study|Withdrawal by Subject|7|||
25201610|NCT02578641|50428889|FG000|Overall Study|Progressive Disease|69|||
25201611|NCT02578641|50428890|FG001|Overall Study|Progressive Disease|21|||
25201612|NCT02578641|50428889|FG000|Overall Study|No Study Drug|2|||
25201613|NCT02578641|50428890|FG001|Overall Study|No Study Drug|0|||
25201614|NCT02578641|50428889|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
25201615|NCT02578641|50428890|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
25201616|NCT02578641|50428889|FG000|Overall Study|Non-compliance with Study Schedule|1|||
25201617|NCT02578641|50428890|FG001|Overall Study|Non-compliance with Study Schedule|0|||
25201618|NCT02578641|50428889|FG000|Overall Study|Other|1|||
25201619|NCT02578641|50428890|FG001|Overall Study|Other|10|||
25201620|NCT02578641|50428889|FG000|Overall Study|Not treated|1|||
25201621|NCT02578641|50428890|FG001|Overall Study|Not treated|4|||
25201622|NCT02431260|50428918|FG000|Overall Study|Subject Decision|0|||
25201623|NCT02431260|50428919|FG001|Overall Study|Subject Decision|1|||
25201624|NCT02431260|50428920|FG002|Overall Study|Subject Decision|1|||
25201625|NCT02431260|50428921|FG003|Overall Study|Subject Decision|0|||
25201626|NCT02431260|50428922|FG004|Overall Study|Subject Decision|0|||
25201627|NCT02431260|50428923|FG005|Overall Study|Subject Decision|0|||
25201628|NCT02431260|50428924|FG006|Overall Study|Subject Decision|0|||
25201629|NCT02431260|50428925|FG007|Overall Study|Subject Decision|0|||
25201630|NCT02431260|50428926|FG008|Overall Study|Subject Decision|1|||
25201631|NCT02431260|50428927|FG009|Overall Study|Subject Decision|1|||
25201632|NCT02431260|50428928|FG010|Overall Study|Subject Decision|0|||
25201633|NCT02431260|50428929|FG011|Overall Study|Subject Decision|1|||
25201634|NCT02431260|50428930|FG012|Overall Study|Subject Decision|0|||
25201635|NCT02431260|50428931|FG013|Overall Study|Subject Decision|0|||
25201636|NCT02431260|50428918|FG000|Overall Study|Death|4|||
25201637|NCT02431260|50428919|FG001|Overall Study|Death|4|||
25201638|NCT02431260|50428920|FG002|Overall Study|Death|3|||
25201639|NCT02431260|50428921|FG003|Overall Study|Death|4|||
25201640|NCT02431260|50428922|FG004|Overall Study|Death|2|||
25201641|NCT02431260|50428923|FG005|Overall Study|Death|2|||
25201642|NCT02431260|50428924|FG006|Overall Study|Death|3|||
25201643|NCT02431260|50428925|FG007|Overall Study|Death|1|||
25201644|NCT02431260|50428926|FG008|Overall Study|Death|6|||
25201645|NCT02431260|50428927|FG009|Overall Study|Death|6|||
25201646|NCT02431260|50428928|FG010|Overall Study|Death|3|||
25201647|NCT02431260|50428929|FG011|Overall Study|Death|2|||
25201648|NCT02431260|50428930|FG012|Overall Study|Death|5|||
25201649|NCT02431260|50428931|FG013|Overall Study|Death|1|||
25201650|NCT02431260|50428918|FG000|Overall Study|Lost to Follow-up|0|||
25201651|NCT02431260|50428919|FG001|Overall Study|Lost to Follow-up|0|||
25201652|NCT02431260|50428920|FG002|Overall Study|Lost to Follow-up|0|||
25201653|NCT02431260|50428921|FG003|Overall Study|Lost to Follow-up|0|||
25201654|NCT02431260|50428922|FG004|Overall Study|Lost to Follow-up|0|||
25201655|NCT02431260|50428923|FG005|Overall Study|Lost to Follow-up|1|||
25201656|NCT02431260|50428924|FG006|Overall Study|Lost to Follow-up|0|||
25201657|NCT02431260|50428925|FG007|Overall Study|Lost to Follow-up|0|||
25201658|NCT02431260|50428926|FG008|Overall Study|Lost to Follow-up|0|||
25201659|NCT02431260|50428927|FG009|Overall Study|Lost to Follow-up|0|||
25201660|NCT02431260|50428928|FG010|Overall Study|Lost to Follow-up|0|||
25201661|NCT02431260|50428929|FG011|Overall Study|Lost to Follow-up|0|||
25201662|NCT02431260|50428930|FG012|Overall Study|Lost to Follow-up|0|||
25201663|NCT02431260|50428931|FG013|Overall Study|Lost to Follow-up|0|||
25201664|NCT02431260|50428918|FG000|Overall Study|Study Terminated by the Sponsor|0|||
25201665|NCT02431260|50428919|FG001|Overall Study|Study Terminated by the Sponsor|0|||
25201666|NCT02431260|50428920|FG002|Overall Study|Study Terminated by the Sponsor|2|||
25201667|NCT02431260|50428921|FG003|Overall Study|Study Terminated by the Sponsor|1|||
25315678|NCT00903968|50631388|FG004|Overall Study|Withdrawal by Subject|1|||
25315679|NCT00903968|50631389|FG005|Overall Study|Withdrawal by Subject|1|||
25315680|NCT00903968|50631390|FG006|Overall Study|Withdrawal by Subject|0|||
25315681|NCT00903968|50631391|FG007|Overall Study|Withdrawal by Subject|4|||
25315682|NCT00903968|50631384|FG000|Overall Study|Non-Compliance|0|||
25315683|NCT00903968|50631385|FG001|Overall Study|Non-Compliance|0|||
25315684|NCT00903968|50631386|FG002|Overall Study|Non-Compliance|0|||
25315685|NCT00903968|50631387|FG003|Overall Study|Non-Compliance|0|||
25315686|NCT00903968|50631388|FG004|Overall Study|Non-Compliance|0|||
25315687|NCT00903968|50631389|FG005|Overall Study|Non-Compliance|1|||
25315688|NCT00903968|50631390|FG006|Overall Study|Non-Compliance|0|||
25315689|NCT00903968|50631391|FG007|Overall Study|Non-Compliance|0|||
25315690|NCT00903968|50631384|FG000|Overall Study|Physician Decision|0|||
25315691|NCT00903968|50631385|FG001|Overall Study|Physician Decision|0|||
25315692|NCT00903968|50631386|FG002|Overall Study|Physician Decision|0|||
25315693|NCT00903968|50631387|FG003|Overall Study|Physician Decision|0|||
25315694|NCT00903968|50631388|FG004|Overall Study|Physician Decision|0|||
25315695|NCT00903968|50631389|FG005|Overall Study|Physician Decision|1|||
25315696|NCT00903968|50631390|FG006|Overall Study|Physician Decision|0|||
25315697|NCT00903968|50631391|FG007|Overall Study|Physician Decision|0|||
25315698|NCT00903968|50631384|FG000|Overall Study|Progressive Disease|2|||
25315699|NCT00903968|50631385|FG001|Overall Study|Progressive Disease|3|||
25315700|NCT00903968|50631386|FG002|Overall Study|Progressive Disease|2|||
25315701|NCT00903968|50631387|FG003|Overall Study|Progressive Disease|3|||
25315702|NCT00903968|50631388|FG004|Overall Study|Progressive Disease|3|||
25315703|NCT00903968|50631389|FG005|Overall Study|Progressive Disease|3|||
25201668|NCT02431260|50428922|FG004|Overall Study|Study Terminated by the Sponsor|1|||
25201669|NCT02431260|50428923|FG005|Overall Study|Study Terminated by the Sponsor|0|||
25201670|NCT02431260|50428924|FG006|Overall Study|Study Terminated by the Sponsor|1|||
25201671|NCT02431260|50428925|FG007|Overall Study|Study Terminated by the Sponsor|2|||
25201672|NCT02431260|50428926|FG008|Overall Study|Study Terminated by the Sponsor|1|||
25201673|NCT02431260|50428927|FG009|Overall Study|Study Terminated by the Sponsor|1|||
25201674|NCT02431260|50428928|FG010|Overall Study|Study Terminated by the Sponsor|1|||
25201675|NCT02431260|50428929|FG011|Overall Study|Study Terminated by the Sponsor|0|||
25201676|NCT02431260|50428930|FG012|Overall Study|Study Terminated by the Sponsor|4|||
25201677|NCT02431260|50428931|FG013|Overall Study|Study Terminated by the Sponsor|0|||
25201678|NCT02431260|50428918|FG000|Overall Study|Physician Decision|0|||
25201679|NCT02431260|50428919|FG001|Overall Study|Physician Decision|0|||
25201680|NCT02431260|50428920|FG002|Overall Study|Physician Decision|0|||
25201681|NCT02431260|50428921|FG003|Overall Study|Physician Decision|0|||
25201682|NCT02431260|50428922|FG004|Overall Study|Physician Decision|0|||
25201683|NCT02431260|50428923|FG005|Overall Study|Physician Decision|1|||
25201684|NCT02431260|50428924|FG006|Overall Study|Physician Decision|0|||
25201685|NCT02431260|50428925|FG007|Overall Study|Physician Decision|0|||
25201686|NCT02431260|50428926|FG008|Overall Study|Physician Decision|0|||
25201687|NCT02431260|50428927|FG009|Overall Study|Physician Decision|0|||
25201688|NCT02431260|50428928|FG010|Overall Study|Physician Decision|0|||
25201689|NCT02431260|50428929|FG011|Overall Study|Physician Decision|0|||
25201690|NCT02431260|50428930|FG012|Overall Study|Physician Decision|0|||
25201691|NCT02431260|50428931|FG013|Overall Study|Physician Decision|0|||
25201692|NCT02431260|50428918|FG000|Overall Study|Other Unspecified|0|||
25201693|NCT02431260|50428919|FG001|Overall Study|Other Unspecified|0|||
25201694|NCT02431260|50428920|FG002|Overall Study|Other Unspecified|0|||
25201695|NCT02431260|50428921|FG003|Overall Study|Other Unspecified|0|||
25201696|NCT02431260|50428922|FG004|Overall Study|Other Unspecified|0|||
25201697|NCT02431260|50428923|FG005|Overall Study|Other Unspecified|0|||
25201698|NCT02431260|50428924|FG006|Overall Study|Other Unspecified|0|||
25201699|NCT02431260|50428925|FG007|Overall Study|Other Unspecified|0|||
25201700|NCT02431260|50428926|FG008|Overall Study|Other Unspecified|0|||
25201701|NCT02431260|50428927|FG009|Overall Study|Other Unspecified|0|||
25201702|NCT02431260|50428928|FG010|Overall Study|Other Unspecified|0|||
25315704|NCT00903968|50631390|FG006|Overall Study|Progressive Disease|0|||
25315705|NCT00903968|50631391|FG007|Overall Study|Progressive Disease|18|||
25315706|NCT00903968|50631384|FG000|Overall Study|Lack of Efficacy|0|||
25315707|NCT00903968|50631385|FG001|Overall Study|Lack of Efficacy|0|||
25315708|NCT00903968|50631386|FG002|Overall Study|Lack of Efficacy|0|||
25315709|NCT00903968|50631387|FG003|Overall Study|Lack of Efficacy|0|||
25315710|NCT00903968|50631388|FG004|Overall Study|Lack of Efficacy|0|||
25315711|NCT00903968|50631389|FG005|Overall Study|Lack of Efficacy|0|||
25315712|NCT00903968|50631390|FG006|Overall Study|Lack of Efficacy|0|||
25315713|NCT00903968|50631391|FG007|Overall Study|Lack of Efficacy|3|||
25315714|NCT00903344|50631414|FG000|Overall Study|Pregnancy|2|||
25315715|NCT00903344|50631415|FG001|Overall Study|Pregnancy|3|||
25315716|NCT00903344|50631414|FG000|Overall Study|Lost to Follow-up|3|||
25201703|NCT02431260|50428929|FG011|Overall Study|Other Unspecified|1|||
25201704|NCT02431260|50428930|FG012|Overall Study|Other Unspecified|1|||
25201705|NCT02431260|50428931|FG013|Overall Study|Other Unspecified|0|||
25201706|NCT02430870|50429126|FG000|Part 2|Voluntary Withdrawal|0|||
25201707|NCT02430870|50429127|FG001|Part 2|Voluntary Withdrawal|0|||
25201708|NCT02430870|50429128|FG002|Part 2|Voluntary Withdrawal|0|||
25201709|NCT02430870|50429129|FG003|Part 2|Voluntary Withdrawal|0|||
25201710|NCT02430870|50429130|FG004|Part 2|Voluntary Withdrawal|0|||
25201711|NCT02430870|50429131|FG005|Part 2|Voluntary Withdrawal|0|||
25201712|NCT02430870|50429132|FG006|Part 2|Voluntary Withdrawal|1|||
25201713|NCT02430870|50429133|FG007|Part 2|Voluntary Withdrawal|0|||
25201714|NCT02430870|50429126|FG000|Part 2|Other Reason Not Specified|0|||
25201715|NCT02430870|50429127|FG001|Part 2|Other Reason Not Specified|0|||
25201716|NCT02430870|50429128|FG002|Part 2|Other Reason Not Specified|0|||
25201717|NCT02430870|50429129|FG003|Part 2|Other Reason Not Specified|0|||
25201718|NCT02430870|50429130|FG004|Part 2|Other Reason Not Specified|0|||
25201719|NCT02430870|50429131|FG005|Part 2|Other Reason Not Specified|0|||
25201720|NCT02430870|50429132|FG006|Part 2|Other Reason Not Specified|0|||
25201721|NCT02430870|50429133|FG007|Part 2|Other Reason Not Specified|1|||
25201722|NCT02430480|50429188|FG000|Overall Study|Death|1|||
25201723|NCT02430480|50429188|FG000|Overall Study|Anesthesia concerns|1|||
25201724|NCT02430480|50429188|FG000|Overall Study|Progressed on treatment|1|||
25201725|NCT02429934|50429206|FG000|Overall Study|Withdrawal by Subject|0|||
25201726|NCT02429934|50429207|FG001|Overall Study|Withdrawal by Subject|2|||
25201727|NCT02429934|50429206|FG000|Overall Study|Adverse Event|2|||
25201728|NCT02429934|50429207|FG001|Overall Study|Adverse Event|0|||
25201729|NCT02429934|50429206|FG000|Overall Study|Lost to Follow-up|1|||
25201730|NCT02429934|50429207|FG001|Overall Study|Lost to Follow-up|1|||
25201731|NCT02429934|50429206|FG000|Overall Study|Physician Decision|1|||
25201732|NCT02429934|50429207|FG001|Overall Study|Physician Decision|0|||
25201733|NCT02429856|50429221|FG000|Overall Study|Death|12|||
25201734|NCT02429856|50429222|FG001|Overall Study|Death|13|||
25201735|NCT02429856|50429221|FG000|Overall Study|Lost to Follow-up|6|||
25201736|NCT02429856|50429222|FG001|Overall Study|Lost to Follow-up|5|||
25201737|NCT02429856|50429221|FG000|Overall Study|Withdrawal by Subject|1|||
25201738|NCT02429856|50429222|FG001|Overall Study|Withdrawal by Subject|1|||
25201739|NCT02429778|50429232|FG000|Overall Study|Lost to Follow-up|2|||
25201740|NCT02429778|50429233|FG001|Overall Study|Lost to Follow-up|0|||
25201741|NCT02429778|50429232|FG000|Overall Study|Withdrawal by Subject|5|||
25201742|NCT02429778|50429233|FG001|Overall Study|Withdrawal by Subject|0|||
25201743|NCT02403180|50429241|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
25201744|NCT02403180|50429242|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
25201745|NCT02403180|50429241|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
25201746|NCT02403180|50429242|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
25201747|NCT00558467|50429276|FG000|Overall Study|Adverse Event|1|||
25201748|NCT00558467|50429277|FG001|Overall Study|Adverse Event|2|||
25201749|NCT00558467|50429276|FG000|Overall Study|Lack of Efficacy|0|||
25201750|NCT00558467|50429277|FG001|Overall Study|Lack of Efficacy|1|||
25201751|NCT00558467|50429276|FG000|Overall Study|Patient moving out of state|0|||
25201752|NCT00558467|50429277|FG001|Overall Study|Patient moving out of state|1|||
25201753|NCT02402166|50429283|FG000|Overall Study|Adverse Event|2|||
25201754|NCT02402166|50429283|FG000|Overall Study|Withdrawal by Subject|2|||
25201755|NCT02402166|50429283|FG000|Overall Study|Lost to Follow-up|1|||
25201756|NCT02378220|50429303|FG000|Overall Study|Death|6|||
25201757|NCT02378220|50429304|FG001|Overall Study|Death|1|||
25201758|NCT04226495|50429313|FG000|Overall Study|Withdrawal by Subject|3|||
25201759|NCT04226495|50429314|FG001|Overall Study|Withdrawal by Subject|3|||
25201760|NCT04226495|50429313|FG000|Overall Study|PI discretion|2|||
25201761|NCT04226495|50429314|FG001|Overall Study|PI discretion|4|||
25201762|NCT02401308|50429322|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
25201763|NCT02401308|50429323|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
25201764|NCT02401230|50429332|FG000|Overall Study|Adverse Event|3|||
25201765|NCT02401230|50429333|FG001|Overall Study|Adverse Event|2|||
25201766|NCT02401230|50429334|FG002|Overall Study|Adverse Event|0|||
25201767|NCT02401230|50429332|FG000|Overall Study|Withdrawal by Subject|2|||
25201768|NCT02401230|50429333|FG001|Overall Study|Withdrawal by Subject|1|||
24976305|NCT03466060|50065213|FG002|Period 1|Grade 2 Conjunctivitis|1|||
25201769|NCT02401230|50429334|FG002|Overall Study|Withdrawal by Subject|1|||
25201770|NCT02401230|50429332|FG000|Overall Study|Lost to Follow-up|1|||
25201771|NCT02401230|50429333|FG001|Overall Study|Lost to Follow-up|3|||
25077105|NCT02439320|50184948|FG000|Overall Study|Noncompliance with Protocol|10|||
25201772|NCT02401230|50429334|FG002|Overall Study|Lost to Follow-up|3|||
25201773|NCT02429310|50429375|FG000|Overall Study|Lost to Follow-up|1|||
25201774|NCT02429310|50429376|FG001|Overall Study|Lost to Follow-up|2|||
25201775|NCT02429310|50429375|FG000|Overall Study|Protocol Violation|1|||
25201776|NCT02429310|50429376|FG001|Overall Study|Protocol Violation|1|||
24976306|NCT03466060|50065214|FG003|Period 1|Grade 2 Conjunctivitis|0|||
25201777|NCT02428608|50429402|FG000|Overall Study|Pregnancy|2|||
25201778|NCT02428608|50429402|FG000|Overall Study|Lost to Follow-up|37|||
25201779|NCT02428608|50429402|FG000|Overall Study|Withdrawal by Subject|2|||
25201780|NCT02428608|50429402|FG000|Overall Study|scheduling conflicts|15|||
25201781|NCT02428608|50429402|FG000|Overall Study|moved away|10|||
25201782|NCT02428608|50429402|FG000|Overall Study|Death|1|||
25201783|NCT02428608|50429402|FG000|Overall Study|various|16|||
25201784|NCT02428296|50429422|FG000|Overall Study|Adverse Event|7|||
25201785|NCT02428296|50429422|FG000|Overall Study|Withdrawal by Subject|2|||
25201786|NCT02427984|50429436|FG000|Overall Study|Lost to Follow-up|13|||
25201787|NCT02427984|50429437|FG001|Overall Study|Lost to Follow-up|5|||
25201788|NCT02427984|50429438|FG002|Overall Study|Lost to Follow-up|18|||
25201789|NCT00556673|50429656|FG000|Overall Study|Protocol deviation|3|||
25201790|NCT00556673|50429657|FG001|Overall Study|Protocol deviation|2|||
25201791|NCT02402322|50429681|FG000|Pretreatment|Withdrawal by Subject|3|||
25201792|NCT02402322|50429682|FG001|Pretreatment|Withdrawal by Subject|1|||
25201793|NCT02402322|50429683|FG002|Pretreatment|Withdrawal by Subject|1|||
25201794|NCT02402322|50429681|FG000|Follow-up|Withdrawal by Subject|6|||
25201795|NCT02402322|50429682|FG001|Follow-up|Withdrawal by Subject|3|||
25201796|NCT02402322|50429683|FG002|Follow-up|Withdrawal by Subject|24|||
25201797|NCT00555425|50429799|FG000|Overall Study|Missed Medication > 1 wk|34|||
25201798|NCT00555425|50429800|FG001|Overall Study|Missed Medication > 1 wk|15|||
25201799|NCT00555425|50429799|FG000|Overall Study|Missed 3 physician management visits|1|||
25201800|NCT00555425|50429800|FG001|Overall Study|Missed 3 physician management visits|0|||
25201801|NCT00555425|50429799|FG000|Overall Study|Met criteria for protective transfer|16|||
25201802|NCT00555425|50429800|FG001|Overall Study|Met criteria for protective transfer|3|||
25201803|NCT00555425|50429799|FG000|Overall Study|Became pregnant and transferred care|0|||
25201804|NCT00555425|50429800|FG001|Overall Study|Became pregnant and transferred care|1|||
25201805|NCT00554099|50429981|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
25201806|NCT00554099|50429982|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
25201807|NCT00554099|50429983|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
25201808|NCT00554099|50429981|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
25201809|NCT00554099|50429982|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
25201810|NCT00554099|50429983|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
25201811|NCT00554099|50429981|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
25201812|NCT00554099|50429982|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
25201813|NCT00554099|50429983|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
25201814|NCT00554099|50429981|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
25201815|NCT00554099|50429982|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
25201816|NCT00554099|50429983|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
25201817|NCT00554099|50429981|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
25201818|NCT00554099|50429982|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
25201819|NCT00554099|50429983|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
25201820|NCT00554099|50429981|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
25201821|NCT00554099|50429982|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
25201822|NCT00554099|50429983|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
25315717|NCT00903344|50631415|FG001|Overall Study|Lost to Follow-up|0|||
25315718|NCT00903032|50631423|FG000|Overall Study|Withdrawal by Subject|5|||
25315719|NCT00903032|50631424|FG001|Overall Study|Withdrawal by Subject|3|||
25315720|NCT00903032|50631423|FG000|Overall Study|Lost to Follow-up|2|||
25315721|NCT00903032|50631424|FG001|Overall Study|Lost to Follow-up|2|||
25315722|NCT00902564|50631439|FG000|Overall Study|Withdrawal by Subject|2|||
25315723|NCT00626197|50631446|FG000|Overall Study|Did not cooperate|2|||
25315724|NCT00626197|50631447|FG001|Overall Study|Did not cooperate|6|||
25315725|NCT00626197|50631448|FG002|Overall Study|Did not cooperate|1|||
25315726|NCT00626197|50631446|FG000|Overall Study|Failure to return|6|||
25315727|NCT00626197|50631447|FG001|Overall Study|Failure to return|5|||
25315728|NCT00626197|50631448|FG002|Overall Study|Failure to return|6|||
25315729|NCT00626197|50631446|FG000|Overall Study|Adverse event, serious fatal|3|||
25315730|NCT00626197|50631447|FG001|Overall Study|Adverse event, serious fatal|6|||
25315731|NCT00626197|50631448|FG002|Overall Study|Adverse event, serious fatal|6|||
25315732|NCT00626197|50631446|FG000|Overall Study|Adverse Event|1|||
25315733|NCT00626197|50631447|FG001|Overall Study|Adverse Event|1|||
25315734|NCT00626197|50631448|FG002|Overall Study|Adverse Event|2|||
25315735|NCT00626197|50631446|FG000|Overall Study|Withdrawal by Subject|17|||
25315736|NCT00626197|50631447|FG001|Overall Study|Withdrawal by Subject|17|||
25315737|NCT00626197|50631448|FG002|Overall Study|Withdrawal by Subject|7|||
25315738|NCT00626197|50631446|FG000|Overall Study|Administrative reasons|15|||
25315739|NCT00626197|50631447|FG001|Overall Study|Administrative reasons|19|||
25315740|NCT00626197|50631448|FG002|Overall Study|Administrative reasons|55|||
25315741|NCT00626275|50631462|FG000|Part A - Treatment Period 1|Adverse Event|1|||
25315742|NCT00626275|50631463|FG001|Part A - Treatment Period 1|Adverse Event|0|||
25315743|NCT00626275|50631464|FG002|Part A - Treatment Period 1|Adverse Event|0|||
25315744|NCT00626275|50631465|FG003|Part A - Treatment Period 1|Adverse Event|0|||
25315745|NCT00626275|50631466|FG004|Part A - Treatment Period 1|Adverse Event|0|||
25315746|NCT00626275|50631467|FG005|Part A - Treatment Period 1|Adverse Event|0|||
25201823|NCT00554099|50429981|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
25201824|NCT00554099|50429982|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
25201825|NCT00554099|50429983|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
25201826|NCT00554099|50429981|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
25201827|NCT00554099|50429982|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
25201828|NCT00554099|50429983|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
25201829|NCT00554099|50429981|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
25201830|NCT00554099|50429982|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
25201831|NCT00554099|50429983|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
25201832|NCT02377362|50430017|FG000|Part A Second Treatment|Protocol Violation|0|||
25201833|NCT02377362|50430018|FG001|Part A Second Treatment|Protocol Violation|0|||
25201834|NCT02377362|50430019|FG002|Part A Second Treatment|Protocol Violation|0|||
25201835|NCT02377362|50430020|FG003|Part A Second Treatment|Protocol Violation|0|||
25201836|NCT02377362|50430021|FG004|Part A Second Treatment|Protocol Violation|1|||
25201837|NCT02377362|50430022|FG005|Part A Second Treatment|Protocol Violation|0|||
25201838|NCT02377362|50430023|FG006|Part A Second Treatment|Protocol Violation|0|||
25201839|NCT02377362|50430024|FG007|Part A Second Treatment|Protocol Violation|0|||
25201840|NCT02377362|50430025|FG008|Part A Second Treatment|Protocol Violation|0|||
25315747|NCT00626275|50631468|FG006|Part A - Treatment Period 1|Adverse Event|0|||
25315748|NCT00626275|50631469|FG007|Part A - Treatment Period 1|Adverse Event|0|||
25315749|NCT00626275|50631462|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
25315750|NCT00626275|50631463|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
25315751|NCT00626275|50631464|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
25315752|NCT00626275|50631465|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
25315753|NCT00626275|50631466|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
25315754|NCT00626275|50631467|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
25315755|NCT00626275|50631468|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
25315756|NCT00626275|50631469|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
25315757|NCT00626275|50631462|FG000|Part B|Lost to Follow-up|0|||
25315758|NCT00626275|50631463|FG001|Part B|Lost to Follow-up|0|||
25315759|NCT00626275|50631464|FG002|Part B|Lost to Follow-up|0|||
25315760|NCT00626275|50631465|FG003|Part B|Lost to Follow-up|0|||
25315761|NCT00626275|50631466|FG004|Part B|Lost to Follow-up|0|||
25315762|NCT00626275|50631467|FG005|Part B|Lost to Follow-up|0|||
25315763|NCT00626275|50631468|FG006|Part B|Lost to Follow-up|1|||
25315764|NCT00626275|50631469|FG007|Part B|Lost to Follow-up|0|||
25315765|NCT00626275|50631462|FG000|Part B|Withdrawal by Subject|0|||
25315766|NCT00626275|50631463|FG001|Part B|Withdrawal by Subject|0|||
25315767|NCT00626275|50631464|FG002|Part B|Withdrawal by Subject|0|||
25315768|NCT00626275|50631465|FG003|Part B|Withdrawal by Subject|0|||
25315769|NCT00626275|50631466|FG004|Part B|Withdrawal by Subject|0|||
25315770|NCT00626275|50631467|FG005|Part B|Withdrawal by Subject|0|||
25315771|NCT00626275|50631468|FG006|Part B|Withdrawal by Subject|0|||
25315772|NCT00626275|50631469|FG007|Part B|Withdrawal by Subject|1|||
25315773|NCT00623935|50631483|FG000|Overall Study|Death|1|||
25315774|NCT00623935|50631483|FG000|Overall Study|Patient Declined Transplant|1|||
25315775|NCT00623779|50631490|FG000|Overall Study|Adverse Event|1|||
25315776|NCT00623779|50631491|FG001|Overall Study|Adverse Event|3|||
25315777|NCT00623779|50631492|FG002|Overall Study|Adverse Event|0|||
25315778|NCT00623779|50631490|FG000|Overall Study|Criteria from CSR|2|||
25315779|NCT00623779|50631491|FG001|Overall Study|Criteria from CSR|0|||
25315780|NCT00623779|50631492|FG002|Overall Study|Criteria from CSR|1|||
25315781|NCT00629707|50631523|FG000|Overall Study|Withdrawal by Subject|0|||
25315782|NCT00629707|50631524|FG001|Overall Study|Withdrawal by Subject|1|||
25315783|NCT00629707|50631523|FG000|Overall Study|Physician Decision|0|||
25315784|NCT00629707|50631524|FG001|Overall Study|Physician Decision|1|||
25315785|NCT00902330|50631532|FG000|Overall Study|Too overwhelmed by treatment|2|||
25315786|NCT00902330|50631533|FG001|Overall Study|Too overwhelmed by treatment|5|||
25315787|NCT00902330|50631532|FG000|Overall Study|Adverse Event|1|||
25315788|NCT00902330|50631533|FG001|Overall Study|Adverse Event|0|||
25315789|NCT00902330|50631532|FG000|Overall Study|No post baseline data|1|||
25315790|NCT00902330|50631533|FG001|Overall Study|No post baseline data|0|||
25315791|NCT00901394|50631570|FG000|Overall Study|Physician Decision|1|||
25315792|NCT00901394|50631571|FG001|Overall Study|Physician Decision|1|||
25315793|NCT00901394|50631572|FG002|Overall Study|Physician Decision|2|||
25315794|NCT00896532|50631588|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315795|NCT00896532|50631589|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315796|NCT00896532|50631590|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315797|NCT00896532|50631591|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
25201841|NCT02377362|50430026|FG009|Part A Second Treatment|Protocol Violation|0|||
25201842|NCT02377362|50430027|FG010|Part A Second Treatment|Protocol Violation|0|||
25201843|NCT02377362|50430028|FG011|Part A Second Treatment|Protocol Violation|0|||
25315798|NCT00896532|50631592|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315799|NCT00896532|50631593|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
25315800|NCT00896532|50631594|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315801|NCT00896532|50631595|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315802|NCT00896532|50631596|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315803|NCT00896532|50631597|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315804|NCT00896532|50631598|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315805|NCT00896532|50631599|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315806|NCT00896532|50631600|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315807|NCT00896532|50631601|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315808|NCT00896532|50631602|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315809|NCT00896532|50631603|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315810|NCT00896532|50631604|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315811|NCT00896532|50631605|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315812|NCT00896532|50631606|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315813|NCT00896532|50631607|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315814|NCT00896532|50631608|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315815|NCT00896532|50631609|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315816|NCT00896532|50631610|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
25315817|NCT00896532|50631588|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
25315818|NCT00896532|50631589|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
25315819|NCT00896532|50631590|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
25315820|NCT00896532|50631591|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
25315821|NCT00896532|50631592|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
25315822|NCT00896532|50631593|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
25315823|NCT00896532|50631594|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
25315824|NCT00896532|50631595|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
25315825|NCT00896532|50631596|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
25315826|NCT00896532|50631597|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
25315827|NCT00896532|50631598|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
25315828|NCT00896532|50631599|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
25315829|NCT00896532|50631600|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
25315830|NCT00896532|50631601|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
25315831|NCT00896532|50631602|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
25315832|NCT00896532|50631603|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
25315833|NCT00896532|50631604|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
25201844|NCT02377362|50430029|FG012|Part A Second Treatment|Protocol Violation|0|||
25315834|NCT00896532|50631605|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
25315835|NCT00896532|50631606|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
25315836|NCT00896532|50631607|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
25315837|NCT00896532|50631608|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
25315838|NCT00896532|50631609|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
25315839|NCT00896532|50631610|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
25315840|NCT00896532|50631588|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
25315841|NCT00896532|50631589|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
25315842|NCT00896532|50631590|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
25315843|NCT00896532|50631591|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
25315844|NCT00896532|50631592|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
25315845|NCT00896532|50631593|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
25315846|NCT00896532|50631594|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
25315847|NCT00896532|50631595|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
25315848|NCT00896532|50631596|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
25315849|NCT00896532|50631597|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
25315850|NCT00896532|50631598|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
25315851|NCT00896532|50631599|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
25315852|NCT00896532|50631600|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
25315853|NCT00896532|50631601|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
25315854|NCT00896532|50631602|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
25201845|NCT02377362|50430017|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
25201846|NCT02377362|50430018|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
25201847|NCT02377362|50430019|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
25201848|NCT02377362|50430020|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
25201849|NCT02377362|50430021|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
25201850|NCT02377362|50430022|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
25201851|NCT02377362|50430023|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
25201852|NCT02377362|50430024|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
25201853|NCT02377362|50430025|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
25201854|NCT02377362|50430026|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
25201855|NCT02377362|50430027|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
25201856|NCT02377362|50430028|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
25201857|NCT02377362|50430029|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
25201858|NCT02377362|50430017|FG000|Part B Overall|Protocol Violation|0|||
25201859|NCT02377362|50430018|FG001|Part B Overall|Protocol Violation|0|||
25201860|NCT02377362|50430019|FG002|Part B Overall|Protocol Violation|0|||
25201861|NCT02377362|50430020|FG003|Part B Overall|Protocol Violation|0|||
25201862|NCT02377362|50430021|FG004|Part B Overall|Protocol Violation|0|||
25201863|NCT02377362|50430022|FG005|Part B Overall|Protocol Violation|0|||
25201864|NCT02377362|50430023|FG006|Part B Overall|Protocol Violation|0|||
25201865|NCT02377362|50430024|FG007|Part B Overall|Protocol Violation|0|||
25201866|NCT02377362|50430025|FG008|Part B Overall|Protocol Violation|0|||
25201867|NCT02377362|50430026|FG009|Part B Overall|Protocol Violation|1|||
25201868|NCT02377362|50430027|FG010|Part B Overall|Protocol Violation|0|||
25201869|NCT02377362|50430028|FG011|Part B Overall|Protocol Violation|0|||
25201870|NCT02377362|50430029|FG012|Part B Overall|Protocol Violation|0|||
25201871|NCT02377362|50430017|FG000|Part B Overall|Adverse Event|0|||
25201872|NCT02377362|50430018|FG001|Part B Overall|Adverse Event|0|||
25201873|NCT02377362|50430019|FG002|Part B Overall|Adverse Event|0|||
25201874|NCT02377362|50430020|FG003|Part B Overall|Adverse Event|0|||
25201875|NCT02377362|50430021|FG004|Part B Overall|Adverse Event|0|||
25201876|NCT02377362|50430022|FG005|Part B Overall|Adverse Event|0|||
25201877|NCT02377362|50430023|FG006|Part B Overall|Adverse Event|1|||
25201878|NCT02377362|50430024|FG007|Part B Overall|Adverse Event|1|||
25201879|NCT02377362|50430025|FG008|Part B Overall|Adverse Event|0|||
25201880|NCT02377362|50430026|FG009|Part B Overall|Adverse Event|0|||
25201881|NCT02377362|50430027|FG010|Part B Overall|Adverse Event|0|||
25201882|NCT02377362|50430028|FG011|Part B Overall|Adverse Event|0|||
25201883|NCT02377362|50430029|FG012|Part B Overall|Adverse Event|0|||
25201884|NCT02377362|50430017|FG000|Part B Overall|Withdrawal by Subject|0|||
25201885|NCT02377362|50430018|FG001|Part B Overall|Withdrawal by Subject|0|||
25201886|NCT02377362|50430019|FG002|Part B Overall|Withdrawal by Subject|0|||
25201887|NCT02377362|50430020|FG003|Part B Overall|Withdrawal by Subject|0|||
25201888|NCT02377362|50430021|FG004|Part B Overall|Withdrawal by Subject|0|||
25201889|NCT02377362|50430022|FG005|Part B Overall|Withdrawal by Subject|0|||
25201890|NCT02377362|50430023|FG006|Part B Overall|Withdrawal by Subject|1|||
25201891|NCT02377362|50430024|FG007|Part B Overall|Withdrawal by Subject|0|||
25201892|NCT02377362|50430025|FG008|Part B Overall|Withdrawal by Subject|0|||
25201893|NCT02377362|50430026|FG009|Part B Overall|Withdrawal by Subject|0|||
25201894|NCT02377362|50430027|FG010|Part B Overall|Withdrawal by Subject|0|||
25201895|NCT02377362|50430028|FG011|Part B Overall|Withdrawal by Subject|1|||
25201896|NCT02377362|50430029|FG012|Part B Overall|Withdrawal by Subject|0|||
25201897|NCT00553631|50430069|FG000|Overall Study|Withdrawal by Subject|0|||
25201898|NCT00553631|50430070|FG001|Overall Study|Withdrawal by Subject|1|||
25201899|NCT00553631|50430069|FG000|Overall Study|Lost to Follow-up|1|||
25201900|NCT00553631|50430070|FG001|Overall Study|Lost to Follow-up|0|||
25201901|NCT00553319|50430088|FG000|Overall Study|Lost to Follow-up|10|||
25201902|NCT00553319|50430089|FG001|Overall Study|Lost to Follow-up|9|||
25201903|NCT00553319|50430090|FG002|Overall Study|Lost to Follow-up|5|||
25201904|NCT00553319|50430088|FG000|Overall Study|wanted treatment elsewhere|2|||
25201905|NCT00553319|50430089|FG001|Overall Study|wanted treatment elsewhere|1|||
25201906|NCT00553319|50430090|FG002|Overall Study|wanted treatment elsewhere|1|||
25201907|NCT00553319|50430088|FG000|Overall Study|non-compliance|0|||
25201908|NCT00553319|50430089|FG001|Overall Study|non-compliance|0|||
25201909|NCT00553319|50430090|FG002|Overall Study|non-compliance|2|||
25201910|NCT00553319|50430088|FG000|Overall Study|incarceration|1|||
25201911|NCT00553319|50430089|FG001|Overall Study|incarceration|0|||
25201912|NCT00553319|50430090|FG002|Overall Study|incarceration|0|||
25201913|NCT00553319|50430088|FG000|Overall Study|moved|1|||
25201914|NCT00553319|50430089|FG001|Overall Study|moved|0|||
25201915|NCT00553319|50430090|FG002|Overall Study|moved|1|||
25201916|NCT01649856|50430276|FG000|Overall Study|Withdrawal by Subject|14|||
25201917|NCT01649856|50430277|FG001|Overall Study|Withdrawal by Subject|14|||
25201918|NCT01649856|50430276|FG000|Overall Study|Protocol Violation|4|||
25201919|NCT01649856|50430277|FG001|Overall Study|Protocol Violation|4|||
25171205|NCT01772537|50308059|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
25171206|NCT01772537|50308060|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
25171207|NCT01772147|50308073|FG000|Overall Study|Adverse Event|13|||
25171208|NCT01772147|50308074|FG001|Overall Study|Adverse Event|10|||
25171209|NCT01772147|50308075|FG002|Overall Study|Adverse Event|6|||
25171210|NCT01772147|50308073|FG000|Overall Study|Withdrew Consent|7|||
25171211|NCT01772147|50308074|FG001|Overall Study|Withdrew Consent|8|||
25171212|NCT01772147|50308075|FG002|Overall Study|Withdrew Consent|4|||
25171213|NCT01772147|50308073|FG000|Overall Study|Lost to Follow-up|1|||
25171214|NCT01772147|50308074|FG001|Overall Study|Lost to Follow-up|0|||
25171215|NCT01772147|50308075|FG002|Overall Study|Lost to Follow-up|1|||
25171216|NCT01772147|50308073|FG000|Overall Study|Protocol Deviation|2|||
25171217|NCT01772147|50308074|FG001|Overall Study|Protocol Deviation|1|||
25171218|NCT01772147|50308075|FG002|Overall Study|Protocol Deviation|1|||
25171219|NCT01772147|50308073|FG000|Overall Study|Lack of Efficacy|8|||
25171220|NCT01772147|50308074|FG001|Overall Study|Lack of Efficacy|6|||
25171221|NCT01772147|50308075|FG002|Overall Study|Lack of Efficacy|6|||
25171222|NCT01771913|50308085|FG000|Overall Study|Withdrawal by Subject|1|||
25171223|NCT01771913|50308086|FG001|Overall Study|Withdrawal by Subject|0|||
25171224|NCT01606787|50308094|FG000|Overall Study|Withdrawal by Subject|4|||
25171225|NCT01606787|50308095|FG001|Overall Study|Withdrawal by Subject|5|||
25171226|NCT01606787|50308094|FG000|Overall Study|Surgery canceled|0|||
25171227|NCT01606787|50308095|FG001|Overall Study|Surgery canceled|2|||
25171228|NCT01778855|50308103|FG000|Overall Study|Death|0|||
25171229|NCT01778855|50308104|FG001|Overall Study|Death|1|||
25171230|NCT01777997|50308110|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
25171231|NCT01777997|50308110|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
25171232|NCT01777997|50308110|FG000|Weeks 48 to 72/96 on ART|Death|1|||
25171233|NCT01777997|50308110|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
25171234|NCT01770509|50308116|FG000|Overall Study|Injury|0|||
25171235|NCT01770509|50308117|FG001|Overall Study|Injury|1|||
25171236|NCT01770509|50308116|FG000|Overall Study|Lost to Follow-up|1|||
25171237|NCT01770509|50308117|FG001|Overall Study|Lost to Follow-up|2|||
25171238|NCT01770353|50308125|FG000|Overall Study|Progressive disease|2|||
25171239|NCT01770353|50308126|FG001|Overall Study|Progressive disease|1|||
25171240|NCT01770353|50308125|FG000|Overall Study|Adverse Event|0|||
25171241|NCT01770353|50308126|FG001|Overall Study|Adverse Event|1|||
25171242|NCT01770353|50308125|FG000|Overall Study|Protocol Violation|1|||
25171243|NCT01770353|50308126|FG001|Overall Study|Protocol Violation|0|||
25171244|NCT01770353|50308125|FG000|Overall Study|Physician Decision|0|||
25171245|NCT01770353|50308126|FG001|Overall Study|Physician Decision|3|||
25171246|NCT01770353|50308125|FG000|Overall Study|Clinical deterioration|3|||
25171247|NCT01770353|50308126|FG001|Overall Study|Clinical deterioration|6|||
25171248|NCT01770353|50308125|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
25171249|NCT01770353|50308126|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
25171250|NCT01777763|50308142|FG000|Overall Study|Adverse Event|2|||
25171251|NCT01777763|50308143|FG001|Overall Study|Adverse Event|32|||
25171252|NCT01777763|50308142|FG000|Overall Study|Protocol Violation|1|||
25171253|NCT01777763|50308143|FG001|Overall Study|Protocol Violation|7|||
25171254|NCT01777763|50308142|FG000|Overall Study|Withdrawal by Subject|0|||
25171255|NCT01777763|50308143|FG001|Overall Study|Withdrawal by Subject|2|||
25171256|NCT01777763|50308142|FG000|Overall Study|Treatment Failure|1|||
25171257|NCT01777763|50308143|FG001|Overall Study|Treatment Failure|6|||
25171258|NCT01769339|50308149|FG000|Overall Study|Lost to Follow-up|42|||
25171259|NCT01769339|50308149|FG000|Overall Study|Adverse Event|1|||
25171260|NCT01769105|50308155|FG000|First Intervention|Protocol Violation|2|||
25171261|NCT01769105|50308156|FG001|First Intervention|Protocol Violation|2|||
25171262|NCT01769105|50308155|FG000|Cross-over|Lost to Follow-up|5|||
25171263|NCT01769105|50308156|FG001|Cross-over|Lost to Follow-up|0|||
25171264|NCT01777139|50308164|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
25171265|NCT01777139|50308165|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
25171266|NCT01777139|50308164|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
25171267|NCT01777139|50308165|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
25171268|NCT01777139|50308164|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
25171269|NCT01777139|50308165|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
25171270|NCT01777139|50308164|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
25171271|NCT01777139|50308165|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
25171272|NCT01777139|50308164|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
25171273|NCT01777139|50308165|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
25171274|NCT01777139|50308164|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
25171275|NCT01777139|50308165|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
25201920|NCT01649856|50430276|FG000|Overall Study|Treatment Failure|1|||
25201921|NCT01649856|50430277|FG001|Overall Study|Treatment Failure|1|||
25201922|NCT01649856|50430276|FG000|Overall Study|Death|69|||
25201923|NCT01649856|50430277|FG001|Overall Study|Death|34|||
25201924|NCT01649856|50430276|FG000|Overall Study|Stable or Progressed Disease|5|||
25201925|NCT01649856|50430277|FG001|Overall Study|Stable or Progressed Disease|3|||
25201926|NCT01649856|50430276|FG000|Overall Study|Lost to Follow-up|20|||
25201927|NCT01649856|50430277|FG001|Overall Study|Lost to Follow-up|16|||
25201928|NCT01649856|50430276|FG000|Overall Study|Lack of Compliance|6|||
25201929|NCT01649856|50430277|FG001|Overall Study|Lack of Compliance|1|||
25201930|NCT01649856|50430276|FG000|Overall Study|Other|20|||
25201931|NCT01649856|50430277|FG001|Overall Study|Other|5|||
25201932|NCT02375724|50430298|FG000|Overall Study|Lack of Efficacy|1|||
25201933|NCT02375724|50430299|FG001|Overall Study|Lack of Efficacy|1|||
25201934|NCT02375724|50430298|FG000|Overall Study|Withdrawal by Subject|1|||
25201935|NCT02375724|50430299|FG001|Overall Study|Withdrawal by Subject|1|||
25201936|NCT02375724|50430298|FG000|Overall Study|Lost to Follow-up|1|||
25201937|NCT02375724|50430299|FG001|Overall Study|Lost to Follow-up|0|||
25201938|NCT02375724|50430298|FG000|Overall Study|Protocol Violation|1|||
25171276|NCT01777139|50308164|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
25171277|NCT01777139|50308165|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
25171278|NCT01777139|50308164|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
25171279|NCT01777139|50308165|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
25171280|NCT01768637|50308174|FG000|Overall Study|Lost to Follow-up|2|||
25171281|NCT01768637|50308175|FG001|Overall Study|Lost to Follow-up|7|||
25171282|NCT01768637|50308174|FG000|Overall Study|Difficult blood draw|1|||
25171283|NCT01768637|50308175|FG001|Overall Study|Difficult blood draw|0|||
25171284|NCT01768559|50308184|FG000|Overall Study|Randomized but not treated|0|||
25171285|NCT01768559|50308185|FG001|Overall Study|Randomized but not treated|0|||
25171286|NCT01768559|50308186|FG002|Overall Study|Randomized but not treated|1|||
25171287|NCT01768559|50308184|FG000|Overall Study|Adverse Event|15|||
25171288|NCT01768559|50308185|FG001|Overall Study|Adverse Event|2|||
25171289|NCT01768559|50308186|FG002|Overall Study|Adverse Event|5|||
25171290|NCT01768559|50308184|FG000|Overall Study|Lack of Efficacy|6|||
25171291|NCT01768559|50308185|FG001|Overall Study|Lack of Efficacy|4|||
25171292|NCT01768559|50308186|FG002|Overall Study|Lack of Efficacy|0|||
25171293|NCT01768559|50308184|FG000|Overall Study|Poor compliance to protocol|0|||
25171294|NCT01768559|50308185|FG001|Overall Study|Poor compliance to protocol|3|||
25171295|NCT01768559|50308186|FG002|Overall Study|Poor compliance to protocol|2|||
25171296|NCT01768559|50308184|FG000|Overall Study|Other than specified|9|||
25171297|NCT01768559|50308185|FG001|Overall Study|Other than specified|8|||
25171298|NCT01768559|50308186|FG002|Overall Study|Other than specified|5|||
25171299|NCT00983619|50308210|FG000|Overall Study|Lost to Follow-up|0|||
25171300|NCT00983619|50308211|FG001|Overall Study|Lost to Follow-up|1|||
25171301|NCT00983619|50308212|FG002|Overall Study|Lost to Follow-up|0|||
25171302|NCT00983619|50308213|FG003|Overall Study|Lost to Follow-up|0|||
25171303|NCT00983619|50308214|FG004|Overall Study|Lost to Follow-up|0|||
25171304|NCT00983619|50308215|FG005|Overall Study|Lost to Follow-up|2|||
25171305|NCT00983619|50308216|FG006|Overall Study|Lost to Follow-up|0|||
25171306|NCT00983619|50308217|FG007|Overall Study|Lost to Follow-up|0|||
25171307|NCT00983619|50308218|FG008|Overall Study|Lost to Follow-up|0|||
25171308|NCT00983619|50308219|FG009|Overall Study|Lost to Follow-up|0|||
25171309|NCT00983619|50308220|FG010|Overall Study|Lost to Follow-up|0|||
25171310|NCT00983619|50308221|FG011|Overall Study|Lost to Follow-up|2|||
25171311|NCT00983619|50308210|FG000|Overall Study|Withdrawal by Subject|2|||
25171312|NCT00983619|50308211|FG001|Overall Study|Withdrawal by Subject|1|||
25171313|NCT00983619|50308212|FG002|Overall Study|Withdrawal by Subject|1|||
25171314|NCT00983619|50308213|FG003|Overall Study|Withdrawal by Subject|3|||
25171315|NCT00983619|50308214|FG004|Overall Study|Withdrawal by Subject|1|||
25171316|NCT00983619|50308215|FG005|Overall Study|Withdrawal by Subject|23|||
25171317|NCT00983619|50308216|FG006|Overall Study|Withdrawal by Subject|0|||
25171318|NCT00983619|50308217|FG007|Overall Study|Withdrawal by Subject|0|||
25171319|NCT00983619|50308218|FG008|Overall Study|Withdrawal by Subject|0|||
25171320|NCT00983619|50308219|FG009|Overall Study|Withdrawal by Subject|0|||
25171321|NCT00983619|50308220|FG010|Overall Study|Withdrawal by Subject|1|||
25201939|NCT02375724|50430299|FG001|Overall Study|Protocol Violation|0|||
25201940|NCT02375724|50430298|FG000|Overall Study|Adverse Event|2|||
25201941|NCT02375724|50430299|FG001|Overall Study|Adverse Event|4|||
25201942|NCT02398188|50430307|FG000|Overall Study|Adverse Event|2|||
25171322|NCT00983619|50308221|FG011|Overall Study|Withdrawal by Subject|1|||
25171323|NCT00983619|50308210|FG000|Overall Study|Death|0|||
25171324|NCT00983619|50308211|FG001|Overall Study|Death|2|||
25171325|NCT00983619|50308212|FG002|Overall Study|Death|2|||
25171326|NCT00983619|50308213|FG003|Overall Study|Death|1|||
25201943|NCT02398188|50430308|FG001|Overall Study|Adverse Event|3|||
25201944|NCT02398188|50430307|FG000|Overall Study|Lost to Follow-up|5|||
25201945|NCT02398188|50430308|FG001|Overall Study|Lost to Follow-up|0|||
25201946|NCT02398188|50430307|FG000|Overall Study|Non-compliance|4|||
25201947|NCT02398188|50430308|FG001|Overall Study|Non-compliance|4|||
25201948|NCT02398188|50430307|FG000|Overall Study|Protocol Violation|6|||
25201949|NCT02398188|50430308|FG001|Overall Study|Protocol Violation|10|||
25201950|NCT02398188|50430307|FG000|Overall Study|Sponsor Decision|2|||
25201951|NCT02398188|50430308|FG001|Overall Study|Sponsor Decision|1|||
25201952|NCT02398188|50430307|FG000|Overall Study|Pregnancy|1|||
25201953|NCT02398188|50430308|FG001|Overall Study|Pregnancy|0|||
25201954|NCT02398188|50430307|FG000|Overall Study|Withdrawal by Subject|7|||
25201955|NCT02398188|50430308|FG001|Overall Study|Withdrawal by Subject|16|||
25201956|NCT02426580|50430316|FG000|Overall Study|Death|2|||
25201957|NCT02426580|50430317|FG001|Overall Study|Death|2|||
25201958|NCT02426580|50430316|FG000|Overall Study|Lost to Follow-up|0|||
25201959|NCT02426580|50430317|FG001|Overall Study|Lost to Follow-up|9|||
25201960|NCT02426580|50430316|FG000|Overall Study|transfer to hemodialysis|5|||
25201961|NCT02426580|50430317|FG001|Overall Study|transfer to hemodialysis|5|||
25201962|NCT02426580|50430316|FG000|Overall Study|Kidney transplant|3|||
25201963|NCT02426580|50430317|FG001|Overall Study|Kidney transplant|0|||
25201964|NCT02426580|50430316|FG000|Overall Study|Allergic to egg white|1|||
25201965|NCT02426580|50430317|FG001|Overall Study|Allergic to egg white|0|||
25201966|NCT01651260|50430323|FG000|Overall Study|unable to apply product|3|||
25201967|NCT02425098|50430343|FG000|Overall Study|Lost to Follow-up|7|||
25201968|NCT02425098|50430344|FG001|Overall Study|Lost to Follow-up|7|||
25201969|NCT02425098|50430343|FG000|Overall Study|Withdrawal by Subject|4|||
25201970|NCT02425098|50430344|FG001|Overall Study|Withdrawal by Subject|8|||
25201971|NCT02425098|50430343|FG000|Overall Study|Pregnancy|2|||
25201972|NCT02425098|50430344|FG001|Overall Study|Pregnancy|0|||
25201973|NCT02425098|50430343|FG000|Overall Study|Reason not Specified|0|||
25201974|NCT02425098|50430344|FG001|Overall Study|Reason not Specified|1|||
25201975|NCT02424630|50430352|FG000|Overall Study|No rotator cuff tear|1|||
25201976|NCT02424630|50430353|FG001|Overall Study|No rotator cuff tear|2|||
25201977|NCT02424630|50430352|FG000|Overall Study|Open procedure|0|||
25201978|NCT02424630|50430353|FG001|Overall Study|Open procedure|1|||
25201979|NCT02397408|50430359|FG000|Overall Study|Physician Decision|4|||
25201980|NCT02397408|50430359|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
25201981|NCT02397096|50430365|FG000|Day 1 to Week 24|Adverse Event|7|||
25201982|NCT02397096|50430366|FG001|Day 1 to Week 24|Adverse Event|1|||
25201983|NCT02397096|50430365|FG000|Day 1 to Week 24|Death|1|||
25201984|NCT02397096|50430366|FG001|Day 1 to Week 24|Death|0|||
25201985|NCT02397096|50430365|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
25201986|NCT02397096|50430366|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
25201987|NCT02397096|50430365|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
25201988|NCT02397096|50430366|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
25201989|NCT02397096|50430365|FG000|Day 1 to Week 24|Physician Decision|2|||
25201990|NCT02397096|50430366|FG001|Day 1 to Week 24|Physician Decision|3|||
25201991|NCT02397096|50430365|FG000|Day 1 to Week 24|Protocol Violation|1|||
25201992|NCT02397096|50430366|FG001|Day 1 to Week 24|Protocol Violation|4|||
25201993|NCT02397096|50430365|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
25201994|NCT02397096|50430366|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
25201995|NCT02397096|50430365|FG000|Week 24 to Week 48|Adverse Event|6|||
25201996|NCT02397096|50430366|FG001|Week 24 to Week 48|Adverse Event|2|||
25201997|NCT02397096|50430365|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
25201998|NCT02397096|50430366|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
25201999|NCT02397096|50430365|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
25202000|NCT02397096|50430366|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
25202001|NCT02397096|50430365|FG000|Week 24 to Week 48|Physician Decision|2|||
25202002|NCT02397096|50430366|FG001|Week 24 to Week 48|Physician Decision|1|||
25202003|NCT02397096|50430365|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
25202004|NCT02397096|50430366|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
25202005|NCT02397096|50430365|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
25202006|NCT02397096|50430366|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
25202007|NCT02397096|50430365|FG000|Study Extensions|Ongoing|399|||
25202008|NCT02397096|50430366|FG001|Study Extensions|Ongoing|202|||
25315855|NCT00896532|50631603|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
25202009|NCT02372058|50430376|FG000|Overall Study|Withdrawal by Subject|3|||
25202010|NCT02396316|50430384|FG000|Overall Study|Physician Decision|1|||
25202011|NCT02396316|50430385|FG001|Overall Study|Physician Decision|0|||
25202012|NCT02396316|50430384|FG000|Overall Study|Progressive disease|6|||
25202013|NCT02396316|50430385|FG001|Overall Study|Progressive disease|3|||
25202014|NCT02396316|50430384|FG000|Overall Study|Protocol Violation|0|||
25202015|NCT02396316|50430385|FG001|Overall Study|Protocol Violation|1|||
25202016|NCT02396316|50430384|FG000|Overall Study|Treatment unblinded|0|||
25202017|NCT02396316|50430385|FG001|Overall Study|Treatment unblinded|1|||
25202018|NCT02395536|50430395|FG000|Overall Study|Lost to Follow-up|4|||
25202019|NCT02395536|50430396|FG001|Overall Study|Lost to Follow-up|4|||
25202020|NCT02395536|50430395|FG000|Overall Study|Death|2|||
25202021|NCT02395536|50430396|FG001|Overall Study|Death|0|||
25202022|NCT02395536|50430395|FG000|Overall Study|Physician Decision|4|||
25202023|NCT02395536|50430396|FG001|Overall Study|Physician Decision|6|||
25202024|NCT02395536|50430395|FG000|Overall Study|Withdrawal by Subject|9|||
25202025|NCT02395536|50430396|FG001|Overall Study|Withdrawal by Subject|17|||
25202026|NCT02395536|50430395|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
25202027|NCT02395536|50430396|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
25202028|NCT02395536|50430395|FG000|Overall Study|Insurance issue|0|||
25202029|NCT02395536|50430396|FG001|Overall Study|Insurance issue|1|||
25202030|NCT00552929|50430412|FG000|Overall Study|Lost to Follow-up|0|||
25202031|NCT00552929|50430413|FG001|Overall Study|Lost to Follow-up|0|||
25202032|NCT00552929|50430414|FG002|Overall Study|Lost to Follow-up|0|||
25202033|NCT00552929|50430415|FG003|Overall Study|Lost to Follow-up|0|||
25202034|NCT00552929|50430416|FG004|Overall Study|Lost to Follow-up|0|||
25202035|NCT00552929|50430417|FG005|Overall Study|Lost to Follow-up|0|||
25202036|NCT00552929|50430418|FG006|Overall Study|Lost to Follow-up|0|||
25202037|NCT00552929|50430419|FG007|Overall Study|Lost to Follow-up|0|||
25202038|NCT00552929|50430420|FG008|Overall Study|Lost to Follow-up|1|||
25202039|NCT00552929|50430421|FG009|Overall Study|Lost to Follow-up|0|||
25202040|NCT00552929|50430412|FG000|Overall Study|Not Eligible|0|||
25202041|NCT00552929|50430413|FG001|Overall Study|Not Eligible|0|||
25202042|NCT00552929|50430414|FG002|Overall Study|Not Eligible|0|||
25202043|NCT00552929|50430415|FG003|Overall Study|Not Eligible|0|||
25202044|NCT00552929|50430416|FG004|Overall Study|Not Eligible|0|||
25202045|NCT00552929|50430417|FG005|Overall Study|Not Eligible|1|||
25202046|NCT00552929|50430418|FG006|Overall Study|Not Eligible|0|||
25202047|NCT00552929|50430419|FG007|Overall Study|Not Eligible|0|||
25202048|NCT00552929|50430420|FG008|Overall Study|Not Eligible|0|||
25202049|NCT00552929|50430421|FG009|Overall Study|Not Eligible|0|||
25202050|NCT02395302|50430443|FG000|Overall Study|Screen Failure|3|||
25202051|NCT02395302|50430443|FG000|Overall Study|Run In Failure|7|||
25202052|NCT02395302|50430443|FG000|Overall Study|Withdrawal by Subject|2|||
25202053|NCT02395302|50430443|FG000|Overall Study|Physician Decision|2|||
25202054|NCT02371980|50430477|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
25202055|NCT02371980|50430478|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
25202056|NCT02371980|50430479|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
25202057|NCT02371980|50430480|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
25202058|NCT02371980|50430481|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
25202059|NCT02371980|50430477|FG000|Open-label Period|Significant Protocol Deviation|19|||
25202060|NCT02371980|50430478|FG001|Open-label Period|Significant Protocol Deviation|0|||
25202061|NCT02371980|50430479|FG002|Open-label Period|Significant Protocol Deviation|0|||
25202062|NCT02371980|50430480|FG003|Open-label Period|Significant Protocol Deviation|0|||
25202063|NCT02371980|50430481|FG004|Open-label Period|Significant Protocol Deviation|0|||
25202064|NCT02371980|50430477|FG000|Open-label Period|Noncompliance with Study Drug|10|||
25202065|NCT02371980|50430478|FG001|Open-label Period|Noncompliance with Study Drug|0|||
25202066|NCT02371980|50430479|FG002|Open-label Period|Noncompliance with Study Drug|0|||
25202067|NCT02371980|50430480|FG003|Open-label Period|Noncompliance with Study Drug|0|||
25202068|NCT02371980|50430481|FG004|Open-label Period|Noncompliance with Study Drug|0|||
25202069|NCT02371980|50430477|FG000|Open-label Period|Lost to Follow-up|55|||
25202070|NCT02371980|50430478|FG001|Open-label Period|Lost to Follow-up|0|||
25202071|NCT02371980|50430479|FG002|Open-label Period|Lost to Follow-up|0|||
25202072|NCT02371980|50430480|FG003|Open-label Period|Lost to Follow-up|0|||
25202073|NCT02371980|50430481|FG004|Open-label Period|Lost to Follow-up|0|||
25202074|NCT02371980|50430477|FG000|Open-label Period|Voluntary Withdrawal|91|||
25202075|NCT02371980|50430478|FG001|Open-label Period|Voluntary Withdrawal|0|||
25202076|NCT02371980|50430479|FG002|Open-label Period|Voluntary Withdrawal|0|||
25202077|NCT02371980|50430480|FG003|Open-label Period|Voluntary Withdrawal|0|||
25202078|NCT02371980|50430481|FG004|Open-label Period|Voluntary Withdrawal|0|||
25202079|NCT02371980|50430477|FG000|Open-label Period|Pregnancy|1|||
25202080|NCT02371980|50430478|FG001|Open-label Period|Pregnancy|0|||
25202081|NCT02371980|50430479|FG002|Open-label Period|Pregnancy|0|||
25202082|NCT02371980|50430480|FG003|Open-label Period|Pregnancy|0|||
25202083|NCT02371980|50430481|FG004|Open-label Period|Pregnancy|0|||
25202084|NCT02371980|50430477|FG000|Open-label Period|Lack of Efficacy|116|||
25202085|NCT02371980|50430478|FG001|Open-label Period|Lack of Efficacy|0|||
25202086|NCT02371980|50430479|FG002|Open-label Period|Lack of Efficacy|0|||
25202087|NCT02371980|50430480|FG003|Open-label Period|Lack of Efficacy|0|||
25202088|NCT02371980|50430481|FG004|Open-label Period|Lack of Efficacy|0|||
25202089|NCT02371980|50430477|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
25202090|NCT02371980|50430478|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
25202091|NCT02371980|50430479|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
25202092|NCT02371980|50430480|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
25202093|NCT02371980|50430481|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
25202094|NCT02371980|50430477|FG000|Open-label Period|Reason not Specified|9|||
25202095|NCT02371980|50430478|FG001|Open-label Period|Reason not Specified|0|||
25202096|NCT02371980|50430479|FG002|Open-label Period|Reason not Specified|0|||
25202097|NCT02371980|50430480|FG003|Open-label Period|Reason not Specified|0|||
25202098|NCT02371980|50430481|FG004|Open-label Period|Reason not Specified|0|||
25202099|NCT02371980|50430477|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
25202100|NCT02371980|50430478|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
25202101|NCT02371980|50430479|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
25202102|NCT02371980|50430480|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
25202103|NCT02371980|50430481|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
25202104|NCT02371980|50430477|FG000|Double-blind Period|Significant Protocol Deviation|0|||
25202105|NCT02371980|50430478|FG001|Double-blind Period|Significant Protocol Deviation|2|||
25202106|NCT02371980|50430479|FG002|Double-blind Period|Significant Protocol Deviation|7|||
25202107|NCT02371980|50430480|FG003|Double-blind Period|Significant Protocol Deviation|3|||
25202108|NCT02371980|50430481|FG004|Double-blind Period|Significant Protocol Deviation|3|||
25202109|NCT02371980|50430477|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
25202110|NCT02371980|50430478|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
25202111|NCT02371980|50430479|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
25202112|NCT02371980|50430480|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
25202113|NCT02371980|50430481|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
25202114|NCT02371980|50430477|FG000|Double-blind Period|Lost to Follow-up|0|||
25202115|NCT02371980|50430478|FG001|Double-blind Period|Lost to Follow-up|8|||
25202116|NCT02371980|50430479|FG002|Double-blind Period|Lost to Follow-up|8|||
25202117|NCT02371980|50430480|FG003|Double-blind Period|Lost to Follow-up|6|||
25202118|NCT02371980|50430481|FG004|Double-blind Period|Lost to Follow-up|5|||
25202119|NCT02371980|50430477|FG000|Double-blind Period|Voluntary Withdrawal|0|||
25202120|NCT02371980|50430478|FG001|Double-blind Period|Voluntary Withdrawal|12|||
25202121|NCT02371980|50430479|FG002|Double-blind Period|Voluntary Withdrawal|8|||
25202122|NCT02371980|50430480|FG003|Double-blind Period|Voluntary Withdrawal|9|||
25202123|NCT02371980|50430481|FG004|Double-blind Period|Voluntary Withdrawal|11|||
25202124|NCT02371980|50430477|FG000|Double-blind Period|Relapse|0|||
25202125|NCT02371980|50430478|FG001|Double-blind Period|Relapse|50|||
25202126|NCT02371980|50430479|FG002|Double-blind Period|Relapse|25|||
25202127|NCT02371980|50430480|FG003|Double-blind Period|Relapse|25|||
25202128|NCT02371980|50430481|FG004|Double-blind Period|Relapse|26|||
25202129|NCT02371980|50430477|FG000|Double-blind Period|Reason not Specified|0|||
25202130|NCT02371980|50430478|FG001|Double-blind Period|Reason not Specified|3|||
25202131|NCT02371980|50430479|FG002|Double-blind Period|Reason not Specified|3|||
25202132|NCT02371980|50430480|FG003|Double-blind Period|Reason not Specified|2|||
25202133|NCT02371980|50430481|FG004|Double-blind Period|Reason not Specified|1|||
25202134|NCT02371980|50430477|FG000|Double-blind Period|Missing|0|||
25202135|NCT02371980|50430478|FG001|Double-blind Period|Missing|1|||
25202136|NCT02371980|50430479|FG002|Double-blind Period|Missing|0|||
25202137|NCT02371980|50430480|FG003|Double-blind Period|Missing|0|||
25202138|NCT02371980|50430481|FG004|Double-blind Period|Missing|0|||
25202139|NCT02371746|50430621|FG000|Overall Study|Consent withdrawn|0|||
25202140|NCT02371746|50430622|FG001|Overall Study|Consent withdrawn|0|||
25202141|NCT02371746|50430623|FG002|Overall Study|Consent withdrawn|0|||
25202142|NCT02371746|50430624|FG003|Overall Study|Consent withdrawn|0|||
25202143|NCT02371746|50430625|FG004|Overall Study|Consent withdrawn|0|||
25202144|NCT02371746|50430626|FG005|Overall Study|Consent withdrawn|0|||
25202145|NCT02371746|50430627|FG006|Overall Study|Consent withdrawn|1|||
25202146|NCT02421666|50430675|FG000|6-month Follow-up|Lost to Follow-up|8|||
25202147|NCT02421666|50430676|FG001|6-month Follow-up|Lost to Follow-up|7|||
25202148|NCT02421666|50430675|FG000|6-month Follow-up|Withdrawal by Subject|5|||
25202149|NCT02421666|50430676|FG001|6-month Follow-up|Withdrawal by Subject|6|||
25202150|NCT02421666|50430675|FG000|12-month Follow-up|Lost to Follow-up|5|||
25202151|NCT02421666|50430676|FG001|12-month Follow-up|Lost to Follow-up|5|||
25202152|NCT02421666|50430675|FG000|12-month Follow-up|Withdrawal by Subject|6|||
25202153|NCT02421666|50430676|FG001|12-month Follow-up|Withdrawal by Subject|11|||
25202154|NCT02394756|50430686|FG000|Period 1|Lens Discomfort|0|||
25202155|NCT02394756|50430687|FG001|Period 1|Lens Discomfort|0|||
25202156|NCT02394756|50430688|FG002|Period 1|Lens Discomfort|0|||
25202157|NCT02394756|50430689|FG003|Period 1|Lens Discomfort|0|||
25202158|NCT02394756|50430690|FG004|Period 1|Lens Discomfort|0|||
25202159|NCT02394756|50430691|FG005|Period 1|Lens Discomfort|1|||
25202160|NCT02394756|50430686|FG000|Period 1|Withdrawal by Subject|0|||
25202161|NCT02394756|50430687|FG001|Period 1|Withdrawal by Subject|1|||
25202162|NCT02394756|50430688|FG002|Period 1|Withdrawal by Subject|1|||
25202163|NCT02394756|50430689|FG003|Period 1|Withdrawal by Subject|1|||
25202164|NCT02394756|50430690|FG004|Period 1|Withdrawal by Subject|0|||
25202165|NCT02394756|50430691|FG005|Period 1|Withdrawal by Subject|0|||
25202166|NCT02394756|50430686|FG000|Period 2|Unsatisfactory Visual Response|0|||
25202167|NCT02394756|50430687|FG001|Period 2|Unsatisfactory Visual Response|0|||
25202168|NCT02394756|50430688|FG002|Period 2|Unsatisfactory Visual Response|0|||
25202169|NCT02394756|50430689|FG003|Period 2|Unsatisfactory Visual Response|0|||
25202170|NCT02394756|50430690|FG004|Period 2|Unsatisfactory Visual Response|1|||
25202171|NCT02394756|50430691|FG005|Period 2|Unsatisfactory Visual Response|0|||
25202172|NCT02370888|50430712|FG000|Overall Study|disease progression|2|||
25202173|NCT02370888|50430712|FG000|Overall Study|did not meet chimerism criteria|6|||
25202174|NCT02394600|50430736|FG000|Overall Study|Adverse Event|3|||
25202175|NCT02394600|50430737|FG001|Overall Study|Adverse Event|0|||
25202176|NCT02394600|50430736|FG000|Overall Study|Lost to Follow-up|0|||
25202177|NCT02394600|50430737|FG001|Overall Study|Lost to Follow-up|1|||
25202178|NCT02394600|50430736|FG000|Overall Study|Withdrawal by Subject|0|||
25202179|NCT02394600|50430737|FG001|Overall Study|Withdrawal by Subject|1|||
25202180|NCT02394600|50430736|FG000|Overall Study|Protocol Violation|1|||
25202181|NCT02394600|50430737|FG001|Overall Study|Protocol Violation|0|||
25202182|NCT04685499|50430753|FG000|Overall Study|Study Terminated Early|1|||
25202183|NCT02421588|50430829|FG000|Overall Study|Non-treatment-related AE|8|||
25202184|NCT02421588|50430830|FG001|Overall Study|Non-treatment-related AE|8|||
25202185|NCT02421588|50430829|FG000|Overall Study|Progressive disease|152|||
25202186|NCT02421588|50430830|FG001|Overall Study|Progressive disease|135|||
25202187|NCT02421588|50430829|FG000|Overall Study|Death|11|||
25202188|NCT02421588|50430830|FG001|Overall Study|Death|3|||
25202189|NCT02421588|50430829|FG000|Overall Study|Physician Decision|8|||
25202190|NCT02421588|50430830|FG001|Overall Study|Physician Decision|17|||
25202191|NCT02421588|50430829|FG000|Overall Study|Other reason not specified|3|||
25202192|NCT02421588|50430830|FG001|Overall Study|Other reason not specified|1|||
25202193|NCT02421588|50430829|FG000|Overall Study|Symptomatic deterioration|13|||
25202194|NCT02421588|50430830|FG001|Overall Study|Symptomatic deterioration|19|||
25202195|NCT02421588|50430829|FG000|Overall Study|Treatment-related AE|10|||
25202196|NCT02421588|50430830|FG001|Overall Study|Treatment-related AE|14|||
25202197|NCT02421588|50430829|FG000|Overall Study|Withdrawal by Subject|14|||
25202198|NCT02421588|50430830|FG001|Overall Study|Withdrawal by Subject|16|||
25202199|NCT02421588|50430829|FG000|Overall Study|Not treated|2|||
25202200|NCT02421588|50430830|FG001|Overall Study|Not treated|8|||
25202201|NCT02421510|50430839|FG000|Overall Study|Other|4|||
25202202|NCT02421510|50430840|FG001|Overall Study|Other|2|||
25202203|NCT02421510|50430841|FG002|Overall Study|Other|3|||
25202204|NCT02421510|50430839|FG000|Overall Study|Protocol Violation|1|||
25202205|NCT02421510|50430840|FG001|Overall Study|Protocol Violation|2|||
25202206|NCT02421510|50430841|FG002|Overall Study|Protocol Violation|0|||
25202207|NCT02421510|50430839|FG000|Overall Study|Death|1|||
25202208|NCT02421510|50430840|FG001|Overall Study|Death|0|||
25202209|NCT02421510|50430841|FG002|Overall Study|Death|0|||
25202210|NCT02421510|50430839|FG000|Overall Study|Noncompliance with study drug|1|||
25202211|NCT02421510|50430840|FG001|Overall Study|Noncompliance with study drug|0|||
25202212|NCT02421510|50430841|FG002|Overall Study|Noncompliance with study drug|0|||
25202213|NCT02421510|50430839|FG000|Overall Study|Physician Decision|1|||
25202214|NCT02421510|50430840|FG001|Overall Study|Physician Decision|1|||
25202215|NCT02421510|50430841|FG002|Overall Study|Physician Decision|3|||
25202216|NCT02421510|50430839|FG000|Overall Study|Adverse Event|9|||
25202217|NCT02421510|50430840|FG001|Overall Study|Adverse Event|10|||
25202218|NCT02421510|50430841|FG002|Overall Study|Adverse Event|18|||
25202219|NCT02421510|50430839|FG000|Overall Study|Pregnancy|1|||
25202220|NCT02421510|50430840|FG001|Overall Study|Pregnancy|1|||
25202221|NCT02421510|50430841|FG002|Overall Study|Pregnancy|0|||
25202222|NCT02421510|50430839|FG000|Overall Study|Withdrawal by Subject|14|||
25202223|NCT02421510|50430840|FG001|Overall Study|Withdrawal by Subject|18|||
25202224|NCT02421510|50430841|FG002|Overall Study|Withdrawal by Subject|12|||
25202225|NCT02421510|50430839|FG000|Overall Study|Lost to Follow-up|1|||
25202226|NCT02421510|50430840|FG001|Overall Study|Lost to Follow-up|1|||
25202227|NCT02421510|50430841|FG002|Overall Study|Lost to Follow-up|0|||
25202228|NCT00552617|50430859|FG000|Overall Study|Not Treated|0|||
25202229|NCT00552617|50430860|FG001|Overall Study|Not Treated|0|||
25202230|NCT00552617|50430861|FG002|Overall Study|Not Treated|1|||
25171327|NCT00983619|50308214|FG004|Overall Study|Death|2|||
25171328|NCT00983619|50308215|FG005|Overall Study|Death|30|||
25171329|NCT00983619|50308216|FG006|Overall Study|Death|1|||
25171330|NCT00983619|50308217|FG007|Overall Study|Death|0|||
25171331|NCT00983619|50308218|FG008|Overall Study|Death|1|||
25171332|NCT00983619|50308219|FG009|Overall Study|Death|2|||
25171333|NCT00983619|50308220|FG010|Overall Study|Death|9|||
25202231|NCT00552617|50430862|FG003|Overall Study|Not Treated|0|||
25202232|NCT00552617|50430863|FG004|Overall Study|Not Treated|0|||
25202233|NCT00552617|50430864|FG005|Overall Study|Not Treated|0|||
25202234|NCT00552617|50430865|FG006|Overall Study|Not Treated|0|||
25202235|NCT00552617|50430866|FG007|Overall Study|Not Treated|0|||
25202236|NCT00552617|50430867|FG008|Overall Study|Not Treated|0|||
25202237|NCT00552617|50430868|FG009|Overall Study|Not Treated|1|||
25202238|NCT00552617|50430859|FG000|Overall Study|Lost to Follow-up|0|||
25202239|NCT00552617|50430860|FG001|Overall Study|Lost to Follow-up|0|||
25202240|NCT00552617|50430861|FG002|Overall Study|Lost to Follow-up|0|||
25202241|NCT00552617|50430862|FG003|Overall Study|Lost to Follow-up|1|||
25202242|NCT00552617|50430863|FG004|Overall Study|Lost to Follow-up|0|||
25171334|NCT00983619|50308221|FG011|Overall Study|Death|8|||
25171335|NCT00983619|50308210|FG000|Overall Study|Other|1|||
25202243|NCT00552617|50430864|FG005|Overall Study|Lost to Follow-up|2|||
25202244|NCT00552617|50430865|FG006|Overall Study|Lost to Follow-up|0|||
25202245|NCT00552617|50430866|FG007|Overall Study|Lost to Follow-up|0|||
25202246|NCT00552617|50430867|FG008|Overall Study|Lost to Follow-up|2|||
25202247|NCT00552617|50430868|FG009|Overall Study|Lost to Follow-up|0|||
25202248|NCT02421120|50430890|FG000|Overall Study|Adverse Event|1|||
25202249|NCT02420262|50430896|FG000|Overall Study|Adverse Event|1|||
25202250|NCT02420262|50430897|FG001|Overall Study|Adverse Event|0|||
25202251|NCT02420262|50430896|FG000|Overall Study|Withdrawal by Subject|1|||
25202252|NCT02420262|50430897|FG001|Overall Study|Withdrawal by Subject|4|||
25202253|NCT02420262|50430896|FG000|Overall Study|Unclassified|0|||
25202254|NCT02420262|50430897|FG001|Overall Study|Unclassified|1|||
25202255|NCT00552305|50430903|FG000|Overall Study|Adverse Event|43|||
25202256|NCT00552305|50430903|FG000|Overall Study|Lack of Efficacy|120|||
25202257|NCT00552305|50430903|FG000|Overall Study|Lost to Follow-up|4|||
25202258|NCT00552305|50430903|FG000|Overall Study|Protocol Violation|3|||
25202259|NCT00552305|50430903|FG000|Overall Study|Withdrawal by Subject|44|||
25202260|NCT00552305|50430903|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
25202261|NCT00552305|50430903|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
25202262|NCT00552305|50430903|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
25202263|NCT00552305|50430903|FG000|Overall Study|Unsatisfactory compliance|11|||
25202264|NCT00552305|50430903|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
25202265|NCT00552305|50430903|FG000|Overall Study|AE/Other: prohibited drug required|1|||
25202266|NCT00552305|50430903|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
25202267|NCT00552305|50430903|FG000|Overall Study|Other: Site closed|4|||
25202268|NCT00552305|50430903|FG000|Overall Study|Other: Personal problems|1|||
25202269|NCT00552305|50430903|FG000|Overall Study|Other: Unable to attend visits|1|||
25202270|NCT00552305|50430903|FG000|Overall Study|Other: Subject underwent surgery|4|||
25202271|NCT00552305|50430903|FG000|Overall Study|Other: Subject became pregnant|1|||
25202272|NCT00552305|50430903|FG000|Overall Study|Other: Health problems, not drug related|1|||
25202273|NCT00552305|50430903|FG000|Overall Study|Other: Subject moved from area|2|||
25202274|NCT00552305|50430903|FG000|Overall Study|Other: Subject incarcerated|1|||
25202275|NCT00552305|50430903|FG000|Overall Study|Other: Subject went to rehab|1|||
25202276|NCT00552071|50430929|FG000|Overall Study|Adverse Event|1|||
25202277|NCT00552071|50430930|FG001|Overall Study|Adverse Event|0|||
25202278|NCT00552071|50430929|FG000|Overall Study|Lack of Efficacy|1|||
25202279|NCT00552071|50430930|FG001|Overall Study|Lack of Efficacy|0|||
25202280|NCT00552071|50430929|FG000|Overall Study|Physician Decision|1|||
25202281|NCT00552071|50430930|FG001|Overall Study|Physician Decision|0|||
25202282|NCT00552071|50430929|FG000|Overall Study|Pregnancy|1|||
25202283|NCT00552071|50430930|FG001|Overall Study|Pregnancy|0|||
25202284|NCT00552071|50430929|FG000|Overall Study|Death|0|||
25202285|NCT00552071|50430930|FG001|Overall Study|Death|1|||
25202286|NCT00552071|50430929|FG000|Overall Study|Withdrawal by Subject|0|||
25202287|NCT00552071|50430930|FG001|Overall Study|Withdrawal by Subject|1|||
25202288|NCT00551759|50430938|FG000|Overall Study|Adverse Event|7|||
25202289|NCT00551759|50430938|FG000|Overall Study|Death|5|||
25202290|NCT00551759|50430938|FG000|Overall Study|Ineligible|1|||
25202291|NCT00551525|50430942|FG000|Overall Study|Protocol Violation|5|||
25202292|NCT02370498|50430969|FG000|Overall Study|Adverse Event|10|||
25202293|NCT02370498|50430970|FG001|Overall Study|Adverse Event|8|||
25202294|NCT02370498|50430969|FG000|Overall Study|Death|263|||
25202295|NCT02370498|50430970|FG001|Overall Study|Death|265|||
25202296|NCT02370498|50430969|FG000|Overall Study|Protocol Violation|1|||
25202297|NCT02370498|50430970|FG001|Overall Study|Protocol Violation|2|||
25202298|NCT02370498|50430969|FG000|Overall Study|Withdrawal by Subject|7|||
25202299|NCT02370498|50430970|FG001|Overall Study|Withdrawal by Subject|12|||
25202300|NCT02370498|50430969|FG000|Overall Study|Sponsor's decision|15|||
25202301|NCT02370498|50430970|FG001|Overall Study|Sponsor's decision|9|||
25202302|NCT02347332|50430995|FG000|Overall Study|Not treated|5|||
25202303|NCT02347332|50430996|FG001|Overall Study|Not treated|2|||
25202304|NCT02347332|50430995|FG000|Overall Study|Progressive disease|141|||
25202305|NCT02347332|50430996|FG001|Overall Study|Progressive disease|159|||
25202306|NCT02347332|50430995|FG000|Overall Study|Adverse Event|50|||
25202307|NCT02347332|50430996|FG001|Overall Study|Adverse Event|41|||
25202308|NCT02347332|50430995|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
25202309|NCT02347332|50430996|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
25202310|NCT02347332|50430995|FG000|Overall Study|Protocol Violation|1|||
25315856|NCT00896532|50631604|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
25315857|NCT00896532|50631605|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
25202311|NCT02347332|50430996|FG001|Overall Study|Protocol Violation|1|||
25202312|NCT02347332|50430995|FG000|Overall Study|Lost to Follow-up|2|||
25202313|NCT02347332|50430996|FG001|Overall Study|Lost to Follow-up|1|||
25202314|NCT02347332|50430995|FG000|Overall Study|Physician Decision|4|||
25202315|NCT02347332|50430996|FG001|Overall Study|Physician Decision|3|||
25202316|NCT02347332|50430995|FG000|Overall Study|Withdrawal by Subject|20|||
25202317|NCT02347332|50430996|FG001|Overall Study|Withdrawal by Subject|14|||
25202318|NCT02347332|50430995|FG000|Overall Study|Protocol requirement|1|||
25202319|NCT02347332|50430996|FG001|Overall Study|Protocol requirement|1|||
25202320|NCT02347332|50430995|FG000|Overall Study|Switch Post-Trial program|0|||
25202321|NCT02347332|50430996|FG001|Overall Study|Switch Post-Trial program|1|||
25202322|NCT02347176|50431019|FG000|Overall Study|Lost to Follow-up|2|||
25202323|NCT02347176|50431020|FG001|Overall Study|Lost to Follow-up|3|||
25202324|NCT02347176|50431021|FG002|Overall Study|Lost to Follow-up|1|||
25202325|NCT02347176|50431022|FG003|Overall Study|Lost to Follow-up|1|||
25202326|NCT02347176|50431019|FG000|Overall Study|Withdrawal by Subject|9|||
25202327|NCT02347176|50431020|FG001|Overall Study|Withdrawal by Subject|5|||
25202328|NCT02347176|50431021|FG002|Overall Study|Withdrawal by Subject|5|||
25202329|NCT02347176|50431022|FG003|Overall Study|Withdrawal by Subject|3|||
25202330|NCT02347176|50431019|FG000|Overall Study|Other|1|||
25202331|NCT02347176|50431020|FG001|Overall Study|Other|2|||
25202332|NCT02347176|50431021|FG002|Overall Study|Other|2|||
25202333|NCT02347176|50431022|FG003|Overall Study|Other|0|||
25202334|NCT02370420|50431034|FG000|Overall Study|Physician Decision|3|||
25202335|NCT02370420|50431035|FG001|Overall Study|Physician Decision|3|||
25202336|NCT02370420|50431034|FG000|Overall Study|Lost to Follow-up|11|||
25202337|NCT02370420|50431035|FG001|Overall Study|Lost to Follow-up|9|||
25202338|NCT02347098|50431057|FG000|Overall Study|Death|1|||
25202339|NCT02347098|50431058|FG001|Overall Study|Death|0|||
25202340|NCT02347098|50431057|FG000|Overall Study|Withdrawal by Subject|1|||
25202341|NCT02347098|50431058|FG001|Overall Study|Withdrawal by Subject|0|||
25202342|NCT02347098|50431057|FG000|Overall Study|Lost to Follow-up|2|||
25202343|NCT02347098|50431058|FG001|Overall Study|Lost to Follow-up|2|||
25202344|NCT02347098|50431057|FG000|Overall Study|Refuse Follow-up Visit|1|||
25202345|NCT02347098|50431058|FG001|Overall Study|Refuse Follow-up Visit|5|||
25202346|NCT02347098|50431057|FG000|Overall Study|no visit due to illness|2|||
25202347|NCT02347098|50431058|FG001|Overall Study|no visit due to illness|1|||
25202348|NCT02346708|50431075|FG000|Overall Study|Adverse Event|2|||
25202349|NCT02346708|50431076|FG001|Overall Study|Adverse Event|0|||
25202350|NCT02346708|50431075|FG000|Overall Study|Protocol Violation|0|||
25202351|NCT02346708|50431076|FG001|Overall Study|Protocol Violation|1|||
25202352|NCT02346240|50431566|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202353|NCT02346240|50431567|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
25202354|NCT02346240|50431568|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
25202355|NCT02346240|50431569|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
25202356|NCT02346240|50431570|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202357|NCT02346240|50431571|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202358|NCT02346240|50431572|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202359|NCT02346240|50431573|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202360|NCT02346240|50431574|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202361|NCT02346240|50431575|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202362|NCT02346240|50431576|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202363|NCT02346240|50431577|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202364|NCT02346240|50431578|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202365|NCT02346240|50431579|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202366|NCT02346240|50431580|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202367|NCT02346240|50431581|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202368|NCT02346240|50431582|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202369|NCT02346240|50431583|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202370|NCT02346240|50431584|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202371|NCT02346240|50431585|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202372|NCT02346240|50431586|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202373|NCT02346240|50431587|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202374|NCT02346240|50431588|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202375|NCT02346240|50431589|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
25202376|NCT02346240|50431566|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202377|NCT02346240|50431567|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
25202378|NCT02346240|50431568|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202379|NCT02346240|50431569|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202380|NCT02346240|50431570|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202381|NCT02346240|50431571|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202382|NCT02346240|50431572|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202383|NCT02346240|50431573|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202384|NCT02346240|50431574|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202385|NCT02346240|50431575|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202386|NCT02346240|50431576|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202387|NCT02346240|50431577|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202388|NCT02346240|50431578|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202389|NCT02346240|50431579|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202390|NCT02346240|50431580|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202391|NCT02346240|50431581|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202392|NCT02346240|50431582|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202393|NCT02346240|50431583|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202394|NCT02346240|50431584|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202395|NCT02346240|50431585|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202396|NCT02346240|50431586|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202397|NCT02346240|50431587|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202398|NCT02346240|50431588|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202399|NCT02346240|50431589|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
25202400|NCT02346240|50431566|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202401|NCT02346240|50431567|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
25202402|NCT02346240|50431568|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202403|NCT02346240|50431569|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202404|NCT02346240|50431570|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202405|NCT02346240|50431571|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202406|NCT02346240|50431572|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202407|NCT02346240|50431573|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202408|NCT02346240|50431574|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202409|NCT02346240|50431575|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202410|NCT02346240|50431576|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202411|NCT02346240|50431577|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202412|NCT02346240|50431578|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202413|NCT02346240|50431579|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202414|NCT02346240|50431580|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202415|NCT02346240|50431581|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202416|NCT02346240|50431582|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202417|NCT02346240|50431583|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202418|NCT02346240|50431584|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202419|NCT02346240|50431585|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202420|NCT02346240|50431586|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202421|NCT02346240|50431587|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202422|NCT02346240|50431588|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202423|NCT02346240|50431589|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
25202424|NCT02346240|50431566|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
25202425|NCT02346240|50431567|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
25202426|NCT02346240|50431568|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
25202427|NCT02346240|50431569|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
25202428|NCT02346240|50431570|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202429|NCT02346240|50431571|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202430|NCT02346240|50431572|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202431|NCT02346240|50431573|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202432|NCT02346240|50431574|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202433|NCT02346240|50431575|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202434|NCT02346240|50431576|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202435|NCT02346240|50431577|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202436|NCT02346240|50431578|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202437|NCT02346240|50431579|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202438|NCT02346240|50431580|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202439|NCT02346240|50431581|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202440|NCT02346240|50431582|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202441|NCT02346240|50431583|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202442|NCT02346240|50431584|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202443|NCT02346240|50431585|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202444|NCT02346240|50431586|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202445|NCT02346240|50431587|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202446|NCT02346240|50431588|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202447|NCT02346240|50431589|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
25202448|NCT02346240|50431566|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
25202449|NCT02346240|50431567|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
25202450|NCT02346240|50431568|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
25202451|NCT02346240|50431569|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
25202452|NCT02346240|50431570|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25315858|NCT00896532|50631606|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
25202453|NCT02346240|50431571|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202454|NCT02346240|50431572|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202455|NCT02346240|50431573|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202456|NCT02346240|50431574|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202457|NCT02346240|50431575|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202458|NCT02346240|50431576|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202459|NCT02346240|50431577|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202460|NCT02346240|50431578|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202461|NCT02346240|50431579|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202462|NCT02346240|50431580|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202463|NCT02346240|50431581|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202464|NCT02346240|50431582|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202465|NCT02346240|50431583|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202466|NCT02346240|50431584|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25315859|NCT00896532|50631607|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
25315860|NCT00896532|50631608|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
25315861|NCT00896532|50631609|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
25315862|NCT00896532|50631610|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
25315863|NCT00896532|50631588|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315864|NCT00896532|50631589|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315865|NCT00896532|50631590|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
25315866|NCT00896532|50631591|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315867|NCT00896532|50631592|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
25315868|NCT00896532|50631593|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315869|NCT00896532|50631594|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315870|NCT00896532|50631595|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315871|NCT00896532|50631596|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315872|NCT00896532|50631597|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315873|NCT00896532|50631598|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315874|NCT00896532|50631599|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315875|NCT00896532|50631600|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315876|NCT00896532|50631601|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315877|NCT00896532|50631602|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315878|NCT00896532|50631603|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315879|NCT00896532|50631604|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315880|NCT00896532|50631605|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315881|NCT00896532|50631606|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315882|NCT00896532|50631607|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315883|NCT00896532|50631608|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315884|NCT00896532|50631609|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315885|NCT00896532|50631610|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
25315886|NCT00896532|50631588|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
25315887|NCT00896532|50631589|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315888|NCT00896532|50631590|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315889|NCT00896532|50631591|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
25315890|NCT00896532|50631592|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315891|NCT00896532|50631593|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315892|NCT00896532|50631594|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315893|NCT00896532|50631595|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25171336|NCT00983619|50308211|FG001|Overall Study|Other|0|||
25171337|NCT00983619|50308212|FG002|Overall Study|Other|0|||
25171338|NCT00983619|50308213|FG003|Overall Study|Other|1|||
25171339|NCT00983619|50308214|FG004|Overall Study|Other|0|||
25171340|NCT00983619|50308215|FG005|Overall Study|Other|12|||
25171341|NCT00983619|50308216|FG006|Overall Study|Other|2|||
25171342|NCT00983619|50308217|FG007|Overall Study|Other|2|||
25171343|NCT00983619|50308218|FG008|Overall Study|Other|0|||
25171344|NCT00983619|50308219|FG009|Overall Study|Other|1|||
25171345|NCT00983619|50308220|FG010|Overall Study|Other|1|||
25171346|NCT00983619|50308221|FG011|Overall Study|Other|0|||
25171347|NCT00653068|50308271|FG000|Overall Study|Death|9|||
25171348|NCT00653068|50308271|FG000|Overall Study|Lack of Efficacy|34|||
25171349|NCT00653068|50308271|FG000|Overall Study|Physician Decision|4|||
25171350|NCT00653068|50308271|FG000|Overall Study|Withdrawal by Subject|1|||
25171351|NCT00653068|50308271|FG000|Overall Study|Ineligible|2|||
25171352|NCT01767857|50308280|FG000|Overall Study|Adverse Event|27|||
25202467|NCT02346240|50431585|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202468|NCT02346240|50431586|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202469|NCT02346240|50431587|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202470|NCT02346240|50431588|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202471|NCT02346240|50431589|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
25202472|NCT02346240|50431566|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202473|NCT02346240|50431567|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
25202474|NCT02346240|50431568|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202475|NCT02346240|50431569|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
25202476|NCT02346240|50431570|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202477|NCT02346240|50431571|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202478|NCT02346240|50431572|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202479|NCT02346240|50431573|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202480|NCT02346240|50431574|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202481|NCT02346240|50431575|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202482|NCT02346240|50431576|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202483|NCT02346240|50431577|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202484|NCT02346240|50431578|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202485|NCT02346240|50431579|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202486|NCT02346240|50431580|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202487|NCT02346240|50431581|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202488|NCT02346240|50431582|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202489|NCT02346240|50431583|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202490|NCT02346240|50431584|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202491|NCT02346240|50431585|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202492|NCT02346240|50431586|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202493|NCT02346240|50431587|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202494|NCT02346240|50431588|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202495|NCT02346240|50431589|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
25202496|NCT02346240|50431566|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202497|NCT02346240|50431567|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202498|NCT02346240|50431568|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
25202499|NCT02346240|50431569|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202500|NCT02346240|50431570|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202501|NCT02346240|50431571|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202502|NCT02346240|50431572|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202503|NCT02346240|50431573|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202504|NCT02346240|50431574|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202505|NCT02346240|50431575|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202506|NCT02346240|50431576|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202507|NCT02346240|50431577|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202508|NCT02346240|50431578|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202509|NCT02346240|50431579|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202510|NCT02346240|50431580|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202511|NCT02346240|50431581|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202512|NCT02346240|50431582|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202513|NCT02346240|50431583|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202514|NCT02346240|50431584|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202515|NCT02346240|50431585|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202516|NCT02346240|50431586|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202517|NCT02346240|50431587|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202518|NCT02346240|50431588|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202519|NCT02346240|50431589|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
25202520|NCT02346240|50431566|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202521|NCT02346240|50431567|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202522|NCT02346240|50431568|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202523|NCT02346240|50431569|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202524|NCT02346240|50431570|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202525|NCT02346240|50431571|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202526|NCT02346240|50431572|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202527|NCT02346240|50431573|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
25202528|NCT02346240|50431574|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
25202529|NCT02346240|50431575|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202530|NCT02346240|50431576|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202531|NCT02346240|50431577|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202532|NCT02346240|50431578|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202533|NCT02346240|50431579|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
25202534|NCT02346240|50431580|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
25202535|NCT02346240|50431581|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
25202536|NCT02346240|50431582|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
25202537|NCT02346240|50431583|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202538|NCT02346240|50431584|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202539|NCT02346240|50431585|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202540|NCT02346240|50431586|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202541|NCT02346240|50431587|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202542|NCT02346240|50431588|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202543|NCT02346240|50431589|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25202544|NCT02346240|50431566|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202545|NCT02346240|50431567|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202546|NCT02346240|50431568|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202547|NCT02346240|50431569|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202548|NCT02346240|50431570|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202549|NCT02346240|50431571|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202550|NCT02346240|50431572|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202551|NCT02346240|50431573|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202552|NCT02346240|50431574|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202553|NCT02346240|50431575|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202554|NCT02346240|50431576|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202555|NCT02346240|50431577|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202556|NCT02346240|50431578|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202557|NCT02346240|50431579|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
25202558|NCT02346240|50431580|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202559|NCT02346240|50431581|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
25171353|NCT01767857|50308281|FG001|Overall Study|Adverse Event|7|||
25171354|NCT01767857|50308280|FG000|Overall Study|Death|28|||
25171355|NCT01767857|50308281|FG001|Overall Study|Death|13|||
25171356|NCT01767857|50308280|FG000|Overall Study|Lack of Efficacy|299|||
25171357|NCT01767857|50308281|FG001|Overall Study|Lack of Efficacy|151|||
25171358|NCT01767857|50308280|FG000|Overall Study|Lost to Follow-up|1|||
25171359|NCT01767857|50308281|FG001|Overall Study|Lost to Follow-up|1|||
25171360|NCT01767857|50308280|FG000|Overall Study|Withdrawal by Subject|38|||
25171361|NCT01767857|50308281|FG001|Overall Study|Withdrawal by Subject|18|||
25171362|NCT01767857|50308280|FG000|Overall Study|Physician Decision|17|||
25171363|NCT01767857|50308281|FG001|Overall Study|Physician Decision|10|||
25171364|NCT01767857|50308280|FG000|Overall Study|Protocol Terminated|1|||
25171365|NCT01767857|50308281|FG001|Overall Study|Protocol Terminated|0|||
25171366|NCT01767857|50308280|FG000|Overall Study|Randomized But Never Treated|19|||
25171367|NCT01767857|50308281|FG001|Overall Study|Randomized But Never Treated|13|||
25171368|NCT01775501|50308288|FG000|Overall Study|Discontinued prior to treatment|1|||
25171369|NCT01775189|50308317|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
25171370|NCT01775189|50308318|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
25171371|NCT01775189|50308319|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
25171372|NCT01775189|50308320|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
25202560|NCT02346240|50431582|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202561|NCT02346240|50431583|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25077106|NCT02439320|50184949|FG001|Overall Study|Noncompliance with Protocol|11|||
25171373|NCT01775189|50308321|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
25171374|NCT01775189|50308322|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
25171375|NCT01775189|50308323|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
25171376|NCT01775189|50308317|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
25202562|NCT02346240|50431584|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202563|NCT02346240|50431585|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202564|NCT02346240|50431586|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202565|NCT02346240|50431587|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202566|NCT02346240|50431588|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202567|NCT02346240|50431589|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25202568|NCT02346240|50431566|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202569|NCT02346240|50431567|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202570|NCT02346240|50431568|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202571|NCT02346240|50431569|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202572|NCT02346240|50431570|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202573|NCT02346240|50431571|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202574|NCT02346240|50431572|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202575|NCT02346240|50431573|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202576|NCT02346240|50431574|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202577|NCT02346240|50431575|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202578|NCT02346240|50431576|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202579|NCT02346240|50431577|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202580|NCT02346240|50431578|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202581|NCT02346240|50431579|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202582|NCT02346240|50431580|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
25202583|NCT02346240|50431581|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202584|NCT02346240|50431582|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202585|NCT02346240|50431583|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202586|NCT02346240|50431584|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202587|NCT02346240|50431585|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202588|NCT02346240|50431586|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202589|NCT02346240|50431587|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202590|NCT02346240|50431588|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202591|NCT02346240|50431589|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25202592|NCT02346240|50431566|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25202593|NCT02346240|50431567|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25202594|NCT02346240|50431568|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25202595|NCT02346240|50431569|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25202596|NCT02346240|50431570|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25202597|NCT02346240|50431571|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
25202598|NCT02346240|50431572|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
25202599|NCT02346240|50431573|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
25202600|NCT02346240|50431574|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
25202601|NCT02346240|50431575|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25202602|NCT02346240|50431576|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
25202603|NCT02346240|50431577|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
25202604|NCT02346240|50431578|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25202605|NCT02346240|50431579|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
25202606|NCT02346240|50431580|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
25202607|NCT02346240|50431581|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
25202608|NCT02346240|50431582|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
25202609|NCT02346240|50431583|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25202610|NCT02346240|50431584|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25202611|NCT02346240|50431585|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25202612|NCT02346240|50431586|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25202613|NCT02346240|50431587|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25202614|NCT02346240|50431588|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25202615|NCT02346240|50431589|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25202616|NCT02346240|50431566|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202617|NCT02346240|50431567|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25171377|NCT01775189|50308318|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
25171378|NCT01775189|50308319|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
25171379|NCT01775189|50308320|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
25171380|NCT01775189|50308321|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
25171381|NCT01775189|50308322|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
25171382|NCT01775189|50308323|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
25171383|NCT01775189|50308317|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
25202618|NCT02346240|50431568|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202619|NCT02346240|50431569|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202620|NCT02346240|50431570|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202621|NCT02346240|50431571|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202622|NCT02346240|50431572|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202623|NCT02346240|50431573|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202624|NCT02346240|50431574|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202625|NCT02346240|50431575|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202626|NCT02346240|50431576|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202627|NCT02346240|50431577|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202628|NCT02346240|50431578|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202629|NCT02346240|50431579|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
25202630|NCT02346240|50431580|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
25202631|NCT02346240|50431581|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
25202632|NCT02346240|50431582|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
25202633|NCT02346240|50431583|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202634|NCT02346240|50431584|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202635|NCT02346240|50431585|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202636|NCT02346240|50431586|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202637|NCT02346240|50431587|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202638|NCT02346240|50431588|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202639|NCT02346240|50431589|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25202640|NCT02346240|50431566|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202641|NCT02346240|50431567|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202642|NCT02346240|50431568|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202643|NCT02346240|50431569|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202644|NCT02346240|50431570|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202645|NCT02346240|50431571|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202646|NCT02346240|50431572|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
25202647|NCT02346240|50431573|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202648|NCT02346240|50431574|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202649|NCT02346240|50431575|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202650|NCT02346240|50431576|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202651|NCT02346240|50431577|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202652|NCT02346240|50431578|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202653|NCT02346240|50431579|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202654|NCT02346240|50431580|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202655|NCT02346240|50431581|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202656|NCT02346240|50431582|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202657|NCT02346240|50431583|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202658|NCT02346240|50431584|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202659|NCT02346240|50431585|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202660|NCT02346240|50431586|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202661|NCT02346240|50431587|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202662|NCT02346240|50431588|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202663|NCT02346240|50431589|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
25202664|NCT02346240|50431566|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202665|NCT02346240|50431567|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202666|NCT02346240|50431568|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202667|NCT02346240|50431569|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202668|NCT02346240|50431570|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202669|NCT02346240|50431571|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202670|NCT02346240|50431572|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202671|NCT02346240|50431573|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202672|NCT02346240|50431574|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
25202673|NCT02346240|50431575|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202674|NCT02346240|50431576|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202675|NCT02346240|50431577|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
25202676|NCT02346240|50431578|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202677|NCT02346240|50431579|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
25202678|NCT02346240|50431580|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
25202679|NCT02346240|50431581|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202680|NCT02346240|50431582|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202681|NCT02346240|50431583|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202682|NCT02346240|50431584|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202683|NCT02346240|50431585|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202684|NCT02346240|50431586|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202685|NCT02346240|50431587|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202686|NCT02346240|50431588|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202687|NCT02346240|50431589|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
25202688|NCT02346240|50431566|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202689|NCT02346240|50431567|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202690|NCT02346240|50431568|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202691|NCT02346240|50431569|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202692|NCT02346240|50431570|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202693|NCT02346240|50431571|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202694|NCT02346240|50431572|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202695|NCT02346240|50431573|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202696|NCT02346240|50431574|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202697|NCT02346240|50431575|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
25202698|NCT02346240|50431576|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202699|NCT02346240|50431577|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202700|NCT02346240|50431578|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202701|NCT02346240|50431579|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202702|NCT02346240|50431580|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202703|NCT02346240|50431581|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202704|NCT02346240|50431582|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202705|NCT02346240|50431583|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202706|NCT02346240|50431584|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202707|NCT02346240|50431585|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202708|NCT02346240|50431586|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202709|NCT02346240|50431587|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202710|NCT02346240|50431588|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202711|NCT02346240|50431589|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
25202712|NCT02346240|50431566|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202713|NCT02346240|50431567|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202714|NCT02346240|50431568|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202715|NCT02346240|50431569|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202716|NCT02346240|50431570|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202717|NCT02346240|50431571|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202718|NCT02346240|50431572|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202719|NCT02346240|50431573|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202720|NCT02346240|50431574|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202721|NCT02346240|50431575|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202722|NCT02346240|50431576|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
25202723|NCT02346240|50431577|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202724|NCT02346240|50431578|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202725|NCT02346240|50431579|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202726|NCT02346240|50431580|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202727|NCT02346240|50431581|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202728|NCT02346240|50431582|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202729|NCT02346240|50431583|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202730|NCT02346240|50431584|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202731|NCT02346240|50431585|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202732|NCT02346240|50431586|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202733|NCT02346240|50431587|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202734|NCT02346240|50431588|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202735|NCT02346240|50431589|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
25202736|NCT02346240|50431566|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202737|NCT02346240|50431567|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202738|NCT02346240|50431568|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202739|NCT02346240|50431569|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202740|NCT02346240|50431570|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202741|NCT02346240|50431571|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202742|NCT02346240|50431572|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202743|NCT02346240|50431573|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202744|NCT02346240|50431574|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202745|NCT02346240|50431575|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202746|NCT02346240|50431576|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202747|NCT02346240|50431577|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202748|NCT02346240|50431578|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202749|NCT02346240|50431579|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202750|NCT02346240|50431580|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
25202751|NCT02346240|50431581|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202752|NCT02346240|50431582|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202753|NCT02346240|50431583|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202754|NCT02346240|50431584|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202755|NCT02346240|50431585|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202756|NCT02346240|50431586|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202757|NCT02346240|50431587|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202758|NCT02346240|50431588|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202759|NCT02346240|50431589|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
25202760|NCT02346240|50431566|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202761|NCT02346240|50431567|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202762|NCT02346240|50431568|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202763|NCT02346240|50431569|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202764|NCT02346240|50431570|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202765|NCT02346240|50431571|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202766|NCT02346240|50431572|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202767|NCT02346240|50431573|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202768|NCT02346240|50431574|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202769|NCT02346240|50431575|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202770|NCT02346240|50431576|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202771|NCT02346240|50431577|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202772|NCT02346240|50431578|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202773|NCT02346240|50431579|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202774|NCT02346240|50431580|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
25202775|NCT02346240|50431581|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202776|NCT02346240|50431582|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202777|NCT02346240|50431583|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202778|NCT02346240|50431584|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202779|NCT02346240|50431585|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202780|NCT02346240|50431586|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202781|NCT02346240|50431587|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202782|NCT02346240|50431588|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202783|NCT02346240|50431589|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
25202784|NCT02346240|50431566|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202785|NCT02346240|50431567|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202786|NCT02346240|50431568|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202787|NCT02346240|50431569|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202788|NCT02346240|50431570|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202789|NCT02346240|50431571|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202790|NCT02346240|50431572|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202791|NCT02346240|50431573|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25315894|NCT00896532|50631596|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25202792|NCT02346240|50431574|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202793|NCT02346240|50431575|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202794|NCT02346240|50431576|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202795|NCT02346240|50431577|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202796|NCT02346240|50431578|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202797|NCT02346240|50431579|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202798|NCT02346240|50431580|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
25202799|NCT02346240|50431581|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202800|NCT02346240|50431582|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202801|NCT02346240|50431583|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202802|NCT02346240|50431584|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202803|NCT02346240|50431585|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202804|NCT02346240|50431586|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202805|NCT02346240|50431587|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202806|NCT02346240|50431588|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202807|NCT02346240|50431589|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
25202808|NCT02346240|50431566|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
25202809|NCT02346240|50431567|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
25202810|NCT02346240|50431568|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
25202811|NCT02346240|50431569|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
25202812|NCT02346240|50431570|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
25202813|NCT02346240|50431571|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
25202814|NCT02346240|50431572|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
25202815|NCT02346240|50431573|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
25202816|NCT02346240|50431574|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
25202817|NCT02346240|50431575|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
25202818|NCT02346240|50431576|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
25202819|NCT02346240|50431577|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
25202820|NCT02346240|50431578|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
25202821|NCT02346240|50431579|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
25202822|NCT02346240|50431580|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
25202823|NCT02346240|50431581|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
25202824|NCT02346240|50431582|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
25202825|NCT02346240|50431583|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
25202826|NCT02346240|50431584|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
25202827|NCT02346240|50431585|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
25202828|NCT02346240|50431586|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
25202829|NCT02346240|50431587|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
25202830|NCT02346240|50431588|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
25202831|NCT02346240|50431589|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
25202832|NCT02346240|50431566|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202833|NCT02346240|50431567|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202834|NCT02346240|50431568|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202835|NCT02346240|50431569|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202836|NCT02346240|50431570|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202837|NCT02346240|50431571|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202838|NCT02346240|50431572|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202839|NCT02346240|50431573|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202840|NCT02346240|50431574|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202841|NCT02346240|50431575|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202842|NCT02346240|50431576|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202843|NCT02346240|50431577|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202844|NCT02346240|50431578|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202845|NCT02346240|50431579|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202846|NCT02346240|50431580|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202847|NCT02346240|50431581|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202848|NCT02346240|50431582|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202849|NCT02346240|50431583|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202850|NCT02346240|50431584|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
25202851|NCT02346240|50431585|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
25202852|NCT02346240|50431586|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202853|NCT02346240|50431587|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
25202854|NCT02346240|50431588|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202855|NCT02346240|50431589|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
25202856|NCT02346240|50431566|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202857|NCT02346240|50431567|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202858|NCT02346240|50431568|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202859|NCT02346240|50431569|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202860|NCT02346240|50431570|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202861|NCT02346240|50431571|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202862|NCT02346240|50431572|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202863|NCT02346240|50431573|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202864|NCT02346240|50431574|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202865|NCT02346240|50431575|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202866|NCT02346240|50431576|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202867|NCT02346240|50431577|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202868|NCT02346240|50431578|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202869|NCT02346240|50431579|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202870|NCT02346240|50431580|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202871|NCT02346240|50431581|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202872|NCT02346240|50431582|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202873|NCT02346240|50431583|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202874|NCT02346240|50431584|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
25202875|NCT02346240|50431585|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202876|NCT02346240|50431586|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202877|NCT02346240|50431587|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
25202878|NCT02346240|50431588|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202879|NCT02346240|50431589|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25202880|NCT02346240|50431566|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202881|NCT02346240|50431567|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202882|NCT02346240|50431568|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202883|NCT02346240|50431569|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202884|NCT02346240|50431570|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202885|NCT02346240|50431571|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202886|NCT02346240|50431572|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202887|NCT02346240|50431573|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202888|NCT02346240|50431574|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202889|NCT02346240|50431575|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202890|NCT02346240|50431576|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202891|NCT02346240|50431577|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202892|NCT02346240|50431578|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202893|NCT02346240|50431579|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202894|NCT02346240|50431580|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202895|NCT02346240|50431581|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25315895|NCT00896532|50631597|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315896|NCT00896532|50631598|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315897|NCT00896532|50631599|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315898|NCT00896532|50631600|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315899|NCT00896532|50631601|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315900|NCT00896532|50631602|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315901|NCT00896532|50631603|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315902|NCT00896532|50631604|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315903|NCT00896532|50631605|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315904|NCT00896532|50631606|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315905|NCT00896532|50631607|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315906|NCT00896532|50631608|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315907|NCT00896532|50631609|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315908|NCT00896532|50631610|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
25315909|NCT00896532|50631588|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315910|NCT00896532|50631589|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315911|NCT00896532|50631590|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
25315912|NCT00896532|50631591|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315913|NCT00896532|50631592|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315914|NCT00896532|50631593|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315915|NCT00896532|50631594|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25202896|NCT02346240|50431582|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202897|NCT02346240|50431583|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202898|NCT02346240|50431584|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202899|NCT02346240|50431585|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202900|NCT02346240|50431586|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202901|NCT02346240|50431587|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
25202902|NCT02346240|50431588|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202903|NCT02346240|50431589|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
25202904|NCT02346240|50431566|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202905|NCT02346240|50431567|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202906|NCT02346240|50431568|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202907|NCT02346240|50431569|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202908|NCT02346240|50431570|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202909|NCT02346240|50431571|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202910|NCT02346240|50431572|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202911|NCT02346240|50431573|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202912|NCT02346240|50431574|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202913|NCT02346240|50431575|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202914|NCT02346240|50431576|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202915|NCT02346240|50431577|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202916|NCT02346240|50431578|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202917|NCT02346240|50431579|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202918|NCT02346240|50431580|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202919|NCT02346240|50431581|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202920|NCT02346240|50431582|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202921|NCT02346240|50431583|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
25202922|NCT02346240|50431584|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
25202923|NCT02346240|50431585|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
25202924|NCT02346240|50431586|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25202925|NCT02346240|50431587|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
25202926|NCT02346240|50431588|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
25202927|NCT02346240|50431589|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
25202928|NCT02346240|50431566|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202929|NCT02346240|50431567|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202930|NCT02346240|50431568|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202931|NCT02346240|50431569|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202932|NCT02346240|50431570|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202933|NCT02346240|50431571|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202934|NCT02346240|50431572|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202935|NCT02346240|50431573|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202936|NCT02346240|50431574|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202937|NCT02346240|50431575|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202938|NCT02346240|50431576|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202939|NCT02346240|50431577|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202940|NCT02346240|50431578|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202941|NCT02346240|50431579|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202942|NCT02346240|50431580|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202943|NCT02346240|50431581|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202944|NCT02346240|50431582|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202945|NCT02346240|50431583|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202946|NCT02346240|50431584|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
25202947|NCT02346240|50431585|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
25202948|NCT02346240|50431586|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25202949|NCT02346240|50431587|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
25202950|NCT02346240|50431588|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
25202951|NCT02346240|50431589|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
25202952|NCT02346240|50431566|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202953|NCT02346240|50431567|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202954|NCT02346240|50431568|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202955|NCT02346240|50431569|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202956|NCT02346240|50431570|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202957|NCT02346240|50431571|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202958|NCT02346240|50431572|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202959|NCT02346240|50431573|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202960|NCT02346240|50431574|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202961|NCT02346240|50431575|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202962|NCT02346240|50431576|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202963|NCT02346240|50431577|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202964|NCT02346240|50431578|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202965|NCT02346240|50431579|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202966|NCT02346240|50431580|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202967|NCT02346240|50431581|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202968|NCT02346240|50431582|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202969|NCT02346240|50431583|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202970|NCT02346240|50431584|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
25202971|NCT02346240|50431585|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202972|NCT02346240|50431586|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
25202973|NCT02346240|50431587|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
25202974|NCT02346240|50431588|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
25202975|NCT02346240|50431589|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
25202976|NCT02346240|50431566|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202977|NCT02346240|50431567|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202978|NCT02346240|50431568|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202979|NCT02346240|50431569|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202980|NCT02346240|50431570|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202981|NCT02346240|50431571|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202982|NCT02346240|50431572|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202983|NCT02346240|50431573|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202984|NCT02346240|50431574|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202985|NCT02346240|50431575|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202986|NCT02346240|50431576|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202987|NCT02346240|50431577|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202988|NCT02346240|50431578|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202989|NCT02346240|50431579|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202990|NCT02346240|50431580|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202991|NCT02346240|50431581|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202992|NCT02346240|50431582|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202993|NCT02346240|50431583|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202994|NCT02346240|50431584|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
25202995|NCT02346240|50431585|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202996|NCT02346240|50431586|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202997|NCT02346240|50431587|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202998|NCT02346240|50431588|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25202999|NCT02346240|50431589|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
25203000|NCT02392104|50431640|FG000|Overall Study|discontinuation of warfarin|3|||
25203001|NCT02392104|50431640|FG000|Overall Study|bleeding event|1|||
25203002|NCT02392104|50431640|FG000|Overall Study|transferred care to another doctor|2|||
25203003|NCT02392104|50431640|FG000|Overall Study|INR goal range changed|1|||
25203004|NCT02392104|50431640|FG000|Overall Study|admitted to skilled nursing facility|3|||
25203005|NCT02392104|50431640|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
25203006|NCT02391948|50431658|FG000|6-month Assessment|Death|0|||
25203007|NCT02391948|50431659|FG001|6-month Assessment|Death|0|||
25203008|NCT02391948|50431660|FG002|6-month Assessment|Death|0|||
25203009|NCT02391948|50431661|FG003|6-month Assessment|Death|0|||
25203010|NCT02391948|50431662|FG004|6-month Assessment|Death|1|||
25203011|NCT02391948|50431658|FG000|6-month Assessment|Withdrawal by Subject|0|||
25203012|NCT02391948|50431659|FG001|6-month Assessment|Withdrawal by Subject|0|||
25315916|NCT00896532|50631595|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315917|NCT00896532|50631596|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315918|NCT00896532|50631597|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25203013|NCT02391948|50431660|FG002|6-month Assessment|Withdrawal by Subject|1|||
25203014|NCT02391948|50431661|FG003|6-month Assessment|Withdrawal by Subject|2|||
25203015|NCT02391948|50431662|FG004|6-month Assessment|Withdrawal by Subject|0|||
25203016|NCT02391948|50431658|FG000|6-month Assessment|Lost to Follow-up|4|||
25203017|NCT02391948|50431659|FG001|6-month Assessment|Lost to Follow-up|5|||
25203018|NCT02391948|50431660|FG002|6-month Assessment|Lost to Follow-up|2|||
25203019|NCT02391948|50431661|FG003|6-month Assessment|Lost to Follow-up|3|||
25203020|NCT02391948|50431662|FG004|6-month Assessment|Lost to Follow-up|1|||
25203021|NCT02391948|50431658|FG000|6-month Assessment|Medical issue/illness|1|||
25203022|NCT02391948|50431659|FG001|6-month Assessment|Medical issue/illness|1|||
25203023|NCT02391948|50431660|FG002|6-month Assessment|Medical issue/illness|0|||
25203024|NCT02391948|50431661|FG003|6-month Assessment|Medical issue/illness|0|||
25203025|NCT02391948|50431662|FG004|6-month Assessment|Medical issue/illness|0|||
25203026|NCT02391948|50431658|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
25203027|NCT02391948|50431659|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
25203028|NCT02391948|50431660|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
25203029|NCT02391948|50431661|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
25203030|NCT02391948|50431662|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
25203031|NCT02391948|50431658|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
25203032|NCT02391948|50431659|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
25203033|NCT02391948|50431660|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
25203034|NCT02391948|50431661|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
25203035|NCT02391948|50431662|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
25203036|NCT02391948|50431658|FG000|12-month Assessment|Death|0|||
25203037|NCT02391948|50431659|FG001|12-month Assessment|Death|0|||
25203038|NCT02391948|50431660|FG002|12-month Assessment|Death|0|||
25203039|NCT02391948|50431661|FG003|12-month Assessment|Death|1|||
25203040|NCT02391948|50431662|FG004|12-month Assessment|Death|0|||
25203041|NCT02391948|50431658|FG000|12-month Assessment|Withdrawal by Subject|1|||
25203042|NCT02391948|50431659|FG001|12-month Assessment|Withdrawal by Subject|0|||
25203043|NCT02391948|50431660|FG002|12-month Assessment|Withdrawal by Subject|0|||
25203044|NCT02391948|50431661|FG003|12-month Assessment|Withdrawal by Subject|1|||
25203045|NCT02391948|50431662|FG004|12-month Assessment|Withdrawal by Subject|0|||
25203046|NCT02391948|50431658|FG000|12-month Assessment|Lost to Follow-up|5|||
25203047|NCT02391948|50431659|FG001|12-month Assessment|Lost to Follow-up|4|||
25203048|NCT02391948|50431660|FG002|12-month Assessment|Lost to Follow-up|4|||
25203049|NCT02391948|50431661|FG003|12-month Assessment|Lost to Follow-up|4|||
25203050|NCT02391948|50431662|FG004|12-month Assessment|Lost to Follow-up|5|||
25203051|NCT02391948|50431658|FG000|12-month Assessment|Medical issue/illness|0|||
25203052|NCT02391948|50431659|FG001|12-month Assessment|Medical issue/illness|1|||
25203053|NCT02391948|50431660|FG002|12-month Assessment|Medical issue/illness|0|||
25203054|NCT02391948|50431661|FG003|12-month Assessment|Medical issue/illness|1|||
25203055|NCT02391948|50431662|FG004|12-month Assessment|Medical issue/illness|0|||
25203056|NCT02391948|50431658|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
25203057|NCT02391948|50431659|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
25203058|NCT02391948|50431660|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
25203059|NCT02391948|50431661|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
25203060|NCT02391948|50431662|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
25203061|NCT02391948|50431658|FG000|18-month Assessment|Death|0|||
25203062|NCT02391948|50431659|FG001|18-month Assessment|Death|0|||
25203063|NCT02391948|50431660|FG002|18-month Assessment|Death|0|||
25203064|NCT02391948|50431661|FG003|18-month Assessment|Death|1|||
25203065|NCT02391948|50431662|FG004|18-month Assessment|Death|1|||
25203066|NCT02391948|50431658|FG000|18-month Assessment|Withdrawal by Subject|1|||
25203067|NCT02391948|50431659|FG001|18-month Assessment|Withdrawal by Subject|0|||
25203068|NCT02391948|50431660|FG002|18-month Assessment|Withdrawal by Subject|0|||
25203069|NCT02391948|50431661|FG003|18-month Assessment|Withdrawal by Subject|1|||
25203070|NCT02391948|50431662|FG004|18-month Assessment|Withdrawal by Subject|0|||
25203071|NCT02391948|50431658|FG000|18-month Assessment|Lost to Follow-up|2|||
25203072|NCT02391948|50431659|FG001|18-month Assessment|Lost to Follow-up|6|||
25203073|NCT02391948|50431660|FG002|18-month Assessment|Lost to Follow-up|2|||
25203074|NCT02391948|50431661|FG003|18-month Assessment|Lost to Follow-up|2|||
25203075|NCT02391948|50431662|FG004|18-month Assessment|Lost to Follow-up|3|||
25203076|NCT02391948|50431658|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
25203077|NCT02391948|50431659|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
25203078|NCT02391948|50431660|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
25203079|NCT02391948|50431661|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
25203080|NCT02391948|50431662|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
25203081|NCT02391948|50431658|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
25203082|NCT02391948|50431659|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
25203083|NCT02391948|50431660|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
25203084|NCT02391948|50431661|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
25203085|NCT02391948|50431662|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
25203086|NCT02391948|50431658|FG000|24-month Assessment|Death|0|||
25203087|NCT02391948|50431659|FG001|24-month Assessment|Death|0|||
25203088|NCT02391948|50431660|FG002|24-month Assessment|Death|0|||
25203089|NCT02391948|50431661|FG003|24-month Assessment|Death|0|||
25203090|NCT02391948|50431662|FG004|24-month Assessment|Death|1|||
25203091|NCT02391948|50431658|FG000|24-month Assessment|Withdrawal by Subject|1|||
25203092|NCT02391948|50431659|FG001|24-month Assessment|Withdrawal by Subject|1|||
25203093|NCT02391948|50431660|FG002|24-month Assessment|Withdrawal by Subject|0|||
25203094|NCT02391948|50431661|FG003|24-month Assessment|Withdrawal by Subject|0|||
25203095|NCT02391948|50431662|FG004|24-month Assessment|Withdrawal by Subject|1|||
25203096|NCT02391948|50431658|FG000|24-month Assessment|Lost to Follow-up|5|||
25203097|NCT02391948|50431659|FG001|24-month Assessment|Lost to Follow-up|4|||
25203098|NCT02391948|50431660|FG002|24-month Assessment|Lost to Follow-up|0|||
25203099|NCT02391948|50431661|FG003|24-month Assessment|Lost to Follow-up|0|||
25203100|NCT02391948|50431662|FG004|24-month Assessment|Lost to Follow-up|0|||
25203101|NCT02391948|50431658|FG000|24-month Assessment|Medical issue/illness|0|||
25203102|NCT02391948|50431659|FG001|24-month Assessment|Medical issue/illness|0|||
25203103|NCT02391948|50431660|FG002|24-month Assessment|Medical issue/illness|1|||
25203104|NCT02391948|50431661|FG003|24-month Assessment|Medical issue/illness|0|||
25203105|NCT02391948|50431662|FG004|24-month Assessment|Medical issue/illness|0|||
25203106|NCT02391948|50431658|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
25203107|NCT02391948|50431659|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
25203108|NCT02391948|50431660|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
25203109|NCT02391948|50431661|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
25203110|NCT02391948|50431662|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
25203111|NCT02369874|50431905|FG000|Overall Study|Lost to Follow-up|2|||
25203112|NCT02369874|50431906|FG001|Overall Study|Lost to Follow-up|2|||
25203113|NCT02369874|50431907|FG002|Overall Study|Lost to Follow-up|2|||
25203114|NCT02369874|50431905|FG000|Overall Study|Withdrawal by Subject|7|||
25203115|NCT02369874|50431906|FG001|Overall Study|Withdrawal by Subject|9|||
25203116|NCT02369874|50431907|FG002|Overall Study|Withdrawal by Subject|27|||
25203117|NCT02369874|50431905|FG000|Overall Study|Miscellaneous|1|||
25203118|NCT02369874|50431906|FG001|Overall Study|Miscellaneous|1|||
25203119|NCT02369874|50431907|FG002|Overall Study|Miscellaneous|0|||
25203120|NCT02369874|50431905|FG000|Overall Study|On Treatment/Off Study|34|||
25203121|NCT02369874|50431906|FG001|Overall Study|On Treatment/Off Study|45|||
25203122|NCT02369874|50431907|FG002|Overall Study|On Treatment/Off Study|32|||
25203123|NCT02368314|50432059|FG000|Overall Study|Withdrawal by Subject|2|||
25203124|NCT02368314|50432060|FG001|Overall Study|Withdrawal by Subject|1|||
25203125|NCT02368314|50432059|FG000|Overall Study|Adverse Event|1|||
25203126|NCT02368314|50432060|FG001|Overall Study|Adverse Event|2|||
25203127|NCT02366910|50432070|FG000|Overall Study|Withdrawal by Subject|2|||
25203128|NCT02366910|50432070|FG000|Overall Study|Screen Failure|3|||
25203129|NCT01649232|50432088|FG000|Overall Study|Physician Decision|2|||
25203130|NCT01649232|50432089|FG001|Overall Study|Physician Decision|0|||
25203131|NCT02345226|50432398|FG000|Double-Blind Phase|Adverse Event|5|||
25203132|NCT02345226|50432399|FG001|Double-Blind Phase|Adverse Event|6|||
25203133|NCT02345226|50432398|FG000|Double-Blind Phase|Death|3|||
25203134|NCT02345226|50432399|FG001|Double-Blind Phase|Death|0|||
25203135|NCT02345226|50432398|FG000|Double-Blind Phase|Pregnancy|0|||
25203136|NCT02345226|50432399|FG001|Double-Blind Phase|Pregnancy|1|||
25203137|NCT02345226|50432398|FG000|Double-Blind Phase|Lack of Efficacy|1|||
25315919|NCT00896532|50631598|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25203138|NCT02345226|50432399|FG001|Double-Blind Phase|Lack of Efficacy|0|||
25203139|NCT02345226|50432398|FG000|Double-Blind Phase|Investigator's Discretion|4|||
25203140|NCT02345226|50432399|FG001|Double-Blind Phase|Investigator's Discretion|3|||
25203141|NCT02345226|50432398|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
25203142|NCT02345226|50432399|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
25203143|NCT02345226|50432398|FG000|Double-Blind Phase|Withdrew Consent|41|||
25203144|NCT02345226|50432399|FG001|Double-Blind Phase|Withdrew Consent|39|||
25203145|NCT02345226|50432398|FG000|Double-Blind Phase|Lost to Follow-up|12|||
25203146|NCT02345226|50432399|FG001|Double-Blind Phase|Lost to Follow-up|16|||
25203147|NCT02345226|50432398|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
25203148|NCT02345226|50432399|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
25203149|NCT02345226|50432398|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
25203150|NCT02345226|50432399|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
25203151|NCT00551369|50432970|FG000|Overall Study|Protocol Violation|5|||
25077107|NCT02439320|50184950|FG002|Overall Study|Noncompliance with Protocol|7|||
25203152|NCT00551369|50432970|FG000|Overall Study|Withdrawal by Subject|1|||
25203153|NCT00551369|50432970|FG000|Overall Study|Not treated per protocol and re|1|||
25203154|NCT00551291|50432983|FG000|Overall Study|Physician Decision|1|||
25203155|NCT00551213|50433089|FG000|Overall Study|Adverse Event|6|||
25203156|NCT00551213|50433090|FG001|Overall Study|Adverse Event|3|||
25203157|NCT00551213|50433089|FG000|Overall Study|Progressive Disease|41|||
25203158|NCT00551213|50433090|FG001|Overall Study|Progressive Disease|12|||
25203159|NCT00551213|50433089|FG000|Overall Study|Withdrawal by Subject|2|||
25203160|NCT00551213|50433090|FG001|Overall Study|Withdrawal by Subject|0|||
25203161|NCT00551213|50433089|FG000|Overall Study|Not Treated|1|||
25203162|NCT00551213|50433090|FG001|Overall Study|Not Treated|2|||
25203163|NCT00550043|50433227|FG000|Overall Study|Adverse Event|0|||
25203164|NCT00550043|50433228|FG001|Overall Study|Adverse Event|0|||
25203165|NCT00550043|50433229|FG002|Overall Study|Adverse Event|0|||
25203166|NCT00550043|50433230|FG003|Overall Study|Adverse Event|1|||
25203167|NCT00550043|50433231|FG004|Overall Study|Adverse Event|1|||
25203168|NCT00550043|50433227|FG000|Overall Study|Subject Withdrew Consent|0|||
25203169|NCT00550043|50433228|FG001|Overall Study|Subject Withdrew Consent|2|||
25203170|NCT00550043|50433229|FG002|Overall Study|Subject Withdrew Consent|1|||
25203171|NCT00550043|50433230|FG003|Overall Study|Subject Withdrew Consent|0|||
25203172|NCT00550043|50433231|FG004|Overall Study|Subject Withdrew Consent|0|||
25203173|NCT00550043|50433227|FG000|Overall Study|Other Reasons- Unspecified|0|||
25203174|NCT00550043|50433228|FG001|Overall Study|Other Reasons- Unspecified|1|||
25203175|NCT00550043|50433229|FG002|Overall Study|Other Reasons- Unspecified|0|||
25203176|NCT00550043|50433230|FG003|Overall Study|Other Reasons- Unspecified|1|||
25203177|NCT00550043|50433231|FG004|Overall Study|Other Reasons- Unspecified|0|||
25203178|NCT03188822|50433959|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
25203179|NCT03188822|50433959|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
25203180|NCT04976777|50434102|FG000|Overall Study|COVID-19 Infection|1|||
25203181|NCT04976777|50434103|FG001|Overall Study|COVID-19 Infection|0|||
25203182|NCT00555971|50434286|FG000|Overall Study|Adverse Event|1|||
25203183|NCT00555971|50434287|FG001|Overall Study|Adverse Event|1|||
25203184|NCT02343120|50435163|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
25203185|NCT02343120|50435164|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
25203186|NCT02343120|50435165|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
25203187|NCT02343120|50435166|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
25203188|NCT02343120|50435167|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
25203189|NCT02343120|50435163|FG000|Part 1: Dose Escalation|Death|1|||
25203190|NCT02343120|50435164|FG001|Part 1: Dose Escalation|Death|2|||
25203191|NCT02343120|50435165|FG002|Part 1: Dose Escalation|Death|2|||
25203192|NCT02343120|50435166|FG003|Part 1: Dose Escalation|Death|2|||
25203193|NCT02343120|50435167|FG004|Part 1: Dose Escalation|Death|1|||
25203194|NCT02343120|50435163|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
25203195|NCT02343120|50435164|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
25203196|NCT02343120|50435165|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
25203197|NCT02343120|50435166|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
25203198|NCT02343120|50435167|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
25203199|NCT02343120|50435163|FG000|Part 2: Expansion|Sponsor decision|0|||
25203200|NCT02343120|50435164|FG001|Part 2: Expansion|Sponsor decision|0|||
25203201|NCT02343120|50435165|FG002|Part 2: Expansion|Sponsor decision|0|||
25203202|NCT02343120|50435166|FG003|Part 2: Expansion|Sponsor decision|165|||
25203203|NCT02343120|50435167|FG004|Part 2: Expansion|Sponsor decision|67|||
25203204|NCT02343120|50435163|FG000|Part 2: Expansion|Death|0|||
25203205|NCT02343120|50435164|FG001|Part 2: Expansion|Death|0|||
25203206|NCT02343120|50435165|FG002|Part 2: Expansion|Death|0|||
25203207|NCT02343120|50435166|FG003|Part 2: Expansion|Death|74|||
25203208|NCT02343120|50435167|FG004|Part 2: Expansion|Death|17|||
25203209|NCT02343120|50435163|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
25203210|NCT02343120|50435164|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
25203211|NCT02343120|50435165|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
25203212|NCT02343120|50435166|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
25203213|NCT02343120|50435167|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
25203214|NCT02343120|50435163|FG000|Part 2: Expansion|Lost to Follow-up|0|||
25203215|NCT02343120|50435164|FG001|Part 2: Expansion|Lost to Follow-up|0|||
25203216|NCT02343120|50435165|FG002|Part 2: Expansion|Lost to Follow-up|0|||
25203217|NCT02343120|50435166|FG003|Part 2: Expansion|Lost to Follow-up|5|||
25203218|NCT02343120|50435167|FG004|Part 2: Expansion|Lost to Follow-up|2|||
25203219|NCT02343120|50435163|FG000|Part 2: Expansion|Other|0|||
25203220|NCT02343120|50435164|FG001|Part 2: Expansion|Other|0|||
25203221|NCT02343120|50435165|FG002|Part 2: Expansion|Other|0|||
25203222|NCT02343120|50435166|FG003|Part 2: Expansion|Other|1|||
25203223|NCT02343120|50435167|FG004|Part 2: Expansion|Other|5|||
25203224|NCT02343120|50435163|FG000|Part 2: Expansion|Adverse Event|0|||
25203225|NCT02343120|50435164|FG001|Part 2: Expansion|Adverse Event|0|||
25203226|NCT02343120|50435165|FG002|Part 2: Expansion|Adverse Event|0|||
25203227|NCT02343120|50435166|FG003|Part 2: Expansion|Adverse Event|1|||
25203228|NCT02343120|50435167|FG004|Part 2: Expansion|Adverse Event|1|||
25203229|NCT02342886|50435433|FG000|Overall Study|Treatment non-compliance|1|||
25203230|NCT02342886|50435434|FG001|Overall Study|Treatment non-compliance|0|||
25203231|NCT02342886|50435435|FG002|Overall Study|Treatment non-compliance|0|||
25203232|NCT02342886|50435436|FG003|Overall Study|Treatment non-compliance|1|||
25203233|NCT02342886|50435437|FG004|Overall Study|Treatment non-compliance|0|||
25203234|NCT02342886|50435433|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
25203235|NCT02342886|50435434|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
25203236|NCT02342886|50435435|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
25203237|NCT02342886|50435436|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
25203238|NCT02342886|50435437|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
25203239|NCT02342886|50435433|FG000|Overall Study|Adverse event/specific toxicity|4|||
25203240|NCT02342886|50435434|FG001|Overall Study|Adverse event/specific toxicity|3|||
25203241|NCT02342886|50435435|FG002|Overall Study|Adverse event/specific toxicity|11|||
25203242|NCT02342886|50435436|FG003|Overall Study|Adverse event/specific toxicity|2|||
25203243|NCT02342886|50435437|FG004|Overall Study|Adverse event/specific toxicity|1|||
25203244|NCT02342886|50435433|FG000|Overall Study|Lost to Follow-up|1|||
25203245|NCT02342886|50435434|FG001|Overall Study|Lost to Follow-up|0|||
25203246|NCT02342886|50435435|FG002|Overall Study|Lost to Follow-up|0|||
25203247|NCT02342886|50435436|FG003|Overall Study|Lost to Follow-up|0|||
25203248|NCT02342886|50435437|FG004|Overall Study|Lost to Follow-up|0|||
25203249|NCT02342886|50435433|FG000|Overall Study|Death|1|||
25203250|NCT02342886|50435434|FG001|Overall Study|Death|2|||
25203251|NCT02342886|50435435|FG002|Overall Study|Death|1|||
25203252|NCT02342886|50435436|FG003|Overall Study|Death|0|||
25203253|NCT02342886|50435437|FG004|Overall Study|Death|1|||
25203254|NCT02342886|50435433|FG000|Overall Study|Withdrawal by Subject|0|||
25203255|NCT02342886|50435434|FG001|Overall Study|Withdrawal by Subject|1|||
25203256|NCT02342886|50435435|FG002|Overall Study|Withdrawal by Subject|0|||
25203257|NCT02342886|50435436|FG003|Overall Study|Withdrawal by Subject|1|||
25203258|NCT02342886|50435437|FG004|Overall Study|Withdrawal by Subject|0|||
25203259|NCT02342886|50435433|FG000|Overall Study|Investigator/sponsor decision|0|||
25203260|NCT02342886|50435434|FG001|Overall Study|Investigator/sponsor decision|2|||
25203261|NCT02342886|50435435|FG002|Overall Study|Investigator/sponsor decision|0|||
25203262|NCT02342886|50435436|FG003|Overall Study|Investigator/sponsor decision|3|||
25203263|NCT02342886|50435437|FG004|Overall Study|Investigator/sponsor decision|1|||
25203264|NCT02342886|50435433|FG000|Overall Study|Pregnancy|0|||
25203265|NCT02342886|50435434|FG001|Overall Study|Pregnancy|0|||
25203266|NCT02342886|50435435|FG002|Overall Study|Pregnancy|2|||
25203267|NCT02342886|50435436|FG003|Overall Study|Pregnancy|0|||
25203268|NCT02342886|50435437|FG004|Overall Study|Pregnancy|0|||
25203269|NCT02342886|50435433|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
25203270|NCT02342886|50435434|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
25203271|NCT02342886|50435435|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
25203272|NCT02342886|50435436|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
25203273|NCT02342886|50435437|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
25203274|NCT02342886|50435433|FG000|Overall Study|Protocol Violation|0|||
25203275|NCT02342886|50435434|FG001|Overall Study|Protocol Violation|0|||
25203276|NCT02342886|50435435|FG002|Overall Study|Protocol Violation|0|||
25203277|NCT02342886|50435436|FG003|Overall Study|Protocol Violation|2|||
25203278|NCT02342886|50435437|FG004|Overall Study|Protocol Violation|0|||
25203279|NCT02390076|50435473|FG000|Overall Study|Lost to Follow-up|2|||
25203280|NCT02390076|50435474|FG001|Overall Study|Lost to Follow-up|1|||
25203281|NCT02390076|50435475|FG002|Overall Study|Lost to Follow-up|4|||
25203282|NCT02389998|50435494|FG000|Overall Study|car accident|1|||
25203283|NCT02389998|50435495|FG001|Overall Study|car accident|0|||
25203284|NCT02389764|50435521|FG000|Overall Study|Lack of Efficacy|9|||
25203285|NCT02366130|50435592|FG000|Overall Study|Withdrawal by Subject|3|||
25203286|NCT02366130|50435592|FG000|Overall Study|Ineligible|6|||
25203287|NCT02389452|50435654|FG000|Overall Study|Lost to Follow-up|13|||
25203288|NCT02389452|50435654|FG000|Overall Study|Adverse Event|1|||
25203289|NCT02389452|50435654|FG000|Overall Study|Withdrawal by Subject|5|||
25203290|NCT02389452|50435654|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
25203291|NCT02365584|50435692|FG000|Overall Study|Adverse Event|2|||
25203292|NCT02365584|50435693|FG001|Overall Study|Adverse Event|2|||
25203293|NCT02365584|50435692|FG000|Overall Study|Withdrawal by Subject|1|||
25203294|NCT02365584|50435693|FG001|Overall Study|Withdrawal by Subject|0|||
25203295|NCT02365584|50435692|FG000|Overall Study|Disease Progression|9|||
25203296|NCT02365584|50435693|FG001|Overall Study|Disease Progression|12|||
25203297|NCT02342418|50435705|FG000|Overall Study|Adverse Event|0|||
25203298|NCT02342418|50435706|FG001|Overall Study|Adverse Event|1|||
25203299|NCT02365506|50435747|FG000|Overall Study|Investigator's Discretion|0|||
25203300|NCT02365506|50435748|FG001|Overall Study|Investigator's Discretion|0|||
25203301|NCT02365506|50435749|FG002|Overall Study|Investigator's Discretion|1|||
25203302|NCT02312934|50435786|FG000|Overall Study|Lost to Follow-up|1|||
25203303|NCT02312934|50435787|FG001|Overall Study|Lost to Follow-up|0|||
25203304|NCT02312934|50435786|FG000|Overall Study|Physician Decision|1|||
25203305|NCT02312934|50435787|FG001|Overall Study|Physician Decision|0|||
25203306|NCT02341482|50435821|FG000|Overall Study|Adverse Event|1|||
25203307|NCT02312856|50435861|FG000|Overall Study|Death|1|||
25203308|NCT02312856|50435861|FG000|Overall Study|Lost to Follow-up|3|||
25203309|NCT01602120|50436326|FG000|Overall Study|Adverse Event|3|||
25203310|NCT01602120|50436327|FG001|Overall Study|Adverse Event|6|||
25203311|NCT01602120|50436328|FG002|Overall Study|Adverse Event|0|||
25203312|NCT01602120|50436329|FG003|Overall Study|Adverse Event|2|||
25203313|NCT01602120|50436326|FG000|Overall Study|Death|0|||
25203314|NCT01602120|50436327|FG001|Overall Study|Death|4|||
25203315|NCT01602120|50436328|FG002|Overall Study|Death|0|||
25203316|NCT01602120|50436329|FG003|Overall Study|Death|0|||
25203317|NCT01602120|50436326|FG000|Overall Study|Lost to Follow-up|0|||
25203318|NCT01602120|50436327|FG001|Overall Study|Lost to Follow-up|1|||
25203319|NCT01602120|50436328|FG002|Overall Study|Lost to Follow-up|0|||
25203320|NCT01602120|50436329|FG003|Overall Study|Lost to Follow-up|1|||
25203321|NCT01602120|50436326|FG000|Overall Study|Protocol Violation|1|||
25203322|NCT01602120|50436327|FG001|Overall Study|Protocol Violation|1|||
25203323|NCT01602120|50436328|FG002|Overall Study|Protocol Violation|0|||
25203324|NCT01602120|50436329|FG003|Overall Study|Protocol Violation|0|||
25203325|NCT01602120|50436326|FG000|Overall Study|Non-compliance|0|||
25203326|NCT01602120|50436327|FG001|Overall Study|Non-compliance|3|||
25203327|NCT01602120|50436328|FG002|Overall Study|Non-compliance|0|||
25203328|NCT01602120|50436329|FG003|Overall Study|Non-compliance|1|||
25203329|NCT01602120|50436326|FG000|Overall Study|Withdrawal by Subject|8|||
25203330|NCT01602120|50436327|FG001|Overall Study|Withdrawal by Subject|17|||
25203331|NCT01602120|50436328|FG002|Overall Study|Withdrawal by Subject|0|||
25203332|NCT01602120|50436329|FG003|Overall Study|Withdrawal by Subject|3|||
25203333|NCT01602120|50436326|FG000|Overall Study|Study Terminated by Sponsor|12|||
25203334|NCT01602120|50436327|FG001|Overall Study|Study Terminated by Sponsor|24|||
25203335|NCT01602120|50436328|FG002|Overall Study|Study Terminated by Sponsor|17|||
25203336|NCT01602120|50436329|FG003|Overall Study|Study Terminated by Sponsor|44|||
25203337|NCT01602120|50436326|FG000|Overall Study|Physician Decision|2|||
25203338|NCT01602120|50436327|FG001|Overall Study|Physician Decision|3|||
25203339|NCT01602120|50436328|FG002|Overall Study|Physician Decision|0|||
25203340|NCT01602120|50436329|FG003|Overall Study|Physician Decision|0|||
25203341|NCT01602120|50436326|FG000|Overall Study|Unspecified Reason|3|||
25203342|NCT01602120|50436327|FG001|Overall Study|Unspecified Reason|1|||
25203343|NCT01602120|50436328|FG002|Overall Study|Unspecified Reason|0|||
25203344|NCT01602120|50436329|FG003|Overall Study|Unspecified Reason|2|||
25203345|NCT04543955|50437136|FG000|Overall Study|Company cancelled study|1|||
25203346|NCT04543955|50437137|FG001|Overall Study|Company cancelled study|0|||
25203347|NCT02049515|50437205|FG000|Overall Study|Adverse Event|46|||
25203348|NCT02049515|50437206|FG001|Overall Study|Adverse Event|2|||
25203349|NCT02049515|50437205|FG000|Overall Study|Protocol-specified Disease Progression|23|||
25203350|NCT02049515|50437206|FG001|Overall Study|Protocol-specified Disease Progression|2|||
25203351|NCT02049515|50437205|FG000|Overall Study|Death|6|||
25203352|NCT02049515|50437206|FG001|Overall Study|Death|0|||
25203353|NCT02049515|50437205|FG000|Overall Study|Physician Decision|5|||
25203354|NCT02049515|50437206|FG001|Overall Study|Physician Decision|1|||
25203355|NCT02049515|50437205|FG000|Overall Study|Withdrawal by Subject|3|||
25203356|NCT02049515|50437206|FG001|Overall Study|Withdrawal by Subject|0|||
25203357|NCT02049515|50437205|FG000|Overall Study|Termination of the Study by Sponsor|2|||
25203358|NCT02049515|50437206|FG001|Overall Study|Termination of the Study by Sponsor|0|||
25203359|NCT02049515|50437205|FG000|Overall Study|Protocol Violation|1|||
25171384|NCT01775189|50308318|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
25171385|NCT01775189|50308319|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
25171386|NCT01775189|50308320|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
25171387|NCT01775189|50308321|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
25171388|NCT01775189|50308322|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
25171389|NCT01775189|50308323|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
25171390|NCT01775189|50308317|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
25171391|NCT01775189|50308318|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
25171392|NCT01775189|50308319|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
25171393|NCT01775189|50308320|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
25171394|NCT01775189|50308321|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
25171395|NCT01775189|50308322|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
25203360|NCT02049515|50437206|FG001|Overall Study|Protocol Violation|1|||
25203361|NCT02049515|50437205|FG000|Overall Study|Clinical Deterioration|1|||
25203362|NCT02049515|50437206|FG001|Overall Study|Clinical Deterioration|0|||
25203363|NCT02049515|50437205|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
25203364|NCT02049515|50437206|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
25203365|NCT02049515|50437205|FG000|Overall Study|Treatment Interruption >42 Days|1|||
25203366|NCT02049515|50437206|FG001|Overall Study|Treatment Interruption >42 Days|0|||
25203367|NCT02049515|50437205|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
25203368|NCT02049515|50437206|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
25203369|NCT04436744|50437696|FG000|Overall Study|Adverse Event|1|||
25203370|NCT04436744|50437697|FG001|Overall Study|Adverse Event|1|||
25203371|NCT04436744|50437696|FG000|Overall Study|Death|1|||
25203372|NCT04436744|50437697|FG001|Overall Study|Death|0|||
25203373|NCT04436744|50437696|FG000|Overall Study|Lost to Follow-up|0|||
25203374|NCT04436744|50437697|FG001|Overall Study|Lost to Follow-up|2|||
25203375|NCT04436744|50437696|FG000|Overall Study|Physician Decision|0|||
25203376|NCT04436744|50437697|FG001|Overall Study|Physician Decision|1|||
25203377|NCT04436744|50437696|FG000|Overall Study|Progressive Disease|0|||
25203378|NCT04436744|50437697|FG001|Overall Study|Progressive Disease|4|||
25203379|NCT04436744|50437696|FG000|Overall Study|Protocol Deviation|1|||
25203380|NCT04436744|50437697|FG001|Overall Study|Protocol Deviation|1|||
25203381|NCT04436744|50437696|FG000|Overall Study|Withdrawal by Subject|1|||
25203382|NCT04436744|50437697|FG001|Overall Study|Withdrawal by Subject|2|||
25203383|NCT04359758|50437737|FG000|Overall Study|Lost to Follow-up|0|||
25203384|NCT04359758|50437738|FG001|Overall Study|Lost to Follow-up|2|||
25203385|NCT04359758|50437737|FG000|Overall Study|Protocol Violation|3|||
25203386|NCT04359758|50437738|FG001|Overall Study|Protocol Violation|0|||
25203387|NCT02243306|50437853|FG000|Overall Study|Adverse Event|0|||
25203388|NCT02243306|50437854|FG001|Overall Study|Adverse Event|1|||
25203389|NCT02243306|50437853|FG000|Overall Study|Other: Reached stopping criteria|0|||
25203390|NCT02243306|50437854|FG001|Overall Study|Other: Reached stopping criteria|1|||
25203391|NCT02243306|50437853|FG000|Overall Study|Physician Decision|0|||
25203392|NCT02243306|50437854|FG001|Overall Study|Physician Decision|1|||
25203393|NCT03214679|50438010|FG000|Overall Study|Lost to Follow-up|12|||
25203394|NCT03214679|50438011|FG001|Overall Study|Lost to Follow-up|14|||
25203395|NCT03214679|50438010|FG000|Overall Study|not eligible|2|||
25203396|NCT03214679|50438011|FG001|Overall Study|not eligible|0|||
25203397|NCT01602380|50438358|FG000|Overall Study|Death|63|||
25315920|NCT00896532|50631599|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315921|NCT00896532|50631600|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315922|NCT00896532|50631601|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315923|NCT00896532|50631602|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315924|NCT00896532|50631603|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315925|NCT00896532|50631604|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315926|NCT00896532|50631605|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315927|NCT00896532|50631606|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315928|NCT00896532|50631607|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315929|NCT00896532|50631608|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315930|NCT00896532|50631609|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315931|NCT00896532|50631610|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
25315932|NCT00896532|50631588|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315933|NCT00896532|50631589|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315934|NCT00896532|50631590|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
25315935|NCT00896532|50631591|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315936|NCT00896532|50631592|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315937|NCT00896532|50631593|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315938|NCT00896532|50631594|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315939|NCT00896532|50631595|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315940|NCT00896532|50631596|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315941|NCT00896532|50631597|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315942|NCT00896532|50631598|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315943|NCT00896532|50631599|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315944|NCT00896532|50631600|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25171396|NCT01775189|50308323|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
25171397|NCT01775189|50308317|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
25171398|NCT01775189|50308318|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
25171399|NCT01775189|50308319|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
25171400|NCT01775189|50308320|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
25171401|NCT01775189|50308321|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
25171402|NCT01775189|50308322|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
25171403|NCT01775189|50308323|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
25171404|NCT01775189|50308317|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
25203398|NCT01602380|50438359|FG001|Overall Study|Death|68|||
25203399|NCT01602380|50438358|FG000|Overall Study|Withdrawal by Subject|22|||
25203400|NCT01602380|50438359|FG001|Overall Study|Withdrawal by Subject|29|||
25203401|NCT01602380|50438358|FG000|Overall Study|Lost to Follow-up|6|||
25203402|NCT01602380|50438359|FG001|Overall Study|Lost to Follow-up|1|||
25203403|NCT01602380|50438358|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
25203404|NCT01602380|50438359|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
25203405|NCT01349465|50439315|FG000|Overall Study|Adverse Event|1|||
25203406|NCT01349465|50439316|FG001|Overall Study|Adverse Event|0|||
25203407|NCT01349465|50439315|FG000|Overall Study|Death|3|||
25203408|NCT01349465|50439316|FG001|Overall Study|Death|0|||
25203409|NCT01349465|50439315|FG000|Overall Study|Lost to Follow-up|10|||
25203410|NCT01349465|50439316|FG001|Overall Study|Lost to Follow-up|1|||
25203411|NCT01349465|50439315|FG000|Overall Study|Withdrawal by Subject|4|||
25203412|NCT01349465|50439316|FG001|Overall Study|Withdrawal by Subject|2|||
25203413|NCT01349465|50439315|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
25203414|NCT01349465|50439316|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
25203415|NCT01648764|50440435|FG000|Overall Study|Progressive Disease|0|||
25203416|NCT01648764|50440436|FG001|Overall Study|Progressive Disease|1|||
25203417|NCT01648764|50440437|FG002|Overall Study|Progressive Disease|0|||
25203418|NCT01648764|50440438|FG003|Overall Study|Progressive Disease|0|||
25203419|NCT01648764|50440439|FG004|Overall Study|Progressive Disease|0|||
25203420|NCT01648764|50440440|FG005|Overall Study|Progressive Disease|1|||
25203421|NCT01648764|50440441|FG006|Overall Study|Progressive Disease|1|||
25203422|NCT01648764|50440442|FG007|Overall Study|Progressive Disease|0|||
25203423|NCT01648764|50440443|FG008|Overall Study|Progressive Disease|0|||
25203424|NCT01648764|50440444|FG009|Overall Study|Progressive Disease|2|||
25203425|NCT01648764|50440445|FG010|Overall Study|Progressive Disease|0|||
25203426|NCT01648764|50440446|FG011|Overall Study|Progressive Disease|1|||
25203427|NCT01648764|50440447|FG012|Overall Study|Progressive Disease|2|||
25203428|NCT01648764|50440448|FG013|Overall Study|Progressive Disease|1|||
25203429|NCT01648764|50440435|FG000|Overall Study|Adverse Event|0|||
25203430|NCT01648764|50440436|FG001|Overall Study|Adverse Event|0|||
25203431|NCT01648764|50440437|FG002|Overall Study|Adverse Event|0|||
25203432|NCT01648764|50440438|FG003|Overall Study|Adverse Event|0|||
25203433|NCT01648764|50440439|FG004|Overall Study|Adverse Event|0|||
25203434|NCT01648764|50440440|FG005|Overall Study|Adverse Event|1|||
25203435|NCT01648764|50440441|FG006|Overall Study|Adverse Event|0|||
25203436|NCT01648764|50440442|FG007|Overall Study|Adverse Event|0|||
25203437|NCT01648764|50440443|FG008|Overall Study|Adverse Event|0|||
25203438|NCT01648764|50440444|FG009|Overall Study|Adverse Event|1|||
25203439|NCT01648764|50440445|FG010|Overall Study|Adverse Event|0|||
25203440|NCT01648764|50440446|FG011|Overall Study|Adverse Event|3|||
25203441|NCT01648764|50440447|FG012|Overall Study|Adverse Event|1|||
25203442|NCT01648764|50440448|FG013|Overall Study|Adverse Event|1|||
25203443|NCT01648764|50440435|FG000|Overall Study|Death|0|||
25203444|NCT01648764|50440436|FG001|Overall Study|Death|0|||
25203445|NCT01648764|50440437|FG002|Overall Study|Death|0|||
25203446|NCT01648764|50440438|FG003|Overall Study|Death|0|||
25203447|NCT01648764|50440439|FG004|Overall Study|Death|0|||
25203448|NCT01648764|50440440|FG005|Overall Study|Death|0|||
25203449|NCT01648764|50440441|FG006|Overall Study|Death|1|||
25203450|NCT01648764|50440442|FG007|Overall Study|Death|0|||
25203451|NCT01648764|50440443|FG008|Overall Study|Death|0|||
25203452|NCT01648764|50440444|FG009|Overall Study|Death|0|||
25203453|NCT01648764|50440445|FG010|Overall Study|Death|0|||
25203454|NCT01648764|50440446|FG011|Overall Study|Death|0|||
25203455|NCT01648764|50440447|FG012|Overall Study|Death|0|||
25203456|NCT01648764|50440448|FG013|Overall Study|Death|1|||
25203457|NCT01648764|50440435|FG000|Overall Study|Withdrawal by Subject|0|||
25203458|NCT01648764|50440436|FG001|Overall Study|Withdrawal by Subject|0|||
25203459|NCT01648764|50440437|FG002|Overall Study|Withdrawal by Subject|0|||
25203460|NCT01648764|50440438|FG003|Overall Study|Withdrawal by Subject|0|||
25203461|NCT01648764|50440439|FG004|Overall Study|Withdrawal by Subject|0|||
25203462|NCT01648764|50440440|FG005|Overall Study|Withdrawal by Subject|0|||
25203463|NCT01648764|50440441|FG006|Overall Study|Withdrawal by Subject|2|||
25203464|NCT01648764|50440442|FG007|Overall Study|Withdrawal by Subject|0|||
25203465|NCT01648764|50440443|FG008|Overall Study|Withdrawal by Subject|0|||
25203466|NCT01648764|50440444|FG009|Overall Study|Withdrawal by Subject|0|||
25203467|NCT01648764|50440445|FG010|Overall Study|Withdrawal by Subject|0|||
25203468|NCT01648764|50440446|FG011|Overall Study|Withdrawal by Subject|0|||
25203469|NCT01648764|50440447|FG012|Overall Study|Withdrawal by Subject|1|||
25203470|NCT01648764|50440448|FG013|Overall Study|Withdrawal by Subject|0|||
25203471|NCT01648764|50440435|FG000|Overall Study|Investigator Decision|0|||
25203472|NCT01648764|50440436|FG001|Overall Study|Investigator Decision|0|||
25203473|NCT01648764|50440437|FG002|Overall Study|Investigator Decision|0|||
25203474|NCT01648764|50440438|FG003|Overall Study|Investigator Decision|0|||
25203475|NCT01648764|50440439|FG004|Overall Study|Investigator Decision|0|||
25203476|NCT01648764|50440440|FG005|Overall Study|Investigator Decision|0|||
25203477|NCT01648764|50440441|FG006|Overall Study|Investigator Decision|1|||
25203478|NCT01648764|50440442|FG007|Overall Study|Investigator Decision|0|||
25203479|NCT01648764|50440443|FG008|Overall Study|Investigator Decision|0|||
25203480|NCT01648764|50440444|FG009|Overall Study|Investigator Decision|0|||
25203481|NCT01648764|50440445|FG010|Overall Study|Investigator Decision|0|||
25203482|NCT01648764|50440446|FG011|Overall Study|Investigator Decision|1|||
25203483|NCT01648764|50440447|FG012|Overall Study|Investigator Decision|0|||
25203484|NCT01648764|50440448|FG013|Overall Study|Investigator Decision|0|||
25203485|NCT02364336|50440484|FG000|Overall Study|Adverse Event|0|||
25203486|NCT02364336|50440485|FG001|Overall Study|Adverse Event|1|||
25203487|NCT02810951|50440716|FG000|Overall Study|Adverse Event|1|||
25203488|NCT02310906|50440812|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
25203489|NCT02310906|50440813|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
25203490|NCT02310906|50440814|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
25203491|NCT02310906|50440815|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
25203492|NCT02310906|50440812|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
25203493|NCT02310906|50440813|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
25203494|NCT02310906|50440814|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
25203495|NCT02310906|50440815|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
25203496|NCT02310906|50440812|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
25203497|NCT02310906|50440813|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
25203498|NCT02310906|50440814|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
25203499|NCT02310906|50440815|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
25203500|NCT02310906|50440812|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
25203501|NCT02310906|50440813|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
25203502|NCT02310906|50440814|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
25203503|NCT02310906|50440815|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
25203504|NCT02340780|50440856|FG000|Overall Study|Ineligible|1|||
25203505|NCT02340078|50440869|FG000|Overall Study|Protocol Violation|1|||
25203506|NCT02340000|50440885|FG000|Time Period 1|Withdrawal by Subject|6|||
25203507|NCT02340000|50440886|FG001|Time Period 1|Withdrawal by Subject|8|||
25203508|NCT02340000|50440885|FG000|Time Period 1|Lost to Follow-up|6|||
25203509|NCT02340000|50440886|FG001|Time Period 1|Lost to Follow-up|7|||
25203510|NCT02340000|50440885|FG000|Time Period 2|Withdrawal by Subject|9|||
25203511|NCT02340000|50440886|FG001|Time Period 2|Withdrawal by Subject|7|||
25203512|NCT02340000|50440885|FG000|Time Period 2|Lost to Follow-up|10|||
25203513|NCT02340000|50440886|FG001|Time Period 2|Lost to Follow-up|8|||
25203514|NCT02364180|50440917|FG000|Overall Study|Screen Fail|1|||
25203515|NCT02310750|50441566|FG000|HP Period 1|Lost to Follow-up|0|||
25203516|NCT02310750|50441567|FG001|HP Period 1|Lost to Follow-up|0|||
25203517|NCT02310750|50441568|FG002|HP Period 1|Lost to Follow-up|0|||
25203518|NCT02310750|50441569|FG003|HP Period 1|Lost to Follow-up|0|||
25203519|NCT02310750|50441570|FG004|HP Period 1|Lost to Follow-up|0|||
25203520|NCT02310750|50441571|FG005|HP Period 1|Lost to Follow-up|0|||
25203521|NCT02310750|50441572|FG006|HP Period 1|Lost to Follow-up|1|||
25203522|NCT02310750|50441573|FG007|HP Period 1|Lost to Follow-up|0|||
25203523|NCT02310750|50441574|FG008|HP Period 1|Lost to Follow-up|0|||
25203524|NCT02310750|50441575|FG009|HP Period 1|Lost to Follow-up|0|||
25203525|NCT02310750|50441576|FG010|HP Period 1|Lost to Follow-up|0|||
25203526|NCT02310750|50441577|FG011|HP Period 1|Lost to Follow-up|0|||
25203527|NCT02310750|50441578|FG012|HP Period 1|Lost to Follow-up|0|||
25203528|NCT02310750|50441579|FG013|HP Period 1|Lost to Follow-up|0|||
25203529|NCT02310750|50441580|FG014|HP Period 1|Lost to Follow-up|0|||
25203530|NCT02310750|50441581|FG015|HP Period 1|Lost to Follow-up|0|||
25203531|NCT02310750|50441566|FG000|HP Period 1|Withdrawal by Subject|1|||
25203532|NCT02310750|50441567|FG001|HP Period 1|Withdrawal by Subject|0|||
25203533|NCT02310750|50441568|FG002|HP Period 1|Withdrawal by Subject|0|||
25203534|NCT02310750|50441569|FG003|HP Period 1|Withdrawal by Subject|1|||
25203535|NCT02310750|50441570|FG004|HP Period 1|Withdrawal by Subject|0|||
25203536|NCT02310750|50441571|FG005|HP Period 1|Withdrawal by Subject|0|||
25203537|NCT02310750|50441572|FG006|HP Period 1|Withdrawal by Subject|0|||
25203538|NCT02310750|50441573|FG007|HP Period 1|Withdrawal by Subject|0|||
25203539|NCT02310750|50441574|FG008|HP Period 1|Withdrawal by Subject|0|||
25203540|NCT02310750|50441575|FG009|HP Period 1|Withdrawal by Subject|0|||
25203541|NCT02310750|50441576|FG010|HP Period 1|Withdrawal by Subject|0|||
25203542|NCT02310750|50441577|FG011|HP Period 1|Withdrawal by Subject|0|||
25203543|NCT02310750|50441578|FG012|HP Period 1|Withdrawal by Subject|0|||
25203544|NCT02310750|50441579|FG013|HP Period 1|Withdrawal by Subject|0|||
25203545|NCT02310750|50441580|FG014|HP Period 1|Withdrawal by Subject|0|||
25203546|NCT02310750|50441581|FG015|HP Period 1|Withdrawal by Subject|0|||
25203547|NCT02310750|50441566|FG000|HP Washout 1|Lost to Follow-up|0|||
25203548|NCT02310750|50441567|FG001|HP Washout 1|Lost to Follow-up|0|||
25203549|NCT02310750|50441568|FG002|HP Washout 1|Lost to Follow-up|1|||
25203550|NCT02310750|50441569|FG003|HP Washout 1|Lost to Follow-up|1|||
25203551|NCT02310750|50441570|FG004|HP Washout 1|Lost to Follow-up|2|||
25203552|NCT02310750|50441571|FG005|HP Washout 1|Lost to Follow-up|2|||
25203553|NCT02310750|50441572|FG006|HP Washout 1|Lost to Follow-up|3|||
25203554|NCT02310750|50441573|FG007|HP Washout 1|Lost to Follow-up|0|||
25203555|NCT02310750|50441574|FG008|HP Washout 1|Lost to Follow-up|0|||
25203556|NCT02310750|50441575|FG009|HP Washout 1|Lost to Follow-up|0|||
25203557|NCT02310750|50441576|FG010|HP Washout 1|Lost to Follow-up|0|||
25203558|NCT02310750|50441577|FG011|HP Washout 1|Lost to Follow-up|0|||
25203559|NCT02310750|50441578|FG012|HP Washout 1|Lost to Follow-up|0|||
25203560|NCT02310750|50441579|FG013|HP Washout 1|Lost to Follow-up|0|||
25203561|NCT02310750|50441580|FG014|HP Washout 1|Lost to Follow-up|0|||
25203562|NCT02310750|50441581|FG015|HP Washout 1|Lost to Follow-up|0|||
25203563|NCT02310750|50441566|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
25203564|NCT02310750|50441567|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
25203565|NCT02310750|50441568|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
25203566|NCT02310750|50441569|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
25203567|NCT02310750|50441570|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
25203568|NCT02310750|50441571|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
25203569|NCT02310750|50441572|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
25203570|NCT02310750|50441573|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
25203571|NCT02310750|50441574|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
25203572|NCT02310750|50441575|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
25203573|NCT02310750|50441576|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
25203574|NCT02310750|50441577|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
25203575|NCT02310750|50441578|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
25203576|NCT02310750|50441579|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
25203577|NCT02310750|50441580|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
25203578|NCT02310750|50441581|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
25203579|NCT02310750|50441566|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
25203580|NCT02310750|50441567|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
25203581|NCT02310750|50441568|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
25203582|NCT02310750|50441569|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
25203583|NCT02310750|50441570|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
25203584|NCT02310750|50441571|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
25203585|NCT02310750|50441572|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
25203586|NCT02310750|50441573|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
25203587|NCT02310750|50441574|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
25203588|NCT02310750|50441575|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
25203589|NCT02310750|50441576|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
25203590|NCT02310750|50441577|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
25203591|NCT02310750|50441578|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
25203592|NCT02310750|50441579|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
25203593|NCT02310750|50441580|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
25203594|NCT02310750|50441581|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
25203595|NCT02310750|50441566|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
25203596|NCT02310750|50441567|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
25203597|NCT02310750|50441568|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
25203598|NCT02310750|50441569|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
25203599|NCT02310750|50441570|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
25203600|NCT02310750|50441571|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
25203601|NCT02310750|50441572|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
25203602|NCT02310750|50441573|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
25203603|NCT02310750|50441574|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
25203604|NCT02310750|50441575|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
25203605|NCT02310750|50441576|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
25203606|NCT02310750|50441577|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
25203607|NCT02310750|50441578|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
25203608|NCT02310750|50441579|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
25203609|NCT02310750|50441580|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
25203610|NCT02310750|50441581|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
25203611|NCT02310750|50441566|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
25203612|NCT02310750|50441567|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
25203613|NCT02310750|50441568|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
25203614|NCT02310750|50441569|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
25203615|NCT02310750|50441570|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
25203616|NCT02310750|50441571|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
25203617|NCT02310750|50441572|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
25203618|NCT02310750|50441573|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
25203619|NCT02310750|50441574|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
25203620|NCT02310750|50441575|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
25203621|NCT02310750|50441576|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
25203622|NCT02310750|50441577|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
25203623|NCT02310750|50441578|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
25203624|NCT02310750|50441579|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
25203625|NCT02310750|50441580|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
25203626|NCT02310750|50441581|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
25203627|NCT02310750|50441566|FG000|HP Washout 2|Lost to Follow-up|0|||
25203628|NCT02310750|50441567|FG001|HP Washout 2|Lost to Follow-up|0|||
25203629|NCT02310750|50441568|FG002|HP Washout 2|Lost to Follow-up|0|||
25203630|NCT02310750|50441569|FG003|HP Washout 2|Lost to Follow-up|0|||
25203631|NCT02310750|50441570|FG004|HP Washout 2|Lost to Follow-up|1|||
25203632|NCT02310750|50441571|FG005|HP Washout 2|Lost to Follow-up|0|||
25203633|NCT02310750|50441572|FG006|HP Washout 2|Lost to Follow-up|7|||
25203634|NCT02310750|50441573|FG007|HP Washout 2|Lost to Follow-up|0|||
25203635|NCT02310750|50441574|FG008|HP Washout 2|Lost to Follow-up|0|||
25203636|NCT02310750|50441575|FG009|HP Washout 2|Lost to Follow-up|0|||
25203637|NCT02310750|50441576|FG010|HP Washout 2|Lost to Follow-up|0|||
25203638|NCT02310750|50441577|FG011|HP Washout 2|Lost to Follow-up|0|||
25203639|NCT02310750|50441578|FG012|HP Washout 2|Lost to Follow-up|0|||
25203640|NCT02310750|50441579|FG013|HP Washout 2|Lost to Follow-up|0|||
25203641|NCT02310750|50441580|FG014|HP Washout 2|Lost to Follow-up|0|||
25203642|NCT02310750|50441581|FG015|HP Washout 2|Lost to Follow-up|0|||
25203643|NCT02310672|50441686|FG000|Overall Study|Death|1|||
25203644|NCT02310672|50441686|FG000|Overall Study|Lost to Follow-up|1|||
25203645|NCT02310672|50441686|FG000|Overall Study|Withdrawal by Subject|1|||
25203646|NCT02310672|50441686|FG000|Overall Study|Sponsor's decision|12|||
25203647|NCT02363946|50441832|FG000|Overall Study|Lost to Follow-up|0|||
25203648|NCT02363946|50441833|FG001|Overall Study|Lost to Follow-up|0|||
25203649|NCT02363946|50441834|FG002|Overall Study|Lost to Follow-up|0|||
25203650|NCT02363946|50441835|FG003|Overall Study|Lost to Follow-up|0|||
25203651|NCT02363946|50441836|FG004|Overall Study|Lost to Follow-up|0|||
25203652|NCT02363946|50441837|FG005|Overall Study|Lost to Follow-up|0|||
25203653|NCT02363946|50441838|FG006|Overall Study|Lost to Follow-up|0|||
25203654|NCT02363946|50441839|FG007|Overall Study|Lost to Follow-up|1|||
25203655|NCT02363946|50441840|FG008|Overall Study|Lost to Follow-up|0|||
25203656|NCT02363946|50441841|FG009|Overall Study|Lost to Follow-up|0|||
25203657|NCT02363946|50441842|FG010|Overall Study|Lost to Follow-up|0|||
25203658|NCT02363946|50441843|FG011|Overall Study|Lost to Follow-up|0|||
25203659|NCT02363946|50441844|FG012|Overall Study|Lost to Follow-up|0|||
25203660|NCT02363478|50441872|FG000|Overall Study|Lost to Follow-up|4|||
25203661|NCT02363478|50441872|FG000|Overall Study|Adverse Event|4|||
25203662|NCT02310126|50441879|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
25203663|NCT02310126|50441880|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
25203664|NCT02310126|50441879|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
25203665|NCT02310126|50441880|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
25203666|NCT02338362|50441888|FG000|Overall Study|Withdrawal by Subject|1|||
25203667|NCT02338362|50441889|FG001|Overall Study|Withdrawal by Subject|1|||
25203668|NCT02363322|50441897|FG000|Overall Study|Lost to Follow-up|1|||
25203669|NCT02363322|50441898|FG001|Overall Study|Lost to Follow-up|0|||
25203670|NCT02361762|50441906|FG000|Overall Study|Withdrawal by Subject|0|||
25203671|NCT02361762|50441907|FG001|Overall Study|Withdrawal by Subject|1|||
25203672|NCT02361762|50441906|FG000|Overall Study|Lost to Follow-up|0|||
25203673|NCT02361762|50441907|FG001|Overall Study|Lost to Follow-up|1|||
25203674|NCT02337738|50441916|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
25203675|NCT02337738|50441917|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
25203676|NCT02337738|50441918|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
25203677|NCT02337738|50441916|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
25203678|NCT02337738|50441917|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
25203679|NCT02337738|50441918|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
25203680|NCT02337738|50441916|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
25203681|NCT02337738|50441917|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
25203682|NCT02337738|50441918|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
25203683|NCT02337738|50441916|FG000|Overall Study|Voluntary Withdrawal|10|||
25203684|NCT02337738|50441917|FG001|Overall Study|Voluntary Withdrawal|5|||
25203685|NCT02337738|50441918|FG002|Overall Study|Voluntary Withdrawal|2|||
25203686|NCT02337738|50441916|FG000|Overall Study|Lack of Efficacy|2|||
25203687|NCT02337738|50441917|FG001|Overall Study|Lack of Efficacy|4|||
25203688|NCT02337738|50441918|FG002|Overall Study|Lack of Efficacy|0|||
25203689|NCT02337738|50441916|FG000|Overall Study|Investigator's Judgment|1|||
25203690|NCT02337738|50441917|FG001|Overall Study|Investigator's Judgment|1|||
25203691|NCT02337738|50441918|FG002|Overall Study|Investigator's Judgment|3|||
25203692|NCT02309112|50441929|FG000|Overall Study|Withdrawal by Subject|1|||
25203693|NCT02309112|50441930|FG001|Overall Study|Withdrawal by Subject|0|||
25203694|NCT02309112|50441931|FG002|Overall Study|Withdrawal by Subject|1|||
25203695|NCT02309112|50441929|FG000|Overall Study|Lost to Follow-up|0|||
25203696|NCT02309112|50441930|FG001|Overall Study|Lost to Follow-up|1|||
25203697|NCT02309112|50441931|FG002|Overall Study|Lost to Follow-up|0|||
25203698|NCT02361216|50441943|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
25203699|NCT02361216|50441944|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
25203700|NCT02361216|50441943|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
25203701|NCT02361216|50441944|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
25203702|NCT02361216|50441943|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
25203703|NCT02361216|50441944|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
25203704|NCT02361216|50441943|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
25203705|NCT02361216|50441944|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
25203706|NCT02361216|50441943|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
25203707|NCT02361216|50441944|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
25203708|NCT02361216|50441943|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
25203709|NCT02361216|50441944|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
25203710|NCT00559988|50442377|FG000|Overall Study|Death|147|||
25203711|NCT00559988|50442378|FG001|Overall Study|Death|140|||
25203712|NCT00559988|50442377|FG000|Overall Study|Withdrawal by Subject|152|||
25203713|NCT00559988|50442378|FG001|Overall Study|Withdrawal by Subject|139|||
25203714|NCT00559988|50442377|FG000|Overall Study|Lost to Follow-up|42|||
25203715|NCT00559988|50442378|FG001|Overall Study|Lost to Follow-up|56|||
25203716|NCT00559988|50442377|FG000|Overall Study|ICD device explanted|10|||
25203717|NCT00559988|50442378|FG001|Overall Study|ICD device explanted|17|||
25203718|NCT00559754|50442440|FG000|Overall Study|Disease progression|1|||
25203719|NCT00559754|50442440|FG000|Overall Study|Adverse Event|5|||
25203720|NCT00559754|50442440|FG000|Overall Study|Protocol Violation|1|||
25203721|NCT00559754|50442440|FG000|Overall Study|Investigator criteria|2|||
25203722|NCT00559754|50442440|FG000|Overall Study|Withdrawal by Subject|2|||
25203723|NCT00559364|50442554|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
25203724|NCT00559364|50442555|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
25203725|NCT02308020|50442618|FG000|Overall Study|Lost to Follow-up|1|||
25203726|NCT02308020|50442619|FG001|Overall Study|Lost to Follow-up|7|||
25203727|NCT02308020|50442620|FG002|Overall Study|Lost to Follow-up|0|||
25203728|NCT02308020|50442621|FG003|Overall Study|Lost to Follow-up|0|||
25203729|NCT02308020|50442622|FG004|Overall Study|Lost to Follow-up|1|||
25203730|NCT02308020|50442623|FG005|Overall Study|Lost to Follow-up|2|||
25203731|NCT02308020|50442618|FG000|Overall Study|Sponsor Decision|0|||
25203732|NCT02308020|50442619|FG001|Overall Study|Sponsor Decision|8|||
25203733|NCT02308020|50442620|FG002|Overall Study|Sponsor Decision|0|||
25203734|NCT02308020|50442621|FG003|Overall Study|Sponsor Decision|2|||
25203735|NCT02308020|50442622|FG004|Overall Study|Sponsor Decision|2|||
25203736|NCT02308020|50442623|FG005|Overall Study|Sponsor Decision|1|||
25203737|NCT02308020|50442618|FG000|Overall Study|Withdrawal by Subject|3|||
25203738|NCT02308020|50442619|FG001|Overall Study|Withdrawal by Subject|5|||
25203739|NCT02308020|50442620|FG002|Overall Study|Withdrawal by Subject|3|||
25203740|NCT02308020|50442621|FG003|Overall Study|Withdrawal by Subject|2|||
25203741|NCT02308020|50442622|FG004|Overall Study|Withdrawal by Subject|1|||
25203742|NCT02308020|50442623|FG005|Overall Study|Withdrawal by Subject|2|||
25203743|NCT02359890|50442643|FG000|Overall Study|Not meeting eligibility|4|||
25203744|NCT02359890|50442643|FG000|Overall Study|Never treated with study catheter|6|||
25203745|NCT02306850|50442647|FG000|Overall Study|Lack of Efficacy|2|||
25203746|NCT02306694|50442652|FG000|Overall Study|Withdrawal by Subject|3|||
25203747|NCT02306694|50442652|FG000|Overall Study|Lost to Follow-up|1|||
25203748|NCT01648140|50442664|FG000|Overall Study|Physician Decision|1|||
25203749|NCT01648140|50442665|FG001|Overall Study|Physician Decision|0|||
25203750|NCT01648140|50442666|FG002|Overall Study|Physician Decision|0|||
25203751|NCT01648140|50442667|FG003|Overall Study|Physician Decision|0|||
25203752|NCT01648140|50442664|FG000|Overall Study|Lack of Efficacy|4|||
25203753|NCT01648140|50442665|FG001|Overall Study|Lack of Efficacy|7|||
25203754|NCT01648140|50442666|FG002|Overall Study|Lack of Efficacy|1|||
25203755|NCT01648140|50442667|FG003|Overall Study|Lack of Efficacy|0|||
25203756|NCT01648140|50442664|FG000|Overall Study|Adverse Event|3|||
25203757|NCT01648140|50442665|FG001|Overall Study|Adverse Event|1|||
25203758|NCT01648140|50442666|FG002|Overall Study|Adverse Event|2|||
25203759|NCT01648140|50442667|FG003|Overall Study|Adverse Event|0|||
25203760|NCT01648140|50442664|FG000|Overall Study|Withdrawal by Subject|2|||
25203761|NCT01648140|50442665|FG001|Overall Study|Withdrawal by Subject|3|||
25203762|NCT01648140|50442666|FG002|Overall Study|Withdrawal by Subject|3|||
25203763|NCT01648140|50442667|FG003|Overall Study|Withdrawal by Subject|2|||
25203764|NCT01648140|50442664|FG000|Overall Study|Lost to Follow-up|2|||
24976307|NCT03466060|50065215|FG004|Period 1|Grade 2 Conjunctivitis|0|||
25203765|NCT01648140|50442665|FG001|Overall Study|Lost to Follow-up|1|||
25203766|NCT01648140|50442666|FG002|Overall Study|Lost to Follow-up|2|||
25203767|NCT01648140|50442667|FG003|Overall Study|Lost to Follow-up|0|||
25203768|NCT02336178|50442686|FG000|Overall Study|Lost to Follow-up|1|||
25203769|NCT02336178|50442686|FG000|Overall Study|Protocol Violation|1|||
25203770|NCT02336178|50442686|FG000|Overall Study|Withdrawal by Subject|1|||
25203771|NCT02336178|50442686|FG000|Overall Study|Other|1|||
25203772|NCT02357940|50442700|FG000|Overall Study|Adverse Event|0|||
25203773|NCT02357940|50442701|FG001|Overall Study|Adverse Event|1|||
25203774|NCT02357940|50442700|FG000|Overall Study|Investigator's judgement|0|||
25203775|NCT02357940|50442701|FG001|Overall Study|Investigator's judgement|1|||
25203776|NCT02335242|50442709|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
25203777|NCT02335242|50442710|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
25203778|NCT02335242|50442709|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
25203779|NCT02335242|50442710|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
25203780|NCT02335242|50442709|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
25203781|NCT02335242|50442710|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
25203782|NCT02334384|50442722|FG000|Overall Study|Lost to Follow-up|1|||
25203783|NCT02334384|50442723|FG001|Overall Study|Lost to Follow-up|1|||
25203784|NCT02334306|50442731|FG000|Double-blind Period|Adverse Event|0|||
25203785|NCT02334306|50442732|FG001|Double-blind Period|Adverse Event|1|||
25203786|NCT02334306|50442731|FG000|Double-blind Period|Withdrawal by Subject|1|||
25203787|NCT02334306|50442732|FG001|Double-blind Period|Withdrawal by Subject|1|||
25315945|NCT00896532|50631601|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315946|NCT00896532|50631602|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315947|NCT00896532|50631603|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315948|NCT00896532|50631604|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315949|NCT00896532|50631605|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315950|NCT00896532|50631606|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315951|NCT00896532|50631607|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315952|NCT00896532|50631608|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315953|NCT00896532|50631609|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315954|NCT00896532|50631610|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
25315955|NCT00896532|50631588|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315956|NCT00896532|50631589|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315957|NCT00896532|50631590|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315958|NCT00896532|50631591|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
25315959|NCT00896532|50631592|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315960|NCT00896532|50631593|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315961|NCT00896532|50631594|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315962|NCT00896532|50631595|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315963|NCT00896532|50631596|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315964|NCT00896532|50631597|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315965|NCT00896532|50631598|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315966|NCT00896532|50631599|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315967|NCT00896532|50631600|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315968|NCT00896532|50631601|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315969|NCT00896532|50631602|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315970|NCT00896532|50631603|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315971|NCT00896532|50631604|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25203788|NCT02305758|50442741|FG000|Overall Study|Death|27|||
25203789|NCT02305758|50442742|FG001|Overall Study|Death|27|||
25203790|NCT02305758|50442741|FG000|Overall Study|Withdrew consent|9|||
25203791|NCT02305758|50442742|FG001|Overall Study|Withdrew consent|2|||
25203792|NCT02305758|50442741|FG000|Overall Study|Lost to Follow-up|6|||
25203793|NCT02305758|50442742|FG001|Overall Study|Lost to Follow-up|1|||
25203794|NCT02305758|50442741|FG000|Overall Study|Study Terminated by Sponsor|21|||
25203795|NCT02305758|50442742|FG001|Overall Study|Study Terminated by Sponsor|34|||
25203796|NCT02305758|50442741|FG000|Overall Study|Other, not specified|2|||
25203797|NCT02305758|50442742|FG001|Overall Study|Other, not specified|1|||
25203798|NCT02305446|50442748|FG000|Overall Study|Adverse Event|1|||
25203799|NCT02303574|50442885|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
25203800|NCT02303574|50442886|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
25203801|NCT02303574|50442887|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
25203802|NCT02303574|50442888|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
25203803|NCT02303574|50442889|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
25203804|NCT02303574|50442890|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
25203805|NCT02303574|50442891|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
25203806|NCT02303574|50442892|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
25203807|NCT02303574|50442893|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
25203808|NCT02303574|50442894|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
25203809|NCT02303574|50442885|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
25203810|NCT02303574|50442886|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
25203811|NCT02303574|50442887|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
25203812|NCT02303574|50442888|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
25203813|NCT02303574|50442889|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
25203814|NCT02303574|50442890|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
25203815|NCT02303574|50442891|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
25203816|NCT02303574|50442892|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
25203817|NCT02303574|50442893|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
25203818|NCT02303574|50442894|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
25203819|NCT02354976|50442930|FG000|Overall Study|Other - reason not specified|1|||
25203820|NCT02354976|50442931|FG001|Overall Study|Other - reason not specified|0|||
25203821|NCT02354976|50442932|FG002|Overall Study|Other - reason not specified|1|||
25203822|NCT02354976|50442930|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
25203823|NCT02354976|50442931|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
25203824|NCT02354976|50442932|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
25203825|NCT02354976|50442930|FG000|Overall Study|Adverse Event|1|||
25203826|NCT02354976|50442931|FG001|Overall Study|Adverse Event|0|||
25203827|NCT02354976|50442932|FG002|Overall Study|Adverse Event|2|||
25203828|NCT02303262|50442940|FG000|Overall Study|Withdrawal by Subject|2|||
25203829|NCT00558896|50442951|FG000|Overall Study|Adverse Event|1|||
25203830|NCT00558896|50442952|FG001|Overall Study|Adverse Event|1|||
25203831|NCT00558896|50442953|FG002|Overall Study|Adverse Event|1|||
25203832|NCT00558896|50442954|FG003|Overall Study|Adverse Event|3|||
25203833|NCT00558896|50442955|FG004|Overall Study|Adverse Event|4|||
25203834|NCT00558896|50442956|FG005|Overall Study|Adverse Event|10|||
25203835|NCT00558896|50442957|FG006|Overall Study|Adverse Event|3|||
25203836|NCT00558896|50442951|FG000|Overall Study|Death|3|||
25203837|NCT00558896|50442952|FG001|Overall Study|Death|0|||
25203838|NCT00558896|50442953|FG002|Overall Study|Death|2|||
25203839|NCT00558896|50442954|FG003|Overall Study|Death|3|||
25203840|NCT00558896|50442955|FG004|Overall Study|Death|2|||
25203841|NCT00558896|50442956|FG005|Overall Study|Death|2|||
25203842|NCT00558896|50442957|FG006|Overall Study|Death|6|||
25203843|NCT00558896|50442951|FG000|Overall Study|Withdrawal by Subject|2|||
25203844|NCT00558896|50442952|FG001|Overall Study|Withdrawal by Subject|1|||
25315972|NCT00896532|50631605|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315973|NCT00896532|50631606|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315974|NCT00896532|50631607|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25203845|NCT00558896|50442953|FG002|Overall Study|Withdrawal by Subject|1|||
25203846|NCT00558896|50442954|FG003|Overall Study|Withdrawal by Subject|1|||
25203847|NCT00558896|50442955|FG004|Overall Study|Withdrawal by Subject|1|||
25203848|NCT00558896|50442956|FG005|Overall Study|Withdrawal by Subject|5|||
25203849|NCT00558896|50442957|FG006|Overall Study|Withdrawal by Subject|5|||
25203850|NCT00558896|50442951|FG000|Overall Study|Alternative Treatment|2|||
25203851|NCT00558896|50442952|FG001|Overall Study|Alternative Treatment|2|||
25203852|NCT00558896|50442953|FG002|Overall Study|Alternative Treatment|0|||
25203853|NCT00558896|50442954|FG003|Overall Study|Alternative Treatment|2|||
25203854|NCT00558896|50442955|FG004|Overall Study|Alternative Treatment|6|||
25203855|NCT00558896|50442956|FG005|Overall Study|Alternative Treatment|7|||
25203856|NCT00558896|50442957|FG006|Overall Study|Alternative Treatment|1|||
25203857|NCT00558896|50442951|FG000|Overall Study|Physician discretion|3|||
25203858|NCT00558896|50442952|FG001|Overall Study|Physician discretion|2|||
25203859|NCT00558896|50442953|FG002|Overall Study|Physician discretion|1|||
25203860|NCT00558896|50442954|FG003|Overall Study|Physician discretion|2|||
25203861|NCT00558896|50442955|FG004|Overall Study|Physician discretion|1|||
25203862|NCT00558896|50442956|FG005|Overall Study|Physician discretion|3|||
25203863|NCT00558896|50442957|FG006|Overall Study|Physician discretion|3|||
25203864|NCT00558896|50442951|FG000|Overall Study|Continues on treatment|10|||
25203865|NCT00558896|50442952|FG001|Overall Study|Continues on treatment|1|||
25203866|NCT00558896|50442953|FG002|Overall Study|Continues on treatment|0|||
25203867|NCT00558896|50442954|FG003|Overall Study|Continues on treatment|1|||
25203868|NCT00558896|50442955|FG004|Overall Study|Continues on treatment|9|||
25203869|NCT00558896|50442956|FG005|Overall Study|Continues on treatment|25|||
25203870|NCT00558896|50442957|FG006|Overall Study|Continues on treatment|6|||
25203871|NCT00558428|50443091|FG000|Overall Study|Adverse Event|6|||
25203872|NCT00558428|50443092|FG001|Overall Study|Adverse Event|22|||
25203873|NCT00558428|50443093|FG002|Overall Study|Adverse Event|3|||
25203874|NCT00558428|50443094|FG003|Overall Study|Adverse Event|4|||
25203875|NCT00558428|50443091|FG000|Overall Study|Lost to Follow-up|0|||
25203876|NCT00558428|50443092|FG001|Overall Study|Lost to Follow-up|1|||
25203877|NCT00558428|50443093|FG002|Overall Study|Lost to Follow-up|0|||
25203878|NCT00558428|50443094|FG003|Overall Study|Lost to Follow-up|0|||
25203879|NCT00558428|50443091|FG000|Overall Study|Lack of Efficacy|0|||
25203880|NCT00558428|50443092|FG001|Overall Study|Lack of Efficacy|0|||
25203881|NCT00558428|50443093|FG002|Overall Study|Lack of Efficacy|1|||
25203882|NCT00558428|50443094|FG003|Overall Study|Lack of Efficacy|2|||
25203883|NCT00558428|50443091|FG000|Overall Study|Non compliant with protocol|1|||
25203884|NCT00558428|50443092|FG001|Overall Study|Non compliant with protocol|0|||
25203885|NCT00558428|50443093|FG002|Overall Study|Non compliant with protocol|0|||
25203886|NCT00558428|50443094|FG003|Overall Study|Non compliant with protocol|3|||
25203887|NCT00558428|50443091|FG000|Overall Study|Consent withdrawn|2|||
25203888|NCT00558428|50443092|FG001|Overall Study|Consent withdrawn|1|||
25171405|NCT01775189|50308318|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
25171406|NCT01775189|50308319|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
25171407|NCT01775189|50308320|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
25171408|NCT01775189|50308321|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
25171409|NCT01775189|50308322|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
25171410|NCT01775189|50308323|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
25171411|NCT01770743|50308389|FG000|Overall Study|Adverse Event|1|||
25171412|NCT01770743|50308390|FG001|Overall Study|Adverse Event|0|||
25171413|NCT01770743|50308391|FG002|Overall Study|Adverse Event|0|||
25203889|NCT00558428|50443093|FG002|Overall Study|Consent withdrawn|0|||
25203890|NCT00558428|50443094|FG003|Overall Study|Consent withdrawn|1|||
25203891|NCT00558428|50443091|FG000|Overall Study|Other|3|||
25203892|NCT00558428|50443092|FG001|Overall Study|Other|0|||
25203893|NCT00558428|50443093|FG002|Overall Study|Other|0|||
25203894|NCT00558428|50443094|FG003|Overall Study|Other|1|||
25203895|NCT00558272|50443133|FG000|Overall Study|Adverse Event|10|||
25203896|NCT00558272|50443134|FG001|Overall Study|Adverse Event|0|||
25203897|NCT00558272|50443133|FG000|Overall Study|Death|1|||
25203898|NCT00558272|50443134|FG001|Overall Study|Death|0|||
25203899|NCT00558272|50443133|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
25203900|NCT00558272|50443134|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
25203901|NCT00558272|50443133|FG000|Overall Study|AZ study team decision|0|||
25203902|NCT00558272|50443134|FG001|Overall Study|AZ study team decision|1|||
25203903|NCT00558272|50443133|FG000|Overall Study|Incorrectly enrolled|1|||
25203904|NCT00558272|50443134|FG001|Overall Study|Incorrectly enrolled|0|||
25203905|NCT00558272|50443133|FG000|Overall Study|Withdrawal by Subject|0|||
25203906|NCT00558272|50443134|FG001|Overall Study|Withdrawal by Subject|1|||
25203907|NCT00557492|50443284|FG000|Overall Study|Change in health insurance|1|||
25203908|NCT02354586|50443387|FG000|Overall Study|Death|230|||
25077108|NCT02439320|50184948|FG000|Overall Study|Pregnancy|0|||
25171414|NCT01770743|50308392|FG003|Overall Study|Adverse Event|0|||
25171415|NCT01770743|50308393|FG004|Overall Study|Adverse Event|0|||
25203909|NCT02354586|50443387|FG000|Overall Study|Withdrawal by Subject|59|||
25203910|NCT02354586|50443387|FG000|Overall Study|Lost to Follow-up|11|||
25203911|NCT02354586|50443387|FG000|Overall Study|Sponsor decision|51|||
25203912|NCT02354586|50443387|FG000|Overall Study|Site closure|2|||
25203913|NCT02354586|50443387|FG000|Overall Study|Intercurrent illness|1|||
25203914|NCT02354586|50443387|FG000|Overall Study|Protocol Violation|3|||
25203915|NCT02354586|50443387|FG000|Overall Study|Physician Decision|13|||
25203916|NCT02354586|50443387|FG000|Overall Study|Lack of Efficacy|86|||
25203917|NCT02354586|50443387|FG000|Overall Study|Adverse Event|7|||
25203918|NCT02332824|50443412|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
25203919|NCT02332824|50443413|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
25203920|NCT02332824|50443414|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
25203921|NCT02332824|50443415|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
25203922|NCT02332824|50443416|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
25203923|NCT02332824|50443417|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
25203924|NCT02332824|50443412|FG000|Overall Study|Voluntary Withdrawal|1|||
25203925|NCT02332824|50443413|FG001|Overall Study|Voluntary Withdrawal|0|||
25203926|NCT02332824|50443414|FG002|Overall Study|Voluntary Withdrawal|0|||
25203927|NCT02332824|50443415|FG003|Overall Study|Voluntary Withdrawal|0|||
25203928|NCT02332824|50443416|FG004|Overall Study|Voluntary Withdrawal|0|||
25203929|NCT02332824|50443417|FG005|Overall Study|Voluntary Withdrawal|0|||
25203930|NCT02332824|50443412|FG000|Overall Study|Inconvenient schedule|1|||
25203931|NCT02332824|50443413|FG001|Overall Study|Inconvenient schedule|1|||
25203932|NCT02332824|50443414|FG002|Overall Study|Inconvenient schedule|0|||
25203933|NCT02332824|50443415|FG003|Overall Study|Inconvenient schedule|0|||
25203934|NCT02332824|50443416|FG004|Overall Study|Inconvenient schedule|0|||
25203935|NCT02332824|50443417|FG005|Overall Study|Inconvenient schedule|0|||
25203936|NCT02332824|50443412|FG000|Overall Study|Transfer|0|||
25203937|NCT02332824|50443413|FG001|Overall Study|Transfer|0|||
25203938|NCT02332824|50443414|FG002|Overall Study|Transfer|1|||
25203939|NCT02332824|50443415|FG003|Overall Study|Transfer|1|||
25203940|NCT02332824|50443416|FG004|Overall Study|Transfer|0|||
25203941|NCT02332824|50443417|FG005|Overall Study|Transfer|0|||
25203942|NCT00556712|50443564|FG000|Overall Study|Adverse Event|7|||
25203943|NCT00556712|50443565|FG001|Overall Study|Adverse Event|19|||
25203944|NCT00556712|50443564|FG000|Overall Study|Death|5|||
25203945|NCT00556712|50443565|FG001|Overall Study|Death|10|||
25203946|NCT00556712|50443564|FG000|Overall Study|Progressive Disease|383|||
25203947|NCT00556712|50443565|FG001|Overall Study|Progressive Disease|320|||
25203948|NCT00556712|50443564|FG000|Overall Study|Protocol Violation|3|||
25203949|NCT00556712|50443565|FG001|Overall Study|Protocol Violation|2|||
25203950|NCT00556712|50443564|FG000|Overall Study|Refused Treatment|17|||
25203951|NCT00556712|50443565|FG001|Overall Study|Refused Treatment|16|||
25203952|NCT00556712|50443564|FG000|Overall Study|Failure to Return|2|||
25203953|NCT00556712|50443565|FG001|Overall Study|Failure to Return|3|||
25203954|NCT00556712|50443564|FG000|Overall Study|Other|2|||
25203955|NCT00556712|50443565|FG001|Overall Study|Other|2|||
25203956|NCT00556712|50443564|FG000|Overall Study|Ongoing at Data Cutoff|32|||
25203957|NCT00556712|50443565|FG001|Overall Study|Ongoing at Data Cutoff|66|||
25203958|NCT00556322|50443639|FG000|Overall Study|Insufficient therapeutic response|158|||
25203959|NCT00556322|50443640|FG001|Overall Study|Insufficient therapeutic response|168|||
25203960|NCT00556322|50443639|FG000|Overall Study|Adverse Event|7|||
25203961|NCT00556322|50443640|FG001|Overall Study|Adverse Event|4|||
25203962|NCT00556322|50443639|FG000|Overall Study|Other|4|||
25203963|NCT00556322|50443640|FG001|Overall Study|Other|1|||
25203964|NCT00556322|50443639|FG000|Overall Study|Lost to Follow-up|5|||
25203965|NCT00556322|50443640|FG001|Overall Study|Lost to Follow-up|3|||
25203966|NCT00556322|50443639|FG000|Overall Study|Withdrawal by Subject|19|||
25203967|NCT00556322|50443640|FG001|Overall Study|Withdrawal by Subject|7|||
25203968|NCT00556322|50443639|FG000|Overall Study|Protocol Violation|5|||
25203969|NCT00556322|50443640|FG001|Overall Study|Protocol Violation|1|||
25203970|NCT00556322|50443639|FG000|Overall Study|Ongoing at data cutoff|3|||
25203971|NCT00556322|50443640|FG001|Overall Study|Ongoing at data cutoff|5|||
25203972|NCT00556322|50443639|FG000|Overall Study|Death|20|||
25203973|NCT00556322|50443640|FG001|Overall Study|Death|14|||
25203974|NCT00556166|50443658|FG000|Overall Study|Withdrawal by Subject|1|||
25203975|NCT02332590|50443818|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
25203976|NCT02332590|50443819|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
25203977|NCT02332590|50443818|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
25203978|NCT02332590|50443819|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
25203979|NCT02332590|50443818|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
25203980|NCT02332590|50443819|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
25203981|NCT02332590|50443818|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
25203982|NCT02332590|50443819|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
25203983|NCT02332590|50443818|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
25203984|NCT02332590|50443819|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
25203985|NCT02332590|50443818|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
25203986|NCT02332590|50443819|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
25203987|NCT02332590|50443818|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
25203988|NCT02332590|50443819|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
25203989|NCT02332590|50443818|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
25203990|NCT02332590|50443819|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
25203991|NCT02332590|50443818|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
25203992|NCT02332590|50443819|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
25203993|NCT00554840|50443890|FG000|Overall Study|Physician Decision|0|||
25203994|NCT00554840|50443891|FG001|Overall Study|Physician Decision|1|||
25203995|NCT02302716|50443916|FG000|Overall Study|Adverse Event|1|||
25203996|NCT02302716|50443917|FG001|Overall Study|Adverse Event|1|||
25203997|NCT02302716|50443916|FG000|Overall Study|Death|0|||
25203998|NCT02302716|50443917|FG001|Overall Study|Death|1|||
25203999|NCT02302716|50443916|FG000|Overall Study|Lack of Efficacy|0|||
25204000|NCT02302716|50443917|FG001|Overall Study|Lack of Efficacy|1|||
25204001|NCT02302716|50443916|FG000|Overall Study|Lost to Follow-up|2|||
25204002|NCT02302716|50443917|FG001|Overall Study|Lost to Follow-up|4|||
25204003|NCT02302716|50443916|FG000|Overall Study|Physician Decision|3|||
25204004|NCT02302716|50443917|FG001|Overall Study|Physician Decision|4|||
25204005|NCT02302716|50443916|FG000|Overall Study|Withdrawal by Subject|13|||
25204006|NCT02302716|50443917|FG001|Overall Study|Withdrawal by Subject|7|||
25204007|NCT02302716|50443916|FG000|Overall Study|Protocol Violation|0|||
25204008|NCT02302716|50443917|FG001|Overall Study|Protocol Violation|1|||
25204009|NCT00554606|50443946|FG000|Overall Study|Adverse Event|3|||
25204010|NCT00554606|50443946|FG000|Overall Study|Abnormal laboratory values|1|||
25204011|NCT00554606|50443946|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
25204012|NCT00554606|50443946|FG000|Overall Study|Subject withdrew consent|2|||
25204013|NCT00554606|50443946|FG000|Overall Study|Lost to Follow-up|2|||
25204014|NCT00554606|50443946|FG000|Overall Study|Administrative problems|60|||
25204015|NCT00554606|50443946|FG000|Overall Study|Death|1|||
25204016|NCT00554606|50443946|FG000|Overall Study|Protocol deviation|2|||
25204017|NCT02354508|50443982|FG000|Period 1: Core Phase|Adverse Event|1|||
25204018|NCT02354508|50443983|FG001|Period 1: Core Phase|Adverse Event|1|||
25204019|NCT02354508|50443984|FG002|Period 1: Core Phase|Adverse Event|2|||
25204020|NCT02354508|50443982|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
25204021|NCT02354508|50443983|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
25204022|NCT02354508|50443984|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
25204023|NCT02354508|50443982|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
25204024|NCT02354508|50443983|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
25204025|NCT02354508|50443984|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
25204026|NCT02354508|50443982|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
25204027|NCT02354508|50443983|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
25204028|NCT02354508|50443984|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
25204029|NCT02354508|50443982|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
25204030|NCT02354508|50443983|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
25204031|NCT02354508|50443984|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
25204032|NCT02354508|50443982|FG000|Period 2: Extension Phase|Physician Decision|5|||
25204033|NCT02354508|50443983|FG001|Period 2: Extension Phase|Physician Decision|0|||
25204034|NCT02354508|50443984|FG002|Period 2: Extension Phase|Physician Decision|1|||
25204035|NCT02354508|50443982|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
25204036|NCT02354508|50443983|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
25204037|NCT02354508|50443984|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
25204038|NCT02354508|50443982|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
25204039|NCT02354508|50443983|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
25204040|NCT02354508|50443984|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
25204041|NCT02354508|50443982|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
25204042|NCT02354508|50443983|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
25204043|NCT02354508|50443984|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
25204044|NCT00554216|50444036|FG000|Overall Study|Lost to Follow-up|92|||
25204045|NCT00554216|50444037|FG001|Overall Study|Lost to Follow-up|31|||
25204046|NCT00554216|50444038|FG002|Overall Study|Lost to Follow-up|63|||
25204047|NCT00554216|50444036|FG000|Overall Study|Adverse Event|16|||
25204048|NCT00554216|50444037|FG001|Overall Study|Adverse Event|16|||
25204049|NCT00554216|50444038|FG002|Overall Study|Adverse Event|36|||
25204050|NCT00554216|50444036|FG000|Overall Study|Withdrawal by Subject|92|||
25204051|NCT00554216|50444037|FG001|Overall Study|Withdrawal by Subject|31|||
25204052|NCT00554216|50444038|FG002|Overall Study|Withdrawal by Subject|43|||
25204053|NCT00554216|50444036|FG000|Overall Study|Non compliance|10|||
25204054|NCT00554216|50444037|FG001|Overall Study|Non compliance|4|||
25204055|NCT00554216|50444038|FG002|Overall Study|Non compliance|5|||
25204056|NCT00554216|50444036|FG000|Overall Study|Pregnancy|2|||
25204057|NCT00554216|50444037|FG001|Overall Study|Pregnancy|1|||
25204058|NCT00554216|50444038|FG002|Overall Study|Pregnancy|14|||
25077109|NCT02439320|50184949|FG001|Overall Study|Pregnancy|1|||
25204059|NCT00554216|50444036|FG000|Overall Study|Restricted med|3|||
25204060|NCT00554216|50444037|FG001|Overall Study|Restricted med|1|||
25204061|NCT00554216|50444038|FG002|Overall Study|Restricted med|1|||
25204062|NCT00554216|50444036|FG000|Overall Study|Other|12|||
25204063|NCT00554216|50444037|FG001|Overall Study|Other|7|||
25204064|NCT00554216|50444038|FG002|Overall Study|Other|10|||
25204065|NCT00554216|50444036|FG000|Overall Study|Lack of Efficacy|15|||
25204066|NCT00554216|50444037|FG001|Overall Study|Lack of Efficacy|3|||
25204067|NCT00554216|50444038|FG002|Overall Study|Lack of Efficacy|0|||
25204068|NCT02353572|50444063|FG000|Overall Study|Withdrawal by Subject|1|||
25204069|NCT02353572|50444063|FG000|Overall Study|Study terminated|2|||
25204070|NCT00552578|50444075|FG000|Overall Study|Lost to Follow-up|1|||
25204071|NCT00552578|50444076|FG001|Overall Study|Lost to Follow-up|1|||
25204072|NCT02301936|50444084|FG000|Overall Study|Lost to Follow-up|1|||
25204073|NCT02301936|50444085|FG001|Overall Study|Lost to Follow-up|0|||
25204074|NCT00552344|50444124|FG000|Overall Study|Lack of Efficacy|55|||
25204075|NCT00552344|50444124|FG000|Overall Study|Loss of efficacy|75|||
25204076|NCT00552344|50444124|FG000|Overall Study|Lost to Follow-up|8|||
25204077|NCT00552344|50444124|FG000|Overall Study|Withdrawal by Subject|48|||
25204078|NCT00552344|50444124|FG000|Overall Study|SAE, non-fatal|6|||
25204079|NCT00552344|50444124|FG000|Overall Study|AE, non-serious non-fatal|38|||
25204080|NCT00552344|50444124|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
25204081|NCT00552344|50444124|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
25204082|NCT00552344|50444124|FG000|Overall Study|Other Reason|22|||
25204083|NCT00553514|50444161|FG000|Overall Study|Protocol deviation|0|||
25204084|NCT00553514|50444162|FG001|Overall Study|Protocol deviation|0|||
25204085|NCT00553514|50444163|FG002|Overall Study|Protocol deviation|0|||
25204086|NCT00553514|50444164|FG003|Overall Study|Protocol deviation|1|||
25204087|NCT00553514|50444165|FG004|Overall Study|Protocol deviation|0|||
25204088|NCT00553514|50444161|FG000|Overall Study|Lack of ovarian response|4|||
25204089|NCT00553514|50444162|FG001|Overall Study|Lack of ovarian response|5|||
25204090|NCT00553514|50444163|FG002|Overall Study|Lack of ovarian response|5|||
25204091|NCT00553514|50444164|FG003|Overall Study|Lack of ovarian response|5|||
25204092|NCT00553514|50444165|FG004|Overall Study|Lack of ovarian response|6|||
25204093|NCT00553514|50444161|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
25204094|NCT00553514|50444162|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
25204095|NCT00553514|50444163|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
25204096|NCT00553514|50444164|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
25204097|NCT00553514|50444165|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
25204098|NCT00553514|50444161|FG000|Overall Study|Risk of multiple pregnancy|0|||
25204099|NCT00553514|50444162|FG001|Overall Study|Risk of multiple pregnancy|2|||
25204100|NCT00553514|50444163|FG002|Overall Study|Risk of multiple pregnancy|0|||
25204101|NCT00553514|50444164|FG003|Overall Study|Risk of multiple pregnancy|1|||
25204102|NCT00553514|50444165|FG004|Overall Study|Risk of multiple pregnancy|0|||
25204103|NCT00553514|50444161|FG000|Overall Study|Other|1|||
25204104|NCT00553514|50444162|FG001|Overall Study|Other|1|||
25204105|NCT00553514|50444163|FG002|Overall Study|Other|0|||
25171416|NCT01770743|50308389|FG000|Overall Study|Withdrawal by Subject|0|||
25171417|NCT01770743|50308390|FG001|Overall Study|Withdrawal by Subject|0|||
25171418|NCT01770743|50308391|FG002|Overall Study|Withdrawal by Subject|1|||
25171419|NCT01770743|50308392|FG003|Overall Study|Withdrawal by Subject|1|||
25171420|NCT01770743|50308393|FG004|Overall Study|Withdrawal by Subject|1|||
25171421|NCT01770743|50308389|FG000|Overall Study|Lost to Follow-up|0|||
25171422|NCT01770743|50308390|FG001|Overall Study|Lost to Follow-up|2|||
25171423|NCT01770743|50308391|FG002|Overall Study|Lost to Follow-up|0|||
25171424|NCT01770743|50308392|FG003|Overall Study|Lost to Follow-up|0|||
25171425|NCT01770743|50308393|FG004|Overall Study|Lost to Follow-up|1|||
25171426|NCT01770743|50308389|FG000|Overall Study|Sponsor Terminated Subject|1|||
25171427|NCT01770743|50308390|FG001|Overall Study|Sponsor Terminated Subject|0|||
25171428|NCT01770743|50308391|FG002|Overall Study|Sponsor Terminated Subject|0|||
25171429|NCT01770743|50308392|FG003|Overall Study|Sponsor Terminated Subject|1|||
25171430|NCT01770743|50308393|FG004|Overall Study|Sponsor Terminated Subject|0|||
25171431|NCT01770743|50308389|FG000|Overall Study|Moving Out of State|0|||
25171432|NCT01770743|50308390|FG001|Overall Study|Moving Out of State|1|||
25171433|NCT01770743|50308391|FG002|Overall Study|Moving Out of State|0|||
25171434|NCT01770743|50308392|FG003|Overall Study|Moving Out of State|0|||
25171435|NCT01770743|50308393|FG004|Overall Study|Moving Out of State|0|||
25171436|NCT01767467|50308489|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
25171437|NCT01767467|50308490|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
25171438|NCT01767467|50308489|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
25171439|NCT01767467|50308490|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
25171440|NCT01767467|50308489|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
25171441|NCT01767467|50308490|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
25171442|NCT01767467|50308489|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
25171443|NCT01767467|50308490|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
25171444|NCT01767467|50308489|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
25171445|NCT01767467|50308490|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
25171446|NCT01767467|50308489|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
25171447|NCT01767467|50308490|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
25171448|NCT01767467|50308489|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
25171449|NCT01767467|50308490|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
25204106|NCT00553514|50444164|FG003|Overall Study|Other|0|||
25204107|NCT00553514|50444165|FG004|Overall Study|Other|1|||
25204108|NCT00553436|50444189|FG000|Overall Study|Conversion to another procedure|1|||
25204109|NCT00553202|50444220|FG000|Overall Study|Death|16|||
25204110|NCT00553202|50444220|FG000|Overall Study|Lost to Follow-up|1|||
25204111|NCT00553202|50444220|FG000|Overall Study|Physician Decision|28|||
25204112|NCT00553202|50444220|FG000|Overall Study|Withdrawal by Subject|1|||
25204113|NCT00553202|50444220|FG000|Overall Study|No donor identified|16|||
25204114|NCT00553202|50444220|FG000|Overall Study|Fails to meet organ function|6|||
25204115|NCT00552188|50444244|FG000|Overall Study|Adverse Event|0|||
25204116|NCT00552188|50444245|FG001|Overall Study|Adverse Event|2|||
25204117|NCT00552188|50444244|FG000|Overall Study|Lost to Follow-up|2|||
25204118|NCT00552188|50444245|FG001|Overall Study|Lost to Follow-up|1|||
25204119|NCT00552188|50444244|FG000|Overall Study|Withdrawal of consent|0|||
25204120|NCT00552188|50444245|FG001|Overall Study|Withdrawal of consent|1|||
25204121|NCT00552188|50444244|FG000|Overall Study|Subject returned to home country|0|||
25204122|NCT00552188|50444245|FG001|Overall Study|Subject returned to home country|1|||
25204123|NCT00552110|50444265|FG000|Overall Study|Serious or Life-Threatening AE|0|||
25204124|NCT00552110|50444266|FG001|Overall Study|Serious or Life-Threatening AE|0|||
25204125|NCT00552110|50444267|FG002|Overall Study|Serious or Life-Threatening AE|1|||
25204126|NCT00552110|50444268|FG003|Overall Study|Serious or Life-Threatening AE|0|||
25204127|NCT00552110|50444269|FG004|Overall Study|Serious or Life-Threatening AE|0|||
25204128|NCT00552110|50444265|FG000|Overall Study|Lack of Efficacy|1|||
25204129|NCT00552110|50444266|FG001|Overall Study|Lack of Efficacy|0|||
25204130|NCT00552110|50444267|FG002|Overall Study|Lack of Efficacy|0|||
25204131|NCT00552110|50444268|FG003|Overall Study|Lack of Efficacy|1|||
25204132|NCT00552110|50444269|FG004|Overall Study|Lack of Efficacy|4|||
25204133|NCT00552110|50444265|FG000|Overall Study|Withdrawal by Subject|0|||
25204134|NCT00552110|50444266|FG001|Overall Study|Withdrawal by Subject|2|||
25204135|NCT00552110|50444267|FG002|Overall Study|Withdrawal by Subject|0|||
25204136|NCT00552110|50444268|FG003|Overall Study|Withdrawal by Subject|3|||
25204137|NCT00552110|50444269|FG004|Overall Study|Withdrawal by Subject|2|||
25204138|NCT00552110|50444265|FG000|Overall Study|Lost to Follow-up|0|||
25204139|NCT00552110|50444266|FG001|Overall Study|Lost to Follow-up|0|||
25204140|NCT00552110|50444267|FG002|Overall Study|Lost to Follow-up|0|||
25204141|NCT00552110|50444268|FG003|Overall Study|Lost to Follow-up|1|||
25204142|NCT00552110|50444269|FG004|Overall Study|Lost to Follow-up|1|||
25204143|NCT00552110|50444265|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
25204144|NCT00552110|50444266|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
25204145|NCT00552110|50444267|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
25204146|NCT00552110|50444268|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
25204147|NCT00552110|50444269|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
25204148|NCT00552110|50444265|FG000|Overall Study|Withdrawn per Sponsor|0|||
25204149|NCT00552110|50444266|FG001|Overall Study|Withdrawn per Sponsor|1|||
25204150|NCT00552110|50444267|FG002|Overall Study|Withdrawn per Sponsor|0|||
25204151|NCT00552110|50444268|FG003|Overall Study|Withdrawn per Sponsor|0|||
25204152|NCT00552110|50444269|FG004|Overall Study|Withdrawn per Sponsor|1|||
25204153|NCT00552110|50444265|FG000|Overall Study|Use of Prohibited Medication|1|||
25204154|NCT00552110|50444266|FG001|Overall Study|Use of Prohibited Medication|1|||
25204155|NCT00552110|50444267|FG002|Overall Study|Use of Prohibited Medication|0|||
25204156|NCT00552110|50444268|FG003|Overall Study|Use of Prohibited Medication|0|||
25204157|NCT00552110|50444269|FG004|Overall Study|Use of Prohibited Medication|0|||
25204158|NCT00552110|50444265|FG000|Overall Study|Delay of Study due to Relabeling|0|||
25204159|NCT00552110|50444266|FG001|Overall Study|Delay of Study due to Relabeling|0|||
25204160|NCT00552110|50444267|FG002|Overall Study|Delay of Study due to Relabeling|0|||
25204161|NCT00552110|50444268|FG003|Overall Study|Delay of Study due to Relabeling|1|||
25204162|NCT00552110|50444269|FG004|Overall Study|Delay of Study due to Relabeling|0|||
25204163|NCT00552110|50444265|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
25204164|NCT00552110|50444266|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
25204165|NCT00552110|50444267|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
25204166|NCT00552110|50444268|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
25204167|NCT00552110|50444269|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
25204168|NCT00552110|50444265|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
25204169|NCT00552110|50444266|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
25204170|NCT00552110|50444267|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
25204171|NCT00552110|50444268|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
25204172|NCT00552110|50444269|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
25204173|NCT02301624|50444292|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
25204174|NCT02301624|50444293|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
25204175|NCT02301624|50444292|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
25204176|NCT02301624|50444293|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
25204177|NCT02301624|50444292|FG000|Open-label Maintenance Phase|Adverse Event|2|||
25204178|NCT02301624|50444293|FG001|Open-label Maintenance Phase|Adverse Event|5|||
25204179|NCT02301624|50444292|FG000|Open-label Maintenance Phase|Physician Decision|3|||
25204180|NCT02301624|50444293|FG001|Open-label Maintenance Phase|Physician Decision|3|||
25204181|NCT02301624|50444292|FG000|Open-label Maintenance Phase|Death|2|||
25315975|NCT00896532|50631608|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25204182|NCT02301624|50444293|FG001|Open-label Maintenance Phase|Death|1|||
25204183|NCT02301624|50444292|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
25204184|NCT02301624|50444293|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
25204185|NCT02301546|50444334|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
25204186|NCT02301546|50444335|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
25204187|NCT02301546|50444334|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
25204188|NCT02301546|50444335|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
25204189|NCT02301546|50444334|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
25204190|NCT02301546|50444335|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
25204191|NCT02301546|50444334|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
25204192|NCT02301546|50444335|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
25204193|NCT02301546|50444334|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
25204194|NCT02301546|50444335|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
25204195|NCT02301546|50444334|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
25204196|NCT02301546|50444335|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
25204197|NCT02301546|50444334|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
25204198|NCT02301546|50444335|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
25204199|NCT02351934|50444359|FG000|Allocation|POD weight<pre-op weight|3|||
25204200|NCT02351934|50444360|FG001|Allocation|POD weight<pre-op weight|0|||
25204201|NCT02351934|50444359|FG000|Allocation|Hypotension preventing administration|2|||
25204202|NCT02351934|50444360|FG001|Allocation|Hypotension preventing administration|0|||
25204203|NCT02351934|50444359|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
25204204|NCT02351934|50444360|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
25204205|NCT02351934|50444359|FG000|Follow-Up|POD weight<pre-op weight|3|||
25204206|NCT02351934|50444360|FG001|Follow-Up|POD weight<pre-op weight|0|||
25204207|NCT02351934|50444359|FG000|Follow-Up|Acute Kidney Injury|1|||
25204208|NCT02351934|50444360|FG001|Follow-Up|Acute Kidney Injury|0|||
25204209|NCT02351934|50444359|FG000|Follow-Up|Early dismissal|3|||
25204210|NCT02351934|50444360|FG001|Follow-Up|Early dismissal|0|||
25204211|NCT02351934|50444359|FG000|Follow-Up|Hypotension|3|||
25204212|NCT02351934|50444360|FG001|Follow-Up|Hypotension|0|||
25204213|NCT02351934|50444359|FG000|Follow-Up|No documentation|2|||
25204214|NCT02351934|50444360|FG001|Follow-Up|No documentation|0|||
25204215|NCT02351934|50444359|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
25204216|NCT02351934|50444360|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
25204217|NCT02351934|50444359|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
25204218|NCT02351934|50444360|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
25204219|NCT02351856|50444400|FG000|Overall Study|Adverse Event|2|||
25204220|NCT02351856|50444400|FG000|Overall Study|Physician Decision|5|||
25077110|NCT02439320|50184950|FG002|Overall Study|Pregnancy|1|||
25204221|NCT02351856|50444400|FG000|Overall Study|Study terminated by sponsor|1|||
25204222|NCT02349360|50444440|FG000|Overall Study|Withdrawal by Subject|0|||
25204223|NCT02349360|50444441|FG001|Overall Study|Withdrawal by Subject|1|||
25204224|NCT00551642|50444466|FG000|Treatment Period|Protocol Deviation|6|||
25204225|NCT00551642|50444467|FG001|Treatment Period|Protocol Deviation|11|||
25204226|NCT00551642|50444466|FG000|Treatment Period|Delivery device failure|1|||
25204227|NCT00551642|50444467|FG001|Treatment Period|Delivery device failure|3|||
25204228|NCT00551642|50444466|FG000|Treatment Period|Physician Decision|0|||
25204229|NCT00551642|50444467|FG001|Treatment Period|Physician Decision|1|||
25204230|NCT00551642|50444466|FG000|Treatment Period|Death|33|||
25204231|NCT00551642|50444467|FG001|Treatment Period|Death|31|||
25204232|NCT00551642|50444466|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
25204233|NCT00551642|50444467|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
25204234|NCT00551642|50444466|FG000|Treatment Period|Adverse Event|15|||
25204235|NCT00551642|50444467|FG001|Treatment Period|Adverse Event|12|||
25204236|NCT00551642|50444466|FG000|Treatment Period|Withdrawal by Subject|2|||
25204237|NCT00551642|50444467|FG001|Treatment Period|Withdrawal by Subject|1|||
25204238|NCT00550550|50444561|FG000|Overall Study|Adverse Event|13|||
25204239|NCT00550550|50444562|FG001|Overall Study|Adverse Event|5|||
25204240|NCT00550550|50444561|FG000|Overall Study|Treatment Failure|0|||
25204241|NCT00550550|50444562|FG001|Overall Study|Treatment Failure|1|||
25204242|NCT00550550|50444561|FG000|Overall Study|Lost to Follow-up|4|||
25204243|NCT00550550|50444562|FG001|Overall Study|Lost to Follow-up|0|||
25204244|NCT00550550|50444561|FG000|Overall Study|Withdrawal by Subject|10|||
25204245|NCT00550550|50444562|FG001|Overall Study|Withdrawal by Subject|8|||
25204246|NCT00550550|50444561|FG000|Overall Study|Protocol Violation|5|||
25204247|NCT00550550|50444562|FG001|Overall Study|Protocol Violation|14|||
25204248|NCT00550550|50444561|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
25204249|NCT00550550|50444562|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
25204250|NCT00550550|50444561|FG000|Overall Study|Randomized But Not Treated|1|||
25204251|NCT00550550|50444562|FG001|Overall Study|Randomized But Not Treated|0|||
25204252|NCT02301156|50444613|FG000|Overall Study|Adverse Event|13|||
25204253|NCT02301156|50444614|FG001|Overall Study|Adverse Event|14|||
25204254|NCT02301156|50444613|FG000|Overall Study|Death|1|||
25204255|NCT02301156|50444614|FG001|Overall Study|Death|5|||
25204256|NCT02301156|50444613|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
25204257|NCT02301156|50444614|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
25204258|NCT02301156|50444613|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
25204259|NCT02301156|50444614|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
25204260|NCT02301156|50444613|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
25204261|NCT02301156|50444614|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
25204262|NCT02301156|50444613|FG000|Overall Study|Reason not Specified|6|||
25204263|NCT02301156|50444614|FG001|Overall Study|Reason not Specified|3|||
25204264|NCT02301390|50444695|FG000|Overall Study|Withdrawal by Subject|3|||
25204265|NCT02301390|50444696|FG001|Overall Study|Withdrawal by Subject|5|||
25204266|NCT02301390|50444695|FG000|Overall Study|Protocol Violation|1|||
25204267|NCT02301390|50444696|FG001|Overall Study|Protocol Violation|0|||
25204268|NCT02301390|50444695|FG000|Overall Study|Physician Decision|1|||
25204269|NCT02301390|50444696|FG001|Overall Study|Physician Decision|0|||
25204270|NCT02301390|50444695|FG000|Overall Study|Lost to Follow-up|0|||
25204271|NCT02301390|50444696|FG001|Overall Study|Lost to Follow-up|1|||
25204272|NCT02301390|50444695|FG000|Overall Study|Death|2|||
25204273|NCT02301390|50444696|FG001|Overall Study|Death|2|||
25204274|NCT02301390|50444695|FG000|Overall Study|Procedure not completed|0|||
25204275|NCT02301390|50444696|FG001|Overall Study|Procedure not completed|4|||
25204276|NCT02301390|50444695|FG000|Overall Study|Missed multiple visits|1|||
25204277|NCT02301390|50444696|FG001|Overall Study|Missed multiple visits|1|||
25204278|NCT02301390|50444695|FG000|Overall Study|study terminated|2|||
25204279|NCT02301390|50444696|FG001|Overall Study|study terminated|0|||
25204280|NCT02300610|50444813|FG000|Overall Study|Withdrawal by Subject|1|||
25204281|NCT02300610|50444814|FG001|Overall Study|Withdrawal by Subject|0|||
25204282|NCT02300610|50444815|FG002|Overall Study|Withdrawal by Subject|1|||
25204283|NCT02300298|50444860|FG000|Disposition for Nintedanib|Progressive disease|10|||
25204284|NCT02300298|50444861|FG001|Disposition for Nintedanib|Progressive disease|0|||
25204285|NCT02300298|50444860|FG000|Disposition for Docetaxel|Progressive disease|0|||
25204286|NCT02300298|50444861|FG001|Disposition for Docetaxel|Progressive disease|6|||
25204287|NCT02300298|50444860|FG000|Disposition for Docetaxel|other adverse event|0|||
25204288|NCT02300298|50444861|FG001|Disposition for Docetaxel|other adverse event|4|||
25204289|NCT02300220|50444867|FG000|Overall Study|Lost to Follow-up|1|||
25204290|NCT02300220|50444868|FG001|Overall Study|Lost to Follow-up|2|||
25204291|NCT02300220|50444867|FG000|Overall Study|Death|1|||
25204292|NCT02300220|50444868|FG001|Overall Study|Death|1|||
25204293|NCT02300220|50444867|FG000|Overall Study|Adverse Event|1|||
25204294|NCT02300220|50444868|FG001|Overall Study|Adverse Event|1|||
25204295|NCT02300220|50444867|FG000|Overall Study|Protocol Violation|1|||
25204296|NCT02300220|50444868|FG001|Overall Study|Protocol Violation|0|||
25204297|NCT02300220|50444867|FG000|Overall Study|Withdrawal by Subject|0|||
25204298|NCT02300220|50444868|FG001|Overall Study|Withdrawal by Subject|2|||
25204299|NCT02300220|50444867|FG000|Overall Study|Did not tolerate IMP|0|||
25204300|NCT02300220|50444868|FG001|Overall Study|Did not tolerate IMP|1|||
25204301|NCT02327130|50444892|FG000|Overall Study|Discharged in less than 5 days|5|||
25204302|NCT02327130|50444892|FG000|Overall Study|Physician Decision|2|||
25204303|NCT02327130|50444892|FG000|Overall Study|Unable to provide breath sample|1|||
25204304|NCT02327130|50444892|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
25204305|NCT02327130|50444892|FG000|Overall Study|Met exclusion criteria|3|||
25204306|NCT02326272|50444947|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25204307|NCT02326272|50444948|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
25204308|NCT02326272|50444949|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
25204309|NCT02326272|50444950|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25204310|NCT02326272|50444951|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25204311|NCT02326272|50444952|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25204312|NCT02326272|50444953|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25204313|NCT02326272|50444954|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25204314|NCT02326272|50444955|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25204315|NCT02326272|50444956|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25204316|NCT02326272|50444957|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25204317|NCT02326272|50444958|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25204318|NCT02326272|50444959|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25204319|NCT02326272|50444960|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25204320|NCT02326272|50444961|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
25204321|NCT02326272|50444947|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
25204322|NCT02326272|50444948|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
25204323|NCT02326272|50444949|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25204324|NCT02326272|50444950|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25204325|NCT02326272|50444951|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25204326|NCT02326272|50444952|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25204327|NCT02326272|50444953|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25204328|NCT02326272|50444954|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25204329|NCT02326272|50444955|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25204330|NCT02326272|50444956|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25204331|NCT02326272|50444957|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25204332|NCT02326272|50444958|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25204333|NCT02326272|50444959|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25204334|NCT02326272|50444960|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25204335|NCT02326272|50444961|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
25204336|NCT02326272|50444947|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
25204337|NCT02326272|50444948|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
25204338|NCT02326272|50444949|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
25204339|NCT02326272|50444950|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25204340|NCT02326272|50444951|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25204341|NCT02326272|50444952|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25204342|NCT02326272|50444953|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25204343|NCT02326272|50444954|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25204344|NCT02326272|50444955|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25204345|NCT02326272|50444956|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25204346|NCT02326272|50444957|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25204347|NCT02326272|50444958|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25204348|NCT02326272|50444959|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25204349|NCT02326272|50444960|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
25204350|NCT02326272|50444961|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
24976308|NCT03466060|50065216|FG005|Period 1|Grade 2 Conjunctivitis|0|||
24976309|NCT03466060|50065211|FG000|Period 2|Lens Handling Difficulties|0|||
24976310|NCT03466060|50065212|FG001|Period 2|Lens Handling Difficulties|0|||
24976311|NCT03466060|50065213|FG002|Period 2|Lens Handling Difficulties|1|||
24976312|NCT03466060|50065214|FG003|Period 2|Lens Handling Difficulties|0|||
25204351|NCT02326272|50444947|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
25204352|NCT02326272|50444948|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
25204353|NCT02326272|50444949|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
25204354|NCT02326272|50444950|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
25204355|NCT02326272|50444951|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
25204356|NCT02326272|50444952|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
25204357|NCT02326272|50444953|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
25204358|NCT02326272|50444954|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
25204359|NCT02326272|50444955|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
25204360|NCT02326272|50444956|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
25204361|NCT02326272|50444957|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
25204362|NCT02326272|50444958|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
25204363|NCT02326272|50444959|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
25204364|NCT02326272|50444960|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
25204365|NCT02326272|50444961|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
25204366|NCT02326272|50444947|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
25204367|NCT02326272|50444948|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
25204368|NCT02326272|50444949|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
25204369|NCT02326272|50444950|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
25204370|NCT02326272|50444951|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
25204371|NCT02326272|50444952|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
25204372|NCT02326272|50444953|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
25204373|NCT02326272|50444954|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
25204374|NCT02326272|50444955|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
25204375|NCT02326272|50444956|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
25204376|NCT02326272|50444957|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
25204377|NCT02326272|50444958|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
25204378|NCT02326272|50444959|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
25204379|NCT02326272|50444960|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
25204380|NCT02326272|50444961|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
25204381|NCT02326272|50444947|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
25204382|NCT02326272|50444948|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
25204383|NCT02326272|50444949|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
25077111|NCT02439320|50184948|FG000|Overall Study|Withdrawal by Subject|12|||
25077112|NCT02439320|50184949|FG001|Overall Study|Withdrawal by Subject|16|||
25204384|NCT02326272|50444950|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
25204385|NCT02326272|50444951|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
25204386|NCT02326272|50444952|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
25204387|NCT02326272|50444953|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
25204388|NCT02326272|50444954|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
25204389|NCT02326272|50444955|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
25204390|NCT02326272|50444956|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
25204391|NCT02326272|50444957|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
25204392|NCT02326272|50444958|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
25204393|NCT02326272|50444959|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
25204394|NCT02326272|50444960|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
25204395|NCT02326272|50444961|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
25204396|NCT02326272|50444947|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
25204397|NCT02326272|50444948|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
25204398|NCT02326272|50444949|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
25204399|NCT02326272|50444950|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
25204400|NCT02326272|50444951|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
25204401|NCT02326272|50444952|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
25204402|NCT02326272|50444953|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
25204403|NCT02326272|50444954|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
25204404|NCT02326272|50444955|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
25204405|NCT02326272|50444956|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
25204406|NCT02326272|50444957|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
25204407|NCT02326272|50444958|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
25204408|NCT02326272|50444959|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
25204409|NCT02326272|50444960|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
25204410|NCT02326272|50444961|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
25204411|NCT02326272|50444947|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25204412|NCT02326272|50444948|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25204413|NCT02326272|50444949|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25204414|NCT02326272|50444950|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25204415|NCT02326272|50444951|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
25204416|NCT02326272|50444952|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
25204417|NCT02326272|50444953|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
25204418|NCT02326272|50444954|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
25204419|NCT02326272|50444955|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
25204420|NCT02326272|50444956|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25204421|NCT02326272|50444957|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25204422|NCT02326272|50444958|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25204423|NCT02326272|50444959|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25204424|NCT02326272|50444960|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25204425|NCT02326272|50444961|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
25204426|NCT02326272|50444947|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25204427|NCT02326272|50444948|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25204428|NCT02326272|50444949|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25204429|NCT02326272|50444950|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25204430|NCT02326272|50444951|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25204431|NCT02326272|50444952|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
25204432|NCT02326272|50444953|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
25204433|NCT02326272|50444954|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25204434|NCT02326272|50444955|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
25204435|NCT02326272|50444956|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
25204436|NCT02326272|50444957|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25204437|NCT02326272|50444958|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25204438|NCT02326272|50444959|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25204439|NCT02326272|50444960|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25204440|NCT02326272|50444961|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
25204441|NCT02326272|50444947|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
24976313|NCT03466060|50065215|FG004|Period 2|Lens Handling Difficulties|0|||
24976314|NCT03466060|50065216|FG005|Period 2|Lens Handling Difficulties|0|||
25204442|NCT02326272|50444948|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25204443|NCT02326272|50444949|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25204444|NCT02326272|50444950|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25204445|NCT02326272|50444951|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25204446|NCT02326272|50444952|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
25204447|NCT02326272|50444953|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25204448|NCT02326272|50444954|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
25204449|NCT02326272|50444955|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25204450|NCT02326272|50444956|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25204451|NCT02326272|50444957|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25204452|NCT02326272|50444958|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25204453|NCT02326272|50444959|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25204454|NCT02326272|50444960|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25204455|NCT02326272|50444961|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
25204456|NCT02326272|50444947|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25204457|NCT02326272|50444948|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25204458|NCT02326272|50444949|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25204459|NCT02326272|50444950|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
25204460|NCT02326272|50444951|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25204461|NCT02326272|50444952|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
25204462|NCT02326272|50444953|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
25204463|NCT02326272|50444954|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
25204464|NCT02326272|50444955|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25204465|NCT02326272|50444956|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
25204466|NCT02326272|50444957|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25204467|NCT02326272|50444958|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25204468|NCT02326272|50444959|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25204469|NCT02326272|50444960|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
24976315|NCT00092547|50065232|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
25077113|NCT02439320|50184950|FG002|Overall Study|Withdrawal by Subject|14|||
25171450|NCT01767467|50308489|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
25171451|NCT01767467|50308490|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
25171452|NCT01767467|50308489|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
25171453|NCT01767467|50308490|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
25171454|NCT01767467|50308489|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
25171455|NCT01767467|50308490|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
25171456|NCT01767467|50308489|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
25171457|NCT01767467|50308490|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
25171458|NCT01767467|50308489|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
25171459|NCT01767467|50308490|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
25171460|NCT01767467|50308489|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
25171461|NCT01767467|50308490|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
25171462|NCT01767467|50308489|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
25171463|NCT01767467|50308490|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
25171464|NCT04126083|50308563|FG000|Overall Study|Withdrawal by Subject|1|||
25171465|NCT01766921|50308603|FG000|Overall Study|Administrative Reason|5|||
25171466|NCT01766921|50308604|FG001|Overall Study|Administrative Reason|5|||
25171467|NCT01766921|50308603|FG000|Overall Study|Death|1|||
25171468|NCT01766921|50308604|FG001|Overall Study|Death|1|||
25171469|NCT01766921|50308603|FG000|Overall Study|Lost to Follow-up|1|||
25171470|NCT01766921|50308604|FG001|Overall Study|Lost to Follow-up|3|||
25171471|NCT01766921|50308603|FG000|Overall Study|Unclassified|2|||
25171472|NCT01766921|50308604|FG001|Overall Study|Unclassified|2|||
25171473|NCT01766921|50308603|FG000|Overall Study|Protocol Violation|1|||
25171474|NCT01766921|50308604|FG001|Overall Study|Protocol Violation|1|||
25171475|NCT01766921|50308603|FG000|Overall Study|Withdrawal by Subject|14|||
25171476|NCT01766921|50308604|FG001|Overall Study|Withdrawal by Subject|5|||
25171477|NCT01774799|50308622|FG000|Overall Study|Lost to Follow-up|1|||
25171478|NCT01774799|50308623|FG001|Overall Study|Lost to Follow-up|1|||
25171479|NCT01774799|50308624|FG002|Overall Study|Lost to Follow-up|0|||
25171480|NCT01774799|50308625|FG003|Overall Study|Lost to Follow-up|0|||
25171481|NCT01774253|50308631|FG000|Overall Study|Lack of Efficacy|4|||
25171482|NCT01774253|50308631|FG000|Overall Study|Physician Decision|2|||
25171483|NCT01774253|50308631|FG000|Overall Study|Withdrawal by Subject|2|||
25171484|NCT01774253|50308631|FG000|Overall Study|Death|1|||
25171485|NCT01765751|50308671|FG000|Overall Study|Lost to Follow-up|0|||
25204470|NCT02326272|50444961|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
25204471|NCT02326272|50444947|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
25204472|NCT02326272|50444948|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
25204473|NCT02326272|50444949|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
25204474|NCT02326272|50444950|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
25204475|NCT02326272|50444951|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
25204476|NCT02326272|50444952|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
25204477|NCT02326272|50444953|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
25204478|NCT02326272|50444954|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
25204479|NCT02326272|50444955|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
25204480|NCT02326272|50444956|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
25204481|NCT02326272|50444957|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
25204482|NCT02326272|50444958|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
25204483|NCT02326272|50444959|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
25204484|NCT02326272|50444960|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
25204485|NCT02326272|50444961|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
25204486|NCT02326272|50444947|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25204487|NCT02326272|50444948|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25204488|NCT02326272|50444949|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25204489|NCT02326272|50444950|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25204490|NCT02326272|50444951|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25204491|NCT02326272|50444952|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25204492|NCT02326272|50444953|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
25204493|NCT02326272|50444954|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25204494|NCT02326272|50444955|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25204495|NCT02326272|50444956|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25204496|NCT02326272|50444957|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25204497|NCT02326272|50444958|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25204498|NCT02326272|50444959|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25204499|NCT02326272|50444960|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25204500|NCT02326272|50444961|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
25204501|NCT02326272|50444947|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
25204502|NCT02326272|50444948|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
25204503|NCT02326272|50444949|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
25204504|NCT02326272|50444950|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
25204505|NCT02326272|50444951|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
25204506|NCT02326272|50444952|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
25204507|NCT02326272|50444953|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
25204508|NCT02326272|50444954|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
25204509|NCT02326272|50444955|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
25204510|NCT02326272|50444956|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
25204511|NCT02326272|50444957|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
25204512|NCT02326272|50444958|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
25204513|NCT02326272|50444959|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
25204514|NCT02326272|50444960|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
25204515|NCT02326272|50444961|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
25204516|NCT02326272|50444947|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25204517|NCT02326272|50444948|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25204518|NCT02326272|50444949|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25204519|NCT02326272|50444950|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25204520|NCT02326272|50444951|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25204521|NCT02326272|50444952|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
25204522|NCT02326272|50444953|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
25204523|NCT02326272|50444954|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
25204524|NCT02326272|50444955|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
25204525|NCT02326272|50444956|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25204526|NCT02326272|50444957|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25204527|NCT02326272|50444958|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25204528|NCT02326272|50444959|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25204529|NCT02326272|50444960|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25204530|NCT02326272|50444961|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
25204531|NCT02326272|50444947|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
25204532|NCT02326272|50444948|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
25204533|NCT02326272|50444949|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
25204534|NCT02326272|50444950|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
25204535|NCT02326272|50444951|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
25204536|NCT02326272|50444952|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
25204537|NCT02326272|50444953|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
25204538|NCT02326272|50444954|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
25204539|NCT02326272|50444955|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
25204540|NCT02326272|50444956|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
25204541|NCT02326272|50444957|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
25204542|NCT02326272|50444958|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
25204543|NCT02326272|50444959|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
25204544|NCT02326272|50444960|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
25204545|NCT02326272|50444961|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
25204546|NCT02326272|50444947|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
25204547|NCT02326272|50444948|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
25204548|NCT02326272|50444949|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
25204549|NCT02326272|50444950|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
25204550|NCT02326272|50444951|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
25204551|NCT02326272|50444952|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
25204552|NCT02326272|50444953|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
25204553|NCT02326272|50444954|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
25204554|NCT02326272|50444955|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
25204555|NCT02326272|50444956|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
25204556|NCT02326272|50444957|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
25204557|NCT02326272|50444958|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
25204558|NCT02326272|50444959|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
25204559|NCT02326272|50444960|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
25204560|NCT02326272|50444961|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
25204561|NCT02326272|50444947|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
25204562|NCT02326272|50444948|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
25204563|NCT02326272|50444949|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
25204564|NCT02326272|50444950|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
25204565|NCT02326272|50444951|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
25204566|NCT02326272|50444952|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
25204567|NCT02326272|50444953|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
25204568|NCT02326272|50444954|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
25204569|NCT02326272|50444955|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
25204570|NCT02326272|50444956|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
25204571|NCT02326272|50444957|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
25204572|NCT02326272|50444958|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
25204573|NCT02326272|50444959|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
25204574|NCT02326272|50444960|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
25204575|NCT02326272|50444961|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
25204576|NCT02326272|50444947|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25204577|NCT02326272|50444948|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25204578|NCT02326272|50444949|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25204579|NCT02326272|50444950|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25204580|NCT02326272|50444951|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25204581|NCT02326272|50444952|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25204582|NCT02326272|50444953|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25204583|NCT02326272|50444954|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25204584|NCT02326272|50444955|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25204585|NCT02326272|50444956|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25204586|NCT02326272|50444957|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
25204587|NCT02326272|50444958|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
25204588|NCT02326272|50444959|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
25204589|NCT02326272|50444960|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
25204590|NCT02326272|50444961|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
25204591|NCT02326272|50444947|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25204592|NCT02326272|50444948|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25204593|NCT02326272|50444949|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
24976316|NCT00092547|50065233|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
25204594|NCT02326272|50444950|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25204595|NCT02326272|50444951|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25204596|NCT02326272|50444952|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25204597|NCT02326272|50444953|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25204598|NCT02326272|50444954|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25204599|NCT02326272|50444955|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25204600|NCT02326272|50444956|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25204601|NCT02326272|50444957|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
25204602|NCT02326272|50444958|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25204603|NCT02326272|50444959|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
25204604|NCT02326272|50444960|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25204605|NCT02326272|50444961|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
25204606|NCT02326272|50444947|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25204607|NCT02326272|50444948|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25204608|NCT02326272|50444949|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25204609|NCT02326272|50444950|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25204610|NCT02326272|50444951|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25204611|NCT02326272|50444952|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25204612|NCT02326272|50444953|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25204613|NCT02326272|50444954|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25204614|NCT02326272|50444955|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25204615|NCT02326272|50444956|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25204616|NCT02326272|50444957|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25204617|NCT02326272|50444958|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
25204618|NCT02326272|50444959|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25204619|NCT02326272|50444960|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25204620|NCT02326272|50444961|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
25204621|NCT02326272|50444947|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25204622|NCT02326272|50444948|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25204623|NCT02326272|50444949|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25204624|NCT02326272|50444950|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25204625|NCT02326272|50444951|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25204626|NCT02326272|50444952|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25204627|NCT02326272|50444953|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25204628|NCT02326272|50444954|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25204629|NCT02326272|50444955|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25204630|NCT02326272|50444956|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25204631|NCT02326272|50444957|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
25204632|NCT02326272|50444958|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25204633|NCT02326272|50444959|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
25204634|NCT02326272|50444960|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
25204635|NCT02326272|50444961|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
25204636|NCT02326272|50444947|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25204637|NCT02326272|50444948|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25204638|NCT02326272|50444949|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25204639|NCT02326272|50444950|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25204640|NCT02326272|50444951|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25204641|NCT02326272|50444952|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25204642|NCT02326272|50444953|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25204643|NCT02326272|50444954|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25204644|NCT02326272|50444955|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25204645|NCT02326272|50444956|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25204646|NCT02326272|50444957|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25204647|NCT02326272|50444958|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
25204648|NCT02326272|50444959|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25204649|NCT02326272|50444960|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
25204650|NCT02326272|50444961|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
25204651|NCT02326272|50444947|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25204652|NCT02326272|50444948|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25204653|NCT02326272|50444949|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25204654|NCT02326272|50444950|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25204655|NCT02326272|50444951|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25204656|NCT02326272|50444952|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25204657|NCT02326272|50444953|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25204658|NCT02326272|50444954|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25204659|NCT02326272|50444955|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25204660|NCT02326272|50444956|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25204661|NCT02326272|50444957|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25204662|NCT02326272|50444958|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
25204663|NCT02326272|50444959|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
25204664|NCT02326272|50444960|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
25204665|NCT02326272|50444961|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
25204666|NCT02326272|50444947|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
25204667|NCT02326272|50444948|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
25204668|NCT02326272|50444949|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
25204669|NCT02326272|50444950|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
25204670|NCT02326272|50444951|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
25204671|NCT02326272|50444952|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
25204672|NCT02326272|50444953|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
25204673|NCT02326272|50444954|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
25204674|NCT02326272|50444955|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
25204675|NCT02326272|50444956|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
25204676|NCT02326272|50444957|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
25204677|NCT02326272|50444958|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
25204678|NCT02326272|50444959|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
25204679|NCT02326272|50444960|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
25204680|NCT02326272|50444961|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
25204681|NCT02326272|50444947|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
25204682|NCT02326272|50444948|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
25204683|NCT02326272|50444949|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
25204684|NCT02326272|50444950|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
25204685|NCT02326272|50444951|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
25204686|NCT02326272|50444952|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
25204687|NCT02326272|50444953|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
25204688|NCT02326272|50444954|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
25204689|NCT02326272|50444955|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
25204690|NCT02326272|50444956|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
25204691|NCT02326272|50444957|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
25204692|NCT02326272|50444958|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
25204693|NCT02326272|50444959|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
25204694|NCT02326272|50444960|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
25204695|NCT02326272|50444961|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
25204696|NCT02325414|50444998|FG000|Overall Study|Withdrawal by Subject|3|||
25204697|NCT02325414|50444999|FG001|Overall Study|Withdrawal by Subject|1|||
25204698|NCT02325414|50444998|FG000|Overall Study|Lost to Follow-up|5|||
25204699|NCT02325414|50444999|FG001|Overall Study|Lost to Follow-up|5|||
25204700|NCT02349048|50445017|FG000|Overall Study|Withdrawal by Subject|4|||
25204701|NCT02349048|50445018|FG001|Overall Study|Withdrawal by Subject|0|||
25204702|NCT02349048|50445017|FG000|Overall Study|Lost to Follow-up|1|||
25204703|NCT02349048|50445018|FG001|Overall Study|Lost to Follow-up|0|||
25204704|NCT02299206|50445065|FG000|Overall Study|Lost to Follow-up|1|||
25204705|NCT02299206|50445065|FG000|Overall Study|Withdrawal by Subject|1|||
25204706|NCT02298192|50445084|FG000|Overall Study|Unclassified|3|||
25204707|NCT02298192|50445085|FG001|Overall Study|Unclassified|2|||
25204708|NCT02298192|50445084|FG000|Overall Study|Withdrawal criteria|2|||
25204709|NCT02298192|50445085|FG001|Overall Study|Withdrawal criteria|0|||
25204710|NCT02298192|50445084|FG000|Overall Study|Withdrawal by Subject|6|||
25204711|NCT02298192|50445085|FG001|Overall Study|Withdrawal by Subject|1|||
25204712|NCT02298192|50445084|FG000|Overall Study|Lost to Follow-up|2|||
25204713|NCT02298192|50445085|FG001|Overall Study|Lost to Follow-up|1|||
25204714|NCT02298192|50445084|FG000|Overall Study|Adverse Event|6|||
25204715|NCT02298192|50445085|FG001|Overall Study|Adverse Event|2|||
25204716|NCT02280408|50445211|FG000|Overall Study|Lost to Follow-up|0|||
25204717|NCT02280408|50445212|FG001|Overall Study|Lost to Follow-up|2|||
25204718|NCT02280408|50445213|FG002|Overall Study|Lost to Follow-up|0|||
25204719|NCT02280408|50445214|FG003|Overall Study|Lost to Follow-up|0|||
25204720|NCT02296476|50445290|FG000|Overall Study|Disease Progression|6|||
25204721|NCT02296476|50445291|FG001|Overall Study|Disease Progression|4|||
25204722|NCT02296476|50445292|FG002|Overall Study|Disease Progression|2|||
25204723|NCT00552032|50445333|FG000|Overall Study|Withdrawal by Subject|2|||
25204724|NCT00552032|50445334|FG001|Overall Study|Withdrawal by Subject|2|||
25204725|NCT00552032|50445333|FG000|Overall Study|Protocol Violation|7|||
25204726|NCT00552032|50445334|FG001|Overall Study|Protocol Violation|12|||
25204727|NCT00552032|50445333|FG000|Overall Study|Lost to Follow-up|8|||
25204728|NCT00552032|50445334|FG001|Overall Study|Lost to Follow-up|5|||
25204729|NCT02988817|50446094|FG000|Overall Study|Withdrawal by Subject|1|||
25171486|NCT01765751|50308672|FG001|Overall Study|Lost to Follow-up|2|||
25171487|NCT01765751|50308673|FG002|Overall Study|Lost to Follow-up|1|||
25171488|NCT01736657|50308693|FG000|Overall Study|insufficient vascular access|1|||
25171489|NCT01736579|50308708|FG000|Overall Study|Termination of Study by Sponsor|2|||
25171490|NCT01736579|50308709|FG001|Overall Study|Termination of Study by Sponsor|2|||
25171491|NCT01765673|50308740|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
25171492|NCT01764659|50308747|FG000|Overall Study|Death|1|||
25171493|NCT01764659|50308747|FG000|Overall Study|Physician Decision|1|||
25171494|NCT01736189|50308753|FG000|Overall Study|Violation of registration criteria|41|||
25171495|NCT01736189|50308753|FG000|Overall Study|Protocol Violation|4|||
25171496|NCT01736189|50308753|FG000|Overall Study|Criteria and protocol violations|1|||
25171497|NCT01735175|50308785|FG000|Overall Study|Withdrawal by Subject|9|||
25171498|NCT01735175|50308786|FG001|Overall Study|Withdrawal by Subject|2|||
25171499|NCT01735175|50308785|FG000|Overall Study|Lost to Follow-up|4|||
25171500|NCT01735175|50308786|FG001|Overall Study|Lost to Follow-up|2|||
25171501|NCT01735175|50308785|FG000|Overall Study|Death|3|||
25171502|NCT01735175|50308786|FG001|Overall Study|Death|2|||
25171503|NCT01735175|50308785|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
25171504|NCT01735175|50308786|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
25171505|NCT01762943|50308798|FG000|Overall Study|Physician Decision|1|||
25171506|NCT01762943|50308799|FG001|Overall Study|Physician Decision|1|||
25171507|NCT01762943|50308798|FG000|Overall Study|Protocol Violation|1|||
25171508|NCT01762943|50308799|FG001|Overall Study|Protocol Violation|0|||
25171509|NCT01762943|50308798|FG000|Overall Study|Withdrawal by Subject|2|||
25171510|NCT01762943|50308799|FG001|Overall Study|Withdrawal by Subject|1|||
25171511|NCT01734785|50308862|FG000|Open-Label Period|Adverse Event|0|||
25171512|NCT01734785|50308863|FG001|Open-Label Period|Adverse Event|0|||
25171513|NCT01734785|50308864|FG002|Open-Label Period|Adverse Event|0|||
25171514|NCT01734785|50308865|FG003|Open-Label Period|Adverse Event|9|||
25171515|NCT01734785|50308862|FG000|Open-Label Period|Lack of Efficacy|0|||
25171516|NCT01734785|50308863|FG001|Open-Label Period|Lack of Efficacy|0|||
25171517|NCT01734785|50308864|FG002|Open-Label Period|Lack of Efficacy|0|||
25171518|NCT01734785|50308865|FG003|Open-Label Period|Lack of Efficacy|1|||
25171519|NCT01734785|50308862|FG000|Open-Label Period|Protocol Violation|0|||
25171520|NCT01734785|50308863|FG001|Open-Label Period|Protocol Violation|0|||
25171521|NCT01734785|50308864|FG002|Open-Label Period|Protocol Violation|0|||
25171522|NCT01734785|50308865|FG003|Open-Label Period|Protocol Violation|13|||
25171523|NCT01734785|50308862|FG000|Open-Label Period|Lost to Follow-up|0|||
25171524|NCT01734785|50308863|FG001|Open-Label Period|Lost to Follow-up|0|||
25171525|NCT01734785|50308864|FG002|Open-Label Period|Lost to Follow-up|0|||
25171526|NCT01734785|50308865|FG003|Open-Label Period|Lost to Follow-up|14|||
25171527|NCT01734785|50308862|FG000|Open-Label Period|Withdrawal by Subject|0|||
25171528|NCT01734785|50308863|FG001|Open-Label Period|Withdrawal by Subject|0|||
25171529|NCT01734785|50308864|FG002|Open-Label Period|Withdrawal by Subject|0|||
25171530|NCT01734785|50308865|FG003|Open-Label Period|Withdrawal by Subject|12|||
25171531|NCT01734785|50308862|FG000|Open-Label Period|Other Reasons|0|||
25171532|NCT01734785|50308863|FG001|Open-Label Period|Other Reasons|0|||
25171533|NCT01734785|50308864|FG002|Open-Label Period|Other Reasons|0|||
25171534|NCT01734785|50308865|FG003|Open-Label Period|Other Reasons|224|||
25171535|NCT01734785|50308862|FG000|Double-Blind Period|Adverse Event|0|||
25171536|NCT01734785|50308863|FG001|Double-Blind Period|Adverse Event|3|||
25171537|NCT01734785|50308864|FG002|Double-Blind Period|Adverse Event|2|||
25171538|NCT01734785|50308865|FG003|Double-Blind Period|Adverse Event|0|||
25171539|NCT01734785|50308862|FG000|Double-Blind Period|Lack of Efficacy|0|||
25171540|NCT01734785|50308863|FG001|Double-Blind Period|Lack of Efficacy|1|||
25171541|NCT01734785|50308864|FG002|Double-Blind Period|Lack of Efficacy|0|||
25171542|NCT01734785|50308865|FG003|Double-Blind Period|Lack of Efficacy|0|||
25171543|NCT01734785|50308862|FG000|Double-Blind Period|Protocol Violation|0|||
25171544|NCT01734785|50308863|FG001|Double-Blind Period|Protocol Violation|1|||
25171545|NCT01734785|50308864|FG002|Double-Blind Period|Protocol Violation|1|||
25171546|NCT01734785|50308865|FG003|Double-Blind Period|Protocol Violation|0|||
25171547|NCT01734785|50308862|FG000|Double-Blind Period|Lost to Follow-up|2|||
25171548|NCT01734785|50308863|FG001|Double-Blind Period|Lost to Follow-up|4|||
25171549|NCT01734785|50308864|FG002|Double-Blind Period|Lost to Follow-up|2|||
25171550|NCT01734785|50308865|FG003|Double-Blind Period|Lost to Follow-up|0|||
25171551|NCT01734785|50308862|FG000|Double-Blind Period|Withdrawal by Subject|2|||
25171552|NCT01734785|50308863|FG001|Double-Blind Period|Withdrawal by Subject|0|||
25171553|NCT01734785|50308864|FG002|Double-Blind Period|Withdrawal by Subject|0|||
25171554|NCT01734785|50308865|FG003|Double-Blind Period|Withdrawal by Subject|0|||
25171555|NCT01734785|50308862|FG000|Double-Blind Period|Not treated|1|||
25171556|NCT01734785|50308863|FG001|Double-Blind Period|Not treated|0|||
25171557|NCT01734785|50308864|FG002|Double-Blind Period|Not treated|0|||
25171558|NCT01734785|50308865|FG003|Double-Blind Period|Not treated|0|||
25204730|NCT02988817|50446095|FG001|Overall Study|Withdrawal by Subject|0|||
25204731|NCT02988817|50446096|FG002|Overall Study|Withdrawal by Subject|0|||
25204732|NCT02988817|50446097|FG003|Overall Study|Withdrawal by Subject|1|||
25204733|NCT02988817|50446098|FG004|Overall Study|Withdrawal by Subject|3|||
25204734|NCT02988817|50446099|FG005|Overall Study|Withdrawal by Subject|1|||
25204735|NCT02988817|50446100|FG006|Overall Study|Withdrawal by Subject|2|||
25204736|NCT02988817|50446101|FG007|Overall Study|Withdrawal by Subject|1|||
25204737|NCT02988817|50446102|FG008|Overall Study|Withdrawal by Subject|1|||
25204738|NCT02988817|50446103|FG009|Overall Study|Withdrawal by Subject|1|||
25204739|NCT02988817|50446104|FG010|Overall Study|Withdrawal by Subject|1|||
25204740|NCT02988817|50446105|FG011|Overall Study|Withdrawal by Subject|12|||
25204741|NCT02988817|50446106|FG012|Overall Study|Withdrawal by Subject|6|||
25204742|NCT02988817|50446107|FG013|Overall Study|Withdrawal by Subject|6|||
25204743|NCT02988817|50446108|FG014|Overall Study|Withdrawal by Subject|4|||
25204744|NCT02988817|50446109|FG015|Overall Study|Withdrawal by Subject|5|||
25204745|NCT02988817|50446110|FG016|Overall Study|Withdrawal by Subject|4|||
25204746|NCT02988817|50446111|FG017|Overall Study|Withdrawal by Subject|11|||
25204747|NCT02988817|50446112|FG018|Overall Study|Withdrawal by Subject|4|||
25204748|NCT02988817|50446113|FG019|Overall Study|Withdrawal by Subject|2|||
25204749|NCT02988817|50446094|FG000|Overall Study|Death|0|||
25204750|NCT02988817|50446095|FG001|Overall Study|Death|1|||
25204751|NCT02988817|50446096|FG002|Overall Study|Death|3|||
25204752|NCT02988817|50446097|FG003|Overall Study|Death|1|||
25204753|NCT02988817|50446098|FG004|Overall Study|Death|6|||
25204754|NCT02988817|50446099|FG005|Overall Study|Death|10|||
25204755|NCT02988817|50446100|FG006|Overall Study|Death|1|||
25204756|NCT02988817|50446101|FG007|Overall Study|Death|2|||
25204757|NCT02988817|50446102|FG008|Overall Study|Death|1|||
25204758|NCT02988817|50446103|FG009|Overall Study|Death|5|||
25204759|NCT02988817|50446104|FG010|Overall Study|Death|1|||
25204760|NCT02988817|50446105|FG011|Overall Study|Death|8|||
25204761|NCT02988817|50446106|FG012|Overall Study|Death|9|||
25204762|NCT02988817|50446107|FG013|Overall Study|Death|17|||
25204763|NCT02988817|50446108|FG014|Overall Study|Death|18|||
25204764|NCT02988817|50446109|FG015|Overall Study|Death|30|||
25204765|NCT02988817|50446110|FG016|Overall Study|Death|17|||
25204766|NCT02988817|50446111|FG017|Overall Study|Death|38|||
25204767|NCT02988817|50446112|FG018|Overall Study|Death|14|||
25204768|NCT02988817|50446113|FG019|Overall Study|Death|16|||
25204769|NCT02988817|50446094|FG000|Overall Study|Other|0|||
25204770|NCT02988817|50446095|FG001|Overall Study|Other|0|||
25204771|NCT02988817|50446096|FG002|Overall Study|Other|0|||
25204772|NCT02988817|50446097|FG003|Overall Study|Other|1|||
25204773|NCT02988817|50446098|FG004|Overall Study|Other|1|||
25204774|NCT02988817|50446099|FG005|Overall Study|Other|0|||
25204775|NCT02988817|50446100|FG006|Overall Study|Other|0|||
25204776|NCT02988817|50446101|FG007|Overall Study|Other|0|||
25204777|NCT02988817|50446102|FG008|Overall Study|Other|0|||
25204778|NCT02988817|50446103|FG009|Overall Study|Other|0|||
25204779|NCT02988817|50446104|FG010|Overall Study|Other|0|||
25204780|NCT02988817|50446105|FG011|Overall Study|Other|0|||
25204781|NCT02988817|50446106|FG012|Overall Study|Other|0|||
25204782|NCT02988817|50446107|FG013|Overall Study|Other|0|||
25204783|NCT02988817|50446108|FG014|Overall Study|Other|0|||
25204784|NCT02988817|50446109|FG015|Overall Study|Other|1|||
25204785|NCT02988817|50446110|FG016|Overall Study|Other|0|||
25204786|NCT02988817|50446111|FG017|Overall Study|Other|0|||
25204787|NCT02988817|50446112|FG018|Overall Study|Other|0|||
25204788|NCT02988817|50446113|FG019|Overall Study|Other|0|||
25204789|NCT02988817|50446094|FG000|Overall Study|Lost to Follow-up|0|||
25204790|NCT02988817|50446095|FG001|Overall Study|Lost to Follow-up|0|||
25204791|NCT02988817|50446096|FG002|Overall Study|Lost to Follow-up|0|||
25204792|NCT02988817|50446097|FG003|Overall Study|Lost to Follow-up|0|||
25204793|NCT02988817|50446098|FG004|Overall Study|Lost to Follow-up|0|||
25204794|NCT02988817|50446099|FG005|Overall Study|Lost to Follow-up|0|||
25204795|NCT02988817|50446100|FG006|Overall Study|Lost to Follow-up|0|||
25204796|NCT02988817|50446101|FG007|Overall Study|Lost to Follow-up|0|||
25204797|NCT02988817|50446102|FG008|Overall Study|Lost to Follow-up|1|||
25204798|NCT02988817|50446103|FG009|Overall Study|Lost to Follow-up|0|||
25204799|NCT02988817|50446104|FG010|Overall Study|Lost to Follow-up|1|||
25204800|NCT02988817|50446105|FG011|Overall Study|Lost to Follow-up|1|||
25204801|NCT02988817|50446106|FG012|Overall Study|Lost to Follow-up|0|||
25204802|NCT02988817|50446107|FG013|Overall Study|Lost to Follow-up|0|||
25204803|NCT02988817|50446108|FG014|Overall Study|Lost to Follow-up|1|||
25204804|NCT02988817|50446109|FG015|Overall Study|Lost to Follow-up|1|||
25204805|NCT02988817|50446110|FG016|Overall Study|Lost to Follow-up|2|||
25204806|NCT02988817|50446111|FG017|Overall Study|Lost to Follow-up|3|||
25204807|NCT02988817|50446112|FG018|Overall Study|Lost to Follow-up|0|||
25204808|NCT02988817|50446113|FG019|Overall Study|Lost to Follow-up|0|||
25204809|NCT02988817|50446094|FG000|Overall Study|Sponsor decision|0|||
25204810|NCT02988817|50446095|FG001|Overall Study|Sponsor decision|0|||
25204811|NCT02988817|50446096|FG002|Overall Study|Sponsor decision|0|||
25204812|NCT02988817|50446097|FG003|Overall Study|Sponsor decision|0|||
25204813|NCT02988817|50446098|FG004|Overall Study|Sponsor decision|0|||
25204814|NCT02988817|50446099|FG005|Overall Study|Sponsor decision|0|||
25204815|NCT02988817|50446100|FG006|Overall Study|Sponsor decision|0|||
25204816|NCT02988817|50446101|FG007|Overall Study|Sponsor decision|0|||
25204817|NCT02988817|50446102|FG008|Overall Study|Sponsor decision|0|||
25204818|NCT02988817|50446103|FG009|Overall Study|Sponsor decision|0|||
25204819|NCT02988817|50446104|FG010|Overall Study|Sponsor decision|0|||
25204820|NCT02988817|50446105|FG011|Overall Study|Sponsor decision|1|||
25204821|NCT02988817|50446106|FG012|Overall Study|Sponsor decision|1|||
25204822|NCT02988817|50446107|FG013|Overall Study|Sponsor decision|2|||
25204823|NCT02988817|50446108|FG014|Overall Study|Sponsor decision|2|||
25204824|NCT02988817|50446109|FG015|Overall Study|Sponsor decision|6|||
25204825|NCT02988817|50446110|FG016|Overall Study|Sponsor decision|2|||
25204826|NCT02988817|50446111|FG017|Overall Study|Sponsor decision|3|||
25204827|NCT02988817|50446112|FG018|Overall Study|Sponsor decision|2|||
25204828|NCT02988817|50446113|FG019|Overall Study|Sponsor decision|7|||
25204829|NCT02988817|50446094|FG000|Overall Study|Physician Decision|0|||
25204830|NCT02988817|50446095|FG001|Overall Study|Physician Decision|0|||
25315976|NCT00896532|50631609|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315977|NCT00896532|50631610|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
25315978|NCT00896532|50631588|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315979|NCT00896532|50631589|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
25315980|NCT00896532|50631590|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315981|NCT00896532|50631591|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
25315982|NCT00896532|50631592|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
25315983|NCT00896532|50631593|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315984|NCT00896532|50631594|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315985|NCT00896532|50631595|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315986|NCT00896532|50631596|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315987|NCT00896532|50631597|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315988|NCT00896532|50631598|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315989|NCT00896532|50631599|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315990|NCT00896532|50631600|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315991|NCT00896532|50631601|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315992|NCT00896532|50631602|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315993|NCT00896532|50631603|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315994|NCT00896532|50631604|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315995|NCT00896532|50631605|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315996|NCT00896532|50631606|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315997|NCT00896532|50631607|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315998|NCT00896532|50631608|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25315999|NCT00896532|50631609|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25316000|NCT00896532|50631610|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
25316001|NCT00896532|50631588|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25077114|NCT02439320|50184948|FG000|Overall Study|Physician Decision|2|||
25077115|NCT02439320|50184949|FG001|Overall Study|Physician Decision|1|||
25077116|NCT02439320|50184950|FG002|Overall Study|Physician Decision|0|||
25077117|NCT02439320|50184948|FG000|Overall Study|Sponsor Request|0|||
25077118|NCT02439320|50184949|FG001|Overall Study|Sponsor Request|2|||
25077119|NCT02439320|50184950|FG002|Overall Study|Sponsor Request|1|||
25171559|NCT01734395|50308874|FG000|Overall Study|Other|65|||
25316002|NCT00896532|50631589|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25316003|NCT00896532|50631590|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25316004|NCT00896532|50631591|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25316005|NCT00896532|50631592|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25077120|NCT02439320|50184948|FG000|Overall Study|Randomization Failure|35|||
25171560|NCT01734395|50308874|FG000|Overall Study|Lost to Follow-up|287|||
25171561|NCT01734395|50308874|FG000|Overall Study|Lack of Efficacy|5|||
25171562|NCT01734395|50308874|FG000|Overall Study|Adverse Event|40|||
25171563|NCT01734395|50308874|FG000|Overall Study|Withdrawal by Subject|10|||
25171564|NCT01734395|50308874|FG000|Overall Study|Missing the reasons for not completed|3|||
25171565|NCT01597505|50308908|FG000|Overall Study|Physician Decision|5|||
25171566|NCT01597505|50308909|FG001|Overall Study|Physician Decision|0|||
25204831|NCT02988817|50446096|FG002|Overall Study|Physician Decision|0|||
25077121|NCT02439320|50184949|FG001|Overall Study|Randomization Failure|46|||
25204832|NCT02988817|50446097|FG003|Overall Study|Physician Decision|0|||
25204833|NCT02988817|50446098|FG004|Overall Study|Physician Decision|0|||
25204834|NCT02988817|50446099|FG005|Overall Study|Physician Decision|0|||
25077122|NCT02439320|50184950|FG002|Overall Study|Randomization Failure|34|||
25204835|NCT02988817|50446100|FG006|Overall Study|Physician Decision|0|||
25204836|NCT02988817|50446101|FG007|Overall Study|Physician Decision|0|||
25204837|NCT02988817|50446102|FG008|Overall Study|Physician Decision|0|||
25204838|NCT02988817|50446103|FG009|Overall Study|Physician Decision|0|||
25204839|NCT02988817|50446104|FG010|Overall Study|Physician Decision|0|||
25204840|NCT02988817|50446105|FG011|Overall Study|Physician Decision|0|||
25204841|NCT02988817|50446106|FG012|Overall Study|Physician Decision|0|||
25204842|NCT02988817|50446107|FG013|Overall Study|Physician Decision|0|||
25204843|NCT02988817|50446108|FG014|Overall Study|Physician Decision|0|||
25204844|NCT02988817|50446109|FG015|Overall Study|Physician Decision|1|||
25204845|NCT02988817|50446110|FG016|Overall Study|Physician Decision|0|||
25204846|NCT02988817|50446111|FG017|Overall Study|Physician Decision|0|||
25204847|NCT02988817|50446112|FG018|Overall Study|Physician Decision|1|||
25204848|NCT02988817|50446113|FG019|Overall Study|Physician Decision|1|||
25204849|NCT03312530|50446237|FG000|Overall Study|Death|5|||
25204850|NCT03312530|50446238|FG001|Overall Study|Death|5|||
25204851|NCT03312530|50446239|FG002|Overall Study|Death|4|||
25204852|NCT03312530|50446240|FG003|Overall Study|Death|10|||
25204853|NCT03312530|50446241|FG004|Overall Study|Death|8|||
25204854|NCT03312530|50446237|FG000|Overall Study|Lost to Follow-up|0|||
25204855|NCT03312530|50446238|FG001|Overall Study|Lost to Follow-up|0|||
25204856|NCT03312530|50446239|FG002|Overall Study|Lost to Follow-up|0|||
25204857|NCT03312530|50446240|FG003|Overall Study|Lost to Follow-up|1|||
25204858|NCT03312530|50446241|FG004|Overall Study|Lost to Follow-up|0|||
25204859|NCT03312530|50446237|FG000|Overall Study|Participant in another sponsor study.|0|||
25204860|NCT03312530|50446238|FG001|Overall Study|Participant in another sponsor study.|0|||
25204861|NCT03312530|50446239|FG002|Overall Study|Participant in another sponsor study.|0|||
25204862|NCT03312530|50446240|FG003|Overall Study|Participant in another sponsor study.|1|||
25204863|NCT03312530|50446241|FG004|Overall Study|Participant in another sponsor study.|0|||
25204864|NCT03312530|50446237|FG000|Overall Study|Study terminated by sponsor|1|||
25204865|NCT03312530|50446238|FG001|Overall Study|Study terminated by sponsor|0|||
25204866|NCT03312530|50446239|FG002|Overall Study|Study terminated by sponsor|2|||
25204867|NCT03312530|50446240|FG003|Overall Study|Study terminated by sponsor|3|||
25204868|NCT03312530|50446241|FG004|Overall Study|Study terminated by sponsor|7|||
25204869|NCT03312530|50446237|FG000|Overall Study|Withdrawal by Subject|0|||
25204870|NCT03312530|50446238|FG001|Overall Study|Withdrawal by Subject|1|||
25204871|NCT03312530|50446239|FG002|Overall Study|Withdrawal by Subject|0|||
25204872|NCT03312530|50446240|FG003|Overall Study|Withdrawal by Subject|0|||
25204873|NCT03312530|50446241|FG004|Overall Study|Withdrawal by Subject|0|||
25204874|NCT03312530|50446237|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
25204875|NCT03312530|50446238|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
25204876|NCT03312530|50446239|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
25204877|NCT03312530|50446240|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
25204878|NCT03312530|50446241|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
25204879|NCT02296320|50446372|FG000|Overall Study|Withdrawal by Subject|4|||
25204880|NCT02296320|50446373|FG001|Overall Study|Withdrawal by Subject|0|||
25204881|NCT02296320|50446374|FG002|Overall Study|Withdrawal by Subject|2|||
25204882|NCT02296320|50446372|FG000|Overall Study|Death|24|||
25204883|NCT02296320|50446373|FG001|Overall Study|Death|3|||
25204884|NCT02296320|50446374|FG002|Overall Study|Death|27|||
25204885|NCT02296320|50446372|FG000|Overall Study|Lost to Follow-up|5|||
25204886|NCT02296320|50446373|FG001|Overall Study|Lost to Follow-up|2|||
25204887|NCT02296320|50446374|FG002|Overall Study|Lost to Follow-up|7|||
25204888|NCT02296320|50446372|FG000|Overall Study|Not treated|2|||
25204889|NCT02296320|50446373|FG001|Overall Study|Not treated|0|||
25204890|NCT02296320|50446374|FG002|Overall Study|Not treated|0|||
25204891|NCT02296320|50446372|FG000|Overall Study|Not - specified|0|||
25204892|NCT02296320|50446373|FG001|Overall Study|Not - specified|0|||
25204893|NCT02296320|50446374|FG002|Overall Study|Not - specified|1|||
25204894|NCT02296242|50446413|FG000|Overall Study|Death|1|||
25204895|NCT02296242|50446414|FG001|Overall Study|Death|1|||
25204896|NCT02296242|50446415|FG002|Overall Study|Death|1|||
25204897|NCT02296242|50446416|FG003|Overall Study|Death|1|||
25204898|NCT02296242|50446417|FG004|Overall Study|Death|1|||
25204899|NCT02296242|50446413|FG000|Overall Study|Withdrawal by Subject|0|||
25204900|NCT02296242|50446414|FG001|Overall Study|Withdrawal by Subject|0|||
25204901|NCT02296242|50446415|FG002|Overall Study|Withdrawal by Subject|1|||
25204902|NCT02296242|50446416|FG003|Overall Study|Withdrawal by Subject|1|||
25204903|NCT02296242|50446417|FG004|Overall Study|Withdrawal by Subject|3|||
25204904|NCT02296242|50446413|FG000|Overall Study|Disease Progression|1|||
25204905|NCT02296242|50446414|FG001|Overall Study|Disease Progression|3|||
25204906|NCT02296242|50446415|FG002|Overall Study|Disease Progression|2|||
25204907|NCT02296242|50446416|FG003|Overall Study|Disease Progression|8|||
25204908|NCT02296242|50446417|FG004|Overall Study|Disease Progression|11|||
25204909|NCT02296242|50446413|FG000|Overall Study|Unacceptable Toxicity|0|||
25204910|NCT02296242|50446414|FG001|Overall Study|Unacceptable Toxicity|0|||
25204911|NCT02296242|50446415|FG002|Overall Study|Unacceptable Toxicity|0|||
25077123|NCT02469038|50184966|FG000|Overall Study|Physician Decision|4|||
25171567|NCT01597505|50308908|FG000|Overall Study|Adverse Event|19|||
25171568|NCT01597505|50308909|FG001|Overall Study|Adverse Event|7|||
25171569|NCT01597505|50308908|FG000|Overall Study|Lost to Follow-up|4|||
25171570|NCT01597505|50308909|FG001|Overall Study|Lost to Follow-up|2|||
25171571|NCT01597505|50308908|FG000|Overall Study|Withdrawal by Subject|10|||
25171572|NCT01597505|50308909|FG001|Overall Study|Withdrawal by Subject|18|||
25171573|NCT01597505|50308908|FG000|Overall Study|Other|5|||
25171574|NCT01597505|50308909|FG001|Overall Study|Other|6|||
25171575|NCT01597505|50308908|FG000|Overall Study|Missing|1|||
25171576|NCT01597505|50308909|FG001|Overall Study|Missing|0|||
25171577|NCT01760447|50308948|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
25171578|NCT01760447|50308949|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
25171579|NCT01760447|50308950|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
25171580|NCT01760447|50308951|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
25171581|NCT01760447|50308948|FG000|Weeks 0-20|Withdrawal by Subject|2|||
25171582|NCT01760447|50308949|FG001|Weeks 0-20|Withdrawal by Subject|0|||
25171583|NCT01760447|50308950|FG002|Weeks 0-20|Withdrawal by Subject|1|||
25171584|NCT01760447|50308951|FG003|Weeks 0-20|Withdrawal by Subject|0|||
25171585|NCT01760447|50308948|FG000|Weeks 0-20|Lost to Follow-up|1|||
25171586|NCT01760447|50308949|FG001|Weeks 0-20|Lost to Follow-up|0|||
25171587|NCT01760447|50308950|FG002|Weeks 0-20|Lost to Follow-up|1|||
25171588|NCT01760447|50308951|FG003|Weeks 0-20|Lost to Follow-up|1|||
25171589|NCT01760447|50308948|FG000|Weeks 0-20|Randomized but not treated|0|||
25171590|NCT01760447|50308949|FG001|Weeks 0-20|Randomized but not treated|0|||
25171591|NCT01760447|50308950|FG002|Weeks 0-20|Randomized but not treated|2|||
25171592|NCT01760447|50308951|FG003|Weeks 0-20|Randomized but not treated|0|||
25171593|NCT01760447|50308948|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
25171594|NCT01760447|50308949|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
25171595|NCT01760447|50308950|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
25171596|NCT01760447|50308951|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
25171597|NCT01760447|50308948|FG000|Weeks 20-54|Withdrawal by Subject|2|||
25171598|NCT01760447|50308949|FG001|Weeks 20-54|Withdrawal by Subject|1|||
25171599|NCT01760447|50308950|FG002|Weeks 20-54|Withdrawal by Subject|1|||
25171600|NCT01760447|50308951|FG003|Weeks 20-54|Withdrawal by Subject|2|||
25171601|NCT01760447|50308948|FG000|Weeks 20-54|Lost to Follow-up|0|||
25171602|NCT01760447|50308949|FG001|Weeks 20-54|Lost to Follow-up|0|||
25171603|NCT01760447|50308950|FG002|Weeks 20-54|Lost to Follow-up|1|||
25171604|NCT01760447|50308951|FG003|Weeks 20-54|Lost to Follow-up|2|||
25171605|NCT01732913|50309040|FG000|Overall Study|Study Terminated by Sponsor|105|||
25171606|NCT01732913|50309041|FG001|Overall Study|Study Terminated by Sponsor|55|||
25171607|NCT01732913|50309040|FG000|Overall Study|Withdrawal by Subject|27|||
25171608|NCT01732913|50309041|FG001|Overall Study|Withdrawal by Subject|4|||
25171609|NCT01732913|50309040|FG000|Overall Study|Physician Decision|14|||
25171610|NCT01732913|50309041|FG001|Overall Study|Physician Decision|7|||
25171611|NCT01732913|50309040|FG000|Overall Study|Other|7|||
25171612|NCT01732913|50309041|FG001|Overall Study|Other|1|||
25171613|NCT01732913|50309040|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
25171614|NCT01732913|50309041|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
25171615|NCT01732835|50309072|FG000|6-month Primary Endpoint|Did not receive device|19|||
25171616|NCT01732835|50309072|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
25171617|NCT01732835|50309072|FG000|6-month Primary Endpoint|Adverse Event|3|||
25171618|NCT01732835|50309072|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
25171619|NCT01732835|50309072|FG000|2-year Extended Follow-up|Adverse Event|3|||
25171620|NCT01732835|50309072|FG000|2-year Extended Follow-up|Death|1|||
25171621|NCT01759511|50309126|FG000|Overall Study|Adverse Event|4|||
25171622|NCT01759511|50309126|FG000|Overall Study|Death|2|||
25171623|NCT01759511|50309126|FG000|Overall Study|Lack of Efficacy|2|||
25171624|NCT01759511|50309126|FG000|Overall Study|Physician Decision|1|||
25171625|NCT01759511|50309126|FG000|Overall Study|Progressive Disease|5|||
25171626|NCT01759511|50309126|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
25171627|NCT01759511|50309126|FG000|Overall Study|Study Terminated by Sponsor|13|||
25171628|NCT01759511|50309126|FG000|Overall Study|Withdrawal by Subject|3|||
25171629|NCT01732757|50309144|FG000|Overall Study|Lost to Follow-up|1|||
25171630|NCT01732757|50309145|FG001|Overall Study|Lost to Follow-up|0|||
25171631|NCT01732757|50309146|FG002|Overall Study|Lost to Follow-up|0|||
25171632|NCT01758731|50309154|FG000|Overall Study|Physician Decision|1|||
25171633|NCT01606319|50309164|FG000|Overall Study|Lost to Follow-up|17|||
25171634|NCT01606319|50309165|FG001|Overall Study|Lost to Follow-up|14|||
25316006|NCT00896532|50631593|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25171635|NCT01606319|50309164|FG000|Overall Study|Withdrawal by Subject|9|||
25171636|NCT01606319|50309165|FG001|Overall Study|Withdrawal by Subject|12|||
25171637|NCT01606319|50309164|FG000|Overall Study|Physician Decision|1|||
25171638|NCT01606319|50309165|FG001|Overall Study|Physician Decision|2|||
25316007|NCT00896532|50631594|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25171639|NCT01606319|50309164|FG000|Overall Study|Lack of Efficacy|6|||
25171640|NCT01606319|50309165|FG001|Overall Study|Lack of Efficacy|8|||
25204912|NCT02296242|50446416|FG003|Overall Study|Unacceptable Toxicity|0|||
25204913|NCT02296242|50446417|FG004|Overall Study|Unacceptable Toxicity|1|||
25204914|NCT02296242|50446413|FG000|Overall Study|Patient Condition Changed|0|||
25204915|NCT02296242|50446414|FG001|Overall Study|Patient Condition Changed|0|||
25204916|NCT02296242|50446415|FG002|Overall Study|Patient Condition Changed|2|||
25204917|NCT02296242|50446416|FG003|Overall Study|Patient Condition Changed|0|||
25204918|NCT02296242|50446417|FG004|Overall Study|Patient Condition Changed|1|||
25204919|NCT02296242|50446413|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
25204920|NCT02296242|50446414|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
25204921|NCT02296242|50446415|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
25204922|NCT02296242|50446416|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
25204923|NCT02296242|50446417|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
25204924|NCT02296242|50446413|FG000|Overall Study|Lost to Follow-up|1|||
25204925|NCT02296242|50446414|FG001|Overall Study|Lost to Follow-up|0|||
25204926|NCT02296242|50446415|FG002|Overall Study|Lost to Follow-up|0|||
25204927|NCT02296242|50446416|FG003|Overall Study|Lost to Follow-up|0|||
25204928|NCT02296242|50446417|FG004|Overall Study|Lost to Follow-up|0|||
25204929|NCT02296242|50446413|FG000|Overall Study|Need for Hydroxyurea|2|||
25204930|NCT02296242|50446414|FG001|Overall Study|Need for Hydroxyurea|0|||
25204931|NCT02296242|50446415|FG002|Overall Study|Need for Hydroxyurea|0|||
25204932|NCT02296242|50446416|FG003|Overall Study|Need for Hydroxyurea|0|||
25204933|NCT02296242|50446417|FG004|Overall Study|Need for Hydroxyurea|0|||
25204934|NCT02296242|50446413|FG000|Overall Study|Screened for Other Protocol|0|||
25204935|NCT02296242|50446414|FG001|Overall Study|Screened for Other Protocol|1|||
25204936|NCT02296242|50446415|FG002|Overall Study|Screened for Other Protocol|0|||
25204937|NCT02296242|50446416|FG003|Overall Study|Screened for Other Protocol|0|||
25204938|NCT02296242|50446417|FG004|Overall Study|Screened for Other Protocol|0|||
25204939|NCT02296242|50446413|FG000|Overall Study|Physician Decision|0|||
25204940|NCT02296242|50446414|FG001|Overall Study|Physician Decision|1|||
25204941|NCT02296242|50446415|FG002|Overall Study|Physician Decision|0|||
25204942|NCT02296242|50446416|FG003|Overall Study|Physician Decision|1|||
25204943|NCT02296242|50446417|FG004|Overall Study|Physician Decision|0|||
25204944|NCT02296242|50446413|FG000|Overall Study|Alternative Treatment|0|||
25204945|NCT02296242|50446414|FG001|Overall Study|Alternative Treatment|0|||
25204946|NCT02296242|50446415|FG002|Overall Study|Alternative Treatment|0|||
25204947|NCT02296242|50446416|FG003|Overall Study|Alternative Treatment|1|||
25204948|NCT02296242|50446417|FG004|Overall Study|Alternative Treatment|0|||
25204949|NCT02296242|50446413|FG000|Overall Study|Adverse Event|0|||
25204950|NCT02296242|50446414|FG001|Overall Study|Adverse Event|0|||
25204951|NCT02296242|50446415|FG002|Overall Study|Adverse Event|0|||
25204952|NCT02296242|50446416|FG003|Overall Study|Adverse Event|1|||
25204953|NCT02296242|50446417|FG004|Overall Study|Adverse Event|0|||
25204954|NCT02296242|50446413|FG000|Overall Study|Lack of Efficacy|0|||
25204955|NCT02296242|50446414|FG001|Overall Study|Lack of Efficacy|0|||
25204956|NCT02296242|50446415|FG002|Overall Study|Lack of Efficacy|0|||
25204957|NCT02296242|50446416|FG003|Overall Study|Lack of Efficacy|0|||
25204958|NCT02296242|50446417|FG004|Overall Study|Lack of Efficacy|3|||
25204959|NCT02295774|50446437|FG000|Overall Study|Physician Decision|1|||
25204960|NCT02295774|50446437|FG000|Overall Study|Withdrawal by Subject|2|||
25204961|NCT02294682|50446452|FG000|Overall Study|Could not swallow pills|1|||
25204962|NCT02294682|50446453|FG001|Overall Study|Could not swallow pills|0|||
25204963|NCT02294604|50446462|FG000|Overall Study|Did not provide samples for culture|0|||
25204964|NCT02294604|50446463|FG001|Overall Study|Did not provide samples for culture|1|||
25204965|NCT02294604|50446464|FG002|Overall Study|Did not provide samples for culture|0|||
25204966|NCT02294604|50446462|FG000|Overall Study|Culture contamination|1|||
25204967|NCT02294604|50446463|FG001|Overall Study|Culture contamination|2|||
25204968|NCT02294604|50446464|FG002|Overall Study|Culture contamination|0|||
25204969|NCT01645176|50446483|FG000|Overall Study|Lack of Efficacy|4|||
25204970|NCT01645176|50446483|FG000|Overall Study|did not complete final MRI|1|||
25204971|NCT02322216|50446498|FG000|Overall Study|Adverse Event|1|||
25204972|NCT02322216|50446499|FG001|Overall Study|Adverse Event|0|||
25204973|NCT02322216|50446498|FG000|Overall Study|Withdrawal by Subject|1|||
25204974|NCT02322216|50446499|FG001|Overall Study|Withdrawal by Subject|4|||
25204975|NCT01647516|50446540|FG000|Induction Period (IP)|Physician Decision|2|||
25204976|NCT01647516|50446541|FG001|Induction Period (IP)|Physician Decision|0|||
25204977|NCT01647516|50446542|FG002|Induction Period (IP)|Physician Decision|0|||
25204978|NCT01647516|50446543|FG003|Induction Period (IP)|Physician Decision|0|||
25204979|NCT01647516|50446544|FG004|Induction Period (IP)|Physician Decision|0|||
25204980|NCT01647516|50446545|FG005|Induction Period (IP)|Physician Decision|0|||
25204981|NCT01647516|50446540|FG000|Induction Period (IP)|Adverse Event|1|||
25204982|NCT01647516|50446541|FG001|Induction Period (IP)|Adverse Event|2|||
25204983|NCT01647516|50446542|FG002|Induction Period (IP)|Adverse Event|0|||
25204984|NCT01647516|50446543|FG003|Induction Period (IP)|Adverse Event|0|||
25204985|NCT01647516|50446544|FG004|Induction Period (IP)|Adverse Event|0|||
25204986|NCT01647516|50446545|FG005|Induction Period (IP)|Adverse Event|0|||
25204987|NCT01647516|50446540|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
25204988|NCT01647516|50446541|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
25204989|NCT01647516|50446542|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
25204990|NCT01647516|50446543|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
25204991|NCT01647516|50446544|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
25204992|NCT01647516|50446545|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
25204993|NCT01647516|50446540|FG000|Induction Period (IP)|Participant Choice|0|||
25204994|NCT01647516|50446541|FG001|Induction Period (IP)|Participant Choice|0|||
25204995|NCT01647516|50446542|FG002|Induction Period (IP)|Participant Choice|1|||
25204996|NCT01647516|50446543|FG003|Induction Period (IP)|Participant Choice|0|||
25204997|NCT01647516|50446544|FG004|Induction Period (IP)|Participant Choice|0|||
25204998|NCT01647516|50446545|FG005|Induction Period (IP)|Participant Choice|0|||
25204999|NCT01647516|50446540|FG000|Induction Period (IP)|Lack of Efficacy|1|||
25205000|NCT01647516|50446541|FG001|Induction Period (IP)|Lack of Efficacy|0|||
25205001|NCT01647516|50446542|FG002|Induction Period (IP)|Lack of Efficacy|0|||
25205002|NCT01647516|50446543|FG003|Induction Period (IP)|Lack of Efficacy|0|||
25205003|NCT01647516|50446544|FG004|Induction Period (IP)|Lack of Efficacy|0|||
25205004|NCT01647516|50446545|FG005|Induction Period (IP)|Lack of Efficacy|0|||
25205005|NCT01647516|50446540|FG000|Induction Period (IP)|No study drug received|1|||
25205006|NCT01647516|50446541|FG001|Induction Period (IP)|No study drug received|1|||
25205007|NCT01647516|50446542|FG002|Induction Period (IP)|No study drug received|0|||
25205008|NCT01647516|50446543|FG003|Induction Period (IP)|No study drug received|0|||
25205009|NCT01647516|50446544|FG004|Induction Period (IP)|No study drug received|0|||
25205010|NCT01647516|50446545|FG005|Induction Period (IP)|No study drug received|0|||
25205011|NCT01647516|50446540|FG000|Maintenance Period (MP)|Adverse Event|2|||
25205012|NCT01647516|50446541|FG001|Maintenance Period (MP)|Adverse Event|1|||
25205013|NCT01647516|50446542|FG002|Maintenance Period (MP)|Adverse Event|0|||
25205014|NCT01647516|50446543|FG003|Maintenance Period (MP)|Adverse Event|0|||
25205015|NCT01647516|50446544|FG004|Maintenance Period (MP)|Adverse Event|0|||
25205016|NCT01647516|50446545|FG005|Maintenance Period (MP)|Adverse Event|0|||
25205017|NCT01647516|50446540|FG000|Maintenance Period (MP)|Non-compliance|1|||
25205018|NCT01647516|50446541|FG001|Maintenance Period (MP)|Non-compliance|0|||
25205019|NCT01647516|50446542|FG002|Maintenance Period (MP)|Non-compliance|0|||
25205020|NCT01647516|50446543|FG003|Maintenance Period (MP)|Non-compliance|0|||
25205021|NCT01647516|50446544|FG004|Maintenance Period (MP)|Non-compliance|0|||
25205022|NCT01647516|50446545|FG005|Maintenance Period (MP)|Non-compliance|0|||
25205023|NCT01647516|50446540|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
25205024|NCT01647516|50446541|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
25205025|NCT01647516|50446542|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
25205026|NCT01647516|50446543|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
25205027|NCT01647516|50446544|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
25205028|NCT01647516|50446545|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
25205029|NCT01647516|50446540|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
25205030|NCT01647516|50446541|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
25205031|NCT01647516|50446542|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
25205032|NCT01647516|50446543|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
25205033|NCT01647516|50446544|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
25205034|NCT01647516|50446545|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
25205035|NCT01647516|50446540|FG000|Open-Label Period|Adverse Event|0|||
25205036|NCT01647516|50446541|FG001|Open-Label Period|Adverse Event|0|||
25205037|NCT01647516|50446542|FG002|Open-Label Period|Adverse Event|0|||
25205038|NCT01647516|50446543|FG003|Open-Label Period|Adverse Event|5|||
25205039|NCT01647516|50446544|FG004|Open-Label Period|Adverse Event|6|||
25205040|NCT01647516|50446545|FG005|Open-Label Period|Adverse Event|3|||
25205041|NCT01647516|50446540|FG000|Open-Label Period|Pregnancy|0|||
25205042|NCT01647516|50446541|FG001|Open-Label Period|Pregnancy|0|||
25205043|NCT01647516|50446542|FG002|Open-Label Period|Pregnancy|0|||
25205044|NCT01647516|50446543|FG003|Open-Label Period|Pregnancy|0|||
25205045|NCT01647516|50446544|FG004|Open-Label Period|Pregnancy|0|||
25205046|NCT01647516|50446545|FG005|Open-Label Period|Pregnancy|1|||
25205047|NCT01647516|50446540|FG000|Open-Label Period|Non-compliance|0|||
25205048|NCT01647516|50446541|FG001|Open-Label Period|Non-compliance|0|||
25205049|NCT01647516|50446542|FG002|Open-Label Period|Non-compliance|0|||
25205050|NCT01647516|50446543|FG003|Open-Label Period|Non-compliance|1|||
25205051|NCT01647516|50446544|FG004|Open-Label Period|Non-compliance|0|||
25205052|NCT01647516|50446545|FG005|Open-Label Period|Non-compliance|1|||
25205053|NCT01647516|50446540|FG000|Open-Label Period|Physician Decision|0|||
25205054|NCT01647516|50446541|FG001|Open-Label Period|Physician Decision|0|||
25205055|NCT01647516|50446542|FG002|Open-Label Period|Physician Decision|0|||
25205056|NCT01647516|50446543|FG003|Open-Label Period|Physician Decision|1|||
25205057|NCT01647516|50446544|FG004|Open-Label Period|Physician Decision|1|||
25205058|NCT01647516|50446545|FG005|Open-Label Period|Physician Decision|0|||
25205059|NCT01647516|50446540|FG000|Open-Label Period|Withdrawal by Subject|0|||
25205060|NCT01647516|50446541|FG001|Open-Label Period|Withdrawal by Subject|0|||
25205061|NCT01647516|50446542|FG002|Open-Label Period|Withdrawal by Subject|0|||
25205062|NCT01647516|50446543|FG003|Open-Label Period|Withdrawal by Subject|9|||
25205063|NCT01647516|50446544|FG004|Open-Label Period|Withdrawal by Subject|11|||
25205064|NCT01647516|50446545|FG005|Open-Label Period|Withdrawal by Subject|6|||
25205065|NCT01647516|50446540|FG000|Open-Label Period|Lost to Follow-up|0|||
25205066|NCT01647516|50446541|FG001|Open-Label Period|Lost to Follow-up|0|||
25205067|NCT01647516|50446542|FG002|Open-Label Period|Lost to Follow-up|0|||
25205068|NCT01647516|50446543|FG003|Open-Label Period|Lost to Follow-up|1|||
25205069|NCT01647516|50446544|FG004|Open-Label Period|Lost to Follow-up|0|||
25205070|NCT01647516|50446545|FG005|Open-Label Period|Lost to Follow-up|1|||
25205071|NCT01647516|50446540|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
25205072|NCT01647516|50446541|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
25205073|NCT01647516|50446542|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
25205074|NCT01647516|50446543|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
25205075|NCT01647516|50446544|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
25205076|NCT01647516|50446545|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
25205077|NCT01647516|50446540|FG000|Open-Label Period|Lack of Efficacy|0|||
25205078|NCT01647516|50446541|FG001|Open-Label Period|Lack of Efficacy|0|||
25205079|NCT01647516|50446542|FG002|Open-Label Period|Lack of Efficacy|0|||
25205080|NCT01647516|50446543|FG003|Open-Label Period|Lack of Efficacy|7|||
25205081|NCT01647516|50446544|FG004|Open-Label Period|Lack of Efficacy|9|||
25205082|NCT01647516|50446545|FG005|Open-Label Period|Lack of Efficacy|10|||
25205083|NCT01647516|50446540|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
25205084|NCT01647516|50446541|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
25205085|NCT01647516|50446542|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
25205086|NCT01647516|50446543|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
25205087|NCT01647516|50446544|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
25205088|NCT01647516|50446545|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
25205089|NCT01647516|50446540|FG000|Open-Label Period|No completion / discontinuation visit|0|||
25205090|NCT01647516|50446541|FG001|Open-Label Period|No completion / discontinuation visit|0|||
25205091|NCT01647516|50446542|FG002|Open-Label Period|No completion / discontinuation visit|0|||
25205092|NCT01647516|50446543|FG003|Open-Label Period|No completion / discontinuation visit|0|||
25205093|NCT01647516|50446544|FG004|Open-Label Period|No completion / discontinuation visit|2|||
25205094|NCT01647516|50446545|FG005|Open-Label Period|No completion / discontinuation visit|1|||
25205095|NCT01647282|50446562|FG000|Overall Study|Physician Decision|7|||
25205096|NCT01647282|50446563|FG001|Overall Study|Physician Decision|5|||
25205097|NCT02321436|50446571|FG000|Overall Study|Withdrawal by Subject|1|||
25205098|NCT02321436|50446572|FG001|Overall Study|Withdrawal by Subject|0|||
25205099|NCT02321436|50446571|FG000|Overall Study|Lost to Follow-up|0|||
25205100|NCT02321436|50446572|FG001|Overall Study|Lost to Follow-up|1|||
25205101|NCT02319642|50446581|FG000|Overall Study|Adverse Event|2|||
25205102|NCT02319642|50446582|FG001|Overall Study|Adverse Event|4|||
25205103|NCT02319642|50446581|FG000|Overall Study|Lack of Efficacy|1|||
25205104|NCT02319642|50446582|FG001|Overall Study|Lack of Efficacy|1|||
25205105|NCT02319642|50446581|FG000|Overall Study|Withdrawal by Subject|1|||
25205106|NCT02319642|50446582|FG001|Overall Study|Withdrawal by Subject|1|||
25205107|NCT02280096|50446592|FG000|Overall Study|Pregnancy|1|||
25205108|NCT02280096|50446593|FG001|Overall Study|Pregnancy|0|||
25205109|NCT02280096|50446592|FG000|Overall Study|Functional neurological disorder|1|||
25205110|NCT02280096|50446593|FG001|Overall Study|Functional neurological disorder|0|||
25205111|NCT02280096|50446592|FG000|Overall Study|Lack of attachment|0|||
25205112|NCT02280096|50446593|FG001|Overall Study|Lack of attachment|1|||
25205113|NCT02279862|50446610|FG000|Overall Study|Study drug toxicity|3|||
25205114|NCT02279862|50446611|FG001|Overall Study|Study drug toxicity|6|||
25205115|NCT02279862|50446610|FG000|Overall Study|No longer meets criteria|0|||
25205116|NCT02279862|50446611|FG001|Overall Study|No longer meets criteria|1|||
25205117|NCT02279862|50446610|FG000|Overall Study|Administrative reason by sponsor|0|||
25205118|NCT02279862|50446611|FG001|Overall Study|Administrative reason by sponsor|1|||
25205119|NCT02279862|50446610|FG000|Overall Study|Disease progression|5|||
25205120|NCT02279862|50446611|FG001|Overall Study|Disease progression|2|||
25205121|NCT02279862|50446610|FG000|Overall Study|Study closed by sponsor|16|||
25205122|NCT02279862|50446611|FG001|Overall Study|Study closed by sponsor|13|||
25205123|NCT02279862|50446610|FG000|Overall Study|Other|1|||
25205124|NCT02279862|50446611|FG001|Overall Study|Other|2|||
25205125|NCT02279862|50446610|FG000|Overall Study|Withdrawal by Subject|1|||
25205126|NCT02279862|50446611|FG001|Overall Study|Withdrawal by Subject|0|||
25205127|NCT02318940|50446619|FG000|Overall Study|lost the record|1|||
25205128|NCT02318940|50446620|FG001|Overall Study|lost the record|0|||
25205129|NCT02294058|50446629|FG000|Overall Study|Adverse Event|16|||
25205130|NCT02294058|50446630|FG001|Overall Study|Adverse Event|7|||
25205131|NCT02294058|50446631|FG002|Overall Study|Adverse Event|13|||
25205132|NCT02294058|50446629|FG000|Overall Study|Lack of Efficacy|3|||
25205133|NCT02294058|50446630|FG001|Overall Study|Lack of Efficacy|3|||
25205134|NCT02294058|50446631|FG002|Overall Study|Lack of Efficacy|0|||
25205135|NCT02294058|50446629|FG000|Overall Study|Lost to Follow-up|1|||
25205136|NCT02294058|50446630|FG001|Overall Study|Lost to Follow-up|0|||
25205137|NCT02294058|50446631|FG002|Overall Study|Lost to Follow-up|2|||
25205138|NCT02294058|50446629|FG000|Overall Study|Withdrawal by Subject|10|||
25205139|NCT02294058|50446630|FG001|Overall Study|Withdrawal by Subject|14|||
25205140|NCT02294058|50446631|FG002|Overall Study|Withdrawal by Subject|13|||
25205141|NCT02294058|50446629|FG000|Overall Study|Physician Decision|2|||
25205142|NCT02294058|50446630|FG001|Overall Study|Physician Decision|1|||
25205143|NCT02294058|50446631|FG002|Overall Study|Physician Decision|0|||
25205144|NCT02294058|50446629|FG000|Overall Study|Miscellaneous|4|||
25205145|NCT02294058|50446630|FG001|Overall Study|Miscellaneous|1|||
25205146|NCT02294058|50446631|FG002|Overall Study|Miscellaneous|1|||
25205147|NCT05065619|50446642|FG000|Overall Study|Lost to Follow-up|1|||
25205148|NCT05065619|50446643|FG001|Overall Study|Lost to Follow-up|0|||
25205149|NCT05065619|50446642|FG000|Overall Study|Withdrawal by Subject|1|||
25205150|NCT05065619|50446643|FG001|Overall Study|Withdrawal by Subject|0|||
25205151|NCT02293902|50446652|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
25205152|NCT02293902|50446653|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
25205153|NCT02293902|50446654|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
25205154|NCT02293902|50446655|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
25205155|NCT02293902|50446656|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
25205156|NCT02293902|50446652|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
25205157|NCT02293902|50446653|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
25205158|NCT02293902|50446654|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
25205159|NCT02293902|50446655|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
25205160|NCT02293902|50446656|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
25205161|NCT02293902|50446652|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
25205162|NCT02293902|50446653|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
25205163|NCT02293902|50446654|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
25205164|NCT02293902|50446655|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
25205165|NCT02293902|50446656|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
25205166|NCT02293902|50446652|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
25205167|NCT02293902|50446653|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
25205168|NCT02293902|50446654|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
25205169|NCT02293902|50446655|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
25205170|NCT02293902|50446656|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
25205171|NCT02293902|50446652|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
25205172|NCT02293902|50446653|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
25205173|NCT02293902|50446654|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
25205174|NCT02293902|50446655|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
25205175|NCT02293902|50446656|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
25205176|NCT02278614|50446676|FG000|Overall Study|Withdrawal by Subject|3|||
25205177|NCT02278614|50446677|FG001|Overall Study|Withdrawal by Subject|5|||
25205178|NCT02278614|50446676|FG000|Overall Study|Adverse Event|1|||
25205179|NCT02278614|50446677|FG001|Overall Study|Adverse Event|0|||
25205180|NCT02278614|50446676|FG000|Overall Study|left eye was not eligible|1|||
25205181|NCT02278614|50446677|FG001|Overall Study|left eye was not eligible|0|||
25205182|NCT02318706|50446687|FG000|Double-blind Phase|Adverse Event|7|||
25205183|NCT02318706|50446688|FG001|Double-blind Phase|Adverse Event|4|||
25205184|NCT02318706|50446689|FG002|Double-blind Phase|Adverse Event|3|||
25205185|NCT02318706|50446690|FG003|Double-blind Phase|Adverse Event|10|||
25205186|NCT02318706|50446691|FG004|Double-blind Phase|Adverse Event|0|||
25205187|NCT02318706|50446687|FG000|Double-blind Phase|Lost to Follow-up|1|||
25205188|NCT02318706|50446688|FG001|Double-blind Phase|Lost to Follow-up|0|||
25205189|NCT02318706|50446689|FG002|Double-blind Phase|Lost to Follow-up|0|||
25205190|NCT02318706|50446690|FG003|Double-blind Phase|Lost to Follow-up|0|||
25205191|NCT02318706|50446691|FG004|Double-blind Phase|Lost to Follow-up|0|||
25205192|NCT02318706|50446687|FG000|Double-blind Phase|Protocol Violation|4|||
25205193|NCT02318706|50446688|FG001|Double-blind Phase|Protocol Violation|2|||
25205194|NCT02318706|50446689|FG002|Double-blind Phase|Protocol Violation|4|||
25316008|NCT00896532|50631595|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25205195|NCT02318706|50446690|FG003|Double-blind Phase|Protocol Violation|3|||
25205196|NCT02318706|50446691|FG004|Double-blind Phase|Protocol Violation|0|||
25205197|NCT02318706|50446687|FG000|Double-blind Phase|Withdrawal by Subject|9|||
25205198|NCT02318706|50446688|FG001|Double-blind Phase|Withdrawal by Subject|5|||
25205199|NCT02318706|50446689|FG002|Double-blind Phase|Withdrawal by Subject|7|||
25205200|NCT02318706|50446690|FG003|Double-blind Phase|Withdrawal by Subject|10|||
25205201|NCT02318706|50446691|FG004|Double-blind Phase|Withdrawal by Subject|0|||
25205202|NCT02318706|50446687|FG000|Double-blind Phase|Other|4|||
25205203|NCT02318706|50446688|FG001|Double-blind Phase|Other|1|||
25205204|NCT02318706|50446689|FG002|Double-blind Phase|Other|2|||
25205205|NCT02318706|50446690|FG003|Double-blind Phase|Other|1|||
25205206|NCT02318706|50446691|FG004|Double-blind Phase|Other|0|||
25205207|NCT02318706|50446687|FG000|Double-blind Phase|Death|0|||
25205208|NCT02318706|50446688|FG001|Double-blind Phase|Death|0|||
25205209|NCT02318706|50446689|FG002|Double-blind Phase|Death|2|||
25205210|NCT02318706|50446690|FG003|Double-blind Phase|Death|0|||
25205211|NCT02318706|50446691|FG004|Double-blind Phase|Death|0|||
25205212|NCT02318706|50446687|FG000|Open-label Extension Phase|Adverse Event|0|||
25205213|NCT02318706|50446688|FG001|Open-label Extension Phase|Adverse Event|0|||
25205214|NCT02318706|50446689|FG002|Open-label Extension Phase|Adverse Event|0|||
25205215|NCT02318706|50446690|FG003|Open-label Extension Phase|Adverse Event|0|||
25205216|NCT02318706|50446691|FG004|Open-label Extension Phase|Adverse Event|21|||
25205217|NCT02318706|50446687|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
25205218|NCT02318706|50446688|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
25205219|NCT02318706|50446689|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
25205220|NCT02318706|50446690|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
25205221|NCT02318706|50446691|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
25205222|NCT02318706|50446687|FG000|Open-label Extension Phase|Death|0|||
25205223|NCT02318706|50446688|FG001|Open-label Extension Phase|Death|0|||
25205224|NCT02318706|50446689|FG002|Open-label Extension Phase|Death|0|||
25205225|NCT02318706|50446690|FG003|Open-label Extension Phase|Death|0|||
25205226|NCT02318706|50446691|FG004|Open-label Extension Phase|Death|1|||
25205227|NCT02318706|50446687|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
25205228|NCT02318706|50446688|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
25205229|NCT02318706|50446689|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
25205230|NCT02318706|50446690|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
25205231|NCT02318706|50446691|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
25205232|NCT04747275|50446733|FG000|Overall Study|Study terminated|0|||
25205233|NCT04747275|50446734|FG001|Overall Study|Study terminated|1|||
25205234|NCT04583280|50446742|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
25205235|NCT04583280|50446743|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
25205236|NCT04489940|50446762|FG000|Overall Study|Other|2|||
25205237|NCT04489940|50446762|FG000|Overall Study|Withdrawal by Subject|2|||
25205238|NCT04489940|50446762|FG000|Overall Study|Death|5|||
25205239|NCT04489940|50446762|FG000|Overall Study|Lost to Follow-up|1|||
25205240|NCT04365257|50446768|FG000|Overall Study|Physician Decision|1|||
25205241|NCT04365257|50446769|FG001|Overall Study|Physician Decision|0|||
25205242|NCT04365257|50446768|FG000|Overall Study|Patient Noncompliance|1|||
25205243|NCT04365257|50446769|FG001|Overall Study|Patient Noncompliance|0|||
25205244|NCT04365257|50446768|FG000|Overall Study|Withdrawal by Subject|0|||
25205245|NCT04365257|50446769|FG001|Overall Study|Withdrawal by Subject|1|||
25205246|NCT03395223|50446801|FG000|Overall Study|Lost to Follow-up|3|||
25205247|NCT03395223|50446801|FG000|Overall Study|Other|1|||
25205248|NCT02937818|50446833|FG000|Overall Study|Participants decision|1|||
25205249|NCT02937818|50446834|FG001|Overall Study|Participants decision|0|||
25205250|NCT02937818|50446835|FG002|Overall Study|Participants decision|1|||
25205251|NCT02937818|50446836|FG003|Overall Study|Participants decision|1|||
25205252|NCT02937818|50446833|FG000|Overall Study|Adverse Event|2|||
25205253|NCT02937818|50446834|FG001|Overall Study|Adverse Event|4|||
25205254|NCT02937818|50446835|FG002|Overall Study|Adverse Event|1|||
25205255|NCT02937818|50446836|FG003|Overall Study|Adverse Event|1|||
25205256|NCT02937818|50446833|FG000|Overall Study|Disease progression|17|||
25205257|NCT02937818|50446834|FG001|Overall Study|Disease progression|14|||
25205258|NCT02937818|50446835|FG002|Overall Study|Disease progression|7|||
25205259|NCT02937818|50446836|FG003|Overall Study|Disease progression|18|||
25205260|NCT02937818|50446833|FG000|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1|||
25205261|NCT02937818|50446834|FG001|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2|||
25205262|NCT02937818|50446835|FG002|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
25205263|NCT02937818|50446836|FG003|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
25205264|NCT02937818|50446833|FG000|Overall Study|Condition under investigation worsened|0|||
25205265|NCT02937818|50446834|FG001|Overall Study|Condition under investigation worsened|0|||
25205266|NCT02937818|50446835|FG002|Overall Study|Condition under investigation worsened|1|||
25205267|NCT02937818|50446836|FG003|Overall Study|Condition under investigation worsened|0|||
24976317|NCT00092547|50065234|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
25205268|NCT02937818|50446833|FG000|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
25205269|NCT02937818|50446834|FG001|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
25205270|NCT02937818|50446835|FG002|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
25205271|NCT02937818|50446836|FG003|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1|||
25205272|NCT02864940|50446851|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
25205273|NCT02864940|50446852|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
25205274|NCT02756611|50446871|FG000|Overall Study|Death|70|||
25205275|NCT02756611|50446871|FG000|Overall Study|Withdrawal by Subject|2|||
25205276|NCT02756611|50446871|FG000|Overall Study|Lost to Follow-up|3|||
25205277|NCT02756611|50446871|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
25205278|NCT02756611|50446871|FG000|Overall Study|Other|10|||
25205279|NCT02624518|50446875|FG000|Overall Study|Physician Decision|1|||
25205280|NCT02287623|50446881|FG000|Overall Study|Protocol Violation|0|||
25205281|NCT02287623|50446882|FG001|Overall Study|Protocol Violation|1|||
25205282|NCT01794520|50446904|FG000|Overall Study|Adverse events- related to progression|0|||
25205283|NCT01794520|50446905|FG001|Overall Study|Adverse events- related to progression|0|||
25205284|NCT01794520|50446906|FG002|Overall Study|Adverse events- related to progression|1|||
25205285|NCT01794520|50446907|FG003|Overall Study|Adverse events- related to progression|2|||
25205286|NCT01794520|50446908|FG004|Overall Study|Adverse events- related to progression|0|||
25205287|NCT01794520|50446909|FG005|Overall Study|Adverse events- related to progression|1|||
25205288|NCT01794520|50446910|FG006|Overall Study|Adverse events- related to progression|0|||
25205289|NCT01794520|50446904|FG000|Overall Study|Adverse event- not related to progression|1|||
25205290|NCT01794520|50446905|FG001|Overall Study|Adverse event- not related to progression|1|||
25205291|NCT01794520|50446906|FG002|Overall Study|Adverse event- not related to progression|0|||
25205292|NCT01794520|50446907|FG003|Overall Study|Adverse event- not related to progression|0|||
25205293|NCT01794520|50446908|FG004|Overall Study|Adverse event- not related to progression|2|||
25205294|NCT01794520|50446909|FG005|Overall Study|Adverse event- not related to progression|0|||
25205295|NCT01794520|50446910|FG006|Overall Study|Adverse event- not related to progression|0|||
25205296|NCT01794520|50446904|FG000|Overall Study|Progressive disease|5|||
25205297|NCT01794520|50446905|FG001|Overall Study|Progressive disease|6|||
25205298|NCT01794520|50446906|FG002|Overall Study|Progressive disease|2|||
25205299|NCT01794520|50446907|FG003|Overall Study|Progressive disease|5|||
25205300|NCT01794520|50446908|FG004|Overall Study|Progressive disease|27|||
25205301|NCT01794520|50446909|FG005|Overall Study|Progressive disease|18|||
25205302|NCT01794520|50446910|FG006|Overall Study|Progressive disease|0|||
25205303|NCT01794520|50446904|FG000|Overall Study|Withdrew consent|0|||
25205304|NCT01794520|50446905|FG001|Overall Study|Withdrew consent|0|||
25205305|NCT01794520|50446906|FG002|Overall Study|Withdrew consent|1|||
25205306|NCT01794520|50446907|FG003|Overall Study|Withdrew consent|1|||
25205307|NCT01794520|50446908|FG004|Overall Study|Withdrew consent|0|||
25205308|NCT01794520|50446909|FG005|Overall Study|Withdrew consent|0|||
25205309|NCT01794520|50446910|FG006|Overall Study|Withdrew consent|0|||
25205310|NCT01794520|50446904|FG000|Overall Study|Lost to Follow-up|0|||
25205311|NCT01794520|50446905|FG001|Overall Study|Lost to Follow-up|0|||
25205312|NCT01794520|50446906|FG002|Overall Study|Lost to Follow-up|0|||
25205313|NCT01794520|50446907|FG003|Overall Study|Lost to Follow-up|0|||
25205314|NCT01794520|50446908|FG004|Overall Study|Lost to Follow-up|1|||
25205315|NCT01794520|50446909|FG005|Overall Study|Lost to Follow-up|0|||
25205316|NCT01794520|50446910|FG006|Overall Study|Lost to Follow-up|0|||
25205317|NCT01794520|50446904|FG000|Overall Study|Toxicity|0|||
25205318|NCT01794520|50446905|FG001|Overall Study|Toxicity|2|||
25205319|NCT01794520|50446906|FG002|Overall Study|Toxicity|0|||
25205320|NCT01794520|50446907|FG003|Overall Study|Toxicity|0|||
25205321|NCT01794520|50446908|FG004|Overall Study|Toxicity|0|||
25205322|NCT01794520|50446909|FG005|Overall Study|Toxicity|0|||
25205323|NCT01794520|50446910|FG006|Overall Study|Toxicity|0|||
25205324|NCT01794520|50446904|FG000|Overall Study|Study terminated by sponsor|0|||
25205325|NCT01794520|50446905|FG001|Overall Study|Study terminated by sponsor|0|||
25205326|NCT01794520|50446906|FG002|Overall Study|Study terminated by sponsor|1|||
25205327|NCT01794520|50446907|FG003|Overall Study|Study terminated by sponsor|0|||
25205328|NCT01794520|50446908|FG004|Overall Study|Study terminated by sponsor|1|||
25205329|NCT01794520|50446909|FG005|Overall Study|Study terminated by sponsor|0|||
25205330|NCT01794520|50446910|FG006|Overall Study|Study terminated by sponsor|7|||
25205331|NCT01794520|50446904|FG000|Overall Study|Death|0|||
25205332|NCT01794520|50446905|FG001|Overall Study|Death|0|||
25205333|NCT01794520|50446906|FG002|Overall Study|Death|0|||
25205334|NCT01794520|50446907|FG003|Overall Study|Death|0|||
25205335|NCT01794520|50446908|FG004|Overall Study|Death|1|||
25205336|NCT01794520|50446909|FG005|Overall Study|Death|0|||
25205337|NCT01794520|50446910|FG006|Overall Study|Death|22|||
25205338|NCT01794520|50446904|FG000|Overall Study|Other, not specified|0|||
25205339|NCT01794520|50446905|FG001|Overall Study|Other, not specified|0|||
25205340|NCT01794520|50446906|FG002|Overall Study|Other, not specified|1|||
25205341|NCT01794520|50446907|FG003|Overall Study|Other, not specified|1|||
25205342|NCT01794520|50446908|FG004|Overall Study|Other, not specified|4|||
25205343|NCT01794520|50446909|FG005|Overall Study|Other, not specified|1|||
25205344|NCT01794520|50446910|FG006|Overall Study|Other, not specified|2|||
25205345|NCT01774019|50446933|FG000|Overall Study|No longer meets protocol criteria|2|||
25205346|NCT01774019|50446934|FG001|Overall Study|No longer meets protocol criteria|0|||
25205347|NCT01774019|50446933|FG000|Overall Study|Withdrawal by Subject|1|||
25205348|NCT01774019|50446934|FG001|Overall Study|Withdrawal by Subject|0|||
25205349|NCT01774019|50446933|FG000|Overall Study|Surgery delayed > 120 days|1|||
25205350|NCT01774019|50446934|FG001|Overall Study|Surgery delayed > 120 days|0|||
25205351|NCT01774019|50446933|FG000|Overall Study|Patient refused surgery|1|||
25205352|NCT01774019|50446934|FG001|Overall Study|Patient refused surgery|1|||
25205353|NCT01774019|50446933|FG000|Overall Study|Unable to implant study device|1|||
25205354|NCT01774019|50446934|FG001|Overall Study|Unable to implant study device|0|||
25205355|NCT01774019|50446933|FG000|Overall Study|Lost to Follow-up|0|||
25205356|NCT01774019|50446934|FG001|Overall Study|Lost to Follow-up|3|||
25205357|NCT03251924|50447310|FG000|Overall Study|Disease Progression|6|||
25205358|NCT03251924|50447311|FG001|Overall Study|Disease Progression|6|||
25205359|NCT03251924|50447312|FG002|Overall Study|Disease Progression|7|||
25205360|NCT03251924|50447313|FG003|Overall Study|Disease Progression|8|||
25205361|NCT03251924|50447314|FG004|Overall Study|Disease Progression|8|||
25205362|NCT03251924|50447315|FG005|Overall Study|Disease Progression|7|||
25205363|NCT03251924|50447316|FG006|Overall Study|Disease Progression|6|||
25205364|NCT03251924|50447317|FG007|Overall Study|Disease Progression|10|||
25205365|NCT03251924|50447318|FG008|Overall Study|Disease Progression|6|||
25205366|NCT03251924|50447310|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
25205367|NCT03251924|50447311|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
25205368|NCT03251924|50447312|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
25205369|NCT03251924|50447313|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
25205370|NCT03251924|50447314|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
25205371|NCT03251924|50447315|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
25205372|NCT03251924|50447316|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
25205373|NCT03251924|50447317|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
25205374|NCT03251924|50447318|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
25205375|NCT03251924|50447310|FG000|Overall Study|Death|0|||
25205376|NCT03251924|50447311|FG001|Overall Study|Death|1|||
25205377|NCT03251924|50447312|FG002|Overall Study|Death|0|||
25205378|NCT03251924|50447313|FG003|Overall Study|Death|1|||
25205379|NCT03251924|50447314|FG004|Overall Study|Death|1|||
25205380|NCT03251924|50447315|FG005|Overall Study|Death|1|||
25205381|NCT03251924|50447316|FG006|Overall Study|Death|0|||
25205382|NCT03251924|50447317|FG007|Overall Study|Death|0|||
25205383|NCT03251924|50447318|FG008|Overall Study|Death|0|||
25205384|NCT03251924|50447310|FG000|Overall Study|Study Drug Toxicity|0|||
25205385|NCT03251924|50447311|FG001|Overall Study|Study Drug Toxicity|0|||
25205386|NCT03251924|50447312|FG002|Overall Study|Study Drug Toxicity|0|||
25205387|NCT03251924|50447313|FG003|Overall Study|Study Drug Toxicity|1|||
25205388|NCT03251924|50447314|FG004|Overall Study|Study Drug Toxicity|0|||
25205389|NCT03251924|50447315|FG005|Overall Study|Study Drug Toxicity|0|||
25205390|NCT03251924|50447316|FG006|Overall Study|Study Drug Toxicity|0|||
25205391|NCT03251924|50447317|FG007|Overall Study|Study Drug Toxicity|0|||
25205392|NCT03251924|50447318|FG008|Overall Study|Study Drug Toxicity|1|||
25205393|NCT03251924|50447310|FG000|Overall Study|Other Reasons|0|||
25205394|NCT03251924|50447311|FG001|Overall Study|Other Reasons|0|||
25205395|NCT03251924|50447312|FG002|Overall Study|Other Reasons|0|||
25205396|NCT03251924|50447313|FG003|Overall Study|Other Reasons|0|||
25205397|NCT03251924|50447314|FG004|Overall Study|Other Reasons|0|||
25205398|NCT03251924|50447315|FG005|Overall Study|Other Reasons|0|||
25205399|NCT03251924|50447316|FG006|Overall Study|Other Reasons|0|||
25205400|NCT03251924|50447317|FG007|Overall Study|Other Reasons|0|||
25205401|NCT03251924|50447318|FG008|Overall Study|Other Reasons|1|||
25205402|NCT03251924|50447310|FG000|Overall Study|Participant request to discontinue study treatment|0|||
25205403|NCT03251924|50447311|FG001|Overall Study|Participant request to discontinue study treatment|0|||
25205404|NCT03251924|50447312|FG002|Overall Study|Participant request to discontinue study treatment|0|||
25205405|NCT03251924|50447313|FG003|Overall Study|Participant request to discontinue study treatment|0|||
25205406|NCT03251924|50447314|FG004|Overall Study|Participant request to discontinue study treatment|0|||
25205407|NCT03251924|50447315|FG005|Overall Study|Participant request to discontinue study treatment|0|||
25205408|NCT03251924|50447316|FG006|Overall Study|Participant request to discontinue study treatment|0|||
25205409|NCT03251924|50447317|FG007|Overall Study|Participant request to discontinue study treatment|1|||
25205410|NCT03251924|50447318|FG008|Overall Study|Participant request to discontinue study treatment|0|||
25316009|NCT00896532|50631596|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
25205411|NCT01350141|50447514|FG000|Overall Study|Lost to Follow-up|1|||
25205412|NCT01350141|50447515|FG001|Overall Study|Lost to Follow-up|0|||
25205413|NCT01350141|50447516|FG002|Overall Study|Lost to Follow-up|1|||
25205414|NCT01350141|50447514|FG000|Overall Study|Withdrawal by Subject|1|||
25205415|NCT01350141|50447515|FG001|Overall Study|Withdrawal by Subject|0|||
25205416|NCT01350141|50447516|FG002|Overall Study|Withdrawal by Subject|0|||
25205417|NCT01350141|50447514|FG000|Overall Study|Randomized but not treated|1|||
25205418|NCT01350141|50447515|FG001|Overall Study|Randomized but not treated|0|||
25205419|NCT01350141|50447516|FG002|Overall Study|Randomized but not treated|0|||
25205420|NCT05045625|50448055|FG000|Overall Study|Lost to Follow-up|3|||
25205421|NCT04830969|50448437|FG000|Overall Study|Withdrawal by Subject|6|||
25205422|NCT04830969|50448438|FG001|Overall Study|Withdrawal by Subject|2|||
25205423|NCT04830969|50448437|FG000|Overall Study|Protocol Violation|3|||
25205424|NCT04830969|50448438|FG001|Overall Study|Protocol Violation|9|||
25205425|NCT04830969|50448437|FG000|Overall Study|Lost to Follow-up|4|||
25205426|NCT04830969|50448438|FG001|Overall Study|Lost to Follow-up|4|||
25205427|NCT02384993|50448749|FG000|Overall Study|Adverse Event|0|||
25205428|NCT02384993|50448750|FG001|Overall Study|Adverse Event|1|||
25205429|NCT01352117|50448798|FG000|Overall Study|Death|15|||
25205430|NCT01352117|50448799|FG001|Overall Study|Death|16|||
25205431|NCT01352117|50448798|FG000|Overall Study|Withdrawal by Subject|1|||
25205432|NCT01352117|50448799|FG001|Overall Study|Withdrawal by Subject|0|||
25205433|NCT01352117|50448798|FG000|Overall Study|Lost to Follow-up|2|||
25205434|NCT01352117|50448799|FG001|Overall Study|Lost to Follow-up|7|||
25205435|NCT01352117|50448798|FG000|Overall Study|Non-adherent to study requirements|1|||
25205436|NCT01352117|50448799|FG001|Overall Study|Non-adherent to study requirements|1|||
25205437|NCT01352117|50448798|FG000|Overall Study|Did not initiate study treatment|1|||
25205438|NCT01352117|50448799|FG001|Overall Study|Did not initiate study treatment|0|||
25205439|NCT01352117|50448798|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
25205440|NCT01352117|50448799|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
25205441|NCT03578237|50448891|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
25205442|NCT03578237|50448892|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
25205443|NCT04173507|50448971|FG000|Overall Study|On Treatment|3|||
25205444|NCT04173507|50448971|FG000|Overall Study|Adverse Event|3|||
25205445|NCT04173507|50448971|FG000|Overall Study|Progression/Relapse|34|||
25205446|NCT04173507|50448971|FG000|Overall Study|Death|2|||
25205447|NCT02220725|50448979|FG000|Overall Study|Lost to Follow-up|0|||
25205448|NCT02220725|50448980|FG001|Overall Study|Lost to Follow-up|0|||
25205449|NCT02220725|50448981|FG002|Overall Study|Lost to Follow-up|0|||
25205450|NCT02220725|50448982|FG003|Overall Study|Lost to Follow-up|1|||
25205451|NCT02220725|50448979|FG000|Overall Study|Withdrawal by Subject|0|||
25205452|NCT02220725|50448980|FG001|Overall Study|Withdrawal by Subject|0|||
25205453|NCT02220725|50448981|FG002|Overall Study|Withdrawal by Subject|0|||
25205454|NCT02220725|50448982|FG003|Overall Study|Withdrawal by Subject|1|||
25205455|NCT02259517|50449028|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
25205456|NCT02259517|50449029|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
25205457|NCT02259517|50449030|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
25205458|NCT02259517|50449028|FG000|Overall Study|Withdrawal by Subject|0|||
25205459|NCT02259517|50449029|FG001|Overall Study|Withdrawal by Subject|0|||
25205460|NCT02259517|50449030|FG002|Overall Study|Withdrawal by Subject|3|||
25205461|NCT02277990|50449073|FG000|Overall Study|Death|170|||
25205462|NCT02277990|50449074|FG001|Overall Study|Death|188|||
25205463|NCT02277990|50449073|FG000|Overall Study|Withdrawal by Subject|64|||
25205464|NCT02277990|50449074|FG001|Overall Study|Withdrawal by Subject|53|||
25205465|NCT02277990|50449073|FG000|Overall Study|Physician Decision|40|||
25205466|NCT02277990|50449074|FG001|Overall Study|Physician Decision|34|||
25205467|NCT02277990|50449073|FG000|Overall Study|Lost to Follow-up|66|||
25205468|NCT02277990|50449074|FG001|Overall Study|Lost to Follow-up|69|||
25205469|NCT02277990|50449073|FG000|Overall Study|Had other reason|26|||
25205470|NCT02277990|50449074|FG001|Overall Study|Had other reason|32|||
25205471|NCT02317614|50449096|FG000|Overall Study|Lost to Follow-up|1|||
25205472|NCT02317614|50449097|FG001|Overall Study|Lost to Follow-up|1|||
25205473|NCT02317614|50449096|FG000|Overall Study|Withdrawal by Subject|1|||
25205474|NCT02317614|50449097|FG001|Overall Study|Withdrawal by Subject|0|||
25205475|NCT02317614|50449096|FG000|Overall Study|Death|1|||
25205476|NCT02317614|50449097|FG001|Overall Study|Death|1|||
25205477|NCT02276040|50449110|FG000|Overall Study|Physician Decision|15|||
25205478|NCT02315664|50449116|FG000|Overall Study|Lost to Follow-up|1|||
25205479|NCT02315664|50449117|FG001|Overall Study|Lost to Follow-up|1|||
25205480|NCT02315664|50449116|FG000|Overall Study|Withdrawal by Subject|0|||
25205481|NCT02315664|50449117|FG001|Overall Study|Withdrawal by Subject|3|||
25205482|NCT02314728|50449145|FG000|Overall Study|Protocol Violation|1|||
25205483|NCT02314728|50449146|FG001|Overall Study|Protocol Violation|0|||
25205484|NCT02314728|50449145|FG000|Overall Study|Lost to Follow-up|0|||
25205485|NCT02314728|50449146|FG001|Overall Study|Lost to Follow-up|1|||
25205486|NCT02275338|50449165|FG000|Overall Study|Adverse Event|15|||
25205487|NCT02275338|50449165|FG000|Overall Study|Lack of Efficacy|3|||
25205488|NCT02275338|50449165|FG000|Overall Study|Withdrawal by Subject|4|||
25205489|NCT02275338|50449165|FG000|Overall Study|Disease progression (death)|1|||
25205490|NCT02275338|50449165|FG000|Overall Study|Ineligible to start Phase 2|4|||
25205491|NCT02275338|50449165|FG000|Overall Study|Reason not specified|5|||
25205492|NCT02275338|50449165|FG000|Overall Study|Does not meet entry criteria|1|||
25205493|NCT02313558|50449172|FG000|Overall Study|Withdrawal by Subject|2|||
25205494|NCT02313558|50449173|FG001|Overall Study|Withdrawal by Subject|0|||
25205495|NCT02313558|50449172|FG000|Overall Study|Lost to Follow-up|4|||
25205496|NCT02313558|50449173|FG001|Overall Study|Lost to Follow-up|4|||
25205497|NCT01646268|50449201|FG000|Overall Study|Adverse Event|6|||
25205498|NCT01646268|50449202|FG001|Overall Study|Adverse Event|7|||
25205499|NCT01646268|50449201|FG000|Overall Study|Lack of Efficacy|1|||
25205500|NCT01646268|50449202|FG001|Overall Study|Lack of Efficacy|3|||
25205501|NCT01646268|50449201|FG000|Overall Study|Protocol Violation|0|||
25205502|NCT01646268|50449202|FG001|Overall Study|Protocol Violation|1|||
25205503|NCT01646268|50449201|FG000|Overall Study|Withdrawal by Subject|2|||
25205504|NCT01646268|50449202|FG001|Overall Study|Withdrawal by Subject|5|||
25205505|NCT01646268|50449201|FG000|Overall Study|Other|2|||
25205506|NCT01646268|50449202|FG001|Overall Study|Other|0|||
25205507|NCT02275026|50449208|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
25205508|NCT02275026|50449208|FG000|Overall Study|Withdrawal by Subject|4|||
25205509|NCT02275026|50449208|FG000|Overall Study|Ineligible due to medical history|13|||
25205510|NCT02275026|50449208|FG000|Overall Study|MRI malfunction precluded testing|1|||
25205511|NCT02275026|50449208|FG000|Overall Study|Ineligible after MRI findings|1|||
25205512|NCT02275026|50449208|FG000|Overall Study|Lost to Follow-up|2|||
25205513|NCT02275026|50449208|FG000|Overall Study|Scanner failure|1|||
25205514|NCT02711852|50449275|FG000|Overall Study|Death|5|||
25205515|NCT02711852|50449275|FG000|Overall Study|Lost to Follow-up|1|||
25205516|NCT02711852|50449275|FG000|Overall Study|Completed follow-up|3|||
25205517|NCT02711852|50449275|FG000|Overall Study|Withdrawal by Subject|1|||
25205518|NCT04579250|50449315|FG000|Overall Study|Withdrawal by Subject|1|||
25205519|NCT04579250|50449316|FG001|Overall Study|Withdrawal by Subject|1|||
25205520|NCT04579250|50449317|FG002|Overall Study|Withdrawal by Subject|0|||
25205521|NCT04579250|50449315|FG000|Overall Study|Lost to Follow-up|1|||
25205522|NCT04579250|50449316|FG001|Overall Study|Lost to Follow-up|1|||
25205523|NCT04579250|50449317|FG002|Overall Study|Lost to Follow-up|0|||
25205524|NCT04579250|50449315|FG000|Overall Study|Moved from area|0|||
25205525|NCT04579250|50449316|FG001|Overall Study|Moved from area|1|||
25205526|NCT04579250|50449317|FG002|Overall Study|Moved from area|2|||
25205527|NCT03175367|50449344|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
25205528|NCT03175367|50449345|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
25205529|NCT03175367|50449346|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
25205530|NCT03175367|50449347|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
25205531|NCT03175367|50449348|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
25205532|NCT03175367|50449349|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
25205533|NCT03175367|50449350|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
25205534|NCT03175367|50449344|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
25205535|NCT03175367|50449345|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
25205536|NCT03175367|50449346|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
25205537|NCT03175367|50449347|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
25205538|NCT03175367|50449348|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
25205539|NCT03175367|50449349|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
25205540|NCT03175367|50449350|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
25205541|NCT03175367|50449344|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
25205542|NCT03175367|50449345|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
25205543|NCT03175367|50449346|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
25205544|NCT03175367|50449347|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
25205545|NCT03175367|50449348|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
25205546|NCT03175367|50449349|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
25205547|NCT03175367|50449350|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
25205548|NCT03175367|50449344|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
25205549|NCT03175367|50449345|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
25205550|NCT03175367|50449346|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
25205551|NCT03175367|50449347|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
25205552|NCT03175367|50449348|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
25205553|NCT03175367|50449349|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
25205554|NCT03175367|50449350|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
25205555|NCT03175367|50449344|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
25205556|NCT03175367|50449345|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
25205557|NCT03175367|50449346|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
25316010|NCT00896532|50631597|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25205558|NCT03175367|50449347|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
25205559|NCT03175367|50449348|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
25205560|NCT03175367|50449349|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
25205561|NCT03175367|50449350|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
25205562|NCT03175367|50449344|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
25205563|NCT03175367|50449345|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
25205564|NCT03175367|50449346|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
25205565|NCT03175367|50449347|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
25205566|NCT03175367|50449348|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
25205567|NCT03175367|50449349|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
25205568|NCT03175367|50449350|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
25205569|NCT03175367|50449344|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
25205570|NCT03175367|50449345|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
25205571|NCT03175367|50449346|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
25205572|NCT03175367|50449347|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
25205573|NCT03175367|50449348|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
25205574|NCT03175367|50449349|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
25205575|NCT03175367|50449350|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
25205576|NCT03174275|50449407|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
25205577|NCT03174275|50449407|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
25205578|NCT03174275|50449407|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
25205579|NCT03174275|50449407|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
25205580|NCT03174275|50449407|FG000|Adjuvant Chemotherapy|Progression|1|||
25205581|NCT03174275|50449407|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
25205582|NCT03174275|50449407|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
25205583|NCT03174275|50449407|FG000|Adjuvant Durvalumab|Progression|1|||
25205584|NCT03174275|50449407|FG000|Adjuvant Durvalumab|Adverse Event|3|||
25205585|NCT03174275|50449407|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
25205586|NCT03174275|50449407|FG000|Adjuvant Radiotherapy|Progression|1|||
25205587|NCT03174275|50449407|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
25205588|NCT03990363|50449508|FG000|Overall Study|Withdrawal by Subject|10|||
25205589|NCT03990363|50449509|FG001|Overall Study|Withdrawal by Subject|9|||
25205590|NCT03990363|50449510|FG002|Overall Study|Withdrawal by Subject|18|||
25205591|NCT03990363|50449511|FG003|Overall Study|Withdrawal by Subject|11|||
25205592|NCT03990363|50449512|FG004|Overall Study|Withdrawal by Subject|9|||
25205593|NCT03990363|50449508|FG000|Overall Study|Physician Decision|1|||
25205594|NCT03990363|50449509|FG001|Overall Study|Physician Decision|0|||
25205595|NCT03990363|50449510|FG002|Overall Study|Physician Decision|0|||
25205596|NCT03990363|50449511|FG003|Overall Study|Physician Decision|0|||
25205597|NCT03990363|50449512|FG004|Overall Study|Physician Decision|0|||
25205598|NCT03990363|50449508|FG000|Overall Study|Adverse Event|1|||
25205599|NCT03990363|50449509|FG001|Overall Study|Adverse Event|3|||
25205600|NCT03990363|50449510|FG002|Overall Study|Adverse Event|2|||
25205601|NCT03990363|50449511|FG003|Overall Study|Adverse Event|2|||
25205602|NCT03990363|50449512|FG004|Overall Study|Adverse Event|0|||
25205603|NCT03990363|50449508|FG000|Overall Study|Death|14|||
25205604|NCT03990363|50449509|FG001|Overall Study|Death|8|||
25205605|NCT03990363|50449510|FG002|Overall Study|Death|14|||
25205606|NCT03990363|50449511|FG003|Overall Study|Death|10|||
25205607|NCT03990363|50449512|FG004|Overall Study|Death|11|||
25205608|NCT03990363|50449508|FG000|Overall Study|Failure to meet randomization criteria|0|||
25205609|NCT03990363|50449509|FG001|Overall Study|Failure to meet randomization criteria|1|||
25205610|NCT03990363|50449510|FG002|Overall Study|Failure to meet randomization criteria|1|||
25205611|NCT03990363|50449511|FG003|Overall Study|Failure to meet randomization criteria|0|||
25205612|NCT03990363|50449512|FG004|Overall Study|Failure to meet randomization criteria|0|||
25205613|NCT03990363|50449508|FG000|Overall Study|Lost to Follow-up|0|||
24976318|NCT00092547|50065232|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
25171641|NCT01606319|50309164|FG000|Overall Study|Adverse Event|1|||
25171642|NCT01606319|50309165|FG001|Overall Study|Adverse Event|4|||
25171643|NCT01757405|50309173|FG000|Overall Study|Lost to Follow-up|1|||
25171644|NCT01757405|50309174|FG001|Overall Study|Lost to Follow-up|1|||
25171645|NCT01757405|50309173|FG000|Overall Study|Withdrawal by Subject|0|||
25171646|NCT01757405|50309174|FG001|Overall Study|Withdrawal by Subject|1|||
25171647|NCT01455597|50309180|FG000|Overall Study|Adverse Event|7|||
25171648|NCT01455597|50309181|FG001|Overall Study|Adverse Event|0|||
25171649|NCT01455597|50309182|FG002|Overall Study|Adverse Event|5|||
25171650|NCT01455597|50309183|FG003|Overall Study|Adverse Event|1|||
25171651|NCT01455597|50309180|FG000|Overall Study|Lack of Efficacy|0|||
25205614|NCT03990363|50449509|FG001|Overall Study|Lost to Follow-up|0|||
25205615|NCT03990363|50449510|FG002|Overall Study|Lost to Follow-up|0|||
25205616|NCT03990363|50449511|FG003|Overall Study|Lost to Follow-up|1|||
25205617|NCT03990363|50449512|FG004|Overall Study|Lost to Follow-up|2|||
25205618|NCT03990363|50449508|FG000|Overall Study|Non-compliance with study drug|2|||
25171652|NCT01455597|50309181|FG001|Overall Study|Lack of Efficacy|1|||
25205619|NCT03990363|50449509|FG001|Overall Study|Non-compliance with study drug|1|||
25205620|NCT03990363|50449510|FG002|Overall Study|Non-compliance with study drug|2|||
25205621|NCT03990363|50449511|FG003|Overall Study|Non-compliance with study drug|0|||
25205622|NCT03990363|50449512|FG004|Overall Study|Non-compliance with study drug|0|||
25205623|NCT03990363|50449508|FG000|Overall Study|Study terminated by sponsor|0|||
25205624|NCT03990363|50449509|FG001|Overall Study|Study terminated by sponsor|1|||
25205625|NCT03990363|50449510|FG002|Overall Study|Study terminated by sponsor|0|||
25205626|NCT03990363|50449511|FG003|Overall Study|Study terminated by sponsor|0|||
25205627|NCT03990363|50449512|FG004|Overall Study|Study terminated by sponsor|0|||
25205628|NCT03990363|50449508|FG000|Overall Study|Site terminated by sponsor|2|||
25205629|NCT03990363|50449509|FG001|Overall Study|Site terminated by sponsor|1|||
25205630|NCT03990363|50449510|FG002|Overall Study|Site terminated by sponsor|2|||
25205631|NCT03990363|50449511|FG003|Overall Study|Site terminated by sponsor|0|||
25205632|NCT03990363|50449512|FG004|Overall Study|Site terminated by sponsor|2|||
25205633|NCT03990363|50449508|FG000|Overall Study|Not categorized|5|||
25205634|NCT03990363|50449509|FG001|Overall Study|Not categorized|5|||
25205635|NCT03990363|50449510|FG002|Overall Study|Not categorized|3|||
25205636|NCT03990363|50449511|FG003|Overall Study|Not categorized|2|||
25205637|NCT03990363|50449512|FG004|Overall Study|Not categorized|2|||
25205638|NCT04661839|50449582|FG000|Overall Study|Not Treated|0|||
25205639|NCT04661839|50449583|FG001|Overall Study|Not Treated|0|||
25205640|NCT04661839|50449584|FG002|Overall Study|Not Treated|1|||
25205641|NCT04661839|50449585|FG003|Overall Study|Not Treated|0|||
25205642|NCT04661839|50449582|FG000|Overall Study|Lost to Follow-up|1|||
25205643|NCT04661839|50449583|FG001|Overall Study|Lost to Follow-up|0|||
25205644|NCT04661839|50449584|FG002|Overall Study|Lost to Follow-up|0|||
25205645|NCT04661839|50449585|FG003|Overall Study|Lost to Follow-up|1|||
25205646|NCT02240485|50449686|FG000|3 Months Post-admission|Lost to Follow-up|1|||
25205647|NCT02240485|50449687|FG001|3 Months Post-admission|Lost to Follow-up|5|||
25205648|NCT02240485|50449686|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
25205649|NCT02240485|50449687|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
25205650|NCT02240485|50449686|FG000|9 Months Post-admission|Lost to Follow-up|3|||
25205651|NCT02240485|50449687|FG001|9 Months Post-admission|Lost to Follow-up|1|||
25205652|NCT02240485|50449686|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
25205653|NCT02240485|50449687|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
25205654|NCT02240485|50449686|FG000|18 Months Post-admission|Lost to Follow-up|1|||
25205655|NCT02240485|50449687|FG001|18 Months Post-admission|Lost to Follow-up|1|||
25205656|NCT02240485|50449686|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
25205657|NCT02240485|50449687|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
25205658|NCT04149535|50449710|FG000|Overall Study|Death|11|||
25205659|NCT04149535|50449711|FG001|Overall Study|Death|7|||
25205660|NCT04149535|50449710|FG000|Overall Study|Physician Decision|10|||
25205661|NCT04149535|50449711|FG001|Overall Study|Physician Decision|4|||
25205662|NCT04149535|50449710|FG000|Overall Study|Withdrawal by Subject|6|||
25205663|NCT04149535|50449711|FG001|Overall Study|Withdrawal by Subject|7|||
25205664|NCT04149535|50449710|FG000|Overall Study|Not described|2|||
25205665|NCT04149535|50449711|FG001|Overall Study|Not described|0|||
25205666|NCT02210559|50449729|FG000|Overall Study|Progressive Disease|3|||
25205667|NCT02210559|50449730|FG001|Overall Study|Progressive Disease|2|||
25205668|NCT02210559|50449729|FG000|Overall Study|Adverse Event|2|||
25205669|NCT02210559|50449730|FG001|Overall Study|Adverse Event|2|||
25205670|NCT02210559|50449729|FG000|Overall Study|Physician Decision|1|||
25205671|NCT02210559|50449730|FG001|Overall Study|Physician Decision|0|||
25205672|NCT02210559|50449729|FG000|Overall Study|Withdrawal by Subject|0|||
25205673|NCT02210559|50449730|FG001|Overall Study|Withdrawal by Subject|1|||
25205674|NCT02210559|50449729|FG000|Overall Study|Other than specified|0|||
25205675|NCT02210559|50449730|FG001|Overall Study|Other than specified|1|||
25205676|NCT02073279|50449887|FG000|Double-blind Period|Adverse Event|1|||
24976319|NCT00092547|50065233|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
24976320|NCT00092547|50065234|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
24976321|NCT00092547|50065232|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
25171653|NCT01455597|50309182|FG002|Overall Study|Lack of Efficacy|2|||
25205677|NCT02073279|50449888|FG001|Double-blind Period|Adverse Event|1|||
25205678|NCT02073279|50449887|FG000|Double-blind Period|Switched to another treatment|1|||
25205679|NCT02073279|50449888|FG001|Double-blind Period|Switched to another treatment|2|||
25205680|NCT02073279|50449887|FG000|Double-blind Period|Protocol Violation|0|||
25205681|NCT02073279|50449888|FG001|Double-blind Period|Protocol Violation|1|||
25205682|NCT02073279|50449887|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
25205683|NCT02073279|50449888|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
25205684|NCT02073279|50449887|FG000|Double-blind Period|Withdrawal by Subject|2|||
25171654|NCT01455597|50309183|FG003|Overall Study|Lack of Efficacy|0|||
25171655|NCT01455597|50309180|FG000|Overall Study|Lost to Follow-up|3|||
25171656|NCT01455597|50309181|FG001|Overall Study|Lost to Follow-up|0|||
25171657|NCT01455597|50309182|FG002|Overall Study|Lost to Follow-up|2|||
25171658|NCT01455597|50309183|FG003|Overall Study|Lost to Follow-up|1|||
25171659|NCT01455597|50309180|FG000|Overall Study|Withdrew Consent|6|||
25171660|NCT01455597|50309181|FG001|Overall Study|Withdrew Consent|5|||
25171661|NCT01455597|50309182|FG002|Overall Study|Withdrew Consent|8|||
25205685|NCT02073279|50449888|FG001|Double-blind Period|Withdrawal by Subject|2|||
25205686|NCT02073279|50449887|FG000|Open-label Extension Period|Adverse Event|1|||
25205687|NCT02073279|50449888|FG001|Open-label Extension Period|Adverse Event|0|||
25205688|NCT02073279|50449887|FG000|Open-label Extension Period|Lack of Efficacy|1|||
25205689|NCT02073279|50449888|FG001|Open-label Extension Period|Lack of Efficacy|0|||
25205690|NCT02073279|50449887|FG000|Open-label Extension Period|Lost to Follow-up|0|||
25205691|NCT02073279|50449888|FG001|Open-label Extension Period|Lost to Follow-up|4|||
25205692|NCT02073279|50449887|FG000|Open-label Extension Period|Switched to another treatment|1|||
25205693|NCT02073279|50449888|FG001|Open-label Extension Period|Switched to another treatment|4|||
25205694|NCT02073279|50449887|FG000|Open-label Extension Period|Protocol Violation|0|||
25205695|NCT02073279|50449888|FG001|Open-label Extension Period|Protocol Violation|1|||
25205696|NCT02073279|50449887|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
25205697|NCT02073279|50449888|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
25205698|NCT02073279|50449887|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
25205699|NCT02073279|50449888|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
25205700|NCT01673867|50450144|FG000|Randomization|Adverse event unrelated to study drug|1|||
25205701|NCT01673867|50450145|FG001|Randomization|Adverse event unrelated to study drug|0|||
25205702|NCT01673867|50450144|FG000|Randomization|Participant request to discontinue study treatment|0|||
25205703|NCT01673867|50450145|FG001|Randomization|Participant request to discontinue study treatment|4|||
25205704|NCT01673867|50450144|FG000|Randomization|Withdrawal by participant|0|||
25205705|NCT01673867|50450145|FG001|Randomization|Withdrawal by participant|12|||
25205706|NCT01673867|50450144|FG000|Randomization|Lost to Follow-up|0|||
25205707|NCT01673867|50450145|FG001|Randomization|Lost to Follow-up|1|||
25205708|NCT01673867|50450144|FG000|Randomization|Participant no longer meets study criteria|4|||
25205709|NCT01673867|50450145|FG001|Randomization|Participant no longer meets study criteria|5|||
25205710|NCT01673867|50450144|FG000|Treatment|Disease Progression|208|||
25205711|NCT01673867|50450145|FG001|Treatment|Disease Progression|178|||
25205712|NCT01673867|50450144|FG000|Treatment|Study Drug Toxicity|23|||
25205713|NCT01673867|50450145|FG001|Treatment|Study Drug Toxicity|43|||
25205714|NCT01673867|50450144|FG000|Treatment|Death|2|||
25205715|NCT01673867|50450145|FG001|Treatment|Death|3|||
25205716|NCT01673867|50450144|FG000|Treatment|Adverse event unrelated to study drug|23|||
25205717|NCT01673867|50450145|FG001|Treatment|Adverse event unrelated to study drug|10|||
25205718|NCT01673867|50450144|FG000|Treatment|Participant request to discontinue study treatment|7|||
25205719|NCT01673867|50450145|FG001|Treatment|Participant request to discontinue study treatment|17|||
25205720|NCT01673867|50450144|FG000|Treatment|Withdrawal by participant|5|||
25205721|NCT01673867|50450145|FG001|Treatment|Withdrawal by participant|5|||
25205722|NCT01673867|50450144|FG000|Treatment|Maximum clinical benefit|1|||
25205723|NCT01673867|50450145|FG001|Treatment|Maximum clinical benefit|10|||
25205724|NCT01673867|50450144|FG000|Treatment|Participant no longer meets study criteria|2|||
25205725|NCT01673867|50450145|FG001|Treatment|Participant no longer meets study criteria|0|||
25205726|NCT01673867|50450144|FG000|Treatment|Administrative reason by sponsor|3|||
25205727|NCT01673867|50450145|FG001|Treatment|Administrative reason by sponsor|0|||
25205728|NCT01673867|50450144|FG000|Treatment|Other reason|11|||
25205729|NCT01673867|50450145|FG001|Treatment|Other reason|2|||
25205730|NCT02041533|50450241|FG000|Pre-Treatment Period|Disease Progression|1|||
25205731|NCT02041533|50450242|FG001|Pre-Treatment Period|Disease Progression|1|||
25205732|NCT02041533|50450241|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
25205733|NCT02041533|50450242|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
25205734|NCT02041533|50450241|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
25205735|NCT02041533|50450242|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
25205736|NCT02041533|50450241|FG000|Treatment Period|Disease progression|189|||
25205737|NCT02041533|50450242|FG001|Treatment Period|Disease progression|146|||
25205738|NCT02041533|50450241|FG000|Treatment Period|Study drug toxicity|30|||
25205739|NCT02041533|50450242|FG001|Treatment Period|Study drug toxicity|34|||
25205740|NCT02041533|50450241|FG000|Treatment Period|Death|1|||
25205741|NCT02041533|50450242|FG001|Treatment Period|Death|0|||
25205742|NCT02041533|50450241|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
25205743|NCT02041533|50450242|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
25205744|NCT02041533|50450241|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
25205745|NCT02041533|50450242|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
25205746|NCT02041533|50450241|FG000|Treatment Period|Participant withdrew consent|2|||
25205747|NCT02041533|50450242|FG001|Treatment Period|Participant withdrew consent|2|||
25205748|NCT02041533|50450241|FG000|Treatment Period|Maximum clinical benefit|0|||
25205749|NCT02041533|50450242|FG001|Treatment Period|Maximum clinical benefit|18|||
25205750|NCT02041533|50450241|FG000|Treatment Period|Poor/Non-compliance|1|||
25205751|NCT02041533|50450242|FG001|Treatment Period|Poor/Non-compliance|0|||
25205752|NCT02041533|50450241|FG000|Treatment Period|Administrative reason by sponsor|1|||
25205753|NCT02041533|50450242|FG001|Treatment Period|Administrative reason by sponsor|0|||
25205754|NCT02041533|50450241|FG000|Treatment Period|Other reasons|9|||
25205755|NCT02041533|50450242|FG001|Treatment Period|Other reasons|2|||
25205756|NCT02041533|50450241|FG000|Treatment Period|Not Reported|0|||
25205757|NCT02041533|50450242|FG001|Treatment Period|Not Reported|1|||
25205758|NCT02907203|50450249|FG000|Overall Study|Death|1|||
25205759|NCT02907203|50450249|FG000|Overall Study|Lost to Follow-up|3|||
25205760|NCT02907203|50450249|FG000|Overall Study|Withdrawal by Subject|3|||
25205761|NCT02907203|50450249|FG000|Overall Study|Surgical bypass|1|||
25205762|NCT00559585|50451424|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
25205763|NCT00559585|50451425|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
25205764|NCT00559585|50451424|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
25205765|NCT00559585|50451425|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
25205766|NCT00559585|50451424|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
25205767|NCT00559585|50451425|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
25205768|NCT00559585|50451424|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
25205769|NCT00559585|50451425|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
25205770|NCT00559585|50451424|FG000|Double Blind ST Period Main Study|Death|1|||
25205771|NCT00559585|50451425|FG001|Double Blind ST Period Main Study|Death|1|||
25205772|NCT00559585|50451424|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
25205773|NCT00559585|50451425|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
25205774|NCT00559585|50451424|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
25205775|NCT00559585|50451425|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
25205776|NCT00559585|50451424|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
25205777|NCT00559585|50451425|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
25205778|NCT00559585|50451424|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
25205779|NCT00559585|50451425|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
25205780|NCT00559585|50451424|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
25205781|NCT00559585|50451425|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
25205782|NCT00559585|50451424|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
25205783|NCT00559585|50451425|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
25205784|NCT00559585|50451424|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
25205785|NCT00559585|50451425|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
25205786|NCT00559585|50451424|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
25205787|NCT00559585|50451425|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
25205788|NCT00559585|50451424|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
25205789|NCT00559585|50451425|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
25205790|NCT00559585|50451424|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
25205791|NCT00559585|50451425|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
25205792|NCT00559585|50451424|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
25205793|NCT00559585|50451425|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
25205794|NCT00559585|50451424|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
25205795|NCT00559585|50451425|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
25205796|NCT00559585|50451424|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
25205797|NCT00559585|50451425|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
25205798|NCT00559585|50451424|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
25205799|NCT00559585|50451425|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
25205800|NCT00559585|50451424|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
25205801|NCT00559585|50451425|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
25205802|NCT00559585|50451424|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
25205803|NCT00559585|50451425|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
25205804|NCT00559585|50451424|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
25205805|NCT00559585|50451425|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
25205806|NCT00559585|50451424|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
25205807|NCT00559585|50451425|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
25205808|NCT00559585|50451424|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
25205809|NCT00559585|50451425|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
25205810|NCT00559585|50451424|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
25205811|NCT00559585|50451425|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
25316011|NCT00896532|50631598|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25316012|NCT00896532|50631599|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25316013|NCT00896532|50631600|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25316014|NCT00896532|50631601|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
24976322|NCT00092547|50065233|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
24976323|NCT00092547|50065234|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
25205812|NCT00559585|50451424|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
25205813|NCT00559585|50451425|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
25205814|NCT00559585|50451424|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
25205815|NCT00559585|50451425|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
25205816|NCT00559585|50451424|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
25205817|NCT00559585|50451425|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
25205818|NCT00559507|50451465|FG000|Overall Study|Not treated, patient ineligible|3|||
25205819|NCT00559273|50451733|FG000|Correction Period (20 Weeks)|Death|3|||
25205820|NCT00559273|50451734|FG001|Correction Period (20 Weeks)|Death|4|||
25205821|NCT00559273|50451733|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
25205822|NCT00559273|50451734|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
25205823|NCT00559273|50451733|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
25205824|NCT00559273|50451734|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
25205825|NCT00559273|50451733|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
25205826|NCT00559273|50451734|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
25205827|NCT00559273|50451733|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
25205828|NCT00559273|50451734|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
25205829|NCT00559273|50451733|FG000|Evaluation Period (8 Weeks)|Death|1|||
25205830|NCT00559273|50451734|FG001|Evaluation Period (8 Weeks)|Death|3|||
25205831|NCT00559273|50451733|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
25205832|NCT00559273|50451734|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
25205833|NCT00559273|50451733|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
25205834|NCT00559273|50451734|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
25205835|NCT00559273|50451733|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
25205836|NCT00559273|50451734|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
25205837|NCT00558259|50451789|FG000|Overall Study|Adverse Event|50|||
25205838|NCT00558259|50451790|FG001|Overall Study|Adverse Event|81|||
25205839|NCT00558259|50451789|FG000|Overall Study|Protocol Violation|9|||
25205840|NCT00558259|50451790|FG001|Overall Study|Protocol Violation|5|||
25205841|NCT00558259|50451789|FG000|Overall Study|Withdrawal by Subject|12|||
25205842|NCT00558259|50451790|FG001|Overall Study|Withdrawal by Subject|13|||
25205843|NCT00558103|50451937|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
25205844|NCT00558103|50451938|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
25205845|NCT00558103|50451939|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
25205846|NCT00558103|50451940|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
25205847|NCT00558103|50451941|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
25205848|NCT00558103|50451942|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
25205849|NCT00558103|50451937|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
25205850|NCT00558103|50451938|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
25205851|NCT00558103|50451939|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
25205852|NCT00558103|50451940|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
25205853|NCT00558103|50451941|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
25205854|NCT00558103|50451942|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
25205855|NCT00558103|50451937|FG000|Randomized Treatment Phase|Disease Progression|1|||
25205856|NCT00558103|50451938|FG001|Randomized Treatment Phase|Disease Progression|0|||
25205857|NCT00558103|50451939|FG002|Randomized Treatment Phase|Disease Progression|1|||
25205858|NCT00558103|50451940|FG003|Randomized Treatment Phase|Disease Progression|0|||
25205859|NCT00558103|50451941|FG004|Randomized Treatment Phase|Disease Progression|0|||
25205860|NCT00558103|50451942|FG005|Randomized Treatment Phase|Disease Progression|0|||
25205861|NCT00558103|50451937|FG000|Randomized Treatment Phase|Adverse Event|0|||
25205862|NCT00558103|50451938|FG001|Randomized Treatment Phase|Adverse Event|0|||
25205863|NCT00558103|50451939|FG002|Randomized Treatment Phase|Adverse Event|0|||
25205864|NCT00558103|50451940|FG003|Randomized Treatment Phase|Adverse Event|1|||
25316015|NCT00896532|50631602|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25316016|NCT00896532|50631603|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25316017|NCT00896532|50631604|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25316018|NCT00896532|50631605|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25316019|NCT00896532|50631606|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25316020|NCT00896532|50631607|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25316021|NCT00896532|50631608|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25316022|NCT00896532|50631609|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25077124|NCT02469038|50184967|FG001|Overall Study|Physician Decision|5|||
25077125|NCT02468648|50184973|FG000|Overall Study|Death|1|||
24976324|NCT00092547|50065232|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
25171662|NCT01455597|50309183|FG003|Overall Study|Withdrew Consent|5|||
25171663|NCT01455597|50309180|FG000|Overall Study|Reason not Specified|1|||
25171664|NCT01455597|50309181|FG001|Overall Study|Reason not Specified|2|||
25171665|NCT01455597|50309182|FG002|Overall Study|Reason not Specified|3|||
25171666|NCT01455597|50309183|FG003|Overall Study|Reason not Specified|3|||
25171667|NCT01757171|50309206|FG000|Overall Study|Adverse Event|5|||
25171668|NCT01757171|50309207|FG001|Overall Study|Adverse Event|1|||
25171669|NCT01757171|50309206|FG000|Overall Study|Disease Progression|1|||
25171670|NCT01757171|50309207|FG001|Overall Study|Disease Progression|0|||
25171671|NCT01757171|50309206|FG000|Overall Study|Hospitalization|1|||
25171672|NCT01757171|50309207|FG001|Overall Study|Hospitalization|0|||
25171673|NCT01757171|50309206|FG000|Overall Study|ECOG decline|1|||
25171674|NCT01757171|50309207|FG001|Overall Study|ECOG decline|0|||
25171675|NCT01756235|50309213|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
25077126|NCT02468414|50184979|FG000|Overall Study|Early Study Termination by Sponsor|1|||
25077127|NCT02468414|50184980|FG001|Overall Study|Early Study Termination by Sponsor|0|||
25077128|NCT02468414|50184979|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
25077129|NCT02468414|50184980|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
25077130|NCT02468414|50184979|FG000|Overall Study|Screen Failure|1|||
25077131|NCT02468414|50184980|FG001|Overall Study|Screen Failure|0|||
25205865|NCT00558103|50451941|FG004|Randomized Treatment Phase|Adverse Event|1|||
25205866|NCT00558103|50451942|FG005|Randomized Treatment Phase|Adverse Event|0|||
25205867|NCT00558103|50451937|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
25205868|NCT00558103|50451938|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
25205869|NCT00558103|50451939|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
25205870|NCT00558103|50451940|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
25205871|NCT00558103|50451941|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
25205872|NCT00558103|50451942|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
25205873|NCT00558103|50451937|FG000|Monotherapy Extension Phase|Disease Progression|0|||
25205874|NCT00558103|50451938|FG001|Monotherapy Extension Phase|Disease Progression|0|||
25205875|NCT00558103|50451939|FG002|Monotherapy Extension Phase|Disease Progression|0|||
25205876|NCT00558103|50451940|FG003|Monotherapy Extension Phase|Disease Progression|0|||
25205877|NCT00558103|50451941|FG004|Monotherapy Extension Phase|Disease Progression|0|||
25205878|NCT00558103|50451942|FG005|Monotherapy Extension Phase|Disease Progression|8|||
25205879|NCT00558025|50451979|FG000|Overall Study|Adverse Event|1|||
25205880|NCT00558025|50451980|FG001|Overall Study|Adverse Event|1|||
25205881|NCT00558025|50451979|FG000|Overall Study|Withdrawal by Subject|2|||
25205882|NCT00558025|50451980|FG001|Overall Study|Withdrawal by Subject|2|||
25205883|NCT00558025|50451979|FG000|Overall Study|Protocol Violation|1|||
25205884|NCT00558025|50451980|FG001|Overall Study|Protocol Violation|0|||
25205885|NCT00557323|50452033|FG000|Overall Study|Death|3|||
25205886|NCT00557323|50452033|FG000|Overall Study|Withdrawal by Subject|2|||
25205887|NCT00557323|50452033|FG000|Overall Study|Administrative change|2|||
25205888|NCT00557245|50452067|FG000|Overall Study|Lost to Follow-up|7|||
25205889|NCT00557245|50452068|FG001|Overall Study|Lost to Follow-up|8|||
25205890|NCT00557245|50452069|FG002|Overall Study|Lost to Follow-up|10|||
25205891|NCT00557245|50452067|FG000|Overall Study|Ineligible|5|||
25205892|NCT00557245|50452068|FG001|Overall Study|Ineligible|4|||
25205893|NCT00557245|50452069|FG002|Overall Study|Ineligible|2|||
25205894|NCT00556075|50452130|FG000|Overall Study|Lost to Follow-up|3|||
25205895|NCT00556075|50452131|FG001|Overall Study|Lost to Follow-up|0|||
25205896|NCT00556075|50452132|FG002|Overall Study|Lost to Follow-up|3|||
25205897|NCT00556075|50452130|FG000|Overall Study|Withdrawal by Subject|3|||
25205898|NCT00556075|50452131|FG001|Overall Study|Withdrawal by Subject|3|||
25205899|NCT00556075|50452132|FG002|Overall Study|Withdrawal by Subject|0|||
25205900|NCT00556075|50452130|FG000|Overall Study|Protocol Violation|1|||
25205901|NCT00556075|50452131|FG001|Overall Study|Protocol Violation|1|||
25205902|NCT00556075|50452132|FG002|Overall Study|Protocol Violation|3|||
25205903|NCT00556075|50452130|FG000|Overall Study|Not eligible|1|||
25205904|NCT00556075|50452131|FG001|Overall Study|Not eligible|1|||
25205905|NCT00556075|50452132|FG002|Overall Study|Not eligible|2|||
25205906|NCT00556075|50452130|FG000|Overall Study|Adverse Event|1|||
25205907|NCT00556075|50452131|FG001|Overall Study|Adverse Event|2|||
25205908|NCT00556075|50452132|FG002|Overall Study|Adverse Event|0|||
25205909|NCT00556075|50452130|FG000|Overall Study|Personal issues|4|||
25205910|NCT00556075|50452131|FG001|Overall Study|Personal issues|1|||
25205911|NCT00556075|50452132|FG002|Overall Study|Personal issues|0|||
25205912|NCT00556075|50452130|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
25205913|NCT00556075|50452131|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
25205914|NCT00556075|50452132|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
25205915|NCT02289690|50452163|FG000|Overall Study|Adverse Event Related to Progression|0|||
25205916|NCT02289690|50452164|FG001|Overall Study|Adverse Event Related to Progression|1|||
25316023|NCT00896532|50631610|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
25316024|NCT00896532|50631588|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25077132|NCT02466386|50184986|FG000|Overall Study|Adverse Event|5|||
25171676|NCT01730729|50309217|FG000|Overall Study|Adverse Event|1|||
25171677|NCT01730729|50309217|FG000|Overall Study|Death|1|||
25171678|NCT01730729|50309217|FG000|Overall Study|Progressive Disease|12|||
25171679|NCT01756157|50309221|FG000|First Intervention Period|Withdrawal by Subject|1|||
25171680|NCT01756157|50309222|FG001|First Intervention Period|Withdrawal by Subject|0|||
25171681|NCT01756157|50309221|FG000|First Intervention Period|Lost to Follow-up|0|||
25171682|NCT01756157|50309222|FG001|First Intervention Period|Lost to Follow-up|2|||
25171683|NCT01756079|50309228|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
25171684|NCT01756079|50309228|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
25171685|NCT01756079|50309228|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
25171686|NCT01756079|50309228|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
25171687|NCT01756079|50309228|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
25171688|NCT04967885|50309235|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
25316025|NCT00896532|50631589|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316026|NCT00896532|50631590|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316027|NCT00896532|50631591|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25171689|NCT04967885|50309236|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
25171690|NCT04967885|50309235|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
25171691|NCT04967885|50309236|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
25171692|NCT04967885|50309235|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
25171693|NCT04967885|50309236|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
25171694|NCT04967885|50309235|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
25171695|NCT04967885|50309236|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
25171696|NCT04967885|50309235|FG000|EMI-II Intervention|Lost to Follow-up|14|||
25171697|NCT04967885|50309236|FG001|EMI-II Intervention|Lost to Follow-up|10|||
25205917|NCT02289690|50452165|FG002|Overall Study|Adverse Event Related to Progression|1|||
25205918|NCT02289690|50452166|FG003|Overall Study|Adverse Event Related to Progression|0|||
25205919|NCT02289690|50452167|FG004|Overall Study|Adverse Event Related to Progression|1|||
25205920|NCT02289690|50452168|FG005|Overall Study|Adverse Event Related to Progression|0|||
25205921|NCT02289690|50452169|FG006|Overall Study|Adverse Event Related to Progression|1|||
25205922|NCT02289690|50452170|FG007|Overall Study|Adverse Event Related to Progression|0|||
25205923|NCT02289690|50452171|FG008|Overall Study|Adverse Event Related to Progression|0|||
25205924|NCT02289690|50452172|FG009|Overall Study|Adverse Event Related to Progression|0|||
25205925|NCT02289690|50452163|FG000|Overall Study|Withdrawal by Subject|1|||
25205926|NCT02289690|50452164|FG001|Overall Study|Withdrawal by Subject|0|||
25205927|NCT02289690|50452165|FG002|Overall Study|Withdrawal by Subject|0|||
25205928|NCT02289690|50452166|FG003|Overall Study|Withdrawal by Subject|0|||
25205929|NCT02289690|50452167|FG004|Overall Study|Withdrawal by Subject|1|||
25205930|NCT02289690|50452168|FG005|Overall Study|Withdrawal by Subject|1|||
25205931|NCT02289690|50452169|FG006|Overall Study|Withdrawal by Subject|0|||
25205932|NCT02289690|50452170|FG007|Overall Study|Withdrawal by Subject|0|||
25205933|NCT02289690|50452171|FG008|Overall Study|Withdrawal by Subject|4|||
25205934|NCT02289690|50452172|FG009|Overall Study|Withdrawal by Subject|2|||
25205935|NCT02289690|50452163|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
25205936|NCT02289690|50452164|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
25205937|NCT02289690|50452165|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
25205938|NCT02289690|50452166|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
25205939|NCT02289690|50452167|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
25205940|NCT02289690|50452168|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
25205941|NCT02289690|50452169|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
25205942|NCT02289690|50452170|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
25205943|NCT02289690|50452171|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
25205944|NCT02289690|50452172|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
25205945|NCT02289690|50452163|FG000|Overall Study|Lost to Follow-up|0|||
25205946|NCT02289690|50452164|FG001|Overall Study|Lost to Follow-up|0|||
25205947|NCT02289690|50452165|FG002|Overall Study|Lost to Follow-up|0|||
25205948|NCT02289690|50452166|FG003|Overall Study|Lost to Follow-up|0|||
25205949|NCT02289690|50452167|FG004|Overall Study|Lost to Follow-up|0|||
25205950|NCT02289690|50452168|FG005|Overall Study|Lost to Follow-up|0|||
25205951|NCT02289690|50452169|FG006|Overall Study|Lost to Follow-up|0|||
25205952|NCT02289690|50452170|FG007|Overall Study|Lost to Follow-up|1|||
25205953|NCT02289690|50452171|FG008|Overall Study|Lost to Follow-up|0|||
25205954|NCT02289690|50452172|FG009|Overall Study|Lost to Follow-up|2|||
25205955|NCT02289690|50452163|FG000|Overall Study|Death|0|||
25205956|NCT02289690|50452164|FG001|Overall Study|Death|0|||
25205957|NCT02289690|50452165|FG002|Overall Study|Death|0|||
25205958|NCT02289690|50452166|FG003|Overall Study|Death|0|||
25205959|NCT02289690|50452167|FG004|Overall Study|Death|0|||
25205960|NCT02289690|50452168|FG005|Overall Study|Death|0|||
25205961|NCT02289690|50452169|FG006|Overall Study|Death|0|||
25205962|NCT02289690|50452170|FG007|Overall Study|Death|49|||
25205963|NCT02289690|50452171|FG008|Overall Study|Death|45|||
25205964|NCT02289690|50452172|FG009|Overall Study|Death|41|||
25205965|NCT02289690|50452163|FG000|Overall Study|Sponsor Discontinued Study|0|||
25205966|NCT02289690|50452164|FG001|Overall Study|Sponsor Discontinued Study|0|||
25205967|NCT02289690|50452165|FG002|Overall Study|Sponsor Discontinued Study|0|||
25205968|NCT02289690|50452166|FG003|Overall Study|Sponsor Discontinued Study|0|||
25205969|NCT02289690|50452167|FG004|Overall Study|Sponsor Discontinued Study|0|||
25205970|NCT02289690|50452168|FG005|Overall Study|Sponsor Discontinued Study|0|||
25205971|NCT02289690|50452169|FG006|Overall Study|Sponsor Discontinued Study|0|||
25205972|NCT02289690|50452170|FG007|Overall Study|Sponsor Discontinued Study|9|||
25205973|NCT02289690|50452171|FG008|Overall Study|Sponsor Discontinued Study|7|||
25205974|NCT02289690|50452172|FG009|Overall Study|Sponsor Discontinued Study|15|||
25205975|NCT02289690|50452163|FG000|Overall Study|Other|0|||
25205976|NCT02289690|50452164|FG001|Overall Study|Other|0|||
25171698|NCT04571060|50309253|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
25205977|NCT02289690|50452165|FG002|Overall Study|Other|0|||
25205978|NCT02289690|50452166|FG003|Overall Study|Other|1|||
25205979|NCT02289690|50452167|FG004|Overall Study|Other|1|||
25205980|NCT02289690|50452168|FG005|Overall Study|Other|0|||
25205981|NCT02289690|50452169|FG006|Overall Study|Other|1|||
25205982|NCT02289690|50452170|FG007|Overall Study|Other|2|||
25205983|NCT02289690|50452171|FG008|Overall Study|Other|3|||
25205984|NCT02289690|50452172|FG009|Overall Study|Other|1|||
25205985|NCT02289456|50452275|FG000|Induction Period|Death|2|||
25205986|NCT02289456|50452275|FG000|Induction Period|Adverse Event|11|||
25205987|NCT02289456|50452275|FG000|Induction Period|Progressive Disease (PD)|4|||
25205988|NCT02289456|50452275|FG000|Induction Period|Symptomatic Deterioration|4|||
25205989|NCT02289456|50452275|FG000|Induction Period|Withdrawal by Subject|2|||
25205990|NCT02289456|50452275|FG000|Induction Period|Miscellaneous|1|||
25205991|NCT02289456|50452275|FG000|Monotherapy Period|Death|1|||
25205992|NCT02289456|50452275|FG000|Monotherapy Period|Adverse Event|1|||
25205993|NCT02289456|50452275|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
25205994|NCT02289456|50452275|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
25205995|NCT02289456|50452275|FG000|Monotherapy Period|Withdrawal by Subject|2|||
25205996|NCT02289456|50452275|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
25205997|NCT02289456|50452275|FG000|Monotherapy Period|Miscellaneous|1|||
25205998|NCT02274948|50452324|FG000|Overall Study|Lost to Follow-up|28|||
25205999|NCT02274948|50452325|FG001|Overall Study|Lost to Follow-up|25|||
25206000|NCT02274948|50452324|FG000|Overall Study|Withdrawal by Subject|64|||
25206001|NCT02274948|50452325|FG001|Overall Study|Withdrawal by Subject|58|||
25206002|NCT02274948|50452324|FG000|Overall Study|Stopped on family Practitioner advice|2|||
25206003|NCT02274948|50452325|FG001|Overall Study|Stopped on family Practitioner advice|5|||
25206004|NCT02274948|50452324|FG000|Overall Study|Left the area|4|||
25206005|NCT02274948|50452325|FG001|Overall Study|Left the area|3|||
25206006|NCT02274792|50452341|FG000|Overall Study|Withdrawal by Subject|13|||
25206007|NCT02274792|50452341|FG000|Overall Study|Lost to Follow-up|8|||
25206008|NCT02274792|50452341|FG000|Overall Study|Protocol Specified Criteria|2|||
25206009|NCT02274792|50452341|FG000|Overall Study|Sponsor Decision|2|||
25206010|NCT02274558|50452371|FG000|Overall Study|Adverse Event|2|||
25206011|NCT02274558|50452372|FG001|Overall Study|Adverse Event|4|||
25206012|NCT02274558|50452373|FG002|Overall Study|Adverse Event|2|||
25206013|NCT02274558|50452371|FG000|Overall Study|Non-compliance|2|||
25206014|NCT02274558|50452372|FG001|Overall Study|Non-compliance|1|||
25206015|NCT02274558|50452373|FG002|Overall Study|Non-compliance|0|||
25206016|NCT02274558|50452371|FG000|Overall Study|Withdrawal by Subject|1|||
25206017|NCT02274558|50452372|FG001|Overall Study|Withdrawal by Subject|5|||
25206018|NCT02274558|50452373|FG002|Overall Study|Withdrawal by Subject|4|||
25206019|NCT02274558|50452371|FG000|Overall Study|Death|0|||
25206020|NCT02274558|50452372|FG001|Overall Study|Death|0|||
25206021|NCT02274558|50452373|FG002|Overall Study|Death|1|||
25206022|NCT02274558|50452371|FG000|Overall Study|Lost to Follow-up|2|||
25206023|NCT02274558|50452372|FG001|Overall Study|Lost to Follow-up|1|||
25206024|NCT02274558|50452373|FG002|Overall Study|Lost to Follow-up|1|||
25206025|NCT02274558|50452371|FG000|Overall Study|Physician Decision|0|||
25206026|NCT02274558|50452372|FG001|Overall Study|Physician Decision|2|||
25206027|NCT02274558|50452373|FG002|Overall Study|Physician Decision|1|||
25206028|NCT02287896|50452390|FG000|Second Injection Visit|Withdrawal by Subject|0|||
25206029|NCT02287896|50452391|FG001|Second Injection Visit|Withdrawal by Subject|1|||
25206030|NCT00553501|50452449|FG000|Overall Study|Adverse Event|2|||
25206031|NCT00553501|50452449|FG000|Overall Study|Death|1|||
25206032|NCT00553501|50452449|FG000|Overall Study|Progression|1|||
25206033|NCT02287584|50452477|FG000|the Double-blind Phase|Adverse Event|17|||
25206034|NCT02287584|50452478|FG001|the Double-blind Phase|Adverse Event|17|||
25206035|NCT02287584|50452479|FG002|the Double-blind Phase|Adverse Event|12|||
25316028|NCT00896532|50631592|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316029|NCT00896532|50631593|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316030|NCT00896532|50631594|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316031|NCT00896532|50631595|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316032|NCT00896532|50631596|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25206036|NCT02287584|50452480|FG003|the Double-blind Phase|Adverse Event|0|||
25206037|NCT02287584|50452481|FG004|the Double-blind Phase|Adverse Event|0|||
25206038|NCT02287584|50452482|FG005|the Double-blind Phase|Adverse Event|0|||
25206039|NCT02287584|50452477|FG000|the Double-blind Phase|Lack of Efficacy|18|||
25206040|NCT02287584|50452478|FG001|the Double-blind Phase|Lack of Efficacy|8|||
25206041|NCT02287584|50452479|FG002|the Double-blind Phase|Lack of Efficacy|8|||
25206042|NCT02287584|50452480|FG003|the Double-blind Phase|Lack of Efficacy|0|||
25206043|NCT02287584|50452481|FG004|the Double-blind Phase|Lack of Efficacy|0|||
25206044|NCT02287584|50452482|FG005|the Double-blind Phase|Lack of Efficacy|0|||
25206045|NCT02287584|50452477|FG000|the Double-blind Phase|Lost to Follow-up|0|||
25206046|NCT02287584|50452478|FG001|the Double-blind Phase|Lost to Follow-up|1|||
25206047|NCT02287584|50452479|FG002|the Double-blind Phase|Lost to Follow-up|1|||
25206048|NCT02287584|50452480|FG003|the Double-blind Phase|Lost to Follow-up|0|||
25206049|NCT02287584|50452481|FG004|the Double-blind Phase|Lost to Follow-up|0|||
25206050|NCT02287584|50452482|FG005|the Double-blind Phase|Lost to Follow-up|0|||
25206051|NCT02287584|50452477|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
25206052|NCT02287584|50452478|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
25206053|NCT02287584|50452479|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
25206054|NCT02287584|50452480|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
25206055|NCT02287584|50452481|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
25206056|NCT02287584|50452482|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
25206057|NCT02287584|50452477|FG000|the Double-blind Phase|Pregnancy|0|||
25206058|NCT02287584|50452478|FG001|the Double-blind Phase|Pregnancy|1|||
25206059|NCT02287584|50452479|FG002|the Double-blind Phase|Pregnancy|0|||
25206060|NCT02287584|50452480|FG003|the Double-blind Phase|Pregnancy|0|||
25206061|NCT02287584|50452481|FG004|the Double-blind Phase|Pregnancy|0|||
25206062|NCT02287584|50452482|FG005|the Double-blind Phase|Pregnancy|0|||
25206063|NCT02287584|50452477|FG000|the Double-blind Phase|Protocol Violation|0|||
25206064|NCT02287584|50452478|FG001|the Double-blind Phase|Protocol Violation|3|||
25206065|NCT02287584|50452479|FG002|the Double-blind Phase|Protocol Violation|0|||
25206066|NCT02287584|50452480|FG003|the Double-blind Phase|Protocol Violation|0|||
25206067|NCT02287584|50452481|FG004|the Double-blind Phase|Protocol Violation|0|||
25206068|NCT02287584|50452482|FG005|the Double-blind Phase|Protocol Violation|0|||
25206069|NCT02287584|50452477|FG000|the Double-blind Phase|other reasons|0|||
25206070|NCT02287584|50452478|FG001|the Double-blind Phase|other reasons|0|||
25206071|NCT02287584|50452479|FG002|the Double-blind Phase|other reasons|1|||
25206072|NCT02287584|50452480|FG003|the Double-blind Phase|other reasons|0|||
25206073|NCT02287584|50452481|FG004|the Double-blind Phase|other reasons|0|||
25206074|NCT02287584|50452482|FG005|the Double-blind Phase|other reasons|0|||
25206075|NCT02287584|50452477|FG000|the Open-label Phase|Did not receive drug|0|||
25206076|NCT02287584|50452478|FG001|the Open-label Phase|Did not receive drug|0|||
25206077|NCT02287584|50452479|FG002|the Open-label Phase|Did not receive drug|0|||
25206078|NCT02287584|50452480|FG003|the Open-label Phase|Did not receive drug|7|||
25206079|NCT02287584|50452481|FG004|the Open-label Phase|Did not receive drug|6|||
25206080|NCT02287584|50452482|FG005|the Open-label Phase|Did not receive drug|4|||
25206081|NCT02287584|50452477|FG000|the Open-label Phase|Adverse Event|0|||
25206082|NCT02287584|50452478|FG001|the Open-label Phase|Adverse Event|0|||
25206083|NCT02287584|50452479|FG002|the Open-label Phase|Adverse Event|0|||
25206084|NCT02287584|50452480|FG003|the Open-label Phase|Adverse Event|15|||
25206085|NCT02287584|50452481|FG004|the Open-label Phase|Adverse Event|12|||
25206086|NCT02287584|50452482|FG005|the Open-label Phase|Adverse Event|16|||
25206087|NCT02287584|50452477|FG000|the Open-label Phase|Lack of Efficacy|0|||
25206088|NCT02287584|50452478|FG001|the Open-label Phase|Lack of Efficacy|0|||
25206089|NCT02287584|50452479|FG002|the Open-label Phase|Lack of Efficacy|0|||
25206090|NCT02287584|50452480|FG003|the Open-label Phase|Lack of Efficacy|8|||
25206091|NCT02287584|50452481|FG004|the Open-label Phase|Lack of Efficacy|3|||
25206092|NCT02287584|50452482|FG005|the Open-label Phase|Lack of Efficacy|7|||
25206093|NCT02287584|50452477|FG000|the Open-label Phase|Lost to Follow-up|0|||
25206094|NCT02287584|50452478|FG001|the Open-label Phase|Lost to Follow-up|0|||
25206095|NCT02287584|50452479|FG002|the Open-label Phase|Lost to Follow-up|0|||
25206096|NCT02287584|50452480|FG003|the Open-label Phase|Lost to Follow-up|4|||
25206097|NCT02287584|50452481|FG004|the Open-label Phase|Lost to Follow-up|1|||
25206098|NCT02287584|50452482|FG005|the Open-label Phase|Lost to Follow-up|2|||
25206099|NCT02287584|50452477|FG000|the Open-label Phase|Withdrawal by Subject|0|||
25206100|NCT02287584|50452478|FG001|the Open-label Phase|Withdrawal by Subject|0|||
25206101|NCT02287584|50452479|FG002|the Open-label Phase|Withdrawal by Subject|0|||
25206102|NCT02287584|50452480|FG003|the Open-label Phase|Withdrawal by Subject|18|||
25206103|NCT02287584|50452481|FG004|the Open-label Phase|Withdrawal by Subject|29|||
25206104|NCT02287584|50452482|FG005|the Open-label Phase|Withdrawal by Subject|21|||
25206105|NCT02287584|50452477|FG000|the Open-label Phase|non-compliance|0|||
25206106|NCT02287584|50452478|FG001|the Open-label Phase|non-compliance|0|||
25206107|NCT02287584|50452479|FG002|the Open-label Phase|non-compliance|0|||
25206108|NCT02287584|50452480|FG003|the Open-label Phase|non-compliance|2|||
25206109|NCT02287584|50452481|FG004|the Open-label Phase|non-compliance|5|||
25206110|NCT02287584|50452482|FG005|the Open-label Phase|non-compliance|1|||
25206111|NCT02287584|50452477|FG000|the Open-label Phase|other reasons|0|||
24976325|NCT00092547|50065233|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
24976326|NCT00092547|50065234|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
25206112|NCT02287584|50452478|FG001|the Open-label Phase|other reasons|0|||
25206113|NCT02287584|50452479|FG002|the Open-label Phase|other reasons|0|||
25206114|NCT02287584|50452480|FG003|the Open-label Phase|other reasons|3|||
25206115|NCT02287584|50452481|FG004|the Open-label Phase|other reasons|6|||
25206116|NCT02287584|50452482|FG005|the Open-label Phase|other reasons|6|||
25206117|NCT00553267|50452515|FG000|Overall Study|Adverse Event|8|||
25316033|NCT00896532|50631597|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25206118|NCT00553267|50452516|FG001|Overall Study|Adverse Event|10|||
25206119|NCT00553267|50452517|FG002|Overall Study|Adverse Event|5|||
25206120|NCT00553267|50452515|FG000|Overall Study|Non compliant with protocol|3|||
25206121|NCT00553267|50452516|FG001|Overall Study|Non compliant with protocol|3|||
25206122|NCT00553267|50452517|FG002|Overall Study|Non compliant with protocol|2|||
25206123|NCT00553267|50452515|FG000|Overall Study|Lost to Follow-up|0|||
25206124|NCT00553267|50452516|FG001|Overall Study|Lost to Follow-up|0|||
25206125|NCT00553267|50452517|FG002|Overall Study|Lost to Follow-up|1|||
25206126|NCT00553267|50452515|FG000|Overall Study|Consent withdrawn|2|||
25206127|NCT00553267|50452516|FG001|Overall Study|Consent withdrawn|3|||
25206128|NCT00553267|50452517|FG002|Overall Study|Consent withdrawn|1|||
25206129|NCT00553267|50452515|FG000|Overall Study|Specified category|1|||
25206130|NCT00553267|50452516|FG001|Overall Study|Specified category|2|||
25206131|NCT00553267|50452517|FG002|Overall Study|Specified category|1|||
25206132|NCT02271984|50452531|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
25206133|NCT02271984|50452532|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
25206134|NCT02271984|50452533|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
25206135|NCT02271984|50452534|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
25206136|NCT02271984|50452535|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
25206137|NCT02271984|50452536|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
25206138|NCT02271984|50452537|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
25206139|NCT02271984|50452538|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
25206140|NCT02271984|50452539|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
25206141|NCT02271984|50452540|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
25206142|NCT02271984|50452541|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
25206143|NCT02271984|50452542|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
25206144|NCT02287038|50452593|FG000|Overall Study|Stopped attending appointments|3|||
25206145|NCT02287038|50452594|FG001|Overall Study|Stopped attending appointments|2|||
25206146|NCT02287038|50452593|FG000|Overall Study|Anxiety after starting medication|0|||
25206147|NCT02287038|50452594|FG001|Overall Study|Anxiety after starting medication|1|||
25206148|NCT02287038|50452593|FG000|Overall Study|Nausea after starting medication|1|||
25206149|NCT02287038|50452594|FG001|Overall Study|Nausea after starting medication|0|||
25206150|NCT02287038|50452593|FG000|Overall Study|Abnormal ECG after starting medication|1|||
25206151|NCT02287038|50452594|FG001|Overall Study|Abnormal ECG after starting medication|0|||
25206152|NCT02286960|50452604|FG000|Overall Study|Lost to Follow-up|3|||
25206153|NCT02286960|50452605|FG001|Overall Study|Lost to Follow-up|3|||
25206154|NCT02286102|50452622|FG000|Overall Study|Screen Failure|1|||
25206155|NCT02286102|50452623|FG001|Overall Study|Screen Failure|1|||
25206156|NCT02285166|50452629|FG000|Overall Study|Case Report Forms Uncollected|564|||
25206157|NCT02285166|50452629|FG000|Overall Study|Protocol Deviation|402|||
25206158|NCT00555061|50452692|FG000|Overall Study|Adverse Event|3|||
25206159|NCT00555061|50452692|FG000|Overall Study|Protocol Violation|1|||
25206160|NCT00555061|50452692|FG000|Overall Study|Lost to Follow-up|2|||
25206161|NCT00555061|50452692|FG000|Overall Study|Withdrawal by Subject|2|||
25206162|NCT00555061|50452692|FG000|Overall Study|Participant enrolled, but never treated|1|||
25206163|NCT01642212|50452710|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
25206164|NCT01642212|50452711|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
25206165|NCT01642212|50452712|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
25206166|NCT01642212|50452713|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
25206167|NCT01642212|50452714|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
25206168|NCT01642212|50452710|FG000|Double-blind Treatment|Other|0|||
25206169|NCT01642212|50452711|FG001|Double-blind Treatment|Other|2|||
25206170|NCT01642212|50452712|FG002|Double-blind Treatment|Other|1|||
25206171|NCT01642212|50452713|FG003|Double-blind Treatment|Other|0|||
25206172|NCT01642212|50452714|FG004|Double-blind Treatment|Other|0|||
25206173|NCT01642212|50452710|FG000|Double-blind Treatment|Non-compliance|0|||
25206174|NCT01642212|50452711|FG001|Double-blind Treatment|Non-compliance|1|||
25206175|NCT01642212|50452712|FG002|Double-blind Treatment|Non-compliance|0|||
25206176|NCT01642212|50452713|FG003|Double-blind Treatment|Non-compliance|0|||
25206177|NCT01642212|50452714|FG004|Double-blind Treatment|Non-compliance|0|||
25206178|NCT01642212|50452710|FG000|Double-blind Treatment|Adverse Event|0|||
25206179|NCT01642212|50452711|FG001|Double-blind Treatment|Adverse Event|0|||
25206180|NCT01642212|50452712|FG002|Double-blind Treatment|Adverse Event|1|||
25206181|NCT01642212|50452713|FG003|Double-blind Treatment|Adverse Event|0|||
25206182|NCT01642212|50452714|FG004|Double-blind Treatment|Adverse Event|0|||
25206183|NCT01642212|50452710|FG000|Open-label Extension|Adverse Event|0|||
25206184|NCT01642212|50452711|FG001|Open-label Extension|Adverse Event|0|||
25206185|NCT01642212|50452712|FG002|Open-label Extension|Adverse Event|0|||
25206186|NCT01642212|50452713|FG003|Open-label Extension|Adverse Event|3|||
25206187|NCT01642212|50452714|FG004|Open-label Extension|Adverse Event|0|||
25206188|NCT01642212|50452710|FG000|Open-label Extension|Sponsor Decision|0|||
25206189|NCT01642212|50452711|FG001|Open-label Extension|Sponsor Decision|0|||
25206190|NCT01642212|50452712|FG002|Open-label Extension|Sponsor Decision|0|||
25206191|NCT01642212|50452713|FG003|Open-label Extension|Sponsor Decision|7|||
25206192|NCT01642212|50452714|FG004|Open-label Extension|Sponsor Decision|4|||
25206193|NCT01642212|50452710|FG000|Open-label Extension|Consent Withdrawn|0|||
25206194|NCT01642212|50452711|FG001|Open-label Extension|Consent Withdrawn|0|||
25206195|NCT01642212|50452712|FG002|Open-label Extension|Consent Withdrawn|0|||
25206196|NCT01642212|50452713|FG003|Open-label Extension|Consent Withdrawn|0|||
25206197|NCT01642212|50452714|FG004|Open-label Extension|Consent Withdrawn|2|||
25206198|NCT01642212|50452710|FG000|Open-label Extension|Lost to Follow-up|0|||
25206199|NCT01642212|50452711|FG001|Open-label Extension|Lost to Follow-up|0|||
25206200|NCT01642212|50452712|FG002|Open-label Extension|Lost to Follow-up|0|||
25206201|NCT01642212|50452713|FG003|Open-label Extension|Lost to Follow-up|0|||
25206202|NCT01642212|50452714|FG004|Open-label Extension|Lost to Follow-up|1|||
25206203|NCT01642212|50452710|FG000|Open-label Extension|Other|0|||
25206204|NCT01642212|50452711|FG001|Open-label Extension|Other|0|||
25206205|NCT01642212|50452712|FG002|Open-label Extension|Other|0|||
25206206|NCT01642212|50452713|FG003|Open-label Extension|Other|0|||
25206207|NCT01642212|50452714|FG004|Open-label Extension|Other|1|||
25206208|NCT00552175|50452739|FG000|Overall Study|Lack of Efficacy|2|||
25206209|NCT00552175|50452740|FG001|Overall Study|Lack of Efficacy|0|||
25206210|NCT00552175|50452741|FG002|Overall Study|Lack of Efficacy|1|||
25206211|NCT00552175|50452739|FG000|Overall Study|Adverse Event|9|||
25206212|NCT00552175|50452740|FG001|Overall Study|Adverse Event|9|||
25206213|NCT00552175|50452741|FG002|Overall Study|Adverse Event|10|||
25206214|NCT00552175|50452739|FG000|Overall Study|Withdrawal by Subject|2|||
25206215|NCT00552175|50452740|FG001|Overall Study|Withdrawal by Subject|2|||
25206216|NCT00552175|50452741|FG002|Overall Study|Withdrawal by Subject|1|||
25206217|NCT00552175|50452739|FG000|Overall Study|Lost to Follow-up|0|||
25206218|NCT00552175|50452740|FG001|Overall Study|Lost to Follow-up|0|||
25206219|NCT00552175|50452741|FG002|Overall Study|Lost to Follow-up|1|||
25206220|NCT00552175|50452739|FG000|Overall Study|Entry Criteria Not Met|1|||
25206221|NCT00552175|50452740|FG001|Overall Study|Entry Criteria Not Met|1|||
25206222|NCT00552175|50452741|FG002|Overall Study|Entry Criteria Not Met|0|||
25206223|NCT00552175|50452739|FG000|Overall Study|Reason Not Specified|3|||
25206224|NCT00552175|50452740|FG001|Overall Study|Reason Not Specified|1|||
25206225|NCT00552175|50452741|FG002|Overall Study|Reason Not Specified|1|||
25206226|NCT01644474|50452752|FG000|Overall Study|Poor compliance to protocol|1|||
25206227|NCT01644474|50452753|FG001|Overall Study|Poor compliance to protocol|0|||
25206228|NCT01644474|50452752|FG000|Overall Study|Consent withdrawn by participant|0|||
25206229|NCT01644474|50452753|FG001|Overall Study|Consent withdrawn by participant|1|||
25206230|NCT01644474|50452752|FG000|Overall Study|Participant moved|0|||
25206231|NCT01644474|50452753|FG001|Overall Study|Participant moved|1|||
25206232|NCT01644474|50452752|FG000|Overall Study|Adverse Event|4|||
25206233|NCT01644474|50452753|FG001|Overall Study|Adverse Event|5|||
25206234|NCT01644474|50452752|FG000|Overall Study|Site scheduling error|1|||
25206235|NCT01644474|50452753|FG001|Overall Study|Site scheduling error|1|||
25206236|NCT01644474|50452752|FG000|Overall Study|Protocol Violation|1|||
25206237|NCT01644474|50452753|FG001|Overall Study|Protocol Violation|0|||
25206238|NCT02285010|50452788|FG000|Overall Study|not abdominal hysterectomy|2|||
25206239|NCT02285010|50452789|FG001|Overall Study|not abdominal hysterectomy|0|||
25206240|NCT02285010|50452788|FG000|Overall Study|Not spinal anesthesia|3|||
25206241|NCT02285010|50452789|FG001|Overall Study|Not spinal anesthesia|1|||
25206242|NCT00551161|50452833|FG000|Overall Study|Withdrawal by Subject|1|||
25206243|NCT00550771|50452869|FG000|Overall Study|Adverse Event|11|||
25206244|NCT00550771|50452870|FG001|Overall Study|Adverse Event|3|||
25206245|NCT00550771|50452869|FG000|Overall Study|Discontinued for study-related reasons|0|||
25206246|NCT00550771|50452870|FG001|Overall Study|Discontinued for study-related reasons|1|||
25206247|NCT00550771|50452869|FG000|Overall Study|Physician Decision|2|||
25206248|NCT00550771|50452870|FG001|Overall Study|Physician Decision|0|||
25206249|NCT00550771|50452869|FG000|Overall Study|Withdrawal by Subject|0|||
25206250|NCT00550771|50452870|FG001|Overall Study|Withdrawal by Subject|1|||
25206251|NCT00550771|50452869|FG000|Overall Study|Protocol Violation|4|||
25206252|NCT00550771|50452870|FG001|Overall Study|Protocol Violation|5|||
25206253|NCT00550537|50452903|FG000|Overall Study|Death|18|||
25316034|NCT00896532|50631598|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316035|NCT00896532|50631599|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316036|NCT00896532|50631600|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
25206254|NCT00550537|50452903|FG000|Overall Study|Adverse Event|20|||
25206255|NCT00550537|50452903|FG000|Overall Study|Disease progression before|46|||
25206256|NCT00550537|50452903|FG000|Overall Study|Withdrawal by Subject|7|||
25206257|NCT00550537|50452903|FG000|Overall Study|Change in treatment plan|4|||
25206258|NCT00550537|50452903|FG000|Overall Study|Other complicating ilness|3|||
25206259|NCT00550537|50452903|FG000|Overall Study|Declining performance status|2|||
25206260|NCT00550537|50452903|FG000|Overall Study|Treated closer to home|4|||
25206261|NCT00550147|50452921|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
25206262|NCT00550147|50452921|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
25206263|NCT00550147|50452921|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
25206264|NCT00550147|50452921|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
25206265|NCT00550147|50452921|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
25206266|NCT00550459|50453132|FG000|Overall Study|Adverse Event|0|||
25206267|NCT00550459|50453133|FG001|Overall Study|Adverse Event|2|||
25206268|NCT00550459|50453132|FG000|Overall Study|Withdrawal by Subject|1|||
25206269|NCT00550459|50453133|FG001|Overall Study|Withdrawal by Subject|1|||
25206270|NCT01643928|50453432|FG000|Overall Study|Lost to Follow-up|1|||
25206271|NCT01643928|50453433|FG001|Overall Study|Lost to Follow-up|0|||
25206272|NCT01643928|50453434|FG002|Overall Study|Lost to Follow-up|2|||
25206273|NCT01643928|50453435|FG003|Overall Study|Lost to Follow-up|0|||
25206274|NCT01643928|50453436|FG004|Overall Study|Lost to Follow-up|0|||
25206275|NCT01643928|50453432|FG000|Overall Study|Withdrawal by Subject|2|||
25206276|NCT01643928|50453433|FG001|Overall Study|Withdrawal by Subject|0|||
25206277|NCT01643928|50453434|FG002|Overall Study|Withdrawal by Subject|0|||
25206278|NCT01643928|50453435|FG003|Overall Study|Withdrawal by Subject|1|||
25206279|NCT01643928|50453436|FG004|Overall Study|Withdrawal by Subject|0|||
25206280|NCT01643928|50453432|FG000|Overall Study|Pregnancy|0|||
25206281|NCT01643928|50453433|FG001|Overall Study|Pregnancy|0|||
25206282|NCT01643928|50453434|FG002|Overall Study|Pregnancy|0|||
25206283|NCT01643928|50453435|FG003|Overall Study|Pregnancy|1|||
25206284|NCT01643928|50453436|FG004|Overall Study|Pregnancy|0|||
25206285|NCT01643928|50453432|FG000|Overall Study|Other|5|||
25206286|NCT01643928|50453433|FG001|Overall Study|Other|1|||
25206287|NCT01643928|50453434|FG002|Overall Study|Other|1|||
25206288|NCT01643928|50453435|FG003|Overall Study|Other|0|||
25206289|NCT01643928|50453436|FG004|Overall Study|Other|0|||
25206290|NCT01643928|50453432|FG000|Overall Study|Adverse Event|2|||
25206291|NCT01643928|50453433|FG001|Overall Study|Adverse Event|1|||
25206292|NCT01643928|50453434|FG002|Overall Study|Adverse Event|0|||
25206293|NCT01643928|50453435|FG003|Overall Study|Adverse Event|1|||
25206294|NCT01643928|50453436|FG004|Overall Study|Adverse Event|2|||
25206295|NCT03237845|50453647|FG000|Overall Study|Adverse Event|0|||
25206296|NCT03237845|50453648|FG001|Overall Study|Adverse Event|1|||
25206297|NCT03237845|50453647|FG000|Overall Study|Lost to Follow-up|13|||
25206298|NCT03237845|50453648|FG001|Overall Study|Lost to Follow-up|10|||
25206299|NCT03237845|50453647|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
25206300|NCT03237845|50453648|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
25206301|NCT03237845|50453647|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
25206302|NCT03237845|50453648|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
25206303|NCT03237845|50453647|FG000|Overall Study|Physician Decision|1|||
25206304|NCT03237845|50453648|FG001|Overall Study|Physician Decision|2|||
25206305|NCT03237845|50453647|FG000|Overall Study|Pregnancy|1|||
25206306|NCT03237845|50453648|FG001|Overall Study|Pregnancy|0|||
25206307|NCT03237845|50453647|FG000|Overall Study|Protocol Deviation|0|||
25206308|NCT03237845|50453648|FG001|Overall Study|Protocol Deviation|1|||
25206309|NCT03237845|50453647|FG000|Overall Study|Technical Problems|8|||
25206310|NCT03237845|50453648|FG001|Overall Study|Technical Problems|1|||
25206311|NCT03237845|50453647|FG000|Overall Study|Withdrawal by Subject|3|||
25206312|NCT03237845|50453648|FG001|Overall Study|Withdrawal by Subject|3|||
25206313|NCT03237845|50453647|FG000|Overall Study|Other Reasons|4|||
25206314|NCT03237845|50453648|FG001|Overall Study|Other Reasons|0|||
25206315|NCT01643850|50453735|FG000|Overall Study|Withdrawal by Subject|0|||
25206316|NCT01643850|50453736|FG001|Overall Study|Withdrawal by Subject|0|||
25206317|NCT01643850|50453737|FG002|Overall Study|Withdrawal by Subject|0|||
25206318|NCT01643850|50453738|FG003|Overall Study|Withdrawal by Subject|0|||
25206319|NCT01643850|50453739|FG004|Overall Study|Withdrawal by Subject|1|||
25206320|NCT01643850|50453740|FG005|Overall Study|Withdrawal by Subject|0|||
25206321|NCT01643850|50453741|FG006|Overall Study|Withdrawal by Subject|0|||
25206322|NCT01643850|50453742|FG007|Overall Study|Withdrawal by Subject|0|||
25206323|NCT01643850|50453743|FG008|Overall Study|Withdrawal by Subject|0|||
25206324|NCT01643850|50453735|FG000|Overall Study|Lost to Follow-up|0|||
25206325|NCT01643850|50453736|FG001|Overall Study|Lost to Follow-up|0|||
25206326|NCT01643850|50453737|FG002|Overall Study|Lost to Follow-up|0|||
25206327|NCT01643850|50453738|FG003|Overall Study|Lost to Follow-up|0|||
25206328|NCT01643850|50453739|FG004|Overall Study|Lost to Follow-up|0|||
25206329|NCT01643850|50453740|FG005|Overall Study|Lost to Follow-up|0|||
25206330|NCT01643850|50453741|FG006|Overall Study|Lost to Follow-up|1|||
25206331|NCT01643850|50453742|FG007|Overall Study|Lost to Follow-up|0|||
25206332|NCT01643850|50453743|FG008|Overall Study|Lost to Follow-up|1|||
25206333|NCT01643850|50453735|FG000|Overall Study|Adverse Event|0|||
25206334|NCT01643850|50453736|FG001|Overall Study|Adverse Event|0|||
25206335|NCT01643850|50453737|FG002|Overall Study|Adverse Event|0|||
25206336|NCT01643850|50453738|FG003|Overall Study|Adverse Event|0|||
25206337|NCT01643850|50453739|FG004|Overall Study|Adverse Event|1|||
25206338|NCT01643850|50453740|FG005|Overall Study|Adverse Event|0|||
25206339|NCT01643850|50453741|FG006|Overall Study|Adverse Event|0|||
25206340|NCT01643850|50453742|FG007|Overall Study|Adverse Event|0|||
25206341|NCT01643850|50453743|FG008|Overall Study|Adverse Event|0|||
25206342|NCT01643850|50453735|FG000|Overall Study|Administrative Problems|0|||
25206343|NCT01643850|50453736|FG001|Overall Study|Administrative Problems|0|||
25206344|NCT01643850|50453737|FG002|Overall Study|Administrative Problems|1|||
25206345|NCT01643850|50453738|FG003|Overall Study|Administrative Problems|0|||
25206346|NCT01643850|50453739|FG004|Overall Study|Administrative Problems|1|||
25206347|NCT01643850|50453740|FG005|Overall Study|Administrative Problems|0|||
25206348|NCT01643850|50453741|FG006|Overall Study|Administrative Problems|0|||
25206349|NCT01643850|50453742|FG007|Overall Study|Administrative Problems|0|||
25206350|NCT01643850|50453743|FG008|Overall Study|Administrative Problems|0|||
25206351|NCT02271594|50453811|FG000|Overall Study|Study closed; recruiting failure|19|||
25206352|NCT02271594|50453812|FG001|Overall Study|Study closed; recruiting failure|12|||
25206353|NCT02535923|50453831|FG000|Overall Study|Lost to Follow-up|5|||
25206354|NCT02535923|50453832|FG001|Overall Study|Lost to Follow-up|5|||
25206355|NCT02535923|50453831|FG000|Overall Study|Withdrawal by Subject|4|||
25206356|NCT02535923|50453832|FG001|Overall Study|Withdrawal by Subject|3|||
25206357|NCT02270736|50453841|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
25206358|NCT02270736|50453842|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
25206359|NCT02270736|50453843|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
25206360|NCT02270736|50453844|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
25206361|NCT02270736|50453845|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
25206362|NCT02270736|50453841|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
25206363|NCT02270736|50453842|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
25206364|NCT02270736|50453843|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
25206365|NCT02270736|50453844|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
25206366|NCT02270736|50453845|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
25206367|NCT02270736|50453841|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
25206368|NCT02270736|50453842|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
25206369|NCT02270736|50453843|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
25206370|NCT02270736|50453844|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
25206371|NCT02270736|50453845|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
25206372|NCT02270736|50453841|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
25206373|NCT02270736|50453842|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
25206374|NCT02270736|50453843|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
25206375|NCT02270736|50453844|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
25206376|NCT02270736|50453845|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
25206377|NCT02270736|50453841|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
25206378|NCT02270736|50453842|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
25206379|NCT02270736|50453843|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
25206380|NCT02270736|50453844|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
25206381|NCT02270736|50453845|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
25206382|NCT02270736|50453841|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
25206383|NCT02270736|50453842|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
25206384|NCT02270736|50453843|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
25206385|NCT02270736|50453844|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
25206386|NCT02270736|50453845|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
25206387|NCT02270736|50453841|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
25206388|NCT02270736|50453842|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
25206389|NCT02270736|50453843|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
25206390|NCT02270736|50453844|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
25206391|NCT02270736|50453845|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
25206392|NCT02270736|50453841|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
25206393|NCT02270736|50453842|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
25206394|NCT02270736|50453843|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
25206395|NCT02270736|50453844|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
25206396|NCT02270736|50453845|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
25206397|NCT02270736|50453841|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
25206398|NCT02270736|50453842|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
25206399|NCT02270736|50453843|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
25206400|NCT02270736|50453844|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
25206401|NCT02270736|50453845|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
25206402|NCT02269098|50453860|FG000|Overall Study|Lost to Follow-up|14|||
25206403|NCT02269098|50453861|FG001|Overall Study|Lost to Follow-up|9|||
25206404|NCT02283762|50454005|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
25206405|NCT02283762|50454006|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
25206406|NCT02283762|50454005|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
25206407|NCT02283762|50454006|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
25206408|NCT02283762|50454005|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
25206409|NCT02283762|50454006|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
25206410|NCT02283762|50454005|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
25206411|NCT02283762|50454006|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
25206412|NCT02283762|50454005|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
25206413|NCT02283762|50454006|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
25206414|NCT02283762|50454005|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
25206415|NCT02283762|50454006|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
25206416|NCT02283762|50454005|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
25206417|NCT02283762|50454006|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
25206418|NCT02283762|50454005|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
25206419|NCT02283762|50454006|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
25206420|NCT02283762|50454005|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
25206421|NCT02283762|50454006|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
25206422|NCT02283762|50454005|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
25206423|NCT02283762|50454006|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
25206424|NCT02283762|50454005|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
25206425|NCT02283762|50454006|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
25206426|NCT02283762|50454005|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
25206427|NCT02283762|50454006|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
25206428|NCT02283294|50454106|FG000|Overall Study|Lost to Follow-up|1|||
25206429|NCT02283294|50454107|FG001|Overall Study|Lost to Follow-up|1|||
25206430|NCT02283294|50454106|FG000|Overall Study|Withdrawal by Subject|1|||
25206431|NCT02283294|50454107|FG001|Overall Study|Withdrawal by Subject|6|||
25206432|NCT02283294|50454106|FG000|Overall Study|Protocol Violation|1|||
25206433|NCT02283294|50454107|FG001|Overall Study|Protocol Violation|0|||
25206434|NCT02283294|50454106|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
25206435|NCT02283294|50454107|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
25206436|NCT02282982|50454123|FG000|Overall Study|Lost to Follow-up|15|||
25206437|NCT02282982|50454123|FG000|Overall Study|Withdrew consent|2|||
25206438|NCT02282982|50454123|FG000|Overall Study|Death|4|||
25206439|NCT02282982|50454123|FG000|Overall Study|Lack of product|156|||
25206440|NCT02282982|50454123|FG000|Overall Study|Palivizumab is ended|11|||
25206441|NCT02282982|50454123|FG000|Overall Study|Other, not specified|18|||
25206442|NCT02268864|50454165|FG000|Overall Study|Withdrawal by Subject|2|||
25206443|NCT02268864|50454166|FG001|Overall Study|Withdrawal by Subject|0|||
25206444|NCT02268864|50454167|FG002|Overall Study|Withdrawal by Subject|0|||
25206445|NCT02268864|50454165|FG000|Overall Study|Death|0|||
25206446|NCT02268864|50454166|FG001|Overall Study|Death|1|||
25206447|NCT02268864|50454167|FG002|Overall Study|Death|0|||
25206448|NCT02268786|50454196|FG000|Overall Study|No Euploid Embryos available|42|||
25206449|NCT02268786|50454197|FG001|Overall Study|No Euploid Embryos available|0|||
25206450|NCT02268786|50454196|FG000|Overall Study|Withdrawal by Subject|7|||
25206451|NCT02268786|50454197|FG001|Overall Study|Withdrawal by Subject|14|||
25206452|NCT02268786|50454196|FG000|Overall Study|Thaw Failure|6|||
25206453|NCT02268786|50454197|FG001|Overall Study|Thaw Failure|4|||
25206454|NCT02268786|50454196|FG000|Overall Study|Protocol Violation|1|||
25206455|NCT02268786|50454197|FG001|Overall Study|Protocol Violation|0|||
25206456|NCT02268396|50454212|FG000|Overall Study|Adverse Event|3|||
25206457|NCT02268396|50454212|FG000|Overall Study|Administrative|2|||
25206458|NCT02268396|50454212|FG000|Overall Study|Withdrawal by Subject|1|||
25206459|NCT02268396|50454212|FG000|Overall Study|Lost to Follow-up|2|||
25206460|NCT02268396|50454212|FG000|Overall Study|Protocol-Specified Criteria|2|||
25206461|NCT02268396|50454212|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
25206462|NCT02268084|50454218|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
25206463|NCT02268084|50454219|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
25206464|NCT02268084|50454218|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
25206465|NCT02268084|50454219|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
25206466|NCT01643772|50454248|FG000|Overall Study|Protocol Violation|0|||
25206467|NCT01643772|50454249|FG001|Overall Study|Protocol Violation|0|||
25206468|NCT01643772|50454250|FG002|Overall Study|Protocol Violation|0|||
25206469|NCT01643772|50454251|FG003|Overall Study|Protocol Violation|1|||
25206470|NCT01643772|50454248|FG000|Overall Study|Adverse Event|0|||
25206471|NCT01643772|50454249|FG001|Overall Study|Adverse Event|0|||
25206472|NCT01643772|50454250|FG002|Overall Study|Adverse Event|0|||
25206473|NCT01643772|50454251|FG003|Overall Study|Adverse Event|1|||
25206474|NCT02265744|50454354|FG000|Overall Study|Poor/Non-compliance|1|||
25206475|NCT02265744|50454355|FG001|Overall Study|Poor/Non-compliance|1|||
25206476|NCT02265744|50454356|FG002|Overall Study|Poor/Non-compliance|0|||
25206477|NCT02265744|50454357|FG003|Overall Study|Poor/Non-compliance|0|||
25206478|NCT02265744|50454358|FG004|Overall Study|Poor/Non-compliance|2|||
25206479|NCT02265744|50454354|FG000|Overall Study|Lost to Follow-up|0|||
25206480|NCT02265744|50454355|FG001|Overall Study|Lost to Follow-up|0|||
25206481|NCT02265744|50454356|FG002|Overall Study|Lost to Follow-up|0|||
25206482|NCT02265744|50454357|FG003|Overall Study|Lost to Follow-up|1|||
25206483|NCT02265744|50454358|FG004|Overall Study|Lost to Follow-up|0|||
25206484|NCT02265744|50454354|FG000|Overall Study|Death|0|||
25206485|NCT02265744|50454355|FG001|Overall Study|Death|0|||
25206486|NCT02265744|50454356|FG002|Overall Study|Death|0|||
25206487|NCT02265744|50454357|FG003|Overall Study|Death|2|||
25206488|NCT02265744|50454358|FG004|Overall Study|Death|0|||
25206489|NCT02265744|50454354|FG000|Overall Study|Withdrawal by Subject|2|||
25206490|NCT02265744|50454355|FG001|Overall Study|Withdrawal by Subject|0|||
25206491|NCT02265744|50454356|FG002|Overall Study|Withdrawal by Subject|0|||
25206492|NCT02265744|50454357|FG003|Overall Study|Withdrawal by Subject|2|||
25206493|NCT02265744|50454358|FG004|Overall Study|Withdrawal by Subject|0|||
25206494|NCT02265744|50454354|FG000|Overall Study|Participant request to discontinue|2|||
25206495|NCT02265744|50454355|FG001|Overall Study|Participant request to discontinue|2|||
25206496|NCT02265744|50454356|FG002|Overall Study|Participant request to discontinue|2|||
25206497|NCT02265744|50454357|FG003|Overall Study|Participant request to discontinue|0|||
25206498|NCT02265744|50454358|FG004|Overall Study|Participant request to discontinue|0|||
25206499|NCT02265744|50454354|FG000|Overall Study|Adverse Event|8|||
25206500|NCT02265744|50454355|FG001|Overall Study|Adverse Event|4|||
25206501|NCT02265744|50454356|FG002|Overall Study|Adverse Event|9|||
25206502|NCT02265744|50454357|FG003|Overall Study|Adverse Event|8|||
25206503|NCT02265744|50454358|FG004|Overall Study|Adverse Event|2|||
25206504|NCT02265744|50454354|FG000|Overall Study|Lack of Efficacy|2|||
25206505|NCT02265744|50454355|FG001|Overall Study|Lack of Efficacy|4|||
25206506|NCT02265744|50454356|FG002|Overall Study|Lack of Efficacy|3|||
25206507|NCT02265744|50454357|FG003|Overall Study|Lack of Efficacy|4|||
25206508|NCT02265744|50454358|FG004|Overall Study|Lack of Efficacy|5|||
25206509|NCT02265744|50454354|FG000|Overall Study|Reason not provided by Investigator|1|||
25206510|NCT02265744|50454355|FG001|Overall Study|Reason not provided by Investigator|0|||
25206511|NCT02265744|50454356|FG002|Overall Study|Reason not provided by Investigator|0|||
25206512|NCT02265744|50454357|FG003|Overall Study|Reason not provided by Investigator|2|||
25206513|NCT02265744|50454358|FG004|Overall Study|Reason not provided by Investigator|0|||
25206514|NCT02265744|50454354|FG000|Overall Study|Administrative reason by sponsor|3|||
25206515|NCT02265744|50454355|FG001|Overall Study|Administrative reason by sponsor|2|||
25206516|NCT02265744|50454356|FG002|Overall Study|Administrative reason by sponsor|2|||
25206517|NCT02265744|50454357|FG003|Overall Study|Administrative reason by sponsor|3|||
25206518|NCT02265744|50454358|FG004|Overall Study|Administrative reason by sponsor|3|||
25206519|NCT02265744|50454354|FG000|Overall Study|Subject no longer meets study criteria|0|||
25206520|NCT02265744|50454355|FG001|Overall Study|Subject no longer meets study criteria|0|||
25206521|NCT02265744|50454356|FG002|Overall Study|Subject no longer meets study criteria|0|||
25206522|NCT02265744|50454357|FG003|Overall Study|Subject no longer meets study criteria|0|||
25206523|NCT02265744|50454358|FG004|Overall Study|Subject no longer meets study criteria|1|||
25206524|NCT02265744|50454354|FG000|Overall Study|Pregnancy|1|||
25206525|NCT02265744|50454355|FG001|Overall Study|Pregnancy|2|||
25206526|NCT02265744|50454356|FG002|Overall Study|Pregnancy|1|||
24976327|NCT00092547|50065232|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
24976328|NCT00092547|50065233|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
24976329|NCT00092547|50065234|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
24976330|NCT00092547|50065232|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
24976331|NCT00092547|50065233|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
24976332|NCT00092547|50065234|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
24976333|NCT00092547|50065232|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
24976334|NCT00092547|50065233|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
24976335|NCT00092547|50065234|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
25206527|NCT02265744|50454357|FG003|Overall Study|Pregnancy|1|||
25206528|NCT02265744|50454358|FG004|Overall Study|Pregnancy|0|||
25206529|NCT00085735|50454387|FG000|Overall Study|Adverse Event|1|||
25206530|NCT00085735|50454388|FG001|Overall Study|Adverse Event|0|||
25206531|NCT00085735|50454389|FG002|Overall Study|Adverse Event|0|||
25206532|NCT00085735|50454390|FG003|Overall Study|Adverse Event|0|||
25206533|NCT00085735|50454391|FG004|Overall Study|Adverse Event|0|||
25206534|NCT00085735|50454392|FG005|Overall Study|Adverse Event|0|||
25206535|NCT00085735|50454387|FG000|Overall Study|Lack of Efficacy|2|||
25206536|NCT00085735|50454388|FG001|Overall Study|Lack of Efficacy|4|||
25206537|NCT00085735|50454389|FG002|Overall Study|Lack of Efficacy|6|||
25206538|NCT00085735|50454390|FG003|Overall Study|Lack of Efficacy|3|||
25206539|NCT00085735|50454391|FG004|Overall Study|Lack of Efficacy|4|||
25206540|NCT00085735|50454392|FG005|Overall Study|Lack of Efficacy|3|||
25206541|NCT00085735|50454387|FG000|Overall Study|Lost to Follow-up|0|||
25206542|NCT00085735|50454388|FG001|Overall Study|Lost to Follow-up|1|||
25206543|NCT00085735|50454389|FG002|Overall Study|Lost to Follow-up|0|||
25206544|NCT00085735|50454390|FG003|Overall Study|Lost to Follow-up|0|||
25206545|NCT00085735|50454391|FG004|Overall Study|Lost to Follow-up|1|||
25206546|NCT00085735|50454392|FG005|Overall Study|Lost to Follow-up|0|||
25206547|NCT00085735|50454387|FG000|Overall Study|Physician Decision|2|||
25206548|NCT00085735|50454388|FG001|Overall Study|Physician Decision|3|||
25206549|NCT00085735|50454389|FG002|Overall Study|Physician Decision|2|||
25206550|NCT00085735|50454390|FG003|Overall Study|Physician Decision|3|||
25206551|NCT00085735|50454391|FG004|Overall Study|Physician Decision|11|||
25206552|NCT00085735|50454392|FG005|Overall Study|Physician Decision|8|||
25206553|NCT00085735|50454387|FG000|Overall Study|Protocol Violation|1|||
25206554|NCT00085735|50454388|FG001|Overall Study|Protocol Violation|0|||
25206555|NCT00085735|50454389|FG002|Overall Study|Protocol Violation|0|||
25206556|NCT00085735|50454390|FG003|Overall Study|Protocol Violation|0|||
25077133|NCT02466386|50184986|FG000|Overall Study|Protocol Violation|2|||
25206557|NCT00085735|50454391|FG004|Overall Study|Protocol Violation|0|||
25206558|NCT00085735|50454392|FG005|Overall Study|Protocol Violation|0|||
25206559|NCT00085735|50454387|FG000|Overall Study|Withdrawal by Subject|1|||
25206560|NCT00085735|50454388|FG001|Overall Study|Withdrawal by Subject|0|||
25206561|NCT00085735|50454389|FG002|Overall Study|Withdrawal by Subject|4|||
25206562|NCT00085735|50454390|FG003|Overall Study|Withdrawal by Subject|5|||
25206563|NCT00085735|50454391|FG004|Overall Study|Withdrawal by Subject|7|||
25206564|NCT00085735|50454392|FG005|Overall Study|Withdrawal by Subject|8|||
25206565|NCT00085735|50454387|FG000|Overall Study|Patient ineligible|1|||
25206566|NCT00085735|50454388|FG001|Overall Study|Patient ineligible|0|||
25206567|NCT00085735|50454389|FG002|Overall Study|Patient ineligible|3|||
25206568|NCT00085735|50454390|FG003|Overall Study|Patient ineligible|7|||
25206569|NCT00085735|50454391|FG004|Overall Study|Patient ineligible|17|||
25206570|NCT00085735|50454392|FG005|Overall Study|Patient ineligible|8|||
25206571|NCT00085735|50454387|FG000|Overall Study|Excess residual disease|2|||
25206572|NCT00085735|50454388|FG001|Overall Study|Excess residual disease|2|||
25206573|NCT00085735|50454389|FG002|Overall Study|Excess residual disease|1|||
25206574|NCT00085735|50454390|FG003|Overall Study|Excess residual disease|1|||
25077134|NCT02466386|50184986|FG000|Overall Study|Withdrawal by Subject|14|||
25206575|NCT00085735|50454391|FG004|Overall Study|Excess residual disease|1|||
25206576|NCT00085735|50454392|FG005|Overall Study|Excess residual disease|4|||
25206577|NCT00085735|50454387|FG000|Overall Study|Reason not documented|1|||
25206578|NCT00085735|50454388|FG001|Overall Study|Reason not documented|0|||
25206579|NCT00085735|50454389|FG002|Overall Study|Reason not documented|1|||
25206580|NCT00085735|50454390|FG003|Overall Study|Reason not documented|0|||
25206581|NCT00085735|50454391|FG004|Overall Study|Reason not documented|1|||
25206582|NCT00085735|50454392|FG005|Overall Study|Reason not documented|0|||
25206583|NCT00085735|50454387|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
25206584|NCT00085735|50454388|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
25206585|NCT00085735|50454389|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
25206586|NCT00085735|50454390|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
25206587|NCT00085735|50454391|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
25206588|NCT00085735|50454392|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
25206589|NCT04537793|50454698|FG000|Part B (24 Weeks)|Adverse Event|0|||
25206590|NCT04537793|50454699|FG001|Part B (24 Weeks)|Adverse Event|1|||
25206591|NCT01938001|50455970|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
25206592|NCT01938001|50455971|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
25206593|NCT01938001|50455970|FG000|Pre-Treatment|Death|1|||
25206594|NCT01938001|50455971|FG001|Pre-Treatment|Death|0|||
25206595|NCT01938001|50455970|FG000|Treatment|Death|2|||
25206596|NCT01938001|50455971|FG001|Treatment|Death|0|||
25206597|NCT01938001|50455970|FG000|Treatment|Adverse Event|14|||
25206598|NCT01938001|50455971|FG001|Treatment|Adverse Event|8|||
25206599|NCT01938001|50455970|FG000|Treatment|Progressive Disease|21|||
25206600|NCT01938001|50455971|FG001|Treatment|Progressive Disease|54|||
25206601|NCT01938001|50455970|FG000|Treatment|Withdrawal by Subject|13|||
25206602|NCT01938001|50455971|FG001|Treatment|Withdrawal by Subject|7|||
25206603|NCT01938001|50455970|FG000|Treatment|Other reasons|2|||
25206604|NCT01938001|50455971|FG001|Treatment|Other reasons|1|||
25206605|NCT01066663|50456144|FG000|Overall Study|Adverse Event|0|||
25206606|NCT01066663|50456145|FG001|Overall Study|Adverse Event|0|||
25206607|NCT01066663|50456146|FG002|Overall Study|Adverse Event|1|||
25206608|NCT03930745|50458379|FG000|Overall Study|Lost to Follow-up|10|||
25206609|NCT03930745|50458380|FG001|Overall Study|Lost to Follow-up|5|||
25206610|NCT03930745|50458379|FG000|Overall Study|Withdrawal by Subject|1|||
25206611|NCT03930745|50458380|FG001|Overall Study|Withdrawal by Subject|2|||
25206612|NCT03930745|50458379|FG000|Overall Study|Protocol Violation|2|||
25206613|NCT03930745|50458380|FG001|Overall Study|Protocol Violation|2|||
25206614|NCT03930745|50458379|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
25206615|NCT03930745|50458380|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
25206616|NCT03930745|50458379|FG000|Overall Study|Adverse Event|0|||
25206617|NCT03930745|50458380|FG001|Overall Study|Adverse Event|1|||
25206618|NCT03930745|50458379|FG000|Overall Study|Pregnancy|0|||
25206619|NCT03930745|50458380|FG001|Overall Study|Pregnancy|1|||
25206620|NCT04473326|50461134|FG000|Overall Study|Death|0|||
25206621|NCT04473326|50461135|FG001|Overall Study|Death|1|||
25206622|NCT04473326|50461134|FG000|Overall Study|Withdrawal by Subject|1|||
25206623|NCT04473326|50461135|FG001|Overall Study|Withdrawal by Subject|2|||
25206624|NCT03838484|50461717|FG000|Overall Study|Lost to Follow-up|0|||
25077135|NCT02466386|50184986|FG000|Overall Study|Lost to Follow-up|5|||
25206625|NCT03838484|50461718|FG001|Overall Study|Lost to Follow-up|1|||
25206626|NCT03838484|50461719|FG002|Overall Study|Lost to Follow-up|0|||
25206627|NCT03838484|50461720|FG003|Overall Study|Lost to Follow-up|0|||
25206628|NCT01349192|50461952|FG000|Overall Study|Protocol Violation|0|||
25206629|NCT01349192|50461953|FG001|Overall Study|Protocol Violation|1|||
25206630|NCT01349192|50461952|FG000|Overall Study|Withdrawal by Subject|0|||
25206631|NCT01349192|50461953|FG001|Overall Study|Withdrawal by Subject|2|||
25206632|NCT01349192|50461952|FG000|Overall Study|Lost to Follow-up|1|||
25206633|NCT01349192|50461953|FG001|Overall Study|Lost to Follow-up|3|||
25206634|NCT01349192|50461952|FG000|Overall Study|Failure to adhere to Protocol|2|||
25206635|NCT01349192|50461953|FG001|Overall Study|Failure to adhere to Protocol|0|||
25206636|NCT01721876|50462308|FG000|Overall Study|Not treated|1|||
25206637|NCT01721876|50462309|FG001|Overall Study|Not treated|4|||
25206638|NCT01721876|50462308|FG000|Overall Study|Disease progression / relapse|123|||
25206639|NCT01721876|50462309|FG001|Overall Study|Disease progression / relapse|156|||
25206640|NCT01721876|50462308|FG000|Overall Study|Death|6|||
25206641|NCT01721876|50462309|FG001|Overall Study|Death|13|||
25206642|NCT01721876|50462308|FG000|Overall Study|Adverse Event|41|||
25206643|NCT01721876|50462309|FG001|Overall Study|Adverse Event|165|||
25206644|NCT01721876|50462308|FG000|Overall Study|Protocol Violation|2|||
25206645|NCT01721876|50462309|FG001|Overall Study|Protocol Violation|1|||
25206646|NCT01721876|50462308|FG000|Overall Study|Withdrawal by Subject|15|||
25206647|NCT01721876|50462309|FG001|Overall Study|Withdrawal by Subject|38|||
25206648|NCT01721876|50462308|FG000|Overall Study|Reason not listed|34|||
25206649|NCT01721876|50462309|FG001|Overall Study|Reason not listed|63|||
25206650|NCT01721876|50462308|FG000|Overall Study|Sponsor terminated trial|0|||
25206651|NCT01721876|50462309|FG001|Overall Study|Sponsor terminated trial|4|||
25206652|NCT02029443|50462341|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
25206653|NCT02029443|50462342|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
25206654|NCT02029443|50462343|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
25206655|NCT02029443|50462344|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
25206656|NCT02029443|50462345|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
25206657|NCT02029443|50462341|FG000|Overall Study|Death|13|||
25206658|NCT02029443|50462342|FG001|Overall Study|Death|2|||
25206659|NCT02029443|50462343|FG002|Overall Study|Death|2|||
25206660|NCT02029443|50462344|FG003|Overall Study|Death|11|||
25206661|NCT02029443|50462345|FG004|Overall Study|Death|2|||
25206662|NCT02029443|50462341|FG000|Overall Study|Lost to Follow-up|1|||
25206663|NCT02029443|50462342|FG001|Overall Study|Lost to Follow-up|0|||
25206664|NCT02029443|50462343|FG002|Overall Study|Lost to Follow-up|1|||
25206665|NCT02029443|50462344|FG003|Overall Study|Lost to Follow-up|1|||
25206666|NCT02029443|50462345|FG004|Overall Study|Lost to Follow-up|0|||
25206667|NCT02029443|50462341|FG000|Overall Study|Started other anti-cancer therapy|17|||
25206668|NCT02029443|50462342|FG001|Overall Study|Started other anti-cancer therapy|4|||
25206669|NCT02029443|50462343|FG002|Overall Study|Started other anti-cancer therapy|7|||
25206670|NCT02029443|50462344|FG003|Overall Study|Started other anti-cancer therapy|9|||
25206671|NCT02029443|50462345|FG004|Overall Study|Started other anti-cancer therapy|3|||
25206672|NCT02029443|50462341|FG000|Overall Study|Withdrawal by Subject|3|||
25206673|NCT02029443|50462342|FG001|Overall Study|Withdrawal by Subject|1|||
25206674|NCT02029443|50462343|FG002|Overall Study|Withdrawal by Subject|1|||
25206675|NCT02029443|50462344|FG003|Overall Study|Withdrawal by Subject|1|||
25206676|NCT02029443|50462345|FG004|Overall Study|Withdrawal by Subject|0|||
25206677|NCT02029443|50462341|FG000|Overall Study|Other|6|||
25206678|NCT02029443|50462342|FG001|Overall Study|Other|6|||
25206679|NCT02029443|50462343|FG002|Overall Study|Other|4|||
25206680|NCT02029443|50462344|FG003|Overall Study|Other|2|||
25206681|NCT02029443|50462345|FG004|Overall Study|Other|0|||
25206682|NCT02265510|50462596|FG000|Overall Study|Withdrawal by Subject|1|||
25206683|NCT02265510|50462597|FG001|Overall Study|Withdrawal by Subject|1|||
25206684|NCT02265510|50462598|FG002|Overall Study|Withdrawal by Subject|2|||
25206685|NCT02265510|50462599|FG003|Overall Study|Withdrawal by Subject|1|||
25206686|NCT02265510|50462600|FG004|Overall Study|Withdrawal by Subject|0|||
25206687|NCT02265510|50462601|FG005|Overall Study|Withdrawal by Subject|2|||
25206688|NCT02265510|50462602|FG006|Overall Study|Withdrawal by Subject|0|||
25206689|NCT02265510|50462603|FG007|Overall Study|Withdrawal by Subject|2|||
25077136|NCT02466386|50184986|FG000|Overall Study|Lack of Efficacy|8|||
25206690|NCT02265510|50462604|FG008|Overall Study|Withdrawal by Subject|0|||
25206691|NCT02265510|50462605|FG009|Overall Study|Withdrawal by Subject|0|||
25206692|NCT02265510|50462606|FG010|Overall Study|Withdrawal by Subject|0|||
25206693|NCT02265510|50462607|FG011|Overall Study|Withdrawal by Subject|0|||
25206694|NCT02265510|50462608|FG012|Overall Study|Withdrawal by Subject|1|||
25206695|NCT02265510|50462609|FG013|Overall Study|Withdrawal by Subject|0|||
25077137|NCT02466386|50184986|FG000|Overall Study|Other|10|||
25206696|NCT02265510|50462596|FG000|Overall Study|Disease Progression|0|||
25206697|NCT02265510|50462597|FG001|Overall Study|Disease Progression|1|||
25206698|NCT02265510|50462598|FG002|Overall Study|Disease Progression|2|||
25206699|NCT02265510|50462599|FG003|Overall Study|Disease Progression|1|||
25206700|NCT02265510|50462600|FG004|Overall Study|Disease Progression|1|||
25206701|NCT02265510|50462601|FG005|Overall Study|Disease Progression|0|||
25206702|NCT02265510|50462602|FG006|Overall Study|Disease Progression|0|||
25206703|NCT02265510|50462603|FG007|Overall Study|Disease Progression|0|||
25206704|NCT02265510|50462604|FG008|Overall Study|Disease Progression|0|||
25206705|NCT02265510|50462605|FG009|Overall Study|Disease Progression|0|||
25206706|NCT02265510|50462606|FG010|Overall Study|Disease Progression|0|||
25206707|NCT02265510|50462607|FG011|Overall Study|Disease Progression|0|||
25206708|NCT02265510|50462608|FG012|Overall Study|Disease Progression|0|||
25206709|NCT02265510|50462609|FG013|Overall Study|Disease Progression|0|||
25206710|NCT02265510|50462596|FG000|Overall Study|Death|2|||
25206711|NCT02265510|50462597|FG001|Overall Study|Death|0|||
25206712|NCT02265510|50462598|FG002|Overall Study|Death|2|||
25206713|NCT02265510|50462599|FG003|Overall Study|Death|2|||
25206714|NCT02265510|50462600|FG004|Overall Study|Death|1|||
25206715|NCT02265510|50462601|FG005|Overall Study|Death|3|||
25206716|NCT02265510|50462602|FG006|Overall Study|Death|2|||
25206717|NCT02265510|50462603|FG007|Overall Study|Death|1|||
25206718|NCT02265510|50462604|FG008|Overall Study|Death|3|||
25206719|NCT02265510|50462605|FG009|Overall Study|Death|3|||
25206720|NCT02265510|50462606|FG010|Overall Study|Death|4|||
25206721|NCT02265510|50462607|FG011|Overall Study|Death|12|||
25206722|NCT02265510|50462608|FG012|Overall Study|Death|7|||
25206723|NCT02265510|50462609|FG013|Overall Study|Death|6|||
25206724|NCT02265510|50462596|FG000|Overall Study|Lost to Follow-up|0|||
25206725|NCT02265510|50462597|FG001|Overall Study|Lost to Follow-up|0|||
25206726|NCT02265510|50462598|FG002|Overall Study|Lost to Follow-up|0|||
25206727|NCT02265510|50462599|FG003|Overall Study|Lost to Follow-up|0|||
25206728|NCT02265510|50462600|FG004|Overall Study|Lost to Follow-up|1|||
25206729|NCT02265510|50462601|FG005|Overall Study|Lost to Follow-up|0|||
25206730|NCT02265510|50462602|FG006|Overall Study|Lost to Follow-up|0|||
25206731|NCT02265510|50462603|FG007|Overall Study|Lost to Follow-up|0|||
25206732|NCT02265510|50462604|FG008|Overall Study|Lost to Follow-up|0|||
25206733|NCT02265510|50462605|FG009|Overall Study|Lost to Follow-up|2|||
25206734|NCT02265510|50462606|FG010|Overall Study|Lost to Follow-up|0|||
25206735|NCT02265510|50462607|FG011|Overall Study|Lost to Follow-up|0|||
25206736|NCT02265510|50462608|FG012|Overall Study|Lost to Follow-up|0|||
25206737|NCT02265510|50462609|FG013|Overall Study|Lost to Follow-up|2|||
25206738|NCT02265510|50462596|FG000|Overall Study|Other|0|||
25206739|NCT02265510|50462597|FG001|Overall Study|Other|1|||
25206740|NCT02265510|50462598|FG002|Overall Study|Other|0|||
25206741|NCT02265510|50462599|FG003|Overall Study|Other|0|||
25206742|NCT02265510|50462600|FG004|Overall Study|Other|0|||
25206743|NCT02265510|50462601|FG005|Overall Study|Other|0|||
25206744|NCT02265510|50462602|FG006|Overall Study|Other|0|||
25206745|NCT02265510|50462603|FG007|Overall Study|Other|0|||
25206746|NCT02265510|50462604|FG008|Overall Study|Other|0|||
25206747|NCT02265510|50462605|FG009|Overall Study|Other|0|||
25206748|NCT02265510|50462606|FG010|Overall Study|Other|0|||
25206749|NCT02265510|50462607|FG011|Overall Study|Other|0|||
25206750|NCT02265510|50462608|FG012|Overall Study|Other|0|||
25206751|NCT02265510|50462609|FG013|Overall Study|Other|0|||
25206752|NCT02265510|50462596|FG000|Overall Study|Study Terminated by Sponsor|0|||
25206753|NCT02265510|50462597|FG001|Overall Study|Study Terminated by Sponsor|0|||
25206754|NCT02265510|50462598|FG002|Overall Study|Study Terminated by Sponsor|0|||
25206755|NCT02265510|50462599|FG003|Overall Study|Study Terminated by Sponsor|0|||
25206756|NCT02265510|50462600|FG004|Overall Study|Study Terminated by Sponsor|0|||
25206757|NCT02265510|50462601|FG005|Overall Study|Study Terminated by Sponsor|1|||
25206758|NCT02265510|50462602|FG006|Overall Study|Study Terminated by Sponsor|1|||
25206759|NCT02265510|50462603|FG007|Overall Study|Study Terminated by Sponsor|1|||
25206760|NCT02265510|50462604|FG008|Overall Study|Study Terminated by Sponsor|1|||
25206761|NCT02265510|50462605|FG009|Overall Study|Study Terminated by Sponsor|2|||
25206762|NCT02265510|50462606|FG010|Overall Study|Study Terminated by Sponsor|1|||
25206763|NCT02265510|50462607|FG011|Overall Study|Study Terminated by Sponsor|4|||
25206764|NCT02265510|50462608|FG012|Overall Study|Study Terminated by Sponsor|1|||
25206765|NCT02265510|50462609|FG013|Overall Study|Study Terminated by Sponsor|2|||
25206766|NCT01238211|50462710|FG000|Overall Study|Continues active treatment|31|||
25206767|NCT01238211|50462710|FG000|Overall Study|Adverse Event|7|||
25206768|NCT01238211|50462710|FG000|Overall Study|Death|4|||
25206769|NCT01238211|50462710|FG000|Overall Study|Relapse/Progression|2|||
25206770|NCT01238211|50462710|FG000|Overall Study|Withdrawal by Subject|7|||
25206771|NCT01238211|50462710|FG000|Overall Study|Non-protocol treatment|4|||
25206772|NCT01238211|50462710|FG000|Overall Study|Investigator/Patient Decision|3|||
25206773|NCT02264574|50462886|FG000|Overall Study|Death|21|||
25206774|NCT02264574|50462887|FG001|Overall Study|Death|21|||
25206775|NCT02264574|50462886|FG000|Overall Study|Withdrawal by Subject|8|||
25206776|NCT02264574|50462887|FG001|Overall Study|Withdrawal by Subject|6|||
25206777|NCT02264574|50462886|FG000|Overall Study|Other, Not Specified|0|||
25206778|NCT02264574|50462887|FG001|Overall Study|Other, Not Specified|3|||
25206779|NCT01641900|50462927|FG000|Overall Study|Withdrawal by Subject|2|||
25206780|NCT01641900|50462928|FG001|Overall Study|Withdrawal by Subject|2|||
25206781|NCT01640808|50463001|FG000|Overall Study|Unable to continue dynamic CT|14|||
25206782|NCT01640808|50463002|FG001|Overall Study|Unable to continue dynamic CT|4|||
25206783|NCT01640808|50463001|FG000|Overall Study|Withdrawal by Subject|12|||
25206784|NCT01640808|50463002|FG001|Overall Study|Withdrawal by Subject|4|||
25206785|NCT01640808|50463001|FG000|Overall Study|Lost to Follow-up|4|||
25206786|NCT01640808|50463002|FG001|Overall Study|Lost to Follow-up|0|||
25206787|NCT01640808|50463001|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
25206788|NCT01640808|50463002|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
25206789|NCT01640808|50463001|FG000|Overall Study|Administration of anticancer drugs|2|||
25206790|NCT01640808|50463002|FG001|Overall Study|Administration of anticancer drugs|1|||
25206791|NCT01640808|50463001|FG000|Overall Study|Physician Decision|19|||
25206792|NCT01640808|50463002|FG001|Overall Study|Physician Decision|5|||
25206793|NCT01640808|50463001|FG000|Overall Study|Randomized but not treated|4|||
25206794|NCT01640808|50463002|FG001|Overall Study|Randomized but not treated|2|||
25206795|NCT02263326|50463023|FG000|Overall Study|Lost to Follow-up|1|||
25206796|NCT02263326|50463024|FG001|Overall Study|Lost to Follow-up|1|||
25206797|NCT02260986|50463135|FG000|Overall Study|Adverse Event|24|||
25206798|NCT02260986|50463136|FG001|Overall Study|Adverse Event|0|||
25206799|NCT02260986|50463137|FG002|Overall Study|Adverse Event|11|||
25206800|NCT02260986|50463135|FG000|Overall Study|Lack of Efficacy|27|||
25206801|NCT02260986|50463136|FG001|Overall Study|Lack of Efficacy|3|||
25206802|NCT02260986|50463137|FG002|Overall Study|Lack of Efficacy|0|||
25206803|NCT02260986|50463135|FG000|Overall Study|Protocol Violation|14|||
25206804|NCT02260986|50463136|FG001|Overall Study|Protocol Violation|5|||
25206805|NCT02260986|50463137|FG002|Overall Study|Protocol Violation|16|||
25206806|NCT02260986|50463135|FG000|Overall Study|Car accident|0|||
25206807|NCT02260986|50463136|FG001|Overall Study|Car accident|0|||
25206808|NCT02260986|50463137|FG002|Overall Study|Car accident|1|||
25206809|NCT02260986|50463135|FG000|Overall Study|Withdrawal by Subject|17|||
25206810|NCT02260986|50463136|FG001|Overall Study|Withdrawal by Subject|4|||
25206811|NCT02260986|50463137|FG002|Overall Study|Withdrawal by Subject|9|||
25206812|NCT02260986|50463135|FG000|Overall Study|Incorrect randomization|0|||
25206813|NCT02260986|50463136|FG001|Overall Study|Incorrect randomization|1|||
25206814|NCT02260986|50463137|FG002|Overall Study|Incorrect randomization|0|||
25206815|NCT02260986|50463135|FG000|Overall Study|Lack of investigation product supply|2|||
25206816|NCT02260986|50463136|FG001|Overall Study|Lack of investigation product supply|0|||
25206817|NCT02260986|50463137|FG002|Overall Study|Lack of investigation product supply|1|||
25206818|NCT02260986|50463135|FG000|Overall Study|Lost to Follow-up|4|||
25206819|NCT02260986|50463136|FG001|Overall Study|Lost to Follow-up|0|||
25206820|NCT02260986|50463137|FG002|Overall Study|Lost to Follow-up|3|||
25206821|NCT02260986|50463135|FG000|Overall Study|Pregnancy|2|||
25206822|NCT02260986|50463136|FG001|Overall Study|Pregnancy|0|||
25206823|NCT02260986|50463137|FG002|Overall Study|Pregnancy|0|||
25206824|NCT02259582|50463153|FG000|Overall Study|Physician Decision|0|||
25206825|NCT02259582|50463154|FG001|Overall Study|Physician Decision|1|||
25206826|NCT02259582|50463155|FG002|Overall Study|Physician Decision|0|||
25206827|NCT02259582|50463153|FG000|Overall Study|Death|0|||
25206828|NCT02259582|50463154|FG001|Overall Study|Death|0|||
25206829|NCT02259582|50463155|FG002|Overall Study|Death|1|||
25206830|NCT02259582|50463153|FG000|Overall Study|Adverse Event|1|||
25206831|NCT02259582|50463154|FG001|Overall Study|Adverse Event|0|||
25206832|NCT02259582|50463155|FG002|Overall Study|Adverse Event|1|||
25206833|NCT02259582|50463153|FG000|Overall Study|Withdrawal by Subject|0|||
25206834|NCT02259582|50463154|FG001|Overall Study|Withdrawal by Subject|0|||
25206835|NCT02259582|50463155|FG002|Overall Study|Withdrawal by Subject|1|||
25206836|NCT02259582|50463153|FG000|Overall Study|Disease progression|14|||
25206837|NCT02259582|50463154|FG001|Overall Study|Disease progression|15|||
25206838|NCT02259582|50463155|FG002|Overall Study|Disease progression|17|||
25171699|NCT04571060|50309254|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
25171700|NCT04571060|50309253|FG000|Overall Study|Never treated migraine|47|||
25171701|NCT04571060|50309254|FG001|Overall Study|Never treated migraine|36|||
25171702|NCT04571060|50309253|FG000|Overall Study|Protocol Violation|4|||
25171703|NCT04571060|50309254|FG001|Overall Study|Protocol Violation|2|||
25171704|NCT04571060|50309253|FG000|Overall Study|Withdrawal by Subject|6|||
25171705|NCT04571060|50309254|FG001|Overall Study|Withdrawal by Subject|2|||
25171706|NCT04571060|50309253|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
25171707|NCT04571060|50309254|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
25171708|NCT04426318|50309262|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
25206839|NCT02259582|50463153|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
25206840|NCT02259582|50463154|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
25206841|NCT02259582|50463155|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
25206842|NCT03238651|50463168|FG000|Overall Study|Other|0|||
25206843|NCT03238651|50463169|FG001|Overall Study|Other|0|||
25206844|NCT03238651|50463170|FG002|Overall Study|Other|0|||
25206845|NCT03238651|50463171|FG003|Overall Study|Other|0|||
25206846|NCT03238651|50463172|FG004|Overall Study|Other|1|||
25206847|NCT03238651|50463168|FG000|Overall Study|Progressive Disease|2|||
25206848|NCT03238651|50463169|FG001|Overall Study|Progressive Disease|2|||
25206849|NCT03238651|50463170|FG002|Overall Study|Progressive Disease|2|||
25206850|NCT03238651|50463171|FG003|Overall Study|Progressive Disease|2|||
25206851|NCT03238651|50463172|FG004|Overall Study|Progressive Disease|0|||
25206852|NCT03238651|50463168|FG000|Overall Study|Withdrawal by Subject|0|||
25206853|NCT03238651|50463169|FG001|Overall Study|Withdrawal by Subject|1|||
25206854|NCT03238651|50463170|FG002|Overall Study|Withdrawal by Subject|0|||
25206855|NCT03238651|50463171|FG003|Overall Study|Withdrawal by Subject|1|||
25206856|NCT03238651|50463172|FG004|Overall Study|Withdrawal by Subject|0|||
25206857|NCT03238651|50463168|FG000|Overall Study|Adverse Event|1|||
25206858|NCT03238651|50463169|FG001|Overall Study|Adverse Event|3|||
25206859|NCT03238651|50463170|FG002|Overall Study|Adverse Event|2|||
25206860|NCT03238651|50463171|FG003|Overall Study|Adverse Event|0|||
25316037|NCT00896532|50631601|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316038|NCT00896532|50631602|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316039|NCT00896532|50631603|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316040|NCT00896532|50631604|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316041|NCT00896532|50631605|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316042|NCT00896532|50631606|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316043|NCT00896532|50631607|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316044|NCT00896532|50631608|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316045|NCT00896532|50631609|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316046|NCT00896532|50631610|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
25316047|NCT00896532|50631588|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316048|NCT00896532|50631589|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316049|NCT00896532|50631590|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316050|NCT00896532|50631591|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316051|NCT00896532|50631592|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316052|NCT00896532|50631593|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316053|NCT00896532|50631594|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316054|NCT00896532|50631595|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316055|NCT00896532|50631596|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316056|NCT00896532|50631597|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316057|NCT00896532|50631598|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
25316058|NCT00896532|50631599|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316059|NCT00896532|50631600|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
25316060|NCT00896532|50631601|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316061|NCT00896532|50631602|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316062|NCT00896532|50631603|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316063|NCT00896532|50631604|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316064|NCT00896532|50631605|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316065|NCT00896532|50631606|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316066|NCT00896532|50631607|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316067|NCT00896532|50631608|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316068|NCT00896532|50631609|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316069|NCT00896532|50631610|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
25316070|NCT00896532|50631588|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25316071|NCT00896532|50631589|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25316072|NCT00896532|50631590|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25316073|NCT00896532|50631591|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25316074|NCT00896532|50631592|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25316075|NCT00896532|50631593|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25316076|NCT00896532|50631594|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25316077|NCT00896532|50631595|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25316078|NCT00896532|50631596|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25316079|NCT00896532|50631597|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25316080|NCT00896532|50631598|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25206861|NCT03238651|50463172|FG004|Overall Study|Adverse Event|0|||
25206862|NCT05490771|50463196|FG000|Overall Study|Disease progression|18|||
25206863|NCT05490771|50463196|FG000|Overall Study|Adverse Event|3|||
25206864|NCT05490771|50463196|FG000|Overall Study|Other complicating disease|1|||
25206865|NCT05490771|50463196|FG000|Overall Study|Withdrawal by Subject|3|||
25206866|NCT05490771|50463196|FG000|Overall Study|Physician Decision|1|||
25206867|NCT05490771|50463196|FG000|Overall Study|Still on treatment|2|||
25206868|NCT05490771|50463196|FG000|Overall Study|Never start protocol therapy|5|||
25206869|NCT05490771|50463196|FG000|Overall Study|Ineligible|2|||
25206870|NCT05346055|50463200|FG000|Overall Study|Withdrawal by Subject|1|||
25206871|NCT05346055|50463200|FG000|Overall Study|Protocol Violation|1|||
25206872|NCT05346055|50463200|FG000|Overall Study|Therapist decision|1|||
25206873|NCT05211739|50463210|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
25206874|NCT05211739|50463211|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
25206875|NCT05211739|50463210|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
25206876|NCT05211739|50463211|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
25206877|NCT05211739|50463210|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
25206878|NCT05211739|50463211|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
25206879|NCT05211739|50463210|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
25206880|NCT05211739|50463211|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
25206881|NCT05085405|50463239|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
25206882|NCT05085405|50463240|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
25206883|NCT05085405|50463241|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
25206884|NCT05085405|50463242|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
25206885|NCT05085405|50463243|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
25206886|NCT05085405|50463244|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
25206887|NCT05085405|50463239|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
25206888|NCT05085405|50463240|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
25206889|NCT05085405|50463241|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
25206890|NCT05085405|50463242|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
25206891|NCT05085405|50463243|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
25206892|NCT05085405|50463244|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
25206893|NCT04932941|50463260|FG000|Overall Study|Lost to Follow-up|3|||
25206894|NCT04932941|50463261|FG001|Overall Study|Lost to Follow-up|1|||
25206895|NCT04932941|50463260|FG000|Overall Study|Withdrawal by Subject|7|||
25206896|NCT04932941|50463261|FG001|Overall Study|Withdrawal by Subject|4|||
25206897|NCT04932941|50463260|FG000|Overall Study|Other|4|||
25206898|NCT04932941|50463261|FG001|Overall Study|Other|2|||
25206899|NCT04677504|50463308|FG000|Overall Study|Death|31|||
25206900|NCT04677504|50463309|FG001|Overall Study|Death|24|||
25206901|NCT04677504|50463308|FG000|Overall Study|Progressive Disease|1|||
25206902|NCT04677504|50463309|FG001|Overall Study|Progressive Disease|0|||
25206903|NCT04677504|50463308|FG000|Overall Study|Symptomatic Deterioration|1|||
25206904|NCT04677504|50463309|FG001|Overall Study|Symptomatic Deterioration|0|||
25206905|NCT04677504|50463308|FG000|Overall Study|Withdrawal by Subject|2|||
25206906|NCT04677504|50463309|FG001|Overall Study|Withdrawal by Subject|5|||
25206907|NCT04677504|50463308|FG000|Overall Study|Ongoing in study|48|||
25206908|NCT04677504|50463309|FG001|Overall Study|Ongoing in study|50|||
25206909|NCT04662073|50463332|FG000|Overall Study|Withdrawal by Subject|1|||
25206910|NCT04662073|50463333|FG001|Overall Study|Withdrawal by Subject|0|||
25206911|NCT04656418|50463341|FG000|Overall Study|Withdrawal by Subject|1|||
25206912|NCT04656418|50463342|FG001|Overall Study|Withdrawal by Subject|3|||
25206913|NCT04622306|50463349|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
25206914|NCT04622306|50463350|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
25206915|NCT04622306|50463351|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
25206916|NCT04622306|50463352|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
25206917|NCT04622306|50463353|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
25206918|NCT04622306|50463354|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
25206919|NCT04622306|50463349|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
25206920|NCT04622306|50463350|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
25206921|NCT04622306|50463351|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
25206922|NCT04622306|50463352|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
25206923|NCT04622306|50463353|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
25206924|NCT04622306|50463354|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
25206925|NCT04614246|50463368|FG000|Overall Study|Adverse Event|0|||
25206926|NCT04614246|50463369|FG001|Overall Study|Adverse Event|1|||
25206927|NCT04614246|50463370|FG002|Overall Study|Adverse Event|1|||
25206928|NCT04614246|50463371|FG003|Overall Study|Adverse Event|2|||
25206929|NCT04614246|50463372|FG004|Overall Study|Adverse Event|1|||
25206930|NCT04614246|50463368|FG000|Overall Study|Lost to Follow-up|0|||
25206931|NCT04614246|50463369|FG001|Overall Study|Lost to Follow-up|1|||
25206932|NCT04614246|50463370|FG002|Overall Study|Lost to Follow-up|0|||
25206933|NCT04614246|50463371|FG003|Overall Study|Lost to Follow-up|1|||
25206934|NCT04614246|50463372|FG004|Overall Study|Lost to Follow-up|3|||
25206935|NCT04614246|50463368|FG000|Overall Study|Other reason|0|||
25206936|NCT04614246|50463369|FG001|Overall Study|Other reason|1|||
25206937|NCT04614246|50463370|FG002|Overall Study|Other reason|2|||
25206938|NCT04614246|50463371|FG003|Overall Study|Other reason|0|||
25206939|NCT04614246|50463372|FG004|Overall Study|Other reason|0|||
25206940|NCT04614246|50463368|FG000|Overall Study|Withdrawal by Subject|4|||
25206941|NCT04614246|50463369|FG001|Overall Study|Withdrawal by Subject|2|||
25206942|NCT04614246|50463370|FG002|Overall Study|Withdrawal by Subject|4|||
25206943|NCT04614246|50463371|FG003|Overall Study|Withdrawal by Subject|3|||
25206944|NCT04614246|50463372|FG004|Overall Study|Withdrawal by Subject|4|||
25206945|NCT04614246|50463368|FG000|Overall Study|Physician Decision|0|||
25206946|NCT04614246|50463369|FG001|Overall Study|Physician Decision|2|||
25206947|NCT04614246|50463370|FG002|Overall Study|Physician Decision|1|||
25206948|NCT04614246|50463371|FG003|Overall Study|Physician Decision|0|||
25206949|NCT04614246|50463372|FG004|Overall Study|Physician Decision|0|||
25206950|NCT04614246|50463368|FG000|Overall Study|Study terminated by sponsor|10|||
25206951|NCT04614246|50463369|FG001|Overall Study|Study terminated by sponsor|15|||
25206952|NCT04614246|50463370|FG002|Overall Study|Study terminated by sponsor|12|||
25206953|NCT04614246|50463371|FG003|Overall Study|Study terminated by sponsor|13|||
25206954|NCT04614246|50463372|FG004|Overall Study|Study terminated by sponsor|9|||
25206955|NCT04614246|50463368|FG000|Overall Study|Pregnancy|2|||
25206956|NCT04614246|50463369|FG001|Overall Study|Pregnancy|0|||
25206957|NCT04614246|50463370|FG002|Overall Study|Pregnancy|1|||
25206958|NCT04614246|50463371|FG003|Overall Study|Pregnancy|0|||
25206959|NCT04614246|50463372|FG004|Overall Study|Pregnancy|0|||
25206960|NCT04601103|50463387|FG000|Overall Study|Needed crown & cleaning|0|||
25206961|NCT04601103|50463388|FG001|Overall Study|Needed crown & cleaning|0|||
25206962|NCT04601103|50463389|FG002|Overall Study|Needed crown & cleaning|1|||
25206963|NCT04601103|50463387|FG000|Overall Study|study was terminated|18|||
25206964|NCT04601103|50463388|FG001|Overall Study|study was terminated|18|||
25206965|NCT04601103|50463389|FG002|Overall Study|study was terminated|16|||
25206966|NCT04575597|50463403|FG000|Overall Study|Death|0|||
25206967|NCT04575597|50463404|FG001|Overall Study|Death|0|||
25206968|NCT04575597|50463405|FG002|Overall Study|Death|0|||
25206969|NCT04575597|50463406|FG003|Overall Study|Death|1|||
25206970|NCT04575597|50463407|FG004|Overall Study|Death|3|||
25206971|NCT04575597|50463408|FG005|Overall Study|Death|14|||
25206972|NCT04575597|50463403|FG000|Overall Study|Lost to Follow-up|2|||
25206973|NCT04575597|50463404|FG001|Overall Study|Lost to Follow-up|1|||
25206974|NCT04575597|50463405|FG002|Overall Study|Lost to Follow-up|1|||
25206975|NCT04575597|50463406|FG003|Overall Study|Lost to Follow-up|2|||
25206976|NCT04575597|50463407|FG004|Overall Study|Lost to Follow-up|10|||
25206977|NCT04575597|50463408|FG005|Overall Study|Lost to Follow-up|8|||
25206978|NCT04575597|50463403|FG000|Overall Study|Withdrawal by Subject|2|||
25206979|NCT04575597|50463404|FG001|Overall Study|Withdrawal by Subject|2|||
25206980|NCT04575597|50463405|FG002|Overall Study|Withdrawal by Subject|4|||
25206981|NCT04575597|50463406|FG003|Overall Study|Withdrawal by Subject|2|||
25206982|NCT04575597|50463407|FG004|Overall Study|Withdrawal by Subject|25|||
25206983|NCT04575597|50463408|FG005|Overall Study|Withdrawal by Subject|28|||
25206984|NCT04575597|50463403|FG000|Overall Study|Not Recorded|0|||
25206985|NCT04575597|50463404|FG001|Overall Study|Not Recorded|0|||
25206986|NCT04575597|50463405|FG002|Overall Study|Not Recorded|0|||
25206987|NCT04575597|50463406|FG003|Overall Study|Not Recorded|0|||
25206988|NCT04575597|50463407|FG004|Overall Study|Not Recorded|0|||
25206989|NCT04575597|50463408|FG005|Overall Study|Not Recorded|2|||
25206990|NCT04575597|50463403|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
25206991|NCT04575597|50463404|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
25206992|NCT04575597|50463405|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
25206993|NCT04575597|50463406|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
25206994|NCT04575597|50463407|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
25206995|NCT04575597|50463408|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
25206996|NCT04546724|50463430|FG000|Overall Study|Withdrawal by Subject|145|||
25206997|NCT04546724|50463431|FG001|Overall Study|Withdrawal by Subject|41|||
25206998|NCT04546724|50463430|FG000|Overall Study|Adverse Event|1|||
25206999|NCT04546724|50463431|FG001|Overall Study|Adverse Event|1|||
25207000|NCT04546724|50463430|FG000|Overall Study|Lost to Follow-up|186|||
25207001|NCT04546724|50463431|FG001|Overall Study|Lost to Follow-up|63|||
25207002|NCT04546724|50463430|FG000|Overall Study|Physician Decision|8|||
25207003|NCT04546724|50463431|FG001|Overall Study|Physician Decision|2|||
25207004|NCT04546724|50463430|FG000|Overall Study|Death|2|||
25207005|NCT04546724|50463431|FG001|Overall Study|Death|1|||
25207006|NCT04546724|50463430|FG000|Overall Study|subject has been out of town|1|||
25207007|NCT04546724|50463431|FG001|Overall Study|subject has been out of town|0|||
25207008|NCT04546724|50463430|FG000|Overall Study|subject is incarcerated|2|||
25207009|NCT04546724|50463431|FG001|Overall Study|subject is incarcerated|0|||
25207010|NCT04546724|50463430|FG000|Overall Study|subject is relocating|12|||
25207011|NCT04546724|50463431|FG001|Overall Study|subject is relocating|4|||
25207012|NCT04546724|50463430|FG000|Overall Study|Subject in another study|1|||
25207013|NCT04546724|50463431|FG001|Overall Study|Subject in another study|1|||
25207014|NCT04514510|50463460|FG000|Overall Study|Lost to Follow-up|0|||
25207015|NCT04514510|50463461|FG001|Overall Study|Lost to Follow-up|1|||
25207016|NCT04514510|50463460|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
25207017|NCT04514510|50463461|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
25207018|NCT04439136|50463473|FG000|Overall Study|Ineligible|1|||
25207019|NCT04439136|50463473|FG000|Overall Study|Never Started Treatment|2|||
25207020|NCT04439136|50463473|FG000|Overall Study|Adverse Event|4|||
25207021|NCT04439136|50463473|FG000|Overall Study|Death|3|||
25207022|NCT04439136|50463473|FG000|Overall Study|Disease Progression|27|||
25207023|NCT04439136|50463473|FG000|Overall Study|Alternative Therapy|1|||
25207024|NCT04439136|50463473|FG000|Overall Study|Increased Tumor Burden|1|||
25207025|NCT04439136|50463473|FG000|Overall Study|Symptomatic Detrioration|1|||
25207026|NCT04439123|50463477|FG000|Overall Study|Adverse Event|11|||
25207027|NCT04439123|50463477|FG000|Overall Study|Death|1|||
25207028|NCT04439123|50463477|FG000|Overall Study|Disease progression|19|||
25207029|NCT04439123|50463477|FG000|Overall Study|Withdrawal by Subject|2|||
25207030|NCT04439123|50463477|FG000|Overall Study|Still on treatment|2|||
25207031|NCT04439110|50463481|FG000|Overall Study|Ineligible|2|||
25207032|NCT04439110|50463481|FG000|Overall Study|Adverse Event|4|||
25207033|NCT04439110|50463481|FG000|Overall Study|Death|2|||
25207034|NCT04439110|50463481|FG000|Overall Study|Disease proression|25|||
25207035|NCT04439110|50463481|FG000|Overall Study|Withdrawal by Subject|1|||
25207036|NCT04439110|50463481|FG000|Overall Study|Alternative therapy|1|||
25207037|NCT04439110|50463481|FG000|Overall Study|Other complicating disease|1|||
25207038|NCT04439110|50463481|FG000|Overall Study|Personal reasons|1|||
25207039|NCT04439110|50463481|FG000|Overall Study|Still on treatment|1|||
25207040|NCT04391842|50463485|FG000|Overall Study|Withdrawal by Subject|2|||
25207041|NCT04327024|50463508|FG000|Overall Study|Death|1|||
25207042|NCT04327024|50463509|FG001|Overall Study|Death|2|||
25207043|NCT04327024|50463510|FG002|Overall Study|Death|1|||
25207044|NCT04327024|50463508|FG000|Overall Study|Non-compliance with study drug|0|||
25207045|NCT04327024|50463509|FG001|Overall Study|Non-compliance with study drug|1|||
25207046|NCT04327024|50463510|FG002|Overall Study|Non-compliance with study drug|0|||
25207047|NCT04327024|50463508|FG000|Overall Study|Withdrawal by Subject|1|||
25207048|NCT04327024|50463509|FG001|Overall Study|Withdrawal by Subject|1|||
25207049|NCT04327024|50463510|FG002|Overall Study|Withdrawal by Subject|2|||
25207050|NCT04322149|50463523|FG000|Overall Study|Adverse Event|1|||
25207051|NCT04322149|50463524|FG001|Overall Study|Adverse Event|1|||
25207052|NCT04322149|50463525|FG002|Overall Study|Adverse Event|0|||
25207053|NCT04322149|50463526|FG003|Overall Study|Adverse Event|0|||
25207054|NCT04322149|50463523|FG000|Overall Study|Withdrawal by Subject|0|||
25207055|NCT04322149|50463524|FG001|Overall Study|Withdrawal by Subject|0|||
25207056|NCT04322149|50463525|FG002|Overall Study|Withdrawal by Subject|0|||
25207057|NCT04322149|50463526|FG003|Overall Study|Withdrawal by Subject|2|||
25207058|NCT04322149|50463523|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
25207059|NCT04322149|50463524|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
25207060|NCT04322149|50463525|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
25207061|NCT04322149|50463526|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
25207062|NCT04294459|50463547|FG000|Overall Study|Adverse Event|0|||
25207063|NCT04294459|50463548|FG001|Overall Study|Adverse Event|1|||
25207064|NCT04226742|50463557|FG000|Overall Study|Lost to Follow-up|16|||
24976336|NCT00092547|50065232|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
25207065|NCT04226742|50463558|FG001|Overall Study|Lost to Follow-up|13|||
25207066|NCT04226742|50463557|FG000|Overall Study|Withdrawal by Subject|5|||
25207067|NCT04226742|50463558|FG001|Overall Study|Withdrawal by Subject|3|||
25207068|NCT04194528|50463564|FG000|Overall Study|Adverse Event|1|||
25207069|NCT04146012|50463596|FG000|Overall Study|Study Terminated|30|||
25207070|NCT04146012|50463597|FG001|Overall Study|Study Terminated|15|||
25207071|NCT04105842|50463603|FG000|Overall Study|Withdrawal by Subject|2|||
25207072|NCT04085458|50463609|FG000|Overall Study|Other|1|||
25207073|NCT04085458|50463609|FG000|Overall Study|Withdrawal by Subject|2|||
25207074|NCT04085458|50463609|FG000|Overall Study|Adverse Event|2|||
25207075|NCT04033159|50463615|FG000|Washout Period|Physician Decision|0|||
25207076|NCT04033159|50463616|FG001|Washout Period|Physician Decision|1|||
25207077|NCT04033159|50463617|FG002|Washout Period|Physician Decision|0|||
25207078|NCT04033159|50463615|FG000|Washout Period|Study terminated by Sponsor|0|||
25207079|NCT04033159|50463616|FG001|Washout Period|Study terminated by Sponsor|7|||
25207080|NCT04033159|50463617|FG002|Washout Period|Study terminated by Sponsor|0|||
25207081|NCT04033159|50463615|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
25207082|NCT04033159|50463616|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
25207083|NCT04033159|50463617|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
25207084|NCT03969888|50463633|FG000|Overall Study|Never Received Study Drug|0|||
25207085|NCT03969888|50463634|FG001|Overall Study|Never Received Study Drug|0|||
25207086|NCT03969888|50463635|FG002|Overall Study|Never Received Study Drug|1|||
25207087|NCT03969888|50463636|FG003|Overall Study|Never Received Study Drug|0|||
25207088|NCT03969888|50463637|FG004|Overall Study|Never Received Study Drug|0|||
25207089|NCT03969888|50463638|FG005|Overall Study|Never Received Study Drug|0|||
25207090|NCT03969888|50463639|FG006|Overall Study|Never Received Study Drug|1|||
25207091|NCT03969888|50463640|FG007|Overall Study|Never Received Study Drug|0|||
25207092|NCT03969888|50463633|FG000|Overall Study|Reason Not Specified|0|||
25207093|NCT03969888|50463634|FG001|Overall Study|Reason Not Specified|0|||
25207094|NCT03969888|50463635|FG002|Overall Study|Reason Not Specified|0|||
25207095|NCT03969888|50463636|FG003|Overall Study|Reason Not Specified|0|||
25207096|NCT03969888|50463637|FG004|Overall Study|Reason Not Specified|0|||
25207097|NCT03969888|50463638|FG005|Overall Study|Reason Not Specified|0|||
25207098|NCT03969888|50463639|FG006|Overall Study|Reason Not Specified|0|||
25207099|NCT03969888|50463640|FG007|Overall Study|Reason Not Specified|1|||
25207100|NCT03952559|50463664|FG000|Double Blind Treatment Period|Adverse Event|0|||
25207101|NCT03952559|50463665|FG001|Double Blind Treatment Period|Adverse Event|2|||
25207102|NCT03952559|50463666|FG002|Double Blind Treatment Period|Adverse Event|1|||
25207103|NCT03952559|50463667|FG003|Double Blind Treatment Period|Adverse Event|0|||
25207104|NCT03952559|50463668|FG004|Double Blind Treatment Period|Adverse Event|1|||
25207105|NCT03952559|50463664|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
25207106|NCT03952559|50463665|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
25207107|NCT03952559|50463666|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
25207108|NCT03952559|50463667|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
25207109|NCT03952559|50463668|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
25207110|NCT03952559|50463664|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
25207111|NCT03952559|50463665|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
25207112|NCT03952559|50463666|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
25207113|NCT03952559|50463667|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
25207114|NCT03952559|50463668|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
25207115|NCT03952559|50463664|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
25207116|NCT03952559|50463665|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
25207117|NCT03952559|50463666|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
25207118|NCT03952559|50463667|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
25207119|NCT03952559|50463668|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
25207120|NCT03945175|50463704|FG000|Overall Study|Did not meet inclusion criteria|31|||
25207121|NCT03945175|50463704|FG000|Overall Study|Withdrew consent|2|||
25207122|NCT03945175|50463704|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
25207123|NCT03945175|50463704|FG000|Overall Study|Early termination during Mydayis treatment|1|||
25207124|NCT03942406|50463715|FG000|Overall Study|Lost to Follow-up|4|||
25207125|NCT03942406|50463716|FG001|Overall Study|Lost to Follow-up|5|||
25207126|NCT03942406|50463717|FG002|Overall Study|Lost to Follow-up|3|||
25207127|NCT03942406|50463718|FG003|Overall Study|Lost to Follow-up|7|||
25207128|NCT03942406|50463719|FG004|Overall Study|Lost to Follow-up|1|||
25207129|NCT03942406|50463720|FG005|Overall Study|Lost to Follow-up|0|||
25207130|NCT03942406|50463721|FG006|Overall Study|Lost to Follow-up|0|||
25207131|NCT03942406|50463715|FG000|Overall Study|Withdrawal by Subject|3|||
25207132|NCT03942406|50463716|FG001|Overall Study|Withdrawal by Subject|1|||
25207133|NCT03942406|50463717|FG002|Overall Study|Withdrawal by Subject|1|||
25207134|NCT03942406|50463718|FG003|Overall Study|Withdrawal by Subject|3|||
25207135|NCT03942406|50463719|FG004|Overall Study|Withdrawal by Subject|0|||
25207136|NCT03942406|50463720|FG005|Overall Study|Withdrawal by Subject|0|||
25207137|NCT03942406|50463721|FG006|Overall Study|Withdrawal by Subject|0|||
25207138|NCT03942406|50463715|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
25207139|NCT03942406|50463716|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
25207140|NCT03942406|50463717|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
25207141|NCT03942406|50463718|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
25207142|NCT03942406|50463719|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
25207143|NCT03942406|50463720|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
25207144|NCT03942406|50463721|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
25207145|NCT03909100|50463755|FG000|Overall Study|Protocol Deviation|2|||
25207146|NCT03909100|50463755|FG000|Overall Study|Technical Problems|4|||
25207147|NCT03909100|50463755|FG000|Overall Study|Withdrawal by Subject|4|||
25207148|NCT03909100|50463755|FG000|Overall Study|Lost to Follow-up|1|||
25207149|NCT03909100|50463755|FG000|Overall Study|Reason not Specified|4|||
25207150|NCT03896295|50463777|FG000|Overall Study|Adverse Event|0|||
25207151|NCT03896295|50463778|FG001|Overall Study|Adverse Event|1|||
25207152|NCT03896295|50463777|FG000|Overall Study|COVID-19|7|||
25207153|NCT03896295|50463778|FG001|Overall Study|COVID-19|29|||
25207154|NCT03816332|50463822|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
25207155|NCT03816332|50463822|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
25207156|NCT03734666|50463834|FG000|Overall Study|Other|7|||
25207157|NCT03734666|50463835|FG001|Overall Study|Other|4|||
25207158|NCT03734666|50463834|FG000|Overall Study|Lost to Follow-up|12|||
25207159|NCT03734666|50463835|FG001|Overall Study|Lost to Follow-up|12|||
25207160|NCT03635489|50463848|FG000|Overall Study|Death|6|||
25207161|NCT03635489|50463849|FG001|Overall Study|Death|3|||
25207162|NCT03635489|50463848|FG000|Overall Study|Lost to Follow-up|0|||
25207163|NCT03635489|50463849|FG001|Overall Study|Lost to Follow-up|1|||
25207164|NCT03635489|50463848|FG000|Overall Study|Withdrawal by Subject|1|||
25207165|NCT03635489|50463849|FG001|Overall Study|Withdrawal by Subject|2|||
25207166|NCT03633617|50463860|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
25207167|NCT03633617|50463861|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
25207168|NCT03633617|50463862|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
25207169|NCT03633617|50463863|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
25207170|NCT03633617|50463864|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
25207171|NCT03633617|50463865|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
25207172|NCT03633617|50463866|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
25207173|NCT03633617|50463867|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
25207174|NCT03633617|50463868|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
25207175|NCT03633617|50463869|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
25207176|NCT03633617|50463870|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
25207177|NCT03633617|50463860|FG000|Part A|Unconfirmed early termination visit|1|||
25207178|NCT03633617|50463861|FG001|Part A|Unconfirmed early termination visit|0|||
25207179|NCT03633617|50463862|FG002|Part A|Unconfirmed early termination visit|0|||
25207180|NCT03633617|50463863|FG003|Part A|Unconfirmed early termination visit|0|||
25207181|NCT03633617|50463864|FG004|Part A|Unconfirmed early termination visit|0|||
25207182|NCT03633617|50463865|FG005|Part A|Unconfirmed early termination visit|0|||
25207183|NCT03633617|50463866|FG006|Part A|Unconfirmed early termination visit|0|||
25207184|NCT03633617|50463867|FG007|Part A|Unconfirmed early termination visit|0|||
25207185|NCT03633617|50463868|FG008|Part A|Unconfirmed early termination visit|0|||
25207186|NCT03633617|50463869|FG009|Part A|Unconfirmed early termination visit|0|||
25207187|NCT03633617|50463870|FG010|Part A|Unconfirmed early termination visit|0|||
25207188|NCT03633617|50463860|FG000|Part A|Adverse Event|0|||
25207189|NCT03633617|50463861|FG001|Part A|Adverse Event|1|||
25207190|NCT03633617|50463862|FG002|Part A|Adverse Event|0|||
25207191|NCT03633617|50463863|FG003|Part A|Adverse Event|0|||
25207192|NCT03633617|50463864|FG004|Part A|Adverse Event|0|||
25207193|NCT03633617|50463865|FG005|Part A|Adverse Event|0|||
25207194|NCT03633617|50463866|FG006|Part A|Adverse Event|0|||
25207195|NCT03633617|50463867|FG007|Part A|Adverse Event|0|||
25207196|NCT03633617|50463868|FG008|Part A|Adverse Event|0|||
25207197|NCT03633617|50463869|FG009|Part A|Adverse Event|0|||
25207198|NCT03633617|50463870|FG010|Part A|Adverse Event|0|||
25207199|NCT03633617|50463860|FG000|Part A|Pregnancy|1|||
25207200|NCT03633617|50463861|FG001|Part A|Pregnancy|0|||
25207201|NCT03633617|50463862|FG002|Part A|Pregnancy|0|||
25207202|NCT03633617|50463863|FG003|Part A|Pregnancy|0|||
25207203|NCT03633617|50463864|FG004|Part A|Pregnancy|0|||
25207204|NCT03633617|50463865|FG005|Part A|Pregnancy|0|||
25207205|NCT03633617|50463866|FG006|Part A|Pregnancy|0|||
25207206|NCT03633617|50463867|FG007|Part A|Pregnancy|0|||
25207207|NCT03633617|50463868|FG008|Part A|Pregnancy|0|||
25207208|NCT03633617|50463869|FG009|Part A|Pregnancy|0|||
25207209|NCT03633617|50463870|FG010|Part A|Pregnancy|0|||
25207210|NCT03633617|50463860|FG000|Part A|Withdrawal by Subject|0|||
25207211|NCT03633617|50463861|FG001|Part A|Withdrawal by Subject|1|||
25207212|NCT03633617|50463862|FG002|Part A|Withdrawal by Subject|0|||
25207213|NCT03633617|50463863|FG003|Part A|Withdrawal by Subject|0|||
25207214|NCT03633617|50463864|FG004|Part A|Withdrawal by Subject|0|||
25207215|NCT03633617|50463865|FG005|Part A|Withdrawal by Subject|0|||
24976337|NCT00092547|50065233|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
25207216|NCT03633617|50463866|FG006|Part A|Withdrawal by Subject|0|||
25207217|NCT03633617|50463867|FG007|Part A|Withdrawal by Subject|0|||
25207218|NCT03633617|50463868|FG008|Part A|Withdrawal by Subject|0|||
25207219|NCT03633617|50463869|FG009|Part A|Withdrawal by Subject|0|||
25207220|NCT03633617|50463870|FG010|Part A|Withdrawal by Subject|0|||
25207221|NCT03633617|50463860|FG000|Part B|Adverse Event|0|||
25207222|NCT03633617|50463861|FG001|Part B|Adverse Event|0|||
25207223|NCT03633617|50463862|FG002|Part B|Adverse Event|2|||
25207224|NCT03633617|50463863|FG003|Part B|Adverse Event|2|||
25207225|NCT03633617|50463864|FG004|Part B|Adverse Event|1|||
25207226|NCT03633617|50463865|FG005|Part B|Adverse Event|0|||
25207227|NCT03633617|50463866|FG006|Part B|Adverse Event|0|||
25207228|NCT03633617|50463867|FG007|Part B|Adverse Event|0|||
25207229|NCT03633617|50463868|FG008|Part B|Adverse Event|0|||
25207230|NCT03633617|50463869|FG009|Part B|Adverse Event|0|||
25207231|NCT03633617|50463870|FG010|Part B|Adverse Event|0|||
25207232|NCT03633617|50463860|FG000|Part B|Withdrawal by Subject|0|||
25207233|NCT03633617|50463861|FG001|Part B|Withdrawal by Subject|0|||
25207234|NCT03633617|50463862|FG002|Part B|Withdrawal by Subject|1|||
25207235|NCT03633617|50463863|FG003|Part B|Withdrawal by Subject|0|||
25207236|NCT03633617|50463864|FG004|Part B|Withdrawal by Subject|2|||
25207237|NCT03633617|50463865|FG005|Part B|Withdrawal by Subject|0|||
25207238|NCT03633617|50463866|FG006|Part B|Withdrawal by Subject|0|||
25207239|NCT03633617|50463867|FG007|Part B|Withdrawal by Subject|0|||
25207240|NCT03633617|50463868|FG008|Part B|Withdrawal by Subject|0|||
25207241|NCT03633617|50463869|FG009|Part B|Withdrawal by Subject|0|||
25207242|NCT03633617|50463870|FG010|Part B|Withdrawal by Subject|0|||
25207243|NCT03633617|50463860|FG000|Part B|Lost to Follow-up|0|||
25207244|NCT03633617|50463861|FG001|Part B|Lost to Follow-up|0|||
25207245|NCT03633617|50463862|FG002|Part B|Lost to Follow-up|0|||
25207246|NCT03633617|50463863|FG003|Part B|Lost to Follow-up|0|||
25207247|NCT03633617|50463864|FG004|Part B|Lost to Follow-up|1|||
25207248|NCT03633617|50463865|FG005|Part B|Lost to Follow-up|0|||
25207249|NCT03633617|50463866|FG006|Part B|Lost to Follow-up|0|||
25207250|NCT03633617|50463867|FG007|Part B|Lost to Follow-up|0|||
25207251|NCT03633617|50463868|FG008|Part B|Lost to Follow-up|0|||
25207252|NCT03633617|50463869|FG009|Part B|Lost to Follow-up|0|||
25207253|NCT03633617|50463870|FG010|Part B|Lost to Follow-up|0|||
25207254|NCT03633617|50463860|FG000|Part B|Physician Decision|0|||
25207255|NCT03633617|50463861|FG001|Part B|Physician Decision|0|||
25207256|NCT03633617|50463862|FG002|Part B|Physician Decision|0|||
25207257|NCT03633617|50463863|FG003|Part B|Physician Decision|0|||
25207258|NCT03633617|50463864|FG004|Part B|Physician Decision|1|||
25207259|NCT03633617|50463865|FG005|Part B|Physician Decision|0|||
25207260|NCT03633617|50463866|FG006|Part B|Physician Decision|0|||
25207261|NCT03633617|50463867|FG007|Part B|Physician Decision|0|||
25207262|NCT03633617|50463868|FG008|Part B|Physician Decision|0|||
25207263|NCT03633617|50463869|FG009|Part B|Physician Decision|0|||
25207264|NCT03633617|50463870|FG010|Part B|Physician Decision|0|||
25207265|NCT03633617|50463860|FG000|Part B|COVID-19 Restrictions|0|||
25207266|NCT03633617|50463861|FG001|Part B|COVID-19 Restrictions|0|||
25207267|NCT03633617|50463862|FG002|Part B|COVID-19 Restrictions|1|||
25207268|NCT03633617|50463863|FG003|Part B|COVID-19 Restrictions|0|||
25207269|NCT03633617|50463864|FG004|Part B|COVID-19 Restrictions|0|||
25207270|NCT03633617|50463865|FG005|Part B|COVID-19 Restrictions|0|||
25207271|NCT03633617|50463866|FG006|Part B|COVID-19 Restrictions|0|||
25207272|NCT03633617|50463867|FG007|Part B|COVID-19 Restrictions|0|||
25207273|NCT03633617|50463868|FG008|Part B|COVID-19 Restrictions|0|||
25207274|NCT03633617|50463869|FG009|Part B|COVID-19 Restrictions|0|||
25207275|NCT03633617|50463870|FG010|Part B|COVID-19 Restrictions|0|||
25207276|NCT03633617|50463860|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
25207277|NCT03633617|50463861|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
25207278|NCT03633617|50463862|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
25207279|NCT03633617|50463863|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
25207280|NCT03633617|50463864|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
25207281|NCT03633617|50463865|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
25207282|NCT03633617|50463866|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
25207283|NCT03633617|50463867|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
25207284|NCT03633617|50463868|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
25207285|NCT03633617|50463869|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
25207286|NCT03633617|50463870|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
25207287|NCT03633617|50463860|FG000|Part C (& Follow-up)|Adverse Event|0|||
25207288|NCT03633617|50463861|FG001|Part C (& Follow-up)|Adverse Event|0|||
25207289|NCT03633617|50463862|FG002|Part C (& Follow-up)|Adverse Event|0|||
25207290|NCT03633617|50463863|FG003|Part C (& Follow-up)|Adverse Event|0|||
25207291|NCT03633617|50463864|FG004|Part C (& Follow-up)|Adverse Event|0|||
25207292|NCT03633617|50463865|FG005|Part C (& Follow-up)|Adverse Event|1|||
25207293|NCT03633617|50463866|FG006|Part C (& Follow-up)|Adverse Event|0|||
25207294|NCT03633617|50463867|FG007|Part C (& Follow-up)|Adverse Event|1|||
25207295|NCT03633617|50463868|FG008|Part C (& Follow-up)|Adverse Event|0|||
25207296|NCT03633617|50463869|FG009|Part C (& Follow-up)|Adverse Event|0|||
25207297|NCT03633617|50463870|FG010|Part C (& Follow-up)|Adverse Event|0|||
25207298|NCT03633617|50463860|FG000|Part C (& Follow-up)|Pregnancy|0|||
25207299|NCT03633617|50463861|FG001|Part C (& Follow-up)|Pregnancy|0|||
25207300|NCT03633617|50463862|FG002|Part C (& Follow-up)|Pregnancy|0|||
25207301|NCT03633617|50463863|FG003|Part C (& Follow-up)|Pregnancy|0|||
25207302|NCT03633617|50463864|FG004|Part C (& Follow-up)|Pregnancy|0|||
25207303|NCT03633617|50463865|FG005|Part C (& Follow-up)|Pregnancy|0|||
25207304|NCT03633617|50463866|FG006|Part C (& Follow-up)|Pregnancy|0|||
25207305|NCT03633617|50463867|FG007|Part C (& Follow-up)|Pregnancy|0|||
25207306|NCT03633617|50463868|FG008|Part C (& Follow-up)|Pregnancy|0|||
25207307|NCT03633617|50463869|FG009|Part C (& Follow-up)|Pregnancy|1|||
25207308|NCT03633617|50463870|FG010|Part C (& Follow-up)|Pregnancy|0|||
25207309|NCT03633617|50463860|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
25207310|NCT03633617|50463861|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
25207311|NCT03633617|50463862|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
25207312|NCT03633617|50463863|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
25207313|NCT03633617|50463864|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
25207314|NCT03633617|50463865|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
25207315|NCT03633617|50463866|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
25207316|NCT03633617|50463867|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
25207317|NCT03633617|50463868|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
25207318|NCT03633617|50463869|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
25207319|NCT03633617|50463870|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
25207320|NCT03633617|50463860|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
25207321|NCT03633617|50463861|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
25207322|NCT03633617|50463862|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
25207323|NCT03633617|50463863|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
25207324|NCT03633617|50463864|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
25207325|NCT03633617|50463865|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
25207326|NCT03633617|50463866|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
25207327|NCT03633617|50463867|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
25207328|NCT03633617|50463868|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
25207329|NCT03633617|50463869|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
25207330|NCT03633617|50463870|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
25207331|NCT03633617|50463860|FG000|Part C (& Follow-up)|Physician Decision|0|||
25207332|NCT03633617|50463861|FG001|Part C (& Follow-up)|Physician Decision|0|||
25207333|NCT03633617|50463862|FG002|Part C (& Follow-up)|Physician Decision|0|||
25207334|NCT03633617|50463863|FG003|Part C (& Follow-up)|Physician Decision|0|||
25207335|NCT03633617|50463864|FG004|Part C (& Follow-up)|Physician Decision|0|||
25207336|NCT03633617|50463865|FG005|Part C (& Follow-up)|Physician Decision|0|||
25207337|NCT03633617|50463866|FG006|Part C (& Follow-up)|Physician Decision|0|||
25207338|NCT03633617|50463867|FG007|Part C (& Follow-up)|Physician Decision|1|||
25207339|NCT03633617|50463868|FG008|Part C (& Follow-up)|Physician Decision|0|||
25207340|NCT03633617|50463869|FG009|Part C (& Follow-up)|Physician Decision|0|||
25207341|NCT03633617|50463870|FG010|Part C (& Follow-up)|Physician Decision|1|||
25207342|NCT03633617|50463860|FG000|Part C (& Follow-up)|COVID-19 related|0|||
25207343|NCT03633617|50463861|FG001|Part C (& Follow-up)|COVID-19 related|0|||
25207344|NCT03633617|50463862|FG002|Part C (& Follow-up)|COVID-19 related|0|||
25207345|NCT03633617|50463863|FG003|Part C (& Follow-up)|COVID-19 related|0|||
25207346|NCT03633617|50463864|FG004|Part C (& Follow-up)|COVID-19 related|0|||
25207347|NCT03633617|50463865|FG005|Part C (& Follow-up)|COVID-19 related|1|||
25207348|NCT03633617|50463866|FG006|Part C (& Follow-up)|COVID-19 related|0|||
25207349|NCT03633617|50463867|FG007|Part C (& Follow-up)|COVID-19 related|0|||
25207350|NCT03633617|50463868|FG008|Part C (& Follow-up)|COVID-19 related|0|||
25207351|NCT03633617|50463869|FG009|Part C (& Follow-up)|COVID-19 related|0|||
25207352|NCT03633617|50463870|FG010|Part C (& Follow-up)|COVID-19 related|0|||
25207353|NCT03633617|50463860|FG000|Part C (& Follow-up)|Protocol Violation|0|||
25207354|NCT03633617|50463861|FG001|Part C (& Follow-up)|Protocol Violation|0|||
25207355|NCT03633617|50463862|FG002|Part C (& Follow-up)|Protocol Violation|0|||
25207356|NCT03633617|50463863|FG003|Part C (& Follow-up)|Protocol Violation|0|||
25207357|NCT03633617|50463864|FG004|Part C (& Follow-up)|Protocol Violation|0|||
25207358|NCT03633617|50463865|FG005|Part C (& Follow-up)|Protocol Violation|0|||
25207359|NCT03633617|50463866|FG006|Part C (& Follow-up)|Protocol Violation|0|||
25207360|NCT03633617|50463867|FG007|Part C (& Follow-up)|Protocol Violation|0|||
25207361|NCT03633617|50463868|FG008|Part C (& Follow-up)|Protocol Violation|0|||
25207362|NCT03633617|50463869|FG009|Part C (& Follow-up)|Protocol Violation|3|||
25207363|NCT03633617|50463870|FG010|Part C (& Follow-up)|Protocol Violation|1|||
25207364|NCT03633617|50463860|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
25207365|NCT03633617|50463861|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
25207366|NCT03633617|50463862|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
25207367|NCT03633617|50463863|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
24976338|NCT00092547|50065234|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
25207368|NCT03633617|50463864|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
25207369|NCT03633617|50463865|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
25207370|NCT03633617|50463866|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
25207371|NCT03633617|50463867|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
25207372|NCT03633617|50463868|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
25207373|NCT03633617|50463869|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
25207374|NCT03633617|50463870|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
25207375|NCT03631784|50463900|FG000|Overall Study|Death|48|||
25207376|NCT03631784|50463901|FG001|Overall Study|Death|28|||
25207377|NCT03631784|50463900|FG000|Overall Study|Lost to Follow-up|1|||
25207378|NCT03631784|50463901|FG001|Overall Study|Lost to Follow-up|0|||
25207379|NCT03631784|50463900|FG000|Overall Study|Withdrawal by Subject|0|||
25207380|NCT03631784|50463901|FG001|Overall Study|Withdrawal by Subject|3|||
25207381|NCT03631784|50463900|FG000|Overall Study|Participants Ongoing|63|||
25207382|NCT03631784|50463901|FG001|Overall Study|Participants Ongoing|71|||
25207383|NCT03617705|50463907|FG000|Overall Study|Withdrawal by Subject|2|||
25207384|NCT03617705|50463907|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
25207385|NCT03617705|50463907|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
25207386|NCT03607422|50463917|FG000|Overall Study|Adverse Event|7|||
25207387|NCT03607422|50463918|FG001|Overall Study|Adverse Event|3|||
25207388|NCT03607422|50463919|FG002|Overall Study|Adverse Event|2|||
25207389|NCT03607422|50463920|FG003|Overall Study|Adverse Event|0|||
25207390|NCT03607422|50463921|FG004|Overall Study|Adverse Event|2|||
25207391|NCT03607422|50463922|FG005|Overall Study|Adverse Event|0|||
25207392|NCT03607422|50463917|FG000|Overall Study|Withdrawal by Subject|11|||
25207393|NCT03607422|50463918|FG001|Overall Study|Withdrawal by Subject|3|||
25207394|NCT03607422|50463919|FG002|Overall Study|Withdrawal by Subject|6|||
25207395|NCT03607422|50463920|FG003|Overall Study|Withdrawal by Subject|2|||
25207396|NCT03607422|50463921|FG004|Overall Study|Withdrawal by Subject|0|||
25207397|NCT03607422|50463922|FG005|Overall Study|Withdrawal by Subject|0|||
25207398|NCT03607422|50463917|FG000|Overall Study|Lost to Follow-up|0|||
25207399|NCT03607422|50463918|FG001|Overall Study|Lost to Follow-up|0|||
25207400|NCT03607422|50463919|FG002|Overall Study|Lost to Follow-up|1|||
25207401|NCT03607422|50463920|FG003|Overall Study|Lost to Follow-up|0|||
25207402|NCT03607422|50463921|FG004|Overall Study|Lost to Follow-up|0|||
25207403|NCT03607422|50463922|FG005|Overall Study|Lost to Follow-up|0|||
25207404|NCT03607422|50463917|FG000|Overall Study|Other|12|||
25207405|NCT03607422|50463918|FG001|Overall Study|Other|4|||
25207406|NCT03607422|50463919|FG002|Overall Study|Other|1|||
25207407|NCT03607422|50463920|FG003|Overall Study|Other|2|||
25207408|NCT03607422|50463921|FG004|Overall Study|Other|0|||
25207409|NCT03607422|50463922|FG005|Overall Study|Other|2|||
25207410|NCT03607422|50463917|FG000|Overall Study|Ongoing at Time of Analysis|8|||
25207411|NCT03607422|50463918|FG001|Overall Study|Ongoing at Time of Analysis|0|||
25207412|NCT03607422|50463919|FG002|Overall Study|Ongoing at Time of Analysis|2|||
25207413|NCT03607422|50463920|FG003|Overall Study|Ongoing at Time of Analysis|1|||
25207414|NCT03607422|50463921|FG004|Overall Study|Ongoing at Time of Analysis|1|||
25207415|NCT03607422|50463922|FG005|Overall Study|Ongoing at Time of Analysis|1|||
25207416|NCT03568318|50463960|FG000|Overall Study|Adverse Event|3|||
25207417|NCT03568318|50463961|FG001|Overall Study|Adverse Event|1|||
25207418|NCT03568318|50463962|FG002|Overall Study|Adverse Event|1|||
25207419|NCT03568318|50463963|FG003|Overall Study|Adverse Event|0|||
25207420|NCT03568318|50463964|FG004|Overall Study|Adverse Event|1|||
25207421|NCT03568318|50463965|FG005|Overall Study|Adverse Event|0|||
25207422|NCT03568318|50463960|FG000|Overall Study|Withdrawal by Subject|6|||
25207423|NCT03568318|50463961|FG001|Overall Study|Withdrawal by Subject|5|||
25207424|NCT03568318|50463962|FG002|Overall Study|Withdrawal by Subject|2|||
25207425|NCT03568318|50463963|FG003|Overall Study|Withdrawal by Subject|1|||
25207426|NCT03568318|50463964|FG004|Overall Study|Withdrawal by Subject|0|||
25207427|NCT03568318|50463965|FG005|Overall Study|Withdrawal by Subject|0|||
25207428|NCT03568318|50463960|FG000|Overall Study|Lost to Follow-up|3|||
25207429|NCT03568318|50463961|FG001|Overall Study|Lost to Follow-up|2|||
25207430|NCT03568318|50463962|FG002|Overall Study|Lost to Follow-up|2|||
25207431|NCT03568318|50463963|FG003|Overall Study|Lost to Follow-up|2|||
25207432|NCT03568318|50463964|FG004|Overall Study|Lost to Follow-up|1|||
25207433|NCT03568318|50463965|FG005|Overall Study|Lost to Follow-up|0|||
25316081|NCT00896532|50631599|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25207434|NCT03568318|50463960|FG000|Overall Study|Other|3|||
25207435|NCT03568318|50463961|FG001|Overall Study|Other|1|||
25207436|NCT03568318|50463962|FG002|Overall Study|Other|3|||
25207437|NCT03568318|50463963|FG003|Overall Study|Other|0|||
25207438|NCT03568318|50463964|FG004|Overall Study|Other|0|||
25207439|NCT03568318|50463965|FG005|Overall Study|Other|0|||
25207440|NCT03568318|50463960|FG000|Overall Study|Ongoing at Time of Analysis|5|||
25207441|NCT03568318|50463961|FG001|Overall Study|Ongoing at Time of Analysis|3|||
25207442|NCT03568318|50463962|FG002|Overall Study|Ongoing at Time of Analysis|2|||
25207443|NCT03568318|50463963|FG003|Overall Study|Ongoing at Time of Analysis|1|||
25207444|NCT03568318|50463964|FG004|Overall Study|Ongoing at Time of Analysis|0|||
25207445|NCT03568318|50463965|FG005|Overall Study|Ongoing at Time of Analysis|0|||
25207446|NCT03550794|50463981|FG000|Overall Study|No longer met inclusion criteria|1|||
25207447|NCT03550794|50463982|FG001|Overall Study|No longer met inclusion criteria|2|||
25207448|NCT03550794|50463981|FG000|Overall Study|Goals of care changed|1|||
25207449|NCT03550794|50463982|FG001|Overall Study|Goals of care changed|0|||
25207450|NCT03550794|50463981|FG000|Overall Study|Withdrawal by Subject|2|||
25207451|NCT03550794|50463982|FG001|Overall Study|Withdrawal by Subject|0|||
25207452|NCT03550794|50463981|FG000|Overall Study|Death|0|||
25207453|NCT03550794|50463982|FG001|Overall Study|Death|1|||
25207454|NCT03459846|50464007|FG000|Overall Study|Death|52|||
25207455|NCT03459846|50464008|FG001|Overall Study|Death|46|||
25207456|NCT03459846|50464007|FG000|Overall Study|Study terminated by sponsor|24|||
25207457|NCT03459846|50464008|FG001|Overall Study|Study terminated by sponsor|28|||
25207458|NCT03459846|50464007|FG000|Overall Study|Withdrawal by Subject|2|||
25207459|NCT03459846|50464008|FG001|Overall Study|Withdrawal by Subject|2|||
25207460|NCT03427125|50464034|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
25207461|NCT03427125|50464035|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
25207462|NCT03427125|50464036|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
25207463|NCT03341273|50464051|FG000|Overall Study|Lost to Follow-up|7|||
25207464|NCT03341273|50464052|FG001|Overall Study|Lost to Follow-up|7|||
25207465|NCT03341273|50464051|FG000|Overall Study|Withdrawal by Subject|4|||
25207466|NCT03341273|50464052|FG001|Overall Study|Withdrawal by Subject|2|||
25207467|NCT03341273|50464051|FG000|Overall Study|Physician Decision|1|||
25207468|NCT03341273|50464052|FG001|Overall Study|Physician Decision|0|||
25207469|NCT03341273|50464051|FG000|Overall Study|Protocol Violation|0|||
25207470|NCT03341273|50464052|FG001|Overall Study|Protocol Violation|1|||
25207471|NCT03341273|50464051|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
25207472|NCT03341273|50464052|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
25207473|NCT03341273|50464051|FG000|Overall Study|Became ineligible after enrollment|1|||
25207474|NCT03341273|50464052|FG001|Overall Study|Became ineligible after enrollment|0|||
25207475|NCT03341273|50464051|FG000|Overall Study|Not Eligible at Enrollment|0|||
25207476|NCT03341273|50464052|FG001|Overall Study|Not Eligible at Enrollment|1|||
25207477|NCT03341273|50464051|FG000|Overall Study|Participant incarcerated|1|||
25207478|NCT03341273|50464052|FG001|Overall Study|Participant incarcerated|0|||
25207479|NCT03307785|50464069|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
25207480|NCT03307785|50464070|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
25207481|NCT03307785|50464071|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
25207482|NCT03307785|50464072|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
25207483|NCT03307785|50464073|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
25207484|NCT03307785|50464074|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
25207485|NCT03307785|50464075|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
25207486|NCT03307785|50464076|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
25207487|NCT03307785|50464077|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
25207488|NCT03307785|50464078|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
25207489|NCT03307785|50464079|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
24976339|NCT00092547|50065232|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
24976340|NCT00092547|50065233|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
24976341|NCT00092547|50065234|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
25207490|NCT03307785|50464069|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
25207491|NCT03307785|50464070|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
25207492|NCT03307785|50464071|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
25207493|NCT03307785|50464072|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
25207494|NCT03307785|50464073|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
25207495|NCT03307785|50464074|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
25207496|NCT03307785|50464075|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
25207497|NCT03307785|50464076|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
25207498|NCT03307785|50464077|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
25207499|NCT03307785|50464078|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
25207500|NCT03307785|50464079|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
25207501|NCT03307785|50464069|FG000|Part A: Up to 28.5 Months|Death|4|||
25207502|NCT03307785|50464070|FG001|Part A: Up to 28.5 Months|Death|4|||
25207503|NCT03307785|50464071|FG002|Part A: Up to 28.5 Months|Death|0|||
25207504|NCT03307785|50464072|FG003|Part A: Up to 28.5 Months|Death|0|||
25207505|NCT03307785|50464073|FG004|Part A: Up to 28.5 Months|Death|0|||
25207506|NCT03307785|50464074|FG005|Part A: Up to 28.5 Months|Death|0|||
25207507|NCT03307785|50464075|FG006|Part A: Up to 28.5 Months|Death|0|||
25207508|NCT03307785|50464076|FG007|Part A: Up to 28.5 Months|Death|0|||
25207509|NCT03307785|50464077|FG008|Part A: Up to 28.5 Months|Death|0|||
25207510|NCT03307785|50464078|FG009|Part A: Up to 28.5 Months|Death|0|||
25207511|NCT03307785|50464079|FG010|Part A: Up to 28.5 Months|Death|0|||
25207512|NCT03307785|50464069|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
25207513|NCT03307785|50464070|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
25207514|NCT03307785|50464071|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
25207515|NCT03307785|50464072|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
25207516|NCT03307785|50464073|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
25207517|NCT03307785|50464074|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
25207518|NCT03307785|50464075|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
25207519|NCT03307785|50464076|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
25207520|NCT03307785|50464077|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
25207521|NCT03307785|50464078|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
25207522|NCT03307785|50464079|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
25207523|NCT03307785|50464069|FG000|Part B: Up to 28.5 Months|Disease progression|0|||
25207524|NCT03307785|50464070|FG001|Part B: Up to 28.5 Months|Disease progression|0|||
25207525|NCT03307785|50464071|FG002|Part B: Up to 28.5 Months|Disease progression|1|||
25207526|NCT03307785|50464072|FG003|Part B: Up to 28.5 Months|Disease progression|0|||
25207527|NCT03307785|50464073|FG004|Part B: Up to 28.5 Months|Disease progression|0|||
25207528|NCT03307785|50464074|FG005|Part B: Up to 28.5 Months|Disease progression|0|||
25207529|NCT03307785|50464075|FG006|Part B: Up to 28.5 Months|Disease progression|0|||
25207530|NCT03307785|50464076|FG007|Part B: Up to 28.5 Months|Disease progression|0|||
25207531|NCT03307785|50464077|FG008|Part B: Up to 28.5 Months|Disease progression|0|||
25207532|NCT03307785|50464078|FG009|Part B: Up to 28.5 Months|Disease progression|0|||
25207533|NCT03307785|50464079|FG010|Part B: Up to 28.5 Months|Disease progression|0|||
25207534|NCT03307785|50464069|FG000|Part B: Up to 28.5 Months|Physician Decision|0|||
25207535|NCT03307785|50464070|FG001|Part B: Up to 28.5 Months|Physician Decision|0|||
25207536|NCT03307785|50464071|FG002|Part B: Up to 28.5 Months|Physician Decision|1|||
25207537|NCT03307785|50464072|FG003|Part B: Up to 28.5 Months|Physician Decision|0|||
25207538|NCT03307785|50464073|FG004|Part B: Up to 28.5 Months|Physician Decision|0|||
25207539|NCT03307785|50464074|FG005|Part B: Up to 28.5 Months|Physician Decision|0|||
25207540|NCT03307785|50464075|FG006|Part B: Up to 28.5 Months|Physician Decision|0|||
25207541|NCT03307785|50464076|FG007|Part B: Up to 28.5 Months|Physician Decision|0|||
25207542|NCT03307785|50464077|FG008|Part B: Up to 28.5 Months|Physician Decision|0|||
25207543|NCT03307785|50464078|FG009|Part B: Up to 28.5 Months|Physician Decision|0|||
25207544|NCT03307785|50464079|FG010|Part B: Up to 28.5 Months|Physician Decision|0|||
25207545|NCT03307785|50464069|FG000|Part B: Up to 28.5 Months|Death|0|||
25207546|NCT03307785|50464070|FG001|Part B: Up to 28.5 Months|Death|0|||
25207547|NCT03307785|50464071|FG002|Part B: Up to 28.5 Months|Death|7|||
25207548|NCT03307785|50464072|FG003|Part B: Up to 28.5 Months|Death|0|||
25207549|NCT03307785|50464073|FG004|Part B: Up to 28.5 Months|Death|0|||
25207550|NCT03307785|50464074|FG005|Part B: Up to 28.5 Months|Death|0|||
25207551|NCT03307785|50464075|FG006|Part B: Up to 28.5 Months|Death|0|||
25207552|NCT03307785|50464076|FG007|Part B: Up to 28.5 Months|Death|0|||
25207553|NCT03307785|50464077|FG008|Part B: Up to 28.5 Months|Death|0|||
25207554|NCT03307785|50464078|FG009|Part B: Up to 28.5 Months|Death|0|||
25207555|NCT03307785|50464079|FG010|Part B: Up to 28.5 Months|Death|0|||
25207556|NCT03307785|50464069|FG000|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
25207557|NCT03307785|50464070|FG001|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
25207558|NCT03307785|50464071|FG002|Part B: Up to 28.5 Months|Withdrawal by Subject|1|||
25207559|NCT03307785|50464072|FG003|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
25207560|NCT03307785|50464073|FG004|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
25207561|NCT03307785|50464074|FG005|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
25207562|NCT03307785|50464075|FG006|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
25207563|NCT03307785|50464076|FG007|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
25207564|NCT03307785|50464077|FG008|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
25207565|NCT03307785|50464078|FG009|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
25207566|NCT03307785|50464079|FG010|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
25207567|NCT03307785|50464069|FG000|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
25207568|NCT03307785|50464070|FG001|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
25207569|NCT03307785|50464071|FG002|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|4|||
25207570|NCT03307785|50464072|FG003|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
25207571|NCT03307785|50464073|FG004|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
25207572|NCT03307785|50464074|FG005|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
25207573|NCT03307785|50464075|FG006|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
25207574|NCT03307785|50464076|FG007|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
25207575|NCT03307785|50464077|FG008|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
25207576|NCT03307785|50464078|FG009|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
25207577|NCT03307785|50464079|FG010|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
25207578|NCT03307785|50464069|FG000|Part C: Up to 22.5 Months|Disease progression|0|||
25207579|NCT03307785|50464070|FG001|Part C: Up to 22.5 Months|Disease progression|0|||
25207580|NCT03307785|50464071|FG002|Part C: Up to 22.5 Months|Disease progression|0|||
25207581|NCT03307785|50464072|FG003|Part C: Up to 22.5 Months|Disease progression|0|||
25207582|NCT03307785|50464073|FG004|Part C: Up to 22.5 Months|Disease progression|1|||
25207583|NCT03307785|50464074|FG005|Part C: Up to 22.5 Months|Disease progression|0|||
25207584|NCT03307785|50464075|FG006|Part C: Up to 22.5 Months|Disease progression|0|||
25207585|NCT03307785|50464076|FG007|Part C: Up to 22.5 Months|Disease progression|0|||
25207586|NCT03307785|50464077|FG008|Part C: Up to 22.5 Months|Disease progression|0|||
25207587|NCT03307785|50464078|FG009|Part C: Up to 22.5 Months|Disease progression|0|||
25207588|NCT03307785|50464079|FG010|Part C: Up to 22.5 Months|Disease progression|0|||
25316082|NCT00896532|50631600|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
25207589|NCT03307785|50464069|FG000|Part C: Up to 22.5 Months|Physician Decision|0|||
25207590|NCT03307785|50464070|FG001|Part C: Up to 22.5 Months|Physician Decision|0|||
25207591|NCT03307785|50464071|FG002|Part C: Up to 22.5 Months|Physician Decision|0|||
25207592|NCT03307785|50464072|FG003|Part C: Up to 22.5 Months|Physician Decision|3|||
25207593|NCT03307785|50464073|FG004|Part C: Up to 22.5 Months|Physician Decision|1|||
25207594|NCT03307785|50464074|FG005|Part C: Up to 22.5 Months|Physician Decision|0|||
25207595|NCT03307785|50464075|FG006|Part C: Up to 22.5 Months|Physician Decision|0|||
25207596|NCT03307785|50464076|FG007|Part C: Up to 22.5 Months|Physician Decision|0|||
25207597|NCT03307785|50464077|FG008|Part C: Up to 22.5 Months|Physician Decision|0|||
25207598|NCT03307785|50464078|FG009|Part C: Up to 22.5 Months|Physician Decision|0|||
25207599|NCT03307785|50464079|FG010|Part C: Up to 22.5 Months|Physician Decision|0|||
25207600|NCT03307785|50464069|FG000|Part C: Up to 22.5 Months|Death|0|||
25207601|NCT03307785|50464070|FG001|Part C: Up to 22.5 Months|Death|0|||
25207602|NCT03307785|50464071|FG002|Part C: Up to 22.5 Months|Death|0|||
25207603|NCT03307785|50464072|FG003|Part C: Up to 22.5 Months|Death|1|||
25207604|NCT03307785|50464073|FG004|Part C: Up to 22.5 Months|Death|4|||
25207605|NCT03307785|50464074|FG005|Part C: Up to 22.5 Months|Death|0|||
25207606|NCT03307785|50464075|FG006|Part C: Up to 22.5 Months|Death|0|||
25207607|NCT03307785|50464076|FG007|Part C: Up to 22.5 Months|Death|0|||
25207608|NCT03307785|50464077|FG008|Part C: Up to 22.5 Months|Death|0|||
25207609|NCT03307785|50464078|FG009|Part C: Up to 22.5 Months|Death|0|||
25207610|NCT03307785|50464079|FG010|Part C: Up to 22.5 Months|Death|0|||
25207611|NCT03307785|50464069|FG000|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
25207612|NCT03307785|50464070|FG001|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
25207613|NCT03307785|50464071|FG002|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
25207614|NCT03307785|50464072|FG003|Part C: Up to 22.5 Months|Withdrawal by Subject|1|||
25207615|NCT03307785|50464073|FG004|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
25207616|NCT03307785|50464074|FG005|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
25207617|NCT03307785|50464075|FG006|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
25207618|NCT03307785|50464076|FG007|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
25207619|NCT03307785|50464077|FG008|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
25207620|NCT03307785|50464078|FG009|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
25207621|NCT03307785|50464079|FG010|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
25207622|NCT03307785|50464069|FG000|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
25207623|NCT03307785|50464070|FG001|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
25207624|NCT03307785|50464071|FG002|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
25207625|NCT03307785|50464072|FG003|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
25207626|NCT03307785|50464073|FG004|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
25207627|NCT03307785|50464074|FG005|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
25207628|NCT03307785|50464075|FG006|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
25207629|NCT03307785|50464076|FG007|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
25207630|NCT03307785|50464077|FG008|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
25207631|NCT03307785|50464078|FG009|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
25207632|NCT03307785|50464079|FG010|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
25207633|NCT03307785|50464069|FG000|Part D: Up to 9.5 Months|Physician Decision|0|||
25207634|NCT03307785|50464070|FG001|Part D: Up to 9.5 Months|Physician Decision|0|||
25207635|NCT03307785|50464071|FG002|Part D: Up to 9.5 Months|Physician Decision|0|||
25207636|NCT03307785|50464072|FG003|Part D: Up to 9.5 Months|Physician Decision|0|||
25207637|NCT03307785|50464073|FG004|Part D: Up to 9.5 Months|Physician Decision|0|||
25207638|NCT03307785|50464074|FG005|Part D: Up to 9.5 Months|Physician Decision|1|||
25207639|NCT03307785|50464075|FG006|Part D: Up to 9.5 Months|Physician Decision|0|||
25207640|NCT03307785|50464076|FG007|Part D: Up to 9.5 Months|Physician Decision|0|||
25207641|NCT03307785|50464077|FG008|Part D: Up to 9.5 Months|Physician Decision|0|||
25207642|NCT03307785|50464078|FG009|Part D: Up to 9.5 Months|Physician Decision|0|||
25207643|NCT03307785|50464079|FG010|Part D: Up to 9.5 Months|Physician Decision|0|||
25207644|NCT03307785|50464069|FG000|Part D: Up to 9.5 Months|Death|0|||
25207645|NCT03307785|50464070|FG001|Part D: Up to 9.5 Months|Death|0|||
25207646|NCT03307785|50464071|FG002|Part D: Up to 9.5 Months|Death|0|||
25207647|NCT03307785|50464072|FG003|Part D: Up to 9.5 Months|Death|0|||
25207648|NCT03307785|50464073|FG004|Part D: Up to 9.5 Months|Death|0|||
25207649|NCT03307785|50464074|FG005|Part D: Up to 9.5 Months|Death|1|||
25207650|NCT03307785|50464075|FG006|Part D: Up to 9.5 Months|Death|0|||
25207651|NCT03307785|50464076|FG007|Part D: Up to 9.5 Months|Death|0|||
25207652|NCT03307785|50464077|FG008|Part D: Up to 9.5 Months|Death|0|||
25207653|NCT03307785|50464078|FG009|Part D: Up to 9.5 Months|Death|0|||
25207654|NCT03307785|50464079|FG010|Part D: Up to 9.5 Months|Death|0|||
25207655|NCT03307785|50464069|FG000|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
25207656|NCT03307785|50464070|FG001|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
25207657|NCT03307785|50464071|FG002|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
25207658|NCT03307785|50464072|FG003|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
25207659|NCT03307785|50464073|FG004|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
25207660|NCT03307785|50464074|FG005|Part D: Up to 9.5 Months|Withdrawal by Subject|1|||
25207661|NCT03307785|50464075|FG006|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
25207662|NCT03307785|50464076|FG007|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
25207663|NCT03307785|50464077|FG008|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
25207664|NCT03307785|50464078|FG009|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
25207665|NCT03307785|50464079|FG010|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
25207666|NCT03307785|50464069|FG000|Part E: Up to 4.4 Months|Death|0|||
25207667|NCT03307785|50464070|FG001|Part E: Up to 4.4 Months|Death|0|||
25207668|NCT03307785|50464071|FG002|Part E: Up to 4.4 Months|Death|0|||
25207669|NCT03307785|50464072|FG003|Part E: Up to 4.4 Months|Death|0|||
25207670|NCT03307785|50464073|FG004|Part E: Up to 4.4 Months|Death|0|||
25207671|NCT03307785|50464074|FG005|Part E: Up to 4.4 Months|Death|0|||
25207672|NCT03307785|50464075|FG006|Part E: Up to 4.4 Months|Death|1|||
25207673|NCT03307785|50464076|FG007|Part E: Up to 4.4 Months|Death|0|||
25207674|NCT03307785|50464077|FG008|Part E: Up to 4.4 Months|Death|0|||
25207675|NCT03307785|50464078|FG009|Part E: Up to 4.4 Months|Death|0|||
25207676|NCT03307785|50464079|FG010|Part E: Up to 4.4 Months|Death|0|||
25207677|NCT03307785|50464069|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
25207678|NCT03307785|50464070|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
25207679|NCT03307785|50464071|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
25207680|NCT03307785|50464072|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
25207681|NCT03307785|50464073|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
25207682|NCT03307785|50464074|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
25207683|NCT03307785|50464075|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
25207684|NCT03307785|50464076|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
25207685|NCT03307785|50464077|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
25207686|NCT03307785|50464078|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
25207687|NCT03307785|50464079|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
25207688|NCT03307785|50464069|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
25207689|NCT03307785|50464070|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
25207690|NCT03307785|50464071|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
25207691|NCT03307785|50464072|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
25207692|NCT03307785|50464073|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
25207693|NCT03307785|50464074|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
25207694|NCT03307785|50464075|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
25207695|NCT03307785|50464076|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
25207696|NCT03307785|50464077|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
25207697|NCT03307785|50464078|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
25207698|NCT03307785|50464079|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
25207699|NCT03284710|50464104|FG000|Overall Study|Withdrawal by Subject|1|||
25207700|NCT03284710|50464105|FG001|Overall Study|Withdrawal by Subject|0|||
25207701|NCT03284710|50464106|FG002|Overall Study|Withdrawal by Subject|1|||
25207702|NCT03284710|50464107|FG003|Overall Study|Withdrawal by Subject|6|||
25207703|NCT03284710|50464104|FG000|Overall Study|Lost to Follow-up|3|||
25207704|NCT03284710|50464105|FG001|Overall Study|Lost to Follow-up|3|||
25207705|NCT03284710|50464106|FG002|Overall Study|Lost to Follow-up|1|||
25207706|NCT03284710|50464107|FG003|Overall Study|Lost to Follow-up|0|||
25207707|NCT03284710|50464104|FG000|Overall Study|Physician Decision|1|||
25207708|NCT03284710|50464105|FG001|Overall Study|Physician Decision|0|||
25207709|NCT03284710|50464106|FG002|Overall Study|Physician Decision|0|||
25207710|NCT03284710|50464107|FG003|Overall Study|Physician Decision|0|||
25207711|NCT03284710|50464104|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
25207712|NCT03284710|50464105|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
25207713|NCT03284710|50464106|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
25207714|NCT03284710|50464107|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
25207715|NCT03284710|50464104|FG000|Overall Study|HIV Infection|0|||
25207716|NCT03284710|50464105|FG001|Overall Study|HIV Infection|2|||
25207717|NCT03284710|50464106|FG002|Overall Study|HIV Infection|2|||
25207718|NCT03284710|50464107|FG003|Overall Study|HIV Infection|1|||
25207719|NCT03248167|50464126|FG000|Overall Study|Withdrawal by Subject|2|||
25207720|NCT03248167|50464127|FG001|Overall Study|Withdrawal by Subject|2|||
25207721|NCT03248167|50464126|FG000|Overall Study|Physician Decision|0|||
25207722|NCT03248167|50464127|FG001|Overall Study|Physician Decision|1|||
25207723|NCT03248167|50464126|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
25207724|NCT03248167|50464127|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
25207725|NCT03248167|50464126|FG000|Overall Study|Lost to Follow-up|1|||
25207726|NCT03248167|50464127|FG001|Overall Study|Lost to Follow-up|0|||
25207727|NCT03220737|50464141|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
25207728|NCT03220737|50464142|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
25207729|NCT03220737|50464143|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
25207730|NCT03220737|50464144|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
25207731|NCT03220737|50464145|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
25207732|NCT03220737|50464146|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
25207733|NCT03220737|50464147|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
25207734|NCT03220737|50464141|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
25207735|NCT03220737|50464142|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
25207736|NCT03220737|50464143|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
25207737|NCT03220737|50464144|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
25207738|NCT03220737|50464145|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
25207739|NCT03220737|50464146|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
25207740|NCT03220737|50464147|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
25207741|NCT03220737|50464141|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
25207742|NCT03220737|50464142|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
25207743|NCT03220737|50464143|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
25207744|NCT03220737|50464144|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
25207745|NCT03220737|50464145|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
25207746|NCT03220737|50464146|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
25207747|NCT03220737|50464147|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
25207748|NCT03220737|50464141|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
25207749|NCT03220737|50464142|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
25207750|NCT03220737|50464143|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
25207751|NCT03220737|50464144|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
25207752|NCT03220737|50464145|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
25207753|NCT03220737|50464146|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
25207754|NCT03220737|50464147|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
25207755|NCT03220737|50464141|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
25207756|NCT03220737|50464142|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
25207757|NCT03220737|50464143|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
25207758|NCT03220737|50464144|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
25207759|NCT03220737|50464145|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
25207760|NCT03220737|50464146|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
25207761|NCT03220737|50464147|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
25207762|NCT03220737|50464141|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
25207763|NCT03220737|50464142|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
25207764|NCT03220737|50464143|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
25207765|NCT03220737|50464144|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
25207766|NCT03220737|50464145|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
25207767|NCT03220737|50464146|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
25207768|NCT03220737|50464147|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
25207769|NCT03220737|50464141|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
25207770|NCT03220737|50464142|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
25207771|NCT03220737|50464143|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
25207772|NCT03220737|50464144|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
25207773|NCT03220737|50464145|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
25207774|NCT03220737|50464146|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
25207775|NCT03220737|50464147|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
25207776|NCT03220737|50464141|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
25207777|NCT03220737|50464142|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
25207778|NCT03220737|50464143|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
25207779|NCT03220737|50464144|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
25207780|NCT03220737|50464145|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
25207781|NCT03220737|50464146|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
25207782|NCT03220737|50464147|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
25207783|NCT03198728|50464171|FG000|Overall Study|Adverse Event|10|||
25207784|NCT03198728|50464172|FG001|Overall Study|Adverse Event|5|||
25207785|NCT03198728|50464171|FG000|Overall Study|Lost to Follow-up|21|||
25207786|NCT03198728|50464172|FG001|Overall Study|Lost to Follow-up|7|||
25207787|NCT03198728|50464171|FG000|Overall Study|Physician Decision|7|||
25207788|NCT03198728|50464172|FG001|Overall Study|Physician Decision|2|||
25207789|NCT03198728|50464171|FG000|Overall Study|Withdrawal by Subject|14|||
25207790|NCT03198728|50464172|FG001|Overall Study|Withdrawal by Subject|10|||
25207791|NCT03144804|50464204|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
25207792|NCT03142334|50464210|FG000|Overall Study|Death|18|||
25207793|NCT03142334|50464211|FG001|Overall Study|Death|33|||
25207794|NCT03142334|50464210|FG000|Overall Study|Withdrawal by Subject|15|||
25207795|NCT03142334|50464211|FG001|Overall Study|Withdrawal by Subject|11|||
25207796|NCT03142334|50464210|FG000|Overall Study|Ongoing on trial follow up|463|||
25207797|NCT03142334|50464211|FG001|Overall Study|Ongoing on trial follow up|454|||
25207798|NCT03126539|50464219|FG000|Overall Study|Lost to Follow-up|1|||
25207799|NCT03126539|50464220|FG001|Overall Study|Lost to Follow-up|1|||
25207800|NCT03126539|50464221|FG002|Overall Study|Lost to Follow-up|1|||
25207801|NCT03126539|50464222|FG003|Overall Study|Lost to Follow-up|0|||
25207802|NCT03126539|50464223|FG004|Overall Study|Lost to Follow-up|0|||
25207803|NCT03123250|50464236|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
25207804|NCT03099096|50464240|FG000|Overall Study|Adverse Event|1|||
25207805|NCT03099096|50464240|FG000|Overall Study|Physician Decision|1|||
25207806|NCT03096782|50464244|FG000|Overall Study|Death|1|||
25207807|NCT03096782|50464244|FG000|Overall Study|Participant Relapsed|1|||
25207808|NCT03064126|50464252|FG000|Overall Study|Death|6|||
25207809|NCT03064126|50464253|FG001|Overall Study|Death|2|||
25207810|NCT03064126|50464254|FG002|Overall Study|Death|2|||
25207811|NCT03064126|50464255|FG003|Overall Study|Death|1|||
25207812|NCT03064126|50464252|FG000|Overall Study|Investigator Discretion|1|||
25207813|NCT03064126|50464253|FG001|Overall Study|Investigator Discretion|0|||
25207814|NCT03064126|50464254|FG002|Overall Study|Investigator Discretion|0|||
25207815|NCT03064126|50464255|FG003|Overall Study|Investigator Discretion|0|||
25207816|NCT03064126|50464252|FG000|Overall Study|Withdrawal by Subject|7|||
25207817|NCT03064126|50464253|FG001|Overall Study|Withdrawal by Subject|4|||
25207818|NCT03064126|50464254|FG002|Overall Study|Withdrawal by Subject|0|||
25207819|NCT03064126|50464255|FG003|Overall Study|Withdrawal by Subject|0|||
25207820|NCT03064126|50464252|FG000|Overall Study|Subject moved|1|||
25207821|NCT03064126|50464253|FG001|Overall Study|Subject moved|0|||
25207822|NCT03064126|50464254|FG002|Overall Study|Subject moved|0|||
25207823|NCT03064126|50464255|FG003|Overall Study|Subject moved|0|||
25207824|NCT03064126|50464252|FG000|Overall Study|Protocol Violation|11|||
25207825|NCT03064126|50464253|FG001|Overall Study|Protocol Violation|1|||
25207826|NCT03064126|50464254|FG002|Overall Study|Protocol Violation|1|||
25207827|NCT03064126|50464255|FG003|Overall Study|Protocol Violation|0|||
25207828|NCT03043664|50464266|FG000|Overall Study|Lost to Follow-up|1|||
25207829|NCT03041467|50464272|FG000|Overall Study|Death|40|||
25207830|NCT03041467|50464273|FG001|Overall Study|Death|36|||
25207831|NCT03041467|50464272|FG000|Overall Study|Withdrawal by Subject|36|||
25207832|NCT03041467|50464273|FG001|Overall Study|Withdrawal by Subject|37|||
25207833|NCT03041467|50464272|FG000|Overall Study|Lost to Follow-up|6|||
25207834|NCT03041467|50464273|FG001|Overall Study|Lost to Follow-up|7|||
25207835|NCT03041467|50464272|FG000|Overall Study|Declined consent for study extension|21|||
25207836|NCT03041467|50464273|FG001|Overall Study|Declined consent for study extension|33|||
25207837|NCT03041467|50464272|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
25207838|NCT03041467|50464273|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
25207839|NCT03041467|50464272|FG000|Overall Study|48 Month visit not completed|9|||
25207840|NCT03041467|50464273|FG001|Overall Study|48 Month visit not completed|4|||
25207841|NCT03019406|50464285|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
25207842|NCT03019406|50464286|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
25207843|NCT03019406|50464287|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
25207844|NCT03019406|50464288|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
25207845|NCT02972593|50464303|FG000|Overall Study|Lost to Follow-up|19|||
25207846|NCT02972593|50464304|FG001|Overall Study|Lost to Follow-up|15|||
25207847|NCT02972593|50464303|FG000|Overall Study|Protocol Violation|1|||
25207848|NCT02972593|50464304|FG001|Overall Study|Protocol Violation|0|||
25207849|NCT02949700|50464316|FG000|Phase I|Withdrawal by Subject|1|||
25207850|NCT02949700|50464317|FG001|Phase I|Withdrawal by Subject|1|||
25207851|NCT02949700|50464318|FG002|Phase I|Withdrawal by Subject|0|||
25207852|NCT02949700|50464319|FG003|Phase I|Withdrawal by Subject|0|||
25207853|NCT02949700|50464316|FG000|Phase I|Protocol Violation|1|||
25316083|NCT00896532|50631601|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
25171709|NCT04426318|50309263|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
25171710|NCT04356963|50309278|FG000|First Session|Withdrawal by Subject|1|||
25171711|NCT04356963|50309278|FG000|Second Session|Withdrawal by Subject|3|||
25171712|NCT04356963|50309278|FG000|Second Session|Lost to Follow-up|1|||
25171713|NCT04356963|50309278|FG000|Third Session|Lost to Follow-up|6|||
25171714|NCT04356963|50309278|FG000|Third Session|Withdrawal by Subject|1|||
25171715|NCT03941483|50309291|FG000|Overall Study|Miscellaneous|2|||
25171716|NCT03941483|50309292|FG001|Overall Study|Miscellaneous|3|||
25171717|NCT03941483|50309293|FG002|Overall Study|Miscellaneous|0|||
25171718|NCT03941483|50309291|FG000|Overall Study|Study Terminated by Sponsor|1|||
25171719|NCT03941483|50309292|FG001|Overall Study|Study Terminated by Sponsor|0|||
25207854|NCT02949700|50464317|FG001|Phase I|Protocol Violation|0|||
25207855|NCT02949700|50464318|FG002|Phase I|Protocol Violation|0|||
25207856|NCT02949700|50464319|FG003|Phase I|Protocol Violation|0|||
25207857|NCT02949700|50464316|FG000|Phase II|Withdrawal by Subject|0|||
25207858|NCT02949700|50464317|FG001|Phase II|Withdrawal by Subject|0|||
25207859|NCT02949700|50464318|FG002|Phase II|Withdrawal by Subject|0|||
25207860|NCT02949700|50464319|FG003|Phase II|Withdrawal by Subject|2|||
25207861|NCT02949700|50464316|FG000|Phase II|Protocol Violation|0|||
25207862|NCT02949700|50464317|FG001|Phase II|Protocol Violation|0|||
25207863|NCT02949700|50464318|FG002|Phase II|Protocol Violation|1|||
25207864|NCT02949700|50464319|FG003|Phase II|Protocol Violation|3|||
25207865|NCT02947087|50464330|FG000|Overall Study|Withdrawal by Subject|3|||
25207866|NCT02947087|50464331|FG001|Overall Study|Withdrawal by Subject|2|||
25207867|NCT02879448|50464343|FG000|Overall Study|No implant attempt|17|||
25207868|NCT02879448|50464344|FG001|Overall Study|No implant attempt|28|||
25207869|NCT02879448|50464343|FG000|Overall Study|Withdrawal by Subject|20|||
25207870|NCT02879448|50464344|FG001|Overall Study|Withdrawal by Subject|46|||
25207871|NCT02879448|50464343|FG000|Overall Study|Death|63|||
25207872|NCT02879448|50464344|FG001|Overall Study|Death|85|||
25207873|NCT02879448|50464343|FG000|Overall Study|Lost to Follow-up|3|||
25207874|NCT02879448|50464344|FG001|Overall Study|Lost to Follow-up|4|||
25207875|NCT02879448|50464343|FG000|Overall Study|Missing visit|34|||
25207876|NCT02879448|50464344|FG001|Overall Study|Missing visit|39|||
25207877|NCT02879448|50464343|FG000|Overall Study|Pending evaluation|1|||
25207878|NCT02879448|50464344|FG001|Overall Study|Pending evaluation|0|||
25207879|NCT02868216|50464352|FG000|Overall Study|Death|0|||
25207880|NCT02868216|50464353|FG001|Overall Study|Death|1|||
25207881|NCT02868216|50464352|FG000|Overall Study|coronary artery bypass|1|||
25207882|NCT02868216|50464353|FG001|Overall Study|coronary artery bypass|0|||
25207883|NCT02868216|50464352|FG000|Overall Study|Withdrawal by Subject|7|||
25207884|NCT02868216|50464353|FG001|Overall Study|Withdrawal by Subject|5|||
25207885|NCT02841995|50464362|FG000|Overall Study|Disease progression|5|||
25207886|NCT02841995|50464363|FG001|Overall Study|Disease progression|11|||
25207887|NCT02841995|50464364|FG002|Overall Study|Disease progression|8|||
25207888|NCT02841995|50464362|FG000|Overall Study|Withdrawal by Subject|2|||
25207889|NCT02841995|50464363|FG001|Overall Study|Withdrawal by Subject|4|||
25207890|NCT02841995|50464364|FG002|Overall Study|Withdrawal by Subject|4|||
25207891|NCT02841995|50464362|FG000|Overall Study|Adverse Event|2|||
25207892|NCT02841995|50464363|FG001|Overall Study|Adverse Event|0|||
25207893|NCT02841995|50464364|FG002|Overall Study|Adverse Event|1|||
25207894|NCT02841995|50464362|FG000|Overall Study|Investigator decision|2|||
25207895|NCT02841995|50464363|FG001|Overall Study|Investigator decision|0|||
25207896|NCT02841995|50464364|FG002|Overall Study|Investigator decision|1|||
25207897|NCT02841995|50464362|FG000|Overall Study|Death|0|||
25207898|NCT02841995|50464363|FG001|Overall Study|Death|0|||
25207899|NCT02841995|50464364|FG002|Overall Study|Death|2|||
25207900|NCT02841995|50464362|FG000|Overall Study|Noncompliance to protocol|1|||
25207901|NCT02841995|50464363|FG001|Overall Study|Noncompliance to protocol|0|||
25207902|NCT02841995|50464364|FG002|Overall Study|Noncompliance to protocol|0|||
25207903|NCT02841995|50464362|FG000|Overall Study|Sponsor decision|1|||
25207904|NCT02841995|50464363|FG001|Overall Study|Sponsor decision|0|||
25207905|NCT02841995|50464364|FG002|Overall Study|Sponsor decision|0|||
25207906|NCT02841995|50464362|FG000|Overall Study|Other|4|||
25207907|NCT02841995|50464363|FG001|Overall Study|Other|1|||
25207908|NCT02841995|50464364|FG002|Overall Study|Other|5|||
25207909|NCT02702414|50464421|FG000|Overall Study|Death|77|||
25207910|NCT02702414|50464422|FG001|Overall Study|Death|34|||
25207911|NCT02702414|50464421|FG000|Overall Study|Lost to Follow-up|0|||
25207912|NCT02702414|50464422|FG001|Overall Study|Lost to Follow-up|1|||
25207913|NCT02702414|50464421|FG000|Overall Study|Withdrawal by Subject|0|||
25207914|NCT02702414|50464422|FG001|Overall Study|Withdrawal by Subject|1|||
25207915|NCT02702414|50464421|FG000|Overall Study|Participants Ongoing in Study|27|||
25207916|NCT02702414|50464422|FG001|Overall Study|Participants Ongoing in Study|15|||
25207917|NCT02702414|50464421|FG000|Overall Study|Not Treated|1|||
25316084|NCT00896532|50631602|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25316085|NCT00896532|50631603|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25316086|NCT00896532|50631604|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25207918|NCT02702414|50464422|FG001|Overall Study|Not Treated|0|||
25207919|NCT02667587|50464432|FG000|Pre-Treatment|Not reported|1|||
25207920|NCT02667587|50464433|FG001|Pre-Treatment|Not reported|0|||
25207921|NCT02667587|50464432|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
25207922|NCT02667587|50464433|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
25207923|NCT02667587|50464432|FG000|Pre-Treatment|Participant withdrew consent|0|||
25207924|NCT02667587|50464433|FG001|Pre-Treatment|Participant withdrew consent|1|||
25207925|NCT02667587|50464432|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
25207926|NCT02667587|50464433|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
25207927|NCT02667587|50464432|FG000|End of Treatment|Other reasons|11|||
25207928|NCT02667587|50464433|FG001|End of Treatment|Other reasons|8|||
25207929|NCT02667587|50464432|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
25207930|NCT02667587|50464433|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
25207931|NCT02667587|50464432|FG000|End of Treatment|Poor/Non-Compliance|0|||
25207932|NCT02667587|50464433|FG001|End of Treatment|Poor/Non-Compliance|1|||
25207933|NCT02667587|50464432|FG000|End of Treatment|Maximum Clinical Benefit|3|||
25207934|NCT02667587|50464433|FG001|End of Treatment|Maximum Clinical Benefit|3|||
25207935|NCT02667587|50464432|FG000|End of Treatment|Participant Withdrew Consent|5|||
25207936|NCT02667587|50464433|FG001|End of Treatment|Participant Withdrew Consent|6|||
25207937|NCT02667587|50464432|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
25207938|NCT02667587|50464433|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
25207939|NCT02667587|50464432|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
25207940|NCT02667587|50464433|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
25207941|NCT02667587|50464432|FG000|End of Treatment|Death|2|||
25207942|NCT02667587|50464433|FG001|End of Treatment|Death|1|||
25207943|NCT02667587|50464432|FG000|End of Treatment|Study Drug Toxicity|74|||
25207944|NCT02667587|50464433|FG001|End of Treatment|Study Drug Toxicity|18|||
25207945|NCT02667587|50464432|FG000|End of Treatment|Disease progression|177|||
25207946|NCT02667587|50464433|FG001|End of Treatment|Disease progression|222|||
25207947|NCT02667587|50464432|FG000|End of Treatment|Lost to Follow-up|1|||
25207948|NCT02667587|50464433|FG001|End of Treatment|Lost to Follow-up|3|||
25207949|NCT02643966|50464439|FG000|First Screening Round|ineligible|1|||
25207950|NCT02643966|50464439|FG000|First Screening Round|excluded from analysis|2|||
25207951|NCT02643966|50464439|FG000|First Screening Round|Lost to Follow-up|56|||
25207952|NCT02643966|50464439|FG000|First Screening Round|Withdrawal by Subject|28|||
25207953|NCT02643966|50464439|FG000|First Screening Round|Death|1|||
25207954|NCT02643966|50464439|FG000|Between First and Second Screening|Lost to Follow-up|65|||
25207955|NCT02643966|50464439|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
25207956|NCT02643966|50464439|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
25207957|NCT02643966|50464439|FG000|Second Screening Round|Withdrawal by Subject|20|||
25207958|NCT02643966|50464439|FG000|Second Screening Round|Lost to Follow-up|57|||
25207959|NCT02643966|50464439|FG000|Second Screening Round|Physician Decision|2|||
25207960|NCT02643966|50464439|FG000|Second Screening Round|Death|4|||
25207961|NCT02643966|50464439|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
25207962|NCT02643966|50464439|FG000|Between Second and Third Screening|Death|1|||
25207963|NCT02643966|50464439|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
25207964|NCT02643966|50464439|FG000|Third Screening Round|PI excluded|2|||
25207965|NCT02643966|50464439|FG000|Third Screening Round|Lost to Follow-up|241|||
25207966|NCT02632409|50464453|FG000|Randomized|AE unrelated to study Drug|0|||
25207967|NCT02632409|50464454|FG001|Randomized|AE unrelated to study Drug|1|||
25207968|NCT02632409|50464453|FG000|Randomized|Participant withdrew consent|2|||
25207969|NCT02632409|50464454|FG001|Randomized|Participant withdrew consent|1|||
25207970|NCT02632409|50464453|FG000|Randomized|No Longer meets study criteria|5|||
25207971|NCT02632409|50464454|FG001|Randomized|No Longer meets study criteria|0|||
25207972|NCT02632409|50464453|FG000|Randomized|other reasons|1|||
25207973|NCT02632409|50464454|FG001|Randomized|other reasons|0|||
25207974|NCT02632409|50464453|FG000|Treatment Period|Ongoing Treatment|20|||
25207975|NCT02632409|50464454|FG001|Treatment Period|Ongoing Treatment|21|||
25207976|NCT02632409|50464453|FG000|Treatment Period|Disease Recurrence|147|||
25207977|NCT02632409|50464454|FG001|Treatment Period|Disease Recurrence|90|||
25207978|NCT02632409|50464453|FG000|Treatment Period|Study Drug Toxicity|8|||
25207979|NCT02632409|50464454|FG001|Treatment Period|Study Drug Toxicity|49|||
25207980|NCT02632409|50464453|FG000|Treatment Period|Death|1|||
25207981|NCT02632409|50464454|FG001|Treatment Period|Death|0|||
25207982|NCT02632409|50464453|FG000|Treatment Period|AE unrelated to study drug|15|||
25207983|NCT02632409|50464454|FG001|Treatment Period|AE unrelated to study drug|16|||
25207984|NCT02632409|50464453|FG000|Treatment Period|Request to discontinue treatment|4|||
25207985|NCT02632409|50464454|FG001|Treatment Period|Request to discontinue treatment|19|||
25207986|NCT02632409|50464453|FG000|Treatment Period|Participant withdrew consent|7|||
25207987|NCT02632409|50464454|FG001|Treatment Period|Participant withdrew consent|5|||
25207988|NCT02632409|50464453|FG000|Treatment Period|Lost to Follow-up|0|||
25207989|NCT02632409|50464454|FG001|Treatment Period|Lost to Follow-up|1|||
25207990|NCT02632409|50464453|FG000|Treatment Period|Maximum clinical benefit|1|||
25207991|NCT02632409|50464454|FG001|Treatment Period|Maximum clinical benefit|0|||
25207992|NCT02632409|50464453|FG000|Treatment Period|No longer meets study criteria|3|||
25207993|NCT02632409|50464454|FG001|Treatment Period|No longer meets study criteria|0|||
25207994|NCT02632409|50464453|FG000|Treatment Period|Administrative Reason by sponsor|0|||
25207995|NCT02632409|50464454|FG001|Treatment Period|Administrative Reason by sponsor|1|||
25207996|NCT02632409|50464453|FG000|Treatment Period|Other Reasons|10|||
25316087|NCT00896532|50631605|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25316088|NCT00896532|50631606|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25207997|NCT02632409|50464454|FG001|Treatment Period|Other Reasons|6|||
25207998|NCT02554383|50464477|FG000|Overall Study|Ineligible|3|||
25207999|NCT02554383|50464478|FG001|Overall Study|Ineligible|2|||
25208000|NCT02554383|50464477|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
25208001|NCT02554383|50464478|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
25208002|NCT02554383|50464477|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
25208003|NCT02554383|50464478|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
25208004|NCT02554383|50464477|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
25208005|NCT02554383|50464478|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
25208006|NCT02522871|50464486|FG000|Overall Study|Protocol Violation|1|||
25208007|NCT02522871|50464487|FG001|Overall Study|Protocol Violation|4|||
25208008|NCT02522871|50464486|FG000|Overall Study|Treated without randomization|1|||
25208009|NCT02522871|50464487|FG001|Overall Study|Treated without randomization|0|||
25208010|NCT02522871|50464486|FG000|Overall Study|Death|9|||
25208011|NCT02522871|50464487|FG001|Overall Study|Death|9|||
25208012|NCT02522871|50464486|FG000|Overall Study|Died in operating room prior to transplant|0|||
25208013|NCT02522871|50464487|FG001|Overall Study|Died in operating room prior to transplant|1|||
25208014|NCT02519439|50464502|FG000|Overall Study|Study Termination|19|||
25208015|NCT02519439|50464502|FG000|Overall Study|Withdrawal by Subject|1|||
25208016|NCT02519439|50464502|FG000|Overall Study|Adverse Event|1|||
25208017|NCT02500797|50464514|FG000|Overall Study|Cancel (rapid disease progression)|0|||
25208018|NCT02500797|50464515|FG001|Overall Study|Cancel (rapid disease progression)|0|||
25208019|NCT02500797|50464516|FG002|Overall Study|Cancel (rapid disease progression)|0|||
25208020|NCT02500797|50464517|FG003|Overall Study|Cancel (rapid disease progression)|0|||
25208021|NCT02500797|50464518|FG004|Overall Study|Cancel (rapid disease progression)|1|||
25208022|NCT02500797|50464519|FG005|Overall Study|Cancel (rapid disease progression)|1|||
25208023|NCT02500797|50464520|FG006|Overall Study|Cancel (rapid disease progression)|0|||
25208024|NCT02500797|50464521|FG007|Overall Study|Cancel (rapid disease progression)|0|||
25208025|NCT02500797|50464514|FG000|Overall Study|Withdrawal by Subject|1|||
25208026|NCT02500797|50464515|FG001|Overall Study|Withdrawal by Subject|0|||
25208027|NCT02500797|50464516|FG002|Overall Study|Withdrawal by Subject|0|||
25208028|NCT02500797|50464517|FG003|Overall Study|Withdrawal by Subject|0|||
25208029|NCT02500797|50464518|FG004|Overall Study|Withdrawal by Subject|0|||
25208030|NCT02500797|50464519|FG005|Overall Study|Withdrawal by Subject|0|||
25208031|NCT02500797|50464520|FG006|Overall Study|Withdrawal by Subject|0|||
25208032|NCT02500797|50464521|FG007|Overall Study|Withdrawal by Subject|0|||
25208033|NCT02147184|50464552|FG000|Overall Study|Lost to Follow-up|28|||
25208034|NCT02147184|50464553|FG001|Overall Study|Lost to Follow-up|15|||
25208035|NCT02147184|50464552|FG000|Overall Study|Study Burden|11|||
25208036|NCT02147184|50464553|FG001|Overall Study|Study Burden|7|||
25208037|NCT02147184|50464552|FG000|Overall Study|Pregnancy|6|||
25208038|NCT02147184|50464553|FG001|Overall Study|Pregnancy|0|||
25208039|NCT02147184|50464552|FG000|Overall Study|Moved out of state|3|||
25208040|NCT02147184|50464553|FG001|Overall Study|Moved out of state|3|||
25208041|NCT02147184|50464552|FG000|Overall Study|Physician Decision|0|||
25208042|NCT02147184|50464553|FG001|Overall Study|Physician Decision|2|||
25208043|NCT02147184|50464552|FG000|Overall Study|Other|1|||
25208044|NCT02147184|50464553|FG001|Overall Study|Other|0|||
25208045|NCT02101021|50464564|FG000|Overall Study|Death|4|||
25208046|NCT02101021|50464565|FG001|Overall Study|Death|3|||
25208047|NCT02101021|50464566|FG002|Overall Study|Death|6|||
25208048|NCT02101021|50464567|FG003|Overall Study|Death|0|||
25208049|NCT02101021|50464568|FG004|Overall Study|Death|3|||
25208050|NCT02101021|50464564|FG000|Overall Study|Withdrew Consent from study|1|||
25208051|NCT02101021|50464565|FG001|Overall Study|Withdrew Consent from study|1|||
25208052|NCT02101021|50464566|FG002|Overall Study|Withdrew Consent from study|0|||
25208053|NCT02101021|50464567|FG003|Overall Study|Withdrew Consent from study|2|||
25208054|NCT02101021|50464568|FG004|Overall Study|Withdrew Consent from study|0|||
25208055|NCT02101021|50464564|FG000|Overall Study|Lost to Follow-up|1|||
25208056|NCT02101021|50464565|FG001|Overall Study|Lost to Follow-up|0|||
25208057|NCT02101021|50464566|FG002|Overall Study|Lost to Follow-up|0|||
25208058|NCT02101021|50464567|FG003|Overall Study|Lost to Follow-up|0|||
25208059|NCT02101021|50464568|FG004|Overall Study|Lost to Follow-up|0|||
25208060|NCT02101021|50464564|FG000|Overall Study|Study Terminated by Sponsor|1|||
25208061|NCT02101021|50464565|FG001|Overall Study|Study Terminated by Sponsor|0|||
25208062|NCT02101021|50464566|FG002|Overall Study|Study Terminated by Sponsor|1|||
25208063|NCT02101021|50464567|FG003|Overall Study|Study Terminated by Sponsor|1|||
25208064|NCT02101021|50464568|FG004|Overall Study|Study Terminated by Sponsor|1|||
25208065|NCT02031536|50464593|FG000|Overall Study|ineligible|1|||
25208066|NCT02031536|50464594|FG001|Overall Study|ineligible|0|||
25208067|NCT02028455|50464608|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
25316089|NCT00896532|50631607|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25208068|NCT02028455|50464609|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
25208069|NCT02028455|50464610|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
25208070|NCT02028455|50464611|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
25208071|NCT02028455|50464612|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
25208072|NCT02028455|50464613|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
25208073|NCT02028455|50464614|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
25208074|NCT02028455|50464615|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
25208075|NCT02028455|50464608|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
25208076|NCT02028455|50464609|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
25208077|NCT02028455|50464610|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
25208078|NCT02028455|50464611|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
25208079|NCT02028455|50464612|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
25208080|NCT02028455|50464613|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
25208081|NCT02028455|50464614|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
25208082|NCT02028455|50464615|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
25208083|NCT02028455|50464608|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
25208084|NCT02028455|50464609|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
25208085|NCT02028455|50464610|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
25208086|NCT02028455|50464611|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
25208087|NCT02028455|50464612|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
25208088|NCT02028455|50464613|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
25208089|NCT02028455|50464614|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
25208090|NCT02028455|50464615|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
25208091|NCT02028455|50464608|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
25208092|NCT02028455|50464609|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
25208093|NCT02028455|50464610|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
25208094|NCT02028455|50464611|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
25208095|NCT02028455|50464612|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
25208096|NCT02028455|50464613|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
25208097|NCT02028455|50464614|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
25208098|NCT02028455|50464615|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
25208099|NCT02019641|50464639|FG000|10-Week Follow up|Withdrawal by investigator|2|||
25208100|NCT02019641|50464640|FG001|10-Week Follow up|Withdrawal by investigator|0|||
25208101|NCT02019641|50464641|FG002|10-Week Follow up|Withdrawal by investigator|0|||
25208102|NCT02019641|50464639|FG000|10-Week Follow up|Withdrawal by Subject|1|||
25208103|NCT02019641|50464640|FG001|10-Week Follow up|Withdrawal by Subject|1|||
25208104|NCT02019641|50464641|FG002|10-Week Follow up|Withdrawal by Subject|0|||
25208105|NCT02019641|50464639|FG000|20-Week Follow up|Withdrawal by investigator|0|||
25208106|NCT02019641|50464640|FG001|20-Week Follow up|Withdrawal by investigator|0|||
25208107|NCT02019641|50464641|FG002|20-Week Follow up|Withdrawal by investigator|1|||
25208108|NCT01964430|50464650|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
25208109|NCT01964430|50464651|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
25208110|NCT01964430|50464650|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
25208111|NCT01964430|50464651|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
25208112|NCT01964430|50464650|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
25208113|NCT01964430|50464651|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
25208114|NCT01964430|50464650|FG000|Treatment Period|Adverse Event|71|||
25208115|NCT01964430|50464651|FG001|Treatment Period|Adverse Event|37|||
25208116|NCT01964430|50464650|FG000|Treatment Period|Withdrawal by Subject|36|||
25208117|NCT01964430|50464651|FG001|Treatment Period|Withdrawal by Subject|27|||
25208118|NCT01964430|50464650|FG000|Treatment Period|Death|1|||
25208119|NCT01964430|50464651|FG001|Treatment Period|Death|3|||
25208120|NCT01964430|50464650|FG000|Treatment Period|Protocol Deviation|0|||
25208121|NCT01964430|50464651|FG001|Treatment Period|Protocol Deviation|1|||
25208122|NCT01964430|50464650|FG000|Treatment Period|Physician Decision|5|||
25208123|NCT01964430|50464651|FG001|Treatment Period|Physician Decision|4|||
25208124|NCT01964430|50464650|FG000|Treatment Period|Disease Relapse|28|||
25208125|NCT01964430|50464651|FG001|Treatment Period|Disease Relapse|38|||
25208126|NCT01964430|50464650|FG000|Treatment Period|Other reasons|1|||
25208127|NCT01964430|50464651|FG001|Treatment Period|Other reasons|3|||
25208128|NCT01928394|50464680|FG000|Treatment Period|Disease progression|17|||
25208129|NCT01928394|50464681|FG001|Treatment Period|Disease progression|2|||
25208130|NCT01928394|50464682|FG002|Treatment Period|Disease progression|12|||
25208131|NCT01928394|50464683|FG003|Treatment Period|Disease progression|48|||
25208132|NCT01928394|50464684|FG004|Treatment Period|Disease progression|3|||
25208133|NCT01928394|50464685|FG005|Treatment Period|Disease progression|25|||
25208134|NCT01928394|50464686|FG006|Treatment Period|Disease progression|38|||
25208135|NCT01928394|50464687|FG007|Treatment Period|Disease progression|16|||
25208136|NCT01928394|50464688|FG008|Treatment Period|Disease progression|3|||
25208137|NCT01928394|50464689|FG009|Treatment Period|Disease progression|11|||
25208138|NCT01928394|50464690|FG010|Treatment Period|Disease progression|22|||
25208139|NCT01928394|50464691|FG011|Treatment Period|Disease progression|73|||
25208140|NCT01928394|50464692|FG012|Treatment Period|Disease progression|38|||
25208141|NCT01928394|50464693|FG013|Treatment Period|Disease progression|118|||
25208142|NCT01928394|50464694|FG014|Treatment Period|Disease progression|59|||
25208143|NCT01928394|50464695|FG015|Treatment Period|Disease progression|1|||
25208144|NCT01928394|50464696|FG016|Treatment Period|Disease progression|43|||
25208145|NCT01928394|50464697|FG017|Treatment Period|Disease progression|56|||
25208146|NCT01928394|50464698|FG018|Treatment Period|Disease progression|50|||
25208147|NCT01928394|50464699|FG019|Treatment Period|Disease progression|71|||
25208148|NCT01928394|50464700|FG020|Treatment Period|Disease progression|30|||
25208149|NCT01928394|50464701|FG021|Treatment Period|Disease progression|31|||
25208150|NCT01928394|50464702|FG022|Treatment Period|Disease progression|31|||
25208151|NCT01928394|50464680|FG000|Treatment Period|Study drug toxicity|1|||
25208152|NCT01928394|50464681|FG001|Treatment Period|Study drug toxicity|1|||
25208153|NCT01928394|50464682|FG002|Treatment Period|Study drug toxicity|3|||
25208154|NCT01928394|50464683|FG003|Treatment Period|Study drug toxicity|3|||
25208155|NCT01928394|50464684|FG004|Treatment Period|Study drug toxicity|0|||
25208156|NCT01928394|50464685|FG005|Treatment Period|Study drug toxicity|9|||
25208157|NCT01928394|50464686|FG006|Treatment Period|Study drug toxicity|7|||
25208158|NCT01928394|50464687|FG007|Treatment Period|Study drug toxicity|1|||
25208159|NCT01928394|50464688|FG008|Treatment Period|Study drug toxicity|0|||
25208160|NCT01928394|50464689|FG009|Treatment Period|Study drug toxicity|5|||
25208161|NCT01928394|50464690|FG010|Treatment Period|Study drug toxicity|2|||
25208162|NCT01928394|50464691|FG011|Treatment Period|Study drug toxicity|3|||
25208163|NCT01928394|50464692|FG012|Treatment Period|Study drug toxicity|7|||
25208164|NCT01928394|50464693|FG013|Treatment Period|Study drug toxicity|5|||
25208165|NCT01928394|50464694|FG014|Treatment Period|Study drug toxicity|12|||
25208166|NCT01928394|50464695|FG015|Treatment Period|Study drug toxicity|0|||
25208167|NCT01928394|50464696|FG016|Treatment Period|Study drug toxicity|3|||
25208168|NCT01928394|50464697|FG017|Treatment Period|Study drug toxicity|3|||
25208169|NCT01928394|50464698|FG018|Treatment Period|Study drug toxicity|12|||
25208170|NCT01928394|50464699|FG019|Treatment Period|Study drug toxicity|15|||
25208171|NCT01928394|50464700|FG020|Treatment Period|Study drug toxicity|4|||
25208172|NCT01928394|50464701|FG021|Treatment Period|Study drug toxicity|7|||
25208173|NCT01928394|50464702|FG022|Treatment Period|Study drug toxicity|4|||
25208174|NCT01928394|50464680|FG000|Treatment Period|AE unrelated to study drug|0|||
25208175|NCT01928394|50464681|FG001|Treatment Period|AE unrelated to study drug|0|||
25208176|NCT01928394|50464682|FG002|Treatment Period|AE unrelated to study drug|2|||
25208177|NCT01928394|50464683|FG003|Treatment Period|AE unrelated to study drug|3|||
25208178|NCT01928394|50464684|FG004|Treatment Period|AE unrelated to study drug|0|||
25208179|NCT01928394|50464685|FG005|Treatment Period|AE unrelated to study drug|5|||
25208180|NCT01928394|50464686|FG006|Treatment Period|AE unrelated to study drug|1|||
25208181|NCT01928394|50464687|FG007|Treatment Period|AE unrelated to study drug|0|||
25208182|NCT01928394|50464688|FG008|Treatment Period|AE unrelated to study drug|0|||
25208183|NCT01928394|50464689|FG009|Treatment Period|AE unrelated to study drug|2|||
25208184|NCT01928394|50464690|FG010|Treatment Period|AE unrelated to study drug|0|||
25208185|NCT01928394|50464691|FG011|Treatment Period|AE unrelated to study drug|12|||
25208186|NCT01928394|50464692|FG012|Treatment Period|AE unrelated to study drug|6|||
25208187|NCT01928394|50464693|FG013|Treatment Period|AE unrelated to study drug|13|||
25208188|NCT01928394|50464694|FG014|Treatment Period|AE unrelated to study drug|6|||
25208189|NCT01928394|50464695|FG015|Treatment Period|AE unrelated to study drug|1|||
25208190|NCT01928394|50464696|FG016|Treatment Period|AE unrelated to study drug|1|||
25208191|NCT01928394|50464697|FG017|Treatment Period|AE unrelated to study drug|6|||
25208192|NCT01928394|50464698|FG018|Treatment Period|AE unrelated to study drug|3|||
25208193|NCT01928394|50464699|FG019|Treatment Period|AE unrelated to study drug|5|||
25208194|NCT01928394|50464700|FG020|Treatment Period|AE unrelated to study drug|1|||
25208195|NCT01928394|50464701|FG021|Treatment Period|AE unrelated to study drug|1|||
25208196|NCT01928394|50464702|FG022|Treatment Period|AE unrelated to study drug|0|||
25208197|NCT01928394|50464680|FG000|Treatment Period|Participant request to stop therapy|0|||
25208198|NCT01928394|50464681|FG001|Treatment Period|Participant request to stop therapy|0|||
25208199|NCT01928394|50464682|FG002|Treatment Period|Participant request to stop therapy|0|||
25208200|NCT01928394|50464683|FG003|Treatment Period|Participant request to stop therapy|0|||
25208201|NCT01928394|50464684|FG004|Treatment Period|Participant request to stop therapy|0|||
25208202|NCT01928394|50464685|FG005|Treatment Period|Participant request to stop therapy|3|||
25208203|NCT01928394|50464686|FG006|Treatment Period|Participant request to stop therapy|3|||
25208204|NCT01928394|50464687|FG007|Treatment Period|Participant request to stop therapy|0|||
25208205|NCT01928394|50464688|FG008|Treatment Period|Participant request to stop therapy|0|||
25208206|NCT01928394|50464689|FG009|Treatment Period|Participant request to stop therapy|0|||
25208207|NCT01928394|50464690|FG010|Treatment Period|Participant request to stop therapy|3|||
25208208|NCT01928394|50464691|FG011|Treatment Period|Participant request to stop therapy|2|||
25208209|NCT01928394|50464692|FG012|Treatment Period|Participant request to stop therapy|1|||
25208210|NCT01928394|50464693|FG013|Treatment Period|Participant request to stop therapy|2|||
25208211|NCT01928394|50464694|FG014|Treatment Period|Participant request to stop therapy|4|||
25208212|NCT01928394|50464695|FG015|Treatment Period|Participant request to stop therapy|0|||
25208213|NCT01928394|50464696|FG016|Treatment Period|Participant request to stop therapy|1|||
25208214|NCT01928394|50464697|FG017|Treatment Period|Participant request to stop therapy|3|||
25208215|NCT01928394|50464698|FG018|Treatment Period|Participant request to stop therapy|1|||
25208216|NCT01928394|50464699|FG019|Treatment Period|Participant request to stop therapy|1|||
25208217|NCT01928394|50464700|FG020|Treatment Period|Participant request to stop therapy|3|||
25208218|NCT01928394|50464701|FG021|Treatment Period|Participant request to stop therapy|1|||
25208219|NCT01928394|50464702|FG022|Treatment Period|Participant request to stop therapy|3|||
25208220|NCT01928394|50464680|FG000|Treatment Period|Participant withdrew consent|0|||
25316090|NCT00896532|50631608|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25316091|NCT00896532|50631609|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25316092|NCT00896532|50631610|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
25316093|NCT00896532|50631588|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
25316094|NCT00896532|50631589|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
25316095|NCT00896532|50631590|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
25316096|NCT00896532|50631591|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
25316097|NCT00896532|50631592|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
25316098|NCT00896532|50631593|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
25316099|NCT00896532|50631594|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
25316100|NCT00896532|50631595|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
25316101|NCT00896532|50631596|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
25316102|NCT00896532|50631597|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
25316103|NCT00896532|50631598|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
25316104|NCT00896532|50631599|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
25316105|NCT00896532|50631600|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
25208221|NCT01928394|50464681|FG001|Treatment Period|Participant withdrew consent|0|||
25316106|NCT00896532|50631601|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
25316107|NCT00896532|50631602|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
25316108|NCT00896532|50631603|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
25316109|NCT00896532|50631604|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
25316110|NCT00896532|50631605|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
25316111|NCT00896532|50631606|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
25316112|NCT00896532|50631607|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
25316113|NCT00896532|50631608|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
25316114|NCT00896532|50631609|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
25316115|NCT00896532|50631610|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
25316116|NCT00896532|50631588|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316117|NCT00896532|50631589|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316118|NCT00896532|50631590|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316119|NCT00896532|50631591|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316120|NCT00896532|50631592|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316121|NCT00896532|50631593|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25208222|NCT01928394|50464682|FG002|Treatment Period|Participant withdrew consent|1|||
25208223|NCT01928394|50464683|FG003|Treatment Period|Participant withdrew consent|1|||
25208224|NCT01928394|50464684|FG004|Treatment Period|Participant withdrew consent|0|||
25208225|NCT01928394|50464685|FG005|Treatment Period|Participant withdrew consent|1|||
25208226|NCT01928394|50464686|FG006|Treatment Period|Participant withdrew consent|0|||
25208227|NCT01928394|50464687|FG007|Treatment Period|Participant withdrew consent|1|||
25208228|NCT01928394|50464688|FG008|Treatment Period|Participant withdrew consent|0|||
25208229|NCT01928394|50464689|FG009|Treatment Period|Participant withdrew consent|0|||
25208230|NCT01928394|50464690|FG010|Treatment Period|Participant withdrew consent|1|||
25208231|NCT01928394|50464691|FG011|Treatment Period|Participant withdrew consent|1|||
25208232|NCT01928394|50464692|FG012|Treatment Period|Participant withdrew consent|1|||
25208233|NCT01928394|50464693|FG013|Treatment Period|Participant withdrew consent|0|||
25208234|NCT01928394|50464694|FG014|Treatment Period|Participant withdrew consent|2|||
25208235|NCT01928394|50464695|FG015|Treatment Period|Participant withdrew consent|0|||
25208236|NCT01928394|50464696|FG016|Treatment Period|Participant withdrew consent|2|||
25208237|NCT01928394|50464697|FG017|Treatment Period|Participant withdrew consent|1|||
25208238|NCT01928394|50464698|FG018|Treatment Period|Participant withdrew consent|1|||
25316122|NCT00896532|50631594|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316123|NCT00896532|50631595|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25208239|NCT01928394|50464699|FG019|Treatment Period|Participant withdrew consent|1|||
25208240|NCT01928394|50464700|FG020|Treatment Period|Participant withdrew consent|0|||
25208241|NCT01928394|50464701|FG021|Treatment Period|Participant withdrew consent|2|||
25208242|NCT01928394|50464702|FG022|Treatment Period|Participant withdrew consent|0|||
25208243|NCT01928394|50464680|FG000|Treatment Period|Poor/non-compliance|0|||
25208244|NCT01928394|50464681|FG001|Treatment Period|Poor/non-compliance|0|||
25208245|NCT01928394|50464682|FG002|Treatment Period|Poor/non-compliance|0|||
25208246|NCT01928394|50464683|FG003|Treatment Period|Poor/non-compliance|1|||
25208247|NCT01928394|50464684|FG004|Treatment Period|Poor/non-compliance|0|||
25208248|NCT01928394|50464685|FG005|Treatment Period|Poor/non-compliance|0|||
25208249|NCT01928394|50464686|FG006|Treatment Period|Poor/non-compliance|0|||
25208250|NCT01928394|50464687|FG007|Treatment Period|Poor/non-compliance|0|||
25208251|NCT01928394|50464688|FG008|Treatment Period|Poor/non-compliance|0|||
25208252|NCT01928394|50464689|FG009|Treatment Period|Poor/non-compliance|0|||
25208253|NCT01928394|50464690|FG010|Treatment Period|Poor/non-compliance|0|||
25208254|NCT01928394|50464691|FG011|Treatment Period|Poor/non-compliance|0|||
25208255|NCT01928394|50464692|FG012|Treatment Period|Poor/non-compliance|1|||
25208256|NCT01928394|50464693|FG013|Treatment Period|Poor/non-compliance|0|||
25208257|NCT01928394|50464694|FG014|Treatment Period|Poor/non-compliance|1|||
25208258|NCT01928394|50464695|FG015|Treatment Period|Poor/non-compliance|0|||
25208259|NCT01928394|50464696|FG016|Treatment Period|Poor/non-compliance|0|||
25208260|NCT01928394|50464697|FG017|Treatment Period|Poor/non-compliance|1|||
25208261|NCT01928394|50464698|FG018|Treatment Period|Poor/non-compliance|0|||
25208262|NCT01928394|50464699|FG019|Treatment Period|Poor/non-compliance|1|||
25208263|NCT01928394|50464700|FG020|Treatment Period|Poor/non-compliance|0|||
25208264|NCT01928394|50464701|FG021|Treatment Period|Poor/non-compliance|0|||
25208265|NCT01928394|50464702|FG022|Treatment Period|Poor/non-compliance|0|||
25208266|NCT01928394|50464680|FG000|Treatment Period|other reason|0|||
25208267|NCT01928394|50464681|FG001|Treatment Period|other reason|0|||
25208268|NCT01928394|50464682|FG002|Treatment Period|other reason|0|||
25208269|NCT01928394|50464683|FG003|Treatment Period|other reason|0|||
25208270|NCT01928394|50464684|FG004|Treatment Period|other reason|0|||
25208271|NCT01928394|50464685|FG005|Treatment Period|other reason|0|||
25208272|NCT01928394|50464686|FG006|Treatment Period|other reason|0|||
25208273|NCT01928394|50464687|FG007|Treatment Period|other reason|0|||
25208274|NCT01928394|50464688|FG008|Treatment Period|other reason|0|||
25208275|NCT01928394|50464689|FG009|Treatment Period|other reason|0|||
25208276|NCT01928394|50464690|FG010|Treatment Period|other reason|1|||
25208277|NCT01928394|50464691|FG011|Treatment Period|other reason|1|||
25208278|NCT01928394|50464692|FG012|Treatment Period|other reason|1|||
25208279|NCT01928394|50464693|FG013|Treatment Period|other reason|0|||
25208280|NCT01928394|50464694|FG014|Treatment Period|other reason|1|||
25208281|NCT01928394|50464695|FG015|Treatment Period|other reason|0|||
25208282|NCT01928394|50464696|FG016|Treatment Period|other reason|0|||
25208283|NCT01928394|50464697|FG017|Treatment Period|other reason|0|||
25208284|NCT01928394|50464698|FG018|Treatment Period|other reason|2|||
25208285|NCT01928394|50464699|FG019|Treatment Period|other reason|2|||
25208286|NCT01928394|50464700|FG020|Treatment Period|other reason|0|||
25208287|NCT01928394|50464701|FG021|Treatment Period|other reason|0|||
25208288|NCT01928394|50464702|FG022|Treatment Period|other reason|0|||
25208289|NCT01928394|50464680|FG000|Treatment Period|Maximum clinical benefit|0|||
25208290|NCT01928394|50464681|FG001|Treatment Period|Maximum clinical benefit|0|||
25208291|NCT01928394|50464682|FG002|Treatment Period|Maximum clinical benefit|0|||
25208292|NCT01928394|50464683|FG003|Treatment Period|Maximum clinical benefit|0|||
25208293|NCT01928394|50464684|FG004|Treatment Period|Maximum clinical benefit|0|||
25208294|NCT01928394|50464685|FG005|Treatment Period|Maximum clinical benefit|0|||
25208295|NCT01928394|50464686|FG006|Treatment Period|Maximum clinical benefit|0|||
25208296|NCT01928394|50464687|FG007|Treatment Period|Maximum clinical benefit|0|||
25208297|NCT01928394|50464688|FG008|Treatment Period|Maximum clinical benefit|0|||
25208298|NCT01928394|50464689|FG009|Treatment Period|Maximum clinical benefit|0|||
25208299|NCT01928394|50464690|FG010|Treatment Period|Maximum clinical benefit|1|||
25208300|NCT01928394|50464691|FG011|Treatment Period|Maximum clinical benefit|1|||
25208301|NCT01928394|50464692|FG012|Treatment Period|Maximum clinical benefit|0|||
25208302|NCT01928394|50464693|FG013|Treatment Period|Maximum clinical benefit|0|||
25208303|NCT01928394|50464694|FG014|Treatment Period|Maximum clinical benefit|1|||
25208304|NCT01928394|50464695|FG015|Treatment Period|Maximum clinical benefit|0|||
25208305|NCT01928394|50464696|FG016|Treatment Period|Maximum clinical benefit|0|||
25208306|NCT01928394|50464697|FG017|Treatment Period|Maximum clinical benefit|1|||
25208307|NCT01928394|50464698|FG018|Treatment Period|Maximum clinical benefit|1|||
25208308|NCT01928394|50464699|FG019|Treatment Period|Maximum clinical benefit|0|||
25208309|NCT01928394|50464700|FG020|Treatment Period|Maximum clinical benefit|2|||
25208310|NCT01928394|50464701|FG021|Treatment Period|Maximum clinical benefit|0|||
25208311|NCT01928394|50464702|FG022|Treatment Period|Maximum clinical benefit|0|||
25208312|NCT01928394|50464680|FG000|Treatment Period|Lost to Follow-up|0|||
25208313|NCT01928394|50464681|FG001|Treatment Period|Lost to Follow-up|0|||
25208314|NCT01928394|50464682|FG002|Treatment Period|Lost to Follow-up|0|||
25208315|NCT01928394|50464683|FG003|Treatment Period|Lost to Follow-up|0|||
25208316|NCT01928394|50464684|FG004|Treatment Period|Lost to Follow-up|0|||
25208317|NCT01928394|50464685|FG005|Treatment Period|Lost to Follow-up|0|||
25208318|NCT01928394|50464686|FG006|Treatment Period|Lost to Follow-up|0|||
25208319|NCT01928394|50464687|FG007|Treatment Period|Lost to Follow-up|0|||
25208320|NCT01928394|50464688|FG008|Treatment Period|Lost to Follow-up|0|||
25208321|NCT01928394|50464689|FG009|Treatment Period|Lost to Follow-up|0|||
25208322|NCT01928394|50464690|FG010|Treatment Period|Lost to Follow-up|0|||
25208323|NCT01928394|50464691|FG011|Treatment Period|Lost to Follow-up|0|||
25208324|NCT01928394|50464692|FG012|Treatment Period|Lost to Follow-up|0|||
25208325|NCT01928394|50464693|FG013|Treatment Period|Lost to Follow-up|0|||
25208326|NCT01928394|50464694|FG014|Treatment Period|Lost to Follow-up|0|||
25208327|NCT01928394|50464695|FG015|Treatment Period|Lost to Follow-up|0|||
25208328|NCT01928394|50464696|FG016|Treatment Period|Lost to Follow-up|0|||
25208329|NCT01928394|50464697|FG017|Treatment Period|Lost to Follow-up|0|||
25208330|NCT01928394|50464698|FG018|Treatment Period|Lost to Follow-up|0|||
25208331|NCT01928394|50464699|FG019|Treatment Period|Lost to Follow-up|0|||
25208332|NCT01928394|50464700|FG020|Treatment Period|Lost to Follow-up|0|||
25208333|NCT01928394|50464701|FG021|Treatment Period|Lost to Follow-up|0|||
25208334|NCT01928394|50464702|FG022|Treatment Period|Lost to Follow-up|1|||
25208335|NCT01928394|50464680|FG000|Treatment Period|Death|0|||
25208336|NCT01928394|50464681|FG001|Treatment Period|Death|0|||
25208337|NCT01928394|50464682|FG002|Treatment Period|Death|0|||
25208338|NCT01928394|50464683|FG003|Treatment Period|Death|0|||
25208339|NCT01928394|50464684|FG004|Treatment Period|Death|0|||
25208340|NCT01928394|50464685|FG005|Treatment Period|Death|0|||
25208341|NCT01928394|50464686|FG006|Treatment Period|Death|0|||
25208342|NCT01928394|50464687|FG007|Treatment Period|Death|0|||
25208343|NCT01928394|50464688|FG008|Treatment Period|Death|0|||
25208344|NCT01928394|50464689|FG009|Treatment Period|Death|0|||
25208345|NCT01928394|50464690|FG010|Treatment Period|Death|0|||
25208346|NCT01928394|50464691|FG011|Treatment Period|Death|0|||
25208347|NCT01928394|50464692|FG012|Treatment Period|Death|0|||
25208348|NCT01928394|50464693|FG013|Treatment Period|Death|1|||
25208349|NCT01928394|50464694|FG014|Treatment Period|Death|2|||
25208350|NCT01928394|50464695|FG015|Treatment Period|Death|0|||
25208351|NCT01928394|50464696|FG016|Treatment Period|Death|0|||
25208352|NCT01928394|50464697|FG017|Treatment Period|Death|0|||
25208353|NCT01928394|50464698|FG018|Treatment Period|Death|0|||
25208354|NCT01928394|50464699|FG019|Treatment Period|Death|0|||
25208355|NCT01928394|50464700|FG020|Treatment Period|Death|0|||
25208356|NCT01928394|50464701|FG021|Treatment Period|Death|0|||
25208357|NCT01928394|50464702|FG022|Treatment Period|Death|0|||
25208358|NCT01928394|50464680|FG000|Follow-up Period|Participant withdrew consent|3|||
25208359|NCT01928394|50464681|FG001|Follow-up Period|Participant withdrew consent|0|||
25208360|NCT01928394|50464682|FG002|Follow-up Period|Participant withdrew consent|1|||
25208361|NCT01928394|50464683|FG003|Follow-up Period|Participant withdrew consent|4|||
25208362|NCT01928394|50464684|FG004|Follow-up Period|Participant withdrew consent|0|||
25208363|NCT01928394|50464685|FG005|Follow-up Period|Participant withdrew consent|2|||
25208364|NCT01928394|50464686|FG006|Follow-up Period|Participant withdrew consent|5|||
25208365|NCT01928394|50464687|FG007|Follow-up Period|Participant withdrew consent|1|||
25208366|NCT01928394|50464688|FG008|Follow-up Period|Participant withdrew consent|0|||
25208367|NCT01928394|50464689|FG009|Follow-up Period|Participant withdrew consent|0|||
25208368|NCT01928394|50464690|FG010|Follow-up Period|Participant withdrew consent|5|||
25208369|NCT01928394|50464691|FG011|Follow-up Period|Participant withdrew consent|8|||
25208370|NCT01928394|50464692|FG012|Follow-up Period|Participant withdrew consent|2|||
25208371|NCT01928394|50464693|FG013|Follow-up Period|Participant withdrew consent|12|||
25208372|NCT01928394|50464694|FG014|Follow-up Period|Participant withdrew consent|7|||
25208373|NCT01928394|50464695|FG015|Follow-up Period|Participant withdrew consent|0|||
25208374|NCT01928394|50464696|FG016|Follow-up Period|Participant withdrew consent|5|||
25208375|NCT01928394|50464697|FG017|Follow-up Period|Participant withdrew consent|3|||
25208376|NCT01928394|50464698|FG018|Follow-up Period|Participant withdrew consent|2|||
25208377|NCT01928394|50464699|FG019|Follow-up Period|Participant withdrew consent|7|||
25208378|NCT01928394|50464700|FG020|Follow-up Period|Participant withdrew consent|4|||
25208379|NCT01928394|50464701|FG021|Follow-up Period|Participant withdrew consent|6|||
25208380|NCT01928394|50464702|FG022|Follow-up Period|Participant withdrew consent|2|||
25208381|NCT01928394|50464680|FG000|Follow-up Period|Death|0|||
25208382|NCT01928394|50464681|FG001|Follow-up Period|Death|0|||
25208383|NCT01928394|50464682|FG002|Follow-up Period|Death|2|||
25208384|NCT01928394|50464683|FG003|Follow-up Period|Death|6|||
25208385|NCT01928394|50464684|FG004|Follow-up Period|Death|0|||
25208386|NCT01928394|50464685|FG005|Follow-up Period|Death|6|||
25208387|NCT01928394|50464686|FG006|Follow-up Period|Death|6|||
25208388|NCT01928394|50464687|FG007|Follow-up Period|Death|2|||
25208389|NCT01928394|50464688|FG008|Follow-up Period|Death|1|||
25208390|NCT01928394|50464689|FG009|Follow-up Period|Death|2|||
25208391|NCT01928394|50464690|FG010|Follow-up Period|Death|4|||
25208392|NCT01928394|50464691|FG011|Follow-up Period|Death|12|||
25208393|NCT01928394|50464692|FG012|Follow-up Period|Death|11|||
25208394|NCT01928394|50464693|FG013|Follow-up Period|Death|25|||
25208395|NCT01928394|50464694|FG014|Follow-up Period|Death|18|||
25208396|NCT01928394|50464695|FG015|Follow-up Period|Death|0|||
25208397|NCT01928394|50464696|FG016|Follow-up Period|Death|6|||
25208398|NCT01928394|50464697|FG017|Follow-up Period|Death|5|||
25208399|NCT01928394|50464698|FG018|Follow-up Period|Death|13|||
25208400|NCT01928394|50464699|FG019|Follow-up Period|Death|13|||
25208401|NCT01928394|50464700|FG020|Follow-up Period|Death|5|||
25208402|NCT01928394|50464701|FG021|Follow-up Period|Death|3|||
25208403|NCT01928394|50464702|FG022|Follow-up Period|Death|2|||
25208404|NCT01928394|50464680|FG000|Follow-up Period|other reason|0|||
25208405|NCT01928394|50464681|FG001|Follow-up Period|other reason|0|||
25208406|NCT01928394|50464682|FG002|Follow-up Period|other reason|0|||
25208407|NCT01928394|50464683|FG003|Follow-up Period|other reason|0|||
25208408|NCT01928394|50464684|FG004|Follow-up Period|other reason|0|||
25208409|NCT01928394|50464685|FG005|Follow-up Period|other reason|0|||
25208410|NCT01928394|50464686|FG006|Follow-up Period|other reason|1|||
25208411|NCT01928394|50464687|FG007|Follow-up Period|other reason|3|||
25208412|NCT01928394|50464688|FG008|Follow-up Period|other reason|0|||
25208413|NCT01928394|50464689|FG009|Follow-up Period|other reason|0|||
25208414|NCT01928394|50464690|FG010|Follow-up Period|other reason|2|||
25208415|NCT01928394|50464691|FG011|Follow-up Period|other reason|1|||
25208416|NCT01928394|50464692|FG012|Follow-up Period|other reason|0|||
25208417|NCT01928394|50464693|FG013|Follow-up Period|other reason|1|||
25208418|NCT01928394|50464694|FG014|Follow-up Period|other reason|4|||
25208419|NCT01928394|50464695|FG015|Follow-up Period|other reason|0|||
25208420|NCT01928394|50464696|FG016|Follow-up Period|other reason|2|||
25208421|NCT01928394|50464697|FG017|Follow-up Period|other reason|0|||
25208422|NCT01928394|50464698|FG018|Follow-up Period|other reason|1|||
25208423|NCT01928394|50464699|FG019|Follow-up Period|other reason|1|||
25208424|NCT01928394|50464700|FG020|Follow-up Period|other reason|0|||
25208425|NCT01928394|50464701|FG021|Follow-up Period|other reason|0|||
25208426|NCT01928394|50464702|FG022|Follow-up Period|other reason|1|||
25208427|NCT01928394|50464680|FG000|Follow-up Period|Lost to Follow-up|0|||
25208428|NCT01928394|50464681|FG001|Follow-up Period|Lost to Follow-up|0|||
25208429|NCT01928394|50464682|FG002|Follow-up Period|Lost to Follow-up|0|||
25208430|NCT01928394|50464683|FG003|Follow-up Period|Lost to Follow-up|0|||
25208431|NCT01928394|50464684|FG004|Follow-up Period|Lost to Follow-up|0|||
25208432|NCT01928394|50464685|FG005|Follow-up Period|Lost to Follow-up|0|||
25208433|NCT01928394|50464686|FG006|Follow-up Period|Lost to Follow-up|0|||
25208434|NCT01928394|50464687|FG007|Follow-up Period|Lost to Follow-up|0|||
25208435|NCT01928394|50464688|FG008|Follow-up Period|Lost to Follow-up|0|||
25208436|NCT01928394|50464689|FG009|Follow-up Period|Lost to Follow-up|0|||
25208437|NCT01928394|50464690|FG010|Follow-up Period|Lost to Follow-up|0|||
25208438|NCT01928394|50464691|FG011|Follow-up Period|Lost to Follow-up|1|||
25208439|NCT01928394|50464692|FG012|Follow-up Period|Lost to Follow-up|1|||
25208440|NCT01928394|50464693|FG013|Follow-up Period|Lost to Follow-up|0|||
25208441|NCT01928394|50464694|FG014|Follow-up Period|Lost to Follow-up|1|||
25208442|NCT01928394|50464695|FG015|Follow-up Period|Lost to Follow-up|0|||
25208443|NCT01928394|50464696|FG016|Follow-up Period|Lost to Follow-up|1|||
25208444|NCT01928394|50464697|FG017|Follow-up Period|Lost to Follow-up|0|||
25208445|NCT01928394|50464698|FG018|Follow-up Period|Lost to Follow-up|0|||
25208446|NCT01928394|50464699|FG019|Follow-up Period|Lost to Follow-up|0|||
25208447|NCT01928394|50464700|FG020|Follow-up Period|Lost to Follow-up|0|||
25208448|NCT01928394|50464701|FG021|Follow-up Period|Lost to Follow-up|0|||
25208449|NCT01928394|50464702|FG022|Follow-up Period|Lost to Follow-up|1|||
25208450|NCT01898494|50464754|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
25208451|NCT01898494|50464755|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
25208452|NCT01898494|50464756|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
25208453|NCT01898494|50464757|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
25208454|NCT01898494|50464758|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
25208455|NCT01898494|50464754|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
25208456|NCT01898494|50464755|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
25208457|NCT01898494|50464756|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
25208458|NCT01898494|50464757|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
25208459|NCT01898494|50464758|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
25208460|NCT01898494|50464754|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
25208461|NCT01898494|50464755|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
25208462|NCT01898494|50464756|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
25208463|NCT01898494|50464757|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
25208464|NCT01898494|50464758|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
25208465|NCT01898494|50464754|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
25208466|NCT01898494|50464755|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
25208467|NCT01898494|50464756|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
25208468|NCT01898494|50464757|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
25208469|NCT01898494|50464758|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
25208470|NCT01898494|50464754|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
25208471|NCT01898494|50464755|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
25208472|NCT01898494|50464756|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
25208473|NCT01898494|50464757|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
25208474|NCT01898494|50464758|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
25208475|NCT01898494|50464754|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
25208476|NCT01898494|50464755|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
25208477|NCT01898494|50464756|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
25208478|NCT01898494|50464757|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
25208479|NCT01898494|50464758|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
25208480|NCT01898494|50464754|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
25208481|NCT01898494|50464755|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
25208482|NCT01898494|50464756|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
25208483|NCT01898494|50464757|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
25208484|NCT01898494|50464758|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
25208485|NCT01898494|50464754|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
25208486|NCT01898494|50464755|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
25208487|NCT01898494|50464756|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
25208488|NCT01898494|50464757|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
25208489|NCT01898494|50464758|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
25208490|NCT01898494|50464754|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
25208491|NCT01898494|50464755|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
25208492|NCT01898494|50464756|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
25208493|NCT01898494|50464757|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
25208494|NCT01898494|50464758|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
25208495|NCT01898494|50464754|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
25208496|NCT01898494|50464755|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
25208497|NCT01898494|50464756|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
25208498|NCT01898494|50464757|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
25208499|NCT01898494|50464758|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
25208500|NCT01898494|50464754|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
25208501|NCT01898494|50464755|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
25208502|NCT01898494|50464756|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
25208503|NCT01898494|50464757|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
25208504|NCT01898494|50464758|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
25208505|NCT01898494|50464754|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
25208506|NCT01898494|50464755|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
25208507|NCT01898494|50464756|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
25208508|NCT01898494|50464757|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
25208509|NCT01898494|50464758|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
25208510|NCT01898494|50464754|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
25208511|NCT01898494|50464755|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
25208512|NCT01898494|50464756|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
25208513|NCT01898494|50464757|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
25208514|NCT01898494|50464758|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
25208515|NCT01898494|50464754|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
25208516|NCT01898494|50464755|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
25208517|NCT01898494|50464756|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
25208518|NCT01898494|50464757|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
25208519|NCT01898494|50464758|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
25316124|NCT00896532|50631596|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25077138|NCT01633060|50184992|FG000|Randomization Phase|Protocol deviation|1|||
25077139|NCT01633060|50184993|FG001|Randomization Phase|Protocol deviation|2|||
25077140|NCT01633060|50184992|FG000|Randomization Phase|Technical problem|0|||
25077141|NCT01633060|50184993|FG001|Randomization Phase|Technical problem|1|||
25077142|NCT01633060|50184992|FG000|Treatment Phase|Adverse Event|24|||
25077143|NCT01633060|50184993|FG001|Treatment Phase|Adverse Event|3|||
25077144|NCT01633060|50184992|FG000|Treatment Phase|Lost to Follow-up|1|||
25077145|NCT01633060|50184993|FG001|Treatment Phase|Lost to Follow-up|0|||
25077146|NCT01633060|50184992|FG000|Treatment Phase|Physician Decision|16|||
25077147|NCT01633060|50184993|FG001|Treatment Phase|Physician Decision|7|||
25077148|NCT01633060|50184992|FG000|Treatment Phase|Progressive Disease|210|||
25077149|NCT01633060|50184993|FG001|Treatment Phase|Progressive Disease|120|||
25077150|NCT01633060|50184992|FG000|Treatment Phase|Protocol Deviation|1|||
25077151|NCT01633060|50184993|FG001|Treatment Phase|Protocol Deviation|0|||
25077152|NCT01633060|50184992|FG000|Treatment Phase|Study Terminated by sponsor|7|||
25077153|NCT01633060|50184993|FG001|Treatment Phase|Study Terminated by sponsor|3|||
25077154|NCT01633060|50184992|FG000|Treatment Phase|Subject/guardian decision|25|||
25077155|NCT01633060|50184993|FG001|Treatment Phase|Subject/guardian decision|4|||
25077156|NCT01633060|50184992|FG000|Treatment Phase|Death|4|||
25077157|NCT01633060|50184993|FG001|Treatment Phase|Death|3|||
25077158|NCT01633060|50184992|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
25077159|NCT01633060|50184993|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
25077160|NCT01633060|50184992|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
25077161|NCT01633060|50184993|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
25077162|NCT01633060|50184992|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
25077163|NCT01633060|50184993|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
25077164|NCT01633060|50184992|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
25077165|NCT01633060|50184993|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
25077166|NCT01633060|50184992|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
25077167|NCT01633060|50184993|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
25208520|NCT01863043|50464776|FG000|Overall Study|Death|6|||
25208521|NCT01863043|50464777|FG001|Overall Study|Death|1|||
25208522|NCT01863043|50464776|FG000|Overall Study|Withdrawal by Subject|0|||
25208523|NCT01863043|50464777|FG001|Overall Study|Withdrawal by Subject|2|||
25208524|NCT01863043|50464776|FG000|Overall Study|Adverse Event|7|||
25208525|NCT01863043|50464777|FG001|Overall Study|Adverse Event|8|||
25208526|NCT01863043|50464776|FG000|Overall Study|exclusion criteria found after enrollment|0|||
25208527|NCT01863043|50464777|FG001|Overall Study|exclusion criteria found after enrollment|1|||
25208528|NCT01841359|50464783|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
25316125|NCT00896532|50631597|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316126|NCT00896532|50631598|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316127|NCT00896532|50631599|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316128|NCT00896532|50631600|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316129|NCT00896532|50631601|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316130|NCT00896532|50631602|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316131|NCT00896532|50631603|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
25316132|NCT00896532|50631604|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
25316133|NCT00896532|50631605|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316134|NCT00896532|50631606|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316135|NCT00896532|50631607|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316136|NCT00896532|50631608|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316137|NCT00896532|50631609|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316138|NCT00896532|50631610|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
25316139|NCT00896532|50631588|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25316140|NCT00896532|50631589|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25316141|NCT00896532|50631590|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25208529|NCT01841359|50464783|FG000|Overall Study|Concommitant medical issues|2|||
25208530|NCT01841359|50464783|FG000|Overall Study|Adverse Event|3|||
25208531|NCT01841359|50464783|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
25208532|NCT01824875|50464792|FG000|Overall Study|Disease progression|22|||
25208533|NCT01824875|50464793|FG001|Overall Study|Disease progression|15|||
25208534|NCT01824875|50464792|FG000|Overall Study|Withdrawal by Subject|5|||
25208535|NCT01824875|50464793|FG001|Overall Study|Withdrawal by Subject|4|||
25208536|NCT01824875|50464792|FG000|Overall Study|Adverse Event|4|||
25208537|NCT01824875|50464793|FG001|Overall Study|Adverse Event|10|||
25208538|NCT01824875|50464792|FG000|Overall Study|Alternative therapy|3|||
25208539|NCT01824875|50464793|FG001|Overall Study|Alternative therapy|0|||
25208540|NCT01824875|50464792|FG000|Overall Study|Complicating disease|1|||
25208541|NCT01824875|50464793|FG001|Overall Study|Complicating disease|0|||
25208542|NCT01824875|50464792|FG000|Overall Study|Physician Decision|0|||
25208543|NCT01824875|50464793|FG001|Overall Study|Physician Decision|1|||
25208544|NCT01824875|50464792|FG000|Overall Study|Non-compliance|1|||
25208545|NCT01824875|50464793|FG001|Overall Study|Non-compliance|1|||
25208546|NCT01824875|50464792|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
25208547|NCT01824875|50464793|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
25208548|NCT01824875|50464792|FG000|Overall Study|Administrative issues|0|||
25208549|NCT01824875|50464793|FG001|Overall Study|Administrative issues|2|||
25208550|NCT01824875|50464792|FG000|Overall Study|Ineligible or never started treatment|9|||
25208551|NCT01824875|50464793|FG001|Overall Study|Ineligible or never started treatment|5|||
25208552|NCT01824875|50464792|FG000|Overall Study|Other|0|||
25208553|NCT01824875|50464793|FG001|Overall Study|Other|2|||
25208554|NCT01660451|50464815|FG000|Overall Study|Protocol Violation|0|||
25316142|NCT00896532|50631591|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25208555|NCT01660451|50464816|FG001|Overall Study|Protocol Violation|1|||
25208556|NCT01660451|50464817|FG002|Overall Study|Protocol Violation|1|||
25208557|NCT01660451|50464815|FG000|Overall Study|Adverse Event (AE) without Clinical PD|11|||
25208558|NCT01660451|50464816|FG001|Overall Study|Adverse Event (AE) without Clinical PD|8|||
25208559|NCT01660451|50464817|FG002|Overall Study|Adverse Event (AE) without Clinical PD|26|||
25208560|NCT01660451|50464815|FG000|Overall Study|AE with Clinical PD|1|||
25208561|NCT01660451|50464816|FG001|Overall Study|AE with Clinical PD|3|||
25208562|NCT01660451|50464817|FG002|Overall Study|AE with Clinical PD|9|||
25208563|NCT01660451|50464815|FG000|Overall Study|Sponsor Decision|0|||
25208564|NCT01660451|50464816|FG001|Overall Study|Sponsor Decision|0|||
25208565|NCT01660451|50464817|FG002|Overall Study|Sponsor Decision|1|||
25208566|NCT01660451|50464815|FG000|Overall Study|Protocol Deviation|0|||
25208567|NCT01660451|50464816|FG001|Overall Study|Protocol Deviation|0|||
25208568|NCT01660451|50464817|FG002|Overall Study|Protocol Deviation|1|||
25208569|NCT01660451|50464815|FG000|Overall Study|Physician Decision|1|||
25208570|NCT01660451|50464816|FG001|Overall Study|Physician Decision|2|||
25208571|NCT01660451|50464817|FG002|Overall Study|Physician Decision|5|||
25208572|NCT01660451|50464815|FG000|Overall Study|Withdrawal by Subject|1|||
25208573|NCT01660451|50464816|FG001|Overall Study|Withdrawal by Subject|0|||
25208574|NCT01660451|50464817|FG002|Overall Study|Withdrawal by Subject|16|||
25208575|NCT01660451|50464815|FG000|Overall Study|Ongoing with treatment|3|||
25208576|NCT01660451|50464816|FG001|Overall Study|Ongoing with treatment|3|||
25208577|NCT01660451|50464817|FG002|Overall Study|Ongoing with treatment|46|||
25208578|NCT01390584|50464836|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
25208579|NCT01390584|50464837|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
25208580|NCT01390584|50464838|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
25208581|NCT01385176|50464849|FG000|Randomization Phase|Death|1|||
25208582|NCT01385176|50464850|FG001|Randomization Phase|Death|2|||
25208583|NCT01385176|50464849|FG000|6-18 Month All VNS Active|Death|1|||
25208584|NCT01385176|50464850|FG001|6-18 Month All VNS Active|Death|2|||
25208585|NCT01385176|50464849|FG000|6-18 Month All VNS Active|Physician Decision|0|||
25208586|NCT01385176|50464850|FG001|6-18 Month All VNS Active|Physician Decision|1|||
25208587|NCT01385176|50464849|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
25208588|NCT01385176|50464850|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
25208589|NCT01385176|50464849|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
25208590|NCT01385176|50464850|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
25208591|NCT01290692|50464861|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
25208592|NCT01251965|50464868|FG000|Overall Study|Participant/physician decision|1|||
25208593|NCT01251965|50464869|FG001|Overall Study|Participant/physician decision|2|||
25208594|NCT01251965|50464870|FG002|Overall Study|Participant/physician decision|0|||
25208595|NCT01251965|50464868|FG000|Overall Study|Death|0|||
25208596|NCT01251965|50464869|FG001|Overall Study|Death|0|||
25208597|NCT01251965|50464870|FG002|Overall Study|Death|11|||
25208598|NCT01242800|50464881|FG000|Overall Study|Patient refusal|0|||
25208599|NCT01242800|50464882|FG001|Overall Study|Patient refusal|10|||
25208600|NCT01242800|50464881|FG000|Overall Study|Physician Decision|0|||
25208601|NCT01242800|50464882|FG001|Overall Study|Physician Decision|1|||
25208602|NCT01242800|50464881|FG000|Overall Study|Disease progression|0|||
25208603|NCT01242800|50464882|FG001|Overall Study|Disease progression|3|||
25208604|NCT01242800|50464881|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
25208605|NCT01242800|50464882|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
25208606|NCT01242800|50464881|FG000|Overall Study|Reasons not reported|0|||
25208607|NCT01242800|50464882|FG001|Overall Study|Reasons not reported|4|||
25208608|NCT01216683|50464891|FG000|Induction|Never started treatment|0|||
25208609|NCT01216683|50464892|FG001|Induction|Never started treatment|6|||
25208610|NCT01216683|50464893|FG002|Induction|Never started treatment|3|||
25208611|NCT01216683|50464891|FG000|Induction|Lack of Efficacy|4|||
25208612|NCT01216683|50464892|FG001|Induction|Lack of Efficacy|3|||
25208613|NCT01216683|50464893|FG002|Induction|Lack of Efficacy|7|||
25208614|NCT01216683|50464891|FG000|Induction|Adverse Event|0|||
25208615|NCT01216683|50464892|FG001|Induction|Adverse Event|5|||
25208616|NCT01216683|50464893|FG002|Induction|Adverse Event|5|||
25208617|NCT01216683|50464891|FG000|Induction|Death|0|||
25208618|NCT01216683|50464892|FG001|Induction|Death|0|||
25208619|NCT01216683|50464893|FG002|Induction|Death|2|||
25208620|NCT01216683|50464891|FG000|Induction|Withdrawal by Subject|0|||
25208621|NCT01216683|50464892|FG001|Induction|Withdrawal by Subject|4|||
25208622|NCT01216683|50464893|FG002|Induction|Withdrawal by Subject|2|||
25208623|NCT01216683|50464891|FG000|Induction|Other disease|0|||
25208624|NCT01216683|50464892|FG001|Induction|Other disease|1|||
25208625|NCT01216683|50464893|FG002|Induction|Other disease|2|||
25208626|NCT01216683|50464891|FG000|Continuation|Lack of Efficacy|3|||
25208627|NCT01216683|50464892|FG001|Continuation|Lack of Efficacy|2|||
25208628|NCT01216683|50464893|FG002|Continuation|Lack of Efficacy|7|||
25208629|NCT01216683|50464891|FG000|Continuation|Adverse Event|5|||
25208630|NCT01216683|50464892|FG001|Continuation|Adverse Event|3|||
25208631|NCT01216683|50464893|FG002|Continuation|Adverse Event|16|||
25208632|NCT01216683|50464891|FG000|Continuation|Death|1|||
25208633|NCT01216683|50464892|FG001|Continuation|Death|0|||
25208634|NCT01216683|50464893|FG002|Continuation|Death|2|||
25208635|NCT01216683|50464891|FG000|Continuation|Withdrawal by Subject|4|||
25208636|NCT01216683|50464892|FG001|Continuation|Withdrawal by Subject|5|||
25208637|NCT01216683|50464893|FG002|Continuation|Withdrawal by Subject|9|||
25208638|NCT01216683|50464891|FG000|Continuation|Other diseases|0|||
25208639|NCT01216683|50464892|FG001|Continuation|Other diseases|2|||
25208640|NCT01216683|50464893|FG002|Continuation|Other diseases|1|||
25208641|NCT01216683|50464891|FG000|Continuation|Physician Decision|1|||
25208642|NCT01216683|50464892|FG001|Continuation|Physician Decision|0|||
25208643|NCT01216683|50464893|FG002|Continuation|Physician Decision|1|||
25208644|NCT01216683|50464891|FG000|Continuation|Non-compliance|1|||
25208645|NCT01216683|50464892|FG001|Continuation|Non-compliance|0|||
25208646|NCT01216683|50464893|FG002|Continuation|Non-compliance|1|||
25208647|NCT01216683|50464891|FG000|Continuation|Insurance change|0|||
25208648|NCT01216683|50464892|FG001|Continuation|Insurance change|1|||
25208649|NCT01216683|50464893|FG002|Continuation|Insurance change|0|||
24976342|NCT00092547|50065232|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
24976343|NCT00092547|50065233|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
25171720|NCT03941483|50309293|FG002|Overall Study|Study Terminated by Sponsor|0|||
25208650|NCT01216683|50464891|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
25208651|NCT01216683|50464892|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
25208652|NCT01216683|50464893|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
25208653|NCT01216683|50464891|FG000|Continuation|Not reported|0|||
25208654|NCT01216683|50464892|FG001|Continuation|Not reported|0|||
25208655|NCT01216683|50464893|FG002|Continuation|Not reported|1|||
25208656|NCT01216683|50464891|FG000|Continuation|Never started treatment|0|||
25208657|NCT01216683|50464892|FG001|Continuation|Never started treatment|1|||
25208658|NCT01216683|50464893|FG002|Continuation|Never started treatment|5|||
25208659|NCT01145495|50464914|FG000|Overall Study|Adverse Event|6|||
25208660|NCT01145495|50464914|FG000|Overall Study|Withdrawal by Subject|6|||
25208661|NCT01145495|50464914|FG000|Overall Study|Disease progression after respone|2|||
25208662|NCT01124695|50464920|FG000|Overall Study|Disease progression|77|||
25208663|NCT01124695|50464920|FG000|Overall Study|Adverse Event|11|||
25208664|NCT01124695|50464920|FG000|Overall Study|Death|1|||
25208665|NCT01124695|50464920|FG000|Overall Study|Withdrawal by Subject|7|||
25208666|NCT01124695|50464920|FG000|Overall Study|Physician Decision|3|||
25208667|NCT01124695|50464920|FG000|Overall Study|Alternative therapy|9|||
25208668|NCT01124695|50464920|FG000|Overall Study|No documentation that patient went off treatment|4|||
25208669|NCT01124695|50464920|FG000|Overall Study|Ineligible|9|||
25208670|NCT01124695|50464920|FG000|Overall Study|Ineligible and never start treatment|2|||
25208671|NCT01084083|50464931|FG000|Overall Study|Adverse Event|5|||
25208672|NCT01084083|50464931|FG000|Overall Study|Death|1|||
25208673|NCT01084083|50464931|FG000|Overall Study|Withdrawal by Subject|2|||
25208674|NCT01084083|50464931|FG000|Overall Study|Complicating disease|1|||
25208675|NCT01084083|50464931|FG000|Overall Study|Other|2|||
25208676|NCT01084083|50464931|FG000|Overall Study|Never started assigned therapy|1|||
25208677|NCT01079780|50464939|FG000|Overall Study|Disease progression|43|||
24976344|NCT00092547|50065234|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
25171721|NCT03941483|50309291|FG000|Overall Study|Withdrawal by Subject|1|||
25171722|NCT03941483|50309292|FG001|Overall Study|Withdrawal by Subject|4|||
25171723|NCT03941483|50309293|FG002|Overall Study|Withdrawal by Subject|1|||
25171724|NCT03941483|50309291|FG000|Overall Study|Lost to Follow-up|2|||
25171725|NCT03941483|50309292|FG001|Overall Study|Lost to Follow-up|1|||
25171726|NCT03941483|50309293|FG002|Overall Study|Lost to Follow-up|8|||
25171727|NCT03941483|50309291|FG000|Overall Study|Death|3|||
25171728|NCT03941483|50309292|FG001|Overall Study|Death|2|||
25171729|NCT03941483|50309293|FG002|Overall Study|Death|6|||
25171730|NCT03689855|50309329|FG000|Overall Study|Adverse Event|3|||
25171731|NCT03689855|50309329|FG000|Overall Study|Withdrawal by Subject|1|||
25171732|NCT03635996|50309342|FG000|Overall Study|Study terminated by Sponsor|94|||
25171733|NCT03635996|50309342|FG000|Overall Study|Withdrawal by Subject|20|||
25171734|NCT03635996|50309342|FG000|Overall Study|Ablation|26|||
25171735|NCT03635996|50309342|FG000|Overall Study|Adverse Event|7|||
25171736|NCT03635996|50309342|FG000|Overall Study|Physician Decision|3|||
25171737|NCT03635996|50309342|FG000|Overall Study|Prohibited medication|5|||
25171738|NCT03635996|50309342|FG000|Overall Study|Did not meet eligibility criteria|5|||
25171739|NCT03635996|50309342|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
25171740|NCT03635996|50309342|FG000|Overall Study|Protocol Violation|1|||
25171741|NCT03635996|50309342|FG000|Overall Study|Lost to Follow-up|1|||
25171742|NCT03595878|50309349|FG000|Overall Study|Death|2|||
25171743|NCT03595878|50309350|FG001|Overall Study|Death|1|||
25171744|NCT03595878|50309351|FG002|Overall Study|Death|0|||
25171745|NCT03595878|50309349|FG000|Overall Study|Disease progression|2|||
25171746|NCT03595878|50309350|FG001|Overall Study|Disease progression|1|||
25171747|NCT03595878|50309351|FG002|Overall Study|Disease progression|2|||
25171748|NCT03168464|50309397|FG000|Overall Study|Death|9|||
25171749|NCT03168464|50309397|FG000|Overall Study|Progression of disease|6|||
25171750|NCT02985957|50309408|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25208678|NCT01079780|50464940|FG001|Overall Study|Disease progression|7|||
25208679|NCT01079780|50464941|FG002|Overall Study|Disease progression|31|||
25208680|NCT01079780|50464939|FG000|Overall Study|Adverse Event|13|||
25208681|NCT01079780|50464940|FG001|Overall Study|Adverse Event|5|||
25208682|NCT01079780|50464941|FG002|Overall Study|Adverse Event|7|||
25208683|NCT01079780|50464939|FG000|Overall Study|Death|2|||
25208684|NCT01079780|50464940|FG001|Overall Study|Death|0|||
25208685|NCT01079780|50464941|FG002|Overall Study|Death|2|||
25208686|NCT01079780|50464939|FG000|Overall Study|Withdrawal by Subject|6|||
25208687|NCT01079780|50464940|FG001|Overall Study|Withdrawal by Subject|4|||
25208688|NCT01079780|50464941|FG002|Overall Study|Withdrawal by Subject|4|||
25208689|NCT01079780|50464939|FG000|Overall Study|Alternative therapy|2|||
25208690|NCT01079780|50464940|FG001|Overall Study|Alternative therapy|0|||
25208691|NCT01079780|50464941|FG002|Overall Study|Alternative therapy|2|||
25208692|NCT01079780|50464939|FG000|Overall Study|Physician Decision|1|||
25208693|NCT01079780|50464940|FG001|Overall Study|Physician Decision|0|||
25208694|NCT01079780|50464941|FG002|Overall Study|Physician Decision|1|||
25208695|NCT01079780|50464939|FG000|Overall Study|Error made in lesion measurement|1|||
25208696|NCT01079780|50464940|FG001|Overall Study|Error made in lesion measurement|0|||
25208697|NCT01079780|50464941|FG002|Overall Study|Error made in lesion measurement|0|||
25208698|NCT01079780|50464939|FG000|Overall Study|Patient had surgery|1|||
25208699|NCT01079780|50464940|FG001|Overall Study|Patient had surgery|0|||
25208700|NCT01079780|50464941|FG002|Overall Study|Patient had surgery|0|||
25208701|NCT01079780|50464939|FG000|Overall Study|Treatment cycle delay|0|||
25208702|NCT01079780|50464940|FG001|Overall Study|Treatment cycle delay|0|||
25208703|NCT01079780|50464941|FG002|Overall Study|Treatment cycle delay|1|||
25208704|NCT01079780|50464939|FG000|Overall Study|Never started treatment|1|||
25208705|NCT01079780|50464940|FG001|Overall Study|Never started treatment|0|||
25208706|NCT01079780|50464941|FG002|Overall Study|Never started treatment|2|||
25208707|NCT01013961|50464951|FG000|Overall Study|Adverse Event|2|||
25208708|NCT01013961|50464952|FG001|Overall Study|Adverse Event|2|||
25208709|NCT01013961|50464951|FG000|Overall Study|Withdrawal by Subject|1|||
25208710|NCT01013961|50464952|FG001|Overall Study|Withdrawal by Subject|0|||
25208711|NCT01013961|50464951|FG000|Overall Study|Physician Decision|0|||
25208712|NCT01013961|50464952|FG001|Overall Study|Physician Decision|1|||
25208713|NCT00834093|50464967|FG000|Overall Study|Progressive Disease|3|||
25208714|NCT00834093|50464967|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
25208715|NCT00606294|50464973|FG000|Overall Study|Withdrawal by Subject|36|||
25208716|NCT00606294|50464974|FG001|Overall Study|Withdrawal by Subject|0|||
25208717|NCT00583596|50464980|FG000|Overall Study|Lost to Follow-up|110|||
25208718|NCT00583596|50464980|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
25208719|NCT00583596|50464980|FG000|Overall Study|Death|2|||
25208720|NCT00583596|50464980|FG000|Overall Study|Withdrawal by Subject|6|||
25208721|NCT00583596|50464980|FG000|Overall Study|Lost to Follow-up|94|||
25208722|NCT00583596|50464980|FG000|Overall Study|Data not complete|1|||
25208723|NCT00583596|50464980|FG000|Overall Study|Not consented|15|||
25208724|NCT00583596|50464980|FG000|Overall Study|Outside f-up window|26|||
25208725|NCT00316888|50464991|FG000|Overall Study|Adverse Event|4|||
25208726|NCT00316888|50464992|FG001|Overall Study|Adverse Event|5|||
25208727|NCT00316888|50464991|FG000|Overall Study|Withdrawal by Subject|2|||
25208728|NCT00316888|50464992|FG001|Overall Study|Withdrawal by Subject|2|||
25208729|NCT00316888|50464991|FG000|Overall Study|Not start protocol therapy|0|||
25208730|NCT00316888|50464992|FG001|Overall Study|Not start protocol therapy|1|||
25208731|NCT00274924|50465001|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
25208732|NCT00274924|50465002|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
25208733|NCT00274924|50465003|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
25208734|NCT00274924|50465001|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
25208735|NCT00274924|50465002|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
25208736|NCT00274924|50465003|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
25208737|NCT00274924|50465001|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
25208738|NCT00274924|50465002|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
25208739|NCT00274924|50465003|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
25208740|NCT00274924|50465001|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
25208741|NCT00274924|50465002|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
25208742|NCT00274924|50465003|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
25208743|NCT00274924|50465001|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
25208744|NCT00274924|50465002|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
25208745|NCT00274924|50465003|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
25208746|NCT00274924|50465001|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
25208747|NCT00274924|50465002|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
25208748|NCT00274924|50465003|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
25208749|NCT00274924|50465001|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
25208750|NCT00274924|50465002|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
25208751|NCT00274924|50465003|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
25208752|NCT00274924|50465001|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
25208753|NCT00274924|50465002|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
25208754|NCT00274924|50465003|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
25208755|NCT00274924|50465001|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
25208756|NCT00274924|50465002|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
25208757|NCT00274924|50465003|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
25208758|NCT00274924|50465001|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
25208759|NCT00274924|50465002|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
25208760|NCT00274924|50465003|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
25208761|NCT00274924|50465001|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
25208762|NCT00274924|50465002|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
25208763|NCT00274924|50465003|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
25208764|NCT00274924|50465001|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
25208765|NCT00274924|50465002|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
25208766|NCT00274924|50465003|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
25208767|NCT00274924|50465001|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
25208768|NCT00274924|50465002|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
25208769|NCT00274924|50465003|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
25208770|NCT00104884|50465010|FG000|Overall Study|Disease progression|4|||
25208771|NCT00096174|50465014|FG000|Overall Study|Lack of Efficacy|9|||
25208772|NCT00096174|50465014|FG000|Overall Study|Adverse Event|15|||
25208773|NCT00096174|50465014|FG000|Overall Study|Death|6|||
25208774|NCT00096174|50465014|FG000|Overall Study|Withdrawal by Subject|15|||
25208775|NCT00096174|50465014|FG000|Overall Study|Not started protocol therapy|3|||
25208776|NCT00096174|50465014|FG000|Overall Study|Ineligible|6|||
25208777|NCT00096174|50465014|FG000|Overall Study|other reason|8|||
25208778|NCT00080938|50465018|FG000|Overall Study|Adverse Event|3|||
25208779|NCT00080938|50465018|FG000|Overall Study|Withdrawal by Subject|6|||
25208780|NCT00080938|50465018|FG000|Overall Study|Death|2|||
25208781|NCT00080938|50465018|FG000|Overall Study|Lack of Efficacy|7|||
25208782|NCT00080938|50465018|FG000|Overall Study|other disease|1|||
25208783|NCT00080938|50465018|FG000|Overall Study|Not started protocol therapy|1|||
25208784|NCT00080938|50465018|FG000|Overall Study|Ineligible|4|||
25208785|NCT00078949|50465026|FG000|Overall Study|No treated|4|||
25208786|NCT00078949|50465027|FG001|Overall Study|No treated|5|||
25208787|NCT00078949|50465028|FG002|Overall Study|No treated|3|||
25208788|NCT00078949|50465029|FG003|Overall Study|No treated|3|||
25208789|NCT00074282|50465041|FG000|Step 1|Adverse Event|32|||
25208790|NCT00074282|50465042|FG001|Step 1|Adverse Event|0|||
25208791|NCT00074282|50465043|FG002|Step 1|Adverse Event|0|||
25208792|NCT00074282|50465041|FG000|Step 1|Death|6|||
25208793|NCT00074282|50465042|FG001|Step 1|Death|0|||
25208794|NCT00074282|50465043|FG002|Step 1|Death|0|||
25208795|NCT00074282|50465041|FG000|Step 1|Withdrawal by Subject|7|||
25208796|NCT00074282|50465042|FG001|Step 1|Withdrawal by Subject|0|||
25208797|NCT00074282|50465043|FG002|Step 1|Withdrawal by Subject|0|||
25208798|NCT00074282|50465041|FG000|Step 1|Disease progression|2|||
25208799|NCT00074282|50465042|FG001|Step 1|Disease progression|0|||
25208800|NCT00074282|50465043|FG002|Step 1|Disease progression|0|||
25208801|NCT00074282|50465041|FG000|Step 1|Alternative therapy|2|||
25208802|NCT00074282|50465042|FG001|Step 1|Alternative therapy|0|||
25208803|NCT00074282|50465043|FG002|Step 1|Alternative therapy|0|||
25208804|NCT00074282|50465041|FG000|Step 1|Other complicating disease|2|||
25208805|NCT00074282|50465042|FG001|Step 1|Other complicating disease|0|||
25208806|NCT00074282|50465043|FG002|Step 1|Other complicating disease|0|||
25208807|NCT00074282|50465041|FG000|Step 1|Physician Decision|1|||
25208808|NCT00074282|50465042|FG001|Step 1|Physician Decision|0|||
25208809|NCT00074282|50465043|FG002|Step 1|Physician Decision|0|||
25208810|NCT00074282|50465041|FG000|Step 1|Ineligible|4|||
25208811|NCT00074282|50465042|FG001|Step 1|Ineligible|0|||
25208812|NCT00074282|50465043|FG002|Step 1|Ineligible|0|||
25208813|NCT00074282|50465041|FG000|Step 1|Never started treatment|2|||
25208814|NCT00074282|50465042|FG001|Step 1|Never started treatment|0|||
25208815|NCT00074282|50465043|FG002|Step 1|Never started treatment|0|||
25208816|NCT00074282|50465041|FG000|Step 2|Adverse Event|0|||
25208817|NCT00074282|50465042|FG001|Step 2|Adverse Event|2|||
25208818|NCT00074282|50465043|FG002|Step 2|Adverse Event|12|||
25208819|NCT00074282|50465041|FG000|Step 2|Disease progression|0|||
25208820|NCT00074282|50465042|FG001|Step 2|Disease progression|0|||
25208821|NCT00074282|50465043|FG002|Step 2|Disease progression|5|||
25208822|NCT00074282|50465041|FG000|Step 2|Death|0|||
25208823|NCT00074282|50465042|FG001|Step 2|Death|0|||
25208824|NCT00074282|50465043|FG002|Step 2|Death|3|||
25208825|NCT00074282|50465041|FG000|Step 2|Withdrawal by Subject|0|||
25208826|NCT00074282|50465042|FG001|Step 2|Withdrawal by Subject|0|||
25208827|NCT00074282|50465043|FG002|Step 2|Withdrawal by Subject|2|||
25208828|NCT00074282|50465041|FG000|Step 2|Physician Decision|0|||
25208829|NCT00074282|50465042|FG001|Step 2|Physician Decision|0|||
25208830|NCT00074282|50465043|FG002|Step 2|Physician Decision|1|||
25208831|NCT00074282|50465041|FG000|Step 2|Ineligible|0|||
25208832|NCT00074282|50465042|FG001|Step 2|Ineligible|0|||
25208833|NCT00074282|50465043|FG002|Step 2|Ineligible|1|||
25208834|NCT00071981|50465055|FG000|Overall Study|Lack of Efficacy|37|||
25208835|NCT00071981|50465056|FG001|Overall Study|Lack of Efficacy|29|||
25208836|NCT00071981|50465057|FG002|Overall Study|Lack of Efficacy|30|||
25208837|NCT00071981|50465058|FG003|Overall Study|Lack of Efficacy|43|||
25208838|NCT00071981|50465055|FG000|Overall Study|Adverse Event|4|||
25208839|NCT00071981|50465056|FG001|Overall Study|Adverse Event|4|||
25208840|NCT00071981|50465057|FG002|Overall Study|Adverse Event|3|||
25208841|NCT00071981|50465058|FG003|Overall Study|Adverse Event|1|||
25208842|NCT00071981|50465055|FG000|Overall Study|Death|0|||
25208843|NCT00071981|50465056|FG001|Overall Study|Death|0|||
25208844|NCT00071981|50465057|FG002|Overall Study|Death|1|||
25208845|NCT00071981|50465058|FG003|Overall Study|Death|1|||
25208846|NCT00071981|50465055|FG000|Overall Study|Withdrawal by Subject|3|||
25316143|NCT00896532|50631592|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25316144|NCT00896532|50631593|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25316145|NCT00896532|50631594|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25316146|NCT00896532|50631595|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25316147|NCT00896532|50631596|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25316148|NCT00896532|50631597|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25316149|NCT00896532|50631598|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25316150|NCT00896532|50631599|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25316151|NCT00896532|50631600|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25316152|NCT00896532|50631601|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25077168|NCT01633060|50184992|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
25077169|NCT01633060|50184993|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
25077170|NCT01632904|50185002|FG000|Overall Study|Adverse Event|4|||
25077171|NCT01632904|50185003|FG001|Overall Study|Adverse Event|1|||
25077172|NCT01632904|50185002|FG000|Overall Study|Physician Decision|0|||
25316153|NCT00896532|50631602|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25316154|NCT00896532|50631603|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
25316155|NCT00896532|50631604|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
25316156|NCT00896532|50631605|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
25316157|NCT00896532|50631606|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25316158|NCT00896532|50631607|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25316159|NCT00896532|50631608|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25316160|NCT00896532|50631609|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25316161|NCT00896532|50631610|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
25316162|NCT00896532|50631588|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316163|NCT00896532|50631589|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316164|NCT00896532|50631590|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316165|NCT00896532|50631591|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316166|NCT00896532|50631592|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316167|NCT00896532|50631593|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316168|NCT00896532|50631594|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316169|NCT00896532|50631595|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316170|NCT00896532|50631596|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316171|NCT00896532|50631597|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316172|NCT00896532|50631598|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316173|NCT00896532|50631599|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316174|NCT00896532|50631600|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316175|NCT00896532|50631601|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316176|NCT00896532|50631602|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316177|NCT00896532|50631603|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25077173|NCT01632904|50185003|FG001|Overall Study|Physician Decision|1|||
25077174|NCT01632904|50185002|FG000|Overall Study|Subject decision|3|||
25208847|NCT00071981|50465056|FG001|Overall Study|Withdrawal by Subject|1|||
25208848|NCT00071981|50465057|FG002|Overall Study|Withdrawal by Subject|0|||
25208849|NCT00071981|50465058|FG003|Overall Study|Withdrawal by Subject|0|||
25208850|NCT00071981|50465055|FG000|Overall Study|No protocol therapy|2|||
25208851|NCT00071981|50465056|FG001|Overall Study|No protocol therapy|5|||
25208852|NCT00071981|50465057|FG002|Overall Study|No protocol therapy|1|||
25208853|NCT00071981|50465058|FG003|Overall Study|No protocol therapy|0|||
25208854|NCT00071981|50465055|FG000|Overall Study|others (not specified in the study)|0|||
25208855|NCT00071981|50465056|FG001|Overall Study|others (not specified in the study)|2|||
25208856|NCT00071981|50465057|FG002|Overall Study|others (not specified in the study)|2|||
25316178|NCT00896532|50631604|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
25316179|NCT00896532|50631605|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316180|NCT00896532|50631606|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316181|NCT00896532|50631607|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316182|NCT00896532|50631608|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316183|NCT00896532|50631609|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316184|NCT00896532|50631610|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
25316185|NCT00896532|50631588|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
25316186|NCT00896532|50631589|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
25316187|NCT00896532|50631590|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
25316188|NCT00896532|50631591|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
25316189|NCT00896532|50631592|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
25316190|NCT00896532|50631593|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
25316191|NCT00896532|50631594|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
25316192|NCT00896532|50631595|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
25316193|NCT00896532|50631596|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
25316194|NCT00896532|50631597|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
25316195|NCT00896532|50631598|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
25316196|NCT00896532|50631599|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
25316197|NCT00896532|50631600|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
25316198|NCT00896532|50631601|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
25316199|NCT00896532|50631602|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
25316200|NCT00896532|50631603|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
25316201|NCT00896532|50631604|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
25316202|NCT00896532|50631605|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
25316203|NCT00896532|50631606|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
25316204|NCT00896532|50631607|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
25316205|NCT00896532|50631608|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
25316206|NCT00896532|50631609|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
25316207|NCT00896532|50631610|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
25316208|NCT00896532|50631588|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316209|NCT00896532|50631589|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316210|NCT00896532|50631590|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316211|NCT00896532|50631591|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316212|NCT00896532|50631592|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316213|NCT00896532|50631593|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316214|NCT00896532|50631594|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316215|NCT00896532|50631595|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316216|NCT00896532|50631596|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316217|NCT00896532|50631597|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316218|NCT00896532|50631598|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316219|NCT00896532|50631599|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316220|NCT00896532|50631600|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316221|NCT00896532|50631601|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316222|NCT00896532|50631602|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316223|NCT00896532|50631603|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316224|NCT00896532|50631604|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
25316225|NCT00896532|50631605|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316226|NCT00896532|50631606|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316227|NCT00896532|50631607|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316228|NCT00896532|50631608|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316229|NCT00896532|50631609|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316230|NCT00896532|50631610|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
25316231|NCT00896532|50631588|FG000|Months 48-72: Follow-on Phase|Death|0|||
25316232|NCT00896532|50631589|FG001|Months 48-72: Follow-on Phase|Death|0|||
25208857|NCT00071981|50465058|FG003|Overall Study|others (not specified in the study)|0|||
25208858|NCT00070291|50465068|FG000|Step 1|Withdrawal by Subject|1|||
25208859|NCT00070291|50465068|FG000|Step 1|Adverse Event|1|||
25208860|NCT00070291|50465068|FG000|Step 2|Adverse Event|1|||
25208861|NCT00064350|50465075|FG000|Induction Treatment|Disease Progression|5|||
25208862|NCT00064350|50465076|FG001|Induction Treatment|Disease Progression|1|||
25208863|NCT00064350|50465077|FG002|Induction Treatment|Disease Progression|110|||
25208864|NCT00064350|50465075|FG000|Induction Treatment|Adverse Event|0|||
25208865|NCT00064350|50465076|FG001|Induction Treatment|Adverse Event|2|||
25208866|NCT00064350|50465077|FG002|Induction Treatment|Adverse Event|49|||
25208867|NCT00064350|50465075|FG000|Induction Treatment|Death|0|||
25208868|NCT00064350|50465076|FG001|Induction Treatment|Death|0|||
25208869|NCT00064350|50465077|FG002|Induction Treatment|Death|9|||
25208870|NCT00064350|50465075|FG000|Induction Treatment|Withdrawal by Subject|0|||
25208871|NCT00064350|50465076|FG001|Induction Treatment|Withdrawal by Subject|0|||
25208872|NCT00064350|50465077|FG002|Induction Treatment|Withdrawal by Subject|21|||
25208873|NCT00064350|50465075|FG000|Induction Treatment|Ineligible or never started treatment|3|||
25208874|NCT00064350|50465076|FG001|Induction Treatment|Ineligible or never started treatment|6|||
25208875|NCT00064350|50465077|FG002|Induction Treatment|Ineligible or never started treatment|34|||
25208876|NCT00064350|50465075|FG000|Induction Treatment|Other|0|||
25208877|NCT00064350|50465076|FG001|Induction Treatment|Other|0|||
25208878|NCT00064350|50465077|FG002|Induction Treatment|Other|13|||
25208879|NCT00064350|50465075|FG000|Randomization|Adverse Event|8|||
25208880|NCT00064350|50465076|FG001|Randomization|Adverse Event|3|||
25208881|NCT00064350|50465077|FG002|Randomization|Adverse Event|0|||
25208882|NCT00064350|50465075|FG000|Randomization|Death|3|||
25208883|NCT00064350|50465076|FG001|Randomization|Death|0|||
25208884|NCT00064350|50465077|FG002|Randomization|Death|0|||
25208885|NCT00064350|50465075|FG000|Randomization|Withdrawal by Subject|1|||
25208886|NCT00064350|50465076|FG001|Randomization|Withdrawal by Subject|0|||
25208887|NCT00064350|50465077|FG002|Randomization|Withdrawal by Subject|0|||
25208888|NCT00064350|50465075|FG000|Randomization|Ineligible or never started treatment|9|||
25208889|NCT00064350|50465076|FG001|Randomization|Ineligible or never started treatment|15|||
25208890|NCT00064350|50465077|FG002|Randomization|Ineligible or never started treatment|0|||
25208891|NCT00064350|50465075|FG000|Randomization|Other|5|||
25208892|NCT00064350|50465076|FG001|Randomization|Other|0|||
25208893|NCT00064350|50465077|FG002|Randomization|Other|0|||
25208894|NCT00064350|50465075|FG000|Cross-Over|Adverse Event|0|||
25208895|NCT00064350|50465076|FG001|Cross-Over|Adverse Event|1|||
25208896|NCT00064350|50465077|FG002|Cross-Over|Adverse Event|0|||
25208897|NCT00064350|50465075|FG000|Cross-Over|Death|1|||
25208898|NCT00064350|50465076|FG001|Cross-Over|Death|3|||
25208899|NCT00064350|50465077|FG002|Cross-Over|Death|0|||
25208900|NCT00064350|50465075|FG000|Cross-Over|Withdrawal by Subject|2|||
25208901|NCT00064350|50465076|FG001|Cross-Over|Withdrawal by Subject|2|||
25208902|NCT00064350|50465077|FG002|Cross-Over|Withdrawal by Subject|0|||
25208903|NCT00064350|50465075|FG000|Cross-Over|Ineligible or never started treatment|3|||
25208904|NCT00064350|50465076|FG001|Cross-Over|Ineligible or never started treatment|6|||
25208905|NCT00064350|50465077|FG002|Cross-Over|Ineligible or never started treatment|0|||
25208906|NCT00064350|50465075|FG000|Cross-Over|Other|0|||
25208907|NCT00064350|50465076|FG001|Cross-Over|Other|2|||
25208908|NCT00064350|50465077|FG002|Cross-Over|Other|0|||
25208909|NCT00063986|50465086|FG000|Overall Study|Withdrawal by Subject|1|||
25208910|NCT00063986|50465086|FG000|Overall Study|Ineligible|1|||
25208911|NCT00063986|50465086|FG000|Overall Study|Intra-operatively ineligible|4|||
25208912|NCT00057954|50465094|FG000|Overall Study|Death|1|||
25208913|NCT00057954|50465094|FG000|Overall Study|Disease progression|1|||
25208914|NCT00049530|50465098|FG000|Overall Study|Lack of Efficacy|25|||
25208915|NCT00049530|50465098|FG000|Overall Study|Adverse Event|2|||
25208916|NCT00049530|50465098|FG000|Overall Study|Death|1|||
25208917|NCT00049530|50465098|FG000|Overall Study|symptomatic deterioration|1|||
25208918|NCT00049530|50465098|FG000|Overall Study|ineligible|3|||
25208919|NCT00045305|50465102|FG000|Overall Study|Lack of Efficacy|6|||
25208920|NCT00045305|50465102|FG000|Overall Study|Adverse Event|3|||
25208921|NCT00045305|50465102|FG000|Overall Study|Death|3|||
25208922|NCT00045305|50465102|FG000|Overall Study|site error|2|||
25208923|NCT00033657|50465108|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
25208924|NCT00033657|50465109|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
25208925|NCT00033657|50465108|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
25208926|NCT00033657|50465109|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
25208927|NCT00033657|50465108|FG000|Neoadjuvant Chemotherapy|Death|1|||
25208928|NCT00033657|50465109|FG001|Neoadjuvant Chemotherapy|Death|1|||
25208929|NCT00033657|50465108|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
25208930|NCT00033657|50465109|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
25208931|NCT00033657|50465108|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
25208932|NCT00033657|50465109|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
25208933|NCT00033657|50465108|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
25208934|NCT00033657|50465109|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
25208935|NCT00033657|50465108|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
25208936|NCT00033657|50465109|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
25208937|NCT00033657|50465108|FG000|Surgical Resection|not complete resection|0|||
25208938|NCT00033657|50465109|FG001|Surgical Resection|not complete resection|3|||
25208939|NCT00033657|50465108|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
25208940|NCT00033657|50465109|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
25208941|NCT00033657|50465108|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
25208942|NCT00033657|50465109|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
25208943|NCT00033657|50465108|FG000|Adjuvant Chemotherapy|Death|2|||
25208944|NCT00033657|50465109|FG001|Adjuvant Chemotherapy|Death|1|||
25208945|NCT00033657|50465108|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
25208946|NCT00033657|50465109|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
25208947|NCT00033657|50465108|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
25208948|NCT00033657|50465109|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
25208949|NCT00033657|50465108|FG000|Adjuvant Chemotherapy|Other|0|||
25208950|NCT00033657|50465109|FG001|Adjuvant Chemotherapy|Other|2|||
25208951|NCT00003389|50465119|FG000|Overall Study|Disease progression|6|||
25208952|NCT00003389|50465120|FG001|Overall Study|Disease progression|1|||
25208953|NCT00003389|50465119|FG000|Overall Study|Adverse Event|13|||
25208954|NCT00003389|50465120|FG001|Overall Study|Adverse Event|2|||
25208955|NCT00003389|50465119|FG000|Overall Study|Death|0|||
25208956|NCT00003389|50465120|FG001|Overall Study|Death|3|||
25208957|NCT00003389|50465119|FG000|Overall Study|Withdrawal by Subject|12|||
25208958|NCT00003389|50465120|FG001|Overall Study|Withdrawal by Subject|5|||
25208959|NCT00003389|50465119|FG000|Overall Study|Alternative therapy|2|||
25208960|NCT00003389|50465120|FG001|Overall Study|Alternative therapy|1|||
25208961|NCT00003389|50465119|FG000|Overall Study|Complicating disease|1|||
25208962|NCT00003389|50465120|FG001|Overall Study|Complicating disease|0|||
25208963|NCT00003389|50465119|FG000|Overall Study|Off-treatment reason missing|31|||
25208964|NCT00003389|50465120|FG001|Overall Study|Off-treatment reason missing|21|||
25208965|NCT00003389|50465119|FG000|Overall Study|Ineligible|33|||
25208966|NCT00003389|50465120|FG001|Overall Study|Ineligible|27|||
25208967|NCT00003138|50465128|FG000|Step 1|Reasons off treatment not documented|60|||
25208968|NCT00003138|50465129|FG001|Step 1|Reasons off treatment not documented|57|||
25208969|NCT00003138|50465128|FG000|Step 1|Never started treatment|1|||
25208970|NCT00003138|50465129|FG001|Step 1|Never started treatment|0|||
25208971|NCT00003138|50465128|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
25208972|NCT00003138|50465129|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
25208973|NCT00003138|50465128|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
25208974|NCT00003138|50465129|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
25208975|NCT00003138|50465128|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
25208976|NCT00003138|50465129|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
25208977|NCT00003138|50465128|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
25208978|NCT00003138|50465129|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
25208979|NCT00002525|50465140|FG000|Overall Study|Adverse Event|36|||
25208980|NCT00002525|50465141|FG001|Overall Study|Adverse Event|0|||
25208981|NCT00002525|50465140|FG000|Overall Study|Death|5|||
25208982|NCT00002525|50465141|FG001|Overall Study|Death|0|||
25208983|NCT00002525|50465140|FG000|Overall Study|Withdrawal by Subject|11|||
25208984|NCT00002525|50465141|FG001|Overall Study|Withdrawal by Subject|0|||
25208985|NCT00002525|50465140|FG000|Overall Study|Start non-protocol therapy|1|||
25208986|NCT00002525|50465141|FG001|Overall Study|Start non-protocol therapy|0|||
25208987|NCT00002525|50465140|FG000|Overall Study|Other complicating disease|1|||
25208988|NCT00002525|50465141|FG001|Overall Study|Other complicating disease|0|||
25208989|NCT00002525|50465140|FG000|Overall Study|Duke's A, B1, D disease|92|||
25208990|NCT00002525|50465141|FG001|Overall Study|Duke's A, B1, D disease|0|||
25208991|NCT00002525|50465140|FG000|Overall Study|Error|6|||
25208992|NCT00002525|50465141|FG001|Overall Study|Error|0|||
25208993|NCT00002525|50465140|FG000|Overall Study|Other|26|||
25208994|NCT00002525|50465141|FG001|Overall Study|Other|0|||
25208995|NCT00002525|50465140|FG000|Overall Study|Never start protocol therapy|8|||
25208996|NCT00002525|50465141|FG001|Overall Study|Never start protocol therapy|0|||
25316233|NCT00896532|50631590|FG002|Months 48-72: Follow-on Phase|Death|0|||
25316234|NCT00896532|50631591|FG003|Months 48-72: Follow-on Phase|Death|0|||
25316235|NCT00896532|50631592|FG004|Months 48-72: Follow-on Phase|Death|0|||
25316236|NCT00896532|50631593|FG005|Months 48-72: Follow-on Phase|Death|0|||
25316237|NCT00896532|50631594|FG006|Months 48-72: Follow-on Phase|Death|0|||
25316238|NCT00896532|50631595|FG007|Months 48-72: Follow-on Phase|Death|0|||
25316239|NCT00896532|50631596|FG008|Months 48-72: Follow-on Phase|Death|0|||
25316240|NCT00896532|50631597|FG009|Months 48-72: Follow-on Phase|Death|0|||
25316241|NCT00896532|50631598|FG010|Months 48-72: Follow-on Phase|Death|0|||
25316242|NCT00896532|50631599|FG011|Months 48-72: Follow-on Phase|Death|0|||
25316243|NCT00896532|50631600|FG012|Months 48-72: Follow-on Phase|Death|0|||
25316244|NCT00896532|50631601|FG013|Months 48-72: Follow-on Phase|Death|0|||
25316245|NCT00896532|50631602|FG014|Months 48-72: Follow-on Phase|Death|0|||
25316246|NCT00896532|50631603|FG015|Months 48-72: Follow-on Phase|Death|0|||
25316247|NCT00896532|50631604|FG016|Months 48-72: Follow-on Phase|Death|0|||
25316248|NCT00896532|50631605|FG017|Months 48-72: Follow-on Phase|Death|0|||
25316249|NCT00896532|50631606|FG018|Months 48-72: Follow-on Phase|Death|1|||
25316250|NCT00896532|50631607|FG019|Months 48-72: Follow-on Phase|Death|0|||
25316251|NCT00896532|50631608|FG020|Months 48-72: Follow-on Phase|Death|0|||
25316252|NCT00896532|50631609|FG021|Months 48-72: Follow-on Phase|Death|0|||
25316253|NCT00896532|50631610|FG022|Months 48-72: Follow-on Phase|Death|0|||
25316254|NCT00896532|50631588|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25208997|NCT02259348|50465149|FG000|Overall Study|Donors|6|||
25208998|NCT02259348|50465149|FG000|Overall Study|Death|4|||
25208999|NCT02259114|50465410|FG000|Overall Study|Progressive Disease|14|||
25209000|NCT02259114|50465411|FG001|Overall Study|Progressive Disease|2|||
25209001|NCT02259114|50465412|FG002|Overall Study|Progressive Disease|10|||
25209002|NCT02259114|50465413|FG003|Overall Study|Progressive Disease|2|||
25209003|NCT02259114|50465414|FG004|Overall Study|Progressive Disease|5|||
25209004|NCT02259114|50465410|FG000|Overall Study|Adverse Event|2|||
25209005|NCT02259114|50465411|FG001|Overall Study|Adverse Event|1|||
25209006|NCT02259114|50465412|FG002|Overall Study|Adverse Event|0|||
25209007|NCT02259114|50465413|FG003|Overall Study|Adverse Event|0|||
25209008|NCT02259114|50465414|FG004|Overall Study|Adverse Event|1|||
25209009|NCT02259114|50465410|FG000|Overall Study|Death|3|||
25209010|NCT02259114|50465411|FG001|Overall Study|Death|0|||
25209011|NCT02259114|50465412|FG002|Overall Study|Death|1|||
25209012|NCT02259114|50465413|FG003|Overall Study|Death|0|||
25209013|NCT02259114|50465414|FG004|Overall Study|Death|0|||
25209014|NCT02259114|50465410|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
25209015|NCT02259114|50465411|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
25209016|NCT02259114|50465412|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
25209017|NCT02259114|50465413|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
25209018|NCT02259114|50465414|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
25209019|NCT02259114|50465410|FG000|Overall Study|Withdrawal by Subject|0|||
25209020|NCT02259114|50465411|FG001|Overall Study|Withdrawal by Subject|0|||
25209021|NCT02259114|50465412|FG002|Overall Study|Withdrawal by Subject|1|||
25209022|NCT02259114|50465413|FG003|Overall Study|Withdrawal by Subject|1|||
25209023|NCT02259114|50465414|FG004|Overall Study|Withdrawal by Subject|0|||
25209024|NCT02259114|50465410|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
25209025|NCT02259114|50465411|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
25209026|NCT02259114|50465412|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
25209027|NCT02259114|50465413|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
25209028|NCT02259114|50465414|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
25209029|NCT02259114|50465410|FG000|Overall Study|Not Treated|1|||
25209030|NCT02259114|50465411|FG001|Overall Study|Not Treated|0|||
25209031|NCT02259114|50465412|FG002|Overall Study|Not Treated|0|||
25209032|NCT02259114|50465413|FG003|Overall Study|Not Treated|0|||
25209033|NCT02259114|50465414|FG004|Overall Study|Not Treated|0|||
25209034|NCT03112603|50465428|FG000|End of Randomization Period|Lost to Follow-up|1|||
25209035|NCT03112603|50465429|FG001|End of Randomization Period|Lost to Follow-up|0|||
25209036|NCT03112603|50465430|FG002|End of Randomization Period|Lost to Follow-up|0|||
25209037|NCT03112603|50465428|FG000|End of Randomization Period|Subject/Guardian Decision|4|||
25209038|NCT03112603|50465429|FG001|End of Randomization Period|Subject/Guardian Decision|11|||
25209039|NCT03112603|50465430|FG002|End of Randomization Period|Subject/Guardian Decision|0|||
25209040|NCT03112603|50465428|FG000|End of Randomization Period|Physician Decision|4|||
25209041|NCT03112603|50465429|FG001|End of Randomization Period|Physician Decision|14|||
25209042|NCT03112603|50465430|FG002|End of Randomization Period|Physician Decision|0|||
25209043|NCT03112603|50465428|FG000|End of Randomization Period|Failure to meet protocol continuation criteria|4|||
25209044|NCT03112603|50465429|FG001|End of Randomization Period|Failure to meet protocol continuation criteria|5|||
25209045|NCT03112603|50465430|FG002|End of Randomization Period|Failure to meet protocol continuation criteria|0|||
25209046|NCT03112603|50465428|FG000|End of Randomization Period|Death|8|||
25209047|NCT03112603|50465429|FG001|End of Randomization Period|Death|7|||
25209048|NCT03112603|50465430|FG002|End of Randomization Period|Death|0|||
25209049|NCT03112603|50465428|FG000|End of Randomization Period|Disease Relapse|9|||
25209050|NCT03112603|50465429|FG001|End of Randomization Period|Disease Relapse|7|||
25209051|NCT03112603|50465430|FG002|End of Randomization Period|Disease Relapse|0|||
25209052|NCT03112603|50465428|FG000|End of Randomization Period|Lack of Efficacy|24|||
25316255|NCT00896532|50631589|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316256|NCT00896532|50631590|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316257|NCT00896532|50631591|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316258|NCT00896532|50631592|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316259|NCT00896532|50631593|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316260|NCT00896532|50631594|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316261|NCT00896532|50631595|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316262|NCT00896532|50631596|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316263|NCT00896532|50631597|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316264|NCT00896532|50631598|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316265|NCT00896532|50631599|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25209053|NCT03112603|50465429|FG001|End of Randomization Period|Lack of Efficacy|70|||
25209054|NCT03112603|50465430|FG002|End of Randomization Period|Lack of Efficacy|0|||
25209055|NCT03112603|50465428|FG000|End of Randomization Period|Adverse Event|28|||
25209056|NCT03112603|50465429|FG001|End of Randomization Period|Adverse Event|8|||
25209057|NCT03112603|50465430|FG002|End of Randomization Period|Adverse Event|0|||
25209058|NCT03112603|50465428|FG000|End of Randomization Period|Ongoing Treatment|83|||
25209059|NCT03112603|50465429|FG001|End of Randomization Period|Ongoing Treatment|42|||
25209060|NCT03112603|50465430|FG002|End of Randomization Period|Ongoing Treatment|0|||
25209061|NCT03112603|50465428|FG000|End of Cross Over Period|Death|0|||
25209062|NCT03112603|50465429|FG001|End of Cross Over Period|Death|0|||
25209063|NCT03112603|50465430|FG002|End of Cross Over Period|Death|1|||
25209064|NCT03112603|50465428|FG000|End of Cross Over Period|Subject/Guardian Decision|0|||
25209065|NCT03112603|50465429|FG001|End of Cross Over Period|Subject/Guardian Decision|0|||
25209066|NCT03112603|50465430|FG002|End of Cross Over Period|Subject/Guardian Decision|3|||
25209067|NCT03112603|50465428|FG000|End of Cross Over Period|Physician Decision|0|||
25209068|NCT03112603|50465429|FG001|End of Cross Over Period|Physician Decision|0|||
25209069|NCT03112603|50465430|FG002|End of Cross Over Period|Physician Decision|3|||
25209070|NCT03112603|50465428|FG000|End of Cross Over Period|Lack of Efficacy|0|||
25209071|NCT03112603|50465429|FG001|End of Cross Over Period|Lack of Efficacy|0|||
25209072|NCT03112603|50465430|FG002|End of Cross Over Period|Lack of Efficacy|4|||
25209073|NCT03112603|50465428|FG000|End of Cross Over Period|Adverse Event|0|||
25209074|NCT03112603|50465429|FG001|End of Cross Over Period|Adverse Event|0|||
25209075|NCT03112603|50465430|FG002|End of Cross Over Period|Adverse Event|4|||
25209076|NCT03112603|50465428|FG000|End of Cross Over Period|Treatment Ongoing|0|||
25209077|NCT03112603|50465429|FG001|End of Cross Over Period|Treatment Ongoing|0|||
25209078|NCT03112603|50465430|FG002|End of Cross Over Period|Treatment Ongoing|46|||
25209079|NCT02258334|50465479|FG000|Overall Study|Adverse Event|1|||
25209080|NCT02258334|50465480|FG001|Overall Study|Adverse Event|0|||
25209081|NCT02258334|50465481|FG002|Overall Study|Adverse Event|0|||
25209082|NCT02258334|50465482|FG003|Overall Study|Adverse Event|0|||
25209083|NCT04960202|50465519|FG000|Overall Study|Other|12|||
25209084|NCT04960202|50465520|FG001|Overall Study|Other|10|||
25209085|NCT04960202|50465519|FG000|Overall Study|Withdrawal by Subject|43|||
25209086|NCT04960202|50465520|FG001|Overall Study|Withdrawal by Subject|45|||
25209087|NCT04960202|50465519|FG000|Overall Study|Lost to Follow-up|20|||
25209088|NCT04960202|50465520|FG001|Overall Study|Lost to Follow-up|17|||
25209089|NCT04960202|50465519|FG000|Overall Study|Death|0|||
25209090|NCT04960202|50465520|FG001|Overall Study|Death|15|||
25209091|NCT02257632|50465590|FG000|Overall Study|Withdrawal by Subject|0|||
25209092|NCT02257632|50465591|FG001|Overall Study|Withdrawal by Subject|1|||
25209093|NCT02257632|50465590|FG000|Overall Study|Adverse Event|1|||
25209094|NCT02257632|50465591|FG001|Overall Study|Adverse Event|2|||
25209095|NCT01642914|50465625|FG000|Overall Study|Adverse Event|11|||
25209096|NCT01642914|50465626|FG001|Overall Study|Adverse Event|7|||
25209097|NCT01642914|50465627|FG002|Overall Study|Adverse Event|15|||
25209098|NCT01642914|50465625|FG000|Overall Study|Lack of Efficacy|9|||
25209099|NCT01642914|50465626|FG001|Overall Study|Lack of Efficacy|4|||
25209100|NCT01642914|50465627|FG002|Overall Study|Lack of Efficacy|2|||
25209101|NCT01642914|50465625|FG000|Overall Study|Protocol Violation|15|||
25209102|NCT01642914|50465626|FG001|Overall Study|Protocol Violation|13|||
25209103|NCT01642914|50465627|FG002|Overall Study|Protocol Violation|6|||
25209104|NCT01642914|50465625|FG000|Overall Study|Withdrawal by Subject|5|||
25209105|NCT01642914|50465626|FG001|Overall Study|Withdrawal by Subject|5|||
25209106|NCT01642914|50465627|FG002|Overall Study|Withdrawal by Subject|10|||
25209107|NCT01642914|50465625|FG000|Overall Study|Lost to Follow-up|5|||
25209108|NCT01642914|50465626|FG001|Overall Study|Lost to Follow-up|3|||
25209109|NCT01642914|50465627|FG002|Overall Study|Lost to Follow-up|7|||
25209110|NCT01642914|50465625|FG000|Overall Study|Other Reason|1|||
25209111|NCT01642914|50465626|FG001|Overall Study|Other Reason|0|||
25209112|NCT01642914|50465627|FG002|Overall Study|Other Reason|0|||
25209113|NCT01642602|50465686|FG000|Overall Study|Adverse Event|2|||
25209114|NCT02256540|50465752|FG000|Overall Study|Withdrawal by Subject|0|||
25209115|NCT02256540|50465753|FG001|Overall Study|Withdrawal by Subject|1|||
25209116|NCT02256540|50465754|FG002|Overall Study|Withdrawal by Subject|1|||
25209117|NCT02256540|50465752|FG000|Overall Study|Back pain preventing exercise|0|||
25209118|NCT02256540|50465753|FG001|Overall Study|Back pain preventing exercise|0|||
25209119|NCT02256540|50465754|FG002|Overall Study|Back pain preventing exercise|1|||
25209120|NCT01640184|50465778|FG000|Overall Study|Death|1|||
25209121|NCT01640184|50465779|FG001|Overall Study|Death|0|||
25209122|NCT01640184|50465780|FG002|Overall Study|Death|0|||
25209123|NCT01640184|50465778|FG000|Overall Study|Lost to Follow-up|4|||
25209124|NCT01640184|50465779|FG001|Overall Study|Lost to Follow-up|1|||
25209125|NCT01640184|50465780|FG002|Overall Study|Lost to Follow-up|0|||
25209126|NCT01640184|50465778|FG000|Overall Study|Physician Decision|3|||
25209127|NCT01640184|50465779|FG001|Overall Study|Physician Decision|0|||
25209128|NCT01640184|50465780|FG002|Overall Study|Physician Decision|0|||
25209129|NCT01640184|50465778|FG000|Overall Study|Withdrawal by Subject|0|||
25209130|NCT01640184|50465779|FG001|Overall Study|Withdrawal by Subject|1|||
25209131|NCT01640184|50465780|FG002|Overall Study|Withdrawal by Subject|1|||
25209132|NCT01640184|50465778|FG000|Overall Study|Protocol Violation|0|||
25209133|NCT01640184|50465779|FG001|Overall Study|Protocol Violation|0|||
25209134|NCT01640184|50465780|FG002|Overall Study|Protocol Violation|1|||
25209135|NCT02256384|50465800|FG000|Overall Study|Withdrawal by Subject|12|||
25077175|NCT01632904|50185003|FG001|Overall Study|Subject decision|2|||
25077176|NCT01632904|50185002|FG000|Overall Study|Disease Progression|0|||
25077177|NCT01632904|50185003|FG001|Overall Study|Disease Progression|1|||
25077178|NCT01632904|50185002|FG000|Overall Study|Reason for discontinuation not available|0|||
25077179|NCT01632904|50185003|FG001|Overall Study|Reason for discontinuation not available|1|||
25077180|NCT03834779|50185011|FG000|Overall Study|Death|1|||
25077181|NCT03834779|50185012|FG001|Overall Study|Death|2|||
25077182|NCT03834779|50185011|FG000|Overall Study|Lost to Follow-up|6|||
25077183|NCT03834779|50185012|FG001|Overall Study|Lost to Follow-up|4|||
25077184|NCT03726437|50185021|FG000|Overall Study|Lost to Follow-up|85|||
25077185|NCT03726437|50185022|FG001|Overall Study|Lost to Follow-up|76|||
25077186|NCT02465528|50185032|FG000|Overall Study|Progressive disease|0|||
25077187|NCT02465528|50185033|FG001|Overall Study|Progressive disease|2|||
25077188|NCT02465528|50185034|FG002|Overall Study|Progressive disease|9|||
25077189|NCT02465528|50185035|FG003|Overall Study|Progressive disease|4|||
25077190|NCT02465528|50185032|FG000|Overall Study|Study terminated by sponsor|1|||
25077191|NCT02465528|50185033|FG001|Overall Study|Study terminated by sponsor|2|||
25077192|NCT02465528|50185034|FG002|Overall Study|Study terminated by sponsor|0|||
25077193|NCT02465528|50185035|FG003|Overall Study|Study terminated by sponsor|0|||
25077194|NCT02465528|50185032|FG000|Overall Study|Withdrawal by Subject|0|||
25077195|NCT02465528|50185033|FG001|Overall Study|Withdrawal by Subject|0|||
25209136|NCT02256384|50465800|FG000|Overall Study|Equipment not capturing data|2|||
25209137|NCT02255760|50465843|FG000|Overall Study|Lost to Follow-up|0|||
25209138|NCT02255760|50465844|FG001|Overall Study|Lost to Follow-up|1|||
25209139|NCT02255760|50465845|FG002|Overall Study|Lost to Follow-up|0|||
25209140|NCT02255760|50465846|FG003|Overall Study|Lost to Follow-up|0|||
25209141|NCT02255760|50465847|FG004|Overall Study|Lost to Follow-up|0|||
25209142|NCT01641822|50465943|FG000|Run-in Phase|Noncompliance with study drug|1|||
25209143|NCT01641822|50465944|FG001|Run-in Phase|Noncompliance with study drug|0|||
25209144|NCT01641822|50465945|FG002|Run-in Phase|Noncompliance with study drug|0|||
25209145|NCT01641822|50465943|FG000|Run-in Phase|Adverse Event|3|||
25209146|NCT01641822|50465944|FG001|Run-in Phase|Adverse Event|0|||
25209147|NCT01641822|50465945|FG002|Run-in Phase|Adverse Event|0|||
25209148|NCT01641822|50465943|FG000|Run-in Phase|Withdrew consent|1|||
25209149|NCT01641822|50465944|FG001|Run-in Phase|Withdrew consent|0|||
25209150|NCT01641822|50465945|FG002|Run-in Phase|Withdrew consent|0|||
25209151|NCT01641822|50465943|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
25209152|NCT01641822|50465944|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
25209153|NCT01641822|50465945|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
25209154|NCT01641822|50465943|FG000|Comparative Phase|Noncompliance with study drug|0|||
25209155|NCT01641822|50465944|FG001|Comparative Phase|Noncompliance with study drug|1|||
25209156|NCT01641822|50465945|FG002|Comparative Phase|Noncompliance with study drug|0|||
25209157|NCT01641822|50465943|FG000|Comparative Phase|Investigator's discretion|0|||
25209158|NCT01641822|50465944|FG001|Comparative Phase|Investigator's discretion|0|||
25209159|NCT01641822|50465945|FG002|Comparative Phase|Investigator's discretion|1|||
25209160|NCT01641822|50465943|FG000|Comparative Phase|Pregnancy|0|||
25209161|NCT01641822|50465944|FG001|Comparative Phase|Pregnancy|0|||
25209162|NCT01641822|50465945|FG002|Comparative Phase|Pregnancy|1|||
25209163|NCT01641822|50465943|FG000|Comparative Phase|Adverse event, serious fatal|0|||
25209164|NCT01641822|50465944|FG001|Comparative Phase|Adverse event, serious fatal|1|||
25209165|NCT01641822|50465945|FG002|Comparative Phase|Adverse event, serious fatal|0|||
25209166|NCT01641822|50465943|FG000|Comparative Phase|Withdrew consent|0|||
25209167|NCT01641822|50465944|FG001|Comparative Phase|Withdrew consent|3|||
25209168|NCT01641822|50465945|FG002|Comparative Phase|Withdrew consent|7|||
25209169|NCT01641822|50465943|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
25209170|NCT01641822|50465944|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
25209171|NCT01641822|50465945|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
25209172|NCT01641198|50466025|FG000|After 12 Months of Function|Lost to Follow-up|3|||
25209173|NCT01641198|50466026|FG001|After 12 Months of Function|Lost to Follow-up|2|||
25209174|NCT01641198|50466027|FG002|After 12 Months of Function|Lost to Follow-up|2|||
25209175|NCT01641198|50466025|FG000|After 12 Months of Function|Protocol Violation|1|||
25209176|NCT01641198|50466026|FG001|After 12 Months of Function|Protocol Violation|0|||
25209177|NCT01641198|50466027|FG002|After 12 Months of Function|Protocol Violation|0|||
25209178|NCT01641198|50466025|FG000|After 12 Months of Function|Adverse Event|0|||
25077196|NCT02465528|50185034|FG002|Overall Study|Withdrawal by Subject|2|||
25077197|NCT02465528|50185035|FG003|Overall Study|Withdrawal by Subject|0|||
25209179|NCT01641198|50466026|FG001|After 12 Months of Function|Adverse Event|1|||
25209180|NCT01641198|50466027|FG002|After 12 Months of Function|Adverse Event|0|||
25077198|NCT02465528|50185032|FG000|Overall Study|Adverse Event|0|||
25209181|NCT01641198|50466025|FG000|After 24 Months of Function|Lost to Follow-up|4|||
25209182|NCT01641198|50466026|FG001|After 24 Months of Function|Lost to Follow-up|9|||
25077199|NCT02465528|50185033|FG001|Overall Study|Adverse Event|0|||
25077200|NCT02465528|50185034|FG002|Overall Study|Adverse Event|0|||
25077201|NCT02465528|50185035|FG003|Overall Study|Adverse Event|1|||
25077202|NCT02465528|50185032|FG000|Overall Study|Physician Decision|0|||
25209183|NCT01641198|50466027|FG002|After 24 Months of Function|Lost to Follow-up|6|||
25209184|NCT01641198|50466025|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
25209185|NCT01641198|50466026|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
25209186|NCT01641198|50466027|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
25209187|NCT01641198|50466025|FG000|At 15-20 Years of Function|Death|1|||
25209188|NCT01641198|50466026|FG001|At 15-20 Years of Function|Death|0|||
25209189|NCT01641198|50466027|FG002|At 15-20 Years of Function|Death|1|||
25209190|NCT01639560|50466112|FG000|Overall Study|Withdrawal by Subject|9|||
25209191|NCT01639560|50466113|FG001|Overall Study|Withdrawal by Subject|14|||
25209192|NCT01639560|50466112|FG000|Overall Study|Lack of Efficacy|1|||
25209193|NCT01639560|50466113|FG001|Overall Study|Lack of Efficacy|2|||
25209194|NCT01639560|50466112|FG000|Overall Study|Lost to Follow-up|9|||
25209195|NCT01639560|50466113|FG001|Overall Study|Lost to Follow-up|11|||
25209196|NCT01639560|50466112|FG000|Overall Study|Adverse Event|0|||
25209197|NCT01639560|50466113|FG001|Overall Study|Adverse Event|2|||
25209198|NCT01601652|50466135|FG000|Overall Study|Death|1|||
25209199|NCT03952130|50466173|FG000|Overall Study|Adverse Event|0|||
25209200|NCT03952130|50466174|FG001|Overall Study|Adverse Event|1|||
25209201|NCT03952130|50466173|FG000|Overall Study|Lost to Follow-up|1|||
25209202|NCT03952130|50466174|FG001|Overall Study|Lost to Follow-up|0|||
25209203|NCT03952130|50466173|FG000|Overall Study|Withdrawal by Subject|1|||
25209204|NCT03952130|50466174|FG001|Overall Study|Withdrawal by Subject|5|||
25209205|NCT01640964|50466218|FG000|Overall Study|Lost to Follow-up|0|||
25209206|NCT01640964|50466219|FG001|Overall Study|Lost to Follow-up|0|||
25209207|NCT01640964|50466220|FG002|Overall Study|Lost to Follow-up|1|||
25209208|NCT01640964|50466218|FG000|Overall Study|Protocol Deviation|1|||
25209209|NCT01640964|50466219|FG001|Overall Study|Protocol Deviation|1|||
25209210|NCT01640964|50466220|FG002|Overall Study|Protocol Deviation|2|||
25209211|NCT01638390|50466340|FG000|Overall Study|screening failures|21|||
25209212|NCT01600716|50466371|FG000|Overall Study|Other Reasons|3|||
25209213|NCT01600716|50466372|FG001|Overall Study|Other Reasons|1|||
25209214|NCT01600716|50466371|FG000|Overall Study|Personal Reasons|0|||
25209215|NCT01600716|50466372|FG001|Overall Study|Personal Reasons|2|||
25209216|NCT01600716|50466371|FG000|Overall Study|Lost to Follow-up|0|||
25209217|NCT01600716|50466372|FG001|Overall Study|Lost to Follow-up|2|||
25209218|NCT01600716|50466371|FG000|Overall Study|Pregnancy|1|||
25209219|NCT01600716|50466372|FG001|Overall Study|Pregnancy|0|||
25209220|NCT01600716|50466371|FG000|Overall Study|Lack of Efficacy|2|||
25209221|NCT01600716|50466372|FG001|Overall Study|Lack of Efficacy|1|||
25209222|NCT01600716|50466371|FG000|Overall Study|Adverse Event|1|||
25209223|NCT01600716|50466372|FG001|Overall Study|Adverse Event|1|||
25209224|NCT01600326|50466488|FG000|Overall Study|Lost to Follow-up|1|||
25209225|NCT01600326|50466489|FG001|Overall Study|Lost to Follow-up|1|||
25209226|NCT01637142|50466625|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
25209227|NCT01636986|50466643|FG000|Overall Study|Withdrawal by Subject|0|||
25209228|NCT01636986|50466644|FG001|Overall Study|Withdrawal by Subject|1|||
25209229|NCT01636986|50466643|FG000|Overall Study|Corneal Staining|0|||
25209230|NCT01636986|50466644|FG001|Overall Study|Corneal Staining|1|||
25209231|NCT01601496|50466736|FG000|Overall Study|Physician Decision|1|||
25209232|NCT01601496|50466736|FG000|Overall Study|Withdrawal by Subject|1|||
25209233|NCT01601496|50466736|FG000|Overall Study|Lost to Follow-up|6|||
25209234|NCT01601496|50466736|FG000|Overall Study|Death|4|||
25209235|NCT01601496|50466736|FG000|Overall Study|Other: patient refusal to continue|3|||
25209236|NCT03211832|50466742|FG000|Overall Study|No longer with agency|32|||
25209237|NCT03211832|50466743|FG001|Overall Study|No longer with agency|49|||
25209238|NCT03211832|50466744|FG002|Overall Study|No longer with agency|30|||
25209239|NCT03211832|50466742|FG000|Overall Study|Declined survey|3|||
25209240|NCT03211832|50466743|FG001|Overall Study|Declined survey|3|||
25209241|NCT03211832|50466744|FG002|Overall Study|Declined survey|2|||
25209242|NCT03211832|50466742|FG000|Overall Study|Not available during data collection|1|||
25209243|NCT03211832|50466743|FG001|Overall Study|Not available during data collection|0|||
25209244|NCT03211832|50466744|FG002|Overall Study|Not available during data collection|2|||
25209245|NCT04887948|50466753|FG000|Overall Study|Death|1|||
25209246|NCT04887948|50466754|FG001|Overall Study|Death|0|||
25209247|NCT04887948|50466755|FG002|Overall Study|Death|0|||
25209248|NCT04887948|50466753|FG000|Overall Study|Lost to Follow-up|1|||
25209249|NCT04887948|50466754|FG001|Overall Study|Lost to Follow-up|0|||
25209250|NCT04887948|50466755|FG002|Overall Study|Lost to Follow-up|3|||
25209251|NCT04887948|50466753|FG000|Overall Study|Physician Decision|0|||
25209252|NCT04887948|50466754|FG001|Overall Study|Physician Decision|4|||
25209253|NCT04887948|50466755|FG002|Overall Study|Physician Decision|1|||
25209254|NCT04887948|50466753|FG000|Overall Study|Protocol Violation|1|||
25209255|NCT04887948|50466754|FG001|Overall Study|Protocol Violation|1|||
25209256|NCT04887948|50466755|FG002|Overall Study|Protocol Violation|0|||
25209257|NCT04887948|50466753|FG000|Overall Study|Withdrawal by Subject|0|||
25209258|NCT04887948|50466754|FG001|Overall Study|Withdrawal by Subject|6|||
25209259|NCT04887948|50466755|FG002|Overall Study|Withdrawal by Subject|1|||
25209260|NCT04887948|50466753|FG000|Overall Study|No longer met eligibility criteria|1|||
25209261|NCT04887948|50466754|FG001|Overall Study|No longer met eligibility criteria|2|||
25209262|NCT04887948|50466755|FG002|Overall Study|No longer met eligibility criteria|1|||
25209263|NCT04887948|50466753|FG000|Overall Study|Other|2|||
25209264|NCT04887948|50466754|FG001|Overall Study|Other|1|||
25209265|NCT04887948|50466755|FG002|Overall Study|Other|1|||
25209266|NCT01638000|50466893|FG000|Overall Study|Randomized but Never Received Drug|7|||
25209267|NCT01638000|50466894|FG001|Overall Study|Randomized but Never Received Drug|10|||
25209268|NCT01638000|50466893|FG000|Overall Study|Adverse Event|14|||
25209269|NCT01638000|50466894|FG001|Overall Study|Adverse Event|16|||
25209270|NCT01638000|50466893|FG000|Overall Study|Lack of Efficacy|5|||
25209271|NCT01638000|50466894|FG001|Overall Study|Lack of Efficacy|6|||
25209272|NCT01638000|50466893|FG000|Overall Study|Protocol Violation|11|||
25209273|NCT01638000|50466894|FG001|Overall Study|Protocol Violation|13|||
25209274|NCT01638000|50466893|FG000|Overall Study|Withdrawal by Subject|21|||
25209275|NCT01638000|50466894|FG001|Overall Study|Withdrawal by Subject|24|||
25209276|NCT01638000|50466893|FG000|Overall Study|Miscellaneous|2|||
25209277|NCT01638000|50466894|FG001|Overall Study|Miscellaneous|2|||
25209278|NCT01637922|50466953|FG000|Overall Study|Adverse Event|0|||
25209279|NCT01637922|50466954|FG001|Overall Study|Adverse Event|1|||
25209280|NCT01637922|50466953|FG000|Overall Study|Protocol Violation|0|||
25209281|NCT01637922|50466954|FG001|Overall Study|Protocol Violation|1|||
25209282|NCT01637922|50466953|FG000|Overall Study|Withdrawal by Subject|0|||
25209283|NCT01637922|50466954|FG001|Overall Study|Withdrawal by Subject|3|||
25209284|NCT01637922|50466953|FG000|Overall Study|Lost to Follow-up|2|||
25209285|NCT01637922|50466954|FG001|Overall Study|Lost to Follow-up|0|||
25209286|NCT01920932|50467103|FG000|Overall Study|Death|1|||
25209287|NCT01920932|50467103|FG000|Overall Study|Withdrawal of consent|1|||
25209288|NCT03496662|50467180|FG000|Overall Study|Adverse Event|1|||
25209289|NCT03496662|50467181|FG001|Overall Study|Adverse Event|0|||
25209290|NCT03496662|50467182|FG002|Overall Study|Adverse Event|1|||
25209291|NCT03496662|50467180|FG000|Overall Study|Physician Decision|1|||
25209292|NCT03496662|50467181|FG001|Overall Study|Physician Decision|0|||
25209293|NCT03496662|50467182|FG002|Overall Study|Physician Decision|3|||
25209294|NCT03496662|50467180|FG000|Overall Study|Withdrawal by Subject|0|||
25209295|NCT03496662|50467181|FG001|Overall Study|Withdrawal by Subject|0|||
25209296|NCT03496662|50467182|FG002|Overall Study|Withdrawal by Subject|2|||
25209297|NCT03496662|50467180|FG000|Overall Study|Death|0|||
25209298|NCT03496662|50467181|FG001|Overall Study|Death|0|||
25209299|NCT03496662|50467182|FG002|Overall Study|Death|2|||
25209300|NCT03496662|50467180|FG000|Overall Study|Noncompliance|0|||
25209301|NCT03496662|50467181|FG001|Overall Study|Noncompliance|0|||
25209302|NCT03496662|50467182|FG002|Overall Study|Noncompliance|1|||
25209303|NCT01638546|50467192|FG000|Overall Study|Adverse Event|1|||
25209304|NCT01638546|50467193|FG001|Overall Study|Adverse Event|3|||
25209305|NCT01000051|50467203|FG000|Overall Study|Withdrawal by Subject|1|||
25209306|NCT01000051|50467204|FG001|Overall Study|Withdrawal by Subject|1|||
25209307|NCT01000051|50467203|FG000|Overall Study|Disease Progression|1|||
25209308|NCT01000051|50467204|FG001|Overall Study|Disease Progression|0|||
25209309|NCT01000051|50467203|FG000|Overall Study|Serious noncompliance|1|||
25209310|NCT01000051|50467204|FG001|Overall Study|Serious noncompliance|0|||
25209311|NCT03172494|50467222|FG000|Overall Study|Adverse Event|5|||
25209312|NCT03172494|50467223|FG001|Overall Study|Adverse Event|1|||
25209313|NCT03172494|50467224|FG002|Overall Study|Adverse Event|15|||
25209314|NCT03172494|50467222|FG000|Overall Study|Protocol Violation|3|||
25209315|NCT03172494|50467223|FG001|Overall Study|Protocol Violation|2|||
25209316|NCT03172494|50467224|FG002|Overall Study|Protocol Violation|1|||
25209317|NCT03172494|50467222|FG000|Overall Study|Lack of Efficacy|0|||
25209318|NCT03172494|50467223|FG001|Overall Study|Lack of Efficacy|0|||
25209319|NCT03172494|50467224|FG002|Overall Study|Lack of Efficacy|4|||
25209320|NCT03172494|50467222|FG000|Overall Study|Pregnancy|0|||
25209321|NCT03172494|50467223|FG001|Overall Study|Pregnancy|1|||
25209322|NCT03172494|50467224|FG002|Overall Study|Pregnancy|0|||
25209323|NCT03172494|50467222|FG000|Overall Study|Withdrawal by Subject|10|||
25209324|NCT03172494|50467223|FG001|Overall Study|Withdrawal by Subject|8|||
25209325|NCT03172494|50467224|FG002|Overall Study|Withdrawal by Subject|8|||
25209326|NCT03172494|50467222|FG000|Overall Study|Severe hypoglycaemic episode|0|||
25209327|NCT03172494|50467223|FG001|Overall Study|Severe hypoglycaemic episode|0|||
25209328|NCT03172494|50467224|FG002|Overall Study|Severe hypoglycaemic episode|1|||
25209329|NCT03172494|50467222|FG000|Overall Study|Non-compliance towards treatment|2|||
25209330|NCT03172494|50467223|FG001|Overall Study|Non-compliance towards treatment|0|||
25209331|NCT03172494|50467224|FG002|Overall Study|Non-compliance towards treatment|0|||
25209332|NCT01636362|50467325|FG000|Overall Study|Physician Decision|6|||
25316266|NCT00896532|50631600|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25209333|NCT01636362|50467325|FG000|Overall Study|Subject healed, not returning|1|||
25209334|NCT01636362|50467325|FG000|Overall Study|Withdrawal by Subject|1|||
25209335|NCT02797184|50467354|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
25209336|NCT02797184|50467355|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
25209337|NCT03042468|50467397|FG000|Overall Study|Death|0|||
25209338|NCT03042468|50467398|FG001|Overall Study|Death|1|||
25209339|NCT03042468|50467399|FG002|Overall Study|Death|1|||
25209340|NCT03042468|50467400|FG003|Overall Study|Death|0|||
25209341|NCT03042468|50467401|FG004|Overall Study|Death|0|||
25209342|NCT03042468|50467402|FG005|Overall Study|Death|0|||
25209343|NCT03042468|50467397|FG000|Overall Study|Withdrawal by Subject|0|||
25209344|NCT03042468|50467398|FG001|Overall Study|Withdrawal by Subject|0|||
25209345|NCT03042468|50467399|FG002|Overall Study|Withdrawal by Subject|0|||
25209346|NCT03042468|50467400|FG003|Overall Study|Withdrawal by Subject|0|||
25209347|NCT03042468|50467401|FG004|Overall Study|Withdrawal by Subject|0|||
25209348|NCT03042468|50467402|FG005|Overall Study|Withdrawal by Subject|1|||
25209349|NCT03042468|50467397|FG000|Overall Study|Lost to Follow-up|0|||
25209350|NCT03042468|50467398|FG001|Overall Study|Lost to Follow-up|0|||
25209351|NCT03042468|50467399|FG002|Overall Study|Lost to Follow-up|0|||
25209352|NCT03042468|50467400|FG003|Overall Study|Lost to Follow-up|0|||
25209353|NCT03042468|50467401|FG004|Overall Study|Lost to Follow-up|1|||
25209354|NCT03042468|50467402|FG005|Overall Study|Lost to Follow-up|1|||
25209355|NCT01634178|50467420|FG000|Treatment Period 1|Adverse Event|0|||
25209356|NCT01634178|50467421|FG001|Treatment Period 1|Adverse Event|1|||
25209357|NCT01634178|50467420|FG000|Treatment Period 2|Adverse Event|1|||
25209358|NCT01634178|50467421|FG001|Treatment Period 2|Adverse Event|0|||
25209359|NCT02412306|50467463|FG000|Overall Study|Lost to Follow-up|0|||
25209360|NCT02412306|50467464|FG001|Overall Study|Lost to Follow-up|1|||
25209361|NCT02412306|50467465|FG002|Overall Study|Lost to Follow-up|0|||
25209362|NCT02412306|50467466|FG003|Overall Study|Lost to Follow-up|0|||
25209363|NCT02412306|50467467|FG004|Overall Study|Lost to Follow-up|0|||
25209364|NCT02412306|50467463|FG000|Overall Study|Withdrawal by Subject|0|||
25209365|NCT02412306|50467464|FG001|Overall Study|Withdrawal by Subject|0|||
25209366|NCT02412306|50467465|FG002|Overall Study|Withdrawal by Subject|1|||
25209367|NCT02412306|50467466|FG003|Overall Study|Withdrawal by Subject|0|||
25209368|NCT02412306|50467467|FG004|Overall Study|Withdrawal by Subject|0|||
25209369|NCT02412306|50467463|FG000|Overall Study|Death|5|||
25209370|NCT02412306|50467464|FG001|Overall Study|Death|7|||
25209371|NCT02412306|50467465|FG002|Overall Study|Death|15|||
25209372|NCT02412306|50467466|FG003|Overall Study|Death|0|||
25209373|NCT02412306|50467467|FG004|Overall Study|Death|2|||
25209374|NCT04285723|50467490|FG000|Overall Study|Subject decision|1|||
25209375|NCT04285723|50467491|FG001|Overall Study|Subject decision|2|||
25209376|NCT04285723|50467490|FG000|Overall Study|Physician Decision|1|||
25209377|NCT04285723|50467491|FG001|Overall Study|Physician Decision|0|||
25209378|NCT04285723|50467490|FG000|Overall Study|No efficiency|1|||
25209379|NCT04285723|50467491|FG001|Overall Study|No efficiency|0|||
25209380|NCT01352221|50467505|FG000|Double-blind Phase|Adverse Event|6|||
25209381|NCT01352221|50467506|FG001|Double-blind Phase|Adverse Event|4|||
25209382|NCT01352221|50467507|FG002|Double-blind Phase|Adverse Event|0|||
25209383|NCT01352221|50467508|FG003|Double-blind Phase|Adverse Event|0|||
25209384|NCT01352221|50467505|FG000|Double-blind Phase|Withdrawal by Subject|3|||
25209385|NCT01352221|50467506|FG001|Double-blind Phase|Withdrawal by Subject|5|||
25209386|NCT01352221|50467507|FG002|Double-blind Phase|Withdrawal by Subject|0|||
25209387|NCT01352221|50467508|FG003|Double-blind Phase|Withdrawal by Subject|0|||
25209388|NCT01352221|50467505|FG000|Double-blind Phase|Lost to Follow-up|0|||
25209389|NCT01352221|50467506|FG001|Double-blind Phase|Lost to Follow-up|1|||
25209390|NCT01352221|50467507|FG002|Double-blind Phase|Lost to Follow-up|0|||
25209391|NCT01352221|50467508|FG003|Double-blind Phase|Lost to Follow-up|0|||
25209392|NCT01352221|50467505|FG000|Double-blind Phase|Protocol Violation|0|||
25209393|NCT01352221|50467506|FG001|Double-blind Phase|Protocol Violation|1|||
25209394|NCT01352221|50467507|FG002|Double-blind Phase|Protocol Violation|0|||
25209395|NCT01352221|50467508|FG003|Double-blind Phase|Protocol Violation|0|||
25209396|NCT01352221|50467505|FG000|Open-label Phase|Physician Decision|0|||
25209397|NCT01352221|50467506|FG001|Open-label Phase|Physician Decision|0|||
25209398|NCT01352221|50467507|FG002|Open-label Phase|Physician Decision|2|||
25209399|NCT01352221|50467508|FG003|Open-label Phase|Physician Decision|1|||
25209400|NCT01352221|50467505|FG000|Open-label Phase|Pregnancy|0|||
25209401|NCT01352221|50467506|FG001|Open-label Phase|Pregnancy|0|||
25209402|NCT01352221|50467507|FG002|Open-label Phase|Pregnancy|1|||
25209403|NCT01352221|50467508|FG003|Open-label Phase|Pregnancy|0|||
25209404|NCT01352221|50467505|FG000|Open-label Phase|Adverse Event|0|||
25209405|NCT01352221|50467506|FG001|Open-label Phase|Adverse Event|0|||
25209406|NCT01352221|50467507|FG002|Open-label Phase|Adverse Event|8|||
25209407|NCT01352221|50467508|FG003|Open-label Phase|Adverse Event|4|||
25209408|NCT01352221|50467505|FG000|Open-label Phase|Withdrawal by Subject|0|||
25209409|NCT01352221|50467506|FG001|Open-label Phase|Withdrawal by Subject|0|||
25209410|NCT01352221|50467507|FG002|Open-label Phase|Withdrawal by Subject|1|||
25209411|NCT01352221|50467508|FG003|Open-label Phase|Withdrawal by Subject|6|||
25209412|NCT01352221|50467505|FG000|Open-label Phase|Worsening of IBD|0|||
25209413|NCT01352221|50467506|FG001|Open-label Phase|Worsening of IBD|0|||
25209414|NCT01352221|50467507|FG002|Open-label Phase|Worsening of IBD|1|||
25209415|NCT01352221|50467508|FG003|Open-label Phase|Worsening of IBD|0|||
25209416|NCT01634100|50467534|FG000|Overall Study|Withdrawal by Subject|1|||
25209417|NCT01634100|50467535|FG001|Overall Study|Withdrawal by Subject|0|||
25209418|NCT01634100|50467536|FG002|Overall Study|Withdrawal by Subject|1|||
25209419|NCT01634100|50467537|FG003|Overall Study|Withdrawal by Subject|0|||
25209420|NCT01634100|50467538|FG004|Overall Study|Withdrawal by Subject|0|||
25209421|NCT01634100|50467539|FG005|Overall Study|Withdrawal by Subject|0|||
25209422|NCT03662659|50467549|FG000|Pre-treatment|Participant no longer met study criteria|1|||
25209423|NCT03662659|50467550|FG001|Pre-treatment|Participant no longer met study criteria|1|||
25209424|NCT03662659|50467549|FG000|Pre-treatment|Other reasons|1|||
25209425|NCT03662659|50467550|FG001|Pre-treatment|Other reasons|0|||
25209426|NCT03662659|50467549|FG000|Treatment|Completed Treatment|0|||
25209427|NCT03662659|50467550|FG001|Treatment|Completed Treatment|3|||
25209428|NCT03662659|50467549|FG000|Treatment|Disease Progression|69|||
25209429|NCT03662659|50467550|FG001|Treatment|Disease Progression|78|||
25209430|NCT03662659|50467549|FG000|Treatment|Study Drug Toxicity|18|||
25209431|NCT03662659|50467550|FG001|Treatment|Study Drug Toxicity|8|||
25209432|NCT03662659|50467549|FG000|Treatment|Death|12|||
25209433|NCT03662659|50467550|FG001|Treatment|Death|7|||
25209434|NCT03662659|50467549|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
25209435|NCT03662659|50467550|FG001|Treatment|Adverse Event unrelated to Study Drug|4|||
25209436|NCT03662659|50467549|FG000|Treatment|Withdrawal by Subject|1|||
25209437|NCT03662659|50467550|FG001|Treatment|Withdrawal by Subject|1|||
25209438|NCT03662659|50467549|FG000|Treatment|Poor/Non-compliance|1|||
25209439|NCT03662659|50467550|FG001|Treatment|Poor/Non-compliance|0|||
25209440|NCT03662659|50467549|FG000|Treatment|Participant no longer meets study criteria|1|||
25209441|NCT03662659|50467550|FG001|Treatment|Participant no longer meets study criteria|0|||
25209442|NCT03662659|50467549|FG000|Treatment|Other reasons|6|||
25209443|NCT03662659|50467550|FG001|Treatment|Other reasons|5|||
25209444|NCT01633944|50467558|FG000|Open-label Titration Phase|Adverse Event|109|||
25209445|NCT01633944|50467559|FG001|Open-label Titration Phase|Adverse Event|0|||
25209446|NCT01633944|50467560|FG002|Open-label Titration Phase|Adverse Event|0|||
25209447|NCT01633944|50467558|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
25209448|NCT01633944|50467559|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
25209449|NCT01633944|50467560|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
25209450|NCT01633944|50467558|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
25209451|NCT01633944|50467559|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
25209452|NCT01633944|50467560|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
25209453|NCT01633944|50467558|FG000|Open-label Titration Phase|Protocol Violation|24|||
25209454|NCT01633944|50467559|FG001|Open-label Titration Phase|Protocol Violation|0|||
25209455|NCT01633944|50467560|FG002|Open-label Titration Phase|Protocol Violation|0|||
25209456|NCT01633944|50467558|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
25209457|NCT01633944|50467559|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
25209458|NCT01633944|50467560|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
25209459|NCT01633944|50467558|FG000|Open-label Titration Phase|Other|68|||
25209460|NCT01633944|50467559|FG001|Open-label Titration Phase|Other|0|||
25209461|NCT01633944|50467560|FG002|Open-label Titration Phase|Other|0|||
25209462|NCT01633944|50467558|FG000|Double-blind Treatment Phase|Adverse Event|0|||
25209463|NCT01633944|50467559|FG001|Double-blind Treatment Phase|Adverse Event|13|||
25209464|NCT01633944|50467560|FG002|Double-blind Treatment Phase|Adverse Event|7|||
25209465|NCT01633944|50467558|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
25209466|NCT01633944|50467559|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
25209467|NCT01633944|50467560|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
25209468|NCT01633944|50467558|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
25209469|NCT01633944|50467559|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
25209470|NCT01633944|50467560|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
25209471|NCT01633944|50467558|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
25209472|NCT01633944|50467559|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
25209473|NCT01633944|50467560|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
25209474|NCT01633944|50467558|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
25209475|NCT01633944|50467559|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
25209476|NCT01633944|50467560|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
25209477|NCT01633944|50467558|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
25209478|NCT01633944|50467559|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
25209479|NCT01633944|50467560|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
25209480|NCT01633944|50467558|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
25209481|NCT01633944|50467559|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
25209482|NCT01633944|50467560|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
25209483|NCT01633944|50467558|FG000|Double-blind Treatment Phase|Other|0|||
25209484|NCT01633944|50467559|FG001|Double-blind Treatment Phase|Other|7|||
25209485|NCT01633944|50467560|FG002|Double-blind Treatment Phase|Other|0|||
25209486|NCT01633788|50467605|FG000|Overall Study|Adverse Event|1|||
25209487|NCT01633788|50467606|FG001|Overall Study|Adverse Event|3|||
25209488|NCT01633788|50467607|FG002|Overall Study|Adverse Event|3|||
25209489|NCT01633788|50467608|FG003|Overall Study|Adverse Event|3|||
25209490|NCT01633788|50467605|FG000|Overall Study|Lost to Follow-up|2|||
25209491|NCT01633788|50467606|FG001|Overall Study|Lost to Follow-up|2|||
25209492|NCT01633788|50467607|FG002|Overall Study|Lost to Follow-up|2|||
25209493|NCT01633788|50467608|FG003|Overall Study|Lost to Follow-up|0|||
25209494|NCT01633788|50467605|FG000|Overall Study|Personal Reasons|3|||
25209495|NCT01633788|50467606|FG001|Overall Study|Personal Reasons|1|||
25209496|NCT01633788|50467607|FG002|Overall Study|Personal Reasons|1|||
25209497|NCT01633788|50467608|FG003|Overall Study|Personal Reasons|3|||
25209498|NCT01633788|50467605|FG000|Overall Study|Protocol Violation|1|||
25209499|NCT01633788|50467606|FG001|Overall Study|Protocol Violation|0|||
25209500|NCT01633788|50467607|FG002|Overall Study|Protocol Violation|1|||
25209501|NCT01633788|50467608|FG003|Overall Study|Protocol Violation|0|||
25209502|NCT01633788|50467605|FG000|Overall Study|Other Reasons|0|||
25209503|NCT01633788|50467606|FG001|Overall Study|Other Reasons|2|||
25209504|NCT01633788|50467607|FG002|Overall Study|Other Reasons|3|||
25209505|NCT01633788|50467608|FG003|Overall Study|Other Reasons|7|||
25209506|NCT04154943|50467618|FG000|Overall Study|Study Ongoing|68|||
25209507|NCT04154943|50467618|FG000|Overall Study|Lost to Follow-up|1|||
25209508|NCT04154943|50467618|FG000|Overall Study|Decision by the Investigator|1|||
25209509|NCT04154943|50467618|FG000|Overall Study|Death|5|||
25209510|NCT04154943|50467618|FG000|Overall Study|Withdrawal by Subject|4|||
25209511|NCT03476239|50467639|FG000|Overall Study|Withdrawal by Subject|10|||
25209512|NCT03476239|50467639|FG000|Overall Study|Death|80|||
25209513|NCT03476239|50467639|FG000|Overall Study|Lost to Follow-up|8|||
25209514|NCT03468985|50467647|FG000|Overall Study|Adverse Event|0|||
25209515|NCT03468985|50467648|FG001|Overall Study|Adverse Event|2|||
25209516|NCT03468985|50467649|FG002|Overall Study|Adverse Event|0|||
25209517|NCT03468985|50467650|FG003|Overall Study|Adverse Event|0|||
25209518|NCT03468985|50467647|FG000|Overall Study|Withdrawal by Subject|0|||
25209519|NCT03468985|50467648|FG001|Overall Study|Withdrawal by Subject|0|||
25209520|NCT03468985|50467649|FG002|Overall Study|Withdrawal by Subject|0|||
25209521|NCT03468985|50467650|FG003|Overall Study|Withdrawal by Subject|1|||
25209522|NCT02678312|50467665|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
25209523|NCT02678312|50467666|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
25209524|NCT02678312|50467667|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
25209525|NCT02678312|50467668|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
25209526|NCT02678312|50467669|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
25209527|NCT02678312|50467665|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
25209528|NCT02678312|50467666|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
25209529|NCT02678312|50467667|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
25209530|NCT02678312|50467668|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
25209531|NCT02678312|50467669|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
25209532|NCT02678312|50467665|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
25209533|NCT02678312|50467666|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
25209534|NCT02678312|50467667|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
25209535|NCT02678312|50467668|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
25209536|NCT02678312|50467669|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
25209537|NCT02678312|50467665|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
25209538|NCT02678312|50467666|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
25209539|NCT02678312|50467667|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
25209540|NCT02678312|50467668|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
25209541|NCT02678312|50467669|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
25209542|NCT02678312|50467665|FG000|Part 2 Double Blind Epoch|Death|0|||
25209543|NCT02678312|50467666|FG001|Part 2 Double Blind Epoch|Death|0|||
25209544|NCT02678312|50467667|FG002|Part 2 Double Blind Epoch|Death|0|||
25209545|NCT02678312|50467668|FG003|Part 2 Double Blind Epoch|Death|8|||
25209546|NCT02678312|50467669|FG004|Part 2 Double Blind Epoch|Death|12|||
25209547|NCT02678312|50467665|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
25209548|NCT02678312|50467666|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
25209549|NCT02678312|50467667|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
25209550|NCT02678312|50467668|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
25209551|NCT02678312|50467669|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
25209552|NCT02678312|50467665|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
25209553|NCT02678312|50467666|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
25209554|NCT02678312|50467667|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
24976345|NCT00092547|50065232|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
25209555|NCT02678312|50467668|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
25209556|NCT02678312|50467669|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
25209557|NCT02678312|50467665|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
25209558|NCT02678312|50467666|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
25209559|NCT02678312|50467667|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
25209560|NCT02678312|50467668|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
25209561|NCT02678312|50467669|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
25209562|NCT02256631|50467916|FG000|Overall Study|Lost to Follow-up|1|||
25209563|NCT02256631|50467917|FG001|Overall Study|Lost to Follow-up|1|||
25209564|NCT02256631|50467918|FG002|Overall Study|Lost to Follow-up|0|||
25209565|NCT02256631|50467919|FG003|Overall Study|Lost to Follow-up|2|||
25209566|NCT02256631|50467920|FG004|Overall Study|Lost to Follow-up|0|||
25209567|NCT02256631|50467921|FG005|Overall Study|Lost to Follow-up|4|||
25209568|NCT02256631|50467922|FG006|Overall Study|Lost to Follow-up|1|||
25209569|NCT02256631|50467916|FG000|Overall Study|Withdrawal by Subject|0|||
25209570|NCT02256631|50467917|FG001|Overall Study|Withdrawal by Subject|0|||
25209571|NCT02256631|50467918|FG002|Overall Study|Withdrawal by Subject|0|||
25209572|NCT02256631|50467919|FG003|Overall Study|Withdrawal by Subject|1|||
25209573|NCT02256631|50467920|FG004|Overall Study|Withdrawal by Subject|1|||
25209574|NCT02256631|50467921|FG005|Overall Study|Withdrawal by Subject|0|||
25209575|NCT02256631|50467922|FG006|Overall Study|Withdrawal by Subject|1|||
25209576|NCT02256631|50467916|FG000|Overall Study|Unable to get to clinic|0|||
25209577|NCT02256631|50467917|FG001|Overall Study|Unable to get to clinic|2|||
25209578|NCT02256631|50467918|FG002|Overall Study|Unable to get to clinic|0|||
25209579|NCT02256631|50467919|FG003|Overall Study|Unable to get to clinic|1|||
25209580|NCT02256631|50467920|FG004|Overall Study|Unable to get to clinic|0|||
25209581|NCT02256631|50467921|FG005|Overall Study|Unable to get to clinic|1|||
25209582|NCT02256631|50467922|FG006|Overall Study|Unable to get to clinic|2|||
25209583|NCT02163733|50468020|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
25209584|NCT02163733|50468021|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
25209585|NCT02163733|50468022|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
25316267|NCT00896532|50631601|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316268|NCT00896532|50631602|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316269|NCT00896532|50631603|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316270|NCT00896532|50631604|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316271|NCT00896532|50631605|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316272|NCT00896532|50631606|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316273|NCT00896532|50631607|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316274|NCT00896532|50631608|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316275|NCT00896532|50631609|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
25316276|NCT00896532|50631610|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
25316277|NCT00896532|50631588|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316278|NCT00896532|50631589|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316279|NCT00896532|50631590|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316280|NCT00896532|50631591|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316281|NCT00896532|50631592|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316282|NCT00896532|50631593|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316283|NCT00896532|50631594|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316284|NCT00896532|50631595|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316285|NCT00896532|50631596|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316286|NCT00896532|50631597|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316287|NCT00896532|50631598|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316288|NCT00896532|50631599|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316289|NCT00896532|50631600|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316290|NCT00896532|50631601|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316291|NCT00896532|50631602|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316292|NCT00896532|50631603|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316293|NCT00896532|50631604|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316294|NCT00896532|50631605|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316295|NCT00896532|50631606|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316296|NCT00896532|50631607|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25077203|NCT02465528|50185033|FG001|Overall Study|Physician Decision|0|||
25171751|NCT02985957|50309409|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25171752|NCT02985957|50309410|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25171753|NCT02985957|50309411|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25171754|NCT02985957|50309412|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
25171755|NCT02985957|50309413|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25171756|NCT02985957|50309414|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25171757|NCT02985957|50309408|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
25171758|NCT02985957|50309409|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
25171759|NCT02985957|50309410|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
25171760|NCT02985957|50309411|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
25209586|NCT02163733|50468020|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
25209587|NCT02163733|50468021|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
25209588|NCT02163733|50468022|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
25209589|NCT02279745|50468052|FG000|Overall Study|Adverse Event|7|||
25209590|NCT02279745|50468052|FG000|Overall Study|Death|6|||
25209591|NCT02279745|50468052|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
25209592|NCT02279745|50468052|FG000|Overall Study|Withdrawal by Subject|2|||
25209593|NCT02279745|50468052|FG000|Overall Study|Pregnancy|1|||
25209594|NCT02279745|50468052|FG000|Overall Study|Study Non-compliance|1|||
25209595|NCT02279745|50468052|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
25209596|NCT01761877|50468091|FG000|Overall Study|Adverse Event|7|||
25209597|NCT01761877|50468092|FG001|Overall Study|Adverse Event|0|||
25209598|NCT01761877|50468091|FG000|Overall Study|Withdrawal by Subject|6|||
25209599|NCT01761877|50468092|FG001|Overall Study|Withdrawal by Subject|4|||
25209600|NCT01761877|50468091|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
25209601|NCT01761877|50468092|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
25209602|NCT01761877|50468091|FG000|Overall Study|Death|0|||
25209603|NCT01761877|50468092|FG001|Overall Study|Death|1|||
25209604|NCT01761877|50468091|FG000|Overall Study|MRI intolerant|1|||
25209605|NCT01761877|50468092|FG001|Overall Study|MRI intolerant|6|||
25209606|NCT03093259|50468346|FG000|Overall Study|Adverse Event|1|||
25209607|NCT03093259|50468347|FG001|Overall Study|Adverse Event|0|||
25209608|NCT03093259|50468346|FG000|Overall Study|Withdrawal by Subject|1|||
25209609|NCT03093259|50468347|FG001|Overall Study|Withdrawal by Subject|0|||
25209610|NCT02997865|50468639|FG000|Overall Study|Death|2|||
25209611|NCT02997865|50468640|FG001|Overall Study|Death|1|||
25209612|NCT02997865|50468639|FG000|Overall Study|Lost to Follow-up|6|||
25209613|NCT02997865|50468640|FG001|Overall Study|Lost to Follow-up|3|||
25209614|NCT02997865|50468639|FG000|Overall Study|Withdrawal by Subject|5|||
25209615|NCT02997865|50468640|FG001|Overall Study|Withdrawal by Subject|0|||
25209616|NCT01575834|50469878|FG000|Overall Study|Withdrawal by Subject|352|||
25209617|NCT01575834|50469879|FG001|Overall Study|Withdrawal by Subject|390|||
25209618|NCT01575834|50469878|FG000|Overall Study|Death|81|||
25209619|NCT01575834|50469879|FG001|Overall Study|Death|74|||
25209620|NCT01575834|50469878|FG000|Overall Study|Other|70|||
25209621|NCT01575834|50469879|FG001|Overall Study|Other|70|||
25209622|NCT01575834|50469878|FG000|Overall Study|Adverse Event|63|||
25209623|NCT01575834|50469879|FG001|Overall Study|Adverse Event|61|||
25209624|NCT01575834|50469878|FG000|Overall Study|Lost to Follow-up|55|||
25209625|NCT01575834|50469879|FG001|Overall Study|Lost to Follow-up|68|||
25209626|NCT01575834|50469878|FG000|Overall Study|Noncompliance|52|||
25209627|NCT01575834|50469879|FG001|Overall Study|Noncompliance|27|||
25209628|NCT01575834|50469878|FG000|Overall Study|Administrative decision|15|||
25209629|NCT01575834|50469879|FG001|Overall Study|Administrative decision|33|||
25209630|NCT01575834|50469878|FG000|Overall Study|Ineligibility Determined|5|||
25209631|NCT01575834|50469879|FG001|Overall Study|Ineligibility Determined|8|||
25209632|NCT01575834|50469878|FG000|Overall Study|Protocol Deviation|4|||
25209633|NCT01575834|50469879|FG001|Overall Study|Protocol Deviation|3|||
25209634|NCT01575834|50469878|FG000|Overall Study|Requirement for Alternative Therapy|2|||
25209635|NCT01575834|50469879|FG001|Overall Study|Requirement for Alternative Therapy|4|||
25209636|NCT02253654|50469991|FG000|Overall Study|Withdrawal by Subject|12|||
25209637|NCT02253654|50469992|FG001|Overall Study|Withdrawal by Subject|4|||
25209638|NCT02253654|50469991|FG000|Overall Study|Decision by Sponsor|1|||
25209639|NCT02253654|50469992|FG001|Overall Study|Decision by Sponsor|1|||
25209640|NCT02253654|50469991|FG000|Overall Study|Lost to Follow-up|2|||
25209641|NCT02253654|50469992|FG001|Overall Study|Lost to Follow-up|5|||
25209642|NCT02253654|50469991|FG000|Overall Study|Death|4|||
25209643|NCT02253654|50469992|FG001|Overall Study|Death|7|||
25209644|NCT02253654|50469991|FG000|Overall Study|Did Not Receive Study Treatment|4|||
25209645|NCT02253654|50469992|FG001|Overall Study|Did Not Receive Study Treatment|1|||
25209646|NCT02252406|50470000|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
25209647|NCT02252406|50470001|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
25209648|NCT02252406|50470000|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
25209649|NCT02252406|50470001|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
25209650|NCT02252406|50470000|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
25209651|NCT02252406|50470001|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
25209652|NCT02252406|50470000|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
25209653|NCT02252406|50470001|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
25077204|NCT02465528|50185034|FG002|Overall Study|Physician Decision|1|||
25209654|NCT02252406|50470000|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
25209655|NCT02252406|50470001|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
25209656|NCT02246478|50470011|FG000|Multiple-dose Phase|Protocol Violation|1|||
25209657|NCT02246478|50470012|FG001|Multiple-dose Phase|Protocol Violation|0|||
25209658|NCT02246478|50470013|FG002|Multiple-dose Phase|Protocol Violation|0|||
25209659|NCT02246478|50470014|FG003|Multiple-dose Phase|Protocol Violation|1|||
25209660|NCT02252016|50470033|FG000|Overall Study|Lost to Follow-up|2|||
25209661|NCT02252016|50470034|FG001|Overall Study|Lost to Follow-up|1|||
25209662|NCT02252016|50470033|FG000|Overall Study|Physician Decision|1|||
25209663|NCT02252016|50470034|FG001|Overall Study|Physician Decision|0|||
25209664|NCT02252016|50470033|FG000|Overall Study|Withdrawal by Subject|0|||
25209665|NCT02252016|50470034|FG001|Overall Study|Withdrawal by Subject|2|||
25209666|NCT02249832|50470040|FG000|Overall Study|Withdrawal by Subject|3|||
25209667|NCT02249832|50470040|FG000|Overall Study|Lost to Follow-up|10|||
25209668|NCT02248974|50470051|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
25209669|NCT02248974|50470052|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
25209670|NCT02248974|50470051|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
25209671|NCT02248974|50470052|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
25209672|NCT02248974|50470051|FG000|1-Day Follow-Up|Enrolled in another study|1|||
25209673|NCT02248974|50470052|FG001|1-Day Follow-Up|Enrolled in another study|0|||
25209674|NCT02248974|50470051|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
25209675|NCT02248974|50470052|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
25209676|NCT02248974|50470051|FG000|1-Week Follow-Up|Enrolled in another study|1|||
25209677|NCT02248974|50470052|FG001|1-Week Follow-Up|Enrolled in another study|1|||
25209678|NCT02248974|50470051|FG000|1-Week Follow-Up|Transferred to another facility|1|||
25209679|NCT02248974|50470052|FG001|1-Week Follow-Up|Transferred to another facility|0|||
25209680|NCT02248974|50470051|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
25209681|NCT02248974|50470052|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
25209682|NCT02248974|50470051|FG000|1-Week Follow-Up|Death|1|||
25209683|NCT02248974|50470052|FG001|1-Week Follow-Up|Death|1|||
25209684|NCT02248974|50470051|FG000|1-Week Follow-Up|Excluded because of age|0|||
25209685|NCT02248974|50470052|FG001|1-Week Follow-Up|Excluded because of age|1|||
25209686|NCT02248974|50470051|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
25209687|NCT02248974|50470052|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
25209688|NCT02248974|50470051|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
25209689|NCT02248974|50470052|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
25209690|NCT02248974|50470051|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
25209691|NCT02248974|50470052|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
25209692|NCT02248974|50470051|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
25209693|NCT02248974|50470052|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
25209694|NCT02248974|50470051|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
25209695|NCT02248974|50470052|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
25209696|NCT02246166|50470060|FG000|Overall Study|Protocol Violation|1|||
25209697|NCT02246166|50470061|FG001|Overall Study|Protocol Violation|0|||
25209698|NCT02706847|50470070|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
25209699|NCT02706847|50470071|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
25209700|NCT02706847|50470072|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
25209701|NCT02706847|50470073|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
25209702|NCT02706847|50470070|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
25209703|NCT02706847|50470071|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
25209704|NCT02706847|50470072|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
25209705|NCT02706847|50470073|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
25209706|NCT02706847|50470070|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
25209707|NCT02706847|50470071|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
25209708|NCT02706847|50470072|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
25209709|NCT02706847|50470073|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
25209710|NCT02706847|50470070|FG000|Period 1: Day 1 to Week 12|Other|4|||
25209711|NCT02706847|50470071|FG001|Period 1: Day 1 to Week 12|Other|4|||
25209712|NCT02706847|50470072|FG002|Period 1: Day 1 to Week 12|Other|2|||
25209713|NCT02706847|50470073|FG003|Period 1: Day 1 to Week 12|Other|2|||
25209714|NCT02706847|50470070|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
25209715|NCT02706847|50470071|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
25209716|NCT02706847|50470072|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
25209717|NCT02706847|50470073|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
25209718|NCT02706847|50470070|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
25209719|NCT02706847|50470071|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
25209720|NCT02706847|50470072|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
25209721|NCT02706847|50470073|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
25209722|NCT02706847|50470070|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
25209723|NCT02706847|50470071|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
25209724|NCT02706847|50470072|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
25209725|NCT02706847|50470073|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
25209726|NCT02706847|50470070|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
25209727|NCT02706847|50470071|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
25209728|NCT02706847|50470072|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
25209729|NCT02706847|50470073|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
25209730|NCT02706847|50470070|FG000|Period 1: Week 12 to Week 24|Other|1|||
25209731|NCT02706847|50470071|FG001|Period 1: Week 12 to Week 24|Other|0|||
24976346|NCT00092547|50065233|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
25209732|NCT02706847|50470072|FG002|Period 1: Week 12 to Week 24|Other|1|||
25209733|NCT02706847|50470073|FG003|Period 1: Week 12 to Week 24|Other|4|||
25209734|NCT02706847|50470070|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
25209735|NCT02706847|50470071|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
25209736|NCT02706847|50470072|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
25209737|NCT02706847|50470073|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
25209738|NCT02706847|50470070|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
25209739|NCT02706847|50470071|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
25209740|NCT02706847|50470072|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
25209741|NCT02706847|50470073|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
25209742|NCT02706847|50470070|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
25209743|NCT02706847|50470071|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
25209744|NCT02706847|50470072|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
25209745|NCT02706847|50470073|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
25209746|NCT02706847|50470070|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
25209747|NCT02706847|50470071|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
25209748|NCT02706847|50470072|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
25209749|NCT02706847|50470073|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
25209750|NCT02706847|50470070|FG000|Period 2: Week 24 to Week 260|Other|8|||
25209751|NCT02706847|50470071|FG001|Period 2: Week 24 to Week 260|Other|5|||
25209752|NCT02706847|50470072|FG002|Period 2: Week 24 to Week 260|Other|15|||
25209753|NCT02706847|50470073|FG003|Period 2: Week 24 to Week 260|Other|15|||
25209754|NCT02245620|50470086|FG000|Overall Study|Physician Decision|1|||
25209755|NCT02245620|50470087|FG001|Overall Study|Physician Decision|1|||
25209756|NCT02244996|50470095|FG000|Overall Study|Lack of Efficacy|2|||
25209757|NCT02244996|50470096|FG001|Overall Study|Lack of Efficacy|6|||
25209758|NCT02243280|50470131|FG000|Treated|Adverse Event|1|||
25209759|NCT02243280|50470132|FG001|Treated|Adverse Event|0|||
25209760|NCT02243280|50470133|FG002|Treated|Adverse Event|0|||
25209761|NCT02243280|50470134|FG003|Treated|Adverse Event|0|||
25209762|NCT02243280|50470135|FG004|Treated|Adverse Event|0|||
25209763|NCT02243280|50470136|FG005|Treated|Adverse Event|0|||
25209764|NCT02243280|50470137|FG006|Treated|Adverse Event|0|||
25209765|NCT02243280|50470138|FG007|Treated|Adverse Event|0|||
25209766|NCT02243280|50470139|FG008|Treated|Adverse Event|0|||
25209767|NCT02243280|50470140|FG009|Treated|Adverse Event|0|||
25209768|NCT02243280|50470141|FG010|Treated|Adverse Event|1|||
25209769|NCT02243280|50470131|FG000|Treated|Lost to Follow-up|0|||
25209770|NCT02243280|50470132|FG001|Treated|Lost to Follow-up|0|||
25209771|NCT02243280|50470133|FG002|Treated|Lost to Follow-up|0|||
25209772|NCT02243280|50470134|FG003|Treated|Lost to Follow-up|0|||
25209773|NCT02243280|50470135|FG004|Treated|Lost to Follow-up|0|||
25209774|NCT02243280|50470136|FG005|Treated|Lost to Follow-up|0|||
25209775|NCT02243280|50470137|FG006|Treated|Lost to Follow-up|0|||
25209776|NCT02243280|50470138|FG007|Treated|Lost to Follow-up|0|||
25209777|NCT02243280|50470139|FG008|Treated|Lost to Follow-up|1|||
25209778|NCT02243280|50470140|FG009|Treated|Lost to Follow-up|0|||
25209779|NCT02243280|50470141|FG010|Treated|Lost to Follow-up|2|||
25209780|NCT02248818|50470199|FG000|Screening|Protocol Violation|0|||
25209781|NCT02248818|50470200|FG001|Screening|Protocol Violation|0|||
25209782|NCT02248818|50470201|FG002|Screening|Protocol Violation|0|||
25209783|NCT02248818|50470202|FG003|Screening|Protocol Violation|0|||
25209784|NCT02248818|50470203|FG004|Screening|Protocol Violation|0|||
25209785|NCT02248818|50470204|FG005|Screening|Protocol Violation|0|||
25209786|NCT02248818|50470205|FG006|Screening|Protocol Violation|0|||
25209787|NCT02248818|50470206|FG007|Screening|Protocol Violation|0|||
25209788|NCT02248818|50470207|FG008|Screening|Protocol Violation|7|||
25209789|NCT02248818|50470199|FG000|Screening|Study fully enrolled|0|||
25209790|NCT02248818|50470200|FG001|Screening|Study fully enrolled|0|||
25209791|NCT02248818|50470201|FG002|Screening|Study fully enrolled|0|||
25209792|NCT02248818|50470202|FG003|Screening|Study fully enrolled|0|||
25209793|NCT02248818|50470203|FG004|Screening|Study fully enrolled|0|||
25209794|NCT02248818|50470204|FG005|Screening|Study fully enrolled|0|||
25209795|NCT02248818|50470205|FG006|Screening|Study fully enrolled|0|||
25209796|NCT02248818|50470206|FG007|Screening|Study fully enrolled|0|||
25209797|NCT02248818|50470207|FG008|Screening|Study fully enrolled|14|||
25209798|NCT02248818|50470199|FG000|Screening|Physician Decision|0|||
25209799|NCT02248818|50470200|FG001|Screening|Physician Decision|0|||
25209800|NCT02248818|50470201|FG002|Screening|Physician Decision|0|||
25209801|NCT02248818|50470202|FG003|Screening|Physician Decision|0|||
25209802|NCT02248818|50470203|FG004|Screening|Physician Decision|0|||
25209803|NCT02248818|50470204|FG005|Screening|Physician Decision|0|||
25209804|NCT02248818|50470205|FG006|Screening|Physician Decision|0|||
25209805|NCT02248818|50470206|FG007|Screening|Physician Decision|0|||
25209806|NCT02248818|50470207|FG008|Screening|Physician Decision|73|||
25209807|NCT02248818|50470199|FG000|Screening|Withdrawal by Subject|0|||
25209808|NCT02248818|50470200|FG001|Screening|Withdrawal by Subject|0|||
25209809|NCT02248818|50470201|FG002|Screening|Withdrawal by Subject|0|||
25209810|NCT02248818|50470202|FG003|Screening|Withdrawal by Subject|0|||
25209811|NCT02248818|50470203|FG004|Screening|Withdrawal by Subject|0|||
25209812|NCT02248818|50470204|FG005|Screening|Withdrawal by Subject|0|||
25209813|NCT02248818|50470205|FG006|Screening|Withdrawal by Subject|0|||
25209814|NCT02248818|50470206|FG007|Screening|Withdrawal by Subject|0|||
25209815|NCT02248818|50470207|FG008|Screening|Withdrawal by Subject|6|||
25209816|NCT02248818|50470199|FG000|Screening|Lost to Follow-up|0|||
25209817|NCT02248818|50470200|FG001|Screening|Lost to Follow-up|0|||
25209818|NCT02248818|50470201|FG002|Screening|Lost to Follow-up|0|||
25209819|NCT02248818|50470202|FG003|Screening|Lost to Follow-up|0|||
25209820|NCT02248818|50470203|FG004|Screening|Lost to Follow-up|0|||
25209821|NCT02248818|50470204|FG005|Screening|Lost to Follow-up|0|||
25209822|NCT02248818|50470205|FG006|Screening|Lost to Follow-up|0|||
25209823|NCT02248818|50470206|FG007|Screening|Lost to Follow-up|0|||
25209824|NCT02248818|50470207|FG008|Screening|Lost to Follow-up|7|||
25209825|NCT02248818|50470199|FG000|Randomised Study|Administrative - randomization error|0|||
25209826|NCT02248818|50470200|FG001|Randomised Study|Administrative - randomization error|0|||
25209827|NCT02248818|50470201|FG002|Randomised Study|Administrative - randomization error|0|||
25209828|NCT02248818|50470202|FG003|Randomised Study|Administrative - randomization error|0|||
25209829|NCT02248818|50470203|FG004|Randomised Study|Administrative - randomization error|0|||
25209830|NCT02248818|50470204|FG005|Randomised Study|Administrative - randomization error|8|||
25209831|NCT02248818|50470205|FG006|Randomised Study|Administrative - randomization error|0|||
25209832|NCT02248818|50470206|FG007|Randomised Study|Administrative - randomization error|0|||
25209833|NCT02248818|50470207|FG008|Randomised Study|Administrative - randomization error|0|||
25209834|NCT02247960|50470236|FG000|Patient Consent and Randomization|Physician Decision|2|||
25209835|NCT02247960|50470237|FG001|Patient Consent and Randomization|Physician Decision|2|||
25209836|NCT02247960|50470236|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
25209837|NCT02247960|50470237|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
25209838|NCT02247960|50470236|FG000|Catheter Removed|Lost to Follow-up|7|||
25209839|NCT02247960|50470237|FG001|Catheter Removed|Lost to Follow-up|10|||
25209840|NCT02247804|50470326|FG000|Treatment Period 1|Adverse Event|9|||
25209841|NCT02247804|50470327|FG001|Treatment Period 1|Adverse Event|2|||
25209842|NCT02247804|50470328|FG002|Treatment Period 1|Adverse Event|0|||
25209843|NCT02247804|50470326|FG000|Treatment Period 1|Lack of Efficacy|0|||
25209844|NCT02247804|50470327|FG001|Treatment Period 1|Lack of Efficacy|0|||
25209845|NCT02247804|50470328|FG002|Treatment Period 1|Lack of Efficacy|2|||
25209846|NCT02247804|50470326|FG000|Treatment Period 1|Lost to Follow-up|1|||
25209847|NCT02247804|50470327|FG001|Treatment Period 1|Lost to Follow-up|0|||
25209848|NCT02247804|50470328|FG002|Treatment Period 1|Lost to Follow-up|2|||
25209849|NCT02247804|50470326|FG000|Treatment Period 1|Personal Reasons|7|||
25209850|NCT02247804|50470327|FG001|Treatment Period 1|Personal Reasons|1|||
25209851|NCT02247804|50470328|FG002|Treatment Period 1|Personal Reasons|2|||
25209852|NCT02247804|50470326|FG000|Treatment Period 1|Protocol Deviation|0|||
25209853|NCT02247804|50470327|FG001|Treatment Period 1|Protocol Deviation|0|||
25209854|NCT02247804|50470328|FG002|Treatment Period 1|Protocol Deviation|1|||
25209855|NCT02247804|50470326|FG000|Treatment Period 1|Randomized but not Treated|5|||
25209856|NCT02247804|50470327|FG001|Treatment Period 1|Randomized but not Treated|1|||
25209857|NCT02247804|50470328|FG002|Treatment Period 1|Randomized but not Treated|1|||
25209858|NCT02247804|50470326|FG000|Treatment Period 2|Adverse Event|6|||
25209859|NCT02247804|50470327|FG001|Treatment Period 2|Adverse Event|3|||
25209860|NCT02247804|50470328|FG002|Treatment Period 2|Adverse Event|3|||
25209861|NCT02247804|50470326|FG000|Treatment Period 2|Lack of Efficacy|0|||
25209862|NCT02247804|50470327|FG001|Treatment Period 2|Lack of Efficacy|0|||
25209863|NCT02247804|50470328|FG002|Treatment Period 2|Lack of Efficacy|1|||
25209864|NCT02247804|50470326|FG000|Treatment Period 2|Lost to Follow-up|0|||
25209865|NCT02247804|50470327|FG001|Treatment Period 2|Lost to Follow-up|1|||
25209866|NCT02247804|50470328|FG002|Treatment Period 2|Lost to Follow-up|1|||
25209867|NCT02247804|50470326|FG000|Treatment Period 2|Personal Reasons|2|||
25209868|NCT02247804|50470327|FG001|Treatment Period 2|Personal Reasons|1|||
25209869|NCT02247804|50470328|FG002|Treatment Period 2|Personal Reasons|1|||
25209870|NCT02247804|50470326|FG000|Treatment Period 2|Reason not Specified|0|||
25209871|NCT02247804|50470327|FG001|Treatment Period 2|Reason not Specified|0|||
25209872|NCT02247804|50470328|FG002|Treatment Period 2|Reason not Specified|2|||
25209873|NCT02247804|50470326|FG000|Treatment Period 3|Adverse Event|4|||
25209874|NCT02247804|50470327|FG001|Treatment Period 3|Adverse Event|3|||
25209875|NCT02247804|50470328|FG002|Treatment Period 3|Adverse Event|3|||
25209876|NCT02247804|50470326|FG000|Treatment Period 3|Lack of Efficacy|0|||
25209877|NCT02247804|50470327|FG001|Treatment Period 3|Lack of Efficacy|1|||
25209878|NCT02247804|50470328|FG002|Treatment Period 3|Lack of Efficacy|0|||
25209879|NCT02247804|50470326|FG000|Treatment Period 3|Lost to Follow-up|1|||
25209880|NCT02247804|50470327|FG001|Treatment Period 3|Lost to Follow-up|2|||
25209881|NCT02247804|50470328|FG002|Treatment Period 3|Lost to Follow-up|2|||
25209882|NCT02247804|50470326|FG000|Treatment Period 3|Personal Reasons|4|||
25209883|NCT02247804|50470327|FG001|Treatment Period 3|Personal Reasons|3|||
25209884|NCT02247804|50470328|FG002|Treatment Period 3|Personal Reasons|2|||
25209885|NCT02247804|50470326|FG000|Treatment Period 3|Reason not Specified|2|||
25209886|NCT02247804|50470327|FG001|Treatment Period 3|Reason not Specified|1|||
25209887|NCT02247804|50470328|FG002|Treatment Period 3|Reason not Specified|3|||
25209888|NCT02243202|50470353|FG000|Overall Study|Adverse Event|5|||
25209889|NCT02243202|50470354|FG001|Overall Study|Adverse Event|6|||
25209890|NCT02243202|50470355|FG002|Overall Study|Adverse Event|10|||
25209891|NCT02243202|50470356|FG003|Overall Study|Adverse Event|4|||
25209892|NCT02243202|50470353|FG000|Overall Study|Lost to Follow-up|9|||
25209893|NCT02243202|50470354|FG001|Overall Study|Lost to Follow-up|9|||
25209894|NCT02243202|50470355|FG002|Overall Study|Lost to Follow-up|14|||
25209895|NCT02243202|50470356|FG003|Overall Study|Lost to Follow-up|11|||
25209896|NCT02243202|50470353|FG000|Overall Study|Protocol Violation|3|||
25209897|NCT02243202|50470354|FG001|Overall Study|Protocol Violation|1|||
25209898|NCT02243202|50470355|FG002|Overall Study|Protocol Violation|2|||
25209899|NCT02243202|50470356|FG003|Overall Study|Protocol Violation|1|||
25209900|NCT02243202|50470353|FG000|Overall Study|Withdrawal by Subject|7|||
25209901|NCT02243202|50470354|FG001|Overall Study|Withdrawal by Subject|6|||
25209902|NCT02243202|50470355|FG002|Overall Study|Withdrawal by Subject|4|||
25209903|NCT02243202|50470356|FG003|Overall Study|Withdrawal by Subject|4|||
25209904|NCT02243202|50470353|FG000|Overall Study|Other|1|||
25209905|NCT02243202|50470354|FG001|Overall Study|Other|3|||
25209906|NCT02243202|50470355|FG002|Overall Study|Other|1|||
25209907|NCT02243202|50470356|FG003|Overall Study|Other|2|||
25209908|NCT02243202|50470353|FG000|Overall Study|Randomized but not received treatment|0|||
25209909|NCT02243202|50470354|FG001|Overall Study|Randomized but not received treatment|0|||
25209910|NCT02243202|50470355|FG002|Overall Study|Randomized but not received treatment|0|||
25209911|NCT02243202|50470356|FG003|Overall Study|Randomized but not received treatment|1|||
25209912|NCT02243046|50470369|FG000|Overall Study|Lost to Follow-up|1|||
25209913|NCT02243046|50470370|FG001|Overall Study|Lost to Follow-up|1|||
25209914|NCT02243046|50470371|FG002|Overall Study|Lost to Follow-up|4|||
25209915|NCT02207946|50470381|FG000|Overall Study|Lost to Follow-up|1|||
25209916|NCT02207946|50470382|FG001|Overall Study|Lost to Follow-up|0|||
25209917|NCT02207946|50470381|FG000|Overall Study|Adverse Event|0|||
25209918|NCT02207946|50470382|FG001|Overall Study|Adverse Event|1|||
25209919|NCT03976076|50470389|FG000|Overall Study|Withdrawal by Subject|2|||
25209920|NCT03551210|50470588|FG000|Overall Study|Adverse Event|5|||
25209921|NCT03551210|50470589|FG001|Overall Study|Adverse Event|6|||
25209922|NCT03551210|50470588|FG000|Overall Study|Withdrawal by Subject|1|||
25209923|NCT03551210|50470589|FG001|Overall Study|Withdrawal by Subject|7|||
25209924|NCT03551210|50470588|FG000|Overall Study|Needed in other antibiotic treatment|2|||
25209925|NCT03551210|50470589|FG001|Overall Study|Needed in other antibiotic treatment|5|||
25209926|NCT03551210|50470588|FG000|Overall Study|Lost to Follow-up|1|||
25209927|NCT03551210|50470589|FG001|Overall Study|Lost to Follow-up|1|||
25209928|NCT03551210|50470588|FG000|Overall Study|Absence of visit 4 and 5|1|||
25209929|NCT03551210|50470589|FG001|Overall Study|Absence of visit 4 and 5|0|||
25209930|NCT03551210|50470588|FG000|Overall Study|No drug for dispensing|0|||
25209931|NCT03551210|50470589|FG001|Overall Study|No drug for dispensing|1|||
25209932|NCT02207634|50470726|FG000|Overall Study|Withdrawal by Subject|21|||
25209933|NCT02207634|50470727|FG001|Overall Study|Withdrawal by Subject|31|||
25209934|NCT02207634|50470726|FG000|Overall Study|Lost to Follow-up|1|||
25209935|NCT02207634|50470727|FG001|Overall Study|Lost to Follow-up|0|||
25209936|NCT03452228|50470770|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
25209937|NCT03452228|50470771|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
25209938|NCT03452228|50470772|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
25209939|NCT03452228|50470770|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
25209940|NCT03452228|50470771|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
25209941|NCT03452228|50470772|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
25209942|NCT03452228|50470770|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
25209943|NCT03452228|50470771|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
25209944|NCT03452228|50470772|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
25209945|NCT03452228|50470770|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
25209946|NCT03452228|50470771|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
25209947|NCT03452228|50470772|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
25209948|NCT02207556|50470835|FG000|Overall Study|Physician Decision|1|||
25209949|NCT02207556|50470836|FG001|Overall Study|Physician Decision|0|||
25209950|NCT02207556|50470835|FG000|Overall Study|Withdrawal by Subject|1|||
25209951|NCT02207556|50470836|FG001|Overall Study|Withdrawal by Subject|0|||
25209952|NCT02207556|50470835|FG000|Overall Study|Death|0|||
25209953|NCT02207556|50470836|FG001|Overall Study|Death|5|||
25209954|NCT03732638|50470851|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
25209955|NCT03732638|50470852|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
25209956|NCT03732638|50470851|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
25209957|NCT03732638|50470852|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
25209958|NCT03732638|50470851|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
25209959|NCT03732638|50470852|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
25209960|NCT03732638|50470851|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
25209961|NCT03732638|50470852|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
25209962|NCT03732638|50470851|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
25209963|NCT03732638|50470852|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
25209964|NCT03732638|50470851|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
25209965|NCT03732638|50470852|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
25209966|NCT03732638|50470851|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
25209967|NCT03732638|50470852|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
25209968|NCT03732638|50470851|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
25209969|NCT03732638|50470852|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
25209970|NCT03732638|50470851|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
25209971|NCT03732638|50470852|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
25316297|NCT00896532|50631608|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316298|NCT00896532|50631609|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
25316299|NCT00896532|50631610|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
25316300|NCT00574873|50631659|FG000|Overall Study|Withdrawal by Subject|18|||
25316301|NCT00574873|50631660|FG001|Overall Study|Withdrawal by Subject|19|||
25316302|NCT00574873|50631659|FG000|Overall Study|Investigator request|18|||
25316303|NCT00574873|50631660|FG001|Overall Study|Investigator request|8|||
25316304|NCT00574873|50631659|FG000|Overall Study|Death|15|||
25316305|NCT00574873|50631660|FG001|Overall Study|Death|14|||
25316306|NCT00574873|50631659|FG000|Overall Study|Lost to Follow-up|14|||
25316307|NCT00574873|50631660|FG001|Overall Study|Lost to Follow-up|5|||
25316308|NCT00574873|50631659|FG000|Overall Study|Other|40|||
25316309|NCT00574873|50631660|FG001|Overall Study|Other|4|||
25316310|NCT00574873|50631659|FG000|Overall Study|Discontinuation of study by sponsor|5|||
25316311|NCT00574873|50631660|FG001|Overall Study|Discontinuation of study by sponsor|199|||
25316312|NCT00574873|50631659|FG000|Overall Study|Blank, site closed per local regulations|2|||
25316313|NCT00574873|50631660|FG001|Overall Study|Blank, site closed per local regulations|2|||
25316314|NCT00574873|50631659|FG000|Overall Study|Extension Study|126|||
25316315|NCT00574873|50631660|FG001|Overall Study|Extension Study|0|||
25316316|NCT00902174|50631668|FG000|Overall Study|Adverse Event|27|||
25316317|NCT00902174|50631669|FG001|Overall Study|Adverse Event|7|||
25316318|NCT00902174|50631668|FG000|Overall Study|Lack of Efficacy|1|||
25209972|NCT03732638|50470851|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
25209973|NCT03732638|50470852|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
25316319|NCT00902174|50631669|FG001|Overall Study|Lack of Efficacy|5|||
25316320|NCT00902174|50631668|FG000|Overall Study|Death|2|||
25316321|NCT00902174|50631669|FG001|Overall Study|Death|2|||
25316322|NCT00902174|50631668|FG000|Overall Study|Withdrawal by Subject|2|||
25316323|NCT00902174|50631669|FG001|Overall Study|Withdrawal by Subject|1|||
25316324|NCT00902174|50631668|FG000|Overall Study|Abnormal labs|1|||
25316325|NCT00902174|50631669|FG001|Overall Study|Abnormal labs|1|||
25316326|NCT00902174|50631668|FG000|Overall Study|Protocol Violation|1|||
25316327|NCT00902174|50631669|FG001|Overall Study|Protocol Violation|1|||
25316328|NCT00902174|50631668|FG000|Overall Study|Administration problem|0|||
25316329|NCT00902174|50631669|FG001|Overall Study|Administration problem|1|||
25316330|NCT01609842|50631682|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
25316331|NCT01609842|50631683|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
25316332|NCT00623623|50631708|FG000|Overall Study|Previous enrolment into this study|1|||
25316333|NCT00623623|50631709|FG001|Overall Study|Previous enrolment into this study|1|||
25316334|NCT00896454|50631715|FG000|Overall Study|Death|10|||
25316335|NCT00896454|50631715|FG000|Overall Study|Adverse Event|8|||
25316336|NCT00896454|50631715|FG000|Overall Study|Disease Progression|5|||
25316337|NCT00896454|50631715|FG000|Overall Study|Other|4|||
25316338|NCT00896454|50631715|FG000|Overall Study|Requirement for alternative therapy|3|||
25316339|NCT00896454|50631715|FG000|Overall Study|Ongoing in study|2|||
25316340|NCT00896454|50631715|FG000|Overall Study|Withdrawal by Subject|1|||
25316341|NCT00629239|50631721|FG000|Overall Study|Adverse Event|7|||
25316342|NCT00629239|50631722|FG001|Overall Study|Adverse Event|4|||
25316343|NCT00629239|50631721|FG000|Overall Study|Physician Decision|1|||
25316344|NCT00629239|50631722|FG001|Overall Study|Physician Decision|0|||
25316345|NCT00625807|50631730|FG000|Overall Study|schedule conflict|2|||
25316346|NCT00625807|50631731|FG001|Overall Study|schedule conflict|8|||
25316347|NCT00629083|50631741|FG000|Overall Study|Adverse Event|0|||
25316348|NCT00629083|50631742|FG001|Overall Study|Adverse Event|2|||
25316349|NCT00629083|50631741|FG000|Overall Study|Lack of Efficacy|3|||
25316350|NCT00629083|50631742|FG001|Overall Study|Lack of Efficacy|1|||
25316351|NCT00629083|50631741|FG000|Overall Study|Withdrawal by Subject|10|||
25316352|NCT00629083|50631742|FG001|Overall Study|Withdrawal by Subject|2|||
25316353|NCT00629083|50631741|FG000|Overall Study|Lost to Follow-up|12|||
25316354|NCT00629083|50631742|FG001|Overall Study|Lost to Follow-up|8|||
25316355|NCT00629083|50631741|FG000|Overall Study|Moved out of country/state|2|||
25316356|NCT00629083|50631742|FG001|Overall Study|Moved out of country/state|1|||
25316357|NCT00629083|50631741|FG000|Overall Study|Refused to return for 12 month visit|1|||
25316358|NCT00629083|50631742|FG001|Overall Study|Refused to return for 12 month visit|0|||
25316359|NCT00901628|50631752|FG000|Overall Study|disconnection of catheter|4|||
25077205|NCT02465528|50185035|FG003|Overall Study|Physician Decision|0|||
25077206|NCT02438384|50185050|FG000|Overall Study|Lost to Follow-up|8|||
25209974|NCT03732638|50470851|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
25209975|NCT03732638|50470852|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
25209976|NCT03732638|50470851|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
25209977|NCT03732638|50470852|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
25209978|NCT03732638|50470851|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
25209979|NCT03732638|50470852|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
25209980|NCT03732638|50470851|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
25209981|NCT03732638|50470852|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
25209982|NCT03732638|50470851|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
25209983|NCT03732638|50470852|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
25209984|NCT03732638|50470851|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
25209985|NCT03732638|50470852|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
25209986|NCT03732638|50470851|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
25209987|NCT03732638|50470852|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
25209988|NCT03732638|50470851|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
25209989|NCT03732638|50470852|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
25209990|NCT03732638|50470851|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
25209991|NCT03732638|50470852|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
25209992|NCT03732638|50470851|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
25209993|NCT03732638|50470852|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
25209994|NCT03732638|50470851|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
25209995|NCT03732638|50470852|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
25209996|NCT03732638|50470851|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
25209997|NCT03732638|50470852|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
25209998|NCT03732638|50470851|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
25209999|NCT03732638|50470852|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
25210000|NCT03732638|50470851|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
25210001|NCT03732638|50470852|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
25210002|NCT03266588|50470891|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
25210003|NCT03266588|50470892|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
25210004|NCT03266588|50470893|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
25210005|NCT03266588|50470891|FG000|Observational Period|Withdrawal by Subject|44|||
25210006|NCT03266588|50470892|FG001|Observational Period|Withdrawal by Subject|22|||
25210007|NCT03266588|50470893|FG002|Observational Period|Withdrawal by Subject|13|||
25210008|NCT03266588|50470891|FG000|Observational Period|Non-compliance|18|||
25210009|NCT03266588|50470892|FG001|Observational Period|Non-compliance|12|||
25210010|NCT03266588|50470893|FG002|Observational Period|Non-compliance|10|||
25210011|NCT03266588|50470891|FG000|Observational Period|Lost to Follow-up|8|||
25210012|NCT03266588|50470892|FG001|Observational Period|Lost to Follow-up|12|||
25210013|NCT03266588|50470893|FG002|Observational Period|Lost to Follow-up|4|||
25210014|NCT03266588|50470891|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
25210015|NCT03266588|50470892|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
25210016|NCT03266588|50470893|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
25210017|NCT03266588|50470891|FG000|Observational Period|Protocol Deviation|1|||
25210018|NCT03266588|50470892|FG001|Observational Period|Protocol Deviation|0|||
25210019|NCT03266588|50470893|FG002|Observational Period|Protocol Deviation|0|||
25210020|NCT03266588|50470891|FG000|Observational Period|Other Reasons|3|||
25210021|NCT03266588|50470892|FG001|Observational Period|Other Reasons|0|||
25210022|NCT03266588|50470893|FG002|Observational Period|Other Reasons|1|||
25210023|NCT03266588|50470891|FG000|Long-term Treatment Period|Adverse Event|33|||
25210024|NCT03266588|50470892|FG001|Long-term Treatment Period|Adverse Event|17|||
25210025|NCT03266588|50470893|FG002|Long-term Treatment Period|Adverse Event|8|||
25210026|NCT03266588|50470891|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
25210027|NCT03266588|50470892|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
25210028|NCT03266588|50470893|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
25210029|NCT03266588|50470891|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
25210030|NCT03266588|50470892|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
25210031|NCT03266588|50470893|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
25210032|NCT03266588|50470891|FG000|Long-term Treatment Period|Non-Compliance|126|||
25210033|NCT03266588|50470892|FG001|Long-term Treatment Period|Non-Compliance|57|||
25210034|NCT03266588|50470893|FG002|Long-term Treatment Period|Non-Compliance|7|||
25210035|NCT03266588|50470891|FG000|Long-term Treatment Period|Pregnancy|11|||
25210036|NCT03266588|50470892|FG001|Long-term Treatment Period|Pregnancy|5|||
25210037|NCT03266588|50470893|FG002|Long-term Treatment Period|Pregnancy|0|||
25210038|NCT03266588|50470891|FG000|Long-term Treatment Period|Protocol Deviation|17|||
25210039|NCT03266588|50470892|FG001|Long-term Treatment Period|Protocol Deviation|10|||
25210040|NCT03266588|50470893|FG002|Long-term Treatment Period|Protocol Deviation|4|||
25210041|NCT03266588|50470891|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
25210042|NCT03266588|50470892|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
25210043|NCT03266588|50470893|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
25210044|NCT03266588|50470891|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
25210045|NCT03266588|50470892|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
25210046|NCT03266588|50470893|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
25210047|NCT03266588|50470891|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
25210048|NCT03266588|50470892|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
25210049|NCT03266588|50470893|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
25210050|NCT03266588|50470891|FG000|Long-term Treatment Period|Other Reasons|5|||
25210051|NCT03266588|50470892|FG001|Long-term Treatment Period|Other Reasons|0|||
25210052|NCT03266588|50470893|FG002|Long-term Treatment Period|Other Reasons|0|||
25210053|NCT03266588|50470891|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
25210054|NCT03266588|50470892|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
25210055|NCT03266588|50470893|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
25210056|NCT03238196|50470957|FG000|Overall Study|Adverse Event|3|||
25210057|NCT03238196|50470958|FG001|Overall Study|Adverse Event|0|||
25210058|NCT03238196|50470959|FG002|Overall Study|Adverse Event|2|||
25210059|NCT03238196|50470960|FG003|Overall Study|Adverse Event|2|||
25210060|NCT03238196|50470957|FG000|Overall Study|Withdrawal by Subject|4|||
25210061|NCT03238196|50470958|FG001|Overall Study|Withdrawal by Subject|1|||
25210062|NCT03238196|50470959|FG002|Overall Study|Withdrawal by Subject|1|||
25210063|NCT03238196|50470960|FG003|Overall Study|Withdrawal by Subject|0|||
25210064|NCT03238196|50470957|FG000|Overall Study|Disease progression|14|||
25210065|NCT03238196|50470958|FG001|Overall Study|Disease progression|2|||
25210066|NCT03238196|50470959|FG002|Overall Study|Disease progression|3|||
25210067|NCT03238196|50470960|FG003|Overall Study|Disease progression|2|||
25210068|NCT03238196|50470957|FG000|Overall Study|Still on treatment|1|||
25210069|NCT03238196|50470958|FG001|Overall Study|Still on treatment|0|||
25210070|NCT03238196|50470959|FG002|Overall Study|Still on treatment|0|||
25210071|NCT03238196|50470960|FG003|Overall Study|Still on treatment|0|||
25210072|NCT03019640|50470988|FG000|Overall Study|Screen Failures|4|||
25210073|NCT03019640|50470988|FG000|Overall Study|Adverse Event|3|||
25210074|NCT03019640|50470988|FG000|Overall Study|Participant Relapsed|1|||
25210075|NCT02240706|50471056|FG000|Overall Study|Lack of Efficacy|2|||
25210076|NCT02240706|50471057|FG001|Overall Study|Lack of Efficacy|2|||
25210077|NCT02240706|50471058|FG002|Overall Study|Lack of Efficacy|2|||
25210078|NCT02240706|50471059|FG003|Overall Study|Lack of Efficacy|2|||
25210079|NCT02240706|50471060|FG004|Overall Study|Lack of Efficacy|5|||
25210080|NCT02240706|50471061|FG005|Overall Study|Lack of Efficacy|0|||
25210081|NCT02240706|50471062|FG006|Overall Study|Lack of Efficacy|0|||
25210082|NCT02240706|50471056|FG000|Overall Study|Adverse Event|1|||
25210083|NCT02240706|50471057|FG001|Overall Study|Adverse Event|0|||
25210084|NCT02240706|50471058|FG002|Overall Study|Adverse Event|1|||
25210085|NCT02240706|50471059|FG003|Overall Study|Adverse Event|0|||
25210086|NCT02240706|50471060|FG004|Overall Study|Adverse Event|2|||
25210087|NCT02240706|50471061|FG005|Overall Study|Adverse Event|0|||
25210088|NCT02240706|50471062|FG006|Overall Study|Adverse Event|0|||
25210089|NCT02240706|50471056|FG000|Overall Study|Progressive disease|0|||
25210090|NCT02240706|50471057|FG001|Overall Study|Progressive disease|0|||
25210091|NCT02240706|50471058|FG002|Overall Study|Progressive disease|0|||
25210092|NCT02240706|50471059|FG003|Overall Study|Progressive disease|0|||
25210093|NCT02240706|50471060|FG004|Overall Study|Progressive disease|1|||
25210094|NCT02240706|50471061|FG005|Overall Study|Progressive disease|0|||
25210095|NCT02240706|50471062|FG006|Overall Study|Progressive disease|0|||
25210096|NCT02240706|50471056|FG000|Overall Study|Dose limiting toxicity|0|||
25210097|NCT02240706|50471057|FG001|Overall Study|Dose limiting toxicity|0|||
25210098|NCT02240706|50471058|FG002|Overall Study|Dose limiting toxicity|0|||
25210099|NCT02240706|50471059|FG003|Overall Study|Dose limiting toxicity|0|||
25210100|NCT02240706|50471060|FG004|Overall Study|Dose limiting toxicity|1|||
25210101|NCT02240706|50471061|FG005|Overall Study|Dose limiting toxicity|0|||
25210102|NCT02240706|50471062|FG006|Overall Study|Dose limiting toxicity|0|||
25210103|NCT02240706|50471056|FG000|Overall Study|Refused to continue taking medication|0|||
25210104|NCT02240706|50471057|FG001|Overall Study|Refused to continue taking medication|1|||
25210105|NCT02240706|50471058|FG002|Overall Study|Refused to continue taking medication|3|||
25210106|NCT02240706|50471059|FG003|Overall Study|Refused to continue taking medication|1|||
25210107|NCT02240706|50471060|FG004|Overall Study|Refused to continue taking medication|2|||
25210108|NCT02240706|50471061|FG005|Overall Study|Refused to continue taking medication|0|||
25210109|NCT02240706|50471062|FG006|Overall Study|Refused to continue taking medication|0|||
25210110|NCT02240706|50471056|FG000|Overall Study|Insurance billing concerns|0|||
25316360|NCT00901628|50631753|FG001|Overall Study|disconnection of catheter|8|||
25316361|NCT00901628|50631752|FG000|Overall Study|disconnection of drain|0|||
25316362|NCT00901628|50631753|FG001|Overall Study|disconnection of drain|1|||
24976347|NCT00092547|50065234|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
25077207|NCT02438384|50185051|FG001|Overall Study|Lost to Follow-up|6|||
25210111|NCT02240706|50471057|FG001|Overall Study|Insurance billing concerns|0|||
25210112|NCT02240706|50471058|FG002|Overall Study|Insurance billing concerns|0|||
25210113|NCT02240706|50471059|FG003|Overall Study|Insurance billing concerns|1|||
25210114|NCT02240706|50471060|FG004|Overall Study|Insurance billing concerns|0|||
25210115|NCT02240706|50471061|FG005|Overall Study|Insurance billing concerns|0|||
25210116|NCT02240706|50471062|FG006|Overall Study|Insurance billing concerns|0|||
25210117|NCT01600092|50471087|FG000|Overall Study|Adverse Event|2|||
25210118|NCT01600092|50471088|FG001|Overall Study|Adverse Event|0|||
25210119|NCT01600092|50471087|FG000|Overall Study|Lost to Follow-up|4|||
25210120|NCT01600092|50471088|FG001|Overall Study|Lost to Follow-up|6|||
25210121|NCT01600092|50471087|FG000|Overall Study|Withdrawal by parent/guardian|8|||
25210122|NCT01600092|50471088|FG001|Overall Study|Withdrawal by parent/guardian|6|||
25210123|NCT01600092|50471087|FG000|Overall Study|Physician Decision|1|||
25210124|NCT01600092|50471088|FG001|Overall Study|Physician Decision|1|||
25210125|NCT01600092|50471087|FG000|Overall Study|Randomized but not vaccinated|3|||
25210126|NCT01600092|50471088|FG001|Overall Study|Randomized but not vaccinated|3|||
25210127|NCT02240628|50471100|FG000|Overall Study|Physician Decision|6|||
25210128|NCT02240628|50471101|FG001|Overall Study|Physician Decision|5|||
25210129|NCT02207400|50471123|FG000|Overall Study|Adverse Event|1|||
25210130|NCT02207400|50471124|FG001|Overall Study|Adverse Event|1|||
25210131|NCT02207400|50471123|FG000|Overall Study|Lost to Follow-up|6|||
25210132|NCT02207400|50471124|FG001|Overall Study|Lost to Follow-up|7|||
25210133|NCT02207400|50471123|FG000|Overall Study|Protocol Violation|1|||
25210134|NCT02207400|50471124|FG001|Overall Study|Protocol Violation|1|||
25210135|NCT02207400|50471123|FG000|Overall Study|Withdrawal by Subject|8|||
25210136|NCT02207400|50471124|FG001|Overall Study|Withdrawal by Subject|4|||
25210137|NCT02207400|50471123|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
25210138|NCT02207400|50471124|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
25210139|NCT02207244|50471496|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
25210140|NCT02207244|50471497|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
25210141|NCT02207244|50471498|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
25210142|NCT02207244|50471499|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
25210143|NCT02207244|50471500|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
25210144|NCT02207244|50471501|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
25210145|NCT02207244|50471502|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
25210146|NCT02207244|50471503|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
25210147|NCT02207244|50471504|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
25210148|NCT02207244|50471505|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
25210149|NCT02207244|50471506|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
25210150|NCT02207244|50471496|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
25210151|NCT02207244|50471497|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
25210152|NCT02207244|50471498|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
25210153|NCT02207244|50471499|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
25210154|NCT02207244|50471500|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
25210155|NCT02207244|50471501|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
25210156|NCT02207244|50471502|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
25210157|NCT02207244|50471503|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
25210158|NCT02207244|50471504|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
25210159|NCT02207244|50471505|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
25210160|NCT02207244|50471506|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
25210161|NCT02207244|50471496|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
25210162|NCT02207244|50471497|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
25210163|NCT02207244|50471498|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
25210164|NCT02207244|50471499|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
25210165|NCT02207244|50471500|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
25210166|NCT02207244|50471501|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
25210167|NCT02207244|50471502|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
25210168|NCT02207244|50471503|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
25210169|NCT02207244|50471504|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
25210170|NCT02207244|50471505|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
25210171|NCT02207244|50471506|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
25210172|NCT02207244|50471496|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
25210173|NCT02207244|50471497|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
25210174|NCT02207244|50471498|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
25210175|NCT02207244|50471499|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
25210176|NCT02207244|50471500|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
25210177|NCT02207244|50471501|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
25210178|NCT02207244|50471502|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
25210179|NCT02207244|50471503|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
25210180|NCT02207244|50471504|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
25210181|NCT02207244|50471505|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
25210182|NCT02207244|50471506|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
25210183|NCT02207244|50471496|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
25210184|NCT02207244|50471497|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
25210185|NCT02207244|50471498|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
25210186|NCT02207244|50471499|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
25210187|NCT02207244|50471500|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
25210188|NCT02207244|50471501|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
25210189|NCT02207244|50471502|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
25210190|NCT02207244|50471503|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
25210191|NCT02207244|50471504|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
25210192|NCT02207244|50471505|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
25210193|NCT02207244|50471506|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
25210194|NCT02207244|50471496|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
25210195|NCT02207244|50471497|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
25210196|NCT02207244|50471498|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
25210197|NCT02207244|50471499|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
25210198|NCT02207244|50471500|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
25210199|NCT02207244|50471501|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
25210200|NCT02207244|50471502|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
25210201|NCT02207244|50471503|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
25210202|NCT02207244|50471504|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
25210203|NCT02207244|50471505|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
25210204|NCT02207244|50471506|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
25210205|NCT02207244|50471496|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
25210206|NCT02207244|50471497|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
25210207|NCT02207244|50471498|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
25210208|NCT02207244|50471499|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
25210209|NCT02207244|50471500|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
25210210|NCT02207244|50471501|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
25210211|NCT02207244|50471502|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
25210212|NCT02207244|50471503|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
25210213|NCT02207244|50471504|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
25210214|NCT02207244|50471505|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
25210215|NCT02207244|50471506|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
25210216|NCT02207244|50471496|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
25210217|NCT02207244|50471497|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
25210218|NCT02207244|50471498|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
25210219|NCT02207244|50471499|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
25210220|NCT02207244|50471500|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
25210221|NCT02207244|50471501|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
25210222|NCT02207244|50471502|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
25210223|NCT02207244|50471503|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
25210224|NCT02207244|50471504|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
25210225|NCT02207244|50471505|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
25210226|NCT02207244|50471506|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
25210227|NCT02207244|50471496|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
25210228|NCT02207244|50471497|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
25210229|NCT02207244|50471498|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
25210230|NCT02207244|50471499|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
25210231|NCT02207244|50471500|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
25210232|NCT02207244|50471501|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
25210233|NCT02207244|50471502|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
25210234|NCT02207244|50471503|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
25210235|NCT02207244|50471504|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
25210236|NCT02207244|50471505|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
25210237|NCT02207244|50471506|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
25210238|NCT02207244|50471496|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
25210239|NCT02207244|50471497|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
25210240|NCT02207244|50471498|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
25210241|NCT02207244|50471499|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
25210242|NCT02207244|50471500|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
25210243|NCT02207244|50471501|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
25210244|NCT02207244|50471502|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
25210245|NCT02207244|50471503|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
25210246|NCT02207244|50471504|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
25316363|NCT00901628|50631752|FG000|Overall Study|peroneal nerve palsy|0|||
25210247|NCT02207244|50471505|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
25210248|NCT02207244|50471506|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
25210249|NCT02207244|50471496|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
25210250|NCT02207244|50471497|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
25210251|NCT02207244|50471498|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
25210252|NCT02207244|50471499|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
25210253|NCT02207244|50471500|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
25210254|NCT02207244|50471501|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
25210255|NCT02207244|50471502|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
25210256|NCT02207244|50471503|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
25210257|NCT02207244|50471504|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
25210258|NCT02207244|50471505|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
25210259|NCT02207244|50471506|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
25210260|NCT02207244|50471496|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
25210261|NCT02207244|50471497|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
25210262|NCT02207244|50471498|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
25210263|NCT02207244|50471499|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
25210264|NCT02207244|50471500|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
25210265|NCT02207244|50471501|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
25210266|NCT02207244|50471502|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
25210267|NCT02207244|50471503|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
25210268|NCT02207244|50471504|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
25210269|NCT02207244|50471505|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
25210270|NCT02207244|50471506|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
25210271|NCT02207244|50471496|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
25210272|NCT02207244|50471497|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
25210273|NCT02207244|50471498|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
25210274|NCT02207244|50471499|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
25210275|NCT02207244|50471500|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
25210276|NCT02207244|50471501|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
25210277|NCT02207244|50471502|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
25210278|NCT02207244|50471503|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
25210279|NCT02207244|50471504|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
25210280|NCT02207244|50471505|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
25210281|NCT02207244|50471506|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
25210282|NCT02207244|50471496|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
25210283|NCT02207244|50471497|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
25210284|NCT02207244|50471498|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
25210285|NCT02207244|50471499|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
25210286|NCT02207244|50471500|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
25210287|NCT02207244|50471501|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
25210288|NCT02207244|50471502|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
25210289|NCT02207244|50471503|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
25210290|NCT02207244|50471504|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
25210291|NCT02207244|50471505|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
25210292|NCT02207244|50471506|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
25210293|NCT02207244|50471496|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
25210294|NCT02207244|50471497|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
25210295|NCT02207244|50471498|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
25210296|NCT02207244|50471499|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
25210297|NCT02207244|50471500|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
25210298|NCT02207244|50471501|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
25210299|NCT02207244|50471502|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
25210300|NCT02207244|50471503|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
25210301|NCT02207244|50471504|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
25210302|NCT02207244|50471505|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
25210303|NCT02207244|50471506|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
25210304|NCT02207244|50471496|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
25210305|NCT02207244|50471497|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
25210306|NCT02207244|50471498|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
25210307|NCT02207244|50471499|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
25210308|NCT02207244|50471500|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
25210309|NCT02207244|50471501|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
25210310|NCT02207244|50471502|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
25210311|NCT02207244|50471503|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
25210312|NCT02207244|50471504|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
25210313|NCT02207244|50471505|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
25210314|NCT02207244|50471506|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
25210315|NCT02207244|50471496|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
25210316|NCT02207244|50471497|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
25210317|NCT02207244|50471498|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
25210318|NCT02207244|50471499|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
25210319|NCT02207244|50471500|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
25210320|NCT02207244|50471501|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
25210321|NCT02207244|50471502|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
25210322|NCT02207244|50471503|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
25210323|NCT02207244|50471504|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
25210324|NCT02207244|50471505|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
25210325|NCT02207244|50471506|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
25210326|NCT02207244|50471496|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
25210327|NCT02207244|50471497|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
25210328|NCT02207244|50471498|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
25210329|NCT02207244|50471499|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
25210330|NCT02207244|50471500|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
25210331|NCT02207244|50471501|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
25210332|NCT02207244|50471502|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
25210333|NCT02207244|50471503|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
25210334|NCT02207244|50471504|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
25210335|NCT02207244|50471505|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
25210336|NCT02207244|50471506|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
25210337|NCT02207244|50471496|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
25210338|NCT02207244|50471497|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
25210339|NCT02207244|50471498|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
25210340|NCT02207244|50471499|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
25210341|NCT02207244|50471500|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
25210342|NCT02207244|50471501|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
25210343|NCT02207244|50471502|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
25210344|NCT02207244|50471503|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
25210345|NCT02207244|50471504|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
25210346|NCT02207244|50471505|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
25210347|NCT02207244|50471506|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
25210348|NCT02207244|50471496|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
25210349|NCT02207244|50471497|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
25210350|NCT02207244|50471498|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
25210351|NCT02207244|50471499|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
25210352|NCT02207244|50471500|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
25210353|NCT02207244|50471501|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
25210354|NCT02207244|50471502|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
25210355|NCT02207244|50471503|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
25210356|NCT02207244|50471504|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
25210357|NCT02207244|50471505|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
25210358|NCT02207244|50471506|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
25210359|NCT02207244|50471496|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
25210360|NCT02207244|50471497|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
25210361|NCT02207244|50471498|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
25210362|NCT02207244|50471499|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
25210363|NCT02207244|50471500|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
25210364|NCT02207244|50471501|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
25210365|NCT02207244|50471502|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
25210366|NCT02207244|50471503|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
25210367|NCT02207244|50471504|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
25210368|NCT02207244|50471505|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
25210369|NCT02207244|50471506|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
25210370|NCT02207244|50471496|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
25210371|NCT02207244|50471497|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
25210372|NCT02207244|50471498|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
25210373|NCT02207244|50471499|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
25210374|NCT02207244|50471500|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
25210375|NCT02207244|50471501|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
25210376|NCT02207244|50471502|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
25210377|NCT02207244|50471503|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
25210378|NCT02207244|50471504|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
25210379|NCT02207244|50471505|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
25210380|NCT02207244|50471506|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
25210381|NCT02207244|50471496|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
25210382|NCT02207244|50471497|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
25210383|NCT02207244|50471498|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
25210384|NCT02207244|50471499|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
25210385|NCT02207244|50471500|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
25210386|NCT02207244|50471501|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
25210387|NCT02207244|50471502|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
25210388|NCT02207244|50471503|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
25210389|NCT02207244|50471504|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
25210390|NCT02207244|50471505|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
25210391|NCT02207244|50471506|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
25210392|NCT02207244|50471496|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
25210393|NCT02207244|50471497|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
25210394|NCT02207244|50471498|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
25210395|NCT02207244|50471499|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
25210396|NCT02207244|50471500|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
25210397|NCT02207244|50471501|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
25210398|NCT02207244|50471502|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
25210399|NCT02207244|50471503|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
25210400|NCT02207244|50471504|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
25210401|NCT02207244|50471505|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
25210402|NCT02207244|50471506|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
25210403|NCT02207244|50471496|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
25210404|NCT02207244|50471497|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
25210405|NCT02207244|50471498|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
25210406|NCT02207244|50471499|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
25210407|NCT02207244|50471500|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
25210408|NCT02207244|50471501|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
25210409|NCT02207244|50471502|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
25210410|NCT02207244|50471503|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
25210411|NCT02207244|50471504|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
25210412|NCT02207244|50471505|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
25210413|NCT02207244|50471506|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
25210414|NCT02207244|50471496|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
25210415|NCT02207244|50471497|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
25210416|NCT02207244|50471498|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
25210417|NCT02207244|50471499|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
25210418|NCT02207244|50471500|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
25210419|NCT02207244|50471501|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
25210420|NCT02207244|50471502|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
25210421|NCT02207244|50471503|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
25210422|NCT02207244|50471504|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
25210423|NCT02207244|50471505|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
25210424|NCT02207244|50471506|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
25210425|NCT02207244|50471496|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
25210426|NCT02207244|50471497|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
25210427|NCT02207244|50471498|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
25210428|NCT02207244|50471499|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
25210429|NCT02207244|50471500|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
25210430|NCT02207244|50471501|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
25210431|NCT02207244|50471502|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
25210432|NCT02207244|50471503|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
25210433|NCT02207244|50471504|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
25210434|NCT02207244|50471505|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
25210435|NCT02207244|50471506|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
25210436|NCT02207244|50471496|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
25210437|NCT02207244|50471497|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
25210438|NCT02207244|50471498|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
25210439|NCT02207244|50471499|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
25210440|NCT02207244|50471500|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
25210441|NCT02207244|50471501|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
25210442|NCT02207244|50471502|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
25210443|NCT02207244|50471503|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
25210444|NCT02207244|50471504|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
25210445|NCT02207244|50471505|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
25210446|NCT02207244|50471506|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
25210447|NCT02207244|50471496|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
25210448|NCT02207244|50471497|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
25210449|NCT02207244|50471498|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
25210450|NCT02207244|50471499|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
25210451|NCT02207244|50471500|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
25210452|NCT02207244|50471501|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
25210453|NCT02207244|50471502|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
25210454|NCT02207244|50471503|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
25210455|NCT02207244|50471504|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
25210456|NCT02207244|50471505|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
25210457|NCT02207244|50471506|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
25210458|NCT02207088|50471559|FG000|Overall Study|Adverse Event|2|||
25210459|NCT02206620|50471574|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
25210460|NCT02206620|50471575|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
25210461|NCT02206620|50471574|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
25210462|NCT02206620|50471575|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
25210463|NCT02239926|50471589|FG000|Overall Study|Withdrawal by Subject|0|||
25210464|NCT02239926|50471590|FG001|Overall Study|Withdrawal by Subject|1|||
25210465|NCT02239692|50471598|FG000|Overall Study|Incomplete colonoscopy|1|||
25210466|NCT02239692|50471599|FG001|Overall Study|Incomplete colonoscopy|2|||
25210467|NCT02239692|50471598|FG000|Overall Study|Adverse Event|0|||
25210468|NCT02239692|50471599|FG001|Overall Study|Adverse Event|1|||
25210469|NCT02239692|50471598|FG000|Overall Study|Physician Decision|0|||
25210470|NCT02239692|50471599|FG001|Overall Study|Physician Decision|1|||
25210471|NCT02239692|50471598|FG000|Overall Study|Lost to Follow-up|1|||
25210472|NCT02239692|50471599|FG001|Overall Study|Lost to Follow-up|4|||
25210473|NCT02239692|50471598|FG000|Overall Study|Withdrawal by Subject|3|||
25210474|NCT02239692|50471599|FG001|Overall Study|Withdrawal by Subject|5|||
25210475|NCT02239692|50471598|FG000|Overall Study|Other reason|1|||
25210476|NCT02239692|50471599|FG001|Overall Study|Other reason|0|||
25210477|NCT02206152|50471627|FG000|Pre-Randomization|Withdrawal by Subject|2|||
25210478|NCT02204982|50471635|FG000|Overall Study|Patient ineligible-medical monitor|1|||
25210479|NCT02204982|50471636|FG001|Overall Study|Patient ineligible-medical monitor|0|||
25210480|NCT02204982|50471635|FG000|Overall Study|Withdrawal by Subject|1|||
25210481|NCT02204982|50471636|FG001|Overall Study|Withdrawal by Subject|0|||
25210482|NCT02204982|50471635|FG000|Overall Study|Adverse Event|1|||
25210483|NCT02204982|50471636|FG001|Overall Study|Adverse Event|0|||
25210484|NCT02204982|50471635|FG000|Overall Study|Adverse Event and Investigator decision|1|||
25210485|NCT02204982|50471636|FG001|Overall Study|Adverse Event and Investigator decision|0|||
25210486|NCT02204982|50471635|FG000|Overall Study|Physician Decision|0|||
25210487|NCT02204982|50471636|FG001|Overall Study|Physician Decision|2|||
25210488|NCT02204982|50471635|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
25210489|NCT02204982|50471636|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
25210490|NCT02204982|50471635|FG000|Overall Study|Termination of Study bySponsor|0|||
25210491|NCT02204982|50471636|FG001|Overall Study|Termination of Study bySponsor|1|||
25210492|NCT02239536|50471644|FG000|Overall Study|Non-neoplastic polyp|23|||
25210493|NCT02239536|50471645|FG001|Overall Study|Non-neoplastic polyp|17|||
25210494|NCT02239224|50471655|FG000|Overall Study|Administrative|0|||
25210495|NCT02239224|50471656|FG001|Overall Study|Administrative|0|||
25210496|NCT02239224|50471657|FG002|Overall Study|Administrative|3|||
25210497|NCT02239224|50471658|FG003|Overall Study|Administrative|1|||
25210498|NCT01600014|50471668|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
25210499|NCT01600014|50471669|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
25210500|NCT01600014|50471668|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
25210501|NCT01600014|50471669|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
25210502|NCT01600014|50471668|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
25210503|NCT01600014|50471669|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
25210504|NCT01600014|50471668|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
25210505|NCT01600014|50471669|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
24976348|NCT00092547|50065232|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
24976349|NCT00092547|50065233|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
25210506|NCT01600014|50471668|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
25210507|NCT01600014|50471669|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
25210508|NCT01600014|50471668|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
25210509|NCT01600014|50471669|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
25210510|NCT01600014|50471668|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
25210511|NCT01600014|50471669|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
25210512|NCT01600014|50471668|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
25210513|NCT01600014|50471669|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
25210514|NCT01600014|50471668|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
25210515|NCT01600014|50471669|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
25210516|NCT01600014|50471668|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
25210517|NCT01600014|50471669|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
25210518|NCT01600014|50471668|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
25210519|NCT01600014|50471669|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
25210520|NCT01600014|50471668|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
25210521|NCT01600014|50471669|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
25210522|NCT01600014|50471668|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
25210523|NCT01600014|50471669|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
25210524|NCT01600014|50471668|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
25210525|NCT01600014|50471669|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
25210526|NCT01600014|50471668|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
25210527|NCT01600014|50471669|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
25210528|NCT01600014|50471668|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
25210529|NCT01600014|50471669|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
25210530|NCT01600014|50471668|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
25210531|NCT01600014|50471669|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
25210532|NCT02237196|50471691|FG000|Overall Study|Adverse Event|0|||
25210533|NCT02237196|50471692|FG001|Overall Study|Adverse Event|1|||
25210534|NCT02237196|50471693|FG002|Overall Study|Adverse Event|1|||
25210535|NCT02237196|50471694|FG003|Overall Study|Adverse Event|0|||
25210536|NCT02237196|50471691|FG000|Overall Study|Lost to Follow-up|4|||
25210537|NCT02237196|50471692|FG001|Overall Study|Lost to Follow-up|2|||
25210538|NCT02237196|50471693|FG002|Overall Study|Lost to Follow-up|4|||
25210539|NCT02237196|50471694|FG003|Overall Study|Lost to Follow-up|6|||
25210540|NCT02237196|50471691|FG000|Overall Study|Physician Decision|2|||
25210541|NCT02237196|50471692|FG001|Overall Study|Physician Decision|0|||
25210542|NCT02237196|50471693|FG002|Overall Study|Physician Decision|0|||
25210543|NCT02237196|50471694|FG003|Overall Study|Physician Decision|1|||
25210544|NCT02237196|50471691|FG000|Overall Study|Pregnancy|0|||
25210545|NCT02237196|50471692|FG001|Overall Study|Pregnancy|0|||
25210546|NCT02237196|50471693|FG002|Overall Study|Pregnancy|1|||
25210547|NCT02237196|50471694|FG003|Overall Study|Pregnancy|1|||
25210548|NCT02237196|50471691|FG000|Overall Study|Withdrawal by Subject|1|||
25210549|NCT02237196|50471692|FG001|Overall Study|Withdrawal by Subject|1|||
25210550|NCT02237196|50471693|FG002|Overall Study|Withdrawal by Subject|4|||
25210551|NCT02237196|50471694|FG003|Overall Study|Withdrawal by Subject|1|||
25210552|NCT02237196|50471691|FG000|Overall Study|Site Error|1|||
25210553|NCT02237196|50471692|FG001|Overall Study|Site Error|2|||
25210554|NCT02237196|50471693|FG002|Overall Study|Site Error|0|||
25316364|NCT00901628|50631753|FG001|Overall Study|peroneal nerve palsy|1|||
25210555|NCT02237196|50471694|FG003|Overall Study|Site Error|2|||
25210556|NCT02237118|50471710|FG000|Overall Study|Protocol Violation|0|||
25210557|NCT02237118|50471711|FG001|Overall Study|Protocol Violation|1|||
25210558|NCT02237118|50471710|FG000|Overall Study|consent withdrawn|1|||
25210559|NCT02237118|50471711|FG001|Overall Study|consent withdrawn|0|||
25210560|NCT02234622|50471727|FG000|Overall Study|Withdrawal by Subject|16|||
25210561|NCT02234622|50471728|FG001|Overall Study|Withdrawal by Subject|22|||
25210562|NCT02234622|50471727|FG000|Overall Study|Lost to Follow-up|27|||
25210563|NCT02234622|50471728|FG001|Overall Study|Lost to Follow-up|14|||
25210564|NCT03250273|50471738|FG000|Overall Study|Disease Progression|2|||
25210565|NCT03250273|50471739|FG001|Overall Study|Disease Progression|11|||
25210566|NCT03250273|50471738|FG000|Overall Study|Death|0|||
25210567|NCT03250273|50471739|FG001|Overall Study|Death|1|||
24976350|NCT00092547|50065234|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
24976351|NCT00092547|50065232|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
24976352|NCT00092547|50065233|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
24976353|NCT00092547|50065234|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
24976354|NCT00092547|50065232|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
24976355|NCT00092547|50065233|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
24976356|NCT00092547|50065234|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
24976357|NCT00092547|50065232|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
24976358|NCT00092547|50065233|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
24976359|NCT00092547|50065234|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
24976360|NCT00092547|50065232|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
25210568|NCT02203032|50471745|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
25210569|NCT02203032|50471746|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
25210570|NCT02203032|50471747|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
25210571|NCT02203032|50471748|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
25210572|NCT02203032|50471745|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
25210573|NCT02203032|50471746|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
25210574|NCT02203032|50471747|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
25210575|NCT02203032|50471748|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
25210576|NCT02203032|50471745|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
25210577|NCT02203032|50471746|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
25210578|NCT02203032|50471747|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
25210579|NCT02203032|50471748|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
25210580|NCT02203032|50471745|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
25210581|NCT02203032|50471746|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
25210582|NCT02203032|50471747|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
25210583|NCT02203032|50471748|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
25210584|NCT02203032|50471745|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
25210585|NCT02203032|50471746|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
25210586|NCT02203032|50471747|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
25210587|NCT02203032|50471748|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
25210588|NCT02203032|50471745|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
25210589|NCT02203032|50471746|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
25210590|NCT02203032|50471747|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
25210591|NCT02203032|50471748|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
25210592|NCT02203032|50471745|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
25210593|NCT02203032|50471746|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
25210594|NCT02203032|50471747|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
25210595|NCT02203032|50471748|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
25210596|NCT02203032|50471745|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
25210597|NCT02203032|50471746|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
25210598|NCT02203032|50471747|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
25210599|NCT02203032|50471748|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
25210600|NCT02203032|50471745|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
25210601|NCT02203032|50471746|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
25210602|NCT02203032|50471747|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
25210603|NCT02203032|50471748|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
25210604|NCT02203032|50471745|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
25210605|NCT02203032|50471746|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
25210606|NCT02203032|50471747|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
25210607|NCT02203032|50471748|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
25210608|NCT02203032|50471745|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
25210609|NCT02203032|50471746|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
25210610|NCT02203032|50471747|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
25210611|NCT02203032|50471748|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
25210612|NCT02203032|50471745|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
25210613|NCT02203032|50471746|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
25210614|NCT02203032|50471747|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
25210615|NCT02203032|50471748|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
25210616|NCT02169414|50471760|FG000|Overall Study|Withdrawal by Subject|1|||
25210617|NCT02169414|50471761|FG001|Overall Study|Withdrawal by Subject|0|||
25210618|NCT02169414|50471762|FG002|Overall Study|Withdrawal by Subject|0|||
25210619|NCT02169414|50471763|FG003|Overall Study|Withdrawal by Subject|0|||
25210620|NCT02169414|50471760|FG000|Overall Study|Adverse Event|0|||
25210621|NCT02169414|50471761|FG001|Overall Study|Adverse Event|1|||
25210622|NCT02169414|50471762|FG002|Overall Study|Adverse Event|0|||
25210623|NCT02169414|50471763|FG003|Overall Study|Adverse Event|0|||
25210624|NCT03213457|50471780|FG000|Overall Study|Not Treated|1|||
25210625|NCT03213457|50471781|FG001|Overall Study|Not Treated|1|||
25210626|NCT03213457|50471782|FG002|Overall Study|Not Treated|0|||
25210627|NCT03213457|50471780|FG000|Overall Study|Adverse Event|16|||
25210628|NCT03213457|50471781|FG001|Overall Study|Adverse Event|9|||
25210629|NCT03213457|50471782|FG002|Overall Study|Adverse Event|41|||
25210630|NCT03213457|50471780|FG000|Overall Study|Non-Compliance With Study Drug|1|||
25210631|NCT03213457|50471781|FG001|Overall Study|Non-Compliance With Study Drug|2|||
25210632|NCT03213457|50471782|FG002|Overall Study|Non-Compliance With Study Drug|7|||
25210633|NCT03213457|50471780|FG000|Overall Study|Non-Compliance Other, Not Specified|0|||
25210634|NCT03213457|50471781|FG001|Overall Study|Non-Compliance Other, Not Specified|1|||
25210635|NCT03213457|50471782|FG002|Overall Study|Non-Compliance Other, Not Specified|5|||
25210636|NCT03213457|50471780|FG000|Overall Study|Withdrawal by Subject|18|||
25210637|NCT03213457|50471781|FG001|Overall Study|Withdrawal by Subject|7|||
25210638|NCT03213457|50471782|FG002|Overall Study|Withdrawal by Subject|35|||
25210639|NCT03213457|50471780|FG000|Overall Study|Lost to Follow-up|12|||
25210640|NCT03213457|50471781|FG001|Overall Study|Lost to Follow-up|12|||
25210641|NCT03213457|50471782|FG002|Overall Study|Lost to Follow-up|33|||
25210642|NCT03213457|50471780|FG000|Overall Study|Pregnancy|11|||
25210643|NCT03213457|50471781|FG001|Overall Study|Pregnancy|0|||
25210644|NCT03213457|50471782|FG002|Overall Study|Pregnancy|7|||
25210645|NCT03213457|50471780|FG000|Overall Study|Protocol Violation|1|||
25210646|NCT03213457|50471781|FG001|Overall Study|Protocol Violation|1|||
25210647|NCT03213457|50471782|FG002|Overall Study|Protocol Violation|6|||
25210648|NCT03213457|50471780|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4|||
25210649|NCT03213457|50471781|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0|||
25210650|NCT03213457|50471782|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2|||
25210651|NCT03213457|50471780|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
25210652|NCT03213457|50471781|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
25210653|NCT03213457|50471782|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3|||
25210654|NCT03213457|50471780|FG000|Overall Study|Lack of Efficacy|12|||
25210655|NCT03213457|50471781|FG001|Overall Study|Lack of Efficacy|2|||
25210656|NCT03213457|50471782|FG002|Overall Study|Lack of Efficacy|9|||
25210657|NCT03213457|50471780|FG000|Overall Study|Other, Not Specified|11|||
25210658|NCT03213457|50471781|FG001|Overall Study|Other, Not Specified|3|||
25210659|NCT03213457|50471782|FG002|Overall Study|Other, Not Specified|26|||
25210660|NCT02201940|50471792|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
25210661|NCT02201940|50471793|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
25210662|NCT02201940|50471792|FG000|Overall Study|Lack of Efficacy|2|||
25210663|NCT02201940|50471793|FG001|Overall Study|Lack of Efficacy|113|||
25210664|NCT02201940|50471792|FG000|Overall Study|Lost to Follow-up|5|||
25210665|NCT02201940|50471793|FG001|Overall Study|Lost to Follow-up|0|||
25210666|NCT02201940|50471792|FG000|Overall Study|Withdrew Consent|2|||
25210667|NCT02201940|50471793|FG001|Overall Study|Withdrew Consent|1|||
25210668|NCT02201940|50471792|FG000|Overall Study|Investigator's Discretion|1|||
25210669|NCT02201940|50471793|FG001|Overall Study|Investigator's Discretion|1|||
25210670|NCT02201940|50471792|FG000|Overall Study|Death|1|||
25210671|NCT02201940|50471793|FG001|Overall Study|Death|0|||
25210672|NCT02201940|50471792|FG000|Overall Study|Adverse Event|0|||
25210673|NCT02201940|50471793|FG001|Overall Study|Adverse Event|1|||
25210674|NCT02232984|50471799|FG000|Overall Study|Withdrawal by Subject|5|||
25210675|NCT02232984|50471799|FG000|Overall Study|Death|1|||
25210676|NCT02232984|50471799|FG000|Overall Study|Investigator withdrawal|10|||
25210677|NCT02232984|50471799|FG000|Overall Study|Device implant unsuccessful|53|||
25210678|NCT02232984|50471799|FG000|Overall Study|not disclosed by site|7|||
25210679|NCT02232984|50471799|FG000|Overall Study|Protocol Violation|1|||
25210680|NCT02169336|50471809|FG000|Overall Study|Lack of Efficacy|1|||
25210681|NCT02169336|50471810|FG001|Overall Study|Lack of Efficacy|1|||
25210682|NCT02169336|50471811|FG002|Overall Study|Lack of Efficacy|0|||
25210683|NCT02169336|50471809|FG000|Overall Study|Adverse Event|2|||
25210684|NCT02169336|50471810|FG001|Overall Study|Adverse Event|3|||
25210685|NCT02169336|50471811|FG002|Overall Study|Adverse Event|1|||
25210686|NCT02169336|50471809|FG000|Overall Study|Withdrawal by Subject|1|||
25210687|NCT02169336|50471810|FG001|Overall Study|Withdrawal by Subject|0|||
25210688|NCT02169336|50471811|FG002|Overall Study|Withdrawal by Subject|0|||
25210689|NCT02169336|50471809|FG000|Overall Study|Physician Decision|0|||
25210690|NCT02169336|50471810|FG001|Overall Study|Physician Decision|0|||
25210691|NCT02169336|50471811|FG002|Overall Study|Physician Decision|1|||
25210692|NCT02169336|50471809|FG000|Overall Study|Subject declined to continue dosing|0|||
25210693|NCT02169336|50471810|FG001|Overall Study|Subject declined to continue dosing|0|||
25210694|NCT02169336|50471811|FG002|Overall Study|Subject declined to continue dosing|1|||
25210695|NCT02609828|50471827|FG000|Overall Study|Adverse Event|8|||
25210696|NCT02609828|50471828|FG001|Overall Study|Adverse Event|1|||
25210697|NCT02609828|50471829|FG002|Overall Study|Adverse Event|0|||
25210698|NCT02609828|50471830|FG003|Overall Study|Adverse Event|6|||
25210699|NCT02609828|50471827|FG000|Overall Study|Death|15|||
25210700|NCT02609828|50471828|FG001|Overall Study|Death|1|||
25210701|NCT02609828|50471829|FG002|Overall Study|Death|1|||
25210702|NCT02609828|50471830|FG003|Overall Study|Death|19|||
25210703|NCT02609828|50471827|FG000|Overall Study|Insufficient clinical response|2|||
25210704|NCT02609828|50471828|FG001|Overall Study|Insufficient clinical response|1|||
25210705|NCT02609828|50471829|FG002|Overall Study|Insufficient clinical response|0|||
25210706|NCT02609828|50471830|FG003|Overall Study|Insufficient clinical response|0|||
25210707|NCT02609828|50471827|FG000|Overall Study|Lost to Follow-up|0|||
25210708|NCT02609828|50471828|FG001|Overall Study|Lost to Follow-up|0|||
25210709|NCT02609828|50471829|FG002|Overall Study|Lost to Follow-up|0|||
25210710|NCT02609828|50471830|FG003|Overall Study|Lost to Follow-up|1|||
25210711|NCT02609828|50471827|FG000|Overall Study|Protocol Violation|2|||
25210712|NCT02609828|50471828|FG001|Overall Study|Protocol Violation|0|||
24976361|NCT00092547|50065233|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
25077208|NCT02438384|50185052|FG002|Overall Study|Lost to Follow-up|4|||
25210713|NCT02609828|50471829|FG002|Overall Study|Protocol Violation|0|||
25210714|NCT02609828|50471830|FG003|Overall Study|Protocol Violation|1|||
25210715|NCT02609828|50471827|FG000|Overall Study|Withdrawal by Subject|12|||
25210716|NCT02609828|50471828|FG001|Overall Study|Withdrawal by Subject|1|||
25210717|NCT02609828|50471829|FG002|Overall Study|Withdrawal by Subject|0|||
25210718|NCT02609828|50471830|FG003|Overall Study|Withdrawal by Subject|10|||
25210719|NCT02609828|50471827|FG000|Overall Study|Other|3|||
25210720|NCT02609828|50471828|FG001|Overall Study|Other|0|||
25210721|NCT02609828|50471829|FG002|Overall Study|Other|0|||
25210722|NCT02609828|50471830|FG003|Overall Study|Other|6|||
25210723|NCT02609828|50471827|FG000|Overall Study|Randomized but not treated|1|||
25210724|NCT02609828|50471828|FG001|Overall Study|Randomized but not treated|0|||
25210725|NCT02609828|50471829|FG002|Overall Study|Randomized but not treated|0|||
25210726|NCT02609828|50471830|FG003|Overall Study|Randomized but not treated|0|||
25210727|NCT01632306|50471846|FG000|Overall Study|Protocol Violation|1|||
25210728|NCT01632306|50471847|FG001|Overall Study|Protocol Violation|0|||
25210729|NCT01632306|50471848|FG002|Overall Study|Protocol Violation|0|||
25210730|NCT02201784|50471856|FG000|Overall Study|Failure to achieve adequate block|2|||
25210731|NCT02201784|50471857|FG001|Overall Study|Failure to achieve adequate block|0|||
25210732|NCT02201472|50471863|FG000|Overall Study|Lack of Efficacy|2|||
25210733|NCT02168946|50471908|FG000|Overall Study|Adverse Event|8|||
25210734|NCT02168946|50471909|FG001|Overall Study|Adverse Event|5|||
25210735|NCT02168946|50471908|FG000|Overall Study|Lost to Follow-up|3|||
25210736|NCT02168946|50471909|FG001|Overall Study|Lost to Follow-up|0|||
25210737|NCT02168946|50471908|FG000|Overall Study|Subject unable to come back for visits|1|||
25210738|NCT02168946|50471909|FG001|Overall Study|Subject unable to come back for visits|0|||
25210739|NCT02168478|50471930|FG000|Overall Study|Withdrawal by Subject|1|||
25210740|NCT02168478|50471930|FG000|Overall Study|Did Not Consent to Participation|2|||
25210741|NCT02168478|50471930|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
25210742|NCT02200614|50473105|FG000|Double Blind Treatment|Adverse Event|86|||
25210743|NCT02200614|50473106|FG001|Double Blind Treatment|Adverse Event|48|||
25210744|NCT02200614|50473105|FG000|Double Blind Treatment|Confirmed metastasis|120|||
25210745|NCT02200614|50473106|FG001|Double Blind Treatment|Confirmed metastasis|140|||
25210746|NCT02200614|50473105|FG000|Double Blind Treatment|Judgment of the investigator|59|||
25210747|NCT02200614|50473106|FG001|Double Blind Treatment|Judgment of the investigator|99|||
25210748|NCT02200614|50473105|FG000|Double Blind Treatment|Metastasis by local reading|1|||
25210749|NCT02200614|50473106|FG001|Double Blind Treatment|Metastasis by local reading|3|||
25210750|NCT02200614|50473105|FG000|Double Blind Treatment|Other reason|6|||
25210751|NCT02200614|50473106|FG001|Double Blind Treatment|Other reason|2|||
25210752|NCT02200614|50473105|FG000|Double Blind Treatment|Personal reason|77|||
25210753|NCT02200614|50473106|FG001|Double Blind Treatment|Personal reason|85|||
25210754|NCT02200614|50473105|FG000|Double Blind Treatment|Protocol deviation|14|||
25210755|NCT02200614|50473106|FG001|Double Blind Treatment|Protocol deviation|7|||
25210756|NCT02200614|50473105|FG000|Double Blind Treatment|Not treated|1|||
25210757|NCT02200614|50473106|FG001|Double Blind Treatment|Not treated|0|||
25210758|NCT02200614|50473105|FG000|Open Label|Adverse Event|41|||
25210759|NCT02200614|50473106|FG001|Open Label|Adverse Event|11|||
25210760|NCT02200614|50473105|FG000|Open Label|Confirmed metastasis|1|||
25210761|NCT02200614|50473106|FG001|Open Label|Confirmed metastasis|0|||
25210762|NCT02200614|50473105|FG000|Open Label|Judgment of the investigator|29|||
25210763|NCT02200614|50473106|FG001|Open Label|Judgment of the investigator|2|||
25210764|NCT02200614|50473105|FG000|Open Label|Metastasis by local reading|138|||
25210765|NCT02200614|50473106|FG001|Open Label|Metastasis by local reading|27|||
25210766|NCT02200614|50473105|FG000|Open Label|Other reason|22|||
25210767|NCT02200614|50473106|FG001|Open Label|Other reason|4|||
25210768|NCT02200614|50473105|FG000|Open Label|Personal reason|60|||
25210769|NCT02200614|50473106|FG001|Open Label|Personal reason|8|||
25210770|NCT02200614|50473105|FG000|Open Label|Protocol deviation|3|||
25210771|NCT02200614|50473106|FG001|Open Label|Protocol deviation|2|||
25210772|NCT02200614|50473105|FG000|Open Label|Missing|2|||
25210773|NCT02200614|50473106|FG001|Open Label|Missing|2|||
25210774|NCT02231892|50473117|FG000|Overall Study|Lost to Follow-up|1|||
25210775|NCT02231892|50473118|FG001|Overall Study|Lost to Follow-up|0|||
25210776|NCT02231892|50473119|FG002|Overall Study|Lost to Follow-up|3|||
25210777|NCT02231892|50473117|FG000|Overall Study|Withdrawal by Subject|4|||
25210778|NCT02231892|50473118|FG001|Overall Study|Withdrawal by Subject|3|||
25210779|NCT02231892|50473119|FG002|Overall Study|Withdrawal by Subject|15|||
25210780|NCT02231892|50473117|FG000|Overall Study|Physician Decision|0|||
25210781|NCT02231892|50473118|FG001|Overall Study|Physician Decision|2|||
25210782|NCT02231892|50473119|FG002|Overall Study|Physician Decision|4|||
25210783|NCT02231892|50473117|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
25210784|NCT02231892|50473118|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
25210785|NCT02231892|50473119|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
25210786|NCT02231892|50473117|FG000|Overall Study|Participant motor threshold was >83%|0|||
25210787|NCT02231892|50473118|FG001|Overall Study|Participant motor threshold was >83%|0|||
25210788|NCT02231892|50473119|FG002|Overall Study|Participant motor threshold was >83%|9|||
25210789|NCT02231892|50473117|FG000|Overall Study|Could not find motor threshold|2|||
25210790|NCT02231892|50473118|FG001|Overall Study|Could not find motor threshold|0|||
25210791|NCT02231892|50473119|FG002|Overall Study|Could not find motor threshold|1|||
25210792|NCT02231892|50473117|FG000|Overall Study|Could not find reliable motor hotspot|0|||
25210793|NCT02231892|50473118|FG001|Overall Study|Could not find reliable motor hotspot|0|||
25210794|NCT02231892|50473119|FG002|Overall Study|Could not find reliable motor hotspot|1|||
25210795|NCT02231580|50473135|FG000|Overall Study|Adverse Event|5|||
25210796|NCT02231580|50473136|FG001|Overall Study|Adverse Event|0|||
25210797|NCT02166606|50473144|FG000|Overall Study|Adverse Event|3|||
25210798|NCT02166606|50473144|FG000|Overall Study|Death|31|||
25210799|NCT02166606|50473144|FG000|Overall Study|Protocol Violation|7|||
25316365|NCT00623545|50631759|FG000|Overall Study|Adverse Event|6|||
25316366|NCT00623545|50631759|FG000|Overall Study|Withdrawal by Subject|4|||
25316367|NCT00628927|50631766|FG000|Overall Study|Problems performing blood draw|6|||
25316368|NCT00628927|50631767|FG001|Overall Study|Problems performing blood draw|0|||
25316369|NCT00628927|50631766|FG000|Overall Study|Lost to Follow-up|1|||
25316370|NCT00628927|50631767|FG001|Overall Study|Lost to Follow-up|0|||
25210800|NCT02166606|50473144|FG000|Overall Study|Lost to Follow-up|30|||
25316371|NCT00628927|50631766|FG000|Overall Study|Equipment failure|1|||
25316372|NCT00628927|50631767|FG001|Overall Study|Equipment failure|0|||
25316373|NCT00623467|50631778|FG000|Overall Study|Lost to Follow-up|1|||
25316374|NCT00623467|50631778|FG000|Overall Study|Protocol Violation|4|||
25316375|NCT00623467|50631778|FG000|Overall Study|Withdrawal by Subject|2|||
25316376|NCT00838539|50631796|FG000|Overall Study|Disease Progression|2|||
25316377|NCT00838539|50631797|FG001|Overall Study|Disease Progression|4|||
25316378|NCT00838539|50631798|FG002|Overall Study|Disease Progression|3|||
25316379|NCT00838539|50631799|FG003|Overall Study|Disease Progression|2|||
25316380|NCT00838539|50631800|FG004|Overall Study|Disease Progression|4|||
25316381|NCT00838539|50631801|FG005|Overall Study|Disease Progression|2|||
25316382|NCT00838539|50631802|FG006|Overall Study|Disease Progression|3|||
25316383|NCT00838539|50631803|FG007|Overall Study|Disease Progression|4|||
25316384|NCT00838539|50631804|FG008|Overall Study|Disease Progression|4|||
25316385|NCT00838539|50631805|FG009|Overall Study|Disease Progression|5|||
25316386|NCT00838539|50631806|FG010|Overall Study|Disease Progression|1|||
25316387|NCT00838539|50631807|FG011|Overall Study|Disease Progression|4|||
25316388|NCT00838539|50631796|FG000|Overall Study|Adverse Event|1|||
25316389|NCT00838539|50631797|FG001|Overall Study|Adverse Event|1|||
25316390|NCT00838539|50631798|FG002|Overall Study|Adverse Event|1|||
25316391|NCT00838539|50631799|FG003|Overall Study|Adverse Event|1|||
25316392|NCT00838539|50631800|FG004|Overall Study|Adverse Event|2|||
25316393|NCT00838539|50631801|FG005|Overall Study|Adverse Event|1|||
25316394|NCT00838539|50631802|FG006|Overall Study|Adverse Event|0|||
25316395|NCT00838539|50631803|FG007|Overall Study|Adverse Event|2|||
25316396|NCT00838539|50631804|FG008|Overall Study|Adverse Event|0|||
25316397|NCT00838539|50631805|FG009|Overall Study|Adverse Event|1|||
25316398|NCT00838539|50631806|FG010|Overall Study|Adverse Event|2|||
25316399|NCT00838539|50631807|FG011|Overall Study|Adverse Event|0|||
25316400|NCT00838539|50631796|FG000|Overall Study|Withdrawal by Subject|0|||
25316401|NCT00838539|50631797|FG001|Overall Study|Withdrawal by Subject|1|||
25316402|NCT00838539|50631798|FG002|Overall Study|Withdrawal by Subject|0|||
25316403|NCT00838539|50631799|FG003|Overall Study|Withdrawal by Subject|0|||
25316404|NCT00838539|50631800|FG004|Overall Study|Withdrawal by Subject|0|||
25316405|NCT00838539|50631801|FG005|Overall Study|Withdrawal by Subject|0|||
25316406|NCT00838539|50631802|FG006|Overall Study|Withdrawal by Subject|0|||
25316407|NCT00838539|50631803|FG007|Overall Study|Withdrawal by Subject|0|||
25316408|NCT00838539|50631804|FG008|Overall Study|Withdrawal by Subject|0|||
25316409|NCT00838539|50631805|FG009|Overall Study|Withdrawal by Subject|1|||
25316410|NCT00838539|50631806|FG010|Overall Study|Withdrawal by Subject|2|||
25316411|NCT00838539|50631807|FG011|Overall Study|Withdrawal by Subject|0|||
25316412|NCT00838539|50631796|FG000|Overall Study|Death|0|||
25316413|NCT00838539|50631797|FG001|Overall Study|Death|0|||
25316414|NCT00838539|50631798|FG002|Overall Study|Death|0|||
25316415|NCT00838539|50631799|FG003|Overall Study|Death|0|||
25316416|NCT00838539|50631800|FG004|Overall Study|Death|0|||
25316417|NCT00838539|50631801|FG005|Overall Study|Death|0|||
25316418|NCT00838539|50631802|FG006|Overall Study|Death|1|||
25316419|NCT00838539|50631803|FG007|Overall Study|Death|0|||
25316420|NCT00838539|50631804|FG008|Overall Study|Death|0|||
25316421|NCT00838539|50631805|FG009|Overall Study|Death|0|||
25316422|NCT00838539|50631806|FG010|Overall Study|Death|0|||
25316423|NCT00838539|50631807|FG011|Overall Study|Death|0|||
25316424|NCT00838539|50631796|FG000|Overall Study|Physician Decision|0|||
25316425|NCT00838539|50631797|FG001|Overall Study|Physician Decision|0|||
25316426|NCT00838539|50631798|FG002|Overall Study|Physician Decision|0|||
25316427|NCT00838539|50631799|FG003|Overall Study|Physician Decision|0|||
24976362|NCT00092547|50065234|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
25316428|NCT00838539|50631800|FG004|Overall Study|Physician Decision|0|||
25316429|NCT00838539|50631801|FG005|Overall Study|Physician Decision|0|||
25077209|NCT02463032|50185062|FG000|Overall Study|Lack of Efficacy|61|||
25316430|NCT00838539|50631802|FG006|Overall Study|Physician Decision|0|||
25210801|NCT02166606|50473144|FG000|Overall Study|Withdrawal by Subject|1|||
25316431|NCT00838539|50631803|FG007|Overall Study|Physician Decision|0|||
25316432|NCT00838539|50631804|FG008|Overall Study|Physician Decision|1|||
25316433|NCT00838539|50631805|FG009|Overall Study|Physician Decision|0|||
25210802|NCT02166606|50473144|FG000|Overall Study|Physician Decision|1|||
25210803|NCT02166606|50473144|FG000|Overall Study|Device upgrade|1|||
25210804|NCT02166606|50473144|FG000|Overall Study|Enrolled after End of Enrollment|4|||
25210805|NCT02230956|50473151|FG000|Overall Study|Adverse Event|1|||
25210806|NCT02230956|50473152|FG001|Overall Study|Adverse Event|1|||
25210807|NCT02230956|50473153|FG002|Overall Study|Adverse Event|0|||
25210808|NCT02230956|50473151|FG000|Overall Study|Lack of Efficacy|1|||
25210809|NCT02230956|50473152|FG001|Overall Study|Lack of Efficacy|1|||
25210810|NCT02230956|50473153|FG002|Overall Study|Lack of Efficacy|1|||
25210811|NCT02230956|50473151|FG000|Overall Study|Lost to Follow-up|1|||
25210812|NCT02230956|50473152|FG001|Overall Study|Lost to Follow-up|1|||
25210813|NCT02230956|50473153|FG002|Overall Study|Lost to Follow-up|2|||
25210814|NCT02230956|50473151|FG000|Overall Study|Personal Reasons|2|||
25210815|NCT02230956|50473152|FG001|Overall Study|Personal Reasons|1|||
25210816|NCT02230956|50473153|FG002|Overall Study|Personal Reasons|1|||
25210817|NCT02230956|50473151|FG000|Overall Study|Protocol Violation|0|||
25210818|NCT02230956|50473152|FG001|Overall Study|Protocol Violation|1|||
25210819|NCT02230956|50473153|FG002|Overall Study|Protocol Violation|1|||
25210820|NCT02230956|50473151|FG000|Overall Study|Other Miscellaneous Reason|0|||
25210821|NCT02230956|50473152|FG001|Overall Study|Other Miscellaneous Reason|1|||
25210822|NCT02230956|50473153|FG002|Overall Study|Other Miscellaneous Reason|2|||
25210823|NCT02230410|50473161|FG000|Overall Study|Screen Failure|3|||
25210824|NCT02230332|50473167|FG000|Overall Study|Adverse Event|2|||
25210825|NCT02230332|50473168|FG001|Overall Study|Adverse Event|1|||
25210826|NCT02230332|50473167|FG000|Overall Study|Lost to Follow-up|1|||
25210827|NCT02230332|50473168|FG001|Overall Study|Lost to Follow-up|0|||
25210828|NCT02230332|50473167|FG000|Overall Study|Protocol Violation|1|||
25210829|NCT02230332|50473168|FG001|Overall Study|Protocol Violation|0|||
25210830|NCT02230254|50473174|FG000|Overall Study|Lost to Follow-up|3|||
25210831|NCT02198664|50473180|FG000|Overall Study|Adverse Event|2|||
25210832|NCT02198664|50473181|FG001|Overall Study|Adverse Event|0|||
25210833|NCT02198664|50473180|FG000|Overall Study|Withdrawal by Subject|11|||
25210834|NCT02198664|50473181|FG001|Overall Study|Withdrawal by Subject|8|||
25210835|NCT02198664|50473180|FG000|Overall Study|Failure to tolerate|2|||
25210836|NCT02198664|50473181|FG001|Overall Study|Failure to tolerate|0|||
25210837|NCT02198664|50473180|FG000|Overall Study|Not stated|1|||
25210838|NCT02198664|50473181|FG001|Overall Study|Not stated|0|||
25210839|NCT02165826|50473192|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
25210840|NCT02165826|50473193|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
25210841|NCT02165826|50473194|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
25210842|NCT02165826|50473192|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
25210843|NCT02165826|50473193|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
25210844|NCT02165826|50473194|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
25210845|NCT02165826|50473192|FG000|Main Treatment Period|Lost to Follow-up|4|||
25210846|NCT02165826|50473193|FG001|Main Treatment Period|Lost to Follow-up|2|||
25210847|NCT02165826|50473194|FG002|Main Treatment Period|Lost to Follow-up|1|||
25210848|NCT02165826|50473192|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
25210849|NCT02165826|50473193|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
25210850|NCT02165826|50473194|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
25210851|NCT02165826|50473192|FG000|Main Treatment Period|Lack of Efficacy|2|||
25210852|NCT02165826|50473193|FG001|Main Treatment Period|Lack of Efficacy|0|||
25210853|NCT02165826|50473194|FG002|Main Treatment Period|Lack of Efficacy|0|||
25210854|NCT02165826|50473192|FG000|Main Treatment Period|Reason Not Specified|8|||
25210855|NCT02165826|50473193|FG001|Main Treatment Period|Reason Not Specified|5|||
25210856|NCT02165826|50473194|FG002|Main Treatment Period|Reason Not Specified|16|||
25210857|NCT02165826|50473192|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
25210858|NCT02165826|50473193|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
25210859|NCT02165826|50473194|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
25210860|NCT02165826|50473192|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
25210861|NCT02165826|50473193|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
25210862|NCT02165826|50473194|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
25210863|NCT02165826|50473192|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
25210864|NCT02165826|50473193|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
25210865|NCT02165826|50473194|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
25210866|NCT02165826|50473192|FG000|Down-Titration Period|Reason Not Specified|1|||
25210867|NCT02165826|50473193|FG001|Down-Titration Period|Reason Not Specified|0|||
25210868|NCT02165826|50473194|FG002|Down-Titration Period|Reason Not Specified|2|||
25210869|NCT02198040|50473231|FG000|Overall Study|Work reasons|0|||
25210870|NCT02198040|50473232|FG001|Overall Study|Work reasons|1|||
25210871|NCT02198040|50473233|FG002|Overall Study|Work reasons|0|||
25210872|NCT02198040|50473231|FG000|Overall Study|Withdrawal by Subject|0|||
25210873|NCT02198040|50473232|FG001|Overall Study|Withdrawal by Subject|0|||
25210874|NCT02198040|50473233|FG002|Overall Study|Withdrawal by Subject|1|||
25210875|NCT02197806|50473247|FG000|Overall Study|Adverse Event|0|||
25210876|NCT02197806|50473248|FG001|Overall Study|Adverse Event|1|||
25210877|NCT02197806|50473249|FG002|Overall Study|Adverse Event|0|||
25210878|NCT02197806|50473250|FG003|Overall Study|Adverse Event|1|||
25210879|NCT02229864|50473297|FG000|Overall Study|Death|2|||
25210880|NCT02229864|50473297|FG000|Overall Study|Lost to Follow-up|1|||
25210881|NCT02229552|50473301|FG000|Baseline|Withdrawal by Subject|6|||
25210882|NCT02229552|50473301|FG000|1-year Follow up|Withdrawal by Subject|7|||
25210883|NCT02229552|50473301|FG000|1-year Follow up|Lost to Follow-up|18|||
25210884|NCT02229552|50473301|FG000|2-Year Follow up|Withdrawal by Subject|9|||
25210885|NCT02229552|50473301|FG000|2-Year Follow up|Lost to Follow-up|17|||
25210886|NCT02229396|50473308|FG000|Overall Study|Adverse Event|6|||
25210887|NCT02229396|50473309|FG001|Overall Study|Adverse Event|12|||
25210888|NCT02229396|50473310|FG002|Overall Study|Adverse Event|12|||
25210889|NCT02229396|50473308|FG000|Overall Study|Death|2|||
25210890|NCT02229396|50473309|FG001|Overall Study|Death|3|||
25210891|NCT02229396|50473310|FG002|Overall Study|Death|1|||
25210892|NCT02229396|50473308|FG000|Overall Study|Lost to Follow-up|14|||
25210893|NCT02229396|50473309|FG001|Overall Study|Lost to Follow-up|14|||
25210894|NCT02229396|50473310|FG002|Overall Study|Lost to Follow-up|21|||
25210895|NCT02229396|50473308|FG000|Overall Study|Protocol Violation|2|||
25210896|NCT02229396|50473309|FG001|Overall Study|Protocol Violation|1|||
25210897|NCT02229396|50473310|FG002|Overall Study|Protocol Violation|0|||
25210898|NCT02229396|50473308|FG000|Overall Study|Patient Incorrectly Randomized|0|||
25210899|NCT02229396|50473309|FG001|Overall Study|Patient Incorrectly Randomized|0|||
25210900|NCT02229396|50473310|FG002|Overall Study|Patient Incorrectly Randomized|1|||
25210901|NCT02229396|50473308|FG000|Overall Study|Other|10|||
25210902|NCT02229396|50473309|FG001|Overall Study|Other|18|||
25210903|NCT02229396|50473310|FG002|Overall Study|Other|15|||
25210904|NCT02229396|50473308|FG000|Overall Study|Withdrawal by Subject|42|||
25210905|NCT02229396|50473309|FG001|Overall Study|Withdrawal by Subject|28|||
25210906|NCT02229396|50473310|FG002|Overall Study|Withdrawal by Subject|41|||
25210907|NCT02229396|50473308|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
25210908|NCT02229396|50473309|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
25210909|NCT02229396|50473310|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
25210910|NCT02229396|50473308|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
25210911|NCT02229396|50473309|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
25210912|NCT02229396|50473310|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
25210913|NCT02197416|50473325|FG000|Overall Study|Other reasons|0|||
25210914|NCT02197416|50473326|FG001|Overall Study|Other reasons|2|||
25210915|NCT02197416|50473327|FG002|Overall Study|Other reasons|5|||
25210916|NCT02197416|50473325|FG000|Overall Study|Withdrawal by Subject|0|||
25210917|NCT02197416|50473326|FG001|Overall Study|Withdrawal by Subject|2|||
25210918|NCT02197416|50473327|FG002|Overall Study|Withdrawal by Subject|1|||
25210919|NCT02197416|50473325|FG000|Overall Study|Protocol Violation|1|||
25210920|NCT02197416|50473326|FG001|Overall Study|Protocol Violation|0|||
25210921|NCT02197416|50473327|FG002|Overall Study|Protocol Violation|1|||
25210922|NCT02197416|50473325|FG000|Overall Study|Adverse Event|0|||
25210923|NCT02197416|50473326|FG001|Overall Study|Adverse Event|0|||
25210924|NCT02197416|50473327|FG002|Overall Study|Adverse Event|1|||
25210925|NCT02165202|50473335|FG000|Oral Phase|Refused further participation|5|||
25210926|NCT02165202|50473336|FG001|Oral Phase|Refused further participation|1|||
25210927|NCT02165202|50473335|FG000|Oral Phase|Study product Related Toxicity|1|||
25210928|NCT02165202|50473336|FG001|Oral Phase|Study product Related Toxicity|0|||
25210929|NCT02165202|50473335|FG000|Oral Phase|Unable to contact Participant|1|||
25210930|NCT02165202|50473336|FG001|Oral Phase|Unable to contact Participant|1|||
25210931|NCT02165202|50473335|FG000|Oral Phase|Clinical reasons|1|||
25210932|NCT02165202|50473336|FG001|Oral Phase|Clinical reasons|0|||
25210933|NCT02165202|50473335|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
25210934|NCT02165202|50473336|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
25210935|NCT02165202|50473335|FG000|Oral Phase|CMC advised termination|1|||
25210936|NCT02165202|50473336|FG001|Oral Phase|CMC advised termination|0|||
25210937|NCT02165202|50473335|FG000|Oral Phase|Relocated, no follow-up planned|1|||
25210938|NCT02165202|50473336|FG001|Oral Phase|Relocated, no follow-up planned|0|||
25210939|NCT02165202|50473335|FG000|Oral Phase|Abnormal EKG|0|||
25210940|NCT02165202|50473336|FG001|Oral Phase|Abnormal EKG|1|||
25210941|NCT02165202|50473335|FG000|Injection Phase|Abnormal Lab Value|5|||
25210942|NCT02165202|50473336|FG001|Injection Phase|Abnormal Lab Value|1|||
25210943|NCT02165202|50473335|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
25210944|NCT02165202|50473336|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
25210945|NCT02165202|50473335|FG000|Injection Phase|Unable to attend within Visit Window|1|||
25210946|NCT02165202|50473336|FG001|Injection Phase|Unable to attend within Visit Window|0|||
25210947|NCT02165202|50473335|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
25210948|NCT02165202|50473336|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
25210949|NCT02165202|50473335|FG000|Injection Phase|End of Study|2|||
25316434|NCT00838539|50631806|FG010|Overall Study|Physician Decision|0|||
25210950|NCT02165202|50473336|FG001|Injection Phase|End of Study|1|||
25210951|NCT02165202|50473335|FG000|Injection Phase|Study Product related Toxicity|1|||
25210952|NCT02165202|50473336|FG001|Injection Phase|Study Product related Toxicity|0|||
25210953|NCT02165202|50473335|FG000|Injection Phase|No longer interested|0|||
25210954|NCT02165202|50473336|FG001|Injection Phase|No longer interested|1|||
25210955|NCT02165202|50473335|FG000|Injection Phase|Participant unwilling to comply|1|||
25210956|NCT02165202|50473336|FG001|Injection Phase|Participant unwilling to comply|0|||
25210957|NCT01628874|50473344|FG000|Overall Study|Physician Decision|1|||
25210958|NCT01628874|50473345|FG001|Overall Study|Physician Decision|1|||
25210959|NCT01628874|50473344|FG000|Overall Study|Age >4 months|4|||
25210960|NCT01628874|50473345|FG001|Overall Study|Age >4 months|2|||
25210961|NCT02196714|50473370|FG000|Overall Study|Protocol Violation|0|||
25210962|NCT02196714|50473371|FG001|Overall Study|Protocol Violation|0|||
25210963|NCT02196714|50473372|FG002|Overall Study|Protocol Violation|1|||
25210964|NCT02196714|50473373|FG003|Overall Study|Protocol Violation|0|||
25210965|NCT02196558|50473397|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
25210966|NCT02196558|50473398|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
25210967|NCT02196558|50473399|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
25210968|NCT02196558|50473397|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
25210969|NCT02196558|50473398|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
25210970|NCT02196558|50473399|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
25210971|NCT02196558|50473397|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
25210972|NCT02196558|50473398|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
25210973|NCT02196558|50473399|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
25210974|NCT02196558|50473397|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
25210975|NCT02196558|50473398|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
25210976|NCT02196558|50473399|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
25210977|NCT02196558|50473397|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
25210978|NCT02196558|50473398|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
25210979|NCT02196558|50473399|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
25210980|NCT02196324|50473420|FG000|Overall Study|Withdrawal by Subject|8|||
25210981|NCT02196324|50473421|FG001|Overall Study|Withdrawal by Subject|4|||
25210982|NCT02196324|50473420|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
25210983|NCT02196324|50473421|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
25210984|NCT02196324|50473420|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
25210985|NCT02196324|50473421|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
25210986|NCT02196324|50473420|FG000|Overall Study|Other|1|||
25210987|NCT02196324|50473421|FG001|Overall Study|Other|0|||
25210988|NCT02195700|50473429|FG000|Overall Study|Protocol Violation|0|||
25210989|NCT02195700|50473430|FG001|Overall Study|Protocol Violation|2|||
25210990|NCT02195700|50473429|FG000|Overall Study|Noncompliance|1|||
25210991|NCT02195700|50473430|FG001|Overall Study|Noncompliance|0|||
25210992|NCT02195700|50473429|FG000|Overall Study|Adverse Event|1|||
25210993|NCT02195700|50473430|FG001|Overall Study|Adverse Event|2|||
25210994|NCT02195700|50473429|FG000|Overall Study|Withdrawal by Subject|3|||
25210995|NCT02195700|50473430|FG001|Overall Study|Withdrawal by Subject|2|||
25210996|NCT02195700|50473429|FG000|Overall Study|Lost to Follow-up|1|||
25210997|NCT02195700|50473430|FG001|Overall Study|Lost to Follow-up|1|||
25210998|NCT02228460|50473445|FG000|Overall Study|Adverse Event|1|||
25210999|NCT02228460|50473445|FG000|Overall Study|Lost to Follow-up|1|||
25211000|NCT02227446|50473461|FG000|Overall Study|not eligible post randomization|18|||
25211001|NCT02227446|50473462|FG001|Overall Study|not eligible post randomization|29|||
25211002|NCT02227446|50473461|FG000|Overall Study|Withdrawal by Subject|4|||
25211003|NCT02227446|50473462|FG001|Overall Study|Withdrawal by Subject|5|||
25211004|NCT02227368|50473470|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
25211005|NCT02227368|50473471|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
25211006|NCT02227368|50473470|FG000|Overall Study|Lost to Follow-up|1|||
25211007|NCT02227368|50473471|FG001|Overall Study|Lost to Follow-up|0|||
25211008|NCT02227368|50473470|FG000|Overall Study|Adverse Event|1|||
25211009|NCT02227368|50473471|FG001|Overall Study|Adverse Event|0|||
25211010|NCT02162862|50473480|FG000|Overall Study|Lost to Follow-up|0|||
25211011|NCT02162862|50473481|FG001|Overall Study|Lost to Follow-up|11|||
25211012|NCT02162862|50473482|FG002|Overall Study|Lost to Follow-up|0|||
25211013|NCT02162862|50473480|FG000|Overall Study|Subject did not feel the med was needed|0|||
25211014|NCT02162862|50473481|FG001|Overall Study|Subject did not feel the med was needed|0|||
25211015|NCT02162862|50473482|FG002|Overall Study|Subject did not feel the med was needed|4|||
25211016|NCT02226198|50473520|FG000|Lead-in Phase|Protocol Violation|1|||
25211017|NCT02226198|50473521|FG001|Lead-in Phase|Protocol Violation|0|||
25211018|NCT02226198|50473522|FG002|Lead-in Phase|Protocol Violation|0|||
25211019|NCT02226198|50473520|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
25211020|NCT02226198|50473521|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
25211021|NCT02226198|50473522|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
25211022|NCT02226120|50473693|FG000|Overall Study|Adverse Event|60|||
25211023|NCT02226120|50473693|FG000|Overall Study|Death|172|||
25211024|NCT02226120|50473693|FG000|Overall Study|Study terminated by sponsor|1|||
25211025|NCT02226120|50473693|FG000|Overall Study|Technical problems|4|||
25211026|NCT02226120|50473693|FG000|Overall Study|Lost to Follow-up|13|||
25211027|NCT02226120|50473693|FG000|Overall Study|Physician Decision|21|||
25211028|NCT02226120|50473693|FG000|Overall Study|Withdrawal by parent/guardian|36|||
25211029|NCT02226120|50473693|FG000|Overall Study|Non-compliance with study drug|10|||
25211030|NCT02226120|50473693|FG000|Overall Study|Protocol deviation|1|||
25211031|NCT02226120|50473693|FG000|Overall Study|missing treatment disposition pages|2|||
25211032|NCT02194998|50473871|FG000|On-HCV Treatment|Did not pick up study medication|0|||
25211033|NCT02194998|50473872|FG001|On-HCV Treatment|Did not pick up study medication|1|||
25211034|NCT02194998|50473873|FG002|On-HCV Treatment|Did not pick up study medication|0|||
25211035|NCT02194998|50473874|FG003|On-HCV Treatment|Did not pick up study medication|0|||
25211036|NCT02194998|50473871|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
25211037|NCT02194998|50473872|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
25211038|NCT02194998|50473873|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
25211039|NCT02194998|50473874|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
25211040|NCT02194062|50473887|FG000|Overall Study|Lost to Follow-up|2|||
25211041|NCT02194062|50473888|FG001|Overall Study|Lost to Follow-up|2|||
25211042|NCT02194062|50473889|FG002|Overall Study|Lost to Follow-up|5|||
25211043|NCT02193828|50473910|FG000|Overall Study|Withdrawal by Subject|0|||
25211044|NCT02193828|50473911|FG001|Overall Study|Withdrawal by Subject|0|||
25211045|NCT02193828|50473912|FG002|Overall Study|Withdrawal by Subject|1|||
25211046|NCT02193828|50473913|FG003|Overall Study|Withdrawal by Subject|1|||
25211047|NCT02192970|50473934|FG000|Overall Study|Lost to Follow-up|6|||
25211048|NCT02192970|50473935|FG001|Overall Study|Lost to Follow-up|0|||
25211049|NCT02192190|50474119|FG000|Overall Study|Adverse Event|1|||
25211050|NCT02192190|50474120|FG001|Overall Study|Adverse Event|1|||
25211051|NCT02192190|50474121|FG002|Overall Study|Adverse Event|0|||
25211052|NCT02192190|50474122|FG003|Overall Study|Adverse Event|0|||
25211053|NCT02192190|50474123|FG004|Overall Study|Adverse Event|0|||
25211054|NCT02192190|50474124|FG005|Overall Study|Adverse Event|0|||
25211055|NCT02192190|50474119|FG000|Overall Study|Lost to Follow-up|3|||
25211056|NCT02192190|50474120|FG001|Overall Study|Lost to Follow-up|3|||
25211057|NCT02192190|50474121|FG002|Overall Study|Lost to Follow-up|2|||
25211058|NCT02192190|50474122|FG003|Overall Study|Lost to Follow-up|1|||
25211059|NCT02192190|50474123|FG004|Overall Study|Lost to Follow-up|4|||
25211060|NCT02192190|50474124|FG005|Overall Study|Lost to Follow-up|3|||
25211061|NCT02192190|50474119|FG000|Overall Study|Physician Decision|2|||
25211062|NCT02192190|50474120|FG001|Overall Study|Physician Decision|0|||
25211063|NCT02192190|50474121|FG002|Overall Study|Physician Decision|0|||
25211064|NCT02192190|50474122|FG003|Overall Study|Physician Decision|0|||
25211065|NCT02192190|50474123|FG004|Overall Study|Physician Decision|0|||
25211066|NCT02192190|50474124|FG005|Overall Study|Physician Decision|0|||
25211067|NCT02192190|50474119|FG000|Overall Study|Terminated by Sponsor|43|||
25211068|NCT02192190|50474120|FG001|Overall Study|Terminated by Sponsor|23|||
25211069|NCT02192190|50474121|FG002|Overall Study|Terminated by Sponsor|20|||
25211070|NCT02192190|50474122|FG003|Overall Study|Terminated by Sponsor|23|||
25211071|NCT02192190|50474123|FG004|Overall Study|Terminated by Sponsor|21|||
25211072|NCT02192190|50474124|FG005|Overall Study|Terminated by Sponsor|23|||
25211073|NCT02192190|50474119|FG000|Overall Study|Withdrawal by Subject|4|||
25211074|NCT02192190|50474120|FG001|Overall Study|Withdrawal by Subject|1|||
25211075|NCT02192190|50474121|FG002|Overall Study|Withdrawal by Subject|2|||
25211076|NCT02192190|50474122|FG003|Overall Study|Withdrawal by Subject|1|||
25211077|NCT02192190|50474123|FG004|Overall Study|Withdrawal by Subject|5|||
25211078|NCT02192190|50474124|FG005|Overall Study|Withdrawal by Subject|3|||
25211079|NCT02192190|50474119|FG000|Overall Study|Could not Keep Visit Schedule|1|||
25211080|NCT02192190|50474120|FG001|Overall Study|Could not Keep Visit Schedule|0|||
25211081|NCT02192190|50474121|FG002|Overall Study|Could not Keep Visit Schedule|0|||
25211082|NCT02192190|50474122|FG003|Overall Study|Could not Keep Visit Schedule|0|||
25211083|NCT02192190|50474123|FG004|Overall Study|Could not Keep Visit Schedule|0|||
25211084|NCT02192190|50474124|FG005|Overall Study|Could not Keep Visit Schedule|0|||
25211085|NCT02192190|50474119|FG000|Overall Study|Positive Drug Screen|0|||
25211086|NCT02192190|50474120|FG001|Overall Study|Positive Drug Screen|0|||
25211087|NCT02192190|50474121|FG002|Overall Study|Positive Drug Screen|0|||
25211088|NCT02192190|50474122|FG003|Overall Study|Positive Drug Screen|1|||
25211089|NCT02192190|50474123|FG004|Overall Study|Positive Drug Screen|0|||
25316435|NCT00838539|50631807|FG011|Overall Study|Physician Decision|0|||
25316436|NCT00838539|50631796|FG000|Overall Study|Clinical Progression|0|||
25316437|NCT00838539|50631797|FG001|Overall Study|Clinical Progression|0|||
25316438|NCT00838539|50631798|FG002|Overall Study|Clinical Progression|0|||
25316439|NCT00838539|50631799|FG003|Overall Study|Clinical Progression|0|||
25316440|NCT00838539|50631800|FG004|Overall Study|Clinical Progression|0|||
25211090|NCT02192190|50474124|FG005|Overall Study|Positive Drug Screen|0|||
25211091|NCT02192190|50474119|FG000|Overall Study|Inadequate Pain Relief|0|||
25211092|NCT02192190|50474120|FG001|Overall Study|Inadequate Pain Relief|1|||
25211093|NCT02192190|50474121|FG002|Overall Study|Inadequate Pain Relief|1|||
25211094|NCT02192190|50474122|FG003|Overall Study|Inadequate Pain Relief|0|||
25211095|NCT02192190|50474123|FG004|Overall Study|Inadequate Pain Relief|0|||
25211096|NCT02192190|50474124|FG005|Overall Study|Inadequate Pain Relief|0|||
25316441|NCT00838539|50631801|FG005|Overall Study|Clinical Progression|0|||
25211097|NCT02224638|50474152|FG000|Overall Study|Adverse Event|1|||
25211098|NCT02224638|50474153|FG001|Overall Study|Adverse Event|1|||
25211099|NCT02224560|50474168|FG000|Overall Study|Protocol Deviation|1|||
25211100|NCT02224560|50474169|FG001|Overall Study|Protocol Deviation|0|||
25211101|NCT02224560|50474170|FG002|Overall Study|Protocol Deviation|0|||
25211102|NCT02224560|50474168|FG000|Overall Study|Withdrawal by Subject|2|||
25211103|NCT02224560|50474169|FG001|Overall Study|Withdrawal by Subject|0|||
25211104|NCT02224560|50474170|FG002|Overall Study|Withdrawal by Subject|1|||
25211105|NCT02224560|50474168|FG000|Overall Study|Met Withdrawal Criteria|1|||
25211106|NCT02224560|50474169|FG001|Overall Study|Met Withdrawal Criteria|0|||
25211107|NCT02224560|50474170|FG002|Overall Study|Met Withdrawal Criteria|0|||
25211108|NCT02224560|50474168|FG000|Overall Study|Adverse Event|4|||
25211109|NCT02224560|50474169|FG001|Overall Study|Adverse Event|1|||
25211110|NCT02224560|50474170|FG002|Overall Study|Adverse Event|1|||
25211111|NCT02224560|50474168|FG000|Overall Study|Withdrawn by Investigator|1|||
25211112|NCT02224560|50474169|FG001|Overall Study|Withdrawn by Investigator|1|||
25211113|NCT02224560|50474170|FG002|Overall Study|Withdrawn by Investigator|0|||
25211114|NCT02161458|50474182|FG000|Overall Study|Withdrawal by Subject|0|||
25211115|NCT02161458|50474183|FG001|Overall Study|Withdrawal by Subject|4|||
25316442|NCT00838539|50631802|FG006|Overall Study|Clinical Progression|1|||
25316443|NCT00838539|50631803|FG007|Overall Study|Clinical Progression|0|||
25316444|NCT00838539|50631804|FG008|Overall Study|Clinical Progression|0|||
25316445|NCT00838539|50631805|FG009|Overall Study|Clinical Progression|0|||
25316446|NCT00838539|50631806|FG010|Overall Study|Clinical Progression|0|||
25316447|NCT00838539|50631807|FG011|Overall Study|Clinical Progression|0|||
25316448|NCT00838539|50631796|FG000|Overall Study|Symptomatic Deterioration|0|||
25316449|NCT00838539|50631797|FG001|Overall Study|Symptomatic Deterioration|0|||
25316450|NCT00838539|50631798|FG002|Overall Study|Symptomatic Deterioration|1|||
25316451|NCT00838539|50631799|FG003|Overall Study|Symptomatic Deterioration|1|||
25211116|NCT02161458|50474184|FG002|Overall Study|Withdrawal by Subject|4|||
25211117|NCT02161458|50474185|FG003|Overall Study|Withdrawal by Subject|0|||
25211118|NCT02161458|50474182|FG000|Overall Study|Lost to Follow-up|0|||
25211119|NCT02161458|50474183|FG001|Overall Study|Lost to Follow-up|2|||
25211120|NCT02161458|50474184|FG002|Overall Study|Lost to Follow-up|1|||
25211121|NCT02161458|50474185|FG003|Overall Study|Lost to Follow-up|0|||
25211122|NCT02223858|50474197|FG000|Overall Study|Death|1|||
25211123|NCT02223858|50474198|FG001|Overall Study|Death|1|||
25211124|NCT02223858|50474197|FG000|Overall Study|Lost to Follow-up|6|||
25211125|NCT02223858|50474198|FG001|Overall Study|Lost to Follow-up|11|||
25211126|NCT02223858|50474197|FG000|Overall Study|Withdrawal by Subject|8|||
25211127|NCT02223858|50474198|FG001|Overall Study|Withdrawal by Subject|5|||
25211128|NCT02223858|50474197|FG000|Overall Study|Refused|9|||
25211129|NCT02223858|50474198|FG001|Overall Study|Refused|9|||
25211130|NCT02223390|50474206|FG000|Overall Study|Lost to Follow-up|9|||
25211131|NCT02223390|50474207|FG001|Overall Study|Lost to Follow-up|4|||
25211132|NCT04914000|50476119|FG000|Overall Study|Lost to Follow-up|8|||
25211133|NCT04914000|50476119|FG000|Overall Study|Withdrawal by Subject|1|||
25211134|NCT04530825|50476136|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
25211135|NCT04530825|50476137|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
25211136|NCT04530825|50476138|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
25211137|NCT04530825|50476139|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
25211138|NCT04530825|50476136|FG000|Overall Study|Did not complete follow-up|3|||
25211139|NCT04530825|50476137|FG001|Overall Study|Did not complete follow-up|0|||
25211140|NCT04530825|50476138|FG002|Overall Study|Did not complete follow-up|0|||
25211141|NCT04530825|50476139|FG003|Overall Study|Did not complete follow-up|0|||
25211142|NCT04169373|50476153|FG000|Week 1 to Week 14|Adverse Event|1|||
25211143|NCT04169373|50476154|FG001|Week 1 to Week 14|Adverse Event|0|||
25211144|NCT04169373|50476155|FG002|Week 1 to Week 14|Adverse Event|1|||
25211145|NCT04169373|50476156|FG003|Week 1 to Week 14|Adverse Event|2|||
25211146|NCT04169373|50476153|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
25211147|NCT04169373|50476154|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
25316452|NCT00838539|50631800|FG004|Overall Study|Symptomatic Deterioration|0|||
25316453|NCT00838539|50631801|FG005|Overall Study|Symptomatic Deterioration|1|||
25316454|NCT00838539|50631802|FG006|Overall Study|Symptomatic Deterioration|0|||
25316455|NCT00838539|50631803|FG007|Overall Study|Symptomatic Deterioration|0|||
25316456|NCT00838539|50631804|FG008|Overall Study|Symptomatic Deterioration|0|||
25316457|NCT00838539|50631805|FG009|Overall Study|Symptomatic Deterioration|1|||
25077210|NCT02463032|50185063|FG001|Overall Study|Lack of Efficacy|50|||
25211148|NCT04169373|50476155|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
25211149|NCT04169373|50476156|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
25211150|NCT04169373|50476153|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
25211151|NCT04169373|50476154|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
25211152|NCT04169373|50476155|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
25211153|NCT04169373|50476156|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
25211154|NCT04169373|50476153|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
25211155|NCT04169373|50476154|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
25211156|NCT04169373|50476155|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
25211157|NCT04169373|50476156|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
25211158|NCT04169373|50476153|FG000|Week 1 to Week 14|Other|1|||
25211159|NCT04169373|50476154|FG001|Week 1 to Week 14|Other|3|||
25211160|NCT04169373|50476155|FG002|Week 1 to Week 14|Other|3|||
25211161|NCT04169373|50476156|FG003|Week 1 to Week 14|Other|5|||
25211162|NCT04169373|50476153|FG000|Week 14 to Week 52|Adverse Event|1|||
25211163|NCT04169373|50476154|FG001|Week 14 to Week 52|Adverse Event|0|||
25211164|NCT04169373|50476155|FG002|Week 14 to Week 52|Adverse Event|0|||
25211165|NCT04169373|50476156|FG003|Week 14 to Week 52|Adverse Event|1|||
25211166|NCT04169373|50476153|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
25211167|NCT04169373|50476154|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
25211168|NCT04169373|50476155|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
25211169|NCT04169373|50476156|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
25211170|NCT04169373|50476153|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
25211171|NCT04169373|50476154|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
25211172|NCT04169373|50476155|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
25211173|NCT04169373|50476156|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
25211174|NCT04169373|50476153|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
25211175|NCT04169373|50476154|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
25211176|NCT04169373|50476155|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
25211177|NCT04169373|50476156|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
25211178|NCT04169373|50476153|FG000|Week 14 to Week 52|Other|4|||
25211179|NCT04169373|50476154|FG001|Week 14 to Week 52|Other|5|||
25211180|NCT04169373|50476155|FG002|Week 14 to Week 52|Other|4|||
25211181|NCT04169373|50476156|FG003|Week 14 to Week 52|Other|5|||
25211182|NCT04169373|50476153|FG000|Week 14 to Week 52|Ongoing|0|||
25211183|NCT04169373|50476154|FG001|Week 14 to Week 52|Ongoing|1|||
25211184|NCT04169373|50476155|FG002|Week 14 to Week 52|Ongoing|0|||
25211185|NCT04169373|50476156|FG003|Week 14 to Week 52|Ongoing|0|||
25211186|NCT04154930|50476171|FG000|Overall Study|Withdrawal by Subject|15|||
25211187|NCT04154930|50476172|FG001|Overall Study|Withdrawal by Subject|6|||
25211188|NCT04154930|50476171|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
25211189|NCT04154930|50476172|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
25211190|NCT04154930|50476171|FG000|Overall Study|Lost to Follow-up|14|||
25211191|NCT04154930|50476172|FG001|Overall Study|Lost to Follow-up|6|||
25211192|NCT04154930|50476171|FG000|Overall Study|Other|6|||
25211193|NCT04154930|50476172|FG001|Overall Study|Other|0|||
25211194|NCT04124471|50476178|FG000|Overall Study|screen failure|1|||
25211195|NCT04093024|50476184|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
25211196|NCT04093024|50476185|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
25211197|NCT04093024|50476184|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
25211198|NCT04093024|50476185|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
25211199|NCT04093024|50476184|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
25211200|NCT04093024|50476185|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
25211201|NCT04093024|50476184|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
25211202|NCT04093024|50476185|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
25211203|NCT03971474|50476221|FG000|Overall Study|Adverse Event|11|||
25211204|NCT03971474|50476222|FG001|Overall Study|Adverse Event|7|||
25211205|NCT03971474|50476221|FG000|Overall Study|Refusal unrelated to adverse event|5|||
25211206|NCT03971474|50476222|FG001|Overall Study|Refusal unrelated to adverse event|1|||
25211207|NCT03971474|50476221|FG000|Overall Study|Progression/relapse|40|||
25211208|NCT03971474|50476222|FG001|Overall Study|Progression/relapse|47|||
25211209|NCT03971474|50476221|FG000|Overall Study|Death|6|||
25211210|NCT03971474|50476222|FG001|Overall Study|Death|3|||
25211211|NCT03971474|50476221|FG000|Overall Study|Other - not protocol specified|5|||
25211212|NCT03971474|50476222|FG001|Overall Study|Other - not protocol specified|4|||
25211213|NCT03971474|50476221|FG000|Overall Study|On treatment|0|||
25211214|NCT03971474|50476222|FG001|Overall Study|On treatment|7|||
25211215|NCT03633929|50476229|FG000|Overall Study|Lost to Follow-up|1|||
25211216|NCT03633929|50476229|FG000|Overall Study|Did not login to software. Did not participate|3|||
25211217|NCT03625687|50476233|FG000|Overall Study|Death|1|||
25211218|NCT03062358|50476256|FG000|Overall Study|Death|220|||
25211219|NCT03062358|50476257|FG001|Overall Study|Death|127|||
25211220|NCT03062358|50476256|FG000|Overall Study|Withdrawal by Subject|2|||
25211221|NCT03062358|50476257|FG001|Overall Study|Withdrawal by Subject|1|||
25211222|NCT03062358|50476256|FG000|Overall Study|Ongoing in Trial|78|||
25211223|NCT03062358|50476257|FG001|Overall Study|Ongoing in Trial|25|||
24976363|NCT00092547|50065232|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
25211224|NCT02913482|50476267|FG000|Overall Study|Death|0|||
25211225|NCT02913482|50476268|FG001|Overall Study|Death|2|||
25211226|NCT02913482|50476269|FG002|Overall Study|Death|2|||
25211227|NCT02913482|50476267|FG000|Overall Study|Progressive Disease|1|||
25211228|NCT02913482|50476268|FG001|Overall Study|Progressive Disease|1|||
25211229|NCT02913482|50476269|FG002|Overall Study|Progressive Disease|1|||
25211230|NCT02869633|50476281|FG000|Overall Study|Death|2|||
25211231|NCT02869633|50476282|FG001|Overall Study|Death|1|||
25211232|NCT02869633|50476281|FG000|Overall Study|Patient refused follow-up|1|||
25211233|NCT02869633|50476282|FG001|Overall Study|Patient refused follow-up|0|||
25211234|NCT02869633|50476281|FG000|Overall Study|Provider discretion|1|||
25211235|NCT02869633|50476282|FG001|Overall Study|Provider discretion|0|||
25211236|NCT02869633|50476281|FG000|Overall Study|Investigator decision|1|||
25211237|NCT02869633|50476282|FG001|Overall Study|Investigator decision|0|||
25211238|NCT02869633|50476281|FG000|Overall Study|Lost to Follow-up|0|||
25211239|NCT02869633|50476282|FG001|Overall Study|Lost to Follow-up|1|||
25211240|NCT02869633|50476281|FG000|Overall Study|Not eligible|6|||
25211241|NCT02869633|50476282|FG001|Overall Study|Not eligible|1|||
25211242|NCT02869633|50476281|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
25211243|NCT02869633|50476282|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
25211244|NCT02869633|50476281|FG000|Overall Study|Withdrawal by Subject|0|||
25211245|NCT02869633|50476282|FG001|Overall Study|Withdrawal by Subject|1|||
25211246|NCT02785952|50476292|FG000|Overall Study|Adverse Event|31|||
25211247|NCT02785952|50476293|FG001|Overall Study|Adverse Event|19|||
25211248|NCT02785952|50476292|FG000|Overall Study|Refusal unrelated to adverse events|10|||
25211249|NCT02785952|50476293|FG001|Overall Study|Refusal unrelated to adverse events|5|||
25211250|NCT02785952|50476292|FG000|Overall Study|Disease progression/relapse|61|||
25211251|NCT02785952|50476293|FG001|Overall Study|Disease progression/relapse|89|||
25211252|NCT02785952|50476292|FG000|Overall Study|Death|11|||
25211253|NCT02785952|50476293|FG001|Overall Study|Death|7|||
25211254|NCT02785952|50476292|FG000|Overall Study|Other- not protocol specified|6|||
25211255|NCT02785952|50476293|FG001|Overall Study|Other- not protocol specified|4|||
25211256|NCT02785952|50476292|FG000|Overall Study|On protocol treatment|6|||
25211257|NCT02785952|50476293|FG001|Overall Study|On protocol treatment|3|||
25211258|NCT02674685|50476301|FG000|Overall Study|Withdrawal by Subject|4|||
25211259|NCT02654236|50476308|FG000|Overall Study|Withdrawal by Subject|0|||
25211260|NCT02654236|50476309|FG001|Overall Study|Withdrawal by Subject|0|||
25211261|NCT02654236|50476310|FG002|Overall Study|Withdrawal by Subject|2|||
25211262|NCT02372136|50476320|FG000|Overall Study|Death|3|||
25211263|NCT02372136|50476321|FG001|Overall Study|Death|1|||
25211264|NCT02194829|50476331|FG000|Overall Study|Adverse Event|2|||
25211265|NCT02194829|50476332|FG001|Overall Study|Adverse Event|2|||
25211266|NCT02194829|50476331|FG000|Overall Study|Death|0|||
25211267|NCT02194829|50476332|FG001|Overall Study|Death|1|||
25211268|NCT02194829|50476331|FG000|Overall Study|Disease progression|0|||
25211269|NCT02194829|50476332|FG001|Overall Study|Disease progression|1|||
25211270|NCT02194829|50476331|FG000|Overall Study|Withdrawal by Subject|0|||
25211271|NCT02194829|50476332|FG001|Overall Study|Withdrawal by Subject|1|||
25211272|NCT02194829|50476331|FG000|Overall Study|Never started protocol therapy|0|||
25211273|NCT02194829|50476332|FG001|Overall Study|Never started protocol therapy|1|||
25211274|NCT02087046|50476339|FG000|Overall Study|Adverse Event|4|||
25211275|NCT02087046|50476339|FG000|Overall Study|Death|1|||
25211276|NCT02087046|50476339|FG000|Overall Study|Lost to Follow-up|3|||
25211277|NCT02087046|50476339|FG000|Overall Study|Withdrawal by Subject|2|||
25211278|NCT02087046|50476339|FG000|Overall Study|Physician Decision|1|||
25211279|NCT01390038|50476348|FG000|Overall Study|Death|1|||
25211280|NCT01390038|50476348|FG000|Overall Study|Lost to Follow-up|1|||
25211281|NCT01390038|50476348|FG000|Overall Study|Withdrawal by Subject|4|||
25211282|NCT01390038|50476348|FG000|Overall Study|Simpliciti System Removal|2|||
25211283|NCT00621192|50476366|FG000|Overall Study|Withdrawal by Subject|0|||
25211284|NCT00621192|50476367|FG001|Overall Study|Withdrawal by Subject|0|||
25211285|NCT00621192|50476368|FG002|Overall Study|Withdrawal by Subject|2|||
25211286|NCT00621192|50476369|FG003|Overall Study|Withdrawal by Subject|0|||
25211287|NCT00621192|50476366|FG000|Overall Study|Physician Decision|1|||
25211288|NCT00621192|50476367|FG001|Overall Study|Physician Decision|3|||
25211289|NCT00621192|50476368|FG002|Overall Study|Physician Decision|0|||
25211290|NCT00621192|50476369|FG003|Overall Study|Physician Decision|0|||
25211291|NCT00621192|50476366|FG000|Overall Study|Protocol Violation|1|||
25211292|NCT00621192|50476367|FG001|Overall Study|Protocol Violation|0|||
25211293|NCT00621192|50476368|FG002|Overall Study|Protocol Violation|0|||
25211294|NCT00621192|50476369|FG003|Overall Study|Protocol Violation|1|||
25211295|NCT00621192|50476366|FG000|Overall Study|Adverse Event|0|||
25211296|NCT00621192|50476367|FG001|Overall Study|Adverse Event|1|||
25211297|NCT00621192|50476368|FG002|Overall Study|Adverse Event|0|||
25211298|NCT00621192|50476369|FG003|Overall Study|Adverse Event|1|||
25211299|NCT00621192|50476366|FG000|Overall Study|Death|2|||
25211300|NCT00621192|50476367|FG001|Overall Study|Death|5|||
25211301|NCT00621192|50476368|FG002|Overall Study|Death|0|||
25211302|NCT00621192|50476369|FG003|Overall Study|Death|0|||
25211303|NCT00621192|50476366|FG000|Overall Study|Final Assessments not Completed|0|||
25211304|NCT00621192|50476367|FG001|Overall Study|Final Assessments not Completed|0|||
25316458|NCT00838539|50631806|FG010|Overall Study|Symptomatic Deterioration|0|||
25211305|NCT00621192|50476368|FG002|Overall Study|Final Assessments not Completed|3|||
25211306|NCT00621192|50476369|FG003|Overall Study|Final Assessments not Completed|1|||
25211307|NCT00364286|50476379|FG000|Overall Study|Withdrawal by Subject|1|||
25211308|NCT00364286|50476379|FG000|Overall Study|Adverse Event|2|||
25211309|NCT00278200|50476385|FG000|Overall Study|Death|1|||
25211310|NCT00278200|50476386|FG001|Overall Study|Death|3|||
25211311|NCT00278200|50476385|FG000|Overall Study|Physician Decision|0|||
25211312|NCT00278200|50476386|FG001|Overall Study|Physician Decision|1|||
25211313|NCT00255346|50476397|FG000|Overall Study|Adverse Event|1|||
25211314|NCT00255346|50476398|FG001|Overall Study|Adverse Event|0|||
25211315|NCT00255346|50476399|FG002|Overall Study|Adverse Event|0|||
25211316|NCT00255346|50476400|FG003|Overall Study|Adverse Event|0|||
25211317|NCT00255346|50476401|FG004|Overall Study|Adverse Event|0|||
25211318|NCT02222922|50478565|FG000|Overall Study|Death|0|||
25211319|NCT02222922|50478566|FG001|Overall Study|Death|0|||
25211320|NCT02222922|50478567|FG002|Overall Study|Death|0|||
25211321|NCT02222922|50478568|FG003|Overall Study|Death|0|||
25211322|NCT02222922|50478569|FG004|Overall Study|Death|13|||
25211323|NCT02222922|50478570|FG005|Overall Study|Death|0|||
25211324|NCT02222922|50478571|FG006|Overall Study|Death|0|||
25211325|NCT02222922|50478572|FG007|Overall Study|Death|0|||
25211326|NCT02222922|50478573|FG008|Overall Study|Death|2|||
25211327|NCT02222922|50478565|FG000|Overall Study|Lost to Follow-up|0|||
25211328|NCT02222922|50478566|FG001|Overall Study|Lost to Follow-up|0|||
25211329|NCT02222922|50478567|FG002|Overall Study|Lost to Follow-up|1|||
25211330|NCT02222922|50478568|FG003|Overall Study|Lost to Follow-up|0|||
25211331|NCT02222922|50478569|FG004|Overall Study|Lost to Follow-up|9|||
25316459|NCT00838539|50631807|FG011|Overall Study|Symptomatic Deterioration|0|||
25316460|NCT00837759|50631847|FG000|Overall Study|Protocol Violation|3|||
25316461|NCT00837759|50631847|FG000|Overall Study|Lost to Follow-up|1|||
24976364|NCT00092547|50065233|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
25211332|NCT02222922|50478570|FG005|Overall Study|Lost to Follow-up|1|||
25211333|NCT02222922|50478571|FG006|Overall Study|Lost to Follow-up|0|||
25211334|NCT02222922|50478572|FG007|Overall Study|Lost to Follow-up|0|||
25211335|NCT02222922|50478573|FG008|Overall Study|Lost to Follow-up|0|||
25211336|NCT02222922|50478565|FG000|Overall Study|Other|0|||
25211337|NCT02222922|50478566|FG001|Overall Study|Other|0|||
25211338|NCT02222922|50478567|FG002|Overall Study|Other|0|||
25211339|NCT02222922|50478568|FG003|Overall Study|Other|2|||
25211340|NCT02222922|50478569|FG004|Overall Study|Other|10|||
25211341|NCT02222922|50478570|FG005|Overall Study|Other|2|||
25211342|NCT02222922|50478571|FG006|Overall Study|Other|2|||
25211343|NCT02222922|50478572|FG007|Overall Study|Other|4|||
25211344|NCT02222922|50478573|FG008|Overall Study|Other|1|||
25211345|NCT02222922|50478565|FG000|Overall Study|Participant refused further follow-up|1|||
25211346|NCT02222922|50478566|FG001|Overall Study|Participant refused further follow-up|0|||
25211347|NCT02222922|50478567|FG002|Overall Study|Participant refused further follow-up|0|||
25211348|NCT02222922|50478568|FG003|Overall Study|Participant refused further follow-up|1|||
25211349|NCT02222922|50478569|FG004|Overall Study|Participant refused further follow-up|6|||
25211350|NCT02222922|50478570|FG005|Overall Study|Participant refused further follow-up|0|||
25211351|NCT02222922|50478571|FG006|Overall Study|Participant refused further follow-up|0|||
25211352|NCT02222922|50478572|FG007|Overall Study|Participant refused further follow-up|0|||
25211353|NCT02222922|50478573|FG008|Overall Study|Participant refused further follow-up|3|||
25211354|NCT02161146|50478625|FG000|Overall Study|Adverse Event|1|||
25211355|NCT02161146|50478626|FG001|Overall Study|Adverse Event|1|||
25211356|NCT02161146|50478627|FG002|Overall Study|Adverse Event|0|||
25211357|NCT02161146|50478628|FG003|Overall Study|Adverse Event|1|||
25211358|NCT02161146|50478629|FG004|Overall Study|Adverse Event|0|||
25211359|NCT02161146|50478625|FG000|Overall Study|Lost to Follow-up|0|||
25211360|NCT02161146|50478626|FG001|Overall Study|Lost to Follow-up|1|||
25211361|NCT02161146|50478627|FG002|Overall Study|Lost to Follow-up|0|||
25211362|NCT02161146|50478628|FG003|Overall Study|Lost to Follow-up|0|||
25211363|NCT02161146|50478629|FG004|Overall Study|Lost to Follow-up|0|||
25211364|NCT02161146|50478625|FG000|Overall Study|Personal Reasons|0|||
25211365|NCT02161146|50478626|FG001|Overall Study|Personal Reasons|1|||
25211366|NCT02161146|50478627|FG002|Overall Study|Personal Reasons|0|||
25211367|NCT02161146|50478628|FG003|Overall Study|Personal Reasons|2|||
25316462|NCT00891774|50631851|FG000|Overall Study|Lost to Follow-up|5|||
25316463|NCT00891774|50631851|FG000|Overall Study|Illness (Self/Mother)|3|||
25211368|NCT02161146|50478629|FG004|Overall Study|Personal Reasons|1|||
25211369|NCT02161146|50478625|FG000|Overall Study|Other Miscellaneous Reasons|0|||
25211370|NCT02161146|50478626|FG001|Overall Study|Other Miscellaneous Reasons|1|||
25211371|NCT02161146|50478627|FG002|Overall Study|Other Miscellaneous Reasons|0|||
25211372|NCT02161146|50478628|FG003|Overall Study|Other Miscellaneous Reasons|0|||
25211373|NCT02161146|50478629|FG004|Overall Study|Other Miscellaneous Reasons|0|||
25211374|NCT02222688|50478864|FG000|Overall Study|Withdrawal by Subject|0|||
25211375|NCT02222688|50478865|FG001|Overall Study|Withdrawal by Subject|0|||
25211376|NCT02222688|50478866|FG002|Overall Study|Withdrawal by Subject|0|||
25211377|NCT02222688|50478867|FG003|Overall Study|Withdrawal by Subject|2|||
25211378|NCT02222688|50478868|FG004|Overall Study|Withdrawal by Subject|1|||
25211379|NCT02222688|50478869|FG005|Overall Study|Withdrawal by Subject|0|||
25211380|NCT02222688|50478870|FG006|Overall Study|Withdrawal by Subject|1|||
25211381|NCT02222688|50478864|FG000|Overall Study|Disease progression|1|||
25211382|NCT02222688|50478865|FG001|Overall Study|Disease progression|0|||
25211383|NCT02222688|50478866|FG002|Overall Study|Disease progression|0|||
25211384|NCT02222688|50478867|FG003|Overall Study|Disease progression|0|||
25211385|NCT02222688|50478868|FG004|Overall Study|Disease progression|0|||
25211386|NCT02222688|50478869|FG005|Overall Study|Disease progression|0|||
25211387|NCT02222688|50478870|FG006|Overall Study|Disease progression|0|||
25211388|NCT02159352|50478922|FG000|Overall Study|Adverse Event|3|||
25211389|NCT02159352|50478923|FG001|Overall Study|Adverse Event|1|||
25211390|NCT02159352|50478922|FG000|Overall Study|Withdrawal by Subject|0|||
25211391|NCT02159352|50478923|FG001|Overall Study|Withdrawal by Subject|1|||
25211392|NCT02187744|50478960|FG000|Study|Participant refused further follow-up|1|||
25211393|NCT02187744|50478961|FG001|Study|Participant refused further follow-up|0|||
25211394|NCT02187744|50478960|FG000|Study|Other|2|||
25211395|NCT02187744|50478961|FG001|Study|Other|1|||
25211396|NCT02187744|50478960|FG000|Study|Lost to Follow-up|0|||
25211397|NCT02187744|50478961|FG001|Study|Lost to Follow-up|2|||
25211398|NCT02187744|50478960|FG000|Study|Related adverse event, not serious|0|||
25211399|NCT02187744|50478961|FG001|Study|Related adverse event, not serious|2|||
25211400|NCT02187744|50478960|FG000|Study|Death|1|||
25211401|NCT02187744|50478961|FG001|Study|Death|0|||
25211402|NCT02187744|50478960|FG000|Study|Related adverse event, serious non-fatal|0|||
25211403|NCT02187744|50478961|FG001|Study|Related adverse event, serious non-fatal|1|||
25211404|NCT02187744|50478960|FG000|Treatment|Death|1|||
25211405|NCT02187744|50478961|FG001|Treatment|Death|0|||
25211406|NCT02187744|50478960|FG000|Treatment|Related adverse event, serious non-fatal|0|||
25211407|NCT02187744|50478961|FG001|Treatment|Related adverse event, serious non-fatal|1|||
25211408|NCT02187744|50478960|FG000|Treatment|Related adverse event, not serious|0|||
25211409|NCT02187744|50478961|FG001|Treatment|Related adverse event, not serious|2|||
25211410|NCT02187744|50478960|FG000|Treatment|Lost to Follow-up|0|||
25211411|NCT02187744|50478961|FG001|Treatment|Lost to Follow-up|1|||
25211412|NCT02187744|50478960|FG000|Treatment|Other|2|||
25211413|NCT02187744|50478961|FG001|Treatment|Other|0|||
25211414|NCT02187744|50478960|FG000|Treatment|Participant refused continued treatment|1|||
25211415|NCT02187744|50478961|FG001|Treatment|Participant refused continued treatment|1|||
25211416|NCT02186652|50479123|FG000|Overall Study|Lost to Follow-up|2|||
25211417|NCT02186652|50479124|FG001|Overall Study|Lost to Follow-up|0|||
25211418|NCT02185794|50479160|FG000|Overall Study|Enrolled but Never Dosed|1|||
25211419|NCT02185794|50479161|FG001|Overall Study|Enrolled but Never Dosed|6|||
25211420|NCT02185794|50479162|FG002|Overall Study|Enrolled but Never Dosed|3|||
25211421|NCT02185794|50479163|FG003|Overall Study|Enrolled but Never Dosed|1|||
25211422|NCT02185794|50479164|FG004|Overall Study|Enrolled but Never Dosed|1|||
25211423|NCT02185794|50479165|FG005|Overall Study|Enrolled but Never Dosed|0|||
25211424|NCT02185794|50479160|FG000|Overall Study|Investigator's Discretion|1|||
25211425|NCT02185794|50479161|FG001|Overall Study|Investigator's Discretion|0|||
25211426|NCT02185794|50479162|FG002|Overall Study|Investigator's Discretion|1|||
25211427|NCT02185794|50479163|FG003|Overall Study|Investigator's Discretion|2|||
25211428|NCT02185794|50479164|FG004|Overall Study|Investigator's Discretion|2|||
25211429|NCT02185794|50479165|FG005|Overall Study|Investigator's Discretion|15|||
25211430|NCT02185794|50479160|FG000|Overall Study|Withdrew Consent|2|||
25211431|NCT02185794|50479161|FG001|Overall Study|Withdrew Consent|5|||
25211432|NCT02185794|50479162|FG002|Overall Study|Withdrew Consent|10|||
25211433|NCT02185794|50479163|FG003|Overall Study|Withdrew Consent|2|||
25211434|NCT02185794|50479164|FG004|Overall Study|Withdrew Consent|0|||
25211435|NCT02185794|50479165|FG005|Overall Study|Withdrew Consent|0|||
25211436|NCT02185794|50479160|FG000|Overall Study|Lost to Follow-up|1|||
25211437|NCT02185794|50479161|FG001|Overall Study|Lost to Follow-up|2|||
25211438|NCT02185794|50479162|FG002|Overall Study|Lost to Follow-up|2|||
25211439|NCT02185794|50479163|FG003|Overall Study|Lost to Follow-up|3|||
25211440|NCT02185794|50479164|FG004|Overall Study|Lost to Follow-up|0|||
25211441|NCT02185794|50479165|FG005|Overall Study|Lost to Follow-up|1|||
25211442|NCT02221674|50479196|FG000|Overall Study|Lost to Follow-up|1|||
25211443|NCT02221674|50479197|FG001|Overall Study|Lost to Follow-up|0|||
25211444|NCT02221674|50479198|FG002|Overall Study|Lost to Follow-up|0|||
25211445|NCT02221284|50479213|FG000|Overall Study|Case Report Forms Uncollected|56|||
25211446|NCT02221284|50479213|FG000|Overall Study|Protocol Deviation|5|||
25211447|NCT02187042|50479374|FG000|Overall Study|Death|1|||
25211448|NCT02187042|50479375|FG001|Overall Study|Death|1|||
25211449|NCT02187042|50479374|FG000|Overall Study|Toxicity|6|||
25211450|NCT02187042|50479375|FG001|Overall Study|Toxicity|5|||
25211451|NCT02187042|50479374|FG000|Overall Study|Participant choice|1|||
25211452|NCT02187042|50479375|FG001|Overall Study|Participant choice|0|||
25211453|NCT02187042|50479374|FG000|Overall Study|Doctor choice|1|||
25211454|NCT02187042|50479375|FG001|Overall Study|Doctor choice|0|||
25211455|NCT02187042|50479374|FG000|Overall Study|Progressive disease|4|||
25211456|NCT02187042|50479375|FG001|Overall Study|Progressive disease|8|||
25211457|NCT02220894|50479549|FG000|Overall Study|Adverse Event|118|||
25211458|NCT02220894|50479550|FG001|Overall Study|Adverse Event|70|||
25211459|NCT02220894|50479549|FG000|Overall Study|Death|252|||
25211460|NCT02220894|50479550|FG001|Overall Study|Death|368|||
25211461|NCT02220894|50479549|FG000|Overall Study|Lost to Follow-up|0|||
25211462|NCT02220894|50479550|FG001|Overall Study|Lost to Follow-up|2|||
25211463|NCT02220894|50479549|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
25211464|NCT02220894|50479550|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
25211465|NCT02220894|50479549|FG000|Overall Study|Withdrawal by Subject|2|||
25211466|NCT02220894|50479550|FG001|Overall Study|Withdrawal by Subject|13|||
25211467|NCT02220894|50479549|FG000|Overall Study|Ongoing in Study|265|||
25211468|NCT02220894|50479550|FG001|Overall Study|Ongoing in Study|183|||
25211469|NCT02219334|50479567|FG000|Overall Study|Withdrawal by Subject|1|||
25211470|NCT02219334|50479568|FG001|Overall Study|Withdrawal by Subject|0|||
25211471|NCT02219334|50479567|FG000|Overall Study|Protocol Violation|7|||
25211472|NCT02219334|50479568|FG001|Overall Study|Protocol Violation|3|||
25211473|NCT02159040|50479586|FG000|Overall Study|Death|1|||
25211474|NCT02218008|50479611|FG000|Stage 1 (S1)|Adverse Event|6|||
25211475|NCT02218008|50479612|FG001|Stage 1 (S1)|Adverse Event|5|||
25211476|NCT02218008|50479613|FG002|Stage 1 (S1)|Adverse Event|11|||
25211477|NCT02218008|50479614|FG003|Stage 1 (S1)|Adverse Event|0|||
25211478|NCT02218008|50479615|FG004|Stage 1 (S1)|Adverse Event|0|||
25211479|NCT02218008|50479616|FG005|Stage 1 (S1)|Adverse Event|0|||
25211480|NCT02218008|50479611|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
25211481|NCT02218008|50479612|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
25211482|NCT02218008|50479613|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
25211483|NCT02218008|50479614|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
25211484|NCT02218008|50479615|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
25211485|NCT02218008|50479616|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
25211486|NCT02218008|50479611|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
25211487|NCT02218008|50479612|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
25211488|NCT02218008|50479613|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
25211489|NCT02218008|50479614|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
25211490|NCT02218008|50479615|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
25211491|NCT02218008|50479616|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
25211492|NCT02218008|50479611|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
25211493|NCT02218008|50479612|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
25211494|NCT02218008|50479613|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
25211495|NCT02218008|50479614|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
25211496|NCT02218008|50479615|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
25211497|NCT02218008|50479616|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
25211498|NCT02218008|50479611|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
25211499|NCT02218008|50479612|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
25211500|NCT02218008|50479613|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
25211501|NCT02218008|50479614|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
25211502|NCT02218008|50479615|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
25211503|NCT02218008|50479616|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
25211504|NCT02218008|50479611|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
25211505|NCT02218008|50479612|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
25211506|NCT02218008|50479613|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
25211507|NCT02218008|50479614|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
25211508|NCT02218008|50479615|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
25211509|NCT02218008|50479616|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
25211510|NCT02218008|50479611|FG000|Stage 1 (S1)|Pregnancy|0|||
25211511|NCT02218008|50479612|FG001|Stage 1 (S1)|Pregnancy|0|||
25211512|NCT02218008|50479613|FG002|Stage 1 (S1)|Pregnancy|1|||
25211513|NCT02218008|50479614|FG003|Stage 1 (S1)|Pregnancy|0|||
25211514|NCT02218008|50479615|FG004|Stage 1 (S1)|Pregnancy|0|||
25211515|NCT02218008|50479616|FG005|Stage 1 (S1)|Pregnancy|0|||
25211516|NCT02218008|50479611|FG000|Stage 1 (S1)|Protocol Violation|0|||
25211517|NCT02218008|50479612|FG001|Stage 1 (S1)|Protocol Violation|0|||
25211518|NCT02218008|50479613|FG002|Stage 1 (S1)|Protocol Violation|1|||
24976365|NCT00092547|50065234|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
25211519|NCT02218008|50479614|FG003|Stage 1 (S1)|Protocol Violation|0|||
25211520|NCT02218008|50479615|FG004|Stage 1 (S1)|Protocol Violation|0|||
25211521|NCT02218008|50479616|FG005|Stage 1 (S1)|Protocol Violation|0|||
25211522|NCT02218008|50479611|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
25211523|NCT02218008|50479612|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
25211524|NCT02218008|50479613|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
25211525|NCT02218008|50479614|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
25211526|NCT02218008|50479615|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
25211527|NCT02218008|50479616|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
25211528|NCT02218008|50479611|FG000|Stage 2 (S2)|Adverse Event|0|||
25211529|NCT02218008|50479612|FG001|Stage 2 (S2)|Adverse Event|0|||
25211530|NCT02218008|50479613|FG002|Stage 2 (S2)|Adverse Event|0|||
25211531|NCT02218008|50479614|FG003|Stage 2 (S2)|Adverse Event|2|||
25211532|NCT02218008|50479615|FG004|Stage 2 (S2)|Adverse Event|3|||
25211533|NCT02218008|50479616|FG005|Stage 2 (S2)|Adverse Event|3|||
25211534|NCT02218008|50479611|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
25211535|NCT02218008|50479612|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
25211536|NCT02218008|50479613|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
25211537|NCT02218008|50479614|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
25211538|NCT02218008|50479615|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
25211539|NCT02218008|50479616|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
25211540|NCT02218008|50479611|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
25211541|NCT02218008|50479612|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
25211542|NCT02218008|50479613|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
25211543|NCT02218008|50479614|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
25211544|NCT02218008|50479615|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
25211545|NCT02218008|50479616|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
25211546|NCT02218008|50479611|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
25211547|NCT02218008|50479612|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
25211548|NCT02218008|50479613|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
25211549|NCT02218008|50479614|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
25211550|NCT02218008|50479615|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
25211551|NCT02218008|50479616|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
25211552|NCT02218008|50479611|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
25211553|NCT02218008|50479612|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
25316464|NCT00891774|50631851|FG000|Overall Study|Withdrawal by Subject|2|||
25316465|NCT00891774|50631851|FG000|Overall Study|Protocol Violation|4|||
25211554|NCT02218008|50479613|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
25211555|NCT02218008|50479614|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
25211556|NCT02218008|50479615|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
25211557|NCT02218008|50479616|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
25211558|NCT01632150|50479713|FG000|Overall Study|Disease progression|27|||
25211559|NCT01632150|50479713|FG000|Overall Study|Study drug toxicity|1|||
25211560|NCT01632150|50479713|FG000|Overall Study|Unrelated adverse event|7|||
25211561|NCT01632150|50479713|FG000|Overall Study|Withdrawal by Subject|2|||
25211562|NCT01632150|50479713|FG000|Overall Study|Patient underwent autologous transplant|1|||
25211563|NCT01632150|50479713|FG000|Overall Study|Moved to compassionate program|2|||
25211564|NCT02185014|50479738|FG000|Overall Study|Adverse Event|18|||
25211565|NCT02185014|50479738|FG000|Overall Study|Withdrew Consent|8|||
25211566|NCT02185014|50479738|FG000|Overall Study|Lost to Follow-up|4|||
25211567|NCT02185014|50479738|FG000|Overall Study|Lack of Efficacy|14|||
25211568|NCT02185014|50479738|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
25211569|NCT02185014|50479738|FG000|Overall Study|Subject Noncompliance|1|||
25211570|NCT02185014|50479738|FG000|Overall Study|Other|4|||
25211571|NCT02184156|50479788|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
25211572|NCT02184156|50479789|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
25211573|NCT02184156|50479788|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
25211574|NCT02184156|50479789|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
25211575|NCT02158884|50479812|FG000|Baseline Assessment|Missed performance assessment|3|||
25211576|NCT02158884|50479812|FG000|Baseline Assessment|Missed SMFA|1|||
25211577|NCT02158884|50479812|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
25211578|NCT02158884|50479812|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
25211579|NCT02158884|50479812|FG000|6 Month Assessment|Missed SMFA|20|||
25211580|NCT02158884|50479812|FG000|12 Month Assessment|Missed SMFA|17|||
25211581|NCT02158806|50479855|FG000|Overall Study|Death|2|||
25211582|NCT02158806|50479856|FG001|Overall Study|Death|0|||
25211583|NCT02158806|50479855|FG000|Overall Study|Withdrawal by Subject|2|||
25211584|NCT02158806|50479856|FG001|Overall Study|Withdrawal by Subject|0|||
25211585|NCT02158806|50479855|FG000|Overall Study|Lost to Follow-up|0|||
25211586|NCT02158806|50479856|FG001|Overall Study|Lost to Follow-up|3|||
25211587|NCT02158806|50479855|FG000|Overall Study|Moved out of area|0|||
25316466|NCT05421754|50631855|FG000|Overall Study|Technical issue with sensor|1|||
25316467|NCT04913675|50631871|FG000|Overall Study|Death|0|||
25316468|NCT04913675|50631872|FG001|Overall Study|Death|2|||
25211588|NCT02158806|50479856|FG001|Overall Study|Moved out of area|1|||
25211589|NCT02158806|50479855|FG000|Overall Study|Transferred to palliative care|0|||
25211590|NCT02158806|50479856|FG001|Overall Study|Transferred to palliative care|1|||
25211591|NCT02158728|50479887|FG000|Overall Study|no procedure according to CIP done|3|||
25211592|NCT02158728|50479887|FG000|Overall Study|no qualified dataset|24|||
25211593|NCT02157948|50479932|FG000|Overall Study|Withdrawal by Subject|4|||
25211594|NCT02157948|50479933|FG001|Overall Study|Withdrawal by Subject|5|||
25211595|NCT02157948|50479932|FG000|Overall Study|Lost to Follow-up|3|||
25211596|NCT02157948|50479933|FG001|Overall Study|Lost to Follow-up|2|||
25211597|NCT02157948|50479932|FG000|Overall Study|Protocol Specified Criteria|2|||
25211598|NCT02157948|50479933|FG001|Overall Study|Protocol Specified Criteria|1|||
25211599|NCT02157948|50479932|FG000|Overall Study|Decision by Sponsor|0|||
25211600|NCT02157948|50479933|FG001|Overall Study|Decision by Sponsor|1|||
25211601|NCT02182830|50479974|FG000|Overall Study|Not Treated|1|||
25211602|NCT02182830|50479975|FG001|Overall Study|Not Treated|1|||
25211603|NCT02182830|50479974|FG000|Overall Study|Trial stopped, reason missing|3|||
25211604|NCT02182830|50479975|FG001|Overall Study|Trial stopped, reason missing|3|||
25211605|NCT02182830|50479974|FG000|Overall Study|Consent withdrawn|8|||
25211606|NCT02182830|50479975|FG001|Overall Study|Consent withdrawn|8|||
25211607|NCT02182830|50479974|FG000|Overall Study|Lost to Follow-up|3|||
25211608|NCT02182830|50479975|FG001|Overall Study|Lost to Follow-up|3|||
25211609|NCT02182440|50480549|FG000|Overall Study|Adverse Event|0|||
25211610|NCT02182440|50480550|FG001|Overall Study|Adverse Event|1|||
25211611|NCT02182440|50480551|FG002|Overall Study|Adverse Event|0|||
25211612|NCT02182440|50480552|FG003|Overall Study|Adverse Event|0|||
25211613|NCT02182440|50480549|FG000|Overall Study|Death|31|||
25211614|NCT02182440|50480550|FG001|Overall Study|Death|8|||
25211615|NCT02182440|50480551|FG002|Overall Study|Death|5|||
25211616|NCT02182440|50480552|FG003|Overall Study|Death|16|||
25211617|NCT02182440|50480549|FG000|Overall Study|Protocol Violation|0|||
25211618|NCT02182440|50480550|FG001|Overall Study|Protocol Violation|1|||
25211619|NCT02182440|50480551|FG002|Overall Study|Protocol Violation|0|||
25211620|NCT02182440|50480552|FG003|Overall Study|Protocol Violation|0|||
25211621|NCT02182440|50480549|FG000|Overall Study|Physician Decision|1|||
25211622|NCT02182440|50480550|FG001|Overall Study|Physician Decision|0|||
25211623|NCT02182440|50480551|FG002|Overall Study|Physician Decision|0|||
25211624|NCT02182440|50480552|FG003|Overall Study|Physician Decision|0|||
25211625|NCT02182440|50480549|FG000|Overall Study|Withdrawal by Subject|1|||
25211626|NCT02182440|50480550|FG001|Overall Study|Withdrawal by Subject|1|||
25211627|NCT02182440|50480551|FG002|Overall Study|Withdrawal by Subject|3|||
25211628|NCT02182440|50480552|FG003|Overall Study|Withdrawal by Subject|4|||
25211629|NCT02182440|50480549|FG000|Overall Study|different, e.g adm other hospital|12|||
25211630|NCT02182440|50480550|FG001|Overall Study|different, e.g adm other hospital|3|||
25211631|NCT02182440|50480551|FG002|Overall Study|different, e.g adm other hospital|3|||
25211632|NCT02182440|50480552|FG003|Overall Study|different, e.g adm other hospital|10|||
25211633|NCT02181816|50480594|FG000|Overall Study|Case Report Forms Uncollected|38|||
25211634|NCT02181816|50480594|FG000|Overall Study|Protocol Deviation|21|||
25211635|NCT02156466|50480750|FG000|Overall Study|Adverse Event|0|||
25211636|NCT02156466|50480751|FG001|Overall Study|Adverse Event|0|||
25211637|NCT02156466|50480752|FG002|Overall Study|Adverse Event|1|||
25211638|NCT02156466|50480753|FG003|Overall Study|Adverse Event|1|||
25211639|NCT02156466|50480754|FG004|Overall Study|Adverse Event|0|||
25211640|NCT02156466|50480750|FG000|Overall Study|Quantiferon Positivity|0|||
25211641|NCT02156466|50480751|FG001|Overall Study|Quantiferon Positivity|0|||
25211642|NCT02156466|50480752|FG002|Overall Study|Quantiferon Positivity|0|||
25211643|NCT02156466|50480753|FG003|Overall Study|Quantiferon Positivity|1|||
25211644|NCT02156466|50480754|FG004|Overall Study|Quantiferon Positivity|0|||
25211645|NCT02216526|50480793|FG000|Overall Study|Adverse Event|1|||
25211646|NCT02216526|50480794|FG001|Overall Study|Adverse Event|1|||
25211647|NCT02216526|50480795|FG002|Overall Study|Adverse Event|0|||
25211648|NCT02216526|50480793|FG000|Overall Study|Death|0|||
25211649|NCT02216526|50480794|FG001|Overall Study|Death|1|||
25211650|NCT02216526|50480795|FG002|Overall Study|Death|3|||
25211651|NCT02216526|50480793|FG000|Overall Study|Protocol Violation|2|||
25211652|NCT02216526|50480794|FG001|Overall Study|Protocol Violation|0|||
25211653|NCT02216526|50480795|FG002|Overall Study|Protocol Violation|2|||
25211654|NCT02216526|50480793|FG000|Overall Study|Hospitalization|2|||
25211655|NCT02216526|50480794|FG001|Overall Study|Hospitalization|1|||
25211656|NCT02216526|50480795|FG002|Overall Study|Hospitalization|3|||
25211657|NCT02216214|50480835|FG000|Overall Study|Randomized Never Received Study Drug|1|||
25211658|NCT02216214|50480836|FG001|Overall Study|Randomized Never Received Study Drug|0|||
25211659|NCT02216214|50480835|FG000|Overall Study|Adverse Event|10|||
25211660|NCT02216214|50480836|FG001|Overall Study|Adverse Event|8|||
25211661|NCT02216214|50480835|FG000|Overall Study|Lack of Efficacy|2|||
25211662|NCT02216214|50480836|FG001|Overall Study|Lack of Efficacy|2|||
25211663|NCT02216214|50480835|FG000|Overall Study|Lost to Follow-up|3|||
25211664|NCT02216214|50480836|FG001|Overall Study|Lost to Follow-up|2|||
25211665|NCT02216214|50480835|FG000|Overall Study|Protocol Violation|4|||
25211666|NCT02216214|50480836|FG001|Overall Study|Protocol Violation|2|||
25211667|NCT02216214|50480835|FG000|Overall Study|Withdrawal by Subject|22|||
25211668|NCT02216214|50480836|FG001|Overall Study|Withdrawal by Subject|20|||
25211669|NCT02216214|50480835|FG000|Overall Study|Study Terminated By Sponsor|0|||
25211670|NCT02216214|50480836|FG001|Overall Study|Study Terminated By Sponsor|1|||
25211671|NCT02216214|50480835|FG000|Overall Study|Miscellaneous|1|||
25211672|NCT02216214|50480836|FG001|Overall Study|Miscellaneous|1|||
25211673|NCT02214186|50480867|FG000|Overall Study|Lost to Follow-up|1|||
25211674|NCT02214186|50480868|FG001|Overall Study|Lost to Follow-up|1|||
25211675|NCT02214186|50480867|FG000|Overall Study|Protocol Violation|1|||
25211676|NCT02214186|50480868|FG001|Overall Study|Protocol Violation|1|||
25211677|NCT02181504|50480924|FG000|Overall Study|Adverse Event|1|||
25211678|NCT02181504|50480925|FG001|Overall Study|Adverse Event|1|||
25211679|NCT02181504|50480926|FG002|Overall Study|Adverse Event|1|||
25211680|NCT02179398|50480956|FG000|Overall Study|Lack of obligatory data|3|||
25211681|NCT02179398|50480957|FG001|Overall Study|Lack of obligatory data|3|||
25211682|NCT02179398|50480956|FG000|Overall Study|Lost to Follow-up|0|||
25211683|NCT02179398|50480957|FG001|Overall Study|Lost to Follow-up|1|||
25211684|NCT02156076|50480971|FG000|Treatment Period|no longer meets study criteria|0|||
25211685|NCT02156076|50480972|FG001|Treatment Period|no longer meets study criteria|0|||
25211686|NCT02156076|50480973|FG002|Treatment Period|no longer meets study criteria|1|||
25211687|NCT02156076|50480974|FG003|Treatment Period|no longer meets study criteria|0|||
25211688|NCT02156076|50480971|FG000|Treatment Period|Poor/non-compliance|0|||
25211689|NCT02156076|50480972|FG001|Treatment Period|Poor/non-compliance|1|||
25211690|NCT02156076|50480973|FG002|Treatment Period|Poor/non-compliance|0|||
25211691|NCT02156076|50480974|FG003|Treatment Period|Poor/non-compliance|0|||
25211692|NCT02156076|50480971|FG000|Treatment Period|Lost to Follow-up|0|||
25211693|NCT02156076|50480972|FG001|Treatment Period|Lost to Follow-up|0|||
25211694|NCT02156076|50480973|FG002|Treatment Period|Lost to Follow-up|0|||
25211695|NCT02156076|50480974|FG003|Treatment Period|Lost to Follow-up|1|||
25211696|NCT02156076|50480971|FG000|Treatment Period|Withdrawal by Subject|0|||
25211697|NCT02156076|50480972|FG001|Treatment Period|Withdrawal by Subject|0|||
25211698|NCT02156076|50480973|FG002|Treatment Period|Withdrawal by Subject|1|||
25211699|NCT02156076|50480974|FG003|Treatment Period|Withdrawal by Subject|0|||
25211700|NCT02156076|50480971|FG000|Treatment Period|Subject request to discontinue treatment|0|||
25211701|NCT02156076|50480972|FG001|Treatment Period|Subject request to discontinue treatment|1|||
25211702|NCT02156076|50480973|FG002|Treatment Period|Subject request to discontinue treatment|0|||
25211703|NCT02156076|50480974|FG003|Treatment Period|Subject request to discontinue treatment|0|||
25211704|NCT02156076|50480971|FG000|Treatment Period|Adverse Event|0|||
25211705|NCT02156076|50480972|FG001|Treatment Period|Adverse Event|0|||
25211706|NCT02156076|50480973|FG002|Treatment Period|Adverse Event|0|||
25211707|NCT02156076|50480974|FG003|Treatment Period|Adverse Event|1|||
25211708|NCT02156076|50480971|FG000|Follow-up Period|Withdrawal by Subject|1|||
25211709|NCT02156076|50480972|FG001|Follow-up Period|Withdrawal by Subject|0|||
25211710|NCT02156076|50480973|FG002|Follow-up Period|Withdrawal by Subject|0|||
25211711|NCT02156076|50480974|FG003|Follow-up Period|Withdrawal by Subject|0|||
25211712|NCT02213094|50480986|FG000|Overall Study|Adverse Event|1|||
25211713|NCT02213094|50480987|FG001|Overall Study|Adverse Event|0|||
25211714|NCT02155608|50480995|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
25211715|NCT02155608|50480996|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
25211716|NCT02155608|50480995|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
25211717|NCT02155608|50480996|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
25211718|NCT01629966|50481011|FG000|Overall Study|Pregnancy|0|||
25211719|NCT01629966|50481012|FG001|Overall Study|Pregnancy|1|||
25211720|NCT01629966|50481013|FG002|Overall Study|Pregnancy|0|||
25211721|NCT01629966|50481011|FG000|Overall Study|Lost to Follow-up|10|||
25211722|NCT01629966|50481012|FG001|Overall Study|Lost to Follow-up|13|||
25211723|NCT01629966|50481013|FG002|Overall Study|Lost to Follow-up|9|||
25211724|NCT01629966|50481011|FG000|Overall Study|Withdrawal by Subject|8|||
25211725|NCT01629966|50481012|FG001|Overall Study|Withdrawal by Subject|9|||
25211726|NCT01629966|50481013|FG002|Overall Study|Withdrawal by Subject|16|||
25211727|NCT01629966|50481011|FG000|Overall Study|Protocol Violation|7|||
25211728|NCT01629966|50481012|FG001|Overall Study|Protocol Violation|9|||
25211729|NCT01629966|50481013|FG002|Overall Study|Protocol Violation|7|||
25211730|NCT01629966|50481011|FG000|Overall Study|Lack of Efficacy|5|||
25211731|NCT01629966|50481012|FG001|Overall Study|Lack of Efficacy|2|||
25211732|NCT01629966|50481013|FG002|Overall Study|Lack of Efficacy|4|||
25211733|NCT01629966|50481011|FG000|Overall Study|Adverse Event|11|||
25211734|NCT01629966|50481012|FG001|Overall Study|Adverse Event|18|||
25211735|NCT01629966|50481013|FG002|Overall Study|Adverse Event|30|||
25211736|NCT02177838|50481053|FG000|Overall Study|Withdrawal by Subject|1|||
25211737|NCT02177838|50481053|FG000|Overall Study|Physician Decision|1|||
25211738|NCT02177838|50481053|FG000|Overall Study|Death|1|||
25211739|NCT02177136|50481150|FG000|DB Phase|Withdrawal by Subject|2|||
25211740|NCT02177136|50481151|FG001|DB Phase|Withdrawal by Subject|0|||
25211741|NCT02177136|50481152|FG002|DB Phase|Withdrawal by Subject|0|||
25211742|NCT02177136|50481153|FG003|DB Phase|Withdrawal by Subject|0|||
25211743|NCT02177136|50481150|FG000|DB Phase|Discontinued Due to Pruritus|1|||
25211744|NCT02177136|50481151|FG001|DB Phase|Discontinued Due to Pruritus|3|||
25211745|NCT02177136|50481152|FG002|DB Phase|Discontinued Due to Pruritus|0|||
25211746|NCT02177136|50481153|FG003|DB Phase|Discontinued Due to Pruritus|0|||
25211747|NCT02177136|50481150|FG000|DB Phase|Adverse Event|3|||
25211748|NCT02177136|50481151|FG001|DB Phase|Adverse Event|2|||
25211749|NCT02177136|50481152|FG002|DB Phase|Adverse Event|3|||
25211750|NCT02177136|50481153|FG003|DB Phase|Adverse Event|0|||
25211751|NCT02177136|50481150|FG000|DB Phase|Protocol Violation|0|||
25211752|NCT02177136|50481151|FG001|DB Phase|Protocol Violation|0|||
25211753|NCT02177136|50481152|FG002|DB Phase|Protocol Violation|1|||
25211754|NCT02177136|50481153|FG003|DB Phase|Protocol Violation|0|||
25211755|NCT02177136|50481150|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
25211756|NCT02177136|50481151|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
25211757|NCT02177136|50481152|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
25211758|NCT02177136|50481153|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
25211759|NCT02177136|50481150|FG000|LTSE Phase|Withdrawal by Subject|0|||
25211760|NCT02177136|50481151|FG001|LTSE Phase|Withdrawal by Subject|0|||
25211761|NCT02177136|50481152|FG002|LTSE Phase|Withdrawal by Subject|0|||
25211762|NCT02177136|50481153|FG003|LTSE Phase|Withdrawal by Subject|6|||
25211763|NCT02177136|50481150|FG000|LTSE Phase|Adverse Event|0|||
25211764|NCT02177136|50481151|FG001|LTSE Phase|Adverse Event|0|||
25211765|NCT02177136|50481152|FG002|LTSE Phase|Adverse Event|0|||
25211766|NCT02177136|50481153|FG003|LTSE Phase|Adverse Event|10|||
25211767|NCT02177136|50481150|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
25211768|NCT02177136|50481151|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
25211769|NCT02177136|50481152|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
25211770|NCT02177136|50481153|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
25211771|NCT02177136|50481150|FG000|LTSE Phase|Physician Decision|0|||
25211772|NCT02177136|50481151|FG001|LTSE Phase|Physician Decision|0|||
25211773|NCT02177136|50481152|FG002|LTSE Phase|Physician Decision|0|||
25211774|NCT02177136|50481153|FG003|LTSE Phase|Physician Decision|2|||
25211775|NCT02177136|50481150|FG000|LTSE Phase|Lost to Follow-up|0|||
25211776|NCT02177136|50481151|FG001|LTSE Phase|Lost to Follow-up|0|||
25211777|NCT02177136|50481152|FG002|LTSE Phase|Lost to Follow-up|0|||
25211778|NCT02177136|50481153|FG003|LTSE Phase|Lost to Follow-up|1|||
25211779|NCT02177136|50481150|FG000|LTSE Phase|Participant Moved|0|||
25211780|NCT02177136|50481151|FG001|LTSE Phase|Participant Moved|0|||
25211781|NCT02177136|50481152|FG002|LTSE Phase|Participant Moved|0|||
25211782|NCT02177136|50481153|FG003|LTSE Phase|Participant Moved|1|||
25211783|NCT02176356|50481181|FG000|Overall Study|Screen Failure|14|||
25211784|NCT02176356|50481181|FG000|Overall Study|Lost to Follow-up|4|||
25211785|NCT02176356|50481181|FG000|Overall Study|Personal Reasons|3|||
25211786|NCT02176356|50481181|FG000|Overall Study|Other Miscellaneous Reasons|2|||
25211787|NCT02210208|50481191|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
25211788|NCT02210208|50481191|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
25211789|NCT02210208|50481191|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
25211790|NCT02209506|50481211|FG000|Overall Study|Withdrawal by Subject|0|||
25211791|NCT02209506|50481212|FG001|Overall Study|Withdrawal by Subject|0|||
25211792|NCT02209506|50481213|FG002|Overall Study|Withdrawal by Subject|0|||
25211793|NCT02209506|50481214|FG003|Overall Study|Withdrawal by Subject|0|||
25211794|NCT02209506|50481215|FG004|Overall Study|Withdrawal by Subject|1|||
25211795|NCT02153736|50481232|FG000|Overall Study|Lost to Follow-up|1|||
25211796|NCT02153736|50481233|FG001|Overall Study|Lost to Follow-up|0|||
25211797|NCT02153736|50481232|FG000|Overall Study|Medical status change made ineligible|1|||
25211798|NCT02153736|50481233|FG001|Overall Study|Medical status change made ineligible|0|||
25211799|NCT02153736|50481232|FG000|Overall Study|Death|0|||
25211800|NCT02153736|50481233|FG001|Overall Study|Death|1|||
25211801|NCT02153736|50481232|FG000|Overall Study|Withdrawal by Subject|0|||
25211802|NCT02153736|50481233|FG001|Overall Study|Withdrawal by Subject|1|||
25211803|NCT02175966|50481241|FG000|Follow-up Period|Lack of Efficacy|10|||
25211804|NCT02175966|50481242|FG001|Follow-up Period|Lack of Efficacy|6|||
25211805|NCT02153346|50481248|FG000|Overall Study|Lost to Follow-up|11|||
25211806|NCT02174562|50481255|FG000|Overall Study|Withdrawal by Subject|7|||
25211807|NCT02174562|50481256|FG001|Overall Study|Withdrawal by Subject|2|||
25211808|NCT02174562|50481255|FG000|Overall Study|Death|2|||
25211809|NCT02174562|50481256|FG001|Overall Study|Death|0|||
25211810|NCT02174562|50481255|FG000|Overall Study|Lost to Follow-up|0|||
25211811|NCT02174562|50481256|FG001|Overall Study|Lost to Follow-up|3|||
25211812|NCT02136576|50481265|FG000|Overall Study|Lost to Follow-up|2|||
25211813|NCT02136576|50481266|FG001|Overall Study|Lost to Follow-up|0|||
25211814|NCT02136576|50481267|FG002|Overall Study|Lost to Follow-up|0|||
25077211|NCT02463032|50185062|FG000|Overall Study|Death|8|||
25211815|NCT02153112|50481524|FG000|Overall Study|Adverse Event|0|||
25211816|NCT02153112|50481525|FG001|Overall Study|Adverse Event|0|||
25211817|NCT02153112|50481526|FG002|Overall Study|Adverse Event|1|||
25211818|NCT02153112|50481527|FG003|Overall Study|Adverse Event|0|||
25211819|NCT02153112|50481528|FG004|Overall Study|Adverse Event|0|||
25211820|NCT02153112|50481529|FG005|Overall Study|Adverse Event|0|||
25211821|NCT02153112|50481530|FG006|Overall Study|Adverse Event|0|||
25211822|NCT02153112|50481531|FG007|Overall Study|Adverse Event|0|||
25211823|NCT02153112|50481532|FG008|Overall Study|Adverse Event|0|||
25211824|NCT02153112|50481533|FG009|Overall Study|Adverse Event|0|||
25077212|NCT02463032|50185063|FG001|Overall Study|Death|8|||
25211825|NCT02153112|50481524|FG000|Overall Study|Lost to Follow-up|1|||
25211826|NCT02153112|50481525|FG001|Overall Study|Lost to Follow-up|1|||
25211827|NCT02153112|50481526|FG002|Overall Study|Lost to Follow-up|0|||
25211828|NCT02153112|50481527|FG003|Overall Study|Lost to Follow-up|0|||
25211829|NCT02153112|50481528|FG004|Overall Study|Lost to Follow-up|2|||
25211830|NCT02153112|50481529|FG005|Overall Study|Lost to Follow-up|1|||
25211831|NCT02153112|50481530|FG006|Overall Study|Lost to Follow-up|1|||
25211832|NCT02153112|50481531|FG007|Overall Study|Lost to Follow-up|0|||
25211833|NCT02153112|50481532|FG008|Overall Study|Lost to Follow-up|1|||
25211834|NCT02153112|50481533|FG009|Overall Study|Lost to Follow-up|1|||
25211835|NCT02153112|50481524|FG000|Overall Study|Withdrawal by Subject|3|||
25211836|NCT02153112|50481525|FG001|Overall Study|Withdrawal by Subject|1|||
25211837|NCT02153112|50481526|FG002|Overall Study|Withdrawal by Subject|2|||
25211838|NCT02153112|50481527|FG003|Overall Study|Withdrawal by Subject|2|||
25211839|NCT02153112|50481528|FG004|Overall Study|Withdrawal by Subject|1|||
25211840|NCT02153112|50481529|FG005|Overall Study|Withdrawal by Subject|1|||
25211841|NCT02153112|50481530|FG006|Overall Study|Withdrawal by Subject|7|||
25211842|NCT02153112|50481531|FG007|Overall Study|Withdrawal by Subject|2|||
25211843|NCT02153112|50481532|FG008|Overall Study|Withdrawal by Subject|13|||
25211844|NCT02153112|50481533|FG009|Overall Study|Withdrawal by Subject|12|||
25211845|NCT02153112|50481524|FG000|Overall Study|Reason not Specified|0|||
25211846|NCT02153112|50481525|FG001|Overall Study|Reason not Specified|0|||
25211847|NCT02153112|50481526|FG002|Overall Study|Reason not Specified|0|||
25211848|NCT02153112|50481527|FG003|Overall Study|Reason not Specified|0|||
25211849|NCT02153112|50481528|FG004|Overall Study|Reason not Specified|0|||
25211850|NCT02153112|50481529|FG005|Overall Study|Reason not Specified|0|||
25211851|NCT02153112|50481530|FG006|Overall Study|Reason not Specified|0|||
25211852|NCT02153112|50481531|FG007|Overall Study|Reason not Specified|0|||
25211853|NCT02153112|50481532|FG008|Overall Study|Reason not Specified|1|||
25211854|NCT02153112|50481533|FG009|Overall Study|Reason not Specified|1|||
25211855|NCT02133924|50481583|FG000|Overall Study|Death|38|||
25211856|NCT02133924|50481583|FG000|Overall Study|Physician Decision|1|||
25211857|NCT02133924|50481583|FG000|Overall Study|Withdrawal by Subject|3|||
25211858|NCT02173704|50481674|FG000|Overall Study|Adverse Event|1|||
25211859|NCT02173704|50481675|FG001|Overall Study|Adverse Event|0|||
25211860|NCT02173704|50481674|FG000|Overall Study|Lost to Follow-up|1|||
25211861|NCT02173704|50481675|FG001|Overall Study|Lost to Follow-up|0|||
25211862|NCT02173704|50481674|FG000|Overall Study|Other|1|||
25211863|NCT02173704|50481675|FG001|Overall Study|Other|0|||
25211864|NCT02173704|50481674|FG000|Overall Study|Protocol Violation|1|||
25211865|NCT02173704|50481675|FG001|Overall Study|Protocol Violation|0|||
25211866|NCT02173704|50481674|FG000|Overall Study|Withdrawal by Subject|9|||
25211867|NCT02173704|50481675|FG001|Overall Study|Withdrawal by Subject|4|||
25211868|NCT02173548|50481696|FG000|Overall Study|Lost to Follow-up|0|||
25211869|NCT02173548|50481697|FG001|Overall Study|Lost to Follow-up|2|||
25211870|NCT02173548|50481696|FG000|Overall Study|Withdrawal by Subject|1|||
25211871|NCT02173548|50481697|FG001|Overall Study|Withdrawal by Subject|0|||
25211872|NCT02173158|50481713|FG000|Efficacy Phase|Adverse Event|1|||
25211873|NCT02152566|50481735|FG000|Overall Study|Lost to Follow-up|1|||
25211874|NCT02152566|50481735|FG000|Overall Study|Withdrawal by Subject|2|||
25211875|NCT02171130|50481764|FG000|Overall Study|Death|1|||
25211876|NCT02171130|50481764|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
25211877|NCT02171130|50481764|FG000|Overall Study|Discontinued; Site Termination|5|||
25211878|NCT02171130|50481764|FG000|Overall Study|Withdrawal by Subject|3|||
25211879|NCT02171130|50481764|FG000|Overall Study|Physician Decision|1|||
25211880|NCT02171130|50481764|FG000|Overall Study|Lost to Follow-up|1|||
25211881|NCT02171130|50481764|FG000|Overall Study|Met Exclusion Criteria|1|||
25211882|NCT03603314|50487790|FG000|Overall Study|Lost to Follow-up|0|||
25211883|NCT03603314|50487791|FG001|Overall Study|Lost to Follow-up|3|||
25211884|NCT03603314|50487792|FG002|Overall Study|Lost to Follow-up|0|||
25211885|NCT03603314|50487790|FG000|Overall Study|Protocol Violation|0|||
25211886|NCT03603314|50487791|FG001|Overall Study|Protocol Violation|1|||
25211887|NCT03603314|50487792|FG002|Overall Study|Protocol Violation|0|||
25211888|NCT03603314|50487790|FG000|Overall Study|Adverse Event|2|||
25211889|NCT03603314|50487791|FG001|Overall Study|Adverse Event|0|||
25211890|NCT03603314|50487792|FG002|Overall Study|Adverse Event|0|||
25211891|NCT03603314|50487790|FG000|Overall Study|Physician Decision|1|||
25211892|NCT03603314|50487791|FG001|Overall Study|Physician Decision|1|||
25211893|NCT03603314|50487792|FG002|Overall Study|Physician Decision|0|||
25211894|NCT03603314|50487790|FG000|Overall Study|Withdrawal by Subject|4|||
25211895|NCT03603314|50487791|FG001|Overall Study|Withdrawal by Subject|5|||
25211896|NCT03603314|50487792|FG002|Overall Study|Withdrawal by Subject|3|||
25211897|NCT03603314|50487790|FG000|Overall Study|Other|0|||
25211898|NCT03603314|50487791|FG001|Overall Study|Other|1|||
25211899|NCT03603314|50487792|FG002|Overall Study|Other|0|||
25211900|NCT04302350|50487807|FG000|Overall Study|Physician Decision|1|||
25211901|NCT04302350|50487808|FG001|Overall Study|Physician Decision|1|||
25211902|NCT04302350|50487809|FG002|Overall Study|Physician Decision|2|||
25211903|NCT04302350|50487807|FG000|Overall Study|Lack of Efficacy|1|||
25211904|NCT04302350|50487808|FG001|Overall Study|Lack of Efficacy|1|||
25211905|NCT04302350|50487809|FG002|Overall Study|Lack of Efficacy|4|||
25211906|NCT04302350|50487807|FG000|Overall Study|Adverse Event|0|||
25211907|NCT04302350|50487808|FG001|Overall Study|Adverse Event|1|||
25211908|NCT04302350|50487809|FG002|Overall Study|Adverse Event|2|||
25211909|NCT02335424|50487831|FG000|Overall Study|Withdrawal by Subject|19|||
25211910|NCT02335424|50487831|FG000|Overall Study|Adverse Event|25|||
25211911|NCT02335424|50487831|FG000|Overall Study|Death|273|||
24976366|NCT00092547|50065232|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
24976367|NCT00092547|50065233|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
25077213|NCT02463032|50185062|FG000|Overall Study|Adverse Event|2|||
25077214|NCT02463032|50185063|FG001|Overall Study|Adverse Event|6|||
25077215|NCT02496884|50185073|FG000|Overall Study|Counted twice as enrolled|2|||
25077216|NCT02496884|50185074|FG001|Overall Study|Counted twice as enrolled|0|||
25077217|NCT02496884|50185075|FG002|Overall Study|Counted twice as enrolled|0|||
25077218|NCT02496884|50185076|FG003|Overall Study|Counted twice as enrolled|0|||
25077219|NCT02496884|50185073|FG000|Overall Study|Withdrawal by Subject|0|||
25077220|NCT02496884|50185074|FG001|Overall Study|Withdrawal by Subject|3|||
25077221|NCT02496884|50185075|FG002|Overall Study|Withdrawal by Subject|0|||
25077222|NCT02496884|50185076|FG003|Overall Study|Withdrawal by Subject|0|||
25077223|NCT02462876|50185086|FG000|Overall Study|Death|3|||
25077224|NCT02462876|50185086|FG000|Overall Study|Lost to Follow-up|7|||
25077225|NCT02462876|50185086|FG000|Overall Study|Surgical Bypass|9|||
25077226|NCT02462876|50185086|FG000|Overall Study|Amputation Above the Metatarsals|1|||
25077227|NCT02462876|50185086|FG000|Overall Study|36 months follow-up visit missed|1|||
25077228|NCT02462876|50185086|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
25077229|NCT02462876|50185086|FG000|Overall Study|Patient did not come back to the vascular department|1|||
25077230|NCT02462876|50185086|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
25077231|NCT02462876|50185086|FG000|Overall Study|Patient refused to come back|1|||
25077232|NCT02462876|50185086|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
25077233|NCT02462876|50185086|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
25077234|NCT03386721|50185105|FG000|Overall Study|Death|12|||
25077235|NCT03386721|50185106|FG001|Overall Study|Death|21|||
25077236|NCT03386721|50185107|FG002|Overall Study|Death|2|||
25077237|NCT03386721|50185108|FG003|Overall Study|Death|5|||
25077238|NCT03386721|50185109|FG004|Overall Study|Death|1|||
25077239|NCT03386721|50185110|FG005|Overall Study|Death|12|||
25077240|NCT03386721|50185111|FG006|Overall Study|Death|1|||
25077241|NCT03386721|50185112|FG007|Overall Study|Death|1|||
25077242|NCT03386721|50185113|FG008|Overall Study|Death|12|||
25077243|NCT03386721|50185114|FG009|Overall Study|Death|20|||
25077244|NCT03386721|50185115|FG010|Overall Study|Death|21|||
25077245|NCT03386721|50185116|FG011|Overall Study|Death|21|||
25077246|NCT03386721|50185117|FG012|Overall Study|Death|14|||
25077247|NCT03386721|50185118|FG013|Overall Study|Death|2|||
25077248|NCT03386721|50185119|FG014|Overall Study|Death|1|||
25077249|NCT03386721|50185105|FG000|Overall Study|Lost to Follow-up|1|||
25077250|NCT03386721|50185106|FG001|Overall Study|Lost to Follow-up|3|||
25077251|NCT03386721|50185107|FG002|Overall Study|Lost to Follow-up|0|||
25077252|NCT03386721|50185108|FG003|Overall Study|Lost to Follow-up|0|||
25077253|NCT03386721|50185109|FG004|Overall Study|Lost to Follow-up|0|||
25077254|NCT03386721|50185110|FG005|Overall Study|Lost to Follow-up|2|||
25077255|NCT03386721|50185111|FG006|Overall Study|Lost to Follow-up|1|||
25077256|NCT03386721|50185112|FG007|Overall Study|Lost to Follow-up|0|||
25077257|NCT03386721|50185113|FG008|Overall Study|Lost to Follow-up|1|||
25077258|NCT03386721|50185114|FG009|Overall Study|Lost to Follow-up|2|||
25077259|NCT03386721|50185115|FG010|Overall Study|Lost to Follow-up|1|||
25077260|NCT03386721|50185116|FG011|Overall Study|Lost to Follow-up|0|||
25077261|NCT03386721|50185117|FG012|Overall Study|Lost to Follow-up|0|||
25211912|NCT02335424|50487831|FG000|Overall Study|Lost to Follow-up|3|||
25211913|NCT02335424|50487831|FG000|Overall Study|Physician Decision|13|||
25316469|NCT04913675|50631873|FG002|Overall Study|Death|2|||
24976368|NCT00092547|50065234|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
24976369|NCT00092547|50065232|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
24976370|NCT00092547|50065233|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
24976371|NCT00092547|50065234|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
24976372|NCT00092547|50065232|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
24976373|NCT00092547|50065233|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
24976374|NCT00092547|50065234|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
25077262|NCT03386721|50185118|FG013|Overall Study|Lost to Follow-up|0|||
25077263|NCT03386721|50185119|FG014|Overall Study|Lost to Follow-up|0|||
25077264|NCT03386721|50185105|FG000|Overall Study|Reason not specified|3|||
25077265|NCT03386721|50185106|FG001|Overall Study|Reason not specified|0|||
25077266|NCT03386721|50185107|FG002|Overall Study|Reason not specified|0|||
25077267|NCT03386721|50185108|FG003|Overall Study|Reason not specified|0|||
25077268|NCT03386721|50185109|FG004|Overall Study|Reason not specified|0|||
25077269|NCT03386721|50185110|FG005|Overall Study|Reason not specified|3|||
25077270|NCT03386721|50185111|FG006|Overall Study|Reason not specified|1|||
25077271|NCT03386721|50185112|FG007|Overall Study|Reason not specified|0|||
25077272|NCT03386721|50185113|FG008|Overall Study|Reason not specified|0|||
25077273|NCT03386721|50185114|FG009|Overall Study|Reason not specified|1|||
25077274|NCT03386721|50185115|FG010|Overall Study|Reason not specified|2|||
25077275|NCT03386721|50185116|FG011|Overall Study|Reason not specified|6|||
25077276|NCT03386721|50185117|FG012|Overall Study|Reason not specified|1|||
25077277|NCT03386721|50185118|FG013|Overall Study|Reason not specified|0|||
25077278|NCT03386721|50185119|FG014|Overall Study|Reason not specified|0|||
25077279|NCT03386721|50185105|FG000|Overall Study|Progressive Disease|0|||
25077280|NCT03386721|50185106|FG001|Overall Study|Progressive Disease|0|||
25077281|NCT03386721|50185107|FG002|Overall Study|Progressive Disease|1|||
25077282|NCT03386721|50185108|FG003|Overall Study|Progressive Disease|0|||
25077283|NCT03386721|50185109|FG004|Overall Study|Progressive Disease|0|||
25077284|NCT03386721|50185110|FG005|Overall Study|Progressive Disease|1|||
25077285|NCT03386721|50185111|FG006|Overall Study|Progressive Disease|0|||
25077286|NCT03386721|50185112|FG007|Overall Study|Progressive Disease|0|||
25077287|NCT03386721|50185113|FG008|Overall Study|Progressive Disease|2|||
25077288|NCT03386721|50185114|FG009|Overall Study|Progressive Disease|1|||
25077289|NCT03386721|50185115|FG010|Overall Study|Progressive Disease|1|||
25077290|NCT03386721|50185116|FG011|Overall Study|Progressive Disease|0|||
25077291|NCT03386721|50185117|FG012|Overall Study|Progressive Disease|1|||
25077292|NCT03386721|50185118|FG013|Overall Study|Progressive Disease|0|||
25077293|NCT03386721|50185119|FG014|Overall Study|Progressive Disease|0|||
25077294|NCT03386721|50185105|FG000|Overall Study|Site Terminated by Sponsor|5|||
25077295|NCT03386721|50185106|FG001|Overall Study|Site Terminated by Sponsor|5|||
25077296|NCT03386721|50185107|FG002|Overall Study|Site Terminated by Sponsor|0|||
25077297|NCT03386721|50185108|FG003|Overall Study|Site Terminated by Sponsor|0|||
25077298|NCT03386721|50185109|FG004|Overall Study|Site Terminated by Sponsor|1|||
25077299|NCT03386721|50185110|FG005|Overall Study|Site Terminated by Sponsor|3|||
25077300|NCT03386721|50185111|FG006|Overall Study|Site Terminated by Sponsor|0|||
25077301|NCT03386721|50185112|FG007|Overall Study|Site Terminated by Sponsor|1|||
25077302|NCT03386721|50185113|FG008|Overall Study|Site Terminated by Sponsor|4|||
25077303|NCT03386721|50185114|FG009|Overall Study|Site Terminated by Sponsor|5|||
25077304|NCT03386721|50185115|FG010|Overall Study|Site Terminated by Sponsor|3|||
25077305|NCT03386721|50185116|FG011|Overall Study|Site Terminated by Sponsor|11|||
25077306|NCT03386721|50185117|FG012|Overall Study|Site Terminated by Sponsor|6|||
25077307|NCT03386721|50185118|FG013|Overall Study|Site Terminated by Sponsor|0|||
25077308|NCT03386721|50185119|FG014|Overall Study|Site Terminated by Sponsor|0|||
25077309|NCT03386721|50185105|FG000|Overall Study|Symptomatic Deterioration|0|||
25077310|NCT03386721|50185106|FG001|Overall Study|Symptomatic Deterioration|0|||
25077311|NCT03386721|50185107|FG002|Overall Study|Symptomatic Deterioration|0|||
25077312|NCT03386721|50185108|FG003|Overall Study|Symptomatic Deterioration|0|||
25077313|NCT03386721|50185109|FG004|Overall Study|Symptomatic Deterioration|0|||
25077314|NCT03386721|50185110|FG005|Overall Study|Symptomatic Deterioration|0|||
25077315|NCT03386721|50185111|FG006|Overall Study|Symptomatic Deterioration|0|||
25077316|NCT03386721|50185112|FG007|Overall Study|Symptomatic Deterioration|0|||
25077317|NCT03386721|50185113|FG008|Overall Study|Symptomatic Deterioration|1|||
25077318|NCT03386721|50185114|FG009|Overall Study|Symptomatic Deterioration|0|||
25077319|NCT03386721|50185115|FG010|Overall Study|Symptomatic Deterioration|0|||
25077320|NCT03386721|50185116|FG011|Overall Study|Symptomatic Deterioration|1|||
25077321|NCT03386721|50185117|FG012|Overall Study|Symptomatic Deterioration|0|||
25077322|NCT03386721|50185118|FG013|Overall Study|Symptomatic Deterioration|0|||
25077323|NCT03386721|50185119|FG014|Overall Study|Symptomatic Deterioration|0|||
25077324|NCT03386721|50185105|FG000|Overall Study|Withdrawal by Subject|1|||
25077325|NCT03386721|50185106|FG001|Overall Study|Withdrawal by Subject|2|||
25077326|NCT03386721|50185107|FG002|Overall Study|Withdrawal by Subject|0|||
25077327|NCT03386721|50185108|FG003|Overall Study|Withdrawal by Subject|0|||
25077328|NCT03386721|50185109|FG004|Overall Study|Withdrawal by Subject|0|||
25077329|NCT03386721|50185110|FG005|Overall Study|Withdrawal by Subject|0|||
25077330|NCT03386721|50185111|FG006|Overall Study|Withdrawal by Subject|0|||
25077331|NCT03386721|50185112|FG007|Overall Study|Withdrawal by Subject|0|||
25077332|NCT03386721|50185113|FG008|Overall Study|Withdrawal by Subject|2|||
25077333|NCT03386721|50185114|FG009|Overall Study|Withdrawal by Subject|1|||
25077334|NCT03386721|50185115|FG010|Overall Study|Withdrawal by Subject|3|||
25077335|NCT03386721|50185116|FG011|Overall Study|Withdrawal by Subject|2|||
25077336|NCT03386721|50185117|FG012|Overall Study|Withdrawal by Subject|3|||
25077337|NCT03386721|50185118|FG013|Overall Study|Withdrawal by Subject|0|||
25077338|NCT03386721|50185119|FG014|Overall Study|Withdrawal by Subject|0|||
25077339|NCT02462720|50185151|FG000|Part 2|Withdrawal by Subject|1|||
25077340|NCT02462720|50185152|FG001|Part 2|Withdrawal by Subject|0|||
25077341|NCT02462720|50185151|FG000|Part 2|Protocol Violation|0|||
25077342|NCT02462720|50185152|FG001|Part 2|Protocol Violation|1|||
25316470|NCT04913675|50631871|FG000|Overall Study|Lost to Follow-up|12|||
25077343|NCT02246218|50185162|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
25077344|NCT02246218|50185163|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
25077345|NCT02246218|50185162|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
25077346|NCT02246218|50185163|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
25077347|NCT02246218|50185162|FG000|Overall Study|Adverse Event|1|||
25077348|NCT02246218|50185163|FG001|Overall Study|Adverse Event|1|||
25077349|NCT02246218|50185162|FG000|Overall Study|Lost to Follow-up|1|||
25077350|NCT02246218|50185163|FG001|Overall Study|Lost to Follow-up|0|||
25077351|NCT02244580|50185169|FG000|Overall Study|No cancer tissues available|241|||
25077352|NCT02244424|50185179|FG000|Overall Study|Lost to Follow-up|20|||
25077353|NCT02244424|50185180|FG001|Overall Study|Lost to Follow-up|10|||
25211914|NCT02335424|50487831|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
25211915|NCT02335424|50487831|FG000|Overall Study|Protocol Violation|1|||
25211916|NCT02335424|50487831|FG000|Overall Study|Screen failure|1|||
25211917|NCT03805412|50487838|FG000|Overall Study|Lost to Follow-up|0|||
25211918|NCT03805412|50487839|FG001|Overall Study|Lost to Follow-up|1|||
25077354|NCT00159783|50185189|FG000|Overall Study|Adverse Event|5|||
25077355|NCT00159783|50185190|FG001|Overall Study|Adverse Event|7|||
25077356|NCT00159783|50185191|FG002|Overall Study|Adverse Event|9|||
25211919|NCT04791319|50487859|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
25211920|NCT04791319|50487860|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
25211921|NCT04791319|50487861|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
25211922|NCT04791319|50487862|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
25211923|NCT04791319|50487863|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
25211924|NCT04791319|50487864|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
25211925|NCT04791319|50487865|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
25211926|NCT04791319|50487866|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
25211927|NCT04791319|50487867|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
25211928|NCT04791319|50487868|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
25211929|NCT04791319|50487869|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
25211930|NCT04791319|50487859|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
25211931|NCT04791319|50487860|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
25211932|NCT04791319|50487861|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
25211933|NCT04791319|50487862|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
25211934|NCT04791319|50487863|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
25211935|NCT04791319|50487864|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
25211936|NCT04791319|50487865|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
25211937|NCT04791319|50487866|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
25211938|NCT04791319|50487867|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
25211939|NCT04791319|50487868|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
25211940|NCT04791319|50487869|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
25211941|NCT04791319|50487859|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
25211942|NCT04791319|50487860|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
25211943|NCT04791319|50487861|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
25211944|NCT04791319|50487862|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
25211945|NCT04791319|50487863|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
25211946|NCT04791319|50487864|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
25211947|NCT04791319|50487865|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
25211948|NCT04791319|50487866|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
25211949|NCT04791319|50487867|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
25211950|NCT04791319|50487868|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
25211951|NCT04791319|50487869|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
25077357|NCT00159783|50185189|FG000|Overall Study|Lack of Efficacy|1|||
25211952|NCT04791319|50487859|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
25211953|NCT04791319|50487860|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
25211954|NCT04791319|50487861|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
25211955|NCT04791319|50487862|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
25211956|NCT04791319|50487863|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
25211957|NCT04791319|50487864|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
25211958|NCT04791319|50487865|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
25077358|NCT00159783|50185190|FG001|Overall Study|Lack of Efficacy|2|||
25077359|NCT00159783|50185191|FG002|Overall Study|Lack of Efficacy|3|||
25077360|NCT00159783|50185189|FG000|Overall Study|Withdrawal by Subject|7|||
25077361|NCT00159783|50185190|FG001|Overall Study|Withdrawal by Subject|11|||
25077362|NCT00159783|50185191|FG002|Overall Study|Withdrawal by Subject|12|||
25077363|NCT00159783|50185189|FG000|Overall Study|Lost to Follow-up|6|||
25077364|NCT00159783|50185190|FG001|Overall Study|Lost to Follow-up|5|||
25211959|NCT04791319|50487866|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
25211960|NCT04791319|50487867|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
25211961|NCT04791319|50487868|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
25211962|NCT04791319|50487869|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
25211963|NCT04791319|50487859|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
25211964|NCT04791319|50487860|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
25211965|NCT04791319|50487861|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
25211966|NCT04791319|50487862|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
25211967|NCT04791319|50487863|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
25211968|NCT04791319|50487864|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
25211969|NCT04791319|50487865|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
25211970|NCT04791319|50487866|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
25211971|NCT04791319|50487867|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
25211972|NCT04791319|50487868|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
25211973|NCT04791319|50487869|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
25211974|NCT04791319|50487859|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
25211975|NCT04791319|50487860|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
25211976|NCT04791319|50487861|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
25211977|NCT04791319|50487862|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
25211978|NCT04791319|50487863|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
25211979|NCT04791319|50487864|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
25211980|NCT04791319|50487865|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
25211981|NCT04791319|50487866|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
25211982|NCT04791319|50487867|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
25211983|NCT04791319|50487868|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
25211984|NCT04791319|50487869|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
25211985|NCT04791319|50487859|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
25211986|NCT04791319|50487860|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
25211987|NCT04791319|50487861|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
25211988|NCT04791319|50487862|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
25211989|NCT04791319|50487863|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
25211990|NCT04791319|50487864|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
25211991|NCT04791319|50487865|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
25211992|NCT04791319|50487866|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
25211993|NCT04791319|50487867|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
25211994|NCT04791319|50487868|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
25211995|NCT04791319|50487869|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
25211996|NCT04791319|50487859|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
25211997|NCT04791319|50487860|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
25211998|NCT04791319|50487861|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
25211999|NCT04791319|50487862|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
25212000|NCT04791319|50487863|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
25212001|NCT04791319|50487864|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
25212002|NCT04791319|50487865|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
25212003|NCT04791319|50487866|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
25212004|NCT04791319|50487867|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
25212005|NCT04791319|50487868|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
25212006|NCT04791319|50487869|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
25212007|NCT04791319|50487859|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
25212008|NCT04791319|50487860|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
25212009|NCT04791319|50487861|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
25212010|NCT04791319|50487862|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
25212011|NCT04791319|50487863|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
25212012|NCT04791319|50487864|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
25212013|NCT04791319|50487865|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
25212014|NCT04791319|50487866|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
25212015|NCT04791319|50487867|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
25212016|NCT04791319|50487868|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
25212017|NCT04791319|50487869|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
25212018|NCT03472495|50487926|FG000|Overall Study|Treatment no longer indicated|1|||
25212019|NCT03472495|50487927|FG001|Overall Study|Treatment no longer indicated|2|||
25212020|NCT03472495|50487926|FG000|Overall Study|Physician Decision|0|||
25212021|NCT03472495|50487927|FG001|Overall Study|Physician Decision|2|||
25212022|NCT03234907|50487935|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
25212023|NCT03234907|50487936|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
25212024|NCT03234907|50487937|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
25212025|NCT03234907|50487938|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
25212026|NCT03234907|50487939|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
25212027|NCT03234907|50487940|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
25212028|NCT03234907|50487935|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
25212029|NCT03234907|50487936|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
25212030|NCT03234907|50487937|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
25212031|NCT03234907|50487938|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
25212032|NCT03234907|50487939|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
25212033|NCT03234907|50487940|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
25212034|NCT03234907|50487935|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
25212035|NCT03234907|50487936|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
25212036|NCT03234907|50487937|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
25212037|NCT03234907|50487938|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
25212038|NCT03234907|50487939|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
25212039|NCT03234907|50487940|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
25212040|NCT03234907|50487935|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
25212041|NCT03234907|50487936|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
25212042|NCT03234907|50487937|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
25212043|NCT03234907|50487938|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
25212044|NCT03234907|50487939|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
25212045|NCT03234907|50487940|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
25212046|NCT03234907|50487935|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
25212047|NCT03234907|50487936|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
25212048|NCT03234907|50487937|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
25212049|NCT03234907|50487938|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
25212050|NCT03234907|50487939|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
25212051|NCT03234907|50487940|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
25212052|NCT03234907|50487935|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
25212053|NCT03234907|50487936|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
25212054|NCT03234907|50487937|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
25212055|NCT03234907|50487938|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
25212056|NCT03234907|50487939|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
25212057|NCT03234907|50487940|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
25212058|NCT03234907|50487935|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
25212059|NCT03234907|50487936|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
25212060|NCT03234907|50487937|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
25212061|NCT03234907|50487938|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
25212062|NCT03234907|50487939|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
25316471|NCT04913675|50631872|FG001|Overall Study|Lost to Follow-up|8|||
25316472|NCT04913675|50631873|FG002|Overall Study|Lost to Follow-up|4|||
25316473|NCT04913675|50631871|FG000|Overall Study|Physician Decision|0|||
25316474|NCT04913675|50631872|FG001|Overall Study|Physician Decision|1|||
25316475|NCT04913675|50631873|FG002|Overall Study|Physician Decision|1|||
25316476|NCT04913675|50631871|FG000|Overall Study|Withdrawal by Subject|25|||
25316477|NCT04913675|50631872|FG001|Overall Study|Withdrawal by Subject|33|||
25316478|NCT04913675|50631873|FG002|Overall Study|Withdrawal by Subject|12|||
25316479|NCT04644276|50631892|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
25316480|NCT04644276|50631893|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
25316481|NCT04644276|50631894|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
25316482|NCT03845296|50631923|FG000|Overall Study|On Treatment|2|||
25316483|NCT03845296|50631924|FG001|Overall Study|On Treatment|1|||
25316484|NCT03845296|50631923|FG000|Overall Study|Adverse Event|4|||
25316485|NCT03845296|50631924|FG001|Overall Study|Adverse Event|11|||
25316486|NCT03845296|50631923|FG000|Overall Study|Refusal unrelated to adverse event|0|||
25316487|NCT03845296|50631924|FG001|Overall Study|Refusal unrelated to adverse event|1|||
25316488|NCT03845296|50631923|FG000|Overall Study|Progression/relapse|14|||
25316489|NCT03845296|50631924|FG001|Overall Study|Progression/relapse|18|||
25316490|NCT03845296|50631923|FG000|Overall Study|Death|4|||
25316491|NCT03845296|50631924|FG001|Overall Study|Death|0|||
25316492|NCT03845296|50631923|FG000|Overall Study|Other - not protocol specified|1|||
25212063|NCT03234907|50487940|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
25212064|NCT03818581|50487954|FG000|Overall Study|Adverse Event|1|||
25212065|NCT03818581|50487955|FG001|Overall Study|Adverse Event|0|||
25212066|NCT03818581|50487956|FG002|Overall Study|Adverse Event|0|||
25212067|NCT03818581|50487957|FG003|Overall Study|Adverse Event|0|||
25212068|NCT03818581|50487958|FG004|Overall Study|Adverse Event|0|||
25212069|NCT03818581|50487954|FG000|Overall Study|Covid-19|2|||
25212070|NCT03818581|50487955|FG001|Overall Study|Covid-19|0|||
25212071|NCT03818581|50487956|FG002|Overall Study|Covid-19|0|||
25212072|NCT03818581|50487957|FG003|Overall Study|Covid-19|0|||
25212073|NCT03818581|50487958|FG004|Overall Study|Covid-19|1|||
25212074|NCT03818581|50487954|FG000|Overall Study|Withdrawal by Subject|0|||
25212075|NCT03818581|50487955|FG001|Overall Study|Withdrawal by Subject|0|||
25212076|NCT03818581|50487956|FG002|Overall Study|Withdrawal by Subject|0|||
25212077|NCT03818581|50487957|FG003|Overall Study|Withdrawal by Subject|0|||
25212078|NCT03818581|50487958|FG004|Overall Study|Withdrawal by Subject|1|||
25212079|NCT03818581|50487954|FG000|Overall Study|No longer met study criteria|1|||
25212080|NCT03818581|50487955|FG001|Overall Study|No longer met study criteria|0|||
25212081|NCT03818581|50487956|FG002|Overall Study|No longer met study criteria|0|||
25212082|NCT03818581|50487957|FG003|Overall Study|No longer met study criteria|0|||
25212083|NCT03818581|50487958|FG004|Overall Study|No longer met study criteria|2|||
25212084|NCT03736447|50487972|FG000|Overall Study|Adverse Event|5|||
25212085|NCT03736447|50487973|FG001|Overall Study|Adverse Event|1|||
25212086|NCT03736447|50487972|FG000|Overall Study|Withdrawal by Subject|5|||
25212087|NCT03736447|50487973|FG001|Overall Study|Withdrawal by Subject|1|||
25212088|NCT03736447|50487972|FG000|Overall Study|Lost to Follow-up|1|||
25212089|NCT03736447|50487973|FG001|Overall Study|Lost to Follow-up|0|||
25212090|NCT03736447|50487972|FG000|Overall Study|Physician Decision|1|||
25212091|NCT03736447|50487973|FG001|Overall Study|Physician Decision|0|||
25212092|NCT03736447|50487972|FG000|Overall Study|Continued commitment to study treatment|3|||
25212093|NCT03736447|50487973|FG001|Overall Study|Continued commitment to study treatment|0|||
25212094|NCT03736447|50487972|FG000|Overall Study|Taste aversion to study product|0|||
25212095|NCT03736447|50487973|FG001|Overall Study|Taste aversion to study product|1|||
25212096|NCT00788125|50487988|FG000|Overall Study|Death|6|||
25212097|NCT02132754|50488026|FG000|Overall Study|Adverse Event|0|||
25212098|NCT02132754|50488027|FG001|Overall Study|Adverse Event|0|||
25212099|NCT02132754|50488028|FG002|Overall Study|Adverse Event|0|||
25212100|NCT02132754|50488029|FG003|Overall Study|Adverse Event|0|||
25212101|NCT02132754|50488030|FG004|Overall Study|Adverse Event|0|||
25212102|NCT02132754|50488031|FG005|Overall Study|Adverse Event|0|||
25212103|NCT02132754|50488032|FG006|Overall Study|Adverse Event|0|||
25212104|NCT02132754|50488033|FG007|Overall Study|Adverse Event|0|||
25212105|NCT02132754|50488034|FG008|Overall Study|Adverse Event|0|||
25212106|NCT02132754|50488035|FG009|Overall Study|Adverse Event|0|||
25212107|NCT02132754|50488036|FG010|Overall Study|Adverse Event|0|||
25212108|NCT02132754|50488037|FG011|Overall Study|Adverse Event|0|||
25212109|NCT02132754|50488038|FG012|Overall Study|Adverse Event|0|||
25212110|NCT02132754|50488039|FG013|Overall Study|Adverse Event|0|||
25212111|NCT02132754|50488040|FG014|Overall Study|Adverse Event|0|||
25212112|NCT02132754|50488041|FG015|Overall Study|Adverse Event|0|||
25212113|NCT02132754|50488042|FG016|Overall Study|Adverse Event|0|||
25212114|NCT02132754|50488043|FG017|Overall Study|Adverse Event|1|||
25212115|NCT02132754|50488044|FG018|Overall Study|Adverse Event|0|||
25212116|NCT02132754|50488045|FG019|Overall Study|Adverse Event|0|||
25212117|NCT02132754|50488046|FG020|Overall Study|Adverse Event|0|||
25212118|NCT02132754|50488047|FG021|Overall Study|Adverse Event|0|||
25212119|NCT02132754|50488048|FG022|Overall Study|Adverse Event|0|||
25212120|NCT02132754|50488049|FG023|Overall Study|Adverse Event|0|||
25212121|NCT02132754|50488050|FG024|Overall Study|Adverse Event|0|||
25212122|NCT02132754|50488051|FG025|Overall Study|Adverse Event|1|||
25212123|NCT02132754|50488052|FG026|Overall Study|Adverse Event|1|||
25212124|NCT02132754|50488053|FG027|Overall Study|Adverse Event|0|||
25212125|NCT02132754|50488054|FG028|Overall Study|Adverse Event|0|||
25212126|NCT02132754|50488055|FG029|Overall Study|Adverse Event|0|||
25212127|NCT02132754|50488056|FG030|Overall Study|Adverse Event|1|||
25212128|NCT02132754|50488057|FG031|Overall Study|Adverse Event|0|||
25212129|NCT02132754|50488058|FG032|Overall Study|Adverse Event|1|||
25212130|NCT02132754|50488059|FG033|Overall Study|Adverse Event|1|||
25212131|NCT02132754|50488026|FG000|Overall Study|Clinical Progression|0|||
25212132|NCT02132754|50488027|FG001|Overall Study|Clinical Progression|0|||
25212133|NCT02132754|50488028|FG002|Overall Study|Clinical Progression|0|||
25212134|NCT02132754|50488029|FG003|Overall Study|Clinical Progression|0|||
25212135|NCT02132754|50488030|FG004|Overall Study|Clinical Progression|0|||
25212136|NCT02132754|50488031|FG005|Overall Study|Clinical Progression|0|||
25212137|NCT02132754|50488032|FG006|Overall Study|Clinical Progression|0|||
25212138|NCT02132754|50488033|FG007|Overall Study|Clinical Progression|0|||
25212139|NCT02132754|50488034|FG008|Overall Study|Clinical Progression|0|||
25212140|NCT02132754|50488035|FG009|Overall Study|Clinical Progression|1|||
25212141|NCT02132754|50488036|FG010|Overall Study|Clinical Progression|0|||
25212142|NCT02132754|50488037|FG011|Overall Study|Clinical Progression|0|||
25212143|NCT02132754|50488038|FG012|Overall Study|Clinical Progression|0|||
25212144|NCT02132754|50488039|FG013|Overall Study|Clinical Progression|0|||
25212145|NCT02132754|50488040|FG014|Overall Study|Clinical Progression|0|||
25212146|NCT02132754|50488041|FG015|Overall Study|Clinical Progression|0|||
25212147|NCT02132754|50488042|FG016|Overall Study|Clinical Progression|1|||
25212148|NCT02132754|50488043|FG017|Overall Study|Clinical Progression|1|||
25212149|NCT02132754|50488044|FG018|Overall Study|Clinical Progression|0|||
25212150|NCT02132754|50488045|FG019|Overall Study|Clinical Progression|1|||
25212151|NCT02132754|50488046|FG020|Overall Study|Clinical Progression|0|||
25212152|NCT02132754|50488047|FG021|Overall Study|Clinical Progression|0|||
25212153|NCT02132754|50488048|FG022|Overall Study|Clinical Progression|1|||
25212154|NCT02132754|50488049|FG023|Overall Study|Clinical Progression|0|||
25212155|NCT02132754|50488050|FG024|Overall Study|Clinical Progression|1|||
25212156|NCT02132754|50488051|FG025|Overall Study|Clinical Progression|1|||
25212157|NCT02132754|50488052|FG026|Overall Study|Clinical Progression|0|||
25212158|NCT02132754|50488053|FG027|Overall Study|Clinical Progression|1|||
25212159|NCT02132754|50488054|FG028|Overall Study|Clinical Progression|1|||
25212160|NCT02132754|50488055|FG029|Overall Study|Clinical Progression|0|||
25212161|NCT02132754|50488056|FG030|Overall Study|Clinical Progression|1|||
25212162|NCT02132754|50488057|FG031|Overall Study|Clinical Progression|0|||
25212163|NCT02132754|50488058|FG032|Overall Study|Clinical Progression|0|||
25212164|NCT02132754|50488059|FG033|Overall Study|Clinical Progression|2|||
25212165|NCT02132754|50488026|FG000|Overall Study|Death|0|||
25212166|NCT02132754|50488027|FG001|Overall Study|Death|0|||
25212167|NCT02132754|50488028|FG002|Overall Study|Death|0|||
25212168|NCT02132754|50488029|FG003|Overall Study|Death|0|||
25212169|NCT02132754|50488030|FG004|Overall Study|Death|0|||
25212170|NCT02132754|50488031|FG005|Overall Study|Death|0|||
25212171|NCT02132754|50488032|FG006|Overall Study|Death|0|||
25212172|NCT02132754|50488033|FG007|Overall Study|Death|0|||
25212173|NCT02132754|50488034|FG008|Overall Study|Death|0|||
25212174|NCT02132754|50488035|FG009|Overall Study|Death|0|||
25212175|NCT02132754|50488036|FG010|Overall Study|Death|0|||
25212176|NCT02132754|50488037|FG011|Overall Study|Death|0|||
25212177|NCT02132754|50488038|FG012|Overall Study|Death|0|||
25212178|NCT02132754|50488039|FG013|Overall Study|Death|0|||
25212179|NCT02132754|50488040|FG014|Overall Study|Death|0|||
25212180|NCT02132754|50488041|FG015|Overall Study|Death|1|||
25212181|NCT02132754|50488042|FG016|Overall Study|Death|0|||
25212182|NCT02132754|50488043|FG017|Overall Study|Death|0|||
25212183|NCT02132754|50488044|FG018|Overall Study|Death|0|||
25212184|NCT02132754|50488045|FG019|Overall Study|Death|1|||
25212185|NCT02132754|50488046|FG020|Overall Study|Death|0|||
25212186|NCT02132754|50488047|FG021|Overall Study|Death|1|||
25212187|NCT02132754|50488048|FG022|Overall Study|Death|0|||
25212188|NCT02132754|50488049|FG023|Overall Study|Death|0|||
25212189|NCT02132754|50488050|FG024|Overall Study|Death|0|||
25212190|NCT02132754|50488051|FG025|Overall Study|Death|0|||
25212191|NCT02132754|50488052|FG026|Overall Study|Death|1|||
25212192|NCT02132754|50488053|FG027|Overall Study|Death|0|||
25212193|NCT02132754|50488054|FG028|Overall Study|Death|0|||
25212194|NCT02132754|50488055|FG029|Overall Study|Death|0|||
25212195|NCT02132754|50488056|FG030|Overall Study|Death|0|||
25212196|NCT02132754|50488057|FG031|Overall Study|Death|0|||
25212197|NCT02132754|50488058|FG032|Overall Study|Death|0|||
25212198|NCT02132754|50488059|FG033|Overall Study|Death|2|||
25212199|NCT02132754|50488026|FG000|Overall Study|Excluded Medication|0|||
25212200|NCT02132754|50488027|FG001|Overall Study|Excluded Medication|0|||
25212201|NCT02132754|50488028|FG002|Overall Study|Excluded Medication|0|||
25212202|NCT02132754|50488029|FG003|Overall Study|Excluded Medication|0|||
25212203|NCT02132754|50488030|FG004|Overall Study|Excluded Medication|0|||
25212204|NCT02132754|50488031|FG005|Overall Study|Excluded Medication|0|||
25212205|NCT02132754|50488032|FG006|Overall Study|Excluded Medication|0|||
25212206|NCT02132754|50488033|FG007|Overall Study|Excluded Medication|0|||
25212207|NCT02132754|50488034|FG008|Overall Study|Excluded Medication|0|||
25212208|NCT02132754|50488035|FG009|Overall Study|Excluded Medication|0|||
25212209|NCT02132754|50488036|FG010|Overall Study|Excluded Medication|0|||
25212210|NCT02132754|50488037|FG011|Overall Study|Excluded Medication|0|||
25212211|NCT02132754|50488038|FG012|Overall Study|Excluded Medication|0|||
25212212|NCT02132754|50488039|FG013|Overall Study|Excluded Medication|0|||
25212213|NCT02132754|50488040|FG014|Overall Study|Excluded Medication|0|||
25212214|NCT02132754|50488041|FG015|Overall Study|Excluded Medication|0|||
25212215|NCT02132754|50488042|FG016|Overall Study|Excluded Medication|0|||
25212216|NCT02132754|50488043|FG017|Overall Study|Excluded Medication|0|||
25212217|NCT02132754|50488044|FG018|Overall Study|Excluded Medication|0|||
25212218|NCT02132754|50488045|FG019|Overall Study|Excluded Medication|0|||
25212219|NCT02132754|50488046|FG020|Overall Study|Excluded Medication|1|||
25212220|NCT02132754|50488047|FG021|Overall Study|Excluded Medication|0|||
25212221|NCT02132754|50488048|FG022|Overall Study|Excluded Medication|0|||
25212222|NCT02132754|50488049|FG023|Overall Study|Excluded Medication|0|||
25212223|NCT02132754|50488050|FG024|Overall Study|Excluded Medication|0|||
25212224|NCT02132754|50488051|FG025|Overall Study|Excluded Medication|0|||
25212225|NCT02132754|50488052|FG026|Overall Study|Excluded Medication|0|||
25212226|NCT02132754|50488053|FG027|Overall Study|Excluded Medication|0|||
25212227|NCT02132754|50488054|FG028|Overall Study|Excluded Medication|0|||
25212228|NCT02132754|50488055|FG029|Overall Study|Excluded Medication|0|||
25212229|NCT02132754|50488056|FG030|Overall Study|Excluded Medication|0|||
25212230|NCT02132754|50488057|FG031|Overall Study|Excluded Medication|0|||
25212231|NCT02132754|50488058|FG032|Overall Study|Excluded Medication|0|||
25212232|NCT02132754|50488059|FG033|Overall Study|Excluded Medication|1|||
25212233|NCT02132754|50488026|FG000|Overall Study|Physician Decision|0|||
25212234|NCT02132754|50488027|FG001|Overall Study|Physician Decision|0|||
25212235|NCT02132754|50488028|FG002|Overall Study|Physician Decision|0|||
25212236|NCT02132754|50488029|FG003|Overall Study|Physician Decision|0|||
25212237|NCT02132754|50488030|FG004|Overall Study|Physician Decision|0|||
25212238|NCT02132754|50488031|FG005|Overall Study|Physician Decision|0|||
25212239|NCT02132754|50488032|FG006|Overall Study|Physician Decision|0|||
25212240|NCT02132754|50488033|FG007|Overall Study|Physician Decision|0|||
25212241|NCT02132754|50488034|FG008|Overall Study|Physician Decision|0|||
25212242|NCT02132754|50488035|FG009|Overall Study|Physician Decision|1|||
25212243|NCT02132754|50488036|FG010|Overall Study|Physician Decision|0|||
25212244|NCT02132754|50488037|FG011|Overall Study|Physician Decision|1|||
25212245|NCT02132754|50488038|FG012|Overall Study|Physician Decision|1|||
25212246|NCT02132754|50488039|FG013|Overall Study|Physician Decision|0|||
25212247|NCT02132754|50488040|FG014|Overall Study|Physician Decision|0|||
25212248|NCT02132754|50488041|FG015|Overall Study|Physician Decision|1|||
25212249|NCT02132754|50488042|FG016|Overall Study|Physician Decision|0|||
25212250|NCT02132754|50488043|FG017|Overall Study|Physician Decision|0|||
25212251|NCT02132754|50488044|FG018|Overall Study|Physician Decision|0|||
25212252|NCT02132754|50488045|FG019|Overall Study|Physician Decision|0|||
25212253|NCT02132754|50488046|FG020|Overall Study|Physician Decision|0|||
25212254|NCT02132754|50488047|FG021|Overall Study|Physician Decision|0|||
25212255|NCT02132754|50488048|FG022|Overall Study|Physician Decision|0|||
25212256|NCT02132754|50488049|FG023|Overall Study|Physician Decision|0|||
25212257|NCT02132754|50488050|FG024|Overall Study|Physician Decision|1|||
25212258|NCT02132754|50488051|FG025|Overall Study|Physician Decision|0|||
25212259|NCT02132754|50488052|FG026|Overall Study|Physician Decision|0|||
25212260|NCT02132754|50488053|FG027|Overall Study|Physician Decision|0|||
25212261|NCT02132754|50488054|FG028|Overall Study|Physician Decision|0|||
25212262|NCT02132754|50488055|FG029|Overall Study|Physician Decision|0|||
25212263|NCT02132754|50488056|FG030|Overall Study|Physician Decision|0|||
25212264|NCT02132754|50488057|FG031|Overall Study|Physician Decision|1|||
25212265|NCT02132754|50488058|FG032|Overall Study|Physician Decision|0|||
25212266|NCT02132754|50488059|FG033|Overall Study|Physician Decision|3|||
25212267|NCT02132754|50488026|FG000|Overall Study|Progressive Disease|1|||
25212268|NCT02132754|50488027|FG001|Overall Study|Progressive Disease|1|||
25212269|NCT02132754|50488028|FG002|Overall Study|Progressive Disease|1|||
25212270|NCT02132754|50488029|FG003|Overall Study|Progressive Disease|1|||
25212271|NCT02132754|50488030|FG004|Overall Study|Progressive Disease|1|||
25212272|NCT02132754|50488031|FG005|Overall Study|Progressive Disease|1|||
25212273|NCT02132754|50488032|FG006|Overall Study|Progressive Disease|1|||
25212274|NCT02132754|50488033|FG007|Overall Study|Progressive Disease|1|||
25212275|NCT02132754|50488034|FG008|Overall Study|Progressive Disease|1|||
25212276|NCT02132754|50488035|FG009|Overall Study|Progressive Disease|3|||
25212277|NCT02132754|50488036|FG010|Overall Study|Progressive Disease|3|||
25212278|NCT02132754|50488037|FG011|Overall Study|Progressive Disease|2|||
25212279|NCT02132754|50488038|FG012|Overall Study|Progressive Disease|2|||
25212280|NCT02132754|50488039|FG013|Overall Study|Progressive Disease|3|||
25212281|NCT02132754|50488040|FG014|Overall Study|Progressive Disease|2|||
25212282|NCT02132754|50488041|FG015|Overall Study|Progressive Disease|1|||
25212283|NCT02132754|50488042|FG016|Overall Study|Progressive Disease|2|||
25212284|NCT02132754|50488043|FG017|Overall Study|Progressive Disease|1|||
25212285|NCT02132754|50488044|FG018|Overall Study|Progressive Disease|3|||
25212286|NCT02132754|50488045|FG019|Overall Study|Progressive Disease|1|||
25212287|NCT02132754|50488046|FG020|Overall Study|Progressive Disease|1|||
25212288|NCT02132754|50488047|FG021|Overall Study|Progressive Disease|3|||
25212289|NCT02132754|50488048|FG022|Overall Study|Progressive Disease|2|||
25212290|NCT02132754|50488049|FG023|Overall Study|Progressive Disease|3|||
25212291|NCT02132754|50488050|FG024|Overall Study|Progressive Disease|0|||
25212292|NCT02132754|50488051|FG025|Overall Study|Progressive Disease|1|||
25212293|NCT02132754|50488052|FG026|Overall Study|Progressive Disease|2|||
25212294|NCT02132754|50488053|FG027|Overall Study|Progressive Disease|1|||
25212295|NCT02132754|50488054|FG028|Overall Study|Progressive Disease|2|||
25212296|NCT02132754|50488055|FG029|Overall Study|Progressive Disease|3|||
25212297|NCT02132754|50488056|FG030|Overall Study|Progressive Disease|1|||
25212298|NCT02132754|50488057|FG031|Overall Study|Progressive Disease|1|||
25212299|NCT02132754|50488058|FG032|Overall Study|Progressive Disease|3|||
25212300|NCT02132754|50488059|FG033|Overall Study|Progressive Disease|6|||
25212301|NCT02132754|50488026|FG000|Overall Study|Screen Failure|0|||
25212302|NCT02132754|50488027|FG001|Overall Study|Screen Failure|0|||
25212303|NCT02132754|50488028|FG002|Overall Study|Screen Failure|0|||
25212304|NCT02132754|50488029|FG003|Overall Study|Screen Failure|0|||
25212305|NCT02132754|50488030|FG004|Overall Study|Screen Failure|0|||
25212306|NCT02132754|50488031|FG005|Overall Study|Screen Failure|0|||
25212307|NCT02132754|50488032|FG006|Overall Study|Screen Failure|0|||
25212308|NCT02132754|50488033|FG007|Overall Study|Screen Failure|0|||
25212309|NCT02132754|50488034|FG008|Overall Study|Screen Failure|0|||
25212310|NCT02132754|50488035|FG009|Overall Study|Screen Failure|0|||
25212311|NCT02132754|50488036|FG010|Overall Study|Screen Failure|0|||
25212312|NCT02132754|50488037|FG011|Overall Study|Screen Failure|0|||
25212313|NCT02132754|50488038|FG012|Overall Study|Screen Failure|0|||
25212314|NCT02132754|50488039|FG013|Overall Study|Screen Failure|0|||
25212315|NCT02132754|50488040|FG014|Overall Study|Screen Failure|0|||
25212316|NCT02132754|50488041|FG015|Overall Study|Screen Failure|0|||
25212317|NCT02132754|50488042|FG016|Overall Study|Screen Failure|0|||
25212318|NCT02132754|50488043|FG017|Overall Study|Screen Failure|0|||
25212319|NCT02132754|50488044|FG018|Overall Study|Screen Failure|0|||
25212320|NCT02132754|50488045|FG019|Overall Study|Screen Failure|1|||
25212321|NCT02132754|50488046|FG020|Overall Study|Screen Failure|0|||
25212322|NCT02132754|50488047|FG021|Overall Study|Screen Failure|1|||
25212323|NCT02132754|50488048|FG022|Overall Study|Screen Failure|0|||
25212324|NCT02132754|50488049|FG023|Overall Study|Screen Failure|0|||
25212325|NCT02132754|50488050|FG024|Overall Study|Screen Failure|0|||
25212326|NCT02132754|50488051|FG025|Overall Study|Screen Failure|0|||
25212327|NCT02132754|50488052|FG026|Overall Study|Screen Failure|0|||
25212328|NCT02132754|50488053|FG027|Overall Study|Screen Failure|0|||
25212329|NCT02132754|50488054|FG028|Overall Study|Screen Failure|0|||
25212330|NCT02132754|50488055|FG029|Overall Study|Screen Failure|0|||
25212331|NCT02132754|50488056|FG030|Overall Study|Screen Failure|0|||
25212332|NCT02132754|50488057|FG031|Overall Study|Screen Failure|0|||
25212333|NCT02132754|50488058|FG032|Overall Study|Screen Failure|0|||
25212334|NCT02132754|50488059|FG033|Overall Study|Screen Failure|0|||
25212335|NCT02132754|50488026|FG000|Overall Study|Transferred to Extension Study|0|||
25212336|NCT02132754|50488027|FG001|Overall Study|Transferred to Extension Study|0|||
25212337|NCT02132754|50488028|FG002|Overall Study|Transferred to Extension Study|0|||
25212338|NCT02132754|50488029|FG003|Overall Study|Transferred to Extension Study|0|||
25212339|NCT02132754|50488030|FG004|Overall Study|Transferred to Extension Study|0|||
25212340|NCT02132754|50488031|FG005|Overall Study|Transferred to Extension Study|0|||
25212341|NCT02132754|50488032|FG006|Overall Study|Transferred to Extension Study|0|||
25212342|NCT02132754|50488033|FG007|Overall Study|Transferred to Extension Study|0|||
25212343|NCT02132754|50488034|FG008|Overall Study|Transferred to Extension Study|0|||
25212344|NCT02132754|50488035|FG009|Overall Study|Transferred to Extension Study|0|||
25212345|NCT02132754|50488036|FG010|Overall Study|Transferred to Extension Study|0|||
25212346|NCT02132754|50488037|FG011|Overall Study|Transferred to Extension Study|0|||
25212347|NCT02132754|50488038|FG012|Overall Study|Transferred to Extension Study|0|||
25212348|NCT02132754|50488039|FG013|Overall Study|Transferred to Extension Study|0|||
25212349|NCT02132754|50488040|FG014|Overall Study|Transferred to Extension Study|0|||
25212350|NCT02132754|50488041|FG015|Overall Study|Transferred to Extension Study|0|||
25212351|NCT02132754|50488042|FG016|Overall Study|Transferred to Extension Study|0|||
25212352|NCT02132754|50488043|FG017|Overall Study|Transferred to Extension Study|0|||
25212353|NCT02132754|50488044|FG018|Overall Study|Transferred to Extension Study|0|||
25212354|NCT02132754|50488045|FG019|Overall Study|Transferred to Extension Study|0|||
25212355|NCT02132754|50488046|FG020|Overall Study|Transferred to Extension Study|0|||
25212356|NCT02132754|50488047|FG021|Overall Study|Transferred to Extension Study|0|||
25212357|NCT02132754|50488048|FG022|Overall Study|Transferred to Extension Study|0|||
25212358|NCT02132754|50488049|FG023|Overall Study|Transferred to Extension Study|0|||
25212359|NCT02132754|50488050|FG024|Overall Study|Transferred to Extension Study|0|||
25212360|NCT02132754|50488051|FG025|Overall Study|Transferred to Extension Study|0|||
25212361|NCT02132754|50488052|FG026|Overall Study|Transferred to Extension Study|0|||
25212362|NCT02132754|50488053|FG027|Overall Study|Transferred to Extension Study|0|||
25212363|NCT02132754|50488054|FG028|Overall Study|Transferred to Extension Study|0|||
25212364|NCT02132754|50488055|FG029|Overall Study|Transferred to Extension Study|0|||
25212365|NCT02132754|50488056|FG030|Overall Study|Transferred to Extension Study|0|||
25212366|NCT02132754|50488057|FG031|Overall Study|Transferred to Extension Study|0|||
25212367|NCT02132754|50488058|FG032|Overall Study|Transferred to Extension Study|0|||
25212368|NCT02132754|50488059|FG033|Overall Study|Transferred to Extension Study|6|||
25212369|NCT02132754|50488026|FG000|Overall Study|Withdrawal by Subject|0|||
25212370|NCT02132754|50488027|FG001|Overall Study|Withdrawal by Subject|0|||
25212371|NCT02132754|50488028|FG002|Overall Study|Withdrawal by Subject|0|||
25212372|NCT02132754|50488029|FG003|Overall Study|Withdrawal by Subject|0|||
25212373|NCT02132754|50488030|FG004|Overall Study|Withdrawal by Subject|0|||
25212374|NCT02132754|50488031|FG005|Overall Study|Withdrawal by Subject|0|||
25212375|NCT02132754|50488032|FG006|Overall Study|Withdrawal by Subject|0|||
25212376|NCT02132754|50488033|FG007|Overall Study|Withdrawal by Subject|0|||
25212377|NCT02132754|50488034|FG008|Overall Study|Withdrawal by Subject|0|||
25212378|NCT02132754|50488035|FG009|Overall Study|Withdrawal by Subject|1|||
25212379|NCT02132754|50488036|FG010|Overall Study|Withdrawal by Subject|0|||
25212380|NCT02132754|50488037|FG011|Overall Study|Withdrawal by Subject|0|||
25212381|NCT02132754|50488038|FG012|Overall Study|Withdrawal by Subject|1|||
25212382|NCT02132754|50488039|FG013|Overall Study|Withdrawal by Subject|0|||
25212383|NCT02132754|50488040|FG014|Overall Study|Withdrawal by Subject|1|||
25212384|NCT02132754|50488041|FG015|Overall Study|Withdrawal by Subject|2|||
25212385|NCT02132754|50488042|FG016|Overall Study|Withdrawal by Subject|1|||
25212386|NCT02132754|50488043|FG017|Overall Study|Withdrawal by Subject|0|||
25212387|NCT02132754|50488044|FG018|Overall Study|Withdrawal by Subject|0|||
25212388|NCT02132754|50488045|FG019|Overall Study|Withdrawal by Subject|0|||
25212389|NCT02132754|50488046|FG020|Overall Study|Withdrawal by Subject|1|||
25212390|NCT02132754|50488047|FG021|Overall Study|Withdrawal by Subject|0|||
25212391|NCT02132754|50488048|FG022|Overall Study|Withdrawal by Subject|0|||
25212392|NCT02132754|50488049|FG023|Overall Study|Withdrawal by Subject|0|||
25212393|NCT02132754|50488050|FG024|Overall Study|Withdrawal by Subject|1|||
25212394|NCT02132754|50488051|FG025|Overall Study|Withdrawal by Subject|0|||
25212395|NCT02132754|50488052|FG026|Overall Study|Withdrawal by Subject|0|||
25212396|NCT02132754|50488053|FG027|Overall Study|Withdrawal by Subject|1|||
25212397|NCT02132754|50488054|FG028|Overall Study|Withdrawal by Subject|0|||
25212398|NCT02132754|50488055|FG029|Overall Study|Withdrawal by Subject|0|||
25212399|NCT02132754|50488056|FG030|Overall Study|Withdrawal by Subject|0|||
25212400|NCT02132754|50488057|FG031|Overall Study|Withdrawal by Subject|1|||
25212401|NCT02132754|50488058|FG032|Overall Study|Withdrawal by Subject|0|||
25212402|NCT02132754|50488059|FG033|Overall Study|Withdrawal by Subject|2|||
25212403|NCT02151786|50488169|FG000|Overall Study|Unavailability of Case Report Form|26|||
25212404|NCT02151786|50488169|FG000|Overall Study|Outside the Contract Period|1|||
25212405|NCT02151786|50488169|FG000|Overall Study|Randomized, not Treated|1|||
25212406|NCT02151786|50488169|FG000|Overall Study|Unavailability of Information|8|||
25212407|NCT02132130|50488177|FG000|Overall Study|Lost to Follow-up|0|||
25212408|NCT02132130|50488178|FG001|Overall Study|Lost to Follow-up|2|||
25212409|NCT02132130|50488179|FG002|Overall Study|Lost to Follow-up|0|||
25212410|NCT02132130|50488180|FG003|Overall Study|Lost to Follow-up|0|||
25212411|NCT02132130|50488177|FG000|Overall Study|Withdrawal by Subject|0|||
25212412|NCT02132130|50488178|FG001|Overall Study|Withdrawal by Subject|0|||
25212413|NCT02132130|50488179|FG002|Overall Study|Withdrawal by Subject|0|||
25212414|NCT02132130|50488180|FG003|Overall Study|Withdrawal by Subject|1|||
25212415|NCT02131662|50488199|FG000|Overall Study|Protocol Violation|1|||
25212416|NCT02131662|50488200|FG001|Overall Study|Protocol Violation|0|||
25212417|NCT02131662|50488201|FG002|Overall Study|Protocol Violation|0|||
25212418|NCT02131662|50488202|FG003|Overall Study|Protocol Violation|0|||
25212419|NCT02131662|50488203|FG004|Overall Study|Protocol Violation|0|||
25212420|NCT02131662|50488199|FG000|Overall Study|Other|2|||
25212421|NCT02131662|50488200|FG001|Overall Study|Other|4|||
25212422|NCT02131662|50488201|FG002|Overall Study|Other|3|||
25212423|NCT02131662|50488202|FG003|Overall Study|Other|3|||
25212424|NCT02131662|50488203|FG004|Overall Study|Other|4|||
25212425|NCT02131662|50488199|FG000|Overall Study|Adverse Event|0|||
25212426|NCT02131662|50488200|FG001|Overall Study|Adverse Event|1|||
25212427|NCT02131662|50488201|FG002|Overall Study|Adverse Event|1|||
25212428|NCT02131662|50488202|FG003|Overall Study|Adverse Event|1|||
25212429|NCT02131662|50488203|FG004|Overall Study|Adverse Event|3|||
25212430|NCT02131662|50488199|FG000|Overall Study|Pregnancy|0|||
25212431|NCT02131662|50488200|FG001|Overall Study|Pregnancy|1|||
25212432|NCT02131662|50488201|FG002|Overall Study|Pregnancy|0|||
25212433|NCT02131662|50488202|FG003|Overall Study|Pregnancy|1|||
25212434|NCT02131662|50488203|FG004|Overall Study|Pregnancy|0|||
25212435|NCT02131662|50488199|FG000|Overall Study|Wish for pregnancy|0|||
25212436|NCT02131662|50488200|FG001|Overall Study|Wish for pregnancy|0|||
25212437|NCT02131662|50488201|FG002|Overall Study|Wish for pregnancy|0|||
25212438|NCT02131662|50488202|FG003|Overall Study|Wish for pregnancy|0|||
25212439|NCT02131662|50488203|FG004|Overall Study|Wish for pregnancy|1|||
25212440|NCT02131662|50488199|FG000|Overall Study|Lack of Efficacy|1|||
25212441|NCT02131662|50488200|FG001|Overall Study|Lack of Efficacy|0|||
25212442|NCT02131662|50488201|FG002|Overall Study|Lack of Efficacy|0|||
25212443|NCT02131662|50488202|FG003|Overall Study|Lack of Efficacy|0|||
25212444|NCT02131662|50488203|FG004|Overall Study|Lack of Efficacy|1|||
25077365|NCT00159783|50185191|FG002|Overall Study|Lost to Follow-up|11|||
25212445|NCT02131662|50488199|FG000|Overall Study|Withdrawal by Subject|1|||
25212446|NCT02131662|50488200|FG001|Overall Study|Withdrawal by Subject|5|||
25212447|NCT02131662|50488201|FG002|Overall Study|Withdrawal by Subject|1|||
25212448|NCT02131662|50488202|FG003|Overall Study|Withdrawal by Subject|5|||
25212449|NCT02131662|50488203|FG004|Overall Study|Withdrawal by Subject|6|||
25212450|NCT02131662|50488199|FG000|Overall Study|Lost to Follow-up|1|||
25212451|NCT02131662|50488200|FG001|Overall Study|Lost to Follow-up|3|||
25212452|NCT02131662|50488201|FG002|Overall Study|Lost to Follow-up|0|||
25212453|NCT02131662|50488202|FG003|Overall Study|Lost to Follow-up|9|||
25212454|NCT02131662|50488203|FG004|Overall Study|Lost to Follow-up|0|||
25212455|NCT02131662|50488199|FG000|Overall Study|Not treated|2|||
25212456|NCT02131662|50488200|FG001|Overall Study|Not treated|0|||
25212457|NCT02131662|50488201|FG002|Overall Study|Not treated|2|||
25212458|NCT02131662|50488202|FG003|Overall Study|Not treated|2|||
25212459|NCT02131662|50488203|FG004|Overall Study|Not treated|3|||
25212460|NCT02106156|50488222|FG000|Overall Study|Patient Died|19|||
25212461|NCT02106156|50488223|FG001|Overall Study|Patient Died|0|||
25212462|NCT02106156|50488224|FG002|Overall Study|Patient Died|0|||
25212463|NCT02106156|50488222|FG000|Overall Study|Lack of Tolerability|305|||
25212464|NCT02106156|50488223|FG001|Overall Study|Lack of Tolerability|3|||
25212465|NCT02106156|50488224|FG002|Overall Study|Lack of Tolerability|0|||
25212466|NCT02106156|50488222|FG000|Overall Study|Lack of Virological Response|1044|||
25212467|NCT02106156|50488223|FG001|Overall Study|Lack of Virological Response|8|||
25212468|NCT02106156|50488224|FG002|Overall Study|Lack of Virological Response|0|||
25212469|NCT02106156|50488222|FG000|Overall Study|Concomitant Disease|74|||
25212470|NCT02106156|50488223|FG001|Overall Study|Concomitant Disease|2|||
25212471|NCT02106156|50488224|FG002|Overall Study|Concomitant Disease|0|||
25212472|NCT02106156|50488222|FG000|Overall Study|Lack of Compliance|211|||
25212473|NCT02106156|50488223|FG001|Overall Study|Lack of Compliance|7|||
25212474|NCT02106156|50488224|FG002|Overall Study|Lack of Compliance|0|||
25212475|NCT02106156|50488222|FG000|Overall Study|Patients Request|307|||
25212476|NCT02106156|50488223|FG001|Overall Study|Patients Request|9|||
25212477|NCT02106156|50488224|FG002|Overall Study|Patients Request|0|||
25212478|NCT02106156|50488222|FG000|Overall Study|Lost to Follow-up|451|||
25212479|NCT02106156|50488223|FG001|Overall Study|Lost to Follow-up|8|||
25212480|NCT02106156|50488224|FG002|Overall Study|Lost to Follow-up|0|||
25212481|NCT02106156|50488222|FG000|Overall Study|Unplanned Event|82|||
25212482|NCT02106156|50488223|FG001|Overall Study|Unplanned Event|2|||
25212483|NCT02106156|50488224|FG002|Overall Study|Unplanned Event|0|||
25212484|NCT02106156|50488222|FG000|Overall Study|Change of Laboratory Parameter|10|||
25212485|NCT02106156|50488223|FG001|Overall Study|Change of Laboratory Parameter|0|||
25212486|NCT02106156|50488224|FG002|Overall Study|Change of Laboratory Parameter|0|||
25212487|NCT02106156|50488222|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
25212488|NCT02106156|50488223|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
25212489|NCT02106156|50488224|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
25212490|NCT02106156|50488222|FG000|Overall Study|Relocation/Change of Physician|40|||
25212491|NCT02106156|50488223|FG001|Overall Study|Relocation/Change of Physician|1|||
25212492|NCT02106156|50488224|FG002|Overall Study|Relocation/Change of Physician|0|||
25212493|NCT01598610|50488231|FG000|Overall Study|Adverse Event|1|||
25212494|NCT01625988|50488237|FG000|Overall Study|Lost to Follow-up|5|||
25212495|NCT01625988|50488238|FG001|Overall Study|Lost to Follow-up|6|||
25212496|NCT01625988|50488237|FG000|Overall Study|Withdrawal by Subject|8|||
25212497|NCT01625988|50488238|FG001|Overall Study|Withdrawal by Subject|3|||
25212498|NCT01625988|50488237|FG000|Overall Study|Adverse Event|0|||
25212499|NCT01625988|50488238|FG001|Overall Study|Adverse Event|1|||
25212500|NCT01625988|50488237|FG000|Overall Study|Lack of Efficacy|0|||
25212501|NCT01625988|50488238|FG001|Overall Study|Lack of Efficacy|1|||
25212502|NCT01625988|50488237|FG000|Overall Study|Randomized Inappropriately|1|||
25212503|NCT01625988|50488238|FG001|Overall Study|Randomized Inappropriately|0|||
25212504|NCT01625988|50488237|FG000|Overall Study|Protocol Violation|0|||
25212505|NCT01625988|50488238|FG001|Overall Study|Protocol Violation|2|||
25212506|NCT02131272|50488249|FG000|Overall Study|Withdrawal by parent|0|||
25212507|NCT02131272|50488250|FG001|Overall Study|Withdrawal by parent|1|||
25212508|NCT02131272|50488249|FG000|Overall Study|Withdrawal by Subject|0|||
25212509|NCT02131272|50488250|FG001|Overall Study|Withdrawal by Subject|1|||
25212510|NCT02131272|50488249|FG000|Overall Study|Withdrawal Criteria|1|||
25316493|NCT03845296|50631924|FG001|Overall Study|Other - not protocol specified|3|||
25212511|NCT02131272|50488250|FG001|Overall Study|Withdrawal Criteria|0|||
25212512|NCT02130882|50488258|FG000|Overall Study|Withdrawal by Subject|0|||
25212513|NCT02130882|50488259|FG001|Overall Study|Withdrawal by Subject|1|||
25212514|NCT02130570|50488267|FG000|Overall Study|Death|3|||
25212515|NCT02130570|50488268|FG001|Overall Study|Death|5|||
25212516|NCT02130570|50488267|FG000|Overall Study|Withdrawal by Subject|6|||
25212517|NCT02130570|50488268|FG001|Overall Study|Withdrawal by Subject|3|||
25212518|NCT02130570|50488267|FG000|Overall Study|Part of practice that discontinued study|0|||
25212519|NCT02130570|50488268|FG001|Overall Study|Part of practice that discontinued study|5|||
25212520|NCT02149836|50488275|FG000|Overall Study|Withdrawal by Subject|1|||
25212521|NCT02130024|50488281|FG000|Overall Study|Adverse Event|10|||
25212522|NCT02130024|50488282|FG001|Overall Study|Adverse Event|11|||
25212523|NCT02130024|50488281|FG000|Overall Study|Death|2|||
25212524|NCT02130024|50488282|FG001|Overall Study|Death|2|||
25212525|NCT02130024|50488281|FG000|Overall Study|Lost to Follow-up|1|||
25212526|NCT02130024|50488282|FG001|Overall Study|Lost to Follow-up|1|||
25212527|NCT02130024|50488281|FG000|Overall Study|Physician Decision|1|||
25212528|NCT02130024|50488282|FG001|Overall Study|Physician Decision|3|||
25212529|NCT02130024|50488281|FG000|Overall Study|Protocol Deviation|4|||
25212530|NCT02130024|50488282|FG001|Overall Study|Protocol Deviation|0|||
25212531|NCT02130024|50488281|FG000|Overall Study|Site Administration Problems|1|||
25212532|NCT02130024|50488282|FG001|Overall Study|Site Administration Problems|0|||
25212533|NCT02130024|50488281|FG000|Overall Study|Subject Withdrew Consent|6|||
25212534|NCT02130024|50488282|FG001|Overall Study|Subject Withdrew Consent|14|||
25212535|NCT02105688|50488290|FG000|Part A: Double-Blind|Adverse Event|1|||
25212536|NCT02105688|50488291|FG001|Part A: Double-Blind|Adverse Event|0|||
25212537|NCT02105688|50488290|FG000|Part A: Double-Blind|Death|0|||
25212538|NCT02105688|50488291|FG001|Part A: Double-Blind|Death|1|||
25212539|NCT02105688|50488290|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
25212540|NCT02105688|50488291|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
25212541|NCT02105688|50488290|FG000|Part A: Double-Blind|Physician Decision|0|||
25212542|NCT02105688|50488291|FG001|Part A: Double-Blind|Physician Decision|1|||
25212543|NCT02105688|50488290|FG000|Part A: Double-Blind|Status Unknown|0|||
25212544|NCT02105688|50488291|FG001|Part A: Double-Blind|Status Unknown|2|||
25212545|NCT02105688|50488290|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
25212546|NCT02105688|50488291|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
25212547|NCT02105688|50488290|FG000|Part B: Observational Follow-up|Death|2|||
25212548|NCT02105688|50488291|FG001|Part B: Observational Follow-up|Death|1|||
25212549|NCT02105688|50488290|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
25212550|NCT02105688|50488291|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
25212551|NCT02105688|50488290|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
25212552|NCT02105688|50488291|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
25212553|NCT02105688|50488290|FG000|Part B: Observational Follow-up|Physician Decision|3|||
25212554|NCT02105688|50488291|FG001|Part B: Observational Follow-up|Physician Decision|1|||
25212555|NCT02105454|50488298|FG000|Overall Study|Withdrawal by Subject|1|||
25212556|NCT01625910|50488304|FG000|Overall Study|Lost to Follow-up|3|||
25212557|NCT01625910|50488305|FG001|Overall Study|Lost to Follow-up|4|||
25212558|NCT02104752|50488315|FG000|Overall Study|Withdrawal by Subject|1|||
25212559|NCT02104752|50488316|FG001|Overall Study|Withdrawal by Subject|0|||
25212560|NCT02104752|50488315|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
25212561|NCT02104752|50488316|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
25212562|NCT02102724|50488324|FG000|Overall Study|Lost to Follow-up|1|||
25212563|NCT02102724|50488325|FG001|Overall Study|Lost to Follow-up|0|||
25212564|NCT02102724|50488324|FG000|Overall Study|surgery for brain aneurysm|1|||
25212565|NCT02102724|50488325|FG001|Overall Study|surgery for brain aneurysm|1|||
25212566|NCT02102490|50488331|FG000|Overall Study|Death|6|||
25212567|NCT02102490|50488331|FG000|Overall Study|Lost to Follow-up|1|||
25212568|NCT02101554|50488338|FG000|Overall Study|Protocol Violation|0|||
25212569|NCT02101554|50488339|FG001|Overall Study|Protocol Violation|1|||
25212570|NCT02101554|50488340|FG002|Overall Study|Protocol Violation|0|||
25212571|NCT02101554|50488338|FG000|Overall Study|Insufficient Clinical Response|0|||
25212572|NCT02101554|50488339|FG001|Overall Study|Insufficient Clinical Response|2|||
25212573|NCT02101554|50488340|FG002|Overall Study|Insufficient Clinical Response|0|||
25212574|NCT02101554|50488338|FG000|Overall Study|Adverse Event|2|||
25212575|NCT02101554|50488339|FG001|Overall Study|Adverse Event|1|||
25212576|NCT02101554|50488340|FG002|Overall Study|Adverse Event|1|||
25212577|NCT02101554|50488338|FG000|Overall Study|Lost to Follow-up|0|||
25212578|NCT02101554|50488339|FG001|Overall Study|Lost to Follow-up|1|||
25212579|NCT02101554|50488340|FG002|Overall Study|Lost to Follow-up|0|||
25212580|NCT02101554|50488338|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
25212581|NCT02101554|50488339|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
25212582|NCT02101554|50488340|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
25212583|NCT02128932|50488351|FG000|Overall Study|Withdrawal by Subject|11|||
25212584|NCT02128932|50488352|FG001|Overall Study|Withdrawal by Subject|7|||
25212585|NCT02128932|50488353|FG002|Overall Study|Withdrawal by Subject|8|||
25212586|NCT02128932|50488351|FG000|Overall Study|Death|2|||
24976375|NCT00092547|50065232|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
25212587|NCT02128932|50488352|FG001|Overall Study|Death|0|||
25212588|NCT02128932|50488353|FG002|Overall Study|Death|2|||
25212589|NCT02128932|50488351|FG000|Overall Study|Lost to Follow-up|2|||
25212590|NCT02128932|50488352|FG001|Overall Study|Lost to Follow-up|1|||
25212591|NCT02128932|50488353|FG002|Overall Study|Lost to Follow-up|1|||
25212592|NCT02128932|50488351|FG000|Overall Study|No reason for withdrawal|12|||
25212593|NCT02128932|50488352|FG001|Overall Study|No reason for withdrawal|11|||
25212594|NCT02128932|50488353|FG002|Overall Study|No reason for withdrawal|7|||
25212595|NCT02128542|50488363|FG000|Overall Study|Lost to Follow-up|3|||
25212596|NCT02128542|50488364|FG001|Overall Study|Lost to Follow-up|0|||
25212597|NCT02128542|50488363|FG000|Overall Study|Withdrew Consent|1|||
25212598|NCT02128542|50488364|FG001|Overall Study|Withdrew Consent|0|||
25212599|NCT02127372|50488374|FG000|Overall Study|Withdrawal by Subject|1|||
25212600|NCT02127372|50488375|FG001|Overall Study|Withdrawal by Subject|0|||
25212601|NCT02126826|50488389|FG000|Overall Study|Withdrawal by Subject|0|||
25212602|NCT02126826|50488390|FG001|Overall Study|Withdrawal by Subject|0|||
25212603|NCT02126826|50488391|FG002|Overall Study|Withdrawal by Subject|0|||
25212604|NCT02126826|50488392|FG003|Overall Study|Withdrawal by Subject|1|||
25212605|NCT02126826|50488393|FG004|Overall Study|Withdrawal by Subject|0|||
25212606|NCT02126826|50488394|FG005|Overall Study|Withdrawal by Subject|0|||
25212607|NCT02126826|50488395|FG006|Overall Study|Withdrawal by Subject|0|||
25212608|NCT02126670|50488420|FG000|Overall Study|Withdrawal by Subject|1|||
25212609|NCT02126670|50488421|FG001|Overall Study|Withdrawal by Subject|0|||
25212610|NCT02126670|50488422|FG002|Overall Study|Withdrawal by Subject|0|||
25212611|NCT02126670|50488423|FG003|Overall Study|Withdrawal by Subject|1|||
25212612|NCT02125734|50488435|FG000|Period 2|Adverse Event|0|||
25212613|NCT02125734|50488436|FG001|Period 2|Adverse Event|1|||
25212614|NCT02124798|50488442|FG000|Overall Study|Adverse Event|3|||
25212615|NCT02124798|50488442|FG000|Overall Study|Lost to Follow-up|1|||
25212616|NCT02146326|50488450|FG000|Overall Study|Lost to Follow-up|3|||
25212617|NCT02146326|50488451|FG001|Overall Study|Lost to Follow-up|3|||
25212618|NCT02146326|50488452|FG002|Overall Study|Lost to Follow-up|11|||
25212619|NCT02146326|50488453|FG003|Overall Study|Lost to Follow-up|19|||
25212620|NCT02146326|50488450|FG000|Overall Study|Withdrawal by Subject|2|||
25212621|NCT02146326|50488451|FG001|Overall Study|Withdrawal by Subject|1|||
25212622|NCT02146326|50488452|FG002|Overall Study|Withdrawal by Subject|15|||
25212623|NCT02146326|50488453|FG003|Overall Study|Withdrawal by Subject|11|||
25212624|NCT02146326|50488450|FG000|Overall Study|Separated from mental health center|23|||
25212625|NCT02146326|50488451|FG001|Overall Study|Separated from mental health center|33|||
25212626|NCT02146326|50488452|FG002|Overall Study|Separated from mental health center|0|||
25212627|NCT02146326|50488453|FG003|Overall Study|Separated from mental health center|0|||
25212628|NCT02146326|50488450|FG000|Overall Study|Incarcerated|0|||
25212629|NCT02146326|50488451|FG001|Overall Study|Incarcerated|0|||
25212630|NCT02146326|50488452|FG002|Overall Study|Incarcerated|3|||
25212631|NCT02146326|50488453|FG003|Overall Study|Incarcerated|8|||
25212632|NCT02146326|50488450|FG000|Overall Study|Death|0|||
25212633|NCT02146326|50488451|FG001|Overall Study|Death|0|||
25212634|NCT02146326|50488452|FG002|Overall Study|Death|4|||
25212635|NCT02146326|50488453|FG003|Overall Study|Death|4|||
25212636|NCT02146326|50488450|FG000|Overall Study|Unable to complete interview|0|||
25212637|NCT02146326|50488451|FG001|Overall Study|Unable to complete interview|0|||
25212638|NCT02146326|50488452|FG002|Overall Study|Unable to complete interview|10|||
25212639|NCT02146326|50488453|FG003|Overall Study|Unable to complete interview|6|||
25212640|NCT02146248|50488469|FG000|Overall Study|Withdrawal by Subject|2|||
25212641|NCT02145468|50488479|FG000|Overall Study|Withdrawal by Subject|5|||
25212642|NCT02145468|50488480|FG001|Overall Study|Withdrawal by Subject|8|||
25212643|NCT02124564|50488486|FG000|Treatment Period|Adverse Event|2|||
25212644|NCT02124564|50488486|FG000|Treatment Period|Lack of Efficacy|3|||
25212645|NCT02124564|50488486|FG000|Treatment Period|Withdrawal by Subject|2|||
25212646|NCT02145390|50488491|FG000|Overall Study|Withdrawal by Subject|1|||
25212647|NCT02100696|50488501|FG000|Induction Phase|Adverse Event|0|||
25212648|NCT02100696|50488502|FG001|Induction Phase|Adverse Event|0|||
25212649|NCT02100696|50488503|FG002|Induction Phase|Adverse Event|1|||
25212650|NCT02100696|50488504|FG003|Induction Phase|Adverse Event|0|||
25212651|NCT02100696|50488505|FG004|Induction Phase|Adverse Event|0|||
25212652|NCT02100696|50488506|FG005|Induction Phase|Adverse Event|0|||
25212653|NCT02100696|50488501|FG000|Induction Phase|Lost to Follow-up|1|||
25212654|NCT02100696|50488502|FG001|Induction Phase|Lost to Follow-up|0|||
25212655|NCT02100696|50488503|FG002|Induction Phase|Lost to Follow-up|1|||
25212656|NCT02100696|50488504|FG003|Induction Phase|Lost to Follow-up|0|||
25212657|NCT02100696|50488505|FG004|Induction Phase|Lost to Follow-up|0|||
25212658|NCT02100696|50488506|FG005|Induction Phase|Lost to Follow-up|0|||
25212659|NCT02100696|50488501|FG000|Induction Phase|Protocol Violation|0|||
25212660|NCT02100696|50488502|FG001|Induction Phase|Protocol Violation|1|||
25212661|NCT02100696|50488503|FG002|Induction Phase|Protocol Violation|1|||
25212662|NCT02100696|50488504|FG003|Induction Phase|Protocol Violation|0|||
25212663|NCT02100696|50488505|FG004|Induction Phase|Protocol Violation|0|||
25212664|NCT02100696|50488506|FG005|Induction Phase|Protocol Violation|0|||
25212665|NCT02100696|50488501|FG000|Induction Phase|Withdrawal by Subject|8|||
25212666|NCT02100696|50488502|FG001|Induction Phase|Withdrawal by Subject|2|||
25212667|NCT02100696|50488503|FG002|Induction Phase|Withdrawal by Subject|13|||
25212668|NCT02100696|50488504|FG003|Induction Phase|Withdrawal by Subject|0|||
25212669|NCT02100696|50488505|FG004|Induction Phase|Withdrawal by Subject|0|||
25212670|NCT02100696|50488506|FG005|Induction Phase|Withdrawal by Subject|0|||
25212671|NCT02100696|50488501|FG000|Induction Phase|Physician Decision|1|||
25212672|NCT02100696|50488502|FG001|Induction Phase|Physician Decision|0|||
25212673|NCT02100696|50488503|FG002|Induction Phase|Physician Decision|2|||
25212674|NCT02100696|50488504|FG003|Induction Phase|Physician Decision|0|||
25212675|NCT02100696|50488505|FG004|Induction Phase|Physician Decision|0|||
25212676|NCT02100696|50488506|FG005|Induction Phase|Physician Decision|0|||
25212677|NCT02100696|50488501|FG000|Induction Phase|Multiple Reasons|5|||
25212678|NCT02100696|50488502|FG001|Induction Phase|Multiple Reasons|2|||
25212679|NCT02100696|50488503|FG002|Induction Phase|Multiple Reasons|8|||
25212680|NCT02100696|50488504|FG003|Induction Phase|Multiple Reasons|0|||
25212681|NCT02100696|50488505|FG004|Induction Phase|Multiple Reasons|0|||
25212682|NCT02100696|50488506|FG005|Induction Phase|Multiple Reasons|0|||
25212683|NCT02100696|50488501|FG000|Maintenance Phase|Adverse Event|0|||
25212684|NCT02100696|50488502|FG001|Maintenance Phase|Adverse Event|0|||
25212685|NCT02100696|50488503|FG002|Maintenance Phase|Adverse Event|0|||
25212686|NCT02100696|50488504|FG003|Maintenance Phase|Adverse Event|0|||
25212687|NCT02100696|50488505|FG004|Maintenance Phase|Adverse Event|0|||
25212688|NCT02100696|50488506|FG005|Maintenance Phase|Adverse Event|2|||
25212689|NCT02100696|50488501|FG000|Maintenance Phase|Lost to Follow-up|0|||
25212690|NCT02100696|50488502|FG001|Maintenance Phase|Lost to Follow-up|0|||
25212691|NCT02100696|50488503|FG002|Maintenance Phase|Lost to Follow-up|0|||
25212692|NCT02100696|50488504|FG003|Maintenance Phase|Lost to Follow-up|0|||
25212693|NCT02100696|50488505|FG004|Maintenance Phase|Lost to Follow-up|1|||
25212694|NCT02100696|50488506|FG005|Maintenance Phase|Lost to Follow-up|0|||
25212695|NCT02100696|50488501|FG000|Maintenance Phase|Protocol Violation|0|||
25212696|NCT02100696|50488502|FG001|Maintenance Phase|Protocol Violation|0|||
25212697|NCT02100696|50488503|FG002|Maintenance Phase|Protocol Violation|0|||
25212698|NCT02100696|50488504|FG003|Maintenance Phase|Protocol Violation|0|||
25212699|NCT02100696|50488505|FG004|Maintenance Phase|Protocol Violation|1|||
25212700|NCT02100696|50488506|FG005|Maintenance Phase|Protocol Violation|0|||
25212701|NCT02100696|50488501|FG000|Maintenance Phase|Withdrawal by Subject|0|||
25212702|NCT02100696|50488502|FG001|Maintenance Phase|Withdrawal by Subject|0|||
25212703|NCT02100696|50488503|FG002|Maintenance Phase|Withdrawal by Subject|0|||
25212704|NCT02100696|50488504|FG003|Maintenance Phase|Withdrawal by Subject|1|||
25212705|NCT02100696|50488505|FG004|Maintenance Phase|Withdrawal by Subject|4|||
25212706|NCT02100696|50488506|FG005|Maintenance Phase|Withdrawal by Subject|2|||
25212707|NCT02100696|50488501|FG000|Maintenance Phase|Physician Decision|0|||
25212708|NCT02100696|50488502|FG001|Maintenance Phase|Physician Decision|0|||
25212709|NCT02100696|50488503|FG002|Maintenance Phase|Physician Decision|0|||
25212710|NCT02100696|50488504|FG003|Maintenance Phase|Physician Decision|0|||
25212711|NCT02100696|50488505|FG004|Maintenance Phase|Physician Decision|1|||
25212712|NCT02100696|50488506|FG005|Maintenance Phase|Physician Decision|0|||
25212713|NCT02100696|50488501|FG000|Maintenance Phase|Multiple Reasons|0|||
25212714|NCT02100696|50488502|FG001|Maintenance Phase|Multiple Reasons|0|||
25212715|NCT02100696|50488503|FG002|Maintenance Phase|Multiple Reasons|0|||
25212716|NCT02100696|50488504|FG003|Maintenance Phase|Multiple Reasons|0|||
25212717|NCT02100696|50488505|FG004|Maintenance Phase|Multiple Reasons|2|||
25212718|NCT02100696|50488506|FG005|Maintenance Phase|Multiple Reasons|1|||
25212719|NCT02145156|50488530|FG000|Overall Study|No match to vaccination records|60|||
25212720|NCT02145156|50488531|FG001|Overall Study|No match to vaccination records|52|||
25212721|NCT02145156|50488532|FG002|Overall Study|No match to vaccination records|41|||
25212722|NCT02123472|50488540|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
25212723|NCT02123472|50488541|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
25212724|NCT02145078|50488547|FG000|Overall Study|Death|1|||
25212725|NCT02145078|50488547|FG000|Overall Study|Reason not given|3|||
25212726|NCT02144610|50488553|FG000|Overall Study|Physician Decision|1|||
25212727|NCT02144610|50488554|FG001|Overall Study|Physician Decision|0|||
25212728|NCT02144610|50488553|FG000|Overall Study|Withdrawal by Subject|1|||
25212729|NCT02144610|50488554|FG001|Overall Study|Withdrawal by Subject|5|||
25212730|NCT02144610|50488553|FG000|Overall Study|Death|2|||
25212731|NCT02144610|50488554|FG001|Overall Study|Death|2|||
25212732|NCT02144610|50488553|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
25212733|NCT02144610|50488554|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
25212734|NCT02144610|50488553|FG000|Overall Study|Other|0|||
25212735|NCT02144610|50488554|FG001|Overall Study|Other|1|||
25212736|NCT02100228|50488562|FG000|Overall Study|Other|19|||
25212737|NCT02100228|50488563|FG001|Overall Study|Other|19|||
25212738|NCT02100228|50488562|FG000|Overall Study|Administrative reason|0|||
25212739|NCT02100228|50488563|FG001|Overall Study|Administrative reason|1|||
25212740|NCT02100228|50488562|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
25212741|NCT02100228|50488563|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
25212742|NCT02100228|50488562|FG000|Overall Study|Non-compliance|0|||
25212743|NCT02100228|50488563|FG001|Overall Study|Non-compliance|3|||
25212744|NCT02100228|50488562|FG000|Overall Study|Lost to Follow-up|0|||
25212745|NCT02100228|50488563|FG001|Overall Study|Lost to Follow-up|1|||
25212746|NCT02100228|50488562|FG000|Overall Study|Withdrawal by Subject|27|||
25212747|NCT02100228|50488563|FG001|Overall Study|Withdrawal by Subject|37|||
25212748|NCT02100228|50488562|FG000|Overall Study|Adverse Event|16|||
25212749|NCT02100228|50488563|FG001|Overall Study|Adverse Event|12|||
25212750|NCT02100228|50488562|FG000|Overall Study|Death|1|||
25212751|NCT02100228|50488563|FG001|Overall Study|Death|1|||
25212752|NCT02099838|50488571|FG000|Overall Study|Death|1|||
25212753|NCT02099838|50488572|FG001|Overall Study|Death|0|||
25212754|NCT02099838|50488571|FG000|Overall Study|Lost to Follow-up|3|||
25212755|NCT02099838|50488572|FG001|Overall Study|Lost to Follow-up|1|||
25212756|NCT02099838|50488571|FG000|Overall Study|Withdrawal by Subject|0|||
25212757|NCT02099838|50488572|FG001|Overall Study|Withdrawal by Subject|1|||
25212758|NCT02144220|50488578|FG000|Overall Study|technology incompatibility|9|||
25212759|NCT02144220|50488578|FG000|Overall Study|Lack of Efficacy|4|||
25212760|NCT02144220|50488578|FG000|Overall Study|Physician Decision|3|||
25212761|NCT02144220|50488578|FG000|Overall Study|Withdrawal by Subject|2|||
25212762|NCT02144220|50488578|FG000|Overall Study|Protocol Violation|1|||
25212763|NCT02099682|50488582|FG000|Overall Study|Data Not Available|51|||
25212764|NCT02099682|50488582|FG000|Overall Study|Lost to Follow-up|31|||
25212765|NCT02099682|50488582|FG000|Overall Study|Other|29|||
25212766|NCT02142894|50488586|FG000|Overall Study|Protocol Violation|8|||
25212767|NCT02098746|50488590|FG000|Overall Study|Changes of Investigator|2|||
25212768|NCT02098746|50488590|FG000|Overall Study|Other Miscellaneous Reasons|1|||
25212769|NCT02098746|50488590|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
25212770|NCT02098746|50488590|FG000|Overall Study|Data Not Available After Treatment|1|||
25212771|NCT02122770|50488598|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
25212772|NCT02122770|50488599|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
25212773|NCT02122770|50488600|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
25212774|NCT02122770|50488601|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
25212775|NCT02122770|50488602|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
25212776|NCT02122770|50488603|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
25212777|NCT02122770|50488598|FG000|Part A: Drug-drug Interaction 2|Other|0|||
25212778|NCT02122770|50488599|FG001|Part A: Drug-drug Interaction 2|Other|0|||
25212779|NCT02122770|50488600|FG002|Part A: Drug-drug Interaction 2|Other|1|||
25212780|NCT02122770|50488601|FG003|Part A: Drug-drug Interaction 2|Other|0|||
25212781|NCT02122770|50488602|FG004|Part A: Drug-drug Interaction 2|Other|0|||
25212782|NCT02122770|50488603|FG005|Part A: Drug-drug Interaction 2|Other|0|||
25212783|NCT02122770|50488598|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
25212784|NCT02122770|50488599|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
25212785|NCT02122770|50488600|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
25212786|NCT02122770|50488601|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
25212787|NCT02122770|50488602|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
25212788|NCT02122770|50488603|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
25212789|NCT02122770|50488598|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
25212790|NCT02122770|50488599|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
25212791|NCT02122770|50488600|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
25212792|NCT02122770|50488601|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
25212793|NCT02122770|50488602|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
25212794|NCT02122770|50488603|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
25212795|NCT02122770|50488598|FG000|Part B: Standard of Care|Adverse Event|0|||
25212796|NCT02122770|50488599|FG001|Part B: Standard of Care|Adverse Event|0|||
25212797|NCT02122770|50488600|FG002|Part B: Standard of Care|Adverse Event|0|||
25212798|NCT02122770|50488601|FG003|Part B: Standard of Care|Adverse Event|0|||
25212799|NCT02122770|50488602|FG004|Part B: Standard of Care|Adverse Event|4|||
25212800|NCT02122770|50488603|FG005|Part B: Standard of Care|Adverse Event|1|||
25212801|NCT02122770|50488598|FG000|Part B: Standard of Care|Other|0|||
25212802|NCT02122770|50488599|FG001|Part B: Standard of Care|Other|0|||
25212803|NCT02122770|50488600|FG002|Part B: Standard of Care|Other|0|||
25212804|NCT02122770|50488601|FG003|Part B: Standard of Care|Other|0|||
25212805|NCT02122770|50488602|FG004|Part B: Standard of Care|Other|0|||
25212806|NCT02122770|50488603|FG005|Part B: Standard of Care|Other|2|||
25212807|NCT02122770|50488598|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
25212808|NCT02122770|50488599|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
25212809|NCT02122770|50488600|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
25212810|NCT02122770|50488601|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
25212811|NCT02122770|50488602|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
25212812|NCT02122770|50488603|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
25212813|NCT02122770|50488598|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
25212814|NCT02122770|50488599|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
25212815|NCT02122770|50488600|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
25212816|NCT02122770|50488601|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
25212817|NCT02122770|50488602|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
25212818|NCT02122770|50488603|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
25212819|NCT02122770|50488598|FG000|Part B: Standard of Care|Progressive Disease|0|||
25212820|NCT02122770|50488599|FG001|Part B: Standard of Care|Progressive Disease|0|||
25212821|NCT02122770|50488600|FG002|Part B: Standard of Care|Progressive Disease|0|||
25212822|NCT02122770|50488601|FG003|Part B: Standard of Care|Progressive Disease|0|||
25212823|NCT02122770|50488602|FG004|Part B: Standard of Care|Progressive Disease|10|||
25316494|NCT02115282|50631971|FG000|Overall Study|Disease progression during treatment|216|||
25316495|NCT02115282|50631972|FG001|Overall Study|Disease progression during treatment|229|||
25316496|NCT02115282|50631971|FG000|Overall Study|Adverse Event|49|||
25077366|NCT00159783|50185189|FG000|Overall Study|Other|0|||
25212824|NCT02122770|50488603|FG005|Part B: Standard of Care|Progressive Disease|8|||
25212825|NCT02122380|50488628|FG000|First Intervention (30 Days)|Adverse Event|1|||
25212826|NCT02122380|50488629|FG001|First Intervention (30 Days)|Adverse Event|0|||
25212827|NCT02122380|50488628|FG000|First Intervention (30 Days)|Physician Decision|0|||
25212828|NCT02122380|50488629|FG001|First Intervention (30 Days)|Physician Decision|1|||
25212829|NCT02122380|50488628|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
25212830|NCT02122380|50488629|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
25212831|NCT02122380|50488628|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
25212832|NCT02122380|50488629|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
25212833|NCT02122380|50488628|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
25212834|NCT02122380|50488629|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
25212835|NCT02122146|50488644|FG000|Part 1: Dose Escalation|Death|0|||
25212836|NCT02122146|50488645|FG001|Part 1: Dose Escalation|Death|1|||
25212837|NCT02122146|50488646|FG002|Part 1: Dose Escalation|Death|1|||
25212838|NCT02122146|50488647|FG003|Part 1: Dose Escalation|Death|0|||
25212839|NCT02122146|50488648|FG004|Part 1: Dose Escalation|Death|0|||
25212840|NCT02122146|50488649|FG005|Part 1: Dose Escalation|Death|0|||
25212841|NCT02122146|50488650|FG006|Part 1: Dose Escalation|Death|0|||
25212842|NCT02122146|50488651|FG007|Part 1: Dose Escalation|Death|0|||
25212843|NCT02122146|50488644|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
25212844|NCT02122146|50488645|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
25212845|NCT02122146|50488646|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
25212846|NCT02122146|50488647|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
25212847|NCT02122146|50488648|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
25212848|NCT02122146|50488649|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
25212849|NCT02122146|50488650|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
25212850|NCT02122146|50488651|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
25212851|NCT02122146|50488644|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
25212852|NCT02122146|50488645|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
25212853|NCT02122146|50488646|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
25212854|NCT02122146|50488647|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
25212855|NCT02122146|50488648|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
25212856|NCT02122146|50488649|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
25212857|NCT02122146|50488650|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
25212858|NCT02122146|50488651|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
25212859|NCT02122146|50488644|FG000|Part 1: Dose Escalation|Other|1|||
25212860|NCT02122146|50488645|FG001|Part 1: Dose Escalation|Other|0|||
25212861|NCT02122146|50488646|FG002|Part 1: Dose Escalation|Other|0|||
25212862|NCT02122146|50488647|FG003|Part 1: Dose Escalation|Other|0|||
25212863|NCT02122146|50488648|FG004|Part 1: Dose Escalation|Other|0|||
25212864|NCT02122146|50488649|FG005|Part 1: Dose Escalation|Other|1|||
25212865|NCT02122146|50488650|FG006|Part 1: Dose Escalation|Other|1|||
25212866|NCT02122146|50488651|FG007|Part 1: Dose Escalation|Other|2|||
25212867|NCT02121834|50488677|FG000|Overall Study|Protocol Violation|0|||
25212868|NCT02121834|50488678|FG001|Overall Study|Protocol Violation|1|||
25212869|NCT02121834|50488679|FG002|Overall Study|Protocol Violation|0|||
25212870|NCT02121834|50488680|FG003|Overall Study|Protocol Violation|0|||
25212871|NCT02121834|50488681|FG004|Overall Study|Protocol Violation|0|||
25212872|NCT02121834|50488682|FG005|Overall Study|Protocol Violation|0|||
25212873|NCT02121834|50488683|FG006|Overall Study|Protocol Violation|0|||
25212874|NCT02121834|50488677|FG000|Overall Study|Withdrawal by Subject|0|||
25212875|NCT02121834|50488678|FG001|Overall Study|Withdrawal by Subject|1|||
25212876|NCT02121834|50488679|FG002|Overall Study|Withdrawal by Subject|1|||
25212877|NCT02121834|50488680|FG003|Overall Study|Withdrawal by Subject|0|||
25212878|NCT02121834|50488681|FG004|Overall Study|Withdrawal by Subject|0|||
25212879|NCT02121834|50488682|FG005|Overall Study|Withdrawal by Subject|0|||
25212880|NCT02121834|50488683|FG006|Overall Study|Withdrawal by Subject|0|||
25212881|NCT02121834|50488677|FG000|Overall Study|Lost to Follow-up|0|||
25212882|NCT02121834|50488678|FG001|Overall Study|Lost to Follow-up|0|||
25212883|NCT02121834|50488679|FG002|Overall Study|Lost to Follow-up|1|||
25212884|NCT02121834|50488680|FG003|Overall Study|Lost to Follow-up|0|||
25212885|NCT02121834|50488681|FG004|Overall Study|Lost to Follow-up|0|||
25212886|NCT02121834|50488682|FG005|Overall Study|Lost to Follow-up|0|||
25212887|NCT02121834|50488683|FG006|Overall Study|Lost to Follow-up|0|||
25212888|NCT02121756|50488711|FG000|Overall Study|Adverse Event|3|||
25212889|NCT02121756|50488712|FG001|Overall Study|Adverse Event|0|||
25212890|NCT02121756|50488711|FG000|Overall Study|Protocol Violation|1|||
25212891|NCT02121756|50488712|FG001|Overall Study|Protocol Violation|1|||
25212892|NCT02121756|50488711|FG000|Overall Study|Physician Decision|2|||
25212893|NCT02121756|50488712|FG001|Overall Study|Physician Decision|1|||
25316497|NCT02115282|50631972|FG001|Overall Study|Adverse Event|23|||
25212894|NCT02142504|50488724|FG000|Overall Study|Protocol Violation|2|||
25212895|NCT02142504|50488725|FG001|Overall Study|Protocol Violation|1|||
25212896|NCT02142504|50488726|FG002|Overall Study|Protocol Violation|2|||
25212897|NCT02142504|50488724|FG000|Overall Study|Adverse Event|2|||
25212898|NCT02142504|50488725|FG001|Overall Study|Adverse Event|3|||
25212899|NCT02142504|50488726|FG002|Overall Study|Adverse Event|4|||
25212900|NCT02142504|50488724|FG000|Overall Study|Lost to Follow-up|12|||
25212901|NCT02142504|50488725|FG001|Overall Study|Lost to Follow-up|19|||
25212902|NCT02142504|50488726|FG002|Overall Study|Lost to Follow-up|17|||
25212903|NCT02142504|50488724|FG000|Overall Study|Withdrawal by Subject|7|||
25212904|NCT02142504|50488725|FG001|Overall Study|Withdrawal by Subject|9|||
25212905|NCT02142504|50488726|FG002|Overall Study|Withdrawal by Subject|11|||
25212906|NCT02142504|50488724|FG000|Overall Study|Pregnancy|4|||
25212907|NCT02142504|50488725|FG001|Overall Study|Pregnancy|4|||
25212908|NCT02142504|50488726|FG002|Overall Study|Pregnancy|2|||
25212909|NCT02142504|50488724|FG000|Overall Study|Physician Decision|0|||
25212910|NCT02142504|50488725|FG001|Overall Study|Physician Decision|1|||
25212911|NCT02142504|50488726|FG002|Overall Study|Physician Decision|3|||
25212912|NCT02142504|50488724|FG000|Overall Study|Reason Not Specified|4|||
25212913|NCT02142504|50488725|FG001|Overall Study|Reason Not Specified|5|||
25212914|NCT02142504|50488726|FG002|Overall Study|Reason Not Specified|4|||
25212915|NCT02121522|50488734|FG000|Overall Study|Adverse Event|1|||
25212916|NCT02121210|50488740|FG000|Overall Study|Adverse Event|5|||
25212917|NCT02121210|50488741|FG001|Overall Study|Adverse Event|7|||
25212918|NCT02121210|50488740|FG000|Overall Study|Lack of Efficacy|2|||
25212919|NCT02121210|50488741|FG001|Overall Study|Lack of Efficacy|0|||
25212920|NCT02121210|50488740|FG000|Overall Study|Other than specified above|0|||
25212921|NCT02121210|50488741|FG001|Overall Study|Other than specified above|2|||
25212922|NCT02141490|50488750|FG000|Overall Study|Screening failures|4|||
25212923|NCT02141490|50488751|FG001|Overall Study|Screening failures|0|||
25212924|NCT02141490|50488752|FG002|Overall Study|Screening failures|0|||
25212925|NCT02097108|50488762|FG000|Overall Study|Adverse Event|1|||
25212926|NCT02097108|50488762|FG000|Overall Study|patient was abroad for 6 months|1|||
25212927|NCT02097030|50488768|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
24976376|NCT00092547|50065233|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
24976377|NCT00092547|50065234|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
24976378|NCT03802994|50065250|FG000|Overall Study|Lost to Follow-up|0|||
24976379|NCT03802994|50065251|FG001|Overall Study|Lost to Follow-up|2|||
25212928|NCT02097030|50488769|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
25212929|NCT02097030|50488768|FG000|First Intervention (3 Days)|Visual Acuity|0|||
25212930|NCT02097030|50488769|FG001|First Intervention (3 Days)|Visual Acuity|1|||
25212931|NCT02096952|50488779|FG000|Overall Study|Adverse Event|1|||
25212932|NCT02120898|50488786|FG000|Overall Study|Withdrawal by Subject|4|||
25212933|NCT02120898|50488787|FG001|Overall Study|Withdrawal by Subject|2|||
25212934|NCT02120898|50488788|FG002|Overall Study|Withdrawal by Subject|2|||
25212935|NCT02120898|50488786|FG000|Overall Study|Non-compliance with study drug|3|||
25212936|NCT02120898|50488787|FG001|Overall Study|Non-compliance with study drug|0|||
25212937|NCT02120898|50488788|FG002|Overall Study|Non-compliance with study drug|0|||
25212938|NCT02120898|50488786|FG000|Overall Study|Adverse Event|1|||
25212939|NCT02120898|50488787|FG001|Overall Study|Adverse Event|2|||
25212940|NCT02120898|50488788|FG002|Overall Study|Adverse Event|1|||
25212941|NCT02120898|50488786|FG000|Overall Study|Protocol Violation|1|||
25212942|NCT02120898|50488787|FG001|Overall Study|Protocol Violation|2|||
25212943|NCT02120898|50488788|FG002|Overall Study|Protocol Violation|0|||
25212944|NCT02120898|50488786|FG000|Overall Study|Lost to Follow-up|0|||
25212945|NCT02120898|50488787|FG001|Overall Study|Lost to Follow-up|0|||
25212946|NCT02120898|50488788|FG002|Overall Study|Lost to Follow-up|1|||
25212947|NCT02120664|50488801|FG000|Overall Study|Withdrawal by Subject|0|||
25212948|NCT02120664|50488802|FG001|Overall Study|Withdrawal by Subject|0|||
25212949|NCT02120664|50488803|FG002|Overall Study|Withdrawal by Subject|0|||
25212950|NCT02120664|50488804|FG003|Overall Study|Withdrawal by Subject|1|||
25077367|NCT00159783|50185190|FG001|Overall Study|Other|2|||
25212951|NCT02120664|50488805|FG004|Overall Study|Withdrawal by Subject|0|||
25212952|NCT01627860|50488820|FG000|Overall Study|Adverse Event|9|||
25212953|NCT01627860|50488821|FG001|Overall Study|Adverse Event|4|||
25212954|NCT01627860|50488820|FG000|Overall Study|Withdrawal by Subject|2|||
25212955|NCT01627860|50488821|FG001|Overall Study|Withdrawal by Subject|1|||
25212956|NCT01627860|50488820|FG000|Overall Study|Seizure frequency doubled|0|||
25212957|NCT01627860|50488821|FG001|Overall Study|Seizure frequency doubled|1|||
25212958|NCT01627860|50488820|FG000|Overall Study|Protocol Violation|1|||
25212959|NCT01627860|50488821|FG001|Overall Study|Protocol Violation|0|||
24976380|NCT03802994|50065252|FG002|Overall Study|Lost to Follow-up|3|||
25212960|NCT01627782|50488831|FG000|Overall Study|Adverse Event|1|||
25212961|NCT01627782|50488832|FG001|Overall Study|Adverse Event|2|||
25212962|NCT01627782|50488833|FG002|Overall Study|Adverse Event|0|||
25212963|NCT01627782|50488834|FG003|Overall Study|Adverse Event|1|||
25212964|NCT01627782|50488831|FG000|Overall Study|Lack of Efficacy|11|||
25212965|NCT01627782|50488832|FG001|Overall Study|Lack of Efficacy|1|||
25212966|NCT01627782|50488833|FG002|Overall Study|Lack of Efficacy|15|||
25212967|NCT01627782|50488834|FG003|Overall Study|Lack of Efficacy|2|||
25212968|NCT01627782|50488831|FG000|Overall Study|Protocol Violation|1|||
25212969|NCT01627782|50488832|FG001|Overall Study|Protocol Violation|0|||
25212970|NCT01627782|50488833|FG002|Overall Study|Protocol Violation|0|||
25212971|NCT01627782|50488834|FG003|Overall Study|Protocol Violation|0|||
25212972|NCT01627782|50488831|FG000|Overall Study|Withdrawal by Subject|2|||
25212973|NCT01627782|50488832|FG001|Overall Study|Withdrawal by Subject|1|||
25212974|NCT01627782|50488833|FG002|Overall Study|Withdrawal by Subject|0|||
25212975|NCT01627782|50488834|FG003|Overall Study|Withdrawal by Subject|0|||
25212976|NCT01627782|50488831|FG000|Overall Study|Other|0|||
25212977|NCT01627782|50488832|FG001|Overall Study|Other|2|||
25212978|NCT01627782|50488833|FG002|Overall Study|Other|0|||
25212979|NCT01627782|50488834|FG003|Overall Study|Other|3|||
25212980|NCT01627782|50488831|FG000|Overall Study|Randomized But Not Treated|1|||
25212981|NCT01627782|50488832|FG001|Overall Study|Randomized But Not Treated|0|||
25212982|NCT01627782|50488833|FG002|Overall Study|Randomized But Not Treated|0|||
25212983|NCT01627782|50488834|FG003|Overall Study|Randomized But Not Treated|0|||
25212984|NCT01598532|50488846|FG000|Overall Study|Lost to Follow-up|3|||
25212985|NCT01598532|50488846|FG000|Overall Study|Did not meet inclusion criteria|8|||
25212986|NCT02119650|50488855|FG000|Overall Study|Adverse Event|3|||
25212987|NCT02119650|50488856|FG001|Overall Study|Adverse Event|4|||
25212988|NCT02119650|50488855|FG000|Overall Study|Subject decision|2|||
25212989|NCT02119650|50488856|FG001|Overall Study|Subject decision|3|||
25212990|NCT02119650|50488855|FG000|Overall Study|Disease progression|11|||
25212991|NCT02119650|50488856|FG001|Overall Study|Disease progression|14|||
25212992|NCT02119650|50488855|FG000|Overall Study|Death|5|||
25212993|NCT02119650|50488856|FG001|Overall Study|Death|1|||
25212994|NCT02119650|50488855|FG000|Overall Study|Noncompliance with study treatment|1|||
25212995|NCT02119650|50488856|FG001|Overall Study|Noncompliance with study treatment|1|||
25212996|NCT02119650|50488855|FG000|Overall Study|Study terminated by the sponsor|1|||
25212997|NCT02119650|50488856|FG001|Overall Study|Study terminated by the sponsor|0|||
25212998|NCT02119650|50488855|FG000|Overall Study|Physician Decision|0|||
25212999|NCT02119650|50488856|FG001|Overall Study|Physician Decision|2|||
25213000|NCT02119650|50488855|FG000|Overall Study|Multiple reasons for termination|2|||
25213001|NCT02119650|50488856|FG001|Overall Study|Multiple reasons for termination|1|||
25213002|NCT02119416|50488865|FG000|Overall Study|Protocol Violation|1|||
25213003|NCT02119416|50488866|FG001|Overall Study|Protocol Violation|1|||
25213004|NCT02119416|50488867|FG002|Overall Study|Protocol Violation|1|||
25213005|NCT02119416|50488865|FG000|Overall Study|wrong pubertal stage|1|||
25213006|NCT02119416|50488866|FG001|Overall Study|wrong pubertal stage|0|||
25213007|NCT02119416|50488867|FG002|Overall Study|wrong pubertal stage|1|||
25213008|NCT02140164|50488878|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
25213009|NCT02119260|50488889|FG000|Overall Study|Adverse Event|1|||
25213010|NCT02119260|50488890|FG001|Overall Study|Adverse Event|0|||
25213011|NCT02119260|50488891|FG002|Overall Study|Adverse Event|0|||
25213012|NCT02119260|50488892|FG003|Overall Study|Adverse Event|0|||
25213013|NCT02119260|50488893|FG004|Overall Study|Adverse Event|0|||
25213014|NCT02119260|50488894|FG005|Overall Study|Adverse Event|0|||
25213015|NCT02119260|50488895|FG006|Overall Study|Adverse Event|0|||
25213016|NCT02119260|50488889|FG000|Overall Study|Withdrew consent|0|||
25213017|NCT02119260|50488890|FG001|Overall Study|Withdrew consent|1|||
25213018|NCT02119260|50488891|FG002|Overall Study|Withdrew consent|1|||
25213019|NCT02119260|50488892|FG003|Overall Study|Withdrew consent|0|||
25213020|NCT02119260|50488893|FG004|Overall Study|Withdrew consent|0|||
25213021|NCT02119260|50488894|FG005|Overall Study|Withdrew consent|0|||
25213022|NCT02119260|50488895|FG006|Overall Study|Withdrew consent|0|||
25213023|NCT02119104|50488920|FG000|Overall Study|Protocol Violation|16|||
25213024|NCT02119026|50488926|FG000|1st-line Treatment|Adverse Event|9|||
25213025|NCT02119026|50488927|FG001|1st-line Treatment|Adverse Event|14|||
25213026|NCT02119026|50488926|FG000|1st-line Treatment|Physician Decision|3|||
25213027|NCT02119026|50488927|FG001|1st-line Treatment|Physician Decision|8|||
25213028|NCT02119026|50488926|FG000|1st-line Treatment|Withdrawal by Subject|4|||
25213029|NCT02119026|50488927|FG001|1st-line Treatment|Withdrawal by Subject|10|||
25213030|NCT02119026|50488926|FG000|1st-line Treatment|Patient condition or compliance|6|||
25213031|NCT02119026|50488927|FG001|1st-line Treatment|Patient condition or compliance|4|||
25213032|NCT02119026|50488926|FG000|1st-line Treatment|Surgery of metastases|2|||
25213033|NCT02119026|50488927|FG001|1st-line Treatment|Surgery of metastases|1|||
25213034|NCT02119026|50488926|FG000|1st-line Treatment|Death|2|||
24976381|NCT03802994|50065253|FG003|Overall Study|Lost to Follow-up|2|||
24976382|NCT03802994|50065254|FG004|Overall Study|Lost to Follow-up|2|||
25213035|NCT02119026|50488927|FG001|1st-line Treatment|Death|1|||
25213036|NCT02119026|50488926|FG000|2nd-line Treatment|Lost to Follow-up|2|||
25213037|NCT02119026|50488927|FG001|2nd-line Treatment|Lost to Follow-up|0|||
25213038|NCT02119026|50488926|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
25213039|NCT02119026|50488927|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
25213040|NCT02119026|50488926|FG000|2nd-line Treatment|Adverse Event|4|||
25213041|NCT02119026|50488927|FG001|2nd-line Treatment|Adverse Event|1|||
25213042|NCT02095158|50488933|FG000|Overall Study|Adverse Event|14|||
25213043|NCT02095158|50488933|FG000|Overall Study|Lack of Efficacy|3|||
25213044|NCT02095158|50488933|FG000|Overall Study|Pregnancy|1|||
25213045|NCT02095158|50488933|FG000|Overall Study|Lost to Follow-up|20|||
25213046|NCT02095158|50488933|FG000|Overall Study|Personal Reasons|35|||
25213047|NCT02095158|50488933|FG000|Overall Study|Protocol Violation|1|||
25213048|NCT02095158|50488933|FG000|Overall Study|Other Miscellaneous Reasons|1|||
25213049|NCT02094612|50488939|FG000|Overall Study|Lost to Follow-up|47|||
25213050|NCT02094612|50488940|FG001|Overall Study|Lost to Follow-up|47|||
25213051|NCT02094612|50488939|FG000|Overall Study|Never started ADHD medication|32|||
25213052|NCT02094612|50488940|FG001|Overall Study|Never started ADHD medication|23|||
25213053|NCT02139306|50488948|FG000|Overall Study|Withdrawal by Subject|4|||
25213054|NCT02139306|50488949|FG001|Overall Study|Withdrawal by Subject|6|||
25213055|NCT02139306|50488948|FG000|Overall Study|Adverse Event|3|||
25213056|NCT02139306|50488949|FG001|Overall Study|Adverse Event|4|||
25213057|NCT02139306|50488948|FG000|Overall Study|Physician Decision|0|||
25213058|NCT02139306|50488949|FG001|Overall Study|Physician Decision|1|||
25213059|NCT02139306|50488948|FG000|Overall Study|Other Unspecified|2|||
25213060|NCT02139306|50488949|FG001|Overall Study|Other Unspecified|3|||
25213061|NCT02139306|50488948|FG000|Overall Study|Protocol Violation|4|||
25213062|NCT02139306|50488949|FG001|Overall Study|Protocol Violation|0|||
25213063|NCT02094300|50488956|FG000|Overall Study|Death|7|||
25213064|NCT02094300|50488956|FG000|Overall Study|Lost to Follow-up|10|||
25213065|NCT02094300|50488956|FG000|Overall Study|Still be eligible for follow-up|3|||
25213066|NCT02118792|50488962|FG000|Overall Study|Withdrawal by Subject|6|||
25213067|NCT02118792|50488963|FG001|Overall Study|Withdrawal by Subject|3|||
25213068|NCT02118792|50488962|FG000|Overall Study|Lost to Follow-up|4|||
25213069|NCT02118792|50488963|FG001|Overall Study|Lost to Follow-up|4|||
25213070|NCT02118792|50488962|FG000|Overall Study|Adverse Event|5|||
25213071|NCT02118792|50488963|FG001|Overall Study|Adverse Event|4|||
25213072|NCT02118792|50488962|FG000|Overall Study|Withdrawal by parent/guardian|14|||
25213073|NCT02118792|50488963|FG001|Overall Study|Withdrawal by parent/guardian|20|||
25213074|NCT02118792|50488962|FG000|Overall Study|Other|1|||
25213075|NCT02118792|50488963|FG001|Overall Study|Other|6|||
25213076|NCT02118792|50488962|FG000|Overall Study|Randomised but not treated|1|||
25213077|NCT02118792|50488963|FG001|Overall Study|Randomised but not treated|0|||
25213078|NCT02118714|50488971|FG000|Overall Study|Lost to Follow-up|2|||
25213079|NCT02118714|50488971|FG000|Overall Study|Protocol Violation|1|||
25213080|NCT02138916|50488978|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
25213081|NCT02138916|50488979|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
25213082|NCT02138916|50488980|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
25213083|NCT02138916|50488978|FG000|Overall Study|Death|14|||
25213084|NCT02138916|50488979|FG001|Overall Study|Death|11|||
25213085|NCT02138916|50488980|FG002|Overall Study|Death|12|||
25213086|NCT02138916|50488978|FG000|Overall Study|Withdrawal by Subject|27|||
25213087|NCT02138916|50488979|FG001|Overall Study|Withdrawal by Subject|31|||
25213088|NCT02138916|50488980|FG002|Overall Study|Withdrawal by Subject|32|||
25213089|NCT02138916|50488978|FG000|Overall Study|Study specific withdrawal criteria|0|||
25213090|NCT02138916|50488979|FG001|Overall Study|Study specific withdrawal criteria|0|||
25213091|NCT02138916|50488980|FG002|Overall Study|Study specific withdrawal criteria|1|||
25213092|NCT02138916|50488978|FG000|Overall Study|incorrect enrolment|1|||
25213093|NCT02138916|50488979|FG001|Overall Study|incorrect enrolment|1|||
25213094|NCT02138916|50488980|FG002|Overall Study|incorrect enrolment|0|||
25213095|NCT02138916|50488978|FG000|Overall Study|Severe non-compliance|1|||
25213096|NCT02138916|50488979|FG001|Overall Study|Severe non-compliance|2|||
25213097|NCT02138916|50488980|FG002|Overall Study|Severe non-compliance|1|||
25213098|NCT02138916|50488978|FG000|Overall Study|Lost to Follow-up|4|||
25213099|NCT02138916|50488979|FG001|Overall Study|Lost to Follow-up|2|||
25213100|NCT02138916|50488980|FG002|Overall Study|Lost to Follow-up|3|||
25213101|NCT02138916|50488978|FG000|Overall Study|Adverse Event|4|||
25213102|NCT02138916|50488979|FG001|Overall Study|Adverse Event|4|||
25213103|NCT02138916|50488980|FG002|Overall Study|Adverse Event|3|||
25213104|NCT02118012|50488990|FG000|Overall Study|Adverse Event|0|||
25213105|NCT02118012|50488991|FG001|Overall Study|Adverse Event|1|||
25213106|NCT02118012|50488990|FG000|Overall Study|Physician Decision|0|||
25213107|NCT02118012|50488991|FG001|Overall Study|Physician Decision|1|||
25213108|NCT02093520|50488999|FG000|Overall Study|Not treated|6|||
25213109|NCT02093520|50489000|FG001|Overall Study|Not treated|22|||
25213110|NCT02138838|50489008|FG000|Overall Study|Study Closure|7|||
25213111|NCT02138838|50489009|FG001|Overall Study|Study Closure|6|||
25213112|NCT02138838|50489008|FG000|Overall Study|Withdrawal by Subject|1|||
25213113|NCT02138838|50489009|FG001|Overall Study|Withdrawal by Subject|5|||
25213114|NCT02138214|50489018|FG000|Overall Study|Withdrawal by Subject|0|||
25213115|NCT02138214|50489019|FG001|Overall Study|Withdrawal by Subject|1|||
25213116|NCT02138214|50489020|FG002|Overall Study|Withdrawal by Subject|0|||
25213117|NCT02138214|50489018|FG000|Overall Study|Lost to Follow-up|0|||
25213118|NCT02138214|50489019|FG001|Overall Study|Lost to Follow-up|2|||
25213119|NCT02138214|50489020|FG002|Overall Study|Lost to Follow-up|4|||
25213120|NCT02138214|50489018|FG000|Overall Study|Screen Failure|0|||
25213121|NCT02138214|50489019|FG001|Overall Study|Screen Failure|1|||
25213122|NCT02138214|50489020|FG002|Overall Study|Screen Failure|0|||
25213123|NCT02092662|50489029|FG000|Overall Study|Lost to Follow-up|13|||
25213124|NCT02092662|50489030|FG001|Overall Study|Lost to Follow-up|0|||
25213125|NCT02092350|50489039|FG000|Overall Study|Adverse Event|0|||
25213126|NCT02092350|50489040|FG001|Overall Study|Adverse Event|3|||
25213127|NCT02092350|50489039|FG000|Overall Study|Death|2|||
25213128|NCT02092350|50489040|FG001|Overall Study|Death|5|||
25213129|NCT02092350|50489039|FG000|Overall Study|Lost to Follow-up|3|||
25213130|NCT02092350|50489040|FG001|Overall Study|Lost to Follow-up|1|||
25213131|NCT02092350|50489039|FG000|Overall Study|Protocol Violation|1|||
25213132|NCT02092350|50489040|FG001|Overall Study|Protocol Violation|0|||
25213133|NCT02092350|50489039|FG000|Overall Study|Physician Decision|1|||
25213134|NCT02092350|50489040|FG001|Overall Study|Physician Decision|1|||
25213135|NCT02092350|50489039|FG000|Overall Study|Screen Failure|1|||
25213136|NCT02092350|50489040|FG001|Overall Study|Screen Failure|0|||
25213137|NCT02092350|50489039|FG000|Overall Study|Withdrawal by Subject|2|||
25213138|NCT02092350|50489040|FG001|Overall Study|Withdrawal by Subject|2|||
25213139|NCT02117544|50489048|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
25213140|NCT02117544|50489049|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
25213141|NCT02138136|50489056|FG000|Overall Study|Protocol Violation|4|||
25213142|NCT02138136|50489056|FG000|Overall Study|Physician Decision|7|||
25213143|NCT02138136|50489056|FG000|Overall Study|Lack of Efficacy|35|||
25213144|NCT02138136|50489056|FG000|Overall Study|Pregnancy|2|||
25213145|NCT02138136|50489056|FG000|Overall Study|Adverse Event|18|||
25213146|NCT02138136|50489056|FG000|Overall Study|Withdrawal by Subject|36|||
25213147|NCT02138136|50489056|FG000|Overall Study|Lost to Follow-up|32|||
25213148|NCT02138136|50489056|FG000|Overall Study|Withdrawn by Sponsor|5|||
25213149|NCT01626690|50489063|FG000|Overall Study|Protocol Violation|1|||
25213150|NCT01626690|50489064|FG001|Overall Study|Protocol Violation|0|||
25213151|NCT01626690|50489063|FG000|Overall Study|Adverse Event|1|||
25213152|NCT01626690|50489064|FG001|Overall Study|Adverse Event|0|||
25213153|NCT01626456|50489074|FG000|Overall Study|Withdrawal by Subject|21|||
25213154|NCT01626456|50489075|FG001|Overall Study|Withdrawal by Subject|46|||
25213155|NCT01626456|50489074|FG000|Overall Study|Adverse Event|2|||
25213156|NCT01626456|50489075|FG001|Overall Study|Adverse Event|27|||
25213157|NCT01626456|50489074|FG000|Overall Study|Lost to Follow-up|2|||
25213158|NCT01626456|50489075|FG001|Overall Study|Lost to Follow-up|27|||
25213159|NCT01626456|50489074|FG000|Overall Study|Lack of Efficacy|6|||
25213160|NCT01626456|50489075|FG001|Overall Study|Lack of Efficacy|7|||
25213161|NCT01626456|50489074|FG000|Overall Study|Physician Decision|1|||
25213162|NCT01626456|50489075|FG001|Overall Study|Physician Decision|4|||
25213163|NCT01626456|50489074|FG000|Overall Study|Protocol Violation|1|||
25213164|NCT01626456|50489075|FG001|Overall Study|Protocol Violation|1|||
25213165|NCT01626456|50489074|FG000|Overall Study|Site Closure|2|||
25213166|NCT01626456|50489075|FG001|Overall Study|Site Closure|3|||
25213167|NCT01626456|50489074|FG000|Overall Study|Incarceration|0|||
25213168|NCT01626456|50489075|FG001|Overall Study|Incarceration|2|||
25213169|NCT02116608|50489093|FG000|Overall Study|Lost to Follow-up|0|||
25213170|NCT02116608|50489094|FG001|Overall Study|Lost to Follow-up|0|||
25213171|NCT02116608|50489095|FG002|Overall Study|Lost to Follow-up|1|||
25213172|NCT02116608|50489093|FG000|Overall Study|Physician Decision|0|||
25213173|NCT02116608|50489094|FG001|Overall Study|Physician Decision|1|||
25213174|NCT02116608|50489095|FG002|Overall Study|Physician Decision|0|||
25213175|NCT02116608|50489093|FG000|Overall Study|Death|0|||
25213176|NCT02116608|50489094|FG001|Overall Study|Death|1|||
25213177|NCT02116608|50489095|FG002|Overall Study|Death|0|||
25213178|NCT02092116|50489105|FG000|Overall Study|Withdrawal by Subject|0|||
25213179|NCT02092116|50489106|FG001|Overall Study|Withdrawal by Subject|3|||
25213180|NCT02092116|50489105|FG000|Overall Study|Adverse Event|0|||
25213181|NCT02092116|50489106|FG001|Overall Study|Adverse Event|1|||
25213182|NCT02091726|50489112|FG000|Overall Study|Lost to Follow-up|6|||
25213183|NCT02091414|50489116|FG000|Overall Study|Withdrawal by Subject|2|||
25213184|NCT02091414|50489116|FG000|Overall Study|Death|2|||
25213185|NCT02116530|50489122|FG000|Overall Study|Withdrawal by Subject|1|||
25213186|NCT02116530|50489123|FG001|Overall Study|Withdrawal by Subject|2|||
25213187|NCT02116530|50489122|FG000|Overall Study|Adverse Event|4|||
25213188|NCT02116530|50489123|FG001|Overall Study|Adverse Event|0|||
25213189|NCT02116530|50489122|FG000|Overall Study|Physician Decision|1|||
25213190|NCT02116530|50489123|FG001|Overall Study|Physician Decision|0|||
25213191|NCT02116530|50489122|FG000|Overall Study|Lost to Follow-up|1|||
25213192|NCT02116530|50489123|FG001|Overall Study|Lost to Follow-up|0|||
25213193|NCT02116530|50489122|FG000|Overall Study|Other Medical Problems|2|||
25213194|NCT02116530|50489123|FG001|Overall Study|Other Medical Problems|2|||
25213195|NCT02072226|50489131|FG000|Overall Study|Lost to Follow-up|11|||
25213196|NCT02072226|50489132|FG001|Overall Study|Lost to Follow-up|7|||
25213197|NCT02072226|50489131|FG000|Overall Study|Patient Non-compliance|2|||
25213198|NCT02072226|50489132|FG001|Overall Study|Patient Non-compliance|3|||
25213199|NCT02072226|50489131|FG000|Overall Study|Death|1|||
25213200|NCT02072226|50489132|FG001|Overall Study|Death|0|||
25213201|NCT02072226|50489131|FG000|Overall Study|Patient Withdrawal of Consent|1|||
25213202|NCT02072226|50489132|FG001|Overall Study|Patient Withdrawal of Consent|0|||
25213203|NCT02090634|50489140|FG000|Overall Study|Lost to Follow-up|0|||
25213204|NCT02090634|50489141|FG001|Overall Study|Lost to Follow-up|1|||
25213205|NCT02090634|50489140|FG000|Overall Study|Death|0|||
25213206|NCT02090634|50489141|FG001|Overall Study|Death|1|||
25213207|NCT02090634|50489140|FG000|Overall Study|Protocol Violation|3|||
25213208|NCT02090634|50489141|FG001|Overall Study|Protocol Violation|1|||
25213209|NCT02090634|50489140|FG000|Overall Study|Adverse Event|2|||
25213210|NCT02090634|50489141|FG001|Overall Study|Adverse Event|0|||
25213211|NCT02114892|50489149|FG000|Overall Study|Lost to Follow-up|1|||
25213212|NCT02114892|50489150|FG001|Overall Study|Lost to Follow-up|2|||
25213213|NCT02070978|50489159|FG000|Overall Study|Adverse Event|6|||
25213214|NCT02070978|50489160|FG001|Overall Study|Adverse Event|2|||
25213215|NCT02070978|50489161|FG002|Overall Study|Adverse Event|0|||
25213216|NCT02070978|50489159|FG000|Overall Study|Lost to Follow-up|1|||
25213217|NCT02070978|50489160|FG001|Overall Study|Lost to Follow-up|3|||
25213218|NCT02070978|50489161|FG002|Overall Study|Lost to Follow-up|4|||
25213219|NCT02070978|50489159|FG000|Overall Study|Withdrawal by Subject|3|||
25213220|NCT02070978|50489160|FG001|Overall Study|Withdrawal by Subject|5|||
25213221|NCT02070978|50489161|FG002|Overall Study|Withdrawal by Subject|3|||
25213222|NCT02070978|50489159|FG000|Overall Study|Protocol Violation|1|||
25213223|NCT02070978|50489160|FG001|Overall Study|Protocol Violation|0|||
25213224|NCT02070978|50489161|FG002|Overall Study|Protocol Violation|3|||
25213225|NCT02070978|50489159|FG000|Overall Study|Lack of Efficacy|0|||
25213226|NCT02070978|50489160|FG001|Overall Study|Lack of Efficacy|1|||
25213227|NCT02070978|50489161|FG002|Overall Study|Lack of Efficacy|0|||
25213228|NCT02070978|50489159|FG000|Overall Study|Death|0|||
25213229|NCT02070978|50489160|FG001|Overall Study|Death|0|||
25213230|NCT02070978|50489161|FG002|Overall Study|Death|2|||
25213231|NCT02070978|50489159|FG000|Overall Study|Un-specified|3|||
25213232|NCT02070978|50489160|FG001|Overall Study|Un-specified|2|||
25213233|NCT02070978|50489161|FG002|Overall Study|Un-specified|2|||
25213234|NCT02070978|50489159|FG000|Overall Study|Terminated by Sponsor|33|||
25213235|NCT02070978|50489160|FG001|Overall Study|Terminated by Sponsor|40|||
25213236|NCT02070978|50489161|FG002|Overall Study|Terminated by Sponsor|39|||
25213237|NCT02114268|50489175|FG000|Overall Study|Lost to Follow-up|4|||
25213238|NCT02114268|50489176|FG001|Overall Study|Lost to Follow-up|1|||
25213239|NCT02114268|50489177|FG002|Overall Study|Lost to Follow-up|1|||
25213240|NCT02114268|50489178|FG003|Overall Study|Lost to Follow-up|0|||
25213241|NCT02114268|50489179|FG004|Overall Study|Lost to Follow-up|0|||
25213242|NCT02114268|50489180|FG005|Overall Study|Lost to Follow-up|2|||
25213243|NCT02114268|50489175|FG000|Overall Study|Withdrawal by Subject|1|||
25213244|NCT02114268|50489176|FG001|Overall Study|Withdrawal by Subject|0|||
25316498|NCT02115282|50631971|FG000|Overall Study|Death|1|||
25316499|NCT02115282|50631972|FG001|Overall Study|Death|3|||
25316500|NCT02115282|50631971|FG000|Overall Study|Alternative therapy|1|||
25316501|NCT02115282|50631972|FG001|Overall Study|Alternative therapy|1|||
25316502|NCT02115282|50631971|FG000|Overall Study|Complicating disease|0|||
25316503|NCT02115282|50631972|FG001|Overall Study|Complicating disease|3|||
25316504|NCT02115282|50631971|FG000|Overall Study|Withdrawal by Subject|12|||
25316505|NCT02115282|50631972|FG001|Overall Study|Withdrawal by Subject|10|||
25316506|NCT02115282|50631971|FG000|Overall Study|Symptomatic progression/deterioration|7|||
25316507|NCT02115282|50631972|FG001|Overall Study|Symptomatic progression/deterioration|18|||
25316508|NCT02115282|50631971|FG000|Overall Study|Non-compliance|5|||
25316509|NCT02115282|50631972|FG001|Overall Study|Non-compliance|1|||
25316510|NCT02115282|50631971|FG000|Overall Study|Protocol Violation|2|||
25316511|NCT02115282|50631972|FG001|Overall Study|Protocol Violation|2|||
25316512|NCT02115282|50631971|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
25316513|NCT02115282|50631972|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
25316514|NCT02115282|50631971|FG000|Overall Study|Not start protocol therapy|9|||
25213245|NCT02114268|50489177|FG002|Overall Study|Withdrawal by Subject|0|||
25213246|NCT02114268|50489178|FG003|Overall Study|Withdrawal by Subject|0|||
25213247|NCT02114268|50489179|FG004|Overall Study|Withdrawal by Subject|0|||
25213248|NCT02114268|50489180|FG005|Overall Study|Withdrawal by Subject|1|||
25213249|NCT02114268|50489175|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
25213250|NCT02114268|50489176|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
25316515|NCT02115282|50631972|FG001|Overall Study|Not start protocol therapy|10|||
25316516|NCT01596621|50631980|FG000|Overall Study|Death|4|||
25316517|NCT01596621|50631980|FG000|Overall Study|Withdrawal by Subject|9|||
25316518|NCT01596621|50631980|FG000|Overall Study|Disease Progression|49|||
25316519|NCT01596621|50631980|FG000|Overall Study|Lost to Follow-up|3|||
25316520|NCT01596621|50631980|FG000|Overall Study|Other than specified|13|||
25213251|NCT02114268|50489177|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
25213252|NCT02114268|50489178|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
25213253|NCT02114268|50489179|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
25213254|NCT02114268|50489180|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
25213255|NCT02089230|50489202|FG000|Overall Study|Death|0|||
25213256|NCT02089230|50489203|FG001|Overall Study|Death|0|||
25213257|NCT02089230|50489204|FG002|Overall Study|Death|2|||
25213258|NCT02089230|50489202|FG000|Overall Study|Seeking Alternative Therapy|0|||
25213259|NCT02089230|50489203|FG001|Overall Study|Seeking Alternative Therapy|0|||
25213260|NCT02089230|50489204|FG002|Overall Study|Seeking Alternative Therapy|4|||
25213261|NCT02070744|50489216|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
25213262|NCT02070744|50489217|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
25213263|NCT02070744|50489218|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
25213264|NCT02070744|50489219|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
25213265|NCT02070744|50489220|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
25213266|NCT02070744|50489216|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
25213267|NCT02070744|50489217|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
25213268|NCT02070744|50489218|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
25213269|NCT02070744|50489219|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
25213270|NCT02070744|50489220|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
25213271|NCT02070744|50489216|FG000|OLE Phase (48 Weeks)|Other|0|||
25213272|NCT02070744|50489217|FG001|OLE Phase (48 Weeks)|Other|0|||
25213273|NCT02070744|50489218|FG002|OLE Phase (48 Weeks)|Other|0|||
25213274|NCT02070744|50489219|FG003|OLE Phase (48 Weeks)|Other|0|||
25213275|NCT02070744|50489220|FG004|OLE Phase (48 Weeks)|Other|1|||
25213276|NCT02113956|50489237|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
25213277|NCT02113956|50489238|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
25213278|NCT02113956|50489237|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
25213279|NCT02113956|50489238|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
25213280|NCT02113956|50489237|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
25213281|NCT02113956|50489238|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
25213282|NCT02070588|50489247|FG000|Overall Study|Withdrawal by Subject|29|||
25213283|NCT02070588|50489248|FG001|Overall Study|Withdrawal by Subject|1|||
25213284|NCT02070588|50489249|FG002|Overall Study|Withdrawal by Subject|0|||
25213285|NCT02070588|50489247|FG000|Overall Study|Writhdrawal due to early termination|9|||
25213286|NCT02070588|50489248|FG001|Overall Study|Writhdrawal due to early termination|0|||
25213287|NCT02070588|50489249|FG002|Overall Study|Writhdrawal due to early termination|0|||
25213288|NCT02070588|50489247|FG000|Overall Study|Adverse Event|1|||
25213289|NCT02070588|50489248|FG001|Overall Study|Adverse Event|0|||
25213290|NCT02070588|50489249|FG002|Overall Study|Adverse Event|0|||
25213291|NCT02111850|50489268|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
25213292|NCT02111850|50489269|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
25213293|NCT02111850|50489270|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
25213294|NCT02111850|50489271|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
25213295|NCT02111850|50489272|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
25213296|NCT02111850|50489273|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
25213297|NCT02111850|50489274|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
25213298|NCT02111850|50489275|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
25213299|NCT02111850|50489276|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
25213300|NCT02111850|50489277|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
25213301|NCT02111850|50489278|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
25213302|NCT02087904|50489308|FG000|Overall Study|Did Not Receive Study Drug|0|||
25213303|NCT02087904|50489309|FG001|Overall Study|Did Not Receive Study Drug|0|||
25213304|NCT02087904|50489310|FG002|Overall Study|Did Not Receive Study Drug|2|||
25213305|NCT02087904|50489311|FG003|Overall Study|Did Not Receive Study Drug|1|||
25213306|NCT02087904|50489308|FG000|Overall Study|Adverse Event|8|||
25213307|NCT02087904|50489309|FG001|Overall Study|Adverse Event|4|||
25213308|NCT02087904|50489310|FG002|Overall Study|Adverse Event|4|||
25213309|NCT02087904|50489311|FG003|Overall Study|Adverse Event|12|||
25213310|NCT02087904|50489308|FG000|Overall Study|Lack of Efficacy|3|||
25213311|NCT02087904|50489309|FG001|Overall Study|Lack of Efficacy|6|||
25213312|NCT02087904|50489310|FG002|Overall Study|Lack of Efficacy|3|||
25213313|NCT02087904|50489311|FG003|Overall Study|Lack of Efficacy|2|||
25213314|NCT02087904|50489308|FG000|Overall Study|Other|6|||
25213315|NCT02087904|50489309|FG001|Overall Study|Other|2|||
25213316|NCT02087904|50489310|FG002|Overall Study|Other|4|||
25213317|NCT02087904|50489311|FG003|Overall Study|Other|4|||
25213318|NCT02087904|50489308|FG000|Overall Study|Withdrawal by Subject|8|||
25213319|NCT02087904|50489309|FG001|Overall Study|Withdrawal by Subject|3|||
25213320|NCT02087904|50489310|FG002|Overall Study|Withdrawal by Subject|7|||
25316521|NCT01337245|50631984|FG000|Overall Study|Lost to Follow-up|1|||
25213321|NCT02087904|50489311|FG003|Overall Study|Withdrawal by Subject|4|||
25213322|NCT02087904|50489308|FG000|Overall Study|Lost to Follow-up|0|||
25213323|NCT02087904|50489309|FG001|Overall Study|Lost to Follow-up|4|||
25213324|NCT02087904|50489310|FG002|Overall Study|Lost to Follow-up|2|||
25213325|NCT02087904|50489311|FG003|Overall Study|Lost to Follow-up|2|||
25213326|NCT02087670|50489323|FG000|Overall Study|Withdrawal by Subject|3|||
25213327|NCT02087670|50489324|FG001|Overall Study|Withdrawal by Subject|2|||
25213328|NCT02086968|50489332|FG000|Overall Study|Adverse Event|1|||
25213329|NCT02086968|50489333|FG001|Overall Study|Adverse Event|5|||
25213330|NCT02086968|50489332|FG000|Overall Study|Lost to Follow-up|2|||
25213331|NCT02086968|50489333|FG001|Overall Study|Lost to Follow-up|3|||
25213332|NCT02086968|50489332|FG000|Overall Study|Study drug received outside protocol|0|||
25213333|NCT02086968|50489333|FG001|Overall Study|Study drug received outside protocol|1|||
25213334|NCT02086968|50489332|FG000|Overall Study|Physician Decision|4|||
25213335|NCT02086968|50489333|FG001|Overall Study|Physician Decision|0|||
25213336|NCT02086968|50489332|FG000|Overall Study|Withdrawal by Subject|1|||
25213337|NCT02086968|50489333|FG001|Overall Study|Withdrawal by Subject|4|||
25213338|NCT02086110|50489341|FG000|Overall Study|Withdrawal by Subject|1|||
25213339|NCT02086110|50489342|FG001|Overall Study|Withdrawal by Subject|1|||
25213340|NCT02085252|50489351|FG000|Overall Study|Withdrawal of Consent|1|||
25213341|NCT02085252|50489352|FG001|Overall Study|Withdrawal of Consent|0|||
25213342|NCT02085252|50489351|FG000|Overall Study|Adverse Event|0|||
25213343|NCT02085252|50489352|FG001|Overall Study|Adverse Event|1|||
25213344|NCT02085252|50489351|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
25213345|NCT02085252|50489352|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
25213346|NCT02085252|50489351|FG000|Overall Study|Reason Not Specified|0|||
25213347|NCT02085252|50489352|FG001|Overall Study|Reason Not Specified|1|||
25213348|NCT02085252|50489351|FG000|Overall Study|Reason Unknown|0|||
25213349|NCT02085252|50489352|FG001|Overall Study|Reason Unknown|1|||
25213350|NCT02084238|50489358|FG000|Overall Study|Lost to Follow-up|2|||
25213351|NCT02084082|50489371|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
25213352|NCT02084082|50489372|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
25213353|NCT02084082|50489373|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
25213354|NCT02084082|50489374|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
25213355|NCT02084082|50489371|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
25213356|NCT02084082|50489372|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
25213357|NCT02084082|50489373|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
25213358|NCT02084082|50489374|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
25213359|NCT02083926|50489386|FG000|Overall Study|Withdrawal by Subject|1|||
25213360|NCT02083926|50489387|FG001|Overall Study|Withdrawal by Subject|0|||
25213361|NCT02083380|50489397|FG000|Overall Study|Lack of Efficacy|68|||
25213362|NCT02083380|50489398|FG001|Overall Study|Lack of Efficacy|79|||
25213363|NCT02083380|50489399|FG002|Overall Study|Lack of Efficacy|64|||
25213364|NCT02083380|50489397|FG000|Overall Study|Withdrawal by Subject|9|||
25213365|NCT02083380|50489398|FG001|Overall Study|Withdrawal by Subject|3|||
25213366|NCT02083380|50489399|FG002|Overall Study|Withdrawal by Subject|7|||
25213367|NCT02083380|50489397|FG000|Overall Study|Physician Decision|1|||
25213368|NCT02083380|50489398|FG001|Overall Study|Physician Decision|6|||
25213369|NCT02083380|50489399|FG002|Overall Study|Physician Decision|3|||
25213370|NCT02083380|50489397|FG000|Overall Study|Adverse Event|0|||
25213371|NCT02083380|50489398|FG001|Overall Study|Adverse Event|0|||
25213372|NCT02083380|50489399|FG002|Overall Study|Adverse Event|1|||
25213373|NCT02083380|50489397|FG000|Overall Study|Lost to Follow-up|5|||
25213374|NCT02083380|50489398|FG001|Overall Study|Lost to Follow-up|3|||
25213375|NCT02083380|50489399|FG002|Overall Study|Lost to Follow-up|3|||
25213376|NCT02083380|50489397|FG000|Overall Study|Other|8|||
25213377|NCT02083380|50489398|FG001|Overall Study|Other|4|||
25213378|NCT02083380|50489399|FG002|Overall Study|Other|6|||
25213379|NCT02109744|50489414|FG000|Overall Study|Death|1|||
25213380|NCT02109744|50489415|FG001|Overall Study|Death|1|||
25213381|NCT02109744|50489414|FG000|Overall Study|no marrow exam|1|||
25213382|NCT02109744|50489415|FG001|Overall Study|no marrow exam|0|||
25213383|NCT02109432|50489421|FG000|Overall Study|Withdrawal by Subject|1|||
25213384|NCT02109042|50489425|FG000|Overall Study|Sponsor Decision|15|||
25213385|NCT02066922|50489430|FG000|Overall Study|Adverse Event|1|||
25213386|NCT02108262|50489441|FG000|Overall Study|Non-compliance|0|||
25213387|NCT02108262|50489442|FG001|Overall Study|Non-compliance|2|||
25213388|NCT02108262|50489443|FG002|Overall Study|Non-compliance|1|||
25213389|NCT02108262|50489444|FG003|Overall Study|Non-compliance|1|||
25213390|NCT02108262|50489441|FG000|Overall Study|Randomized by error/screen failure|0|||
25213391|NCT02108262|50489442|FG001|Overall Study|Randomized by error/screen failure|0|||
25213392|NCT02108262|50489443|FG002|Overall Study|Randomized by error/screen failure|1|||
25213393|NCT02108262|50489444|FG003|Overall Study|Randomized by error/screen failure|0|||
25213394|NCT02108262|50489441|FG000|Overall Study|Distance to center|0|||
25213395|NCT02108262|50489442|FG001|Overall Study|Distance to center|1|||
25213396|NCT02108262|50489443|FG002|Overall Study|Distance to center|1|||
25213397|NCT02108262|50489444|FG003|Overall Study|Distance to center|0|||
25213398|NCT02108262|50489441|FG000|Overall Study|Adverse Event|0|||
25213399|NCT02108262|50489442|FG001|Overall Study|Adverse Event|11|||
25213400|NCT02108262|50489443|FG002|Overall Study|Adverse Event|6|||
25213401|NCT02108262|50489444|FG003|Overall Study|Adverse Event|12|||
25213402|NCT02108262|50489441|FG000|Overall Study|Death|0|||
25213403|NCT02108262|50489442|FG001|Overall Study|Death|2|||
25213404|NCT02108262|50489443|FG002|Overall Study|Death|2|||
25213405|NCT02108262|50489444|FG003|Overall Study|Death|1|||
25213406|NCT02108262|50489441|FG000|Overall Study|Lost to Follow-up|0|||
25213407|NCT02108262|50489442|FG001|Overall Study|Lost to Follow-up|0|||
25213408|NCT02108262|50489443|FG002|Overall Study|Lost to Follow-up|1|||
25213409|NCT02108262|50489444|FG003|Overall Study|Lost to Follow-up|0|||
25213410|NCT02108262|50489441|FG000|Overall Study|Physician Decision|0|||
25213411|NCT02108262|50489442|FG001|Overall Study|Physician Decision|0|||
25213412|NCT02108262|50489443|FG002|Overall Study|Physician Decision|2|||
25213413|NCT02108262|50489444|FG003|Overall Study|Physician Decision|0|||
25213414|NCT02108262|50489441|FG000|Overall Study|Withdrawal by Subject|0|||
25213415|NCT02108262|50489442|FG001|Overall Study|Withdrawal by Subject|7|||
25213416|NCT02108262|50489443|FG002|Overall Study|Withdrawal by Subject|3|||
25213417|NCT02108262|50489444|FG003|Overall Study|Withdrawal by Subject|4|||
25213418|NCT02108262|50489441|FG000|Overall Study|Due to key hepatic values|0|||
25213419|NCT02108262|50489442|FG001|Overall Study|Due to key hepatic values|1|||
25213420|NCT02108262|50489443|FG002|Overall Study|Due to key hepatic values|0|||
25213421|NCT02108262|50489444|FG003|Overall Study|Due to key hepatic values|0|||
25213422|NCT02108262|50489441|FG000|Overall Study|Unable to contact patient|0|||
25213423|NCT02108262|50489442|FG001|Overall Study|Unable to contact patient|3|||
25213424|NCT02108262|50489443|FG002|Overall Study|Unable to contact patient|1|||
25213425|NCT02108262|50489444|FG003|Overall Study|Unable to contact patient|2|||
25213426|NCT02108262|50489441|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
25213427|NCT02108262|50489442|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
25213428|NCT02108262|50489443|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
25213429|NCT02108262|50489444|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
25213430|NCT02108262|50489441|FG000|Overall Study|Patient did not want another infusion|0|||
25213431|NCT02108262|50489442|FG001|Overall Study|Patient did not want another infusion|3|||
25213432|NCT02108262|50489443|FG002|Overall Study|Patient did not want another infusion|3|||
25213433|NCT02108262|50489444|FG003|Overall Study|Patient did not want another infusion|2|||
25213434|NCT02108262|50489441|FG000|Overall Study|Vacation|0|||
25213435|NCT02108262|50489442|FG001|Overall Study|Vacation|1|||
25213436|NCT02108262|50489443|FG002|Overall Study|Vacation|0|||
25213437|NCT02108262|50489444|FG003|Overall Study|Vacation|0|||
25213438|NCT02108262|50489441|FG000|Overall Study|Patient decision|0|||
25213439|NCT02108262|50489442|FG001|Overall Study|Patient decision|7|||
25213440|NCT02108262|50489443|FG002|Overall Study|Patient decision|9|||
25213441|NCT02108262|50489444|FG003|Overall Study|Patient decision|14|||
25213442|NCT02108262|50489441|FG000|Overall Study|Missed IV due to pharmacy error|0|||
25213443|NCT02108262|50489442|FG001|Overall Study|Missed IV due to pharmacy error|0|||
25213444|NCT02108262|50489443|FG002|Overall Study|Missed IV due to pharmacy error|1|||
25213445|NCT02108262|50489444|FG003|Overall Study|Missed IV due to pharmacy error|0|||
25213446|NCT02107482|50489453|FG000|Overall Study|inconveinence|2|||
25213447|NCT02107482|50489453|FG000|Overall Study|Lost to Follow-up|1|||
25213448|NCT02107482|50489453|FG000|Overall Study|Lack of Efficacy|1|||
25213449|NCT02066298|50489463|FG000|Overall Study|Lost to Follow-up|3|||
25213450|NCT02066298|50489464|FG001|Overall Study|Lost to Follow-up|2|||
25213451|NCT02066298|50489465|FG002|Overall Study|Lost to Follow-up|3|||
25213452|NCT02066298|50489466|FG003|Overall Study|Lost to Follow-up|2|||
25213453|NCT02066298|50489467|FG004|Overall Study|Lost to Follow-up|3|||
25213454|NCT02066298|50489468|FG005|Overall Study|Lost to Follow-up|4|||
25213455|NCT02066298|50489463|FG000|Overall Study|Withdrawal by Subject|6|||
25213456|NCT02066298|50489464|FG001|Overall Study|Withdrawal by Subject|6|||
25213457|NCT02066298|50489465|FG002|Overall Study|Withdrawal by Subject|6|||
25213458|NCT02066298|50489466|FG003|Overall Study|Withdrawal by Subject|4|||
25213459|NCT02066298|50489467|FG004|Overall Study|Withdrawal by Subject|5|||
25213460|NCT02066298|50489468|FG005|Overall Study|Withdrawal by Subject|8|||
25213461|NCT02066298|50489463|FG000|Overall Study|Physician Decision|0|||
25213462|NCT02066298|50489464|FG001|Overall Study|Physician Decision|0|||
25213463|NCT02066298|50489465|FG002|Overall Study|Physician Decision|1|||
25213464|NCT02066298|50489466|FG003|Overall Study|Physician Decision|0|||
25213465|NCT02066298|50489467|FG004|Overall Study|Physician Decision|1|||
25213466|NCT02066298|50489468|FG005|Overall Study|Physician Decision|0|||
25213467|NCT02082912|50489482|FG000|Overall Study|Physician Decision|0|||
25213468|NCT02082912|50489483|FG001|Overall Study|Physician Decision|1|||
25213469|NCT02082522|50489491|FG000|Overall Study|Sponsor termination|5|||
25213470|NCT02082522|50489492|FG001|Overall Study|Sponsor termination|3|||
25213471|NCT02082522|50489491|FG000|Overall Study|Withdrawal by Subject|2|||
25213472|NCT02082522|50489492|FG001|Overall Study|Withdrawal by Subject|4|||
25213473|NCT02082522|50489491|FG000|Overall Study|Death|1|||
25213474|NCT02082522|50489492|FG001|Overall Study|Death|0|||
25213475|NCT02082522|50489491|FG000|Overall Study|Lost to Follow-up|1|||
25213476|NCT02082522|50489492|FG001|Overall Study|Lost to Follow-up|0|||
25213477|NCT02082522|50489491|FG000|Overall Study|Physician Decision|3|||
25213478|NCT02082522|50489492|FG001|Overall Study|Physician Decision|1|||
25213479|NCT02082522|50489491|FG000|Overall Study|Disease progression|2|||
25213480|NCT02082522|50489492|FG001|Overall Study|Disease progression|2|||
25213481|NCT02082522|50489491|FG000|Overall Study|Chemotherapy change|1|||
25213482|NCT02082522|50489492|FG001|Overall Study|Chemotherapy change|3|||
25213483|NCT02082210|50489504|FG000|Overall Study|Death|0|||
25213484|NCT02082210|50489505|FG001|Overall Study|Death|0|||
25213485|NCT02082210|50489506|FG002|Overall Study|Death|1|||
25213486|NCT02082210|50489507|FG003|Overall Study|Death|1|||
25213487|NCT02082210|50489508|FG004|Overall Study|Death|1|||
25213488|NCT02082210|50489509|FG005|Overall Study|Death|0|||
25213489|NCT02082210|50489504|FG000|Overall Study|Withdrawal by Subject|0|||
25213490|NCT02082210|50489505|FG001|Overall Study|Withdrawal by Subject|0|||
25213491|NCT02082210|50489506|FG002|Overall Study|Withdrawal by Subject|0|||
25213492|NCT02082210|50489507|FG003|Overall Study|Withdrawal by Subject|1|||
25213493|NCT02082210|50489508|FG004|Overall Study|Withdrawal by Subject|2|||
25213494|NCT02082210|50489509|FG005|Overall Study|Withdrawal by Subject|2|||
25213495|NCT02082210|50489504|FG000|Overall Study|Clinical Progression|0|||
25213496|NCT02082210|50489505|FG001|Overall Study|Clinical Progression|0|||
25213497|NCT02082210|50489506|FG002|Overall Study|Clinical Progression|0|||
25213498|NCT02082210|50489507|FG003|Overall Study|Clinical Progression|1|||
25213499|NCT02082210|50489508|FG004|Overall Study|Clinical Progression|0|||
25213500|NCT02082210|50489509|FG005|Overall Study|Clinical Progression|0|||
25213501|NCT02082210|50489504|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
25213502|NCT02082210|50489505|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
25213503|NCT02082210|50489506|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
25213504|NCT02082210|50489507|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
25213505|NCT02082210|50489508|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
25213506|NCT02082210|50489509|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
25213507|NCT02082210|50489504|FG000|Overall Study|Physician Decision|0|||
25213508|NCT02082210|50489505|FG001|Overall Study|Physician Decision|0|||
25213509|NCT02082210|50489506|FG002|Overall Study|Physician Decision|1|||
25213510|NCT02082210|50489507|FG003|Overall Study|Physician Decision|1|||
25213511|NCT02082210|50489508|FG004|Overall Study|Physician Decision|0|||
25213512|NCT02082210|50489509|FG005|Overall Study|Physician Decision|0|||
25213513|NCT02107092|50489535|FG000|Overall Study|Miscellaneous|3|||
25213514|NCT02107092|50489535|FG000|Overall Study|Subject compliance|3|||
25213515|NCT02107092|50489535|FG000|Overall Study|Hypo-or hyperkalemia|2|||
25213516|NCT02107092|50489535|FG000|Overall Study|Met ECG withdrawal criteria|3|||
25213517|NCT02107092|50489535|FG000|Overall Study|Physician Decision|3|||
25213518|NCT02107092|50489535|FG000|Overall Study|Lost to Follow-up|2|||
25213519|NCT02107092|50489535|FG000|Overall Study|Withdrawal by Subject|9|||
25213520|NCT02107092|50489535|FG000|Overall Study|Adverse Event|7|||
25213521|NCT02107092|50489535|FG000|Overall Study|Expected progression of CKD|12|||
25213522|NCT02107014|50489539|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
25213523|NCT01624974|50489545|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
25213524|NCT01624974|50489546|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
25213525|NCT01624974|50489545|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
25213526|NCT01624974|50489546|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
25213527|NCT01624974|50489545|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
25213528|NCT01624974|50489546|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
25213529|NCT01624974|50489545|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
25213530|NCT01624974|50489546|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
25213531|NCT01624974|50489545|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
25213532|NCT01624974|50489546|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
25213533|NCT01624974|50489545|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
25213534|NCT01624974|50489546|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
25213535|NCT01624974|50489545|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
25213536|NCT01624974|50489546|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
25213537|NCT01624974|50489545|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
25213538|NCT01624974|50489546|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
25213539|NCT01624974|50489545|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
25213540|NCT01624974|50489546|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
25213541|NCT01624974|50489545|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
25213542|NCT01624974|50489546|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
25213543|NCT01624974|50489545|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
25213544|NCT01624974|50489546|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
25213545|NCT01624974|50489545|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
25213546|NCT01624974|50489546|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
25213547|NCT02065518|50489557|FG000|Overall Study|Lost to Follow-up|3|||
25213548|NCT02065518|50489558|FG001|Overall Study|Lost to Follow-up|4|||
25213549|NCT02065518|50489559|FG002|Overall Study|Lost to Follow-up|0|||
25213550|NCT02065518|50489560|FG003|Overall Study|Lost to Follow-up|3|||
25213551|NCT02065518|50489557|FG000|Overall Study|Withdrawal by Subject|3|||
25213552|NCT02065518|50489558|FG001|Overall Study|Withdrawal by Subject|4|||
25213553|NCT02065518|50489559|FG002|Overall Study|Withdrawal by Subject|9|||
25316522|NCT00566098|50631994|FG000|Collection of MILs|Withdrawal by Subject|1|||
25316523|NCT00566098|50631994|FG000|Collection of MILs|Relapsed|1|||
25316524|NCT00566098|50631994|FG000|Generation of MILs Product|Relapsed|1|||
25316525|NCT00566098|50631994|FG000|Administration of ASCT+MILs|Death|10|||
25316526|NCT00566098|50631994|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
25316527|NCT00248287|50632001|FG000|Overall Study|Adverse Event|11|||
25316528|NCT00248287|50632002|FG001|Overall Study|Adverse Event|10|||
25316529|NCT00248287|50632001|FG000|Overall Study|Death|1|||
25316530|NCT00248287|50632002|FG001|Overall Study|Death|0|||
25316531|NCT00248287|50632001|FG000|Overall Study|Lost to Follow-up|0|||
25316532|NCT00248287|50632002|FG001|Overall Study|Lost to Follow-up|1|||
25316533|NCT00248287|50632001|FG000|Overall Study|Investigator Request|4|||
25316534|NCT00248287|50632002|FG001|Overall Study|Investigator Request|3|||
25316535|NCT00248287|50632001|FG000|Overall Study|Patient Request|5|||
25316536|NCT00248287|50632002|FG001|Overall Study|Patient Request|3|||
25316537|NCT00248287|50632001|FG000|Overall Study|Other|3|||
25316538|NCT00248287|50632002|FG001|Overall Study|Other|2|||
25316539|NCT00837213|50632010|FG000|Overall Study|Lost to Follow-up|3|||
25316540|NCT00837213|50632011|FG001|Overall Study|Lost to Follow-up|2|||
25316541|NCT00837213|50632010|FG000|Overall Study|Withdrawal by Subject|2|||
25316542|NCT00837213|50632011|FG001|Overall Study|Withdrawal by Subject|2|||
25316543|NCT00837213|50632010|FG000|Overall Study|not stated|1|||
25316544|NCT00837213|50632011|FG001|Overall Study|not stated|1|||
25316545|NCT00902486|50632021|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
25316546|NCT00902486|50632022|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
25316547|NCT00902486|50632023|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
25316548|NCT00902486|50632024|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
25316549|NCT00902486|50632025|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
25316550|NCT00902486|50632026|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
25316551|NCT00902486|50632021|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
25316552|NCT00902486|50632022|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
25316553|NCT00902486|50632023|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
25316554|NCT00902486|50632024|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
25316555|NCT00902486|50632025|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
25316556|NCT00902486|50632026|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
25316557|NCT00902486|50632021|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
25316558|NCT00902486|50632022|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
25316559|NCT00902486|50632023|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
25316560|NCT00902486|50632024|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
25316561|NCT00902486|50632025|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
25316562|NCT00902486|50632026|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
25316563|NCT00902486|50632021|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
25316564|NCT00902486|50632022|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
25316565|NCT00902486|50632023|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
25316566|NCT00902486|50632024|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
25316567|NCT00902486|50632025|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
25316568|NCT00902486|50632026|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
25316569|NCT00902486|50632021|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
25316570|NCT00902486|50632022|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
25316571|NCT00902486|50632023|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
25316572|NCT00902486|50632024|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
25316573|NCT00902486|50632025|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
25316574|NCT00902486|50632026|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
25316575|NCT00902486|50632021|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
25316576|NCT00902486|50632022|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
25316577|NCT00902486|50632023|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
25316578|NCT00902486|50632024|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
25316579|NCT00902486|50632025|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
25316580|NCT00902486|50632026|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
25316581|NCT00902486|50632021|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
25316582|NCT00902486|50632022|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
25213554|NCT02065518|50489560|FG003|Overall Study|Withdrawal by Subject|2|||
25316583|NCT00902486|50632023|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
25213555|NCT01624662|50489574|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
25213556|NCT01624662|50489575|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
25213557|NCT01624662|50489576|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
25213558|NCT01624662|50489577|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
25213559|NCT01624662|50489574|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
25213560|NCT01624662|50489575|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
25213561|NCT01624662|50489576|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
25213562|NCT01624662|50489577|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
25213563|NCT01624662|50489574|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
25213564|NCT01624662|50489575|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
25213565|NCT01624662|50489576|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
25213566|NCT01624662|50489577|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
25213567|NCT01624662|50489574|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
25213568|NCT01624662|50489575|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
25213569|NCT01624662|50489576|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
25213570|NCT01624662|50489577|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
25213571|NCT01624662|50489574|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
25213572|NCT01624662|50489575|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
25213573|NCT01624662|50489576|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
25213574|NCT01624662|50489577|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
25213575|NCT01624662|50489574|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
25213576|NCT01624662|50489575|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
25213577|NCT01624662|50489576|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
25213578|NCT01624662|50489577|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
25213579|NCT01624662|50489574|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
25213580|NCT01624662|50489575|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
25213581|NCT01624662|50489576|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
25213582|NCT01624662|50489577|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
25213583|NCT01624506|50489600|FG000|Overall Study|Lost to Follow-up|29|||
25213584|NCT01624506|50489601|FG001|Overall Study|Lost to Follow-up|15|||
25213585|NCT01624506|50489600|FG000|Overall Study|Withdrawal by Subject|9|||
25213586|NCT01624506|50489601|FG001|Overall Study|Withdrawal by Subject|2|||
25213587|NCT01624506|50489600|FG000|Overall Study|Death|1|||
25213588|NCT01624506|50489601|FG001|Overall Study|Death|0|||
25213589|NCT01624506|50489600|FG000|Overall Study|LINX explants|23|||
25213590|NCT01624506|50489601|FG001|Overall Study|LINX explants|0|||
25213591|NCT01624506|50489600|FG000|Overall Study|Adverse Event|3|||
25213592|NCT01624506|50489601|FG001|Overall Study|Adverse Event|0|||
25213593|NCT02106390|50489610|FG000|Overall Study|Withdrawal by Subject|15|||
25213594|NCT02106390|50489611|FG001|Overall Study|Withdrawal by Subject|16|||
25213595|NCT02106390|50489612|FG002|Overall Study|Withdrawal by Subject|15|||
25213596|NCT02106390|50489610|FG000|Overall Study|Lost to Follow-up|25|||
25213597|NCT02106390|50489611|FG001|Overall Study|Lost to Follow-up|20|||
25213598|NCT02106390|50489612|FG002|Overall Study|Lost to Follow-up|13|||
25213599|NCT02106390|50489610|FG000|Overall Study|Other: Administrative Reason|8|||
25213600|NCT02106390|50489611|FG001|Overall Study|Other: Administrative Reason|5|||
25213601|NCT02106390|50489612|FG002|Overall Study|Other: Administrative Reason|12|||
25213602|NCT02106390|50489610|FG000|Overall Study|Other: Unspecified|1|||
25213603|NCT02106390|50489611|FG001|Overall Study|Other: Unspecified|4|||
25213604|NCT02106390|50489612|FG002|Overall Study|Other: Unspecified|2|||
25213605|NCT02106390|50489610|FG000|Overall Study|Adverse Event|0|||
25213606|NCT02106390|50489611|FG001|Overall Study|Adverse Event|2|||
25213607|NCT02106390|50489612|FG002|Overall Study|Adverse Event|1|||
25213608|NCT02106390|50489610|FG000|Overall Study|Protocol Violation|0|||
25213609|NCT02106390|50489611|FG001|Overall Study|Protocol Violation|1|||
25213610|NCT02106390|50489612|FG002|Overall Study|Protocol Violation|0|||
25213611|NCT02064894|50489626|FG000|Overall Study|Withdrawal by Subject|43|||
25213612|NCT02064894|50489627|FG001|Overall Study|Withdrawal by Subject|102|||
25213613|NCT02064894|50489628|FG002|Overall Study|Withdrawal by Subject|115|||
25213614|NCT02081586|50489640|FG000|Overall Study|Lost to Follow-up|0|||
25213615|NCT02081586|50489641|FG001|Overall Study|Lost to Follow-up|1|||
25213616|NCT02081586|50489642|FG002|Overall Study|Lost to Follow-up|0|||
25213617|NCT02081586|50489643|FG003|Overall Study|Lost to Follow-up|1|||
25213618|NCT02081586|50489640|FG000|Overall Study|Head injury not related to study|0|||
25213619|NCT02081586|50489641|FG001|Overall Study|Head injury not related to study|0|||
25213620|NCT02081586|50489642|FG002|Overall Study|Head injury not related to study|1|||
25213621|NCT02081586|50489643|FG003|Overall Study|Head injury not related to study|0|||
25213622|NCT02081196|50489655|FG000|Overall Study|Lost to Follow-up|1|||
24976383|NCT03465904|50065279|FG000|Overall Study|Withdrawal by Subject|9|||
24976384|NCT03465904|50065280|FG001|Overall Study|Withdrawal by Subject|5|||
25213623|NCT02064816|50489663|FG000|Overall Study|Adverse Event|3|||
25213624|NCT02064816|50489664|FG001|Overall Study|Adverse Event|2|||
25213625|NCT02064816|50489663|FG000|Overall Study|Withdrawal by Subject|2|||
25213626|NCT02064816|50489664|FG001|Overall Study|Withdrawal by Subject|1|||
25213627|NCT02064816|50489663|FG000|Overall Study|Lost to Follow-up|2|||
25213628|NCT02064816|50489664|FG001|Overall Study|Lost to Follow-up|1|||
25213629|NCT02064816|50489663|FG000|Overall Study|Therapeutic failure|0|||
25213630|NCT02064816|50489664|FG001|Overall Study|Therapeutic failure|1|||
25213631|NCT02064816|50489663|FG000|Overall Study|Other|1|||
25213632|NCT02064816|50489664|FG001|Overall Study|Other|3|||
25213633|NCT02080260|50489670|FG000|Overall Study|Death|18|||
25213634|NCT02080260|50489670|FG000|Overall Study|Withdrawal by Subject|1|||
25213635|NCT01624194|50489676|FG000|Overall Study|Lost to Follow-up|1|||
25213636|NCT01624194|50489677|FG001|Overall Study|Lost to Follow-up|0|||
25213637|NCT01624194|50489676|FG000|Overall Study|Withdrawal by Subject|1|||
25213638|NCT01624194|50489677|FG001|Overall Study|Withdrawal by Subject|0|||
25213639|NCT02079636|50489699|FG000|Overall Study|Death|2|||
25213640|NCT02079636|50489700|FG001|Overall Study|Death|1|||
25213641|NCT02079636|50489701|FG002|Overall Study|Death|0|||
25213642|NCT02079636|50489702|FG003|Overall Study|Death|5|||
25213643|NCT02079636|50489703|FG004|Overall Study|Death|1|||
25213644|NCT02079636|50489704|FG005|Overall Study|Death|2|||
25213645|NCT02079636|50489705|FG006|Overall Study|Death|1|||
25213646|NCT02079636|50489706|FG007|Overall Study|Death|0|||
25213647|NCT02079636|50489707|FG008|Overall Study|Death|0|||
25213648|NCT02079636|50489708|FG009|Overall Study|Death|0|||
25213649|NCT02079636|50489709|FG010|Overall Study|Death|0|||
25213650|NCT02079636|50489710|FG011|Overall Study|Death|1|||
25213651|NCT02079636|50489711|FG012|Overall Study|Death|1|||
25213652|NCT02079636|50489712|FG013|Overall Study|Death|0|||
25213653|NCT02079636|50489713|FG014|Overall Study|Death|2|||
25213654|NCT02079636|50489699|FG000|Overall Study|Adverse Event|1|||
25213655|NCT02079636|50489700|FG001|Overall Study|Adverse Event|1|||
25213656|NCT02079636|50489701|FG002|Overall Study|Adverse Event|0|||
25213657|NCT02079636|50489702|FG003|Overall Study|Adverse Event|1|||
25213658|NCT02079636|50489703|FG004|Overall Study|Adverse Event|1|||
25213659|NCT02079636|50489704|FG005|Overall Study|Adverse Event|2|||
25213660|NCT02079636|50489705|FG006|Overall Study|Adverse Event|0|||
25213661|NCT02079636|50489706|FG007|Overall Study|Adverse Event|0|||
25213662|NCT02079636|50489707|FG008|Overall Study|Adverse Event|0|||
25213663|NCT02079636|50489708|FG009|Overall Study|Adverse Event|0|||
25213664|NCT02079636|50489709|FG010|Overall Study|Adverse Event|0|||
25213665|NCT02079636|50489710|FG011|Overall Study|Adverse Event|0|||
25213666|NCT02079636|50489711|FG012|Overall Study|Adverse Event|0|||
25316584|NCT00902486|50632024|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
25316585|NCT00902486|50632025|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
25316586|NCT00902486|50632026|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
25316587|NCT00902486|50632021|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
25316588|NCT00902486|50632022|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
25316589|NCT00902486|50632023|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
25316590|NCT00902486|50632024|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
25316591|NCT00902486|50632025|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
25316592|NCT00902486|50632026|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
25316593|NCT00902486|50632021|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
25316594|NCT00902486|50632022|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
25213667|NCT02079636|50489712|FG013|Overall Study|Adverse Event|0|||
25213668|NCT02079636|50489713|FG014|Overall Study|Adverse Event|0|||
25213669|NCT02079636|50489699|FG000|Overall Study|Progressive disease|0|||
25213670|NCT02079636|50489700|FG001|Overall Study|Progressive disease|0|||
25213671|NCT02079636|50489701|FG002|Overall Study|Progressive disease|0|||
25213672|NCT02079636|50489702|FG003|Overall Study|Progressive disease|2|||
25213673|NCT02079636|50489703|FG004|Overall Study|Progressive disease|0|||
25213674|NCT02079636|50489704|FG005|Overall Study|Progressive disease|0|||
25213675|NCT02079636|50489705|FG006|Overall Study|Progressive disease|0|||
25213676|NCT02079636|50489706|FG007|Overall Study|Progressive disease|0|||
25213677|NCT02079636|50489707|FG008|Overall Study|Progressive disease|0|||
25213678|NCT02079636|50489708|FG009|Overall Study|Progressive disease|0|||
25213679|NCT02079636|50489709|FG010|Overall Study|Progressive disease|0|||
25213680|NCT02079636|50489710|FG011|Overall Study|Progressive disease|0|||
25213681|NCT02079636|50489711|FG012|Overall Study|Progressive disease|1|||
25213682|NCT02079636|50489712|FG013|Overall Study|Progressive disease|0|||
25213683|NCT02079636|50489713|FG014|Overall Study|Progressive disease|0|||
25213684|NCT02079636|50489699|FG000|Overall Study|Withdrawal by Subject|0|||
25213685|NCT02079636|50489700|FG001|Overall Study|Withdrawal by Subject|0|||
25213686|NCT02079636|50489701|FG002|Overall Study|Withdrawal by Subject|0|||
25213687|NCT02079636|50489702|FG003|Overall Study|Withdrawal by Subject|4|||
25213688|NCT02079636|50489703|FG004|Overall Study|Withdrawal by Subject|0|||
25213689|NCT02079636|50489704|FG005|Overall Study|Withdrawal by Subject|1|||
25213690|NCT02079636|50489705|FG006|Overall Study|Withdrawal by Subject|0|||
25213691|NCT02079636|50489706|FG007|Overall Study|Withdrawal by Subject|0|||
25213692|NCT02079636|50489707|FG008|Overall Study|Withdrawal by Subject|0|||
25213693|NCT02079636|50489708|FG009|Overall Study|Withdrawal by Subject|2|||
25213694|NCT02079636|50489709|FG010|Overall Study|Withdrawal by Subject|1|||
25213695|NCT02079636|50489710|FG011|Overall Study|Withdrawal by Subject|1|||
25213696|NCT02079636|50489711|FG012|Overall Study|Withdrawal by Subject|1|||
25213697|NCT02079636|50489712|FG013|Overall Study|Withdrawal by Subject|0|||
25213698|NCT02079636|50489713|FG014|Overall Study|Withdrawal by Subject|2|||
25213699|NCT02079636|50489699|FG000|Overall Study|Physician Decision|0|||
25213700|NCT02079636|50489700|FG001|Overall Study|Physician Decision|0|||
25213701|NCT02079636|50489701|FG002|Overall Study|Physician Decision|0|||
25213702|NCT02079636|50489702|FG003|Overall Study|Physician Decision|0|||
25213703|NCT02079636|50489703|FG004|Overall Study|Physician Decision|0|||
25213704|NCT02079636|50489704|FG005|Overall Study|Physician Decision|1|||
25213705|NCT02079636|50489705|FG006|Overall Study|Physician Decision|0|||
25213706|NCT02079636|50489706|FG007|Overall Study|Physician Decision|0|||
25213707|NCT02079636|50489707|FG008|Overall Study|Physician Decision|0|||
25213708|NCT02079636|50489708|FG009|Overall Study|Physician Decision|1|||
25213709|NCT02079636|50489709|FG010|Overall Study|Physician Decision|1|||
25213710|NCT02079636|50489710|FG011|Overall Study|Physician Decision|0|||
25213711|NCT02079636|50489711|FG012|Overall Study|Physician Decision|0|||
25213712|NCT02079636|50489712|FG013|Overall Study|Physician Decision|0|||
25213713|NCT02079636|50489713|FG014|Overall Study|Physician Decision|1|||
25213714|NCT02079636|50489699|FG000|Overall Study|Lost to Follow-up|0|||
25213715|NCT02079636|50489700|FG001|Overall Study|Lost to Follow-up|0|||
25213716|NCT02079636|50489701|FG002|Overall Study|Lost to Follow-up|0|||
25213717|NCT02079636|50489702|FG003|Overall Study|Lost to Follow-up|0|||
25213718|NCT02079636|50489703|FG004|Overall Study|Lost to Follow-up|0|||
25213719|NCT02079636|50489704|FG005|Overall Study|Lost to Follow-up|0|||
25213720|NCT02079636|50489705|FG006|Overall Study|Lost to Follow-up|0|||
25213721|NCT02079636|50489706|FG007|Overall Study|Lost to Follow-up|1|||
25213722|NCT02079636|50489707|FG008|Overall Study|Lost to Follow-up|0|||
25213723|NCT02079636|50489708|FG009|Overall Study|Lost to Follow-up|0|||
25213724|NCT02079636|50489709|FG010|Overall Study|Lost to Follow-up|0|||
25213725|NCT02079636|50489710|FG011|Overall Study|Lost to Follow-up|0|||
25213726|NCT02079636|50489711|FG012|Overall Study|Lost to Follow-up|0|||
25213727|NCT02079636|50489712|FG013|Overall Study|Lost to Follow-up|0|||
25213728|NCT02079636|50489713|FG014|Overall Study|Lost to Follow-up|0|||
25213729|NCT02079246|50489777|FG000|OLEX|Withdrawal before treatment|1|||
25213730|NCT02079246|50489778|FG001|OLEX|Withdrawal before treatment|0|||
25213731|NCT02079246|50489777|FG000|OLEX|Death|11|||
25213732|NCT02079246|50489778|FG001|OLEX|Death|0|||
25213733|NCT02079246|50489777|FG000|OLEX|Adverse Event|66|||
25213734|NCT02079246|50489778|FG001|OLEX|Adverse Event|0|||
25213735|NCT02079246|50489777|FG000|OLEX|Withdrawal by Subject|60|||
25213736|NCT02079246|50489778|FG001|OLEX|Withdrawal by Subject|0|||
25213737|NCT02079246|50489777|FG000|OLEX|Lost to Follow-up|6|||
25213738|NCT02079246|50489778|FG001|OLEX|Lost to Follow-up|0|||
25213739|NCT02079246|50489777|FG000|OLEX|Protocol Violation|6|||
25213740|NCT02079246|50489778|FG001|OLEX|Protocol Violation|0|||
25213741|NCT02079246|50489777|FG000|OLEX|Lack of Efficacy|3|||
25213742|NCT02079246|50489778|FG001|OLEX|Lack of Efficacy|0|||
25213743|NCT02079246|50489777|FG000|OLEX|Results of the lead-in studies|58|||
25213744|NCT02079246|50489778|FG001|OLEX|Results of the lead-in studies|0|||
25213745|NCT02079246|50489777|FG000|OLEX|Other: Disallowed medication|8|||
25213746|NCT02079246|50489778|FG001|OLEX|Other: Disallowed medication|0|||
25213747|NCT02079246|50489777|FG000|OLEX|Other: Insufficient compliance|2|||
25213748|NCT02079246|50489778|FG001|OLEX|Other: Insufficient compliance|0|||
25213749|NCT02079246|50489777|FG000|OLEX|Other: Caregiver unavailable|3|||
25213750|NCT02079246|50489778|FG001|OLEX|Other: Caregiver unavailable|0|||
25213751|NCT02079246|50489777|FG000|OLEX|Other: Coordinator decision|1|||
25213752|NCT02079246|50489778|FG001|OLEX|Other: Coordinator decision|0|||
25213753|NCT02079246|50489777|FG000|OLEX|Other: Worsening of condition|1|||
25213754|NCT02079246|50489778|FG001|OLEX|Other: Worsening of condition|0|||
25213755|NCT02079246|50489777|FG000|OLEX|Other: Moved to nursing home|1|||
25213756|NCT02079246|50489778|FG001|OLEX|Other: Moved to nursing home|0|||
25213757|NCT02079246|50489777|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
25213758|NCT02079246|50489778|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
25213759|NCT02079246|50489777|FG000|OLEX-MEM|Adverse Event|0|||
25213760|NCT02079246|50489778|FG001|OLEX-MEM|Adverse Event|6|||
25213761|NCT02079246|50489777|FG000|OLEX-MEM|Withdrawal by Subject|0|||
25213762|NCT02079246|50489778|FG001|OLEX-MEM|Withdrawal by Subject|7|||
25213763|NCT02079246|50489777|FG000|OLEX-MEM|Protocol Violation|0|||
25213764|NCT02079246|50489778|FG001|OLEX-MEM|Protocol Violation|2|||
25213765|NCT02079246|50489777|FG000|OLEX-MEM|Lost to Follow-up|0|||
25213766|NCT02079246|50489778|FG001|OLEX-MEM|Lost to Follow-up|1|||
25213767|NCT02079246|50489777|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
25213768|NCT02079246|50489778|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
25213769|NCT02077374|50489789|FG000|Overall Study|Withdrawal by Subject|0|||
25213770|NCT02077374|50489790|FG001|Overall Study|Withdrawal by Subject|1|||
25213771|NCT02077374|50489789|FG000|Overall Study|Protocol Violation|0|||
25213772|NCT02077374|50489790|FG001|Overall Study|Protocol Violation|1|||
25213773|NCT02077140|50489804|FG000|Overall Study|Lost to Follow-up|4|||
25213774|NCT02077140|50489805|FG001|Overall Study|Lost to Follow-up|1|||
25213775|NCT02077140|50489806|FG002|Overall Study|Lost to Follow-up|2|||
25213776|NCT02077140|50489807|FG003|Overall Study|Lost to Follow-up|2|||
25213777|NCT02077140|50489808|FG004|Overall Study|Lost to Follow-up|3|||
25213778|NCT02077140|50489804|FG000|Overall Study|Withdrawal by Subject|0|||
25213779|NCT02077140|50489805|FG001|Overall Study|Withdrawal by Subject|1|||
25213780|NCT02077140|50489806|FG002|Overall Study|Withdrawal by Subject|0|||
25213781|NCT02077140|50489807|FG003|Overall Study|Withdrawal by Subject|2|||
25213782|NCT02077140|50489808|FG004|Overall Study|Withdrawal by Subject|2|||
25213783|NCT02047110|50489827|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
25213784|NCT02047110|50489828|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
25213785|NCT02047110|50489829|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
25213786|NCT02047110|50489830|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
25213787|NCT02047110|50489827|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
25213788|NCT02047110|50489828|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
25213789|NCT02047110|50489829|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
25213790|NCT02047110|50489830|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
25213791|NCT02047110|50489827|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
25213792|NCT02047110|50489828|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
25213793|NCT02047110|50489829|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
25213794|NCT02047110|50489830|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
25213795|NCT02047110|50489827|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
25213796|NCT02047110|50489828|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
25213797|NCT02047110|50489829|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
25213798|NCT02047110|50489830|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
25213799|NCT02047110|50489827|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
25213800|NCT02047110|50489828|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
25213801|NCT02047110|50489829|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
25213802|NCT02047110|50489830|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
25213803|NCT02047110|50489827|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
25213804|NCT02047110|50489828|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
25213805|NCT02047110|50489829|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
25213806|NCT02047110|50489830|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
25213807|NCT02047110|50489827|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
25213808|NCT02047110|50489828|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
25213809|NCT02047110|50489829|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
25213810|NCT02047110|50489830|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
25213811|NCT02047110|50489827|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
25213812|NCT02047110|50489828|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
25213813|NCT02047110|50489829|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
25213814|NCT02047110|50489830|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
25213815|NCT02047110|50489827|FG000|Escape Treatment Period|Adverse Event|1|||
25213816|NCT02047110|50489828|FG001|Escape Treatment Period|Adverse Event|2|||
25213817|NCT02047110|50489829|FG002|Escape Treatment Period|Adverse Event|2|||
25213818|NCT02047110|50489830|FG003|Escape Treatment Period|Adverse Event|0|||
25213819|NCT02047110|50489827|FG000|Escape Treatment Period|Other than specified|1|||
25213820|NCT02047110|50489828|FG001|Escape Treatment Period|Other than specified|2|||
25213821|NCT02047110|50489829|FG002|Escape Treatment Period|Other than specified|0|||
25213822|NCT02047110|50489830|FG003|Escape Treatment Period|Other than specified|1|||
25213823|NCT02047110|50489827|FG000|OLE Treatment Period|Other than specified|0|||
25213824|NCT02047110|50489828|FG001|OLE Treatment Period|Other than specified|0|||
25213825|NCT02047110|50489829|FG002|OLE Treatment Period|Other than specified|1|||
25213826|NCT02047110|50489830|FG003|OLE Treatment Period|Other than specified|0|||
25213827|NCT02046564|50489849|FG000|Overall Study|Adverse Event|6|||
25213828|NCT02046564|50489850|FG001|Overall Study|Adverse Event|3|||
25213829|NCT02046564|50489849|FG000|Overall Study|Physician Decision|0|||
25213830|NCT02046564|50489850|FG001|Overall Study|Physician Decision|1|||
24976385|NCT03465904|50065279|FG000|Overall Study|Lost to Follow-up|10|||
25213831|NCT02046564|50489849|FG000|Overall Study|Protocol Violation|3|||
25213832|NCT02046564|50489850|FG001|Overall Study|Protocol Violation|1|||
25213833|NCT02046564|50489849|FG000|Overall Study|Withdrawal by Subject|4|||
25213834|NCT02046564|50489850|FG001|Overall Study|Withdrawal by Subject|10|||
25213835|NCT02046564|50489849|FG000|Overall Study|Subject met withdrawal criteria|2|||
25213836|NCT02046564|50489850|FG001|Overall Study|Subject met withdrawal criteria|5|||
25213837|NCT02046174|50489856|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
25213838|NCT02046174|50489857|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
25213839|NCT02045862|50489945|FG000|Overall Study|Death|0|||
25213840|NCT02045862|50489946|FG001|Overall Study|Death|0|||
25213841|NCT02045862|50489947|FG002|Overall Study|Death|1|||
25213842|NCT02045862|50489945|FG000|Overall Study|Miscellaneous|5|||
25213843|NCT02045862|50489946|FG001|Overall Study|Miscellaneous|0|||
25213844|NCT02045862|50489947|FG002|Overall Study|Miscellaneous|8|||
25213845|NCT02045862|50489945|FG000|Overall Study|Withdrawal by Patient|18|||
25213846|NCT02045862|50489946|FG001|Overall Study|Withdrawal by Patient|27|||
25213847|NCT02045862|50489947|FG002|Overall Study|Withdrawal by Patient|57|||
25213848|NCT02045862|50489945|FG000|Overall Study|Protocol Violation|0|||
25213849|NCT02045862|50489946|FG001|Overall Study|Protocol Violation|0|||
25213850|NCT02045862|50489947|FG002|Overall Study|Protocol Violation|6|||
25213851|NCT02045862|50489945|FG000|Overall Study|Lack of Efficacy|8|||
25213852|NCT02045862|50489946|FG001|Overall Study|Lack of Efficacy|4|||
25213853|NCT02045862|50489947|FG002|Overall Study|Lack of Efficacy|13|||
25213854|NCT02045862|50489945|FG000|Overall Study|Randomized but not Received Study Drug|0|||
25213855|NCT02045862|50489946|FG001|Overall Study|Randomized but not Received Study Drug|2|||
25213856|NCT02045862|50489947|FG002|Overall Study|Randomized but not Received Study Drug|8|||
25213857|NCT02045862|50489945|FG000|Overall Study|Adverse Event|7|||
25213858|NCT02045862|50489946|FG001|Overall Study|Adverse Event|5|||
25213859|NCT02045862|50489947|FG002|Overall Study|Adverse Event|27|||
25213860|NCT02045862|50489945|FG000|Overall Study|Lost to Follow-up|1|||
25316595|NCT00902486|50632023|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
25316596|NCT00902486|50632024|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
25316597|NCT00902486|50632025|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
25316598|NCT00902486|50632026|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
25316599|NCT00902486|50632021|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
25316600|NCT00902486|50632022|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
25316601|NCT00902486|50632023|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
25316602|NCT00902486|50632024|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
25316603|NCT00902486|50632025|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
25316604|NCT00902486|50632026|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
25316605|NCT00902486|50632021|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
25316606|NCT00902486|50632022|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
25316607|NCT00902486|50632023|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
25316608|NCT00902486|50632024|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
25316609|NCT00902486|50632025|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
25316610|NCT00902486|50632026|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
25316611|NCT00836745|50632056|FG000|Overall Study|Death|2|||
25316612|NCT00836745|50632056|FG000|Overall Study|Lost to Follow-up|10|||
25316613|NCT00836745|50632056|FG000|Overall Study|Adverse Event|3|||
25316614|NCT00836745|50632056|FG000|Overall Study|Objective progression or relapse|4|||
25316615|NCT00836745|50632056|FG000|Overall Study|Other|2|||
25316616|NCT00891618|50632060|FG000|Overall Study|Withdrawal by Subject|1|||
25316617|NCT00836589|50632064|FG000|Overall Study|Lost to Follow-up|246|||
25316618|NCT00836589|50632064|FG000|Overall Study|Death|429|||
25316619|NCT00836589|50632064|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
25316620|NCT00574795|50632076|FG000|Infant Series|Withdrawal by Subject|2|||
25316621|NCT00574795|50632076|FG000|Infant Series|Protocol Violation|2|||
25316622|NCT00574795|50632076|FG000|Infant Series|Adverse Event|1|||
25213861|NCT02045862|50489946|FG001|Overall Study|Lost to Follow-up|2|||
25213862|NCT02045862|50489947|FG002|Overall Study|Lost to Follow-up|6|||
25213863|NCT02075658|50489957|FG000|Overall Study|Physician Decision|2|||
25213864|NCT02075658|50489958|FG001|Overall Study|Physician Decision|2|||
25316623|NCT00574795|50632076|FG000|After Infant Series|Withdrawal by Subject|1|||
25316624|NCT00574795|50632076|FG000|After Infant Series|Adverse Event|2|||
25316625|NCT00574795|50632076|FG000|Toddler Dose|Withdrawal by Subject|1|||
25316626|NCT02297516|50632093|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
25316627|NCT02297516|50632094|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
25316628|NCT02297516|50632093|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
25316629|NCT02297516|50632094|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
25316630|NCT02297516|50632093|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
25316631|NCT02297516|50632094|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
25316632|NCT00836277|50632107|FG000|Overall Study|Not evaluable for response|6|||
25316633|NCT00835731|50632113|FG000|Overall Study|Withdrawal by Subject|1|||
25316634|NCT00835731|50632114|FG001|Overall Study|Withdrawal by Subject|0|||
25316635|NCT00835731|50632113|FG000|Overall Study|Physician Decision|1|||
25316636|NCT00835731|50632114|FG001|Overall Study|Physician Decision|1|||
25316637|NCT00835341|50632122|FG000|Overall Study|Lost to Follow-up|3|||
25316638|NCT00835341|50632123|FG001|Overall Study|Lost to Follow-up|12|||
25316639|NCT00574249|50632131|FG000|Overall Study|Adverse Event|6|||
25316640|NCT00574249|50632132|FG001|Overall Study|Adverse Event|18|||
25316641|NCT00574249|50632131|FG000|Overall Study|Lack of Efficacy|5|||
25316642|NCT00574249|50632132|FG001|Overall Study|Lack of Efficacy|3|||
25316643|NCT00574249|50632131|FG000|Overall Study|Lost to Follow-up|4|||
25316644|NCT00574249|50632132|FG001|Overall Study|Lost to Follow-up|3|||
25316645|NCT00574249|50632131|FG000|Overall Study|Protocol Violation|5|||
25316646|NCT00574249|50632132|FG001|Overall Study|Protocol Violation|2|||
25316647|NCT00574249|50632131|FG000|Overall Study|History of carcinoma|1|||
24976386|NCT03465904|50065280|FG001|Overall Study|Lost to Follow-up|9|||
25213865|NCT02063880|50489966|FG000|Overall Study|Death|21|||
25213866|NCT02063880|50489967|FG001|Overall Study|Death|18|||
25213867|NCT02063880|50489966|FG000|Overall Study|Lost to Follow-up|7|||
25213868|NCT02063880|50489967|FG001|Overall Study|Lost to Follow-up|7|||
25213869|NCT02063880|50489966|FG000|Overall Study|Ineligible|0|||
25213870|NCT02063880|50489967|FG001|Overall Study|Ineligible|2|||
25213871|NCT02044848|50489975|FG000|Overall Study|Administrative Problems|2|||
25213872|NCT02044848|50489976|FG001|Overall Study|Administrative Problems|3|||
25213873|NCT02044458|50489984|FG000|Overall Study|Protocol Violation|3|||
25213874|NCT02044458|50489985|FG001|Overall Study|Protocol Violation|8|||
25213875|NCT02044302|50489993|FG000|Overall Study|study terminated|2|||
25213876|NCT02044302|50489994|FG001|Overall Study|study terminated|0|||
25213877|NCT02062944|50489998|FG000|Overall Study|Lost to Follow-up|1|||
25213878|NCT02062944|50489998|FG000|Overall Study|New hemotological disorder identified|1|||
25213879|NCT02062944|50489998|FG000|Overall Study|Uncontrolled Hypertension|1|||
25213880|NCT02062944|50489998|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
25316648|NCT00574249|50632132|FG001|Overall Study|History of carcinoma|0|||
25316649|NCT00574249|50632131|FG000|Overall Study|Withdrawal by Subject|3|||
25316650|NCT00574249|50632132|FG001|Overall Study|Withdrawal by Subject|0|||
25316651|NCT00574249|50632131|FG000|Overall Study|Physician Decision|1|||
25316652|NCT00574249|50632132|FG001|Overall Study|Physician Decision|0|||
25316653|NCT00574249|50632131|FG000|Overall Study|Pregnancy|1|||
25316654|NCT00574249|50632132|FG001|Overall Study|Pregnancy|0|||
25316655|NCT00574249|50632131|FG000|Overall Study|Excluded by company|0|||
25316656|NCT00574249|50632132|FG001|Overall Study|Excluded by company|1|||
25316657|NCT00574249|50632131|FG000|Overall Study|PPD test taken twice|0|||
25316658|NCT00574249|50632132|FG001|Overall Study|PPD test taken twice|1|||
25316659|NCT00891228|50632141|FG000|Overall Study|Adverse Event|0|||
25316660|NCT00891228|50632142|FG001|Overall Study|Adverse Event|2|||
25316661|NCT00891228|50632143|FG002|Overall Study|Adverse Event|3|||
25316662|NCT00891228|50632141|FG000|Overall Study|Withdrawal by Subject|2|||
25316663|NCT00891228|50632142|FG001|Overall Study|Withdrawal by Subject|4|||
25316664|NCT00891228|50632143|FG002|Overall Study|Withdrawal by Subject|5|||
25316665|NCT00891228|50632141|FG000|Overall Study|Protocol Violation|3|||
25316666|NCT00891228|50632142|FG001|Overall Study|Protocol Violation|1|||
25316667|NCT00891228|50632143|FG002|Overall Study|Protocol Violation|2|||
25316668|NCT00891228|50632141|FG000|Overall Study|Physician Decision|2|||
25316669|NCT00891228|50632142|FG001|Overall Study|Physician Decision|1|||
25316670|NCT00891228|50632143|FG002|Overall Study|Physician Decision|0|||
25316671|NCT00891228|50632141|FG000|Overall Study|Lost to Follow-up|4|||
25316672|NCT00891228|50632142|FG001|Overall Study|Lost to Follow-up|4|||
25316673|NCT00891228|50632143|FG002|Overall Study|Lost to Follow-up|5|||
25316674|NCT00891228|50632141|FG000|Overall Study|Pregnancy|0|||
25316675|NCT00891228|50632142|FG001|Overall Study|Pregnancy|1|||
25316676|NCT00891228|50632143|FG002|Overall Study|Pregnancy|0|||
25316677|NCT00896168|50632153|FG000|Overall Study|Adverse Event|4|||
25316678|NCT00896168|50632154|FG001|Overall Study|Adverse Event|7|||
25316679|NCT00896168|50632153|FG000|Overall Study|Treatment failure|8|||
25316680|NCT00896168|50632154|FG001|Overall Study|Treatment failure|10|||
25316681|NCT00896168|50632153|FG000|Overall Study|Lost to Follow-up|1|||
25316682|NCT00896168|50632154|FG001|Overall Study|Lost to Follow-up|1|||
25316683|NCT00896168|50632153|FG000|Overall Study|Other|1|||
25316684|NCT00896168|50632154|FG001|Overall Study|Other|1|||
25316685|NCT00833703|50632162|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
25316686|NCT00833703|50632163|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
25213881|NCT02062632|50490003|FG000|Overall Study|No treatment data|1|||
25213882|NCT02062398|50490007|FG000|Overall Study|Implant removal|1|||
25213883|NCT02061540|50490011|FG000|Overall Study|Adverse Event|2|||
25213884|NCT02061540|50490011|FG000|Overall Study|Withdrawal by Subject|2|||
25213885|NCT02043366|50490026|FG000|Overall Study|Lost to Follow-up|2|||
25213886|NCT02043366|50490027|FG001|Overall Study|Lost to Follow-up|2|||
25213887|NCT02043366|50490028|FG002|Overall Study|Lost to Follow-up|2|||
25213888|NCT02043366|50490029|FG003|Overall Study|Lost to Follow-up|2|||
25213889|NCT02043366|50490030|FG004|Overall Study|Lost to Follow-up|2|||
25213890|NCT02043366|50490031|FG005|Overall Study|Lost to Follow-up|2|||
25213891|NCT02060370|50490047|FG000|Overall Study|Physician Decision|1|||
25213892|NCT01622088|50490051|FG000|Overall Study|Adverse Event|20|||
25213893|NCT01622088|50490051|FG000|Overall Study|Lost to Follow-up|1|||
25213894|NCT01622088|50490051|FG000|Overall Study|Withdrawal by Subject|20|||
25213895|NCT01622088|50490051|FG000|Overall Study|Investigator Decision|1|||
25213896|NCT01622088|50490051|FG000|Overall Study|Death|53|||
25213897|NCT01622088|50490051|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
25213898|NCT01621542|50490062|FG000|Overall Study|Adverse Event|0|||
25213899|NCT01621542|50490063|FG001|Overall Study|Adverse Event|0|||
25213900|NCT01621542|50490064|FG002|Overall Study|Adverse Event|1|||
25213901|NCT01621542|50490065|FG003|Overall Study|Adverse Event|3|||
25213902|NCT01621542|50490066|FG004|Overall Study|Adverse Event|0|||
25213903|NCT01621542|50490067|FG005|Overall Study|Adverse Event|0|||
25213904|NCT01621542|50490062|FG000|Overall Study|Death|0|||
25213905|NCT01621542|50490063|FG001|Overall Study|Death|1|||
25213906|NCT01621542|50490064|FG002|Overall Study|Death|0|||
25213907|NCT01621542|50490065|FG003|Overall Study|Death|0|||
25213908|NCT01621542|50490066|FG004|Overall Study|Death|0|||
25213909|NCT01621542|50490067|FG005|Overall Study|Death|0|||
25213910|NCT01621542|50490062|FG000|Overall Study|Physician Decision|1|||
25213911|NCT01621542|50490063|FG001|Overall Study|Physician Decision|0|||
25213912|NCT01621542|50490064|FG002|Overall Study|Physician Decision|1|||
25213913|NCT01621542|50490065|FG003|Overall Study|Physician Decision|13|||
25213914|NCT01621542|50490066|FG004|Overall Study|Physician Decision|3|||
25213915|NCT01621542|50490067|FG005|Overall Study|Physician Decision|1|||
25213916|NCT01621542|50490062|FG000|Overall Study|Withdrawal by Subject|2|||
25213917|NCT01621542|50490063|FG001|Overall Study|Withdrawal by Subject|0|||
25213918|NCT01621542|50490064|FG002|Overall Study|Withdrawal by Subject|1|||
25213919|NCT01621542|50490065|FG003|Overall Study|Withdrawal by Subject|3|||
25213920|NCT01621542|50490066|FG004|Overall Study|Withdrawal by Subject|3|||
25213921|NCT01621542|50490067|FG005|Overall Study|Withdrawal by Subject|3|||
25213922|NCT01621542|50490062|FG000|Overall Study|progression/treatment failure|2|||
25213923|NCT01621542|50490063|FG001|Overall Study|progression/treatment failure|4|||
25213924|NCT01621542|50490064|FG002|Overall Study|progression/treatment failure|3|||
25213925|NCT01621542|50490065|FG003|Overall Study|progression/treatment failure|7|||
25213926|NCT01621542|50490066|FG004|Overall Study|progression/treatment failure|3|||
25213927|NCT01621542|50490067|FG005|Overall Study|progression/treatment failure|5|||
25213928|NCT01621542|50490062|FG000|Overall Study|Protocol Violation|0|||
25213929|NCT01621542|50490063|FG001|Overall Study|Protocol Violation|0|||
25213930|NCT01621542|50490064|FG002|Overall Study|Protocol Violation|0|||
25213931|NCT01621542|50490065|FG003|Overall Study|Protocol Violation|1|||
25213932|NCT01621542|50490066|FG004|Overall Study|Protocol Violation|0|||
25213933|NCT01621542|50490067|FG005|Overall Study|Protocol Violation|0|||
25213934|NCT01621542|50490062|FG000|Overall Study|study stopped by sponsor|0|||
25213935|NCT01621542|50490063|FG001|Overall Study|study stopped by sponsor|0|||
25213936|NCT01621542|50490064|FG002|Overall Study|study stopped by sponsor|0|||
25213937|NCT01621542|50490065|FG003|Overall Study|study stopped by sponsor|1|||
25213938|NCT01621542|50490066|FG004|Overall Study|study stopped by sponsor|0|||
25213939|NCT01621542|50490067|FG005|Overall Study|study stopped by sponsor|0|||
25213940|NCT02021292|50490083|FG000|Overall Study|Physician Decision|0|||
25213941|NCT02021292|50490084|FG001|Overall Study|Physician Decision|1|||
25213942|NCT02021292|50490083|FG000|Overall Study|Lost to Follow-up|0|||
25213943|NCT02021292|50490084|FG001|Overall Study|Lost to Follow-up|1|||
25213944|NCT02021292|50490083|FG000|Overall Study|Death|0|||
25213945|NCT02021292|50490084|FG001|Overall Study|Death|1|||
25213946|NCT02059980|50490094|FG000|Overall Study|Lost to Follow-up|2|||
25213947|NCT02059980|50490095|FG001|Overall Study|Lost to Follow-up|1|||
25213948|NCT02043132|50490103|FG000|Overall Study|Lost to Follow-up|1|||
25213949|NCT02043132|50490104|FG001|Overall Study|Lost to Follow-up|1|||
25213950|NCT02043132|50490103|FG000|Overall Study|screen failures|4|||
25213951|NCT02043132|50490104|FG001|Overall Study|screen failures|8|||
25213952|NCT02059434|50490119|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
25213953|NCT02059434|50490120|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
25213954|NCT02059434|50490121|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
25213955|NCT02059434|50490122|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
25213956|NCT02059434|50490123|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
25213957|NCT02059434|50490124|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
25213958|NCT02059434|50490125|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
25213959|NCT02059434|50490126|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
25213960|NCT02059434|50490127|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
25213961|NCT02059434|50490119|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
25213962|NCT02059434|50490120|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
25213963|NCT02059434|50490121|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
25213964|NCT02059434|50490122|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
25213965|NCT02059434|50490123|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
25213966|NCT02059434|50490124|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
25213967|NCT02059434|50490125|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
25213968|NCT02059434|50490126|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
25213969|NCT02059434|50490127|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
25213970|NCT02059434|50490119|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
25213971|NCT02059434|50490120|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
25213972|NCT02059434|50490121|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
25213973|NCT02059434|50490122|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
25213974|NCT02059434|50490123|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
25213975|NCT02059434|50490124|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
25213976|NCT02059434|50490125|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
25213977|NCT02059434|50490126|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
25213978|NCT02059434|50490127|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
25213979|NCT02059434|50490119|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
25213980|NCT02059434|50490120|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
25213981|NCT02059434|50490121|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
25213982|NCT02059434|50490122|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
25213983|NCT02059434|50490123|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
25213984|NCT02059434|50490124|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
25213985|NCT02059434|50490125|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
25213986|NCT02059434|50490126|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
25213987|NCT02059434|50490127|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
25213988|NCT02059434|50490119|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
25213989|NCT02059434|50490120|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
25213990|NCT02059434|50490121|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
25213991|NCT02059434|50490122|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
25213992|NCT02059434|50490123|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
25213993|NCT02059434|50490124|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
25213994|NCT02059434|50490125|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
25213995|NCT02059434|50490126|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
25213996|NCT02059434|50490127|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
25213997|NCT02059278|50490157|FG000|Overall Study|Adverse Event|1|||
25213998|NCT02059278|50490158|FG001|Overall Study|Adverse Event|1|||
25213999|NCT02059278|50490157|FG000|Overall Study|Lost to Follow-up|1|||
25214000|NCT02059278|50490158|FG001|Overall Study|Lost to Follow-up|0|||
25214001|NCT02059278|50490157|FG000|Overall Study|Withdrawal by Subject|0|||
25214002|NCT02059278|50490158|FG001|Overall Study|Withdrawal by Subject|3|||
25214003|NCT02059278|50490157|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
25214004|NCT02059278|50490158|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
25214005|NCT02020512|50490164|FG000|Overall Study|Adverse Event|1|||
25214006|NCT02020512|50490164|FG000|Overall Study|Lost to Follow-up|3|||
25214007|NCT02020512|50490164|FG000|Overall Study|Protocol Violation|4|||
25214008|NCT02041962|50490170|FG000|Overall Study|Lost Aetna Coverage|43|||
25214009|NCT02041962|50490171|FG001|Overall Study|Lost Aetna Coverage|40|||
25214010|NCT02041962|50490170|FG000|Overall Study|Death|1|||
25214011|NCT02041962|50490171|FG001|Overall Study|Death|1|||
25214012|NCT02041962|50490170|FG000|Overall Study|Lost to Follow-up|37|||
25214013|NCT02041962|50490171|FG001|Overall Study|Lost to Follow-up|32|||
25214014|NCT02041962|50490170|FG000|Overall Study|Withdrawal by Subject|0|||
25214015|NCT02041962|50490171|FG001|Overall Study|Withdrawal by Subject|11|||
25214016|NCT02041494|50490179|FG000|Overall Study|Death|1|||
25214017|NCT02041494|50490180|FG001|Overall Study|Death|3|||
25214018|NCT02041494|50490179|FG000|Overall Study|Lost to Follow-up|2|||
25214019|NCT02041494|50490180|FG001|Overall Study|Lost to Follow-up|6|||
25214020|NCT02041494|50490179|FG000|Overall Study|study terminated|16|||
25214021|NCT02041494|50490180|FG001|Overall Study|study terminated|11|||
25214022|NCT02041104|50490211|FG000|Overall Study|Lost to Follow-up|1|||
25214023|NCT02041104|50490212|FG001|Overall Study|Lost to Follow-up|4|||
25214024|NCT02041104|50490211|FG000|Overall Study|discomfort during OGTT|0|||
25214025|NCT02041104|50490212|FG001|Overall Study|discomfort during OGTT|3|||
25214026|NCT02019420|50490222|FG000|Overall Study|Did not receive study drug|2|||
25214027|NCT02019420|50490223|FG001|Overall Study|Did not receive study drug|2|||
25214028|NCT02019420|50490222|FG000|Overall Study|Withdrawal by Subject|1|||
25214029|NCT02019420|50490223|FG001|Overall Study|Withdrawal by Subject|3|||
25214030|NCT02019420|50490222|FG000|Overall Study|At request of sponsor or investigator|0|||
25214031|NCT02019420|50490223|FG001|Overall Study|At request of sponsor or investigator|1|||
25214032|NCT02019420|50490222|FG000|Overall Study|Death|104|||
25214033|NCT02019420|50490223|FG001|Overall Study|Death|99|||
25214034|NCT02019420|50490222|FG000|Overall Study|Transferred to other care facility|1|||
25214035|NCT02019420|50490223|FG001|Overall Study|Transferred to other care facility|1|||
25214036|NCT02019264|50490231|FG000|Overall Study|Not treated|6|||
25214037|NCT02019264|50490232|FG001|Overall Study|Not treated|4|||
25214038|NCT02019264|50490231|FG000|Overall Study|Lost to Follow-up|50|||
25214039|NCT02019264|50490232|FG001|Overall Study|Lost to Follow-up|47|||
25214040|NCT02019264|50490231|FG000|Overall Study|Withdrawal by Subject|142|||
25214041|NCT02019264|50490232|FG001|Overall Study|Withdrawal by Subject|117|||
25214042|NCT02019264|50490231|FG000|Overall Study|Administrative reason|36|||
25214043|NCT02019264|50490232|FG001|Overall Study|Administrative reason|28|||
25214044|NCT02019264|50490231|FG000|Overall Study|Missing|14|||
25214045|NCT02019264|50490232|FG001|Overall Study|Missing|11|||
25214046|NCT02019108|50490240|FG000|Overall Study|Lost to Follow-up|5|||
25214047|NCT02019108|50490241|FG001|Overall Study|Lost to Follow-up|7|||
25214048|NCT02018562|50490249|FG000|Overall Study|Withdrawal by Subject|2|||
25214049|NCT02018562|50490250|FG001|Overall Study|Withdrawal by Subject|0|||
25214050|NCT02018562|50490249|FG000|Overall Study|Discharged prior to study completion|1|||
25214051|NCT02018562|50490250|FG001|Overall Study|Discharged prior to study completion|0|||
25214052|NCT02058966|50490256|FG000|Open-Label Methamphetamine|Adverse Event|1|||
25214053|NCT02058966|50490256|FG000|First Intervention|Withdrawal by Subject|1|||
25214054|NCT02017860|50490268|FG000|Overall Study|Adverse Event|1|||
25214055|NCT02017860|50490268|FG000|Overall Study|Withdrawal by Subject|1|||
25214056|NCT02040870|50490272|FG000|Overall Study|Completed treatment phase|6|||
25214057|NCT02040870|50490272|FG000|Overall Study|Adverse Event|7|||
25214058|NCT02040870|50490272|FG000|Overall Study|Progressive disease|58|||
25214059|NCT02040870|50490272|FG000|Overall Study|Physician Decision|6|||
25214060|NCT02040870|50490272|FG000|Overall Study|Subject/guardian decision|10|||
25214061|NCT02040870|50490272|FG000|Overall Study|Lost to Follow-up|3|||
25214062|NCT02040870|50490272|FG000|Overall Study|Death|13|||
25214063|NCT02016690|50490276|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
25214064|NCT02016690|50490276|FG000|Overall Study|Excluded from SAS: Duplication|2|||
25214065|NCT02016690|50490276|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
25214066|NCT02016690|50490276|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
25214067|NCT02016690|50490276|FG000|Overall Study|Did not meet inclusion criteria|13|||
25214068|NCT02016690|50490276|FG000|Overall Study|Hospitalized for RSV at study start|3|||
25214069|NCT02016300|50490282|FG000|Overall Study|Lost to Follow-up|0|||
25214070|NCT02016300|50490283|FG001|Overall Study|Lost to Follow-up|3|||
25214071|NCT02040090|50490291|FG000|Overall Study|Adverse Event|2|||
25214072|NCT02040090|50490292|FG001|Overall Study|Adverse Event|0|||
25214073|NCT02040090|50490291|FG000|Overall Study|Physician Decision|1|||
25214074|NCT02040090|50490292|FG001|Overall Study|Physician Decision|0|||
25214075|NCT02040090|50490291|FG000|Overall Study|Withdrawal by Subject|0|||
25214076|NCT02040090|50490292|FG001|Overall Study|Withdrawal by Subject|1|||
25214077|NCT02040090|50490291|FG000|Overall Study|Lost to Follow-up|0|||
25214078|NCT02040090|50490292|FG001|Overall Study|Lost to Follow-up|1|||
25214079|NCT02058498|50490298|FG000|Overall Study|Withdrawal by Subject|4|||
25214080|NCT02039778|50490302|FG000|Overall Study|Death|2|||
25214081|NCT02039778|50490302|FG000|Overall Study|Withdrawal by Subject|1|||
25214082|NCT02039778|50490302|FG000|Overall Study|Never started the protocol treatment|1|||
25214083|NCT02015754|50490306|FG000|Overall Study|Disease progression|5|||
25214084|NCT02015754|50490306|FG000|Overall Study|Change in treatment modality|5|||
25214085|NCT02015754|50490306|FG000|Overall Study|Lost to Follow-up|1|||
25214086|NCT02015676|50490313|FG000|Overall Study|Adverse Event|2|||
25214087|NCT02015676|50490314|FG001|Overall Study|Adverse Event|18|||
25214088|NCT02015676|50490315|FG002|Overall Study|Adverse Event|0|||
25214089|NCT02015676|50490313|FG000|Overall Study|Lack of Efficacy|2|||
25214090|NCT02015676|50490314|FG001|Overall Study|Lack of Efficacy|4|||
25214091|NCT02015676|50490315|FG002|Overall Study|Lack of Efficacy|0|||
25214092|NCT02015676|50490313|FG000|Overall Study|Protocol Violation|1|||
25214093|NCT02015676|50490314|FG001|Overall Study|Protocol Violation|0|||
25214094|NCT02015676|50490315|FG002|Overall Study|Protocol Violation|0|||
25214095|NCT02015676|50490313|FG000|Overall Study|Withdrawal by Subject|1|||
25214096|NCT02015676|50490314|FG001|Overall Study|Withdrawal by Subject|7|||
25077368|NCT00159783|50185191|FG002|Overall Study|Other|4|||
25214097|NCT02015676|50490315|FG002|Overall Study|Withdrawal by Subject|1|||
25214098|NCT02015676|50490313|FG000|Overall Study|Administrative reasons|0|||
25214099|NCT02015676|50490314|FG001|Overall Study|Administrative reasons|3|||
25214100|NCT02015676|50490315|FG002|Overall Study|Administrative reasons|1|||
25214101|NCT02015676|50490313|FG000|Overall Study|Death|0|||
25214102|NCT02015676|50490314|FG001|Overall Study|Death|1|||
25214103|NCT02015676|50490315|FG002|Overall Study|Death|0|||
25214104|NCT02015676|50490313|FG000|Overall Study|Disease progression|3|||
25214105|NCT02015676|50490314|FG001|Overall Study|Disease progression|1|||
24976387|NCT03465904|50065279|FG000|Overall Study|Protocol Violation|8|||
25214106|NCT02015676|50490315|FG002|Overall Study|Disease progression|1|||
25214107|NCT02015520|50490323|FG000|Overall Study|Lack of Efficacy|1|||
25214108|NCT02015520|50490324|FG001|Overall Study|Lack of Efficacy|0|||
25214109|NCT02015520|50490325|FG002|Overall Study|Lack of Efficacy|3|||
25214110|NCT02015520|50490326|FG003|Overall Study|Lack of Efficacy|2|||
25214111|NCT02015520|50490323|FG000|Overall Study|Adverse Event|0|||
25214112|NCT02015520|50490324|FG001|Overall Study|Adverse Event|0|||
25214113|NCT02015520|50490325|FG002|Overall Study|Adverse Event|0|||
25214114|NCT02015520|50490326|FG003|Overall Study|Adverse Event|1|||
25214115|NCT02015520|50490323|FG000|Overall Study|Withdrawal by Subject|2|||
25214116|NCT02015520|50490324|FG001|Overall Study|Withdrawal by Subject|2|||
25214117|NCT02015520|50490325|FG002|Overall Study|Withdrawal by Subject|1|||
25214118|NCT02015520|50490326|FG003|Overall Study|Withdrawal by Subject|0|||
25214119|NCT02015520|50490323|FG000|Overall Study|Death|1|||
25214120|NCT02015520|50490324|FG001|Overall Study|Death|0|||
25214121|NCT02015520|50490325|FG002|Overall Study|Death|0|||
25214122|NCT02015520|50490326|FG003|Overall Study|Death|0|||
25214123|NCT02015520|50490323|FG000|Overall Study|Lost to Follow-up|0|||
25214124|NCT02015520|50490324|FG001|Overall Study|Lost to Follow-up|0|||
25214125|NCT02015520|50490325|FG002|Overall Study|Lost to Follow-up|1|||
25214126|NCT02015520|50490326|FG003|Overall Study|Lost to Follow-up|0|||
25214127|NCT02015520|50490323|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
25214128|NCT02015520|50490324|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
25214129|NCT02015520|50490325|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
25214130|NCT02015520|50490326|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
25214131|NCT02015520|50490323|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
25214132|NCT02015520|50490324|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
25214133|NCT02015520|50490325|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
25214134|NCT02015520|50490326|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
25214135|NCT02058108|50490338|FG000|Overall Study|Abnormal Laboratory Values|0|||
25214136|NCT02058108|50490339|FG001|Overall Study|Abnormal Laboratory Values|1|||
25214137|NCT02058108|50490338|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
25214138|NCT02058108|50490339|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
25214139|NCT02058108|50490338|FG000|Overall Study|No longer requires study drug|0|||
25214140|NCT02058108|50490339|FG001|Overall Study|No longer requires study drug|1|||
25214141|NCT02058108|50490338|FG000|Overall Study|Withdrawal by Subject|1|||
25214142|NCT02058108|50490339|FG001|Overall Study|Withdrawal by Subject|0|||
25214143|NCT02058108|50490338|FG000|Overall Study|Administrative problems|3|||
25214144|NCT02058108|50490339|FG001|Overall Study|Administrative problems|3|||
25214145|NCT02058108|50490338|FG000|Overall Study|Protocol Violation|0|||
25214146|NCT02058108|50490339|FG001|Overall Study|Protocol Violation|1|||
25214147|NCT02057874|50490347|FG000|Overall Study|participant did not return for scan|1|||
25214148|NCT02038920|50490354|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
25214149|NCT02038920|50490355|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
25214150|NCT02038920|50490356|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
25214151|NCT02038920|50490357|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
25214152|NCT02038920|50490358|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
25214153|NCT02038920|50490359|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
25214154|NCT02038920|50490354|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
25214155|NCT02038920|50490355|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
25214156|NCT02038920|50490356|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
25214157|NCT02038920|50490357|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
25214158|NCT02038920|50490358|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
25214159|NCT02038920|50490359|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
25214160|NCT02038920|50490354|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
25214161|NCT02038920|50490355|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
25214162|NCT02038920|50490356|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
25214163|NCT02038920|50490357|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
25214164|NCT02038920|50490358|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
25214165|NCT02038920|50490359|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
25214166|NCT02038920|50490354|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
25214167|NCT02038920|50490355|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
25214168|NCT02038920|50490356|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
25214169|NCT02038920|50490357|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
25214170|NCT02038920|50490358|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
25214171|NCT02038920|50490359|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
25214172|NCT02038920|50490354|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
25214173|NCT02038920|50490355|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
25214174|NCT02038920|50490356|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
25214175|NCT02038920|50490357|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
25214176|NCT02038920|50490358|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
25214177|NCT02038920|50490359|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
25214178|NCT02038920|50490354|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
25214179|NCT02038920|50490355|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
25214180|NCT02038920|50490356|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
25214181|NCT02038920|50490357|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
25214182|NCT02038920|50490358|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
25214183|NCT02038920|50490359|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
25214184|NCT02038920|50490354|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
25214185|NCT02038920|50490355|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
25214186|NCT02038920|50490356|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
25214187|NCT02038920|50490357|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
25214188|NCT02038920|50490358|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
25214189|NCT02038920|50490359|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
25214190|NCT02038920|50490354|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
25214191|NCT02038920|50490355|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
25214192|NCT02038920|50490356|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
25214193|NCT02038920|50490357|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
25214194|NCT02038920|50490358|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
25214195|NCT02038920|50490359|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
25214196|NCT02038920|50490354|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
25214197|NCT02038920|50490355|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
25214198|NCT02038920|50490356|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
25214199|NCT02038920|50490357|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
25214200|NCT02038920|50490358|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
25214201|NCT02038920|50490359|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
25214202|NCT02038920|50490354|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
25214203|NCT02038920|50490355|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
25214204|NCT02038920|50490356|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
25214205|NCT02038920|50490357|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
25214206|NCT02038920|50490358|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
25214207|NCT02038920|50490359|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
25214208|NCT02038920|50490354|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
25214209|NCT02038920|50490355|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
25214210|NCT02038920|50490356|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
25214211|NCT02038920|50490357|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
25214212|NCT02038920|50490358|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
25214213|NCT02038920|50490359|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
25214214|NCT02038920|50490354|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
25214215|NCT02038920|50490355|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
25214216|NCT02038920|50490356|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
25214217|NCT02038920|50490357|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
25214218|NCT02038920|50490358|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
25214219|NCT02038920|50490359|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
25214220|NCT02038764|50490381|FG000|Overall Study|Adverse Event|0|||
25214221|NCT02038764|50490382|FG001|Overall Study|Adverse Event|0|||
25214222|NCT02038764|50490383|FG002|Overall Study|Adverse Event|1|||
25214223|NCT02038764|50490384|FG003|Overall Study|Adverse Event|0|||
25214224|NCT02038764|50490385|FG004|Overall Study|Adverse Event|0|||
25214225|NCT02038764|50490381|FG000|Overall Study|Lost to Follow-up|0|||
25214226|NCT02038764|50490382|FG001|Overall Study|Lost to Follow-up|1|||
25214227|NCT02038764|50490383|FG002|Overall Study|Lost to Follow-up|0|||
25214228|NCT02038764|50490384|FG003|Overall Study|Lost to Follow-up|0|||
25214229|NCT02038764|50490385|FG004|Overall Study|Lost to Follow-up|0|||
25214230|NCT02038764|50490381|FG000|Overall Study|Withdrawal by Subject|0|||
25214231|NCT02038764|50490382|FG001|Overall Study|Withdrawal by Subject|0|||
25077369|NCT00646204|50185202|FG000|Overall Study|Adverse Event|3|||
25077370|NCT00646204|50185203|FG001|Overall Study|Adverse Event|0|||
25077371|NCT00646204|50185202|FG000|Overall Study|Withdrawal by Subject|1|||
25077372|NCT00646204|50185203|FG001|Overall Study|Withdrawal by Subject|0|||
25077373|NCT02936323|50185220|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
25077374|NCT02936323|50185221|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
25214232|NCT02038764|50490383|FG002|Overall Study|Withdrawal by Subject|0|||
25214233|NCT02038764|50490384|FG003|Overall Study|Withdrawal by Subject|0|||
25214234|NCT02038764|50490385|FG004|Overall Study|Withdrawal by Subject|1|||
25077375|NCT02936323|50185222|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
25077376|NCT02936323|50185223|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
25077377|NCT02936323|50185224|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
25214235|NCT02038764|50490381|FG000|Overall Study|Other|1|||
25214236|NCT02038764|50490382|FG001|Overall Study|Other|0|||
25214237|NCT02038764|50490383|FG002|Overall Study|Other|1|||
25214238|NCT02038764|50490384|FG003|Overall Study|Other|0|||
25214239|NCT02038764|50490385|FG004|Overall Study|Other|0|||
25214240|NCT02057718|50490403|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
25214241|NCT02057718|50490404|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
25214242|NCT02057718|50490403|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
25214243|NCT02057718|50490404|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
25214244|NCT02057718|50490403|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
25214245|NCT02057718|50490404|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
25214246|NCT02057718|50490403|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
25214247|NCT02057718|50490404|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
25214248|NCT02057718|50490403|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
25214249|NCT02057718|50490404|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
25214250|NCT02057718|50490403|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
25214251|NCT02057718|50490404|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
25214252|NCT02057718|50490403|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
25214253|NCT02057718|50490404|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
25214254|NCT02057718|50490403|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
25214255|NCT02057718|50490404|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
25214256|NCT02057718|50490403|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
25214257|NCT02057718|50490404|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
25214258|NCT02057718|50490403|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
25214259|NCT02057718|50490404|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
25214260|NCT02057718|50490403|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
25214261|NCT02057718|50490404|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
25214262|NCT01622868|50490412|FG000|Overall Study|Protocol Violation|7|||
25214263|NCT01622868|50490413|FG001|Overall Study|Protocol Violation|0|||
25214264|NCT02014740|50490421|FG000|Overall Study|Lost to Follow-up|4|||
25214265|NCT02014740|50490422|FG001|Overall Study|Lost to Follow-up|4|||
25214266|NCT02014740|50490421|FG000|Overall Study|Withdrawal by Subject|2|||
25214267|NCT02014740|50490422|FG001|Overall Study|Withdrawal by Subject|1|||
25214268|NCT02014584|50490430|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
25214269|NCT02014584|50490431|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
25214270|NCT02014584|50490432|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
25214271|NCT02014584|50490433|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
25214272|NCT02014584|50490434|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
25214273|NCT02014584|50490435|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
25214274|NCT02014584|50490430|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
25214275|NCT02014584|50490431|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
25214276|NCT02014584|50490432|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
25214277|NCT02014584|50490433|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
25214278|NCT02014584|50490434|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
25214279|NCT02014584|50490435|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
25214280|NCT02014584|50490430|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
25214281|NCT02014584|50490431|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
25214282|NCT02014584|50490432|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
25214283|NCT02014584|50490433|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
25214284|NCT02014584|50490434|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
25214285|NCT02014584|50490435|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
25214286|NCT02014584|50490430|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
25214287|NCT02014584|50490431|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
25214288|NCT02014584|50490432|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
25214289|NCT02014584|50490433|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
25214290|NCT02014584|50490434|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
25214291|NCT02014584|50490435|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
25214292|NCT02014584|50490430|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
25214293|NCT02014584|50490431|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
25214294|NCT02014584|50490432|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
25214295|NCT02014584|50490433|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
25214296|NCT02014584|50490434|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
25214297|NCT02014584|50490435|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
25214298|NCT02014272|50490447|FG000|Intervention Period 1|Withdrawal by Subject|1|||
25214299|NCT02014272|50490448|FG001|Intervention Period 1|Withdrawal by Subject|0|||
25214300|NCT02014272|50490447|FG000|Intervention Period 1|Adverse Event|0|||
25214301|NCT02014272|50490448|FG001|Intervention Period 1|Adverse Event|1|||
25214302|NCT02037984|50490462|FG000|Overall Study|Lack of Efficacy|0|||
25214303|NCT02037984|50490463|FG001|Overall Study|Lack of Efficacy|0|||
25214304|NCT02037984|50490464|FG002|Overall Study|Lack of Efficacy|3|||
25214305|NCT02037984|50490465|FG003|Overall Study|Lack of Efficacy|10|||
25214306|NCT02037984|50490466|FG004|Overall Study|Lack of Efficacy|2|||
25214307|NCT02037984|50490467|FG005|Overall Study|Lack of Efficacy|2|||
25214308|NCT02037984|50490468|FG006|Overall Study|Lack of Efficacy|4|||
25214309|NCT02037984|50490469|FG007|Overall Study|Lack of Efficacy|3|||
25214310|NCT02037984|50490462|FG000|Overall Study|Lost to Follow-up|1|||
25214311|NCT02037984|50490463|FG001|Overall Study|Lost to Follow-up|0|||
25214312|NCT02037984|50490464|FG002|Overall Study|Lost to Follow-up|3|||
25214313|NCT02037984|50490465|FG003|Overall Study|Lost to Follow-up|5|||
25214314|NCT02037984|50490466|FG004|Overall Study|Lost to Follow-up|2|||
25214315|NCT02037984|50490467|FG005|Overall Study|Lost to Follow-up|2|||
25214316|NCT02037984|50490468|FG006|Overall Study|Lost to Follow-up|2|||
25214317|NCT02037984|50490469|FG007|Overall Study|Lost to Follow-up|4|||
25214318|NCT02037984|50490462|FG000|Overall Study|Physician Decision|0|||
25214319|NCT02037984|50490463|FG001|Overall Study|Physician Decision|0|||
25214320|NCT02037984|50490464|FG002|Overall Study|Physician Decision|0|||
25214321|NCT02037984|50490465|FG003|Overall Study|Physician Decision|0|||
25214322|NCT02037984|50490466|FG004|Overall Study|Physician Decision|0|||
25214323|NCT02037984|50490467|FG005|Overall Study|Physician Decision|0|||
25214324|NCT02037984|50490468|FG006|Overall Study|Physician Decision|1|||
25214325|NCT02037984|50490469|FG007|Overall Study|Physician Decision|0|||
25214326|NCT02037984|50490462|FG000|Overall Study|Protocol Violation|0|||
25214327|NCT02037984|50490463|FG001|Overall Study|Protocol Violation|0|||
25214328|NCT02037984|50490464|FG002|Overall Study|Protocol Violation|0|||
25214329|NCT02037984|50490465|FG003|Overall Study|Protocol Violation|0|||
25214330|NCT02037984|50490466|FG004|Overall Study|Protocol Violation|0|||
25214331|NCT02037984|50490467|FG005|Overall Study|Protocol Violation|1|||
25214332|NCT02037984|50490468|FG006|Overall Study|Protocol Violation|2|||
25214333|NCT02037984|50490469|FG007|Overall Study|Protocol Violation|0|||
25214334|NCT02037984|50490462|FG000|Overall Study|Technical Problems|0|||
25214335|NCT02037984|50490463|FG001|Overall Study|Technical Problems|0|||
25214336|NCT02037984|50490464|FG002|Overall Study|Technical Problems|3|||
25214337|NCT02037984|50490465|FG003|Overall Study|Technical Problems|3|||
25214338|NCT02037984|50490466|FG004|Overall Study|Technical Problems|2|||
25214339|NCT02037984|50490467|FG005|Overall Study|Technical Problems|3|||
25214340|NCT02037984|50490468|FG006|Overall Study|Technical Problems|4|||
25214341|NCT02037984|50490469|FG007|Overall Study|Technical Problems|2|||
25214342|NCT02037984|50490462|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
25214343|NCT02037984|50490463|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
25214344|NCT02037984|50490464|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
25214345|NCT02037984|50490465|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
25214346|NCT02037984|50490466|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
25214347|NCT02037984|50490467|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
25214348|NCT02037984|50490468|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
25214349|NCT02037984|50490469|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
25214350|NCT02037984|50490462|FG000|Overall Study|Withdrawal by Subject|0|||
25214351|NCT02037984|50490463|FG001|Overall Study|Withdrawal by Subject|0|||
25214352|NCT02037984|50490464|FG002|Overall Study|Withdrawal by Subject|0|||
25214353|NCT02037984|50490465|FG003|Overall Study|Withdrawal by Subject|1|||
25214354|NCT02037984|50490466|FG004|Overall Study|Withdrawal by Subject|1|||
25214355|NCT02037984|50490467|FG005|Overall Study|Withdrawal by Subject|3|||
25214356|NCT02037984|50490468|FG006|Overall Study|Withdrawal by Subject|0|||
25214357|NCT02037984|50490469|FG007|Overall Study|Withdrawal by Subject|1|||
25214358|NCT02057406|50490500|FG000|Overall Study|Physician Decision|0|||
25214359|NCT02057406|50490501|FG001|Overall Study|Physician Decision|0|||
25214360|NCT02057406|50490502|FG002|Overall Study|Physician Decision|2|||
25214361|NCT02057406|50490500|FG000|Overall Study|Withdrawal by Subject|0|||
25214362|NCT02057406|50490501|FG001|Overall Study|Withdrawal by Subject|2|||
25316687|NCT00833547|50632171|FG000|Overall Study|Withdrawal by Subject|2|||
25316688|NCT00833547|50632172|FG001|Overall Study|Withdrawal by Subject|2|||
25316689|NCT00833469|50632178|FG000|Overall Study|Withdrawal by Subject|1|||
25316690|NCT00833469|50632178|FG000|Overall Study|Lost to Follow-up|1|||
25316691|NCT00832377|50632182|FG000|Overall Study|Protocol Violation|1|||
25214363|NCT02057406|50490502|FG002|Overall Study|Withdrawal by Subject|0|||
25214364|NCT02057406|50490500|FG000|Overall Study|Lost to Follow-up|0|||
25214365|NCT02057406|50490501|FG001|Overall Study|Lost to Follow-up|0|||
25214366|NCT02057406|50490502|FG002|Overall Study|Lost to Follow-up|1|||
25214367|NCT02057406|50490500|FG000|Overall Study|Death|1|||
25214368|NCT02057406|50490501|FG001|Overall Study|Death|0|||
25214369|NCT02057406|50490502|FG002|Overall Study|Death|0|||
25214370|NCT02057406|50490500|FG000|Overall Study|Protocol Violation|0|||
25214371|NCT02057406|50490501|FG001|Overall Study|Protocol Violation|1|||
25214372|NCT02057406|50490502|FG002|Overall Study|Protocol Violation|0|||
25214373|NCT02057406|50490500|FG000|Overall Study|Patient transportation issues|0|||
25214374|NCT02057406|50490501|FG001|Overall Study|Patient transportation issues|0|||
25316692|NCT00892008|50632186|FG000|Overall Study|Death|5|||
25316693|NCT00892008|50632186|FG000|Overall Study|Lack of Efficacy|3|||
25214375|NCT02057406|50490502|FG002|Overall Study|Patient transportation issues|1|||
25214376|NCT02036580|50490513|FG000|Overall Study|Withdrawal by Subject|0|||
25214377|NCT02036580|50490514|FG001|Overall Study|Withdrawal by Subject|1|||
25214378|NCT02036580|50490515|FG002|Overall Study|Withdrawal by Subject|0|||
25214379|NCT02036580|50490513|FG000|Overall Study|Adverse Event|1|||
25214380|NCT02036580|50490514|FG001|Overall Study|Adverse Event|0|||
25214381|NCT02036580|50490515|FG002|Overall Study|Adverse Event|0|||
25214382|NCT02014116|50490532|FG000|Overall Study|Progressive Disease|3|||
25214383|NCT02014116|50490533|FG001|Overall Study|Progressive Disease|4|||
25214384|NCT02014116|50490534|FG002|Overall Study|Progressive Disease|2|||
25214385|NCT02014116|50490535|FG003|Overall Study|Progressive Disease|6|||
25214386|NCT02014116|50490536|FG004|Overall Study|Progressive Disease|1|||
25214387|NCT02014116|50490537|FG005|Overall Study|Progressive Disease|13|||
25214388|NCT02014116|50490538|FG006|Overall Study|Progressive Disease|1|||
25214389|NCT02014116|50490539|FG007|Overall Study|Progressive Disease|3|||
25214390|NCT02014116|50490540|FG008|Overall Study|Progressive Disease|7|||
25214391|NCT02014116|50490532|FG000|Overall Study|Adverse Event|0|||
25214392|NCT02014116|50490533|FG001|Overall Study|Adverse Event|0|||
25214393|NCT02014116|50490534|FG002|Overall Study|Adverse Event|0|||
25214394|NCT02014116|50490535|FG003|Overall Study|Adverse Event|0|||
25214395|NCT02014116|50490536|FG004|Overall Study|Adverse Event|1|||
25214396|NCT02014116|50490537|FG005|Overall Study|Adverse Event|0|||
25214397|NCT02014116|50490538|FG006|Overall Study|Adverse Event|0|||
25214398|NCT02014116|50490539|FG007|Overall Study|Adverse Event|1|||
25214399|NCT02014116|50490540|FG008|Overall Study|Adverse Event|0|||
25214400|NCT02014116|50490532|FG000|Overall Study|Lost to Follow-up|0|||
25214401|NCT02014116|50490533|FG001|Overall Study|Lost to Follow-up|0|||
25214402|NCT02014116|50490534|FG002|Overall Study|Lost to Follow-up|0|||
25214403|NCT02014116|50490535|FG003|Overall Study|Lost to Follow-up|0|||
25214404|NCT02014116|50490536|FG004|Overall Study|Lost to Follow-up|0|||
25214405|NCT02014116|50490537|FG005|Overall Study|Lost to Follow-up|1|||
25214406|NCT02014116|50490538|FG006|Overall Study|Lost to Follow-up|0|||
25214407|NCT02014116|50490539|FG007|Overall Study|Lost to Follow-up|0|||
25214408|NCT02014116|50490540|FG008|Overall Study|Lost to Follow-up|1|||
25214409|NCT02014116|50490532|FG000|Overall Study|Death|0|||
25214410|NCT02014116|50490533|FG001|Overall Study|Death|0|||
25214411|NCT02014116|50490534|FG002|Overall Study|Death|0|||
25214412|NCT02014116|50490535|FG003|Overall Study|Death|0|||
25214413|NCT02014116|50490536|FG004|Overall Study|Death|0|||
25214414|NCT02014116|50490537|FG005|Overall Study|Death|0|||
25214415|NCT02014116|50490538|FG006|Overall Study|Death|0|||
25214416|NCT02014116|50490539|FG007|Overall Study|Death|1|||
25214417|NCT02014116|50490540|FG008|Overall Study|Death|1|||
25214418|NCT02014116|50490532|FG000|Overall Study|Withdrawal by Subject|0|||
25214419|NCT02014116|50490533|FG001|Overall Study|Withdrawal by Subject|0|||
25214420|NCT02014116|50490534|FG002|Overall Study|Withdrawal by Subject|1|||
25214421|NCT02014116|50490535|FG003|Overall Study|Withdrawal by Subject|1|||
25214422|NCT02014116|50490536|FG004|Overall Study|Withdrawal by Subject|0|||
25214423|NCT02014116|50490537|FG005|Overall Study|Withdrawal by Subject|1|||
25214424|NCT02014116|50490538|FG006|Overall Study|Withdrawal by Subject|0|||
25214425|NCT02014116|50490539|FG007|Overall Study|Withdrawal by Subject|0|||
25077378|NCT02936323|50185225|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
25214426|NCT02014116|50490540|FG008|Overall Study|Withdrawal by Subject|0|||
25214427|NCT02014116|50490532|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
25214428|NCT02014116|50490533|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
25214429|NCT02014116|50490534|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
25214430|NCT02014116|50490535|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
25214431|NCT02014116|50490536|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
25214432|NCT02014116|50490537|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
25214433|NCT02014116|50490538|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
25214434|NCT02014116|50490539|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
25214435|NCT02014116|50490540|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
25214436|NCT02014116|50490532|FG000|Overall Study|Physician Decision|0|||
25214437|NCT02014116|50490533|FG001|Overall Study|Physician Decision|0|||
25214438|NCT02014116|50490534|FG002|Overall Study|Physician Decision|0|||
25214439|NCT02014116|50490535|FG003|Overall Study|Physician Decision|0|||
25214440|NCT02014116|50490536|FG004|Overall Study|Physician Decision|0|||
25214441|NCT02014116|50490537|FG005|Overall Study|Physician Decision|0|||
25214442|NCT02014116|50490538|FG006|Overall Study|Physician Decision|0|||
25316694|NCT00892008|50632186|FG000|Overall Study|Lost to Follow-up|142|||
25214443|NCT02014116|50490539|FG007|Overall Study|Physician Decision|0|||
25214444|NCT02014116|50490540|FG008|Overall Study|Physician Decision|1|||
24976388|NCT03465904|50065280|FG001|Overall Study|Protocol Violation|5|||
24976389|NCT03465904|50065279|FG000|Overall Study|Ineligible for mITT analysis|62|||
25214445|NCT02057250|50490567|FG000|AID Assessment Phase|Adverse Event|3|||
25214446|NCT02057250|50490568|FG001|AID Assessment Phase|Adverse Event|2|||
25214447|NCT02057250|50490569|FG002|AID Assessment Phase|Adverse Event|6|||
25214448|NCT02057250|50490570|FG003|AID Assessment Phase|Adverse Event|1|||
25316695|NCT00892008|50632186|FG000|Overall Study|Other|378|||
25214449|NCT02057250|50490571|FG004|AID Assessment Phase|Adverse Event|0|||
25214450|NCT02057250|50490567|FG000|AID Assessment Phase|Other than specified above|1|||
25214451|NCT02057250|50490568|FG001|AID Assessment Phase|Other than specified above|1|||
25214452|NCT02057250|50490569|FG002|AID Assessment Phase|Other than specified above|1|||
25214453|NCT02057250|50490570|FG003|AID Assessment Phase|Other than specified above|1|||
25214454|NCT02057250|50490571|FG004|AID Assessment Phase|Other than specified above|0|||
25214455|NCT02057250|50490567|FG000|Extension Phase|Adverse Event|0|||
25214456|NCT02057250|50490568|FG001|Extension Phase|Adverse Event|0|||
25214457|NCT02057250|50490569|FG002|Extension Phase|Adverse Event|0|||
25214458|NCT02057250|50490570|FG003|Extension Phase|Adverse Event|0|||
25214459|NCT02057250|50490571|FG004|Extension Phase|Adverse Event|15|||
25214460|NCT02057250|50490567|FG000|Extension Phase|Lack of Efficacy|0|||
25214461|NCT02057250|50490568|FG001|Extension Phase|Lack of Efficacy|0|||
25214462|NCT02057250|50490569|FG002|Extension Phase|Lack of Efficacy|0|||
25214463|NCT02057250|50490570|FG003|Extension Phase|Lack of Efficacy|0|||
25214464|NCT02057250|50490571|FG004|Extension Phase|Lack of Efficacy|10|||
25214465|NCT02057250|50490567|FG000|Extension Phase|Entered in this period but not treated|0|||
25214466|NCT02057250|50490568|FG001|Extension Phase|Entered in this period but not treated|0|||
25214467|NCT02057250|50490569|FG002|Extension Phase|Entered in this period but not treated|0|||
25214468|NCT02057250|50490570|FG003|Extension Phase|Entered in this period but not treated|0|||
25214469|NCT02057250|50490571|FG004|Extension Phase|Entered in this period but not treated|4|||
25214470|NCT02057250|50490567|FG000|Extension Phase|Other than specified above|0|||
25214471|NCT02057250|50490568|FG001|Extension Phase|Other than specified above|0|||
25214472|NCT02057250|50490569|FG002|Extension Phase|Other than specified above|0|||
25214473|NCT02057250|50490570|FG003|Extension Phase|Other than specified above|0|||
25214474|NCT02057250|50490571|FG004|Extension Phase|Other than specified above|7|||
25214475|NCT02036502|50490591|FG000|Part 1:Dose Determination/Escalation|Death|3|||
25214476|NCT02036502|50490592|FG001|Part 1:Dose Determination/Escalation|Death|2|||
25214477|NCT02036502|50490593|FG002|Part 1:Dose Determination/Escalation|Death|0|||
25214478|NCT02036502|50490594|FG003|Part 1:Dose Determination/Escalation|Death|0|||
25214479|NCT02036502|50490595|FG004|Part 1:Dose Determination/Escalation|Death|0|||
25214480|NCT02036502|50490596|FG005|Part 1:Dose Determination/Escalation|Death|0|||
25214481|NCT02036502|50490597|FG006|Part 1:Dose Determination/Escalation|Death|0|||
25214482|NCT02036502|50490598|FG007|Part 1:Dose Determination/Escalation|Death|0|||
25214483|NCT02036502|50490591|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
25214484|NCT02036502|50490592|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
25214485|NCT02036502|50490593|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
25214486|NCT02036502|50490594|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
25214487|NCT02036502|50490595|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
25214488|NCT02036502|50490596|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
25214489|NCT02036502|50490597|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
25214490|NCT02036502|50490598|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
25214491|NCT02036502|50490591|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
25214492|NCT02036502|50490592|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
25214493|NCT02036502|50490593|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
25214494|NCT02036502|50490594|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
25214495|NCT02036502|50490595|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
25214496|NCT02036502|50490596|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
25214497|NCT02036502|50490597|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
25214498|NCT02036502|50490598|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
25214499|NCT02036502|50490591|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
25214500|NCT02036502|50490592|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
25214501|NCT02036502|50490593|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
25214502|NCT02036502|50490594|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
25214503|NCT02036502|50490595|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
25214504|NCT02036502|50490596|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
25214505|NCT02036502|50490597|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
25214506|NCT02036502|50490598|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
25214507|NCT02036502|50490591|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
25214508|NCT02036502|50490592|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
25214509|NCT02036502|50490593|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
25214510|NCT02036502|50490594|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
25214511|NCT02036502|50490595|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
25214512|NCT02036502|50490596|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
25214513|NCT02036502|50490597|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
25214514|NCT02036502|50490598|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
25214515|NCT02036502|50490591|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
25214516|NCT02036502|50490592|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
25214517|NCT02036502|50490593|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
25214518|NCT02036502|50490594|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
25214519|NCT02036502|50490595|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
25214520|NCT02036502|50490596|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
25214521|NCT02036502|50490597|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
25214522|NCT02036502|50490598|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
25214523|NCT02036502|50490591|FG000|Part 2:Dose Confirmation|Death|0|||
25214524|NCT02036502|50490592|FG001|Part 2:Dose Confirmation|Death|0|||
25214525|NCT02036502|50490593|FG002|Part 2:Dose Confirmation|Death|1|||
25214526|NCT02036502|50490594|FG003|Part 2:Dose Confirmation|Death|0|||
25214527|NCT02036502|50490595|FG004|Part 2:Dose Confirmation|Death|0|||
25214528|NCT02036502|50490596|FG005|Part 2:Dose Confirmation|Death|0|||
25214529|NCT02036502|50490597|FG006|Part 2:Dose Confirmation|Death|0|||
25214530|NCT02036502|50490598|FG007|Part 2:Dose Confirmation|Death|0|||
25214531|NCT02036502|50490591|FG000|Part 2:Dose Confirmation|Not treated|0|||
25214532|NCT02036502|50490592|FG001|Part 2:Dose Confirmation|Not treated|0|||
25214533|NCT02036502|50490593|FG002|Part 2:Dose Confirmation|Not treated|0|||
25214534|NCT02036502|50490594|FG003|Part 2:Dose Confirmation|Not treated|1|||
25214535|NCT02036502|50490595|FG004|Part 2:Dose Confirmation|Not treated|0|||
25214536|NCT02036502|50490596|FG005|Part 2:Dose Confirmation|Not treated|0|||
25214537|NCT02036502|50490597|FG006|Part 2:Dose Confirmation|Not treated|0|||
25214538|NCT02036502|50490598|FG007|Part 2:Dose Confirmation|Not treated|0|||
25214539|NCT02036502|50490591|FG000|Part 3:Dose Expansion|Adverse Event|0|||
25214540|NCT02036502|50490592|FG001|Part 3:Dose Expansion|Adverse Event|0|||
25214541|NCT02036502|50490593|FG002|Part 3:Dose Expansion|Adverse Event|0|||
25214542|NCT02036502|50490594|FG003|Part 3:Dose Expansion|Adverse Event|0|||
25214543|NCT02036502|50490595|FG004|Part 3:Dose Expansion|Adverse Event|0|||
25214544|NCT02036502|50490596|FG005|Part 3:Dose Expansion|Adverse Event|4|||
25214545|NCT02036502|50490597|FG006|Part 3:Dose Expansion|Adverse Event|0|||
25214546|NCT02036502|50490598|FG007|Part 3:Dose Expansion|Adverse Event|2|||
25214547|NCT02036502|50490591|FG000|Part 3:Dose Expansion|Death|0|||
25214548|NCT02036502|50490592|FG001|Part 3:Dose Expansion|Death|0|||
25214549|NCT02036502|50490593|FG002|Part 3:Dose Expansion|Death|0|||
25214550|NCT02036502|50490594|FG003|Part 3:Dose Expansion|Death|0|||
25214551|NCT02036502|50490595|FG004|Part 3:Dose Expansion|Death|0|||
25214552|NCT02036502|50490596|FG005|Part 3:Dose Expansion|Death|24|||
25214553|NCT02036502|50490597|FG006|Part 3:Dose Expansion|Death|0|||
25214554|NCT02036502|50490598|FG007|Part 3:Dose Expansion|Death|3|||
25214555|NCT02036502|50490591|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
25214556|NCT02036502|50490592|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
25214557|NCT02036502|50490593|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
25214558|NCT02036502|50490594|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
25214559|NCT02036502|50490595|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
25214560|NCT02036502|50490596|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
25214561|NCT02036502|50490597|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
25214562|NCT02036502|50490598|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
25214563|NCT02036502|50490591|FG000|Part 3:Dose Expansion|Physician Decision|0|||
25214564|NCT02036502|50490592|FG001|Part 3:Dose Expansion|Physician Decision|0|||
25214565|NCT02036502|50490593|FG002|Part 3:Dose Expansion|Physician Decision|0|||
25214566|NCT02036502|50490594|FG003|Part 3:Dose Expansion|Physician Decision|0|||
25214567|NCT02036502|50490595|FG004|Part 3:Dose Expansion|Physician Decision|0|||
25214568|NCT02036502|50490596|FG005|Part 3:Dose Expansion|Physician Decision|1|||
25214569|NCT02036502|50490597|FG006|Part 3:Dose Expansion|Physician Decision|0|||
25214570|NCT02036502|50490598|FG007|Part 3:Dose Expansion|Physician Decision|0|||
25214571|NCT02036502|50490591|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
25214572|NCT02036502|50490592|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
25214573|NCT02036502|50490593|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
25214574|NCT02036502|50490594|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
25214575|NCT02036502|50490595|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
25214576|NCT02036502|50490596|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
25214577|NCT02036502|50490597|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
25214578|NCT02036502|50490598|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
25214579|NCT02036502|50490591|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
25214580|NCT02036502|50490592|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
25214581|NCT02036502|50490593|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
25214582|NCT02036502|50490594|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
25214583|NCT02036502|50490595|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
25214584|NCT02036502|50490596|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
25214585|NCT02036502|50490597|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
25214586|NCT02036502|50490598|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
25214587|NCT02036502|50490591|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
25214588|NCT02036502|50490592|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
25214589|NCT02036502|50490593|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
25214590|NCT02036502|50490594|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
25214591|NCT02036502|50490595|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
25214592|NCT02036502|50490596|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
25214593|NCT02036502|50490597|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
25214594|NCT02036502|50490598|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
25214595|NCT02036502|50490591|FG000|Part 3:Dose Expansion|Not Treated|0|||
25214596|NCT02036502|50490592|FG001|Part 3:Dose Expansion|Not Treated|0|||
25214597|NCT02036502|50490593|FG002|Part 3:Dose Expansion|Not Treated|0|||
25214598|NCT02036502|50490594|FG003|Part 3:Dose Expansion|Not Treated|0|||
25214599|NCT02036502|50490595|FG004|Part 3:Dose Expansion|Not Treated|0|||
25214600|NCT02036502|50490596|FG005|Part 3:Dose Expansion|Not Treated|2|||
25214601|NCT02036502|50490597|FG006|Part 3:Dose Expansion|Not Treated|0|||
25214602|NCT02036502|50490598|FG007|Part 3:Dose Expansion|Not Treated|0|||
25214603|NCT02056626|50490622|FG000|Overall Study|patient did not follow directions|3|||
25214604|NCT02056626|50490623|FG001|Overall Study|patient did not follow directions|1|||
25214605|NCT02056626|50490624|FG002|Overall Study|patient did not follow directions|0|||
25214606|NCT02056626|50490625|FG003|Overall Study|patient did not follow directions|0|||
25214607|NCT02035332|50490635|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
25214608|NCT02056392|50490645|FG000|Overall Study|Lost to Follow-up|0|||
25214609|NCT02056392|50490646|FG001|Overall Study|Lost to Follow-up|1|||
25214610|NCT02056392|50490647|FG002|Overall Study|Lost to Follow-up|2|||
25214611|NCT02056392|50490648|FG003|Overall Study|Lost to Follow-up|0|||
25214612|NCT02056392|50490649|FG004|Overall Study|Lost to Follow-up|0|||
25214613|NCT02056392|50490650|FG005|Overall Study|Lost to Follow-up|0|||
25214614|NCT02056392|50490645|FG000|Overall Study|Protocol Violation|1|||
25214615|NCT02056392|50490646|FG001|Overall Study|Protocol Violation|0|||
25214616|NCT02056392|50490647|FG002|Overall Study|Protocol Violation|1|||
25214617|NCT02056392|50490648|FG003|Overall Study|Protocol Violation|0|||
25214618|NCT02056392|50490649|FG004|Overall Study|Protocol Violation|0|||
25214619|NCT02056392|50490650|FG005|Overall Study|Protocol Violation|0|||
25214620|NCT02056392|50490645|FG000|Overall Study|Withdrawal by Subject|1|||
25214621|NCT02056392|50490646|FG001|Overall Study|Withdrawal by Subject|0|||
25214622|NCT02056392|50490647|FG002|Overall Study|Withdrawal by Subject|0|||
25214623|NCT02056392|50490648|FG003|Overall Study|Withdrawal by Subject|0|||
25214624|NCT02056392|50490649|FG004|Overall Study|Withdrawal by Subject|1|||
25214625|NCT02056392|50490650|FG005|Overall Study|Withdrawal by Subject|0|||
25214626|NCT02034708|50490660|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
25214627|NCT02034708|50490661|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
25214628|NCT02034708|50490660|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
24976390|NCT03465904|50065280|FG001|Overall Study|Ineligible for mITT analysis|47|||
24976391|NCT03802916|50065288|FG000|Overall Study|Adverse Event|0|||
24976392|NCT03802916|50065289|FG001|Overall Study|Adverse Event|1|||
24976393|NCT03802916|50065288|FG000|Overall Study|Withdrawal by Subject|0|||
24976394|NCT03802916|50065289|FG001|Overall Study|Withdrawal by Subject|1|||
24976395|NCT00076011|50065297|FG000|Overall Study|Death|1|||
24976396|NCT00076011|50065297|FG000|Overall Study|Adverse Event|10|||
24976397|NCT00076011|50065297|FG000|Overall Study|Lack of Efficacy|25|||
24976398|NCT00076011|50065297|FG000|Overall Study|Withdrawal by Subject|1|||
24976399|NCT00076011|50065297|FG000|Overall Study|Study terminated by sponsor|3|||
24976400|NCT00076011|50065297|FG000|Overall Study|Other|11|||
24976401|NCT00076011|50065297|FG000|Overall Study|Ongoing|1|||
24976402|NCT03465436|50065305|FG000|Period 1|Protocol Violation|0|||
24976403|NCT03465436|50065306|FG001|Period 1|Protocol Violation|0|||
24976404|NCT03465436|50065307|FG002|Period 1|Protocol Violation|1|||
24976405|NCT03465436|50065308|FG003|Period 1|Protocol Violation|0|||
24976406|NCT03465436|50065305|FG000|Period 2|Protocol Violation|0|||
24976407|NCT03465436|50065306|FG001|Period 2|Protocol Violation|1|||
24976408|NCT03465436|50065307|FG002|Period 2|Protocol Violation|0|||
24976409|NCT03465436|50065308|FG003|Period 2|Protocol Violation|0|||
24976410|NCT03465436|50065305|FG000|Period 3|Protocol Violation|1|||
24976411|NCT03465436|50065306|FG001|Period 3|Protocol Violation|1|||
25077379|NCT02936323|50185226|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
25214629|NCT02034708|50490661|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
25214630|NCT02034708|50490660|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
25214631|NCT02034708|50490661|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
25214632|NCT02034708|50490660|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
25214633|NCT02034708|50490661|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
25214634|NCT02034552|50490675|FG000|Overall Study|Never treated|3|||
25214635|NCT02034552|50490676|FG001|Overall Study|Never treated|2|||
25214636|NCT02034552|50490677|FG002|Overall Study|Never treated|0|||
25214637|NCT02034552|50490675|FG000|Overall Study|Radiological progression|3|||
25214638|NCT02034552|50490676|FG001|Overall Study|Radiological progression|5|||
24976412|NCT03465436|50065307|FG002|Period 3|Protocol Violation|0|||
24976413|NCT03465436|50065308|FG003|Period 3|Protocol Violation|0|||
24976414|NCT03465436|50065305|FG000|Period 4|Protocol Violation|0|||
24976415|NCT03465436|50065306|FG001|Period 4|Protocol Violation|0|||
24976416|NCT03465436|50065307|FG002|Period 4|Protocol Violation|1|||
24976417|NCT03465436|50065308|FG003|Period 4|Protocol Violation|0|||
24976418|NCT00053846|50065322|FG000|Overall Study|Changed mind|8|||
24976419|NCT00053846|50065323|FG001|Overall Study|Changed mind|13|||
24976420|NCT00053846|50065322|FG000|Overall Study|Became too ill|8|||
24976421|NCT00053846|50065323|FG001|Overall Study|Became too ill|7|||
24976422|NCT00053846|50065322|FG000|Overall Study|Expired|5|||
25214639|NCT02034552|50490677|FG002|Overall Study|Radiological progression|4|||
25214640|NCT02034552|50490675|FG000|Overall Study|AE not assoc. with disease progression|1|||
25214641|NCT02034552|50490676|FG001|Overall Study|AE not assoc. with disease progression|4|||
25214642|NCT02034552|50490677|FG002|Overall Study|AE not assoc. with disease progression|2|||
25214643|NCT02034552|50490675|FG000|Overall Study|AE associated with disease progression|0|||
25214644|NCT02034552|50490676|FG001|Overall Study|AE associated with disease progression|1|||
25214645|NCT02034552|50490677|FG002|Overall Study|AE associated with disease progression|0|||
25214646|NCT02034552|50490675|FG000|Overall Study|Withdrawal by Subject|2|||
25214647|NCT02034552|50490676|FG001|Overall Study|Withdrawal by Subject|1|||
25214648|NCT02034552|50490677|FG002|Overall Study|Withdrawal by Subject|1|||
25316696|NCT00892008|50632186|FG000|Overall Study|Adverse Event|37|||
25316697|NCT00623233|50632190|FG000|Overall Study|Adverse Event|10|||
25316698|NCT00623233|50632190|FG000|Overall Study|Physician Decision|10|||
25316699|NCT00623233|50632190|FG000|Overall Study|Lost to Follow-up|1|||
25316700|NCT00623233|50632190|FG000|Overall Study|Withdrawal by Subject|3|||
25316701|NCT03369236|50632205|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
25316702|NCT03369236|50632206|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
25316703|NCT03369236|50632205|FG000|Open-label Extension Period|Lack of Efficacy|2|||
25316704|NCT03369236|50632206|FG001|Open-label Extension Period|Lack of Efficacy|1|||
25316705|NCT03369236|50632205|FG000|Open-label Extension Period|Adverse Event|0|||
25316706|NCT03369236|50632206|FG001|Open-label Extension Period|Adverse Event|1|||
25316707|NCT03369236|50632205|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
25316708|NCT03369236|50632206|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
25316709|NCT00621751|50632220|FG000|Overall Study|Adverse Event|0|||
25316710|NCT00621751|50632221|FG001|Overall Study|Adverse Event|1|||
25316711|NCT00891930|50632238|FG000|Part 1: Panitumumab +Irinotecan|Death|38|||
25316712|NCT00891930|50632238|FG000|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1|||
25316713|NCT00891930|50632238|FG000|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1|||
25316714|NCT00891930|50632238|FG000|Part 2: Panitumumab + Ganitumab|Death|30|||
25316715|NCT00891930|50632238|FG000|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1|||
25316716|NCT00895622|50632249|FG000|Overall Study|Protocol Violation|5|||
25316717|NCT00895622|50632250|FG001|Overall Study|Protocol Violation|4|||
25316718|NCT00895622|50632251|FG002|Overall Study|Protocol Violation|4|||
25316719|NCT00891462|50632270|FG000|Overall Study|Withdrawal by Subject|9|||
25316720|NCT00891462|50632271|FG001|Overall Study|Withdrawal by Subject|6|||
25316721|NCT00891462|50632272|FG002|Overall Study|Withdrawal by Subject|7|||
25316722|NCT00891462|50632270|FG000|Overall Study|Adverse Event|7|||
25316723|NCT00891462|50632271|FG001|Overall Study|Adverse Event|8|||
25316724|NCT00891462|50632272|FG002|Overall Study|Adverse Event|7|||
25316725|NCT00891462|50632270|FG000|Overall Study|Lack of Efficacy|10|||
25316726|NCT00891462|50632271|FG001|Overall Study|Lack of Efficacy|5|||
25316727|NCT00891462|50632272|FG002|Overall Study|Lack of Efficacy|1|||
25316728|NCT00891462|50632270|FG000|Overall Study|COPD exacerbation|7|||
25316729|NCT00891462|50632271|FG001|Overall Study|COPD exacerbation|4|||
25316730|NCT00891462|50632272|FG002|Overall Study|COPD exacerbation|1|||
25316731|NCT00891462|50632270|FG000|Overall Study|Other Reason|2|||
25316732|NCT00891462|50632271|FG001|Overall Study|Other Reason|5|||
25316733|NCT00891462|50632272|FG002|Overall Study|Other Reason|3|||
25316734|NCT00891462|50632270|FG000|Overall Study|Protocol Violation|2|||
25316735|NCT00891462|50632271|FG001|Overall Study|Protocol Violation|1|||
25316736|NCT00891462|50632272|FG002|Overall Study|Protocol Violation|3|||
25316737|NCT00891462|50632270|FG000|Overall Study|Inclusion/exclusion criteria|0|||
25316738|NCT00891462|50632271|FG001|Overall Study|Inclusion/exclusion criteria|2|||
25316739|NCT00891462|50632272|FG002|Overall Study|Inclusion/exclusion criteria|2|||
25316740|NCT00891462|50632270|FG000|Overall Study|Lost to Follow-up|0|||
25316741|NCT00891462|50632271|FG001|Overall Study|Lost to Follow-up|2|||
25316742|NCT00891462|50632272|FG002|Overall Study|Lost to Follow-up|0|||
25316743|NCT00900146|50632287|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
25316744|NCT00900146|50632288|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
25214649|NCT02034552|50490675|FG000|Overall Study|Non-compliance with study drug|0|||
25316745|NCT00900146|50632289|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
25316746|NCT00900146|50632290|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
25316747|NCT00900146|50632291|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
25214650|NCT02034552|50490676|FG001|Overall Study|Non-compliance with study drug|0|||
25316748|NCT00900146|50632287|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
25316749|NCT00900146|50632288|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
25316750|NCT00900146|50632289|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
25316751|NCT00900146|50632290|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
25316752|NCT00900146|50632291|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
25316753|NCT00900146|50632287|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
25214651|NCT02034552|50490677|FG002|Overall Study|Non-compliance with study drug|1|||
25214652|NCT02034552|50490675|FG000|Overall Study|Clinical progression|5|||
25214653|NCT02034552|50490676|FG001|Overall Study|Clinical progression|7|||
25214654|NCT02034552|50490677|FG002|Overall Study|Clinical progression|9|||
25214655|NCT02034474|50490687|FG000|Overall Study|Adverse Event|3|||
25214656|NCT02034474|50490688|FG001|Overall Study|Adverse Event|2|||
25214657|NCT02034474|50490687|FG000|Overall Study|Withdrawal by Subject|1|||
25214658|NCT02034474|50490688|FG001|Overall Study|Withdrawal by Subject|2|||
25214659|NCT02011542|50490696|FG000|Overall Study|Physician Decision|1|||
25214660|NCT02011386|50490700|FG000|Overall Study|Non-compliance|2|||
25214661|NCT02011386|50490700|FG000|Overall Study|Lack of Efficacy|3|||
25214662|NCT02010684|50490706|FG000|Overall Study|Lost to Follow-up|8|||
25214663|NCT02010684|50490707|FG001|Overall Study|Lost to Follow-up|18|||
25077380|NCT02936323|50185227|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
25214664|NCT02010684|50490706|FG000|Overall Study|Withdrawal by Subject|4|||
25214665|NCT02010684|50490707|FG001|Overall Study|Withdrawal by Subject|5|||
25214666|NCT02034162|50490715|FG000|Double-blind|Lost to Follow-up|3|||
25214667|NCT02034162|50490716|FG001|Double-blind|Lost to Follow-up|0|||
25214668|NCT02034162|50490717|FG002|Double-blind|Lost to Follow-up|0|||
25214669|NCT02034162|50490715|FG000|Double-blind|Physician Decision|1|||
25214670|NCT02034162|50490716|FG001|Double-blind|Physician Decision|0|||
25214671|NCT02034162|50490717|FG002|Double-blind|Physician Decision|0|||
25214672|NCT02034162|50490715|FG000|Double-blind|Protocol Violation|0|||
25214673|NCT02034162|50490716|FG001|Double-blind|Protocol Violation|1|||
25214674|NCT02034162|50490717|FG002|Double-blind|Protocol Violation|0|||
25214675|NCT02034162|50490715|FG000|Double-blind|Withdrawal by Subject|5|||
25214676|NCT02034162|50490716|FG001|Double-blind|Withdrawal by Subject|7|||
25214677|NCT02034162|50490717|FG002|Double-blind|Withdrawal by Subject|0|||
25214678|NCT02034006|50490730|FG000|Overall Study|Withdrawal by Subject|7|||
25214679|NCT02034006|50490730|FG000|Overall Study|Lost to Follow-up|5|||
25214680|NCT02034006|50490730|FG000|Overall Study|Death|1|||
25214681|NCT02034006|50490730|FG000|Overall Study|Pregnancy|1|||
25214682|NCT02054910|50490739|FG000|Overall Study|Lost to Follow-up|4|||
25214683|NCT02054910|50490740|FG001|Overall Study|Lost to Follow-up|1|||
25214684|NCT02033850|50490750|FG000|Overall Study|Death|1|||
25214685|NCT02033850|50490751|FG001|Overall Study|Death|0|||
25214686|NCT02033850|50490750|FG000|Overall Study|unrelated medical reason|1|||
25214687|NCT02033850|50490751|FG001|Overall Study|unrelated medical reason|1|||
25214688|NCT02054130|50490761|FG000|Overall Study|Withdrawal by Subject|4|||
25214689|NCT02054130|50490762|FG001|Overall Study|Withdrawal by Subject|4|||
25214690|NCT02054130|50490763|FG002|Overall Study|Withdrawal by Subject|7|||
25214691|NCT02054130|50490764|FG003|Overall Study|Withdrawal by Subject|10|||
25214692|NCT02054130|50490761|FG000|Overall Study|Death|0|||
25214693|NCT02054130|50490762|FG001|Overall Study|Death|1|||
25214694|NCT02054130|50490763|FG002|Overall Study|Death|0|||
25214695|NCT02054130|50490764|FG003|Overall Study|Death|0|||
25214696|NCT02054130|50490761|FG000|Overall Study|Lost to Follow-up|0|||
25214697|NCT02054130|50490762|FG001|Overall Study|Lost to Follow-up|0|||
25214698|NCT02054130|50490763|FG002|Overall Study|Lost to Follow-up|1|||
25214699|NCT02054130|50490764|FG003|Overall Study|Lost to Follow-up|2|||
25214700|NCT02054130|50490761|FG000|Overall Study|Missed dose|4|||
25214701|NCT02054130|50490762|FG001|Overall Study|Missed dose|6|||
25214702|NCT02054130|50490763|FG002|Overall Study|Missed dose|7|||
25214703|NCT02054130|50490764|FG003|Overall Study|Missed dose|10|||
25214704|NCT02009046|50490779|FG000|Overall Study|Lost to Follow-up|256|||
25214705|NCT02009046|50490780|FG001|Overall Study|Lost to Follow-up|206|||
25214706|NCT02052960|50490796|FG000|Overall Study|Adverse Event|19|||
25214707|NCT02052960|50490797|FG001|Overall Study|Adverse Event|17|||
25214708|NCT02052960|50490796|FG000|Overall Study|Protocol Violation|4|||
25214709|NCT02052960|50490797|FG001|Overall Study|Protocol Violation|3|||
25214710|NCT02052960|50490796|FG000|Overall Study|Withdrawal by Subject|6|||
25214711|NCT02052960|50490797|FG001|Overall Study|Withdrawal by Subject|11|||
25214712|NCT02052960|50490796|FG000|Overall Study|Other|25|||
25214713|NCT02052960|50490797|FG001|Overall Study|Other|15|||
25214714|NCT02008890|50490809|FG000|Period 1|Withdrawal by Subject|7|||
25214715|NCT02008890|50490810|FG001|Period 1|Withdrawal by Subject|7|||
25214716|NCT02008890|50490811|FG002|Period 1|Withdrawal by Subject|5|||
25214717|NCT02008890|50490812|FG003|Period 1|Withdrawal by Subject|0|||
25214718|NCT02008890|50490813|FG004|Period 1|Withdrawal by Subject|0|||
25214719|NCT02008890|50490809|FG000|Period 1|Pregnancy|1|||
25214720|NCT02008890|50490810|FG001|Period 1|Pregnancy|0|||
25214721|NCT02008890|50490811|FG002|Period 1|Pregnancy|0|||
25214722|NCT02008890|50490812|FG003|Period 1|Pregnancy|0|||
25214723|NCT02008890|50490813|FG004|Period 1|Pregnancy|0|||
25214724|NCT02008890|50490809|FG000|Period 1|Physician Decision|1|||
25214725|NCT02008890|50490810|FG001|Period 1|Physician Decision|0|||
25214726|NCT02008890|50490811|FG002|Period 1|Physician Decision|1|||
25214727|NCT02008890|50490812|FG003|Period 1|Physician Decision|0|||
25214728|NCT02008890|50490813|FG004|Period 1|Physician Decision|0|||
25214729|NCT02008890|50490809|FG000|Period 1|Adverse Event|6|||
25214730|NCT02008890|50490810|FG001|Period 1|Adverse Event|8|||
25214731|NCT02008890|50490811|FG002|Period 1|Adverse Event|6|||
25214732|NCT02008890|50490812|FG003|Period 1|Adverse Event|0|||
25214733|NCT02008890|50490813|FG004|Period 1|Adverse Event|0|||
25214734|NCT02008890|50490809|FG000|Period 2|Adverse Event|12|||
25214735|NCT02008890|50490810|FG001|Period 2|Adverse Event|7|||
25214736|NCT02008890|50490811|FG002|Period 2|Adverse Event|0|||
25214737|NCT02008890|50490812|FG003|Period 2|Adverse Event|5|||
25214738|NCT02008890|50490813|FG004|Period 2|Adverse Event|5|||
25214739|NCT02008890|50490809|FG000|Period 2|Withdrawal by Subject|11|||
25214740|NCT02008890|50490810|FG001|Period 2|Withdrawal by Subject|8|||
25214741|NCT02008890|50490811|FG002|Period 2|Withdrawal by Subject|0|||
25214742|NCT02008890|50490812|FG003|Period 2|Withdrawal by Subject|7|||
25214743|NCT02008890|50490813|FG004|Period 2|Withdrawal by Subject|2|||
25214744|NCT02008890|50490809|FG000|Period 2|Physician Decision|4|||
25214745|NCT02008890|50490810|FG001|Period 2|Physician Decision|0|||
25214746|NCT02008890|50490811|FG002|Period 2|Physician Decision|0|||
25214747|NCT02008890|50490812|FG003|Period 2|Physician Decision|2|||
25214748|NCT02008890|50490813|FG004|Period 2|Physician Decision|1|||
25214749|NCT02008890|50490809|FG000|Period 2|Lost to Follow-up|0|||
25214750|NCT02008890|50490810|FG001|Period 2|Lost to Follow-up|0|||
25214751|NCT02008890|50490811|FG002|Period 2|Lost to Follow-up|1|||
25214752|NCT02008890|50490812|FG003|Period 2|Lost to Follow-up|0|||
25214753|NCT02008890|50490813|FG004|Period 2|Lost to Follow-up|0|||
25214754|NCT02008890|50490809|FG000|Extension Period|Withdrawal by Subject|3|||
25214755|NCT02008890|50490810|FG001|Extension Period|Withdrawal by Subject|2|||
25214756|NCT02008890|50490811|FG002|Extension Period|Withdrawal by Subject|0|||
25214757|NCT02008890|50490812|FG003|Extension Period|Withdrawal by Subject|4|||
25214758|NCT02008890|50490813|FG004|Extension Period|Withdrawal by Subject|2|||
25214759|NCT02008890|50490809|FG000|Extension Period|Lost to Follow-up|1|||
25214760|NCT02008890|50490810|FG001|Extension Period|Lost to Follow-up|0|||
25214761|NCT02008890|50490811|FG002|Extension Period|Lost to Follow-up|0|||
25214762|NCT02008890|50490812|FG003|Extension Period|Lost to Follow-up|0|||
25214763|NCT02008890|50490813|FG004|Extension Period|Lost to Follow-up|0|||
25214764|NCT02008890|50490809|FG000|Extension Period|Adverse Event|1|||
25214765|NCT02008890|50490810|FG001|Extension Period|Adverse Event|3|||
25214766|NCT02008890|50490811|FG002|Extension Period|Adverse Event|0|||
25214767|NCT02008890|50490812|FG003|Extension Period|Adverse Event|0|||
25214768|NCT02008890|50490813|FG004|Extension Period|Adverse Event|2|||
25214769|NCT02052414|50490828|FG000|Overall Study|Adverse Event|12|||
25214770|NCT02052414|50490828|FG000|Overall Study|Lack of Efficacy|2|||
25214771|NCT02052414|50490828|FG000|Overall Study|Withdrawal by Subject|3|||
25214772|NCT02007954|50490833|FG000|Overall Study|Received liver transplant|3|||
25214773|NCT02007954|50490833|FG000|Overall Study|Switch in treatment modality|2|||
25214774|NCT02007954|50490833|FG000|Overall Study|Disease progression and unrelated AE|1|||
25214775|NCT02007954|50490833|FG000|Overall Study|Death|1|||
25214776|NCT02049450|50490837|FG000|Overall Study|Adverse Event|2|||
25214777|NCT02049450|50490837|FG000|Overall Study|Withdrawal by Subject|1|||
25214778|NCT02049450|50490837|FG000|Overall Study|Patients/guardian decision|1|||
25214779|NCT02031432|50490848|FG000|Overall Study|Protocol Violation|1|||
25214780|NCT02031432|50490848|FG000|Overall Study|Lack of Efficacy|5|||
25214781|NCT02031432|50490848|FG000|Overall Study|Cancer Progression|2|||
25214782|NCT02031432|50490848|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
25214783|NCT02031432|50490848|FG000|Overall Study|Adverse Event|8|||
25214784|NCT02031432|50490848|FG000|Overall Study|Withdrawal by Subject|5|||
25214785|NCT02031432|50490848|FG000|Overall Study|Lost to Follow-up|1|||
25214786|NCT02031432|50490848|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
25214787|NCT02031432|50490848|FG000|Overall Study|Death|10|||
25214788|NCT02031276|50490855|FG000|Period 1 Double-blind IV|Adverse Event|6|||
25214789|NCT02031276|50490856|FG001|Period 1 Double-blind IV|Adverse Event|5|||
25214790|NCT02031276|50490857|FG002|Period 1 Double-blind IV|Adverse Event|1|||
25214791|NCT02031276|50490855|FG000|Period 1 Double-blind IV|Other|0|||
25214792|NCT02031276|50490856|FG001|Period 1 Double-blind IV|Other|1|||
25214793|NCT02031276|50490857|FG002|Period 1 Double-blind IV|Other|0|||
25214794|NCT02031276|50490855|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
25214795|NCT02031276|50490856|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
25214796|NCT02031276|50490857|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
25214797|NCT02031276|50490855|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
25316754|NCT00900146|50632288|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
25214798|NCT02031276|50490856|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
25214799|NCT02031276|50490857|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
25214800|NCT02031276|50490855|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
25214801|NCT02031276|50490856|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
25214802|NCT02031276|50490857|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
25214803|NCT02031276|50490855|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
25214804|NCT02031276|50490856|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
25214805|NCT02031276|50490857|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
25214806|NCT02031276|50490855|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
25214807|NCT02031276|50490856|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
25316755|NCT00900146|50632289|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
25316756|NCT00900146|50632290|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
25316757|NCT00900146|50632291|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
25316758|NCT00900146|50632287|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
25316759|NCT00900146|50632288|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
25316760|NCT00900146|50632289|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
25316761|NCT00900146|50632290|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
25316762|NCT00900146|50632291|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
25316763|NCT00900146|50632287|FG000|Intermediate: Period III|Lost to Follow-up|2|||
25316764|NCT00900146|50632288|FG001|Intermediate: Period III|Lost to Follow-up|0|||
25316765|NCT00900146|50632289|FG002|Intermediate: Period III|Lost to Follow-up|0|||
25316766|NCT00900146|50632290|FG003|Intermediate: Period III|Lost to Follow-up|0|||
25316767|NCT00900146|50632291|FG004|Intermediate: Period III|Lost to Follow-up|1|||
25316768|NCT00900146|50632287|FG000|Intermediate: Period III|Administrative problems|85|||
25316769|NCT00900146|50632288|FG001|Intermediate: Period III|Administrative problems|92|||
25316770|NCT00900146|50632289|FG002|Intermediate: Period III|Administrative problems|84|||
25316771|NCT00900146|50632290|FG003|Intermediate: Period III|Administrative problems|90|||
25316772|NCT00900146|50632291|FG004|Intermediate: Period III|Administrative problems|163|||
25316773|NCT00895310|50632303|FG000|Overall Study|Withdrawal by Subject|1|||
25316774|NCT00895154|50632309|FG000|Overall Study|Lost to Follow-up|1|||
25316775|NCT00895154|50632310|FG001|Overall Study|Lost to Follow-up|1|||
25316776|NCT00895154|50632309|FG000|Overall Study|Withdrawal by Subject|0|||
25316777|NCT00895154|50632310|FG001|Overall Study|Withdrawal by Subject|1|||
25316778|NCT00888654|50632316|FG000|Overall Study|Problems swallowing oral meds.|1|||
25316779|NCT00888654|50632316|FG000|Overall Study|Not enough oral meds before surgery|3|||
25316780|NCT00888654|50632316|FG000|Overall Study|Surgery aborted|2|||
25316781|NCT00888654|50632316|FG000|Overall Study|Withdrawal by Subject|1|||
25316782|NCT00888654|50632316|FG000|Overall Study|Inelig. due to contraindication of med|1|||
25316783|NCT00888654|50632316|FG000|Overall Study|Change in surg date|1|||
25316784|NCT00888654|50632316|FG000|Overall Study|Stopped meds due to headaches|1|||
25316785|NCT00899678|50632323|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
25316786|NCT00899678|50632324|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
25316787|NCT00899678|50632325|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
25316788|NCT00899678|50632323|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
25316789|NCT00899678|50632324|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
25316790|NCT00899678|50632325|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
25316791|NCT00899678|50632323|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
25316792|NCT00899678|50632324|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
25316793|NCT00899678|50632325|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
25316794|NCT00899678|50632323|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
25316795|NCT00899678|50632324|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
25316796|NCT00899678|50632325|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
25316797|NCT00899678|50632323|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
25316798|NCT00899678|50632324|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
25316799|NCT00899678|50632325|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
25316800|NCT00899678|50632323|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
25077381|NCT02936323|50185228|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
25077382|NCT02936323|50185229|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
25214808|NCT02031276|50490857|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
25214809|NCT02031276|50490855|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
25214810|NCT02031276|50490856|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
25214811|NCT02031276|50490857|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
25214812|NCT02031276|50490855|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
25214813|NCT02031276|50490856|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
25214814|NCT02031276|50490857|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
25214815|NCT02007720|50490871|FG000|Overall Study|Withdrawal by Subject|9|||
25214816|NCT02007720|50490872|FG001|Overall Study|Withdrawal by Subject|11|||
25316801|NCT00899678|50632324|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
25316802|NCT00899678|50632325|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
25316803|NCT00899678|50632323|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
25316804|NCT00899678|50632324|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
25316805|NCT00899678|50632325|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
25214817|NCT02007720|50490871|FG000|Overall Study|study terminated by sponsor|58|||
25214818|NCT02007720|50490872|FG001|Overall Study|study terminated by sponsor|54|||
25316806|NCT00899678|50632323|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
25316807|NCT00899678|50632324|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
25316808|NCT00899678|50632325|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
25077383|NCT02936323|50185220|FG000|Phase 1 Dose Escalation|Death|2|||
25214819|NCT02007720|50490871|FG000|Overall Study|technical problem|4|||
25214820|NCT02007720|50490872|FG001|Overall Study|technical problem|2|||
25214821|NCT02007720|50490871|FG000|Overall Study|patient followd less than 165 days|11|||
25214822|NCT02007720|50490872|FG001|Overall Study|patient followd less than 165 days|5|||
25214823|NCT01363440|50490882|FG000|Overall Study|Adverse Event|5|||
25214824|NCT01363440|50490883|FG001|Overall Study|Adverse Event|4|||
25214825|NCT01363440|50490884|FG002|Overall Study|Adverse Event|4|||
25214826|NCT01363440|50490882|FG000|Overall Study|Death|3|||
25214827|NCT01363440|50490883|FG001|Overall Study|Death|7|||
25214828|NCT01363440|50490884|FG002|Overall Study|Death|5|||
25214829|NCT01363440|50490882|FG000|Overall Study|Withdrawal by Subject|9|||
25214830|NCT01363440|50490883|FG001|Overall Study|Withdrawal by Subject|11|||
25214831|NCT01363440|50490884|FG002|Overall Study|Withdrawal by Subject|11|||
25214832|NCT01363440|50490882|FG000|Overall Study|Lost to Follow-up|2|||
25214833|NCT01363440|50490883|FG001|Overall Study|Lost to Follow-up|4|||
25214834|NCT01363440|50490884|FG002|Overall Study|Lost to Follow-up|5|||
25214835|NCT01363440|50490882|FG000|Overall Study|Other|4|||
25214836|NCT01363440|50490883|FG001|Overall Study|Other|5|||
25214837|NCT01363440|50490884|FG002|Overall Study|Other|2|||
25214838|NCT02007252|50490897|FG000|Overall Study|Administrative problems|3|||
25214839|NCT02007252|50490898|FG001|Overall Study|Administrative problems|7|||
25214840|NCT02007252|50490897|FG000|Overall Study|Abnormal laboratory value(s)|1|||
25214841|NCT02007252|50490898|FG001|Overall Study|Abnormal laboratory value(s)|0|||
25214842|NCT02007252|50490897|FG000|Overall Study|Adverse Event|7|||
25214843|NCT02007252|50490898|FG001|Overall Study|Adverse Event|4|||
25214844|NCT02007096|50490906|FG000|Overall Study|medication not available|2|||
25214845|NCT02007096|50490907|FG001|Overall Study|medication not available|0|||
25214846|NCT02007096|50490906|FG000|Overall Study|did not inject saline|0|||
25214847|NCT02007096|50490907|FG001|Overall Study|did not inject saline|3|||
25214848|NCT02007096|50490906|FG000|Overall Study|did not follow postoperative protocol|8|||
25214849|NCT02007096|50490907|FG001|Overall Study|did not follow postoperative protocol|11|||
25214850|NCT02007096|50490906|FG000|Overall Study|converted to open surgery|1|||
25214851|NCT02007096|50490907|FG001|Overall Study|converted to open surgery|1|||
25214852|NCT02007096|50490906|FG000|Overall Study|no mesh placed|0|||
25214853|NCT02007096|50490907|FG001|Overall Study|no mesh placed|1|||
25214854|NCT02006706|50490913|FG000|Overall Study|Lost to Follow-up|1|||
25214855|NCT02049138|50490920|FG000|Overall Study|Adverse Event|46|||
25214856|NCT02049138|50490921|FG001|Overall Study|Adverse Event|25|||
25214857|NCT02049138|50490922|FG002|Overall Study|Adverse Event|1|||
25214858|NCT02049138|50490920|FG000|Overall Study|Withdrawal by Subject|57|||
25214859|NCT02049138|50490921|FG001|Overall Study|Withdrawal by Subject|21|||
25214860|NCT02049138|50490922|FG002|Overall Study|Withdrawal by Subject|5|||
25214861|NCT02049138|50490920|FG000|Overall Study|Lost to Follow-up|18|||
25214862|NCT02049138|50490921|FG001|Overall Study|Lost to Follow-up|5|||
25214863|NCT02049138|50490922|FG002|Overall Study|Lost to Follow-up|1|||
25214864|NCT02049138|50490920|FG000|Overall Study|Lack of Efficacy|10|||
25214865|NCT02049138|50490921|FG001|Overall Study|Lack of Efficacy|26|||
25214866|NCT02049138|50490922|FG002|Overall Study|Lack of Efficacy|1|||
25214867|NCT02049138|50490920|FG000|Overall Study|Non-Compliance|15|||
25214868|NCT02049138|50490921|FG001|Overall Study|Non-Compliance|6|||
25214869|NCT02049138|50490922|FG002|Overall Study|Non-Compliance|0|||
25214870|NCT02049138|50490920|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
25214871|NCT02049138|50490921|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
25214872|NCT02049138|50490922|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
25214873|NCT02049138|50490920|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
25214874|NCT02049138|50490921|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
25214875|NCT02049138|50490922|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
25214876|NCT02049138|50490920|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
25214877|NCT02049138|50490921|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
25214878|NCT02049138|50490922|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
25214879|NCT02049138|50490920|FG000|Overall Study|Other|15|||
25214880|NCT02049138|50490921|FG001|Overall Study|Other|13|||
25214881|NCT02049138|50490922|FG002|Overall Study|Other|0|||
25214882|NCT02049138|50490920|FG000|Overall Study|Missing|0|||
25214883|NCT02049138|50490921|FG001|Overall Study|Missing|1|||
25214884|NCT02049138|50490922|FG002|Overall Study|Missing|0|||
25214885|NCT02048904|50490933|FG000|Overall Study|Withdrawal by Subject|7|||
25214886|NCT02048904|50490933|FG000|Overall Study|Physician Decision|70|||
25214887|NCT02006628|50490939|FG000|Overall Study|Adverse Event|1|||
25214888|NCT02006628|50490940|FG001|Overall Study|Adverse Event|1|||
25214889|NCT02006628|50490939|FG000|Overall Study|Withdrawal by Subject|2|||
25214890|NCT02006628|50490940|FG001|Overall Study|Withdrawal by Subject|1|||
25214891|NCT02048826|50490948|FG000|Overall Study|Withdrawal by Subject|1|||
25214892|NCT02048826|50490949|FG001|Overall Study|Withdrawal by Subject|0|||
25214893|NCT02006472|50490960|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
25214894|NCT02006472|50490961|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
25214895|NCT02006472|50490962|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
25214896|NCT02006472|50490963|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
25214897|NCT02006472|50490964|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
25214898|NCT02006472|50490960|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
25214899|NCT02006472|50490961|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
25214900|NCT02006472|50490962|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
25214901|NCT02006472|50490963|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
25214902|NCT02006472|50490964|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
25214903|NCT02006472|50490960|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
25214904|NCT02006472|50490961|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
25214905|NCT02006472|50490962|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
25214906|NCT02006472|50490963|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
25214907|NCT02006472|50490964|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
25214908|NCT02006472|50490960|FG000|Period 1 (Through Week 26)|Other|1|||
25214909|NCT02006472|50490961|FG001|Period 1 (Through Week 26)|Other|5|||
25214910|NCT02006472|50490962|FG002|Period 1 (Through Week 26)|Other|0|||
25214911|NCT02006472|50490963|FG003|Period 1 (Through Week 26)|Other|2|||
25214912|NCT02006472|50490964|FG004|Period 1 (Through Week 26)|Other|3|||
25214913|NCT02006472|50490960|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
25214914|NCT02006472|50490961|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
25214915|NCT02006472|50490962|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
25214916|NCT02006472|50490963|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
25214917|NCT02006472|50490964|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
25214918|NCT02006472|50490960|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
25214919|NCT02006472|50490961|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
25214920|NCT02006472|50490962|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
25214921|NCT02006472|50490963|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
25214922|NCT02006472|50490964|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
25214923|NCT02006472|50490960|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
25214924|NCT02006472|50490961|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
25214925|NCT02006472|50490962|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
25214926|NCT02006472|50490963|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
25214927|NCT02006472|50490964|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
25214928|NCT02006472|50490960|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
25214929|NCT02006472|50490961|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
25214930|NCT02006472|50490962|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
25214931|NCT02006472|50490963|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
25214932|NCT02006472|50490964|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
25214933|NCT02006472|50490960|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
25214934|NCT02006472|50490961|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
25214935|NCT02006472|50490962|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
25214936|NCT02006472|50490963|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
25214937|NCT02006472|50490964|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
25214938|NCT02006472|50490960|FG000|Period 2 (Through Week 52)|Other|0|||
25214939|NCT02006472|50490961|FG001|Period 2 (Through Week 52)|Other|1|||
25214940|NCT02006472|50490962|FG002|Period 2 (Through Week 52)|Other|0|||
25214941|NCT02006472|50490963|FG003|Period 2 (Through Week 52)|Other|1|||
25214942|NCT02006472|50490964|FG004|Period 2 (Through Week 52)|Other|0|||
25214943|NCT02006472|50490960|FG000|Period 2 (Through Week 52)|Not treated|0|||
25214944|NCT02006472|50490961|FG001|Period 2 (Through Week 52)|Not treated|0|||
25214945|NCT02006472|50490962|FG002|Period 2 (Through Week 52)|Not treated|2|||
25214946|NCT02006472|50490963|FG003|Period 2 (Through Week 52)|Not treated|0|||
25214947|NCT02006472|50490964|FG004|Period 2 (Through Week 52)|Not treated|0|||
25214948|NCT02006472|50490960|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
25214949|NCT02006472|50490961|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
25214950|NCT02006472|50490962|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
25214951|NCT02006472|50490963|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
25214952|NCT02006472|50490964|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
25214953|NCT02006472|50490960|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
25214954|NCT02006472|50490961|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
25214955|NCT02006472|50490962|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
25214956|NCT02006472|50490963|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
25214957|NCT02006472|50490964|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
25214958|NCT02005692|50490981|FG000|Overall Study|Protocol Violation|1|||
25214959|NCT02005692|50490981|FG000|Overall Study|Withdrawal by Subject|1|||
25214960|NCT02005692|50490981|FG000|Overall Study|Discharged earlier than anticipated|5|||
25077384|NCT02936323|50185221|FG001|Phase 1 Dose Escalation|Death|1|||
25214961|NCT02029638|50490989|FG000|Overall Study|Death|0|||
25214962|NCT02029638|50490990|FG001|Overall Study|Death|0|||
25214963|NCT02029638|50490991|FG002|Overall Study|Death|1|||
25214964|NCT02029638|50490989|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
25214965|NCT02029638|50490990|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
25214966|NCT02029638|50490991|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
25214967|NCT02047734|50491002|FG000|Overall Study|Adverse Event|18|||
25214968|NCT02047734|50491003|FG001|Overall Study|Adverse Event|13|||
25214969|NCT02047734|50491004|FG002|Overall Study|Adverse Event|13|||
25214970|NCT02047734|50491002|FG000|Overall Study|Lack of Efficacy|4|||
25214971|NCT02047734|50491003|FG001|Overall Study|Lack of Efficacy|5|||
25214972|NCT02047734|50491004|FG002|Overall Study|Lack of Efficacy|1|||
25214973|NCT02047734|50491002|FG000|Overall Study|Protocol Violation|3|||
25214974|NCT02047734|50491003|FG001|Overall Study|Protocol Violation|1|||
25214975|NCT02047734|50491004|FG002|Overall Study|Protocol Violation|1|||
25214976|NCT02047734|50491002|FG000|Overall Study|Lost to Follow-up|1|||
25214977|NCT02047734|50491003|FG001|Overall Study|Lost to Follow-up|4|||
25214978|NCT02047734|50491004|FG002|Overall Study|Lost to Follow-up|0|||
25214979|NCT02047734|50491002|FG000|Overall Study|Death|0|||
25214980|NCT02047734|50491003|FG001|Overall Study|Death|1|||
25214981|NCT02047734|50491004|FG002|Overall Study|Death|0|||
25214982|NCT02047734|50491002|FG000|Overall Study|Withdrawal by Subject|30|||
25214983|NCT02047734|50491003|FG001|Overall Study|Withdrawal by Subject|31|||
25214984|NCT02047734|50491004|FG002|Overall Study|Withdrawal by Subject|19|||
25214985|NCT02047734|50491002|FG000|Overall Study|Physician Decision|7|||
25214986|NCT02047734|50491003|FG001|Overall Study|Physician Decision|6|||
25214987|NCT02047734|50491004|FG002|Overall Study|Physician Decision|5|||
25214988|NCT02047734|50491002|FG000|Overall Study|Miscellaneous|2|||
25214989|NCT02047734|50491003|FG001|Overall Study|Miscellaneous|4|||
25214990|NCT02047734|50491004|FG002|Overall Study|Miscellaneous|6|||
25214991|NCT02047734|50491002|FG000|Overall Study|Did Not Receive Study Drug|2|||
25214992|NCT02047734|50491003|FG001|Overall Study|Did Not Receive Study Drug|4|||
25214993|NCT02047734|50491004|FG002|Overall Study|Did Not Receive Study Drug|1|||
25214994|NCT02053350|50491012|FG000|Overall Study|Withdrawal by Subject|1|||
25214995|NCT02053350|50491012|FG000|Overall Study|Adverse Event|4|||
25214996|NCT01994850|50491016|FG000|Overall Study|Physician Decision|1|||
25214997|NCT01994850|50491016|FG000|Overall Study|Withdrawal by Subject|1|||
25214998|NCT02027844|50491023|FG000|Overall Study|Withdrawal by Subject|3|||
25214999|NCT02027844|50491024|FG001|Overall Study|Withdrawal by Subject|2|||
25215000|NCT02027844|50491025|FG002|Overall Study|Withdrawal by Subject|1|||
25215001|NCT02027844|50491023|FG000|Overall Study|Lost to Follow-up|0|||
25215002|NCT02027844|50491024|FG001|Overall Study|Lost to Follow-up|2|||
25215003|NCT02027844|50491025|FG002|Overall Study|Lost to Follow-up|1|||
25215004|NCT02027844|50491023|FG000|Overall Study|Protocol Violation|0|||
25215005|NCT02027844|50491024|FG001|Overall Study|Protocol Violation|2|||
25215006|NCT02027844|50491025|FG002|Overall Study|Protocol Violation|0|||
25215007|NCT02027844|50491023|FG000|Overall Study|Incomlete data|2|||
25215008|NCT02027844|50491024|FG001|Overall Study|Incomlete data|0|||
25215009|NCT02027844|50491025|FG002|Overall Study|Incomlete data|0|||
25215010|NCT01994382|50491050|FG000|Overall Study|Informed consent withdrawn|0|||
25215011|NCT01994382|50491051|FG001|Overall Study|Informed consent withdrawn|0|||
25215012|NCT01994382|50491052|FG002|Overall Study|Informed consent withdrawn|0|||
25215013|NCT01994382|50491053|FG003|Overall Study|Informed consent withdrawn|0|||
25215014|NCT01994382|50491054|FG004|Overall Study|Informed consent withdrawn|0|||
25215015|NCT01994382|50491055|FG005|Overall Study|Informed consent withdrawn|0|||
25215016|NCT01994382|50491056|FG006|Overall Study|Informed consent withdrawn|1|||
25215017|NCT01994382|50491057|FG007|Overall Study|Informed consent withdrawn|0|||
25215018|NCT01994382|50491058|FG008|Overall Study|Informed consent withdrawn|0|||
25215019|NCT01994382|50491059|FG009|Overall Study|Informed consent withdrawn|0|||
25215020|NCT01994382|50491060|FG010|Overall Study|Informed consent withdrawn|0|||
25215021|NCT01994382|50491061|FG011|Overall Study|Informed consent withdrawn|0|||
25215022|NCT01994382|50491062|FG012|Overall Study|Informed consent withdrawn|0|||
25215023|NCT01994382|50491063|FG013|Overall Study|Informed consent withdrawn|0|||
25215024|NCT01994382|50491064|FG014|Overall Study|Informed consent withdrawn|0|||
25215025|NCT01994382|50491065|FG015|Overall Study|Informed consent withdrawn|0|||
25215026|NCT01994382|50491066|FG016|Overall Study|Informed consent withdrawn|0|||
25215027|NCT01994382|50491050|FG000|Overall Study|Progressive disease|3|||
25215028|NCT01994382|50491051|FG001|Overall Study|Progressive disease|4|||
25215029|NCT01994382|50491052|FG002|Overall Study|Progressive disease|4|||
25215030|NCT01994382|50491053|FG003|Overall Study|Progressive disease|3|||
25215031|NCT01994382|50491054|FG004|Overall Study|Progressive disease|2|||
25215032|NCT01994382|50491055|FG005|Overall Study|Progressive disease|3|||
25215033|NCT01994382|50491056|FG006|Overall Study|Progressive disease|3|||
25215034|NCT01994382|50491057|FG007|Overall Study|Progressive disease|6|||
25215035|NCT01994382|50491058|FG008|Overall Study|Progressive disease|2|||
25215036|NCT01994382|50491059|FG009|Overall Study|Progressive disease|2|||
25215037|NCT01994382|50491060|FG010|Overall Study|Progressive disease|13|||
25215038|NCT01994382|50491061|FG011|Overall Study|Progressive disease|8|||
25215039|NCT01994382|50491062|FG012|Overall Study|Progressive disease|7|||
25215040|NCT01994382|50491063|FG013|Overall Study|Progressive disease|3|||
25215041|NCT01994382|50491064|FG014|Overall Study|Progressive disease|6|||
25215042|NCT01994382|50491065|FG015|Overall Study|Progressive disease|44|||
25215043|NCT01994382|50491066|FG016|Overall Study|Progressive disease|28|||
25215044|NCT01994382|50491050|FG000|Overall Study|Physician Decision|0|||
25215045|NCT01994382|50491051|FG001|Overall Study|Physician Decision|1|||
25215046|NCT01994382|50491052|FG002|Overall Study|Physician Decision|0|||
25215047|NCT01994382|50491053|FG003|Overall Study|Physician Decision|0|||
25215048|NCT01994382|50491054|FG004|Overall Study|Physician Decision|0|||
25215049|NCT01994382|50491055|FG005|Overall Study|Physician Decision|0|||
25215050|NCT01994382|50491056|FG006|Overall Study|Physician Decision|0|||
25215051|NCT01994382|50491057|FG007|Overall Study|Physician Decision|0|||
25215052|NCT01994382|50491058|FG008|Overall Study|Physician Decision|0|||
25215053|NCT01994382|50491059|FG009|Overall Study|Physician Decision|0|||
25215054|NCT01994382|50491060|FG010|Overall Study|Physician Decision|3|||
25215055|NCT01994382|50491061|FG011|Overall Study|Physician Decision|1|||
25215056|NCT01994382|50491062|FG012|Overall Study|Physician Decision|1|||
25215057|NCT01994382|50491063|FG013|Overall Study|Physician Decision|0|||
25215058|NCT01994382|50491064|FG014|Overall Study|Physician Decision|1|||
25215059|NCT01994382|50491065|FG015|Overall Study|Physician Decision|4|||
25215060|NCT01994382|50491066|FG016|Overall Study|Physician Decision|2|||
25215061|NCT01994382|50491050|FG000|Overall Study|Death|0|||
25215062|NCT01994382|50491051|FG001|Overall Study|Death|0|||
25215063|NCT01994382|50491052|FG002|Overall Study|Death|0|||
25215064|NCT01994382|50491053|FG003|Overall Study|Death|0|||
25215065|NCT01994382|50491054|FG004|Overall Study|Death|1|||
25215066|NCT01994382|50491055|FG005|Overall Study|Death|0|||
25215067|NCT01994382|50491056|FG006|Overall Study|Death|0|||
25215068|NCT01994382|50491057|FG007|Overall Study|Death|0|||
25215069|NCT01994382|50491058|FG008|Overall Study|Death|1|||
25215070|NCT01994382|50491059|FG009|Overall Study|Death|1|||
25215071|NCT01994382|50491060|FG010|Overall Study|Death|0|||
25215072|NCT01994382|50491061|FG011|Overall Study|Death|0|||
25215073|NCT01994382|50491062|FG012|Overall Study|Death|0|||
25215074|NCT01994382|50491063|FG013|Overall Study|Death|0|||
25215075|NCT01994382|50491064|FG014|Overall Study|Death|0|||
25215076|NCT01994382|50491065|FG015|Overall Study|Death|1|||
25215077|NCT01994382|50491066|FG016|Overall Study|Death|0|||
25215078|NCT01994382|50491050|FG000|Overall Study|Adverse Event|0|||
25215079|NCT01994382|50491051|FG001|Overall Study|Adverse Event|1|||
25215080|NCT01994382|50491052|FG002|Overall Study|Adverse Event|2|||
25215081|NCT01994382|50491053|FG003|Overall Study|Adverse Event|0|||
25215082|NCT01994382|50491054|FG004|Overall Study|Adverse Event|0|||
25215083|NCT01994382|50491055|FG005|Overall Study|Adverse Event|0|||
25215084|NCT01994382|50491056|FG006|Overall Study|Adverse Event|0|||
25215085|NCT01994382|50491057|FG007|Overall Study|Adverse Event|0|||
25215086|NCT01994382|50491058|FG008|Overall Study|Adverse Event|0|||
25215087|NCT01994382|50491059|FG009|Overall Study|Adverse Event|0|||
25215088|NCT01994382|50491060|FG010|Overall Study|Adverse Event|15|||
25215089|NCT01994382|50491061|FG011|Overall Study|Adverse Event|2|||
25215090|NCT01994382|50491062|FG012|Overall Study|Adverse Event|7|||
25215091|NCT01994382|50491063|FG013|Overall Study|Adverse Event|3|||
25215092|NCT01994382|50491064|FG014|Overall Study|Adverse Event|17|||
25215093|NCT01994382|50491065|FG015|Overall Study|Adverse Event|6|||
25215094|NCT01994382|50491066|FG016|Overall Study|Adverse Event|3|||
25215095|NCT01994382|50491050|FG000|Overall Study|Other than specified|0|||
25215096|NCT01994382|50491051|FG001|Overall Study|Other than specified|0|||
25215097|NCT01994382|50491052|FG002|Overall Study|Other than specified|0|||
25215098|NCT01994382|50491053|FG003|Overall Study|Other than specified|0|||
25215099|NCT01994382|50491054|FG004|Overall Study|Other than specified|0|||
25215100|NCT01994382|50491055|FG005|Overall Study|Other than specified|0|||
25215101|NCT01994382|50491056|FG006|Overall Study|Other than specified|0|||
25215102|NCT01994382|50491057|FG007|Overall Study|Other than specified|0|||
25215103|NCT01994382|50491058|FG008|Overall Study|Other than specified|0|||
25215104|NCT01994382|50491059|FG009|Overall Study|Other than specified|0|||
25215105|NCT01994382|50491060|FG010|Overall Study|Other than specified|2|||
25215106|NCT01994382|50491061|FG011|Overall Study|Other than specified|0|||
25215107|NCT01994382|50491062|FG012|Overall Study|Other than specified|2|||
25215108|NCT01994382|50491063|FG013|Overall Study|Other than specified|0|||
25215109|NCT01994382|50491064|FG014|Overall Study|Other than specified|0|||
25215110|NCT01994382|50491065|FG015|Overall Study|Other than specified|4|||
25215111|NCT01994382|50491066|FG016|Overall Study|Other than specified|4|||
25215112|NCT01994382|50491050|FG000|Overall Study|Withdrawal by Subject|0|||
25215113|NCT01994382|50491051|FG001|Overall Study|Withdrawal by Subject|0|||
25215114|NCT01994382|50491052|FG002|Overall Study|Withdrawal by Subject|0|||
25215115|NCT01994382|50491053|FG003|Overall Study|Withdrawal by Subject|0|||
25215116|NCT01994382|50491054|FG004|Overall Study|Withdrawal by Subject|0|||
25215117|NCT01994382|50491055|FG005|Overall Study|Withdrawal by Subject|0|||
25215118|NCT01994382|50491056|FG006|Overall Study|Withdrawal by Subject|0|||
25215119|NCT01994382|50491057|FG007|Overall Study|Withdrawal by Subject|0|||
25215120|NCT01994382|50491058|FG008|Overall Study|Withdrawal by Subject|0|||
25215121|NCT01994382|50491059|FG009|Overall Study|Withdrawal by Subject|0|||
25215122|NCT01994382|50491060|FG010|Overall Study|Withdrawal by Subject|6|||
25215123|NCT01994382|50491061|FG011|Overall Study|Withdrawal by Subject|0|||
25215124|NCT01994382|50491062|FG012|Overall Study|Withdrawal by Subject|2|||
25215125|NCT01994382|50491063|FG013|Overall Study|Withdrawal by Subject|0|||
25215126|NCT01994382|50491064|FG014|Overall Study|Withdrawal by Subject|4|||
25215127|NCT01994382|50491065|FG015|Overall Study|Withdrawal by Subject|3|||
25215128|NCT01994382|50491066|FG016|Overall Study|Withdrawal by Subject|0|||
25215129|NCT01994382|50491050|FG000|Overall Study|Lost to Follow-up|0|||
25215130|NCT01994382|50491051|FG001|Overall Study|Lost to Follow-up|0|||
25215131|NCT01994382|50491052|FG002|Overall Study|Lost to Follow-up|0|||
25215132|NCT01994382|50491053|FG003|Overall Study|Lost to Follow-up|0|||
25215133|NCT01994382|50491054|FG004|Overall Study|Lost to Follow-up|0|||
25215134|NCT01994382|50491055|FG005|Overall Study|Lost to Follow-up|0|||
25215135|NCT01994382|50491056|FG006|Overall Study|Lost to Follow-up|0|||
25215136|NCT01994382|50491057|FG007|Overall Study|Lost to Follow-up|0|||
25215137|NCT01994382|50491058|FG008|Overall Study|Lost to Follow-up|0|||
25215138|NCT01994382|50491059|FG009|Overall Study|Lost to Follow-up|0|||
25215139|NCT01994382|50491060|FG010|Overall Study|Lost to Follow-up|1|||
25215140|NCT01994382|50491061|FG011|Overall Study|Lost to Follow-up|0|||
25215141|NCT01994382|50491062|FG012|Overall Study|Lost to Follow-up|0|||
25215142|NCT01994382|50491063|FG013|Overall Study|Lost to Follow-up|0|||
25215143|NCT01994382|50491064|FG014|Overall Study|Lost to Follow-up|0|||
25215144|NCT01994382|50491065|FG015|Overall Study|Lost to Follow-up|0|||
25215145|NCT01994382|50491066|FG016|Overall Study|Lost to Follow-up|0|||
25215146|NCT01994382|50491050|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
25215147|NCT01994382|50491051|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
25215148|NCT01994382|50491052|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
25215149|NCT01994382|50491053|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
25215150|NCT01994382|50491054|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
25215151|NCT01994382|50491055|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
25215152|NCT01994382|50491056|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
25215153|NCT01994382|50491057|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
25215154|NCT01994382|50491058|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
25215155|NCT01994382|50491059|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
25215156|NCT01994382|50491060|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
25215157|NCT01994382|50491061|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
25215158|NCT01994382|50491062|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
25215159|NCT01994382|50491063|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
25215160|NCT01994382|50491064|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
25215161|NCT01994382|50491065|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
25215162|NCT01994382|50491066|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
25215163|NCT01994382|50491050|FG000|Overall Study|Protocol violation/noncompliance|0|||
25215164|NCT01994382|50491051|FG001|Overall Study|Protocol violation/noncompliance|0|||
25215165|NCT01994382|50491052|FG002|Overall Study|Protocol violation/noncompliance|0|||
25215166|NCT01994382|50491053|FG003|Overall Study|Protocol violation/noncompliance|0|||
25215167|NCT01994382|50491054|FG004|Overall Study|Protocol violation/noncompliance|0|||
25215168|NCT01994382|50491055|FG005|Overall Study|Protocol violation/noncompliance|0|||
25215169|NCT01994382|50491056|FG006|Overall Study|Protocol violation/noncompliance|0|||
25215170|NCT01994382|50491057|FG007|Overall Study|Protocol violation/noncompliance|0|||
25215171|NCT01994382|50491058|FG008|Overall Study|Protocol violation/noncompliance|0|||
25215172|NCT01994382|50491059|FG009|Overall Study|Protocol violation/noncompliance|0|||
25215173|NCT01994382|50491060|FG010|Overall Study|Protocol violation/noncompliance|0|||
25215174|NCT01994382|50491061|FG011|Overall Study|Protocol violation/noncompliance|1|||
25215175|NCT01994382|50491062|FG012|Overall Study|Protocol violation/noncompliance|0|||
25215176|NCT01994382|50491063|FG013|Overall Study|Protocol violation/noncompliance|0|||
25215177|NCT01994382|50491064|FG014|Overall Study|Protocol violation/noncompliance|0|||
25215178|NCT01994382|50491065|FG015|Overall Study|Protocol violation/noncompliance|0|||
25215179|NCT01994382|50491066|FG016|Overall Study|Protocol violation/noncompliance|2|||
25215180|NCT01994382|50491050|FG000|Overall Study|Rolled over to Phase 2a|0|||
25215181|NCT01994382|50491051|FG001|Overall Study|Rolled over to Phase 2a|0|||
25215182|NCT01994382|50491052|FG002|Overall Study|Rolled over to Phase 2a|1|||
25215183|NCT01994382|50491053|FG003|Overall Study|Rolled over to Phase 2a|0|||
25215184|NCT01994382|50491054|FG004|Overall Study|Rolled over to Phase 2a|0|||
25215185|NCT01994382|50491055|FG005|Overall Study|Rolled over to Phase 2a|0|||
25215186|NCT01994382|50491056|FG006|Overall Study|Rolled over to Phase 2a|0|||
25215187|NCT01994382|50491057|FG007|Overall Study|Rolled over to Phase 2a|0|||
25215188|NCT01994382|50491058|FG008|Overall Study|Rolled over to Phase 2a|0|||
25215189|NCT01994382|50491059|FG009|Overall Study|Rolled over to Phase 2a|2|||
25215190|NCT01994382|50491060|FG010|Overall Study|Rolled over to Phase 2a|0|||
25215191|NCT01994382|50491061|FG011|Overall Study|Rolled over to Phase 2a|0|||
25215192|NCT01994382|50491062|FG012|Overall Study|Rolled over to Phase 2a|0|||
25215193|NCT01994382|50491063|FG013|Overall Study|Rolled over to Phase 2a|0|||
25215194|NCT01994382|50491064|FG014|Overall Study|Rolled over to Phase 2a|0|||
25215195|NCT01994382|50491065|FG015|Overall Study|Rolled over to Phase 2a|0|||
25215196|NCT01994382|50491066|FG016|Overall Study|Rolled over to Phase 2a|0|||
25215197|NCT02003898|50491109|FG000|Overall Study|Death|3|||
25215198|NCT02003898|50491109|FG000|Overall Study|Lost to Follow-up|12|||
25215199|NCT02003898|50491109|FG000|Overall Study|Withdrawal by Subject|52|||
25215200|NCT01994226|50491115|FG000|Overall Study|Protocol Violation|13|||
25215201|NCT01994226|50491116|FG001|Overall Study|Protocol Violation|10|||
25215202|NCT01994226|50491115|FG000|Overall Study|Early Cessation of treatment|6|||
25215203|NCT01994226|50491116|FG001|Overall Study|Early Cessation of treatment|11|||
25215204|NCT02002884|50491125|FG000|Main Period (MP)|Other|0|||
25215205|NCT02002884|50491126|FG001|Main Period (MP)|Other|3|||
25215206|NCT02002884|50491127|FG002|Main Period (MP)|Other|3|||
25215207|NCT02002884|50491128|FG003|Main Period (MP)|Other|0|||
25215208|NCT02002884|50491125|FG000|Main Period (MP)|Adverse Event|0|||
25215209|NCT02002884|50491126|FG001|Main Period (MP)|Adverse Event|1|||
25215210|NCT02002884|50491127|FG002|Main Period (MP)|Adverse Event|1|||
25215211|NCT02002884|50491128|FG003|Main Period (MP)|Adverse Event|0|||
25215212|NCT02002884|50491125|FG000|Main Period (MP)|Withdrawal by Subject|6|||
25215213|NCT02002884|50491126|FG001|Main Period (MP)|Withdrawal by Subject|2|||
25215214|NCT02002884|50491127|FG002|Main Period (MP)|Withdrawal by Subject|2|||
25215215|NCT02002884|50491128|FG003|Main Period (MP)|Withdrawal by Subject|0|||
25215216|NCT02002884|50491125|FG000|Main Period (MP)|Lost to Follow-up|0|||
25215217|NCT02002884|50491126|FG001|Main Period (MP)|Lost to Follow-up|0|||
25215218|NCT02002884|50491127|FG002|Main Period (MP)|Lost to Follow-up|2|||
25215219|NCT02002884|50491128|FG003|Main Period (MP)|Lost to Follow-up|0|||
25215220|NCT02002884|50491125|FG000|Open-Label Extension Period (OLEX)|Other|0|||
25215221|NCT02002884|50491126|FG001|Open-Label Extension Period (OLEX)|Other|0|||
25215222|NCT02002884|50491127|FG002|Open-Label Extension Period (OLEX)|Other|0|||
25215223|NCT02002884|50491128|FG003|Open-Label Extension Period (OLEX)|Other|24|||
25215224|NCT02002884|50491125|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
25215225|NCT02002884|50491126|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
25215226|NCT02002884|50491127|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
25215227|NCT02002884|50491128|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
25215228|NCT02002884|50491125|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
25215229|NCT02002884|50491126|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
25215230|NCT02002884|50491127|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
25215231|NCT02002884|50491128|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
25215232|NCT02002884|50491125|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
25215233|NCT02002884|50491126|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
25215234|NCT02002884|50491127|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
25215235|NCT02002884|50491128|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
25215236|NCT02002884|50491125|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
25215237|NCT02002884|50491126|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
25215238|NCT02002884|50491127|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
25215239|NCT02002884|50491128|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
25215240|NCT02002182|50491140|FG000|Overall Study|Withdraw from study|3|||
25215241|NCT02002182|50491141|FG001|Overall Study|Withdraw from study|1|||
25215242|NCT02002182|50491140|FG000|Overall Study|Health Reasons|1|||
25215243|NCT02002182|50491141|FG001|Overall Study|Health Reasons|0|||
25215244|NCT02002182|50491140|FG000|Overall Study|Death|1|||
25215245|NCT02002182|50491141|FG001|Overall Study|Death|0|||
25215246|NCT01990950|50491147|FG000|Overall Study|Death|3|||
25215247|NCT01990950|50491147|FG000|Overall Study|Lost to Follow-up|2|||
25215248|NCT01990950|50491147|FG000|Overall Study|Withdrawal by Subject|6|||
25215249|NCT02001558|50491153|FG000|Overall Study|Lost to Follow-up|8|||
25215250|NCT02001558|50491154|FG001|Overall Study|Lost to Follow-up|14|||
25215251|NCT02023866|50491160|FG000|Overall Study|Non-compliance|2|||
25215252|NCT02023866|50491160|FG000|Overall Study|Adverse Event|3|||
25215253|NCT02023866|50491160|FG000|Overall Study|Withdrawal by Subject|1|||
25215254|NCT02023242|50491166|FG000|Overall Study|Lost to Follow-up|3|||
25215255|NCT02023242|50491167|FG001|Overall Study|Lost to Follow-up|1|||
25215256|NCT02023242|50491166|FG000|Overall Study|Death|0|||
25215257|NCT02023242|50491167|FG001|Overall Study|Death|1|||
25215258|NCT01967940|50491176|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
25215259|NCT01967940|50491177|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
25215260|NCT01967940|50491178|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
25215261|NCT01967940|50491179|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
25215262|NCT01967940|50491176|FG000|Part 2|Adverse Event|0|||
25215263|NCT01967940|50491177|FG001|Part 2|Adverse Event|0|||
25215264|NCT01967940|50491178|FG002|Part 2|Adverse Event|0|||
25215265|NCT01967940|50491179|FG003|Part 2|Adverse Event|1|||
25215266|NCT01967940|50491176|FG000|Part 2|Unknown Reason|0|||
25215267|NCT01967940|50491177|FG001|Part 2|Unknown Reason|0|||
25215268|NCT01967940|50491178|FG002|Part 2|Unknown Reason|0|||
25215269|NCT01967940|50491179|FG003|Part 2|Unknown Reason|1|||
25215270|NCT01990560|50491189|FG000|Overall Study|Withdrawal by Subject|1|||
25215271|NCT01998984|50491197|FG000|Overall Study|Adverse Event|0|||
25215272|NCT01998984|50491198|FG001|Overall Study|Adverse Event|0|||
25215273|NCT01998984|50491199|FG002|Overall Study|Adverse Event|0|||
25215274|NCT01998984|50491200|FG003|Overall Study|Adverse Event|1|||
25215275|NCT01998984|50491197|FG000|Overall Study|Lost to Follow-up|0|||
25215276|NCT01998984|50491198|FG001|Overall Study|Lost to Follow-up|1|||
25215277|NCT01998984|50491199|FG002|Overall Study|Lost to Follow-up|0|||
25215278|NCT01998984|50491200|FG003|Overall Study|Lost to Follow-up|1|||
25215279|NCT01998984|50491197|FG000|Overall Study|Withdrawal by Subject|0|||
25215280|NCT01998984|50491198|FG001|Overall Study|Withdrawal by Subject|0|||
25215281|NCT01998984|50491199|FG002|Overall Study|Withdrawal by Subject|1|||
25215282|NCT01998984|50491200|FG003|Overall Study|Withdrawal by Subject|0|||
25215283|NCT01998984|50491197|FG000|Overall Study|Other|0|||
25215284|NCT01998984|50491198|FG001|Overall Study|Other|0|||
25215285|NCT01998984|50491199|FG002|Overall Study|Other|0|||
25215286|NCT01998984|50491200|FG003|Overall Study|Other|1|||
25215287|NCT01967706|50491212|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
25215288|NCT01967706|50491213|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
25215289|NCT01967706|50491214|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
25215290|NCT01967706|50491215|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
25215291|NCT01967628|50491226|FG000|Overall Study|Withdrawal by Subject|2|||
25215292|NCT01967628|50491227|FG001|Overall Study|Withdrawal by Subject|0|||
25215293|NCT01967628|50491226|FG000|Overall Study|Unable to complete bronchoscopy|4|||
25215294|NCT01967628|50491227|FG001|Overall Study|Unable to complete bronchoscopy|6|||
25215295|NCT01967628|50491226|FG000|Overall Study|Lost to Follow-up|1|||
25215296|NCT01967628|50491227|FG001|Overall Study|Lost to Follow-up|0|||
25215297|NCT01967628|50491226|FG000|Overall Study|Low protein concentration in sample|20|||
25215298|NCT01967628|50491227|FG001|Overall Study|Low protein concentration in sample|25|||
25215299|NCT01998906|50491236|FG000|Overall Study|Participants ongoing in follow-up|77|||
25215300|NCT01998906|50491237|FG001|Overall Study|Participants ongoing in follow-up|60|||
25215301|NCT01998906|50491238|FG002|Overall Study|Participants ongoing in follow-up|58|||
25215302|NCT01998906|50491236|FG000|Overall Study|Death|21|||
25215303|NCT01998906|50491237|FG001|Overall Study|Death|30|||
25215304|NCT01998906|50491238|FG002|Overall Study|Death|17|||
25215305|NCT01998906|50491236|FG000|Overall Study|Lack of Efficacy|10|||
25215306|NCT01998906|50491237|FG001|Overall Study|Lack of Efficacy|9|||
25215307|NCT01998906|50491238|FG002|Overall Study|Lack of Efficacy|8|||
25215308|NCT01998906|50491236|FG000|Overall Study|Failure to return|0|||
25215309|NCT01998906|50491237|FG001|Overall Study|Failure to return|2|||
25215310|NCT01998906|50491238|FG002|Overall Study|Failure to return|4|||
25215311|NCT01998906|50491236|FG000|Overall Study|Violation of Selection Criteria|0|||
25215312|NCT01998906|50491237|FG001|Overall Study|Violation of Selection Criteria|0|||
25215313|NCT01998906|50491238|FG002|Overall Study|Violation of Selection Criteria|1|||
25215314|NCT01998906|50491236|FG000|Overall Study|Withdrawal by Subject|1|||
25215315|NCT01998906|50491237|FG001|Overall Study|Withdrawal by Subject|4|||
25215316|NCT01998906|50491238|FG002|Overall Study|Withdrawal by Subject|3|||
25215317|NCT01998906|50491236|FG000|Overall Study|Administrative/Other|2|||
25215318|NCT01998906|50491237|FG001|Overall Study|Administrative/Other|1|||
25215319|NCT01998906|50491238|FG002|Overall Study|Administrative/Other|3|||
25215320|NCT01998906|50491236|FG000|Overall Study|Other|3|||
25215321|NCT01998906|50491237|FG001|Overall Study|Other|8|||
25215322|NCT01998906|50491238|FG002|Overall Study|Other|4|||
25215323|NCT01967550|50491251|FG000|Overall Study|Withdrawal by Subject|1|||
25215324|NCT01967550|50491252|FG001|Overall Study|Withdrawal by Subject|0|||
25215325|NCT01967550|50491251|FG000|Overall Study|Adverse Event|2|||
25215326|NCT01967550|50491252|FG001|Overall Study|Adverse Event|0|||
25215327|NCT01967550|50491251|FG000|Overall Study|Protocol Violation|2|||
25215328|NCT01967550|50491252|FG001|Overall Study|Protocol Violation|1|||
25215329|NCT01967550|50491251|FG000|Overall Study|Non Compliance|0|||
25215330|NCT01967550|50491252|FG001|Overall Study|Non Compliance|1|||
25215331|NCT01989546|50491258|FG000|Overall Study|Clinical Progression|1|||
25215332|NCT01989546|50491258|FG000|Overall Study|Disease progression on study|8|||
25215333|NCT01997892|50491262|FG000|Overall Study|Physician Decision|2|||
25215334|NCT01997892|50491262|FG000|Overall Study|Lost to Follow-up|6|||
25215335|NCT01997892|50491262|FG000|Overall Study|Death|14|||
25215336|NCT01997892|50491262|FG000|Overall Study|Renal transplant|8|||
25215337|NCT01997892|50491262|FG000|Overall Study|Other|3|||
25215338|NCT01997892|50491262|FG000|Overall Study|Study completion data not recorded|35|||
25215339|NCT01989468|50491274|FG000|Overall Study|Adverse Event|10|||
25215340|NCT01989468|50491275|FG001|Overall Study|Adverse Event|15|||
25215341|NCT01989468|50491276|FG002|Overall Study|Adverse Event|4|||
25215342|NCT01989468|50491277|FG003|Overall Study|Adverse Event|5|||
25215343|NCT01989468|50491278|FG004|Overall Study|Adverse Event|4|||
25215344|NCT01989468|50491274|FG000|Overall Study|Lack of Efficacy|11|||
24976423|NCT00053846|50065323|FG001|Overall Study|Expired|0|||
24976424|NCT00053846|50065322|FG000|Overall Study|Became ineligible|3|||
25215345|NCT01989468|50491275|FG001|Overall Study|Lack of Efficacy|11|||
25215346|NCT01989468|50491276|FG002|Overall Study|Lack of Efficacy|7|||
25215347|NCT01989468|50491277|FG003|Overall Study|Lack of Efficacy|4|||
25215348|NCT01989468|50491278|FG004|Overall Study|Lack of Efficacy|2|||
24976425|NCT00053846|50065323|FG001|Overall Study|Became ineligible|1|||
24976426|NCT00053846|50065322|FG000|Overall Study|Did not return data|1|||
24976427|NCT00053846|50065323|FG001|Overall Study|Did not return data|2|||
24976428|NCT00053846|50065322|FG000|Overall Study|Quit due to side effects|1|||
24976429|NCT00053846|50065323|FG001|Overall Study|Quit due to side effects|3|||
24976430|NCT00053846|50065322|FG000|Overall Study|Pills too large|0|||
24976431|NCT00053846|50065323|FG001|Overall Study|Pills too large|1|||
24976432|NCT00090987|50065329|FG000|Overall Study|Adverse Event|5|||
24976433|NCT00090987|50065329|FG000|Overall Study|Lack of Efficacy|7|||
24976434|NCT00090987|50065329|FG000|Overall Study|Withdrawal by Subject|3|||
24976435|NCT00090987|50065329|FG000|Overall Study|alternative therapy|1|||
24976436|NCT00090987|50065329|FG000|Overall Study|Non-compliance|4|||
25077385|NCT02936323|50185222|FG002|Phase 1 Dose Escalation|Death|3|||
25077386|NCT02936323|50185223|FG003|Phase 1 Dose Escalation|Death|1|||
25077387|NCT02936323|50185224|FG004|Phase 1 Dose Escalation|Death|2|||
25215349|NCT01989468|50491274|FG000|Overall Study|Lost to Follow-up|5|||
25215350|NCT01989468|50491275|FG001|Overall Study|Lost to Follow-up|2|||
25215351|NCT01989468|50491276|FG002|Overall Study|Lost to Follow-up|0|||
25215352|NCT01989468|50491277|FG003|Overall Study|Lost to Follow-up|1|||
25215353|NCT01989468|50491278|FG004|Overall Study|Lost to Follow-up|1|||
25215354|NCT01989468|50491274|FG000|Overall Study|Physician Decision|4|||
25215355|NCT01989468|50491275|FG001|Overall Study|Physician Decision|1|||
25215356|NCT01989468|50491276|FG002|Overall Study|Physician Decision|0|||
25215357|NCT01989468|50491277|FG003|Overall Study|Physician Decision|1|||
25215358|NCT01989468|50491278|FG004|Overall Study|Physician Decision|0|||
25215359|NCT01989468|50491274|FG000|Overall Study|Pregnancy|0|||
25215360|NCT01989468|50491275|FG001|Overall Study|Pregnancy|1|||
25215361|NCT01989468|50491276|FG002|Overall Study|Pregnancy|0|||
25215362|NCT01989468|50491277|FG003|Overall Study|Pregnancy|0|||
25215363|NCT01989468|50491278|FG004|Overall Study|Pregnancy|0|||
25215364|NCT01989468|50491274|FG000|Overall Study|Technical Problems|3|||
25215365|NCT01989468|50491275|FG001|Overall Study|Technical Problems|1|||
25215366|NCT01989468|50491276|FG002|Overall Study|Technical Problems|3|||
25215367|NCT01989468|50491277|FG003|Overall Study|Technical Problems|1|||
25215368|NCT01989468|50491278|FG004|Overall Study|Technical Problems|0|||
25215369|NCT01989468|50491274|FG000|Overall Study|Subject Guardian Decision|11|||
25215370|NCT01989468|50491275|FG001|Overall Study|Subject Guardian Decision|6|||
25215371|NCT01989468|50491276|FG002|Overall Study|Subject Guardian Decision|4|||
25215372|NCT01989468|50491277|FG003|Overall Study|Subject Guardian Decision|4|||
25215373|NCT01989468|50491278|FG004|Overall Study|Subject Guardian Decision|1|||
25215374|NCT01989468|50491274|FG000|Overall Study|Death|3|||
25215375|NCT01989468|50491275|FG001|Overall Study|Death|0|||
25215376|NCT01989468|50491276|FG002|Overall Study|Death|1|||
25215377|NCT01989468|50491277|FG003|Overall Study|Death|0|||
25215378|NCT01989468|50491278|FG004|Overall Study|Death|0|||
25215379|NCT01989156|50491294|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
25215380|NCT01989156|50491295|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
25215381|NCT01989156|50491296|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
25215382|NCT01989156|50491294|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
25215383|NCT01989156|50491295|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
25215384|NCT01989156|50491296|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
25215385|NCT01989156|50491294|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
25215386|NCT01989156|50491295|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
25215387|NCT01989156|50491296|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
25215388|NCT01989156|50491294|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
25215389|NCT01989156|50491295|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
25215390|NCT01989156|50491296|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
25215391|NCT01989156|50491294|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
25215392|NCT01989156|50491295|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
25215393|NCT01989156|50491296|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
25215394|NCT01989156|50491294|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
25215395|NCT01989156|50491295|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
25215396|NCT01989156|50491296|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
25215397|NCT01989156|50491294|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
25215398|NCT01989156|50491295|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
25215399|NCT01989156|50491296|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
25215400|NCT01989156|50491294|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
24976437|NCT00090987|50065329|FG000|Overall Study|Incarcerated|1|||
24976438|NCT03464422|50065333|FG000|Overall Study|Lost to Follow-up|2|||
25077388|NCT02936323|50185225|FG005|Phase 1 Dose Escalation|Death|3|||
25077389|NCT02936323|50185226|FG006|Phase 1 Dose Escalation|Death|3|||
25215401|NCT01989156|50491295|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
25215402|NCT01989156|50491296|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
25215403|NCT01620762|50491307|FG000|Overall Study|Protocol Violation|1|||
25215404|NCT01620762|50491308|FG001|Overall Study|Protocol Violation|1|||
25215405|NCT01620762|50491309|FG002|Overall Study|Protocol Violation|1|||
25215406|NCT01620762|50491307|FG000|Overall Study|Adverse Event|9|||
25215407|NCT01620762|50491308|FG001|Overall Study|Adverse Event|5|||
25215408|NCT01620762|50491309|FG002|Overall Study|Adverse Event|2|||
25215409|NCT01620762|50491307|FG000|Overall Study|Withdrawal by Subject|23|||
25215410|NCT01620762|50491308|FG001|Overall Study|Withdrawal by Subject|26|||
25215411|NCT01620762|50491309|FG002|Overall Study|Withdrawal by Subject|27|||
25215412|NCT01620762|50491307|FG000|Overall Study|Lost to Follow-up|11|||
25215413|NCT01620762|50491308|FG001|Overall Study|Lost to Follow-up|17|||
25215414|NCT01620762|50491309|FG002|Overall Study|Lost to Follow-up|10|||
25215415|NCT01620762|50491307|FG000|Overall Study|Protocol deviation|1|||
25215416|NCT01620762|50491308|FG001|Overall Study|Protocol deviation|1|||
25215417|NCT01620762|50491309|FG002|Overall Study|Protocol deviation|6|||
25215418|NCT01620762|50491307|FG000|Overall Study|Subject deterioration|0|||
25215419|NCT01620762|50491308|FG001|Overall Study|Subject deterioration|1|||
25215420|NCT01620762|50491309|FG002|Overall Study|Subject deterioration|1|||
25215421|NCT01620762|50491307|FG000|Overall Study|Non-specified|3|||
25215422|NCT01620762|50491308|FG001|Overall Study|Non-specified|6|||
25215423|NCT01620762|50491309|FG002|Overall Study|Non-specified|5|||
25215424|NCT01620762|50491307|FG000|Overall Study|Use of prohibted therapies|0|||
25215425|NCT01620762|50491308|FG001|Overall Study|Use of prohibted therapies|1|||
25215426|NCT01620762|50491309|FG002|Overall Study|Use of prohibted therapies|1|||
25215427|NCT01966068|50491319|FG000|Overall Study|Withdrawal by Subject|57|||
25215428|NCT01966068|50491319|FG000|Overall Study|Lost to Follow-up|81|||
25215429|NCT01620528|50491327|FG000|Treatment Period|Did Not Receive Study Drug|0|||
25215430|NCT01620528|50491328|FG001|Treatment Period|Did Not Receive Study Drug|0|||
25215431|NCT01620528|50491329|FG002|Treatment Period|Did Not Receive Study Drug|1|||
25215432|NCT01620528|50491327|FG000|Treatment Period|Withdrawal by Subject|35|||
25215433|NCT01620528|50491328|FG001|Treatment Period|Withdrawal by Subject|21|||
25215434|NCT01620528|50491329|FG002|Treatment Period|Withdrawal by Subject|16|||
25215435|NCT01620528|50491327|FG000|Treatment Period|Adverse Event|17|||
25215436|NCT01620528|50491328|FG001|Treatment Period|Adverse Event|13|||
25215437|NCT01620528|50491329|FG002|Treatment Period|Adverse Event|21|||
25215438|NCT01620528|50491327|FG000|Treatment Period|Lost to Follow-up|16|||
25215439|NCT01620528|50491328|FG001|Treatment Period|Lost to Follow-up|8|||
25215440|NCT01620528|50491329|FG002|Treatment Period|Lost to Follow-up|14|||
25215441|NCT01620528|50491327|FG000|Treatment Period|Other|9|||
25316809|NCT00899678|50632323|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
25316810|NCT00899678|50632324|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
25316811|NCT00899678|50632325|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
25316812|NCT00887484|50632333|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
25316813|NCT00887484|50632333|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
25316814|NCT00887484|50632333|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
25316815|NCT00886938|50632342|FG000|Overall Study|Adverse Event|1|||
25316816|NCT00886938|50632342|FG000|Overall Study|Withdrawal by Subject|1|||
25316817|NCT00620659|50632346|FG000|Treatment Period 1|Adverse Event|1|||
25316818|NCT00620659|50632347|FG001|Treatment Period 1|Adverse Event|0|||
25316819|NCT00620659|50632348|FG002|Treatment Period 1|Adverse Event|0|||
25316820|NCT00620659|50632349|FG003|Treatment Period 1|Adverse Event|3|||
25316821|NCT00620659|50632350|FG004|Treatment Period 1|Adverse Event|0|||
25316822|NCT00620659|50632351|FG005|Treatment Period 1|Adverse Event|0|||
25316823|NCT00620659|50632346|FG000|Treatment Period 1|Protocol Violation|1|||
25316824|NCT00620659|50632347|FG001|Treatment Period 1|Protocol Violation|0|||
25316825|NCT00620659|50632348|FG002|Treatment Period 1|Protocol Violation|0|||
25316826|NCT00620659|50632349|FG003|Treatment Period 1|Protocol Violation|0|||
25316827|NCT00620659|50632350|FG004|Treatment Period 1|Protocol Violation|0|||
25316828|NCT00620659|50632351|FG005|Treatment Period 1|Protocol Violation|0|||
25316829|NCT00620659|50632346|FG000|Treatment Period 1|Withdrawal by Subject|1|||
25316830|NCT00620659|50632347|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25316831|NCT00620659|50632348|FG002|Treatment Period 1|Withdrawal by Subject|1|||
25316832|NCT00620659|50632349|FG003|Treatment Period 1|Withdrawal by Subject|0|||
25316833|NCT00620659|50632350|FG004|Treatment Period 1|Withdrawal by Subject|1|||
25316834|NCT00620659|50632351|FG005|Treatment Period 1|Withdrawal by Subject|0|||
25316835|NCT00620659|50632346|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
25316836|NCT00620659|50632347|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
25316837|NCT00620659|50632348|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
25316838|NCT00620659|50632349|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
25316839|NCT00620659|50632350|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
25316840|NCT00620659|50632351|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
25316841|NCT00620659|50632346|FG000|Treatment Period 2|Adverse Event|0|||
25316842|NCT00620659|50632347|FG001|Treatment Period 2|Adverse Event|3|||
25316843|NCT00620659|50632348|FG002|Treatment Period 2|Adverse Event|0|||
25215442|NCT01620528|50491328|FG001|Treatment Period|Other|5|||
25215443|NCT01620528|50491329|FG002|Treatment Period|Other|7|||
25215444|NCT01620528|50491327|FG000|Treatment Period|Subject Noncompliant|11|||
25215445|NCT01620528|50491328|FG001|Treatment Period|Subject Noncompliant|2|||
25215446|NCT01620528|50491329|FG002|Treatment Period|Subject Noncompliant|2|||
25215447|NCT01620528|50491327|FG000|Treatment Period|Pregnancy|7|||
25215448|NCT01620528|50491328|FG001|Treatment Period|Pregnancy|2|||
25215449|NCT01620528|50491329|FG002|Treatment Period|Pregnancy|2|||
25215450|NCT01620528|50491327|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
25215451|NCT01620528|50491328|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
25215452|NCT01620528|50491329|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
25215453|NCT01620528|50491327|FG000|Treatment Period|Exclusionary Medication Received|0|||
25215454|NCT01620528|50491328|FG001|Treatment Period|Exclusionary Medication Received|1|||
25215455|NCT01620528|50491329|FG002|Treatment Period|Exclusionary Medication Received|0|||
25215456|NCT01620528|50491327|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
25215457|NCT01620528|50491328|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
25215458|NCT01620528|50491329|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
25215459|NCT01620528|50491327|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
25215460|NCT01620528|50491328|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
25215461|NCT01620528|50491329|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
25215462|NCT01620528|50491327|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
25215463|NCT01620528|50491328|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
25215464|NCT01620528|50491329|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
25215465|NCT01620528|50491327|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
25215466|NCT01620528|50491328|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
25215467|NCT01620528|50491329|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
25215468|NCT01620528|50491327|FG000|Post-Treatment Follow-Up Period|Other|6|||
25215469|NCT01620528|50491328|FG001|Post-Treatment Follow-Up Period|Other|4|||
25215470|NCT01620528|50491329|FG002|Post-Treatment Follow-Up Period|Other|2|||
25215471|NCT01965834|50491337|FG000|Overall Study|Lack of Efficacy|4|||
25215472|NCT01965600|50491341|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
25215473|NCT01965600|50491342|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
25215474|NCT01965600|50491343|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
25215475|NCT01965600|50491344|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
25215476|NCT01965600|50491341|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
25215477|NCT01965600|50491342|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
25215478|NCT01965600|50491343|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
25215479|NCT01965600|50491344|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
25215480|NCT01965600|50491341|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
25215481|NCT01965600|50491342|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
25215482|NCT01965600|50491343|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
25215483|NCT01965600|50491344|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
25215484|NCT01965600|50491341|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
25215485|NCT01965600|50491342|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
25215486|NCT01965600|50491343|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
25215487|NCT01965600|50491344|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
25215488|NCT01965600|50491341|FG000|Second Intervention|Study terminated by Sponsor|0|||
25215489|NCT01965600|50491342|FG001|Second Intervention|Study terminated by Sponsor|0|||
25215490|NCT01965600|50491343|FG002|Second Intervention|Study terminated by Sponsor|2|||
25215491|NCT01965600|50491344|FG003|Second Intervention|Study terminated by Sponsor|2|||
25215492|NCT01996332|50491352|FG000|Overall Study|Adverse Event|117|||
25215493|NCT01996332|50491352|FG000|Overall Study|Lack of Efficacy|1245|||
25215494|NCT01996332|50491352|FG000|Overall Study|Death|264|||
25215495|NCT01996332|50491352|FG000|Overall Study|Protocol Violation|9|||
25215496|NCT01996332|50491352|FG000|Overall Study|Withdrawal by Subject|71|||
25215497|NCT01996332|50491352|FG000|Overall Study|Other|20|||
25215498|NCT01996332|50491352|FG000|Overall Study|Clinical Deterioration|28|||
25215499|NCT01996332|50491352|FG000|Overall Study|Physician Decision|17|||
25215500|NCT01996332|50491352|FG000|Overall Study|Lost to Follow-up|34|||
25215501|NCT01996254|50491358|FG000|Overall Study|Change in Eligibility|0|||
25215502|NCT01996254|50491359|FG001|Overall Study|Change in Eligibility|2|||
25215503|NCT01996254|50491360|FG002|Overall Study|Change in Eligibility|0|||
25215504|NCT01996254|50491358|FG000|Overall Study|Withdrawal by Subject|0|||
25215505|NCT01996254|50491359|FG001|Overall Study|Withdrawal by Subject|3|||
25215506|NCT01996254|50491360|FG002|Overall Study|Withdrawal by Subject|4|||
25215507|NCT01996254|50491358|FG000|Overall Study|Lost to Follow-up|1|||
25215508|NCT01996254|50491359|FG001|Overall Study|Lost to Follow-up|0|||
25215509|NCT01996254|50491360|FG002|Overall Study|Lost to Follow-up|4|||
25215510|NCT01987986|50491374|FG000|Overall Study|Lost to Follow-up|1|||
25215511|NCT01987986|50491375|FG001|Overall Study|Lost to Follow-up|0|||
25215512|NCT01987986|50491376|FG002|Overall Study|Lost to Follow-up|0|||
25215513|NCT01987986|50491377|FG003|Overall Study|Lost to Follow-up|0|||
25215514|NCT01987986|50491374|FG000|Overall Study|Adverse Event|1|||
25215515|NCT01987986|50491375|FG001|Overall Study|Adverse Event|0|||
25215516|NCT01987986|50491376|FG002|Overall Study|Adverse Event|2|||
25215517|NCT01987986|50491377|FG003|Overall Study|Adverse Event|0|||
25215518|NCT01987908|50491387|FG000|Placebo Lead-in Period|Adverse Event|2|||
25215519|NCT01987908|50491388|FG001|Placebo Lead-in Period|Adverse Event|0|||
25215520|NCT01987908|50491389|FG002|Placebo Lead-in Period|Adverse Event|0|||
25215521|NCT01987908|50491387|FG000|Placebo Lead-in Period|Physician Decision|2|||
25215522|NCT01987908|50491388|FG001|Placebo Lead-in Period|Physician Decision|0|||
25215523|NCT01987908|50491389|FG002|Placebo Lead-in Period|Physician Decision|0|||
25215524|NCT01987908|50491387|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
25215525|NCT01987908|50491388|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
25215526|NCT01987908|50491389|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
25215527|NCT01987908|50491387|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
25215528|NCT01987908|50491388|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
25215529|NCT01987908|50491389|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
25215530|NCT01987908|50491387|FG000|Treatment Period|Adverse Event|0|||
25215531|NCT01987908|50491388|FG001|Treatment Period|Adverse Event|1|||
25215532|NCT01987908|50491389|FG002|Treatment Period|Adverse Event|1|||
25215533|NCT01987908|50491387|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
25215534|NCT01987908|50491388|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
25215535|NCT01987908|50491389|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
25215536|NCT01987908|50491387|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
25215537|NCT01987908|50491388|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
25215538|NCT01987908|50491389|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
25215539|NCT01995552|50491413|FG000|Overall Study|Protocol Violation|1|||
25215540|NCT01995552|50491413|FG000|Overall Study|Lack of Efficacy|15|||
25215541|NCT01995552|50491413|FG000|Overall Study|Death|1|||
25215542|NCT01987830|50491419|FG000|Overall Study|Never received baseline scan|1|||
25215543|NCT01987596|50491425|FG000|Overall Study|Physician Decision|1|||
25215544|NCT01987596|50491426|FG001|Overall Study|Physician Decision|0|||
25215545|NCT01987596|50491425|FG000|Overall Study|Progressive Disease; missing all period|0|||
25215546|NCT01987596|50491426|FG001|Overall Study|Progressive Disease; missing all period|1|||
25215547|NCT01964976|50491440|FG000|Overall Study|Protocol Violation|31|||
25215548|NCT01964898|50491449|FG000|Overall Study|ineligible post-randomization|1|||
25215549|NCT01964898|50491450|FG001|Overall Study|ineligible post-randomization|1|||
25215550|NCT01964898|50491449|FG000|Overall Study|did not receive the allocated interventi|2|||
25215551|NCT01964898|50491450|FG001|Overall Study|did not receive the allocated interventi|1|||
25215552|NCT01964898|50491449|FG000|Overall Study|Lost to Follow-up|3|||
25215553|NCT01964898|50491450|FG001|Overall Study|Lost to Follow-up|5|||
25215554|NCT01964898|50491449|FG000|Overall Study|Withdrawal by Subject|1|||
25215555|NCT01964898|50491450|FG001|Overall Study|Withdrawal by Subject|0|||
25215556|NCT01964352|50491460|FG000|Overall Study|Adverse Event|13|||
25215557|NCT01964352|50491461|FG001|Overall Study|Adverse Event|3|||
25215558|NCT01964352|50491462|FG002|Overall Study|Adverse Event|4|||
25215559|NCT01964352|50491463|FG003|Overall Study|Adverse Event|3|||
25215560|NCT01964352|50491460|FG000|Overall Study|Lack of Efficacy|6|||
25215561|NCT01964352|50491461|FG001|Overall Study|Lack of Efficacy|0|||
25215562|NCT01964352|50491462|FG002|Overall Study|Lack of Efficacy|0|||
25215563|NCT01964352|50491463|FG003|Overall Study|Lack of Efficacy|0|||
25215564|NCT01964352|50491460|FG000|Overall Study|Protocol Violation|2|||
25215565|NCT01964352|50491461|FG001|Overall Study|Protocol Violation|4|||
25215566|NCT01964352|50491462|FG002|Overall Study|Protocol Violation|0|||
25215567|NCT01964352|50491463|FG003|Overall Study|Protocol Violation|2|||
25215568|NCT01964352|50491460|FG000|Overall Study|Lost to Follow-up|1|||
25215569|NCT01964352|50491461|FG001|Overall Study|Lost to Follow-up|0|||
25316844|NCT00620659|50632349|FG003|Treatment Period 2|Adverse Event|0|||
25316845|NCT00620659|50632350|FG004|Treatment Period 2|Adverse Event|2|||
25316846|NCT00620659|50632351|FG005|Treatment Period 2|Adverse Event|0|||
25316847|NCT00620659|50632346|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25316848|NCT00620659|50632347|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25316849|NCT00620659|50632348|FG002|Treatment Period 2|Withdrawal by Subject|1|||
25316850|NCT00620659|50632349|FG003|Treatment Period 2|Withdrawal by Subject|0|||
25316851|NCT00620659|50632350|FG004|Treatment Period 2|Withdrawal by Subject|3|||
25215570|NCT01964352|50491462|FG002|Overall Study|Lost to Follow-up|0|||
25215571|NCT01964352|50491463|FG003|Overall Study|Lost to Follow-up|1|||
25215572|NCT01964352|50491460|FG000|Overall Study|Withdrawal by Subject|4|||
25215573|NCT01964352|50491461|FG001|Overall Study|Withdrawal by Subject|2|||
25316852|NCT00620659|50632351|FG005|Treatment Period 2|Withdrawal by Subject|0|||
25215574|NCT01964352|50491462|FG002|Overall Study|Withdrawal by Subject|1|||
25215575|NCT01964352|50491463|FG003|Overall Study|Withdrawal by Subject|0|||
25215576|NCT01964352|50491460|FG000|Overall Study|Other than stated above|0|||
25215577|NCT01964352|50491461|FG001|Overall Study|Other than stated above|2|||
25215578|NCT01964352|50491462|FG002|Overall Study|Other than stated above|1|||
25215579|NCT01964352|50491463|FG003|Overall Study|Other than stated above|2|||
25215580|NCT01946412|50491473|FG000|Overall Study|Adverse Event|1|||
25316853|NCT00620659|50632346|FG000|Placebo Washout Period 2|Adverse Event|2|||
25215581|NCT01946412|50491473|FG000|Overall Study|Non-Compliance|1|||
25215582|NCT01946412|50491473|FG000|Overall Study|Continued with commercial Kalydeco|2|||
25215583|NCT01946412|50491473|FG000|Overall Study|Difficulty in swallowing|1|||
25215584|NCT01946178|50491479|FG000|Overall Study|Pregnancy|1|||
25215585|NCT01946178|50491479|FG000|Overall Study|Lost to Follow-up|1|||
25215586|NCT01945944|50491489|FG000|Overall Study|Adverse Event|0|||
25215587|NCT01945944|50491490|FG001|Overall Study|Adverse Event|2|||
25215588|NCT01945944|50491489|FG000|Overall Study|Physician Decision|1|||
25215589|NCT01945944|50491490|FG001|Overall Study|Physician Decision|0|||
25215590|NCT01945944|50491489|FG000|Overall Study|Withdrawal by Subject|0|||
25215591|NCT01945944|50491490|FG001|Overall Study|Withdrawal by Subject|1|||
25215592|NCT01945866|50491500|FG000|Overall Study|Eyes did not complete or were dropped|2|||
25215593|NCT01945866|50491501|FG001|Overall Study|Eyes did not complete or were dropped|0|||
25215594|NCT01986114|50491508|FG000|Overall Study|Adverse Event|59|||
25215595|NCT01986114|50491508|FG000|Overall Study|Lack of Efficacy|23|||
25215596|NCT01986114|50491508|FG000|Overall Study|Withdrawal by Subject|58|||
25215597|NCT01986114|50491508|FG000|Overall Study|Noncompliance|3|||
25215598|NCT01986114|50491508|FG000|Overall Study|Protocol Violation|1|||
25215599|NCT01986114|50491508|FG000|Overall Study|Lost to Follow-up|5|||
25215600|NCT01986114|50491508|FG000|Overall Study|Other reason|7|||
25215601|NCT01945710|50491521|FG000|Overall Study|Progressive Disease|5|||
25215602|NCT01945710|50491522|FG001|Overall Study|Progressive Disease|4|||
25215603|NCT01945710|50491523|FG002|Overall Study|Progressive Disease|3|||
25215604|NCT01945710|50491524|FG003|Overall Study|Progressive Disease|2|||
25215605|NCT01945710|50491525|FG004|Overall Study|Progressive Disease|7|||
25215606|NCT01945710|50491526|FG005|Overall Study|Progressive Disease|3|||
25215607|NCT01945710|50491527|FG006|Overall Study|Progressive Disease|19|||
25215608|NCT01945710|50491521|FG000|Overall Study|Adverse Event|0|||
25215609|NCT01945710|50491522|FG001|Overall Study|Adverse Event|1|||
25215610|NCT01945710|50491523|FG002|Overall Study|Adverse Event|0|||
25215611|NCT01945710|50491524|FG003|Overall Study|Adverse Event|0|||
25215612|NCT01945710|50491525|FG004|Overall Study|Adverse Event|0|||
25215613|NCT01945710|50491526|FG005|Overall Study|Adverse Event|0|||
25215614|NCT01945710|50491527|FG006|Overall Study|Adverse Event|0|||
25215615|NCT01945710|50491521|FG000|Overall Study|Other|2|||
25215616|NCT01945710|50491522|FG001|Overall Study|Other|0|||
25215617|NCT01945710|50491523|FG002|Overall Study|Other|3|||
25215618|NCT01945710|50491524|FG003|Overall Study|Other|1|||
25215619|NCT01945710|50491525|FG004|Overall Study|Other|1|||
25215620|NCT01945710|50491526|FG005|Overall Study|Other|0|||
25215621|NCT01945710|50491527|FG006|Overall Study|Other|4|||
25316854|NCT00620659|50632347|FG001|Placebo Washout Period 2|Adverse Event|0|||
25316855|NCT00620659|50632348|FG002|Placebo Washout Period 2|Adverse Event|0|||
25316856|NCT00620659|50632349|FG003|Placebo Washout Period 2|Adverse Event|0|||
25316857|NCT00620659|50632350|FG004|Placebo Washout Period 2|Adverse Event|0|||
25316858|NCT00620659|50632351|FG005|Placebo Washout Period 2|Adverse Event|0|||
25316859|NCT00620659|50632346|FG000|Treatment Period 3|Adverse Event|0|||
25316860|NCT00620659|50632347|FG001|Treatment Period 3|Adverse Event|2|||
25316861|NCT00620659|50632348|FG002|Treatment Period 3|Adverse Event|0|||
25316862|NCT00620659|50632349|FG003|Treatment Period 3|Adverse Event|0|||
25316863|NCT00620659|50632350|FG004|Treatment Period 3|Adverse Event|0|||
25316864|NCT00620659|50632351|FG005|Treatment Period 3|Adverse Event|0|||
25316865|NCT00620659|50632346|FG000|Treatment Period 3|Withdrawal by Subject|0|||
25316866|NCT00620659|50632347|FG001|Treatment Period 3|Withdrawal by Subject|0|||
25316867|NCT00620659|50632348|FG002|Treatment Period 3|Withdrawal by Subject|0|||
25316868|NCT00620659|50632349|FG003|Treatment Period 3|Withdrawal by Subject|1|||
25316869|NCT00620659|50632350|FG004|Treatment Period 3|Withdrawal by Subject|0|||
25316870|NCT00620659|50632351|FG005|Treatment Period 3|Withdrawal by Subject|0|||
25316871|NCT00894686|50632364|FG000|Overall Study|Withdrawal by Subject|50|||
25316872|NCT00894686|50632364|FG000|Overall Study|Physician Decision|1|||
25316873|NCT00894686|50632364|FG000|Overall Study|Other|5|||
25316874|NCT00885846|50632371|FG000|Overall Study|Withdrawal by Subject|2|||
25316875|NCT00885846|50632372|FG001|Overall Study|Withdrawal by Subject|5|||
25316876|NCT00885846|50632373|FG002|Overall Study|Withdrawal by Subject|2|||
25316877|NCT00621517|50632383|FG000|Overall Study|Lost to Follow-up|3|||
25077390|NCT02936323|50185227|FG007|Phase 1 Dose Escalation|Death|0|||
25215622|NCT01945710|50491521|FG000|Overall Study|Withdrawal by Subject|0|||
25215623|NCT01945710|50491522|FG001|Overall Study|Withdrawal by Subject|1|||
25215624|NCT01945710|50491523|FG002|Overall Study|Withdrawal by Subject|1|||
25215625|NCT01945710|50491524|FG003|Overall Study|Withdrawal by Subject|0|||
25215626|NCT01945710|50491525|FG004|Overall Study|Withdrawal by Subject|1|||
25215627|NCT01945710|50491526|FG005|Overall Study|Withdrawal by Subject|0|||
25316878|NCT00621517|50632384|FG001|Overall Study|Lost to Follow-up|3|||
25215628|NCT01945710|50491527|FG006|Overall Study|Withdrawal by Subject|0|||
25215629|NCT01945242|50491547|FG000|Overall Study|Physician Decision|3|||
25215630|NCT01945242|50491548|FG001|Overall Study|Physician Decision|3|||
25316879|NCT00621517|50632383|FG000|Overall Study|Withdrawal by Subject|3|||
25215631|NCT01945086|50491558|FG000|Overall Study|Withdrawal by Subject|1|||
25215632|NCT01945086|50491559|FG001|Overall Study|Withdrawal by Subject|0|||
25215633|NCT01945086|50491560|FG002|Overall Study|Withdrawal by Subject|1|||
25215634|NCT01945086|50491558|FG000|Overall Study|Adverse Event|0|||
25215635|NCT01945086|50491559|FG001|Overall Study|Adverse Event|0|||
25215636|NCT01945086|50491560|FG002|Overall Study|Adverse Event|1|||
25215637|NCT01963728|50491570|FG000|Overall Study|Study terminated early|0|||
25215638|NCT01963728|50491571|FG001|Overall Study|Study terminated early|1|||
25215639|NCT01963260|50491587|FG000|Overall Study|Withdrawal by Subject|2|||
25215640|NCT01963260|50491588|FG001|Overall Study|Withdrawal by Subject|0|||
25215641|NCT01963260|50491589|FG002|Overall Study|Withdrawal by Subject|0|||
25215642|NCT01963260|50491590|FG003|Overall Study|Withdrawal by Subject|1|||
25215643|NCT01963260|50491591|FG004|Overall Study|Withdrawal by Subject|2|||
25215644|NCT01963260|50491592|FG005|Overall Study|Withdrawal by Subject|0|||
25215645|NCT01963260|50491593|FG006|Overall Study|Withdrawal by Subject|0|||
25215646|NCT01963260|50491594|FG007|Overall Study|Withdrawal by Subject|0|||
25215647|NCT01963260|50491595|FG008|Overall Study|Withdrawal by Subject|0|||
25215648|NCT01963260|50491596|FG009|Overall Study|Withdrawal by Subject|0|||
25215649|NCT01962948|50491629|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
25215650|NCT01962948|50491630|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
25215651|NCT01962948|50491631|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
25215652|NCT01962948|50491632|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
25215653|NCT01985334|50491647|FG000|Overall Study|Administrative problems|1|||
25215654|NCT01985334|50491648|FG001|Overall Study|Administrative problems|1|||
25215655|NCT01985334|50491649|FG002|Overall Study|Administrative problems|0|||
24976439|NCT03464422|50065333|FG000|Overall Study|Withdrawal by Subject|2|||
24976440|NCT03489304|50065339|FG000|Overall Study|Lost to Follow-up|4|||
24976441|NCT03543358|50065343|FG000|Overall Study|Death|1|||
24976442|NCT03543358|50065344|FG001|Overall Study|Death|0|||
24976443|NCT03543358|50065343|FG000|Overall Study|Disease Progression|1|||
24976444|NCT03543358|50065344|FG001|Overall Study|Disease Progression|0|||
24976445|NCT03543358|50065343|FG000|Overall Study|Parent Study Closure|1|||
24976446|NCT03543358|50065344|FG001|Overall Study|Parent Study Closure|0|||
24976447|NCT03485950|50065350|FG000|Overall Study|Adverse Event|1|||
24976448|NCT03485950|50065351|FG001|Overall Study|Adverse Event|0|||
24976449|NCT03485950|50065350|FG000|Overall Study|Death|3|||
24976450|NCT03485950|50065351|FG001|Overall Study|Death|2|||
24976451|NCT03485950|50065350|FG000|Overall Study|Withdrawal by Subject|3|||
24976452|NCT03485950|50065351|FG001|Overall Study|Withdrawal by Subject|0|||
24976453|NCT00060944|50065359|FG000|Overall Study|Adverse Event|12|||
24976454|NCT00060944|50065360|FG001|Overall Study|Adverse Event|10|||
24976455|NCT00060944|50065359|FG000|Overall Study|Death|2|||
24976456|NCT00060944|50065360|FG001|Overall Study|Death|3|||
24976457|NCT00060944|50065359|FG000|Overall Study|Withdrawal by Subject|18|||
24976458|NCT00060944|50065360|FG001|Overall Study|Withdrawal by Subject|5|||
24976459|NCT00060944|50065359|FG000|Overall Study|Disease Progression|93|||
24976460|NCT00060944|50065360|FG001|Overall Study|Disease Progression|94|||
24976461|NCT00060944|50065359|FG000|Overall Study|Lost to Follow-up|1|||
25215656|NCT01985334|50491650|FG003|Overall Study|Administrative problems|2|||
25215657|NCT01985334|50491651|FG004|Overall Study|Administrative problems|0|||
25215658|NCT01985334|50491652|FG005|Overall Study|Administrative problems|1|||
25215659|NCT01985334|50491653|FG006|Overall Study|Administrative problems|1|||
25215660|NCT01985334|50491654|FG007|Overall Study|Administrative problems|3|||
25215661|NCT01985334|50491647|FG000|Overall Study|Death|1|||
25215662|NCT01985334|50491648|FG001|Overall Study|Death|0|||
25215663|NCT01985334|50491649|FG002|Overall Study|Death|0|||
25215664|NCT01985334|50491650|FG003|Overall Study|Death|3|||
25215665|NCT01985334|50491651|FG004|Overall Study|Death|0|||
25316880|NCT00621517|50632384|FG001|Overall Study|Withdrawal by Subject|4|||
25316881|NCT00621517|50632383|FG000|Overall Study|Adverse Event|1|||
25316882|NCT00621517|50632384|FG001|Overall Study|Adverse Event|0|||
25316883|NCT00573937|50632392|FG000|Overall Study|Study Terminated|0|||
25316884|NCT00573937|50632393|FG001|Overall Study|Study Terminated|1|||
25316885|NCT00573859|50632399|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
25316886|NCT00573859|50632399|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
25316887|NCT00831441|50632405|FG000|Randomized|Death|82|||
24976462|NCT00060944|50065360|FG001|Overall Study|Lost to Follow-up|0|||
25215666|NCT01985334|50491652|FG005|Overall Study|Death|0|||
24976463|NCT00060944|50065359|FG000|Overall Study|Subject Ineligible To Continue|2|||
24976464|NCT00060944|50065360|FG001|Overall Study|Subject Ineligible To Continue|1|||
24976465|NCT00060944|50065359|FG000|Overall Study|Treatment Switch|0|||
24976466|NCT00060944|50065360|FG001|Overall Study|Treatment Switch|13|||
24976467|NCT00060944|50065359|FG000|Overall Study|Other|2|||
25215667|NCT01985334|50491653|FG006|Overall Study|Death|1|||
25215668|NCT01985334|50491654|FG007|Overall Study|Death|2|||
24976468|NCT00060944|50065360|FG001|Overall Study|Other|4|||
25215669|NCT01985334|50491647|FG000|Overall Study|Worsening of disease|0|||
25215670|NCT01985334|50491648|FG001|Overall Study|Worsening of disease|0|||
25215671|NCT01985334|50491649|FG002|Overall Study|Worsening of disease|0|||
25215672|NCT01985334|50491650|FG003|Overall Study|Worsening of disease|1|||
25215673|NCT01985334|50491651|FG004|Overall Study|Worsening of disease|0|||
25215674|NCT01985334|50491652|FG005|Overall Study|Worsening of disease|3|||
25215675|NCT01985334|50491653|FG006|Overall Study|Worsening of disease|0|||
25215676|NCT01985334|50491654|FG007|Overall Study|Worsening of disease|1|||
25215677|NCT01985334|50491647|FG000|Overall Study|Other|2|||
25215678|NCT01985334|50491648|FG001|Overall Study|Other|9|||
25215679|NCT01985334|50491649|FG002|Overall Study|Other|7|||
25215680|NCT01985334|50491650|FG003|Overall Study|Other|17|||
25215681|NCT01985334|50491651|FG004|Overall Study|Other|4|||
25215682|NCT01985334|50491652|FG005|Overall Study|Other|8|||
25215683|NCT01985334|50491653|FG006|Overall Study|Other|4|||
25215684|NCT01985334|50491654|FG007|Overall Study|Other|7|||
25215685|NCT01985334|50491647|FG000|Overall Study|Protocol deviation|6|||
25215686|NCT01985334|50491648|FG001|Overall Study|Protocol deviation|31|||
25215687|NCT01985334|50491649|FG002|Overall Study|Protocol deviation|25|||
25215688|NCT01985334|50491650|FG003|Overall Study|Protocol deviation|84|||
25215689|NCT01985334|50491651|FG004|Overall Study|Protocol deviation|17|||
25215690|NCT01985334|50491652|FG005|Overall Study|Protocol deviation|47|||
25215691|NCT01985334|50491653|FG006|Overall Study|Protocol deviation|15|||
25215692|NCT01985334|50491654|FG007|Overall Study|Protocol deviation|42|||
25215693|NCT01985334|50491647|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
25215694|NCT01985334|50491648|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
25215695|NCT01985334|50491649|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
25215696|NCT01985334|50491650|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
25215697|NCT01985334|50491651|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
25215698|NCT01985334|50491652|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
25215699|NCT01985334|50491653|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
25215700|NCT01985334|50491654|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
25215701|NCT01985334|50491647|FG000|Overall Study|Subject withdrawal of consent|3|||
25215702|NCT01985334|50491648|FG001|Overall Study|Subject withdrawal of consent|6|||
25215703|NCT01985334|50491649|FG002|Overall Study|Subject withdrawal of consent|2|||
25215704|NCT01985334|50491650|FG003|Overall Study|Subject withdrawal of consent|28|||
25215705|NCT01985334|50491651|FG004|Overall Study|Subject withdrawal of consent|4|||
25215706|NCT01985334|50491652|FG005|Overall Study|Subject withdrawal of consent|19|||
25215707|NCT01985334|50491653|FG006|Overall Study|Subject withdrawal of consent|0|||
25215708|NCT01985334|50491654|FG007|Overall Study|Subject withdrawal of consent|20|||
25215709|NCT01985334|50491647|FG000|Overall Study|Adverse Event|0|||
25215710|NCT01985334|50491648|FG001|Overall Study|Adverse Event|8|||
25215711|NCT01985334|50491649|FG002|Overall Study|Adverse Event|2|||
25215712|NCT01985334|50491650|FG003|Overall Study|Adverse Event|26|||
25215713|NCT01985334|50491651|FG004|Overall Study|Adverse Event|3|||
25215714|NCT01985334|50491652|FG005|Overall Study|Adverse Event|18|||
25215715|NCT01985334|50491653|FG006|Overall Study|Adverse Event|3|||
25215716|NCT01985334|50491654|FG007|Overall Study|Adverse Event|15|||
25215717|NCT01985334|50491647|FG000|Overall Study|Other|4|||
25215718|NCT01985334|50491648|FG001|Overall Study|Other|2|||
25215719|NCT01985334|50491649|FG002|Overall Study|Other|3|||
25215720|NCT01985334|50491650|FG003|Overall Study|Other|10|||
25215721|NCT01985334|50491651|FG004|Overall Study|Other|1|||
25316888|NCT00831441|50632406|FG001|Randomized|Death|81|||
25316889|NCT00831441|50632405|FG000|Randomized|Adverse Event|248|||
25316890|NCT00831441|50632406|FG001|Randomized|Adverse Event|321|||
25316891|NCT00831441|50632405|FG000|Randomized|Emergency procedure|2|||
25316892|NCT00831441|50632406|FG001|Randomized|Emergency procedure|2|||
25316893|NCT00831441|50632405|FG000|Randomized|Elective procedure|26|||
25316894|NCT00831441|50632406|FG001|Randomized|Elective procedure|25|||
25316895|NCT00831441|50632405|FG000|Randomized|Physician Decision|26|||
25316896|NCT00831441|50632406|FG001|Randomized|Physician Decision|35|||
25316897|NCT00831441|50632405|FG000|Randomized|No longer met criteria|13|||
25215722|NCT01985334|50491652|FG005|Overall Study|Other|6|||
25215723|NCT01985334|50491653|FG006|Overall Study|Other|2|||
25215724|NCT01985334|50491654|FG007|Overall Study|Other|2|||
25316898|NCT00831441|50632406|FG001|Randomized|No longer met criteria|19|||
25316899|NCT00831441|50632405|FG000|Randomized|Withdrawal by Subject|178|||
25215725|NCT01985334|50491647|FG000|Overall Study|Medication non-compliance|0|||
25215726|NCT01985334|50491648|FG001|Overall Study|Medication non-compliance|4|||
25215727|NCT01985334|50491649|FG002|Overall Study|Medication non-compliance|1|||
25215728|NCT01985334|50491650|FG003|Overall Study|Medication non-compliance|6|||
25215729|NCT01985334|50491651|FG004|Overall Study|Medication non-compliance|2|||
25215730|NCT01985334|50491652|FG005|Overall Study|Medication non-compliance|3|||
25215731|NCT01985334|50491653|FG006|Overall Study|Medication non-compliance|1|||
25215732|NCT01985334|50491654|FG007|Overall Study|Medication non-compliance|3|||
25215733|NCT01985334|50491647|FG000|Overall Study|Use of prohibited treatment|1|||
25215734|NCT01985334|50491648|FG001|Overall Study|Use of prohibited treatment|4|||
25316900|NCT00831441|50632406|FG001|Randomized|Withdrawal by Subject|212|||
25215735|NCT01985334|50491649|FG002|Overall Study|Use of prohibited treatment|1|||
25215736|NCT01985334|50491650|FG003|Overall Study|Use of prohibited treatment|2|||
25215737|NCT01985334|50491651|FG004|Overall Study|Use of prohibited treatment|1|||
25215738|NCT01985334|50491652|FG005|Overall Study|Use of prohibited treatment|6|||
25215739|NCT01985334|50491653|FG006|Overall Study|Use of prohibited treatment|2|||
25215740|NCT01985334|50491654|FG007|Overall Study|Use of prohibited treatment|0|||
25215741|NCT01985334|50491647|FG000|Overall Study|Investigator decision|0|||
25215742|NCT01985334|50491648|FG001|Overall Study|Investigator decision|3|||
25215743|NCT01985334|50491649|FG002|Overall Study|Investigator decision|0|||
25215744|NCT01985334|50491650|FG003|Overall Study|Investigator decision|7|||
25215745|NCT01985334|50491651|FG004|Overall Study|Investigator decision|1|||
25215746|NCT01985334|50491652|FG005|Overall Study|Investigator decision|1|||
25215747|NCT01985334|50491653|FG006|Overall Study|Investigator decision|0|||
25215748|NCT01985334|50491654|FG007|Overall Study|Investigator decision|4|||
25215749|NCT01985334|50491647|FG000|Overall Study|Lost to Follow-up|0|||
25215750|NCT01985334|50491648|FG001|Overall Study|Lost to Follow-up|2|||
25215751|NCT01985334|50491649|FG002|Overall Study|Lost to Follow-up|0|||
25215752|NCT01985334|50491650|FG003|Overall Study|Lost to Follow-up|3|||
25215753|NCT01985334|50491651|FG004|Overall Study|Lost to Follow-up|1|||
25215754|NCT01985334|50491652|FG005|Overall Study|Lost to Follow-up|4|||
25215755|NCT01985334|50491653|FG006|Overall Study|Lost to Follow-up|0|||
25215756|NCT01985334|50491654|FG007|Overall Study|Lost to Follow-up|3|||
25215757|NCT01944774|50491689|FG000|Overall Study|Withdrawal by Subject|2|||
25215758|NCT01944774|50491690|FG001|Overall Study|Withdrawal by Subject|3|||
25215759|NCT01944774|50491691|FG002|Overall Study|Withdrawal by Subject|3|||
25215760|NCT01944774|50491689|FG000|Overall Study|Adverse Event|3|||
25215761|NCT01944774|50491690|FG001|Overall Study|Adverse Event|2|||
25215762|NCT01944774|50491691|FG002|Overall Study|Adverse Event|3|||
25215763|NCT01944774|50491689|FG000|Overall Study|Lack of Efficacy|1|||
25215764|NCT01944774|50491690|FG001|Overall Study|Lack of Efficacy|2|||
25215765|NCT01944774|50491691|FG002|Overall Study|Lack of Efficacy|2|||
25215766|NCT01944774|50491689|FG000|Overall Study|Lost to Follow-up|0|||
25215767|NCT01944774|50491690|FG001|Overall Study|Lost to Follow-up|1|||
25215768|NCT01944774|50491691|FG002|Overall Study|Lost to Follow-up|0|||
25215769|NCT01944462|50491702|FG000|PPPP Educational Program|Lost to Follow-up|60|||
25215770|NCT01943292|50491710|FG000|Overall Study|Withdrawal by Subject|1|||
25215771|NCT01943292|50491711|FG001|Overall Study|Withdrawal by Subject|0|||
25215772|NCT01943292|50491712|FG002|Overall Study|Withdrawal by Subject|0|||
25215773|NCT01961544|50491720|FG000|Overall Study|Protocol Violation|1|||
25215774|NCT01961544|50491720|FG000|Overall Study|Withdrawal by Subject|7|||
25215775|NCT01961544|50491720|FG000|Overall Study|Adverse Event|1|||
25215776|NCT01961544|50491720|FG000|Overall Study|Physician Decision|2|||
25215777|NCT01961544|50491720|FG000|Overall Study|Poor Tolerance|1|||
25215778|NCT01961544|50491720|FG000|Overall Study|Aggravation of Steral Pain|1|||
25215779|NCT01942590|50491726|FG000|Overall Study|Withdrawal by Subject|0|||
25215780|NCT01942590|50491727|FG001|Overall Study|Withdrawal by Subject|1|||
25215781|NCT01942590|50491726|FG000|Overall Study|Adverse Event|1|||
25215782|NCT01942590|50491727|FG001|Overall Study|Adverse Event|0|||
25215783|NCT01984242|50491737|FG000|Overall Study|Death|52|||
25215784|NCT01984242|50491738|FG001|Overall Study|Death|50|||
25215785|NCT01984242|50491739|FG002|Overall Study|Death|52|||
25215786|NCT01984242|50491737|FG000|Overall Study|Withdrawal by Subject|5|||
25215787|NCT01984242|50491738|FG001|Overall Study|Withdrawal by Subject|3|||
25215788|NCT01984242|50491739|FG002|Overall Study|Withdrawal by Subject|10|||
25215789|NCT01984242|50491737|FG000|Overall Study|Physician Decision|0|||
25215790|NCT01984242|50491738|FG001|Overall Study|Physician Decision|0|||
25215791|NCT01984242|50491739|FG002|Overall Study|Physician Decision|1|||
25215792|NCT01984242|50491737|FG000|Overall Study|Lost to Follow-up|4|||
25215793|NCT01984242|50491738|FG001|Overall Study|Lost to Follow-up|0|||
25215794|NCT01984242|50491739|FG002|Overall Study|Lost to Follow-up|3|||
25215795|NCT01984242|50491737|FG000|Overall Study|Sponsor Decision|1|||
25215796|NCT01984242|50491738|FG001|Overall Study|Sponsor Decision|0|||
25215797|NCT01984242|50491739|FG002|Overall Study|Sponsor Decision|0|||
25077391|NCT02936323|50185228|FG008|Phase 1 Dose Escalation|Death|0|||
25215798|NCT01984242|50491737|FG000|Overall Study|Non-Compliance|1|||
25077392|NCT02936323|50185229|FG009|Phase 1 Dose Escalation|Death|0|||
25215799|NCT01984242|50491738|FG001|Overall Study|Non-Compliance|0|||
25215800|NCT01984242|50491739|FG002|Overall Study|Non-Compliance|0|||
25215801|NCT01984242|50491737|FG000|Overall Study|Study terminated by Sponsor|38|||
25215802|NCT01984242|50491738|FG001|Overall Study|Study terminated by Sponsor|50|||
25215803|NCT01984242|50491739|FG002|Overall Study|Study terminated by Sponsor|34|||
25215804|NCT01984242|50491737|FG000|Overall Study|Disease Progression|0|||
25215805|NCT01984242|50491738|FG001|Overall Study|Disease Progression|0|||
25215806|NCT01984242|50491739|FG002|Overall Study|Disease Progression|1|||
25215807|NCT01941498|50491755|FG000|Overall Study|Relocated out of state|1|||
25215808|NCT01960998|50491776|FG000|Overall Study|Lost to Follow-up|3|||
25215809|NCT01960998|50491777|FG001|Overall Study|Lost to Follow-up|7|||
25215810|NCT01960998|50491776|FG000|Overall Study|Death|0|||
25215811|NCT01960998|50491777|FG001|Overall Study|Death|1|||
25215812|NCT01960998|50491776|FG000|Overall Study|Withdrawal by Subject|8|||
25215813|NCT01960998|50491777|FG001|Overall Study|Withdrawal by Subject|2|||
25215814|NCT01960998|50491776|FG000|Overall Study|lost computer access|0|||
25215815|NCT01960998|50491777|FG001|Overall Study|lost computer access|1|||
25215816|NCT01941186|50491787|FG000|Follow-up|Lost to Follow-up|1|||
25215817|NCT01941186|50491788|FG001|Follow-up|Lost to Follow-up|0|||
25215818|NCT01960842|50491807|FG000|Overall Study|Adverse Event|1|||
25215819|NCT01960842|50491807|FG000|Overall Study|Withdrawal by Subject|2|||
25215820|NCT01984164|50491813|FG000|Overall Study|Withdrawal by Subject|4|||
25215821|NCT01984164|50491814|FG001|Overall Study|Withdrawal by Subject|3|||
25215822|NCT01984164|50491813|FG000|Overall Study|Adverse Event|5|||
25215823|NCT01984164|50491814|FG001|Overall Study|Adverse Event|19|||
25215824|NCT01984164|50491813|FG000|Overall Study|Lost to Follow-up|1|||
25215825|NCT01984164|50491814|FG001|Overall Study|Lost to Follow-up|3|||
25215826|NCT01941030|50491822|FG000|Overall Study|Death|3|||
25215827|NCT01941030|50491823|FG001|Overall Study|Death|2|||
25215828|NCT01941030|50491822|FG000|Overall Study|Lost to Follow-up|6|||
25215829|NCT01941030|50491823|FG001|Overall Study|Lost to Follow-up|5|||
25215830|NCT01941030|50491822|FG000|Overall Study|Withdrawal by Subject|4|||
25215831|NCT01941030|50491823|FG001|Overall Study|Withdrawal by Subject|6|||
25215832|NCT01983930|50491831|FG000|Overall Study|Withdrawal by Subject|9|||
25215833|NCT01983930|50491832|FG001|Overall Study|Withdrawal by Subject|8|||
25215834|NCT01983930|50491831|FG000|Overall Study|Adverse Event|0|||
25215835|NCT01983930|50491832|FG001|Overall Study|Adverse Event|1|||
25215836|NCT01983774|50491845|FG000|Overall Study|Lung Transplant|0|||
25215837|NCT01983774|50491846|FG001|Overall Study|Lung Transplant|1|||
25215838|NCT01983774|50491845|FG000|Overall Study|Lost to Follow-up|1|||
25215839|NCT01983774|50491846|FG001|Overall Study|Lost to Follow-up|0|||
25215840|NCT01982682|50491854|FG000|Overall Study|Physician Decision|1|||
25215841|NCT01940484|50491859|FG000|Overall Study|Withdrawal by Subject|3|||
25215842|NCT01940484|50491859|FG000|Overall Study|Underwent transplantation|4|||
25215843|NCT01940484|50491859|FG000|Overall Study|Death|2|||
25215844|NCT01940484|50491859|FG000|Overall Study|Adverse Event|1|||
25215845|NCT01939548|50491866|FG000|Overall Study|Non compliance|0|||
25215846|NCT01939548|50491867|FG001|Overall Study|Non compliance|2|||
25215847|NCT01939548|50491868|FG002|Overall Study|Non compliance|0|||
25215848|NCT01939548|50491866|FG000|Overall Study|Study Terminated by Sponsor|17|||
25215849|NCT01939548|50491867|FG001|Overall Study|Study Terminated by Sponsor|19|||
25215850|NCT01939548|50491868|FG002|Overall Study|Study Terminated by Sponsor|12|||
25215851|NCT01939548|50491866|FG000|Overall Study|Insufficient Clinical Response|1|||
25215852|NCT01939548|50491867|FG001|Overall Study|Insufficient Clinical Response|0|||
25215853|NCT01939548|50491868|FG002|Overall Study|Insufficient Clinical Response|0|||
25215854|NCT01939548|50491866|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
25215855|NCT01939548|50491867|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
25215856|NCT01939548|50491868|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
25215857|NCT01939548|50491866|FG000|Overall Study|Withdrawal by Subject|4|||
25215858|NCT01939548|50491867|FG001|Overall Study|Withdrawal by Subject|4|||
25215859|NCT01939548|50491868|FG002|Overall Study|Withdrawal by Subject|1|||
25215860|NCT01939548|50491866|FG000|Overall Study|Protocol Violation|7|||
25215861|NCT01939548|50491867|FG001|Overall Study|Protocol Violation|6|||
25215862|NCT01939548|50491868|FG002|Overall Study|Protocol Violation|5|||
25215863|NCT01939548|50491866|FG000|Overall Study|Lost to Follow-up|5|||
25215864|NCT01939548|50491867|FG001|Overall Study|Lost to Follow-up|5|||
25215865|NCT01939548|50491868|FG002|Overall Study|Lost to Follow-up|3|||
25215866|NCT01939548|50491866|FG000|Overall Study|Adverse Event|2|||
25215867|NCT01939548|50491867|FG001|Overall Study|Adverse Event|9|||
25215868|NCT01939548|50491868|FG002|Overall Study|Adverse Event|7|||
25215869|NCT01939548|50491866|FG000|Overall Study|Death|0|||
25215870|NCT01939548|50491867|FG001|Overall Study|Death|0|||
25215871|NCT01939548|50491868|FG002|Overall Study|Death|1|||
25215872|NCT01939548|50491866|FG000|Overall Study|Participant dropped|0|||
25215873|NCT01939548|50491867|FG001|Overall Study|Participant dropped|0|||
25215874|NCT01939548|50491868|FG002|Overall Study|Participant dropped|1|||
25215875|NCT01939548|50491866|FG000|Overall Study|Participant unwilling to continue|0|||
25215876|NCT01939548|50491867|FG001|Overall Study|Participant unwilling to continue|1|||
25215877|NCT01939548|50491868|FG002|Overall Study|Participant unwilling to continue|0|||
25215878|NCT01939548|50491866|FG000|Overall Study|Participant withdrew consent|0|||
25215879|NCT01939548|50491867|FG001|Overall Study|Participant withdrew consent|2|||
25215880|NCT01939548|50491868|FG002|Overall Study|Participant withdrew consent|0|||
25215881|NCT01939548|50491866|FG000|Overall Study|Did not complete follow-up|0|||
25215882|NCT01939548|50491867|FG001|Overall Study|Did not complete follow-up|1|||
25215883|NCT01939548|50491868|FG002|Overall Study|Did not complete follow-up|0|||
25215884|NCT01960296|50491878|FG000|Overall Study|Postponed surgery|1|||
25215885|NCT01960296|50491879|FG001|Overall Study|Postponed surgery|0|||
25215886|NCT01960296|50491878|FG000|Overall Study|Received different procedure|1|||
25215887|NCT01960296|50491879|FG001|Overall Study|Received different procedure|3|||
25215888|NCT01982292|50491887|FG000|Overall Study|Adverse Event|2|||
25077393|NCT02936323|50185220|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
25215889|NCT01982292|50491888|FG001|Overall Study|Adverse Event|0|||
25215890|NCT01982292|50491887|FG000|Overall Study|Death|1|||
25215891|NCT01982292|50491888|FG001|Overall Study|Death|0|||
25215892|NCT01982292|50491887|FG000|Overall Study|Lost to Follow-up|2|||
25215893|NCT01982292|50491888|FG001|Overall Study|Lost to Follow-up|0|||
25215894|NCT01982292|50491887|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
25215895|NCT01982292|50491888|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
25215896|NCT01982292|50491887|FG000|Overall Study|Protocol Deviation|1|||
25215897|NCT01982292|50491888|FG001|Overall Study|Protocol Deviation|0|||
25215898|NCT01982292|50491887|FG000|Overall Study|Patient/Guardian Decision|3|||
25215899|NCT01982292|50491888|FG001|Overall Study|Patient/Guardian Decision|1|||
25215900|NCT01982292|50491887|FG000|Overall Study|Technical Problems|2|||
25215901|NCT01982292|50491888|FG001|Overall Study|Technical Problems|0|||
25215902|NCT01939314|50491896|FG000|Overall Study|Withdrawal by Subject|3|||
25215903|NCT01939314|50491897|FG001|Overall Study|Withdrawal by Subject|1|||
25215904|NCT01939314|50491896|FG000|Overall Study|Protocol Violation|1|||
25215905|NCT01939314|50491897|FG001|Overall Study|Protocol Violation|0|||
25215906|NCT01939314|50491896|FG000|Overall Study|Pregnancy|0|||
25215907|NCT01939314|50491897|FG001|Overall Study|Pregnancy|1|||
25215908|NCT01939314|50491896|FG000|Overall Study|Lost to Follow-up|5|||
25215909|NCT01939314|50491897|FG001|Overall Study|Lost to Follow-up|6|||
25215910|NCT01939158|50491909|FG000|Overall Study|Adverse Event|1|||
25215911|NCT01939158|50491910|FG001|Overall Study|Adverse Event|0|||
25215912|NCT01939158|50491911|FG002|Overall Study|Adverse Event|0|||
25215913|NCT01939158|50491912|FG003|Overall Study|Adverse Event|0|||
25215914|NCT01939158|50491909|FG000|Overall Study|Withdrawal by Subject|22|||
25215915|NCT01939158|50491910|FG001|Overall Study|Withdrawal by Subject|25|||
25215916|NCT01939158|50491911|FG002|Overall Study|Withdrawal by Subject|15|||
25215917|NCT01939158|50491912|FG003|Overall Study|Withdrawal by Subject|17|||
25215918|NCT01939158|50491909|FG000|Overall Study|Migrated/moved from study area|5|||
25215919|NCT01939158|50491910|FG001|Overall Study|Migrated/moved from study area|7|||
25215920|NCT01939158|50491911|FG002|Overall Study|Migrated/moved from study area|3|||
25215921|NCT01939158|50491912|FG003|Overall Study|Migrated/moved from study area|6|||
25215922|NCT01939158|50491909|FG000|Overall Study|Lost to Follow-up|18|||
25215923|NCT01939158|50491910|FG001|Overall Study|Lost to Follow-up|17|||
25215924|NCT01939158|50491911|FG002|Overall Study|Lost to Follow-up|17|||
25215925|NCT01939158|50491912|FG003|Overall Study|Lost to Follow-up|17|||
25215926|NCT01939158|50491909|FG000|Overall Study|Death|0|||
25215927|NCT01939158|50491910|FG001|Overall Study|Death|0|||
25215928|NCT01939158|50491911|FG002|Overall Study|Death|1|||
25215929|NCT01939158|50491912|FG003|Overall Study|Death|1|||
25215930|NCT01939158|50491909|FG000|Overall Study|No longer meets eligibility criteria|0|||
25215931|NCT01939158|50491910|FG001|Overall Study|No longer meets eligibility criteria|0|||
25215932|NCT01939158|50491911|FG002|Overall Study|No longer meets eligibility criteria|1|||
25215933|NCT01939158|50491912|FG003|Overall Study|No longer meets eligibility criteria|0|||
25215934|NCT01939158|50491909|FG000|Overall Study|Other|1|||
25215935|NCT01939158|50491910|FG001|Overall Study|Other|3|||
25215936|NCT01939158|50491911|FG002|Overall Study|Other|4|||
25215937|NCT01939158|50491912|FG003|Overall Study|Other|3|||
25215938|NCT01939002|50491928|FG000|Overall Study|Adverse Event|13|||
25215939|NCT01939002|50491929|FG001|Overall Study|Adverse Event|13|||
25215940|NCT01939002|50491928|FG000|Overall Study|Withdrawal by Subject|5|||
25215941|NCT01939002|50491929|FG001|Overall Study|Withdrawal by Subject|3|||
25215942|NCT01939002|50491928|FG000|Overall Study|Other|1|||
25215943|NCT01939002|50491929|FG001|Overall Study|Other|2|||
25215944|NCT01938846|50491943|FG000|Overall Study|Progressive disease|26|||
25215945|NCT01938846|50491944|FG001|Overall Study|Progressive disease|18|||
25215946|NCT01938846|50491945|FG002|Overall Study|Progressive disease|16|||
25215947|NCT01938846|50491943|FG000|Overall Study|Adverse Event|8|||
25215948|NCT01938846|50491944|FG001|Overall Study|Adverse Event|4|||
25215949|NCT01938846|50491945|FG002|Overall Study|Adverse Event|3|||
25215950|NCT01938846|50491943|FG000|Overall Study|Withdrawal by Subject|2|||
25215951|NCT01938846|50491944|FG001|Overall Study|Withdrawal by Subject|2|||
25215952|NCT01938846|50491945|FG002|Overall Study|Withdrawal by Subject|1|||
25215953|NCT01938846|50491943|FG000|Overall Study|Other than listed|5|||
25215954|NCT01938846|50491944|FG001|Overall Study|Other than listed|1|||
25215955|NCT01938846|50491945|FG002|Overall Study|Other than listed|4|||
25215956|NCT01960140|50491986|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
25215957|NCT01981356|50491996|FG000|Overall Study|Lost to Follow-up|4|||
25215958|NCT01981356|50491997|FG001|Overall Study|Lost to Follow-up|1|||
25215959|NCT01981356|50491996|FG000|Overall Study|Withdrawal by Subject|1|||
25215960|NCT01981356|50491997|FG001|Overall Study|Withdrawal by Subject|1|||
25215961|NCT01981356|50491996|FG000|Overall Study|Protocol Violation|2|||
25215962|NCT01981356|50491997|FG001|Overall Study|Protocol Violation|0|||
25215963|NCT01981122|50492006|FG000|Overall Study|Withdrawal by Subject|0|||
25215964|NCT01981122|50492007|FG001|Overall Study|Withdrawal by Subject|2|||
25215965|NCT01981122|50492006|FG000|Overall Study|Protocol Violation|0|||
25215966|NCT01981122|50492007|FG001|Overall Study|Protocol Violation|1|||
25215967|NCT01981122|50492006|FG000|Overall Study|Lost to Follow-up|0|||
25215968|NCT01981122|50492007|FG001|Overall Study|Lost to Follow-up|1|||
25215969|NCT01981122|50492006|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
25215970|NCT01981122|50492007|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
25215971|NCT01981122|50492006|FG000|Overall Study|Death|14|||
25215972|NCT01981122|50492007|FG001|Overall Study|Death|15|||
25215973|NCT01959672|50492013|FG000|Overall Study|Death|1|||
25215974|NCT01980888|50492022|FG000|Overall Study|Study Terminated by Sponsor|116|||
25215975|NCT01980888|50492023|FG001|Overall Study|Study Terminated by Sponsor|122|||
25215976|NCT01980888|50492022|FG000|Overall Study|Withdrew Consent|17|||
25215977|NCT01980888|50492023|FG001|Overall Study|Withdrew Consent|6|||
25215978|NCT01980888|50492022|FG000|Overall Study|Investigator's Discretion|8|||
25215979|NCT01980888|50492023|FG001|Overall Study|Investigator's Discretion|3|||
25215980|NCT01980888|50492022|FG000|Overall Study|Non-Compliance with Study Drug|3|||
25215981|NCT01980888|50492023|FG001|Overall Study|Non-Compliance with Study Drug|2|||
25215982|NCT01937364|50492040|FG000|Overall Study|Adverse Event|2|||
25215983|NCT01937364|50492041|FG001|Overall Study|Adverse Event|1|||
25215984|NCT01979952|50492049|FG000|Overall Study|Adverse Event|4|||
25215985|NCT01979952|50492050|FG001|Overall Study|Adverse Event|5|||
25215986|NCT01979952|50492049|FG000|Overall Study|Protocol Violation|1|||
25215987|NCT01979952|50492050|FG001|Overall Study|Protocol Violation|0|||
25215988|NCT01979952|50492049|FG000|Overall Study|Withdrawal by Subject|2|||
25215989|NCT01979952|50492050|FG001|Overall Study|Withdrawal by Subject|1|||
25215990|NCT01979952|50492049|FG000|Overall Study|Other than specified above|1|||
25215991|NCT01979952|50492050|FG001|Overall Study|Other than specified above|0|||
25215992|NCT01999218|50492059|FG000|Overall Study|Hyperglycemia|18|||
25215993|NCT01999218|50492060|FG001|Overall Study|Hyperglycemia|17|||
25215994|NCT01999218|50492061|FG002|Overall Study|Hyperglycemia|17|||
25215995|NCT01999218|50492059|FG000|Overall Study|Lack of Efficacy|1|||
25215996|NCT01999218|50492060|FG001|Overall Study|Lack of Efficacy|0|||
25215997|NCT01999218|50492061|FG002|Overall Study|Lack of Efficacy|1|||
25215998|NCT01999218|50492059|FG000|Overall Study|Lost to Follow-up|22|||
25215999|NCT01999218|50492060|FG001|Overall Study|Lost to Follow-up|17|||
25216000|NCT01999218|50492061|FG002|Overall Study|Lost to Follow-up|18|||
25216001|NCT01999218|50492059|FG000|Overall Study|Non-Compliance With Study Drug|6|||
25216002|NCT01999218|50492060|FG001|Overall Study|Non-Compliance With Study Drug|4|||
25216003|NCT01999218|50492061|FG002|Overall Study|Non-Compliance With Study Drug|1|||
25216004|NCT01999218|50492059|FG000|Overall Study|Physician Decision|1|||
25216005|NCT01999218|50492060|FG001|Overall Study|Physician Decision|4|||
25216006|NCT01999218|50492061|FG002|Overall Study|Physician Decision|6|||
25216007|NCT01999218|50492059|FG000|Overall Study|Protocol Violation|4|||
25216008|NCT01999218|50492060|FG001|Overall Study|Protocol Violation|5|||
25216009|NCT01999218|50492061|FG002|Overall Study|Protocol Violation|4|||
25216010|NCT01999218|50492059|FG000|Overall Study|Screen failure|0|||
25216011|NCT01999218|50492060|FG001|Overall Study|Screen failure|1|||
25216012|NCT01999218|50492061|FG002|Overall Study|Screen failure|0|||
25216013|NCT01999218|50492059|FG000|Overall Study|Study Terminated By Sponsor|7|||
25216014|NCT01999218|50492060|FG001|Overall Study|Study Terminated By Sponsor|5|||
25216015|NCT01999218|50492061|FG002|Overall Study|Study Terminated By Sponsor|12|||
25216016|NCT01999218|50492059|FG000|Overall Study|Participant moves|2|||
25216017|NCT01999218|50492060|FG001|Overall Study|Participant moves|5|||
25216018|NCT01999218|50492061|FG002|Overall Study|Participant moves|3|||
25216019|NCT01999218|50492059|FG000|Overall Study|Withdrawal by Subject|28|||
25216020|NCT01999218|50492060|FG001|Overall Study|Withdrawal by Subject|29|||
25216021|NCT01999218|50492061|FG002|Overall Study|Withdrawal by Subject|34|||
25216022|NCT01999218|50492059|FG000|Overall Study|Creatinine/eGFR|0|||
25216023|NCT01999218|50492060|FG001|Overall Study|Creatinine/eGFR|0|||
25216024|NCT01999218|50492061|FG002|Overall Study|Creatinine/eGFR|1|||
25216025|NCT01999218|50492059|FG000|Overall Study|Death|7|||
25077394|NCT02936323|50185221|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
25216026|NCT01999218|50492060|FG001|Overall Study|Death|1|||
25216027|NCT01999218|50492061|FG002|Overall Study|Death|2|||
25216028|NCT01999218|50492059|FG000|Overall Study|Excluded Medication|1|||
25216029|NCT01999218|50492060|FG001|Overall Study|Excluded Medication|1|||
25216030|NCT01999218|50492061|FG002|Overall Study|Excluded Medication|2|||
25216031|NCT01999218|50492059|FG000|Overall Study|Adverse Event|9|||
25216032|NCT01999218|50492060|FG001|Overall Study|Adverse Event|7|||
25216033|NCT01999218|50492061|FG002|Overall Study|Adverse Event|7|||
25216034|NCT01999218|50492059|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
25316901|NCT00831441|50632405|FG000|Randomized|Lost to Follow-up|26|||
25216035|NCT01999218|50492060|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
25216036|NCT01999218|50492061|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
25216037|NCT01937130|50492073|FG000|Overall Study|Withdrawal by Subject|0|||
25216038|NCT01937130|50492074|FG001|Overall Study|Withdrawal by Subject|0|||
25216039|NCT01937130|50492075|FG002|Overall Study|Withdrawal by Subject|0|||
25216040|NCT01937130|50492076|FG003|Overall Study|Withdrawal by Subject|1|||
25216041|NCT01937130|50492073|FG000|Overall Study|Adverse Event|0|||
25216042|NCT01937130|50492074|FG001|Overall Study|Adverse Event|1|||
25216043|NCT01937130|50492075|FG002|Overall Study|Adverse Event|0|||
25216044|NCT01937130|50492076|FG003|Overall Study|Adverse Event|1|||
25216045|NCT01937130|50492073|FG000|Overall Study|Death|1|||
25216046|NCT01937130|50492074|FG001|Overall Study|Death|1|||
25216047|NCT01937130|50492075|FG002|Overall Study|Death|1|||
25216048|NCT01937130|50492076|FG003|Overall Study|Death|0|||
25216049|NCT01937130|50492073|FG000|Overall Study|Lost to Follow-up|2|||
25216050|NCT01937130|50492074|FG001|Overall Study|Lost to Follow-up|0|||
25216051|NCT01937130|50492075|FG002|Overall Study|Lost to Follow-up|2|||
25216052|NCT01937130|50492076|FG003|Overall Study|Lost to Follow-up|0|||
25216053|NCT01937130|50492073|FG000|Overall Study|Physician Decision|0|||
25216054|NCT01937130|50492074|FG001|Overall Study|Physician Decision|1|||
25216055|NCT01937130|50492075|FG002|Overall Study|Physician Decision|0|||
25216056|NCT01937130|50492076|FG003|Overall Study|Physician Decision|0|||
25216057|NCT01937130|50492073|FG000|Overall Study|Patients unable to swallow|0|||
25216058|NCT01937130|50492074|FG001|Overall Study|Patients unable to swallow|1|||
25216059|NCT01937130|50492075|FG002|Overall Study|Patients unable to swallow|0|||
25216060|NCT01937130|50492076|FG003|Overall Study|Patients unable to swallow|0|||
25216061|NCT01937130|50492073|FG000|Overall Study|Patient lost to FU due to death|2|||
25216062|NCT01937130|50492074|FG001|Overall Study|Patient lost to FU due to death|0|||
25216063|NCT01937130|50492075|FG002|Overall Study|Patient lost to FU due to death|0|||
25216064|NCT01937130|50492076|FG003|Overall Study|Patient lost to FU due to death|0|||
25216065|NCT01936974|50492088|FG000|Overall Study|Physician Decision|2|||
25216066|NCT01936974|50492089|FG001|Overall Study|Physician Decision|5|||
25216067|NCT01959516|50492095|FG000|Epoch 1|Adverse Event|4|||
25216068|NCT01959516|50492096|FG001|Epoch 1|Adverse Event|1|||
25216069|NCT01959516|50492095|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
25216070|NCT01959516|50492096|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
25216071|NCT01959516|50492095|FG000|Epoch 1|Subject withdrew consent|3|||
25216072|NCT01959516|50492096|FG001|Epoch 1|Subject withdrew consent|2|||
25216073|NCT01959516|50492095|FG000|Epoch 1|Administrative problems|1|||
25216074|NCT01959516|50492096|FG001|Epoch 1|Administrative problems|0|||
25216075|NCT01959516|50492095|FG000|Epoch 1|Use of prohibited treatment|1|||
25216076|NCT01959516|50492096|FG001|Epoch 1|Use of prohibited treatment|0|||
25216077|NCT01959516|50492095|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
25216078|NCT01959516|50492096|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
25216079|NCT01959516|50492095|FG000|Epoch 1|Protocol deviation|0|||
25216080|NCT01959516|50492096|FG001|Epoch 1|Protocol deviation|1|||
25216081|NCT01959516|50492095|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
25216082|NCT01959516|50492096|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
25216083|NCT01959516|50492095|FG000|Epoch 2|Subject withdrew consent|1|||
25216084|NCT01959516|50492096|FG001|Epoch 2|Subject withdrew consent|0|||
25216085|NCT01959516|50492095|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
25216086|NCT01959516|50492096|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
25216087|NCT01979016|50492104|FG000|Overall Study|Withdrawal by Subject|2|||
25216088|NCT01979016|50492105|FG001|Overall Study|Withdrawal by Subject|0|||
25216089|NCT01979016|50492104|FG000|Overall Study|Adverse Event|0|||
25216090|NCT01979016|50492105|FG001|Overall Study|Adverse Event|1|||
25216091|NCT01935336|50492115|FG000|Overall Study|Adverse Event|1|||
25216092|NCT01935336|50492116|FG001|Overall Study|Adverse Event|0|||
25216093|NCT01935336|50492117|FG002|Overall Study|Adverse Event|0|||
25216094|NCT01935336|50492118|FG003|Overall Study|Adverse Event|0|||
25216095|NCT01935336|50492115|FG000|Overall Study|Progressive disease|5|||
25216096|NCT01935336|50492116|FG001|Overall Study|Progressive disease|3|||
25216097|NCT01935336|50492117|FG002|Overall Study|Progressive disease|47|||
25216098|NCT01935336|50492118|FG003|Overall Study|Progressive disease|66|||
25316902|NCT00831441|50632406|FG001|Randomized|Lost to Follow-up|35|||
25216099|NCT01978236|50492134|FG000|Overall Study|Discontinued due to study close|2|||
25216100|NCT01977846|50492140|FG000|Total Study - Prospective|Death|0|||
25216101|NCT01977846|50492141|FG001|Total Study - Prospective|Death|1|||
25216102|NCT01977846|50492140|FG000|Total Study - Prospective|Lost to Follow-up|0|||
25216103|NCT01977846|50492141|FG001|Total Study - Prospective|Lost to Follow-up|8|||
25216104|NCT01977846|50492140|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
25216105|NCT01977846|50492141|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
25216106|NCT01977846|50492140|FG000|Total Study - Prospective|Not available at time of visit|0|||
25216107|NCT01977846|50492141|FG001|Total Study - Prospective|Not available at time of visit|5|||
25216108|NCT01977846|50492140|FG000|Total Study - Prospective|No show|0|||
25216109|NCT01977846|50492141|FG001|Total Study - Prospective|No show|1|||
25216110|NCT01977846|50492140|FG000|Total Study - Prospective|Protocol Violation|0|||
25216111|NCT01977846|50492141|FG001|Total Study - Prospective|Protocol Violation|1|||
25216112|NCT01934790|50492148|FG000|Treatment|Adverse Event|3|||
25216113|NCT01934790|50492148|FG000|Treatment|Clinical progression|6|||
25216114|NCT01934790|50492148|FG000|Treatment|Radiological progression|4|||
25216115|NCT01934790|50492148|FG000|Treatment|Withdrawal by Subject|2|||
25216116|NCT01934790|50492148|FG000|Treatment|Study drug never administered|1|||
25216117|NCT01934790|50492148|FG000|Active Follow up|Death|20|||
25216118|NCT01934790|50492148|FG000|Active Follow up|Physician Decision|2|||
25216119|NCT01934790|50492148|FG000|Active Follow up|Progressive disease|1|||
25216120|NCT01934790|50492148|FG000|Active Follow up|Other reason|1|||
25216121|NCT01934556|50492155|FG000|Overall Study|Withdrawal by Subject|0|||
25216122|NCT01934556|50492156|FG001|Overall Study|Withdrawal by Subject|1|||
25216123|NCT01934556|50492157|FG002|Overall Study|Withdrawal by Subject|1|||
25216124|NCT01934556|50492155|FG000|Overall Study|Lost to Follow-up|4|||
25216125|NCT01934556|50492156|FG001|Overall Study|Lost to Follow-up|10|||
25216126|NCT01934556|50492157|FG002|Overall Study|Lost to Follow-up|7|||
25216127|NCT01934556|50492155|FG000|Overall Study|Death|1|||
25216128|NCT01934556|50492156|FG001|Overall Study|Death|5|||
25216129|NCT01934556|50492157|FG002|Overall Study|Death|2|||
25216130|NCT01977690|50492167|FG000|Overall Study|Withdrawal by Subject|0|||
25216131|NCT01977690|50492168|FG001|Overall Study|Withdrawal by Subject|4|||
25216132|NCT01934010|50492243|FG000|Overall Study|Adverse Event|1|||
25216133|NCT01934010|50492244|FG001|Overall Study|Adverse Event|1|||
25216134|NCT01934010|50492245|FG002|Overall Study|Adverse Event|0|||
25216135|NCT01934010|50492243|FG000|Overall Study|Withdrawal by Subject|15|||
25216136|NCT01934010|50492244|FG001|Overall Study|Withdrawal by Subject|6|||
25216137|NCT01934010|50492245|FG002|Overall Study|Withdrawal by Subject|2|||
25216138|NCT01934010|50492243|FG000|Overall Study|Lost to Follow-up|7|||
25216139|NCT01934010|50492244|FG001|Overall Study|Lost to Follow-up|4|||
25216140|NCT01934010|50492245|FG002|Overall Study|Lost to Follow-up|0|||
25216141|NCT01620138|50492264|FG000|Overall Study|Withdrawal by Subject|3|||
25216142|NCT01620138|50492265|FG001|Overall Study|Withdrawal by Subject|0|||
25216143|NCT01620138|50492264|FG000|Overall Study|Lack of Efficacy|1|||
25216144|NCT01620138|50492265|FG001|Overall Study|Lack of Efficacy|0|||
25216145|NCT01620138|50492264|FG000|Overall Study|Adverse Event|2|||
25216146|NCT01620138|50492265|FG001|Overall Study|Adverse Event|0|||
25216147|NCT01977612|50492273|FG000|Overall Study|Lost to Follow-up|1|||
25216148|NCT01977612|50492274|FG001|Overall Study|Lost to Follow-up|1|||
25216149|NCT01932996|50492282|FG000|Overall Study|Protocol Violation|2|||
25216150|NCT01932996|50492283|FG001|Overall Study|Protocol Violation|0|||
25216151|NCT01932762|50492293|FG000|Overall Study|Withdrawal by Subject|1|||
25216152|NCT01932762|50492294|FG001|Overall Study|Withdrawal by Subject|2|||
25216153|NCT01932762|50492295|FG002|Overall Study|Withdrawal by Subject|0|||
25216154|NCT01932762|50492296|FG003|Overall Study|Withdrawal by Subject|0|||
25216155|NCT01932762|50492293|FG000|Overall Study|Lost to Follow-up|4|||
25216156|NCT01932762|50492294|FG001|Overall Study|Lost to Follow-up|0|||
25216157|NCT01932762|50492295|FG002|Overall Study|Lost to Follow-up|0|||
25216158|NCT01932762|50492296|FG003|Overall Study|Lost to Follow-up|1|||
25216159|NCT01932762|50492293|FG000|Overall Study|Physician Decision|1|||
25216160|NCT01932762|50492294|FG001|Overall Study|Physician Decision|0|||
25216161|NCT01932762|50492295|FG002|Overall Study|Physician Decision|0|||
25216162|NCT01932762|50492296|FG003|Overall Study|Physician Decision|0|||
25216163|NCT01618968|50492310|FG000|Overall Study|Adverse Event|1|||
25216164|NCT01618968|50492311|FG001|Overall Study|Adverse Event|0|||
25216165|NCT01618968|50492312|FG002|Overall Study|Adverse Event|0|||
25216166|NCT01618968|50492313|FG003|Overall Study|Adverse Event|0|||
25216167|NCT01618968|50492310|FG000|Overall Study|Death|0|||
25216168|NCT01618968|50492311|FG001|Overall Study|Death|0|||
25216169|NCT01618968|50492312|FG002|Overall Study|Death|0|||
25216170|NCT01618968|50492313|FG003|Overall Study|Death|1|||
25216171|NCT01932294|50492322|FG000|Overall Study|Death|43|||
25216172|NCT01932294|50492322|FG000|Overall Study|Lost to Follow-up|8|||
25216173|NCT01932294|50492322|FG000|Overall Study|VAD Implantation|20|||
25216174|NCT01932294|50492322|FG000|Overall Study|Heart Transplantation|16|||
25216175|NCT01932294|50492322|FG000|Overall Study|Transferred to other hospitals|12|||
25216176|NCT01931670|50492330|FG000|Treatment Period|Exclusionary Medication Received|1|||
25216177|NCT01931670|50492331|FG001|Treatment Period|Exclusionary Medication Received|1|||
25216178|NCT01931670|50492332|FG002|Treatment Period|Exclusionary Medication Received|1|||
25216179|NCT01931670|50492330|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
25216180|NCT01931670|50492331|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
25216181|NCT01931670|50492332|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
25216182|NCT01931670|50492330|FG000|Treatment Period|Subject Noncompliant|4|||
25216183|NCT01931670|50492331|FG001|Treatment Period|Subject Noncompliant|9|||
25216184|NCT01931670|50492332|FG002|Treatment Period|Subject Noncompliant|5|||
25216185|NCT01931670|50492330|FG000|Treatment Period|Adverse Event|19|||
25216186|NCT01931670|50492331|FG001|Treatment Period|Adverse Event|8|||
25216187|NCT01931670|50492332|FG002|Treatment Period|Adverse Event|21|||
25216188|NCT01931670|50492330|FG000|Treatment Period|Lack of Efficacy|11|||
25216189|NCT01931670|50492331|FG001|Treatment Period|Lack of Efficacy|2|||
25216190|NCT01931670|50492332|FG002|Treatment Period|Lack of Efficacy|2|||
25216191|NCT01931670|50492330|FG000|Treatment Period|Pregnancy|7|||
25216192|NCT01931670|50492331|FG001|Treatment Period|Pregnancy|2|||
25216193|NCT01931670|50492332|FG002|Treatment Period|Pregnancy|0|||
25216194|NCT01931670|50492330|FG000|Treatment Period|Other|8|||
25216195|NCT01931670|50492331|FG001|Treatment Period|Other|7|||
25216196|NCT01931670|50492332|FG002|Treatment Period|Other|2|||
25216197|NCT01931670|50492330|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
25216198|NCT01931670|50492331|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
25216199|NCT01931670|50492332|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
25216200|NCT01931670|50492330|FG000|Treatment Period|Lost to Follow-up|19|||
25216201|NCT01931670|50492331|FG001|Treatment Period|Lost to Follow-up|5|||
25216202|NCT01931670|50492332|FG002|Treatment Period|Lost to Follow-up|7|||
25216203|NCT01931670|50492330|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
25216204|NCT01931670|50492331|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
25216205|NCT01931670|50492332|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
25216206|NCT01931670|50492330|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
25216207|NCT01931670|50492331|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
25216208|NCT01931670|50492332|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
25216209|NCT01931670|50492330|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
25216210|NCT01931670|50492331|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
25216211|NCT01931670|50492332|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
25216212|NCT01931670|50492330|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
25216213|NCT01931670|50492331|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
25216214|NCT01931670|50492332|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
25216215|NCT01931670|50492330|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
25216216|NCT01931670|50492331|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
25216217|NCT01931670|50492332|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
25216218|NCT01931670|50492330|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
25216219|NCT01931670|50492331|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
25216220|NCT01931670|50492332|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
25216221|NCT01977456|50492340|FG000|Overall Study|Death|5|||
25216222|NCT01957644|50492349|FG000|Overall Study|Adverse Event|4|||
25216223|NCT01957644|50492350|FG001|Overall Study|Adverse Event|2|||
25216224|NCT01957644|50492351|FG002|Overall Study|Adverse Event|0|||
25216225|NCT01957644|50492352|FG003|Overall Study|Adverse Event|0|||
25216226|NCT01957644|50492353|FG004|Overall Study|Adverse Event|1|||
25216227|NCT01957644|50492349|FG000|Overall Study|Progressive disease / relapse|0|||
25216228|NCT01957644|50492350|FG001|Overall Study|Progressive disease / relapse|1|||
25216229|NCT01957644|50492351|FG002|Overall Study|Progressive disease / relapse|0|||
25216230|NCT01957644|50492352|FG003|Overall Study|Progressive disease / relapse|1|||
25216231|NCT01957644|50492353|FG004|Overall Study|Progressive disease / relapse|0|||
25216232|NCT01957644|50492349|FG000|Overall Study|Other reason|1|||
25216233|NCT01957644|50492350|FG001|Overall Study|Other reason|2|||
25216234|NCT01957644|50492351|FG002|Overall Study|Other reason|1|||
25216235|NCT01957644|50492352|FG003|Overall Study|Other reason|1|||
25216236|NCT01957644|50492353|FG004|Overall Study|Other reason|0|||
25216237|NCT01957644|50492349|FG000|Overall Study|Withdrawal by Subject|1|||
25216238|NCT01957644|50492350|FG001|Overall Study|Withdrawal by Subject|0|||
25216239|NCT01957644|50492351|FG002|Overall Study|Withdrawal by Subject|0|||
25216240|NCT01957644|50492352|FG003|Overall Study|Withdrawal by Subject|0|||
25216241|NCT01957644|50492353|FG004|Overall Study|Withdrawal by Subject|0|||
25216242|NCT01957644|50492349|FG000|Overall Study|Protocol Violation|0|||
25216243|NCT01957644|50492350|FG001|Overall Study|Protocol Violation|1|||
25216244|NCT01957644|50492351|FG002|Overall Study|Protocol Violation|0|||
25216245|NCT01957644|50492352|FG003|Overall Study|Protocol Violation|0|||
25216246|NCT01957644|50492353|FG004|Overall Study|Protocol Violation|0|||
25216247|NCT01931202|50492370|FG000|Overall Study|Withdrawal by Subject|0|||
25216248|NCT01931202|50492371|FG001|Overall Study|Withdrawal by Subject|0|||
25216249|NCT01931202|50492372|FG002|Overall Study|Withdrawal by Subject|2|||
25216250|NCT01931202|50492370|FG000|Overall Study|Lost to Follow-up|0|||
25216251|NCT01931202|50492371|FG001|Overall Study|Lost to Follow-up|5|||
25077395|NCT02936323|50185222|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
25216252|NCT01931202|50492372|FG002|Overall Study|Lost to Follow-up|2|||
25216253|NCT01930890|50492387|FG000|Overall Study|Study Termination|14|||
25216254|NCT01930890|50492388|FG001|Overall Study|Study Termination|28|||
25216255|NCT01930890|50492389|FG002|Overall Study|Study Termination|13|||
25216256|NCT01930890|50492390|FG003|Overall Study|Study Termination|25|||
25216257|NCT01930890|50492387|FG000|Overall Study|Death|0|||
25216258|NCT01930890|50492388|FG001|Overall Study|Death|0|||
25216259|NCT01930890|50492389|FG002|Overall Study|Death|0|||
25216260|NCT01930890|50492390|FG003|Overall Study|Death|1|||
25216261|NCT01930890|50492387|FG000|Overall Study|Investigator Decision|0|||
25216262|NCT01930890|50492388|FG001|Overall Study|Investigator Decision|1|||
25216263|NCT01930890|50492389|FG002|Overall Study|Investigator Decision|0|||
25216264|NCT01930890|50492390|FG003|Overall Study|Investigator Decision|0|||
25216265|NCT01930890|50492387|FG000|Overall Study|Consent Withdrawn|0|||
25216266|NCT01930890|50492388|FG001|Overall Study|Consent Withdrawn|3|||
25216267|NCT01930890|50492389|FG002|Overall Study|Consent Withdrawn|0|||
25216268|NCT01930890|50492390|FG003|Overall Study|Consent Withdrawn|1|||
25216269|NCT01930890|50492387|FG000|Overall Study|Adverse Event|0|||
25216270|NCT01930890|50492388|FG001|Overall Study|Adverse Event|1|||
25216271|NCT01930890|50492389|FG002|Overall Study|Adverse Event|0|||
25216272|NCT01930890|50492390|FG003|Overall Study|Adverse Event|0|||
25216273|NCT01930188|50492403|FG000|Overall Study|unclassified|4|||
25216274|NCT01930188|50492404|FG001|Overall Study|unclassified|5|||
25216275|NCT01930188|50492405|FG002|Overall Study|unclassified|3|||
25216276|NCT01930188|50492403|FG000|Overall Study|Missing follow-up information|2|||
25216277|NCT01930188|50492404|FG001|Overall Study|Missing follow-up information|2|||
25216278|NCT01930188|50492405|FG002|Overall Study|Missing follow-up information|3|||
25216279|NCT01930188|50492403|FG000|Overall Study|Lost to Follow-up|5|||
25216280|NCT01930188|50492404|FG001|Overall Study|Lost to Follow-up|2|||
25216281|NCT01930188|50492405|FG002|Overall Study|Lost to Follow-up|2|||
25216282|NCT01930188|50492403|FG000|Overall Study|Death|2|||
25216283|NCT01930188|50492404|FG001|Overall Study|Death|1|||
25216284|NCT01930188|50492405|FG002|Overall Study|Death|3|||
25216285|NCT01930188|50492403|FG000|Overall Study|Withdrawal by Subject|9|||
25216286|NCT01930188|50492404|FG001|Overall Study|Withdrawal by Subject|11|||
25216287|NCT01930188|50492405|FG002|Overall Study|Withdrawal by Subject|8|||
25216288|NCT01977222|50492414|FG000|Overall Study|Withdrawal by Subject|1|||
25216289|NCT01957488|50492418|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
25216290|NCT01957488|50492419|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
25216291|NCT01957488|50492420|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
25216292|NCT01957488|50492421|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
25216293|NCT01957488|50492422|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
25216294|NCT01957488|50492423|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
25216295|NCT01957488|50492418|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
25216296|NCT01957488|50492419|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
25216297|NCT01957488|50492420|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
25216298|NCT01957488|50492421|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
25216299|NCT01957488|50492422|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
25216300|NCT01957488|50492423|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
25216301|NCT01957488|50492418|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
25216302|NCT01957488|50492419|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
25216303|NCT01957488|50492420|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
25216304|NCT01957488|50492421|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
25216305|NCT01957488|50492422|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
25216306|NCT01957488|50492423|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
25216307|NCT01957488|50492418|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
25216308|NCT01957488|50492419|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
25216309|NCT01957488|50492420|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
25216310|NCT01957488|50492421|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
25216311|NCT01957488|50492422|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
25216312|NCT01957488|50492423|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
25216313|NCT01957488|50492418|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
25216314|NCT01957488|50492419|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
25216315|NCT01957488|50492420|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
25216316|NCT01957488|50492421|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
25216317|NCT01957488|50492422|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
25216318|NCT01957488|50492423|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
25216319|NCT01957488|50492418|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
25216320|NCT01957488|50492419|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
25216321|NCT01957488|50492420|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
25216322|NCT01957488|50492421|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
25216323|NCT01957488|50492422|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
25216324|NCT01957488|50492423|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
25216325|NCT01957488|50492418|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
25216326|NCT01957488|50492419|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
25216327|NCT01957488|50492420|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
25216328|NCT01957488|50492421|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
25216329|NCT01957488|50492422|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
25216330|NCT01957488|50492423|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
25216331|NCT01957488|50492418|FG000|Test Period 2 (2 Weeks)|Other|1|||
25316903|NCT00831441|50632405|FG000|Randomized|Administrative reason by sponsor|2780|||
25316904|NCT00831441|50632406|FG001|Randomized|Administrative reason by sponsor|2671|||
25216332|NCT01957488|50492419|FG001|Test Period 2 (2 Weeks)|Other|0|||
25216333|NCT01957488|50492420|FG002|Test Period 2 (2 Weeks)|Other|0|||
25316905|NCT00831441|50632405|FG000|Randomized|poor/non-compliance|30|||
25316906|NCT00831441|50632406|FG001|Randomized|poor/non-compliance|38|||
25316907|NCT00831441|50632405|FG000|Randomized|non-specified|276|||
25316908|NCT00831441|50632406|FG001|Randomized|non-specified|266|||
25316909|NCT00831441|50632405|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
25316910|NCT00831441|50632406|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
25316911|NCT00831441|50632405|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
25316912|NCT00831441|50632406|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
25316913|NCT00831441|50632405|FG000|Follow Up (30 Days)|Death|63|||
25316914|NCT00831441|50632406|FG001|Follow Up (30 Days)|Death|86|||
25316915|NCT00831441|50632405|FG000|Follow Up (30 Days)|non-specified|16|||
25316916|NCT00831441|50632406|FG001|Follow Up (30 Days)|non-specified|26|||
25316917|NCT00831441|50632405|FG000|Follow Up (30 Days)|missing end of study status|0|||
25316918|NCT00831441|50632406|FG001|Follow Up (30 Days)|missing end of study status|1|||
25316919|NCT00831129|50632415|FG000|Overall Study|Adverse Event|0|||
25316920|NCT00831129|50632416|FG001|Overall Study|Adverse Event|1|||
25316921|NCT00831129|50632415|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
25316922|NCT00831129|50632416|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
25316923|NCT00620113|50632426|FG000|Overall Study|Adverse Event|3|||
25316924|NCT00620113|50632427|FG001|Overall Study|Adverse Event|2|||
25316925|NCT00620113|50632428|FG002|Overall Study|Adverse Event|2|||
25316926|NCT00620113|50632429|FG003|Overall Study|Adverse Event|1|||
25316927|NCT00620113|50632426|FG000|Overall Study|Lack of Efficacy|2|||
25316928|NCT00620113|50632427|FG001|Overall Study|Lack of Efficacy|3|||
25316929|NCT00620113|50632428|FG002|Overall Study|Lack of Efficacy|0|||
25316930|NCT00620113|50632429|FG003|Overall Study|Lack of Efficacy|2|||
25316931|NCT00620113|50632426|FG000|Overall Study|Physician Decision|1|||
25316932|NCT00620113|50632427|FG001|Overall Study|Physician Decision|0|||
25316933|NCT00620113|50632428|FG002|Overall Study|Physician Decision|0|||
25316934|NCT00620113|50632429|FG003|Overall Study|Physician Decision|2|||
25316935|NCT00620113|50632426|FG000|Overall Study|Protocol Violation|2|||
25316936|NCT00620113|50632427|FG001|Overall Study|Protocol Violation|1|||
25316937|NCT00620113|50632428|FG002|Overall Study|Protocol Violation|0|||
25316938|NCT00620113|50632429|FG003|Overall Study|Protocol Violation|0|||
25316939|NCT00620113|50632426|FG000|Overall Study|Withdrawal by Subject|5|||
25316940|NCT00620113|50632427|FG001|Overall Study|Withdrawal by Subject|1|||
25316941|NCT00620113|50632428|FG002|Overall Study|Withdrawal by Subject|3|||
25316942|NCT00620113|50632429|FG003|Overall Study|Withdrawal by Subject|5|||
25316943|NCT00830115|50632439|FG000|Overall Study|Adverse Event|2|||
25316944|NCT00830115|50632439|FG000|Overall Study|Improvement/recovery|1|||
25316945|NCT00830037|50632447|FG000|Overall Study|Withdrawal by Subject|2|||
25316946|NCT00830037|50632448|FG001|Overall Study|Withdrawal by Subject|3|||
25316947|NCT00830037|50632447|FG000|Overall Study|Lost to Follow-up|1|||
25316948|NCT00830037|50632448|FG001|Overall Study|Lost to Follow-up|2|||
25316949|NCT00830037|50632447|FG000|Overall Study|Active when terminated by DSMB|15|||
25316950|NCT00830037|50632448|FG001|Overall Study|Active when terminated by DSMB|14|||
25316951|NCT00829413|50632454|FG000|Overall Study|No study drug admimnistered|13|||
25316952|NCT00829413|50632454|FG000|Overall Study|Training Patients|67|||
25316953|NCT00829413|50632454|FG000|Overall Study|No truth standard procedure available|9|||
25316954|NCT00829413|50632454|FG000|Overall Study|Technically inadequate truth standard|2|||
25316955|NCT00829413|50632454|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
25316956|NCT00829179|50632465|FG000|Overall Study|Withdrawal by Subject|1|||
25316957|NCT00591591|50632471|FG000|Overall Study|Withdrawal by Subject|1|||
25316958|NCT00591591|50632472|FG001|Overall Study|Withdrawal by Subject|37|||
25316959|NCT00591591|50632471|FG000|Overall Study|Lack of Efficacy|10|||
25316960|NCT00591591|50632472|FG001|Overall Study|Lack of Efficacy|2|||
25316961|NCT00828945|50632478|FG000|Overall Study|Death|4|||
25316962|NCT00828945|50632478|FG000|Overall Study|Participant was missing|1|||
25316963|NCT00828945|50632478|FG000|Overall Study|Other|36|||
25216334|NCT01957488|50492421|FG003|Test Period 2 (2 Weeks)|Other|0|||
25216335|NCT01957488|50492422|FG004|Test Period 2 (2 Weeks)|Other|0|||
25216336|NCT01957488|50492423|FG005|Test Period 2 (2 Weeks)|Other|0|||
25216337|NCT01957488|50492418|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
25316964|NCT00966875|50632491|FG000|Part A|Adverse Event|2|||
25316965|NCT00966875|50632492|FG001|Part A|Adverse Event|1|||
25316966|NCT00966875|50632493|FG002|Part A|Adverse Event|0|||
25316967|NCT00966875|50632494|FG003|Part A|Adverse Event|1|||
25316968|NCT00966875|50632495|FG004|Part A|Adverse Event|0|||
25316969|NCT00966875|50632496|FG005|Part A|Adverse Event|1|||
25316970|NCT00966875|50632497|FG006|Part A|Adverse Event|0|||
25316971|NCT00966875|50632498|FG007|Part A|Adverse Event|3|||
25316972|NCT00966875|50632499|FG008|Part A|Adverse Event|3|||
25316973|NCT00966875|50632491|FG000|Part A|Entry Criteria|0|||
25216338|NCT01957488|50492419|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
25316974|NCT00966875|50632492|FG001|Part A|Entry Criteria|0|||
25316975|NCT00966875|50632493|FG002|Part A|Entry Criteria|0|||
25316976|NCT00966875|50632494|FG003|Part A|Entry Criteria|0|||
25216339|NCT01957488|50492420|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
25216340|NCT01957488|50492421|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
25216341|NCT01957488|50492422|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
25216342|NCT01957488|50492423|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
25216343|NCT01957488|50492418|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
25216344|NCT01957488|50492419|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
25216345|NCT01957488|50492420|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
25216346|NCT01957488|50492421|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
25216347|NCT01957488|50492422|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
25216348|NCT01957488|50492423|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
25216349|NCT01957488|50492418|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
25216350|NCT01957488|50492419|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
25216351|NCT01957488|50492420|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
25216352|NCT01957488|50492421|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
25216353|NCT01957488|50492422|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
25216354|NCT01957488|50492423|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
25216355|NCT01957488|50492418|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
25216356|NCT01957488|50492419|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
25216357|NCT01957488|50492420|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
25216358|NCT01957488|50492421|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
25216359|NCT01957488|50492422|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
25216360|NCT01957488|50492423|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
25216361|NCT01957488|50492418|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
25216362|NCT01957488|50492419|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
25216363|NCT01957488|50492420|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
25216364|NCT01957488|50492421|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
25216365|NCT01957488|50492422|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
25216366|NCT01957488|50492423|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
25216367|NCT01976364|50492431|FG000|Main Study (36 Months)|Adverse Event|63|||
25216368|NCT01976364|50492432|FG001|Main Study (36 Months)|Adverse Event|0|||
25216369|NCT01976364|50492433|FG002|Main Study (36 Months)|Adverse Event|0|||
25077396|NCT02936323|50185223|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
25077397|NCT02936323|50185224|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
25077398|NCT02936323|50185225|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
25077399|NCT02936323|50185226|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
25216370|NCT01976364|50492431|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
25216371|NCT01976364|50492432|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
25216372|NCT01976364|50492433|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
25216373|NCT01976364|50492431|FG000|Main Study (36 Months)|Other|13|||
25216374|NCT01976364|50492432|FG001|Main Study (36 Months)|Other|0|||
25216375|NCT01976364|50492433|FG002|Main Study (36 Months)|Other|0|||
25216376|NCT01976364|50492431|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
25216377|NCT01976364|50492432|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
25216378|NCT01976364|50492433|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
25216379|NCT01976364|50492431|FG000|Main Study (36 Months)|Medication error|1|||
25216380|NCT01976364|50492432|FG001|Main Study (36 Months)|Medication error|0|||
25216381|NCT01976364|50492433|FG002|Main Study (36 Months)|Medication error|0|||
25216382|NCT01976364|50492431|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
25216383|NCT01976364|50492432|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
25216384|NCT01976364|50492433|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
25216385|NCT01976364|50492431|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
25216386|NCT01976364|50492432|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
25216387|NCT01976364|50492433|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
25216388|NCT01976364|50492431|FG000|Main Study (36 Months)|Protocol Violation|13|||
25216389|NCT01976364|50492432|FG001|Main Study (36 Months)|Protocol Violation|0|||
25216390|NCT01976364|50492433|FG002|Main Study (36 Months)|Protocol Violation|0|||
25216391|NCT01976364|50492431|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
25216392|NCT01976364|50492432|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
25216393|NCT01976364|50492433|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
25216394|NCT01976364|50492431|FG000|Main Study (36 Months)|Death|5|||
25216395|NCT01976364|50492432|FG001|Main Study (36 Months)|Death|0|||
25216396|NCT01976364|50492433|FG002|Main Study (36 Months)|Death|0|||
25216397|NCT01976364|50492431|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
25216398|NCT01976364|50492432|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
25216399|NCT01976364|50492433|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
25077400|NCT02936323|50185227|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
25077401|NCT02936323|50185228|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
25216400|NCT01976364|50492431|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
25216401|NCT01976364|50492432|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
25216402|NCT01976364|50492433|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
25216403|NCT01976364|50492431|FG000|Sub-study (12 Months)|Protocol Violation|0|||
25216404|NCT01976364|50492432|FG001|Sub-study (12 Months)|Protocol Violation|1|||
25216405|NCT01976364|50492433|FG002|Sub-study (12 Months)|Protocol Violation|1|||
25216406|NCT01976364|50492431|FG000|Sub-study (12 Months)|Adverse Event|0|||
25216407|NCT01976364|50492432|FG001|Sub-study (12 Months)|Adverse Event|4|||
25216408|NCT01976364|50492433|FG002|Sub-study (12 Months)|Adverse Event|3|||
25216409|NCT01956240|50492444|FG000|Overall Study|Lost to Follow-up|6|||
25216410|NCT01956240|50492445|FG001|Overall Study|Lost to Follow-up|20|||
25216411|NCT01956240|50492444|FG000|Overall Study|Adverse Event|17|||
25216412|NCT01956240|50492445|FG001|Overall Study|Adverse Event|4|||
25216413|NCT01929876|50492451|FG000|Period 2|Non-Compliance|1|||
25216414|NCT01929408|50492455|FG000|Overall Study|received HCT as initial treatment|8|||
25216415|NCT01929018|50492461|FG000|Overall Study|Lost to Follow-up|1|||
25216416|NCT01929018|50492462|FG001|Overall Study|Lost to Follow-up|0|||
25216417|NCT01929018|50492461|FG000|Overall Study|Hospitalization|0|||
25216418|NCT01929018|50492462|FG001|Overall Study|Hospitalization|1|||
25216419|NCT01928940|50492470|FG000|Overall Study|Adverse Event|0|||
25216420|NCT01928940|50492471|FG001|Overall Study|Adverse Event|1|||
25216421|NCT01928862|50492483|FG000|Overall Study|Lost to Follow-up|1|||
25216422|NCT01928862|50492484|FG001|Overall Study|Lost to Follow-up|0|||
25216423|NCT01928862|50492485|FG002|Overall Study|Lost to Follow-up|0|||
25216424|NCT01928862|50492486|FG003|Overall Study|Lost to Follow-up|0|||
25216425|NCT01928862|50492487|FG004|Overall Study|Lost to Follow-up|1|||
25216426|NCT01954056|50492502|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
25216427|NCT01954056|50492503|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
25216428|NCT01953354|50492511|FG000|Overall Study|Withdrawal by Subject|0|||
25216429|NCT01953354|50492512|FG001|Overall Study|Withdrawal by Subject|1|||
25216430|NCT01953354|50492511|FG000|Overall Study|Decision of Sponsor|0|||
25216431|NCT01953354|50492512|FG001|Overall Study|Decision of Sponsor|1|||
25216432|NCT01953354|50492511|FG000|Overall Study|Disease Exacerbation|1|||
25216433|NCT01953354|50492512|FG001|Overall Study|Disease Exacerbation|0|||
25216434|NCT01975272|50492521|FG000|Overall Study|Excluded after protocol amendment|1|||
25216435|NCT01975272|50492522|FG001|Overall Study|Excluded after protocol amendment|1|||
25216436|NCT01975272|50492523|FG002|Overall Study|Excluded after protocol amendment|2|||
25216437|NCT01951638|50492536|FG000|Treatment Period|Protocol Violation|0|||
25216438|NCT01951638|50492537|FG001|Treatment Period|Protocol Violation|0|||
25216439|NCT01951638|50492538|FG002|Treatment Period|Protocol Violation|0|||
25216440|NCT01951638|50492539|FG003|Treatment Period|Protocol Violation|2|||
25216441|NCT01951638|50492540|FG004|Treatment Period|Protocol Violation|0|||
25216442|NCT01951638|50492536|FG000|Treatment Period|Protocol-driven decision point|1|||
25216443|NCT01951638|50492537|FG001|Treatment Period|Protocol-driven decision point|3|||
25216444|NCT01951638|50492538|FG002|Treatment Period|Protocol-driven decision point|0|||
25216445|NCT01951638|50492539|FG003|Treatment Period|Protocol-driven decision point|0|||
25216446|NCT01951638|50492540|FG004|Treatment Period|Protocol-driven decision point|0|||
25216447|NCT01951638|50492536|FG000|Treatment Period|Logistical difficulties|0|||
25216448|NCT01951638|50492537|FG001|Treatment Period|Logistical difficulties|1|||
25216449|NCT01951638|50492538|FG002|Treatment Period|Logistical difficulties|1|||
25216450|NCT01951638|50492539|FG003|Treatment Period|Logistical difficulties|0|||
25216451|NCT01951638|50492540|FG004|Treatment Period|Logistical difficulties|0|||
25216452|NCT01951638|50492536|FG000|Treatment Period|Withdrawal by Subject|9|||
25216453|NCT01951638|50492537|FG001|Treatment Period|Withdrawal by Subject|6|||
25216454|NCT01951638|50492538|FG002|Treatment Period|Withdrawal by Subject|4|||
25216455|NCT01951638|50492539|FG003|Treatment Period|Withdrawal by Subject|5|||
25216456|NCT01951638|50492540|FG004|Treatment Period|Withdrawal by Subject|4|||
25216457|NCT01951638|50492536|FG000|Treatment Period|Death|0|||
25216458|NCT01951638|50492537|FG001|Treatment Period|Death|0|||
25216459|NCT01951638|50492538|FG002|Treatment Period|Death|0|||
25216460|NCT01951638|50492539|FG003|Treatment Period|Death|3|||
25216461|NCT01951638|50492540|FG004|Treatment Period|Death|1|||
25216462|NCT01951638|50492536|FG000|Treatment Period|Adverse Event|3|||
25216463|NCT01951638|50492537|FG001|Treatment Period|Adverse Event|4|||
25216464|NCT01951638|50492538|FG002|Treatment Period|Adverse Event|8|||
25216465|NCT01951638|50492539|FG003|Treatment Period|Adverse Event|6|||
25216466|NCT01951638|50492540|FG004|Treatment Period|Adverse Event|5|||
25216467|NCT01951638|50492536|FG000|Follow-up Period|Protocol Violation|0|||
25216468|NCT01951638|50492537|FG001|Follow-up Period|Protocol Violation|0|||
25216469|NCT01951638|50492538|FG002|Follow-up Period|Protocol Violation|0|||
25216470|NCT01951638|50492539|FG003|Follow-up Period|Protocol Violation|1|||
25216471|NCT01951638|50492540|FG004|Follow-up Period|Protocol Violation|0|||
25216472|NCT01951638|50492536|FG000|Follow-up Period|Logistical difficulties|0|||
25216473|NCT01951638|50492537|FG001|Follow-up Period|Logistical difficulties|2|||
25216474|NCT01951638|50492538|FG002|Follow-up Period|Logistical difficulties|0|||
25216475|NCT01951638|50492539|FG003|Follow-up Period|Logistical difficulties|0|||
25216476|NCT01951638|50492540|FG004|Follow-up Period|Logistical difficulties|1|||
25216477|NCT01951638|50492536|FG000|Follow-up Period|Withdrawal by Subject|1|||
25216478|NCT01951638|50492537|FG001|Follow-up Period|Withdrawal by Subject|5|||
25316977|NCT00966875|50632495|FG004|Part A|Entry Criteria|0|||
25316978|NCT00966875|50632496|FG005|Part A|Entry Criteria|2|||
25216479|NCT01951638|50492538|FG002|Follow-up Period|Withdrawal by Subject|2|||
25216480|NCT01951638|50492539|FG003|Follow-up Period|Withdrawal by Subject|1|||
25216481|NCT01951638|50492540|FG004|Follow-up Period|Withdrawal by Subject|2|||
25216482|NCT01951638|50492536|FG000|Follow-up Period|Lost to Follow-up|0|||
25216483|NCT01951638|50492537|FG001|Follow-up Period|Lost to Follow-up|1|||
25216484|NCT01951638|50492538|FG002|Follow-up Period|Lost to Follow-up|0|||
25216485|NCT01951638|50492539|FG003|Follow-up Period|Lost to Follow-up|1|||
25216486|NCT01951638|50492540|FG004|Follow-up Period|Lost to Follow-up|0|||
25216487|NCT01951638|50492536|FG000|Follow-up Period|Death|1|||
25216488|NCT01951638|50492537|FG001|Follow-up Period|Death|0|||
25216489|NCT01951638|50492538|FG002|Follow-up Period|Death|1|||
25216490|NCT01951638|50492539|FG003|Follow-up Period|Death|4|||
25216491|NCT01951638|50492540|FG004|Follow-up Period|Death|1|||
25316979|NCT00966875|50632497|FG006|Part A|Entry Criteria|0|||
25316980|NCT00966875|50632498|FG007|Part A|Entry Criteria|0|||
25316981|NCT00966875|50632499|FG008|Part A|Entry Criteria|0|||
25316982|NCT00966875|50632491|FG000|Part A|Lack of Efficacy|0|||
25316983|NCT00966875|50632492|FG001|Part A|Lack of Efficacy|1|||
25316984|NCT00966875|50632493|FG002|Part A|Lack of Efficacy|0|||
25316985|NCT00966875|50632494|FG003|Part A|Lack of Efficacy|0|||
25316986|NCT00966875|50632495|FG004|Part A|Lack of Efficacy|0|||
25316987|NCT00966875|50632496|FG005|Part A|Lack of Efficacy|0|||
25316988|NCT00966875|50632497|FG006|Part A|Lack of Efficacy|4|||
25316989|NCT00966875|50632498|FG007|Part A|Lack of Efficacy|0|||
25316990|NCT00966875|50632499|FG008|Part A|Lack of Efficacy|0|||
25316991|NCT00966875|50632491|FG000|Part A|Lost to Follow-up|2|||
25316992|NCT00966875|50632492|FG001|Part A|Lost to Follow-up|0|||
25316993|NCT00966875|50632493|FG002|Part A|Lost to Follow-up|0|||
25316994|NCT00966875|50632494|FG003|Part A|Lost to Follow-up|0|||
25316995|NCT00966875|50632495|FG004|Part A|Lost to Follow-up|0|||
25316996|NCT00966875|50632496|FG005|Part A|Lost to Follow-up|1|||
25316997|NCT00966875|50632497|FG006|Part A|Lost to Follow-up|0|||
25316998|NCT00966875|50632498|FG007|Part A|Lost to Follow-up|0|||
25316999|NCT00966875|50632499|FG008|Part A|Lost to Follow-up|0|||
25317000|NCT00966875|50632491|FG000|Part A|Parent/Caregiver Decision|0|||
25317001|NCT00966875|50632492|FG001|Part A|Parent/Caregiver Decision|0|||
25317002|NCT00966875|50632493|FG002|Part A|Parent/Caregiver Decision|0|||
25317003|NCT00966875|50632494|FG003|Part A|Parent/Caregiver Decision|1|||
25317004|NCT00966875|50632495|FG004|Part A|Parent/Caregiver Decision|0|||
25317005|NCT00966875|50632496|FG005|Part A|Parent/Caregiver Decision|0|||
25317006|NCT00966875|50632497|FG006|Part A|Parent/Caregiver Decision|0|||
25317007|NCT00966875|50632498|FG007|Part A|Parent/Caregiver Decision|0|||
25317008|NCT00966875|50632499|FG008|Part A|Parent/Caregiver Decision|0|||
25317009|NCT00966875|50632491|FG000|Part A|Physician Decision|0|||
25317010|NCT00966875|50632492|FG001|Part A|Physician Decision|0|||
25317011|NCT00966875|50632493|FG002|Part A|Physician Decision|0|||
25317012|NCT00966875|50632494|FG003|Part A|Physician Decision|0|||
25317013|NCT00966875|50632495|FG004|Part A|Physician Decision|1|||
25317014|NCT00966875|50632496|FG005|Part A|Physician Decision|0|||
25317015|NCT00966875|50632497|FG006|Part A|Physician Decision|1|||
25317016|NCT00966875|50632498|FG007|Part A|Physician Decision|0|||
25317017|NCT00966875|50632499|FG008|Part A|Physician Decision|2|||
25317018|NCT00966875|50632491|FG000|Part A|Sponsor Decision|0|||
25317019|NCT00966875|50632492|FG001|Part A|Sponsor Decision|0|||
25317020|NCT00966875|50632493|FG002|Part A|Sponsor Decision|1|||
25317021|NCT00966875|50632494|FG003|Part A|Sponsor Decision|0|||
25317022|NCT00966875|50632495|FG004|Part A|Sponsor Decision|1|||
25317023|NCT00966875|50632496|FG005|Part A|Sponsor Decision|0|||
25216492|NCT01951638|50492536|FG000|Follow-up Period|Adverse Event|0|||
25216493|NCT01951638|50492537|FG001|Follow-up Period|Adverse Event|1|||
25216494|NCT01951638|50492538|FG002|Follow-up Period|Adverse Event|2|||
25216495|NCT01951638|50492539|FG003|Follow-up Period|Adverse Event|1|||
25216496|NCT01951638|50492540|FG004|Follow-up Period|Adverse Event|1|||
25216497|NCT01928472|50492556|FG000|Overall Study|Death|0|||
25216498|NCT01928472|50492557|FG001|Overall Study|Death|0|||
25216499|NCT01928472|50492558|FG002|Overall Study|Death|1|||
25216500|NCT01928472|50492559|FG003|Overall Study|Death|0|||
25216501|NCT01928472|50492556|FG000|Overall Study|Withdrawal by Subject|4|||
25216502|NCT01928472|50492557|FG001|Overall Study|Withdrawal by Subject|4|||
25216503|NCT01928472|50492558|FG002|Overall Study|Withdrawal by Subject|1|||
25317024|NCT00966875|50632497|FG006|Part A|Sponsor Decision|0|||
25317025|NCT00966875|50632498|FG007|Part A|Sponsor Decision|2|||
25317026|NCT00966875|50632499|FG008|Part A|Sponsor Decision|1|||
25317027|NCT00966875|50632491|FG000|Part A|Withdrawal by Subject|2|||
25317028|NCT00966875|50632492|FG001|Part A|Withdrawal by Subject|2|||
25317029|NCT00966875|50632493|FG002|Part A|Withdrawal by Subject|1|||
25317030|NCT00966875|50632494|FG003|Part A|Withdrawal by Subject|1|||
25216504|NCT01928472|50492559|FG003|Overall Study|Withdrawal by Subject|2|||
25317031|NCT00966875|50632495|FG004|Part A|Withdrawal by Subject|3|||
25317032|NCT00966875|50632496|FG005|Part A|Withdrawal by Subject|0|||
25317033|NCT00966875|50632497|FG006|Part A|Withdrawal by Subject|5|||
25317034|NCT00966875|50632498|FG007|Part A|Withdrawal by Subject|1|||
25317035|NCT00966875|50632499|FG008|Part A|Withdrawal by Subject|1|||
25317036|NCT00966875|50632491|FG000|Part A|Protocol Violation|0|||
25317037|NCT00966875|50632492|FG001|Part A|Protocol Violation|0|||
25216505|NCT01928472|50492556|FG000|Overall Study|Lost to Follow-up|2|||
25216506|NCT01928472|50492557|FG001|Overall Study|Lost to Follow-up|3|||
25216507|NCT01928472|50492558|FG002|Overall Study|Lost to Follow-up|4|||
25216508|NCT01928472|50492559|FG003|Overall Study|Lost to Follow-up|0|||
25216509|NCT01928472|50492556|FG000|Overall Study|Administrative Reason|2|||
25216510|NCT01928472|50492557|FG001|Overall Study|Administrative Reason|1|||
25216511|NCT01928472|50492558|FG002|Overall Study|Administrative Reason|0|||
25216512|NCT01928472|50492559|FG003|Overall Study|Administrative Reason|0|||
25216513|NCT01928472|50492556|FG000|Overall Study|Unclassified|0|||
25216514|NCT01928472|50492557|FG001|Overall Study|Unclassified|0|||
25216515|NCT01928472|50492558|FG002|Overall Study|Unclassified|1|||
25216516|NCT01928472|50492559|FG003|Overall Study|Unclassified|0|||
25216517|NCT01351415|50494420|FG000|Overall Study|Withdrawal by Subject|15|||
25216518|NCT01351415|50494421|FG001|Overall Study|Withdrawal by Subject|17|||
25216519|NCT01351415|50494420|FG000|Overall Study|Trial termination by the Sponsor|28|||
25216520|NCT01351415|50494421|FG001|Overall Study|Trial termination by the Sponsor|19|||
25216521|NCT01351415|50494420|FG000|Overall Study|Lost to Follow-up|5|||
25216522|NCT01351415|50494421|FG001|Overall Study|Lost to Follow-up|7|||
25216523|NCT01351415|50494420|FG000|Overall Study|Death|190|||
25216524|NCT01351415|50494421|FG001|Overall Study|Death|187|||
25216525|NCT01351415|50494420|FG000|Overall Study|Physician Decision|2|||
25216526|NCT01351415|50494421|FG001|Overall Study|Physician Decision|3|||
25216527|NCT01351415|50494420|FG000|Overall Study|Reason unknown|0|||
25216528|NCT01351415|50494421|FG001|Overall Study|Reason unknown|2|||
25216529|NCT01351415|50494420|FG000|Overall Study|Never Started|5|||
25216530|NCT01351415|50494421|FG001|Overall Study|Never Started|5|||
25216531|NCT04811339|50494529|FG000|Overall Study|lack of transportation not wanting to return|4|||
25216532|NCT04811339|50494530|FG001|Overall Study|lack of transportation not wanting to return|8|||
25216533|NCT04811339|50494531|FG002|Overall Study|lack of transportation not wanting to return|0|||
25216534|NCT04811339|50494529|FG000|Overall Study|Adverse Event|3|||
25216535|NCT04811339|50494530|FG001|Overall Study|Adverse Event|0|||
25216536|NCT04811339|50494531|FG002|Overall Study|Adverse Event|0|||
25216537|NCT04811339|50494529|FG000|Overall Study|Lost to Follow-up|1|||
25216538|NCT04811339|50494530|FG001|Overall Study|Lost to Follow-up|0|||
25216539|NCT04811339|50494531|FG002|Overall Study|Lost to Follow-up|0|||
25216540|NCT04811339|50494529|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
25216541|NCT04811339|50494530|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
25216542|NCT04811339|50494531|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
25216543|NCT04811339|50494529|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
25216544|NCT04811339|50494530|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
25216545|NCT04811339|50494531|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
25216546|NCT04811339|50494529|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
25216547|NCT04811339|50494530|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
25216548|NCT04811339|50494531|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
25216549|NCT04811339|50494529|FG000|Overall Study|Withdrawal by Subject|0|||
25216550|NCT04811339|50494530|FG001|Overall Study|Withdrawal by Subject|3|||
25216551|NCT04811339|50494531|FG002|Overall Study|Withdrawal by Subject|0|||
25216552|NCT04811339|50494529|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
25216553|NCT04811339|50494530|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
25216554|NCT04811339|50494531|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
25216555|NCT04811339|50494529|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
25216556|NCT04811339|50494530|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
25216557|NCT04811339|50494531|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
25216558|NCT04652453|50494544|FG000|Overall Study|Death|8|||
25216559|NCT04652453|50494545|FG001|Overall Study|Death|2|||
25216560|NCT04652453|50494546|FG002|Overall Study|Death|0|||
25216561|NCT04652453|50494544|FG000|Overall Study|Hospice|5|||
25216562|NCT04652453|50494545|FG001|Overall Study|Hospice|5|||
25216563|NCT04652453|50494546|FG002|Overall Study|Hospice|0|||
25216564|NCT04652453|50494544|FG000|Overall Study|Withdrawal by Subject|2|||
25216565|NCT04652453|50494545|FG001|Overall Study|Withdrawal by Subject|0|||
25216566|NCT04652453|50494546|FG002|Overall Study|Withdrawal by Subject|0|||
25216567|NCT04332107|50494554|FG000|Day 3|Lost to Follow-up|23|||
25216568|NCT04332107|50494555|FG001|Day 3|Lost to Follow-up|14|||
25216569|NCT04332107|50494554|FG000|Day 3|Missing outcome data|3|||
25216570|NCT04332107|50494555|FG001|Day 3|Missing outcome data|6|||
25216571|NCT04332107|50494554|FG000|Day 14|Lost to Follow-up|13|||
25216572|NCT04332107|50494555|FG001|Day 14|Lost to Follow-up|4|||
25216573|NCT04332107|50494554|FG000|Day 14|Missing outcome data|4|||
25216574|NCT04332107|50494555|FG001|Day 14|Missing outcome data|4|||
25216575|NCT04332107|50494554|FG000|Day 21|Lost to Follow-up|10|||
25216576|NCT04332107|50494555|FG001|Day 21|Lost to Follow-up|2|||
25216577|NCT03375203|50494570|FG000|Overall Study|Protocol Violation|0|||
24976469|NCT00060944|50065359|FG000|Overall Study|randomized but not treated|6|||
25216578|NCT03375203|50494571|FG001|Overall Study|Protocol Violation|0|||
25216579|NCT03375203|50494572|FG002|Overall Study|Protocol Violation|1|||
25216580|NCT03375203|50494573|FG003|Overall Study|Protocol Violation|0|||
25216581|NCT03375203|50494574|FG004|Overall Study|Protocol Violation|0|||
25216582|NCT03375203|50494570|FG000|Overall Study|Adverse Event|2|||
25216583|NCT03375203|50494571|FG001|Overall Study|Adverse Event|3|||
25216584|NCT03375203|50494572|FG002|Overall Study|Adverse Event|0|||
25216585|NCT03375203|50494573|FG003|Overall Study|Adverse Event|2|||
25216586|NCT03375203|50494574|FG004|Overall Study|Adverse Event|2|||
25216587|NCT03375203|50494570|FG000|Overall Study|Withdrawal by Subject|3|||
25216588|NCT03375203|50494571|FG001|Overall Study|Withdrawal by Subject|0|||
25216589|NCT03375203|50494572|FG002|Overall Study|Withdrawal by Subject|1|||
25216590|NCT03375203|50494573|FG003|Overall Study|Withdrawal by Subject|0|||
25216591|NCT03375203|50494574|FG004|Overall Study|Withdrawal by Subject|2|||
25216592|NCT03375203|50494570|FG000|Overall Study|Non-compliance with study drug|1|||
25216593|NCT03375203|50494571|FG001|Overall Study|Non-compliance with study drug|0|||
25216594|NCT03375203|50494572|FG002|Overall Study|Non-compliance with study drug|0|||
25216595|NCT03375203|50494573|FG003|Overall Study|Non-compliance with study drug|0|||
25216596|NCT03375203|50494574|FG004|Overall Study|Non-compliance with study drug|0|||
25216597|NCT03375203|50494570|FG000|Overall Study|Randomized, not treated.|0|||
25216598|NCT03375203|50494571|FG001|Overall Study|Randomized, not treated.|1|||
25216599|NCT03375203|50494572|FG002|Overall Study|Randomized, not treated.|0|||
25216600|NCT03375203|50494573|FG003|Overall Study|Randomized, not treated.|0|||
25216601|NCT03375203|50494574|FG004|Overall Study|Randomized, not treated.|0|||
25216602|NCT03075839|50494596|FG000|Overall Study|Lost to Follow-up|4|||
25216603|NCT02919683|50494602|FG000|Post-Surgery Follow-Up|Death|2|||
25216604|NCT02919683|50494603|FG001|Post-Surgery Follow-Up|Death|2|||
25216605|NCT02919683|50494602|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
25216606|NCT02919683|50494603|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
25216607|NCT01928082|50494610|FG000|Overall Study|Study terminated.|1|||
25216608|NCT01972776|50494620|FG000|Part 1|Withdrawal by Subject|0|||
25216609|NCT01972776|50494621|FG001|Part 1|Withdrawal by Subject|0|||
25216610|NCT01972776|50494622|FG002|Part 1|Withdrawal by Subject|1|||
25216611|NCT01972776|50494623|FG003|Part 1|Withdrawal by Subject|0|||
25216612|NCT01972776|50494624|FG004|Part 1|Withdrawal by Subject|0|||
25216613|NCT01972776|50494625|FG005|Part 1|Withdrawal by Subject|0|||
25216614|NCT01972776|50494620|FG000|Part 1|Adverse Event|0|||
25216615|NCT01972776|50494621|FG001|Part 1|Adverse Event|0|||
25216616|NCT01972776|50494622|FG002|Part 1|Adverse Event|1|||
25216617|NCT01972776|50494623|FG003|Part 1|Adverse Event|1|||
25216618|NCT01972776|50494624|FG004|Part 1|Adverse Event|0|||
25216619|NCT01972776|50494625|FG005|Part 1|Adverse Event|0|||
25216620|NCT01972776|50494620|FG000|Part 2|Adverse Event|0|||
25216621|NCT01972776|50494621|FG001|Part 2|Adverse Event|0|||
25216622|NCT01972776|50494622|FG002|Part 2|Adverse Event|0|||
25216623|NCT01972776|50494623|FG003|Part 2|Adverse Event|0|||
25216624|NCT01972776|50494624|FG004|Part 2|Adverse Event|3|||
25216625|NCT01972776|50494625|FG005|Part 2|Adverse Event|0|||
25216626|NCT01972776|50494620|FG000|Part 2|Administrative problems|0|||
25216627|NCT01972776|50494621|FG001|Part 2|Administrative problems|0|||
25216628|NCT01972776|50494622|FG002|Part 2|Administrative problems|0|||
25216629|NCT01972776|50494623|FG003|Part 2|Administrative problems|0|||
25216630|NCT01972776|50494624|FG004|Part 2|Administrative problems|10|||
25216631|NCT01972776|50494625|FG005|Part 2|Administrative problems|7|||
25216632|NCT03763331|50494641|FG000|Overall Study|Lost to Follow-up|1|||
25216633|NCT03763331|50494642|FG001|Overall Study|Lost to Follow-up|0|||
25216634|NCT03763331|50494641|FG000|Overall Study|Withdrawal by Subject|1|||
25216635|NCT03763331|50494642|FG001|Overall Study|Withdrawal by Subject|0|||
25216636|NCT03763331|50494641|FG000|Overall Study|Non-compliance|0|||
25216637|NCT03763331|50494642|FG001|Overall Study|Non-compliance|3|||
25216638|NCT00001259|50494669|FG000|Study 2|Adverse Event|0|||
25216639|NCT00001259|50494670|FG001|Study 2|Adverse Event|0|||
25216640|NCT00001259|50494671|FG002|Study 2|Adverse Event|0|||
25216641|NCT00001259|50494672|FG003|Study 2|Adverse Event|0|||
25216642|NCT00001259|50494673|FG004|Study 2|Adverse Event|2|||
25216643|NCT00001259|50494674|FG005|Study 2|Adverse Event|0|||
25216644|NCT00001259|50494675|FG006|Study 2|Adverse Event|0|||
25216645|NCT01926444|50494689|FG000|Overall Study|Colonoscopy not performed|0|||
25216646|NCT01926444|50494690|FG001|Overall Study|Colonoscopy not performed|0|||
25216647|NCT01926444|50494691|FG002|Overall Study|Colonoscopy not performed|4|||
25216648|NCT01926444|50494692|FG003|Overall Study|Colonoscopy not performed|2|||
25216649|NCT05003167|50494702|FG000|Overall Study|Withdrawal by Subject|1|||
25216650|NCT04988035|50494708|FG000|Overall Study|Death|19|||
25216651|NCT04988035|50494709|FG001|Overall Study|Death|13|||
25216652|NCT04988035|50494708|FG000|Overall Study|Lost to Follow-up|12|||
25216653|NCT04988035|50494709|FG001|Overall Study|Lost to Follow-up|6|||
25216654|NCT04988035|50494708|FG000|Overall Study|Protocol Violation|0|||
25216655|NCT04988035|50494709|FG001|Overall Study|Protocol Violation|1|||
25216656|NCT04988035|50494708|FG000|Overall Study|Withdrawal by Subject|2|||
25216657|NCT04988035|50494709|FG001|Overall Study|Withdrawal by Subject|4|||
25216658|NCT04988035|50494708|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
25216659|NCT04988035|50494709|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
25216660|NCT04847674|50494727|FG000|Overall Study|Withdrawal by Subject|0|||
25216661|NCT04847674|50494728|FG001|Overall Study|Withdrawal by Subject|1|||
25216662|NCT04847674|50494729|FG002|Overall Study|Withdrawal by Subject|0|||
25216663|NCT04847674|50494727|FG000|Overall Study|Lost to Follow-up|0|||
25216664|NCT04847674|50494728|FG001|Overall Study|Lost to Follow-up|0|||
25216665|NCT04847674|50494729|FG002|Overall Study|Lost to Follow-up|2|||
25216666|NCT04847674|50494727|FG000|Overall Study|Other than specified|21|||
25216667|NCT04847674|50494728|FG001|Overall Study|Other than specified|20|||
25216668|NCT04847674|50494729|FG002|Overall Study|Other than specified|20|||
25216669|NCT04649060|50494741|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
25216670|NCT04649060|50494742|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
25216671|NCT04649060|50494741|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
25216672|NCT04649060|50494742|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
25216673|NCT04649060|50494741|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
25216674|NCT04649060|50494742|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
25216675|NCT04649060|50494741|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
25216676|NCT04649060|50494742|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
25216677|NCT04649060|50494741|FG000|Arm A/Arm B Treatment|Patient Request|1|||
25216678|NCT04649060|50494742|FG001|Arm A/Arm B Treatment|Patient Request|0|||
25216679|NCT04649060|50494741|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
25216680|NCT04649060|50494742|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
25216681|NCT04649060|50494741|FG000|Arm A/Arm B Treatment|Other|1|||
25216682|NCT04649060|50494742|FG001|Arm A/Arm B Treatment|Other|0|||
25216683|NCT04649060|50494741|FG000|Crossover (Arm B)|Adverse Event|0|||
25216684|NCT04649060|50494742|FG001|Crossover (Arm B)|Adverse Event|1|||
25216685|NCT04649060|50494741|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
25216686|NCT04649060|50494742|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
25216687|NCT04640272|50494749|FG000|Overall Study|Subject moved out of area|1|||
25216688|NCT04511650|50494756|FG000|Overall Study|Lost to Follow-up|1|||
25216689|NCT04511650|50494757|FG001|Overall Study|Lost to Follow-up|0|||
25216690|NCT04511650|50494758|FG002|Overall Study|Lost to Follow-up|0|||
25216691|NCT04511650|50494756|FG000|Overall Study|Withdrawal by Subject|1|||
25216692|NCT04511650|50494757|FG001|Overall Study|Withdrawal by Subject|0|||
25216693|NCT04511650|50494758|FG002|Overall Study|Withdrawal by Subject|0|||
25216694|NCT04511650|50494756|FG000|Overall Study|reason not provided|0|||
25216695|NCT04511650|50494757|FG001|Overall Study|reason not provided|0|||
25216696|NCT04511650|50494758|FG002|Overall Study|reason not provided|1|||
25216697|NCT04511650|50494756|FG000|Overall Study|Death|1|||
25216698|NCT04511650|50494757|FG001|Overall Study|Death|1|||
25216699|NCT04511650|50494758|FG002|Overall Study|Death|1|||
25216700|NCT04295499|50494790|FG000|Overall Study|moving out of state|1|||
25216701|NCT04295499|50494791|FG001|Overall Study|moving out of state|0|||
25216702|NCT04295499|50494790|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
25216703|NCT04295499|50494791|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
25216704|NCT04285580|50494799|FG000|Overall Study|Protocol Violation|0|||
25216705|NCT04285580|50494800|FG001|Overall Study|Protocol Violation|1|||
25216706|NCT04200248|50494818|FG000|Overall Study|Personal reasons|0|||
25216707|NCT04200248|50494819|FG001|Overall Study|Personal reasons|0|||
25216708|NCT04200248|50494820|FG002|Overall Study|Personal reasons|1|||
25216709|NCT04200248|50494818|FG000|Overall Study|Discontinued prior to treatment|3|||
25216710|NCT04200248|50494819|FG001|Overall Study|Discontinued prior to treatment|3|||
25216711|NCT04200248|50494820|FG002|Overall Study|Discontinued prior to treatment|2|||
25216712|NCT04137887|50494830|FG000|Overall Study|Death|102|||
25216713|NCT04137887|50494831|FG001|Overall Study|Death|92|||
25216714|NCT04137887|50494830|FG000|Overall Study|Withdrawal by Subject|2|||
25216715|NCT04137887|50494831|FG001|Overall Study|Withdrawal by Subject|3|||
25216716|NCT04137887|50494830|FG000|Overall Study|Randomized but not treated|0|||
25216717|NCT04137887|50494831|FG001|Overall Study|Randomized but not treated|1|||
25216718|NCT03726879|50494850|FG000|Overall Study|Death|6|||
25216719|NCT03726879|50494851|FG001|Overall Study|Death|4|||
25216720|NCT03726879|50494850|FG000|Overall Study|Physician Decision|0|||
25216721|NCT03726879|50494851|FG001|Overall Study|Physician Decision|2|||
25216722|NCT03726879|50494850|FG000|Overall Study|Protocol Violation|0|||
25216723|NCT03726879|50494851|FG001|Overall Study|Protocol Violation|1|||
25216724|NCT03726879|50494850|FG000|Overall Study|Withdrawal by Subject|5|||
25216725|NCT03726879|50494851|FG001|Overall Study|Withdrawal by Subject|5|||
25216726|NCT03726879|50494850|FG000|Overall Study|TSH result is unstable|0|||
25077402|NCT02936323|50185229|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
25216727|NCT03726879|50494851|FG001|Overall Study|TSH result is unstable|1|||
25216728|NCT03726879|50494850|FG000|Overall Study|Continuing on Study|215|||
25216729|NCT03726879|50494851|FG001|Overall Study|Continuing on Study|215|||
25216730|NCT03637764|50494861|FG000|Overall Study|Adverse Event|2|||
25216731|NCT03637764|50494862|FG001|Overall Study|Adverse Event|0|||
25216732|NCT03637764|50494863|FG002|Overall Study|Adverse Event|0|||
25216733|NCT03637764|50494864|FG003|Overall Study|Adverse Event|1|||
25216734|NCT03637764|50494861|FG000|Overall Study|Progressive Disease|23|||
25216735|NCT03637764|50494862|FG001|Overall Study|Progressive Disease|23|||
25216736|NCT03637764|50494863|FG002|Overall Study|Progressive Disease|18|||
25216737|NCT03637764|50494864|FG003|Overall Study|Progressive Disease|31|||
25216738|NCT03637764|50494861|FG000|Overall Study|Withdrawal by Subject|1|||
25216739|NCT03637764|50494862|FG001|Overall Study|Withdrawal by Subject|3|||
25216740|NCT03637764|50494863|FG002|Overall Study|Withdrawal by Subject|0|||
25216741|NCT03637764|50494864|FG003|Overall Study|Withdrawal by Subject|1|||
25216742|NCT03557008|50494897|FG000|Overall Study|Withdrawal by Subject|2|||
25216743|NCT03557008|50494898|FG001|Overall Study|Withdrawal by Subject|2|||
25216744|NCT03557008|50494897|FG000|Overall Study|Early termination from study|3|||
25216745|NCT03557008|50494898|FG001|Overall Study|Early termination from study|1|||
25216746|NCT03040999|50494906|FG000|Overall Study|Lost to Follow-up|1|||
25216747|NCT03040999|50494907|FG001|Overall Study|Lost to Follow-up|0|||
25216748|NCT03040999|50494906|FG000|Overall Study|Withdrawal by Subject|7|||
25216749|NCT03040999|50494907|FG001|Overall Study|Withdrawal by Subject|12|||
25216750|NCT03040999|50494906|FG000|Overall Study|Death|128|||
25216751|NCT03040999|50494907|FG001|Overall Study|Death|138|||
25216752|NCT03040999|50494906|FG000|Overall Study|Participants Ongoing in Trial|266|||
25216753|NCT03040999|50494907|FG001|Overall Study|Participants Ongoing in Trial|252|||
25216754|NCT02990338|50494915|FG000|Overall Study|Ongoing|30|||
25216755|NCT02990338|50494916|FG001|Overall Study|Ongoing|36|||
25216756|NCT02576509|50494931|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
25216757|NCT02576509|50494932|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
25216758|NCT02576509|50494931|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
25216759|NCT02576509|50494932|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
25216760|NCT02576509|50494931|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
25216761|NCT02576509|50494932|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
25216762|NCT02576509|50494931|FG000|Treatment Period|Disease progression|245|||
25216763|NCT02576509|50494932|FG001|Treatment Period|Disease progression|240|||
25216764|NCT02576509|50494931|FG000|Treatment Period|Study drug toxicity|32|||
25216765|NCT02576509|50494932|FG001|Treatment Period|Study drug toxicity|41|||
25216766|NCT02576509|50494931|FG000|Treatment Period|Death|1|||
25216767|NCT02576509|50494932|FG001|Treatment Period|Death|1|||
25216768|NCT02576509|50494931|FG000|Treatment Period|Adverse event unrelated to study drug|37|||
25216769|NCT02576509|50494932|FG001|Treatment Period|Adverse event unrelated to study drug|40|||
25216770|NCT02576509|50494931|FG000|Treatment Period|Participant request to stop treatment|8|||
25216771|NCT02576509|50494932|FG001|Treatment Period|Participant request to stop treatment|17|||
25216772|NCT02576509|50494931|FG000|Treatment Period|Participant withdrew consent|2|||
25216773|NCT02576509|50494932|FG001|Treatment Period|Participant withdrew consent|7|||
25216774|NCT02576509|50494931|FG000|Treatment Period|Lost to Follow-up|0|||
25216775|NCT02576509|50494932|FG001|Treatment Period|Lost to Follow-up|1|||
25216776|NCT02576509|50494931|FG000|Treatment Period|Maximum clinical benefit|1|||
25216777|NCT02576509|50494932|FG001|Treatment Period|Maximum clinical benefit|0|||
25216778|NCT02576509|50494931|FG000|Treatment Period|Poor/non-compliance|0|||
25216779|NCT02576509|50494932|FG001|Treatment Period|Poor/non-compliance|1|||
25216780|NCT02576509|50494931|FG000|Treatment Period|Participant no longer meets criteria|1|||
25216781|NCT02576509|50494932|FG001|Treatment Period|Participant no longer meets criteria|0|||
25216782|NCT02576509|50494931|FG000|Treatment Period|Other reason|2|||
25216783|NCT02576509|50494932|FG001|Treatment Period|Other reason|7|||
25216784|NCT02576509|50494931|FG000|Follow-up Period|Death|41|||
25216785|NCT02576509|50494932|FG001|Follow-up Period|Death|35|||
25216786|NCT02576509|50494931|FG000|Follow-up Period|Participant withdrew consent|7|||
25216787|NCT02576509|50494932|FG001|Follow-up Period|Participant withdrew consent|14|||
25216788|NCT02576509|50494931|FG000|Follow-up Period|Lost to Follow-up|0|||
25216789|NCT02576509|50494932|FG001|Follow-up Period|Lost to Follow-up|1|||
25216790|NCT02576509|50494931|FG000|Follow-up Period|Other reason|1|||
25216791|NCT02576509|50494932|FG001|Follow-up Period|Other reason|2|||
25216792|NCT02366728|50494941|FG000|Overall Study|Death|0|||
25216793|NCT02366728|50494942|FG001|Overall Study|Death|0|||
25216794|NCT02366728|50494943|FG002|Overall Study|Death|1|||
25216795|NCT02366728|50494941|FG000|Overall Study|Adverse Event|1|||
25216796|NCT02366728|50494942|FG001|Overall Study|Adverse Event|0|||
25216797|NCT02366728|50494943|FG002|Overall Study|Adverse Event|0|||
25216798|NCT02366728|50494941|FG000|Overall Study|Screen Failure|2|||
25216799|NCT02366728|50494942|FG001|Overall Study|Screen Failure|1|||
25216800|NCT02366728|50494943|FG002|Overall Study|Screen Failure|0|||
25216801|NCT02366728|50494941|FG000|Overall Study|Only yielded 2 vaccines|1|||
25216802|NCT02366728|50494942|FG001|Overall Study|Only yielded 2 vaccines|0|||
25216803|NCT02366728|50494943|FG002|Overall Study|Only yielded 2 vaccines|0|||
25216804|NCT02355002|50494953|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
25216805|NCT02355002|50494954|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
25216806|NCT02355002|50494953|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
25216807|NCT02355002|50494954|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
25216808|NCT02355002|50494953|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
25216809|NCT02355002|50494954|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
25216810|NCT02355002|50494953|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
25216811|NCT02355002|50494954|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
25216812|NCT02355002|50494953|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
25216813|NCT02355002|50494954|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
25216814|NCT02355002|50494953|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
25216815|NCT02355002|50494954|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
25216816|NCT02355002|50494953|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
25216817|NCT02355002|50494954|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
25216818|NCT02246920|50494964|FG000|Overall Study|Adverse Event|3|||
25216819|NCT02246920|50494965|FG001|Overall Study|Adverse Event|1|||
25216820|NCT02246920|50494966|FG002|Overall Study|Adverse Event|1|||
25216821|NCT02246920|50494964|FG000|Overall Study|Lost to Follow-up|2|||
25216822|NCT02246920|50494965|FG001|Overall Study|Lost to Follow-up|1|||
25216823|NCT02246920|50494966|FG002|Overall Study|Lost to Follow-up|0|||
25216824|NCT02246920|50494964|FG000|Overall Study|Protocol Violation|2|||
25216825|NCT02246920|50494965|FG001|Overall Study|Protocol Violation|5|||
25216826|NCT02246920|50494966|FG002|Overall Study|Protocol Violation|1|||
25216827|NCT02246920|50494964|FG000|Overall Study|Withdrawal by Subject|0|||
25216828|NCT02246920|50494965|FG001|Overall Study|Withdrawal by Subject|0|||
25216829|NCT02246920|50494966|FG002|Overall Study|Withdrawal by Subject|1|||
25216830|NCT01832402|50494976|FG000|Overall Study|Lost to Follow-up|2|||
25216831|NCT01832402|50494977|FG001|Overall Study|Lost to Follow-up|0|||
25216832|NCT01832402|50494976|FG000|Overall Study|Withdrawal by Subject|3|||
25216833|NCT01832402|50494977|FG001|Overall Study|Withdrawal by Subject|3|||
25216834|NCT01832402|50494976|FG000|Overall Study|Declining Performance status|2|||
25216835|NCT01832402|50494977|FG001|Overall Study|Declining Performance status|1|||
25216836|NCT01661881|50494987|FG000|Overall Study|Disease Progression|1|||
25216837|NCT00667628|50494997|FG000|Overall Study|Lost to Follow-up|1|||
25216838|NCT00667628|50494998|FG001|Overall Study|Lost to Follow-up|0|||
25216839|NCT00667628|50494997|FG000|Overall Study|Death|6|||
25216840|NCT00667628|50494998|FG001|Overall Study|Death|6|||
25216841|NCT00667628|50494997|FG000|Overall Study|Investigator Considers in Best Interest|1|||
25216842|NCT00667628|50494998|FG001|Overall Study|Investigator Considers in Best Interest|0|||
25216843|NCT00667628|50494997|FG000|Overall Study|Sponsor Terminated Study|17|||
25216844|NCT00667628|50494998|FG001|Overall Study|Sponsor Terminated Study|21|||
25216845|NCT00321555|50495004|FG000|Overall Study|Developed antibodies|1|||
25216846|NCT00321555|50495004|FG000|Overall Study|Switched to alternative treatment|3|||
25216847|NCT00321555|50495004|FG000|Overall Study|Physician Decision|1|||
25216848|NCT00321555|50495004|FG000|Overall Study|Disease progression on study|1|||
25216849|NCT01597908|50495014|FG000|Randomized Phase|Death|217|||
25216850|NCT01597908|50495015|FG001|Randomized Phase|Death|238|||
25216851|NCT01597908|50495016|FG002|Randomized Phase|Death|0|||
25216852|NCT01597908|50495014|FG000|Randomized Phase|Sponsor Decision|93|||
25216853|NCT01597908|50495015|FG001|Randomized Phase|Sponsor Decision|39|||
25216854|NCT01597908|50495016|FG002|Randomized Phase|Sponsor Decision|0|||
25216855|NCT01597908|50495014|FG000|Randomized Phase|Lost to Follow-up|9|||
25216856|NCT01597908|50495015|FG001|Randomized Phase|Lost to Follow-up|16|||
25216857|NCT01597908|50495016|FG002|Randomized Phase|Lost to Follow-up|0|||
25216858|NCT01597908|50495014|FG000|Randomized Phase|Physician Decision|6|||
25216859|NCT01597908|50495015|FG001|Randomized Phase|Physician Decision|3|||
25216860|NCT01597908|50495016|FG002|Randomized Phase|Physician Decision|0|||
25216861|NCT01597908|50495014|FG000|Randomized Phase|Withdrawal by Subject|26|||
25216862|NCT01597908|50495015|FG001|Randomized Phase|Withdrawal by Subject|22|||
25216863|NCT01597908|50495016|FG002|Randomized Phase|Withdrawal by Subject|0|||
25216864|NCT01597908|50495014|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
25216865|NCT01597908|50495015|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
25216866|NCT01597908|50495016|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
25317038|NCT00966875|50632493|FG002|Part A|Protocol Violation|0|||
25317039|NCT00966875|50632494|FG003|Part A|Protocol Violation|0|||
25216867|NCT01597908|50495014|FG000|Crossover Phase|Death|0|||
25216868|NCT01597908|50495015|FG001|Crossover Phase|Death|0|||
25216869|NCT01597908|50495016|FG002|Crossover Phase|Death|11|||
25216870|NCT01597908|50495014|FG000|Crossover Phase|Withdrawal by Subject|0|||
25216871|NCT01597908|50495015|FG001|Crossover Phase|Withdrawal by Subject|0|||
25216872|NCT01597908|50495016|FG002|Crossover Phase|Withdrawal by Subject|3|||
25317040|NCT00966875|50632495|FG004|Part A|Protocol Violation|0|||
25216873|NCT01597908|50495014|FG000|Crossover Phase|Sponsor Decision|0|||
25216874|NCT01597908|50495015|FG001|Crossover Phase|Sponsor Decision|0|||
25216875|NCT01597908|50495016|FG002|Crossover Phase|Sponsor Decision|20|||
25216876|NCT01951170|50495025|FG000|Overall Study|Investigator decision|1|||
25317041|NCT00966875|50632496|FG005|Part A|Protocol Violation|0|||
25216877|NCT01951092|50495029|FG000|Overall Study|Lost to Follow-up|10|||
25216878|NCT01951092|50495029|FG000|Overall Study|Incarceration|1|||
25216879|NCT01951092|50495029|FG000|Overall Study|Transfer of Care|1|||
25216880|NCT01949532|50495035|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
25216881|NCT01949532|50495036|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
25216882|NCT01949142|50495044|FG000|Overall Study|Withdrawal of consent|1|||
25216883|NCT01949142|50495045|FG001|Overall Study|Withdrawal of consent|0|||
25216884|NCT01949142|50495044|FG000|Overall Study|Lost to Follow-up|1|||
25216885|NCT01949142|50495045|FG001|Overall Study|Lost to Follow-up|1|||
25216886|NCT01949142|50495044|FG000|Overall Study|Parent changed their mind|1|||
25216887|NCT01949142|50495045|FG001|Overall Study|Parent changed their mind|0|||
25216888|NCT01948908|50495055|FG000|Overall Study|Protocol Violation|1|||
25216889|NCT01948908|50495056|FG001|Overall Study|Protocol Violation|0|||
25216890|NCT01948908|50495057|FG002|Overall Study|Protocol Violation|2|||
25216891|NCT01925274|50495068|FG000|Overall Study|Death|1|||
25216892|NCT01925274|50495069|FG001|Overall Study|Death|0|||
25216893|NCT01925274|50495070|FG002|Overall Study|Death|0|||
25216894|NCT01925274|50495068|FG000|Overall Study|Lost to Follow-up|0|||
25216895|NCT01925274|50495069|FG001|Overall Study|Lost to Follow-up|1|||
25216896|NCT01925274|50495070|FG002|Overall Study|Lost to Follow-up|0|||
25216897|NCT01925274|50495068|FG000|Overall Study|Withdrawal by Subject|1|||
25216898|NCT01925274|50495069|FG001|Overall Study|Withdrawal by Subject|2|||
25216899|NCT01925274|50495070|FG002|Overall Study|Withdrawal by Subject|0|||
25216900|NCT01925274|50495068|FG000|Overall Study|Study terminated by sponsor|4|||
25216901|NCT01925274|50495069|FG001|Overall Study|Study terminated by sponsor|0|||
25216902|NCT01925274|50495070|FG002|Overall Study|Study terminated by sponsor|0|||
25216903|NCT01925274|50495068|FG000|Overall Study|Protocol amendment|1|||
25216904|NCT01925274|50495069|FG001|Overall Study|Protocol amendment|3|||
25216905|NCT01925274|50495070|FG002|Overall Study|Protocol amendment|6|||
25216906|NCT01948830|50495082|FG000|Overall Study|Physician Decision|1|||
25216907|NCT01948830|50495083|FG001|Overall Study|Physician Decision|3|||
25216908|NCT01948830|50495082|FG000|Overall Study|Protocol deviation|1|||
25216909|NCT01948830|50495083|FG001|Overall Study|Protocol deviation|2|||
25216910|NCT01948830|50495082|FG000|Overall Study|Lost to Follow-up|5|||
25216911|NCT01948830|50495083|FG001|Overall Study|Lost to Follow-up|4|||
25216912|NCT01948830|50495082|FG000|Overall Study|Withdrawal by Subject|14|||
25216913|NCT01948830|50495083|FG001|Overall Study|Withdrawal by Subject|17|||
25216914|NCT01948830|50495082|FG000|Overall Study|Adverse Event|9|||
25216915|NCT01948830|50495083|FG001|Overall Study|Adverse Event|2|||
25216916|NCT01948830|50495082|FG000|Overall Study|Death|3|||
25216917|NCT01948830|50495083|FG001|Overall Study|Death|4|||
25216918|NCT01972464|50495091|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
25216919|NCT01972464|50495092|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
25216920|NCT01972464|50495091|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
25216921|NCT01972464|50495092|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
25216922|NCT01972464|50495091|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
25216923|NCT01972464|50495092|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
25216924|NCT01972464|50495091|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
25216925|NCT01972464|50495092|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
25216926|NCT01948050|50495101|FG000|Overall Study|Withdrawal by Subject|0|||
25216927|NCT01948050|50495102|FG001|Overall Study|Withdrawal by Subject|1|||
25216928|NCT01947894|50495111|FG000|Overall Study|Other|3|||
25216929|NCT01947894|50495112|FG001|Overall Study|Other|4|||
25216930|NCT01947894|50495113|FG002|Overall Study|Other|3|||
25216931|NCT01947894|50495111|FG000|Overall Study|Withdrawal by Subject|12|||
25216932|NCT01947894|50495112|FG001|Overall Study|Withdrawal by Subject|4|||
25216933|NCT01947894|50495113|FG002|Overall Study|Withdrawal by Subject|1|||
25216934|NCT01947894|50495111|FG000|Overall Study|Death|12|||
25216935|NCT01947894|50495112|FG001|Overall Study|Death|1|||
25216936|NCT01947894|50495113|FG002|Overall Study|Death|0|||
25216937|NCT01947894|50495111|FG000|Overall Study|Physician Decision|2|||
25216938|NCT01947894|50495112|FG001|Overall Study|Physician Decision|0|||
25216939|NCT01947894|50495113|FG002|Overall Study|Physician Decision|0|||
25216940|NCT01947894|50495111|FG000|Overall Study|Adverse Event|5|||
25216941|NCT01947894|50495112|FG001|Overall Study|Adverse Event|1|||
25216942|NCT01947894|50495113|FG002|Overall Study|Adverse Event|0|||
25216943|NCT01947894|50495111|FG000|Overall Study|Switched to other growth hormone brand|53|||
25216944|NCT01947894|50495112|FG001|Overall Study|Switched to other growth hormone brand|8|||
25216945|NCT01947894|50495113|FG002|Overall Study|Switched to other growth hormone brand|23|||
25216946|NCT01947582|50495121|FG000|Overall Study|Withdrawal by Subject|1|||
25216947|NCT01924806|50495127|FG000|Overall Study|Physician Decision|2|||
25216948|NCT01924806|50495128|FG001|Overall Study|Physician Decision|1|||
25216949|NCT01924182|50495136|FG000|Overall Study|Withdrawal by Subject|1|||
25216950|NCT01924182|50495137|FG001|Overall Study|Withdrawal by Subject|0|||
25216951|NCT01972308|50495145|FG000|Overall Study|Withdrawal by Subject|0|||
25216952|NCT01972308|50495146|FG001|Overall Study|Withdrawal by Subject|1|||
25216953|NCT01972308|50495145|FG000|Overall Study|Lost to Follow-up|4|||
25216954|NCT01972308|50495146|FG001|Overall Study|Lost to Follow-up|6|||
25216955|NCT01972308|50495145|FG000|Overall Study|Death|4|||
25216956|NCT01972308|50495146|FG001|Overall Study|Death|1|||
25216957|NCT01946880|50495156|FG000|Overall Study|Lost to Follow-up|1|||
25216958|NCT01946880|50495157|FG001|Overall Study|Lost to Follow-up|0|||
25216959|NCT01946880|50495156|FG000|Overall Study|Physician Decision|1|||
25216960|NCT01946880|50495157|FG001|Overall Study|Physician Decision|1|||
25216961|NCT01946880|50495156|FG000|Overall Study|Withdrawal by Subject|3|||
25216962|NCT01946880|50495157|FG001|Overall Study|Withdrawal by Subject|2|||
25216963|NCT01946880|50495156|FG000|Overall Study|Met Primary Endpoint|1|||
25216964|NCT01946880|50495157|FG001|Overall Study|Met Primary Endpoint|0|||
25216965|NCT01946880|50495156|FG000|Overall Study|Personal and Family Issues|1|||
25216966|NCT01946880|50495157|FG001|Overall Study|Personal and Family Issues|0|||
25216967|NCT01972152|50495163|FG000|First Treatment Visit|Lost to Follow-up|0|||
25216968|NCT01972152|50495164|FG001|First Treatment Visit|Lost to Follow-up|1|||
25216969|NCT01972152|50495165|FG002|First Treatment Visit|Lost to Follow-up|0|||
25216970|NCT01972152|50495166|FG003|First Treatment Visit|Lost to Follow-up|0|||
25216971|NCT01972152|50495167|FG004|First Treatment Visit|Lost to Follow-up|0|||
25216972|NCT01972152|50495168|FG005|First Treatment Visit|Lost to Follow-up|0|||
25216973|NCT01972152|50495163|FG000|Second Treatment Visit|Protocol Violation|0|||
25216974|NCT01972152|50495164|FG001|Second Treatment Visit|Protocol Violation|1|||
25216975|NCT01972152|50495165|FG002|Second Treatment Visit|Protocol Violation|0|||
25216976|NCT01972152|50495166|FG003|Second Treatment Visit|Protocol Violation|0|||
25216977|NCT01972152|50495167|FG004|Second Treatment Visit|Protocol Violation|0|||
25216978|NCT01972152|50495168|FG005|Second Treatment Visit|Protocol Violation|0|||
25216979|NCT01972074|50495182|FG000|Overall Study|Adverse Event|4|||
25216980|NCT01972074|50495183|FG001|Overall Study|Adverse Event|1|||
25216981|NCT01972074|50495184|FG002|Overall Study|Adverse Event|0|||
25216982|NCT01972074|50495182|FG000|Overall Study|Lack of Efficacy|1|||
25216983|NCT01972074|50495183|FG001|Overall Study|Lack of Efficacy|1|||
25216984|NCT01972074|50495184|FG002|Overall Study|Lack of Efficacy|0|||
25216985|NCT01972074|50495182|FG000|Overall Study|Lost to Follow-up|0|||
25216986|NCT01972074|50495183|FG001|Overall Study|Lost to Follow-up|1|||
25216987|NCT01972074|50495184|FG002|Overall Study|Lost to Follow-up|1|||
25216988|NCT01972074|50495182|FG000|Overall Study|Withdrawal by Subject|1|||
25216989|NCT01972074|50495183|FG001|Overall Study|Withdrawal by Subject|1|||
25216990|NCT01972074|50495184|FG002|Overall Study|Withdrawal by Subject|1|||
25216991|NCT01972074|50495182|FG000|Overall Study|Scanner Unavailable|0|||
25216992|NCT01972074|50495183|FG001|Overall Study|Scanner Unavailable|0|||
25216993|NCT01972074|50495184|FG002|Overall Study|Scanner Unavailable|1|||
25216994|NCT01970982|50495194|FG000|Overall Study|Withdrawal by Subject|0|||
25216995|NCT01970982|50495195|FG001|Overall Study|Withdrawal by Subject|0|||
25216996|NCT01970982|50495196|FG002|Overall Study|Withdrawal by Subject|2|||
25216997|NCT01946802|50495205|FG000|Overall Study|Death|1|||
25216998|NCT01946802|50495205|FG000|Overall Study|Withdrawal by Subject|2|||
25216999|NCT01946802|50495205|FG000|Overall Study|Combined septic shock|1|||
25217000|NCT01946802|50495205|FG000|Overall Study|Protocol Violation|1|||
25217001|NCT01618266|50495209|FG000|Overall Study|Lost to Follow-up|9|||
25217002|NCT01618266|50495209|FG000|Overall Study|Treatment satisfaction|10|||
25217003|NCT01618266|50495209|FG000|Overall Study|Other reasons|11|||
25217004|NCT01618266|50495209|FG000|Overall Study|Lack of Efficacy|23|||
25217005|NCT01618266|50495209|FG000|Overall Study|Protocol Violation|43|||
25217006|NCT01919112|50495216|FG000|Secondary Analysis-day 30|Death|1|||
25217007|NCT01919112|50495217|FG001|Secondary Analysis-day 30|Death|1|||
25217008|NCT01919112|50495218|FG002|Secondary Analysis-day 30|Death|1|||
25217009|NCT01919112|50495216|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
25217010|NCT01919112|50495217|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
25217011|NCT01919112|50495218|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
25217012|NCT01918332|50495230|FG000|Overall Study|Adverse Event|0|||
25217013|NCT01918332|50495231|FG001|Overall Study|Adverse Event|0|||
25217014|NCT01918332|50495232|FG002|Overall Study|Adverse Event|0|||
25317042|NCT00966875|50632497|FG006|Part A|Protocol Violation|2|||
25317043|NCT00966875|50632498|FG007|Part A|Protocol Violation|1|||
25217015|NCT01918332|50495233|FG003|Overall Study|Adverse Event|1|||
25217016|NCT01918332|50495230|FG000|Overall Study|Withdrawal by Subject|2|||
25217017|NCT01918332|50495231|FG001|Overall Study|Withdrawal by Subject|3|||
25217018|NCT01918332|50495232|FG002|Overall Study|Withdrawal by Subject|2|||
25217019|NCT01918332|50495233|FG003|Overall Study|Withdrawal by Subject|3|||
25217020|NCT01918332|50495230|FG000|Overall Study|Protocol Violation|6|||
25217021|NCT01918332|50495231|FG001|Overall Study|Protocol Violation|2|||
25217022|NCT01918332|50495232|FG002|Overall Study|Protocol Violation|6|||
25217023|NCT01918332|50495233|FG003|Overall Study|Protocol Violation|3|||
25217024|NCT01918332|50495230|FG000|Overall Study|lipid result by central lab did not meet|0|||
25217025|NCT01918332|50495231|FG001|Overall Study|lipid result by central lab did not meet|0|||
25217026|NCT01918332|50495232|FG002|Overall Study|lipid result by central lab did not meet|1|||
25217027|NCT01918332|50495233|FG003|Overall Study|lipid result by central lab did not meet|0|||
25317044|NCT00966875|50632499|FG008|Part A|Protocol Violation|1|||
25317045|NCT00966875|50632491|FG000|Part B|Adverse Event|0|||
25217028|NCT01922934|50495245|FG000|Eligible Patients|Death|0|||
25217029|NCT01922934|50495246|FG001|Eligible Patients|Death|7|||
25217030|NCT01922934|50495245|FG000|Eligible Patients|Physician Decision|17|||
25217031|NCT01922934|50495246|FG001|Eligible Patients|Physician Decision|0|||
25217032|NCT01922934|50495245|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
25217033|NCT01922934|50495246|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
25217034|NCT01922934|50495245|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
25217035|NCT01922934|50495246|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
25217036|NCT01922934|50495245|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
25217037|NCT01922934|50495246|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
25217038|NCT01922934|50495245|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
25217039|NCT01922934|50495246|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
25217040|NCT01970592|50495254|FG000|Overall Study|Withdrawal by Subject|4|||
25217041|NCT01970592|50495254|FG000|Overall Study|Physician Decision|1|||
25217042|NCT01970592|50495254|FG000|Overall Study|Adverse Event|1|||
25217043|NCT01920594|50495260|FG000|Overall Study|Adverse Event|4|||
25217044|NCT01920594|50495261|FG001|Overall Study|Adverse Event|2|||
25217045|NCT01920594|50495260|FG000|Overall Study|Lost to Follow-up|1|||
25217046|NCT01920594|50495261|FG001|Overall Study|Lost to Follow-up|0|||
25217047|NCT01920594|50495260|FG000|Overall Study|Recovery|2|||
25217048|NCT01920594|50495261|FG001|Overall Study|Recovery|0|||
25217049|NCT01920594|50495260|FG000|Overall Study|Investigator discretion|0|||
25217050|NCT01920594|50495261|FG001|Overall Study|Investigator discretion|1|||
25217051|NCT01917084|50495267|FG000|Overall Study|Withdrawal by Subject|1|||
25217052|NCT01917006|50495278|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
25217053|NCT01917006|50495279|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
25217054|NCT01917006|50495280|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
25217055|NCT01917006|50495281|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
25217056|NCT01917006|50495282|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
25217057|NCT01917006|50495283|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
25217058|NCT01917006|50495284|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
25217059|NCT01917006|50495285|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
25217060|NCT01917006|50495278|FG000|Randomized-treatment Period|Personal Reasons|0|||
25217061|NCT01917006|50495279|FG001|Randomized-treatment Period|Personal Reasons|0|||
25217062|NCT01917006|50495280|FG002|Randomized-treatment Period|Personal Reasons|0|||
25217063|NCT01917006|50495281|FG003|Randomized-treatment Period|Personal Reasons|0|||
25217064|NCT01917006|50495282|FG004|Randomized-treatment Period|Personal Reasons|0|||
25217065|NCT01917006|50495283|FG005|Randomized-treatment Period|Personal Reasons|1|||
25217066|NCT01917006|50495284|FG006|Randomized-treatment Period|Personal Reasons|0|||
25217067|NCT01917006|50495285|FG007|Randomized-treatment Period|Personal Reasons|0|||
25217068|NCT01917006|50495278|FG000|Randomized-treatment Period|Protocol Violation|1|||
25217069|NCT01917006|50495279|FG001|Randomized-treatment Period|Protocol Violation|0|||
25217070|NCT01917006|50495280|FG002|Randomized-treatment Period|Protocol Violation|0|||
25217071|NCT01917006|50495281|FG003|Randomized-treatment Period|Protocol Violation|0|||
25217072|NCT01917006|50495282|FG004|Randomized-treatment Period|Protocol Violation|0|||
25217073|NCT01917006|50495283|FG005|Randomized-treatment Period|Protocol Violation|0|||
25217074|NCT01917006|50495284|FG006|Randomized-treatment Period|Protocol Violation|0|||
25217075|NCT01917006|50495285|FG007|Randomized-treatment Period|Protocol Violation|0|||
25217076|NCT01917006|50495278|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
25217077|NCT01917006|50495279|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
25217078|NCT01917006|50495280|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
25217079|NCT01917006|50495281|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
25217080|NCT01917006|50495282|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
25217081|NCT01917006|50495283|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
25217082|NCT01917006|50495284|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
25217083|NCT01917006|50495285|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
25217084|NCT01917006|50495278|FG000|Open-label Period|Adverse Event|0|||
25217085|NCT01917006|50495279|FG001|Open-label Period|Adverse Event|0|||
25217086|NCT01917006|50495280|FG002|Open-label Period|Adverse Event|0|||
25217087|NCT01917006|50495281|FG003|Open-label Period|Adverse Event|0|||
25217088|NCT01917006|50495282|FG004|Open-label Period|Adverse Event|0|||
25217089|NCT01917006|50495283|FG005|Open-label Period|Adverse Event|0|||
25217090|NCT01917006|50495284|FG006|Open-label Period|Adverse Event|0|||
25217091|NCT01917006|50495285|FG007|Open-label Period|Adverse Event|1|||
25217092|NCT01917006|50495278|FG000|Open-label Period|Lost to Follow-up|0|||
25217093|NCT01917006|50495279|FG001|Open-label Period|Lost to Follow-up|0|||
25217094|NCT01917006|50495280|FG002|Open-label Period|Lost to Follow-up|0|||
25217095|NCT01917006|50495281|FG003|Open-label Period|Lost to Follow-up|0|||
25217096|NCT01917006|50495282|FG004|Open-label Period|Lost to Follow-up|0|||
25217097|NCT01917006|50495283|FG005|Open-label Period|Lost to Follow-up|0|||
25217098|NCT01917006|50495284|FG006|Open-label Period|Lost to Follow-up|0|||
25217099|NCT01917006|50495285|FG007|Open-label Period|Lost to Follow-up|1|||
25217100|NCT01916304|50495302|FG000|Overall Study|Screening failure|17|||
25217101|NCT01916226|50495310|FG000|Overall Study|Adverse Event|1|||
25217102|NCT01916226|50495311|FG001|Overall Study|Adverse Event|0|||
25217103|NCT01916226|50495312|FG002|Overall Study|Adverse Event|1|||
25217104|NCT01916226|50495313|FG003|Overall Study|Adverse Event|1|||
25217105|NCT01916226|50495310|FG000|Overall Study|Lack of Efficacy|0|||
25217106|NCT01916226|50495311|FG001|Overall Study|Lack of Efficacy|0|||
25217107|NCT01916226|50495312|FG002|Overall Study|Lack of Efficacy|2|||
25217108|NCT01916226|50495313|FG003|Overall Study|Lack of Efficacy|1|||
25217109|NCT01916226|50495310|FG000|Overall Study|Protocol Violation|0|||
25217110|NCT01916226|50495311|FG001|Overall Study|Protocol Violation|1|||
25217111|NCT01916226|50495312|FG002|Overall Study|Protocol Violation|0|||
25217112|NCT01916226|50495313|FG003|Overall Study|Protocol Violation|1|||
25217113|NCT01916226|50495310|FG000|Overall Study|Physician Decision|0|||
25217114|NCT01916226|50495311|FG001|Overall Study|Physician Decision|0|||
25217115|NCT01916226|50495312|FG002|Overall Study|Physician Decision|0|||
25217116|NCT01916226|50495313|FG003|Overall Study|Physician Decision|1|||
25217117|NCT01969500|50495326|FG000|Overall Study|Death|0|||
25217118|NCT01969500|50495327|FG001|Overall Study|Death|1|||
25217119|NCT01969500|50495326|FG000|Overall Study|extended hospitalization|1|||
25217120|NCT01969500|50495327|FG001|Overall Study|extended hospitalization|1|||
25217121|NCT01915914|50495333|FG000|Acute Phase|Withdrawal by Subject|4|||
25217122|NCT01915914|50495334|FG001|Acute Phase|Withdrawal by Subject|0|||
25217123|NCT01915914|50495335|FG002|Acute Phase|Withdrawal by Subject|0|||
25217124|NCT01915914|50495336|FG003|Acute Phase|Withdrawal by Subject|0|||
25217125|NCT01915914|50495333|FG000|Acute Phase|Lost to Follow-up|4|||
25217126|NCT01915914|50495334|FG001|Acute Phase|Lost to Follow-up|0|||
25217127|NCT01915914|50495335|FG002|Acute Phase|Lost to Follow-up|0|||
25217128|NCT01915914|50495336|FG003|Acute Phase|Lost to Follow-up|0|||
25217129|NCT01915914|50495333|FG000|Acute Phase|Physician Decision|1|||
25217130|NCT01915914|50495334|FG001|Acute Phase|Physician Decision|0|||
25217131|NCT01915914|50495335|FG002|Acute Phase|Physician Decision|0|||
25217132|NCT01915914|50495336|FG003|Acute Phase|Physician Decision|0|||
25217133|NCT01915914|50495333|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
25217134|NCT01915914|50495334|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
25217135|NCT01915914|50495335|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
25217136|NCT01915914|50495336|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
25217137|NCT01915914|50495333|FG000|Acute Phase|"Not Achieved treatment success"|1|||
25217138|NCT01915914|50495334|FG001|Acute Phase|"Not Achieved treatment success"|0|||
25217139|NCT01915914|50495335|FG002|Acute Phase|"Not Achieved treatment success"|0|||
25217140|NCT01915914|50495336|FG003|Acute Phase|"Not Achieved treatment success"|0|||
25217141|NCT01915914|50495333|FG000|Acute Phase|Missing|1|||
25217142|NCT01915914|50495334|FG001|Acute Phase|Missing|0|||
25217143|NCT01915914|50495335|FG002|Acute Phase|Missing|0|||
25217144|NCT01915914|50495336|FG003|Acute Phase|Missing|0|||
25217145|NCT01915914|50495333|FG000|Maintenance Phase|Withdrawal by Subject|0|||
25217146|NCT01915914|50495334|FG001|Maintenance Phase|Withdrawal by Subject|1|||
25217147|NCT01915914|50495335|FG002|Maintenance Phase|Withdrawal by Subject|1|||
25217148|NCT01915914|50495336|FG003|Maintenance Phase|Withdrawal by Subject|0|||
25217149|NCT01915914|50495333|FG000|Maintenance Phase|Lost to Follow-up|0|||
25217150|NCT01915914|50495334|FG001|Maintenance Phase|Lost to Follow-up|4|||
25217151|NCT01915914|50495335|FG002|Maintenance Phase|Lost to Follow-up|1|||
25217152|NCT01915914|50495336|FG003|Maintenance Phase|Lost to Follow-up|0|||
25217153|NCT01915914|50495333|FG000|Maintenance Phase|Missing|0|||
25217154|NCT01915914|50495334|FG001|Maintenance Phase|Missing|1|||
25217155|NCT01915914|50495335|FG002|Maintenance Phase|Missing|0|||
25217156|NCT01915914|50495336|FG003|Maintenance Phase|Missing|0|||
25217157|NCT01915914|50495333|FG000|Follow-up Phase|Withdrawal by Subject|0|||
25217158|NCT01915914|50495334|FG001|Follow-up Phase|Withdrawal by Subject|0|||
25217159|NCT01915914|50495335|FG002|Follow-up Phase|Withdrawal by Subject|0|||
25217160|NCT01915914|50495336|FG003|Follow-up Phase|Withdrawal by Subject|1|||
25217161|NCT01915914|50495333|FG000|Follow-up Phase|Physician Decision|0|||
25217162|NCT01915914|50495334|FG001|Follow-up Phase|Physician Decision|0|||
25077403|NCT02936323|50185220|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
25077404|NCT02936323|50185221|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
25217163|NCT01915914|50495335|FG002|Follow-up Phase|Physician Decision|0|||
25217164|NCT01915914|50495336|FG003|Follow-up Phase|Physician Decision|1|||
25217165|NCT01919970|50495356|FG000|Overall Study|Withdrawal by Subject|3|||
25217166|NCT01919970|50495357|FG001|Overall Study|Withdrawal by Subject|0|||
25217167|NCT01919814|50495363|FG000|Overall Study|Adverse Event|1|||
25217168|NCT01919814|50495364|FG001|Overall Study|Adverse Event|0|||
25217169|NCT01919814|50495363|FG000|Overall Study|Protocol Violation|1|||
25217170|NCT01919814|50495364|FG001|Overall Study|Protocol Violation|0|||
25217171|NCT01919814|50495363|FG000|Overall Study|Withdrawal by Subject|1|||
25217172|NCT01919814|50495364|FG001|Overall Study|Withdrawal by Subject|0|||
25217173|NCT01968954|50495372|FG000|Overall Study|Adverse Event|6|||
25217174|NCT01968954|50495373|FG001|Overall Study|Adverse Event|3|||
25217175|NCT01968954|50495372|FG000|Overall Study|Death|1|||
25217176|NCT01968954|50495373|FG001|Overall Study|Death|2|||
25217177|NCT01968954|50495372|FG000|Overall Study|Lost to Follow-up|6|||
25217178|NCT01968954|50495373|FG001|Overall Study|Lost to Follow-up|4|||
25217179|NCT01968954|50495372|FG000|Overall Study|Withdrawal by Subject|20|||
25217180|NCT01968954|50495373|FG001|Overall Study|Withdrawal by Subject|23|||
25217181|NCT01968954|50495372|FG000|Overall Study|Other|7|||
25217182|NCT01968954|50495373|FG001|Overall Study|Other|8|||
25217183|NCT01968954|50495372|FG000|Overall Study|Protocol Violation|0|||
25217184|NCT01968954|50495373|FG001|Overall Study|Protocol Violation|1|||
25217185|NCT01968954|50495372|FG000|Overall Study|Did not met inclusion criteria|0|||
25217186|NCT01968954|50495373|FG001|Overall Study|Did not met inclusion criteria|2|||
25217187|NCT01919190|50495382|FG000|Overall Study|Intra-op findings, etc.|3|||
25217188|NCT01919190|50495383|FG001|Overall Study|Intra-op findings, etc.|0|||
25217189|NCT01620060|50495390|FG000|Overall Study|Adverse Event|9|||
25217190|NCT01620060|50495390|FG000|Overall Study|Protocol Violation|1|||
25217191|NCT01620060|50495390|FG000|Overall Study|Withdrawal by Subject|1|||
25217192|NCT01620060|50495390|FG000|Overall Study|Did not comply with Study Produre|1|||
25217193|NCT01620060|50495390|FG000|Overall Study|Family emergency|1|||
25217194|NCT01620060|50495390|FG000|Overall Study|Per Sponsor Decision|2|||
25217195|NCT01914666|50495397|FG000|Treatment Period|Lack of Efficacy|0|||
25217196|NCT01914666|50495398|FG001|Treatment Period|Lack of Efficacy|0|||
25217197|NCT01914666|50495399|FG002|Treatment Period|Lack of Efficacy|2|||
25217198|NCT01914666|50495397|FG000|Treatment Period|Adverse Event|10|||
25217199|NCT01914666|50495398|FG001|Treatment Period|Adverse Event|4|||
25317046|NCT00966875|50632492|FG001|Part B|Adverse Event|1|||
24976470|NCT00060944|50065360|FG001|Overall Study|randomized but not treated|4|||
24976471|NCT03462082|50065366|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
24976472|NCT03462082|50065367|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
24976473|NCT03462082|50065368|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
25217200|NCT01914666|50495399|FG002|Treatment Period|Adverse Event|2|||
25217201|NCT01914666|50495397|FG000|Treatment Period|Withdrawal by Subject|3|||
25217202|NCT01914666|50495398|FG001|Treatment Period|Withdrawal by Subject|2|||
25217203|NCT01914666|50495399|FG002|Treatment Period|Withdrawal by Subject|2|||
25217204|NCT01914666|50495397|FG000|Treatment Period|Physician Decision|0|||
25217205|NCT01914666|50495398|FG001|Treatment Period|Physician Decision|0|||
25217206|NCT01914666|50495399|FG002|Treatment Period|Physician Decision|2|||
25217207|NCT01913340|50495407|FG000|Overall Study|Death|2|||
25217208|NCT01913340|50495408|FG001|Overall Study|Death|5|||
25217209|NCT01913340|50495407|FG000|Overall Study|Lost to Follow-up|1|||
25217210|NCT01913340|50495408|FG001|Overall Study|Lost to Follow-up|1|||
25217211|NCT01864200|50495416|FG000|Overall Study|Lost to Follow-up|1|||
25217212|NCT01864200|50495417|FG001|Overall Study|Lost to Follow-up|3|||
25217213|NCT01864200|50495416|FG000|Overall Study|Protocol Violation|1|||
25217214|NCT01864200|50495417|FG001|Overall Study|Protocol Violation|0|||
25217215|NCT01912872|50495427|FG000|Overall Study|Lost to Follow-up|2|||
25217216|NCT01912872|50495428|FG001|Overall Study|Lost to Follow-up|3|||
25217217|NCT01912872|50495429|FG002|Overall Study|Lost to Follow-up|5|||
25217218|NCT01912872|50495430|FG003|Overall Study|Lost to Follow-up|5|||
25217219|NCT01912872|50495427|FG000|Overall Study|Other unspecified|3|||
25217220|NCT01912872|50495428|FG001|Overall Study|Other unspecified|1|||
25217221|NCT01912872|50495429|FG002|Overall Study|Other unspecified|3|||
25217222|NCT01912872|50495430|FG003|Overall Study|Other unspecified|0|||
25217223|NCT01912872|50495427|FG000|Overall Study|Informed consent withdrawn|0|||
25217224|NCT01912872|50495428|FG001|Overall Study|Informed consent withdrawn|0|||
25217225|NCT01912872|50495429|FG002|Overall Study|Informed consent withdrawn|1|||
25217226|NCT01912872|50495430|FG003|Overall Study|Informed consent withdrawn|1|||
25217227|NCT01912872|50495427|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
25217228|NCT01912872|50495428|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
25217229|NCT01912872|50495429|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
25217230|NCT01912872|50495430|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
25217231|NCT01912872|50495427|FG000|Overall Study|Protocol Violation|0|||
25217232|NCT01912872|50495428|FG001|Overall Study|Protocol Violation|0|||
25217233|NCT01912872|50495429|FG002|Overall Study|Protocol Violation|1|||
25217234|NCT01912872|50495430|FG003|Overall Study|Protocol Violation|0|||
25217235|NCT01912872|50495427|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25217236|NCT01912872|50495428|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
25217237|NCT01912872|50495429|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
25217238|NCT01912872|50495430|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
25217239|NCT01912872|50495427|FG000|Overall Study|Withdrawal of study medication|0|||
25217240|NCT01912872|50495428|FG001|Overall Study|Withdrawal of study medication|0|||
25217241|NCT01912872|50495429|FG002|Overall Study|Withdrawal of study medication|0|||
25217242|NCT01912872|50495430|FG003|Overall Study|Withdrawal of study medication|2|||
25317047|NCT00966875|50632493|FG002|Part B|Adverse Event|1|||
25317048|NCT00966875|50632494|FG003|Part B|Adverse Event|0|||
25217243|NCT01912872|50495427|FG000|Overall Study|Missing|0|||
25217244|NCT01912872|50495428|FG001|Overall Study|Missing|0|||
25217245|NCT01912872|50495429|FG002|Overall Study|Missing|0|||
25217246|NCT01912872|50495430|FG003|Overall Study|Missing|1|||
25217247|NCT01912404|50495443|FG000|Overall Study|Due to personal reasons|1|||
25217248|NCT01912404|50495444|FG001|Overall Study|Due to personal reasons|0|||
25217249|NCT01911780|50495452|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
25217250|NCT01911780|50495453|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
25217251|NCT01911780|50495452|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
25217252|NCT01911780|50495453|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
25217253|NCT01911780|50495452|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
25217254|NCT01911780|50495453|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
25217255|NCT01911780|50495452|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
25217256|NCT01911780|50495453|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
25217257|NCT01911780|50495452|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
25217258|NCT01911780|50495453|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
25217259|NCT01911780|50495452|FG000|Extension Period (52 Weeks)|Personal reason|1|||
25217260|NCT01911780|50495453|FG001|Extension Period (52 Weeks)|Personal reason|1|||
25217261|NCT01911546|50495463|FG000|Overall Study|Lost to Follow-up|1|||
25217262|NCT01911546|50495463|FG000|Overall Study|Everolimus was discontinued|5|||
25217263|NCT01910298|50495469|FG000|Overall Study|Adverse Event|1|||
25217264|NCT01910298|50495470|FG001|Overall Study|Adverse Event|0|||
25217265|NCT01910298|50495469|FG000|Overall Study|Withdrawal by Subject|2|||
25217266|NCT01910298|50495470|FG001|Overall Study|Withdrawal by Subject|7|||
25217267|NCT01910298|50495469|FG000|Overall Study|Protocol Deviation|0|||
25217268|NCT01910298|50495470|FG001|Overall Study|Protocol Deviation|5|||
25217269|NCT01910298|50495469|FG000|Overall Study|Lost to Follow-up|1|||
25217270|NCT01910298|50495470|FG001|Overall Study|Lost to Follow-up|1|||
25217271|NCT01910298|50495469|FG000|Overall Study|Study Terminated by Sponsor|1|||
25217272|NCT01910298|50495470|FG001|Overall Study|Study Terminated by Sponsor|17|||
25217273|NCT01910298|50495469|FG000|Overall Study|Other Miscellaneous Reasons|0|||
25217274|NCT01910298|50495470|FG001|Overall Study|Other Miscellaneous Reasons|2|||
25217275|NCT01909674|50495478|FG000|Overall Study|Withdrawal by Subject|5|||
25217276|NCT01909674|50495479|FG001|Overall Study|Withdrawal by Subject|2|||
25217277|NCT01908816|50495489|FG000|Overall Study|Subject's no longer requires study drug|0|||
25217278|NCT01908816|50495490|FG001|Overall Study|Subject's no longer requires study drug|0|||
25217279|NCT01908816|50495491|FG002|Overall Study|Subject's no longer requires study drug|0|||
25217280|NCT01908816|50495492|FG003|Overall Study|Subject's no longer requires study drug|1|||
25217281|NCT01908816|50495489|FG000|Overall Study|Protocol deviation|1|||
25217282|NCT01908816|50495490|FG001|Overall Study|Protocol deviation|2|||
25217283|NCT01908816|50495491|FG002|Overall Study|Protocol deviation|1|||
25217284|NCT01908816|50495492|FG003|Overall Study|Protocol deviation|1|||
25217285|NCT01908816|50495489|FG000|Overall Study|Withdrawal by Subject|0|||
25217286|NCT01908816|50495490|FG001|Overall Study|Withdrawal by Subject|4|||
25217287|NCT01908816|50495491|FG002|Overall Study|Withdrawal by Subject|2|||
25217288|NCT01908816|50495492|FG003|Overall Study|Withdrawal by Subject|2|||
25217289|NCT01908816|50495489|FG000|Overall Study|Lost to Follow-up|3|||
25217290|NCT01908816|50495490|FG001|Overall Study|Lost to Follow-up|5|||
25217291|NCT01908816|50495491|FG002|Overall Study|Lost to Follow-up|4|||
25217292|NCT01908816|50495492|FG003|Overall Study|Lost to Follow-up|2|||
25217293|NCT01908816|50495489|FG000|Overall Study|Death|1|||
25217294|NCT01908816|50495490|FG001|Overall Study|Death|0|||
25217295|NCT01908816|50495491|FG002|Overall Study|Death|7|||
25217296|NCT01908816|50495492|FG003|Overall Study|Death|1|||
25217297|NCT01908816|50495489|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25217298|NCT01908816|50495490|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
25217299|NCT01908816|50495491|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
25217300|NCT01908816|50495492|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
25217301|NCT01908816|50495489|FG000|Overall Study|Early termination|87|||
25217302|NCT01908816|50495490|FG001|Overall Study|Early termination|60|||
25217303|NCT01908816|50495491|FG002|Overall Study|Early termination|43|||
25217304|NCT01908816|50495492|FG003|Overall Study|Early termination|28|||
25217305|NCT01908582|50495505|FG000|Period 2|Physician Decision|1|||
25217306|NCT01908582|50495505|FG000|Period 2|Withdrawal by Subject|1|||
25217307|NCT01908426|50495514|FG000|Overall Study|Adverse Event|98|||
25217308|NCT01908426|50495515|FG001|Overall Study|Adverse Event|11|||
25217309|NCT01908426|50495514|FG000|Overall Study|Clinical Deterioration|72|||
25217310|NCT01908426|50495515|FG001|Overall Study|Clinical Deterioration|38|||
25217311|NCT01908426|50495514|FG000|Overall Study|Lack of Efficacy|3|||
25077405|NCT02936323|50185222|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
25217312|NCT01908426|50495515|FG001|Overall Study|Lack of Efficacy|0|||
25217313|NCT01908426|50495514|FG000|Overall Study|Lost to Follow-up|0|||
25217314|NCT01908426|50495515|FG001|Overall Study|Lost to Follow-up|1|||
25217315|NCT01908426|50495514|FG000|Overall Study|Physician Decision|3|||
25217316|NCT01908426|50495515|FG001|Overall Study|Physician Decision|3|||
25217317|NCT01908426|50495514|FG000|Overall Study|Withdrawal by Subject|11|||
25217318|NCT01908426|50495515|FG001|Overall Study|Withdrawal by Subject|6|||
25217319|NCT01908426|50495514|FG000|Overall Study|Progressive Disease|206|||
25217320|NCT01908426|50495515|FG001|Overall Study|Progressive Disease|152|||
25217321|NCT01908426|50495514|FG000|Overall Study|Protocol Violation|1|||
25217322|NCT01908426|50495515|FG001|Overall Study|Protocol Violation|0|||
25217323|NCT01908426|50495514|FG000|Overall Study|No Study Treatment Given|3|||
25217324|NCT01908426|50495515|FG001|Overall Study|No Study Treatment Given|0|||
25217325|NCT01907100|50495525|FG000|Overall Study|PD based on modified RECIST criteria|31|||
25217326|NCT01907100|50495526|FG001|Overall Study|PD based on modified RECIST criteria|32|||
25217327|NCT01907100|50495527|FG002|Overall Study|PD based on modified RECIST criteria|95|||
25217328|NCT01907100|50495528|FG003|Overall Study|PD based on modified RECIST criteria|92|||
25217329|NCT01907100|50495525|FG000|Overall Study|Withdrawal by Subject|2|||
25217330|NCT01907100|50495526|FG001|Overall Study|Withdrawal by Subject|5|||
25217331|NCT01907100|50495527|FG002|Overall Study|Withdrawal by Subject|10|||
25217332|NCT01907100|50495528|FG003|Overall Study|Withdrawal by Subject|13|||
25217333|NCT01907100|50495525|FG000|Overall Study|Protocol Violation|0|||
25217334|NCT01907100|50495526|FG001|Overall Study|Protocol Violation|0|||
25217335|NCT01907100|50495527|FG002|Overall Study|Protocol Violation|1|||
25217336|NCT01907100|50495528|FG003|Overall Study|Protocol Violation|1|||
25217337|NCT01907100|50495525|FG000|Overall Study|Lost to Follow-up|0|||
25217338|NCT01907100|50495526|FG001|Overall Study|Lost to Follow-up|0|||
25217339|NCT01907100|50495527|FG002|Overall Study|Lost to Follow-up|0|||
25217340|NCT01907100|50495528|FG003|Overall Study|Lost to Follow-up|1|||
25217341|NCT01907100|50495525|FG000|Overall Study|Not treated|2|||
25217342|NCT01907100|50495526|FG001|Overall Study|Not treated|0|||
25217343|NCT01907100|50495527|FG002|Overall Study|Not treated|1|||
25217344|NCT01907100|50495528|FG003|Overall Study|Not treated|2|||
25217345|NCT01907100|50495525|FG000|Overall Study|Other than reasons specified|1|||
25217346|NCT01907100|50495526|FG001|Overall Study|Other than reasons specified|0|||
25217347|NCT01907100|50495527|FG002|Overall Study|Other than reasons specified|10|||
25217348|NCT01907100|50495528|FG003|Overall Study|Other than reasons specified|6|||
25217349|NCT01907100|50495525|FG000|Overall Study|Adverse event (AE)|6|||
25217350|NCT01907100|50495526|FG001|Overall Study|Adverse event (AE)|3|||
25217351|NCT01907100|50495527|FG002|Overall Study|Adverse event (AE)|22|||
25217352|NCT01907100|50495528|FG003|Overall Study|Adverse event (AE)|23|||
25217353|NCT01907100|50495525|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
25217354|NCT01907100|50495526|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
25217355|NCT01907100|50495527|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
25217356|NCT01907100|50495528|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
25217357|NCT01889862|50495536|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
25217358|NCT01889862|50495537|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
25217359|NCT01889862|50495538|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
25217360|NCT01889862|50495539|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
25217361|NCT01889862|50495540|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
25217362|NCT01889862|50495536|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
25217363|NCT01889862|50495537|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
25217364|NCT01889862|50495538|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
25217365|NCT01889862|50495539|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
25217366|NCT01889862|50495540|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
25217367|NCT01889862|50495536|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
25217368|NCT01889862|50495537|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
25217369|NCT01889862|50495538|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
25217370|NCT01889862|50495539|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
25217371|NCT01889862|50495540|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
25217372|NCT01889862|50495536|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
25217373|NCT01889862|50495537|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
25217374|NCT01889862|50495538|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
25217375|NCT01889862|50495539|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
25217376|NCT01889862|50495540|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
25217377|NCT01889862|50495536|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
25217378|NCT01889862|50495537|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
25217379|NCT01889862|50495538|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
25217380|NCT01889862|50495539|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
25217381|NCT01889862|50495540|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
25217382|NCT01889862|50495536|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
25217383|NCT01889862|50495537|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
25217384|NCT01889862|50495538|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
25217385|NCT01889862|50495539|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
25217386|NCT01889862|50495540|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
25217387|NCT01889862|50495536|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
25217388|NCT01889862|50495537|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
25217389|NCT01889862|50495538|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
25217390|NCT01889862|50495539|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
25217391|NCT01889862|50495540|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
25217392|NCT01889862|50495536|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
25217393|NCT01889862|50495537|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
25217394|NCT01889862|50495538|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
25217395|NCT01889862|50495539|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
25217396|NCT01889862|50495540|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
25217397|NCT01889862|50495536|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
25217398|NCT01889862|50495537|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
25217399|NCT01889862|50495538|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
25217400|NCT01889862|50495539|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
25217401|NCT01889862|50495540|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
25217402|NCT01889862|50495536|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
25217403|NCT01889862|50495537|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
25217404|NCT01889862|50495538|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
25217405|NCT01889862|50495539|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
25217406|NCT01889862|50495540|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
25217407|NCT01887912|50495567|FG000|Overall Study|Serious adverse event|400|||
25217408|NCT01887912|50495568|FG001|Overall Study|Serious adverse event|198|||
25217409|NCT01887912|50495567|FG000|Overall Study|Other Adverse Event|34|||
25217410|NCT01887912|50495568|FG001|Overall Study|Other Adverse Event|15|||
25217411|NCT01887912|50495567|FG000|Overall Study|Protocol Violation|67|||
25217412|NCT01887912|50495568|FG001|Overall Study|Protocol Violation|37|||
25217413|NCT01887912|50495567|FG000|Overall Study|Lost to Follow-up|163|||
25217414|NCT01887912|50495568|FG001|Overall Study|Lost to Follow-up|74|||
25217415|NCT01887912|50495567|FG000|Overall Study|Withdrawal by Subject|606|||
25217416|NCT01887912|50495568|FG001|Overall Study|Withdrawal by Subject|349|||
25217417|NCT01887912|50495567|FG000|Overall Study|Other|122|||
25217418|NCT01887912|50495568|FG001|Overall Study|Other|58|||
25217419|NCT01887678|50495576|FG000|Overall Study|Adverse Event|4|||
25217420|NCT01887678|50495577|FG001|Overall Study|Adverse Event|6|||
25217421|NCT01887678|50495576|FG000|Overall Study|Exceeded rescue medication dosage|4|||
25217422|NCT01887678|50495577|FG001|Overall Study|Exceeded rescue medication dosage|5|||
25217423|NCT01887678|50495576|FG000|Overall Study|Withdrawal of consent|3|||
25217424|NCT01887678|50495577|FG001|Overall Study|Withdrawal of consent|4|||
25217425|NCT01887678|50495576|FG000|Overall Study|Lost to Follow-up|4|||
25217426|NCT01887678|50495577|FG001|Overall Study|Lost to Follow-up|2|||
25217427|NCT01887678|50495576|FG000|Overall Study|Deterioration of clinical condition|0|||
25217428|NCT01887678|50495577|FG001|Overall Study|Deterioration of clinical condition|4|||
25217429|NCT01887678|50495576|FG000|Overall Study|Lack of Efficacy|1|||
25217430|NCT01887678|50495577|FG001|Overall Study|Lack of Efficacy|2|||
25217431|NCT01887678|50495576|FG000|Overall Study|Non-compliance|0|||
25217432|NCT01887678|50495577|FG001|Overall Study|Non-compliance|3|||
25217433|NCT01887678|50495576|FG000|Overall Study|Specified|1|||
25217434|NCT01887678|50495577|FG001|Overall Study|Specified|2|||
25317049|NCT00966875|50632495|FG004|Part B|Adverse Event|1|||
25317050|NCT00966875|50632496|FG005|Part B|Adverse Event|0|||
25317051|NCT00966875|50632497|FG006|Part B|Adverse Event|5|||
25317052|NCT00966875|50632498|FG007|Part B|Adverse Event|2|||
25317053|NCT00966875|50632499|FG008|Part B|Adverse Event|2|||
25317054|NCT00966875|50632491|FG000|Part B|Death|0|||
25317055|NCT00966875|50632492|FG001|Part B|Death|0|||
25317056|NCT00966875|50632493|FG002|Part B|Death|1|||
25317057|NCT00966875|50632494|FG003|Part B|Death|0|||
25317058|NCT00966875|50632495|FG004|Part B|Death|0|||
25317059|NCT00966875|50632496|FG005|Part B|Death|0|||
25317060|NCT00966875|50632497|FG006|Part B|Death|0|||
25317061|NCT00966875|50632498|FG007|Part B|Death|1|||
25317062|NCT00966875|50632499|FG008|Part B|Death|0|||
25317063|NCT00966875|50632491|FG000|Part B|Lack of Efficacy|2|||
25317064|NCT00966875|50632492|FG001|Part B|Lack of Efficacy|1|||
25317065|NCT00966875|50632493|FG002|Part B|Lack of Efficacy|1|||
25317066|NCT00966875|50632494|FG003|Part B|Lack of Efficacy|1|||
25317067|NCT00966875|50632495|FG004|Part B|Lack of Efficacy|2|||
25317068|NCT00966875|50632496|FG005|Part B|Lack of Efficacy|3|||
25317069|NCT00966875|50632497|FG006|Part B|Lack of Efficacy|12|||
25317070|NCT00966875|50632498|FG007|Part B|Lack of Efficacy|9|||
25317071|NCT00966875|50632499|FG008|Part B|Lack of Efficacy|6|||
25317072|NCT00966875|50632491|FG000|Part B|Lost to Follow-up|0|||
25317073|NCT00966875|50632492|FG001|Part B|Lost to Follow-up|0|||
25217435|NCT01887600|50495585|FG000|Overall Study|Death|39|||
25217436|NCT01887600|50495586|FG001|Overall Study|Death|16|||
25217437|NCT01887600|50495585|FG000|Overall Study|Lack of Efficacy|3|||
25217438|NCT01887600|50495586|FG001|Overall Study|Lack of Efficacy|26|||
25217439|NCT01887600|50495585|FG000|Overall Study|Lost to Follow-up|5|||
25217440|NCT01887600|50495586|FG001|Overall Study|Lost to Follow-up|1|||
25317074|NCT00966875|50632493|FG002|Part B|Lost to Follow-up|0|||
25317075|NCT00966875|50632494|FG003|Part B|Lost to Follow-up|1|||
25317076|NCT00966875|50632495|FG004|Part B|Lost to Follow-up|0|||
25317077|NCT00966875|50632496|FG005|Part B|Lost to Follow-up|0|||
25317078|NCT00966875|50632497|FG006|Part B|Lost to Follow-up|0|||
25317079|NCT00966875|50632498|FG007|Part B|Lost to Follow-up|0|||
25317080|NCT00966875|50632499|FG008|Part B|Lost to Follow-up|1|||
25317081|NCT00966875|50632491|FG000|Part B|Physician Decision|0|||
25317082|NCT00966875|50632492|FG001|Part B|Physician Decision|0|||
25317083|NCT00966875|50632493|FG002|Part B|Physician Decision|1|||
25217441|NCT01887600|50495585|FG000|Overall Study|Physician Decision|7|||
25217442|NCT01887600|50495586|FG001|Overall Study|Physician Decision|8|||
25217443|NCT01887600|50495585|FG000|Overall Study|Protocol Deviation|3|||
25217444|NCT01887600|50495586|FG001|Overall Study|Protocol Deviation|0|||
25217445|NCT01887600|50495585|FG000|Overall Study|Withdrawal by Subject|58|||
25217446|NCT01887600|50495586|FG001|Overall Study|Withdrawal by Subject|52|||
25217447|NCT01887600|50495585|FG000|Overall Study|Adverse Event|21|||
25217448|NCT01887600|50495586|FG001|Overall Study|Adverse Event|9|||
25217449|NCT01887600|50495585|FG000|Overall Study|Non-compliance with study drug|3|||
25217450|NCT01887600|50495586|FG001|Overall Study|Non-compliance with study drug|0|||
25217451|NCT01887600|50495585|FG000|Overall Study|Miscellaneous|6|||
25217452|NCT01887600|50495586|FG001|Overall Study|Miscellaneous|2|||
25217453|NCT01887600|50495585|FG000|Overall Study|Progressive Disease|1|||
25217454|NCT01887600|50495586|FG001|Overall Study|Progressive Disease|0|||
25217455|NCT01887288|50495593|FG000|Overall Study|The study was terminated and the PI has|16|||
25217456|NCT01887210|50495599|FG000|Overall Study|Withdrawal by Subject|1|||
25217457|NCT01887210|50495600|FG001|Overall Study|Withdrawal by Subject|3|||
25217458|NCT01887210|50495599|FG000|Overall Study|Lost to Follow-up|0|||
25217459|NCT01887210|50495600|FG001|Overall Study|Lost to Follow-up|1|||
25217460|NCT01885182|50495631|FG000|Overall Study|Adverse Event|11|||
25217461|NCT01885182|50495632|FG001|Overall Study|Adverse Event|13|||
25217462|NCT01885182|50495631|FG000|Overall Study|Withdrawal by Subject|13|||
25217463|NCT01885182|50495632|FG001|Overall Study|Withdrawal by Subject|6|||
25217464|NCT01885182|50495631|FG000|Overall Study|Lost to Follow-up|2|||
25217465|NCT01885182|50495632|FG001|Overall Study|Lost to Follow-up|2|||
25217466|NCT01885182|50495631|FG000|Overall Study|Lack of Efficacy|8|||
25217467|NCT01885182|50495632|FG001|Overall Study|Lack of Efficacy|1|||
25217468|NCT01885104|50495642|FG000|Overall Study|Withdrawal of Consent|1|||
25217469|NCT01885104|50495643|FG001|Overall Study|Withdrawal of Consent|0|||
25217470|NCT01885104|50495642|FG000|Overall Study|Lost to Follow-up|0|||
25217471|NCT01885104|50495643|FG001|Overall Study|Lost to Follow-up|1|||
25217472|NCT01885104|50495642|FG000|Overall Study|Physician Decision|1|||
25217473|NCT01885104|50495643|FG001|Overall Study|Physician Decision|0|||
25217474|NCT01881750|50495651|FG000|Overall Study|Changes in concomitant therapies|2|||
25217475|NCT01881750|50495652|FG001|Overall Study|Changes in concomitant therapies|3|||
25217476|NCT01881750|50495651|FG000|Overall Study|Lost to Follow-up|0|||
25217477|NCT01881750|50495652|FG001|Overall Study|Lost to Follow-up|1|||
25217478|NCT01906008|50495662|FG000|Overall Study|Lost to Follow-up|2|||
25217479|NCT01906008|50495663|FG001|Overall Study|Lost to Follow-up|0|||
25217480|NCT01906008|50495662|FG000|Overall Study|Oxaliplatin toxicity|2|||
25217481|NCT01906008|50495663|FG001|Overall Study|Oxaliplatin toxicity|0|||
25217482|NCT01906008|50495662|FG000|Overall Study|Protocol Violation|0|||
25217483|NCT01906008|50495663|FG001|Overall Study|Protocol Violation|1|||
25217484|NCT01906008|50495662|FG000|Overall Study|Withdrawal by Subject|1|||
25217485|NCT01906008|50495663|FG001|Overall Study|Withdrawal by Subject|5|||
25217486|NCT01906008|50495662|FG000|Overall Study|Did not start study med|3|||
25217487|NCT01906008|50495663|FG001|Overall Study|Did not start study med|4|||
25217488|NCT01906008|50495662|FG000|Overall Study|Oxaliplatin stops|10|||
25217489|NCT01906008|50495663|FG001|Overall Study|Oxaliplatin stops|8|||
25217490|NCT01906008|50495662|FG000|Overall Study|Hospice|1|||
25217491|NCT01906008|50495663|FG001|Overall Study|Hospice|0|||
25217492|NCT01906008|50495662|FG000|Overall Study|Physician Decision|3|||
25217493|NCT01906008|50495663|FG001|Overall Study|Physician Decision|3|||
25217494|NCT01906008|50495662|FG000|Overall Study|Lack of compliance of study med|5|||
25217495|NCT01906008|50495663|FG001|Overall Study|Lack of compliance of study med|3|||
25217496|NCT01906008|50495662|FG000|Overall Study|Adverse Event|0|||
25217497|NCT01906008|50495663|FG001|Overall Study|Adverse Event|3|||
25217498|NCT01863732|50495673|FG000|Overall Study|Adverse Event|2|||
25217499|NCT01863732|50495674|FG001|Overall Study|Adverse Event|0|||
25217500|NCT01863732|50495675|FG002|Overall Study|Adverse Event|3|||
25217501|NCT01863732|50495676|FG003|Overall Study|Adverse Event|3|||
25217502|NCT01863732|50495673|FG000|Overall Study|Lack of Efficacy|1|||
25217503|NCT01863732|50495674|FG001|Overall Study|Lack of Efficacy|0|||
25217504|NCT01863732|50495675|FG002|Overall Study|Lack of Efficacy|2|||
25217505|NCT01863732|50495676|FG003|Overall Study|Lack of Efficacy|1|||
25217506|NCT01863732|50495673|FG000|Overall Study|Lost to Follow-up|2|||
25217507|NCT01863732|50495674|FG001|Overall Study|Lost to Follow-up|2|||
25217508|NCT01863732|50495675|FG002|Overall Study|Lost to Follow-up|1|||
25217509|NCT01863732|50495676|FG003|Overall Study|Lost to Follow-up|1|||
25217510|NCT01863732|50495673|FG000|Overall Study|Physician Decision|1|||
25217511|NCT01863732|50495674|FG001|Overall Study|Physician Decision|0|||
25217512|NCT01863732|50495675|FG002|Overall Study|Physician Decision|1|||
25217513|NCT01863732|50495676|FG003|Overall Study|Physician Decision|0|||
25217514|NCT01863732|50495673|FG000|Overall Study|Pregnancy|0|||
25217515|NCT01863732|50495674|FG001|Overall Study|Pregnancy|0|||
25217516|NCT01863732|50495675|FG002|Overall Study|Pregnancy|0|||
25217517|NCT01863732|50495676|FG003|Overall Study|Pregnancy|1|||
25217518|NCT01863732|50495673|FG000|Overall Study|Technical problems|0|||
25217519|NCT01863732|50495674|FG001|Overall Study|Technical problems|1|||
25217520|NCT01863732|50495675|FG002|Overall Study|Technical problems|1|||
25217521|NCT01863732|50495676|FG003|Overall Study|Technical problems|0|||
25217522|NCT01863732|50495673|FG000|Overall Study|Subject/guardian decision|6|||
25217523|NCT01863732|50495674|FG001|Overall Study|Subject/guardian decision|9|||
25217524|NCT01863732|50495675|FG002|Overall Study|Subject/guardian decision|3|||
25217525|NCT01863732|50495676|FG003|Overall Study|Subject/guardian decision|1|||
25217526|NCT01863732|50495673|FG000|Overall Study|Death|1|||
25217527|NCT01863732|50495674|FG001|Overall Study|Death|0|||
25217528|NCT01863732|50495675|FG002|Overall Study|Death|0|||
25217529|NCT01863732|50495676|FG003|Overall Study|Death|1|||
25217530|NCT01905540|50495689|FG000|Period 3|Other|1|||
25217531|NCT01905540|50495690|FG001|Period 3|Other|0|||
25217532|NCT01905540|50495691|FG002|Period 3|Other|1|||
25217533|NCT01905540|50495692|FG003|Period 3|Other|1|||
25217534|NCT01904760|50495704|FG000|Overall Study|Protocol Violation|1|||
25217535|NCT01904760|50495705|FG001|Overall Study|Protocol Violation|0|||
25217536|NCT01904604|50495714|FG000|Overall Study|Withdrew before receiving dosing|0|||
25217537|NCT01904604|50495715|FG001|Overall Study|Withdrew before receiving dosing|1|||
25217538|NCT01904604|50495716|FG002|Overall Study|Withdrew before receiving dosing|0|||
25217539|NCT01904604|50495714|FG000|Overall Study|Non-compliance|1|||
25217540|NCT01904604|50495715|FG001|Overall Study|Non-compliance|0|||
25217541|NCT01904604|50495716|FG002|Overall Study|Non-compliance|0|||
25217542|NCT01904604|50495714|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
25217543|NCT01904604|50495715|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
25217544|NCT01904604|50495716|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
25217545|NCT01904604|50495714|FG000|Overall Study|Patch site reactions|1|||
25217546|NCT01904604|50495715|FG001|Overall Study|Patch site reactions|1|||
25217547|NCT01904604|50495716|FG002|Overall Study|Patch site reactions|0|||
25217548|NCT01904604|50495714|FG000|Overall Study|Increased syncope|0|||
25217549|NCT01904604|50495715|FG001|Overall Study|Increased syncope|1|||
25217550|NCT01904604|50495716|FG002|Overall Study|Increased syncope|0|||
25217551|NCT01904604|50495714|FG000|Overall Study|Unrelated illness|0|||
25217552|NCT01904604|50495715|FG001|Overall Study|Unrelated illness|1|||
25217553|NCT01904604|50495716|FG002|Overall Study|Unrelated illness|0|||
25217554|NCT01904604|50495714|FG000|Overall Study|Passed Week 52 OFC|1|||
25217555|NCT01904604|50495715|FG001|Overall Study|Passed Week 52 OFC|0|||
25217556|NCT01904604|50495716|FG002|Overall Study|Passed Week 52 OFC|0|||
25217557|NCT01904604|50495714|FG000|Overall Study|Withdrawal by Subject|1|||
25217558|NCT01904604|50495715|FG001|Overall Study|Withdrawal by Subject|2|||
25217559|NCT01904604|50495716|FG002|Overall Study|Withdrawal by Subject|0|||
25217560|NCT01904604|50495714|FG000|Overall Study|Participant Relocated|1|||
25217561|NCT01904604|50495715|FG001|Overall Study|Participant Relocated|1|||
25217562|NCT01904604|50495716|FG002|Overall Study|Participant Relocated|1|||
25217563|NCT01904604|50495714|FG000|Overall Study|Lost to Follow-up|0|||
25217564|NCT01904604|50495715|FG001|Overall Study|Lost to Follow-up|0|||
25217565|NCT01904604|50495716|FG002|Overall Study|Lost to Follow-up|1|||
25217566|NCT01904058|50495731|FG000|Overall Study|Adverse Event|2|||
25217567|NCT01904058|50495732|FG001|Overall Study|Adverse Event|0|||
25217568|NCT01904058|50495733|FG002|Overall Study|Adverse Event|0|||
25217569|NCT01904058|50495734|FG003|Overall Study|Adverse Event|0|||
25217570|NCT01904058|50495731|FG000|Overall Study|Withdrawal by Subject|1|||
25217571|NCT01904058|50495732|FG001|Overall Study|Withdrawal by Subject|0|||
25217572|NCT01904058|50495733|FG002|Overall Study|Withdrawal by Subject|1|||
25217573|NCT01904058|50495734|FG003|Overall Study|Withdrawal by Subject|0|||
25217574|NCT01904058|50495731|FG000|Overall Study|Pregnancy|0|||
25217575|NCT01904058|50495732|FG001|Overall Study|Pregnancy|0|||
25217576|NCT01904058|50495733|FG002|Overall Study|Pregnancy|0|||
25217577|NCT01904058|50495734|FG003|Overall Study|Pregnancy|1|||
25217578|NCT01881126|50495752|FG000|Overall Study|Non-compliance|1|||
25217579|NCT01881126|50495753|FG001|Overall Study|Non-compliance|1|||
25217580|NCT01881126|50495752|FG000|Overall Study|Adverse Event|0|||
25217581|NCT01881126|50495753|FG001|Overall Study|Adverse Event|1|||
25217582|NCT01614600|50495759|FG000|Overall Study|Unacceptable fit|1|||
25217583|NCT01614600|50495759|FG000|Overall Study|Discomfort|1|||
25217584|NCT01614600|50495759|FG000|Overall Study|Unable to remove lens at the end of day|1|||
25217585|NCT01614600|50495759|FG000|Overall Study|Protocol deviation|1|||
25217586|NCT01880736|50495767|FG000|Overall Study|Adverse Event|0|||
25217587|NCT01880736|50495768|FG001|Overall Study|Adverse Event|0|||
25217588|NCT01880736|50495769|FG002|Overall Study|Adverse Event|0|||
25217589|NCT01880736|50495770|FG003|Overall Study|Adverse Event|1|||
25217590|NCT01880736|50495767|FG000|Overall Study|Withdrawal Criteria|1|||
25217591|NCT01880736|50495768|FG001|Overall Study|Withdrawal Criteria|2|||
25217592|NCT01880736|50495769|FG002|Overall Study|Withdrawal Criteria|1|||
25217593|NCT01880736|50495770|FG003|Overall Study|Withdrawal Criteria|5|||
25217594|NCT01880424|50495782|FG000|Overall Study|Adverse Event|7|||
25217595|NCT01880424|50495783|FG001|Overall Study|Adverse Event|6|||
25217596|NCT01880424|50495782|FG000|Overall Study|Lack of Efficacy|1|||
25217597|NCT01880424|50495783|FG001|Overall Study|Lack of Efficacy|4|||
25217598|NCT01880424|50495782|FG000|Overall Study|Lost to Follow-up|3|||
25217599|NCT01880424|50495783|FG001|Overall Study|Lost to Follow-up|2|||
25217600|NCT01880424|50495782|FG000|Overall Study|Protocol Violation|11|||
25217601|NCT01880424|50495783|FG001|Overall Study|Protocol Violation|13|||
25217602|NCT01880424|50495782|FG000|Overall Study|Withdrawal by Subject|10|||
25217603|NCT01880424|50495783|FG001|Overall Study|Withdrawal by Subject|30|||
25217604|NCT01880424|50495782|FG000|Overall Study|Other|1|||
25217605|NCT01880424|50495783|FG001|Overall Study|Other|0|||
25217606|NCT01862874|50495791|FG000|Overall Study|Randomized not treated|1|||
25217607|NCT01862874|50495792|FG001|Overall Study|Randomized not treated|0|||
25217608|NCT01862874|50495791|FG000|Overall Study|Adverse Event|0|||
25217609|NCT01862874|50495792|FG001|Overall Study|Adverse Event|3|||
25217610|NCT01862874|50495791|FG000|Overall Study|Lost to Follow-up|26|||
25217611|NCT01862874|50495792|FG001|Overall Study|Lost to Follow-up|29|||
25217612|NCT01862874|50495791|FG000|Overall Study|Physician Decision|5|||
25217613|NCT01862874|50495792|FG001|Overall Study|Physician Decision|3|||
25217614|NCT01862874|50495791|FG000|Overall Study|Withdrawn by parent/guardian|1|||
25217615|NCT01862874|50495792|FG001|Overall Study|Withdrawn by parent/guardian|1|||
25217616|NCT01862874|50495791|FG000|Overall Study|Withdrawal by Subject|46|||
25217617|NCT01862874|50495792|FG001|Overall Study|Withdrawal by Subject|40|||
25217618|NCT01862874|50495791|FG000|Overall Study|Death|0|||
25217619|NCT01862874|50495792|FG001|Overall Study|Death|1|||
25217620|NCT01879722|50495808|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
25217621|NCT01879722|50495809|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
25217622|NCT01879722|50495810|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
25217623|NCT01879722|50495811|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
25217624|NCT01879722|50495812|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
25217625|NCT01879722|50495813|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
25217626|NCT01879722|50495814|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
25217627|NCT01879722|50495815|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
25217628|NCT01879722|50495816|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
25217629|NCT01879722|50495817|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
25217630|NCT01879722|50495808|FG000|Overall Study|Voluntary Withdrawal|0|||
25217631|NCT01879722|50495809|FG001|Overall Study|Voluntary Withdrawal|0|||
25217632|NCT01879722|50495810|FG002|Overall Study|Voluntary Withdrawal|0|||
25217633|NCT01879722|50495811|FG003|Overall Study|Voluntary Withdrawal|0|||
25217634|NCT01879722|50495812|FG004|Overall Study|Voluntary Withdrawal|0|||
25217635|NCT01879722|50495813|FG005|Overall Study|Voluntary Withdrawal|0|||
25217636|NCT01879722|50495814|FG006|Overall Study|Voluntary Withdrawal|0|||
25217637|NCT01879722|50495815|FG007|Overall Study|Voluntary Withdrawal|0|||
25217638|NCT01879722|50495816|FG008|Overall Study|Voluntary Withdrawal|1|||
25217639|NCT01879722|50495817|FG009|Overall Study|Voluntary Withdrawal|0|||
25217640|NCT01879410|50495844|FG000|Overall Study|Adverse Event|9|||
25217641|NCT01879410|50495845|FG001|Overall Study|Adverse Event|14|||
25217642|NCT01879410|50495844|FG000|Overall Study|Lack of Efficacy|4|||
25217643|NCT01879410|50495845|FG001|Overall Study|Lack of Efficacy|6|||
25217644|NCT01879410|50495844|FG000|Overall Study|Protocol Violation|1|||
25217645|NCT01879410|50495845|FG001|Overall Study|Protocol Violation|7|||
25217646|NCT01879410|50495844|FG000|Overall Study|Lost to Follow-up|2|||
25217647|NCT01879410|50495845|FG001|Overall Study|Lost to Follow-up|1|||
25217648|NCT01879410|50495844|FG000|Overall Study|Withdrawal by Subject|7|||
25217649|NCT01879410|50495845|FG001|Overall Study|Withdrawal by Subject|8|||
25217650|NCT01879410|50495844|FG000|Overall Study|Randomised in Error|1|||
25217651|NCT01879410|50495845|FG001|Overall Study|Randomised in Error|2|||
25217652|NCT01903434|50495851|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
25217653|NCT01903434|50495852|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
25217654|NCT01903434|50495851|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
25217655|NCT01903434|50495852|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
25217656|NCT01903356|50495858|FG000|Overall Study|Lost to Follow-up|7|||
25217657|NCT01903356|50495858|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
25217658|NCT01903356|50495858|FG000|Overall Study|Violated the dosage and administration|3|||
25217659|NCT01862796|50495865|FG000|Overall Study|Prohibited medications|0|||
25217660|NCT01862796|50495866|FG001|Overall Study|Prohibited medications|0|||
25217661|NCT01862796|50495867|FG002|Overall Study|Prohibited medications|1|||
25217662|NCT01878084|50495875|FG000|Overall Study|Physician Decision|2|||
25217663|NCT01862640|50495884|FG000|Overall Study|Adverse Event|4|||
25217664|NCT01862640|50495885|FG001|Overall Study|Adverse Event|10|||
25217665|NCT01862640|50495886|FG002|Overall Study|Adverse Event|6|||
25217666|NCT01862640|50495887|FG003|Overall Study|Adverse Event|8|||
25217667|NCT01862640|50495884|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
25217668|NCT01862640|50495885|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
25217669|NCT01862640|50495886|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
25217670|NCT01862640|50495887|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
25077406|NCT02936323|50185223|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
25217671|NCT01862640|50495884|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
25217672|NCT01862640|50495885|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
25217673|NCT01862640|50495886|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
25217674|NCT01862640|50495887|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
25217675|NCT01862640|50495884|FG000|Overall Study|Withdrawal by Subject|2|||
25217676|NCT01862640|50495885|FG001|Overall Study|Withdrawal by Subject|4|||
25217677|NCT01862640|50495886|FG002|Overall Study|Withdrawal by Subject|8|||
25217678|NCT01862640|50495887|FG003|Overall Study|Withdrawal by Subject|5|||
25217679|NCT01862640|50495884|FG000|Overall Study|Protocol Deviation|0|||
25217680|NCT01862640|50495885|FG001|Overall Study|Protocol Deviation|0|||
25217681|NCT01862640|50495886|FG002|Overall Study|Protocol Deviation|1|||
25217682|NCT01862640|50495887|FG003|Overall Study|Protocol Deviation|0|||
25217683|NCT01902966|50495896|FG000|Overall Study|Death|1|||
25217684|NCT01902966|50495896|FG000|Overall Study|Physician Decision|1|||
25217685|NCT01902966|50495896|FG000|Overall Study|Withdrawal by Subject|1|||
25217686|NCT01862484|50495902|FG000|Overall Study|Lack of Efficacy|1|||
25217687|NCT01862484|50495903|FG001|Overall Study|Lack of Efficacy|1|||
25217688|NCT01862484|50495902|FG000|Overall Study|Lost to Follow-up|1|||
25217689|NCT01862484|50495903|FG001|Overall Study|Lost to Follow-up|2|||
25217690|NCT01862484|50495902|FG000|Overall Study|Protocol Violation|0|||
25217691|NCT01862484|50495903|FG001|Overall Study|Protocol Violation|2|||
25217692|NCT01862484|50495902|FG000|Overall Study|Withdrawal by Subject|0|||
25217693|NCT01862484|50495903|FG001|Overall Study|Withdrawal by Subject|3|||
25217694|NCT01902888|50495909|FG000|Overall Study|Study Terminated|3|||
25217695|NCT01862328|50495920|FG000|Overall Study|Progressive Disease|3|||
25217696|NCT01862328|50495921|FG001|Overall Study|Progressive Disease|11|||
25217697|NCT01862328|50495922|FG002|Overall Study|Progressive Disease|5|||
25217698|NCT01862328|50495923|FG003|Overall Study|Progressive Disease|6|||
25217699|NCT01862328|50495924|FG004|Overall Study|Progressive Disease|7|||
25217700|NCT01862328|50495925|FG005|Overall Study|Progressive Disease|4|||
25217701|NCT01862328|50495926|FG006|Overall Study|Progressive Disease|3|||
25217702|NCT01862328|50495920|FG000|Overall Study|Adverse Event|0|||
25217703|NCT01862328|50495921|FG001|Overall Study|Adverse Event|4|||
25217704|NCT01862328|50495922|FG002|Overall Study|Adverse Event|0|||
25217705|NCT01862328|50495923|FG003|Overall Study|Adverse Event|1|||
25217706|NCT01862328|50495924|FG004|Overall Study|Adverse Event|0|||
25217707|NCT01862328|50495925|FG005|Overall Study|Adverse Event|2|||
25217708|NCT01862328|50495926|FG006|Overall Study|Adverse Event|4|||
25217709|NCT01862328|50495920|FG000|Overall Study|Other|0|||
25217710|NCT01862328|50495921|FG001|Overall Study|Other|2|||
25217711|NCT01862328|50495922|FG002|Overall Study|Other|1|||
25217712|NCT01862328|50495923|FG003|Overall Study|Other|0|||
25217713|NCT01862328|50495924|FG004|Overall Study|Other|4|||
25217714|NCT01862328|50495925|FG005|Overall Study|Other|0|||
25217715|NCT01862328|50495926|FG006|Overall Study|Other|1|||
25217716|NCT01862328|50495920|FG000|Overall Study|Withdrawal by Subject|1|||
25217717|NCT01862328|50495921|FG001|Overall Study|Withdrawal by Subject|1|||
25217718|NCT01862328|50495922|FG002|Overall Study|Withdrawal by Subject|0|||
25217719|NCT01862328|50495923|FG003|Overall Study|Withdrawal by Subject|0|||
25217720|NCT01862328|50495924|FG004|Overall Study|Withdrawal by Subject|1|||
25217721|NCT01862328|50495925|FG005|Overall Study|Withdrawal by Subject|1|||
25217722|NCT01862328|50495926|FG006|Overall Study|Withdrawal by Subject|1|||
25217723|NCT01862328|50495920|FG000|Overall Study|Symptomatic Deterioration|0|||
25217724|NCT01862328|50495921|FG001|Overall Study|Symptomatic Deterioration|0|||
25217725|NCT01862328|50495922|FG002|Overall Study|Symptomatic Deterioration|0|||
25217726|NCT01862328|50495923|FG003|Overall Study|Symptomatic Deterioration|0|||
25217727|NCT01862328|50495924|FG004|Overall Study|Symptomatic Deterioration|0|||
25217728|NCT01862328|50495925|FG005|Overall Study|Symptomatic Deterioration|0|||
25217729|NCT01862328|50495926|FG006|Overall Study|Symptomatic Deterioration|1|||
25217730|NCT01862250|50495948|FG000|Overall Study|Adverse Event|4|||
25217731|NCT01860846|50495952|FG000|Overall Study|Lost to Follow-up|33|||
25217732|NCT01901874|50495956|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
25217733|NCT01901874|50495956|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
25217734|NCT01901874|50495956|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
25217735|NCT01901874|50495956|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
25217736|NCT01901874|50495956|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
25217737|NCT01901874|50495956|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
25217738|NCT01860534|50495962|FG000|ROP #1|Needed treatment for ROP|0|||
25217739|NCT01860534|50495963|FG001|ROP #1|Needed treatment for ROP|1|||
25217740|NCT01860534|50495962|FG000|ROP #2|discharged prior to ROP #2|1|||
25217741|NCT01860534|50495963|FG001|ROP #2|discharged prior to ROP #2|0|||
25217742|NCT01901328|50495973|FG000|Overall Study|Lost to Follow-up|1|||
25217743|NCT01901328|50495974|FG001|Overall Study|Lost to Follow-up|0|||
25217744|NCT01901328|50495973|FG000|Overall Study|Physician Decision|0|||
25217745|NCT01901328|50495974|FG001|Overall Study|Physician Decision|1|||
25217746|NCT01901328|50495973|FG000|Overall Study|Protocol Violation|1|||
25217747|NCT01901328|50495974|FG001|Overall Study|Protocol Violation|1|||
25217748|NCT01901328|50495973|FG000|Overall Study|Study Terminated by Sponsor|19|||
25217749|NCT01901328|50495974|FG001|Overall Study|Study Terminated by Sponsor|16|||
25217750|NCT01901328|50495973|FG000|Overall Study|Withdrawal by Subject|1|||
25217751|NCT01901328|50495974|FG001|Overall Study|Withdrawal by Subject|2|||
25217752|NCT01901328|50495973|FG000|Overall Study|Lack of Efficacy|0|||
25217753|NCT01901328|50495974|FG001|Overall Study|Lack of Efficacy|1|||
25217754|NCT01859988|50495987|FG000|Overall Study|Withdrawal by Subject|6|||
25217755|NCT01859988|50495988|FG001|Overall Study|Withdrawal by Subject|3|||
25217756|NCT01859988|50495989|FG002|Overall Study|Withdrawal by Subject|4|||
25217757|NCT01859988|50495990|FG003|Overall Study|Withdrawal by Subject|3|||
25217758|NCT01859988|50495991|FG004|Overall Study|Withdrawal by Subject|2|||
25217759|NCT01859988|50495992|FG005|Overall Study|Withdrawal by Subject|2|||
25217760|NCT01859988|50495987|FG000|Overall Study|Lack of Efficacy|1|||
25217761|NCT01859988|50495988|FG001|Overall Study|Lack of Efficacy|1|||
25217762|NCT01859988|50495989|FG002|Overall Study|Lack of Efficacy|5|||
25217763|NCT01859988|50495990|FG003|Overall Study|Lack of Efficacy|0|||
25217764|NCT01859988|50495991|FG004|Overall Study|Lack of Efficacy|7|||
25217765|NCT01859988|50495992|FG005|Overall Study|Lack of Efficacy|9|||
25217766|NCT01859988|50495987|FG000|Overall Study|Physician Decision|1|||
25217767|NCT01859988|50495988|FG001|Overall Study|Physician Decision|3|||
25217768|NCT01859988|50495989|FG002|Overall Study|Physician Decision|1|||
25217769|NCT01859988|50495990|FG003|Overall Study|Physician Decision|3|||
25217770|NCT01859988|50495991|FG004|Overall Study|Physician Decision|4|||
25217771|NCT01859988|50495992|FG005|Overall Study|Physician Decision|1|||
25217772|NCT01859988|50495987|FG000|Overall Study|Adverse Event|2|||
25217773|NCT01859988|50495988|FG001|Overall Study|Adverse Event|1|||
25217774|NCT01859988|50495989|FG002|Overall Study|Adverse Event|3|||
25217775|NCT01859988|50495990|FG003|Overall Study|Adverse Event|1|||
25217776|NCT01859988|50495991|FG004|Overall Study|Adverse Event|2|||
25217777|NCT01859988|50495992|FG005|Overall Study|Adverse Event|2|||
25217778|NCT01859988|50495987|FG000|Overall Study|Lost to Follow-up|1|||
25217779|NCT01859988|50495988|FG001|Overall Study|Lost to Follow-up|2|||
25217780|NCT01859988|50495989|FG002|Overall Study|Lost to Follow-up|3|||
25217781|NCT01859988|50495990|FG003|Overall Study|Lost to Follow-up|0|||
25217782|NCT01859988|50495991|FG004|Overall Study|Lost to Follow-up|3|||
25217783|NCT01859988|50495992|FG005|Overall Study|Lost to Follow-up|2|||
25217784|NCT01859988|50495987|FG000|Overall Study|Protocol Violation|0|||
25217785|NCT01859988|50495988|FG001|Overall Study|Protocol Violation|0|||
25217786|NCT01859988|50495989|FG002|Overall Study|Protocol Violation|1|||
25217787|NCT01859988|50495990|FG003|Overall Study|Protocol Violation|0|||
25217788|NCT01859988|50495991|FG004|Overall Study|Protocol Violation|0|||
25217789|NCT01859988|50495992|FG005|Overall Study|Protocol Violation|0|||
25217790|NCT01859988|50495987|FG000|Overall Study|Other than specified above|0|||
25217791|NCT01859988|50495988|FG001|Overall Study|Other than specified above|2|||
25217792|NCT01859988|50495989|FG002|Overall Study|Other than specified above|11|||
25217793|NCT01859988|50495990|FG003|Overall Study|Other than specified above|3|||
25217794|NCT01859988|50495991|FG004|Overall Study|Other than specified above|5|||
25217795|NCT01859988|50495992|FG005|Overall Study|Other than specified above|3|||
25217796|NCT01859598|50496006|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
25217797|NCT01876446|50496014|FG000|Overall Study|Death|0|||
25217798|NCT01876446|50496015|FG001|Overall Study|Death|1|||
25217799|NCT01876446|50496014|FG000|Overall Study|Withdrawal by Subject|1|||
25217800|NCT01876446|50496015|FG001|Overall Study|Withdrawal by Subject|2|||
25217801|NCT01876446|50496014|FG000|Overall Study|Physician Decision|1|||
25217802|NCT01876446|50496015|FG001|Overall Study|Physician Decision|3|||
25217803|NCT01900626|50496023|FG000|Overall Study|study was closed due to low enrollment|1|||
25217804|NCT01900626|50496024|FG001|Overall Study|study was closed due to low enrollment|1|||
25217805|NCT01900314|50496034|FG000|Overall Study|Lost to Follow-up|1|||
25217806|NCT01900314|50496035|FG001|Overall Study|Lost to Follow-up|0|||
25217807|NCT01900314|50496034|FG000|Overall Study|Protocol Violation|0|||
25217808|NCT01900314|50496035|FG001|Overall Study|Protocol Violation|1|||
25217809|NCT01900314|50496034|FG000|Overall Study|Withdrawal by Subject|3|||
25217810|NCT01900314|50496035|FG001|Overall Study|Withdrawal by Subject|3|||
25217811|NCT01899768|50496042|FG000|Part A|Adverse Event|2|||
25217812|NCT01899768|50496042|FG000|Part A|Withdrawal by Subject|1|||
25217813|NCT01899768|50496042|FG000|Part B|Adverse Event|1|||
25217814|NCT01899768|50496042|FG000|Part B|Withdrawal by Subject|1|||
25217815|NCT01898598|50496052|FG000|Overall Study|Adverse Event|1|||
25217816|NCT01898598|50496053|FG001|Overall Study|Adverse Event|0|||
25217817|NCT01898598|50496052|FG000|Overall Study|Withdrawal by Subject|3|||
25217818|NCT01898598|50496053|FG001|Overall Study|Withdrawal by Subject|0|||
25217819|NCT01898598|50496052|FG000|Overall Study|Lost to Follow-up|0|||
25217820|NCT01898598|50496053|FG001|Overall Study|Lost to Follow-up|1|||
25217821|NCT01898598|50496052|FG000|Overall Study|Other|0|||
25217822|NCT01898598|50496053|FG001|Overall Study|Other|1|||
25217823|NCT01898442|50496062|FG000|Overall Study|Hemolysis/technical problems|1|||
25217824|NCT01898442|50496063|FG001|Overall Study|Hemolysis/technical problems|2|||
25217825|NCT01898442|50496064|FG002|Overall Study|Hemolysis/technical problems|2|||
25217826|NCT01898442|50496062|FG000|Overall Study|Patient vomited pills|0|||
25217827|NCT01898442|50496063|FG001|Overall Study|Patient vomited pills|0|||
25217828|NCT01898442|50496064|FG002|Overall Study|Patient vomited pills|1|||
25217829|NCT01898286|50496072|FG000|Overall Study|Withdrawal by Subject|1|||
25217830|NCT01898286|50496072|FG000|Overall Study|Protocol Violation|1|||
25217831|NCT01898286|50496072|FG000|Overall Study|Lost to Follow-up|1|||
25217832|NCT01898208|50496079|FG000|Overall Study|Positive blood culture|17|||
25217833|NCT01898208|50496080|FG001|Overall Study|Positive blood culture|23|||
25217834|NCT01898208|50496081|FG002|Overall Study|Positive blood culture|15|||
25217835|NCT01898208|50496079|FG000|Overall Study|Death/comfort care within 24 hours|10|||
25217836|NCT01898208|50496080|FG001|Overall Study|Death/comfort care within 24 hours|9|||
25217837|NCT01898208|50496081|FG002|Overall Study|Death/comfort care within 24 hours|8|||
25217838|NCT01898208|50496079|FG000|Overall Study|Negative Gram Stain|6|||
25217839|NCT01898208|50496080|FG001|Overall Study|Negative Gram Stain|9|||
25217840|NCT01898208|50496081|FG002|Overall Study|Negative Gram Stain|6|||
25217841|NCT01898208|50496079|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
25217842|NCT01898208|50496080|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
25217843|NCT01898208|50496081|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
25217844|NCT01898208|50496079|FG000|Overall Study|System/Technical Error|1|||
25217845|NCT01898208|50496080|FG001|Overall Study|System/Technical Error|2|||
25217846|NCT01898208|50496081|FG002|Overall Study|System/Technical Error|3|||
25217847|NCT01898208|50496079|FG000|Overall Study|Lost to Follow-up|3|||
25217848|NCT01898208|50496080|FG001|Overall Study|Lost to Follow-up|1|||
25217849|NCT01898208|50496081|FG002|Overall Study|Lost to Follow-up|1|||
25217850|NCT01898130|50496089|FG000|Treatment|Withdrawal by Subject|2|||
25217851|NCT01898130|50496089|FG000|Treatment|Progressive Disease|4|||
25217852|NCT01898130|50496089|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
25217853|NCT01876368|50496095|FG000|Overall Study|Adverse Event|2|||
25217854|NCT01876368|50496096|FG001|Overall Study|Adverse Event|5|||
25217855|NCT01876368|50496095|FG000|Overall Study|Lack of Efficacy|1|||
25217856|NCT01876368|50496096|FG001|Overall Study|Lack of Efficacy|0|||
25217857|NCT01876368|50496095|FG000|Overall Study|Lost to Follow-up|0|||
25217858|NCT01876368|50496096|FG001|Overall Study|Lost to Follow-up|1|||
25217859|NCT01876368|50496095|FG000|Overall Study|Non-compliance with study treatment|0|||
25217860|NCT01876368|50496096|FG001|Overall Study|Non-compliance with study treatment|1|||
25217861|NCT01876368|50496095|FG000|Overall Study|Physician Decision|0|||
25217862|NCT01876368|50496096|FG001|Overall Study|Physician Decision|2|||
25217863|NCT01876368|50496095|FG000|Overall Study|Protocol deviation|3|||
25217864|NCT01876368|50496096|FG001|Overall Study|Protocol deviation|3|||
25217865|NCT01876368|50496095|FG000|Overall Study|Subject/guardian decision|3|||
25217866|NCT01876368|50496096|FG001|Overall Study|Subject/guardian decision|1|||
25217867|NCT01874340|50496106|FG000|Overall Study|Study terminated by Sponsor|6|||
25217868|NCT01874340|50496107|FG001|Overall Study|Study terminated by Sponsor|8|||
25217869|NCT01874340|50496108|FG002|Overall Study|Study terminated by Sponsor|8|||
25217870|NCT01874340|50496109|FG003|Overall Study|Study terminated by Sponsor|4|||
25217871|NCT01874340|50496106|FG000|Overall Study|Withdrawal by Subject|0|||
25217872|NCT01874340|50496107|FG001|Overall Study|Withdrawal by Subject|0|||
25217873|NCT01874340|50496108|FG002|Overall Study|Withdrawal by Subject|0|||
25217874|NCT01874340|50496109|FG003|Overall Study|Withdrawal by Subject|1|||
25217875|NCT01897896|50496121|FG000|Overall Study|Death|1|||
25217876|NCT01897896|50496122|FG001|Overall Study|Death|0|||
25217877|NCT01897896|50496121|FG000|Overall Study|Adverse Event|11|||
25217878|NCT01897896|50496122|FG001|Overall Study|Adverse Event|1|||
25217879|NCT01897896|50496121|FG000|Overall Study|Lost to Follow-up|1|||
25217880|NCT01897896|50496122|FG001|Overall Study|Lost to Follow-up|0|||
25217881|NCT01897896|50496121|FG000|Overall Study|Non-compliance with study drug dosing|1|||
25217882|NCT01897896|50496122|FG001|Overall Study|Non-compliance with study drug dosing|1|||
25217883|NCT01897896|50496121|FG000|Overall Study|Withdrawal by Subject|7|||
25217884|NCT01897896|50496122|FG001|Overall Study|Withdrawal by Subject|1|||
25217885|NCT01897896|50496121|FG000|Overall Study|Require drug that interfere with study|1|||
25217886|NCT01897896|50496122|FG001|Overall Study|Require drug that interfere with study|4|||
25217887|NCT01897896|50496121|FG000|Overall Study|Protocol Violation|1|||
25217888|NCT01897896|50496122|FG001|Overall Study|Protocol Violation|1|||
25217889|NCT01897896|50496121|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
25217890|NCT01897896|50496122|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
25217891|NCT01897896|50496121|FG000|Overall Study|Caregiver can no longer participate|0|||
25217892|NCT01897896|50496122|FG001|Overall Study|Caregiver can no longer participate|2|||
25217893|NCT01897896|50496121|FG000|Overall Study|Other than specified|2|||
25217894|NCT01897896|50496122|FG001|Overall Study|Other than specified|1|||
25217895|NCT01858194|50496132|FG000|Overall Study|Total Artificial Heart Implant|0|||
25217896|NCT01858194|50496133|FG001|Overall Study|Total Artificial Heart Implant|1|||
25217897|NCT01858194|50496132|FG000|Overall Study|Lost to Follow-up|0|||
25217898|NCT01858194|50496133|FG001|Overall Study|Lost to Follow-up|1|||
25217899|NCT01873950|50496141|FG000|Period 5|Withdrawal by Subject|0|||
25217900|NCT01873950|50496142|FG001|Period 5|Withdrawal by Subject|0|||
25317084|NCT00966875|50632494|FG003|Part B|Physician Decision|0|||
25217901|NCT01873950|50496143|FG002|Period 5|Withdrawal by Subject|0|||
25217902|NCT01873950|50496144|FG003|Period 5|Withdrawal by Subject|1|||
25217903|NCT01873950|50496145|FG004|Period 5|Withdrawal by Subject|0|||
25217904|NCT01857102|50496159|FG000|Period 1|No longer meets Eligibility Criteria|0|||
25217905|NCT01857102|50496160|FG001|Period 1|No longer meets Eligibility Criteria|2|||
25217906|NCT01857102|50496159|FG000|Period 1|Lost to Follow-up|0|||
25217907|NCT01857102|50496160|FG001|Period 1|Lost to Follow-up|3|||
25217908|NCT01857102|50496159|FG000|Period 1|Unsatisfactory Lens Fit|1|||
25217909|NCT01857102|50496160|FG001|Period 1|Unsatisfactory Lens Fit|0|||
25217910|NCT01857102|50496159|FG000|Period 1|Unsatisfactory Visual Response|1|||
25217911|NCT01857102|50496160|FG001|Period 1|Unsatisfactory Visual Response|0|||
25217912|NCT01857102|50496159|FG000|Period 1|Physician Decision|1|||
25217913|NCT01857102|50496160|FG001|Period 1|Physician Decision|0|||
25217914|NCT01857102|50496159|FG000|Period 2|Lens Discomfort|1|||
25317085|NCT00966875|50632495|FG004|Part B|Physician Decision|2|||
25317086|NCT00966875|50632496|FG005|Part B|Physician Decision|1|||
25317087|NCT00966875|50632497|FG006|Part B|Physician Decision|0|||
25317088|NCT00966875|50632498|FG007|Part B|Physician Decision|0|||
25317089|NCT00966875|50632499|FG008|Part B|Physician Decision|2|||
25317090|NCT00966875|50632491|FG000|Part B|Sponsor Decision|1|||
25317091|NCT00966875|50632492|FG001|Part B|Sponsor Decision|0|||
25317092|NCT00966875|50632493|FG002|Part B|Sponsor Decision|0|||
25317093|NCT00966875|50632494|FG003|Part B|Sponsor Decision|0|||
25317094|NCT00966875|50632495|FG004|Part B|Sponsor Decision|0|||
25317095|NCT00966875|50632496|FG005|Part B|Sponsor Decision|1|||
25317096|NCT00966875|50632497|FG006|Part B|Sponsor Decision|0|||
25317097|NCT00966875|50632498|FG007|Part B|Sponsor Decision|2|||
25317098|NCT00966875|50632499|FG008|Part B|Sponsor Decision|1|||
25317099|NCT00966875|50632491|FG000|Part B|Withdrawal by Subject|2|||
25317100|NCT00966875|50632492|FG001|Part B|Withdrawal by Subject|1|||
25317101|NCT00966875|50632493|FG002|Part B|Withdrawal by Subject|2|||
25317102|NCT00966875|50632494|FG003|Part B|Withdrawal by Subject|1|||
25317103|NCT00966875|50632495|FG004|Part B|Withdrawal by Subject|2|||
25317104|NCT00966875|50632496|FG005|Part B|Withdrawal by Subject|1|||
25317105|NCT00966875|50632497|FG006|Part B|Withdrawal by Subject|4|||
25317106|NCT00966875|50632498|FG007|Part B|Withdrawal by Subject|5|||
25317107|NCT00966875|50632499|FG008|Part B|Withdrawal by Subject|5|||
25317108|NCT00966875|50632491|FG000|Part B|Entry Criteria|0|||
25317109|NCT00966875|50632492|FG001|Part B|Entry Criteria|0|||
25317110|NCT00966875|50632493|FG002|Part B|Entry Criteria|0|||
25317111|NCT00966875|50632494|FG003|Part B|Entry Criteria|0|||
25317112|NCT00966875|50632495|FG004|Part B|Entry Criteria|0|||
25317113|NCT00966875|50632496|FG005|Part B|Entry Criteria|0|||
25317114|NCT00966875|50632497|FG006|Part B|Entry Criteria|1|||
25317115|NCT00966875|50632498|FG007|Part B|Entry Criteria|0|||
25317116|NCT00966875|50632499|FG008|Part B|Entry Criteria|1|||
25317117|NCT00828711|50632575|FG000|Overall Study|Lost to Follow-up|1|||
25317118|NCT00828711|50632576|FG001|Overall Study|Lost to Follow-up|0|||
25317119|NCT00828711|50632577|FG002|Overall Study|Lost to Follow-up|0|||
25317120|NCT00966719|50632587|FG000|Overall Study|Lost to Follow-up|6|||
25317121|NCT00966719|50632588|FG001|Overall Study|Lost to Follow-up|11|||
25317122|NCT00818649|50632594|FG000|Overall Study|Declining performance status|2|||
25317123|NCT00818649|50632594|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
25317124|NCT00818649|50632594|FG000|Overall Study|Adverse Event|1|||
25317125|NCT00961571|50632599|FG000|Overall Study|Physician Decision|39|||
25317126|NCT00964223|50632603|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
25317127|NCT00620815|50632611|FG000|Overall Study|Adverse Event|1|||
25317128|NCT00620815|50632612|FG001|Overall Study|Adverse Event|1|||
25317129|NCT00620815|50632613|FG002|Overall Study|Adverse Event|2|||
25317130|NCT00620815|50632611|FG000|Overall Study|Withdrawal by Subject|1|||
25317131|NCT00620815|50632612|FG001|Overall Study|Withdrawal by Subject|2|||
25317132|NCT00620815|50632613|FG002|Overall Study|Withdrawal by Subject|0|||
25317133|NCT00620815|50632611|FG000|Overall Study|Lost to Follow-up|1|||
25317134|NCT00620815|50632612|FG001|Overall Study|Lost to Follow-up|6|||
25317135|NCT00620815|50632613|FG002|Overall Study|Lost to Follow-up|3|||
25317136|NCT00620815|50632611|FG000|Overall Study|Inappropriate enrolment|0|||
24976474|NCT03462082|50065369|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
24976475|NCT03462082|50065370|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
25217915|NCT01857102|50496160|FG001|Period 2|Lens Discomfort|0|||
25217916|NCT01857102|50496159|FG000|Period 2|Unsatisfactory Lens Fit|1|||
25317137|NCT00620815|50632612|FG001|Overall Study|Inappropriate enrolment|0|||
25317138|NCT00620815|50632613|FG002|Overall Study|Inappropriate enrolment|1|||
25317139|NCT00620815|50632611|FG000|Overall Study|Protocol Violation|1|||
25317140|NCT00620815|50632612|FG001|Overall Study|Protocol Violation|2|||
25317141|NCT00620815|50632613|FG002|Overall Study|Protocol Violation|1|||
25317142|NCT03372941|50632639|FG000|Overall Study|Lost to Follow-up|2|||
25317143|NCT03372941|50632640|FG001|Overall Study|Lost to Follow-up|4|||
25317144|NCT00619957|50632648|FG000|Month 24 Double-Blind|Adverse Event|9|||
25217917|NCT01857102|50496160|FG001|Period 2|Unsatisfactory Lens Fit|0|||
25217918|NCT01872078|50496172|FG000|Overall Study|Adverse Event|0|||
25217919|NCT01872078|50496173|FG001|Overall Study|Adverse Event|0|||
25217920|NCT01872078|50496174|FG002|Overall Study|Adverse Event|1|||
25217921|NCT01872078|50496175|FG003|Overall Study|Adverse Event|0|||
25217922|NCT01872078|50496172|FG000|Overall Study|Dose administration non-compliance|0|||
25217923|NCT01872078|50496173|FG001|Overall Study|Dose administration non-compliance|0|||
25217924|NCT01872078|50496174|FG002|Overall Study|Dose administration non-compliance|0|||
25217925|NCT01872078|50496175|FG003|Overall Study|Dose administration non-compliance|1|||
25217926|NCT01872078|50496172|FG000|Overall Study|Protocol Violation|0|||
25217927|NCT01872078|50496173|FG001|Overall Study|Protocol Violation|0|||
25217928|NCT01872078|50496174|FG002|Overall Study|Protocol Violation|1|||
25217929|NCT01872078|50496175|FG003|Overall Study|Protocol Violation|0|||
25217930|NCT01872078|50496172|FG000|Overall Study|Withdrawal by Subject|0|||
25317145|NCT00619957|50632649|FG001|Month 24 Double-Blind|Adverse Event|7|||
25317146|NCT00619957|50632648|FG000|Month 24 Double-Blind|Protocol Violation|1|||
25317147|NCT00619957|50632649|FG001|Month 24 Double-Blind|Protocol Violation|0|||
25317148|NCT00619957|50632648|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
25317149|NCT00619957|50632649|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
25317150|NCT00619957|50632648|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
25317151|NCT00619957|50632649|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
25317152|NCT00619957|50632648|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
25317153|NCT00619957|50632649|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
25317154|NCT00619957|50632648|FG000|Month 48 Open-Label|Adverse Event|4|||
25317155|NCT00619957|50632649|FG001|Month 48 Open-Label|Adverse Event|4|||
25317156|NCT00619957|50632648|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
25317157|NCT00619957|50632649|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
25317158|NCT00619957|50632648|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
25317159|NCT00619957|50632649|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
25317160|NCT00961415|50632659|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
25317161|NCT00961415|50632660|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
25317162|NCT00961415|50632661|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
25317163|NCT00961415|50632659|FG000|Induction Treatment Phase|Death|77|||
25317164|NCT00961415|50632660|FG001|Induction Treatment Phase|Death|0|||
25317165|NCT00961415|50632661|FG002|Induction Treatment Phase|Death|0|||
25317166|NCT00961415|50632659|FG000|Induction Treatment Phase|Protocol Violation|1|||
25317167|NCT00961415|50632660|FG001|Induction Treatment Phase|Protocol Violation|0|||
25317168|NCT00961415|50632661|FG002|Induction Treatment Phase|Protocol Violation|0|||
25317169|NCT00961415|50632659|FG000|Induction Treatment Phase|Physician Decision|2|||
25317170|NCT00961415|50632660|FG001|Induction Treatment Phase|Physician Decision|0|||
25317171|NCT00961415|50632661|FG002|Induction Treatment Phase|Physician Decision|0|||
25317172|NCT00961415|50632659|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
25317173|NCT00961415|50632660|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
25317174|NCT00961415|50632661|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
25317175|NCT00961415|50632659|FG000|Induction Treatment Phase|Other Reason|5|||
25317176|NCT00961415|50632660|FG001|Induction Treatment Phase|Other Reason|0|||
25317177|NCT00961415|50632661|FG002|Induction Treatment Phase|Other Reason|0|||
25317178|NCT00961415|50632659|FG000|Maintenance Treatment Phase|Death|0|||
25317179|NCT00961415|50632660|FG001|Maintenance Treatment Phase|Death|42|||
25317180|NCT00961415|50632661|FG002|Maintenance Treatment Phase|Death|34|||
25317181|NCT00961415|50632659|FG000|Maintenance Treatment Phase|Investigators decision|0|||
25317182|NCT00961415|50632660|FG001|Maintenance Treatment Phase|Investigators decision|2|||
25317183|NCT00961415|50632661|FG002|Maintenance Treatment Phase|Investigators decision|0|||
25317184|NCT00961415|50632659|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
25317185|NCT00961415|50632660|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
25317186|NCT00961415|50632661|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
25317187|NCT00961415|50632659|FG000|Maintenance Treatment Phase|Other reason|0|||
25317188|NCT00961415|50632660|FG001|Maintenance Treatment Phase|Other reason|1|||
25317189|NCT00961415|50632661|FG002|Maintenance Treatment Phase|Other reason|3|||
25317190|NCT00963599|50632679|FG000|Overall Study|Adverse Event|2|||
25217931|NCT01872078|50496173|FG001|Overall Study|Withdrawal by Subject|0|||
25317191|NCT00963599|50632680|FG001|Overall Study|Adverse Event|0|||
25217932|NCT01872078|50496174|FG002|Overall Study|Withdrawal by Subject|1|||
25217933|NCT01872078|50496175|FG003|Overall Study|Withdrawal by Subject|0|||
25217934|NCT01872078|50496172|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
25217935|NCT01872078|50496173|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
25217936|NCT01872078|50496174|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
25217937|NCT01872078|50496175|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
25217938|NCT01896726|50496185|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
25217939|NCT01896726|50496185|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
25217940|NCT01856790|50496192|FG000|Closed Loop Control|Withdrawal by Subject|2|||
25217941|NCT01856790|50496192|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
25317192|NCT00963599|50632681|FG002|Overall Study|Adverse Event|1|||
25317193|NCT00963599|50632682|FG003|Overall Study|Adverse Event|2|||
25317194|NCT00963599|50632679|FG000|Overall Study|Lack of Efficacy|0|||
25317195|NCT00963599|50632680|FG001|Overall Study|Lack of Efficacy|2|||
25317196|NCT00963599|50632681|FG002|Overall Study|Lack of Efficacy|1|||
25317197|NCT00963599|50632682|FG003|Overall Study|Lack of Efficacy|4|||
25317198|NCT00963599|50632679|FG000|Overall Study|Lost to Follow-up|0|||
25317199|NCT00963599|50632680|FG001|Overall Study|Lost to Follow-up|1|||
25317200|NCT00963599|50632681|FG002|Overall Study|Lost to Follow-up|1|||
25317201|NCT00963599|50632682|FG003|Overall Study|Lost to Follow-up|1|||
25317202|NCT00963599|50632679|FG000|Overall Study|Protocol Violation|2|||
25317203|NCT00963599|50632680|FG001|Overall Study|Protocol Violation|2|||
25317204|NCT00963599|50632681|FG002|Overall Study|Protocol Violation|3|||
25317205|NCT00963599|50632682|FG003|Overall Study|Protocol Violation|4|||
25317206|NCT00963599|50632679|FG000|Overall Study|Withdrawal by Subject|2|||
25317207|NCT00963599|50632680|FG001|Overall Study|Withdrawal by Subject|1|||
25317208|NCT00963599|50632681|FG002|Overall Study|Withdrawal by Subject|3|||
25317209|NCT00963599|50632682|FG003|Overall Study|Withdrawal by Subject|3|||
25317210|NCT00619801|50632694|FG000|Overall Study|Lack of Efficacy|0|||
25317211|NCT00619801|50632695|FG001|Overall Study|Lack of Efficacy|1|||
25317212|NCT00619801|50632694|FG000|Overall Study|Withdrawal by Subject|1|||
25317213|NCT00619801|50632695|FG001|Overall Study|Withdrawal by Subject|1|||
25317214|NCT00619801|50632694|FG000|Overall Study|Loss of efficacy|0|||
25317215|NCT00619801|50632695|FG001|Overall Study|Loss of efficacy|1|||
25317216|NCT00962741|50632701|FG000|Overall Study|Failed to return|3|||
25317217|NCT00962741|50632701|FG000|Overall Study|Lost to Follow-up|2|||
25317218|NCT00962741|50632701|FG000|Overall Study|Withdrawal by Subject|1|||
25317219|NCT00962741|50632701|FG000|Overall Study|Lack of Efficacy|1|||
25317220|NCT00962741|50632701|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
25317221|NCT00619645|50632705|FG000|Overall Study|Adverse Event|1|||
25317222|NCT00619177|50632709|FG000|Overall Study|Adverse Event|18|||
25317223|NCT00619177|50632709|FG000|Overall Study|Lost to Follow-up|2|||
25317224|NCT00619177|50632709|FG000|Overall Study|Lack of Efficacy|1|||
25317225|NCT00619177|50632709|FG000|Overall Study|Missing termination information|481|||
25317226|NCT00619177|50632709|FG000|Overall Study|Not specified reasons|6|||
25317227|NCT00818259|50632720|FG000|Part I|Withdrawal by Subject|1|||
25317228|NCT00818259|50632721|FG001|Part I|Withdrawal by Subject|0|||
25317229|NCT00818259|50632722|FG002|Part I|Withdrawal by Subject|0|||
25317230|NCT00818259|50632723|FG003|Part I|Withdrawal by Subject|0|||
25317231|NCT00818259|50632724|FG004|Part I|Withdrawal by Subject|0|||
25317232|NCT00818259|50632725|FG005|Part I|Withdrawal by Subject|0|||
25317233|NCT00818259|50632726|FG006|Part I|Withdrawal by Subject|0|||
25317234|NCT00818259|50632727|FG007|Part I|Withdrawal by Subject|0|||
25317235|NCT00818259|50632728|FG008|Part I|Withdrawal by Subject|0|||
25317236|NCT00818259|50632720|FG000|Part II|Physician Decision|0|||
25317237|NCT00818259|50632721|FG001|Part II|Physician Decision|0|||
25317238|NCT00818259|50632722|FG002|Part II|Physician Decision|1|||
25317239|NCT00818259|50632723|FG003|Part II|Physician Decision|0|||
25317240|NCT00818259|50632724|FG004|Part II|Physician Decision|0|||
25317241|NCT00818259|50632725|FG005|Part II|Physician Decision|0|||
25317242|NCT00818259|50632726|FG006|Part II|Physician Decision|0|||
25317243|NCT00818259|50632727|FG007|Part II|Physician Decision|0|||
25317244|NCT00818259|50632728|FG008|Part II|Physician Decision|0|||
25317245|NCT00818259|50632720|FG000|Part II|Lack of Efficacy|0|||
25217942|NCT01856322|50496206|FG000|Overall Study|off study due to lack of accrual|0|||
25317246|NCT00818259|50632721|FG001|Part II|Lack of Efficacy|0|||
25317247|NCT00818259|50632722|FG002|Part II|Lack of Efficacy|0|||
25317248|NCT00818259|50632723|FG003|Part II|Lack of Efficacy|1|||
25317249|NCT00818259|50632724|FG004|Part II|Lack of Efficacy|0|||
25317250|NCT00818259|50632725|FG005|Part II|Lack of Efficacy|0|||
25317251|NCT00818259|50632726|FG006|Part II|Lack of Efficacy|0|||
25317252|NCT00818259|50632727|FG007|Part II|Lack of Efficacy|0|||
25317253|NCT00818259|50632728|FG008|Part II|Lack of Efficacy|0|||
25317254|NCT00818259|50632720|FG000|Part II|Not Treated|0|||
25317255|NCT00818259|50632721|FG001|Part II|Not Treated|0|||
25317256|NCT00818259|50632722|FG002|Part II|Not Treated|0|||
25317257|NCT00818259|50632723|FG003|Part II|Not Treated|1|||
25317258|NCT00818259|50632724|FG004|Part II|Not Treated|0|||
25317259|NCT00818259|50632725|FG005|Part II|Not Treated|0|||
25217943|NCT01856322|50496207|FG001|Overall Study|off study due to lack of accrual|0|||
25217944|NCT01856322|50496208|FG002|Overall Study|off study due to lack of accrual|3|||
25217945|NCT01896102|50496215|FG000|Overall Study|Death|1|||
25217946|NCT01896102|50496215|FG000|Overall Study|Participant to receive allogenic transplant|2|||
25217947|NCT01871532|50496222|FG000|Overall Study|Withdrawal by Subject|1|||
25217948|NCT01871532|50496223|FG001|Overall Study|Withdrawal by Subject|2|||
25217949|NCT01855074|50496229|FG000|Overall Study|Adverse Event|1|||
25217950|NCT01855074|50496229|FG000|Overall Study|Lost to Follow-up|4|||
25217951|NCT01855074|50496229|FG000|Overall Study|Withdrawal by Subject|8|||
25217952|NCT01855074|50496229|FG000|Overall Study|Started but not treated|1|||
25217953|NCT01871142|50496233|FG000|Overall Study|Adverse Event|1|||
25217954|NCT01895322|50496247|FG000|Overall Study|Adverse Event|1|||
25217955|NCT01895322|50496247|FG000|Overall Study|Withdrawal by Subject|2|||
25217956|NCT01895322|50496247|FG000|Overall Study|Protocol Violation|10|||
25217957|NCT01894776|50496252|FG000|Overall Study|Withdrawal by Subject|1|||
25217958|NCT01894620|50496258|FG000|Overall Study|Withdrawal by Subject|0|||
25217959|NCT01894620|50496259|FG001|Overall Study|Withdrawal by Subject|1|||
25217960|NCT01854918|50496269|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
25317260|NCT00818259|50632726|FG006|Part II|Not Treated|0|||
25317261|NCT00818259|50632727|FG007|Part II|Not Treated|0|||
25317262|NCT00818259|50632728|FG008|Part II|Not Treated|0|||
24976476|NCT03462082|50065371|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
24976477|NCT03462082|50065372|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
24976478|NCT03462082|50065373|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
24976479|NCT03461146|50065383|FG000|Overall Study|Adverse Event|2|||
24976480|NCT03461146|50065383|FG000|Overall Study|Physician Decision|1|||
24976481|NCT03541252|50065387|FG000|Overall Study|Withdrawal by Subject|1|||
24976482|NCT00031460|50065393|FG000|Overall Study|Lost to Follow-up|0|||
25317263|NCT00818259|50632720|FG000|Part IV|Physician Decision|0|||
25317264|NCT00818259|50632721|FG001|Part IV|Physician Decision|0|||
25317265|NCT00818259|50632722|FG002|Part IV|Physician Decision|0|||
25317266|NCT00818259|50632723|FG003|Part IV|Physician Decision|0|||
25317267|NCT00818259|50632724|FG004|Part IV|Physician Decision|0|||
25317268|NCT00818259|50632725|FG005|Part IV|Physician Decision|1|||
25317269|NCT00818259|50632726|FG006|Part IV|Physician Decision|0|||
25317270|NCT00818259|50632727|FG007|Part IV|Physician Decision|0|||
25317271|NCT00818259|50632728|FG008|Part IV|Physician Decision|0|||
25317272|NCT00818259|50632720|FG000|Part V|Adverse Event|0|||
25317273|NCT00818259|50632721|FG001|Part V|Adverse Event|0|||
25317274|NCT00818259|50632722|FG002|Part V|Adverse Event|0|||
25317275|NCT00818259|50632723|FG003|Part V|Adverse Event|0|||
25317276|NCT00818259|50632724|FG004|Part V|Adverse Event|0|||
25317277|NCT00818259|50632725|FG005|Part V|Adverse Event|0|||
25317278|NCT00818259|50632726|FG006|Part V|Adverse Event|0|||
25317279|NCT00818259|50632727|FG007|Part V|Adverse Event|1|||
25317280|NCT00818259|50632728|FG008|Part V|Adverse Event|0|||
25317281|NCT00619099|50632746|FG000|Overall Study|Progressive Disease|7|||
25317282|NCT00619099|50632747|FG001|Overall Study|Progressive Disease|5|||
25317283|NCT00619099|50632746|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
25317284|NCT00619099|50632747|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
24976483|NCT00031460|50065394|FG001|Overall Study|Lost to Follow-up|1|||
24976484|NCT00031460|50065393|FG000|Overall Study|Withdrawal by Subject|1|||
25217961|NCT01854918|50496270|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
24976485|NCT00031460|50065394|FG001|Overall Study|Withdrawal by Subject|1|||
24976486|NCT00031460|50065393|FG000|Overall Study|Non-Compliant|1|||
25217962|NCT01854918|50496269|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
25317285|NCT00619099|50632746|FG000|Overall Study|Adverse Event|4|||
25317286|NCT00619099|50632747|FG001|Overall Study|Adverse Event|3|||
25317287|NCT00619099|50632746|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
25317288|NCT00619099|50632747|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
25317289|NCT00619099|50632746|FG000|Overall Study|Withdrawal by Subject|10|||
25317290|NCT00619099|50632747|FG001|Overall Study|Withdrawal by Subject|2|||
25217963|NCT01854918|50496270|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
25217964|NCT01854918|50496269|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
25217965|NCT01854918|50496270|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
25217966|NCT01854918|50496269|FG000|SOC-controlled Period (Year 1)|Death|5|||
25217967|NCT01854918|50496270|FG001|SOC-controlled Period (Year 1)|Death|5|||
25217968|NCT01854918|50496269|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
25217969|NCT01854918|50496270|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
25217970|NCT01854918|50496269|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
25217971|NCT01854918|50496270|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
25217972|NCT01854918|50496269|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
25217973|NCT01854918|50496270|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
25217974|NCT01854918|50496269|FG000|All-IP Period (Years 2 and 3)|Death|5|||
25217975|NCT01854918|50496270|FG001|All-IP Period (Years 2 and 3)|Death|16|||
25217976|NCT01894230|50496285|FG000|Overall Study|Lost to Follow-up|2|||
25217977|NCT01894230|50496286|FG001|Overall Study|Lost to Follow-up|2|||
25217978|NCT01894230|50496285|FG000|Overall Study|Withdrawal by Subject|4|||
25217979|NCT01894230|50496286|FG001|Overall Study|Withdrawal by Subject|4|||
25217980|NCT01894230|50496285|FG000|Overall Study|Non-adherent|0|||
25217981|NCT01894230|50496286|FG001|Overall Study|Non-adherent|1|||
25217982|NCT01894230|50496285|FG000|Overall Study|Death|1|||
25217983|NCT01894230|50496286|FG001|Overall Study|Death|0|||
25217984|NCT01894152|50496292|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
25217985|NCT01854528|50496298|FG000|Overall Study|Adverse Event|0|||
25217986|NCT01854528|50496299|FG001|Overall Study|Adverse Event|4|||
25217987|NCT01854528|50496298|FG000|Overall Study|Withdrawal by Subject|0|||
25217988|NCT01854528|50496299|FG001|Overall Study|Withdrawal by Subject|2|||
25217989|NCT01854528|50496298|FG000|Overall Study|Virologic Failure|0|||
25217990|NCT01854528|50496299|FG001|Overall Study|Virologic Failure|9|||
25217991|NCT01853982|50496307|FG000|Overall Study|Withdrawal by Subject|1|||
25217992|NCT01853982|50496308|FG001|Overall Study|Withdrawal by Subject|0|||
25217993|NCT01853982|50496307|FG000|Overall Study|Death|1|||
25217994|NCT01853982|50496308|FG001|Overall Study|Death|0|||
25217995|NCT01853982|50496307|FG000|Overall Study|Lost to Follow-up|0|||
25217996|NCT01853982|50496308|FG001|Overall Study|Lost to Follow-up|1|||
25217997|NCT01853280|50496316|FG000|Overall Study|Lack of Efficacy|2|||
25217998|NCT01853280|50496317|FG001|Overall Study|Lack of Efficacy|2|||
25217999|NCT01853280|50496316|FG000|Overall Study|Lost to Follow-up|0|||
25218000|NCT01853280|50496317|FG001|Overall Study|Lost to Follow-up|1|||
25218001|NCT01853280|50496316|FG000|Overall Study|Physician Decision|0|||
25218002|NCT01853280|50496317|FG001|Overall Study|Physician Decision|1|||
25218003|NCT01853280|50496316|FG000|Overall Study|Withdrawal by Subject|0|||
25218004|NCT01853280|50496317|FG001|Overall Study|Withdrawal by Subject|1|||
25218005|NCT01853280|50496316|FG000|Overall Study|Ineligible|0|||
25218006|NCT01853280|50496317|FG001|Overall Study|Ineligible|1|||
25218007|NCT01892436|50496327|FG000|Overall Study|Withdrawal by Subject|8|||
25218008|NCT01892436|50496328|FG001|Overall Study|Withdrawal by Subject|15|||
25218009|NCT01892436|50496329|FG002|Overall Study|Withdrawal by Subject|4|||
25218010|NCT01892436|50496330|FG003|Overall Study|Withdrawal by Subject|4|||
25218011|NCT01892436|50496327|FG000|Overall Study|Death|1|||
25218012|NCT01892436|50496328|FG001|Overall Study|Death|1|||
25218013|NCT01892436|50496329|FG002|Overall Study|Death|0|||
25218014|NCT01892436|50496330|FG003|Overall Study|Death|0|||
25218015|NCT01892436|50496327|FG000|Overall Study|Physician Decision|2|||
25218016|NCT01892436|50496328|FG001|Overall Study|Physician Decision|1|||
25218017|NCT01892436|50496329|FG002|Overall Study|Physician Decision|0|||
25218018|NCT01892436|50496330|FG003|Overall Study|Physician Decision|1|||
25218019|NCT01892436|50496327|FG000|Overall Study|Pregnancy|0|||
25218020|NCT01892436|50496328|FG001|Overall Study|Pregnancy|2|||
25218021|NCT01892436|50496329|FG002|Overall Study|Pregnancy|1|||
25218022|NCT01892436|50496330|FG003|Overall Study|Pregnancy|0|||
25218023|NCT01892436|50496327|FG000|Overall Study|Technical problems|2|||
25218024|NCT01892436|50496328|FG001|Overall Study|Technical problems|1|||
25218025|NCT01892436|50496329|FG002|Overall Study|Technical problems|1|||
25218026|NCT01892436|50496330|FG003|Overall Study|Technical problems|1|||
25218027|NCT01892436|50496327|FG000|Overall Study|Lack of Efficacy|1|||
25077407|NCT02936323|50185224|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
25218028|NCT01892436|50496328|FG001|Overall Study|Lack of Efficacy|2|||
25218029|NCT01892436|50496329|FG002|Overall Study|Lack of Efficacy|2|||
25218030|NCT01892436|50496330|FG003|Overall Study|Lack of Efficacy|2|||
25218031|NCT01892436|50496327|FG000|Overall Study|Lost to Follow-up|1|||
25218032|NCT01892436|50496328|FG001|Overall Study|Lost to Follow-up|1|||
25218033|NCT01892436|50496329|FG002|Overall Study|Lost to Follow-up|1|||
25218034|NCT01892436|50496330|FG003|Overall Study|Lost to Follow-up|3|||
25218035|NCT01892436|50496327|FG000|Overall Study|non-compliance with treatment|1|||
25218036|NCT01892436|50496328|FG001|Overall Study|non-compliance with treatment|0|||
25218037|NCT01892436|50496329|FG002|Overall Study|non-compliance with treatment|0|||
25218038|NCT01892436|50496330|FG003|Overall Study|non-compliance with treatment|0|||
25218039|NCT01892436|50496327|FG000|Overall Study|Adverse Event|7|||
25218040|NCT01892436|50496328|FG001|Overall Study|Adverse Event|6|||
25218041|NCT01892436|50496329|FG002|Overall Study|Adverse Event|2|||
25218042|NCT01892436|50496330|FG003|Overall Study|Adverse Event|3|||
25218043|NCT01853046|50496342|FG000|Overall Study|Withdrawal by Subject|1|||
25218044|NCT01853046|50496343|FG001|Overall Study|Withdrawal by Subject|1|||
25218045|NCT01853046|50496342|FG000|Overall Study|Adverse Event|4|||
25218046|NCT01853046|50496343|FG001|Overall Study|Adverse Event|2|||
25218047|NCT01853046|50496342|FG000|Overall Study|Disease progression|13|||
25218048|NCT01853046|50496343|FG001|Overall Study|Disease progression|3|||
25218049|NCT01891890|50496353|FG000|Overall Study|Lost to Follow-up|0|||
25218050|NCT01891890|50496354|FG001|Overall Study|Lost to Follow-up|0|||
25218051|NCT01891890|50496355|FG002|Overall Study|Lost to Follow-up|1|||
25218052|NCT01891890|50496353|FG000|Overall Study|Study ended before endpoint reached|7|||
25218053|NCT01891890|50496354|FG001|Overall Study|Study ended before endpoint reached|3|||
25218054|NCT01891890|50496355|FG002|Overall Study|Study ended before endpoint reached|6|||
25218055|NCT01852812|50496366|FG000|Overall Study|Adverse Event|0|||
25218056|NCT01852812|50496367|FG001|Overall Study|Adverse Event|0|||
25218057|NCT01852812|50496368|FG002|Overall Study|Adverse Event|1|||
25218058|NCT01852812|50496366|FG000|Overall Study|Non-compliance With Study Drug|0|||
25218059|NCT01852812|50496367|FG001|Overall Study|Non-compliance With Study Drug|1|||
25218060|NCT01852812|50496368|FG002|Overall Study|Non-compliance With Study Drug|0|||
25218061|NCT01869348|50496378|FG000|Overall Study|Withdrawal by Subject|1|||
25218062|NCT01869348|50496379|FG001|Overall Study|Withdrawal by Subject|1|||
25218063|NCT01869192|50496387|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
25218064|NCT01869192|50496388|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
25218065|NCT01869192|50496387|FG000|Postoperative Chemotherapy|Physician Decision|0|||
25218066|NCT01869192|50496388|FG001|Postoperative Chemotherapy|Physician Decision|2|||
25218067|NCT01868646|50496396|FG000|Overall Study|Do not meet inclusion criteria|3|||
25218068|NCT01868646|50496397|FG001|Overall Study|Do not meet inclusion criteria|5|||
25218069|NCT01852110|50496405|FG000|Overall Study|Adverse Event|12|||
25218070|NCT01852110|50496406|FG001|Overall Study|Adverse Event|5|||
25218071|NCT01852110|50496407|FG002|Overall Study|Adverse Event|0|||
25218072|NCT01852110|50496408|FG003|Overall Study|Adverse Event|0|||
25218073|NCT01852110|50496409|FG004|Overall Study|Adverse Event|0|||
25218074|NCT01852110|50496410|FG005|Overall Study|Adverse Event|0|||
25218075|NCT01852110|50496405|FG000|Overall Study|Lost to Follow-up|1|||
25218076|NCT01852110|50496406|FG001|Overall Study|Lost to Follow-up|3|||
25218077|NCT01852110|50496407|FG002|Overall Study|Lost to Follow-up|0|||
25218078|NCT01852110|50496408|FG003|Overall Study|Lost to Follow-up|0|||
25218079|NCT01852110|50496409|FG004|Overall Study|Lost to Follow-up|0|||
25218080|NCT01852110|50496410|FG005|Overall Study|Lost to Follow-up|0|||
25218081|NCT01852110|50496405|FG000|Overall Study|Non-compliance with Study Drug|2|||
25218082|NCT01852110|50496406|FG001|Overall Study|Non-compliance with Study Drug|1|||
25218083|NCT01852110|50496407|FG002|Overall Study|Non-compliance with Study Drug|0|||
25218084|NCT01852110|50496408|FG003|Overall Study|Non-compliance with Study Drug|0|||
25218085|NCT01852110|50496409|FG004|Overall Study|Non-compliance with Study Drug|0|||
25218086|NCT01852110|50496410|FG005|Overall Study|Non-compliance with Study Drug|0|||
25218087|NCT01852110|50496405|FG000|Overall Study|Physician Decision|1|||
25218088|NCT01852110|50496406|FG001|Overall Study|Physician Decision|0|||
25218089|NCT01852110|50496407|FG002|Overall Study|Physician Decision|0|||
25218090|NCT01852110|50496408|FG003|Overall Study|Physician Decision|0|||
25218091|NCT01852110|50496409|FG004|Overall Study|Physician Decision|0|||
25218092|NCT01852110|50496410|FG005|Overall Study|Physician Decision|0|||
25218093|NCT01852110|50496405|FG000|Overall Study|Protocol Violation|0|||
25218094|NCT01852110|50496406|FG001|Overall Study|Protocol Violation|1|||
25218095|NCT01852110|50496407|FG002|Overall Study|Protocol Violation|0|||
25218096|NCT01852110|50496408|FG003|Overall Study|Protocol Violation|0|||
25218097|NCT01852110|50496409|FG004|Overall Study|Protocol Violation|0|||
25218098|NCT01852110|50496410|FG005|Overall Study|Protocol Violation|0|||
25218099|NCT01852110|50496405|FG000|Overall Study|Study Terminated by Sponsor|30|||
25218100|NCT01852110|50496406|FG001|Overall Study|Study Terminated by Sponsor|32|||
25218101|NCT01852110|50496407|FG002|Overall Study|Study Terminated by Sponsor|0|||
25218102|NCT01852110|50496408|FG003|Overall Study|Study Terminated by Sponsor|0|||
25218103|NCT01852110|50496409|FG004|Overall Study|Study Terminated by Sponsor|0|||
25218104|NCT01852110|50496410|FG005|Overall Study|Study Terminated by Sponsor|0|||
25218105|NCT01852110|50496405|FG000|Overall Study|Withdrawal by Subject|4|||
25218106|NCT01852110|50496406|FG001|Overall Study|Withdrawal by Subject|4|||
25218107|NCT01852110|50496407|FG002|Overall Study|Withdrawal by Subject|0|||
25218108|NCT01852110|50496408|FG003|Overall Study|Withdrawal by Subject|0|||
25077408|NCT02936323|50185225|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
25218109|NCT01852110|50496409|FG004|Overall Study|Withdrawal by Subject|0|||
25218110|NCT01852110|50496410|FG005|Overall Study|Withdrawal by Subject|0|||
25218111|NCT01851720|50496426|FG000|Overall Study|Lost to Follow-up|0|||
25218112|NCT01851720|50496427|FG001|Overall Study|Lost to Follow-up|1|||
25218113|NCT01851330|50496436|FG000|Overall Study|Lack of Efficacy|10|||
25218114|NCT01851330|50496437|FG001|Overall Study|Lack of Efficacy|9|||
25218115|NCT01851330|50496438|FG002|Overall Study|Lack of Efficacy|2|||
25218116|NCT01851330|50496436|FG000|Overall Study|Lost to Follow-up|1|||
25218117|NCT01851330|50496437|FG001|Overall Study|Lost to Follow-up|6|||
25218118|NCT01851330|50496438|FG002|Overall Study|Lost to Follow-up|9|||
25218119|NCT01851330|50496436|FG000|Overall Study|Withdrew Consent|2|||
25317291|NCT00619099|50632746|FG000|Overall Study|Physician Decision|9|||
25317292|NCT00619099|50632747|FG001|Overall Study|Physician Decision|6|||
25317293|NCT00962585|50632757|FG000|Overall Study|Adverse Event|0|||
25317294|NCT00962585|50632758|FG001|Overall Study|Adverse Event|2|||
25317295|NCT00962585|50632759|FG002|Overall Study|Adverse Event|1|||
25317296|NCT00962585|50632760|FG003|Overall Study|Adverse Event|0|||
25317297|NCT00962585|50632757|FG000|Overall Study|Lost to Follow-up|3|||
25317298|NCT00962585|50632758|FG001|Overall Study|Lost to Follow-up|0|||
25317299|NCT00962585|50632759|FG002|Overall Study|Lost to Follow-up|1|||
25317300|NCT00962585|50632760|FG003|Overall Study|Lost to Follow-up|0|||
25317301|NCT00962585|50632757|FG000|Overall Study|Protocol Violation|0|||
25317302|NCT00962585|50632758|FG001|Overall Study|Protocol Violation|0|||
25317303|NCT00962585|50632759|FG002|Overall Study|Protocol Violation|1|||
25317304|NCT00962585|50632760|FG003|Overall Study|Protocol Violation|0|||
25218120|NCT01851330|50496437|FG001|Overall Study|Withdrew Consent|1|||
25218121|NCT01851330|50496438|FG002|Overall Study|Withdrew Consent|0|||
25218122|NCT01851330|50496436|FG000|Overall Study|Investigator's Discretion|0|||
25218123|NCT01851330|50496437|FG001|Overall Study|Investigator's Discretion|0|||
25218124|NCT01851330|50496438|FG002|Overall Study|Investigator's Discretion|1|||
25218125|NCT01868022|50496455|FG000|Overall Study|Withdrawal by Subject|0|||
25218126|NCT01868022|50496456|FG001|Overall Study|Withdrawal by Subject|0|||
25218127|NCT01868022|50496457|FG002|Overall Study|Withdrawal by Subject|1|||
25218128|NCT01868022|50496458|FG003|Overall Study|Withdrawal by Subject|1|||
25218129|NCT01868022|50496459|FG004|Overall Study|Withdrawal by Subject|0|||
25218130|NCT01868022|50496460|FG005|Overall Study|Withdrawal by Subject|0|||
25218131|NCT01868022|50496461|FG006|Overall Study|Withdrawal by Subject|0|||
25218132|NCT01868022|50496462|FG007|Overall Study|Withdrawal by Subject|1|||
25218133|NCT01868022|50496463|FG008|Overall Study|Withdrawal by Subject|0|||
25218134|NCT01868022|50496455|FG000|Overall Study|Adverse Event|0|||
25218135|NCT01868022|50496456|FG001|Overall Study|Adverse Event|0|||
25218136|NCT01868022|50496457|FG002|Overall Study|Adverse Event|0|||
25218137|NCT01868022|50496458|FG003|Overall Study|Adverse Event|0|||
25218138|NCT01868022|50496459|FG004|Overall Study|Adverse Event|2|||
25218139|NCT01868022|50496460|FG005|Overall Study|Adverse Event|0|||
25218140|NCT01868022|50496461|FG006|Overall Study|Adverse Event|0|||
25218141|NCT01868022|50496462|FG007|Overall Study|Adverse Event|2|||
25218142|NCT01868022|50496463|FG008|Overall Study|Adverse Event|2|||
25218143|NCT01868022|50496455|FG000|Overall Study|Physician Decision|0|||
25218144|NCT01868022|50496456|FG001|Overall Study|Physician Decision|0|||
25218145|NCT01868022|50496457|FG002|Overall Study|Physician Decision|0|||
25218146|NCT01868022|50496458|FG003|Overall Study|Physician Decision|0|||
25218147|NCT01868022|50496459|FG004|Overall Study|Physician Decision|0|||
25218148|NCT01868022|50496460|FG005|Overall Study|Physician Decision|1|||
25218149|NCT01868022|50496461|FG006|Overall Study|Physician Decision|0|||
25218150|NCT01868022|50496462|FG007|Overall Study|Physician Decision|2|||
25218151|NCT01868022|50496463|FG008|Overall Study|Physician Decision|0|||
25218152|NCT01868022|50496455|FG000|Overall Study|Study closed/terminated|0|||
25218153|NCT01868022|50496456|FG001|Overall Study|Study closed/terminated|0|||
25218154|NCT01868022|50496457|FG002|Overall Study|Study closed/terminated|0|||
25218155|NCT01868022|50496458|FG003|Overall Study|Study closed/terminated|0|||
25218156|NCT01868022|50496459|FG004|Overall Study|Study closed/terminated|0|||
25218157|NCT01868022|50496460|FG005|Overall Study|Study closed/terminated|0|||
25218158|NCT01868022|50496461|FG006|Overall Study|Study closed/terminated|0|||
25218159|NCT01868022|50496462|FG007|Overall Study|Study closed/terminated|1|||
25218160|NCT01868022|50496463|FG008|Overall Study|Study closed/terminated|0|||
25218161|NCT01868022|50496455|FG000|Overall Study|Ongoing|0|||
25317305|NCT00962585|50632757|FG000|Overall Study|Withdrawal by Subject|1|||
25317306|NCT00962585|50632758|FG001|Overall Study|Withdrawal by Subject|0|||
25317307|NCT00962585|50632759|FG002|Overall Study|Withdrawal by Subject|0|||
25317308|NCT00962585|50632760|FG003|Overall Study|Withdrawal by Subject|0|||
25317309|NCT00962585|50632757|FG000|Overall Study|Withdrew Consent|2|||
25317310|NCT00962585|50632758|FG001|Overall Study|Withdrew Consent|0|||
25077409|NCT02936323|50185226|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
25218162|NCT01868022|50496456|FG001|Overall Study|Ongoing|0|||
25218163|NCT01868022|50496457|FG002|Overall Study|Ongoing|0|||
25218164|NCT01868022|50496458|FG003|Overall Study|Ongoing|0|||
25218165|NCT01868022|50496459|FG004|Overall Study|Ongoing|0|||
25218166|NCT01868022|50496460|FG005|Overall Study|Ongoing|0|||
25218167|NCT01868022|50496461|FG006|Overall Study|Ongoing|0|||
25218168|NCT01868022|50496462|FG007|Overall Study|Ongoing|3|||
25218169|NCT01868022|50496463|FG008|Overall Study|Ongoing|0|||
25218170|NCT01850004|50496489|FG000|Overall Study|Poor/Non-compliance|1|||
25218171|NCT01850004|50496489|FG000|Overall Study|Participant Withdrew Consent|9|||
25218172|NCT01850004|50496489|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
25218173|NCT01850004|50496489|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
25218174|NCT01850004|50496489|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
25218175|NCT01850004|50496489|FG000|Overall Study|Other Reasons|2|||
25218176|NCT01850004|50496489|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
25218177|NCT01850004|50496489|FG000|Overall Study|Maximum Clinical Benefit|4|||
25218178|NCT01867710|50496497|FG000|Overall Study|Death|25|||
25218179|NCT01867710|50496498|FG001|Overall Study|Death|15|||
25218180|NCT01867710|50496499|FG002|Overall Study|Death|27|||
25218181|NCT01867710|50496500|FG003|Overall Study|Death|20|||
25218182|NCT01867710|50496497|FG000|Overall Study|Lost to Follow-up|3|||
25218183|NCT01867710|50496498|FG001|Overall Study|Lost to Follow-up|4|||
25218184|NCT01867710|50496499|FG002|Overall Study|Lost to Follow-up|3|||
25218185|NCT01867710|50496500|FG003|Overall Study|Lost to Follow-up|2|||
25218186|NCT01867710|50496497|FG000|Overall Study|Withdrawal of consent|2|||
25218187|NCT01867710|50496498|FG001|Overall Study|Withdrawal of consent|5|||
25218188|NCT01867710|50496499|FG002|Overall Study|Withdrawal of consent|1|||
25218189|NCT01867710|50496500|FG003|Overall Study|Withdrawal of consent|2|||
25218190|NCT01867710|50496497|FG000|Overall Study|Study Terminated by Sponsor|9|||
25218191|NCT01867710|50496498|FG001|Overall Study|Study Terminated by Sponsor|13|||
25218192|NCT01867710|50496499|FG002|Overall Study|Study Terminated by Sponsor|8|||
25218193|NCT01867710|50496500|FG003|Overall Study|Study Terminated by Sponsor|16|||
25218194|NCT01867710|50496497|FG000|Overall Study|Biochemical progression|0|||
25218195|NCT01867710|50496498|FG001|Overall Study|Biochemical progression|1|||
25218196|NCT01867710|50496499|FG002|Overall Study|Biochemical progression|0|||
25218197|NCT01867710|50496500|FG003|Overall Study|Biochemical progression|0|||
25218198|NCT01867710|50496497|FG000|Overall Study|Clinical progression|0|||
25218199|NCT01867710|50496498|FG001|Overall Study|Clinical progression|0|||
25218200|NCT01867710|50496499|FG002|Overall Study|Clinical progression|1|||
25218201|NCT01867710|50496500|FG003|Overall Study|Clinical progression|0|||
25218202|NCT01867710|50496497|FG000|Overall Study|Disease progression|1|||
25218203|NCT01867710|50496498|FG001|Overall Study|Disease progression|0|||
25218204|NCT01867710|50496499|FG002|Overall Study|Disease progression|0|||
25218205|NCT01867710|50496500|FG003|Overall Study|Disease progression|0|||
25218206|NCT01867710|50496497|FG000|Overall Study|Patient decision|0|||
25218207|NCT01867710|50496498|FG001|Overall Study|Patient decision|0|||
25218208|NCT01867710|50496499|FG002|Overall Study|Patient decision|0|||
25218209|NCT01867710|50496500|FG003|Overall Study|Patient decision|1|||
25218210|NCT01867710|50496497|FG000|Overall Study|Patient to follow subsequent treatment|0|||
25218211|NCT01867710|50496498|FG001|Overall Study|Patient to follow subsequent treatment|1|||
25218212|NCT01867710|50496499|FG002|Overall Study|Patient to follow subsequent treatment|0|||
25218213|NCT01867710|50496500|FG003|Overall Study|Patient to follow subsequent treatment|0|||
25218214|NCT01867710|50496497|FG000|Overall Study|Progressive disease|1|||
25218215|NCT01867710|50496498|FG001|Overall Study|Progressive disease|0|||
25218216|NCT01867710|50496499|FG002|Overall Study|Progressive disease|0|||
25218217|NCT01867710|50496500|FG003|Overall Study|Progressive disease|0|||
25218218|NCT01867710|50496497|FG000|Overall Study|Protocol Violation|0|||
25218219|NCT01867710|50496498|FG001|Overall Study|Protocol Violation|0|||
25218220|NCT01867710|50496499|FG002|Overall Study|Protocol Violation|0|||
25218221|NCT01867710|50496500|FG003|Overall Study|Protocol Violation|1|||
25218222|NCT01867710|50496497|FG000|Overall Study|PSA-progression|0|||
25218223|NCT01867710|50496498|FG001|Overall Study|PSA-progression|1|||
25218224|NCT01867710|50496499|FG002|Overall Study|PSA-progression|0|||
25218225|NCT01867710|50496500|FG003|Overall Study|PSA-progression|0|||
25218226|NCT01867710|50496497|FG000|Overall Study|Study medication no longer effective|0|||
25218227|NCT01867710|50496498|FG001|Overall Study|Study medication no longer effective|1|||
25218228|NCT01867710|50496499|FG002|Overall Study|Study medication no longer effective|0|||
25077410|NCT02936323|50185227|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
25077411|NCT02936323|50185228|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
25218229|NCT01867710|50496500|FG003|Overall Study|Study medication no longer effective|0|||
25218230|NCT01849848|50496510|FG000|Overall Study|Physician Decision|1|||
25218231|NCT01849848|50496510|FG000|Overall Study|Progression of the primary disease|3|||
25218232|NCT01849458|50496514|FG000|Overall Study|Lost to Follow-up|4|||
25218233|NCT01832766|50496518|FG000|Washout|Lost to Follow-up|0|||
25218234|NCT01832766|50496519|FG001|Washout|Lost to Follow-up|1|||
25218235|NCT01832532|50496527|FG000|Overall Study|Withdrawal by Subject|5|||
25218236|NCT01832532|50496528|FG001|Overall Study|Withdrawal by Subject|2|||
25218237|NCT01848990|50496537|FG000|Overall Study|Adverse Event|6|||
25218238|NCT01848990|50496538|FG001|Overall Study|Adverse Event|2|||
25218239|NCT01848990|50496539|FG002|Overall Study|Adverse Event|0|||
25218240|NCT01848990|50496537|FG000|Overall Study|Lost to Follow-up|6|||
25218241|NCT01848990|50496538|FG001|Overall Study|Lost to Follow-up|2|||
25218242|NCT01848990|50496539|FG002|Overall Study|Lost to Follow-up|2|||
25218243|NCT01848990|50496537|FG000|Overall Study|Protocol Violation|1|||
25218244|NCT01848990|50496538|FG001|Overall Study|Protocol Violation|1|||
25218245|NCT01848990|50496539|FG002|Overall Study|Protocol Violation|0|||
25218246|NCT01848990|50496537|FG000|Overall Study|Withdrawal by Subject|29|||
25218247|NCT01848990|50496538|FG001|Overall Study|Withdrawal by Subject|10|||
25218248|NCT01848990|50496539|FG002|Overall Study|Withdrawal by Subject|11|||
25218249|NCT01848990|50496537|FG000|Overall Study|Physician Decision|1|||
25218250|NCT01848990|50496538|FG001|Overall Study|Physician Decision|1|||
25218251|NCT01848990|50496539|FG002|Overall Study|Physician Decision|0|||
25218252|NCT01848990|50496537|FG000|Overall Study|Non Compliance|1|||
25218253|NCT01848990|50496538|FG001|Overall Study|Non Compliance|0|||
25218254|NCT01848990|50496539|FG002|Overall Study|Non Compliance|0|||
25218255|NCT01848990|50496537|FG000|Overall Study|Death|1|||
25218256|NCT01848990|50496538|FG001|Overall Study|Death|0|||
25218257|NCT01848990|50496539|FG002|Overall Study|Death|1|||
25218258|NCT01848990|50496537|FG000|Overall Study|Other|1|||
25218259|NCT01848990|50496538|FG001|Overall Study|Other|4|||
25218260|NCT01848990|50496539|FG002|Overall Study|Other|2|||
25317311|NCT00962585|50632759|FG002|Overall Study|Withdrew Consent|0|||
25317312|NCT00962585|50632760|FG003|Overall Study|Withdrew Consent|0|||
25317313|NCT00621985|50632772|FG000|Dexamethasone Admission|Adverse Event|1|||
25317314|NCT00961259|50632782|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
25317315|NCT00961259|50632783|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
25317316|NCT00961259|50632784|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
25317317|NCT00961181|50632793|FG000|Overall Study|Death|2|||
25317318|NCT00961181|50632793|FG000|Overall Study|Withdrawal by Subject|2|||
25317319|NCT00961181|50632793|FG000|Overall Study|Lost to Follow-up|1|||
25317320|NCT00817635|50632802|FG000|Overall Study|Adverse Event|1|||
25317321|NCT00817635|50632803|FG001|Overall Study|Adverse Event|0|||
25317322|NCT00817635|50632804|FG002|Overall Study|Adverse Event|0|||
25317323|NCT00817635|50632805|FG003|Overall Study|Adverse Event|1|||
25317324|NCT00817635|50632806|FG004|Overall Study|Adverse Event|1|||
25317325|NCT00817635|50632802|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
25317326|NCT00817635|50632803|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
25317327|NCT00817635|50632804|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
25317328|NCT00817635|50632805|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
25317329|NCT00817635|50632806|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
25317330|NCT00817635|50632802|FG000|Overall Study|Withdrawal by Subject|2|||
25317331|NCT00817635|50632803|FG001|Overall Study|Withdrawal by Subject|1|||
25317332|NCT00817635|50632804|FG002|Overall Study|Withdrawal by Subject|0|||
25317333|NCT00817635|50632805|FG003|Overall Study|Withdrawal by Subject|1|||
25317334|NCT00817635|50632806|FG004|Overall Study|Withdrawal by Subject|2|||
25317335|NCT00817635|50632802|FG000|Overall Study|Lost to Follow-up|0|||
25317336|NCT00817635|50632803|FG001|Overall Study|Lost to Follow-up|1|||
25317337|NCT00817635|50632804|FG002|Overall Study|Lost to Follow-up|0|||
25317338|NCT00817635|50632805|FG003|Overall Study|Lost to Follow-up|1|||
25317339|NCT00817635|50632806|FG004|Overall Study|Lost to Follow-up|0|||
25317340|NCT00817635|50632802|FG000|Overall Study|Administrative Problems|0|||
25317341|NCT00817635|50632803|FG001|Overall Study|Administrative Problems|0|||
25317342|NCT00817635|50632804|FG002|Overall Study|Administrative Problems|0|||
25317343|NCT00817635|50632805|FG003|Overall Study|Administrative Problems|0|||
25317344|NCT00817635|50632806|FG004|Overall Study|Administrative Problems|1|||
25317345|NCT00817635|50632802|FG000|Overall Study|Protocol Violation|5|||
25317346|NCT00817635|50632803|FG001|Overall Study|Protocol Violation|1|||
25317347|NCT00817635|50632804|FG002|Overall Study|Protocol Violation|3|||
25317348|NCT00817635|50632805|FG003|Overall Study|Protocol Violation|2|||
25317349|NCT00817635|50632806|FG004|Overall Study|Protocol Violation|3|||
25317350|NCT00817479|50632827|FG000|Overall Study|Physician Decision|1|||
25317351|NCT00817479|50632828|FG001|Overall Study|Physician Decision|1|||
25218261|NCT01867086|50496551|FG000|Overall Study|Disease Progression|1|||
25317352|NCT00961961|50632838|FG000|Phase I|Withdrawal by Subject|7|||
25317353|NCT00961961|50632839|FG001|Phase I|Withdrawal by Subject|0|||
25317354|NCT00961961|50632840|FG002|Phase I|Withdrawal by Subject|0|||
25317355|NCT00961961|50632841|FG003|Phase I|Withdrawal by Subject|0|||
25317356|NCT00961961|50632838|FG000|Phase I|Lost to Follow-up|10|||
25317357|NCT00961961|50632839|FG001|Phase I|Lost to Follow-up|0|||
25317358|NCT00961961|50632840|FG002|Phase I|Lost to Follow-up|0|||
25218262|NCT01831596|50496555|FG000|Overall Study|Other|8|||
25218263|NCT01848834|50496564|FG000|Overall Study|Adverse Event|3|||
25218264|NCT01848834|50496565|FG001|Overall Study|Adverse Event|11|||
25218265|NCT01848834|50496566|FG002|Overall Study|Adverse Event|3|||
25218266|NCT01848834|50496567|FG003|Overall Study|Adverse Event|5|||
25218267|NCT01848834|50496568|FG004|Overall Study|Adverse Event|9|||
25317359|NCT00961961|50632841|FG003|Phase I|Lost to Follow-up|0|||
25218268|NCT01848834|50496564|FG000|Overall Study|Death|2|||
25218269|NCT01848834|50496565|FG001|Overall Study|Death|11|||
25218270|NCT01848834|50496566|FG002|Overall Study|Death|1|||
25218271|NCT01848834|50496567|FG003|Overall Study|Death|8|||
25218272|NCT01848834|50496568|FG004|Overall Study|Death|27|||
25218273|NCT01848834|50496564|FG000|Overall Study|Excluded Medication|5|||
25218274|NCT01848834|50496565|FG001|Overall Study|Excluded Medication|4|||
25218275|NCT01848834|50496566|FG002|Overall Study|Excluded Medication|3|||
25218276|NCT01848834|50496567|FG003|Overall Study|Excluded Medication|6|||
25218277|NCT01848834|50496568|FG004|Overall Study|Excluded Medication|6|||
25218278|NCT01848834|50496564|FG000|Overall Study|Lost to Follow-up|5|||
25218279|NCT01848834|50496565|FG001|Overall Study|Lost to Follow-up|5|||
25218280|NCT01848834|50496566|FG002|Overall Study|Lost to Follow-up|3|||
25218281|NCT01848834|50496567|FG003|Overall Study|Lost to Follow-up|0|||
25218282|NCT01848834|50496568|FG004|Overall Study|Lost to Follow-up|3|||
25218283|NCT01848834|50496564|FG000|Overall Study|Physician Decision|1|||
25218284|NCT01848834|50496565|FG001|Overall Study|Physician Decision|3|||
25218285|NCT01848834|50496566|FG002|Overall Study|Physician Decision|4|||
25218286|NCT01848834|50496567|FG003|Overall Study|Physician Decision|0|||
25218287|NCT01848834|50496568|FG004|Overall Study|Physician Decision|11|||
25218288|NCT01848834|50496564|FG000|Overall Study|Protocol Violation|0|||
25218289|NCT01848834|50496565|FG001|Overall Study|Protocol Violation|0|||
25218290|NCT01848834|50496566|FG002|Overall Study|Protocol Violation|0|||
25218291|NCT01848834|50496567|FG003|Overall Study|Protocol Violation|0|||
25218292|NCT01848834|50496568|FG004|Overall Study|Protocol Violation|1|||
25218293|NCT01848834|50496564|FG000|Overall Study|Sponsor Decision|1|||
25218294|NCT01848834|50496565|FG001|Overall Study|Sponsor Decision|1|||
25218295|NCT01848834|50496566|FG002|Overall Study|Sponsor Decision|0|||
25218296|NCT01848834|50496567|FG003|Overall Study|Sponsor Decision|1|||
25218297|NCT01848834|50496568|FG004|Overall Study|Sponsor Decision|1|||
25218298|NCT01848834|50496564|FG000|Overall Study|Withdrawal by Subject|2|||
25218299|NCT01848834|50496565|FG001|Overall Study|Withdrawal by Subject|13|||
25218300|NCT01848834|50496566|FG002|Overall Study|Withdrawal by Subject|10|||
25218301|NCT01848834|50496567|FG003|Overall Study|Withdrawal by Subject|6|||
25218302|NCT01848834|50496568|FG004|Overall Study|Withdrawal by Subject|36|||
25218303|NCT01867008|50496584|FG000|Overall Study|Withdrawal by Subject|1|||
25218304|NCT01848756|50496588|FG000|Overall Study|Adverse Event|1|||
25218305|NCT01848756|50496588|FG000|Overall Study|Withdrawal by Subject|1|||
25218306|NCT01848756|50496588|FG000|Overall Study|Enrolled in Error|1|||
25218307|NCT01830972|50496595|FG000|Part II|Withdrawal by Subject|2|||
25218308|NCT01830972|50496596|FG001|Part II|Withdrawal by Subject|2|||
25218309|NCT01830972|50496595|FG000|Part III|Withdrawal by Subject|1|||
25218310|NCT01830972|50496596|FG001|Part III|Withdrawal by Subject|0|||
25218311|NCT01830972|50496595|FG000|Part III|Noncompliance|1|||
25218312|NCT01830972|50496596|FG001|Part III|Noncompliance|0|||
25218313|NCT01830972|50496595|FG000|Part IV|Withdrawal by Subject|2|||
25218314|NCT01830972|50496596|FG001|Part IV|Withdrawal by Subject|1|||
25218315|NCT01830972|50496595|FG000|Part IV|Non-Compliance|1|||
25218316|NCT01830972|50496596|FG001|Part IV|Non-Compliance|0|||
25218317|NCT01848288|50496612|FG000|Overall Study|Death|1|||
25218318|NCT01848288|50496612|FG000|Overall Study|Protocol Violation|1|||
25218319|NCT01848288|50496612|FG000|Overall Study|Withdrawal by Subject|1|||
25218320|NCT01848210|50496619|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
25218321|NCT01848210|50496620|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
25218322|NCT01848210|50496619|FG000|Overall Study|Lost to Follow-up|24|||
25218323|NCT01848210|50496620|FG001|Overall Study|Lost to Follow-up|12|||
25218324|NCT01848210|50496619|FG000|Overall Study|Protocol Violation|3|||
25218325|NCT01848210|50496620|FG001|Overall Study|Protocol Violation|5|||
25218326|NCT01848210|50496619|FG000|Overall Study|Use of Forbidden Drugs|9|||
25218327|NCT01848210|50496620|FG001|Overall Study|Use of Forbidden Drugs|10|||
25218328|NCT01848210|50496619|FG000|Overall Study|Impedition Condition|5|||
25218329|NCT01848210|50496620|FG001|Overall Study|Impedition Condition|9|||
25317360|NCT00961961|50632838|FG000|Phase I|Lack of Efficacy|94|||
25317361|NCT00961961|50632839|FG001|Phase I|Lack of Efficacy|0|||
25218330|NCT01848210|50496619|FG000|Overall Study|Adverse Event|7|||
25218331|NCT01848210|50496620|FG001|Overall Study|Adverse Event|9|||
25218332|NCT01848210|50496619|FG000|Overall Study|Discontinuation Criterion|5|||
25218333|NCT01848210|50496620|FG001|Overall Study|Discontinuation Criterion|7|||
25218334|NCT01848210|50496619|FG000|Overall Study|Hypesensitivity|1|||
25218335|NCT01848210|50496620|FG001|Overall Study|Hypesensitivity|0|||
25218336|NCT01848210|50496619|FG000|Overall Study|Hepatic Function Alteration|4|||
25218337|NCT01848210|50496620|FG001|Overall Study|Hepatic Function Alteration|0|||
25218338|NCT01848210|50496619|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
25218339|NCT01848210|50496620|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
25218340|NCT01848210|50496619|FG000|Overall Study|Administrative|1|||
25218341|NCT01848210|50496620|FG001|Overall Study|Administrative|0|||
25218342|NCT01830816|50496629|FG000|Overall Study|Progressive Disease|12|||
25218343|NCT01830816|50496630|FG001|Overall Study|Progressive Disease|7|||
25218344|NCT01830816|50496631|FG002|Overall Study|Progressive Disease|7|||
25218345|NCT01830816|50496629|FG000|Overall Study|Adverse Event|3|||
25218346|NCT01830816|50496630|FG001|Overall Study|Adverse Event|4|||
25218347|NCT01830816|50496631|FG002|Overall Study|Adverse Event|0|||
25218348|NCT01830816|50496629|FG000|Overall Study|Study Terminated by Sponsor|1|||
25218349|NCT01830816|50496630|FG001|Overall Study|Study Terminated by Sponsor|1|||
25218350|NCT01830816|50496631|FG002|Overall Study|Study Terminated by Sponsor|0|||
25218351|NCT01830816|50496629|FG000|Overall Study|Withdrawal by Subject|1|||
25218352|NCT01830816|50496630|FG001|Overall Study|Withdrawal by Subject|1|||
25218353|NCT01830816|50496631|FG002|Overall Study|Withdrawal by Subject|0|||
25218354|NCT01830816|50496629|FG000|Overall Study|Lost to Follow-up|0|||
25218355|NCT01830816|50496630|FG001|Overall Study|Lost to Follow-up|1|||
25218356|NCT01830816|50496631|FG002|Overall Study|Lost to Follow-up|0|||
25218357|NCT01830816|50496629|FG000|Overall Study|Symptomatic Deterioration|1|||
25218358|NCT01830816|50496630|FG001|Overall Study|Symptomatic Deterioration|0|||
25218359|NCT01830816|50496631|FG002|Overall Study|Symptomatic Deterioration|0|||
25218360|NCT01830816|50496629|FG000|Overall Study|Reason not Specified|2|||
25218361|NCT01830816|50496630|FG001|Overall Study|Reason not Specified|0|||
25218362|NCT01830816|50496631|FG002|Overall Study|Reason not Specified|0|||
25218363|NCT01846416|50496645|FG000|Treatment Phase|Death|2|||
25218364|NCT01846416|50496646|FG001|Treatment Phase|Death|9|||
25218365|NCT01846416|50496647|FG002|Treatment Phase|Death|1|||
25218366|NCT01846416|50496645|FG000|Treatment Phase|Withdrawal by Subject|2|||
25218367|NCT01846416|50496646|FG001|Treatment Phase|Withdrawal by Subject|4|||
25218368|NCT01846416|50496647|FG002|Treatment Phase|Withdrawal by Subject|2|||
25218369|NCT01846416|50496645|FG000|Treatment Phase|Other|1|||
25218370|NCT01846416|50496646|FG001|Treatment Phase|Other|5|||
25218371|NCT01846416|50496647|FG002|Treatment Phase|Other|1|||
25218372|NCT01846416|50496645|FG000|Treatment Phase|Physician Decision|1|||
25218373|NCT01846416|50496646|FG001|Treatment Phase|Physician Decision|2|||
25218374|NCT01846416|50496647|FG002|Treatment Phase|Physician Decision|0|||
25218375|NCT01846416|50496645|FG000|Treatment Phase|Adverse Event|3|||
25218376|NCT01846416|50496646|FG001|Treatment Phase|Adverse Event|4|||
25218377|NCT01846416|50496647|FG002|Treatment Phase|Adverse Event|0|||
25218378|NCT01846416|50496645|FG000|Treatment Phase|Non-compliance|0|||
25218379|NCT01846416|50496646|FG001|Treatment Phase|Non-compliance|2|||
25218380|NCT01846416|50496647|FG002|Treatment Phase|Non-compliance|0|||
25218381|NCT01846416|50496645|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
25218382|NCT01846416|50496646|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
25218383|NCT01846416|50496647|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
25218384|NCT01846416|50496645|FG000|Treatment Phase|Progressive Disease|21|||
25218385|NCT01846416|50496646|FG001|Treatment Phase|Progressive Disease|63|||
25218386|NCT01846416|50496647|FG002|Treatment Phase|Progressive Disease|9|||
25218387|NCT01846416|50496645|FG000|Survival Follow-up|Death|21|||
25218388|NCT01846416|50496646|FG001|Survival Follow-up|Death|62|||
25218389|NCT01846416|50496647|FG002|Survival Follow-up|Death|9|||
25218390|NCT01846416|50496645|FG000|Survival Follow-up|Lost to Follow-up|0|||
25218391|NCT01846416|50496646|FG001|Survival Follow-up|Lost to Follow-up|2|||
25218392|NCT01846416|50496647|FG002|Survival Follow-up|Lost to Follow-up|2|||
25218393|NCT01846416|50496645|FG000|Survival Follow-up|Withdrawal by Subject|2|||
25218394|NCT01846416|50496646|FG001|Survival Follow-up|Withdrawal by Subject|7|||
25218395|NCT01846416|50496647|FG002|Survival Follow-up|Withdrawal by Subject|0|||
25218396|NCT01846416|50496645|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
25218397|NCT01846416|50496646|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
25218398|NCT01846416|50496647|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
25218399|NCT01846416|50496645|FG000|Survival Follow-up|Other|3|||
25218400|NCT01846416|50496646|FG001|Survival Follow-up|Other|1|||
25218401|NCT01846416|50496647|FG002|Survival Follow-up|Other|1|||
25218402|NCT01865448|50496658|FG000|Overall Study|Adverse Event|1|||
25218403|NCT01865448|50496659|FG001|Overall Study|Adverse Event|1|||
25218404|NCT01865448|50496658|FG000|Overall Study|Pregnancy|0|||
25218405|NCT01865448|50496659|FG001|Overall Study|Pregnancy|1|||
25218406|NCT01865448|50496658|FG000|Overall Study|dropout unrelated to study|1|||
25218407|NCT01865448|50496659|FG001|Overall Study|dropout unrelated to study|1|||
25317362|NCT00961961|50632840|FG002|Phase I|Lack of Efficacy|0|||
25317363|NCT00961961|50632841|FG003|Phase I|Lack of Efficacy|0|||
25218408|NCT01804140|50496666|FG000|Overall Study|No sampling or biopsy procedures done|114|||
25218409|NCT01846104|50496670|FG000|Overall Study|Withdrawal by Subject|1|||
25218410|NCT01803282|50496686|FG000|Overall Study|Progressive Disease|4|||
25218411|NCT01803282|50496687|FG001|Overall Study|Progressive Disease|3|||
25218412|NCT01803282|50496688|FG002|Overall Study|Progressive Disease|6|||
25218413|NCT01803282|50496689|FG003|Overall Study|Progressive Disease|22|||
25218414|NCT01803282|50496690|FG004|Overall Study|Progressive Disease|5|||
25218415|NCT01803282|50496691|FG005|Overall Study|Progressive Disease|8|||
25218416|NCT01803282|50496692|FG006|Overall Study|Progressive Disease|23|||
25317364|NCT00961961|50632838|FG000|Phase I|Adverse Event|7|||
25218417|NCT01803282|50496693|FG007|Overall Study|Progressive Disease|24|||
25218418|NCT01803282|50496694|FG008|Overall Study|Progressive Disease|3|||
25218419|NCT01803282|50496695|FG009|Overall Study|Progressive Disease|29|||
25218420|NCT01803282|50496696|FG010|Overall Study|Progressive Disease|6|||
25218421|NCT01803282|50496697|FG011|Overall Study|Progressive Disease|11|||
25218422|NCT01803282|50496686|FG000|Overall Study|Death|0|||
25218423|NCT01803282|50496687|FG001|Overall Study|Death|0|||
25218424|NCT01803282|50496688|FG002|Overall Study|Death|0|||
25218425|NCT01803282|50496689|FG003|Overall Study|Death|0|||
25218426|NCT01803282|50496690|FG004|Overall Study|Death|2|||
25218427|NCT01803282|50496691|FG005|Overall Study|Death|1|||
25218428|NCT01803282|50496692|FG006|Overall Study|Death|1|||
25218429|NCT01803282|50496693|FG007|Overall Study|Death|5|||
25218430|NCT01803282|50496694|FG008|Overall Study|Death|1|||
25218431|NCT01803282|50496695|FG009|Overall Study|Death|1|||
25218432|NCT01803282|50496696|FG010|Overall Study|Death|0|||
25218433|NCT01803282|50496697|FG011|Overall Study|Death|0|||
25218434|NCT01803282|50496686|FG000|Overall Study|Withdrew Consent|0|||
25218435|NCT01803282|50496687|FG001|Overall Study|Withdrew Consent|0|||
25218436|NCT01803282|50496688|FG002|Overall Study|Withdrew Consent|0|||
25218437|NCT01803282|50496689|FG003|Overall Study|Withdrew Consent|6|||
25218438|NCT01803282|50496690|FG004|Overall Study|Withdrew Consent|1|||
25218439|NCT01803282|50496691|FG005|Overall Study|Withdrew Consent|0|||
25218440|NCT01803282|50496692|FG006|Overall Study|Withdrew Consent|8|||
25218441|NCT01803282|50496693|FG007|Overall Study|Withdrew Consent|3|||
25218442|NCT01803282|50496694|FG008|Overall Study|Withdrew Consent|1|||
25218443|NCT01803282|50496695|FG009|Overall Study|Withdrew Consent|5|||
25218444|NCT01803282|50496696|FG010|Overall Study|Withdrew Consent|0|||
25218445|NCT01803282|50496697|FG011|Overall Study|Withdrew Consent|1|||
25218446|NCT01803282|50496686|FG000|Overall Study|Investigator's Discretion|0|||
25218447|NCT01803282|50496687|FG001|Overall Study|Investigator's Discretion|0|||
25218448|NCT01803282|50496688|FG002|Overall Study|Investigator's Discretion|0|||
25218449|NCT01803282|50496689|FG003|Overall Study|Investigator's Discretion|7|||
25218450|NCT01803282|50496690|FG004|Overall Study|Investigator's Discretion|2|||
25218451|NCT01803282|50496691|FG005|Overall Study|Investigator's Discretion|1|||
25218452|NCT01803282|50496692|FG006|Overall Study|Investigator's Discretion|7|||
25218453|NCT01803282|50496693|FG007|Overall Study|Investigator's Discretion|10|||
25218454|NCT01803282|50496694|FG008|Overall Study|Investigator's Discretion|6|||
25218455|NCT01803282|50496695|FG009|Overall Study|Investigator's Discretion|7|||
25218456|NCT01803282|50496696|FG010|Overall Study|Investigator's Discretion|1|||
25218457|NCT01803282|50496697|FG011|Overall Study|Investigator's Discretion|0|||
25218458|NCT01803282|50496686|FG000|Overall Study|Adverse Event|0|||
25218459|NCT01803282|50496687|FG001|Overall Study|Adverse Event|0|||
25218460|NCT01803282|50496688|FG002|Overall Study|Adverse Event|0|||
25218461|NCT01803282|50496689|FG003|Overall Study|Adverse Event|0|||
25218462|NCT01803282|50496690|FG004|Overall Study|Adverse Event|0|||
25218463|NCT01803282|50496691|FG005|Overall Study|Adverse Event|0|||
25218464|NCT01803282|50496692|FG006|Overall Study|Adverse Event|1|||
25218465|NCT01803282|50496693|FG007|Overall Study|Adverse Event|2|||
25218466|NCT01803282|50496694|FG008|Overall Study|Adverse Event|0|||
25218467|NCT01803282|50496695|FG009|Overall Study|Adverse Event|1|||
25218468|NCT01803282|50496696|FG010|Overall Study|Adverse Event|0|||
25218469|NCT01803282|50496697|FG011|Overall Study|Adverse Event|3|||
25218470|NCT01803282|50496686|FG000|Overall Study|Non-Compliance with Study Drug|0|||
25218471|NCT01803282|50496687|FG001|Overall Study|Non-Compliance with Study Drug|0|||
25218472|NCT01803282|50496688|FG002|Overall Study|Non-Compliance with Study Drug|0|||
25218473|NCT01803282|50496689|FG003|Overall Study|Non-Compliance with Study Drug|1|||
25218474|NCT01803282|50496690|FG004|Overall Study|Non-Compliance with Study Drug|0|||
25218475|NCT01803282|50496691|FG005|Overall Study|Non-Compliance with Study Drug|0|||
25218476|NCT01803282|50496692|FG006|Overall Study|Non-Compliance with Study Drug|0|||
25218477|NCT01803282|50496693|FG007|Overall Study|Non-Compliance with Study Drug|0|||
25218478|NCT01803282|50496694|FG008|Overall Study|Non-Compliance with Study Drug|0|||
25218479|NCT01803282|50496695|FG009|Overall Study|Non-Compliance with Study Drug|0|||
25218480|NCT01803282|50496696|FG010|Overall Study|Non-Compliance with Study Drug|0|||
25218481|NCT01803282|50496697|FG011|Overall Study|Non-Compliance with Study Drug|0|||
25218482|NCT01803282|50496686|FG000|Overall Study|Unknown Reason|0|||
25218483|NCT01803282|50496687|FG001|Overall Study|Unknown Reason|0|||
25218484|NCT01803282|50496688|FG002|Overall Study|Unknown Reason|0|||
25218485|NCT01803282|50496689|FG003|Overall Study|Unknown Reason|0|||
25317365|NCT00961961|50632839|FG001|Phase I|Adverse Event|0|||
25218486|NCT01803282|50496690|FG004|Overall Study|Unknown Reason|0|||
25218487|NCT01803282|50496691|FG005|Overall Study|Unknown Reason|0|||
25218488|NCT01803282|50496692|FG006|Overall Study|Unknown Reason|0|||
25218489|NCT01803282|50496693|FG007|Overall Study|Unknown Reason|1|||
25218490|NCT01803282|50496694|FG008|Overall Study|Unknown Reason|0|||
25218491|NCT01803282|50496695|FG009|Overall Study|Unknown Reason|0|||
25218492|NCT01803282|50496696|FG010|Overall Study|Unknown Reason|0|||
25317366|NCT00961961|50632840|FG002|Phase I|Adverse Event|0|||
25218493|NCT01803282|50496697|FG011|Overall Study|Unknown Reason|0|||
25218494|NCT01803282|50496686|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
25218495|NCT01803282|50496687|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
25218496|NCT01803282|50496688|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
25218497|NCT01803282|50496689|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
25218498|NCT01803282|50496690|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
25218499|NCT01803282|50496691|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
25218500|NCT01803282|50496692|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
25218501|NCT01803282|50496693|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
25218502|NCT01803282|50496694|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
25218503|NCT01803282|50496695|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
25218504|NCT01803282|50496696|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
25218505|NCT01803282|50496697|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
25218506|NCT01803282|50496686|FG000|Overall Study|Enrolled but Never Treated|0|||
25218507|NCT01803282|50496687|FG001|Overall Study|Enrolled but Never Treated|0|||
25218508|NCT01803282|50496688|FG002|Overall Study|Enrolled but Never Treated|0|||
25218509|NCT01803282|50496689|FG003|Overall Study|Enrolled but Never Treated|0|||
25218510|NCT01803282|50496690|FG004|Overall Study|Enrolled but Never Treated|1|||
25218511|NCT01803282|50496691|FG005|Overall Study|Enrolled but Never Treated|0|||
25218512|NCT01803282|50496692|FG006|Overall Study|Enrolled but Never Treated|1|||
25218513|NCT01803282|50496693|FG007|Overall Study|Enrolled but Never Treated|1|||
25218514|NCT01803282|50496694|FG008|Overall Study|Enrolled but Never Treated|0|||
25218515|NCT01803282|50496695|FG009|Overall Study|Enrolled but Never Treated|1|||
25218516|NCT01803282|50496696|FG010|Overall Study|Enrolled but Never Treated|0|||
25218517|NCT01803282|50496697|FG011|Overall Study|Enrolled but Never Treated|0|||
25218518|NCT01844778|50496726|FG000|Overall Study|Protocol deviation|0|||
25218519|NCT01844778|50496727|FG001|Overall Study|Protocol deviation|1|||
25218520|NCT01844778|50496728|FG002|Overall Study|Protocol deviation|2|||
25218521|NCT01844778|50496726|FG000|Overall Study|Withdrawal by Subject|2|||
25218522|NCT01844778|50496727|FG001|Overall Study|Withdrawal by Subject|0|||
25218523|NCT01844778|50496728|FG002|Overall Study|Withdrawal by Subject|0|||
25218524|NCT01844778|50496726|FG000|Overall Study|Adverse Event|0|||
25218525|NCT01844778|50496727|FG001|Overall Study|Adverse Event|2|||
25218526|NCT01844778|50496728|FG002|Overall Study|Adverse Event|2|||
25218527|NCT01802580|50496742|FG000|Overall Study|Physician Decision|1|||
25218528|NCT01802580|50496743|FG001|Overall Study|Physician Decision|0|||
25218529|NCT01802580|50496742|FG000|Overall Study|Protocol Violation|2|||
25218530|NCT01802580|50496743|FG001|Overall Study|Protocol Violation|0|||
25218531|NCT01802580|50496742|FG000|Overall Study|Withdrawal by Subject|5|||
25218532|NCT01802580|50496743|FG001|Overall Study|Withdrawal by Subject|6|||
25218533|NCT01802580|50496742|FG000|Overall Study|Other|1|||
25218534|NCT01802580|50496743|FG001|Overall Study|Other|3|||
25218535|NCT01802580|50496742|FG000|Overall Study|Lack of Efficacy|0|||
25218536|NCT01802580|50496743|FG001|Overall Study|Lack of Efficacy|2|||
25218537|NCT01611090|50496751|FG000|Randomized Period|Lost to Follow-up|8|||
25218538|NCT01611090|50496752|FG001|Randomized Period|Lost to Follow-up|3|||
25218539|NCT01611090|50496753|FG002|Randomized Period|Lost to Follow-up|0|||
25218540|NCT01611090|50496751|FG000|Randomized Period|Withdrawal by Subject|22|||
25218541|NCT01611090|50496752|FG001|Randomized Period|Withdrawal by Subject|26|||
25218542|NCT01611090|50496753|FG002|Randomized Period|Withdrawal by Subject|0|||
25218543|NCT01611090|50496751|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
25218544|NCT01611090|50496752|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
25218545|NCT01611090|50496753|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
25218546|NCT01611090|50496751|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
25218547|NCT01611090|50496752|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
25218548|NCT01611090|50496753|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
25218549|NCT01844700|50496762|FG000|Overall Study|Lack of Efficacy|1|||
25218550|NCT01844700|50496763|FG001|Overall Study|Lack of Efficacy|0|||
25218551|NCT01844700|50496762|FG000|Overall Study|refused medication switch|1|||
25218552|NCT01844700|50496763|FG001|Overall Study|refused medication switch|0|||
25218553|NCT01844700|50496762|FG000|Overall Study|Withdrawal by Subject|1|||
25218554|NCT01844700|50496763|FG001|Overall Study|Withdrawal by Subject|0|||
25218555|NCT01844700|50496762|FG000|Overall Study|stopped taking meds|0|||
25218556|NCT01844700|50496763|FG001|Overall Study|stopped taking meds|1|||
25218557|NCT01827384|50496783|FG000|Overall Study|Switched to alternative treatment|0|||
25218558|NCT01827384|50496784|FG001|Overall Study|Switched to alternative treatment|0|||
25218559|NCT01827384|50496785|FG002|Overall Study|Switched to alternative treatment|0|||
25218560|NCT01827384|50496786|FG003|Overall Study|Switched to alternative treatment|0|||
25317367|NCT00961961|50632841|FG003|Phase I|Adverse Event|0|||
25218561|NCT01827384|50496787|FG004|Overall Study|Switched to alternative treatment|0|||
25218562|NCT01827384|50496788|FG005|Overall Study|Switched to alternative treatment|0|||
25218563|NCT01827384|50496789|FG006|Overall Study|Switched to alternative treatment|0|||
25218564|NCT01827384|50496790|FG007|Overall Study|Switched to alternative treatment|0|||
25218565|NCT01827384|50496791|FG008|Overall Study|Switched to alternative treatment|0|||
25218566|NCT01827384|50496792|FG009|Overall Study|Switched to alternative treatment|0|||
25218567|NCT01827384|50496793|FG010|Overall Study|Switched to alternative treatment|0|||
25218568|NCT01827384|50496794|FG011|Overall Study|Switched to alternative treatment|0|||
25317368|NCT00961961|50632838|FG000|Phase I|Physician Decision|8|||
25218569|NCT01827384|50496795|FG012|Overall Study|Switched to alternative treatment|0|||
25218570|NCT01827384|50496796|FG013|Overall Study|Switched to alternative treatment|2|||
25218571|NCT01827384|50496783|FG000|Overall Study|Disease progression before treatment|0|||
25218572|NCT01827384|50496784|FG001|Overall Study|Disease progression before treatment|0|||
25218573|NCT01827384|50496785|FG002|Overall Study|Disease progression before treatment|0|||
25218574|NCT01827384|50496786|FG003|Overall Study|Disease progression before treatment|0|||
25218575|NCT01827384|50496787|FG004|Overall Study|Disease progression before treatment|0|||
25218576|NCT01827384|50496788|FG005|Overall Study|Disease progression before treatment|0|||
25218577|NCT01827384|50496789|FG006|Overall Study|Disease progression before treatment|0|||
25218578|NCT01827384|50496790|FG007|Overall Study|Disease progression before treatment|0|||
25218579|NCT01827384|50496791|FG008|Overall Study|Disease progression before treatment|0|||
25218580|NCT01827384|50496792|FG009|Overall Study|Disease progression before treatment|0|||
25218581|NCT01827384|50496793|FG010|Overall Study|Disease progression before treatment|0|||
25218582|NCT01827384|50496794|FG011|Overall Study|Disease progression before treatment|0|||
25218583|NCT01827384|50496795|FG012|Overall Study|Disease progression before treatment|0|||
25218584|NCT01827384|50496796|FG013|Overall Study|Disease progression before treatment|4|||
25218585|NCT01827384|50496783|FG000|Overall Study|Ineligible|0|||
25218586|NCT01827384|50496784|FG001|Overall Study|Ineligible|0|||
25218587|NCT01827384|50496785|FG002|Overall Study|Ineligible|0|||
25218588|NCT01827384|50496786|FG003|Overall Study|Ineligible|0|||
25218589|NCT01827384|50496787|FG004|Overall Study|Ineligible|0|||
25218590|NCT01827384|50496788|FG005|Overall Study|Ineligible|0|||
25218591|NCT01827384|50496789|FG006|Overall Study|Ineligible|0|||
25218592|NCT01827384|50496790|FG007|Overall Study|Ineligible|0|||
25218593|NCT01827384|50496791|FG008|Overall Study|Ineligible|0|||
25218594|NCT01827384|50496792|FG009|Overall Study|Ineligible|0|||
25218595|NCT01827384|50496793|FG010|Overall Study|Ineligible|0|||
25218596|NCT01827384|50496794|FG011|Overall Study|Ineligible|0|||
25218597|NCT01827384|50496795|FG012|Overall Study|Ineligible|0|||
25218598|NCT01827384|50496796|FG013|Overall Study|Ineligible|19|||
25218599|NCT01827384|50496783|FG000|Overall Study|Participant died before treatment|0|||
25218600|NCT01827384|50496784|FG001|Overall Study|Participant died before treatment|0|||
25218601|NCT01827384|50496785|FG002|Overall Study|Participant died before treatment|0|||
25218602|NCT01827384|50496786|FG003|Overall Study|Participant died before treatment|0|||
25218603|NCT01827384|50496787|FG004|Overall Study|Participant died before treatment|0|||
25218604|NCT01827384|50496788|FG005|Overall Study|Participant died before treatment|0|||
25218605|NCT01827384|50496789|FG006|Overall Study|Participant died before treatment|0|||
25218606|NCT01827384|50496790|FG007|Overall Study|Participant died before treatment|0|||
25218607|NCT01827384|50496791|FG008|Overall Study|Participant died before treatment|0|||
25218608|NCT01827384|50496792|FG009|Overall Study|Participant died before treatment|0|||
25218609|NCT01827384|50496793|FG010|Overall Study|Participant died before treatment|0|||
25218610|NCT01827384|50496794|FG011|Overall Study|Participant died before treatment|0|||
25218611|NCT01827384|50496795|FG012|Overall Study|Participant died before treatment|0|||
25218612|NCT01827384|50496796|FG013|Overall Study|Participant died before treatment|5|||
25218613|NCT01827384|50496783|FG000|Overall Study|Insufficient tumor cells|0|||
25218614|NCT01827384|50496784|FG001|Overall Study|Insufficient tumor cells|0|||
25218615|NCT01827384|50496785|FG002|Overall Study|Insufficient tumor cells|0|||
25218616|NCT01827384|50496786|FG003|Overall Study|Insufficient tumor cells|0|||
25218617|NCT01827384|50496787|FG004|Overall Study|Insufficient tumor cells|0|||
25218618|NCT01827384|50496788|FG005|Overall Study|Insufficient tumor cells|0|||
25218619|NCT01827384|50496789|FG006|Overall Study|Insufficient tumor cells|0|||
25218620|NCT01827384|50496790|FG007|Overall Study|Insufficient tumor cells|0|||
25218621|NCT01827384|50496791|FG008|Overall Study|Insufficient tumor cells|0|||
25218622|NCT01827384|50496792|FG009|Overall Study|Insufficient tumor cells|0|||
25218623|NCT01827384|50496793|FG010|Overall Study|Insufficient tumor cells|0|||
25218624|NCT01827384|50496794|FG011|Overall Study|Insufficient tumor cells|0|||
25218625|NCT01827384|50496795|FG012|Overall Study|Insufficient tumor cells|0|||
25218626|NCT01827384|50496796|FG013|Overall Study|Insufficient tumor cells|13|||
25218627|NCT01827384|50496783|FG000|Overall Study|No actionable mutation|0|||
25218628|NCT01827384|50496784|FG001|Overall Study|No actionable mutation|0|||
25218629|NCT01827384|50496785|FG002|Overall Study|No actionable mutation|0|||
25218630|NCT01827384|50496786|FG003|Overall Study|No actionable mutation|0|||
25218631|NCT01827384|50496787|FG004|Overall Study|No actionable mutation|0|||
25218632|NCT01827384|50496788|FG005|Overall Study|No actionable mutation|0|||
25218633|NCT01827384|50496789|FG006|Overall Study|No actionable mutation|0|||
25218634|NCT01827384|50496790|FG007|Overall Study|No actionable mutation|0|||
25218635|NCT01827384|50496791|FG008|Overall Study|No actionable mutation|0|||
25218636|NCT01827384|50496792|FG009|Overall Study|No actionable mutation|0|||
25218637|NCT01827384|50496793|FG010|Overall Study|No actionable mutation|0|||
25218638|NCT01827384|50496794|FG011|Overall Study|No actionable mutation|0|||
25218639|NCT01827384|50496795|FG012|Overall Study|No actionable mutation|0|||
25218640|NCT01827384|50496796|FG013|Overall Study|No actionable mutation|73|||
25218641|NCT01827384|50496783|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
25218642|NCT01827384|50496784|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
25218643|NCT01827384|50496785|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
25218644|NCT01827384|50496786|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
25218645|NCT01827384|50496787|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
25218646|NCT01827384|50496788|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
25218647|NCT01827384|50496789|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
25218648|NCT01827384|50496790|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
25218649|NCT01827384|50496791|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
25218650|NCT01827384|50496792|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
25218651|NCT01827384|50496793|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
25218652|NCT01827384|50496794|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
25218653|NCT01827384|50496795|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
25218654|NCT01827384|50496796|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
25218655|NCT01844076|50496830|FG000|Overall Study|Adverse Event|1|||
25218656|NCT01844076|50496831|FG001|Overall Study|Adverse Event|0|||
25218657|NCT01844076|50496832|FG002|Overall Study|Adverse Event|0|||
25218658|NCT01844076|50496833|FG003|Overall Study|Adverse Event|0|||
25218659|NCT01844076|50496830|FG000|Overall Study|Withdrawal by Subject|1|||
25218660|NCT01844076|50496831|FG001|Overall Study|Withdrawal by Subject|0|||
25218661|NCT01844076|50496832|FG002|Overall Study|Withdrawal by Subject|0|||
25218662|NCT01844076|50496833|FG003|Overall Study|Withdrawal by Subject|0|||
25218663|NCT01826604|50496845|FG000|Overall Study|Lost to Follow-up|8|||
25218664|NCT01826604|50496846|FG001|Overall Study|Lost to Follow-up|9|||
25218665|NCT01843842|50496854|FG000|Overall Study|Do not meet inclusion criteria|1|||
25218666|NCT01843842|50496855|FG001|Overall Study|Do not meet inclusion criteria|1|||
25218667|NCT01826448|50496863|FG000|Overall Study|Adverse Event|1|||
25218668|NCT01826448|50496864|FG001|Overall Study|Adverse Event|3|||
25218669|NCT01826448|50496863|FG000|Overall Study|Disease progression|2|||
25218670|NCT01826448|50496864|FG001|Overall Study|Disease progression|4|||
25218671|NCT01826448|50496863|FG000|Overall Study|Withdrawal by Subject|1|||
25218672|NCT01826448|50496864|FG001|Overall Study|Withdrawal by Subject|0|||
25218673|NCT01826448|50496863|FG000|Overall Study|Physician Decision|0|||
25218674|NCT01826448|50496864|FG001|Overall Study|Physician Decision|1|||
25218675|NCT01826448|50496863|FG000|Overall Study|2 active cancers|0|||
25218676|NCT01826448|50496864|FG001|Overall Study|2 active cancers|1|||
25218677|NCT01826370|50496870|FG000|Overall Study|Protocol Violation|6|||
25218678|NCT01826370|50496870|FG000|Overall Study|Lost to Follow-up|12|||
25218679|NCT01826370|50496870|FG000|Overall Study|Other reason not defined above|2|||
25218680|NCT01826214|50496876|FG000|Overall Study|Adverse Event|7|||
25218681|NCT01826214|50496877|FG001|Overall Study|Adverse Event|6|||
25218682|NCT01826214|50496876|FG000|Overall Study|Death|3|||
25218683|NCT01826214|50496877|FG001|Overall Study|Death|1|||
25218684|NCT01826214|50496876|FG000|Overall Study|Lost to Follow-up|1|||
25218685|NCT01826214|50496877|FG001|Overall Study|Lost to Follow-up|0|||
25218686|NCT01826214|50496876|FG000|Overall Study|Physician Decision|0|||
25218687|NCT01826214|50496877|FG001|Overall Study|Physician Decision|2|||
25218688|NCT01826214|50496876|FG000|Overall Study|Progressive disease|22|||
25218689|NCT01826214|50496877|FG001|Overall Study|Progressive disease|21|||
25218690|NCT01826214|50496876|FG000|Overall Study|Study terminated by Sponsor|0|||
25218691|NCT01826214|50496877|FG001|Overall Study|Study terminated by Sponsor|1|||
25218692|NCT01826214|50496876|FG000|Overall Study|Subject/guardian decision|2|||
25218693|NCT01826214|50496877|FG001|Overall Study|Subject/guardian decision|3|||
25218694|NCT01843062|50496885|FG000|Overall Study|Protocol Violation|1|||
25218695|NCT01843062|50496886|FG001|Overall Study|Protocol Violation|0|||
25218696|NCT01843062|50496885|FG000|Overall Study|New treatment following progression|2|||
25218697|NCT01843062|50496886|FG001|Overall Study|New treatment following progression|0|||
25218698|NCT01843062|50496885|FG000|Overall Study|Pregnancy|1|||
25218699|NCT01843062|50496886|FG001|Overall Study|Pregnancy|0|||
25218700|NCT01843062|50496885|FG000|Overall Study|Adverse Event|2|||
25218701|NCT01843062|50496886|FG001|Overall Study|Adverse Event|0|||
25218702|NCT01843062|50496885|FG000|Overall Study|Incorrect randomisation|1|||
25218703|NCT01843062|50496886|FG001|Overall Study|Incorrect randomisation|0|||
25218704|NCT01843062|50496885|FG000|Overall Study|Withdrawal by Subject|12|||
25218705|NCT01843062|50496886|FG001|Overall Study|Withdrawal by Subject|3|||
25218706|NCT01843062|50496885|FG000|Overall Study|Death|1|||
25218707|NCT01843062|50496886|FG001|Overall Study|Death|2|||
25218708|NCT01843062|50496885|FG000|Overall Study|Lost to Follow-up|2|||
25218709|NCT01843062|50496886|FG001|Overall Study|Lost to Follow-up|4|||
25218710|NCT01842438|50496894|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
25218711|NCT01842438|50496895|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
25218712|NCT01842438|50496894|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
25218713|NCT01842438|50496895|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
25218714|NCT01842438|50496894|FG000|T2: 6month Follow-up|Death|0|||
25218715|NCT01842438|50496895|FG001|T2: 6month Follow-up|Death|1|||
25218716|NCT01799226|50496907|FG000|Overall Study|Withdrawal by Subject|1|||
25218717|NCT01799226|50496908|FG001|Overall Study|Withdrawal by Subject|0|||
25218718|NCT01799226|50496907|FG000|Overall Study|Disqualified at Day 14|1|||
25218719|NCT01799226|50496908|FG001|Overall Study|Disqualified at Day 14|0|||
25218720|NCT01798992|50496918|FG000|Overall Study|Administrative withdrawal|0|||
25218721|NCT01798992|50496919|FG001|Overall Study|Administrative withdrawal|1|||
25218722|NCT01798992|50496920|FG002|Overall Study|Administrative withdrawal|0|||
25218723|NCT01798992|50496921|FG003|Overall Study|Administrative withdrawal|1|||
25218724|NCT01798992|50496918|FG000|Overall Study|Lost to Follow-up|0|||
25218725|NCT01798992|50496919|FG001|Overall Study|Lost to Follow-up|1|||
25218726|NCT01798992|50496920|FG002|Overall Study|Lost to Follow-up|1|||
25218727|NCT01798992|50496921|FG003|Overall Study|Lost to Follow-up|0|||
25218728|NCT01798992|50496918|FG000|Overall Study|Insufficient biopsy tissue|0|||
25218729|NCT01798992|50496919|FG001|Overall Study|Insufficient biopsy tissue|0|||
25218730|NCT01798992|50496920|FG002|Overall Study|Insufficient biopsy tissue|1|||
25218731|NCT01798992|50496921|FG003|Overall Study|Insufficient biopsy tissue|0|||
25218732|NCT01825200|50496932|FG000|Overall Study|Lost to Follow-up|5|||
25218733|NCT01825200|50496933|FG001|Overall Study|Lost to Follow-up|6|||
25218734|NCT01825200|50496932|FG000|Overall Study|Withdrawal by Subject|0|||
25218735|NCT01825200|50496933|FG001|Overall Study|Withdrawal by Subject|1|||
25218736|NCT01824576|50496939|FG000|Overall Study|Device deficiency|2|||
25218737|NCT01824498|50496949|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
25218738|NCT01824498|50496950|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
25218739|NCT01824498|50496951|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
25218740|NCT01824498|50496952|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
25218741|NCT01824498|50496953|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
25218742|NCT01824498|50496954|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
25218743|NCT01798134|50496962|FG000|Overall Study|Lost to Follow-up|1|||
25218744|NCT01798134|50496962|FG000|Overall Study|Withdrawal by Subject|3|||
25218745|NCT01798134|50496962|FG000|Overall Study|Death|2|||
25218746|NCT01798134|50496962|FG000|Overall Study|Adverse Event|3|||
25218747|NCT01798134|50496962|FG000|Overall Study|Physician Decision|3|||
25218748|NCT01798134|50496962|FG000|Overall Study|Liver transplant/surgery|4|||
25218749|NCT01798056|50496968|FG000|Overall Study|Serious Adverse Event|13|||
25218750|NCT01798056|50496969|FG001|Overall Study|Serious Adverse Event|12|||
25218751|NCT01798056|50496968|FG000|Overall Study|Withdrawal by Subject|12|||
25218752|NCT01798056|50496969|FG001|Overall Study|Withdrawal by Subject|9|||
25218753|NCT01798056|50496968|FG000|Overall Study|Migrated/moved from study area|1|||
25218754|NCT01798056|50496969|FG001|Overall Study|Migrated/moved from study area|1|||
25218755|NCT01798056|50496968|FG000|Overall Study|Lost to Follow-up|1|||
25218756|NCT01798056|50496969|FG001|Overall Study|Lost to Follow-up|1|||
25218757|NCT01798056|50496968|FG000|Overall Study|Other|0|||
25218758|NCT01798056|50496969|FG001|Overall Study|Other|2|||
25218759|NCT01824342|50496979|FG000|Overall Study|Withdrawal by Subject|0|||
25218760|NCT01824342|50496980|FG001|Overall Study|Withdrawal by Subject|3|||
25218761|NCT01824342|50496979|FG000|Overall Study|Adverse Event|1|||
25218762|NCT01824342|50496980|FG001|Overall Study|Adverse Event|1|||
25218763|NCT01824342|50496979|FG000|Overall Study|Disease Progression|1|||
25218764|NCT01824342|50496980|FG001|Overall Study|Disease Progression|1|||
25218765|NCT01824342|50496979|FG000|Overall Study|Physician Decision|5|||
25218766|NCT01824342|50496980|FG001|Overall Study|Physician Decision|0|||
25218767|NCT01824342|50496979|FG000|Overall Study|Death|2|||
25218768|NCT01824342|50496980|FG001|Overall Study|Death|0|||
25218769|NCT01841970|50496986|FG000|Overall Study|Withdrawal by Subject|1|||
25218770|NCT01841970|50496986|FG000|Overall Study|Physician Decision|2|||
25218771|NCT01841970|50496986|FG000|Overall Study|Lost to Follow-up|8|||
25218772|NCT01823328|50496995|FG000|Overall Study|Withdrawal by Subject|8|||
25218773|NCT01823328|50496996|FG001|Overall Study|Withdrawal by Subject|6|||
25218774|NCT01840410|50497004|FG000|Overall Study|Physician Decision|1|||
25218775|NCT01840410|50497005|FG001|Overall Study|Physician Decision|2|||
25218776|NCT01840410|50497004|FG000|Overall Study|Pregnancy|1|||
25218777|NCT01840410|50497005|FG001|Overall Study|Pregnancy|0|||
25218778|NCT01840410|50497004|FG000|Overall Study|Protocol deviation|1|||
25218779|NCT01840410|50497005|FG001|Overall Study|Protocol deviation|0|||
25218780|NCT01840410|50497004|FG000|Overall Study|Lost to Follow-up|1|||
25218781|NCT01840410|50497005|FG001|Overall Study|Lost to Follow-up|0|||
25218782|NCT01840410|50497004|FG000|Overall Study|Withdrawal by Subject|2|||
25218783|NCT01840410|50497005|FG001|Overall Study|Withdrawal by Subject|1|||
25218784|NCT01840410|50497004|FG000|Overall Study|Adverse Event|1|||
25218785|NCT01840410|50497005|FG001|Overall Study|Adverse Event|1|||
25218786|NCT01797432|50497013|FG000|Overall Study|Lost to Follow-up|1|||
25218787|NCT01797432|50497013|FG000|Overall Study|Adverse Event|1|||
25218788|NCT01797432|50497013|FG000|Overall Study|Withdrawal by Subject|1|||
25218789|NCT01797432|50497013|FG000|Overall Study|lived too far from study site|1|||
25218790|NCT01797120|50497019|FG000|Overall Study|Disesae progression|37|||
25218791|NCT01797120|50497020|FG001|Overall Study|Disesae progression|49|||
25218792|NCT01797120|50497019|FG000|Overall Study|Adverse Event|13|||
25218793|NCT01797120|50497020|FG001|Overall Study|Adverse Event|5|||
25218794|NCT01797120|50497019|FG000|Overall Study|Withdrawal by Subject|6|||
25218795|NCT01797120|50497020|FG001|Overall Study|Withdrawal by Subject|6|||
25218796|NCT01797120|50497019|FG000|Overall Study|Symptomatic progression|2|||
25218797|NCT01797120|50497020|FG001|Overall Study|Symptomatic progression|1|||
25218798|NCT01797120|50497019|FG000|Overall Study|Non-compliance|1|||
25218799|NCT01797120|50497020|FG001|Overall Study|Non-compliance|0|||
25218800|NCT01797120|50497019|FG000|Overall Study|Physician Decision|3|||
25218801|NCT01797120|50497020|FG001|Overall Study|Physician Decision|0|||
25218802|NCT01797120|50497019|FG000|Overall Study|still on treatment|2|||
25218803|NCT01797120|50497020|FG001|Overall Study|still on treatment|4|||
25218804|NCT01797120|50497019|FG000|Overall Study|never start protocol therapy|2|||
25218805|NCT01797120|50497020|FG001|Overall Study|never start protocol therapy|0|||
25218806|NCT01796964|50497028|FG000|Overall Study|Adverse Event|1|||
25218807|NCT01796964|50497029|FG001|Overall Study|Adverse Event|1|||
25218808|NCT01796964|50497028|FG000|Overall Study|Death|1|||
25218809|NCT01796964|50497029|FG001|Overall Study|Death|0|||
25218810|NCT01796964|50497028|FG000|Overall Study|Protocol Violation|0|||
25218811|NCT01796964|50497029|FG001|Overall Study|Protocol Violation|1|||
25218812|NCT01796964|50497028|FG000|Overall Study|Withdrawal by Subject|1|||
25218813|NCT01796964|50497029|FG001|Overall Study|Withdrawal by Subject|1|||
25218814|NCT01838694|50497038|FG000|Overall Study|Adverse Event|0|||
25218815|NCT01838694|50497039|FG001|Overall Study|Adverse Event|1|||
25218816|NCT01795638|50497050|FG000|Overall Study|Death|0|||
25218817|NCT01795638|50497051|FG001|Overall Study|Death|3|||
25218818|NCT01795638|50497050|FG000|Overall Study|transferred to quaternary hospital|2|||
25218819|NCT01795638|50497051|FG001|Overall Study|transferred to quaternary hospital|3|||
25218820|NCT01795638|50497050|FG000|Overall Study|Protocol Violation|3|||
25218821|NCT01795638|50497051|FG001|Overall Study|Protocol Violation|0|||
25218822|NCT01795638|50497050|FG000|Overall Study|discharged from hospital|7|||
25218823|NCT01795638|50497051|FG001|Overall Study|discharged from hospital|5|||
25218824|NCT01795638|50497050|FG000|Overall Study|Withdrawal by Subject|1|||
25218825|NCT01795638|50497051|FG001|Overall Study|Withdrawal by Subject|0|||
25218826|NCT01794780|50497065|FG000|Overall Study|Adverse Event|0|||
25218827|NCT01794780|50497066|FG001|Overall Study|Adverse Event|1|||
25218828|NCT01794780|50497067|FG002|Overall Study|Adverse Event|2|||
25218829|NCT01794780|50497068|FG003|Overall Study|Adverse Event|0|||
25218830|NCT01794780|50497069|FG004|Overall Study|Adverse Event|0|||
25218831|NCT01794780|50497070|FG005|Overall Study|Adverse Event|0|||
25218832|NCT01794780|50497071|FG006|Overall Study|Adverse Event|0|||
25218833|NCT01794780|50497072|FG007|Overall Study|Adverse Event|0|||
25218834|NCT01794780|50497065|FG000|Overall Study|Death|0|||
25218835|NCT01794780|50497066|FG001|Overall Study|Death|2|||
25218836|NCT01794780|50497067|FG002|Overall Study|Death|14|||
25218837|NCT01794780|50497068|FG003|Overall Study|Death|1|||
25218838|NCT01794780|50497069|FG004|Overall Study|Death|0|||
25218839|NCT01794780|50497070|FG005|Overall Study|Death|9|||
25218840|NCT01794780|50497071|FG006|Overall Study|Death|4|||
25218841|NCT01794780|50497072|FG007|Overall Study|Death|0|||
25218842|NCT01794780|50497065|FG000|Overall Study|Lost to Follow-up|10|||
25218843|NCT01794780|50497066|FG001|Overall Study|Lost to Follow-up|64|||
25218844|NCT01794780|50497067|FG002|Overall Study|Lost to Follow-up|165|||
25218845|NCT01794780|50497068|FG003|Overall Study|Lost to Follow-up|53|||
25218846|NCT01794780|50497069|FG004|Overall Study|Lost to Follow-up|2|||
25218847|NCT01794780|50497070|FG005|Overall Study|Lost to Follow-up|99|||
25218848|NCT01794780|50497071|FG006|Overall Study|Lost to Follow-up|30|||
25218849|NCT01794780|50497072|FG007|Overall Study|Lost to Follow-up|5|||
25218850|NCT01794780|50497065|FG000|Overall Study|Withdrew informed consent|7|||
25218851|NCT01794780|50497066|FG001|Overall Study|Withdrew informed consent|17|||
25218852|NCT01794780|50497067|FG002|Overall Study|Withdrew informed consent|36|||
25218853|NCT01794780|50497068|FG003|Overall Study|Withdrew informed consent|9|||
25218854|NCT01794780|50497069|FG004|Overall Study|Withdrew informed consent|0|||
25218855|NCT01794780|50497070|FG005|Overall Study|Withdrew informed consent|48|||
25218856|NCT01794780|50497071|FG006|Overall Study|Withdrew informed consent|4|||
25218857|NCT01794780|50497072|FG007|Overall Study|Withdrew informed consent|3|||
25218858|NCT01794780|50497065|FG000|Overall Study|Other|0|||
25218859|NCT01794780|50497066|FG001|Overall Study|Other|12|||
25218860|NCT01794780|50497067|FG002|Overall Study|Other|25|||
25218861|NCT01794780|50497068|FG003|Overall Study|Other|20|||
25218862|NCT01794780|50497069|FG004|Overall Study|Other|1|||
25218863|NCT01794780|50497070|FG005|Overall Study|Other|24|||
25218864|NCT01794780|50497071|FG006|Overall Study|Other|4|||
25218865|NCT01794780|50497072|FG007|Overall Study|Other|1|||
25218866|NCT01838616|50497099|FG000|Titration Period|Adverse Event|18|||
25218867|NCT01838616|50497100|FG001|Titration Period|Adverse Event|48|||
25218868|NCT01838616|50497099|FG000|Titration Period|Lack of Efficacy|5|||
25218869|NCT01838616|50497100|FG001|Titration Period|Lack of Efficacy|12|||
25218870|NCT01838616|50497099|FG000|Titration Period|Withdrawal by Subject|5|||
25218871|NCT01838616|50497100|FG001|Titration Period|Withdrawal by Subject|5|||
25218872|NCT01838616|50497099|FG000|Titration Period|Technical problems|1|||
25218873|NCT01838616|50497100|FG001|Titration Period|Technical problems|0|||
25218874|NCT01838616|50497099|FG000|Titration Period|Other|1|||
25218875|NCT01838616|50497100|FG001|Titration Period|Other|0|||
25218876|NCT01838616|50497099|FG000|Titration Period|Protocol Violation|0|||
25218877|NCT01838616|50497100|FG001|Titration Period|Protocol Violation|1|||
25218878|NCT01838616|50497099|FG000|Continuation Period|Lack of Efficacy|3|||
25218879|NCT01838616|50497100|FG001|Continuation Period|Lack of Efficacy|5|||
25218880|NCT01838616|50497099|FG000|Continuation Period|Adverse Event|8|||
25218881|NCT01838616|50497100|FG001|Continuation Period|Adverse Event|4|||
25218882|NCT01838616|50497099|FG000|Continuation Period|Protocol Violation|2|||
25218883|NCT01838616|50497100|FG001|Continuation Period|Protocol Violation|0|||
25218884|NCT01838616|50497099|FG000|Continuation Period|Lost to Follow-up|1|||
25218885|NCT01838616|50497100|FG001|Continuation Period|Lost to Follow-up|0|||
25218886|NCT01838616|50497099|FG000|Continuation Period|Withdrawal by Subject|0|||
25218887|NCT01838616|50497100|FG001|Continuation Period|Withdrawal by Subject|4|||
25218888|NCT01838616|50497099|FG000|Continuation Period|Technical problems|0|||
25218889|NCT01838616|50497100|FG001|Continuation Period|Technical problems|1|||
25218890|NCT01838616|50497099|FG000|Pick-up Arm|Lack of Efficacy|4|||
25218891|NCT01838616|50497100|FG001|Pick-up Arm|Lack of Efficacy|0|||
25218892|NCT01838616|50497099|FG000|Pick-up Arm|Adverse Event|9|||
25218893|NCT01838616|50497100|FG001|Pick-up Arm|Adverse Event|0|||
25218894|NCT01838616|50497099|FG000|Pick-up Arm|Withdrawal by Subject|1|||
25218895|NCT01838616|50497100|FG001|Pick-up Arm|Withdrawal by Subject|0|||
25218896|NCT01838616|50497099|FG000|Pick-up Arm|Technical problems|1|||
25218897|NCT01838616|50497100|FG001|Pick-up Arm|Technical problems|0|||
25218898|NCT01611792|50497113|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
25218899|NCT01611792|50497114|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
25218900|NCT01611792|50497113|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
25218901|NCT01611792|50497114|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
25218902|NCT01820364|50497121|FG000|Part I: LGX818|Death|1|||
25218903|NCT01820364|50497122|FG001|Part I: LGX818|Death|0|||
25218904|NCT01820364|50497121|FG000|Part I: LGX818|Administrative Problems|3|||
25218905|NCT01820364|50497122|FG001|Part I: LGX818|Administrative Problems|0|||
25218906|NCT01820364|50497121|FG000|Part I: LGX818|Adverse Event|6|||
25218907|NCT01820364|50497122|FG001|Part I: LGX818|Adverse Event|0|||
25218908|NCT01820364|50497121|FG000|Part I: LGX818|Disease Progression|4|||
25218909|NCT01820364|50497122|FG001|Part I: LGX818|Disease Progression|0|||
25218910|NCT01820364|50497121|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
25218911|NCT01820364|50497122|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
25218912|NCT01819506|50497130|FG000|Overall Study|Physician Decision|5|||
25218913|NCT01819506|50497131|FG001|Overall Study|Physician Decision|2|||
25218914|NCT01819506|50497130|FG000|Overall Study|Withdrawal by Subject|3|||
25218915|NCT01819506|50497131|FG001|Overall Study|Withdrawal by Subject|3|||
25218916|NCT01794000|50497139|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
25218917|NCT01794000|50497140|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
25218918|NCT01794000|50497139|FG000|Double-Blind Phase (DBP)|Death|1|||
25218919|NCT01794000|50497140|FG001|Double-Blind Phase (DBP)|Death|2|||
25218920|NCT01794000|50497139|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
25218921|NCT01794000|50497140|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
25218922|NCT01794000|50497139|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
25218923|NCT01794000|50497140|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
25218924|NCT01794000|50497139|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
25218925|NCT01794000|50497140|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
25218926|NCT01794000|50497139|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
25218927|NCT01794000|50497140|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
25218928|NCT01794000|50497139|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
25218929|NCT01794000|50497140|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
25218930|NCT01794000|50497139|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
25218931|NCT01794000|50497140|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
25218932|NCT01609296|50497147|FG000|Overall Study|Death|253|||
25218933|NCT01609296|50497147|FG000|Overall Study|Withdrawal by Subject|151|||
25218934|NCT01609296|50497147|FG000|Overall Study|Lost to Follow-up|21|||
25218935|NCT01609296|50497147|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
25218936|NCT01609296|50497147|FG000|Overall Study|missed visit but known to be alive|28|||
25218937|NCT01609218|50497155|FG000|Period 1|Adverse Event|3|||
25218938|NCT01609218|50497156|FG001|Period 1|Adverse Event|5|||
25218939|NCT01609218|50497155|FG000|Period 1|Sponsor Decision|0|||
25218940|NCT01609218|50497156|FG001|Period 1|Sponsor Decision|1|||
25218941|NCT01609218|50497155|FG000|Period 2|Adverse Event|1|||
25218942|NCT01609218|50497156|FG001|Period 2|Adverse Event|0|||
25218943|NCT01609062|50497164|FG000|Extension Phase|Terminated by Sponsor|14|||
25218944|NCT01609062|50497165|FG001|Extension Phase|Terminated by Sponsor|9|||
25218945|NCT01609062|50497164|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
25218946|NCT01609062|50497165|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
25218947|NCT01609062|50497164|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
25218948|NCT01609062|50497165|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
25218949|NCT01819272|50497178|FG000|Overall Study|Adverse Event|1|||
25218950|NCT01819272|50497179|FG001|Overall Study|Adverse Event|0|||
25218951|NCT01819272|50497180|FG002|Overall Study|Adverse Event|0|||
25218952|NCT01819272|50497181|FG003|Overall Study|Adverse Event|2|||
25218953|NCT01819272|50497182|FG004|Overall Study|Adverse Event|0|||
25218954|NCT01819272|50497183|FG005|Overall Study|Adverse Event|0|||
25218955|NCT01819272|50497178|FG000|Overall Study|Lost to Follow-up|3|||
25218956|NCT01819272|50497179|FG001|Overall Study|Lost to Follow-up|0|||
25218957|NCT01819272|50497180|FG002|Overall Study|Lost to Follow-up|1|||
25218958|NCT01819272|50497181|FG003|Overall Study|Lost to Follow-up|0|||
25218959|NCT01819272|50497182|FG004|Overall Study|Lost to Follow-up|0|||
25218960|NCT01819272|50497183|FG005|Overall Study|Lost to Follow-up|3|||
25218961|NCT01819272|50497178|FG000|Overall Study|Protocol Violation|0|||
25218962|NCT01819272|50497179|FG001|Overall Study|Protocol Violation|0|||
25218963|NCT01819272|50497180|FG002|Overall Study|Protocol Violation|0|||
25218964|NCT01819272|50497181|FG003|Overall Study|Protocol Violation|1|||
25218965|NCT01819272|50497182|FG004|Overall Study|Protocol Violation|2|||
25218966|NCT01819272|50497183|FG005|Overall Study|Protocol Violation|3|||
25218967|NCT01819272|50497178|FG000|Overall Study|Physician Decision|0|||
25218968|NCT01819272|50497179|FG001|Overall Study|Physician Decision|1|||
25218969|NCT01819272|50497180|FG002|Overall Study|Physician Decision|0|||
25218970|NCT01819272|50497181|FG003|Overall Study|Physician Decision|0|||
25218971|NCT01819272|50497182|FG004|Overall Study|Physician Decision|0|||
25218972|NCT01819272|50497183|FG005|Overall Study|Physician Decision|0|||
25218973|NCT01819272|50497178|FG000|Overall Study|Withdrawal of Consent|0|||
25218974|NCT01819272|50497179|FG001|Overall Study|Withdrawal of Consent|1|||
25218975|NCT01819272|50497180|FG002|Overall Study|Withdrawal of Consent|2|||
25218976|NCT01819272|50497181|FG003|Overall Study|Withdrawal of Consent|1|||
25218977|NCT01819272|50497182|FG004|Overall Study|Withdrawal of Consent|0|||
25218978|NCT01819272|50497183|FG005|Overall Study|Withdrawal of Consent|1|||
25218979|NCT01819272|50497178|FG000|Overall Study|Loss of Glucose Control|2|||
25218980|NCT01819272|50497179|FG001|Overall Study|Loss of Glucose Control|1|||
25218981|NCT01819272|50497180|FG002|Overall Study|Loss of Glucose Control|0|||
25218982|NCT01819272|50497181|FG003|Overall Study|Loss of Glucose Control|1|||
25218983|NCT01819272|50497182|FG004|Overall Study|Loss of Glucose Control|2|||
25218984|NCT01819272|50497183|FG005|Overall Study|Loss of Glucose Control|0|||
25218985|NCT01819194|50497197|FG000|Overall Study|Loss of study articles|2|||
25218986|NCT01611558|50497201|FG000|Induction Phase|Study drug toxicity|15|||
25218987|NCT01611558|50497201|FG000|Induction Phase|Disease progression|18|||
25218988|NCT01611558|50497201|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
25218989|NCT01611558|50497201|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
25218990|NCT01611558|50497201|FG000|Induction Phase|Death|1|||
25218991|NCT01611558|50497201|FG000|Maintenance Phase|Withdrawal by Subject|1|||
25218992|NCT01611558|50497201|FG000|Maintenance Phase|Elevated Uric acid|1|||
25218993|NCT01818726|50497208|FG000|Overall Study|Administrative reasons|5|||
25218994|NCT01818726|50497209|FG001|Overall Study|Administrative reasons|1|||
25218995|NCT01818726|50497208|FG000|Overall Study|Withdrawal by Subject|0|||
25218996|NCT01818726|50497209|FG001|Overall Study|Withdrawal by Subject|1|||
25218997|NCT01818726|50497208|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
25218998|NCT01818726|50497209|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
25218999|NCT01818336|50497215|FG000|Overall Study|Declined retest visit|0|||
25219000|NCT01818336|50497216|FG001|Overall Study|Declined retest visit|11|||
25219001|NCT01818336|50497215|FG000|Overall Study|Lost to Follow-up|0|||
25219002|NCT01818336|50497216|FG001|Overall Study|Lost to Follow-up|1|||
25219003|NCT01818258|50497224|FG000|Overall Study|Death|3|||
25219004|NCT01818258|50497225|FG001|Overall Study|Death|0|||
25219005|NCT01818258|50497224|FG000|Overall Study|Withdrawal by Subject|0|||
25219006|NCT01818258|50497225|FG001|Overall Study|Withdrawal by Subject|1|||
25219007|NCT01818258|50497224|FG000|Overall Study|Lost to Follow-up|0|||
25219008|NCT01818258|50497225|FG001|Overall Study|Lost to Follow-up|1|||
25219009|NCT01818258|50497224|FG000|Overall Study|Unable to Travel to Clinic|0|||
25219010|NCT01818258|50497225|FG001|Overall Study|Unable to Travel to Clinic|1|||
25219011|NCT01817790|50497234|FG000|Overall Study|Adverse Event|0|||
25219012|NCT01817790|50497235|FG001|Overall Study|Adverse Event|2|||
25219013|NCT01817790|50497234|FG000|Overall Study|Lost to Follow-up|0|||
25219014|NCT01817790|50497235|FG001|Overall Study|Lost to Follow-up|1|||
25219015|NCT01817790|50497234|FG000|Overall Study|Protocol Violation|2|||
25219016|NCT01817790|50497235|FG001|Overall Study|Protocol Violation|1|||
25219017|NCT01817790|50497234|FG000|Overall Study|Withdrawal by Subject|1|||
25219018|NCT01817790|50497235|FG001|Overall Study|Withdrawal by Subject|3|||
25219019|NCT01817790|50497234|FG000|Overall Study|Other: Could not attend appointment|1|||
25219020|NCT01817790|50497235|FG001|Overall Study|Other: Could not attend appointment|1|||
25219021|NCT01793688|50497243|FG000|Overall Study|Protocol Violation|2|||
25219022|NCT01793142|50497247|FG000|Overall Study|Randomized not treated|7|||
25219023|NCT01792830|50497262|FG000|Overall Study|Withdrawal by Subject|22|||
25219024|NCT01792830|50497263|FG001|Overall Study|Withdrawal by Subject|0|||
25219025|NCT01792830|50497264|FG002|Overall Study|Withdrawal by Subject|0|||
25219026|NCT01792830|50497265|FG003|Overall Study|Withdrawal by Subject|2|||
25219027|NCT01792830|50497266|FG004|Overall Study|Withdrawal by Subject|1|||
25219028|NCT01792830|50497267|FG005|Overall Study|Withdrawal by Subject|1|||
25219029|NCT01792830|50497268|FG006|Overall Study|Withdrawal by Subject|1|||
25219030|NCT01792830|50497269|FG007|Overall Study|Withdrawal by Subject|1|||
25219031|NCT01792830|50497270|FG008|Overall Study|Withdrawal by Subject|7|||
25219032|NCT01792830|50497271|FG009|Overall Study|Withdrawal by Subject|0|||
25219033|NCT01792830|50497272|FG010|Overall Study|Withdrawal by Subject|2|||
25219034|NCT01792830|50497262|FG000|Overall Study|Death|3|||
25219035|NCT01792830|50497263|FG001|Overall Study|Death|0|||
25219036|NCT01792830|50497264|FG002|Overall Study|Death|0|||
25219037|NCT01792830|50497265|FG003|Overall Study|Death|1|||
25219038|NCT01792830|50497266|FG004|Overall Study|Death|0|||
25219039|NCT01792830|50497267|FG005|Overall Study|Death|0|||
25219040|NCT01792830|50497268|FG006|Overall Study|Death|1|||
25219041|NCT01792830|50497269|FG007|Overall Study|Death|0|||
25219042|NCT01792830|50497270|FG008|Overall Study|Death|1|||
25219043|NCT01792830|50497271|FG009|Overall Study|Death|0|||
25219044|NCT01792830|50497272|FG010|Overall Study|Death|1|||
25219045|NCT01792830|50497262|FG000|Overall Study|Adverse Event|0|||
25219046|NCT01792830|50497263|FG001|Overall Study|Adverse Event|0|||
25317369|NCT00961961|50632839|FG001|Phase I|Physician Decision|0|||
25317370|NCT00961961|50632840|FG002|Phase I|Physician Decision|0|||
25317371|NCT00961961|50632841|FG003|Phase I|Physician Decision|0|||
25317372|NCT00961961|50632838|FG000|Phase II|Lost to Follow-up|0|||
25317373|NCT00961961|50632839|FG001|Phase II|Lost to Follow-up|0|||
25317374|NCT00961961|50632840|FG002|Phase II|Lost to Follow-up|10|||
25317375|NCT00961961|50632841|FG003|Phase II|Lost to Follow-up|7|||
25317376|NCT00961961|50632838|FG000|Phase II|Adverse Event|0|||
25317377|NCT00961961|50632839|FG001|Phase II|Adverse Event|0|||
25317378|NCT00961961|50632840|FG002|Phase II|Adverse Event|0|||
25317379|NCT00961961|50632841|FG003|Phase II|Adverse Event|1|||
25317380|NCT00961961|50632838|FG000|Phase II|Physician Decision|0|||
25317381|NCT00961961|50632839|FG001|Phase II|Physician Decision|0|||
25317382|NCT00961961|50632840|FG002|Phase II|Physician Decision|1|||
25317383|NCT00961961|50632841|FG003|Phase II|Physician Decision|0|||
25317384|NCT00961961|50632838|FG000|Phase II|Withdrawal by Subject|0|||
25317385|NCT00961961|50632839|FG001|Phase II|Withdrawal by Subject|0|||
25317386|NCT00961961|50632840|FG002|Phase II|Withdrawal by Subject|1|||
25317387|NCT00961961|50632841|FG003|Phase II|Withdrawal by Subject|0|||
25317388|NCT00817089|50632865|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
25317389|NCT00817089|50632866|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
25317390|NCT00817089|50632867|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
25317391|NCT00817089|50632868|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
25317392|NCT00817089|50632865|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
25317393|NCT00817089|50632866|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
25317394|NCT00817089|50632867|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
25317395|NCT00817089|50632868|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
25317396|NCT00815919|50632882|FG000|Overall Study|Unrelated Fungal Infection|1|||
25317397|NCT00815919|50632882|FG000|Overall Study|AML Relapse|1|||
25317398|NCT00815919|50632882|FG000|Overall Study|Lack of Efficacy|2|||
25317399|NCT00957905|50632888|FG000|Part B|Not Treated|0|||
25317400|NCT00957905|50632889|FG001|Part B|Not Treated|1|||
25317401|NCT00957905|50632888|FG000|Part B|Physician Decision|0|||
25317402|NCT00957905|50632889|FG001|Part B|Physician Decision|1|||
25317403|NCT00957905|50632888|FG000|Part B|Death|0|||
25317404|NCT00957905|50632889|FG001|Part B|Death|1|||
25317405|NCT00957905|50632888|FG000|Part B|Protocol Violation|0|||
25317406|NCT00957905|50632889|FG001|Part B|Protocol Violation|1|||
25317407|NCT00960323|50632895|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
25317408|NCT00617929|50632903|FG000|Overall Study|Physician Decision|1|||
25317409|NCT00815295|50632910|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
25317410|NCT00815295|50632911|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
25317411|NCT00815295|50632912|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
25219047|NCT01792830|50497264|FG002|Overall Study|Adverse Event|0|||
25317412|NCT00814983|50632922|FG000|Overall Study|Screen failure|1|||
25219048|NCT01792830|50497265|FG003|Overall Study|Adverse Event|0|||
25219049|NCT01792830|50497266|FG004|Overall Study|Adverse Event|0|||
25219050|NCT01792830|50497267|FG005|Overall Study|Adverse Event|0|||
25219051|NCT01792830|50497268|FG006|Overall Study|Adverse Event|0|||
25219052|NCT01792830|50497269|FG007|Overall Study|Adverse Event|0|||
25317413|NCT00814983|50632923|FG001|Overall Study|Screen failure|0|||
25317414|NCT00814983|50632922|FG000|Overall Study|Withdrawal by Subject|1|||
25219053|NCT01792830|50497270|FG008|Overall Study|Adverse Event|1|||
25219054|NCT01792830|50497271|FG009|Overall Study|Adverse Event|0|||
25219055|NCT01792830|50497272|FG010|Overall Study|Adverse Event|0|||
25219056|NCT01792518|50497304|FG000|Overall Study|Adverse Event|3|||
25219057|NCT01792518|50497305|FG001|Overall Study|Adverse Event|4|||
25219058|NCT01792518|50497304|FG000|Overall Study|Protocol Violation|0|||
25219059|NCT01792518|50497305|FG001|Overall Study|Protocol Violation|1|||
25219060|NCT01792518|50497304|FG000|Overall Study|Lost to Follow-up|3|||
25219061|NCT01792518|50497305|FG001|Overall Study|Lost to Follow-up|1|||
25219062|NCT01792518|50497304|FG000|Overall Study|Withdrawal by Subject|2|||
25219063|NCT01792518|50497305|FG001|Overall Study|Withdrawal by Subject|0|||
25219064|NCT01792518|50497304|FG000|Overall Study|Other Reason|0|||
25219065|NCT01792518|50497305|FG001|Overall Study|Other Reason|1|||
25219066|NCT01792284|50497311|FG000|Lead-in Period|Adverse Event|15|||
25219067|NCT01792284|50497312|FG001|Lead-in Period|Adverse Event|0|||
25219068|NCT01792284|50497313|FG002|Lead-in Period|Adverse Event|0|||
25219069|NCT01792284|50497311|FG000|Lead-in Period|Lost to Follow-up|2|||
25219070|NCT01792284|50497312|FG001|Lead-in Period|Lost to Follow-up|0|||
25219071|NCT01792284|50497313|FG002|Lead-in Period|Lost to Follow-up|0|||
25219072|NCT01792284|50497311|FG000|Lead-in Period|Protocol Violation|1|||
25219073|NCT01792284|50497312|FG001|Lead-in Period|Protocol Violation|0|||
25219074|NCT01792284|50497313|FG002|Lead-in Period|Protocol Violation|0|||
25219075|NCT01792284|50497311|FG000|Lead-in Period|Withdrawal by Subject|10|||
25219076|NCT01792284|50497312|FG001|Lead-in Period|Withdrawal by Subject|0|||
25219077|NCT01792284|50497313|FG002|Lead-in Period|Withdrawal by Subject|0|||
25219078|NCT01792284|50497311|FG000|Lead-in Period|Physician Decision|1|||
25219079|NCT01792284|50497312|FG001|Lead-in Period|Physician Decision|0|||
25219080|NCT01792284|50497313|FG002|Lead-in Period|Physician Decision|0|||
25219081|NCT01792284|50497311|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
25219082|NCT01792284|50497312|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
25219083|NCT01792284|50497313|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
25219084|NCT01792284|50497311|FG000|Randomization Period 1|Withdrawal by Subject|0|||
25219085|NCT01792284|50497312|FG001|Randomization Period 1|Withdrawal by Subject|1|||
25219086|NCT01792284|50497313|FG002|Randomization Period 1|Withdrawal by Subject|1|||
25219087|NCT01792284|50497311|FG000|Randomization Period 1|Physician Decision|0|||
25219088|NCT01792284|50497312|FG001|Randomization Period 1|Physician Decision|1|||
25219089|NCT01792284|50497313|FG002|Randomization Period 1|Physician Decision|1|||
25219090|NCT01792284|50497311|FG000|Randomization Period 1|Adverse Event|0|||
25219091|NCT01792284|50497312|FG001|Randomization Period 1|Adverse Event|0|||
25219092|NCT01792284|50497313|FG002|Randomization Period 1|Adverse Event|2|||
25219093|NCT01792284|50497311|FG000|Randomization Period 1|Lost to Follow-up|0|||
25219094|NCT01792284|50497312|FG001|Randomization Period 1|Lost to Follow-up|0|||
25219095|NCT01792284|50497313|FG002|Randomization Period 1|Lost to Follow-up|1|||
25219096|NCT01792284|50497311|FG000|Randomization Period 2|Protocol Violation|0|||
25219097|NCT01792284|50497312|FG001|Randomization Period 2|Protocol Violation|1|||
25219098|NCT01792284|50497313|FG002|Randomization Period 2|Protocol Violation|0|||
25219099|NCT01792284|50497311|FG000|Randomization Period 2|Withdrawal by Subject|0|||
25219100|NCT01792284|50497312|FG001|Randomization Period 2|Withdrawal by Subject|2|||
25219101|NCT01792284|50497313|FG002|Randomization Period 2|Withdrawal by Subject|0|||
25219102|NCT01791894|50497321|FG000|Overall Study|Adverse Event|1|||
25219103|NCT01837680|50497328|FG000|Overall Study|Lost to Follow-up|2|||
25219104|NCT01837680|50497329|FG001|Overall Study|Lost to Follow-up|2|||
25219105|NCT01837680|50497328|FG000|Overall Study|lack of insurance|0|||
25219106|NCT01837680|50497329|FG001|Overall Study|lack of insurance|2|||
25219107|NCT01837680|50497328|FG000|Overall Study|allergic reaction|6|||
25219108|NCT01837680|50497329|FG001|Overall Study|allergic reaction|0|||
25219109|NCT01837680|50497328|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
25219110|NCT01837680|50497329|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
25219111|NCT01836276|50497337|FG000|Overall Study|Lost to Follow-up|28|||
25219112|NCT01836276|50497338|FG001|Overall Study|Lost to Follow-up|51|||
25219113|NCT01790568|50497344|FG000|Overall Study|Progression prior to transplant|0|||
25219114|NCT01790568|50497345|FG001|Overall Study|Progression prior to transplant|1|||
25219115|NCT01610076|50497351|FG000|Overall Study|Technical issue with video|0|||
25219116|NCT01610076|50497352|FG001|Overall Study|Technical issue with video|1|||
25219117|NCT01610076|50497351|FG000|Overall Study|Lost to Follow-up|3|||
25219118|NCT01610076|50497352|FG001|Overall Study|Lost to Follow-up|4|||
25219119|NCT01836198|50497361|FG000|Part A, Period 2|Protocol Violation|0|||
25219120|NCT01836198|50497362|FG001|Part A, Period 2|Protocol Violation|1|||
25219121|NCT01836198|50497363|FG002|Part A, Period 2|Protocol Violation|0|||
25219122|NCT01816074|50497383|FG000|Phase 1|Time commitment issues|0|||
25219123|NCT01816074|50497384|FG001|Phase 1|Time commitment issues|0|||
25219124|NCT01816074|50497385|FG002|Phase 1|Time commitment issues|1|||
25219125|NCT01816074|50497386|FG003|Phase 1|Time commitment issues|0|||
25219126|NCT01816074|50497383|FG000|Phase 2|Time commitment Issues|0|||
25219127|NCT01816074|50497384|FG001|Phase 2|Time commitment Issues|2|||
25219128|NCT01816074|50497385|FG002|Phase 2|Time commitment Issues|0|||
25219129|NCT01816074|50497386|FG003|Phase 2|Time commitment Issues|0|||
25219130|NCT01816074|50497383|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
25219131|NCT01816074|50497384|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
25219132|NCT01816074|50497385|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
25219133|NCT01816074|50497386|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
25219134|NCT01816074|50497383|FG000|Phase 2|Physician Decision|0|||
25219135|NCT01816074|50497384|FG001|Phase 2|Physician Decision|0|||
25219136|NCT01816074|50497385|FG002|Phase 2|Physician Decision|0|||
25219137|NCT01816074|50497386|FG003|Phase 2|Physician Decision|1|||
25219138|NCT01816074|50497383|FG000|Phase 2|Withdrawal by Subject|1|||
25219139|NCT01816074|50497384|FG001|Phase 2|Withdrawal by Subject|0|||
25219140|NCT01816074|50497385|FG002|Phase 2|Withdrawal by Subject|0|||
25219141|NCT01816074|50497386|FG003|Phase 2|Withdrawal by Subject|0|||
25219142|NCT01815918|50497412|FG000|Overall Study|Patient samples not analyzable|3|||
25219143|NCT01815918|50497413|FG001|Overall Study|Patient samples not analyzable|4|||
25219144|NCT01815918|50497412|FG000|Overall Study|Lack of Efficacy|15|||
25219145|NCT01815918|50497413|FG001|Overall Study|Lack of Efficacy|15|||
25219146|NCT01789476|50497425|FG000|Overall Study|Lack of Efficacy|6|||
25219147|NCT01789476|50497426|FG001|Overall Study|Lack of Efficacy|2|||
25219148|NCT01789476|50497425|FG000|Overall Study|Adverse Event|1|||
25219149|NCT01789476|50497426|FG001|Overall Study|Adverse Event|0|||
25219150|NCT01789476|50497425|FG000|Overall Study|Unable to get IV access|1|||
25219151|NCT01789476|50497426|FG001|Overall Study|Unable to get IV access|0|||
25219152|NCT01789320|50497432|FG000|Overall Study|Re-enrolled into study|1|||
25219153|NCT01789320|50497432|FG000|Overall Study|Lost to Follow-up|1|||
25219154|NCT01815840|50497438|FG000|Overall Study|Missing|1|||
25219155|NCT01815840|50497439|FG001|Overall Study|Missing|0|||
25219156|NCT01815840|50497438|FG000|Overall Study|Withdrew Consent|31|||
25219157|NCT01815840|50497439|FG001|Overall Study|Withdrew Consent|30|||
25219158|NCT01815840|50497438|FG000|Overall Study|Administrative/Other|1|||
25219159|NCT01815840|50497439|FG001|Overall Study|Administrative/Other|3|||
25219160|NCT01815840|50497438|FG000|Overall Study|Adverse Event|10|||
25219161|NCT01815840|50497439|FG001|Overall Study|Adverse Event|16|||
25219162|NCT01815840|50497438|FG000|Overall Study|Death|2|||
25219163|NCT01815840|50497439|FG001|Overall Study|Death|2|||
25219164|NCT01815840|50497438|FG000|Overall Study|Disease progression|3|||
25219165|NCT01815840|50497439|FG001|Overall Study|Disease progression|2|||
25219166|NCT01815840|50497438|FG000|Overall Study|Investigators Decision|2|||
25219167|NCT01815840|50497439|FG001|Overall Study|Investigators Decision|3|||
25219168|NCT01815840|50497438|FG000|Overall Study|Lost to Follow-up|3|||
25219169|NCT01815840|50497439|FG001|Overall Study|Lost to Follow-up|6|||
25219170|NCT01815840|50497438|FG000|Overall Study|Refused Treatment|5|||
25219171|NCT01815840|50497439|FG001|Overall Study|Refused Treatment|1|||
25219172|NCT01815840|50497438|FG000|Overall Study|Sponsor Termination Treatment|1|||
25219173|NCT01815840|50497439|FG001|Overall Study|Sponsor Termination Treatment|0|||
25219174|NCT01774110|50497445|FG000|Overall Study|Lost to Follow-up|7|||
25219175|NCT01788228|50497452|FG000|Overall Study|Migrated/moved from study area|1|||
25219176|NCT01788228|50497453|FG001|Overall Study|Migrated/moved from study area|0|||
25219177|NCT01607346|50497462|FG000|Overall Study|Adverse Event|3|||
25219178|NCT01787838|50497466|FG000|Overall Study|refused|1413|||
25219179|NCT01787760|50497473|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
25219180|NCT01787760|50497474|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
25219181|NCT01787760|50497475|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
25219182|NCT01787760|50497473|FG000|Overall Study|Decompensated on left exotropia|0|||
25219183|NCT01787760|50497474|FG001|Overall Study|Decompensated on left exotropia|0|||
25219184|NCT01787760|50497475|FG002|Overall Study|Decompensated on left exotropia|1|||
25219185|NCT01787760|50497473|FG000|Overall Study|Dryness|0|||
25219186|NCT01787760|50497474|FG001|Overall Study|Dryness|1|||
25219187|NCT01787760|50497475|FG002|Overall Study|Dryness|0|||
25219188|NCT01787760|50497473|FG000|Overall Study|Relocation|1|||
25219189|NCT01787760|50497474|FG001|Overall Study|Relocation|1|||
25219190|NCT01787760|50497475|FG002|Overall Study|Relocation|0|||
25219191|NCT01787760|50497473|FG000|Overall Study|Lens discomfort|3|||
25219192|NCT01787760|50497474|FG001|Overall Study|Lens discomfort|0|||
25219193|NCT01787760|50497475|FG002|Overall Study|Lens discomfort|0|||
25219194|NCT01787760|50497473|FG000|Overall Study|Lens handling difficulty|1|||
25219195|NCT01787760|50497474|FG001|Overall Study|Lens handling difficulty|2|||
25219196|NCT01787760|50497475|FG002|Overall Study|Lens handling difficulty|0|||
25219197|NCT01787760|50497473|FG000|Overall Study|Protocol Violation|6|||
25219198|NCT01787760|50497474|FG001|Overall Study|Protocol Violation|0|||
25219199|NCT01787760|50497475|FG002|Overall Study|Protocol Violation|1|||
25219200|NCT01787760|50497473|FG000|Overall Study|Withdrawal by Subject|5|||
25219201|NCT01787760|50497474|FG001|Overall Study|Withdrawal by Subject|1|||
25219202|NCT01787760|50497475|FG002|Overall Study|Withdrawal by Subject|2|||
25219203|NCT01787760|50497473|FG000|Overall Study|Lost to Follow-up|1|||
25219204|NCT01787760|50497474|FG001|Overall Study|Lost to Follow-up|0|||
25219205|NCT01787760|50497475|FG002|Overall Study|Lost to Follow-up|1|||
25219206|NCT01787760|50497473|FG000|Overall Study|Stroke|1|||
25219207|NCT01787760|50497474|FG001|Overall Study|Stroke|0|||
25219208|NCT01787760|50497475|FG002|Overall Study|Stroke|0|||
25219209|NCT01787760|50497473|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
25219210|NCT01787760|50497474|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
25219211|NCT01787760|50497475|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
25219212|NCT01787760|50497473|FG000|Overall Study|Unsatisfactory physiological response|2|||
25219213|NCT01787760|50497474|FG001|Overall Study|Unsatisfactory physiological response|4|||
25219214|NCT01787760|50497475|FG002|Overall Study|Unsatisfactory physiological response|0|||
25219215|NCT01787760|50497473|FG000|Overall Study|Unsatisfactory visual response|1|||
25219216|NCT01787760|50497474|FG001|Overall Study|Unsatisfactory visual response|1|||
25219217|NCT01787760|50497475|FG002|Overall Study|Unsatisfactory visual response|0|||
25219218|NCT01787760|50497473|FG000|Overall Study|Near vision blur|1|||
25219219|NCT01787760|50497474|FG001|Overall Study|Near vision blur|0|||
25219220|NCT01787760|50497475|FG002|Overall Study|Near vision blur|0|||
25219221|NCT01815138|50497486|FG000|Overall Study|Withdrawal by Subject|0|||
25219222|NCT01815138|50497487|FG001|Overall Study|Withdrawal by Subject|1|||
25219223|NCT01815138|50497486|FG000|Overall Study|Physician Decision|8|||
25219224|NCT01815138|50497487|FG001|Overall Study|Physician Decision|5|||
25219225|NCT01606800|50497495|FG000|Overall Study|Adverse Event|3|||
25219226|NCT01606800|50497496|FG001|Overall Study|Adverse Event|1|||
25219227|NCT01606800|50497495|FG000|Overall Study|Participant withdrew consent|0|||
25219228|NCT01606800|50497496|FG001|Overall Study|Participant withdrew consent|1|||
25219229|NCT01606800|50497495|FG000|Overall Study|Missing completion status|2|||
25219230|NCT01606800|50497496|FG001|Overall Study|Missing completion status|0|||
25219231|NCT01772550|50497505|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
25219232|NCT01772550|50497506|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
25219233|NCT01772550|50497507|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
25219234|NCT01772550|50497505|FG000|Overall Study|Adverse Event|0|||
25219235|NCT01772550|50497506|FG001|Overall Study|Adverse Event|0|||
25219236|NCT01772550|50497507|FG002|Overall Study|Adverse Event|1|||
25219237|NCT01787292|50497515|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
25219238|NCT01787292|50497516|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
25219239|NCT01787292|50497515|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
25219240|NCT01787292|50497516|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
25219241|NCT01814748|50497529|FG000|Overall Study|Lost to Follow-up|1|||
25219242|NCT01814748|50497530|FG001|Overall Study|Lost to Follow-up|2|||
25219243|NCT01814748|50497529|FG000|Overall Study|Study site terminated by sponsor|1|||
25219244|NCT01814748|50497530|FG001|Overall Study|Study site terminated by sponsor|1|||
25219245|NCT01814748|50497529|FG000|Overall Study|Withdrawal by Subject|6|||
25219246|NCT01814748|50497530|FG001|Overall Study|Withdrawal by Subject|4|||
25219247|NCT01814670|50497536|FG000|Overall Study|Protocol Violation|12|||
25219248|NCT01814046|50497542|FG000|Drug Administration|Death due to complications of RSV|1|||
25219249|NCT01814046|50497543|FG001|Drug Administration|Death due to complications of RSV|0|||
25219250|NCT01814046|50497544|FG002|Drug Administration|Death due to complications of RSV|0|||
25219251|NCT01813890|50497554|FG000|Overall Study|Adverse Event|0|||
25219252|NCT01813890|50497555|FG001|Overall Study|Adverse Event|3|||
25219253|NCT01813890|50497556|FG002|Overall Study|Adverse Event|4|||
25219254|NCT01813890|50497554|FG000|Overall Study|Lack of Efficacy|9|||
25219255|NCT01813890|50497555|FG001|Overall Study|Lack of Efficacy|1|||
25219256|NCT01813890|50497556|FG002|Overall Study|Lack of Efficacy|2|||
25219257|NCT01772316|50497564|FG000|Overall Study|Serious adverse event|1|||
25219258|NCT01772316|50497564|FG000|Overall Study|Inform consent withdrawn|1|||
25219259|NCT01772316|50497564|FG000|Overall Study|Withdrawn by sponsor decision|5|||
25219260|NCT01813422|50497570|FG000|Overall Study|Withdrawal by Subject|14|||
25219261|NCT01813422|50497571|FG001|Overall Study|Withdrawal by Subject|8|||
25219262|NCT01813422|50497570|FG000|Overall Study|Death|2|||
25219263|NCT01813422|50497571|FG001|Overall Study|Death|3|||
25219264|NCT01813422|50497570|FG000|Overall Study|Sponsor Decision|2|||
25219265|NCT01813422|50497571|FG001|Overall Study|Sponsor Decision|1|||
25219266|NCT01813422|50497570|FG000|Overall Study|Lost to Follow-up|2|||
25219267|NCT01813422|50497571|FG001|Overall Study|Lost to Follow-up|4|||
25219268|NCT01786668|50497581|FG000|Overall Study|Adverse Event|0|||
24976487|NCT00031460|50065394|FG001|Overall Study|Non-Compliant|1|||
24976488|NCT00031460|50065393|FG000|Overall Study|Death|0|||
25219269|NCT01786668|50497582|FG001|Overall Study|Adverse Event|1|||
25219270|NCT01786668|50497583|FG002|Overall Study|Adverse Event|1|||
25219271|NCT01786668|50497584|FG003|Overall Study|Adverse Event|2|||
25219272|NCT01786668|50497581|FG000|Overall Study|Withdrawal by Subject|0|||
25219273|NCT01786668|50497582|FG001|Overall Study|Withdrawal by Subject|0|||
25219274|NCT01786668|50497583|FG002|Overall Study|Withdrawal by Subject|3|||
25219275|NCT01786668|50497584|FG003|Overall Study|Withdrawal by Subject|1|||
25219276|NCT01786668|50497581|FG000|Overall Study|Pregnancy|0|||
25219277|NCT01786668|50497582|FG001|Overall Study|Pregnancy|0|||
25219278|NCT01786668|50497583|FG002|Overall Study|Pregnancy|0|||
25219279|NCT01786668|50497584|FG003|Overall Study|Pregnancy|1|||
25219280|NCT01786668|50497581|FG000|Overall Study|Lost to Follow-up|1|||
25219281|NCT01786668|50497582|FG001|Overall Study|Lost to Follow-up|0|||
25219282|NCT01786668|50497583|FG002|Overall Study|Lost to Follow-up|1|||
25219283|NCT01786668|50497584|FG003|Overall Study|Lost to Follow-up|0|||
25219284|NCT01786512|50497605|FG000|Overall Study|Lost to Follow-up|0|||
25219285|NCT01786512|50497606|FG001|Overall Study|Lost to Follow-up|0|||
25219286|NCT01786512|50497607|FG002|Overall Study|Lost to Follow-up|0|||
25219287|NCT01786512|50497608|FG003|Overall Study|Lost to Follow-up|0|||
25219288|NCT01786512|50497609|FG004|Overall Study|Lost to Follow-up|0|||
25219289|NCT01786512|50497610|FG005|Overall Study|Lost to Follow-up|0|||
25219290|NCT01786512|50497611|FG006|Overall Study|Lost to Follow-up|0|||
25219291|NCT01786512|50497612|FG007|Overall Study|Lost to Follow-up|0|||
25219292|NCT01786512|50497613|FG008|Overall Study|Lost to Follow-up|0|||
25219293|NCT01786512|50497614|FG009|Overall Study|Lost to Follow-up|1|||
25219294|NCT01786512|50497615|FG010|Overall Study|Lost to Follow-up|0|||
25219295|NCT01786512|50497605|FG000|Overall Study|Decision by sponsor|0|||
25219296|NCT01786512|50497606|FG001|Overall Study|Decision by sponsor|0|||
25219297|NCT01786512|50497607|FG002|Overall Study|Decision by sponsor|0|||
25219298|NCT01786512|50497608|FG003|Overall Study|Decision by sponsor|0|||
25219299|NCT01786512|50497609|FG004|Overall Study|Decision by sponsor|0|||
25219300|NCT01786512|50497610|FG005|Overall Study|Decision by sponsor|0|||
25219301|NCT01786512|50497611|FG006|Overall Study|Decision by sponsor|0|||
25219302|NCT01786512|50497612|FG007|Overall Study|Decision by sponsor|0|||
25219303|NCT01786512|50497613|FG008|Overall Study|Decision by sponsor|0|||
25219304|NCT01786512|50497614|FG009|Overall Study|Decision by sponsor|0|||
25219305|NCT01786512|50497615|FG010|Overall Study|Decision by sponsor|2|||
25219306|NCT01786512|50497605|FG000|Overall Study|Withdrawal by Subject|0|||
25219307|NCT01786512|50497606|FG001|Overall Study|Withdrawal by Subject|1|||
25219308|NCT01786512|50497607|FG002|Overall Study|Withdrawal by Subject|0|||
25219309|NCT01786512|50497608|FG003|Overall Study|Withdrawal by Subject|0|||
25219310|NCT01786512|50497609|FG004|Overall Study|Withdrawal by Subject|0|||
25219311|NCT01786512|50497610|FG005|Overall Study|Withdrawal by Subject|0|||
25219312|NCT01786512|50497611|FG006|Overall Study|Withdrawal by Subject|1|||
25219313|NCT01786512|50497612|FG007|Overall Study|Withdrawal by Subject|0|||
25219314|NCT01786512|50497613|FG008|Overall Study|Withdrawal by Subject|0|||
25219315|NCT01786512|50497614|FG009|Overall Study|Withdrawal by Subject|3|||
25219316|NCT01786512|50497615|FG010|Overall Study|Withdrawal by Subject|7|||
25219317|NCT01786512|50497605|FG000|Overall Study|Death|0|||
25219318|NCT01786512|50497606|FG001|Overall Study|Death|0|||
25219319|NCT01786512|50497607|FG002|Overall Study|Death|0|||
25219320|NCT01786512|50497608|FG003|Overall Study|Death|0|||
25219321|NCT01786512|50497609|FG004|Overall Study|Death|0|||
25219322|NCT01786512|50497610|FG005|Overall Study|Death|0|||
25219323|NCT01786512|50497611|FG006|Overall Study|Death|0|||
25219324|NCT01786512|50497612|FG007|Overall Study|Death|0|||
25219325|NCT01786512|50497613|FG008|Overall Study|Death|4|||
25219326|NCT01786512|50497614|FG009|Overall Study|Death|1|||
25219327|NCT01786512|50497615|FG010|Overall Study|Death|3|||
25219328|NCT01772160|50497647|FG000|Overall Study|Death|3|||
25219329|NCT01772160|50497647|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
25219330|NCT01772160|50497647|FG000|Overall Study|Consent withdrawal|3|||
25219331|NCT01772160|50497647|FG000|Overall Study|Migrated / moved from the study area|4|||
25219332|NCT01772160|50497647|FG000|Overall Study|Lost to Follow-up|30|||
25219333|NCT01772160|50497647|FG000|Overall Study|Other|5|||
25219334|NCT01770912|50497653|FG000|Overall Study|Lost to Follow-up|2|||
25219335|NCT01770912|50497654|FG001|Overall Study|Lost to Follow-up|0|||
25219336|NCT01811706|50497660|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
25219337|NCT01811706|50497661|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
25219338|NCT01811472|50497672|FG000|Overall Study|Adverse Event|1|||
25219339|NCT01811472|50497673|FG001|Overall Study|Adverse Event|0|||
25219340|NCT01811472|50497674|FG002|Overall Study|Adverse Event|4|||
25219341|NCT01811472|50497672|FG000|Overall Study|Lost to Follow-up|0|||
25219342|NCT01811472|50497673|FG001|Overall Study|Lost to Follow-up|0|||
25219343|NCT01811472|50497674|FG002|Overall Study|Lost to Follow-up|1|||
25219344|NCT01811472|50497672|FG000|Overall Study|Subject/guardian decision|1|||
25219345|NCT01811472|50497673|FG001|Overall Study|Subject/guardian decision|0|||
25219346|NCT01811472|50497674|FG002|Overall Study|Subject/guardian decision|0|||
25219347|NCT01811238|50497683|FG000|Overall Study|Withdrawal by Subject|42|||
25219348|NCT01811238|50497683|FG000|Overall Study|Adverse Event|25|||
25219349|NCT01811238|50497683|FG000|Overall Study|Protocol Violation|4|||
25219350|NCT01811238|50497683|FG000|Overall Study|Lack of Efficacy|4|||
25219351|NCT01811238|50497683|FG000|Overall Study|subject refused study medication|6|||
25219352|NCT01769508|50497688|FG000|Overall Study|Death|3|||
25219353|NCT01769508|50497688|FG000|Overall Study|Withdrawal by Subject|1|||
25219354|NCT01769508|50497688|FG000|Overall Study|Adverse Event|1|||
25219355|NCT01769508|50497688|FG000|Overall Study|Lost to Follow-up|1|||
25219356|NCT01810380|50497695|FG000|Overall Study|Randomised not treated|2|||
25219357|NCT01810380|50497696|FG001|Overall Study|Randomised not treated|1|||
25219358|NCT01810380|50497697|FG002|Overall Study|Randomised not treated|1|||
25219359|NCT01810380|50497695|FG000|Overall Study|Adverse Event|11|||
25219360|NCT01810380|50497696|FG001|Overall Study|Adverse Event|14|||
25219361|NCT01810380|50497697|FG002|Overall Study|Adverse Event|4|||
25219362|NCT01810380|50497695|FG000|Overall Study|Lack of Efficacy|24|||
25219363|NCT01810380|50497696|FG001|Overall Study|Lack of Efficacy|10|||
25219364|NCT01810380|50497697|FG002|Overall Study|Lack of Efficacy|11|||
25219365|NCT01810380|50497695|FG000|Overall Study|Protocol Violation|1|||
25219366|NCT01810380|50497696|FG001|Overall Study|Protocol Violation|0|||
25219367|NCT01810380|50497697|FG002|Overall Study|Protocol Violation|1|||
25219368|NCT01810380|50497695|FG000|Overall Study|Withdrawal by Subject|6|||
25219369|NCT01810380|50497696|FG001|Overall Study|Withdrawal by Subject|0|||
25219370|NCT01810380|50497697|FG002|Overall Study|Withdrawal by Subject|6|||
25219371|NCT01810380|50497695|FG000|Overall Study|Administrative or other reasons|11|||
25219372|NCT01810380|50497696|FG001|Overall Study|Administrative or other reasons|13|||
25219373|NCT01810380|50497697|FG002|Overall Study|Administrative or other reasons|9|||
25219374|NCT01769196|50497707|FG000|Overall Study|Adverse Event|24|||
25219375|NCT01769196|50497708|FG001|Overall Study|Adverse Event|20|||
25219376|NCT01769196|50497707|FG000|Overall Study|Death|21|||
25219377|NCT01769196|50497708|FG001|Overall Study|Death|26|||
25219378|NCT01769196|50497707|FG000|Overall Study|Investigator Discretion|7|||
25317415|NCT00814983|50632923|FG001|Overall Study|Withdrawal by Subject|0|||
25317416|NCT00814983|50632922|FG000|Overall Study|Graft failure|1|||
25317417|NCT00814983|50632923|FG001|Overall Study|Graft failure|0|||
25317418|NCT00960869|50632931|FG000|Overall Study|Adverse Event|17|||
25317419|NCT00960869|50632932|FG001|Overall Study|Adverse Event|26|||
25317420|NCT00960869|50632931|FG000|Overall Study|Withdrawal by Subject|16|||
25317421|NCT00960869|50632932|FG001|Overall Study|Withdrawal by Subject|14|||
25317422|NCT00960869|50632931|FG000|Overall Study|Lost to Follow-up|1|||
25317423|NCT00960869|50632932|FG001|Overall Study|Lost to Follow-up|4|||
25317424|NCT00960869|50632931|FG000|Overall Study|Misc|19|||
25317425|NCT00960869|50632932|FG001|Overall Study|Misc|18|||
25317426|NCT00618787|50632940|FG000|Overall Study|Adverse Event|0|||
25317427|NCT00618787|50632941|FG001|Overall Study|Adverse Event|1|||
25317428|NCT00618787|50632940|FG000|Overall Study|Withdrawal by Subject|2|||
25317429|NCT00618787|50632941|FG001|Overall Study|Withdrawal by Subject|1|||
25317430|NCT00618787|50632940|FG000|Overall Study|Lost to Follow-up|1|||
25317431|NCT00618787|50632941|FG001|Overall Study|Lost to Follow-up|0|||
25317432|NCT00813813|50632949|FG000|Overall Study|Withdrawal by Subject|1|||
25317433|NCT00813813|50632950|FG001|Overall Study|Withdrawal by Subject|1|||
25317434|NCT00813813|50632949|FG000|Overall Study|Lost to Follow-up|2|||
25317435|NCT00813813|50632950|FG001|Overall Study|Lost to Follow-up|7|||
25317436|NCT00813813|50632949|FG000|Overall Study|Other|0|||
25317437|NCT00813813|50632950|FG001|Overall Study|Other|1|||
25317438|NCT00960011|50632958|FG000|Overall Study|Death|5|||
25317439|NCT00960011|50632959|FG001|Overall Study|Death|0|||
25317440|NCT00960011|50632958|FG000|Overall Study|Lost to Follow-up|6|||
25317441|NCT00960011|50632959|FG001|Overall Study|Lost to Follow-up|2|||
25317442|NCT00617851|50633003|FG000|Overall Study|Death|0|||
25317443|NCT00617851|50633004|FG001|Overall Study|Death|0|||
25317444|NCT00617851|50633005|FG002|Overall Study|Death|0|||
25317445|NCT00617851|50633006|FG003|Overall Study|Death|1|||
25317446|NCT00617851|50633003|FG000|Overall Study|Withdrawal by Subject|14|||
25317447|NCT00617851|50633004|FG001|Overall Study|Withdrawal by Subject|7|||
25317448|NCT00617851|50633005|FG002|Overall Study|Withdrawal by Subject|12|||
25317449|NCT00617851|50633006|FG003|Overall Study|Withdrawal by Subject|4|||
25317450|NCT00617851|50633003|FG000|Overall Study|Lost to Follow-up|27|||
25317451|NCT00617851|50633004|FG001|Overall Study|Lost to Follow-up|29|||
25317452|NCT00617851|50633005|FG002|Overall Study|Lost to Follow-up|31|||
25317453|NCT00617851|50633006|FG003|Overall Study|Lost to Follow-up|19|||
25317454|NCT00617851|50633003|FG000|Overall Study|Inappropriate Enrollment|5|||
25317455|NCT00617851|50633004|FG001|Overall Study|Inappropriate Enrollment|4|||
25317456|NCT00617851|50633005|FG002|Overall Study|Inappropriate Enrollment|1|||
25317457|NCT00617851|50633006|FG003|Overall Study|Inappropriate Enrollment|1|||
25317458|NCT00617851|50633003|FG000|Overall Study|Unable to classify|1|||
25317459|NCT00617851|50633004|FG001|Overall Study|Unable to classify|0|||
25317460|NCT00617851|50633005|FG002|Overall Study|Unable to classify|1|||
25219379|NCT01769196|50497708|FG001|Overall Study|Investigator Discretion|3|||
25219380|NCT01769196|50497707|FG000|Overall Study|Lack of Efficacy|3|||
25317461|NCT00617851|50633006|FG003|Overall Study|Unable to classify|0|||
25317462|NCT00812955|50633030|FG000|Overall Study|Adverse Event|7|||
25317463|NCT00812955|50633031|FG001|Overall Study|Adverse Event|6|||
25317464|NCT00812955|50633032|FG002|Overall Study|Adverse Event|3|||
25317465|NCT00812955|50633033|FG003|Overall Study|Adverse Event|4|||
25219381|NCT01769196|50497708|FG001|Overall Study|Lack of Efficacy|2|||
25317466|NCT00812955|50633030|FG000|Overall Study|Lost to Follow-up|2|||
25219382|NCT01769196|50497707|FG000|Overall Study|Progressive disease|11|||
25317467|NCT00812955|50633031|FG001|Overall Study|Lost to Follow-up|1|||
25317468|NCT00812955|50633032|FG002|Overall Study|Lost to Follow-up|1|||
25317469|NCT00812955|50633033|FG003|Overall Study|Lost to Follow-up|2|||
25317470|NCT00812955|50633030|FG000|Overall Study|Withdrawal by Subject|1|||
25317471|NCT00812955|50633031|FG001|Overall Study|Withdrawal by Subject|0|||
25317472|NCT00812955|50633032|FG002|Overall Study|Withdrawal by Subject|1|||
25317473|NCT00812955|50633033|FG003|Overall Study|Withdrawal by Subject|2|||
25219383|NCT01769196|50497708|FG001|Overall Study|Progressive disease|6|||
25219384|NCT01769196|50497707|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
25219385|NCT01769196|50497708|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
25219386|NCT01769196|50497707|FG000|Overall Study|Protocol Violation|0|||
25219387|NCT01769196|50497708|FG001|Overall Study|Protocol Violation|3|||
25219388|NCT01769196|50497707|FG000|Overall Study|Study terminated by sponsor|160|||
25219389|NCT01769196|50497708|FG001|Overall Study|Study terminated by sponsor|161|||
25219390|NCT01769196|50497707|FG000|Overall Study|Participant never dosed with study drug|1|||
25219391|NCT01769196|50497708|FG001|Overall Study|Participant never dosed with study drug|0|||
25219392|NCT01769196|50497707|FG000|Overall Study|Withdrew consent|36|||
25219393|NCT01769196|50497708|FG001|Overall Study|Withdrew consent|40|||
25219394|NCT01810302|50497716|FG000|Overall Study|Death|1|||
25219395|NCT01810302|50497717|FG001|Overall Study|Death|0|||
25219396|NCT01810302|50497716|FG000|Overall Study|Physician Decision|0|||
25219397|NCT01810302|50497717|FG001|Overall Study|Physician Decision|1|||
25219398|NCT01783938|50497725|FG000|Overall Study|Disease Progression|18|||
25219399|NCT01783938|50497726|FG001|Overall Study|Disease Progression|41|||
25219400|NCT01783938|50497725|FG000|Overall Study|Study Drug Toxicity|27|||
25219401|NCT01783938|50497726|FG001|Overall Study|Study Drug Toxicity|14|||
25219402|NCT01783938|50497725|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
25219403|NCT01783938|50497726|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
25219404|NCT01783938|50497725|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
25219405|NCT01783938|50497726|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
25219406|NCT01783938|50497725|FG000|Overall Study|Participant Withdrew Consent|2|||
25219407|NCT01783938|50497726|FG001|Overall Study|Participant Withdrew Consent|0|||
25219408|NCT01783938|50497725|FG000|Overall Study|Maximum Clinical Benefit|1|||
25219409|NCT01783938|50497726|FG001|Overall Study|Maximum Clinical Benefit|0|||
25219410|NCT01783938|50497725|FG000|Overall Study|Other Reasons|3|||
25219411|NCT01783938|50497726|FG001|Overall Study|Other Reasons|1|||
25219412|NCT01768572|50497735|FG000|Overall Study|Adverse Event|7|||
25219413|NCT01768572|50497736|FG001|Overall Study|Adverse Event|8|||
25219414|NCT01768572|50497737|FG002|Overall Study|Adverse Event|4|||
25219415|NCT01768572|50497735|FG000|Overall Study|Lack of Efficacy|1|||
25219416|NCT01768572|50497736|FG001|Overall Study|Lack of Efficacy|3|||
25219417|NCT01768572|50497737|FG002|Overall Study|Lack of Efficacy|1|||
25219418|NCT01768572|50497735|FG000|Overall Study|Other, Not due to an adverse event|1|||
25219419|NCT01768572|50497736|FG001|Overall Study|Other, Not due to an adverse event|1|||
25219420|NCT01768572|50497737|FG002|Overall Study|Other, Not due to an adverse event|1|||
25219421|NCT01783548|50497747|FG000|Overall Study|Adverse Event|8|||
25219422|NCT01783548|50497748|FG001|Overall Study|Adverse Event|4|||
25219423|NCT01783548|50497747|FG000|Overall Study|Withdrawal by Subject|11|||
25219424|NCT01783548|50497748|FG001|Overall Study|Withdrawal by Subject|8|||
25219425|NCT01783548|50497747|FG000|Overall Study|Non-compliance|4|||
25219426|NCT01783548|50497748|FG001|Overall Study|Non-compliance|0|||
25219427|NCT01783548|50497747|FG000|Overall Study|Protocol Violation|2|||
25219428|NCT01783548|50497748|FG001|Overall Study|Protocol Violation|2|||
25219429|NCT01783548|50497747|FG000|Overall Study|Lost to Follow-up|8|||
25219430|NCT01783548|50497748|FG001|Overall Study|Lost to Follow-up|3|||
25219431|NCT01783548|50497747|FG000|Overall Study|Lack of Efficacy|1|||
25219432|NCT01783548|50497748|FG001|Overall Study|Lack of Efficacy|1|||
25219433|NCT01809210|50497761|FG000|Overall Study|Withdrawal by Subject|0|||
25219434|NCT01809210|50497762|FG001|Overall Study|Withdrawal by Subject|0|||
25219435|NCT01809210|50497763|FG002|Overall Study|Withdrawal by Subject|1|||
25219436|NCT01809210|50497764|FG003|Overall Study|Withdrawal by Subject|1|||
25219437|NCT01809210|50497765|FG004|Overall Study|Withdrawal by Subject|1|||
25219438|NCT01809210|50497766|FG005|Overall Study|Withdrawal by Subject|0|||
25219439|NCT01809210|50497767|FG006|Overall Study|Withdrawal by Subject|4|||
25219440|NCT01809210|50497761|FG000|Overall Study|Death|1|||
25219441|NCT01809210|50497762|FG001|Overall Study|Death|1|||
25219442|NCT01809210|50497763|FG002|Overall Study|Death|2|||
25219443|NCT01809210|50497764|FG003|Overall Study|Death|0|||
25219444|NCT01809210|50497765|FG004|Overall Study|Death|1|||
25219445|NCT01809210|50497766|FG005|Overall Study|Death|3|||
25219446|NCT01809210|50497767|FG006|Overall Study|Death|1|||
25219447|NCT01809132|50497786|FG000|Overall Study|Withdrawal by Subject|0|||
25219448|NCT01809132|50497787|FG001|Overall Study|Withdrawal by Subject|0|||
25219449|NCT01809132|50497788|FG002|Overall Study|Withdrawal by Subject|1|||
25219450|NCT01808508|50497799|FG000|Overall Study|Lost to Follow-up|1|||
25219451|NCT01808508|50497800|FG001|Overall Study|Lost to Follow-up|0|||
25219452|NCT01808508|50497801|FG002|Overall Study|Lost to Follow-up|0|||
25219453|NCT01766778|50497811|FG000|Overall Study|Adverse Event|4|||
25219454|NCT01766778|50497812|FG001|Overall Study|Adverse Event|4|||
25219455|NCT01766778|50497811|FG000|Overall Study|Withdrawal by Subject|1|||
25219456|NCT01766778|50497812|FG001|Overall Study|Withdrawal by Subject|0|||
25317474|NCT00812955|50633030|FG000|Overall Study|randomized in error|0|||
25219457|NCT01808196|50497818|FG000|Overall Study|Lost to Follow-up|1|||
25219458|NCT01808118|50497822|FG000|Period 1|Adverse Event|15|||
25219459|NCT01808118|50497823|FG001|Period 1|Adverse Event|0|||
25219460|NCT01808118|50497824|FG002|Period 1|Adverse Event|0|||
25219461|NCT01808118|50497822|FG000|Period 1|Withdrew consent|24|||
25219462|NCT01808118|50497823|FG001|Period 1|Withdrew consent|0|||
25219463|NCT01808118|50497824|FG002|Period 1|Withdrew consent|0|||
25317475|NCT00812955|50633031|FG001|Overall Study|randomized in error|0|||
25317476|NCT00812955|50633032|FG002|Overall Study|randomized in error|1|||
25317477|NCT00812955|50633033|FG003|Overall Study|randomized in error|0|||
25317478|NCT00619489|50633049|FG000|Overall Study|Adverse Event|0|||
25317479|NCT00619489|50633050|FG001|Overall Study|Adverse Event|7|||
25317480|NCT00619489|50633049|FG000|Overall Study|Withdrawal by Subject|1|||
25317481|NCT00619489|50633050|FG001|Overall Study|Withdrawal by Subject|1|||
25317482|NCT00619489|50633049|FG000|Overall Study|Lack of Efficacy|0|||
25317483|NCT00619489|50633050|FG001|Overall Study|Lack of Efficacy|11|||
25317484|NCT00619489|50633049|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
25317485|NCT00619489|50633050|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
25317486|NCT00959699|50633058|FG000|Treatment Period|Adverse Event|3|||
25317487|NCT00959699|50633059|FG001|Treatment Period|Adverse Event|13|||
25317488|NCT00959699|50633058|FG000|Treatment Period|Lack of Efficacy|15|||
25317489|NCT00959699|50633059|FG001|Treatment Period|Lack of Efficacy|6|||
25317490|NCT00959699|50633058|FG000|Treatment Period|Lost to Follow-up|0|||
25317491|NCT00959699|50633059|FG001|Treatment Period|Lost to Follow-up|1|||
25317492|NCT00959699|50633058|FG000|Treatment Period|Withdrawal by Subject|1|||
25317493|NCT00959699|50633059|FG001|Treatment Period|Withdrawal by Subject|3|||
25317494|NCT00959699|50633058|FG000|Treatment Period|Non-Compliance with Protocol|0|||
25317495|NCT00959699|50633059|FG001|Treatment Period|Non-Compliance with Protocol|1|||
25317496|NCT00959699|50633058|FG000|Treatment Period|Did not receive treatment|0|||
25317497|NCT00959699|50633059|FG001|Treatment Period|Did not receive treatment|1|||
25317498|NCT00959699|50633058|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
25317499|NCT00959699|50633059|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
25317500|NCT00959699|50633058|FG000|Follow-up Period|Lost to Follow-up|3|||
25317501|NCT00959699|50633059|FG001|Follow-up Period|Lost to Follow-up|2|||
25317502|NCT00959699|50633058|FG000|Follow-up Period|Withdrawal by Subject|3|||
25317503|NCT00959699|50633059|FG001|Follow-up Period|Withdrawal by Subject|4|||
25317504|NCT00617773|50633066|FG000|Overall Study|Physician Decision|1|||
25317505|NCT00617773|50633066|FG000|Overall Study|Lack of compliance with the protocol|1|||
25317506|NCT00617773|50633066|FG000|Overall Study|Withdrawal by Subject|1|||
25317507|NCT00617773|50633066|FG000|Overall Study|Death|1|||
25317508|NCT00617773|50633066|FG000|Overall Study|Progressive disease|19|||
25317509|NCT00617773|50633066|FG000|Overall Study|Protocol Violation|1|||
25317510|NCT00956813|50633072|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
25317511|NCT00956813|50633073|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
25317512|NCT00956813|50633072|FG000|Flaxseed and Placebo|Ineligible|3|||
25317513|NCT00956813|50633073|FG001|Flaxseed and Placebo|Ineligible|1|||
25317514|NCT00955955|50633083|FG000|Overall Study|Lost to Follow-up|2|||
25317515|NCT00955955|50633084|FG001|Overall Study|Lost to Follow-up|0|||
25317516|NCT00955955|50633085|FG002|Overall Study|Lost to Follow-up|0|||
25317517|NCT00955721|50633101|FG000|Overall Study|Physician Decision|1|||
25317518|NCT00955721|50633102|FG001|Overall Study|Physician Decision|0|||
25317519|NCT00955721|50633101|FG000|Overall Study|Death|1|||
25317520|NCT00955721|50633102|FG001|Overall Study|Death|0|||
25317521|NCT00955721|50633101|FG000|Overall Study|Withdrawal by Subject|1|||
25317522|NCT00955721|50633102|FG001|Overall Study|Withdrawal by Subject|0|||
25317523|NCT00573469|50633112|FG000|Overall Study|Adverse Event|1|||
25317524|NCT00573469|50633113|FG001|Overall Study|Adverse Event|1|||
25317525|NCT00573469|50633114|FG002|Overall Study|Adverse Event|1|||
25317526|NCT00573469|50633112|FG000|Overall Study|Withdrawal by Subject|0|||
25317527|NCT00573469|50633113|FG001|Overall Study|Withdrawal by Subject|2|||
25317528|NCT00573469|50633114|FG002|Overall Study|Withdrawal by Subject|0|||
25317529|NCT00573469|50633112|FG000|Overall Study|Other|5|||
25317530|NCT00573469|50633113|FG001|Overall Study|Other|1|||
25317531|NCT00573469|50633114|FG002|Overall Study|Other|3|||
25317532|NCT00812565|50633130|FG000|Overall Study|Did Not Receive Study Medication|1|||
25317533|NCT00812565|50633131|FG001|Overall Study|Did Not Receive Study Medication|1|||
24976489|NCT00031460|50065394|FG001|Overall Study|Death|1|||
25317534|NCT00812565|50633132|FG002|Overall Study|Did Not Receive Study Medication|0|||
25317535|NCT00812565|50633133|FG003|Overall Study|Did Not Receive Study Medication|0|||
25317536|NCT00812565|50633134|FG004|Overall Study|Did Not Receive Study Medication|0|||
25317537|NCT00812565|50633135|FG005|Overall Study|Did Not Receive Study Medication|0|||
25317538|NCT00812565|50633136|FG006|Overall Study|Did Not Receive Study Medication|0|||
25317539|NCT00812565|50633137|FG007|Overall Study|Did Not Receive Study Medication|0|||
25317540|NCT00812565|50633130|FG000|Overall Study|Adverse Event|0|||
25317541|NCT00812565|50633131|FG001|Overall Study|Adverse Event|0|||
25219464|NCT01808118|50497822|FG000|Period 1|Lost to Follow-up|9|||
25219465|NCT01808118|50497823|FG001|Period 1|Lost to Follow-up|0|||
25219466|NCT01808118|50497824|FG002|Period 1|Lost to Follow-up|0|||
25219467|NCT01808118|50497822|FG000|Period 1|Did not meet criteria for remission|303|||
25219468|NCT01808118|50497823|FG001|Period 1|Did not meet criteria for remission|0|||
25219469|NCT01808118|50497824|FG002|Period 1|Did not meet criteria for remission|0|||
25219470|NCT01808118|50497822|FG000|Period 1|Enrolled in error|7|||
25219471|NCT01808118|50497823|FG001|Period 1|Enrolled in error|0|||
25219472|NCT01808118|50497824|FG002|Period 1|Enrolled in error|0|||
25219473|NCT01808118|50497822|FG000|Period 1|Did not meet inclusion criteria|3|||
25219474|NCT01808118|50497823|FG001|Period 1|Did not meet inclusion criteria|0|||
25219475|NCT01808118|50497824|FG002|Period 1|Did not meet inclusion criteria|0|||
25219476|NCT01808118|50497822|FG000|Period 1|Non-conformance with inclusion criteria|3|||
25219477|NCT01808118|50497823|FG001|Period 1|Non-conformance with inclusion criteria|0|||
25219478|NCT01808118|50497824|FG002|Period 1|Non-conformance with inclusion criteria|0|||
25219479|NCT01808118|50497822|FG000|Period 1|Investigator decision: site closure|2|||
25219480|NCT01808118|50497823|FG001|Period 1|Investigator decision: site closure|0|||
25219481|NCT01808118|50497824|FG002|Period 1|Investigator decision: site closure|0|||
25219482|NCT01808118|50497822|FG000|Period 1|Non-compliance per sponsor|1|||
25219483|NCT01808118|50497823|FG001|Period 1|Non-compliance per sponsor|0|||
25219484|NCT01808118|50497824|FG002|Period 1|Non-compliance per sponsor|0|||
25219485|NCT01808118|50497822|FG000|Period 1|Lack of Efficacy|1|||
25219486|NCT01808118|50497823|FG001|Period 1|Lack of Efficacy|0|||
25219487|NCT01808118|50497824|FG002|Period 1|Lack of Efficacy|0|||
25219488|NCT01808118|50497822|FG000|Period 2|Adverse Event|0|||
25219489|NCT01808118|50497823|FG001|Period 2|Adverse Event|4|||
25219490|NCT01808118|50497824|FG002|Period 2|Adverse Event|0|||
25219491|NCT01808118|50497822|FG000|Period 2|Withdrew consent|0|||
25219492|NCT01808118|50497823|FG001|Period 2|Withdrew consent|7|||
25219493|NCT01808118|50497824|FG002|Period 2|Withdrew consent|6|||
25219494|NCT01808118|50497822|FG000|Period 2|Lost to Follow-up|0|||
25219495|NCT01808118|50497823|FG001|Period 2|Lost to Follow-up|0|||
25219496|NCT01808118|50497824|FG002|Period 2|Lost to Follow-up|2|||
25219497|NCT01808118|50497822|FG000|Period 2|Investigator no longer conducting trials|0|||
25219498|NCT01808118|50497823|FG001|Period 2|Investigator no longer conducting trials|1|||
25219499|NCT01808118|50497824|FG002|Period 2|Investigator no longer conducting trials|0|||
25219500|NCT01808118|50497822|FG000|Period 2|Switched to other therapy|0|||
25219501|NCT01808118|50497823|FG001|Period 2|Switched to other therapy|1|||
25219502|NCT01808118|50497824|FG002|Period 2|Switched to other therapy|0|||
25219503|NCT01807650|50497838|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
25219504|NCT01807650|50497838|FG000|Overall Study|Adverse Event|5|||
25219505|NCT01807650|50497838|FG000|Overall Study|Other|2|||
25219506|NCT01782690|50497879|FG000|Overall Study|Not reported|7|||
25219507|NCT01782690|50497879|FG000|Overall Study|Toxicity of gemcitabine|1|||
25219508|NCT01782690|50497879|FG000|Overall Study|Toxicity of erlotinib|1|||
25219509|NCT01782690|50497879|FG000|Overall Study|Lost to Follow-up|31|||
25219510|NCT01782690|50497879|FG000|Overall Study|Withdrawal of informed consent|2|||
25219511|NCT01782690|50497879|FG000|Overall Study|Absent rash|9|||
25219512|NCT01782690|50497879|FG000|Overall Study|Physician Decision|13|||
25219513|NCT01782690|50497879|FG000|Overall Study|Patient's wish|21|||
25219514|NCT01782690|50497879|FG000|Overall Study|Tumor progression|74|||
25219515|NCT01782690|50497879|FG000|Overall Study|Death|133|||
25219516|NCT01782690|50497879|FG000|Overall Study|Study completion unknown|7|||
25219517|NCT01782378|50497885|FG000|First Series|Lost to Follow-up|7|||
25219518|NCT01782378|50497886|FG001|First Series|Lost to Follow-up|8|||
25219519|NCT01782378|50497885|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
25219520|NCT01782378|50497886|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
25219521|NCT01782378|50497885|FG000|Second Series|Lost to Follow-up|8|||
25219522|NCT01782378|50497886|FG001|Second Series|Lost to Follow-up|7|||
25219523|NCT01782378|50497885|FG000|Second Series|Did not choose to complete S2 Optional|18|||
25219524|NCT01782378|50497886|FG001|Second Series|Did not choose to complete S2 Optional|0|||
25219525|NCT01766310|50497894|FG000|Overall Study|Lost to Follow-up|1|||
25219526|NCT01766310|50497895|FG001|Overall Study|Lost to Follow-up|3|||
25219527|NCT01765920|50497903|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
25219528|NCT01765920|50497904|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
25219529|NCT01765920|50497903|FG000|Overall Study|Patient code disclosure|0|||
25219530|NCT01765920|50497904|FG001|Overall Study|Patient code disclosure|1|||
25219531|NCT01782222|50497913|FG000|Overall Study|Adverse Event|4|||
25219532|NCT01782222|50497914|FG001|Overall Study|Adverse Event|5|||
25219533|NCT01782222|50497915|FG002|Overall Study|Adverse Event|3|||
25219534|NCT01782222|50497913|FG000|Overall Study|Lack of Efficacy|2|||
25219535|NCT01782222|50497914|FG001|Overall Study|Lack of Efficacy|1|||
25219536|NCT01782222|50497915|FG002|Overall Study|Lack of Efficacy|0|||
25219537|NCT01782222|50497913|FG000|Overall Study|Protocol Violation|1|||
25219538|NCT01782222|50497914|FG001|Overall Study|Protocol Violation|0|||
25219539|NCT01782222|50497915|FG002|Overall Study|Protocol Violation|0|||
25219540|NCT01782222|50497913|FG000|Overall Study|Withdrawal by Subject|1|||
25219541|NCT01782222|50497914|FG001|Overall Study|Withdrawal by Subject|4|||
25219542|NCT01782222|50497915|FG002|Overall Study|Withdrawal by Subject|1|||
25219543|NCT01782222|50497913|FG000|Overall Study|Moved to other state|0|||
25219544|NCT01782222|50497914|FG001|Overall Study|Moved to other state|1|||
25219545|NCT01782222|50497915|FG002|Overall Study|Moved to other state|0|||
25219546|NCT01781832|50497923|FG000|Overall Study|Withdrawal by Subject|1|||
25219547|NCT01807182|50497927|FG000|Overall Study|Death|1|||
25219548|NCT01807182|50497927|FG000|Overall Study|New therapy|1|||
25219549|NCT01807182|50497927|FG000|Overall Study|Moved to hospice care|1|||
25219550|NCT01806714|50497933|FG000|Overall Study|No functioning phone number|200|||
25219551|NCT01806714|50497934|FG001|Overall Study|No functioning phone number|170|||
25219552|NCT01765764|50497943|FG000|Treatment Period|Adverse Event|1|||
25219553|NCT01765764|50497944|FG001|Treatment Period|Adverse Event|2|||
25219554|NCT01765764|50497945|FG002|Treatment Period|Adverse Event|1|||
25219555|NCT01765764|50497943|FG000|Treatment Period|Lost to Follow-up|0|||
25219556|NCT01765764|50497944|FG001|Treatment Period|Lost to Follow-up|3|||
25219557|NCT01765764|50497945|FG002|Treatment Period|Lost to Follow-up|2|||
25219558|NCT01765764|50497943|FG000|Treatment Period|Personal Reasons|1|||
25219559|NCT01765764|50497944|FG001|Treatment Period|Personal Reasons|2|||
25219560|NCT01765764|50497945|FG002|Treatment Period|Personal Reasons|1|||
25219561|NCT01765764|50497943|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
25219562|NCT01765764|50497944|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
25219563|NCT01765764|50497945|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
25219564|NCT01806168|50497956|FG000|Overall Study|Adverse Event|1|||
25219565|NCT01806168|50497957|FG001|Overall Study|Adverse Event|0|||
25219566|NCT01806168|50497958|FG002|Overall Study|Adverse Event|0|||
25219567|NCT01806168|50497956|FG000|Overall Study|Withdrawal by Subject|0|||
25219568|NCT01806168|50497957|FG001|Overall Study|Withdrawal by Subject|1|||
25219569|NCT01806168|50497958|FG002|Overall Study|Withdrawal by Subject|2|||
25219570|NCT01806168|50497956|FG000|Overall Study|Protocol Violation|0|||
25219571|NCT01806168|50497957|FG001|Overall Study|Protocol Violation|0|||
25219572|NCT01806168|50497958|FG002|Overall Study|Protocol Violation|1|||
25219573|NCT01804842|50497972|FG000|Overall Study|Adverse Event|1|||
25219574|NCT01804842|50497973|FG001|Overall Study|Adverse Event|1|||
25219575|NCT01804842|50497974|FG002|Overall Study|Adverse Event|0|||
25219576|NCT01804842|50497972|FG000|Overall Study|Lost to Follow-up|1|||
25219577|NCT01804842|50497973|FG001|Overall Study|Lost to Follow-up|0|||
25219578|NCT01804842|50497974|FG002|Overall Study|Lost to Follow-up|0|||
25219579|NCT01804842|50497972|FG000|Overall Study|Non-Compliance|1|||
25219580|NCT01804842|50497973|FG001|Overall Study|Non-Compliance|1|||
25317542|NCT00812565|50633132|FG002|Overall Study|Adverse Event|0|||
25317543|NCT00812565|50633133|FG003|Overall Study|Adverse Event|2|||
25317544|NCT00812565|50633134|FG004|Overall Study|Adverse Event|0|||
25317545|NCT00812565|50633135|FG005|Overall Study|Adverse Event|0|||
25317546|NCT00812565|50633136|FG006|Overall Study|Adverse Event|0|||
25317547|NCT00812565|50633137|FG007|Overall Study|Adverse Event|1|||
25317548|NCT00812565|50633130|FG000|Overall Study|Did Not Come to Study Visit|1|||
25317549|NCT00812565|50633131|FG001|Overall Study|Did Not Come to Study Visit|0|||
25317550|NCT00812565|50633132|FG002|Overall Study|Did Not Come to Study Visit|0|||
25317551|NCT00812565|50633133|FG003|Overall Study|Did Not Come to Study Visit|0|||
25317552|NCT00812565|50633134|FG004|Overall Study|Did Not Come to Study Visit|0|||
25317553|NCT00812565|50633135|FG005|Overall Study|Did Not Come to Study Visit|0|||
25317554|NCT00812565|50633136|FG006|Overall Study|Did Not Come to Study Visit|0|||
25317555|NCT00812565|50633137|FG007|Overall Study|Did Not Come to Study Visit|0|||
25317556|NCT00812565|50633130|FG000|Overall Study|Withdrawal of Consent|1|||
25317557|NCT00812565|50633131|FG001|Overall Study|Withdrawal of Consent|0|||
25317558|NCT00812565|50633132|FG002|Overall Study|Withdrawal of Consent|0|||
25317559|NCT00812565|50633133|FG003|Overall Study|Withdrawal of Consent|0|||
25317560|NCT00812565|50633134|FG004|Overall Study|Withdrawal of Consent|1|||
25317561|NCT00812565|50633135|FG005|Overall Study|Withdrawal of Consent|0|||
25317562|NCT00812565|50633136|FG006|Overall Study|Withdrawal of Consent|0|||
25317563|NCT00812565|50633137|FG007|Overall Study|Withdrawal of Consent|0|||
25317564|NCT00812565|50633130|FG000|Overall Study|Reason Not Specified|0|||
25317565|NCT00812565|50633131|FG001|Overall Study|Reason Not Specified|0|||
25317566|NCT00812565|50633132|FG002|Overall Study|Reason Not Specified|0|||
25317567|NCT00812565|50633133|FG003|Overall Study|Reason Not Specified|0|||
25317568|NCT00812565|50633134|FG004|Overall Study|Reason Not Specified|0|||
25317569|NCT00812565|50633135|FG005|Overall Study|Reason Not Specified|1|||
25317570|NCT00812565|50633136|FG006|Overall Study|Reason Not Specified|0|||
25219581|NCT01804842|50497974|FG002|Overall Study|Non-Compliance|0|||
25219582|NCT01804842|50497972|FG000|Overall Study|Personal Reason|0|||
25219583|NCT01804842|50497973|FG001|Overall Study|Personal Reason|0|||
25219584|NCT01804842|50497974|FG002|Overall Study|Personal Reason|1|||
25219585|NCT01781286|50497982|FG000|Overall Study|Lost to Follow-up|0|||
25219586|NCT01781286|50497983|FG001|Overall Study|Lost to Follow-up|0|||
25219587|NCT01781286|50497984|FG002|Overall Study|Lost to Follow-up|0|||
25317571|NCT00812565|50633137|FG007|Overall Study|Reason Not Specified|0|||
25317572|NCT00812487|50633157|FG000|Overall Study|Lost to Follow-up|2|||
25317573|NCT00812487|50633158|FG001|Overall Study|Lost to Follow-up|0|||
25317574|NCT00812487|50633157|FG000|Overall Study|Withdrawal by Subject|3|||
25219588|NCT01781286|50497985|FG003|Overall Study|Lost to Follow-up|0|||
25219589|NCT01781286|50497986|FG004|Overall Study|Lost to Follow-up|0|||
25219590|NCT01781286|50497987|FG005|Overall Study|Lost to Follow-up|1|||
25219591|NCT01781286|50497982|FG000|Overall Study|Time Constraints|2|||
25219592|NCT01781286|50497983|FG001|Overall Study|Time Constraints|0|||
25219593|NCT01781286|50497984|FG002|Overall Study|Time Constraints|2|||
25219594|NCT01781286|50497985|FG003|Overall Study|Time Constraints|0|||
25219595|NCT01781286|50497986|FG004|Overall Study|Time Constraints|0|||
25219596|NCT01781286|50497987|FG005|Overall Study|Time Constraints|0|||
25219597|NCT01781286|50497982|FG000|Overall Study|Noncompliance|0|||
25219598|NCT01781286|50497983|FG001|Overall Study|Noncompliance|0|||
25219599|NCT01781286|50497984|FG002|Overall Study|Noncompliance|0|||
25219600|NCT01781286|50497985|FG003|Overall Study|Noncompliance|1|||
25219601|NCT01781286|50497986|FG004|Overall Study|Noncompliance|0|||
25219602|NCT01781286|50497987|FG005|Overall Study|Noncompliance|0|||
25219603|NCT01780974|50497999|FG000|Overall Study|Death|1|||
25219604|NCT01780974|50498000|FG001|Overall Study|Death|0|||
25219605|NCT01780974|50497999|FG000|Overall Study|Adverse Event|1|||
25219606|NCT01780974|50498000|FG001|Overall Study|Adverse Event|3|||
25219607|NCT01780662|50498009|FG000|Overall Study|Adverse Event|1|||
25219608|NCT01780662|50498010|FG001|Overall Study|Adverse Event|0|||
25219609|NCT01780662|50498011|FG002|Overall Study|Adverse Event|2|||
25219610|NCT01780662|50498009|FG000|Overall Study|Physician Decision|0|||
25219611|NCT01780662|50498010|FG001|Overall Study|Physician Decision|5|||
25219612|NCT01780662|50498011|FG002|Overall Study|Physician Decision|7|||
25219613|NCT01780662|50498009|FG000|Overall Study|Protocol Violation|0|||
25219614|NCT01780662|50498010|FG001|Overall Study|Protocol Violation|1|||
25219615|NCT01780662|50498011|FG002|Overall Study|Protocol Violation|0|||
25219616|NCT01780662|50498009|FG000|Overall Study|Ineligible|0|||
25219617|NCT01780662|50498010|FG001|Overall Study|Ineligible|0|||
25219618|NCT01780662|50498011|FG002|Overall Study|Ineligible|1|||
25219619|NCT01780584|50498023|FG000|Overall Study|Death|1|||
25219620|NCT01780584|50498024|FG001|Overall Study|Death|0|||
25219621|NCT01780584|50498025|FG002|Overall Study|Death|1|||
25219622|NCT01780584|50498023|FG000|Overall Study|Adverse Event|0|||
25219623|NCT01780584|50498024|FG001|Overall Study|Adverse Event|1|||
25219624|NCT01780584|50498025|FG002|Overall Study|Adverse Event|0|||
25219625|NCT01780584|50498023|FG000|Overall Study|Protocol Violation|0|||
25219626|NCT01780584|50498024|FG001|Overall Study|Protocol Violation|0|||
25219627|NCT01780584|50498025|FG002|Overall Study|Protocol Violation|1|||
25219628|NCT01780506|50498035|FG000|Double-Blind Phase|Randomized but not Treated|3|||
25219629|NCT01780506|50498036|FG001|Double-Blind Phase|Randomized but not Treated|2|||
25219630|NCT01780506|50498035|FG000|Double-Blind Phase|Adverse Event|4|||
25219631|NCT01780506|50498036|FG001|Double-Blind Phase|Adverse Event|14|||
25219632|NCT01780506|50498035|FG000|Double-Blind Phase|Death|1|||
25219633|NCT01780506|50498036|FG001|Double-Blind Phase|Death|2|||
25219634|NCT01780506|50498035|FG000|Double-Blind Phase|Pregnancy|2|||
25219635|NCT01780506|50498036|FG001|Double-Blind Phase|Pregnancy|1|||
25219636|NCT01780506|50498035|FG000|Double-Blind Phase|Lack of Efficacy|1|||
25219637|NCT01780506|50498036|FG001|Double-Blind Phase|Lack of Efficacy|1|||
25219638|NCT01780506|50498035|FG000|Double-Blind Phase|Investigator's Discretion|5|||
25219639|NCT01780506|50498036|FG001|Double-Blind Phase|Investigator's Discretion|2|||
25219640|NCT01780506|50498035|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
25219641|NCT01780506|50498036|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
25219642|NCT01780506|50498035|FG000|Double-Blind Phase|Protocol Violation|4|||
25219643|NCT01780506|50498036|FG001|Double-Blind Phase|Protocol Violation|3|||
25219644|NCT01780506|50498035|FG000|Double-Blind Phase|Withdrew Consent|23|||
25219645|NCT01780506|50498036|FG001|Double-Blind Phase|Withdrew Consent|24|||
25219646|NCT01780506|50498035|FG000|Double-Blind Phase|Lost to Follow-up|23|||
25219647|NCT01780506|50498036|FG001|Double-Blind Phase|Lost to Follow-up|26|||
25219648|NCT01780506|50498035|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
25219649|NCT01780506|50498036|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
25219650|NCT01779648|50498046|FG000|Overall Study|Protocol Violation|1|||
25219651|NCT01779648|50498047|FG001|Overall Study|Protocol Violation|0|||
25219652|NCT01762800|50498055|FG000|Overall Study|Adverse Event|8|||
25219653|NCT01762800|50498056|FG001|Overall Study|Adverse Event|13|||
25219654|NCT01762800|50498055|FG000|Overall Study|Lack of Efficacy|3|||
25219655|NCT01762800|50498056|FG001|Overall Study|Lack of Efficacy|2|||
25219656|NCT01762800|50498055|FG000|Overall Study|Study Closed/Terminated|0|||
25219657|NCT01762800|50498056|FG001|Overall Study|Study Closed/Terminated|1|||
25219658|NCT01762800|50498055|FG000|Overall Study|Physician Decision|1|||
25219659|NCT01762800|50498056|FG001|Overall Study|Physician Decision|1|||
25219660|NCT01762800|50498055|FG000|Overall Study|Withdrawal by Subject|7|||
25219661|NCT01762800|50498056|FG001|Overall Study|Withdrawal by Subject|4|||
25219662|NCT01597596|50498070|FG000|Overall Study|Study terminated by sponsor|1|||
25219663|NCT01597596|50498071|FG001|Overall Study|Study terminated by sponsor|0|||
25219664|NCT01597596|50498070|FG000|Overall Study|Physician Decision|0|||
25219665|NCT01597596|50498071|FG001|Overall Study|Physician Decision|1|||
25219666|NCT01778556|50498079|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
25219667|NCT01778556|50498080|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
25219668|NCT01778556|50498079|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
25219669|NCT01778556|50498080|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
25219670|NCT01778556|50498079|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
25219671|NCT01778556|50498080|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
25219672|NCT01778556|50498079|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
25219673|NCT01778556|50498080|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
25219674|NCT01761162|50498089|FG000|Overall Study|Withdrawal by Subject|3|||
25219675|NCT01778010|50498093|FG000|Overall Study|Withdrawal by Subject|2|||
25219676|NCT01778010|50498093|FG000|Overall Study|abnormal ECG before meds|1|||
25219677|NCT01778010|50498093|FG000|Overall Study|Arrested|1|||
25219678|NCT01778010|50498093|FG000|Overall Study|rash while on placebo|1|||
25219679|NCT01777932|50498110|FG000|Overall Study|Disease progression|136|||
25219680|NCT01777932|50498110|FG000|Overall Study|Death|3|||
25219681|NCT01777932|50498110|FG000|Overall Study|Adverse Event|34|||
25219682|NCT01777932|50498110|FG000|Overall Study|Lost to Follow-up|3|||
25219683|NCT01777932|50498110|FG000|Overall Study|Investigator decision|10|||
25219684|NCT01777932|50498110|FG000|Overall Study|Reimbursement limit|9|||
25219685|NCT01777932|50498110|FG000|Overall Study|Patient refused further treatment|10|||
25219686|NCT01777854|50498114|FG000|Overall Study|Physician Decision|3|||
25219687|NCT01777854|50498115|FG001|Overall Study|Physician Decision|3|||
25219688|NCT01777776|50498123|FG000|Overall Study|Adverse Event|2|||
25219689|NCT01777776|50498124|FG001|Overall Study|Adverse Event|4|||
25219690|NCT01777776|50498125|FG002|Overall Study|Adverse Event|0|||
25219691|NCT01777776|50498126|FG003|Overall Study|Adverse Event|0|||
25219692|NCT01777776|50498123|FG000|Overall Study|Disease Progression|4|||
25219693|NCT01777776|50498124|FG001|Overall Study|Disease Progression|8|||
25219694|NCT01777776|50498125|FG002|Overall Study|Disease Progression|6|||
25219695|NCT01777776|50498126|FG003|Overall Study|Disease Progression|3|||
25219696|NCT01777776|50498123|FG000|Overall Study|Withdrawal by Subject|0|||
25219697|NCT01777776|50498124|FG001|Overall Study|Withdrawal by Subject|0|||
25219698|NCT01777776|50498125|FG002|Overall Study|Withdrawal by Subject|0|||
25219699|NCT01777776|50498126|FG003|Overall Study|Withdrawal by Subject|1|||
25219700|NCT01777620|50498147|FG000|Overall Study|Subject Withdrawal|1|||
25219701|NCT01777620|50498148|FG001|Overall Study|Subject Withdrawal|0|||
25219702|NCT01777542|50498154|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
25219703|NCT01777542|50498155|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
25219704|NCT01736124|50498164|FG000|Post-intervention Assessment|Death|2|||
25219705|NCT01736124|50498165|FG001|Post-intervention Assessment|Death|2|||
25219706|NCT01736124|50498164|FG000|Post-intervention Assessment|lost computer access|1|||
25219707|NCT01736124|50498165|FG001|Post-intervention Assessment|lost computer access|1|||
25219708|NCT01736124|50498164|FG000|Post-intervention Assessment|Moved away|3|||
25219709|NCT01736124|50498165|FG001|Post-intervention Assessment|Moved away|1|||
25219710|NCT01736124|50498164|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
25219711|NCT01736124|50498165|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
25219712|NCT01736124|50498164|FG000|Post-intervention Assessment|Illness|3|||
25219713|NCT01736124|50498165|FG001|Post-intervention Assessment|Illness|2|||
25219714|NCT01736124|50498164|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
25219715|NCT01736124|50498165|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
25219716|NCT01736124|50498164|FG000|Post-intervention Assessment|Temporarily away|3|||
25219717|NCT01736124|50498165|FG001|Post-intervention Assessment|Temporarily away|1|||
25219718|NCT01736124|50498164|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
25219719|NCT01736124|50498165|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
25219720|NCT01736124|50498164|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
25219721|NCT01736124|50498165|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
25219722|NCT01736124|50498164|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
25219723|NCT01736124|50498165|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
25219724|NCT01736124|50498164|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
25219725|NCT01736124|50498165|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
25219726|NCT01736124|50498164|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
25219727|NCT01736124|50498165|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
25219728|NCT01736124|50498164|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
25219729|NCT01736124|50498165|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
25219730|NCT01736124|50498164|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
25219731|NCT01736124|50498165|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
25219732|NCT01736124|50498164|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
25219733|NCT01736124|50498165|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
25219734|NCT01736124|50498164|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
25219735|NCT01736124|50498165|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
25219736|NCT01759446|50498178|FG000|Overall Study|Protocol Violation|1|||
25219737|NCT01759446|50498179|FG001|Overall Study|Protocol Violation|0|||
25219738|NCT01759446|50498180|FG002|Overall Study|Protocol Violation|1|||
25219739|NCT01759446|50498181|FG003|Overall Study|Protocol Violation|0|||
25219740|NCT01759446|50498182|FG004|Overall Study|Protocol Violation|0|||
25219741|NCT01759446|50498178|FG000|Overall Study|Withdrawal by Subject|0|||
25219742|NCT01759446|50498179|FG001|Overall Study|Withdrawal by Subject|1|||
25219743|NCT01759446|50498180|FG002|Overall Study|Withdrawal by Subject|0|||
25219744|NCT01759446|50498181|FG003|Overall Study|Withdrawal by Subject|1|||
25219745|NCT01759446|50498182|FG004|Overall Study|Withdrawal by Subject|0|||
25219746|NCT01777308|50498196|FG000|Overall Study|Withdrawal by Subject|5|||
25219747|NCT01777308|50498197|FG001|Overall Study|Withdrawal by Subject|1|||
25219748|NCT01777308|50498196|FG000|Overall Study|Migrated/moved from study area|1|||
25219749|NCT01777308|50498197|FG001|Overall Study|Migrated/moved from study area|0|||
25219750|NCT01777308|50498196|FG000|Overall Study|Lost to Follow-up|7|||
25219751|NCT01777308|50498197|FG001|Overall Study|Lost to Follow-up|2|||
25219752|NCT01777308|50498196|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
25219753|NCT01777308|50498197|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
25219754|NCT01759368|50498206|FG000|Overall Study|Lost to Follow-up|1|||
25219755|NCT01759368|50498207|FG001|Overall Study|Lost to Follow-up|0|||
25219756|NCT01777152|50498217|FG000|Overall Study|Withdrawal by Subject|22|||
25219757|NCT01777152|50498218|FG001|Overall Study|Withdrawal by Subject|16|||
25219758|NCT01777152|50498217|FG000|Overall Study|Lost to Follow-up|3|||
25219759|NCT01777152|50498218|FG001|Overall Study|Lost to Follow-up|5|||
25219760|NCT01777152|50498217|FG000|Overall Study|Death|68|||
25219761|NCT01777152|50498218|FG001|Overall Study|Death|89|||
25219762|NCT01777152|50498217|FG000|Overall Study|Not eligible, no study drug received|1|||
25219763|NCT01777152|50498218|FG001|Overall Study|Not eligible, no study drug received|0|||
25219764|NCT01777152|50498217|FG000|Overall Study|Change of diagnosis|1|||
25219765|NCT01777152|50498218|FG001|Overall Study|Change of diagnosis|0|||
25219766|NCT01759290|50498225|FG000|Overall Study|Subjects withdrawn consent|5|||
25219767|NCT01759290|50498225|FG000|Overall Study|Physician Decision|2|||
25219768|NCT01759290|50498225|FG000|Overall Study|Death|17|||
25219769|NCT01759290|50498225|FG000|Overall Study|Lost to Follow-up|53|||
25219770|NCT01759290|50498225|FG000|Overall Study|Unknown reason|4|||
25219771|NCT01758900|50498231|FG000|Overall Study|difficulty for further intubation|7|||
25219772|NCT01758900|50498232|FG001|Overall Study|difficulty for further intubation|8|||
25219773|NCT01757184|50498240|FG000|Double-blind Period|Adverse Event|1|||
25219774|NCT01757184|50498241|FG001|Double-blind Period|Adverse Event|0|||
25219775|NCT01757184|50498242|FG002|Double-blind Period|Adverse Event|0|||
25219776|NCT01757184|50498243|FG003|Double-blind Period|Adverse Event|0|||
25219777|NCT01757184|50498240|FG000|Open-label Period|Lost to Follow-up|0|||
25219778|NCT01757184|50498241|FG001|Open-label Period|Lost to Follow-up|0|||
25219779|NCT01757184|50498242|FG002|Open-label Period|Lost to Follow-up|2|||
25219780|NCT01757184|50498243|FG003|Open-label Period|Lost to Follow-up|0|||
25219781|NCT01757184|50498240|FG000|Open-label Period|Withdrawal by Subject|0|||
25219782|NCT01757184|50498241|FG001|Open-label Period|Withdrawal by Subject|0|||
25219783|NCT01757184|50498242|FG002|Open-label Period|Withdrawal by Subject|1|||
25219784|NCT01757184|50498243|FG003|Open-label Period|Withdrawal by Subject|1|||
25219785|NCT01757184|50498240|FG000|Open-label Period|Discontinued by Sponsor|0|||
25219786|NCT01757184|50498241|FG001|Open-label Period|Discontinued by Sponsor|0|||
25219787|NCT01757184|50498242|FG002|Open-label Period|Discontinued by Sponsor|1|||
25219788|NCT01757184|50498243|FG003|Open-label Period|Discontinued by Sponsor|2|||
25219789|NCT01775904|50498257|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
25219790|NCT01775904|50498257|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
25219791|NCT01775670|50498269|FG000|Overall Study|Lost to Follow-up|1|||
25219792|NCT01775670|50498270|FG001|Overall Study|Lost to Follow-up|1|||
25219793|NCT01775124|50498278|FG000|Core Period|Disease Progression|0|||
25219794|NCT01775124|50498279|FG001|Core Period|Disease Progression|1|||
25219795|NCT01775124|50498278|FG000|Core Period|Physician Decision|1|||
25219796|NCT01775124|50498279|FG001|Core Period|Physician Decision|1|||
25219797|NCT01775124|50498278|FG000|Core Period|Death|0|||
25219798|NCT01775124|50498279|FG001|Core Period|Death|1|||
25219799|NCT01775124|50498278|FG000|Core Period|Administrative problems|1|||
25219800|NCT01775124|50498279|FG001|Core Period|Administrative problems|0|||
25219801|NCT01775124|50498278|FG000|Core Period|Withdrawal by Subject|4|||
25219802|NCT01775124|50498279|FG001|Core Period|Withdrawal by Subject|2|||
25219803|NCT01775124|50498278|FG000|Core Period|Adverse Event|5|||
25219804|NCT01775124|50498279|FG001|Core Period|Adverse Event|5|||
25219805|NCT01775124|50498278|FG000|Extension Period|Adverse Event|3|||
25219806|NCT01775124|50498279|FG001|Extension Period|Adverse Event|2|||
25219807|NCT01775124|50498278|FG000|Extension Period|Physician Decision|0|||
25219808|NCT01775124|50498279|FG001|Extension Period|Physician Decision|2|||
25219809|NCT01775124|50498278|FG000|Extension Period|Administrative problems|0|||
25219810|NCT01775124|50498279|FG001|Extension Period|Administrative problems|1|||
25219811|NCT01775124|50498278|FG000|Extension Period|Lost to Follow-up|0|||
25219812|NCT01775124|50498279|FG001|Extension Period|Lost to Follow-up|1|||
25219813|NCT01775124|50498278|FG000|Extension Period|Withdrawal by Subject|9|||
25219814|NCT01775124|50498279|FG001|Extension Period|Withdrawal by Subject|12|||
25219815|NCT01733316|50498286|FG000|RP103 Phase|Non-compliance|1|||
25219816|NCT01733316|50498286|FG000|Long Term Extension Phase|Adverse Event|1|||
25219817|NCT01733316|50498286|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
25219818|NCT01733316|50498286|FG000|Long Term Extension Phase|Sponsor Decision|2|||
25219819|NCT01732926|50498299|FG000|Overall Study|Study Terminated by Sponsor|168|||
25219820|NCT01732926|50498300|FG001|Overall Study|Study Terminated by Sponsor|80|||
25219821|NCT01732926|50498299|FG000|Overall Study|Withdrawal by Subject|46|||
25219822|NCT01732926|50498300|FG001|Overall Study|Withdrawal by Subject|8|||
25219823|NCT01732926|50498299|FG000|Overall Study|Physician Decision|24|||
25219824|NCT01732926|50498300|FG001|Overall Study|Physician Decision|11|||
25219825|NCT01732926|50498299|FG000|Overall Study|Other Reason|21|||
25219826|NCT01732926|50498300|FG001|Overall Study|Other Reason|4|||
25219827|NCT01732926|50498299|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
25219828|NCT01732926|50498300|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
25219829|NCT01732926|50498299|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
25219830|NCT01732926|50498300|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
25219831|NCT01755858|50498308|FG000|Overall Study|Adverse Event|1|||
25219832|NCT01755858|50498309|FG001|Overall Study|Adverse Event|1|||
25219833|NCT01732770|50498319|FG000|Overall Study|Lost to Follow-up|2|||
25219834|NCT01732770|50498320|FG001|Overall Study|Lost to Follow-up|3|||
25219835|NCT01732770|50498319|FG000|Overall Study|Withdrawal by Subject|5|||
25219836|NCT01732770|50498320|FG001|Overall Study|Withdrawal by Subject|3|||
25219837|NCT01732770|50498319|FG000|Overall Study|Decision by Sponsor|2|||
25219838|NCT01732770|50498320|FG001|Overall Study|Decision by Sponsor|2|||
25219839|NCT01732770|50498319|FG000|Overall Study|Death|1|||
25219840|NCT01732770|50498320|FG001|Overall Study|Death|0|||
25219841|NCT01732692|50498328|FG000|Overall Study|Adverse Event|0|||
25219842|NCT01732692|50498329|FG001|Overall Study|Adverse Event|1|||
25219843|NCT01774968|50498337|FG000|Overall Study|Adverse Event|4|||
25219844|NCT01774968|50498338|FG001|Overall Study|Adverse Event|4|||
25219845|NCT01774968|50498337|FG000|Overall Study|Death|0|||
25219846|NCT01774968|50498338|FG001|Overall Study|Death|1|||
25219847|NCT01774968|50498337|FG000|Overall Study|Lost to Follow-up|1|||
25219848|NCT01774968|50498338|FG001|Overall Study|Lost to Follow-up|3|||
25219849|NCT01774968|50498337|FG000|Overall Study|Physician Decision|5|||
25219850|NCT01774968|50498338|FG001|Overall Study|Physician Decision|1|||
25219851|NCT01774968|50498337|FG000|Overall Study|Protocol Violation|14|||
25219852|NCT01774968|50498338|FG001|Overall Study|Protocol Violation|13|||
25219853|NCT01774968|50498337|FG000|Overall Study|Sponsor Decision|0|||
25219854|NCT01774968|50498338|FG001|Overall Study|Sponsor Decision|2|||
25219855|NCT01774968|50498337|FG000|Overall Study|Withdrawal by Subject|6|||
25219856|NCT01774968|50498338|FG001|Overall Study|Withdrawal by Subject|11|||
25219857|NCT01774344|50498346|FG000|Overall Study|Withdrawal by Subject|3|||
25219858|NCT01774344|50498347|FG001|Overall Study|Withdrawal by Subject|10|||
25219859|NCT01774344|50498346|FG000|Overall Study|Protocol Violation|0|||
25219860|NCT01774344|50498347|FG001|Overall Study|Protocol Violation|1|||
25219861|NCT01774344|50498346|FG000|Overall Study|Lost to Follow-up|4|||
25219862|NCT01774344|50498347|FG001|Overall Study|Lost to Follow-up|10|||
25219863|NCT01774344|50498346|FG000|Overall Study|End of survival follow-up not available|2|||
25219864|NCT01774344|50498347|FG001|Overall Study|End of survival follow-up not available|2|||
25219865|NCT01774344|50498346|FG000|Overall Study|Data collection finished|4|||
25219866|NCT01774344|50498347|FG001|Overall Study|Data collection finished|14|||
25219867|NCT01774344|50498346|FG000|Overall Study|Other|0|||
25219868|NCT01774344|50498347|FG001|Overall Study|Other|1|||
25219869|NCT01774344|50498346|FG000|Overall Study|Did not enter Survival Follow up|49|||
25219870|NCT01774344|50498347|FG001|Overall Study|Did not enter Survival Follow up|83|||
25219871|NCT01732536|50498355|FG000|Overall Study|Withdrawal by Subject|1|||
25219872|NCT01732536|50498356|FG001|Overall Study|Withdrawal by Subject|1|||
25219873|NCT01755702|50498365|FG000|Wash Out Period I|Other Reason|3|||
25219874|NCT01755702|50498365|FG000|Washout Period II|Other Reason|5|||
25219875|NCT01732458|50498379|FG000|Overall Study|Lost to Follow-up|0|||
25219876|NCT01732458|50498380|FG001|Overall Study|Lost to Follow-up|2|||
25219877|NCT01732458|50498381|FG002|Overall Study|Lost to Follow-up|0|||
25219878|NCT01732458|50498382|FG003|Overall Study|Lost to Follow-up|0|||
25219879|NCT01732458|50498379|FG000|Overall Study|Non-Compliance With Study Drug|0|||
25219880|NCT01732458|50498380|FG001|Overall Study|Non-Compliance With Study Drug|0|||
25219881|NCT01732458|50498381|FG002|Overall Study|Non-Compliance With Study Drug|1|||
25219882|NCT01732458|50498382|FG003|Overall Study|Non-Compliance With Study Drug|0|||
25219883|NCT01732458|50498379|FG000|Overall Study|Physician Decision|1|||
25219884|NCT01732458|50498380|FG001|Overall Study|Physician Decision|2|||
25219885|NCT01732458|50498381|FG002|Overall Study|Physician Decision|2|||
25219886|NCT01732458|50498382|FG003|Overall Study|Physician Decision|0|||
25219887|NCT01732458|50498379|FG000|Overall Study|Protocol Violation|2|||
25219888|NCT01732458|50498380|FG001|Overall Study|Protocol Violation|0|||
25219889|NCT01732458|50498381|FG002|Overall Study|Protocol Violation|0|||
25219890|NCT01732458|50498382|FG003|Overall Study|Protocol Violation|2|||
25219891|NCT01732458|50498379|FG000|Overall Study|Screen Failure|0|||
25219892|NCT01732458|50498380|FG001|Overall Study|Screen Failure|1|||
25219893|NCT01732458|50498381|FG002|Overall Study|Screen Failure|0|||
25219894|NCT01732458|50498382|FG003|Overall Study|Screen Failure|0|||
25219895|NCT01731990|50498406|FG000|Overall Study|Adverse Event|1|||
25219896|NCT01731990|50498407|FG001|Overall Study|Adverse Event|5|||
25219897|NCT01731990|50498406|FG000|Overall Study|Withdrawal by Subject|1|||
25219898|NCT01731990|50498407|FG001|Overall Study|Withdrawal by Subject|1|||
25219899|NCT01731990|50498406|FG000|Overall Study|Protocol deviation|1|||
25219900|NCT01731990|50498407|FG001|Overall Study|Protocol deviation|2|||
25219901|NCT01731990|50498406|FG000|Overall Study|Death|1|||
25219902|NCT01731990|50498407|FG001|Overall Study|Death|0|||
25219903|NCT01708902|50498420|FG000|Overall Study|Adverse Event|3|||
25219904|NCT01708902|50498421|FG001|Overall Study|Adverse Event|4|||
25219905|NCT01708902|50498422|FG002|Overall Study|Adverse Event|9|||
25219906|NCT01708902|50498423|FG003|Overall Study|Adverse Event|2|||
25219907|NCT01708902|50498424|FG004|Overall Study|Adverse Event|7|||
25219908|NCT01708902|50498425|FG005|Overall Study|Adverse Event|3|||
25219909|NCT01708902|50498426|FG006|Overall Study|Adverse Event|5|||
25219910|NCT01708902|50498420|FG000|Overall Study|Lack of Efficacy|3|||
25219911|NCT01708902|50498421|FG001|Overall Study|Lack of Efficacy|1|||
25219912|NCT01708902|50498422|FG002|Overall Study|Lack of Efficacy|0|||
25219913|NCT01708902|50498423|FG003|Overall Study|Lack of Efficacy|0|||
25219914|NCT01708902|50498424|FG004|Overall Study|Lack of Efficacy|0|||
25219915|NCT01708902|50498425|FG005|Overall Study|Lack of Efficacy|1|||
25219916|NCT01708902|50498426|FG006|Overall Study|Lack of Efficacy|0|||
25219917|NCT01708902|50498420|FG000|Overall Study|Non compliance with protocol|0|||
25219918|NCT01708902|50498421|FG001|Overall Study|Non compliance with protocol|2|||
25219919|NCT01708902|50498422|FG002|Overall Study|Non compliance with protocol|1|||
25219920|NCT01708902|50498423|FG003|Overall Study|Non compliance with protocol|3|||
25219921|NCT01708902|50498424|FG004|Overall Study|Non compliance with protocol|0|||
25219922|NCT01708902|50498425|FG005|Overall Study|Non compliance with protocol|0|||
25219923|NCT01708902|50498426|FG006|Overall Study|Non compliance with protocol|0|||
25219924|NCT01708902|50498420|FG000|Overall Study|Lost to Follow-up|2|||
25219925|NCT01708902|50498421|FG001|Overall Study|Lost to Follow-up|1|||
25219926|NCT01708902|50498422|FG002|Overall Study|Lost to Follow-up|2|||
25219927|NCT01708902|50498423|FG003|Overall Study|Lost to Follow-up|2|||
25219928|NCT01708902|50498424|FG004|Overall Study|Lost to Follow-up|0|||
25219929|NCT01708902|50498425|FG005|Overall Study|Lost to Follow-up|0|||
25219930|NCT01708902|50498426|FG006|Overall Study|Lost to Follow-up|1|||
25219931|NCT01708902|50498420|FG000|Overall Study|Refused to continue trial medication|8|||
25219932|NCT01708902|50498421|FG001|Overall Study|Refused to continue trial medication|0|||
25219933|NCT01708902|50498422|FG002|Overall Study|Refused to continue trial medication|4|||
25219934|NCT01708902|50498423|FG003|Overall Study|Refused to continue trial medication|2|||
25219935|NCT01708902|50498424|FG004|Overall Study|Refused to continue trial medication|8|||
25219936|NCT01708902|50498425|FG005|Overall Study|Refused to continue trial medication|1|||
25219937|NCT01708902|50498426|FG006|Overall Study|Refused to continue trial medication|1|||
25219938|NCT01708902|50498420|FG000|Overall Study|Other Reason|1|||
25219939|NCT01708902|50498421|FG001|Overall Study|Other Reason|0|||
25219940|NCT01708902|50498422|FG002|Overall Study|Other Reason|1|||
25219941|NCT01708902|50498423|FG003|Overall Study|Other Reason|1|||
25219942|NCT01708902|50498424|FG004|Overall Study|Other Reason|1|||
25219943|NCT01708902|50498425|FG005|Overall Study|Other Reason|2|||
25219944|NCT01708902|50498426|FG006|Overall Study|Other Reason|0|||
25219945|NCT01755546|50498445|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
25219946|NCT01755546|50498445|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
25219947|NCT01755546|50498445|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
25219948|NCT01755546|50498445|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
25219949|NCT01755546|50498445|FG000|Titration Phase|Adverse Event|11|||
25219950|NCT01755546|50498445|FG000|Titration Phase|Lack of Efficacy|18|||
25219951|NCT01755546|50498445|FG000|Titration Phase|Protocol Violation|9|||
25219952|NCT01755546|50498445|FG000|Titration Phase|Lost to Follow-up|2|||
25219953|NCT01755546|50498445|FG000|Titration Phase|Other and Continuing|22|||
25219954|NCT01755546|50498445|FG000|Titration Phase|Withdrawal by Subject|8|||
25219955|NCT01755546|50498445|FG000|Long Term Treatment|Adverse Event|12|||
25219956|NCT01755546|50498445|FG000|Long Term Treatment|Lack of Efficacy|6|||
25219957|NCT01755546|50498445|FG000|Long Term Treatment|Protocol Violation|10|||
25219958|NCT01755546|50498445|FG000|Long Term Treatment|Withdrawal by Subject|35|||
25219959|NCT01755546|50498445|FG000|Long Term Treatment|Lost to Follow-up|17|||
25219960|NCT01755546|50498445|FG000|Long Term Treatment|other and ongoing|41|||
25219961|NCT01755234|50498451|FG000|Overall Study|Lost to Follow-up|11|||
25219962|NCT01755234|50498452|FG001|Overall Study|Lost to Follow-up|6|||
25219963|NCT01755234|50498451|FG000|Overall Study|Change in surgical case|2|||
25219964|NCT01755234|50498452|FG001|Overall Study|Change in surgical case|1|||
25219965|NCT01755234|50498451|FG000|Overall Study|case cancelled|1|||
25219966|NCT01755234|50498452|FG001|Overall Study|case cancelled|0|||
25219967|NCT01755234|50498451|FG000|Overall Study|Withdrawal by Subject|0|||
25219968|NCT01755234|50498452|FG001|Overall Study|Withdrawal by Subject|1|||
25219969|NCT01755234|50498451|FG000|Overall Study|unblinded|1|||
25219970|NCT01755234|50498452|FG001|Overall Study|unblinded|0|||
25219971|NCT01731912|50498458|FG000|Overall Study|noncompliance|2|||
25219972|NCT01731678|50498462|FG000|Overall Study|Withdrawal by Subject|3|||
25219973|NCT01731678|50498462|FG000|Overall Study|Did not meet inclusion criteria|1|||
25219974|NCT01731678|50498462|FG000|Overall Study|RMT too high, making TMS difficult|3|||
25219975|NCT01731600|50498468|FG000|Overall Study|Adverse Event|2|||
25219976|NCT01731600|50498469|FG001|Overall Study|Adverse Event|0|||
25219977|NCT01731600|50498468|FG000|Overall Study|Withdrawal criteria|1|||
25219978|NCT01731600|50498469|FG001|Overall Study|Withdrawal criteria|0|||
25219979|NCT01731600|50498468|FG000|Overall Study|Other reasons|3|||
25219980|NCT01731600|50498469|FG001|Overall Study|Other reasons|0|||
25219981|NCT01730586|50498479|FG000|Overall Study|Progressive Disease|2|||
25219982|NCT01730586|50498479|FG000|Overall Study|Inadequate Trial|8|||
25219983|NCT01730586|50498479|FG000|Overall Study|Adverse Event|2|||
25219984|NCT01730586|50498479|FG000|Overall Study|Hospice|1|||
25219985|NCT01707030|50498487|FG000|Overall Study|Death|1|||
25219986|NCT01707030|50498488|FG001|Overall Study|Death|1|||
25219987|NCT01707030|50498487|FG000|Overall Study|Withdrawal by Subject|2|||
25219988|NCT01707030|50498488|FG001|Overall Study|Withdrawal by Subject|3|||
25219989|NCT01707030|50498487|FG000|Overall Study|Lost to Follow-up|8|||
25219990|NCT01707030|50498488|FG001|Overall Study|Lost to Follow-up|13|||
25219991|NCT01755156|50498500|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
25219992|NCT01755156|50498501|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
25219993|NCT01755156|50498500|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
25219994|NCT01755156|50498501|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
25219995|NCT01755156|50498500|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
25219996|NCT01755156|50498501|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
25219997|NCT01755156|50498500|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
25219998|NCT01755156|50498501|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
25219999|NCT01755156|50498500|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
25220000|NCT01755156|50498501|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
25220001|NCT01755156|50498500|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
25220002|NCT01755156|50498501|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
25220003|NCT01755156|50498500|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
25220004|NCT01755156|50498501|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
25220005|NCT01755156|50498500|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
25220006|NCT01755156|50498501|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
25220007|NCT01755156|50498500|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
25220008|NCT01755156|50498501|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
25220009|NCT01755156|50498500|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
25220010|NCT01755156|50498501|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
25220011|NCT01755156|50498500|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
25220012|NCT01755156|50498501|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
25220013|NCT01754922|50498513|FG000|Overall Study|Adverse Event|0|||
25220014|NCT01754922|50498514|FG001|Overall Study|Adverse Event|1|||
25220015|NCT01754766|50498524|FG000|Overall Study|Personal reasons|1|||
25220016|NCT01754766|50498525|FG001|Overall Study|Personal reasons|1|||
25220017|NCT01754766|50498526|FG002|Overall Study|Personal reasons|0|||
25220018|NCT01754376|50498534|FG000|Overall Study|Adverse Event|1|||
25220019|NCT01754376|50498534|FG000|Overall Study|Lack of Efficacy|2|||
25220020|NCT01605396|50498541|FG000|Overall Study|Adverse Event|5|||
25220021|NCT01605396|50498542|FG001|Overall Study|Adverse Event|3|||
25220022|NCT01605396|50498541|FG000|Overall Study|Lost to Follow-up|1|||
25220023|NCT01605396|50498542|FG001|Overall Study|Lost to Follow-up|0|||
25220024|NCT01605396|50498541|FG000|Overall Study|Non-Compliance With Study Drug|1|||
25220025|NCT01605396|50498542|FG001|Overall Study|Non-Compliance With Study Drug|1|||
25220026|NCT01605396|50498541|FG000|Overall Study|Physician Decision|2|||
25220027|NCT01605396|50498542|FG001|Overall Study|Physician Decision|2|||
25220028|NCT01605396|50498541|FG000|Overall Study|Progressive Disease|23|||
25220029|NCT01605396|50498542|FG001|Overall Study|Progressive Disease|27|||
25220030|NCT01605396|50498541|FG000|Overall Study|Withdrawal by Subject|4|||
25220031|NCT01605396|50498542|FG001|Overall Study|Withdrawal by Subject|2|||
25220032|NCT01605396|50498541|FG000|Overall Study|Transfer Off Study|4|||
25220033|NCT01605396|50498542|FG001|Overall Study|Transfer Off Study|5|||
25220034|NCT01730118|50498555|FG000|Dose Escalation|Death on study|5|||
25220035|NCT01730118|50498556|FG001|Dose Escalation|Death on study|7|||
25220036|NCT01730118|50498557|FG002|Dose Escalation|Death on study|2|||
25220037|NCT01730118|50498558|FG003|Dose Escalation|Death on study|6|||
25220038|NCT01730118|50498559|FG004|Dose Escalation|Death on study|0|||
25220039|NCT01730118|50498560|FG005|Dose Escalation|Death on study|0|||
25317575|NCT00812487|50633158|FG001|Overall Study|Withdrawal by Subject|2|||
25220040|NCT01730118|50498561|FG006|Dose Escalation|Death on study|0|||
25220041|NCT01730118|50498555|FG000|Dose Escalation|Died before treatment|0|||
25220042|NCT01730118|50498556|FG001|Dose Escalation|Died before treatment|0|||
25220043|NCT01730118|50498557|FG002|Dose Escalation|Died before treatment|0|||
25220044|NCT01730118|50498558|FG003|Dose Escalation|Died before treatment|0|||
25220045|NCT01730118|50498559|FG004|Dose Escalation|Died before treatment|0|||
25220046|NCT01730118|50498560|FG005|Dose Escalation|Died before treatment|0|||
25220047|NCT01730118|50498561|FG006|Dose Escalation|Died before treatment|1|||
25220048|NCT01730118|50498555|FG000|Dose Escalation|Chose to start a different treatment|1|||
25220049|NCT01730118|50498556|FG001|Dose Escalation|Chose to start a different treatment|0|||
25220050|NCT01730118|50498557|FG002|Dose Escalation|Chose to start a different treatment|0|||
25220051|NCT01730118|50498558|FG003|Dose Escalation|Chose to start a different treatment|0|||
25220052|NCT01730118|50498559|FG004|Dose Escalation|Chose to start a different treatment|0|||
25220053|NCT01730118|50498560|FG005|Dose Escalation|Chose to start a different treatment|0|||
25220054|NCT01730118|50498561|FG006|Dose Escalation|Chose to start a different treatment|0|||
25220055|NCT01730118|50498555|FG000|Dose Escalation|Withdrawal by Subject|0|||
25220056|NCT01730118|50498556|FG001|Dose Escalation|Withdrawal by Subject|0|||
25317576|NCT00812487|50633157|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
25317577|NCT00812487|50633158|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
25317578|NCT00812487|50633157|FG000|Overall Study|Protocol Violation|0|||
25317579|NCT00812487|50633158|FG001|Overall Study|Protocol Violation|1|||
25317580|NCT00617461|50633168|FG000|First Treatment Intervention Period|Adverse Event|2|||
25317581|NCT00617461|50633169|FG001|First Treatment Intervention Period|Adverse Event|0|||
25317582|NCT00617461|50633168|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
25317583|NCT00617461|50633169|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
25220057|NCT01730118|50498557|FG002|Dose Escalation|Withdrawal by Subject|1|||
25220058|NCT01730118|50498558|FG003|Dose Escalation|Withdrawal by Subject|0|||
25220059|NCT01730118|50498559|FG004|Dose Escalation|Withdrawal by Subject|0|||
25220060|NCT01730118|50498560|FG005|Dose Escalation|Withdrawal by Subject|0|||
25220061|NCT01730118|50498561|FG006|Dose Escalation|Withdrawal by Subject|0|||
25220062|NCT01730118|50498555|FG000|Dose Escalation|Disease progression prior to treatment|0|||
25220063|NCT01730118|50498556|FG001|Dose Escalation|Disease progression prior to treatment|0|||
25220064|NCT01730118|50498557|FG002|Dose Escalation|Disease progression prior to treatment|0|||
25220065|NCT01730118|50498558|FG003|Dose Escalation|Disease progression prior to treatment|0|||
25220066|NCT01730118|50498559|FG004|Dose Escalation|Disease progression prior to treatment|0|||
25220067|NCT01730118|50498560|FG005|Dose Escalation|Disease progression prior to treatment|0|||
25220068|NCT01730118|50498561|FG006|Dose Escalation|Disease progression prior to treatment|1|||
25220069|NCT01730118|50498555|FG000|Dose Expansion|Death|0|||
25220070|NCT01730118|50498556|FG001|Dose Expansion|Death|0|||
25220071|NCT01730118|50498557|FG002|Dose Expansion|Death|0|||
25220072|NCT01730118|50498558|FG003|Dose Expansion|Death|0|||
25220073|NCT01730118|50498559|FG004|Dose Expansion|Death|1|||
25220074|NCT01730118|50498560|FG005|Dose Expansion|Death|0|||
25220075|NCT01730118|50498561|FG006|Dose Expansion|Death|0|||
25220076|NCT01730118|50498555|FG000|Dose Expansion|Other medical condition|0|||
25220077|NCT01730118|50498556|FG001|Dose Expansion|Other medical condition|0|||
25220078|NCT01730118|50498557|FG002|Dose Expansion|Other medical condition|0|||
25220079|NCT01730118|50498558|FG003|Dose Expansion|Other medical condition|0|||
25220080|NCT01730118|50498559|FG004|Dose Expansion|Other medical condition|1|||
25220081|NCT01730118|50498560|FG005|Dose Expansion|Other medical condition|0|||
25220082|NCT01730118|50498561|FG006|Dose Expansion|Other medical condition|0|||
25220083|NCT01730118|50498555|FG000|Dose Expansion|Withdrawal by Subject|0|||
25220084|NCT01730118|50498556|FG001|Dose Expansion|Withdrawal by Subject|0|||
25220085|NCT01730118|50498557|FG002|Dose Expansion|Withdrawal by Subject|0|||
25220086|NCT01730118|50498558|FG003|Dose Expansion|Withdrawal by Subject|0|||
25220087|NCT01730118|50498559|FG004|Dose Expansion|Withdrawal by Subject|1|||
25220088|NCT01730118|50498560|FG005|Dose Expansion|Withdrawal by Subject|0|||
25220089|NCT01730118|50498561|FG006|Dose Expansion|Withdrawal by Subject|0|||
25220090|NCT01730118|50498555|FG000|Dose Expansion|Disease progression|0|||
25220091|NCT01730118|50498556|FG001|Dose Expansion|Disease progression|0|||
25220092|NCT01730118|50498557|FG002|Dose Expansion|Disease progression|0|||
25220093|NCT01730118|50498558|FG003|Dose Expansion|Disease progression|0|||
25220094|NCT01730118|50498559|FG004|Dose Expansion|Disease progression|0|||
25220095|NCT01730118|50498560|FG005|Dose Expansion|Disease progression|1|||
25220096|NCT01730118|50498561|FG006|Dose Expansion|Disease progression|0|||
25220097|NCT01730118|50498555|FG000|Dose Expansion|Inability to return|0|||
25220098|NCT01730118|50498556|FG001|Dose Expansion|Inability to return|0|||
25220099|NCT01730118|50498557|FG002|Dose Expansion|Inability to return|0|||
25317584|NCT00617461|50633168|FG000|First Treatment Intervention Period|Protocol Violation|2|||
25220100|NCT01730118|50498558|FG003|Dose Expansion|Inability to return|0|||
25220101|NCT01730118|50498559|FG004|Dose Expansion|Inability to return|0|||
25220102|NCT01730118|50498560|FG005|Dose Expansion|Inability to return|1|||
25220103|NCT01730118|50498561|FG006|Dose Expansion|Inability to return|0|||
25220104|NCT01730118|50498555|FG000|Dose Expansion|Physician Decision|0|||
25220105|NCT01730118|50498556|FG001|Dose Expansion|Physician Decision|0|||
25220106|NCT01730118|50498557|FG002|Dose Expansion|Physician Decision|0|||
25220107|NCT01730118|50498558|FG003|Dose Expansion|Physician Decision|0|||
25220108|NCT01730118|50498559|FG004|Dose Expansion|Physician Decision|0|||
25220109|NCT01730118|50498560|FG005|Dose Expansion|Physician Decision|1|||
25220110|NCT01730118|50498561|FG006|Dose Expansion|Physician Decision|0|||
25220111|NCT01730040|50498585|FG000|Overall Study|Randomized but not treated|0|||
25220112|NCT01730040|50498586|FG001|Overall Study|Randomized but not treated|0|||
25220113|NCT01730040|50498587|FG002|Overall Study|Randomized but not treated|0|||
25220114|NCT01730040|50498588|FG003|Overall Study|Randomized but not treated|0|||
25220115|NCT01730040|50498589|FG004|Overall Study|Randomized but not treated|0|||
25220116|NCT01730040|50498590|FG005|Overall Study|Randomized but not treated|1|||
25220117|NCT01730040|50498591|FG006|Overall Study|Randomized but not treated|0|||
25220118|NCT01730040|50498585|FG000|Overall Study|Subject moved|0|||
25220119|NCT01730040|50498586|FG001|Overall Study|Subject moved|0|||
25220120|NCT01730040|50498587|FG002|Overall Study|Subject moved|1|||
25220121|NCT01730040|50498588|FG003|Overall Study|Subject moved|0|||
25220122|NCT01730040|50498589|FG004|Overall Study|Subject moved|0|||
25220123|NCT01730040|50498590|FG005|Overall Study|Subject moved|0|||
25220124|NCT01730040|50498591|FG006|Overall Study|Subject moved|1|||
25220125|NCT01730040|50498585|FG000|Overall Study|Physician Decision|0|||
25220126|NCT01730040|50498586|FG001|Overall Study|Physician Decision|0|||
25220127|NCT01730040|50498587|FG002|Overall Study|Physician Decision|0|||
25220128|NCT01730040|50498588|FG003|Overall Study|Physician Decision|0|||
25220129|NCT01730040|50498589|FG004|Overall Study|Physician Decision|0|||
25220130|NCT01730040|50498590|FG005|Overall Study|Physician Decision|1|||
25220131|NCT01730040|50498591|FG006|Overall Study|Physician Decision|1|||
25220132|NCT01730040|50498585|FG000|Overall Study|Other than specified|7|||
25220133|NCT01730040|50498586|FG001|Overall Study|Other than specified|8|||
25220134|NCT01730040|50498587|FG002|Overall Study|Other than specified|5|||
25220135|NCT01730040|50498588|FG003|Overall Study|Other than specified|5|||
25220136|NCT01730040|50498589|FG004|Overall Study|Other than specified|5|||
25220137|NCT01730040|50498590|FG005|Overall Study|Other than specified|4|||
25220138|NCT01730040|50498591|FG006|Overall Study|Other than specified|4|||
25220139|NCT01730040|50498585|FG000|Overall Study|Adverse Event|4|||
25220140|NCT01730040|50498586|FG001|Overall Study|Adverse Event|3|||
25220141|NCT01730040|50498587|FG002|Overall Study|Adverse Event|5|||
25220142|NCT01730040|50498588|FG003|Overall Study|Adverse Event|3|||
25220143|NCT01730040|50498589|FG004|Overall Study|Adverse Event|1|||
25220144|NCT01730040|50498590|FG005|Overall Study|Adverse Event|1|||
25220145|NCT01730040|50498591|FG006|Overall Study|Adverse Event|2|||
25220146|NCT01730040|50498585|FG000|Overall Study|Poor compliance to protocol|2|||
25220147|NCT01730040|50498586|FG001|Overall Study|Poor compliance to protocol|4|||
25220148|NCT01730040|50498587|FG002|Overall Study|Poor compliance to protocol|0|||
25220149|NCT01730040|50498588|FG003|Overall Study|Poor compliance to protocol|0|||
25220150|NCT01730040|50498589|FG004|Overall Study|Poor compliance to protocol|0|||
25220151|NCT01730040|50498590|FG005|Overall Study|Poor compliance to protocol|0|||
25220152|NCT01730040|50498591|FG006|Overall Study|Poor compliance to protocol|1|||
25220153|NCT01706328|50498609|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
25220154|NCT01706328|50498610|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
25220155|NCT01706328|50498611|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
25220156|NCT01706328|50498609|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
25220157|NCT01706328|50498610|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
25220158|NCT01706328|50498611|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
25220159|NCT01706328|50498609|FG000|2-week Run-in Period|Physician Decision|4|||
25220160|NCT01706328|50498610|FG001|2-week Run-in Period|Physician Decision|0|||
25220161|NCT01706328|50498611|FG002|2-week Run-in Period|Physician Decision|0|||
25220162|NCT01706328|50498609|FG000|2-week Run-in Period|Adverse Event|4|||
25220163|NCT01706328|50498610|FG001|2-week Run-in Period|Adverse Event|0|||
25220164|NCT01706328|50498611|FG002|2-week Run-in Period|Adverse Event|0|||
25220165|NCT01706328|50498609|FG000|2-week Run-in Period|Lost to Follow-up|2|||
25220166|NCT01706328|50498610|FG001|2-week Run-in Period|Lost to Follow-up|0|||
25220167|NCT01706328|50498611|FG002|2-week Run-in Period|Lost to Follow-up|0|||
25220168|NCT01706328|50498609|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
25220169|NCT01706328|50498610|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
25220170|NCT01706328|50498611|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
25220171|NCT01706328|50498609|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
25220172|NCT01706328|50498610|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
25220173|NCT01706328|50498611|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
25220174|NCT01706328|50498609|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
25220175|NCT01706328|50498610|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
25220176|NCT01706328|50498611|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
25220177|NCT01706328|50498609|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
25220178|NCT01706328|50498610|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
25220179|NCT01706328|50498611|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
25220180|NCT01706328|50498609|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
25220181|NCT01706328|50498610|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
25220182|NCT01706328|50498611|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
25220183|NCT01706328|50498609|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
25220184|NCT01706328|50498610|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
25220185|NCT01706328|50498611|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
25220186|NCT01706328|50498609|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
25220187|NCT01706328|50498610|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
25220188|NCT01706328|50498611|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
25220189|NCT01753518|50498619|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
25220190|NCT01753518|50498620|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
25220191|NCT01753518|50498619|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
25220192|NCT01753518|50498620|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
25220193|NCT01753518|50498619|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
25220194|NCT01753518|50498620|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
25220195|NCT01753518|50498619|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
25220196|NCT01753518|50498620|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
25220197|NCT01706250|50498626|FG000|Overall Study|Lost to Follow-up|2|||
25220198|NCT01729728|50498638|FG000|Overall Study|Adverse Event|0|||
25220199|NCT01729728|50498639|FG001|Overall Study|Adverse Event|6|||
25220200|NCT01729728|50498640|FG002|Overall Study|Adverse Event|0|||
25220201|NCT01729728|50498638|FG000|Overall Study|Protocol Violation|1|||
25220202|NCT01729728|50498639|FG001|Overall Study|Protocol Violation|0|||
25220203|NCT01729728|50498640|FG002|Overall Study|Protocol Violation|1|||
25220204|NCT01729026|50498773|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
25220205|NCT01729026|50498774|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
25220206|NCT01729026|50498773|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
25220207|NCT01729026|50498774|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
25220208|NCT01728792|50498788|FG000|Overall Study|Withdrawal of Consent|1|||
25220209|NCT01728792|50498789|FG001|Overall Study|Withdrawal of Consent|1|||
25220210|NCT01728792|50498790|FG002|Overall Study|Withdrawal of Consent|0|||
25220211|NCT01728792|50498791|FG003|Overall Study|Withdrawal of Consent|1|||
25220212|NCT01728792|50498792|FG004|Overall Study|Withdrawal of Consent|0|||
25220213|NCT01728792|50498788|FG000|Overall Study|Lost to Follow-up|2|||
25220214|NCT01728792|50498789|FG001|Overall Study|Lost to Follow-up|1|||
25220215|NCT01728792|50498790|FG002|Overall Study|Lost to Follow-up|4|||
25220216|NCT01728792|50498791|FG003|Overall Study|Lost to Follow-up|2|||
25220217|NCT01728792|50498792|FG004|Overall Study|Lost to Follow-up|0|||
25220218|NCT01752036|50498804|FG000|Overall Study|Death|2|||
25220219|NCT01728324|50498812|FG000|Termination of DBV|Adverse Event|14|||
25220220|NCT01728324|50498813|FG001|Termination of DBV|Adverse Event|13|||
25220221|NCT01728324|50498814|FG002|Termination of DBV|Adverse Event|4|||
25220222|NCT01728324|50498812|FG000|Termination of DBV|Lack of Efficacy|14|||
25220223|NCT01728324|50498813|FG001|Termination of DBV|Lack of Efficacy|12|||
25220224|NCT01728324|50498814|FG002|Termination of DBV|Lack of Efficacy|8|||
25220225|NCT01728324|50498812|FG000|Termination of DBV|Withdrawal by Subject|9|||
25220226|NCT01728324|50498813|FG001|Termination of DBV|Withdrawal by Subject|6|||
25220227|NCT01728324|50498814|FG002|Termination of DBV|Withdrawal by Subject|2|||
25220228|NCT01728324|50498812|FG000|Termination of DBV|Other than stated|1|||
25220229|NCT01728324|50498813|FG001|Termination of DBV|Other than stated|3|||
25220230|NCT01728324|50498814|FG002|Termination of DBV|Other than stated|0|||
25220231|NCT01728324|50498812|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
25220232|NCT01728324|50498813|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
25220233|NCT01728324|50498814|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
25220234|NCT01728324|50498812|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
25220235|NCT01728324|50498813|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
25220236|NCT01728324|50498814|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
25220237|NCT01728324|50498812|FG000|Termination of FDV|Adverse Event|14|||
25220238|NCT01728324|50498813|FG001|Termination of FDV|Adverse Event|13|||
25220239|NCT01728324|50498814|FG002|Termination of FDV|Adverse Event|4|||
25220240|NCT01728324|50498812|FG000|Termination of FDV|Lack of Efficacy|14|||
25220241|NCT01728324|50498813|FG001|Termination of FDV|Lack of Efficacy|12|||
25220242|NCT01728324|50498814|FG002|Termination of FDV|Lack of Efficacy|8|||
25220243|NCT01728324|50498812|FG000|Termination of FDV|Withdrawal by Subject|9|||
25220244|NCT01728324|50498813|FG001|Termination of FDV|Withdrawal by Subject|6|||
25220245|NCT01728324|50498814|FG002|Termination of FDV|Withdrawal by Subject|2|||
25220246|NCT01728324|50498812|FG000|Termination of FDV|Other than stated|1|||
25220247|NCT01728324|50498813|FG001|Termination of FDV|Other than stated|3|||
25220248|NCT01728324|50498814|FG002|Termination of FDV|Other than stated|0|||
25220249|NCT01728324|50498812|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
25220250|NCT01728324|50498813|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
25220251|NCT01728324|50498814|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
25220252|NCT01728324|50498812|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
25220253|NCT01728324|50498813|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
25220254|NCT01728324|50498814|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
25220255|NCT01728324|50498812|FG000|Termination of RBV|Adverse Event|15|||
25220256|NCT01728324|50498813|FG001|Termination of RBV|Adverse Event|16|||
25220257|NCT01728324|50498814|FG002|Termination of RBV|Adverse Event|5|||
25220258|NCT01728324|50498812|FG000|Termination of RBV|Lack of Efficacy|14|||
25220259|NCT01728324|50498813|FG001|Termination of RBV|Lack of Efficacy|11|||
25220260|NCT01728324|50498814|FG002|Termination of RBV|Lack of Efficacy|7|||
25220261|NCT01728324|50498812|FG000|Termination of RBV|Withdrawal by Subject|9|||
25220262|NCT01728324|50498813|FG001|Termination of RBV|Withdrawal by Subject|5|||
25220263|NCT01728324|50498814|FG002|Termination of RBV|Withdrawal by Subject|2|||
25220264|NCT01728324|50498812|FG000|Termination of RBV|Other than stated|1|||
25220265|NCT01728324|50498813|FG001|Termination of RBV|Other than stated|3|||
25220266|NCT01728324|50498814|FG002|Termination of RBV|Other than stated|1|||
25220267|NCT01728324|50498812|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
25220268|NCT01728324|50498813|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
25220269|NCT01728324|50498814|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
25220270|NCT01728324|50498812|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
25220271|NCT01728324|50498813|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
25220272|NCT01728324|50498814|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
25220273|NCT01728246|50498826|FG000|Overall Study|Participant needed rescue medication|1|||
25220274|NCT01728246|50498827|FG001|Overall Study|Participant needed rescue medication|5|||
25220275|NCT01728246|50498826|FG000|Overall Study|Protocol Violation|1|||
25220276|NCT01728246|50498827|FG001|Overall Study|Protocol Violation|0|||
25220277|NCT01728246|50498826|FG000|Overall Study|Withdrawal by Subject|2|||
25220278|NCT01728246|50498827|FG001|Overall Study|Withdrawal by Subject|3|||
25220279|NCT01728246|50498826|FG000|Overall Study|Lost to Follow-up|23|||
25220280|NCT01728246|50498827|FG001|Overall Study|Lost to Follow-up|22|||
25220281|NCT01728246|50498826|FG000|Overall Study|Lack of Efficacy|1|||
25220282|NCT01728246|50498827|FG001|Overall Study|Lack of Efficacy|1|||
25220283|NCT01728246|50498826|FG000|Overall Study|Adverse Event|8|||
25220284|NCT01728246|50498827|FG001|Overall Study|Adverse Event|5|||
25220285|NCT01705236|50498833|FG000|Overall Study|Lost to Follow-up|1|||
25220286|NCT01705236|50498833|FG000|Overall Study|Administrative problems|2|||
25220287|NCT01705236|50498833|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
25220288|NCT01705236|50498833|FG000|Overall Study|Protocol Violation|3|||
25220289|NCT01705236|50498833|FG000|Overall Study|Abnormal test procedure result(s)|4|||
25220290|NCT01705236|50498833|FG000|Overall Study|Abnormal laboratory value(s)|4|||
25220291|NCT01705236|50498833|FG000|Overall Study|Withdrawal by Subject|5|||
25220292|NCT01705236|50498833|FG000|Overall Study|Adverse Event|5|||
25220293|NCT01705080|50498840|FG000|Overall Study|Missed visit|10|||
25220294|NCT01705080|50498841|FG001|Overall Study|Missed visit|4|||
25220295|NCT01705080|50498842|FG002|Overall Study|Missed visit|1|||
25220296|NCT01705080|50498840|FG000|Overall Study|Death|4|||
25220297|NCT01705080|50498841|FG001|Overall Study|Death|4|||
25220298|NCT01705080|50498842|FG002|Overall Study|Death|6|||
25220299|NCT01705080|50498840|FG000|Overall Study|Withdrawal by Subject|61|||
25220300|NCT01705080|50498841|FG001|Overall Study|Withdrawal by Subject|44|||
25220301|NCT01705080|50498842|FG002|Overall Study|Withdrawal by Subject|9|||
25220302|NCT01704846|50498852|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25220303|NCT01704846|50498853|FG001|Treatment Period 2|Withdrawal by Subject|1|||
25220304|NCT01751802|50498861|FG000|Overall Study|Adverse Event|4|||
25220305|NCT01751802|50498862|FG001|Overall Study|Adverse Event|2|||
25220306|NCT01704456|50498876|FG000|Overall Study|Lost to Follow-up|8|||
25220307|NCT01704456|50498877|FG001|Overall Study|Lost to Follow-up|14|||
25220308|NCT01703988|50498887|FG000|Overall Study|Investigator Judgment|0|||
25220309|NCT01703988|50498888|FG001|Overall Study|Investigator Judgment|0|||
25220310|NCT01703988|50498889|FG002|Overall Study|Investigator Judgment|0|||
25220311|NCT01703988|50498890|FG003|Overall Study|Investigator Judgment|1|||
25220312|NCT01703832|50498903|FG000|Overall Study|Withdrawal by Subject|1|||
25220313|NCT01703832|50498904|FG001|Overall Study|Withdrawal by Subject|0|||
25220314|NCT01703286|50498910|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
25220315|NCT01703286|50498911|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
25220316|NCT01703286|50498912|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
25220317|NCT01703286|50498913|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
25220318|NCT01703286|50498914|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
25220319|NCT01703286|50498915|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
25220320|NCT01703286|50498910|FG000|Period 2 Including Washout|Adverse Event|0|||
25220321|NCT01703286|50498911|FG001|Period 2 Including Washout|Adverse Event|0|||
25220322|NCT01703286|50498912|FG002|Period 2 Including Washout|Adverse Event|0|||
25220323|NCT01703286|50498913|FG003|Period 2 Including Washout|Adverse Event|1|||
25220324|NCT01703286|50498914|FG004|Period 2 Including Washout|Adverse Event|0|||
25220325|NCT01703286|50498915|FG005|Period 2 Including Washout|Adverse Event|0|||
25220326|NCT01703208|50498928|FG000|Overall Study|Death|61|||
25220327|NCT01703208|50498929|FG001|Overall Study|Death|48|||
25220328|NCT01703208|50498928|FG000|Overall Study|Lack of Efficacy|1|||
25220329|NCT01703208|50498929|FG001|Overall Study|Lack of Efficacy|2|||
25220330|NCT01703208|50498928|FG000|Overall Study|Lost to Follow-up|68|||
25220331|NCT01703208|50498929|FG001|Overall Study|Lost to Follow-up|62|||
25220332|NCT01703208|50498928|FG000|Overall Study|Non-Compliance with Study Drug|1|||
25220333|NCT01703208|50498929|FG001|Overall Study|Non-Compliance with Study Drug|0|||
25220334|NCT01703208|50498928|FG000|Overall Study|Excluded Medication|1|||
25220335|NCT01703208|50498929|FG001|Overall Study|Excluded Medication|2|||
25220336|NCT01703208|50498928|FG000|Overall Study|Site Discontinued Study Participation|23|||
25220337|NCT01703208|50498929|FG001|Overall Study|Site Discontinued Study Participation|27|||
25220338|NCT01703208|50498928|FG000|Overall Study|Physician Decision|11|||
25220339|NCT01703208|50498929|FG001|Overall Study|Physician Decision|13|||
25220340|NCT01703208|50498928|FG000|Overall Study|Progressive disease|2|||
25220341|NCT01703208|50498929|FG001|Overall Study|Progressive disease|2|||
25220342|NCT01703208|50498928|FG000|Overall Study|Protocol Violation|1|||
25220343|NCT01703208|50498929|FG001|Overall Study|Protocol Violation|1|||
25220344|NCT01703208|50498928|FG000|Overall Study|Study Terminated by Sponsor|1710|||
25220345|NCT01703208|50498929|FG001|Overall Study|Study Terminated by Sponsor|1716|||
25220346|NCT01703208|50498928|FG000|Overall Study|Withdrawal by Subject|205|||
25220347|NCT01703208|50498929|FG001|Overall Study|Withdrawal by Subject|209|||
25220348|NCT01703208|50498928|FG000|Overall Study|Adverse Event|14|||
25220349|NCT01703208|50498929|FG001|Overall Study|Adverse Event|19|||
25220350|NCT01703208|50498928|FG000|Overall Study|Technical Problems|0|||
25220351|NCT01703208|50498929|FG001|Overall Study|Technical Problems|1|||
25220352|NCT01703208|50498928|FG000|Overall Study|Protocol Deviation|2|||
25220353|NCT01703208|50498929|FG001|Overall Study|Protocol Deviation|0|||
25220354|NCT01727700|50498938|FG000|Overall Study|Adverse Event|0|||
25220355|NCT01727700|50498939|FG001|Overall Study|Adverse Event|7|||
25220356|NCT01727700|50498940|FG002|Overall Study|Adverse Event|1|||
25220357|NCT01727700|50498938|FG000|Overall Study|Particpant withdrew consent|0|||
25220358|NCT01727700|50498939|FG001|Overall Study|Particpant withdrew consent|3|||
25220359|NCT01727700|50498940|FG002|Overall Study|Particpant withdrew consent|1|||
25220360|NCT01727700|50498938|FG000|Overall Study|Protocol Violation|2|||
25220361|NCT01727700|50498939|FG001|Overall Study|Protocol Violation|0|||
25220362|NCT01727700|50498940|FG002|Overall Study|Protocol Violation|0|||
25220363|NCT01727154|50498948|FG000|Overall Study|Death|17|||
25220364|NCT01727154|50498948|FG000|Overall Study|Withdrawal by Subject|14|||
25220365|NCT01727154|50498948|FG000|Overall Study|Subject Withdrew Consent|18|||
25220366|NCT01727154|50498948|FG000|Overall Study|Study Terminated|6|||
25220367|NCT01727154|50498948|FG000|Overall Study|No Discontinuation Documentation|4|||
25220368|NCT01725750|50498954|FG000|Overall Study|Adverse Event|1|||
25220369|NCT01725750|50498955|FG001|Overall Study|Adverse Event|0|||
25220370|NCT01725750|50498954|FG000|Overall Study|Lost to Follow-up|1|||
25220371|NCT01725750|50498955|FG001|Overall Study|Lost to Follow-up|1|||
25220372|NCT01725750|50498954|FG000|Overall Study|Withdrawal by Subject|0|||
25220373|NCT01725750|50498955|FG001|Overall Study|Withdrawal by Subject|9|||
25220374|NCT01725282|50498967|FG000|Overall Study|Adverse Event|1|||
25220375|NCT01725282|50498968|FG001|Overall Study|Adverse Event|3|||
25220376|NCT01725282|50498969|FG002|Overall Study|Adverse Event|6|||
25220377|NCT01725282|50498970|FG003|Overall Study|Adverse Event|4|||
25220378|NCT01725282|50498967|FG000|Overall Study|Exacerbation of Target Disease|1|||
25220379|NCT01725282|50498968|FG001|Overall Study|Exacerbation of Target Disease|0|||
25220380|NCT01725282|50498969|FG002|Overall Study|Exacerbation of Target Disease|0|||
25220381|NCT01725282|50498970|FG003|Overall Study|Exacerbation of Target Disease|1|||
25220382|NCT01725282|50498967|FG000|Overall Study|Met Exclusion Criteria|0|||
25220383|NCT01725282|50498968|FG001|Overall Study|Met Exclusion Criteria|0|||
25220384|NCT01725282|50498969|FG002|Overall Study|Met Exclusion Criteria|1|||
25220385|NCT01725282|50498970|FG003|Overall Study|Met Exclusion Criteria|0|||
25220386|NCT01725282|50498967|FG000|Overall Study|Study Site Withdrawal|0|||
25220387|NCT01725282|50498968|FG001|Overall Study|Study Site Withdrawal|1|||
25220388|NCT01725282|50498969|FG002|Overall Study|Study Site Withdrawal|0|||
25220389|NCT01725282|50498970|FG003|Overall Study|Study Site Withdrawal|0|||
25220390|NCT01725282|50498967|FG000|Overall Study|Withdrawal by Subject|0|||
25220391|NCT01725282|50498968|FG001|Overall Study|Withdrawal by Subject|0|||
25220392|NCT01725282|50498969|FG002|Overall Study|Withdrawal by Subject|1|||
25220393|NCT01725282|50498970|FG003|Overall Study|Withdrawal by Subject|1|||
25220394|NCT01725282|50498967|FG000|Overall Study|Lack of Efficacy|0|||
25220395|NCT01725282|50498968|FG001|Overall Study|Lack of Efficacy|1|||
25220396|NCT01725282|50498969|FG002|Overall Study|Lack of Efficacy|0|||
25220397|NCT01725282|50498970|FG003|Overall Study|Lack of Efficacy|1|||
25220398|NCT01725126|50498986|FG000|Overall Study|Protocol Violation|0|||
25220399|NCT01725126|50498987|FG001|Overall Study|Protocol Violation|1|||
25220400|NCT01725126|50498988|FG002|Overall Study|Protocol Violation|0|||
25220401|NCT01725126|50498989|FG003|Overall Study|Protocol Violation|0|||
25220402|NCT01725126|50498990|FG004|Overall Study|Protocol Violation|0|||
25220403|NCT01725126|50498991|FG005|Overall Study|Protocol Violation|0|||
25220404|NCT01725126|50498986|FG000|Overall Study|Withdrawal by Subject|0|||
25220405|NCT01725126|50498987|FG001|Overall Study|Withdrawal by Subject|0|||
25220406|NCT01725126|50498988|FG002|Overall Study|Withdrawal by Subject|0|||
25220407|NCT01725126|50498989|FG003|Overall Study|Withdrawal by Subject|1|||
25220408|NCT01725126|50498990|FG004|Overall Study|Withdrawal by Subject|0|||
25220409|NCT01725126|50498991|FG005|Overall Study|Withdrawal by Subject|0|||
25220410|NCT01751724|50499016|FG000|Overall Study|extubated bef.start assigned treatment|1|||
25220411|NCT01751724|50499017|FG001|Overall Study|extubated bef.start assigned treatment|0|||
25220412|NCT01751724|50499016|FG000|Overall Study|withdrawn by parent|0|||
25220413|NCT01751724|50499017|FG001|Overall Study|withdrawn by parent|2|||
25220414|NCT01751646|50499025|FG000|Overall Study|Lost to Follow-up|5|||
25220415|NCT01751646|50499026|FG001|Overall Study|Lost to Follow-up|1|||
25220416|NCT01751646|50499025|FG000|Overall Study|Withdrawal by Subject|0|||
25220417|NCT01751646|50499026|FG001|Overall Study|Withdrawal by Subject|4|||
25220418|NCT01751646|50499025|FG000|Overall Study|Starting hormone therapy|1|||
25220419|NCT01751646|50499026|FG001|Overall Study|Starting hormone therapy|0|||
25220420|NCT01751646|50499025|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
25220421|NCT01751646|50499026|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
25220422|NCT01751646|50499025|FG000|Overall Study|Inadvertent enrollment|1|||
25220423|NCT01751646|50499026|FG001|Overall Study|Inadvertent enrollment|1|||
25220424|NCT01751646|50499025|FG000|Overall Study|Moved out of the area|1|||
25220425|NCT01751646|50499026|FG001|Overall Study|Moved out of the area|5|||
25220426|NCT01751646|50499025|FG000|Overall Study|Inability to attend required visits|0|||
25220427|NCT01751646|50499026|FG001|Overall Study|Inability to attend required visits|1|||
25220428|NCT01751646|50499025|FG000|Overall Study|Off study due to multiple obligations|0|||
25220429|NCT01751646|50499026|FG001|Overall Study|Off study due to multiple obligations|1|||
25220430|NCT01751646|50499025|FG000|Overall Study|Fails to comply with study requirements|0|||
25220431|NCT01751646|50499026|FG001|Overall Study|Fails to comply with study requirements|1|||
25220432|NCT01751646|50499025|FG000|Overall Study|Childcare issues|1|||
25220433|NCT01751646|50499026|FG001|Overall Study|Childcare issues|1|||
25220434|NCT01751568|50499039|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
25220435|NCT01751568|50499040|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
25220436|NCT01751568|50499041|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
25220437|NCT01751412|50499049|FG000|Overall Study|Disease Progression Before Treatment|1|||
25220438|NCT01751178|50499056|FG000|Overall Study|Adverse Event|2|||
25220439|NCT01751178|50499057|FG001|Overall Study|Adverse Event|0|||
25220440|NCT01751178|50499058|FG002|Overall Study|Adverse Event|0|||
25220441|NCT01751178|50499056|FG000|Overall Study|Other Reason (unknown)|1|||
25220442|NCT01751178|50499057|FG001|Overall Study|Other Reason (unknown)|0|||
25220443|NCT01751178|50499058|FG002|Overall Study|Other Reason (unknown)|2|||
25220444|NCT01606254|50499074|FG000|Overall Study|Withdrawal by Subject|1|||
25220445|NCT01606254|50499075|FG001|Overall Study|Withdrawal by Subject|3|||
25220446|NCT01606254|50499076|FG002|Overall Study|Withdrawal by Subject|0|||
25220447|NCT01606254|50499077|FG003|Overall Study|Withdrawal by Subject|2|||
25220448|NCT01606254|50499074|FG000|Overall Study|Adverse Event|1|||
25220449|NCT01606254|50499075|FG001|Overall Study|Adverse Event|1|||
25220450|NCT01606254|50499076|FG002|Overall Study|Adverse Event|0|||
25220451|NCT01606254|50499077|FG003|Overall Study|Adverse Event|1|||
25220452|NCT01750242|50499087|FG000|Overall Study|Unreadable Images|3|||
25220453|NCT01723254|50499100|FG000|Overall Study|Conflict with work schedule|0|||
25220454|NCT01723254|50499101|FG001|Overall Study|Conflict with work schedule|0|||
25220455|NCT01723254|50499102|FG002|Overall Study|Conflict with work schedule|0|||
25220456|NCT01723254|50499103|FG003|Overall Study|Conflict with work schedule|0|||
25220457|NCT01723254|50499104|FG004|Overall Study|Conflict with work schedule|0|||
25220458|NCT01723254|50499105|FG005|Overall Study|Conflict with work schedule|0|||
25220459|NCT01723254|50499106|FG006|Overall Study|Conflict with work schedule|0|||
25220460|NCT01723254|50499107|FG007|Overall Study|Conflict with work schedule|1|||
25317585|NCT00617461|50633169|FG001|First Treatment Intervention Period|Protocol Violation|1|||
25317586|NCT00617461|50633168|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
25317587|NCT00617461|50633169|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
25317588|NCT00617461|50633168|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
25317589|NCT00617461|50633169|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
25317590|NCT00617461|50633168|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
25317591|NCT00617461|50633169|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
25317592|NCT00617461|50633168|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
25317593|NCT00617461|50633169|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
25317594|NCT00617461|50633168|FG000|Second Treatment Intervention Period|Adverse Event|0|||
25317595|NCT00617461|50633169|FG001|Second Treatment Intervention Period|Adverse Event|1|||
24976490|NCT00031460|50065393|FG000|Overall Study|Reactivation of Disease|5|||
25220461|NCT01723254|50499100|FG000|Overall Study|Personal issues|0|||
25220462|NCT01723254|50499101|FG001|Overall Study|Personal issues|0|||
25220463|NCT01723254|50499102|FG002|Overall Study|Personal issues|0|||
25317596|NCT00617461|50633168|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
25220464|NCT01723254|50499103|FG003|Overall Study|Personal issues|0|||
25220465|NCT01723254|50499104|FG004|Overall Study|Personal issues|0|||
25220466|NCT01723254|50499105|FG005|Overall Study|Personal issues|1|||
25220467|NCT01723254|50499106|FG006|Overall Study|Personal issues|0|||
25220468|NCT01723254|50499107|FG007|Overall Study|Personal issues|0|||
25220469|NCT01723254|50499100|FG000|Overall Study|No longer have time to participate|0|||
25220470|NCT01723254|50499101|FG001|Overall Study|No longer have time to participate|0|||
25220471|NCT01723254|50499102|FG002|Overall Study|No longer have time to participate|0|||
25220472|NCT01723254|50499103|FG003|Overall Study|No longer have time to participate|1|||
25220473|NCT01723254|50499104|FG004|Overall Study|No longer have time to participate|0|||
25220474|NCT01723254|50499105|FG005|Overall Study|No longer have time to participate|0|||
25220475|NCT01723254|50499106|FG006|Overall Study|No longer have time to participate|0|||
25220476|NCT01723254|50499107|FG007|Overall Study|No longer have time to participate|0|||
25220477|NCT01723254|50499100|FG000|Overall Study|Move/Left to another country/city|0|||
25220478|NCT01723254|50499101|FG001|Overall Study|Move/Left to another country/city|0|||
25220479|NCT01723254|50499102|FG002|Overall Study|Move/Left to another country/city|2|||
25220480|NCT01723254|50499103|FG003|Overall Study|Move/Left to another country/city|1|||
25220481|NCT01723254|50499104|FG004|Overall Study|Move/Left to another country/city|1|||
25220482|NCT01723254|50499105|FG005|Overall Study|Move/Left to another country/city|0|||
25220483|NCT01723254|50499106|FG006|Overall Study|Move/Left to another country/city|0|||
25220484|NCT01723254|50499107|FG007|Overall Study|Move/Left to another country/city|0|||
25220485|NCT01723254|50499100|FG000|Overall Study|Protocol Violation|0|||
25220486|NCT01723254|50499101|FG001|Overall Study|Protocol Violation|1|||
25220487|NCT01723254|50499102|FG002|Overall Study|Protocol Violation|0|||
25220488|NCT01723254|50499103|FG003|Overall Study|Protocol Violation|0|||
25220489|NCT01723254|50499104|FG004|Overall Study|Protocol Violation|0|||
25220490|NCT01723254|50499105|FG005|Overall Study|Protocol Violation|0|||
25220491|NCT01723254|50499106|FG006|Overall Study|Protocol Violation|0|||
25220492|NCT01723254|50499107|FG007|Overall Study|Protocol Violation|0|||
25220493|NCT01723254|50499100|FG000|Overall Study|Withdrawal by Subject|1|||
25220494|NCT01723254|50499101|FG001|Overall Study|Withdrawal by Subject|2|||
25220495|NCT01723254|50499102|FG002|Overall Study|Withdrawal by Subject|1|||
25220496|NCT01723254|50499103|FG003|Overall Study|Withdrawal by Subject|0|||
25220497|NCT01723254|50499104|FG004|Overall Study|Withdrawal by Subject|1|||
25220498|NCT01723254|50499105|FG005|Overall Study|Withdrawal by Subject|1|||
25220499|NCT01723254|50499106|FG006|Overall Study|Withdrawal by Subject|1|||
25220500|NCT01723254|50499107|FG007|Overall Study|Withdrawal by Subject|2|||
25220501|NCT01722162|50499127|FG000|Overall Study|Withdrawal by Subject|1|||
25220502|NCT01722162|50499128|FG001|Overall Study|Withdrawal by Subject|1|||
25220503|NCT01722162|50499127|FG000|Overall Study|Found ineligible|1|||
25220504|NCT01722162|50499128|FG001|Overall Study|Found ineligible|0|||
25220505|NCT01722162|50499127|FG000|Overall Study|Unrelated to study adverse event|2|||
25220506|NCT01722162|50499128|FG001|Overall Study|Unrelated to study adverse event|2|||
25220507|NCT01722162|50499127|FG000|Overall Study|Adverse Event|1|||
25220508|NCT01722162|50499128|FG001|Overall Study|Adverse Event|1|||
25220509|NCT01722162|50499127|FG000|Overall Study|Insurance denial post enrollment|0|||
25220510|NCT01722162|50499128|FG001|Overall Study|Insurance denial post enrollment|1|||
25220511|NCT01722162|50499127|FG000|Overall Study|Noncompliance|0|||
25220512|NCT01722162|50499128|FG001|Overall Study|Noncompliance|1|||
25220513|NCT01721772|50499136|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
25220514|NCT01721772|50499137|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
25220515|NCT01721772|50499136|FG000|Pre-Treatment|Poor/non-compliance|0|||
25220516|NCT01721772|50499137|FG001|Pre-Treatment|Poor/non-compliance|1|||
25220517|NCT01721772|50499136|FG000|Pre-Treatment|Participant withdrew consent|0|||
25220518|NCT01721772|50499137|FG001|Pre-Treatment|Participant withdrew consent|1|||
25220519|NCT01721772|50499136|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
25220520|NCT01721772|50499137|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
25220521|NCT01721772|50499136|FG000|Treatment|Disease progression|119|||
25220522|NCT01721772|50499137|FG001|Treatment|Disease progression|168|||
25220523|NCT01721772|50499136|FG000|Treatment|Study drug toxicity|19|||
25220524|NCT01721772|50499137|FG001|Treatment|Study drug toxicity|10|||
25220525|NCT01721772|50499136|FG000|Treatment|Adverse event unrelated to study drug|7|||
25220526|NCT01721772|50499137|FG001|Treatment|Adverse event unrelated to study drug|7|||
25220527|NCT01721772|50499136|FG000|Treatment|Maximum clinical benefit|16|||
25220528|NCT01721772|50499137|FG001|Treatment|Maximum clinical benefit|4|||
25220529|NCT01721772|50499136|FG000|Treatment|Other|19|||
25220530|NCT01721772|50499137|FG001|Treatment|Other|2|||
25220531|NCT01721772|50499136|FG000|Treatment|Participant withdrew consent|2|||
25220532|NCT01721772|50499137|FG001|Treatment|Participant withdrew consent|5|||
25220533|NCT01721772|50499136|FG000|Treatment|Participant request to discontinue study treatment|21|||
25220534|NCT01721772|50499137|FG001|Treatment|Participant request to discontinue study treatment|8|||
25220535|NCT01721772|50499136|FG000|Treatment|Death|1|||
25220536|NCT01721772|50499137|FG001|Treatment|Death|0|||
25220537|NCT01721772|50499136|FG000|Treatment|Not reported|1|||
25220538|NCT01721772|50499137|FG001|Treatment|Not reported|0|||
25220539|NCT01721772|50499136|FG000|Treatment|Poor/non-compliance|1|||
25220540|NCT01721772|50499137|FG001|Treatment|Poor/non-compliance|0|||
25220541|NCT01721772|50499136|FG000|Treatment|Lost to Follow-up|0|||
25220542|NCT01721772|50499137|FG001|Treatment|Lost to Follow-up|1|||
25220543|NCT01702428|50499147|FG000|Overall Study|Adverse Event|2|||
25220544|NCT01702428|50499148|FG001|Overall Study|Adverse Event|0|||
25220545|NCT01702428|50499149|FG002|Overall Study|Adverse Event|0|||
25220546|NCT01702428|50499150|FG003|Overall Study|Adverse Event|0|||
25220547|NCT01702428|50499147|FG000|Overall Study|Lost to Follow-up|33|||
25220548|NCT01702428|50499148|FG001|Overall Study|Lost to Follow-up|41|||
25220549|NCT01702428|50499149|FG002|Overall Study|Lost to Follow-up|37|||
25220550|NCT01702428|50499150|FG003|Overall Study|Lost to Follow-up|44|||
25220551|NCT01702428|50499147|FG000|Overall Study|Parents cannot assist to site|1|||
25220552|NCT01702428|50499148|FG001|Overall Study|Parents cannot assist to site|0|||
25220553|NCT01702428|50499149|FG002|Overall Study|Parents cannot assist to site|1|||
25220554|NCT01702428|50499150|FG003|Overall Study|Parents cannot assist to site|0|||
25220555|NCT01702428|50499147|FG000|Overall Study|Lost Coverage|0|||
25220556|NCT01702428|50499148|FG001|Overall Study|Lost Coverage|0|||
25220557|NCT01702428|50499149|FG002|Overall Study|Lost Coverage|0|||
25220558|NCT01702428|50499150|FG003|Overall Study|Lost Coverage|1|||
25220559|NCT01702428|50499147|FG000|Overall Study|Lost Health Plan|3|||
25220560|NCT01702428|50499148|FG001|Overall Study|Lost Health Plan|5|||
25220561|NCT01702428|50499149|FG002|Overall Study|Lost Health Plan|0|||
25220562|NCT01702428|50499150|FG003|Overall Study|Lost Health Plan|2|||
25220563|NCT01702428|50499147|FG000|Overall Study|Mother transferred care|0|||
25220564|NCT01702428|50499148|FG001|Overall Study|Mother transferred care|1|||
25220565|NCT01702428|50499149|FG002|Overall Study|Mother transferred care|0|||
25220566|NCT01702428|50499150|FG003|Overall Study|Mother transferred care|0|||
25220567|NCT01702428|50499147|FG000|Overall Study|Parents too busy|1|||
25220568|NCT01702428|50499148|FG001|Overall Study|Parents too busy|0|||
25220569|NCT01702428|50499149|FG002|Overall Study|Parents too busy|0|||
25220570|NCT01702428|50499150|FG003|Overall Study|Parents too busy|0|||
25220571|NCT01702428|50499147|FG000|Overall Study|Protocol Violation|3|||
25220572|NCT01702428|50499148|FG001|Overall Study|Protocol Violation|0|||
25220573|NCT01702428|50499149|FG002|Overall Study|Protocol Violation|1|||
25220574|NCT01702428|50499150|FG003|Overall Study|Protocol Violation|0|||
25220575|NCT01702428|50499147|FG000|Overall Study|Withdrawal by Subject|21|||
25220576|NCT01702428|50499148|FG001|Overall Study|Withdrawal by Subject|23|||
25220577|NCT01702428|50499149|FG002|Overall Study|Withdrawal by Subject|14|||
25220578|NCT01702428|50499150|FG003|Overall Study|Withdrawal by Subject|10|||
25220579|NCT01701258|50499171|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
25220580|NCT01701258|50499172|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
25220581|NCT01701258|50499173|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
25220582|NCT01701258|50499174|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
25220583|NCT01701258|50499175|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
25220584|NCT01701258|50499176|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
25220585|NCT01701258|50499177|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
25220586|NCT01701258|50499178|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
25220587|NCT01701258|50499179|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
25220588|NCT01701258|50499180|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
25220589|NCT01701258|50499181|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
25220590|NCT01701258|50499182|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
25220591|NCT01701258|50499183|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
25220592|NCT01701258|50499171|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
25220593|NCT01701258|50499172|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
25220594|NCT01701258|50499173|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
25220595|NCT01701258|50499174|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
25220596|NCT01701258|50499175|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
25220597|NCT01701258|50499176|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
25220598|NCT01701258|50499177|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
25220599|NCT01701258|50499178|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
25220600|NCT01701258|50499179|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
25220601|NCT01701258|50499180|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
25220602|NCT01701258|50499181|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
25220603|NCT01701258|50499182|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
25220604|NCT01701258|50499183|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
25220605|NCT01701258|50499171|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
25220606|NCT01701258|50499172|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
25220607|NCT01701258|50499173|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
25220608|NCT01701258|50499174|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
25220609|NCT01701258|50499175|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
25220610|NCT01701258|50499176|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
25220611|NCT01701258|50499177|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
25220612|NCT01701258|50499178|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
25220613|NCT01701258|50499179|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
25220614|NCT01701258|50499180|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
25220615|NCT01701258|50499181|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
25220616|NCT01701258|50499182|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
25220617|NCT01701258|50499183|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
25220618|NCT01701258|50499171|FG000|Assessment and Scheduling|Investigator Terminated|2|||
25220619|NCT01701258|50499172|FG001|Assessment and Scheduling|Investigator Terminated|0|||
25220620|NCT01701258|50499173|FG002|Assessment and Scheduling|Investigator Terminated|0|||
25220621|NCT01701258|50499174|FG003|Assessment and Scheduling|Investigator Terminated|0|||
25220622|NCT01701258|50499175|FG004|Assessment and Scheduling|Investigator Terminated|0|||
25220623|NCT01701258|50499176|FG005|Assessment and Scheduling|Investigator Terminated|0|||
25220624|NCT01701258|50499177|FG006|Assessment and Scheduling|Investigator Terminated|0|||
25220625|NCT01701258|50499178|FG007|Assessment and Scheduling|Investigator Terminated|0|||
25220626|NCT01701258|50499179|FG008|Assessment and Scheduling|Investigator Terminated|0|||
25220627|NCT01701258|50499180|FG009|Assessment and Scheduling|Investigator Terminated|0|||
25220628|NCT01701258|50499181|FG010|Assessment and Scheduling|Investigator Terminated|0|||
25220629|NCT01701258|50499182|FG011|Assessment and Scheduling|Investigator Terminated|0|||
25220630|NCT01701258|50499183|FG012|Assessment and Scheduling|Investigator Terminated|0|||
25220631|NCT01700946|50499213|FG000|Overall Study|Lost to Follow-up|1|||
25220632|NCT01700946|50499214|FG001|Overall Study|Lost to Follow-up|0|||
25220633|NCT01700946|50499213|FG000|Overall Study|Physician Decision|7|||
25220634|NCT01700946|50499214|FG001|Overall Study|Physician Decision|12|||
25220635|NCT01700946|50499213|FG000|Overall Study|Withdrawal by Subject|0|||
25220636|NCT01700946|50499214|FG001|Overall Study|Withdrawal by Subject|2|||
25220637|NCT01700946|50499213|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
25220638|NCT01700946|50499214|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
25220639|NCT01700946|50499213|FG000|Overall Study|Relapse|2|||
25220640|NCT01700946|50499214|FG001|Overall Study|Relapse|1|||
25220641|NCT01700946|50499213|FG000|Overall Study|Unacceptable toxicity|1|||
25220642|NCT01700946|50499214|FG001|Overall Study|Unacceptable toxicity|0|||
25220643|NCT01748994|50499226|FG000|Overall Study|Lost to Follow-up|8|||
25220644|NCT01748994|50499227|FG001|Overall Study|Lost to Follow-up|6|||
25220645|NCT01721070|50499233|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
25220646|NCT01748760|50499242|FG000|Overall Study|Withdrawal by Subject|1|||
25220647|NCT01748760|50499243|FG001|Overall Study|Withdrawal by Subject|1|||
25220648|NCT01748760|50499242|FG000|Overall Study|Lost to Follow-up|5|||
25220649|NCT01748760|50499243|FG001|Overall Study|Lost to Follow-up|1|||
25220650|NCT01748292|50499251|FG000|Overall Study|Adverse Event|2|||
25220651|NCT01748292|50499252|FG001|Overall Study|Adverse Event|4|||
25220652|NCT01748292|50499251|FG000|Overall Study|Lost to Follow-up|0|||
25220653|NCT01748292|50499252|FG001|Overall Study|Lost to Follow-up|3|||
25220654|NCT01748292|50499251|FG000|Overall Study|Death|0|||
25220655|NCT01748292|50499252|FG001|Overall Study|Death|3|||
25220656|NCT01748292|50499251|FG000|Overall Study|Withdrawal by Subject|0|||
25220657|NCT01748292|50499252|FG001|Overall Study|Withdrawal by Subject|2|||
25220658|NCT01720602|50499258|FG000|Overall Study|Adverse Event|3|||
25220659|NCT01720602|50499258|FG000|Overall Study|Progressive disease on therapy|2|||
25220660|NCT01746732|50499262|FG000|Lead-In Period|Withdrawal by Subject|1|||
25220661|NCT01746732|50499263|FG001|Lead-In Period|Withdrawal by Subject|0|||
25220662|NCT01746732|50499264|FG002|Lead-In Period|Withdrawal by Subject|0|||
25220663|NCT01746732|50499262|FG000|Period 1|Physician Decision|0|||
25220664|NCT01746732|50499263|FG001|Period 1|Physician Decision|1|||
25220665|NCT01746732|50499264|FG002|Period 1|Physician Decision|0|||
25220666|NCT01746732|50499262|FG000|Period 2|Withdrawal by Subject|0|||
25220667|NCT01746732|50499263|FG001|Period 2|Withdrawal by Subject|0|||
25220668|NCT01746732|50499264|FG002|Period 2|Withdrawal by Subject|2|||
25220669|NCT01746732|50499262|FG000|Period 2|Adverse Event|0|||
25220670|NCT01746732|50499263|FG001|Period 2|Adverse Event|0|||
25220671|NCT01746732|50499264|FG002|Period 2|Adverse Event|1|||
25220672|NCT01746732|50499262|FG000|Period 2|Lost to Follow-up|0|||
25220673|NCT01746732|50499263|FG001|Period 2|Lost to Follow-up|0|||
25220674|NCT01746732|50499264|FG002|Period 2|Lost to Follow-up|1|||
25220675|NCT01720524|50499274|FG000|Part A|Insufficient Clinical Response|2|||
25220676|NCT01720524|50499275|FG001|Part A|Insufficient Clinical Response|4|||
25220677|NCT01720524|50499274|FG000|Part A|Adverse Event|2|||
25220678|NCT01720524|50499275|FG001|Part A|Adverse Event|2|||
25220679|NCT01720524|50499274|FG000|Part A|Death|2|||
25220680|NCT01720524|50499275|FG001|Part A|Death|1|||
25220681|NCT01720524|50499274|FG000|Part A|Lost to Follow-up|0|||
25220682|NCT01720524|50499275|FG001|Part A|Lost to Follow-up|1|||
25220683|NCT01720524|50499274|FG000|Part A|Missed 28 day follow-up visit|1|||
25220684|NCT01720524|50499275|FG001|Part A|Missed 28 day follow-up visit|1|||
25220685|NCT01720524|50499274|FG000|Part A|Withdrawal by Subject|0|||
25220686|NCT01720524|50499275|FG001|Part A|Withdrawal by Subject|1|||
25220687|NCT01720524|50499274|FG000|Part A|Other|0|||
25220688|NCT01720524|50499275|FG001|Part A|Other|1|||
25220689|NCT01720524|50499274|FG000|Part A|Lost to Follow-up|0|||
25220690|NCT01720524|50499275|FG001|Part A|Lost to Follow-up|1|||
25220691|NCT01720524|50499274|FG000|Part B|No longer willing to participate in study|1|||
25220692|NCT01720524|50499275|FG001|Part B|No longer willing to participate in study|4|||
25220693|NCT01720524|50499274|FG000|Part B|Other|2|||
25220694|NCT01720524|50499275|FG001|Part B|Other|0|||
25220695|NCT01720524|50499274|FG000|Part B|Lost to Follow-up|2|||
25220696|NCT01720524|50499275|FG001|Part B|Lost to Follow-up|3|||
25220697|NCT01720524|50499274|FG000|Part B|Death|0|||
25220698|NCT01720524|50499275|FG001|Part B|Death|2|||
25220699|NCT01720446|50499287|FG000|Overall Study|Lost to Follow-up|12|||
25220700|NCT01720446|50499288|FG001|Overall Study|Lost to Follow-up|6|||
25220701|NCT01720446|50499289|FG002|Overall Study|Lost to Follow-up|16|||
25220702|NCT01720446|50499290|FG003|Overall Study|Lost to Follow-up|16|||
25220703|NCT01720446|50499287|FG000|Overall Study|Withdrawal by Subject|2|||
25220704|NCT01720446|50499288|FG001|Overall Study|Withdrawal by Subject|5|||
25220705|NCT01720446|50499289|FG002|Overall Study|Withdrawal by Subject|4|||
25220706|NCT01720446|50499290|FG003|Overall Study|Withdrawal by Subject|4|||
25220707|NCT01746108|50499306|FG000|Overall Study|Migrated /moved from study area|0|||
25220708|NCT01746108|50499307|FG001|Overall Study|Migrated /moved from study area|1|||
25220709|NCT01746108|50499308|FG002|Overall Study|Migrated /moved from study area|0|||
25220710|NCT01746108|50499306|FG000|Overall Study|Adverse event, non-fatal|0|||
25220711|NCT01746108|50499307|FG001|Overall Study|Adverse event, non-fatal|1|||
25220712|NCT01746108|50499308|FG002|Overall Study|Adverse event, non-fatal|0|||
25220713|NCT01746108|50499306|FG000|Overall Study|Withdrawal by Subject|0|||
25220714|NCT01746108|50499307|FG001|Overall Study|Withdrawal by Subject|1|||
25220715|NCT01746108|50499308|FG002|Overall Study|Withdrawal by Subject|0|||
25220716|NCT01746108|50499306|FG000|Overall Study|Lost to Follow-up|0|||
25220717|NCT01746108|50499307|FG001|Overall Study|Lost to Follow-up|1|||
25220718|NCT01746108|50499308|FG002|Overall Study|Lost to Follow-up|0|||
25220719|NCT01717638|50499337|FG000|Overall Study|Lost to Follow-up|0|||
25220720|NCT01717638|50499338|FG001|Overall Study|Lost to Follow-up|0|||
25220721|NCT01717638|50499339|FG002|Overall Study|Lost to Follow-up|0|||
25220722|NCT01717638|50499340|FG003|Overall Study|Lost to Follow-up|0|||
25220723|NCT01717638|50499341|FG004|Overall Study|Lost to Follow-up|0|||
25220724|NCT01717638|50499342|FG005|Overall Study|Lost to Follow-up|1|||
25220725|NCT01717638|50499343|FG006|Overall Study|Lost to Follow-up|0|||
25220726|NCT01717638|50499344|FG007|Overall Study|Lost to Follow-up|0|||
25220727|NCT01717638|50499345|FG008|Overall Study|Lost to Follow-up|0|||
25220728|NCT01717638|50499346|FG009|Overall Study|Lost to Follow-up|0|||
25220729|NCT01717638|50499347|FG010|Overall Study|Lost to Follow-up|0|||
25220730|NCT01717638|50499348|FG011|Overall Study|Lost to Follow-up|0|||
25220731|NCT01717638|50499349|FG012|Overall Study|Lost to Follow-up|0|||
25220732|NCT01717638|50499337|FG000|Overall Study|Father in hospital|0|||
25220733|NCT01717638|50499338|FG001|Overall Study|Father in hospital|0|||
25220734|NCT01717638|50499339|FG002|Overall Study|Father in hospital|0|||
25220735|NCT01717638|50499340|FG003|Overall Study|Father in hospital|0|||
25220736|NCT01717638|50499341|FG004|Overall Study|Father in hospital|0|||
25220737|NCT01717638|50499342|FG005|Overall Study|Father in hospital|0|||
25220738|NCT01717638|50499343|FG006|Overall Study|Father in hospital|0|||
25220739|NCT01717638|50499344|FG007|Overall Study|Father in hospital|0|||
25220740|NCT01717638|50499345|FG008|Overall Study|Father in hospital|0|||
25220741|NCT01717638|50499346|FG009|Overall Study|Father in hospital|0|||
25220742|NCT01717638|50499347|FG010|Overall Study|Father in hospital|0|||
25220743|NCT01717638|50499348|FG011|Overall Study|Father in hospital|0|||
25220744|NCT01717638|50499349|FG012|Overall Study|Father in hospital|1|||
25220745|NCT01717638|50499337|FG000|Overall Study|Withdrawal by Subject|0|||
25220746|NCT01717638|50499338|FG001|Overall Study|Withdrawal by Subject|1|||
25220747|NCT01717638|50499339|FG002|Overall Study|Withdrawal by Subject|1|||
25220748|NCT01717638|50499340|FG003|Overall Study|Withdrawal by Subject|0|||
25220749|NCT01717638|50499341|FG004|Overall Study|Withdrawal by Subject|1|||
25220750|NCT01717638|50499342|FG005|Overall Study|Withdrawal by Subject|0|||
25220751|NCT01717638|50499343|FG006|Overall Study|Withdrawal by Subject|2|||
25220752|NCT01717638|50499344|FG007|Overall Study|Withdrawal by Subject|1|||
25220753|NCT01717638|50499345|FG008|Overall Study|Withdrawal by Subject|2|||
25220754|NCT01717638|50499346|FG009|Overall Study|Withdrawal by Subject|1|||
25220755|NCT01717638|50499347|FG010|Overall Study|Withdrawal by Subject|0|||
25220756|NCT01717638|50499348|FG011|Overall Study|Withdrawal by Subject|0|||
25220757|NCT01717638|50499349|FG012|Overall Study|Withdrawal by Subject|18|||
25220758|NCT01745094|50499387|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
25220759|NCT01745094|50499388|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
25220760|NCT01745094|50499389|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
25220761|NCT01745094|50499390|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
25220762|NCT01745094|50499387|FG000|Overall Study|Adverse Event|0|||
25220763|NCT01745094|50499388|FG001|Overall Study|Adverse Event|0|||
25220764|NCT01745094|50499389|FG002|Overall Study|Adverse Event|3|||
25220765|NCT01745094|50499390|FG003|Overall Study|Adverse Event|0|||
25220766|NCT01745094|50499387|FG000|Overall Study|Withdrawal by Subject|2|||
25220767|NCT01745094|50499388|FG001|Overall Study|Withdrawal by Subject|0|||
25220768|NCT01745094|50499389|FG002|Overall Study|Withdrawal by Subject|1|||
25220769|NCT01745094|50499390|FG003|Overall Study|Withdrawal by Subject|2|||
25220770|NCT01745094|50499387|FG000|Overall Study|Protocol Violation|1|||
25220771|NCT01745094|50499388|FG001|Overall Study|Protocol Violation|0|||
25220772|NCT01745094|50499389|FG002|Overall Study|Protocol Violation|3|||
25220773|NCT01745094|50499390|FG003|Overall Study|Protocol Violation|1|||
25220774|NCT01745094|50499387|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
25220775|NCT01745094|50499388|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
25220776|NCT01745094|50499389|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
25220777|NCT01745094|50499390|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
25220778|NCT01745094|50499387|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
25220779|NCT01745094|50499388|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
25220780|NCT01745094|50499389|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
25220781|NCT01745094|50499390|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
25220782|NCT01745094|50499387|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
25220783|NCT01745094|50499388|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
25220784|NCT01745094|50499389|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
25220785|NCT01745094|50499390|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
25220786|NCT01697748|50499405|FG000|Overall Study|ineligible skin incision|1|||
25220787|NCT01697748|50499406|FG001|Overall Study|ineligible skin incision|2|||
25220788|NCT01697748|50499405|FG000|Overall Study|ineligible uterine incision|4|||
25220789|NCT01697748|50499406|FG001|Overall Study|ineligible uterine incision|1|||
25220790|NCT01697748|50499405|FG000|Overall Study|Lost to Follow-up|53|||
25220791|NCT01697748|50499406|FG001|Overall Study|Lost to Follow-up|65|||
25220792|NCT01717326|50499432|FG000|Overall Study|Death|0|||
25220793|NCT01717326|50499433|FG001|Overall Study|Death|0|||
25220794|NCT01717326|50499434|FG002|Overall Study|Death|0|||
25220795|NCT01717326|50499435|FG003|Overall Study|Death|0|||
25220796|NCT01717326|50499436|FG004|Overall Study|Death|0|||
25220797|NCT01717326|50499437|FG005|Overall Study|Death|0|||
25220798|NCT01717326|50499438|FG006|Overall Study|Death|0|||
25220799|NCT01717326|50499439|FG007|Overall Study|Death|0|||
25220800|NCT01717326|50499440|FG008|Overall Study|Death|0|||
25220801|NCT01717326|50499441|FG009|Overall Study|Death|0|||
25220802|NCT01717326|50499442|FG010|Overall Study|Death|1|||
25220803|NCT01717326|50499443|FG011|Overall Study|Death|0|||
25220804|NCT01717326|50499444|FG012|Overall Study|Death|0|||
25220805|NCT01717326|50499445|FG013|Overall Study|Death|0|||
25220806|NCT01717326|50499446|FG014|Overall Study|Death|0|||
25220807|NCT01717326|50499447|FG015|Overall Study|Death|0|||
25220808|NCT01717326|50499448|FG016|Overall Study|Death|0|||
25220809|NCT01717326|50499449|FG017|Overall Study|Death|0|||
25220810|NCT01717326|50499450|FG018|Overall Study|Death|0|||
25220811|NCT01717326|50499451|FG019|Overall Study|Death|0|||
25220812|NCT01717326|50499432|FG000|Overall Study|Lost to Follow-up|3|||
25220813|NCT01717326|50499433|FG001|Overall Study|Lost to Follow-up|0|||
25220814|NCT01717326|50499434|FG002|Overall Study|Lost to Follow-up|0|||
25220815|NCT01717326|50499435|FG003|Overall Study|Lost to Follow-up|2|||
25220816|NCT01717326|50499436|FG004|Overall Study|Lost to Follow-up|1|||
25220817|NCT01717326|50499437|FG005|Overall Study|Lost to Follow-up|0|||
25220818|NCT01717326|50499438|FG006|Overall Study|Lost to Follow-up|1|||
25220819|NCT01717326|50499439|FG007|Overall Study|Lost to Follow-up|0|||
25220820|NCT01717326|50499440|FG008|Overall Study|Lost to Follow-up|0|||
25220821|NCT01717326|50499441|FG009|Overall Study|Lost to Follow-up|0|||
25220822|NCT01717326|50499442|FG010|Overall Study|Lost to Follow-up|1|||
25220823|NCT01717326|50499443|FG011|Overall Study|Lost to Follow-up|0|||
25220824|NCT01717326|50499444|FG012|Overall Study|Lost to Follow-up|0|||
25220825|NCT01717326|50499445|FG013|Overall Study|Lost to Follow-up|0|||
25220826|NCT01717326|50499446|FG014|Overall Study|Lost to Follow-up|0|||
25220827|NCT01717326|50499447|FG015|Overall Study|Lost to Follow-up|2|||
25220828|NCT01717326|50499448|FG016|Overall Study|Lost to Follow-up|1|||
25220829|NCT01717326|50499449|FG017|Overall Study|Lost to Follow-up|0|||
25220830|NCT01717326|50499450|FG018|Overall Study|Lost to Follow-up|2|||
25220831|NCT01717326|50499451|FG019|Overall Study|Lost to Follow-up|3|||
25220832|NCT01717326|50499432|FG000|Overall Study|Physician Decision|0|||
25220833|NCT01717326|50499433|FG001|Overall Study|Physician Decision|0|||
25220834|NCT01717326|50499434|FG002|Overall Study|Physician Decision|0|||
25220835|NCT01717326|50499435|FG003|Overall Study|Physician Decision|0|||
25220836|NCT01717326|50499436|FG004|Overall Study|Physician Decision|0|||
25220837|NCT01717326|50499437|FG005|Overall Study|Physician Decision|0|||
25220838|NCT01717326|50499438|FG006|Overall Study|Physician Decision|0|||
25220839|NCT01717326|50499439|FG007|Overall Study|Physician Decision|0|||
25220840|NCT01717326|50499440|FG008|Overall Study|Physician Decision|0|||
25220841|NCT01717326|50499441|FG009|Overall Study|Physician Decision|1|||
25220842|NCT01717326|50499442|FG010|Overall Study|Physician Decision|0|||
25220843|NCT01717326|50499443|FG011|Overall Study|Physician Decision|0|||
25220844|NCT01717326|50499444|FG012|Overall Study|Physician Decision|0|||
25220845|NCT01717326|50499445|FG013|Overall Study|Physician Decision|0|||
25220846|NCT01717326|50499446|FG014|Overall Study|Physician Decision|0|||
25220847|NCT01717326|50499447|FG015|Overall Study|Physician Decision|0|||
25220848|NCT01717326|50499448|FG016|Overall Study|Physician Decision|0|||
25220849|NCT01717326|50499449|FG017|Overall Study|Physician Decision|0|||
25220850|NCT01717326|50499450|FG018|Overall Study|Physician Decision|0|||
25220851|NCT01717326|50499451|FG019|Overall Study|Physician Decision|0|||
25220852|NCT01717326|50499432|FG000|Overall Study|Protocol Violation|0|||
25220853|NCT01717326|50499433|FG001|Overall Study|Protocol Violation|0|||
25220854|NCT01717326|50499434|FG002|Overall Study|Protocol Violation|0|||
25220855|NCT01717326|50499435|FG003|Overall Study|Protocol Violation|0|||
25220856|NCT01717326|50499436|FG004|Overall Study|Protocol Violation|1|||
25220857|NCT01717326|50499437|FG005|Overall Study|Protocol Violation|0|||
25220858|NCT01717326|50499438|FG006|Overall Study|Protocol Violation|0|||
25220859|NCT01717326|50499439|FG007|Overall Study|Protocol Violation|0|||
25220860|NCT01717326|50499440|FG008|Overall Study|Protocol Violation|0|||
25220861|NCT01717326|50499441|FG009|Overall Study|Protocol Violation|0|||
25220862|NCT01717326|50499442|FG010|Overall Study|Protocol Violation|0|||
25220863|NCT01717326|50499443|FG011|Overall Study|Protocol Violation|0|||
25220864|NCT01717326|50499444|FG012|Overall Study|Protocol Violation|0|||
25220865|NCT01717326|50499445|FG013|Overall Study|Protocol Violation|0|||
25220866|NCT01717326|50499446|FG014|Overall Study|Protocol Violation|0|||
25220867|NCT01717326|50499447|FG015|Overall Study|Protocol Violation|0|||
25220868|NCT01717326|50499448|FG016|Overall Study|Protocol Violation|0|||
25220869|NCT01717326|50499449|FG017|Overall Study|Protocol Violation|0|||
25220870|NCT01717326|50499450|FG018|Overall Study|Protocol Violation|0|||
25220871|NCT01717326|50499451|FG019|Overall Study|Protocol Violation|0|||
25220872|NCT01717326|50499432|FG000|Overall Study|Withdrawal by Subject|0|||
25220873|NCT01717326|50499433|FG001|Overall Study|Withdrawal by Subject|1|||
25220874|NCT01717326|50499434|FG002|Overall Study|Withdrawal by Subject|0|||
25220875|NCT01717326|50499435|FG003|Overall Study|Withdrawal by Subject|0|||
25220876|NCT01717326|50499436|FG004|Overall Study|Withdrawal by Subject|0|||
25220877|NCT01717326|50499437|FG005|Overall Study|Withdrawal by Subject|0|||
25220878|NCT01717326|50499438|FG006|Overall Study|Withdrawal by Subject|0|||
25220879|NCT01717326|50499439|FG007|Overall Study|Withdrawal by Subject|0|||
25220880|NCT01717326|50499440|FG008|Overall Study|Withdrawal by Subject|0|||
25220881|NCT01717326|50499441|FG009|Overall Study|Withdrawal by Subject|1|||
25220882|NCT01717326|50499442|FG010|Overall Study|Withdrawal by Subject|0|||
25220883|NCT01717326|50499443|FG011|Overall Study|Withdrawal by Subject|0|||
25220884|NCT01717326|50499444|FG012|Overall Study|Withdrawal by Subject|1|||
25220885|NCT01717326|50499445|FG013|Overall Study|Withdrawal by Subject|0|||
25220886|NCT01717326|50499446|FG014|Overall Study|Withdrawal by Subject|0|||
25220887|NCT01717326|50499447|FG015|Overall Study|Withdrawal by Subject|1|||
25220888|NCT01717326|50499448|FG016|Overall Study|Withdrawal by Subject|0|||
25220889|NCT01717326|50499449|FG017|Overall Study|Withdrawal by Subject|0|||
25220890|NCT01717326|50499450|FG018|Overall Study|Withdrawal by Subject|2|||
25220891|NCT01717326|50499451|FG019|Overall Study|Withdrawal by Subject|3|||
25220892|NCT01697592|50499503|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
25220893|NCT01697592|50499504|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
25220894|NCT01697592|50499505|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
25220895|NCT01697592|50499506|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
25220896|NCT01697592|50499507|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
25220897|NCT01697592|50499508|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
25220898|NCT01697592|50499509|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
25220899|NCT01697592|50499510|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
25220900|NCT01697592|50499511|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
25220901|NCT01697592|50499512|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
25220902|NCT01697592|50499503|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
25220903|NCT01697592|50499504|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
25220904|NCT01697592|50499505|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
25220905|NCT01697592|50499506|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
25220906|NCT01697592|50499507|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
25220907|NCT01697592|50499508|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
25220908|NCT01697592|50499509|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
25220909|NCT01697592|50499510|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
25220910|NCT01697592|50499511|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
25220911|NCT01697592|50499512|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
25220912|NCT01697592|50499503|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
25220913|NCT01697592|50499504|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
25220914|NCT01697592|50499505|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
25220915|NCT01697592|50499506|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
25220916|NCT01697592|50499507|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
25220917|NCT01697592|50499508|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
25220918|NCT01697592|50499509|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
25220919|NCT01697592|50499510|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
25220920|NCT01697592|50499511|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
25220921|NCT01697592|50499512|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
25220922|NCT01697592|50499503|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
25317597|NCT00617461|50633169|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
25220923|NCT01697592|50499504|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
25220924|NCT01697592|50499505|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
25220925|NCT01697592|50499506|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
25220926|NCT01697592|50499507|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
25220927|NCT01697592|50499508|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
25220928|NCT01697592|50499509|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
25220929|NCT01697592|50499510|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
25220930|NCT01697592|50499511|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
25220931|NCT01697592|50499512|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
25220932|NCT01697592|50499503|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
25220933|NCT01697592|50499504|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
25220934|NCT01697592|50499505|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
25220935|NCT01697592|50499506|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
25220936|NCT01697592|50499507|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
25220937|NCT01697592|50499508|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
25220938|NCT01697592|50499509|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
25220939|NCT01697592|50499510|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
25220940|NCT01697592|50499511|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
25220941|NCT01697592|50499512|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
25220942|NCT01697592|50499503|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
25220943|NCT01697592|50499504|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
25220944|NCT01697592|50499505|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
25220945|NCT01697592|50499506|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
25220946|NCT01697592|50499507|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
25220947|NCT01697592|50499508|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
25220948|NCT01697592|50499509|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
25220949|NCT01697592|50499510|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
25220950|NCT01697592|50499511|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
25220951|NCT01697592|50499512|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
25220952|NCT01697592|50499503|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
25220953|NCT01697592|50499504|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
25220954|NCT01697592|50499505|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
25220955|NCT01697592|50499506|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
25220956|NCT01697592|50499507|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
25220957|NCT01697592|50499508|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
25220958|NCT01697592|50499509|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
25220959|NCT01697592|50499510|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
25220960|NCT01697592|50499511|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
25220961|NCT01697592|50499512|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
25220962|NCT01697592|50499503|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
25220963|NCT01697592|50499504|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
25220964|NCT01697592|50499505|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
25220965|NCT01697592|50499506|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
25220966|NCT01697592|50499507|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
25220967|NCT01697592|50499508|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
25220968|NCT01697592|50499509|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
25220969|NCT01697592|50499510|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
25220970|NCT01697592|50499511|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
25220971|NCT01697592|50499512|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
25220972|NCT01744782|50499548|FG000|Overall Study|Death|1|||
25220973|NCT01744392|50499552|FG000|Overall Study|Physician Decision|1|||
25220974|NCT01604850|50499559|FG000|Overall Study|Enrolled but never treated|0|||
25220975|NCT01604850|50499560|FG001|Overall Study|Enrolled but never treated|1|||
25220976|NCT01604850|50499559|FG000|Overall Study|Efficacy Failure|50|||
25220977|NCT01604850|50499560|FG001|Overall Study|Efficacy Failure|29|||
25220978|NCT01604850|50499559|FG000|Overall Study|Lost to Follow-up|1|||
25220979|NCT01604850|50499560|FG001|Overall Study|Lost to Follow-up|0|||
25220980|NCT01604850|50499559|FG000|Overall Study|Subject withdrew consent|1|||
25220981|NCT01604850|50499560|FG001|Overall Study|Subject withdrew consent|0|||
25220982|NCT01742286|50499573|FG000|Escalation Phase|Administrative problems|1|||
25220983|NCT01742286|50499574|FG001|Escalation Phase|Administrative problems|1|||
25220984|NCT01742286|50499575|FG002|Escalation Phase|Administrative problems|0|||
25220985|NCT01742286|50499576|FG003|Escalation Phase|Administrative problems|0|||
25220986|NCT01742286|50499577|FG004|Escalation Phase|Administrative problems|0|||
25220987|NCT01742286|50499578|FG005|Escalation Phase|Administrative problems|0|||
25220988|NCT01742286|50499579|FG006|Escalation Phase|Administrative problems|2|||
25220989|NCT01742286|50499573|FG000|Escalation Phase|Adverse Event|0|||
25220990|NCT01742286|50499574|FG001|Escalation Phase|Adverse Event|1|||
25220991|NCT01742286|50499575|FG002|Escalation Phase|Adverse Event|2|||
25220992|NCT01742286|50499576|FG003|Escalation Phase|Adverse Event|0|||
25220993|NCT01742286|50499577|FG004|Escalation Phase|Adverse Event|0|||
25220994|NCT01742286|50499578|FG005|Escalation Phase|Adverse Event|1|||
25220995|NCT01742286|50499579|FG006|Escalation Phase|Adverse Event|0|||
25220996|NCT01742286|50499573|FG000|Escalation Phase|Disease progression|3|||
25220997|NCT01742286|50499574|FG001|Escalation Phase|Disease progression|7|||
25220998|NCT01742286|50499575|FG002|Escalation Phase|Disease progression|4|||
25220999|NCT01742286|50499576|FG003|Escalation Phase|Disease progression|1|||
25221000|NCT01742286|50499577|FG004|Escalation Phase|Disease progression|4|||
25221001|NCT01742286|50499578|FG005|Escalation Phase|Disease progression|3|||
25221002|NCT01742286|50499579|FG006|Escalation Phase|Disease progression|2|||
25221003|NCT01742286|50499573|FG000|Escalation Phase|Death|0|||
25221004|NCT01742286|50499574|FG001|Escalation Phase|Death|0|||
25221005|NCT01742286|50499575|FG002|Escalation Phase|Death|0|||
25221006|NCT01742286|50499576|FG003|Escalation Phase|Death|0|||
25221007|NCT01742286|50499577|FG004|Escalation Phase|Death|0|||
25221008|NCT01742286|50499578|FG005|Escalation Phase|Death|1|||
25221009|NCT01742286|50499579|FG006|Escalation Phase|Death|0|||
25221010|NCT01742286|50499573|FG000|Escalation Phase|Physician Decision|0|||
25221011|NCT01742286|50499574|FG001|Escalation Phase|Physician Decision|3|||
25221012|NCT01742286|50499575|FG002|Escalation Phase|Physician Decision|0|||
25221013|NCT01742286|50499576|FG003|Escalation Phase|Physician Decision|1|||
25221014|NCT01742286|50499577|FG004|Escalation Phase|Physician Decision|0|||
25221015|NCT01742286|50499578|FG005|Escalation Phase|Physician Decision|0|||
25221016|NCT01742286|50499579|FG006|Escalation Phase|Physician Decision|2|||
25221017|NCT01742286|50499573|FG000|Escalation Phase|Subject/guardian decision|1|||
25221018|NCT01742286|50499574|FG001|Escalation Phase|Subject/guardian decision|0|||
25221019|NCT01742286|50499575|FG002|Escalation Phase|Subject/guardian decision|0|||
25221020|NCT01742286|50499576|FG003|Escalation Phase|Subject/guardian decision|0|||
25221021|NCT01742286|50499577|FG004|Escalation Phase|Subject/guardian decision|0|||
25221022|NCT01742286|50499578|FG005|Escalation Phase|Subject/guardian decision|0|||
25221023|NCT01742286|50499579|FG006|Escalation Phase|Subject/guardian decision|0|||
25221024|NCT01742286|50499573|FG000|Expansion Phase|Administrative problems|0|||
25221025|NCT01742286|50499574|FG001|Expansion Phase|Administrative problems|0|||
25221026|NCT01742286|50499575|FG002|Expansion Phase|Administrative problems|0|||
25221027|NCT01742286|50499576|FG003|Expansion Phase|Administrative problems|0|||
25221028|NCT01742286|50499577|FG004|Expansion Phase|Administrative problems|0|||
25221029|NCT01742286|50499578|FG005|Expansion Phase|Administrative problems|0|||
25221030|NCT01742286|50499579|FG006|Expansion Phase|Administrative problems|5|||
25221031|NCT01742286|50499573|FG000|Expansion Phase|Physician Decision|0|||
25221032|NCT01742286|50499574|FG001|Expansion Phase|Physician Decision|0|||
25221033|NCT01742286|50499575|FG002|Expansion Phase|Physician Decision|4|||
25221034|NCT01742286|50499576|FG003|Expansion Phase|Physician Decision|0|||
25221035|NCT01742286|50499577|FG004|Expansion Phase|Physician Decision|0|||
25221036|NCT01742286|50499578|FG005|Expansion Phase|Physician Decision|0|||
25221037|NCT01742286|50499579|FG006|Expansion Phase|Physician Decision|9|||
25221038|NCT01742286|50499573|FG000|Expansion Phase|Adverse Event|0|||
25221039|NCT01742286|50499574|FG001|Expansion Phase|Adverse Event|0|||
25221040|NCT01742286|50499575|FG002|Expansion Phase|Adverse Event|0|||
25221041|NCT01742286|50499576|FG003|Expansion Phase|Adverse Event|0|||
25221042|NCT01742286|50499577|FG004|Expansion Phase|Adverse Event|0|||
25221043|NCT01742286|50499578|FG005|Expansion Phase|Adverse Event|0|||
25221044|NCT01742286|50499579|FG006|Expansion Phase|Adverse Event|6|||
25221045|NCT01742286|50499573|FG000|Expansion Phase|Disease progression|0|||
25221046|NCT01742286|50499574|FG001|Expansion Phase|Disease progression|0|||
25221047|NCT01742286|50499575|FG002|Expansion Phase|Disease progression|3|||
25221048|NCT01742286|50499576|FG003|Expansion Phase|Disease progression|0|||
25221049|NCT01742286|50499577|FG004|Expansion Phase|Disease progression|0|||
25221050|NCT01742286|50499578|FG005|Expansion Phase|Disease progression|0|||
25221051|NCT01742286|50499579|FG006|Expansion Phase|Disease progression|15|||
25221052|NCT01742286|50499573|FG000|Expansion Phase|Withdrawal by Subject|0|||
25221053|NCT01742286|50499574|FG001|Expansion Phase|Withdrawal by Subject|0|||
25221054|NCT01742286|50499575|FG002|Expansion Phase|Withdrawal by Subject|0|||
25221055|NCT01742286|50499576|FG003|Expansion Phase|Withdrawal by Subject|0|||
25221056|NCT01742286|50499577|FG004|Expansion Phase|Withdrawal by Subject|0|||
25221057|NCT01742286|50499578|FG005|Expansion Phase|Withdrawal by Subject|0|||
25221058|NCT01742286|50499579|FG006|Expansion Phase|Withdrawal by Subject|1|||
25221059|NCT01697358|50499604|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
25221060|NCT01697358|50499605|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
25221061|NCT01697358|50499604|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
25221062|NCT01697358|50499605|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
25221063|NCT01697358|50499604|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
25221064|NCT01697358|50499605|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
25221065|NCT01697358|50499604|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
24976491|NCT00031460|50065394|FG001|Overall Study|Reactivation of Disease|9|||
24976492|NCT00031460|50065393|FG000|Overall Study|Disruption of blinded drug supply|2|||
25221066|NCT01697358|50499605|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
25221067|NCT01697358|50499604|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
24976493|NCT00031460|50065394|FG001|Overall Study|Disruption of blinded drug supply|0|||
25221068|NCT01697358|50499605|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
25221069|NCT01697358|50499604|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
25221070|NCT01697358|50499605|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
25221071|NCT01697358|50499604|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
25221072|NCT01697358|50499605|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
25221073|NCT01697358|50499604|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
25221074|NCT01697358|50499605|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
25221075|NCT01697358|50499604|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
25221076|NCT01697358|50499605|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
25221077|NCT01697358|50499604|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
25221078|NCT01697358|50499605|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
25221079|NCT01716234|50499618|FG000|Overall Study|Protocol Violation|0|||
25221080|NCT01716234|50499619|FG001|Overall Study|Protocol Violation|0|||
25221081|NCT01716234|50499620|FG002|Overall Study|Protocol Violation|0|||
25221082|NCT01716234|50499621|FG003|Overall Study|Protocol Violation|1|||
25221083|NCT01716234|50499622|FG004|Overall Study|Protocol Violation|1|||
25221084|NCT01716234|50499623|FG005|Overall Study|Protocol Violation|1|||
25221085|NCT01716234|50499624|FG006|Overall Study|Protocol Violation|0|||
25221086|NCT01716234|50499618|FG000|Overall Study|Lack of Efficacy|0|||
25221087|NCT01716234|50499619|FG001|Overall Study|Lack of Efficacy|0|||
25221088|NCT01716234|50499620|FG002|Overall Study|Lack of Efficacy|0|||
25221089|NCT01716234|50499621|FG003|Overall Study|Lack of Efficacy|1|||
25221090|NCT01716234|50499622|FG004|Overall Study|Lack of Efficacy|0|||
25221091|NCT01716234|50499623|FG005|Overall Study|Lack of Efficacy|0|||
25221092|NCT01716234|50499624|FG006|Overall Study|Lack of Efficacy|0|||
25221093|NCT01716234|50499618|FG000|Overall Study|Did not meet protocol eligibility|0|||
25221094|NCT01716234|50499619|FG001|Overall Study|Did not meet protocol eligibility|0|||
25317598|NCT00617461|50633168|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
25317599|NCT00617461|50633169|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
25317600|NCT00617461|50633168|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
25317601|NCT00617461|50633169|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
25317602|NCT00812331|50633196|FG000|Overall Study|Adverse Event|1|||
25317603|NCT00812331|50633197|FG001|Overall Study|Adverse Event|0|||
25317604|NCT00812331|50633198|FG002|Overall Study|Adverse Event|0|||
25317605|NCT00812331|50633199|FG003|Overall Study|Adverse Event|0|||
25317606|NCT00812331|50633200|FG004|Overall Study|Adverse Event|0|||
25317607|NCT00812253|50633210|FG000|Overall Study|Withdrawal by Subject|3|||
25317608|NCT00812253|50633211|FG001|Overall Study|Withdrawal by Subject|2|||
25317609|NCT00812253|50633210|FG000|Overall Study|Protocol Violation|1|||
25317610|NCT00812253|50633211|FG001|Overall Study|Protocol Violation|1|||
25317611|NCT00812253|50633210|FG000|Overall Study|Lost to Follow-up|2|||
25317612|NCT00812253|50633211|FG001|Overall Study|Lost to Follow-up|0|||
25317613|NCT00616759|50633219|FG000|Overall Study|Physician Decision|2|||
25317614|NCT00616759|50633220|FG001|Overall Study|Physician Decision|0|||
25317615|NCT00616759|50633219|FG000|Overall Study|Withdrawal by Subject|1|||
25317616|NCT00616759|50633220|FG001|Overall Study|Withdrawal by Subject|2|||
25317617|NCT00812097|50633230|FG000|Overall Study|Death|3|||
25317618|NCT00812097|50633231|FG001|Overall Study|Death|10|||
25317619|NCT00812097|50633232|FG002|Overall Study|Death|3|||
25317620|NCT00812097|50633233|FG003|Overall Study|Death|3|||
25317621|NCT00812097|50633230|FG000|Overall Study|Withdrawal by Subject|14|||
25317622|NCT00812097|50633231|FG001|Overall Study|Withdrawal by Subject|12|||
25317623|NCT00812097|50633232|FG002|Overall Study|Withdrawal by Subject|8|||
25317624|NCT00812097|50633233|FG003|Overall Study|Withdrawal by Subject|2|||
25317625|NCT00812097|50633230|FG000|Overall Study|Lost to Follow-up|90|||
25317626|NCT00812097|50633231|FG001|Overall Study|Lost to Follow-up|14|||
25317627|NCT00812097|50633232|FG002|Overall Study|Lost to Follow-up|17|||
25317628|NCT00812097|50633233|FG003|Overall Study|Lost to Follow-up|5|||
25317629|NCT00812097|50633230|FG000|Overall Study|Explantation of study device(s)|27|||
25317630|NCT00812097|50633231|FG001|Overall Study|Explantation of study device(s)|29|||
25317631|NCT00812097|50633232|FG002|Overall Study|Explantation of study device(s)|14|||
25317632|NCT00812097|50633233|FG003|Overall Study|Explantation of study device(s)|20|||
25317633|NCT00812097|50633230|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
25317634|NCT00812097|50633231|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
25317635|NCT00812097|50633232|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
25317636|NCT00812097|50633233|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
24976494|NCT00031460|50065393|FG000|Overall Study|Confirmed unevaluable|0|||
25221095|NCT01716234|50499620|FG002|Overall Study|Did not meet protocol eligibility|1|||
25221096|NCT01716234|50499621|FG003|Overall Study|Did not meet protocol eligibility|0|||
25221097|NCT01716234|50499622|FG004|Overall Study|Did not meet protocol eligibility|0|||
25221098|NCT01716234|50499623|FG005|Overall Study|Did not meet protocol eligibility|4|||
25221099|NCT01716234|50499624|FG006|Overall Study|Did not meet protocol eligibility|0|||
25317637|NCT00811941|50633245|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
25317638|NCT00811941|50633246|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
25317639|NCT00811941|50633245|FG000|All Treated Patients|Adverse Event|2|||
25317640|NCT00811941|50633246|FG001|All Treated Patients|Adverse Event|43|||
25317641|NCT00811941|50633245|FG000|All Treated Patients|Lack of Efficacy|2|||
25317642|NCT00811941|50633246|FG001|All Treated Patients|Lack of Efficacy|3|||
25317643|NCT00811941|50633245|FG000|All Treated Patients|Non-compliance|1|||
25317644|NCT00811941|50633246|FG001|All Treated Patients|Non-compliance|8|||
25317645|NCT00811941|50633245|FG000|All Treated Patients|Protocol Violation|5|||
25317646|NCT00811941|50633246|FG001|All Treated Patients|Protocol Violation|17|||
25317647|NCT00811941|50633245|FG000|All Treated Patients|Withdrawal by Subject|35|||
25317648|NCT00811941|50633246|FG001|All Treated Patients|Withdrawal by Subject|94|||
25317649|NCT00811941|50633245|FG000|All Treated Patients|Lost to Follow-up|3|||
25317650|NCT00811941|50633246|FG001|All Treated Patients|Lost to Follow-up|12|||
25317651|NCT00811941|50633245|FG000|All Treated Patients|Other Reason|4|||
25317652|NCT00811941|50633246|FG001|All Treated Patients|Other Reason|14|||
25317653|NCT00811473|50633254|FG000|Overall Study|Adverse Event|3|||
25317654|NCT00811473|50633255|FG001|Overall Study|Adverse Event|12|||
25317655|NCT00811473|50633254|FG000|Overall Study|Lost to Follow-up|5|||
25317656|NCT00811473|50633255|FG001|Overall Study|Lost to Follow-up|1|||
25317657|NCT00811473|50633254|FG000|Overall Study|Withdrawal by Subject|2|||
25317658|NCT00811473|50633255|FG001|Overall Study|Withdrawal by Subject|4|||
25317659|NCT00811473|50633254|FG000|Overall Study|Severe non-compliance to protocol|2|||
25317660|NCT00811473|50633255|FG001|Overall Study|Severe non-compliance to protocol|4|||
25317661|NCT00811473|50633254|FG000|Overall Study|Lack of therapeutic response|4|||
25317662|NCT00811473|50633255|FG001|Overall Study|Lack of therapeutic response|1|||
25317663|NCT00811473|50633254|FG000|Overall Study|Condition under investigation worsened|1|||
25317664|NCT00811473|50633255|FG001|Overall Study|Condition under investigation worsened|3|||
25317665|NCT00811473|50633254|FG000|Overall Study|Other 2|4|||
25317666|NCT00811473|50633255|FG001|Overall Study|Other 2|1|||
25317667|NCT00811473|50633254|FG000|Overall Study|Incorrect Enrollment|1|||
25317668|NCT00811473|50633255|FG001|Overall Study|Incorrect Enrollment|0|||
25317669|NCT00811473|50633254|FG000|Overall Study|Safety Reasons|1|||
25317670|NCT00811473|50633255|FG001|Overall Study|Safety Reasons|0|||
25317671|NCT00617305|50633268|FG000|Overall Study|Adverse Event|4|||
25317672|NCT00617305|50633269|FG001|Overall Study|Adverse Event|0|||
25317673|NCT00617305|50633270|FG002|Overall Study|Adverse Event|0|||
25317674|NCT00617305|50633268|FG000|Overall Study|Death|1|||
25317675|NCT00617305|50633269|FG001|Overall Study|Death|0|||
25317676|NCT00617305|50633270|FG002|Overall Study|Death|0|||
25317677|NCT00617305|50633268|FG000|Overall Study|Physician Decision|1|||
25317678|NCT00617305|50633269|FG001|Overall Study|Physician Decision|0|||
25317679|NCT00617305|50633270|FG002|Overall Study|Physician Decision|0|||
25317680|NCT00617305|50633268|FG000|Overall Study|Protocol Violation|1|||
25317681|NCT00617305|50633269|FG001|Overall Study|Protocol Violation|0|||
25317682|NCT00617305|50633270|FG002|Overall Study|Protocol Violation|1|||
25317683|NCT00617305|50633268|FG000|Overall Study|Withdrawal by Subject|1|||
25317684|NCT00617305|50633269|FG001|Overall Study|Withdrawal by Subject|0|||
25317685|NCT00617305|50633270|FG002|Overall Study|Withdrawal by Subject|0|||
25317686|NCT00811395|50633287|FG000|Extension Treatment|Adverse Event|1|||
25317687|NCT00811395|50633288|FG001|Extension Treatment|Adverse Event|2|||
25317688|NCT00811395|50633289|FG002|Extension Treatment|Adverse Event|2|||
25317689|NCT00811395|50633290|FG003|Extension Treatment|Adverse Event|2|||
25317690|NCT00811395|50633291|FG004|Extension Treatment|Adverse Event|0|||
25317691|NCT00811395|50633292|FG005|Extension Treatment|Adverse Event|1|||
25317692|NCT00811395|50633287|FG000|Extension Treatment|Progressive disease|1|||
25221100|NCT01716234|50499618|FG000|Overall Study|Adverse Event|7|||
25317693|NCT00811395|50633288|FG001|Extension Treatment|Progressive disease|1|||
25317694|NCT00811395|50633289|FG002|Extension Treatment|Progressive disease|0|||
25317695|NCT00811395|50633290|FG003|Extension Treatment|Progressive disease|0|||
25317696|NCT00811395|50633291|FG004|Extension Treatment|Progressive disease|0|||
25317697|NCT00811395|50633292|FG005|Extension Treatment|Progressive disease|0|||
25317698|NCT00811395|50633287|FG000|Extension Treatment|Participant did not wish to continue|0|||
25317699|NCT00811395|50633288|FG001|Extension Treatment|Participant did not wish to continue|3|||
25317700|NCT00811395|50633289|FG002|Extension Treatment|Participant did not wish to continue|0|||
25317701|NCT00811395|50633290|FG003|Extension Treatment|Participant did not wish to continue|1|||
25317702|NCT00811395|50633291|FG004|Extension Treatment|Participant did not wish to continue|0|||
25317703|NCT00811395|50633292|FG005|Extension Treatment|Participant did not wish to continue|1|||
25317704|NCT00811395|50633287|FG000|Extension Treatment|Other than above|0|||
25317705|NCT00811395|50633288|FG001|Extension Treatment|Other than above|0|||
25317706|NCT00811395|50633289|FG002|Extension Treatment|Other than above|1|||
25317707|NCT00811395|50633290|FG003|Extension Treatment|Other than above|0|||
25317708|NCT00811395|50633291|FG004|Extension Treatment|Other than above|0|||
25317709|NCT00811395|50633292|FG005|Extension Treatment|Other than above|0|||
25317710|NCT00955409|50633319|FG000|Overall Study|Lack of Efficacy|1|||
25317711|NCT00955409|50633320|FG001|Overall Study|Lack of Efficacy|0|||
25317712|NCT00955409|50633321|FG002|Overall Study|Lack of Efficacy|0|||
25317713|NCT00955409|50633322|FG003|Overall Study|Lack of Efficacy|0|||
25317714|NCT00955409|50633323|FG004|Overall Study|Lack of Efficacy|0|||
25317715|NCT00955409|50633324|FG005|Overall Study|Lack of Efficacy|0|||
25317716|NCT00955409|50633325|FG006|Overall Study|Lack of Efficacy|0|||
24976495|NCT00031460|50065394|FG001|Overall Study|Confirmed unevaluable|1|||
24976496|NCT03540160|50065400|FG000|Overall Study|Protocol Violation|1|||
24976497|NCT03540160|50065400|FG000|Overall Study|Physician Decision|8|||
24976498|NCT03540160|50065400|FG000|Overall Study|Lack of Efficacy|60|||
24976499|NCT03540160|50065400|FG000|Overall Study|Pregnancy|1|||
24976500|NCT03540160|50065400|FG000|Overall Study|Adverse Event|20|||
24976501|NCT03540160|50065400|FG000|Overall Study|Withdrawal by Subject|68|||
24976502|NCT03540160|50065400|FG000|Overall Study|COVID-19|2|||
24976503|NCT03540160|50065400|FG000|Overall Study|Study Closure|10|||
24976504|NCT03540160|50065400|FG000|Overall Study|Lost to Follow-up|18|||
24976505|NCT03540160|50065400|FG000|Overall Study|Sponsor decision|191|||
24976506|NCT03459196|50065404|FG000|Overall Study|Subject didn't receive study catheter|2|||
24976507|NCT03459040|50065408|FG000|Overall Study|Death|8|||
25221101|NCT01716234|50499619|FG001|Overall Study|Adverse Event|10|||
25221102|NCT01716234|50499620|FG002|Overall Study|Adverse Event|2|||
25221103|NCT01716234|50499621|FG003|Overall Study|Adverse Event|8|||
25221104|NCT01716234|50499622|FG004|Overall Study|Adverse Event|3|||
25221105|NCT01716234|50499623|FG005|Overall Study|Adverse Event|6|||
25221106|NCT01716234|50499624|FG006|Overall Study|Adverse Event|0|||
25221107|NCT01716234|50499618|FG000|Overall Study|Withdrawal by Subject|3|||
25221108|NCT01716234|50499619|FG001|Overall Study|Withdrawal by Subject|0|||
25221109|NCT01716234|50499620|FG002|Overall Study|Withdrawal by Subject|2|||
25221110|NCT01716234|50499621|FG003|Overall Study|Withdrawal by Subject|2|||
25221111|NCT01716234|50499622|FG004|Overall Study|Withdrawal by Subject|1|||
25221112|NCT01716234|50499623|FG005|Overall Study|Withdrawal by Subject|3|||
25221113|NCT01716234|50499624|FG006|Overall Study|Withdrawal by Subject|0|||
25221114|NCT01716156|50499643|FG000|Overall Study|Protocol Violation|1|||
25221115|NCT01716156|50499644|FG001|Overall Study|Protocol Violation|0|||
25221116|NCT01716156|50499645|FG002|Overall Study|Protocol Violation|0|||
25221117|NCT01716156|50499643|FG000|Overall Study|Withdrawal by Subject|0|||
25221118|NCT01716156|50499644|FG001|Overall Study|Withdrawal by Subject|1|||
25221119|NCT01716156|50499645|FG002|Overall Study|Withdrawal by Subject|2|||
25221120|NCT01716156|50499643|FG000|Overall Study|Lost to Follow-up|1|||
25221121|NCT01716156|50499644|FG001|Overall Study|Lost to Follow-up|0|||
25221122|NCT01716156|50499645|FG002|Overall Study|Lost to Follow-up|0|||
25317717|NCT00955409|50633326|FG007|Overall Study|Lack of Efficacy|0|||
24976508|NCT03459040|50065408|FG000|Overall Study|Withdrawal by Subject|1|||
24976509|NCT03457636|50065413|FG000|Overall Study|Lost to Follow-up|2|||
24976510|NCT03481816|50065419|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
25221123|NCT01739790|50499659|FG000|Overall Study|Early Trial Termination|2|||
25317718|NCT00955409|50633327|FG008|Overall Study|Lack of Efficacy|0|||
25317719|NCT00955409|50633328|FG009|Overall Study|Lack of Efficacy|0|||
25317720|NCT00955409|50633319|FG000|Overall Study|Withdrawal by Subject|1|||
25317721|NCT00955409|50633320|FG001|Overall Study|Withdrawal by Subject|0|||
25317722|NCT00955409|50633321|FG002|Overall Study|Withdrawal by Subject|5|||
25317723|NCT00955409|50633322|FG003|Overall Study|Withdrawal by Subject|2|||
25317724|NCT00955409|50633323|FG004|Overall Study|Withdrawal by Subject|0|||
25317725|NCT00955409|50633324|FG005|Overall Study|Withdrawal by Subject|0|||
25317726|NCT00955409|50633325|FG006|Overall Study|Withdrawal by Subject|2|||
25317727|NCT00955409|50633326|FG007|Overall Study|Withdrawal by Subject|0|||
25317728|NCT00955409|50633327|FG008|Overall Study|Withdrawal by Subject|1|||
25317729|NCT00955409|50633328|FG009|Overall Study|Withdrawal by Subject|0|||
25317730|NCT00955409|50633319|FG000|Overall Study|Caregiver Request|2|||
25317731|NCT00955409|50633320|FG001|Overall Study|Caregiver Request|0|||
25317732|NCT00955409|50633321|FG002|Overall Study|Caregiver Request|6|||
25317733|NCT00955409|50633322|FG003|Overall Study|Caregiver Request|5|||
25317734|NCT00955409|50633323|FG004|Overall Study|Caregiver Request|0|||
25317735|NCT00955409|50633324|FG005|Overall Study|Caregiver Request|2|||
25317736|NCT00955409|50633325|FG006|Overall Study|Caregiver Request|3|||
25317737|NCT00955409|50633326|FG007|Overall Study|Caregiver Request|1|||
25317738|NCT00955409|50633327|FG008|Overall Study|Caregiver Request|3|||
25317739|NCT00955409|50633328|FG009|Overall Study|Caregiver Request|0|||
25317740|NCT00955409|50633319|FG000|Overall Study|Investigator Request|0|||
25317741|NCT00955409|50633320|FG001|Overall Study|Investigator Request|0|||
25317742|NCT00955409|50633321|FG002|Overall Study|Investigator Request|1|||
25317743|NCT00955409|50633322|FG003|Overall Study|Investigator Request|0|||
25317744|NCT00955409|50633323|FG004|Overall Study|Investigator Request|0|||
25317745|NCT00955409|50633324|FG005|Overall Study|Investigator Request|0|||
25317746|NCT00955409|50633325|FG006|Overall Study|Investigator Request|0|||
25317747|NCT00955409|50633326|FG007|Overall Study|Investigator Request|0|||
25317748|NCT00955409|50633327|FG008|Overall Study|Investigator Request|0|||
25317749|NCT00955409|50633328|FG009|Overall Study|Investigator Request|0|||
25317750|NCT00955409|50633319|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
25317751|NCT00955409|50633320|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
25317752|NCT00955409|50633321|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
25317753|NCT00955409|50633322|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
25317754|NCT00955409|50633323|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
25317755|NCT00955409|50633324|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
25317756|NCT00955409|50633325|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
25317757|NCT00955409|50633326|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
25317758|NCT00955409|50633327|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
25317759|NCT00955409|50633328|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
25317760|NCT00955409|50633319|FG000|Overall Study|Lost to Follow-up|0|||
25317761|NCT00955409|50633320|FG001|Overall Study|Lost to Follow-up|0|||
25317762|NCT00955409|50633321|FG002|Overall Study|Lost to Follow-up|1|||
25317763|NCT00955409|50633322|FG003|Overall Study|Lost to Follow-up|0|||
25317764|NCT00955409|50633323|FG004|Overall Study|Lost to Follow-up|0|||
25317765|NCT00955409|50633324|FG005|Overall Study|Lost to Follow-up|0|||
25317766|NCT00955409|50633325|FG006|Overall Study|Lost to Follow-up|1|||
25317767|NCT00955409|50633326|FG007|Overall Study|Lost to Follow-up|0|||
25317768|NCT00955409|50633327|FG008|Overall Study|Lost to Follow-up|0|||
25317769|NCT00955409|50633328|FG009|Overall Study|Lost to Follow-up|0|||
25317770|NCT00955409|50633319|FG000|Overall Study|Failed to Return|2|||
25317771|NCT00955409|50633320|FG001|Overall Study|Failed to Return|0|||
25317772|NCT00955409|50633321|FG002|Overall Study|Failed to Return|0|||
25317773|NCT00955409|50633322|FG003|Overall Study|Failed to Return|0|||
25317774|NCT00955409|50633323|FG004|Overall Study|Failed to Return|0|||
25317775|NCT00955409|50633324|FG005|Overall Study|Failed to Return|0|||
25317776|NCT00955409|50633325|FG006|Overall Study|Failed to Return|0|||
25317777|NCT00955409|50633326|FG007|Overall Study|Failed to Return|2|||
25317778|NCT00955409|50633327|FG008|Overall Study|Failed to Return|0|||
25317779|NCT00955409|50633328|FG009|Overall Study|Failed to Return|0|||
25317780|NCT00955409|50633319|FG000|Overall Study|Adverse Event (AE)|2|||
25317781|NCT00955409|50633320|FG001|Overall Study|Adverse Event (AE)|0|||
25317782|NCT00955409|50633321|FG002|Overall Study|Adverse Event (AE)|0|||
25317783|NCT00955409|50633322|FG003|Overall Study|Adverse Event (AE)|0|||
25317784|NCT00955409|50633323|FG004|Overall Study|Adverse Event (AE)|0|||
24976511|NCT03481816|50065420|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
24976512|NCT03481816|50065419|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
25317785|NCT00955409|50633324|FG005|Overall Study|Adverse Event (AE)|1|||
25317786|NCT00955409|50633325|FG006|Overall Study|Adverse Event (AE)|2|||
25317787|NCT00955409|50633326|FG007|Overall Study|Adverse Event (AE)|0|||
25317788|NCT00955409|50633327|FG008|Overall Study|Adverse Event (AE)|2|||
25317789|NCT00955409|50633328|FG009|Overall Study|Adverse Event (AE)|0|||
25317790|NCT00955409|50633319|FG000|Overall Study|Reason not Specified|2|||
25317791|NCT00955409|50633320|FG001|Overall Study|Reason not Specified|1|||
25317792|NCT00955409|50633321|FG002|Overall Study|Reason not Specified|13|||
25317793|NCT00955409|50633322|FG003|Overall Study|Reason not Specified|1|||
25317794|NCT00955409|50633323|FG004|Overall Study|Reason not Specified|2|||
25317795|NCT00955409|50633324|FG005|Overall Study|Reason not Specified|0|||
25077412|NCT02936323|50185229|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
25077413|NCT02936323|50185220|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
25077414|NCT02936323|50185221|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
25077415|NCT02936323|50185222|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
25077416|NCT02936323|50185223|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
25077417|NCT02936323|50185224|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
25077418|NCT02936323|50185225|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
25077419|NCT02936323|50185226|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
25077420|NCT02936323|50185227|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
25077421|NCT02936323|50185228|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
25077422|NCT02936323|50185229|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
25077423|NCT02936323|50185220|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
25077424|NCT02936323|50185221|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
25077425|NCT02936323|50185222|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
25077426|NCT02936323|50185223|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
25077427|NCT02936323|50185224|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
25077428|NCT02936323|50185225|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
25077429|NCT02936323|50185226|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
25077430|NCT02936323|50185227|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
25077431|NCT02936323|50185228|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
25077432|NCT02936323|50185229|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
25077433|NCT02936323|50185220|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
25077434|NCT02936323|50185221|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
25077435|NCT02936323|50185222|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
25077436|NCT02936323|50185223|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
25077437|NCT02936323|50185224|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
25077438|NCT02936323|50185225|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
25077439|NCT02936323|50185226|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
25077440|NCT02936323|50185227|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
25077441|NCT02936323|50185228|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
25077442|NCT02936323|50185229|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
25077443|NCT02936323|50185220|FG000|Phase 2a Dose Expansion|Death|0|||
25077444|NCT02936323|50185221|FG001|Phase 2a Dose Expansion|Death|0|||
25077445|NCT02936323|50185222|FG002|Phase 2a Dose Expansion|Death|0|||
25077446|NCT02936323|50185223|FG003|Phase 2a Dose Expansion|Death|0|||
25077447|NCT02936323|50185224|FG004|Phase 2a Dose Expansion|Death|0|||
25077448|NCT02936323|50185225|FG005|Phase 2a Dose Expansion|Death|0|||
25221124|NCT01739790|50499660|FG001|Overall Study|Early Trial Termination|4|||
25221125|NCT01696032|50499670|FG000|Overall Study|Withdrawal by Subject|0|||
25221126|NCT01696032|50499671|FG001|Overall Study|Withdrawal by Subject|0|||
25221127|NCT01696032|50499672|FG002|Overall Study|Withdrawal by Subject|1|||
25221128|NCT01696032|50499673|FG003|Overall Study|Withdrawal by Subject|2|||
25221129|NCT01696032|50499670|FG000|Overall Study|Death|14|||
25221130|NCT01696032|50499671|FG001|Overall Study|Death|4|||
25221131|NCT01696032|50499672|FG002|Overall Study|Death|43|||
25221132|NCT01696032|50499673|FG003|Overall Study|Death|18|||
25221133|NCT01696032|50499670|FG000|Overall Study|Lost to Follow-up|0|||
25221134|NCT01696032|50499671|FG001|Overall Study|Lost to Follow-up|1|||
25221135|NCT01696032|50499672|FG002|Overall Study|Lost to Follow-up|0|||
25221136|NCT01696032|50499673|FG003|Overall Study|Lost to Follow-up|0|||
25317796|NCT00955409|50633325|FG006|Overall Study|Reason not Specified|16|||
25077449|NCT02936323|50185226|FG006|Phase 2a Dose Expansion|Death|0|||
25077450|NCT02936323|50185227|FG007|Phase 2a Dose Expansion|Death|4|||
25077451|NCT02936323|50185228|FG008|Phase 2a Dose Expansion|Death|8|||
25221137|NCT01696032|50499670|FG000|Overall Study|Database lock|0|||
25221138|NCT01696032|50499671|FG001|Overall Study|Database lock|1|||
25221139|NCT01696032|50499672|FG002|Overall Study|Database lock|7|||
25317797|NCT00955409|50633326|FG007|Overall Study|Reason not Specified|0|||
25077452|NCT02936323|50185229|FG009|Phase 2a Dose Expansion|Death|10|||
25077453|NCT02243176|50185263|FG000|Overall Study|Other reason|1|||
25077454|NCT02243176|50185264|FG001|Overall Study|Other reason|2|||
25221140|NCT01696032|50499673|FG003|Overall Study|Database lock|2|||
25317798|NCT00955409|50633327|FG008|Overall Study|Reason not Specified|8|||
25317799|NCT00955409|50633328|FG009|Overall Study|Reason not Specified|1|||
25317800|NCT00615901|50633354|FG000|Overall Study|Withdrawal by Subject|2|||
25317801|NCT00615901|50633354|FG000|Overall Study|Adverse Event|7|||
25317802|NCT00616603|50633366|FG000|Overall Study|Physician Decision|2|||
25317803|NCT00616603|50633367|FG001|Overall Study|Physician Decision|0|||
25317804|NCT00616603|50633368|FG002|Overall Study|Physician Decision|2|||
25317805|NCT00810693|50633379|FG000|Treatment Period|Adverse Event|8|||
25317806|NCT00810693|50633380|FG001|Treatment Period|Adverse Event|1|||
25317807|NCT00810693|50633381|FG002|Treatment Period|Adverse Event|7|||
25317808|NCT00810693|50633379|FG000|Treatment Period|Death|0|||
25317809|NCT00810693|50633380|FG001|Treatment Period|Death|1|||
25317810|NCT00810693|50633381|FG002|Treatment Period|Death|2|||
25317811|NCT00810693|50633379|FG000|Treatment Period|Lack of Efficacy|0|||
25317812|NCT00810693|50633380|FG001|Treatment Period|Lack of Efficacy|0|||
25317813|NCT00810693|50633381|FG002|Treatment Period|Lack of Efficacy|1|||
25317814|NCT00810693|50633379|FG000|Treatment Period|Lost to Follow-up|1|||
25317815|NCT00810693|50633380|FG001|Treatment Period|Lost to Follow-up|0|||
25317816|NCT00810693|50633381|FG002|Treatment Period|Lost to Follow-up|0|||
25317817|NCT00810693|50633379|FG000|Treatment Period|Non-compliance|1|||
25317818|NCT00810693|50633380|FG001|Treatment Period|Non-compliance|0|||
25317819|NCT00810693|50633381|FG002|Treatment Period|Non-compliance|0|||
25317820|NCT00810693|50633379|FG000|Treatment Period|Protocol Violation|1|||
25317821|NCT00810693|50633380|FG001|Treatment Period|Protocol Violation|2|||
25317822|NCT00810693|50633381|FG002|Treatment Period|Protocol Violation|2|||
25317823|NCT00810693|50633379|FG000|Treatment Period|Withdrawal by Subject|6|||
25317824|NCT00810693|50633380|FG001|Treatment Period|Withdrawal by Subject|2|||
25317825|NCT00810693|50633381|FG002|Treatment Period|Withdrawal by Subject|3|||
25317826|NCT00810693|50633379|FG000|Treatment Period|Not treated|0|||
25317827|NCT00810693|50633380|FG001|Treatment Period|Not treated|1|||
25317828|NCT00810693|50633381|FG002|Treatment Period|Not treated|1|||
25317829|NCT00810693|50633379|FG000|Follow-up Period (FUP)|Adverse Event|3|||
25317830|NCT00810693|50633380|FG001|Follow-up Period (FUP)|Adverse Event|1|||
25317831|NCT00810693|50633381|FG002|Follow-up Period (FUP)|Adverse Event|1|||
25317832|NCT00810693|50633379|FG000|Follow-up Period (FUP)|Death|2|||
25317833|NCT00810693|50633380|FG001|Follow-up Period (FUP)|Death|0|||
25317834|NCT00810693|50633381|FG002|Follow-up Period (FUP)|Death|1|||
24976513|NCT03481816|50065420|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
25317835|NCT00810693|50633379|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
25317836|NCT00810693|50633380|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
25317837|NCT00810693|50633381|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
25317838|NCT00810693|50633379|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
24976514|NCT03481816|50065419|FG000|Dose Expansion|Withdrawal by Subject|0|||
25317839|NCT00810693|50633380|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
25317840|NCT00810693|50633381|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
25317841|NCT00810693|50633379|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
25317842|NCT00810693|50633380|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
25317843|NCT00810693|50633381|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
25317844|NCT00573313|50633393|FG000|Overall Study|Protocol Violation|5|||
25317845|NCT00573313|50633394|FG001|Overall Study|Protocol Violation|0|||
25317846|NCT00573313|50633395|FG002|Overall Study|Protocol Violation|6|||
25317847|NCT00573313|50633396|FG003|Overall Study|Protocol Violation|0|||
25317848|NCT00953615|50633422|FG000|Overall Study|Adverse Event|1|||
25317849|NCT00810615|50633428|FG000|Overall Study|Withdrawal by Subject|1|||
25317850|NCT00810615|50633429|FG001|Overall Study|Withdrawal by Subject|1|||
25317851|NCT00573391|50633449|FG000|Overall Study|study stopped|2|||
25317852|NCT00573391|50633450|FG001|Overall Study|study stopped|2|||
24976515|NCT03481816|50065420|FG001|Dose Expansion|Withdrawal by Subject|2|||
25317853|NCT00573391|50633449|FG000|Overall Study|Death|1|||
25317854|NCT00573391|50633450|FG001|Overall Study|Death|0|||
25317855|NCT00590967|50633458|FG000|Overall Study|Withdrawal by Subject|1|||
25317856|NCT00590967|50633459|FG001|Overall Study|Withdrawal by Subject|1|||
25317857|NCT00590967|50633458|FG000|Overall Study|Ineligible|1|||
25317858|NCT00590967|50633459|FG001|Overall Study|Ineligible|0|||
25317859|NCT00590967|50633458|FG000|Overall Study|Poor performance status|0|||
25317860|NCT00590967|50633459|FG001|Overall Study|Poor performance status|1|||
24976516|NCT03481816|50065419|FG000|Dose Expansion|Physician Decision|0|||
24976517|NCT03481816|50065420|FG001|Dose Expansion|Physician Decision|5|||
25317861|NCT00590967|50633458|FG000|Overall Study|Non-compliant|0|||
25317862|NCT00590967|50633459|FG001|Overall Study|Non-compliant|2|||
25317863|NCT00590967|50633458|FG000|Overall Study|Did not sign consent form|0|||
25317864|NCT00590967|50633459|FG001|Overall Study|Did not sign consent form|1|||
25317865|NCT00590967|50633458|FG000|Overall Study|Did not receive chemo per protocol|1|||
25317866|NCT00590967|50633459|FG001|Overall Study|Did not receive chemo per protocol|0|||
25317867|NCT00590577|50633469|FG000|Overall Study|Lack of Efficacy|31|||
25317868|NCT00590577|50633470|FG001|Overall Study|Lack of Efficacy|28|||
25317869|NCT00590577|50633471|FG002|Overall Study|Lack of Efficacy|23|||
25317870|NCT00590577|50633472|FG003|Overall Study|Lack of Efficacy|45|||
25317871|NCT00590577|50633469|FG000|Overall Study|Withdrawal by Subject|23|||
25317872|NCT00590577|50633470|FG001|Overall Study|Withdrawal by Subject|28|||
25317873|NCT00590577|50633471|FG002|Overall Study|Withdrawal by Subject|30|||
25317874|NCT00590577|50633472|FG003|Overall Study|Withdrawal by Subject|26|||
25317875|NCT00590577|50633469|FG000|Overall Study|Adverse Event|10|||
25317876|NCT00590577|50633470|FG001|Overall Study|Adverse Event|10|||
25317877|NCT00590577|50633471|FG002|Overall Study|Adverse Event|13|||
25317878|NCT00590577|50633472|FG003|Overall Study|Adverse Event|11|||
25317879|NCT00590577|50633469|FG000|Overall Study|Lost to Follow-up|12|||
25317880|NCT00590577|50633470|FG001|Overall Study|Lost to Follow-up|6|||
25317881|NCT00590577|50633471|FG002|Overall Study|Lost to Follow-up|6|||
25317882|NCT00590577|50633472|FG003|Overall Study|Lost to Follow-up|9|||
25317883|NCT00590577|50633469|FG000|Overall Study|Pregnancy|0|||
25317884|NCT00590577|50633470|FG001|Overall Study|Pregnancy|1|||
25317885|NCT00590577|50633471|FG002|Overall Study|Pregnancy|0|||
25317886|NCT00590577|50633472|FG003|Overall Study|Pregnancy|0|||
25317887|NCT00590577|50633469|FG000|Overall Study|Various reasons|1|||
25317888|NCT00590577|50633470|FG001|Overall Study|Various reasons|3|||
25317889|NCT00590577|50633471|FG002|Overall Study|Various reasons|1|||
25317890|NCT00590577|50633472|FG003|Overall Study|Various reasons|2|||
25317891|NCT00614575|50633482|FG000|Overall Study|Adverse Event|106|||
25317892|NCT00614575|50633482|FG000|Overall Study|Lost to Follow-up|55|||
25317893|NCT00614575|50633482|FG000|Overall Study|Lack of Efficacy|14|||
25317894|NCT00614575|50633482|FG000|Overall Study|Withdrawal by Subject|6|||
25317895|NCT00614575|50633482|FG000|Overall Study|Death|3|||
25317896|NCT00614575|50633482|FG000|Overall Study|Physician Decision|2|||
25317897|NCT00614575|50633482|FG000|Overall Study|No data were collected.|18|||
25317898|NCT00614575|50633482|FG000|Overall Study|Irregularly enrolled patients|23|||
25317899|NCT00614575|50633482|FG000|Overall Study|No treatment|1|||
25317900|NCT00805935|50633490|FG000|Overall Study|Stimulation Failure|1|||
25317901|NCT00805935|50633491|FG001|Overall Study|Stimulation Failure|5|||
25317902|NCT00805935|50633492|FG002|Overall Study|Stimulation Failure|2|||
25317903|NCT00805935|50633493|FG003|Overall Study|Stimulation Failure|2|||
25317904|NCT00805935|50633490|FG000|Overall Study|Cycle cancelled|0|||
25317905|NCT00805935|50633491|FG001|Overall Study|Cycle cancelled|0|||
25317906|NCT00805935|50633492|FG002|Overall Study|Cycle cancelled|2|||
25317907|NCT00805935|50633493|FG003|Overall Study|Cycle cancelled|0|||
25317908|NCT00805935|50633490|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
25317909|NCT00805935|50633491|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
25317910|NCT00805935|50633492|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
25317911|NCT00805935|50633493|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
25317912|NCT00805935|50633490|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
25317913|NCT00805935|50633491|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
25317914|NCT00805935|50633492|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
25317915|NCT00805935|50633493|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
25317916|NCT00805935|50633490|FG000|Overall Study|Lost to Follow-up|1|||
25317917|NCT00805935|50633491|FG001|Overall Study|Lost to Follow-up|0|||
25317918|NCT00805935|50633492|FG002|Overall Study|Lost to Follow-up|0|||
25317919|NCT00805935|50633493|FG003|Overall Study|Lost to Follow-up|0|||
25317920|NCT00805935|50633490|FG000|Overall Study|No positive serum pregnancy|8|||
25317921|NCT00805935|50633491|FG001|Overall Study|No positive serum pregnancy|7|||
25317922|NCT00805935|50633492|FG002|Overall Study|No positive serum pregnancy|6|||
25317923|NCT00805935|50633493|FG003|Overall Study|No positive serum pregnancy|5|||
25317924|NCT00805935|50633490|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
25317925|NCT00805935|50633491|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
25317926|NCT00805935|50633492|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
25317927|NCT00805935|50633493|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
25317928|NCT00805935|50633490|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
25317929|NCT00805935|50633491|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
25317930|NCT00805935|50633492|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
25317931|NCT00805935|50633493|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
25317932|NCT00805935|50633490|FG000|Overall Study|Biochemical pregnancy|0|||
25317933|NCT00805935|50633491|FG001|Overall Study|Biochemical pregnancy|1|||
25317934|NCT00805935|50633492|FG002|Overall Study|Biochemical pregnancy|0|||
25317935|NCT00805935|50633493|FG003|Overall Study|Biochemical pregnancy|0|||
25317936|NCT00805935|50633490|FG000|Overall Study|Chemical pregnancy|0|||
25317937|NCT00805935|50633491|FG001|Overall Study|Chemical pregnancy|5|||
25317938|NCT00805935|50633492|FG002|Overall Study|Chemical pregnancy|3|||
25317939|NCT00805935|50633493|FG003|Overall Study|Chemical pregnancy|2|||
25317940|NCT00805935|50633490|FG000|Overall Study|Ectopic pregnancy|0|||
25317941|NCT00805935|50633491|FG001|Overall Study|Ectopic pregnancy|0|||
25317942|NCT00805935|50633492|FG002|Overall Study|Ectopic pregnancy|1|||
25317943|NCT00805935|50633493|FG003|Overall Study|Ectopic pregnancy|0|||
25317944|NCT00805935|50633490|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
25317945|NCT00805935|50633491|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
25317946|NCT00805935|50633492|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
25317947|NCT00805935|50633493|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
25317948|NCT00805545|50633507|FG000|Overall Study|Protocol Violation|3|||
25317949|NCT00805545|50633508|FG001|Overall Study|Protocol Violation|2|||
25317950|NCT00805545|50633507|FG000|Overall Study|Protocol Violation|3|||
25317951|NCT00805545|50633508|FG001|Overall Study|Protocol Violation|1|||
25317952|NCT00590031|50633540|FG000|Overall Study|Adverse Event|3|||
25317953|NCT00590031|50633540|FG000|Overall Study|Withdrawal by Subject|1|||
25317954|NCT00590031|50633540|FG000|Overall Study|Metastatic Disease|1|||
25317955|NCT00590031|50633540|FG000|Overall Study|Admin Hold|1|||
25317956|NCT00615199|50633548|FG000|Overall Study|Adverse Event|3|||
25317957|NCT00615199|50633549|FG001|Overall Study|Adverse Event|1|||
25317958|NCT00615199|50633550|FG002|Overall Study|Adverse Event|1|||
25317959|NCT00615199|50633551|FG003|Overall Study|Adverse Event|0|||
25317960|NCT00615199|50633548|FG000|Overall Study|Lack of Efficacy|2|||
25317961|NCT00615199|50633549|FG001|Overall Study|Lack of Efficacy|0|||
25317962|NCT00615199|50633550|FG002|Overall Study|Lack of Efficacy|0|||
25317963|NCT00615199|50633551|FG003|Overall Study|Lack of Efficacy|1|||
25317964|NCT00615199|50633548|FG000|Overall Study|Lost to Follow-up|1|||
25317965|NCT00615199|50633549|FG001|Overall Study|Lost to Follow-up|0|||
25317966|NCT00615199|50633550|FG002|Overall Study|Lost to Follow-up|0|||
25317967|NCT00615199|50633551|FG003|Overall Study|Lost to Follow-up|0|||
25317968|NCT00615199|50633548|FG000|Overall Study|Other|0|||
25317969|NCT00615199|50633549|FG001|Overall Study|Other|0|||
25317970|NCT00615199|50633550|FG002|Overall Study|Other|0|||
25317971|NCT00615199|50633551|FG003|Overall Study|Other|1|||
25317972|NCT00615199|50633548|FG000|Overall Study|Withdrawal by Subject|2|||
25317973|NCT00615199|50633549|FG001|Overall Study|Withdrawal by Subject|1|||
25317974|NCT00615199|50633550|FG002|Overall Study|Withdrawal by Subject|0|||
25317975|NCT00615199|50633551|FG003|Overall Study|Withdrawal by Subject|0|||
25317976|NCT00613951|50633564|FG000|Overall Study|Adverse Event|1|||
25317977|NCT00613951|50633565|FG001|Overall Study|Adverse Event|0|||
25317978|NCT00613951|50633566|FG002|Overall Study|Adverse Event|1|||
25317979|NCT00613951|50633564|FG000|Overall Study|Lack of Efficacy|0|||
25317980|NCT00613951|50633565|FG001|Overall Study|Lack of Efficacy|1|||
25317981|NCT00613951|50633566|FG002|Overall Study|Lack of Efficacy|1|||
25317982|NCT00613951|50633564|FG000|Overall Study|Protocol Violation|1|||
25317983|NCT00613951|50633565|FG001|Overall Study|Protocol Violation|1|||
25317984|NCT00613951|50633566|FG002|Overall Study|Protocol Violation|1|||
25317985|NCT00613951|50633564|FG000|Overall Study|Unclassified|5|||
25317986|NCT00613951|50633565|FG001|Overall Study|Unclassified|3|||
25317987|NCT00613951|50633566|FG002|Overall Study|Unclassified|2|||
25317988|NCT00805467|50633581|FG000|Overall Study|Lack of Efficacy|0|||
25317989|NCT00805467|50633582|FG001|Overall Study|Lack of Efficacy|8|||
25317990|NCT00805467|50633583|FG002|Overall Study|Lack of Efficacy|13|||
25317991|NCT00805467|50633584|FG003|Overall Study|Lack of Efficacy|86|||
25317992|NCT00805467|50633581|FG000|Overall Study|Lost to Follow-up|0|||
25317993|NCT00805467|50633582|FG001|Overall Study|Lost to Follow-up|1|||
25317994|NCT00805467|50633583|FG002|Overall Study|Lost to Follow-up|7|||
25317995|NCT00805467|50633584|FG003|Overall Study|Lost to Follow-up|21|||
25317996|NCT00805467|50633581|FG000|Overall Study|Withdrawal by Subject|0|||
25317997|NCT00805467|50633582|FG001|Overall Study|Withdrawal by Subject|6|||
25317998|NCT00805467|50633583|FG002|Overall Study|Withdrawal by Subject|45|||
25317999|NCT00805467|50633584|FG003|Overall Study|Withdrawal by Subject|50|||
25318000|NCT00805467|50633581|FG000|Overall Study|Protocol Violation|0|||
25318001|NCT00805467|50633582|FG001|Overall Study|Protocol Violation|3|||
25318002|NCT00805467|50633583|FG002|Overall Study|Protocol Violation|0|||
25318003|NCT00805467|50633584|FG003|Overall Study|Protocol Violation|5|||
25318004|NCT00805467|50633581|FG000|Overall Study|Adverse Event|0|||
25318005|NCT00805467|50633582|FG001|Overall Study|Adverse Event|13|||
25318006|NCT00805467|50633583|FG002|Overall Study|Adverse Event|26|||
25318007|NCT00805467|50633584|FG003|Overall Study|Adverse Event|57|||
25318008|NCT00805467|50633581|FG000|Overall Study|Death|0|||
25318009|NCT00805467|50633582|FG001|Overall Study|Death|2|||
25318010|NCT00805467|50633583|FG002|Overall Study|Death|7|||
25318011|NCT00805467|50633584|FG003|Overall Study|Death|5|||
25318012|NCT00805467|50633581|FG000|Overall Study|Physician Decision|0|||
25318013|NCT00805467|50633582|FG001|Overall Study|Physician Decision|1|||
25318014|NCT00805467|50633583|FG002|Overall Study|Physician Decision|2|||
25318015|NCT00805467|50633584|FG003|Overall Study|Physician Decision|6|||
25318016|NCT00805467|50633581|FG000|Overall Study|Not reported|0|||
25318017|NCT00805467|50633582|FG001|Overall Study|Not reported|0|||
25318018|NCT00805467|50633583|FG002|Overall Study|Not reported|3|||
25318019|NCT00805467|50633584|FG003|Overall Study|Not reported|7|||
25318020|NCT00958841|50633594|FG000|Overall Study|Abnormal laboratory value(s)|1|||
25318021|NCT00958841|50633594|FG000|Overall Study|Abnormal test procedure result(s)|3|||
25318022|NCT00958841|50633594|FG000|Overall Study|Administrative problems|1|||
25318023|NCT00958841|50633594|FG000|Overall Study|Adverse Event|8|||
25318024|NCT00958841|50633594|FG000|Overall Study|New cancer therapy|5|||
25318025|NCT00958841|50633594|FG000|Overall Study|Withdrawal by Subject|1|||
25318026|NCT00958841|50633594|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
25318027|NCT00958841|50633594|FG000|Overall Study|Completed M6/did not enter extension|27|||
25318028|NCT00958841|50633594|FG000|Overall Study|Discontinued prior to M*|28|||
25318029|NCT03927105|50633657|FG000|Overall Study|Death|1|||
25318030|NCT03927105|50633657|FG000|Overall Study|In observation for potential re-treatment|2|||
25318031|NCT03927105|50633657|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
25318032|NCT00613327|50633661|FG000|Overall Study|Adverse Event|38|||
25318033|NCT00613327|50633661|FG000|Overall Study|Lost to Follow-up|8|||
25318034|NCT00613327|50633661|FG000|Overall Study|Withdrawal by Subject|6|||
25318035|NCT00613327|50633661|FG000|Overall Study|Protocol Violation|2|||
25318036|NCT00613327|50633661|FG000|Overall Study|Other|47|||
25318037|NCT00954941|50633667|FG000|Overall Study|Received treatment at home|1|||
25318038|NCT00954941|50633668|FG001|Overall Study|Received treatment at home|0|||
25318039|NCT00954941|50633667|FG000|Overall Study|Withdrawal by Subject|1|||
25318040|NCT00954941|50633668|FG001|Overall Study|Withdrawal by Subject|0|||
25318041|NCT00954941|50633667|FG000|Overall Study|Insurance Denial|2|||
25318042|NCT00954941|50633668|FG001|Overall Study|Insurance Denial|2|||
25318043|NCT00954941|50633667|FG000|Overall Study|Physician Decision|2|||
25318044|NCT00954941|50633668|FG001|Overall Study|Physician Decision|2|||
25318045|NCT00954941|50633667|FG000|Overall Study|Ineligible|2|||
25318046|NCT00954941|50633668|FG001|Overall Study|Ineligible|2|||
25318047|NCT00954941|50633667|FG000|Overall Study|Adverse Event|0|||
25318048|NCT00954941|50633668|FG001|Overall Study|Adverse Event|1|||
25318049|NCT00954707|50633674|FG000|Overall Study|Death|34|||
25318050|NCT00954707|50633674|FG000|Overall Study|Withdrawal by Subject|100|||
25318051|NCT00954707|50633674|FG000|Overall Study|Lost to Follow-up|33|||
25318052|NCT00589797|50633680|FG000|Overall Study|Death|1|||
25318053|NCT00589797|50633681|FG001|Overall Study|Death|0|||
25318054|NCT00589797|50633680|FG000|Overall Study|Lost to Follow-up|12|||
25318055|NCT00589797|50633681|FG001|Overall Study|Lost to Follow-up|9|||
25318056|NCT00589797|50633680|FG000|Overall Study|Physician Decision|8|||
25318057|NCT00589797|50633681|FG001|Overall Study|Physician Decision|3|||
25318058|NCT00589797|50633680|FG000|Overall Study|Withdrawal by Subject|6|||
25318059|NCT00589797|50633681|FG001|Overall Study|Withdrawal by Subject|5|||
25318060|NCT00589797|50633680|FG000|Overall Study|Non-Randomized Training Subjects|46|||
25318061|NCT00589797|50633681|FG001|Overall Study|Non-Randomized Training Subjects|6|||
25318062|NCT00613171|50633687|FG000|Overall Study|Adverse Event|7|||
25318063|NCT00613171|50633687|FG000|Overall Study|Withdrawal by Subject|3|||
25318064|NCT00613171|50633687|FG000|Overall Study|Reason not Specified|4|||
25318065|NCT00896480|50633692|FG000|Overall Study|Disease progression/recurrence|21|||
25318066|NCT00953225|50633701|FG000|Overall Study|Withdrawal by Subject|2|||
25318067|NCT00953225|50633702|FG001|Overall Study|Withdrawal by Subject|0|||
25318068|NCT00613015|50633714|FG000|Overall Study|Lost to Follow-up|0|||
25318069|NCT00613015|50633715|FG001|Overall Study|Lost to Follow-up|1|||
25318070|NCT00613015|50633716|FG002|Overall Study|Lost to Follow-up|3|||
25318071|NCT00613015|50633717|FG003|Overall Study|Lost to Follow-up|3|||
25318072|NCT00613015|50633718|FG004|Overall Study|Lost to Follow-up|2|||
25318073|NCT00613015|50633719|FG005|Overall Study|Lost to Follow-up|3|||
25318074|NCT00803595|50633736|FG000|Overall Study|Adverse Event|3|||
25221141|NCT01695954|50499689|FG000|Overall Study|Withdrawal by Subject|4|||
25318075|NCT00803595|50633737|FG001|Overall Study|Adverse Event|4|||
25318076|NCT00803595|50633738|FG002|Overall Study|Adverse Event|1|||
25318077|NCT00803595|50633736|FG000|Overall Study|Protocol Violation|7|||
25318078|NCT00803595|50633737|FG001|Overall Study|Protocol Violation|2|||
25221142|NCT01695954|50499690|FG001|Overall Study|Withdrawal by Subject|0|||
25221143|NCT01695954|50499689|FG000|Overall Study|Adverse Event|0|||
25221144|NCT01695954|50499690|FG001|Overall Study|Adverse Event|2|||
25221145|NCT01694706|50499698|FG000|Overall Study|Adverse Event|0|||
25221146|NCT01694706|50499699|FG001|Overall Study|Adverse Event|1|||
25221147|NCT01694706|50499700|FG002|Overall Study|Adverse Event|0|||
25221148|NCT01694706|50499698|FG000|Overall Study|other reason not defined above|1|||
25221149|NCT01694706|50499699|FG001|Overall Study|other reason not defined above|0|||
25221150|NCT01694706|50499700|FG002|Overall Study|other reason not defined above|0|||
25221151|NCT01693692|50499712|FG000|Overall Study|Withdrawal by Subject|12|||
25318079|NCT00803595|50633738|FG002|Overall Study|Protocol Violation|12|||
25221152|NCT01693692|50499713|FG001|Overall Study|Withdrawal by Subject|10|||
25221153|NCT01693692|50499714|FG002|Overall Study|Withdrawal by Subject|11|||
25318080|NCT00803595|50633736|FG000|Overall Study|Withdrawal by Subject|5|||
25318081|NCT00803595|50633737|FG001|Overall Study|Withdrawal by Subject|2|||
25318082|NCT00803595|50633738|FG002|Overall Study|Withdrawal by Subject|3|||
25318083|NCT00953927|50633748|FG000|Overall Study|Lost to Follow-up|61|||
25221154|NCT01693692|50499712|FG000|Overall Study|Adverse Event|7|||
25221155|NCT01693692|50499713|FG001|Overall Study|Adverse Event|14|||
25221156|NCT01693692|50499714|FG002|Overall Study|Adverse Event|9|||
25221157|NCT01693692|50499712|FG000|Overall Study|Physician Decision|0|||
25221158|NCT01693692|50499713|FG001|Overall Study|Physician Decision|0|||
25221159|NCT01693692|50499714|FG002|Overall Study|Physician Decision|1|||
25221160|NCT01693692|50499712|FG000|Overall Study|Protocol Violation|5|||
25221161|NCT01693692|50499713|FG001|Overall Study|Protocol Violation|4|||
25221162|NCT01693692|50499714|FG002|Overall Study|Protocol Violation|6|||
25221163|NCT01693692|50499712|FG000|Overall Study|Lost to Follow-up|2|||
25221164|NCT01693692|50499713|FG001|Overall Study|Lost to Follow-up|2|||
25221165|NCT01693692|50499714|FG002|Overall Study|Lost to Follow-up|3|||
25221166|NCT01693692|50499712|FG000|Overall Study|Other|4|||
25221167|NCT01693692|50499713|FG001|Overall Study|Other|4|||
25221168|NCT01693692|50499714|FG002|Overall Study|Other|6|||
25221169|NCT01693614|50499725|FG000|Overall Study|Adverse Event|7|||
25221170|NCT01693614|50499726|FG001|Overall Study|Adverse Event|11|||
25221171|NCT01693614|50499727|FG002|Overall Study|Adverse Event|5|||
25221172|NCT01693614|50499725|FG000|Overall Study|Disease progression|11|||
25221173|NCT01693614|50499726|FG001|Overall Study|Disease progression|8|||
25221174|NCT01693614|50499727|FG002|Overall Study|Disease progression|7|||
25221175|NCT01693614|50499725|FG000|Overall Study|Protocol Violation|5|||
25221176|NCT01693614|50499726|FG001|Overall Study|Protocol Violation|2|||
25221177|NCT01693614|50499727|FG002|Overall Study|Protocol Violation|1|||
25221178|NCT01693614|50499725|FG000|Overall Study|Death|1|||
25221179|NCT01693614|50499726|FG001|Overall Study|Death|0|||
25221180|NCT01693614|50499727|FG002|Overall Study|Death|0|||
25221181|NCT01693614|50499725|FG000|Overall Study|Physician Decision|1|||
25221182|NCT01693614|50499726|FG001|Overall Study|Physician Decision|1|||
25221183|NCT01693614|50499727|FG002|Overall Study|Physician Decision|4|||
25221184|NCT01693614|50499725|FG000|Overall Study|Withdrawal by subject/guardian|0|||
25221185|NCT01693614|50499726|FG001|Overall Study|Withdrawal by subject/guardian|0|||
25221186|NCT01693614|50499727|FG002|Overall Study|Withdrawal by subject/guardian|2|||
25221187|NCT01693614|50499725|FG000|Overall Study|Withdrawal by Subject|1|||
25221188|NCT01693614|50499726|FG001|Overall Study|Withdrawal by Subject|0|||
25221189|NCT01693614|50499727|FG002|Overall Study|Withdrawal by Subject|5|||
25221190|NCT01715298|50499738|FG000|Overall Study|Lost to Follow-up|0|||
25221191|NCT01715298|50499739|FG001|Overall Study|Lost to Follow-up|2|||
25221192|NCT01715298|50499738|FG000|Overall Study|Patient/guardian decision|7|||
25221193|NCT01715298|50499739|FG001|Overall Study|Patient/guardian decision|9|||
25221194|NCT01713582|50499766|FG000|Overall Study|Disease progression|3|||
25221195|NCT01713582|50499767|FG001|Overall Study|Disease progression|3|||
25221196|NCT01713582|50499768|FG002|Overall Study|Disease progression|3|||
25221197|NCT01713582|50499769|FG003|Overall Study|Disease progression|2|||
25221198|NCT01713582|50499770|FG004|Overall Study|Disease progression|3|||
25221199|NCT01713582|50499771|FG005|Overall Study|Disease progression|3|||
25221200|NCT01713582|50499772|FG006|Overall Study|Disease progression|3|||
25221201|NCT01713582|50499773|FG007|Overall Study|Disease progression|3|||
25221202|NCT01713582|50499774|FG008|Overall Study|Disease progression|3|||
25221203|NCT01713582|50499775|FG009|Overall Study|Disease progression|11|||
25221204|NCT01713582|50499776|FG010|Overall Study|Disease progression|10|||
25221205|NCT01713582|50499777|FG011|Overall Study|Disease progression|5|||
25221206|NCT01713582|50499778|FG012|Overall Study|Disease progression|3|||
25221207|NCT01713582|50499779|FG013|Overall Study|Disease progression|3|||
25221208|NCT01713582|50499780|FG014|Overall Study|Disease progression|6|||
25221209|NCT01713582|50499781|FG015|Overall Study|Disease progression|6|||
25221210|NCT01713582|50499782|FG016|Overall Study|Disease progression|5|||
25221211|NCT01713582|50499783|FG017|Overall Study|Disease progression|2|||
25221212|NCT01713582|50499784|FG018|Overall Study|Disease progression|3|||
25221213|NCT01713582|50499785|FG019|Overall Study|Disease progression|5|||
25221214|NCT01713582|50499786|FG020|Overall Study|Disease progression|15|||
25221215|NCT01713582|50499766|FG000|Overall Study|Death|0|||
25221216|NCT01713582|50499767|FG001|Overall Study|Death|0|||
25221217|NCT01713582|50499768|FG002|Overall Study|Death|0|||
25221218|NCT01713582|50499769|FG003|Overall Study|Death|1|||
25221219|NCT01713582|50499770|FG004|Overall Study|Death|1|||
25221220|NCT01713582|50499771|FG005|Overall Study|Death|3|||
25221221|NCT01713582|50499772|FG006|Overall Study|Death|3|||
25221222|NCT01713582|50499773|FG007|Overall Study|Death|2|||
25221223|NCT01713582|50499774|FG008|Overall Study|Death|3|||
25221224|NCT01713582|50499775|FG009|Overall Study|Death|4|||
25221225|NCT01713582|50499776|FG010|Overall Study|Death|3|||
25221226|NCT01713582|50499777|FG011|Overall Study|Death|0|||
25221227|NCT01713582|50499778|FG012|Overall Study|Death|0|||
25221228|NCT01713582|50499779|FG013|Overall Study|Death|0|||
25221229|NCT01713582|50499780|FG014|Overall Study|Death|0|||
25221230|NCT01713582|50499781|FG015|Overall Study|Death|0|||
25221231|NCT01713582|50499782|FG016|Overall Study|Death|0|||
25221232|NCT01713582|50499783|FG017|Overall Study|Death|0|||
25221233|NCT01713582|50499784|FG018|Overall Study|Death|0|||
25221234|NCT01713582|50499785|FG019|Overall Study|Death|0|||
25221235|NCT01713582|50499786|FG020|Overall Study|Death|0|||
25221236|NCT01713582|50499766|FG000|Overall Study|Adverse event-related|0|||
25221237|NCT01713582|50499767|FG001|Overall Study|Adverse event-related|0|||
25221238|NCT01713582|50499768|FG002|Overall Study|Adverse event-related|0|||
25221239|NCT01713582|50499769|FG003|Overall Study|Adverse event-related|0|||
25221240|NCT01713582|50499770|FG004|Overall Study|Adverse event-related|0|||
25221241|NCT01713582|50499771|FG005|Overall Study|Adverse event-related|0|||
25221242|NCT01713582|50499772|FG006|Overall Study|Adverse event-related|0|||
25221243|NCT01713582|50499773|FG007|Overall Study|Adverse event-related|0|||
25221244|NCT01713582|50499774|FG008|Overall Study|Adverse event-related|0|||
25221245|NCT01713582|50499775|FG009|Overall Study|Adverse event-related|1|||
25221246|NCT01713582|50499776|FG010|Overall Study|Adverse event-related|1|||
25221247|NCT01713582|50499777|FG011|Overall Study|Adverse event-related|0|||
25221248|NCT01713582|50499778|FG012|Overall Study|Adverse event-related|0|||
25221249|NCT01713582|50499779|FG013|Overall Study|Adverse event-related|0|||
25221250|NCT01713582|50499780|FG014|Overall Study|Adverse event-related|0|||
25221251|NCT01713582|50499781|FG015|Overall Study|Adverse event-related|0|||
25221252|NCT01713582|50499782|FG016|Overall Study|Adverse event-related|0|||
25221253|NCT01713582|50499783|FG017|Overall Study|Adverse event-related|0|||
25221254|NCT01713582|50499784|FG018|Overall Study|Adverse event-related|1|||
25221255|NCT01713582|50499785|FG019|Overall Study|Adverse event-related|0|||
25221256|NCT01713582|50499786|FG020|Overall Study|Adverse event-related|0|||
25221257|NCT01713582|50499766|FG000|Overall Study|Adverse event-unrelated|0|||
25221258|NCT01713582|50499767|FG001|Overall Study|Adverse event-unrelated|0|||
25221259|NCT01713582|50499768|FG002|Overall Study|Adverse event-unrelated|0|||
25221260|NCT01713582|50499769|FG003|Overall Study|Adverse event-unrelated|0|||
25221261|NCT01713582|50499770|FG004|Overall Study|Adverse event-unrelated|0|||
25221262|NCT01713582|50499771|FG005|Overall Study|Adverse event-unrelated|1|||
25221263|NCT01713582|50499772|FG006|Overall Study|Adverse event-unrelated|1|||
25221264|NCT01713582|50499773|FG007|Overall Study|Adverse event-unrelated|1|||
25221265|NCT01713582|50499774|FG008|Overall Study|Adverse event-unrelated|0|||
25221266|NCT01713582|50499775|FG009|Overall Study|Adverse event-unrelated|0|||
25221267|NCT01713582|50499776|FG010|Overall Study|Adverse event-unrelated|0|||
25221268|NCT01713582|50499777|FG011|Overall Study|Adverse event-unrelated|0|||
25221269|NCT01713582|50499778|FG012|Overall Study|Adverse event-unrelated|0|||
25221270|NCT01713582|50499779|FG013|Overall Study|Adverse event-unrelated|1|||
25221271|NCT01713582|50499780|FG014|Overall Study|Adverse event-unrelated|1|||
25221272|NCT01713582|50499781|FG015|Overall Study|Adverse event-unrelated|0|||
25221273|NCT01713582|50499782|FG016|Overall Study|Adverse event-unrelated|0|||
25221274|NCT01713582|50499783|FG017|Overall Study|Adverse event-unrelated|0|||
25221275|NCT01713582|50499784|FG018|Overall Study|Adverse event-unrelated|0|||
25221276|NCT01713582|50499785|FG019|Overall Study|Adverse event-unrelated|0|||
25221277|NCT01713582|50499786|FG020|Overall Study|Adverse event-unrelated|0|||
25221278|NCT01713582|50499766|FG000|Overall Study|Withdrawal of consent|0|||
25221279|NCT01713582|50499767|FG001|Overall Study|Withdrawal of consent|0|||
25221280|NCT01713582|50499768|FG002|Overall Study|Withdrawal of consent|1|||
25221281|NCT01713582|50499769|FG003|Overall Study|Withdrawal of consent|0|||
25221282|NCT01713582|50499770|FG004|Overall Study|Withdrawal of consent|0|||
25221283|NCT01713582|50499771|FG005|Overall Study|Withdrawal of consent|1|||
25221284|NCT01713582|50499772|FG006|Overall Study|Withdrawal of consent|0|||
25221285|NCT01713582|50499773|FG007|Overall Study|Withdrawal of consent|0|||
25221286|NCT01713582|50499774|FG008|Overall Study|Withdrawal of consent|0|||
25221287|NCT01713582|50499775|FG009|Overall Study|Withdrawal of consent|1|||
25221288|NCT01713582|50499776|FG010|Overall Study|Withdrawal of consent|0|||
25221289|NCT01713582|50499777|FG011|Overall Study|Withdrawal of consent|0|||
25221290|NCT01713582|50499778|FG012|Overall Study|Withdrawal of consent|0|||
25221291|NCT01713582|50499779|FG013|Overall Study|Withdrawal of consent|0|||
25221292|NCT01713582|50499780|FG014|Overall Study|Withdrawal of consent|0|||
25221293|NCT01713582|50499781|FG015|Overall Study|Withdrawal of consent|0|||
25221294|NCT01713582|50499782|FG016|Overall Study|Withdrawal of consent|0|||
25221295|NCT01713582|50499783|FG017|Overall Study|Withdrawal of consent|0|||
25221296|NCT01713582|50499784|FG018|Overall Study|Withdrawal of consent|1|||
25221297|NCT01713582|50499785|FG019|Overall Study|Withdrawal of consent|0|||
25221298|NCT01713582|50499786|FG020|Overall Study|Withdrawal of consent|0|||
25221299|NCT01713582|50499766|FG000|Overall Study|Lack of Efficacy|0|||
25221300|NCT01713582|50499767|FG001|Overall Study|Lack of Efficacy|0|||
25221301|NCT01713582|50499768|FG002|Overall Study|Lack of Efficacy|0|||
25221302|NCT01713582|50499769|FG003|Overall Study|Lack of Efficacy|0|||
25221303|NCT01713582|50499770|FG004|Overall Study|Lack of Efficacy|0|||
25221304|NCT01713582|50499771|FG005|Overall Study|Lack of Efficacy|0|||
25221305|NCT01713582|50499772|FG006|Overall Study|Lack of Efficacy|0|||
25221306|NCT01713582|50499773|FG007|Overall Study|Lack of Efficacy|0|||
25221307|NCT01713582|50499774|FG008|Overall Study|Lack of Efficacy|0|||
25221308|NCT01713582|50499775|FG009|Overall Study|Lack of Efficacy|1|||
25221309|NCT01713582|50499776|FG010|Overall Study|Lack of Efficacy|2|||
25221310|NCT01713582|50499777|FG011|Overall Study|Lack of Efficacy|0|||
25221311|NCT01713582|50499778|FG012|Overall Study|Lack of Efficacy|0|||
25221312|NCT01713582|50499779|FG013|Overall Study|Lack of Efficacy|0|||
25221313|NCT01713582|50499780|FG014|Overall Study|Lack of Efficacy|0|||
25221314|NCT01713582|50499781|FG015|Overall Study|Lack of Efficacy|0|||
25221315|NCT01713582|50499782|FG016|Overall Study|Lack of Efficacy|0|||
25221316|NCT01713582|50499783|FG017|Overall Study|Lack of Efficacy|0|||
25221317|NCT01713582|50499784|FG018|Overall Study|Lack of Efficacy|0|||
25221318|NCT01713582|50499785|FG019|Overall Study|Lack of Efficacy|0|||
25221319|NCT01713582|50499786|FG020|Overall Study|Lack of Efficacy|0|||
25221320|NCT01713582|50499766|FG000|Overall Study|Withdrawal by Subject|0|||
25221321|NCT01713582|50499767|FG001|Overall Study|Withdrawal by Subject|0|||
25221322|NCT01713582|50499768|FG002|Overall Study|Withdrawal by Subject|0|||
25221323|NCT01713582|50499769|FG003|Overall Study|Withdrawal by Subject|0|||
25221324|NCT01713582|50499770|FG004|Overall Study|Withdrawal by Subject|0|||
25221325|NCT01713582|50499771|FG005|Overall Study|Withdrawal by Subject|0|||
25221326|NCT01713582|50499772|FG006|Overall Study|Withdrawal by Subject|0|||
25221327|NCT01713582|50499773|FG007|Overall Study|Withdrawal by Subject|0|||
25221328|NCT01713582|50499774|FG008|Overall Study|Withdrawal by Subject|0|||
25221329|NCT01713582|50499775|FG009|Overall Study|Withdrawal by Subject|0|||
25221330|NCT01713582|50499776|FG010|Overall Study|Withdrawal by Subject|0|||
25221331|NCT01713582|50499777|FG011|Overall Study|Withdrawal by Subject|0|||
25221332|NCT01713582|50499778|FG012|Overall Study|Withdrawal by Subject|0|||
25221333|NCT01713582|50499779|FG013|Overall Study|Withdrawal by Subject|0|||
25221334|NCT01713582|50499780|FG014|Overall Study|Withdrawal by Subject|0|||
25221335|NCT01713582|50499781|FG015|Overall Study|Withdrawal by Subject|0|||
25221336|NCT01713582|50499782|FG016|Overall Study|Withdrawal by Subject|0|||
25221337|NCT01713582|50499783|FG017|Overall Study|Withdrawal by Subject|1|||
25221338|NCT01713582|50499784|FG018|Overall Study|Withdrawal by Subject|0|||
25221339|NCT01713582|50499785|FG019|Overall Study|Withdrawal by Subject|0|||
25221340|NCT01713582|50499786|FG020|Overall Study|Withdrawal by Subject|0|||
25221341|NCT01713582|50499766|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
25221342|NCT01713582|50499767|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
25221343|NCT01713582|50499768|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
25221344|NCT01713582|50499769|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
25221345|NCT01713582|50499770|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
25221346|NCT01713582|50499771|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
25221347|NCT01713582|50499772|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
25221348|NCT01713582|50499773|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
25221349|NCT01713582|50499774|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
25221350|NCT01713582|50499775|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
25221351|NCT01713582|50499776|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
25221352|NCT01713582|50499777|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
25221353|NCT01713582|50499778|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
25221354|NCT01713582|50499779|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
25221355|NCT01713582|50499780|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
25221356|NCT01713582|50499781|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
25221357|NCT01713582|50499782|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
25221358|NCT01713582|50499783|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
25221359|NCT01713582|50499784|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
25221360|NCT01713582|50499785|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
25221361|NCT01713582|50499786|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
25221362|NCT01713582|50499766|FG000|Overall Study|Disease progression and adverse event|0|||
25221363|NCT01713582|50499767|FG001|Overall Study|Disease progression and adverse event|0|||
25221364|NCT01713582|50499768|FG002|Overall Study|Disease progression and adverse event|0|||
25221365|NCT01713582|50499769|FG003|Overall Study|Disease progression and adverse event|0|||
25221366|NCT01713582|50499770|FG004|Overall Study|Disease progression and adverse event|0|||
25221367|NCT01713582|50499771|FG005|Overall Study|Disease progression and adverse event|0|||
25221368|NCT01713582|50499772|FG006|Overall Study|Disease progression and adverse event|0|||
25221369|NCT01713582|50499773|FG007|Overall Study|Disease progression and adverse event|0|||
25221370|NCT01713582|50499774|FG008|Overall Study|Disease progression and adverse event|0|||
25221371|NCT01713582|50499775|FG009|Overall Study|Disease progression and adverse event|0|||
25221372|NCT01713582|50499776|FG010|Overall Study|Disease progression and adverse event|0|||
25221373|NCT01713582|50499777|FG011|Overall Study|Disease progression and adverse event|0|||
25221374|NCT01713582|50499778|FG012|Overall Study|Disease progression and adverse event|0|||
25221375|NCT01713582|50499779|FG013|Overall Study|Disease progression and adverse event|0|||
25221376|NCT01713582|50499780|FG014|Overall Study|Disease progression and adverse event|0|||
25221377|NCT01713582|50499781|FG015|Overall Study|Disease progression and adverse event|0|||
25221378|NCT01713582|50499782|FG016|Overall Study|Disease progression and adverse event|1|||
25221379|NCT01713582|50499783|FG017|Overall Study|Disease progression and adverse event|0|||
25221380|NCT01713582|50499784|FG018|Overall Study|Disease progression and adverse event|0|||
25221381|NCT01713582|50499785|FG019|Overall Study|Disease progression and adverse event|0|||
25221382|NCT01713582|50499786|FG020|Overall Study|Disease progression and adverse event|0|||
25221383|NCT01739400|50499846|FG000|Overall Study|Physician Decision|3|||
25221384|NCT01739400|50499847|FG001|Overall Study|Physician Decision|0|||
25221385|NCT01739400|50499846|FG000|Overall Study|Lost to Follow-up|2|||
25221386|NCT01739400|50499847|FG001|Overall Study|Lost to Follow-up|0|||
25221387|NCT01739400|50499846|FG000|Overall Study|Death|5|||
25221388|NCT01739400|50499847|FG001|Overall Study|Death|2|||
25221389|NCT01739400|50499846|FG000|Overall Study|Withdrawal by Subject|7|||
25221390|NCT01739400|50499847|FG001|Overall Study|Withdrawal by Subject|7|||
25221391|NCT01713348|50499856|FG000|Overall Study|Withdrawal by Subject|3|||
25221392|NCT01713348|50499857|FG001|Overall Study|Withdrawal by Subject|2|||
25221393|NCT01713348|50499858|FG002|Overall Study|Withdrawal by Subject|2|||
25221394|NCT01713348|50499859|FG003|Overall Study|Withdrawal by Subject|0|||
25221395|NCT01713348|50499856|FG000|Overall Study|Lost to Follow-up|1|||
25221396|NCT01713348|50499857|FG001|Overall Study|Lost to Follow-up|0|||
25221397|NCT01713348|50499858|FG002|Overall Study|Lost to Follow-up|0|||
25221398|NCT01713348|50499859|FG003|Overall Study|Lost to Follow-up|0|||
25221399|NCT01737996|50499872|FG000|Overall Study|Adverse Event|0|||
25221400|NCT01737996|50499873|FG001|Overall Study|Adverse Event|1|||
25221401|NCT01737996|50499874|FG002|Overall Study|Adverse Event|1|||
25221402|NCT01737996|50499872|FG000|Overall Study|Withdrawal by Subject|0|||
25221403|NCT01737996|50499873|FG001|Overall Study|Withdrawal by Subject|0|||
25221404|NCT01737996|50499874|FG002|Overall Study|Withdrawal by Subject|1|||
25221405|NCT01713036|50499882|FG000|Overall Study|Death|1|||
25221406|NCT01712334|50499892|FG000|Treatment Period 1|Randomized in Error|0|||
25221407|NCT01712334|50499893|FG001|Treatment Period 1|Randomized in Error|2|||
25221408|NCT01712256|50499899|FG000|Overall Study|Lost to Follow-up|1|||
25221409|NCT01712178|50499905|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
25221410|NCT01712178|50499906|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
25221411|NCT01712178|50499905|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
25221412|NCT01712178|50499906|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
25221413|NCT01712178|50499905|FG000|Overall Study|Lost to Follow-up|0|||
25221414|NCT01712178|50499906|FG001|Overall Study|Lost to Follow-up|1|||
25221415|NCT01693068|50499914|FG000|Randomization Period|On-study|2|||
25221416|NCT01693068|50499915|FG001|Randomization Period|On-study|5|||
25221417|NCT01693068|50499916|FG002|Randomization Period|On-study|0|||
25221418|NCT01693068|50499914|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
25221419|NCT01693068|50499915|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
25221420|NCT01693068|50499916|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
25221421|NCT01691898|50499930|FG000|Overall Study|Death|34|||
25221422|NCT01691898|50499931|FG001|Overall Study|Death|32|||
25221423|NCT01691898|50499932|FG002|Overall Study|Death|6|||
25221424|NCT01691898|50499933|FG003|Overall Study|Death|3|||
25221425|NCT01691898|50499934|FG004|Overall Study|Death|8|||
25221426|NCT01691898|50499935|FG005|Overall Study|Death|31|||
25221427|NCT01691898|50499930|FG000|Overall Study|Adverse Event|0|||
25221428|NCT01691898|50499931|FG001|Overall Study|Adverse Event|1|||
25221429|NCT01691898|50499932|FG002|Overall Study|Adverse Event|0|||
25221430|NCT01691898|50499933|FG003|Overall Study|Adverse Event|1|||
25221431|NCT01691898|50499934|FG004|Overall Study|Adverse Event|1|||
25221432|NCT01691898|50499935|FG005|Overall Study|Adverse Event|0|||
25221433|NCT01691898|50499930|FG000|Overall Study|Progression of Disease|1|||
25221434|NCT01691898|50499931|FG001|Overall Study|Progression of Disease|2|||
25221435|NCT01691898|50499932|FG002|Overall Study|Progression of Disease|1|||
25221436|NCT01691898|50499933|FG003|Overall Study|Progression of Disease|0|||
25221437|NCT01691898|50499934|FG004|Overall Study|Progression of Disease|0|||
25221438|NCT01691898|50499935|FG005|Overall Study|Progression of Disease|1|||
25221439|NCT01691898|50499930|FG000|Overall Study|Lost to Follow-up|3|||
25221440|NCT01691898|50499931|FG001|Overall Study|Lost to Follow-up|1|||
25221441|NCT01691898|50499932|FG002|Overall Study|Lost to Follow-up|0|||
25221442|NCT01691898|50499933|FG003|Overall Study|Lost to Follow-up|0|||
25221443|NCT01691898|50499934|FG004|Overall Study|Lost to Follow-up|1|||
25221444|NCT01691898|50499935|FG005|Overall Study|Lost to Follow-up|0|||
25221445|NCT01691898|50499930|FG000|Overall Study|Withdrawal by Subject|9|||
25221446|NCT01691898|50499931|FG001|Overall Study|Withdrawal by Subject|8|||
25221447|NCT01691898|50499932|FG002|Overall Study|Withdrawal by Subject|2|||
25221448|NCT01691898|50499933|FG003|Overall Study|Withdrawal by Subject|1|||
25221449|NCT01691898|50499934|FG004|Overall Study|Withdrawal by Subject|3|||
25221450|NCT01691898|50499935|FG005|Overall Study|Withdrawal by Subject|3|||
25221451|NCT01691898|50499930|FG000|Overall Study|Non-Compliance|0|||
25221452|NCT01691898|50499931|FG001|Overall Study|Non-Compliance|0|||
25221453|NCT01691898|50499932|FG002|Overall Study|Non-Compliance|0|||
25221454|NCT01691898|50499933|FG003|Overall Study|Non-Compliance|0|||
24976518|NCT03538054|50065428|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
25221455|NCT01691898|50499934|FG004|Overall Study|Non-Compliance|1|||
25221456|NCT01691898|50499935|FG005|Overall Study|Non-Compliance|0|||
25221457|NCT01737840|50499969|FG000|Overall Study|Diagnosed with an other pathology|2|||
25221458|NCT01737840|50499970|FG001|Overall Study|Diagnosed with an other pathology|2|||
25221459|NCT01691820|50499980|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
25221460|NCT01691820|50499981|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
25221461|NCT01691820|50499980|FG000|Overall Study|Migrated/moved from study area|7|||
25221462|NCT01691820|50499981|FG001|Overall Study|Migrated/moved from study area|4|||
25221463|NCT01691820|50499980|FG000|Overall Study|Lost to Follow-up|6|||
25221464|NCT01691820|50499981|FG001|Overall Study|Lost to Follow-up|17|||
25221465|NCT01691820|50499980|FG000|Overall Study|Other (unspecified)|4|||
25221466|NCT01691820|50499981|FG001|Overall Study|Other (unspecified)|1|||
25221467|NCT01711866|50499991|FG000|Overall Study|Noncompliant|3|||
25221468|NCT01711866|50499991|FG000|Overall Study|Withdrawal by Subject|3|||
25221469|NCT01711866|50499991|FG000|Overall Study|Adverse Event|2|||
25221470|NCT01737762|50499997|FG000|Overall Study|Adverse Event|2|||
25221471|NCT01737762|50499998|FG001|Overall Study|Adverse Event|2|||
25221472|NCT01737762|50499997|FG000|Overall Study|Lost to Follow-up|1|||
25221473|NCT01737762|50499998|FG001|Overall Study|Lost to Follow-up|0|||
25221474|NCT01737762|50499997|FG000|Overall Study|Withdrawal by Subject|2|||
25221475|NCT01737762|50499998|FG001|Overall Study|Withdrawal by Subject|2|||
25221476|NCT01737762|50499997|FG000|Overall Study|Progressive disease|1|||
25221477|NCT01737762|50499998|FG001|Overall Study|Progressive disease|2|||
25221478|NCT01737762|50499997|FG000|Overall Study|Physician Decision|1|||
25221479|NCT01737762|50499998|FG001|Overall Study|Physician Decision|1|||
25221480|NCT01737762|50499997|FG000|Overall Study|Moved from area|2|||
25221481|NCT01737762|50499998|FG001|Overall Study|Moved from area|1|||
25221482|NCT01737762|50499997|FG000|Overall Study|Trial termination|11|||
25221483|NCT01737762|50499998|FG001|Overall Study|Trial termination|9|||
25221484|NCT01691508|50500006|FG000|Overall Study|Adverse Event|3|||
25221485|NCT01691508|50500007|FG001|Overall Study|Adverse Event|3|||
25221486|NCT01691508|50500006|FG000|Overall Study|Withdrawal by Subject|1|||
25221487|NCT01691508|50500007|FG001|Overall Study|Withdrawal by Subject|0|||
25221488|NCT01682460|50500013|FG000|Overall Study|Withdrawal by Subject|2|||
25221489|NCT01682460|50500013|FG000|Overall Study|Did not meet inclusion criteria|2|||
25221490|NCT01691430|50500019|FG000|Overall Study|Death|17|||
25221491|NCT01691430|50500020|FG001|Overall Study|Death|16|||
25221492|NCT01691430|50500019|FG000|Overall Study|Withdrawal by Subject|5|||
25221493|NCT01691430|50500020|FG001|Overall Study|Withdrawal by Subject|1|||
25221494|NCT01691430|50500019|FG000|Overall Study|Lost to Follow-up|0|||
25221495|NCT01691430|50500020|FG001|Overall Study|Lost to Follow-up|3|||
25221496|NCT01709838|50500026|FG000|Overall Study|Withdrawal by Subject|21|||
25221497|NCT01709838|50500026|FG000|Overall Study|Lost to Follow-up|16|||
25221498|NCT01709838|50500026|FG000|Overall Study|Pregnancy|10|||
25221499|NCT01709838|50500026|FG000|Overall Study|Subject/guardian decision|8|||
25221500|NCT01709838|50500026|FG000|Overall Study|Adverse Event|4|||
25221501|NCT01709838|50500026|FG000|Overall Study|Physician Decision|4|||
25221502|NCT01709838|50500026|FG000|Overall Study|Death|3|||
25221503|NCT01709838|50500026|FG000|Overall Study|Protocol Violation|1|||
25221504|NCT01682226|50500032|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
25221505|NCT01682226|50500032|FG000|Overall Study|Participants did not receive treatment|2|||
25221506|NCT01682226|50500032|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
25221507|NCT01688466|50500038|FG000|Overall Study|Withdrawal by Subject|2|||
25221508|NCT01688466|50500039|FG001|Overall Study|Withdrawal by Subject|1|||
25221509|NCT01688466|50500038|FG000|Overall Study|Death|0|||
25221510|NCT01688466|50500039|FG001|Overall Study|Death|1|||
25221511|NCT01688466|50500038|FG000|Overall Study|Adverse Event|0|||
25221512|NCT01688466|50500039|FG001|Overall Study|Adverse Event|4|||
25221513|NCT01688466|50500038|FG000|Overall Study|Not evaluable|0|||
25221514|NCT01688466|50500039|FG001|Overall Study|Not evaluable|1|||
25221515|NCT01682148|50500047|FG000|Overall Study|Withdrawal by Subject|2|||
25221516|NCT01682148|50500048|FG001|Overall Study|Withdrawal by Subject|0|||
25221517|NCT01682148|50500047|FG000|Overall Study|Lost to Follow-up|1|||
25221518|NCT01682148|50500048|FG001|Overall Study|Lost to Follow-up|2|||
25221519|NCT01682148|50500047|FG000|Overall Study|Protocol Violation|1|||
25221520|NCT01682148|50500048|FG001|Overall Study|Protocol Violation|1|||
25221521|NCT01681992|50500062|FG000|Overall Study|Adverse Event|3|||
25221522|NCT01681992|50500063|FG001|Overall Study|Adverse Event|2|||
25221523|NCT01681992|50500064|FG002|Overall Study|Adverse Event|3|||
25221524|NCT01681992|50500062|FG000|Overall Study|Lost to Follow-up|36|||
25221525|NCT01681992|50500063|FG001|Overall Study|Lost to Follow-up|38|||
25221526|NCT01681992|50500064|FG002|Overall Study|Lost to Follow-up|53|||
25221527|NCT01681992|50500062|FG000|Overall Study|As Per Sponsor Decision|0|||
25221528|NCT01681992|50500063|FG001|Overall Study|As Per Sponsor Decision|0|||
25221529|NCT01681992|50500064|FG002|Overall Study|As Per Sponsor Decision|1|||
25221530|NCT01681992|50500062|FG000|Overall Study|Protocol Violation|0|||
25221531|NCT01681992|50500063|FG001|Overall Study|Protocol Violation|0|||
25221532|NCT01681992|50500064|FG002|Overall Study|Protocol Violation|1|||
25221533|NCT01681992|50500062|FG000|Overall Study|Withdrawal by Subject|27|||
25221534|NCT01681992|50500063|FG001|Overall Study|Withdrawal by Subject|30|||
25221535|NCT01681992|50500064|FG002|Overall Study|Withdrawal by Subject|25|||
25221536|NCT01687998|50500074|FG000|Overall Study|Withdrawal by Subject|49|||
25221537|NCT01687998|50500075|FG001|Overall Study|Withdrawal by Subject|51|||
25221538|NCT01687998|50500074|FG000|Overall Study|Known to be Alive at Study End|54|||
25221539|NCT01687998|50500075|FG001|Overall Study|Known to be Alive at Study End|62|||
25221540|NCT01687998|50500074|FG000|Overall Study|Lost to Follow-up|9|||
25221541|NCT01687998|50500075|FG001|Overall Study|Lost to Follow-up|7|||
25221542|NCT01681836|50500081|FG000|Second Intervention|Withdrawal by Subject|0|||
25221543|NCT01681836|50500082|FG001|Second Intervention|Withdrawal by Subject|1|||
25221544|NCT01681368|50500088|FG000|Overall Study|Refused further treatment|1|||
25221545|NCT01681368|50500088|FG000|Overall Study|Refused further follow up|1|||
25221546|NCT01681212|50500092|FG000|Overall Study|No longer met study criteria|5|||
25221547|NCT01681212|50500092|FG000|Overall Study|Administrative reason by sponsor|1|||
25221548|NCT01687296|50500098|FG000|Overall Study|Lack of Efficacy|1|||
25221549|NCT01687296|50500099|FG001|Overall Study|Lack of Efficacy|1|||
25221550|NCT01687296|50500098|FG000|Overall Study|Protocol Violation|0|||
25221551|NCT01687296|50500099|FG001|Overall Study|Protocol Violation|1|||
25221552|NCT01687296|50500098|FG000|Overall Study|Withdrawal by Subject|6|||
25221553|NCT01687296|50500099|FG001|Overall Study|Withdrawal by Subject|3|||
25221554|NCT01568892|50500120|FG000|Open-label Phase|Adverse Event|2|||
25221555|NCT01568892|50500121|FG001|Open-label Phase|Adverse Event|0|||
25221556|NCT01568892|50500120|FG000|Open-label Phase|Lack of Efficacy|4|||
25221557|NCT01568892|50500121|FG001|Open-label Phase|Lack of Efficacy|2|||
25221558|NCT01568892|50500120|FG000|Open-label Phase|Lost to Follow-up|0|||
25221559|NCT01568892|50500121|FG001|Open-label Phase|Lost to Follow-up|1|||
25221560|NCT01568112|50500132|FG000|Overall Study|Randomized But Not Treated|0|||
25221561|NCT01568112|50500133|FG001|Overall Study|Randomized But Not Treated|1|||
25221562|NCT01568112|50500134|FG002|Overall Study|Randomized But Not Treated|0|||
25221563|NCT01568112|50500135|FG003|Overall Study|Randomized But Not Treated|0|||
25221564|NCT01568112|50500132|FG000|Overall Study|Withdrew due to Adverse Event|2|||
25221565|NCT01568112|50500133|FG001|Overall Study|Withdrew due to Adverse Event|4|||
25221566|NCT01568112|50500134|FG002|Overall Study|Withdrew due to Adverse Event|6|||
25221567|NCT01568112|50500135|FG003|Overall Study|Withdrew due to Adverse Event|3|||
25221568|NCT01568112|50500132|FG000|Overall Study|Lost to Follow-up|0|||
25221569|NCT01568112|50500133|FG001|Overall Study|Lost to Follow-up|0|||
25221570|NCT01568112|50500134|FG002|Overall Study|Lost to Follow-up|0|||
25221571|NCT01568112|50500135|FG003|Overall Study|Lost to Follow-up|1|||
25221572|NCT01568112|50500132|FG000|Overall Study|Withdrawal by Subject|2|||
25221573|NCT01568112|50500133|FG001|Overall Study|Withdrawal by Subject|3|||
25221574|NCT01568112|50500134|FG002|Overall Study|Withdrawal by Subject|0|||
25221575|NCT01568112|50500135|FG003|Overall Study|Withdrawal by Subject|7|||
25221576|NCT01568112|50500132|FG000|Overall Study|Withdrawal by Physician|1|||
25221577|NCT01568112|50500133|FG001|Overall Study|Withdrawal by Physician|0|||
25221578|NCT01568112|50500134|FG002|Overall Study|Withdrawal by Physician|1|||
25221579|NCT01568112|50500135|FG003|Overall Study|Withdrawal by Physician|1|||
25221580|NCT01568034|50500146|FG000|Overall Study|Withdrawal by Subject|1|||
25221581|NCT01568034|50500147|FG001|Overall Study|Withdrawal by Subject|0|||
25221582|NCT01568034|50500148|FG002|Overall Study|Withdrawal by Subject|0|||
25221583|NCT01568034|50500149|FG003|Overall Study|Withdrawal by Subject|0|||
25221584|NCT01687218|50500165|FG000|Overall Study|Withdrawal by Subject|2|||
25221585|NCT01687218|50500166|FG001|Overall Study|Withdrawal by Subject|3|||
25221586|NCT01687218|50500167|FG002|Overall Study|Withdrawal by Subject|0|||
25221587|NCT01687218|50500168|FG003|Overall Study|Withdrawal by Subject|1|||
25221588|NCT01687218|50500169|FG004|Overall Study|Withdrawal by Subject|1|||
25221589|NCT01687218|50500170|FG005|Overall Study|Withdrawal by Subject|0|||
25221590|NCT01687218|50500165|FG000|Overall Study|Relocated, no follow-up planned|1|||
25221591|NCT01687218|50500166|FG001|Overall Study|Relocated, no follow-up planned|0|||
25221592|NCT01687218|50500167|FG002|Overall Study|Relocated, no follow-up planned|1|||
25221593|NCT01687218|50500168|FG003|Overall Study|Relocated, no follow-up planned|1|||
25221594|NCT01687218|50500169|FG004|Overall Study|Relocated, no follow-up planned|0|||
25221595|NCT01687218|50500170|FG005|Overall Study|Relocated, no follow-up planned|0|||
25221596|NCT01686828|50500182|FG000|Overall Study|Physician Decision|1|||
25221597|NCT01686828|50500183|FG001|Overall Study|Physician Decision|0|||
25221598|NCT01686828|50500184|FG002|Overall Study|Physician Decision|0|||
25221599|NCT01686828|50500185|FG003|Overall Study|Physician Decision|0|||
25221600|NCT01686828|50500182|FG000|Overall Study|New Job|0|||
25221601|NCT01686828|50500183|FG001|Overall Study|New Job|1|||
25221602|NCT01686828|50500184|FG002|Overall Study|New Job|0|||
25221603|NCT01686828|50500185|FG003|Overall Study|New Job|0|||
25221604|NCT01686828|50500182|FG000|Overall Study|Weight Loss|0|||
25221605|NCT01686828|50500183|FG001|Overall Study|Weight Loss|0|||
25221606|NCT01686828|50500184|FG002|Overall Study|Weight Loss|1|||
25221607|NCT01686828|50500185|FG003|Overall Study|Weight Loss|0|||
25318084|NCT00953927|50633749|FG001|Overall Study|Lost to Follow-up|65|||
25221608|NCT01686438|50500202|FG000|Overall Study|Lost to Follow-up|8|||
25221609|NCT01686438|50500203|FG001|Overall Study|Lost to Follow-up|9|||
25221610|NCT01686438|50500204|FG002|Overall Study|Lost to Follow-up|10|||
25221611|NCT01686438|50500202|FG000|Overall Study|Adverse Event|0|||
25221612|NCT01686438|50500203|FG001|Overall Study|Adverse Event|0|||
25221613|NCT01686438|50500204|FG002|Overall Study|Adverse Event|1|||
25221614|NCT01686438|50500202|FG000|Overall Study|Protocol Violation|0|||
25221615|NCT01686438|50500203|FG001|Overall Study|Protocol Violation|0|||
25221616|NCT01686438|50500204|FG002|Overall Study|Protocol Violation|1|||
25221617|NCT01686438|50500202|FG000|Overall Study|Withdrawal by Subject|0|||
25221618|NCT01686438|50500203|FG001|Overall Study|Withdrawal by Subject|0|||
25221619|NCT01686438|50500204|FG002|Overall Study|Withdrawal by Subject|1|||
25221620|NCT01593696|50500218|FG000|Dose Escalation|Progressive Disease|2|||
25221621|NCT01593696|50500219|FG001|Dose Escalation|Progressive Disease|0|||
25221622|NCT01593696|50500220|FG002|Dose Escalation|Progressive Disease|0|||
25221623|NCT01593696|50500221|FG003|Dose Escalation|Progressive Disease|0|||
25221624|NCT01593696|50500218|FG000|Dose Expansion|Fungal infection|0|||
25221625|NCT01593696|50500219|FG001|Dose Expansion|Fungal infection|0|||
25221626|NCT01593696|50500220|FG002|Dose Expansion|Fungal infection|1|||
25221627|NCT01593696|50500221|FG003|Dose Expansion|Fungal infection|0|||
25221628|NCT01592760|50500234|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
25221629|NCT01592760|50500235|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
25221630|NCT01592760|50500236|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
25221631|NCT01696188|50500249|FG000|Overall Study|Protocol Violation|1|||
25221632|NCT01696188|50500250|FG001|Overall Study|Protocol Violation|1|||
25221633|NCT01603602|50500259|FG000|Overall Study|Adverse Event|1|||
25221634|NCT01603602|50500260|FG001|Overall Study|Adverse Event|0|||
25221635|NCT01603602|50500261|FG002|Overall Study|Adverse Event|0|||
25221636|NCT01603602|50500259|FG000|Overall Study|Personal Reasons|1|||
25221637|NCT01603602|50500260|FG001|Overall Study|Personal Reasons|0|||
25221638|NCT01603602|50500261|FG002|Overall Study|Personal Reasons|1|||
25221639|NCT01684878|50500273|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
25221640|NCT01684878|50500274|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
25221641|NCT01684878|50500275|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
25221642|NCT01684878|50500276|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
25221643|NCT01684878|50500273|FG000|Part 1: Safety Run in Phase|Death|15|||
25221644|NCT01684878|50500274|FG001|Part 1: Safety Run in Phase|Death|20|||
25221645|NCT01684878|50500275|FG002|Part 1: Safety Run in Phase|Death|0|||
25221646|NCT01684878|50500276|FG003|Part 1: Safety Run in Phase|Death|0|||
25221647|NCT01684878|50500273|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
25221648|NCT01684878|50500274|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
25221649|NCT01684878|50500275|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
25318085|NCT00953927|50633748|FG000|Overall Study|Withdrawal by Subject|36|||
25318086|NCT00953927|50633749|FG001|Overall Study|Withdrawal by Subject|25|||
25318087|NCT00953927|50633748|FG000|Overall Study|Death|7|||
25318088|NCT00953927|50633749|FG001|Overall Study|Death|4|||
25318089|NCT00953927|50633748|FG000|Overall Study|Other study discontinuation|1|||
25318090|NCT00953927|50633749|FG001|Overall Study|Other study discontinuation|1|||
25318091|NCT00611767|50633757|FG000|Overall Study|Withdrawal by Subject|4|||
25318092|NCT00611767|50633758|FG001|Overall Study|Withdrawal by Subject|1|||
25318093|NCT00611767|50633757|FG000|Overall Study|Thiopental not available|3|||
25318094|NCT00611767|50633758|FG001|Overall Study|Thiopental not available|0|||
25318095|NCT00611767|50633757|FG000|Overall Study|didn't like the medication|1|||
25318096|NCT00611767|50633758|FG001|Overall Study|didn't like the medication|1|||
25318097|NCT00611767|50633757|FG000|Overall Study|Physician Decision|1|||
25318098|NCT00611767|50633758|FG001|Overall Study|Physician Decision|0|||
25318099|NCT00803361|50633766|FG000|Overall Study|Adverse Event|13|||
25318100|NCT00803361|50633767|FG001|Overall Study|Adverse Event|3|||
25318101|NCT00803361|50633766|FG000|Overall Study|Lack of Efficacy|4|||
25318102|NCT00803361|50633767|FG001|Overall Study|Lack of Efficacy|13|||
25318103|NCT00803361|50633766|FG000|Overall Study|Lost to Follow-up|1|||
25318104|NCT00803361|50633767|FG001|Overall Study|Lost to Follow-up|2|||
25318105|NCT00803361|50633766|FG000|Overall Study|Physician Decision|1|||
25318106|NCT00803361|50633767|FG001|Overall Study|Physician Decision|0|||
25221650|NCT01684878|50500276|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
25221651|NCT01684878|50500273|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
25221652|NCT01684878|50500274|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
25318107|NCT00803361|50633766|FG000|Overall Study|Protocol Violation|2|||
25318108|NCT00803361|50633767|FG001|Overall Study|Protocol Violation|4|||
25221653|NCT01684878|50500275|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
25221654|NCT01684878|50500276|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
25221655|NCT01684878|50500273|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
25318109|NCT00803361|50633766|FG000|Overall Study|Withdrawal by Subject|5|||
25318110|NCT00803361|50633767|FG001|Overall Study|Withdrawal by Subject|6|||
25318111|NCT00611533|50633773|FG000|First Intervention (6 Weeks)|Never started study|0|||
25318112|NCT00611533|50633774|FG001|First Intervention (6 Weeks)|Never started study|1|||
25318113|NCT00611533|50633773|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
25221656|NCT01684878|50500274|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
25221657|NCT01684878|50500275|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
25221658|NCT01684878|50500276|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
25221659|NCT01684878|50500273|FG000|Part 2: Randomized Phase|Death|0|||
25221660|NCT01684878|50500274|FG001|Part 2: Randomized Phase|Death|0|||
25221661|NCT01684878|50500275|FG002|Part 2: Randomized Phase|Death|62|||
25221662|NCT01684878|50500276|FG003|Part 2: Randomized Phase|Death|68|||
25221663|NCT01684878|50500273|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
25221664|NCT01684878|50500274|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
25221665|NCT01684878|50500275|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
25221666|NCT01684878|50500276|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
25221667|NCT01684878|50500273|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
25221668|NCT01684878|50500274|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
25221669|NCT01684878|50500275|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
25221670|NCT01684878|50500276|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
25221671|NCT01684722|50500290|FG000|Overall Study|Lost to Follow-up|78|||
25221672|NCT01684722|50500291|FG001|Overall Study|Lost to Follow-up|56|||
25221673|NCT01684722|50500292|FG002|Overall Study|Lost to Follow-up|75|||
25221674|NCT01684722|50500293|FG003|Overall Study|Lost to Follow-up|89|||
25221675|NCT01684722|50500290|FG000|Overall Study|Death|19|||
25221676|NCT01684722|50500291|FG001|Overall Study|Death|21|||
25221677|NCT01684722|50500292|FG002|Overall Study|Death|19|||
25221678|NCT01684722|50500293|FG003|Overall Study|Death|21|||
25221679|NCT01592292|50500310|FG000|Overall Study|Follow-up loss|3|||
25221680|NCT01592292|50500311|FG001|Overall Study|Follow-up loss|3|||
25221681|NCT01592292|50500312|FG002|Overall Study|Follow-up loss|1|||
25221682|NCT01592292|50500313|FG003|Overall Study|Follow-up loss|0|||
25221683|NCT01592292|50500310|FG000|Overall Study|Withdrew consent|2|||
25221684|NCT01592292|50500311|FG001|Overall Study|Withdrew consent|1|||
25221685|NCT01592292|50500312|FG002|Overall Study|Withdrew consent|0|||
25221686|NCT01592292|50500313|FG003|Overall Study|Withdrew consent|0|||
25221687|NCT01592292|50500310|FG000|Overall Study|Other|1|||
25221688|NCT01592292|50500311|FG001|Overall Study|Other|1|||
25221689|NCT01592292|50500312|FG002|Overall Study|Other|2|||
25221690|NCT01592292|50500313|FG003|Overall Study|Other|1|||
25221691|NCT01590888|50500322|FG000|Overall Study|Adverse Event|3|||
25221692|NCT01590888|50500323|FG001|Overall Study|Adverse Event|0|||
25221693|NCT01590888|50500324|FG002|Overall Study|Adverse Event|1|||
25221694|NCT01590888|50500322|FG000|Overall Study|Lost to Follow-up|1|||
25221695|NCT01590888|50500323|FG001|Overall Study|Lost to Follow-up|0|||
25221696|NCT01590888|50500324|FG002|Overall Study|Lost to Follow-up|0|||
25221697|NCT01565928|50500332|FG000|Overall Study|Adverse Event|3|||
25221698|NCT01565928|50500332|FG000|Overall Study|Other|3|||
25221699|NCT01565928|50500332|FG000|Overall Study|Progressive Disease|13|||
25221700|NCT01565928|50500332|FG000|Overall Study|Withdrawal by Subject|1|||
25221701|NCT01565928|50500332|FG000|Overall Study|Death|2|||
25221702|NCT01565850|50500341|FG000|Overall Study|Adverse Event|0|||
25221703|NCT01565850|50500342|FG001|Overall Study|Adverse Event|1|||
25221704|NCT01565850|50500341|FG000|Overall Study|Lost to Follow-up|12|||
25221705|NCT01565850|50500342|FG001|Overall Study|Lost to Follow-up|4|||
25221706|NCT01565850|50500341|FG000|Overall Study|Investigator's Discretion|2|||
25221707|NCT01565850|50500342|FG001|Overall Study|Investigator's Discretion|1|||
25221708|NCT01565850|50500341|FG000|Overall Study|Participant noncompliance|2|||
25221709|NCT01565850|50500342|FG001|Overall Study|Participant noncompliance|0|||
25221710|NCT01565850|50500341|FG000|Overall Study|Withdrew Consent|4|||
25221711|NCT01565850|50500342|FG001|Overall Study|Withdrew Consent|2|||
25221712|NCT01565694|50500348|FG000|Dose-Titration Period|Adverse Event|4|||
25221713|NCT01565694|50500348|FG000|Dose-Titration Period|Protocol Violation|10|||
25221714|NCT01565694|50500348|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
25221715|NCT01543152|50500357|FG000|Overall Study|Withdrawal by Subject|0|||
25221716|NCT01543152|50500358|FG001|Overall Study|Withdrawal by Subject|2|||
25221717|NCT01543152|50500359|FG002|Overall Study|Withdrawal by Subject|0|||
25221718|NCT01543152|50500360|FG003|Overall Study|Withdrawal by Subject|0|||
25221719|NCT01543152|50500361|FG004|Overall Study|Withdrawal by Subject|0|||
25221720|NCT01590810|50500378|FG000|Overall Study|Physician Decision|0|||
25221721|NCT01590810|50500379|FG001|Overall Study|Physician Decision|1|||
25221722|NCT01590810|50500380|FG002|Overall Study|Physician Decision|1|||
25221723|NCT01590810|50500381|FG003|Overall Study|Physician Decision|0|||
25221724|NCT01590810|50500382|FG004|Overall Study|Physician Decision|0|||
25221725|NCT01542528|50500417|FG000|Overall Study|Lost to Follow-up|2|||
25221726|NCT01542528|50500418|FG001|Overall Study|Lost to Follow-up|1|||
25221727|NCT01542528|50500417|FG000|Overall Study|Physician Decision|1|||
25221728|NCT01542528|50500418|FG001|Overall Study|Physician Decision|0|||
25221729|NCT01542528|50500417|FG000|Overall Study|Withdrawal by Subject|9|||
25221730|NCT01542528|50500418|FG001|Overall Study|Withdrawal by Subject|6|||
25221731|NCT01565148|50500428|FG000|Overall Study|Withdrawal by Subject|1|||
25221732|NCT01565148|50500429|FG001|Overall Study|Withdrawal by Subject|1|||
25221733|NCT01565148|50500430|FG002|Overall Study|Withdrawal by Subject|1|||
25221734|NCT01565148|50500431|FG003|Overall Study|Withdrawal by Subject|2|||
25221735|NCT01565148|50500428|FG000|Overall Study|Lost to Follow-up|4|||
25221736|NCT01565148|50500429|FG001|Overall Study|Lost to Follow-up|4|||
25221737|NCT01565148|50500430|FG002|Overall Study|Lost to Follow-up|0|||
25221738|NCT01565148|50500431|FG003|Overall Study|Lost to Follow-up|3|||
25221739|NCT01565148|50500428|FG000|Overall Study|Rescue Therapy|8|||
25221740|NCT01565148|50500429|FG001|Overall Study|Rescue Therapy|5|||
25221741|NCT01565148|50500430|FG002|Overall Study|Rescue Therapy|5|||
25221742|NCT01565148|50500431|FG003|Overall Study|Rescue Therapy|8|||
25221743|NCT01565148|50500428|FG000|Overall Study|Death|0|||
25221744|NCT01565148|50500429|FG001|Overall Study|Death|0|||
25221745|NCT01565148|50500430|FG002|Overall Study|Death|1|||
25221746|NCT01565148|50500431|FG003|Overall Study|Death|0|||
25221747|NCT01565148|50500428|FG000|Overall Study|Physician Decision|2|||
25221748|NCT01565148|50500429|FG001|Overall Study|Physician Decision|5|||
25221749|NCT01565148|50500430|FG002|Overall Study|Physician Decision|0|||
25221750|NCT01565148|50500431|FG003|Overall Study|Physician Decision|0|||
25221751|NCT01564758|50500445|FG000|Overall Study|Death|8|||
25221752|NCT01564758|50500445|FG000|Overall Study|Adverse Event|3|||
25221753|NCT01564758|50500445|FG000|Overall Study|Other|3|||
25221754|NCT01541826|50500452|FG000|Overall Study|Lost to Follow-up|2|||
25221755|NCT01541826|50500453|FG001|Overall Study|Lost to Follow-up|3|||
25221756|NCT01541826|50500454|FG002|Overall Study|Lost to Follow-up|0|||
25221757|NCT01541826|50500452|FG000|Overall Study|Withdrawal by Subject|2|||
25221758|NCT01541826|50500453|FG001|Overall Study|Withdrawal by Subject|0|||
25221759|NCT01541826|50500454|FG002|Overall Study|Withdrawal by Subject|0|||
25221760|NCT01541748|50500462|FG000|Overall Study|Lost to Follow-up|17|||
25221761|NCT01541748|50500462|FG000|Overall Study|Moved out of state|1|||
25221762|NCT01541748|50500462|FG000|Overall Study|Withdrawal by Subject|7|||
25221763|NCT01541748|50500462|FG000|Overall Study|Screen failure|5|||
25221764|NCT01541748|50500462|FG000|Overall Study|Did not receive study device|1|||
25221765|NCT01589094|50500475|FG000|Overall Study|Did not receive treatment|2|||
25221766|NCT01563978|50500481|FG000|Overall Study|Physician Decision|1|||
25221767|NCT01563978|50500482|FG001|Overall Study|Physician Decision|0|||
25221768|NCT01563978|50500481|FG000|Overall Study|Lost to Follow-up|1|||
25221769|NCT01563978|50500482|FG001|Overall Study|Lost to Follow-up|0|||
25221770|NCT01563978|50500481|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
25221771|NCT01563978|50500482|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
25221772|NCT01563978|50500481|FG000|Overall Study|Adverse Event|1|||
25221773|NCT01563978|50500482|FG001|Overall Study|Adverse Event|2|||
25221774|NCT01563354|50500491|FG000|Core Phase|Adverse Event|5|||
25221775|NCT01563354|50500492|FG001|Core Phase|Adverse Event|15|||
25221776|NCT01563354|50500493|FG002|Core Phase|Adverse Event|13|||
25221777|NCT01563354|50500491|FG000|Core Phase|Withdrawal by Subject|1|||
25221778|NCT01563354|50500492|FG001|Core Phase|Withdrawal by Subject|0|||
25221779|NCT01563354|50500493|FG002|Core Phase|Withdrawal by Subject|3|||
25221780|NCT01563354|50500491|FG000|Core Phase|Lost to Follow-up|1|||
25221781|NCT01563354|50500492|FG001|Core Phase|Lost to Follow-up|0|||
25221782|NCT01563354|50500493|FG002|Core Phase|Lost to Follow-up|0|||
25221783|NCT01563354|50500491|FG000|Core Phase|Death|1|||
25221784|NCT01563354|50500492|FG001|Core Phase|Death|5|||
25221785|NCT01563354|50500493|FG002|Core Phase|Death|2|||
25221786|NCT01563354|50500491|FG000|Core Phase|Diseasse progression|18|||
25221787|NCT01563354|50500492|FG001|Core Phase|Diseasse progression|7|||
25221788|NCT01563354|50500493|FG002|Core Phase|Diseasse progression|8|||
25221789|NCT01563354|50500491|FG000|Core Phase|Protocol deviation|2|||
25221790|NCT01563354|50500492|FG001|Core Phase|Protocol deviation|0|||
25221791|NCT01563354|50500493|FG002|Core Phase|Protocol deviation|0|||
25221792|NCT01563354|50500491|FG000|Core Phase|PI decision - did not enter extension|0|||
25221793|NCT01563354|50500492|FG001|Core Phase|PI decision - did not enter extension|1|||
25221794|NCT01563354|50500493|FG002|Core Phase|PI decision - did not enter extension|0|||
25221795|NCT01563354|50500491|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
25221796|NCT01563354|50500492|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
25221797|NCT01563354|50500493|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
25221798|NCT01563354|50500491|FG000|Extension Phase|Adverse Event|0|||
25221799|NCT01563354|50500492|FG001|Extension Phase|Adverse Event|3|||
25221800|NCT01563354|50500493|FG002|Extension Phase|Adverse Event|2|||
25221801|NCT01563354|50500491|FG000|Extension Phase|Withdrawal by Subject|0|||
25221802|NCT01563354|50500492|FG001|Extension Phase|Withdrawal by Subject|1|||
25221803|NCT01563354|50500493|FG002|Extension Phase|Withdrawal by Subject|0|||
25221804|NCT01563354|50500491|FG000|Extension Phase|Administration problems|3|||
25221805|NCT01563354|50500492|FG001|Extension Phase|Administration problems|2|||
25221806|NCT01563354|50500493|FG002|Extension Phase|Administration problems|3|||
25221807|NCT01563354|50500491|FG000|Extension Phase|Disease progression|9|||
25221808|NCT01563354|50500492|FG001|Extension Phase|Disease progression|8|||
25221809|NCT01563354|50500493|FG002|Extension Phase|Disease progression|10|||
25221810|NCT01588548|50500507|FG000|Overall Study|Withdrawal by Subject|0|||
25221811|NCT01588548|50500508|FG001|Overall Study|Withdrawal by Subject|1|||
25221812|NCT01588548|50500509|FG002|Overall Study|Withdrawal by Subject|1|||
25221813|NCT01588548|50500510|FG003|Overall Study|Withdrawal by Subject|1|||
25221814|NCT01588548|50500511|FG004|Overall Study|Withdrawal by Subject|2|||
25221815|NCT01588548|50500512|FG005|Overall Study|Withdrawal by Subject|3|||
25221816|NCT01588548|50500507|FG000|Overall Study|Adverse Event|0|||
25221817|NCT01588548|50500508|FG001|Overall Study|Adverse Event|0|||
25221818|NCT01588548|50500509|FG002|Overall Study|Adverse Event|1|||
25221819|NCT01588548|50500510|FG003|Overall Study|Adverse Event|2|||
25221820|NCT01588548|50500511|FG004|Overall Study|Adverse Event|1|||
25221821|NCT01588548|50500512|FG005|Overall Study|Adverse Event|0|||
25221822|NCT01588548|50500507|FG000|Overall Study|Condition Under Investigation Worsened|3|||
25221823|NCT01588548|50500508|FG001|Overall Study|Condition Under Investigation Worsened|6|||
25221824|NCT01588548|50500509|FG002|Overall Study|Condition Under Investigation Worsened|4|||
25221825|NCT01588548|50500510|FG003|Overall Study|Condition Under Investigation Worsened|4|||
25221826|NCT01588548|50500511|FG004|Overall Study|Condition Under Investigation Worsened|3|||
25221827|NCT01588548|50500512|FG005|Overall Study|Condition Under Investigation Worsened|3|||
25221828|NCT01587924|50500530|FG000|Overall Study|Adverse Event|0|||
25221829|NCT01587924|50500531|FG001|Overall Study|Adverse Event|2|||
25221830|NCT01587924|50500532|FG002|Overall Study|Adverse Event|0|||
25221831|NCT01587924|50500533|FG003|Overall Study|Adverse Event|0|||
25221832|NCT01587924|50500530|FG000|Overall Study|Protocol Violation|2|||
25221833|NCT01587924|50500531|FG001|Overall Study|Protocol Violation|1|||
25221834|NCT01587924|50500532|FG002|Overall Study|Protocol Violation|2|||
25221835|NCT01587924|50500533|FG003|Overall Study|Protocol Violation|1|||
25221836|NCT01587924|50500530|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
25221837|NCT01587924|50500531|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
25221838|NCT01587924|50500532|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
25221839|NCT01587924|50500533|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
25221840|NCT01587924|50500530|FG000|Overall Study|Withdrawal by Subject|0|||
25221841|NCT01587924|50500531|FG001|Overall Study|Withdrawal by Subject|1|||
25221842|NCT01587924|50500532|FG002|Overall Study|Withdrawal by Subject|1|||
25221843|NCT01587924|50500533|FG003|Overall Study|Withdrawal by Subject|0|||
25221844|NCT01539642|50500545|FG000|Overall Study|Lack of Efficacy|20|||
25221845|NCT01539642|50500546|FG001|Overall Study|Lack of Efficacy|18|||
25221846|NCT01539642|50500545|FG000|Overall Study|Patient ready for early discharge|8|||
25221847|NCT01539642|50500546|FG001|Overall Study|Patient ready for early discharge|7|||
25221848|NCT01539642|50500545|FG000|Overall Study|Adverse Event|6|||
25221849|NCT01539642|50500546|FG001|Overall Study|Adverse Event|4|||
25221850|NCT01539642|50500545|FG000|Overall Study|Withdrawal by Subject|2|||
25221851|NCT01539642|50500546|FG001|Overall Study|Withdrawal by Subject|2|||
25221852|NCT01586364|50500552|FG000|Overall Study|Withdrawal by Subject|40|||
25221853|NCT01586364|50500552|FG000|Overall Study|Adverse Event|37|||
25221854|NCT01586364|50500552|FG000|Overall Study|Lost to Follow-up|17|||
25221855|NCT01586364|50500552|FG000|Overall Study|Protocol Violation|16|||
25221856|NCT01586364|50500552|FG000|Overall Study|Lack of Efficacy|1|||
25221857|NCT01586364|50500552|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
25221858|NCT01586364|50500552|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
25221859|NCT01586364|50500552|FG000|Overall Study|Other-Site closure due to PI illness|1|||
25221860|NCT01586364|50500552|FG000|Overall Study|Other-PI discretion, site closing|2|||
25221861|NCT01586364|50500552|FG000|Overall Study|Other-Not specified|1|||
25221862|NCT01538628|50500558|FG000|Overall Study|Withdrawal by Subject|1|||
25221863|NCT01538628|50500559|FG001|Overall Study|Withdrawal by Subject|1|||
25221864|NCT01538628|50500558|FG000|Overall Study|Lost to Follow-up|0|||
25221865|NCT01538628|50500559|FG001|Overall Study|Lost to Follow-up|1|||
25221866|NCT01538472|50500566|FG000|Overall Study|Disease Progression|3|||
25221867|NCT01538472|50500566|FG000|Overall Study|Death|1|||
25221868|NCT01562028|50500572|FG000|Overall Study|Withdrawal by Subject|1|||
25221869|NCT01562028|50500573|FG001|Overall Study|Withdrawal by Subject|1|||
25221870|NCT01562028|50500572|FG000|Overall Study|Lost to Follow-up|2|||
25221871|NCT01562028|50500573|FG001|Overall Study|Lost to Follow-up|1|||
25221872|NCT01585584|50500579|FG000|Overall Study|Lack of Efficacy|1|||
25221873|NCT01585584|50500579|FG000|Overall Study|Withdrawal by Subject|1|||
25221874|NCT01585584|50500579|FG000|Overall Study|Physician Decision|2|||
25221875|NCT01561560|50500583|FG000|First Two Weeks of Wear|Time/job conflict|0|||
25221876|NCT01561560|50500584|FG001|First Two Weeks of Wear|Time/job conflict|1|||
25221877|NCT01561560|50500583|FG000|First Two Weeks of Wear|Adverse Event|0|||
25318114|NCT00611533|50633774|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
25318115|NCT00611533|50633773|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
25318116|NCT00611533|50633774|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
25221878|NCT01561560|50500584|FG001|First Two Weeks of Wear|Adverse Event|1|||
25221879|NCT01561560|50500583|FG000|Second Two Weeks of Wear|Adverse Event|0|||
25221880|NCT01561560|50500584|FG001|Second Two Weeks of Wear|Adverse Event|1|||
25221881|NCT01537068|50500592|FG000|Overall Study|Lost to Follow-up|2|||
25221882|NCT01537068|50500593|FG001|Overall Study|Lost to Follow-up|1|||
25221883|NCT01537068|50500592|FG000|Overall Study|Adverse Event|0|||
25221884|NCT01537068|50500593|FG001|Overall Study|Adverse Event|1|||
25221885|NCT01537068|50500592|FG000|Overall Study|Withdrawal by Subject|1|||
25318117|NCT00953147|50633793|FG000|Overall Study|Adverse Event|8|||
25221886|NCT01537068|50500593|FG001|Overall Study|Withdrawal by Subject|1|||
25221887|NCT01537068|50500592|FG000|Overall Study|Lack of Efficacy|1|||
25221888|NCT01537068|50500593|FG001|Overall Study|Lack of Efficacy|0|||
25221889|NCT01585428|50500601|FG000|Overall Study|Death during treatment|1|||
25221890|NCT01585428|50500602|FG001|Overall Study|Death during treatment|0|||
25221891|NCT01585272|50500609|FG000|Overall Study|Adverse Event|22|||
25221892|NCT01585272|50500609|FG000|Overall Study|Protocol Violation|7|||
25221893|NCT01585272|50500609|FG000|Overall Study|Withdrawal by Subject|10|||
25221894|NCT01585194|50500613|FG000|Overall Study|Withdrawal by Subject|1|||
25221895|NCT01585194|50500613|FG000|Overall Study|Physician Decision|2|||
25221896|NCT01585194|50500613|FG000|Overall Study|Lack of insurance|1|||
25221897|NCT01560780|50500619|FG000|Overall Study|Death|2|||
25221898|NCT01560780|50500620|FG001|Overall Study|Death|1|||
25221899|NCT01560780|50500619|FG000|Overall Study|Patient Preference|11|||
25221900|NCT01560780|50500620|FG001|Overall Study|Patient Preference|11|||
25221901|NCT01585038|50500628|FG000|Overall Study|Adverse Event|2|||
25221902|NCT01585038|50500629|FG001|Overall Study|Adverse Event|2|||
25221903|NCT01560234|50500643|FG000|Overall Study|Lost to Follow-up|3|||
25221904|NCT01560234|50500644|FG001|Overall Study|Lost to Follow-up|0|||
25221905|NCT01560234|50500645|FG002|Overall Study|Lost to Follow-up|1|||
25221906|NCT01560234|50500646|FG003|Overall Study|Lost to Follow-up|0|||
25221907|NCT01560234|50500647|FG004|Overall Study|Lost to Follow-up|0|||
25221908|NCT01560234|50500648|FG005|Overall Study|Lost to Follow-up|2|||
25221909|NCT01560234|50500649|FG006|Overall Study|Lost to Follow-up|0|||
25221910|NCT01560234|50500650|FG007|Overall Study|Lost to Follow-up|2|||
25221911|NCT01559844|50500668|FG000|Overall Study|Consent Withdrawn|7|||
25221912|NCT01559844|50500668|FG000|Overall Study|Death|5|||
25221913|NCT01559844|50500668|FG000|Overall Study|Efficacy Failure|10|||
25221914|NCT01559844|50500668|FG000|Overall Study|No Longer A Transplant Candidate|3|||
25221915|NCT01584648|50500674|FG000|Overall Study|Death|136|||
25221916|NCT01584648|50500675|FG001|Overall Study|Death|146|||
25221917|NCT01584648|50500674|FG000|Overall Study|Lost to Follow-up|9|||
25221918|NCT01584648|50500675|FG001|Overall Study|Lost to Follow-up|9|||
25221919|NCT01584648|50500674|FG000|Overall Study|Investigator discretion|3|||
25221920|NCT01584648|50500675|FG001|Overall Study|Investigator discretion|2|||
25221921|NCT01584648|50500674|FG000|Overall Study|Withdrew consent|13|||
25221922|NCT01584648|50500675|FG001|Overall Study|Withdrew consent|4|||
25221923|NCT01584648|50500674|FG000|Overall Study|Study closed/terminated|50|||
25221924|NCT01584648|50500675|FG001|Overall Study|Study closed/terminated|23|||
25221925|NCT01584648|50500674|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
25221926|NCT01584648|50500675|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
25221927|NCT01559454|50500686|FG000|Overall Study|Lost to Follow-up|3|||
25221928|NCT01559454|50500687|FG001|Overall Study|Lost to Follow-up|2|||
25221929|NCT01559454|50500686|FG000|Overall Study|Withdrawal by Subject|0|||
25221930|NCT01559454|50500687|FG001|Overall Study|Withdrawal by Subject|1|||
25221931|NCT01559454|50500686|FG000|Overall Study|Physician Decision|0|||
25221932|NCT01559454|50500687|FG001|Overall Study|Physician Decision|1|||
25221933|NCT01559454|50500686|FG000|Overall Study|Protocol Violation|0|||
25221934|NCT01559454|50500687|FG001|Overall Study|Protocol Violation|1|||
25221935|NCT01559454|50500686|FG000|Overall Study|Lack of Efficacy|0|||
25221936|NCT01559454|50500687|FG001|Overall Study|Lack of Efficacy|1|||
25221937|NCT01584024|50500693|FG000|Overall Study|Lost to Follow-up|10|||
25221938|NCT01584024|50500693|FG000|Overall Study|Withdrawal by Subject|3|||
25221939|NCT01583166|50500700|FG000|Overall Study|Withdrawal by Subject|4|||
25221940|NCT01583166|50500701|FG001|Overall Study|Withdrawal by Subject|6|||
25221941|NCT01535274|50500709|FG000|Overall Study|Determined to be ineligible|0|||
25221942|NCT01535274|50500710|FG001|Overall Study|Determined to be ineligible|1|||
25221943|NCT01535274|50500709|FG000|Overall Study|Misallocated to propofol intervention|0|||
25221944|NCT01535274|50500710|FG001|Overall Study|Misallocated to propofol intervention|1|||
25221945|NCT01558752|50500720|FG000|Overall Study|Physician Decision|2|||
25221946|NCT01558752|50500721|FG001|Overall Study|Physician Decision|0|||
25221947|NCT01582854|50500729|FG000|Overall Study|Death|8|||
25221948|NCT01582854|50500730|FG001|Overall Study|Death|5|||
25221949|NCT01582854|50500729|FG000|Overall Study|Adverse Event|2|||
25221950|NCT01582854|50500730|FG001|Overall Study|Adverse Event|3|||
25221951|NCT01582854|50500729|FG000|Overall Study|Withdrawal by Participant|8|||
25221952|NCT01582854|50500730|FG001|Overall Study|Withdrawal by Participant|11|||
25221953|NCT01582854|50500729|FG000|Overall Study|Lost to Follow-up|1|||
25221954|NCT01582854|50500730|FG001|Overall Study|Lost to Follow-up|2|||
25221955|NCT01582854|50500729|FG000|Overall Study|Physician Decision|0|||
25221956|NCT01582854|50500730|FG001|Overall Study|Physician Decision|1|||
25221957|NCT01582854|50500729|FG000|Overall Study|Recurrent Stroke|13|||
25221958|NCT01582854|50500730|FG001|Overall Study|Recurrent Stroke|8|||
25221959|NCT01582854|50500729|FG000|Overall Study|Disallowed Concomitant Medication|3|||
25221960|NCT01582854|50500730|FG001|Overall Study|Disallowed Concomitant Medication|2|||
25318118|NCT00953147|50633794|FG001|Overall Study|Adverse Event|16|||
25221961|NCT01582854|50500729|FG000|Overall Study|Carotid or Neurosurgery|0|||
25221962|NCT01582854|50500730|FG001|Overall Study|Carotid or Neurosurgery|1|||
25221963|NCT01582854|50500729|FG000|Overall Study|General Anaesthesia|0|||
25221964|NCT01582854|50500730|FG001|Overall Study|General Anaesthesia|1|||
25221965|NCT01582854|50500729|FG000|Overall Study|Other Miscellaneous Reason|1|||
25221966|NCT01582854|50500730|FG001|Overall Study|Other Miscellaneous Reason|0|||
25221967|NCT01582308|50500736|FG000|Period 1|Withdrawal by Subject|0|||
25221968|NCT01582308|50500737|FG001|Period 1|Withdrawal by Subject|0|||
25221969|NCT01582308|50500738|FG002|Period 1|Withdrawal by Subject|0|||
25221970|NCT01582308|50500739|FG003|Period 1|Withdrawal by Subject|0|||
25221971|NCT01582308|50500740|FG004|Period 1|Withdrawal by Subject|0|||
25221972|NCT01582308|50500741|FG005|Period 1|Withdrawal by Subject|0|||
25221973|NCT01582308|50500742|FG006|Period 1|Withdrawal by Subject|1|||
25221974|NCT01582308|50500743|FG007|Period 1|Withdrawal by Subject|0|||
25221975|NCT01582308|50500744|FG008|Period 1|Withdrawal by Subject|0|||
25221976|NCT01582308|50500745|FG009|Period 1|Withdrawal by Subject|0|||
25221977|NCT01582308|50500736|FG000|10-day Washout Following Period 1|Physician Decision|0|||
25221978|NCT01582308|50500737|FG001|10-day Washout Following Period 1|Physician Decision|0|||
25221979|NCT01582308|50500738|FG002|10-day Washout Following Period 1|Physician Decision|0|||
25221980|NCT01582308|50500739|FG003|10-day Washout Following Period 1|Physician Decision|0|||
25221981|NCT01582308|50500740|FG004|10-day Washout Following Period 1|Physician Decision|1|||
25221982|NCT01582308|50500741|FG005|10-day Washout Following Period 1|Physician Decision|0|||
25221983|NCT01582308|50500742|FG006|10-day Washout Following Period 1|Physician Decision|0|||
25221984|NCT01582308|50500743|FG007|10-day Washout Following Period 1|Physician Decision|0|||
25221985|NCT01582308|50500744|FG008|10-day Washout Following Period 1|Physician Decision|0|||
25221986|NCT01582308|50500745|FG009|10-day Washout Following Period 1|Physician Decision|0|||
25221987|NCT01582308|50500736|FG000|Period 4|Physician Decision|1|||
25221988|NCT01582308|50500737|FG001|Period 4|Physician Decision|0|||
25221989|NCT01582308|50500738|FG002|Period 4|Physician Decision|0|||
25221990|NCT01582308|50500739|FG003|Period 4|Physician Decision|0|||
25221991|NCT01582308|50500740|FG004|Period 4|Physician Decision|0|||
25221992|NCT01582308|50500741|FG005|Period 4|Physician Decision|1|||
25221993|NCT01582308|50500742|FG006|Period 4|Physician Decision|0|||
25221994|NCT01582308|50500743|FG007|Period 4|Physician Decision|0|||
25221995|NCT01582308|50500744|FG008|Period 4|Physician Decision|0|||
25221996|NCT01582308|50500745|FG009|Period 4|Physician Decision|1|||
25221997|NCT01558674|50500760|FG000|Part 1|Study Terminated by Sponsor|10|||
25221998|NCT01558674|50500761|FG001|Part 1|Study Terminated by Sponsor|0|||
25221999|NCT01558674|50500760|FG000|Part 1|Withdrawal by Subject|1|||
25222000|NCT01558674|50500761|FG001|Part 1|Withdrawal by Subject|0|||
25222001|NCT01558596|50500782|FG000|Overall Study|Withdrawal by Subject|1|||
25222002|NCT01558596|50500783|FG001|Overall Study|Withdrawal by Subject|0|||
25222003|NCT01558596|50500782|FG000|Overall Study|surgery elsewhere or cancelled|1|||
25222004|NCT01558596|50500783|FG001|Overall Study|surgery elsewhere or cancelled|1|||
25222005|NCT01558596|50500782|FG000|Overall Study|Protocol Violation|1|||
25222006|NCT01558596|50500783|FG001|Overall Study|Protocol Violation|0|||
25222007|NCT01535040|50500791|FG000|Overall Study|Physician Decision|0|||
25222008|NCT01535040|50500792|FG001|Overall Study|Physician Decision|1|||
25222009|NCT01535040|50500791|FG000|Overall Study|Withdrawal by Subject|13|||
25222010|NCT01535040|50500792|FG001|Overall Study|Withdrawal by Subject|10|||
25222011|NCT01535040|50500791|FG000|Overall Study|Never Started|9|||
25222012|NCT01535040|50500792|FG001|Overall Study|Never Started|4|||
25222013|NCT01535040|50500791|FG000|Overall Study|Toxicity|7|||
25222014|NCT01535040|50500792|FG001|Overall Study|Toxicity|5|||
25222015|NCT01535040|50500791|FG000|Overall Study|Multiple Reasons|1|||
25222016|NCT01535040|50500792|FG001|Overall Study|Multiple Reasons|1|||
25222017|NCT01534962|50500802|FG000|Overall Study|Randomized but did not start treatment|2|||
25222018|NCT01534962|50500803|FG001|Overall Study|Randomized but did not start treatment|0|||
25222019|NCT01534962|50500804|FG002|Overall Study|Randomized but did not start treatment|0|||
25222020|NCT01534962|50500805|FG003|Overall Study|Randomized but did not start treatment|1|||
25222021|NCT01534962|50500802|FG000|Overall Study|Discontinued at AF recurrence|35|||
25222022|NCT01534962|50500803|FG001|Overall Study|Discontinued at AF recurrence|26|||
25222023|NCT01534962|50500804|FG002|Overall Study|Discontinued at AF recurrence|24|||
25222024|NCT01534962|50500805|FG003|Overall Study|Discontinued at AF recurrence|31|||
25222025|NCT01582152|50500817|FG000|Overall Study|Disease Progression|4|||
25222026|NCT01582152|50500818|FG001|Overall Study|Disease Progression|5|||
25222027|NCT01582152|50500817|FG000|Overall Study|Adverse Event|2|||
25222028|NCT01582152|50500818|FG001|Overall Study|Adverse Event|1|||
25222029|NCT01581684|50500834|FG000|Overall Study|Other reason not defined|0|||
25222030|NCT01581684|50500835|FG001|Overall Study|Other reason not defined|0|||
25222031|NCT01581684|50500836|FG002|Overall Study|Other reason not defined|0|||
25222032|NCT01581684|50500837|FG003|Overall Study|Other reason not defined|0|||
25222033|NCT01581684|50500838|FG004|Overall Study|Other reason not defined|0|||
25222034|NCT01581684|50500839|FG005|Overall Study|Other reason not defined|0|||
25222035|NCT01581684|50500840|FG006|Overall Study|Other reason not defined|0|||
25222036|NCT01581684|50500841|FG007|Overall Study|Other reason not defined|0|||
25318119|NCT00953147|50633795|FG002|Overall Study|Adverse Event|6|||
25222037|NCT01581684|50500842|FG008|Overall Study|Other reason not defined|1|||
25222038|NCT01581684|50500843|FG009|Overall Study|Other reason not defined|0|||
25222039|NCT01557582|50500876|FG000|Overall Study|Protocol Violation|4|||
25222040|NCT01557582|50500876|FG000|Overall Study|Operator error|2|||
25222041|NCT01557504|50500882|FG000|Overall Study|Physician Decision|1|||
25222042|NCT01557504|50500883|FG001|Overall Study|Physician Decision|0|||
25222043|NCT01557348|50500897|FG000|Overall Study|Adverse Event|6|||
25222044|NCT01557348|50500898|FG001|Overall Study|Adverse Event|16|||
25222045|NCT01557348|50500897|FG000|Overall Study|Infusion reaction event|5|||
25222046|NCT01557348|50500898|FG001|Overall Study|Infusion reaction event|5|||
25222047|NCT01557348|50500897|FG000|Overall Study|Death|7|||
25222048|NCT01557348|50500898|FG001|Overall Study|Death|4|||
25222049|NCT01557348|50500897|FG000|Overall Study|Insufficient Therapeutic Response|13|||
25222050|NCT01557348|50500898|FG001|Overall Study|Insufficient Therapeutic Response|28|||
25222051|NCT01557348|50500897|FG000|Overall Study|Withdrawal by Subject|5|||
25222052|NCT01557348|50500898|FG001|Overall Study|Withdrawal by Subject|4|||
25222053|NCT01557348|50500897|FG000|Overall Study|Lost to Follow-up|26|||
25222054|NCT01557348|50500898|FG001|Overall Study|Lost to Follow-up|22|||
25222055|NCT01557348|50500897|FG000|Overall Study|Administrative|18|||
25222056|NCT01557348|50500898|FG001|Overall Study|Administrative|11|||
25222057|NCT01580670|50500905|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
25222058|NCT01580670|50500905|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
25222059|NCT01534260|50500911|FG000|Overall Study|Adverse Event|1|||
25222060|NCT01534260|50500912|FG001|Overall Study|Adverse Event|8|||
25222061|NCT01534260|50500911|FG000|Overall Study|Death|2|||
25222062|NCT01534260|50500912|FG001|Overall Study|Death|0|||
25222063|NCT01534260|50500911|FG000|Overall Study|Lack of Efficacy|1|||
25222064|NCT01534260|50500912|FG001|Overall Study|Lack of Efficacy|1|||
25222065|NCT01534260|50500911|FG000|Overall Study|Withdrawal by Subject|1|||
25222066|NCT01534260|50500912|FG001|Overall Study|Withdrawal by Subject|3|||
25222067|NCT01534260|50500911|FG000|Overall Study|Disease Progression|8|||
25222068|NCT01534260|50500912|FG001|Overall Study|Disease Progression|6|||
25222069|NCT01534260|50500911|FG000|Overall Study|Physician Decision|3|||
25222070|NCT01534260|50500912|FG001|Overall Study|Physician Decision|1|||
25222071|NCT01534260|50500911|FG000|Overall Study|No treatment, per protocol|0|||
25222072|NCT01534260|50500912|FG001|Overall Study|No treatment, per protocol|1|||
25222073|NCT01534182|50500920|FG000|Overall Study|Administrative problems|1|||
25222074|NCT01534182|50500921|FG001|Overall Study|Administrative problems|0|||
25222075|NCT01534182|50500920|FG000|Overall Study|Withdrawal by Subject|4|||
25222076|NCT01534182|50500921|FG001|Overall Study|Withdrawal by Subject|7|||
25222077|NCT01534182|50500920|FG000|Overall Study|Adverse Event|7|||
25222078|NCT01534182|50500921|FG001|Overall Study|Adverse Event|3|||
25222079|NCT01579812|50500928|FG000|Overall Study|Ineligible after treatment start|40|||
25222080|NCT01579812|50500928|FG000|Overall Study|Patient choice|3|||
25222081|NCT01579812|50500928|FG000|Overall Study|Noncompliance|3|||
25222082|NCT01579812|50500928|FG000|Overall Study|Withdrawal by Subject|6|||
25222083|NCT01533714|50500941|FG000|Overall Study|Adverse Event|0|||
25222084|NCT01533714|50500942|FG001|Overall Study|Adverse Event|1|||
25318120|NCT00953147|50633793|FG000|Overall Study|Protocol Violation|2|||
25318121|NCT00953147|50633794|FG001|Overall Study|Protocol Violation|8|||
25318122|NCT00953147|50633795|FG002|Overall Study|Protocol Violation|4|||
25318123|NCT00953147|50633793|FG000|Overall Study|Withdrawal by Subject|13|||
25318124|NCT00953147|50633794|FG001|Overall Study|Withdrawal by Subject|15|||
25318125|NCT00953147|50633795|FG002|Overall Study|Withdrawal by Subject|12|||
25318126|NCT00953147|50633793|FG000|Overall Study|Lost to Follow-up|8|||
25318127|NCT00953147|50633794|FG001|Overall Study|Lost to Follow-up|9|||
25318128|NCT00953147|50633795|FG002|Overall Study|Lost to Follow-up|4|||
25318129|NCT00953147|50633793|FG000|Overall Study|Physician Decision|2|||
25318130|NCT00953147|50633794|FG001|Overall Study|Physician Decision|7|||
25318131|NCT00953147|50633795|FG002|Overall Study|Physician Decision|3|||
25318132|NCT00953147|50633793|FG000|Overall Study|Other|4|||
25318133|NCT00953147|50633794|FG001|Overall Study|Other|11|||
25318134|NCT00953147|50633795|FG002|Overall Study|Other|13|||
25318135|NCT00803205|50633805|FG000|Overall Study|Adverse Event|7|||
25318136|NCT00803205|50633806|FG001|Overall Study|Adverse Event|2|||
25318137|NCT00803205|50633805|FG000|Overall Study|Lost to Follow-up|1|||
25318138|NCT00803205|50633806|FG001|Overall Study|Lost to Follow-up|0|||
25318139|NCT00803205|50633805|FG000|Overall Study|Withdrawal by Subject|9|||
25318140|NCT00803205|50633806|FG001|Overall Study|Withdrawal by Subject|9|||
25318141|NCT00803205|50633805|FG000|Overall Study|Physician Decision|1|||
25318142|NCT00803205|50633806|FG001|Overall Study|Physician Decision|0|||
25318143|NCT00803205|50633805|FG000|Overall Study|Protocol Violation|1|||
25222085|NCT01533714|50500943|FG002|Overall Study|Adverse Event|2|||
25222086|NCT01533714|50500944|FG003|Overall Study|Adverse Event|2|||
25222087|NCT01533714|50500945|FG004|Overall Study|Adverse Event|2|||
25222088|NCT01533714|50500946|FG005|Overall Study|Adverse Event|1|||
25222089|NCT01533714|50500941|FG000|Overall Study|Lack of Efficacy|0|||
25222090|NCT01533714|50500942|FG001|Overall Study|Lack of Efficacy|0|||
25222091|NCT01533714|50500943|FG002|Overall Study|Lack of Efficacy|0|||
25222092|NCT01533714|50500944|FG003|Overall Study|Lack of Efficacy|0|||
25222093|NCT01533714|50500945|FG004|Overall Study|Lack of Efficacy|0|||
25222094|NCT01533714|50500946|FG005|Overall Study|Lack of Efficacy|1|||
25222095|NCT01533714|50500941|FG000|Overall Study|Withdrawal by Subject|0|||
25222096|NCT01533714|50500942|FG001|Overall Study|Withdrawal by Subject|1|||
25222097|NCT01533714|50500943|FG002|Overall Study|Withdrawal by Subject|0|||
25222098|NCT01533714|50500944|FG003|Overall Study|Withdrawal by Subject|1|||
25222099|NCT01533714|50500945|FG004|Overall Study|Withdrawal by Subject|1|||
25222100|NCT01533714|50500946|FG005|Overall Study|Withdrawal by Subject|0|||
25222101|NCT01533714|50500941|FG000|Overall Study|Exclusion criteria|0|||
25222102|NCT01533714|50500942|FG001|Overall Study|Exclusion criteria|1|||
25222103|NCT01533714|50500943|FG002|Overall Study|Exclusion criteria|0|||
25222104|NCT01533714|50500944|FG003|Overall Study|Exclusion criteria|0|||
25222105|NCT01533714|50500945|FG004|Overall Study|Exclusion criteria|0|||
25222106|NCT01533714|50500946|FG005|Overall Study|Exclusion criteria|0|||
25222107|NCT01533714|50500941|FG000|Overall Study|Positive for purified protein derivative|0|||
25222108|NCT01533714|50500942|FG001|Overall Study|Positive for purified protein derivative|0|||
25222109|NCT01533714|50500943|FG002|Overall Study|Positive for purified protein derivative|1|||
25222110|NCT01533714|50500944|FG003|Overall Study|Positive for purified protein derivative|0|||
25222111|NCT01533714|50500945|FG004|Overall Study|Positive for purified protein derivative|1|||
25222112|NCT01533714|50500946|FG005|Overall Study|Positive for purified protein derivative|0|||
25222113|NCT01533714|50500941|FG000|Overall Study|Withdrawal criteria|0|||
25222114|NCT01533714|50500942|FG001|Overall Study|Withdrawal criteria|0|||
25222115|NCT01533714|50500943|FG002|Overall Study|Withdrawal criteria|1|||
25222116|NCT01533714|50500944|FG003|Overall Study|Withdrawal criteria|0|||
25222117|NCT01533714|50500945|FG004|Overall Study|Withdrawal criteria|3|||
25222118|NCT01533714|50500946|FG005|Overall Study|Withdrawal criteria|1|||
25222119|NCT01533714|50500941|FG000|Overall Study|Ineligibility reason|0|||
25222120|NCT01533714|50500942|FG001|Overall Study|Ineligibility reason|0|||
25222121|NCT01533714|50500943|FG002|Overall Study|Ineligibility reason|0|||
25222122|NCT01533714|50500944|FG003|Overall Study|Ineligibility reason|1|||
25222123|NCT01533714|50500945|FG004|Overall Study|Ineligibility reason|0|||
25222124|NCT01533714|50500946|FG005|Overall Study|Ineligibility reason|0|||
25222125|NCT01533246|50500960|FG000|Overall Study|Adverse Event|1|||
25222126|NCT01533246|50500960|FG000|Overall Study|Withdrawal by Subject|1|||
25222127|NCT01579578|50500966|FG000|Overall Study|Death|4|||
25222128|NCT01579578|50500967|FG001|Overall Study|Death|1|||
25222129|NCT01579578|50500966|FG000|Overall Study|Lost to Follow-up|1|||
25222130|NCT01579578|50500967|FG001|Overall Study|Lost to Follow-up|1|||
25222131|NCT01579578|50500966|FG000|Overall Study|Withdrawal by Subject|2|||
25222132|NCT01579578|50500967|FG001|Overall Study|Withdrawal by Subject|1|||
25222133|NCT01579578|50500966|FG000|Overall Study|Eligibility criteria|3|||
25222134|NCT01579578|50500967|FG001|Overall Study|Eligibility criteria|9|||
25222135|NCT01579578|50500966|FG000|Overall Study|Ongoing|3|||
25222136|NCT01579578|50500967|FG001|Overall Study|Ongoing|0|||
25222137|NCT01578486|50500973|FG000|Overall Study|Physician Decision|3|||
25222138|NCT01578486|50500973|FG000|Overall Study|Withdrawal by Subject|2|||
25222139|NCT01532934|50500979|FG000|Overall Study|Lost to Follow-up|11|||
25222140|NCT01532934|50500980|FG001|Overall Study|Lost to Follow-up|11|||
25222141|NCT01532934|50500979|FG000|Overall Study|In controlled environment|3|||
25222142|NCT01532934|50500980|FG001|Overall Study|In controlled environment|2|||
25222143|NCT01532388|50500990|FG000|3-month Follow-up|Lost to Follow-up|68|||
25222144|NCT01532388|50500991|FG001|3-month Follow-up|Lost to Follow-up|68|||
25222145|NCT01532388|50500990|FG000|6-month Follow-up|Lost to Follow-up|74|||
25222146|NCT01532388|50500991|FG001|6-month Follow-up|Lost to Follow-up|66|||
25222147|NCT01532388|50500990|FG000|12-month Follow-up|Lost to Follow-up|69|||
25222148|NCT01532388|50500991|FG001|12-month Follow-up|Lost to Follow-up|67|||
25222149|NCT01555164|50500999|FG000|Overall Study|Adverse Event|5|||
25222150|NCT01555164|50501000|FG001|Overall Study|Adverse Event|7|||
25222151|NCT01555164|50500999|FG000|Overall Study|Hyperglycemia|0|||
25222152|NCT01555164|50501000|FG001|Overall Study|Hyperglycemia|1|||
25222153|NCT01555164|50500999|FG000|Overall Study|Investigator's Discretion|2|||
25222154|NCT01555164|50501000|FG001|Overall Study|Investigator's Discretion|2|||
25222155|NCT01555164|50500999|FG000|Overall Study|Lost to Follow-up|4|||
25222156|NCT01555164|50501000|FG001|Overall Study|Lost to Follow-up|3|||
25318144|NCT00803205|50633806|FG001|Overall Study|Protocol Violation|1|||
25318145|NCT00803205|50633805|FG000|Overall Study|Medical Monitor Decision|1|||
25222157|NCT01555164|50500999|FG000|Overall Study|Protocol Violation|9|||
25222158|NCT01555164|50501000|FG001|Overall Study|Protocol Violation|5|||
25222159|NCT01555164|50500999|FG000|Overall Study|Subject Non-compliance|14|||
25222160|NCT01555164|50501000|FG001|Overall Study|Subject Non-compliance|6|||
25222161|NCT01555164|50500999|FG000|Overall Study|Subject Withdrew Consent|6|||
25222162|NCT01555164|50501000|FG001|Overall Study|Subject Withdrew Consent|11|||
25222163|NCT01578330|50501006|FG000|Overall Study|Adverse Event|2|||
25318146|NCT00803205|50633806|FG001|Overall Study|Medical Monitor Decision|0|||
25222164|NCT01578330|50501006|FG000|Overall Study|Protocol Violation|5|||
25222165|NCT01577160|50501010|FG000|Overall Study|Adverse Event|9|||
25222166|NCT01577160|50501010|FG000|Overall Study|Lack of Efficacy|15|||
25222167|NCT01577160|50501010|FG000|Overall Study|Lost to Follow-up|40|||
25222168|NCT01577160|50501010|FG000|Overall Study|Withdrawal by Subject|18|||
25222169|NCT01577160|50501010|FG000|Overall Study|Subject Uncooperative|7|||
25222170|NCT01577160|50501010|FG000|Overall Study|Other|9|||
25222171|NCT01554618|50501016|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
25222172|NCT01554618|50501017|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
25222173|NCT01554618|50501016|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
25222174|NCT01554618|50501017|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
25222175|NCT01554618|50501016|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
25222176|NCT01554618|50501017|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
25222177|NCT01554618|50501016|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
25222178|NCT01554618|50501017|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
25222179|NCT01554618|50501016|FG000|Open-Label Extension Period|Physician Decision|0|||
25222180|NCT01554618|50501017|FG001|Open-Label Extension Period|Physician Decision|1|||
25222181|NCT01554618|50501016|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
25222182|NCT01554618|50501017|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
25222183|NCT01531998|50501027|FG000|Overall Study|Withdrawal by Subject|3|||
25222184|NCT01576146|50501031|FG000|Extension Period 1|Adverse Event|2|||
25222185|NCT01576146|50501031|FG000|Extension Period 1|Death|2|||
25222186|NCT01576146|50501031|FG000|Extension Period 1|Physician Decision|2|||
25222187|NCT01576146|50501031|FG000|Extension Period 1|Withdrawal by Subject|1|||
25222188|NCT01576146|50501031|FG000|Extension Period 1|Lost to Follow-up|1|||
25222189|NCT01576146|50501031|FG000|Extension Period 1|Parathyroidectomy|1|||
25222190|NCT01576146|50501031|FG000|Extension Period 1|Renal Transplant|1|||
25222191|NCT01576146|50501031|FG000|Extension Period 2|Sponsor Decision|13|||
25222192|NCT01576146|50501031|FG000|Extension Period 2|Death|1|||
25222193|NCT01576146|50501031|FG000|Extension Period 2|Adverse Event|1|||
25222194|NCT01576146|50501031|FG000|Extension Period 2|Renal Transplant|1|||
25222195|NCT01576146|50501031|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
25222196|NCT01553916|50501035|FG000|Overall Study|Withdrawal by Subject|2|||
25222197|NCT01553916|50501035|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
25222198|NCT01553136|50501041|FG000|Overall Study|Adverse Event|3|||
25222199|NCT01553136|50501042|FG001|Overall Study|Adverse Event|2|||
25222200|NCT01553136|50501041|FG000|Overall Study|Withdrawal by Subject|2|||
25222201|NCT01553136|50501042|FG001|Overall Study|Withdrawal by Subject|3|||
25222202|NCT01553136|50501041|FG000|Overall Study|Lost to Follow-up|4|||
25222203|NCT01553136|50501042|FG001|Overall Study|Lost to Follow-up|10|||
25222204|NCT01553136|50501041|FG000|Overall Study|Physician Decision|2|||
25222205|NCT01553136|50501042|FG001|Overall Study|Physician Decision|3|||
25222206|NCT01553136|50501041|FG000|Overall Study|Scheduling Difficulties|5|||
25222207|NCT01553136|50501042|FG001|Overall Study|Scheduling Difficulties|4|||
25222208|NCT01552902|50501051|FG000|Overall Study|Adverse Event|1|||
25222209|NCT01552902|50501052|FG001|Overall Study|Adverse Event|15|||
25222210|NCT01552902|50501053|FG002|Overall Study|Adverse Event|14|||
25222211|NCT01552902|50501051|FG000|Overall Study|Protocol Violation|3|||
25222212|NCT01552902|50501052|FG001|Overall Study|Protocol Violation|3|||
25222213|NCT01552902|50501053|FG002|Overall Study|Protocol Violation|3|||
25222214|NCT01552902|50501051|FG000|Overall Study|Lack of Efficacy|4|||
25222215|NCT01552902|50501052|FG001|Overall Study|Lack of Efficacy|3|||
25222216|NCT01552902|50501053|FG002|Overall Study|Lack of Efficacy|1|||
25222217|NCT01552902|50501051|FG000|Overall Study|Withdrawal by Subject|1|||
25222218|NCT01552902|50501052|FG001|Overall Study|Withdrawal by Subject|9|||
25222219|NCT01552902|50501053|FG002|Overall Study|Withdrawal by Subject|6|||
25222220|NCT01552902|50501051|FG000|Overall Study|Lost to Follow-up|1|||
25222221|NCT01552902|50501052|FG001|Overall Study|Lost to Follow-up|3|||
25222222|NCT01552902|50501053|FG002|Overall Study|Lost to Follow-up|6|||
25222223|NCT01552902|50501051|FG000|Overall Study|Other|3|||
25222224|NCT01552902|50501052|FG001|Overall Study|Other|4|||
25222225|NCT01552902|50501053|FG002|Overall Study|Other|3|||
25222226|NCT01529346|50501079|FG000|Overall Study|Lost to Follow-up|2|||
25222227|NCT01529346|50501080|FG001|Overall Study|Lost to Follow-up|0|||
25222228|NCT01529346|50501081|FG002|Overall Study|Lost to Follow-up|1|||
25222229|NCT01529346|50501082|FG003|Overall Study|Lost to Follow-up|0|||
25222230|NCT01529346|50501083|FG004|Overall Study|Lost to Follow-up|0|||
25222231|NCT01529346|50501079|FG000|Overall Study|Other|0|||
25222232|NCT01529346|50501080|FG001|Overall Study|Other|1|||
25222233|NCT01529346|50501081|FG002|Overall Study|Other|1|||
25222234|NCT01529346|50501082|FG003|Overall Study|Other|0|||
25222235|NCT01529346|50501083|FG004|Overall Study|Other|0|||
25222236|NCT01529268|50501107|FG000|Overall Study|Lost to Follow-up|9|||
25222237|NCT01529268|50501108|FG001|Overall Study|Lost to Follow-up|3|||
25222238|NCT01529268|50501107|FG000|Overall Study|Moved|3|||
25222239|NCT01529268|50501108|FG001|Overall Study|Moved|0|||
25222240|NCT01529112|50501116|FG000|Overall Study|Adverse Event|2|||
25222241|NCT01529112|50501117|FG001|Overall Study|Adverse Event|0|||
25222242|NCT01529112|50501116|FG000|Overall Study|Death|59|||
25222243|NCT01529112|50501117|FG001|Overall Study|Death|38|||
25222244|NCT01529112|50501116|FG000|Overall Study|Protocol Violation|1|||
25222245|NCT01529112|50501117|FG001|Overall Study|Protocol Violation|0|||
25222246|NCT01529112|50501116|FG000|Overall Study|Withdrawal by Subject|7|||
25222247|NCT01529112|50501117|FG001|Overall Study|Withdrawal by Subject|3|||
25222248|NCT01551420|50501125|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
25222249|NCT01551420|50501126|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
25222250|NCT01551420|50501125|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
25222251|NCT01551420|50501126|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
25222252|NCT01551420|50501125|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
25222253|NCT01551420|50501126|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
25222254|NCT01551420|50501125|FG000|Screened for Part B Eligibility|Declined participation|8|||
25222255|NCT01551420|50501126|FG001|Screened for Part B Eligibility|Declined participation|1|||
25222256|NCT01551420|50501125|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
25222257|NCT01551420|50501126|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
25222258|NCT01551420|50501125|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
25222259|NCT01551420|50501126|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
25222260|NCT01551420|50501125|FG000|Home Use (Part B)|Withdrawal by staff|0|||
25222261|NCT01551420|50501126|FG001|Home Use (Part B)|Withdrawal by staff|1|||
25222262|NCT01575054|50501134|FG000|Overall Study|Other Reasons|5|||
25222263|NCT01575054|50501135|FG001|Overall Study|Other Reasons|3|||
25222264|NCT01575054|50501134|FG000|Overall Study|Protocol Violation|2|||
25222265|NCT01575054|50501135|FG001|Overall Study|Protocol Violation|1|||
25222266|NCT01575054|50501134|FG000|Overall Study|Personal Reasons|10|||
25222267|NCT01575054|50501135|FG001|Overall Study|Personal Reasons|11|||
25222268|NCT01575054|50501134|FG000|Overall Study|Lost to Follow-up|3|||
25222269|NCT01575054|50501135|FG001|Overall Study|Lost to Follow-up|3|||
25222270|NCT01575054|50501134|FG000|Overall Study|Adverse Event|9|||
25222271|NCT01575054|50501135|FG001|Overall Study|Adverse Event|8|||
25222272|NCT01528254|50501143|FG000|Overall Study|Administrative problems|96|||
25222273|NCT01528254|50501144|FG001|Overall Study|Administrative problems|94|||
25222274|NCT01528254|50501143|FG000|Overall Study|Adverse Event|28|||
25222275|NCT01528254|50501144|FG001|Overall Study|Adverse Event|44|||
25222276|NCT01528254|50501143|FG000|Overall Study|Lost to Follow-up|17|||
25222277|NCT01528254|50501144|FG001|Overall Study|Lost to Follow-up|24|||
25222278|NCT01528254|50501143|FG000|Overall Study|Death|13|||
25222279|NCT01528254|50501144|FG001|Overall Study|Death|9|||
25222280|NCT01528254|50501143|FG000|Overall Study|Protocol deviation|9|||
25222281|NCT01528254|50501144|FG001|Overall Study|Protocol deviation|19|||
25222282|NCT01528254|50501143|FG000|Overall Study|New therapy for study indication|8|||
25222283|NCT01528254|50501144|FG001|Overall Study|New therapy for study indication|6|||
25222284|NCT01528254|50501143|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
25222285|NCT01528254|50501144|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
25222286|NCT01528254|50501143|FG000|Overall Study|Withdrawal by Subject|5|||
25222287|NCT01528254|50501144|FG001|Overall Study|Withdrawal by Subject|4|||
25222288|NCT01528254|50501143|FG000|Overall Study|Abnormal laboratory value(s)|3|||
25222289|NCT01528254|50501144|FG001|Overall Study|Abnormal laboratory value(s)|7|||
25222290|NCT01528254|50501143|FG000|Overall Study|Abnormal test procedure result(s)|1|||
25222291|NCT01528254|50501144|FG001|Overall Study|Abnormal test procedure result(s)|0|||
25222292|NCT01528254|50501143|FG000|Overall Study|No longer requires study drug|1|||
25222293|NCT01528254|50501144|FG001|Overall Study|No longer requires study drug|1|||
25222294|NCT01574352|50501153|FG000|Overall Study|Withdrawal by Subject|6|||
25222295|NCT01574352|50501154|FG001|Overall Study|Withdrawal by Subject|13|||
25222296|NCT01574352|50501153|FG000|Overall Study|Injury in non-camp related sport|1|||
25222297|NCT01574352|50501154|FG001|Overall Study|Injury in non-camp related sport|0|||
25222298|NCT01527006|50501162|FG000|Core Study|Adverse Event|0|||
25222299|NCT01527006|50501163|FG001|Core Study|Adverse Event|2|||
25222300|NCT01527006|50501162|FG000|Core Study|Lost to Follow-up|0|||
25222301|NCT01527006|50501163|FG001|Core Study|Lost to Follow-up|1|||
25222302|NCT01527006|50501162|FG000|Core Study|Subject Choice|1|||
25222303|NCT01527006|50501163|FG001|Core Study|Subject Choice|0|||
25222304|NCT01527006|50501162|FG000|Core Study|Inadequate Therapeutic Effect|1|||
25222305|NCT01527006|50501163|FG001|Core Study|Inadequate Therapeutic Effect|0|||
25222306|NCT01527006|50501162|FG000|Core Study|Withdrawal by Subject|0|||
25222307|NCT01527006|50501163|FG001|Core Study|Withdrawal by Subject|1|||
25222308|NCT01527006|50501162|FG000|Core Study|Other|0|||
25222309|NCT01527006|50501163|FG001|Core Study|Other|2|||
25222310|NCT01527006|50501162|FG000|Extension Phase|Adverse Event|4|||
25222311|NCT01527006|50501163|FG001|Extension Phase|Adverse Event|2|||
25222312|NCT01527006|50501162|FG000|Extension Phase|Lost to Follow-up|0|||
25222313|NCT01527006|50501163|FG001|Extension Phase|Lost to Follow-up|1|||
25222314|NCT01527006|50501162|FG000|Extension Phase|Subject Choice|1|||
25222315|NCT01527006|50501163|FG001|Extension Phase|Subject Choice|1|||
25222316|NCT01527006|50501162|FG000|Extension Phase|Inadequate therapeutic effect|1|||
25222317|NCT01527006|50501163|FG001|Extension Phase|Inadequate therapeutic effect|1|||
25222318|NCT01527006|50501162|FG000|Extension Phase|Other|0|||
25222319|NCT01527006|50501163|FG001|Extension Phase|Other|3|||
25222320|NCT01526928|50501181|FG000|Overall Study|Progressive Disease|35|||
25222321|NCT01526928|50501182|FG001|Overall Study|Progressive Disease|17|||
25222322|NCT01526928|50501183|FG002|Overall Study|Progressive Disease|150|||
25222323|NCT01526928|50501184|FG003|Overall Study|Progressive Disease|182|||
25222324|NCT01526928|50501185|FG004|Overall Study|Progressive Disease|76|||
25222325|NCT01526928|50501186|FG005|Overall Study|Progressive Disease|4|||
25222326|NCT01526928|50501181|FG000|Overall Study|Adverse Event|2|||
25222327|NCT01526928|50501182|FG001|Overall Study|Adverse Event|1|||
25222328|NCT01526928|50501183|FG002|Overall Study|Adverse Event|29|||
25222329|NCT01526928|50501184|FG003|Overall Study|Adverse Event|40|||
25222330|NCT01526928|50501185|FG004|Overall Study|Adverse Event|13|||
25222331|NCT01526928|50501186|FG005|Overall Study|Adverse Event|2|||
25222332|NCT01526928|50501181|FG000|Overall Study|Death|0|||
25222333|NCT01526928|50501182|FG001|Overall Study|Death|0|||
25222334|NCT01526928|50501183|FG002|Overall Study|Death|3|||
25222335|NCT01526928|50501184|FG003|Overall Study|Death|0|||
25222336|NCT01526928|50501185|FG004|Overall Study|Death|0|||
25222337|NCT01526928|50501186|FG005|Overall Study|Death|0|||
25222338|NCT01526928|50501181|FG000|Overall Study|Withdrawal by Subject|1|||
25222339|NCT01526928|50501182|FG001|Overall Study|Withdrawal by Subject|0|||
25222340|NCT01526928|50501183|FG002|Overall Study|Withdrawal by Subject|13|||
25222341|NCT01526928|50501184|FG003|Overall Study|Withdrawal by Subject|11|||
25222342|NCT01526928|50501185|FG004|Overall Study|Withdrawal by Subject|3|||
25222343|NCT01526928|50501186|FG005|Overall Study|Withdrawal by Subject|0|||
25222344|NCT01526928|50501181|FG000|Overall Study|Physician Decision|0|||
25222345|NCT01526928|50501182|FG001|Overall Study|Physician Decision|0|||
25222346|NCT01526928|50501183|FG002|Overall Study|Physician Decision|2|||
25222347|NCT01526928|50501184|FG003|Overall Study|Physician Decision|5|||
25222348|NCT01526928|50501185|FG004|Overall Study|Physician Decision|0|||
25222349|NCT01526928|50501186|FG005|Overall Study|Physician Decision|0|||
25222350|NCT01526928|50501181|FG000|Overall Study|Other Reason|0|||
25222351|NCT01526928|50501182|FG001|Overall Study|Other Reason|1|||
25222352|NCT01526928|50501183|FG002|Overall Study|Other Reason|11|||
25222353|NCT01526928|50501184|FG003|Overall Study|Other Reason|4|||
25222354|NCT01526928|50501185|FG004|Overall Study|Other Reason|1|||
25222355|NCT01526928|50501186|FG005|Overall Study|Other Reason|0|||
25222356|NCT01526928|50501181|FG000|Overall Study|Lost to Follow-up|0|||
25222357|NCT01526928|50501182|FG001|Overall Study|Lost to Follow-up|0|||
25222358|NCT01526928|50501183|FG002|Overall Study|Lost to Follow-up|0|||
25222359|NCT01526928|50501184|FG003|Overall Study|Lost to Follow-up|1|||
25222360|NCT01526928|50501185|FG004|Overall Study|Lost to Follow-up|0|||
25222361|NCT01526928|50501186|FG005|Overall Study|Lost to Follow-up|0|||
25222362|NCT01526928|50501181|FG000|Overall Study|Protocol Deviation|0|||
25222363|NCT01526928|50501182|FG001|Overall Study|Protocol Deviation|0|||
25222364|NCT01526928|50501183|FG002|Overall Study|Protocol Deviation|0|||
25222365|NCT01526928|50501184|FG003|Overall Study|Protocol Deviation|2|||
25222366|NCT01526928|50501185|FG004|Overall Study|Protocol Deviation|0|||
25222367|NCT01526928|50501186|FG005|Overall Study|Protocol Deviation|0|||
25222368|NCT01526928|50501181|FG000|Overall Study|Missing|0|||
25222369|NCT01526928|50501182|FG001|Overall Study|Missing|0|||
25222370|NCT01526928|50501183|FG002|Overall Study|Missing|1|||
25222371|NCT01526928|50501184|FG003|Overall Study|Missing|0|||
25222372|NCT01526928|50501185|FG004|Overall Study|Missing|2|||
25222373|NCT01526928|50501186|FG005|Overall Study|Missing|0|||
25222374|NCT01549860|50501244|FG000|Overall Study|Withdrawal by Subject|1|||
25222375|NCT01549860|50501245|FG001|Overall Study|Withdrawal by Subject|0|||
25222376|NCT01549860|50501244|FG000|Overall Study|Physician Decision|1|||
25222377|NCT01549860|50501245|FG001|Overall Study|Physician Decision|1|||
25222378|NCT01549392|50501253|FG000|Overall Study|Withdrawal by Subject|1|||
25222379|NCT01549392|50501254|FG001|Overall Study|Withdrawal by Subject|0|||
25222380|NCT01526148|50501262|FG000|Overall Study|Adverse Event|6|||
25222381|NCT01526148|50501263|FG001|Overall Study|Adverse Event|5|||
25222382|NCT01526148|50501262|FG000|Overall Study|Lost to Follow-up|3|||
25222383|NCT01526148|50501263|FG001|Overall Study|Lost to Follow-up|6|||
25222384|NCT01526148|50501262|FG000|Overall Study|Withdrawal by Subject|2|||
25222385|NCT01526148|50501263|FG001|Overall Study|Withdrawal by Subject|0|||
25222386|NCT01526148|50501262|FG000|Overall Study|Unstable Medical Condition|1|||
25318147|NCT00803205|50633805|FG000|Overall Study|Acquired a Lung Infection|0|||
25222387|NCT01526148|50501263|FG001|Overall Study|Unstable Medical Condition|0|||
25222388|NCT01526148|50501262|FG000|Overall Study|Unable to discontinue concomitant med|1|||
25222389|NCT01526148|50501263|FG001|Overall Study|Unable to discontinue concomitant med|0|||
25222390|NCT01526148|50501262|FG000|Overall Study|Moved out of state|1|||
25222391|NCT01526148|50501263|FG001|Overall Study|Moved out of state|0|||
25222392|NCT01526148|50501262|FG000|Overall Study|Incarcerated|0|||
25222393|NCT01526148|50501263|FG001|Overall Study|Incarcerated|2|||
25222394|NCT01572948|50501271|FG000|Overall Study|Lost to Follow-up|1|||
25222395|NCT01572948|50501272|FG001|Overall Study|Lost to Follow-up|0|||
25222396|NCT01572948|50501271|FG000|Overall Study|unable to contact|0|||
25222397|NCT01572948|50501272|FG001|Overall Study|unable to contact|1|||
25222398|NCT01525602|50501290|FG000|Overall Study|Adverse Event|1|||
25222399|NCT01525602|50501291|FG001|Overall Study|Adverse Event|0|||
25222400|NCT01525602|50501292|FG002|Overall Study|Adverse Event|1|||
25222401|NCT01525602|50501293|FG003|Overall Study|Adverse Event|1|||
25222402|NCT01525602|50501294|FG004|Overall Study|Adverse Event|3|||
25222403|NCT01525602|50501295|FG005|Overall Study|Adverse Event|3|||
25222404|NCT01525602|50501296|FG006|Overall Study|Adverse Event|0|||
25222405|NCT01525602|50501297|FG007|Overall Study|Adverse Event|1|||
25222406|NCT01525602|50501290|FG000|Overall Study|Disease progression|6|||
25222407|NCT01525602|50501291|FG001|Overall Study|Disease progression|3|||
25222408|NCT01525602|50501292|FG002|Overall Study|Disease progression|2|||
25222409|NCT01525602|50501293|FG003|Overall Study|Disease progression|5|||
25222410|NCT01525602|50501294|FG004|Overall Study|Disease progression|22|||
25222411|NCT01525602|50501295|FG005|Overall Study|Disease progression|2|||
25222412|NCT01525602|50501296|FG006|Overall Study|Disease progression|3|||
25222413|NCT01525602|50501297|FG007|Overall Study|Disease progression|3|||
25222414|NCT01525602|50501290|FG000|Overall Study|Clinical progression|2|||
25222415|NCT01525602|50501291|FG001|Overall Study|Clinical progression|0|||
25222416|NCT01525602|50501292|FG002|Overall Study|Clinical progression|0|||
25222417|NCT01525602|50501293|FG003|Overall Study|Clinical progression|0|||
25222418|NCT01525602|50501294|FG004|Overall Study|Clinical progression|0|||
25222419|NCT01525602|50501295|FG005|Overall Study|Clinical progression|0|||
25222420|NCT01525602|50501296|FG006|Overall Study|Clinical progression|1|||
25222421|NCT01525602|50501297|FG007|Overall Study|Clinical progression|1|||
25222422|NCT01525602|50501290|FG000|Overall Study|Non-compliance|0|||
25222423|NCT01525602|50501291|FG001|Overall Study|Non-compliance|0|||
25222424|NCT01525602|50501292|FG002|Overall Study|Non-compliance|0|||
25222425|NCT01525602|50501293|FG003|Overall Study|Non-compliance|0|||
25222426|NCT01525602|50501294|FG004|Overall Study|Non-compliance|1|||
25222427|NCT01525602|50501295|FG005|Overall Study|Non-compliance|0|||
25222428|NCT01525602|50501296|FG006|Overall Study|Non-compliance|0|||
25222429|NCT01525602|50501297|FG007|Overall Study|Non-compliance|0|||
25222430|NCT01525602|50501290|FG000|Overall Study|Withdrawal by Subject|0|||
25222431|NCT01525602|50501291|FG001|Overall Study|Withdrawal by Subject|0|||
25222432|NCT01525602|50501292|FG002|Overall Study|Withdrawal by Subject|0|||
25222433|NCT01525602|50501293|FG003|Overall Study|Withdrawal by Subject|0|||
25222434|NCT01525602|50501294|FG004|Overall Study|Withdrawal by Subject|3|||
25222435|NCT01525602|50501295|FG005|Overall Study|Withdrawal by Subject|1|||
25222436|NCT01525602|50501296|FG006|Overall Study|Withdrawal by Subject|0|||
25222437|NCT01525602|50501297|FG007|Overall Study|Withdrawal by Subject|1|||
25222438|NCT01525602|50501290|FG000|Overall Study|Physician Decision|0|||
25222439|NCT01525602|50501291|FG001|Overall Study|Physician Decision|0|||
25222440|NCT01525602|50501292|FG002|Overall Study|Physician Decision|0|||
25222441|NCT01525602|50501293|FG003|Overall Study|Physician Decision|0|||
25222442|NCT01525602|50501294|FG004|Overall Study|Physician Decision|3|||
25222443|NCT01525602|50501295|FG005|Overall Study|Physician Decision|0|||
25222444|NCT01525602|50501296|FG006|Overall Study|Physician Decision|1|||
25222445|NCT01525602|50501297|FG007|Overall Study|Physician Decision|0|||
25222446|NCT01525602|50501290|FG000|Overall Study|Death|0|||
25222447|NCT01525602|50501291|FG001|Overall Study|Death|0|||
25222448|NCT01525602|50501292|FG002|Overall Study|Death|0|||
25222449|NCT01525602|50501293|FG003|Overall Study|Death|0|||
25222450|NCT01525602|50501294|FG004|Overall Study|Death|1|||
25222451|NCT01525602|50501295|FG005|Overall Study|Death|1|||
25222452|NCT01525602|50501296|FG006|Overall Study|Death|0|||
25222453|NCT01525602|50501297|FG007|Overall Study|Death|0|||
25222454|NCT01525602|50501290|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
25222455|NCT01525602|50501291|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
25222456|NCT01525602|50501292|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
25222457|NCT01525602|50501293|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
25222458|NCT01525602|50501294|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
25222459|NCT01525602|50501295|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
25222460|NCT01525602|50501296|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
25222461|NCT01525602|50501297|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
25222462|NCT01549002|50501324|FG000|Overall Study|Excessive pain|0|||
25222463|NCT01549002|50501325|FG001|Overall Study|Excessive pain|2|||
25222464|NCT01549002|50501324|FG000|Overall Study|Moderate sedation required|0|||
25222465|NCT01549002|50501325|FG001|Overall Study|Moderate sedation required|2|||
25222466|NCT01548768|50501335|FG000|Overall Study|Withdrawal by Subject|0|||
25222467|NCT01548768|50501336|FG001|Overall Study|Withdrawal by Subject|2|||
25222468|NCT01548768|50501337|FG002|Overall Study|Withdrawal by Subject|1|||
25222469|NCT01548768|50501338|FG003|Overall Study|Withdrawal by Subject|0|||
25222470|NCT01548768|50501335|FG000|Overall Study|Physician Decision|1|||
25222471|NCT01548768|50501336|FG001|Overall Study|Physician Decision|0|||
25222472|NCT01548768|50501337|FG002|Overall Study|Physician Decision|0|||
25222473|NCT01548768|50501338|FG003|Overall Study|Physician Decision|0|||
25222474|NCT01548768|50501335|FG000|Overall Study|Adverse Event|0|||
25222475|NCT01548768|50501336|FG001|Overall Study|Adverse Event|0|||
25222476|NCT01548768|50501337|FG002|Overall Study|Adverse Event|0|||
25222477|NCT01548768|50501338|FG003|Overall Study|Adverse Event|1|||
25222478|NCT01548768|50501335|FG000|Overall Study|Non-Compliance|0|||
25222479|NCT01548768|50501336|FG001|Overall Study|Non-Compliance|0|||
25222480|NCT01548768|50501337|FG002|Overall Study|Non-Compliance|0|||
25222481|NCT01548768|50501338|FG003|Overall Study|Non-Compliance|3|||
25222482|NCT01572792|50501355|FG000|Lead-in Study|Lost to Follow-up|5|||
25222483|NCT01572792|50501356|FG001|Lead-in Study|Lost to Follow-up|9|||
25222484|NCT01572792|50501357|FG002|Lead-in Study|Lost to Follow-up|4|||
25222485|NCT01572792|50501358|FG003|Lead-in Study|Lost to Follow-up|2|||
25222486|NCT01572792|50501359|FG004|Lead-in Study|Lost to Follow-up|4|||
25222487|NCT01572792|50501355|FG000|Lead-in Study|Withdrawal by Subject|22|||
25222488|NCT01572792|50501356|FG001|Lead-in Study|Withdrawal by Subject|11|||
25222489|NCT01572792|50501357|FG002|Lead-in Study|Withdrawal by Subject|12|||
25222490|NCT01572792|50501358|FG003|Lead-in Study|Withdrawal by Subject|24|||
25222491|NCT01572792|50501359|FG004|Lead-in Study|Withdrawal by Subject|11|||
25222492|NCT01572792|50501355|FG000|Lead-in Study|Protocol Violation|19|||
25222493|NCT01572792|50501356|FG001|Lead-in Study|Protocol Violation|10|||
25222494|NCT01572792|50501357|FG002|Lead-in Study|Protocol Violation|12|||
25222495|NCT01572792|50501358|FG003|Lead-in Study|Protocol Violation|13|||
25222496|NCT01572792|50501359|FG004|Lead-in Study|Protocol Violation|21|||
25222497|NCT01572792|50501355|FG000|Lead-in Study|Lack of Efficacy|20|||
25222498|NCT01572792|50501356|FG001|Lead-in Study|Lack of Efficacy|5|||
25222499|NCT01572792|50501357|FG002|Lead-in Study|Lack of Efficacy|4|||
25222500|NCT01572792|50501358|FG003|Lead-in Study|Lack of Efficacy|8|||
25222501|NCT01572792|50501359|FG004|Lead-in Study|Lack of Efficacy|10|||
25222502|NCT01572792|50501355|FG000|Lead-in Study|Adverse Event|21|||
25222503|NCT01572792|50501356|FG001|Lead-in Study|Adverse Event|21|||
25222504|NCT01572792|50501357|FG002|Lead-in Study|Adverse Event|22|||
25222505|NCT01572792|50501358|FG003|Lead-in Study|Adverse Event|16|||
25222506|NCT01572792|50501359|FG004|Lead-in Study|Adverse Event|14|||
25222507|NCT01572792|50501355|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
25222508|NCT01572792|50501356|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
25222509|NCT01572792|50501357|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
25222510|NCT01572792|50501358|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
25222511|NCT01572792|50501359|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
25222512|NCT01572792|50501355|FG000|Extension Study|Lost to Follow-up|6|||
25222513|NCT01572792|50501356|FG001|Extension Study|Lost to Follow-up|2|||
25222514|NCT01572792|50501357|FG002|Extension Study|Lost to Follow-up|0|||
25222515|NCT01572792|50501358|FG003|Extension Study|Lost to Follow-up|3|||
25222516|NCT01572792|50501359|FG004|Extension Study|Lost to Follow-up|3|||
25222517|NCT01572792|50501355|FG000|Extension Study|Withdrawal by Subject|7|||
25222518|NCT01572792|50501356|FG001|Extension Study|Withdrawal by Subject|6|||
25222519|NCT01572792|50501357|FG002|Extension Study|Withdrawal by Subject|11|||
25222520|NCT01572792|50501358|FG003|Extension Study|Withdrawal by Subject|8|||
25222521|NCT01572792|50501359|FG004|Extension Study|Withdrawal by Subject|14|||
25222522|NCT01572792|50501355|FG000|Extension Study|Protocol Violation|0|||
25222523|NCT01572792|50501356|FG001|Extension Study|Protocol Violation|4|||
25222524|NCT01572792|50501357|FG002|Extension Study|Protocol Violation|3|||
25222525|NCT01572792|50501358|FG003|Extension Study|Protocol Violation|4|||
25222526|NCT01572792|50501359|FG004|Extension Study|Protocol Violation|3|||
25222527|NCT01572792|50501355|FG000|Extension Study|Lack of Efficacy|2|||
25222528|NCT01572792|50501356|FG001|Extension Study|Lack of Efficacy|3|||
25222529|NCT01572792|50501357|FG002|Extension Study|Lack of Efficacy|3|||
25222530|NCT01572792|50501358|FG003|Extension Study|Lack of Efficacy|2|||
25222531|NCT01572792|50501359|FG004|Extension Study|Lack of Efficacy|2|||
25222532|NCT01572792|50501355|FG000|Extension Study|Adverse Event|7|||
25222533|NCT01572792|50501356|FG001|Extension Study|Adverse Event|6|||
25222534|NCT01572792|50501357|FG002|Extension Study|Adverse Event|5|||
25222535|NCT01572792|50501358|FG003|Extension Study|Adverse Event|6|||
25222536|NCT01572792|50501359|FG004|Extension Study|Adverse Event|4|||
25222537|NCT01572792|50501355|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
25222538|NCT01572792|50501356|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
25222539|NCT01572792|50501357|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
25222540|NCT01572792|50501358|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
25222541|NCT01572792|50501359|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
25222542|NCT01547598|50501374|FG000|Overall Study|Withdrew consent|1|||
25318148|NCT00803205|50633806|FG001|Overall Study|Acquired a Lung Infection|1|||
24976519|NCT03538054|50065428|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
25222543|NCT01547598|50501375|FG001|Overall Study|Withdrew consent|1|||
25222544|NCT01547598|50501374|FG000|Overall Study|Lost to Follow-up|1|||
25222545|NCT01547598|50501375|FG001|Overall Study|Lost to Follow-up|1|||
25222546|NCT01547598|50501374|FG000|Overall Study|Adverse Event|1|||
25222547|NCT01547598|50501375|FG001|Overall Study|Adverse Event|1|||
25222548|NCT01547598|50501374|FG000|Overall Study|Protocol Violation|1|||
25222549|NCT01547598|50501375|FG001|Overall Study|Protocol Violation|1|||
25222550|NCT01547598|50501374|FG000|Overall Study|Other Miscellaneous Reasons|2|||
25222551|NCT01547598|50501375|FG001|Overall Study|Other Miscellaneous Reasons|1|||
25222552|NCT01547286|50501382|FG000|Overall Study|Did not meet all eligibility criteria|1|||
25222553|NCT01547286|50501382|FG000|Overall Study|Physician Decision|1|||
25222554|NCT01547130|50501389|FG000|Overall Study|Lost to Follow-up|9|||
25222555|NCT01547130|50501390|FG001|Overall Study|Lost to Follow-up|5|||
25222556|NCT01524978|50501415|FG000|Overall Study|Other|16|||
25222557|NCT01524978|50501416|FG001|Overall Study|Other|2|||
25222558|NCT01524978|50501417|FG002|Overall Study|Other|1|||
25222559|NCT01524978|50501418|FG003|Overall Study|Other|2|||
25222560|NCT01524978|50501419|FG004|Overall Study|Other|1|||
25222561|NCT01524978|50501420|FG005|Overall Study|Other|3|||
25222562|NCT01524978|50501421|FG006|Overall Study|Other|17|||
25222563|NCT01524978|50501422|FG007|Overall Study|Other|1|||
25222564|NCT01524978|50501423|FG008|Overall Study|Other|2|||
25222565|NCT01524978|50501424|FG009|Overall Study|Other|2|||
25222566|NCT01524978|50501425|FG010|Overall Study|Other|5|||
25222567|NCT01524978|50501415|FG000|Overall Study|Withdrawal by Subject|12|||
25222568|NCT01524978|50501416|FG001|Overall Study|Withdrawal by Subject|0|||
25222569|NCT01524978|50501417|FG002|Overall Study|Withdrawal by Subject|1|||
25222570|NCT01524978|50501418|FG003|Overall Study|Withdrawal by Subject|1|||
25222571|NCT01524978|50501419|FG004|Overall Study|Withdrawal by Subject|3|||
25222572|NCT01524978|50501420|FG005|Overall Study|Withdrawal by Subject|1|||
25222573|NCT01524978|50501421|FG006|Overall Study|Withdrawal by Subject|6|||
25222574|NCT01524978|50501422|FG007|Overall Study|Withdrawal by Subject|2|||
25222575|NCT01524978|50501423|FG008|Overall Study|Withdrawal by Subject|4|||
25222576|NCT01524978|50501424|FG009|Overall Study|Withdrawal by Subject|0|||
25222577|NCT01524978|50501425|FG010|Overall Study|Withdrawal by Subject|5|||
25222578|NCT01524978|50501415|FG000|Overall Study|Lost to Follow-up|0|||
25222579|NCT01524978|50501416|FG001|Overall Study|Lost to Follow-up|0|||
25222580|NCT01524978|50501417|FG002|Overall Study|Lost to Follow-up|3|||
25222581|NCT01524978|50501418|FG003|Overall Study|Lost to Follow-up|0|||
25222582|NCT01524978|50501419|FG004|Overall Study|Lost to Follow-up|1|||
25222583|NCT01524978|50501420|FG005|Overall Study|Lost to Follow-up|1|||
25222584|NCT01524978|50501421|FG006|Overall Study|Lost to Follow-up|2|||
25222585|NCT01524978|50501422|FG007|Overall Study|Lost to Follow-up|0|||
25222586|NCT01524978|50501423|FG008|Overall Study|Lost to Follow-up|1|||
25222587|NCT01524978|50501424|FG009|Overall Study|Lost to Follow-up|1|||
25222588|NCT01524978|50501425|FG010|Overall Study|Lost to Follow-up|1|||
25222589|NCT01524978|50501415|FG000|Overall Study|Death|34|||
25222590|NCT01524978|50501416|FG001|Overall Study|Death|2|||
25222591|NCT01524978|50501417|FG002|Overall Study|Death|5|||
25222592|NCT01524978|50501418|FG003|Overall Study|Death|24|||
25222593|NCT01524978|50501419|FG004|Overall Study|Death|4|||
25222594|NCT01524978|50501420|FG005|Overall Study|Death|4|||
25222595|NCT01524978|50501421|FG006|Overall Study|Death|1|||
25222596|NCT01524978|50501422|FG007|Overall Study|Death|9|||
25222597|NCT01524978|50501423|FG008|Overall Study|Death|5|||
25222598|NCT01524978|50501424|FG009|Overall Study|Death|6|||
25222599|NCT01524978|50501425|FG010|Overall Study|Death|17|||
25222600|NCT01524900|50501445|FG000|Overall Study|Lost to Follow-up|3|||
25222601|NCT01524900|50501446|FG001|Overall Study|Lost to Follow-up|12|||
25222602|NCT01524900|50501447|FG002|Overall Study|Lost to Follow-up|1|||
25222603|NCT01524900|50501448|FG003|Overall Study|Lost to Follow-up|0|||
25222604|NCT01524900|50501449|FG004|Overall Study|Lost to Follow-up|0|||
25222605|NCT01524900|50501445|FG000|Overall Study|Other reason than stated above|1|||
25222606|NCT01524900|50501446|FG001|Overall Study|Other reason than stated above|1|||
25222607|NCT01524900|50501447|FG002|Overall Study|Other reason than stated above|0|||
25222608|NCT01524900|50501448|FG003|Overall Study|Other reason than stated above|0|||
25222609|NCT01524900|50501449|FG004|Overall Study|Other reason than stated above|0|||
25222610|NCT01524900|50501445|FG000|Overall Study|No reason documented|2|||
25222611|NCT01524900|50501446|FG001|Overall Study|No reason documented|1|||
25222612|NCT01524900|50501447|FG002|Overall Study|No reason documented|0|||
25222613|NCT01524900|50501448|FG003|Overall Study|No reason documented|1|||
25222614|NCT01524900|50501449|FG004|Overall Study|No reason documented|0|||
25222615|NCT01524198|50501464|FG000|Overall Study|Protocol Violation|8|||
25222616|NCT01524198|50501465|FG001|Overall Study|Protocol Violation|6|||
25222617|NCT01524198|50501464|FG000|Overall Study|Withdrawal by Subject|15|||
25222618|NCT01524198|50501465|FG001|Overall Study|Withdrawal by Subject|10|||
25222619|NCT01523886|50501473|FG000|Overall Study|surgery cancelled|0|||
25222620|NCT01523886|50501474|FG001|Overall Study|surgery cancelled|1|||
25222621|NCT01546038|50501486|FG000|Overall Study|Death|15|||
25222622|NCT01546038|50501487|FG001|Overall Study|Death|6|||
25222623|NCT01546038|50501488|FG002|Overall Study|Death|4|||
25222624|NCT01546038|50501489|FG003|Overall Study|Death|2|||
25222625|NCT01546038|50501490|FG004|Overall Study|Death|9|||
25222626|NCT01546038|50501491|FG005|Overall Study|Death|3|||
25222627|NCT01546038|50501492|FG006|Overall Study|Death|46|||
25222628|NCT01546038|50501493|FG007|Overall Study|Death|76|||
25222629|NCT01546038|50501494|FG008|Overall Study|Death|39|||
25222630|NCT01546038|50501486|FG000|Overall Study|Lost to Follow-up|0|||
25222631|NCT01546038|50501487|FG001|Overall Study|Lost to Follow-up|0|||
25222632|NCT01546038|50501488|FG002|Overall Study|Lost to Follow-up|0|||
25222633|NCT01546038|50501489|FG003|Overall Study|Lost to Follow-up|0|||
25222634|NCT01546038|50501490|FG004|Overall Study|Lost to Follow-up|1|||
25222635|NCT01546038|50501491|FG005|Overall Study|Lost to Follow-up|0|||
25222636|NCT01546038|50501492|FG006|Overall Study|Lost to Follow-up|2|||
25222637|NCT01546038|50501493|FG007|Overall Study|Lost to Follow-up|1|||
25222638|NCT01546038|50501494|FG008|Overall Study|Lost to Follow-up|0|||
25222639|NCT01546038|50501486|FG000|Overall Study|Withdrawal by Subject|1|||
25222640|NCT01546038|50501487|FG001|Overall Study|Withdrawal by Subject|0|||
25222641|NCT01546038|50501488|FG002|Overall Study|Withdrawal by Subject|0|||
25222642|NCT01546038|50501489|FG003|Overall Study|Withdrawal by Subject|1|||
25222643|NCT01546038|50501490|FG004|Overall Study|Withdrawal by Subject|0|||
25222644|NCT01546038|50501491|FG005|Overall Study|Withdrawal by Subject|1|||
25222645|NCT01546038|50501492|FG006|Overall Study|Withdrawal by Subject|3|||
25222646|NCT01546038|50501493|FG007|Overall Study|Withdrawal by Subject|3|||
25222647|NCT01546038|50501494|FG008|Overall Study|Withdrawal by Subject|1|||
25222648|NCT01546038|50501486|FG000|Overall Study|: Randomized, not treated|0|||
25222649|NCT01546038|50501487|FG001|Overall Study|: Randomized, not treated|0|||
25222650|NCT01546038|50501488|FG002|Overall Study|: Randomized, not treated|0|||
25222651|NCT01546038|50501489|FG003|Overall Study|: Randomized, not treated|0|||
25222652|NCT01546038|50501490|FG004|Overall Study|: Randomized, not treated|0|||
25222653|NCT01546038|50501491|FG005|Overall Study|: Randomized, not treated|0|||
25222654|NCT01546038|50501492|FG006|Overall Study|: Randomized, not treated|2|||
25222655|NCT01546038|50501493|FG007|Overall Study|: Randomized, not treated|4|||
25222656|NCT01546038|50501494|FG008|Overall Study|: Randomized, not treated|3|||
25222657|NCT01571232|50501546|FG000|Overall Study|Lost to Follow-up|0|||
25222658|NCT01571232|50501547|FG001|Overall Study|Lost to Follow-up|1|||
25222659|NCT01571232|50501546|FG000|Overall Study|Withdrawal by Subject|1|||
25222660|NCT01571232|50501547|FG001|Overall Study|Withdrawal by Subject|0|||
25222661|NCT01544478|50501554|FG000|Overall Study|Adverse Event|1|||
25222662|NCT01544478|50501554|FG000|Overall Study|Death|1|||
25222663|NCT01544478|50501554|FG000|Overall Study|Lost to Follow-up|48|||
25222664|NCT01544478|50501554|FG000|Overall Study|Physician Decision|15|||
25222665|NCT01544478|50501554|FG000|Overall Study|Pregnancy|1|||
25222666|NCT01544478|50501554|FG000|Overall Study|Withdrawal by Subject|52|||
25222667|NCT01522950|50501561|FG000|Overall Study|Withdrawal by Subject|3|||
25222668|NCT01522950|50501562|FG001|Overall Study|Withdrawal by Subject|2|||
25222669|NCT01522950|50501563|FG002|Overall Study|Withdrawal by Subject|1|||
25222670|NCT01522950|50501561|FG000|Overall Study|Adverse Event|3|||
25222671|NCT01522950|50501562|FG001|Overall Study|Adverse Event|1|||
25222672|NCT01522950|50501563|FG002|Overall Study|Adverse Event|1|||
25222673|NCT01522950|50501561|FG000|Overall Study|Protocol Violation|0|||
25222674|NCT01522950|50501562|FG001|Overall Study|Protocol Violation|0|||
25222675|NCT01522950|50501563|FG002|Overall Study|Protocol Violation|2|||
25222676|NCT01522950|50501561|FG000|Overall Study|Death|0|||
25222677|NCT01522950|50501562|FG001|Overall Study|Death|1|||
25222678|NCT01522950|50501563|FG002|Overall Study|Death|1|||
25222679|NCT01522950|50501561|FG000|Overall Study|Study Medication Sensitivity|0|||
25222680|NCT01522950|50501562|FG001|Overall Study|Study Medication Sensitivity|1|||
25222681|NCT01522950|50501563|FG002|Overall Study|Study Medication Sensitivity|0|||
25222682|NCT01522404|50501573|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
25222683|NCT01522404|50501574|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
25222684|NCT01522404|50501573|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
25318149|NCT00803205|50633805|FG000|Overall Study|Sponsor Decision|0|||
25318150|NCT00803205|50633806|FG001|Overall Study|Sponsor Decision|1|||
25318151|NCT00952523|50633812|FG000|Overall Study|Withdrawal by Subject|7|||
25318152|NCT02232737|50633821|FG000|Overall Study|Lost to Follow-up|18|||
25318153|NCT02232737|50633822|FG001|Overall Study|Lost to Follow-up|28|||
25318154|NCT02232737|50633823|FG002|Overall Study|Lost to Follow-up|33|||
25318155|NCT02232737|50633821|FG000|Overall Study|Personal reasons|7|||
25318156|NCT02232737|50633822|FG001|Overall Study|Personal reasons|8|||
25318157|NCT02232737|50633823|FG002|Overall Study|Personal reasons|14|||
25318158|NCT02232737|50633821|FG000|Overall Study|Adverse Event|6|||
25318159|NCT02232737|50633822|FG001|Overall Study|Adverse Event|3|||
25318160|NCT02232737|50633823|FG002|Overall Study|Adverse Event|8|||
25222685|NCT01522404|50501574|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
25222686|NCT01522404|50501573|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
25222687|NCT01522404|50501574|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
25222688|NCT01570686|50501590|FG000|Overall Study|Abnormal test procedure result(s)|1|||
25318161|NCT02232737|50633821|FG000|Overall Study|Incarcerated|2|||
25222689|NCT01570686|50501591|FG001|Overall Study|Abnormal test procedure result(s)|1|||
25222690|NCT01570686|50501590|FG000|Overall Study|Administrative problems|0|||
25222691|NCT01570686|50501591|FG001|Overall Study|Administrative problems|1|||
25222692|NCT01570686|50501590|FG000|Overall Study|Adverse Event|8|||
25222693|NCT01570686|50501591|FG001|Overall Study|Adverse Event|6|||
25222694|NCT01570686|50501590|FG000|Overall Study|Lost to Follow-up|4|||
25222695|NCT01570686|50501591|FG001|Overall Study|Lost to Follow-up|3|||
25222696|NCT01570686|50501590|FG000|Overall Study|Protocol Deviation|3|||
25222697|NCT01570686|50501591|FG001|Overall Study|Protocol Deviation|0|||
25222698|NCT01570686|50501590|FG000|Overall Study|Withdrawal by Subject|4|||
25222699|NCT01570686|50501591|FG001|Overall Study|Withdrawal by Subject|4|||
25222700|NCT01570686|50501590|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
25222701|NCT01570686|50501591|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
25222702|NCT01522248|50501599|FG000|Overall Study|Lost to Follow-up|1|||
25222703|NCT01522248|50501600|FG001|Overall Study|Lost to Follow-up|0|||
25222704|NCT01543776|50501613|FG000|Overall Study|Withdrawal by Subject|2|||
25222705|NCT01543776|50501614|FG001|Overall Study|Withdrawal by Subject|2|||
25222706|NCT01518192|50501623|FG000|Overall Study|Lost to Follow-up|29|||
25222707|NCT01518192|50501624|FG001|Overall Study|Lost to Follow-up|26|||
25222708|NCT01518192|50501625|FG002|Overall Study|Lost to Follow-up|35|||
25222709|NCT01569594|50501639|FG000|Overall Study|Physician Decision|4|||
25222710|NCT01569594|50501639|FG000|Overall Study|Death|13|||
25222711|NCT01569594|50501639|FG000|Overall Study|Lost to Follow-up|22|||
25222712|NCT01569594|50501639|FG000|Overall Study|Adverse Event|2|||
25222713|NCT01569594|50501639|FG000|Overall Study|Withdrawal by Subject|13|||
25222714|NCT01569594|50501639|FG000|Overall Study|Other|4|||
25222715|NCT01569594|50501639|FG000|Overall Study|No ECM used|9|||
25222716|NCT01517802|50501643|FG000|Overall Study|Death|1|||
25222717|NCT01520922|50501649|FG000|Treatment Phase|Physician Decision|2|||
25222718|NCT01520922|50501650|FG001|Treatment Phase|Physician Decision|1|||
25222719|NCT01520922|50501649|FG000|Treatment Phase|Progression|0|||
25222720|NCT01520922|50501650|FG001|Treatment Phase|Progression|2|||
25222721|NCT01520922|50501649|FG000|Treatment Phase|Adverse Event|3|||
25222722|NCT01520922|50501650|FG001|Treatment Phase|Adverse Event|5|||
25222723|NCT01520922|50501649|FG000|Follow up|Lost to Follow-up|0|||
25222724|NCT01520922|50501650|FG001|Follow up|Lost to Follow-up|1|||
25222725|NCT01520922|50501649|FG000|Survival Follow-up|Withdrawal by Subject|1|||
25222726|NCT01520922|50501650|FG001|Survival Follow-up|Withdrawal by Subject|0|||
25222727|NCT01569438|50501658|FG000|Overall Study|Lack of Efficacy|1|||
25222728|NCT01569438|50501659|FG001|Overall Study|Lack of Efficacy|2|||
25222729|NCT01569438|50501658|FG000|Overall Study|Withdrawal by Subject|0|||
25222730|NCT01569438|50501659|FG001|Overall Study|Withdrawal by Subject|3|||
25222731|NCT01569438|50501658|FG000|Overall Study|Adverse Event|2|||
25222732|NCT01569438|50501659|FG001|Overall Study|Adverse Event|15|||
25222733|NCT01569438|50501658|FG000|Overall Study|Protocol Violation|2|||
25222734|NCT01569438|50501659|FG001|Overall Study|Protocol Violation|0|||
25222735|NCT01569438|50501658|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
25222736|NCT01569438|50501659|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
25222737|NCT01569438|50501658|FG000|Overall Study|Sponsor/Physician decision|1|||
25222738|NCT01569438|50501659|FG001|Overall Study|Sponsor/Physician decision|1|||
25222739|NCT01569438|50501658|FG000|Overall Study|Unable to adhere to study schedule|0|||
25222740|NCT01569438|50501659|FG001|Overall Study|Unable to adhere to study schedule|1|||
25222741|NCT01517412|50501667|FG000|Overall Study|Adverse Event|10|||
25222742|NCT01517412|50501668|FG001|Overall Study|Adverse Event|11|||
25222743|NCT01517412|50501667|FG000|Overall Study|Lack of Efficacy|10|||
25222744|NCT01517412|50501668|FG001|Overall Study|Lack of Efficacy|5|||
25222745|NCT01517412|50501667|FG000|Overall Study|Poor compliance to protocol|8|||
25222746|NCT01517412|50501668|FG001|Overall Study|Poor compliance to protocol|3|||
25222747|NCT01517412|50501667|FG000|Overall Study|Other than specified above|8|||
25222748|NCT01517412|50501668|FG001|Overall Study|Other than specified above|5|||
25222749|NCT01517178|50501674|FG000|Period 1|Adverse Event|1|||
25222750|NCT01517178|50501675|FG001|Period 1|Adverse Event|2|||
25222751|NCT01517178|50501674|FG000|Period 1|Lack of Efficacy|0|||
25222752|NCT01517178|50501675|FG001|Period 1|Lack of Efficacy|1|||
25222753|NCT01517178|50501674|FG000|Period 1|E.g. study termination|3|||
25222754|NCT01517178|50501675|FG001|Period 1|E.g. study termination|1|||
25222755|NCT01517178|50501674|FG000|Period 1|Withdrawal by Subject|0|||
25222756|NCT01517178|50501675|FG001|Period 1|Withdrawal by Subject|1|||
25222757|NCT01517178|50501674|FG000|Period 2|Adverse Event|1|||
25222758|NCT01517178|50501675|FG001|Period 2|Adverse Event|0|||
25222759|NCT01517178|50501674|FG000|Period 2|Withdrawal by Subject|3|||
25222760|NCT01517178|50501675|FG001|Period 2|Withdrawal by Subject|0|||
25222761|NCT01517178|50501674|FG000|Period 2|E.g. study termination|2|||
25222762|NCT01517178|50501675|FG001|Period 2|E.g. study termination|2|||
25222763|NCT01489956|50501683|FG000|Overall Study|Lost to Follow-up|1|||
25222764|NCT01489956|50501684|FG001|Overall Study|Lost to Follow-up|0|||
25222765|NCT01489956|50501685|FG002|Overall Study|Lost to Follow-up|0|||
25222766|NCT01489956|50501683|FG000|Overall Study|Withdrawal by Subject|0|||
25222767|NCT01489956|50501684|FG001|Overall Study|Withdrawal by Subject|0|||
25222768|NCT01489956|50501685|FG002|Overall Study|Withdrawal by Subject|1|||
25222769|NCT01516008|50501696|FG000|Overall Study|Adverse Event|0|||
25222770|NCT01516008|50501697|FG001|Overall Study|Adverse Event|2|||
25222771|NCT01516008|50501698|FG002|Overall Study|Adverse Event|7|||
25222772|NCT01516008|50501696|FG000|Overall Study|Lack of Efficacy|44|||
25222773|NCT01516008|50501697|FG001|Overall Study|Lack of Efficacy|14|||
25222774|NCT01516008|50501698|FG002|Overall Study|Lack of Efficacy|10|||
25222775|NCT01516008|50501696|FG000|Overall Study|Protocol Violation|1|||
25222776|NCT01516008|50501697|FG001|Overall Study|Protocol Violation|0|||
25222777|NCT01516008|50501698|FG002|Overall Study|Protocol Violation|0|||
25222778|NCT01516008|50501696|FG000|Overall Study|Reason not specified|0|||
25222779|NCT01516008|50501697|FG001|Overall Study|Reason not specified|0|||
25222780|NCT01516008|50501698|FG002|Overall Study|Reason not specified|1|||
25222781|NCT01489254|50501709|FG000|Double-blind Part|Adverse Event|7|||
25318162|NCT02232737|50633822|FG001|Overall Study|Incarcerated|1|||
25318163|NCT02232737|50633823|FG002|Overall Study|Incarcerated|2|||
25318164|NCT02232737|50633821|FG000|Overall Study|Withdrawal by Subject|0|||
25318165|NCT02232737|50633822|FG001|Overall Study|Withdrawal by Subject|1|||
25318166|NCT02232737|50633823|FG002|Overall Study|Withdrawal by Subject|2|||
25318167|NCT02232737|50633821|FG000|Overall Study|Death|0|||
25318168|NCT02232737|50633822|FG001|Overall Study|Death|1|||
25318169|NCT02232737|50633823|FG002|Overall Study|Death|1|||
25318170|NCT02232737|50633821|FG000|Overall Study|Physician Decision|1|||
25318171|NCT02232737|50633822|FG001|Overall Study|Physician Decision|3|||
25318172|NCT02232737|50633823|FG002|Overall Study|Physician Decision|1|||
25318173|NCT02232737|50633821|FG000|Overall Study|Protocol Violation|1|||
25318174|NCT02232737|50633822|FG001|Overall Study|Protocol Violation|0|||
25222782|NCT01489254|50501710|FG001|Double-blind Part|Adverse Event|2|||
25222783|NCT01489254|50501711|FG002|Double-blind Part|Adverse Event|2|||
25318175|NCT02232737|50633823|FG002|Overall Study|Protocol Violation|1|||
25318176|NCT02232737|50633821|FG000|Overall Study|Reason unknown|1|||
25318177|NCT02232737|50633822|FG001|Overall Study|Reason unknown|0|||
25318178|NCT02232737|50633823|FG002|Overall Study|Reason unknown|0|||
25318179|NCT00952367|50633831|FG000|Overall Study|Withdrawal by Subject|2|||
25318180|NCT00952367|50633831|FG000|Overall Study|Noncoordination|1|||
25318181|NCT00952367|50633831|FG000|Overall Study|Protocol Violation|3|||
25222784|NCT01489254|50501712|FG003|Double-blind Part|Adverse Event|0|||
25318182|NCT00948857|50633837|FG000|Overall Study|Lost to Follow-up|1|||
25318183|NCT00948857|50633838|FG001|Overall Study|Lost to Follow-up|0|||
25318184|NCT00948389|50633853|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
25318185|NCT00948389|50633854|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
25318186|NCT00948389|50633855|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
25318187|NCT00948389|50633856|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
25318188|NCT00948389|50633857|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
25318189|NCT00948389|50633853|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
25318190|NCT00948389|50633854|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
25318191|NCT00948389|50633855|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
25318192|NCT00948389|50633856|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
25318193|NCT00948389|50633857|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
25318194|NCT00948389|50633853|FG000|Overall Study|Both Progression and Toxicity|1|||
25318195|NCT00948389|50633854|FG001|Overall Study|Both Progression and Toxicity|0|||
25318196|NCT00948389|50633855|FG002|Overall Study|Both Progression and Toxicity|0|||
25318197|NCT00948389|50633856|FG003|Overall Study|Both Progression and Toxicity|0|||
25318198|NCT00948389|50633857|FG004|Overall Study|Both Progression and Toxicity|0|||
25318199|NCT00948155|50633873|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
25318200|NCT00948155|50633874|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
25318201|NCT00948155|50633873|FG000|Washout 14 Days|Lost to Follow-up|1|||
25318202|NCT00948155|50633874|FG001|Washout 14 Days|Lost to Follow-up|2|||
25318203|NCT00958217|50633884|FG000|Overall Study|Death|2|||
25318204|NCT00958217|50633885|FG001|Overall Study|Death|1|||
25318205|NCT00958217|50633884|FG000|Overall Study|Withdrawal by Subject|4|||
25222785|NCT01489254|50501709|FG000|Double-blind Part|Pregnancy|1|||
25318206|NCT00958217|50633885|FG001|Overall Study|Withdrawal by Subject|3|||
25318207|NCT00958217|50633884|FG000|Overall Study|Lost to Follow-up|17|||
25318208|NCT00958217|50633885|FG001|Overall Study|Lost to Follow-up|19|||
25318209|NCT00958217|50633884|FG000|Overall Study|Moved out of area|1|||
25318210|NCT00958217|50633885|FG001|Overall Study|Moved out of area|1|||
25318211|NCT00958217|50633884|FG000|Overall Study|Inpatient hospitalization|0|||
25318212|NCT00958217|50633885|FG001|Overall Study|Inpatient hospitalization|1|||
25318213|NCT00891020|50633895|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
25318214|NCT00891020|50633896|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
25318215|NCT00891020|50633897|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
25222786|NCT01489254|50501710|FG001|Double-blind Part|Pregnancy|3|||
25222787|NCT01489254|50501711|FG002|Double-blind Part|Pregnancy|0|||
25222788|NCT01489254|50501712|FG003|Double-blind Part|Pregnancy|0|||
25318216|NCT00891020|50633895|FG000|24 Week Treatment Period|Death|0|||
25318217|NCT00891020|50633896|FG001|24 Week Treatment Period|Death|2|||
25222789|NCT01489254|50501709|FG000|Double-blind Part|Withdrawal by Subject|12|||
25222790|NCT01489254|50501710|FG001|Double-blind Part|Withdrawal by Subject|20|||
25222791|NCT01489254|50501711|FG002|Double-blind Part|Withdrawal by Subject|1|||
25222792|NCT01489254|50501712|FG003|Double-blind Part|Withdrawal by Subject|0|||
25222793|NCT01489254|50501709|FG000|Double-blind Part|Lost to Follow-up|1|||
25222794|NCT01489254|50501710|FG001|Double-blind Part|Lost to Follow-up|2|||
25222795|NCT01489254|50501711|FG002|Double-blind Part|Lost to Follow-up|0|||
25222796|NCT01489254|50501712|FG003|Double-blind Part|Lost to Follow-up|0|||
25222797|NCT01489254|50501709|FG000|Double-blind Part|Other reasons for not completing study|4|||
25222798|NCT01489254|50501710|FG001|Double-blind Part|Other reasons for not completing study|6|||
25222799|NCT01489254|50501711|FG002|Double-blind Part|Other reasons for not completing study|0|||
25222800|NCT01489254|50501712|FG003|Double-blind Part|Other reasons for not completing study|0|||
25222801|NCT01489254|50501709|FG000|Open-label Extension Part|Adverse Event|0|||
25222802|NCT01489254|50501710|FG001|Open-label Extension Part|Adverse Event|0|||
25222803|NCT01489254|50501711|FG002|Open-label Extension Part|Adverse Event|0|||
25222804|NCT01489254|50501712|FG003|Open-label Extension Part|Adverse Event|10|||
25222805|NCT01489254|50501709|FG000|Open-label Extension Part|Pregnancy|0|||
25222806|NCT01489254|50501710|FG001|Open-label Extension Part|Pregnancy|0|||
25222807|NCT01489254|50501711|FG002|Open-label Extension Part|Pregnancy|0|||
25222808|NCT01489254|50501712|FG003|Open-label Extension Part|Pregnancy|3|||
25222809|NCT01489254|50501709|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
25222810|NCT01489254|50501710|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
25222811|NCT01489254|50501711|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
25222812|NCT01489254|50501712|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
25222813|NCT01489254|50501709|FG000|Open-label Extension Part|Protocol Violation|0|||
25222814|NCT01489254|50501710|FG001|Open-label Extension Part|Protocol Violation|0|||
25222815|NCT01489254|50501711|FG002|Open-label Extension Part|Protocol Violation|0|||
25222816|NCT01489254|50501712|FG003|Open-label Extension Part|Protocol Violation|1|||
25222817|NCT01489254|50501709|FG000|Open-label Extension Part|Lost to Follow-up|0|||
25222818|NCT01489254|50501710|FG001|Open-label Extension Part|Lost to Follow-up|0|||
25222819|NCT01489254|50501711|FG002|Open-label Extension Part|Lost to Follow-up|0|||
25222820|NCT01489254|50501712|FG003|Open-label Extension Part|Lost to Follow-up|9|||
25222821|NCT01489254|50501709|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
25222822|NCT01489254|50501710|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
25222823|NCT01489254|50501711|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
25222824|NCT01489254|50501712|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
25222825|NCT01489020|50501727|FG000|Overall Study|Withdrawal by Subject|1|||
25222826|NCT01489020|50501728|FG001|Overall Study|Withdrawal by Subject|0|||
25222827|NCT01489020|50501729|FG002|Overall Study|Withdrawal by Subject|0|||
25222828|NCT01489020|50501730|FG003|Overall Study|Withdrawal by Subject|0|||
25222829|NCT01489020|50501731|FG004|Overall Study|Withdrawal by Subject|0|||
25222830|NCT01489020|50501732|FG005|Overall Study|Withdrawal by Subject|0|||
25222831|NCT01489020|50501727|FG000|Overall Study|Adverse Event|0|||
25222832|NCT01489020|50501728|FG001|Overall Study|Adverse Event|0|||
25222833|NCT01489020|50501729|FG002|Overall Study|Adverse Event|3|||
25222834|NCT01489020|50501730|FG003|Overall Study|Adverse Event|0|||
25222835|NCT01489020|50501731|FG004|Overall Study|Adverse Event|3|||
25222836|NCT01489020|50501732|FG005|Overall Study|Adverse Event|0|||
25222837|NCT01489020|50501727|FG000|Overall Study|Concomitant disease|0|||
25222838|NCT01489020|50501728|FG001|Overall Study|Concomitant disease|0|||
25222839|NCT01489020|50501729|FG002|Overall Study|Concomitant disease|0|||
25222840|NCT01489020|50501730|FG003|Overall Study|Concomitant disease|0|||
25222841|NCT01489020|50501731|FG004|Overall Study|Concomitant disease|3|||
25222842|NCT01489020|50501732|FG005|Overall Study|Concomitant disease|0|||
25222843|NCT01514760|50501752|FG000|Overall Study|Lost to Follow-up|2|||
25222844|NCT01514682|50501758|FG000|Overall Study|Withdrawal by Subject|2|||
25222845|NCT01514682|50501759|FG001|Overall Study|Withdrawal by Subject|3|||
25222846|NCT01514682|50501758|FG000|Overall Study|Physician Decision|4|||
25222847|NCT01514682|50501759|FG001|Overall Study|Physician Decision|3|||
25222848|NCT01514448|50501767|FG000|Overall Study|Death|7|||
25222849|NCT01514448|50501768|FG001|Overall Study|Death|8|||
25222850|NCT01514448|50501767|FG000|Overall Study|Withdrawal by Subject|2|||
25222851|NCT01514448|50501768|FG001|Overall Study|Withdrawal by Subject|0|||
25222852|NCT01514448|50501767|FG000|Overall Study|Lost to Follow-up|2|||
25222853|NCT01514448|50501768|FG001|Overall Study|Lost to Follow-up|0|||
25222854|NCT01514448|50501767|FG000|Overall Study|New Cancer Therapy|1|||
25077455|NCT02243176|50185263|FG000|Overall Study|protocol specified withdrawal critera|1|||
25222855|NCT01514448|50501768|FG001|Overall Study|New Cancer Therapy|0|||
25222856|NCT01514370|50501777|FG000|Overall Study|Protocol Violation|2|||
25222857|NCT01514370|50501778|FG001|Overall Study|Protocol Violation|3|||
25222858|NCT01514370|50501777|FG000|Overall Study|Lost to Follow-up|0|||
25222859|NCT01514370|50501778|FG001|Overall Study|Lost to Follow-up|2|||
25222860|NCT01514370|50501777|FG000|Overall Study|Withdrawal by Subject|2|||
25222861|NCT01514370|50501778|FG001|Overall Study|Withdrawal by Subject|1|||
25222862|NCT01514370|50501777|FG000|Overall Study|Adverse Event|1|||
25222863|NCT01514370|50501778|FG001|Overall Study|Adverse Event|3|||
25222864|NCT01514370|50501777|FG000|Overall Study|Other|6|||
25222865|NCT01514370|50501778|FG001|Overall Study|Other|7|||
25222866|NCT01519674|50501788|FG000|Overall Study|Adverse Event|3|||
25222867|NCT01519674|50501789|FG001|Overall Study|Adverse Event|3|||
25222868|NCT01519674|50501790|FG002|Overall Study|Adverse Event|0|||
25222869|NCT01519674|50501788|FG000|Overall Study|Lack of Efficacy|1|||
25222870|NCT01519674|50501789|FG001|Overall Study|Lack of Efficacy|1|||
25222871|NCT01519674|50501790|FG002|Overall Study|Lack of Efficacy|1|||
25222872|NCT01519674|50501788|FG000|Overall Study|Protocol Violation|0|||
25222873|NCT01519674|50501789|FG001|Overall Study|Protocol Violation|3|||
25222874|NCT01519674|50501790|FG002|Overall Study|Protocol Violation|1|||
25222875|NCT01519674|50501788|FG000|Overall Study|Withdrawal Criteria|7|||
25222876|NCT01519674|50501789|FG001|Overall Study|Withdrawal Criteria|2|||
25222877|NCT01519674|50501790|FG002|Overall Study|Withdrawal Criteria|7|||
25222878|NCT01519674|50501788|FG000|Overall Study|Unsclassified|10|||
25222879|NCT01519674|50501789|FG001|Overall Study|Unsclassified|4|||
25222880|NCT01519674|50501790|FG002|Overall Study|Unsclassified|3|||
25222881|NCT01519518|50501800|FG000|Overall Study|Consent not available|7|||
25222882|NCT01519518|50501801|FG001|Overall Study|Consent not available|10|||
25222883|NCT01519206|50501807|FG000|Overall Study|Lost to Follow-up|3|||
25222884|NCT01519206|50501807|FG000|Overall Study|Missed Visit|2|||
25222885|NCT01518972|50501820|FG000|Overall Study|Lost to Follow-up|2|||
25222886|NCT01518972|50501821|FG001|Overall Study|Lost to Follow-up|1|||
25222887|NCT01518972|50501820|FG000|Overall Study|Withdrawal by Subject|1|||
25222888|NCT01518972|50501821|FG001|Overall Study|Withdrawal by Subject|0|||
25222889|NCT01518972|50501820|FG000|Overall Study|Moved from area|1|||
25222890|NCT01518972|50501821|FG001|Overall Study|Moved from area|0|||
25222891|NCT01518972|50501820|FG000|Overall Study|Transportation problems|1|||
25222892|NCT01518972|50501821|FG001|Overall Study|Transportation problems|0|||
25222893|NCT01518972|50501820|FG000|Overall Study|Exclusionary medical condition|1|||
25222894|NCT01518972|50501821|FG001|Overall Study|Exclusionary medical condition|0|||
25222895|NCT01518972|50501820|FG000|Overall Study|Missed safety visits|0|||
25222896|NCT01518972|50501821|FG001|Overall Study|Missed safety visits|1|||
25222897|NCT01518972|50501820|FG000|Overall Study|Exclusionary medication|0|||
25222898|NCT01518972|50501821|FG001|Overall Study|Exclusionary medication|1|||
25222899|NCT01518972|50501820|FG000|Overall Study|Declined medication starting on day 12|0|||
25222900|NCT01518972|50501821|FG001|Overall Study|Declined medication starting on day 12|1|||
25222901|NCT01514136|50501829|FG000|Test Period 1; Test A|Protocol Violation|1|||
25222902|NCT01514136|50501830|FG001|Test Period 1; Test A|Protocol Violation|0|||
25222903|NCT01514136|50501831|FG002|Test Period 1; Test A|Protocol Violation|0|||
25222904|NCT01514136|50501832|FG003|Test Period 1; Test A|Protocol Violation|0|||
25222905|NCT01514136|50501833|FG004|Test Period 1; Test A|Protocol Violation|0|||
25222906|NCT01514136|50501834|FG005|Test Period 1; Test A|Protocol Violation|0|||
25222907|NCT01514136|50501835|FG006|Test Period 1; Test A|Protocol Violation|0|||
25222908|NCT01514136|50501836|FG007|Test Period 1; Test A|Protocol Violation|0|||
25222909|NCT01514136|50501829|FG000|Test Period 1; Test A|Break from study holiday|2|||
25222910|NCT01514136|50501830|FG001|Test Period 1; Test A|Break from study holiday|0|||
25222911|NCT01514136|50501831|FG002|Test Period 1; Test A|Break from study holiday|0|||
25222912|NCT01514136|50501832|FG003|Test Period 1; Test A|Break from study holiday|0|||
25222913|NCT01514136|50501833|FG004|Test Period 1; Test A|Break from study holiday|0|||
25222914|NCT01514136|50501834|FG005|Test Period 1; Test A|Break from study holiday|0|||
25222915|NCT01514136|50501835|FG006|Test Period 1; Test A|Break from study holiday|0|||
25222916|NCT01514136|50501836|FG007|Test Period 1; Test A|Break from study holiday|0|||
25222917|NCT01514136|50501829|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
25222918|NCT01514136|50501830|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
25222919|NCT01514136|50501831|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
25222920|NCT01514136|50501832|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
25222921|NCT01514136|50501833|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
25222922|NCT01514136|50501834|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
25222923|NCT01514136|50501835|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
25318218|NCT00891020|50633897|FG002|24 Week Treatment Period|Death|0|||
25318219|NCT00891020|50633895|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
25318220|NCT00891020|50633896|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
25318221|NCT00891020|50633897|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
25318222|NCT00891020|50633895|FG000|24 Week Treatment Period|Failure to return|4|||
25222924|NCT01514136|50501836|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
25222925|NCT01514136|50501829|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
25222926|NCT01514136|50501830|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
25222927|NCT01514136|50501831|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
25222928|NCT01514136|50501832|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
25222929|NCT01514136|50501833|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
25222930|NCT01514136|50501834|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
25222931|NCT01514136|50501835|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
25222932|NCT01514136|50501836|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
25222933|NCT01514136|50501829|FG000|Test Period 2; Test A*|Adverse Event|0|||
25222934|NCT01514136|50501830|FG001|Test Period 2; Test A*|Adverse Event|0|||
25222935|NCT01514136|50501831|FG002|Test Period 2; Test A*|Adverse Event|0|||
25222936|NCT01514136|50501832|FG003|Test Period 2; Test A*|Adverse Event|0|||
25222937|NCT01514136|50501833|FG004|Test Period 2; Test A*|Adverse Event|1|||
25222938|NCT01514136|50501834|FG005|Test Period 2; Test A*|Adverse Event|0|||
25222939|NCT01514136|50501835|FG006|Test Period 2; Test A*|Adverse Event|0|||
25222940|NCT01514136|50501836|FG007|Test Period 2; Test A*|Adverse Event|0|||
25222941|NCT01514136|50501829|FG000|Test Period 2; Test A*|Holiday|0|||
25318223|NCT00891020|50633896|FG001|24 Week Treatment Period|Failure to return|5|||
25318224|NCT00891020|50633897|FG002|24 Week Treatment Period|Failure to return|5|||
25318225|NCT00891020|50633895|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
25318226|NCT00891020|50633896|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
25318227|NCT00891020|50633897|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
25222942|NCT01514136|50501830|FG001|Test Period 2; Test A*|Holiday|0|||
25222943|NCT01514136|50501831|FG002|Test Period 2; Test A*|Holiday|0|||
25222944|NCT01514136|50501832|FG003|Test Period 2; Test A*|Holiday|0|||
25222945|NCT01514136|50501833|FG004|Test Period 2; Test A*|Holiday|1|||
25222946|NCT01514136|50501834|FG005|Test Period 2; Test A*|Holiday|0|||
25222947|NCT01514136|50501835|FG006|Test Period 2; Test A*|Holiday|0|||
25222948|NCT01514136|50501836|FG007|Test Period 2; Test A*|Holiday|0|||
25222949|NCT01514136|50501829|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
25222950|NCT01514136|50501830|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
25222951|NCT01514136|50501831|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
25222952|NCT01514136|50501832|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
25222953|NCT01514136|50501833|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
25222954|NCT01514136|50501834|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
25222955|NCT01514136|50501835|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
25222956|NCT01514136|50501836|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
25222957|NCT01514136|50501829|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
25222958|NCT01514136|50501830|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
25222959|NCT01514136|50501831|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
25222960|NCT01514136|50501832|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
25222961|NCT01514136|50501833|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
25222962|NCT01514136|50501834|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
25222963|NCT01514136|50501835|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
25222964|NCT01514136|50501836|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
25222965|NCT01514136|50501829|FG000|Test Period 2; Test C*|holiday|0|||
25222966|NCT01514136|50501830|FG001|Test Period 2; Test C*|holiday|0|||
25222967|NCT01514136|50501831|FG002|Test Period 2; Test C*|holiday|0|||
25222968|NCT01514136|50501832|FG003|Test Period 2; Test C*|holiday|0|||
25222969|NCT01514136|50501833|FG004|Test Period 2; Test C*|holiday|0|||
25222970|NCT01514136|50501834|FG005|Test Period 2; Test C*|holiday|0|||
25222971|NCT01514136|50501835|FG006|Test Period 2; Test C*|holiday|1|||
25222972|NCT01514136|50501836|FG007|Test Period 2; Test C*|holiday|0|||
25222973|NCT01514136|50501829|FG000|Test Period 2; Test C*|Protocol Violation|0|||
25222974|NCT01514136|50501830|FG001|Test Period 2; Test C*|Protocol Violation|0|||
25222975|NCT01514136|50501831|FG002|Test Period 2; Test C*|Protocol Violation|0|||
25222976|NCT01514136|50501832|FG003|Test Period 2; Test C*|Protocol Violation|0|||
25222977|NCT01514136|50501833|FG004|Test Period 2; Test C*|Protocol Violation|0|||
25222978|NCT01514136|50501834|FG005|Test Period 2; Test C*|Protocol Violation|0|||
25222979|NCT01514136|50501835|FG006|Test Period 2; Test C*|Protocol Violation|1|||
25222980|NCT01514136|50501836|FG007|Test Period 2; Test C*|Protocol Violation|0|||
25222981|NCT01513590|50501864|FG000|Overall Study|Adverse Event|2|||
25222982|NCT01513590|50501865|FG001|Overall Study|Adverse Event|3|||
25222983|NCT01513590|50501864|FG000|Overall Study|Withdrawal Criteria|3|||
25222984|NCT01513590|50501865|FG001|Overall Study|Withdrawal Criteria|0|||
25222985|NCT01513590|50501864|FG000|Overall Study|Unclassified|5|||
25222986|NCT01513590|50501865|FG001|Overall Study|Unclassified|10|||
25222987|NCT01512264|50501875|FG000|Overall Study|Lost to Follow-up|0|||
25222988|NCT01512264|50501876|FG001|Overall Study|Lost to Follow-up|0|||
25222989|NCT01512264|50501877|FG002|Overall Study|Lost to Follow-up|0|||
25222990|NCT01512264|50501878|FG003|Overall Study|Lost to Follow-up|1|||
25318228|NCT00891020|50633895|FG000|24 Week Treatment Period|Other protocol violation|1|||
25318229|NCT00891020|50633896|FG001|24 Week Treatment Period|Other protocol violation|1|||
25318230|NCT00891020|50633897|FG002|24 Week Treatment Period|Other protocol violation|2|||
25222991|NCT01512108|50501890|FG000|Overall Study|Adverse Event|9|||
25222992|NCT01512108|50501891|FG001|Overall Study|Adverse Event|4|||
25222993|NCT01512108|50501890|FG000|Overall Study|Protocol Violation|1|||
25222994|NCT01512108|50501891|FG001|Overall Study|Protocol Violation|2|||
25222995|NCT01512108|50501890|FG000|Overall Study|Withdrawal Criteria|1|||
25222996|NCT01512108|50501891|FG001|Overall Study|Withdrawal Criteria|0|||
25222997|NCT01512108|50501890|FG000|Overall Study|Unclassified|11|||
25222998|NCT01512108|50501891|FG001|Overall Study|Unclassified|3|||
25222999|NCT01486758|50501899|FG000|Overall Study|Lost to Follow-up|0|||
25223000|NCT01486758|50501900|FG001|Overall Study|Lost to Follow-up|1|||
25223001|NCT01463982|50501911|FG000|Overall Study|Withdrawal by Subject|0|||
25223002|NCT01463982|50501912|FG001|Overall Study|Withdrawal by Subject|1|||
25223003|NCT01463982|50501913|FG002|Overall Study|Withdrawal by Subject|1|||
25223004|NCT01463982|50501914|FG003|Overall Study|Withdrawal by Subject|0|||
25223005|NCT01463982|50501911|FG000|Overall Study|Treatment delay over 5 week|0|||
25223006|NCT01463982|50501912|FG001|Overall Study|Treatment delay over 5 week|0|||
25223007|NCT01463982|50501913|FG002|Overall Study|Treatment delay over 5 week|1|||
25223008|NCT01463982|50501914|FG003|Overall Study|Treatment delay over 5 week|0|||
25223009|NCT01486446|50501926|FG000|Overall Study|Adverse Event|1|||
25223010|NCT01486446|50501927|FG001|Overall Study|Adverse Event|0|||
25223011|NCT01485354|50501933|FG000|Overall Study|Withdrawal by Subject|5|||
25223012|NCT01510158|50501940|FG000|Overall Study|Adverse Event|7|||
25223013|NCT01510158|50501941|FG001|Overall Study|Adverse Event|8|||
25223014|NCT01510158|50501942|FG002|Overall Study|Adverse Event|5|||
25223015|NCT01510158|50501940|FG000|Overall Study|Gout flare|1|||
25223016|NCT01510158|50501941|FG001|Overall Study|Gout flare|0|||
25223017|NCT01510158|50501942|FG002|Overall Study|Gout flare|0|||
25223018|NCT01510158|50501940|FG000|Overall Study|Protocol Violation|17|||
25223019|NCT01510158|50501941|FG001|Overall Study|Protocol Violation|16|||
25223020|NCT01510158|50501942|FG002|Overall Study|Protocol Violation|24|||
25223021|NCT01510158|50501940|FG000|Overall Study|Sponsor terminated study.|2|||
25223022|NCT01510158|50501941|FG001|Overall Study|Sponsor terminated study.|0|||
25223023|NCT01510158|50501942|FG002|Overall Study|Sponsor terminated study.|2|||
25223024|NCT01510158|50501940|FG000|Overall Study|Lost to Follow-up|13|||
25223025|NCT01510158|50501941|FG001|Overall Study|Lost to Follow-up|16|||
25223026|NCT01510158|50501942|FG002|Overall Study|Lost to Follow-up|9|||
25223027|NCT01510158|50501940|FG000|Overall Study|Withdrawal by Subject|10|||
25223028|NCT01510158|50501941|FG001|Overall Study|Withdrawal by Subject|13|||
25223029|NCT01510158|50501942|FG002|Overall Study|Withdrawal by Subject|10|||
25223030|NCT01510158|50501940|FG000|Overall Study|Death|1|||
25223031|NCT01510158|50501941|FG001|Overall Study|Death|0|||
25223032|NCT01510158|50501942|FG002|Overall Study|Death|0|||
25223033|NCT01485120|50501959|FG000|Overall Study|Withdrawal by Subject|2|||
25223034|NCT01484496|50501966|FG000|Period 1|Protocol Violation|3|||
25223035|NCT01484496|50501967|FG001|Period 1|Protocol Violation|4|||
25223036|NCT01484496|50501968|FG002|Period 1|Protocol Violation|0|||
25223037|NCT01484496|50501969|FG003|Period 1|Protocol Violation|0|||
25223038|NCT01484496|50501966|FG000|Period 1|Physician Decision|5|||
25223039|NCT01484496|50501967|FG001|Period 1|Physician Decision|1|||
25223040|NCT01484496|50501968|FG002|Period 1|Physician Decision|0|||
25223041|NCT01484496|50501969|FG003|Period 1|Physician Decision|0|||
25223042|NCT01484496|50501966|FG000|Period 1|Lack of Efficacy|10|||
25223043|NCT01484496|50501967|FG001|Period 1|Lack of Efficacy|15|||
25223044|NCT01484496|50501968|FG002|Period 1|Lack of Efficacy|0|||
25223045|NCT01484496|50501969|FG003|Period 1|Lack of Efficacy|0|||
25223046|NCT01484496|50501966|FG000|Period 1|Adverse Event|25|||
25223047|NCT01484496|50501967|FG001|Period 1|Adverse Event|40|||
25223048|NCT01484496|50501968|FG002|Period 1|Adverse Event|0|||
25223049|NCT01484496|50501969|FG003|Period 1|Adverse Event|0|||
25223050|NCT01484496|50501966|FG000|Period 1|Withdrawal by Subject|15|||
25223051|NCT01484496|50501967|FG001|Period 1|Withdrawal by Subject|12|||
25223052|NCT01484496|50501968|FG002|Period 1|Withdrawal by Subject|0|||
25223053|NCT01484496|50501969|FG003|Period 1|Withdrawal by Subject|0|||
25223054|NCT01484496|50501966|FG000|Period 1|Lost to Follow-up|2|||
25223055|NCT01484496|50501967|FG001|Period 1|Lost to Follow-up|6|||
25223056|NCT01484496|50501968|FG002|Period 1|Lost to Follow-up|0|||
25223057|NCT01484496|50501969|FG003|Period 1|Lost to Follow-up|0|||
25223058|NCT01484496|50501966|FG000|Period 1|Positive Pregnancy|1|||
25223059|NCT01484496|50501967|FG001|Period 1|Positive Pregnancy|6|||
25223060|NCT01484496|50501968|FG002|Period 1|Positive Pregnancy|0|||
25223061|NCT01484496|50501969|FG003|Period 1|Positive Pregnancy|0|||
25223062|NCT01484496|50501966|FG000|Period 1|Treatment Failure|3|||
25223063|NCT01484496|50501967|FG001|Period 1|Treatment Failure|6|||
25223064|NCT01484496|50501968|FG002|Period 1|Treatment Failure|0|||
25223065|NCT01484496|50501969|FG003|Period 1|Treatment Failure|0|||
25077456|NCT02243176|50185264|FG001|Overall Study|protocol specified withdrawal critera|3|||
25077457|NCT02243176|50185263|FG000|Overall Study|Protocol Violation|2|||
25223066|NCT01484496|50501966|FG000|Period 1|Lack of Compliance|2|||
25223067|NCT01484496|50501967|FG001|Period 1|Lack of Compliance|1|||
25223068|NCT01484496|50501968|FG002|Period 1|Lack of Compliance|0|||
25223069|NCT01484496|50501969|FG003|Period 1|Lack of Compliance|0|||
25223070|NCT01484496|50501966|FG000|Period 1|Unable to Visit Site|0|||
25223071|NCT01484496|50501967|FG001|Period 1|Unable to Visit Site|2|||
25223072|NCT01484496|50501968|FG002|Period 1|Unable to Visit Site|0|||
25223073|NCT01484496|50501969|FG003|Period 1|Unable to Visit Site|0|||
25223074|NCT01484496|50501966|FG000|Period 2|Lack of Efficacy|0|||
25223075|NCT01484496|50501967|FG001|Period 2|Lack of Efficacy|0|||
25223076|NCT01484496|50501968|FG002|Period 2|Lack of Efficacy|1|||
25223077|NCT01484496|50501969|FG003|Period 2|Lack of Efficacy|3|||
25223078|NCT01484496|50501966|FG000|Period 2|Adverse Event|0|||
25223079|NCT01484496|50501967|FG001|Period 2|Adverse Event|0|||
25223080|NCT01484496|50501968|FG002|Period 2|Adverse Event|5|||
25223081|NCT01484496|50501969|FG003|Period 2|Adverse Event|13|||
25223082|NCT01484496|50501966|FG000|Period 2|Other|0|||
25223083|NCT01484496|50501967|FG001|Period 2|Other|0|||
25223084|NCT01484496|50501968|FG002|Period 2|Other|9|||
25223085|NCT01484496|50501969|FG003|Period 2|Other|6|||
25223086|NCT01509846|50501982|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
25223087|NCT01509846|50501983|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
25223088|NCT01509846|50501984|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
25223089|NCT01509846|50501985|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
25223090|NCT01509846|50501986|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
25223091|NCT01509846|50501982|FG000|Received Vaccination 2|Illness|0|||
25223092|NCT01509846|50501983|FG001|Received Vaccination 2|Illness|0|||
25223093|NCT01509846|50501984|FG002|Received Vaccination 2|Illness|0|||
25223094|NCT01509846|50501985|FG003|Received Vaccination 2|Illness|0|||
25223095|NCT01509846|50501986|FG004|Received Vaccination 2|Illness|1|||
25223096|NCT01509846|50501982|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
25223097|NCT01509846|50501983|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
25223098|NCT01509846|50501984|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
25223099|NCT01509846|50501985|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
25223100|NCT01509846|50501986|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
25223101|NCT01509846|50501982|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
25223102|NCT01509846|50501983|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
25223103|NCT01509846|50501984|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
25223104|NCT01509846|50501985|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
25223105|NCT01509846|50501986|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
25223106|NCT01509846|50501982|FG000|Received Vaccination 3|Pregnancy|0|||
25223107|NCT01509846|50501983|FG001|Received Vaccination 3|Pregnancy|0|||
25223108|NCT01509846|50501984|FG002|Received Vaccination 3|Pregnancy|0|||
25223109|NCT01509846|50501985|FG003|Received Vaccination 3|Pregnancy|1|||
25223110|NCT01509846|50501986|FG004|Received Vaccination 3|Pregnancy|0|||
25223111|NCT01509846|50501982|FG000|Received Vaccination 3|Lost to Follow-up|0|||
25223112|NCT01509846|50501983|FG001|Received Vaccination 3|Lost to Follow-up|0|||
25223113|NCT01509846|50501984|FG002|Received Vaccination 3|Lost to Follow-up|1|||
25223114|NCT01509846|50501985|FG003|Received Vaccination 3|Lost to Follow-up|0|||
25223115|NCT01509846|50501986|FG004|Received Vaccination 3|Lost to Follow-up|0|||
25223116|NCT01462344|50502007|FG000|Overall Study|Withdrawal by Subject|245|||
25223117|NCT01462344|50502008|FG001|Overall Study|Withdrawal by Subject|226|||
25223118|NCT01462344|50502007|FG000|Overall Study|Adverse Event|24|||
25223119|NCT01462344|50502008|FG001|Overall Study|Adverse Event|23|||
25223120|NCT01462344|50502007|FG000|Overall Study|Asthma Exacerbation|34|||
25223121|NCT01462344|50502008|FG001|Overall Study|Asthma Exacerbation|35|||
25223122|NCT01462344|50502007|FG000|Overall Study|Lack of Efficacy|5|||
25223123|NCT01462344|50502008|FG001|Overall Study|Lack of Efficacy|6|||
25223124|NCT01462344|50502007|FG000|Overall Study|Protocol Violation|68|||
25223125|NCT01462344|50502008|FG001|Overall Study|Protocol Violation|53|||
25223126|NCT01462344|50502007|FG000|Overall Study|Lost to Follow-up|7|||
25223127|NCT01462344|50502008|FG001|Overall Study|Lost to Follow-up|7|||
25223128|NCT01484028|50502014|FG000|Period 1|Lost to Follow-up|0|||
25223129|NCT01484028|50502015|FG001|Period 1|Lost to Follow-up|1|||
25223130|NCT01484028|50502016|FG002|Period 1|Lost to Follow-up|0|||
25223131|NCT01484028|50502017|FG003|Period 1|Lost to Follow-up|0|||
25223132|NCT01484028|50502014|FG000|Period 1|Non-Compliance to Protocol|0|||
25223133|NCT01484028|50502015|FG001|Period 1|Non-Compliance to Protocol|1|||
25223134|NCT01484028|50502016|FG002|Period 1|Non-Compliance to Protocol|0|||
25223135|NCT01484028|50502017|FG003|Period 1|Non-Compliance to Protocol|1|||
25223136|NCT01484028|50502014|FG000|Period 1|Lens Discomfort|0|||
25223137|NCT01484028|50502015|FG001|Period 1|Lens Discomfort|1|||
25223138|NCT01484028|50502016|FG002|Period 1|Lens Discomfort|0|||
25223139|NCT01484028|50502017|FG003|Period 1|Lens Discomfort|0|||
25223140|NCT01462266|50502027|FG000|Overall Study|Adverse Event|7|||
25223141|NCT01462266|50502028|FG001|Overall Study|Adverse Event|6|||
25223142|NCT01462266|50502027|FG000|Overall Study|Death|2|||
25223143|NCT01462266|50502028|FG001|Overall Study|Death|1|||
25223144|NCT01462266|50502027|FG000|Overall Study|Lack of Efficacy|0|||
25223145|NCT01462266|50502028|FG001|Overall Study|Lack of Efficacy|2|||
25223146|NCT01462266|50502027|FG000|Overall Study|Lost to Follow-up|4|||
25223147|NCT01462266|50502028|FG001|Overall Study|Lost to Follow-up|3|||
25223148|NCT01462266|50502027|FG000|Overall Study|Non-compliance with study drug|3|||
25223149|NCT01462266|50502028|FG001|Overall Study|Non-compliance with study drug|0|||
25223150|NCT01462266|50502027|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
25223151|NCT01462266|50502028|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
25223152|NCT01462266|50502027|FG000|Overall Study|Physician Decision|2|||
25223153|NCT01462266|50502028|FG001|Overall Study|Physician Decision|5|||
25223154|NCT01462266|50502027|FG000|Overall Study|Protocol Violation|1|||
25223155|NCT01462266|50502028|FG001|Overall Study|Protocol Violation|3|||
25223156|NCT01462266|50502027|FG000|Overall Study|Withdrawal by Subject|7|||
25223157|NCT01462266|50502028|FG001|Overall Study|Withdrawal by Subject|2|||
25223158|NCT01462266|50502027|FG000|Overall Study|Screen failure|1|||
25223159|NCT01462266|50502028|FG001|Overall Study|Screen failure|1|||
25223160|NCT01508910|50502037|FG000|Treatment|Death|2|||
25223161|NCT01508910|50502038|FG001|Treatment|Death|3|||
25223162|NCT01508910|50502039|FG002|Treatment|Death|2|||
25223163|NCT01508910|50502040|FG003|Treatment|Death|0|||
25223164|NCT01508910|50502037|FG000|Treatment|Lost to Follow-up|0|||
25223165|NCT01508910|50502038|FG001|Treatment|Lost to Follow-up|0|||
25223166|NCT01508910|50502039|FG002|Treatment|Lost to Follow-up|2|||
25223167|NCT01508910|50502040|FG003|Treatment|Lost to Follow-up|1|||
25223168|NCT01508910|50502037|FG000|Treatment|Withdrawal by Subject|0|||
25223169|NCT01508910|50502038|FG001|Treatment|Withdrawal by Subject|1|||
25223170|NCT01508910|50502039|FG002|Treatment|Withdrawal by Subject|6|||
25223171|NCT01508910|50502040|FG003|Treatment|Withdrawal by Subject|1|||
25223172|NCT01508910|50502037|FG000|Treatment|Sponsor Decision|0|||
25223173|NCT01508910|50502038|FG001|Treatment|Sponsor Decision|0|||
25223174|NCT01508910|50502039|FG002|Treatment|Sponsor Decision|0|||
25223175|NCT01508910|50502040|FG003|Treatment|Sponsor Decision|1|||
25223176|NCT01462110|50502054|FG000|Overall Study|Adverse Event|1|||
25223177|NCT01462110|50502055|FG001|Overall Study|Adverse Event|0|||
25223178|NCT01508676|50502063|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
25223179|NCT01508676|50502064|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
25223180|NCT01508676|50502063|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
25223181|NCT01508676|50502064|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
25223182|NCT01508676|50502063|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
25223183|NCT01508676|50502064|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
25223184|NCT01508676|50502063|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
25223185|NCT01508676|50502064|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
25223186|NCT01508676|50502063|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
25223187|NCT01508676|50502064|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
25223188|NCT01508130|50502073|FG000|Overall Study|Adverse Event|81|||
25223189|NCT01508130|50502074|FG001|Overall Study|Adverse Event|28|||
25223190|NCT01508130|50502073|FG000|Overall Study|Death|3|||
25223191|NCT01508130|50502074|FG001|Overall Study|Death|1|||
25223192|NCT01508130|50502073|FG000|Overall Study|Protocol Violation|2|||
25223193|NCT01508130|50502074|FG001|Overall Study|Protocol Violation|0|||
25223194|NCT01508130|50502073|FG000|Overall Study|Lost to Follow-up|25|||
25223195|NCT01508130|50502074|FG001|Overall Study|Lost to Follow-up|2|||
25223196|NCT01508130|50502073|FG000|Overall Study|Withdrawal by Subject|3|||
25223197|NCT01508130|50502074|FG001|Overall Study|Withdrawal by Subject|3|||
25223198|NCT01508130|50502073|FG000|Overall Study|Subject's substantial non-compliance|25|||
25223199|NCT01508130|50502074|FG001|Overall Study|Subject's substantial non-compliance|9|||
25223200|NCT01508130|50502073|FG000|Overall Study|Insufficient therapeutic response|74|||
25223201|NCT01508130|50502074|FG001|Overall Study|Insufficient therapeutic response|23|||
25223202|NCT01508130|50502073|FG000|Overall Study|Administrative|14|||
25223203|NCT01508130|50502074|FG001|Overall Study|Administrative|3|||
25223204|NCT01482312|50502082|FG000|Period 1, 90 Minutes of Wear|Other|1|||
25223205|NCT01482312|50502083|FG001|Period 1, 90 Minutes of Wear|Other|0|||
25223206|NCT01482312|50502084|FG002|Period 1, 90 Minutes of Wear|Other|0|||
25223207|NCT01482312|50502082|FG000|Period 2, 90 Minutes of Wear|Other|1|||
25223208|NCT01482312|50502083|FG001|Period 2, 90 Minutes of Wear|Other|0|||
25223209|NCT01482312|50502084|FG002|Period 2, 90 Minutes of Wear|Other|0|||
25223210|NCT01461096|50502094|FG000|Overall Study|Death|3|||
25223211|NCT01461096|50502095|FG001|Overall Study|Death|6|||
25223212|NCT01461096|50502094|FG000|Overall Study|Severe debilitation, unable to continue|1|||
25223213|NCT01461096|50502095|FG001|Overall Study|Severe debilitation, unable to continue|1|||
25223214|NCT01461096|50502094|FG000|Overall Study|Subj not able to get to clinic|15|||
25223215|NCT01461096|50502095|FG001|Overall Study|Subj not able to get to clinic|13|||
25223216|NCT01461096|50502094|FG000|Overall Study|Site is closing|27|||
25223217|NCT01461096|50502095|FG001|Overall Study|Site is closing|30|||
25223218|NCT01461096|50502094|FG000|Overall Study|Withdrawal by Subject|5|||
25223219|NCT01461096|50502095|FG001|Overall Study|Withdrawal by Subject|3|||
25223220|NCT01461096|50502094|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
25223221|NCT01461096|50502095|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
25223222|NCT01461096|50502094|FG000|Overall Study|Lost to Follow-up|8|||
25223223|NCT01461096|50502095|FG001|Overall Study|Lost to Follow-up|4|||
25223224|NCT01507896|50502102|FG000|Overall Study|Withdrawal by Subject|1|||
25223225|NCT01507896|50502102|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
25223226|NCT01507662|50502117|FG000|Overall Study|Death|26|||
25223227|NCT01507662|50502118|FG001|Overall Study|Death|18|||
25223228|NCT01507662|50502117|FG000|Overall Study|Withdrawal by Subject|290|||
25223229|NCT01507662|50502118|FG001|Overall Study|Withdrawal by Subject|287|||
25223230|NCT01507662|50502117|FG000|Overall Study|Lost to Follow-up|498|||
25223231|NCT01507662|50502118|FG001|Overall Study|Lost to Follow-up|523|||
25223232|NCT01507662|50502117|FG000|Overall Study|Proxy interview done|2|||
25223233|NCT01507662|50502118|FG001|Overall Study|Proxy interview done|3|||
25223234|NCT01506960|50502124|FG000|Overall Study|Did not meet angiographic criteria|47|||
25223235|NCT01480674|50502130|FG000|Overall Study|Death|23|||
25223236|NCT01480674|50502130|FG000|Overall Study|Lost to Follow-up|2|||
25223237|NCT01480674|50502130|FG000|Overall Study|visit not done|10|||
25223238|NCT01506882|50502136|FG000|Overall Study|Lack of Efficacy|4|||
25223239|NCT01506882|50502137|FG001|Overall Study|Lack of Efficacy|3|||
25223240|NCT01506882|50502136|FG000|Overall Study|Lost to Follow-up|1|||
25223241|NCT01506882|50502137|FG001|Overall Study|Lost to Follow-up|0|||
25223242|NCT01506882|50502136|FG000|Overall Study|Withdrawal by Subject|9|||
25223243|NCT01506882|50502137|FG001|Overall Study|Withdrawal by Subject|3|||
25223244|NCT01506882|50502136|FG000|Overall Study|SAE, non-fatal|2|||
25223245|NCT01506882|50502137|FG001|Overall Study|SAE, non-fatal|0|||
25223246|NCT01506882|50502136|FG000|Overall Study|AE, non-serious non-fatal|3|||
25223247|NCT01506882|50502137|FG001|Overall Study|AE, non-serious non-fatal|1|||
25223248|NCT01506882|50502136|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
25223249|NCT01506882|50502137|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
25223250|NCT01506882|50502136|FG000|Overall Study|Other Reason|2|||
25223251|NCT01506882|50502137|FG001|Overall Study|Other Reason|0|||
25223252|NCT01506726|50502147|FG000|Overall Study|Adverse Event|1|||
25223253|NCT01506726|50502148|FG001|Overall Study|Adverse Event|2|||
25223254|NCT01505868|50502159|FG000|Overall Study|Withdrawal by Subject|1|||
25223255|NCT01505868|50502160|FG001|Overall Study|Withdrawal by Subject|0|||
25223256|NCT01505868|50502161|FG002|Overall Study|Withdrawal by Subject|0|||
25223257|NCT01505868|50502162|FG003|Overall Study|Withdrawal by Subject|0|||
25223258|NCT01505868|50502163|FG004|Overall Study|Withdrawal by Subject|0|||
25223259|NCT01505634|50502178|FG000|Overall Study|Withdrawal by Subject|2|||
25223260|NCT01505634|50502179|FG001|Overall Study|Withdrawal by Subject|5|||
25223261|NCT01505634|50502180|FG002|Overall Study|Withdrawal by Subject|1|||
25223262|NCT01505634|50502178|FG000|Overall Study|Physician Decision|1|||
25223263|NCT01505634|50502179|FG001|Overall Study|Physician Decision|1|||
25223264|NCT01505634|50502180|FG002|Overall Study|Physician Decision|0|||
25223265|NCT01505634|50502178|FG000|Overall Study|Adverse Event|1|||
25223266|NCT01505634|50502179|FG001|Overall Study|Adverse Event|0|||
25223267|NCT01505634|50502180|FG002|Overall Study|Adverse Event|0|||
25223268|NCT01505634|50502178|FG000|Overall Study|Insufficient supply of drug at site|1|||
25223269|NCT01505634|50502179|FG001|Overall Study|Insufficient supply of drug at site|0|||
25223270|NCT01505634|50502180|FG002|Overall Study|Insufficient supply of drug at site|0|||
25223271|NCT01505634|50502178|FG000|Overall Study|Protocol Violation|2|||
25223272|NCT01505634|50502179|FG001|Overall Study|Protocol Violation|0|||
25223273|NCT01505634|50502180|FG002|Overall Study|Protocol Violation|0|||
25223274|NCT01505634|50502178|FG000|Overall Study|Lost to Follow-up|1|||
25223275|NCT01505634|50502179|FG001|Overall Study|Lost to Follow-up|4|||
25223276|NCT01505634|50502180|FG002|Overall Study|Lost to Follow-up|4|||
25223277|NCT01505634|50502178|FG000|Overall Study|Death|1|||
25223278|NCT01505634|50502179|FG001|Overall Study|Death|0|||
25223279|NCT01505634|50502180|FG002|Overall Study|Death|0|||
25223280|NCT01505634|50502178|FG000|Overall Study|In a conflict zone|0|||
25223281|NCT01505634|50502179|FG001|Overall Study|In a conflict zone|0|||
25223282|NCT01505634|50502180|FG002|Overall Study|In a conflict zone|1|||
25223283|NCT01460628|50502188|FG000|Overall Study|Adverse Event|3|||
25223284|NCT01460628|50502188|FG000|Overall Study|Withdrawal by Subject|2|||
25223285|NCT01480596|50502194|FG000|Overall Study|Adverse Event|3|||
25223286|NCT01480596|50502195|FG001|Overall Study|Adverse Event|0|||
25223287|NCT01480596|50502194|FG000|Overall Study|MG exacerbation or change in medication|2|||
25223288|NCT01480596|50502195|FG001|Overall Study|MG exacerbation or change in medication|2|||
25223289|NCT01480284|50502203|FG000|Overall Study|Withdrawal by Subject|2|||
25223290|NCT01480284|50502204|FG001|Overall Study|Withdrawal by Subject|0|||
25223291|NCT01480284|50502203|FG000|Overall Study|Adverse Event|1|||
25223292|NCT01480284|50502204|FG001|Overall Study|Adverse Event|0|||
25223293|NCT01480284|50502203|FG000|Overall Study|Study closed/terminated|3|||
25223294|NCT01480284|50502204|FG001|Overall Study|Study closed/terminated|0|||
25223295|NCT01480284|50502203|FG000|Overall Study|Lost to Follow-up|1|||
25223296|NCT01480284|50502204|FG001|Overall Study|Lost to Follow-up|0|||
25223297|NCT01480284|50502203|FG000|Overall Study|Physician Decision|1|||
25223298|NCT01480284|50502204|FG001|Overall Study|Physician Decision|0|||
25223299|NCT01459614|50502212|FG000|Overall Study|Adverse Event|1|||
25223300|NCT01459614|50502213|FG001|Overall Study|Adverse Event|0|||
24976520|NCT03538054|50065428|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
25223301|NCT01459068|50502221|FG000|Overall Study|Withdrawal by Subject|8|||
25223302|NCT01459068|50502222|FG001|Overall Study|Withdrawal by Subject|18|||
25223303|NCT01459068|50502221|FG000|Overall Study|Lost to Follow-up|31|||
25223304|NCT01459068|50502222|FG001|Overall Study|Lost to Follow-up|15|||
25223305|NCT01459068|50502221|FG000|Overall Study|Death|0|||
25223306|NCT01459068|50502222|FG001|Overall Study|Death|1|||
25223307|NCT01458522|50502230|FG000|Overall Study|Withdrawal by Subject|2|||
25223308|NCT01458522|50502231|FG001|Overall Study|Withdrawal by Subject|2|||
25223309|NCT01458522|50502230|FG000|Overall Study|Physician Decision|1|||
25223310|NCT01458522|50502231|FG001|Overall Study|Physician Decision|9|||
25223311|NCT01505010|50502245|FG000|Overall Study|Protocol Violation|0|||
25223312|NCT01505010|50502246|FG001|Overall Study|Protocol Violation|1|||
25223313|NCT01505010|50502245|FG000|Overall Study|Lost to Follow-up|0|||
25223314|NCT01505010|50502246|FG001|Overall Study|Lost to Follow-up|1|||
25223315|NCT01458366|50502257|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
25223316|NCT01458366|50502258|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
25223317|NCT01458366|50502259|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
25223318|NCT01458366|50502260|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
25223319|NCT01458366|50502261|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
25223320|NCT01458366|50502257|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
25223321|NCT01458366|50502258|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
25223322|NCT01458366|50502259|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
25223323|NCT01458366|50502260|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
25223324|NCT01458366|50502261|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
25223325|NCT01458210|50502269|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
25223326|NCT01458210|50502269|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
25223327|NCT01458210|50502269|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
25223328|NCT01458210|50502269|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
25223329|NCT01478958|50502279|FG000|Overall Study|Withdrawal by Subject|1|||
25223330|NCT01478958|50502280|FG001|Overall Study|Withdrawal by Subject|1|||
25223331|NCT01478958|50502281|FG002|Overall Study|Withdrawal by Subject|1|||
25223332|NCT01478958|50502279|FG000|Overall Study|Weight loss|1|||
25223333|NCT01478958|50502280|FG001|Overall Study|Weight loss|0|||
25223334|NCT01478958|50502281|FG002|Overall Study|Weight loss|0|||
25223335|NCT01478958|50502279|FG000|Overall Study|Re-located|0|||
25223336|NCT01478958|50502280|FG001|Overall Study|Re-located|1|||
25223337|NCT01478958|50502281|FG002|Overall Study|Re-located|0|||
25223338|NCT01478958|50502279|FG000|Overall Study|Unable to comply|0|||
25223339|NCT01478958|50502280|FG001|Overall Study|Unable to comply|0|||
25223340|NCT01478958|50502281|FG002|Overall Study|Unable to comply|2|||
25223341|NCT01458132|50502291|FG000|Overall Study|Other|15|||
25223342|NCT01458132|50502292|FG001|Overall Study|Other|3|||
25223343|NCT01457352|50502300|FG000|Period 1|Adverse Event|2|||
25223344|NCT01457352|50502301|FG001|Period 1|Adverse Event|0|||
25223345|NCT01457352|50502300|FG000|Period 1|Withdrawal by Subject|2|||
25223346|NCT01457352|50502301|FG001|Period 1|Withdrawal by Subject|0|||
25223347|NCT01457352|50502300|FG000|Period 1|Physician Decision|2|||
25223348|NCT01457352|50502301|FG001|Period 1|Physician Decision|0|||
25223349|NCT01457352|50502300|FG000|Period 1|MS related disease progression|1|||
25223350|NCT01457352|50502301|FG001|Period 1|MS related disease progression|0|||
25223351|NCT01457352|50502300|FG000|Period 1|Withdrawn|1|||
25223352|NCT01457352|50502301|FG001|Period 1|Withdrawn|0|||
25223353|NCT01457352|50502300|FG000|Period 1|withdrew per sponsor|1|||
25223354|NCT01457352|50502301|FG001|Period 1|withdrew per sponsor|0|||
25223355|NCT01457352|50502300|FG000|Period 1|Protocol Violation|4|||
25223356|NCT01457352|50502301|FG001|Period 1|Protocol Violation|0|||
25223357|NCT01457352|50502300|FG000|Period 1|Did not meet eligibility criteria|3|||
25223358|NCT01457352|50502301|FG001|Period 1|Did not meet eligibility criteria|0|||
25223359|NCT01457352|50502300|FG000|Period 2|Withdrawal by Subject|23|||
25223360|NCT01457352|50502301|FG001|Period 2|Withdrawal by Subject|0|||
25223361|NCT01457352|50502300|FG000|Period 2|Adverse Event|22|||
25223362|NCT01457352|50502301|FG001|Period 2|Adverse Event|0|||
25223363|NCT01457352|50502300|FG000|Period 2|no analysis|10|||
25223364|NCT01457352|50502301|FG001|Period 2|no analysis|0|||
25223365|NCT01457352|50502300|FG000|Period 2|Lack of Efficacy|8|||
25223366|NCT01457352|50502301|FG001|Period 2|Lack of Efficacy|0|||
25223367|NCT01457352|50502300|FG000|Period 2|Protocol Violation|4|||
25223368|NCT01457352|50502301|FG001|Period 2|Protocol Violation|0|||
25223369|NCT01457352|50502300|FG000|Period 2|Sponsor's withdrawal|7|||
25223370|NCT01457352|50502301|FG001|Period 2|Sponsor's withdrawal|0|||
25223371|NCT01457352|50502300|FG000|Period 2|Lost to Follow-up|1|||
25223372|NCT01457352|50502301|FG001|Period 2|Lost to Follow-up|0|||
25318231|NCT00891020|50633895|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
25318232|NCT00891020|50633896|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
25223373|NCT01457352|50502300|FG000|Period 2|dose change|1|||
25223374|NCT01457352|50502301|FG001|Period 2|dose change|0|||
25223375|NCT01457352|50502300|FG000|Period 2|Physician Decision|1|||
25223376|NCT01457352|50502301|FG001|Period 2|Physician Decision|0|||
25223377|NCT01457352|50502300|FG000|Period 2|Did not meet eligibility criteria|3|||
25223378|NCT01457352|50502301|FG001|Period 2|Did not meet eligibility criteria|0|||
25223379|NCT01457352|50502300|FG000|Period 3|Adverse Event|1|||
25223380|NCT01457352|50502301|FG001|Period 3|Adverse Event|1|||
25223381|NCT01457352|50502300|FG000|Period 3|Withdrawal by Subject|0|||
25223382|NCT01457352|50502301|FG001|Period 3|Withdrawal by Subject|2|||
25223383|NCT01457352|50502300|FG000|Period 3|incorrect treatment|0|||
25223384|NCT01457352|50502301|FG001|Period 3|incorrect treatment|1|||
25223385|NCT01457352|50502300|FG000|Period 3|Sponsor's withdrawal|0|||
25223386|NCT01457352|50502301|FG001|Period 3|Sponsor's withdrawal|1|||
25223387|NCT01457118|50502315|FG000|Overall Study|Adverse Event|1|||
25223388|NCT01457118|50502316|FG001|Overall Study|Adverse Event|0|||
25223389|NCT01457118|50502317|FG002|Overall Study|Adverse Event|0|||
25223390|NCT01457118|50502318|FG003|Overall Study|Adverse Event|1|||
25223391|NCT01457118|50502315|FG000|Overall Study|Clinical Progression|0|||
25223392|NCT01457118|50502316|FG001|Overall Study|Clinical Progression|1|||
25223393|NCT01457118|50502317|FG002|Overall Study|Clinical Progression|0|||
25223394|NCT01457118|50502318|FG003|Overall Study|Clinical Progression|1|||
25223395|NCT01457118|50502315|FG000|Overall Study|Physician Decision|2|||
25223396|NCT01457118|50502316|FG001|Overall Study|Physician Decision|0|||
25223397|NCT01457118|50502317|FG002|Overall Study|Physician Decision|0|||
25223398|NCT01457118|50502318|FG003|Overall Study|Physician Decision|0|||
25223399|NCT01457118|50502315|FG000|Overall Study|Progressive Disease by RECIST|12|||
25223400|NCT01457118|50502316|FG001|Overall Study|Progressive Disease by RECIST|3|||
25223401|NCT01457118|50502317|FG002|Overall Study|Progressive Disease by RECIST|1|||
25223402|NCT01457118|50502318|FG003|Overall Study|Progressive Disease by RECIST|0|||
25223403|NCT01457118|50502315|FG000|Overall Study|Withdrawal by Subject|5|||
25223404|NCT01457118|50502316|FG001|Overall Study|Withdrawal by Subject|0|||
25223405|NCT01457118|50502317|FG002|Overall Study|Withdrawal by Subject|0|||
25223406|NCT01457118|50502318|FG003|Overall Study|Withdrawal by Subject|0|||
25223407|NCT01456962|50502330|FG000|Overall Study|Lost to Follow-up|2|||
25223408|NCT01456962|50502331|FG001|Overall Study|Lost to Follow-up|1|||
25223409|NCT01501110|50502339|FG000|Overall Study|Death|0|||
25223410|NCT01501110|50502340|FG001|Overall Study|Death|1|||
25223411|NCT01500720|50502348|FG000|Overall Study|Randomized But Not Treated|1|||
25223412|NCT01500720|50502349|FG001|Overall Study|Randomized But Not Treated|1|||
25223413|NCT01500720|50502348|FG000|Overall Study|Other|4|||
25223414|NCT01500720|50502349|FG001|Overall Study|Other|8|||
25223415|NCT01500252|50502357|FG000|Overall Study|Death|4|||
25223416|NCT01500252|50502358|FG001|Overall Study|Death|2|||
25223417|NCT01500252|50502357|FG000|Overall Study|Lost to Follow-up|5|||
25223418|NCT01500252|50502358|FG001|Overall Study|Lost to Follow-up|4|||
25223419|NCT01476696|50502365|FG000|Overall Study|Sponsor decision|2|||
25223420|NCT01476696|50502366|FG001|Overall Study|Sponsor decision|1|||
25223421|NCT01476696|50502367|FG002|Overall Study|Sponsor decision|0|||
25223422|NCT01476696|50502365|FG000|Overall Study|Withdrawal by Subject|1|||
25223423|NCT01476696|50502366|FG001|Overall Study|Withdrawal by Subject|0|||
25223424|NCT01476696|50502367|FG002|Overall Study|Withdrawal by Subject|0|||
25223425|NCT01500096|50502384|FG000|Overall Study|Lost to Follow-up|1|||
25223426|NCT01500096|50502385|FG001|Overall Study|Lost to Follow-up|0|||
25223427|NCT01500096|50502386|FG002|Overall Study|Lost to Follow-up|0|||
25223428|NCT01500096|50502387|FG003|Overall Study|Lost to Follow-up|2|||
25223429|NCT01455012|50502399|FG000|Overall Study|Adverse Event|0|||
25223430|NCT01455012|50502400|FG001|Overall Study|Adverse Event|2|||
25223431|NCT01455012|50502399|FG000|Overall Study|Lack of Efficacy|6|||
25223432|NCT01455012|50502400|FG001|Overall Study|Lack of Efficacy|1|||
25223433|NCT01455012|50502399|FG000|Overall Study|Withdrawal by Subject|3|||
25223434|NCT01455012|50502400|FG001|Overall Study|Withdrawal by Subject|1|||
25223435|NCT01455012|50502399|FG000|Overall Study|Unknown reason|2|||
25223436|NCT01455012|50502400|FG001|Overall Study|Unknown reason|0|||
25223437|NCT01454778|50502406|FG000|Overall Study|Lost to Follow-up|2|||
25223438|NCT01454778|50502406|FG000|Overall Study|Death|1|||
25223439|NCT01454076|50502415|FG000|Overall Study|Other|2|||
25223440|NCT01454076|50502416|FG001|Overall Study|Other|0|||
25223441|NCT01454076|50502417|FG002|Overall Study|Other|0|||
25223442|NCT01454076|50502418|FG003|Overall Study|Other|1|||
25223443|NCT01454076|50502419|FG004|Overall Study|Other|2|||
25223444|NCT01454076|50502415|FG000|Overall Study|Withdrawal by Subject|3|||
25223445|NCT01454076|50502416|FG001|Overall Study|Withdrawal by Subject|4|||
25223446|NCT01454076|50502417|FG002|Overall Study|Withdrawal by Subject|2|||
25223447|NCT01454076|50502418|FG003|Overall Study|Withdrawal by Subject|1|||
25223448|NCT01454076|50502419|FG004|Overall Study|Withdrawal by Subject|2|||
25223449|NCT01454076|50502415|FG000|Overall Study|Adverse Event|8|||
25223450|NCT01454076|50502416|FG001|Overall Study|Adverse Event|2|||
25223451|NCT01454076|50502417|FG002|Overall Study|Adverse Event|7|||
25223452|NCT01454076|50502418|FG003|Overall Study|Adverse Event|0|||
25223453|NCT01454076|50502419|FG004|Overall Study|Adverse Event|2|||
25223454|NCT01453998|50502443|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
25223455|NCT01453998|50502444|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
25223456|NCT01453998|50502445|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
25223457|NCT01453374|50502456|FG000|Overall Study|Adverse Event|7|||
25223458|NCT01453374|50502456|FG000|Overall Study|Lack of Efficacy|1|||
25223459|NCT01453374|50502456|FG000|Overall Study|Lost to Follow-up|3|||
25223460|NCT01453374|50502456|FG000|Overall Study|Withdrawal by Subject|5|||
25223461|NCT01453374|50502456|FG000|Overall Study|Incarcerated|2|||
25223462|NCT01453296|50502462|FG000|Treatment Period 1|Adverse Event|0|||
25223463|NCT01453296|50502463|FG001|Treatment Period 1|Adverse Event|1|||
25223464|NCT01453296|50502462|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
25223465|NCT01453296|50502463|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
25223466|NCT01453296|50502462|FG000|Treatment Period 2|Adverse Event|1|||
25223467|NCT01453296|50502463|FG001|Treatment Period 2|Adverse Event|0|||
25223468|NCT01453296|50502462|FG000|Treatment Period 2|Withdrawal by Subject|1|||
25223469|NCT01453296|50502463|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25223470|NCT01453140|50502469|FG000|Overall Study|Adverse Event|3|||
25223471|NCT01499940|50502477|FG000|Overall Study|Study was withdrawn before completion.|9|||
25223472|NCT01499160|50502481|FG000|Overall Study|Adverse Event|1|||
25223473|NCT01499160|50502481|FG000|Overall Study|Withdrawal by Subject|1|||
25223474|NCT01498692|50502486|FG000|Overall Study|Death|4|||
25223475|NCT01498692|50502486|FG000|Overall Study|Withdrawal by Subject|1|||
25223476|NCT01498692|50502486|FG000|Overall Study|Missed 12-month visit|3|||
25223477|NCT01498068|50502492|FG000|Overall Study|Withdrawal by Subject|1|||
25223478|NCT01498068|50502493|FG001|Overall Study|Withdrawal by Subject|1|||
25223479|NCT01497366|50502501|FG000|Overall Study|Virologic failure|2|||
25223480|NCT01497366|50502502|FG001|Overall Study|Virologic failure|50|||
25223481|NCT01497366|50502501|FG000|Overall Study|Lost to Follow-up|11|||
25223482|NCT01497366|50502502|FG001|Overall Study|Lost to Follow-up|10|||
25223483|NCT01497366|50502501|FG000|Overall Study|Withdrawal by Subject|6|||
25223484|NCT01497366|50502502|FG001|Overall Study|Withdrawal by Subject|6|||
25223485|NCT01497366|50502501|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
25223486|NCT01497366|50502502|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
25223487|NCT01497366|50502501|FG000|Overall Study|Other|5|||
25223488|NCT01497366|50502502|FG001|Overall Study|Other|0|||
25223489|NCT01497366|50502501|FG000|Overall Study|Death|1|||
25223490|NCT01497366|50502502|FG001|Overall Study|Death|1|||
25223491|NCT01497366|50502501|FG000|Overall Study|Randomized but not treated|7|||
25223492|NCT01497366|50502502|FG001|Overall Study|Randomized but not treated|21|||
25223493|NCT01496976|50502509|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
25223494|NCT01475838|50502515|FG000|Randomized Phase|Randomized but Not Treated|0|||
25223495|NCT01475838|50502516|FG001|Randomized Phase|Randomized but Not Treated|5|||
25223496|NCT01475838|50502515|FG000|Randomized Phase|Adverse Event|6|||
25223497|NCT01475838|50502516|FG001|Randomized Phase|Adverse Event|1|||
25223498|NCT01475838|50502515|FG000|Randomized Phase|Pregnancy|0|||
25223499|NCT01475838|50502516|FG001|Randomized Phase|Pregnancy|1|||
25223500|NCT01475838|50502515|FG000|Randomized Phase|Investigators Discretion|1|||
25223501|NCT01475838|50502516|FG001|Randomized Phase|Investigators Discretion|2|||
25223502|NCT01475838|50502515|FG000|Randomized Phase|Withdrew Consent|10|||
25223503|NCT01475838|50502516|FG001|Randomized Phase|Withdrew Consent|14|||
25223504|NCT01475838|50502515|FG000|Randomized Phase|Lost to Follow-up|3|||
25223505|NCT01475838|50502516|FG001|Randomized Phase|Lost to Follow-up|4|||
25223506|NCT01475838|50502515|FG000|Randomized Phase|Participant Noncompliance|1|||
25223507|NCT01475838|50502516|FG001|Randomized Phase|Participant Noncompliance|5|||
25223508|NCT01475838|50502515|FG000|Randomized Phase|Protocol Violation|9|||
25223509|NCT01475838|50502516|FG001|Randomized Phase|Protocol Violation|4|||
25223510|NCT01475838|50502515|FG000|Extension Phase|Participant Noncompliance|1|||
25223511|NCT01475838|50502516|FG001|Extension Phase|Participant Noncompliance|0|||
25223512|NCT01451814|50502525|FG000|Overall Study|Withdrawal by Subject|1|||
25223513|NCT01451814|50502526|FG001|Overall Study|Withdrawal by Subject|1|||
25223514|NCT01451814|50502525|FG000|Overall Study|Lost to Follow-up|5|||
25223515|NCT01451814|50502526|FG001|Overall Study|Lost to Follow-up|4|||
25223516|NCT01475370|50502535|FG000|Overall Study|Exacerbation of primary disease|2|||
25223517|NCT01475370|50502536|FG001|Overall Study|Exacerbation of primary disease|2|||
25223518|NCT01475370|50502537|FG002|Overall Study|Exacerbation of primary disease|2|||
25223519|NCT01475370|50502535|FG000|Overall Study|Study drug administration difficult|0|||
25223520|NCT01475370|50502536|FG001|Overall Study|Study drug administration difficult|1|||
25223521|NCT01475370|50502537|FG002|Overall Study|Study drug administration difficult|1|||
25223522|NCT01475370|50502535|FG000|Overall Study|Other than specified|1|||
25223523|NCT01475370|50502536|FG001|Overall Study|Other than specified|0|||
25223524|NCT01475370|50502537|FG002|Overall Study|Other than specified|0|||
25223525|NCT01496430|50502548|FG000|Overall Study|Adverse Event|0|||
25223526|NCT01496430|50502549|FG001|Overall Study|Adverse Event|0|||
25223527|NCT01496430|50502550|FG002|Overall Study|Adverse Event|1|||
25223528|NCT01496430|50502548|FG000|Overall Study|Major Protocol Deviation|0|||
25223529|NCT01496430|50502549|FG001|Overall Study|Major Protocol Deviation|0|||
25223530|NCT01496430|50502550|FG002|Overall Study|Major Protocol Deviation|1|||
25223531|NCT01496430|50502548|FG000|Overall Study|Lost to Follow-up|2|||
25223532|NCT01496430|50502549|FG001|Overall Study|Lost to Follow-up|3|||
25223533|NCT01496430|50502550|FG002|Overall Study|Lost to Follow-up|1|||
25223534|NCT01496430|50502548|FG000|Overall Study|Voluntary Withdrawal|2|||
25223535|NCT01496430|50502549|FG001|Overall Study|Voluntary Withdrawal|1|||
25223536|NCT01496430|50502550|FG002|Overall Study|Voluntary Withdrawal|6|||
25223537|NCT01496430|50502548|FG000|Overall Study|Principal Investigator Discretion|0|||
25223538|NCT01496430|50502549|FG001|Overall Study|Principal Investigator Discretion|1|||
25223539|NCT01496430|50502550|FG002|Overall Study|Principal Investigator Discretion|1|||
25223540|NCT01496430|50502548|FG000|Overall Study|Other|2|||
25223541|NCT01496430|50502549|FG001|Overall Study|Other|0|||
25223542|NCT01496430|50502550|FG002|Overall Study|Other|0|||
25223543|NCT01451424|50502562|FG000|Overall Study|Withdrawal by Subject|1|||
25223544|NCT01451424|50502563|FG001|Overall Study|Withdrawal by Subject|1|||
25223545|NCT01451424|50502564|FG002|Overall Study|Withdrawal by Subject|0|||
25223546|NCT01451424|50502565|FG003|Overall Study|Withdrawal by Subject|2|||
25223547|NCT01451424|50502562|FG000|Overall Study|Lost to Follow-up|0|||
25223548|NCT01451424|50502563|FG001|Overall Study|Lost to Follow-up|1|||
25223549|NCT01451424|50502564|FG002|Overall Study|Lost to Follow-up|0|||
25223550|NCT01451424|50502565|FG003|Overall Study|Lost to Follow-up|1|||
25223551|NCT01451424|50502562|FG000|Overall Study|Physician Decision|0|||
25223552|NCT01451424|50502563|FG001|Overall Study|Physician Decision|0|||
25223553|NCT01451424|50502564|FG002|Overall Study|Physician Decision|1|||
25223554|NCT01451424|50502565|FG003|Overall Study|Physician Decision|1|||
25223555|NCT01451424|50502562|FG000|Overall Study|Adverse Event|0|||
25223556|NCT01451424|50502563|FG001|Overall Study|Adverse Event|0|||
25223557|NCT01451424|50502564|FG002|Overall Study|Adverse Event|0|||
25223558|NCT01451424|50502565|FG003|Overall Study|Adverse Event|1|||
25223559|NCT01475214|50502583|FG000|Overall Study|Lost to Follow-up|1|||
25223560|NCT01475214|50502584|FG001|Overall Study|Lost to Follow-up|0|||
25223561|NCT01475214|50502585|FG002|Overall Study|Lost to Follow-up|1|||
25223562|NCT01475214|50502583|FG000|Overall Study|Physician Decision|2|||
25223563|NCT01475214|50502584|FG001|Overall Study|Physician Decision|0|||
25223564|NCT01475214|50502585|FG002|Overall Study|Physician Decision|0|||
25223565|NCT01475214|50502583|FG000|Overall Study|Withdrawal by Subject|2|||
25223566|NCT01475214|50502584|FG001|Overall Study|Withdrawal by Subject|4|||
25223567|NCT01475214|50502585|FG002|Overall Study|Withdrawal by Subject|1|||
25223568|NCT01496274|50502596|FG000|Overall Study|Protocol Violation|0|||
25223569|NCT01496274|50502597|FG001|Overall Study|Protocol Violation|1|||
25223570|NCT01496274|50502596|FG000|Overall Study|Adverse Event|1|||
25223571|NCT01496274|50502597|FG001|Overall Study|Adverse Event|1|||
25223572|NCT01496274|50502596|FG000|Overall Study|Withdrawal by Subject|2|||
25223573|NCT01496274|50502597|FG001|Overall Study|Withdrawal by Subject|0|||
25223574|NCT01496274|50502596|FG000|Overall Study|Lost to Follow-up|0|||
25223575|NCT01496274|50502597|FG001|Overall Study|Lost to Follow-up|3|||
25223576|NCT01475136|50502622|FG000|Overall Study|Sponsor Decision|0|||
25223577|NCT01475136|50502623|FG001|Overall Study|Sponsor Decision|1|||
25223578|NCT01475136|50502624|FG002|Overall Study|Sponsor Decision|0|||
25223579|NCT01475136|50502625|FG003|Overall Study|Sponsor Decision|0|||
25223580|NCT01475136|50502622|FG000|Overall Study|Entry Criteria Not Met|0|||
25223581|NCT01475136|50502623|FG001|Overall Study|Entry Criteria Not Met|2|||
25223582|NCT01475136|50502624|FG002|Overall Study|Entry Criteria Not Met|3|||
25223583|NCT01475136|50502625|FG003|Overall Study|Entry Criteria Not Met|1|||
25223584|NCT01475136|50502622|FG000|Overall Study|Withdrawal by Subject|0|||
25223585|NCT01475136|50502623|FG001|Overall Study|Withdrawal by Subject|0|||
25223586|NCT01475136|50502624|FG002|Overall Study|Withdrawal by Subject|0|||
25223587|NCT01475136|50502625|FG003|Overall Study|Withdrawal by Subject|2|||
25223588|NCT01475136|50502622|FG000|Overall Study|Adverse Event|1|||
25223589|NCT01475136|50502623|FG001|Overall Study|Adverse Event|0|||
25223590|NCT01475136|50502624|FG002|Overall Study|Adverse Event|0|||
25223591|NCT01475136|50502625|FG003|Overall Study|Adverse Event|1|||
25223592|NCT01475136|50502622|FG000|Overall Study|Death|0|||
25223593|NCT01475136|50502623|FG001|Overall Study|Death|0|||
25223594|NCT01475136|50502624|FG002|Overall Study|Death|0|||
25223595|NCT01475136|50502625|FG003|Overall Study|Death|1|||
25223596|NCT01474746|50502637|FG000|Overall Study|Lost to Follow-up|1|||
25223597|NCT01474746|50502638|FG001|Overall Study|Lost to Follow-up|1|||
25223598|NCT01474746|50502637|FG000|Overall Study|Withdrawal by Subject|2|||
25223599|NCT01474746|50502638|FG001|Overall Study|Withdrawal by Subject|1|||
25223600|NCT01450800|50502646|FG000|Overall Study|Protocol Violation|1|||
25223601|NCT01450800|50502647|FG001|Overall Study|Protocol Violation|3|||
25318233|NCT00891020|50633897|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
25223602|NCT01474512|50502658|FG000|Induction Period|Adverse Event|6|||
25223603|NCT01474512|50502659|FG001|Induction Period|Adverse Event|10|||
25223604|NCT01474512|50502660|FG002|Induction Period|Adverse Event|10|||
25318234|NCT00891020|50633895|FG000|24 Week Treatment Period|Withdrew consent|6|||
25318235|NCT00891020|50633896|FG001|24 Week Treatment Period|Withdrew consent|3|||
25223605|NCT01474512|50502661|FG003|Induction Period|Adverse Event|0|||
25223606|NCT01474512|50502662|FG004|Induction Period|Adverse Event|0|||
25318236|NCT00891020|50633897|FG002|24 Week Treatment Period|Withdrew consent|15|||
25223607|NCT01474512|50502663|FG005|Induction Period|Adverse Event|0|||
25223608|NCT01474512|50502664|FG006|Induction Period|Adverse Event|0|||
25223609|NCT01474512|50502665|FG007|Induction Period|Adverse Event|0|||
25223610|NCT01474512|50502666|FG008|Induction Period|Adverse Event|0|||
25223611|NCT01474512|50502667|FG009|Induction Period|Adverse Event|0|||
25223612|NCT01474512|50502668|FG010|Induction Period|Adverse Event|0|||
25223613|NCT01474512|50502669|FG011|Induction Period|Adverse Event|0|||
25223614|NCT01474512|50502670|FG012|Induction Period|Adverse Event|0|||
25223615|NCT01474512|50502671|FG013|Induction Period|Adverse Event|0|||
25223616|NCT01474512|50502672|FG014|Induction Period|Adverse Event|0|||
25223617|NCT01474512|50502673|FG015|Induction Period|Adverse Event|0|||
25223618|NCT01474512|50502674|FG016|Induction Period|Adverse Event|0|||
25223619|NCT01474512|50502675|FG017|Induction Period|Adverse Event|0|||
25318237|NCT00891020|50633895|FG000|24 Week Treatment Period|Administrative/Other|5|||
25318238|NCT00891020|50633896|FG001|24 Week Treatment Period|Administrative/Other|6|||
25318239|NCT00891020|50633897|FG002|24 Week Treatment Period|Administrative/Other|1|||
25318240|NCT00891020|50633895|FG000|Long-term Extension Period|Adverse Event|1|||
25318241|NCT00891020|50633896|FG001|Long-term Extension Period|Adverse Event|11|||
25318242|NCT00891020|50633897|FG002|Long-term Extension Period|Adverse Event|10|||
25318243|NCT00891020|50633895|FG000|Long-term Extension Period|Death|0|||
25318244|NCT00891020|50633896|FG001|Long-term Extension Period|Death|0|||
25318245|NCT00891020|50633897|FG002|Long-term Extension Period|Death|1|||
25318246|NCT00891020|50633895|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
25318247|NCT00891020|50633896|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
25318248|NCT00891020|50633897|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
25318249|NCT00891020|50633895|FG000|Long-term Extension Period|Protocol Violation|0|||
25318250|NCT00891020|50633896|FG001|Long-term Extension Period|Protocol Violation|1|||
25318251|NCT00891020|50633897|FG002|Long-term Extension Period|Protocol Violation|1|||
25318252|NCT00891020|50633895|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
25318253|NCT00891020|50633896|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
25318254|NCT00891020|50633897|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
25318255|NCT00891020|50633895|FG000|Long-term Extension Period|Failure to return|0|||
25318256|NCT00891020|50633896|FG001|Long-term Extension Period|Failure to return|2|||
25318257|NCT00891020|50633897|FG002|Long-term Extension Period|Failure to return|3|||
25318258|NCT00891020|50633895|FG000|Long-term Extension Period|Administrative|1|||
25318259|NCT00891020|50633896|FG001|Long-term Extension Period|Administrative|2|||
25318260|NCT00891020|50633897|FG002|Long-term Extension Period|Administrative|2|||
25318261|NCT00611455|50633909|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
25318262|NCT00611455|50633910|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
25318263|NCT00611455|50633911|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
25318264|NCT00611455|50633909|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
25318265|NCT00611455|50633910|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
25318266|NCT00611455|50633911|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
25318267|NCT00611455|50633909|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
25318268|NCT00611455|50633910|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
25318269|NCT00611455|50633911|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
25318270|NCT00611455|50633909|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
25318271|NCT00611455|50633910|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
25318272|NCT00611455|50633911|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
25318273|NCT00611455|50633909|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
25318274|NCT00611455|50633910|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
25318275|NCT00611455|50633911|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
25318276|NCT00611455|50633909|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
25318277|NCT00611455|50633910|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
25318278|NCT00611455|50633911|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
25318279|NCT00611455|50633909|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
25318280|NCT00611455|50633910|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
25318281|NCT00611455|50633911|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
25318282|NCT00611455|50633909|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
25318283|NCT00611455|50633910|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
25318284|NCT00611455|50633911|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
25318285|NCT00611455|50633909|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
25318286|NCT00611455|50633910|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
25318287|NCT00611455|50633911|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
25318288|NCT00611455|50633909|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
25318289|NCT00611455|50633910|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
25318290|NCT00611455|50633911|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
25318291|NCT00611455|50633909|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
25223620|NCT01474512|50502658|FG000|Induction Period|Lack of Efficacy|7|||
25318292|NCT00611455|50633910|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
25318293|NCT00611455|50633911|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
24976521|NCT03480802|50065436|FG000|Overall Study|Lost to Follow-up|5|||
25223621|NCT01474512|50502659|FG001|Induction Period|Lack of Efficacy|1|||
25223622|NCT01474512|50502660|FG002|Induction Period|Lack of Efficacy|0|||
25223623|NCT01474512|50502661|FG003|Induction Period|Lack of Efficacy|0|||
25223624|NCT01474512|50502662|FG004|Induction Period|Lack of Efficacy|0|||
25223625|NCT01474512|50502663|FG005|Induction Period|Lack of Efficacy|0|||
25223626|NCT01474512|50502664|FG006|Induction Period|Lack of Efficacy|0|||
25223627|NCT01474512|50502665|FG007|Induction Period|Lack of Efficacy|0|||
25223628|NCT01474512|50502666|FG008|Induction Period|Lack of Efficacy|0|||
25223629|NCT01474512|50502667|FG009|Induction Period|Lack of Efficacy|0|||
25223630|NCT01474512|50502668|FG010|Induction Period|Lack of Efficacy|0|||
25223631|NCT01474512|50502669|FG011|Induction Period|Lack of Efficacy|0|||
25223632|NCT01474512|50502670|FG012|Induction Period|Lack of Efficacy|0|||
25223633|NCT01474512|50502671|FG013|Induction Period|Lack of Efficacy|0|||
25223634|NCT01474512|50502672|FG014|Induction Period|Lack of Efficacy|0|||
25223635|NCT01474512|50502673|FG015|Induction Period|Lack of Efficacy|0|||
25223636|NCT01474512|50502674|FG016|Induction Period|Lack of Efficacy|0|||
25223637|NCT01474512|50502675|FG017|Induction Period|Lack of Efficacy|0|||
25223638|NCT01474512|50502658|FG000|Induction Period|Withdrawal by Subject|6|||
25223639|NCT01474512|50502659|FG001|Induction Period|Withdrawal by Subject|6|||
25223640|NCT01474512|50502660|FG002|Induction Period|Withdrawal by Subject|5|||
25223641|NCT01474512|50502661|FG003|Induction Period|Withdrawal by Subject|0|||
25223642|NCT01474512|50502662|FG004|Induction Period|Withdrawal by Subject|0|||
25223643|NCT01474512|50502663|FG005|Induction Period|Withdrawal by Subject|0|||
25223644|NCT01474512|50502664|FG006|Induction Period|Withdrawal by Subject|0|||
25223645|NCT01474512|50502665|FG007|Induction Period|Withdrawal by Subject|0|||
25223646|NCT01474512|50502666|FG008|Induction Period|Withdrawal by Subject|0|||
25223647|NCT01474512|50502667|FG009|Induction Period|Withdrawal by Subject|0|||
25223648|NCT01474512|50502668|FG010|Induction Period|Withdrawal by Subject|0|||
25223649|NCT01474512|50502669|FG011|Induction Period|Withdrawal by Subject|0|||
25223650|NCT01474512|50502670|FG012|Induction Period|Withdrawal by Subject|0|||
25223651|NCT01474512|50502671|FG013|Induction Period|Withdrawal by Subject|0|||
25223652|NCT01474512|50502672|FG014|Induction Period|Withdrawal by Subject|0|||
25223653|NCT01474512|50502673|FG015|Induction Period|Withdrawal by Subject|0|||
25223654|NCT01474512|50502674|FG016|Induction Period|Withdrawal by Subject|0|||
25223655|NCT01474512|50502675|FG017|Induction Period|Withdrawal by Subject|0|||
25223656|NCT01474512|50502658|FG000|Induction Period|Protocol Violation|3|||
25223657|NCT01474512|50502659|FG001|Induction Period|Protocol Violation|6|||
25223658|NCT01474512|50502660|FG002|Induction Period|Protocol Violation|0|||
25223659|NCT01474512|50502661|FG003|Induction Period|Protocol Violation|0|||
25223660|NCT01474512|50502662|FG004|Induction Period|Protocol Violation|0|||
25223661|NCT01474512|50502663|FG005|Induction Period|Protocol Violation|0|||
25223662|NCT01474512|50502664|FG006|Induction Period|Protocol Violation|0|||
25223663|NCT01474512|50502665|FG007|Induction Period|Protocol Violation|0|||
25223664|NCT01474512|50502666|FG008|Induction Period|Protocol Violation|0|||
25223665|NCT01474512|50502667|FG009|Induction Period|Protocol Violation|0|||
25223666|NCT01474512|50502668|FG010|Induction Period|Protocol Violation|0|||
25223667|NCT01474512|50502669|FG011|Induction Period|Protocol Violation|0|||
25223668|NCT01474512|50502670|FG012|Induction Period|Protocol Violation|0|||
25223669|NCT01474512|50502671|FG013|Induction Period|Protocol Violation|0|||
25223670|NCT01474512|50502672|FG014|Induction Period|Protocol Violation|0|||
25223671|NCT01474512|50502673|FG015|Induction Period|Protocol Violation|0|||
25223672|NCT01474512|50502674|FG016|Induction Period|Protocol Violation|0|||
25223673|NCT01474512|50502675|FG017|Induction Period|Protocol Violation|0|||
25223674|NCT01474512|50502658|FG000|Induction Period|Sponsor Decision|1|||
25223675|NCT01474512|50502659|FG001|Induction Period|Sponsor Decision|1|||
25223676|NCT01474512|50502660|FG002|Induction Period|Sponsor Decision|1|||
25223677|NCT01474512|50502661|FG003|Induction Period|Sponsor Decision|0|||
25223678|NCT01474512|50502662|FG004|Induction Period|Sponsor Decision|0|||
25223679|NCT01474512|50502663|FG005|Induction Period|Sponsor Decision|0|||
25223680|NCT01474512|50502664|FG006|Induction Period|Sponsor Decision|0|||
25223681|NCT01474512|50502665|FG007|Induction Period|Sponsor Decision|0|||
25223682|NCT01474512|50502666|FG008|Induction Period|Sponsor Decision|0|||
25223683|NCT01474512|50502667|FG009|Induction Period|Sponsor Decision|0|||
25223684|NCT01474512|50502668|FG010|Induction Period|Sponsor Decision|0|||
25223685|NCT01474512|50502669|FG011|Induction Period|Sponsor Decision|0|||
25223686|NCT01474512|50502670|FG012|Induction Period|Sponsor Decision|0|||
25223687|NCT01474512|50502671|FG013|Induction Period|Sponsor Decision|0|||
25223688|NCT01474512|50502672|FG014|Induction Period|Sponsor Decision|0|||
25223689|NCT01474512|50502673|FG015|Induction Period|Sponsor Decision|0|||
25223690|NCT01474512|50502674|FG016|Induction Period|Sponsor Decision|0|||
25223691|NCT01474512|50502675|FG017|Induction Period|Sponsor Decision|0|||
25223692|NCT01474512|50502658|FG000|Induction Period|Lost to Follow-up|1|||
25223693|NCT01474512|50502659|FG001|Induction Period|Lost to Follow-up|0|||
25223694|NCT01474512|50502660|FG002|Induction Period|Lost to Follow-up|2|||
25223695|NCT01474512|50502661|FG003|Induction Period|Lost to Follow-up|0|||
25223696|NCT01474512|50502662|FG004|Induction Period|Lost to Follow-up|0|||
25223697|NCT01474512|50502663|FG005|Induction Period|Lost to Follow-up|0|||
25223698|NCT01474512|50502664|FG006|Induction Period|Lost to Follow-up|0|||
25223699|NCT01474512|50502665|FG007|Induction Period|Lost to Follow-up|0|||
25223700|NCT01474512|50502666|FG008|Induction Period|Lost to Follow-up|0|||
25223701|NCT01474512|50502667|FG009|Induction Period|Lost to Follow-up|0|||
25223702|NCT01474512|50502668|FG010|Induction Period|Lost to Follow-up|0|||
25223703|NCT01474512|50502669|FG011|Induction Period|Lost to Follow-up|0|||
25223704|NCT01474512|50502670|FG012|Induction Period|Lost to Follow-up|0|||
25223705|NCT01474512|50502671|FG013|Induction Period|Lost to Follow-up|0|||
25223706|NCT01474512|50502672|FG014|Induction Period|Lost to Follow-up|0|||
25223707|NCT01474512|50502673|FG015|Induction Period|Lost to Follow-up|0|||
25223708|NCT01474512|50502674|FG016|Induction Period|Lost to Follow-up|0|||
25223709|NCT01474512|50502675|FG017|Induction Period|Lost to Follow-up|0|||
25223710|NCT01474512|50502658|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
25223711|NCT01474512|50502659|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
25223712|NCT01474512|50502660|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
25223713|NCT01474512|50502661|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
25223714|NCT01474512|50502662|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
25223715|NCT01474512|50502663|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
25223716|NCT01474512|50502664|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
25223717|NCT01474512|50502665|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
25223718|NCT01474512|50502666|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
25223719|NCT01474512|50502667|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
25223720|NCT01474512|50502668|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
25223721|NCT01474512|50502669|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
25223722|NCT01474512|50502670|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
25223723|NCT01474512|50502671|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
25223724|NCT01474512|50502672|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
25223725|NCT01474512|50502673|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
25223726|NCT01474512|50502674|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
25223727|NCT01474512|50502675|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
25223728|NCT01474512|50502658|FG000|Maintenance Period|Adverse Event|0|||
25223729|NCT01474512|50502659|FG001|Maintenance Period|Adverse Event|0|||
25223730|NCT01474512|50502660|FG002|Maintenance Period|Adverse Event|0|||
25223731|NCT01474512|50502661|FG003|Maintenance Period|Adverse Event|4|||
25223732|NCT01474512|50502662|FG004|Maintenance Period|Adverse Event|2|||
25223733|NCT01474512|50502663|FG005|Maintenance Period|Adverse Event|7|||
25223734|NCT01474512|50502664|FG006|Maintenance Period|Adverse Event|0|||
25223735|NCT01474512|50502665|FG007|Maintenance Period|Adverse Event|19|||
25223736|NCT01474512|50502666|FG008|Maintenance Period|Adverse Event|1|||
25223737|NCT01474512|50502667|FG009|Maintenance Period|Adverse Event|3|||
25223738|NCT01474512|50502668|FG010|Maintenance Period|Adverse Event|0|||
25223739|NCT01474512|50502669|FG011|Maintenance Period|Adverse Event|0|||
25223740|NCT01474512|50502670|FG012|Maintenance Period|Adverse Event|0|||
25223741|NCT01474512|50502671|FG013|Maintenance Period|Adverse Event|0|||
25223742|NCT01474512|50502672|FG014|Maintenance Period|Adverse Event|0|||
25223743|NCT01474512|50502673|FG015|Maintenance Period|Adverse Event|0|||
25223744|NCT01474512|50502674|FG016|Maintenance Period|Adverse Event|0|||
25223745|NCT01474512|50502675|FG017|Maintenance Period|Adverse Event|0|||
25223746|NCT01474512|50502658|FG000|Maintenance Period|Withdrawal by Subject|0|||
25223747|NCT01474512|50502659|FG001|Maintenance Period|Withdrawal by Subject|0|||
25223748|NCT01474512|50502660|FG002|Maintenance Period|Withdrawal by Subject|0|||
25223749|NCT01474512|50502661|FG003|Maintenance Period|Withdrawal by Subject|6|||
25223750|NCT01474512|50502662|FG004|Maintenance Period|Withdrawal by Subject|2|||
25223751|NCT01474512|50502663|FG005|Maintenance Period|Withdrawal by Subject|3|||
25223752|NCT01474512|50502664|FG006|Maintenance Period|Withdrawal by Subject|1|||
25223753|NCT01474512|50502665|FG007|Maintenance Period|Withdrawal by Subject|6|||
25223754|NCT01474512|50502666|FG008|Maintenance Period|Withdrawal by Subject|3|||
25223755|NCT01474512|50502667|FG009|Maintenance Period|Withdrawal by Subject|1|||
25223756|NCT01474512|50502668|FG010|Maintenance Period|Withdrawal by Subject|0|||
25223757|NCT01474512|50502669|FG011|Maintenance Period|Withdrawal by Subject|0|||
25223758|NCT01474512|50502670|FG012|Maintenance Period|Withdrawal by Subject|0|||
25223759|NCT01474512|50502671|FG013|Maintenance Period|Withdrawal by Subject|0|||
25223760|NCT01474512|50502672|FG014|Maintenance Period|Withdrawal by Subject|0|||
25223761|NCT01474512|50502673|FG015|Maintenance Period|Withdrawal by Subject|0|||
25223762|NCT01474512|50502674|FG016|Maintenance Period|Withdrawal by Subject|0|||
25223763|NCT01474512|50502675|FG017|Maintenance Period|Withdrawal by Subject|0|||
25223764|NCT01474512|50502658|FG000|Maintenance Period|Lost to Follow-up|0|||
25223765|NCT01474512|50502659|FG001|Maintenance Period|Lost to Follow-up|0|||
25223766|NCT01474512|50502660|FG002|Maintenance Period|Lost to Follow-up|0|||
25223767|NCT01474512|50502661|FG003|Maintenance Period|Lost to Follow-up|3|||
25223768|NCT01474512|50502662|FG004|Maintenance Period|Lost to Follow-up|3|||
25223769|NCT01474512|50502663|FG005|Maintenance Period|Lost to Follow-up|0|||
25223770|NCT01474512|50502664|FG006|Maintenance Period|Lost to Follow-up|0|||
25223771|NCT01474512|50502665|FG007|Maintenance Period|Lost to Follow-up|2|||
25223772|NCT01474512|50502666|FG008|Maintenance Period|Lost to Follow-up|1|||
25223773|NCT01474512|50502667|FG009|Maintenance Period|Lost to Follow-up|1|||
25223774|NCT01474512|50502668|FG010|Maintenance Period|Lost to Follow-up|0|||
25223775|NCT01474512|50502669|FG011|Maintenance Period|Lost to Follow-up|0|||
25223776|NCT01474512|50502670|FG012|Maintenance Period|Lost to Follow-up|0|||
25223777|NCT01474512|50502671|FG013|Maintenance Period|Lost to Follow-up|0|||
25223778|NCT01474512|50502672|FG014|Maintenance Period|Lost to Follow-up|0|||
25223779|NCT01474512|50502673|FG015|Maintenance Period|Lost to Follow-up|0|||
25223780|NCT01474512|50502674|FG016|Maintenance Period|Lost to Follow-up|0|||
25223781|NCT01474512|50502675|FG017|Maintenance Period|Lost to Follow-up|0|||
25223782|NCT01474512|50502658|FG000|Maintenance Period|Death|0|||
25223783|NCT01474512|50502659|FG001|Maintenance Period|Death|0|||
25223784|NCT01474512|50502660|FG002|Maintenance Period|Death|0|||
25223785|NCT01474512|50502661|FG003|Maintenance Period|Death|0|||
25223786|NCT01474512|50502662|FG004|Maintenance Period|Death|0|||
25223787|NCT01474512|50502663|FG005|Maintenance Period|Death|2|||
25223788|NCT01474512|50502664|FG006|Maintenance Period|Death|0|||
25223789|NCT01474512|50502665|FG007|Maintenance Period|Death|0|||
25223790|NCT01474512|50502666|FG008|Maintenance Period|Death|0|||
25223791|NCT01474512|50502667|FG009|Maintenance Period|Death|0|||
25223792|NCT01474512|50502668|FG010|Maintenance Period|Death|0|||
25223793|NCT01474512|50502669|FG011|Maintenance Period|Death|0|||
25223794|NCT01474512|50502670|FG012|Maintenance Period|Death|0|||
25223795|NCT01474512|50502671|FG013|Maintenance Period|Death|0|||
25223796|NCT01474512|50502672|FG014|Maintenance Period|Death|0|||
25223797|NCT01474512|50502673|FG015|Maintenance Period|Death|0|||
25223798|NCT01474512|50502674|FG016|Maintenance Period|Death|0|||
25223799|NCT01474512|50502675|FG017|Maintenance Period|Death|0|||
25223800|NCT01474512|50502658|FG000|Maintenance Period|Physician Decision|0|||
25223801|NCT01474512|50502659|FG001|Maintenance Period|Physician Decision|0|||
25223802|NCT01474512|50502660|FG002|Maintenance Period|Physician Decision|0|||
25223803|NCT01474512|50502661|FG003|Maintenance Period|Physician Decision|0|||
25223804|NCT01474512|50502662|FG004|Maintenance Period|Physician Decision|0|||
25223805|NCT01474512|50502663|FG005|Maintenance Period|Physician Decision|1|||
25223806|NCT01474512|50502664|FG006|Maintenance Period|Physician Decision|0|||
25223807|NCT01474512|50502665|FG007|Maintenance Period|Physician Decision|2|||
25223808|NCT01474512|50502666|FG008|Maintenance Period|Physician Decision|0|||
25223809|NCT01474512|50502667|FG009|Maintenance Period|Physician Decision|0|||
25223810|NCT01474512|50502668|FG010|Maintenance Period|Physician Decision|0|||
25223811|NCT01474512|50502669|FG011|Maintenance Period|Physician Decision|0|||
25223812|NCT01474512|50502670|FG012|Maintenance Period|Physician Decision|0|||
25223813|NCT01474512|50502671|FG013|Maintenance Period|Physician Decision|0|||
25223814|NCT01474512|50502672|FG014|Maintenance Period|Physician Decision|0|||
25223815|NCT01474512|50502673|FG015|Maintenance Period|Physician Decision|0|||
25223816|NCT01474512|50502674|FG016|Maintenance Period|Physician Decision|0|||
25223817|NCT01474512|50502675|FG017|Maintenance Period|Physician Decision|0|||
25223818|NCT01474512|50502658|FG000|Maintenance Period|Clinical Relapse|0|||
25223819|NCT01474512|50502659|FG001|Maintenance Period|Clinical Relapse|0|||
25223820|NCT01474512|50502660|FG002|Maintenance Period|Clinical Relapse|0|||
25223821|NCT01474512|50502661|FG003|Maintenance Period|Clinical Relapse|1|||
25223822|NCT01474512|50502662|FG004|Maintenance Period|Clinical Relapse|0|||
25223823|NCT01474512|50502663|FG005|Maintenance Period|Clinical Relapse|0|||
25223824|NCT01474512|50502664|FG006|Maintenance Period|Clinical Relapse|0|||
25223825|NCT01474512|50502665|FG007|Maintenance Period|Clinical Relapse|0|||
25223826|NCT01474512|50502666|FG008|Maintenance Period|Clinical Relapse|0|||
25223827|NCT01474512|50502667|FG009|Maintenance Period|Clinical Relapse|0|||
25223828|NCT01474512|50502668|FG010|Maintenance Period|Clinical Relapse|0|||
25223829|NCT01474512|50502669|FG011|Maintenance Period|Clinical Relapse|0|||
25223830|NCT01474512|50502670|FG012|Maintenance Period|Clinical Relapse|0|||
25223831|NCT01474512|50502671|FG013|Maintenance Period|Clinical Relapse|0|||
25223832|NCT01474512|50502672|FG014|Maintenance Period|Clinical Relapse|0|||
25223833|NCT01474512|50502673|FG015|Maintenance Period|Clinical Relapse|0|||
25223834|NCT01474512|50502674|FG016|Maintenance Period|Clinical Relapse|0|||
25223835|NCT01474512|50502675|FG017|Maintenance Period|Clinical Relapse|0|||
25223836|NCT01474512|50502658|FG000|Maintenance Period|Lack of Efficacy|0|||
25223837|NCT01474512|50502659|FG001|Maintenance Period|Lack of Efficacy|0|||
25223838|NCT01474512|50502660|FG002|Maintenance Period|Lack of Efficacy|0|||
25223839|NCT01474512|50502661|FG003|Maintenance Period|Lack of Efficacy|1|||
25223840|NCT01474512|50502662|FG004|Maintenance Period|Lack of Efficacy|0|||
25223841|NCT01474512|50502663|FG005|Maintenance Period|Lack of Efficacy|0|||
25223842|NCT01474512|50502664|FG006|Maintenance Period|Lack of Efficacy|0|||
25223843|NCT01474512|50502665|FG007|Maintenance Period|Lack of Efficacy|11|||
25223844|NCT01474512|50502666|FG008|Maintenance Period|Lack of Efficacy|11|||
25318294|NCT00611455|50633909|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
25318295|NCT00611455|50633910|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
25318296|NCT00611455|50633911|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
25223845|NCT01474512|50502667|FG009|Maintenance Period|Lack of Efficacy|12|||
25223846|NCT01474512|50502668|FG010|Maintenance Period|Lack of Efficacy|0|||
25318297|NCT00611455|50633909|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
25318298|NCT00611455|50633910|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
25223847|NCT01474512|50502669|FG011|Maintenance Period|Lack of Efficacy|0|||
25223848|NCT01474512|50502670|FG012|Maintenance Period|Lack of Efficacy|0|||
25223849|NCT01474512|50502671|FG013|Maintenance Period|Lack of Efficacy|0|||
25223850|NCT01474512|50502672|FG014|Maintenance Period|Lack of Efficacy|0|||
25223851|NCT01474512|50502673|FG015|Maintenance Period|Lack of Efficacy|0|||
25223852|NCT01474512|50502674|FG016|Maintenance Period|Lack of Efficacy|0|||
25223853|NCT01474512|50502675|FG017|Maintenance Period|Lack of Efficacy|0|||
25223854|NCT01474512|50502658|FG000|Maintenance Period|Protocol Violation|0|||
25223855|NCT01474512|50502659|FG001|Maintenance Period|Protocol Violation|0|||
25223856|NCT01474512|50502660|FG002|Maintenance Period|Protocol Violation|0|||
25223857|NCT01474512|50502661|FG003|Maintenance Period|Protocol Violation|1|||
25223858|NCT01474512|50502662|FG004|Maintenance Period|Protocol Violation|0|||
25223859|NCT01474512|50502663|FG005|Maintenance Period|Protocol Violation|0|||
25223860|NCT01474512|50502664|FG006|Maintenance Period|Protocol Violation|0|||
25223861|NCT01474512|50502665|FG007|Maintenance Period|Protocol Violation|1|||
25223862|NCT01474512|50502666|FG008|Maintenance Period|Protocol Violation|0|||
25223863|NCT01474512|50502667|FG009|Maintenance Period|Protocol Violation|1|||
25223864|NCT01474512|50502668|FG010|Maintenance Period|Protocol Violation|0|||
25223865|NCT01474512|50502669|FG011|Maintenance Period|Protocol Violation|0|||
25223866|NCT01474512|50502670|FG012|Maintenance Period|Protocol Violation|0|||
25223867|NCT01474512|50502671|FG013|Maintenance Period|Protocol Violation|0|||
25223868|NCT01474512|50502672|FG014|Maintenance Period|Protocol Violation|0|||
25223869|NCT01474512|50502673|FG015|Maintenance Period|Protocol Violation|0|||
25223870|NCT01474512|50502674|FG016|Maintenance Period|Protocol Violation|0|||
25223871|NCT01474512|50502675|FG017|Maintenance Period|Protocol Violation|0|||
25223872|NCT01474512|50502658|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
25223873|NCT01474512|50502659|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
25223874|NCT01474512|50502660|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
25223875|NCT01474512|50502661|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
25223876|NCT01474512|50502662|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
25223877|NCT01474512|50502663|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
25223878|NCT01474512|50502664|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
25223879|NCT01474512|50502665|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
25223880|NCT01474512|50502666|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
25223881|NCT01474512|50502667|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
25223882|NCT01474512|50502668|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
25223883|NCT01474512|50502669|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
25223884|NCT01474512|50502670|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
25223885|NCT01474512|50502671|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
25223886|NCT01474512|50502672|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
25223887|NCT01474512|50502673|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
25223888|NCT01474512|50502674|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
25223889|NCT01474512|50502675|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
25223890|NCT01474512|50502658|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
25223891|NCT01474512|50502659|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
25223892|NCT01474512|50502660|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
25223893|NCT01474512|50502661|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
25223894|NCT01474512|50502662|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
25223895|NCT01474512|50502663|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
25223896|NCT01474512|50502664|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
25223897|NCT01474512|50502665|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
25223898|NCT01474512|50502666|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
25223899|NCT01474512|50502667|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
25223900|NCT01474512|50502668|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
25223901|NCT01474512|50502669|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
25223902|NCT01474512|50502670|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
25223903|NCT01474512|50502671|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
25223904|NCT01474512|50502672|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
25223905|NCT01474512|50502673|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
25223906|NCT01474512|50502674|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
25223907|NCT01474512|50502675|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
25223908|NCT01474512|50502658|FG000|Long-Term Extension Period|Adverse Event|0|||
25223909|NCT01474512|50502659|FG001|Long-Term Extension Period|Adverse Event|0|||
25223910|NCT01474512|50502660|FG002|Long-Term Extension Period|Adverse Event|0|||
25223911|NCT01474512|50502661|FG003|Long-Term Extension Period|Adverse Event|0|||
25223912|NCT01474512|50502662|FG004|Long-Term Extension Period|Adverse Event|0|||
25223913|NCT01474512|50502663|FG005|Long-Term Extension Period|Adverse Event|0|||
25223914|NCT01474512|50502664|FG006|Long-Term Extension Period|Adverse Event|0|||
25223915|NCT01474512|50502665|FG007|Long-Term Extension Period|Adverse Event|0|||
25077458|NCT02243176|50185264|FG001|Overall Study|Protocol Violation|1|||
25223916|NCT01474512|50502666|FG008|Long-Term Extension Period|Adverse Event|0|||
25223917|NCT01474512|50502667|FG009|Long-Term Extension Period|Adverse Event|0|||
25077459|NCT02243176|50185263|FG000|Overall Study|Withdrawal by Subject|8|||
25223918|NCT01474512|50502668|FG010|Long-Term Extension Period|Adverse Event|0|||
25223919|NCT01474512|50502669|FG011|Long-Term Extension Period|Adverse Event|1|||
25223920|NCT01474512|50502670|FG012|Long-Term Extension Period|Adverse Event|57|||
25223921|NCT01474512|50502671|FG013|Long-Term Extension Period|Adverse Event|58|||
25223922|NCT01474512|50502672|FG014|Long-Term Extension Period|Adverse Event|0|||
25223923|NCT01474512|50502673|FG015|Long-Term Extension Period|Adverse Event|0|||
25223924|NCT01474512|50502674|FG016|Long-Term Extension Period|Adverse Event|0|||
25223925|NCT01474512|50502675|FG017|Long-Term Extension Period|Adverse Event|0|||
25223926|NCT01474512|50502658|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
25223927|NCT01474512|50502659|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
25223928|NCT01474512|50502660|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
25223929|NCT01474512|50502661|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
25223930|NCT01474512|50502662|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
25223931|NCT01474512|50502663|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
25223932|NCT01474512|50502664|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
25223933|NCT01474512|50502665|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
25223934|NCT01474512|50502666|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
25223935|NCT01474512|50502667|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
25223936|NCT01474512|50502668|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
25223937|NCT01474512|50502669|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
25223938|NCT01474512|50502670|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
25223939|NCT01474512|50502671|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
25223940|NCT01474512|50502672|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
25223941|NCT01474512|50502673|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
25223942|NCT01474512|50502674|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
25223943|NCT01474512|50502675|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
25223944|NCT01474512|50502658|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
25223945|NCT01474512|50502659|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
25223946|NCT01474512|50502660|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
25223947|NCT01474512|50502661|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
25223948|NCT01474512|50502662|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
25223949|NCT01474512|50502663|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
25223950|NCT01474512|50502664|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
25223951|NCT01474512|50502665|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
25223952|NCT01474512|50502666|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
25223953|NCT01474512|50502667|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
25223954|NCT01474512|50502668|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
25223955|NCT01474512|50502669|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
25223956|NCT01474512|50502670|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
25223957|NCT01474512|50502671|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
25223958|NCT01474512|50502672|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
25223959|NCT01474512|50502673|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
25223960|NCT01474512|50502674|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
25223961|NCT01474512|50502675|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
25223962|NCT01474512|50502658|FG000|Long-Term Extension Period|Physician Decision|0|||
25223963|NCT01474512|50502659|FG001|Long-Term Extension Period|Physician Decision|0|||
25223964|NCT01474512|50502660|FG002|Long-Term Extension Period|Physician Decision|0|||
25223965|NCT01474512|50502661|FG003|Long-Term Extension Period|Physician Decision|0|||
25223966|NCT01474512|50502662|FG004|Long-Term Extension Period|Physician Decision|0|||
25223967|NCT01474512|50502663|FG005|Long-Term Extension Period|Physician Decision|0|||
25223968|NCT01474512|50502664|FG006|Long-Term Extension Period|Physician Decision|0|||
25223969|NCT01474512|50502665|FG007|Long-Term Extension Period|Physician Decision|0|||
25223970|NCT01474512|50502666|FG008|Long-Term Extension Period|Physician Decision|0|||
25223971|NCT01474512|50502667|FG009|Long-Term Extension Period|Physician Decision|0|||
25223972|NCT01474512|50502668|FG010|Long-Term Extension Period|Physician Decision|0|||
25223973|NCT01474512|50502669|FG011|Long-Term Extension Period|Physician Decision|0|||
25223974|NCT01474512|50502670|FG012|Long-Term Extension Period|Physician Decision|21|||
25223975|NCT01474512|50502671|FG013|Long-Term Extension Period|Physician Decision|21|||
25223976|NCT01474512|50502672|FG014|Long-Term Extension Period|Physician Decision|0|||
25223977|NCT01474512|50502673|FG015|Long-Term Extension Period|Physician Decision|0|||
25223978|NCT01474512|50502674|FG016|Long-Term Extension Period|Physician Decision|0|||
25223979|NCT01474512|50502675|FG017|Long-Term Extension Period|Physician Decision|0|||
25223980|NCT01474512|50502658|FG000|Long-Term Extension Period|Clinical Relapse|0|||
25223981|NCT01474512|50502659|FG001|Long-Term Extension Period|Clinical Relapse|0|||
25223982|NCT01474512|50502660|FG002|Long-Term Extension Period|Clinical Relapse|0|||
25223983|NCT01474512|50502661|FG003|Long-Term Extension Period|Clinical Relapse|0|||
25223984|NCT01474512|50502662|FG004|Long-Term Extension Period|Clinical Relapse|0|||
25223985|NCT01474512|50502663|FG005|Long-Term Extension Period|Clinical Relapse|0|||
25223986|NCT01474512|50502664|FG006|Long-Term Extension Period|Clinical Relapse|0|||
25223987|NCT01474512|50502665|FG007|Long-Term Extension Period|Clinical Relapse|0|||
25223988|NCT01474512|50502666|FG008|Long-Term Extension Period|Clinical Relapse|0|||
25223989|NCT01474512|50502667|FG009|Long-Term Extension Period|Clinical Relapse|0|||
25223990|NCT01474512|50502668|FG010|Long-Term Extension Period|Clinical Relapse|0|||
25223991|NCT01474512|50502669|FG011|Long-Term Extension Period|Clinical Relapse|0|||
25223992|NCT01474512|50502670|FG012|Long-Term Extension Period|Clinical Relapse|9|||
25223993|NCT01474512|50502671|FG013|Long-Term Extension Period|Clinical Relapse|9|||
25223994|NCT01474512|50502672|FG014|Long-Term Extension Period|Clinical Relapse|0|||
25223995|NCT01474512|50502673|FG015|Long-Term Extension Period|Clinical Relapse|0|||
25223996|NCT01474512|50502674|FG016|Long-Term Extension Period|Clinical Relapse|0|||
25223997|NCT01474512|50502675|FG017|Long-Term Extension Period|Clinical Relapse|0|||
25223998|NCT01474512|50502658|FG000|Long-Term Extension Period|Death|0|||
25223999|NCT01474512|50502659|FG001|Long-Term Extension Period|Death|0|||
25224000|NCT01474512|50502660|FG002|Long-Term Extension Period|Death|0|||
25224001|NCT01474512|50502661|FG003|Long-Term Extension Period|Death|0|||
25224002|NCT01474512|50502662|FG004|Long-Term Extension Period|Death|0|||
25224003|NCT01474512|50502663|FG005|Long-Term Extension Period|Death|0|||
25224004|NCT01474512|50502664|FG006|Long-Term Extension Period|Death|0|||
25224005|NCT01474512|50502665|FG007|Long-Term Extension Period|Death|0|||
25224006|NCT01474512|50502666|FG008|Long-Term Extension Period|Death|0|||
25224007|NCT01474512|50502667|FG009|Long-Term Extension Period|Death|0|||
25224008|NCT01474512|50502668|FG010|Long-Term Extension Period|Death|0|||
25224009|NCT01474512|50502669|FG011|Long-Term Extension Period|Death|0|||
25224010|NCT01474512|50502670|FG012|Long-Term Extension Period|Death|9|||
25224011|NCT01474512|50502671|FG013|Long-Term Extension Period|Death|9|||
25224012|NCT01474512|50502672|FG014|Long-Term Extension Period|Death|0|||
25224013|NCT01474512|50502673|FG015|Long-Term Extension Period|Death|0|||
25224014|NCT01474512|50502674|FG016|Long-Term Extension Period|Death|0|||
25224015|NCT01474512|50502675|FG017|Long-Term Extension Period|Death|0|||
25224016|NCT01474512|50502658|FG000|Long-Term Extension Period|Sponsor Decision|0|||
25224017|NCT01474512|50502659|FG001|Long-Term Extension Period|Sponsor Decision|0|||
25224018|NCT01474512|50502660|FG002|Long-Term Extension Period|Sponsor Decision|0|||
25224019|NCT01474512|50502661|FG003|Long-Term Extension Period|Sponsor Decision|0|||
25224020|NCT01474512|50502662|FG004|Long-Term Extension Period|Sponsor Decision|0|||
25224021|NCT01474512|50502663|FG005|Long-Term Extension Period|Sponsor Decision|0|||
25224022|NCT01474512|50502664|FG006|Long-Term Extension Period|Sponsor Decision|0|||
25224023|NCT01474512|50502665|FG007|Long-Term Extension Period|Sponsor Decision|0|||
25224024|NCT01474512|50502666|FG008|Long-Term Extension Period|Sponsor Decision|0|||
25224025|NCT01474512|50502667|FG009|Long-Term Extension Period|Sponsor Decision|0|||
25224026|NCT01474512|50502668|FG010|Long-Term Extension Period|Sponsor Decision|0|||
25224027|NCT01474512|50502669|FG011|Long-Term Extension Period|Sponsor Decision|0|||
25224028|NCT01474512|50502670|FG012|Long-Term Extension Period|Sponsor Decision|6|||
25224029|NCT01474512|50502671|FG013|Long-Term Extension Period|Sponsor Decision|6|||
25224030|NCT01474512|50502672|FG014|Long-Term Extension Period|Sponsor Decision|0|||
25224031|NCT01474512|50502673|FG015|Long-Term Extension Period|Sponsor Decision|0|||
25224032|NCT01474512|50502674|FG016|Long-Term Extension Period|Sponsor Decision|0|||
25224033|NCT01474512|50502675|FG017|Long-Term Extension Period|Sponsor Decision|0|||
25224034|NCT01474512|50502658|FG000|Long-Term Extension Period|Protocol Violation|0|||
25224035|NCT01474512|50502659|FG001|Long-Term Extension Period|Protocol Violation|0|||
25224036|NCT01474512|50502660|FG002|Long-Term Extension Period|Protocol Violation|0|||
25224037|NCT01474512|50502661|FG003|Long-Term Extension Period|Protocol Violation|0|||
25224038|NCT01474512|50502662|FG004|Long-Term Extension Period|Protocol Violation|0|||
25224039|NCT01474512|50502663|FG005|Long-Term Extension Period|Protocol Violation|0|||
25224040|NCT01474512|50502664|FG006|Long-Term Extension Period|Protocol Violation|0|||
25224041|NCT01474512|50502665|FG007|Long-Term Extension Period|Protocol Violation|0|||
25224042|NCT01474512|50502666|FG008|Long-Term Extension Period|Protocol Violation|0|||
25224043|NCT01474512|50502667|FG009|Long-Term Extension Period|Protocol Violation|0|||
25224044|NCT01474512|50502668|FG010|Long-Term Extension Period|Protocol Violation|0|||
25224045|NCT01474512|50502669|FG011|Long-Term Extension Period|Protocol Violation|0|||
25224046|NCT01474512|50502670|FG012|Long-Term Extension Period|Protocol Violation|5|||
25224047|NCT01474512|50502671|FG013|Long-Term Extension Period|Protocol Violation|5|||
25224048|NCT01474512|50502672|FG014|Long-Term Extension Period|Protocol Violation|0|||
25224049|NCT01474512|50502673|FG015|Long-Term Extension Period|Protocol Violation|0|||
25318299|NCT00611455|50633911|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
25318300|NCT00611455|50633909|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
25224050|NCT01474512|50502674|FG016|Long-Term Extension Period|Protocol Violation|0|||
25224051|NCT01474512|50502675|FG017|Long-Term Extension Period|Protocol Violation|0|||
25224052|NCT01474512|50502658|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
25224053|NCT01474512|50502659|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
25318301|NCT00611455|50633910|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
25224054|NCT01474512|50502660|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
25224055|NCT01474512|50502661|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
25224056|NCT01474512|50502662|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
25224057|NCT01474512|50502663|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
25224058|NCT01474512|50502664|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
25224059|NCT01474512|50502665|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
25224060|NCT01474512|50502666|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
25224061|NCT01474512|50502667|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
25224062|NCT01474512|50502668|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
25224063|NCT01474512|50502669|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
25224064|NCT01474512|50502670|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
25224065|NCT01474512|50502671|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
25224066|NCT01474512|50502672|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
25224067|NCT01474512|50502673|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
25224068|NCT01474512|50502674|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
25224069|NCT01474512|50502675|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
25224070|NCT01474512|50502658|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
25224071|NCT01474512|50502659|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
25224072|NCT01474512|50502660|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
25224073|NCT01474512|50502661|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
25224074|NCT01474512|50502662|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
25224075|NCT01474512|50502663|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
25224076|NCT01474512|50502664|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
25224077|NCT01474512|50502665|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
25224078|NCT01474512|50502666|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
25224079|NCT01474512|50502667|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
25224080|NCT01474512|50502668|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
25318302|NCT00611455|50633911|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
25318303|NCT00611455|50633909|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
25318304|NCT00611455|50633910|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
25318305|NCT00611455|50633911|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
25318306|NCT00611455|50633909|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
25318307|NCT00611455|50633910|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
25318308|NCT00611455|50633911|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
25318309|NCT00611455|50633909|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
25318310|NCT00611455|50633910|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
25318311|NCT00611455|50633911|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
25318312|NCT00611455|50633909|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
25318313|NCT00611455|50633910|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
25318314|NCT00611455|50633911|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
25318315|NCT00611455|50633909|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
25318316|NCT00611455|50633910|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
25318317|NCT00611455|50633911|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
25318318|NCT00611455|50633909|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
25318319|NCT00611455|50633910|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
25318320|NCT00611455|50633911|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
25318321|NCT00611455|50633909|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
25318322|NCT00611455|50633910|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
25318323|NCT00611455|50633911|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
25318324|NCT00952289|50633923|FG000|All Participants|Death|9|||
25318325|NCT00952289|50633924|FG001|All Participants|Death|9|||
25318326|NCT00952289|50633923|FG000|All Participants|Adverse Event|8|||
25318327|NCT00952289|50633924|FG001|All Participants|Adverse Event|8|||
25318328|NCT00952289|50633923|FG000|All Participants|Disease progression|3|||
25318329|NCT00952289|50633924|FG001|All Participants|Disease progression|12|||
25318330|NCT00952289|50633923|FG000|All Participants|Withdrawal by Subject|1|||
25318331|NCT00952289|50633924|FG001|All Participants|Withdrawal by Subject|10|||
25318332|NCT00952289|50633923|FG000|All Participants|Data lost during site relocation|0|||
25318333|NCT00952289|50633924|FG001|All Participants|Data lost during site relocation|1|||
25318334|NCT00952289|50633923|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
25318335|NCT00952289|50633924|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
24976522|NCT03480802|50065437|FG001|Overall Study|Lost to Follow-up|1|||
24976523|NCT03480802|50065436|FG000|Overall Study|Withdrawal by Subject|2|||
25224081|NCT01474512|50502669|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
25224082|NCT01474512|50502670|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
25224083|NCT01474512|50502671|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
25224084|NCT01474512|50502672|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
25224085|NCT01474512|50502673|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
25224086|NCT01474512|50502674|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
25224087|NCT01474512|50502675|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
25224088|NCT01474512|50502658|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
25224089|NCT01474512|50502659|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
25224090|NCT01474512|50502660|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
25224091|NCT01474512|50502661|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
25224092|NCT01474512|50502662|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
25224093|NCT01474512|50502663|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
25224094|NCT01474512|50502664|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
25224095|NCT01474512|50502665|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
25224096|NCT01474512|50502666|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
25224097|NCT01474512|50502667|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
25224098|NCT01474512|50502668|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
25224099|NCT01474512|50502669|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
25224100|NCT01474512|50502670|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
25224101|NCT01474512|50502671|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
25224102|NCT01474512|50502672|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
25224103|NCT01474512|50502673|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
25224104|NCT01474512|50502674|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
25224105|NCT01474512|50502675|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
25224106|NCT01474512|50502658|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
25224107|NCT01474512|50502659|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
25318336|NCT00952289|50633923|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
25318337|NCT00952289|50633924|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
25318338|NCT00952289|50633923|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
25318339|NCT00952289|50633924|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
25318340|NCT00952289|50633923|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
25318341|NCT00952289|50633924|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
25318342|NCT00952289|50633923|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
25318343|NCT00952289|50633924|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
25318344|NCT00947531|50633932|FG000|Overall Study|Withdrawal by Subject|10|||
25318345|NCT00947531|50633933|FG001|Overall Study|Withdrawal by Subject|7|||
25318346|NCT00947531|50633932|FG000|Overall Study|Administrative Reason|0|||
25318347|NCT00947531|50633933|FG001|Overall Study|Administrative Reason|1|||
25318348|NCT00947531|50633932|FG000|Overall Study|Adverse Event|2|||
25318349|NCT00947531|50633933|FG001|Overall Study|Adverse Event|2|||
25224108|NCT01474512|50502660|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
25224109|NCT01474512|50502661|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
25224110|NCT01474512|50502662|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
25224111|NCT01474512|50502663|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
25224112|NCT01474512|50502664|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
25224113|NCT01474512|50502665|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
25224114|NCT01474512|50502666|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
25224115|NCT01474512|50502667|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
25224116|NCT01474512|50502668|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
25224117|NCT01474512|50502669|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
25318350|NCT00947531|50633932|FG000|Overall Study|Lack of Efficacy|1|||
25318351|NCT00947531|50633933|FG001|Overall Study|Lack of Efficacy|0|||
25318352|NCT00947531|50633932|FG000|Overall Study|Other|1|||
25318353|NCT00947531|50633933|FG001|Overall Study|Other|1|||
24976524|NCT03480802|50065437|FG001|Overall Study|Withdrawal by Subject|1|||
24976525|NCT03480802|50065436|FG000|Overall Study|Relocated|0|||
24976526|NCT03480802|50065437|FG001|Overall Study|Relocated|1|||
24976527|NCT00050960|50065447|FG000|Overall Study|Progressive Disease|137|||
24976528|NCT00050960|50065448|FG001|Overall Study|Progressive Disease|93|||
24976529|NCT00050960|50065447|FG000|Overall Study|Stable Disease|19|||
24976530|NCT00050960|50065448|FG001|Overall Study|Stable Disease|48|||
24976531|NCT00050960|50065447|FG000|Overall Study|Partial Response|14|||
24976532|NCT00050960|50065448|FG001|Overall Study|Partial Response|19|||
24976533|NCT00050960|50065447|FG000|Overall Study|Complete Response|0|||
25224118|NCT01474512|50502670|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
25224119|NCT01474512|50502671|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
24976534|NCT00050960|50065448|FG001|Overall Study|Complete Response|2|||
24976535|NCT00050960|50065447|FG000|Overall Study|Adverse Event|62|||
25224120|NCT01474512|50502672|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
25224121|NCT01474512|50502673|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
25224122|NCT01474512|50502674|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
25224123|NCT01474512|50502675|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
25224124|NCT01474512|50502658|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
25224125|NCT01474512|50502659|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
25224126|NCT01474512|50502660|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
25224127|NCT01474512|50502661|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
25224128|NCT01474512|50502662|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
25224129|NCT01474512|50502663|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
25224130|NCT01474512|50502664|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
25224131|NCT01474512|50502665|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
25224132|NCT01474512|50502666|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
25224133|NCT01474512|50502667|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
25224134|NCT01474512|50502668|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
25224135|NCT01474512|50502669|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
25224136|NCT01474512|50502670|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
25224137|NCT01474512|50502671|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
25224138|NCT01474512|50502672|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
25224139|NCT01474512|50502673|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
25224140|NCT01474512|50502674|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
25224141|NCT01474512|50502675|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
25224142|NCT01474512|50502658|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
25224143|NCT01474512|50502659|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
25224144|NCT01474512|50502660|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
25224145|NCT01474512|50502661|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
25224146|NCT01474512|50502662|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
25224147|NCT01474512|50502663|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
25224148|NCT01474512|50502664|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
25224149|NCT01474512|50502665|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
25224150|NCT01474512|50502666|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
25224151|NCT01474512|50502667|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
25224152|NCT01474512|50502668|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
25224153|NCT01474512|50502669|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
25224154|NCT01474512|50502670|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
25224155|NCT01474512|50502671|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
25224156|NCT01474512|50502672|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
25224157|NCT01474512|50502673|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
25224158|NCT01474512|50502674|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
25224159|NCT01474512|50502675|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
25224160|NCT01474512|50502658|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
25224161|NCT01474512|50502659|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
25224162|NCT01474512|50502660|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
25224163|NCT01474512|50502661|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
25224164|NCT01474512|50502662|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
25224165|NCT01474512|50502663|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
25224166|NCT01474512|50502664|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
25224167|NCT01474512|50502665|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
25224168|NCT01474512|50502666|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
25224169|NCT01474512|50502667|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
25224170|NCT01474512|50502668|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
25224171|NCT01474512|50502669|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
25224172|NCT01474512|50502670|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
25224173|NCT01474512|50502671|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
25224174|NCT01474512|50502672|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
25224175|NCT01474512|50502673|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
25224176|NCT01474512|50502674|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
25224177|NCT01474512|50502675|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
25224178|NCT01474512|50502658|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
25224179|NCT01474512|50502659|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
25224180|NCT01474512|50502660|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
25224181|NCT01474512|50502661|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
25224182|NCT01474512|50502662|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
25224183|NCT01474512|50502663|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
25224184|NCT01474512|50502664|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
25318354|NCT00612313|50633941|FG000|Overall Study|Withdrawal by Subject|6|||
25318355|NCT00612313|50633942|FG001|Overall Study|Withdrawal by Subject|9|||
25224185|NCT01474512|50502665|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
25224186|NCT01474512|50502666|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
25224187|NCT01474512|50502667|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
25224188|NCT01474512|50502668|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
25224189|NCT01474512|50502669|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
25224190|NCT01474512|50502670|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
25224191|NCT01474512|50502671|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
25224192|NCT01474512|50502672|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
25224193|NCT01474512|50502673|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
25224194|NCT01474512|50502674|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
25224195|NCT01474512|50502675|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
25224196|NCT01474512|50502658|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
25224197|NCT01474512|50502659|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
25224198|NCT01474512|50502660|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
25224199|NCT01474512|50502661|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
25224200|NCT01474512|50502662|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
25224201|NCT01474512|50502663|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
25224202|NCT01474512|50502664|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
25224203|NCT01474512|50502665|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
25224204|NCT01474512|50502666|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
25224205|NCT01474512|50502667|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
25224206|NCT01474512|50502668|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
25224207|NCT01474512|50502669|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
25224208|NCT01474512|50502670|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
25224209|NCT01474512|50502671|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
25224210|NCT01474512|50502672|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
25224211|NCT01474512|50502673|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
25224212|NCT01474512|50502674|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
25224213|NCT01474512|50502675|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
25224214|NCT01474512|50502658|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
25224215|NCT01474512|50502659|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
25224216|NCT01474512|50502660|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
25224217|NCT01474512|50502661|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
25224218|NCT01474512|50502662|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
25224219|NCT01474512|50502663|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
25224220|NCT01474512|50502664|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
25224221|NCT01474512|50502665|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
25224222|NCT01474512|50502666|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
25224223|NCT01474512|50502667|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
25224224|NCT01474512|50502668|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
25224225|NCT01474512|50502669|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
25224226|NCT01474512|50502670|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
25224227|NCT01474512|50502671|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
25224228|NCT01474512|50502672|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
25224229|NCT01474512|50502673|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
25224230|NCT01474512|50502674|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
25224231|NCT01474512|50502675|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
25224232|NCT01474512|50502658|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
25224233|NCT01474512|50502659|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
25224234|NCT01474512|50502660|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
25224235|NCT01474512|50502661|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
25224236|NCT01474512|50502662|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
25224237|NCT01474512|50502663|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
25224238|NCT01474512|50502664|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
25224239|NCT01474512|50502665|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
25224240|NCT01474512|50502666|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
25224241|NCT01474512|50502667|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
25224242|NCT01474512|50502668|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
25224243|NCT01474512|50502669|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
25224244|NCT01474512|50502670|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
25224245|NCT01474512|50502671|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
25224246|NCT01474512|50502672|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
25224247|NCT01474512|50502673|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
25224248|NCT01474512|50502674|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
25224249|NCT01474512|50502675|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
25224250|NCT01474512|50502658|FG000|Post-Treatment Follow-Up|Death|0|||
25224251|NCT01474512|50502659|FG001|Post-Treatment Follow-Up|Death|0|||
25224252|NCT01474512|50502660|FG002|Post-Treatment Follow-Up|Death|0|||
25224253|NCT01474512|50502661|FG003|Post-Treatment Follow-Up|Death|0|||
25224254|NCT01474512|50502662|FG004|Post-Treatment Follow-Up|Death|0|||
25224255|NCT01474512|50502663|FG005|Post-Treatment Follow-Up|Death|0|||
25224256|NCT01474512|50502664|FG006|Post-Treatment Follow-Up|Death|0|||
25224257|NCT01474512|50502665|FG007|Post-Treatment Follow-Up|Death|0|||
25224258|NCT01474512|50502666|FG008|Post-Treatment Follow-Up|Death|0|||
25224259|NCT01474512|50502667|FG009|Post-Treatment Follow-Up|Death|0|||
25224260|NCT01474512|50502668|FG010|Post-Treatment Follow-Up|Death|0|||
25224261|NCT01474512|50502669|FG011|Post-Treatment Follow-Up|Death|0|||
25224262|NCT01474512|50502670|FG012|Post-Treatment Follow-Up|Death|0|||
25224263|NCT01474512|50502671|FG013|Post-Treatment Follow-Up|Death|0|||
25224264|NCT01474512|50502672|FG014|Post-Treatment Follow-Up|Death|0|||
25224265|NCT01474512|50502673|FG015|Post-Treatment Follow-Up|Death|0|||
25224266|NCT01474512|50502674|FG016|Post-Treatment Follow-Up|Death|1|||
25224267|NCT01474512|50502675|FG017|Post-Treatment Follow-Up|Death|0|||
25224268|NCT01474434|50502709|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
25224269|NCT01474434|50502710|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
25224270|NCT01474434|50502711|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
25224271|NCT01474434|50502712|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
25224272|NCT01474434|50502709|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
25224273|NCT01474434|50502710|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
25224274|NCT01474434|50502711|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
25224275|NCT01474434|50502712|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
25224276|NCT01474434|50502709|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
25224277|NCT01474434|50502710|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
25224278|NCT01474434|50502711|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
25224279|NCT01474434|50502712|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
25224280|NCT01473732|50502728|FG000|Overall Study|Adverse Event|1|||
25224281|NCT01473732|50502729|FG001|Overall Study|Adverse Event|0|||
25224282|NCT01473732|50502728|FG000|Overall Study|Death|1|||
25224283|NCT01473732|50502729|FG001|Overall Study|Death|0|||
25224284|NCT01450098|50502737|FG000|Period 3|Protocol Violation|0|||
25224285|NCT01450098|50502738|FG001|Period 3|Protocol Violation|1|||
25224286|NCT01450098|50502737|FG000|Period 3|Withdrawal by Subject|0|||
25224287|NCT01450098|50502738|FG001|Period 3|Withdrawal by Subject|2|||
25224288|NCT01449708|50502753|FG000|Overall Study|Protocol Violation|0|||
25224289|NCT01449708|50502754|FG001|Overall Study|Protocol Violation|1|||
25224290|NCT01449708|50502753|FG000|Overall Study|surgical complication|1|||
25224291|NCT01449708|50502754|FG001|Overall Study|surgical complication|2|||
25224292|NCT01449708|50502753|FG000|Overall Study|respiratory failure|1|||
25224293|NCT01449708|50502754|FG001|Overall Study|respiratory failure|0|||
25224294|NCT01449630|50502772|FG000|Period 1|Physician Decision|1|||
25224295|NCT01449630|50502773|FG001|Period 1|Physician Decision|0|||
25224296|NCT01449630|50502774|FG002|Period 1|Physician Decision|0|||
24976536|NCT00050960|50065448|FG001|Overall Study|Adverse Event|61|||
24976537|NCT00050960|50065447|FG000|Overall Study|Lost to Follow-up|0|||
24976538|NCT00050960|50065448|FG001|Overall Study|Lost to Follow-up|1|||
24976539|NCT00050960|50065447|FG000|Overall Study|Withdrawal by Subject|23|||
24976540|NCT00050960|50065448|FG001|Overall Study|Withdrawal by Subject|18|||
24976541|NCT00050960|50065447|FG000|Overall Study|Administrative|31|||
24976542|NCT00050960|50065448|FG001|Overall Study|Administrative|46|||
24976543|NCT00050960|50065447|FG000|Overall Study|Non-compliance|3|||
24976544|NCT00050960|50065448|FG001|Overall Study|Non-compliance|1|||
24976545|NCT00050960|50065447|FG000|Overall Study|Death|13|||
25224297|NCT01449630|50502775|FG003|Period 1|Physician Decision|1|||
25224298|NCT01449630|50502776|FG004|Period 1|Physician Decision|0|||
25224299|NCT01449630|50502777|FG005|Period 1|Physician Decision|0|||
25224300|NCT01449630|50502778|FG006|Period 1|Physician Decision|0|||
25224301|NCT01449630|50502779|FG007|Period 1|Physician Decision|0|||
25224302|NCT01449630|50502780|FG008|Period 1|Physician Decision|0|||
25224303|NCT01449630|50502772|FG000|Period 1|Sponsor Decision|0|||
25224304|NCT01449630|50502773|FG001|Period 1|Sponsor Decision|0|||
25224305|NCT01449630|50502774|FG002|Period 1|Sponsor Decision|0|||
25224306|NCT01449630|50502775|FG003|Period 1|Sponsor Decision|0|||
25224307|NCT01449630|50502776|FG004|Period 1|Sponsor Decision|0|||
25224308|NCT01449630|50502777|FG005|Period 1|Sponsor Decision|1|||
25224309|NCT01449630|50502778|FG006|Period 1|Sponsor Decision|0|||
25224310|NCT01449630|50502779|FG007|Period 1|Sponsor Decision|0|||
25224311|NCT01449630|50502780|FG008|Period 1|Sponsor Decision|0|||
25224312|NCT01449630|50502772|FG000|Period 2|Sponsor Decision|0|||
25224313|NCT01449630|50502773|FG001|Period 2|Sponsor Decision|0|||
25224314|NCT01449630|50502774|FG002|Period 2|Sponsor Decision|0|||
25224315|NCT01449630|50502775|FG003|Period 2|Sponsor Decision|0|||
25224316|NCT01449630|50502776|FG004|Period 2|Sponsor Decision|0|||
24976546|NCT00050960|50065448|FG001|Overall Study|Death|15|||
24976547|NCT03456856|50065454|FG000|Overall Study|Lost to Follow-up|2|||
24976548|NCT03456856|50065454|FG000|Overall Study|Withdrawal by Subject|1|||
25224317|NCT01449630|50502777|FG005|Period 2|Sponsor Decision|0|||
25224318|NCT01449630|50502778|FG006|Period 2|Sponsor Decision|1|||
25224319|NCT01449630|50502779|FG007|Period 2|Sponsor Decision|0|||
25224320|NCT01449630|50502780|FG008|Period 2|Sponsor Decision|0|||
25224321|NCT01493778|50502802|FG000|Overall Study|Withdrawal by Subject|8|||
25224322|NCT01473420|50502817|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
25224323|NCT01473420|50502818|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
25224324|NCT01473420|50502817|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
25224325|NCT01473420|50502818|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
25224326|NCT01473420|50502817|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
25224327|NCT01473420|50502818|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
25224328|NCT01473420|50502817|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
25224329|NCT01473420|50502818|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
25224330|NCT01473420|50502817|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
25224331|NCT01473420|50502818|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
25224332|NCT01473420|50502817|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
25224333|NCT01473420|50502818|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
25224334|NCT01473420|50502817|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
25224335|NCT01473420|50502818|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
25224336|NCT01473420|50502817|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
25224337|NCT01473420|50502818|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
25224338|NCT01473420|50502817|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
25224339|NCT01473420|50502818|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
25224340|NCT01473420|50502817|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
25224341|NCT01473420|50502818|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
25224342|NCT01473420|50502817|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
25224343|NCT01473420|50502818|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
25224344|NCT01473420|50502817|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
25224345|NCT01473420|50502818|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
25224346|NCT01473420|50502817|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
25224347|NCT01473420|50502818|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
25224348|NCT01492686|50502832|FG000|Double-blind Phase|Adverse Event|0|||
25224349|NCT01492686|50502833|FG001|Double-blind Phase|Adverse Event|2|||
25224350|NCT01492686|50502832|FG000|Double-blind Phase|Physician Decision|0|||
25224351|NCT01492686|50502833|FG001|Double-blind Phase|Physician Decision|1|||
25224352|NCT01492686|50502832|FG000|Double-blind Phase|Withdrawal by Subject|0|||
25224353|NCT01492686|50502833|FG001|Double-blind Phase|Withdrawal by Subject|2|||
25224354|NCT01492686|50502832|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
25224355|NCT01492686|50502833|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
25224356|NCT01492686|50502832|FG000|Open-label Phase|Adverse Event|1|||
25224357|NCT01492686|50502833|FG001|Open-label Phase|Adverse Event|2|||
25224358|NCT01492686|50502832|FG000|Open-label Phase|Physician Decision|1|||
25224359|NCT01492686|50502833|FG001|Open-label Phase|Physician Decision|0|||
25224360|NCT01492686|50502832|FG000|Open-label Phase|Withdrawal by Subject|6|||
25224361|NCT01492686|50502833|FG001|Open-label Phase|Withdrawal by Subject|7|||
25224362|NCT01492686|50502832|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
25224363|NCT01492686|50502833|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
25224364|NCT01449006|50502843|FG000|Overall Study|Lost to Follow-up|1|||
25224365|NCT01449006|50502844|FG001|Overall Study|Lost to Follow-up|0|||
25224366|NCT01449006|50502843|FG000|Overall Study|Withdrawal by Subject|1|||
25224367|NCT01449006|50502844|FG001|Overall Study|Withdrawal by Subject|0|||
25224368|NCT01449006|50502843|FG000|Overall Study|Protocol Violation|1|||
25224369|NCT01449006|50502844|FG001|Overall Study|Protocol Violation|0|||
25224370|NCT01448850|50502852|FG000|Overall Study|Death|3|||
25224371|NCT01448850|50502853|FG001|Overall Study|Death|6|||
25224372|NCT01448850|50502852|FG000|Overall Study|Withdrawal by Subject|13|||
25224373|NCT01448850|50502853|FG001|Overall Study|Withdrawal by Subject|21|||
25224374|NCT01448850|50502852|FG000|Overall Study|Lost to Follow-up|3|||
25224375|NCT01448850|50502853|FG001|Overall Study|Lost to Follow-up|1|||
25224376|NCT01448850|50502852|FG000|Overall Study|Other|15|||
25224377|NCT01448850|50502853|FG001|Overall Study|Other|12|||
25224378|NCT01491672|50502863|FG000|Overall Study|Lost to Follow-up|0|||
25224379|NCT01491672|50502864|FG001|Overall Study|Lost to Follow-up|4|||
25224380|NCT01491672|50502865|FG002|Overall Study|Lost to Follow-up|1|||
25224381|NCT01491672|50502863|FG000|Overall Study|Withdrawal by Subject|6|||
25224382|NCT01491672|50502864|FG001|Overall Study|Withdrawal by Subject|7|||
25224383|NCT01491672|50502865|FG002|Overall Study|Withdrawal by Subject|0|||
25224384|NCT01491672|50502863|FG000|Overall Study|Adverse Event|8|||
25224385|NCT01491672|50502864|FG001|Overall Study|Adverse Event|10|||
25224386|NCT01491672|50502865|FG002|Overall Study|Adverse Event|4|||
25224387|NCT01491672|50502863|FG000|Overall Study|Disease progression|42|||
25224388|NCT01491672|50502864|FG001|Overall Study|Disease progression|34|||
25224389|NCT01491672|50502865|FG002|Overall Study|Disease progression|6|||
25224390|NCT01491672|50502863|FG000|Overall Study|Protocol deviation|0|||
25224391|NCT01491672|50502864|FG001|Overall Study|Protocol deviation|1|||
25224392|NCT01491672|50502865|FG002|Overall Study|Protocol deviation|0|||
25224393|NCT01491672|50502863|FG000|Overall Study|Death|0|||
25224394|NCT01491672|50502864|FG001|Overall Study|Death|4|||
25224395|NCT01491672|50502865|FG002|Overall Study|Death|0|||
25224396|NCT01447446|50502881|FG000|Overall Study|Death|6|||
25224397|NCT01447446|50502882|FG001|Overall Study|Death|3|||
25224398|NCT01447446|50502883|FG002|Overall Study|Death|2|||
25224399|NCT01447446|50502884|FG003|Overall Study|Death|1|||
25224400|NCT01447446|50502885|FG004|Overall Study|Death|7|||
25224401|NCT01447446|50502886|FG005|Overall Study|Death|0|||
25224402|NCT01447446|50502881|FG000|Overall Study|Adverse Event|3|||
25224403|NCT01447446|50502882|FG001|Overall Study|Adverse Event|0|||
25224404|NCT01447446|50502883|FG002|Overall Study|Adverse Event|1|||
25224405|NCT01447446|50502884|FG003|Overall Study|Adverse Event|0|||
25224406|NCT01447446|50502885|FG004|Overall Study|Adverse Event|2|||
25224407|NCT01447446|50502886|FG005|Overall Study|Adverse Event|0|||
25224408|NCT01447446|50502881|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
25224409|NCT01447446|50502882|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
25224410|NCT01447446|50502883|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
25224411|NCT01447446|50502884|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
25224412|NCT01447446|50502885|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
25224413|NCT01447446|50502886|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
25224414|NCT01447446|50502881|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
25224415|NCT01447446|50502882|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
25224416|NCT01447446|50502883|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
25224417|NCT01447446|50502884|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
25224418|NCT01447446|50502885|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
25224419|NCT01447446|50502886|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
25224420|NCT01447446|50502881|FG000|Overall Study|Administrative/Other|34|||
25224421|NCT01447446|50502882|FG001|Overall Study|Administrative/Other|9|||
25224422|NCT01447446|50502883|FG002|Overall Study|Administrative/Other|10|||
25224423|NCT01447446|50502884|FG003|Overall Study|Administrative/Other|2|||
25224424|NCT01447446|50502885|FG004|Overall Study|Administrative/Other|33|||
25224425|NCT01447446|50502886|FG005|Overall Study|Administrative/Other|4|||
25224426|NCT01447446|50502881|FG000|Overall Study|SVR12 Assessment|13|||
25224427|NCT01447446|50502882|FG001|Overall Study|SVR12 Assessment|1|||
25224428|NCT01447446|50502883|FG002|Overall Study|SVR12 Assessment|2|||
25224429|NCT01447446|50502884|FG003|Overall Study|SVR12 Assessment|1|||
25224430|NCT01447446|50502885|FG004|Overall Study|SVR12 Assessment|5|||
25224431|NCT01447446|50502886|FG005|Overall Study|SVR12 Assessment|5|||
25224432|NCT01447446|50502881|FG000|Overall Study|New Treatment Started|8|||
25224433|NCT01447446|50502882|FG001|Overall Study|New Treatment Started|2|||
25224434|NCT01447446|50502883|FG002|Overall Study|New Treatment Started|1|||
25224435|NCT01447446|50502884|FG003|Overall Study|New Treatment Started|0|||
25224436|NCT01447446|50502885|FG004|Overall Study|New Treatment Started|2|||
25224437|NCT01447446|50502886|FG005|Overall Study|New Treatment Started|0|||
25224438|NCT01447446|50502881|FG000|Overall Study|Reason not Specified|1|||
25224439|NCT01447446|50502882|FG001|Overall Study|Reason not Specified|1|||
25224440|NCT01447446|50502883|FG002|Overall Study|Reason not Specified|1|||
25224441|NCT01447446|50502884|FG003|Overall Study|Reason not Specified|1|||
25224442|NCT01447446|50502885|FG004|Overall Study|Reason not Specified|1|||
25224443|NCT01447446|50502886|FG005|Overall Study|Reason not Specified|0|||
25224444|NCT01490814|50502908|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
25224445|NCT01490814|50502909|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
25224446|NCT01490814|50502908|FG000|Overall Study|Physician Decision|1|||
25224447|NCT01490814|50502909|FG001|Overall Study|Physician Decision|0|||
25224448|NCT01490814|50502908|FG000|Overall Study|Withdrawal by Subject|0|||
25224449|NCT01490814|50502909|FG001|Overall Study|Withdrawal by Subject|5|||
25224450|NCT01471782|50502921|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
25224451|NCT01471782|50502922|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
25224452|NCT01471782|50502923|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
25224453|NCT01471782|50502924|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
25224454|NCT01471782|50502925|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
25224455|NCT01471782|50502926|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
25224456|NCT01471782|50502921|FG000|Overall Study|Lack of Efficacy|1|||
25224457|NCT01471782|50502922|FG001|Overall Study|Lack of Efficacy|2|||
25224458|NCT01471782|50502923|FG002|Overall Study|Lack of Efficacy|1|||
25224459|NCT01471782|50502924|FG003|Overall Study|Lack of Efficacy|1|||
25224460|NCT01471782|50502925|FG004|Overall Study|Lack of Efficacy|5|||
25224461|NCT01471782|50502926|FG005|Overall Study|Lack of Efficacy|18|||
25318356|NCT00612313|50633941|FG000|Overall Study|Lost to Follow-up|11|||
25224462|NCT01471782|50502921|FG000|Overall Study|Adverse Event|1|||
25224463|NCT01471782|50502922|FG001|Overall Study|Adverse Event|1|||
25224464|NCT01471782|50502923|FG002|Overall Study|Adverse Event|2|||
25224465|NCT01471782|50502924|FG003|Overall Study|Adverse Event|2|||
25224466|NCT01471782|50502925|FG004|Overall Study|Adverse Event|3|||
25224467|NCT01471782|50502926|FG005|Overall Study|Adverse Event|1|||
25224468|NCT01471782|50502921|FG000|Overall Study|Other|0|||
25224469|NCT01471782|50502922|FG001|Overall Study|Other|0|||
25224470|NCT01471782|50502923|FG002|Overall Study|Other|1|||
25224471|NCT01471782|50502924|FG003|Overall Study|Other|1|||
25224472|NCT01471782|50502925|FG004|Overall Study|Other|6|||
25224473|NCT01471782|50502926|FG005|Overall Study|Other|5|||
25224474|NCT01471782|50502921|FG000|Overall Study|Change of Chemotherapy|1|||
25224475|NCT01471782|50502922|FG001|Overall Study|Change of Chemotherapy|1|||
25224476|NCT01471782|50502923|FG002|Overall Study|Change of Chemotherapy|0|||
25224477|NCT01471782|50502924|FG003|Overall Study|Change of Chemotherapy|0|||
25224478|NCT01471782|50502925|FG004|Overall Study|Change of Chemotherapy|1|||
25224479|NCT01471782|50502926|FG005|Overall Study|Change of Chemotherapy|4|||
25224480|NCT01471782|50502921|FG000|Overall Study|Disease Relapse|0|||
25224481|NCT01471782|50502922|FG001|Overall Study|Disease Relapse|0|||
25224482|NCT01471782|50502923|FG002|Overall Study|Disease Relapse|0|||
25224483|NCT01471782|50502924|FG003|Overall Study|Disease Relapse|1|||
25224484|NCT01471782|50502925|FG004|Overall Study|Disease Relapse|2|||
25224485|NCT01471782|50502926|FG005|Overall Study|Disease Relapse|1|||
25224486|NCT01471782|50502921|FG000|Overall Study|Physician Decision|0|||
25224487|NCT01471782|50502922|FG001|Overall Study|Physician Decision|0|||
25224488|NCT01471782|50502923|FG002|Overall Study|Physician Decision|0|||
25224489|NCT01471782|50502924|FG003|Overall Study|Physician Decision|0|||
25224490|NCT01471782|50502925|FG004|Overall Study|Physician Decision|3|||
25224491|NCT01471782|50502926|FG005|Overall Study|Physician Decision|8|||
25224492|NCT01471782|50502921|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
25224493|NCT01471782|50502922|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
25224494|NCT01471782|50502923|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
25224495|NCT01471782|50502924|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
25224496|NCT01471782|50502925|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
25224497|NCT01471782|50502926|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
25224498|NCT01471782|50502921|FG000|Overall Study|Death|0|||
25224499|NCT01471782|50502922|FG001|Overall Study|Death|0|||
25224500|NCT01471782|50502923|FG002|Overall Study|Death|0|||
25224501|NCT01471782|50502924|FG003|Overall Study|Death|0|||
25224502|NCT01471782|50502925|FG004|Overall Study|Death|0|||
25224503|NCT01471782|50502926|FG005|Overall Study|Death|1|||
25224504|NCT01490580|50502953|FG000|Overall Study|Parents withdrew consent|0|||
25224505|NCT01490580|50502954|FG001|Overall Study|Parents withdrew consent|2|||
25224506|NCT01490190|50502964|FG000|Overall Study|Withdrawal by Subject|9|||
25318357|NCT00612313|50633942|FG001|Overall Study|Lost to Follow-up|4|||
25318358|NCT00890552|50633954|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
25318359|NCT00890552|50633954|FG000|On-treatment|Early prog disease/ death|10|||
25318360|NCT00946985|50633958|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
25318361|NCT00946985|50633958|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
25318362|NCT00946985|50633958|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
25318363|NCT00946985|50633958|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
25318364|NCT00946985|50633958|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
25318365|NCT00946985|50633958|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
25318366|NCT00946985|50633958|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
25318367|NCT00946985|50633958|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
25318368|NCT00946985|50633958|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
25318369|NCT00611923|50633964|FG000|Overall Study|Withdrawal by Subject|2|||
25318370|NCT00611923|50633965|FG001|Overall Study|Withdrawal by Subject|2|||
25318371|NCT00609973|50633975|FG000|Overall Study|Adverse Event|2|||
25318372|NCT00609973|50633976|FG001|Overall Study|Adverse Event|1|||
25318373|NCT00609973|50633975|FG000|Overall Study|Protocol Violation|4|||
25318374|NCT00609973|50633976|FG001|Overall Study|Protocol Violation|3|||
25318375|NCT00609973|50633975|FG000|Overall Study|Lost to Follow-up|2|||
25318376|NCT00609973|50633976|FG001|Overall Study|Lost to Follow-up|1|||
25318377|NCT00609973|50633975|FG000|Overall Study|Withdrawal by Subject|0|||
25318378|NCT00609973|50633976|FG001|Overall Study|Withdrawal by Subject|1|||
25318379|NCT00803049|50633986|FG000|Overall Study|Adverse Event|21|||
25318380|NCT00803049|50633987|FG001|Overall Study|Adverse Event|33|||
25318381|NCT00803049|50633988|FG002|Overall Study|Adverse Event|13|||
25318382|NCT00803049|50633989|FG003|Overall Study|Adverse Event|27|||
25318383|NCT00803049|50633986|FG000|Overall Study|Lack of Efficacy|10|||
25318384|NCT00803049|50633987|FG001|Overall Study|Lack of Efficacy|19|||
25318385|NCT00803049|50633988|FG002|Overall Study|Lack of Efficacy|6|||
25318386|NCT00803049|50633989|FG003|Overall Study|Lack of Efficacy|13|||
25318387|NCT00803049|50633986|FG000|Overall Study|Lost to Follow-up|0|||
25318388|NCT00803049|50633987|FG001|Overall Study|Lost to Follow-up|2|||
25318389|NCT00803049|50633988|FG002|Overall Study|Lost to Follow-up|0|||
25318390|NCT00803049|50633989|FG003|Overall Study|Lost to Follow-up|3|||
25318391|NCT00803049|50633986|FG000|Overall Study|Death|2|||
25318392|NCT00803049|50633987|FG001|Overall Study|Death|1|||
25224507|NCT01490190|50502964|FG000|Overall Study|Adverse Event|17|||
25318393|NCT00803049|50633988|FG002|Overall Study|Death|0|||
25224508|NCT01490190|50502964|FG000|Overall Study|Protocol Violation|5|||
25224509|NCT01490190|50502964|FG000|Overall Study|Lost to Follow-up|13|||
25224510|NCT01490190|50502964|FG000|Overall Study|Relocation|1|||
25224511|NCT01490190|50502964|FG000|Overall Study|Inconvenience|1|||
25224512|NCT01490190|50502964|FG000|Overall Study|Ring expulsion|2|||
25224513|NCT01446042|50502971|FG000|Overall Study|Withdrawal by Subject|12|||
25318394|NCT00803049|50633989|FG003|Overall Study|Death|2|||
25318395|NCT00803049|50633986|FG000|Overall Study|Progressive Disease|6|||
25318396|NCT00803049|50633987|FG001|Overall Study|Progressive Disease|10|||
25318397|NCT00803049|50633988|FG002|Overall Study|Progressive Disease|6|||
25318398|NCT00803049|50633989|FG003|Overall Study|Progressive Disease|6|||
25318399|NCT00803049|50633986|FG000|Overall Study|Withdrawal by Subject|19|||
25224514|NCT01446042|50502972|FG001|Overall Study|Withdrawal by Subject|2|||
25224515|NCT01446042|50502973|FG002|Overall Study|Withdrawal by Subject|4|||
25224516|NCT01446042|50502971|FG000|Overall Study|Adverse Event|1|||
25224517|NCT01446042|50502972|FG001|Overall Study|Adverse Event|0|||
25224518|NCT01446042|50502973|FG002|Overall Study|Adverse Event|4|||
25224519|NCT01446042|50502971|FG000|Overall Study|Lost to Follow-up|5|||
25224520|NCT01446042|50502972|FG001|Overall Study|Lost to Follow-up|0|||
25224521|NCT01446042|50502973|FG002|Overall Study|Lost to Follow-up|0|||
25224522|NCT01446042|50502971|FG000|Overall Study|Other reasons|2|||
25224523|NCT01446042|50502972|FG001|Overall Study|Other reasons|1|||
25224524|NCT01446042|50502973|FG002|Overall Study|Other reasons|1|||
25224525|NCT01445886|50502981|FG000|Overall Study|Lost to Follow-up|2|||
25224526|NCT01445886|50502981|FG000|Overall Study|Protocol Violation|3|||
25224527|NCT01470612|50502989|FG000|Overall Study|Adverse Event|20|||
25224528|NCT01470612|50502990|FG001|Overall Study|Adverse Event|80|||
25224529|NCT01470612|50502989|FG000|Overall Study|Death|0|||
25224530|NCT01470612|50502990|FG001|Overall Study|Death|1|||
25224531|NCT01470612|50502989|FG000|Overall Study|Lack of Efficacy|20|||
25224532|NCT01470612|50502990|FG001|Overall Study|Lack of Efficacy|326|||
25224533|NCT01470612|50502989|FG000|Overall Study|Lost to Follow-up|2|||
25224534|NCT01470612|50502990|FG001|Overall Study|Lost to Follow-up|5|||
25224535|NCT01470612|50502989|FG000|Overall Study|Did not meet entrance criteria|0|||
25224536|NCT01470612|50502990|FG001|Overall Study|Did not meet entrance criteria|1|||
25224537|NCT01470612|50502989|FG000|Overall Study|Pregnancy|2|||
25224538|NCT01470612|50502990|FG001|Overall Study|Pregnancy|10|||
25224539|NCT01470612|50502989|FG000|Overall Study|Protocol Violation|2|||
25224540|NCT01470612|50502990|FG001|Overall Study|Protocol Violation|7|||
25224541|NCT01470612|50502989|FG000|Overall Study|Withdrawal by Subject|24|||
25224542|NCT01470612|50502990|FG001|Overall Study|Withdrawal by Subject|79|||
25224543|NCT01470612|50502989|FG000|Overall Study|Other|14|||
25224544|NCT01470612|50502990|FG001|Overall Study|Other|156|||
25224545|NCT01445730|50502996|FG000|Overall Study|Adverse Event|1|||
25224546|NCT01445730|50502996|FG000|Overall Study|For the advice of a dentist|1|||
25224547|NCT01445730|50502996|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
25224548|NCT01445652|50503002|FG000|Overall Study|Not comfortable in lenses|5|||
25224549|NCT01445652|50503003|FG001|Overall Study|Not comfortable in lenses|0|||
25224550|NCT01445652|50503002|FG000|Overall Study|Failed to attend scheduled visit|2|||
25224551|NCT01445652|50503003|FG001|Overall Study|Failed to attend scheduled visit|3|||
25224552|NCT01445652|50503002|FG000|Overall Study|Failed teach session|2|||
25224553|NCT01445652|50503003|FG001|Overall Study|Failed teach session|0|||
25224554|NCT01445652|50503002|FG000|Overall Study|Adverse Event|1|||
25224555|NCT01445652|50503003|FG001|Overall Study|Adverse Event|0|||
25318400|NCT00803049|50633987|FG001|Overall Study|Withdrawal by Subject|43|||
25318401|NCT00803049|50633988|FG002|Overall Study|Withdrawal by Subject|16|||
25224556|NCT01470144|50503009|FG000|Overall Study|Adverse Event|2|||
25224557|NCT01470144|50503009|FG000|Overall Study|Death|1|||
25224558|NCT01470144|50503009|FG000|Overall Study|Lung transplant|6|||
25224559|NCT01470144|50503009|FG000|Overall Study|Patient's and investigator's decision|1|||
25224560|NCT01443858|50503016|FG000|Overall Study|Withdrawal by Subject|9|||
25224561|NCT01443858|50503017|FG001|Overall Study|Withdrawal by Subject|8|||
25224562|NCT01443858|50503018|FG002|Overall Study|Withdrawal by Subject|5|||
25224563|NCT01443858|50503016|FG000|Overall Study|Lack of Efficacy|1|||
25224564|NCT01443858|50503017|FG001|Overall Study|Lack of Efficacy|0|||
25224565|NCT01443858|50503018|FG002|Overall Study|Lack of Efficacy|0|||
25224566|NCT01443858|50503016|FG000|Overall Study|Lost to Follow-up|5|||
25224567|NCT01443858|50503017|FG001|Overall Study|Lost to Follow-up|5|||
25224568|NCT01443858|50503018|FG002|Overall Study|Lost to Follow-up|2|||
25224569|NCT01443078|50503026|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
25224570|NCT01443078|50503026|FG000|Overall Study|Withdrawal by Subject|1|||
25224571|NCT01443078|50503026|FG000|Overall Study|Patient had brain mets|1|||
25318402|NCT00803049|50633989|FG003|Overall Study|Withdrawal by Subject|44|||
25224572|NCT01439880|50503032|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
25224573|NCT01439880|50503033|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
25224574|NCT01439880|50503032|FG000|SOC-controlled Period (Year 1)|Death|2|||
25224575|NCT01439880|50503033|FG001|SOC-controlled Period (Year 1)|Death|1|||
25224576|NCT01439880|50503032|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
25224577|NCT01439880|50503033|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
25224578|NCT01439880|50503032|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
25224579|NCT01439880|50503033|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
25224580|NCT01439880|50503032|FG000|SOC-controlled Period (Year 1)|Other|8|||
25224581|NCT01439880|50503033|FG001|SOC-controlled Period (Year 1)|Other|13|||
25224582|NCT01439880|50503032|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
25224583|NCT01439880|50503033|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
25224584|NCT01439880|50503032|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
25224585|NCT01439880|50503033|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
25224586|NCT01439880|50503032|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
25224587|NCT01439880|50503033|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
25224588|NCT01439880|50503032|FG000|All-IP Period (Years 2 to 5)|Death|3|||
25224589|NCT01439880|50503033|FG001|All-IP Period (Years 2 to 5)|Death|13|||
25224590|NCT01439880|50503032|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
25224591|NCT01439880|50503033|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
25224592|NCT01439880|50503032|FG000|All-IP Period (Years 2 to 5)|Other|14|||
25224593|NCT01439880|50503033|FG001|All-IP Period (Years 2 to 5)|Other|31|||
25224594|NCT01439880|50503032|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
25224595|NCT01439880|50503033|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
25224596|NCT01469364|50503050|FG000|Overall Study|Adverse Event|1|||
25224597|NCT01469364|50503050|FG000|Overall Study|Withdrawal by Subject|1|||
25224598|NCT01439724|50503056|FG000|Overall Study|missing consultation|9|||
25224599|NCT01439724|50503057|FG001|Overall Study|missing consultation|8|||
25224600|NCT01439568|50503065|FG000|Overall Study|Lost to Follow-up|1|||
25224601|NCT01439568|50503066|FG001|Overall Study|Lost to Follow-up|0|||
25224602|NCT01439568|50503065|FG000|Overall Study|Withdrawal by Subject|2|||
25224603|NCT01439568|50503066|FG001|Overall Study|Withdrawal by Subject|2|||
25224604|NCT01469052|50503078|FG000|Overall Study|Adverse Event|2|||
25224605|NCT01469052|50503079|FG001|Overall Study|Adverse Event|3|||
25224606|NCT01469052|50503080|FG002|Overall Study|Adverse Event|0|||
25224607|NCT01469052|50503081|FG003|Overall Study|Adverse Event|2|||
25224608|NCT01469052|50503082|FG004|Overall Study|Adverse Event|0|||
25224609|NCT01469052|50503083|FG005|Overall Study|Adverse Event|1|||
25224610|NCT01469052|50503078|FG000|Overall Study|Progressive disease|3|||
25224611|NCT01469052|50503079|FG001|Overall Study|Progressive disease|0|||
25224612|NCT01469052|50503080|FG002|Overall Study|Progressive disease|5|||
25224613|NCT01469052|50503081|FG003|Overall Study|Progressive disease|3|||
25224614|NCT01469052|50503082|FG004|Overall Study|Progressive disease|7|||
25224615|NCT01469052|50503083|FG005|Overall Study|Progressive disease|2|||
25224616|NCT01469052|50503078|FG000|Overall Study|Lack of Efficacy|0|||
25224617|NCT01469052|50503079|FG001|Overall Study|Lack of Efficacy|0|||
25224618|NCT01469052|50503080|FG002|Overall Study|Lack of Efficacy|0|||
25224619|NCT01469052|50503081|FG003|Overall Study|Lack of Efficacy|0|||
25224620|NCT01469052|50503082|FG004|Overall Study|Lack of Efficacy|0|||
25224621|NCT01469052|50503083|FG005|Overall Study|Lack of Efficacy|2|||
25224622|NCT01469052|50503078|FG000|Overall Study|Moved to rollover protocol|1|||
25224623|NCT01469052|50503079|FG001|Overall Study|Moved to rollover protocol|0|||
25224624|NCT01469052|50503080|FG002|Overall Study|Moved to rollover protocol|1|||
25224625|NCT01469052|50503081|FG003|Overall Study|Moved to rollover protocol|0|||
25224626|NCT01469052|50503082|FG004|Overall Study|Moved to rollover protocol|0|||
25224627|NCT01469052|50503083|FG005|Overall Study|Moved to rollover protocol|1|||
25224628|NCT01469052|50503078|FG000|Overall Study|Other|0|||
25224629|NCT01469052|50503079|FG001|Overall Study|Other|1|||
25224630|NCT01469052|50503080|FG002|Overall Study|Other|0|||
25224631|NCT01469052|50503081|FG003|Overall Study|Other|0|||
25224632|NCT01469052|50503082|FG004|Overall Study|Other|1|||
25224633|NCT01469052|50503083|FG005|Overall Study|Other|0|||
25224634|NCT01468818|50503095|FG000|Overall Study|Death during treatment|2|||
25224635|NCT01442376|50503102|FG000|Overall Study|Adverse Event|0|||
25224636|NCT01442376|50503103|FG001|Overall Study|Adverse Event|3|||
25224637|NCT01442376|50503104|FG002|Overall Study|Adverse Event|2|||
25224638|NCT01442376|50503102|FG000|Overall Study|Death|0|||
25224639|NCT01442376|50503103|FG001|Overall Study|Death|1|||
25224640|NCT01442376|50503104|FG002|Overall Study|Death|1|||
25224641|NCT01442376|50503102|FG000|Overall Study|Withdrawal of consent|0|||
25224642|NCT01442376|50503103|FG001|Overall Study|Withdrawal of consent|0|||
25224643|NCT01442376|50503104|FG002|Overall Study|Withdrawal of consent|1|||
25224644|NCT01442376|50503102|FG000|Overall Study|Patients not treated|2|||
25224645|NCT01442376|50503103|FG001|Overall Study|Patients not treated|3|||
25224646|NCT01442376|50503104|FG002|Overall Study|Patients not treated|1|||
25224647|NCT01442376|50503102|FG000|Overall Study|Not eligible for subsequent cycles|1|||
25224648|NCT01442376|50503103|FG001|Overall Study|Not eligible for subsequent cycles|2|||
25224649|NCT01442376|50503104|FG002|Overall Study|Not eligible for subsequent cycles|0|||
25224650|NCT01442064|50503118|FG000|Overall Study|Adverse Event|2|||
25224651|NCT01442064|50503119|FG001|Overall Study|Adverse Event|2|||
25224652|NCT01442064|50503120|FG002|Overall Study|Adverse Event|2|||
25224653|NCT01442064|50503121|FG003|Overall Study|Adverse Event|1|||
25224654|NCT01442064|50503122|FG004|Overall Study|Adverse Event|2|||
25224655|NCT01442064|50503123|FG005|Overall Study|Adverse Event|0|||
25224656|NCT01442064|50503118|FG000|Overall Study|Death|0|||
25224657|NCT01442064|50503119|FG001|Overall Study|Death|1|||
25224658|NCT01442064|50503120|FG002|Overall Study|Death|3|||
25224659|NCT01442064|50503121|FG003|Overall Study|Death|3|||
25224660|NCT01442064|50503122|FG004|Overall Study|Death|1|||
25224661|NCT01442064|50503123|FG005|Overall Study|Death|3|||
25224662|NCT01442064|50503118|FG000|Overall Study|Lost to Follow-up|5|||
25224663|NCT01442064|50503119|FG001|Overall Study|Lost to Follow-up|5|||
25224664|NCT01442064|50503120|FG002|Overall Study|Lost to Follow-up|1|||
25224665|NCT01442064|50503121|FG003|Overall Study|Lost to Follow-up|1|||
25224666|NCT01442064|50503122|FG004|Overall Study|Lost to Follow-up|3|||
25224667|NCT01442064|50503123|FG005|Overall Study|Lost to Follow-up|3|||
25224668|NCT01442064|50503118|FG000|Overall Study|Physician Decision|1|||
25224669|NCT01442064|50503119|FG001|Overall Study|Physician Decision|1|||
25224670|NCT01442064|50503120|FG002|Overall Study|Physician Decision|2|||
25224671|NCT01442064|50503121|FG003|Overall Study|Physician Decision|3|||
25224672|NCT01442064|50503122|FG004|Overall Study|Physician Decision|3|||
25224673|NCT01442064|50503123|FG005|Overall Study|Physician Decision|1|||
25224674|NCT01442064|50503118|FG000|Overall Study|Withdrawal by Subject|6|||
25224675|NCT01442064|50503119|FG001|Overall Study|Withdrawal by Subject|3|||
25224676|NCT01442064|50503120|FG002|Overall Study|Withdrawal by Subject|2|||
25224677|NCT01442064|50503121|FG003|Overall Study|Withdrawal by Subject|2|||
25224678|NCT01442064|50503122|FG004|Overall Study|Withdrawal by Subject|2|||
25224679|NCT01442064|50503123|FG005|Overall Study|Withdrawal by Subject|1|||
25224680|NCT01442064|50503118|FG000|Overall Study|Sponsor decision|82|||
25224681|NCT01442064|50503119|FG001|Overall Study|Sponsor decision|88|||
25224682|NCT01442064|50503120|FG002|Overall Study|Sponsor decision|92|||
25224683|NCT01442064|50503121|FG003|Overall Study|Sponsor decision|88|||
25224684|NCT01442064|50503122|FG004|Overall Study|Sponsor decision|95|||
25224685|NCT01442064|50503123|FG005|Overall Study|Sponsor decision|87|||
25224686|NCT01442064|50503118|FG000|Overall Study|Subject non-compliance|0|||
25224687|NCT01442064|50503119|FG001|Overall Study|Subject non-compliance|0|||
25224688|NCT01442064|50503120|FG002|Overall Study|Subject non-compliance|0|||
25224689|NCT01442064|50503121|FG003|Overall Study|Subject non-compliance|0|||
25224690|NCT01442064|50503122|FG004|Overall Study|Subject non-compliance|0|||
25224691|NCT01442064|50503123|FG005|Overall Study|Subject non-compliance|2|||
25224692|NCT01442064|50503118|FG000|Overall Study|Condition mandated other intervention|1|||
25224693|NCT01442064|50503119|FG001|Overall Study|Condition mandated other intervention|1|||
25224694|NCT01442064|50503120|FG002|Overall Study|Condition mandated other intervention|2|||
25224695|NCT01442064|50503121|FG003|Overall Study|Condition mandated other intervention|0|||
25224696|NCT01442064|50503122|FG004|Overall Study|Condition mandated other intervention|0|||
25224697|NCT01442064|50503123|FG005|Overall Study|Condition mandated other intervention|2|||
25224698|NCT01467960|50503146|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
25224699|NCT01467960|50503147|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
25224700|NCT01467960|50503148|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
25224701|NCT01467960|50503149|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
25224702|NCT01467960|50503150|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
25224703|NCT01467960|50503151|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
25224704|NCT01441596|50503168|FG000|Overall Study|Other reason not defined below|0|||
25224705|NCT01441596|50503169|FG001|Overall Study|Other reason not defined below|2|||
25224706|NCT01441596|50503170|FG002|Overall Study|Other reason not defined below|1|||
25224707|NCT01441596|50503168|FG000|Overall Study|Withdrawal by Subject|4|||
25224708|NCT01441596|50503169|FG001|Overall Study|Withdrawal by Subject|0|||
25224709|NCT01441596|50503170|FG002|Overall Study|Withdrawal by Subject|2|||
25224710|NCT01441596|50503168|FG000|Overall Study|Not treated|0|||
25224711|NCT01441596|50503169|FG001|Overall Study|Not treated|1|||
25224712|NCT01441596|50503170|FG002|Overall Study|Not treated|1|||
25224713|NCT01441440|50503181|FG000|Overall Study|Death|1|||
25224714|NCT01441440|50503182|FG001|Overall Study|Death|0|||
25224715|NCT01441440|50503183|FG002|Overall Study|Death|1|||
25224716|NCT01441440|50503181|FG000|Overall Study|Adverse Event|2|||
25224717|NCT01441440|50503182|FG001|Overall Study|Adverse Event|9|||
25224718|NCT01441440|50503183|FG002|Overall Study|Adverse Event|9|||
25224719|NCT01441440|50503181|FG000|Overall Study|Lost to Follow-up|0|||
25224720|NCT01441440|50503182|FG001|Overall Study|Lost to Follow-up|2|||
24976549|NCT00058214|50065458|FG000|Overall Study|Adverse Event|1|||
24976550|NCT00097773|50065466|FG000|Overall Study|Lost to Follow-up|2|||
25224721|NCT01441440|50503183|FG002|Overall Study|Lost to Follow-up|1|||
25224722|NCT01441440|50503181|FG000|Overall Study|Withdrawal by Subject|11|||
25224723|NCT01441440|50503182|FG001|Overall Study|Withdrawal by Subject|9|||
25224724|NCT01441440|50503183|FG002|Overall Study|Withdrawal by Subject|9|||
25224725|NCT01441440|50503181|FG000|Overall Study|Pregnancy|1|||
25224726|NCT01441440|50503182|FG001|Overall Study|Pregnancy|0|||
25224727|NCT01441440|50503183|FG002|Overall Study|Pregnancy|0|||
25224728|NCT01441440|50503181|FG000|Overall Study|Lack of Efficacy|1|||
25224729|NCT01441440|50503182|FG001|Overall Study|Lack of Efficacy|0|||
25224730|NCT01441440|50503183|FG002|Overall Study|Lack of Efficacy|1|||
25224731|NCT01441440|50503181|FG000|Overall Study|Moving|0|||
25224732|NCT01441440|50503182|FG001|Overall Study|Moving|1|||
25224733|NCT01441440|50503183|FG002|Overall Study|Moving|1|||
25224734|NCT01441440|50503181|FG000|Overall Study|Work-related matter|0|||
25224735|NCT01441440|50503182|FG001|Overall Study|Work-related matter|1|||
25224736|NCT01441440|50503183|FG002|Overall Study|Work-related matter|0|||
25224737|NCT01441440|50503181|FG000|Overall Study|Difficllty in keeping the schedule|1|||
25224738|NCT01441440|50503182|FG001|Overall Study|Difficllty in keeping the schedule|1|||
25224739|NCT01441440|50503183|FG002|Overall Study|Difficllty in keeping the schedule|0|||
25224740|NCT01438476|50503193|FG000|Overall Study|Protocol Violation|1|||
25224741|NCT01438476|50503194|FG001|Overall Study|Protocol Violation|0|||
25224742|NCT01438476|50503193|FG000|Overall Study|Withdrawal by Subject|1|||
25224743|NCT01438476|50503194|FG001|Overall Study|Withdrawal by Subject|0|||
25224744|NCT01438476|50503193|FG000|Overall Study|No Surgery- Disease|8|||
25224745|NCT01438476|50503194|FG001|Overall Study|No Surgery- Disease|10|||
25224746|NCT01438476|50503193|FG000|Overall Study|Communication barrier|0|||
25224747|NCT01438476|50503194|FG001|Overall Study|Communication barrier|1|||
25224748|NCT01467570|50503202|FG000|Overall Study|Lost to Follow-up|8|||
25224749|NCT01467570|50503203|FG001|Overall Study|Lost to Follow-up|9|||
25224750|NCT01437540|50503213|FG000|Overall Study|Not listed below|7|||
25224751|NCT01437540|50503214|FG001|Overall Study|Not listed below|6|||
25224752|NCT01437540|50503213|FG000|Overall Study|COPD exacerbation|13|||
25224753|NCT01437540|50503214|FG001|Overall Study|COPD exacerbation|3|||
25224754|NCT01437540|50503213|FG000|Overall Study|Lost to Follow-up|3|||
25224755|NCT01437540|50503214|FG001|Overall Study|Lost to Follow-up|5|||
25224756|NCT01437540|50503213|FG000|Overall Study|Lack of Efficacy|23|||
25224757|NCT01437540|50503214|FG001|Overall Study|Lack of Efficacy|11|||
25224758|NCT01437540|50503213|FG000|Overall Study|Protocol Violation|24|||
25224759|NCT01437540|50503214|FG001|Overall Study|Protocol Violation|12|||
25224760|NCT01437540|50503213|FG000|Overall Study|Adverse Event|26|||
25224761|NCT01437540|50503214|FG001|Overall Study|Adverse Event|13|||
25224762|NCT01437540|50503213|FG000|Overall Study|Withdrawal by Subject|31|||
25224763|NCT01437540|50503214|FG001|Overall Study|Withdrawal by Subject|15|||
25224764|NCT01440972|50503222|FG000|Overall Study|Withdrawal by Subject|3|||
25224765|NCT01440972|50503223|FG001|Overall Study|Withdrawal by Subject|2|||
25224766|NCT01420536|50503231|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
25224767|NCT01420536|50503232|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
25224768|NCT01420068|50503242|FG000|Overall Study|Administrative problems|1|||
25224769|NCT01420068|50503243|FG001|Overall Study|Administrative problems|3|||
25224770|NCT01420068|50503242|FG000|Overall Study|Withdrawal by Subject|1|||
25224771|NCT01420068|50503243|FG001|Overall Study|Withdrawal by Subject|2|||
25224772|NCT01467492|50503251|FG000|Overall Study|Withdrawal by Subject|6|||
25224773|NCT01467492|50503252|FG001|Overall Study|Withdrawal by Subject|4|||
25224774|NCT01467492|50503251|FG000|Overall Study|Study Terminated by Sponsor|6|||
25224775|NCT01467492|50503252|FG001|Overall Study|Study Terminated by Sponsor|4|||
25224776|NCT01467492|50503251|FG000|Overall Study|Adverse Event|4|||
25224777|NCT01467492|50503252|FG001|Overall Study|Adverse Event|3|||
25224778|NCT01467492|50503251|FG000|Overall Study|Lost to Follow-up|3|||
25224779|NCT01467492|50503252|FG001|Overall Study|Lost to Follow-up|2|||
25224780|NCT01467492|50503251|FG000|Overall Study|Undefined|2|||
25224781|NCT01467492|50503252|FG001|Overall Study|Undefined|0|||
25224782|NCT01467492|50503251|FG000|Overall Study|Enrolled But Not Treated|1|||
25224783|NCT01467492|50503252|FG001|Overall Study|Enrolled But Not Treated|0|||
25224784|NCT01466790|50503267|FG000|Overall Study|Adverse Event|1|||
25224785|NCT01466790|50503268|FG001|Overall Study|Adverse Event|0|||
25224786|NCT01466790|50503269|FG002|Overall Study|Adverse Event|0|||
25224787|NCT01466790|50503270|FG003|Overall Study|Adverse Event|0|||
25224788|NCT01466790|50503271|FG004|Overall Study|Adverse Event|2|||
25224789|NCT01466790|50503272|FG005|Overall Study|Adverse Event|0|||
25224790|NCT01466790|50503273|FG006|Overall Study|Adverse Event|0|||
25224791|NCT01466790|50503274|FG007|Overall Study|Adverse Event|0|||
25224792|NCT01466790|50503267|FG000|Overall Study|Lost to Follow-up|2|||
25224793|NCT01466790|50503268|FG001|Overall Study|Lost to Follow-up|0|||
25224794|NCT01466790|50503269|FG002|Overall Study|Lost to Follow-up|0|||
25224795|NCT01466790|50503270|FG003|Overall Study|Lost to Follow-up|0|||
25224796|NCT01466790|50503271|FG004|Overall Study|Lost to Follow-up|0|||
25224797|NCT01466790|50503272|FG005|Overall Study|Lost to Follow-up|0|||
25224798|NCT01466790|50503273|FG006|Overall Study|Lost to Follow-up|0|||
25224799|NCT01466790|50503274|FG007|Overall Study|Lost to Follow-up|0|||
25224800|NCT01466790|50503267|FG000|Overall Study|Withdrawal by Subject|1|||
25224801|NCT01466790|50503268|FG001|Overall Study|Withdrawal by Subject|1|||
25224802|NCT01466790|50503269|FG002|Overall Study|Withdrawal by Subject|0|||
25224803|NCT01466790|50503270|FG003|Overall Study|Withdrawal by Subject|0|||
25224804|NCT01466790|50503271|FG004|Overall Study|Withdrawal by Subject|1|||
25224805|NCT01466790|50503272|FG005|Overall Study|Withdrawal by Subject|0|||
25224806|NCT01466790|50503273|FG006|Overall Study|Withdrawal by Subject|1|||
25224807|NCT01466790|50503274|FG007|Overall Study|Withdrawal by Subject|1|||
25224808|NCT01418352|50503292|FG000|Overall Study|Lost to Follow-up|2|||
25224809|NCT01418352|50503293|FG001|Overall Study|Lost to Follow-up|0|||
25224810|NCT01418352|50503294|FG002|Overall Study|Lost to Follow-up|0|||
25224811|NCT01418352|50503295|FG003|Overall Study|Lost to Follow-up|0|||
25224812|NCT01418352|50503292|FG000|Overall Study|Adverse Event|0|||
25224813|NCT01418352|50503293|FG001|Overall Study|Adverse Event|1|||
25224814|NCT01418352|50503294|FG002|Overall Study|Adverse Event|0|||
25224815|NCT01418352|50503295|FG003|Overall Study|Adverse Event|0|||
25224816|NCT01418352|50503292|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
25224817|NCT01418352|50503293|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
25224818|NCT01418352|50503294|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
25224819|NCT01418352|50503295|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
25224820|NCT01418352|50503292|FG000|Overall Study|Subject Withdrew Consent|0|||
25224821|NCT01418352|50503293|FG001|Overall Study|Subject Withdrew Consent|1|||
25224822|NCT01418352|50503294|FG002|Overall Study|Subject Withdrew Consent|2|||
25224823|NCT01418352|50503295|FG003|Overall Study|Subject Withdrew Consent|1|||
25224824|NCT01418352|50503292|FG000|Overall Study|Protocol Deviation|0|||
25224825|NCT01418352|50503293|FG001|Overall Study|Protocol Deviation|0|||
25224826|NCT01418352|50503294|FG002|Overall Study|Protocol Deviation|1|||
25224827|NCT01418352|50503295|FG003|Overall Study|Protocol Deviation|0|||
25224828|NCT01418352|50503292|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
25224829|NCT01418352|50503293|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
25224830|NCT01418352|50503294|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
25224831|NCT01418352|50503295|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
25224832|NCT01436370|50503313|FG000|Overall Study|Lost to Follow-up|0|||
25224833|NCT01436370|50503314|FG001|Overall Study|Lost to Follow-up|0|||
25224834|NCT01436370|50503315|FG002|Overall Study|Lost to Follow-up|0|||
25224835|NCT01436370|50503316|FG003|Overall Study|Lost to Follow-up|0|||
25224836|NCT01436370|50503317|FG004|Overall Study|Lost to Follow-up|1|||
25224837|NCT01436370|50503318|FG005|Overall Study|Lost to Follow-up|0|||
25224838|NCT01436370|50503319|FG006|Overall Study|Lost to Follow-up|0|||
25224839|NCT01436370|50503320|FG007|Overall Study|Lost to Follow-up|0|||
25224840|NCT01465464|50503348|FG000|Overall Study|Adverse Event|96|||
25224841|NCT01465464|50503349|FG001|Overall Study|Adverse Event|49|||
25224842|NCT01465464|50503348|FG000|Overall Study|Lack of Efficacy|139|||
25224843|NCT01465464|50503349|FG001|Overall Study|Lack of Efficacy|190|||
25224844|NCT01465464|50503348|FG000|Overall Study|Physician Decision|13|||
25224845|NCT01465464|50503349|FG001|Overall Study|Physician Decision|5|||
25224846|NCT01465464|50503348|FG000|Overall Study|Protocol Violation|1|||
25224847|NCT01465464|50503349|FG001|Overall Study|Protocol Violation|1|||
25224848|NCT01465464|50503348|FG000|Overall Study|Withdrawal by Subject|46|||
25224849|NCT01465464|50503349|FG001|Overall Study|Withdrawal by Subject|30|||
25224850|NCT01465464|50503348|FG000|Overall Study|Other|9|||
25224851|NCT01465464|50503349|FG001|Overall Study|Other|3|||
25224852|NCT01465464|50503348|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
25224853|NCT01465464|50503349|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
25224854|NCT01417104|50503357|FG000|Overall Study|Withdrawal by Subject|5|||
25224855|NCT01417104|50503358|FG001|Overall Study|Withdrawal by Subject|1|||
25224856|NCT01417104|50503357|FG000|Overall Study|Failure to make contact|0|||
25224857|NCT01417104|50503358|FG001|Overall Study|Failure to make contact|1|||
25224858|NCT01417104|50503357|FG000|Overall Study|Adverse Event|1|||
25224859|NCT01417104|50503358|FG001|Overall Study|Adverse Event|0|||
25224860|NCT01465386|50503364|FG000|Overall Study|Lack of Efficacy|3|||
25224861|NCT01465386|50503364|FG000|Overall Study|Adverse Event|1|||
25224862|NCT01465230|50503368|FG000|Overall Study|Withdrawal by Subject|2|||
25224863|NCT01435356|50503374|FG000|Overall Study|Adverse Event|2|||
25224864|NCT01435356|50503375|FG001|Overall Study|Adverse Event|0|||
25224865|NCT01435356|50503374|FG000|Overall Study|Disease progression/recurrence|17|||
25224866|NCT01435356|50503375|FG001|Overall Study|Disease progression/recurrence|10|||
25224867|NCT01435356|50503374|FG000|Overall Study|Protocol Violation|0|||
25224868|NCT01435356|50503375|FG001|Overall Study|Protocol Violation|1|||
25224869|NCT01435356|50503374|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
25224870|NCT01435356|50503375|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
25224871|NCT01435356|50503374|FG000|Overall Study|Withdrawal by Subject|1|||
25224872|NCT01435356|50503375|FG001|Overall Study|Withdrawal by Subject|1|||
25224873|NCT01435356|50503374|FG000|Overall Study|Facial palsy|1|||
25224874|NCT01435356|50503375|FG001|Overall Study|Facial palsy|0|||
25224875|NCT01435356|50503374|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
25224876|NCT01435356|50503375|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
25224877|NCT01435356|50503374|FG000|Overall Study|Physician Decision|1|||
25224878|NCT01435356|50503375|FG001|Overall Study|Physician Decision|0|||
25224879|NCT01435356|50503374|FG000|Overall Study|Patient decision|3|||
25224880|NCT01435356|50503375|FG001|Overall Study|Patient decision|0|||
25224881|NCT01435356|50503374|FG000|Overall Study|Patient moved to another city|1|||
25224882|NCT01435356|50503375|FG001|Overall Study|Patient moved to another city|1|||
25224883|NCT01435122|50503381|FG000|Overall Study|Early withdrawal due to toxicity|8|||
25224884|NCT01434810|50503387|FG000|Overall Study|Did not receive treatment|11|||
25224885|NCT01434810|50503388|FG001|Overall Study|Did not receive treatment|3|||
25224886|NCT01434810|50503387|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
25224887|NCT01434810|50503388|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
25224888|NCT01393626|50503398|FG000|Overall Study|Adverse Event|2|||
25224889|NCT01393626|50503399|FG001|Overall Study|Adverse Event|1|||
25224890|NCT01393626|50503400|FG002|Overall Study|Adverse Event|5|||
25224891|NCT01393626|50503401|FG003|Overall Study|Adverse Event|0|||
25224892|NCT01393626|50503398|FG000|Overall Study|Did not meet entrance criteria|1|||
25224893|NCT01393626|50503399|FG001|Overall Study|Did not meet entrance criteria|0|||
25224894|NCT01393626|50503400|FG002|Overall Study|Did not meet entrance criteria|0|||
25224895|NCT01393626|50503401|FG003|Overall Study|Did not meet entrance criteria|0|||
25224896|NCT01393626|50503398|FG000|Overall Study|Lack of Efficacy|6|||
25224897|NCT01393626|50503399|FG001|Overall Study|Lack of Efficacy|6|||
25224898|NCT01393626|50503400|FG002|Overall Study|Lack of Efficacy|4|||
25224899|NCT01393626|50503401|FG003|Overall Study|Lack of Efficacy|1|||
25224900|NCT01393626|50503398|FG000|Overall Study|Lost to Follow-up|1|||
25224901|NCT01393626|50503399|FG001|Overall Study|Lost to Follow-up|1|||
25224902|NCT01393626|50503400|FG002|Overall Study|Lost to Follow-up|1|||
25224903|NCT01393626|50503401|FG003|Overall Study|Lost to Follow-up|0|||
25224904|NCT01393626|50503398|FG000|Overall Study|Withdrawal by Subject|6|||
25224905|NCT01393626|50503399|FG001|Overall Study|Withdrawal by Subject|4|||
25224906|NCT01393626|50503400|FG002|Overall Study|Withdrawal by Subject|0|||
25224907|NCT01393626|50503401|FG003|Overall Study|Withdrawal by Subject|0|||
25224908|NCT01393626|50503398|FG000|Overall Study|Other|1|||
25224909|NCT01393626|50503399|FG001|Overall Study|Other|0|||
25224910|NCT01393626|50503400|FG002|Overall Study|Other|0|||
25224911|NCT01393626|50503401|FG003|Overall Study|Other|0|||
25224912|NCT01393626|50503398|FG000|Overall Study|Protocol Violation|1|||
25224913|NCT01393626|50503399|FG001|Overall Study|Protocol Violation|0|||
25224914|NCT01393626|50503400|FG002|Overall Study|Protocol Violation|2|||
25224915|NCT01393626|50503401|FG003|Overall Study|Protocol Violation|0|||
25224916|NCT01434654|50503420|FG000|Overall Study|Withdrawal by Subject|1|||
25224917|NCT01434654|50503421|FG001|Overall Study|Withdrawal by Subject|0|||
25224918|NCT01434654|50503420|FG000|Overall Study|Lost to Follow-up|1|||
25224919|NCT01434654|50503421|FG001|Overall Study|Lost to Follow-up|0|||
25224920|NCT01393158|50503431|FG000|Overall Study|Adverse Event|1|||
25224921|NCT01393158|50503432|FG001|Overall Study|Adverse Event|0|||
25224922|NCT01413360|50503444|FG000|Overall Study|Lost to Follow-up|2|||
25224923|NCT01413360|50503444|FG000|Overall Study|Adverse Event|1|||
25224924|NCT01413204|50503451|FG000|Overall Study|Adverse Event|1|||
25224925|NCT01413204|50503452|FG001|Overall Study|Adverse Event|2|||
25224926|NCT01413204|50503453|FG002|Overall Study|Adverse Event|2|||
25224927|NCT01413204|50503451|FG000|Overall Study|Physician Decision|3|||
25224928|NCT01413204|50503452|FG001|Overall Study|Physician Decision|0|||
25224929|NCT01413204|50503453|FG002|Overall Study|Physician Decision|2|||
25224930|NCT01413204|50503451|FG000|Overall Study|Withdrawal by Subject|1|||
25224931|NCT01413204|50503452|FG001|Overall Study|Withdrawal by Subject|4|||
25224932|NCT01413204|50503453|FG002|Overall Study|Withdrawal by Subject|4|||
25224933|NCT01413204|50503451|FG000|Overall Study|Clearly not eligible for the study|0|||
25224934|NCT01413204|50503452|FG001|Overall Study|Clearly not eligible for the study|0|||
25224935|NCT01413204|50503453|FG002|Overall Study|Clearly not eligible for the study|1|||
25224936|NCT01413204|50503451|FG000|Overall Study|Fasting plasma glucose level increased|1|||
25224937|NCT01413204|50503452|FG001|Overall Study|Fasting plasma glucose level increased|0|||
25224938|NCT01413204|50503453|FG002|Overall Study|Fasting plasma glucose level increased|10|||
25224939|NCT01392378|50503466|FG000|Infant Series|Adverse Event|0|||
25224940|NCT01392378|50503467|FG001|Infant Series|Adverse Event|0|||
25224941|NCT01392378|50503468|FG002|Infant Series|Adverse Event|0|||
25224942|NCT01392378|50503469|FG003|Infant Series|Adverse Event|1|||
25224943|NCT01392378|50503470|FG004|Infant Series|Adverse Event|0|||
25224944|NCT01392378|50503466|FG000|Infant Series|Lost to Follow-up|0|||
25224945|NCT01392378|50503467|FG001|Infant Series|Lost to Follow-up|0|||
25224946|NCT01392378|50503468|FG002|Infant Series|Lost to Follow-up|0|||
25224947|NCT01392378|50503469|FG003|Infant Series|Lost to Follow-up|1|||
25224948|NCT01392378|50503470|FG004|Infant Series|Lost to Follow-up|0|||
25224949|NCT01392378|50503466|FG000|Infant Series|Protocol Violation|0|||
25224950|NCT01392378|50503467|FG001|Infant Series|Protocol Violation|1|||
25224951|NCT01392378|50503468|FG002|Infant Series|Protocol Violation|0|||
25224952|NCT01392378|50503469|FG003|Infant Series|Protocol Violation|0|||
25224953|NCT01392378|50503470|FG004|Infant Series|Protocol Violation|0|||
25224954|NCT01392378|50503466|FG000|Infant Series|Withdrawal by Parent|4|||
25224955|NCT01392378|50503467|FG001|Infant Series|Withdrawal by Parent|1|||
25224956|NCT01392378|50503468|FG002|Infant Series|Withdrawal by Parent|0|||
25224957|NCT01392378|50503469|FG003|Infant Series|Withdrawal by Parent|0|||
25224958|NCT01392378|50503470|FG004|Infant Series|Withdrawal by Parent|0|||
25224959|NCT01392378|50503466|FG000|After Infant Series|Lost to Follow-up|0|||
25224960|NCT01392378|50503467|FG001|After Infant Series|Lost to Follow-up|0|||
25224961|NCT01392378|50503468|FG002|After Infant Series|Lost to Follow-up|1|||
25224962|NCT01392378|50503469|FG003|After Infant Series|Lost to Follow-up|0|||
25224963|NCT01392378|50503470|FG004|After Infant Series|Lost to Follow-up|0|||
25224964|NCT01392378|50503466|FG000|After Infant Series|Withdrawal by Parent|0|||
25224965|NCT01392378|50503467|FG001|After Infant Series|Withdrawal by Parent|1|||
25224966|NCT01392378|50503468|FG002|After Infant Series|Withdrawal by Parent|1|||
25224967|NCT01392378|50503469|FG003|After Infant Series|Withdrawal by Parent|0|||
25224968|NCT01392378|50503470|FG004|After Infant Series|Withdrawal by Parent|1|||
25224969|NCT01392378|50503466|FG000|Toddler Dose|Lost to Follow-up|0|||
25224970|NCT01392378|50503467|FG001|Toddler Dose|Lost to Follow-up|0|||
25224971|NCT01392378|50503468|FG002|Toddler Dose|Lost to Follow-up|0|||
25224972|NCT01392378|50503469|FG003|Toddler Dose|Lost to Follow-up|1|||
25224973|NCT01392378|50503470|FG004|Toddler Dose|Lost to Follow-up|0|||
25224974|NCT01392378|50503466|FG000|Toddler Dose|Withdrawal by Parent|0|||
25224975|NCT01392378|50503467|FG001|Toddler Dose|Withdrawal by Parent|1|||
25224976|NCT01392378|50503468|FG002|Toddler Dose|Withdrawal by Parent|0|||
25224977|NCT01392378|50503469|FG003|Toddler Dose|Withdrawal by Parent|1|||
25224978|NCT01392378|50503470|FG004|Toddler Dose|Withdrawal by Parent|1|||
25224979|NCT01412424|50503492|FG000|Core Treatment Period|Treatment Failure|24|||
25224980|NCT01412424|50503492|FG000|Core Treatment Period|Adverse Event|21|||
25224981|NCT01412424|50503492|FG000|Core Treatment Period|Patient Request|5|||
25224982|NCT01412424|50503492|FG000|Core Treatment Period|Lost to Follow-up|2|||
25224983|NCT01412424|50503492|FG000|Core Treatment Period|Sponsor Request|1|||
25224984|NCT01412424|50503492|FG000|Extension Treatment Period|Adverse Event|2|||
25224985|NCT01412424|50503492|FG000|Extension Treatment Period|Treatment Failure|2|||
25224986|NCT01412424|50503492|FG000|Extension Treatment Period|Patient Request|2|||
25224987|NCT01433250|50503504|FG000|Overall Study|Protocol Violation|0|||
25224988|NCT01433250|50503505|FG001|Overall Study|Protocol Violation|1|||
25224989|NCT01433250|50503504|FG000|Overall Study|Withdrawal by Subject|3|||
25224990|NCT01433250|50503505|FG001|Overall Study|Withdrawal by Subject|2|||
25224991|NCT01433172|50503514|FG000|Overall Study|Withdrawal by Subject|0|||
25224992|NCT01433172|50503515|FG001|Overall Study|Withdrawal by Subject|1|||
25224993|NCT01433172|50503516|FG002|Overall Study|Withdrawal by Subject|0|||
25224994|NCT01433172|50503514|FG000|Overall Study|Disease Progression|0|||
25224995|NCT01433172|50503515|FG001|Overall Study|Disease Progression|0|||
25224996|NCT01433172|50503516|FG002|Overall Study|Disease Progression|1|||
25224997|NCT01433172|50503514|FG000|Overall Study|Death|0|||
25224998|NCT01433172|50503515|FG001|Overall Study|Death|2|||
25224999|NCT01433172|50503516|FG002|Overall Study|Death|0|||
25225000|NCT01432938|50503524|FG000|First Intervention|Protocol Violation|1|||
25225001|NCT01432938|50503525|FG001|First Intervention|Protocol Violation|0|||
25225002|NCT01432938|50503524|FG000|First Intervention|Physician Decision|1|||
25225003|NCT01432938|50503525|FG001|First Intervention|Physician Decision|0|||
25225004|NCT01432938|50503524|FG000|Second Intervention|Adverse Event|1|||
25225005|NCT01432938|50503525|FG001|Second Intervention|Adverse Event|0|||
25225006|NCT01392300|50503534|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
25225007|NCT01392300|50503535|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
25225008|NCT01392300|50503536|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
25225009|NCT01392300|50503534|FG000|Main Period (MP)|Withdrawal by Subject|5|||
25225010|NCT01392300|50503535|FG001|Main Period (MP)|Withdrawal by Subject|1|||
25225011|NCT01392300|50503536|FG002|Main Period (MP)|Withdrawal by Subject|0|||
25225012|NCT01392300|50503534|FG000|Main Period (MP)|Lost to Follow-up|3|||
25225013|NCT01392300|50503535|FG001|Main Period (MP)|Lost to Follow-up|3|||
25225014|NCT01392300|50503536|FG002|Main Period (MP)|Lost to Follow-up|0|||
25225015|NCT01392300|50503534|FG000|Main Period (MP)|Non-compliance|1|||
25225016|NCT01392300|50503535|FG001|Main Period (MP)|Non-compliance|0|||
25225017|NCT01392300|50503536|FG002|Main Period (MP)|Non-compliance|0|||
25225018|NCT01392300|50503534|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
25225019|NCT01392300|50503535|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
25225020|NCT01392300|50503536|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
25225021|NCT01392300|50503534|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
25225022|NCT01392300|50503535|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
25225023|NCT01392300|50503536|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
25225024|NCT01392300|50503534|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
25225025|NCT01392300|50503535|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
25225026|NCT01392300|50503536|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
25318403|NCT00803049|50633986|FG000|Overall Study|Protocol Violation|0|||
25318404|NCT00803049|50633987|FG001|Overall Study|Protocol Violation|1|||
25318405|NCT00803049|50633988|FG002|Overall Study|Protocol Violation|1|||
25318406|NCT00803049|50633989|FG003|Overall Study|Protocol Violation|0|||
25318407|NCT00803049|50633986|FG000|Overall Study|Randomized and Not Treated|0|||
25318408|NCT00803049|50633987|FG001|Overall Study|Randomized and Not Treated|0|||
25318409|NCT00803049|50633988|FG002|Overall Study|Randomized and Not Treated|0|||
25318410|NCT00803049|50633989|FG003|Overall Study|Randomized and Not Treated|2|||
25318411|NCT00803049|50633986|FG000|Overall Study|Other than Specified Above|3|||
25225027|NCT01392300|50503534|FG000|Open Label Extension (OLEX) Period|Death|0|||
25225028|NCT01392300|50503535|FG001|Open Label Extension (OLEX) Period|Death|0|||
25225029|NCT01392300|50503536|FG002|Open Label Extension (OLEX) Period|Death|4|||
25225030|NCT01392300|50503534|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
25318412|NCT00803049|50633987|FG001|Overall Study|Other than Specified Above|9|||
25225031|NCT01392300|50503535|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
25318413|NCT00803049|50633988|FG002|Overall Study|Other than Specified Above|2|||
25318414|NCT00803049|50633989|FG003|Overall Study|Other than Specified Above|5|||
25225032|NCT01392300|50503536|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
25225033|NCT01392300|50503534|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
25225034|NCT01392300|50503535|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
25225035|NCT01392300|50503536|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
25225036|NCT01392300|50503534|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
25225037|NCT01392300|50503535|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
25225038|NCT01392300|50503536|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
25225039|NCT01432626|50503543|FG000|Overall Study|LV function recovered|2|||
25225040|NCT01432626|50503543|FG000|Overall Study|Withdrawal by Subject|2|||
25225041|NCT01432626|50503543|FG000|Overall Study|Only 1 image competed|2|||
25225042|NCT01432626|50503543|FG000|Overall Study|Imaging agent not available|1|||
25225043|NCT01391832|50503549|FG000|Overall Study|Withdrawal by Subject|21|||
25225044|NCT01391832|50503550|FG001|Overall Study|Withdrawal by Subject|22|||
25225045|NCT01391832|50503549|FG000|Overall Study|Lost to Follow-up|0|||
25225046|NCT01391832|50503550|FG001|Overall Study|Lost to Follow-up|1|||
25225047|NCT01410474|50503558|FG000|Overall Study|Withdrawal by Subject|0|||
25225048|NCT01410474|50503559|FG001|Overall Study|Withdrawal by Subject|1|||
25225049|NCT01391130|50503574|FG000|Overall Study|Withdrawal by Subject|3|||
25225050|NCT01391130|50503575|FG001|Overall Study|Withdrawal by Subject|2|||
25225051|NCT01391130|50503574|FG000|Overall Study|Physician Decision|2|||
25225052|NCT01391130|50503575|FG001|Overall Study|Physician Decision|3|||
25225053|NCT01391130|50503574|FG000|Overall Study|Did not Receive Drug|1|||
25225054|NCT01391130|50503575|FG001|Overall Study|Did not Receive Drug|1|||
25225055|NCT01410240|50503584|FG000|Overall Study|Physician Decision|0|||
25225056|NCT01410240|50503585|FG001|Overall Study|Physician Decision|0|||
25225057|NCT01410240|50503586|FG002|Overall Study|Physician Decision|1|||
25225058|NCT01410240|50503584|FG000|Overall Study|Missed week 6 assessments|1|||
25225059|NCT01410240|50503585|FG001|Overall Study|Missed week 6 assessments|1|||
25225060|NCT01410240|50503586|FG002|Overall Study|Missed week 6 assessments|1|||
25225061|NCT01409928|50503595|FG000|Overall Study|Physician Decision|12|||
25225062|NCT01431534|50503602|FG000|Treatment Phase|Adverse Event|0|||
25225063|NCT01431534|50503603|FG001|Treatment Phase|Adverse Event|0|||
25225064|NCT01431534|50503604|FG002|Treatment Phase|Adverse Event|1|||
25225065|NCT01431534|50503602|FG000|Treatment Phase|Progressive Disease|4|||
25225066|NCT01431534|50503603|FG001|Treatment Phase|Progressive Disease|3|||
25225067|NCT01431534|50503604|FG002|Treatment Phase|Progressive Disease|10|||
25225068|NCT01409382|50503614|FG000|Overall Study|Lost to Follow-up|1|||
25225069|NCT01409382|50503615|FG001|Overall Study|Lost to Follow-up|1|||
25225070|NCT01409382|50503614|FG000|Overall Study|Protocol Violation|0|||
25225071|NCT01409382|50503615|FG001|Overall Study|Protocol Violation|3|||
25225072|NCT01409382|50503614|FG000|Overall Study|Multiple pregnancy|2|||
25225073|NCT01409382|50503615|FG001|Overall Study|Multiple pregnancy|4|||
25225074|NCT01409382|50503614|FG000|Overall Study|Still pregnant when study ended|13|||
25225075|NCT01409382|50503615|FG001|Overall Study|Still pregnant when study ended|2|||
25225076|NCT01409382|50503614|FG000|Overall Study|Did not manage to get pregnant|64|||
25225077|NCT01409382|50503615|FG001|Overall Study|Did not manage to get pregnant|70|||
25225078|NCT01409382|50503614|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
25225079|NCT01409382|50503615|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
25225080|NCT01408914|50503628|FG000|Overall Study|Could not complete tx in protocol period|5|||
25225081|NCT01408914|50503629|FG001|Overall Study|Could not complete tx in protocol period|5|||
25225082|NCT01408914|50503630|FG002|Overall Study|Could not complete tx in protocol period|6|||
25225083|NCT01408914|50503628|FG000|Overall Study|Lost to Follow-up|4|||
25225084|NCT01408914|50503629|FG001|Overall Study|Lost to Follow-up|1|||
25225085|NCT01408914|50503630|FG002|Overall Study|Lost to Follow-up|2|||
25225086|NCT01408914|50503628|FG000|Overall Study|Physician Decision|1|||
25225087|NCT01408914|50503629|FG001|Overall Study|Physician Decision|1|||
25225088|NCT01408914|50503630|FG002|Overall Study|Physician Decision|0|||
25225089|NCT01408914|50503628|FG000|Overall Study|Withdrawal by Subject|1|||
25225090|NCT01408914|50503629|FG001|Overall Study|Withdrawal by Subject|0|||
25225091|NCT01408914|50503630|FG002|Overall Study|Withdrawal by Subject|1|||
25225092|NCT01408914|50503628|FG000|Overall Study|Moved out of study jurisdiction|1|||
25225093|NCT01408914|50503629|FG001|Overall Study|Moved out of study jurisdiction|1|||
25225094|NCT01408914|50503630|FG002|Overall Study|Moved out of study jurisdiction|0|||
25225095|NCT01408914|50503628|FG000|Overall Study|Late exclusion|0|||
25225096|NCT01408914|50503629|FG001|Overall Study|Late exclusion|3|||
25318415|NCT00890084|50633999|FG000|Overall Study|Adverse Event|16|||
25225097|NCT01408914|50503630|FG002|Overall Study|Late exclusion|3|||
25225098|NCT01408914|50503628|FG000|Overall Study|Change in local TB/HIV norms|0|||
25225099|NCT01408914|50503629|FG001|Overall Study|Change in local TB/HIV norms|1|||
25225100|NCT01408914|50503630|FG002|Overall Study|Change in local TB/HIV norms|1|||
25225101|NCT01431144|50503640|FG000|Overall Study|Implant mobility and removal|2|||
25225102|NCT01431144|50503641|FG001|Overall Study|Implant mobility and removal|0|||
25225103|NCT01430754|50503650|FG000|Run-In Phase|Circadian Period Ineligible|24|||
25225104|NCT01430754|50503651|FG001|Run-In Phase|Circadian Period Ineligible|0|||
25225105|NCT01430754|50503650|FG000|Run-In Phase|Protocol Violation|6|||
25225106|NCT01430754|50503651|FG001|Run-In Phase|Protocol Violation|0|||
25225107|NCT01430754|50503650|FG000|Run-In Phase|Adverse Event|2|||
25225108|NCT01430754|50503651|FG001|Run-In Phase|Adverse Event|0|||
25225109|NCT01430754|50503650|FG000|Run-In Phase|Other|2|||
25225110|NCT01430754|50503651|FG001|Run-In Phase|Other|0|||
25225111|NCT01430754|50503650|FG000|Run-In Phase|Withdrawal by Subject|2|||
25225112|NCT01430754|50503651|FG001|Run-In Phase|Withdrawal by Subject|0|||
25225113|NCT01430754|50503650|FG000|Run-In Phase|Lost to Follow-up|1|||
25225114|NCT01430754|50503651|FG001|Run-In Phase|Lost to Follow-up|0|||
25225115|NCT01390428|50503665|FG000|Overall Study|Elective Surgery|0|||
25225116|NCT01390428|50503666|FG001|Overall Study|Elective Surgery|0|||
25225117|NCT01390428|50503667|FG002|Overall Study|Elective Surgery|0|||
25225118|NCT01390428|50503668|FG003|Overall Study|Elective Surgery|0|||
25225119|NCT01390428|50503669|FG004|Overall Study|Elective Surgery|1|||
25225120|NCT01390428|50503670|FG005|Overall Study|Elective Surgery|0|||
25225121|NCT01390428|50503665|FG000|Overall Study|Withdrawal by Subject|0|||
25225122|NCT01390428|50503666|FG001|Overall Study|Withdrawal by Subject|0|||
25225123|NCT01390428|50503667|FG002|Overall Study|Withdrawal by Subject|1|||
25225124|NCT01390428|50503668|FG003|Overall Study|Withdrawal by Subject|0|||
25225125|NCT01390428|50503669|FG004|Overall Study|Withdrawal by Subject|0|||
25225126|NCT01390428|50503670|FG005|Overall Study|Withdrawal by Subject|0|||
25225127|NCT01430130|50503684|FG000|Overall Study|Lost to Follow-up|1|||
25225128|NCT01430130|50503684|FG000|Overall Study|Infection on Control Side of Incision|1|||
25225129|NCT01407354|50503690|FG000|First Intervention|Withdrawal by Subject|0|||
25225130|NCT01407354|50503691|FG001|First Intervention|Withdrawal by Subject|2|||
25225131|NCT01407354|50503690|FG000|First Intervention|Adverse Event|1|||
25225132|NCT01407354|50503691|FG001|First Intervention|Adverse Event|0|||
25225133|NCT01407354|50503690|FG000|First Intervention|Physician Decision|1|||
25225134|NCT01407354|50503691|FG001|First Intervention|Physician Decision|0|||
25225135|NCT01407276|50503706|FG000|Overall Study|Withdrawal by Subject|0|||
25225136|NCT01407276|50503707|FG001|Overall Study|Withdrawal by Subject|0|||
25225137|NCT01407276|50503708|FG002|Overall Study|Withdrawal by Subject|0|||
25225138|NCT01407276|50503709|FG003|Overall Study|Withdrawal by Subject|0|||
25225139|NCT01407276|50503710|FG004|Overall Study|Withdrawal by Subject|0|||
25225140|NCT01407276|50503711|FG005|Overall Study|Withdrawal by Subject|0|||
25225141|NCT01407276|50503712|FG006|Overall Study|Withdrawal by Subject|0|||
25225142|NCT01407276|50503713|FG007|Overall Study|Withdrawal by Subject|1|||
25225143|NCT01390272|50503740|FG000|Overall Study|Death|3|||
25225144|NCT01390272|50503741|FG001|Overall Study|Death|2|||
25225145|NCT01390272|50503740|FG000|Overall Study|Withdrawal by Subject|9|||
25225146|NCT01390272|50503741|FG001|Overall Study|Withdrawal by Subject|5|||
25225147|NCT01390272|50503740|FG000|Overall Study|Patient moved, no longer eligible|5|||
25225148|NCT01390272|50503741|FG001|Overall Study|Patient moved, no longer eligible|8|||
25225149|NCT01429584|50503749|FG000|Overall Study|Withdrawal by Subject|1|||
25225150|NCT01429584|50503750|FG001|Overall Study|Withdrawal by Subject|0|||
25225151|NCT01429584|50503749|FG000|Overall Study|Protocol Violation|0|||
25225152|NCT01429584|50503750|FG001|Overall Study|Protocol Violation|1|||
25225153|NCT01406652|50503758|FG000|Overall Study|Lost-to-follow-up|3|||
25225154|NCT01406652|50503759|FG001|Overall Study|Lost-to-follow-up|4|||
25225155|NCT01406652|50503758|FG000|Overall Study|Withdrawal by Subject|2|||
25225156|NCT01406652|50503759|FG001|Overall Study|Withdrawal by Subject|2|||
25225157|NCT01406652|50503758|FG000|Overall Study|Insufficient follow-up|5|||
25225158|NCT01406652|50503759|FG001|Overall Study|Insufficient follow-up|4|||
25225159|NCT01406652|50503758|FG000|Overall Study|Infection not sure|10|||
25225160|NCT01406652|50503759|FG001|Overall Study|Infection not sure|10|||
25225161|NCT01406574|50503767|FG000|Overall Study|Adverse Event|0|||
25225162|NCT01406574|50503768|FG001|Overall Study|Adverse Event|0|||
25225163|NCT01406574|50503769|FG002|Overall Study|Adverse Event|1|||
25225164|NCT01406574|50503770|FG003|Overall Study|Adverse Event|3|||
25225165|NCT01406574|50503767|FG000|Overall Study|Physician Decision|0|||
25225166|NCT01406574|50503768|FG001|Overall Study|Physician Decision|0|||
25225167|NCT01406574|50503769|FG002|Overall Study|Physician Decision|0|||
25225168|NCT01406574|50503770|FG003|Overall Study|Physician Decision|1|||
25225169|NCT01406574|50503767|FG000|Overall Study|Withdrawal by Subject|0|||
25225170|NCT01406574|50503768|FG001|Overall Study|Withdrawal by Subject|1|||
25225171|NCT01406574|50503769|FG002|Overall Study|Withdrawal by Subject|0|||
25225172|NCT01406574|50503770|FG003|Overall Study|Withdrawal by Subject|0|||
25225173|NCT01406574|50503767|FG000|Overall Study|Definite progression of primary disease|1|||
25225174|NCT01406574|50503768|FG001|Overall Study|Definite progression of primary disease|0|||
25225175|NCT01406574|50503769|FG002|Overall Study|Definite progression of primary disease|0|||
25318416|NCT00890084|50633999|FG000|Overall Study|Lost to Follow-up|126|||
25225176|NCT01406574|50503770|FG003|Overall Study|Definite progression of primary disease|0|||
25225177|NCT01405950|50503783|FG000|Overall Study|Withdrawal by Subject|1|||
25225178|NCT01405950|50503784|FG001|Overall Study|Withdrawal by Subject|0|||
25225179|NCT01405950|50503785|FG002|Overall Study|Withdrawal by Subject|0|||
25225180|NCT01405950|50503786|FG003|Overall Study|Withdrawal by Subject|0|||
25225181|NCT01405560|50503794|FG000|Overall Study|Physician Decision|1|||
25225182|NCT01428882|50503800|FG000|Overall Study|Lack of Efficacy|2|||
25225183|NCT01428882|50503801|FG001|Overall Study|Lack of Efficacy|7|||
25225184|NCT01428882|50503800|FG000|Overall Study|Protocol Violation|4|||
25225185|NCT01428882|50503801|FG001|Overall Study|Protocol Violation|3|||
25225186|NCT01428258|50503809|FG000|Intervention 1|Withdrawal by Subject|2|||
25225187|NCT01428258|50503810|FG001|Intervention 1|Withdrawal by Subject|0|||
25225188|NCT01389882|50503826|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
25225189|NCT01389882|50503827|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
25225190|NCT01389882|50503826|FG000|Overall Study|Withdrawal by Subject|0|||
25225191|NCT01389882|50503827|FG001|Overall Study|Withdrawal by Subject|1|||
25225192|NCT01442688|50503835|FG000|First Intervention|Withdrawal by Subject|1|||
25225193|NCT01442688|50503836|FG001|First Intervention|Withdrawal by Subject|0|||
25225194|NCT01442688|50503835|FG000|First Intervention|subject incarcerated|1|||
25225195|NCT01442688|50503836|FG001|First Intervention|subject incarcerated|0|||
25225196|NCT01442688|50503835|FG000|Second Intervention|Adverse Event|1|||
25225197|NCT01442688|50503836|FG001|Second Intervention|Adverse Event|0|||
25225198|NCT01466166|50503842|FG000|Overall Study|Death|1|||
25225199|NCT01466166|50503842|FG000|Overall Study|Lost to Follow-up|7|||
25225200|NCT01466166|50503842|FG000|Overall Study|Infusion Reaction (IR)|27|||
25225201|NCT01466166|50503842|FG000|Overall Study|Adverse Event (Other than IR)|11|||
25225202|NCT01466166|50503842|FG000|Overall Study|Elevated Serum Uric Acid|78|||
25225203|NCT01466166|50503842|FG000|Overall Study|Withdrawal by Subject|13|||
25225204|NCT01466166|50503842|FG000|Overall Study|Sponsor Decision|4|||
25225205|NCT01466166|50503842|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
25225206|NCT01466166|50503842|FG000|Overall Study|Other|20|||
25225207|NCT01426854|50503848|FG000|Overall Study|Adverse Event|1|||
25225208|NCT01426854|50503849|FG001|Overall Study|Adverse Event|5|||
25225209|NCT01426854|50503848|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
25225210|NCT01426854|50503849|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
25225211|NCT01426854|50503848|FG000|Overall Study|Lost to Follow-up|3|||
25225212|NCT01426854|50503849|FG001|Overall Study|Lost to Follow-up|0|||
25225213|NCT01426854|50503848|FG000|Overall Study|Noncompliance|0|||
25225214|NCT01426854|50503849|FG001|Overall Study|Noncompliance|1|||
25225215|NCT01426854|50503848|FG000|Overall Study|Treatment Failure|0|||
25225216|NCT01426854|50503849|FG001|Overall Study|Treatment Failure|16|||
25225217|NCT01426854|50503848|FG000|Overall Study|Protocol Deviation|0|||
25225218|NCT01426854|50503849|FG001|Overall Study|Protocol Deviation|1|||
25225219|NCT01426854|50503848|FG000|Overall Study|Other|3|||
25225220|NCT01426854|50503849|FG001|Overall Study|Other|2|||
25225221|NCT01426386|50503861|FG000|Overall Study|Adverse Event|0|||
25225222|NCT01426386|50503862|FG001|Overall Study|Adverse Event|1|||
25225223|NCT01426386|50503863|FG002|Overall Study|Adverse Event|0|||
25225224|NCT01426386|50503864|FG003|Overall Study|Adverse Event|0|||
25225225|NCT01426386|50503865|FG004|Overall Study|Adverse Event|0|||
25225226|NCT01426386|50503866|FG005|Overall Study|Adverse Event|0|||
25225227|NCT01426386|50503861|FG000|Overall Study|Did not attend scheduled visit|1|||
25225228|NCT01426386|50503862|FG001|Overall Study|Did not attend scheduled visit|4|||
25225229|NCT01426386|50503863|FG002|Overall Study|Did not attend scheduled visit|0|||
25225230|NCT01426386|50503864|FG003|Overall Study|Did not attend scheduled visit|0|||
25225231|NCT01426386|50503865|FG004|Overall Study|Did not attend scheduled visit|2|||
25225232|NCT01426386|50503866|FG005|Overall Study|Did not attend scheduled visit|1|||
25225233|NCT01426386|50503861|FG000|Overall Study|Poor response|2|||
25225234|NCT01426386|50503862|FG001|Overall Study|Poor response|1|||
25225235|NCT01426386|50503863|FG002|Overall Study|Poor response|2|||
25225236|NCT01426386|50503864|FG003|Overall Study|Poor response|0|||
25225237|NCT01426386|50503865|FG004|Overall Study|Poor response|1|||
25225238|NCT01426386|50503866|FG005|Overall Study|Poor response|0|||
25225239|NCT01426386|50503861|FG000|Overall Study|Personal reasons|0|||
25225240|NCT01426386|50503862|FG001|Overall Study|Personal reasons|0|||
25225241|NCT01426386|50503863|FG002|Overall Study|Personal reasons|0|||
25225242|NCT01426386|50503864|FG003|Overall Study|Personal reasons|0|||
25225243|NCT01426386|50503865|FG004|Overall Study|Personal reasons|1|||
25225244|NCT01426386|50503866|FG005|Overall Study|Personal reasons|0|||
25225245|NCT01404234|50503880|FG000|Overall Study|Withdrawal by Subject|2|||
25225246|NCT01403610|50503888|FG000|Overall Study|Withdrawal by Subject|2|||
25318417|NCT00802893|50634012|FG000|Overall Study|study terminated|3|||
25318418|NCT00608569|50634033|FG000|Overall Study|Death|4|||
25225247|NCT01403610|50503889|FG001|Overall Study|Withdrawal by Subject|0|||
25225248|NCT01403610|50503890|FG002|Overall Study|Withdrawal by Subject|0|||
25225249|NCT01403610|50503891|FG003|Overall Study|Withdrawal by Subject|0|||
25318419|NCT00608569|50634034|FG001|Overall Study|Death|3|||
25225250|NCT01403610|50503888|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
25225251|NCT01403610|50503889|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
25318420|NCT00608569|50634033|FG000|Overall Study|Lost to Follow-up|4|||
25225252|NCT01403610|50503890|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
25225253|NCT01403610|50503891|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
25225254|NCT01403064|50503905|FG000|Overall Study|Death|0|||
25225255|NCT01403064|50503906|FG001|Overall Study|Death|0|||
25225256|NCT01403064|50503907|FG002|Overall Study|Death|1|||
25225257|NCT01403064|50503908|FG003|Overall Study|Death|1|||
25225258|NCT01403064|50503905|FG000|Overall Study|Withdrawal by Subject|0|||
25225259|NCT01403064|50503906|FG001|Overall Study|Withdrawal by Subject|0|||
25225260|NCT01403064|50503907|FG002|Overall Study|Withdrawal by Subject|1|||
25225261|NCT01403064|50503908|FG003|Overall Study|Withdrawal by Subject|1|||
25225262|NCT01403064|50503905|FG000|Overall Study|Other|1|||
25318421|NCT00608569|50634034|FG001|Overall Study|Lost to Follow-up|5|||
25318422|NCT00608569|50634033|FG000|Overall Study|Withdrawal by Subject|1|||
25318423|NCT00608569|50634034|FG001|Overall Study|Withdrawal by Subject|0|||
25318424|NCT00608569|50634033|FG000|Overall Study|Adverse Event|1|||
25318425|NCT00608569|50634034|FG001|Overall Study|Adverse Event|0|||
25318426|NCT00608569|50634033|FG000|Overall Study|Unable to adhere with study requirements|0|||
25318427|NCT00608569|50634034|FG001|Overall Study|Unable to adhere with study requirements|1|||
25318428|NCT00610675|50634040|FG000|Overall Study|Untreated|4|||
25318429|NCT00610675|50634040|FG000|Overall Study|Adverse Event|67|||
25318430|NCT00610675|50634040|FG000|Overall Study|Insufficient Effect|31|||
25318431|NCT00610675|50634040|FG000|Overall Study|Withdrawal by Subject|28|||
25318432|NCT00610675|50634040|FG000|Overall Study|Reasons unrelated to trial|27|||
25318433|NCT00610675|50634040|FG000|Overall Study|Lack of Compliance|7|||
25318434|NCT00610675|50634040|FG000|Overall Study|Lost to Follow-up|31|||
25318435|NCT00610675|50634040|FG000|Overall Study|Other reason (not specified)|25|||
25318436|NCT00888134|50634044|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
25318437|NCT00888134|50634044|FG000|Follow-up|being followed for long-term survival|1|||
25318438|NCT00573157|50634051|FG000|Overall Study|Adverse Event|3|||
25318439|NCT00573157|50634052|FG001|Overall Study|Adverse Event|1|||
25318440|NCT00573157|50634051|FG000|Overall Study|Other|1|||
25318441|NCT00573157|50634052|FG001|Overall Study|Other|1|||
25318442|NCT00802737|50634061|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
25318443|NCT00802737|50634062|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
25318444|NCT00802737|50634063|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
25318445|NCT00802737|50634061|FG000|Overall Study|Death|6|||
25318446|NCT00802737|50634062|FG001|Overall Study|Death|5|||
25318447|NCT00802737|50634063|FG002|Overall Study|Death|1|||
25318448|NCT00802737|50634061|FG000|Overall Study|Adverse Event|1|||
25318449|NCT00802737|50634062|FG001|Overall Study|Adverse Event|0|||
25318450|NCT00802737|50634063|FG002|Overall Study|Adverse Event|0|||
25318451|NCT00802737|50634061|FG000|Overall Study|Received Prohibited Therapy|1|||
25318452|NCT00802737|50634062|FG001|Overall Study|Received Prohibited Therapy|0|||
25318453|NCT00802737|50634063|FG002|Overall Study|Received Prohibited Therapy|0|||
25318454|NCT00802737|50634061|FG000|Overall Study|Ongoing CLL-Treatment|0|||
25318455|NCT00802737|50634062|FG001|Overall Study|Ongoing CLL-Treatment|1|||
25318456|NCT00802737|50634063|FG002|Overall Study|Ongoing CLL-Treatment|0|||
25318457|NCT00802737|50634061|FG000|Overall Study|Participant too Unwell|0|||
25318458|NCT00802737|50634062|FG001|Overall Study|Participant too Unwell|2|||
25318459|NCT00802737|50634063|FG002|Overall Study|Participant too Unwell|0|||
25318460|NCT00588861|50634074|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
25318461|NCT00588861|50634075|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
25318462|NCT00588861|50634074|FG000|6 Months|Patients did not return for follow-up|98|||
25318463|NCT00588861|50634075|FG001|6 Months|Patients did not return for follow-up|73|||
25318464|NCT00588861|50634074|FG000|1 Year|Patients did not return for follow-up|89|||
25225263|NCT01403064|50503906|FG001|Overall Study|Other|0|||
25225264|NCT01403064|50503907|FG002|Overall Study|Other|2|||
25225265|NCT01403064|50503908|FG003|Overall Study|Other|1|||
25225266|NCT01402986|50503927|FG000|Overall Study|Withdrawal by Subject|7|||
25225267|NCT01402986|50503928|FG001|Overall Study|Withdrawal by Subject|10|||
25225268|NCT01402986|50503929|FG002|Overall Study|Withdrawal by Subject|7|||
25225269|NCT01402986|50503930|FG003|Overall Study|Withdrawal by Subject|13|||
25225270|NCT01402986|50503927|FG000|Overall Study|Death|0|||
25225271|NCT01402986|50503928|FG001|Overall Study|Death|0|||
25318465|NCT00588861|50634075|FG001|1 Year|Patients did not return for follow-up|82|||
25318466|NCT00588861|50634074|FG000|2 Years|Patients did not return for follow-up|92|||
25318467|NCT00588861|50634075|FG001|2 Years|Patients did not return for follow-up|87|||
25077460|NCT02243176|50185264|FG001|Overall Study|Withdrawal by Subject|7|||
25225272|NCT01402986|50503929|FG002|Overall Study|Death|0|||
25318468|NCT00588861|50634074|FG000|4 Years|Patients did not return for follow-up|91|||
25318469|NCT00588861|50634075|FG001|4 Years|Patients did not return for follow-up|103|||
25318470|NCT00588861|50634074|FG000|6 Years|Patients did not return for follow-up|104|||
25225273|NCT01402986|50503930|FG003|Overall Study|Death|2|||
25225274|NCT01402986|50503927|FG000|Overall Study|Lost to Follow-up|0|||
25225275|NCT01402986|50503928|FG001|Overall Study|Lost to Follow-up|0|||
25225276|NCT01402986|50503929|FG002|Overall Study|Lost to Follow-up|0|||
25318471|NCT00588861|50634075|FG001|6 Years|Patients did not return for follow-up|109|||
25318472|NCT00588861|50634074|FG000|8 Years|Patients did not return for follow-up|105|||
25318473|NCT00588861|50634075|FG001|8 Years|Patients did not return for follow-up|114|||
25318474|NCT00588861|50634074|FG000|10 Years|Incomplete due to study termination|107|||
25318475|NCT00588861|50634075|FG001|10 Years|Incomplete due to study termination|114|||
25318476|NCT00887978|50634083|FG000|Overall Study|Adverse Event|18|||
25318477|NCT00887978|50634084|FG001|Overall Study|Adverse Event|5|||
25318478|NCT00887978|50634083|FG000|Overall Study|Clinical Worsening|4|||
25225277|NCT01402986|50503930|FG003|Overall Study|Lost to Follow-up|1|||
25225278|NCT01402986|50503927|FG000|Overall Study|Other|2|||
25225279|NCT01402986|50503928|FG001|Overall Study|Other|5|||
25225280|NCT01402986|50503929|FG002|Overall Study|Other|1|||
25225281|NCT01402986|50503930|FG003|Overall Study|Other|6|||
25225282|NCT01402908|50503942|FG000|Overall Study|Withdrawal by Subject|30|||
25225283|NCT01402908|50503943|FG001|Overall Study|Withdrawal by Subject|17|||
25225284|NCT01402908|50503942|FG000|Overall Study|Lost to Follow-up|3|||
25225285|NCT01402908|50503943|FG001|Overall Study|Lost to Follow-up|1|||
25225286|NCT01402908|50503942|FG000|Overall Study|Physician Decision|1|||
25225287|NCT01402908|50503943|FG001|Overall Study|Physician Decision|0|||
25225288|NCT01389258|50503949|FG000|Overall Study|Lost to Follow-up|5|||
25225289|NCT01389102|50503959|FG000|Overall Study|Adverse Event|1|||
25318479|NCT00887978|50634084|FG001|Overall Study|Clinical Worsening|4|||
25318480|NCT00887978|50634083|FG000|Overall Study|Death|2|||
25318481|NCT00887978|50634084|FG001|Overall Study|Death|3|||
25318482|NCT00887978|50634083|FG000|Overall Study|Withdrawal by Subject|1|||
25318483|NCT00887978|50634084|FG001|Overall Study|Withdrawal by Subject|2|||
25318484|NCT00887978|50634083|FG000|Overall Study|Lost to Follow-up|0|||
25318485|NCT00887978|50634084|FG001|Overall Study|Lost to Follow-up|1|||
25318486|NCT00608023|50634093|FG000|Overall Study|Withdrawal by Subject|8|||
25318487|NCT00608023|50634094|FG001|Overall Study|Withdrawal by Subject|10|||
25318488|NCT00608023|50634095|FG002|Overall Study|Withdrawal by Subject|7|||
25318489|NCT00608023|50634093|FG000|Overall Study|Adverse Event|1|||
25318490|NCT00608023|50634094|FG001|Overall Study|Adverse Event|4|||
25318491|NCT00608023|50634095|FG002|Overall Study|Adverse Event|5|||
25318492|NCT00608023|50634093|FG000|Overall Study|Lost to Follow-up|2|||
25225290|NCT01389102|50503960|FG001|Overall Study|Adverse Event|3|||
25225291|NCT01389102|50503961|FG002|Overall Study|Adverse Event|2|||
25225292|NCT01389102|50503962|FG003|Overall Study|Adverse Event|2|||
25225293|NCT01389102|50503963|FG004|Overall Study|Adverse Event|2|||
25225294|NCT01389102|50503964|FG005|Overall Study|Adverse Event|2|||
25225295|NCT01389102|50503959|FG000|Overall Study|Hurricane Katrina|4|||
25318493|NCT00608023|50634094|FG001|Overall Study|Lost to Follow-up|2|||
25318494|NCT00608023|50634095|FG002|Overall Study|Lost to Follow-up|1|||
25318495|NCT00608023|50634093|FG000|Overall Study|Protocol Violation|1|||
25318496|NCT00608023|50634094|FG001|Overall Study|Protocol Violation|3|||
25318497|NCT00608023|50634095|FG002|Overall Study|Protocol Violation|1|||
25318498|NCT00608023|50634093|FG000|Overall Study|Unknown reason|0|||
25318499|NCT00608023|50634094|FG001|Overall Study|Unknown reason|3|||
25318500|NCT00608023|50634095|FG002|Overall Study|Unknown reason|0|||
25318501|NCT00802659|50634110|FG000|Overall Study|Physician Decision|0|||
25318502|NCT00802659|50634111|FG001|Overall Study|Physician Decision|1|||
25318503|NCT00802659|50634112|FG002|Overall Study|Physician Decision|0|||
24976551|NCT00097773|50065467|FG001|Overall Study|Lost to Follow-up|2|||
25225296|NCT01389102|50503960|FG001|Overall Study|Hurricane Katrina|2|||
25225297|NCT01389102|50503961|FG002|Overall Study|Hurricane Katrina|3|||
25225298|NCT01389102|50503962|FG003|Overall Study|Hurricane Katrina|0|||
25225299|NCT01389102|50503963|FG004|Overall Study|Hurricane Katrina|3|||
25225300|NCT01389102|50503964|FG005|Overall Study|Hurricane Katrina|1|||
25225301|NCT01389102|50503959|FG000|Overall Study|Lost to Follow-up|4|||
25225302|NCT01389102|50503960|FG001|Overall Study|Lost to Follow-up|1|||
25225303|NCT01389102|50503961|FG002|Overall Study|Lost to Follow-up|1|||
25225304|NCT01389102|50503962|FG003|Overall Study|Lost to Follow-up|2|||
25225305|NCT01389102|50503963|FG004|Overall Study|Lost to Follow-up|4|||
25225306|NCT01389102|50503964|FG005|Overall Study|Lost to Follow-up|1|||
25225307|NCT01389102|50503959|FG000|Overall Study|Protocol Violation|0|||
25225308|NCT01389102|50503960|FG001|Overall Study|Protocol Violation|0|||
25225309|NCT01389102|50503961|FG002|Overall Study|Protocol Violation|3|||
25225310|NCT01389102|50503962|FG003|Overall Study|Protocol Violation|0|||
25225311|NCT01389102|50503963|FG004|Overall Study|Protocol Violation|1|||
25225312|NCT01389102|50503964|FG005|Overall Study|Protocol Violation|1|||
25225313|NCT01389102|50503959|FG000|Overall Study|Withdrawal by Subject|7|||
25318504|NCT00802659|50634113|FG003|Overall Study|Physician Decision|0|||
25318505|NCT00607789|50634125|FG000|Overall Study|Adverse Event|3|||
25318506|NCT00607789|50634126|FG001|Overall Study|Adverse Event|0|||
25318507|NCT00607789|50634125|FG000|Overall Study|Lack of Efficacy|0|||
25318508|NCT00607789|50634126|FG001|Overall Study|Lack of Efficacy|1|||
25318509|NCT00607789|50634125|FG000|Overall Study|Inadequate adherence|3|||
25225314|NCT01389102|50503960|FG001|Overall Study|Withdrawal by Subject|4|||
25225315|NCT01389102|50503961|FG002|Overall Study|Withdrawal by Subject|9|||
25225316|NCT01389102|50503962|FG003|Overall Study|Withdrawal by Subject|2|||
25225317|NCT01389102|50503963|FG004|Overall Study|Withdrawal by Subject|3|||
25225318|NCT01389102|50503964|FG005|Overall Study|Withdrawal by Subject|3|||
25318510|NCT00607789|50634126|FG001|Overall Study|Inadequate adherence|0|||
25318511|NCT00607789|50634125|FG000|Overall Study|Lost to Follow-up|0|||
25225319|NCT01389102|50503959|FG000|Overall Study|Subject Traveling Out of Country|0|||
25225320|NCT01389102|50503960|FG001|Overall Study|Subject Traveling Out of Country|0|||
25225321|NCT01389102|50503961|FG002|Overall Study|Subject Traveling Out of Country|0|||
25225322|NCT01389102|50503962|FG003|Overall Study|Subject Traveling Out of Country|1|||
25225323|NCT01389102|50503963|FG004|Overall Study|Subject Traveling Out of Country|0|||
25225324|NCT01389102|50503964|FG005|Overall Study|Subject Traveling Out of Country|0|||
25225325|NCT01389102|50503959|FG000|Overall Study|Subject Moved|2|||
25225326|NCT01389102|50503960|FG001|Overall Study|Subject Moved|0|||
25225327|NCT01389102|50503961|FG002|Overall Study|Subject Moved|1|||
25225328|NCT01389102|50503962|FG003|Overall Study|Subject Moved|0|||
25225329|NCT01389102|50503963|FG004|Overall Study|Subject Moved|0|||
25225330|NCT01389102|50503964|FG005|Overall Study|Subject Moved|0|||
25225331|NCT01389102|50503959|FG000|Overall Study|Unavailable due to husband's illness|0|||
25225332|NCT01389102|50503960|FG001|Overall Study|Unavailable due to husband's illness|1|||
25225333|NCT01389102|50503961|FG002|Overall Study|Unavailable due to husband's illness|0|||
25225334|NCT01389102|50503962|FG003|Overall Study|Unavailable due to husband's illness|0|||
25225335|NCT01389102|50503963|FG004|Overall Study|Unavailable due to husband's illness|0|||
25225336|NCT01389102|50503964|FG005|Overall Study|Unavailable due to husband's illness|0|||
25225337|NCT01389102|50503959|FG000|Overall Study|Investigator Judgement|0|||
25225338|NCT01389102|50503960|FG001|Overall Study|Investigator Judgement|1|||
25225339|NCT01389102|50503961|FG002|Overall Study|Investigator Judgement|0|||
25225340|NCT01389102|50503962|FG003|Overall Study|Investigator Judgement|0|||
25225341|NCT01389102|50503963|FG004|Overall Study|Investigator Judgement|0|||
25318512|NCT00607789|50634126|FG001|Overall Study|Lost to Follow-up|5|||
25318513|NCT00607789|50634125|FG000|Overall Study|Withdrawal by Subject|1|||
25318514|NCT00607789|50634126|FG001|Overall Study|Withdrawal by Subject|0|||
25318515|NCT00887822|50634134|FG000|Overall Study|Insufficient therapeutic response|53|||
25225342|NCT01389102|50503964|FG005|Overall Study|Investigator Judgement|0|||
25225343|NCT01402284|50503984|FG000|Overall Study|Withdrawal consent|2|||
25225344|NCT01402284|50503984|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
25225345|NCT01402284|50503984|FG000|Overall Study|Physician Decision|1|||
25225346|NCT01402284|50503984|FG000|Overall Study|Disease progression on study|10|||
25225347|NCT01388790|50503988|FG000|Overall Study|Ongoing at data cut-off date|8|||
25318516|NCT00887822|50634135|FG001|Overall Study|Insufficient therapeutic response|55|||
25318517|NCT00887822|50634134|FG000|Overall Study|Adverse Event|14|||
25318518|NCT00887822|50634135|FG001|Overall Study|Adverse Event|17|||
25318519|NCT00887822|50634134|FG000|Overall Study|Failure to return|11|||
25318520|NCT00887822|50634135|FG001|Overall Study|Failure to return|11|||
25318521|NCT00887822|50634134|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
24976552|NCT00097773|50065468|FG002|Overall Study|Lost to Follow-up|0|||
24976553|NCT00097773|50065469|FG003|Overall Study|Lost to Follow-up|1|||
25077461|NCT02243176|50185263|FG000|Overall Study|Adverse Event|2|||
25225348|NCT01388478|50503992|FG000|Overall Study|Adverse Event|4|||
25225349|NCT01388478|50503992|FG000|Overall Study|Withdrawal by Subject|1|||
25225350|NCT01424670|50503998|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
25225351|NCT01424670|50503999|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
25225352|NCT01424670|50503998|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
25225353|NCT01424670|50503999|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
25225354|NCT01424670|50503998|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
25225355|NCT01424670|50503999|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
25225356|NCT01424670|50503998|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
25225357|NCT01424670|50503999|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
25225358|NCT01424670|50503998|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
25225359|NCT01424670|50503999|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
25225360|NCT01424670|50503998|FG000|Continuation Period|Adverse Event|13|||
25225361|NCT01424670|50503999|FG001|Continuation Period|Adverse Event|5|||
25225362|NCT01424670|50503998|FG000|Continuation Period|Lost to Follow-up|2|||
25225363|NCT01424670|50503999|FG001|Continuation Period|Lost to Follow-up|0|||
25225364|NCT01424670|50503998|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
25225365|NCT01424670|50503999|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
25225366|NCT01424670|50503998|FG000|Continuation Period|Physician Decision|5|||
25225367|NCT01424670|50503999|FG001|Continuation Period|Physician Decision|4|||
25225368|NCT01424670|50503998|FG000|Continuation Period|Withdrawal by Subject|13|||
25225369|NCT01424670|50503999|FG001|Continuation Period|Withdrawal by Subject|4|||
25225370|NCT01424514|50504007|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
25225371|NCT01424514|50504008|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
25225372|NCT01424514|50504007|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
25225373|NCT01424514|50504008|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
25318522|NCT00887822|50634135|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
25318523|NCT00887822|50634134|FG000|Overall Study|Administrative/Other than specified|5|||
25318524|NCT00887822|50634135|FG001|Overall Study|Administrative/Other than specified|4|||
24976554|NCT00097773|50065466|FG000|Overall Study|Physician Decision|2|||
25225374|NCT01423812|50504021|FG000|Overall Study|Lost to Follow-up|2|||
24976555|NCT00097773|50065467|FG001|Overall Study|Physician Decision|2|||
25225375|NCT01423812|50504022|FG001|Overall Study|Lost to Follow-up|2|||
25225376|NCT01423812|50504021|FG000|Overall Study|Withdrawal by Subject|1|||
25225377|NCT01423812|50504022|FG001|Overall Study|Withdrawal by Subject|2|||
25225378|NCT01400958|50504032|FG000|Overall Study|Physician Decision|0|||
25225379|NCT01400958|50504033|FG001|Overall Study|Physician Decision|1|||
25225380|NCT01400958|50504032|FG000|Overall Study|Withdrawal by Subject|0|||
25225381|NCT01400958|50504033|FG001|Overall Study|Withdrawal by Subject|1|||
25225382|NCT01400958|50504032|FG000|Overall Study|Adverse Event|1|||
25225383|NCT01400958|50504033|FG001|Overall Study|Adverse Event|0|||
25225384|NCT01388166|50504039|FG000|Overall Study|Adverse Event|16|||
25225385|NCT01388166|50504039|FG000|Overall Study|Lost to Follow-up|30|||
25225386|NCT01388166|50504039|FG000|Overall Study|Others than specified above|13|||
25225387|NCT01400412|50504045|FG000|Overall Study|Lost to Follow-up|4|||
25225388|NCT01400412|50504046|FG001|Overall Study|Lost to Follow-up|7|||
25225389|NCT01400412|50504045|FG000|Overall Study|Withdrawal by Subject|3|||
25225390|NCT01400412|50504046|FG001|Overall Study|Withdrawal by Subject|4|||
25225391|NCT01400412|50504045|FG000|Overall Study|Unable to complete|3|||
25225392|NCT01400412|50504046|FG001|Overall Study|Unable to complete|3|||
25225393|NCT01400412|50504045|FG000|Overall Study|Never started study treatment|0|||
25225394|NCT01400412|50504046|FG001|Overall Study|Never started study treatment|3|||
25225395|NCT01422876|50504064|FG000|Week 24|Lost to Follow-up|1|||
25225396|NCT01422876|50504065|FG001|Week 24|Lost to Follow-up|1|||
25225397|NCT01422876|50504066|FG002|Week 24|Lost to Follow-up|2|||
25225398|NCT01422876|50504067|FG003|Week 24|Lost to Follow-up|4|||
25225399|NCT01422876|50504068|FG004|Week 24|Lost to Follow-up|2|||
25225400|NCT01422876|50504069|FG005|Week 24|Lost to Follow-up|0|||
25225401|NCT01422876|50504070|FG006|Week 24|Lost to Follow-up|1|||
25225402|NCT01422876|50504071|FG007|Week 24|Lost to Follow-up|3|||
25225403|NCT01422876|50504072|FG008|Week 24|Lost to Follow-up|3|||
25225404|NCT01422876|50504073|FG009|Week 24|Lost to Follow-up|4|||
25225405|NCT01422876|50504064|FG000|Week 24|Consent withdrawn|5|||
25225406|NCT01422876|50504065|FG001|Week 24|Consent withdrawn|1|||
25225407|NCT01422876|50504066|FG002|Week 24|Consent withdrawn|3|||
25225408|NCT01422876|50504067|FG003|Week 24|Consent withdrawn|4|||
25225409|NCT01422876|50504068|FG004|Week 24|Consent withdrawn|5|||
25225410|NCT01422876|50504069|FG005|Week 24|Consent withdrawn|6|||
25225411|NCT01422876|50504070|FG006|Week 24|Consent withdrawn|5|||
25225412|NCT01422876|50504071|FG007|Week 24|Consent withdrawn|4|||
25225413|NCT01422876|50504072|FG008|Week 24|Consent withdrawn|3|||
25225414|NCT01422876|50504073|FG009|Week 24|Consent withdrawn|6|||
25225415|NCT01422876|50504064|FG000|Week 24|Death|0|||
25225416|NCT01422876|50504065|FG001|Week 24|Death|1|||
25225417|NCT01422876|50504066|FG002|Week 24|Death|0|||
25225418|NCT01422876|50504067|FG003|Week 24|Death|0|||
25225419|NCT01422876|50504068|FG004|Week 24|Death|0|||
25225420|NCT01422876|50504069|FG005|Week 24|Death|0|||
25225421|NCT01422876|50504070|FG006|Week 24|Death|0|||
25225422|NCT01422876|50504071|FG007|Week 24|Death|0|||
25225423|NCT01422876|50504072|FG008|Week 24|Death|0|||
25225424|NCT01422876|50504073|FG009|Week 24|Death|0|||
25225425|NCT01422876|50504064|FG000|Week 52|Lost to Follow-up|3|||
25225426|NCT01422876|50504065|FG001|Week 52|Lost to Follow-up|5|||
25225427|NCT01422876|50504066|FG002|Week 52|Lost to Follow-up|7|||
25225428|NCT01422876|50504067|FG003|Week 52|Lost to Follow-up|5|||
25225429|NCT01422876|50504068|FG004|Week 52|Lost to Follow-up|8|||
25225430|NCT01422876|50504069|FG005|Week 52|Lost to Follow-up|5|||
25225431|NCT01422876|50504070|FG006|Week 52|Lost to Follow-up|5|||
25225432|NCT01422876|50504071|FG007|Week 52|Lost to Follow-up|8|||
25225433|NCT01422876|50504072|FG008|Week 52|Lost to Follow-up|7|||
25225434|NCT01422876|50504073|FG009|Week 52|Lost to Follow-up|8|||
25225435|NCT01422876|50504064|FG000|Week 52|Consent withdrawn|9|||
25225436|NCT01422876|50504065|FG001|Week 52|Consent withdrawn|4|||
25225437|NCT01422876|50504066|FG002|Week 52|Consent withdrawn|6|||
25225438|NCT01422876|50504067|FG003|Week 52|Consent withdrawn|12|||
25225439|NCT01422876|50504068|FG004|Week 52|Consent withdrawn|7|||
25225440|NCT01422876|50504069|FG005|Week 52|Consent withdrawn|12|||
25225441|NCT01422876|50504070|FG006|Week 52|Consent withdrawn|10|||
25225442|NCT01422876|50504071|FG007|Week 52|Consent withdrawn|12|||
25225443|NCT01422876|50504072|FG008|Week 52|Consent withdrawn|13|||
24976556|NCT00097773|50065468|FG002|Overall Study|Physician Decision|3|||
24976557|NCT00097773|50065469|FG003|Overall Study|Physician Decision|1|||
25225444|NCT01422876|50504073|FG009|Week 52|Consent withdrawn|9|||
25225445|NCT01422876|50504064|FG000|Week 52|Death|0|||
25225446|NCT01422876|50504065|FG001|Week 52|Death|1|||
25225447|NCT01422876|50504066|FG002|Week 52|Death|0|||
25225448|NCT01422876|50504067|FG003|Week 52|Death|1|||
24976558|NCT00097773|50065466|FG000|Overall Study|Withdrawal by Subject|3|||
25225449|NCT01422876|50504068|FG004|Week 52|Death|0|||
25225450|NCT01422876|50504069|FG005|Week 52|Death|0|||
25225451|NCT01422876|50504070|FG006|Week 52|Death|1|||
25225452|NCT01422876|50504071|FG007|Week 52|Death|3|||
25225453|NCT01422876|50504072|FG008|Week 52|Death|1|||
25225454|NCT01422876|50504073|FG009|Week 52|Death|0|||
25225455|NCT01422720|50504091|FG000|Overall Study|Adverse Event|16|||
25225456|NCT01422720|50504091|FG000|Overall Study|Lack of Efficacy|1|||
25225457|NCT01422720|50504091|FG000|Overall Study|Withdrawal by Subject|4|||
25225458|NCT01422720|50504091|FG000|Overall Study|Ineligibility|1|||
25225459|NCT01387932|50504101|FG000|Randomized and Treated|Physician Decision|3|||
25225460|NCT01387932|50504102|FG001|Randomized and Treated|Physician Decision|2|||
25225461|NCT01387932|50504101|FG000|Randomized and Treated|Withdrawal by Subject|4|||
25225462|NCT01387932|50504102|FG001|Randomized and Treated|Withdrawal by Subject|2|||
25225463|NCT01387932|50504101|FG000|Survival Follow-up|Liver Transplant|24|||
25225464|NCT01387932|50504102|FG001|Survival Follow-up|Liver Transplant|28|||
25225465|NCT01387932|50504101|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
25225466|NCT01387932|50504102|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
25225467|NCT01387932|50504101|FG000|Survival Follow-up|Withdrawal by Subject|2|||
25225468|NCT01387932|50504102|FG001|Survival Follow-up|Withdrawal by Subject|4|||
25225469|NCT01387932|50504101|FG000|Survival Follow-up|Lost to Follow-up|6|||
25225470|NCT01387932|50504102|FG001|Survival Follow-up|Lost to Follow-up|5|||
25225471|NCT01422408|50504110|FG000|Overall Study|Adverse Event|1|||
25225472|NCT01422408|50504110|FG000|Overall Study|Withdrawal by Subject|3|||
25225473|NCT01399788|50504114|FG000|First Intervention Period|Adverse Event|1|||
25225474|NCT01399788|50504115|FG001|First Intervention Period|Adverse Event|0|||
25225475|NCT01387542|50504121|FG000|Overall Study|Adverse Event|3|||
25225476|NCT01387542|50504121|FG000|Overall Study|Withdrawal by Subject|1|||
25225477|NCT01387542|50504121|FG000|Overall Study|Changed diagnosis|1|||
25225478|NCT01387542|50504121|FG000|Overall Study|Insufficient response|1|||
25225479|NCT01387542|50504121|FG000|Overall Study|Non-compliant|1|||
25225480|NCT01387542|50504121|FG000|Overall Study|Lost to Follow-up|1|||
25225481|NCT01387230|50504128|FG000|Overall Study|Adverse Event|0|||
25225482|NCT01387230|50504129|FG001|Overall Study|Adverse Event|1|||
25225483|NCT01387230|50504130|FG002|Overall Study|Adverse Event|3|||
25225484|NCT01387230|50504128|FG000|Overall Study|Lack of Efficacy|8|||
25225485|NCT01387230|50504129|FG001|Overall Study|Lack of Efficacy|5|||
25225486|NCT01387230|50504130|FG002|Overall Study|Lack of Efficacy|4|||
25225487|NCT01387230|50504128|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
25225488|NCT01387230|50504129|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
25225489|NCT01387230|50504130|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
25225490|NCT01387230|50504128|FG000|Overall Study|Lost to Follow-up|0|||
25225491|NCT01387230|50504129|FG001|Overall Study|Lost to Follow-up|0|||
25225492|NCT01387230|50504130|FG002|Overall Study|Lost to Follow-up|1|||
25225493|NCT01387230|50504128|FG000|Overall Study|Withdrawal by Subject|4|||
25225494|NCT01387230|50504129|FG001|Overall Study|Withdrawal by Subject|1|||
25225495|NCT01387230|50504130|FG002|Overall Study|Withdrawal by Subject|0|||
25225496|NCT01387074|50504138|FG000|Overall Study|Lost to Follow-up|7|||
24976559|NCT00097773|50065467|FG001|Overall Study|Withdrawal by Subject|3|||
25318525|NCT00887822|50634134|FG000|Overall Study|Death|2|||
25318526|NCT00887822|50634135|FG001|Overall Study|Death|3|||
25318527|NCT00887822|50634134|FG000|Overall Study|Protocol Violation|0|||
25318528|NCT00887822|50634135|FG001|Overall Study|Protocol Violation|1|||
25318529|NCT00887822|50634134|FG000|Overall Study|Randomized but not treated|0|||
25318530|NCT00887822|50634135|FG001|Overall Study|Randomized but not treated|1|||
25318531|NCT00951665|50634147|FG000|Phase 1b|Adverse Event|2|||
25318532|NCT00951665|50634148|FG001|Phase 1b|Adverse Event|1|||
25318533|NCT00951665|50634149|FG002|Phase 1b|Adverse Event|0|||
25318534|NCT00951665|50634150|FG003|Phase 1b|Adverse Event|1|||
25318535|NCT00951665|50634151|FG004|Phase 1b|Adverse Event|0|||
25318536|NCT00951665|50634152|FG005|Phase 1b|Adverse Event|0|||
25318537|NCT00951665|50634147|FG000|Phase 1b|Death|1|||
24976560|NCT00097773|50065468|FG002|Overall Study|Withdrawal by Subject|3|||
24976561|NCT00097773|50065469|FG003|Overall Study|Withdrawal by Subject|1|||
24976562|NCT00097773|50065466|FG000|Overall Study|Adverse Event|0|||
25225497|NCT01387074|50504138|FG000|Overall Study|Lack of Efficacy|1|||
25225498|NCT01386606|50504146|FG000|Overall Study|Adverse Event|0|||
25225499|NCT01386606|50504147|FG001|Overall Study|Adverse Event|1|||
25225500|NCT01386606|50504148|FG002|Overall Study|Adverse Event|0|||
25225501|NCT01386606|50504149|FG003|Overall Study|Adverse Event|0|||
25225502|NCT01386606|50504146|FG000|Overall Study|Withdrawal by Subject|0|||
25077462|NCT02243176|50185264|FG001|Overall Study|Adverse Event|2|||
25225503|NCT01386606|50504147|FG001|Overall Study|Withdrawal by Subject|1|||
25225504|NCT01386606|50504148|FG002|Overall Study|Withdrawal by Subject|1|||
25077463|NCT00002663|50185275|FG000|Overall Study|Death|4|||
25225505|NCT01386606|50504149|FG003|Overall Study|Withdrawal by Subject|0|||
25225506|NCT01386606|50504146|FG000|Overall Study|Protocol Violation|1|||
25225507|NCT01386606|50504147|FG001|Overall Study|Protocol Violation|0|||
25225508|NCT01386606|50504148|FG002|Overall Study|Protocol Violation|1|||
25225509|NCT01386606|50504149|FG003|Overall Study|Protocol Violation|1|||
25318538|NCT00951665|50634148|FG001|Phase 1b|Death|0|||
25318539|NCT00951665|50634149|FG002|Phase 1b|Death|2|||
25318540|NCT00951665|50634150|FG003|Phase 1b|Death|0|||
25318541|NCT00951665|50634151|FG004|Phase 1b|Death|0|||
25318542|NCT00951665|50634152|FG005|Phase 1b|Death|0|||
24976563|NCT00097773|50065467|FG001|Overall Study|Adverse Event|1|||
25077464|NCT00002663|50185276|FG001|Overall Study|Death|1|||
25318543|NCT00951665|50634147|FG000|Phase 1b|Physician Decision|4|||
25318544|NCT00951665|50634148|FG001|Phase 1b|Physician Decision|0|||
25318545|NCT00951665|50634149|FG002|Phase 1b|Physician Decision|1|||
25318546|NCT00951665|50634150|FG003|Phase 1b|Physician Decision|0|||
25318547|NCT00951665|50634151|FG004|Phase 1b|Physician Decision|0|||
25318548|NCT00951665|50634152|FG005|Phase 1b|Physician Decision|0|||
25318549|NCT00951665|50634147|FG000|Phase 1b|Withdrawal by Subject|0|||
25318550|NCT00951665|50634148|FG001|Phase 1b|Withdrawal by Subject|1|||
25318551|NCT00951665|50634149|FG002|Phase 1b|Withdrawal by Subject|0|||
25318552|NCT00951665|50634150|FG003|Phase 1b|Withdrawal by Subject|0|||
25318553|NCT00951665|50634151|FG004|Phase 1b|Withdrawal by Subject|0|||
25318554|NCT00951665|50634152|FG005|Phase 1b|Withdrawal by Subject|0|||
25318555|NCT00951665|50634147|FG000|Phase 1b|Disease Progression|13|||
25318556|NCT00951665|50634148|FG001|Phase 1b|Disease Progression|2|||
25318557|NCT00951665|50634149|FG002|Phase 1b|Disease Progression|14|||
25318558|NCT00951665|50634150|FG003|Phase 1b|Disease Progression|0|||
25318559|NCT00951665|50634151|FG004|Phase 1b|Disease Progression|0|||
25318560|NCT00951665|50634152|FG005|Phase 1b|Disease Progression|0|||
25318561|NCT00951665|50634147|FG000|Phase 1b|Protocol Violation|2|||
25318562|NCT00951665|50634148|FG001|Phase 1b|Protocol Violation|0|||
25318563|NCT00951665|50634149|FG002|Phase 1b|Protocol Violation|0|||
25318564|NCT00951665|50634150|FG003|Phase 1b|Protocol Violation|0|||
25318565|NCT00951665|50634151|FG004|Phase 1b|Protocol Violation|0|||
25318566|NCT00951665|50634152|FG005|Phase 1b|Protocol Violation|0|||
25318567|NCT00951665|50634147|FG000|Phase 2a|Adverse Event|0|||
25318568|NCT00951665|50634148|FG001|Phase 2a|Adverse Event|0|||
25318569|NCT00951665|50634149|FG002|Phase 2a|Adverse Event|0|||
25318570|NCT00951665|50634150|FG003|Phase 2a|Adverse Event|0|||
25318571|NCT00951665|50634151|FG004|Phase 2a|Adverse Event|2|||
25318572|NCT00951665|50634152|FG005|Phase 2a|Adverse Event|0|||
25318573|NCT00951665|50634147|FG000|Phase 2a|Death|0|||
25318574|NCT00951665|50634148|FG001|Phase 2a|Death|0|||
25318575|NCT00951665|50634149|FG002|Phase 2a|Death|0|||
25318576|NCT00951665|50634150|FG003|Phase 2a|Death|0|||
25318577|NCT00951665|50634151|FG004|Phase 2a|Death|1|||
25318578|NCT00951665|50634152|FG005|Phase 2a|Death|1|||
25318579|NCT00951665|50634147|FG000|Phase 2a|Lost to Follow-up|0|||
25318580|NCT00951665|50634148|FG001|Phase 2a|Lost to Follow-up|0|||
25318581|NCT00951665|50634149|FG002|Phase 2a|Lost to Follow-up|0|||
25318582|NCT00951665|50634150|FG003|Phase 2a|Lost to Follow-up|0|||
25318583|NCT00951665|50634151|FG004|Phase 2a|Lost to Follow-up|1|||
25318584|NCT00951665|50634152|FG005|Phase 2a|Lost to Follow-up|0|||
25318585|NCT00951665|50634147|FG000|Phase 2a|Physician Decision|0|||
25318586|NCT00951665|50634148|FG001|Phase 2a|Physician Decision|0|||
25318587|NCT00951665|50634149|FG002|Phase 2a|Physician Decision|0|||
25318588|NCT00951665|50634150|FG003|Phase 2a|Physician Decision|0|||
25318589|NCT00951665|50634151|FG004|Phase 2a|Physician Decision|0|||
25318590|NCT00951665|50634152|FG005|Phase 2a|Physician Decision|1|||
25318591|NCT00951665|50634147|FG000|Phase 2a|Withdrawal by Subject|0|||
25318592|NCT00951665|50634148|FG001|Phase 2a|Withdrawal by Subject|0|||
25318593|NCT00951665|50634149|FG002|Phase 2a|Withdrawal by Subject|0|||
25318594|NCT00951665|50634150|FG003|Phase 2a|Withdrawal by Subject|0|||
25318595|NCT00951665|50634151|FG004|Phase 2a|Withdrawal by Subject|2|||
25318596|NCT00951665|50634152|FG005|Phase 2a|Withdrawal by Subject|0|||
25318597|NCT00951665|50634147|FG000|Phase 2a|Disease Progression|0|||
25318598|NCT00951665|50634148|FG001|Phase 2a|Disease Progression|0|||
25318599|NCT00951665|50634149|FG002|Phase 2a|Disease Progression|0|||
25318600|NCT00951665|50634150|FG003|Phase 2a|Disease Progression|0|||
25318601|NCT00951665|50634151|FG004|Phase 2a|Disease Progression|6|||
25318602|NCT00951665|50634152|FG005|Phase 2a|Disease Progression|5|||
25318603|NCT00801099|50634186|FG000|Overall Study|Lost to Follow-up|101|||
25318604|NCT00887744|50634190|FG000|Overall Study|Adverse Event|3|||
25318605|NCT00887744|50634190|FG000|Overall Study|Death|1|||
25318606|NCT00887744|50634190|FG000|Overall Study|Lost to Follow-up|3|||
25318607|NCT00887744|50634190|FG000|Overall Study|Withdrawal by Subject|18|||
25318608|NCT00887744|50634190|FG000|Overall Study|Various reasons|9|||
25318609|NCT00951509|50634194|FG000|Overall Study|Withdrawal by Subject|2|||
25318610|NCT00610441|50634206|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
25318611|NCT00610441|50634207|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
25318612|NCT00610441|50634208|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
25318613|NCT00610441|50634209|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
25318614|NCT00610441|50634206|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
25318615|NCT00610441|50634207|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
25318616|NCT00610441|50634208|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
25318617|NCT00610441|50634209|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
25318618|NCT00610441|50634206|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
25318619|NCT00610441|50634207|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
25318620|NCT00610441|50634208|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
25318621|NCT00610441|50634209|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
25318622|NCT00610441|50634206|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
25318623|NCT00610441|50634207|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
25318624|NCT00610441|50634208|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
25318625|NCT00610441|50634209|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
25318626|NCT00610441|50634206|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
25318627|NCT00610441|50634207|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
25318628|NCT00610441|50634208|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
25318629|NCT00610441|50634209|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
25318630|NCT00610441|50634206|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
25318631|NCT00610441|50634207|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
25318632|NCT00610441|50634208|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
25318633|NCT00610441|50634209|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
25318634|NCT00610441|50634206|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
25318635|NCT00610441|50634207|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
25318636|NCT00610441|50634208|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
25318637|NCT00610441|50634209|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
25318638|NCT00610441|50634206|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
25225510|NCT01386606|50504146|FG000|Overall Study|Lost to Follow-up|2|||
25225511|NCT01386606|50504147|FG001|Overall Study|Lost to Follow-up|0|||
25225512|NCT01386606|50504148|FG002|Overall Study|Lost to Follow-up|0|||
25225513|NCT01386606|50504149|FG003|Overall Study|Lost to Follow-up|0|||
25225514|NCT01386606|50504146|FG000|Overall Study|Subject incarcerated|0|||
25225515|NCT01386606|50504147|FG001|Overall Study|Subject incarcerated|1|||
25225516|NCT01386606|50504148|FG002|Overall Study|Subject incarcerated|0|||
25225517|NCT01386606|50504149|FG003|Overall Study|Subject incarcerated|0|||
25225518|NCT01386606|50504146|FG000|Overall Study|Unable to draw PK|1|||
25225519|NCT01386606|50504147|FG001|Overall Study|Unable to draw PK|0|||
25225520|NCT01386606|50504148|FG002|Overall Study|Unable to draw PK|0|||
25225521|NCT01386606|50504149|FG003|Overall Study|Unable to draw PK|0|||
25225522|NCT01386606|50504146|FG000|Overall Study|T levels too high|0|||
25225523|NCT01386606|50504147|FG001|Overall Study|T levels too high|1|||
25225524|NCT01386606|50504148|FG002|Overall Study|T levels too high|1|||
25225525|NCT01386606|50504149|FG003|Overall Study|T levels too high|0|||
25225526|NCT01385748|50504166|FG000|Overall Study|Withdrawal by Subject|7|||
25225527|NCT01385748|50504167|FG001|Overall Study|Withdrawal by Subject|4|||
25225528|NCT01385748|50504168|FG002|Overall Study|Withdrawal by Subject|5|||
25225529|NCT01385748|50504166|FG000|Overall Study|Noncompliance|3|||
25225530|NCT01385748|50504167|FG001|Overall Study|Noncompliance|1|||
25225531|NCT01385748|50504168|FG002|Overall Study|Noncompliance|6|||
25225532|NCT01385748|50504166|FG000|Overall Study|Other|1|||
25225533|NCT01385748|50504167|FG001|Overall Study|Other|7|||
25225534|NCT01385748|50504168|FG002|Overall Study|Other|1|||
25225535|NCT01385748|50504166|FG000|Overall Study|Adverse Event|4|||
25225536|NCT01385748|50504167|FG001|Overall Study|Adverse Event|2|||
25225537|NCT01385748|50504168|FG002|Overall Study|Adverse Event|1|||
25225538|NCT01397448|50504183|FG000|Overall Study|Adverse Event|4|||
25225539|NCT01397448|50504184|FG001|Overall Study|Adverse Event|4|||
25225540|NCT01397448|50504185|FG002|Overall Study|Adverse Event|6|||
25225541|NCT01397448|50504183|FG000|Overall Study|Withdrawal by Subject|4|||
25225542|NCT01397448|50504184|FG001|Overall Study|Withdrawal by Subject|4|||
25225543|NCT01397448|50504185|FG002|Overall Study|Withdrawal by Subject|3|||
25225544|NCT01397448|50504183|FG000|Overall Study|Lack of Efficacy|2|||
25225545|NCT01397448|50504184|FG001|Overall Study|Lack of Efficacy|0|||
25225546|NCT01397448|50504185|FG002|Overall Study|Lack of Efficacy|5|||
25225547|NCT01397448|50504183|FG000|Overall Study|Other|8|||
25225548|NCT01397448|50504184|FG001|Overall Study|Other|7|||
25225549|NCT01397448|50504185|FG002|Overall Study|Other|4|||
25225550|NCT01385202|50504193|FG000|Overall Study|Lost to Follow-up|6|||
25318639|NCT00610441|50634207|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
25318640|NCT00610441|50634208|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
25318641|NCT00610441|50634209|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
25225551|NCT01385202|50504193|FG000|Overall Study|Not Eligible|11|||
25225552|NCT01385202|50504193|FG000|Overall Study|Withdrawn|1|||
25225553|NCT01384734|50504204|FG000|Overall Study|Adverse Event|0|||
25318642|NCT00610441|50634206|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
25318643|NCT00610441|50634207|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
25318644|NCT00610441|50634208|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
25318645|NCT00610441|50634209|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
25318646|NCT00799617|50634223|FG000|Main Testosterone Trial|Randomized in error|1|||
25318647|NCT00799617|50634224|FG001|Main Testosterone Trial|Randomized in error|1|||
25318648|NCT00799617|50634223|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
25318649|NCT00799617|50634224|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
25318650|NCT00799617|50634223|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
25318651|NCT00799617|50634224|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
25318652|NCT00799617|50634223|FG000|Sexual Funtion Trial|No Baseline Data|4|||
25318653|NCT00799617|50634224|FG001|Sexual Funtion Trial|No Baseline Data|7|||
25318654|NCT00799617|50634223|FG000|Physical Function Trial|Lost to Follow-up|6|||
25318655|NCT00799617|50634224|FG001|Physical Function Trial|Lost to Follow-up|11|||
25318656|NCT00799617|50634223|FG000|Vitality Trial|Lost to Follow-up|7|||
25318657|NCT00799617|50634224|FG001|Vitality Trial|Lost to Follow-up|22|||
25318658|NCT00799617|50634223|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
25318659|NCT00799617|50634224|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
25318660|NCT00799617|50634223|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
25318661|NCT00799617|50634224|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
25318662|NCT00799617|50634223|FG000|Bone Trial|Month 12 scan not available|6|||
25318663|NCT00799617|50634224|FG001|Bone Trial|Month 12 scan not available|16|||
25318664|NCT00799617|50634223|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
25318665|NCT00799617|50634224|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
25318666|NCT00799617|50634223|FG000|Anemia Trial|Withdrawal by Subject|3|||
25318667|NCT00799617|50634224|FG001|Anemia Trial|Withdrawal by Subject|3|||
25318668|NCT00607087|50634233|FG000|Overall Study|Withdrawal by Subject|9|||
25318669|NCT00607087|50634234|FG001|Overall Study|Withdrawal by Subject|4|||
25318670|NCT00607087|50634235|FG002|Overall Study|Withdrawal by Subject|4|||
25318671|NCT00607087|50634233|FG000|Overall Study|Adverse Event|3|||
25318672|NCT00607087|50634234|FG001|Overall Study|Adverse Event|2|||
25318673|NCT00607087|50634235|FG002|Overall Study|Adverse Event|3|||
25318674|NCT00607087|50634233|FG000|Overall Study|Other reason|1|||
25318675|NCT00607087|50634234|FG001|Overall Study|Other reason|5|||
25318676|NCT00607087|50634235|FG002|Overall Study|Other reason|2|||
25225554|NCT01384734|50504205|FG001|Overall Study|Adverse Event|3|||
25225555|NCT01384734|50504206|FG002|Overall Study|Adverse Event|0|||
25225556|NCT01384734|50504207|FG003|Overall Study|Adverse Event|2|||
25225557|NCT01384734|50504208|FG004|Overall Study|Adverse Event|7|||
25225558|NCT01384734|50504204|FG000|Overall Study|Death|1|||
25225559|NCT01384734|50504205|FG001|Overall Study|Death|0|||
25225560|NCT01384734|50504206|FG002|Overall Study|Death|1|||
25225561|NCT01384734|50504207|FG003|Overall Study|Death|0|||
25225562|NCT01384734|50504208|FG004|Overall Study|Death|0|||
25225563|NCT01384734|50504204|FG000|Overall Study|Continuation criteria not met|0|||
25225564|NCT01384734|50504205|FG001|Overall Study|Continuation criteria not met|0|||
25225565|NCT01384734|50504206|FG002|Overall Study|Continuation criteria not met|1|||
25225566|NCT01384734|50504207|FG003|Overall Study|Continuation criteria not met|1|||
25225567|NCT01384734|50504208|FG004|Overall Study|Continuation criteria not met|0|||
25225568|NCT01384734|50504204|FG000|Overall Study|Lack of Efficacy|3|||
25225569|NCT01384734|50504205|FG001|Overall Study|Lack of Efficacy|7|||
25225570|NCT01384734|50504206|FG002|Overall Study|Lack of Efficacy|4|||
25225571|NCT01384734|50504207|FG003|Overall Study|Lack of Efficacy|4|||
25225572|NCT01384734|50504208|FG004|Overall Study|Lack of Efficacy|2|||
25225573|NCT01384734|50504204|FG000|Overall Study|Lost to Follow-up|5|||
25225574|NCT01384734|50504205|FG001|Overall Study|Lost to Follow-up|3|||
25318677|NCT00607087|50634233|FG000|Overall Study|Poor compliance to protocol|1|||
25318678|NCT00607087|50634234|FG001|Overall Study|Poor compliance to protocol|0|||
25318679|NCT00607087|50634235|FG002|Overall Study|Poor compliance to protocol|1|||
25318680|NCT00607087|50634233|FG000|Overall Study|Lost to Follow-up|1|||
25225575|NCT01384734|50504206|FG002|Overall Study|Lost to Follow-up|3|||
25225576|NCT01384734|50504207|FG003|Overall Study|Lost to Follow-up|8|||
25225577|NCT01384734|50504208|FG004|Overall Study|Lost to Follow-up|5|||
25225578|NCT01384734|50504204|FG000|Overall Study|Non-compliance with study drug|1|||
25225579|NCT01384734|50504205|FG001|Overall Study|Non-compliance with study drug|2|||
25225580|NCT01384734|50504206|FG002|Overall Study|Non-compliance with study drug|6|||
25225581|NCT01384734|50504207|FG003|Overall Study|Non-compliance with study drug|0|||
25225582|NCT01384734|50504208|FG004|Overall Study|Non-compliance with study drug|2|||
25225583|NCT01384734|50504204|FG000|Overall Study|Pregnancy|0|||
25225584|NCT01384734|50504205|FG001|Overall Study|Pregnancy|1|||
25318681|NCT00607087|50634234|FG001|Overall Study|Lost to Follow-up|0|||
25318682|NCT00607087|50634235|FG002|Overall Study|Lost to Follow-up|0|||
25318683|NCT00607087|50634233|FG000|Period 1|Withdrawal by Subject|7|||
25318684|NCT00607087|50634234|FG001|Period 1|Withdrawal by Subject|2|||
25225585|NCT01384734|50504206|FG002|Overall Study|Pregnancy|0|||
25225586|NCT01384734|50504207|FG003|Overall Study|Pregnancy|0|||
25318685|NCT00607087|50634235|FG002|Period 1|Withdrawal by Subject|3|||
25225587|NCT01384734|50504208|FG004|Overall Study|Pregnancy|1|||
25225588|NCT01384734|50504204|FG000|Overall Study|Sponsor terminated|0|||
25225589|NCT01384734|50504205|FG001|Overall Study|Sponsor terminated|0|||
25225590|NCT01384734|50504206|FG002|Overall Study|Sponsor terminated|0|||
25225591|NCT01384734|50504207|FG003|Overall Study|Sponsor terminated|0|||
25225592|NCT01384734|50504208|FG004|Overall Study|Sponsor terminated|1|||
25225593|NCT01384734|50504204|FG000|Overall Study|Withdrawal by Subject|5|||
25225594|NCT01384734|50504205|FG001|Overall Study|Withdrawal by Subject|5|||
25225595|NCT01384734|50504206|FG002|Overall Study|Withdrawal by Subject|6|||
25225596|NCT01384734|50504207|FG003|Overall Study|Withdrawal by Subject|7|||
25225597|NCT01384734|50504208|FG004|Overall Study|Withdrawal by Subject|9|||
25225598|NCT01384734|50504204|FG000|Overall Study|Investigator relocating|0|||
25225599|NCT01384734|50504205|FG001|Overall Study|Investigator relocating|2|||
25225600|NCT01384734|50504206|FG002|Overall Study|Investigator relocating|0|||
25225601|NCT01384734|50504207|FG003|Overall Study|Investigator relocating|3|||
25225602|NCT01384734|50504208|FG004|Overall Study|Investigator relocating|1|||
25225603|NCT01384734|50504204|FG000|Overall Study|Unable to come back for visit|1|||
25225604|NCT01384734|50504205|FG001|Overall Study|Unable to come back for visit|0|||
25225605|NCT01384734|50504206|FG002|Overall Study|Unable to come back for visit|1|||
25225606|NCT01384734|50504207|FG003|Overall Study|Unable to come back for visit|1|||
25225607|NCT01384734|50504208|FG004|Overall Study|Unable to come back for visit|0|||
25225608|NCT01384734|50504204|FG000|Overall Study|Prison|0|||
25225609|NCT01384734|50504205|FG001|Overall Study|Prison|0|||
25225610|NCT01384734|50504206|FG002|Overall Study|Prison|1|||
25225611|NCT01384734|50504207|FG003|Overall Study|Prison|0|||
25225612|NCT01384734|50504208|FG004|Overall Study|Prison|0|||
25225613|NCT01384734|50504204|FG000|Overall Study|As per Exclusion criteria|0|||
25225614|NCT01384734|50504205|FG001|Overall Study|As per Exclusion criteria|1|||
25225615|NCT01384734|50504206|FG002|Overall Study|As per Exclusion criteria|0|||
25225616|NCT01384734|50504207|FG003|Overall Study|As per Exclusion criteria|0|||
25225617|NCT01384734|50504208|FG004|Overall Study|As per Exclusion criteria|0|||
25225618|NCT01384734|50504204|FG000|Overall Study|Missed End of treatment visit|0|||
25225619|NCT01384734|50504205|FG001|Overall Study|Missed End of treatment visit|0|||
25225620|NCT01384734|50504206|FG002|Overall Study|Missed End of treatment visit|0|||
25225621|NCT01384734|50504207|FG003|Overall Study|Missed End of treatment visit|1|||
25225622|NCT01384734|50504208|FG004|Overall Study|Missed End of treatment visit|0|||
25225623|NCT01384734|50504204|FG000|Overall Study|Adhesion problem|0|||
25225624|NCT01384734|50504205|FG001|Overall Study|Adhesion problem|0|||
25225625|NCT01384734|50504206|FG002|Overall Study|Adhesion problem|0|||
25225626|NCT01384734|50504207|FG003|Overall Study|Adhesion problem|1|||
25225627|NCT01384734|50504208|FG004|Overall Study|Adhesion problem|0|||
25225628|NCT01384734|50504204|FG000|Overall Study|Early termination|0|||
25225629|NCT01384734|50504205|FG001|Overall Study|Early termination|0|||
25225630|NCT01384734|50504206|FG002|Overall Study|Early termination|0|||
25225631|NCT01384734|50504207|FG003|Overall Study|Early termination|0|||
25225632|NCT01384734|50504208|FG004|Overall Study|Early termination|1|||
25225633|NCT01384734|50504204|FG000|Overall Study|Physician Decision|1|||
25225634|NCT01384734|50504205|FG001|Overall Study|Physician Decision|0|||
25225635|NCT01384734|50504206|FG002|Overall Study|Physician Decision|0|||
25225636|NCT01384734|50504207|FG003|Overall Study|Physician Decision|0|||
25225637|NCT01384734|50504208|FG004|Overall Study|Physician Decision|0|||
25225638|NCT01396512|50504219|FG000|Overall Study|Withdrawal by Subject|0|||
25225639|NCT01396512|50504220|FG001|Overall Study|Withdrawal by Subject|1|||
25225640|NCT01396434|50504229|FG000|Overall Study|Lost to Follow-up|1|||
25225641|NCT01396434|50504230|FG001|Overall Study|Lost to Follow-up|0|||
25225642|NCT01396434|50504231|FG002|Overall Study|Lost to Follow-up|0|||
25225643|NCT01396434|50504229|FG000|Overall Study|Other|10|||
25225644|NCT01396434|50504230|FG001|Overall Study|Other|0|||
25225645|NCT01396434|50504231|FG002|Overall Study|Other|0|||
25225646|NCT01383954|50504239|FG000|Overall Study|Lack of Efficacy|2|||
25225647|NCT01383954|50504239|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
25225648|NCT01383954|50504239|FG000|Overall Study|Adverse Event|1|||
25225649|NCT01383954|50504239|FG000|Overall Study|Reason Not Specified|9|||
25225650|NCT01383486|50504243|FG000|Overall Study|Lost to Follow-up|10|||
25225651|NCT01383486|50504243|FG000|Overall Study|Incomplete information for analysis|2|||
25225652|NCT01383486|50504243|FG000|Overall Study|Did not take any product|6|||
25225653|NCT01383174|50504250|FG000|3 Month Assessment|Death|0|||
25225654|NCT01383174|50504251|FG001|3 Month Assessment|Death|1|||
25225655|NCT01383174|50504250|FG000|3 Month Assessment|Lost to Follow-up|2|||
25225656|NCT01383174|50504251|FG001|3 Month Assessment|Lost to Follow-up|0|||
25077465|NCT00002663|50185277|FG002|Overall Study|Death|1|||
25077466|NCT00002663|50185278|FG003|Overall Study|Death|0|||
25225657|NCT01383174|50504250|FG000|3 Month Assessment|Refused to complete|4|||
25225658|NCT01383174|50504251|FG001|3 Month Assessment|Refused to complete|0|||
25225659|NCT01383174|50504250|FG000|6 Month Assessment|Lost to Follow-up|1|||
25225660|NCT01383174|50504251|FG001|6 Month Assessment|Lost to Follow-up|1|||
25225661|NCT01383174|50504250|FG000|6 Month Assessment|Refused to complete|4|||
25225662|NCT01383174|50504251|FG001|6 Month Assessment|Refused to complete|0|||
25225663|NCT01396278|50504262|FG000|Overall Study|Adverse Event|0|||
25225664|NCT01396278|50504263|FG001|Overall Study|Adverse Event|0|||
25225665|NCT01396278|50504264|FG002|Overall Study|Adverse Event|0|||
25318686|NCT00607087|50634233|FG000|Period 1|Adverse Event|3|||
25318687|NCT00607087|50634234|FG001|Period 1|Adverse Event|0|||
25318688|NCT00607087|50634235|FG002|Period 1|Adverse Event|0|||
25318689|NCT00607087|50634233|FG000|Period 1|Poor compliance to protocol|1|||
25318690|NCT00607087|50634234|FG001|Period 1|Poor compliance to protocol|0|||
25318691|NCT00607087|50634235|FG002|Period 1|Poor compliance to protocol|0|||
25225666|NCT01396278|50504265|FG003|Overall Study|Adverse Event|2|||
25225667|NCT01396278|50504266|FG004|Overall Study|Adverse Event|0|||
25225668|NCT01396278|50504262|FG000|Overall Study|Withdraw due to trial termination|2|||
25225669|NCT01396278|50504263|FG001|Overall Study|Withdraw due to trial termination|1|||
25225670|NCT01396278|50504264|FG002|Overall Study|Withdraw due to trial termination|1|||
25225671|NCT01396278|50504265|FG003|Overall Study|Withdraw due to trial termination|0|||
25225672|NCT01396278|50504266|FG004|Overall Study|Withdraw due to trial termination|2|||
25225673|NCT01383096|50504281|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
25225674|NCT01383096|50504282|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
25225675|NCT01383096|50504283|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
25225676|NCT01383096|50504281|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
25225677|NCT01383096|50504282|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
25318692|NCT00607087|50634233|FG000|Period 1|Lost to Follow-up|1|||
25318693|NCT00607087|50634234|FG001|Period 1|Lost to Follow-up|0|||
25318694|NCT00607087|50634235|FG002|Period 1|Lost to Follow-up|0|||
25318695|NCT00607087|50634233|FG000|Period 1|Other reason|0|||
25318696|NCT00607087|50634234|FG001|Period 1|Other reason|4|||
25318697|NCT00607087|50634235|FG002|Period 1|Other reason|2|||
25225678|NCT01383096|50504283|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
25225679|NCT01383096|50504281|FG000|Third Intervention (8 Days)|Elevated AST|0|||
25225680|NCT01383096|50504282|FG001|Third Intervention (8 Days)|Elevated AST|1|||
25225681|NCT01383096|50504283|FG002|Third Intervention (8 Days)|Elevated AST|0|||
25225682|NCT01383096|50504281|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
25225683|NCT01383096|50504282|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
25225684|NCT01383096|50504283|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
25225685|NCT01383096|50504281|FG000|Third Intervention (8 Days)|Adverse Event|1|||
25225686|NCT01383096|50504282|FG001|Third Intervention (8 Days)|Adverse Event|0|||
25225687|NCT01383096|50504283|FG002|Third Intervention (8 Days)|Adverse Event|0|||
25225688|NCT01383096|50504281|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
25225689|NCT01383096|50504282|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
25225690|NCT01383096|50504283|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
25225691|NCT01383096|50504281|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
25225692|NCT01383096|50504282|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
25225693|NCT01383096|50504283|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
25225694|NCT01383096|50504281|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
25225695|NCT01383096|50504282|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
25225696|NCT01383096|50504283|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
25225697|NCT01383096|50504281|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
25225698|NCT01383096|50504282|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
25225699|NCT01383096|50504283|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
25225700|NCT01383096|50504281|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
25225701|NCT01383096|50504282|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
25225702|NCT01383096|50504283|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
25225703|NCT01383096|50504281|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
25225704|NCT01383096|50504282|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
25225705|NCT01383096|50504283|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
25225706|NCT01383018|50504320|FG000|Overall Study|Adverse Event|14|||
25225707|NCT01383018|50504320|FG000|Overall Study|Death|10|||
25225708|NCT01383018|50504320|FG000|Overall Study|Lost to Follow-up|5|||
25225709|NCT01383018|50504320|FG000|Overall Study|Physician Decision|5|||
25225710|NCT01383018|50504320|FG000|Overall Study|Withdrawal by Subject|9|||
25225711|NCT01383018|50504320|FG000|Overall Study|Subject not implanted|76|||
25225712|NCT01383018|50504320|FG000|Overall Study|Missed Visit|247|||
25225713|NCT01383018|50504320|FG000|Overall Study|Site closed early-not compliance related|7|||
25225714|NCT01383018|50504320|FG000|Overall Study|Patient moved away from site|1|||
25225715|NCT01383018|50504320|FG000|Overall Study|Subject Incarcerated|1|||
25225716|NCT01382940|50504334|FG000|Overall Study|Adverse Event|19|||
25318698|NCT00607087|50634233|FG000|Period 2|Withdrawal by Subject|0|||
25318699|NCT00607087|50634234|FG001|Period 2|Withdrawal by Subject|1|||
25318700|NCT00607087|50634235|FG002|Period 2|Withdrawal by Subject|1|||
25318701|NCT00607087|50634233|FG000|Period 2|Other reason|1|||
25318702|NCT00607087|50634234|FG001|Period 2|Other reason|1|||
25318703|NCT00607087|50634235|FG002|Period 2|Other reason|0|||
25225717|NCT01382940|50504334|FG000|Overall Study|Lost to Follow-up|4|||
25225718|NCT01382940|50504334|FG000|Overall Study|Physician Decision|7|||
25225719|NCT01382940|50504334|FG000|Overall Study|Withdrawal by Subject|23|||
25225720|NCT01382940|50504334|FG000|Overall Study|Protocol Violation|20|||
25225721|NCT01381926|50504340|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
25225722|NCT01381926|50504341|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
25225723|NCT01381926|50504340|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
25225724|NCT01381926|50504341|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
25225725|NCT01395888|50504351|FG000|2-week Run-in Period|Adverse Event|2|||
25225726|NCT01395888|50504352|FG001|2-week Run-in Period|Adverse Event|0|||
25225727|NCT01395888|50504353|FG002|2-week Run-in Period|Adverse Event|0|||
25225728|NCT01395888|50504351|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
25225729|NCT01395888|50504352|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
25225730|NCT01395888|50504353|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
25225731|NCT01395888|50504351|FG000|2-week Run-in Period|Lost to Follow-up|1|||
25225732|NCT01395888|50504352|FG001|2-week Run-in Period|Lost to Follow-up|0|||
25225733|NCT01395888|50504353|FG002|2-week Run-in Period|Lost to Follow-up|0|||
25225734|NCT01395888|50504351|FG000|2-week Run-in Period|Protocol Violation|2|||
25225735|NCT01395888|50504352|FG001|2-week Run-in Period|Protocol Violation|0|||
25225736|NCT01395888|50504353|FG002|2-week Run-in Period|Protocol Violation|0|||
25318704|NCT00607087|50634233|FG000|Period 2|Adverse Event|0|||
25318705|NCT00607087|50634234|FG001|Period 2|Adverse Event|1|||
25318706|NCT00607087|50634235|FG002|Period 2|Adverse Event|3|||
25318707|NCT00607087|50634233|FG000|Period 2|Poor compliance to protocol|0|||
25318708|NCT00607087|50634234|FG001|Period 2|Poor compliance to protocol|0|||
25318709|NCT00607087|50634235|FG002|Period 2|Poor compliance to protocol|1|||
25318710|NCT00607087|50634233|FG000|Period 3|Withdrawal by Subject|2|||
25318711|NCT00607087|50634234|FG001|Period 3|Withdrawal by Subject|1|||
25318712|NCT00607087|50634235|FG002|Period 3|Withdrawal by Subject|0|||
25318713|NCT00607087|50634233|FG000|Period 3|Adverse Event|0|||
25318714|NCT00607087|50634234|FG001|Period 3|Adverse Event|1|||
25318715|NCT00607087|50634235|FG002|Period 3|Adverse Event|0|||
25318716|NCT00610363|50634245|FG000|Overall Study|Non-compliance with protocol|0|||
25318717|NCT00610363|50634246|FG001|Overall Study|Non-compliance with protocol|1|||
25318718|NCT00610363|50634245|FG000|Overall Study|Adverse Event|3|||
25318719|NCT00610363|50634246|FG001|Overall Study|Adverse Event|1|||
25318720|NCT00610363|50634245|FG000|Overall Study|Lack of Efficacy|2|||
25318721|NCT00610363|50634246|FG001|Overall Study|Lack of Efficacy|0|||
25318722|NCT00610363|50634245|FG000|Overall Study|Lost to Follow-up|4|||
25318723|NCT00610363|50634246|FG001|Overall Study|Lost to Follow-up|0|||
25318724|NCT00610363|50634245|FG000|Overall Study|Withdrawal by Subject|1|||
25318725|NCT00610363|50634246|FG001|Overall Study|Withdrawal by Subject|0|||
25318726|NCT00610363|50634245|FG000|Overall Study|Other than specified above|1|||
25318727|NCT00610363|50634246|FG001|Overall Study|Other than specified above|1|||
25318728|NCT00887588|50634255|FG000|Core Period|Death|1|||
25318729|NCT00887588|50634256|FG001|Core Period|Death|1|||
25318730|NCT00887588|50634255|FG000|Core Period|Lost to Follow-up|3|||
25318731|NCT00887588|50634256|FG001|Core Period|Lost to Follow-up|1|||
25318732|NCT00887588|50634255|FG000|Core Period|Withdrawal by Subject|6|||
25318733|NCT00887588|50634256|FG001|Core Period|Withdrawal by Subject|8|||
25318734|NCT00887588|50634255|FG000|Core Period|Adverse Event|9|||
25318735|NCT00887588|50634256|FG001|Core Period|Adverse Event|11|||
25318736|NCT00887588|50634255|FG000|Extension Period|Adverse Event|4|||
25318737|NCT00887588|50634256|FG001|Extension Period|Adverse Event|4|||
25318738|NCT00887588|50634255|FG000|Extension Period|Death|0|||
25318739|NCT00887588|50634256|FG001|Extension Period|Death|1|||
25318740|NCT00887588|50634255|FG000|Extension Period|Protocol deviation|1|||
25318741|NCT00887588|50634256|FG001|Extension Period|Protocol deviation|0|||
25318742|NCT00887588|50634255|FG000|Extension Period|Lost to Follow-up|1|||
25318743|NCT00887588|50634256|FG001|Extension Period|Lost to Follow-up|0|||
25318744|NCT00945893|50634264|FG000|Overall Study|Lost to Follow-up|2|||
25318745|NCT00945893|50634265|FG001|Overall Study|Lost to Follow-up|8|||
25318746|NCT00945893|50634264|FG000|Overall Study|Withdrawal of consent|1|||
25318747|NCT00945893|50634265|FG001|Overall Study|Withdrawal of consent|2|||
25225737|NCT01395888|50504351|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
25318748|NCT00799383|50634277|FG000|Overall Study|Protocol Violation|1|||
25318749|NCT00799383|50634278|FG001|Overall Study|Protocol Violation|1|||
25318750|NCT00799383|50634277|FG000|Overall Study|Adverse Event|0|||
25318751|NCT00799383|50634278|FG001|Overall Study|Adverse Event|1|||
25318752|NCT00799383|50634277|FG000|Overall Study|Lost to Follow-up|1|||
25318753|NCT00799383|50634278|FG001|Overall Study|Lost to Follow-up|2|||
25318754|NCT00799383|50634277|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
25318755|NCT00799383|50634278|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
25318756|NCT00799383|50634277|FG000|Overall Study|Withdrawal by Subject|0|||
25318757|NCT00799383|50634278|FG001|Overall Study|Withdrawal by Subject|1|||
25318758|NCT00610207|50634284|FG000|Overall Study|Lost to Follow-up|3|||
25318759|NCT00798759|50634290|FG000|Overall Study|Adverse Event|3|||
25318760|NCT00798759|50634291|FG001|Overall Study|Adverse Event|3|||
25318761|NCT00798759|50634290|FG000|Overall Study|Lost to Follow-up|1|||
25318762|NCT00798759|50634291|FG001|Overall Study|Lost to Follow-up|1|||
25318763|NCT00798759|50634290|FG000|Overall Study|Protocol Violation|4|||
25318764|NCT00798759|50634291|FG001|Overall Study|Protocol Violation|8|||
25318765|NCT00798759|50634290|FG000|Overall Study|Other|0|||
25318766|NCT00798759|50634291|FG001|Overall Study|Other|1|||
25318767|NCT00887432|50634299|FG000|Overall Study|Start Excluded Therapy|3|||
25318768|NCT00887432|50634300|FG001|Overall Study|Start Excluded Therapy|0|||
25318769|NCT00887432|50634299|FG000|Overall Study|Did not complete treatment|6|||
25318770|NCT00887432|50634300|FG001|Overall Study|Did not complete treatment|8|||
25318771|NCT00887432|50634299|FG000|Overall Study|Protocol Violation|2|||
25318772|NCT00887432|50634300|FG001|Overall Study|Protocol Violation|3|||
25318773|NCT00887432|50634299|FG000|Overall Study|Withdrawal by Subject|3|||
25318774|NCT00887432|50634300|FG001|Overall Study|Withdrawal by Subject|2|||
25318775|NCT00887432|50634299|FG000|Overall Study|Lost to Follow-up|1|||
25318776|NCT00887432|50634300|FG001|Overall Study|Lost to Follow-up|0|||
25318777|NCT00887432|50634299|FG000|Overall Study|No reason provided|0|||
25318778|NCT00887432|50634300|FG001|Overall Study|No reason provided|1|||
25318779|NCT00951275|50634306|FG000|Overall Study|Administrative Reason|1|||
25318780|NCT00951275|50634306|FG000|Overall Study|Adverse Event|7|||
25318781|NCT00951275|50634306|FG000|Overall Study|Withdrawal by Subject|4|||
25318782|NCT00951275|50634306|FG000|Overall Study|Protocol Violation|1|||
25318783|NCT00798603|50634310|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
25225738|NCT01395888|50504352|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
25225739|NCT01395888|50504353|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
25225740|NCT01395888|50504351|FG000|Treatment Period (TP)|Adverse Event|0|||
25225741|NCT01395888|50504352|FG001|Treatment Period (TP)|Adverse Event|7|||
25225742|NCT01395888|50504353|FG002|Treatment Period (TP)|Adverse Event|6|||
25225743|NCT01395888|50504351|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
25225744|NCT01395888|50504352|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
25225745|NCT01395888|50504353|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
25225746|NCT01395888|50504351|FG000|Treatment Period (TP)|Protocol Violation|0|||
25225747|NCT01395888|50504352|FG001|Treatment Period (TP)|Protocol Violation|1|||
25225748|NCT01395888|50504353|FG002|Treatment Period (TP)|Protocol Violation|5|||
25225749|NCT01395888|50504351|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
25225750|NCT01395888|50504352|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
25225751|NCT01395888|50504353|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
25225752|NCT01395888|50504351|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
25225753|NCT01395888|50504352|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
25225754|NCT01395888|50504353|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
25225755|NCT01395810|50504363|FG000|Overall Study|Adverse Event|0|||
25225756|NCT01395810|50504364|FG001|Overall Study|Adverse Event|1|||
25225757|NCT01395810|50504365|FG002|Overall Study|Adverse Event|0|||
25225758|NCT01395810|50504366|FG003|Overall Study|Adverse Event|0|||
25225759|NCT01395810|50504363|FG000|Overall Study|Lack of Efficacy|0|||
25225760|NCT01395810|50504364|FG001|Overall Study|Lack of Efficacy|1|||
25225761|NCT01395810|50504365|FG002|Overall Study|Lack of Efficacy|0|||
25225762|NCT01395810|50504366|FG003|Overall Study|Lack of Efficacy|0|||
25225763|NCT01395810|50504363|FG000|Overall Study|Withdrawal criteria|0|||
25225764|NCT01395810|50504364|FG001|Overall Study|Withdrawal criteria|2|||
25225765|NCT01395810|50504365|FG002|Overall Study|Withdrawal criteria|0|||
25225766|NCT01395810|50504366|FG003|Overall Study|Withdrawal criteria|0|||
25225767|NCT01395810|50504363|FG000|Overall Study|Unclassified|2|||
25225768|NCT01395810|50504364|FG001|Overall Study|Unclassified|0|||
25225769|NCT01395810|50504365|FG002|Overall Study|Unclassified|0|||
25225770|NCT01395810|50504366|FG003|Overall Study|Unclassified|0|||
25225771|NCT01381692|50504379|FG000|Overall Study|Adverse Event|1|||
25225772|NCT01381692|50504380|FG001|Overall Study|Adverse Event|0|||
25225773|NCT01381692|50504381|FG002|Overall Study|Adverse Event|0|||
25225774|NCT01381692|50504382|FG003|Overall Study|Adverse Event|0|||
25225775|NCT01381692|50504383|FG004|Overall Study|Adverse Event|0|||
25225776|NCT01381692|50504384|FG005|Overall Study|Adverse Event|0|||
25225777|NCT01395030|50504392|FG000|Overall Study|Did not complete FCH PET/CT|7|||
25225778|NCT01381068|50504400|FG000|Overall Study|Death|1|||
25225779|NCT01381068|50504401|FG001|Overall Study|Death|0|||
25225780|NCT01394952|50504409|FG000|Overall Study|Lost to Follow-up|0|||
25225781|NCT01394952|50504410|FG001|Overall Study|Lost to Follow-up|5|||
25225782|NCT01394952|50504409|FG000|Overall Study|Withdrawal by Subject|10|||
25225783|NCT01394952|50504410|FG001|Overall Study|Withdrawal by Subject|5|||
25225784|NCT01394952|50504409|FG000|Overall Study|Physician Decision|2|||
25318784|NCT00798603|50634310|FG000|Overall Study|Withdrawal by Subject|10|||
25318785|NCT00798603|50634310|FG000|Overall Study|Adverse Event|22|||
25318786|NCT00798603|50634310|FG000|Overall Study|Physician Decision|1|||
25318787|NCT00798603|50634310|FG000|Overall Study|Lack of insurance coverage|1|||
25318788|NCT00887354|50634316|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
25225785|NCT01394952|50504410|FG001|Overall Study|Physician Decision|0|||
25225786|NCT01394952|50504409|FG000|Overall Study|Sponsor Decision|5|||
25225787|NCT01394952|50504410|FG001|Overall Study|Sponsor Decision|7|||
25225788|NCT01394718|50504418|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
25225789|NCT01394718|50504419|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
25225790|NCT01394250|50504427|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
25225791|NCT01394250|50504428|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
25225792|NCT01394250|50504427|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
25225793|NCT01394250|50504428|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
25225794|NCT01380990|50504436|FG000|Overall Study|Treatment Failure|1|||
25225795|NCT01380990|50504437|FG001|Overall Study|Treatment Failure|0|||
25225796|NCT01380990|50504436|FG000|Overall Study|Death|0|||
25225797|NCT01380990|50504437|FG001|Overall Study|Death|1|||
25225798|NCT01380834|50504449|FG000|Overall Study|Physician Decision|1|||
25225799|NCT01380834|50504450|FG001|Overall Study|Physician Decision|0|||
25225800|NCT00214422|50504459|FG000|Overall Study|Physician Decision|2|||
25225801|NCT00214422|50504460|FG001|Overall Study|Physician Decision|0|||
25225802|NCT00214422|50504461|FG002|Overall Study|Physician Decision|0|||
25225803|NCT00214422|50504459|FG000|Overall Study|Developed esophageal ca|1|||
25225804|NCT00214422|50504460|FG001|Overall Study|Developed esophageal ca|0|||
25318789|NCT00887354|50634317|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
25318790|NCT00887354|50634316|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
25318791|NCT00887354|50634317|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
25318792|NCT00887354|50634316|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
25318793|NCT00887354|50634317|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
25318794|NCT00887354|50634316|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
25318795|NCT00887354|50634317|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
25318796|NCT00887354|50634316|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
25318797|NCT00887354|50634317|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
25318798|NCT00887354|50634316|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
25318799|NCT00887354|50634317|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
25318800|NCT00887354|50634316|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
25318801|NCT00887354|50634317|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
25318802|NCT00887354|50634316|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
25318803|NCT00887354|50634317|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
25318804|NCT00887354|50634316|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
25318805|NCT00887354|50634317|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
25318806|NCT00887354|50634316|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
25318807|NCT00887354|50634317|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
25318808|NCT00887354|50634316|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
25318809|NCT00887354|50634317|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
25318810|NCT00887354|50634316|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
25318811|NCT00887354|50634317|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
25318812|NCT00887354|50634316|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
25318813|NCT00887354|50634317|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
25318814|NCT00887354|50634316|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
25318815|NCT00887354|50634317|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
25318816|NCT00887354|50634316|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
25318817|NCT00887354|50634317|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
25318818|NCT00951041|50634326|FG000|Overall Study|Withdrawal by Subject|1|||
25225805|NCT00214422|50504461|FG002|Overall Study|Developed esophageal ca|0|||
25225806|NCT00214422|50504459|FG000|Overall Study|Pt taken off study|1|||
25225807|NCT00214422|50504460|FG001|Overall Study|Pt taken off study|1|||
25225808|NCT00214422|50504461|FG002|Overall Study|Pt taken off study|0|||
25225809|NCT00214422|50504459|FG000|Overall Study|Disease progression on study|1|||
25225810|NCT00214422|50504460|FG001|Overall Study|Disease progression on study|0|||
25225811|NCT00214422|50504461|FG002|Overall Study|Disease progression on study|0|||
25318819|NCT00951041|50634327|FG001|Overall Study|Withdrawal by Subject|1|||
25318820|NCT00951041|50634326|FG000|Overall Study|Lost to Follow-up|1|||
25318821|NCT00951041|50634327|FG001|Overall Study|Lost to Follow-up|0|||
25318822|NCT00951041|50634326|FG000|Overall Study|Other|3|||
25318823|NCT00951041|50634327|FG001|Overall Study|Other|0|||
25318824|NCT02763462|50634334|FG000|Overall Study|Protocol Violation|6|||
25318825|NCT00610129|50634348|FG000|Overall Study|Not treated since patients ineligible|3|||
25318826|NCT00945815|50634352|FG000|Overall Study|Death|3|||
25225812|NCT00214422|50504459|FG000|Overall Study|Unable to make a radiation treatment|0|||
25225813|NCT00214422|50504460|FG001|Overall Study|Unable to make a radiation treatment|0|||
25225814|NCT00214422|50504461|FG002|Overall Study|Unable to make a radiation treatment|1|||
25318827|NCT00945815|50634352|FG000|Overall Study|Not protocol specified|1|||
25318828|NCT00945815|50634352|FG000|Overall Study|Ineligible|3|||
25318829|NCT00945815|50634352|FG000|Overall Study|Did not begin protocol therapy|1|||
25225815|NCT00218634|50504475|FG000|Overall Study|Lost to Follow-up|8|||
25318830|NCT00606307|50634356|FG000|Overall Study|Adverse Event|2|||
25318831|NCT00606307|50634356|FG000|Overall Study|Withdrawal by Subject|2|||
25318832|NCT00606307|50634356|FG000|Overall Study|Disease progression|6|||
25318833|NCT00606307|50634356|FG000|Overall Study|QTc prolongation|1|||
25318834|NCT00798369|50634366|FG000|Overall Study|Subject withdrew consent|0|||
25318835|NCT00798369|50634367|FG001|Overall Study|Subject withdrew consent|0|||
25318836|NCT00798369|50634368|FG002|Overall Study|Subject withdrew consent|1|||
25318837|NCT00798369|50634369|FG003|Overall Study|Subject withdrew consent|1|||
25318838|NCT00798369|50634370|FG004|Overall Study|Subject withdrew consent|0|||
25318839|NCT00798369|50634371|FG005|Overall Study|Subject withdrew consent|2|||
25225816|NCT00218634|50504476|FG001|Overall Study|Lost to Follow-up|15|||
25225817|NCT00217620|50504485|FG000|Overall Study|Adverse Event|2|||
25225818|NCT00217620|50504485|FG000|Overall Study|Progression|31|||
25225819|NCT00217620|50504485|FG000|Overall Study|Not Protocol Specified|4|||
25225820|NCT00217620|50504485|FG000|Overall Study|Ineligible|13|||
25225821|NCT00217620|50504485|FG000|Overall Study|Never received treatment|1|||
25225822|NCT00217464|50504493|FG000|Overall Study|Progression|15|||
25225823|NCT00217464|50504493|FG000|Overall Study|Other|2|||
25225824|NCT00214500|50504497|FG000|Treatment Period|Adverse Event|1|||
25225825|NCT00214500|50504497|FG000|Extension Period|Withdrawal by Subject|2|||
25225826|NCT00211536|50504506|FG000|Overall Study|Withdrawal by Subject|2|||
25225827|NCT00211536|50504507|FG001|Overall Study|Withdrawal by Subject|2|||
25225828|NCT00211536|50504506|FG000|Overall Study|Physician Decision|0|||
25225829|NCT00211536|50504507|FG001|Overall Study|Physician Decision|5|||
25225830|NCT00211536|50504506|FG000|Overall Study|Adverse Event|2|||
25225831|NCT00211536|50504507|FG001|Overall Study|Adverse Event|0|||
25225832|NCT03028740|50504591|FG000|Overall Study|Did not Receive Study Drug|4|||
25225833|NCT03028740|50504592|FG001|Overall Study|Did not Receive Study Drug|5|||
25225834|NCT03028740|50504591|FG000|Overall Study|Adverse Event|8|||
25225835|NCT03028740|50504592|FG001|Overall Study|Adverse Event|26|||
25225836|NCT03028740|50504591|FG000|Overall Study|Lack of Efficacy|0|||
25225837|NCT03028740|50504592|FG001|Overall Study|Lack of Efficacy|1|||
25225838|NCT03028740|50504591|FG000|Overall Study|Withdrawal by Subject|48|||
25225839|NCT03028740|50504592|FG001|Overall Study|Withdrawal by Subject|101|||
25225840|NCT03028740|50504591|FG000|Overall Study|Lost to Follow-up|30|||
25225841|NCT03028740|50504592|FG001|Overall Study|Lost to Follow-up|54|||
25225842|NCT03028740|50504591|FG000|Overall Study|Physician Decision|4|||
25225843|NCT03028740|50504592|FG001|Overall Study|Physician Decision|11|||
25225844|NCT03028740|50504591|FG000|Overall Study|Protocol Violation|4|||
25225845|NCT03028740|50504592|FG001|Overall Study|Protocol Violation|8|||
25225846|NCT03028740|50504591|FG000|Overall Study|Non-compliance with Study Drug|0|||
25225847|NCT03028740|50504592|FG001|Overall Study|Non-compliance with Study Drug|2|||
25225848|NCT03028740|50504591|FG000|Overall Study|Study Terminated by Sponsor|467|||
25225849|NCT03028740|50504592|FG001|Overall Study|Study Terminated by Sponsor|917|||
25225850|NCT03028740|50504591|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
25225851|NCT03028740|50504592|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
25225852|NCT03028740|50504591|FG000|Overall Study|Reason not Specified|1|||
25225853|NCT03028740|50504592|FG001|Overall Study|Reason not Specified|5|||
25225854|NCT02980692|50504615|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
25225855|NCT02980692|50504616|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
25225856|NCT02980692|50504617|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
25225857|NCT02980692|50504618|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
25225858|NCT02980692|50504619|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
25225859|NCT02980692|50504615|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
25225860|NCT02980692|50504616|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
25225861|NCT02980692|50504617|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
25225862|NCT02980692|50504618|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
25225863|NCT02980692|50504619|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
25225864|NCT02980692|50504615|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
25225865|NCT02980692|50504616|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
25225866|NCT02980692|50504617|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
25225867|NCT02980692|50504618|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
25225868|NCT02980692|50504619|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
25225869|NCT02980692|50504615|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
25225870|NCT02980692|50504616|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
25225871|NCT02980692|50504617|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
25225872|NCT02980692|50504618|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
25225873|NCT02980692|50504619|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
25225874|NCT02980692|50504615|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
25225875|NCT02980692|50504616|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
25225876|NCT02980692|50504617|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
25225877|NCT02980692|50504618|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
25225878|NCT02980692|50504619|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
25318840|NCT00798369|50634366|FG000|Overall Study|Lost to Follow-up|1|||
25225879|NCT02980692|50504615|FG000|Double Blind Placebo Controlled Period|Other|1|||
25225880|NCT02980692|50504616|FG001|Double Blind Placebo Controlled Period|Other|0|||
25225881|NCT02980692|50504617|FG002|Double Blind Placebo Controlled Period|Other|0|||
25225882|NCT02980692|50504618|FG003|Double Blind Placebo Controlled Period|Other|0|||
25225883|NCT02980692|50504619|FG004|Double Blind Placebo Controlled Period|Other|1|||
25225884|NCT02980692|50504615|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
25225885|NCT02980692|50504616|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
25225886|NCT02980692|50504617|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
25225887|NCT02980692|50504618|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
25225888|NCT02980692|50504619|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
25225889|NCT02980692|50504615|FG000|Double-blind Follow-up Period|Adverse Event|0|||
25225890|NCT02980692|50504616|FG001|Double-blind Follow-up Period|Adverse Event|0|||
25225891|NCT02980692|50504617|FG002|Double-blind Follow-up Period|Adverse Event|0|||
25225892|NCT02980692|50504618|FG003|Double-blind Follow-up Period|Adverse Event|1|||
25225893|NCT02980692|50504619|FG004|Double-blind Follow-up Period|Adverse Event|1|||
25225894|NCT02980692|50504615|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
25225895|NCT02980692|50504616|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
25225896|NCT02980692|50504617|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
25225897|NCT02980692|50504618|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
25225898|NCT02980692|50504619|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
25225899|NCT02980692|50504615|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
25225900|NCT02980692|50504616|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
25225901|NCT02980692|50504617|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
25225902|NCT02980692|50504618|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
25225903|NCT02980692|50504619|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
25225904|NCT02980692|50504615|FG000|Double-blind Follow-up Period|Pregnancy|0|||
25225905|NCT02980692|50504616|FG001|Double-blind Follow-up Period|Pregnancy|0|||
25225906|NCT02980692|50504617|FG002|Double-blind Follow-up Period|Pregnancy|1|||
25225907|NCT02980692|50504618|FG003|Double-blind Follow-up Period|Pregnancy|1|||
25225908|NCT02980692|50504619|FG004|Double-blind Follow-up Period|Pregnancy|0|||
25225909|NCT02980692|50504615|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
25225910|NCT02980692|50504616|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
25225911|NCT02980692|50504617|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
25225912|NCT02980692|50504618|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
25225913|NCT02980692|50504619|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
25225914|NCT02980692|50504615|FG000|Double-blind Follow-up Period|Other|0|||
25225915|NCT02980692|50504616|FG001|Double-blind Follow-up Period|Other|0|||
25225916|NCT02980692|50504617|FG002|Double-blind Follow-up Period|Other|1|||
25225917|NCT02980692|50504618|FG003|Double-blind Follow-up Period|Other|1|||
25225918|NCT02980692|50504619|FG004|Double-blind Follow-up Period|Other|3|||
25225919|NCT00089778|50504925|FG000|Overall Study|Protocol Violation|0|||
25225920|NCT00089778|50504926|FG001|Overall Study|Protocol Violation|0|||
25225921|NCT00089778|50504927|FG002|Overall Study|Protocol Violation|1|||
25225922|NCT00089544|50504939|FG000|Overall Study|Ineligible|1|||
25225923|NCT00089544|50504940|FG001|Overall Study|Ineligible|0|||
25225924|NCT00089076|50504946|FG000|Overall Study|Alternate Therapy|1|||
25225925|NCT00089076|50504946|FG000|Overall Study|Withdrawal by Subject|2|||
25225926|NCT00089076|50504946|FG000|Overall Study|Progression|7|||
25225927|NCT00088374|50504950|FG000|Overall Study|patient did not receive any 17AAG|1|||
25225928|NCT00088374|50504950|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
25225929|NCT00087594|50504956|FG000|Overall Study|Adverse Event|2|||
25225930|NCT00087594|50504957|FG001|Overall Study|Adverse Event|3|||
25225931|NCT00087594|50504956|FG000|Overall Study|Lost to Follow-up|0|||
25225932|NCT00087594|50504957|FG001|Overall Study|Lost to Follow-up|2|||
25225933|NCT00087594|50504956|FG000|Overall Study|Withdrawal by Subject|4|||
25225934|NCT00087594|50504957|FG001|Overall Study|Withdrawal by Subject|2|||
25225935|NCT00087594|50504956|FG000|Overall Study|Lack of Efficacy|2|||
25225936|NCT00087594|50504957|FG001|Overall Study|Lack of Efficacy|5|||
24976564|NCT00097773|50065468|FG002|Overall Study|Adverse Event|0|||
24976565|NCT00097773|50065469|FG003|Overall Study|Adverse Event|0|||
24976566|NCT00097773|50065466|FG000|Overall Study|Other|1|||
24976567|NCT00097773|50065467|FG001|Overall Study|Other|0|||
24976568|NCT00097773|50065468|FG002|Overall Study|Other|2|||
24976569|NCT00097773|50065469|FG003|Overall Study|Other|0|||
25225937|NCT00087516|50504966|FG000|Overall Study|Adverse Event|10|||
25225938|NCT00087516|50504967|FG001|Overall Study|Adverse Event|10|||
25225939|NCT00087516|50504968|FG002|Overall Study|Adverse Event|3|||
25225940|NCT00087516|50504969|FG003|Overall Study|Adverse Event|6|||
25077467|NCT00002663|50185279|FG004|Overall Study|Death|0|||
24976570|NCT03480022|50065486|FG000|Overall Study|Pregnancy|2|||
24976571|NCT03480022|50065487|FG001|Overall Study|Pregnancy|0|||
24976572|NCT03480022|50065486|FG000|Overall Study|Adverse Event|6|||
24976573|NCT03480022|50065487|FG001|Overall Study|Adverse Event|0|||
24976574|NCT03480022|50065486|FG000|Overall Study|Lack of Efficacy|0|||
24976575|NCT03480022|50065487|FG001|Overall Study|Lack of Efficacy|2|||
24976576|NCT03480022|50065486|FG000|Overall Study|Physician Decision|0|||
24976577|NCT03480022|50065487|FG001|Overall Study|Physician Decision|1|||
24976578|NCT03480022|50065486|FG000|Overall Study|Withdrawal by Subject|2|||
24976579|NCT03480022|50065487|FG001|Overall Study|Withdrawal by Subject|0|||
24976580|NCT03480022|50065486|FG000|Overall Study|Medication concerns|1|||
25225941|NCT00087516|50504966|FG000|Overall Study|Lack of Efficacy|82|||
25225942|NCT00087516|50504967|FG001|Overall Study|Lack of Efficacy|80|||
25225943|NCT00087516|50504968|FG002|Overall Study|Lack of Efficacy|39|||
25225944|NCT00087516|50504969|FG003|Overall Study|Lack of Efficacy|29|||
25225945|NCT00087516|50504966|FG000|Overall Study|Lost to Follow-up|8|||
25225946|NCT00087516|50504967|FG001|Overall Study|Lost to Follow-up|6|||
25225947|NCT00087516|50504968|FG002|Overall Study|Lost to Follow-up|5|||
25225948|NCT00087516|50504969|FG003|Overall Study|Lost to Follow-up|5|||
25225949|NCT00087516|50504966|FG000|Overall Study|Protocol Violation|4|||
25225950|NCT00087516|50504967|FG001|Overall Study|Protocol Violation|8|||
25225951|NCT00087516|50504968|FG002|Overall Study|Protocol Violation|3|||
25225952|NCT00087516|50504969|FG003|Overall Study|Protocol Violation|6|||
25225953|NCT00087516|50504966|FG000|Overall Study|Withdrawal by Subject|16|||
25225954|NCT00087516|50504967|FG001|Overall Study|Withdrawal by Subject|27|||
25225955|NCT00087516|50504968|FG002|Overall Study|Withdrawal by Subject|11|||
25225956|NCT00087516|50504969|FG003|Overall Study|Withdrawal by Subject|12|||
25225957|NCT00087516|50504966|FG000|Overall Study|Site terminated|0|||
25225958|NCT00087516|50504967|FG001|Overall Study|Site terminated|2|||
25225959|NCT00087516|50504968|FG002|Overall Study|Site terminated|1|||
25225960|NCT00087516|50504969|FG003|Overall Study|Site terminated|0|||
25225961|NCT00087516|50504966|FG000|Overall Study|Protocol specified discontinuation|35|||
25225962|NCT00087516|50504967|FG001|Overall Study|Protocol specified discontinuation|33|||
24976581|NCT03480022|50065487|FG001|Overall Study|Medication concerns|0|||
24976582|NCT03480022|50065486|FG000|Overall Study|Family member COVID exposure|0|||
24976583|NCT03480022|50065487|FG001|Overall Study|Family member COVID exposure|1|||
24976584|NCT03533608|50065493|FG000|Overall Study|Withdrawal by Subject|3|||
25225963|NCT00087516|50504968|FG002|Overall Study|Protocol specified discontinuation|33|||
25225964|NCT00087516|50504969|FG003|Overall Study|Protocol specified discontinuation|26|||
25225965|NCT00087516|50504966|FG000|Overall Study|Patient moved|3|||
25225966|NCT00087516|50504967|FG001|Overall Study|Patient moved|2|||
25225967|NCT00087516|50504968|FG002|Overall Study|Patient moved|1|||
25225968|NCT00087516|50504969|FG003|Overall Study|Patient moved|0|||
25225969|NCT00087516|50504966|FG000|Overall Study|Patient was non-compliant|3|||
25225970|NCT00087516|50504967|FG001|Overall Study|Patient was non-compliant|1|||
25225971|NCT00087516|50504968|FG002|Overall Study|Patient was non-compliant|0|||
25225972|NCT00087516|50504969|FG003|Overall Study|Patient was non-compliant|0|||
25225973|NCT00087516|50504966|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
25225974|NCT00087516|50504967|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
25225975|NCT00087516|50504968|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
25225976|NCT00087516|50504969|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
25225977|NCT00087516|50504966|FG000|Overall Study|Other|0|||
25225978|NCT00087516|50504967|FG001|Overall Study|Other|0|||
25225979|NCT00087516|50504968|FG002|Overall Study|Other|1|||
25225980|NCT00087516|50504969|FG003|Overall Study|Other|0|||
25225981|NCT00087126|50504983|FG000|Overall Study|Ineligible - second primary|1|||
25225982|NCT00087126|50504983|FG000|Overall Study|Never treated|1|||
25225983|NCT03490734|50504996|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
25225984|NCT03490734|50504997|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
25225985|NCT03490734|50504998|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
25318841|NCT00798369|50634367|FG001|Overall Study|Lost to Follow-up|1|||
25318842|NCT00798369|50634368|FG002|Overall Study|Lost to Follow-up|1|||
24976585|NCT03533608|50065493|FG000|Overall Study|Physician Decision|2|||
25225986|NCT03490734|50504999|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
24976586|NCT00049322|50065500|FG000|Overall Study|disease burden|0|||
24976587|NCT00049322|50065501|FG001|Overall Study|disease burden|3|||
25225987|NCT03490734|50504996|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
25225988|NCT03490734|50504997|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
25225989|NCT03490734|50504998|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
25225990|NCT03490734|50504999|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
25225991|NCT03490734|50504996|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
25225992|NCT03490734|50504997|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
25225993|NCT03490734|50504998|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
25225994|NCT03490734|50504999|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
24976588|NCT00049322|50065500|FG000|Overall Study|Adverse Event|1|||
24976589|NCT00049322|50065501|FG001|Overall Study|Adverse Event|0|||
24976590|NCT00049322|50065500|FG000|Overall Study|refused angio|0|||
25318843|NCT00798369|50634369|FG003|Overall Study|Lost to Follow-up|0|||
25318844|NCT00798369|50634370|FG004|Overall Study|Lost to Follow-up|1|||
25318845|NCT00798369|50634371|FG005|Overall Study|Lost to Follow-up|0|||
25318846|NCT00798369|50634366|FG000|Overall Study|Adminstrative problems|0|||
25318847|NCT00798369|50634367|FG001|Overall Study|Adminstrative problems|0|||
25318848|NCT00798369|50634368|FG002|Overall Study|Adminstrative problems|0|||
25318849|NCT00798369|50634369|FG003|Overall Study|Adminstrative problems|0|||
25225995|NCT03490734|50504996|FG000|Post-intervention Scan Visit|Adverse Event|2|||
25225996|NCT03490734|50504997|FG001|Post-intervention Scan Visit|Adverse Event|0|||
25318850|NCT00798369|50634370|FG004|Overall Study|Adminstrative problems|0|||
25318851|NCT00798369|50634371|FG005|Overall Study|Adminstrative problems|1|||
25318852|NCT00950963|50634388|FG000|Overall Study|Lost to Follow-up|29|||
25318853|NCT00950963|50634389|FG001|Overall Study|Lost to Follow-up|24|||
25225997|NCT03490734|50504998|FG002|Post-intervention Scan Visit|Adverse Event|0|||
25225998|NCT03490734|50504999|FG003|Post-intervention Scan Visit|Adverse Event|0|||
25225999|NCT03490734|50504996|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
25226000|NCT03490734|50504997|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
25226001|NCT03490734|50504998|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
25226002|NCT03490734|50504999|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
25226003|NCT03490734|50504996|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
25226004|NCT03490734|50504997|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
25226005|NCT03490734|50504998|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
25226006|NCT03490734|50504999|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
25318854|NCT00608959|50634397|FG000|Part 1|Did not meet eligibility criteria|1|||
25318855|NCT00945659|50634410|FG000|Overall Study|Lost to Follow-up|7|||
25318856|NCT00945659|50634411|FG001|Overall Study|Lost to Follow-up|20|||
25318857|NCT00945659|50634412|FG002|Overall Study|Lost to Follow-up|17|||
25318858|NCT00798135|50634420|FG000|Overall Study|Disease progression, relapse|11|||
25318859|NCT00798135|50634420|FG000|Overall Study|Disease progression, refractory|1|||
25318860|NCT00798135|50634420|FG000|Overall Study|Physician Decision|1|||
25318861|NCT00941603|50634430|FG000|Overall Study|Adverse Event|10|||
25318862|NCT00941603|50634431|FG001|Overall Study|Adverse Event|15|||
25318863|NCT00941603|50634432|FG002|Overall Study|Adverse Event|5|||
25318864|NCT00941603|50634433|FG003|Overall Study|Adverse Event|1|||
25318865|NCT00941603|50634434|FG004|Overall Study|Adverse Event|4|||
25318866|NCT00941603|50634435|FG005|Overall Study|Adverse Event|0|||
25318867|NCT00941603|50634430|FG000|Overall Study|Lost to Follow-up|0|||
25318868|NCT00941603|50634431|FG001|Overall Study|Lost to Follow-up|0|||
25318869|NCT00941603|50634432|FG002|Overall Study|Lost to Follow-up|0|||
25318870|NCT00941603|50634433|FG003|Overall Study|Lost to Follow-up|1|||
25318871|NCT00941603|50634434|FG004|Overall Study|Lost to Follow-up|0|||
25318872|NCT00941603|50634435|FG005|Overall Study|Lost to Follow-up|2|||
25318873|NCT00941603|50634430|FG000|Overall Study|Withdrawal by Subject|0|||
25318874|NCT00941603|50634431|FG001|Overall Study|Withdrawal by Subject|0|||
25318875|NCT00941603|50634432|FG002|Overall Study|Withdrawal by Subject|0|||
25318876|NCT00941603|50634433|FG003|Overall Study|Withdrawal by Subject|2|||
25318877|NCT00941603|50634434|FG004|Overall Study|Withdrawal by Subject|0|||
25318878|NCT00941603|50634435|FG005|Overall Study|Withdrawal by Subject|1|||
25318879|NCT00941603|50634430|FG000|Overall Study|Protocol Violation|0|||
25318880|NCT00941603|50634431|FG001|Overall Study|Protocol Violation|1|||
25318881|NCT00941603|50634432|FG002|Overall Study|Protocol Violation|0|||
25318882|NCT00941603|50634433|FG003|Overall Study|Protocol Violation|0|||
25226007|NCT00086346|50505010|FG000|Randomization|Did not receive test article|4|||
25226008|NCT00086346|50505011|FG001|Randomization|Did not receive test article|4|||
25226009|NCT00086346|50505010|FG000|Patients Dosed With Test Article|Adverse Event|94|||
25318883|NCT00941603|50634434|FG004|Overall Study|Protocol Violation|0|||
25318884|NCT00941603|50634435|FG005|Overall Study|Protocol Violation|0|||
25318885|NCT00941603|50634430|FG000|Overall Study|Did not meet protocol eligibility|1|||
25318886|NCT00941603|50634431|FG001|Overall Study|Did not meet protocol eligibility|0|||
25318887|NCT00941603|50634432|FG002|Overall Study|Did not meet protocol eligibility|0|||
25318888|NCT00941603|50634433|FG003|Overall Study|Did not meet protocol eligibility|0|||
25318889|NCT00941603|50634434|FG004|Overall Study|Did not meet protocol eligibility|0|||
25318890|NCT00941603|50634435|FG005|Overall Study|Did not meet protocol eligibility|0|||
25318891|NCT00797823|50634452|FG000|First Period (Initial Randomization)|Physician Decision|1|||
25318892|NCT00797823|50634453|FG001|First Period (Initial Randomization)|Physician Decision|0|||
25318893|NCT00797823|50634454|FG002|First Period (Initial Randomization)|Physician Decision|0|||
25318894|NCT00797667|50634464|FG000|Overall Study|Lack of Efficacy|0|||
25318895|NCT00797667|50634465|FG001|Overall Study|Lack of Efficacy|1|||
25318896|NCT00797667|50634466|FG002|Overall Study|Lack of Efficacy|0|||
25318897|NCT00797667|50634464|FG000|Overall Study|Lost to Follow-up|8|||
25318898|NCT00797667|50634465|FG001|Overall Study|Lost to Follow-up|12|||
25318899|NCT00797667|50634466|FG002|Overall Study|Lost to Follow-up|2|||
25318900|NCT00797667|50634464|FG000|Overall Study|Physician Decision|3|||
25318901|NCT00797667|50634465|FG001|Overall Study|Physician Decision|1|||
25318902|NCT00797667|50634466|FG002|Overall Study|Physician Decision|0|||
25318903|NCT00797667|50634464|FG000|Overall Study|Pregnancy|2|||
25318904|NCT00797667|50634465|FG001|Overall Study|Pregnancy|0|||
25318905|NCT00797667|50634466|FG002|Overall Study|Pregnancy|0|||
25318906|NCT00797667|50634464|FG000|Overall Study|Protocol Violation|2|||
25318907|NCT00797667|50634465|FG001|Overall Study|Protocol Violation|7|||
25318908|NCT00797667|50634466|FG002|Overall Study|Protocol Violation|0|||
25318909|NCT00797667|50634464|FG000|Overall Study|Study Terminated by Sponsor|217|||
25318910|NCT00797667|50634465|FG001|Overall Study|Study Terminated by Sponsor|216|||
25318911|NCT00797667|50634466|FG002|Overall Study|Study Terminated by Sponsor|115|||
25318912|NCT00797667|50634464|FG000|Overall Study|Withdrawal by Subject|9|||
25318913|NCT00797667|50634465|FG001|Overall Study|Withdrawal by Subject|14|||
25318914|NCT00797667|50634466|FG002|Overall Study|Withdrawal by Subject|2|||
25318915|NCT00797667|50634464|FG000|Overall Study|Adverse Event|19|||
25318916|NCT00797667|50634465|FG001|Overall Study|Adverse Event|8|||
25318917|NCT00797667|50634466|FG002|Overall Study|Adverse Event|8|||
25318918|NCT00950807|50634474|FG000|Treatment Period 1|Lack of Efficacy|1|||
25318919|NCT00950807|50634475|FG001|Treatment Period 1|Lack of Efficacy|0|||
25318920|NCT00950807|50634476|FG002|Treatment Period 1|Lack of Efficacy|0|||
25318921|NCT00950807|50634477|FG003|Treatment Period 1|Lack of Efficacy|0|||
25318922|NCT00950807|50634478|FG004|Treatment Period 1|Lack of Efficacy|0|||
25318923|NCT00950807|50634479|FG005|Treatment Period 1|Lack of Efficacy|1|||
25318924|NCT00950807|50634480|FG006|Treatment Period 1|Lack of Efficacy|0|||
25318925|NCT00950807|50634481|FG007|Treatment Period 1|Lack of Efficacy|0|||
25226010|NCT00086346|50505011|FG001|Patients Dosed With Test Article|Adverse Event|11|||
25226011|NCT00086346|50505010|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
25226012|NCT00086346|50505011|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
25226013|NCT00086346|50505010|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
25226014|NCT00086346|50505011|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
25226015|NCT00086346|50505010|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
25318926|NCT00950807|50634482|FG008|Treatment Period 1|Lack of Efficacy|0|||
25318927|NCT00950807|50634483|FG009|Treatment Period 1|Lack of Efficacy|0|||
25318928|NCT00950807|50634474|FG000|Treatment Period 1|Protocol Violation|1|||
25318929|NCT00950807|50634475|FG001|Treatment Period 1|Protocol Violation|0|||
25226016|NCT00086346|50505011|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
25226017|NCT00086346|50505010|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
25226018|NCT00086346|50505011|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
25226019|NCT00086346|50505010|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
25226020|NCT00086346|50505011|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
25226021|NCT00085566|50505020|FG000|Overall Study|Adverse Event|0|||
25226022|NCT00085566|50505021|FG001|Overall Study|Adverse Event|0|||
25226023|NCT00085566|50505022|FG002|Overall Study|Adverse Event|10|||
25226024|NCT00085566|50505020|FG000|Overall Study|Patient Not treated|0|||
25226025|NCT00085566|50505021|FG001|Overall Study|Patient Not treated|0|||
25226026|NCT00085566|50505022|FG002|Overall Study|Patient Not treated|3|||
25226027|NCT00085566|50505020|FG000|Overall Study|Clinical progression|0|||
25226028|NCT00085566|50505021|FG001|Overall Study|Clinical progression|0|||
25226029|NCT00085566|50505022|FG002|Overall Study|Clinical progression|1|||
25226030|NCT00085098|50505032|FG000|Overall Study|Withdrawal by Subject|0|||
25226031|NCT00085098|50505033|FG001|Overall Study|Withdrawal by Subject|1|||
25226032|NCT00085098|50505032|FG000|Overall Study|Ineligible|1|||
25318930|NCT00950807|50634476|FG002|Treatment Period 1|Protocol Violation|0|||
25226033|NCT00085098|50505033|FG001|Overall Study|Ineligible|1|||
25226034|NCT00084864|50505046|FG000|Overall Study|Adverse Event|1|||
25226035|NCT00084864|50505047|FG001|Overall Study|Adverse Event|0|||
25318931|NCT00950807|50634477|FG003|Treatment Period 1|Protocol Violation|0|||
25318932|NCT00950807|50634478|FG004|Treatment Period 1|Protocol Violation|0|||
25318933|NCT00950807|50634479|FG005|Treatment Period 1|Protocol Violation|0|||
25318934|NCT00950807|50634480|FG006|Treatment Period 1|Protocol Violation|0|||
25318935|NCT00950807|50634481|FG007|Treatment Period 1|Protocol Violation|0|||
25318936|NCT00950807|50634482|FG008|Treatment Period 1|Protocol Violation|0|||
25318937|NCT00950807|50634483|FG009|Treatment Period 1|Protocol Violation|0|||
25318938|NCT00950807|50634474|FG000|Treatment Period 1|Lost to Follow-up|0|||
25318939|NCT00950807|50634475|FG001|Treatment Period 1|Lost to Follow-up|0|||
25318940|NCT00950807|50634476|FG002|Treatment Period 1|Lost to Follow-up|1|||
25318941|NCT00950807|50634477|FG003|Treatment Period 1|Lost to Follow-up|0|||
25318942|NCT00950807|50634478|FG004|Treatment Period 1|Lost to Follow-up|0|||
25318943|NCT00950807|50634479|FG005|Treatment Period 1|Lost to Follow-up|0|||
25318944|NCT00950807|50634480|FG006|Treatment Period 1|Lost to Follow-up|0|||
25318945|NCT00950807|50634481|FG007|Treatment Period 1|Lost to Follow-up|0|||
25318946|NCT00950807|50634482|FG008|Treatment Period 1|Lost to Follow-up|0|||
25318947|NCT00950807|50634483|FG009|Treatment Period 1|Lost to Follow-up|0|||
25318948|NCT00950807|50634474|FG000|Treatment Period 1|Withdrawal by Subject|1|||
25318949|NCT00950807|50634475|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25318950|NCT00950807|50634476|FG002|Treatment Period 1|Withdrawal by Subject|0|||
25318951|NCT00950807|50634477|FG003|Treatment Period 1|Withdrawal by Subject|0|||
25318952|NCT00950807|50634478|FG004|Treatment Period 1|Withdrawal by Subject|1|||
25318953|NCT00950807|50634479|FG005|Treatment Period 1|Withdrawal by Subject|0|||
25318954|NCT00950807|50634480|FG006|Treatment Period 1|Withdrawal by Subject|0|||
25318955|NCT00950807|50634481|FG007|Treatment Period 1|Withdrawal by Subject|0|||
25318956|NCT00950807|50634482|FG008|Treatment Period 1|Withdrawal by Subject|1|||
25318957|NCT00950807|50634483|FG009|Treatment Period 1|Withdrawal by Subject|0|||
25318958|NCT00950807|50634474|FG000|Treatment Period 1|Adverse Event|0|||
25318959|NCT00950807|50634475|FG001|Treatment Period 1|Adverse Event|0|||
25318960|NCT00950807|50634476|FG002|Treatment Period 1|Adverse Event|0|||
25318961|NCT00950807|50634477|FG003|Treatment Period 1|Adverse Event|0|||
25318962|NCT00950807|50634478|FG004|Treatment Period 1|Adverse Event|0|||
25318963|NCT00950807|50634479|FG005|Treatment Period 1|Adverse Event|1|||
25318964|NCT00950807|50634480|FG006|Treatment Period 1|Adverse Event|0|||
25318965|NCT00950807|50634481|FG007|Treatment Period 1|Adverse Event|0|||
25318966|NCT00950807|50634482|FG008|Treatment Period 1|Adverse Event|0|||
25318967|NCT00950807|50634483|FG009|Treatment Period 1|Adverse Event|0|||
25318968|NCT00950807|50634474|FG000|Washout Period 1|Lack of Efficacy|0|||
25318969|NCT00950807|50634475|FG001|Washout Period 1|Lack of Efficacy|0|||
25318970|NCT00950807|50634476|FG002|Washout Period 1|Lack of Efficacy|0|||
25318971|NCT00950807|50634477|FG003|Washout Period 1|Lack of Efficacy|0|||
25318972|NCT00950807|50634478|FG004|Washout Period 1|Lack of Efficacy|0|||
25318973|NCT00950807|50634479|FG005|Washout Period 1|Lack of Efficacy|0|||
25318974|NCT00950807|50634480|FG006|Washout Period 1|Lack of Efficacy|1|||
25318975|NCT00950807|50634481|FG007|Washout Period 1|Lack of Efficacy|0|||
25318976|NCT00950807|50634482|FG008|Washout Period 1|Lack of Efficacy|0|||
25318977|NCT00950807|50634483|FG009|Washout Period 1|Lack of Efficacy|0|||
25318978|NCT00950807|50634474|FG000|Washout Period 1|Withdrawal by Subject|0|||
25318979|NCT00950807|50634475|FG001|Washout Period 1|Withdrawal by Subject|0|||
25318980|NCT00950807|50634476|FG002|Washout Period 1|Withdrawal by Subject|0|||
25318981|NCT00950807|50634477|FG003|Washout Period 1|Withdrawal by Subject|0|||
25318982|NCT00950807|50634478|FG004|Washout Period 1|Withdrawal by Subject|0|||
25318983|NCT00950807|50634479|FG005|Washout Period 1|Withdrawal by Subject|0|||
25318984|NCT00950807|50634480|FG006|Washout Period 1|Withdrawal by Subject|0|||
25318985|NCT00950807|50634481|FG007|Washout Period 1|Withdrawal by Subject|0|||
25318986|NCT00950807|50634482|FG008|Washout Period 1|Withdrawal by Subject|1|||
25318987|NCT00950807|50634483|FG009|Washout Period 1|Withdrawal by Subject|0|||
25318988|NCT00950807|50634474|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
25318989|NCT00950807|50634475|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
25318990|NCT00950807|50634476|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
25318991|NCT00950807|50634477|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
25318992|NCT00950807|50634478|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
25318993|NCT00950807|50634479|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
25318994|NCT00950807|50634480|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
25318995|NCT00950807|50634481|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
25318996|NCT00950807|50634482|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
25318997|NCT00950807|50634483|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
25318998|NCT00950807|50634474|FG000|Washout Period 1|Adverse Event|2|||
25318999|NCT00950807|50634475|FG001|Washout Period 1|Adverse Event|0|||
25319000|NCT00950807|50634476|FG002|Washout Period 1|Adverse Event|0|||
25319001|NCT00950807|50634477|FG003|Washout Period 1|Adverse Event|1|||
25319002|NCT00950807|50634478|FG004|Washout Period 1|Adverse Event|1|||
25319003|NCT00950807|50634479|FG005|Washout Period 1|Adverse Event|0|||
25319004|NCT00950807|50634480|FG006|Washout Period 1|Adverse Event|0|||
25319005|NCT00950807|50634481|FG007|Washout Period 1|Adverse Event|0|||
25319006|NCT00950807|50634482|FG008|Washout Period 1|Adverse Event|0|||
25319007|NCT00950807|50634483|FG009|Washout Period 1|Adverse Event|0|||
25319008|NCT00950807|50634474|FG000|Treatment Period 2|Lack of Efficacy|1|||
25319009|NCT00950807|50634475|FG001|Treatment Period 2|Lack of Efficacy|0|||
25319010|NCT00950807|50634476|FG002|Treatment Period 2|Lack of Efficacy|0|||
25319011|NCT00950807|50634477|FG003|Treatment Period 2|Lack of Efficacy|0|||
25319012|NCT00950807|50634478|FG004|Treatment Period 2|Lack of Efficacy|0|||
25319013|NCT00950807|50634479|FG005|Treatment Period 2|Lack of Efficacy|0|||
25319014|NCT00950807|50634480|FG006|Treatment Period 2|Lack of Efficacy|0|||
25319015|NCT00950807|50634481|FG007|Treatment Period 2|Lack of Efficacy|0|||
25319016|NCT00950807|50634482|FG008|Treatment Period 2|Lack of Efficacy|0|||
25319017|NCT00950807|50634483|FG009|Treatment Period 2|Lack of Efficacy|0|||
25319018|NCT00950807|50634474|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25319019|NCT00950807|50634475|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25319020|NCT00950807|50634476|FG002|Treatment Period 2|Withdrawal by Subject|0|||
25319021|NCT00950807|50634477|FG003|Treatment Period 2|Withdrawal by Subject|0|||
25319022|NCT00950807|50634478|FG004|Treatment Period 2|Withdrawal by Subject|0|||
25319023|NCT00950807|50634479|FG005|Treatment Period 2|Withdrawal by Subject|0|||
25319024|NCT00950807|50634480|FG006|Treatment Period 2|Withdrawal by Subject|1|||
25319025|NCT00950807|50634481|FG007|Treatment Period 2|Withdrawal by Subject|2|||
25319026|NCT00950807|50634482|FG008|Treatment Period 2|Withdrawal by Subject|0|||
25319027|NCT00950807|50634483|FG009|Treatment Period 2|Withdrawal by Subject|0|||
25319028|NCT00950807|50634474|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
25319029|NCT00950807|50634475|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
25319030|NCT00950807|50634476|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
25226036|NCT00084864|50505048|FG002|Overall Study|Adverse Event|0|||
25226037|NCT00084864|50505049|FG003|Overall Study|Adverse Event|0|||
25226038|NCT00084318|50505061|FG000|Overall Study|Withdrawal by Subject|5|||
25319031|NCT00950807|50634477|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
25319032|NCT00950807|50634478|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
25319033|NCT00950807|50634479|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
25319034|NCT00950807|50634480|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
25319035|NCT00950807|50634481|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
25319036|NCT00950807|50634482|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
25319037|NCT00950807|50634483|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
25319038|NCT00950807|50634474|FG000|Treatment Period 2|Adverse Event|0|||
25319039|NCT00950807|50634475|FG001|Treatment Period 2|Adverse Event|1|||
25319040|NCT00950807|50634476|FG002|Treatment Period 2|Adverse Event|0|||
25319041|NCT00950807|50634477|FG003|Treatment Period 2|Adverse Event|1|||
25319042|NCT00950807|50634478|FG004|Treatment Period 2|Adverse Event|0|||
25319043|NCT00950807|50634479|FG005|Treatment Period 2|Adverse Event|1|||
25319044|NCT00950807|50634480|FG006|Treatment Period 2|Adverse Event|0|||
25319045|NCT00950807|50634481|FG007|Treatment Period 2|Adverse Event|1|||
25319046|NCT00950807|50634482|FG008|Treatment Period 2|Adverse Event|0|||
25319047|NCT00950807|50634483|FG009|Treatment Period 2|Adverse Event|0|||
25319048|NCT00950807|50634474|FG000|Washout Period 2|Lack of Efficacy|1|||
25319049|NCT00950807|50634475|FG001|Washout Period 2|Lack of Efficacy|0|||
24976591|NCT00049322|50065501|FG001|Overall Study|refused angio|3|||
25319050|NCT00950807|50634476|FG002|Washout Period 2|Lack of Efficacy|0|||
25319051|NCT00950807|50634477|FG003|Washout Period 2|Lack of Efficacy|0|||
25319052|NCT00950807|50634478|FG004|Washout Period 2|Lack of Efficacy|0|||
25319053|NCT00950807|50634479|FG005|Washout Period 2|Lack of Efficacy|0|||
25319054|NCT00950807|50634480|FG006|Washout Period 2|Lack of Efficacy|0|||
25319055|NCT00950807|50634481|FG007|Washout Period 2|Lack of Efficacy|0|||
25319056|NCT00950807|50634482|FG008|Washout Period 2|Lack of Efficacy|0|||
25319057|NCT00950807|50634483|FG009|Washout Period 2|Lack of Efficacy|0|||
25319058|NCT00950807|50634474|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
25319059|NCT00950807|50634475|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
25319060|NCT00950807|50634476|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
25319061|NCT00950807|50634477|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
25319062|NCT00950807|50634478|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
24976592|NCT03437512|50065511|FG000|Randomized|Withdrawal by Subject|0|||
24976593|NCT03437512|50065512|FG001|Randomized|Withdrawal by Subject|2|||
24976594|NCT03437512|50065511|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
25226039|NCT00084318|50505062|FG001|Overall Study|Withdrawal by Subject|2|||
25226040|NCT00084318|50505061|FG000|Overall Study|Protocol Violation|15|||
25226041|NCT00084318|50505062|FG001|Overall Study|Protocol Violation|11|||
25226042|NCT00084318|50505061|FG000|Overall Study|No protocol treatment|2|||
25319063|NCT00950807|50634479|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
25319064|NCT00950807|50634480|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
25319065|NCT00950807|50634481|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
25319066|NCT00950807|50634482|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
25319067|NCT00950807|50634483|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
25319068|NCT00950807|50634474|FG000|Washout Period 2|Adverse Event|3|||
25226043|NCT00084318|50505062|FG001|Overall Study|No protocol treatment|0|||
25226044|NCT00084084|50505070|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
25226045|NCT00084084|50505070|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
25226046|NCT00083616|50505075|FG000|Overall Study|Disease Progression|16|||
25226047|NCT00083616|50505075|FG000|Overall Study|Lost to Follow-up|1|||
25226048|NCT00083616|50505075|FG000|Overall Study|Physician Decision|2|||
25226049|NCT00083616|50505075|FG000|Overall Study|Withdrawal by Subject|3|||
25226050|NCT00083616|50505075|FG000|Overall Study|Ineligibility determined|2|||
25226051|NCT00083616|50505075|FG000|Overall Study|Non-compliance|1|||
25226052|NCT00083616|50505075|FG000|Overall Study|Other|6|||
25226053|NCT00083226|50505079|FG000|Overall Study|Lack of Efficacy|19|||
25226054|NCT00083226|50505079|FG000|Overall Study|Adverse Event|9|||
25226055|NCT00083226|50505079|FG000|Overall Study|Death|4|||
25226056|NCT00083226|50505079|FG000|Overall Study|Withdrawal by Subject|4|||
25226057|NCT00083226|50505079|FG000|Overall Study|Other|2|||
25226058|NCT00083226|50505079|FG000|Overall Study|ineligible or not receiving treatment|4|||
25226059|NCT00082758|50505086|FG000|Overall Study|Adverse Event|0|||
25226060|NCT00082758|50505087|FG001|Overall Study|Adverse Event|2|||
25226061|NCT00082758|50505088|FG002|Overall Study|Adverse Event|0|||
25226062|NCT00082758|50505086|FG000|Overall Study|Lack of Efficacy|12|||
25226063|NCT00082758|50505087|FG001|Overall Study|Lack of Efficacy|13|||
25226064|NCT00082758|50505088|FG002|Overall Study|Lack of Efficacy|0|||
25226065|NCT00082758|50505086|FG000|Overall Study|Physician Decision|0|||
25226066|NCT00082758|50505087|FG001|Overall Study|Physician Decision|1|||
25226067|NCT00082758|50505088|FG002|Overall Study|Physician Decision|0|||
25226068|NCT00082758|50505086|FG000|Overall Study|Withdrawal by Subject|3|||
25226069|NCT00082758|50505087|FG001|Overall Study|Withdrawal by Subject|0|||
25226070|NCT00082758|50505088|FG002|Overall Study|Withdrawal by Subject|0|||
25226071|NCT00082758|50505086|FG000|Overall Study|Protocol Violation|0|||
25226072|NCT00082758|50505087|FG001|Overall Study|Protocol Violation|1|||
25226073|NCT00082758|50505088|FG002|Overall Study|Protocol Violation|0|||
25226074|NCT00088452|50505099|FG000|Overall Study|Did not receive intervention|1|||
25226075|NCT00088452|50505100|FG001|Overall Study|Did not receive intervention|0|||
25226076|NCT00088452|50505101|FG002|Overall Study|Did not receive intervention|1|||
25226077|NCT04686084|50505200|FG000|Overall Study|Lost to Follow-up|1|||
25226078|NCT04685538|50505207|FG000|Overall Study|Adverse Event|0|||
25226079|NCT04685538|50505208|FG001|Overall Study|Adverse Event|1|||
25226080|NCT04685538|50505207|FG000|Overall Study|Lost to Follow-up|0|||
25226081|NCT04685538|50505208|FG001|Overall Study|Lost to Follow-up|2|||
25226082|NCT04213326|50505220|FG000|Overall Study|Consent withdrawn|51|||
25226083|NCT04213326|50505221|FG001|Overall Study|Consent withdrawn|241|||
25226084|NCT04213326|50505220|FG000|Overall Study|Lost to Follow-up|50|||
25226085|NCT04213326|50505221|FG001|Overall Study|Lost to Follow-up|902|||
25226086|NCT04213326|50505220|FG000|Overall Study|Protocol Violation|3|||
25226087|NCT04213326|50505221|FG001|Overall Study|Protocol Violation|25|||
25226088|NCT04213326|50505220|FG000|Overall Study|Participant eligibility changed|106|||
25226089|NCT04213326|50505221|FG001|Overall Study|Participant eligibility changed|19|||
25226090|NCT04213326|50505220|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
25226091|NCT04213326|50505221|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
25226092|NCT04213326|50505220|FG000|Overall Study|Incomplete study visit|0|||
25226093|NCT04213326|50505221|FG001|Overall Study|Incomplete study visit|367|||
25226094|NCT01625286|50505234|FG000|Overall Study|Adverse Event|0|||
25226095|NCT01625286|50505235|FG001|Overall Study|Adverse Event|0|||
25226096|NCT01625286|50505236|FG002|Overall Study|Adverse Event|0|||
25226097|NCT01625286|50505237|FG003|Overall Study|Adverse Event|0|||
25226098|NCT01625286|50505238|FG004|Overall Study|Adverse Event|1|||
25226099|NCT01625286|50505239|FG005|Overall Study|Adverse Event|2|||
25226100|NCT01625286|50505240|FG006|Overall Study|Adverse Event|1|||
25226101|NCT01625286|50505234|FG000|Overall Study|Death|0|||
25226102|NCT01625286|50505235|FG001|Overall Study|Death|0|||
25226103|NCT01625286|50505236|FG002|Overall Study|Death|1|||
25226104|NCT01625286|50505237|FG003|Overall Study|Death|1|||
25226105|NCT01625286|50505238|FG004|Overall Study|Death|0|||
25226106|NCT01625286|50505239|FG005|Overall Study|Death|11|||
25226107|NCT01625286|50505240|FG006|Overall Study|Death|16|||
25226108|NCT01625286|50505234|FG000|Overall Study|Withdrawal by Subject|0|||
25226109|NCT01625286|50505235|FG001|Overall Study|Withdrawal by Subject|1|||
25226110|NCT01625286|50505236|FG002|Overall Study|Withdrawal by Subject|0|||
25226111|NCT01625286|50505237|FG003|Overall Study|Withdrawal by Subject|1|||
25226112|NCT01625286|50505238|FG004|Overall Study|Withdrawal by Subject|0|||
25226113|NCT01625286|50505239|FG005|Overall Study|Withdrawal by Subject|0|||
25226114|NCT01625286|50505240|FG006|Overall Study|Withdrawal by Subject|1|||
25226115|NCT01625286|50505234|FG000|Overall Study|Any reason not specifically recorded|0|||
25226116|NCT01625286|50505235|FG001|Overall Study|Any reason not specifically recorded|0|||
25226117|NCT01625286|50505236|FG002|Overall Study|Any reason not specifically recorded|0|||
25226118|NCT01625286|50505237|FG003|Overall Study|Any reason not specifically recorded|0|||
25226119|NCT01625286|50505238|FG004|Overall Study|Any reason not specifically recorded|0|||
25319069|NCT00950807|50634475|FG001|Washout Period 2|Adverse Event|0|||
25226120|NCT01625286|50505239|FG005|Overall Study|Any reason not specifically recorded|1|||
25226121|NCT01625286|50505240|FG006|Overall Study|Any reason not specifically recorded|0|||
25226122|NCT01625286|50505234|FG000|Overall Study|Progressive disease|6|||
25226123|NCT01625286|50505235|FG001|Overall Study|Progressive disease|3|||
25226124|NCT01625286|50505236|FG002|Overall Study|Progressive disease|4|||
25226125|NCT01625286|50505237|FG003|Overall Study|Progressive disease|5|||
25226126|NCT01625286|50505238|FG004|Overall Study|Progressive disease|5|||
25226127|NCT01625286|50505239|FG005|Overall Study|Progressive disease|0|||
25226128|NCT01625286|50505240|FG006|Overall Study|Progressive disease|0|||
25226129|NCT01625286|50505234|FG000|Overall Study|Lost to Follow-up|0|||
25226130|NCT01625286|50505235|FG001|Overall Study|Lost to Follow-up|0|||
25226131|NCT01625286|50505236|FG002|Overall Study|Lost to Follow-up|0|||
25226132|NCT01625286|50505237|FG003|Overall Study|Lost to Follow-up|0|||
25226133|NCT01625286|50505238|FG004|Overall Study|Lost to Follow-up|0|||
25226134|NCT01625286|50505239|FG005|Overall Study|Lost to Follow-up|0|||
25226135|NCT01625286|50505240|FG006|Overall Study|Lost to Follow-up|1|||
25226136|NCT04083222|50505285|FG000|Overall Study|Voluntary Withdrawal|0|||
25226137|NCT04083222|50505286|FG001|Overall Study|Voluntary Withdrawal|1|||
25226138|NCT04083222|50505285|FG000|Overall Study|Reason not Specified|0|||
25226139|NCT04083222|50505286|FG001|Overall Study|Reason not Specified|1|||
25226140|NCT03286842|50505292|FG000|Overall Study|Patients rolled over to another study|80|||
25226141|NCT00639678|50505307|FG000|Overall Study|Withdrawal by Subject|3|||
25226142|NCT00639678|50505308|FG001|Overall Study|Withdrawal by Subject|0|||
25226143|NCT00639678|50505309|FG002|Overall Study|Withdrawal by Subject|4|||
25226144|NCT00639678|50505310|FG003|Overall Study|Withdrawal by Subject|0|||
25226145|NCT00639678|50505307|FG000|Overall Study|Lost to Follow-up|1|||
25226146|NCT00639678|50505308|FG001|Overall Study|Lost to Follow-up|0|||
25226147|NCT00639678|50505309|FG002|Overall Study|Lost to Follow-up|6|||
25226148|NCT00639678|50505310|FG003|Overall Study|Lost to Follow-up|0|||
25226149|NCT00639678|50505307|FG000|Overall Study|Adverse Event|0|||
25226150|NCT00639678|50505308|FG001|Overall Study|Adverse Event|1|||
25226151|NCT00639678|50505309|FG002|Overall Study|Adverse Event|0|||
25226152|NCT00639678|50505310|FG003|Overall Study|Adverse Event|0|||
25226153|NCT00639678|50505307|FG000|Overall Study|Lack of Compliance|0|||
25226154|NCT00639678|50505308|FG001|Overall Study|Lack of Compliance|0|||
25226155|NCT00639678|50505309|FG002|Overall Study|Lack of Compliance|1|||
25226156|NCT00639678|50505310|FG003|Overall Study|Lack of Compliance|0|||
25226157|NCT00638508|50505335|FG000|Overall Study|Physician Decision|5|||
25226158|NCT00638508|50505336|FG001|Overall Study|Physician Decision|2|||
25226159|NCT00637806|50505349|FG000|Double-blind Phase|Study Discontinued|2|||
25226160|NCT00637806|50505350|FG001|Double-blind Phase|Study Discontinued|0|||
25226161|NCT00637806|50505351|FG002|Double-blind Phase|Study Discontinued|1|||
25226162|NCT00637806|50505352|FG003|Double-blind Phase|Study Discontinued|0|||
25226163|NCT00637806|50505349|FG000|Extension Phase|Study Discontinued|0|||
25226164|NCT00637806|50505350|FG001|Extension Phase|Study Discontinued|0|||
25226165|NCT00637806|50505351|FG002|Extension Phase|Study Discontinued|0|||
25226166|NCT00637806|50505352|FG003|Extension Phase|Study Discontinued|1|||
25226167|NCT00637728|50505363|FG000|Double-blind Phase|Adverse Event|1|||
25226168|NCT00637728|50505364|FG001|Double-blind Phase|Adverse Event|0|||
25226169|NCT00637728|50505365|FG002|Double-blind Phase|Adverse Event|0|||
25226170|NCT00637728|50505363|FG000|Double-blind Phase|Non-compliance|2|||
25226171|NCT00637728|50505364|FG001|Double-blind Phase|Non-compliance|0|||
25226172|NCT00637728|50505365|FG002|Double-blind Phase|Non-compliance|0|||
25226173|NCT00637728|50505363|FG000|Double-blind Phase|Study Discontinued|1|||
25226174|NCT00637728|50505364|FG001|Double-blind Phase|Study Discontinued|1|||
25226175|NCT00637728|50505365|FG002|Double-blind Phase|Study Discontinued|0|||
25226176|NCT00637572|50505374|FG000|Overall Study|Adverse Event|1|||
25226177|NCT00637572|50505375|FG001|Overall Study|Adverse Event|2|||
25226178|NCT00637572|50505374|FG000|Overall Study|Death|0|||
25226179|NCT00637572|50505375|FG001|Overall Study|Death|1|||
25226180|NCT00637572|50505374|FG000|Overall Study|Lost to Follow-up|0|||
25226181|NCT00637572|50505375|FG001|Overall Study|Lost to Follow-up|1|||
25226182|NCT00637572|50505374|FG000|Overall Study|Physician Decision|1|||
25226183|NCT00637572|50505375|FG001|Overall Study|Physician Decision|1|||
25226184|NCT00637572|50505374|FG000|Overall Study|Withdrawal by Subject|0|||
25226185|NCT00637572|50505375|FG001|Overall Study|Withdrawal by Subject|2|||
25226186|NCT00637572|50505374|FG000|Overall Study|Illicit Drug Use|1|||
25226187|NCT00637572|50505375|FG001|Overall Study|Illicit Drug Use|0|||
25226188|NCT00637416|50505383|FG000|Overall Study|Lost to Follow-up|1|||
25226189|NCT00637416|50505384|FG001|Overall Study|Lost to Follow-up|1|||
25226190|NCT00637416|50505383|FG000|Overall Study|Unable to take study drug|0|||
25226191|NCT00637416|50505384|FG001|Overall Study|Unable to take study drug|1|||
25226192|NCT00636792|50505390|FG000|Overall Study|Adverse Event|16|||
25226193|NCT00636792|50505390|FG000|Overall Study|Physician Decision|7|||
25226194|NCT00636792|50505390|FG000|Overall Study|Progressive Disease|4|||
25226195|NCT00636792|50505390|FG000|Overall Study|Withdrawal by Subject|3|||
25226196|NCT00636792|50505390|FG000|Overall Study|Other|3|||
25226197|NCT00636636|50505422|FG000|Overall Study|Other reason|4|||
25226198|NCT00636636|50505423|FG001|Overall Study|Other reason|6|||
25226199|NCT00636636|50505422|FG000|Overall Study|Adverse Event|19|||
25226200|NCT00636636|50505423|FG001|Overall Study|Adverse Event|8|||
25226201|NCT00636636|50505422|FG000|Overall Study|Lack of Efficacy|7|||
25226202|NCT00636636|50505423|FG001|Overall Study|Lack of Efficacy|12|||
25226203|NCT00636636|50505422|FG000|Overall Study|Protocol Violation|2|||
25226204|NCT00636636|50505423|FG001|Overall Study|Protocol Violation|2|||
25226205|NCT00636636|50505422|FG000|Overall Study|Lost to Follow-up|0|||
25226206|NCT00636636|50505423|FG001|Overall Study|Lost to Follow-up|1|||
25226207|NCT00636636|50505422|FG000|Overall Study|Death|0|||
25226208|NCT00636636|50505423|FG001|Overall Study|Death|1|||
25226209|NCT00636636|50505422|FG000|Overall Study|Withdrawal by Subject|4|||
25226210|NCT00636636|50505423|FG001|Overall Study|Withdrawal by Subject|9|||
25226211|NCT00635778|50505436|FG000|Overall Study|Adverse Event|1|||
25226212|NCT00635778|50505437|FG001|Overall Study|Adverse Event|0|||
25226213|NCT00635778|50505438|FG002|Overall Study|Adverse Event|0|||
25226214|NCT00635778|50505439|FG003|Overall Study|Adverse Event|3|||
25226215|NCT00635778|50505440|FG004|Overall Study|Adverse Event|3|||
25226216|NCT00635778|50505441|FG005|Overall Study|Adverse Event|6|||
25226217|NCT00635778|50505442|FG006|Overall Study|Adverse Event|1|||
25226218|NCT00635778|50505436|FG000|Overall Study|Withdrawal by Subject|0|||
25226219|NCT00635778|50505437|FG001|Overall Study|Withdrawal by Subject|0|||
25226220|NCT00635778|50505438|FG002|Overall Study|Withdrawal by Subject|0|||
25226221|NCT00635778|50505439|FG003|Overall Study|Withdrawal by Subject|1|||
25226222|NCT00635778|50505440|FG004|Overall Study|Withdrawal by Subject|0|||
25226223|NCT00635778|50505441|FG005|Overall Study|Withdrawal by Subject|1|||
25226224|NCT00635778|50505442|FG006|Overall Study|Withdrawal by Subject|1|||
25226225|NCT00635778|50505436|FG000|Overall Study|Progressive disease|0|||
25226226|NCT00635778|50505437|FG001|Overall Study|Progressive disease|3|||
25226227|NCT00635778|50505438|FG002|Overall Study|Progressive disease|3|||
25226228|NCT00635778|50505439|FG003|Overall Study|Progressive disease|4|||
25226229|NCT00635778|50505440|FG004|Overall Study|Progressive disease|5|||
25226230|NCT00635778|50505441|FG005|Overall Study|Progressive disease|14|||
25226231|NCT00635778|50505442|FG006|Overall Study|Progressive disease|4|||
25226232|NCT00634920|50505462|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
25226233|NCT00634920|50505463|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
25226234|NCT00634920|50505464|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
25226235|NCT00634920|50505462|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
25226236|NCT00634920|50505463|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
25226237|NCT00634920|50505464|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
25226238|NCT00634920|50505462|FG000|Period 1 - Pre-Randomization|Rejections|0|||
25226239|NCT00634920|50505463|FG001|Period 1 - Pre-Randomization|Rejections|0|||
25226240|NCT00634920|50505464|FG002|Period 1 - Pre-Randomization|Rejections|55|||
25226241|NCT00634920|50505462|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
25226242|NCT00634920|50505463|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
25226243|NCT00634920|50505464|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
25226244|NCT00634920|50505462|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
25226245|NCT00634920|50505463|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
25226246|NCT00634920|50505464|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
25226247|NCT00634920|50505462|FG000|Period 1 - Pre-Randomization|Other issues|0|||
25226248|NCT00634920|50505463|FG001|Period 1 - Pre-Randomization|Other issues|0|||
25226249|NCT00634920|50505464|FG002|Period 1 - Pre-Randomization|Other issues|6|||
25226250|NCT00634920|50505462|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
25226251|NCT00634920|50505463|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
25226252|NCT00634920|50505464|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
25226253|NCT00634920|50505462|FG000|Period 2 - Post-Randomization|Rejection|11|||
25226254|NCT00634920|50505463|FG001|Period 2 - Post-Randomization|Rejection|5|||
25226255|NCT00634920|50505464|FG002|Period 2 - Post-Randomization|Rejection|0|||
25226256|NCT00634920|50505462|FG000|Period 2 - Post-Randomization|Death|2|||
25226257|NCT00634920|50505463|FG001|Period 2 - Post-Randomization|Death|5|||
25226258|NCT00634920|50505464|FG002|Period 2 - Post-Randomization|Death|0|||
25226259|NCT00634920|50505462|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
25226260|NCT00634920|50505463|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
25226261|NCT00634920|50505464|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
25226262|NCT00634920|50505462|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
25226263|NCT00634920|50505463|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
25226264|NCT00634920|50505464|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
25226265|NCT00634842|50505472|FG000|Overall Study|Adverse Event|2|||
25226266|NCT00634842|50505473|FG001|Overall Study|Adverse Event|3|||
25226267|NCT00634842|50505472|FG000|Overall Study|Protocol Violation|8|||
25226268|NCT00634842|50505473|FG001|Overall Study|Protocol Violation|4|||
25226269|NCT00634842|50505472|FG000|Overall Study|Move to another state|1|||
25226270|NCT00634842|50505473|FG001|Overall Study|Move to another state|0|||
25226271|NCT00634842|50505472|FG000|Overall Study|Inclusion criteria were not met|1|||
25226272|NCT00634842|50505473|FG001|Overall Study|Inclusion criteria were not met|0|||
25226273|NCT00634842|50505472|FG000|Overall Study|Lost to Follow-up|1|||
25226274|NCT00634842|50505473|FG001|Overall Study|Lost to Follow-up|2|||
25226275|NCT00634842|50505472|FG000|Overall Study|Physician Decision|1|||
25226276|NCT00634842|50505473|FG001|Overall Study|Physician Decision|0|||
25226277|NCT00634842|50505472|FG000|Overall Study|Withdrawal by Subject|1|||
25226278|NCT00634842|50505473|FG001|Overall Study|Withdrawal by Subject|3|||
25226279|NCT00634842|50505472|FG000|Overall Study|Lack of time and intolerance to drug|0|||
25226280|NCT00634842|50505473|FG001|Overall Study|Lack of time and intolerance to drug|1|||
25226281|NCT00634842|50505472|FG000|Overall Study|Discontinued due to injection|0|||
25226282|NCT00634842|50505473|FG001|Overall Study|Discontinued due to injection|2|||
25226283|NCT00634842|50505472|FG000|Overall Study|No need of study drug to treat diabetes|0|||
25226284|NCT00634842|50505473|FG001|Overall Study|No need of study drug to treat diabetes|1|||
25226285|NCT00634842|50505472|FG000|Overall Study|No wish to keep taking Avandia|0|||
25226286|NCT00634842|50505473|FG001|Overall Study|No wish to keep taking Avandia|1|||
25226287|NCT00634842|50505472|FG000|Overall Study|Subject off study drug for too long|0|||
25226288|NCT00634842|50505473|FG001|Overall Study|Subject off study drug for too long|1|||
25226289|NCT00633984|50505481|FG000|Overall Study|Lost to Follow-up|0|||
25226290|NCT00633984|50505482|FG001|Overall Study|Lost to Follow-up|6|||
25226291|NCT00633984|50505481|FG000|Overall Study|Withdrawal by Subject|8|||
25226292|NCT00633984|50505482|FG001|Overall Study|Withdrawal by Subject|7|||
25226293|NCT00633984|50505481|FG000|Overall Study|Hospitalized|1|||
25226294|NCT00633984|50505482|FG001|Overall Study|Hospitalized|0|||
25226295|NCT01921218|50505510|FG000|Overall Study|Death|2|||
25226296|NCT01921218|50505511|FG001|Overall Study|Death|1|||
25226297|NCT01921218|50505510|FG000|Overall Study|Withdrawal by Subject|0|||
25226298|NCT01921218|50505511|FG001|Overall Study|Withdrawal by Subject|2|||
25226299|NCT01921218|50505510|FG000|Overall Study|Kidney transplant|1|||
25226300|NCT01921218|50505511|FG001|Overall Study|Kidney transplant|1|||
25226301|NCT00633750|50505517|FG000|Overall Study|Adverse Event|2|||
25226302|NCT00633750|50505517|FG000|Overall Study|Withdrawal by Subject|3|||
25226303|NCT00633360|50505525|FG000|Overall Study|Lost to Follow-up|1|||
25226304|NCT00633360|50505526|FG001|Overall Study|Lost to Follow-up|1|||
25226305|NCT00633360|50505525|FG000|Overall Study|Adverse Event|3|||
25226306|NCT00633360|50505526|FG001|Overall Study|Adverse Event|1|||
25226307|NCT00633360|50505525|FG000|Overall Study|Protocol Violation|0|||
25226308|NCT00633360|50505526|FG001|Overall Study|Protocol Violation|1|||
25226309|NCT00633126|50505534|FG000|Overall Study|Did not receive full dose|1|||
25226310|NCT00989664|50505538|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
25226311|NCT00989664|50505538|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
25226312|NCT00989664|50505538|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
25226313|NCT00989664|50505538|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
25226314|NCT00989664|50505538|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
25226315|NCT00989664|50505538|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
25226316|NCT00989664|50505538|FG000|Long-Term Follow-Up|Death|3|||
25226317|NCT00632736|50505544|FG000|Overall Study|Adverse Event|104|||
25226318|NCT00632736|50505544|FG000|Overall Study|Lost to Follow-up|15|||
25226319|NCT00632736|50505544|FG000|Overall Study|Protocol Violation|14|||
25226320|NCT00632736|50505544|FG000|Overall Study|Withdrawal by Subject|99|||
25226321|NCT00632736|50505544|FG000|Overall Study|Lack of Efficacy|5|||
25226322|NCT00632736|50505544|FG000|Overall Study|Sponsor terminated study|5|||
25226323|NCT00632736|50505544|FG000|Overall Study|Non-compliance|10|||
25226324|NCT00632736|50505544|FG000|Overall Study|Other|16|||
25226325|NCT00989196|50505548|FG000|Treatment Period|Lost to Follow-up|1|||
25226326|NCT00989196|50505549|FG001|Treatment Period|Lost to Follow-up|0|||
25226327|NCT00632502|50505557|FG000|Overall Study|Adverse Event|0|||
25226328|NCT00632502|50505558|FG001|Overall Study|Adverse Event|1|||
25226329|NCT00632502|50505557|FG000|Overall Study|Randomized not treated|3|||
25226330|NCT00632502|50505558|FG001|Overall Study|Randomized not treated|0|||
25226331|NCT00632424|50505568|FG000|Overall Study|Disease Progression|17|||
25226332|NCT00632424|50505568|FG000|Overall Study|Study Drug Toxicity|1|||
25226333|NCT00631488|50505585|FG000|Overall Study|Adverse Event|1|||
25226334|NCT00631488|50505586|FG001|Overall Study|Adverse Event|0|||
25226335|NCT00631488|50505587|FG002|Overall Study|Adverse Event|0|||
25226336|NCT00631488|50505585|FG000|Overall Study|Lost to Follow-up|2|||
25226337|NCT00631488|50505586|FG001|Overall Study|Lost to Follow-up|2|||
25226338|NCT00631488|50505587|FG002|Overall Study|Lost to Follow-up|0|||
25226339|NCT00631488|50505585|FG000|Overall Study|Physician Decision|1|||
25226340|NCT00631488|50505586|FG001|Overall Study|Physician Decision|0|||
25226341|NCT00631488|50505587|FG002|Overall Study|Physician Decision|1|||
25226342|NCT00631488|50505585|FG000|Overall Study|Protocol Violation|0|||
25226343|NCT00631488|50505586|FG001|Overall Study|Protocol Violation|0|||
25226344|NCT00631488|50505587|FG002|Overall Study|Protocol Violation|1|||
25226345|NCT00988884|50505597|FG000|Overall Study|Adverse Event|0|||
25226346|NCT00988884|50505598|FG001|Overall Study|Adverse Event|1|||
25226347|NCT00988884|50505597|FG000|Overall Study|Lost to Follow-up|20|||
25226348|NCT00988884|50505598|FG001|Overall Study|Lost to Follow-up|16|||
25226349|NCT00988884|50505597|FG000|Overall Study|Protocol Violation|0|||
25226350|NCT00988884|50505598|FG001|Overall Study|Protocol Violation|1|||
25226351|NCT00988884|50505597|FG000|Overall Study|Withdrawal by Subject|15|||
25226352|NCT00988884|50505598|FG001|Overall Study|Withdrawal by Subject|18|||
25226353|NCT00631020|50505604|FG000|Overall Study|Lost to Follow-up|7|||
25226354|NCT00631020|50505604|FG000|Overall Study|Incarcerated|1|||
25226355|NCT00987402|50505610|FG000|Overall Study|Insufficient data entry|86|||
25226356|NCT00987402|50505611|FG001|Overall Study|Insufficient data entry|98|||
25226357|NCT00630864|50505617|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
25226358|NCT00630864|50505617|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
25226359|NCT00630786|50505624|FG000|Overall Study|Physician Decision|0|||
25226360|NCT00630786|50505625|FG001|Overall Study|Physician Decision|0|||
25226361|NCT00630786|50505626|FG002|Overall Study|Physician Decision|1|||
25226362|NCT00630786|50505624|FG000|Overall Study|Withdrawal by Subject|0|||
25226363|NCT00630786|50505625|FG001|Overall Study|Withdrawal by Subject|1|||
25226364|NCT00630786|50505626|FG002|Overall Study|Withdrawal by Subject|1|||
25226365|NCT00630786|50505624|FG000|Overall Study|Lost to Follow-up|0|||
25226366|NCT00630786|50505625|FG001|Overall Study|Lost to Follow-up|1|||
25226367|NCT00630786|50505626|FG002|Overall Study|Lost to Follow-up|0|||
25226368|NCT00630786|50505624|FG000|Overall Study|Other|1|||
25226369|NCT00630786|50505625|FG001|Overall Study|Other|0|||
25226370|NCT00630786|50505626|FG002|Overall Study|Other|0|||
25226371|NCT00630396|50505632|FG000|Overall Study|Death|4|||
25226372|NCT00630396|50505632|FG000|Overall Study|Lost to Follow-up|3|||
25226373|NCT00985686|50505640|FG000|Overall Study|Lost to Follow-up|1|||
25226374|NCT00985686|50505641|FG001|Overall Study|Lost to Follow-up|1|||
25226375|NCT00985686|50505642|FG002|Overall Study|Lost to Follow-up|0|||
25226376|NCT00985686|50505643|FG003|Overall Study|Lost to Follow-up|2|||
25226377|NCT00984594|50505653|FG000|Overall Study|Lost to Follow-up|1|||
25226378|NCT00984594|50505654|FG001|Overall Study|Lost to Follow-up|0|||
25226379|NCT00984594|50505653|FG000|Overall Study|Withdrawal by Subject|0|||
25226380|NCT00984594|50505654|FG001|Overall Study|Withdrawal by Subject|1|||
25226381|NCT00984204|50505662|FG000|Overall Study|Death|1|||
25226382|NCT00984204|50505662|FG000|Overall Study|Lost to Follow-up|4|||
25226383|NCT00984204|50505662|FG000|Overall Study|Lack of Efficacy|10|||
25226384|NCT00983892|50505668|FG000|Overall Study|Withdrawal by Subject|10|||
25226385|NCT00983892|50505669|FG001|Overall Study|Withdrawal by Subject|12|||
25226386|NCT00983580|50505677|FG000|Overall Study|Cancel Prior to treatment|1|||
25226387|NCT00983580|50505678|FG001|Overall Study|Cancel Prior to treatment|3|||
25226388|NCT00983580|50505677|FG000|Overall Study|Protocol Violation|1|||
25226389|NCT00983580|50505678|FG001|Overall Study|Protocol Violation|1|||
25226390|NCT00983580|50505677|FG000|Overall Study|Ineligible|3|||
25226391|NCT00983580|50505678|FG001|Overall Study|Ineligible|0|||
25226392|NCT00982878|50505685|FG000|Overall Study|Physician Decision|1|||
25226393|NCT00982488|50505694|FG000|Overall Study|Administrative reason by sponsor|81|||
25226394|NCT00982488|50505695|FG001|Overall Study|Administrative reason by sponsor|3|||
25226395|NCT00982488|50505696|FG002|Overall Study|Administrative reason by sponsor|11|||
25226396|NCT00982488|50505697|FG003|Overall Study|Administrative reason by sponsor|0|||
25226397|NCT00982488|50505698|FG004|Overall Study|Administrative reason by sponsor|0|||
25226398|NCT00982488|50505694|FG000|Overall Study|Adverse event unrelated to study drug|5|||
25226399|NCT00982488|50505695|FG001|Overall Study|Adverse event unrelated to study drug|1|||
25226400|NCT00982488|50505696|FG002|Overall Study|Adverse event unrelated to study drug|0|||
25226401|NCT00982488|50505697|FG003|Overall Study|Adverse event unrelated to study drug|0|||
25226402|NCT00982488|50505698|FG004|Overall Study|Adverse event unrelated to study drug|0|||
25226403|NCT00982488|50505694|FG000|Overall Study|Death|11|||
25226404|NCT00982488|50505695|FG001|Overall Study|Death|0|||
25226405|NCT00982488|50505696|FG002|Overall Study|Death|2|||
25226406|NCT00982488|50505697|FG003|Overall Study|Death|0|||
25226407|NCT00982488|50505698|FG004|Overall Study|Death|0|||
25226408|NCT00982488|50505694|FG000|Overall Study|Disease progression|30|||
25226409|NCT00982488|50505695|FG001|Overall Study|Disease progression|5|||
25319070|NCT00950807|50634476|FG002|Washout Period 2|Adverse Event|0|||
25077468|NCT00002663|50185280|FG005|Overall Study|Death|13|||
25226410|NCT00982488|50505696|FG002|Overall Study|Disease progression|10|||
25226411|NCT00982488|50505697|FG003|Overall Study|Disease progression|1|||
25226412|NCT00982488|50505698|FG004|Overall Study|Disease progression|1|||
25226413|NCT00982488|50505694|FG000|Overall Study|Lost to Follow-up|1|||
25226414|NCT00982488|50505695|FG001|Overall Study|Lost to Follow-up|0|||
25226415|NCT00982488|50505696|FG002|Overall Study|Lost to Follow-up|0|||
25226416|NCT00982488|50505697|FG003|Overall Study|Lost to Follow-up|0|||
25226417|NCT00982488|50505698|FG004|Overall Study|Lost to Follow-up|0|||
25226418|NCT00982488|50505694|FG000|Overall Study|Maximum clinical benefit|1|||
25226419|NCT00982488|50505695|FG001|Overall Study|Maximum clinical benefit|1|||
25226420|NCT00982488|50505696|FG002|Overall Study|Maximum clinical benefit|1|||
25226421|NCT00982488|50505697|FG003|Overall Study|Maximum clinical benefit|0|||
25226422|NCT00982488|50505698|FG004|Overall Study|Maximum clinical benefit|0|||
25077469|NCT00002663|50185281|FG006|Overall Study|Death|0|||
25226423|NCT00982488|50505694|FG000|Overall Study|Other|15|||
25226424|NCT00982488|50505695|FG001|Overall Study|Other|1|||
25226425|NCT00982488|50505696|FG002|Overall Study|Other|3|||
25226426|NCT00982488|50505697|FG003|Overall Study|Other|1|||
25226427|NCT00982488|50505698|FG004|Overall Study|Other|0|||
25226428|NCT00982488|50505694|FG000|Overall Study|Poor compliance/noncompliance|0|||
25226429|NCT00982488|50505695|FG001|Overall Study|Poor compliance/noncompliance|1|||
25226430|NCT00982488|50505696|FG002|Overall Study|Poor compliance/noncompliance|0|||
25226431|NCT00982488|50505697|FG003|Overall Study|Poor compliance/noncompliance|0|||
25226432|NCT00982488|50505698|FG004|Overall Study|Poor compliance/noncompliance|0|||
25226433|NCT00982488|50505694|FG000|Overall Study|Stem cell transplant|2|||
25226434|NCT00982488|50505695|FG001|Overall Study|Stem cell transplant|0|||
25226435|NCT00982488|50505696|FG002|Overall Study|Stem cell transplant|0|||
25226436|NCT00982488|50505697|FG003|Overall Study|Stem cell transplant|1|||
25226437|NCT00982488|50505698|FG004|Overall Study|Stem cell transplant|0|||
25226438|NCT00982488|50505694|FG000|Overall Study|Study drug toxicity|34|||
25226439|NCT00982488|50505695|FG001|Overall Study|Study drug toxicity|1|||
25226440|NCT00982488|50505696|FG002|Overall Study|Study drug toxicity|6|||
25226441|NCT00982488|50505697|FG003|Overall Study|Study drug toxicity|0|||
25226442|NCT00982488|50505698|FG004|Overall Study|Study drug toxicity|0|||
25226443|NCT00982488|50505694|FG000|Overall Study|Withdrawal by Subject|5|||
25226444|NCT00982488|50505695|FG001|Overall Study|Withdrawal by Subject|1|||
25226445|NCT00982488|50505696|FG002|Overall Study|Withdrawal by Subject|1|||
25226446|NCT00982488|50505697|FG003|Overall Study|Withdrawal by Subject|0|||
25226447|NCT00982488|50505698|FG004|Overall Study|Withdrawal by Subject|0|||
25226448|NCT00982410|50505712|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
25226449|NCT00982410|50505713|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
25226450|NCT00982410|50505712|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
25226451|NCT00982410|50505713|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
25226452|NCT00982410|50505712|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
25226453|NCT00982410|50505713|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
25226454|NCT00982410|50505712|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
25226455|NCT00982410|50505713|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
25226456|NCT00982410|50505712|FG000|6-month Follow-up Assessment|participant no transportation|1|||
25226457|NCT00982410|50505713|FG001|6-month Follow-up Assessment|participant no transportation|0|||
25226458|NCT00982410|50505712|FG000|6-month Follow-up Assessment|incarceration|0|||
25226459|NCT00982410|50505713|FG001|6-month Follow-up Assessment|incarceration|2|||
25226460|NCT00982410|50505712|FG000|6-month Follow-up Assessment|patent surgery|0|||
25226461|NCT00982410|50505713|FG001|6-month Follow-up Assessment|patent surgery|1|||
25226462|NCT00982410|50505712|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
25226463|NCT00982410|50505713|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
25226464|NCT00982410|50505712|FG000|12-month Follow-up Assessment|Death|0|||
25226465|NCT00982410|50505713|FG001|12-month Follow-up Assessment|Death|2|||
25226466|NCT00982410|50505712|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
25226467|NCT00982410|50505713|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
25226468|NCT00982410|50505712|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
25226469|NCT00982410|50505713|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
25226470|NCT00982410|50505712|FG000|12-month Follow-up Assessment|incarceration|2|||
25226471|NCT00982410|50505713|FG001|12-month Follow-up Assessment|incarceration|1|||
25226472|NCT00982410|50505712|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
25226473|NCT00982410|50505713|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
25226474|NCT00982020|50505722|FG000|Overall Study|Adverse Event|19|||
25226475|NCT00982020|50505723|FG001|Overall Study|Adverse Event|15|||
25226476|NCT00982020|50505722|FG000|Overall Study|Withdrawal by Subject|11|||
25226477|NCT00982020|50505723|FG001|Overall Study|Withdrawal by Subject|14|||
25226478|NCT00982020|50505722|FG000|Overall Study|Lost to Follow-up|5|||
25226479|NCT00982020|50505723|FG001|Overall Study|Lost to Follow-up|11|||
25226480|NCT00982020|50505722|FG000|Overall Study|Lack of Efficacy|10|||
25226481|NCT00982020|50505723|FG001|Overall Study|Lack of Efficacy|4|||
25226482|NCT00982020|50505722|FG000|Overall Study|Parent/Caregiver Decision|5|||
25226483|NCT00982020|50505723|FG001|Overall Study|Parent/Caregiver Decision|5|||
25226484|NCT00982020|50505722|FG000|Overall Study|Treatment Non-compliance|3|||
25226485|NCT00982020|50505723|FG001|Overall Study|Treatment Non-compliance|6|||
25226486|NCT00982020|50505722|FG000|Overall Study|Physician Decision|2|||
25226487|NCT00982020|50505723|FG001|Overall Study|Physician Decision|5|||
25226488|NCT00982020|50505722|FG000|Overall Study|Entry Criteria Not Met|2|||
25226489|NCT00982020|50505723|FG001|Overall Study|Entry Criteria Not Met|1|||
25226490|NCT00982020|50505722|FG000|Overall Study|Protocol Violation|0|||
25226491|NCT00982020|50505723|FG001|Overall Study|Protocol Violation|2|||
25226492|NCT00982020|50505722|FG000|Overall Study|Clinical Relapse|0|||
25226493|NCT00982020|50505723|FG001|Overall Study|Clinical Relapse|1|||
25226494|NCT00981084|50505736|FG000|Post Intervention (Data Analysis)|poor effort|1|||
25226495|NCT00981084|50505737|FG001|Post Intervention (Data Analysis)|poor effort|1|||
25226496|NCT00981084|50505736|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
25319071|NCT00950807|50634477|FG003|Washout Period 2|Adverse Event|1|||
25226497|NCT00981084|50505737|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
25226498|NCT00980148|50505747|FG000|Overall Study|Discharged from facility|89|||
25226499|NCT00980148|50505748|FG001|Overall Study|Discharged from facility|96|||
25226500|NCT00980148|50505747|FG000|Overall Study|Received other antichlamydia treatment|20|||
25226501|NCT00980148|50505748|FG001|Overall Study|Received other antichlamydia treatment|14|||
25226502|NCT00980148|50505747|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
25226503|NCT00980148|50505748|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
25226504|NCT00980148|50505747|FG000|Overall Study|Various other reasons|8|||
25226505|NCT00980148|50505748|FG001|Overall Study|Various other reasons|9|||
25226506|NCT04553406|50505785|FG000|Overall Study|Study Discontinuation|0|||
25226507|NCT04553406|50505786|FG001|Overall Study|Study Discontinuation|1|||
25226508|NCT03033576|50505802|FG000|Overall Study|Ineligible|1|||
25226509|NCT03033576|50505803|FG001|Overall Study|Ineligible|1|||
25226510|NCT03033576|50505802|FG000|Overall Study|Adverse Event|4|||
25226511|NCT03033576|50505803|FG001|Overall Study|Adverse Event|20|||
25226512|NCT03033576|50505802|FG000|Overall Study|Progression/relapse|9|||
25226513|NCT03033576|50505803|FG001|Overall Study|Progression/relapse|36|||
25226514|NCT03033576|50505802|FG000|Overall Study|Death|1|||
25226515|NCT03033576|50505803|FG001|Overall Study|Death|1|||
25226516|NCT03033576|50505802|FG000|Overall Study|Patient refusal|1|||
25226517|NCT03033576|50505803|FG001|Overall Study|Patient refusal|6|||
25226518|NCT03033576|50505802|FG000|Overall Study|Other, unspecified reasons|0|||
25226519|NCT03033576|50505803|FG001|Overall Study|Other, unspecified reasons|4|||
25226520|NCT03033576|50505802|FG000|Overall Study|Currently on protocol therapy|0|||
25226521|NCT03033576|50505803|FG001|Overall Study|Currently on protocol therapy|2|||
25226522|NCT04129944|50505813|FG000|Overall Study|Death|0|||
25226523|NCT04129944|50505814|FG001|Overall Study|Death|0|||
25226524|NCT04129944|50505815|FG002|Overall Study|Death|0|||
25226525|NCT04129944|50505816|FG003|Overall Study|Death|1|||
25226526|NCT04129944|50505813|FG000|Overall Study|Lost to Follow-up|1|||
25226527|NCT04129944|50505814|FG001|Overall Study|Lost to Follow-up|0|||
25226528|NCT04129944|50505815|FG002|Overall Study|Lost to Follow-up|0|||
25226529|NCT04129944|50505816|FG003|Overall Study|Lost to Follow-up|0|||
25226530|NCT04129944|50505813|FG000|Overall Study|Withdrawal by Subject|1|||
25226531|NCT04129944|50505814|FG001|Overall Study|Withdrawal by Subject|0|||
25226532|NCT04129944|50505815|FG002|Overall Study|Withdrawal by Subject|1|||
25226533|NCT04129944|50505816|FG003|Overall Study|Withdrawal by Subject|2|||
25226534|NCT03829332|50505880|FG000|Overall Study|Death|145|||
25226535|NCT03829332|50505881|FG001|Overall Study|Death|135|||
25226536|NCT03829332|50505880|FG000|Overall Study|Withdrawal by Subject|10|||
25226537|NCT03829332|50505881|FG001|Overall Study|Withdrawal by Subject|4|||
25226538|NCT03829332|50505880|FG000|Overall Study|Ongoing in Study|154|||
25226539|NCT03829332|50505881|FG001|Overall Study|Ongoing in Study|175|||
25226540|NCT01899144|50507515|FG000|Treatment Period 2|Other|1|||
25226541|NCT01899144|50507515|FG000|Treatment Period 3|Other|2|||
25226542|NCT01899144|50507515|FG000|Treatment Period 5|Other|1|||
25226543|NCT01168219|50510765|FG000|Overall Study|off study before starting treatment|2|||
25226544|NCT01168219|50510765|FG000|Overall Study|withdrew before transplant|1|||
25226545|NCT01168219|50510765|FG000|Overall Study|ineligible due to CML|2|||
25226546|NCT01115803|50510776|FG000|Overall Study|Withdrawal by Subject|0|||
25226547|NCT01115803|50510777|FG001|Overall Study|Withdrawal by Subject|0|||
25226548|NCT01115803|50510778|FG002|Overall Study|Withdrawal by Subject|0|||
25226549|NCT01115803|50510779|FG003|Overall Study|Withdrawal by Subject|0|||
25226550|NCT01115803|50510780|FG004|Overall Study|Withdrawal by Subject|0|||
25226551|NCT01115803|50510781|FG005|Overall Study|Withdrawal by Subject|0|||
25226552|NCT01115803|50510782|FG006|Overall Study|Withdrawal by Subject|1|||
25226553|NCT01115803|50510776|FG000|Overall Study|Lost to Follow-up|0|||
25226554|NCT01115803|50510777|FG001|Overall Study|Lost to Follow-up|0|||
25226555|NCT01115803|50510778|FG002|Overall Study|Lost to Follow-up|1|||
25319072|NCT00950807|50634478|FG004|Washout Period 2|Adverse Event|0|||
25319073|NCT00950807|50634479|FG005|Washout Period 2|Adverse Event|0|||
25319074|NCT00950807|50634480|FG006|Washout Period 2|Adverse Event|0|||
25319075|NCT00950807|50634481|FG007|Washout Period 2|Adverse Event|0|||
25319076|NCT00950807|50634482|FG008|Washout Period 2|Adverse Event|0|||
25319077|NCT00950807|50634483|FG009|Washout Period 2|Adverse Event|0|||
25077470|NCT00002663|50185282|FG007|Overall Study|Death|1|||
25077471|NCT00002663|50185283|FG008|Overall Study|Death|1|||
25226556|NCT01115803|50510779|FG003|Overall Study|Lost to Follow-up|0|||
25226557|NCT01115803|50510780|FG004|Overall Study|Lost to Follow-up|0|||
25226558|NCT01115803|50510781|FG005|Overall Study|Lost to Follow-up|0|||
25226559|NCT01115803|50510782|FG006|Overall Study|Lost to Follow-up|0|||
25226560|NCT01115803|50510776|FG000|Overall Study|Progressive Disease during Cycle1|0|||
25226561|NCT01115803|50510777|FG001|Overall Study|Progressive Disease during Cycle1|0|||
25226562|NCT01115803|50510778|FG002|Overall Study|Progressive Disease during Cycle1|0|||
25226563|NCT01115803|50510779|FG003|Overall Study|Progressive Disease during Cycle1|0|||
25077472|NCT00002663|50185284|FG009|Overall Study|Death|1|||
25226564|NCT01115803|50510780|FG004|Overall Study|Progressive Disease during Cycle1|0|||
25319078|NCT00950807|50634474|FG000|Treatment Period 3|Withdrawal by Subject|0|||
25226565|NCT01115803|50510781|FG005|Overall Study|Progressive Disease during Cycle1|0|||
25226566|NCT01115803|50510782|FG006|Overall Study|Progressive Disease during Cycle1|1|||
25226567|NCT01115569|50510803|FG000|Conversion/Titration Phase|Adverse Event|59|||
25226568|NCT01115569|50510804|FG001|Conversion/Titration Phase|Adverse Event|0|||
25226569|NCT01115569|50510803|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
25226570|NCT01115569|50510804|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
25226571|NCT01115569|50510803|FG000|Conversion/Titration Phase|Physician Decision|5|||
25226572|NCT01115569|50510804|FG001|Conversion/Titration Phase|Physician Decision|0|||
25226573|NCT01115569|50510803|FG000|Conversion/Titration Phase|Protocol Violation|68|||
25226574|NCT01115569|50510804|FG001|Conversion/Titration Phase|Protocol Violation|0|||
25226575|NCT01115569|50510803|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
25226576|NCT01115569|50510804|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
25226577|NCT01115569|50510803|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
25226578|NCT01115569|50510804|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
25226579|NCT01115569|50510803|FG000|Maintenance Phase|Adverse Event|0|||
25226580|NCT01115569|50510804|FG001|Maintenance Phase|Adverse Event|43|||
25226581|NCT01115569|50510803|FG000|Maintenance Phase|Lost to Follow-up|0|||
25226582|NCT01115569|50510804|FG001|Maintenance Phase|Lost to Follow-up|8|||
25226583|NCT01115569|50510803|FG000|Maintenance Phase|Physician Decision|0|||
25226584|NCT01115569|50510804|FG001|Maintenance Phase|Physician Decision|3|||
25226585|NCT01115569|50510803|FG000|Maintenance Phase|Protocol Violation|0|||
25226586|NCT01115569|50510804|FG001|Maintenance Phase|Protocol Violation|9|||
25226587|NCT01115569|50510803|FG000|Maintenance Phase|Withdrawal by Subject|0|||
25226588|NCT01115569|50510804|FG001|Maintenance Phase|Withdrawal by Subject|27|||
25226589|NCT01115569|50510803|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
25226590|NCT01115569|50510804|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
25226591|NCT01115569|50510803|FG000|Maintenance Phase|Administrative|0|||
25226592|NCT01115569|50510804|FG001|Maintenance Phase|Administrative|1|||
25226593|NCT01107886|50510811|FG000|Overall Study|Lost to Follow-up|15|||
25226594|NCT01107886|50510812|FG001|Overall Study|Lost to Follow-up|13|||
25226595|NCT01107886|50510811|FG000|Overall Study|Withdrawal by Subject|180|||
25226596|NCT01107886|50510812|FG001|Overall Study|Withdrawal by Subject|196|||
25226597|NCT01107886|50510811|FG000|Overall Study|Administrative withdrawal of consent|7|||
25226598|NCT01107886|50510812|FG001|Overall Study|Administrative withdrawal of consent|5|||
25226599|NCT01107457|50510823|FG000|Part A|Adverse Event|1|||
25226600|NCT01107457|50510824|FG001|Part A|Adverse Event|2|||
25226601|NCT01107457|50510825|FG002|Part A|Adverse Event|1|||
25226602|NCT01107457|50510826|FG003|Part A|Adverse Event|0|||
25226603|NCT01107457|50510827|FG004|Part A|Adverse Event|0|||
25226604|NCT01107457|50510828|FG005|Part A|Adverse Event|0|||
25226605|NCT01107457|50510823|FG000|Part A|Withdrawal by Subject|3|||
25226606|NCT01107457|50510824|FG001|Part A|Withdrawal by Subject|3|||
25226607|NCT01107457|50510825|FG002|Part A|Withdrawal by Subject|0|||
25226608|NCT01107457|50510826|FG003|Part A|Withdrawal by Subject|3|||
25226609|NCT01107457|50510827|FG004|Part A|Withdrawal by Subject|1|||
25226610|NCT01107457|50510828|FG005|Part A|Withdrawal by Subject|0|||
25226611|NCT01107457|50510823|FG000|Part A|Lost to Follow-up|0|||
25226612|NCT01107457|50510824|FG001|Part A|Lost to Follow-up|1|||
25226613|NCT01107457|50510825|FG002|Part A|Lost to Follow-up|0|||
25226614|NCT01107457|50510826|FG003|Part A|Lost to Follow-up|0|||
25226615|NCT01107457|50510827|FG004|Part A|Lost to Follow-up|0|||
25226616|NCT01107457|50510828|FG005|Part A|Lost to Follow-up|0|||
25226617|NCT01107457|50510823|FG000|Part A|Lack of Efficacy|1|||
25226618|NCT01107457|50510824|FG001|Part A|Lack of Efficacy|0|||
25226619|NCT01107457|50510825|FG002|Part A|Lack of Efficacy|0|||
25226620|NCT01107457|50510826|FG003|Part A|Lack of Efficacy|0|||
25226621|NCT01107457|50510827|FG004|Part A|Lack of Efficacy|0|||
25226622|NCT01107457|50510828|FG005|Part A|Lack of Efficacy|0|||
25226623|NCT01107457|50510823|FG000|Part A|Protocol Violation|0|||
25226624|NCT01107457|50510824|FG001|Part A|Protocol Violation|1|||
25226625|NCT01107457|50510825|FG002|Part A|Protocol Violation|0|||
25319079|NCT00950807|50634475|FG001|Treatment Period 3|Withdrawal by Subject|0|||
25319080|NCT00950807|50634476|FG002|Treatment Period 3|Withdrawal by Subject|0|||
25319081|NCT00950807|50634477|FG003|Treatment Period 3|Withdrawal by Subject|0|||
25226626|NCT01107457|50510826|FG003|Part A|Protocol Violation|0|||
25226627|NCT01107457|50510827|FG004|Part A|Protocol Violation|0|||
25226628|NCT01107457|50510828|FG005|Part A|Protocol Violation|0|||
25226629|NCT01107457|50510823|FG000|Part B and C|Adverse Event|0|||
25226630|NCT01107457|50510824|FG001|Part B and C|Adverse Event|0|||
25226631|NCT01107457|50510825|FG002|Part B and C|Adverse Event|0|||
25226632|NCT01107457|50510826|FG003|Part B and C|Adverse Event|0|||
25226633|NCT01107457|50510827|FG004|Part B and C|Adverse Event|0|||
25226634|NCT01107457|50510828|FG005|Part B and C|Adverse Event|12|||
25226635|NCT01107457|50510823|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
25226636|NCT01107457|50510824|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
25226637|NCT01107457|50510825|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
25319082|NCT00950807|50634478|FG004|Treatment Period 3|Withdrawal by Subject|0|||
25226638|NCT01107457|50510826|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
25226639|NCT01107457|50510827|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
25226640|NCT01107457|50510828|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
25226641|NCT01107457|50510823|FG000|Part B and C|Physician Decision|0|||
25226642|NCT01107457|50510824|FG001|Part B and C|Physician Decision|0|||
25226643|NCT01107457|50510825|FG002|Part B and C|Physician Decision|0|||
25226644|NCT01107457|50510826|FG003|Part B and C|Physician Decision|0|||
25226645|NCT01107457|50510827|FG004|Part B and C|Physician Decision|0|||
25226646|NCT01107457|50510828|FG005|Part B and C|Physician Decision|3|||
25226647|NCT01107457|50510823|FG000|Part B and C|Lack of Efficacy|0|||
25226648|NCT01107457|50510824|FG001|Part B and C|Lack of Efficacy|0|||
25226649|NCT01107457|50510825|FG002|Part B and C|Lack of Efficacy|0|||
25226650|NCT01107457|50510826|FG003|Part B and C|Lack of Efficacy|0|||
25226651|NCT01107457|50510827|FG004|Part B and C|Lack of Efficacy|0|||
25226652|NCT01107457|50510828|FG005|Part B and C|Lack of Efficacy|7|||
25226653|NCT01107457|50510823|FG000|Part B and C|Lost to Follow-up|0|||
25226654|NCT01107457|50510824|FG001|Part B and C|Lost to Follow-up|0|||
25226655|NCT01107457|50510825|FG002|Part B and C|Lost to Follow-up|0|||
25226656|NCT01107457|50510826|FG003|Part B and C|Lost to Follow-up|0|||
25226657|NCT01107457|50510827|FG004|Part B and C|Lost to Follow-up|0|||
25226658|NCT01107457|50510828|FG005|Part B and C|Lost to Follow-up|10|||
25226659|NCT01107457|50510823|FG000|Part B and C|Protocol Violation|0|||
25226660|NCT01107457|50510824|FG001|Part B and C|Protocol Violation|0|||
25226661|NCT01107457|50510825|FG002|Part B and C|Protocol Violation|0|||
25226662|NCT01107457|50510826|FG003|Part B and C|Protocol Violation|0|||
25226663|NCT01107457|50510827|FG004|Part B and C|Protocol Violation|0|||
25226664|NCT01107457|50510828|FG005|Part B and C|Protocol Violation|1|||
25226665|NCT01107457|50510823|FG000|Part B and C|Sponsor Decision|0|||
25226666|NCT01107457|50510824|FG001|Part B and C|Sponsor Decision|0|||
25226667|NCT01107457|50510825|FG002|Part B and C|Sponsor Decision|0|||
25226668|NCT01107457|50510826|FG003|Part B and C|Sponsor Decision|0|||
25226669|NCT01107457|50510827|FG004|Part B and C|Sponsor Decision|0|||
25226670|NCT01107457|50510828|FG005|Part B and C|Sponsor Decision|66|||
25226671|NCT01107457|50510823|FG000|Part B and C|Withdrawal by Subject|0|||
25226672|NCT01107457|50510824|FG001|Part B and C|Withdrawal by Subject|0|||
25226673|NCT01107457|50510825|FG002|Part B and C|Withdrawal by Subject|0|||
25226674|NCT01107457|50510826|FG003|Part B and C|Withdrawal by Subject|0|||
25226675|NCT01107457|50510827|FG004|Part B and C|Withdrawal by Subject|0|||
25226676|NCT01107457|50510828|FG005|Part B and C|Withdrawal by Subject|16|||
25226677|NCT01107457|50510823|FG000|Part B and C|Clinical Relapse|0|||
25226678|NCT01107457|50510824|FG001|Part B and C|Clinical Relapse|0|||
25226679|NCT01107457|50510825|FG002|Part B and C|Clinical Relapse|0|||
25226680|NCT01107457|50510826|FG003|Part B and C|Clinical Relapse|0|||
25226681|NCT01107457|50510827|FG004|Part B and C|Clinical Relapse|0|||
25226682|NCT01107457|50510828|FG005|Part B and C|Clinical Relapse|4|||
25226683|NCT04545385|50510858|FG000|Overall Study|Withdrawal by Subject|2|||
25226684|NCT04545385|50510859|FG001|Overall Study|Withdrawal by Subject|0|||
25226685|NCT04545385|50510858|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
25226686|NCT04545385|50510859|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
25226687|NCT04545385|50510858|FG000|Overall Study|Study termination|10|||
25226688|NCT04545385|50510859|FG001|Overall Study|Study termination|10|||
25226689|NCT04545385|50510858|FG000|Overall Study|Sponsor decision|2|||
25226690|NCT04545385|50510859|FG001|Overall Study|Sponsor decision|2|||
25226691|NCT04545385|50510858|FG000|Overall Study|Other than specified|1|||
25226692|NCT04545385|50510859|FG001|Overall Study|Other than specified|0|||
25226693|NCT03783026|50510874|FG000|Treatment Phase|Adverse Event|15|||
25226694|NCT03783026|50510874|FG000|Treatment Phase|Lack of Efficacy|11|||
25226695|NCT03783026|50510874|FG000|Treatment Phase|Withdrawal by Subject|6|||
25226696|NCT03783026|50510874|FG000|Treatment Phase|Lost to Follow-up|2|||
25226697|NCT03783026|50510874|FG000|Treatment Phase|Protocol Deviation|8|||
25226698|NCT03783026|50510874|FG000|Treatment Phase|Did Not Receive Treatment|1|||
25226699|NCT03783026|50510874|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
25226700|NCT03635112|50510891|FG000|Overall Study|Adverse Event|5|||
25226701|NCT03635112|50510892|FG001|Overall Study|Adverse Event|9|||
25226702|NCT03635112|50510893|FG002|Overall Study|Adverse Event|14|||
25226703|NCT03635112|50510891|FG000|Overall Study|Lost to Follow-up|1|||
25226704|NCT03635112|50510892|FG001|Overall Study|Lost to Follow-up|0|||
25226705|NCT03635112|50510893|FG002|Overall Study|Lost to Follow-up|1|||
25226706|NCT03635112|50510891|FG000|Overall Study|Physician Decision|5|||
25226707|NCT03635112|50510892|FG001|Overall Study|Physician Decision|7|||
25226708|NCT03635112|50510893|FG002|Overall Study|Physician Decision|5|||
25226709|NCT03635112|50510891|FG000|Overall Study|Protocol Violation|0|||
25226710|NCT03635112|50510892|FG001|Overall Study|Protocol Violation|0|||
25226711|NCT03635112|50510893|FG002|Overall Study|Protocol Violation|1|||
25226712|NCT03635112|50510891|FG000|Overall Study|Study Terminated by Sponsor|11|||
25226713|NCT03635112|50510892|FG001|Overall Study|Study Terminated by Sponsor|17|||
25226714|NCT03635112|50510893|FG002|Overall Study|Study Terminated by Sponsor|21|||
25226715|NCT03635112|50510891|FG000|Overall Study|Withdrawal by Subject|4|||
25226716|NCT03635112|50510892|FG001|Overall Study|Withdrawal by Subject|9|||
25226717|NCT03635112|50510893|FG002|Overall Study|Withdrawal by Subject|7|||
25226718|NCT03635112|50510891|FG000|Overall Study|Miscellaneous|0|||
25226719|NCT03635112|50510892|FG001|Overall Study|Miscellaneous|0|||
25226720|NCT03635112|50510893|FG002|Overall Study|Miscellaneous|1|||
25226721|NCT03588728|50510906|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
25226722|NCT03588728|50510907|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
25226723|NCT03588728|50510908|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
25226724|NCT03588728|50510909|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
25226725|NCT03588728|50510906|FG000|Overall Study|Lab shut down due to COVID-19|0|||
25226726|NCT03588728|50510907|FG001|Overall Study|Lab shut down due to COVID-19|0|||
25226727|NCT03588728|50510908|FG002|Overall Study|Lab shut down due to COVID-19|0|||
25226728|NCT03588728|50510909|FG003|Overall Study|Lab shut down due to COVID-19|1|||
25226729|NCT03588728|50510906|FG000|Overall Study|multiple technical issues|1|||
25226730|NCT03588728|50510907|FG001|Overall Study|multiple technical issues|0|||
25226731|NCT03588728|50510908|FG002|Overall Study|multiple technical issues|0|||
25226732|NCT03588728|50510909|FG003|Overall Study|multiple technical issues|0|||
25226733|NCT03588728|50510906|FG000|Overall Study|Hospitalized for COVID|1|||
25226734|NCT03588728|50510907|FG001|Overall Study|Hospitalized for COVID|0|||
25226735|NCT03588728|50510908|FG002|Overall Study|Hospitalized for COVID|0|||
25226736|NCT03588728|50510909|FG003|Overall Study|Hospitalized for COVID|0|||
25226737|NCT03588728|50510906|FG000|Overall Study|Schedule change unable to attend sessions|1|||
25226738|NCT03588728|50510907|FG001|Overall Study|Schedule change unable to attend sessions|0|||
25226739|NCT03588728|50510908|FG002|Overall Study|Schedule change unable to attend sessions|0|||
25226740|NCT03588728|50510909|FG003|Overall Study|Schedule change unable to attend sessions|0|||
25226741|NCT02987543|50510931|FG000|Overall Study|Ongoing study at data cut off|49|||
25226742|NCT02987543|50510932|FG001|Overall Study|Ongoing study at data cut off|21|||
25226743|NCT02987543|50510933|FG002|Overall Study|Ongoing study at data cut off|19|||
25226744|NCT02987543|50510934|FG003|Overall Study|Ongoing study at data cut off|12|||
25226745|NCT02987543|50510931|FG000|Overall Study|Death|88|||
25226746|NCT02987543|50510932|FG001|Overall Study|Death|54|||
25226747|NCT02987543|50510933|FG002|Overall Study|Death|67|||
25226748|NCT02987543|50510934|FG003|Overall Study|Death|28|||
25226749|NCT02987543|50510931|FG000|Overall Study|Lost to Follow-up|3|||
25226750|NCT02987543|50510932|FG001|Overall Study|Lost to Follow-up|0|||
25226751|NCT02987543|50510933|FG002|Overall Study|Lost to Follow-up|1|||
25226752|NCT02987543|50510934|FG003|Overall Study|Lost to Follow-up|0|||
25226753|NCT02987543|50510931|FG000|Overall Study|Screen failure|0|||
25226754|NCT02987543|50510932|FG001|Overall Study|Screen failure|0|||
25226755|NCT02987543|50510933|FG002|Overall Study|Screen failure|0|||
25226756|NCT02987543|50510934|FG003|Overall Study|Screen failure|1|||
25226757|NCT02987543|50510931|FG000|Overall Study|Withdrawal by Subject|21|||
25226758|NCT02987543|50510932|FG001|Overall Study|Withdrawal by Subject|7|||
25226759|NCT02987543|50510933|FG002|Overall Study|Withdrawal by Subject|7|||
25226760|NCT02987543|50510934|FG003|Overall Study|Withdrawal by Subject|6|||
25226761|NCT02987543|50510931|FG000|Overall Study|Study terminated by sponsor|1|||
25226762|NCT02987543|50510932|FG001|Overall Study|Study terminated by sponsor|0|||
25226763|NCT02987543|50510933|FG002|Overall Study|Study terminated by sponsor|0|||
25226764|NCT02987543|50510934|FG003|Overall Study|Study terminated by sponsor|0|||
25226765|NCT02987543|50510931|FG000|Overall Study|Investigator decision|0|||
25226766|NCT02987543|50510932|FG001|Overall Study|Investigator decision|1|||
25226767|NCT02987543|50510933|FG002|Overall Study|Investigator decision|0|||
25226768|NCT02987543|50510934|FG003|Overall Study|Investigator decision|0|||
25226769|NCT02987543|50510931|FG000|Overall Study|Disease progression|0|||
25226770|NCT02987543|50510932|FG001|Overall Study|Disease progression|0|||
25226771|NCT02987543|50510933|FG002|Overall Study|Disease progression|0|||
25226772|NCT02987543|50510934|FG003|Overall Study|Disease progression|1|||
25226773|NCT02983045|50510950|FG000|Overall Study|Withdrawal by Subject|0|||
25226774|NCT02983045|50510951|FG001|Overall Study|Withdrawal by Subject|1|||
25226775|NCT02983045|50510952|FG002|Overall Study|Withdrawal by Subject|0|||
25226776|NCT02983045|50510953|FG003|Overall Study|Withdrawal by Subject|5|||
25226777|NCT02983045|50510954|FG004|Overall Study|Withdrawal by Subject|0|||
25226778|NCT02983045|50510955|FG005|Overall Study|Withdrawal by Subject|72|||
25226779|NCT02983045|50510956|FG006|Overall Study|Withdrawal by Subject|0|||
25226780|NCT02983045|50510957|FG007|Overall Study|Withdrawal by Subject|0|||
25226781|NCT02983045|50510958|FG008|Overall Study|Withdrawal by Subject|0|||
25226782|NCT02983045|50510959|FG009|Overall Study|Withdrawal by Subject|2|||
25226783|NCT02983045|50510950|FG000|Overall Study|Lost to Follow-up|0|||
25226784|NCT02983045|50510951|FG001|Overall Study|Lost to Follow-up|0|||
25226785|NCT02983045|50510952|FG002|Overall Study|Lost to Follow-up|0|||
25226786|NCT02983045|50510953|FG003|Overall Study|Lost to Follow-up|0|||
25226787|NCT02983045|50510954|FG004|Overall Study|Lost to Follow-up|0|||
25226788|NCT02983045|50510955|FG005|Overall Study|Lost to Follow-up|10|||
25226789|NCT02983045|50510956|FG006|Overall Study|Lost to Follow-up|0|||
25226790|NCT02983045|50510957|FG007|Overall Study|Lost to Follow-up|0|||
25226791|NCT02983045|50510958|FG008|Overall Study|Lost to Follow-up|0|||
25226792|NCT02983045|50510959|FG009|Overall Study|Lost to Follow-up|0|||
25226793|NCT02564263|50510983|FG000|Overall Study|Adverse Event|31|||
25226794|NCT02564263|50510984|FG001|Overall Study|Adverse Event|29|||
25226795|NCT02564263|50510983|FG000|Overall Study|Death|270|||
25226796|NCT02564263|50510984|FG001|Overall Study|Death|262|||
25226797|NCT02564263|50510983|FG000|Overall Study|Withdrawal by Subject|4|||
25226798|NCT02564263|50510984|FG001|Overall Study|Withdrawal by Subject|19|||
25226799|NCT02564263|50510983|FG000|Overall Study|Sponsor's decision|9|||
25226800|NCT02564263|50510984|FG001|Overall Study|Sponsor's decision|4|||
25226801|NCT02379819|50510991|FG000|Overall Study|Withdrawal by Subject|10|||
25226802|NCT02379819|50510991|FG000|Overall Study|Death|2|||
25226803|NCT02379819|50510991|FG000|Overall Study|Lack of Efficacy|1|||
25226804|NCT02379819|50510991|FG000|Overall Study|Lost to Follow-up|1|||
25226805|NCT02368886|50510999|FG000|Overall Study|Cancel|1|||
25226806|NCT02368886|50511000|FG001|Overall Study|Cancel|1|||
25226807|NCT02368886|50511001|FG002|Overall Study|Cancel|1|||
25226808|NCT02368886|50511002|FG003|Overall Study|Cancel|3|||
25226809|NCT02368886|50510999|FG000|Overall Study|Ineligible|0|||
25226810|NCT02368886|50511000|FG001|Overall Study|Ineligible|0|||
25226811|NCT02368886|50511001|FG002|Overall Study|Ineligible|0|||
25226812|NCT02368886|50511002|FG003|Overall Study|Ineligible|1|||
25226813|NCT02227238|50511012|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
25226814|NCT02227238|50511013|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
25226815|NCT02227238|50511014|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
25226816|NCT02227238|50511012|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
25226817|NCT02227238|50511013|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
25226818|NCT02227238|50511014|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
25226819|NCT02227238|50511012|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
25226820|NCT02227238|50511013|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
25226821|NCT02227238|50511014|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
25226822|NCT02227238|50511012|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
25226823|NCT02227238|50511013|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
25226824|NCT02227238|50511014|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
25226825|NCT02227238|50511012|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
25226826|NCT02227238|50511013|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
25226827|NCT02227238|50511014|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
25226828|NCT02227238|50511012|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
25226829|NCT02227238|50511013|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
25226830|NCT02227238|50511014|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
25226831|NCT02227238|50511012|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
25226832|NCT02227238|50511013|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
25226833|NCT02227238|50511014|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
25226834|NCT02227238|50511012|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
25226835|NCT02227238|50511013|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
25226836|NCT02227238|50511014|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
25226837|NCT02227238|50511012|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
25226838|NCT02227238|50511013|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
25226839|NCT02227238|50511014|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
25226840|NCT02227238|50511012|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
25226841|NCT02227238|50511013|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
25226842|NCT02227238|50511014|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
25226843|NCT02227238|50511012|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
25226844|NCT02227238|50511013|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
25226845|NCT02227238|50511014|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
25226846|NCT02227238|50511012|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
25226847|NCT02227238|50511013|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
25226848|NCT02227238|50511014|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
25226849|NCT02227238|50511012|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
25226850|NCT02227238|50511013|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
25226851|NCT02227238|50511014|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
25226852|NCT02227238|50511012|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
25226853|NCT02227238|50511013|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
25226854|NCT02227238|50511014|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
25226855|NCT02126969|50511035|FG000|Overall Study|Withdrawal by Subject|1|||
25226856|NCT02126969|50511036|FG001|Overall Study|Withdrawal by Subject|2|||
25226857|NCT01715285|50511044|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
25226858|NCT01715285|50511045|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
25226859|NCT01715285|50511046|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
25226860|NCT01715285|50511044|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
25226861|NCT01715285|50511045|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
25226862|NCT01715285|50511046|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
25226863|NCT01715285|50511044|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
25226864|NCT01715285|50511045|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
25226865|NCT01715285|50511046|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
25226866|NCT01715285|50511044|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
25226867|NCT01715285|50511045|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
25226868|NCT01715285|50511046|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
25226869|NCT01715285|50511044|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
25226870|NCT01715285|50511045|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
25226871|NCT01715285|50511046|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
25226872|NCT01715285|50511044|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
25226873|NCT01715285|50511045|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
25226874|NCT01715285|50511046|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
25226875|NCT01715285|50511044|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
25226876|NCT01715285|50511045|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
25226877|NCT01715285|50511046|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
25226878|NCT01715285|50511044|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
25226879|NCT01715285|50511045|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
25226880|NCT01715285|50511046|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
25226881|NCT01715285|50511044|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
25226882|NCT01715285|50511045|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
25226883|NCT01715285|50511046|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
25226884|NCT01715285|50511044|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
25226885|NCT01715285|50511045|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
25226886|NCT01715285|50511046|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
25226887|NCT01715285|50511044|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
25226888|NCT01715285|50511045|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
25226889|NCT01715285|50511046|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
25226890|NCT01715285|50511044|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
25226891|NCT01715285|50511045|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
25226892|NCT01715285|50511046|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
25226893|NCT01715285|50511044|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
25226894|NCT01715285|50511045|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
25226895|NCT01715285|50511046|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
25226896|NCT01715285|50511044|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
25226897|NCT01715285|50511045|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
25226898|NCT01715285|50511046|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
25226899|NCT01250496|50511055|FG000|Overall Study|Study terminated|124|||
25226900|NCT01250496|50511056|FG001|Overall Study|Study terminated|124|||
25226901|NCT01105975|50511072|FG000|Overall Study|Adverse Event|2|||
25226902|NCT01105975|50511073|FG001|Overall Study|Adverse Event|1|||
25226903|NCT01105975|50511074|FG002|Overall Study|Adverse Event|5|||
25226904|NCT01105975|50511075|FG003|Overall Study|Adverse Event|1|||
25226905|NCT01105975|50511076|FG004|Overall Study|Adverse Event|0|||
25226906|NCT01105975|50511077|FG005|Overall Study|Adverse Event|1|||
25226907|NCT01105975|50511078|FG006|Overall Study|Adverse Event|2|||
25226908|NCT01105975|50511079|FG007|Overall Study|Adverse Event|4|||
25226909|NCT01105975|50511080|FG008|Overall Study|Adverse Event|1|||
25226910|NCT01105975|50511081|FG009|Overall Study|Adverse Event|4|||
25226911|NCT01105975|50511072|FG000|Overall Study|Withdrawal by Subject|2|||
25226912|NCT01105975|50511073|FG001|Overall Study|Withdrawal by Subject|2|||
25226913|NCT01105975|50511074|FG002|Overall Study|Withdrawal by Subject|2|||
25226914|NCT01105975|50511075|FG003|Overall Study|Withdrawal by Subject|0|||
25226915|NCT01105975|50511076|FG004|Overall Study|Withdrawal by Subject|4|||
25226916|NCT01105975|50511077|FG005|Overall Study|Withdrawal by Subject|1|||
25226917|NCT01105975|50511078|FG006|Overall Study|Withdrawal by Subject|2|||
25226918|NCT01105975|50511079|FG007|Overall Study|Withdrawal by Subject|1|||
25226919|NCT01105975|50511080|FG008|Overall Study|Withdrawal by Subject|0|||
25226920|NCT01105975|50511081|FG009|Overall Study|Withdrawal by Subject|3|||
25226921|NCT01105975|50511072|FG000|Overall Study|Lost to Follow-up|1|||
25226922|NCT01105975|50511073|FG001|Overall Study|Lost to Follow-up|0|||
25226923|NCT01105975|50511074|FG002|Overall Study|Lost to Follow-up|0|||
25226924|NCT01105975|50511075|FG003|Overall Study|Lost to Follow-up|1|||
25226925|NCT01105975|50511076|FG004|Overall Study|Lost to Follow-up|1|||
25226926|NCT01105975|50511077|FG005|Overall Study|Lost to Follow-up|0|||
25226927|NCT01105975|50511078|FG006|Overall Study|Lost to Follow-up|0|||
25226928|NCT01105975|50511079|FG007|Overall Study|Lost to Follow-up|0|||
25226929|NCT01105975|50511080|FG008|Overall Study|Lost to Follow-up|1|||
25226930|NCT01105975|50511081|FG009|Overall Study|Lost to Follow-up|0|||
25226931|NCT01105975|50511072|FG000|Overall Study|Physician Decision|0|||
25226932|NCT01105975|50511073|FG001|Overall Study|Physician Decision|0|||
25226933|NCT01105975|50511074|FG002|Overall Study|Physician Decision|0|||
25226934|NCT01105975|50511075|FG003|Overall Study|Physician Decision|0|||
25226935|NCT01105975|50511076|FG004|Overall Study|Physician Decision|0|||
25226936|NCT01105975|50511077|FG005|Overall Study|Physician Decision|0|||
25226937|NCT01105975|50511078|FG006|Overall Study|Physician Decision|2|||
25226938|NCT01105975|50511079|FG007|Overall Study|Physician Decision|0|||
25226939|NCT01105975|50511080|FG008|Overall Study|Physician Decision|0|||
25226940|NCT01105975|50511081|FG009|Overall Study|Physician Decision|0|||
25226941|NCT01105975|50511072|FG000|Overall Study|Protocol Violation|0|||
25226942|NCT01105975|50511073|FG001|Overall Study|Protocol Violation|2|||
25226943|NCT01105975|50511074|FG002|Overall Study|Protocol Violation|2|||
25226944|NCT01105975|50511075|FG003|Overall Study|Protocol Violation|0|||
25226945|NCT01105975|50511076|FG004|Overall Study|Protocol Violation|1|||
25226946|NCT01105975|50511077|FG005|Overall Study|Protocol Violation|1|||
25226947|NCT01105975|50511078|FG006|Overall Study|Protocol Violation|1|||
25226948|NCT01105975|50511079|FG007|Overall Study|Protocol Violation|1|||
25226949|NCT01105975|50511080|FG008|Overall Study|Protocol Violation|2|||
25226950|NCT01105975|50511081|FG009|Overall Study|Protocol Violation|2|||
25226951|NCT01105975|50511072|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
25226952|NCT01105975|50511073|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
25226953|NCT01105975|50511074|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
25226954|NCT01105975|50511075|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
25226955|NCT01105975|50511076|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
25226956|NCT01105975|50511077|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
25226957|NCT01105975|50511078|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
25226958|NCT01105975|50511079|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
25226959|NCT01105975|50511080|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
25226960|NCT01105975|50511081|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
25226961|NCT00831623|50511122|FG000|Overall Study|Withdrawal by Subject|9|||
25226962|NCT00831623|50511122|FG000|Overall Study|Lost to Follow-up|1|||
25226963|NCT00831623|50511122|FG000|Overall Study|Not 2 years post-treatment|12|||
25226964|NCT00079417|50511126|FG000|Overall Study|Physician Decision|2|||
25226965|NCT00079417|50511126|FG000|Overall Study|Ineligible|7|||
25226966|NCT05292755|50516175|FG000|Overall Study|Lost to Follow-up|5|||
25226967|NCT05292755|50516176|FG001|Overall Study|Lost to Follow-up|9|||
25226968|NCT04590781|50516190|FG000|Overall Study|Death|0|||
25226969|NCT04590781|50516191|FG001|Overall Study|Death|2|||
25226970|NCT04590781|50516190|FG000|Overall Study|Withdrawal by Subject|2|||
25226971|NCT04590781|50516191|FG001|Overall Study|Withdrawal by Subject|0|||
25226972|NCT04248868|50516198|FG000|Overall Study|Death|1|||
25226973|NCT04248868|50516198|FG000|Overall Study|Lost to Follow-up|3|||
25226974|NCT04248868|50516198|FG000|Overall Study|Protocol Violation|2|||
25226975|NCT04211831|50516205|FG000|Overall Study|Withdrawal by Subject|4|||
25226976|NCT04211831|50516206|FG001|Overall Study|Withdrawal by Subject|1|||
25226977|NCT04211831|50516207|FG002|Overall Study|Withdrawal by Subject|1|||
25226978|NCT04211831|50516205|FG000|Overall Study|Protocol Violation|0|||
25226979|NCT04211831|50516206|FG001|Overall Study|Protocol Violation|0|||
25226980|NCT04211831|50516207|FG002|Overall Study|Protocol Violation|1|||
25226981|NCT04211831|50516205|FG000|Overall Study|Adverse Event|0|||
25226982|NCT04211831|50516206|FG001|Overall Study|Adverse Event|1|||
25226983|NCT04211831|50516207|FG002|Overall Study|Adverse Event|0|||
25226984|NCT04211831|50516205|FG000|Overall Study|Lack of Efficacy|0|||
25226985|NCT04211831|50516206|FG001|Overall Study|Lack of Efficacy|0|||
25226986|NCT04211831|50516207|FG002|Overall Study|Lack of Efficacy|1|||
25226987|NCT04211831|50516205|FG000|Overall Study|Lost to Follow-up|0|||
25226988|NCT04211831|50516206|FG001|Overall Study|Lost to Follow-up|0|||
25226989|NCT04211831|50516207|FG002|Overall Study|Lost to Follow-up|2|||
25226990|NCT04211831|50516205|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
24976595|NCT03437512|50065512|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
25226991|NCT04211831|50516206|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
25226992|NCT04211831|50516207|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
25226993|NCT04211831|50516205|FG000|Overall Study|Other|0|||
25226994|NCT04211831|50516206|FG001|Overall Study|Other|1|||
25226995|NCT04211831|50516207|FG002|Overall Study|Other|0|||
25226996|NCT04067518|50516265|FG000|Overall Study|Adverse Event|1|||
25226997|NCT04067518|50516266|FG001|Overall Study|Adverse Event|3|||
25226998|NCT04067518|50516265|FG000|Overall Study|Screen failures|0|||
25226999|NCT04067518|50516266|FG001|Overall Study|Screen failures|1|||
25227000|NCT04067518|50516265|FG000|Overall Study|Enrolled but not treated|0|||
25227001|NCT04067518|50516266|FG001|Overall Study|Enrolled but not treated|1|||
25227002|NCT03912233|50516307|FG000|Overall Study|Adverse Event|1|||
25077473|NCT00002663|50185275|FG000|Overall Study|Lost to Follow-up|3|||
25227003|NCT03912233|50516308|FG001|Overall Study|Adverse Event|0|||
25227004|NCT03912233|50516309|FG002|Overall Study|Adverse Event|0|||
25227005|NCT03912233|50516310|FG003|Overall Study|Adverse Event|0|||
25227006|NCT03912233|50516311|FG004|Overall Study|Adverse Event|0|||
25227007|NCT03912233|50516312|FG005|Overall Study|Adverse Event|0|||
25227008|NCT03912233|50516307|FG000|Overall Study|Physician Decision|1|||
25227009|NCT03912233|50516308|FG001|Overall Study|Physician Decision|0|||
25227010|NCT03912233|50516309|FG002|Overall Study|Physician Decision|0|||
25227011|NCT03912233|50516310|FG003|Overall Study|Physician Decision|0|||
25227012|NCT03912233|50516311|FG004|Overall Study|Physician Decision|0|||
25227013|NCT03912233|50516312|FG005|Overall Study|Physician Decision|0|||
25227014|NCT03912233|50516307|FG000|Overall Study|Other|0|||
25227015|NCT03912233|50516308|FG001|Overall Study|Other|0|||
25227016|NCT03912233|50516309|FG002|Overall Study|Other|0|||
25227017|NCT03912233|50516310|FG003|Overall Study|Other|0|||
25227018|NCT03912233|50516311|FG004|Overall Study|Other|7|||
25227019|NCT03912233|50516312|FG005|Overall Study|Other|12|||
25227020|NCT03834519|50516336|FG000|Overall Study|Ongoing|234|||
25227021|NCT03834519|50516337|FG001|Overall Study|Ongoing|111|||
25227022|NCT03834519|50516336|FG000|Overall Study|Withdrawal by Subject|4|||
25227023|NCT03834519|50516337|FG001|Overall Study|Withdrawal by Subject|7|||
25227024|NCT03834519|50516336|FG000|Overall Study|Death|291|||
25227025|NCT03834519|50516337|FG001|Overall Study|Death|146|||
25227026|NCT03546062|50516364|FG000|Overall Study|Adverse Event|6|||
25227027|NCT03546062|50516365|FG001|Overall Study|Adverse Event|5|||
25227028|NCT03546062|50516366|FG002|Overall Study|Adverse Event|8|||
25227029|NCT03539952|50516376|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
25227030|NCT03539952|50516377|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
25227031|NCT03539952|50516376|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
25227032|NCT03539952|50516377|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
25227033|NCT03539952|50516376|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
25227034|NCT03539952|50516377|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
25227035|NCT03539952|50516376|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
25227036|NCT03539952|50516377|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
25227037|NCT03539952|50516376|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
25227038|NCT03539952|50516377|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
25227039|NCT03539952|50516376|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
25227040|NCT03539952|50516377|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
25227041|NCT03539952|50516376|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
25227042|NCT03539952|50516377|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
25227043|NCT03471078|50516404|FG000|Overall Study|Withdrawal by Subject|9|||
25227044|NCT03471078|50516405|FG001|Overall Study|Withdrawal by Subject|1|||
25227045|NCT03471078|50516404|FG000|Overall Study|Adverse Event|4|||
25227046|NCT03471078|50516405|FG001|Overall Study|Adverse Event|1|||
25227047|NCT03471078|50516404|FG000|Overall Study|Physician Decision|3|||
25227048|NCT03471078|50516405|FG001|Overall Study|Physician Decision|2|||
25227049|NCT03471078|50516404|FG000|Overall Study|Death|2|||
25227050|NCT03471078|50516405|FG001|Overall Study|Death|0|||
25227051|NCT03471078|50516404|FG000|Overall Study|Other|3|||
25227052|NCT03471078|50516405|FG001|Overall Study|Other|2|||
25227053|NCT03155997|50516413|FG000|Overall Study|Withdrawal by Subject|119|||
25227054|NCT03155997|50516414|FG001|Overall Study|Withdrawal by Subject|134|||
25227055|NCT03155997|50516413|FG000|Overall Study|Lost to Follow-up|12|||
25227056|NCT03155997|50516414|FG001|Overall Study|Lost to Follow-up|13|||
25227057|NCT03155997|50516413|FG000|Overall Study|Missing disposition data|0|||
25227058|NCT03155997|50516414|FG001|Overall Study|Missing disposition data|1|||
25227059|NCT03155997|50516413|FG000|Overall Study|On study treatment|2027|||
25227060|NCT03155997|50516414|FG001|Overall Study|On study treatment|2074|||
25227061|NCT02929108|50516427|FG000|Overall Study|Hospice patient death|100|||
25077474|NCT00002663|50185276|FG001|Overall Study|Lost to Follow-up|0|||
25077475|NCT00002663|50185277|FG002|Overall Study|Lost to Follow-up|0|||
25077476|NCT00002663|50185278|FG003|Overall Study|Lost to Follow-up|1|||
25077477|NCT00002663|50185279|FG004|Overall Study|Lost to Follow-up|0|||
25077478|NCT00002663|50185280|FG005|Overall Study|Lost to Follow-up|1|||
25077479|NCT00002663|50185281|FG006|Overall Study|Lost to Follow-up|0|||
25227062|NCT02929108|50516428|FG001|Overall Study|Hospice patient death|64|||
25227063|NCT02929108|50516429|FG002|Overall Study|Hospice patient death|28|||
25227064|NCT02929108|50516430|FG003|Overall Study|Hospice patient death|46|||
25227065|NCT02929108|50516431|FG004|Overall Study|Hospice patient death|55|||
25227066|NCT02929108|50516432|FG005|Overall Study|Hospice patient death|28|||
25227067|NCT02929108|50516433|FG006|Overall Study|Hospice patient death|78|||
25227068|NCT02661295|50516441|FG000|Overall Study|Death|1|||
25227069|NCT02661295|50516441|FG000|Overall Study|Transferred Out|1|||
25227070|NCT02661295|50516441|FG000|Overall Study|Kidney Transplant|1|||
25227071|NCT02661295|50516441|FG000|Overall Study|Withdrawn due to side effects|8|||
25227072|NCT02661295|50516441|FG000|Overall Study|Withdrawn due to access type|1|||
25227073|NCT02661295|50516441|FG000|Overall Study|Withdrawn due to allergies|1|||
25077480|NCT00002663|50185282|FG007|Overall Study|Lost to Follow-up|0|||
25077481|NCT00002663|50185283|FG008|Overall Study|Lost to Follow-up|0|||
25077482|NCT00002663|50185284|FG009|Overall Study|Lost to Follow-up|0|||
25077483|NCT00002663|50185275|FG000|Overall Study|Other|0|||
25227074|NCT02661295|50516441|FG000|Overall Study|Withdrawn due to non-compliance|1|||
25227075|NCT02661295|50516441|FG000|Overall Study|Withdrawal by Subject|3|||
25227076|NCT02661295|50516441|FG000|Overall Study|Failed screening|2|||
25227077|NCT02527434|50516448|FG000|Overall Study|Lost to Follow-up|2|||
25227078|NCT02527434|50516449|FG001|Overall Study|Lost to Follow-up|2|||
25227079|NCT02527434|50516450|FG002|Overall Study|Lost to Follow-up|0|||
25227080|NCT02527434|50516448|FG000|Overall Study|Death|19|||
25227081|NCT02527434|50516449|FG001|Overall Study|Death|6|||
25227082|NCT02527434|50516450|FG002|Overall Study|Death|17|||
25227083|NCT02527434|50516448|FG000|Overall Study|Withdrawal by Subject|5|||
25227084|NCT02527434|50516449|FG001|Overall Study|Withdrawal by Subject|3|||
25227085|NCT02527434|50516450|FG002|Overall Study|Withdrawal by Subject|3|||
25227086|NCT02527434|50516448|FG000|Overall Study|Reason Not Specified|1|||
25227087|NCT02527434|50516449|FG001|Overall Study|Reason Not Specified|0|||
25227088|NCT02527434|50516450|FG002|Overall Study|Reason Not Specified|0|||
25227089|NCT02527434|50516448|FG000|Overall Study|Site closure|1|||
25227090|NCT02527434|50516449|FG001|Overall Study|Site closure|0|||
25227091|NCT02527434|50516450|FG002|Overall Study|Site closure|0|||
25227092|NCT02412748|50516479|FG000|Overall Study|Lost to Follow-up|38|||
25227093|NCT02412748|50516480|FG001|Overall Study|Lost to Follow-up|39|||
25227094|NCT01844726|50516505|FG000|Overall Study|Withdrawal by Subject|0|||
25227095|NCT01844726|50516506|FG001|Overall Study|Withdrawal by Subject|1|||
25227096|NCT01844726|50516505|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
25227097|NCT01844726|50516506|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
25227098|NCT03180840|50522084|FG000|Overall Study|Withdrawal by Subject|1|||
25227099|NCT02538666|50522096|FG000|Pre-Treatment|Disease progression|1|||
25227100|NCT02538666|50522097|FG001|Pre-Treatment|Disease progression|0|||
25227101|NCT02538666|50522098|FG002|Pre-Treatment|Disease progression|0|||
25227102|NCT02538666|50522096|FG000|Pre-Treatment|no longer meets study criteria|1|||
25227103|NCT02538666|50522097|FG001|Pre-Treatment|no longer meets study criteria|0|||
25227104|NCT02538666|50522098|FG002|Pre-Treatment|no longer meets study criteria|0|||
25227105|NCT02538666|50522096|FG000|Pre-Treatment|Withdrew Consent|0|||
25227106|NCT02538666|50522097|FG001|Pre-Treatment|Withdrew Consent|1|||
25227107|NCT02538666|50522098|FG002|Pre-Treatment|Withdrew Consent|1|||
25227108|NCT02538666|50522096|FG000|Treatment|Disease progression|270|||
25227109|NCT02538666|50522097|FG001|Treatment|Disease progression|227|||
25227110|NCT02538666|50522098|FG002|Treatment|Disease progression|165|||
25227111|NCT02538666|50522096|FG000|Treatment|Study drug toxicity|1|||
25227112|NCT02538666|50522097|FG001|Treatment|Study drug toxicity|29|||
25227113|NCT02538666|50522098|FG002|Treatment|Study drug toxicity|92|||
25227114|NCT02538666|50522096|FG000|Treatment|Death|0|||
25227115|NCT02538666|50522097|FG001|Treatment|Death|2|||
25227116|NCT02538666|50522098|FG002|Treatment|Death|3|||
25227117|NCT02538666|50522096|FG000|Treatment|Adverse event unrelated to study drug|8|||
25227118|NCT02538666|50522097|FG001|Treatment|Adverse event unrelated to study drug|10|||
25227119|NCT02538666|50522098|FG002|Treatment|Adverse event unrelated to study drug|15|||
25227120|NCT02538666|50522096|FG000|Treatment|Participant request to discontinue study treatment|3|||
25227121|NCT02538666|50522097|FG001|Treatment|Participant request to discontinue study treatment|6|||
25227122|NCT02538666|50522098|FG002|Treatment|Participant request to discontinue study treatment|11|||
25227123|NCT02538666|50522096|FG000|Treatment|Participant withdrew consent|2|||
25227124|NCT02538666|50522097|FG001|Treatment|Participant withdrew consent|5|||
25227125|NCT02538666|50522098|FG002|Treatment|Participant withdrew consent|3|||
25227126|NCT02538666|50522096|FG000|Treatment|Lost to Follow-up|0|||
25227127|NCT02538666|50522097|FG001|Treatment|Lost to Follow-up|1|||
25227128|NCT02538666|50522098|FG002|Treatment|Lost to Follow-up|1|||
25227129|NCT02538666|50522096|FG000|Treatment|Maximum clinical benefit|4|||
25227130|NCT02538666|50522097|FG001|Treatment|Maximum clinical benefit|3|||
25227131|NCT02538666|50522098|FG002|Treatment|Maximum clinical benefit|4|||
25227132|NCT02538666|50522096|FG000|Treatment|Poor/non-compliance|0|||
25227133|NCT02538666|50522097|FG001|Treatment|Poor/non-compliance|1|||
25227134|NCT02538666|50522098|FG002|Treatment|Poor/non-compliance|0|||
25227135|NCT02538666|50522096|FG000|Treatment|Participant no longer meets study criteria|0|||
25227136|NCT02538666|50522097|FG001|Treatment|Participant no longer meets study criteria|2|||
25227137|NCT02538666|50522098|FG002|Treatment|Participant no longer meets study criteria|0|||
25227138|NCT02538666|50522096|FG000|Treatment|Administrative reason by sponsor|0|||
25227139|NCT02538666|50522097|FG001|Treatment|Administrative reason by sponsor|0|||
25227140|NCT02538666|50522098|FG002|Treatment|Administrative reason by sponsor|1|||
25227141|NCT02538666|50522096|FG000|Treatment|Other reasons|8|||
25227142|NCT02538666|50522097|FG001|Treatment|Other reasons|15|||
25227143|NCT02538666|50522098|FG002|Treatment|Other reasons|5|||
25227144|NCT02538666|50522096|FG000|Treatment|Not reported|2|||
25227145|NCT02538666|50522097|FG001|Treatment|Not reported|2|||
25227146|NCT02538666|50522098|FG002|Treatment|Not reported|2|||
25227147|NCT02407236|50522152|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
25227148|NCT02407236|50522153|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
25227149|NCT02407236|50522154|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
25227150|NCT02407236|50522155|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
25227151|NCT02407236|50522156|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
25227152|NCT02407236|50522157|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
25227153|NCT02407236|50522158|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
25227154|NCT02407236|50522159|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
25227155|NCT02407236|50522160|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
25227156|NCT02407236|50522161|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
25227157|NCT02407236|50522162|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
25227158|NCT02407236|50522163|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
25227159|NCT02407236|50522164|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
25227160|NCT02407236|50522152|FG000|Induction Study (8 Weeks)|Death|0|||
25227161|NCT02407236|50522153|FG001|Induction Study (8 Weeks)|Death|0|||
25227162|NCT02407236|50522154|FG002|Induction Study (8 Weeks)|Death|1|||
25227163|NCT02407236|50522155|FG003|Induction Study (8 Weeks)|Death|0|||
25227164|NCT02407236|50522156|FG004|Induction Study (8 Weeks)|Death|0|||
25227165|NCT02407236|50522157|FG005|Induction Study (8 Weeks)|Death|0|||
25227166|NCT02407236|50522158|FG006|Induction Study (8 Weeks)|Death|0|||
25227167|NCT02407236|50522159|FG007|Induction Study (8 Weeks)|Death|0|||
25227168|NCT02407236|50522160|FG008|Induction Study (8 Weeks)|Death|0|||
25227169|NCT02407236|50522161|FG009|Induction Study (8 Weeks)|Death|0|||
25227170|NCT02407236|50522162|FG010|Induction Study (8 Weeks)|Death|0|||
25227171|NCT02407236|50522163|FG011|Induction Study (8 Weeks)|Death|0|||
25227172|NCT02407236|50522164|FG012|Induction Study (8 Weeks)|Death|0|||
25227173|NCT02407236|50522152|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
25227174|NCT02407236|50522153|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
25227175|NCT02407236|50522154|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
25227176|NCT02407236|50522155|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
25227177|NCT02407236|50522156|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
25227178|NCT02407236|50522157|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
25227179|NCT02407236|50522158|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
25227180|NCT02407236|50522159|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
25227181|NCT02407236|50522160|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
25227182|NCT02407236|50522161|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
25227183|NCT02407236|50522162|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
25227184|NCT02407236|50522163|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
25227185|NCT02407236|50522164|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
25227186|NCT02407236|50522152|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
25227187|NCT02407236|50522153|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
25227188|NCT02407236|50522154|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
25227189|NCT02407236|50522155|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
25227190|NCT02407236|50522156|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
25227191|NCT02407236|50522157|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
25227192|NCT02407236|50522158|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
25227193|NCT02407236|50522159|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
25227194|NCT02407236|50522160|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
25227195|NCT02407236|50522161|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
25227196|NCT02407236|50522162|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
25227197|NCT02407236|50522163|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
25227198|NCT02407236|50522164|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
25227199|NCT02407236|50522152|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
25227200|NCT02407236|50522153|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
25227201|NCT02407236|50522154|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
25227202|NCT02407236|50522155|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
25227203|NCT02407236|50522156|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
25227204|NCT02407236|50522157|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
25227205|NCT02407236|50522158|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
25227206|NCT02407236|50522159|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
25227207|NCT02407236|50522160|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
25227208|NCT02407236|50522161|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
25227209|NCT02407236|50522162|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
25227210|NCT02407236|50522163|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
25227211|NCT02407236|50522164|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
25227212|NCT02407236|50522152|FG000|Induction Study (8 Weeks)|Other|2|||
25227213|NCT02407236|50522153|FG001|Induction Study (8 Weeks)|Other|1|||
25227214|NCT02407236|50522154|FG002|Induction Study (8 Weeks)|Other|5|||
25227215|NCT02407236|50522155|FG003|Induction Study (8 Weeks)|Other|0|||
25227216|NCT02407236|50522156|FG004|Induction Study (8 Weeks)|Other|0|||
25227217|NCT02407236|50522157|FG005|Induction Study (8 Weeks)|Other|0|||
25227218|NCT02407236|50522158|FG006|Induction Study (8 Weeks)|Other|0|||
25227219|NCT02407236|50522159|FG007|Induction Study (8 Weeks)|Other|0|||
25227220|NCT02407236|50522160|FG008|Induction Study (8 Weeks)|Other|0|||
25227221|NCT02407236|50522161|FG009|Induction Study (8 Weeks)|Other|0|||
25227222|NCT02407236|50522162|FG010|Induction Study (8 Weeks)|Other|0|||
25227223|NCT02407236|50522163|FG011|Induction Study (8 Weeks)|Other|0|||
25227224|NCT02407236|50522164|FG012|Induction Study (8 Weeks)|Other|0|||
25227225|NCT02407236|50522152|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
25227226|NCT02407236|50522153|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
25227227|NCT02407236|50522154|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
25227228|NCT02407236|50522155|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
25227229|NCT02407236|50522156|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
25227230|NCT02407236|50522157|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
25227231|NCT02407236|50522158|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
25227232|NCT02407236|50522159|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
25227233|NCT02407236|50522160|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
25227234|NCT02407236|50522161|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
25227235|NCT02407236|50522162|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
25227236|NCT02407236|50522163|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
25227237|NCT02407236|50522164|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
25227238|NCT02407236|50522152|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
25227239|NCT02407236|50522153|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
25227240|NCT02407236|50522154|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
25227241|NCT02407236|50522155|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
25227242|NCT02407236|50522156|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
25227243|NCT02407236|50522157|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
25227244|NCT02407236|50522158|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
25227245|NCT02407236|50522159|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
25227246|NCT02407236|50522160|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
25227247|NCT02407236|50522161|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
25227248|NCT02407236|50522162|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
25227249|NCT02407236|50522163|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
25227250|NCT02407236|50522164|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
25227251|NCT02407236|50522152|FG000|Maintenance Study (44 Weeks)|Other|0|||
25227252|NCT02407236|50522153|FG001|Maintenance Study (44 Weeks)|Other|0|||
25227253|NCT02407236|50522154|FG002|Maintenance Study (44 Weeks)|Other|0|||
25227254|NCT02407236|50522155|FG003|Maintenance Study (44 Weeks)|Other|5|||
25227255|NCT02407236|50522156|FG004|Maintenance Study (44 Weeks)|Other|7|||
25227256|NCT02407236|50522157|FG005|Maintenance Study (44 Weeks)|Other|8|||
25227257|NCT02407236|50522158|FG006|Maintenance Study (44 Weeks)|Other|4|||
25227258|NCT02407236|50522159|FG007|Maintenance Study (44 Weeks)|Other|6|||
25227259|NCT02407236|50522160|FG008|Maintenance Study (44 Weeks)|Other|0|||
25227260|NCT02407236|50522161|FG009|Maintenance Study (44 Weeks)|Other|0|||
25227261|NCT02407236|50522162|FG010|Maintenance Study (44 Weeks)|Other|0|||
25227262|NCT02407236|50522163|FG011|Maintenance Study (44 Weeks)|Other|0|||
25227263|NCT02407236|50522164|FG012|Maintenance Study (44 Weeks)|Other|0|||
25227264|NCT02407236|50522152|FG000|Maintenance Study (44 Weeks)|Death|0|||
25227265|NCT02407236|50522153|FG001|Maintenance Study (44 Weeks)|Death|0|||
25227266|NCT02407236|50522154|FG002|Maintenance Study (44 Weeks)|Death|0|||
25227267|NCT02407236|50522155|FG003|Maintenance Study (44 Weeks)|Death|0|||
25227268|NCT02407236|50522156|FG004|Maintenance Study (44 Weeks)|Death|0|||
25227269|NCT02407236|50522157|FG005|Maintenance Study (44 Weeks)|Death|0|||
25227270|NCT02407236|50522158|FG006|Maintenance Study (44 Weeks)|Death|0|||
25227271|NCT02407236|50522159|FG007|Maintenance Study (44 Weeks)|Death|1|||
25227272|NCT02407236|50522160|FG008|Maintenance Study (44 Weeks)|Death|0|||
25227273|NCT02407236|50522161|FG009|Maintenance Study (44 Weeks)|Death|0|||
25227274|NCT02407236|50522162|FG010|Maintenance Study (44 Weeks)|Death|0|||
25227275|NCT02407236|50522163|FG011|Maintenance Study (44 Weeks)|Death|0|||
25227276|NCT02407236|50522164|FG012|Maintenance Study (44 Weeks)|Death|0|||
25227277|NCT02407236|50522152|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
25227278|NCT02407236|50522153|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
25227279|NCT02407236|50522154|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
25227280|NCT02407236|50522155|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
25227281|NCT02407236|50522156|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
25227282|NCT02407236|50522157|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
25227283|NCT02407236|50522158|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
25227284|NCT02407236|50522159|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
25227285|NCT02407236|50522160|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
25227286|NCT02407236|50522161|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
25227287|NCT02407236|50522162|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
25227288|NCT02407236|50522163|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
25227289|NCT02407236|50522164|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
25227290|NCT02407236|50522152|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
25227291|NCT02407236|50522153|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
25227292|NCT02407236|50522154|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
25227293|NCT02407236|50522155|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
25227294|NCT02407236|50522156|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
25227295|NCT02407236|50522157|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
25227296|NCT02407236|50522158|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
25227297|NCT02407236|50522159|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
25227298|NCT02407236|50522160|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
25227299|NCT02407236|50522161|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
25227300|NCT02407236|50522162|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
25227301|NCT02407236|50522163|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
25227302|NCT02407236|50522164|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
25227303|NCT02407236|50522152|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
25227304|NCT02407236|50522153|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
25227305|NCT02407236|50522154|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
25227306|NCT02407236|50522155|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
25227307|NCT02407236|50522156|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
25227308|NCT02407236|50522157|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
25227309|NCT02407236|50522158|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
25227310|NCT02407236|50522159|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
25227311|NCT02407236|50522160|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
25227312|NCT02407236|50522161|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
25227313|NCT02407236|50522162|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
25227314|NCT02407236|50522163|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
25227315|NCT02407236|50522164|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
25227316|NCT02407236|50522152|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
25227317|NCT02407236|50522153|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
25227318|NCT02407236|50522154|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
25227319|NCT02407236|50522155|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
25227320|NCT02407236|50522156|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
25227321|NCT02407236|50522157|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
25227322|NCT02407236|50522158|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
25227323|NCT02407236|50522159|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
25227324|NCT02407236|50522160|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
25227325|NCT02407236|50522161|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
25227326|NCT02407236|50522162|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
25227327|NCT02407236|50522163|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
25227328|NCT02407236|50522164|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
25227329|NCT01893138|50522192|FG000|Double-Blind Period|Withdrawal by Subject|1|||
25227330|NCT01893138|50522193|FG001|Double-Blind Period|Withdrawal by Subject|1|||
25227331|NCT01893138|50522192|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
25227332|NCT01893138|50522193|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
25227333|NCT01893138|50522192|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
25227334|NCT01893138|50522193|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
25227335|NCT01893138|50522192|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
25227336|NCT01893138|50522193|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
25227337|NCT01893138|50522192|FG000|Open Label - Unblinded Period|Adverse Event|1|||
25227338|NCT01893138|50522193|FG001|Open Label - Unblinded Period|Adverse Event|0|||
25227339|NCT04309500|50522205|FG000|Overall Study|Lost to Follow-up|1|||
25227340|NCT04309500|50522206|FG001|Overall Study|Lost to Follow-up|0|||
25227341|NCT04309500|50522207|FG002|Overall Study|Lost to Follow-up|0|||
25227342|NCT04309500|50522208|FG003|Overall Study|Lost to Follow-up|0|||
25227343|NCT03671304|50523543|FG000|Overall Study|study terminated|7|||
25227344|NCT03517722|50523549|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
25227345|NCT03517722|50523550|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
25227346|NCT03517722|50523549|FG000|Double Blind Period: Week 0-52|Death|0|||
25227347|NCT03517722|50523550|FG001|Double Blind Period: Week 0-52|Death|4|||
25227348|NCT03517722|50523549|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
25227349|NCT03517722|50523550|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
25227350|NCT03517722|50523549|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
25227351|NCT03517722|50523550|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
25227352|NCT03517722|50523549|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
25227353|NCT03517722|50523550|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
25227354|NCT03517722|50523549|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
25227355|NCT03517722|50523550|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
25227356|NCT03517722|50523549|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
25227357|NCT03517722|50523550|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
25227358|NCT03517722|50523549|FG000|Double Blind Period: Week 0-52|Other|4|||
25227359|NCT03517722|50523550|FG001|Double Blind Period: Week 0-52|Other|3|||
25227360|NCT03517722|50523549|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
25227361|NCT03517722|50523550|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
25227362|NCT03517722|50523549|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
24976596|NCT00058058|50065518|FG000|Overall Study|Withdrawal by Subject|4|||
25227363|NCT03517722|50523550|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
25227364|NCT03517722|50523549|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
25227365|NCT03517722|50523550|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
25227366|NCT03517722|50523549|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
25227367|NCT03517722|50523550|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
25227368|NCT03517722|50523549|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
25227369|NCT03517722|50523550|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
25227370|NCT03447990|50523564|FG000|Overall Study|Withdrawal by Subject|0|||
25227371|NCT03447990|50523565|FG001|Overall Study|Withdrawal by Subject|0|||
25227372|NCT03447990|50523566|FG002|Overall Study|Withdrawal by Subject|0|||
25227373|NCT03447990|50523567|FG003|Overall Study|Withdrawal by Subject|0|||
25227374|NCT03447990|50523568|FG004|Overall Study|Withdrawal by Subject|0|||
25227375|NCT03447990|50523569|FG005|Overall Study|Withdrawal by Subject|0|||
25227376|NCT03447990|50523570|FG006|Overall Study|Withdrawal by Subject|1|||
25227377|NCT01376778|50523622|FG000|Overall Study|Lost to Follow-up|3|||
25227378|NCT01376778|50523623|FG001|Overall Study|Lost to Follow-up|2|||
25227379|NCT01074294|50523632|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
25227380|NCT01074294|50523633|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
25227381|NCT01074294|50523634|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
25227382|NCT01074294|50523635|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
25227383|NCT01074294|50523632|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
25227384|NCT01074294|50523633|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
25227385|NCT01074294|50523634|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
25227386|NCT01074294|50523635|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
25227387|NCT01074294|50523632|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
25227388|NCT01074294|50523633|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
25227389|NCT01074294|50523634|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
25227390|NCT01074294|50523635|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
25227391|NCT01074294|50523632|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
25227392|NCT01074294|50523633|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
25227393|NCT01074294|50523634|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
25227394|NCT01074294|50523635|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
25227395|NCT01074294|50523632|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
25227396|NCT01074294|50523633|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
25227397|NCT01074294|50523634|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
25227398|NCT01074294|50523635|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
25227399|NCT01074294|50523632|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
25227400|NCT01074294|50523633|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
25227401|NCT01074294|50523634|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
25227402|NCT01074294|50523635|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
25227403|NCT01074294|50523632|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
25227404|NCT01074294|50523633|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
25227405|NCT01074294|50523634|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
25227406|NCT01074294|50523635|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
25227407|NCT01074294|50523632|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
25227408|NCT01074294|50523633|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
25227409|NCT01074294|50523634|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
25227410|NCT01074294|50523635|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
25227411|NCT01074294|50523632|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
25227412|NCT01074294|50523633|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
25227413|NCT01074294|50523634|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
25227414|NCT01074294|50523635|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
25227415|NCT01074294|50523632|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
25227416|NCT01074294|50523633|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
25227417|NCT01074294|50523634|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
25227418|NCT01074294|50523635|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
25227419|NCT01074294|50523632|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
25227420|NCT01074294|50523633|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
25227421|NCT01074294|50523634|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
25227422|NCT01074294|50523635|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
25227423|NCT01074294|50523632|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
25227424|NCT01074294|50523633|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
25227425|NCT01074294|50523634|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
25227426|NCT01074294|50523635|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
25227427|NCT01074294|50523632|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
25227428|NCT01074294|50523633|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
25227429|NCT01074294|50523634|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
25227430|NCT01074294|50523635|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
25227431|NCT04556838|50525448|FG000|Overall Study|Withdrawal by Subject|3|||
25227432|NCT04556838|50525449|FG001|Overall Study|Withdrawal by Subject|1|||
25227433|NCT04556838|50525450|FG002|Overall Study|Withdrawal by Subject|2|||
25227434|NCT04556838|50525448|FG000|Overall Study|Adverse Event|0|||
25227435|NCT04556838|50525449|FG001|Overall Study|Adverse Event|1|||
25227436|NCT04556838|50525450|FG002|Overall Study|Adverse Event|1|||
25227437|NCT04556838|50525448|FG000|Overall Study|Lost to Follow-up|0|||
25227438|NCT04556838|50525449|FG001|Overall Study|Lost to Follow-up|0|||
25227439|NCT04556838|50525450|FG002|Overall Study|Lost to Follow-up|2|||
25227440|NCT04556838|50525448|FG000|Overall Study|Subject travel|0|||
25227441|NCT04556838|50525449|FG001|Overall Study|Subject travel|1|||
25227442|NCT04556838|50525450|FG002|Overall Study|Subject travel|0|||
25227443|NCT04556838|50525448|FG000|Overall Study|Physician Decision|1|||
25227444|NCT04556838|50525449|FG001|Overall Study|Physician Decision|0|||
25227445|NCT04556838|50525450|FG002|Overall Study|Physician Decision|0|||
25227446|NCT03671148|50525473|FG000|Overall Study|Adverse Event|3|||
25227447|NCT03671148|50525474|FG001|Overall Study|Adverse Event|2|||
25227448|NCT03671148|50525473|FG000|Overall Study|Withdrawal by Subject|8|||
25227449|NCT03671148|50525474|FG001|Overall Study|Withdrawal by Subject|2|||
25227450|NCT03671148|50525473|FG000|Overall Study|Lost to Follow-up|1|||
25227451|NCT03671148|50525474|FG001|Overall Study|Lost to Follow-up|2|||
25227452|NCT03671148|50525473|FG000|Overall Study|Lack of Efficacy|7|||
25227453|NCT03671148|50525474|FG001|Overall Study|Lack of Efficacy|2|||
25227454|NCT03671148|50525473|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
25227455|NCT03671148|50525474|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
25227456|NCT03671148|50525473|FG000|Overall Study|Other|1|||
25227457|NCT03671148|50525474|FG001|Overall Study|Other|0|||
25227458|NCT03671148|50525473|FG000|Overall Study|Incomplete Randomization Visit|1|||
25227459|NCT03671148|50525474|FG001|Overall Study|Incomplete Randomization Visit|0|||
25227460|NCT02004522|50525482|FG000|Overall Study|Adverse Event|55|||
25227461|NCT02004522|50525483|FG001|Overall Study|Adverse Event|6|||
25227462|NCT02004522|50525482|FG000|Overall Study|Withdrawal by Subject|13|||
25227463|NCT02004522|50525483|FG001|Overall Study|Withdrawal by Subject|7|||
25227464|NCT02004522|50525482|FG000|Overall Study|Death|12|||
25227465|NCT02004522|50525483|FG001|Overall Study|Death|3|||
25227466|NCT02004522|50525482|FG000|Overall Study|Physician Decision|3|||
25227467|NCT02004522|50525483|FG001|Overall Study|Physician Decision|4|||
25227468|NCT02004522|50525482|FG000|Overall Study|Protocol Violation|1|||
25227469|NCT02004522|50525483|FG001|Overall Study|Protocol Violation|0|||
25227470|NCT02004522|50525482|FG000|Overall Study|Other is reason listed by PI|4|||
25227471|NCT02004522|50525483|FG001|Overall Study|Other is reason listed by PI|1|||
25227472|NCT02004522|50525482|FG000|Overall Study|Never Dosed|2|||
25227473|NCT02004522|50525483|FG001|Overall Study|Never Dosed|4|||
25227474|NCT02004522|50525482|FG000|Overall Study|Disease Progression|35|||
25227475|NCT02004522|50525483|FG001|Overall Study|Disease Progression|31|||
25227476|NCT02004522|50525482|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
25227477|NCT02004522|50525483|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
25227478|NCT02000622|50525491|FG000|Overall Study|Withdrawal by Subject|5|||
25227479|NCT02000622|50525492|FG001|Overall Study|Withdrawal by Subject|7|||
25227480|NCT02000622|50525491|FG000|Overall Study|Lost to Follow-up|4|||
25227481|NCT02000622|50525492|FG001|Overall Study|Lost to Follow-up|0|||
25227482|NCT02000622|50525491|FG000|Overall Study|Death|159|||
25227483|NCT02000622|50525492|FG001|Overall Study|Death|73|||
25227484|NCT02000622|50525491|FG000|Overall Study|Withdrawn due to site closure|1|||
25227485|NCT02000622|50525492|FG001|Overall Study|Withdrawn due to site closure|0|||
25227486|NCT01430442|50525510|FG000|Overall Study|Subject Withdrew Consent|3|||
25227487|NCT01430442|50525511|FG001|Overall Study|Subject Withdrew Consent|0|||
25227488|NCT01430442|50525512|FG002|Overall Study|Subject Withdrew Consent|1|||
25227489|NCT01430442|50525513|FG003|Overall Study|Subject Withdrew Consent|0|||
25227490|NCT01430442|50525514|FG004|Overall Study|Subject Withdrew Consent|2|||
25227491|NCT01430442|50525515|FG005|Overall Study|Subject Withdrew Consent|1|||
25227492|NCT01430442|50525516|FG006|Overall Study|Subject Withdrew Consent|5|||
25227493|NCT01430442|50525517|FG007|Overall Study|Subject Withdrew Consent|2|||
25227494|NCT01430442|50525510|FG000|Overall Study|Lost to Follow-up|2|||
25227495|NCT01430442|50525511|FG001|Overall Study|Lost to Follow-up|0|||
25227496|NCT01430442|50525512|FG002|Overall Study|Lost to Follow-up|1|||
25227497|NCT01430442|50525513|FG003|Overall Study|Lost to Follow-up|2|||
25227498|NCT01430442|50525514|FG004|Overall Study|Lost to Follow-up|2|||
25227499|NCT01430442|50525515|FG005|Overall Study|Lost to Follow-up|1|||
25227500|NCT01430442|50525516|FG006|Overall Study|Lost to Follow-up|5|||
25227501|NCT01430442|50525517|FG007|Overall Study|Lost to Follow-up|1|||
25227502|NCT01430442|50525510|FG000|Overall Study|Pregnancy|1|||
25227503|NCT01430442|50525511|FG001|Overall Study|Pregnancy|0|||
25227504|NCT01430442|50525512|FG002|Overall Study|Pregnancy|0|||
25227505|NCT01430442|50525513|FG003|Overall Study|Pregnancy|0|||
25227506|NCT01430442|50525514|FG004|Overall Study|Pregnancy|0|||
25227507|NCT01430442|50525515|FG005|Overall Study|Pregnancy|1|||
25227508|NCT01430442|50525516|FG006|Overall Study|Pregnancy|0|||
25227509|NCT01430442|50525517|FG007|Overall Study|Pregnancy|0|||
25227510|NCT01430442|50525510|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
25227511|NCT01430442|50525511|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
25227512|NCT01430442|50525512|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
25227513|NCT01430442|50525513|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
25227514|NCT01430442|50525514|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
25227515|NCT01430442|50525515|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
25227516|NCT01430442|50525516|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
25227517|NCT01430442|50525517|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
25227518|NCT01420926|50525537|FG000|Overall Study|Adverse Event|6|||
25227519|NCT01420926|50525538|FG001|Overall Study|Adverse Event|4|||
25227520|NCT01420926|50525537|FG000|Overall Study|Death|18|||
25227521|NCT01420926|50525538|FG001|Overall Study|Death|17|||
25227522|NCT01420926|50525537|FG000|Overall Study|Withdrawal by Subject|11|||
25227523|NCT01420926|50525538|FG001|Overall Study|Withdrawal by Subject|17|||
25227524|NCT01420926|50525537|FG000|Overall Study|Non-protocol treatment|17|||
25227525|NCT01420926|50525538|FG001|Overall Study|Non-protocol treatment|20|||
25227526|NCT01420926|50525537|FG000|Overall Study|Physician Decision|8|||
25227527|NCT01420926|50525538|FG001|Overall Study|Physician Decision|5|||
25227528|NCT04303572|50526094|FG000|Overall Study|Study closed due to poor enrollment|1|||
25227529|NCT04150068|50526101|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
25227530|NCT04150068|50526102|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
25227531|NCT04150068|50526103|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
25227532|NCT04150068|50526101|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
25227533|NCT04150068|50526102|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
25227534|NCT04150068|50526103|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
25227535|NCT03551730|50526138|FG000|Overall Study|Adverse Event|1|||
25227536|NCT03551730|50526139|FG001|Overall Study|Adverse Event|0|||
25227537|NCT03551730|50526140|FG002|Overall Study|Adverse Event|0|||
25227538|NCT03551730|50526141|FG003|Overall Study|Adverse Event|0|||
25227539|NCT02656290|50526151|FG000|Overall Study|Subjects Remain On Study|26|||
25227540|NCT02534844|50526157|FG000|Part B|Withdrawal by Subject|0|||
25227541|NCT02534844|50526158|FG001|Part B|Withdrawal by Subject|0|||
25227542|NCT02534844|50526159|FG002|Part B|Withdrawal by Subject|0|||
25227543|NCT02534844|50526160|FG003|Part B|Withdrawal by Subject|0|||
25227544|NCT02534844|50526161|FG004|Part B|Withdrawal by Subject|2|||
25227545|NCT02534844|50526162|FG005|Part B|Withdrawal by Subject|1|||
25227546|NCT01818492|50526179|FG000|Overall Study|Adverse Event|2|||
25227547|NCT01818492|50526179|FG000|Overall Study|Death|3|||
25227548|NCT01818492|50526179|FG000|Overall Study|Withdrawal by Subject|1|||
25227549|NCT01818492|50526179|FG000|Overall Study|Additional therapy when not allowed PP|4|||
25227550|NCT01239030|50526189|FG000|Double Blind|Adverse Event|0|||
25227551|NCT01239030|50526190|FG001|Double Blind|Adverse Event|1|||
25227552|NCT01239030|50526191|FG002|Double Blind|Adverse Event|0|||
25227553|NCT01239030|50526192|FG003|Double Blind|Adverse Event|2|||
25227554|NCT01239030|50526193|FG004|Double Blind|Adverse Event|0|||
25227555|NCT01239030|50526189|FG000|Double Blind|Withdrawal by Subject|0|||
25227556|NCT01239030|50526190|FG001|Double Blind|Withdrawal by Subject|1|||
25227557|NCT01239030|50526191|FG002|Double Blind|Withdrawal by Subject|1|||
25227558|NCT01239030|50526192|FG003|Double Blind|Withdrawal by Subject|0|||
25227559|NCT01239030|50526193|FG004|Double Blind|Withdrawal by Subject|1|||
25227560|NCT01239030|50526189|FG000|Double Blind|Lost to Follow-up|1|||
25227561|NCT01239030|50526190|FG001|Double Blind|Lost to Follow-up|1|||
25227562|NCT01239030|50526191|FG002|Double Blind|Lost to Follow-up|0|||
25227563|NCT01239030|50526192|FG003|Double Blind|Lost to Follow-up|0|||
25227564|NCT01239030|50526193|FG004|Double Blind|Lost to Follow-up|0|||
25227565|NCT01239030|50526189|FG000|Double Blind|Physician Decision|0|||
25227566|NCT01239030|50526190|FG001|Double Blind|Physician Decision|1|||
25227567|NCT01239030|50526191|FG002|Double Blind|Physician Decision|0|||
25227568|NCT01239030|50526192|FG003|Double Blind|Physician Decision|0|||
25227569|NCT01239030|50526193|FG004|Double Blind|Physician Decision|0|||
25227570|NCT01239030|50526189|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
25227571|NCT01239030|50526190|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
25227572|NCT01239030|50526191|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
25227573|NCT01239030|50526192|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
25227574|NCT01239030|50526193|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
25227575|NCT01239030|50526189|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
25227576|NCT01239030|50526190|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
25227577|NCT01239030|50526191|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
25227578|NCT01239030|50526192|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
25227579|NCT01239030|50526193|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
25227580|NCT01239030|50526189|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
25227581|NCT01239030|50526190|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
25227582|NCT01239030|50526191|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
25227583|NCT01239030|50526192|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
25227584|NCT01239030|50526193|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
25227585|NCT01239030|50526189|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
25227586|NCT01239030|50526190|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
25227587|NCT01239030|50526191|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
25227588|NCT01239030|50526192|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
25227589|NCT01239030|50526193|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
25227590|NCT01086540|50526208|FG000|Overall Study|Death|3|||
25227591|NCT01086540|50526209|FG001|Overall Study|Death|1|||
25227592|NCT01086540|50526208|FG000|Overall Study|Physician Decision|2|||
25227593|NCT01086540|50526209|FG001|Overall Study|Physician Decision|1|||
25227594|NCT01086540|50526208|FG000|Overall Study|Addition of new therapy for PAH|1|||
25227595|NCT01086540|50526209|FG001|Overall Study|Addition of new therapy for PAH|0|||
25227596|NCT04567524|50529524|FG000|Overall Study|Adverse Event|1|||
25227597|NCT04567524|50529525|FG001|Overall Study|Adverse Event|1|||
25227598|NCT04567524|50529526|FG002|Overall Study|Adverse Event|0|||
25227599|NCT04567524|50529527|FG003|Overall Study|Adverse Event|0|||
25227600|NCT04567524|50529524|FG000|Overall Study|Withdrawal by Subject|2|||
25227601|NCT04567524|50529525|FG001|Overall Study|Withdrawal by Subject|0|||
25227602|NCT04567524|50529526|FG002|Overall Study|Withdrawal by Subject|0|||
25227603|NCT04567524|50529527|FG003|Overall Study|Withdrawal by Subject|1|||
25227604|NCT03370302|50529563|FG000|Dose Escalation Phase|Other|0|||
25227605|NCT03370302|50529564|FG001|Dose Escalation Phase|Other|1|||
25227606|NCT03370302|50529565|FG002|Dose Escalation Phase|Other|1|||
25227607|NCT03370302|50529566|FG003|Dose Escalation Phase|Other|0|||
25227608|NCT03370302|50529567|FG004|Dose Escalation Phase|Other|0|||
25227609|NCT03370302|50529568|FG005|Dose Escalation Phase|Other|0|||
25227610|NCT03370302|50529563|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
25227611|NCT03370302|50529564|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
25227612|NCT03370302|50529565|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
25227613|NCT03370302|50529566|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
25227614|NCT03370302|50529567|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
25227615|NCT03370302|50529568|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
25227616|NCT03370302|50529563|FG000|Dose Escalation Phase|Adverse Event|1|||
25227617|NCT03370302|50529564|FG001|Dose Escalation Phase|Adverse Event|0|||
25227618|NCT03370302|50529565|FG002|Dose Escalation Phase|Adverse Event|2|||
25227619|NCT03370302|50529566|FG003|Dose Escalation Phase|Adverse Event|0|||
25227620|NCT03370302|50529567|FG004|Dose Escalation Phase|Adverse Event|0|||
25227621|NCT03370302|50529568|FG005|Dose Escalation Phase|Adverse Event|0|||
25227622|NCT03370302|50529563|FG000|Dose Escalation Phase|Progressive Disease|2|||
25227623|NCT03370302|50529564|FG001|Dose Escalation Phase|Progressive Disease|4|||
25227624|NCT03370302|50529565|FG002|Dose Escalation Phase|Progressive Disease|2|||
25227625|NCT03370302|50529566|FG003|Dose Escalation Phase|Progressive Disease|0|||
25227626|NCT03370302|50529567|FG004|Dose Escalation Phase|Progressive Disease|3|||
25227627|NCT03370302|50529568|FG005|Dose Escalation Phase|Progressive Disease|1|||
25227628|NCT03370302|50529563|FG000|Dose Expansion Phase|Progressive Disease|0|||
25227629|NCT03370302|50529564|FG001|Dose Expansion Phase|Progressive Disease|0|||
25227630|NCT03370302|50529565|FG002|Dose Expansion Phase|Progressive Disease|0|||
25227631|NCT03370302|50529566|FG003|Dose Expansion Phase|Progressive Disease|6|||
25227632|NCT03370302|50529567|FG004|Dose Expansion Phase|Progressive Disease|0|||
25227633|NCT03370302|50529568|FG005|Dose Expansion Phase|Progressive Disease|0|||
25227634|NCT03327324|50529592|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
25227635|NCT03327324|50529593|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
25227636|NCT03327324|50529594|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
25227637|NCT03327324|50529595|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
25227638|NCT03327324|50529596|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
25227639|NCT03327324|50529597|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
25227640|NCT03327324|50529592|FG000|Baseline (Month 0-Month 3)|Refused|0|||
25227641|NCT03327324|50529593|FG001|Baseline (Month 0-Month 3)|Refused|0|||
25227642|NCT03327324|50529594|FG002|Baseline (Month 0-Month 3)|Refused|0|||
25227643|NCT03327324|50529595|FG003|Baseline (Month 0-Month 3)|Refused|0|||
25227644|NCT03327324|50529596|FG004|Baseline (Month 0-Month 3)|Refused|1|||
25227645|NCT03327324|50529597|FG005|Baseline (Month 0-Month 3)|Refused|0|||
25227646|NCT03327324|50529592|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
25227647|NCT03327324|50529593|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
25227648|NCT03327324|50529594|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
25227649|NCT03327324|50529595|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
25227650|NCT03327324|50529596|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
25227651|NCT03327324|50529597|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
25227652|NCT03327324|50529592|FG000|Baseline (Month 0-Month 3)|Death|0|||
25227653|NCT03327324|50529593|FG001|Baseline (Month 0-Month 3)|Death|0|||
25227654|NCT03327324|50529594|FG002|Baseline (Month 0-Month 3)|Death|0|||
25227655|NCT03327324|50529595|FG003|Baseline (Month 0-Month 3)|Death|0|||
25227656|NCT03327324|50529596|FG004|Baseline (Month 0-Month 3)|Death|1|||
25227657|NCT03327324|50529597|FG005|Baseline (Month 0-Month 3)|Death|0|||
25227658|NCT03327324|50529592|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
25227659|NCT03327324|50529593|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
25227660|NCT03327324|50529594|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
25227661|NCT03327324|50529595|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
25227662|NCT03327324|50529596|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
25227663|NCT03327324|50529597|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
25227664|NCT03327324|50529592|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
25227665|NCT03327324|50529593|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
25227666|NCT03327324|50529594|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
25227667|NCT03327324|50529595|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
25227668|NCT03327324|50529596|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
25227669|NCT03327324|50529597|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
25227670|NCT03327324|50529592|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
25227671|NCT03327324|50529593|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
25227672|NCT03327324|50529594|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
25227673|NCT03327324|50529595|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
25227674|NCT03327324|50529596|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
25227675|NCT03327324|50529597|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
25227676|NCT03327324|50529592|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
25227677|NCT03327324|50529593|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
25227678|NCT03327324|50529594|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
25227679|NCT03327324|50529595|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
25227680|NCT03327324|50529596|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
25227681|NCT03327324|50529597|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
25227682|NCT03327324|50529592|FG000|Intervention (Month 3-Month 6)|Death|1|||
25227683|NCT03327324|50529593|FG001|Intervention (Month 3-Month 6)|Death|0|||
25227684|NCT03327324|50529594|FG002|Intervention (Month 3-Month 6)|Death|1|||
25227685|NCT03327324|50529595|FG003|Intervention (Month 3-Month 6)|Death|1|||
25227686|NCT03327324|50529596|FG004|Intervention (Month 3-Month 6)|Death|1|||
25227687|NCT03327324|50529597|FG005|Intervention (Month 3-Month 6)|Death|0|||
25227688|NCT03327324|50529592|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
25227689|NCT03327324|50529593|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
25227690|NCT03327324|50529594|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
25227691|NCT03327324|50529595|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
25227692|NCT03327324|50529596|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
25227693|NCT03327324|50529597|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
25227694|NCT03327324|50529592|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
25227695|NCT03327324|50529593|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
25227696|NCT03327324|50529594|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
25227697|NCT03327324|50529595|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
25227698|NCT03327324|50529596|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
25227699|NCT03327324|50529597|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
25227700|NCT03327324|50529592|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
25227701|NCT03327324|50529593|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
25227702|NCT03327324|50529594|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
25227703|NCT03327324|50529595|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
25227704|NCT03327324|50529596|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
25227705|NCT03327324|50529597|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
25227706|NCT03327324|50529592|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
25227707|NCT03327324|50529593|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
25227708|NCT03327324|50529594|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
25227709|NCT03327324|50529595|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
25227710|NCT03327324|50529596|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
25227711|NCT03327324|50529597|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
25227712|NCT03327324|50529592|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
25227713|NCT03327324|50529593|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
25227714|NCT03327324|50529594|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
25227715|NCT03327324|50529595|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
25227716|NCT03327324|50529596|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
25227717|NCT03327324|50529597|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
25227718|NCT03327324|50529592|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
25227719|NCT03327324|50529593|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
25227720|NCT03327324|50529594|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
25227721|NCT03327324|50529595|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
25227722|NCT03327324|50529596|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
25227723|NCT03327324|50529597|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
25227724|NCT03327324|50529592|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
25227725|NCT03327324|50529593|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
25227726|NCT03327324|50529594|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
25227727|NCT03327324|50529595|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
25227728|NCT03327324|50529596|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
25227729|NCT03327324|50529597|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
25227730|NCT03252522|50529603|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
25227731|NCT03252522|50529604|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
25227732|NCT03252522|50529605|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
25227733|NCT03252522|50529603|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
25227734|NCT03252522|50529604|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
25227735|NCT03252522|50529605|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
25227736|NCT03252522|50529603|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
25227737|NCT03252522|50529604|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
25227738|NCT03252522|50529605|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
25227739|NCT03252522|50529603|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
25227740|NCT03252522|50529604|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
25319083|NCT00950807|50634479|FG005|Treatment Period 3|Withdrawal by Subject|0|||
25319084|NCT00950807|50634480|FG006|Treatment Period 3|Withdrawal by Subject|0|||
25319085|NCT00950807|50634481|FG007|Treatment Period 3|Withdrawal by Subject|0|||
25319086|NCT00950807|50634482|FG008|Treatment Period 3|Withdrawal by Subject|0|||
25319087|NCT00950807|50634483|FG009|Treatment Period 3|Withdrawal by Subject|1|||
25319088|NCT00950807|50634474|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
25319089|NCT00950807|50634475|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
25319090|NCT00950807|50634476|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
25319091|NCT00950807|50634477|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
25319092|NCT00950807|50634478|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
25319093|NCT00950807|50634479|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
24976597|NCT00058058|50065518|FG000|Overall Study|Ineligible|20|||
24976598|NCT00058058|50065518|FG000|Overall Study|Claustrophobic|5|||
24976599|NCT00058058|50065518|FG000|Overall Study|technical issues|6|||
24976600|NCT00058058|50065518|FG000|Overall Study|Poor positioning, illness,pain|3|||
25227741|NCT03252522|50529605|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
25227742|NCT03252522|50529603|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
25227743|NCT03252522|50529604|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
25227744|NCT03252522|50529605|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
25227745|NCT03252522|50529603|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
25227746|NCT03252522|50529604|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
25227747|NCT03252522|50529605|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
25227748|NCT03252522|50529603|FG000|Phase 2: Open Label|Adverse Event|0|||
25227749|NCT03252522|50529604|FG001|Phase 2: Open Label|Adverse Event|0|||
25227750|NCT03252522|50529605|FG002|Phase 2: Open Label|Adverse Event|2|||
25227751|NCT03252522|50529603|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
25227752|NCT03252522|50529604|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
25227753|NCT03252522|50529605|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
25227754|NCT02828358|50529619|FG000|Overall Study|Physician Decision|7|||
25227755|NCT02828358|50529620|FG001|Overall Study|Physician Decision|1|||
25227756|NCT02828358|50529619|FG000|Overall Study|Treatment Failure|6|||
25227757|NCT02828358|50529620|FG001|Overall Study|Treatment Failure|0|||
25227758|NCT02828358|50529619|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
25227759|NCT02828358|50529620|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
25227760|NCT02828358|50529619|FG000|Overall Study|Refusal of further protocol therapy|2|||
25227761|NCT02828358|50529620|FG001|Overall Study|Refusal of further protocol therapy|0|||
25227762|NCT02828358|50529619|FG000|Overall Study|Relapse|25|||
25227763|NCT02828358|50529620|FG001|Overall Study|Relapse|0|||
25227764|NCT02828358|50529619|FG000|Overall Study|Still on therapy|5|||
25227765|NCT02828358|50529620|FG001|Overall Study|Still on therapy|0|||
25227766|NCT02756364|50529628|FG000|Overall Study|Site Terminated by Sponsor|24|||
25227767|NCT02756364|50529629|FG001|Overall Study|Site Terminated by Sponsor|30|||
25227768|NCT02756364|50529630|FG002|Overall Study|Site Terminated by Sponsor|21|||
25227769|NCT02756364|50529628|FG000|Overall Study|Death|20|||
25227770|NCT02756364|50529629|FG001|Overall Study|Death|15|||
25227771|NCT02756364|50529630|FG002|Overall Study|Death|18|||
25227772|NCT02756364|50529628|FG000|Overall Study|Withdrawal by Patient|2|||
25227773|NCT02756364|50529629|FG001|Overall Study|Withdrawal by Patient|1|||
25227774|NCT02756364|50529630|FG002|Overall Study|Withdrawal by Patient|8|||
25227775|NCT02756364|50529628|FG000|Overall Study|Lost to Follow-up|0|||
25227776|NCT02756364|50529629|FG001|Overall Study|Lost to Follow-up|1|||
25227777|NCT02756364|50529630|FG002|Overall Study|Lost to Follow-up|1|||
25227778|NCT02272842|50529640|FG000|Overall Study|Lost to Follow-up|8|||
25227779|NCT02272842|50529641|FG001|Overall Study|Lost to Follow-up|8|||
25227780|NCT02272842|50529640|FG000|Overall Study|Withdrawal by Subject|8|||
25227781|NCT02272842|50529641|FG001|Overall Study|Withdrawal by Subject|2|||
25227782|NCT01906476|50529650|FG000|Overall Study|Lost to Follow-up|17|||
25227783|NCT01906476|50529651|FG001|Overall Study|Lost to Follow-up|16|||
25227784|NCT05343624|50529657|FG000|Overall Study|Chart review not completed|1|||
25227785|NCT04208412|50529699|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
25227786|NCT04208412|50529700|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
25227787|NCT04208412|50529699|FG000|Overall Study|Withdrawal by Subject|1|||
25227788|NCT04208412|50529700|FG001|Overall Study|Withdrawal by Subject|0|||
25227789|NCT04208412|50529699|FG000|Overall Study|Lost to Follow-up|0|||
25227790|NCT04208412|50529700|FG001|Overall Study|Lost to Follow-up|1|||
25227791|NCT04095858|50529710|FG000|Overall Study|Death|1|||
25227792|NCT04095858|50529711|FG001|Overall Study|Death|0|||
25227793|NCT04095858|50529710|FG000|Overall Study|Study terminated by Sponsor|2|||
25227794|NCT04095858|50529711|FG001|Overall Study|Study terminated by Sponsor|4|||
25227795|NCT03937986|50529717|FG000|Overall Study|COVID-19 Pandemic|1|||
25227796|NCT03738150|50529732|FG000|Base Study|Withdrawal by Subject|1|||
25227797|NCT03738150|50529732|FG000|Extension Study|Withdrawal by Subject|1|||
25227798|NCT03567174|50529748|FG000|Overall Study|Death|24|||
25227799|NCT03567174|50529749|FG001|Overall Study|Death|31|||
25227800|NCT03567174|50529748|FG000|Overall Study|Lost to Follow-up|165|||
25227801|NCT03567174|50529749|FG001|Overall Study|Lost to Follow-up|174|||
25227802|NCT03529110|50529760|FG000|Overall Study|Progressive Disease|66|||
25227803|NCT03529110|50529761|FG001|Overall Study|Progressive Disease|158|||
25227804|NCT03529110|50529760|FG000|Overall Study|Clinical Progression|4|||
25227805|NCT03529110|50529761|FG001|Overall Study|Clinical Progression|12|||
25227806|NCT03529110|50529760|FG000|Overall Study|Adverse Event|35|||
25227807|NCT03529110|50529761|FG001|Overall Study|Adverse Event|17|||
25227808|NCT03529110|50529760|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
25319094|NCT00950807|50634480|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
25227809|NCT03529110|50529761|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
25227810|NCT03529110|50529760|FG000|Overall Study|Lack of Efficacy|3|||
25319095|NCT00950807|50634481|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
25227811|NCT03529110|50529761|FG001|Overall Study|Lack of Efficacy|3|||
25227812|NCT03529110|50529760|FG000|Overall Study|Physician Decision|2|||
25227813|NCT03529110|50529761|FG001|Overall Study|Physician Decision|8|||
25319096|NCT00950807|50634482|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
25227814|NCT03529110|50529760|FG000|Overall Study|Miscellaneous|2|||
25227815|NCT03529110|50529761|FG001|Overall Study|Miscellaneous|5|||
25227816|NCT02663622|50529805|FG000|Overall Study|Death|3|||
25227817|NCT02663622|50529806|FG001|Overall Study|Death|1|||
25227818|NCT02663622|50529807|FG002|Overall Study|Death|1|||
25227819|NCT02663622|50529808|FG003|Overall Study|Death|8|||
25227820|NCT02663622|50529805|FG000|Overall Study|Protocol Violation|0|||
25227821|NCT02663622|50529806|FG001|Overall Study|Protocol Violation|0|||
25227822|NCT02663622|50529807|FG002|Overall Study|Protocol Violation|0|||
25227823|NCT02663622|50529808|FG003|Overall Study|Protocol Violation|1|||
25227824|NCT02545998|50529834|FG000|Overall Study|Lost to Follow-up|12|||
25227825|NCT02545998|50529835|FG001|Overall Study|Lost to Follow-up|3|||
25227826|NCT02545998|50529834|FG000|Overall Study|Withdrawal by Subject|3|||
25227827|NCT02545998|50529835|FG001|Overall Study|Withdrawal by Subject|2|||
25227828|NCT02257242|50529859|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
25227829|NCT02257242|50529860|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
25227830|NCT02257242|50529861|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
25227831|NCT02257242|50529862|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
25227832|NCT02257242|50529863|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
25227833|NCT02257242|50529864|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
25227834|NCT02257242|50529865|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
25227835|NCT02257242|50529866|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
25227836|NCT02257242|50529867|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
25227837|NCT01943916|50529897|FG000|Overall Study|Technically invalid images|10|||
25227838|NCT01943916|50529897|FG000|Overall Study|Enrollment Failure|23|||
25227839|NCT01943916|50529897|FG000|Overall Study|Pilot Phase exclusion|100|||
25227840|NCT01943916|50529897|FG000|Overall Study|Quality Assurance Reader Fail|130|||
25227841|NCT01943916|50529897|FG000|Overall Study|Technical Failure|39|||
25227842|NCT01943916|50529897|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
25227843|NCT01943916|50529897|FG000|Overall Study|No Truth Panel Review|38|||
25227844|NCT01943916|50529897|FG000|Overall Study|Protocol Deviation|1|||
25227845|NCT01564368|50529906|FG000|Overall Study|Ineligible|18|||
25227846|NCT01564368|50529906|FG000|Overall Study|Not Randomized in Parent study|116|||
25227847|NCT01564368|50529906|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
25227848|NCT01564368|50529906|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
25227849|NCT00281658|50529914|FG000|Randomized Phase|Adverse Event|0|||
25227850|NCT00281658|50529915|FG001|Randomized Phase|Adverse Event|2|||
25227851|NCT00281658|50529916|FG002|Randomized Phase|Adverse Event|0|||
25227852|NCT00281658|50529917|FG003|Randomized Phase|Adverse Event|0|||
25227853|NCT00281658|50529914|FG000|Randomized Phase|Lost to Follow-up|34|||
25227854|NCT00281658|50529915|FG001|Randomized Phase|Lost to Follow-up|27|||
25227855|NCT00281658|50529916|FG002|Randomized Phase|Lost to Follow-up|0|||
25227856|NCT00281658|50529917|FG003|Randomized Phase|Lost to Follow-up|0|||
25227857|NCT00281658|50529914|FG000|Randomized Phase|Withdrawal by Subject|8|||
25227858|NCT00281658|50529915|FG001|Randomized Phase|Withdrawal by Subject|7|||
25227859|NCT00281658|50529916|FG002|Randomized Phase|Withdrawal by Subject|0|||
25227860|NCT00281658|50529917|FG003|Randomized Phase|Withdrawal by Subject|0|||
25227861|NCT00281658|50529914|FG000|Randomized Phase|Study closed/terminated|1|||
25227862|NCT00281658|50529915|FG001|Randomized Phase|Study closed/terminated|1|||
25227863|NCT00281658|50529916|FG002|Randomized Phase|Study closed/terminated|0|||
25227864|NCT00281658|50529917|FG003|Randomized Phase|Study closed/terminated|0|||
25227865|NCT00281658|50529914|FG000|Randomized Phase|Disease progression|36|||
25227866|NCT00281658|50529915|FG001|Randomized Phase|Disease progression|27|||
25227867|NCT00281658|50529916|FG002|Randomized Phase|Disease progression|0|||
25227868|NCT00281658|50529917|FG003|Randomized Phase|Disease progression|0|||
25227869|NCT00281658|50529914|FG000|Randomized Phase|Physician Decision|1|||
25227870|NCT00281658|50529915|FG001|Randomized Phase|Physician Decision|1|||
25227871|NCT00281658|50529916|FG002|Randomized Phase|Physician Decision|0|||
25227872|NCT00281658|50529917|FG003|Randomized Phase|Physician Decision|0|||
25227873|NCT00281658|50529914|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
25227874|NCT00281658|50529915|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
25227875|NCT00281658|50529916|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
25227876|NCT00281658|50529917|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
25227877|NCT00281658|50529914|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
25227878|NCT00281658|50529915|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
25227879|NCT00281658|50529916|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
25227880|NCT00281658|50529917|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
25227881|NCT00281658|50529914|FG000|Randomized Phase|Treatment ongoing|1|||
25227882|NCT00281658|50529915|FG001|Randomized Phase|Treatment ongoing|0|||
25227883|NCT00281658|50529916|FG002|Randomized Phase|Treatment ongoing|0|||
25227884|NCT00281658|50529917|FG003|Randomized Phase|Treatment ongoing|0|||
25227885|NCT00281658|50529914|FG000|Open Label Phase|Adverse Event|0|||
25227886|NCT00281658|50529915|FG001|Open Label Phase|Adverse Event|0|||
25227887|NCT00281658|50529916|FG002|Open Label Phase|Adverse Event|1|||
25227888|NCT00281658|50529917|FG003|Open Label Phase|Adverse Event|0|||
25227889|NCT00281658|50529914|FG000|Open Label Phase|Lost to Follow-up|0|||
25227890|NCT00281658|50529915|FG001|Open Label Phase|Lost to Follow-up|0|||
25227891|NCT00281658|50529916|FG002|Open Label Phase|Lost to Follow-up|16|||
25227892|NCT00281658|50529917|FG003|Open Label Phase|Lost to Follow-up|2|||
25227893|NCT00281658|50529914|FG000|Open Label Phase|Withdrawal by Subject|0|||
25227894|NCT00281658|50529915|FG001|Open Label Phase|Withdrawal by Subject|0|||
25227895|NCT00281658|50529916|FG002|Open Label Phase|Withdrawal by Subject|3|||
25227896|NCT00281658|50529917|FG003|Open Label Phase|Withdrawal by Subject|2|||
25227897|NCT00281658|50529914|FG000|Open Label Phase|Disease progression|0|||
25227898|NCT00281658|50529915|FG001|Open Label Phase|Disease progression|0|||
25227899|NCT00281658|50529916|FG002|Open Label Phase|Disease progression|18|||
25227900|NCT00281658|50529917|FG003|Open Label Phase|Disease progression|0|||
25227901|NCT00281658|50529914|FG000|Open Label Phase|Physician Decision|0|||
25227902|NCT00281658|50529915|FG001|Open Label Phase|Physician Decision|0|||
25227903|NCT00281658|50529916|FG002|Open Label Phase|Physician Decision|1|||
25227904|NCT00281658|50529917|FG003|Open Label Phase|Physician Decision|0|||
25227905|NCT00281658|50529914|FG000|Open Label Phase|Relocation of patient|0|||
25227906|NCT00281658|50529915|FG001|Open Label Phase|Relocation of patient|0|||
25227907|NCT00281658|50529916|FG002|Open Label Phase|Relocation of patient|1|||
25227908|NCT00281658|50529917|FG003|Open Label Phase|Relocation of patient|0|||
25227909|NCT00281658|50529914|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
25227910|NCT00281658|50529915|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
25227911|NCT00281658|50529916|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
25227912|NCT00281658|50529917|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
25227913|NCT02758626|50531317|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
25227914|NCT02758626|50531318|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
25227915|NCT02758626|50531317|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
25227916|NCT02758626|50531318|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
25227917|NCT02758626|50531317|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
25227918|NCT02758626|50531318|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
25227919|NCT02758626|50531317|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
25227920|NCT02758626|50531318|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
25227921|NCT02357784|50531324|FG000|Overall Study|Withdrawal by Subject|1|||
25227922|NCT01448616|50531331|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
25227923|NCT01448616|50531332|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
25227924|NCT01448616|50531333|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
25227925|NCT01448616|50531334|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
25227926|NCT01448616|50531331|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
25227927|NCT01448616|50531332|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
25227928|NCT01448616|50531333|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
25227929|NCT01448616|50531334|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
25227930|NCT01448616|50531331|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
25227931|NCT01448616|50531332|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
25227932|NCT01448616|50531333|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
25227933|NCT01448616|50531334|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
25227934|NCT01448616|50531331|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
25227935|NCT01448616|50531332|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
25227936|NCT01448616|50531333|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
25227937|NCT01448616|50531334|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
25227938|NCT01448616|50531331|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
25227939|NCT01448616|50531332|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
25227940|NCT01448616|50531333|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
25227941|NCT01448616|50531334|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
25227942|NCT00074412|50531371|FG000|Overall Study|Death|30|||
25227943|NCT00074412|50531372|FG001|Overall Study|Death|26|||
25227944|NCT00074412|50531371|FG000|Overall Study|Lost to Follow-up|52|||
25077484|NCT00002663|50185276|FG001|Overall Study|Other|1|||
25227945|NCT00074412|50531372|FG001|Overall Study|Lost to Follow-up|58|||
25227946|NCT04505592|50532382|FG000|Overall Study|Death|2|||
25227947|NCT04505592|50532383|FG001|Overall Study|Death|1|||
25227948|NCT04521114|50538773|FG000|Overall Study|Lost to Follow-up|1|||
25227949|NCT04521114|50538774|FG001|Overall Study|Lost to Follow-up|2|||
25227950|NCT04521114|50538775|FG002|Overall Study|Lost to Follow-up|0|||
25077485|NCT00002663|50185277|FG002|Overall Study|Other|0|||
25227951|NCT04521114|50538773|FG000|Overall Study|Withdrawal by Subject|1|||
25227952|NCT04521114|50538774|FG001|Overall Study|Withdrawal by Subject|2|||
25227953|NCT04521114|50538775|FG002|Overall Study|Withdrawal by Subject|2|||
25227954|NCT04521114|50538773|FG000|Overall Study|Adverse Event|1|||
25227955|NCT04521114|50538774|FG001|Overall Study|Adverse Event|0|||
25227956|NCT04521114|50538775|FG002|Overall Study|Adverse Event|0|||
25227957|NCT04521114|50538773|FG000|Overall Study|Sponsor Wish|1|||
25227958|NCT04521114|50538774|FG001|Overall Study|Sponsor Wish|0|||
25227959|NCT04521114|50538775|FG002|Overall Study|Sponsor Wish|0|||
25227960|NCT04521114|50538773|FG000|Overall Study|Withdrawal of Consent|2|||
25227961|NCT04521114|50538774|FG001|Overall Study|Withdrawal of Consent|2|||
25227962|NCT04521114|50538775|FG002|Overall Study|Withdrawal of Consent|0|||
25227963|NCT04360824|50538797|FG000|Overall Study|Withdrawal by Subject|2|||
25227964|NCT04360824|50538798|FG001|Overall Study|Withdrawal by Subject|1|||
25227965|NCT04360824|50538797|FG000|Overall Study|Did not receive assigned treatment|1|||
25227966|NCT04360824|50538798|FG001|Overall Study|Did not receive assigned treatment|3|||
25227967|NCT03711786|50538807|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
25227968|NCT03711786|50538808|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
25227969|NCT03711786|50538807|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
25227970|NCT03711786|50538808|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
25227971|NCT03711786|50538807|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
25227972|NCT03711786|50538808|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
25227973|NCT03711786|50538807|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
25227974|NCT03711786|50538808|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
25227975|NCT03711786|50538807|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
25227976|NCT03711786|50538808|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
25227977|NCT03711786|50538807|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
25227978|NCT03711786|50538808|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
25227979|NCT03691974|50538818|FG000|Overall Study|Physician Decision|1|||
25227980|NCT03691974|50538819|FG001|Overall Study|Physician Decision|0|||
25227981|NCT03691974|50538818|FG000|Overall Study|Adverse Event|1|||
25227982|NCT03691974|50538819|FG001|Overall Study|Adverse Event|0|||
25227983|NCT03691974|50538818|FG000|Overall Study|Withdrawal by Subject|11|||
25227984|NCT03691974|50538819|FG001|Overall Study|Withdrawal by Subject|9|||
25227985|NCT03691974|50538818|FG000|Overall Study|Protocol Violation|1|||
25227986|NCT03691974|50538819|FG001|Overall Study|Protocol Violation|0|||
25227987|NCT03691974|50538818|FG000|Overall Study|Lost to Follow-up|8|||
25227988|NCT03691974|50538819|FG001|Overall Study|Lost to Follow-up|7|||
25227989|NCT03525678|50538840|FG000|Overall Study|Ongoing at the time of interim analysis|60|||
25227990|NCT03525678|50538841|FG001|Overall Study|Ongoing at the time of interim analysis|65|||
25227991|NCT03525678|50538842|FG002|Overall Study|Ongoing at the time of interim analysis|21|||
25227992|NCT03525678|50538840|FG000|Overall Study|Withdrawal by Subject|3|||
25227993|NCT03525678|50538841|FG001|Overall Study|Withdrawal by Subject|1|||
25227994|NCT03525678|50538842|FG002|Overall Study|Withdrawal by Subject|0|||
25227995|NCT03525678|50538840|FG000|Overall Study|Physician Decision|1|||
25227996|NCT03525678|50538841|FG001|Overall Study|Physician Decision|2|||
25227997|NCT03525678|50538842|FG002|Overall Study|Physician Decision|0|||
25227998|NCT03525678|50538840|FG000|Overall Study|Lost to Follow-up|1|||
25227999|NCT03525678|50538841|FG001|Overall Study|Lost to Follow-up|0|||
25228000|NCT03525678|50538842|FG002|Overall Study|Lost to Follow-up|0|||
25228001|NCT03525678|50538840|FG000|Overall Study|Death|32|||
25228002|NCT03525678|50538841|FG001|Overall Study|Death|31|||
25228003|NCT03525678|50538842|FG002|Overall Study|Death|4|||
25228004|NCT02829918|50538850|FG000|Overall Study|Death|2|||
25228005|NCT02829918|50538850|FG000|Overall Study|Withdrawal by Subject|4|||
25228006|NCT02829918|50538850|FG000|Overall Study|Adverse Event|1|||
25228007|NCT02829918|50538850|FG000|Overall Study|Progression|1|||
25228008|NCT02454972|50538863|FG000|Overall Study|Progressive disease|17|||
25228009|NCT02454972|50538864|FG001|Overall Study|Progressive disease|16|||
25228010|NCT02454972|50538865|FG002|Overall Study|Progressive disease|59|||
25228011|NCT02454972|50538866|FG003|Overall Study|Progressive disease|23|||
25228012|NCT02454972|50538867|FG004|Overall Study|Progressive disease|16|||
25228013|NCT02454972|50538868|FG005|Overall Study|Progressive disease|12|||
25228014|NCT02454972|50538869|FG006|Overall Study|Progressive disease|19|||
25228015|NCT02454972|50538870|FG007|Overall Study|Progressive disease|27|||
25228016|NCT02454972|50538871|FG008|Overall Study|Progressive disease|0|||
25228017|NCT02454972|50538863|FG000|Overall Study|Death|0|||
25228018|NCT02454972|50538864|FG001|Overall Study|Death|0|||
25228019|NCT02454972|50538865|FG002|Overall Study|Death|5|||
25228020|NCT02454972|50538866|FG003|Overall Study|Death|1|||
25228021|NCT02454972|50538867|FG004|Overall Study|Death|0|||
25228022|NCT02454972|50538868|FG005|Overall Study|Death|0|||
25228023|NCT02454972|50538869|FG006|Overall Study|Death|0|||
25228024|NCT02454972|50538870|FG007|Overall Study|Death|0|||
25228025|NCT02454972|50538871|FG008|Overall Study|Death|95|||
25228026|NCT02454972|50538863|FG000|Overall Study|Physician Decision|0|||
25228027|NCT02454972|50538864|FG001|Overall Study|Physician Decision|1|||
25228028|NCT02454972|50538865|FG002|Overall Study|Physician Decision|2|||
25228029|NCT02454972|50538866|FG003|Overall Study|Physician Decision|1|||
25228030|NCT02454972|50538867|FG004|Overall Study|Physician Decision|2|||
25228031|NCT02454972|50538868|FG005|Overall Study|Physician Decision|0|||
25228032|NCT02454972|50538869|FG006|Overall Study|Physician Decision|0|||
25228033|NCT02454972|50538870|FG007|Overall Study|Physician Decision|1|||
25228034|NCT02454972|50538871|FG008|Overall Study|Physician Decision|0|||
25228035|NCT02454972|50538863|FG000|Overall Study|Non treatment-related adverse event|2|||
25228036|NCT02454972|50538864|FG001|Overall Study|Non treatment-related adverse event|0|||
25228037|NCT02454972|50538865|FG002|Overall Study|Non treatment-related adverse event|1|||
25228038|NCT02454972|50538866|FG003|Overall Study|Non treatment-related adverse event|0|||
25228039|NCT02454972|50538867|FG004|Overall Study|Non treatment-related adverse event|0|||
25228040|NCT02454972|50538868|FG005|Overall Study|Non treatment-related adverse event|1|||
25228041|NCT02454972|50538869|FG006|Overall Study|Non treatment-related adverse event|0|||
25228042|NCT02454972|50538870|FG007|Overall Study|Non treatment-related adverse event|1|||
25228043|NCT02454972|50538871|FG008|Overall Study|Non treatment-related adverse event|0|||
25228044|NCT02454972|50538863|FG000|Overall Study|Treatment-related adverse events|0|||
25228045|NCT02454972|50538864|FG001|Overall Study|Treatment-related adverse events|1|||
25228046|NCT02454972|50538865|FG002|Overall Study|Treatment-related adverse events|1|||
25228047|NCT02454972|50538866|FG003|Overall Study|Treatment-related adverse events|0|||
25228048|NCT02454972|50538867|FG004|Overall Study|Treatment-related adverse events|2|||
25228049|NCT02454972|50538868|FG005|Overall Study|Treatment-related adverse events|0|||
25228050|NCT02454972|50538869|FG006|Overall Study|Treatment-related adverse events|0|||
25228051|NCT02454972|50538870|FG007|Overall Study|Treatment-related adverse events|2|||
25228052|NCT02454972|50538871|FG008|Overall Study|Treatment-related adverse events|0|||
25228053|NCT02454972|50538863|FG000|Overall Study|Patient moves to compassionate use|0|||
25228054|NCT02454972|50538864|FG001|Overall Study|Patient moves to compassionate use|0|||
25228055|NCT02454972|50538865|FG002|Overall Study|Patient moves to compassionate use|0|||
25228056|NCT02454972|50538866|FG003|Overall Study|Patient moves to compassionate use|0|||
25228057|NCT02454972|50538867|FG004|Overall Study|Patient moves to compassionate use|0|||
25228058|NCT02454972|50538868|FG005|Overall Study|Patient moves to compassionate use|0|||
25228059|NCT02454972|50538869|FG006|Overall Study|Patient moves to compassionate use|2|||
25228060|NCT02454972|50538870|FG007|Overall Study|Patient moves to compassionate use|0|||
25228061|NCT02454972|50538871|FG008|Overall Study|Patient moves to compassionate use|0|||
25228062|NCT02454972|50538863|FG000|Overall Study|Withdrawal by Subject|0|||
25228063|NCT02454972|50538864|FG001|Overall Study|Withdrawal by Subject|1|||
25228064|NCT02454972|50538865|FG002|Overall Study|Withdrawal by Subject|5|||
25228065|NCT02454972|50538866|FG003|Overall Study|Withdrawal by Subject|2|||
25228066|NCT02454972|50538867|FG004|Overall Study|Withdrawal by Subject|3|||
25228067|NCT02454972|50538868|FG005|Overall Study|Withdrawal by Subject|2|||
25228068|NCT02454972|50538869|FG006|Overall Study|Withdrawal by Subject|0|||
25228069|NCT02454972|50538870|FG007|Overall Study|Withdrawal by Subject|1|||
25228070|NCT02454972|50538871|FG008|Overall Study|Withdrawal by Subject|2|||
25228071|NCT02454972|50538863|FG000|Overall Study|Multiple delay/holds on treatment|0|||
25228072|NCT02454972|50538864|FG001|Overall Study|Multiple delay/holds on treatment|0|||
25228073|NCT02454972|50538865|FG002|Overall Study|Multiple delay/holds on treatment|0|||
25228074|NCT02454972|50538866|FG003|Overall Study|Multiple delay/holds on treatment|1|||
25228075|NCT02454972|50538867|FG004|Overall Study|Multiple delay/holds on treatment|0|||
25228076|NCT02454972|50538868|FG005|Overall Study|Multiple delay/holds on treatment|0|||
25228077|NCT02454972|50538869|FG006|Overall Study|Multiple delay/holds on treatment|0|||
25228078|NCT02454972|50538870|FG007|Overall Study|Multiple delay/holds on treatment|0|||
25228079|NCT02454972|50538871|FG008|Overall Study|Multiple delay/holds on treatment|0|||
25228080|NCT02454972|50538863|FG000|Overall Study|Never treated|0|||
25228081|NCT02454972|50538864|FG001|Overall Study|Never treated|0|||
25228082|NCT02454972|50538865|FG002|Overall Study|Never treated|3|||
25228083|NCT02454972|50538866|FG003|Overall Study|Never treated|1|||
25228084|NCT02454972|50538867|FG004|Overall Study|Never treated|1|||
25228085|NCT02454972|50538868|FG005|Overall Study|Never treated|0|||
25228086|NCT02454972|50538869|FG006|Overall Study|Never treated|0|||
25228087|NCT02454972|50538870|FG007|Overall Study|Never treated|0|||
25228088|NCT02454972|50538871|FG008|Overall Study|Never treated|5|||
25228089|NCT02454972|50538863|FG000|Overall Study|Lost to Follow-up|0|||
25228090|NCT02454972|50538864|FG001|Overall Study|Lost to Follow-up|0|||
25228091|NCT02454972|50538865|FG002|Overall Study|Lost to Follow-up|0|||
25228092|NCT02454972|50538866|FG003|Overall Study|Lost to Follow-up|0|||
25228093|NCT02454972|50538867|FG004|Overall Study|Lost to Follow-up|0|||
25228094|NCT02454972|50538868|FG005|Overall Study|Lost to Follow-up|0|||
25228095|NCT02454972|50538869|FG006|Overall Study|Lost to Follow-up|0|||
25228096|NCT02454972|50538870|FG007|Overall Study|Lost to Follow-up|0|||
25228097|NCT02454972|50538871|FG008|Overall Study|Lost to Follow-up|2|||
24976601|NCT03532048|50065525|FG000|Overall Study|Lost to Follow-up|12|||
25228098|NCT02454972|50538863|FG000|Overall Study|Study termination|0|||
25228099|NCT02454972|50538864|FG001|Overall Study|Study termination|0|||
25228100|NCT02454972|50538865|FG002|Overall Study|Study termination|0|||
25228101|NCT02454972|50538866|FG003|Overall Study|Study termination|0|||
25228102|NCT02454972|50538867|FG004|Overall Study|Study termination|0|||
25228103|NCT02454972|50538868|FG005|Overall Study|Study termination|0|||
25228104|NCT02454972|50538869|FG006|Overall Study|Study termination|0|||
25228105|NCT02454972|50538870|FG007|Overall Study|Study termination|0|||
25228106|NCT02454972|50538871|FG008|Overall Study|Study termination|6|||
25228107|NCT01096368|50538888|FG000|Overall Study|Death|0|||
25228108|NCT01096368|50538889|FG001|Overall Study|Death|1|||
25228109|NCT01096368|50538890|FG002|Overall Study|Death|0|||
25228110|NCT01096368|50538891|FG003|Overall Study|Death|0|||
25228111|NCT01096368|50538892|FG004|Overall Study|Death|0|||
25228112|NCT01096368|50538888|FG000|Overall Study|Physician Decision|0|||
25228113|NCT01096368|50538889|FG001|Overall Study|Physician Decision|13|||
25228114|NCT01096368|50538890|FG002|Overall Study|Physician Decision|2|||
25228115|NCT01096368|50538891|FG003|Overall Study|Physician Decision|4|||
25228116|NCT01096368|50538892|FG004|Overall Study|Physician Decision|6|||
25228117|NCT01096368|50538888|FG000|Overall Study|Withdrawal by Subject|0|||
25228118|NCT01096368|50538889|FG001|Overall Study|Withdrawal by Subject|52|||
25228119|NCT01096368|50538890|FG002|Overall Study|Withdrawal by Subject|0|||
25228120|NCT01096368|50538891|FG003|Overall Study|Withdrawal by Subject|10|||
25228121|NCT01096368|50538892|FG004|Overall Study|Withdrawal by Subject|14|||
25228122|NCT01096368|50538888|FG000|Overall Study|Ineligible|0|||
25228123|NCT01096368|50538889|FG001|Overall Study|Ineligible|3|||
25228124|NCT01096368|50538890|FG002|Overall Study|Ineligible|2|||
25228125|NCT01096368|50538891|FG003|Overall Study|Ineligible|0|||
25228126|NCT01096368|50538892|FG004|Overall Study|Ineligible|25|||
25228127|NCT01096368|50538888|FG000|Overall Study|Did not start treatment|0|||
25228128|NCT01096368|50538889|FG001|Overall Study|Did not start treatment|4|||
25228129|NCT01096368|50538890|FG002|Overall Study|Did not start treatment|4|||
25228130|NCT01096368|50538891|FG003|Overall Study|Did not start treatment|0|||
25228131|NCT01096368|50538892|FG004|Overall Study|Did not start treatment|0|||
25228132|NCT01096368|50538888|FG000|Overall Study|Progressive disease|0|||
25228133|NCT01096368|50538889|FG001|Overall Study|Progressive disease|6|||
25228134|NCT01096368|50538890|FG002|Overall Study|Progressive disease|0|||
25228135|NCT01096368|50538891|FG003|Overall Study|Progressive disease|10|||
25228136|NCT01096368|50538892|FG004|Overall Study|Progressive disease|3|||
25228137|NCT01096368|50538888|FG000|Overall Study|Other|0|||
25228138|NCT01096368|50538889|FG001|Overall Study|Other|0|||
25228139|NCT01096368|50538890|FG002|Overall Study|Other|1|||
25228140|NCT01096368|50538891|FG003|Overall Study|Other|0|||
25228141|NCT01096368|50538892|FG004|Overall Study|Other|0|||
25228142|NCT01096368|50538888|FG000|Overall Study|Treated with institutional review|0|||
25228143|NCT01096368|50538889|FG001|Overall Study|Treated with institutional review|0|||
25228144|NCT01096368|50538890|FG002|Overall Study|Treated with institutional review|0|||
25228145|NCT01096368|50538891|FG003|Overall Study|Treated with institutional review|0|||
25228146|NCT01096368|50538892|FG004|Overall Study|Treated with institutional review|1|||
25228147|NCT00063882|50538913|FG000|Overall Study|Protocol Violation|3|||
25228148|NCT00063882|50538914|FG001|Overall Study|Protocol Violation|3|||
25228149|NCT00063882|50538913|FG000|Overall Study|Withdrawal by Subject|2|||
25228150|NCT00063882|50538914|FG001|Overall Study|Withdrawal by Subject|1|||
25228151|NCT01279044|50538923|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
25228152|NCT01279044|50538924|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
25228153|NCT01279044|50538925|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
25228154|NCT01279044|50538923|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
25228155|NCT01279044|50538924|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
25228156|NCT01279044|50538925|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
25228157|NCT01279044|50538923|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
25228158|NCT01279044|50538924|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
25228159|NCT01279044|50538925|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
25228160|NCT01278342|50538934|FG000|Overall Study|Physician Decision|0|||
25228161|NCT01278342|50538935|FG001|Overall Study|Physician Decision|1|||
25228162|NCT01278342|50538936|FG002|Overall Study|Physician Decision|0|||
25228163|NCT01278342|50538934|FG000|Overall Study|Lost to Follow-up|1|||
25228164|NCT01278342|50538935|FG001|Overall Study|Lost to Follow-up|0|||
25228165|NCT01278342|50538936|FG002|Overall Study|Lost to Follow-up|0|||
25319097|NCT00950807|50634483|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
25228166|NCT01278342|50538934|FG000|Overall Study|Administrative problems|2|||
25228167|NCT01278342|50538935|FG001|Overall Study|Administrative problems|0|||
25319098|NCT00950807|50634474|FG000|Treatment Period 3|Adverse Event|0|||
25228168|NCT01278342|50538936|FG002|Overall Study|Administrative problems|0|||
25228169|NCT01278342|50538934|FG000|Overall Study|Other|1|||
25228170|NCT01278342|50538935|FG001|Overall Study|Other|0|||
25228171|NCT01278342|50538936|FG002|Overall Study|Other|0|||
25228172|NCT01278030|50538946|FG000|Overall Study|Withdrawal by Subject|8|||
25228173|NCT01278030|50538947|FG001|Overall Study|Withdrawal by Subject|4|||
25228174|NCT01277718|50538953|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
25228175|NCT01277718|50538954|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
25228176|NCT01277718|50538953|FG000|Period 2 - Second Intervention|Physician Decision|0|||
25228177|NCT01277718|50538954|FG001|Period 2 - Second Intervention|Physician Decision|2|||
25228178|NCT01276236|50538962|FG000|Overall Study|Lack of Efficacy|2|||
25228179|NCT01276236|50538962|FG000|Overall Study|Withdrawal by Subject|4|||
25228180|NCT01275222|50538972|FG000|Phase l by Treatment|Adverse Event|1|||
25228181|NCT01275222|50538973|FG001|Phase l by Treatment|Adverse Event|4|||
25228182|NCT01275222|50538974|FG002|Phase l by Treatment|Adverse Event|2|||
25228183|NCT01275222|50538975|FG003|Phase l by Treatment|Adverse Event|3|||
25228184|NCT01275222|50538976|FG004|Phase l by Treatment|Adverse Event|0|||
25228185|NCT01275222|50538977|FG005|Phase l by Treatment|Adverse Event|0|||
25228186|NCT01275222|50538972|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
25228187|NCT01275222|50538973|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
25228188|NCT01275222|50538974|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
25228189|NCT01275222|50538975|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
25228190|NCT01275222|50538976|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
25228191|NCT01275222|50538977|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
25228192|NCT01275222|50538972|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
25228193|NCT01275222|50538973|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
25228194|NCT01275222|50538974|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
25228195|NCT01275222|50538975|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
25228196|NCT01275222|50538976|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
25228197|NCT01275222|50538977|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
25228198|NCT01275222|50538972|FG000|Phase l by Treatment|Disease progression|12|||
25228199|NCT01275222|50538973|FG001|Phase l by Treatment|Disease progression|8|||
25228200|NCT01275222|50538974|FG002|Phase l by Treatment|Disease progression|2|||
25228201|NCT01275222|50538975|FG003|Phase l by Treatment|Disease progression|5|||
25228202|NCT01275222|50538976|FG004|Phase l by Treatment|Disease progression|0|||
25228203|NCT01275222|50538977|FG005|Phase l by Treatment|Disease progression|0|||
25228204|NCT01275222|50538972|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
25228205|NCT01275222|50538973|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
25228206|NCT01275222|50538974|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
25228207|NCT01275222|50538975|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
25228208|NCT01275222|50538976|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
25228209|NCT01275222|50538977|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
25228210|NCT01275222|50538972|FG000|Phase l by Treatment|Death|0|||
25228211|NCT01275222|50538973|FG001|Phase l by Treatment|Death|1|||
25228212|NCT01275222|50538974|FG002|Phase l by Treatment|Death|0|||
25228213|NCT01275222|50538975|FG003|Phase l by Treatment|Death|1|||
25228214|NCT01275222|50538976|FG004|Phase l by Treatment|Death|0|||
25228215|NCT01275222|50538977|FG005|Phase l by Treatment|Death|0|||
25228216|NCT01275222|50538972|FG000|Phase ll by Stratum|Adverse Event|0|||
25228217|NCT01275222|50538973|FG001|Phase ll by Stratum|Adverse Event|0|||
25228218|NCT01275222|50538974|FG002|Phase ll by Stratum|Adverse Event|0|||
25228219|NCT01275222|50538975|FG003|Phase ll by Stratum|Adverse Event|0|||
25228220|NCT01275222|50538976|FG004|Phase ll by Stratum|Adverse Event|2|||
25228221|NCT01275222|50538977|FG005|Phase ll by Stratum|Adverse Event|10|||
25228222|NCT01275222|50538972|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
25228223|NCT01275222|50538973|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
25228224|NCT01275222|50538974|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
25228225|NCT01275222|50538975|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
25228226|NCT01275222|50538976|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
25228227|NCT01275222|50538977|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
25228228|NCT01275222|50538972|FG000|Phase ll by Stratum|Disease progression|0|||
25228229|NCT01275222|50538973|FG001|Phase ll by Stratum|Disease progression|0|||
25228230|NCT01275222|50538974|FG002|Phase ll by Stratum|Disease progression|0|||
25228231|NCT01275222|50538975|FG003|Phase ll by Stratum|Disease progression|0|||
25228232|NCT01275222|50538976|FG004|Phase ll by Stratum|Disease progression|23|||
25228233|NCT01275222|50538977|FG005|Phase ll by Stratum|Disease progression|31|||
25228234|NCT01275222|50538972|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
25228235|NCT01275222|50538973|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
25228236|NCT01275222|50538974|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
25228237|NCT01275222|50538975|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
25228238|NCT01275222|50538976|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
25228239|NCT01275222|50538977|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
25228240|NCT01275222|50538972|FG000|Phase ll by Stratum|Death|0|||
25228241|NCT01275222|50538973|FG001|Phase ll by Stratum|Death|0|||
25228242|NCT01275222|50538974|FG002|Phase ll by Stratum|Death|0|||
25228243|NCT01275222|50538975|FG003|Phase ll by Stratum|Death|0|||
25228244|NCT01275222|50538976|FG004|Phase ll by Stratum|Death|1|||
25228245|NCT01275222|50538977|FG005|Phase ll by Stratum|Death|1|||
25228246|NCT01275144|50538995|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
25228247|NCT01275144|50538996|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
25228248|NCT01275066|50539007|FG000|Overall Study|Withdrawal by Subject|0|||
25228249|NCT01275066|50539008|FG001|Overall Study|Withdrawal by Subject|0|||
25228250|NCT01275066|50539009|FG002|Overall Study|Withdrawal by Subject|1|||
25228251|NCT01275066|50539007|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
25228252|NCT01275066|50539008|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
25228253|NCT01275066|50539009|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
25228254|NCT01273038|50539019|FG000|Second Intervention (14 Days)|Adverse Event|0|||
25228255|NCT01273038|50539020|FG001|Second Intervention (14 Days)|Adverse Event|1|||
25228256|NCT01273038|50539019|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
25228257|NCT01273038|50539020|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
25228258|NCT01272180|50539030|FG000|Overall Study|Adverse Event|0|||
25228259|NCT01272180|50539031|FG001|Overall Study|Adverse Event|0|||
25228260|NCT01272180|50539032|FG002|Overall Study|Adverse Event|1|||
25228261|NCT01272180|50539033|FG003|Overall Study|Adverse Event|0|||
25228262|NCT01272180|50539030|FG000|Overall Study|Withdrawal by Subject|2|||
25228263|NCT01272180|50539031|FG001|Overall Study|Withdrawal by Subject|6|||
25228264|NCT01272180|50539032|FG002|Overall Study|Withdrawal by Subject|3|||
25228265|NCT01272180|50539033|FG003|Overall Study|Withdrawal by Subject|2|||
25228266|NCT01272180|50539030|FG000|Overall Study|Lost to Follow-up|15|||
25228267|NCT01272180|50539031|FG001|Overall Study|Lost to Follow-up|14|||
25228268|NCT01272180|50539032|FG002|Overall Study|Lost to Follow-up|8|||
25228269|NCT01272180|50539033|FG003|Overall Study|Lost to Follow-up|10|||
25228270|NCT01272180|50539030|FG000|Overall Study|Inappropriate enrollment|0|||
25228271|NCT01272180|50539031|FG001|Overall Study|Inappropriate enrollment|0|||
25228272|NCT01272180|50539032|FG002|Overall Study|Inappropriate enrollment|1|||
25228273|NCT01272180|50539033|FG003|Overall Study|Inappropriate enrollment|1|||
25228274|NCT01272180|50539030|FG000|Overall Study|Protocol Violation|0|||
25228275|NCT01272180|50539031|FG001|Overall Study|Protocol Violation|1|||
25228276|NCT01272180|50539032|FG002|Overall Study|Protocol Violation|0|||
25228277|NCT01272180|50539033|FG003|Overall Study|Protocol Violation|1|||
25228278|NCT01271712|50539049|FG000|Double Blind Treatment|Death|2|||
25228279|NCT01271712|50539050|FG001|Double Blind Treatment|Death|0|||
25228280|NCT01271712|50539049|FG000|Double Blind Treatment|Lack of Efficacy|1|||
25228281|NCT01271712|50539050|FG001|Double Blind Treatment|Lack of Efficacy|0|||
25228282|NCT01271712|50539049|FG000|Double Blind Treatment|Adverse Event|9|||
25228283|NCT01271712|50539050|FG001|Double Blind Treatment|Adverse Event|4|||
25228284|NCT01271712|50539049|FG000|Double Blind Treatment|Progressive disease|23|||
25228285|NCT01271712|50539050|FG001|Double Blind Treatment|Progressive disease|3|||
25228286|NCT01271712|50539049|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
25228287|NCT01271712|50539050|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
25228288|NCT01271712|50539049|FG000|Double Blind Treatment|Non compliance with study drug|2|||
25228289|NCT01271712|50539050|FG001|Double Blind Treatment|Non compliance with study drug|0|||
25228290|NCT01271712|50539049|FG000|Double Blind Treatment|receive no study drug|1|||
25228291|NCT01271712|50539050|FG001|Double Blind Treatment|receive no study drug|0|||
25228292|NCT01271712|50539049|FG000|Open Label Treatment|Death|6|||
25228293|NCT01271712|50539050|FG001|Open Label Treatment|Death|5|||
25228294|NCT01271712|50539049|FG000|Open Label Treatment|Withdrawal by Subject|6|||
25228295|NCT01271712|50539050|FG001|Open Label Treatment|Withdrawal by Subject|11|||
25228296|NCT01271712|50539049|FG000|Open Label Treatment|Physician Decision|2|||
25228297|NCT01271712|50539050|FG001|Open Label Treatment|Physician Decision|0|||
25228298|NCT01271712|50539049|FG000|Open Label Treatment|Adverse Event|14|||
25228299|NCT01271712|50539050|FG001|Open Label Treatment|Adverse Event|8|||
25228300|NCT01271712|50539049|FG000|Open Label Treatment|Progressive disease|59|||
25228301|NCT01271712|50539050|FG001|Open Label Treatment|Progressive disease|32|||
25228302|NCT01271712|50539049|FG000|Open Label Treatment|transferred to rollover study|1|||
25228303|NCT01271712|50539050|FG001|Open Label Treatment|transferred to rollover study|0|||
25228304|NCT01271712|50539049|FG000|Open Label Treatment|Non-compliance with study drug|1|||
25228305|NCT01271712|50539050|FG001|Open Label Treatment|Non-compliance with study drug|0|||
25228306|NCT01271712|50539049|FG000|Open Label Treatment|Protocol Violation|0|||
25228307|NCT01271712|50539050|FG001|Open Label Treatment|Protocol Violation|1|||
25228308|NCT01271712|50539049|FG000|Open Label Treatment|Switching to other therapy|2|||
25228309|NCT01271712|50539050|FG001|Open Label Treatment|Switching to other therapy|1|||
25228310|NCT01271712|50539049|FG000|Safety Follow-up|Death|11|||
25228311|NCT01271712|50539050|FG001|Safety Follow-up|Death|7|||
25228312|NCT01271712|50539049|FG000|Safety Follow-up|Withdrawal by Subject|4|||
25228313|NCT01271712|50539050|FG001|Safety Follow-up|Withdrawal by Subject|2|||
25228314|NCT01271712|50539049|FG000|Safety Follow-up|Protocol Violation|1|||
25228315|NCT01271712|50539050|FG001|Safety Follow-up|Protocol Violation|1|||
25228316|NCT01271712|50539049|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
25228317|NCT01271712|50539050|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
25228318|NCT01271712|50539049|FG000|Safety Follow-up|No follow-up|1|||
25228319|NCT01271712|50539050|FG001|Safety Follow-up|No follow-up|1|||
25228320|NCT01271712|50539049|FG000|Safety Follow-up|Progressive disease|1|||
25228321|NCT01271712|50539050|FG001|Safety Follow-up|Progressive disease|0|||
25228322|NCT01271712|50539049|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
25228323|NCT01271712|50539050|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
25228324|NCT01271010|50539059|FG000|Overall Study|Reason not specified|11|||
25228325|NCT01271010|50539059|FG000|Overall Study|Start of new CLL therapy|1|||
25228326|NCT01271010|50539059|FG000|Overall Study|Protocol Violation|1|||
25228327|NCT01271010|50539059|FG000|Overall Study|Death|2|||
25228328|NCT01271010|50539059|FG000|Overall Study|Progression and relapse of disease|1|||
25228329|NCT01271010|50539059|FG000|Overall Study|Withdrawal by Subject|18|||
25228330|NCT01271010|50539059|FG000|Overall Study|Disease progression|27|||
25228331|NCT01270620|50539065|FG000|Overall Study|Withdrawal by Subject|1|||
25228332|NCT01270620|50539066|FG001|Overall Study|Withdrawal by Subject|3|||
25228333|NCT01270464|50539081|FG000|Overall Study|Protocol Violation|4|||
25077486|NCT00002663|50185278|FG003|Overall Study|Other|0|||
25077487|NCT00002663|50185279|FG004|Overall Study|Other|0|||
25077488|NCT00002663|50185280|FG005|Overall Study|Other|1|||
25077489|NCT00002663|50185281|FG006|Overall Study|Other|1|||
25077490|NCT00002663|50185282|FG007|Overall Study|Other|0|||
25077491|NCT00002663|50185283|FG008|Overall Study|Other|0|||
25077492|NCT00002663|50185284|FG009|Overall Study|Other|0|||
25228334|NCT01270464|50539082|FG001|Overall Study|Protocol Violation|3|||
25228335|NCT01270464|50539083|FG002|Overall Study|Protocol Violation|2|||
25228336|NCT01270464|50539081|FG000|Overall Study|Lack of Efficacy|2|||
25228337|NCT01270464|50539082|FG001|Overall Study|Lack of Efficacy|3|||
25228338|NCT01270464|50539083|FG002|Overall Study|Lack of Efficacy|1|||
25228339|NCT01270464|50539081|FG000|Overall Study|Adverse Event|9|||
25228340|NCT01270464|50539082|FG001|Overall Study|Adverse Event|1|||
25228341|NCT01270464|50539083|FG002|Overall Study|Adverse Event|7|||
25228342|NCT01270464|50539081|FG000|Overall Study|Withdrawal by Subject|2|||
25228343|NCT01270464|50539082|FG001|Overall Study|Withdrawal by Subject|1|||
25228344|NCT01270464|50539083|FG002|Overall Study|Withdrawal by Subject|4|||
25228345|NCT01270464|50539081|FG000|Overall Study|Lost to Follow-up|2|||
25228346|NCT01270464|50539082|FG001|Overall Study|Lost to Follow-up|3|||
25228347|NCT01270464|50539083|FG002|Overall Study|Lost to Follow-up|1|||
25228348|NCT01270464|50539081|FG000|Overall Study|Other|1|||
25228349|NCT01270464|50539082|FG001|Overall Study|Other|1|||
25228350|NCT01270464|50539083|FG002|Overall Study|Other|3|||
25228351|NCT00249834|50539099|FG000|Overall Study|Ovarian stimulation failed|1|||
25228352|NCT00249834|50539100|FG001|Overall Study|Ovarian stimulation failed|0|||
25228353|NCT00249834|50539101|FG002|Overall Study|Ovarian stimulation failed|0|||
25228354|NCT00249834|50539102|FG003|Overall Study|Ovarian stimulation failed|0|||
25228355|NCT00249834|50539103|FG004|Overall Study|Ovarian stimulation failed|0|||
25228356|NCT00249834|50539104|FG005|Overall Study|Ovarian stimulation failed|0|||
25228357|NCT00249834|50539105|FG006|Overall Study|Ovarian stimulation failed|0|||
25228358|NCT00249834|50539106|FG007|Overall Study|Ovarian stimulation failed|0|||
25228359|NCT00249834|50539099|FG000|Overall Study|Failure of down-regulation|0|||
25228360|NCT00249834|50539100|FG001|Overall Study|Failure of down-regulation|0|||
25228361|NCT00249834|50539101|FG002|Overall Study|Failure of down-regulation|0|||
25228362|NCT00249834|50539102|FG003|Overall Study|Failure of down-regulation|0|||
25228363|NCT00249834|50539103|FG004|Overall Study|Failure of down-regulation|0|||
25228364|NCT00249834|50539104|FG005|Overall Study|Failure of down-regulation|0|||
25228365|NCT00249834|50539105|FG006|Overall Study|Failure of down-regulation|1|||
25228366|NCT00249834|50539106|FG007|Overall Study|Failure of down-regulation|0|||
25228367|NCT00249834|50539099|FG000|Overall Study|Protocol Violation|0|||
25228368|NCT00249834|50539100|FG001|Overall Study|Protocol Violation|19|||
25228369|NCT00249834|50539101|FG002|Overall Study|Protocol Violation|14|||
25228370|NCT00249834|50539102|FG003|Overall Study|Protocol Violation|8|||
25228371|NCT00249834|50539103|FG004|Overall Study|Protocol Violation|5|||
25228372|NCT00249834|50539104|FG005|Overall Study|Protocol Violation|2|||
25228373|NCT00249834|50539105|FG006|Overall Study|Protocol Violation|0|||
25228374|NCT00249834|50539106|FG007|Overall Study|Protocol Violation|0|||
25228375|NCT00249444|50539120|FG000|Overall Study|Lost to Follow-up|2|||
25228376|NCT00249444|50539121|FG001|Overall Study|Lost to Follow-up|2|||
25228377|NCT00249444|50539120|FG000|Overall Study|non-compliant|9|||
25228378|NCT00249444|50539121|FG001|Overall Study|non-compliant|11|||
25228379|NCT00249444|50539120|FG000|Overall Study|Adverse Event|1|||
25228380|NCT00249444|50539121|FG001|Overall Study|Adverse Event|1|||
25228381|NCT00249444|50539120|FG000|Overall Study|life event|0|||
25228382|NCT00249444|50539121|FG001|Overall Study|life event|1|||
25228383|NCT00249288|50539129|FG000|Overall Study|Lost to Follow-up|3|||
25228384|NCT00249288|50539130|FG001|Overall Study|Lost to Follow-up|3|||
25319099|NCT00950807|50634475|FG001|Treatment Period 3|Adverse Event|0|||
25077493|NCT00002663|50185275|FG000|Overall Study|Physician Decision|0|||
25228385|NCT00249288|50539129|FG000|Overall Study|Withdrawal by Subject|2|||
25228386|NCT00249288|50539130|FG001|Overall Study|Withdrawal by Subject|2|||
25228387|NCT00248040|50539147|FG000|Overall Study|transplantectomy|2|||
25228388|NCT00248040|50539148|FG001|Overall Study|transplantectomy|1|||
25228389|NCT00248040|50539149|FG002|Overall Study|transplantectomy|3|||
25228390|NCT00248040|50539147|FG000|Overall Study|transplant cancelled post treat start|1|||
25228391|NCT00248040|50539148|FG001|Overall Study|transplant cancelled post treat start|0|||
25077494|NCT00002663|50185276|FG001|Overall Study|Physician Decision|0|||
25077495|NCT00002663|50185277|FG002|Overall Study|Physician Decision|0|||
25228392|NCT00248040|50539149|FG002|Overall Study|transplant cancelled post treat start|0|||
25228393|NCT00248040|50539147|FG000|Overall Study|Death|0|||
25228394|NCT00248040|50539148|FG001|Overall Study|Death|0|||
25228395|NCT00248040|50539149|FG002|Overall Study|Death|1|||
25228396|NCT00247962|50539160|FG000|Overall Study|Adverse Event|15|||
25228397|NCT00247962|50539161|FG001|Overall Study|Adverse Event|12|||
25228398|NCT00247962|50539160|FG000|Overall Study|Lost to Follow-up|3|||
25228399|NCT00247962|50539161|FG001|Overall Study|Lost to Follow-up|1|||
25228400|NCT00247962|50539160|FG000|Overall Study|Physician Decision|0|||
25228401|NCT00247962|50539161|FG001|Overall Study|Physician Decision|1|||
25228402|NCT00247962|50539160|FG000|Overall Study|Protocol Violation|1|||
25228403|NCT00247962|50539161|FG001|Overall Study|Protocol Violation|1|||
25228404|NCT00247962|50539160|FG000|Overall Study|Withdrawal by Subject|3|||
25228405|NCT00247962|50539161|FG001|Overall Study|Withdrawal by Subject|2|||
25228406|NCT00247962|50539160|FG000|Overall Study|Lack of Efficacy|4|||
25228407|NCT00247962|50539161|FG001|Overall Study|Lack of Efficacy|2|||
25228408|NCT00247416|50539169|FG000|Overall Study|3 patients were found to be ineligible|1|||
25228409|NCT00247416|50539170|FG001|Overall Study|3 patients were found to be ineligible|2|||
25228410|NCT00246090|50539178|FG000|Overall Study|Adverse Event|25|||
25228411|NCT00246090|50539178|FG000|Overall Study|Withdrawal by Subject|7|||
25228412|NCT00246090|50539178|FG000|Overall Study|Progressive Disease|212|||
25228413|NCT00246090|50539178|FG000|Overall Study|Clinical Progression|30|||
25228414|NCT00246090|50539178|FG000|Overall Study|Physician Decision|11|||
25228415|NCT00246090|50539178|FG000|Overall Study|Not Otherwise Specified|10|||
25228416|NCT00246012|50539191|FG000|Overall Study|Adverse Event|0|||
25228417|NCT00246012|50539192|FG001|Overall Study|Adverse Event|0|||
25228418|NCT00246012|50539193|FG002|Overall Study|Adverse Event|0|||
25228419|NCT00246012|50539194|FG003|Overall Study|Adverse Event|0|||
25228420|NCT00246012|50539195|FG004|Overall Study|Adverse Event|0|||
25228421|NCT00246012|50539196|FG005|Overall Study|Adverse Event|1|||
25228422|NCT00246012|50539197|FG006|Overall Study|Adverse Event|0|||
25228423|NCT00246012|50539198|FG007|Overall Study|Adverse Event|0|||
25228424|NCT00246012|50539199|FG008|Overall Study|Adverse Event|2|||
25228425|NCT00246012|50539191|FG000|Overall Study|Withdrawal by Subject|0|||
25228426|NCT00246012|50539192|FG001|Overall Study|Withdrawal by Subject|0|||
25228427|NCT00246012|50539193|FG002|Overall Study|Withdrawal by Subject|0|||
25228428|NCT00246012|50539194|FG003|Overall Study|Withdrawal by Subject|0|||
25228429|NCT00246012|50539195|FG004|Overall Study|Withdrawal by Subject|0|||
25228430|NCT00246012|50539196|FG005|Overall Study|Withdrawal by Subject|1|||
25228431|NCT00246012|50539197|FG006|Overall Study|Withdrawal by Subject|0|||
25228432|NCT00246012|50539198|FG007|Overall Study|Withdrawal by Subject|0|||
25228433|NCT00246012|50539199|FG008|Overall Study|Withdrawal by Subject|0|||
25228434|NCT00246012|50539191|FG000|Overall Study|Disease progression|3|||
25228435|NCT00246012|50539192|FG001|Overall Study|Disease progression|1|||
25228436|NCT00246012|50539193|FG002|Overall Study|Disease progression|2|||
25228437|NCT00246012|50539194|FG003|Overall Study|Disease progression|3|||
25228438|NCT00246012|50539195|FG004|Overall Study|Disease progression|3|||
25228439|NCT00246012|50539196|FG005|Overall Study|Disease progression|25|||
25228440|NCT00246012|50539197|FG006|Overall Study|Disease progression|30|||
25228441|NCT00246012|50539198|FG007|Overall Study|Disease progression|27|||
25228442|NCT00246012|50539199|FG008|Overall Study|Disease progression|26|||
25228443|NCT00246012|50539191|FG000|Overall Study|Other|0|||
25228444|NCT00246012|50539192|FG001|Overall Study|Other|0|||
25228445|NCT00246012|50539193|FG002|Overall Study|Other|0|||
25228446|NCT00246012|50539194|FG003|Overall Study|Other|0|||
25228447|NCT00246012|50539195|FG004|Overall Study|Other|0|||
25228448|NCT00246012|50539196|FG005|Overall Study|Other|0|||
25228449|NCT00246012|50539197|FG006|Overall Study|Other|0|||
25228450|NCT00246012|50539198|FG007|Overall Study|Other|1|||
25228451|NCT00246012|50539199|FG008|Overall Study|Other|0|||
25228452|NCT00246012|50539191|FG000|Overall Study|Randomly assigned but not treated|0|||
25228453|NCT00246012|50539192|FG001|Overall Study|Randomly assigned but not treated|0|||
25228454|NCT00246012|50539193|FG002|Overall Study|Randomly assigned but not treated|0|||
25228455|NCT00246012|50539194|FG003|Overall Study|Randomly assigned but not treated|0|||
25228456|NCT00246012|50539195|FG004|Overall Study|Randomly assigned but not treated|0|||
25228457|NCT00246012|50539196|FG005|Overall Study|Randomly assigned but not treated|1|||
25228458|NCT00246012|50539197|FG006|Overall Study|Randomly assigned but not treated|1|||
25228459|NCT00246012|50539198|FG007|Overall Study|Randomly assigned but not treated|0|||
25077496|NCT00002663|50185278|FG003|Overall Study|Physician Decision|0|||
25228460|NCT00246012|50539199|FG008|Overall Study|Randomly assigned but not treated|0|||
25228461|NCT00245856|50539221|FG000|Period Two|Withdrawal by Subject|0|||
25228462|NCT00245856|50539222|FG001|Period Two|Withdrawal by Subject|1|||
25228463|NCT00245466|50539232|FG000|Overall Study|Adverse Event|2|||
25228464|NCT00245466|50539233|FG001|Overall Study|Adverse Event|8|||
25228465|NCT00245466|50539234|FG002|Overall Study|Adverse Event|4|||
25228466|NCT00245466|50539232|FG000|Overall Study|Low prostate specific antigen suppr|16|||
25228467|NCT00245466|50539233|FG001|Overall Study|Low prostate specific antigen suppr|14|||
25228468|NCT00245466|50539234|FG002|Overall Study|Low prostate specific antigen suppr|5|||
25228469|NCT00245466|50539232|FG000|Overall Study|Insufficient testosterone suppr|12|||
25228470|NCT00245466|50539233|FG001|Overall Study|Insufficient testosterone suppr|12|||
25228471|NCT00245466|50539234|FG002|Overall Study|Insufficient testosterone suppr|21|||
25228472|NCT00245466|50539232|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
25228473|NCT00245466|50539233|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
25228474|NCT00245466|50539234|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
25228475|NCT00245466|50539232|FG000|Overall Study|Withdrawal by Subject|2|||
25228476|NCT00245466|50539233|FG001|Overall Study|Withdrawal by Subject|2|||
25228477|NCT00245466|50539234|FG002|Overall Study|Withdrawal by Subject|1|||
25228478|NCT00245466|50539232|FG000|Overall Study|Lost to Follow-up|3|||
25228479|NCT00245466|50539233|FG001|Overall Study|Lost to Follow-up|0|||
25228480|NCT00245466|50539234|FG002|Overall Study|Lost to Follow-up|0|||
25228481|NCT00245466|50539232|FG000|Overall Study|Disease progression|0|||
25228482|NCT00245466|50539233|FG001|Overall Study|Disease progression|3|||
25228483|NCT00245466|50539234|FG002|Overall Study|Disease progression|1|||
25228484|NCT00245466|50539232|FG000|Overall Study|Protocol Violation|1|||
25228485|NCT00245466|50539233|FG001|Overall Study|Protocol Violation|2|||
25228486|NCT00245466|50539234|FG002|Overall Study|Protocol Violation|2|||
25228487|NCT00245466|50539232|FG000|Overall Study|Death|0|||
25228488|NCT00245466|50539233|FG001|Overall Study|Death|2|||
25228489|NCT00245466|50539234|FG002|Overall Study|Death|0|||
25228490|NCT00245466|50539232|FG000|Overall Study|Administrative reasons|0|||
25228491|NCT00245466|50539233|FG001|Overall Study|Administrative reasons|1|||
25228492|NCT00245466|50539234|FG002|Overall Study|Administrative reasons|0|||
25228493|NCT00244764|50539242|FG000|Overall Study|Adverse Event|37|||
25228494|NCT00244764|50539242|FG000|Overall Study|Lost to Follow-up|23|||
25228495|NCT00244764|50539242|FG000|Overall Study|Withdrawal by Subject|12|||
25228496|NCT00244764|50539242|FG000|Overall Study|Disease Progression|13|||
25228497|NCT00244764|50539242|FG000|Overall Study|Protocol Violation|2|||
25228498|NCT00244764|50539242|FG000|Overall Study|Death|1|||
25228499|NCT00244764|50539242|FG000|Overall Study|Off Study Medication for >21 Days|1|||
25228500|NCT00244764|50539242|FG000|Overall Study|Declining Performance Status|1|||
25228501|NCT00244764|50539242|FG000|Overall Study|Participant was Hospitalized until Death|1|||
25228502|NCT00244764|50539242|FG000|Overall Study|Primary Investigator Discretion|2|||
25228503|NCT00244764|50539242|FG000|Overall Study|Sponsor Terminated Study|2|||
25228504|NCT00244764|50539242|FG000|Overall Study|Developed Secondary Malignancy|1|||
25228505|NCT00244374|50539247|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
25228506|NCT00244374|50539248|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
25228507|NCT00244374|50539249|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
25228508|NCT00244374|50539250|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
25228509|NCT00244374|50539251|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
25228510|NCT00244374|50539247|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
25228511|NCT00244374|50539248|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
25228512|NCT00244374|50539249|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
25228513|NCT00244374|50539250|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
25228514|NCT00244374|50539251|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
25228515|NCT00244374|50539247|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
25228516|NCT00244374|50539248|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
25228517|NCT00244374|50539249|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
25228518|NCT00244374|50539250|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
25228519|NCT00244374|50539251|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
25228520|NCT00244374|50539247|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
25228521|NCT00244374|50539248|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
25228522|NCT00244374|50539249|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
25228523|NCT00244374|50539250|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
25228524|NCT00244374|50539251|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
25228525|NCT00244374|50539247|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
25228526|NCT00244374|50539248|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
25228527|NCT00244374|50539249|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
25228528|NCT00244374|50539250|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
25228529|NCT00244374|50539251|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
25228530|NCT00244374|50539247|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
25228531|NCT00244374|50539248|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
25228532|NCT00244374|50539249|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
25228533|NCT00244374|50539250|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
25228534|NCT00244374|50539251|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
25228535|NCT00244374|50539247|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
25228536|NCT00244374|50539248|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
25228537|NCT00244374|50539249|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
25228538|NCT00244374|50539250|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
25228539|NCT00244374|50539251|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
25228540|NCT00244374|50539247|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
25228541|NCT00244374|50539248|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
25228542|NCT00244374|50539249|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
25228543|NCT00244374|50539250|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
25228544|NCT00244374|50539251|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
25228545|NCT00244374|50539247|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
25228546|NCT00244374|50539248|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
25228547|NCT00244374|50539249|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
25228548|NCT00244374|50539250|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
25228549|NCT00244374|50539251|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
25228550|NCT00242658|50539269|FG000|Overall Study|Lost to Follow-up|22|||
25228551|NCT00242658|50539270|FG001|Overall Study|Lost to Follow-up|19|||
25228552|NCT00242580|50539279|FG000|Overall Study|Adverse Event|3|||
25228553|NCT00242580|50539280|FG001|Overall Study|Adverse Event|0|||
25228554|NCT00242580|50539281|FG002|Overall Study|Adverse Event|2|||
25228555|NCT00242580|50539279|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
25228556|NCT00242580|50539280|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
25228557|NCT00242580|50539281|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
25228558|NCT00242580|50539279|FG000|Overall Study|Protocol Violation|0|||
25228559|NCT00242580|50539280|FG001|Overall Study|Protocol Violation|0|||
25228560|NCT00242580|50539281|FG002|Overall Study|Protocol Violation|1|||
25228561|NCT00242580|50539279|FG000|Overall Study|Subject withdrew consent|2|||
25228562|NCT00242580|50539280|FG001|Overall Study|Subject withdrew consent|2|||
25228563|NCT00242580|50539281|FG002|Overall Study|Subject withdrew consent|5|||
25228564|NCT00242580|50539279|FG000|Overall Study|Lost to Follow-up|0|||
25228565|NCT00242580|50539280|FG001|Overall Study|Lost to Follow-up|3|||
25228566|NCT00242580|50539281|FG002|Overall Study|Lost to Follow-up|0|||
25228567|NCT00242580|50539279|FG000|Overall Study|Death|1|||
25228568|NCT00242580|50539280|FG001|Overall Study|Death|2|||
25228569|NCT00242580|50539281|FG002|Overall Study|Death|1|||
25228570|NCT00241644|50539293|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
25228571|NCT00241644|50539294|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
25228572|NCT00241644|50539295|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
25228573|NCT00241644|50539296|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
25228574|NCT00241644|50539293|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
25228575|NCT00241644|50539294|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
25228576|NCT00241644|50539295|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
25228577|NCT00241644|50539296|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
25228578|NCT00241644|50539293|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
25228579|NCT00241644|50539294|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
25228580|NCT00241644|50539295|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
25228581|NCT00241644|50539296|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
25228582|NCT00241644|50539293|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
25228583|NCT00241644|50539294|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
25228584|NCT00241644|50539295|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
25228585|NCT00241644|50539296|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
25228586|NCT00241644|50539293|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
25228587|NCT00241644|50539294|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
25228588|NCT00241644|50539295|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
25228589|NCT00241644|50539296|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
25228590|NCT00241644|50539293|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
25228591|NCT00241644|50539294|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
25228592|NCT00241644|50539295|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
25228593|NCT00241644|50539296|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
25228594|NCT00241644|50539293|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
25228595|NCT00241644|50539294|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
25319100|NCT00950807|50634476|FG002|Treatment Period 3|Adverse Event|0|||
25319101|NCT00950807|50634477|FG003|Treatment Period 3|Adverse Event|0|||
25228596|NCT00241644|50539295|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
25228597|NCT00241644|50539296|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
25228598|NCT00241644|50539293|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
25228599|NCT00241644|50539294|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
25319102|NCT00950807|50634478|FG004|Treatment Period 3|Adverse Event|0|||
25228600|NCT00241644|50539295|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
25228601|NCT00241644|50539296|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
25228602|NCT00241644|50539293|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
25228603|NCT00241644|50539294|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
25228604|NCT00241644|50539295|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
25228605|NCT00241644|50539296|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
25228606|NCT00241644|50539293|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
25228607|NCT00241644|50539294|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
25228608|NCT00241644|50539295|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
25228609|NCT00241644|50539296|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
25228610|NCT00241644|50539293|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
25228611|NCT00241644|50539294|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
25228612|NCT00241644|50539295|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
25228613|NCT00241644|50539296|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
25228614|NCT00241644|50539293|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
25228615|NCT00241644|50539294|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
25228616|NCT00241644|50539295|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
25228617|NCT00241644|50539296|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
25228618|NCT00241644|50539293|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
25228619|NCT00241644|50539294|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
25228620|NCT00241644|50539295|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
25228621|NCT00241644|50539296|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
25228622|NCT03804684|50539317|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
25228623|NCT03804684|50539318|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
25228624|NCT04295772|50539333|FG000|Overall Study|Protocol Violation|1|||
25228625|NCT04295772|50539334|FG001|Overall Study|Protocol Violation|0|||
25228626|NCT04295772|50539333|FG000|Overall Study|Ongoing for safety monitoring|14|||
25228627|NCT04295772|50539334|FG001|Overall Study|Ongoing for safety monitoring|1|||
25228628|NCT04295772|50539333|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
25228629|NCT04295772|50539334|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
25228630|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criterion #1|24|||
25228631|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criterion #1|0|||
25228632|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
25228633|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
25228634|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
25228635|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
25228636|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
25228637|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
25228638|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
25228639|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
25228640|NCT03888066|50539343|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
25228641|NCT03888066|50539344|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
25228642|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
25228643|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
25228644|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
25228645|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
25228646|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
25228647|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
25228648|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
25228649|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
25228650|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criterion #2|5|||
25228651|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criterion #2|0|||
25228652|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
25228653|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
25228654|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
25228655|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
25228656|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
25228657|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
25228658|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criterion #3|11|||
25228659|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criterion #3|0|||
25228660|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
25228661|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
25228662|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
25228663|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
25228664|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
25228665|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
25228666|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criterion #4|3|||
25228667|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criterion #4|0|||
25228668|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
25228669|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
25228670|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
25228671|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
25228672|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
25228673|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
25228674|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
25228675|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
25228676|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
25228677|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
25228678|NCT03888066|50539343|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
25228679|NCT03888066|50539344|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
25228680|NCT03888066|50539343|FG000|Run-in Phase|AE (Adverse Event)|17|||
25228681|NCT03888066|50539344|FG001|Run-in Phase|AE (Adverse Event)|0|||
25228682|NCT03888066|50539343|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
25228683|NCT03888066|50539344|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
25228684|NCT03888066|50539343|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
25228685|NCT03888066|50539344|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
25228686|NCT03888066|50539343|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
25228687|NCT03888066|50539344|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
25228688|NCT03888066|50539343|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
25228689|NCT03888066|50539344|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
25228690|NCT03888066|50539343|FG000|Run-in Phase|Withdrawal by Subject|43|||
25228691|NCT03888066|50539344|FG001|Run-in Phase|Withdrawal by Subject|0|||
25228692|NCT03888066|50539343|FG000|Run-in Phase|AE; Physician Decision|1|||
25228693|NCT03888066|50539344|FG001|Run-in Phase|AE; Physician Decision|0|||
25228694|NCT03888066|50539343|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
25228695|NCT03888066|50539344|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
25228696|NCT03888066|50539343|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
25228697|NCT03888066|50539344|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
25228698|NCT03888066|50539343|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
25228699|NCT03888066|50539344|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
25228700|NCT03888066|50539343|FG000|Run-in Phase|Death|1|||
25228701|NCT03888066|50539344|FG001|Run-in Phase|Death|0|||
25228702|NCT03888066|50539343|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
25228703|NCT03888066|50539344|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
25228704|NCT03888066|50539343|FG000|Run-in Phase|Physician Decision|1|||
25228705|NCT03888066|50539344|FG001|Run-in Phase|Physician Decision|0|||
25228706|NCT03888066|50539343|FG000|Run-in Phase|Protocol Violation|13|||
25228707|NCT03888066|50539344|FG001|Run-in Phase|Protocol Violation|0|||
25228708|NCT03888066|50539343|FG000|Run-in Phase|Sponsor Request|34|||
25228709|NCT03888066|50539344|FG001|Run-in Phase|Sponsor Request|0|||
25228710|NCT03888066|50539343|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
25228711|NCT03888066|50539344|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
25228712|NCT03888066|50539343|FG000|Run-in Phase|Withdrawal Of Consent|1|||
25228713|NCT03888066|50539344|FG001|Run-in Phase|Withdrawal Of Consent|0|||
25228714|NCT03888066|50539343|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
25228715|NCT03888066|50539344|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
25228716|NCT03888066|50539343|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
25228717|NCT03888066|50539344|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
25228718|NCT03888066|50539343|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
25228719|NCT03888066|50539344|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
25228720|NCT03888066|50539343|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
25228721|NCT03888066|50539344|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
25228722|NCT03888066|50539343|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
25228723|NCT03888066|50539344|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
25228724|NCT03888066|50539343|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
25228725|NCT03888066|50539344|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
25228726|NCT03888066|50539343|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
25228727|NCT03888066|50539344|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
25228728|NCT03888066|50539343|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
25228729|NCT03888066|50539344|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
25228730|NCT03888066|50539343|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
25228731|NCT03888066|50539344|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
25228732|NCT03888066|50539343|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
25228733|NCT03888066|50539344|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
25228734|NCT03888066|50539343|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
25228735|NCT03888066|50539344|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
25228736|NCT03888066|50539343|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
25228737|NCT03888066|50539344|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
25228738|NCT02017704|50539353|FG000|Overall Study|Withdrawal by Subject|2|||
25228739|NCT02017704|50539354|FG001|Overall Study|Withdrawal by Subject|0|||
25228740|NCT01049334|50539364|FG000|Overall Study|Withdrawal by Subject|5|||
25228741|NCT01049334|50539365|FG001|Overall Study|Withdrawal by Subject|3|||
25228742|NCT01049334|50539364|FG000|Overall Study|Adverse Event|2|||
25228743|NCT01049334|50539365|FG001|Overall Study|Adverse Event|3|||
25228744|NCT01049334|50539364|FG000|Overall Study|Physician Decision|2|||
25228745|NCT01049334|50539365|FG001|Overall Study|Physician Decision|0|||
25228746|NCT01049334|50539364|FG000|Overall Study|Protocol Violation|0|||
25228747|NCT01049334|50539365|FG001|Overall Study|Protocol Violation|1|||
25228748|NCT01048944|50539375|FG000|Overall Study|Protocol Violation|8|||
25228749|NCT01048944|50539376|FG001|Overall Study|Protocol Violation|10|||
25228750|NCT01048944|50539377|FG002|Overall Study|Protocol Violation|10|||
25228751|NCT01048944|50539378|FG003|Overall Study|Protocol Violation|2|||
25228752|NCT01048866|50539390|FG000|Overall Study|Adverse Event|1|||
25228753|NCT01048866|50539391|FG001|Overall Study|Adverse Event|0|||
25228754|NCT01048866|50539390|FG000|Overall Study|Protocol Violation|1|||
25228755|NCT01048866|50539391|FG001|Overall Study|Protocol Violation|0|||
25228756|NCT01048866|50539390|FG000|Overall Study|Physician Decision|1|||
25228757|NCT01048866|50539391|FG001|Overall Study|Physician Decision|0|||
25228758|NCT01048866|50539390|FG000|Overall Study|Withdrawal by Subject|0|||
25228759|NCT01048866|50539391|FG001|Overall Study|Withdrawal by Subject|2|||
25228760|NCT01048866|50539390|FG000|Overall Study|Lost to Follow-up|0|||
25228761|NCT01048866|50539391|FG001|Overall Study|Lost to Follow-up|2|||
25228762|NCT01048866|50539390|FG000|Overall Study|Other|1|||
25228763|NCT01048866|50539391|FG001|Overall Study|Other|1|||
25228764|NCT01048788|50539400|FG000|Overall Study|Adverse Event|5|||
25228765|NCT01048788|50539401|FG001|Overall Study|Adverse Event|1|||
25228766|NCT01048788|50539402|FG002|Overall Study|Adverse Event|1|||
25228767|NCT01048788|50539400|FG000|Overall Study|Lack of Efficacy|0|||
25228768|NCT01048788|50539401|FG001|Overall Study|Lack of Efficacy|0|||
25228769|NCT01048788|50539402|FG002|Overall Study|Lack of Efficacy|1|||
25228770|NCT01048788|50539400|FG000|Overall Study|Withdrawal by Subject|0|||
25228771|NCT01048788|50539401|FG001|Overall Study|Withdrawal by Subject|1|||
25228772|NCT01048788|50539402|FG002|Overall Study|Withdrawal by Subject|0|||
25228773|NCT01048242|50539412|FG000|Overall Study|See study flow chart|4|||
25228774|NCT01048242|50539413|FG001|Overall Study|See study flow chart|2|||
25228775|NCT01047306|50539421|FG000|Overall Study|Withdrawal by Subject|2|||
25228776|NCT01047306|50539422|FG001|Overall Study|Withdrawal by Subject|0|||
25228777|NCT01047306|50539421|FG000|Overall Study|Lost to Follow-up|1|||
25228778|NCT01047306|50539422|FG001|Overall Study|Lost to Follow-up|0|||
25228779|NCT01046682|50539432|FG000|Overall Study|Adverse Event|2|||
25228780|NCT01046682|50539433|FG001|Overall Study|Adverse Event|0|||
25228781|NCT01044732|50539441|FG000|Overall Study|Lost to Follow-up|2|||
25228782|NCT01044732|50539442|FG001|Overall Study|Lost to Follow-up|1|||
25228783|NCT01044732|50539441|FG000|Overall Study|Physician Decision|5|||
25228784|NCT01044732|50539442|FG001|Overall Study|Physician Decision|3|||
25228785|NCT01044732|50539441|FG000|Overall Study|Protocol Violation|11|||
25228786|NCT01044732|50539442|FG001|Overall Study|Protocol Violation|12|||
25228787|NCT01044732|50539441|FG000|Overall Study|Withdrawal by Subject|0|||
25228788|NCT01044732|50539442|FG001|Overall Study|Withdrawal by Subject|1|||
25228789|NCT01044732|50539441|FG000|Overall Study|Inadequate bowel preparation|11|||
25228790|NCT01044732|50539442|FG001|Overall Study|Inadequate bowel preparation|17|||
25228791|NCT01044732|50539441|FG000|Overall Study|Inability to reach cecum|5|||
25228792|NCT01044732|50539442|FG001|Overall Study|Inability to reach cecum|2|||
25228793|NCT01044732|50539441|FG000|Overall Study|Technical error or malfunction|15|||
25228794|NCT01044732|50539442|FG001|Overall Study|Technical error or malfunction|14|||
25228795|NCT01044498|50539452|FG000|Overall Study|Withdrew consent|1|||
25228796|NCT01044498|50539453|FG001|Overall Study|Withdrew consent|1|||
25228797|NCT01044498|50539452|FG000|Overall Study|Adverse Event|1|||
25228798|NCT01044498|50539453|FG001|Overall Study|Adverse Event|1|||
25228799|NCT01044498|50539452|FG000|Overall Study|Other|1|||
25228800|NCT01044498|50539453|FG001|Overall Study|Other|0|||
25228801|NCT01043874|50539459|FG000|Overall Study|Adverse Event|3|||
25228802|NCT01043874|50539459|FG000|Overall Study|Withdrawal by Subject|1|||
25228803|NCT01043874|50539459|FG000|Overall Study|Lack of Efficacy|1|||
25228804|NCT01043874|50539459|FG000|Overall Study|Administrative Problems|1|||
25228805|NCT01042938|50539465|FG000|Overall Study|Withdrawal by Subject|1|||
25228806|NCT01042938|50539466|FG001|Overall Study|Withdrawal by Subject|1|||
25228807|NCT01042938|50539465|FG000|Overall Study|Protocol Violation|1|||
25228808|NCT01042938|50539466|FG001|Overall Study|Protocol Violation|1|||
25228809|NCT01042938|50539465|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
25228810|NCT01042938|50539466|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
25228811|NCT01042158|50539474|FG000|Overall Study|Physician Decision|1|||
25228812|NCT03408444|50539482|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
25228813|NCT03408444|50539483|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
25228814|NCT03408444|50539484|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
24976602|NCT03532048|50065526|FG001|Overall Study|Lost to Follow-up|17|||
24976603|NCT03532048|50065525|FG000|Overall Study|Withdrawal by Subject|7|||
25228815|NCT03408444|50539485|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
25228816|NCT03408444|50539482|FG000|Overall Study|Lens Discomfort|0|||
25228817|NCT03408444|50539483|FG001|Overall Study|Lens Discomfort|1|||
25228818|NCT03408444|50539484|FG002|Overall Study|Lens Discomfort|0|||
25228819|NCT03408444|50539485|FG003|Overall Study|Lens Discomfort|0|||
25228820|NCT03408444|50539482|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
25228821|NCT03408444|50539483|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
25228822|NCT03408444|50539484|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
25228823|NCT03408444|50539485|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
25228824|NCT03408444|50539482|FG000|Overall Study|Withdrawal by Subject|0|||
25228825|NCT03408444|50539483|FG001|Overall Study|Withdrawal by Subject|2|||
25228826|NCT03408444|50539484|FG002|Overall Study|Withdrawal by Subject|3|||
25228827|NCT03408444|50539485|FG003|Overall Study|Withdrawal by Subject|0|||
25228828|NCT03408444|50539482|FG000|Overall Study|Lost to Follow-up|0|||
25228829|NCT03408444|50539483|FG001|Overall Study|Lost to Follow-up|0|||
25228830|NCT03408444|50539484|FG002|Overall Study|Lost to Follow-up|1|||
25228831|NCT03408444|50539485|FG003|Overall Study|Lost to Follow-up|0|||
25228832|NCT03408444|50539482|FG000|Overall Study|Adverse Event|0|||
25228833|NCT03408444|50539483|FG001|Overall Study|Adverse Event|0|||
25228834|NCT03408444|50539484|FG002|Overall Study|Adverse Event|0|||
25228835|NCT03408444|50539485|FG003|Overall Study|Adverse Event|1|||
25228836|NCT03408444|50539482|FG000|Overall Study|Lens Handling Difficulties|0|||
25228837|NCT03408444|50539483|FG001|Overall Study|Lens Handling Difficulties|0|||
25228838|NCT03408444|50539484|FG002|Overall Study|Lens Handling Difficulties|1|||
25228839|NCT03408444|50539485|FG003|Overall Study|Lens Handling Difficulties|0|||
25228840|NCT03408444|50539482|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
25228841|NCT03408444|50539483|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
25228842|NCT03408444|50539484|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
25228843|NCT03408444|50539485|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
25228844|NCT03400956|50539515|FG000|Treatment Period 1|Adverse Event|0|||
25228845|NCT03400956|50539516|FG001|Treatment Period 1|Adverse Event|1|||
25228846|NCT03400956|50539517|FG002|Treatment Period 1|Adverse Event|0|||
25228847|NCT03400956|50539515|FG000|Treatment Period 1|Lost to Follow-up|0|||
25228848|NCT03400956|50539516|FG001|Treatment Period 1|Lost to Follow-up|0|||
25228849|NCT03400956|50539517|FG002|Treatment Period 1|Lost to Follow-up|1|||
25228850|NCT03400956|50539515|FG000|Treatment Period 1|Protocol Violation|0|||
25228851|NCT03400956|50539516|FG001|Treatment Period 1|Protocol Violation|2|||
25228852|NCT03400956|50539517|FG002|Treatment Period 1|Protocol Violation|0|||
25228853|NCT03400956|50539515|FG000|Treatment Period 1|Study terminated by sponsor|3|||
25228854|NCT03400956|50539516|FG001|Treatment Period 1|Study terminated by sponsor|1|||
25228855|NCT03400956|50539517|FG002|Treatment Period 1|Study terminated by sponsor|1|||
25228856|NCT03400956|50539515|FG000|Treatment Period 1|Withdrawal by Subject|0|||
25228857|NCT03400956|50539516|FG001|Treatment Period 1|Withdrawal by Subject|2|||
25228858|NCT03400956|50539517|FG002|Treatment Period 1|Withdrawal by Subject|4|||
25228859|NCT03400956|50539515|FG000|Treatment Period 1|Other|1|||
25228860|NCT03400956|50539516|FG001|Treatment Period 1|Other|2|||
25228861|NCT03400956|50539517|FG002|Treatment Period 1|Other|3|||
25228862|NCT03400956|50539515|FG000|Post-treatment Period 1|Adverse Event|0|||
25228863|NCT03400956|50539516|FG001|Post-treatment Period 1|Adverse Event|0|||
24976604|NCT03532048|50065526|FG001|Overall Study|Withdrawal by Subject|0|||
25228864|NCT03400956|50539517|FG002|Post-treatment Period 1|Adverse Event|1|||
25228865|NCT03400956|50539515|FG000|Post-treatment Period 1|Physician Decision|2|||
25228866|NCT03400956|50539516|FG001|Post-treatment Period 1|Physician Decision|3|||
25228867|NCT03400956|50539517|FG002|Post-treatment Period 1|Physician Decision|0|||
25228868|NCT03400956|50539515|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
25228869|NCT03400956|50539516|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
25228870|NCT03400956|50539517|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
25228871|NCT03400956|50539515|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
25228872|NCT03400956|50539516|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
25228873|NCT03400956|50539517|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
25228874|NCT03400956|50539515|FG000|Post-treatment Period 1|Other|4|||
25228875|NCT03400956|50539516|FG001|Post-treatment Period 1|Other|3|||
25228876|NCT03400956|50539517|FG002|Post-treatment Period 1|Other|4|||
25228877|NCT03400956|50539515|FG000|Treatment Period 2|Adverse Event|2|||
25228878|NCT03400956|50539516|FG001|Treatment Period 2|Adverse Event|1|||
25228879|NCT03400956|50539517|FG002|Treatment Period 2|Adverse Event|1|||
25228880|NCT03400956|50539515|FG000|Treatment Period 2|Lost to Follow-up|1|||
25228881|NCT03400956|50539516|FG001|Treatment Period 2|Lost to Follow-up|1|||
25228882|NCT03400956|50539517|FG002|Treatment Period 2|Lost to Follow-up|0|||
25228883|NCT03400956|50539515|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25228884|NCT03400956|50539516|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25228885|NCT03400956|50539517|FG002|Treatment Period 2|Withdrawal by Subject|3|||
25228886|NCT03400956|50539515|FG000|Treatment Period 2|Other|1|||
25228887|NCT03400956|50539516|FG001|Treatment Period 2|Other|1|||
25228888|NCT03400956|50539517|FG002|Treatment Period 2|Other|0|||
25228889|NCT03400956|50539515|FG000|Follow-up Period|Withdrawal by Subject|0|||
25228890|NCT03400956|50539516|FG001|Follow-up Period|Withdrawal by Subject|0|||
25228891|NCT03400956|50539517|FG002|Follow-up Period|Withdrawal by Subject|1|||
25228892|NCT03400956|50539515|FG000|Follow-up Period|Other|0|||
25228893|NCT03400956|50539516|FG001|Follow-up Period|Other|0|||
25228894|NCT03400956|50539517|FG002|Follow-up Period|Other|1|||
25228895|NCT00012012|50539530|FG000|Overall Study|Protocol Violation|1|||
25228896|NCT00012012|50539531|FG001|Overall Study|Protocol Violation|1|||
25228897|NCT00012012|50539530|FG000|Overall Study|Withdrawal by Subject|0|||
25228898|NCT00012012|50539531|FG001|Overall Study|Withdrawal by Subject|2|||
25228899|NCT00010374|50539537|FG000|Overall Study|False positive phrenic nerve test|1|||
25228900|NCT00559962|50539559|FG000|Overall Study|Adverse Event|1|||
25228901|NCT00559962|50539560|FG001|Overall Study|Adverse Event|7|||
25228902|NCT00559962|50539561|FG002|Overall Study|Adverse Event|8|||
25228903|NCT00559962|50539562|FG003|Overall Study|Adverse Event|5|||
25228904|NCT00559962|50539563|FG004|Overall Study|Adverse Event|11|||
25228905|NCT00559962|50539564|FG005|Overall Study|Adverse Event|4|||
25228906|NCT00559962|50539565|FG006|Overall Study|Adverse Event|4|||
25228907|NCT00559962|50539566|FG007|Overall Study|Adverse Event|2|||
25228908|NCT00559962|50539559|FG000|Overall Study|Lost to Follow-up|0|||
25228909|NCT00559962|50539560|FG001|Overall Study|Lost to Follow-up|1|||
25228910|NCT00559962|50539561|FG002|Overall Study|Lost to Follow-up|0|||
25228911|NCT00559962|50539562|FG003|Overall Study|Lost to Follow-up|0|||
25228912|NCT00559962|50539563|FG004|Overall Study|Lost to Follow-up|0|||
25228913|NCT00559962|50539564|FG005|Overall Study|Lost to Follow-up|0|||
25228914|NCT00559962|50539565|FG006|Overall Study|Lost to Follow-up|0|||
25228915|NCT00559962|50539566|FG007|Overall Study|Lost to Follow-up|0|||
25228916|NCT00559962|50539559|FG000|Overall Study|Withdrawal by Subject|1|||
25228917|NCT00559962|50539560|FG001|Overall Study|Withdrawal by Subject|1|||
25228918|NCT00559962|50539561|FG002|Overall Study|Withdrawal by Subject|2|||
25228919|NCT00559962|50539562|FG003|Overall Study|Withdrawal by Subject|0|||
25228920|NCT00559962|50539563|FG004|Overall Study|Withdrawal by Subject|3|||
25228921|NCT00559962|50539564|FG005|Overall Study|Withdrawal by Subject|1|||
25228922|NCT00559962|50539565|FG006|Overall Study|Withdrawal by Subject|0|||
25228923|NCT00559962|50539566|FG007|Overall Study|Withdrawal by Subject|2|||
25228924|NCT00559962|50539559|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
25228925|NCT00559962|50539560|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
25228926|NCT00559962|50539561|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
25228927|NCT00559962|50539562|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
25228928|NCT00559962|50539563|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
25228929|NCT00559962|50539564|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
25228930|NCT00559962|50539565|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
25228931|NCT00559962|50539566|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
25228932|NCT00559104|50539587|FG000|Overall Study|Lack of Efficacy|9|||
25228933|NCT00559104|50539588|FG001|Overall Study|Lack of Efficacy|0|||
25228934|NCT00558636|50539596|FG000|Treatment|Adverse Event|9|||
25228935|NCT00558636|50539597|FG001|Treatment|Adverse Event|2|||
25228936|NCT00558636|50539596|FG000|Treatment|Withdrawal by Subject|2|||
25228937|NCT00558636|50539597|FG001|Treatment|Withdrawal by Subject|0|||
25228938|NCT00558636|50539596|FG000|Treatment|Premature termination of the study|35|||
25228939|NCT00558636|50539597|FG001|Treatment|Premature termination of the study|37|||
25228940|NCT00558636|50539596|FG000|Treatment|Disease progression|1|||
25228941|NCT00558636|50539597|FG001|Treatment|Disease progression|5|||
25228942|NCT00558636|50539596|FG000|Follow-up|Premature termination of the study|12|||
25228943|NCT00558636|50539597|FG001|Follow-up|Premature termination of the study|7|||
25228944|NCT00558558|50539603|FG000|Overall Study|Unable to swallow|1|||
25228945|NCT00558558|50539603|FG000|Overall Study|Withdrawal by Subject|1|||
25228946|NCT00558558|50539603|FG000|Overall Study|Lack of Efficacy|4|||
25228947|NCT00557622|50539609|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
25228948|NCT00557622|50539610|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
25228949|NCT00557622|50539609|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
25228950|NCT00557622|50539610|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
25228951|NCT00557622|50539609|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
25228952|NCT00557622|50539610|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
25228953|NCT00557466|50539622|FG000|Overall Study|Adverse Event|3|||
25228954|NCT00557466|50539623|FG001|Overall Study|Adverse Event|1|||
25228955|NCT00557466|50539624|FG002|Overall Study|Adverse Event|4|||
25228956|NCT00557466|50539625|FG003|Overall Study|Adverse Event|1|||
25228957|NCT00557466|50539626|FG004|Overall Study|Adverse Event|2|||
25228958|NCT00557466|50539627|FG005|Overall Study|Adverse Event|4|||
25228959|NCT00557466|50539622|FG000|Overall Study|Abnormal laboratory value(s)|1|||
25228960|NCT00557466|50539623|FG001|Overall Study|Abnormal laboratory value(s)|2|||
25228961|NCT00557466|50539624|FG002|Overall Study|Abnormal laboratory value(s)|0|||
25228962|NCT00557466|50539625|FG003|Overall Study|Abnormal laboratory value(s)|0|||
25228963|NCT00557466|50539626|FG004|Overall Study|Abnormal laboratory value(s)|0|||
25228964|NCT00557466|50539627|FG005|Overall Study|Abnormal laboratory value(s)|0|||
25228965|NCT00557466|50539622|FG000|Overall Study|Protocol deviation|0|||
25228966|NCT00557466|50539623|FG001|Overall Study|Protocol deviation|1|||
25228967|NCT00557466|50539624|FG002|Overall Study|Protocol deviation|0|||
25228968|NCT00557466|50539625|FG003|Overall Study|Protocol deviation|2|||
25228969|NCT00557466|50539626|FG004|Overall Study|Protocol deviation|0|||
25228970|NCT00557466|50539627|FG005|Overall Study|Protocol deviation|0|||
25228971|NCT00557466|50539622|FG000|Overall Study|Subject withdrew consent|0|||
25228972|NCT00557466|50539623|FG001|Overall Study|Subject withdrew consent|0|||
25228973|NCT00557466|50539624|FG002|Overall Study|Subject withdrew consent|0|||
25228974|NCT00557466|50539625|FG003|Overall Study|Subject withdrew consent|0|||
25228975|NCT00557466|50539626|FG004|Overall Study|Subject withdrew consent|1|||
25228976|NCT00557466|50539627|FG005|Overall Study|Subject withdrew consent|2|||
25228977|NCT00557466|50539622|FG000|Overall Study|Administrative problems|0|||
25228978|NCT00557466|50539623|FG001|Overall Study|Administrative problems|1|||
25228979|NCT00557466|50539624|FG002|Overall Study|Administrative problems|1|||
25228980|NCT00557466|50539625|FG003|Overall Study|Administrative problems|0|||
25228981|NCT00557466|50539626|FG004|Overall Study|Administrative problems|0|||
25228982|NCT00557466|50539627|FG005|Overall Study|Administrative problems|0|||
25228983|NCT00557466|50539622|FG000|Overall Study|Abnormal test procedure results|0|||
25228984|NCT00557466|50539623|FG001|Overall Study|Abnormal test procedure results|0|||
25228985|NCT00557466|50539624|FG002|Overall Study|Abnormal test procedure results|1|||
25228986|NCT00557466|50539625|FG003|Overall Study|Abnormal test procedure results|0|||
25228987|NCT00557466|50539626|FG004|Overall Study|Abnormal test procedure results|0|||
25228988|NCT00557466|50539627|FG005|Overall Study|Abnormal test procedure results|0|||
25228989|NCT00557466|50539622|FG000|Overall Study|Lost to Follow-up|0|||
25228990|NCT00557466|50539623|FG001|Overall Study|Lost to Follow-up|0|||
25228991|NCT00557466|50539624|FG002|Overall Study|Lost to Follow-up|0|||
25228992|NCT00557466|50539625|FG003|Overall Study|Lost to Follow-up|1|||
25228993|NCT00557466|50539626|FG004|Overall Study|Lost to Follow-up|0|||
25228994|NCT00557466|50539627|FG005|Overall Study|Lost to Follow-up|0|||
25228995|NCT00557310|50539641|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
25228996|NCT00557310|50539641|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
25228997|NCT00557310|50539641|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
25228998|NCT00557310|50539641|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
25228999|NCT00557310|50539641|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
25229000|NCT00557310|50539641|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
25229001|NCT00555438|50539645|FG000|10 Days Post-operative|Death|4|||
25229002|NCT00555438|50539645|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
25229003|NCT00553644|50539649|FG000|Overall Study|Adverse Event|17|||
25229004|NCT00553644|50539649|FG000|Overall Study|Withdrawal by Subject|4|||
25229005|NCT00553644|50539649|FG000|Overall Study|Physician Decision|1|||
25229006|NCT00553644|50539649|FG000|Overall Study|Alternative therapy|6|||
25229007|NCT00553332|50539653|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
25229008|NCT00552396|50539664|FG000|Overall Study|protocol withdrawal criteria|3|||
25229009|NCT00552396|50539665|FG001|Overall Study|protocol withdrawal criteria|3|||
25229010|NCT00552396|50539666|FG002|Overall Study|protocol withdrawal criteria|3|||
25229011|NCT00552396|50539667|FG003|Overall Study|protocol withdrawal criteria|6|||
25229012|NCT00552396|50539668|FG004|Overall Study|protocol withdrawal criteria|3|||
25319103|NCT00950807|50634479|FG005|Treatment Period 3|Adverse Event|0|||
25229013|NCT00552396|50539669|FG005|Overall Study|protocol withdrawal criteria|3|||
25229014|NCT00552396|50539670|FG006|Overall Study|protocol withdrawal criteria|9|||
25229015|NCT00552240|50539706|FG000|Overall Study|Adverse Event|9|||
25229016|NCT00552240|50539707|FG001|Overall Study|Adverse Event|9|||
25229017|NCT00552240|50539706|FG000|Overall Study|Protocol Violation|1|||
25229018|NCT00552240|50539707|FG001|Overall Study|Protocol Violation|1|||
25229019|NCT00552240|50539706|FG000|Overall Study|Lost to Follow-up|5|||
25229020|NCT00552240|50539707|FG001|Overall Study|Lost to Follow-up|6|||
25229021|NCT00552240|50539706|FG000|Overall Study|Withdrawal by Subject|2|||
25229022|NCT00552240|50539707|FG001|Overall Study|Withdrawal by Subject|2|||
25229023|NCT00552240|50539706|FG000|Overall Study|Lack of Efficacy|6|||
25229024|NCT00552240|50539707|FG001|Overall Study|Lack of Efficacy|0|||
25229025|NCT00552240|50539706|FG000|Overall Study|Other|1|||
25229026|NCT00552240|50539707|FG001|Overall Study|Other|0|||
25229027|NCT00552084|50539715|FG000|Overall Study|Adverse Event|2|||
25229028|NCT00552084|50539716|FG001|Overall Study|Adverse Event|3|||
25229029|NCT00552084|50539715|FG000|Overall Study|Withdrawal by Subject|4|||
25229030|NCT00552084|50539716|FG001|Overall Study|Withdrawal by Subject|5|||
25229031|NCT00552084|50539715|FG000|Overall Study|Protocol Violation|1|||
25229032|NCT00552084|50539716|FG001|Overall Study|Protocol Violation|0|||
25229033|NCT00552084|50539715|FG000|Overall Study|change in anti-arrythmic drug|1|||
25229034|NCT00552084|50539716|FG001|Overall Study|change in anti-arrythmic drug|1|||
25229035|NCT00550836|50539724|FG000|Overall Study|Withdrawal by Subject|3|||
25229036|NCT00550836|50539725|FG001|Overall Study|Withdrawal by Subject|9|||
25229037|NCT00550680|50539731|FG000|Overall Study|Administrative Reasons|1|||
25229038|NCT00550680|50539731|FG000|Overall Study|Adverse Event|5|||
25229039|NCT00550680|50539731|FG000|Overall Study|Death|3|||
25229040|NCT00550680|50539731|FG000|Overall Study|Early Improvement|1|||
25229041|NCT00550680|50539731|FG000|Overall Study|Lost to Follow-up|3|||
25229042|NCT00550680|50539731|FG000|Overall Study|Lack of Efficacy|1|||
25229043|NCT00550680|50539731|FG000|Overall Study|Other|10|||
25229044|NCT00550680|50539731|FG000|Overall Study|Protocol Violation|7|||
25229045|NCT00550680|50539731|FG000|Overall Study|Refused Treatment|19|||
25229046|NCT00550680|50539731|FG000|Overall Study|Screen Failure|6|||
25229047|NCT00554190|50539735|FG000|Overall Study|Termination forms not completed|10|||
25229048|NCT00556374|50539741|FG000|Overall Study|Withdrawal by Subject|190|||
25229049|NCT00556374|50539742|FG001|Overall Study|Withdrawal by Subject|172|||
25229050|NCT00556374|50539741|FG000|Overall Study|Death|50|||
25229051|NCT00556374|50539742|FG001|Overall Study|Death|43|||
25229052|NCT00556374|50539741|FG000|Overall Study|Lost to Follow-up|7|||
25229053|NCT00556374|50539742|FG001|Overall Study|Lost to Follow-up|5|||
25229054|NCT04677959|50539771|FG000|Overall Study|Adverse Event|1|||
25229055|NCT04677959|50539772|FG001|Overall Study|Adverse Event|9|||
25229056|NCT04677959|50539771|FG000|Overall Study|Withdrawal by Subject|2|||
25229057|NCT04677959|50539772|FG001|Overall Study|Withdrawal by Subject|15|||
25229058|NCT04677959|50539771|FG000|Overall Study|Withdrawal by parent/guardian|0|||
25229059|NCT04677959|50539772|FG001|Overall Study|Withdrawal by parent/guardian|1|||
25229060|NCT04677959|50539771|FG000|Overall Study|Non-compliance with study drug|0|||
25229061|NCT04677959|50539772|FG001|Overall Study|Non-compliance with study drug|2|||
25229062|NCT04677959|50539771|FG000|Overall Study|Protocol deviation|0|||
25229063|NCT04677959|50539772|FG001|Overall Study|Protocol deviation|11|||
25229064|NCT04677959|50539771|FG000|Overall Study|Lost to Follow-up|9|||
25229065|NCT04677959|50539772|FG001|Overall Study|Lost to Follow-up|13|||
25229066|NCT04677959|50539771|FG000|Overall Study|Other than specified|0|||
25229067|NCT04677959|50539772|FG001|Overall Study|Other than specified|8|||
25229068|NCT04330638|50539799|FG000|Overall Study|Adverse Event|9|||
25229069|NCT04330638|50539800|FG001|Overall Study|Adverse Event|10|||
25229070|NCT04330638|50539801|FG002|Overall Study|Adverse Event|15|||
25319104|NCT00950807|50634480|FG006|Treatment Period 3|Adverse Event|1|||
25319105|NCT00950807|50634481|FG007|Treatment Period 3|Adverse Event|0|||
25229071|NCT04330638|50539802|FG003|Overall Study|Adverse Event|6|||
25229072|NCT04330638|50539803|FG004|Overall Study|Adverse Event|10|||
25229073|NCT04330638|50539804|FG005|Overall Study|Adverse Event|5|||
25229074|NCT04330638|50539799|FG000|Overall Study|Other|2|||
25229075|NCT04330638|50539800|FG001|Overall Study|Other|2|||
25229076|NCT04330638|50539801|FG002|Overall Study|Other|5|||
25229077|NCT04330638|50539802|FG003|Overall Study|Other|1|||
25229078|NCT04330638|50539803|FG004|Overall Study|Other|3|||
25229079|NCT04330638|50539804|FG005|Overall Study|Other|2|||
25229080|NCT04330638|50539799|FG000|Overall Study|Withdrawal by Subject|4|||
25229081|NCT04330638|50539800|FG001|Overall Study|Withdrawal by Subject|0|||
25229082|NCT04330638|50539801|FG002|Overall Study|Withdrawal by Subject|0|||
25229083|NCT04330638|50539802|FG003|Overall Study|Withdrawal by Subject|0|||
25229084|NCT04330638|50539803|FG004|Overall Study|Withdrawal by Subject|0|||
25229085|NCT04330638|50539804|FG005|Overall Study|Withdrawal by Subject|0|||
25229086|NCT04330638|50539799|FG000|Overall Study|Lost to Follow-up|3|||
25229087|NCT04330638|50539800|FG001|Overall Study|Lost to Follow-up|2|||
25229088|NCT04330638|50539801|FG002|Overall Study|Lost to Follow-up|3|||
25229089|NCT04330638|50539802|FG003|Overall Study|Lost to Follow-up|2|||
25229090|NCT04330638|50539803|FG004|Overall Study|Lost to Follow-up|3|||
25229091|NCT04330638|50539804|FG005|Overall Study|Lost to Follow-up|0|||
25229092|NCT04194541|50539825|FG000|Day 1 Through 13|Lost to Follow-up|3|||
25229093|NCT04194541|50539825|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
25229094|NCT04194541|50539825|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
25229095|NCT04006392|50539843|FG000|Overall Study|Lost to Follow-up|0|||
25229096|NCT04006392|50539844|FG001|Overall Study|Lost to Follow-up|1|||
25229097|NCT03959423|50539852|FG000|Overall Study|Withdrawal by Subject|2|||
25229098|NCT03959423|50539853|FG001|Overall Study|Withdrawal by Subject|3|||
25229099|NCT03959423|50539852|FG000|Overall Study|Physician Decision|0|||
25229100|NCT03959423|50539853|FG001|Overall Study|Physician Decision|1|||
25229101|NCT03959423|50539852|FG000|Overall Study|Lost to Follow-up|1|||
25229102|NCT03959423|50539853|FG001|Overall Study|Lost to Follow-up|0|||
25229103|NCT03959423|50539852|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
25229104|NCT03959423|50539853|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
25229105|NCT03786783|50539859|FG000|Overall Study|Death|1|||
25229106|NCT03786783|50539859|FG000|Overall Study|Physician Decision|6|||
25229107|NCT03786783|50539859|FG000|Overall Study|Withdrawal by Subject|2|||
25229108|NCT03786783|50539859|FG000|Overall Study|Disease Progression|7|||
25229109|NCT03786783|50539859|FG000|Overall Study|Patient/Parent Refusal|4|||
25229110|NCT03432494|50539873|FG000|Overall Study|Death|1|||
25229111|NCT03432494|50539873|FG000|Overall Study|Noncompliance|1|||
25229112|NCT03312634|50539879|FG000|Overall Study|Adverse Event|6|||
25229113|NCT03312634|50539880|FG001|Overall Study|Adverse Event|0|||
25229114|NCT03312634|50539879|FG000|Overall Study|Sponsor request|2|||
25229115|NCT03312634|50539880|FG001|Overall Study|Sponsor request|0|||
25229116|NCT03312634|50539879|FG000|Overall Study|Withdrawal by Subject|11|||
25229117|NCT03312634|50539880|FG001|Overall Study|Withdrawal by Subject|9|||
25229118|NCT03312634|50539879|FG000|Overall Study|Ongoing in study at DCO|88|||
25229119|NCT03312634|50539880|FG001|Overall Study|Ongoing in study at DCO|0|||
25229120|NCT03312634|50539879|FG000|Overall Study|Enrolled in an interventional study|0|||
25229121|NCT03312634|50539880|FG001|Overall Study|Enrolled in an interventional study|52|||
25229122|NCT03312634|50539879|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
25229123|NCT03312634|50539880|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
25229124|NCT03312634|50539879|FG000|Overall Study|Death|0|||
25229125|NCT03312634|50539880|FG001|Overall Study|Death|1|||
25229126|NCT03312634|50539879|FG000|Overall Study|Non-compliance|0|||
25229127|NCT03312634|50539880|FG001|Overall Study|Non-compliance|2|||
25229128|NCT03312634|50539879|FG000|Overall Study|Lost to Follow-up|0|||
25229129|NCT03312634|50539880|FG001|Overall Study|Lost to Follow-up|1|||
25229130|NCT03312634|50539879|FG000|Overall Study|Enrolled into non-interventional study|0|||
25229131|NCT03312634|50539880|FG001|Overall Study|Enrolled into non-interventional study|5|||
25229132|NCT03312634|50539879|FG000|Overall Study|Worsening clinical condition|0|||
25229133|NCT03312634|50539880|FG001|Overall Study|Worsening clinical condition|1|||
25229134|NCT03312634|50539879|FG000|Overall Study|Participant did not want to travel|0|||
25319106|NCT00950807|50634482|FG008|Treatment Period 3|Adverse Event|0|||
25319107|NCT00950807|50634483|FG009|Treatment Period 3|Adverse Event|0|||
25319108|NCT00797511|50634505|FG000|Overall Study|Withdrawal by Subject|1|||
25319109|NCT00608881|50634512|FG000|Overall Study|Death|22|||
25319110|NCT00608881|50634513|FG001|Overall Study|Death|13|||
25319111|NCT00608881|50634512|FG000|Overall Study|Adverse Event|5|||
25319112|NCT00608881|50634513|FG001|Overall Study|Adverse Event|3|||
25319113|NCT00608881|50634512|FG000|Overall Study|Lost to Follow-up|28|||
25319114|NCT00608881|50634513|FG001|Overall Study|Lost to Follow-up|14|||
25319115|NCT00608881|50634512|FG000|Overall Study|Withdrawal by Subject|18|||
25319116|NCT00608881|50634513|FG001|Overall Study|Withdrawal by Subject|29|||
25229135|NCT03312634|50539880|FG001|Overall Study|Participant did not want to travel|1|||
25229136|NCT03287830|50539891|FG000|Overall Study|Withdrawal by Subject|1|||
25229137|NCT03287830|50539892|FG001|Overall Study|Withdrawal by Subject|1|||
25229138|NCT03287830|50539891|FG000|Overall Study|not meeting inclusion criteria|5|||
25229139|NCT03287830|50539892|FG001|Overall Study|not meeting inclusion criteria|12|||
25229140|NCT03181633|50539902|FG000|Overall Study|Withdrawal by Subject|1|||
25229141|NCT03181633|50539902|FG000|Overall Study|Missing follow-up visit|1|||
25229142|NCT03122223|50539919|FG000|Overall Study|Withdrawal by Subject|2|||
25229143|NCT03122223|50539920|FG001|Overall Study|Withdrawal by Subject|2|||
25229144|NCT03122223|50539921|FG002|Overall Study|Withdrawal by Subject|1|||
25229145|NCT03122223|50539922|FG003|Overall Study|Withdrawal by Subject|0|||
25229146|NCT03122223|50539919|FG000|Overall Study|Lost to Follow-up|0|||
25229147|NCT03122223|50539920|FG001|Overall Study|Lost to Follow-up|2|||
25229148|NCT03122223|50539921|FG002|Overall Study|Lost to Follow-up|2|||
25229149|NCT03122223|50539922|FG003|Overall Study|Lost to Follow-up|0|||
25229150|NCT03122223|50539919|FG000|Overall Study|Participant unable to adhere|1|||
25229151|NCT03122223|50539920|FG001|Overall Study|Participant unable to adhere|1|||
25319117|NCT00608881|50634512|FG000|Overall Study|Physician Decision|5|||
25319118|NCT00608881|50634513|FG001|Overall Study|Physician Decision|5|||
25319119|NCT00608881|50634512|FG000|Overall Study|Institutionalized|1|||
25229152|NCT03122223|50539921|FG002|Overall Study|Participant unable to adhere|1|||
25229153|NCT03122223|50539922|FG003|Overall Study|Participant unable to adhere|0|||
25229154|NCT03077087|50539932|FG000|Overall Study|Physician Decision|2|||
25229155|NCT03075527|50539936|FG000|Overall Study|Ongoing treatment|2|||
25229156|NCT02853604|50539942|FG000|Overall Study|Withdrawal by Subject|12|||
25229157|NCT02853604|50539943|FG001|Overall Study|Withdrawal by Subject|35|||
25229158|NCT02853604|50539942|FG000|Overall Study|Lost to Follow-up|4|||
25229159|NCT02853604|50539943|FG001|Overall Study|Lost to Follow-up|8|||
25229160|NCT02853604|50539942|FG000|Overall Study|Death|1|||
25229161|NCT02853604|50539943|FG001|Overall Study|Death|5|||
25229162|NCT02853604|50539942|FG000|Overall Study|Miscellaneous|11|||
25229163|NCT02853604|50539943|FG001|Overall Study|Miscellaneous|2|||
25229164|NCT02853604|50539942|FG000|Overall Study|Progressive Disease|0|||
25229165|NCT02853604|50539943|FG001|Overall Study|Progressive Disease|2|||
25229166|NCT02632552|50539969|FG000|Overall Study|Lost to Follow-up|14|||
25229167|NCT02632552|50539970|FG001|Overall Study|Lost to Follow-up|8|||
25229168|NCT02632552|50539969|FG000|Overall Study|Withdrawal by Subject|2|||
25229169|NCT02632552|50539970|FG001|Overall Study|Withdrawal by Subject|0|||
25229170|NCT02632552|50539969|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
25229171|NCT02632552|50539970|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
25229172|NCT02525562|50540017|FG000|Overall Study|Death|9|||
25229173|NCT02525562|50540018|FG001|Overall Study|Death|0|||
25229174|NCT02525562|50540019|FG002|Overall Study|Death|0|||
25229175|NCT02525562|50540017|FG000|Overall Study|Lost to Follow-up|19|||
25229176|NCT02525562|50540018|FG001|Overall Study|Lost to Follow-up|0|||
25229177|NCT02525562|50540019|FG002|Overall Study|Lost to Follow-up|0|||
25229178|NCT02525562|50540017|FG000|Overall Study|Withdrawal by Subject|37|||
25229179|NCT02525562|50540018|FG001|Overall Study|Withdrawal by Subject|0|||
25229180|NCT02525562|50540019|FG002|Overall Study|Withdrawal by Subject|0|||
25229181|NCT02525562|50540017|FG000|Overall Study|Revision/Removal of Study Device|4|||
25229182|NCT02525562|50540018|FG001|Overall Study|Revision/Removal of Study Device|0|||
25229183|NCT02525562|50540019|FG002|Overall Study|Revision/Removal of Study Device|0|||
25229184|NCT02525562|50540017|FG000|Overall Study|Study Closed by Sponsor|154|||
25229185|NCT02525562|50540018|FG001|Overall Study|Study Closed by Sponsor|0|||
25229186|NCT02525562|50540019|FG002|Overall Study|Study Closed by Sponsor|0|||
25229187|NCT01992653|50540032|FG000|Overall Study|Death|0|||
25229188|NCT01992653|50540033|FG001|Overall Study|Death|0|||
25229189|NCT01992653|50540034|FG002|Overall Study|Death|1|||
25229190|NCT01992653|50540035|FG003|Overall Study|Death|0|||
25229191|NCT01992653|50540036|FG004|Overall Study|Death|1|||
25229192|NCT01992653|50540037|FG005|Overall Study|Death|0|||
25229193|NCT01992653|50540038|FG006|Overall Study|Death|4|||
25229194|NCT01992653|50540039|FG007|Overall Study|Death|2|||
25229195|NCT01992653|50540032|FG000|Overall Study|Lost to Follow-up|0|||
25229196|NCT01992653|50540033|FG001|Overall Study|Lost to Follow-up|0|||
25229197|NCT01992653|50540034|FG002|Overall Study|Lost to Follow-up|0|||
25229198|NCT01992653|50540035|FG003|Overall Study|Lost to Follow-up|0|||
25229199|NCT01992653|50540036|FG004|Overall Study|Lost to Follow-up|0|||
25229200|NCT01992653|50540037|FG005|Overall Study|Lost to Follow-up|0|||
25229201|NCT01992653|50540038|FG006|Overall Study|Lost to Follow-up|0|||
25229202|NCT01992653|50540039|FG007|Overall Study|Lost to Follow-up|1|||
25229203|NCT01992653|50540032|FG000|Overall Study|Study Completed|0|||
25229204|NCT01992653|50540033|FG001|Overall Study|Study Completed|0|||
25229205|NCT01992653|50540034|FG002|Overall Study|Study Completed|0|||
25229206|NCT01992653|50540035|FG003|Overall Study|Study Completed|0|||
25229207|NCT01992653|50540036|FG004|Overall Study|Study Completed|0|||
25229208|NCT01992653|50540037|FG005|Overall Study|Study Completed|0|||
25229209|NCT01992653|50540038|FG006|Overall Study|Study Completed|0|||
25229210|NCT01992653|50540039|FG007|Overall Study|Study Completed|1|||
25229211|NCT01992653|50540032|FG000|Overall Study|Disease Progression|0|||
25229212|NCT01992653|50540033|FG001|Overall Study|Disease Progression|0|||
25229213|NCT01992653|50540034|FG002|Overall Study|Disease Progression|0|||
25229214|NCT01992653|50540035|FG003|Overall Study|Disease Progression|0|||
25229215|NCT01992653|50540036|FG004|Overall Study|Disease Progression|0|||
25229216|NCT01992653|50540037|FG005|Overall Study|Disease Progression|0|||
25229217|NCT01992653|50540038|FG006|Overall Study|Disease Progression|4|||
25229218|NCT01992653|50540039|FG007|Overall Study|Disease Progression|0|||
25229219|NCT01682083|50540076|FG000|Overall Study|Lost to Follow-up|11|||
25229220|NCT01682083|50540077|FG001|Overall Study|Lost to Follow-up|18|||
25229221|NCT01682083|50540076|FG000|Overall Study|Withdrawal by Subject|31|||
25229222|NCT01682083|50540077|FG001|Overall Study|Withdrawal by Subject|40|||
25229223|NCT01682083|50540076|FG000|Overall Study|Death|60|||
25229224|NCT01682083|50540077|FG001|Overall Study|Death|93|||
25229225|NCT01682083|50540076|FG000|Overall Study|Physician Decision|5|||
25229226|NCT01682083|50540077|FG001|Overall Study|Physician Decision|4|||
25229227|NCT01654276|50540083|FG000|Overall Study|Lack of Efficacy|1|||
25229228|NCT01654276|50540083|FG000|Overall Study|Lost to Follow-up|4|||
25229229|NCT01654276|50540083|FG000|Overall Study|Withdrawal by Subject|1|||
25229230|NCT01399658|50540087|FG000|Overall Study|Ineligible|1|||
25229231|NCT01399658|50540087|FG000|Overall Study|Machine Technical Issue|3|||
25229232|NCT01399658|50540087|FG000|Overall Study|Alternative therapy|1|||
25229233|NCT01399658|50540087|FG000|Overall Study|No reason given|1|||
25229234|NCT00590122|50540093|FG000|Overall Study|swallowed oral dissolving dose|1|||
25229235|NCT00590122|50540094|FG001|Overall Study|swallowed oral dissolving dose|0|||
25229236|NCT01386658|50540136|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
25229237|NCT01386658|50540137|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
25229238|NCT01386658|50540136|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
25229239|NCT01386658|50540137|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
25229240|NCT01386684|50540147|FG000|Overall Study|Lost to Follow-up|51|||
25229241|NCT01386684|50540147|FG000|Overall Study|Other|51|||
25229242|NCT01386684|50540147|FG000|Overall Study|Death|47|||
25229243|NCT01386684|50540147|FG000|Overall Study|Withdrawal of Consent|44|||
25229244|NCT01386684|50540147|FG000|Overall Study|Alternative Therapy Required|37|||
25229245|NCT01386684|50540147|FG000|Overall Study|Disease Progression|28|||
25229246|NCT01386684|50540147|FG000|Overall Study|Adverse Event|20|||
25229247|NCT01386684|50540147|FG000|Overall Study|Noncompliance|8|||
25229248|NCT01386684|50540147|FG000|Overall Study|Protocol Violation|4|||
25229249|NCT01386684|50540147|FG000|Overall Study|Missing|3|||
25229250|NCT04980014|50540164|FG000|Overall Study|Participants who are Duplicated|1|||
25229251|NCT04980014|50540164|FG000|Overall Study|Follow-up Failure|13|||
25229252|NCT04980014|50540164|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
25229253|NCT04980014|50540164|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
25229254|NCT04980014|50540164|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
25229255|NCT03735849|50540188|FG000|Overall Study|Lost to Follow-up|1|||
25229256|NCT03735849|50540189|FG001|Overall Study|Lost to Follow-up|0|||
25229257|NCT03735849|50540190|FG002|Overall Study|Lost to Follow-up|0|||
25229258|NCT03735849|50540188|FG000|Overall Study|Participant unable to adhere to visit|1|||
25229259|NCT03735849|50540189|FG001|Overall Study|Participant unable to adhere to visit|0|||
25229260|NCT03735849|50540190|FG002|Overall Study|Participant unable to adhere to visit|0|||
25229261|NCT03735849|50540188|FG000|Overall Study|Not Randomized|0|||
25229262|NCT03735849|50540189|FG001|Overall Study|Not Randomized|0|||
25229263|NCT03735849|50540190|FG002|Overall Study|Not Randomized|4|||
25229264|NCT03552393|50540197|FG000|Core Period|Kidney Transplant|1|||
25229265|NCT03552393|50540197|FG000|Core Period|Prohibited Medication|1|||
25229266|NCT03552393|50540197|FG000|Safety Extension Period|Kidney Transplant|4|||
25229267|NCT03333382|50540203|FG000|Overall Study|Lost to Follow-up|1|||
25229268|NCT03333382|50540204|FG001|Overall Study|Lost to Follow-up|0|||
25229269|NCT03107611|50540243|FG000|Overall Study|Adverse Event|1|||
25229270|NCT03107611|50540244|FG001|Overall Study|Adverse Event|0|||
25229271|NCT03107611|50540245|FG002|Overall Study|Adverse Event|2|||
25229272|NCT03107611|50540243|FG000|Overall Study|Lost to Follow-up|3|||
25229273|NCT03107611|50540244|FG001|Overall Study|Lost to Follow-up|3|||
25229274|NCT03107611|50540245|FG002|Overall Study|Lost to Follow-up|3|||
25229275|NCT03107611|50540243|FG000|Overall Study|Protocol Violation|0|||
25229276|NCT03107611|50540244|FG001|Overall Study|Protocol Violation|0|||
25229277|NCT03107611|50540245|FG002|Overall Study|Protocol Violation|1|||
25229278|NCT03107611|50540243|FG000|Overall Study|Withdrawal by Subject|1|||
25229279|NCT03107611|50540244|FG001|Overall Study|Withdrawal by Subject|0|||
25229280|NCT03107611|50540245|FG002|Overall Study|Withdrawal by Subject|1|||
25229281|NCT03107611|50540243|FG000|Overall Study|Worsening signs/symptoms|2|||
25229282|NCT03107611|50540244|FG001|Overall Study|Worsening signs/symptoms|1|||
25229283|NCT03107611|50540245|FG002|Overall Study|Worsening signs/symptoms|2|||
25229284|NCT02720016|50540256|FG000|Overall Study|Separation of couple|6|||
25229285|NCT02720016|50540257|FG001|Overall Study|Separation of couple|8|||
25229286|NCT02720016|50540258|FG002|Overall Study|Separation of couple|2|||
25229287|NCT02720016|50540256|FG000|Overall Study|Withdrawal by Subject|6|||
25229288|NCT02720016|50540257|FG001|Overall Study|Withdrawal by Subject|6|||
25229289|NCT02720016|50540258|FG002|Overall Study|Withdrawal by Subject|4|||
25229290|NCT02720016|50540256|FG000|Overall Study|Scheduling issues|2|||
25229291|NCT02720016|50540257|FG001|Overall Study|Scheduling issues|4|||
25229292|NCT02720016|50540258|FG002|Overall Study|Scheduling issues|7|||
25229293|NCT02720016|50540256|FG000|Overall Study|Childcare|2|||
25229294|NCT02720016|50540257|FG001|Overall Study|Childcare|0|||
25229295|NCT02720016|50540258|FG002|Overall Study|Childcare|2|||
25229296|NCT02720016|50540256|FG000|Overall Study|Withdrawal by PI|2|||
25229297|NCT02720016|50540257|FG001|Overall Study|Withdrawal by PI|2|||
25229298|NCT02720016|50540258|FG002|Overall Study|Withdrawal by PI|0|||
25229299|NCT02720016|50540256|FG000|Overall Study|Moved away|2|||
25229300|NCT02720016|50540257|FG001|Overall Study|Moved away|0|||
25229301|NCT02720016|50540258|FG002|Overall Study|Moved away|0|||
25229302|NCT02720016|50540256|FG000|Overall Study|Not Primary Health Concern|0|||
25229303|NCT02720016|50540257|FG001|Overall Study|Not Primary Health Concern|0|||
25229304|NCT02720016|50540258|FG002|Overall Study|Not Primary Health Concern|2|||
25229305|NCT02720016|50540256|FG000|Overall Study|Transportation issues|0|||
25229306|NCT02720016|50540257|FG001|Overall Study|Transportation issues|0|||
25229307|NCT02720016|50540258|FG002|Overall Study|Transportation issues|1|||
25229308|NCT02720016|50540256|FG000|Overall Study|Other|0|||
25229309|NCT02720016|50540257|FG001|Overall Study|Other|0|||
25229310|NCT02720016|50540258|FG002|Overall Study|Other|2|||
25229311|NCT02607956|50540269|FG000|Double-Blinded Phase|Withdrew Consent|17|||
25229312|NCT02607956|50540270|FG001|Double-Blinded Phase|Withdrew Consent|19|||
25229313|NCT02607956|50540271|FG002|Double-Blinded Phase|Withdrew Consent|0|||
25229314|NCT02607956|50540272|FG003|Double-Blinded Phase|Withdrew Consent|0|||
25229315|NCT02607956|50540269|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
25229316|NCT02607956|50540270|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
25229317|NCT02607956|50540271|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
25229318|NCT02607956|50540272|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
25229319|NCT02607956|50540269|FG000|Double-Blinded Phase|Randomized but never treated|7|||
25229320|NCT02607956|50540270|FG001|Double-Blinded Phase|Randomized but never treated|5|||
25229321|NCT02607956|50540271|FG002|Double-Blinded Phase|Randomized but never treated|0|||
25229322|NCT02607956|50540272|FG003|Double-Blinded Phase|Randomized but never treated|0|||
25229323|NCT02607956|50540269|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
25229324|NCT02607956|50540270|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
25229325|NCT02607956|50540271|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
25229326|NCT02607956|50540272|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
25229327|NCT02607956|50540269|FG000|Double-Blinded Phase|Death|4|||
25229328|NCT02607956|50540270|FG001|Double-Blinded Phase|Death|4|||
25229329|NCT02607956|50540271|FG002|Double-Blinded Phase|Death|0|||
25229330|NCT02607956|50540272|FG003|Double-Blinded Phase|Death|0|||
25229331|NCT02607956|50540269|FG000|Double-Blinded Phase|Adverse Event|4|||
25229332|NCT02607956|50540270|FG001|Double-Blinded Phase|Adverse Event|3|||
25229333|NCT02607956|50540271|FG002|Double-Blinded Phase|Adverse Event|0|||
25229334|NCT02607956|50540272|FG003|Double-Blinded Phase|Adverse Event|0|||
25229335|NCT02607956|50540269|FG000|Double-Blinded Phase|Protocol Violation|3|||
25229336|NCT02607956|50540270|FG001|Double-Blinded Phase|Protocol Violation|1|||
25229337|NCT02607956|50540271|FG002|Double-Blinded Phase|Protocol Violation|0|||
25229338|NCT02607956|50540272|FG003|Double-Blinded Phase|Protocol Violation|0|||
25229339|NCT02607956|50540269|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
25229340|NCT02607956|50540270|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
25229341|NCT02607956|50540271|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
25229342|NCT02607956|50540272|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
25229343|NCT02607956|50540269|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
25229344|NCT02607956|50540270|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
25229345|NCT02607956|50540271|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
25229346|NCT02607956|50540272|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
25229347|NCT02607956|50540269|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
25229348|NCT02607956|50540270|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
25229349|NCT02607956|50540271|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
25229350|NCT02607956|50540272|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
25229351|NCT02607956|50540269|FG000|Open-Label Extension Phase|Death|0|||
25229352|NCT02607956|50540270|FG001|Open-Label Extension Phase|Death|0|||
25229353|NCT02607956|50540271|FG002|Open-Label Extension Phase|Death|1|||
25229354|NCT02607956|50540272|FG003|Open-Label Extension Phase|Death|3|||
25229355|NCT02607956|50540269|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
25229356|NCT02607956|50540270|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
25229357|NCT02607956|50540271|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
25229358|NCT02607956|50540272|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
25229359|NCT02607956|50540269|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
25229360|NCT02607956|50540270|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
25229361|NCT02607956|50540271|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
25229362|NCT02607956|50540272|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
25229363|NCT02607956|50540269|FG000|Open-Label Extension Phase|Protocol Violation|0|||
25229364|NCT02607956|50540270|FG001|Open-Label Extension Phase|Protocol Violation|0|||
25229365|NCT02607956|50540271|FG002|Open-Label Extension Phase|Protocol Violation|0|||
25229366|NCT02607956|50540272|FG003|Open-Label Extension Phase|Protocol Violation|2|||
25077497|NCT00002663|50185279|FG004|Overall Study|Physician Decision|1|||
25229367|NCT02607956|50540269|FG000|Open-Label Extension Phase|Pregnancy|0|||
25229368|NCT02607956|50540270|FG001|Open-Label Extension Phase|Pregnancy|0|||
25229369|NCT02607956|50540271|FG002|Open-Label Extension Phase|Pregnancy|0|||
25229370|NCT02607956|50540272|FG003|Open-Label Extension Phase|Pregnancy|1|||
25229371|NCT02564523|50540302|FG000|Overall Study|Withdrawal by Subject|3|||
25229372|NCT02564523|50540303|FG001|Overall Study|Withdrawal by Subject|0|||
25229373|NCT02564523|50540304|FG002|Overall Study|Withdrawal by Subject|1|||
25229374|NCT02564523|50540305|FG003|Overall Study|Withdrawal by Subject|0|||
25229375|NCT02564523|50540306|FG004|Overall Study|Withdrawal by Subject|1|||
25229376|NCT02564523|50540307|FG005|Overall Study|Withdrawal by Subject|0|||
25229377|NCT02564523|50540308|FG006|Overall Study|Withdrawal by Subject|1|||
25229378|NCT02564523|50540309|FG007|Overall Study|Withdrawal by Subject|0|||
25229379|NCT02564523|50540310|FG008|Overall Study|Withdrawal by Subject|0|||
25229380|NCT02564523|50540311|FG009|Overall Study|Withdrawal by Subject|0|||
25229381|NCT02564523|50540312|FG010|Overall Study|Withdrawal by Subject|1|||
25229382|NCT02564523|50540313|FG011|Overall Study|Withdrawal by Subject|0|||
25229383|NCT02564523|50540314|FG012|Overall Study|Withdrawal by Subject|1|||
25229384|NCT02564523|50540315|FG013|Overall Study|Withdrawal by Subject|0|||
25229385|NCT02564523|50540316|FG014|Overall Study|Withdrawal by Subject|0|||
25229386|NCT02564523|50540317|FG015|Overall Study|Withdrawal by Subject|0|||
25229387|NCT02564523|50540318|FG016|Overall Study|Withdrawal by Subject|0|||
25229388|NCT02564523|50540319|FG017|Overall Study|Withdrawal by Subject|0|||
25229389|NCT02564523|50540302|FG000|Overall Study|Adverse Event|0|||
25229390|NCT02564523|50540303|FG001|Overall Study|Adverse Event|0|||
25229391|NCT02564523|50540304|FG002|Overall Study|Adverse Event|0|||
25229392|NCT02564523|50540305|FG003|Overall Study|Adverse Event|0|||
25229393|NCT02564523|50540306|FG004|Overall Study|Adverse Event|0|||
25229394|NCT02564523|50540307|FG005|Overall Study|Adverse Event|0|||
25229395|NCT02564523|50540308|FG006|Overall Study|Adverse Event|0|||
25229396|NCT02564523|50540309|FG007|Overall Study|Adverse Event|0|||
25229397|NCT02564523|50540310|FG008|Overall Study|Adverse Event|0|||
25229398|NCT02564523|50540311|FG009|Overall Study|Adverse Event|0|||
25229399|NCT02564523|50540312|FG010|Overall Study|Adverse Event|0|||
25229400|NCT02564523|50540313|FG011|Overall Study|Adverse Event|0|||
25229401|NCT02564523|50540314|FG012|Overall Study|Adverse Event|0|||
25229402|NCT02564523|50540315|FG013|Overall Study|Adverse Event|0|||
25229403|NCT02564523|50540316|FG014|Overall Study|Adverse Event|0|||
25229404|NCT02564523|50540317|FG015|Overall Study|Adverse Event|0|||
25229405|NCT02564523|50540318|FG016|Overall Study|Adverse Event|0|||
25229406|NCT02564523|50540319|FG017|Overall Study|Adverse Event|1|||
25229407|NCT02564523|50540302|FG000|Overall Study|Death|0|||
25229408|NCT02564523|50540303|FG001|Overall Study|Death|0|||
25229409|NCT02564523|50540304|FG002|Overall Study|Death|0|||
25229410|NCT02564523|50540305|FG003|Overall Study|Death|0|||
25229411|NCT02564523|50540306|FG004|Overall Study|Death|0|||
25229412|NCT02564523|50540307|FG005|Overall Study|Death|0|||
25229413|NCT02564523|50540308|FG006|Overall Study|Death|1|||
25229414|NCT02564523|50540309|FG007|Overall Study|Death|0|||
25229415|NCT02564523|50540310|FG008|Overall Study|Death|0|||
25229416|NCT02564523|50540311|FG009|Overall Study|Death|0|||
25229417|NCT02564523|50540312|FG010|Overall Study|Death|1|||
25229418|NCT02564523|50540313|FG011|Overall Study|Death|0|||
25229419|NCT02564523|50540314|FG012|Overall Study|Death|0|||
25229420|NCT02564523|50540315|FG013|Overall Study|Death|0|||
25229421|NCT02564523|50540316|FG014|Overall Study|Death|0|||
25229422|NCT02564523|50540317|FG015|Overall Study|Death|0|||
25229423|NCT02564523|50540318|FG016|Overall Study|Death|0|||
25229424|NCT02564523|50540319|FG017|Overall Study|Death|0|||
25229425|NCT02564523|50540302|FG000|Overall Study|Lost to Follow-up|2|||
25229426|NCT02564523|50540303|FG001|Overall Study|Lost to Follow-up|1|||
25229427|NCT02564523|50540304|FG002|Overall Study|Lost to Follow-up|4|||
25229428|NCT02564523|50540305|FG003|Overall Study|Lost to Follow-up|0|||
25229429|NCT02564523|50540306|FG004|Overall Study|Lost to Follow-up|1|||
25229430|NCT02564523|50540307|FG005|Overall Study|Lost to Follow-up|0|||
25229431|NCT02564523|50540308|FG006|Overall Study|Lost to Follow-up|1|||
25229432|NCT02564523|50540309|FG007|Overall Study|Lost to Follow-up|0|||
25229433|NCT02564523|50540310|FG008|Overall Study|Lost to Follow-up|0|||
25229434|NCT02564523|50540311|FG009|Overall Study|Lost to Follow-up|0|||
25229435|NCT02564523|50540312|FG010|Overall Study|Lost to Follow-up|0|||
25229436|NCT02564523|50540313|FG011|Overall Study|Lost to Follow-up|1|||
25229437|NCT02564523|50540314|FG012|Overall Study|Lost to Follow-up|1|||
25229438|NCT02564523|50540315|FG013|Overall Study|Lost to Follow-up|0|||
25229439|NCT02564523|50540316|FG014|Overall Study|Lost to Follow-up|0|||
25229440|NCT02564523|50540317|FG015|Overall Study|Lost to Follow-up|0|||
25229441|NCT02564523|50540318|FG016|Overall Study|Lost to Follow-up|0|||
25229442|NCT02564523|50540319|FG017|Overall Study|Lost to Follow-up|0|||
25229443|NCT02564523|50540302|FG000|Overall Study|Physician Decision|0|||
25229444|NCT02564523|50540303|FG001|Overall Study|Physician Decision|0|||
25229445|NCT02564523|50540304|FG002|Overall Study|Physician Decision|0|||
25229446|NCT02564523|50540305|FG003|Overall Study|Physician Decision|0|||
25229447|NCT02564523|50540306|FG004|Overall Study|Physician Decision|1|||
25229448|NCT02564523|50540307|FG005|Overall Study|Physician Decision|0|||
25229449|NCT02564523|50540308|FG006|Overall Study|Physician Decision|0|||
25229450|NCT02564523|50540309|FG007|Overall Study|Physician Decision|0|||
25229451|NCT02564523|50540310|FG008|Overall Study|Physician Decision|0|||
25229452|NCT02564523|50540311|FG009|Overall Study|Physician Decision|0|||
25229453|NCT02564523|50540312|FG010|Overall Study|Physician Decision|1|||
25229454|NCT02564523|50540313|FG011|Overall Study|Physician Decision|0|||
25229455|NCT02564523|50540314|FG012|Overall Study|Physician Decision|0|||
25229456|NCT02564523|50540315|FG013|Overall Study|Physician Decision|0|||
25229457|NCT02564523|50540316|FG014|Overall Study|Physician Decision|0|||
25229458|NCT02564523|50540317|FG015|Overall Study|Physician Decision|0|||
25229459|NCT02564523|50540318|FG016|Overall Study|Physician Decision|0|||
25229460|NCT02564523|50540319|FG017|Overall Study|Physician Decision|0|||
25229461|NCT02564523|50540302|FG000|Overall Study|Protocol Violation|2|||
25229462|NCT02564523|50540303|FG001|Overall Study|Protocol Violation|2|||
25229463|NCT02564523|50540304|FG002|Overall Study|Protocol Violation|5|||
25229464|NCT02564523|50540305|FG003|Overall Study|Protocol Violation|0|||
25229465|NCT02564523|50540306|FG004|Overall Study|Protocol Violation|1|||
25229466|NCT02564523|50540307|FG005|Overall Study|Protocol Violation|0|||
25229467|NCT02564523|50540308|FG006|Overall Study|Protocol Violation|0|||
25229468|NCT02564523|50540309|FG007|Overall Study|Protocol Violation|0|||
25229469|NCT02564523|50540310|FG008|Overall Study|Protocol Violation|0|||
25229470|NCT02564523|50540311|FG009|Overall Study|Protocol Violation|0|||
25229471|NCT02564523|50540312|FG010|Overall Study|Protocol Violation|0|||
25229472|NCT02564523|50540313|FG011|Overall Study|Protocol Violation|0|||
25229473|NCT02564523|50540314|FG012|Overall Study|Protocol Violation|0|||
25229474|NCT02564523|50540315|FG013|Overall Study|Protocol Violation|0|||
25229475|NCT02564523|50540316|FG014|Overall Study|Protocol Violation|0|||
25229476|NCT02564523|50540317|FG015|Overall Study|Protocol Violation|0|||
25229477|NCT02564523|50540318|FG016|Overall Study|Protocol Violation|0|||
25229478|NCT02564523|50540319|FG017|Overall Study|Protocol Violation|0|||
25229479|NCT02564523|50540302|FG000|Overall Study|Other|3|||
25229480|NCT02564523|50540303|FG001|Overall Study|Other|0|||
25229481|NCT02564523|50540304|FG002|Overall Study|Other|0|||
25229482|NCT02564523|50540305|FG003|Overall Study|Other|1|||
25229483|NCT02564523|50540306|FG004|Overall Study|Other|0|||
25229484|NCT02564523|50540307|FG005|Overall Study|Other|0|||
25229485|NCT02564523|50540308|FG006|Overall Study|Other|0|||
25229486|NCT02564523|50540309|FG007|Overall Study|Other|0|||
25229487|NCT02564523|50540310|FG008|Overall Study|Other|0|||
25229488|NCT02564523|50540311|FG009|Overall Study|Other|0|||
25229489|NCT02564523|50540312|FG010|Overall Study|Other|0|||
25229490|NCT02564523|50540313|FG011|Overall Study|Other|0|||
25229491|NCT02564523|50540314|FG012|Overall Study|Other|0|||
25229492|NCT02564523|50540315|FG013|Overall Study|Other|0|||
25229493|NCT02564523|50540316|FG014|Overall Study|Other|0|||
25229494|NCT02564523|50540317|FG015|Overall Study|Other|0|||
25229495|NCT02564523|50540318|FG016|Overall Study|Other|0|||
25229496|NCT02564523|50540319|FG017|Overall Study|Other|0|||
25229497|NCT01447628|50540426|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
25229498|NCT01447628|50540427|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
25229499|NCT01447628|50540428|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
25229500|NCT01447628|50540429|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
25229501|NCT00515853|50540451|FG000|Overall Study|Lost to Follow-up|9|||
25229502|NCT00515853|50540452|FG001|Overall Study|Lost to Follow-up|13|||
25229503|NCT00515853|50540451|FG000|Overall Study|Withdrawal by Subject|6|||
25229504|NCT00515853|50540452|FG001|Overall Study|Withdrawal by Subject|4|||
25229505|NCT00003458|50540458|FG000|Overall Study|Not evaluable|4|||
25229506|NCT04613739|50540483|FG000|Overall Study|Lost to Follow-up|6|||
25229507|NCT04613739|50540484|FG001|Overall Study|Lost to Follow-up|9|||
25229508|NCT04613739|50540483|FG000|Overall Study|potentially duplicative/fraudulent|1|||
25229509|NCT04613739|50540484|FG001|Overall Study|potentially duplicative/fraudulent|3|||
25229510|NCT04407806|50540511|FG000|Overall Study|Withdrawal by Subject|1|||
25229511|NCT04407806|50540512|FG001|Overall Study|Withdrawal by Subject|2|||
25229512|NCT04324021|50540521|FG000|Overall Study|Adverse Event|1|||
25229513|NCT04324021|50540522|FG001|Overall Study|Adverse Event|0|||
25229514|NCT04324021|50540523|FG002|Overall Study|Adverse Event|0|||
25229515|NCT04324021|50540521|FG000|Overall Study|Lack of Efficacy|0|||
25229516|NCT04324021|50540522|FG001|Overall Study|Lack of Efficacy|0|||
25229517|NCT04324021|50540523|FG002|Overall Study|Lack of Efficacy|1|||
25229518|NCT04324021|50540521|FG000|Overall Study|Death|1|||
25229519|NCT04324021|50540522|FG001|Overall Study|Death|1|||
25229520|NCT04324021|50540523|FG002|Overall Study|Death|0|||
25229521|NCT04209621|50540534|FG000|Overall Study|Death|1|||
25229522|NCT04209621|50540534|FG000|Overall Study|Study Terminated Early|2|||
25229523|NCT04186663|50540539|FG000|Overall Study|Lost to Follow-up|1|||
25229524|NCT04186663|50540539|FG000|Overall Study|Unable to complete blood draw|3|||
25229525|NCT04158219|50540543|FG000|Overall Study|Lost to Follow-up|1|||
25229526|NCT03954743|50540576|FG000|Overall Study|Adverse Event|1|||
25229527|NCT03954743|50540577|FG001|Overall Study|Adverse Event|0|||
25229528|NCT03954743|50540576|FG000|Overall Study|Lost to Follow-up|6|||
25229529|NCT03954743|50540577|FG001|Overall Study|Lost to Follow-up|4|||
25229530|NCT03954743|50540576|FG000|Overall Study|Protocol Violation|1|||
25229531|NCT03954743|50540577|FG001|Overall Study|Protocol Violation|0|||
25229532|NCT03954743|50540576|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
25229533|NCT03954743|50540577|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
25229534|NCT03954743|50540576|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
25229535|NCT03954743|50540577|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
25229536|NCT03880565|50540598|FG000|Overall Study|Withdrawal by Subject|1|||
25229537|NCT03880565|50540599|FG001|Overall Study|Withdrawal by Subject|0|||
25229538|NCT03782792|50540607|FG000|Overall Study|Patient left the country|0|||
25229539|NCT03782792|50540608|FG001|Overall Study|Patient left the country|1|||
25229540|NCT03782792|50540607|FG000|Overall Study|Withdrawal by Subject|1|||
25229541|NCT03782792|50540608|FG001|Overall Study|Withdrawal by Subject|2|||
25229542|NCT03733119|50540618|FG000|Overall Study|Physician Decision|2|||
25229543|NCT03733119|50540619|FG001|Overall Study|Physician Decision|1|||
25229544|NCT03733119|50540618|FG000|Overall Study|ineligible to treat per protocol|0|||
25229545|NCT03733119|50540619|FG001|Overall Study|ineligible to treat per protocol|1|||
25229546|NCT03661996|50540630|FG000|Overall Study|Adverse Event|0|||
25229547|NCT03661996|50540631|FG001|Overall Study|Adverse Event|0|||
25229548|NCT03661996|50540632|FG002|Overall Study|Adverse Event|1|||
25229549|NCT03661996|50540633|FG003|Overall Study|Adverse Event|1|||
25229550|NCT03661996|50540634|FG004|Overall Study|Adverse Event|0|||
25229551|NCT03661996|50540630|FG000|Overall Study|Lost to Follow-up|5|||
25229552|NCT03661996|50540631|FG001|Overall Study|Lost to Follow-up|1|||
25229553|NCT03661996|50540632|FG002|Overall Study|Lost to Follow-up|2|||
25229554|NCT03661996|50540633|FG003|Overall Study|Lost to Follow-up|2|||
25229555|NCT03661996|50540634|FG004|Overall Study|Lost to Follow-up|6|||
25229556|NCT03661996|50540630|FG000|Overall Study|Physician Decision|1|||
25229557|NCT03661996|50540631|FG001|Overall Study|Physician Decision|1|||
25229558|NCT03661996|50540632|FG002|Overall Study|Physician Decision|1|||
25229559|NCT03661996|50540633|FG003|Overall Study|Physician Decision|2|||
25229560|NCT03661996|50540634|FG004|Overall Study|Physician Decision|0|||
25229561|NCT03661996|50540630|FG000|Overall Study|Protocol Violation|0|||
25229562|NCT03661996|50540631|FG001|Overall Study|Protocol Violation|0|||
25229563|NCT03661996|50540632|FG002|Overall Study|Protocol Violation|0|||
25229564|NCT03661996|50540633|FG003|Overall Study|Protocol Violation|0|||
25229565|NCT03661996|50540634|FG004|Overall Study|Protocol Violation|1|||
25229566|NCT03661996|50540630|FG000|Overall Study|Withdrawal by Subject|3|||
25229567|NCT03661996|50540631|FG001|Overall Study|Withdrawal by Subject|5|||
25229568|NCT03661996|50540632|FG002|Overall Study|Withdrawal by Subject|1|||
25229569|NCT03661996|50540633|FG003|Overall Study|Withdrawal by Subject|7|||
25229570|NCT03661996|50540634|FG004|Overall Study|Withdrawal by Subject|7|||
25229571|NCT03661996|50540630|FG000|Overall Study|Sponsors Decision|2|||
25229572|NCT03661996|50540631|FG001|Overall Study|Sponsors Decision|0|||
25229573|NCT03661996|50540632|FG002|Overall Study|Sponsors Decision|0|||
25229574|NCT03661996|50540633|FG003|Overall Study|Sponsors Decision|0|||
25229575|NCT03661996|50540634|FG004|Overall Study|Sponsors Decision|0|||
25229576|NCT03661996|50540630|FG000|Overall Study|Other|1|||
25229577|NCT03661996|50540631|FG001|Overall Study|Other|1|||
25229578|NCT03661996|50540632|FG002|Overall Study|Other|1|||
25229579|NCT03661996|50540633|FG003|Overall Study|Other|1|||
25229580|NCT03661996|50540634|FG004|Overall Study|Other|0|||
25229581|NCT03633461|50540651|FG000|Overall Study|Lost to Follow-up|0|||
25229582|NCT03633461|50540652|FG001|Overall Study|Lost to Follow-up|1|||
25229583|NCT03499314|50540680|FG000|Overall Study|Time Commitment|1|||
25229584|NCT03499314|50540681|FG001|Overall Study|Time Commitment|2|||
25229585|NCT03499314|50540680|FG000|Overall Study|Medical issue unrelated to research study|1|||
25319120|NCT00608881|50634513|FG001|Overall Study|Institutionalized|2|||
25319121|NCT00945191|50634519|FG000|Overall Study|Did not achieve a complete response|18|||
25319122|NCT00945191|50634519|FG000|Overall Study|Participant relocated to another state|1|||
25319123|NCT00945191|50634519|FG000|Overall Study|Disease progression|3|||
24976605|NCT00008138|50065532|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
24976606|NCT00008138|50065532|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
24976607|NCT00008138|50065532|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
24976608|NCT00008138|50065532|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
24976609|NCT00008138|50065532|FG000|Interval Debulking|Withdrawal by Subject|2|||
24976610|NCT00008138|50065532|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
24976611|NCT00008138|50065532|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
24976612|NCT00008138|50065532|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
24976613|NCT03436732|50065539|FG000|Overall Study|Not treated-enrolled in different study|1|||
24976614|NCT03436732|50065540|FG001|Overall Study|Not treated-enrolled in different study|0|||
24976615|NCT03436732|50065539|FG000|Overall Study|Off study after cycle 1|1|||
24976616|NCT03436732|50065540|FG001|Overall Study|Off study after cycle 1|0|||
24976617|NCT03436732|50065539|FG000|Overall Study|Adverse Event|2|||
24976618|NCT03436732|50065540|FG001|Overall Study|Adverse Event|0|||
25229586|NCT03499314|50540681|FG001|Overall Study|Medical issue unrelated to research study|1|||
25229587|NCT03369431|50540689|FG000|Overall Study|Lost to Follow-up|1|||
25229588|NCT03369431|50540690|FG001|Overall Study|Lost to Follow-up|3|||
25229589|NCT03369431|50540689|FG000|Overall Study|Withdrawal by Subject|2|||
25229590|NCT03369431|50540690|FG001|Overall Study|Withdrawal by Subject|3|||
25229591|NCT03369431|50540689|FG000|Overall Study|Protocol Violation|1|||
25229592|NCT03369431|50540690|FG001|Overall Study|Protocol Violation|1|||
24976619|NCT03436732|50065539|FG000|Overall Study|Death|0|||
25229593|NCT03336866|50540699|FG000|Overall Study|Lost to Follow-up|2|||
25229594|NCT03336866|50540700|FG001|Overall Study|Lost to Follow-up|0|||
25229595|NCT03336866|50540701|FG002|Overall Study|Lost to Follow-up|3|||
25229596|NCT03336866|50540699|FG000|Overall Study|Withdrawal by Subject|1|||
25229597|NCT03336866|50540700|FG001|Overall Study|Withdrawal by Subject|1|||
25229598|NCT03336866|50540701|FG002|Overall Study|Withdrawal by Subject|0|||
25229599|NCT03336866|50540699|FG000|Overall Study|Noncompliance with clinic house rules|0|||
25229600|NCT03336866|50540700|FG001|Overall Study|Noncompliance with clinic house rules|0|||
25229601|NCT03336866|50540701|FG002|Overall Study|Noncompliance with clinic house rules|1|||
25229602|NCT03332173|50540714|FG000|Overall Study|Death|7|||
25229603|NCT03332173|50540714|FG000|Overall Study|Withdrawal by Subject|6|||
25229604|NCT03332173|50540714|FG000|Overall Study|Lost to Follow-up|2|||
25229605|NCT03332173|50540714|FG000|Overall Study|Transferred to long-term extension study|29|||
25229606|NCT03322293|50540721|FG000|Overall Study|Lost to Follow-up|0|||
25229607|NCT03322293|50540722|FG001|Overall Study|Lost to Follow-up|0|||
25229608|NCT03322293|50540723|FG002|Overall Study|Lost to Follow-up|1|||
25229609|NCT03254394|50540745|FG000|Overall Study|Withdrawal by Subject|0|||
25229610|NCT03254394|50540746|FG001|Overall Study|Withdrawal by Subject|2|||
25229611|NCT03253809|50540752|FG000|Overall Study|Unable to obtain study related data|14|||
25229612|NCT02998476|50540831|FG000|Overall Study|Lost to Follow-up|1|||
25229613|NCT02998476|50540832|FG001|Overall Study|Lost to Follow-up|0|||
25229614|NCT02998476|50540831|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
25229615|NCT02998476|50540832|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
25229616|NCT02998476|50540831|FG000|Overall Study|Withdrawal by Subject|1|||
25229617|NCT02998476|50540832|FG001|Overall Study|Withdrawal by Subject|2|||
25229618|NCT02998476|50540831|FG000|Overall Study|Death|45|||
25229619|NCT02998476|50540832|FG001|Overall Study|Death|2|||
25229620|NCT02998476|50540831|FG000|Overall Study|Other|6|||
25229621|NCT02998476|50540832|FG001|Overall Study|Other|1|||
25229622|NCT02924064|50540850|FG000|Overall Study|Adverse Event|2|||
25229623|NCT02924064|50540851|FG001|Overall Study|Adverse Event|2|||
25229624|NCT02924064|50540850|FG000|Overall Study|Lost to Follow-up|0|||
25229625|NCT02924064|50540851|FG001|Overall Study|Lost to Follow-up|2|||
25229626|NCT02924064|50540850|FG000|Overall Study|Physician Decision|0|||
25229627|NCT02924064|50540851|FG001|Overall Study|Physician Decision|2|||
25229628|NCT02924064|50540850|FG000|Overall Study|Protocol Violation|1|||
25229629|NCT02924064|50540851|FG001|Overall Study|Protocol Violation|3|||
25229630|NCT02924064|50540850|FG000|Overall Study|Withdrawal by Subject|4|||
25229631|NCT02924064|50540851|FG001|Overall Study|Withdrawal by Subject|5|||
25229632|NCT02924064|50540850|FG000|Overall Study|Other|17|||
25229633|NCT02924064|50540851|FG001|Overall Study|Other|29|||
25229634|NCT02916706|50540859|FG000|Overall Study|Adverse Event|0|||
25229635|NCT02916706|50540860|FG001|Overall Study|Adverse Event|1|||
25229636|NCT02916706|50540859|FG000|Overall Study|Lost to Follow-up|0|||
25229637|NCT02916706|50540860|FG001|Overall Study|Lost to Follow-up|1|||
25229638|NCT02916706|50540859|FG000|Overall Study|Physician Decision|1|||
25229639|NCT02916706|50540860|FG001|Overall Study|Physician Decision|0|||
25229640|NCT02916706|50540859|FG000|Overall Study|Protocol Violation|3|||
25229641|NCT02916706|50540860|FG001|Overall Study|Protocol Violation|1|||
25229642|NCT02916706|50540859|FG000|Overall Study|Withdrawal by Subject|6|||
25229643|NCT02916706|50540860|FG001|Overall Study|Withdrawal by Subject|9|||
25229644|NCT02916706|50540859|FG000|Overall Study|Other|5|||
25229645|NCT02916706|50540860|FG001|Overall Study|Other|19|||
25229646|NCT02889900|50540866|FG000|Overall Study|Adverse Event|11|||
25229647|NCT02889900|50540866|FG000|Overall Study|Condition under investigation worsened|32|||
25229648|NCT02889900|50540866|FG000|Overall Study|Other|5|||
25229649|NCT02889900|50540866|FG000|Overall Study|Withdrawal by Subject|7|||
25229650|NCT02889900|50540866|FG000|Overall Study|Not treated|2|||
25229651|NCT02866695|50540870|FG000|Overall Study|Adverse Event|1|||
25229652|NCT02866695|50540870|FG000|Overall Study|Lost to Follow-up|1|||
25229653|NCT02834793|50540876|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
25229654|NCT02834793|50540877|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
25229655|NCT02834793|50540878|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
25229656|NCT02834793|50540879|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
25229657|NCT02834793|50540876|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
25229658|NCT02834793|50540877|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
25229659|NCT02834793|50540878|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
25229660|NCT02834793|50540879|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
25229661|NCT02834793|50540876|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
25229662|NCT02834793|50540877|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
25229663|NCT02834793|50540878|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
25229664|NCT02834793|50540879|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
25229665|NCT02834793|50540876|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
25229666|NCT02834793|50540877|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
25229667|NCT02834793|50540878|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
25229668|NCT02834793|50540879|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
25229669|NCT02834793|50540876|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
25229670|NCT02834793|50540877|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
25229671|NCT02834793|50540878|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
25229672|NCT02834793|50540879|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
25229673|NCT02834793|50540876|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
25229674|NCT02834793|50540877|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
25229675|NCT02834793|50540878|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
25229676|NCT02834793|50540879|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
25229677|NCT02834793|50540876|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
25229678|NCT02834793|50540877|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
25229679|NCT02834793|50540878|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
25229680|NCT02834793|50540879|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
25229681|NCT02834793|50540876|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
25229682|NCT02834793|50540877|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
25229683|NCT02834793|50540878|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
25229684|NCT02834793|50540879|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
25229685|NCT02834793|50540876|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
25229686|NCT02834793|50540877|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
25229687|NCT02834793|50540878|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
25229688|NCT02834793|50540879|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
25229689|NCT02834793|50540876|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
25229690|NCT02834793|50540877|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
25229691|NCT02834793|50540878|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
25229692|NCT02834793|50540879|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
25229693|NCT02834793|50540876|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
25229694|NCT02834793|50540877|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
25229695|NCT02834793|50540878|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
25229696|NCT02834793|50540879|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
25229697|NCT02834793|50540876|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
25229698|NCT02834793|50540877|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
25229699|NCT02834793|50540878|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
25229700|NCT02834793|50540879|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
25229701|NCT02834793|50540876|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
25229702|NCT02834793|50540877|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
25229703|NCT02834793|50540878|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
25229704|NCT02834793|50540879|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
25229705|NCT02834793|50540876|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
25229706|NCT02834793|50540877|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
25229707|NCT02834793|50540878|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
25229708|NCT02834793|50540879|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
25229709|NCT02834793|50540876|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
25229710|NCT02834793|50540877|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
25229711|NCT02834793|50540878|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
25229712|NCT02834793|50540879|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
25229713|NCT02810457|50540889|FG000|Overall Study|Randomised but no treatment received|2|||
25229714|NCT02810457|50540890|FG001|Overall Study|Randomised but no treatment received|1|||
25229715|NCT02810457|50540889|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
25229716|NCT02810457|50540890|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
25229717|NCT02810457|50540889|FG000|Overall Study|Adverse Event|37|||
25229718|NCT02810457|50540890|FG001|Overall Study|Adverse Event|43|||
25229719|NCT02810457|50540889|FG000|Overall Study|Patient decision|31|||
25229720|NCT02810457|50540890|FG001|Overall Study|Patient decision|35|||
25229721|NCT02810457|50540889|FG000|Overall Study|Patient lost to follow-up|2|||
25229722|NCT02810457|50540890|FG001|Overall Study|Patient lost to follow-up|2|||
25229723|NCT02810457|50540889|FG000|Overall Study|Death|39|||
25229724|NCT02810457|50540890|FG001|Overall Study|Death|28|||
25229725|NCT02810457|50540889|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
25229726|NCT02810457|50540890|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
25229727|NCT02810457|50540889|FG000|Overall Study|Clinical progression|15|||
25229728|NCT02810457|50540890|FG001|Overall Study|Clinical progression|16|||
25229729|NCT02810457|50540889|FG000|Overall Study|Investigator decision|3|||
25229730|NCT02810457|50540890|FG001|Overall Study|Investigator decision|2|||
25229731|NCT02810457|50540889|FG000|Overall Study|Patient ineligibility|3|||
25229732|NCT02810457|50540890|FG001|Overall Study|Patient ineligibility|0|||
25229733|NCT02810457|50540889|FG000|Overall Study|Miscalculated PD|1|||
25229734|NCT02810457|50540890|FG001|Overall Study|Miscalculated PD|0|||
25229735|NCT02810457|50540889|FG000|Overall Study|Physician Decision|0|||
25229736|NCT02810457|50540890|FG001|Overall Study|Physician Decision|1|||
25229737|NCT02745535|50540896|FG000|Overall Study|Death|1|||
25229738|NCT02745535|50540896|FG000|Overall Study|Adverse Event|3|||
25229739|NCT02745535|50540896|FG000|Overall Study|Lost to Follow-up|2|||
25229740|NCT02625090|50540930|FG000|Overall Study|Participant wants to be pregnant|2|||
25229741|NCT02625090|50540930|FG000|Overall Study|For the Promoter|1|||
25229742|NCT02625090|50540930|FG000|Overall Study|Sponsor's Decision|9|||
25229743|NCT02625090|50540930|FG000|Overall Study|Somnolence|1|||
25229744|NCT02625090|50540930|FG000|Overall Study|Study terminated by Sponsor|7|||
25229745|NCT02625090|50540930|FG000|Overall Study|Negative Benefit/Risk|1|||
25229746|NCT02625090|50540930|FG000|Overall Study|Protocol Deviation|2|||
25229747|NCT02625090|50540930|FG000|Overall Study|Lack of Efficacy|16|||
25229748|NCT02625090|50540930|FG000|Overall Study|Adverse Event|3|||
25229749|NCT02539225|50540937|FG000|Part A|Adverse Event|13|||
25229750|NCT02539225|50540938|FG001|Part A|Adverse Event|4|||
25229751|NCT02539225|50540937|FG000|Part A|Withdrawal by Subject|2|||
25229752|NCT02539225|50540938|FG001|Part A|Withdrawal by Subject|4|||
25229753|NCT02539225|50540937|FG000|Part A|Physician Decision|4|||
25229754|NCT02539225|50540938|FG001|Part A|Physician Decision|7|||
25229755|NCT02539225|50540937|FG000|Part A|Did Not Receive study Drug|1|||
25229756|NCT02539225|50540938|FG001|Part A|Did Not Receive study Drug|1|||
25229757|NCT02539225|50540937|FG000|Pre Treatment for Part B|Progressive disease|1|||
25229758|NCT02539225|50540938|FG001|Pre Treatment for Part B|Progressive disease|1|||
25229759|NCT02539225|50540937|FG000|Pre Treatment for Part B|Adverse Event|1|||
25229760|NCT02539225|50540938|FG001|Pre Treatment for Part B|Adverse Event|1|||
25229761|NCT02539225|50540937|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
25229762|NCT02539225|50540938|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
25229763|NCT02539225|50540937|FG000|Pre Treatment for Part B|Physician Decision|2|||
25229764|NCT02539225|50540938|FG001|Pre Treatment for Part B|Physician Decision|0|||
25229765|NCT02539225|50540937|FG000|Part B|Adverse Event|4|||
25229766|NCT02539225|50540938|FG001|Part B|Adverse Event|4|||
25229767|NCT02539225|50540937|FG000|Part B|Withdrawal by Subject|0|||
25229768|NCT02539225|50540938|FG001|Part B|Withdrawal by Subject|3|||
25229769|NCT02539225|50540937|FG000|Part B|Physician Decision|0|||
25229770|NCT02539225|50540938|FG001|Part B|Physician Decision|9|||
25229771|NCT02526017|50540958|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
25229772|NCT02526017|50540959|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
25229773|NCT02526017|50540960|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
25229774|NCT02526017|50540961|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
25229775|NCT02526017|50540962|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
25229776|NCT02526017|50540963|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
25229777|NCT02526017|50540964|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
25229778|NCT02526017|50540965|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
25229779|NCT02526017|50540966|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
25229780|NCT02369653|50541035|FG000|Overall Study|Lost to Follow-up|0|||
25229781|NCT02369653|50541036|FG001|Overall Study|Lost to Follow-up|1|||
25229782|NCT02369653|50541035|FG000|Overall Study|Administrative reason by sponsor|0|||
25229783|NCT02369653|50541036|FG001|Overall Study|Administrative reason by sponsor|1|||
25229784|NCT02369653|50541035|FG000|Overall Study|Death|1|||
25229785|NCT02369653|50541036|FG001|Overall Study|Death|2|||
25229786|NCT02369653|50541035|FG000|Overall Study|Participant withdrew consent|13|||
25229787|NCT02369653|50541036|FG001|Overall Study|Participant withdrew consent|3|||
25229788|NCT02284568|50541049|FG000|Overall Study|Adverse Event|2|||
25229789|NCT02284568|50541050|FG001|Overall Study|Adverse Event|9|||
25229790|NCT02284568|50541051|FG002|Overall Study|Adverse Event|4|||
25229791|NCT02284568|50541049|FG000|Overall Study|Withdrawal by Subject|22|||
25229792|NCT02284568|50541050|FG001|Overall Study|Withdrawal by Subject|21|||
25229793|NCT02284568|50541051|FG002|Overall Study|Withdrawal by Subject|1|||
25229794|NCT02284568|50541049|FG000|Overall Study|Noncompliance with study drug admin|1|||
25229795|NCT02284568|50541050|FG001|Overall Study|Noncompliance with study drug admin|2|||
25229796|NCT02284568|50541051|FG002|Overall Study|Noncompliance with study drug admin|0|||
25229797|NCT02284568|50541049|FG000|Overall Study|Noncompliance|1|||
25229798|NCT02284568|50541050|FG001|Overall Study|Noncompliance|0|||
25229799|NCT02284568|50541051|FG002|Overall Study|Noncompliance|0|||
25229800|NCT02284568|50541049|FG000|Overall Study|Protocol Violation|0|||
25229801|NCT02284568|50541050|FG001|Overall Study|Protocol Violation|1|||
25229802|NCT02284568|50541051|FG002|Overall Study|Protocol Violation|0|||
25229803|NCT02284568|50541049|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
25229804|NCT02284568|50541050|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
25229805|NCT02284568|50541051|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
25229806|NCT02284568|50541049|FG000|Overall Study|Lost to Follow-up|0|||
25229807|NCT02284568|50541050|FG001|Overall Study|Lost to Follow-up|3|||
25229808|NCT02284568|50541051|FG002|Overall Study|Lost to Follow-up|0|||
25229809|NCT02284568|50541049|FG000|Overall Study|Lack of Efficacy|4|||
25229810|NCT02284568|50541050|FG001|Overall Study|Lack of Efficacy|7|||
25229811|NCT02284568|50541051|FG002|Overall Study|Lack of Efficacy|0|||
25319124|NCT00945191|50634519|FG000|Overall Study|Serious adverse event or adverse event|1|||
25229812|NCT02284568|50541049|FG000|Overall Study|Other|1|||
25229813|NCT02284568|50541050|FG001|Overall Study|Other|2|||
25229814|NCT02284568|50541051|FG002|Overall Study|Other|0|||
25229815|NCT02284568|50541049|FG000|Overall Study|Withdrew before taking study drug|0|||
25229816|NCT02284568|50541050|FG001|Overall Study|Withdrew before taking study drug|1|||
25229817|NCT02284568|50541051|FG002|Overall Study|Withdrew before taking study drug|0|||
25229818|NCT02195986|50541066|FG000|Overall Study|Adverse Event|3|||
25229819|NCT02195986|50541067|FG001|Overall Study|Adverse Event|0|||
25229820|NCT02195986|50541068|FG002|Overall Study|Adverse Event|0|||
25229821|NCT02195986|50541066|FG000|Overall Study|Withdrawal by Subject|0|||
25229822|NCT02195986|50541067|FG001|Overall Study|Withdrawal by Subject|3|||
25229823|NCT02195986|50541068|FG002|Overall Study|Withdrawal by Subject|0|||
25229824|NCT02195986|50541066|FG000|Overall Study|Family Emergency|0|||
25229825|NCT02195986|50541067|FG001|Overall Study|Family Emergency|0|||
25229826|NCT02195986|50541068|FG002|Overall Study|Family Emergency|1|||
25229827|NCT02195986|50541066|FG000|Overall Study|Protocol Violation|0|||
25229828|NCT02195986|50541067|FG001|Overall Study|Protocol Violation|1|||
25229829|NCT02195986|50541068|FG002|Overall Study|Protocol Violation|1|||
25229830|NCT02195986|50541066|FG000|Overall Study|Non-compliance|0|||
25229831|NCT02195986|50541067|FG001|Overall Study|Non-compliance|1|||
25229832|NCT02195986|50541068|FG002|Overall Study|Non-compliance|0|||
25229833|NCT01982630|50541084|FG000|Overall Study|Adverse Event|2|||
25229834|NCT01982630|50541085|FG001|Overall Study|Adverse Event|0|||
25229835|NCT01982630|50541086|FG002|Overall Study|Adverse Event|1|||
25229836|NCT01982630|50541087|FG003|Overall Study|Adverse Event|0|||
25229837|NCT01982630|50541088|FG004|Overall Study|Adverse Event|1|||
25229838|NCT01982630|50541089|FG005|Overall Study|Adverse Event|2|||
25229839|NCT01982630|50541090|FG006|Overall Study|Adverse Event|1|||
25229840|NCT01982630|50541091|FG007|Overall Study|Adverse Event|0|||
25229841|NCT01982630|50541084|FG000|Overall Study|Physician Decision|1|||
25229842|NCT01982630|50541085|FG001|Overall Study|Physician Decision|0|||
25229843|NCT01982630|50541086|FG002|Overall Study|Physician Decision|2|||
25229844|NCT01982630|50541087|FG003|Overall Study|Physician Decision|1|||
25229845|NCT01982630|50541088|FG004|Overall Study|Physician Decision|2|||
25229846|NCT01982630|50541089|FG005|Overall Study|Physician Decision|0|||
25229847|NCT01982630|50541090|FG006|Overall Study|Physician Decision|0|||
25229848|NCT01982630|50541091|FG007|Overall Study|Physician Decision|0|||
25229849|NCT01982630|50541084|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
25229850|NCT01982630|50541085|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
25229851|NCT01982630|50541086|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
25229852|NCT01982630|50541087|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
25229853|NCT01982630|50541088|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
25229854|NCT01982630|50541089|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
25229855|NCT01982630|50541090|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
25229856|NCT01982630|50541091|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
25229857|NCT01982630|50541084|FG000|Overall Study|Withdrawal by Subject|0|||
25229858|NCT01982630|50541085|FG001|Overall Study|Withdrawal by Subject|0|||
25229859|NCT01982630|50541086|FG002|Overall Study|Withdrawal by Subject|0|||
25229860|NCT01982630|50541087|FG003|Overall Study|Withdrawal by Subject|0|||
25229861|NCT01982630|50541088|FG004|Overall Study|Withdrawal by Subject|0|||
25229862|NCT01982630|50541089|FG005|Overall Study|Withdrawal by Subject|1|||
25229863|NCT01982630|50541090|FG006|Overall Study|Withdrawal by Subject|0|||
25229864|NCT01982630|50541091|FG007|Overall Study|Withdrawal by Subject|0|||
25229865|NCT01740297|50541156|FG000|Overall Study|Withdrawal by Subject|4|||
25229866|NCT01740297|50541157|FG001|Overall Study|Withdrawal by Subject|16|||
25229867|NCT01740297|50541158|FG002|Overall Study|Withdrawal by Subject|17|||
25229868|NCT01740297|50541156|FG000|Overall Study|Death|8|||
25229869|NCT01740297|50541157|FG001|Overall Study|Death|46|||
25229870|NCT01740297|50541158|FG002|Overall Study|Death|40|||
25229871|NCT01740297|50541156|FG000|Overall Study|Lost to Follow-up|1|||
25229872|NCT01740297|50541157|FG001|Overall Study|Lost to Follow-up|2|||
25229873|NCT01740297|50541158|FG002|Overall Study|Lost to Follow-up|4|||
25229874|NCT01729754|50541172|FG000|Part 1|Adverse Event|2|||
25229875|NCT01729754|50541173|FG001|Part 1|Adverse Event|0|||
25229876|NCT01729754|50541174|FG002|Part 1|Adverse Event|0|||
25229877|NCT01729754|50541175|FG003|Part 1|Adverse Event|1|||
25229878|NCT01729754|50541176|FG004|Part 1|Adverse Event|0|||
25229879|NCT01729754|50541177|FG005|Part 1|Adverse Event|0|||
25229880|NCT01729754|50541178|FG006|Part 1|Adverse Event|2|||
25319125|NCT00945191|50634519|FG000|Overall Study|Investigator's discretion|1|||
25319126|NCT00606931|50634523|FG000|Overall Study|Withdrawal by Subject|3|||
24976620|NCT03436732|50065540|FG001|Overall Study|Death|1|||
25229881|NCT01729754|50541179|FG007|Part 1|Adverse Event|0|||
25229882|NCT01729754|50541180|FG008|Part 1|Adverse Event|0|||
25229883|NCT01729754|50541181|FG009|Part 1|Adverse Event|5|||
25229884|NCT01729754|50541172|FG000|Part 1|Lack of Efficacy|1|||
25229885|NCT01729754|50541173|FG001|Part 1|Lack of Efficacy|0|||
25229886|NCT01729754|50541174|FG002|Part 1|Lack of Efficacy|0|||
25229887|NCT01729754|50541175|FG003|Part 1|Lack of Efficacy|0|||
25229888|NCT01729754|50541176|FG004|Part 1|Lack of Efficacy|0|||
25229889|NCT01729754|50541177|FG005|Part 1|Lack of Efficacy|0|||
24976621|NCT03436420|50065547|FG000|Overall Study|Lack of Efficacy|3|||
25229890|NCT01729754|50541178|FG006|Part 1|Lack of Efficacy|2|||
25229891|NCT01729754|50541179|FG007|Part 1|Lack of Efficacy|0|||
25229892|NCT01729754|50541180|FG008|Part 1|Lack of Efficacy|0|||
25229893|NCT01729754|50541181|FG009|Part 1|Lack of Efficacy|0|||
25229894|NCT01729754|50541172|FG000|Part 1|Lost to Follow-up|1|||
25229895|NCT01729754|50541173|FG001|Part 1|Lost to Follow-up|0|||
25229896|NCT01729754|50541174|FG002|Part 1|Lost to Follow-up|0|||
25229897|NCT01729754|50541175|FG003|Part 1|Lost to Follow-up|2|||
25229898|NCT01729754|50541176|FG004|Part 1|Lost to Follow-up|0|||
25229899|NCT01729754|50541177|FG005|Part 1|Lost to Follow-up|0|||
25229900|NCT01729754|50541178|FG006|Part 1|Lost to Follow-up|3|||
25229901|NCT01729754|50541179|FG007|Part 1|Lost to Follow-up|0|||
25229902|NCT01729754|50541180|FG008|Part 1|Lost to Follow-up|0|||
25229903|NCT01729754|50541181|FG009|Part 1|Lost to Follow-up|3|||
25229904|NCT01729754|50541172|FG000|Part 1|Non-compliance with Study Drug|1|||
25229905|NCT01729754|50541173|FG001|Part 1|Non-compliance with Study Drug|0|||
25229906|NCT01729754|50541174|FG002|Part 1|Non-compliance with Study Drug|0|||
25229907|NCT01729754|50541175|FG003|Part 1|Non-compliance with Study Drug|0|||
25229908|NCT01729754|50541176|FG004|Part 1|Non-compliance with Study Drug|0|||
25229909|NCT01729754|50541177|FG005|Part 1|Non-compliance with Study Drug|0|||
25229910|NCT01729754|50541178|FG006|Part 1|Non-compliance with Study Drug|0|||
25229911|NCT01729754|50541179|FG007|Part 1|Non-compliance with Study Drug|0|||
25229912|NCT01729754|50541180|FG008|Part 1|Non-compliance with Study Drug|0|||
25229913|NCT01729754|50541181|FG009|Part 1|Non-compliance with Study Drug|0|||
25229914|NCT01729754|50541172|FG000|Part 1|Physician Decision|0|||
25229915|NCT01729754|50541173|FG001|Part 1|Physician Decision|0|||
25229916|NCT01729754|50541174|FG002|Part 1|Physician Decision|0|||
25229917|NCT01729754|50541175|FG003|Part 1|Physician Decision|0|||
25229918|NCT01729754|50541176|FG004|Part 1|Physician Decision|0|||
25229919|NCT01729754|50541177|FG005|Part 1|Physician Decision|0|||
25229920|NCT01729754|50541178|FG006|Part 1|Physician Decision|0|||
25229921|NCT01729754|50541179|FG007|Part 1|Physician Decision|0|||
25229922|NCT01729754|50541180|FG008|Part 1|Physician Decision|0|||
25229923|NCT01729754|50541181|FG009|Part 1|Physician Decision|4|||
25229924|NCT01729754|50541172|FG000|Part 1|Pregnancy|0|||
25229925|NCT01729754|50541173|FG001|Part 1|Pregnancy|0|||
25229926|NCT01729754|50541174|FG002|Part 1|Pregnancy|0|||
25229927|NCT01729754|50541175|FG003|Part 1|Pregnancy|1|||
25229928|NCT01729754|50541176|FG004|Part 1|Pregnancy|0|||
25229929|NCT01729754|50541177|FG005|Part 1|Pregnancy|0|||
25229930|NCT01729754|50541178|FG006|Part 1|Pregnancy|0|||
25229931|NCT01729754|50541179|FG007|Part 1|Pregnancy|0|||
25229932|NCT01729754|50541180|FG008|Part 1|Pregnancy|0|||
25229933|NCT01729754|50541181|FG009|Part 1|Pregnancy|1|||
25229934|NCT01729754|50541172|FG000|Part 1|Progressive Disease|0|||
25229935|NCT01729754|50541173|FG001|Part 1|Progressive Disease|0|||
25229936|NCT01729754|50541174|FG002|Part 1|Progressive Disease|0|||
25229937|NCT01729754|50541175|FG003|Part 1|Progressive Disease|0|||
25229938|NCT01729754|50541176|FG004|Part 1|Progressive Disease|0|||
25229939|NCT01729754|50541177|FG005|Part 1|Progressive Disease|0|||
25229940|NCT01729754|50541178|FG006|Part 1|Progressive Disease|0|||
25229941|NCT01729754|50541179|FG007|Part 1|Progressive Disease|0|||
25229942|NCT01729754|50541180|FG008|Part 1|Progressive Disease|0|||
25229943|NCT01729754|50541181|FG009|Part 1|Progressive Disease|1|||
25229944|NCT01729754|50541172|FG000|Part 1|Protocol Violation|2|||
25229945|NCT01729754|50541173|FG001|Part 1|Protocol Violation|0|||
25229946|NCT01729754|50541174|FG002|Part 1|Protocol Violation|0|||
25229947|NCT01729754|50541175|FG003|Part 1|Protocol Violation|1|||
25229948|NCT01729754|50541176|FG004|Part 1|Protocol Violation|0|||
25229949|NCT01729754|50541177|FG005|Part 1|Protocol Violation|0|||
25229950|NCT01729754|50541178|FG006|Part 1|Protocol Violation|1|||
25229951|NCT01729754|50541179|FG007|Part 1|Protocol Violation|0|||
25229952|NCT01729754|50541180|FG008|Part 1|Protocol Violation|0|||
25229953|NCT01729754|50541181|FG009|Part 1|Protocol Violation|0|||
24976622|NCT00027560|50065551|FG000|Overall Study|Withdrawal by Subject|1|||
24976623|NCT03451084|50065561|FG000|Overall Study|Withdrawal by Subject|2|||
24976624|NCT03451084|50065562|FG001|Overall Study|Withdrawal by Subject|1|||
25229954|NCT01729754|50541172|FG000|Part 1|Withdrawal by Subject|5|||
25229955|NCT01729754|50541173|FG001|Part 1|Withdrawal by Subject|0|||
25229956|NCT01729754|50541174|FG002|Part 1|Withdrawal by Subject|0|||
25229957|NCT01729754|50541175|FG003|Part 1|Withdrawal by Subject|7|||
25229958|NCT01729754|50541176|FG004|Part 1|Withdrawal by Subject|0|||
25229959|NCT01729754|50541177|FG005|Part 1|Withdrawal by Subject|0|||
25229960|NCT01729754|50541178|FG006|Part 1|Withdrawal by Subject|5|||
25229961|NCT01729754|50541179|FG007|Part 1|Withdrawal by Subject|0|||
25229962|NCT01729754|50541180|FG008|Part 1|Withdrawal by Subject|0|||
25229963|NCT01729754|50541181|FG009|Part 1|Withdrawal by Subject|6|||
25229964|NCT01729754|50541172|FG000|Part 1|Other Protocol Specified Criteria|2|||
25229965|NCT01729754|50541173|FG001|Part 1|Other Protocol Specified Criteria|0|||
25229966|NCT01729754|50541174|FG002|Part 1|Other Protocol Specified Criteria|0|||
24976625|NCT03451084|50065563|FG002|Overall Study|Withdrawal by Subject|2|||
25229967|NCT01729754|50541175|FG003|Part 1|Other Protocol Specified Criteria|0|||
25229968|NCT01729754|50541176|FG004|Part 1|Other Protocol Specified Criteria|0|||
25229969|NCT01729754|50541177|FG005|Part 1|Other Protocol Specified Criteria|0|||
25229970|NCT01729754|50541178|FG006|Part 1|Other Protocol Specified Criteria|1|||
25229971|NCT01729754|50541179|FG007|Part 1|Other Protocol Specified Criteria|0|||
25229972|NCT01729754|50541180|FG008|Part 1|Other Protocol Specified Criteria|0|||
25229973|NCT01729754|50541181|FG009|Part 1|Other Protocol Specified Criteria|4|||
25229974|NCT01729754|50541172|FG000|Part 2|Adverse Event|2|||
25229975|NCT01729754|50541173|FG001|Part 2|Adverse Event|0|||
25229976|NCT01729754|50541174|FG002|Part 2|Adverse Event|0|||
25229977|NCT01729754|50541175|FG003|Part 2|Adverse Event|0|||
25229978|NCT01729754|50541176|FG004|Part 2|Adverse Event|0|||
25229979|NCT01729754|50541177|FG005|Part 2|Adverse Event|0|||
25229980|NCT01729754|50541178|FG006|Part 2|Adverse Event|0|||
25229981|NCT01729754|50541179|FG007|Part 2|Adverse Event|0|||
25229982|NCT01729754|50541180|FG008|Part 2|Adverse Event|1|||
25229983|NCT01729754|50541181|FG009|Part 2|Adverse Event|2|||
25229984|NCT01729754|50541172|FG000|Part 2|Lack of Efficacy|0|||
25229985|NCT01729754|50541173|FG001|Part 2|Lack of Efficacy|0|||
25229986|NCT01729754|50541174|FG002|Part 2|Lack of Efficacy|0|||
25229987|NCT01729754|50541175|FG003|Part 2|Lack of Efficacy|0|||
25229988|NCT01729754|50541176|FG004|Part 2|Lack of Efficacy|0|||
25229989|NCT01729754|50541177|FG005|Part 2|Lack of Efficacy|0|||
25229990|NCT01729754|50541178|FG006|Part 2|Lack of Efficacy|0|||
25229991|NCT01729754|50541179|FG007|Part 2|Lack of Efficacy|0|||
25229992|NCT01729754|50541180|FG008|Part 2|Lack of Efficacy|2|||
25229993|NCT01729754|50541181|FG009|Part 2|Lack of Efficacy|2|||
25229994|NCT01729754|50541172|FG000|Part 2|Lost to Follow-up|0|||
25229995|NCT01729754|50541173|FG001|Part 2|Lost to Follow-up|0|||
25229996|NCT01729754|50541174|FG002|Part 2|Lost to Follow-up|0|||
25229997|NCT01729754|50541175|FG003|Part 2|Lost to Follow-up|2|||
25229998|NCT01729754|50541176|FG004|Part 2|Lost to Follow-up|0|||
25229999|NCT01729754|50541177|FG005|Part 2|Lost to Follow-up|0|||
25230000|NCT01729754|50541178|FG006|Part 2|Lost to Follow-up|0|||
25230001|NCT01729754|50541179|FG007|Part 2|Lost to Follow-up|1|||
25230002|NCT01729754|50541180|FG008|Part 2|Lost to Follow-up|0|||
25230003|NCT01729754|50541181|FG009|Part 2|Lost to Follow-up|2|||
25230004|NCT01729754|50541172|FG000|Part 2|Non-Compliance with Study Drug|0|||
25230005|NCT01729754|50541173|FG001|Part 2|Non-Compliance with Study Drug|0|||
25230006|NCT01729754|50541174|FG002|Part 2|Non-Compliance with Study Drug|0|||
25230007|NCT01729754|50541175|FG003|Part 2|Non-Compliance with Study Drug|0|||
25230008|NCT01729754|50541176|FG004|Part 2|Non-Compliance with Study Drug|0|||
25230009|NCT01729754|50541177|FG005|Part 2|Non-Compliance with Study Drug|0|||
25230010|NCT01729754|50541178|FG006|Part 2|Non-Compliance with Study Drug|0|||
25230011|NCT01729754|50541179|FG007|Part 2|Non-Compliance with Study Drug|0|||
25230012|NCT01729754|50541180|FG008|Part 2|Non-Compliance with Study Drug|0|||
25230013|NCT01729754|50541181|FG009|Part 2|Non-Compliance with Study Drug|1|||
25230014|NCT01729754|50541172|FG000|Part 2|Pregnancy|0|||
25230015|NCT01729754|50541173|FG001|Part 2|Pregnancy|0|||
25230016|NCT01729754|50541174|FG002|Part 2|Pregnancy|0|||
25230017|NCT01729754|50541175|FG003|Part 2|Pregnancy|1|||
25230018|NCT01729754|50541176|FG004|Part 2|Pregnancy|0|||
25230019|NCT01729754|50541177|FG005|Part 2|Pregnancy|0|||
25230020|NCT01729754|50541178|FG006|Part 2|Pregnancy|0|||
25230021|NCT01729754|50541179|FG007|Part 2|Pregnancy|0|||
25230022|NCT01729754|50541180|FG008|Part 2|Pregnancy|0|||
25230023|NCT01729754|50541181|FG009|Part 2|Pregnancy|1|||
25230024|NCT01729754|50541172|FG000|Part 2|Withdrawal by Subject|3|||
25230025|NCT01729754|50541173|FG001|Part 2|Withdrawal by Subject|0|||
25230026|NCT01729754|50541174|FG002|Part 2|Withdrawal by Subject|0|||
25230027|NCT01729754|50541175|FG003|Part 2|Withdrawal by Subject|2|||
25230028|NCT01729754|50541176|FG004|Part 2|Withdrawal by Subject|0|||
25230029|NCT01729754|50541177|FG005|Part 2|Withdrawal by Subject|0|||
25230030|NCT01729754|50541178|FG006|Part 2|Withdrawal by Subject|0|||
25230031|NCT01729754|50541179|FG007|Part 2|Withdrawal by Subject|1|||
25230032|NCT01729754|50541180|FG008|Part 2|Withdrawal by Subject|1|||
25230033|NCT01729754|50541181|FG009|Part 2|Withdrawal by Subject|4|||
25230034|NCT01729754|50541172|FG000|Part 2|Other Protocol Specified Criteria|1|||
25230035|NCT01729754|50541173|FG001|Part 2|Other Protocol Specified Criteria|0|||
25230036|NCT01729754|50541174|FG002|Part 2|Other Protocol Specified Criteria|0|||
25230037|NCT01729754|50541175|FG003|Part 2|Other Protocol Specified Criteria|0|||
25230038|NCT01729754|50541176|FG004|Part 2|Other Protocol Specified Criteria|0|||
25230039|NCT01729754|50541177|FG005|Part 2|Other Protocol Specified Criteria|0|||
25230040|NCT01729754|50541178|FG006|Part 2|Other Protocol Specified Criteria|0|||
25230041|NCT01729754|50541179|FG007|Part 2|Other Protocol Specified Criteria|1|||
25230042|NCT01729754|50541180|FG008|Part 2|Other Protocol Specified Criteria|0|||
25230043|NCT01729754|50541181|FG009|Part 2|Other Protocol Specified Criteria|0|||
25230044|NCT01729754|50541172|FG000|Part 3|Adverse Event|0|||
25230045|NCT01729754|50541173|FG001|Part 3|Adverse Event|0|||
25230046|NCT01729754|50541174|FG002|Part 3|Adverse Event|1|||
25230047|NCT01729754|50541175|FG003|Part 3|Adverse Event|0|||
25230048|NCT01729754|50541176|FG004|Part 3|Adverse Event|0|||
25230049|NCT01729754|50541177|FG005|Part 3|Adverse Event|5|||
25230050|NCT01729754|50541178|FG006|Part 3|Adverse Event|0|||
25230051|NCT01729754|50541179|FG007|Part 3|Adverse Event|0|||
25230052|NCT01729754|50541180|FG008|Part 3|Adverse Event|0|||
25230053|NCT01729754|50541181|FG009|Part 3|Adverse Event|3|||
25230054|NCT01729754|50541172|FG000|Part 3|Death|0|||
25230055|NCT01729754|50541173|FG001|Part 3|Death|0|||
25230056|NCT01729754|50541174|FG002|Part 3|Death|0|||
25230057|NCT01729754|50541175|FG003|Part 3|Death|0|||
25230058|NCT01729754|50541176|FG004|Part 3|Death|0|||
25230059|NCT01729754|50541177|FG005|Part 3|Death|2|||
25230060|NCT01729754|50541178|FG006|Part 3|Death|0|||
25230061|NCT01729754|50541179|FG007|Part 3|Death|0|||
25230062|NCT01729754|50541180|FG008|Part 3|Death|0|||
25230063|NCT01729754|50541181|FG009|Part 3|Death|0|||
25230064|NCT01729754|50541172|FG000|Part 3|Lack of Efficacy|0|||
25230065|NCT01729754|50541173|FG001|Part 3|Lack of Efficacy|0|||
25230066|NCT01729754|50541174|FG002|Part 3|Lack of Efficacy|0|||
25230067|NCT01729754|50541175|FG003|Part 3|Lack of Efficacy|0|||
25230068|NCT01729754|50541176|FG004|Part 3|Lack of Efficacy|2|||
25230069|NCT01729754|50541177|FG005|Part 3|Lack of Efficacy|0|||
25230070|NCT01729754|50541178|FG006|Part 3|Lack of Efficacy|0|||
25230071|NCT01729754|50541179|FG007|Part 3|Lack of Efficacy|0|||
25230072|NCT01729754|50541180|FG008|Part 3|Lack of Efficacy|0|||
25230073|NCT01729754|50541181|FG009|Part 3|Lack of Efficacy|4|||
25230074|NCT01729754|50541172|FG000|Part 3|Lost to Follow-up|0|||
25230075|NCT01729754|50541173|FG001|Part 3|Lost to Follow-up|1|||
25230076|NCT01729754|50541174|FG002|Part 3|Lost to Follow-up|2|||
25230077|NCT01729754|50541175|FG003|Part 3|Lost to Follow-up|0|||
25230078|NCT01729754|50541176|FG004|Part 3|Lost to Follow-up|0|||
25230079|NCT01729754|50541177|FG005|Part 3|Lost to Follow-up|3|||
25230080|NCT01729754|50541178|FG006|Part 3|Lost to Follow-up|0|||
25230081|NCT01729754|50541179|FG007|Part 3|Lost to Follow-up|0|||
25230082|NCT01729754|50541180|FG008|Part 3|Lost to Follow-up|1|||
25230083|NCT01729754|50541181|FG009|Part 3|Lost to Follow-up|0|||
25230084|NCT01729754|50541172|FG000|Part 3|Physician Decision|0|||
25230085|NCT01729754|50541173|FG001|Part 3|Physician Decision|0|||
25230086|NCT01729754|50541174|FG002|Part 3|Physician Decision|1|||
25230087|NCT01729754|50541175|FG003|Part 3|Physician Decision|0|||
25230088|NCT01729754|50541176|FG004|Part 3|Physician Decision|0|||
25230089|NCT01729754|50541177|FG005|Part 3|Physician Decision|0|||
25230090|NCT01729754|50541178|FG006|Part 3|Physician Decision|0|||
25230091|NCT01729754|50541179|FG007|Part 3|Physician Decision|0|||
25230092|NCT01729754|50541180|FG008|Part 3|Physician Decision|0|||
25230093|NCT01729754|50541181|FG009|Part 3|Physician Decision|0|||
25230094|NCT01729754|50541172|FG000|Part 3|Withdrawal by Subject|0|||
25230095|NCT01729754|50541173|FG001|Part 3|Withdrawal by Subject|4|||
25230096|NCT01729754|50541174|FG002|Part 3|Withdrawal by Subject|1|||
25230097|NCT01729754|50541175|FG003|Part 3|Withdrawal by Subject|0|||
25230098|NCT01729754|50541176|FG004|Part 3|Withdrawal by Subject|2|||
25230099|NCT01729754|50541177|FG005|Part 3|Withdrawal by Subject|1|||
25230100|NCT01729754|50541178|FG006|Part 3|Withdrawal by Subject|0|||
25230101|NCT01729754|50541179|FG007|Part 3|Withdrawal by Subject|2|||
25230102|NCT01729754|50541180|FG008|Part 3|Withdrawal by Subject|0|||
25230103|NCT01729754|50541181|FG009|Part 3|Withdrawal by Subject|0|||
25230104|NCT01729754|50541172|FG000|Part 3|Other Protocol Specified Criteria|0|||
25230105|NCT01729754|50541173|FG001|Part 3|Other Protocol Specified Criteria|0|||
25230106|NCT01729754|50541174|FG002|Part 3|Other Protocol Specified Criteria|0|||
25230107|NCT01729754|50541175|FG003|Part 3|Other Protocol Specified Criteria|0|||
25230108|NCT01729754|50541176|FG004|Part 3|Other Protocol Specified Criteria|0|||
25230109|NCT01729754|50541177|FG005|Part 3|Other Protocol Specified Criteria|2|||
25230110|NCT01729754|50541178|FG006|Part 3|Other Protocol Specified Criteria|0|||
25230111|NCT01729754|50541179|FG007|Part 3|Other Protocol Specified Criteria|1|||
25230112|NCT01729754|50541180|FG008|Part 3|Other Protocol Specified Criteria|0|||
25230113|NCT01729754|50541181|FG009|Part 3|Other Protocol Specified Criteria|0|||
25230114|NCT01515306|50541226|FG000|Overall Study|Adverse Event|3|||
25230115|NCT01515306|50541227|FG001|Overall Study|Adverse Event|2|||
25230116|NCT01515306|50541226|FG000|Overall Study|Progressive Disease|19|||
25230117|NCT01515306|50541227|FG001|Overall Study|Progressive Disease|9|||
25230118|NCT01515306|50541226|FG000|Overall Study|Withdrawal by Subject|1|||
25230119|NCT01515306|50541227|FG001|Overall Study|Withdrawal by Subject|2|||
25230120|NCT01515306|50541226|FG000|Overall Study|Physician Decision|1|||
25230121|NCT01515306|50541227|FG001|Overall Study|Physician Decision|1|||
25230122|NCT01423851|50541248|FG000|Whole Study|Disease progression|2|||
25230123|NCT01423851|50541249|FG001|Whole Study|Disease progression|1|||
25230124|NCT01423851|50541250|FG002|Whole Study|Disease progression|1|||
25230125|NCT01423851|50541251|FG003|Whole Study|Disease progression|4|||
25230126|NCT01423851|50541252|FG004|Whole Study|Disease progression|1|||
25230127|NCT01423851|50541253|FG005|Whole Study|Disease progression|3|||
25230128|NCT01423851|50541254|FG006|Whole Study|Disease progression|1|||
25230129|NCT01423851|50541255|FG007|Whole Study|Disease progression|4|||
25230130|NCT01423851|50541256|FG008|Whole Study|Disease progression|0|||
25230131|NCT01423851|50541257|FG009|Whole Study|Disease progression|2|||
25230132|NCT01423851|50541258|FG010|Whole Study|Disease progression|10|||
25230133|NCT01423851|50541248|FG000|Whole Study|Physician Decision|0|||
25230134|NCT01423851|50541249|FG001|Whole Study|Physician Decision|1|||
25230135|NCT01423851|50541250|FG002|Whole Study|Physician Decision|2|||
25230136|NCT01423851|50541251|FG003|Whole Study|Physician Decision|0|||
25230137|NCT01423851|50541252|FG004|Whole Study|Physician Decision|2|||
25230138|NCT01423851|50541253|FG005|Whole Study|Physician Decision|0|||
25230139|NCT01423851|50541254|FG006|Whole Study|Physician Decision|2|||
25230140|NCT01423851|50541255|FG007|Whole Study|Physician Decision|1|||
25230141|NCT01423851|50541256|FG008|Whole Study|Physician Decision|3|||
25230142|NCT01423851|50541257|FG009|Whole Study|Physician Decision|4|||
25230143|NCT01423851|50541258|FG010|Whole Study|Physician Decision|12|||
25230144|NCT01423851|50541248|FG000|Whole Study|Withdrawal by Subject|1|||
25230145|NCT01423851|50541249|FG001|Whole Study|Withdrawal by Subject|1|||
25230146|NCT01423851|50541250|FG002|Whole Study|Withdrawal by Subject|0|||
25230147|NCT01423851|50541251|FG003|Whole Study|Withdrawal by Subject|0|||
25230148|NCT01423851|50541252|FG004|Whole Study|Withdrawal by Subject|0|||
25230149|NCT01423851|50541253|FG005|Whole Study|Withdrawal by Subject|0|||
25230150|NCT01423851|50541254|FG006|Whole Study|Withdrawal by Subject|0|||
25230151|NCT01423851|50541255|FG007|Whole Study|Withdrawal by Subject|0|||
25230152|NCT01423851|50541256|FG008|Whole Study|Withdrawal by Subject|2|||
25230153|NCT01423851|50541257|FG009|Whole Study|Withdrawal by Subject|0|||
25230154|NCT01423851|50541258|FG010|Whole Study|Withdrawal by Subject|4|||
25230155|NCT01423851|50541248|FG000|Whole Study|Adverse Event|0|||
25230156|NCT01423851|50541249|FG001|Whole Study|Adverse Event|0|||
25230157|NCT01423851|50541250|FG002|Whole Study|Adverse Event|0|||
25230158|NCT01423851|50541251|FG003|Whole Study|Adverse Event|2|||
25230159|NCT01423851|50541252|FG004|Whole Study|Adverse Event|0|||
25230160|NCT01423851|50541253|FG005|Whole Study|Adverse Event|0|||
25230161|NCT01423851|50541254|FG006|Whole Study|Adverse Event|0|||
25230162|NCT01423851|50541255|FG007|Whole Study|Adverse Event|3|||
25230163|NCT01423851|50541256|FG008|Whole Study|Adverse Event|3|||
25230164|NCT01423851|50541257|FG009|Whole Study|Adverse Event|2|||
25230165|NCT01423851|50541258|FG010|Whole Study|Adverse Event|3|||
25230166|NCT01334606|50541300|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
25230167|NCT01317875|50541316|FG000|Overall Study|Other|0|||
25230168|NCT01317875|50541317|FG001|Overall Study|Other|0|||
25230169|NCT01317875|50541318|FG002|Overall Study|Other|1|||
25230170|NCT01317875|50541319|FG003|Overall Study|Other|0|||
25230171|NCT01317875|50541320|FG004|Overall Study|Other|0|||
25230172|NCT01317875|50541321|FG005|Overall Study|Other|0|||
25230173|NCT01317875|50541322|FG006|Overall Study|Other|0|||
25230174|NCT01317875|50541323|FG007|Overall Study|Other|0|||
25230175|NCT01317875|50541324|FG008|Overall Study|Other|0|||
25230176|NCT01317875|50541325|FG009|Overall Study|Other|0|||
25230177|NCT01317875|50541316|FG000|Overall Study|Noncompliance with study drug|0|||
25230178|NCT01317875|50541317|FG001|Overall Study|Noncompliance with study drug|0|||
25230179|NCT01317875|50541318|FG002|Overall Study|Noncompliance with study drug|1|||
25230180|NCT01317875|50541319|FG003|Overall Study|Noncompliance with study drug|0|||
25230181|NCT01317875|50541320|FG004|Overall Study|Noncompliance with study drug|0|||
25230182|NCT01317875|50541321|FG005|Overall Study|Noncompliance with study drug|0|||
25230183|NCT01317875|50541322|FG006|Overall Study|Noncompliance with study drug|0|||
25230184|NCT01317875|50541323|FG007|Overall Study|Noncompliance with study drug|0|||
25230185|NCT01317875|50541324|FG008|Overall Study|Noncompliance with study drug|0|||
25230186|NCT01317875|50541325|FG009|Overall Study|Noncompliance with study drug|0|||
25230187|NCT01317875|50541316|FG000|Overall Study|Progressive Disease|1|||
25230188|NCT01317875|50541317|FG001|Overall Study|Progressive Disease|0|||
25230189|NCT01317875|50541318|FG002|Overall Study|Progressive Disease|2|||
25230190|NCT01317875|50541319|FG003|Overall Study|Progressive Disease|0|||
25230191|NCT01317875|50541320|FG004|Overall Study|Progressive Disease|1|||
25230192|NCT01317875|50541321|FG005|Overall Study|Progressive Disease|0|||
25230193|NCT01317875|50541322|FG006|Overall Study|Progressive Disease|0|||
25230194|NCT01317875|50541323|FG007|Overall Study|Progressive Disease|1|||
25230195|NCT01317875|50541324|FG008|Overall Study|Progressive Disease|0|||
25230196|NCT01317875|50541325|FG009|Overall Study|Progressive Disease|0|||
25230197|NCT01317875|50541316|FG000|Overall Study|Withdrawal by Subject|0|||
25230198|NCT01317875|50541317|FG001|Overall Study|Withdrawal by Subject|0|||
25230199|NCT01317875|50541318|FG002|Overall Study|Withdrawal by Subject|0|||
25230200|NCT01317875|50541319|FG003|Overall Study|Withdrawal by Subject|0|||
25230201|NCT01317875|50541320|FG004|Overall Study|Withdrawal by Subject|1|||
25230202|NCT01317875|50541321|FG005|Overall Study|Withdrawal by Subject|0|||
25230203|NCT01317875|50541322|FG006|Overall Study|Withdrawal by Subject|0|||
25230204|NCT01317875|50541323|FG007|Overall Study|Withdrawal by Subject|3|||
25230205|NCT01317875|50541324|FG008|Overall Study|Withdrawal by Subject|0|||
25230206|NCT01317875|50541325|FG009|Overall Study|Withdrawal by Subject|0|||
25230207|NCT01317875|50541316|FG000|Overall Study|Physician Decision|0|||
25230208|NCT01317875|50541317|FG001|Overall Study|Physician Decision|1|||
25230209|NCT01317875|50541318|FG002|Overall Study|Physician Decision|1|||
25230210|NCT01317875|50541319|FG003|Overall Study|Physician Decision|0|||
25230211|NCT01317875|50541320|FG004|Overall Study|Physician Decision|2|||
25230212|NCT01317875|50541321|FG005|Overall Study|Physician Decision|0|||
25230213|NCT01317875|50541322|FG006|Overall Study|Physician Decision|0|||
25230214|NCT01317875|50541323|FG007|Overall Study|Physician Decision|2|||
25230215|NCT01317875|50541324|FG008|Overall Study|Physician Decision|0|||
25230216|NCT01317875|50541325|FG009|Overall Study|Physician Decision|0|||
25230217|NCT01317875|50541316|FG000|Overall Study|Death|0|||
25230218|NCT01317875|50541317|FG001|Overall Study|Death|0|||
25230219|NCT01317875|50541318|FG002|Overall Study|Death|2|||
25230220|NCT01317875|50541319|FG003|Overall Study|Death|1|||
25230221|NCT01317875|50541320|FG004|Overall Study|Death|0|||
25230222|NCT01317875|50541321|FG005|Overall Study|Death|1|||
25230223|NCT01317875|50541322|FG006|Overall Study|Death|0|||
25230224|NCT01317875|50541323|FG007|Overall Study|Death|4|||
25230225|NCT01317875|50541324|FG008|Overall Study|Death|0|||
25230226|NCT01317875|50541325|FG009|Overall Study|Death|0|||
25230227|NCT01317875|50541316|FG000|Overall Study|Adverse Event|2|||
25230228|NCT01317875|50541317|FG001|Overall Study|Adverse Event|1|||
25230229|NCT01317875|50541318|FG002|Overall Study|Adverse Event|2|||
25230230|NCT01317875|50541319|FG003|Overall Study|Adverse Event|1|||
25230231|NCT01317875|50541320|FG004|Overall Study|Adverse Event|5|||
25230232|NCT01317875|50541321|FG005|Overall Study|Adverse Event|1|||
25230233|NCT01317875|50541322|FG006|Overall Study|Adverse Event|2|||
25230234|NCT01317875|50541323|FG007|Overall Study|Adverse Event|5|||
25230235|NCT01317875|50541324|FG008|Overall Study|Adverse Event|0|||
25230236|NCT01317875|50541325|FG009|Overall Study|Adverse Event|0|||
25230237|NCT00500071|50541401|FG000|Screening and Washout Phase|Protocol Violation|1|||
25230238|NCT00500071|50541401|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
25230239|NCT00500071|50541401|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
25230240|NCT00500071|50541401|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
25230241|NCT00500071|50541401|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
25230242|NCT00500071|50541401|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
25230243|NCT00500071|50541401|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
25230244|NCT00447122|50541409|FG000|Overall Study|worsening medical condition -came off|0|||
25230245|NCT00447122|50541410|FG001|Overall Study|worsening medical condition -came off|1|||
25230246|NCT00447122|50541411|FG002|Overall Study|worsening medical condition -came off|0|||
25230247|NCT00447122|50541412|FG003|Overall Study|worsening medical condition -came off|0|||
25230248|NCT00382252|50541422|FG000|Overall Study|Death|4|||
25230249|NCT00382252|50541422|FG000|Overall Study|Protocol Violation|8|||
25230250|NCT00382252|50541422|FG000|Overall Study|Not treated by RFA|1|||
25230251|NCT00290251|50541429|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
25230252|NCT00290251|50541430|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
25230253|NCT00290251|50541431|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
25230254|NCT00290251|50541432|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
25230255|NCT00290251|50541433|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
25230256|NCT00290251|50541434|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
25230257|NCT00290251|50541429|FG000|Treatment 1 (Months 2-4)|headache|0|||
25230258|NCT00290251|50541430|FG001|Treatment 1 (Months 2-4)|headache|0|||
25230259|NCT00290251|50541431|FG002|Treatment 1 (Months 2-4)|headache|0|||
25230260|NCT00290251|50541432|FG003|Treatment 1 (Months 2-4)|headache|0|||
25230261|NCT00290251|50541433|FG004|Treatment 1 (Months 2-4)|headache|1|||
25230262|NCT00290251|50541434|FG005|Treatment 1 (Months 2-4)|headache|0|||
25230263|NCT00290251|50541429|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
25230264|NCT00290251|50541430|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
25230265|NCT00290251|50541431|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
25230266|NCT00290251|50541432|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
25230267|NCT00290251|50541433|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
25230268|NCT00290251|50541434|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
25230269|NCT01403948|50541470|FG000|Overall Study|Progressive disease|0|||
25230270|NCT01403948|50541471|FG001|Overall Study|Progressive disease|2|||
25230271|NCT01403948|50541472|FG002|Overall Study|Progressive disease|2|||
25230272|NCT01403948|50541473|FG003|Overall Study|Progressive disease|4|||
25230273|NCT01403948|50541474|FG004|Overall Study|Progressive disease|2|||
25230274|NCT01403948|50541475|FG005|Overall Study|Progressive disease|6|||
25230275|NCT01403948|50541476|FG006|Overall Study|Progressive disease|2|||
25230276|NCT01403948|50541477|FG007|Overall Study|Progressive disease|4|||
25230277|NCT01403948|50541478|FG008|Overall Study|Progressive disease|5|||
25230278|NCT01403948|50541479|FG009|Overall Study|Progressive disease|5|||
25230279|NCT01403948|50541470|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
25230280|NCT01403948|50541471|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
25230281|NCT01403948|50541472|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
25230282|NCT01403948|50541473|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
24976626|NCT03451084|50065564|FG003|Overall Study|Withdrawal by Subject|1|||
24976627|NCT03451084|50065561|FG000|Overall Study|Disease recurrence|0|||
25230283|NCT01403948|50541474|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
25230284|NCT01403948|50541475|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
25230285|NCT01403948|50541476|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
25230286|NCT01403948|50541477|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
25230287|NCT01403948|50541478|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
25230288|NCT01403948|50541479|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
24976628|NCT03451084|50065562|FG001|Overall Study|Disease recurrence|2|||
24976629|NCT03451084|50065563|FG002|Overall Study|Disease recurrence|0|||
25230289|NCT01403948|50541470|FG000|Overall Study|Lost to Follow-up|0|||
25230290|NCT01403948|50541471|FG001|Overall Study|Lost to Follow-up|0|||
25230291|NCT01403948|50541472|FG002|Overall Study|Lost to Follow-up|0|||
25230292|NCT01403948|50541473|FG003|Overall Study|Lost to Follow-up|0|||
25230293|NCT01403948|50541474|FG004|Overall Study|Lost to Follow-up|0|||
25230294|NCT01403948|50541475|FG005|Overall Study|Lost to Follow-up|0|||
25230295|NCT01403948|50541476|FG006|Overall Study|Lost to Follow-up|0|||
25230296|NCT01403948|50541477|FG007|Overall Study|Lost to Follow-up|0|||
25230297|NCT01403948|50541478|FG008|Overall Study|Lost to Follow-up|0|||
25230298|NCT01403948|50541479|FG009|Overall Study|Lost to Follow-up|1|||
25230299|NCT01403948|50541470|FG000|Overall Study|Refused cont. medication|0|||
25230300|NCT01403948|50541471|FG001|Overall Study|Refused cont. medication|0|||
25230301|NCT01403948|50541472|FG002|Overall Study|Refused cont. medication|0|||
25230302|NCT01403948|50541473|FG003|Overall Study|Refused cont. medication|0|||
25230303|NCT01403948|50541474|FG004|Overall Study|Refused cont. medication|1|||
25230304|NCT01403948|50541475|FG005|Overall Study|Refused cont. medication|0|||
25230305|NCT01403948|50541476|FG006|Overall Study|Refused cont. medication|0|||
25230306|NCT01403948|50541477|FG007|Overall Study|Refused cont. medication|0|||
25230307|NCT01403948|50541478|FG008|Overall Study|Refused cont. medication|0|||
25230308|NCT01403948|50541479|FG009|Overall Study|Refused cont. medication|1|||
25230309|NCT01403948|50541470|FG000|Overall Study|other than above|1|||
25230310|NCT01403948|50541471|FG001|Overall Study|other than above|2|||
25230311|NCT01403948|50541472|FG002|Overall Study|other than above|1|||
25230312|NCT01403948|50541473|FG003|Overall Study|other than above|0|||
25230313|NCT01403948|50541474|FG004|Overall Study|other than above|1|||
25230314|NCT01403948|50541475|FG005|Overall Study|other than above|1|||
25230315|NCT01403948|50541476|FG006|Overall Study|other than above|2|||
25230316|NCT01403948|50541477|FG007|Overall Study|other than above|0|||
25230317|NCT01403948|50541478|FG008|Overall Study|other than above|0|||
25230318|NCT01403948|50541479|FG009|Overall Study|other than above|0|||
25230319|NCT01404312|50541507|FG000|Overall Study|Death|21|||
25230320|NCT01404312|50541508|FG001|Overall Study|Death|27|||
25230321|NCT01404312|50541507|FG000|Overall Study|Withdrawal by Subject|15|||
25230322|NCT01404312|50541508|FG001|Overall Study|Withdrawal by Subject|18|||
25230323|NCT01404312|50541507|FG000|Overall Study|Participant Unable to get to clinic|93|||
25230324|NCT01404312|50541508|FG001|Overall Study|Participant Unable to get to clinic|103|||
25230325|NCT01404312|50541507|FG000|Overall Study|Lost to Follow-up|115|||
25230326|NCT01404312|50541508|FG001|Overall Study|Lost to Follow-up|111|||
25230327|NCT01404312|50541507|FG000|Overall Study|Site closed|22|||
25230328|NCT01404312|50541508|FG001|Overall Study|Site closed|21|||
25230329|NCT01404312|50541507|FG000|Overall Study|Participant not willing to adhere to req|31|||
25230330|NCT01404312|50541508|FG001|Overall Study|Participant not willing to adhere to req|29|||
25230331|NCT01404312|50541507|FG000|Overall Study|Severe debilitation, unable to continue|1|||
25230332|NCT01404312|50541508|FG001|Overall Study|Severe debilitation, unable to continue|2|||
25230333|NCT01414608|50541517|FG000|Overall Study|Ineligible|5|||
25230334|NCT01414608|50541518|FG001|Overall Study|Ineligible|2|||
25230335|NCT01425008|50541547|FG000|Dose Escalation Phase|Progressive Disease|2|||
25230336|NCT01425008|50541548|FG001|Dose Escalation Phase|Progressive Disease|3|||
25230337|NCT01425008|50541549|FG002|Dose Escalation Phase|Progressive Disease|2|||
25230338|NCT01425008|50541550|FG003|Dose Escalation Phase|Progressive Disease|3|||
25230339|NCT01425008|50541551|FG004|Dose Escalation Phase|Progressive Disease|5|||
25230340|NCT01425008|50541552|FG005|Dose Escalation Phase|Progressive Disease|4|||
25230341|NCT01425008|50541553|FG006|Dose Escalation Phase|Progressive Disease|0|||
25230342|NCT01425008|50541554|FG007|Dose Escalation Phase|Progressive Disease|2|||
25230343|NCT01425008|50541555|FG008|Dose Escalation Phase|Progressive Disease|6|||
25230344|NCT01425008|50541556|FG009|Dose Escalation Phase|Progressive Disease|2|||
25230345|NCT01425008|50541557|FG010|Dose Escalation Phase|Progressive Disease|0|||
25230346|NCT01425008|50541558|FG011|Dose Escalation Phase|Progressive Disease|0|||
25230347|NCT01425008|50541559|FG012|Dose Escalation Phase|Progressive Disease|0|||
25230348|NCT01425008|50541560|FG013|Dose Escalation Phase|Progressive Disease|0|||
25230349|NCT01425008|50541561|FG014|Dose Escalation Phase|Progressive Disease|0|||
25230350|NCT01425008|50541562|FG015|Dose Escalation Phase|Progressive Disease|0|||
25230351|NCT01425008|50541563|FG016|Dose Escalation Phase|Progressive Disease|0|||
25230352|NCT01425008|50541564|FG017|Dose Escalation Phase|Progressive Disease|0|||
25230353|NCT01425008|50541565|FG018|Dose Escalation Phase|Progressive Disease|0|||
25230354|NCT01425008|50541547|FG000|Dose Escalation Phase|Adverse Event|2|||
25230355|NCT01425008|50541548|FG001|Dose Escalation Phase|Adverse Event|0|||
25230356|NCT01425008|50541549|FG002|Dose Escalation Phase|Adverse Event|0|||
25230357|NCT01425008|50541550|FG003|Dose Escalation Phase|Adverse Event|0|||
25230358|NCT01425008|50541551|FG004|Dose Escalation Phase|Adverse Event|0|||
25230359|NCT01425008|50541552|FG005|Dose Escalation Phase|Adverse Event|2|||
25230360|NCT01425008|50541553|FG006|Dose Escalation Phase|Adverse Event|0|||
25230361|NCT01425008|50541554|FG007|Dose Escalation Phase|Adverse Event|0|||
25230362|NCT01425008|50541555|FG008|Dose Escalation Phase|Adverse Event|2|||
25230363|NCT01425008|50541556|FG009|Dose Escalation Phase|Adverse Event|0|||
25230364|NCT01425008|50541557|FG010|Dose Escalation Phase|Adverse Event|0|||
25230365|NCT01425008|50541558|FG011|Dose Escalation Phase|Adverse Event|0|||
25230366|NCT01425008|50541559|FG012|Dose Escalation Phase|Adverse Event|0|||
25230367|NCT01425008|50541560|FG013|Dose Escalation Phase|Adverse Event|0|||
25230368|NCT01425008|50541561|FG014|Dose Escalation Phase|Adverse Event|0|||
25230369|NCT01425008|50541562|FG015|Dose Escalation Phase|Adverse Event|0|||
25230370|NCT01425008|50541563|FG016|Dose Escalation Phase|Adverse Event|0|||
25230371|NCT01425008|50541564|FG017|Dose Escalation Phase|Adverse Event|0|||
25230372|NCT01425008|50541565|FG018|Dose Escalation Phase|Adverse Event|0|||
25230373|NCT01425008|50541547|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25230374|NCT01425008|50541548|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25230375|NCT01425008|50541549|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25230376|NCT01425008|50541550|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25230377|NCT01425008|50541551|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
25230378|NCT01425008|50541552|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25230379|NCT01425008|50541553|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
25230380|NCT01425008|50541554|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
25230381|NCT01425008|50541555|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
25230382|NCT01425008|50541556|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25230383|NCT01425008|50541557|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25230384|NCT01425008|50541558|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25230385|NCT01425008|50541559|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25230386|NCT01425008|50541560|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25230387|NCT01425008|50541561|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25230388|NCT01425008|50541562|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25230389|NCT01425008|50541563|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25230390|NCT01425008|50541564|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25230391|NCT01425008|50541565|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
25230392|NCT01425008|50541547|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
25230393|NCT01425008|50541548|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
25230394|NCT01425008|50541549|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
25230395|NCT01425008|50541550|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
25230396|NCT01425008|50541551|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
25230397|NCT01425008|50541552|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
25230398|NCT01425008|50541553|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
25230399|NCT01425008|50541554|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
25230400|NCT01425008|50541555|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
25230401|NCT01425008|50541556|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
25230402|NCT01425008|50541557|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
25230403|NCT01425008|50541558|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
25230404|NCT01425008|50541559|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
25230405|NCT01425008|50541560|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
25230406|NCT01425008|50541561|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
25230407|NCT01425008|50541562|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
25230408|NCT01425008|50541563|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
25230409|NCT01425008|50541564|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
25230410|NCT01425008|50541565|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
25230411|NCT01425008|50541547|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
25230412|NCT01425008|50541548|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
25230413|NCT01425008|50541549|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
25230414|NCT01425008|50541550|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
25230415|NCT01425008|50541551|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
25230416|NCT01425008|50541552|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
25230417|NCT01425008|50541553|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
25230418|NCT01425008|50541554|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
25230419|NCT01425008|50541555|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
25230420|NCT01425008|50541556|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
25230421|NCT01425008|50541557|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
25230422|NCT01425008|50541558|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
25230423|NCT01425008|50541559|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
25230424|NCT01425008|50541560|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
25230425|NCT01425008|50541561|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
25230426|NCT01425008|50541562|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
25230427|NCT01425008|50541563|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
25230428|NCT01425008|50541564|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
25230429|NCT01425008|50541565|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
25230430|NCT01425008|50541547|FG000|Dose Escalation Phase|Other|0|||
25230431|NCT01425008|50541548|FG001|Dose Escalation Phase|Other|0|||
25230432|NCT01425008|50541549|FG002|Dose Escalation Phase|Other|0|||
25230433|NCT01425008|50541550|FG003|Dose Escalation Phase|Other|0|||
25077498|NCT00002663|50185280|FG005|Overall Study|Physician Decision|0|||
25230434|NCT01425008|50541551|FG004|Dose Escalation Phase|Other|0|||
25230435|NCT01425008|50541552|FG005|Dose Escalation Phase|Other|0|||
25230436|NCT01425008|50541553|FG006|Dose Escalation Phase|Other|0|||
25230437|NCT01425008|50541554|FG007|Dose Escalation Phase|Other|0|||
25230438|NCT01425008|50541555|FG008|Dose Escalation Phase|Other|1|||
25230439|NCT01425008|50541556|FG009|Dose Escalation Phase|Other|0|||
25230440|NCT01425008|50541557|FG010|Dose Escalation Phase|Other|0|||
25230441|NCT01425008|50541558|FG011|Dose Escalation Phase|Other|0|||
25230442|NCT01425008|50541559|FG012|Dose Escalation Phase|Other|0|||
25230443|NCT01425008|50541560|FG013|Dose Escalation Phase|Other|0|||
25230444|NCT01425008|50541561|FG014|Dose Escalation Phase|Other|0|||
25230445|NCT01425008|50541562|FG015|Dose Escalation Phase|Other|0|||
25230446|NCT01425008|50541563|FG016|Dose Escalation Phase|Other|0|||
25230447|NCT01425008|50541564|FG017|Dose Escalation Phase|Other|0|||
25230448|NCT01425008|50541565|FG018|Dose Escalation Phase|Other|0|||
25230449|NCT01425008|50541547|FG000|Dose Expansion Phase|Progressive Disease|0|||
25230450|NCT01425008|50541548|FG001|Dose Expansion Phase|Progressive Disease|0|||
25230451|NCT01425008|50541549|FG002|Dose Expansion Phase|Progressive Disease|0|||
25230452|NCT01425008|50541550|FG003|Dose Expansion Phase|Progressive Disease|0|||
25230453|NCT01425008|50541551|FG004|Dose Expansion Phase|Progressive Disease|0|||
25230454|NCT01425008|50541552|FG005|Dose Expansion Phase|Progressive Disease|0|||
25230455|NCT01425008|50541553|FG006|Dose Expansion Phase|Progressive Disease|0|||
25230456|NCT01425008|50541554|FG007|Dose Expansion Phase|Progressive Disease|0|||
25230457|NCT01425008|50541555|FG008|Dose Expansion Phase|Progressive Disease|0|||
25230458|NCT01425008|50541556|FG009|Dose Expansion Phase|Progressive Disease|0|||
25230459|NCT01425008|50541557|FG010|Dose Expansion Phase|Progressive Disease|10|||
25230460|NCT01425008|50541558|FG011|Dose Expansion Phase|Progressive Disease|4|||
25230461|NCT01425008|50541559|FG012|Dose Expansion Phase|Progressive Disease|12|||
25230462|NCT01425008|50541560|FG013|Dose Expansion Phase|Progressive Disease|1|||
25230463|NCT01425008|50541561|FG014|Dose Expansion Phase|Progressive Disease|5|||
25230464|NCT01425008|50541562|FG015|Dose Expansion Phase|Progressive Disease|8|||
25230465|NCT01425008|50541563|FG016|Dose Expansion Phase|Progressive Disease|9|||
25230466|NCT01425008|50541564|FG017|Dose Expansion Phase|Progressive Disease|2|||
25230467|NCT01425008|50541565|FG018|Dose Expansion Phase|Progressive Disease|10|||
25230468|NCT01425008|50541547|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
25230469|NCT01425008|50541548|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
25230470|NCT01425008|50541549|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
25230471|NCT01425008|50541550|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
25230472|NCT01425008|50541551|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
25230473|NCT01425008|50541552|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
25230474|NCT01425008|50541553|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
25230475|NCT01425008|50541554|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
25230476|NCT01425008|50541555|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
25230477|NCT01425008|50541556|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
25230478|NCT01425008|50541557|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
25230479|NCT01425008|50541558|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
25230480|NCT01425008|50541559|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
25230481|NCT01425008|50541560|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
25230482|NCT01425008|50541561|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
25230483|NCT01425008|50541562|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
25230484|NCT01425008|50541563|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
25230485|NCT01425008|50541564|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
25230486|NCT01425008|50541565|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
25230487|NCT01425008|50541547|FG000|Dose Expansion Phase|Other|0|||
25230488|NCT01425008|50541548|FG001|Dose Expansion Phase|Other|0|||
25230489|NCT01425008|50541549|FG002|Dose Expansion Phase|Other|0|||
25230490|NCT01425008|50541550|FG003|Dose Expansion Phase|Other|0|||
25230491|NCT01425008|50541551|FG004|Dose Expansion Phase|Other|0|||
25230492|NCT01425008|50541552|FG005|Dose Expansion Phase|Other|0|||
25230493|NCT01425008|50541553|FG006|Dose Expansion Phase|Other|0|||
25230494|NCT01425008|50541554|FG007|Dose Expansion Phase|Other|0|||
25230495|NCT01425008|50541555|FG008|Dose Expansion Phase|Other|0|||
25230496|NCT01425008|50541556|FG009|Dose Expansion Phase|Other|0|||
25230497|NCT01425008|50541557|FG010|Dose Expansion Phase|Other|0|||
25230498|NCT01425008|50541558|FG011|Dose Expansion Phase|Other|0|||
25230499|NCT01425008|50541559|FG012|Dose Expansion Phase|Other|1|||
24976630|NCT03451084|50065564|FG003|Overall Study|Disease recurrence|0|||
25230500|NCT01425008|50541560|FG013|Dose Expansion Phase|Other|0|||
25230501|NCT01425008|50541561|FG014|Dose Expansion Phase|Other|0|||
24976631|NCT03451084|50065561|FG000|Overall Study|Lack of Efficacy|0|||
25230502|NCT01425008|50541562|FG015|Dose Expansion Phase|Other|0|||
25230503|NCT01425008|50541563|FG016|Dose Expansion Phase|Other|2|||
25230504|NCT01425008|50541564|FG017|Dose Expansion Phase|Other|0|||
25230505|NCT01425008|50541565|FG018|Dose Expansion Phase|Other|4|||
25230506|NCT01425008|50541547|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
25230507|NCT01425008|50541548|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
25230508|NCT01425008|50541549|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
25230509|NCT01425008|50541550|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
25230510|NCT01425008|50541551|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
25230511|NCT01425008|50541552|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
25230512|NCT01425008|50541553|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
25230513|NCT01425008|50541554|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
25230514|NCT01425008|50541555|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
25230515|NCT01425008|50541556|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
25230516|NCT01425008|50541557|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
25230517|NCT01425008|50541558|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
25230518|NCT01425008|50541559|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
25230519|NCT01425008|50541560|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
25230520|NCT01425008|50541561|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
25230521|NCT01425008|50541562|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
25230522|NCT01425008|50541563|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
25230523|NCT01425008|50541564|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
25230524|NCT01425008|50541565|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
25230525|NCT01425008|50541547|FG000|Dose Expansion Phase|Adverse Event|0|||
25230526|NCT01425008|50541548|FG001|Dose Expansion Phase|Adverse Event|0|||
25230527|NCT01425008|50541549|FG002|Dose Expansion Phase|Adverse Event|0|||
25230528|NCT01425008|50541550|FG003|Dose Expansion Phase|Adverse Event|0|||
25230529|NCT01425008|50541551|FG004|Dose Expansion Phase|Adverse Event|0|||
25230530|NCT01425008|50541552|FG005|Dose Expansion Phase|Adverse Event|0|||
25230531|NCT01425008|50541553|FG006|Dose Expansion Phase|Adverse Event|0|||
25230532|NCT01425008|50541554|FG007|Dose Expansion Phase|Adverse Event|0|||
25230533|NCT01425008|50541555|FG008|Dose Expansion Phase|Adverse Event|0|||
25230534|NCT01425008|50541556|FG009|Dose Expansion Phase|Adverse Event|0|||
25230535|NCT01425008|50541557|FG010|Dose Expansion Phase|Adverse Event|2|||
25230536|NCT01425008|50541558|FG011|Dose Expansion Phase|Adverse Event|3|||
25230537|NCT01425008|50541559|FG012|Dose Expansion Phase|Adverse Event|3|||
25230538|NCT01425008|50541560|FG013|Dose Expansion Phase|Adverse Event|0|||
25230539|NCT01425008|50541561|FG014|Dose Expansion Phase|Adverse Event|1|||
25230540|NCT01425008|50541562|FG015|Dose Expansion Phase|Adverse Event|1|||
25230541|NCT01425008|50541563|FG016|Dose Expansion Phase|Adverse Event|5|||
25230542|NCT01425008|50541564|FG017|Dose Expansion Phase|Adverse Event|0|||
25230543|NCT01425008|50541565|FG018|Dose Expansion Phase|Adverse Event|3|||
25230544|NCT01425008|50541547|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
25230545|NCT01425008|50541548|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
25230546|NCT01425008|50541549|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
25230547|NCT01425008|50541550|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
25230548|NCT01425008|50541551|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
25230549|NCT01425008|50541552|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
25230550|NCT01425008|50541553|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
25230551|NCT01425008|50541554|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
25230552|NCT01425008|50541555|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
25230553|NCT01425008|50541556|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
25230554|NCT01425008|50541557|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
25230555|NCT01425008|50541558|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
25230556|NCT01425008|50541559|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
25230557|NCT01425008|50541560|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
25230558|NCT01425008|50541561|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
25230559|NCT01425008|50541562|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
25230560|NCT01425008|50541563|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
25230561|NCT01425008|50541564|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
25230562|NCT01425008|50541565|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
25230563|NCT01425008|50541547|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25230564|NCT01425008|50541548|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25230565|NCT01425008|50541549|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25230566|NCT01425008|50541550|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25230567|NCT01425008|50541551|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25230568|NCT01425008|50541552|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25230569|NCT01425008|50541553|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25230570|NCT01425008|50541554|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25230571|NCT01425008|50541555|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25230572|NCT01425008|50541556|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25230573|NCT01425008|50541557|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25230574|NCT01425008|50541558|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25230575|NCT01425008|50541559|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25230576|NCT01425008|50541560|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25230577|NCT01425008|50541561|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25230578|NCT01425008|50541562|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25230579|NCT01425008|50541563|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
24976632|NCT03451084|50065562|FG001|Overall Study|Lack of Efficacy|3|||
25230580|NCT01425008|50541564|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
25230581|NCT01425008|50541565|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
25230582|NCT04425902|50541618|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
25230583|NCT04072146|50541631|FG000|Overall Study|Adverse Event|0|||
25230584|NCT04072146|50541632|FG001|Overall Study|Adverse Event|1|||
25230585|NCT03861481|50541646|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
25230586|NCT03861481|50541647|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
25230587|NCT03861481|50541646|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
25230588|NCT03861481|50541647|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
25230589|NCT03861481|50541646|FG000|Overall Study|Relapse|1|||
25230590|NCT03861481|50541647|FG001|Overall Study|Relapse|0|||
25230591|NCT03861481|50541646|FG000|Overall Study|Withdrawal by Subject|0|||
25230592|NCT03861481|50541647|FG001|Overall Study|Withdrawal by Subject|1|||
25230593|NCT03861481|50541646|FG000|Overall Study|Lack of Efficacy|4|||
25230594|NCT03861481|50541647|FG001|Overall Study|Lack of Efficacy|5|||
25230595|NCT03648476|50541659|FG000|Overall Study|Withdrawal by Subject|2|||
25230596|NCT03648476|50541660|FG001|Overall Study|Withdrawal by Subject|1|||
25230597|NCT04545060|50541682|FG000|Overall Study|Adverse Event|0|||
25230598|NCT04545060|50541683|FG001|Overall Study|Adverse Event|1|||
25230599|NCT04545060|50541682|FG000|Overall Study|Death|0|||
25230600|NCT04545060|50541683|FG001|Overall Study|Death|5|||
25230601|NCT04545060|50541682|FG000|Overall Study|Lost to Follow-up|10|||
25230602|NCT04545060|50541683|FG001|Overall Study|Lost to Follow-up|13|||
25230603|NCT04545060|50541682|FG000|Overall Study|Physician Decision|3|||
25230604|NCT04545060|50541683|FG001|Overall Study|Physician Decision|0|||
25230605|NCT04545060|50541682|FG000|Overall Study|Withdrawal by Subject|17|||
25230606|NCT04545060|50541683|FG001|Overall Study|Withdrawal by Subject|22|||
25230607|NCT03533660|50541739|FG000|Overall Study|Withdrawal by Subject|2|||
25230608|NCT03533660|50541740|FG001|Overall Study|Withdrawal by Subject|2|||
25230609|NCT03533660|50541739|FG000|Overall Study|Death|2|||
25230610|NCT03533660|50541740|FG001|Overall Study|Death|4|||
25230611|NCT03533660|50541739|FG000|Overall Study|Adverse Event|0|||
25230612|NCT03533660|50541740|FG001|Overall Study|Adverse Event|2|||
25230613|NCT03416127|50541754|FG000|Overall Study|Withdrawal by Subject|0|||
25230614|NCT03416127|50541755|FG001|Overall Study|Withdrawal by Subject|1|||
25230615|NCT03416127|50541756|FG002|Overall Study|Withdrawal by Subject|1|||
25230616|NCT03260140|50541767|FG000|Overall Study|Death|4|||
25230617|NCT03260140|50541768|FG001|Overall Study|Death|1|||
25230618|NCT03260140|50541767|FG000|Overall Study|Withdrawal by Subject|1|||
25230619|NCT03260140|50541768|FG001|Overall Study|Withdrawal by Subject|4|||
25230620|NCT02986334|50541799|FG000|Overall Study|Withdrawal by Subject|0|||
25230621|NCT02986334|50541800|FG001|Overall Study|Withdrawal by Subject|1|||
25230622|NCT02986334|50541801|FG002|Overall Study|Withdrawal by Subject|2|||
25230623|NCT02986334|50541799|FG000|Overall Study|Lost to Follow-up|1|||
25230624|NCT02986334|50541800|FG001|Overall Study|Lost to Follow-up|2|||
25230625|NCT02986334|50541801|FG002|Overall Study|Lost to Follow-up|1|||
25230626|NCT02986334|50541799|FG000|Overall Study|Adverse Event|0|||
25230627|NCT02986334|50541800|FG001|Overall Study|Adverse Event|2|||
25230628|NCT02986334|50541801|FG002|Overall Study|Adverse Event|1|||
25230629|NCT02986334|50541799|FG000|Overall Study|non compliance in phone ratings|2|||
25319127|NCT00792909|50634530|FG000|Overall Study|Withdrawal by Subject|0|||
25319128|NCT00792909|50634531|FG001|Overall Study|Withdrawal by Subject|1|||
25319129|NCT00792909|50634532|FG002|Overall Study|Withdrawal by Subject|0|||
25319130|NCT00944645|50634543|FG000|Period 2|Adverse Event|1|||
25319131|NCT00944645|50634544|FG001|Period 2|Adverse Event|0|||
25319132|NCT00944645|50634543|FG000|Period 2|Lost to Follow-up|0|||
25319133|NCT00944645|50634544|FG001|Period 2|Lost to Follow-up|3|||
25319134|NCT00944645|50634543|FG000|Period 2|Withdrawal by Subject|7|||
25319135|NCT00944645|50634544|FG001|Period 2|Withdrawal by Subject|6|||
25319136|NCT00606229|50634550|FG000|Overall Study|Adverse Event|11|||
25319137|NCT00606229|50634550|FG000|Overall Study|Lack of Efficacy|1|||
25319138|NCT00606229|50634550|FG000|Overall Study|Withdrawal by Subject|4|||
25319139|NCT00606229|50634550|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
25319140|NCT00606229|50634550|FG000|Overall Study|change of residence or other commitments|2|||
25319141|NCT00950651|50634556|FG000|Overall Study|Adverse Event|17|||
25319142|NCT00950651|50634557|FG001|Overall Study|Adverse Event|20|||
25319143|NCT00950651|50634556|FG000|Overall Study|Death|1|||
25319144|NCT00950651|50634557|FG001|Overall Study|Death|0|||
25319145|NCT00950651|50634556|FG000|Overall Study|Lack of Efficacy|2|||
25319146|NCT00950651|50634557|FG001|Overall Study|Lack of Efficacy|2|||
25319147|NCT00950651|50634556|FG000|Overall Study|Protocol Violation|3|||
25319148|NCT00950651|50634557|FG001|Overall Study|Protocol Violation|4|||
25319149|NCT00950651|50634556|FG000|Overall Study|Withdrawal by Subject|8|||
25319150|NCT00950651|50634557|FG001|Overall Study|Withdrawal by Subject|9|||
25319151|NCT00605293|50634565|FG000|Overall Study|Death|2|||
25319152|NCT00605293|50634566|FG001|Overall Study|Death|1|||
25319153|NCT00605293|50634565|FG000|Overall Study|Insufficient Therapeutic Response|2|||
25319154|NCT00605293|50634566|FG001|Overall Study|Insufficient Therapeutic Response|0|||
25230630|NCT02986334|50541800|FG001|Overall Study|non compliance in phone ratings|1|||
25230631|NCT02986334|50541801|FG002|Overall Study|non compliance in phone ratings|2|||
25230632|NCT02986334|50541799|FG000|Overall Study|undisclosed comorbidities|0|||
25230633|NCT02986334|50541800|FG001|Overall Study|undisclosed comorbidities|1|||
25230634|NCT02986334|50541801|FG002|Overall Study|undisclosed comorbidities|1|||
25230635|NCT02210221|50541823|FG000|Overall Study|Lack of Efficacy|7|||
25230636|NCT02210221|50541823|FG000|Overall Study|Withdrawal by Subject|43|||
25230637|NCT02124902|50541836|FG000|Overall Study|Adverse Event|7|||
25230638|NCT02124902|50541837|FG001|Overall Study|Adverse Event|2|||
25230639|NCT02124902|50541836|FG000|Overall Study|Went to alternative treatment|4|||
25230640|NCT02124902|50541837|FG001|Overall Study|Went to alternative treatment|0|||
25230641|NCT02124902|50541836|FG000|Overall Study|Withdrawal by Subject|2|||
25230642|NCT02124902|50541837|FG001|Overall Study|Withdrawal by Subject|1|||
25230643|NCT02124902|50541836|FG000|Overall Study|Physician Decision|2|||
25230644|NCT02124902|50541837|FG001|Overall Study|Physician Decision|0|||
25230645|NCT02124902|50541836|FG000|Overall Study|Not eligible|1|||
25230646|NCT02124902|50541837|FG001|Overall Study|Not eligible|0|||
25230647|NCT02124902|50541836|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
25230648|NCT02124902|50541837|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
25230649|NCT01940341|50541845|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
25230650|NCT01940341|50541846|FG001|Double-Blind Phase|Randomized but Never Treated|1|||
25230651|NCT01940341|50541845|FG000|Double-Blind Phase|Adverse Event|3|||
25230652|NCT01940341|50541846|FG001|Double-Blind Phase|Adverse Event|2|||
25230653|NCT01940341|50541845|FG000|Double-Blind Phase|Withdrew Consent|3|||
25230654|NCT01940341|50541846|FG001|Double-Blind Phase|Withdrew Consent|2|||
25230655|NCT01940341|50541845|FG000|Double-Blind Phase|Lost to Follow-up|4|||
25230656|NCT01940341|50541846|FG001|Double-Blind Phase|Lost to Follow-up|1|||
25230657|NCT01940341|50541845|FG000|Double-Blind Phase|Pregnancy|0|||
25230658|NCT01940341|50541846|FG001|Double-Blind Phase|Pregnancy|1|||
25230659|NCT01940341|50541845|FG000|Double-Blind Phase|Investigator's Discretion|1|||
25230660|NCT01940341|50541846|FG001|Double-Blind Phase|Investigator's Discretion|0|||
25230661|NCT01940341|50541845|FG000|Double-Blind Phase|Non-Compliance with Study Drug|0|||
25230662|NCT01940341|50541846|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
25230663|NCT01940341|50541845|FG000|Double-Blind Phase|Protocol Specified Criteria|1|||
25230664|NCT01940341|50541846|FG001|Double-Blind Phase|Protocol Specified Criteria|0|||
25230665|NCT01940341|50541845|FG000|Double-Blind Phase|Still on Double-Blind Treatment|269|||
25230666|NCT01940341|50541846|FG001|Double-Blind Phase|Still on Double-Blind Treatment|132|||
25230667|NCT01940341|50541845|FG000|Open-label Extension Phase|Still on Study|4|||
25230668|NCT01940341|50541846|FG001|Open-label Extension Phase|Still on Study|1|||
25230669|NCT01877837|50541854|FG000|Overall Study|Lost to Follow-up|1|||
25230670|NCT01877837|50541854|FG000|Overall Study|Ineligible|4|||
25230671|NCT01624142|50541874|FG000|Overall Study|Withdrawal by Subject|14|||
25230672|NCT01624142|50541875|FG001|Overall Study|Withdrawal by Subject|4|||
25230673|NCT01624142|50541874|FG000|Overall Study|Death|3|||
25230674|NCT01624142|50541875|FG001|Overall Study|Death|6|||
25230675|NCT01624142|50541874|FG000|Overall Study|Study Closure|12|||
25230676|NCT01624142|50541875|FG001|Overall Study|Study Closure|6|||
25230677|NCT01624142|50541874|FG000|Overall Study|Lost to Follow-up|2|||
25230678|NCT01624142|50541875|FG001|Overall Study|Lost to Follow-up|0|||
25230679|NCT01624142|50541874|FG000|Overall Study|Other|1|||
25230680|NCT01624142|50541875|FG001|Overall Study|Other|0|||
25230681|NCT01535807|50541884|FG000|Overall Study|Withdrawal by Subject|1|||
25230682|NCT01535807|50541885|FG001|Overall Study|Withdrawal by Subject|1|||
25230683|NCT01535807|50541884|FG000|Overall Study|Data collection error|1|||
25230684|NCT01535807|50541885|FG001|Overall Study|Data collection error|1|||
25230685|NCT01375764|50541897|FG000|Overall Study|Lost to Follow-up|0|||
25230686|NCT01375764|50541898|FG001|Overall Study|Lost to Follow-up|1|||
25230687|NCT01375764|50541899|FG002|Overall Study|Lost to Follow-up|0|||
25230688|NCT01375764|50541900|FG003|Overall Study|Lost to Follow-up|0|||
25230689|NCT01375764|50541901|FG004|Overall Study|Lost to Follow-up|0|||
25230690|NCT01375764|50541897|FG000|Overall Study|Withdrawal by Subject|2|||
25230691|NCT01375764|50541898|FG001|Overall Study|Withdrawal by Subject|0|||
25230692|NCT01375764|50541899|FG002|Overall Study|Withdrawal by Subject|0|||
25230693|NCT01375764|50541900|FG003|Overall Study|Withdrawal by Subject|0|||
25230694|NCT01375764|50541901|FG004|Overall Study|Withdrawal by Subject|1|||
25230695|NCT01375764|50541897|FG000|Overall Study|Other|0|||
25230696|NCT01375764|50541898|FG001|Overall Study|Other|0|||
25230697|NCT01375764|50541899|FG002|Overall Study|Other|0|||
25230698|NCT01375764|50541900|FG003|Overall Study|Other|1|||
25230699|NCT01375764|50541901|FG004|Overall Study|Other|0|||
25230700|NCT00722046|50541920|FG000|Overall Study|Adverse Event|0|||
25230701|NCT00722046|50541921|FG001|Overall Study|Adverse Event|1|||
25230702|NCT00722046|50541922|FG002|Overall Study|Adverse Event|2|||
25230703|NCT00722046|50541923|FG003|Overall Study|Adverse Event|1|||
25230704|NCT00722046|50541924|FG004|Overall Study|Adverse Event|2|||
25230705|NCT00722046|50541925|FG005|Overall Study|Adverse Event|1|||
25230706|NCT00722046|50541926|FG006|Overall Study|Adverse Event|0|||
25230707|NCT00722046|50541920|FG000|Overall Study|Death|0|||
25230708|NCT00722046|50541921|FG001|Overall Study|Death|1|||
25230709|NCT00722046|50541922|FG002|Overall Study|Death|0|||
25230710|NCT00722046|50541923|FG003|Overall Study|Death|0|||
25230711|NCT00722046|50541924|FG004|Overall Study|Death|0|||
25230712|NCT00722046|50541925|FG005|Overall Study|Death|0|||
25230713|NCT00722046|50541926|FG006|Overall Study|Death|2|||
25230714|NCT00722046|50541920|FG000|Overall Study|Protocol Violation|1|||
25230715|NCT00722046|50541921|FG001|Overall Study|Protocol Violation|0|||
25230716|NCT00722046|50541922|FG002|Overall Study|Protocol Violation|0|||
25230717|NCT00722046|50541923|FG003|Overall Study|Protocol Violation|0|||
25230718|NCT00722046|50541924|FG004|Overall Study|Protocol Violation|0|||
25230719|NCT00722046|50541925|FG005|Overall Study|Protocol Violation|1|||
25230720|NCT00722046|50541926|FG006|Overall Study|Protocol Violation|0|||
25230721|NCT00722046|50541920|FG000|Overall Study|Withdrawal by Subject|3|||
25230722|NCT00722046|50541921|FG001|Overall Study|Withdrawal by Subject|3|||
25230723|NCT00722046|50541922|FG002|Overall Study|Withdrawal by Subject|4|||
25230724|NCT00722046|50541923|FG003|Overall Study|Withdrawal by Subject|4|||
25230725|NCT00722046|50541924|FG004|Overall Study|Withdrawal by Subject|4|||
25230726|NCT00722046|50541925|FG005|Overall Study|Withdrawal by Subject|7|||
25230727|NCT00722046|50541926|FG006|Overall Study|Withdrawal by Subject|3|||
25230728|NCT00722046|50541920|FG000|Overall Study|Randomized, but not treated|1|||
25230729|NCT00722046|50541921|FG001|Overall Study|Randomized, but not treated|1|||
25230730|NCT00722046|50541922|FG002|Overall Study|Randomized, but not treated|0|||
25230731|NCT00722046|50541923|FG003|Overall Study|Randomized, but not treated|2|||
25230732|NCT00722046|50541924|FG004|Overall Study|Randomized, but not treated|0|||
25230733|NCT00722046|50541925|FG005|Overall Study|Randomized, but not treated|0|||
25230734|NCT00722046|50541926|FG006|Overall Study|Randomized, but not treated|0|||
25230735|NCT00722046|50541920|FG000|Overall Study|Other|0|||
25230736|NCT00722046|50541921|FG001|Overall Study|Other|0|||
25230737|NCT00722046|50541922|FG002|Overall Study|Other|1|||
25230738|NCT00722046|50541923|FG003|Overall Study|Other|1|||
25230739|NCT00722046|50541924|FG004|Overall Study|Other|3|||
25230740|NCT00722046|50541925|FG005|Overall Study|Other|2|||
25230741|NCT00722046|50541926|FG006|Overall Study|Other|1|||
25230742|NCT00614523|50541946|FG000|Overall Study|Adverse Event|4|||
25230743|NCT00614523|50541947|FG001|Overall Study|Adverse Event|20|||
25230744|NCT00614523|50541946|FG000|Overall Study|Death|5|||
25230745|NCT00614523|50541947|FG001|Overall Study|Death|8|||
25230746|NCT00614523|50541946|FG000|Overall Study|Lack of Efficacy|9|||
25230747|NCT00614523|50541947|FG001|Overall Study|Lack of Efficacy|11|||
25230748|NCT00614523|50541946|FG000|Overall Study|Lost to Follow-up|0|||
25230749|NCT00614523|50541947|FG001|Overall Study|Lost to Follow-up|1|||
25230750|NCT00614523|50541946|FG000|Overall Study|Protocol Violation|3|||
25230751|NCT00614523|50541947|FG001|Overall Study|Protocol Violation|2|||
25230752|NCT00614523|50541946|FG000|Overall Study|Withdrawal by Subject|12|||
25230753|NCT00614523|50541947|FG001|Overall Study|Withdrawal by Subject|22|||
25230754|NCT00614523|50541946|FG000|Overall Study|Other|6|||
25230755|NCT00614523|50541947|FG001|Overall Study|Other|11|||
25230756|NCT00614523|50541946|FG000|Overall Study|Ineligibility Determined|1|||
25230757|NCT00614523|50541947|FG001|Overall Study|Ineligibility Determined|2|||
25230758|NCT00614523|50541946|FG000|Overall Study|Disease Progression|0|||
25230759|NCT00614523|50541947|FG001|Overall Study|Disease Progression|8|||
25230760|NCT00614523|50541946|FG000|Overall Study|Administrative Decision|23|||
25230761|NCT00614523|50541947|FG001|Overall Study|Administrative Decision|46|||
25230762|NCT00523341|50541955|FG000|Overall Study|Withdrawal by Subject|399|||
25230763|NCT00523341|50541956|FG001|Overall Study|Withdrawal by Subject|427|||
25230764|NCT00523341|50541955|FG000|Overall Study|Other|181|||
25230765|NCT00523341|50541956|FG001|Overall Study|Other|198|||
25230766|NCT00523341|50541955|FG000|Overall Study|Adverse Event|122|||
24976633|NCT03451084|50065563|FG002|Overall Study|Lack of Efficacy|0|||
24976634|NCT03451084|50065564|FG003|Overall Study|Lack of Efficacy|1|||
24976635|NCT03451084|50065561|FG000|Overall Study|Death|1|||
24976636|NCT03451084|50065562|FG001|Overall Study|Death|0|||
25230767|NCT00523341|50541956|FG001|Overall Study|Adverse Event|155|||
25230768|NCT00523341|50541955|FG000|Overall Study|Death|101|||
25230769|NCT00523341|50541956|FG001|Overall Study|Death|110|||
25230770|NCT00523341|50541955|FG000|Overall Study|Lost to Follow-up|73|||
25230771|NCT00523341|50541956|FG001|Overall Study|Lost to Follow-up|61|||
25230772|NCT00523341|50541955|FG000|Overall Study|Non-compliance|20|||
25230773|NCT00523341|50541956|FG001|Overall Study|Non-compliance|13|||
25230774|NCT00523341|50541955|FG000|Overall Study|Physician Decision|14|||
25230775|NCT00523341|50541956|FG001|Overall Study|Physician Decision|13|||
25230776|NCT00523341|50541955|FG000|Overall Study|Requirement for Alternative Therapy|4|||
25230777|NCT00523341|50541956|FG001|Overall Study|Requirement for Alternative Therapy|14|||
24976637|NCT03451084|50065563|FG002|Overall Study|Death|2|||
25230778|NCT00523341|50541955|FG000|Overall Study|Protocol Deviation|6|||
25230779|NCT00523341|50541956|FG001|Overall Study|Protocol Deviation|5|||
25230780|NCT00523341|50541955|FG000|Overall Study|Ineligibility Determined|3|||
25230781|NCT00523341|50541956|FG001|Overall Study|Ineligibility Determined|4|||
24976638|NCT03451084|50065564|FG003|Overall Study|Death|0|||
25230782|NCT00523341|50541955|FG000|Overall Study|Disease Progression|1|||
25230783|NCT00523341|50541956|FG001|Overall Study|Disease Progression|0|||
25230784|NCT00364013|50541964|FG000|Overall Study|Ineligibility determined|4|||
25230785|NCT00364013|50541965|FG001|Overall Study|Ineligibility determined|2|||
25230786|NCT00364013|50541964|FG000|Overall Study|Adverse Event|4|||
25230787|NCT00364013|50541965|FG001|Overall Study|Adverse Event|3|||
25230788|NCT00364013|50541964|FG000|Overall Study|Withdrawal by Subject|13|||
25230789|NCT00364013|50541965|FG001|Overall Study|Withdrawal by Subject|18|||
25230790|NCT00364013|50541964|FG000|Overall Study|Physician Decision|3|||
25230791|NCT00364013|50541965|FG001|Overall Study|Physician Decision|3|||
25230792|NCT00364013|50541964|FG000|Overall Study|Lost to Follow-up|10|||
25230793|NCT00364013|50541965|FG001|Overall Study|Lost to Follow-up|3|||
25230794|NCT00364013|50541964|FG000|Overall Study|Protocol-specified criteria|6|||
25230795|NCT00364013|50541965|FG001|Overall Study|Protocol-specified criteria|6|||
25230796|NCT00364013|50541964|FG000|Overall Study|Other|41|||
25230797|NCT00364013|50541965|FG001|Overall Study|Other|47|||
25230798|NCT00364013|50541964|FG000|Overall Study|Ongoing|20|||
25230799|NCT00364013|50541965|FG001|Overall Study|Ongoing|13|||
25230800|NCT00345839|50541977|FG000|Overall Study|Withdrawal by Subject|91|||
25230801|NCT00345839|50541978|FG001|Overall Study|Withdrawal by Subject|98|||
25230802|NCT00345839|50541977|FG000|Overall Study|Lost to Follow-up|58|||
25230803|NCT00345839|50541978|FG001|Overall Study|Lost to Follow-up|61|||
25230804|NCT00330759|50541986|FG000|Overall Study|Death|316|||
25230805|NCT00330759|50541987|FG001|Overall Study|Death|310|||
25230806|NCT00330759|50541986|FG000|Overall Study|Disease progression|104|||
25230807|NCT00330759|50541987|FG001|Overall Study|Disease progression|126|||
25230808|NCT00330759|50541986|FG000|Overall Study|Withdrawal by Subject|143|||
25230809|NCT00330759|50541987|FG001|Overall Study|Withdrawal by Subject|124|||
25230810|NCT00330759|50541986|FG000|Overall Study|Adverse Event|48|||
25230811|NCT00330759|50541987|FG001|Overall Study|Adverse Event|36|||
25230812|NCT00330759|50541986|FG000|Overall Study|Participant request|31|||
25230813|NCT00330759|50541987|FG001|Overall Study|Participant request|22|||
25230814|NCT00330759|50541986|FG000|Overall Study|Lost to Follow-up|16|||
25230815|NCT00330759|50541987|FG001|Overall Study|Lost to Follow-up|22|||
25230816|NCT00330759|50541986|FG000|Overall Study|Noncompliance|15|||
25230817|NCT00330759|50541987|FG001|Overall Study|Noncompliance|17|||
25230818|NCT00330759|50541986|FG000|Overall Study|Physician Decision|1|||
25230819|NCT00330759|50541987|FG001|Overall Study|Physician Decision|2|||
25230820|NCT00330759|50541986|FG000|Overall Study|Protocol deviation|0|||
25230821|NCT00330759|50541987|FG001|Overall Study|Protocol deviation|2|||
25230822|NCT00330759|50541986|FG000|Overall Study|Ineligibility determined|2|||
25230823|NCT00330759|50541987|FG001|Overall Study|Ineligibility determined|1|||
25230824|NCT00330759|50541986|FG000|Overall Study|Other|36|||
25230825|NCT00330759|50541987|FG001|Overall Study|Other|44|||
25230826|NCT00113763|50541995|FG000|Overall Study|Adverse Event|5|||
25230827|NCT00113763|50541996|FG001|Overall Study|Adverse Event|2|||
25230828|NCT00113763|50541995|FG000|Overall Study|Disease Progression|28|||
25230829|NCT00113763|50541996|FG001|Overall Study|Disease Progression|14|||
25230830|NCT00113763|50541995|FG000|Overall Study|Lost to Follow-up|10|||
25230831|NCT00113763|50541996|FG001|Overall Study|Lost to Follow-up|0|||
25230832|NCT00113763|50541995|FG000|Overall Study|Withdrawal by Subject|1|||
25230833|NCT00113763|50541996|FG001|Overall Study|Withdrawal by Subject|4|||
25230834|NCT00113763|50541995|FG000|Overall Study|Other|27|||
25230835|NCT00113763|50541996|FG001|Overall Study|Other|6|||
25230836|NCT00113763|50541995|FG000|Overall Study|Non-compliance|1|||
25230837|NCT00113763|50541996|FG001|Overall Study|Non-compliance|0|||
25230838|NCT00113763|50541995|FG000|Overall Study|Ongoing|1|||
25230839|NCT00113763|50541996|FG001|Overall Study|Ongoing|0|||
25230840|NCT01470326|50542003|FG000|Overall Study|Protocol Violation|32|||
25230841|NCT01470326|50542003|FG000|Overall Study|No Drug Administration Information|2|||
25230842|NCT01470326|50542003|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
25230843|NCT01480180|50542018|FG000|Main Phase|Withdrawal criteria|12|||
25230844|NCT01480180|50542019|FG001|Main Phase|Withdrawal criteria|1|||
25230845|NCT01480180|50542020|FG002|Main Phase|Withdrawal criteria|0|||
25230846|NCT01480180|50542021|FG003|Main Phase|Withdrawal criteria|0|||
25230847|NCT01480180|50542022|FG004|Main Phase|Withdrawal criteria|0|||
25230848|NCT01480180|50542023|FG005|Main Phase|Withdrawal criteria|0|||
25230849|NCT01480180|50542018|FG000|Main Phase|Lack of Efficacy|1|||
25230850|NCT01480180|50542019|FG001|Main Phase|Lack of Efficacy|0|||
25230851|NCT01480180|50542020|FG002|Main Phase|Lack of Efficacy|0|||
25230852|NCT01480180|50542021|FG003|Main Phase|Lack of Efficacy|0|||
25230853|NCT01480180|50542022|FG004|Main Phase|Lack of Efficacy|0|||
25230854|NCT01480180|50542023|FG005|Main Phase|Lack of Efficacy|0|||
25230855|NCT01480180|50542018|FG000|Main Phase|Non-compliance|3|||
25319155|NCT00605293|50634565|FG000|Overall Study|Adverse Event|1|||
25230856|NCT01480180|50542019|FG001|Main Phase|Non-compliance|0|||
25230857|NCT01480180|50542020|FG002|Main Phase|Non-compliance|0|||
25230858|NCT01480180|50542021|FG003|Main Phase|Non-compliance|0|||
25230859|NCT01480180|50542022|FG004|Main Phase|Non-compliance|0|||
25230860|NCT01480180|50542023|FG005|Main Phase|Non-compliance|0|||
25230861|NCT01480180|50542018|FG000|Main Phase|Unclassified|3|||
25230862|NCT01480180|50542019|FG001|Main Phase|Unclassified|0|||
25230863|NCT01480180|50542020|FG002|Main Phase|Unclassified|0|||
25230864|NCT01480180|50542021|FG003|Main Phase|Unclassified|0|||
25230865|NCT01480180|50542022|FG004|Main Phase|Unclassified|0|||
25230866|NCT01480180|50542023|FG005|Main Phase|Unclassified|0|||
25230867|NCT01480180|50542018|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
25230868|NCT01480180|50542019|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
25230869|NCT01480180|50542020|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
25230870|NCT01480180|50542021|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
25230871|NCT01480180|50542022|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
25230872|NCT01480180|50542023|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
25230873|NCT01480180|50542018|FG000|Extension Phase, Part 1|Unclassified|0|||
25230874|NCT01480180|50542019|FG001|Extension Phase, Part 1|Unclassified|0|||
25230875|NCT01480180|50542020|FG002|Extension Phase, Part 1|Unclassified|1|||
25230876|NCT01480180|50542021|FG003|Extension Phase, Part 1|Unclassified|0|||
25230877|NCT01480180|50542022|FG004|Extension Phase, Part 1|Unclassified|0|||
25230878|NCT01480180|50542023|FG005|Extension Phase, Part 1|Unclassified|0|||
25230879|NCT01480180|50542018|FG000|Extension Phase, Part 1|Adverse Event|0|||
25230880|NCT01480180|50542019|FG001|Extension Phase, Part 1|Adverse Event|0|||
25230881|NCT01480180|50542020|FG002|Extension Phase, Part 1|Adverse Event|4|||
25230882|NCT01480180|50542021|FG003|Extension Phase, Part 1|Adverse Event|1|||
25230883|NCT01480180|50542022|FG004|Extension Phase, Part 1|Adverse Event|0|||
25230884|NCT01480180|50542023|FG005|Extension Phase, Part 1|Adverse Event|0|||
25230885|NCT01480180|50542018|FG000|Extension Phase, Part 1|Change of treatment|0|||
25230886|NCT01480180|50542019|FG001|Extension Phase, Part 1|Change of treatment|0|||
25230887|NCT01480180|50542020|FG002|Extension Phase, Part 1|Change of treatment|0|||
25230888|NCT01480180|50542021|FG003|Extension Phase, Part 1|Change of treatment|9|||
25230889|NCT01480180|50542022|FG004|Extension Phase, Part 1|Change of treatment|0|||
25230890|NCT01480180|50542023|FG005|Extension Phase, Part 1|Change of treatment|0|||
25230891|NCT01480180|50542018|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
25230892|NCT01480180|50542019|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
25230893|NCT01480180|50542020|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
25230894|NCT01480180|50542021|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
25230895|NCT01480180|50542022|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
25230896|NCT01480180|50542023|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
25230897|NCT01480180|50542018|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
25230898|NCT01480180|50542019|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
25230899|NCT01480180|50542020|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
25230900|NCT01480180|50542021|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
25230901|NCT01480180|50542022|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
25230902|NCT01480180|50542023|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
25230903|NCT01480180|50542018|FG000|Extension Phase, Part 2|Unclassified|0|||
25230904|NCT01480180|50542019|FG001|Extension Phase, Part 2|Unclassified|0|||
25230905|NCT01480180|50542020|FG002|Extension Phase, Part 2|Unclassified|3|||
25230906|NCT01480180|50542021|FG003|Extension Phase, Part 2|Unclassified|1|||
25230907|NCT01480180|50542022|FG004|Extension Phase, Part 2|Unclassified|1|||
25230908|NCT01480180|50542023|FG005|Extension Phase, Part 2|Unclassified|0|||
25230909|NCT01545050|50542059|FG000|Overall Study|Lack of Efficacy|0|||
25230910|NCT01545050|50542060|FG001|Overall Study|Lack of Efficacy|0|||
25230911|NCT01545050|50542061|FG002|Overall Study|Lack of Efficacy|0|||
25230912|NCT01545050|50542062|FG003|Overall Study|Lack of Efficacy|3|||
25230913|NCT01545050|50542063|FG004|Overall Study|Lack of Efficacy|2|||
25230914|NCT01545050|50542059|FG000|Overall Study|Adverse Event|1|||
25230915|NCT01545050|50542060|FG001|Overall Study|Adverse Event|1|||
25230916|NCT01545050|50542061|FG002|Overall Study|Adverse Event|2|||
25230917|NCT01545050|50542062|FG003|Overall Study|Adverse Event|2|||
25230918|NCT01545050|50542063|FG004|Overall Study|Adverse Event|0|||
25230919|NCT01545050|50542059|FG000|Overall Study|Discontinued study treatment|1|||
25230920|NCT01545050|50542060|FG001|Overall Study|Discontinued study treatment|0|||
25230921|NCT01545050|50542061|FG002|Overall Study|Discontinued study treatment|0|||
25230922|NCT01545050|50542062|FG003|Overall Study|Discontinued study treatment|0|||
25230923|NCT01545050|50542063|FG004|Overall Study|Discontinued study treatment|0|||
25230924|NCT01545050|50542059|FG000|Overall Study|Withdrawal by Subject|1|||
25230925|NCT01545050|50542060|FG001|Overall Study|Withdrawal by Subject|0|||
25230926|NCT01545050|50542061|FG002|Overall Study|Withdrawal by Subject|0|||
24976639|NCT03451084|50065561|FG000|Overall Study|Physician Decision|0|||
25230927|NCT01545050|50542062|FG003|Overall Study|Withdrawal by Subject|2|||
25230928|NCT01545050|50542063|FG004|Overall Study|Withdrawal by Subject|1|||
25230929|NCT01545050|50542059|FG000|Overall Study|Participant no longer meets study criteria|0|||
25230930|NCT01545050|50542060|FG001|Overall Study|Participant no longer meets study criteria|2|||
25230931|NCT01545050|50542061|FG002|Overall Study|Participant no longer meets study criteria|0|||
25230932|NCT01545050|50542062|FG003|Overall Study|Participant no longer meets study criteria|0|||
25230933|NCT01545050|50542063|FG004|Overall Study|Participant no longer meets study criteria|1|||
25230934|NCT01545050|50542059|FG000|Overall Study|Administrative reason by sponsor|4|||
25230935|NCT01545050|50542060|FG001|Overall Study|Administrative reason by sponsor|2|||
25230936|NCT01545050|50542061|FG002|Overall Study|Administrative reason by sponsor|3|||
25230937|NCT01545050|50542062|FG003|Overall Study|Administrative reason by sponsor|5|||
25230938|NCT01545050|50542063|FG004|Overall Study|Administrative reason by sponsor|5|||
25230939|NCT01555021|50542090|FG000|Overall Study|Lost to Follow-up|1|||
25230940|NCT01555021|50542091|FG001|Overall Study|Lost to Follow-up|2|||
25230941|NCT04721925|50542105|FG000|2-Month Assessment|Lost to Follow-up|5|||
25230942|NCT04721925|50542106|FG001|2-Month Assessment|Lost to Follow-up|3|||
25230943|NCT04721925|50542105|FG000|4-Month Assessment|Lost to Follow-up|3|||
25230944|NCT04721925|50542106|FG001|4-Month Assessment|Lost to Follow-up|6|||
25230945|NCT04710368|50542111|FG000|Overall Study|Withdrawal by Subject|9|||
25230946|NCT04710368|50542111|FG000|Overall Study|Lost to Follow-up|4|||
25230947|NCT04710368|50542111|FG000|Overall Study|Death|2|||
25230948|NCT04710368|50542111|FG000|Overall Study|Patient preference|11|||
25230949|NCT04710368|50542111|FG000|Overall Study|Treatment discontinuation|1|||
25230950|NCT04677660|50542117|FG000|Overall Study|Lost to Follow-up|0|||
25230951|NCT04677660|50542118|FG001|Overall Study|Lost to Follow-up|2|||
25230952|NCT04677660|50542117|FG000|Overall Study|Withdrawal by Subject|0|||
25230953|NCT04677660|50542118|FG001|Overall Study|Withdrawal by Subject|1|||
25230954|NCT04677660|50542117|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
25230955|NCT04677660|50542118|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
25230956|NCT04518995|50542127|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
25230957|NCT04518995|50542128|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
25230958|NCT04518995|50542129|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
25230959|NCT04518995|50542127|FG000|Overall Study|Lack of Efficacy|2|||
25230960|NCT04518995|50542128|FG001|Overall Study|Lack of Efficacy|1|||
25230961|NCT04518995|50542129|FG002|Overall Study|Lack of Efficacy|0|||
25230962|NCT04518995|50542127|FG000|Overall Study|Non-compliance With Study Drug|0|||
25230963|NCT04518995|50542128|FG001|Overall Study|Non-compliance With Study Drug|3|||
25230964|NCT04518995|50542129|FG002|Overall Study|Non-compliance With Study Drug|2|||
25230965|NCT04518995|50542127|FG000|Overall Study|Pregnancy|0|||
25230966|NCT04518995|50542128|FG001|Overall Study|Pregnancy|0|||
25230967|NCT04518995|50542129|FG002|Overall Study|Pregnancy|1|||
25230968|NCT04518995|50542127|FG000|Overall Study|Protocol Violation|2|||
25230969|NCT04518995|50542128|FG001|Overall Study|Protocol Violation|0|||
25230970|NCT04518995|50542129|FG002|Overall Study|Protocol Violation|1|||
25230971|NCT04518995|50542127|FG000|Overall Study|Reason not Specified|4|||
25230972|NCT04518995|50542128|FG001|Overall Study|Reason not Specified|11|||
25230973|NCT04518995|50542129|FG002|Overall Study|Reason not Specified|2|||
25230974|NCT04518995|50542127|FG000|Overall Study|Lost to Follow-up|1|||
25230975|NCT04518995|50542128|FG001|Overall Study|Lost to Follow-up|10|||
25230976|NCT04518995|50542129|FG002|Overall Study|Lost to Follow-up|6|||
25230977|NCT04505722|50542139|FG000|Overall Study|Adverse Event|1|||
25230978|NCT04505722|50542140|FG001|Overall Study|Adverse Event|2|||
25230979|NCT04505722|50542139|FG000|Overall Study|Death|34|||
25230980|NCT04505722|50542140|FG001|Overall Study|Death|63|||
25230981|NCT04505722|50542139|FG000|Overall Study|Lost to Follow-up|271|||
25230982|NCT04505722|50542140|FG001|Overall Study|Lost to Follow-up|333|||
25230983|NCT04505722|50542139|FG000|Overall Study|Physician Decision|17|||
25230984|NCT04505722|50542140|FG001|Overall Study|Physician Decision|17|||
25230985|NCT04505722|50542139|FG000|Overall Study|Protocol Violation|0|||
25230986|NCT04505722|50542140|FG001|Overall Study|Protocol Violation|1|||
25230987|NCT04505722|50542139|FG000|Overall Study|Withdrawal by Subject|376|||
25230988|NCT04505722|50542140|FG001|Overall Study|Withdrawal by Subject|714|||
25230989|NCT04505722|50542139|FG000|Overall Study|Other|61|||
25230990|NCT04505722|50542140|FG001|Overall Study|Other|98|||
25230991|NCT04505722|50542139|FG000|Overall Study|Still ongoing|21138|||
25077499|NCT00002663|50185281|FG006|Overall Study|Physician Decision|0|||
25077500|NCT00002663|50185282|FG007|Overall Study|Physician Decision|0|||
25230992|NCT04505722|50542140|FG001|Overall Study|Still ongoing|20662|||
25230993|NCT04505722|50542139|FG000|Overall Study|Randomized not vaccinated|276|||
25230994|NCT04505722|50542140|FG001|Overall Study|Randomized not vaccinated|260|||
25230995|NCT04474691|50542146|FG000|Overall Study|Withdrawal by Subject|9|||
25230996|NCT04158648|50542156|FG000|Overall Study|Ongoing in the Study|69|||
25230997|NCT04158648|50542156|FG000|Overall Study|Withdrawal by Subject|4|||
25230998|NCT04014075|50542185|FG000|Overall Study|Progressive Disease|48|||
25230999|NCT04014075|50542185|FG000|Overall Study|Adverse Event|11|||
25231000|NCT04014075|50542185|FG000|Overall Study|Clinical Progression|4|||
25231001|NCT04014075|50542185|FG000|Overall Study|Death|2|||
25231002|NCT04014075|50542185|FG000|Overall Study|Withdrawal by Subject|2|||
25231003|NCT04014075|50542185|FG000|Overall Study|Miscellaneous|1|||
25231004|NCT04014075|50542185|FG000|Overall Study|Physician Decision|1|||
25231005|NCT03840174|50542193|FG000|Overall Study|Withdrawal by Subject|1|||
25319156|NCT00605293|50634566|FG001|Overall Study|Adverse Event|0|||
25231006|NCT03840174|50542194|FG001|Overall Study|Withdrawal by Subject|0|||
25231007|NCT03840174|50542195|FG002|Overall Study|Withdrawal by Subject|0|||
25231008|NCT03840174|50542196|FG003|Overall Study|Withdrawal by Subject|0|||
25231009|NCT03786718|50542207|FG000|Overall Study|Lost to Follow-up|3|||
25231010|NCT03786718|50542207|FG000|Overall Study|Withdrawal by Subject|1|||
25231011|NCT03786718|50542207|FG000|Overall Study|Did not use the intervention|2|||
25231012|NCT03786718|50542207|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
25231013|NCT03400943|50542240|FG000|Treatment Period 1|Adverse Event|0|||
25231014|NCT03400943|50542241|FG001|Treatment Period 1|Adverse Event|0|||
25231015|NCT03400943|50542242|FG002|Treatment Period 1|Adverse Event|0|||
25231016|NCT03400943|50542243|FG003|Treatment Period 1|Adverse Event|1|||
25231017|NCT03400943|50542240|FG000|Treatment Period 1|Lost to Follow-up|1|||
25231018|NCT03400943|50542241|FG001|Treatment Period 1|Lost to Follow-up|0|||
25231019|NCT03400943|50542242|FG002|Treatment Period 1|Lost to Follow-up|0|||
25231020|NCT03400943|50542243|FG003|Treatment Period 1|Lost to Follow-up|0|||
25231021|NCT03400943|50542240|FG000|Treatment Period 1|Protocol Violation|0|||
25231022|NCT03400943|50542241|FG001|Treatment Period 1|Protocol Violation|1|||
25231023|NCT03400943|50542242|FG002|Treatment Period 1|Protocol Violation|1|||
25231024|NCT03400943|50542243|FG003|Treatment Period 1|Protocol Violation|0|||
25231025|NCT03400943|50542240|FG000|Treatment Period 1|Study terminated by sponsor|2|||
25231026|NCT03400943|50542241|FG001|Treatment Period 1|Study terminated by sponsor|0|||
25231027|NCT03400943|50542242|FG002|Treatment Period 1|Study terminated by sponsor|0|||
25231028|NCT03400943|50542243|FG003|Treatment Period 1|Study terminated by sponsor|1|||
25231029|NCT03400943|50542240|FG000|Treatment Period 1|Withdrawal by Subject|0|||
25231030|NCT03400943|50542241|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25231031|NCT03400943|50542242|FG002|Treatment Period 1|Withdrawal by Subject|3|||
25231032|NCT03400943|50542243|FG003|Treatment Period 1|Withdrawal by Subject|1|||
25231033|NCT03400943|50542240|FG000|Treatment Period 1|Other|2|||
25231034|NCT03400943|50542241|FG001|Treatment Period 1|Other|1|||
25231035|NCT03400943|50542242|FG002|Treatment Period 1|Other|2|||
25231036|NCT03400943|50542243|FG003|Treatment Period 1|Other|2|||
25231037|NCT03400943|50542240|FG000|Post-treatment Period 1|Adverse Event|2|||
25231038|NCT03400943|50542241|FG001|Post-treatment Period 1|Adverse Event|0|||
25231039|NCT03400943|50542242|FG002|Post-treatment Period 1|Adverse Event|0|||
25231040|NCT03400943|50542243|FG003|Post-treatment Period 1|Adverse Event|0|||
25231041|NCT03400943|50542240|FG000|Post-treatment Period 1|Protocol Violation|1|||
25231042|NCT03400943|50542241|FG001|Post-treatment Period 1|Protocol Violation|0|||
25231043|NCT03400943|50542242|FG002|Post-treatment Period 1|Protocol Violation|0|||
25231044|NCT03400943|50542243|FG003|Post-treatment Period 1|Protocol Violation|0|||
25231045|NCT03400943|50542240|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
25231046|NCT03400943|50542241|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
25231047|NCT03400943|50542242|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
25231048|NCT03400943|50542243|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
25231049|NCT03400943|50542240|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
25231050|NCT03400943|50542241|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
25231051|NCT03400943|50542242|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
25231052|NCT03400943|50542243|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
25231053|NCT03400943|50542240|FG000|Post-treatment Period 1|Other|2|||
25231054|NCT03400943|50542241|FG001|Post-treatment Period 1|Other|0|||
25231055|NCT03400943|50542242|FG002|Post-treatment Period 1|Other|4|||
25231056|NCT03400943|50542243|FG003|Post-treatment Period 1|Other|5|||
25231057|NCT03400943|50542240|FG000|Treatment Period 2|Study terminated by sponsor|0|||
25231058|NCT03400943|50542241|FG001|Treatment Period 2|Study terminated by sponsor|1|||
25231059|NCT03400943|50542242|FG002|Treatment Period 2|Study terminated by sponsor|0|||
25231060|NCT03400943|50542243|FG003|Treatment Period 2|Study terminated by sponsor|0|||
25231061|NCT03400943|50542240|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25231062|NCT03400943|50542241|FG001|Treatment Period 2|Withdrawal by Subject|1|||
25231063|NCT03400943|50542242|FG002|Treatment Period 2|Withdrawal by Subject|0|||
25231064|NCT03400943|50542243|FG003|Treatment Period 2|Withdrawal by Subject|0|||
25231065|NCT03400943|50542240|FG000|Treatment Period 2|Other|1|||
25231066|NCT03400943|50542241|FG001|Treatment Period 2|Other|6|||
25231067|NCT03400943|50542242|FG002|Treatment Period 2|Other|0|||
25231068|NCT03400943|50542243|FG003|Treatment Period 2|Other|0|||
25231069|NCT03400943|50542240|FG000|Follow-up Period|Withdrawal by Subject|1|||
25231070|NCT03400943|50542241|FG001|Follow-up Period|Withdrawal by Subject|0|||
25231071|NCT03400943|50542242|FG002|Follow-up Period|Withdrawal by Subject|0|||
25231072|NCT03400943|50542243|FG003|Follow-up Period|Withdrawal by Subject|0|||
25231073|NCT03366103|50542258|FG000|Overall Study|Disease Progression|3|||
25231074|NCT03366103|50542259|FG001|Overall Study|Disease Progression|1|||
25231075|NCT03366103|50542260|FG002|Overall Study|Disease Progression|0|||
25231076|NCT03366103|50542258|FG000|Overall Study|Adverse Event|0|||
25231077|NCT03366103|50542259|FG001|Overall Study|Adverse Event|1|||
25231078|NCT03366103|50542260|FG002|Overall Study|Adverse Event|0|||
25231079|NCT03321526|50542273|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
25231080|NCT03321526|50542274|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
25231081|NCT03321526|50542273|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
25231082|NCT03321526|50542274|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
25231083|NCT03321526|50542273|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
25231084|NCT03321526|50542274|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
25231085|NCT03321526|50542273|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
25231086|NCT03321526|50542274|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
25231087|NCT03321526|50542273|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
25231088|NCT03321526|50542274|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
25231089|NCT03321526|50542273|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
25231090|NCT03321526|50542274|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
25231091|NCT03321526|50542273|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
25231092|NCT03321526|50542274|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
25231093|NCT03321526|50542273|FG000|Follow-up Phase (2 Weeks)|Other|24|||
25231094|NCT03321526|50542274|FG001|Follow-up Phase (2 Weeks)|Other|24|||
25231095|NCT03153111|50542288|FG000|Overall Study|Death|2|||
25231096|NCT03153111|50542289|FG001|Overall Study|Death|5|||
25231097|NCT03153111|50542288|FG000|Overall Study|Lost to Follow-up|1|||
25231098|NCT03153111|50542289|FG001|Overall Study|Lost to Follow-up|0|||
25231099|NCT03153111|50542288|FG000|Overall Study|Physician Decision|5|||
25231100|NCT03153111|50542289|FG001|Overall Study|Physician Decision|1|||
25231101|NCT03153111|50542288|FG000|Overall Study|Withdrawal by Subject|3|||
25231102|NCT03153111|50542289|FG001|Overall Study|Withdrawal by Subject|3|||
25231103|NCT03126435|50542297|FG000|Overall Study|Death|90|||
25231104|NCT03126435|50542298|FG001|Overall Study|Death|84|||
25231105|NCT03126435|50542297|FG000|Overall Study|Lost to Follow-up|4|||
25231106|NCT03126435|50542298|FG001|Overall Study|Lost to Follow-up|3|||
25231107|NCT03126435|50542297|FG000|Overall Study|Physician Decision|0|||
25231108|NCT03126435|50542298|FG001|Overall Study|Physician Decision|1|||
25231109|NCT03126435|50542297|FG000|Overall Study|Withdrawal by Subject|6|||
25231110|NCT03126435|50542298|FG001|Overall Study|Withdrawal by Subject|12|||
25231111|NCT03126435|50542297|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
25231112|NCT03126435|50542298|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
25231113|NCT02823574|50542319|FG000|Randomization|Disease Progression|0|||
25231114|NCT02823574|50542320|FG001|Randomization|Disease Progression|0|||
25231115|NCT02823574|50542321|FG002|Randomization|Disease Progression|1|||
25231116|NCT02823574|50542322|FG003|Randomization|Disease Progression|0|||
25231117|NCT02823574|50542319|FG000|Randomization|AE unrelated to Study Drug|1|||
25231118|NCT02823574|50542320|FG001|Randomization|AE unrelated to Study Drug|0|||
25231119|NCT02823574|50542321|FG002|Randomization|AE unrelated to Study Drug|0|||
25231120|NCT02823574|50542322|FG003|Randomization|AE unrelated to Study Drug|0|||
25231121|NCT02823574|50542319|FG000|Treatment Period|Poor/Non Compliance|1|||
25231122|NCT02823574|50542320|FG001|Treatment Period|Poor/Non Compliance|0|||
25231123|NCT02823574|50542321|FG002|Treatment Period|Poor/Non Compliance|0|||
25231124|NCT02823574|50542322|FG003|Treatment Period|Poor/Non Compliance|1|||
25231125|NCT02823574|50542319|FG000|Treatment Period|Maximum Clinical Benefit|8|||
25231126|NCT02823574|50542320|FG001|Treatment Period|Maximum Clinical Benefit|4|||
25231127|NCT02823574|50542321|FG002|Treatment Period|Maximum Clinical Benefit|7|||
25231128|NCT02823574|50542322|FG003|Treatment Period|Maximum Clinical Benefit|1|||
25231129|NCT02823574|50542319|FG000|Treatment Period|Lost to Follow-up|1|||
25231130|NCT02823574|50542320|FG001|Treatment Period|Lost to Follow-up|1|||
25231131|NCT02823574|50542321|FG002|Treatment Period|Lost to Follow-up|0|||
25231132|NCT02823574|50542322|FG003|Treatment Period|Lost to Follow-up|0|||
25231133|NCT02823574|50542319|FG000|Treatment Period|Participant withdrew consent|4|||
25231134|NCT02823574|50542320|FG001|Treatment Period|Participant withdrew consent|0|||
25231135|NCT02823574|50542321|FG002|Treatment Period|Participant withdrew consent|0|||
25231136|NCT02823574|50542322|FG003|Treatment Period|Participant withdrew consent|1|||
25231137|NCT02823574|50542319|FG000|Treatment Period|Participant request to discontinue|5|||
25231138|NCT02823574|50542320|FG001|Treatment Period|Participant request to discontinue|0|||
25231139|NCT02823574|50542321|FG002|Treatment Period|Participant request to discontinue|3|||
25231140|NCT02823574|50542322|FG003|Treatment Period|Participant request to discontinue|2|||
25231141|NCT02823574|50542319|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
25231142|NCT02823574|50542320|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
25231143|NCT02823574|50542321|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
25231144|NCT02823574|50542322|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
25231145|NCT02823574|50542319|FG000|Treatment Period|Study Drug Toxicity|11|||
25231146|NCT02823574|50542320|FG001|Treatment Period|Study Drug Toxicity|2|||
25231147|NCT02823574|50542321|FG002|Treatment Period|Study Drug Toxicity|14|||
24976640|NCT03451084|50065562|FG001|Overall Study|Physician Decision|0|||
25231148|NCT02823574|50542322|FG003|Treatment Period|Study Drug Toxicity|4|||
25231149|NCT02823574|50542319|FG000|Treatment Period|Disease Progression|113|||
25231150|NCT02823574|50542320|FG001|Treatment Period|Disease Progression|64|||
24976641|NCT03451084|50065563|FG002|Overall Study|Physician Decision|2|||
25231151|NCT02823574|50542321|FG002|Treatment Period|Disease Progression|82|||
25231152|NCT02823574|50542322|FG003|Treatment Period|Disease Progression|43|||
25231153|NCT02823574|50542319|FG000|Treatment Period|Other reasons|5|||
25231154|NCT02823574|50542320|FG001|Treatment Period|Other reasons|9|||
25231155|NCT02823574|50542321|FG002|Treatment Period|Other reasons|3|||
25231156|NCT02823574|50542322|FG003|Treatment Period|Other reasons|6|||
25231157|NCT02823574|50542319|FG000|Treatment Period|Participant no longer meets study criteria|0|||
25231158|NCT02823574|50542320|FG001|Treatment Period|Participant no longer meets study criteria|0|||
25231159|NCT02823574|50542321|FG002|Treatment Period|Participant no longer meets study criteria|1|||
25231160|NCT02823574|50542322|FG003|Treatment Period|Participant no longer meets study criteria|0|||
25231161|NCT02823574|50542319|FG000|Treatment Period|Death|0|||
25231162|NCT02823574|50542320|FG001|Treatment Period|Death|0|||
25231163|NCT02823574|50542321|FG002|Treatment Period|Death|3|||
25231164|NCT02823574|50542322|FG003|Treatment Period|Death|1|||
25231165|NCT02746809|50542335|FG000|Enrollment|Inclusion Exclusion not met|9|||
25231166|NCT02746809|50542335|FG000|Enrollment|Withdrawal by Subject|1|||
25231167|NCT02746809|50542335|FG000|Enrollment|Expected Enrollment Met|2|||
25231168|NCT02746809|50542335|FG000|Procedure|Death|1|||
25231169|NCT02746809|50542335|FG000|1-Month|Death|5|||
25231170|NCT02746809|50542335|FG000|6-Month|Death|2|||
25231171|NCT02746809|50542335|FG000|6-Month|Withdrawal by Subject|1|||
25231172|NCT02746809|50542335|FG000|12-Month|Death|3|||
25231173|NCT02746809|50542335|FG000|12-Month|Withdrawal by Subject|2|||
25231174|NCT02746809|50542335|FG000|24-Month|Death|1|||
25231175|NCT02746809|50542335|FG000|24-Month|Withdrawal by Subject|1|||
25231176|NCT02746809|50542335|FG000|36-Month|Death|8|||
25231177|NCT02746809|50542335|FG000|36-Month|Withdrawal by Subject|1|||
25231178|NCT02746809|50542335|FG000|48-Month|Death|7|||
25231179|NCT02746809|50542335|FG000|48-Month|Withdrawal by Subject|1|||
25231180|NCT02746809|50542335|FG000|60-Month|Death|1|||
25231181|NCT02746809|50542335|FG000|60-Month|Lost to Follow-up|2|||
25231182|NCT02525796|50542353|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
25231183|NCT02525796|50542354|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
25231184|NCT02525796|50542355|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
25231185|NCT02525796|50542353|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
25231186|NCT02525796|50542354|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
25231187|NCT02525796|50542355|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
25231188|NCT02525796|50542353|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
25231189|NCT02525796|50542354|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
25231190|NCT02525796|50542355|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
25231191|NCT02525796|50542353|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
25231192|NCT02525796|50542354|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
25231193|NCT02525796|50542355|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
25231194|NCT02525796|50542353|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
25231195|NCT02525796|50542354|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
25231196|NCT02525796|50542355|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
25231197|NCT02454933|50542371|FG000|Overall Study|Progressive disease|7|||
25231198|NCT02454933|50542372|FG001|Overall Study|Progressive disease|5|||
25231199|NCT02454933|50542371|FG000|Overall Study|Adverse Event|1|||
25231200|NCT02454933|50542372|FG001|Overall Study|Adverse Event|1|||
25231201|NCT02454933|50542371|FG000|Overall Study|Withdrawal by Subject|0|||
25231202|NCT02454933|50542372|FG001|Overall Study|Withdrawal by Subject|2|||
25231203|NCT02360280|50542379|FG000|Overall Study|Withdrawal by Subject|2|||
25231204|NCT02360280|50542380|FG001|Overall Study|Withdrawal by Subject|0|||
25231205|NCT02360280|50542379|FG000|Overall Study|Adverse Event|0|||
25231206|NCT02360280|50542380|FG001|Overall Study|Adverse Event|1|||
25231207|NCT02360280|50542379|FG000|Overall Study|Lost to Follow-up|1|||
25231208|NCT02360280|50542380|FG001|Overall Study|Lost to Follow-up|0|||
25231209|NCT02201251|50542388|FG000|Overall Study|Adverse Event|1|||
25231210|NCT02201251|50542389|FG001|Overall Study|Adverse Event|1|||
25231211|NCT02201251|50542388|FG000|Overall Study|Protocol Violation|1|||
25231212|NCT02201251|50542389|FG001|Overall Study|Protocol Violation|0|||
25231213|NCT02201251|50542388|FG000|Overall Study|Noncompliance with Study Drug|0|||
25231214|NCT02201251|50542389|FG001|Overall Study|Noncompliance with Study Drug|1|||
25231215|NCT02201251|50542388|FG000|Overall Study|Withdrawal by Subject|2|||
25231216|NCT02201251|50542389|FG001|Overall Study|Withdrawal by Subject|1|||
25231217|NCT02027545|50542397|FG000|Overall Study|Failed to sign HIPAA|0|||
25231218|NCT02027545|50542398|FG001|Overall Study|Failed to sign HIPAA|2|||
25231219|NCT02027545|50542397|FG000|Overall Study|Failed to attend study visit|2|||
25231220|NCT02027545|50542398|FG001|Overall Study|Failed to attend study visit|0|||
25231221|NCT02027545|50542397|FG000|Overall Study|Protocol Violation|1|||
25231222|NCT02027545|50542398|FG001|Overall Study|Protocol Violation|0|||
25231223|NCT01867242|50542428|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
25231224|NCT01867242|50542429|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
25231225|NCT01867242|50542430|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
25231226|NCT01858688|50542438|FG000|Overall Study|Withdrawal by Subject|8|||
25231227|NCT01858688|50542438|FG000|Overall Study|Participant began another therapy|3|||
25231228|NCT01858688|50542438|FG000|Overall Study|Physician Decision|2|||
25231229|NCT01858688|50542438|FG000|Overall Study|Progressive Disease|2|||
25231230|NCT01858688|50542438|FG000|Overall Study|Reason not reproted|5|||
25231231|NCT01698905|50542455|FG000|Overall Study|Adverse Event|4|||
25231232|NCT01698905|50542455|FG000|Overall Study|Physician Decision|2|||
25231233|NCT01698905|50542455|FG000|Overall Study|Pregnancy|1|||
25231234|NCT01698905|50542455|FG000|Overall Study|Protocol Violation|1|||
25231235|NCT01698905|50542455|FG000|Overall Study|Subject/guardian decision|2|||
25231236|NCT01698905|50542455|FG000|Overall Study|Death|1|||
25231237|NCT01599234|50542468|FG000|Overall Study|Adverse Event|9|||
25231238|NCT01599234|50542469|FG001|Overall Study|Adverse Event|5|||
25231239|NCT01599234|50542468|FG000|Overall Study|Withdrawal by Subject|2|||
25231240|NCT01599234|50542469|FG001|Overall Study|Withdrawal by Subject|1|||
25231241|NCT01599234|50542468|FG000|Overall Study|Lost to Follow-up|1|||
25231242|NCT01599234|50542469|FG001|Overall Study|Lost to Follow-up|2|||
25231243|NCT01599234|50542468|FG000|Overall Study|Lack of Efficacy|2|||
25231244|NCT01599234|50542469|FG001|Overall Study|Lack of Efficacy|4|||
25231245|NCT01599234|50542468|FG000|Overall Study|Unable to operate spray|1|||
25231246|NCT01599234|50542469|FG001|Overall Study|Unable to operate spray|0|||
25231247|NCT01599234|50542468|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
25231248|NCT01599234|50542469|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
25231249|NCT01599234|50542468|FG000|Overall Study|Death|1|||
25231250|NCT01599234|50542469|FG001|Overall Study|Death|0|||
25231251|NCT01599234|50542468|FG000|Overall Study|Patient would not stop driving|1|||
25231252|NCT01599234|50542469|FG001|Overall Study|Patient would not stop driving|0|||
25231253|NCT01599234|50542468|FG000|Overall Study|Contra-indication discovered|0|||
25231254|NCT01599234|50542469|FG001|Overall Study|Contra-indication discovered|1|||
25231255|NCT01599234|50542468|FG000|Overall Study|Pregnancy|0|||
25231256|NCT01599234|50542469|FG001|Overall Study|Pregnancy|1|||
25231257|NCT01586910|50542477|FG000|Overall Study|Death|4|||
25231258|NCT01586910|50542478|FG001|Overall Study|Death|4|||
25231259|NCT01586910|50542477|FG000|Overall Study|Withdrawal by Subject|6|||
25231260|NCT01586910|50542478|FG001|Overall Study|Withdrawal by Subject|43|||
25231261|NCT01586910|50542477|FG000|Overall Study|Physician withdrew Subject|5|||
25231262|NCT01586910|50542478|FG001|Overall Study|Physician withdrew Subject|24|||
25231263|NCT01393301|50542498|FG000|Overall Study|Lost to Follow-up|5|||
25231264|NCT01393301|50542499|FG001|Overall Study|Lost to Follow-up|3|||
25231265|NCT01393301|50542498|FG000|Overall Study|Withdrawal by Subject|2|||
25231266|NCT01393301|50542499|FG001|Overall Study|Withdrawal by Subject|0|||
25231267|NCT01393301|50542498|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
25231268|NCT01393301|50542499|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
25231269|NCT01274338|50542511|FG000|Overall Study|Lack of Efficacy|72|||
25231270|NCT01274338|50542512|FG001|Overall Study|Lack of Efficacy|108|||
25231271|NCT01274338|50542513|FG002|Overall Study|Lack of Efficacy|116|||
25231272|NCT01274338|50542514|FG003|Overall Study|Lack of Efficacy|0|||
25231273|NCT01274338|50542515|FG004|Overall Study|Lack of Efficacy|0|||
25231274|NCT01274338|50542516|FG005|Overall Study|Lack of Efficacy|0|||
25231275|NCT01274338|50542511|FG000|Overall Study|Adverse Event|272|||
25231276|NCT01274338|50542512|FG001|Overall Study|Adverse Event|105|||
25231277|NCT01274338|50542513|FG002|Overall Study|Adverse Event|180|||
25231278|NCT01274338|50542514|FG003|Overall Study|Adverse Event|1|||
25231279|NCT01274338|50542515|FG004|Overall Study|Adverse Event|0|||
25231280|NCT01274338|50542516|FG005|Overall Study|Adverse Event|0|||
24976642|NCT03451084|50065564|FG003|Overall Study|Physician Decision|2|||
24976643|NCT03451084|50065561|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
25231281|NCT01274338|50542511|FG000|Overall Study|Death|8|||
25231282|NCT01274338|50542512|FG001|Overall Study|Death|1|||
25231283|NCT01274338|50542513|FG002|Overall Study|Death|0|||
25231284|NCT01274338|50542514|FG003|Overall Study|Death|0|||
25231285|NCT01274338|50542515|FG004|Overall Study|Death|0|||
25231286|NCT01274338|50542516|FG005|Overall Study|Death|0|||
25231287|NCT01274338|50542511|FG000|Overall Study|Withdrawal by Subject|27|||
25231288|NCT01274338|50542512|FG001|Overall Study|Withdrawal by Subject|99|||
25231289|NCT01274338|50542513|FG002|Overall Study|Withdrawal by Subject|17|||
25231290|NCT01274338|50542514|FG003|Overall Study|Withdrawal by Subject|0|||
25231291|NCT01274338|50542515|FG004|Overall Study|Withdrawal by Subject|0|||
25231292|NCT01274338|50542516|FG005|Overall Study|Withdrawal by Subject|0|||
25231293|NCT01274338|50542511|FG000|Overall Study|Did not start treatment|8|||
25231294|NCT01274338|50542512|FG001|Overall Study|Did not start treatment|116|||
25231295|NCT01274338|50542513|FG002|Overall Study|Did not start treatment|7|||
25231296|NCT01274338|50542514|FG003|Overall Study|Did not start treatment|0|||
25231297|NCT01274338|50542515|FG004|Overall Study|Did not start treatment|0|||
25231298|NCT01274338|50542516|FG005|Overall Study|Did not start treatment|0|||
25231299|NCT01274338|50542511|FG000|Overall Study|Alternative therapy|0|||
25231300|NCT01274338|50542512|FG001|Overall Study|Alternative therapy|1|||
25231301|NCT01274338|50542513|FG002|Overall Study|Alternative therapy|0|||
25231302|NCT01274338|50542514|FG003|Overall Study|Alternative therapy|0|||
25231303|NCT01274338|50542515|FG004|Overall Study|Alternative therapy|0|||
25231304|NCT01274338|50542516|FG005|Overall Study|Alternative therapy|0|||
25231305|NCT01274338|50542511|FG000|Overall Study|Other complicating diseases|0|||
25231306|NCT01274338|50542512|FG001|Overall Study|Other complicating diseases|3|||
25231307|NCT01274338|50542513|FG002|Overall Study|Other complicating diseases|1|||
25231308|NCT01274338|50542514|FG003|Overall Study|Other complicating diseases|0|||
25231309|NCT01274338|50542515|FG004|Overall Study|Other complicating diseases|0|||
25231310|NCT01274338|50542516|FG005|Overall Study|Other complicating diseases|0|||
25231311|NCT01274338|50542511|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
25231312|NCT01274338|50542512|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
25231313|NCT01274338|50542513|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
25231314|NCT01274338|50542514|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
25231315|NCT01274338|50542515|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
25231316|NCT01274338|50542516|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
25231317|NCT01274338|50542511|FG000|Overall Study|Pregnancy|0|||
25231318|NCT01274338|50542512|FG001|Overall Study|Pregnancy|0|||
25231319|NCT01274338|50542513|FG002|Overall Study|Pregnancy|1|||
25231320|NCT01274338|50542514|FG003|Overall Study|Pregnancy|0|||
25231321|NCT01274338|50542515|FG004|Overall Study|Pregnancy|0|||
25231322|NCT01274338|50542516|FG005|Overall Study|Pregnancy|0|||
25231323|NCT01274338|50542511|FG000|Overall Study|Reason not reported|12|||
25231324|NCT01274338|50542512|FG001|Overall Study|Reason not reported|21|||
25231325|NCT01274338|50542513|FG002|Overall Study|Reason not reported|3|||
25231326|NCT01274338|50542514|FG003|Overall Study|Reason not reported|0|||
25231327|NCT01274338|50542515|FG004|Overall Study|Reason not reported|1|||
25231328|NCT01274338|50542516|FG005|Overall Study|Reason not reported|0|||
25231329|NCT01251861|50542531|FG000|Overall Study|Disease progression|6|||
25231330|NCT01251861|50542532|FG001|Overall Study|Disease progression|6|||
25231331|NCT01251861|50542531|FG000|Overall Study|Adverse Event|2|||
25231332|NCT01251861|50542532|FG001|Overall Study|Adverse Event|17|||
25231333|NCT01251861|50542531|FG000|Overall Study|Withdrawal by Subject|2|||
25231334|NCT01251861|50542532|FG001|Overall Study|Withdrawal by Subject|2|||
25231335|NCT01251861|50542531|FG000|Overall Study|Alternative therapy|1|||
25231336|NCT01251861|50542532|FG001|Overall Study|Alternative therapy|0|||
25231337|NCT01251861|50542531|FG000|Overall Study|Other complicating disease|0|||
25231338|NCT01251861|50542532|FG001|Overall Study|Other complicating disease|1|||
25231339|NCT01251861|50542531|FG000|Overall Study|Physician Decision|1|||
25231340|NCT01251861|50542532|FG001|Overall Study|Physician Decision|0|||
25231341|NCT01251861|50542531|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
25231342|NCT01251861|50542532|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
25231343|NCT01251861|50542531|FG000|Overall Study|Other|1|||
25231344|NCT01251861|50542532|FG001|Overall Study|Other|0|||
25231345|NCT01251861|50542531|FG000|Overall Study|Never started therapy|4|||
25231346|NCT01251861|50542532|FG001|Overall Study|Never started therapy|1|||
25231347|NCT01251861|50542531|FG000|Overall Study|Potential interaction of drugs|0|||
25231348|NCT01251861|50542532|FG001|Overall Study|Potential interaction of drugs|1|||
25231349|NCT01236560|50542544|FG000|Overall Study|Adverse Event|0|||
25231350|NCT01236560|50542545|FG001|Overall Study|Adverse Event|2|||
25231351|NCT01236560|50542546|FG002|Overall Study|Adverse Event|1|||
25231352|NCT01236560|50542547|FG003|Overall Study|Adverse Event|3|||
25231353|NCT01236560|50542548|FG004|Overall Study|Adverse Event|0|||
25231354|NCT01236560|50542549|FG005|Overall Study|Adverse Event|0|||
25231355|NCT01236560|50542544|FG000|Overall Study|Death|0|||
25231356|NCT01236560|50542545|FG001|Overall Study|Death|1|||
25231357|NCT01236560|50542546|FG002|Overall Study|Death|0|||
25231358|NCT01236560|50542547|FG003|Overall Study|Death|1|||
25231359|NCT01236560|50542548|FG004|Overall Study|Death|0|||
25231360|NCT01236560|50542549|FG005|Overall Study|Death|0|||
25231361|NCT01236560|50542544|FG000|Overall Study|Lost to Follow-up|0|||
25231362|NCT01236560|50542545|FG001|Overall Study|Lost to Follow-up|1|||
25231363|NCT01236560|50542546|FG002|Overall Study|Lost to Follow-up|1|||
25231364|NCT01236560|50542547|FG003|Overall Study|Lost to Follow-up|0|||
25231365|NCT01236560|50542548|FG004|Overall Study|Lost to Follow-up|0|||
25231366|NCT01236560|50542549|FG005|Overall Study|Lost to Follow-up|0|||
25319157|NCT00605293|50634565|FG000|Overall Study|Holidays Dialysis Out|1|||
25231367|NCT01236560|50542544|FG000|Overall Study|Physician Decision|0|||
25231368|NCT01236560|50542545|FG001|Overall Study|Physician Decision|1|||
25231369|NCT01236560|50542546|FG002|Overall Study|Physician Decision|8|||
25231370|NCT01236560|50542547|FG003|Overall Study|Physician Decision|0|||
25231371|NCT01236560|50542548|FG004|Overall Study|Physician Decision|0|||
25231372|NCT01236560|50542549|FG005|Overall Study|Physician Decision|0|||
25231373|NCT01236560|50542544|FG000|Overall Study|Withdrawal by Subject|0|||
25231374|NCT01236560|50542545|FG001|Overall Study|Withdrawal by Subject|0|||
25231375|NCT01236560|50542546|FG002|Overall Study|Withdrawal by Subject|1|||
25231376|NCT01236560|50542547|FG003|Overall Study|Withdrawal by Subject|2|||
25231377|NCT01236560|50542548|FG004|Overall Study|Withdrawal by Subject|0|||
25231378|NCT01236560|50542549|FG005|Overall Study|Withdrawal by Subject|0|||
25231379|NCT01236560|50542544|FG000|Overall Study|Progressive disease|5|||
25231380|NCT01236560|50542545|FG001|Overall Study|Progressive disease|19|||
25231381|NCT01236560|50542546|FG002|Overall Study|Progressive disease|9|||
25231382|NCT01236560|50542547|FG003|Overall Study|Progressive disease|16|||
25231383|NCT01236560|50542548|FG004|Overall Study|Progressive disease|0|||
25319158|NCT00605293|50634566|FG001|Overall Study|Holidays Dialysis Out|0|||
25319159|NCT00605293|50634565|FG000|Overall Study|Blood Transfusion|7|||
25319160|NCT00605293|50634566|FG001|Overall Study|Blood Transfusion|1|||
25319161|NCT00605293|50634565|FG000|Overall Study|Renal Transplantation|3|||
25319162|NCT00605293|50634566|FG001|Overall Study|Renal Transplantation|1|||
25319163|NCT00605293|50634565|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
25319164|NCT00605293|50634566|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
25319165|NCT00605293|50634565|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
25319166|NCT00605293|50634566|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
25319167|NCT00605293|50634565|FG000|Overall Study|Principal Investigator Decision|0|||
25319168|NCT00605293|50634566|FG001|Overall Study|Principal Investigator Decision|1|||
25319169|NCT00572533|50634574|FG000|Overall Study|Death|4|||
25231384|NCT01236560|50542549|FG005|Overall Study|Progressive disease|0|||
25231385|NCT00843882|50542562|FG000|Step 1|Lack of Efficacy|14|||
25231386|NCT00843882|50542563|FG001|Step 1|Lack of Efficacy|10|||
25231387|NCT00843882|50542564|FG002|Step 1|Lack of Efficacy|21|||
25231388|NCT00843882|50542562|FG000|Step 1|Adverse Event|8|||
25231389|NCT00843882|50542563|FG001|Step 1|Adverse Event|17|||
25231390|NCT00843882|50542564|FG002|Step 1|Adverse Event|20|||
25231391|NCT00843882|50542562|FG000|Step 1|Death|1|||
25231392|NCT00843882|50542563|FG001|Step 1|Death|2|||
25231393|NCT00843882|50542564|FG002|Step 1|Death|4|||
25231394|NCT00843882|50542562|FG000|Step 1|Withdrawal by Subject|6|||
25231395|NCT00843882|50542563|FG001|Step 1|Withdrawal by Subject|12|||
25231396|NCT00843882|50542564|FG002|Step 1|Withdrawal by Subject|9|||
25231397|NCT00843882|50542562|FG000|Step 1|Physician Decision|0|||
25231398|NCT00843882|50542563|FG001|Step 1|Physician Decision|5|||
25231399|NCT00843882|50542564|FG002|Step 1|Physician Decision|1|||
25231400|NCT00843882|50542562|FG000|Step 1|Patient and physician's decision|0|||
25231401|NCT00843882|50542563|FG001|Step 1|Patient and physician's decision|0|||
25231402|NCT00843882|50542564|FG002|Step 1|Patient and physician's decision|1|||
25231403|NCT00843882|50542562|FG000|Step 1|Other complicating disease|1|||
25231404|NCT00843882|50542563|FG001|Step 1|Other complicating disease|3|||
25231405|NCT00843882|50542564|FG002|Step 1|Other complicating disease|4|||
25231406|NCT00843882|50542562|FG000|Step 1|Alternative therapy|0|||
25231407|NCT00843882|50542563|FG001|Step 1|Alternative therapy|1|||
25231408|NCT00843882|50542564|FG002|Step 1|Alternative therapy|1|||
25231409|NCT00843882|50542562|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
25231410|NCT00843882|50542563|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
25231411|NCT00843882|50542564|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
25231412|NCT00843882|50542562|FG000|Step 1|Off treatment reason unknown|0|||
25231413|NCT00843882|50542563|FG001|Step 1|Off treatment reason unknown|1|||
25231414|NCT00843882|50542564|FG002|Step 1|Off treatment reason unknown|4|||
25231415|NCT00843882|50542562|FG000|Step 1|Never started treatment|2|||
25231416|NCT00843882|50542563|FG001|Step 1|Never started treatment|0|||
25231417|NCT00843882|50542564|FG002|Step 1|Never started treatment|0|||
25231418|NCT00843882|50542562|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
25231419|NCT00843882|50542563|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
25231420|NCT00843882|50542564|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
25231421|NCT00843882|50542562|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
25231422|NCT00843882|50542563|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
25231423|NCT00843882|50542564|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
25231424|NCT00843882|50542562|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
25231425|NCT00843882|50542563|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
25231426|NCT00843882|50542564|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
25231427|NCT00843882|50542562|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
25231428|NCT00843882|50542563|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
25231429|NCT00843882|50542564|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
25319170|NCT00572533|50634575|FG001|Overall Study|Death|1|||
25319171|NCT00572533|50634574|FG000|Overall Study|Received Kidney Transplant|2|||
25319172|NCT00572533|50634575|FG001|Overall Study|Received Kidney Transplant|1|||
25231430|NCT00843882|50542562|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
25231431|NCT00843882|50542563|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
25319173|NCT00572533|50634574|FG000|Overall Study|Social Issues|1|||
25319174|NCT00572533|50634575|FG001|Overall Study|Social Issues|0|||
25231432|NCT00843882|50542564|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
25231433|NCT00843882|50542562|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
25231434|NCT00843882|50542563|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
25231435|NCT00843882|50542564|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
25231436|NCT00843882|50542562|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
25231437|NCT00843882|50542563|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
25231438|NCT00843882|50542564|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
25231439|NCT00716625|50542577|FG000|Overall Study|Safety was not Assessable|1|||
25231440|NCT00713323|50542604|FG000|Overall Study|Adverse Event|75|||
25231441|NCT00713323|50542604|FG000|Overall Study|Withdrawal by Subject|15|||
25231442|NCT00713323|50542604|FG000|Overall Study|Lost to Follow-up|11|||
25231443|NCT00713323|50542604|FG000|Overall Study|Lack of Efficacy|36|||
25231444|NCT00713323|50542604|FG000|Overall Study|Low creatine clearance at screening|1|||
25231445|NCT00713323|50542604|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
25231446|NCT00713323|50542604|FG000|Overall Study|Surgery cured allodynic pain|1|||
25231447|NCT00713323|50542604|FG000|Overall Study|Pain free|1|||
25231448|NCT00713323|50542604|FG000|Overall Study|Non-compliance|1|||
25231449|NCT00713323|50542604|FG000|Overall Study|Pain resolved|1|||
25231450|NCT00713323|50542604|FG000|Overall Study|Subject travelling to USA|1|||
25231451|NCT00713323|50542604|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
25231452|NCT00713323|50542604|FG000|Overall Study|Treatment that may interact with Sativex|1|||
25231453|NCT00710554|50542621|FG000|Overall Study|Adverse Event|24|||
25231454|NCT00710554|50542622|FG001|Overall Study|Adverse Event|7|||
25231455|NCT00710554|50542621|FG000|Overall Study|Withdrawal by Subject|7|||
25231456|NCT00710554|50542622|FG001|Overall Study|Withdrawal by Subject|3|||
25231457|NCT00710554|50542621|FG000|Overall Study|Lost to Follow-up|7|||
25231458|NCT00710554|50542622|FG001|Overall Study|Lost to Follow-up|1|||
25231459|NCT00710554|50542621|FG000|Overall Study|Lack of Efficacy|11|||
25231460|NCT00710554|50542622|FG001|Overall Study|Lack of Efficacy|12|||
25231461|NCT00710554|50542621|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
25231462|NCT00710554|50542622|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
25231463|NCT00710424|50542630|FG000|Overall Study|Adverse Event|30|||
25231464|NCT00710424|50542631|FG001|Overall Study|Adverse Event|12|||
25231465|NCT00710424|50542630|FG000|Overall Study|Lack of Efficacy|4|||
25231466|NCT00710424|50542631|FG001|Overall Study|Lack of Efficacy|5|||
25231467|NCT00710424|50542630|FG000|Overall Study|Withdrawal by Subject|5|||
25231468|NCT00710424|50542631|FG001|Overall Study|Withdrawal by Subject|3|||
25231469|NCT00710424|50542630|FG000|Overall Study|Lost to Follow-up|0|||
25231470|NCT00710424|50542631|FG001|Overall Study|Lost to Follow-up|1|||
25231471|NCT00710424|50542630|FG000|Overall Study|Refused medication, no side effects|1|||
25231472|NCT00710424|50542631|FG001|Overall Study|Refused medication, no side effects|0|||
25231473|NCT00710424|50542630|FG000|Overall Study|Non-compliance with stable analgesia|1|||
25231474|NCT00710424|50542631|FG001|Overall Study|Non-compliance with stable analgesia|0|||
25231475|NCT00710424|50542630|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
25231476|NCT00710424|50542631|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
25231477|NCT00710424|50542630|FG000|Overall Study|Subject thought medication changed|1|||
25231478|NCT00710424|50542631|FG001|Overall Study|Subject thought medication changed|0|||
25231479|NCT00710424|50542630|FG000|Overall Study|Ceased treatment due to travel|1|||
25231480|NCT00710424|50542631|FG001|Overall Study|Ceased treatment due to travel|0|||
25231481|NCT00710424|50542630|FG000|Overall Study|Subject preferred paracetamol|0|||
25231482|NCT00710424|50542631|FG001|Overall Study|Subject preferred paracetamol|1|||
25231483|NCT00710424|50542630|FG000|Overall Study|Felt good so stopped treatment|0|||
25231484|NCT00710424|50542631|FG001|Overall Study|Felt good so stopped treatment|1|||
25231485|NCT00644228|50542652|FG000|Randomization & Eligibility|Ineligible|31|||
25231486|NCT00644228|50542653|FG001|Randomization & Eligibility|Ineligible|21|||
25231487|NCT00644228|50542652|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
25231488|NCT00644228|50542653|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
25231489|NCT00644228|50542652|FG000|Randomization & Eligibility|Invalid Consent|0|||
25231490|NCT00644228|50542653|FG001|Randomization & Eligibility|Invalid Consent|1|||
25231491|NCT00644228|50542652|FG000|Induction Therapy|Adverse Event|22|||
25231492|NCT00644228|50542653|FG001|Induction Therapy|Adverse Event|55|||
25231493|NCT00644228|50542652|FG000|Induction Therapy|Withdrawal by Subject|10|||
25231494|NCT00644228|50542653|FG001|Induction Therapy|Withdrawal by Subject|3|||
25231495|NCT00644228|50542652|FG000|Induction Therapy|Progression/Relapse|24|||
25231496|NCT00644228|50542653|FG001|Induction Therapy|Progression/Relapse|12|||
25231497|NCT00644228|50542652|FG000|Induction Therapy|Death|3|||
25231498|NCT00644228|50542653|FG001|Induction Therapy|Death|7|||
25231499|NCT00644228|50542652|FG000|Induction Therapy|Not Protocol-Specified|24|||
25231500|NCT00644228|50542653|FG001|Induction Therapy|Not Protocol-Specified|28|||
25231501|NCT00644228|50542652|FG000|Maintenance|Adverse Event|27|||
25231502|NCT00644228|50542653|FG001|Maintenance|Adverse Event|31|||
25231503|NCT00644228|50542652|FG000|Maintenance|Withdrawal by Subject|6|||
25231504|NCT00644228|50542653|FG001|Maintenance|Withdrawal by Subject|4|||
25231505|NCT00644228|50542652|FG000|Maintenance|Progression/Relapse|67|||
25231506|NCT00644228|50542653|FG001|Maintenance|Progression/Relapse|42|||
25231507|NCT00644228|50542652|FG000|Maintenance|Death|3|||
25231508|NCT00644228|50542653|FG001|Maintenance|Death|3|||
25231509|NCT00644228|50542652|FG000|Maintenance|Not Protocol-Specified|14|||
25231510|NCT00644228|50542653|FG001|Maintenance|Not Protocol-Specified|15|||
25231511|NCT00644228|50542652|FG000|Maintenance|On Treatment|26|||
25319175|NCT00572533|50634574|FG000|Overall Study|Transfer out of Facility|0|||
25319176|NCT00572533|50634575|FG001|Overall Study|Transfer out of Facility|1|||
25319177|NCT00949715|50634583|FG000|Overall Study|Physician Decision|1|||
25319178|NCT00949715|50634584|FG001|Overall Study|Physician Decision|0|||
25319179|NCT00949715|50634583|FG000|Overall Study|Lost to Follow-up|1|||
25319180|NCT00949715|50634584|FG001|Overall Study|Lost to Follow-up|0|||
25319181|NCT00949715|50634583|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
25319182|NCT00949715|50634584|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
25319183|NCT00791661|50634592|FG000|7 Day Wash-out|Adverse Event|0|||
25319184|NCT00791661|50634593|FG001|7 Day Wash-out|Adverse Event|0|||
25319185|NCT00791661|50634594|FG002|7 Day Wash-out|Adverse Event|1|||
25319186|NCT00791661|50634592|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
25319187|NCT00791661|50634593|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
25319188|NCT00791661|50634594|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
25319189|NCT00943787|50634618|FG000|Overall Study|Physician Decision|4|||
25319190|NCT00943787|50634618|FG000|Overall Study|Withdrawal by Subject|3|||
25319191|NCT00949325|50634622|FG000|Overall Study|Adverse Event|0|||
25319192|NCT00949325|50634623|FG001|Overall Study|Adverse Event|2|||
25319193|NCT00949325|50634624|FG002|Overall Study|Adverse Event|0|||
25319194|NCT00943319|50634640|FG000|Overall Study|Death|1|||
25319195|NCT00790647|50634644|FG000|Overall Study|Adverse Event|1|||
25319196|NCT00790569|50634653|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
25319197|NCT00790569|50634654|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
25319198|NCT00790569|50634655|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
25319199|NCT00790569|50634653|FG000|End of Treatment (6 Month Interview)|Death|0|||
25319200|NCT00790569|50634654|FG001|End of Treatment (6 Month Interview)|Death|2|||
25319201|NCT00790569|50634655|FG002|End of Treatment (6 Month Interview)|Death|1|||
25319202|NCT00790569|50634653|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
25319203|NCT00790569|50634654|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
25319204|NCT00790569|50634655|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
25319205|NCT00790569|50634653|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
25319206|NCT00790569|50634654|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
25319207|NCT00790569|50634655|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
25319208|NCT00790569|50634653|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
25319209|NCT00790569|50634654|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
25319210|NCT00790569|50634655|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
25319211|NCT00790569|50634653|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
25319212|NCT00790569|50634654|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
25319213|NCT00790569|50634655|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
25319214|NCT00939029|50634665|FG000|Overall Study|Withdrawal by Subject|3|||
25319215|NCT00939029|50634666|FG001|Overall Study|Withdrawal by Subject|7|||
25319216|NCT00939029|50634665|FG000|Overall Study|Lost to Follow-up|3|||
25319217|NCT00939029|50634666|FG001|Overall Study|Lost to Follow-up|4|||
25319218|NCT00939029|50634665|FG000|Overall Study|Adverse Event|0|||
25319219|NCT00939029|50634666|FG001|Overall Study|Adverse Event|1|||
25319220|NCT00587847|50634672|FG000|Overall Study|Lack of Efficacy|5|||
25319221|NCT00587847|50634672|FG000|Overall Study|Adverse Event|2|||
25319222|NCT00784563|50634680|FG000|Years 1 & 2|Withdrawal by Subject|3|||
25319223|NCT00784563|50634681|FG001|Years 1 & 2|Withdrawal by Subject|2|||
25319224|NCT00784563|50634682|FG002|Years 1 & 2|Withdrawal by Subject|0|||
25319225|NCT00784563|50634680|FG000|Years 1 & 2|Adverse Event|0|||
25319226|NCT00784563|50634681|FG001|Years 1 & 2|Adverse Event|3|||
25319227|NCT00784563|50634682|FG002|Years 1 & 2|Adverse Event|0|||
25231512|NCT00644228|50542653|FG001|Maintenance|On Treatment|40|||
25231513|NCT00118846|50542670|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
25231514|NCT00118846|50542671|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
25319228|NCT00784563|50634680|FG000|Year 3|Withdrawal by Subject|0|||
25319229|NCT00784563|50634681|FG001|Year 3|Withdrawal by Subject|0|||
25319230|NCT00784563|50634682|FG002|Year 3|Withdrawal by Subject|2|||
25319231|NCT00784563|50634680|FG000|Year 3|Adverse Event|0|||
25319232|NCT00784563|50634681|FG001|Year 3|Adverse Event|0|||
25319233|NCT00784563|50634682|FG002|Year 3|Adverse Event|1|||
25319234|NCT00938717|50634690|FG000|Overall Study|Adverse Event|10|||
25319235|NCT00938717|50634691|FG001|Overall Study|Adverse Event|41|||
25319236|NCT00938717|50634690|FG000|Overall Study|Protocol Violation|11|||
25319237|NCT00938717|50634691|FG001|Overall Study|Protocol Violation|8|||
25231515|NCT00118846|50542670|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
25231516|NCT00118846|50542671|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
25231517|NCT00118846|50542670|FG000|Overall Study|Physician Decision|1|||
25231518|NCT00118846|50542671|FG001|Overall Study|Physician Decision|0|||
25231519|NCT00118846|50542670|FG000|Overall Study|Medical condition|2|||
25231520|NCT00118846|50542671|FG001|Overall Study|Medical condition|2|||
25231521|NCT00118846|50542670|FG000|Overall Study|Lost to Follow-up|0|||
25231522|NCT00118846|50542671|FG001|Overall Study|Lost to Follow-up|2|||
25231523|NCT00118846|50542670|FG000|Overall Study|Personal reason|4|||
25231524|NCT00118846|50542671|FG001|Overall Study|Personal reason|5|||
25231525|NCT00026312|50542679|FG000|Overall Study|Adverse Event|0|||
25231526|NCT00026312|50542680|FG001|Overall Study|Adverse Event|32|||
25231527|NCT00026312|50542679|FG000|Overall Study|Death|1|||
25231528|NCT00026312|50542680|FG001|Overall Study|Death|7|||
25231529|NCT00026312|50542679|FG000|Overall Study|Lack of Efficacy|19|||
25231530|NCT00026312|50542680|FG001|Overall Study|Lack of Efficacy|114|||
25231531|NCT00026312|50542679|FG000|Overall Study|Lost to Follow-up|0|||
25231532|NCT00026312|50542680|FG001|Overall Study|Lost to Follow-up|5|||
25231533|NCT00026312|50542679|FG000|Overall Study|Physician Decision|1|||
25231534|NCT00026312|50542680|FG001|Overall Study|Physician Decision|37|||
25231535|NCT00026312|50542679|FG000|Overall Study|Protocol Violation|0|||
25231536|NCT00026312|50542680|FG001|Overall Study|Protocol Violation|3|||
25231537|NCT00026312|50542679|FG000|Overall Study|Withdrawal by Subject|1|||
25231538|NCT00026312|50542680|FG001|Overall Study|Withdrawal by Subject|6|||
25231539|NCT00026312|50542679|FG000|Overall Study|Ineligible|4|||
25231540|NCT00026312|50542680|FG001|Overall Study|Ineligible|5|||
25231541|NCT00026312|50542679|FG000|Overall Study|Entry onto another COG study|0|||
25231542|NCT00026312|50542680|FG001|Overall Study|Entry onto another COG study|1|||
25231543|NCT00026312|50542679|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
25231544|NCT00026312|50542680|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
25231545|NCT04705051|50542690|FG000|Overall Study|Enrolled but not treated|1|||
25231546|NCT04705051|50542690|FG000|Overall Study|Study terminated by sponsor|23|||
25231547|NCT04464421|50542697|FG000|Overall Study|Lost to Follow-up|2|||
25231548|NCT04464421|50542698|FG001|Overall Study|Lost to Follow-up|2|||
25231549|NCT04112784|50542716|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
25231550|NCT04112784|50542716|FG000|Overall Study|Screen Failures|4|||
25231551|NCT04049617|50542726|FG000|Overall Study|Adverse Event|0|||
25231552|NCT04049617|50542727|FG001|Overall Study|Adverse Event|0|||
25231553|NCT04049617|50542728|FG002|Overall Study|Adverse Event|0|||
25231554|NCT04049617|50542729|FG003|Overall Study|Adverse Event|1|||
25231555|NCT04049617|50542730|FG004|Overall Study|Adverse Event|0|||
25231556|NCT04049617|50542731|FG005|Overall Study|Adverse Event|0|||
25231557|NCT04049617|50542726|FG000|Overall Study|Death|0|||
25231558|NCT04049617|50542727|FG001|Overall Study|Death|0|||
25231559|NCT04049617|50542728|FG002|Overall Study|Death|0|||
25231560|NCT04049617|50542729|FG003|Overall Study|Death|0|||
25231561|NCT04049617|50542730|FG004|Overall Study|Death|0|||
25231562|NCT04049617|50542731|FG005|Overall Study|Death|1|||
25231563|NCT04049617|50542726|FG000|Overall Study|Lost to Follow-up|0|||
25231564|NCT04049617|50542727|FG001|Overall Study|Lost to Follow-up|0|||
25231565|NCT04049617|50542728|FG002|Overall Study|Lost to Follow-up|0|||
25231566|NCT04049617|50542729|FG003|Overall Study|Lost to Follow-up|1|||
25231567|NCT04049617|50542730|FG004|Overall Study|Lost to Follow-up|0|||
25231568|NCT04049617|50542731|FG005|Overall Study|Lost to Follow-up|0|||
25319238|NCT00938717|50634690|FG000|Overall Study|Withdrawal by Subject|26|||
25319239|NCT00938717|50634691|FG001|Overall Study|Withdrawal by Subject|24|||
25319240|NCT00938717|50634690|FG000|Overall Study|Lost to Follow-up|13|||
25319241|NCT00938717|50634691|FG001|Overall Study|Lost to Follow-up|18|||
25319242|NCT00938717|50634690|FG000|Overall Study|Lack of Efficacy|33|||
25319243|NCT00938717|50634691|FG001|Overall Study|Lack of Efficacy|15|||
25319244|NCT00938717|50634690|FG000|Overall Study|Other reason|5|||
25319245|NCT00938717|50634691|FG001|Overall Study|Other reason|2|||
25319246|NCT00587223|50634697|FG000|Overall Study|Adverse Event|1|||
25319247|NCT00938639|50634706|FG000|Overall Study|Moved away from study area|0|||
25319248|NCT00938639|50634707|FG001|Overall Study|Moved away from study area|1|||
25319249|NCT00938639|50634706|FG000|Overall Study|Lost to Follow-up|1|||
25319250|NCT00938639|50634707|FG001|Overall Study|Lost to Follow-up|2|||
25231569|NCT04049617|50542726|FG000|Overall Study|Withdrew consent|0|||
25231570|NCT04049617|50542727|FG001|Overall Study|Withdrew consent|0|||
25319251|NCT00938639|50634706|FG000|Overall Study|Family issues|1|||
25231571|NCT04049617|50542728|FG002|Overall Study|Withdrew consent|1|||
25231572|NCT04049617|50542729|FG003|Overall Study|Withdrew consent|0|||
25231573|NCT04049617|50542730|FG004|Overall Study|Withdrew consent|0|||
25319252|NCT00938639|50634707|FG001|Overall Study|Family issues|1|||
25231574|NCT04049617|50542731|FG005|Overall Study|Withdrew consent|0|||
25231575|NCT03911154|50542747|FG000|Overall Study|Withdrawal by Subject|1|||
25319253|NCT00938639|50634706|FG000|Overall Study|Participant noncompliance|1|||
25319254|NCT00938639|50634707|FG001|Overall Study|Participant noncompliance|0|||
25077501|NCT00002663|50185283|FG008|Overall Study|Physician Decision|1|||
25231576|NCT03781778|50542765|FG000|Overall Study|Withdrawal by Subject|2|||
25231577|NCT03781778|50542766|FG001|Overall Study|Withdrawal by Subject|2|||
25231578|NCT03710590|50542774|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
25231579|NCT03710590|50542775|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
25231580|NCT03470922|50542836|FG000|Overall Study|Death|107|||
25231581|NCT03470922|50542837|FG001|Overall Study|Death|118|||
25231582|NCT03470922|50542836|FG000|Overall Study|Lost to Follow-up|5|||
25231583|NCT03470922|50542837|FG001|Overall Study|Lost to Follow-up|5|||
25231584|NCT03470922|50542836|FG000|Overall Study|Participant Withdrew Consent|4|||
25231585|NCT03470922|50542837|FG001|Overall Study|Participant Withdrew Consent|9|||
25231586|NCT03470922|50542836|FG000|Overall Study|Other reasons|1|||
25231587|NCT03470922|50542837|FG001|Overall Study|Other reasons|0|||
25231588|NCT03470922|50542836|FG000|Overall Study|Not reported|1|||
25231589|NCT03470922|50542837|FG001|Overall Study|Not reported|0|||
25231590|NCT03465722|50542845|FG000|Overall Study|Withdrawal by Subject|21|||
25231591|NCT03465722|50542846|FG001|Overall Study|Withdrawal by Subject|14|||
25231592|NCT03465722|50542845|FG000|Overall Study|Death|89|||
25231593|NCT03465722|50542846|FG001|Overall Study|Death|87|||
25231594|NCT03465722|50542845|FG000|Overall Study|Lost to Follow-up|5|||
25231595|NCT03465722|50542846|FG001|Overall Study|Lost to Follow-up|3|||
25231596|NCT03465722|50542845|FG000|Overall Study|Administrative/Other|33|||
25231597|NCT03465722|50542846|FG001|Overall Study|Administrative/Other|32|||
25231598|NCT03465722|50542845|FG000|Overall Study|Not treated|1|||
25231599|NCT03465722|50542846|FG001|Overall Study|Not treated|2|||
25231600|NCT03465722|50542845|FG000|Overall Study|Sponsor decision|91|||
25231601|NCT03465722|50542846|FG001|Overall Study|Sponsor decision|98|||
25231602|NCT03205423|50542852|FG000|Overall Study|Personal|1|||
25231603|NCT03205423|50542853|FG001|Overall Study|Personal|1|||
25231604|NCT03205423|50542852|FG000|Overall Study|Physician Decision|0|||
25231605|NCT03205423|50542853|FG001|Overall Study|Physician Decision|2|||
25231606|NCT03104400|50542864|FG000|Overall Study|Adverse Event|5|||
25231607|NCT03104400|50542865|FG001|Overall Study|Adverse Event|7|||
25231608|NCT03104400|50542866|FG002|Overall Study|Adverse Event|11|||
25231609|NCT03104400|50542867|FG003|Overall Study|Adverse Event|9|||
25231610|NCT03104400|50542868|FG004|Overall Study|Adverse Event|21|||
25231611|NCT03104400|50542864|FG000|Overall Study|Withdrawal by Subject|17|||
25231612|NCT03104400|50542865|FG001|Overall Study|Withdrawal by Subject|19|||
25231613|NCT03104400|50542866|FG002|Overall Study|Withdrawal by Subject|29|||
25231614|NCT03104400|50542867|FG003|Overall Study|Withdrawal by Subject|25|||
25231615|NCT03104400|50542868|FG004|Overall Study|Withdrawal by Subject|24|||
25231616|NCT03104400|50542864|FG000|Overall Study|Lost to Follow-up|4|||
25231617|NCT03104400|50542865|FG001|Overall Study|Lost to Follow-up|1|||
25231618|NCT03104400|50542866|FG002|Overall Study|Lost to Follow-up|4|||
25231619|NCT03104400|50542867|FG003|Overall Study|Lost to Follow-up|8|||
25231620|NCT03104400|50542868|FG004|Overall Study|Lost to Follow-up|7|||
25231621|NCT03104400|50542864|FG000|Overall Study|Lack of Efficacy|6|||
25231622|NCT03104400|50542865|FG001|Overall Study|Lack of Efficacy|3|||
25231623|NCT03104400|50542866|FG002|Overall Study|Lack of Efficacy|8|||
25231624|NCT03104400|50542867|FG003|Overall Study|Lack of Efficacy|2|||
25231625|NCT03104400|50542868|FG004|Overall Study|Lack of Efficacy|1|||
25231626|NCT03104400|50542864|FG000|Overall Study|COVID Logistical Restrictions|0|||
25231627|NCT03104400|50542865|FG001|Overall Study|COVID Logistical Restrictions|0|||
25231628|NCT03104400|50542866|FG002|Overall Study|COVID Logistical Restrictions|0|||
25231629|NCT03104400|50542867|FG003|Overall Study|COVID Logistical Restrictions|1|||
25231630|NCT03104400|50542868|FG004|Overall Study|COVID Logistical Restrictions|0|||
25231631|NCT03104400|50542864|FG000|Overall Study|Other|2|||
25231632|NCT03104400|50542865|FG001|Overall Study|Other|3|||
25231633|NCT03104400|50542866|FG002|Overall Study|Other|7|||
25231634|NCT03104400|50542867|FG003|Overall Study|Other|6|||
25231635|NCT03104400|50542868|FG004|Overall Study|Other|4|||
25231636|NCT03104400|50542864|FG000|Overall Study|Other|0|||
25231637|NCT03104400|50542865|FG001|Overall Study|Other|1|||
25231638|NCT03104400|50542866|FG002|Overall Study|Other|0|||
25231639|NCT03104400|50542867|FG003|Overall Study|Other|0|||
25231640|NCT03104400|50542868|FG004|Overall Study|Other|0|||
25231641|NCT03104374|50542885|FG000|Overall Study|Adverse Event|7|||
25319255|NCT00783705|50634719|FG000|Overall Study|Adverse Event|2|||
25077502|NCT00002663|50185284|FG009|Overall Study|Physician Decision|1|||
25231642|NCT03104374|50542886|FG001|Overall Study|Adverse Event|6|||
25231643|NCT03104374|50542887|FG002|Overall Study|Adverse Event|12|||
25231644|NCT03104374|50542888|FG003|Overall Study|Adverse Event|15|||
25231645|NCT03104374|50542885|FG000|Overall Study|Withdrawal by Subject|18|||
25231646|NCT03104374|50542886|FG001|Overall Study|Withdrawal by Subject|10|||
25231647|NCT03104374|50542887|FG002|Overall Study|Withdrawal by Subject|10|||
25231648|NCT03104374|50542888|FG003|Overall Study|Withdrawal by Subject|17|||
25231649|NCT03104374|50542885|FG000|Overall Study|Lost to Follow-up|4|||
25231650|NCT03104374|50542886|FG001|Overall Study|Lost to Follow-up|4|||
25231651|NCT03104374|50542887|FG002|Overall Study|Lost to Follow-up|6|||
25231652|NCT03104374|50542888|FG003|Overall Study|Lost to Follow-up|8|||
25231653|NCT03104374|50542885|FG000|Overall Study|Lack of Efficacy|6|||
25231654|NCT03104374|50542886|FG001|Overall Study|Lack of Efficacy|7|||
25231655|NCT03104374|50542887|FG002|Overall Study|Lack of Efficacy|12|||
25231656|NCT03104374|50542888|FG003|Overall Study|Lack of Efficacy|6|||
25231657|NCT03104374|50542885|FG000|Overall Study|Other|2|||
25231658|NCT03104374|50542886|FG001|Overall Study|Other|2|||
25231659|NCT03104374|50542887|FG002|Overall Study|Other|4|||
25231660|NCT03104374|50542888|FG003|Overall Study|Other|7|||
25231661|NCT03073603|50542900|FG000|Overall Study|Noncompliance|3|||
25231662|NCT03073603|50542901|FG001|Overall Study|Noncompliance|1|||
25231663|NCT03073603|50542900|FG000|Overall Study|Adverse Event|5|||
25231664|NCT03073603|50542901|FG001|Overall Study|Adverse Event|3|||
25231665|NCT03073603|50542900|FG000|Overall Study|Physician Decision|1|||
25231666|NCT03073603|50542901|FG001|Overall Study|Physician Decision|2|||
25231667|NCT03073603|50542900|FG000|Overall Study|Required treatment not allowed by protocol|1|||
25231668|NCT03073603|50542901|FG001|Overall Study|Required treatment not allowed by protocol|0|||
25231669|NCT03073603|50542900|FG000|Overall Study|Financial or insurance-related|8|||
25231670|NCT03073603|50542901|FG001|Overall Study|Financial or insurance-related|0|||
25231671|NCT03073603|50542900|FG000|Overall Study|Withdrawal by Subject|0|||
25231672|NCT03073603|50542901|FG001|Overall Study|Withdrawal by Subject|1|||
25231673|NCT03073603|50542900|FG000|Overall Study|Discontinued DMT|4|||
25231674|NCT03073603|50542901|FG001|Overall Study|Discontinued DMT|0|||
25231675|NCT03073603|50542900|FG000|Overall Study|Restarted DMT|0|||
25231676|NCT03073603|50542901|FG001|Overall Study|Restarted DMT|1|||
25231677|NCT03002155|50542913|FG000|Overall Study|Lost to Follow-up|1|||
25231678|NCT03002155|50542914|FG001|Overall Study|Lost to Follow-up|2|||
25231679|NCT03002155|50542913|FG000|Overall Study|Withdrawal by Subject|1|||
25231680|NCT03002155|50542914|FG001|Overall Study|Withdrawal by Subject|0|||
25231681|NCT03002155|50542913|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
25231682|NCT03002155|50542914|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
25231683|NCT02918006|50542924|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
25231684|NCT02918006|50542925|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
25231685|NCT02918006|50542926|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
25231686|NCT02918006|50542924|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
25231687|NCT02918006|50542925|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
25231688|NCT02918006|50542926|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
25231689|NCT02918006|50542924|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
25231690|NCT02918006|50542925|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
25231691|NCT02918006|50542926|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
25231692|NCT02918006|50542924|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
25231693|NCT02918006|50542925|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
25231694|NCT02918006|50542926|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
25231695|NCT02918006|50542924|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
25231696|NCT02918006|50542925|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
25231697|NCT02918006|50542926|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
25231698|NCT02918006|50542924|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
25231699|NCT02918006|50542925|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
25231700|NCT02918006|50542926|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
25231701|NCT02918006|50542924|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
25231702|NCT02918006|50542925|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
25231703|NCT02918006|50542926|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
25231704|NCT02918006|50542924|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
25231705|NCT02918006|50542925|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
25231706|NCT02918006|50542926|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
25231707|NCT02918006|50542924|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
25231708|NCT02918006|50542925|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
25319256|NCT00783705|50634720|FG001|Overall Study|Adverse Event|0|||
25319257|NCT00783705|50634719|FG000|Overall Study|Withdrawal by Subject|3|||
25319258|NCT00783705|50634720|FG001|Overall Study|Withdrawal by Subject|2|||
25319259|NCT00783705|50634719|FG000|Overall Study|Lost to Follow-up|1|||
25319260|NCT00783705|50634720|FG001|Overall Study|Lost to Follow-up|3|||
25319261|NCT00604669|50634726|FG000|Overall Study|lack of information in chart|7|||
25319262|NCT00938327|50634730|FG000|Overall Study|Adverse Event|2|||
25319263|NCT00938327|50634730|FG000|Overall Study|Protocol Violation|1|||
25231709|NCT02918006|50542926|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
25231710|NCT02658487|50542951|FG000|Overall Study|Death|2|||
25231711|NCT02658487|50542951|FG000|Overall Study|Disease progression|10|||
25231712|NCT02658487|50542951|FG000|Overall Study|Alternative therapy|1|||
25231713|NCT02658487|50542951|FG000|Overall Study|Adverse Event|1|||
25231714|NCT02658487|50542951|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
25231715|NCT02658487|50542951|FG000|Overall Study|Refractory AML|1|||
25319264|NCT00938327|50634730|FG000|Overall Study|Withdrawal by Subject|4|||
25319265|NCT00938327|50634730|FG000|Overall Study|Lost to Follow-up|37|||
25231716|NCT02179749|50542980|FG000|Overall Study|Adverse Event|0|||
25231717|NCT02179749|50542981|FG001|Overall Study|Adverse Event|0|||
25231718|NCT02179749|50542982|FG002|Overall Study|Adverse Event|1|||
25231719|NCT02179749|50542980|FG000|Overall Study|Withdrawal by Subject|0|||
25231720|NCT02179749|50542981|FG001|Overall Study|Withdrawal by Subject|0|||
25231721|NCT02179749|50542982|FG002|Overall Study|Withdrawal by Subject|1|||
25231722|NCT02075593|50542993|FG000|Overall Study|Withdrawal by Subject|1|||
25231723|NCT00700882|50543026|FG000|Overall Study|Never received treatment|6|||
25231724|NCT00700882|50543026|FG000|Overall Study|Ineligible|2|||
25231725|NCT00700882|50543026|FG000|Overall Study|No KIT mutation|51|||
25231726|NCT00641186|50543030|FG000|Overall Study|Adverse Event|3|||
25231727|NCT01595009|50543036|FG000|Core|Patients completed per protocol|85|||
25231728|NCT01595009|50543037|FG001|Core|Patients completed per protocol|44|||
25231729|NCT01595009|50543038|FG002|Core|Patients completed per protocol|0|||
25231730|NCT01595009|50543039|FG003|Core|Patients completed per protocol|0|||
25231731|NCT01595009|50543036|FG000|Core|Adverse Event|19|||
25231732|NCT01595009|50543037|FG001|Core|Adverse Event|23|||
25231733|NCT01595009|50543038|FG002|Core|Adverse Event|0|||
25231734|NCT01595009|50543039|FG003|Core|Adverse Event|0|||
25231735|NCT01595009|50543036|FG000|Core|Disease progression|14|||
25231736|NCT01595009|50543037|FG001|Core|Disease progression|26|||
25231737|NCT01595009|50543038|FG002|Core|Disease progression|0|||
25231738|NCT01595009|50543039|FG003|Core|Disease progression|0|||
25231739|NCT01595009|50543036|FG000|Core|Withdrawal by Subject|4|||
25231740|NCT01595009|50543037|FG001|Core|Withdrawal by Subject|17|||
25231741|NCT01595009|50543038|FG002|Core|Withdrawal by Subject|0|||
25231742|NCT01595009|50543039|FG003|Core|Withdrawal by Subject|0|||
25231743|NCT01595009|50543036|FG000|Core|Death|3|||
25231744|NCT01595009|50543037|FG001|Core|Death|6|||
25231745|NCT01595009|50543038|FG002|Core|Death|0|||
25231746|NCT01595009|50543039|FG003|Core|Death|0|||
25231747|NCT01595009|50543036|FG000|Core|Lost to Follow-up|1|||
25231748|NCT01595009|50543037|FG001|Core|Lost to Follow-up|2|||
25231749|NCT01595009|50543038|FG002|Core|Lost to Follow-up|0|||
25231750|NCT01595009|50543039|FG003|Core|Lost to Follow-up|0|||
25231751|NCT01595009|50543036|FG000|Core|Protocol deviation|0|||
25231752|NCT01595009|50543037|FG001|Core|Protocol deviation|1|||
25231753|NCT01595009|50543038|FG002|Core|Protocol deviation|0|||
25231754|NCT01595009|50543039|FG003|Core|Protocol deviation|0|||
25231755|NCT01595009|50543036|FG000|Core|Administrative problems|0|||
25231756|NCT01595009|50543037|FG001|Core|Administrative problems|1|||
25231757|NCT01595009|50543038|FG002|Core|Administrative problems|0|||
25231758|NCT01595009|50543039|FG003|Core|Administrative problems|0|||
25231759|NCT01595009|50543036|FG000|Extension|Administrative problems|0|||
25231760|NCT01595009|50543037|FG001|Extension|Administrative problems|0|||
25231761|NCT01595009|50543038|FG002|Extension|Administrative problems|0|||
25231762|NCT01595009|50543039|FG003|Extension|Administrative problems|1|||
25231763|NCT01595009|50543036|FG000|Extension|Patients completed per protocol|0|||
25231764|NCT01595009|50543037|FG001|Extension|Patients completed per protocol|0|||
25231765|NCT01595009|50543038|FG002|Extension|Patients completed per protocol|0|||
25231766|NCT01595009|50543039|FG003|Extension|Patients completed per protocol|2|||
25231767|NCT01595009|50543036|FG000|Extension|Disease progression|0|||
25231768|NCT01595009|50543037|FG001|Extension|Disease progression|0|||
25231769|NCT01595009|50543038|FG002|Extension|Disease progression|4|||
25231770|NCT01595009|50543039|FG003|Extension|Disease progression|7|||
25231771|NCT01595009|50543036|FG000|Extension|Adverse Event|0|||
25231772|NCT01595009|50543037|FG001|Extension|Adverse Event|0|||
25231773|NCT01595009|50543038|FG002|Extension|Adverse Event|0|||
25231774|NCT01595009|50543039|FG003|Extension|Adverse Event|1|||
25231775|NCT05553808|50543056|FG000|Overall Study|Death|25|||
25231776|NCT05553808|50543057|FG001|Overall Study|Death|62|||
25231777|NCT05553808|50543056|FG000|Overall Study|Site Closed|6|||
25231778|NCT05553808|50543057|FG001|Overall Study|Site Closed|6|||
25231779|NCT05553808|50543056|FG000|Overall Study|Lost to Follow-up|1|||
25231780|NCT05553808|50543057|FG001|Overall Study|Lost to Follow-up|0|||
25231781|NCT05553808|50543056|FG000|Overall Study|Withdrawal by Subject|3|||
25231782|NCT05553808|50543057|FG001|Overall Study|Withdrawal by Subject|2|||
25231783|NCT04997161|50543073|FG000|Overall Study|Study terminated by sponsor|3|||
25231784|NCT04753216|50543081|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
25231785|NCT04753216|50543081|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
25231786|NCT04753216|50543081|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
25231787|NCT04530747|50543114|FG000|Overall Study|Withdrawal by Subject|1|||
25231788|NCT04530747|50543115|FG001|Overall Study|Withdrawal by Subject|0|||
25231789|NCT04493242|50543126|FG000|Overall Study|Death|10|||
25231790|NCT04493242|50543127|FG001|Overall Study|Death|14|||
25231791|NCT04493242|50543128|FG002|Overall Study|Death|16|||
25231792|NCT04493242|50543126|FG000|Overall Study|Lost to Follow-up|1|||
25231793|NCT04493242|50543127|FG001|Overall Study|Lost to Follow-up|1|||
25231794|NCT04493242|50543128|FG002|Overall Study|Lost to Follow-up|0|||
25231795|NCT04493242|50543126|FG000|Overall Study|Withdrawal by Subject|1|||
25231796|NCT04493242|50543127|FG001|Overall Study|Withdrawal by Subject|0|||
25231797|NCT04493242|50543128|FG002|Overall Study|Withdrawal by Subject|0|||
25231798|NCT04493242|50543126|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
25231799|NCT04493242|50543127|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
25231800|NCT04493242|50543128|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
25231801|NCT04493242|50543126|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
25231802|NCT04493242|50543127|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
25231803|NCT04493242|50543128|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
25231804|NCT04040751|50543149|FG000|Overall Study|Withdrawal by Subject|2|||
25231805|NCT04040751|50543150|FG001|Overall Study|Withdrawal by Subject|0|||
25231806|NCT04040751|50543151|FG002|Overall Study|Withdrawal by Subject|2|||
25231807|NCT04040751|50543152|FG003|Overall Study|Withdrawal by Subject|0|||
25231808|NCT03997916|50543162|FG000|Overall Study|Protocol Violation|35|||
25231809|NCT03596177|50543181|FG000|Single Blind Period|Withdrawal by Subject|1|||
25231810|NCT03596177|50543182|FG001|Single Blind Period|Withdrawal by Subject|1|||
25231811|NCT03596177|50543181|FG000|Single Blind Period|Other|1|||
25231812|NCT03596177|50543182|FG001|Single Blind Period|Other|0|||
25231813|NCT03596177|50543181|FG000|Double Blind Period|Withdrawal by Subject|0|||
25231814|NCT03596177|50543182|FG001|Double Blind Period|Withdrawal by Subject|1|||
25231815|NCT03596177|50543181|FG000|Double Blind Period|Other|0|||
25231816|NCT03596177|50543182|FG001|Double Blind Period|Other|4|||
25231817|NCT03596177|50543181|FG000|Double Blind Period|Death during safety follow-up|0|||
25231818|NCT03596177|50543182|FG001|Double Blind Period|Death during safety follow-up|1|||
25231819|NCT03579459|50543192|FG000|Overall Study|Adverse Event|7|||
25231820|NCT03579459|50543193|FG001|Overall Study|Adverse Event|6|||
25231821|NCT03579459|50543194|FG002|Overall Study|Adverse Event|2|||
25231822|NCT03579459|50543195|FG003|Overall Study|Adverse Event|6|||
25231823|NCT03579459|50543192|FG000|Overall Study|Death|1|||
25231824|NCT03579459|50543193|FG001|Overall Study|Death|0|||
25231825|NCT03579459|50543194|FG002|Overall Study|Death|1|||
25231826|NCT03579459|50543195|FG003|Overall Study|Death|2|||
25231827|NCT03579459|50543192|FG000|Overall Study|Lost to Follow-up|6|||
25231828|NCT03579459|50543193|FG001|Overall Study|Lost to Follow-up|2|||
25231829|NCT03579459|50543194|FG002|Overall Study|Lost to Follow-up|4|||
25231830|NCT03579459|50543195|FG003|Overall Study|Lost to Follow-up|1|||
25231831|NCT03579459|50543192|FG000|Overall Study|Physician Decision|0|||
25231832|NCT03579459|50543193|FG001|Overall Study|Physician Decision|1|||
25231833|NCT03579459|50543194|FG002|Overall Study|Physician Decision|0|||
25231834|NCT03579459|50543195|FG003|Overall Study|Physician Decision|1|||
25231835|NCT03579459|50543192|FG000|Overall Study|Protocol Violation|1|||
25231836|NCT03579459|50543193|FG001|Overall Study|Protocol Violation|2|||
25231837|NCT03579459|50543194|FG002|Overall Study|Protocol Violation|3|||
25231838|NCT03579459|50543195|FG003|Overall Study|Protocol Violation|5|||
25231839|NCT03579459|50543192|FG000|Overall Study|Withdrawal by Subject|12|||
25231840|NCT03579459|50543193|FG001|Overall Study|Withdrawal by Subject|8|||
25231841|NCT03579459|50543194|FG002|Overall Study|Withdrawal by Subject|11|||
25231842|NCT03579459|50543195|FG003|Overall Study|Withdrawal by Subject|8|||
25231843|NCT03579459|50543192|FG000|Overall Study|Medication error without associated adverse event|2|||
25231844|NCT03579459|50543193|FG001|Overall Study|Medication error without associated adverse event|1|||
25231845|NCT03579459|50543194|FG002|Overall Study|Medication error without associated adverse event|1|||
25231846|NCT03579459|50543195|FG003|Overall Study|Medication error without associated adverse event|0|||
25231847|NCT03579459|50543192|FG000|Overall Study|Other|0|||
25231848|NCT03579459|50543193|FG001|Overall Study|Other|1|||
25231849|NCT03579459|50543194|FG002|Overall Study|Other|1|||
25231850|NCT03579459|50543195|FG003|Overall Study|Other|0|||
25231851|NCT03579459|50543192|FG000|Overall Study|Randomized not vaccinated|0|||
25231852|NCT03579459|50543193|FG001|Overall Study|Randomized not vaccinated|2|||
25231853|NCT03579459|50543194|FG002|Overall Study|Randomized not vaccinated|0|||
25231854|NCT03579459|50543195|FG003|Overall Study|Randomized not vaccinated|1|||
25231855|NCT03340766|50543208|FG000|Overall Study|Death|6|||
25231856|NCT03340766|50543209|FG001|Overall Study|Death|6|||
25231857|NCT03340766|50543210|FG002|Overall Study|Death|2|||
25231858|NCT03340766|50543208|FG000|Overall Study|Withdrawal by Subject|2|||
25231859|NCT03340766|50543209|FG001|Overall Study|Withdrawal by Subject|1|||
25231860|NCT03340766|50543210|FG002|Overall Study|Withdrawal by Subject|2|||
25231861|NCT03340766|50543208|FG000|Overall Study|Continuing Study|3|||
25319266|NCT00938327|50634730|FG000|Overall Study|2nd dose received outside of the study|7|||
25231862|NCT03340766|50543209|FG001|Overall Study|Continuing Study|3|||
25231863|NCT03340766|50543210|FG002|Overall Study|Continuing Study|5|||
25231864|NCT04449276|50543241|FG000|Overall Study|Adverse Event|1|||
25231865|NCT04449276|50543242|FG001|Overall Study|Adverse Event|2|||
25231866|NCT04449276|50543243|FG002|Overall Study|Adverse Event|0|||
25231867|NCT04449276|50543244|FG003|Overall Study|Adverse Event|0|||
25231868|NCT04449276|50543245|FG004|Overall Study|Adverse Event|2|||
25231869|NCT04449276|50543246|FG005|Overall Study|Adverse Event|0|||
25231870|NCT04449276|50543247|FG006|Overall Study|Adverse Event|0|||
25231871|NCT04449276|50543248|FG007|Overall Study|Adverse Event|1|||
25231872|NCT04449276|50543241|FG000|Overall Study|Withdrawal by Subject|2|||
25231873|NCT04449276|50543242|FG001|Overall Study|Withdrawal by Subject|0|||
25231874|NCT04449276|50543243|FG002|Overall Study|Withdrawal by Subject|0|||
25231875|NCT04449276|50543244|FG003|Overall Study|Withdrawal by Subject|1|||
25231876|NCT04449276|50543245|FG004|Overall Study|Withdrawal by Subject|0|||
25231877|NCT04449276|50543246|FG005|Overall Study|Withdrawal by Subject|0|||
25231878|NCT04449276|50543247|FG006|Overall Study|Withdrawal by Subject|0|||
25231879|NCT04449276|50543248|FG007|Overall Study|Withdrawal by Subject|0|||
25231880|NCT04449276|50543241|FG000|Overall Study|Other|0|||
25231881|NCT04449276|50543242|FG001|Overall Study|Other|2|||
25231882|NCT04449276|50543243|FG002|Overall Study|Other|3|||
25231883|NCT04449276|50543244|FG003|Overall Study|Other|2|||
25231884|NCT04449276|50543245|FG004|Overall Study|Other|0|||
25231885|NCT04449276|50543246|FG005|Overall Study|Other|0|||
25231886|NCT04449276|50543247|FG006|Overall Study|Other|0|||
25231887|NCT04449276|50543248|FG007|Overall Study|Other|1|||
25231888|NCT04391894|50543288|FG000|Overall Study|Adverse Event|1|||
25231889|NCT04391894|50543289|FG001|Overall Study|Adverse Event|1|||
25231890|NCT04391894|50543290|FG002|Overall Study|Adverse Event|1|||
25231891|NCT04391894|50543291|FG003|Overall Study|Adverse Event|1|||
25231892|NCT04391894|50543292|FG004|Overall Study|Adverse Event|1|||
25231893|NCT04391894|50543288|FG000|Overall Study|Lost to Follow-up|1|||
25231894|NCT04391894|50543289|FG001|Overall Study|Lost to Follow-up|0|||
25231895|NCT04391894|50543290|FG002|Overall Study|Lost to Follow-up|0|||
25231896|NCT04391894|50543291|FG003|Overall Study|Lost to Follow-up|0|||
25231897|NCT04391894|50543292|FG004|Overall Study|Lost to Follow-up|0|||
25231898|NCT04391894|50543288|FG000|Overall Study|Protocol Violation|0|||
25231899|NCT04391894|50543289|FG001|Overall Study|Protocol Violation|0|||
25231900|NCT04391894|50543290|FG002|Overall Study|Protocol Violation|0|||
25231901|NCT04391894|50543291|FG003|Overall Study|Protocol Violation|1|||
25231902|NCT04391894|50543292|FG004|Overall Study|Protocol Violation|0|||
25231903|NCT04391894|50543288|FG000|Overall Study|Withdrawal by Subject|2|||
25231904|NCT04391894|50543289|FG001|Overall Study|Withdrawal by Subject|0|||
25231905|NCT04391894|50543290|FG002|Overall Study|Withdrawal by Subject|3|||
25231906|NCT04391894|50543291|FG003|Overall Study|Withdrawal by Subject|0|||
25231907|NCT04391894|50543292|FG004|Overall Study|Withdrawal by Subject|1|||
25231908|NCT04391894|50543288|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
25231909|NCT04391894|50543289|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
25231910|NCT04391894|50543290|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
25231911|NCT04391894|50543291|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
25231912|NCT04391894|50543292|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
25231913|NCT04166435|50543308|FG000|Overall Study|2 patients ineligible for response|2|||
25231914|NCT03851705|50543314|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
25231915|NCT03851705|50543315|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
25231916|NCT03851705|50543316|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
25231917|NCT03851705|50543317|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
25231918|NCT03851705|50543314|FG000|Part 1: Double-Blind Period|Other reason|1|||
25231919|NCT03851705|50543315|FG001|Part 1: Double-Blind Period|Other reason|0|||
25231920|NCT03851705|50543316|FG002|Part 1: Double-Blind Period|Other reason|0|||
25231921|NCT03851705|50543317|FG003|Part 1: Double-Blind Period|Other reason|0|||
25231922|NCT03851705|50543314|FG000|Part 2: Open-Label Period|Other reason|0|||
25231923|NCT03851705|50543315|FG001|Part 2: Open-Label Period|Other reason|0|||
25231924|NCT03851705|50543316|FG002|Part 2: Open-Label Period|Other reason|0|||
25231925|NCT03851705|50543317|FG003|Part 2: Open-Label Period|Other reason|1|||
25231926|NCT03851705|50543314|FG000|Part 2: Open-Label Period|Death|0|||
25231927|NCT03851705|50543315|FG001|Part 2: Open-Label Period|Death|0|||
25231928|NCT03851705|50543316|FG002|Part 2: Open-Label Period|Death|3|||
25231929|NCT03851705|50543317|FG003|Part 2: Open-Label Period|Death|0|||
25231930|NCT03851705|50543314|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
25231931|NCT03851705|50543315|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
25231932|NCT03851705|50543316|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
25231933|NCT03851705|50543317|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
25231934|NCT03824366|50543330|FG000|Overall Study|Death|1|||
25231935|NCT03824366|50543330|FG000|Overall Study|Previously unidentified metal artifact|1|||
25231936|NCT03824366|50543330|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
25231937|NCT03824366|50543330|FG000|Overall Study|Withdrawal by Subject|1|||
25231938|NCT03810313|50543336|FG000|Overall Study|Study terminated by sponsor|164|||
25231939|NCT03810313|50543337|FG001|Overall Study|Study terminated by sponsor|159|||
25231940|NCT03810313|50543336|FG000|Overall Study|Subject decision|10|||
25231941|NCT03810313|50543337|FG001|Overall Study|Subject decision|11|||
25231942|NCT03810313|50543336|FG000|Overall Study|Lost to Follow-up|3|||
25231943|NCT03810313|50543337|FG001|Overall Study|Lost to Follow-up|3|||
25231944|NCT03810313|50543336|FG000|Overall Study|Adverse Event|2|||
25231945|NCT03810313|50543337|FG001|Overall Study|Adverse Event|1|||
25231946|NCT03810313|50543336|FG000|Overall Study|Death|2|||
25231947|NCT03810313|50543337|FG001|Overall Study|Death|1|||
25231948|NCT03810313|50543336|FG000|Overall Study|Physician Decision|0|||
25231949|NCT03810313|50543337|FG001|Overall Study|Physician Decision|1|||
25231950|NCT03802630|50543346|FG000|Overall Study|Study terminated by sponsor|130|||
25231951|NCT03802630|50543347|FG001|Overall Study|Study terminated by sponsor|134|||
25231952|NCT03802630|50543346|FG000|Overall Study|Subject decision|16|||
25231953|NCT03802630|50543347|FG001|Overall Study|Subject decision|9|||
25231954|NCT03802630|50543346|FG000|Overall Study|Adverse Event|3|||
25231955|NCT03802630|50543347|FG001|Overall Study|Adverse Event|1|||
25231956|NCT03802630|50543346|FG000|Overall Study|Lost to Follow-up|2|||
25231957|NCT03802630|50543347|FG001|Overall Study|Lost to Follow-up|2|||
25231958|NCT03802630|50543346|FG000|Overall Study|Physician Decision|2|||
25231959|NCT03802630|50543347|FG001|Overall Study|Physician Decision|0|||
25231960|NCT03802630|50543346|FG000|Overall Study|Death|0|||
25231961|NCT03802630|50543347|FG001|Overall Study|Death|2|||
25231962|NCT03775213|50543356|FG000|Overall Study|Withdrawal by Subject|51|||
25231963|NCT03775213|50543357|FG001|Overall Study|Withdrawal by Subject|53|||
25231964|NCT03775213|50543356|FG000|Overall Study|Incomplete Survey|7|||
25231965|NCT03775213|50543357|FG001|Overall Study|Incomplete Survey|7|||
25231966|NCT03710564|50543365|FG000|Overall Study|Study Terminated by Sponsor|104|||
25231967|NCT03710564|50543366|FG001|Overall Study|Study Terminated by Sponsor|55|||
25231968|NCT03710564|50543365|FG000|Overall Study|Withdrawal by Subject|57|||
25231969|NCT03710564|50543366|FG001|Overall Study|Withdrawal by Subject|25|||
25231970|NCT03710564|50543365|FG000|Overall Study|Death|10|||
25231971|NCT03710564|50543366|FG001|Overall Study|Death|4|||
25231972|NCT03710564|50543365|FG000|Overall Study|Lost to Follow-up|5|||
25231973|NCT03710564|50543366|FG001|Overall Study|Lost to Follow-up|4|||
25231974|NCT03710564|50543365|FG000|Overall Study|Protocol Violation|3|||
25231975|NCT03710564|50543366|FG001|Overall Study|Protocol Violation|2|||
25231976|NCT03710564|50543365|FG000|Overall Study|Adverse Event|3|||
25231977|NCT03710564|50543366|FG001|Overall Study|Adverse Event|0|||
25231978|NCT03710564|50543365|FG000|Overall Study|Physician Decision|2|||
25231979|NCT03710564|50543366|FG001|Overall Study|Physician Decision|3|||
25231980|NCT03624127|50543376|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
25231981|NCT03624127|50543377|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
25231982|NCT03624127|50543378|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
25231983|NCT03624127|50543376|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
25231984|NCT03624127|50543377|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
25231985|NCT03624127|50543378|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
25231986|NCT03624127|50543376|FG000|Treatment Week 0 - Week 16|Death|0|||
25231987|NCT03624127|50543377|FG001|Treatment Week 0 - Week 16|Death|1|||
25231988|NCT03624127|50543378|FG002|Treatment Week 0 - Week 16|Death|0|||
25231989|NCT03624127|50543376|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
25231990|NCT03624127|50543377|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
25231991|NCT03624127|50543378|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
25231992|NCT03624127|50543376|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
25231993|NCT03624127|50543377|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
25231994|NCT03624127|50543378|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
25231995|NCT03624127|50543376|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
25231996|NCT03624127|50543377|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
25231997|NCT03624127|50543378|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
25231998|NCT03624127|50543376|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
25231999|NCT03624127|50543377|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
25232000|NCT03624127|50543378|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
25232001|NCT03624127|50543376|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
25232002|NCT03624127|50543377|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
25232003|NCT03624127|50543378|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
25232004|NCT03624127|50543376|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
25232005|NCT03624127|50543377|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
25232006|NCT03624127|50543378|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
25232007|NCT03624127|50543376|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
25232008|NCT03624127|50543377|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
25232009|NCT03624127|50543378|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
25232010|NCT03624127|50543376|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
25232011|NCT03624127|50543377|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
25232012|NCT03624127|50543378|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
25232013|NCT03624127|50543376|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
25232014|NCT03624127|50543377|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
25232015|NCT03624127|50543378|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
25232016|NCT03624127|50543376|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
25232017|NCT03624127|50543377|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
25232018|NCT03624127|50543378|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
25232019|NCT03624127|50543376|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
25232020|NCT03624127|50543377|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
25232021|NCT03624127|50543378|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
25232022|NCT03624127|50543376|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
25232023|NCT03624127|50543377|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
25232024|NCT03624127|50543378|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
25232025|NCT03624127|50543376|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
25232026|NCT03624127|50543377|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
25232027|NCT03624127|50543378|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
25232028|NCT03624127|50543376|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
25232029|NCT03624127|50543377|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
25232030|NCT03624127|50543378|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
25232031|NCT03624127|50543376|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
25232032|NCT03624127|50543377|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
25232033|NCT03624127|50543378|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
25232034|NCT03624127|50543376|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
25232035|NCT03624127|50543377|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
25232036|NCT03624127|50543378|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
25232037|NCT03624127|50543376|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
25232038|NCT03624127|50543377|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
25232039|NCT03624127|50543378|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
25232040|NCT03624127|50543376|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
25232041|NCT03624127|50543377|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
25232042|NCT03624127|50543378|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
25232043|NCT03616912|50543396|FG000|Overall Study|Adverse Event|17|||
25232044|NCT03616912|50543397|FG001|Overall Study|Adverse Event|21|||
25232045|NCT03616912|50543398|FG002|Overall Study|Adverse Event|9|||
25232046|NCT03616912|50543399|FG003|Overall Study|Adverse Event|0|||
25232047|NCT03616912|50543400|FG004|Overall Study|Adverse Event|0|||
25232048|NCT03616912|50543401|FG005|Overall Study|Adverse Event|0|||
25232049|NCT03616912|50543396|FG000|Overall Study|Death|1|||
25232050|NCT03616912|50543397|FG001|Overall Study|Death|1|||
25232051|NCT03616912|50543398|FG002|Overall Study|Death|0|||
25232052|NCT03616912|50543399|FG003|Overall Study|Death|0|||
25232053|NCT03616912|50543400|FG004|Overall Study|Death|0|||
25232054|NCT03616912|50543401|FG005|Overall Study|Death|0|||
25232055|NCT03616912|50543396|FG000|Overall Study|Lack of Efficacy|13|||
25232056|NCT03616912|50543397|FG001|Overall Study|Lack of Efficacy|6|||
25232057|NCT03616912|50543398|FG002|Overall Study|Lack of Efficacy|8|||
25232058|NCT03616912|50543399|FG003|Overall Study|Lack of Efficacy|4|||
25232059|NCT03616912|50543400|FG004|Overall Study|Lack of Efficacy|5|||
25232060|NCT03616912|50543401|FG005|Overall Study|Lack of Efficacy|1|||
25232061|NCT03616912|50543396|FG000|Overall Study|Lost to Follow-up|1|||
25232062|NCT03616912|50543397|FG001|Overall Study|Lost to Follow-up|2|||
25232063|NCT03616912|50543398|FG002|Overall Study|Lost to Follow-up|3|||
25232064|NCT03616912|50543399|FG003|Overall Study|Lost to Follow-up|0|||
25232065|NCT03616912|50543400|FG004|Overall Study|Lost to Follow-up|0|||
25232066|NCT03616912|50543401|FG005|Overall Study|Lost to Follow-up|0|||
25232067|NCT03616912|50543396|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
25232068|NCT03616912|50543397|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
25232069|NCT03616912|50543398|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
25232070|NCT03616912|50543399|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
25232071|NCT03616912|50543400|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
25232072|NCT03616912|50543401|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
25232073|NCT03616912|50543396|FG000|Overall Study|Withdrawal by Subject|12|||
25232074|NCT03616912|50543397|FG001|Overall Study|Withdrawal by Subject|12|||
25232075|NCT03616912|50543398|FG002|Overall Study|Withdrawal by Subject|15|||
25232076|NCT03616912|50543399|FG003|Overall Study|Withdrawal by Subject|2|||
25232077|NCT03616912|50543400|FG004|Overall Study|Withdrawal by Subject|0|||
25232078|NCT03616912|50543401|FG005|Overall Study|Withdrawal by Subject|2|||
25232079|NCT03616912|50543396|FG000|Overall Study|Study Terminated by Sponsor|0|||
25232080|NCT03616912|50543397|FG001|Overall Study|Study Terminated by Sponsor|0|||
25232081|NCT03616912|50543398|FG002|Overall Study|Study Terminated by Sponsor|0|||
25232082|NCT03616912|50543399|FG003|Overall Study|Study Terminated by Sponsor|10|||
25232083|NCT03616912|50543400|FG004|Overall Study|Study Terminated by Sponsor|9|||
25232084|NCT03616912|50543401|FG005|Overall Study|Study Terminated by Sponsor|11|||
25232085|NCT03616912|50543396|FG000|Overall Study|Protocol Deviation|1|||
25232086|NCT03616912|50543397|FG001|Overall Study|Protocol Deviation|1|||
25232087|NCT03616912|50543398|FG002|Overall Study|Protocol Deviation|0|||
25077503|NCT00002663|50185275|FG000|Overall Study|Adverse Event|0|||
25232088|NCT03616912|50543399|FG003|Overall Study|Protocol Deviation|0|||
25232089|NCT03616912|50543400|FG004|Overall Study|Protocol Deviation|0|||
25232090|NCT03616912|50543401|FG005|Overall Study|Protocol Deviation|0|||
25232091|NCT03616912|50543396|FG000|Overall Study|Pregnancy|1|||
25232092|NCT03616912|50543397|FG001|Overall Study|Pregnancy|0|||
25232093|NCT03616912|50543398|FG002|Overall Study|Pregnancy|4|||
25232094|NCT03616912|50543399|FG003|Overall Study|Pregnancy|0|||
25232095|NCT03616912|50543400|FG004|Overall Study|Pregnancy|0|||
25232096|NCT03616912|50543401|FG005|Overall Study|Pregnancy|0|||
25232097|NCT03616912|50543396|FG000|Overall Study|Protocol Violation|1|||
25232098|NCT03616912|50543397|FG001|Overall Study|Protocol Violation|0|||
25232099|NCT03616912|50543398|FG002|Overall Study|Protocol Violation|2|||
25232100|NCT03616912|50543399|FG003|Overall Study|Protocol Violation|0|||
25232101|NCT03616912|50543400|FG004|Overall Study|Protocol Violation|0|||
25232102|NCT03616912|50543401|FG005|Overall Study|Protocol Violation|0|||
25232103|NCT03616912|50543396|FG000|Overall Study|Physician Decision|2|||
25232104|NCT03616912|50543397|FG001|Overall Study|Physician Decision|0|||
25232105|NCT03616912|50543398|FG002|Overall Study|Physician Decision|0|||
25232106|NCT03616912|50543399|FG003|Overall Study|Physician Decision|0|||
25232107|NCT03616912|50543400|FG004|Overall Study|Physician Decision|1|||
25232108|NCT03616912|50543401|FG005|Overall Study|Physician Decision|0|||
25232109|NCT03616912|50543396|FG000|Overall Study|Randomized But Never Treated|0|||
25232110|NCT03616912|50543397|FG001|Overall Study|Randomized But Never Treated|2|||
25232111|NCT03616912|50543398|FG002|Overall Study|Randomized But Never Treated|0|||
25232112|NCT03616912|50543399|FG003|Overall Study|Randomized But Never Treated|0|||
25232113|NCT03616912|50543400|FG004|Overall Study|Randomized But Never Treated|0|||
25232114|NCT03616912|50543401|FG005|Overall Study|Randomized But Never Treated|0|||
25232115|NCT03499899|50543418|FG000|Overall Study|Adverse Event|2|||
25232116|NCT03499899|50543419|FG001|Overall Study|Adverse Event|3|||
25232117|NCT03499899|50543420|FG002|Overall Study|Adverse Event|3|||
25232118|NCT03499899|50543418|FG000|Overall Study|Death|0|||
25232119|NCT03499899|50543419|FG001|Overall Study|Death|0|||
25232120|NCT03499899|50543420|FG002|Overall Study|Death|1|||
25232121|NCT03499899|50543418|FG000|Overall Study|Physician Decision|3|||
25232122|NCT03499899|50543419|FG001|Overall Study|Physician Decision|6|||
25232123|NCT03499899|50543420|FG002|Overall Study|Physician Decision|6|||
25232124|NCT03499899|50543418|FG000|Overall Study|Progressive disease|15|||
25232125|NCT03499899|50543419|FG001|Overall Study|Progressive disease|23|||
25232126|NCT03499899|50543420|FG002|Overall Study|Progressive disease|23|||
25232127|NCT03499899|50543418|FG000|Overall Study|Patient decision|0|||
25232128|NCT03499899|50543419|FG001|Overall Study|Patient decision|1|||
25232129|NCT03499899|50543420|FG002|Overall Study|Patient decision|1|||
25232130|NCT03499899|50543418|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
25232131|NCT03499899|50543419|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
25232132|NCT03499899|50543420|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
25232133|NCT03481634|50543436|FG000|Overall Study|Withdrawal by Subject|16|||
25232134|NCT03481634|50543437|FG001|Overall Study|Withdrawal by Subject|19|||
25232135|NCT03481634|50543438|FG002|Overall Study|Withdrawal by Subject|14|||
25232136|NCT03481634|50543436|FG000|Overall Study|Protocol Violation|1|||
25232137|NCT03481634|50543437|FG001|Overall Study|Protocol Violation|0|||
25232138|NCT03481634|50543438|FG002|Overall Study|Protocol Violation|1|||
25232139|NCT03481634|50543436|FG000|Overall Study|Progressive disease|0|||
25232140|NCT03481634|50543437|FG001|Overall Study|Progressive disease|1|||
25232141|NCT03481634|50543438|FG002|Overall Study|Progressive disease|0|||
25232142|NCT03481634|50543436|FG000|Overall Study|Physician Decision|3|||
25232143|NCT03481634|50543437|FG001|Overall Study|Physician Decision|0|||
25232144|NCT03481634|50543438|FG002|Overall Study|Physician Decision|1|||
25232145|NCT03481634|50543436|FG000|Overall Study|Lost to Follow-up|3|||
25232146|NCT03481634|50543437|FG001|Overall Study|Lost to Follow-up|4|||
25232147|NCT03481634|50543438|FG002|Overall Study|Lost to Follow-up|4|||
25232148|NCT03481634|50543436|FG000|Overall Study|Death|4|||
25232149|NCT03481634|50543437|FG001|Overall Study|Death|8|||
25232150|NCT03481634|50543438|FG002|Overall Study|Death|7|||
25232151|NCT03481634|50543436|FG000|Overall Study|Adverse Event|6|||
25232152|NCT03481634|50543437|FG001|Overall Study|Adverse Event|3|||
25232153|NCT03481634|50543438|FG002|Overall Study|Adverse Event|7|||
25232154|NCT03460756|50543451|FG000|Overall Study|Adverse Event|0|||
25232155|NCT03460756|50543452|FG001|Overall Study|Adverse Event|0|||
25232156|NCT03460756|50543453|FG002|Overall Study|Adverse Event|0|||
25232157|NCT03460756|50543454|FG003|Overall Study|Adverse Event|1|||
25232158|NCT03460756|50543451|FG000|Overall Study|Lack of Efficacy|0|||
25232159|NCT03460756|50543452|FG001|Overall Study|Lack of Efficacy|0|||
25232160|NCT03460756|50543453|FG002|Overall Study|Lack of Efficacy|0|||
25232161|NCT03460756|50543454|FG003|Overall Study|Lack of Efficacy|2|||
25232162|NCT03460756|50543451|FG000|Overall Study|Lost to Follow-up|0|||
25232163|NCT03460756|50543452|FG001|Overall Study|Lost to Follow-up|1|||
25232164|NCT03460756|50543453|FG002|Overall Study|Lost to Follow-up|2|||
25232165|NCT03460756|50543454|FG003|Overall Study|Lost to Follow-up|1|||
25232166|NCT03460756|50543451|FG000|Overall Study|Pregnancy|0|||
25232167|NCT03460756|50543452|FG001|Overall Study|Pregnancy|0|||
25232168|NCT03460756|50543453|FG002|Overall Study|Pregnancy|0|||
25232169|NCT03460756|50543454|FG003|Overall Study|Pregnancy|1|||
25232170|NCT03460756|50543451|FG000|Overall Study|Protocol Violation|0|||
25232171|NCT03460756|50543452|FG001|Overall Study|Protocol Violation|0|||
25232172|NCT03460756|50543453|FG002|Overall Study|Protocol Violation|0|||
25232173|NCT03460756|50543454|FG003|Overall Study|Protocol Violation|1|||
25232174|NCT03460756|50543451|FG000|Overall Study|Withdrawal by Subject|0|||
25232175|NCT03460756|50543452|FG001|Overall Study|Withdrawal by Subject|4|||
25232176|NCT03460756|50543453|FG002|Overall Study|Withdrawal by Subject|7|||
25232177|NCT03460756|50543454|FG003|Overall Study|Withdrawal by Subject|3|||
25232178|NCT03373461|50543471|FG000|Part 2|Adverse Event|0|||
25232179|NCT03373461|50543472|FG001|Part 2|Adverse Event|1|||
25232180|NCT03373461|50543473|FG002|Part 2|Adverse Event|0|||
25232181|NCT03373461|50543474|FG003|Part 2|Adverse Event|0|||
25232182|NCT03373461|50543475|FG004|Part 2|Adverse Event|1|||
25232183|NCT03364751|50543526|FG000|Overall Study|Withdrawal by Subject|1|||
25232184|NCT03364751|50543527|FG001|Overall Study|Withdrawal by Subject|0|||
25232185|NCT03364751|50543528|FG002|Overall Study|Withdrawal by Subject|0|||
25232186|NCT03364751|50543529|FG003|Overall Study|Withdrawal by Subject|0|||
25232187|NCT03364751|50543526|FG000|Overall Study|Lost to Follow-up|0|||
25232188|NCT03364751|50543527|FG001|Overall Study|Lost to Follow-up|1|||
25232189|NCT03364751|50543528|FG002|Overall Study|Lost to Follow-up|0|||
25232190|NCT03364751|50543529|FG003|Overall Study|Lost to Follow-up|0|||
25232191|NCT03149003|50543550|FG000|Overall Study|Randomized but not treated|0|||
25232192|NCT03149003|50543551|FG001|Overall Study|Randomized but not treated|1|||
25232193|NCT03149003|50543552|FG002|Overall Study|Randomized but not treated|18|||
25232194|NCT02990806|50543562|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
25232195|NCT02990806|50543563|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
25232196|NCT02990806|50543564|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
25232197|NCT02990806|50543565|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
25232198|NCT02990806|50543562|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
25232199|NCT02990806|50543563|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
25232200|NCT02990806|50543564|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
25232201|NCT02990806|50543565|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
25232202|NCT02990806|50543562|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
25232203|NCT02990806|50543563|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
25232204|NCT02990806|50543564|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
25232205|NCT02990806|50543565|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
25232206|NCT02990806|50543562|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
25232207|NCT02990806|50543563|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
25232208|NCT02990806|50543564|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
25232209|NCT02990806|50543565|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
25232210|NCT02990806|50543562|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
25232211|NCT02990806|50543563|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
25232212|NCT02990806|50543564|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
25232213|NCT02990806|50543565|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
25232214|NCT02990806|50543562|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
25319267|NCT00938327|50634730|FG000|Overall Study|Vaccine not received as out of stock|9|||
25319268|NCT00887198|50634736|FG000|Randomized Period|Ongoing|42|||
25319269|NCT00887198|50634737|FG001|Randomized Period|Ongoing|0|||
25319270|NCT00887198|50634738|FG002|Randomized Period|Ongoing|0|||
25319271|NCT00887198|50634736|FG000|Randomized Period|Adverse Event|50|||
25319272|NCT00887198|50634737|FG001|Randomized Period|Adverse Event|33|||
25319273|NCT00887198|50634738|FG002|Randomized Period|Adverse Event|0|||
25319274|NCT00887198|50634736|FG000|Randomized Period|Lost to Follow-up|1|||
25319275|NCT00887198|50634737|FG001|Randomized Period|Lost to Follow-up|0|||
25319276|NCT00887198|50634738|FG002|Randomized Period|Lost to Follow-up|0|||
25319277|NCT00887198|50634736|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
25319278|NCT00887198|50634737|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
25319279|NCT00887198|50634738|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
25319280|NCT00887198|50634736|FG000|Randomized Period|Withdrawal by Subject|41|||
25319281|NCT00887198|50634737|FG001|Randomized Period|Withdrawal by Subject|56|||
25319282|NCT00887198|50634738|FG002|Randomized Period|Withdrawal by Subject|0|||
25319283|NCT00887198|50634736|FG000|Randomized Period|Progressive disease|366|||
25319284|NCT00887198|50634737|FG001|Randomized Period|Progressive disease|370|||
25319285|NCT00887198|50634738|FG002|Randomized Period|Progressive disease|0|||
25319286|NCT00887198|50634736|FG000|Randomized Period|Other|42|||
25319287|NCT00887198|50634737|FG001|Randomized Period|Other|30|||
25319288|NCT00887198|50634738|FG002|Randomized Period|Other|0|||
25319289|NCT00887198|50634736|FG000|Randomized Period|Randomized, Not treated|4|||
25319290|NCT00887198|50634737|FG001|Randomized Period|Randomized, Not treated|2|||
25319291|NCT00887198|50634738|FG002|Randomized Period|Randomized, Not treated|0|||
25319292|NCT00887198|50634736|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
25319293|NCT00887198|50634737|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
25319294|NCT00887198|50634738|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
25319295|NCT00887198|50634736|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
25319296|NCT00887198|50634737|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
25319297|NCT00887198|50634738|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
25319298|NCT00887198|50634736|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
25319299|NCT00887198|50634737|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
25319300|NCT00887198|50634738|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
25319301|NCT00887198|50634736|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
25319302|NCT00887198|50634737|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
25319303|NCT00887198|50634738|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
25319304|NCT00887198|50634736|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
25319305|NCT00887198|50634737|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
25232215|NCT02990806|50543563|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
25232216|NCT02990806|50543564|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
25232217|NCT02990806|50543565|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
25232218|NCT02990806|50543562|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
25232219|NCT02990806|50543563|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
25232220|NCT02990806|50543564|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
25232221|NCT02990806|50543565|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
25232222|NCT02990806|50543562|FG000|Stage 1 (22 Weeks)|Death|0|||
25232223|NCT02990806|50543563|FG001|Stage 1 (22 Weeks)|Death|1|||
25232224|NCT02990806|50543564|FG002|Stage 1 (22 Weeks)|Death|0|||
25232225|NCT02990806|50543565|FG003|Stage 1 (22 Weeks)|Death|0|||
25232226|NCT02990806|50543562|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
25232227|NCT02990806|50543563|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
25232228|NCT02990806|50543564|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
25232229|NCT02990806|50543565|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
25232230|NCT02990806|50543562|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
25232231|NCT02990806|50543563|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
25232232|NCT02990806|50543564|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
25232233|NCT02990806|50543565|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
25232234|NCT02990806|50543562|FG000|Stage 1 (22 Weeks)|Other|1|||
25232235|NCT02990806|50543563|FG001|Stage 1 (22 Weeks)|Other|3|||
25232236|NCT02990806|50543564|FG002|Stage 1 (22 Weeks)|Other|0|||
25232237|NCT02990806|50543565|FG003|Stage 1 (22 Weeks)|Other|0|||
25232238|NCT02990806|50543562|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
25232239|NCT02990806|50543563|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
25232240|NCT02990806|50543564|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
25232241|NCT02990806|50543565|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
25232242|NCT02990806|50543562|FG000|Stage 2 (32 Weeks)|Death|1|||
25232243|NCT02990806|50543563|FG001|Stage 2 (32 Weeks)|Death|0|||
25232244|NCT02990806|50543564|FG002|Stage 2 (32 Weeks)|Death|0|||
25232245|NCT02990806|50543565|FG003|Stage 2 (32 Weeks)|Death|0|||
25232246|NCT02990806|50543562|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
25232247|NCT02990806|50543563|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
25232248|NCT02990806|50543564|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
25232249|NCT02990806|50543565|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
25232250|NCT02990806|50543562|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
25232251|NCT02990806|50543563|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
25232252|NCT02990806|50543564|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
25232253|NCT02990806|50543565|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
25232254|NCT02990806|50543562|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
25232255|NCT02990806|50543563|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
25232256|NCT02990806|50543564|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
25232257|NCT02990806|50543565|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
25232258|NCT02990806|50543562|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
25232259|NCT02990806|50543563|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
25232260|NCT02990806|50543564|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
25232261|NCT02990806|50543565|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
25232262|NCT02990806|50543562|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
25232263|NCT02990806|50543563|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
25232264|NCT02990806|50543564|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
25232265|NCT02990806|50543565|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
25232266|NCT02990806|50543562|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
25232267|NCT02990806|50543563|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
25232268|NCT02990806|50543564|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
25232269|NCT02990806|50543565|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
25232270|NCT02990806|50543562|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
25232271|NCT02990806|50543563|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
25232272|NCT02990806|50543564|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
25232273|NCT02990806|50543565|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
25232274|NCT02990806|50543562|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
25232275|NCT02990806|50543563|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
25232276|NCT02990806|50543564|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
25232277|NCT02990806|50543565|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
25232278|NCT02990806|50543562|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
25232279|NCT02990806|50543563|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
25232280|NCT02990806|50543564|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
25232281|NCT02990806|50543565|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
25232282|NCT02990806|50543562|FG000|Stage 2 (32 Weeks)|Other|3|||
25232283|NCT02990806|50543563|FG001|Stage 2 (32 Weeks)|Other|0|||
25232284|NCT02990806|50543564|FG002|Stage 2 (32 Weeks)|Other|4|||
25232285|NCT02990806|50543565|FG003|Stage 2 (32 Weeks)|Other|1|||
25232286|NCT02990806|50543562|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
25232287|NCT02990806|50543563|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
25232288|NCT02990806|50543564|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
25232289|NCT02990806|50543565|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
25232290|NCT02990806|50543562|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
25232291|NCT02990806|50543563|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
25232292|NCT02990806|50543564|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
25232293|NCT02990806|50543565|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
25232294|NCT02990806|50543562|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
25232295|NCT02990806|50543563|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
25232296|NCT02990806|50543564|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
25232297|NCT02990806|50543565|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
25232298|NCT02990806|50543562|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
25232299|NCT02990806|50543563|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
25232300|NCT02990806|50543564|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
25232301|NCT02990806|50543565|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
25232302|NCT02990806|50543562|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
25232303|NCT02990806|50543563|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
25232304|NCT02990806|50543564|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
25232305|NCT02990806|50543565|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
25232306|NCT02990806|50543562|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
25232307|NCT02990806|50543563|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
25232308|NCT02990806|50543564|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
25232309|NCT02990806|50543565|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
25232310|NCT02990806|50543562|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
25232311|NCT02990806|50543563|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
25232312|NCT02990806|50543564|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
25232313|NCT02990806|50543565|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
25232314|NCT02990806|50543562|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
25232315|NCT02990806|50543563|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
25232316|NCT02990806|50543564|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
25232317|NCT02990806|50543565|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
25232318|NCT02990806|50543562|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
25232319|NCT02990806|50543563|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
25232320|NCT02990806|50543564|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
25232321|NCT02990806|50543565|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
25232322|NCT02420821|50543636|FG000|Overall Study|Lost to Follow-up|6|||
25232323|NCT02420821|50543637|FG001|Overall Study|Lost to Follow-up|6|||
25232324|NCT02420821|50543636|FG000|Overall Study|Non-compliance|0|||
25232325|NCT02420821|50543637|FG001|Overall Study|Non-compliance|2|||
25232326|NCT02420821|50543636|FG000|Overall Study|Physician Decision|6|||
25232327|NCT02420821|50543637|FG001|Overall Study|Physician Decision|2|||
25232328|NCT02420821|50543636|FG000|Overall Study|Withdrawal by Subject|32|||
25232329|NCT02420821|50543637|FG001|Overall Study|Withdrawal by Subject|25|||
25232330|NCT02420821|50543636|FG000|Overall Study|Death|270|||
25232331|NCT02420821|50543637|FG001|Overall Study|Death|263|||
25232332|NCT02420821|50543636|FG000|Overall Study|Study Terminated By Sponsor|145|||
25232333|NCT02420821|50543637|FG001|Overall Study|Study Terminated By Sponsor|149|||
25232334|NCT02420821|50543636|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
25232335|NCT02420821|50543637|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
25232336|NCT02420821|50543636|FG000|Overall Study|Adverse Event|0|||
25232337|NCT02420821|50543637|FG001|Overall Study|Adverse Event|1|||
25232338|NCT02420821|50543636|FG000|Overall Study|Protinuria|0|||
25232339|NCT02420821|50543637|FG001|Overall Study|Protinuria|1|||
25232340|NCT02420821|50543636|FG000|Overall Study|Progressive Disease|1|||
25232341|NCT02420821|50543637|FG001|Overall Study|Progressive Disease|1|||
25232342|NCT02420821|50543636|FG000|Overall Study|Disease Progression|0|||
25232343|NCT02420821|50543637|FG001|Overall Study|Disease Progression|1|||
25232344|NCT02420821|50543636|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
25232345|NCT02420821|50543637|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
25232346|NCT02039063|50543668|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
25232347|NCT02039063|50543669|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
25232348|NCT02039063|50543670|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
25319306|NCT00887198|50634738|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
24976644|NCT03451084|50065562|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
25232349|NCT02039063|50543671|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
25232350|NCT02039063|50543668|FG000|Treatment Phase|Progression of disease|0|||
25319307|NCT00887198|50634736|FG000|Cross Over (Placebo to AA)|Other|0|||
25232351|NCT02039063|50543669|FG001|Treatment Phase|Progression of disease|0|||
25232352|NCT02039063|50543670|FG002|Treatment Phase|Progression of disease|1|||
25232353|NCT02039063|50543671|FG003|Treatment Phase|Progression of disease|1|||
25232354|NCT02039063|50543668|FG000|Extension Phase|Inadequate therapeutic effect|0|||
25232355|NCT02039063|50543669|FG001|Extension Phase|Inadequate therapeutic effect|1|||
25232356|NCT02039063|50543670|FG002|Extension Phase|Inadequate therapeutic effect|2|||
25232357|NCT02039063|50543671|FG003|Extension Phase|Inadequate therapeutic effect|0|||
25232358|NCT02039063|50543668|FG000|Extension Phase|Progression of disease|0|||
25232359|NCT02039063|50543669|FG001|Extension Phase|Progression of disease|0|||
25232360|NCT02039063|50543670|FG002|Extension Phase|Progression of disease|0|||
25232361|NCT02039063|50543671|FG003|Extension Phase|Progression of disease|1|||
25232362|NCT02039063|50543668|FG000|Extension Phase|Adverse Event|0|||
25232363|NCT02039063|50543669|FG001|Extension Phase|Adverse Event|0|||
25232364|NCT02039063|50543670|FG002|Extension Phase|Adverse Event|1|||
25232365|NCT02039063|50543671|FG003|Extension Phase|Adverse Event|0|||
25232366|NCT01746173|50543692|FG000|Overall Study|Disease Progression|2|||
25232367|NCT02995733|50543732|FG000|Overall Study|Study site closed|9|||
25232368|NCT02995733|50543733|FG001|Overall Study|Study site closed|10|||
25232369|NCT02995733|50543732|FG000|Overall Study|Death|3|||
25232370|NCT02995733|50543733|FG001|Overall Study|Death|4|||
25232371|NCT02995733|50543732|FG000|Overall Study|Withdrawal by Subject|6|||
25232372|NCT02995733|50543733|FG001|Overall Study|Withdrawal by Subject|2|||
25232373|NCT02995733|50543732|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
25232374|NCT02995733|50543733|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
25232375|NCT02995733|50543732|FG000|Overall Study|Lost to Follow-up|48|||
25232376|NCT02995733|50543733|FG001|Overall Study|Lost to Follow-up|37|||
25232377|NCT02995733|50543732|FG000|Overall Study|Other|0|||
25232378|NCT02995733|50543733|FG001|Overall Study|Other|1|||
25232379|NCT02815566|50543750|FG000|Overall Study|Adverse Event|1|||
25232380|NCT02815566|50543751|FG001|Overall Study|Adverse Event|1|||
25232381|NCT02815566|50543750|FG000|Overall Study|Withdrawal by Subject|1|||
25232382|NCT02815566|50543751|FG001|Overall Study|Withdrawal by Subject|0|||
25232383|NCT02815566|50543750|FG000|Overall Study|Lost to Follow-up|0|||
25232384|NCT02815566|50543751|FG001|Overall Study|Lost to Follow-up|1|||
25232385|NCT02525783|50543758|FG000|Overall Study|Lost to Follow-up|10|||
25232386|NCT02466243|50543774|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
25232387|NCT02466243|50543775|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
25232388|NCT02466243|50543774|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
25232389|NCT02466243|50543775|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
25232390|NCT02466243|50543774|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
25232391|NCT02466243|50543775|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
25232392|NCT02466243|50543774|FG000|Part B Open-label Treatment Period|Missing|2|||
25232393|NCT02466243|50543775|FG001|Part B Open-label Treatment Period|Missing|2|||
25232394|NCT02321098|50543788|FG000|12 Weeks Treament|Lost to Follow-up|1|||
25232395|NCT02321098|50543789|FG001|12 Weeks Treament|Lost to Follow-up|1|||
25232396|NCT02321098|50543790|FG002|12 Weeks Treament|Lost to Follow-up|0|||
25232397|NCT02321098|50543788|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
25232398|NCT02321098|50543789|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
25232399|NCT02321098|50543790|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
25232400|NCT02321098|50543788|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
25232401|NCT02321098|50543789|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
25232402|NCT02321098|50543790|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
25232403|NCT02321098|50543788|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
25232404|NCT02321098|50543789|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
25232405|NCT02321098|50543790|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
25232406|NCT01966731|50543799|FG000|Overall Study|Death|2|||
25232407|NCT01966731|50543799|FG000|Overall Study|Lost to Follow-up|1|||
25232408|NCT01966731|50543799|FG000|Overall Study|Physician Decision|2|||
25232409|NCT01966731|50543799|FG000|Overall Study|Follow up is not complete|600|||
25232410|NCT01966731|50543799|FG000|Overall Study|Screening Failure|29|||
25232411|NCT01966731|50543799|FG000|Overall Study|Found to be ineligible|1|||
25232412|NCT01843374|50543805|FG000|Overall Study|Death|155|||
25232413|NCT01843374|50543806|FG001|Overall Study|Death|313|||
25232414|NCT01843374|50543805|FG000|Overall Study|Withdrawal by Subject|14|||
25232415|NCT01843374|50543806|FG001|Overall Study|Withdrawal by Subject|20|||
25232416|NCT01843374|50543805|FG000|Overall Study|Withdrawing due to Other reason|20|||
25232417|NCT01843374|50543806|FG001|Overall Study|Withdrawing due to Other reason|46|||
25232418|NCT01620944|50543828|FG000|Overall Study|Early termination of Study|2|||
25232419|NCT01620944|50543829|FG001|Overall Study|Early termination of Study|1|||
25232420|NCT01627561|50543837|FG000|Overall Study|Lost to Follow-up|1|||
25232421|NCT01627561|50543838|FG001|Overall Study|Lost to Follow-up|0|||
25232422|NCT01627561|50543837|FG000|Overall Study|Withdrawal by Subject|0|||
25232423|NCT01627561|50543838|FG001|Overall Study|Withdrawal by Subject|1|||
25232424|NCT01627561|50543837|FG000|Overall Study|Migrated/moved from study area|0|||
25232425|NCT01627561|50543838|FG001|Overall Study|Migrated/moved from study area|2|||
25232426|NCT01652534|50543872|FG000|Overall Study|Lack of Efficacy|1|||
25232427|NCT01652534|50543873|FG001|Overall Study|Lack of Efficacy|0|||
25232428|NCT04709575|50543881|FG000|Overall Study|Withdrawal by Subject|6|||
25232429|NCT04709575|50543882|FG001|Overall Study|Withdrawal by Subject|2|||
25232430|NCT04709575|50543881|FG000|Overall Study|Lost to Follow-up|2|||
25232431|NCT04709575|50543882|FG001|Overall Study|Lost to Follow-up|2|||
25232432|NCT04709575|50543881|FG000|Overall Study|Adverse Event|1|||
25232433|NCT04709575|50543882|FG001|Overall Study|Adverse Event|0|||
25232434|NCT04709575|50543881|FG000|Overall Study|Protocol Violation|1|||
25232435|NCT04709575|50543882|FG001|Overall Study|Protocol Violation|1|||
25232436|NCT04450407|50543891|FG000|Overall Study|Withdrawal by Subject|10|||
25232437|NCT04450407|50543892|FG001|Overall Study|Withdrawal by Subject|1|||
25232438|NCT04450407|50543893|FG002|Overall Study|Withdrawal by Subject|4|||
25232439|NCT04450407|50543891|FG000|Overall Study|Adverse Event|0|||
25232440|NCT04450407|50543892|FG001|Overall Study|Adverse Event|0|||
25232441|NCT04450407|50543893|FG002|Overall Study|Adverse Event|1|||
25232442|NCT04450407|50543891|FG000|Overall Study|Lost to Follow-up|1|||
25232443|NCT04450407|50543892|FG001|Overall Study|Lost to Follow-up|0|||
25232444|NCT04450407|50543893|FG002|Overall Study|Lost to Follow-up|0|||
25232445|NCT04450407|50543891|FG000|Overall Study|Physician Decision|0|||
25232446|NCT04450407|50543892|FG001|Overall Study|Physician Decision|0|||
25232447|NCT04450407|50543893|FG002|Overall Study|Physician Decision|1|||
25232448|NCT04450407|50543891|FG000|Overall Study|Pregnancy|1|||
25232449|NCT04450407|50543892|FG001|Overall Study|Pregnancy|0|||
25232450|NCT04450407|50543893|FG002|Overall Study|Pregnancy|0|||
25232451|NCT04450407|50543891|FG000|Overall Study|Protocol Violation|2|||
25232452|NCT04450407|50543892|FG001|Overall Study|Protocol Violation|0|||
25232453|NCT04450407|50543893|FG002|Overall Study|Protocol Violation|0|||
25232454|NCT04450407|50543891|FG000|Overall Study|Investigational site terminated by sponsor|3|||
25232455|NCT04450407|50543892|FG001|Overall Study|Investigational site terminated by sponsor|0|||
25232456|NCT04450407|50543893|FG002|Overall Study|Investigational site terminated by sponsor|2|||
25232457|NCT04418765|50543903|FG000|Overall Study|Adverse Event|1|||
25232458|NCT04418765|50543904|FG001|Overall Study|Adverse Event|1|||
25232459|NCT04418765|50543905|FG002|Overall Study|Adverse Event|6|||
25232460|NCT04418765|50543903|FG000|Overall Study|Lack of Efficacy|1|||
25232461|NCT04418765|50543904|FG001|Overall Study|Lack of Efficacy|3|||
25232462|NCT04418765|50543905|FG002|Overall Study|Lack of Efficacy|0|||
25232463|NCT04418765|50543903|FG000|Overall Study|Protocol Violation|0|||
25232464|NCT04418765|50543904|FG001|Overall Study|Protocol Violation|1|||
25232465|NCT04418765|50543905|FG002|Overall Study|Protocol Violation|1|||
25232466|NCT04418765|50543903|FG000|Overall Study|Withdrawal by Subject|1|||
25232467|NCT04418765|50543904|FG001|Overall Study|Withdrawal by Subject|5|||
25232468|NCT04418765|50543905|FG002|Overall Study|Withdrawal by Subject|2|||
25232469|NCT04418765|50543903|FG000|Overall Study|Lost to Follow-up|0|||
25232470|NCT04418765|50543904|FG001|Overall Study|Lost to Follow-up|1|||
25232471|NCT04418765|50543905|FG002|Overall Study|Lost to Follow-up|0|||
25232472|NCT04418765|50543903|FG000|Overall Study|Other than specified|2|||
25232473|NCT04418765|50543904|FG001|Overall Study|Other than specified|0|||
25232474|NCT04418765|50543905|FG002|Overall Study|Other than specified|1|||
25232475|NCT04418765|50543903|FG000|Overall Study|Randomized but not treated|1|||
25232476|NCT04418765|50543904|FG001|Overall Study|Randomized but not treated|0|||
25232477|NCT04418765|50543905|FG002|Overall Study|Randomized but not treated|0|||
25232478|NCT04388826|50543915|FG000|Overall Study|Lost to Follow-up|3|||
25232479|NCT04388826|50543916|FG001|Overall Study|Lost to Follow-up|2|||
25319308|NCT00887198|50634737|FG001|Cross Over (Placebo to AA)|Other|0|||
25319309|NCT00887198|50634738|FG002|Cross Over (Placebo to AA)|Other|19|||
25232480|NCT04388826|50543915|FG000|Overall Study|Adverse Event|1|||
25232481|NCT04388826|50543916|FG001|Overall Study|Adverse Event|0|||
25232482|NCT04218266|50543938|FG000|Overall Study|Death|1|||
25232483|NCT04218266|50543939|FG001|Overall Study|Death|2|||
25232484|NCT04218266|50543940|FG002|Overall Study|Death|3|||
25232485|NCT04218266|50543938|FG000|Overall Study|Adverse Event|13|||
25232486|NCT04218266|50543939|FG001|Overall Study|Adverse Event|14|||
25232487|NCT04218266|50543940|FG002|Overall Study|Adverse Event|11|||
25232488|NCT04218266|50543938|FG000|Overall Study|Other|7|||
25232489|NCT04218266|50543939|FG001|Overall Study|Other|5|||
25232490|NCT04218266|50543940|FG002|Overall Study|Other|14|||
25232491|NCT04218266|50543938|FG000|Overall Study|Physician Decision|1|||
25232492|NCT04218266|50543939|FG001|Overall Study|Physician Decision|3|||
25232493|NCT04218266|50543940|FG002|Overall Study|Physician Decision|2|||
25232494|NCT04218266|50543938|FG000|Overall Study|Non-compliance with study drug|0|||
25232495|NCT04218266|50543939|FG001|Overall Study|Non-compliance with study drug|0|||
25319310|NCT00782067|50634746|FG000|Overall Study|Adverse Event|35|||
25319311|NCT00782067|50634746|FG000|Overall Study|Subject withdrew consent|11|||
25232496|NCT04218266|50543940|FG002|Overall Study|Non-compliance with study drug|1|||
25232497|NCT04218266|50543938|FG000|Overall Study|Withdrawal by Subject|1|||
25232498|NCT04218266|50543939|FG001|Overall Study|Withdrawal by Subject|3|||
25232499|NCT04218266|50543940|FG002|Overall Study|Withdrawal by Subject|1|||
25319312|NCT00782067|50634746|FG000|Overall Study|Lost to Follow-up|2|||
25232500|NCT04218266|50543938|FG000|Overall Study|Study drug never administered|2|||
25232501|NCT04218266|50543939|FG001|Overall Study|Study drug never administered|0|||
25232502|NCT04218266|50543940|FG002|Overall Study|Study drug never administered|0|||
25232503|NCT03894904|50543962|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
25232504|NCT03894904|50543963|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
25232505|NCT03894904|50543962|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
25232506|NCT03894904|50543963|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
25232507|NCT03518086|50543980|FG000|Overall Study|Adverse Event|23|||
25319313|NCT00782067|50634746|FG000|Overall Study|Administrative problems|14|||
25319314|NCT00782067|50634746|FG000|Overall Study|Death|9|||
25319315|NCT00782067|50634746|FG000|Overall Study|Disease progression|43|||
25319316|NCT00782067|50634746|FG000|Overall Study|Protocol deviation|2|||
25319317|NCT00886340|50634752|FG000|Overall Study|Withdrawal by Subject|0|||
25319318|NCT00886340|50634753|FG001|Overall Study|Withdrawal by Subject|7|||
25319319|NCT00605215|50634762|FG000|Overall Study|Death|0|||
25319320|NCT00605215|50634763|FG001|Overall Study|Death|0|||
25319321|NCT00605215|50634764|FG002|Overall Study|Death|1|||
25319322|NCT00605215|50634762|FG000|Overall Study|Adverse Event|19|||
25319323|NCT00605215|50634763|FG001|Overall Study|Adverse Event|21|||
25319324|NCT00605215|50634764|FG002|Overall Study|Adverse Event|26|||
25319325|NCT00605215|50634762|FG000|Overall Study|Refusal to sign the re-consent form|8|||
25319326|NCT00605215|50634763|FG001|Overall Study|Refusal to sign the re-consent form|3|||
25319327|NCT00605215|50634764|FG002|Overall Study|Refusal to sign the re-consent form|3|||
25319328|NCT00605215|50634762|FG000|Overall Study|Withdrawal by Subject|39|||
25319329|NCT00605215|50634763|FG001|Overall Study|Withdrawal by Subject|37|||
25319330|NCT00605215|50634764|FG002|Overall Study|Withdrawal by Subject|27|||
25319331|NCT00605215|50634762|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
25319332|NCT00605215|50634763|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
25319333|NCT00605215|50634764|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
25319334|NCT00605215|50634762|FG000|Overall Study|Protocol Violation|3|||
25319335|NCT00605215|50634763|FG001|Overall Study|Protocol Violation|4|||
25319336|NCT00605215|50634764|FG002|Overall Study|Protocol Violation|1|||
25319337|NCT00605215|50634762|FG000|Overall Study|Pregnancy|8|||
25319338|NCT00605215|50634763|FG001|Overall Study|Pregnancy|5|||
25319339|NCT00605215|50634764|FG002|Overall Study|Pregnancy|4|||
25319340|NCT00605215|50634762|FG000|Overall Study|Lost to Follow-up|8|||
25319341|NCT00605215|50634763|FG001|Overall Study|Lost to Follow-up|5|||
25319342|NCT00605215|50634764|FG002|Overall Study|Lost to Follow-up|2|||
25319343|NCT00605215|50634762|FG000|Overall Study|Other than specified|0|||
25319344|NCT00605215|50634763|FG001|Overall Study|Other than specified|2|||
25319345|NCT00605215|50634764|FG002|Overall Study|Other than specified|1|||
25319346|NCT00604279|50634774|FG000|Overall Study|Lack of Efficacy|22|||
25319347|NCT00604279|50634775|FG001|Overall Study|Lack of Efficacy|9|||
25319348|NCT00604279|50634774|FG000|Overall Study|Lost to Follow-up|9|||
25319349|NCT00604279|50634775|FG001|Overall Study|Lost to Follow-up|14|||
25319350|NCT00604279|50634774|FG000|Overall Study|Pregnancy|2|||
25319351|NCT00604279|50634775|FG001|Overall Study|Pregnancy|0|||
25319352|NCT00604279|50634774|FG000|Overall Study|Protocol Violation|3|||
25319353|NCT00604279|50634775|FG001|Overall Study|Protocol Violation|1|||
25319354|NCT00604279|50634774|FG000|Overall Study|Withdrawal by Subject|16|||
25319355|NCT00604279|50634775|FG001|Overall Study|Withdrawal by Subject|5|||
25319356|NCT00604279|50634774|FG000|Overall Study|Adverse Event|4|||
25319357|NCT00604279|50634775|FG001|Overall Study|Adverse Event|5|||
25319358|NCT00604279|50634774|FG000|Overall Study|Other|8|||
25319359|NCT00604279|50634775|FG001|Overall Study|Other|4|||
25319360|NCT00938015|50634781|FG000|Overall Study|Death|2|||
25319361|NCT00938015|50634781|FG000|Overall Study|Lost to Follow-up|32|||
25319362|NCT00938015|50634781|FG000|Overall Study|Adverse Event|32|||
25319363|NCT00938015|50634781|FG000|Overall Study|Non-responder|52|||
25319364|NCT00938015|50634781|FG000|Overall Study|Reason not related to Etanercept|29|||
25319365|NCT00781911|50634787|FG000|Overall Study|Adverse Event|4|||
25319366|NCT00781911|50634788|FG001|Overall Study|Adverse Event|4|||
25319367|NCT00781911|50634787|FG000|Overall Study|Withdrawal by Subject|1|||
25319368|NCT00781911|50634788|FG001|Overall Study|Withdrawal by Subject|2|||
25319369|NCT00781911|50634787|FG000|Overall Study|Physician Decision|0|||
25319370|NCT00781911|50634788|FG001|Overall Study|Physician Decision|2|||
25319371|NCT00781911|50634787|FG000|Overall Study|Sponsor Decision|1|||
25319372|NCT00781911|50634788|FG001|Overall Study|Sponsor Decision|0|||
25232508|NCT03518086|50543981|FG001|Overall Study|Adverse Event|15|||
25232509|NCT03518086|50543982|FG002|Overall Study|Adverse Event|0|||
25232510|NCT03518086|50543983|FG003|Overall Study|Adverse Event|0|||
25232511|NCT03518086|50543980|FG000|Overall Study|Withdrawal by Subject|8|||
25232512|NCT03518086|50543981|FG001|Overall Study|Withdrawal by Subject|5|||
25232513|NCT03518086|50543982|FG002|Overall Study|Withdrawal by Subject|0|||
25232514|NCT03518086|50543983|FG003|Overall Study|Withdrawal by Subject|0|||
25232515|NCT03518086|50543980|FG000|Overall Study|Lack of Efficacy|5|||
25232516|NCT03518086|50543981|FG001|Overall Study|Lack of Efficacy|5|||
25232517|NCT03518086|50543982|FG002|Overall Study|Lack of Efficacy|0|||
25232518|NCT03518086|50543983|FG003|Overall Study|Lack of Efficacy|0|||
25232519|NCT03518086|50543980|FG000|Overall Study|Protocol Violation|1|||
25232520|NCT03518086|50543981|FG001|Overall Study|Protocol Violation|5|||
25232521|NCT03518086|50543982|FG002|Overall Study|Protocol Violation|0|||
25232522|NCT03518086|50543983|FG003|Overall Study|Protocol Violation|0|||
25232523|NCT03518086|50543980|FG000|Overall Study|Lost to Follow-up|0|||
25232524|NCT03518086|50543981|FG001|Overall Study|Lost to Follow-up|3|||
25232525|NCT03518086|50543982|FG002|Overall Study|Lost to Follow-up|0|||
25232526|NCT03518086|50543983|FG003|Overall Study|Lost to Follow-up|0|||
25232527|NCT03518086|50543980|FG000|Overall Study|Insufficient Diary Data|0|||
25232528|NCT03518086|50543981|FG001|Overall Study|Insufficient Diary Data|2|||
25232529|NCT03518086|50543982|FG002|Overall Study|Insufficient Diary Data|0|||
25232530|NCT03518086|50543983|FG003|Overall Study|Insufficient Diary Data|0|||
25232531|NCT03518086|50543980|FG000|Overall Study|Non- compliance to Protocol|0|||
25232532|NCT03518086|50543981|FG001|Overall Study|Non- compliance to Protocol|1|||
25232533|NCT03518086|50543982|FG002|Overall Study|Non- compliance to Protocol|0|||
25232534|NCT03518086|50543983|FG003|Overall Study|Non- compliance to Protocol|0|||
25232535|NCT03518086|50543980|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
25232536|NCT03518086|50543981|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
25232537|NCT03518086|50543982|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
25232538|NCT03518086|50543983|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
25232539|NCT03518086|50543980|FG000|Overall Study|Site Terminated by Sponsor|0|||
25232540|NCT03518086|50543981|FG001|Overall Study|Site Terminated by Sponsor|1|||
25232541|NCT03518086|50543982|FG002|Overall Study|Site Terminated by Sponsor|0|||
25232542|NCT03518086|50543983|FG003|Overall Study|Site Terminated by Sponsor|0|||
25232543|NCT03225287|50543998|FG000|Overall Study|Adverse Event|0|||
25232544|NCT03225287|50543999|FG001|Overall Study|Adverse Event|0|||
25232545|NCT03225287|50544000|FG002|Overall Study|Adverse Event|1|||
25232546|NCT03225287|50543998|FG000|Overall Study|Protocol non-compliance|0|||
25232547|NCT03225287|50543999|FG001|Overall Study|Protocol non-compliance|0|||
25232548|NCT03225287|50544000|FG002|Overall Study|Protocol non-compliance|1|||
25232549|NCT03225287|50543998|FG000|Overall Study|Subject withdraws consent|3|||
25232550|NCT03225287|50543999|FG001|Overall Study|Subject withdraws consent|0|||
25232551|NCT03225287|50544000|FG002|Overall Study|Subject withdraws consent|0|||
25232552|NCT03225287|50543998|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
25232553|NCT03225287|50543999|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
25232554|NCT03225287|50544000|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
25232555|NCT03225287|50543998|FG000|Overall Study|Trial drug not effective|0|||
25232556|NCT03225287|50543999|FG001|Overall Study|Trial drug not effective|1|||
25232557|NCT03225287|50544000|FG002|Overall Study|Trial drug not effective|0|||
25232558|NCT03225287|50543998|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
25232559|NCT03225287|50543999|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
25232560|NCT03225287|50544000|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
25232561|NCT03225287|50543998|FG000|Overall Study|Stem cell transplantation|0|||
25232562|NCT03225287|50543999|FG001|Overall Study|Stem cell transplantation|1|||
25232563|NCT03225287|50544000|FG002|Overall Study|Stem cell transplantation|0|||
25232564|NCT03099265|50544008|FG000|Overall Study|Adverse Event|1|||
25232565|NCT02658656|50544026|FG000|Screening|Failed eligibility criteria|0|||
25232566|NCT02658656|50544027|FG001|Screening|Failed eligibility criteria|0|||
25232567|NCT02658656|50544028|FG002|Screening|Failed eligibility criteria|263|||
25232568|NCT02658656|50544026|FG000|Randomization|Withdrawal by Subject|8|||
25232569|NCT02658656|50544027|FG001|Randomization|Withdrawal by Subject|7|||
25232570|NCT02658656|50544028|FG002|Randomization|Withdrawal by Subject|0|||
25232571|NCT02658656|50544026|FG000|Randomization|Lost to Follow-up|1|||
25232572|NCT02658656|50544027|FG001|Randomization|Lost to Follow-up|3|||
25232573|NCT02658656|50544028|FG002|Randomization|Lost to Follow-up|0|||
25232574|NCT02658656|50544026|FG000|Randomization|Adverse Event|4|||
25232575|NCT02658656|50544027|FG001|Randomization|Adverse Event|0|||
25232576|NCT02658656|50544028|FG002|Randomization|Adverse Event|0|||
25232577|NCT02658656|50544026|FG000|Randomization|Administrative Termination|3|||
25232578|NCT02658656|50544027|FG001|Randomization|Administrative Termination|1|||
25232579|NCT02658656|50544028|FG002|Randomization|Administrative Termination|0|||
25232580|NCT02658656|50544026|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
25232581|NCT02658656|50544027|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
25232582|NCT02658656|50544028|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
25232583|NCT02658656|50544026|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
25232584|NCT02658656|50544027|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
25232585|NCT02658656|50544028|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
25232586|NCT02658656|50544026|FG000|Randomization|Not eligible for Randomization|1|||
25232587|NCT02658656|50544027|FG001|Randomization|Not eligible for Randomization|0|||
25232588|NCT02658656|50544028|FG002|Randomization|Not eligible for Randomization|0|||
25232589|NCT02658656|50544026|FG000|Randomization|Protocol Violation|1|||
25232590|NCT02658656|50544027|FG001|Randomization|Protocol Violation|0|||
25232591|NCT02658656|50544028|FG002|Randomization|Protocol Violation|0|||
25232592|NCT05141175|50544086|FG000|Overall Study|Withdrawal by Subject|1|||
25232593|NCT04869345|50544092|FG000|Overall Study|Lost to Follow-up|8|||
25232594|NCT04869345|50544093|FG001|Overall Study|Lost to Follow-up|3|||
25232595|NCT03610737|50544165|FG000|Overall Study|Withdrawal by Subject|1|||
25232596|NCT03610737|50544166|FG001|Overall Study|Withdrawal by Subject|5|||
25232597|NCT03610737|50544165|FG000|Overall Study|Death|1|||
25232598|NCT03610737|50544166|FG001|Overall Study|Death|0|||
25232599|NCT03610737|50544165|FG000|Overall Study|Not treated|5|||
25232600|NCT03610737|50544166|FG001|Overall Study|Not treated|2|||
25232601|NCT03610737|50544165|FG000|Overall Study|Missed Visit|1|||
25232602|NCT03610737|50544166|FG001|Overall Study|Missed Visit|2|||
25232603|NCT03321929|50544176|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
25232604|NCT03250624|50544192|FG000|Overall Study|Lack of Efficacy|1|||
25232605|NCT03250624|50544193|FG001|Overall Study|Lack of Efficacy|4|||
25232606|NCT03250624|50544192|FG000|Overall Study|Adverse Event|0|||
25232607|NCT03250624|50544193|FG001|Overall Study|Adverse Event|1|||
25232608|NCT03250624|50544192|FG000|Overall Study|Other|1|||
25232609|NCT03250624|50544193|FG001|Overall Study|Other|2|||
25232610|NCT02563002|50544217|FG000|Overall Study|Death|62|||
25232611|NCT02563002|50544218|FG001|Overall Study|Death|75|||
25232612|NCT02563002|50544217|FG000|Overall Study|Lost to Follow-up|1|||
25232613|NCT02563002|50544218|FG001|Overall Study|Lost to Follow-up|0|||
25232614|NCT02563002|50544217|FG000|Overall Study|Withdrawal by Subject|0|||
25232615|NCT02563002|50544218|FG001|Overall Study|Withdrawal by Subject|9|||
25232616|NCT02563002|50544217|FG000|Overall Study|Ongoing|90|||
25232617|NCT02563002|50544218|FG001|Overall Study|Ongoing|70|||
25232618|NCT02507297|50544229|FG000|Overall Study|Withdrawal by Subject|1|||
25232619|NCT02507297|50544230|FG001|Overall Study|Withdrawal by Subject|0|||
25232620|NCT02507297|50544229|FG000|Overall Study|Lost to Follow-up|0|||
25232621|NCT02507297|50544230|FG001|Overall Study|Lost to Follow-up|1|||
25232622|NCT01333514|50544243|FG000|Overall Study|Withdrawal by Subject|1|||
25232623|NCT01333514|50544244|FG001|Overall Study|Withdrawal by Subject|0|||
25232624|NCT02066636|50544253|FG000|Overall Study|Disease progression|51|||
25232625|NCT02066636|50544254|FG001|Overall Study|Disease progression|60|||
25232626|NCT02066636|50544255|FG002|Overall Study|Disease progression|700|||
25232627|NCT02066636|50544253|FG000|Overall Study|Study drug toxicity|13|||
25232628|NCT02066636|50544254|FG001|Overall Study|Study drug toxicity|2|||
25232629|NCT02066636|50544255|FG002|Overall Study|Study drug toxicity|58|||
25232630|NCT02066636|50544253|FG000|Overall Study|Death|4|||
25232631|NCT02066636|50544254|FG001|Overall Study|Death|2|||
25232632|NCT02066636|50544255|FG002|Overall Study|Death|158|||
25232633|NCT02066636|50544253|FG000|Overall Study|Adverse event unrelated to study drug|6|||
25232634|NCT02066636|50544254|FG001|Overall Study|Adverse event unrelated to study drug|4|||
25077504|NCT00002663|50185276|FG001|Overall Study|Adverse Event|0|||
25232635|NCT02066636|50544255|FG002|Overall Study|Adverse event unrelated to study drug|45|||
25232636|NCT02066636|50544253|FG000|Overall Study|Participant request to discontinue treatment|12|||
25232637|NCT02066636|50544254|FG001|Overall Study|Participant request to discontinue treatment|12|||
25232638|NCT02066636|50544255|FG002|Overall Study|Participant request to discontinue treatment|70|||
25232639|NCT02066636|50544253|FG000|Overall Study|Participant withdrew consent|10|||
25232640|NCT02066636|50544254|FG001|Overall Study|Participant withdrew consent|18|||
25232641|NCT02066636|50544255|FG002|Overall Study|Participant withdrew consent|61|||
25232642|NCT02066636|50544253|FG000|Overall Study|Lost to Follow-up|0|||
25232643|NCT02066636|50544254|FG001|Overall Study|Lost to Follow-up|2|||
25232644|NCT02066636|50544255|FG002|Overall Study|Lost to Follow-up|2|||
25232645|NCT02066636|50544253|FG000|Overall Study|Maximum clinical benefit|2|||
25232646|NCT02066636|50544254|FG001|Overall Study|Maximum clinical benefit|2|||
25232647|NCT02066636|50544255|FG002|Overall Study|Maximum clinical benefit|3|||
25232648|NCT02066636|50544253|FG000|Overall Study|Poor/non-compliance|2|||
25232649|NCT02066636|50544254|FG001|Overall Study|Poor/non-compliance|1|||
25232650|NCT02066636|50544255|FG002|Overall Study|Poor/non-compliance|1|||
25232651|NCT02066636|50544253|FG000|Overall Study|Participant no loner meets study criteria|3|||
25232652|NCT02066636|50544254|FG001|Overall Study|Participant no loner meets study criteria|2|||
25232653|NCT02066636|50544255|FG002|Overall Study|Participant no loner meets study criteria|28|||
25232654|NCT02066636|50544253|FG000|Overall Study|Administrative reasons by sponsor|8|||
25232655|NCT02066636|50544254|FG001|Overall Study|Administrative reasons by sponsor|5|||
25232656|NCT02066636|50544255|FG002|Overall Study|Administrative reasons by sponsor|0|||
25232657|NCT02066636|50544253|FG000|Overall Study|Other reasons|16|||
25232658|NCT02066636|50544254|FG001|Overall Study|Other reasons|15|||
25232659|NCT02066636|50544255|FG002|Overall Study|Other reasons|50|||
25232660|NCT01486264|50544267|FG000|Overall Study|Death|1|||
25232661|NCT01486264|50544268|FG001|Overall Study|Death|1|||
25232662|NCT01486264|50544267|FG000|Overall Study|Adverse Event|3|||
25232663|NCT01486264|50544268|FG001|Overall Study|Adverse Event|3|||
25232664|NCT01486264|50544267|FG000|Overall Study|Lack of Efficacy|6|||
25232665|NCT01486264|50544268|FG001|Overall Study|Lack of Efficacy|10|||
25232666|NCT01486264|50544267|FG000|Overall Study|Withdrawal by Subject|7|||
25232667|NCT01486264|50544268|FG001|Overall Study|Withdrawal by Subject|18|||
25232668|NCT01486264|50544267|FG000|Overall Study|Physician Decision|1|||
25232669|NCT01486264|50544268|FG001|Overall Study|Physician Decision|1|||
25232670|NCT01486264|50544267|FG000|Overall Study|Protocol Violation|3|||
25232671|NCT01486264|50544268|FG001|Overall Study|Protocol Violation|0|||
25232672|NCT01486264|50544267|FG000|Overall Study|Lost to Follow-up|3|||
25232673|NCT01486264|50544268|FG001|Overall Study|Lost to Follow-up|2|||
25232674|NCT01486264|50544267|FG000|Overall Study|Other|5|||
25232675|NCT01486264|50544268|FG001|Overall Study|Other|11|||
25232676|NCT01486264|50544267|FG000|Overall Study|Not treated|0|||
25232677|NCT01486264|50544268|FG001|Overall Study|Not treated|1|||
25232678|NCT01323270|50544276|FG000|Overall Study|Withdrawal by Subject|19|||
25232679|NCT01323270|50544277|FG001|Overall Study|Withdrawal by Subject|10|||
25232680|NCT01323270|50544276|FG000|Overall Study|Protocol Violation|9|||
25232681|NCT01323270|50544277|FG001|Overall Study|Protocol Violation|7|||
25232682|NCT01323270|50544276|FG000|Overall Study|Lost to Follow-up|4|||
25232683|NCT01323270|50544277|FG001|Overall Study|Lost to Follow-up|6|||
25232684|NCT01323270|50544276|FG000|Overall Study|Adverse Event|8|||
25232685|NCT01323270|50544277|FG001|Overall Study|Adverse Event|0|||
25232686|NCT01323270|50544276|FG000|Overall Study|Other|0|||
25232687|NCT01323270|50544277|FG001|Overall Study|Other|3|||
25232688|NCT01323270|50544276|FG000|Overall Study|Physician Decision|0|||
25232689|NCT01323270|50544277|FG001|Overall Study|Physician Decision|2|||
25232690|NCT01323270|50544276|FG000|Overall Study|Not eligible|1|||
25232691|NCT01323270|50544277|FG001|Overall Study|Not eligible|1|||
25232692|NCT01323270|50544276|FG000|Overall Study|Death|1|||
25232693|NCT01323270|50544277|FG001|Overall Study|Death|0|||
25232694|NCT01323270|50544276|FG000|Overall Study|Randomized, but not vaccinated|1|||
25232695|NCT01323270|50544277|FG001|Overall Study|Randomized, but not vaccinated|0|||
25232696|NCT01300728|50544286|FG000|Overall Study|Withdrawal by Subject|1|||
25232697|NCT01300728|50544287|FG001|Overall Study|Withdrawal by Subject|1|||
25232698|NCT01300728|50544286|FG000|Overall Study|Physician Decision|1|||
25232699|NCT01300728|50544287|FG001|Overall Study|Physician Decision|0|||
25232700|NCT01299480|50544298|FG000|Overall Study|No longer willing to participate|19|||
25232701|NCT01299480|50544299|FG001|Overall Study|No longer willing to participate|17|||
25232702|NCT01299480|50544300|FG002|Overall Study|No longer willing to participate|14|||
25232703|NCT01299480|50544301|FG003|Overall Study|No longer willing to participate|13|||
25232704|NCT01299480|50544302|FG004|Overall Study|No longer willing to participate|10|||
25232705|NCT01299480|50544298|FG000|Overall Study|Protocol Violation|7|||
25232706|NCT01299480|50544299|FG001|Overall Study|Protocol Violation|5|||
25232707|NCT01299480|50544300|FG002|Overall Study|Protocol Violation|8|||
25232708|NCT01299480|50544301|FG003|Overall Study|Protocol Violation|1|||
25232709|NCT01299480|50544302|FG004|Overall Study|Protocol Violation|1|||
25232710|NCT01299480|50544298|FG000|Overall Study|Withdrawal by Subject|3|||
25232711|NCT01299480|50544299|FG001|Overall Study|Withdrawal by Subject|4|||
25232712|NCT01299480|50544300|FG002|Overall Study|Withdrawal by Subject|7|||
25232713|NCT01299480|50544301|FG003|Overall Study|Withdrawal by Subject|3|||
25232714|NCT01299480|50544302|FG004|Overall Study|Withdrawal by Subject|4|||
25232715|NCT01299480|50544298|FG000|Overall Study|Adverse Event|6|||
25232716|NCT01299480|50544299|FG001|Overall Study|Adverse Event|4|||
25232717|NCT01299480|50544300|FG002|Overall Study|Adverse Event|5|||
25232718|NCT01299480|50544301|FG003|Overall Study|Adverse Event|4|||
25232719|NCT01299480|50544302|FG004|Overall Study|Adverse Event|0|||
25232720|NCT01299480|50544298|FG000|Overall Study|Withdrawal due to pregnancy|0|||
25232721|NCT01299480|50544299|FG001|Overall Study|Withdrawal due to pregnancy|1|||
25232722|NCT01299480|50544300|FG002|Overall Study|Withdrawal due to pregnancy|1|||
25232723|NCT01299480|50544301|FG003|Overall Study|Withdrawal due to pregnancy|0|||
25319373|NCT00605917|50634796|FG000|Overall Study|Protocol Violation|79|||
25232724|NCT01299480|50544302|FG004|Overall Study|Withdrawal due to pregnancy|0|||
25232725|NCT01299480|50544298|FG000|Overall Study|Physician Decision|1|||
25232726|NCT01299480|50544299|FG001|Overall Study|Physician Decision|1|||
25232727|NCT01299480|50544300|FG002|Overall Study|Physician Decision|0|||
25232728|NCT01299480|50544301|FG003|Overall Study|Physician Decision|2|||
25232729|NCT01299480|50544302|FG004|Overall Study|Physician Decision|0|||
25232730|NCT01299480|50544298|FG000|Overall Study|Lost to Follow-up|3|||
25232731|NCT01299480|50544299|FG001|Overall Study|Lost to Follow-up|1|||
25232732|NCT01299480|50544300|FG002|Overall Study|Lost to Follow-up|2|||
25232733|NCT01299480|50544301|FG003|Overall Study|Lost to Follow-up|1|||
25232734|NCT01299480|50544302|FG004|Overall Study|Lost to Follow-up|2|||
25232735|NCT01299480|50544298|FG000|Overall Study|Other|3|||
25232736|NCT01299480|50544299|FG001|Overall Study|Other|2|||
25232737|NCT01299480|50544300|FG002|Overall Study|Other|3|||
25232738|NCT01299480|50544301|FG003|Overall Study|Other|0|||
25232739|NCT01299480|50544302|FG004|Overall Study|Other|3|||
25232740|NCT01299480|50544298|FG000|Overall Study|Started, but not vaccinated|0|||
25232741|NCT01299480|50544299|FG001|Overall Study|Started, but not vaccinated|0|||
25232742|NCT01299480|50544300|FG002|Overall Study|Started, but not vaccinated|1|||
25232743|NCT01299480|50544301|FG003|Overall Study|Started, but not vaccinated|1|||
25232744|NCT01299480|50544302|FG004|Overall Study|Started, but not vaccinated|0|||
25232745|NCT04799405|50544324|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
25232746|NCT04688671|50544334|FG000|Overall Study|Adverse Event|3|||
25232747|NCT04688671|50544335|FG001|Overall Study|Adverse Event|1|||
25232748|NCT04688671|50544334|FG000|Overall Study|Withdrawal by Subject|3|||
25232749|NCT04688671|50544335|FG001|Overall Study|Withdrawal by Subject|1|||
25232750|NCT04688671|50544334|FG000|Overall Study|Lack of Efficacy|1|||
25232751|NCT04688671|50544335|FG001|Overall Study|Lack of Efficacy|1|||
25232752|NCT04688671|50544334|FG000|Overall Study|Protocol Violation|1|||
25232753|NCT04688671|50544335|FG001|Overall Study|Protocol Violation|0|||
25232754|NCT04688671|50544334|FG000|Overall Study|Lost to Follow-up|0|||
25232755|NCT04688671|50544335|FG001|Overall Study|Lost to Follow-up|1|||
25232756|NCT04529499|50544343|FG000|Overall Study|Withdrawal by Subject|9|||
25232757|NCT04529499|50544344|FG001|Overall Study|Withdrawal by Subject|11|||
25232758|NCT04529499|50544343|FG000|Overall Study|Physician Decision|1|||
25232759|NCT04529499|50544344|FG001|Overall Study|Physician Decision|2|||
25232760|NCT04529499|50544343|FG000|Overall Study|Adverse Event|4|||
25232761|NCT04529499|50544344|FG001|Overall Study|Adverse Event|4|||
25232762|NCT04529499|50544343|FG000|Overall Study|Death|14|||
25232763|NCT04529499|50544344|FG001|Overall Study|Death|11|||
25232764|NCT04529499|50544343|FG000|Overall Study|Lost to Follow-up|1|||
25232765|NCT04529499|50544344|FG001|Overall Study|Lost to Follow-up|1|||
25232766|NCT04529499|50544343|FG000|Overall Study|Others|7|||
25232767|NCT04529499|50544344|FG001|Overall Study|Others|11|||
25232768|NCT04501094|50544352|FG000|Overall Study|Death (unrelated to research)|1|||
25232769|NCT04501094|50544353|FG001|Overall Study|Death (unrelated to research)|0|||
25232770|NCT04414618|50544361|FG000|Overall Study|Death|3|||
25232771|NCT04414618|50544362|FG001|Overall Study|Death|3|||
25232772|NCT04414618|50544361|FG000|Overall Study|Withdrawal by Subject|2|||
25232773|NCT04414618|50544362|FG001|Overall Study|Withdrawal by Subject|1|||
25232774|NCT04414618|50544361|FG000|Overall Study|Lost to Follow-up|2|||
25232775|NCT04414618|50544362|FG001|Overall Study|Lost to Follow-up|3|||
25232776|NCT04414618|50544361|FG000|Overall Study|Physician Decision|1|||
25232777|NCT04414618|50544362|FG001|Overall Study|Physician Decision|0|||
25232778|NCT04412057|50544371|FG000|Overall Study|Death|3|||
25232779|NCT04412057|50544372|FG001|Overall Study|Death|7|||
25232780|NCT04412057|50544371|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
25232781|NCT04412057|50544372|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
25232782|NCT04402060|50544381|FG000|Overall Study|Death|1|||
25232783|NCT04402060|50544382|FG001|Overall Study|Death|12|||
25232784|NCT04402060|50544383|FG002|Overall Study|Death|7|||
25232785|NCT04402060|50544381|FG000|Overall Study|Adverse Event|0|||
25232786|NCT04402060|50544382|FG001|Overall Study|Adverse Event|0|||
25232787|NCT04402060|50544383|FG002|Overall Study|Adverse Event|1|||
25232788|NCT04402060|50544381|FG000|Overall Study|Withdrawal by Subject|0|||
25232789|NCT04402060|50544382|FG001|Overall Study|Withdrawal by Subject|1|||
25232790|NCT04402060|50544383|FG002|Overall Study|Withdrawal by Subject|2|||
25232791|NCT04402060|50544381|FG000|Overall Study|Sponsor Request|0|||
25232792|NCT04402060|50544382|FG001|Overall Study|Sponsor Request|2|||
25232793|NCT04402060|50544383|FG002|Overall Study|Sponsor Request|0|||
25232794|NCT04402060|50544381|FG000|Overall Study|Physician Decision|0|||
25232795|NCT04402060|50544382|FG001|Overall Study|Physician Decision|0|||
25232796|NCT04402060|50544383|FG002|Overall Study|Physician Decision|1|||
25232797|NCT04402060|50544381|FG000|Overall Study|Other|0|||
25232798|NCT04402060|50544382|FG001|Overall Study|Other|1|||
25232799|NCT04402060|50544383|FG002|Overall Study|Other|0|||
25232800|NCT04376684|50544418|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
25232801|NCT04376684|50544419|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
25232802|NCT04376684|50544420|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
25232803|NCT04376684|50544421|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
25232804|NCT04376684|50544418|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
25232805|NCT04376684|50544419|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
25232806|NCT04376684|50544420|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
25232807|NCT04376684|50544421|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
25232808|NCT04376684|50544418|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
25232809|NCT04376684|50544419|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
25232810|NCT04376684|50544420|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
25232811|NCT04376684|50544421|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
25232812|NCT04376684|50544418|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
25232813|NCT04376684|50544419|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
25232814|NCT04376684|50544420|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
25232815|NCT04376684|50544421|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
25232816|NCT04376684|50544418|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
25232817|NCT04376684|50544419|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
25232818|NCT04376684|50544420|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
25232819|NCT04376684|50544421|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
25232820|NCT04376684|50544418|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
25232821|NCT04376684|50544419|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
25232822|NCT04376684|50544420|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
25232823|NCT04376684|50544421|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
25232824|NCT04376684|50544418|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
25232825|NCT04376684|50544419|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
25232826|NCT04376684|50544420|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
25232827|NCT04376684|50544421|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
25232828|NCT04353284|50544433|FG000|Overall Study|Adverse Event|1|||
25232829|NCT04353284|50544434|FG001|Overall Study|Adverse Event|1|||
25232830|NCT04353284|50544433|FG000|Overall Study|Lost to Follow-up|1|||
25232831|NCT04353284|50544434|FG001|Overall Study|Lost to Follow-up|0|||
25232832|NCT04294147|50544442|FG000|Overall Study|Protocol Violation|2|||
25232833|NCT04294147|50544443|FG001|Overall Study|Protocol Violation|0|||
25232834|NCT04231825|50544455|FG000|Overall Study|Protocol Violation|3|||
25232835|NCT04231825|50544456|FG001|Overall Study|Protocol Violation|3|||
25232836|NCT04231825|50544455|FG000|Overall Study|Lost to Follow-up|0|||
25232837|NCT04231825|50544456|FG001|Overall Study|Lost to Follow-up|1|||
25232838|NCT04178772|50544462|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
25232839|NCT04178772|50544462|FG000|Overall Study|study terminated early due to COVID-19|7|||
25232840|NCT04148651|50544466|FG000|Overall Study|Lost to Follow-up|2|||
25232841|NCT03924427|50544479|FG000|Overall Study|Adverse Event|4|||
25232842|NCT03924427|50544479|FG000|Overall Study|Lack of Efficacy|1|||
25232843|NCT03924427|50544479|FG000|Overall Study|Withdrawal by Subject|1|||
25232844|NCT03642132|50544513|FG000|Chemotherapy Period|Adverse Event|1|||
25232845|NCT03642132|50544514|FG001|Chemotherapy Period|Adverse Event|1|||
25232846|NCT03642132|50544515|FG002|Chemotherapy Period|Adverse Event|0|||
25232847|NCT03642132|50544513|FG000|Chemotherapy Period|Physician's decision|4|||
25232848|NCT03642132|50544514|FG001|Chemotherapy Period|Physician's decision|1|||
25232849|NCT03642132|50544515|FG002|Chemotherapy Period|Physician's decision|0|||
25232850|NCT03642132|50544513|FG000|Chemotherapy Period|Progressive disease|0|||
25232851|NCT03642132|50544514|FG001|Chemotherapy Period|Progressive disease|0|||
25232852|NCT03642132|50544515|FG002|Chemotherapy Period|Progressive disease|1|||
25232853|NCT03642132|50544513|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
25232854|NCT03642132|50544514|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
25232855|NCT03642132|50544515|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
25232856|NCT03642132|50544513|FG000|Chemotherapy Period|Other|1|||
25232857|NCT03642132|50544514|FG001|Chemotherapy Period|Other|0|||
25232858|NCT03642132|50544515|FG002|Chemotherapy Period|Other|2|||
25232859|NCT03642132|50544513|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
25232860|NCT03642132|50544514|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
25232861|NCT03642132|50544515|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
25232862|NCT03642132|50544513|FG000|Maintenance Period|Adverse Event|1|||
25232863|NCT03642132|50544514|FG001|Maintenance Period|Adverse Event|2|||
25232864|NCT03642132|50544515|FG002|Maintenance Period|Adverse Event|0|||
25232865|NCT03642132|50544513|FG000|Maintenance Period|Non-compliance with study drug|0|||
25232866|NCT03642132|50544514|FG001|Maintenance Period|Non-compliance with study drug|0|||
25232867|NCT03642132|50544515|FG002|Maintenance Period|Non-compliance with study drug|1|||
25232868|NCT03642132|50544513|FG000|Maintenance Period|Physician's decision|2|||
25232869|NCT03642132|50544514|FG001|Maintenance Period|Physician's decision|2|||
25232870|NCT03642132|50544515|FG002|Maintenance Period|Physician's decision|2|||
25232871|NCT03642132|50544513|FG000|Maintenance Period|Progressive disease|9|||
25232872|NCT03642132|50544514|FG001|Maintenance Period|Progressive disease|3|||
25232873|NCT03642132|50544515|FG002|Maintenance Period|Progressive disease|6|||
25232874|NCT03642132|50544513|FG000|Maintenance Period|Other|0|||
25232875|NCT03642132|50544514|FG001|Maintenance Period|Other|0|||
25232876|NCT03642132|50544515|FG002|Maintenance Period|Other|3|||
25232877|NCT03642132|50544513|FG000|Maintenance Period|Withdrawal by Subject|1|||
25232878|NCT03642132|50544514|FG001|Maintenance Period|Withdrawal by Subject|1|||
25232879|NCT03642132|50544515|FG002|Maintenance Period|Withdrawal by Subject|2|||
25232880|NCT03642132|50544513|FG000|Follow-up Period|Other|0|||
25232881|NCT03642132|50544514|FG001|Follow-up Period|Other|0|||
25232882|NCT03642132|50544515|FG002|Follow-up Period|Other|1|||
25232883|NCT03642132|50544513|FG000|Follow-up Period|Withdrawal by Subject|1|||
25232884|NCT03642132|50544514|FG001|Follow-up Period|Withdrawal by Subject|2|||
25232885|NCT03642132|50544515|FG002|Follow-up Period|Withdrawal by Subject|0|||
25232886|NCT03642132|50544513|FG000|Follow-up Period|Study terminated by sponsor|1|||
25232887|NCT03642132|50544514|FG001|Follow-up Period|Study terminated by sponsor|0|||
25232888|NCT03642132|50544515|FG002|Follow-up Period|Study terminated by sponsor|1|||
25232889|NCT03642132|50544513|FG000|Follow-up Period|Lack of Efficacy|1|||
25232890|NCT03642132|50544514|FG001|Follow-up Period|Lack of Efficacy|0|||
25232891|NCT03642132|50544515|FG002|Follow-up Period|Lack of Efficacy|0|||
25319374|NCT00781599|50634833|FG000|Overall Study|Lost to Follow-up|7|||
25232892|NCT03642132|50544513|FG000|Follow-up Period|Death|1|||
25232893|NCT03642132|50544514|FG001|Follow-up Period|Death|0|||
25232894|NCT03642132|50544515|FG002|Follow-up Period|Death|2|||
25232895|NCT03642132|50544513|FG000|Follow-up Period|Adverse Event|1|||
25232896|NCT03642132|50544514|FG001|Follow-up Period|Adverse Event|0|||
25232897|NCT03642132|50544515|FG002|Follow-up Period|Adverse Event|0|||
25232898|NCT03008122|50544530|FG000|Overall Study|Physician Decision|3|||
25232899|NCT03008122|50544531|FG001|Overall Study|Physician Decision|2|||
25232900|NCT03008122|50544532|FG002|Overall Study|Physician Decision|0|||
25232901|NCT03008122|50544530|FG000|Overall Study|Withdrawal by Subject|1|||
25232902|NCT03008122|50544531|FG001|Overall Study|Withdrawal by Subject|3|||
25232903|NCT03008122|50544532|FG002|Overall Study|Withdrawal by Subject|0|||
25232904|NCT03008122|50544530|FG000|Overall Study|Lost to Follow-up|4|||
25232905|NCT03008122|50544531|FG001|Overall Study|Lost to Follow-up|8|||
25232906|NCT03008122|50544532|FG002|Overall Study|Lost to Follow-up|3|||
25232907|NCT03008122|50544530|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
25232908|NCT03008122|50544531|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
25232909|NCT03008122|50544532|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
25232910|NCT03008122|50544530|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
25232911|NCT03008122|50544531|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
25232912|NCT03008122|50544532|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
25232913|NCT03008122|50544530|FG000|Overall Study|Death|0|||
25232914|NCT03008122|50544531|FG001|Overall Study|Death|0|||
25232915|NCT03008122|50544532|FG002|Overall Study|Death|1|||
25232916|NCT02584634|50544542|FG000|Overall Study|Adverse Event|3|||
25232917|NCT02584634|50544543|FG001|Overall Study|Adverse Event|3|||
25232918|NCT02584634|50544542|FG000|Overall Study|Death|0|||
25232919|NCT02584634|50544543|FG001|Overall Study|Death|1|||
25232920|NCT02584634|50544542|FG000|Overall Study|Lost to Follow-up|0|||
25232921|NCT02584634|50544543|FG001|Overall Study|Lost to Follow-up|1|||
25232922|NCT02584634|50544542|FG000|Overall Study|Physician Decision|1|||
25232923|NCT02584634|50544543|FG001|Overall Study|Physician Decision|1|||
25232924|NCT02584634|50544542|FG000|Overall Study|Progressive disease|7|||
25232925|NCT02584634|50544543|FG001|Overall Study|Progressive disease|14|||
25232926|NCT02584634|50544542|FG000|Overall Study|Withdrawal by Subject|1|||
25232927|NCT02584634|50544543|FG001|Overall Study|Withdrawal by Subject|1|||
25232928|NCT02584634|50544542|FG000|Overall Study|Other|0|||
25232929|NCT02584634|50544543|FG001|Overall Study|Other|2|||
25232930|NCT02584634|50544542|FG000|Overall Study|Ongoing|0|||
25232931|NCT02584634|50544543|FG001|Overall Study|Ongoing|8|||
25232932|NCT02125461|50544583|FG000|Overall Study|Withdrawal by Subject|30|||
25232933|NCT02125461|50544584|FG001|Overall Study|Withdrawal by Subject|16|||
25232934|NCT02125461|50544583|FG000|Overall Study|Lost to Follow-up|8|||
25232935|NCT02125461|50544584|FG001|Overall Study|Lost to Follow-up|3|||
25232936|NCT02125461|50544583|FG000|Overall Study|Death|260|||
25232937|NCT02125461|50544584|FG001|Overall Study|Death|149|||
25232938|NCT02125461|50544583|FG000|Overall Study|Missing Termination Reason|0|||
25232939|NCT02125461|50544584|FG001|Overall Study|Missing Termination Reason|1|||
25232940|NCT02003924|50544592|FG000|Double-blind Phase|Lost to Follow-up|2|||
25232941|NCT02003924|50544593|FG001|Double-blind Phase|Lost to Follow-up|1|||
25232942|NCT02003924|50544594|FG002|Double-blind Phase|Lost to Follow-up|0|||
25232943|NCT02003924|50544592|FG000|Double-blind Phase|Protocol Violation|1|||
25232944|NCT02003924|50544593|FG001|Double-blind Phase|Protocol Violation|2|||
25232945|NCT02003924|50544594|FG002|Double-blind Phase|Protocol Violation|0|||
25232946|NCT02003924|50544592|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
25232947|NCT02003924|50544593|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
25232948|NCT02003924|50544594|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
25232949|NCT02003924|50544592|FG000|Double-blind Phase|Disease Progression|229|||
25232950|NCT02003924|50544593|FG001|Double-blind Phase|Disease Progression|247|||
25232951|NCT02003924|50544594|FG002|Double-blind Phase|Disease Progression|0|||
25232952|NCT02003924|50544592|FG000|Double-blind Phase|Adverse Event|120|||
25232953|NCT02003924|50544593|FG001|Double-blind Phase|Adverse Event|31|||
25232954|NCT02003924|50544594|FG002|Double-blind Phase|Adverse Event|0|||
25232955|NCT02003924|50544592|FG000|Double-blind Phase|Randomized But not Treated|3|||
25232956|NCT02003924|50544593|FG001|Double-blind Phase|Randomized But not Treated|3|||
25232957|NCT02003924|50544594|FG002|Double-blind Phase|Randomized But not Treated|0|||
25232958|NCT02003924|50544592|FG000|Double-blind Phase|Other|29|||
25232959|NCT02003924|50544593|FG001|Double-blind Phase|Other|50|||
25232960|NCT02003924|50544594|FG002|Double-blind Phase|Other|0|||
25232961|NCT02003924|50544592|FG000|Open-label Phase|Lost to Follow-up|0|||
25232962|NCT02003924|50544593|FG001|Open-label Phase|Lost to Follow-up|0|||
25232963|NCT02003924|50544594|FG002|Open-label Phase|Lost to Follow-up|1|||
25232964|NCT02003924|50544592|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
25232965|NCT02003924|50544593|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
25232966|NCT02003924|50544594|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
25232967|NCT02003924|50544592|FG000|Open-label Phase|Disease Progression|59|||
25232968|NCT02003924|50544593|FG001|Open-label Phase|Disease Progression|0|||
25232969|NCT02003924|50544594|FG002|Open-label Phase|Disease Progression|5|||
25232970|NCT02003924|50544592|FG000|Open-label Phase|Adverse Event|25|||
25232971|NCT02003924|50544593|FG001|Open-label Phase|Adverse Event|0|||
25232972|NCT02003924|50544594|FG002|Open-label Phase|Adverse Event|10|||
25232973|NCT02003924|50544592|FG000|Open-label Phase|Other|7|||
25232974|NCT02003924|50544593|FG001|Open-label Phase|Other|0|||
25232975|NCT02003924|50544594|FG002|Open-label Phase|Other|0|||
25232976|NCT02003924|50544592|FG000|Long-term Follow-up Phase|Death|288|||
25232977|NCT02003924|50544593|FG001|Long-term Follow-up Phase|Death|174|||
25232978|NCT02003924|50544594|FG002|Long-term Follow-up Phase|Death|4|||
25232979|NCT02003924|50544592|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
25232980|NCT02003924|50544593|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
25232981|NCT02003924|50544594|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
25232982|NCT02003924|50544592|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
25232983|NCT02003924|50544593|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
25232984|NCT02003924|50544594|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
25232985|NCT02003924|50544592|FG000|Long-term Follow-up Phase|Other|5|||
25232986|NCT02003924|50544593|FG001|Long-term Follow-up Phase|Other|2|||
25232987|NCT02003924|50544594|FG002|Long-term Follow-up Phase|Other|1|||
25232988|NCT01817751|50544606|FG000|Overall Study|Physician Decision|1|||
25232989|NCT01349322|50544622|FG000|Overall Study|Protocol Violation|45|||
25232990|NCT01349322|50544623|FG001|Overall Study|Protocol Violation|47|||
25232991|NCT01182415|50544635|FG000|Overall Study|Lost to Follow-up|1|||
25232992|NCT01030523|50544641|FG000|Initial Study (5 Years)|Death|1|||
25232993|NCT01030523|50544642|FG001|Initial Study (5 Years)|Death|0|||
25232994|NCT01030523|50544641|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
25232995|NCT01030523|50544642|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
25232996|NCT01030523|50544641|FG000|Initial Study (5 Years)|Implant failure|1|||
25232997|NCT01030523|50544642|FG001|Initial Study (5 Years)|Implant failure|0|||
25232998|NCT01030523|50544641|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
25232999|NCT01030523|50544642|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
25233000|NCT01030523|50544641|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
25233001|NCT01030523|50544642|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
25233002|NCT01030523|50544641|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
25233003|NCT01030523|50544642|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
25233004|NCT03893448|50544650|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
25233005|NCT03893448|50544651|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
25233006|NCT03893448|50544650|FG000|Overall Study|Physician Decision|8|||
25233007|NCT03893448|50544651|FG001|Overall Study|Physician Decision|14|||
25233008|NCT03893448|50544650|FG000|Overall Study|Lost to Follow-up|34|||
25233009|NCT03893448|50544651|FG001|Overall Study|Lost to Follow-up|27|||
25233010|NCT03893448|50544650|FG000|Overall Study|Death|1|||
25233011|NCT03893448|50544651|FG001|Overall Study|Death|0|||
25233012|NCT03811574|50544691|FG000|Overall Study|Withdrawal by Subject|2|||
25233013|NCT03811574|50544692|FG001|Overall Study|Withdrawal by Subject|4|||
25233014|NCT03811574|50544693|FG002|Overall Study|Withdrawal by Subject|0|||
25233015|NCT03727750|50544716|FG000|Overall Study|Death|45|||
25233016|NCT03727750|50544716|FG000|Overall Study|Withdrawal by Subject|2|||
25233017|NCT03727750|50544716|FG000|Overall Study|Lost to Follow-up|1|||
25233018|NCT03727750|50544716|FG000|Overall Study|Other|1|||
25233019|NCT03715829|50544726|FG000|Dose Ranging Period|Adverse Event|2|||
25233020|NCT03715829|50544727|FG001|Dose Ranging Period|Adverse Event|4|||
25233021|NCT03715829|50544728|FG002|Dose Ranging Period|Adverse Event|5|||
25233022|NCT03715829|50544729|FG003|Dose Ranging Period|Adverse Event|2|||
25233023|NCT03715829|50544730|FG004|Dose Ranging Period|Adverse Event|3|||
25233024|NCT03715829|50544731|FG005|Dose Ranging Period|Adverse Event|3|||
25233025|NCT03715829|50544732|FG006|Dose Ranging Period|Adverse Event|0|||
25233026|NCT03715829|50544733|FG007|Dose Ranging Period|Adverse Event|0|||
25233027|NCT03715829|50544734|FG008|Dose Ranging Period|Adverse Event|0|||
25233028|NCT03715829|50544735|FG009|Dose Ranging Period|Adverse Event|0|||
24976645|NCT03451084|50065563|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
25233029|NCT03715829|50544736|FG010|Dose Ranging Period|Adverse Event|0|||
25233030|NCT03715829|50544726|FG000|Dose Ranging Period|Lack of Efficacy|0|||
25233031|NCT03715829|50544727|FG001|Dose Ranging Period|Lack of Efficacy|1|||
25233032|NCT03715829|50544728|FG002|Dose Ranging Period|Lack of Efficacy|0|||
25233033|NCT03715829|50544729|FG003|Dose Ranging Period|Lack of Efficacy|1|||
25233034|NCT03715829|50544730|FG004|Dose Ranging Period|Lack of Efficacy|0|||
25233035|NCT03715829|50544731|FG005|Dose Ranging Period|Lack of Efficacy|0|||
25233036|NCT03715829|50544732|FG006|Dose Ranging Period|Lack of Efficacy|0|||
25233037|NCT03715829|50544733|FG007|Dose Ranging Period|Lack of Efficacy|0|||
25233038|NCT03715829|50544734|FG008|Dose Ranging Period|Lack of Efficacy|0|||
24976646|NCT03451084|50065564|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
25233039|NCT03715829|50544735|FG009|Dose Ranging Period|Lack of Efficacy|0|||
25233040|NCT03715829|50544736|FG010|Dose Ranging Period|Lack of Efficacy|0|||
25233041|NCT03715829|50544726|FG000|Dose Ranging Period|Lost to Follow-up|2|||
25319375|NCT00781599|50634834|FG001|Overall Study|Lost to Follow-up|4|||
25233042|NCT03715829|50544727|FG001|Dose Ranging Period|Lost to Follow-up|0|||
25233043|NCT03715829|50544728|FG002|Dose Ranging Period|Lost to Follow-up|1|||
25233044|NCT03715829|50544729|FG003|Dose Ranging Period|Lost to Follow-up|1|||
25233045|NCT03715829|50544730|FG004|Dose Ranging Period|Lost to Follow-up|1|||
25233046|NCT03715829|50544731|FG005|Dose Ranging Period|Lost to Follow-up|2|||
25233047|NCT03715829|50544732|FG006|Dose Ranging Period|Lost to Follow-up|0|||
25233048|NCT03715829|50544733|FG007|Dose Ranging Period|Lost to Follow-up|0|||
25233049|NCT03715829|50544734|FG008|Dose Ranging Period|Lost to Follow-up|0|||
25233050|NCT03715829|50544735|FG009|Dose Ranging Period|Lost to Follow-up|0|||
25233051|NCT03715829|50544736|FG010|Dose Ranging Period|Lost to Follow-up|0|||
25233052|NCT03715829|50544726|FG000|Dose Ranging Period|Protocol Violation|0|||
25233053|NCT03715829|50544727|FG001|Dose Ranging Period|Protocol Violation|0|||
25233054|NCT03715829|50544728|FG002|Dose Ranging Period|Protocol Violation|0|||
25233055|NCT03715829|50544729|FG003|Dose Ranging Period|Protocol Violation|1|||
25233056|NCT03715829|50544730|FG004|Dose Ranging Period|Protocol Violation|0|||
25233057|NCT03715829|50544731|FG005|Dose Ranging Period|Protocol Violation|0|||
25233058|NCT03715829|50544732|FG006|Dose Ranging Period|Protocol Violation|0|||
25233059|NCT03715829|50544733|FG007|Dose Ranging Period|Protocol Violation|0|||
25233060|NCT03715829|50544734|FG008|Dose Ranging Period|Protocol Violation|0|||
25233061|NCT03715829|50544735|FG009|Dose Ranging Period|Protocol Violation|0|||
25233062|NCT03715829|50544736|FG010|Dose Ranging Period|Protocol Violation|0|||
25233063|NCT03715829|50544726|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
25233064|NCT03715829|50544727|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
25233065|NCT03715829|50544728|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
25233066|NCT03715829|50544729|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
25233067|NCT03715829|50544730|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
25233068|NCT03715829|50544731|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
25233069|NCT03715829|50544732|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
25233070|NCT03715829|50544733|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
25233071|NCT03715829|50544734|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
25233072|NCT03715829|50544735|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
25233073|NCT03715829|50544736|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
25233074|NCT03715829|50544726|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
25233075|NCT03715829|50544727|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
25233076|NCT03715829|50544728|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
25233077|NCT03715829|50544729|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
25233078|NCT03715829|50544730|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
25233079|NCT03715829|50544731|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
25233080|NCT03715829|50544732|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
25233081|NCT03715829|50544733|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
25233082|NCT03715829|50544734|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
25233083|NCT03715829|50544735|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
25233084|NCT03715829|50544736|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
25233085|NCT03715829|50544726|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
25233086|NCT03715829|50544727|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
25233087|NCT03715829|50544728|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
25233088|NCT03715829|50544729|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
25233089|NCT03715829|50544730|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
25233090|NCT03715829|50544731|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
25233091|NCT03715829|50544732|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
25233092|NCT03715829|50544733|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
25233093|NCT03715829|50544734|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
25233094|NCT03715829|50544735|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
25233095|NCT03715829|50544736|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
25233096|NCT03715829|50544726|FG000|Dose Ranging Period|Other|0|||
25233097|NCT03715829|50544727|FG001|Dose Ranging Period|Other|0|||
25233098|NCT03715829|50544728|FG002|Dose Ranging Period|Other|2|||
25233099|NCT03715829|50544729|FG003|Dose Ranging Period|Other|0|||
25233100|NCT03715829|50544730|FG004|Dose Ranging Period|Other|0|||
25233101|NCT03715829|50544731|FG005|Dose Ranging Period|Other|3|||
25233102|NCT03715829|50544732|FG006|Dose Ranging Period|Other|0|||
25233103|NCT03715829|50544733|FG007|Dose Ranging Period|Other|0|||
25233104|NCT03715829|50544734|FG008|Dose Ranging Period|Other|0|||
25233105|NCT03715829|50544735|FG009|Dose Ranging Period|Other|0|||
25233106|NCT03715829|50544736|FG010|Dose Ranging Period|Other|0|||
25233107|NCT03715829|50544726|FG000|Extension Period|Adverse Event|0|||
24976647|NCT03451006|50065576|FG000|Overall Study|Withdrawal by Subject|2|||
25233108|NCT03715829|50544727|FG001|Extension Period|Adverse Event|0|||
25233109|NCT03715829|50544728|FG002|Extension Period|Adverse Event|0|||
25233110|NCT03715829|50544729|FG003|Extension Period|Adverse Event|0|||
25233111|NCT03715829|50544730|FG004|Extension Period|Adverse Event|0|||
25233112|NCT03715829|50544731|FG005|Extension Period|Adverse Event|0|||
25233113|NCT03715829|50544732|FG006|Extension Period|Adverse Event|3|||
25233114|NCT03715829|50544733|FG007|Extension Period|Adverse Event|1|||
25233115|NCT03715829|50544734|FG008|Extension Period|Adverse Event|6|||
25233116|NCT03715829|50544735|FG009|Extension Period|Adverse Event|0|||
25233117|NCT03715829|50544736|FG010|Extension Period|Adverse Event|0|||
25233118|NCT03715829|50544726|FG000|Extension Period|Lack of Efficacy|0|||
25233119|NCT03715829|50544727|FG001|Extension Period|Lack of Efficacy|0|||
25233120|NCT03715829|50544728|FG002|Extension Period|Lack of Efficacy|0|||
25233121|NCT03715829|50544729|FG003|Extension Period|Lack of Efficacy|0|||
25233122|NCT03715829|50544730|FG004|Extension Period|Lack of Efficacy|0|||
25233123|NCT03715829|50544731|FG005|Extension Period|Lack of Efficacy|0|||
25233124|NCT03715829|50544732|FG006|Extension Period|Lack of Efficacy|1|||
25233125|NCT03715829|50544733|FG007|Extension Period|Lack of Efficacy|9|||
25233126|NCT03715829|50544734|FG008|Extension Period|Lack of Efficacy|2|||
25233127|NCT03715829|50544735|FG009|Extension Period|Lack of Efficacy|0|||
25233128|NCT03715829|50544736|FG010|Extension Period|Lack of Efficacy|0|||
25233129|NCT03715829|50544726|FG000|Extension Period|Lost to Follow-up|0|||
25233130|NCT03715829|50544727|FG001|Extension Period|Lost to Follow-up|0|||
25233131|NCT03715829|50544728|FG002|Extension Period|Lost to Follow-up|0|||
25233132|NCT03715829|50544729|FG003|Extension Period|Lost to Follow-up|0|||
25233133|NCT03715829|50544730|FG004|Extension Period|Lost to Follow-up|0|||
25233134|NCT03715829|50544731|FG005|Extension Period|Lost to Follow-up|0|||
25233135|NCT03715829|50544732|FG006|Extension Period|Lost to Follow-up|0|||
25233136|NCT03715829|50544733|FG007|Extension Period|Lost to Follow-up|0|||
25233137|NCT03715829|50544734|FG008|Extension Period|Lost to Follow-up|2|||
25233138|NCT03715829|50544735|FG009|Extension Period|Lost to Follow-up|0|||
25233139|NCT03715829|50544736|FG010|Extension Period|Lost to Follow-up|0|||
25233140|NCT03715829|50544726|FG000|Extension Period|Protocol Violation|0|||
25233141|NCT03715829|50544727|FG001|Extension Period|Protocol Violation|0|||
25233142|NCT03715829|50544728|FG002|Extension Period|Protocol Violation|0|||
25233143|NCT03715829|50544729|FG003|Extension Period|Protocol Violation|0|||
25233144|NCT03715829|50544730|FG004|Extension Period|Protocol Violation|0|||
25233145|NCT03715829|50544731|FG005|Extension Period|Protocol Violation|0|||
25233146|NCT03715829|50544732|FG006|Extension Period|Protocol Violation|0|||
25233147|NCT03715829|50544733|FG007|Extension Period|Protocol Violation|0|||
25233148|NCT03715829|50544734|FG008|Extension Period|Protocol Violation|1|||
25233149|NCT03715829|50544735|FG009|Extension Period|Protocol Violation|0|||
25233150|NCT03715829|50544736|FG010|Extension Period|Protocol Violation|0|||
25233151|NCT03715829|50544726|FG000|Extension Period|Withdrawal by Subject|0|||
25233152|NCT03715829|50544727|FG001|Extension Period|Withdrawal by Subject|0|||
25233153|NCT03715829|50544728|FG002|Extension Period|Withdrawal by Subject|0|||
25233154|NCT03715829|50544729|FG003|Extension Period|Withdrawal by Subject|0|||
25233155|NCT03715829|50544730|FG004|Extension Period|Withdrawal by Subject|0|||
25233156|NCT03715829|50544731|FG005|Extension Period|Withdrawal by Subject|0|||
25233157|NCT03715829|50544732|FG006|Extension Period|Withdrawal by Subject|3|||
25233158|NCT03715829|50544733|FG007|Extension Period|Withdrawal by Subject|3|||
25233159|NCT03715829|50544734|FG008|Extension Period|Withdrawal by Subject|12|||
25233160|NCT03715829|50544735|FG009|Extension Period|Withdrawal by Subject|3|||
25233161|NCT03715829|50544736|FG010|Extension Period|Withdrawal by Subject|0|||
25233162|NCT03715829|50544726|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
25233163|NCT03715829|50544727|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
25233164|NCT03715829|50544728|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
25233165|NCT03715829|50544729|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
25233166|NCT03715829|50544730|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
25233167|NCT03715829|50544731|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
25233168|NCT03715829|50544732|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
25233169|NCT03715829|50544733|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
25233170|NCT03715829|50544734|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
25233171|NCT03715829|50544735|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
25233172|NCT03715829|50544736|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
25233173|NCT03715829|50544726|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
25233174|NCT03715829|50544727|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
25233175|NCT03715829|50544728|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
25233176|NCT03715829|50544729|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
25233177|NCT03715829|50544730|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
25233178|NCT03715829|50544731|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
25233179|NCT03715829|50544732|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
25233180|NCT03715829|50544733|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
25233181|NCT03715829|50544734|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
25233182|NCT03715829|50544735|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
25233183|NCT03715829|50544736|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
25233184|NCT03715829|50544726|FG000|Extension Period|Other|0|||
25233185|NCT03715829|50544727|FG001|Extension Period|Other|0|||
25233186|NCT03715829|50544728|FG002|Extension Period|Other|0|||
25233187|NCT03715829|50544729|FG003|Extension Period|Other|0|||
25233188|NCT03715829|50544730|FG004|Extension Period|Other|0|||
25233189|NCT03715829|50544731|FG005|Extension Period|Other|0|||
25233190|NCT03715829|50544732|FG006|Extension Period|Other|1|||
25233191|NCT03715829|50544733|FG007|Extension Period|Other|2|||
25233192|NCT03715829|50544734|FG008|Extension Period|Other|4|||
25233193|NCT03715829|50544735|FG009|Extension Period|Other|0|||
25233194|NCT03715829|50544736|FG010|Extension Period|Other|0|||
25233195|NCT03575104|50544798|FG000|Overall Study|Adverse Event|4|||
25233196|NCT03575104|50544799|FG001|Overall Study|Adverse Event|3|||
25233197|NCT03575104|50544800|FG002|Overall Study|Adverse Event|4|||
25233198|NCT03575104|50544798|FG000|Overall Study|Withdrawal by Subject|13|||
25233199|NCT03575104|50544799|FG001|Overall Study|Withdrawal by Subject|16|||
25233200|NCT03575104|50544800|FG002|Overall Study|Withdrawal by Subject|11|||
25233201|NCT03575104|50544798|FG000|Overall Study|Other reasons|6|||
25233202|NCT03575104|50544799|FG001|Overall Study|Other reasons|8|||
25233203|NCT03575104|50544800|FG002|Overall Study|Other reasons|6|||
25233204|NCT03575104|50544798|FG000|Overall Study|Lost to Follow-up|1|||
25233205|NCT03575104|50544799|FG001|Overall Study|Lost to Follow-up|2|||
25233206|NCT03575104|50544800|FG002|Overall Study|Lost to Follow-up|1|||
25233207|NCT03569475|50544811|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
25233208|NCT03569475|50544812|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
25233209|NCT03569475|50544813|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
25233210|NCT03569475|50544811|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
25233211|NCT03569475|50544812|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
25233212|NCT03569475|50544813|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
25233213|NCT03569475|50544811|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
25233214|NCT03569475|50544812|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
25233215|NCT03569475|50544813|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
25233216|NCT03569475|50544811|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
25233217|NCT03569475|50544812|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
25233218|NCT03569475|50544813|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
25233219|NCT03569475|50544811|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
25233220|NCT03569475|50544812|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
25233221|NCT03569475|50544813|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
25233222|NCT03569475|50544811|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
25233223|NCT03569475|50544812|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
25233224|NCT03569475|50544813|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
25233225|NCT03569475|50544811|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
25233226|NCT03569475|50544812|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
25233227|NCT03569475|50544813|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
25233228|NCT03569475|50544811|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
25233229|NCT03569475|50544812|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
25233230|NCT03569475|50544813|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
25233231|NCT03569475|50544811|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
25233232|NCT03569475|50544812|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
25233233|NCT03569475|50544813|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
25233234|NCT03545191|50544867|FG000|Overall Study|Death|1|||
25233235|NCT03545191|50544868|FG001|Overall Study|Death|0|||
25233236|NCT03545191|50544869|FG002|Overall Study|Death|0|||
25233237|NCT03545191|50544867|FG000|Overall Study|Adverse Event|4|||
25233238|NCT03545191|50544868|FG001|Overall Study|Adverse Event|2|||
25233239|NCT03545191|50544869|FG002|Overall Study|Adverse Event|7|||
25233240|NCT03545191|50544867|FG000|Overall Study|Other reasons|3|||
25233241|NCT03545191|50544868|FG001|Overall Study|Other reasons|11|||
25233242|NCT03545191|50544869|FG002|Overall Study|Other reasons|8|||
25233243|NCT03545191|50544867|FG000|Overall Study|Withdrawal by Subject|13|||
25233244|NCT03545191|50544868|FG001|Overall Study|Withdrawal by Subject|10|||
25233245|NCT03545191|50544869|FG002|Overall Study|Withdrawal by Subject|12|||
25233246|NCT03545191|50544867|FG000|Overall Study|Lost to Follow-up|1|||
25233247|NCT03545191|50544868|FG001|Overall Study|Lost to Follow-up|2|||
25233248|NCT03545191|50544869|FG002|Overall Study|Lost to Follow-up|3|||
25233249|NCT03500549|50544879|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
25233250|NCT03500549|50544880|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
25233251|NCT03500549|50544879|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
25233252|NCT03500549|50544880|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
25233253|NCT03366792|50544900|FG000|Overall Study|Withdrawal by Subject|7|||
25233254|NCT03366792|50544900|FG000|Overall Study|Lost to Follow-up|2|||
25233255|NCT03366792|50544900|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
25319376|NCT00605839|50634852|FG000|Overall Study|Protocol Violation|1|||
25319377|NCT00605839|50634853|FG001|Overall Study|Protocol Violation|0|||
25233256|NCT03366792|50544900|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
25233257|NCT03366337|50544908|FG000|Overall Study|Lost to Follow-up|1|||
25233258|NCT03366337|50544909|FG001|Overall Study|Lost to Follow-up|0|||
25233259|NCT03366337|50544910|FG002|Overall Study|Lost to Follow-up|1|||
25233260|NCT03366337|50544911|FG003|Overall Study|Lost to Follow-up|0|||
25233261|NCT03366337|50544908|FG000|Overall Study|Withdrawal by Subject|2|||
25233262|NCT03366337|50544909|FG001|Overall Study|Withdrawal by Subject|0|||
25233263|NCT03366337|50544910|FG002|Overall Study|Withdrawal by Subject|1|||
25233264|NCT03366337|50544911|FG003|Overall Study|Withdrawal by Subject|1|||
25233265|NCT03342053|50544923|FG000|Overall Study|Adverse Event|2|||
25233266|NCT03342053|50544924|FG001|Overall Study|Adverse Event|0|||
25233267|NCT03342053|50544923|FG000|Overall Study|Withdrawal by Subject|0|||
25233268|NCT03342053|50544924|FG001|Overall Study|Withdrawal by Subject|1|||
25233269|NCT03325777|50544932|FG000|Overall Study|Lost to Follow-up|9|||
25233270|NCT03325777|50544933|FG001|Overall Study|Lost to Follow-up|12|||
25233271|NCT03283241|50544941|FG000|Overall Study|Adverse Event|4|||
25233272|NCT03283241|50544942|FG001|Overall Study|Adverse Event|1|||
25233273|NCT03283241|50544941|FG000|Overall Study|Withdrawal by Subject|0|||
25233274|NCT03283241|50544942|FG001|Overall Study|Withdrawal by Subject|1|||
25233275|NCT03283241|50544941|FG000|Overall Study|Subject relocated to Finland|0|||
25233276|NCT03283241|50544942|FG001|Overall Study|Subject relocated to Finland|1|||
25233277|NCT03242772|50544950|FG000|Overall Study|Lost to Follow-up|2|||
25233278|NCT03242772|50544951|FG001|Overall Study|Lost to Follow-up|0|||
25233279|NCT03242772|50544950|FG000|Overall Study|Physician Decision|0|||
25233280|NCT03242772|50544951|FG001|Overall Study|Physician Decision|1|||
25233281|NCT03242772|50544950|FG000|Overall Study|Withdrawal by Subject|1|||
25233282|NCT03242772|50544951|FG001|Overall Study|Withdrawal by Subject|0|||
25233283|NCT03236311|50544959|FG000|Overall Study|Study terminated by sponsor|0|||
25233284|NCT03236311|50544960|FG001|Overall Study|Study terminated by sponsor|2|||
25233285|NCT03236311|50544959|FG000|Overall Study|Adverse Event|0|||
25233286|NCT03236311|50544960|FG001|Overall Study|Adverse Event|1|||
25233287|NCT03192046|50544968|FG000|Overall Study|Withdrawal by Subject|1|||
25233288|NCT03192046|50544969|FG001|Overall Study|Withdrawal by Subject|1|||
25233289|NCT03190369|50544977|FG000|Overall Study|Poor compliance to protocol|0|||
25233290|NCT03190369|50544978|FG001|Overall Study|Poor compliance to protocol|1|||
25233291|NCT03190369|50544977|FG000|Overall Study|Withdraw before treatment|1|||
25233292|NCT03190369|50544978|FG001|Overall Study|Withdraw before treatment|5|||
25233293|NCT03190369|50544977|FG000|Overall Study|Randomized but not treated|0|||
25233294|NCT03190369|50544978|FG001|Overall Study|Randomized but not treated|2|||
25233295|NCT04657198|50544987|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
25233296|NCT04657198|50544988|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
25233297|NCT04657198|50544989|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
25233298|NCT04590586|50545003|FG000|Overall Study|Death|7|||
25233299|NCT04590586|50545004|FG001|Overall Study|Death|1|||
25233300|NCT04590586|50545005|FG002|Overall Study|Death|37|||
25233301|NCT04590586|50545006|FG003|Overall Study|Death|34|||
25233302|NCT04590586|50545007|FG004|Overall Study|Death|19|||
25233303|NCT04590586|50545008|FG005|Overall Study|Death|3|||
25233304|NCT04590586|50545003|FG000|Overall Study|Lost to Follow-up|3|||
25233305|NCT04590586|50545004|FG001|Overall Study|Lost to Follow-up|0|||
25233306|NCT04590586|50545005|FG002|Overall Study|Lost to Follow-up|11|||
25233307|NCT04590586|50545006|FG003|Overall Study|Lost to Follow-up|11|||
25233308|NCT04590586|50545007|FG004|Overall Study|Lost to Follow-up|6|||
25233309|NCT04590586|50545008|FG005|Overall Study|Lost to Follow-up|0|||
25233310|NCT04590586|50545003|FG000|Overall Study|Withdrawal by Subject|0|||
25233311|NCT04590586|50545004|FG001|Overall Study|Withdrawal by Subject|0|||
25233312|NCT04590586|50545005|FG002|Overall Study|Withdrawal by Subject|6|||
25233313|NCT04590586|50545006|FG003|Overall Study|Withdrawal by Subject|0|||
25233314|NCT04590586|50545007|FG004|Overall Study|Withdrawal by Subject|3|||
25233315|NCT04590586|50545008|FG005|Overall Study|Withdrawal by Subject|0|||
25233316|NCT04590586|50545003|FG000|Overall Study|Other|3|||
25233317|NCT04590586|50545004|FG001|Overall Study|Other|0|||
25233318|NCT04590586|50545005|FG002|Overall Study|Other|1|||
25233319|NCT04590586|50545006|FG003|Overall Study|Other|1|||
25233320|NCT04590586|50545007|FG004|Overall Study|Other|2|||
25233321|NCT04590586|50545008|FG005|Overall Study|Other|1|||
25233322|NCT04312009|50545034|FG000|Overall Study|Withdrawal by Subject|2|||
25233323|NCT04312009|50545035|FG001|Overall Study|Withdrawal by Subject|1|||
25233324|NCT03937466|50545050|FG000|Overall Study|not eligbile after the 2-week diary|9|||
25233325|NCT03937466|50545050|FG000|Overall Study|never returned their diary|6|||
25233326|NCT03937466|50545050|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
25233327|NCT03937466|50545050|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
25233328|NCT03850483|50545063|FG000|Treatment for Stage 1|Adverse Event|1|||
25233329|NCT03850483|50545064|FG001|Treatment for Stage 1|Adverse Event|1|||
25233330|NCT03850483|50545065|FG002|Treatment for Stage 1|Adverse Event|3|||
25233331|NCT03850483|50545066|FG003|Treatment for Stage 1|Adverse Event|0|||
25233332|NCT03850483|50545067|FG004|Treatment for Stage 1|Adverse Event|2|||
25233333|NCT03850483|50545068|FG005|Treatment for Stage 1|Adverse Event|0|||
25233334|NCT03850483|50545069|FG006|Treatment for Stage 1|Adverse Event|2|||
25233335|NCT03850483|50545070|FG007|Treatment for Stage 1|Adverse Event|2|||
25233336|NCT03850483|50545071|FG008|Treatment for Stage 1|Adverse Event|0|||
25233337|NCT03850483|50545072|FG009|Treatment for Stage 1|Adverse Event|0|||
25233338|NCT03850483|50545063|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
25233339|NCT03850483|50545064|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
25233340|NCT03850483|50545065|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
25233341|NCT03850483|50545066|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
25233342|NCT03850483|50545067|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
25233343|NCT03850483|50545068|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
25233344|NCT03850483|50545069|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
25233345|NCT03850483|50545070|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
25233346|NCT03850483|50545071|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
25233347|NCT03850483|50545072|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
25233348|NCT03850483|50545063|FG000|Treatment for Stage 1|Protocol Violation|1|||
24976648|NCT03451006|50065577|FG001|Overall Study|Withdrawal by Subject|2|||
24976649|NCT03450070|50065583|FG000|Overall Study|Withdrawal by Subject|8|||
24976650|NCT03449758|50065587|FG000|Overall Study|Major protocol deviation|1|||
24976651|NCT03449758|50065587|FG000|Overall Study|Treatment inefficacy|5|||
24976652|NCT03449758|50065587|FG000|Overall Study|Adverse Event|9|||
24976653|NCT03449758|50065587|FG000|Overall Study|Consent withdrawal|1|||
24976654|NCT03449758|50065587|FG000|Overall Study|Other unspecified reason|3|||
24976655|NCT03449446|50065599|FG000|Overall Study|Randomized but Never Treated|0|||
24976656|NCT03449446|50065600|FG001|Overall Study|Randomized but Never Treated|0|||
24976657|NCT03449446|50065601|FG002|Overall Study|Randomized but Never Treated|1|||
24976658|NCT03449446|50065602|FG003|Overall Study|Randomized but Never Treated|1|||
24976659|NCT03449446|50065603|FG004|Overall Study|Randomized but Never Treated|1|||
24976660|NCT03449446|50065604|FG005|Overall Study|Randomized but Never Treated|0|||
24976661|NCT03449446|50065605|FG006|Overall Study|Randomized but Never Treated|0|||
24976662|NCT03449446|50065599|FG000|Overall Study|Unknown Reason|33|||
24976663|NCT03449446|50065600|FG001|Overall Study|Unknown Reason|1|||
24976664|NCT03449446|50065601|FG002|Overall Study|Unknown Reason|1|||
24976665|NCT03449446|50065602|FG003|Overall Study|Unknown Reason|1|||
24976666|NCT03449446|50065603|FG004|Overall Study|Unknown Reason|2|||
24976667|NCT03449446|50065604|FG005|Overall Study|Unknown Reason|2|||
24976668|NCT03449446|50065605|FG006|Overall Study|Unknown Reason|0|||
24976669|NCT03449446|50065599|FG000|Overall Study|Withdrew Consent|1|||
25233349|NCT03850483|50545064|FG001|Treatment for Stage 1|Protocol Violation|0|||
25233350|NCT03850483|50545065|FG002|Treatment for Stage 1|Protocol Violation|0|||
25233351|NCT03850483|50545066|FG003|Treatment for Stage 1|Protocol Violation|0|||
25233352|NCT03850483|50545067|FG004|Treatment for Stage 1|Protocol Violation|0|||
25233353|NCT03850483|50545068|FG005|Treatment for Stage 1|Protocol Violation|0|||
25233354|NCT03850483|50545069|FG006|Treatment for Stage 1|Protocol Violation|1|||
25233355|NCT03850483|50545070|FG007|Treatment for Stage 1|Protocol Violation|0|||
25233356|NCT03850483|50545071|FG008|Treatment for Stage 1|Protocol Violation|0|||
25233357|NCT03850483|50545072|FG009|Treatment for Stage 1|Protocol Violation|0|||
25233358|NCT03850483|50545063|FG000|Treatment for Stage 1|Physician Decision|0|||
25233359|NCT03850483|50545064|FG001|Treatment for Stage 1|Physician Decision|0|||
25233360|NCT03850483|50545065|FG002|Treatment for Stage 1|Physician Decision|0|||
25233361|NCT03850483|50545066|FG003|Treatment for Stage 1|Physician Decision|0|||
25233362|NCT03850483|50545067|FG004|Treatment for Stage 1|Physician Decision|0|||
25233363|NCT03850483|50545068|FG005|Treatment for Stage 1|Physician Decision|1|||
25233364|NCT03850483|50545069|FG006|Treatment for Stage 1|Physician Decision|0|||
25233365|NCT03850483|50545070|FG007|Treatment for Stage 1|Physician Decision|0|||
25233366|NCT03850483|50545071|FG008|Treatment for Stage 1|Physician Decision|0|||
25233367|NCT03850483|50545072|FG009|Treatment for Stage 1|Physician Decision|0|||
25233368|NCT03850483|50545063|FG000|Treatment for Stage 1|Other|0|||
25233369|NCT03850483|50545064|FG001|Treatment for Stage 1|Other|0|||
25233370|NCT03850483|50545065|FG002|Treatment for Stage 1|Other|0|||
25233371|NCT03850483|50545066|FG003|Treatment for Stage 1|Other|0|||
25233372|NCT03850483|50545067|FG004|Treatment for Stage 1|Other|2|||
25233373|NCT03850483|50545068|FG005|Treatment for Stage 1|Other|1|||
25233374|NCT03850483|50545069|FG006|Treatment for Stage 1|Other|0|||
25233375|NCT03850483|50545070|FG007|Treatment for Stage 1|Other|0|||
25233376|NCT03850483|50545071|FG008|Treatment for Stage 1|Other|0|||
25233377|NCT03850483|50545072|FG009|Treatment for Stage 1|Other|0|||
25233378|NCT03850483|50545063|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
25233379|NCT03850483|50545064|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
25233380|NCT03850483|50545065|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
25233381|NCT03850483|50545066|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
25233382|NCT03850483|50545067|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
24976670|NCT03449446|50065600|FG001|Overall Study|Withdrew Consent|3|||
25233383|NCT03850483|50545068|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
25233384|NCT03850483|50545069|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
25233385|NCT03850483|50545070|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
25233386|NCT03850483|50545071|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
25233387|NCT03850483|50545072|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
25233388|NCT03850483|50545063|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
25233389|NCT03850483|50545064|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
25233390|NCT03850483|50545065|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
25233391|NCT03850483|50545066|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
25233392|NCT03850483|50545067|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
25233393|NCT03850483|50545068|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
25233394|NCT03850483|50545069|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
25233395|NCT03850483|50545070|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
25233396|NCT03850483|50545071|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
25233397|NCT03850483|50545072|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
25233398|NCT03850483|50545063|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
25233399|NCT03850483|50545064|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
25233400|NCT03850483|50545065|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
25233401|NCT03850483|50545066|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
25233402|NCT03850483|50545067|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
25233403|NCT03850483|50545068|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
25233404|NCT03850483|50545069|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
25233405|NCT03850483|50545070|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
25233406|NCT03850483|50545071|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
25233407|NCT03850483|50545072|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
25233408|NCT03850483|50545063|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
25233409|NCT03850483|50545064|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
25233410|NCT03850483|50545065|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
25233411|NCT03850483|50545066|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
25233412|NCT03850483|50545067|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
25233413|NCT03850483|50545068|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
25233414|NCT03850483|50545069|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
25233415|NCT03850483|50545070|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
25233416|NCT03850483|50545071|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
25233417|NCT03850483|50545072|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
25233418|NCT03850483|50545063|FG000|Treatment for Stage 1|Death|0|||
25233419|NCT03850483|50545064|FG001|Treatment for Stage 1|Death|0|||
25233420|NCT03850483|50545065|FG002|Treatment for Stage 1|Death|0|||
25233421|NCT03850483|50545066|FG003|Treatment for Stage 1|Death|0|||
25233422|NCT03850483|50545067|FG004|Treatment for Stage 1|Death|0|||
25233423|NCT03850483|50545068|FG005|Treatment for Stage 1|Death|1|||
25233424|NCT03850483|50545069|FG006|Treatment for Stage 1|Death|0|||
25233425|NCT03850483|50545070|FG007|Treatment for Stage 1|Death|0|||
25233426|NCT03850483|50545071|FG008|Treatment for Stage 1|Death|0|||
25233427|NCT03850483|50545072|FG009|Treatment for Stage 1|Death|0|||
25233428|NCT03850483|50545063|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
25233429|NCT03850483|50545064|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
25233430|NCT03850483|50545065|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
25233431|NCT03850483|50545066|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
25233432|NCT03850483|50545067|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
25233433|NCT03850483|50545068|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
25233434|NCT03850483|50545069|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
25233435|NCT03850483|50545070|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
25233436|NCT03850483|50545071|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
25233437|NCT03850483|50545072|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
25233438|NCT03850483|50545063|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
25233439|NCT03850483|50545064|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
25233440|NCT03850483|50545065|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
25233441|NCT03850483|50545066|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
25233442|NCT03850483|50545067|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
25233443|NCT03850483|50545068|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
25233444|NCT03850483|50545069|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
25233445|NCT03850483|50545070|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
25233446|NCT03850483|50545071|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
25233447|NCT03850483|50545072|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
25233448|NCT03850483|50545063|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
25233449|NCT03850483|50545064|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
25233450|NCT03850483|50545065|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
25233451|NCT03850483|50545066|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
25233452|NCT03850483|50545067|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
25233453|NCT03850483|50545068|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
25233454|NCT03850483|50545069|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
25233455|NCT03850483|50545070|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
25233456|NCT03850483|50545071|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
25233457|NCT03850483|50545072|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
25233458|NCT03850483|50545063|FG000|Follow-up for Stage 1|Physician Decision|0|||
25233459|NCT03850483|50545064|FG001|Follow-up for Stage 1|Physician Decision|0|||
25233460|NCT03850483|50545065|FG002|Follow-up for Stage 1|Physician Decision|0|||
25233461|NCT03850483|50545066|FG003|Follow-up for Stage 1|Physician Decision|0|||
25233462|NCT03850483|50545067|FG004|Follow-up for Stage 1|Physician Decision|1|||
25233463|NCT03850483|50545068|FG005|Follow-up for Stage 1|Physician Decision|0|||
25233464|NCT03850483|50545069|FG006|Follow-up for Stage 1|Physician Decision|1|||
25233465|NCT03850483|50545070|FG007|Follow-up for Stage 1|Physician Decision|0|||
25233466|NCT03850483|50545071|FG008|Follow-up for Stage 1|Physician Decision|0|||
25233467|NCT03850483|50545072|FG009|Follow-up for Stage 1|Physician Decision|0|||
25233468|NCT03850483|50545063|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
25233469|NCT03850483|50545064|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
25233470|NCT03850483|50545065|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
25233471|NCT03850483|50545066|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
25233472|NCT03850483|50545067|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
25233473|NCT03850483|50545068|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
25233474|NCT03850483|50545069|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
25233475|NCT03850483|50545070|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
25233476|NCT03850483|50545071|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
25233477|NCT03850483|50545072|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
25233478|NCT03850483|50545063|FG000|Follow-up for Stage 1|Adverse Event|0|||
25233479|NCT03850483|50545064|FG001|Follow-up for Stage 1|Adverse Event|0|||
25233480|NCT03850483|50545065|FG002|Follow-up for Stage 1|Adverse Event|1|||
25233481|NCT03850483|50545066|FG003|Follow-up for Stage 1|Adverse Event|0|||
25233482|NCT03850483|50545067|FG004|Follow-up for Stage 1|Adverse Event|0|||
25233483|NCT03850483|50545068|FG005|Follow-up for Stage 1|Adverse Event|1|||
25233484|NCT03850483|50545069|FG006|Follow-up for Stage 1|Adverse Event|0|||
25233485|NCT03850483|50545070|FG007|Follow-up for Stage 1|Adverse Event|0|||
25233486|NCT03850483|50545071|FG008|Follow-up for Stage 1|Adverse Event|0|||
25233487|NCT03850483|50545072|FG009|Follow-up for Stage 1|Adverse Event|0|||
25233488|NCT03850483|50545063|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
25233489|NCT03850483|50545064|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
25233490|NCT03850483|50545065|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
25233491|NCT03850483|50545066|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
25233492|NCT03850483|50545067|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
25233493|NCT03850483|50545068|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
25233494|NCT03850483|50545069|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
25233495|NCT03850483|50545070|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
25233496|NCT03850483|50545071|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
25233497|NCT03850483|50545072|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
25233498|NCT03850483|50545063|FG000|Follow-up for Stage 1|Other|0|||
25233499|NCT03850483|50545064|FG001|Follow-up for Stage 1|Other|2|||
25233500|NCT03850483|50545065|FG002|Follow-up for Stage 1|Other|0|||
25233501|NCT03850483|50545066|FG003|Follow-up for Stage 1|Other|2|||
25233502|NCT03850483|50545067|FG004|Follow-up for Stage 1|Other|0|||
25233503|NCT03850483|50545068|FG005|Follow-up for Stage 1|Other|1|||
25233504|NCT03850483|50545069|FG006|Follow-up for Stage 1|Other|0|||
25233505|NCT03850483|50545070|FG007|Follow-up for Stage 1|Other|0|||
25233506|NCT03850483|50545071|FG008|Follow-up for Stage 1|Other|0|||
25233507|NCT03850483|50545072|FG009|Follow-up for Stage 1|Other|0|||
25233508|NCT03850483|50545063|FG000|Treatment for Stage 2|Adverse Event|0|||
25233509|NCT03850483|50545064|FG001|Treatment for Stage 2|Adverse Event|0|||
25233510|NCT03850483|50545065|FG002|Treatment for Stage 2|Adverse Event|0|||
25233511|NCT03850483|50545066|FG003|Treatment for Stage 2|Adverse Event|0|||
25233512|NCT03850483|50545067|FG004|Treatment for Stage 2|Adverse Event|0|||
25233513|NCT03850483|50545068|FG005|Treatment for Stage 2|Adverse Event|0|||
25233514|NCT03850483|50545069|FG006|Treatment for Stage 2|Adverse Event|0|||
25233515|NCT03850483|50545070|FG007|Treatment for Stage 2|Adverse Event|0|||
25233516|NCT03850483|50545071|FG008|Treatment for Stage 2|Adverse Event|0|||
25233517|NCT03850483|50545072|FG009|Treatment for Stage 2|Adverse Event|1|||
25233518|NCT03850483|50545063|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
25233519|NCT03850483|50545064|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
25233520|NCT03850483|50545065|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
25233521|NCT03850483|50545066|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
25233522|NCT03850483|50545067|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
25233523|NCT03850483|50545068|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
25233524|NCT03850483|50545069|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
25233525|NCT03850483|50545070|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
25233526|NCT03850483|50545071|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
25233527|NCT03850483|50545072|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
25233528|NCT03850483|50545063|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
25233529|NCT03850483|50545064|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
25233530|NCT03850483|50545065|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
25233531|NCT03850483|50545066|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
25233532|NCT03850483|50545067|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
25233533|NCT03850483|50545068|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
25233534|NCT03850483|50545069|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
25233535|NCT03850483|50545070|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
25233536|NCT03850483|50545071|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
25233537|NCT03850483|50545072|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
25233538|NCT03850483|50545063|FG000|Treatment for Stage 2|Physician Decision|0|||
25233539|NCT03850483|50545064|FG001|Treatment for Stage 2|Physician Decision|0|||
25233540|NCT03850483|50545065|FG002|Treatment for Stage 2|Physician Decision|0|||
25233541|NCT03850483|50545066|FG003|Treatment for Stage 2|Physician Decision|0|||
25233542|NCT03850483|50545067|FG004|Treatment for Stage 2|Physician Decision|0|||
25233543|NCT03850483|50545068|FG005|Treatment for Stage 2|Physician Decision|0|||
25233544|NCT03850483|50545069|FG006|Treatment for Stage 2|Physician Decision|0|||
25233545|NCT03850483|50545070|FG007|Treatment for Stage 2|Physician Decision|0|||
25233546|NCT03850483|50545071|FG008|Treatment for Stage 2|Physician Decision|0|||
25233547|NCT03850483|50545072|FG009|Treatment for Stage 2|Physician Decision|1|||
25233548|NCT03850483|50545063|FG000|Treatment for Stage 2|Protocol Violation|0|||
25233549|NCT03850483|50545064|FG001|Treatment for Stage 2|Protocol Violation|0|||
25233550|NCT03850483|50545065|FG002|Treatment for Stage 2|Protocol Violation|0|||
25233551|NCT03850483|50545066|FG003|Treatment for Stage 2|Protocol Violation|0|||
25233552|NCT03850483|50545067|FG004|Treatment for Stage 2|Protocol Violation|0|||
25233553|NCT03850483|50545068|FG005|Treatment for Stage 2|Protocol Violation|0|||
25233554|NCT03850483|50545069|FG006|Treatment for Stage 2|Protocol Violation|0|||
25233555|NCT03850483|50545070|FG007|Treatment for Stage 2|Protocol Violation|0|||
25233556|NCT03850483|50545071|FG008|Treatment for Stage 2|Protocol Violation|1|||
25233557|NCT03850483|50545072|FG009|Treatment for Stage 2|Protocol Violation|0|||
25233558|NCT03850483|50545063|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
25233559|NCT03850483|50545064|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
25233560|NCT03850483|50545065|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
25233561|NCT03850483|50545066|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
25233562|NCT03850483|50545067|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
25233563|NCT03850483|50545068|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
25319378|NCT00605839|50634854|FG002|Overall Study|Protocol Violation|0|||
25319379|NCT00781365|50634864|FG000|Overall Study|Withdrawal by Subject|13|||
25319380|NCT00781365|50634865|FG001|Overall Study|Withdrawal by Subject|8|||
25319381|NCT00781365|50634864|FG000|Overall Study|Did Not Attend Visit|20|||
25319382|NCT00781365|50634865|FG001|Overall Study|Did Not Attend Visit|28|||
25319383|NCT00781365|50634864|FG000|Overall Study|Language barrier|1|||
25319384|NCT00781365|50634865|FG001|Overall Study|Language barrier|0|||
25319385|NCT00937547|50634874|FG000|Overall Study|misdiagnosis|1|||
25319386|NCT00937547|50634875|FG001|Overall Study|misdiagnosis|6|||
25319387|NCT00937547|50634876|FG002|Overall Study|misdiagnosis|7|||
25319388|NCT00780975|50634884|FG000|Overall Study|Progressive disease|3|||
25319389|NCT00780975|50634884|FG000|Overall Study|Toxicity|5|||
25319390|NCT00780273|50634888|FG000|Overall Study|Death|1|||
25319391|NCT00780273|50634888|FG000|Overall Study|Lost to Follow-up|1|||
25319392|NCT00779259|50634893|FG000|Quinine Alone|Adverse Event|2|||
25233564|NCT03850483|50545069|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
25233565|NCT03850483|50545070|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
25233566|NCT03850483|50545071|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
25233567|NCT03850483|50545072|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
25233568|NCT03850483|50545063|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
25233569|NCT03850483|50545064|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
25233570|NCT03850483|50545065|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
25233571|NCT03850483|50545066|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
25233572|NCT03850483|50545067|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
25233573|NCT03850483|50545068|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
25319393|NCT00779025|50634911|FG000|Overall Study|Withdrawal by Subject|1|||
25319394|NCT00936065|50634919|FG000|Overall Study|Adverse Event|1|||
25319395|NCT00936065|50634920|FG001|Overall Study|Adverse Event|0|||
25319396|NCT00936065|50634921|FG002|Overall Study|Adverse Event|1|||
25319397|NCT00936065|50634919|FG000|Overall Study|Lack of Efficacy|1|||
25319398|NCT00936065|50634920|FG001|Overall Study|Lack of Efficacy|0|||
25319399|NCT00936065|50634921|FG002|Overall Study|Lack of Efficacy|1|||
25319400|NCT00936065|50634919|FG000|Overall Study|Lost to Follow-up|1|||
25233574|NCT03850483|50545069|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
25233575|NCT03850483|50545070|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
25319401|NCT00936065|50634920|FG001|Overall Study|Lost to Follow-up|0|||
25319402|NCT00936065|50634921|FG002|Overall Study|Lost to Follow-up|0|||
25319403|NCT00936065|50634919|FG000|Overall Study|Protocol Violation|1|||
25319404|NCT00936065|50634920|FG001|Overall Study|Protocol Violation|2|||
25319405|NCT00936065|50634921|FG002|Overall Study|Protocol Violation|1|||
25233576|NCT03850483|50545071|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
25233577|NCT03850483|50545072|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
25233578|NCT03850483|50545063|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
25233579|NCT03850483|50545064|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
25233580|NCT03850483|50545065|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
25233581|NCT03850483|50545066|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
25233582|NCT03850483|50545067|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
25233583|NCT03850483|50545068|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
25233584|NCT03850483|50545069|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
25233585|NCT03850483|50545070|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
25233586|NCT03850483|50545071|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
25233587|NCT03850483|50545072|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
25233588|NCT03850483|50545063|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
25233589|NCT03850483|50545064|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
25233590|NCT03850483|50545065|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
25233591|NCT03850483|50545066|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
25233592|NCT03850483|50545067|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
25233593|NCT03850483|50545068|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
25233594|NCT03850483|50545069|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
25233595|NCT03850483|50545070|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
25233596|NCT03850483|50545071|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
25233597|NCT03850483|50545072|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
25233598|NCT03850483|50545063|FG000|Follow-up For Stage 2|Other|0|||
25233599|NCT03850483|50545064|FG001|Follow-up For Stage 2|Other|0|||
25233600|NCT03850483|50545065|FG002|Follow-up For Stage 2|Other|0|||
25233601|NCT03850483|50545066|FG003|Follow-up For Stage 2|Other|0|||
25233602|NCT03850483|50545067|FG004|Follow-up For Stage 2|Other|0|||
25233603|NCT03850483|50545068|FG005|Follow-up For Stage 2|Other|0|||
25233604|NCT03850483|50545069|FG006|Follow-up For Stage 2|Other|0|||
25233605|NCT03850483|50545070|FG007|Follow-up For Stage 2|Other|0|||
25233606|NCT03850483|50545071|FG008|Follow-up For Stage 2|Other|0|||
25233607|NCT03850483|50545072|FG009|Follow-up For Stage 2|Other|1|||
25233608|NCT03473925|50545103|FG000|Overall Study|Death|48|||
25233609|NCT03473925|50545104|FG001|Overall Study|Death|44|||
25233610|NCT03473925|50545103|FG000|Overall Study|Sponsor Decision|2|||
25233611|NCT03473925|50545104|FG001|Overall Study|Sponsor Decision|7|||
25233612|NCT03473925|50545103|FG000|Overall Study|Withdrawal by Subject|1|||
25233613|NCT03473925|50545104|FG001|Overall Study|Withdrawal by Subject|3|||
25233614|NCT03473925|50545103|FG000|Overall Study|Not Treated|1|||
25233615|NCT03473925|50545104|FG001|Overall Study|Not Treated|1|||
25233616|NCT03230097|50545112|FG000|Overall Study|Adverse Event|2|||
25233617|NCT03230097|50545113|FG001|Overall Study|Adverse Event|1|||
25233618|NCT03230097|50545112|FG000|Overall Study|non-compliance|0|||
25233619|NCT03230097|50545113|FG001|Overall Study|non-compliance|1|||
25233620|NCT03230097|50545112|FG000|Overall Study|Lost to Follow-up|2|||
25233621|NCT03230097|50545113|FG001|Overall Study|Lost to Follow-up|4|||
25233622|NCT03230097|50545112|FG000|Overall Study|Withdrawal by Subject|7|||
25233623|NCT03230097|50545113|FG001|Overall Study|Withdrawal by Subject|3|||
25233624|NCT03230097|50545112|FG000|Overall Study|Trial termination|4|||
25233625|NCT03230097|50545113|FG001|Overall Study|Trial termination|5|||
25233626|NCT03230097|50545112|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
25233627|NCT03230097|50545113|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
25233628|NCT03230097|50545112|FG000|Overall Study|outcome event|0|||
25233629|NCT03230097|50545113|FG001|Overall Study|outcome event|1|||
25233630|NCT02803593|50545138|FG000|Overall Study|Lost to Follow-up|17|||
25233631|NCT02803593|50545139|FG001|Overall Study|Lost to Follow-up|35|||
25233632|NCT02663908|50545147|FG000|Overall Study|Withdrawal by Subject|8|||
25233633|NCT02663908|50545148|FG001|Overall Study|Withdrawal by Subject|5|||
25233634|NCT02663908|50545147|FG000|Overall Study|Lost to Follow-up|1|||
25233635|NCT02663908|50545148|FG001|Overall Study|Lost to Follow-up|5|||
25233636|NCT02663908|50545147|FG000|Overall Study|Adverse Event|13|||
25233637|NCT02663908|50545148|FG001|Overall Study|Adverse Event|11|||
25233638|NCT02663908|50545147|FG000|Overall Study|Protocol Violation|1|||
25233639|NCT02663908|50545148|FG001|Overall Study|Protocol Violation|2|||
25319406|NCT00936065|50634919|FG000|Overall Study|Withdrawal by Subject|0|||
25319407|NCT00936065|50634920|FG001|Overall Study|Withdrawal by Subject|2|||
25233640|NCT02663908|50545147|FG000|Overall Study|Lack of therapeutic response|2|||
25233641|NCT02663908|50545148|FG001|Overall Study|Lack of therapeutic response|0|||
25233642|NCT02663908|50545147|FG000|Overall Study|COVID-19|1|||
25233643|NCT02663908|50545148|FG001|Overall Study|COVID-19|0|||
25233644|NCT02663908|50545147|FG000|Overall Study|Site closed|1|||
25233645|NCT02663908|50545148|FG001|Overall Study|Site closed|0|||
25233646|NCT02663908|50545147|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
25233647|NCT02663908|50545148|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
25233648|NCT02663908|50545147|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
25233649|NCT02663908|50545148|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
25233650|NCT02663908|50545147|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
25233651|NCT02663908|50545148|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
25233652|NCT02663908|50545147|FG000|Overall Study|Death|1|||
25233653|NCT02663908|50545148|FG001|Overall Study|Death|0|||
25233654|NCT02663908|50545147|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
25233655|NCT02663908|50545148|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
25233656|NCT02663908|50545147|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
25233657|NCT02663908|50545148|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
25233658|NCT02650284|50545156|FG000|Overall Study|Lost to Follow-up|3|||
25233659|NCT02650284|50545157|FG001|Overall Study|Lost to Follow-up|3|||
25233660|NCT02650284|50545156|FG000|Overall Study|Consent incorrectly taken|0|||
25233661|NCT02650284|50545157|FG001|Overall Study|Consent incorrectly taken|1|||
25233662|NCT02175030|50545165|FG000|Overall Study|Failed screen after consent|7|||
25233663|NCT02175030|50545166|FG001|Overall Study|Failed screen after consent|6|||
25233664|NCT02175030|50545165|FG000|Overall Study|Failed IUD Insertion|20|||
25233665|NCT02175030|50545166|FG001|Overall Study|Failed IUD Insertion|21|||
25233666|NCT02175030|50545165|FG000|Overall Study|Physician Decision|1|||
25233667|NCT02175030|50545166|FG001|Overall Study|Physician Decision|1|||
25233668|NCT02175030|50545165|FG000|Overall Study|Lost to Follow-up|6|||
25233669|NCT02175030|50545166|FG001|Overall Study|Lost to Follow-up|6|||
25233670|NCT02175030|50545165|FG000|Overall Study|Withdrawal by Subject|1|||
25233671|NCT02175030|50545166|FG001|Overall Study|Withdrawal by Subject|4|||
25233672|NCT03096834|50545195|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
25233673|NCT03096834|50545196|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
25233674|NCT03096834|50545197|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
25233675|NCT03096834|50545198|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
25233676|NCT03096834|50545195|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
25233677|NCT03096834|50545196|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
25233678|NCT03096834|50545197|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
25233679|NCT03096834|50545198|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
25233680|NCT03096834|50545195|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
25233681|NCT03096834|50545196|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
25233682|NCT03096834|50545197|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
25233683|NCT03096834|50545198|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
25233684|NCT03096834|50545195|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
25233685|NCT03096834|50545196|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
25233686|NCT03096834|50545197|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
25233687|NCT03096834|50545198|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
25233688|NCT03096834|50545195|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
25233689|NCT03096834|50545196|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
25233690|NCT03096834|50545197|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
25233691|NCT03096834|50545198|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
25233692|NCT03096834|50545195|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
25233693|NCT03096834|50545196|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
25233694|NCT03096834|50545197|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
25233695|NCT03096834|50545198|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
25233696|NCT03096834|50545195|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
25233697|NCT03096834|50545196|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
25233698|NCT03096834|50545197|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
25233699|NCT03096834|50545198|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
25233700|NCT03096834|50545195|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
25233701|NCT03096834|50545196|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
25233702|NCT03096834|50545197|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
25233703|NCT03096834|50545198|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
25233704|NCT03096834|50545195|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
25233705|NCT03096834|50545196|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
25233706|NCT03096834|50545197|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
25233707|NCT03096834|50545198|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
24976671|NCT03449446|50065601|FG002|Overall Study|Withdrew Consent|1|||
25233708|NCT03096834|50545195|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
25233709|NCT03096834|50545196|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
25233710|NCT03096834|50545197|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
25233711|NCT03096834|50545198|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
25233712|NCT03096834|50545195|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
25233713|NCT03096834|50545196|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
25233714|NCT03096834|50545197|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
24976672|NCT03449446|50065602|FG003|Overall Study|Withdrew Consent|4|||
25233715|NCT03096834|50545198|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
25233716|NCT03096834|50545195|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
25233717|NCT03096834|50545196|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
25233718|NCT03096834|50545197|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
25233719|NCT03096834|50545198|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
25233720|NCT03015194|50545207|FG000|Overall Study|Death|10|||
25233721|NCT03015194|50545207|FG000|Overall Study|Withdrawal by Subject|2|||
25233722|NCT03012815|50545214|FG000|Overall Study|Lost to Follow-up|1|||
25233723|NCT03012815|50545215|FG001|Overall Study|Lost to Follow-up|0|||
25233724|NCT03012815|50545214|FG000|Overall Study|Physician Decision|3|||
25233725|NCT03012815|50545215|FG001|Overall Study|Physician Decision|2|||
25233726|NCT03012815|50545214|FG000|Overall Study|Adverse Event|1|||
25233727|NCT03012815|50545215|FG001|Overall Study|Adverse Event|0|||
25233728|NCT03001011|50545224|FG000|Overall Study|Adverse Event|9|||
25233729|NCT03001011|50545225|FG001|Overall Study|Adverse Event|3|||
25233730|NCT03001011|50545224|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
25233731|NCT03001011|50545225|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
25233732|NCT03001011|50545224|FG000|Overall Study|Other than specified above|3|||
25233733|NCT03001011|50545225|FG001|Overall Study|Other than specified above|8|||
25233734|NCT02993757|50545234|FG000|Overall Study|Non compliance with the protocol|155|||
25233735|NCT02993757|50545235|FG001|Overall Study|Non compliance with the protocol|170|||
25233736|NCT02993757|50545234|FG000|Overall Study|Lost to Follow-up|1|||
25233737|NCT02993757|50545235|FG001|Overall Study|Lost to Follow-up|0|||
25233738|NCT02993757|50545234|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
25233739|NCT02993757|50545235|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
25233740|NCT02979535|50545243|FG000|Overall Study|Non compliance with the protocol|78|||
25233741|NCT02979535|50545244|FG001|Overall Study|Non compliance with the protocol|82|||
25233742|NCT02979535|50545243|FG000|Overall Study|Consent withdrawn by participant|11|||
25233743|NCT02979535|50545244|FG001|Overall Study|Consent withdrawn by participant|18|||
25233744|NCT02979535|50545243|FG000|Overall Study|Lost to Follow-up|6|||
25233745|NCT02979535|50545244|FG001|Overall Study|Lost to Follow-up|1|||
25233746|NCT02978716|50545253|FG000|Overall Study|Death|25|||
25233747|NCT02978716|50545254|FG001|Overall Study|Death|13|||
25233748|NCT02978716|50545255|FG002|Overall Study|Death|20|||
25233749|NCT02978716|50545253|FG000|Overall Study|Lost to Follow-up|0|||
25233750|NCT02978716|50545254|FG001|Overall Study|Lost to Follow-up|0|||
25233751|NCT02978716|50545255|FG002|Overall Study|Lost to Follow-up|1|||
25233752|NCT02978716|50545253|FG000|Overall Study|Withdrawal by Subject|6|||
25233753|NCT02978716|50545254|FG001|Overall Study|Withdrawal by Subject|4|||
25233754|NCT02978716|50545255|FG002|Overall Study|Withdrawal by Subject|5|||
25233755|NCT02978716|50545253|FG000|Overall Study|Sponsor terminated|2|||
24976673|NCT03449446|50065603|FG004|Overall Study|Withdrew Consent|4|||
25233756|NCT02978716|50545254|FG001|Overall Study|Sponsor terminated|13|||
25233757|NCT02978716|50545255|FG002|Overall Study|Sponsor terminated|9|||
25233758|NCT02978716|50545253|FG000|Overall Study|Other|1|||
25233759|NCT02978716|50545254|FG001|Overall Study|Other|3|||
25233760|NCT02978716|50545255|FG002|Overall Study|Other|0|||
25233761|NCT02973321|50545270|FG000|Overall Study|Other than specified|0|||
25233762|NCT02973321|50545271|FG001|Overall Study|Other than specified|5|||
25233763|NCT02973321|50545272|FG002|Overall Study|Other than specified|3|||
25233764|NCT02973321|50545273|FG003|Overall Study|Other than specified|3|||
25233765|NCT02973321|50545274|FG004|Overall Study|Other than specified|1|||
25233766|NCT02973321|50545270|FG000|Overall Study|Lack of Efficacy|0|||
25233767|NCT02973321|50545271|FG001|Overall Study|Lack of Efficacy|0|||
25233768|NCT02973321|50545272|FG002|Overall Study|Lack of Efficacy|0|||
25233769|NCT02973321|50545273|FG003|Overall Study|Lack of Efficacy|0|||
25233770|NCT02973321|50545274|FG004|Overall Study|Lack of Efficacy|1|||
25233771|NCT02973321|50545270|FG000|Overall Study|Adverse Event|1|||
25233772|NCT02973321|50545271|FG001|Overall Study|Adverse Event|10|||
25233773|NCT02973321|50545272|FG002|Overall Study|Adverse Event|11|||
25233774|NCT02973321|50545273|FG003|Overall Study|Adverse Event|13|||
25233775|NCT02973321|50545274|FG004|Overall Study|Adverse Event|3|||
25233776|NCT02943785|50545289|FG000|Overall Study|Adverse Event|112|||
25233777|NCT02943785|50545290|FG001|Overall Study|Adverse Event|97|||
25233778|NCT02943785|50545289|FG000|Overall Study|Withdrawal by Subject|63|||
25233779|NCT02943785|50545290|FG001|Overall Study|Withdrawal by Subject|126|||
25233780|NCT02943785|50545289|FG000|Overall Study|Physician Decision|23|||
25233781|NCT02943785|50545290|FG001|Overall Study|Physician Decision|47|||
25233782|NCT02943785|50545289|FG000|Overall Study|Death|46|||
25233783|NCT02943785|50545290|FG001|Overall Study|Death|46|||
25233784|NCT02943785|50545289|FG000|Overall Study|Lost to Follow-up|1|||
25233785|NCT02943785|50545290|FG001|Overall Study|Lost to Follow-up|0|||
25233786|NCT02943785|50545289|FG000|Overall Study|Other|16|||
25233787|NCT02943785|50545290|FG001|Overall Study|Other|19|||
25233788|NCT02943785|50545289|FG000|Overall Study|Did not receive any study medication|21|||
25233789|NCT02943785|50545290|FG001|Overall Study|Did not receive any study medication|28|||
25233790|NCT02923674|50545299|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
25233791|NCT02923674|50545300|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
25233792|NCT02923674|50545301|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
25233793|NCT02923674|50545299|FG000|Overall Study|Lost to Follow-up|7|||
25233794|NCT02923674|50545300|FG001|Overall Study|Lost to Follow-up|12|||
25233795|NCT02923674|50545301|FG002|Overall Study|Lost to Follow-up|7|||
25233796|NCT02923674|50545299|FG000|Overall Study|Problem with intervention|2|||
25233797|NCT02923674|50545300|FG001|Overall Study|Problem with intervention|2|||
25233798|NCT02923674|50545301|FG002|Overall Study|Problem with intervention|1|||
25233799|NCT02923674|50545299|FG000|Overall Study|Adverse Event|3|||
25233800|NCT02923674|50545300|FG001|Overall Study|Adverse Event|1|||
25233801|NCT02923674|50545301|FG002|Overall Study|Adverse Event|1|||
25233802|NCT02923674|50545299|FG000|Overall Study|Withdrawal by Subject|2|||
25233803|NCT02923674|50545300|FG001|Overall Study|Withdrawal by Subject|2|||
25233804|NCT02923674|50545301|FG002|Overall Study|Withdrawal by Subject|2|||
25233805|NCT02921971|50545311|FG000|Overall Study|Adverse Event|1|||
25233806|NCT02921971|50545312|FG001|Overall Study|Adverse Event|2|||
25233807|NCT02921971|50545311|FG000|Overall Study|Lack of Efficacy|3|||
25233808|NCT02921971|50545312|FG001|Overall Study|Lack of Efficacy|1|||
25233809|NCT02921971|50545311|FG000|Overall Study|Other than specified above|2|||
25233810|NCT02921971|50545312|FG001|Overall Study|Other than specified above|1|||
25233811|NCT02886286|50545320|FG000|Overall Study|pump motor stall|0|||
25233812|NCT02886286|50545321|FG001|Overall Study|pump motor stall|1|||
25233813|NCT02865187|50545329|FG000|Overall Study|Lost to Follow-up|12|||
25233814|NCT02865187|50545330|FG001|Overall Study|Lost to Follow-up|7|||
25233815|NCT02865187|50545329|FG000|Overall Study|Adverse Event|1|||
25233816|NCT02865187|50545330|FG001|Overall Study|Adverse Event|0|||
25233817|NCT02824198|50545338|FG000|Overall Study|Non-compliance with the protocol|5|||
25233818|NCT02824198|50545339|FG001|Overall Study|Non-compliance with the protocol|1|||
25233819|NCT02824198|50545338|FG000|Overall Study|Lost to Follow-up|5|||
25233820|NCT02824198|50545339|FG001|Overall Study|Lost to Follow-up|2|||
25233821|NCT02824198|50545338|FG000|Overall Study|Withdrawal by Subject|5|||
25233822|NCT02824198|50545339|FG001|Overall Study|Withdrawal by Subject|0|||
25233823|NCT02787551|50545349|FG000|Core Period: 26 Weeks|Adverse Event|10|||
25233824|NCT02787551|50545350|FG001|Core Period: 26 Weeks|Adverse Event|0|||
25233825|NCT02787551|50545349|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
25233826|NCT02787551|50545350|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
25233827|NCT02787551|50545349|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
25233828|NCT02787551|50545350|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
25233829|NCT02787551|50545349|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
25233830|NCT02787551|50545350|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
25233831|NCT02787551|50545349|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
25233832|NCT02787551|50545350|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
25233833|NCT02787551|50545349|FG000|Core Period: 26 Weeks|Other than specified|3|||
25233834|NCT02787551|50545350|FG001|Core Period: 26 Weeks|Other than specified|1|||
25233835|NCT02787551|50545349|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
25233836|NCT02787551|50545350|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
25233837|NCT02787551|50545349|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
25233838|NCT02787551|50545350|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
25233839|NCT02787551|50545349|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
25233840|NCT02787551|50545350|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
25233841|NCT02735044|50545370|FG000|Overall Study|Adverse Event|3|||
25233842|NCT02735044|50545371|FG001|Overall Study|Adverse Event|3|||
25233843|NCT02735044|50545370|FG000|Overall Study|Lack of Efficacy|1|||
25233844|NCT02735044|50545371|FG001|Overall Study|Lack of Efficacy|0|||
25233845|NCT02735044|50545370|FG000|Overall Study|Poor compliance to protocol|7|||
25233846|NCT02735044|50545371|FG001|Overall Study|Poor compliance to protocol|7|||
25233847|NCT02735044|50545370|FG000|Overall Study|Randomized and not treated|0|||
25233848|NCT02735044|50545371|FG001|Overall Study|Randomized and not treated|2|||
25233849|NCT02735044|50545370|FG000|Overall Study|Other, not specified above|5|||
25233850|NCT02735044|50545371|FG001|Overall Study|Other, not specified above|11|||
25233851|NCT02720744|50545379|FG000|Overall Study|Protocol Violation|0|||
25233852|NCT02720744|50545380|FG001|Overall Study|Protocol Violation|2|||
25233853|NCT02720744|50545379|FG000|Overall Study|Pregnancy|2|||
25233854|NCT02720744|50545380|FG001|Overall Study|Pregnancy|0|||
25233855|NCT02720744|50545379|FG000|Overall Study|Lack of Efficacy|2|||
25233856|NCT02720744|50545380|FG001|Overall Study|Lack of Efficacy|8|||
25233857|NCT02720744|50545379|FG000|Overall Study|Adverse Event|21|||
25233858|NCT02720744|50545380|FG001|Overall Study|Adverse Event|3|||
25233859|NCT02720744|50545379|FG000|Overall Study|Withdrawal by Subject|11|||
25233860|NCT02720744|50545380|FG001|Overall Study|Withdrawal by Subject|11|||
25233861|NCT02720744|50545379|FG000|Overall Study|Lost to follow up|2|||
25233862|NCT02720744|50545380|FG001|Overall Study|Lost to follow up|0|||
25233863|NCT02720744|50545379|FG000|Overall Study|Non Compliance with Investigational Product|0|||
25233864|NCT02720744|50545380|FG001|Overall Study|Non Compliance with Investigational Product|1|||
25233865|NCT02720744|50545379|FG000|Overall Study|Excluded Concomitant Medication|0|||
25233866|NCT02720744|50545380|FG001|Overall Study|Excluded Concomitant Medication|1|||
25233867|NCT02694185|50545388|FG000|Overall Study|Withdrawal by Subject|45|||
25233868|NCT02694185|50545389|FG001|Overall Study|Withdrawal by Subject|0|||
25233869|NCT02692651|50545397|FG000|Study Treatment|Death|7|||
25233870|NCT02692651|50545398|FG001|Study Treatment|Death|3|||
25233871|NCT02692651|50545397|FG000|Study Treatment|comfort care|1|||
25233872|NCT02692651|50545398|FG001|Study Treatment|comfort care|1|||
25233873|NCT02692651|50545397|FG000|Study Treatment|Protocol violation per treating team preference|8|||
25233874|NCT02692651|50545398|FG001|Study Treatment|Protocol violation per treating team preference|6|||
25233875|NCT02692651|50545397|FG000|Post Study Treatment Follow-up|Death|4|||
25233876|NCT02692651|50545398|FG001|Post Study Treatment Follow-up|Death|4|||
25233877|NCT02686658|50545410|FG000|Overall Study|Adverse Event|0|||
25233878|NCT02686658|50545411|FG001|Overall Study|Adverse Event|0|||
25233879|NCT02686658|50545412|FG002|Overall Study|Adverse Event|1|||
25233880|NCT02686658|50545413|FG003|Overall Study|Adverse Event|1|||
25233881|NCT02686658|50545414|FG004|Overall Study|Adverse Event|2|||
25233882|NCT02686658|50545415|FG005|Overall Study|Adverse Event|1|||
25233883|NCT02686658|50545410|FG000|Overall Study|Investigator decision|0|||
25233884|NCT02686658|50545411|FG001|Overall Study|Investigator decision|0|||
25233885|NCT02686658|50545412|FG002|Overall Study|Investigator decision|0|||
25233886|NCT02686658|50545413|FG003|Overall Study|Investigator decision|1|||
25233887|NCT02686658|50545414|FG004|Overall Study|Investigator decision|2|||
25233888|NCT02686658|50545415|FG005|Overall Study|Investigator decision|1|||
25233889|NCT02686658|50545410|FG000|Overall Study|Sponsor decision|1|||
25233890|NCT02686658|50545411|FG001|Overall Study|Sponsor decision|2|||
25233891|NCT02686658|50545412|FG002|Overall Study|Sponsor decision|1|||
25233892|NCT02686658|50545413|FG003|Overall Study|Sponsor decision|5|||
25233893|NCT02686658|50545414|FG004|Overall Study|Sponsor decision|13|||
25233894|NCT02686658|50545415|FG005|Overall Study|Sponsor decision|2|||
25233895|NCT02686658|50545410|FG000|Overall Study|Lost to Follow-up|0|||
25233896|NCT02686658|50545411|FG001|Overall Study|Lost to Follow-up|0|||
25233897|NCT02686658|50545412|FG002|Overall Study|Lost to Follow-up|2|||
25233898|NCT02686658|50545413|FG003|Overall Study|Lost to Follow-up|0|||
25233899|NCT02686658|50545414|FG004|Overall Study|Lost to Follow-up|0|||
25233900|NCT02686658|50545415|FG005|Overall Study|Lost to Follow-up|1|||
25233901|NCT02686658|50545410|FG000|Overall Study|Death|1|||
25233902|NCT02686658|50545411|FG001|Overall Study|Death|0|||
25233903|NCT02686658|50545412|FG002|Overall Study|Death|0|||
25233904|NCT02686658|50545413|FG003|Overall Study|Death|1|||
25233905|NCT02686658|50545414|FG004|Overall Study|Death|1|||
25233906|NCT02686658|50545415|FG005|Overall Study|Death|1|||
25233907|NCT02686658|50545410|FG000|Overall Study|Withdrawal by Subject|2|||
25233908|NCT02686658|50545411|FG001|Overall Study|Withdrawal by Subject|5|||
25233909|NCT02686658|50545412|FG002|Overall Study|Withdrawal by Subject|4|||
25233910|NCT02686658|50545413|FG003|Overall Study|Withdrawal by Subject|4|||
25233911|NCT02686658|50545414|FG004|Overall Study|Withdrawal by Subject|17|||
25233912|NCT02686658|50545415|FG005|Overall Study|Withdrawal by Subject|8|||
25233913|NCT02686658|50545410|FG000|Overall Study|Placed in hospice care|0|||
25233914|NCT02686658|50545411|FG001|Overall Study|Placed in hospice care|0|||
25233915|NCT02686658|50545412|FG002|Overall Study|Placed in hospice care|1|||
25233916|NCT02686658|50545413|FG003|Overall Study|Placed in hospice care|0|||
25233917|NCT02686658|50545414|FG004|Overall Study|Placed in hospice care|0|||
25233918|NCT02686658|50545415|FG005|Overall Study|Placed in hospice care|0|||
25233919|NCT02686658|50545410|FG000|Overall Study|Participant non-compliance|0|||
25233920|NCT02686658|50545411|FG001|Overall Study|Participant non-compliance|0|||
25233921|NCT02686658|50545412|FG002|Overall Study|Participant non-compliance|0|||
25233922|NCT02686658|50545413|FG003|Overall Study|Participant non-compliance|0|||
25233923|NCT02686658|50545414|FG004|Overall Study|Participant non-compliance|0|||
25233924|NCT02686658|50545415|FG005|Overall Study|Participant non-compliance|1|||
25233925|NCT02686658|50545410|FG000|Overall Study|Concern over coronavirus disease care|0|||
25233926|NCT02686658|50545411|FG001|Overall Study|Concern over coronavirus disease care|0|||
25233927|NCT02686658|50545412|FG002|Overall Study|Concern over coronavirus disease care|0|||
25233928|NCT02686658|50545413|FG003|Overall Study|Concern over coronavirus disease care|0|||
25233929|NCT02686658|50545414|FG004|Overall Study|Concern over coronavirus disease care|2|||
25233930|NCT02686658|50545415|FG005|Overall Study|Concern over coronavirus disease care|1|||
25233931|NCT02674061|50545431|FG000|Overall Study|Death|229|||
25233932|NCT02674061|50545432|FG001|Overall Study|Death|77|||
25233933|NCT02674061|50545431|FG000|Overall Study|Lost to Follow-up|3|||
25233934|NCT02674061|50545432|FG001|Overall Study|Lost to Follow-up|3|||
25233935|NCT02674061|50545431|FG000|Overall Study|Withdrawal by Subject|9|||
25233936|NCT02674061|50545432|FG001|Overall Study|Withdrawal by Subject|1|||
25233937|NCT02674061|50545431|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
25233938|NCT02674061|50545432|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
25233939|NCT02628444|50545452|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
25233940|NCT02628444|50545453|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
25233941|NCT02628444|50545454|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
25233942|NCT02628444|50545455|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
25233943|NCT02628444|50545456|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
25233944|NCT02628444|50545457|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
25233945|NCT02628444|50545458|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
25233946|NCT02628444|50545459|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
25233947|NCT02628444|50545460|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
25233948|NCT02628444|50545452|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
25233949|NCT02628444|50545453|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
25233950|NCT02628444|50545454|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
25233951|NCT02628444|50545455|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
25233952|NCT02628444|50545456|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
25233953|NCT02628444|50545457|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
25233954|NCT02628444|50545458|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
25233955|NCT02628444|50545459|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
25233956|NCT02628444|50545460|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
25233957|NCT02628444|50545452|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
25233958|NCT02628444|50545453|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
25233959|NCT02628444|50545454|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
25233960|NCT02628444|50545455|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
25233961|NCT02628444|50545456|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
25233962|NCT02628444|50545457|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
25233963|NCT02628444|50545458|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
25233964|NCT02628444|50545459|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
25233965|NCT02628444|50545460|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
25233966|NCT02628444|50545452|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
25233967|NCT02628444|50545453|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
25233968|NCT02628444|50545454|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
25233969|NCT02628444|50545455|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
25233970|NCT02628444|50545456|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
25233971|NCT02628444|50545457|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
25233972|NCT02628444|50545458|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
25233973|NCT02628444|50545459|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
25233974|NCT02628444|50545460|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
25233975|NCT02628444|50545452|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
25233976|NCT02628444|50545453|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
25233977|NCT02628444|50545454|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
25233978|NCT02628444|50545455|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
25233979|NCT02628444|50545456|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
25233980|NCT02628444|50545457|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
25233981|NCT02628444|50545458|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
25233982|NCT02628444|50545459|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
25233983|NCT02628444|50545460|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
25233984|NCT02628444|50545452|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
25233985|NCT02628444|50545453|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
25233986|NCT02628444|50545454|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
25233987|NCT02628444|50545455|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
25233988|NCT02628444|50545456|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
25233989|NCT02628444|50545457|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
25233990|NCT02628444|50545458|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
25233991|NCT02628444|50545459|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
25233992|NCT02628444|50545460|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
25233993|NCT02628444|50545452|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
25233994|NCT02628444|50545453|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
25233995|NCT02628444|50545454|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
25233996|NCT02628444|50545455|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
25233997|NCT02628444|50545456|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
25233998|NCT02628444|50545457|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
25233999|NCT02628444|50545458|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
25234000|NCT02628444|50545459|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
25234001|NCT02628444|50545460|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
25234002|NCT02628444|50545452|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
25234003|NCT02628444|50545453|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
25234004|NCT02628444|50545454|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
25234005|NCT02628444|50545455|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
25234006|NCT02628444|50545456|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
25234007|NCT02628444|50545457|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
25234008|NCT02628444|50545458|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
25234009|NCT02628444|50545459|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
25234010|NCT02628444|50545460|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
25234011|NCT02628444|50545452|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
25234012|NCT02628444|50545453|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
25234013|NCT02628444|50545454|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
25234014|NCT02628444|50545455|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
25234015|NCT02628444|50545456|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
25234016|NCT02628444|50545457|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
25234017|NCT02628444|50545458|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
25234018|NCT02628444|50545459|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
25234019|NCT02628444|50545460|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
25234020|NCT02628444|50545452|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
25234021|NCT02628444|50545453|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
25234022|NCT02628444|50545454|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
25234023|NCT02628444|50545455|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
25234024|NCT02628444|50545456|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
25234025|NCT02628444|50545457|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
25234026|NCT02628444|50545458|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
25234027|NCT02628444|50545459|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
25234028|NCT02628444|50545460|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
25234029|NCT02623725|50545496|FG000|Overall Study|Non compliance with protocol|9|||
25234030|NCT02623725|50545497|FG001|Overall Study|Non compliance with protocol|3|||
25234031|NCT02623725|50545496|FG000|Overall Study|Serious adverse event|0|||
25234032|NCT02623725|50545497|FG001|Overall Study|Serious adverse event|2|||
25234033|NCT02623725|50545496|FG000|Overall Study|Withdrawal by Subject|7|||
25234034|NCT02623725|50545497|FG001|Overall Study|Withdrawal by Subject|1|||
25234035|NCT02608684|50545505|FG000|Overall Study|Physician Decision|2|||
25234036|NCT02608684|50545505|FG000|Overall Study|Withdrawal by Subject|1|||
25234037|NCT02587520|50545527|FG000|Overall Study|Protocol Violation|2|||
25234038|NCT02587520|50545528|FG001|Overall Study|Protocol Violation|0|||
25234039|NCT02587520|50545529|FG002|Overall Study|Protocol Violation|0|||
25234040|NCT02587520|50545530|FG003|Overall Study|Protocol Violation|2|||
25234041|NCT02587520|50545531|FG004|Overall Study|Protocol Violation|0|||
25234042|NCT02587520|50545532|FG005|Overall Study|Protocol Violation|1|||
25234043|NCT02587520|50545533|FG006|Overall Study|Protocol Violation|1|||
25234044|NCT02587520|50545534|FG007|Overall Study|Protocol Violation|1|||
25234045|NCT02587520|50545535|FG008|Overall Study|Protocol Violation|3|||
25234046|NCT02587520|50545536|FG009|Overall Study|Protocol Violation|3|||
25234047|NCT02587520|50545537|FG010|Overall Study|Protocol Violation|1|||
25234048|NCT02587520|50545538|FG011|Overall Study|Protocol Violation|2|||
25234049|NCT02587520|50545539|FG012|Overall Study|Protocol Violation|0|||
25234050|NCT02587520|50545540|FG013|Overall Study|Protocol Violation|0|||
25234051|NCT02587520|50545541|FG014|Overall Study|Protocol Violation|0|||
25234052|NCT02587520|50545542|FG015|Overall Study|Protocol Violation|0|||
25234053|NCT02587520|50545543|FG016|Overall Study|Protocol Violation|0|||
25234054|NCT02587520|50545544|FG017|Overall Study|Protocol Violation|0|||
25234055|NCT02587520|50545527|FG000|Overall Study|Adverse Event|0|||
25234056|NCT02587520|50545528|FG001|Overall Study|Adverse Event|0|||
25234057|NCT02587520|50545529|FG002|Overall Study|Adverse Event|0|||
25234058|NCT02587520|50545530|FG003|Overall Study|Adverse Event|0|||
25234059|NCT02587520|50545531|FG004|Overall Study|Adverse Event|0|||
25234060|NCT02587520|50545532|FG005|Overall Study|Adverse Event|0|||
25234061|NCT02587520|50545533|FG006|Overall Study|Adverse Event|0|||
25234062|NCT02587520|50545534|FG007|Overall Study|Adverse Event|0|||
25234063|NCT02587520|50545535|FG008|Overall Study|Adverse Event|0|||
25234064|NCT02587520|50545536|FG009|Overall Study|Adverse Event|0|||
25234065|NCT02587520|50545537|FG010|Overall Study|Adverse Event|0|||
25234066|NCT02587520|50545538|FG011|Overall Study|Adverse Event|1|||
25234067|NCT02587520|50545539|FG012|Overall Study|Adverse Event|0|||
25234068|NCT02587520|50545540|FG013|Overall Study|Adverse Event|0|||
25234069|NCT02587520|50545541|FG014|Overall Study|Adverse Event|0|||
25234070|NCT02587520|50545542|FG015|Overall Study|Adverse Event|0|||
25234071|NCT02587520|50545543|FG016|Overall Study|Adverse Event|0|||
25234072|NCT02587520|50545544|FG017|Overall Study|Adverse Event|0|||
25234073|NCT02587520|50545527|FG000|Overall Study|Withdrawal by Subject|0|||
25234074|NCT02587520|50545528|FG001|Overall Study|Withdrawal by Subject|0|||
25234075|NCT02587520|50545529|FG002|Overall Study|Withdrawal by Subject|1|||
25234076|NCT02587520|50545530|FG003|Overall Study|Withdrawal by Subject|1|||
25234077|NCT02587520|50545531|FG004|Overall Study|Withdrawal by Subject|0|||
25234078|NCT02587520|50545532|FG005|Overall Study|Withdrawal by Subject|1|||
25234079|NCT02587520|50545533|FG006|Overall Study|Withdrawal by Subject|1|||
25234080|NCT02587520|50545534|FG007|Overall Study|Withdrawal by Subject|0|||
25234081|NCT02587520|50545535|FG008|Overall Study|Withdrawal by Subject|0|||
25234082|NCT02587520|50545536|FG009|Overall Study|Withdrawal by Subject|0|||
25234083|NCT02587520|50545537|FG010|Overall Study|Withdrawal by Subject|0|||
25234084|NCT02587520|50545538|FG011|Overall Study|Withdrawal by Subject|0|||
25234085|NCT02587520|50545539|FG012|Overall Study|Withdrawal by Subject|0|||
25234086|NCT02587520|50545540|FG013|Overall Study|Withdrawal by Subject|1|||
25234087|NCT02587520|50545541|FG014|Overall Study|Withdrawal by Subject|0|||
25234088|NCT02587520|50545542|FG015|Overall Study|Withdrawal by Subject|0|||
25234089|NCT02587520|50545543|FG016|Overall Study|Withdrawal by Subject|0|||
25234090|NCT02587520|50545544|FG017|Overall Study|Withdrawal by Subject|0|||
25234091|NCT02587520|50545527|FG000|Overall Study|Lost to Follow-up|0|||
25234092|NCT02587520|50545528|FG001|Overall Study|Lost to Follow-up|2|||
25234093|NCT02587520|50545529|FG002|Overall Study|Lost to Follow-up|0|||
25234094|NCT02587520|50545530|FG003|Overall Study|Lost to Follow-up|2|||
25234095|NCT02587520|50545531|FG004|Overall Study|Lost to Follow-up|0|||
25234096|NCT02587520|50545532|FG005|Overall Study|Lost to Follow-up|1|||
25234097|NCT02587520|50545533|FG006|Overall Study|Lost to Follow-up|1|||
25234098|NCT02587520|50545534|FG007|Overall Study|Lost to Follow-up|1|||
25234099|NCT02587520|50545535|FG008|Overall Study|Lost to Follow-up|0|||
25234100|NCT02587520|50545536|FG009|Overall Study|Lost to Follow-up|2|||
25234101|NCT02587520|50545537|FG010|Overall Study|Lost to Follow-up|2|||
25234102|NCT02587520|50545538|FG011|Overall Study|Lost to Follow-up|1|||
25234103|NCT02587520|50545539|FG012|Overall Study|Lost to Follow-up|0|||
25234104|NCT02587520|50545540|FG013|Overall Study|Lost to Follow-up|0|||
25234105|NCT02587520|50545541|FG014|Overall Study|Lost to Follow-up|0|||
25234106|NCT02587520|50545542|FG015|Overall Study|Lost to Follow-up|0|||
25234107|NCT02587520|50545543|FG016|Overall Study|Lost to Follow-up|0|||
25234108|NCT02587520|50545544|FG017|Overall Study|Lost to Follow-up|0|||
25234109|NCT02584829|50545584|FG000|Overall Study|Physician Decision|1|||
25234110|NCT02584829|50545585|FG001|Overall Study|Physician Decision|0|||
25234111|NCT02584829|50545584|FG000|Overall Study|Withdrawal by Subject|0|||
25234112|NCT02584829|50545585|FG001|Overall Study|Withdrawal by Subject|1|||
25234113|NCT02584829|50545584|FG000|Overall Study|Progressive Disease|0|||
25234114|NCT02584829|50545585|FG001|Overall Study|Progressive Disease|3|||
24976674|NCT03449446|50065604|FG005|Overall Study|Withdrew Consent|4|||
25234115|NCT02570308|50545598|FG000|Overall Study|Death|1|||
25234116|NCT02570308|50545599|FG001|Overall Study|Death|5|||
25234117|NCT02570308|50545600|FG002|Overall Study|Death|4|||
25234118|NCT02570308|50545601|FG003|Overall Study|Death|4|||
25234119|NCT02570308|50545602|FG004|Overall Study|Death|69|||
25234120|NCT02570308|50545598|FG000|Overall Study|Lost to Follow-up|0|||
25234121|NCT02570308|50545599|FG001|Overall Study|Lost to Follow-up|0|||
25234122|NCT02570308|50545600|FG002|Overall Study|Lost to Follow-up|0|||
25234123|NCT02570308|50545601|FG003|Overall Study|Lost to Follow-up|0|||
25234124|NCT02570308|50545602|FG004|Overall Study|Lost to Follow-up|2|||
25234125|NCT02570308|50545598|FG000|Overall Study|Withdrawal by Subject|0|||
25234126|NCT02570308|50545599|FG001|Overall Study|Withdrawal by Subject|0|||
25234127|NCT02570308|50545600|FG002|Overall Study|Withdrawal by Subject|0|||
25234128|NCT02570308|50545601|FG003|Overall Study|Withdrawal by Subject|0|||
25234129|NCT02570308|50545602|FG004|Overall Study|Withdrawal by Subject|1|||
25234130|NCT02570308|50545598|FG000|Overall Study|Other|0|||
25234131|NCT02570308|50545599|FG001|Overall Study|Other|0|||
25234132|NCT02570308|50545600|FG002|Overall Study|Other|0|||
25234133|NCT02570308|50545601|FG003|Overall Study|Other|0|||
25234134|NCT02570308|50545602|FG004|Overall Study|Other|2|||
25234135|NCT02497612|50545624|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
25234136|NCT02497612|50545625|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
25234137|NCT02497612|50545626|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
25234138|NCT02497612|50545627|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
25234139|NCT02497612|50545624|FG000|Overall Study|Participant's request|2|||
25234140|NCT02497612|50545625|FG001|Overall Study|Participant's request|3|||
25234141|NCT02497612|50545626|FG002|Overall Study|Participant's request|4|||
25234142|NCT02497612|50545627|FG003|Overall Study|Participant's request|1|||
25234143|NCT02497612|50545624|FG000|Overall Study|Investigator's judgement|1|||
25234144|NCT02497612|50545625|FG001|Overall Study|Investigator's judgement|0|||
25234145|NCT02497612|50545626|FG002|Overall Study|Investigator's judgement|0|||
25234146|NCT02497612|50545627|FG003|Overall Study|Investigator's judgement|2|||
25234147|NCT02497612|50545624|FG000|Overall Study|Adverse Event|3|||
25234148|NCT02497612|50545625|FG001|Overall Study|Adverse Event|1|||
25234149|NCT02497612|50545626|FG002|Overall Study|Adverse Event|4|||
25234150|NCT02497612|50545627|FG003|Overall Study|Adverse Event|1|||
25234151|NCT02497612|50545624|FG000|Overall Study|Lost to Follow-up|1|||
25234152|NCT02497612|50545625|FG001|Overall Study|Lost to Follow-up|1|||
25234153|NCT02497612|50545626|FG002|Overall Study|Lost to Follow-up|0|||
25234154|NCT02497612|50545627|FG003|Overall Study|Lost to Follow-up|1|||
25234155|NCT02497612|50545624|FG000|Overall Study|Other unspecified|1|||
25234156|NCT02497612|50545625|FG001|Overall Study|Other unspecified|1|||
25234157|NCT02497612|50545626|FG002|Overall Study|Other unspecified|2|||
25234158|NCT02497612|50545627|FG003|Overall Study|Other unspecified|0|||
25234159|NCT02497612|50545624|FG000|Overall Study|Not eligible|1|||
25234160|NCT02497612|50545625|FG001|Overall Study|Not eligible|0|||
25234161|NCT02497612|50545626|FG002|Overall Study|Not eligible|0|||
25234162|NCT02497612|50545627|FG003|Overall Study|Not eligible|1|||
25234163|NCT02460458|50545637|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47|||
25234164|NCT02460458|50545637|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27|||
25234165|NCT02460458|50545637|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14|||
25234166|NCT02460458|50545637|FG000|First Prospective Phase|Lost to Follow-up|16|||
25234167|NCT02460458|50545637|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9|||
25234168|NCT02457559|50545652|FG000|Overall Study|Progressive Disease|1|||
25234169|NCT02457559|50545653|FG001|Overall Study|Progressive Disease|2|||
25234170|NCT02457559|50545654|FG002|Overall Study|Progressive Disease|3|||
25234171|NCT02457559|50545655|FG003|Overall Study|Progressive Disease|0|||
25234172|NCT02457559|50545656|FG004|Overall Study|Progressive Disease|0|||
25234173|NCT02457559|50545657|FG005|Overall Study|Progressive Disease|2|||
25234174|NCT02457559|50545658|FG006|Overall Study|Progressive Disease|1|||
25234175|NCT02457559|50545659|FG007|Overall Study|Progressive Disease|0|||
25234176|NCT02457559|50545660|FG008|Overall Study|Progressive Disease|1|||
25234177|NCT02457559|50545661|FG009|Overall Study|Progressive Disease|1|||
25234178|NCT02457559|50545662|FG010|Overall Study|Progressive Disease|1|||
25234179|NCT02457559|50545652|FG000|Overall Study|Investigator's Discretion|0|||
25234180|NCT02457559|50545653|FG001|Overall Study|Investigator's Discretion|0|||
25234181|NCT02457559|50545654|FG002|Overall Study|Investigator's Discretion|2|||
25234182|NCT02457559|50545655|FG003|Overall Study|Investigator's Discretion|0|||
25234183|NCT02457559|50545656|FG004|Overall Study|Investigator's Discretion|1|||
25234184|NCT02457559|50545657|FG005|Overall Study|Investigator's Discretion|0|||
25234185|NCT02457559|50545658|FG006|Overall Study|Investigator's Discretion|1|||
25234186|NCT02457559|50545659|FG007|Overall Study|Investigator's Discretion|0|||
25234187|NCT02457559|50545660|FG008|Overall Study|Investigator's Discretion|1|||
25234188|NCT02457559|50545661|FG009|Overall Study|Investigator's Discretion|0|||
25234189|NCT02457559|50545662|FG010|Overall Study|Investigator's Discretion|1|||
25234190|NCT02457559|50545652|FG000|Overall Study|Adverse Event|0|||
25234191|NCT02457559|50545653|FG001|Overall Study|Adverse Event|1|||
25234192|NCT02457559|50545654|FG002|Overall Study|Adverse Event|2|||
25234193|NCT02457559|50545655|FG003|Overall Study|Adverse Event|0|||
25234194|NCT02457559|50545656|FG004|Overall Study|Adverse Event|0|||
25234195|NCT02457559|50545657|FG005|Overall Study|Adverse Event|0|||
25234196|NCT02457559|50545658|FG006|Overall Study|Adverse Event|0|||
25234197|NCT02457559|50545659|FG007|Overall Study|Adverse Event|0|||
25234198|NCT02457559|50545660|FG008|Overall Study|Adverse Event|0|||
25234199|NCT02457559|50545661|FG009|Overall Study|Adverse Event|0|||
25234200|NCT02457559|50545662|FG010|Overall Study|Adverse Event|0|||
25234201|NCT02457559|50545652|FG000|Overall Study|Reason not Specified|1|||
25234202|NCT02457559|50545653|FG001|Overall Study|Reason not Specified|0|||
25234203|NCT02457559|50545654|FG002|Overall Study|Reason not Specified|0|||
25234204|NCT02457559|50545655|FG003|Overall Study|Reason not Specified|0|||
25234205|NCT02457559|50545656|FG004|Overall Study|Reason not Specified|0|||
25234206|NCT02457559|50545657|FG005|Overall Study|Reason not Specified|0|||
25234207|NCT02457559|50545658|FG006|Overall Study|Reason not Specified|0|||
25234208|NCT02457559|50545659|FG007|Overall Study|Reason not Specified|0|||
25234209|NCT02457559|50545660|FG008|Overall Study|Reason not Specified|0|||
25234210|NCT02457559|50545661|FG009|Overall Study|Reason not Specified|2|||
25234211|NCT02457559|50545662|FG010|Overall Study|Reason not Specified|0|||
25234212|NCT02457559|50545652|FG000|Overall Study|Death|0|||
25234213|NCT02457559|50545653|FG001|Overall Study|Death|0|||
25234214|NCT02457559|50545654|FG002|Overall Study|Death|0|||
25234215|NCT02457559|50545655|FG003|Overall Study|Death|0|||
25234216|NCT02457559|50545656|FG004|Overall Study|Death|0|||
25234217|NCT02457559|50545657|FG005|Overall Study|Death|0|||
25234218|NCT02457559|50545658|FG006|Overall Study|Death|0|||
25234219|NCT02457559|50545659|FG007|Overall Study|Death|0|||
25234220|NCT02457559|50545660|FG008|Overall Study|Death|1|||
25234221|NCT02457559|50545661|FG009|Overall Study|Death|1|||
25234222|NCT02457559|50545662|FG010|Overall Study|Death|0|||
25234223|NCT02381652|50545712|FG000|Overall Study|Withdrawal by Subject|0|||
25234224|NCT02381652|50545713|FG001|Overall Study|Withdrawal by Subject|0|||
25234225|NCT02381652|50545714|FG002|Overall Study|Withdrawal by Subject|1|||
25234226|NCT02367794|50545723|FG000|Overall Study|Death|252|||
25234227|NCT02367794|50545724|FG001|Overall Study|Death|245|||
25234228|NCT02367794|50545725|FG002|Overall Study|Death|243|||
25234229|NCT02367794|50545723|FG000|Overall Study|Lost to Follow-up|1|||
25234230|NCT02367794|50545724|FG001|Overall Study|Lost to Follow-up|2|||
25234231|NCT02367794|50545725|FG002|Overall Study|Lost to Follow-up|2|||
25234232|NCT02367794|50545723|FG000|Overall Study|Physician Decision|0|||
25234233|NCT02367794|50545724|FG001|Overall Study|Physician Decision|5|||
25234234|NCT02367794|50545725|FG002|Overall Study|Physician Decision|3|||
25234235|NCT02367794|50545723|FG000|Overall Study|Protocol Violation|1|||
25234236|NCT02367794|50545724|FG001|Overall Study|Protocol Violation|0|||
25234237|NCT02367794|50545725|FG002|Overall Study|Protocol Violation|1|||
25234238|NCT02367794|50545723|FG000|Overall Study|Withdrawal by Subject|25|||
25234239|NCT02367794|50545724|FG001|Overall Study|Withdrawal by Subject|12|||
25234240|NCT02367794|50545725|FG002|Overall Study|Withdrawal by Subject|20|||
25234241|NCT02367794|50545723|FG000|Overall Study|Brain metastasis|1|||
25234242|NCT02367794|50545724|FG001|Overall Study|Brain metastasis|0|||
25234243|NCT02367794|50545725|FG002|Overall Study|Brain metastasis|0|||
25234244|NCT02367794|50545723|FG000|Overall Study|Randomized in error|0|||
25234245|NCT02367794|50545724|FG001|Overall Study|Randomized in error|0|||
25234246|NCT02367794|50545725|FG002|Overall Study|Randomized in error|1|||
25234247|NCT02367794|50545723|FG000|Overall Study|Patient unable to receive carboplatin|0|||
25234248|NCT02367794|50545724|FG001|Overall Study|Patient unable to receive carboplatin|0|||
25234249|NCT02367794|50545725|FG002|Overall Study|Patient unable to receive carboplatin|1|||
25234250|NCT02367794|50545723|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
25234251|NCT02367794|50545724|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
25234252|NCT02367794|50545725|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
25234253|NCT02367794|50545723|FG000|Overall Study|Adverse Event|0|||
25234254|NCT02367794|50545724|FG001|Overall Study|Adverse Event|0|||
25234255|NCT02367794|50545725|FG002|Overall Study|Adverse Event|2|||
25234256|NCT02367794|50545723|FG000|Overall Study|Study Terminated By Sponsor|0|||
25234257|NCT02367794|50545724|FG001|Overall Study|Study Terminated By Sponsor|1|||
25234258|NCT02367794|50545725|FG002|Overall Study|Study Terminated By Sponsor|1|||
25234259|NCT02367794|50545723|FG000|Overall Study|Moved to Roll-Over Study|0|||
25234260|NCT02367794|50545724|FG001|Overall Study|Moved to Roll-Over Study|15|||
25234261|NCT02367794|50545725|FG002|Overall Study|Moved to Roll-Over Study|13|||
25234262|NCT02367794|50545723|FG000|Overall Study|Sponsor Request|60|||
25234263|NCT02367794|50545724|FG001|Overall Study|Sponsor Request|57|||
25234264|NCT02367794|50545725|FG002|Overall Study|Sponsor Request|45|||
24976675|NCT03449446|50065605|FG006|Overall Study|Withdrew Consent|1|||
25234265|NCT02367794|50545723|FG000|Overall Study|Moved into PTAP Study|0|||
25234266|NCT02367794|50545724|FG001|Overall Study|Moved into PTAP Study|2|||
25234267|NCT02367794|50545725|FG002|Overall Study|Moved into PTAP Study|3|||
25234268|NCT02367794|50545723|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
25234269|NCT02367794|50545724|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
25234270|NCT02367794|50545725|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
25234271|NCT02367794|50545723|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
25234272|NCT02367794|50545724|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
25234273|NCT02367794|50545725|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
25234274|NCT02367794|50545723|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
25234275|NCT02367794|50545724|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
24976676|NCT03449446|50065599|FG000|Overall Study|Adverse Event|1|||
25234276|NCT02367794|50545725|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
25234277|NCT02367794|50545723|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
25234278|NCT02367794|50545724|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
25234279|NCT02367794|50545725|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
25234280|NCT02353832|50545758|FG000|Overall Study|Ineligible after enrollment|1|||
25234281|NCT02353832|50545758|FG000|Overall Study|Lost to Follow-up|1|||
25234282|NCT02353728|50545762|FG000|Overall Study|Subject non-compliance|1|||
25234283|NCT02345070|50545769|FG000|Overall Study|Adverse Event|12|||
25234284|NCT02345070|50545770|FG001|Overall Study|Adverse Event|8|||
25234285|NCT02345070|50545771|FG002|Overall Study|Adverse Event|16|||
25234286|NCT02345070|50545769|FG000|Overall Study|Poor compliance to protocol|2|||
25234287|NCT02345070|50545770|FG001|Overall Study|Poor compliance to protocol|0|||
25234288|NCT02345070|50545771|FG002|Overall Study|Poor compliance to protocol|0|||
25234289|NCT02345070|50545769|FG000|Overall Study|Other than specified above|6|||
25234290|NCT02345070|50545770|FG001|Overall Study|Other than specified above|3|||
25234291|NCT02345070|50545771|FG002|Overall Study|Other than specified above|7|||
25234292|NCT02325466|50545779|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
25234293|NCT02325466|50545780|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
25234294|NCT02325466|50545781|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
25234295|NCT02325466|50545779|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
25234296|NCT02325466|50545780|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
25234297|NCT02325466|50545781|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
25234298|NCT02325466|50545779|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
25234299|NCT02325466|50545780|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
25234300|NCT02325466|50545781|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
25234301|NCT02325466|50545779|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
25234302|NCT02325466|50545780|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
25234303|NCT02325466|50545781|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
25234304|NCT02325466|50545779|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
25234305|NCT02325466|50545780|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
25234306|NCT02325466|50545781|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
25234307|NCT02325466|50545779|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
25234308|NCT02325466|50545780|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
25234309|NCT02325466|50545781|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
25234310|NCT02325466|50545779|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
25234311|NCT02325466|50545780|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
25234312|NCT02325466|50545781|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
25234313|NCT02325466|50545779|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
25234314|NCT02325466|50545780|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
25234315|NCT02325466|50545781|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
25234316|NCT02325466|50545779|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
25234317|NCT02325466|50545780|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
25234318|NCT02325466|50545781|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
25234319|NCT02322710|50545792|FG000|Overall Study|No efficacy assessment post-baseline|0|||
25234320|NCT02322710|50545793|FG001|Overall Study|No efficacy assessment post-baseline|1|||
25234321|NCT02322710|50545792|FG000|Overall Study|Protocol Violation|20|||
25234322|NCT02322710|50545793|FG001|Overall Study|Protocol Violation|25|||
25234323|NCT02234310|50545836|FG000|Overall Study|Physician Decision|1|||
25234324|NCT02234310|50545836|FG000|Overall Study|Adverse Event|1|||
25234325|NCT02234310|50545836|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
25234326|NCT02234310|50545836|FG000|Overall Study|Withdrawal by Subject|2|||
25234327|NCT02106195|50545869|FG000|Overall Study|Adverse Event|2|||
25234328|NCT02106195|50545869|FG000|Overall Study|Protocol Violation|1|||
25234329|NCT02104180|50545881|FG000|Overall Study|Protocol Violation|1|||
25234330|NCT02104180|50545882|FG001|Overall Study|Protocol Violation|0|||
25234331|NCT02040857|50545892|FG000|Overall Study|Adverse Event|14|||
25234332|NCT02040857|50545892|FG000|Overall Study|Physician Decision|5|||
25234333|NCT02040857|50545892|FG000|Overall Study|Withdrawal by Subject|31|||
25234334|NCT02040857|50545892|FG000|Overall Study|patient non-compliance|3|||
25234335|NCT02040857|50545892|FG000|Overall Study|Lost to Follow-up|2|||
25234336|NCT02040857|50545892|FG000|Overall Study|recurrence|4|||
25234337|NCT02040857|50545892|FG000|Overall Study|ineligible|1|||
25234338|NCT01943825|50545912|FG000|Overall Study|Lost to Follow-up|9|||
25234339|NCT01943825|50545913|FG001|Overall Study|Lost to Follow-up|3|||
25234340|NCT01943825|50545914|FG002|Overall Study|Lost to Follow-up|12|||
25234341|NCT01943825|50545915|FG003|Overall Study|Lost to Follow-up|8|||
25234342|NCT01943825|50545912|FG000|Overall Study|Withdrawal by Subject|1|||
25234343|NCT01943825|50545913|FG001|Overall Study|Withdrawal by Subject|0|||
25234344|NCT01943825|50545914|FG002|Overall Study|Withdrawal by Subject|3|||
25234345|NCT01943825|50545915|FG003|Overall Study|Withdrawal by Subject|2|||
25234346|NCT01943825|50545912|FG000|Overall Study|Other than specified above|0|||
25234347|NCT01943825|50545913|FG001|Overall Study|Other than specified above|1|||
25234348|NCT01943825|50545914|FG002|Overall Study|Other than specified above|0|||
25234349|NCT01943825|50545915|FG003|Overall Study|Other than specified above|1|||
25234350|NCT01722331|50545947|FG000|Part 1|Adverse Event|5|||
25234351|NCT01722331|50545948|FG001|Part 1|Adverse Event|0|||
25234352|NCT01722331|50545949|FG002|Part 1|Adverse Event|0|||
25234353|NCT01722331|50545950|FG003|Part 1|Adverse Event|0|||
25234354|NCT01722331|50545951|FG004|Part 1|Adverse Event|0|||
25234355|NCT01722331|50545952|FG005|Part 1|Adverse Event|0|||
25234356|NCT01722331|50545953|FG006|Part 1|Adverse Event|0|||
25234357|NCT01722331|50545947|FG000|Part 1|Lack of Efficacy|0|||
25234358|NCT01722331|50545948|FG001|Part 1|Lack of Efficacy|0|||
25234359|NCT01722331|50545949|FG002|Part 1|Lack of Efficacy|1|||
25234360|NCT01722331|50545950|FG003|Part 1|Lack of Efficacy|0|||
25234361|NCT01722331|50545951|FG004|Part 1|Lack of Efficacy|2|||
25234362|NCT01722331|50545952|FG005|Part 1|Lack of Efficacy|0|||
25234363|NCT01722331|50545953|FG006|Part 1|Lack of Efficacy|0|||
25234364|NCT01722331|50545947|FG000|Part 1|Lost to Follow-up|1|||
25234365|NCT01722331|50545948|FG001|Part 1|Lost to Follow-up|0|||
25234366|NCT01722331|50545949|FG002|Part 1|Lost to Follow-up|2|||
25234367|NCT01722331|50545950|FG003|Part 1|Lost to Follow-up|0|||
25234368|NCT01722331|50545951|FG004|Part 1|Lost to Follow-up|1|||
25234369|NCT01722331|50545952|FG005|Part 1|Lost to Follow-up|0|||
25234370|NCT01722331|50545953|FG006|Part 1|Lost to Follow-up|0|||
25234371|NCT01722331|50545947|FG000|Part 1|Physician Decision|0|||
25234372|NCT01722331|50545948|FG001|Part 1|Physician Decision|0|||
25234373|NCT01722331|50545949|FG002|Part 1|Physician Decision|3|||
25234374|NCT01722331|50545950|FG003|Part 1|Physician Decision|0|||
25234375|NCT01722331|50545951|FG004|Part 1|Physician Decision|1|||
25234376|NCT01722331|50545952|FG005|Part 1|Physician Decision|0|||
25234377|NCT01722331|50545953|FG006|Part 1|Physician Decision|0|||
25234378|NCT01722331|50545947|FG000|Part 1|Pregnancy|1|||
25234379|NCT01722331|50545948|FG001|Part 1|Pregnancy|0|||
25234380|NCT01722331|50545949|FG002|Part 1|Pregnancy|0|||
25234381|NCT01722331|50545950|FG003|Part 1|Pregnancy|0|||
25234382|NCT01722331|50545951|FG004|Part 1|Pregnancy|0|||
25234383|NCT01722331|50545952|FG005|Part 1|Pregnancy|0|||
25234384|NCT01722331|50545953|FG006|Part 1|Pregnancy|0|||
25234385|NCT01722331|50545947|FG000|Part 1|Progressive Disease|0|||
25234386|NCT01722331|50545948|FG001|Part 1|Progressive Disease|0|||
25234387|NCT01722331|50545949|FG002|Part 1|Progressive Disease|0|||
25234388|NCT01722331|50545950|FG003|Part 1|Progressive Disease|0|||
25234389|NCT01722331|50545951|FG004|Part 1|Progressive Disease|1|||
25234390|NCT01722331|50545952|FG005|Part 1|Progressive Disease|0|||
25234391|NCT01722331|50545953|FG006|Part 1|Progressive Disease|0|||
25234392|NCT01722331|50545947|FG000|Part 1|Protocol Violation|1|||
25234393|NCT01722331|50545948|FG001|Part 1|Protocol Violation|0|||
25234394|NCT01722331|50545949|FG002|Part 1|Protocol Violation|0|||
25234395|NCT01722331|50545950|FG003|Part 1|Protocol Violation|0|||
25234396|NCT01722331|50545951|FG004|Part 1|Protocol Violation|1|||
25234397|NCT01722331|50545952|FG005|Part 1|Protocol Violation|0|||
25234398|NCT01722331|50545953|FG006|Part 1|Protocol Violation|0|||
25234399|NCT01722331|50545947|FG000|Part 1|Withdrawal by Subject|2|||
25234400|NCT01722331|50545948|FG001|Part 1|Withdrawal by Subject|0|||
25234401|NCT01722331|50545949|FG002|Part 1|Withdrawal by Subject|3|||
25234402|NCT01722331|50545950|FG003|Part 1|Withdrawal by Subject|0|||
25234403|NCT01722331|50545951|FG004|Part 1|Withdrawal by Subject|3|||
25234404|NCT01722331|50545952|FG005|Part 1|Withdrawal by Subject|0|||
25234405|NCT01722331|50545953|FG006|Part 1|Withdrawal by Subject|0|||
25234406|NCT01722331|50545947|FG000|Part 2|Adverse Event|3|||
25234407|NCT01722331|50545948|FG001|Part 2|Adverse Event|0|||
25234408|NCT01722331|50545949|FG002|Part 2|Adverse Event|0|||
25234409|NCT01722331|50545950|FG003|Part 2|Adverse Event|0|||
25234410|NCT01722331|50545951|FG004|Part 2|Adverse Event|0|||
25234411|NCT01722331|50545952|FG005|Part 2|Adverse Event|1|||
25234412|NCT01722331|50545953|FG006|Part 2|Adverse Event|0|||
25234413|NCT01722331|50545947|FG000|Part 2|Lack of Efficacy|3|||
25234414|NCT01722331|50545948|FG001|Part 2|Lack of Efficacy|0|||
25234415|NCT01722331|50545949|FG002|Part 2|Lack of Efficacy|11|||
25234416|NCT01722331|50545950|FG003|Part 2|Lack of Efficacy|0|||
25234417|NCT01722331|50545951|FG004|Part 2|Lack of Efficacy|0|||
25234418|NCT01722331|50545952|FG005|Part 2|Lack of Efficacy|3|||
25234419|NCT01722331|50545953|FG006|Part 2|Lack of Efficacy|3|||
25234420|NCT01722331|50545947|FG000|Part 2|Lost to Follow-up|0|||
25234421|NCT01722331|50545948|FG001|Part 2|Lost to Follow-up|0|||
25234422|NCT01722331|50545949|FG002|Part 2|Lost to Follow-up|3|||
25234423|NCT01722331|50545950|FG003|Part 2|Lost to Follow-up|0|||
25234424|NCT01722331|50545951|FG004|Part 2|Lost to Follow-up|0|||
25319408|NCT00936065|50634921|FG002|Overall Study|Withdrawal by Subject|4|||
25234425|NCT01722331|50545952|FG005|Part 2|Lost to Follow-up|1|||
25234426|NCT01722331|50545953|FG006|Part 2|Lost to Follow-up|1|||
25234427|NCT01722331|50545947|FG000|Part 2|Non-Compliance with Study Drug|1|||
25234428|NCT01722331|50545948|FG001|Part 2|Non-Compliance with Study Drug|0|||
25234429|NCT01722331|50545949|FG002|Part 2|Non-Compliance with Study Drug|1|||
25234430|NCT01722331|50545950|FG003|Part 2|Non-Compliance with Study Drug|0|||
25234431|NCT01722331|50545951|FG004|Part 2|Non-Compliance with Study Drug|0|||
25234432|NCT01722331|50545952|FG005|Part 2|Non-Compliance with Study Drug|0|||
25234433|NCT01722331|50545953|FG006|Part 2|Non-Compliance with Study Drug|0|||
25234434|NCT01722331|50545947|FG000|Part 2|Physician Decision|0|||
25234435|NCT01722331|50545948|FG001|Part 2|Physician Decision|0|||
25234436|NCT01722331|50545949|FG002|Part 2|Physician Decision|2|||
25234437|NCT01722331|50545950|FG003|Part 2|Physician Decision|0|||
25234438|NCT01722331|50545951|FG004|Part 2|Physician Decision|0|||
25234439|NCT01722331|50545952|FG005|Part 2|Physician Decision|0|||
25234440|NCT01722331|50545953|FG006|Part 2|Physician Decision|0|||
25234441|NCT01722331|50545947|FG000|Part 2|Pregnancy|0|||
25234442|NCT01722331|50545948|FG001|Part 2|Pregnancy|0|||
25234443|NCT01722331|50545949|FG002|Part 2|Pregnancy|0|||
25234444|NCT01722331|50545950|FG003|Part 2|Pregnancy|0|||
25234445|NCT01722331|50545951|FG004|Part 2|Pregnancy|0|||
25234446|NCT01722331|50545952|FG005|Part 2|Pregnancy|1|||
25234447|NCT01722331|50545953|FG006|Part 2|Pregnancy|0|||
25234448|NCT01722331|50545947|FG000|Part 2|Progressive Disease|0|||
25234449|NCT01722331|50545948|FG001|Part 2|Progressive Disease|0|||
25234450|NCT01722331|50545949|FG002|Part 2|Progressive Disease|1|||
25234451|NCT01722331|50545950|FG003|Part 2|Progressive Disease|0|||
25234452|NCT01722331|50545951|FG004|Part 2|Progressive Disease|0|||
25234453|NCT01722331|50545952|FG005|Part 2|Progressive Disease|0|||
25234454|NCT01722331|50545953|FG006|Part 2|Progressive Disease|0|||
25234455|NCT01722331|50545947|FG000|Part 2|Protocol Violation|1|||
25234456|NCT01722331|50545948|FG001|Part 2|Protocol Violation|0|||
25234457|NCT01722331|50545949|FG002|Part 2|Protocol Violation|0|||
25234458|NCT01722331|50545950|FG003|Part 2|Protocol Violation|0|||
25234459|NCT01722331|50545951|FG004|Part 2|Protocol Violation|0|||
25234460|NCT01722331|50545952|FG005|Part 2|Protocol Violation|0|||
25234461|NCT01722331|50545953|FG006|Part 2|Protocol Violation|0|||
25234462|NCT01722331|50545947|FG000|Part 2|Withdrawal by Subject|5|||
25234463|NCT01722331|50545948|FG001|Part 2|Withdrawal by Subject|0|||
25234464|NCT01722331|50545949|FG002|Part 2|Withdrawal by Subject|3|||
25234465|NCT01722331|50545950|FG003|Part 2|Withdrawal by Subject|0|||
25234466|NCT01722331|50545951|FG004|Part 2|Withdrawal by Subject|0|||
25234467|NCT01722331|50545952|FG005|Part 2|Withdrawal by Subject|2|||
25234468|NCT01722331|50545953|FG006|Part 2|Withdrawal by Subject|2|||
25234469|NCT01722331|50545947|FG000|Part 2|Other Protocol Specified Criteria|6|||
25234470|NCT01722331|50545948|FG001|Part 2|Other Protocol Specified Criteria|0|||
25234471|NCT01722331|50545949|FG002|Part 2|Other Protocol Specified Criteria|10|||
25234472|NCT01722331|50545950|FG003|Part 2|Other Protocol Specified Criteria|0|||
25234473|NCT01722331|50545951|FG004|Part 2|Other Protocol Specified Criteria|0|||
25234474|NCT01722331|50545952|FG005|Part 2|Other Protocol Specified Criteria|2|||
25234475|NCT01722331|50545953|FG006|Part 2|Other Protocol Specified Criteria|1|||
25234476|NCT01722331|50545947|FG000|Part 3|Adverse Event|2|||
25234477|NCT01722331|50545948|FG001|Part 3|Adverse Event|2|||
25234478|NCT01722331|50545949|FG002|Part 3|Adverse Event|0|||
25234479|NCT01722331|50545950|FG003|Part 3|Adverse Event|1|||
25234480|NCT01722331|50545951|FG004|Part 3|Adverse Event|0|||
25234481|NCT01722331|50545952|FG005|Part 3|Adverse Event|0|||
25234482|NCT01722331|50545953|FG006|Part 3|Adverse Event|0|||
25234483|NCT01722331|50545947|FG000|Part 3|Death|1|||
25234484|NCT01722331|50545948|FG001|Part 3|Death|0|||
25234485|NCT01722331|50545949|FG002|Part 3|Death|0|||
25234486|NCT01722331|50545950|FG003|Part 3|Death|0|||
25234487|NCT01722331|50545951|FG004|Part 3|Death|0|||
25234488|NCT01722331|50545952|FG005|Part 3|Death|0|||
25234489|NCT01722331|50545953|FG006|Part 3|Death|0|||
25234490|NCT01722331|50545947|FG000|Part 3|Lack of Efficacy|1|||
25234491|NCT01722331|50545948|FG001|Part 3|Lack of Efficacy|0|||
25234492|NCT01722331|50545949|FG002|Part 3|Lack of Efficacy|0|||
25234493|NCT01722331|50545950|FG003|Part 3|Lack of Efficacy|0|||
25234494|NCT01722331|50545951|FG004|Part 3|Lack of Efficacy|0|||
25234495|NCT01722331|50545952|FG005|Part 3|Lack of Efficacy|0|||
25234496|NCT01722331|50545953|FG006|Part 3|Lack of Efficacy|0|||
25234497|NCT01722331|50545947|FG000|Part 3|Lost to Follow-up|3|||
25234498|NCT01722331|50545948|FG001|Part 3|Lost to Follow-up|4|||
25234499|NCT01722331|50545949|FG002|Part 3|Lost to Follow-up|0|||
25234500|NCT01722331|50545950|FG003|Part 3|Lost to Follow-up|0|||
25234501|NCT01722331|50545951|FG004|Part 3|Lost to Follow-up|0|||
25234502|NCT01722331|50545952|FG005|Part 3|Lost to Follow-up|1|||
25234503|NCT01722331|50545953|FG006|Part 3|Lost to Follow-up|0|||
25234504|NCT01722331|50545947|FG000|Part 3|Non-Compliance with Study Drug|0|||
25234505|NCT01722331|50545948|FG001|Part 3|Non-Compliance with Study Drug|1|||
25234506|NCT01722331|50545949|FG002|Part 3|Non-Compliance with Study Drug|0|||
25234507|NCT01722331|50545950|FG003|Part 3|Non-Compliance with Study Drug|0|||
25234508|NCT01722331|50545951|FG004|Part 3|Non-Compliance with Study Drug|0|||
25234509|NCT01722331|50545952|FG005|Part 3|Non-Compliance with Study Drug|0|||
25234510|NCT01722331|50545953|FG006|Part 3|Non-Compliance with Study Drug|0|||
25234511|NCT01722331|50545947|FG000|Part 3|Physician Decision|1|||
25234512|NCT01722331|50545948|FG001|Part 3|Physician Decision|1|||
25234513|NCT01722331|50545949|FG002|Part 3|Physician Decision|0|||
25234514|NCT01722331|50545950|FG003|Part 3|Physician Decision|0|||
25234515|NCT01722331|50545951|FG004|Part 3|Physician Decision|0|||
25234516|NCT01722331|50545952|FG005|Part 3|Physician Decision|0|||
25234517|NCT01722331|50545953|FG006|Part 3|Physician Decision|1|||
25234518|NCT01722331|50545947|FG000|Part 3|Protocol Violation|2|||
25234519|NCT01722331|50545948|FG001|Part 3|Protocol Violation|1|||
25234520|NCT01722331|50545949|FG002|Part 3|Protocol Violation|0|||
25234521|NCT01722331|50545950|FG003|Part 3|Protocol Violation|0|||
25234522|NCT01722331|50545951|FG004|Part 3|Protocol Violation|0|||
25234523|NCT01722331|50545952|FG005|Part 3|Protocol Violation|0|||
25234524|NCT01722331|50545953|FG006|Part 3|Protocol Violation|0|||
25234525|NCT01722331|50545947|FG000|Part 3|Withdrawal by Subject|4|||
25234526|NCT01722331|50545948|FG001|Part 3|Withdrawal by Subject|7|||
25234527|NCT01722331|50545949|FG002|Part 3|Withdrawal by Subject|0|||
25234528|NCT01722331|50545950|FG003|Part 3|Withdrawal by Subject|0|||
25234529|NCT01722331|50545951|FG004|Part 3|Withdrawal by Subject|0|||
25234530|NCT01722331|50545952|FG005|Part 3|Withdrawal by Subject|2|||
25234531|NCT01722331|50545953|FG006|Part 3|Withdrawal by Subject|1|||
25234532|NCT01722331|50545947|FG000|Part 3|Other Protocol Specified Criteria|1|||
25234533|NCT01722331|50545948|FG001|Part 3|Other Protocol Specified Criteria|1|||
25234534|NCT01722331|50545949|FG002|Part 3|Other Protocol Specified Criteria|0|||
25234535|NCT01722331|50545950|FG003|Part 3|Other Protocol Specified Criteria|0|||
25234536|NCT01722331|50545951|FG004|Part 3|Other Protocol Specified Criteria|0|||
25234537|NCT01722331|50545952|FG005|Part 3|Other Protocol Specified Criteria|0|||
25234538|NCT01722331|50545953|FG006|Part 3|Other Protocol Specified Criteria|0|||
25234539|NCT01630590|50545965|FG000|Overall Study|Adverse Event|9|||
25234540|NCT01630590|50545965|FG000|Overall Study|Lack of Efficacy|37|||
25234541|NCT01630590|50545965|FG000|Overall Study|Withdrawal by Subject|4|||
25234542|NCT01630590|50545965|FG000|Overall Study|2nd primary tumor|2|||
25234543|NCT01630590|50545965|FG000|Overall Study|Automobile accident|1|||
25234544|NCT01630590|50545965|FG000|Overall Study|Maximum benefit|4|||
25234545|NCT01619085|50545969|FG000|Overall Study|Adverse Event|231|||
25234546|NCT01619085|50545969|FG000|Overall Study|Protocol Violation|4|||
25234547|NCT01619085|50545969|FG000|Overall Study|Lost to Follow-up|3|||
25234548|NCT01619085|50545969|FG000|Overall Study|Withdrawal by Subject|45|||
25234549|NCT01619085|50545969|FG000|Overall Study|Other than specified|96|||
25234550|NCT01619085|50545969|FG000|Overall Study|Not treated|1|||
25234551|NCT01619085|50545969|FG000|Overall Study|Death|145|||
25234552|NCT01499095|50545982|FG000|Overall Study|Randomized But Not Treated|1|||
25234553|NCT01499095|50545983|FG001|Overall Study|Randomized But Not Treated|1|||
25234554|NCT01499095|50545982|FG000|Overall Study|Adverse Event|12|||
25234555|NCT01499095|50545983|FG001|Overall Study|Adverse Event|7|||
25234556|NCT01499095|50545982|FG000|Overall Study|Lack of Efficacy|2|||
25234557|NCT01499095|50545983|FG001|Overall Study|Lack of Efficacy|1|||
25234558|NCT01499095|50545982|FG000|Overall Study|Protocol Violation|6|||
25234559|NCT01499095|50545983|FG001|Overall Study|Protocol Violation|7|||
25234560|NCT01499095|50545982|FG000|Overall Study|Received Rescue Therapy|32|||
25234561|NCT01499095|50545983|FG001|Overall Study|Received Rescue Therapy|40|||
25234562|NCT01499095|50545982|FG000|Overall Study|Diverse Reasons|22|||
25234563|NCT01499095|50545983|FG001|Overall Study|Diverse Reasons|25|||
25234564|NCT01499095|50545982|FG000|Overall Study|Lost to Follow-up|6|||
25234565|NCT01499095|50545983|FG001|Overall Study|Lost to Follow-up|4|||
25234566|NCT01499095|50545982|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
25234567|NCT01499095|50545983|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
25234568|NCT01499095|50545982|FG000|Overall Study|Hypoglycemia|3|||
25234569|NCT01499095|50545983|FG001|Overall Study|Hypoglycemia|1|||
25234570|NCT01499095|50545982|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
25234571|NCT01499095|50545983|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
25234572|NCT01499095|50545982|FG000|Overall Study|Change in Injection Schedule|2|||
25234573|NCT01499095|50545983|FG001|Overall Study|Change in Injection Schedule|0|||
25234574|NCT01499095|50545982|FG000|Overall Study|Perceived Lack of Efficacy|1|||
25234575|NCT01499095|50545983|FG001|Overall Study|Perceived Lack of Efficacy|1|||
25234576|NCT01499082|50545994|FG000|Overall Study|Randomized but not Treated|0|||
25234577|NCT01499082|50545995|FG001|Overall Study|Randomized but not Treated|1|||
25234578|NCT01499082|50545994|FG000|Overall Study|Adverse Event|12|||
25234579|NCT01499082|50545995|FG001|Overall Study|Adverse Event|16|||
25234580|NCT01499082|50545994|FG000|Overall Study|Lack of Efficacy|1|||
25234581|NCT01499082|50545995|FG001|Overall Study|Lack of Efficacy|1|||
25234582|NCT01499082|50545994|FG000|Overall Study|Protocol Violation|6|||
25234583|NCT01499082|50545995|FG001|Overall Study|Protocol Violation|8|||
25234584|NCT01499082|50545994|FG000|Overall Study|Diverse Reasons|18|||
25234585|NCT01499082|50545995|FG001|Overall Study|Diverse Reasons|14|||
25234586|NCT01499082|50545994|FG000|Overall Study|Site Closure for Noncompliance|5|||
25234587|NCT01499082|50545995|FG001|Overall Study|Site Closure for Noncompliance|2|||
25234588|NCT01499082|50545994|FG000|Overall Study|Hypoglycemia|2|||
25234589|NCT01499082|50545995|FG001|Overall Study|Hypoglycemia|3|||
25234590|NCT01499082|50545994|FG000|Overall Study|Lost to Follow-up|1|||
25234591|NCT01499082|50545995|FG001|Overall Study|Lost to Follow-up|3|||
25234592|NCT01488890|50546007|FG000|Overall Study|Serious adverse event|2|||
25234593|NCT01488890|50546008|FG001|Overall Study|Serious adverse event|0|||
25234594|NCT01488890|50546009|FG002|Overall Study|Serious adverse event|0|||
25234595|NCT01488890|50546010|FG003|Overall Study|Serious adverse event|0|||
25234596|NCT01488890|50546007|FG000|Overall Study|Protocol Violation|3|||
25234597|NCT01488890|50546008|FG001|Overall Study|Protocol Violation|0|||
25234598|NCT01488890|50546009|FG002|Overall Study|Protocol Violation|4|||
25234599|NCT01488890|50546010|FG003|Overall Study|Protocol Violation|0|||
25234600|NCT01488890|50546007|FG000|Overall Study|Lost to Follow-up|13|||
25234601|NCT01488890|50546008|FG001|Overall Study|Lost to Follow-up|10|||
25234602|NCT01488890|50546009|FG002|Overall Study|Lost to Follow-up|20|||
25234603|NCT01488890|50546010|FG003|Overall Study|Lost to Follow-up|3|||
25234604|NCT01488890|50546007|FG000|Overall Study|Withdrawal by Subject|14|||
25234605|NCT01488890|50546008|FG001|Overall Study|Withdrawal by Subject|10|||
25234606|NCT01488890|50546009|FG002|Overall Study|Withdrawal by Subject|11|||
25234607|NCT01488890|50546010|FG003|Overall Study|Withdrawal by Subject|2|||
25234608|NCT01436396|50546026|FG000|Overall Study|Protocol Violation|7|||
25234609|NCT01436396|50546027|FG001|Overall Study|Protocol Violation|5|||
25234610|NCT01436396|50546026|FG000|Overall Study|Adverse Event|1|||
25234611|NCT01436396|50546027|FG001|Overall Study|Adverse Event|2|||
25234612|NCT01436396|50546026|FG000|Overall Study|Withdrawal by Subject|19|||
25234613|NCT01436396|50546027|FG001|Overall Study|Withdrawal by Subject|29|||
25234614|NCT01436396|50546026|FG000|Overall Study|Serious adverse event|2|||
25234615|NCT01436396|50546027|FG001|Overall Study|Serious adverse event|3|||
25234616|NCT01436396|50546026|FG000|Overall Study|Lost to Follow-up|3|||
25234617|NCT01436396|50546027|FG001|Overall Study|Lost to Follow-up|3|||
25234618|NCT01411241|50546035|FG000|Overall Study|Protocol Violation|0|||
25234619|NCT01411241|50546036|FG001|Overall Study|Protocol Violation|5|||
25234620|NCT01411241|50546035|FG000|Overall Study|Withdrawal by Subject|9|||
25234621|NCT01411241|50546036|FG001|Overall Study|Withdrawal by Subject|10|||
25234622|NCT01411241|50546035|FG000|Overall Study|Serious Adverse Event|0|||
25234623|NCT01411241|50546036|FG001|Overall Study|Serious Adverse Event|3|||
25234624|NCT01411241|50546035|FG000|Overall Study|Lost to Follow-up|2|||
25234625|NCT01411241|50546036|FG001|Overall Study|Lost to Follow-up|4|||
25234626|NCT01374516|50546044|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
25234627|NCT01374516|50546045|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
25234628|NCT01374516|50546044|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
25234629|NCT01374516|50546045|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
25234630|NCT01374516|50546044|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
25234631|NCT01374516|50546045|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
25234632|NCT01374516|50546044|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
25234633|NCT01374516|50546045|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
25234634|NCT01374516|50546044|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
25234635|NCT01374516|50546045|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
25234636|NCT01374516|50546044|FG000|Surveillance Expansion Period|Protocol Violation|386|||
25234637|NCT01374516|50546045|FG001|Surveillance Expansion Period|Protocol Violation|217|||
25234638|NCT01374516|50546044|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
25234639|NCT01374516|50546045|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
25234640|NCT01374516|50546044|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
25234641|NCT01374516|50546045|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
25234642|NCT01374516|50546044|FG000|Surveillance Expansion Period|Serious adverse event|20|||
25234643|NCT01374516|50546045|FG001|Surveillance Expansion Period|Serious adverse event|5|||
25234644|NCT01373281|50546060|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
25234645|NCT01373281|50546061|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
25234646|NCT01373281|50546060|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
25234647|NCT01373281|50546061|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
25234648|NCT01373281|50546060|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
25234649|NCT01373281|50546061|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
25234650|NCT01373281|50546060|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
25234651|NCT01373281|50546061|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
25234652|NCT01373281|50546060|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
25234653|NCT01373281|50546061|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
25234654|NCT01373281|50546060|FG000|Surveillance Expansion Period|Protocol Violation|9|||
25234655|NCT01373281|50546061|FG001|Surveillance Expansion Period|Protocol Violation|1|||
25234656|NCT01373281|50546060|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
25234657|NCT01373281|50546061|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
25234658|NCT01373281|50546060|FG000|Surveillance Expansion Period|Serious adverse event|3|||
25234659|NCT01373281|50546061|FG001|Surveillance Expansion Period|Serious adverse event|4|||
25234660|NCT01287611|50546076|FG000|Overall Study|Lost to Follow-up|29|||
25234661|NCT01287611|50546077|FG001|Overall Study|Lost to Follow-up|16|||
25234662|NCT01287611|50546076|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
25234663|NCT01287611|50546077|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
25234664|NCT01254422|50546087|FG000|Overall Study|Protocol Violation|1|||
25234665|NCT01254422|50546088|FG001|Overall Study|Protocol Violation|0|||
25234666|NCT01254422|50546087|FG000|Overall Study|Adverse Event|1|||
25234667|NCT01254422|50546088|FG001|Overall Study|Adverse Event|0|||
25234668|NCT01254422|50546087|FG000|Overall Study|Serious adverse event|0|||
25234669|NCT01254422|50546088|FG001|Overall Study|Serious adverse event|1|||
25234670|NCT01254422|50546087|FG000|Overall Study|Lost to Follow-up|1|||
25234671|NCT01254422|50546088|FG001|Overall Study|Lost to Follow-up|0|||
25234672|NCT01187433|50546096|FG000|Overall Study|Protocol Violation|6|||
25234673|NCT01187433|50546097|FG001|Overall Study|Protocol Violation|2|||
25234674|NCT01187433|50546096|FG000|Overall Study|Withdrawal by Subject|5|||
25234675|NCT01187433|50546097|FG001|Overall Study|Withdrawal by Subject|2|||
25234676|NCT01150045|50546107|FG000|Overall Study|Protocol Violation|0|||
25234677|NCT01150045|50546108|FG001|Overall Study|Protocol Violation|1|||
25234678|NCT01150045|50546109|FG002|Overall Study|Protocol Violation|0|||
25234679|NCT01150045|50546110|FG003|Overall Study|Protocol Violation|1|||
25234680|NCT01098032|50546120|FG000|Overall Study|Withdrawal by Subject|1|||
25234681|NCT01098032|50546121|FG001|Overall Study|Withdrawal by Subject|1|||
25234682|NCT01034306|50546129|FG000|Overall Study|Adverse Event|1|||
25234683|NCT01034306|50546130|FG001|Overall Study|Adverse Event|0|||
25234684|NCT01034306|50546129|FG000|Overall Study|Lost to Follow-up|0|||
25234685|NCT01034306|50546130|FG001|Overall Study|Lost to Follow-up|1|||
25234686|NCT01034306|50546129|FG000|Overall Study|Withdrawal by Subject|2|||
25234687|NCT01034306|50546130|FG001|Overall Study|Withdrawal by Subject|2|||
25234688|NCT01034306|50546129|FG000|Overall Study|hospitalized and decided to stop|1|||
25234689|NCT01034306|50546130|FG001|Overall Study|hospitalized and decided to stop|0|||
25234690|NCT01034306|50546129|FG000|Overall Study|Noncomplience|1|||
25234691|NCT01034306|50546130|FG001|Overall Study|Noncomplience|0|||
25234692|NCT00993447|50546138|FG000|Overall Study|Withdrawal by Subject|23|||
25234693|NCT00993447|50546139|FG001|Overall Study|Withdrawal by Subject|8|||
25234694|NCT00993447|50546138|FG000|Overall Study|Protocol Violation|12|||
25234695|NCT00993447|50546139|FG001|Overall Study|Protocol Violation|8|||
25234696|NCT00993447|50546138|FG000|Overall Study|Lost to Follow-up|1|||
25234697|NCT00993447|50546139|FG001|Overall Study|Lost to Follow-up|3|||
25234698|NCT00993447|50546138|FG000|Overall Study|Adverse Event|1|||
25234699|NCT00993447|50546139|FG001|Overall Study|Adverse Event|0|||
25234700|NCT00945009|50546148|FG000|Overall Study|Lack of Efficacy|10|||
25234701|NCT00945009|50546149|FG001|Overall Study|Lack of Efficacy|0|||
25234702|NCT00945009|50546150|FG002|Overall Study|Lack of Efficacy|0|||
25234703|NCT00945009|50546148|FG000|Overall Study|Physician Decision|21|||
25234704|NCT00945009|50546149|FG001|Overall Study|Physician Decision|4|||
25234705|NCT00945009|50546150|FG002|Overall Study|Physician Decision|3|||
25234706|NCT00945009|50546148|FG000|Overall Study|Protocol Violation|6|||
25234707|NCT00945009|50546149|FG001|Overall Study|Protocol Violation|1|||
25234708|NCT00945009|50546150|FG002|Overall Study|Protocol Violation|0|||
25234709|NCT00945009|50546148|FG000|Overall Study|Withdrawal by Subject|1|||
25234710|NCT00945009|50546149|FG001|Overall Study|Withdrawal by Subject|0|||
25234711|NCT00945009|50546150|FG002|Overall Study|Withdrawal by Subject|0|||
25234712|NCT00945009|50546148|FG000|Overall Study|Ineligible|6|||
25234713|NCT00945009|50546149|FG001|Overall Study|Ineligible|1|||
25234714|NCT00945009|50546150|FG002|Overall Study|Ineligible|0|||
25234715|NCT00945009|50546148|FG000|Overall Study|Inevaluable|0|||
25234716|NCT00945009|50546149|FG001|Overall Study|Inevaluable|1|||
25234717|NCT00945009|50546150|FG002|Overall Study|Inevaluable|0|||
25234718|NCT00945009|50546148|FG000|Overall Study|Refusal of further protocol|1|||
25234719|NCT00945009|50546149|FG001|Overall Study|Refusal of further protocol|0|||
25234720|NCT00945009|50546150|FG002|Overall Study|Refusal of further protocol|0|||
25234721|NCT00942877|50546160|FG000|Overall Study|Refused further treatment|1|||
25234722|NCT00942877|50546161|FG001|Overall Study|Refused further treatment|1|||
25077505|NCT00002663|50185277|FG002|Overall Study|Adverse Event|0|||
25077506|NCT00002663|50185278|FG003|Overall Study|Adverse Event|1|||
25077507|NCT00002663|50185279|FG004|Overall Study|Adverse Event|0|||
25077508|NCT00002663|50185280|FG005|Overall Study|Adverse Event|0|||
25077509|NCT00002663|50185281|FG006|Overall Study|Adverse Event|0|||
25077510|NCT00002663|50185282|FG007|Overall Study|Adverse Event|1|||
25077511|NCT00002663|50185283|FG008|Overall Study|Adverse Event|0|||
25077512|NCT00002663|50185284|FG009|Overall Study|Adverse Event|0|||
25077513|NCT02240680|50185295|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
25234723|NCT00942877|50546160|FG000|Overall Study|Patient was not treated|1|||
25234724|NCT00942877|50546161|FG001|Overall Study|Patient was not treated|0|||
25234725|NCT00942877|50546160|FG000|Overall Study|Adverse Event|1|||
25234726|NCT00942877|50546161|FG001|Overall Study|Adverse Event|0|||
25234727|NCT00942877|50546160|FG000|Overall Study|Progressive disease|42|||
25234728|NCT00942877|50546161|FG001|Overall Study|Progressive disease|3|||
25234729|NCT00880893|50546176|FG000|Overall Study|Protocol Violation|13|||
25234730|NCT00880893|50546177|FG001|Overall Study|Protocol Violation|1|||
25234731|NCT00880893|50546176|FG000|Overall Study|Withdrawal by Subject|15|||
25234732|NCT00880893|50546177|FG001|Overall Study|Withdrawal by Subject|11|||
25234733|NCT00880893|50546176|FG000|Overall Study|Lost to Follow-up|76|||
25234734|NCT00880893|50546177|FG001|Overall Study|Lost to Follow-up|33|||
25234735|NCT00880893|50546176|FG000|Overall Study|Serious adverse event|3|||
25077514|NCT02240680|50185296|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
25077515|NCT02240680|50185297|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
25077516|NCT02240680|50185298|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
25234736|NCT00880893|50546177|FG001|Overall Study|Serious adverse event|0|||
25234737|NCT00587301|50546183|FG000|Overall Study|Screen Failure|9|||
25234738|NCT00587301|50546183|FG000|Overall Study|Lost to Follow-up|22|||
25234739|NCT00587301|50546183|FG000|Overall Study|Withdrawal by Subject|7|||
25234740|NCT00587301|50546183|FG000|Overall Study|Protocol Violation|7|||
25234741|NCT00579527|50546187|FG000|Overall Study|Death|4|||
25234742|NCT00576836|50546192|FG000|Overall Study|Death|0|||
25234743|NCT00576836|50546193|FG001|Overall Study|Death|1|||
25234744|NCT00576836|50546192|FG000|Overall Study|Physician Decision|0|||
25234745|NCT00576836|50546193|FG001|Overall Study|Physician Decision|1|||
25234746|NCT00576407|50546197|FG000|Overall Study|Death|7|||
25234747|NCT00576407|50546197|FG000|Overall Study|Physician Decision|1|||
25234748|NCT00531232|50546205|FG000|Overall Study|Investigator decision|0|||
25234749|NCT00531232|50546206|FG001|Overall Study|Investigator decision|0|||
25234750|NCT00531232|50546207|FG002|Overall Study|Investigator decision|4|||
25234751|NCT00531232|50546205|FG000|Overall Study|Participants refused further treatment|0|||
25234752|NCT00531232|50546206|FG001|Overall Study|Participants refused further treatment|1|||
25234753|NCT00531232|50546207|FG002|Overall Study|Participants refused further treatment|2|||
25234754|NCT00531232|50546205|FG000|Overall Study|Adverse events (AEs)|1|||
25234755|NCT00531232|50546206|FG001|Overall Study|Adverse events (AEs)|2|||
25234756|NCT00531232|50546207|FG002|Overall Study|Adverse events (AEs)|2|||
25234757|NCT00531232|50546205|FG000|Overall Study|Treatment failure|1|||
25234758|NCT00531232|50546206|FG001|Overall Study|Treatment failure|3|||
25234759|NCT00531232|50546207|FG002|Overall Study|Treatment failure|7|||
25234760|NCT00531232|50546205|FG000|Overall Study|Disease recurrence|0|||
25234761|NCT00531232|50546206|FG001|Overall Study|Disease recurrence|0|||
25234762|NCT00531232|50546207|FG002|Overall Study|Disease recurrence|1|||
25234763|NCT00531232|50546205|FG000|Overall Study|Deceased|2|||
25234764|NCT00531232|50546206|FG001|Overall Study|Deceased|2|||
25234765|NCT00531232|50546207|FG002|Overall Study|Deceased|2|||
25234766|NCT00531232|50546205|FG000|Overall Study|Withdrawal by Subject|0|||
25234767|NCT00531232|50546206|FG001|Overall Study|Withdrawal by Subject|1|||
25234768|NCT00531232|50546207|FG002|Overall Study|Withdrawal by Subject|2|||
25234769|NCT00531232|50546205|FG000|Overall Study|Other|0|||
25234770|NCT00531232|50546206|FG001|Overall Study|Other|0|||
25234771|NCT00531232|50546207|FG002|Overall Study|Other|5|||
25234772|NCT01701583|50546220|FG000|Overall Study|Withdrawal by Subject|2|||
25234773|NCT01701583|50546221|FG001|Overall Study|Withdrawal by Subject|0|||
25234774|NCT01714817|50546230|FG000|Year 1 Period|Lack of Efficacy|11|||
25234775|NCT01714817|50546231|FG001|Year 1 Period|Lack of Efficacy|9|||
25234776|NCT01714817|50546230|FG000|Year 1 Period|Adverse Event|20|||
25234777|NCT01714817|50546231|FG001|Year 1 Period|Adverse Event|17|||
25234778|NCT01714817|50546230|FG000|Year 1 Period|Withdrawal by Subject|6|||
25234779|NCT01714817|50546231|FG001|Year 1 Period|Withdrawal by Subject|7|||
25234780|NCT01714817|50546230|FG000|Year 1 Period|Death|1|||
25234781|NCT01714817|50546231|FG001|Year 1 Period|Death|1|||
25234782|NCT01714817|50546230|FG000|Year 1 Period|Lost to Follow-up|0|||
25319409|NCT04441788|50634932|FG000|Overall Study|Voluntary Withdrawl|0|||
25319410|NCT04441788|50634933|FG001|Overall Study|Voluntary Withdrawl|1|||
25319411|NCT04441788|50634934|FG002|Overall Study|Voluntary Withdrawl|0|||
25319412|NCT04441788|50634932|FG000|Overall Study|Ineligibility|1|||
25319413|NCT04441788|50634933|FG001|Overall Study|Ineligibility|0|||
25319414|NCT04441788|50634934|FG002|Overall Study|Ineligibility|0|||
25319415|NCT04441788|50634932|FG000|Overall Study|Adverse Event|0|||
25319416|NCT04441788|50634933|FG001|Overall Study|Adverse Event|0|||
25319417|NCT04441788|50634934|FG002|Overall Study|Adverse Event|4|||
25319418|NCT04441788|50634932|FG000|Overall Study|Study Terminated by Sponsor|16|||
25319419|NCT04441788|50634933|FG001|Overall Study|Study Terminated by Sponsor|16|||
25319420|NCT04441788|50634934|FG002|Overall Study|Study Terminated by Sponsor|12|||
25319421|NCT00604825|50634950|FG000|Overall Study|Adverse Event|2|||
25319422|NCT00604825|50634951|FG001|Overall Study|Adverse Event|6|||
25319423|NCT00604825|50634952|FG002|Overall Study|Adverse Event|7|||
25319424|NCT00604825|50634953|FG003|Overall Study|Adverse Event|4|||
25319425|NCT00604825|50634950|FG000|Overall Study|Lost to Follow-up|0|||
25319426|NCT00604825|50634951|FG001|Overall Study|Lost to Follow-up|3|||
25319427|NCT00604825|50634952|FG002|Overall Study|Lost to Follow-up|1|||
25319428|NCT00604825|50634953|FG003|Overall Study|Lost to Follow-up|0|||
25234783|NCT01714817|50546231|FG001|Year 1 Period|Lost to Follow-up|2|||
25234784|NCT01714817|50546230|FG000|Year 1 Period|Poor / non-compliance|0|||
25319429|NCT00604825|50634950|FG000|Overall Study|Protocol Violation|0|||
25319430|NCT00604825|50634951|FG001|Overall Study|Protocol Violation|1|||
25319431|NCT00604825|50634952|FG002|Overall Study|Protocol Violation|0|||
25319432|NCT00604825|50634953|FG003|Overall Study|Protocol Violation|0|||
25077517|NCT02240680|50185295|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
25234785|NCT01714817|50546231|FG001|Year 1 Period|Poor / non-compliance|1|||
25234786|NCT01714817|50546230|FG000|Year 1 Period|Pregnancy|2|||
25319433|NCT00604825|50634950|FG000|Overall Study|Withdrawal by Subject|4|||
25319434|NCT00604825|50634951|FG001|Overall Study|Withdrawal by Subject|3|||
25234787|NCT01714817|50546231|FG001|Year 1 Period|Pregnancy|0|||
25234788|NCT01714817|50546230|FG000|Year 1 Period|Participant no longer meets criteria|6|||
25234789|NCT01714817|50546231|FG001|Year 1 Period|Participant no longer meets criteria|2|||
25234790|NCT01714817|50546230|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
25234791|NCT01714817|50546231|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
25234792|NCT01714817|50546230|FG000|Year 1 Period|Change in Concomitant Medication|0|||
25234793|NCT01714817|50546231|FG001|Year 1 Period|Change in Concomitant Medication|1|||
25234794|NCT01714817|50546230|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
25234795|NCT01714817|50546231|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
25234796|NCT01714817|50546230|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
25234797|NCT01714817|50546231|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
25234798|NCT01714817|50546230|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
25234799|NCT01714817|50546231|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
25234800|NCT01714817|50546230|FG000|Year 2 Period|Lack of Efficacy|4|||
25234801|NCT01714817|50546231|FG001|Year 2 Period|Lack of Efficacy|12|||
25234802|NCT01714817|50546230|FG000|Year 2 Period|Adverse Event|7|||
25234803|NCT01714817|50546231|FG001|Year 2 Period|Adverse Event|6|||
25234804|NCT01714817|50546230|FG000|Year 2 Period|Participant request to stop treatment|4|||
25234805|NCT01714817|50546231|FG001|Year 2 Period|Participant request to stop treatment|4|||
25234806|NCT01714817|50546230|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
25234807|NCT01714817|50546231|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
25234808|NCT01714817|50546230|FG000|Year 2 Period|Participant withdrew consent|1|||
25234809|NCT01714817|50546231|FG001|Year 2 Period|Participant withdrew consent|5|||
25234810|NCT01714817|50546230|FG000|Year 2 Period|Participant no longer meets criteria|1|||
25234811|NCT01714817|50546231|FG001|Year 2 Period|Participant no longer meets criteria|4|||
25234812|NCT01714817|50546230|FG000|Year 2 Period|Lost to Follow-up|2|||
25234813|NCT01714817|50546231|FG001|Year 2 Period|Lost to Follow-up|0|||
25234814|NCT01714817|50546230|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
25234815|NCT01714817|50546231|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
25234816|NCT01714817|50546230|FG000|Year 2 Period|Pregnancy|1|||
25234817|NCT01714817|50546231|FG001|Year 2 Period|Pregnancy|1|||
25234818|NCT01714817|50546230|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
25234819|NCT01714817|50546231|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
25234820|NCT01714817|50546230|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
25234821|NCT01714817|50546231|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
25234822|NCT01714817|50546230|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
25234823|NCT01714817|50546231|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
25234824|NCT01714817|50546230|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
25234825|NCT01714817|50546231|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
25234826|NCT01714817|50546230|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
25234827|NCT01714817|50546231|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
25234828|NCT01714817|50546230|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
25234829|NCT01714817|50546231|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
25234830|NCT01714817|50546230|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
25234831|NCT01714817|50546231|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
25234832|NCT01714817|50546230|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
25234833|NCT01714817|50546231|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
25234834|NCT01714817|50546230|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
25234835|NCT01714817|50546231|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
25234836|NCT01714817|50546230|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
25234837|NCT01714817|50546231|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
25234838|NCT01714817|50546230|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
25234839|NCT01714817|50546231|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
25234840|NCT01714817|50546230|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
25234841|NCT01714817|50546231|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
25234842|NCT01714817|50546230|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
25234843|NCT01714817|50546231|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
25234844|NCT01714817|50546230|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
25234845|NCT01714817|50546231|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
25234846|NCT01714817|50546230|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
25234847|NCT01714817|50546231|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
25234848|NCT01714817|50546230|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
25234849|NCT01714817|50546231|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
25234850|NCT01755689|50546255|FG000|Overall Study|Withdrawal by Subject|1|||
25234851|NCT01755689|50546256|FG001|Overall Study|Withdrawal by Subject|3|||
25234852|NCT01755689|50546257|FG002|Overall Study|Withdrawal by Subject|2|||
25234853|NCT01755689|50546258|FG003|Overall Study|Withdrawal by Subject|1|||
25234854|NCT01755689|50546259|FG004|Overall Study|Withdrawal by Subject|1|||
25234855|NCT01755689|50546255|FG000|Overall Study|Migrated/moved from study area|0|||
25234856|NCT01755689|50546256|FG001|Overall Study|Migrated/moved from study area|1|||
25234857|NCT01755689|50546257|FG002|Overall Study|Migrated/moved from study area|1|||
25234858|NCT01755689|50546258|FG003|Overall Study|Migrated/moved from study area|1|||
25234859|NCT01755689|50546259|FG004|Overall Study|Migrated/moved from study area|1|||
25234860|NCT01755689|50546255|FG000|Overall Study|Lost to Follow-up|1|||
25234861|NCT01755689|50546256|FG001|Overall Study|Lost to Follow-up|0|||
25234862|NCT01755689|50546257|FG002|Overall Study|Lost to Follow-up|1|||
25234863|NCT01755689|50546258|FG003|Overall Study|Lost to Follow-up|0|||
25234864|NCT01755689|50546259|FG004|Overall Study|Lost to Follow-up|2|||
25234865|NCT01755689|50546255|FG000|Overall Study|Pregnancy|1|||
25234866|NCT01755689|50546256|FG001|Overall Study|Pregnancy|1|||
25234867|NCT01755689|50546257|FG002|Overall Study|Pregnancy|2|||
25234868|NCT01755689|50546258|FG003|Overall Study|Pregnancy|4|||
25234869|NCT01755689|50546259|FG004|Overall Study|Pregnancy|2|||
25234870|NCT01762761|50546281|FG000|Overall Study|Adverse Event|15|||
25234871|NCT01762761|50546282|FG001|Overall Study|Adverse Event|17|||
25234872|NCT01762761|50546281|FG000|Overall Study|Lack of Efficacy|9|||
25234873|NCT01762761|50546282|FG001|Overall Study|Lack of Efficacy|25|||
25234874|NCT01762761|50546281|FG000|Overall Study|Protocol Violation|1|||
25234875|NCT01762761|50546282|FG001|Overall Study|Protocol Violation|1|||
25234876|NCT01762761|50546281|FG000|Overall Study|Study closed/terminated|0|||
25234877|NCT01762761|50546282|FG001|Overall Study|Study closed/terminated|2|||
25234878|NCT01762761|50546281|FG000|Overall Study|Lost to Follow-up|3|||
25234879|NCT01762761|50546282|FG001|Overall Study|Lost to Follow-up|6|||
25234880|NCT01762761|50546281|FG000|Overall Study|Physician Decision|4|||
25234881|NCT01762761|50546282|FG001|Overall Study|Physician Decision|6|||
25234882|NCT01762761|50546281|FG000|Overall Study|Withdrawal by Subject|7|||
25234883|NCT01762761|50546282|FG001|Overall Study|Withdrawal by Subject|8|||
25234884|NCT01763788|50546293|FG000|Overall Study|Lost to Follow-up|0|||
25234885|NCT01763788|50546294|FG001|Overall Study|Lost to Follow-up|0|||
25234886|NCT01763788|50546295|FG002|Overall Study|Lost to Follow-up|1|||
25234887|NCT01763788|50546296|FG003|Overall Study|Lost to Follow-up|0|||
25234888|NCT01774370|50546306|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
25234889|NCT01774370|50546306|FG000|Overall Study|Administered prior to the contract date|4|||
25234890|NCT01774370|50546306|FG000|Overall Study|Subjects of contraindications|34|||
25234891|NCT01774370|50546306|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
25234892|NCT01774370|50546306|FG000|Overall Study|Follow-up failure|34|||
25234893|NCT01777295|50546312|FG000|Overall Study|Withdrawal by Subject|2|||
25234894|NCT01777295|50546313|FG001|Overall Study|Withdrawal by Subject|2|||
25234895|NCT01777295|50546312|FG000|Overall Study|Pregnancy|0|||
25234896|NCT01777295|50546313|FG001|Overall Study|Pregnancy|1|||
25234897|NCT01777295|50546312|FG000|Overall Study|Personal problem|1|||
25234898|NCT01777295|50546313|FG001|Overall Study|Personal problem|0|||
25234899|NCT01777295|50546312|FG000|Overall Study|Investigator call for AEs check|1|||
25234900|NCT01777295|50546313|FG001|Overall Study|Investigator call for AEs check|0|||
25234901|NCT01787552|50546350|FG000|Overall Study|Withdrawal by Subject|2|||
25234902|NCT01787552|50546351|FG001|Overall Study|Withdrawal by Subject|0|||
25234903|NCT01787552|50546352|FG002|Overall Study|Withdrawal by Subject|0|||
25234904|NCT01787552|50546353|FG003|Overall Study|Withdrawal by Subject|4|||
25234905|NCT01787552|50546350|FG000|Overall Study|Physician Decision|2|||
25234906|NCT01787552|50546351|FG001|Overall Study|Physician Decision|2|||
25234907|NCT01787552|50546352|FG002|Overall Study|Physician Decision|1|||
25234908|NCT01787552|50546353|FG003|Overall Study|Physician Decision|2|||
25234909|NCT01787552|50546350|FG000|Overall Study|Death|0|||
25234910|NCT01787552|50546351|FG001|Overall Study|Death|0|||
25234911|NCT01787552|50546352|FG002|Overall Study|Death|0|||
25234912|NCT01787552|50546353|FG003|Overall Study|Death|1|||
25234913|NCT01787552|50546350|FG000|Overall Study|Adverse Event|2|||
25234914|NCT01787552|50546351|FG001|Overall Study|Adverse Event|5|||
25234915|NCT01787552|50546352|FG002|Overall Study|Adverse Event|2|||
25234916|NCT01787552|50546353|FG003|Overall Study|Adverse Event|16|||
25234917|NCT01787552|50546350|FG000|Overall Study|Study terminated by Sponsor|0|||
25234918|NCT01787552|50546351|FG001|Overall Study|Study terminated by Sponsor|0|||
25234919|NCT01787552|50546352|FG002|Overall Study|Study terminated by Sponsor|1|||
25234920|NCT01787552|50546353|FG003|Overall Study|Study terminated by Sponsor|3|||
25234921|NCT01787552|50546350|FG000|Overall Study|Progressive Disease|2|||
25234922|NCT01787552|50546351|FG001|Overall Study|Progressive Disease|2|||
25234923|NCT01787552|50546352|FG002|Overall Study|Progressive Disease|1|||
25234924|NCT01787552|50546353|FG003|Overall Study|Progressive Disease|1|||
25234925|NCT01808261|50546370|FG000|Overall Study|Physician Decision|0|||
25234926|NCT01808261|50546371|FG001|Overall Study|Physician Decision|2|||
25234927|NCT01808261|50546370|FG000|Overall Study|Study Closed/Terminated|25|||
25234928|NCT01808261|50546371|FG001|Overall Study|Study Closed/Terminated|23|||
25234929|NCT01808261|50546370|FG000|Overall Study|Adverse event, non-fatal|2|||
25234930|NCT01808261|50546371|FG001|Overall Study|Adverse event, non-fatal|0|||
25234931|NCT01808261|50546370|FG000|Overall Study|Consent withdrawn by subject|6|||
25234932|NCT01808261|50546371|FG001|Overall Study|Consent withdrawn by subject|7|||
25234933|NCT01808261|50546370|FG000|Overall Study|Lost to Follow-up|3|||
25234934|NCT01808261|50546371|FG001|Overall Study|Lost to Follow-up|1|||
25234935|NCT01814826|50546390|FG000|Overall Study|Other|3|||
25234936|NCT01814826|50546391|FG001|Overall Study|Other|5|||
25234937|NCT01814826|50546392|FG002|Overall Study|Other|0|||
25234938|NCT01814826|50546390|FG000|Overall Study|Death|29|||
25234939|NCT01814826|50546391|FG001|Overall Study|Death|24|||
25234940|NCT01814826|50546392|FG002|Overall Study|Death|3|||
25234941|NCT01829711|50546401|FG000|Overall Study|Lost to Follow-up|2|||
25234942|NCT01829711|50546401|FG000|Overall Study|Withdrawal by Subject|3|||
25234943|NCT01829711|50546401|FG000|Overall Study|Death|4|||
25234944|NCT01829711|50546401|FG000|Overall Study|Started new therapies|17|||
25234945|NCT01829711|50546401|FG000|Overall Study|Adverse Event|3|||
25234946|NCT01829711|50546401|FG000|Overall Study|Due to progression of disease|13|||
25234947|NCT01829711|50546401|FG000|Overall Study|Due to lack of response|1|||
25234948|NCT01846273|50546408|FG000|Overall Study|Adverse Event|9|||
25234949|NCT01846273|50546409|FG001|Overall Study|Adverse Event|7|||
25234950|NCT01846273|50546410|FG002|Overall Study|Adverse Event|0|||
25234951|NCT01846273|50546408|FG000|Overall Study|Subject withdrew consent|5|||
25234952|NCT01846273|50546409|FG001|Overall Study|Subject withdrew consent|8|||
25234953|NCT01846273|50546410|FG002|Overall Study|Subject withdrew consent|0|||
25234954|NCT01846273|50546408|FG000|Overall Study|Lost to Follow-up|2|||
25234955|NCT01846273|50546409|FG001|Overall Study|Lost to Follow-up|1|||
25234956|NCT01846273|50546410|FG002|Overall Study|Lost to Follow-up|0|||
25234957|NCT01846273|50546408|FG000|Overall Study|Administrative problems|1|||
25234958|NCT01846273|50546409|FG001|Overall Study|Administrative problems|0|||
25234959|NCT01846273|50546410|FG002|Overall Study|Administrative problems|0|||
25234960|NCT01846273|50546408|FG000|Overall Study|Death|2|||
25234961|NCT01846273|50546409|FG001|Overall Study|Death|1|||
25234962|NCT01846273|50546410|FG002|Overall Study|Death|0|||
25234963|NCT01846273|50546408|FG000|Overall Study|Disease Progression|0|||
25234964|NCT01846273|50546409|FG001|Overall Study|Disease Progression|4|||
25234965|NCT01846273|50546410|FG002|Overall Study|Disease Progression|0|||
25234966|NCT01846273|50546408|FG000|Overall Study|Protocol Deviation|2|||
25234967|NCT01846273|50546409|FG001|Overall Study|Protocol Deviation|3|||
25234968|NCT01846273|50546410|FG002|Overall Study|Protocol Deviation|0|||
25234969|NCT01846273|50546408|FG000|Overall Study|Physician Decision|1|||
25234970|NCT01846273|50546409|FG001|Overall Study|Physician Decision|2|||
25234971|NCT01846273|50546410|FG002|Overall Study|Physician Decision|0|||
25234972|NCT04752475|50546420|FG000|Overall Study|Withdrawal by Subject|1|||
25234973|NCT04752475|50546421|FG001|Overall Study|Withdrawal by Subject|1|||
25234974|NCT03846947|50546467|FG000|Overall Study|technical issues with imaging sequence|2|||
25234975|NCT03675308|50546480|FG000|Overall Study|Adverse Event|3|||
25234976|NCT03675308|50546481|FG001|Overall Study|Adverse Event|2|||
25234977|NCT03675308|50546480|FG000|Overall Study|Withdrawal by Subject|6|||
25234978|NCT03675308|50546481|FG001|Overall Study|Withdrawal by Subject|4|||
25234979|NCT03675308|50546480|FG000|Overall Study|Lost to Follow-up|3|||
25234980|NCT03675308|50546481|FG001|Overall Study|Lost to Follow-up|0|||
25234981|NCT03675308|50546480|FG000|Overall Study|Lack of Efficacy|1|||
25234982|NCT03675308|50546481|FG001|Overall Study|Lack of Efficacy|1|||
25234983|NCT03675308|50546480|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
25234984|NCT03675308|50546481|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
25234985|NCT03675308|50546480|FG000|Overall Study|Other|0|||
25234986|NCT03675308|50546481|FG001|Overall Study|Other|1|||
25234987|NCT03476798|50546487|FG000|Overall Study|Death|1|||
25234988|NCT03476798|50546487|FG000|Overall Study|Withdrawal by Subject|2|||
25234989|NCT03476798|50546487|FG000|Overall Study|Protocol Violation|2|||
25234990|NCT03334253|50546493|FG000|Overall Study|Withdrawal by Subject|1|||
25234991|NCT03334253|50546494|FG001|Overall Study|Withdrawal by Subject|0|||
25234992|NCT03334253|50546493|FG000|Overall Study|Lost to Follow-up|4|||
25234993|NCT03334253|50546494|FG001|Overall Study|Lost to Follow-up|3|||
25234994|NCT03334253|50546493|FG000|Overall Study|Moved residence|2|||
25234995|NCT03334253|50546494|FG001|Overall Study|Moved residence|2|||
25234996|NCT03131219|50546502|FG000|Initial Evaluation Period|Adverse Event|1|||
25234997|NCT03131219|50546503|FG001|Initial Evaluation Period|Adverse Event|0|||
25234998|NCT03131219|50546502|FG000|Initial Evaluation Period|Protocol Violation|1|||
25234999|NCT03131219|50546503|FG001|Initial Evaluation Period|Protocol Violation|0|||
25235000|NCT03131219|50546502|FG000|Initial Evaluation Period|Deemed ineligible post treatment|2|||
25235001|NCT03131219|50546503|FG001|Initial Evaluation Period|Deemed ineligible post treatment|0|||
25235002|NCT02914613|50546511|FG000|Overall Study|Withdrawal by Subject|1|||
25235003|NCT02914613|50546512|FG001|Overall Study|Withdrawal by Subject|2|||
25235004|NCT02914613|50546511|FG000|Overall Study|Adverse Event|1|||
25235005|NCT02914613|50546512|FG001|Overall Study|Adverse Event|0|||
24976677|NCT03449446|50065600|FG001|Overall Study|Adverse Event|2|||
25235006|NCT02586207|50546522|FG000|Overall Study|Physician Decision|1|||
25235007|NCT02586207|50546522|FG000|Overall Study|Withdrawal by Subject|1|||
24976678|NCT03449446|50065601|FG002|Overall Study|Adverse Event|1|||
25235008|NCT02573324|50546529|FG000|Overall Study|Withdrawal by Subject|26|||
25235009|NCT02573324|50546530|FG001|Overall Study|Withdrawal by Subject|23|||
25235010|NCT02573324|50546531|FG002|Overall Study|Withdrawal by Subject|3|||
25235011|NCT02573324|50546529|FG000|Overall Study|Lost to Follow-up|4|||
25235012|NCT02573324|50546530|FG001|Overall Study|Lost to Follow-up|5|||
25235013|NCT02573324|50546531|FG002|Overall Study|Lost to Follow-up|0|||
25235014|NCT02573324|50546529|FG000|Overall Study|Study Terminated by Sponsor|107|||
25235015|NCT02573324|50546530|FG001|Overall Study|Study Terminated by Sponsor|89|||
25235016|NCT02573324|50546531|FG002|Overall Study|Study Terminated by Sponsor|2|||
25235017|NCT02573324|50546529|FG000|Overall Study|Death|182|||
25235018|NCT02573324|50546530|FG001|Overall Study|Death|200|||
25235019|NCT02573324|50546531|FG002|Overall Study|Death|1|||
25235020|NCT02573324|50546529|FG000|Overall Study|Other, Not Specified|20|||
25235021|NCT02573324|50546530|FG001|Overall Study|Other, Not Specified|27|||
25235022|NCT02573324|50546531|FG002|Overall Study|Other, Not Specified|0|||
25235023|NCT02573324|50546529|FG000|Overall Study|Unknown Reason|2|||
25235024|NCT02573324|50546530|FG001|Overall Study|Unknown Reason|0|||
25235025|NCT02573324|50546531|FG002|Overall Study|Unknown Reason|0|||
25235026|NCT02296684|50546547|FG000|Overall Study|Withdrawal by Subject|0|||
25235027|NCT02296684|50546548|FG001|Overall Study|Withdrawal by Subject|1|||
25235028|NCT02296684|50546549|FG002|Overall Study|Withdrawal by Subject|1|||
25235029|NCT02296684|50546547|FG000|Overall Study|Death|2|||
25235030|NCT02296684|50546548|FG001|Overall Study|Death|0|||
25235031|NCT02296684|50546549|FG002|Overall Study|Death|0|||
25235032|NCT02107261|50546558|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
25235033|NCT02107261|50546559|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
25235034|NCT02107261|50546558|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
25235035|NCT02107261|50546559|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
25235036|NCT02014597|50546569|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
25235037|NCT02014597|50546570|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
25235038|NCT01342367|50546582|FG000|Overall Study|Death|1|||
25235039|NCT01342367|50546583|FG001|Overall Study|Death|0|||
25235040|NCT01342367|50546582|FG000|Overall Study|Withdrawal by Subject|1|||
25235041|NCT01342367|50546583|FG001|Overall Study|Withdrawal by Subject|2|||
25235042|NCT01185171|50546589|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
25235043|NCT01185171|50546589|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
25235044|NCT01185171|50546589|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
25235045|NCT01185171|50546589|FG000|Maintenance|Elevated liver transaminases|3|||
25235046|NCT01185171|50546589|FG000|Maintenance|Rush|2|||
25235047|NCT01185171|50546589|FG000|Maintenance|Diarrhea|1|||
25235048|NCT01185171|50546589|FG000|Maintenance|Xerostomia|1|||
25235049|NCT01185171|50546589|FG000|Maintenance|Nausea|1|||
25235050|NCT01185171|50546589|FG000|Maintenance|Comorbid Illness|2|||
25235051|NCT01185171|50546589|FG000|Maintenance|Withdrawal by Subject|1|||
25235052|NCT01185171|50546589|FG000|Maintenance|Disease Recurrence|1|||
25235053|NCT00896493|50546593|FG000|Overall Study|Early disease relapse|3|||
25235054|NCT00408005|50546599|FG000|Induction|Adverse Event|19|||
25235055|NCT00408005|50546600|FG001|Induction|Adverse Event|3|||
25235056|NCT00408005|50546601|FG002|Induction|Adverse Event|0|||
25235057|NCT00408005|50546602|FG003|Induction|Adverse Event|0|||
25235058|NCT00408005|50546603|FG004|Induction|Adverse Event|0|||
25235059|NCT00408005|50546604|FG005|Induction|Adverse Event|0|||
25235060|NCT00408005|50546605|FG006|Induction|Adverse Event|0|||
25235061|NCT00408005|50546606|FG007|Induction|Adverse Event|0|||
25235062|NCT00408005|50546599|FG000|Induction|Death|6|||
25235063|NCT00408005|50546600|FG001|Induction|Death|0|||
25235064|NCT00408005|50546601|FG002|Induction|Death|0|||
25235065|NCT00408005|50546602|FG003|Induction|Death|0|||
25235066|NCT00408005|50546603|FG004|Induction|Death|0|||
25235067|NCT00408005|50546604|FG005|Induction|Death|0|||
25235068|NCT00408005|50546605|FG006|Induction|Death|0|||
25235069|NCT00408005|50546606|FG007|Induction|Death|0|||
25235070|NCT00408005|50546599|FG000|Induction|Physician Decision|83|||
25235071|NCT00408005|50546600|FG001|Induction|Physician Decision|9|||
25235072|NCT00408005|50546601|FG002|Induction|Physician Decision|0|||
25235073|NCT00408005|50546602|FG003|Induction|Physician Decision|0|||
25235074|NCT00408005|50546603|FG004|Induction|Physician Decision|0|||
25235075|NCT00408005|50546604|FG005|Induction|Physician Decision|0|||
25235076|NCT00408005|50546605|FG006|Induction|Physician Decision|0|||
25235077|NCT00408005|50546606|FG007|Induction|Physician Decision|0|||
25235078|NCT00408005|50546599|FG000|Induction|Withdrawal by Subject|2|||
25235079|NCT00408005|50546600|FG001|Induction|Withdrawal by Subject|4|||
25235080|NCT00408005|50546601|FG002|Induction|Withdrawal by Subject|0|||
25235081|NCT00408005|50546602|FG003|Induction|Withdrawal by Subject|0|||
25235082|NCT00408005|50546603|FG004|Induction|Withdrawal by Subject|0|||
25235083|NCT00408005|50546604|FG005|Induction|Withdrawal by Subject|0|||
25235084|NCT00408005|50546605|FG006|Induction|Withdrawal by Subject|0|||
25235085|NCT00408005|50546606|FG007|Induction|Withdrawal by Subject|0|||
25235086|NCT00408005|50546599|FG000|Induction|Ineligible|33|||
25235087|NCT00408005|50546600|FG001|Induction|Ineligible|14|||
25235088|NCT00408005|50546601|FG002|Induction|Ineligible|0|||
25235089|NCT00408005|50546602|FG003|Induction|Ineligible|0|||
25235090|NCT00408005|50546603|FG004|Induction|Ineligible|0|||
25235091|NCT00408005|50546604|FG005|Induction|Ineligible|0|||
25235092|NCT00408005|50546605|FG006|Induction|Ineligible|0|||
25235093|NCT00408005|50546606|FG007|Induction|Ineligible|0|||
25235094|NCT00408005|50546599|FG000|Induction|Refusal of Further Protocol Therapy|225|||
25235095|NCT00408005|50546600|FG001|Induction|Refusal of Further Protocol Therapy|44|||
25235096|NCT00408005|50546601|FG002|Induction|Refusal of Further Protocol Therapy|0|||
25235097|NCT00408005|50546602|FG003|Induction|Refusal of Further Protocol Therapy|0|||
25235098|NCT00408005|50546603|FG004|Induction|Refusal of Further Protocol Therapy|0|||
25235099|NCT00408005|50546604|FG005|Induction|Refusal of Further Protocol Therapy|0|||
25235100|NCT00408005|50546605|FG006|Induction|Refusal of Further Protocol Therapy|0|||
25235101|NCT00408005|50546606|FG007|Induction|Refusal of Further Protocol Therapy|0|||
25235102|NCT00408005|50546599|FG000|Induction|Entered another COG therapeutic protocol|4|||
25235103|NCT00408005|50546600|FG001|Induction|Entered another COG therapeutic protocol|0|||
25235104|NCT00408005|50546601|FG002|Induction|Entered another COG therapeutic protocol|0|||
25235105|NCT00408005|50546602|FG003|Induction|Entered another COG therapeutic protocol|0|||
25235106|NCT00408005|50546603|FG004|Induction|Entered another COG therapeutic protocol|0|||
25235107|NCT00408005|50546604|FG005|Induction|Entered another COG therapeutic protocol|0|||
25235108|NCT00408005|50546605|FG006|Induction|Entered another COG therapeutic protocol|0|||
25235109|NCT00408005|50546606|FG007|Induction|Entered another COG therapeutic protocol|0|||
25235110|NCT00408005|50546599|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
25235111|NCT00408005|50546600|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
25235112|NCT00408005|50546601|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
25235113|NCT00408005|50546602|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
25235114|NCT00408005|50546603|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
25235115|NCT00408005|50546604|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
25235116|NCT00408005|50546605|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
25235117|NCT00408005|50546606|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
25235118|NCT00408005|50546599|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
25235119|NCT00408005|50546600|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
25235120|NCT00408005|50546601|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
25235121|NCT00408005|50546602|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
25235122|NCT00408005|50546603|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
25235123|NCT00408005|50546604|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
25235124|NCT00408005|50546605|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
25235125|NCT00408005|50546606|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
25235126|NCT00408005|50546599|FG000|Induction|Progressive Disease|0|||
25235127|NCT00408005|50546600|FG001|Induction|Progressive Disease|1|||
25235128|NCT00408005|50546601|FG002|Induction|Progressive Disease|0|||
25235129|NCT00408005|50546602|FG003|Induction|Progressive Disease|0|||
25235130|NCT00408005|50546603|FG004|Induction|Progressive Disease|0|||
25235131|NCT00408005|50546604|FG005|Induction|Progressive Disease|0|||
25235132|NCT00408005|50546605|FG006|Induction|Progressive Disease|0|||
25235133|NCT00408005|50546606|FG007|Induction|Progressive Disease|0|||
25235134|NCT00408005|50546599|FG000|Induction|Inevaluable|18|||
25235135|NCT00408005|50546600|FG001|Induction|Inevaluable|14|||
25235136|NCT00408005|50546601|FG002|Induction|Inevaluable|0|||
25235137|NCT00408005|50546602|FG003|Induction|Inevaluable|0|||
25235138|NCT00408005|50546603|FG004|Induction|Inevaluable|0|||
25235139|NCT00408005|50546604|FG005|Induction|Inevaluable|0|||
25235140|NCT00408005|50546605|FG006|Induction|Inevaluable|0|||
25235141|NCT00408005|50546606|FG007|Induction|Inevaluable|0|||
25235142|NCT00408005|50546599|FG000|Induction|Failed to Complete Randomization|3|||
25235143|NCT00408005|50546600|FG001|Induction|Failed to Complete Randomization|2|||
25235144|NCT00408005|50546601|FG002|Induction|Failed to Complete Randomization|0|||
25235145|NCT00408005|50546602|FG003|Induction|Failed to Complete Randomization|0|||
25235146|NCT00408005|50546603|FG004|Induction|Failed to Complete Randomization|0|||
25235147|NCT00408005|50546604|FG005|Induction|Failed to Complete Randomization|0|||
25235148|NCT00408005|50546605|FG006|Induction|Failed to Complete Randomization|0|||
25235149|NCT00408005|50546606|FG007|Induction|Failed to Complete Randomization|0|||
25235150|NCT00408005|50546599|FG000|Induction|Protocol Deviation|3|||
25235151|NCT00408005|50546600|FG001|Induction|Protocol Deviation|1|||
25235152|NCT00408005|50546601|FG002|Induction|Protocol Deviation|0|||
25235153|NCT00408005|50546602|FG003|Induction|Protocol Deviation|0|||
25235154|NCT00408005|50546603|FG004|Induction|Protocol Deviation|0|||
25235155|NCT00408005|50546604|FG005|Induction|Protocol Deviation|0|||
25077518|NCT02240680|50185296|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
25077519|NCT02240680|50185297|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
25077520|NCT02240680|50185298|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
25077521|NCT02240680|50185295|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
25077522|NCT02240680|50185296|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
25235156|NCT00408005|50546605|FG006|Induction|Protocol Deviation|0|||
25235157|NCT00408005|50546606|FG007|Induction|Protocol Deviation|0|||
25235158|NCT00408005|50546599|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
25235159|NCT00408005|50546600|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
25077523|NCT02240680|50185297|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
25077524|NCT02240680|50185298|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
25077525|NCT02240680|50185295|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
25077526|NCT02240680|50185296|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
25077527|NCT02240680|50185297|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
25077528|NCT02240680|50185298|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
25077529|NCT02240680|50185295|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
25077530|NCT02240680|50185296|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
25077531|NCT02240680|50185297|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
25235160|NCT00408005|50546601|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
25235161|NCT00408005|50546602|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
25235162|NCT00408005|50546603|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
25235163|NCT00408005|50546604|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
25235164|NCT00408005|50546605|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
25235165|NCT00408005|50546606|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
25235166|NCT00408005|50546599|FG000|Induction|Recurrent leukemia|1|||
25235167|NCT00408005|50546600|FG001|Induction|Recurrent leukemia|0|||
25235168|NCT00408005|50546601|FG002|Induction|Recurrent leukemia|0|||
25235169|NCT00408005|50546602|FG003|Induction|Recurrent leukemia|0|||
25235170|NCT00408005|50546603|FG004|Induction|Recurrent leukemia|0|||
25235171|NCT00408005|50546604|FG005|Induction|Recurrent leukemia|0|||
25235172|NCT00408005|50546605|FG006|Induction|Recurrent leukemia|0|||
25235173|NCT00408005|50546606|FG007|Induction|Recurrent leukemia|0|||
25235174|NCT00408005|50546599|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
25235175|NCT00408005|50546600|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
25235176|NCT00408005|50546601|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
25235177|NCT00408005|50546602|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
25235178|NCT00408005|50546603|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
25235179|NCT00408005|50546604|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
25235180|NCT00408005|50546605|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
25235181|NCT00408005|50546606|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
25235182|NCT00408005|50546599|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
25319435|NCT00604825|50634952|FG002|Overall Study|Withdrawal by Subject|5|||
25319436|NCT00604825|50634953|FG003|Overall Study|Withdrawal by Subject|5|||
25319437|NCT00604825|50634950|FG000|Overall Study|Lack of Efficacy|3|||
25319438|NCT00604825|50634951|FG001|Overall Study|Lack of Efficacy|2|||
25319439|NCT00604825|50634952|FG002|Overall Study|Lack of Efficacy|1|||
25319440|NCT00604825|50634953|FG003|Overall Study|Lack of Efficacy|0|||
25319441|NCT00604825|50634950|FG000|Overall Study|Did not meet eligibility criteria|0|||
25319442|NCT00604825|50634951|FG001|Overall Study|Did not meet eligibility criteria|0|||
25319443|NCT00604825|50634952|FG002|Overall Study|Did not meet eligibility criteria|2|||
25319444|NCT00604825|50634953|FG003|Overall Study|Did not meet eligibility criteria|0|||
25319445|NCT00604825|50634950|FG000|Overall Study|Physician Decision|0|||
25319446|NCT00604825|50634951|FG001|Overall Study|Physician Decision|0|||
25319447|NCT00604825|50634952|FG002|Overall Study|Physician Decision|0|||
25319448|NCT00604825|50634953|FG003|Overall Study|Physician Decision|1|||
25319449|NCT00604825|50634950|FG000|Overall Study|Exclusion criterion met|0|||
25319450|NCT00604825|50634951|FG001|Overall Study|Exclusion criterion met|0|||
25319451|NCT00604825|50634952|FG002|Overall Study|Exclusion criterion met|0|||
25319452|NCT00604825|50634953|FG003|Overall Study|Exclusion criterion met|1|||
25319453|NCT00937391|50634965|FG000|Stage 2|Withdrawal by Subject|1|||
25319454|NCT00937157|50634982|FG000|Overall Study|Pregnancy|1|||
25319455|NCT00937157|50634982|FG000|Overall Study|Lost to Follow-up|3|||
25319456|NCT00777153|50634989|FG000|Overall Study|Lost to Follow-up|1|||
25319457|NCT00777153|50634990|FG001|Overall Study|Lost to Follow-up|1|||
25319458|NCT00777153|50634991|FG002|Overall Study|Lost to Follow-up|0|||
25319459|NCT00777153|50634989|FG000|Overall Study|Death|85|||
25319460|NCT00777153|50634990|FG001|Overall Study|Death|73|||
25319461|NCT00777153|50634991|FG002|Overall Study|Death|33|||
25319462|NCT00777153|50634989|FG000|Overall Study|Withdrawal by Subject|3|||
25319463|NCT00777153|50634990|FG001|Overall Study|Withdrawal by Subject|4|||
25319464|NCT00777153|50634991|FG002|Overall Study|Withdrawal by Subject|3|||
25319465|NCT00777153|50634989|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
25319466|NCT00777153|50634990|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
25319467|NCT00777153|50634991|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
25319468|NCT00567541|50635005|FG000|Overall Study|Adverse Event|0|||
25319469|NCT00567541|50635006|FG001|Overall Study|Adverse Event|1|||
25319470|NCT00776997|50635012|FG000|Overall Study|Adverse Event|2|||
25077532|NCT02240680|50185298|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
25235183|NCT00408005|50546600|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
25319471|NCT00940823|50635018|FG000|Overall Study|Death|8|||
25319472|NCT00940823|50635019|FG001|Overall Study|Death|12|||
25319473|NCT00940823|50635018|FG000|Overall Study|Lost to Follow-up|27|||
25319474|NCT00940823|50635019|FG001|Overall Study|Lost to Follow-up|20|||
25235184|NCT00408005|50546601|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
25235185|NCT00408005|50546602|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
25235186|NCT00408005|50546603|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
25235187|NCT00408005|50546604|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
25235188|NCT00408005|50546605|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
25235189|NCT00408005|50546606|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
25235190|NCT00408005|50546599|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
25235191|NCT00408005|50546600|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
25235192|NCT00408005|50546601|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
25235193|NCT00408005|50546602|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
25235194|NCT00408005|50546603|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
25235195|NCT00408005|50546604|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
25235196|NCT00408005|50546605|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
25235197|NCT00408005|50546606|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
25235198|NCT00408005|50546599|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
24976679|NCT03449446|50065602|FG003|Overall Study|Adverse Event|0|||
24976680|NCT03449446|50065603|FG004|Overall Study|Adverse Event|0|||
24976681|NCT03449446|50065604|FG005|Overall Study|Adverse Event|2|||
24976682|NCT03449446|50065605|FG006|Overall Study|Adverse Event|0|||
24976683|NCT03449446|50065599|FG000|Overall Study|Lost to Follow-up|0|||
25235199|NCT00408005|50546600|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
25235200|NCT00408005|50546601|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
25235201|NCT00408005|50546602|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
25235202|NCT00408005|50546603|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
25235203|NCT00408005|50546604|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
25235204|NCT00408005|50546605|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
25235205|NCT00408005|50546606|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
25235206|NCT00408005|50546599|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
25235207|NCT00408005|50546600|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
25235208|NCT00408005|50546601|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
25235209|NCT00408005|50546602|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
25235210|NCT00408005|50546603|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
25235211|NCT00408005|50546604|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
25235212|NCT00408005|50546605|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
25235213|NCT00408005|50546606|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
25235214|NCT00408005|50546599|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
25235215|NCT00408005|50546600|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
25235216|NCT00408005|50546601|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
25235217|NCT00408005|50546602|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
25235218|NCT00408005|50546603|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
25235219|NCT00408005|50546604|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
25235220|NCT00408005|50546605|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
25235221|NCT00408005|50546606|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
25235222|NCT00408005|50546599|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
25235223|NCT00408005|50546600|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
25235224|NCT00408005|50546601|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
25235225|NCT00408005|50546602|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
25235226|NCT00408005|50546603|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
25235227|NCT00408005|50546604|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
25235228|NCT00408005|50546605|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
25235229|NCT00408005|50546606|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
25235230|NCT00408005|50546599|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
25235231|NCT00408005|50546600|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
25235232|NCT00408005|50546601|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
25235233|NCT00408005|50546602|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
25235234|NCT00408005|50546603|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
25235235|NCT00408005|50546604|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
25235236|NCT00408005|50546605|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
25235237|NCT00408005|50546606|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
25235238|NCT00408005|50546599|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
24976684|NCT03449446|50065600|FG001|Overall Study|Lost to Follow-up|0|||
25235239|NCT00408005|50546600|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
25235240|NCT00408005|50546601|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
25235241|NCT00408005|50546602|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
25235242|NCT00408005|50546603|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
25235243|NCT00408005|50546604|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
25235244|NCT00408005|50546605|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
25235245|NCT00408005|50546606|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
25235246|NCT00408005|50546599|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
25235247|NCT00408005|50546600|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
25235248|NCT00408005|50546601|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
25235249|NCT00408005|50546602|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
25235250|NCT00408005|50546603|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
25235251|NCT00408005|50546604|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
25235252|NCT00408005|50546605|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
25235253|NCT00408005|50546606|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
25235254|NCT00408005|50546599|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
25235255|NCT00408005|50546600|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
25235256|NCT00408005|50546601|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
25235257|NCT00408005|50546602|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
25235258|NCT00408005|50546603|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
25235259|NCT00408005|50546604|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
25235260|NCT00408005|50546605|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
25235261|NCT00408005|50546606|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
25235262|NCT00408005|50546599|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
25235263|NCT00408005|50546600|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
25235264|NCT00408005|50546601|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
25235265|NCT00408005|50546602|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
25235266|NCT00408005|50546603|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
25235267|NCT00408005|50546604|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
25235268|NCT00408005|50546605|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
25235269|NCT00408005|50546606|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
25235270|NCT00408005|50546599|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
25235271|NCT00408005|50546600|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
25235272|NCT00408005|50546601|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
25235273|NCT00408005|50546602|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
25235274|NCT00408005|50546603|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
25235275|NCT00408005|50546604|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
25235276|NCT00408005|50546605|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
25235277|NCT00408005|50546606|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
25235278|NCT00408005|50546599|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
25235279|NCT00408005|50546600|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
25235280|NCT00408005|50546601|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
25235281|NCT00408005|50546602|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
25235282|NCT00408005|50546603|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
25235283|NCT00408005|50546604|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
25235284|NCT00408005|50546605|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
25235285|NCT00408005|50546606|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
25235286|NCT01875185|50546637|FG000|Overall Study|study was terminated|52|||
25235287|NCT01875185|50546638|FG001|Overall Study|study was terminated|48|||
25235288|NCT01901432|50546667|FG000|Overall Study|Adverse Event|0|||
25235289|NCT01901432|50546668|FG001|Overall Study|Adverse Event|1|||
25235290|NCT01901432|50546669|FG002|Overall Study|Adverse Event|1|||
25235291|NCT01901432|50546670|FG003|Overall Study|Adverse Event|0|||
25235292|NCT01901432|50546671|FG004|Overall Study|Adverse Event|1|||
25235293|NCT01901432|50546667|FG000|Overall Study|Withdrawal by Subject|0|||
25235294|NCT01901432|50546668|FG001|Overall Study|Withdrawal by Subject|0|||
25235295|NCT01901432|50546669|FG002|Overall Study|Withdrawal by Subject|1|||
25235296|NCT01901432|50546670|FG003|Overall Study|Withdrawal by Subject|0|||
25235297|NCT01901432|50546671|FG004|Overall Study|Withdrawal by Subject|5|||
25235298|NCT01901432|50546667|FG000|Overall Study|Physician Decision|0|||
25235299|NCT01901432|50546668|FG001|Overall Study|Physician Decision|0|||
25235300|NCT01901432|50546669|FG002|Overall Study|Physician Decision|0|||
24976685|NCT03449446|50065601|FG002|Overall Study|Lost to Follow-up|2|||
25235301|NCT01901432|50546670|FG003|Overall Study|Physician Decision|0|||
25235302|NCT01901432|50546671|FG004|Overall Study|Physician Decision|2|||
25235303|NCT01901432|50546667|FG000|Overall Study|Patient decision to stop study drug|0|||
25235304|NCT01901432|50546668|FG001|Overall Study|Patient decision to stop study drug|0|||
25235305|NCT01901432|50546669|FG002|Overall Study|Patient decision to stop study drug|0|||
25235306|NCT01901432|50546670|FG003|Overall Study|Patient decision to stop study drug|0|||
25235307|NCT01901432|50546671|FG004|Overall Study|Patient decision to stop study drug|1|||
25235308|NCT01904279|50546692|FG000|Overall Study|Lack of Efficacy|2|||
25235309|NCT01904279|50546693|FG001|Overall Study|Lack of Efficacy|3|||
25235310|NCT01904279|50546692|FG000|Overall Study|Withdrawal by Subject|1|||
25235311|NCT01904279|50546693|FG001|Overall Study|Withdrawal by Subject|0|||
25235312|NCT01917318|50546702|FG000|First Treatment|Withdrawal by Subject|0|||
25235313|NCT01917318|50546703|FG001|First Treatment|Withdrawal by Subject|1|||
25235314|NCT01923168|50546712|FG000|Overall Study|Protocol Violation|1|||
25235315|NCT01923168|50546713|FG001|Overall Study|Protocol Violation|1|||
25235316|NCT01923168|50546714|FG002|Overall Study|Protocol Violation|0|||
25235317|NCT01923168|50546712|FG000|Overall Study|Subject/guardian decision|14|||
25235318|NCT01923168|50546713|FG001|Overall Study|Subject/guardian decision|14|||
25235319|NCT01923168|50546714|FG002|Overall Study|Subject/guardian decision|4|||
25235320|NCT01923168|50546712|FG000|Overall Study|Adverse Event|12|||
25235321|NCT01923168|50546713|FG001|Overall Study|Adverse Event|12|||
25235322|NCT01923168|50546714|FG002|Overall Study|Adverse Event|0|||
25235323|NCT01923168|50546712|FG000|Overall Study|Physician Decision|6|||
25235324|NCT01923168|50546713|FG001|Overall Study|Physician Decision|9|||
25235325|NCT01923168|50546714|FG002|Overall Study|Physician Decision|5|||
25235326|NCT01923168|50546712|FG000|Overall Study|Progressive disease|4|||
25235327|NCT01923168|50546713|FG001|Overall Study|Progressive disease|3|||
25235328|NCT01923168|50546714|FG002|Overall Study|Progressive disease|7|||
25235329|NCT01923168|50546712|FG000|Overall Study|Death|0|||
25235330|NCT01923168|50546713|FG001|Overall Study|Death|0|||
25235331|NCT01923168|50546714|FG002|Overall Study|Death|1|||
25235332|NCT01931098|50546724|FG000|Overall Study|Withdrawal by Subject|0|||
25235333|NCT01931098|50546725|FG001|Overall Study|Withdrawal by Subject|1|||
25235334|NCT01931098|50546724|FG000|Overall Study|Enrolled in different protocol|0|||
25235335|NCT01931098|50546725|FG001|Overall Study|Enrolled in different protocol|1|||
25235336|NCT01931098|50546724|FG000|Overall Study|Unable to begin trmt:active infection|0|||
25235337|NCT01931098|50546725|FG001|Overall Study|Unable to begin trmt:active infection|1|||
25235338|NCT01931098|50546724|FG000|Overall Study|Refused further treatment|0|||
25235339|NCT01931098|50546725|FG001|Overall Study|Refused further treatment|1|||
25235340|NCT01945021|50546733|FG000|Overall Study|Adverse Event|1|||
25235341|NCT01945021|50546733|FG000|Overall Study|Withdrawal of consent|12|||
25235342|NCT01945021|50546733|FG000|Overall Study|Lost to Follow-up|5|||
25235343|NCT01945021|50546733|FG000|Overall Study|Death|65|||
25235344|NCT03951077|50546774|FG000|Overall Study|Adverse Event|1|||
25235345|NCT03951077|50546775|FG001|Overall Study|Adverse Event|0|||
25235346|NCT03951077|50546776|FG002|Overall Study|Adverse Event|0|||
25235347|NCT03951077|50546777|FG003|Overall Study|Adverse Event|0|||
25235348|NCT03951077|50546778|FG004|Overall Study|Adverse Event|0|||
25235349|NCT03951077|50546779|FG005|Overall Study|Adverse Event|0|||
24976686|NCT03449446|50065602|FG003|Overall Study|Lost to Follow-up|1|||
25077533|NCT02240680|50185295|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
25077534|NCT02240680|50185296|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
25077535|NCT02240680|50185297|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
25235350|NCT03951077|50546774|FG000|Overall Study|Withdrawal by Subject|3|||
25235351|NCT03951077|50546775|FG001|Overall Study|Withdrawal by Subject|3|||
25235352|NCT03951077|50546776|FG002|Overall Study|Withdrawal by Subject|0|||
25235353|NCT03951077|50546777|FG003|Overall Study|Withdrawal by Subject|3|||
25235354|NCT03951077|50546778|FG004|Overall Study|Withdrawal by Subject|3|||
25235355|NCT03951077|50546779|FG005|Overall Study|Withdrawal by Subject|2|||
25235356|NCT03951077|50546774|FG000|Overall Study|Lost to Follow-up|1|||
25235357|NCT03951077|50546775|FG001|Overall Study|Lost to Follow-up|1|||
25235358|NCT03951077|50546776|FG002|Overall Study|Lost to Follow-up|2|||
25235359|NCT03951077|50546777|FG003|Overall Study|Lost to Follow-up|3|||
25235360|NCT03951077|50546778|FG004|Overall Study|Lost to Follow-up|2|||
25235361|NCT03951077|50546779|FG005|Overall Study|Lost to Follow-up|3|||
25235362|NCT03951077|50546774|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
25235363|NCT03951077|50546775|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
25235364|NCT03951077|50546776|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
25235365|NCT03951077|50546777|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
25235366|NCT03951077|50546778|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
25235367|NCT03951077|50546779|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
25235368|NCT03951077|50546774|FG000|Overall Study|Other, Not Specified|12|||
25235369|NCT03951077|50546775|FG001|Overall Study|Other, Not Specified|10|||
25235370|NCT03951077|50546776|FG002|Overall Study|Other, Not Specified|10|||
25235371|NCT03951077|50546777|FG003|Overall Study|Other, Not Specified|5|||
25235372|NCT03951077|50546778|FG004|Overall Study|Other, Not Specified|9|||
25235373|NCT03951077|50546779|FG005|Overall Study|Other, Not Specified|6|||
25235374|NCT03951077|50546774|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
25235375|NCT03951077|50546775|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
25235376|NCT03951077|50546776|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
25235377|NCT03951077|50546777|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
25235378|NCT03951077|50546778|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
25235379|NCT03951077|50546779|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
25235380|NCT03873246|50546796|FG000|Overall Study|Adverse Event|1|||
25235381|NCT03873246|50546797|FG001|Overall Study|Adverse Event|3|||
25235382|NCT03873246|50546798|FG002|Overall Study|Adverse Event|3|||
25235383|NCT03873246|50546796|FG000|Overall Study|Lost to Follow-up|4|||
24976687|NCT03449446|50065603|FG004|Overall Study|Lost to Follow-up|3|||
24976688|NCT03449446|50065604|FG005|Overall Study|Lost to Follow-up|0|||
24976689|NCT03449446|50065605|FG006|Overall Study|Lost to Follow-up|0|||
24976690|NCT03449446|50065599|FG000|Overall Study|Investigator's Discretion|0|||
24976691|NCT03449446|50065600|FG001|Overall Study|Investigator's Discretion|1|||
24976692|NCT03449446|50065601|FG002|Overall Study|Investigator's Discretion|1|||
24976693|NCT03449446|50065602|FG003|Overall Study|Investigator's Discretion|2|||
24976694|NCT03449446|50065603|FG004|Overall Study|Investigator's Discretion|0|||
24976695|NCT03449446|50065604|FG005|Overall Study|Investigator's Discretion|0|||
24976696|NCT03449446|50065605|FG006|Overall Study|Investigator's Discretion|0|||
24976697|NCT03449446|50065599|FG000|Overall Study|Non Compliance with Study Drug|1|||
24976698|NCT03449446|50065600|FG001|Overall Study|Non Compliance with Study Drug|0|||
24976699|NCT03449446|50065601|FG002|Overall Study|Non Compliance with Study Drug|0|||
24976700|NCT03449446|50065602|FG003|Overall Study|Non Compliance with Study Drug|0|||
24976701|NCT03449446|50065603|FG004|Overall Study|Non Compliance with Study Drug|0|||
24976702|NCT03449446|50065604|FG005|Overall Study|Non Compliance with Study Drug|0|||
24976703|NCT03449446|50065605|FG006|Overall Study|Non Compliance with Study Drug|0|||
25077536|NCT02240680|50185298|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
24976704|NCT03449446|50065599|FG000|Overall Study|Protocol Violation|0|||
24976705|NCT03449446|50065600|FG001|Overall Study|Protocol Violation|0|||
24976706|NCT03449446|50065601|FG002|Overall Study|Protocol Violation|0|||
24976707|NCT03449446|50065602|FG003|Overall Study|Protocol Violation|0|||
24976708|NCT03449446|50065603|FG004|Overall Study|Protocol Violation|1|||
24976709|NCT03449446|50065604|FG005|Overall Study|Protocol Violation|1|||
24976710|NCT03449446|50065605|FG006|Overall Study|Protocol Violation|0|||
24976711|NCT03449446|50065599|FG000|Overall Study|Death|0|||
24976712|NCT03449446|50065600|FG001|Overall Study|Death|0|||
24976713|NCT03449446|50065601|FG002|Overall Study|Death|0|||
24976714|NCT03449446|50065602|FG003|Overall Study|Death|0|||
24976715|NCT03449446|50065603|FG004|Overall Study|Death|1|||
24976716|NCT03449446|50065604|FG005|Overall Study|Death|0|||
24976717|NCT03449446|50065605|FG006|Overall Study|Death|0|||
24976718|NCT03449134|50065624|FG000|52-Week Treatment Period|Death|2|||
24976719|NCT03449134|50065625|FG001|52-Week Treatment Period|Death|1|||
24976720|NCT03449134|50065626|FG002|52-Week Treatment Period|Death|0|||
24976721|NCT03449134|50065624|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
24976722|NCT03449134|50065625|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
24976723|NCT03449134|50065626|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
24976724|NCT03449134|50065624|FG000|52-Week Treatment Period|Physician Decision|2|||
24976725|NCT03449134|50065625|FG001|52-Week Treatment Period|Physician Decision|3|||
24976726|NCT03449134|50065626|FG002|52-Week Treatment Period|Physician Decision|3|||
24976727|NCT03449134|50065624|FG000|52-Week Treatment Period|Screen Failure|1|||
24976728|NCT03449134|50065625|FG001|52-Week Treatment Period|Screen Failure|0|||
24976729|NCT03449134|50065626|FG002|52-Week Treatment Period|Screen Failure|1|||
24976730|NCT03449134|50065624|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
24976731|NCT03449134|50065625|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
24976732|NCT03449134|50065626|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
24976733|NCT03449134|50065624|FG000|52-Week Treatment Period|Site Closure|1|||
24976734|NCT03449134|50065625|FG001|52-Week Treatment Period|Site Closure|0|||
24976735|NCT03449134|50065626|FG002|52-Week Treatment Period|Site Closure|0|||
24976736|NCT03529162|50065639|FG000|Overall Study|Lost to Follow-up|2|||
24976737|NCT03529162|50065640|FG001|Overall Study|Lost to Follow-up|2|||
24976738|NCT03447730|50065651|FG000|Overall Study|Adverse Event|0|||
24976739|NCT03447730|50065652|FG001|Overall Study|Adverse Event|2|||
24976740|NCT03447730|50065653|FG002|Overall Study|Adverse Event|0|||
24976741|NCT03429556|50065665|FG000|Overall Study|Lost to Follow-up|0|||
24976742|NCT03429556|50065666|FG001|Overall Study|Lost to Follow-up|1|||
24976743|NCT03429556|50065667|FG002|Overall Study|Lost to Follow-up|0|||
24976744|NCT03429556|50065668|FG003|Overall Study|Lost to Follow-up|0|||
24976745|NCT03428152|50065680|FG000|Overall Study|Physician Decision|4|||
24976746|NCT03428152|50065681|FG001|Overall Study|Physician Decision|2|||
25235384|NCT03873246|50546797|FG001|Overall Study|Lost to Follow-up|4|||
25235385|NCT03873246|50546798|FG002|Overall Study|Lost to Follow-up|5|||
25235386|NCT03873246|50546796|FG000|Overall Study|Protocol Violation|0|||
25235387|NCT03873246|50546797|FG001|Overall Study|Protocol Violation|1|||
25235388|NCT03873246|50546798|FG002|Overall Study|Protocol Violation|0|||
25235389|NCT03873246|50546796|FG000|Overall Study|Withdrawal by Subject|0|||
25235390|NCT03873246|50546797|FG001|Overall Study|Withdrawal by Subject|4|||
25235391|NCT03873246|50546798|FG002|Overall Study|Withdrawal by Subject|1|||
25235392|NCT03769649|50546807|FG000|Overall Study|Lost to Follow-up|4|||
25235393|NCT02862548|50546833|FG000|Randomized Phase (Up to Week 48)|Death|0|||
25235394|NCT02862548|50546834|FG001|Randomized Phase (Up to Week 48)|Death|1|||
25235395|NCT02862548|50546833|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
25235396|NCT02862548|50546834|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
25235397|NCT02862548|50546833|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
25235398|NCT02862548|50546834|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
25235399|NCT02862548|50546833|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
25235400|NCT02862548|50546834|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
25235401|NCT02335099|50546853|FG000|Treatment|Withdrawal by Subject|1|||
25235402|NCT02335099|50546854|FG001|Treatment|Withdrawal by Subject|3|||
25235403|NCT02335099|50546853|FG000|Treatment|Lost to Follow-up|2|||
25235404|NCT02335099|50546854|FG001|Treatment|Lost to Follow-up|0|||
25235405|NCT02335099|50546853|FG000|Treatment|Death|1|||
25235406|NCT02335099|50546854|FG001|Treatment|Death|0|||
25319475|NCT00936611|50635027|FG000|Overall Study|Progressive Disease|3|||
25319476|NCT00936611|50635027|FG000|Overall Study|New Systemic Therapy|22|||
25319477|NCT00936611|50635027|FG000|Overall Study|Lost to Follow-up|1|||
25319478|NCT00936611|50635027|FG000|Overall Study|Withdrawal by Subject|2|||
25319479|NCT00936611|50635027|FG000|Overall Study|Still on Follow-up|1|||
25319480|NCT00936611|50635027|FG000|Overall Study|Still on Active Therapy|7|||
25319481|NCT00936611|50635027|FG000|Overall Study|Ineligible for Study Drug|3|||
24976747|NCT03428152|50065680|FG000|Overall Study|Protocol Violation|3|||
24976748|NCT03428152|50065681|FG001|Overall Study|Protocol Violation|5|||
24976749|NCT03428152|50065680|FG000|Overall Study|Lack of Efficacy|0|||
24976750|NCT03428152|50065681|FG001|Overall Study|Lack of Efficacy|4|||
24976751|NCT03444766|50065687|FG000|Overall Study|Other Reasons|2|||
25235407|NCT02335099|50546853|FG000|Treatment|Adverse Event|1|||
25235408|NCT02335099|50546854|FG001|Treatment|Adverse Event|2|||
25235409|NCT02335099|50546853|FG000|Follow-up|Death|0|||
25235410|NCT02335099|50546854|FG001|Follow-up|Death|1|||
25235411|NCT02330562|50546871|FG000|Overall Study|Adverse Event|0|||
25235412|NCT02330562|50546872|FG001|Overall Study|Adverse Event|0|||
25235413|NCT02330562|50546873|FG002|Overall Study|Adverse Event|3|||
25235414|NCT02330562|50546874|FG003|Overall Study|Adverse Event|0|||
25235415|NCT02330562|50546875|FG004|Overall Study|Adverse Event|3|||
25235416|NCT02330562|50546876|FG005|Overall Study|Adverse Event|1|||
25235417|NCT02330562|50546877|FG006|Overall Study|Adverse Event|0|||
25235418|NCT02330562|50546878|FG007|Overall Study|Adverse Event|0|||
25235419|NCT02330562|50546879|FG008|Overall Study|Adverse Event|0|||
25235420|NCT02330562|50546880|FG009|Overall Study|Adverse Event|1|||
25235421|NCT02330562|50546881|FG010|Overall Study|Adverse Event|1|||
25235422|NCT02330562|50546871|FG000|Overall Study|Participant decision|1|||
25235423|NCT02330562|50546872|FG001|Overall Study|Participant decision|0|||
25235424|NCT02330562|50546873|FG002|Overall Study|Participant decision|4|||
25235425|NCT02330562|50546874|FG003|Overall Study|Participant decision|1|||
25235426|NCT02330562|50546875|FG004|Overall Study|Participant decision|5|||
25235427|NCT02330562|50546876|FG005|Overall Study|Participant decision|2|||
25235428|NCT02330562|50546877|FG006|Overall Study|Participant decision|0|||
25235429|NCT02330562|50546878|FG007|Overall Study|Participant decision|0|||
25235430|NCT02330562|50546879|FG008|Overall Study|Participant decision|0|||
25235431|NCT02330562|50546880|FG009|Overall Study|Participant decision|3|||
25235432|NCT02330562|50546881|FG010|Overall Study|Participant decision|0|||
25235433|NCT02330562|50546871|FG000|Overall Study|Disease progression|5|||
25235434|NCT02330562|50546872|FG001|Overall Study|Disease progression|3|||
25235435|NCT02330562|50546873|FG002|Overall Study|Disease progression|20|||
25235436|NCT02330562|50546874|FG003|Overall Study|Disease progression|28|||
25235437|NCT02330562|50546875|FG004|Overall Study|Disease progression|23|||
25235438|NCT02330562|50546876|FG005|Overall Study|Disease progression|7|||
25235439|NCT02330562|50546877|FG006|Overall Study|Disease progression|1|||
25235440|NCT02330562|50546878|FG007|Overall Study|Disease progression|1|||
25235441|NCT02330562|50546879|FG008|Overall Study|Disease progression|1|||
25235442|NCT02330562|50546880|FG009|Overall Study|Disease progression|0|||
25235443|NCT02330562|50546881|FG010|Overall Study|Disease progression|5|||
24976752|NCT03444766|50065687|FG000|Overall Study|Participant Withdrew Consent|5|||
24976753|NCT03444766|50065687|FG000|Overall Study|Lost to Follow-up|2|||
24976754|NCT03444766|50065687|FG000|Overall Study|Death|2|||
24976755|NCT03444766|50065687|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
24976756|NCT03444766|50065687|FG000|Overall Study|Disease Progression|49|||
24976757|NCT03426436|50065691|FG000|Overall Study|Incorrect lead placement|12|||
24976758|NCT03426436|50065691|FG000|Overall Study|Withdrawal by Subject|2|||
24976759|NCT03426436|50065691|FG000|Overall Study|Consent issue|1|||
24976760|NCT03426436|50065691|FG000|Overall Study|ECGs not saved|4|||
24976761|NCT03425188|50065695|FG000|Overall Study|Withdrawal by Subject|1|||
24976762|NCT03423238|50065702|FG000|Overall Study|Lost to Follow-up|1|||
24976763|NCT03423238|50065703|FG001|Overall Study|Lost to Follow-up|0|||
24976764|NCT03423238|50065702|FG000|Overall Study|Withdrawal by Subject|1|||
24976765|NCT03423238|50065703|FG001|Overall Study|Withdrawal by Subject|0|||
24976766|NCT02953678|50065710|FG000|Overall Study|Adverse Event|20|||
24976767|NCT02953678|50065710|FG000|Overall Study|Death|7|||
24976768|NCT02953678|50065710|FG000|Overall Study|Physician Decision|23|||
24976769|NCT02953678|50065710|FG000|Overall Study|Progressive Disease of GVHD|7|||
24976770|NCT02953678|50065710|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
24976771|NCT02953678|50065710|FG000|Overall Study|Withdrawal by participant|3|||
24976772|NCT02953678|50065710|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
24976773|NCT02953678|50065710|FG000|Overall Study|Participants were transferred to commercial product.|3|||
24976774|NCT03412084|50065717|FG000|Overall Study|Withdrawal by Subject|2|||
24976775|NCT03412084|50065718|FG001|Overall Study|Withdrawal by Subject|0|||
24976776|NCT03412084|50065717|FG000|Overall Study|Participant moved|1|||
24976777|NCT03412084|50065718|FG001|Overall Study|Participant moved|0|||
24976778|NCT03412084|50065717|FG000|Overall Study|Lost to Follow-up|1|||
24976779|NCT03412084|50065718|FG001|Overall Study|Lost to Follow-up|1|||
24976780|NCT00090753|50065726|FG000|First Treatment Period|Adverse Event|20|||
25235444|NCT02330562|50546871|FG000|Overall Study|Other reasons|0|||
25235445|NCT02330562|50546872|FG001|Overall Study|Other reasons|0|||
25235446|NCT02330562|50546873|FG002|Overall Study|Other reasons|0|||
25235447|NCT02330562|50546874|FG003|Overall Study|Other reasons|1|||
25235448|NCT02330562|50546875|FG004|Overall Study|Other reasons|0|||
25235449|NCT02330562|50546876|FG005|Overall Study|Other reasons|0|||
25235450|NCT02330562|50546877|FG006|Overall Study|Other reasons|0|||
25235451|NCT02330562|50546878|FG007|Overall Study|Other reasons|0|||
25235452|NCT02330562|50546879|FG008|Overall Study|Other reasons|0|||
25235453|NCT02330562|50546880|FG009|Overall Study|Other reasons|0|||
24976781|NCT00090753|50065727|FG001|First Treatment Period|Adverse Event|8|||
24976782|NCT00090753|50065726|FG000|First Treatment Period|Death|88|||
25235454|NCT02330562|50546881|FG010|Overall Study|Other reasons|0|||
25235455|NCT02330562|50546871|FG000|Overall Study|Withdrawal by Subject|0|||
25235456|NCT02330562|50546872|FG001|Overall Study|Withdrawal by Subject|0|||
25235457|NCT02330562|50546873|FG002|Overall Study|Withdrawal by Subject|0|||
25235458|NCT02330562|50546874|FG003|Overall Study|Withdrawal by Subject|0|||
25235459|NCT02330562|50546875|FG004|Overall Study|Withdrawal by Subject|0|||
25235460|NCT02330562|50546876|FG005|Overall Study|Withdrawal by Subject|0|||
25235461|NCT02330562|50546877|FG006|Overall Study|Withdrawal by Subject|0|||
25235462|NCT02330562|50546878|FG007|Overall Study|Withdrawal by Subject|0|||
25235463|NCT02330562|50546879|FG008|Overall Study|Withdrawal by Subject|0|||
25235464|NCT02330562|50546880|FG009|Overall Study|Withdrawal by Subject|1|||
25235465|NCT02330562|50546881|FG010|Overall Study|Withdrawal by Subject|0|||
25235466|NCT03703102|50546995|FG000|Overall Study|Adverse Event|4|||
25319482|NCT00936221|50635050|FG000|Overall Study|Withdrawal by Subject|1|||
25235467|NCT03703102|50546996|FG001|Overall Study|Adverse Event|3|||
25235468|NCT03703102|50546997|FG002|Overall Study|Adverse Event|7|||
25235469|NCT03703102|50546998|FG003|Overall Study|Adverse Event|3|||
24976783|NCT00090753|50065727|FG001|First Treatment Period|Death|62|||
24976784|NCT00090753|50065726|FG000|First Treatment Period|Lack of Efficacy|2|||
24976785|NCT00090753|50065727|FG001|First Treatment Period|Lack of Efficacy|1|||
24976786|NCT00090753|50065726|FG000|First Treatment Period|Refused Treatment|32|||
24976787|NCT00090753|50065727|FG001|First Treatment Period|Refused Treatment|25|||
24976788|NCT00090753|50065726|FG000|First Treatment Period|Lost to Follow-up|4|||
24976789|NCT00090753|50065727|FG001|First Treatment Period|Lost to Follow-up|4|||
24976790|NCT00090753|50065726|FG000|First Treatment Period|Renal Transplant|70|||
24976791|NCT00090753|50065727|FG001|First Treatment Period|Renal Transplant|50|||
24976792|NCT00090753|50065726|FG000|First Treatment Period|Mircera Commercialization|1|||
24976793|NCT00090753|50065727|FG001|First Treatment Period|Mircera Commercialization|0|||
24976794|NCT00090753|50065726|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
24976795|NCT00090753|50065727|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
24976796|NCT00090753|50065726|FG000|Extended Treatment Period|Adverse Event|11|||
24976797|NCT00090753|50065727|FG001|Extended Treatment Period|Adverse Event|0|||
24976798|NCT00090753|50065726|FG000|Extended Treatment Period|Death|58|||
24976799|NCT00090753|50065727|FG001|Extended Treatment Period|Death|30|||
24976800|NCT00090753|50065726|FG000|Extended Treatment Period|Lack of Efficacy|1|||
24976801|NCT00090753|50065727|FG001|Extended Treatment Period|Lack of Efficacy|0|||
24976802|NCT00090753|50065726|FG000|Extended Treatment Period|Refused Treatment|18|||
24976803|NCT00090753|50065727|FG001|Extended Treatment Period|Refused Treatment|12|||
24976804|NCT00090753|50065726|FG000|Extended Treatment Period|Lost to Follow-up|3|||
25319483|NCT00936221|50635051|FG001|Overall Study|Withdrawal by Subject|1|||
25319484|NCT00776919|50635061|FG000|Overall Study|Withdrawal by Subject|16|||
25319485|NCT00776919|50635062|FG001|Overall Study|Withdrawal by Subject|14|||
25319486|NCT00776919|50635063|FG002|Overall Study|Withdrawal by Subject|15|||
25319487|NCT00776919|50635064|FG003|Overall Study|Withdrawal by Subject|26|||
25319488|NCT00776919|50635061|FG000|Overall Study|Lost to Follow-up|8|||
25319489|NCT00776919|50635062|FG001|Overall Study|Lost to Follow-up|12|||
25319490|NCT00776919|50635063|FG002|Overall Study|Lost to Follow-up|11|||
25319491|NCT00776919|50635064|FG003|Overall Study|Lost to Follow-up|8|||
25319492|NCT00776919|50635061|FG000|Overall Study|Adverse Event|1|||
25319493|NCT00776919|50635062|FG001|Overall Study|Adverse Event|0|||
25319494|NCT00776919|50635063|FG002|Overall Study|Adverse Event|2|||
25319495|NCT00776919|50635064|FG003|Overall Study|Adverse Event|2|||
25319496|NCT00776919|50635061|FG000|Overall Study|Protocol Violation|1|||
25319497|NCT00776919|50635062|FG001|Overall Study|Protocol Violation|2|||
25077537|NCT02240680|50185295|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
25319498|NCT00776919|50635063|FG002|Overall Study|Protocol Violation|0|||
25319499|NCT00776919|50635064|FG003|Overall Study|Protocol Violation|1|||
25235470|NCT03703102|50546999|FG004|Overall Study|Adverse Event|13|||
25235471|NCT03703102|50546995|FG000|Overall Study|Lack of Efficacy|4|||
25235472|NCT03703102|50546996|FG001|Overall Study|Lack of Efficacy|0|||
25235473|NCT03703102|50546997|FG002|Overall Study|Lack of Efficacy|1|||
25235474|NCT03703102|50546998|FG003|Overall Study|Lack of Efficacy|4|||
25235475|NCT03703102|50546999|FG004|Overall Study|Lack of Efficacy|1|||
25235476|NCT03703102|50546995|FG000|Overall Study|Lost to Follow-up|0|||
25235477|NCT03703102|50546996|FG001|Overall Study|Lost to Follow-up|0|||
25235478|NCT03703102|50546997|FG002|Overall Study|Lost to Follow-up|1|||
25235479|NCT03703102|50546998|FG003|Overall Study|Lost to Follow-up|2|||
25235480|NCT03703102|50546999|FG004|Overall Study|Lost to Follow-up|2|||
25235481|NCT03703102|50546995|FG000|Overall Study|Physician Decision|2|||
25235482|NCT03703102|50546996|FG001|Overall Study|Physician Decision|2|||
25235483|NCT03703102|50546997|FG002|Overall Study|Physician Decision|2|||
25235484|NCT03703102|50546998|FG003|Overall Study|Physician Decision|2|||
25235485|NCT03703102|50546999|FG004|Overall Study|Physician Decision|4|||
25235486|NCT03703102|50546995|FG000|Overall Study|Withdrawal by Subject|7|||
25235487|NCT03703102|50546996|FG001|Overall Study|Withdrawal by Subject|5|||
25235488|NCT03703102|50546997|FG002|Overall Study|Withdrawal by Subject|5|||
25235489|NCT03703102|50546998|FG003|Overall Study|Withdrawal by Subject|5|||
25235490|NCT03703102|50546999|FG004|Overall Study|Withdrawal by Subject|9|||
25235491|NCT03703102|50546995|FG000|Overall Study|Ineligibility|0|||
25235492|NCT03703102|50546996|FG001|Overall Study|Ineligibility|0|||
25235493|NCT03703102|50546997|FG002|Overall Study|Ineligibility|1|||
25235494|NCT03703102|50546998|FG003|Overall Study|Ineligibility|0|||
25235495|NCT03703102|50546999|FG004|Overall Study|Ineligibility|0|||
25235496|NCT03703102|50546995|FG000|Overall Study|Protocol Deviation|4|||
25235497|NCT03703102|50546996|FG001|Overall Study|Protocol Deviation|4|||
25235498|NCT03703102|50546997|FG002|Overall Study|Protocol Deviation|3|||
25235499|NCT03703102|50546998|FG003|Overall Study|Protocol Deviation|0|||
25235500|NCT03703102|50546999|FG004|Overall Study|Protocol Deviation|0|||
25235501|NCT03703102|50546995|FG000|Overall Study|Non-Compliance with Study Drug|1|||
25235502|NCT03703102|50546996|FG001|Overall Study|Non-Compliance with Study Drug|1|||
25235503|NCT03703102|50546997|FG002|Overall Study|Non-Compliance with Study Drug|2|||
25235504|NCT03703102|50546998|FG003|Overall Study|Non-Compliance with Study Drug|1|||
25235505|NCT03703102|50546999|FG004|Overall Study|Non-Compliance with Study Drug|4|||
25235506|NCT03395704|50547018|FG000|Overall Study|Adverse Event|2|||
25235507|NCT03395704|50547019|FG001|Overall Study|Adverse Event|1|||
25235508|NCT03395704|50547018|FG000|Overall Study|Withdrawal by Subject|2|||
25235509|NCT03395704|50547019|FG001|Overall Study|Withdrawal by Subject|1|||
25235510|NCT03395704|50547018|FG000|Overall Study|Physician Decision|0|||
25235511|NCT03395704|50547019|FG001|Overall Study|Physician Decision|1|||
25235512|NCT03335813|50547025|FG000|Overall Study|Withdrawal by Subject|1|||
25235513|NCT03246503|50547029|FG000|Overall Study|Lost to Follow-up|23|||
25235514|NCT03246503|50547029|FG000|Overall Study|Withdrawal by Subject|20|||
25235515|NCT03246503|50547029|FG000|Overall Study|Physician Decision|5|||
25235516|NCT03246503|50547029|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
25235517|NCT02514447|50547090|FG000|Overall Study|Withdrawal by Subject|3|||
25235518|NCT02514447|50547091|FG001|Overall Study|Withdrawal by Subject|1|||
25235519|NCT02514447|50547092|FG002|Overall Study|Withdrawal by Subject|1|||
25235520|NCT02514447|50547093|FG003|Overall Study|Withdrawal by Subject|0|||
25235521|NCT02514447|50547094|FG004|Overall Study|Withdrawal by Subject|0|||
25235522|NCT02514447|50547095|FG005|Overall Study|Withdrawal by Subject|0|||
25235523|NCT02514447|50547096|FG006|Overall Study|Withdrawal by Subject|0|||
25235524|NCT02514447|50547097|FG007|Overall Study|Withdrawal by Subject|1|||
25235525|NCT02514447|50547098|FG008|Overall Study|Withdrawal by Subject|1|||
25235526|NCT02514447|50547090|FG000|Overall Study|Death|24|||
25235527|NCT02514447|50547091|FG001|Overall Study|Death|28|||
25235528|NCT02514447|50547092|FG002|Overall Study|Death|29|||
25235529|NCT02514447|50547093|FG003|Overall Study|Death|0|||
25235530|NCT02514447|50547094|FG004|Overall Study|Death|3|||
25235531|NCT02514447|50547095|FG005|Overall Study|Death|4|||
25235532|NCT02514447|50547096|FG006|Overall Study|Death|8|||
25235533|NCT02514447|50547097|FG007|Overall Study|Death|6|||
25235534|NCT02514447|50547098|FG008|Overall Study|Death|5|||
25235535|NCT02514447|50547090|FG000|Overall Study|Lost to Follow-up|1|||
25235536|NCT02514447|50547091|FG001|Overall Study|Lost to Follow-up|0|||
25235537|NCT02514447|50547092|FG002|Overall Study|Lost to Follow-up|0|||
25235538|NCT02514447|50547093|FG003|Overall Study|Lost to Follow-up|0|||
25235539|NCT02514447|50547094|FG004|Overall Study|Lost to Follow-up|0|||
25235540|NCT02514447|50547095|FG005|Overall Study|Lost to Follow-up|0|||
25235541|NCT02514447|50547096|FG006|Overall Study|Lost to Follow-up|0|||
25235542|NCT02514447|50547097|FG007|Overall Study|Lost to Follow-up|0|||
25235543|NCT02514447|50547098|FG008|Overall Study|Lost to Follow-up|1|||
25235544|NCT02514447|50547090|FG000|Overall Study|Sponsor Termination of Study|0|||
25235545|NCT02514447|50547091|FG001|Overall Study|Sponsor Termination of Study|1|||
25235546|NCT02514447|50547092|FG002|Overall Study|Sponsor Termination of Study|1|||
25235547|NCT02514447|50547093|FG003|Overall Study|Sponsor Termination of Study|0|||
25235548|NCT02514447|50547094|FG004|Overall Study|Sponsor Termination of Study|0|||
25235549|NCT02514447|50547095|FG005|Overall Study|Sponsor Termination of Study|0|||
25235550|NCT02514447|50547096|FG006|Overall Study|Sponsor Termination of Study|0|||
25235551|NCT02514447|50547097|FG007|Overall Study|Sponsor Termination of Study|0|||
25235552|NCT02514447|50547098|FG008|Overall Study|Sponsor Termination of Study|0|||
25235553|NCT02514447|50547090|FG000|Overall Study|Study completion per Investigator|1|||
25235554|NCT02514447|50547091|FG001|Overall Study|Study completion per Investigator|0|||
25235555|NCT02514447|50547092|FG002|Overall Study|Study completion per Investigator|1|||
25235556|NCT02514447|50547093|FG003|Overall Study|Study completion per Investigator|2|||
25235557|NCT02514447|50547094|FG004|Overall Study|Study completion per Investigator|0|||
25235558|NCT02514447|50547095|FG005|Overall Study|Study completion per Investigator|0|||
25235559|NCT02514447|50547096|FG006|Overall Study|Study completion per Investigator|0|||
25235560|NCT02514447|50547097|FG007|Overall Study|Study completion per Investigator|0|||
25235561|NCT02514447|50547098|FG008|Overall Study|Study completion per Investigator|1|||
25235562|NCT01785563|50547142|FG000|Overall Study|Physician Decision|10|||
25235563|NCT01785563|50547142|FG000|Overall Study|Withdrawal by Subject|1|||
25235564|NCT01785563|50547142|FG000|Overall Study|Protocol Violation|2|||
25235565|NCT01434290|50547148|FG000|Overall Study|Protocol Violation|6|||
25235566|NCT01434290|50547149|FG001|Overall Study|Protocol Violation|3|||
25235567|NCT01434290|50547148|FG000|Overall Study|No protocol treatment|2|||
25235568|NCT01434290|50547149|FG001|Overall Study|No protocol treatment|4|||
25235569|NCT00750269|50547161|FG000|Overall Study|Protocol Violation|0|||
25235570|NCT00750269|50547162|FG001|Overall Study|Protocol Violation|1|||
25235571|NCT00750269|50547163|FG002|Overall Study|Protocol Violation|1|||
25235572|NCT00750269|50547164|FG003|Overall Study|Protocol Violation|2|||
25235573|NCT00750269|50547165|FG004|Overall Study|Protocol Violation|4|||
25235574|NCT00750269|50547161|FG000|Overall Study|Withdrawal by Subject|0|||
25319500|NCT00776919|50635061|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
25319501|NCT00776919|50635062|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
25319502|NCT00776919|50635063|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
25319503|NCT00776919|50635064|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
25319504|NCT00775983|50635091|FG000|Overall Study|Protocol Violation|1|||
25319505|NCT00775983|50635092|FG001|Overall Study|Protocol Violation|2|||
25319506|NCT00775593|50635098|FG000|Overall Study|Unmet eligibility criteria|6|||
25235575|NCT00750269|50547162|FG001|Overall Study|Withdrawal by Subject|0|||
25235576|NCT00750269|50547163|FG002|Overall Study|Withdrawal by Subject|2|||
25235577|NCT00750269|50547164|FG003|Overall Study|Withdrawal by Subject|2|||
25235578|NCT00750269|50547165|FG004|Overall Study|Withdrawal by Subject|2|||
25235579|NCT00750269|50547161|FG000|Overall Study|Physician Decision|0|||
25235580|NCT00750269|50547162|FG001|Overall Study|Physician Decision|0|||
25235581|NCT00750269|50547163|FG002|Overall Study|Physician Decision|0|||
25235582|NCT00750269|50547164|FG003|Overall Study|Physician Decision|0|||
25235583|NCT00750269|50547165|FG004|Overall Study|Physician Decision|2|||
25235584|NCT00750269|50547161|FG000|Overall Study|Patient too large for positioning|0|||
25235585|NCT00750269|50547162|FG001|Overall Study|Patient too large for positioning|0|||
25235586|NCT00750269|50547163|FG002|Overall Study|Patient too large for positioning|1|||
25319507|NCT00775593|50635098|FG000|Overall Study|Death|1|||
25235587|NCT00750269|50547164|FG003|Overall Study|Patient too large for positioning|0|||
25235588|NCT00750269|50547165|FG004|Overall Study|Patient too large for positioning|0|||
25235589|NCT00750269|50547161|FG000|Overall Study|Site error|0|||
25235590|NCT00750269|50547162|FG001|Overall Study|Site error|0|||
25235591|NCT00750269|50547163|FG002|Overall Study|Site error|0|||
25235592|NCT00750269|50547164|FG003|Overall Study|Site error|1|||
25235593|NCT00750269|50547165|FG004|Overall Study|Site error|0|||
25235594|NCT00750269|50547161|FG000|Overall Study|SBRT plan could not be drawn|0|||
25235595|NCT00750269|50547162|FG001|Overall Study|SBRT plan could not be drawn|0|||
25235596|NCT00750269|50547163|FG002|Overall Study|SBRT plan could not be drawn|0|||
25235597|NCT00750269|50547164|FG003|Overall Study|SBRT plan could not be drawn|0|||
25235598|NCT00750269|50547165|FG004|Overall Study|SBRT plan could not be drawn|1|||
25235599|NCT00750269|50547161|FG000|Overall Study|Fiducials could not be placed|0|||
25235600|NCT00750269|50547162|FG001|Overall Study|Fiducials could not be placed|0|||
25235601|NCT00750269|50547163|FG002|Overall Study|Fiducials could not be placed|0|||
25235602|NCT00750269|50547164|FG003|Overall Study|Fiducials could not be placed|0|||
25235603|NCT00750269|50547165|FG004|Overall Study|Fiducials could not be placed|1|||
25235604|NCT00712322|50547187|FG000|Overall Study|Protocol deviation|0|||
25235605|NCT00712322|50547188|FG001|Overall Study|Protocol deviation|1|||
25235606|NCT00712322|50547189|FG002|Overall Study|Protocol deviation|0|||
25235607|NCT00323856|50547197|FG000|Overall Study|Withdrawal by Subject|1|||
25235608|NCT00323856|50547197|FG000|Overall Study|Was uncooperative and noncompliant|1|||
25235609|NCT00323856|50547197|FG000|Overall Study|Reason not specified|1|||
25235610|NCT00323856|50547197|FG000|Overall Study|Missing|2|||
25235611|NCT04524663|50547210|FG000|Overall Study|Withdrawal by Subject|0|||
25235612|NCT04524663|50547211|FG001|Overall Study|Withdrawal by Subject|2|||
25235613|NCT03738423|50547240|FG000|Overall Study|Withdrawal by Subject|9|||
25235614|NCT03738423|50547241|FG001|Overall Study|Withdrawal by Subject|12|||
25235615|NCT03738423|50547242|FG002|Overall Study|Withdrawal by Subject|9|||
25235616|NCT03738423|50547243|FG003|Overall Study|Withdrawal by Subject|12|||
25235617|NCT03738423|50547244|FG004|Overall Study|Withdrawal by Subject|10|||
25235618|NCT03738423|50547240|FG000|Overall Study|Lack of Efficacy|3|||
25235619|NCT03738423|50547241|FG001|Overall Study|Lack of Efficacy|1|||
25235620|NCT03738423|50547242|FG002|Overall Study|Lack of Efficacy|1|||
25235621|NCT03738423|50547243|FG003|Overall Study|Lack of Efficacy|1|||
25235622|NCT03738423|50547244|FG004|Overall Study|Lack of Efficacy|2|||
25235623|NCT03738423|50547240|FG000|Overall Study|Lost to Follow-up|1|||
25235624|NCT03738423|50547241|FG001|Overall Study|Lost to Follow-up|0|||
25235625|NCT03738423|50547242|FG002|Overall Study|Lost to Follow-up|1|||
25235626|NCT03738423|50547243|FG003|Overall Study|Lost to Follow-up|1|||
25235627|NCT03738423|50547244|FG004|Overall Study|Lost to Follow-up|0|||
25235628|NCT03738423|50547240|FG000|Overall Study|Protocol Violation|1|||
25235629|NCT03738423|50547241|FG001|Overall Study|Protocol Violation|0|||
25235630|NCT03738423|50547242|FG002|Overall Study|Protocol Violation|0|||
25235631|NCT03738423|50547243|FG003|Overall Study|Protocol Violation|0|||
25235632|NCT03738423|50547244|FG004|Overall Study|Protocol Violation|1|||
25235633|NCT03738423|50547240|FG000|Overall Study|Physician Decision|0|||
25235634|NCT03738423|50547241|FG001|Overall Study|Physician Decision|0|||
25235635|NCT03738423|50547242|FG002|Overall Study|Physician Decision|1|||
25235636|NCT03738423|50547243|FG003|Overall Study|Physician Decision|0|||
25235637|NCT03738423|50547244|FG004|Overall Study|Physician Decision|1|||
25235638|NCT03738423|50547240|FG000|Overall Study|Death|0|||
25235639|NCT03738423|50547241|FG001|Overall Study|Death|0|||
25235640|NCT03738423|50547242|FG002|Overall Study|Death|0|||
25235641|NCT03738423|50547243|FG003|Overall Study|Death|0|||
25235642|NCT03738423|50547244|FG004|Overall Study|Death|1|||
25235643|NCT03738423|50547240|FG000|Overall Study|Randomized but never treated|0|||
25235644|NCT03738423|50547241|FG001|Overall Study|Randomized but never treated|0|||
25235645|NCT03738423|50547242|FG002|Overall Study|Randomized but never treated|1|||
25235646|NCT03738423|50547243|FG003|Overall Study|Randomized but never treated|1|||
25319508|NCT00939809|50635102|FG000|Overall Study|Adverse Event|2|||
25235647|NCT03738423|50547244|FG004|Overall Study|Randomized but never treated|0|||
25235648|NCT03712228|50547262|FG000|Treatment Period 1|Lack of Efficacy|0|||
25235649|NCT03712228|50547263|FG001|Treatment Period 1|Lack of Efficacy|0|||
25235650|NCT03712228|50547264|FG002|Treatment Period 1|Lack of Efficacy|0|||
25235651|NCT03712228|50547265|FG003|Treatment Period 1|Lack of Efficacy|0|||
25235652|NCT03712228|50547266|FG004|Treatment Period 1|Lack of Efficacy|0|||
25235653|NCT03712228|50547267|FG005|Treatment Period 1|Lack of Efficacy|1|||
25235654|NCT03712228|50547262|FG000|Treatment Period 2|Pregnancy|0|||
25235655|NCT03712228|50547263|FG001|Treatment Period 2|Pregnancy|0|||
25235656|NCT03712228|50547264|FG002|Treatment Period 2|Pregnancy|0|||
25235657|NCT03712228|50547265|FG003|Treatment Period 2|Pregnancy|1|||
25235658|NCT03712228|50547266|FG004|Treatment Period 2|Pregnancy|0|||
25235659|NCT03712228|50547267|FG005|Treatment Period 2|Pregnancy|0|||
25235660|NCT03712228|50547262|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25235661|NCT03712228|50547263|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25235662|NCT03712228|50547264|FG002|Treatment Period 2|Withdrawal by Subject|0|||
25235663|NCT03712228|50547265|FG003|Treatment Period 2|Withdrawal by Subject|1|||
25235664|NCT03712228|50547266|FG004|Treatment Period 2|Withdrawal by Subject|0|||
25235665|NCT03712228|50547267|FG005|Treatment Period 2|Withdrawal by Subject|0|||
25235666|NCT03600818|50547286|FG000|Overall Study|Adverse Event|4|||
25235667|NCT03600818|50547287|FG001|Overall Study|Adverse Event|7|||
25235668|NCT03600818|50547286|FG000|Overall Study|Lack of Efficacy|9|||
25235669|NCT03600818|50547287|FG001|Overall Study|Lack of Efficacy|4|||
25235670|NCT03600818|50547286|FG000|Overall Study|Withdrawal by Subject|4|||
25235671|NCT03600818|50547287|FG001|Overall Study|Withdrawal by Subject|3|||
25319509|NCT00939809|50635102|FG000|Overall Study|Death|1|||
25319510|NCT00934661|50635108|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
25319511|NCT00934661|50635109|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
25319512|NCT00775437|50635115|FG000|Overall Study|Loss of efficacy|2|||
25319513|NCT00775437|50635115|FG000|Overall Study|Withdrawal by Subject|3|||
25319514|NCT00775437|50635115|FG000|Overall Study|Lost to Follow-up|1|||
25319515|NCT00775203|50635121|FG000|Overall Study|Adverse Event|25|||
25319516|NCT00775203|50635122|FG001|Overall Study|Adverse Event|6|||
25319517|NCT00775203|50635121|FG000|Overall Study|Lack of Efficacy|8|||
25319518|NCT00775203|50635122|FG001|Overall Study|Lack of Efficacy|9|||
25319519|NCT00775203|50635121|FG000|Overall Study|Withdrawal by Subject|11|||
25319520|NCT00775203|50635122|FG001|Overall Study|Withdrawal by Subject|9|||
25319521|NCT00775203|50635121|FG000|Overall Study|Lost to Follow-up|11|||
25319522|NCT00775203|50635122|FG001|Overall Study|Lost to Follow-up|15|||
25319523|NCT00775203|50635121|FG000|Overall Study|Administrative reason|2|||
25319524|NCT00775203|50635122|FG001|Overall Study|Administrative reason|0|||
25319525|NCT00775203|50635121|FG000|Overall Study|Noncompliance|4|||
25319526|NCT00775203|50635122|FG001|Overall Study|Noncompliance|2|||
25319527|NCT00775203|50635121|FG000|Overall Study|Protocol Violation|0|||
25319528|NCT00775203|50635122|FG001|Overall Study|Protocol Violation|1|||
25319529|NCT00775203|50635121|FG000|Overall Study|Entered other study|1|||
25319530|NCT00775203|50635122|FG001|Overall Study|Entered other study|0|||
25319531|NCT00775203|50635121|FG000|Overall Study|Physician Decision|0|||
25319532|NCT00775203|50635122|FG001|Overall Study|Physician Decision|1|||
25319533|NCT00568321|50635131|FG000|Overall Study|Adverse Event|1|||
25319534|NCT00568321|50635132|FG001|Overall Study|Adverse Event|0|||
25319535|NCT00568321|50635133|FG002|Overall Study|Adverse Event|0|||
25319536|NCT00568321|50635131|FG000|Overall Study|Lack of Efficacy|8|||
25319537|NCT00568321|50635132|FG001|Overall Study|Lack of Efficacy|5|||
25319538|NCT00568321|50635133|FG002|Overall Study|Lack of Efficacy|6|||
25319539|NCT00568321|50635131|FG000|Overall Study|Lost to Follow-up|0|||
25319540|NCT00568321|50635132|FG001|Overall Study|Lost to Follow-up|0|||
25319541|NCT00568321|50635133|FG002|Overall Study|Lost to Follow-up|1|||
25319542|NCT00568321|50635131|FG000|Overall Study|Withdrawal by Subject|2|||
25319543|NCT00568321|50635132|FG001|Overall Study|Withdrawal by Subject|0|||
25319544|NCT00568321|50635133|FG002|Overall Study|Withdrawal by Subject|0|||
25319545|NCT00568321|50635131|FG000|Overall Study|Protocol Violation|0|||
25319546|NCT00568321|50635132|FG001|Overall Study|Protocol Violation|0|||
25319547|NCT00568321|50635133|FG002|Overall Study|Protocol Violation|1|||
25319548|NCT00568321|50635131|FG000|Overall Study|Randomized, not treated|2|||
25319549|NCT00568321|50635132|FG001|Overall Study|Randomized, not treated|0|||
25319550|NCT00568321|50635133|FG002|Overall Study|Randomized, not treated|1|||
25235672|NCT03600818|50547286|FG000|Overall Study|Other-unspecified|5|||
25319551|NCT00774345|50635145|FG000|Pre-treatment|Other reasons|2|||
25319552|NCT00774345|50635146|FG001|Pre-treatment|Other reasons|0|||
25319553|NCT00774345|50635145|FG000|Treatment|Adverse Event|61|||
25319554|NCT00774345|50635146|FG001|Treatment|Adverse Event|15|||
25319555|NCT00774345|50635145|FG000|Treatment|Progressive Disease without histologic transformation|51|||
25235673|NCT03600818|50547287|FG001|Overall Study|Other-unspecified|3|||
25319556|NCT00774345|50635146|FG001|Treatment|Progressive Disease without histologic transformation|111|||
25319557|NCT00774345|50635145|FG000|Treatment|Progressive Disease with histologic transformation|4|||
25319558|NCT00774345|50635146|FG001|Treatment|Progressive Disease with histologic transformation|2|||
25235674|NCT03600818|50547286|FG000|Overall Study|Randomized and not treated|0|||
25235675|NCT03600818|50547287|FG001|Overall Study|Randomized and not treated|1|||
25235676|NCT03578276|50547296|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
25235677|NCT03578276|50547297|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
25235678|NCT01627574|50547344|FG000|Overall Study|Withdrawal by Subject|8|||
25235679|NCT01627574|50547345|FG001|Overall Study|Withdrawal by Subject|5|||
25235680|NCT01627574|50547344|FG000|Overall Study|Lost to Follow-up|13|||
25235681|NCT01627574|50547345|FG001|Overall Study|Lost to Follow-up|13|||
25235682|NCT01498458|50547351|FG000|Overall Study|Adverse Event|4|||
25235683|NCT01498458|50547351|FG000|Overall Study|Physician Decision|3|||
25235684|NCT01427712|50547360|FG000|Overall Study|Transfer to a different hospital|2|||
25235685|NCT01427712|50547360|FG000|Overall Study|Lost to Follow-up|1|||
25235686|NCT01427712|50547360|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
25235687|NCT01427712|50547360|FG000|Overall Study|Failure to visit|1|||
25235688|NCT01369147|50547367|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
25235689|NCT01369147|50547368|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
25235690|NCT01369147|50547369|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
25235691|NCT04846231|50547385|FG000|Overall Study|Lost to Follow-up|1|||
25235692|NCT04846231|50547386|FG001|Overall Study|Lost to Follow-up|0|||
25235693|NCT04846231|50547387|FG002|Overall Study|Lost to Follow-up|0|||
25235694|NCT04846231|50547388|FG003|Overall Study|Lost to Follow-up|0|||
25235695|NCT04846231|50547389|FG004|Overall Study|Lost to Follow-up|0|||
25235696|NCT04846231|50547390|FG005|Overall Study|Lost to Follow-up|0|||
25235697|NCT04846231|50547391|FG006|Overall Study|Lost to Follow-up|0|||
25235698|NCT04846231|50547392|FG007|Overall Study|Lost to Follow-up|1|||
25235699|NCT04846231|50547385|FG000|Overall Study|Withdrawal by Subject|0|||
25235700|NCT04846231|50547386|FG001|Overall Study|Withdrawal by Subject|1|||
25235701|NCT04846231|50547387|FG002|Overall Study|Withdrawal by Subject|2|||
25235702|NCT04846231|50547388|FG003|Overall Study|Withdrawal by Subject|1|||
25235703|NCT04846231|50547389|FG004|Overall Study|Withdrawal by Subject|0|||
25235704|NCT04846231|50547390|FG005|Overall Study|Withdrawal by Subject|0|||
25235705|NCT04846231|50547391|FG006|Overall Study|Withdrawal by Subject|0|||
25235706|NCT04846231|50547392|FG007|Overall Study|Withdrawal by Subject|0|||
25235707|NCT04846231|50547385|FG000|Overall Study|Protocol Violation|0|||
25235708|NCT04846231|50547386|FG001|Overall Study|Protocol Violation|1|||
25235709|NCT04846231|50547387|FG002|Overall Study|Protocol Violation|0|||
25235710|NCT04846231|50547388|FG003|Overall Study|Protocol Violation|0|||
25235711|NCT04846231|50547389|FG004|Overall Study|Protocol Violation|0|||
25235712|NCT04846231|50547390|FG005|Overall Study|Protocol Violation|0|||
25235713|NCT04846231|50547391|FG006|Overall Study|Protocol Violation|0|||
25235714|NCT04846231|50547392|FG007|Overall Study|Protocol Violation|0|||
25235715|NCT04846231|50547385|FG000|Overall Study|Adverse Event|0|||
25235716|NCT04846231|50547386|FG001|Overall Study|Adverse Event|0|||
25235717|NCT04846231|50547387|FG002|Overall Study|Adverse Event|0|||
25235718|NCT04846231|50547388|FG003|Overall Study|Adverse Event|0|||
25235719|NCT04846231|50547389|FG004|Overall Study|Adverse Event|0|||
25235720|NCT04846231|50547390|FG005|Overall Study|Adverse Event|0|||
25235721|NCT04846231|50547391|FG006|Overall Study|Adverse Event|1|||
25235722|NCT04846231|50547392|FG007|Overall Study|Adverse Event|1|||
25235723|NCT04533594|50547418|FG000|Overall Study|Death|26|||
25235724|NCT04533438|50547424|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
25235725|NCT04533438|50547425|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
25235726|NCT04447846|50547433|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
25235727|NCT04405245|50547440|FG000|Overall Study|Adverse Event|0|||
25235728|NCT04405245|50547441|FG001|Overall Study|Adverse Event|1|||
25235729|NCT04405245|50547442|FG002|Overall Study|Adverse Event|0|||
25235730|NCT04277507|50547450|FG000|Overall Study|Lost to Follow-up|17|||
25235731|NCT04277507|50547450|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
25235732|NCT04277507|50547450|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
25235733|NCT04277507|50547450|FG000|Overall Study|Withdrawal by Subject|3|||
25235734|NCT04277507|50547450|FG000|Overall Study|Death due to COVID-19|1|||
25235735|NCT04277507|50547450|FG000|Overall Study|Data missing for full evaluation|5|||
25235736|NCT04198805|50547471|FG000|Overall Study|Death|0|||
25235737|NCT04198805|50547472|FG001|Overall Study|Death|0|||
25235738|NCT04198805|50547473|FG002|Overall Study|Death|0|||
25235739|NCT04198805|50547474|FG003|Overall Study|Death|1|||
25235740|NCT04198805|50547471|FG000|Overall Study|Early Termination|8|||
25235741|NCT04198805|50547472|FG001|Overall Study|Early Termination|4|||
25235742|NCT04198805|50547473|FG002|Overall Study|Early Termination|6|||
25235743|NCT04198805|50547474|FG003|Overall Study|Early Termination|9|||
25235744|NCT04179890|50547490|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
25235745|NCT04179890|50547491|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
25235746|NCT04179890|50547490|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
25235747|NCT04179890|50547491|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
25235748|NCT04179890|50547490|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
25235749|NCT04179890|50547491|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
25235750|NCT04179890|50547490|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
25235751|NCT04179890|50547491|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
25235752|NCT04179890|50547490|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
25235753|NCT04179890|50547491|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
25235754|NCT04179890|50547490|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
25319559|NCT00774345|50635145|FG000|Treatment|Withdrawal by Subject|5|||
25319560|NCT00774345|50635146|FG001|Treatment|Withdrawal by Subject|2|||
25319561|NCT00774345|50635145|FG000|Treatment|Lost to Follow-up|1|||
25319562|NCT00774345|50635146|FG001|Treatment|Lost to Follow-up|1|||
25319563|NCT00774345|50635145|FG000|Treatment|Death|4|||
25319564|NCT00774345|50635146|FG001|Treatment|Death|0|||
25319565|NCT00774345|50635145|FG000|Treatment|Other Reasons|32|||
25319566|NCT00774345|50635146|FG001|Treatment|Other Reasons|26|||
25319567|NCT00773253|50635158|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
25319568|NCT00773253|50635159|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
25319569|NCT00773175|50635169|FG000|Overall Study|Adverse Event|2|||
25319570|NCT00773175|50635170|FG001|Overall Study|Adverse Event|0|||
25319571|NCT00773175|50635169|FG000|Overall Study|Consent Withdrawn|0|||
25319572|NCT00773175|50635170|FG001|Overall Study|Consent Withdrawn|2|||
25319573|NCT00566527|50635184|FG000|Overall Study|Reason not provided|3|||
25319574|NCT00566527|50635185|FG001|Overall Study|Reason not provided|11|||
25319575|NCT00566527|50635186|FG002|Overall Study|Reason not provided|10|||
25319576|NCT00566527|50635184|FG000|Overall Study|Adverse Event|2|||
25319577|NCT00566527|50635185|FG001|Overall Study|Adverse Event|0|||
25319578|NCT00566527|50635186|FG002|Overall Study|Adverse Event|1|||
25319579|NCT00566527|50635184|FG000|Overall Study|Physician Decision|3|||
25319580|NCT00566527|50635185|FG001|Overall Study|Physician Decision|8|||
25319581|NCT00566527|50635186|FG002|Overall Study|Physician Decision|20|||
25319582|NCT00566527|50635184|FG000|Overall Study|Lost to Follow-up|3|||
25319583|NCT00566527|50635185|FG001|Overall Study|Lost to Follow-up|4|||
25319584|NCT00566527|50635186|FG002|Overall Study|Lost to Follow-up|4|||
25319585|NCT00566527|50635184|FG000|Overall Study|Withdrawal by Subject|6|||
25319586|NCT00566527|50635185|FG001|Overall Study|Withdrawal by Subject|43|||
25319587|NCT00566527|50635186|FG002|Overall Study|Withdrawal by Subject|43|||
25319588|NCT00773097|50635196|FG000|Overall Study|Withdrawal by Subject|1|||
25235755|NCT04179890|50547491|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
25235756|NCT04179890|50547490|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
25235757|NCT04179890|50547491|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
25235758|NCT04179890|50547490|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
25235759|NCT04179890|50547491|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
25235760|NCT04179890|50547490|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
25235761|NCT04179890|50547491|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
25235762|NCT03721016|50547532|FG000|Overall Study|Adverse Event|0|||
25235763|NCT03721016|50547533|FG001|Overall Study|Adverse Event|1|||
25235764|NCT03721016|50547534|FG002|Overall Study|Adverse Event|1|||
25235765|NCT03721016|50547532|FG000|Overall Study|Withdrawal by Subject|8|||
25235766|NCT03721016|50547533|FG001|Overall Study|Withdrawal by Subject|16|||
25235767|NCT03721016|50547534|FG002|Overall Study|Withdrawal by Subject|13|||
25235768|NCT03721016|50547532|FG000|Overall Study|Lost to Follow-up|4|||
25235769|NCT03721016|50547533|FG001|Overall Study|Lost to Follow-up|6|||
25235770|NCT03721016|50547534|FG002|Overall Study|Lost to Follow-up|5|||
25235771|NCT03721016|50547532|FG000|Overall Study|Physician Decision|0|||
25235772|NCT03721016|50547533|FG001|Overall Study|Physician Decision|1|||
25235773|NCT03721016|50547534|FG002|Overall Study|Physician Decision|2|||
25235774|NCT03721016|50547532|FG000|Overall Study|Protocol Violation|0|||
25235775|NCT03721016|50547533|FG001|Overall Study|Protocol Violation|1|||
25235776|NCT03721016|50547534|FG002|Overall Study|Protocol Violation|0|||
25235777|NCT03721016|50547532|FG000|Overall Study|Site terminated by sponsor|3|||
25235778|NCT03721016|50547533|FG001|Overall Study|Site terminated by sponsor|7|||
25235779|NCT03721016|50547534|FG002|Overall Study|Site terminated by sponsor|6|||
25235780|NCT03721016|50547532|FG000|Overall Study|Subject exited early due to COVID-19|1|||
25235781|NCT03721016|50547533|FG001|Overall Study|Subject exited early due to COVID-19|0|||
25319589|NCT00773097|50635196|FG000|Overall Study|Physician Decision|6|||
25319590|NCT00933335|50635202|FG000|Overall Study|Lost to Follow-up|1|||
25319591|NCT00933335|50635203|FG001|Overall Study|Lost to Follow-up|3|||
25319592|NCT00933335|50635202|FG000|Overall Study|Withdrawal by Subject|0|||
25319593|NCT00933335|50635203|FG001|Overall Study|Withdrawal by Subject|1|||
25319594|NCT00933335|50635202|FG000|Overall Study|Progressive Disease|0|||
25319595|NCT00933335|50635203|FG001|Overall Study|Progressive Disease|11|||
25235782|NCT03721016|50547534|FG002|Overall Study|Subject exited early due to COVID-19|0|||
25235783|NCT03563716|50547544|FG000|Overall Study|Death|20|||
25235784|NCT03563716|50547545|FG001|Overall Study|Death|14|||
25235785|NCT03563716|50547544|FG000|Overall Study|Withdrawal by Subject|3|||
25235786|NCT03563716|50547545|FG001|Overall Study|Withdrawal by Subject|3|||
25235787|NCT03563716|50547544|FG000|Overall Study|Still on Study|45|||
25235788|NCT03563716|50547545|FG001|Overall Study|Still on Study|50|||
25235789|NCT03117998|50547579|FG000|Overall Study|Adverse Event|1|||
25235790|NCT03117998|50547580|FG001|Overall Study|Adverse Event|0|||
25235791|NCT03117998|50547581|FG002|Overall Study|Adverse Event|0|||
25235792|NCT03117998|50547582|FG003|Overall Study|Adverse Event|0|||
25235793|NCT03117998|50547583|FG004|Overall Study|Adverse Event|0|||
25235794|NCT03117998|50547584|FG005|Overall Study|Adverse Event|0|||
25235795|NCT03117998|50547579|FG000|Overall Study|Withdrawal by Subject|0|||
25235796|NCT03117998|50547580|FG001|Overall Study|Withdrawal by Subject|0|||
25235797|NCT03117998|50547581|FG002|Overall Study|Withdrawal by Subject|2|||
25235798|NCT03117998|50547582|FG003|Overall Study|Withdrawal by Subject|3|||
25235799|NCT03117998|50547583|FG004|Overall Study|Withdrawal by Subject|3|||
25235800|NCT03117998|50547584|FG005|Overall Study|Withdrawal by Subject|0|||
25235801|NCT03117998|50547579|FG000|Overall Study|Physician Decision|0|||
25235802|NCT03117998|50547580|FG001|Overall Study|Physician Decision|1|||
25235803|NCT03117998|50547581|FG002|Overall Study|Physician Decision|1|||
25235804|NCT03117998|50547582|FG003|Overall Study|Physician Decision|0|||
25235805|NCT03117998|50547583|FG004|Overall Study|Physician Decision|0|||
25235806|NCT03117998|50547584|FG005|Overall Study|Physician Decision|0|||
25235807|NCT03117998|50547579|FG000|Overall Study|Lost to Follow-up|0|||
25235808|NCT03117998|50547580|FG001|Overall Study|Lost to Follow-up|0|||
25235809|NCT03117998|50547581|FG002|Overall Study|Lost to Follow-up|0|||
25235810|NCT03117998|50547582|FG003|Overall Study|Lost to Follow-up|1|||
25235811|NCT03117998|50547583|FG004|Overall Study|Lost to Follow-up|4|||
25235812|NCT03117998|50547584|FG005|Overall Study|Lost to Follow-up|0|||
25235813|NCT03117998|50547579|FG000|Overall Study|Subject noncompliance|0|||
25235814|NCT03117998|50547580|FG001|Overall Study|Subject noncompliance|0|||
25235815|NCT03117998|50547581|FG002|Overall Study|Subject noncompliance|1|||
25235816|NCT03117998|50547582|FG003|Overall Study|Subject noncompliance|0|||
25235817|NCT03117998|50547583|FG004|Overall Study|Subject noncompliance|0|||
25235818|NCT03117998|50547584|FG005|Overall Study|Subject noncompliance|2|||
25235819|NCT03117998|50547579|FG000|Overall Study|Protocol Violation|0|||
25235820|NCT03117998|50547580|FG001|Overall Study|Protocol Violation|0|||
25235821|NCT03117998|50547581|FG002|Overall Study|Protocol Violation|0|||
25235822|NCT03117998|50547582|FG003|Overall Study|Protocol Violation|0|||
25235823|NCT03117998|50547583|FG004|Overall Study|Protocol Violation|0|||
25235824|NCT03117998|50547584|FG005|Overall Study|Protocol Violation|1|||
25235825|NCT03100370|50547609|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
25235826|NCT03100370|50547610|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
25235827|NCT03100370|50547611|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
25235828|NCT03100370|50547612|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
25235829|NCT03100370|50547613|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
25235830|NCT03100370|50547614|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
25235831|NCT02920008|50547624|FG000|Overall Study|Death|117|||
25235832|NCT02920008|50547625|FG001|Overall Study|Death|127|||
25235833|NCT02920008|50547624|FG000|Overall Study|Withdrawal by Subject|3|||
25235834|NCT02920008|50547625|FG001|Overall Study|Withdrawal by Subject|6|||
25235835|NCT02920008|50547624|FG000|Overall Study|Lost to Follow-up|0|||
25235836|NCT02920008|50547625|FG001|Overall Study|Lost to Follow-up|1|||
25235837|NCT02766335|50547633|FG000|Initial Registration|Adverse Event|6|||
25235838|NCT02766335|50547634|FG001|Initial Registration|Adverse Event|3|||
25235839|NCT02766335|50547635|FG002|Initial Registration|Adverse Event|0|||
25235840|NCT02766335|50547633|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
25235841|NCT02766335|50547634|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
25235842|NCT02766335|50547635|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
25235843|NCT02766335|50547633|FG000|Initial Registration|Progression/relapse|49|||
25235844|NCT02766335|50547634|FG001|Initial Registration|Progression/relapse|15|||
25319596|NCT00933335|50635202|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
25235845|NCT02766335|50547635|FG002|Initial Registration|Progression/relapse|0|||
25235846|NCT02766335|50547633|FG000|Initial Registration|Death|1|||
25235847|NCT02766335|50547634|FG001|Initial Registration|Death|3|||
25235848|NCT02766335|50547635|FG002|Initial Registration|Death|0|||
25235849|NCT02766335|50547633|FG000|Initial Registration|not protocol specified|1|||
25235850|NCT02766335|50547634|FG001|Initial Registration|not protocol specified|9|||
25319597|NCT00933335|50635203|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
25235851|NCT02766335|50547635|FG002|Initial Registration|not protocol specified|0|||
25235852|NCT02766335|50547633|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
25235853|NCT02766335|50547634|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
25235854|NCT02766335|50547635|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
25235855|NCT02766335|50547633|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
25235856|NCT02766335|50547634|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
25235857|NCT02766335|50547635|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
25235858|NCT02577523|50547643|FG000|Overall Study|Adverse Event|1|||
25235859|NCT02577523|50547644|FG001|Overall Study|Adverse Event|1|||
25235860|NCT02577523|50547643|FG000|Overall Study|Lack of Efficacy|1|||
25235861|NCT02577523|50547644|FG001|Overall Study|Lack of Efficacy|1|||
25235862|NCT02577523|50547643|FG000|Overall Study|Withdrawal by Subject|1|||
25235863|NCT02577523|50547644|FG001|Overall Study|Withdrawal by Subject|0|||
25235864|NCT02516241|50547653|FG000|Overall Study|Death|255|||
25235865|NCT02516241|50547654|FG001|Overall Study|Death|262|||
25235866|NCT02516241|50547655|FG002|Overall Study|Death|270|||
25235867|NCT02516241|50547653|FG000|Overall Study|Lost to Follow-up|1|||
25235868|NCT02516241|50547654|FG001|Overall Study|Lost to Follow-up|1|||
25235869|NCT02516241|50547655|FG002|Overall Study|Lost to Follow-up|3|||
25235870|NCT02516241|50547653|FG000|Overall Study|Withdrawal by Subject|2|||
25235871|NCT02516241|50547654|FG001|Overall Study|Withdrawal by Subject|7|||
25235872|NCT02516241|50547655|FG002|Overall Study|Withdrawal by Subject|12|||
25235873|NCT02516241|50547653|FG000|Overall Study|participants ongoing at data cut-off|84|||
25235874|NCT02516241|50547654|FG001|Overall Study|participants ongoing at data cut-off|76|||
25235875|NCT02516241|50547655|FG002|Overall Study|participants ongoing at data cut-off|59|||
25235876|NCT02499328|50547687|FG000|Overall Study|Withdrawal by Subject|1|||
25235877|NCT02499328|50547688|FG001|Overall Study|Withdrawal by Subject|1|||
25235878|NCT02499328|50547689|FG002|Overall Study|Withdrawal by Subject|5|||
25235879|NCT02499328|50547690|FG003|Overall Study|Withdrawal by Subject|3|||
25235880|NCT02499328|50547691|FG004|Overall Study|Withdrawal by Subject|5|||
25235881|NCT02499328|50547692|FG005|Overall Study|Withdrawal by Subject|0|||
25235882|NCT02499328|50547693|FG006|Overall Study|Withdrawal by Subject|0|||
25235883|NCT02499328|50547694|FG007|Overall Study|Withdrawal by Subject|0|||
25235884|NCT02499328|50547695|FG008|Overall Study|Withdrawal by Subject|2|||
25235885|NCT02499328|50547696|FG009|Overall Study|Withdrawal by Subject|2|||
25235886|NCT02499328|50547697|FG010|Overall Study|Withdrawal by Subject|0|||
25235887|NCT02499328|50547698|FG011|Overall Study|Withdrawal by Subject|3|||
25235888|NCT02499328|50547699|FG012|Overall Study|Withdrawal by Subject|7|||
25235889|NCT02499328|50547700|FG013|Overall Study|Withdrawal by Subject|3|||
25235890|NCT02499328|50547701|FG014|Overall Study|Withdrawal by Subject|1|||
25235891|NCT02499328|50547702|FG015|Overall Study|Withdrawal by Subject|0|||
25235892|NCT02499328|50547703|FG016|Overall Study|Withdrawal by Subject|0|||
25235893|NCT02499328|50547704|FG017|Overall Study|Withdrawal by Subject|3|||
25235894|NCT02499328|50547705|FG018|Overall Study|Withdrawal by Subject|0|||
25235895|NCT02499328|50547687|FG000|Overall Study|Lost to Follow-up|0|||
25235896|NCT02499328|50547688|FG001|Overall Study|Lost to Follow-up|1|||
25235897|NCT02499328|50547689|FG002|Overall Study|Lost to Follow-up|1|||
25235898|NCT02499328|50547690|FG003|Overall Study|Lost to Follow-up|2|||
25235899|NCT02499328|50547691|FG004|Overall Study|Lost to Follow-up|0|||
25235900|NCT02499328|50547692|FG005|Overall Study|Lost to Follow-up|0|||
25235901|NCT02499328|50547693|FG006|Overall Study|Lost to Follow-up|0|||
25235902|NCT02499328|50547694|FG007|Overall Study|Lost to Follow-up|2|||
25235903|NCT02499328|50547695|FG008|Overall Study|Lost to Follow-up|3|||
25235904|NCT02499328|50547696|FG009|Overall Study|Lost to Follow-up|0|||
25235905|NCT02499328|50547697|FG010|Overall Study|Lost to Follow-up|0|||
25235906|NCT02499328|50547698|FG011|Overall Study|Lost to Follow-up|0|||
25235907|NCT02499328|50547699|FG012|Overall Study|Lost to Follow-up|0|||
25235908|NCT02499328|50547700|FG013|Overall Study|Lost to Follow-up|0|||
25235909|NCT02499328|50547701|FG014|Overall Study|Lost to Follow-up|0|||
25235910|NCT02499328|50547702|FG015|Overall Study|Lost to Follow-up|0|||
25235911|NCT02499328|50547703|FG016|Overall Study|Lost to Follow-up|0|||
25235912|NCT02499328|50547704|FG017|Overall Study|Lost to Follow-up|0|||
25235913|NCT02499328|50547705|FG018|Overall Study|Lost to Follow-up|1|||
25235914|NCT02499328|50547687|FG000|Overall Study|Death|0|||
25235915|NCT02499328|50547688|FG001|Overall Study|Death|3|||
25235916|NCT02499328|50547689|FG002|Overall Study|Death|3|||
25235917|NCT02499328|50547690|FG003|Overall Study|Death|2|||
25235918|NCT02499328|50547691|FG004|Overall Study|Death|4|||
25235919|NCT02499328|50547692|FG005|Overall Study|Death|7|||
25235920|NCT02499328|50547693|FG006|Overall Study|Death|3|||
25235921|NCT02499328|50547694|FG007|Overall Study|Death|0|||
25235922|NCT02499328|50547695|FG008|Overall Study|Death|2|||
25235923|NCT02499328|50547696|FG009|Overall Study|Death|6|||
25235924|NCT02499328|50547697|FG010|Overall Study|Death|6|||
25235925|NCT02499328|50547698|FG011|Overall Study|Death|20|||
25235926|NCT02499328|50547699|FG012|Overall Study|Death|9|||
25235927|NCT02499328|50547700|FG013|Overall Study|Death|7|||
25235928|NCT02499328|50547701|FG014|Overall Study|Death|3|||
25235929|NCT02499328|50547702|FG015|Overall Study|Death|1|||
25235930|NCT02499328|50547703|FG016|Overall Study|Death|1|||
25235931|NCT02499328|50547704|FG017|Overall Study|Death|16|||
25235932|NCT02499328|50547705|FG018|Overall Study|Death|5|||
25235933|NCT02499328|50547687|FG000|Overall Study|"Other"|2|||
25235934|NCT02499328|50547688|FG001|Overall Study|"Other"|2|||
25235935|NCT02499328|50547689|FG002|Overall Study|"Other"|1|||
25235936|NCT02499328|50547690|FG003|Overall Study|"Other"|3|||
25235937|NCT02499328|50547691|FG004|Overall Study|"Other"|6|||
25235938|NCT02499328|50547692|FG005|Overall Study|"Other"|2|||
25235939|NCT02499328|50547693|FG006|Overall Study|"Other"|3|||
25235940|NCT02499328|50547694|FG007|Overall Study|"Other"|4|||
25235941|NCT02499328|50547695|FG008|Overall Study|"Other"|6|||
25235942|NCT02499328|50547696|FG009|Overall Study|"Other"|16|||
25235943|NCT02499328|50547697|FG010|Overall Study|"Other"|13|||
25235944|NCT02499328|50547698|FG011|Overall Study|"Other"|31|||
25235945|NCT02499328|50547699|FG012|Overall Study|"Other"|8|||
25235946|NCT02499328|50547700|FG013|Overall Study|"Other"|7|||
25235947|NCT02499328|50547701|FG014|Overall Study|"Other"|6|||
25235948|NCT02499328|50547702|FG015|Overall Study|"Other"|0|||
25235949|NCT02499328|50547703|FG016|Overall Study|"Other"|0|||
25235950|NCT02499328|50547704|FG017|Overall Study|"Other"|34|||
25235951|NCT02499328|50547705|FG018|Overall Study|"Other"|43|||
25235952|NCT02499328|50547687|FG000|Overall Study|Disease Progression|0|||
25235953|NCT02499328|50547688|FG001|Overall Study|Disease Progression|0|||
25235954|NCT02499328|50547689|FG002|Overall Study|Disease Progression|0|||
25235955|NCT02499328|50547690|FG003|Overall Study|Disease Progression|0|||
24976805|NCT00090753|50065727|FG001|Extended Treatment Period|Lost to Follow-up|1|||
24976806|NCT00090753|50065726|FG000|Extended Treatment Period|Renal Transplant|15|||
24976807|NCT00090753|50065727|FG001|Extended Treatment Period|Renal Transplant|12|||
24976808|NCT00090753|50065726|FG000|Extended Treatment Period|Mircera Commercialization|188|||
24976809|NCT00090753|50065727|FG001|Extended Treatment Period|Mircera Commercialization|93|||
24976810|NCT00090753|50065726|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
24976811|NCT00090753|50065727|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
24976812|NCT00048932|50065735|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
24976813|NCT00048932|50065736|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
24976814|NCT00048932|50065737|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
25235956|NCT02499328|50547691|FG004|Overall Study|Disease Progression|0|||
25235957|NCT02499328|50547692|FG005|Overall Study|Disease Progression|0|||
25235958|NCT02499328|50547693|FG006|Overall Study|Disease Progression|1|||
25235959|NCT02499328|50547694|FG007|Overall Study|Disease Progression|0|||
25235960|NCT02499328|50547695|FG008|Overall Study|Disease Progression|1|||
25235961|NCT02499328|50547696|FG009|Overall Study|Disease Progression|0|||
25235962|NCT02499328|50547697|FG010|Overall Study|Disease Progression|1|||
25235963|NCT02499328|50547698|FG011|Overall Study|Disease Progression|0|||
25235964|NCT02499328|50547699|FG012|Overall Study|Disease Progression|0|||
25235965|NCT02499328|50547700|FG013|Overall Study|Disease Progression|0|||
25235966|NCT02499328|50547701|FG014|Overall Study|Disease Progression|0|||
25235967|NCT02499328|50547702|FG015|Overall Study|Disease Progression|0|||
25235968|NCT02499328|50547703|FG016|Overall Study|Disease Progression|0|||
25235969|NCT02499328|50547704|FG017|Overall Study|Disease Progression|2|||
25235970|NCT02499328|50547705|FG018|Overall Study|Disease Progression|0|||
25235971|NCT02499328|50547687|FG000|Overall Study|Adverse Event|1|||
25235972|NCT02499328|50547688|FG001|Overall Study|Adverse Event|0|||
25235973|NCT02499328|50547689|FG002|Overall Study|Adverse Event|0|||
25235974|NCT02499328|50547690|FG003|Overall Study|Adverse Event|1|||
25235975|NCT02499328|50547691|FG004|Overall Study|Adverse Event|0|||
25235976|NCT02499328|50547692|FG005|Overall Study|Adverse Event|0|||
25235977|NCT02499328|50547693|FG006|Overall Study|Adverse Event|0|||
25235978|NCT02499328|50547694|FG007|Overall Study|Adverse Event|0|||
25235979|NCT02499328|50547695|FG008|Overall Study|Adverse Event|0|||
25235980|NCT02499328|50547696|FG009|Overall Study|Adverse Event|0|||
25235981|NCT02499328|50547697|FG010|Overall Study|Adverse Event|0|||
25235982|NCT02499328|50547698|FG011|Overall Study|Adverse Event|0|||
25235983|NCT02499328|50547699|FG012|Overall Study|Adverse Event|1|||
25235984|NCT02499328|50547700|FG013|Overall Study|Adverse Event|0|||
25235985|NCT02499328|50547701|FG014|Overall Study|Adverse Event|0|||
25235986|NCT02499328|50547702|FG015|Overall Study|Adverse Event|0|||
25235987|NCT02499328|50547703|FG016|Overall Study|Adverse Event|0|||
25235988|NCT02499328|50547704|FG017|Overall Study|Adverse Event|0|||
25235989|NCT02499328|50547705|FG018|Overall Study|Adverse Event|0|||
25235990|NCT02388906|50547790|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
25235991|NCT02388906|50547791|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
25319598|NCT00933335|50635202|FG000|Overall Study|Co-morbid Illness|1|||
24976815|NCT00048932|50065735|FG000|Double Blind Period (DB)|Adverse Event|51|||
25235992|NCT02388906|50547790|FG000|Treatment Period|Disease progression|121|||
25235993|NCT02388906|50547791|FG001|Treatment Period|Disease progression|101|||
25235994|NCT02388906|50547790|FG000|Treatment Period|Study drug toxicity|41|||
25235995|NCT02388906|50547791|FG001|Treatment Period|Study drug toxicity|208|||
25235996|NCT02388906|50547790|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
25235997|NCT02388906|50547791|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
25235998|NCT02388906|50547790|FG000|Treatment Period|Participant request to stop treatment|5|||
25235999|NCT02388906|50547791|FG001|Treatment Period|Participant request to stop treatment|9|||
25236000|NCT02388906|50547790|FG000|Treatment Period|Participant withdrew consent|2|||
25236001|NCT02388906|50547791|FG001|Treatment Period|Participant withdrew consent|3|||
25236002|NCT02388906|50547790|FG000|Treatment Period|Poor/non-compliance|0|||
25236003|NCT02388906|50547791|FG001|Treatment Period|Poor/non-compliance|1|||
25236004|NCT02388906|50547790|FG000|Treatment Period|Participant no longer meets study criteria|0|||
25236005|NCT02388906|50547791|FG001|Treatment Period|Participant no longer meets study criteria|1|||
25236006|NCT02388906|50547790|FG000|Treatment Period|Other reasons|3|||
25236007|NCT02388906|50547791|FG001|Treatment Period|Other reasons|3|||
25236008|NCT02177695|50547810|FG000|ITT Analysis|Ineligible|5|||
25236009|NCT02177695|50547811|FG001|ITT Analysis|Ineligible|5|||
25236010|NCT02177695|50547810|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
25236011|NCT02177695|50547811|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
25236012|NCT02177695|50547810|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
25236013|NCT02177695|50547811|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
25236014|NCT02177695|50547810|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
25236015|NCT02177695|50547811|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
25236016|NCT01719237|50547826|FG000|Overall Study|Physician Decision|0|||
25236017|NCT01719237|50547827|FG001|Overall Study|Physician Decision|1|||
25319599|NCT00933335|50635203|FG001|Overall Study|Co-morbid Illness|0|||
25319600|NCT00772941|50635215|FG000|Overall Study|CRFs not available|195|||
25319601|NCT00772941|50635215|FG000|Overall Study|Study not completed|16|||
25319602|NCT00772941|50635215|FG000|Overall Study|Missed Visits|374|||
25319603|NCT00772941|50635215|FG000|Overall Study|Poor Compliance|7|||
25319604|NCT00772941|50635215|FG000|Overall Study|GPSP Violation|90|||
25319605|NCT00772707|50635242|FG000|Overall Study|Withdrawn|3|||
25319606|NCT00772629|50635248|FG000|Overall Study|Subject was not vaccinated|1|||
25319607|NCT00772629|50635249|FG001|Overall Study|Subject was not vaccinated|0|||
25319608|NCT00939341|50635255|FG000|Overall Study|Adverse Event|15|||
25319609|NCT00939341|50635255|FG000|Overall Study|Pregnancy|1|||
25319610|NCT00939341|50635255|FG000|Overall Study|Lost to Follow-up|23|||
25319611|NCT00939341|50635255|FG000|Overall Study|Withdrawal by Subject|13|||
25319612|NCT00939341|50635255|FG000|Overall Study|Protocol Violation|6|||
25319613|NCT00939341|50635255|FG000|Overall Study|Incorrect enrolment|8|||
25319614|NCT04292470|50635284|FG000|Overall Study|Withdrawal by Subject|0|||
25319615|NCT04292470|50635285|FG001|Overall Study|Withdrawal by Subject|1|||
25319616|NCT04217590|50635293|FG000|Overall Study|Other|1|||
25319617|NCT04217590|50635294|FG001|Overall Study|Other|1|||
25319618|NCT04217590|50635293|FG000|Overall Study|Withdrawal by Subject|3|||
25319619|NCT04217590|50635294|FG001|Overall Study|Withdrawal by Subject|1|||
25319620|NCT04217590|50635293|FG000|Overall Study|Death|0|||
25319621|NCT04217590|50635294|FG001|Overall Study|Death|1|||
25319622|NCT03963232|50635302|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
25319623|NCT03963232|50635303|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
25319624|NCT03963232|50635302|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
25319625|NCT03963232|50635303|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
25319626|NCT03963232|50635302|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
25319627|NCT03963232|50635303|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
25319628|NCT03963232|50635302|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
25319629|NCT03963232|50635303|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
25319630|NCT03963232|50635302|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
25319631|NCT03963232|50635303|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
25319632|NCT03963232|50635302|FG000|Open-Label Treatment Phase|Adverse Event|1|||
25319633|NCT03963232|50635303|FG001|Open-Label Treatment Phase|Adverse Event|2|||
25319634|NCT03963232|50635302|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
25319635|NCT03963232|50635303|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
25319636|NCT03963232|50635302|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
25319637|NCT03963232|50635303|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
25319638|NCT03963232|50635302|FG000|Open-Label Treatment Phase|Pregnancy|1|||
25319639|NCT03963232|50635303|FG001|Open-Label Treatment Phase|Pregnancy|0|||
25319640|NCT03963232|50635302|FG000|Follow-up Phase|Withdrawal by Subject|7|||
25319641|NCT03963232|50635303|FG001|Follow-up Phase|Withdrawal by Subject|5|||
25319642|NCT03963232|50635302|FG000|Follow-up Phase|Protocol Violation|0|||
25319643|NCT03963232|50635303|FG001|Follow-up Phase|Protocol Violation|2|||
25319644|NCT03963232|50635302|FG000|Follow-up Phase|Adverse Event|0|||
25319645|NCT03963232|50635303|FG001|Follow-up Phase|Adverse Event|1|||
25319646|NCT03963232|50635302|FG000|Follow-up Phase|Lost to Follow-up|0|||
25319647|NCT03963232|50635303|FG001|Follow-up Phase|Lost to Follow-up|1|||
25319648|NCT03856593|50635327|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
25319649|NCT03856593|50635328|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
25319650|NCT03785925|50635336|FG000|Overall Study|Withdrawal by Subject|15|||
25319651|NCT03785925|50635336|FG000|Overall Study|Lost to Follow-up|1|||
25319652|NCT03427411|50635347|FG000|Overall Study|Screen failure - platelets too low|0|||
25319653|NCT03427411|50635348|FG001|Overall Study|Screen failure - platelets too low|1|||
25319654|NCT03330106|50635356|FG000|Part A|Withdrawal by Subject|1|||
25319655|NCT03330106|50635357|FG001|Part A|Withdrawal by Subject|1|||
25319656|NCT03330106|50635358|FG002|Part A|Withdrawal by Subject|0|||
25236018|NCT01956669|50547850|FG000|Overall Study|Disease Progression|12|||
25236019|NCT01956669|50547851|FG001|Overall Study|Disease Progression|7|||
25236020|NCT01956669|50547852|FG002|Overall Study|Disease Progression|7|||
25236021|NCT01956669|50547853|FG003|Overall Study|Disease Progression|8|||
25236022|NCT01956669|50547854|FG004|Overall Study|Disease Progression|4|||
25236023|NCT01956669|50547855|FG005|Overall Study|Disease Progression|3|||
25236024|NCT01956669|50547856|FG006|Overall Study|Disease Progression|5|||
25236025|NCT01956669|50547850|FG000|Overall Study|Adverse Event|0|||
25236026|NCT01956669|50547851|FG001|Overall Study|Adverse Event|2|||
25236027|NCT01956669|50547852|FG002|Overall Study|Adverse Event|2|||
25236028|NCT01956669|50547853|FG003|Overall Study|Adverse Event|1|||
25236029|NCT01956669|50547854|FG004|Overall Study|Adverse Event|0|||
25236030|NCT01956669|50547855|FG005|Overall Study|Adverse Event|0|||
25236031|NCT01956669|50547856|FG006|Overall Study|Adverse Event|0|||
25236032|NCT01956669|50547850|FG000|Overall Study|Physician Decision|0|||
25236033|NCT01956669|50547851|FG001|Overall Study|Physician Decision|2|||
25236034|NCT01956669|50547852|FG002|Overall Study|Physician Decision|0|||
25236035|NCT01956669|50547853|FG003|Overall Study|Physician Decision|0|||
25236036|NCT01956669|50547854|FG004|Overall Study|Physician Decision|0|||
25236037|NCT01956669|50547855|FG005|Overall Study|Physician Decision|1|||
25236038|NCT01956669|50547856|FG006|Overall Study|Physician Decision|0|||
24976816|NCT00048932|50065736|FG001|Double Blind Period (DB)|Adverse Event|19|||
24976817|NCT00048932|50065737|FG002|Double Blind Period (DB)|Adverse Event|0|||
24976818|NCT00048932|50065735|FG000|Double Blind Period (DB)|Death|5|||
24976819|NCT00048932|50065736|FG001|Double Blind Period (DB)|Death|3|||
25236039|NCT01956669|50547850|FG000|Overall Study|Withdrawal by Subject|0|||
25236040|NCT01956669|50547851|FG001|Overall Study|Withdrawal by Subject|0|||
25236041|NCT01956669|50547852|FG002|Overall Study|Withdrawal by Subject|1|||
25236042|NCT01956669|50547853|FG003|Overall Study|Withdrawal by Subject|1|||
25236043|NCT01956669|50547854|FG004|Overall Study|Withdrawal by Subject|0|||
25236044|NCT01956669|50547855|FG005|Overall Study|Withdrawal by Subject|0|||
25236045|NCT01956669|50547856|FG006|Overall Study|Withdrawal by Subject|1|||
25236046|NCT01967823|50547881|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
25236047|NCT01985022|50547891|FG000|Overall Study|Lost to Follow-up|0|||
25319657|NCT03330106|50635359|FG003|Part A|Withdrawal by Subject|0|||
25319658|NCT03330106|50635356|FG000|Part A|Death|2|||
25319659|NCT03330106|50635357|FG001|Part A|Death|1|||
25319660|NCT03330106|50635358|FG002|Part A|Death|0|||
25319661|NCT03330106|50635359|FG003|Part A|Death|0|||
25319662|NCT03330106|50635356|FG000|Part A|Adverse Event|0|||
25319663|NCT03330106|50635357|FG001|Part A|Adverse Event|1|||
25319664|NCT03330106|50635358|FG002|Part A|Adverse Event|0|||
25319665|NCT03330106|50635359|FG003|Part A|Adverse Event|0|||
25319666|NCT03330106|50635356|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
25319667|NCT03330106|50635357|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
25319668|NCT03330106|50635358|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
25319669|NCT03330106|50635359|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
25319670|NCT03330106|50635356|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
25319671|NCT03330106|50635357|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
25319672|NCT03330106|50635358|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
25319673|NCT03330106|50635359|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
25319674|NCT03330106|50635356|FG000|Part A|Progressive Disease|0|||
25319675|NCT03330106|50635357|FG001|Part A|Progressive Disease|1|||
25319676|NCT03330106|50635358|FG002|Part A|Progressive Disease|0|||
25319677|NCT03330106|50635359|FG003|Part A|Progressive Disease|0|||
25319678|NCT03330106|50635356|FG000|Part B|Lost to Follow-up|0|||
25319679|NCT03330106|50635357|FG001|Part B|Lost to Follow-up|0|||
25319680|NCT03330106|50635358|FG002|Part B|Lost to Follow-up|0|||
25319681|NCT03330106|50635359|FG003|Part B|Lost to Follow-up|1|||
25319682|NCT03330106|50635356|FG000|Part B|Withdrawal by Subject|0|||
25319683|NCT03330106|50635357|FG001|Part B|Withdrawal by Subject|0|||
25319684|NCT03330106|50635358|FG002|Part B|Withdrawal by Subject|4|||
25319685|NCT03330106|50635359|FG003|Part B|Withdrawal by Subject|0|||
25319686|NCT03330106|50635356|FG000|Part B|Death|0|||
25319687|NCT03330106|50635357|FG001|Part B|Death|0|||
24976820|NCT00048932|50065737|FG002|Double Blind Period (DB)|Death|0|||
24976821|NCT00048932|50065735|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
24976822|NCT00048932|50065736|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
24976823|NCT00048932|50065737|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
25236048|NCT01985022|50547892|FG001|Overall Study|Lost to Follow-up|1|||
25236049|NCT01985022|50547891|FG000|Overall Study|Protocol Violation|0|||
25236050|NCT01985022|50547892|FG001|Overall Study|Protocol Violation|1|||
25236051|NCT01985022|50547891|FG000|Overall Study|Withdrawal by Subject|4|||
25236052|NCT01985022|50547892|FG001|Overall Study|Withdrawal by Subject|1|||
24976824|NCT00048932|50065735|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
25236053|NCT01989676|50547900|FG000|Overall Study|Death|52|||
25236054|NCT01989676|50547901|FG001|Overall Study|Death|60|||
25236055|NCT01989676|50547900|FG000|Overall Study|Protocol Violation|2|||
25236056|NCT01989676|50547901|FG001|Overall Study|Protocol Violation|1|||
25236057|NCT01989676|50547900|FG000|Overall Study|Lost to Follow-up|8|||
25236058|NCT01989676|50547901|FG001|Overall Study|Lost to Follow-up|18|||
25236059|NCT01989676|50547900|FG000|Overall Study|No longer willing to participate in study|26|||
25236060|NCT01989676|50547901|FG001|Overall Study|No longer willing to participate in study|26|||
25236061|NCT01989676|50547900|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
25236062|NCT01989676|50547901|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
25236063|NCT01989676|50547900|FG000|Overall Study|Other|4|||
25236064|NCT01989676|50547901|FG001|Overall Study|Other|3|||
25236065|NCT02001974|50547911|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
25236066|NCT02001974|50547912|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
25236067|NCT02001974|50547913|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
25236068|NCT02001974|50547911|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
25236069|NCT02001974|50547912|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
25236070|NCT02001974|50547913|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
25236071|NCT02001974|50547911|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
25236072|NCT02001974|50547912|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
25236073|NCT02001974|50547913|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
25236074|NCT02001974|50547911|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
25236075|NCT02001974|50547912|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
25236076|NCT02001974|50547913|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
25236077|NCT04983589|50547923|FG000|Overall Study|Withdrawal by Subject|0|||
25236078|NCT04983589|50547924|FG001|Overall Study|Withdrawal by Subject|3|||
25236079|NCT04983589|50547923|FG000|Overall Study|COVID-19 Infection|1|||
25236080|NCT04983589|50547924|FG001|Overall Study|COVID-19 Infection|0|||
25236081|NCT04983589|50547923|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
25236082|NCT04983589|50547924|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
25236083|NCT04556591|50547944|FG000|Overall Study|Lost to Follow-up|1|||
25236084|NCT04556591|50547945|FG001|Overall Study|Lost to Follow-up|0|||
25236085|NCT04556591|50547944|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
25236086|NCT04556591|50547945|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
25236087|NCT04428034|50547954|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
25236088|NCT04364984|50547965|FG000|Overall Study|Death|2|||
25236089|NCT04364984|50547966|FG001|Overall Study|Death|2|||
25236090|NCT04364984|50547967|FG002|Overall Study|Death|0|||
25236091|NCT04294095|50547977|FG000|Overall Study|Adverse Event|1|||
25236092|NCT04294095|50547978|FG001|Overall Study|Adverse Event|0|||
25236093|NCT04266028|50547994|FG000|Overall Study|Adverse Event|0|||
25236094|NCT04266028|50547995|FG001|Overall Study|Adverse Event|0|||
25236095|NCT04266028|50547996|FG002|Overall Study|Adverse Event|1|||
25236096|NCT04266028|50547997|FG003|Overall Study|Adverse Event|0|||
25236097|NCT04266028|50547998|FG004|Overall Study|Adverse Event|1|||
25236098|NCT04266028|50547999|FG005|Overall Study|Adverse Event|0|||
25236099|NCT04266028|50548000|FG006|Overall Study|Adverse Event|2|||
25236100|NCT04266028|50548001|FG007|Overall Study|Adverse Event|0|||
25236101|NCT04266028|50547994|FG000|Overall Study|temporary halt of the study|0|||
25236102|NCT04266028|50547995|FG001|Overall Study|temporary halt of the study|0|||
25236103|NCT04266028|50547996|FG002|Overall Study|temporary halt of the study|0|||
25236104|NCT04266028|50547997|FG003|Overall Study|temporary halt of the study|0|||
25236105|NCT04266028|50547998|FG004|Overall Study|temporary halt of the study|0|||
25236106|NCT04266028|50547999|FG005|Overall Study|temporary halt of the study|0|||
25236107|NCT04266028|50548000|FG006|Overall Study|temporary halt of the study|2|||
25236108|NCT04266028|50548001|FG007|Overall Study|temporary halt of the study|1|||
25236109|NCT04266028|50547994|FG000|Overall Study|Onset of birch pollen season|0|||
25236110|NCT04266028|50547995|FG001|Overall Study|Onset of birch pollen season|0|||
25236111|NCT04266028|50547996|FG002|Overall Study|Onset of birch pollen season|0|||
25236112|NCT04266028|50547997|FG003|Overall Study|Onset of birch pollen season|0|||
25236113|NCT04266028|50547998|FG004|Overall Study|Onset of birch pollen season|1|||
25236114|NCT04266028|50547999|FG005|Overall Study|Onset of birch pollen season|0|||
25236115|NCT04266028|50548000|FG006|Overall Study|Onset of birch pollen season|0|||
25236116|NCT04266028|50548001|FG007|Overall Study|Onset of birch pollen season|0|||
25236117|NCT03994731|50548051|FG000|Pegloticase + IMM Period|Death|2|||
25236118|NCT03994731|50548052|FG001|Pegloticase + IMM Period|Death|0|||
25236119|NCT03994731|50548051|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
25236120|NCT03994731|50548052|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
25236121|NCT03994731|50548051|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
25236122|NCT03994731|50548052|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
25236123|NCT03829683|50548063|FG000|Overall Study|Lost to Follow-up|1|||
25236124|NCT03829683|50548064|FG001|Overall Study|Lost to Follow-up|0|||
25236125|NCT03829683|50548063|FG000|Overall Study|Physician Decision|3|||
25236126|NCT03829683|50548064|FG001|Overall Study|Physician Decision|1|||
25236127|NCT03829683|50548063|FG000|Overall Study|Withdrawal by Subject|0|||
25236128|NCT03829683|50548064|FG001|Overall Study|Withdrawal by Subject|1|||
25236129|NCT03829683|50548063|FG000|Overall Study|Discharge from hospital|1|||
25236130|NCT03829683|50548064|FG001|Overall Study|Discharge from hospital|0|||
25236131|NCT03801915|50548073|FG000|Overall Study|Screen failure|0|||
25236132|NCT03801915|50548074|FG001|Overall Study|Screen failure|0|||
25236133|NCT03801915|50548075|FG002|Overall Study|Screen failure|1|||
25236134|NCT03801915|50548073|FG000|Overall Study|Ineligible|1|||
25236135|NCT03801915|50548074|FG001|Overall Study|Ineligible|0|||
25236136|NCT03801915|50548075|FG002|Overall Study|Ineligible|0|||
25236137|NCT03801915|50548073|FG000|Overall Study|Physician Decision|2|||
25236138|NCT03801915|50548074|FG001|Overall Study|Physician Decision|1|||
25236139|NCT03801915|50548075|FG002|Overall Study|Physician Decision|0|||
25236140|NCT03581305|50548089|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
25236141|NCT03581305|50548090|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
25236142|NCT03581305|50548089|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
25236143|NCT03581305|50548090|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
25236144|NCT03581305|50548089|FG000|Serotonergic Study|Withdrawal by Subject|5|||
25236145|NCT03581305|50548090|FG001|Serotonergic Study|Withdrawal by Subject|1|||
25236146|NCT03556202|50548101|FG000|Extension Treatment Period|Adverse Event|18|||
25236147|NCT03556202|50548102|FG001|Extension Treatment Period|Adverse Event|14|||
25236148|NCT03556202|50548103|FG002|Extension Treatment Period|Adverse Event|9|||
25236149|NCT03556202|50548101|FG000|Extension Treatment Period|Death|2|||
25236150|NCT03556202|50548102|FG001|Extension Treatment Period|Death|6|||
25236151|NCT03556202|50548103|FG002|Extension Treatment Period|Death|0|||
25236152|NCT03556202|50548101|FG000|Extension Treatment Period|Lack of Efficacy|5|||
25236153|NCT03556202|50548102|FG001|Extension Treatment Period|Lack of Efficacy|12|||
25236154|NCT03556202|50548103|FG002|Extension Treatment Period|Lack of Efficacy|18|||
25236155|NCT03556202|50548101|FG000|Extension Treatment Period|Lost to Follow-up|9|||
25236156|NCT03556202|50548102|FG001|Extension Treatment Period|Lost to Follow-up|20|||
25236157|NCT03556202|50548103|FG002|Extension Treatment Period|Lost to Follow-up|2|||
25236158|NCT03556202|50548101|FG000|Extension Treatment Period|Pregnancy|2|||
25236159|NCT03556202|50548102|FG001|Extension Treatment Period|Pregnancy|4|||
25236160|NCT03556202|50548103|FG002|Extension Treatment Period|Pregnancy|3|||
25236161|NCT03556202|50548101|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
25236162|NCT03556202|50548102|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
25236163|NCT03556202|50548103|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
25236164|NCT03556202|50548101|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
25236165|NCT03556202|50548102|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
25236166|NCT03556202|50548103|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
25236167|NCT03556202|50548101|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
25236168|NCT03556202|50548102|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
25236169|NCT03556202|50548103|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
25236170|NCT03556202|50548101|FG000|Extension Treatment Period|Physician Decision|0|||
25236171|NCT03556202|50548102|FG001|Extension Treatment Period|Physician Decision|8|||
25236172|NCT03556202|50548103|FG002|Extension Treatment Period|Physician Decision|2|||
25236173|NCT03556202|50548101|FG000|Extension Treatment Period|Protocol Violation|0|||
25236174|NCT03556202|50548102|FG001|Extension Treatment Period|Protocol Violation|1|||
25236175|NCT03556202|50548103|FG002|Extension Treatment Period|Protocol Violation|1|||
25236176|NCT03556202|50548101|FG000|Extension Treatment Period|Sponsor Decision|0|||
25236177|NCT03556202|50548102|FG001|Extension Treatment Period|Sponsor Decision|1|||
25236178|NCT03556202|50548103|FG002|Extension Treatment Period|Sponsor Decision|0|||
25236179|NCT03556202|50548101|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
25236180|NCT03556202|50548102|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
25236181|NCT03556202|50548103|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
25236182|NCT03556202|50548101|FG000|Follow-Up Period (12 Weeks)|Death|1|||
25236183|NCT03556202|50548102|FG001|Follow-Up Period (12 Weeks)|Death|0|||
25236184|NCT03556202|50548103|FG002|Follow-Up Period (12 Weeks)|Death|0|||
25236185|NCT03556202|50548101|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
25236186|NCT03556202|50548102|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
25236187|NCT03556202|50548103|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
25236188|NCT03556202|50548101|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
25236189|NCT03556202|50548102|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
25236190|NCT03556202|50548103|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
25236191|NCT03556202|50548101|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
25236192|NCT03556202|50548102|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
25236193|NCT03556202|50548103|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
25236194|NCT03556202|50548101|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
25236195|NCT03556202|50548102|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
25236196|NCT03556202|50548103|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
25077538|NCT02240680|50185296|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
25236197|NCT03556202|50548101|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
25236198|NCT03556202|50548102|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
25319688|NCT03330106|50635358|FG002|Part B|Death|2|||
25236199|NCT03556202|50548103|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
25236200|NCT03556202|50548101|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
25236201|NCT03556202|50548102|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
25236202|NCT03556202|50548103|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
25236203|NCT03556202|50548101|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
25236204|NCT03556202|50548102|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
25236205|NCT03556202|50548103|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
25236206|NCT03556202|50548101|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
25236207|NCT03556202|50548102|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
25236208|NCT03556202|50548103|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
25236209|NCT03556202|50548101|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
25236210|NCT03556202|50548102|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
25236211|NCT03556202|50548103|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
25236212|NCT03556202|50548101|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
25236213|NCT03556202|50548102|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
25236214|NCT03556202|50548103|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
25236215|NCT03556202|50548101|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
25236216|NCT03556202|50548102|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
25236217|NCT03556202|50548103|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
25236218|NCT03556202|50548101|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
25236219|NCT03556202|50548102|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
25236220|NCT03556202|50548103|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
25236221|NCT03541174|50548117|FG000|Part 1 Double-Blind|Adverse Event|6|||
25236222|NCT03541174|50548118|FG001|Part 1 Double-Blind|Adverse Event|5|||
25236223|NCT03541174|50548119|FG002|Part 1 Double-Blind|Adverse Event|2|||
25236224|NCT03541174|50548120|FG003|Part 1 Double-Blind|Adverse Event|0|||
25236225|NCT03541174|50548121|FG004|Part 1 Double-Blind|Adverse Event|0|||
25236226|NCT03541174|50548122|FG005|Part 1 Double-Blind|Adverse Event|0|||
25236227|NCT03541174|50548117|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
25236228|NCT03541174|50548118|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
25236229|NCT03541174|50548119|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
25236230|NCT03541174|50548120|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
25236231|NCT03541174|50548121|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
25236232|NCT03541174|50548122|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
25236233|NCT03541174|50548117|FG000|Part 1 Double-Blind|Other reasons|3|||
25236234|NCT03541174|50548118|FG001|Part 1 Double-Blind|Other reasons|2|||
25236235|NCT03541174|50548119|FG002|Part 1 Double-Blind|Other reasons|3|||
25236236|NCT03541174|50548120|FG003|Part 1 Double-Blind|Other reasons|0|||
25236237|NCT03541174|50548121|FG004|Part 1 Double-Blind|Other reasons|0|||
25236238|NCT03541174|50548122|FG005|Part 1 Double-Blind|Other reasons|0|||
25236239|NCT03541174|50548117|FG000|Part 2 Single-Blind|Adverse Event|0|||
25236240|NCT03541174|50548118|FG001|Part 2 Single-Blind|Adverse Event|0|||
25236241|NCT03541174|50548119|FG002|Part 2 Single-Blind|Adverse Event|0|||
25236242|NCT03541174|50548120|FG003|Part 2 Single-Blind|Adverse Event|25|||
25236243|NCT03541174|50548121|FG004|Part 2 Single-Blind|Adverse Event|0|||
25236244|NCT03541174|50548122|FG005|Part 2 Single-Blind|Adverse Event|0|||
25236245|NCT03541174|50548117|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
25236246|NCT03541174|50548118|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
25236247|NCT03541174|50548119|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
25236248|NCT03541174|50548120|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
25236249|NCT03541174|50548121|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
25236250|NCT03541174|50548122|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
25236251|NCT03541174|50548117|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
25236252|NCT03541174|50548118|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
25236253|NCT03541174|50548119|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
25236254|NCT03541174|50548120|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
25236255|NCT03541174|50548121|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
25236256|NCT03541174|50548122|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
25236257|NCT03541174|50548117|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
25236258|NCT03541174|50548118|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
25236259|NCT03541174|50548119|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
25236260|NCT03541174|50548120|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
25236261|NCT03541174|50548121|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
25236262|NCT03541174|50548122|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
25236263|NCT03541174|50548117|FG000|Part 2 Single-Blind|Death|0|||
25236264|NCT03541174|50548118|FG001|Part 2 Single-Blind|Death|0|||
25077539|NCT02240680|50185297|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
25236265|NCT03541174|50548119|FG002|Part 2 Single-Blind|Death|0|||
25236266|NCT03541174|50548120|FG003|Part 2 Single-Blind|Death|5|||
25236267|NCT03541174|50548121|FG004|Part 2 Single-Blind|Death|0|||
25236268|NCT03541174|50548122|FG005|Part 2 Single-Blind|Death|0|||
25236269|NCT03541174|50548117|FG000|Part 2 Single-Blind|Pregnancy|0|||
25236270|NCT03541174|50548118|FG001|Part 2 Single-Blind|Pregnancy|0|||
25236271|NCT03541174|50548119|FG002|Part 2 Single-Blind|Pregnancy|0|||
25236272|NCT03541174|50548120|FG003|Part 2 Single-Blind|Pregnancy|1|||
25236273|NCT03541174|50548121|FG004|Part 2 Single-Blind|Pregnancy|0|||
25236274|NCT03541174|50548122|FG005|Part 2 Single-Blind|Pregnancy|0|||
25236275|NCT03541174|50548117|FG000|Part 2 Single-Blind|Other reasons|0|||
25236276|NCT03541174|50548118|FG001|Part 2 Single-Blind|Other reasons|0|||
25236277|NCT03541174|50548119|FG002|Part 2 Single-Blind|Other reasons|0|||
25236278|NCT03541174|50548120|FG003|Part 2 Single-Blind|Other reasons|32|||
25236279|NCT03541174|50548121|FG004|Part 2 Single-Blind|Other reasons|0|||
25236280|NCT03541174|50548122|FG005|Part 2 Single-Blind|Other reasons|0|||
25236281|NCT03541174|50548117|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
25236282|NCT03541174|50548118|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
25236283|NCT03541174|50548119|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
25236284|NCT03541174|50548120|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
25236285|NCT03541174|50548121|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
25236286|NCT03541174|50548122|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
25236287|NCT03541174|50548117|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
25236288|NCT03541174|50548118|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
25236289|NCT03541174|50548119|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
25236290|NCT03541174|50548120|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
25236291|NCT03541174|50548121|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
25236292|NCT03541174|50548122|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
25236293|NCT03541174|50548117|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
25236294|NCT03541174|50548118|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
25236295|NCT03541174|50548119|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
25236296|NCT03541174|50548120|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
25236297|NCT03541174|50548121|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
25236298|NCT03541174|50548122|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
25236299|NCT03541174|50548117|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
25236300|NCT03541174|50548118|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
25236301|NCT03541174|50548119|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
25236302|NCT03541174|50548120|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
25236303|NCT03541174|50548121|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
25236304|NCT03541174|50548122|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
25236305|NCT03541174|50548117|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
25236306|NCT03541174|50548118|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
25236307|NCT03541174|50548119|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
25236308|NCT03541174|50548120|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
25236309|NCT03541174|50548121|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
25236310|NCT03541174|50548122|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
25236311|NCT03289039|50548154|FG000|Overall Study|Withdrawal by Subject|0|||
25236312|NCT03289039|50548155|FG001|Overall Study|Withdrawal by Subject|1|||
25236313|NCT03289039|50548154|FG000|Overall Study|Became ineligible prior to treatment start|0|||
25236314|NCT03289039|50548155|FG001|Overall Study|Became ineligible prior to treatment start|1|||
25236315|NCT03289039|50548154|FG000|Overall Study|progressed before treatment start|1|||
25236316|NCT03289039|50548155|FG001|Overall Study|progressed before treatment start|0|||
25236317|NCT03281304|50548163|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
25236318|NCT03281304|50548164|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
25236319|NCT03281304|50548163|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
25236320|NCT03281304|50548164|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
25236321|NCT03281304|50548163|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
25236322|NCT03281304|50548164|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
25236323|NCT03281304|50548163|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
25236324|NCT03281304|50548164|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
25236325|NCT03281304|50548163|FG000|Treatment Phase (up to 42 Months)|Death|0|||
25236326|NCT03281304|50548164|FG001|Treatment Phase (up to 42 Months)|Death|1|||
25236327|NCT03281304|50548163|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
25236328|NCT03281304|50548164|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
25319689|NCT03330106|50635359|FG003|Part B|Death|0|||
25319690|NCT03330106|50635356|FG000|Part B|Clinical Progression|0|||
25236329|NCT03281304|50548163|FG000|Treatment Phase (up to 42 Months)|Other|0|||
25236330|NCT03281304|50548164|FG001|Treatment Phase (up to 42 Months)|Other|2|||
25236331|NCT03281304|50548163|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
25236332|NCT03281304|50548164|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
25236333|NCT03204305|50548173|FG000|Overall Study|Lost to Follow-up|6|||
25236334|NCT03204305|50548174|FG001|Overall Study|Lost to Follow-up|4|||
25236335|NCT03204305|50548175|FG002|Overall Study|Lost to Follow-up|0|||
25236336|NCT03204305|50548176|FG003|Overall Study|Lost to Follow-up|0|||
25236337|NCT03204305|50548173|FG000|Overall Study|Physician Decision|1|||
25236338|NCT03204305|50548174|FG001|Overall Study|Physician Decision|0|||
25236339|NCT03204305|50548175|FG002|Overall Study|Physician Decision|0|||
25236340|NCT03204305|50548176|FG003|Overall Study|Physician Decision|0|||
25236341|NCT03204305|50548173|FG000|Overall Study|failure to place arterial line|2|||
25236342|NCT03204305|50548174|FG001|Overall Study|failure to place arterial line|1|||
25236343|NCT03204305|50548175|FG002|Overall Study|failure to place arterial line|0|||
25236344|NCT03204305|50548176|FG003|Overall Study|failure to place arterial line|0|||
25236345|NCT03204305|50548173|FG000|Overall Study|Withdrawal by Subject|2|||
25236346|NCT03204305|50548174|FG001|Overall Study|Withdrawal by Subject|0|||
25236347|NCT03204305|50548175|FG002|Overall Study|Withdrawal by Subject|0|||
25236348|NCT03204305|50548176|FG003|Overall Study|Withdrawal by Subject|0|||
25236349|NCT03200717|50548188|FG000|Overall Study|Progressive disease|24|||
25236350|NCT03200717|50548189|FG001|Overall Study|Progressive disease|5|||
25236351|NCT03200717|50548188|FG000|Overall Study|Adverse Event|11|||
25236352|NCT03200717|50548189|FG001|Overall Study|Adverse Event|8|||
25236353|NCT03200717|50548188|FG000|Overall Study|Physician Decision|3|||
25236354|NCT03200717|50548189|FG001|Overall Study|Physician Decision|2|||
25236355|NCT03200717|50548188|FG000|Overall Study|Death|2|||
25236356|NCT03200717|50548189|FG001|Overall Study|Death|0|||
25236357|NCT03200717|50548188|FG000|Overall Study|Subject/Guardian Decision|1|||
25236358|NCT03200717|50548189|FG001|Overall Study|Subject/Guardian Decision|0|||
25236359|NCT03105700|50548198|FG000|Overall Study|screen fail|3|||
25236360|NCT03105700|50548198|FG000|Overall Study|Lost to Follow-up|4|||
25236361|NCT02738853|50548221|FG000|Enrollment|Inclusion/Exclusion not met|21|||
25236362|NCT02738853|50548221|FG000|Enrollment|Withdrawal by Subject|3|||
25236363|NCT02738853|50548221|FG000|Enrollment|Subject treated with commercially available device|6|||
25236364|NCT02738853|50548221|FG000|Enrollment|Study Enrollment Closed|3|||
25236365|NCT02738853|50548221|FG000|Procedure|Death|1|||
25236366|NCT02738853|50548221|FG000|1 Month|Death|2|||
25236367|NCT02738853|50548221|FG000|6 Month|Death|4|||
25236368|NCT02738853|50548221|FG000|6 Month|Withdrawal by Subject|2|||
25236369|NCT02738853|50548221|FG000|1 Year|Death|6|||
25236370|NCT02738853|50548221|FG000|1 Year|Withdrawal by Subject|1|||
25236371|NCT02738853|50548221|FG000|2 Year|Death|2|||
25236372|NCT02738853|50548221|FG000|2 Year|Lost to Follow-up|1|||
25236373|NCT02738853|50548221|FG000|3 Year|Death|2|||
25236374|NCT02738853|50548221|FG000|3 Year|Withdrawal by Subject|1|||
25236375|NCT02738853|50548221|FG000|4 Year|Death|9|||
25236376|NCT02738853|50548221|FG000|5 Year|Lost to Follow-up|4|||
25236377|NCT02358538|50548229|FG000|Through Week 26|Adverse Event|0|||
25236378|NCT02358538|50548230|FG001|Through Week 26|Adverse Event|1|||
25236379|NCT02358538|50548231|FG002|Through Week 26|Adverse Event|1|||
25236380|NCT02358538|50548232|FG003|Through Week 26|Adverse Event|2|||
25236381|NCT02358538|50548229|FG000|Through Week 26|Lack of Efficacy|1|||
25236382|NCT02358538|50548230|FG001|Through Week 26|Lack of Efficacy|1|||
25236383|NCT02358538|50548231|FG002|Through Week 26|Lack of Efficacy|3|||
25236384|NCT02358538|50548232|FG003|Through Week 26|Lack of Efficacy|3|||
25236385|NCT02358538|50548229|FG000|Through Week 26|Withdrawal by Subject|1|||
25236386|NCT02358538|50548230|FG001|Through Week 26|Withdrawal by Subject|0|||
25236387|NCT02358538|50548231|FG002|Through Week 26|Withdrawal by Subject|0|||
25236388|NCT02358538|50548232|FG003|Through Week 26|Withdrawal by Subject|0|||
25236389|NCT02358538|50548229|FG000|Through Week 26|Non-Compliance|0|||
25236390|NCT02358538|50548230|FG001|Through Week 26|Non-Compliance|0|||
25236391|NCT02358538|50548231|FG002|Through Week 26|Non-Compliance|1|||
25236392|NCT02358538|50548232|FG003|Through Week 26|Non-Compliance|0|||
25236393|NCT02358538|50548229|FG000|Through Week 26|Family did not see benefit from IP|1|||
25236394|NCT02358538|50548230|FG001|Through Week 26|Family did not see benefit from IP|0|||
25236395|NCT02358538|50548231|FG002|Through Week 26|Family did not see benefit from IP|0|||
25236396|NCT02358538|50548232|FG003|Through Week 26|Family did not see benefit from IP|0|||
25236397|NCT02358538|50548229|FG000|52 Week Extension Period|Lack of Efficacy|0|||
25236398|NCT02358538|50548230|FG001|52 Week Extension Period|Lack of Efficacy|0|||
25236399|NCT02358538|50548231|FG002|52 Week Extension Period|Lack of Efficacy|2|||
25236400|NCT02358538|50548232|FG003|52 Week Extension Period|Lack of Efficacy|4|||
25236401|NCT02197234|50548265|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
25236402|NCT02197234|50548265|FG000|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1|||
25236403|NCT02197234|50548265|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
25236404|NCT02197234|50548265|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
25236405|NCT02197234|50548265|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
25236406|NCT02197234|50548265|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
25236407|NCT02197234|50548265|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
25236408|NCT02056119|50548274|FG000|Overall Study|Death|1|||
25236409|NCT02056119|50548275|FG001|Overall Study|Death|2|||
25236410|NCT02056119|50548274|FG000|Overall Study|Intubated for less than 24 hrs|2|||
25236411|NCT02056119|50548275|FG001|Overall Study|Intubated for less than 24 hrs|7|||
25236412|NCT02056119|50548274|FG000|Overall Study|No aerosol treatments were given.|3|||
25236413|NCT02056119|50548275|FG001|Overall Study|No aerosol treatments were given.|2|||
25236414|NCT02056119|50548274|FG000|Overall Study|Received Metaneb treatment|0|||
25236415|NCT02056119|50548275|FG001|Overall Study|Received Metaneb treatment|2|||
25236416|NCT02056119|50548274|FG000|Overall Study|Protocol Violation|4|||
25236417|NCT02056119|50548275|FG001|Overall Study|Protocol Violation|7|||
25236418|NCT02038452|50548283|FG000|Overall Study|Withdrawal by Subject|7|||
25236419|NCT02038452|50548284|FG001|Overall Study|Withdrawal by Subject|9|||
25236420|NCT02038452|50548283|FG000|Overall Study|Lost to Follow-up|31|||
25236421|NCT02038452|50548284|FG001|Overall Study|Lost to Follow-up|28|||
25236422|NCT01933932|50548296|FG000|Overall Study|Death|173|||
25236423|NCT01933932|50548297|FG001|Overall Study|Death|163|||
25236424|NCT01933932|50548296|FG000|Overall Study|Withdrawal by Subject|11|||
25236425|NCT01933932|50548297|FG001|Overall Study|Withdrawal by Subject|14|||
25236426|NCT01933932|50548296|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
25236427|NCT01933932|50548297|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
25236428|NCT01238172|50548332|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
25236429|NCT01238172|50548333|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
25236430|NCT01238172|50548332|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
25236431|NCT01238172|50548333|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
25236432|NCT00967005|50548341|FG000|Overall Study|Lost to Follow-up|7|||
25236433|NCT00967005|50548342|FG001|Overall Study|Lost to Follow-up|10|||
25236434|NCT00203996|50548400|FG000|Overall Study|Lost to Follow-up|0|||
25236435|NCT00203996|50548401|FG001|Overall Study|Lost to Follow-up|0|||
25236436|NCT00203996|50548402|FG002|Overall Study|Lost to Follow-up|0|||
25236437|NCT00203996|50548403|FG003|Overall Study|Lost to Follow-up|1|||
25236438|NCT00203996|50548404|FG004|Overall Study|Lost to Follow-up|0|||
25236439|NCT00203996|50548405|FG005|Overall Study|Lost to Follow-up|0|||
25236440|NCT00203996|50548406|FG006|Overall Study|Lost to Follow-up|0|||
25236441|NCT00203996|50548407|FG007|Overall Study|Lost to Follow-up|0|||
25236442|NCT00203996|50548408|FG008|Overall Study|Lost to Follow-up|0|||
25236443|NCT00203996|50548409|FG009|Overall Study|Lost to Follow-up|0|||
25236444|NCT00203996|50548400|FG000|Overall Study|Protocol Violation|0|||
25236445|NCT00203996|50548401|FG001|Overall Study|Protocol Violation|0|||
25236446|NCT00203996|50548402|FG002|Overall Study|Protocol Violation|0|||
25236447|NCT00203996|50548403|FG003|Overall Study|Protocol Violation|6|||
25236448|NCT00203996|50548404|FG004|Overall Study|Protocol Violation|1|||
25236449|NCT00203996|50548405|FG005|Overall Study|Protocol Violation|0|||
25236450|NCT00203996|50548406|FG006|Overall Study|Protocol Violation|0|||
25236451|NCT00203996|50548407|FG007|Overall Study|Protocol Violation|0|||
25236452|NCT00203996|50548408|FG008|Overall Study|Protocol Violation|0|||
25236453|NCT00203996|50548409|FG009|Overall Study|Protocol Violation|0|||
25236454|NCT00203996|50548400|FG000|Overall Study|Physician Decision|0|||
25236455|NCT00203996|50548401|FG001|Overall Study|Physician Decision|0|||
25236456|NCT00203996|50548402|FG002|Overall Study|Physician Decision|0|||
25236457|NCT00203996|50548403|FG003|Overall Study|Physician Decision|2|||
25236458|NCT00203996|50548404|FG004|Overall Study|Physician Decision|0|||
25236459|NCT00203996|50548405|FG005|Overall Study|Physician Decision|0|||
25236460|NCT00203996|50548406|FG006|Overall Study|Physician Decision|0|||
25236461|NCT00203996|50548407|FG007|Overall Study|Physician Decision|0|||
25236462|NCT00203996|50548408|FG008|Overall Study|Physician Decision|0|||
25236463|NCT00203996|50548409|FG009|Overall Study|Physician Decision|1|||
25236464|NCT00203996|50548400|FG000|Overall Study|CPAP machine malfunction|0|||
25236465|NCT00203996|50548401|FG001|Overall Study|CPAP machine malfunction|0|||
25236466|NCT00203996|50548402|FG002|Overall Study|CPAP machine malfunction|0|||
25236467|NCT00203996|50548403|FG003|Overall Study|CPAP machine malfunction|1|||
25236468|NCT00203996|50548404|FG004|Overall Study|CPAP machine malfunction|0|||
25236469|NCT00203996|50548405|FG005|Overall Study|CPAP machine malfunction|0|||
25236470|NCT00203996|50548406|FG006|Overall Study|CPAP machine malfunction|0|||
25236471|NCT00203996|50548407|FG007|Overall Study|CPAP machine malfunction|0|||
25236472|NCT00203996|50548408|FG008|Overall Study|CPAP machine malfunction|0|||
25236473|NCT00203996|50548409|FG009|Overall Study|CPAP machine malfunction|0|||
25236474|NCT00203996|50548400|FG000|Overall Study|Scheduling issue|0|||
25236475|NCT00203996|50548401|FG001|Overall Study|Scheduling issue|0|||
25236476|NCT00203996|50548402|FG002|Overall Study|Scheduling issue|0|||
25236477|NCT00203996|50548403|FG003|Overall Study|Scheduling issue|0|||
25236478|NCT00203996|50548404|FG004|Overall Study|Scheduling issue|0|||
25236479|NCT00203996|50548405|FG005|Overall Study|Scheduling issue|0|||
25236480|NCT00203996|50548406|FG006|Overall Study|Scheduling issue|0|||
25236481|NCT00203996|50548407|FG007|Overall Study|Scheduling issue|2|||
25236482|NCT00203996|50548408|FG008|Overall Study|Scheduling issue|0|||
25236483|NCT00203996|50548409|FG009|Overall Study|Scheduling issue|0|||
25236484|NCT00099437|50548427|FG000|Overall Study|Lost to Follow-up|30|||
25236485|NCT00099437|50548428|FG001|Overall Study|Lost to Follow-up|33|||
25236486|NCT00099437|50548427|FG000|Overall Study|Death|293|||
25236487|NCT00099437|50548428|FG001|Overall Study|Death|261|||
25236488|NCT00099437|50548427|FG000|Overall Study|Withdrawal by Subject|6|||
25236489|NCT00099437|50548428|FG001|Overall Study|Withdrawal by Subject|10|||
25236490|NCT00099437|50548427|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
25236491|NCT00099437|50548428|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
25236492|NCT02014558|50548447|FG000|Overall Study|Never Received Study Drug|0|||
25236493|NCT02014558|50548448|FG001|Overall Study|Never Received Study Drug|0|||
25236494|NCT02014558|50548449|FG002|Overall Study|Never Received Study Drug|0|||
25236495|NCT02014558|50548450|FG003|Overall Study|Never Received Study Drug|0|||
25236496|NCT02014558|50548451|FG004|Overall Study|Never Received Study Drug|1|||
25236497|NCT02014558|50548452|FG005|Overall Study|Never Received Study Drug|0|||
25236498|NCT02014558|50548453|FG006|Overall Study|Never Received Study Drug|1|||
25236499|NCT02014558|50548454|FG007|Overall Study|Never Received Study Drug|0|||
25236500|NCT02014558|50548455|FG008|Overall Study|Never Received Study Drug|2|||
25236501|NCT02014558|50548456|FG009|Overall Study|Never Received Study Drug|0|||
25236502|NCT02014558|50548457|FG010|Overall Study|Never Received Study Drug|2|||
25236503|NCT02014558|50548458|FG011|Overall Study|Never Received Study Drug|2|||
25236504|NCT02014558|50548459|FG012|Overall Study|Never Received Study Drug|0|||
25236505|NCT02014558|50548447|FG000|Overall Study|Adverse Event|0|||
25236506|NCT02014558|50548448|FG001|Overall Study|Adverse Event|0|||
25236507|NCT02014558|50548449|FG002|Overall Study|Adverse Event|0|||
25236508|NCT02014558|50548450|FG003|Overall Study|Adverse Event|0|||
25236509|NCT02014558|50548451|FG004|Overall Study|Adverse Event|1|||
25236510|NCT02014558|50548452|FG005|Overall Study|Adverse Event|0|||
25236511|NCT02014558|50548453|FG006|Overall Study|Adverse Event|0|||
25236512|NCT02014558|50548454|FG007|Overall Study|Adverse Event|0|||
25236513|NCT02014558|50548455|FG008|Overall Study|Adverse Event|2|||
25236514|NCT02014558|50548456|FG009|Overall Study|Adverse Event|2|||
25236515|NCT02014558|50548457|FG010|Overall Study|Adverse Event|5|||
25236516|NCT02014558|50548458|FG011|Overall Study|Adverse Event|21|||
25236517|NCT02014558|50548459|FG012|Overall Study|Adverse Event|3|||
25236518|NCT02014558|50548447|FG000|Overall Study|Death|1|||
25236519|NCT02014558|50548448|FG001|Overall Study|Death|0|||
25236520|NCT02014558|50548449|FG002|Overall Study|Death|0|||
25236521|NCT02014558|50548450|FG003|Overall Study|Death|0|||
25236522|NCT02014558|50548451|FG004|Overall Study|Death|0|||
25236523|NCT02014558|50548452|FG005|Overall Study|Death|0|||
25236524|NCT02014558|50548453|FG006|Overall Study|Death|1|||
25236525|NCT02014558|50548454|FG007|Overall Study|Death|1|||
25236526|NCT02014558|50548455|FG008|Overall Study|Death|2|||
25236527|NCT02014558|50548456|FG009|Overall Study|Death|5|||
25236528|NCT02014558|50548457|FG010|Overall Study|Death|5|||
25236529|NCT02014558|50548458|FG011|Overall Study|Death|19|||
25236530|NCT02014558|50548459|FG012|Overall Study|Death|2|||
25236531|NCT02014558|50548447|FG000|Overall Study|Lack of Efficacy|1|||
25236532|NCT02014558|50548448|FG001|Overall Study|Lack of Efficacy|2|||
25236533|NCT02014558|50548449|FG002|Overall Study|Lack of Efficacy|1|||
25236534|NCT02014558|50548450|FG003|Overall Study|Lack of Efficacy|1|||
25236535|NCT02014558|50548451|FG004|Overall Study|Lack of Efficacy|0|||
25236536|NCT02014558|50548452|FG005|Overall Study|Lack of Efficacy|0|||
25236537|NCT02014558|50548453|FG006|Overall Study|Lack of Efficacy|1|||
25236538|NCT02014558|50548454|FG007|Overall Study|Lack of Efficacy|3|||
25236539|NCT02014558|50548455|FG008|Overall Study|Lack of Efficacy|3|||
25236540|NCT02014558|50548456|FG009|Overall Study|Lack of Efficacy|3|||
25236541|NCT02014558|50548457|FG010|Overall Study|Lack of Efficacy|16|||
25236542|NCT02014558|50548458|FG011|Overall Study|Lack of Efficacy|8|||
25236543|NCT02014558|50548459|FG012|Overall Study|Lack of Efficacy|5|||
25236544|NCT02014558|50548447|FG000|Overall Study|Lost to Follow-up|0|||
25236545|NCT02014558|50548448|FG001|Overall Study|Lost to Follow-up|0|||
25236546|NCT02014558|50548449|FG002|Overall Study|Lost to Follow-up|0|||
25236547|NCT02014558|50548450|FG003|Overall Study|Lost to Follow-up|0|||
25236548|NCT02014558|50548451|FG004|Overall Study|Lost to Follow-up|0|||
25236549|NCT02014558|50548452|FG005|Overall Study|Lost to Follow-up|0|||
25236550|NCT02014558|50548453|FG006|Overall Study|Lost to Follow-up|0|||
25236551|NCT02014558|50548454|FG007|Overall Study|Lost to Follow-up|0|||
25236552|NCT02014558|50548455|FG008|Overall Study|Lost to Follow-up|0|||
25236553|NCT02014558|50548456|FG009|Overall Study|Lost to Follow-up|0|||
25236554|NCT02014558|50548457|FG010|Overall Study|Lost to Follow-up|1|||
25236555|NCT02014558|50548458|FG011|Overall Study|Lost to Follow-up|0|||
25236556|NCT02014558|50548459|FG012|Overall Study|Lost to Follow-up|0|||
25236557|NCT02014558|50548447|FG000|Overall Study|Progressive Disease|1|||
25236558|NCT02014558|50548448|FG001|Overall Study|Progressive Disease|0|||
25236559|NCT02014558|50548449|FG002|Overall Study|Progressive Disease|1|||
25236560|NCT02014558|50548450|FG003|Overall Study|Progressive Disease|1|||
25236561|NCT02014558|50548451|FG004|Overall Study|Progressive Disease|1|||
25236562|NCT02014558|50548452|FG005|Overall Study|Progressive Disease|2|||
25236563|NCT02014558|50548453|FG006|Overall Study|Progressive Disease|1|||
25236564|NCT02014558|50548454|FG007|Overall Study|Progressive Disease|6|||
25236565|NCT02014558|50548455|FG008|Overall Study|Progressive Disease|5|||
25236566|NCT02014558|50548456|FG009|Overall Study|Progressive Disease|6|||
25236567|NCT02014558|50548457|FG010|Overall Study|Progressive Disease|22|||
25236568|NCT02014558|50548458|FG011|Overall Study|Progressive Disease|31|||
25236569|NCT02014558|50548459|FG012|Overall Study|Progressive Disease|6|||
25236570|NCT02014558|50548447|FG000|Overall Study|Withdrawal by Subject|0|||
25236571|NCT02014558|50548448|FG001|Overall Study|Withdrawal by Subject|0|||
25236572|NCT02014558|50548449|FG002|Overall Study|Withdrawal by Subject|0|||
25236573|NCT02014558|50548450|FG003|Overall Study|Withdrawal by Subject|0|||
25236574|NCT02014558|50548451|FG004|Overall Study|Withdrawal by Subject|1|||
25236575|NCT02014558|50548452|FG005|Overall Study|Withdrawal by Subject|0|||
25236576|NCT02014558|50548453|FG006|Overall Study|Withdrawal by Subject|0|||
25236577|NCT02014558|50548454|FG007|Overall Study|Withdrawal by Subject|0|||
25236578|NCT02014558|50548455|FG008|Overall Study|Withdrawal by Subject|0|||
25236579|NCT02014558|50548456|FG009|Overall Study|Withdrawal by Subject|2|||
25236580|NCT02014558|50548457|FG010|Overall Study|Withdrawal by Subject|6|||
25236581|NCT02014558|50548458|FG011|Overall Study|Withdrawal by Subject|10|||
25236582|NCT02014558|50548459|FG012|Overall Study|Withdrawal by Subject|0|||
25236583|NCT02014558|50548447|FG000|Overall Study|Miscellaneous|2|||
25236584|NCT02014558|50548448|FG001|Overall Study|Miscellaneous|1|||
25236585|NCT02014558|50548449|FG002|Overall Study|Miscellaneous|1|||
25236586|NCT02014558|50548450|FG003|Overall Study|Miscellaneous|1|||
25236587|NCT02014558|50548451|FG004|Overall Study|Miscellaneous|0|||
25236588|NCT02014558|50548452|FG005|Overall Study|Miscellaneous|1|||
25236589|NCT02014558|50548453|FG006|Overall Study|Miscellaneous|0|||
25236590|NCT02014558|50548454|FG007|Overall Study|Miscellaneous|1|||
25236591|NCT02014558|50548455|FG008|Overall Study|Miscellaneous|1|||
25236592|NCT02014558|50548456|FG009|Overall Study|Miscellaneous|3|||
25236593|NCT02014558|50548457|FG010|Overall Study|Miscellaneous|12|||
25236594|NCT02014558|50548458|FG011|Overall Study|Miscellaneous|11|||
25236595|NCT02014558|50548459|FG012|Overall Study|Miscellaneous|1|||
25236596|NCT02024555|50548514|FG000|Overall Study|Lost to Follow-up|1|||
25236597|NCT02024555|50548515|FG001|Overall Study|Lost to Follow-up|1|||
25236598|NCT02024555|50548514|FG000|Overall Study|Withdrawal by Subject|5|||
25236599|NCT02024555|50548515|FG001|Overall Study|Withdrawal by Subject|1|||
25236600|NCT02040584|50548523|FG000|Overall Study|Adverse Event|13|||
25236601|NCT02040584|50548524|FG001|Overall Study|Adverse Event|6|||
25236602|NCT02040584|50548523|FG000|Overall Study|Protocol Violation|9|||
25236603|NCT02040584|50548524|FG001|Overall Study|Protocol Violation|11|||
25236604|NCT02040584|50548523|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25236605|NCT02040584|50548524|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
25236606|NCT02040584|50548523|FG000|Overall Study|Death|6|||
25236607|NCT02040584|50548524|FG001|Overall Study|Death|3|||
25236608|NCT02040584|50548523|FG000|Overall Study|Transplant rejection/retransplant|0|||
25236609|NCT02040584|50548524|FG001|Overall Study|Transplant rejection/retransplant|1|||
25236610|NCT02040584|50548523|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
25236611|NCT02040584|50548524|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
25236612|NCT02045797|50548543|FG000|Overall Study|Adverse Event|3|||
25236613|NCT02045797|50548544|FG001|Overall Study|Adverse Event|1|||
25236614|NCT02045797|50548545|FG002|Overall Study|Adverse Event|0|||
25236615|NCT02045797|50548543|FG000|Overall Study|Lack of Efficacy|1|||
25236616|NCT02045797|50548544|FG001|Overall Study|Lack of Efficacy|0|||
25236617|NCT02045797|50548545|FG002|Overall Study|Lack of Efficacy|0|||
25236618|NCT02045797|50548543|FG000|Overall Study|Lost to Follow-up|2|||
25236619|NCT02045797|50548544|FG001|Overall Study|Lost to Follow-up|3|||
25236620|NCT02045797|50548545|FG002|Overall Study|Lost to Follow-up|1|||
25236621|NCT02045797|50548543|FG000|Overall Study|Physician Decision|0|||
25236622|NCT02045797|50548544|FG001|Overall Study|Physician Decision|1|||
25236623|NCT02045797|50548545|FG002|Overall Study|Physician Decision|0|||
25236624|NCT02045797|50548543|FG000|Overall Study|Withdrawal by Subject|1|||
25236625|NCT02045797|50548544|FG001|Overall Study|Withdrawal by Subject|2|||
25236626|NCT02045797|50548545|FG002|Overall Study|Withdrawal by Subject|0|||
25236627|NCT03385239|50548575|FG000|Overall Study|Voluntary Withdrawal|2|||
25236628|NCT03385239|50548576|FG001|Overall Study|Voluntary Withdrawal|3|||
25236629|NCT03385239|50548577|FG002|Overall Study|Voluntary Withdrawal|2|||
25236630|NCT03385239|50548578|FG003|Overall Study|Voluntary Withdrawal|3|||
25236631|NCT03385239|50548579|FG004|Overall Study|Voluntary Withdrawal|0|||
25236632|NCT03385239|50548575|FG000|Overall Study|Adverse Event|0|||
25236633|NCT03385239|50548576|FG001|Overall Study|Adverse Event|0|||
25236634|NCT03385239|50548577|FG002|Overall Study|Adverse Event|1|||
25236635|NCT03385239|50548578|FG003|Overall Study|Adverse Event|0|||
25236636|NCT03385239|50548579|FG004|Overall Study|Adverse Event|0|||
25236637|NCT03385239|50548575|FG000|Overall Study|Other|0|||
25236638|NCT03385239|50548576|FG001|Overall Study|Other|0|||
25236639|NCT03385239|50548577|FG002|Overall Study|Other|0|||
25236640|NCT03385239|50548578|FG003|Overall Study|Other|1|||
25236641|NCT03385239|50548579|FG004|Overall Study|Other|0|||
25236642|NCT03020160|50548597|FG000|Overall Study|Withdrawal by Subject|1|||
25236643|NCT03020160|50548598|FG001|Overall Study|Withdrawal by Subject|0|||
24976825|NCT00048932|50065736|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
25236644|NCT02593110|50548609|FG000|Overall Study|Withdrawal by Subject|0|||
25236645|NCT02593110|50548610|FG001|Overall Study|Withdrawal by Subject|3|||
25236646|NCT02593110|50548611|FG002|Overall Study|Withdrawal by Subject|3|||
25236647|NCT02593110|50548612|FG003|Overall Study|Withdrawal by Subject|2|||
25236648|NCT02593110|50548609|FG000|Overall Study|Death|0|||
25236649|NCT02593110|50548610|FG001|Overall Study|Death|0|||
25236650|NCT02593110|50548611|FG002|Overall Study|Death|1|||
25236651|NCT02593110|50548612|FG003|Overall Study|Death|0|||
25236652|NCT02373813|50548625|FG000|Run-In Period|Other, Not Specified|5|||
25236653|NCT02373813|50548626|FG001|Run-In Period|Other, Not Specified|0|||
25236654|NCT02373813|50548627|FG002|Run-In Period|Other, Not Specified|0|||
25236655|NCT02373813|50548628|FG003|Run-In Period|Other, Not Specified|0|||
25236656|NCT02373813|50548625|FG000|Run-In Period|Withdrawal by Subject|16|||
25236657|NCT02373813|50548626|FG001|Run-In Period|Withdrawal by Subject|0|||
25236658|NCT02373813|50548627|FG002|Run-In Period|Withdrawal by Subject|0|||
25236659|NCT02373813|50548628|FG003|Run-In Period|Withdrawal by Subject|0|||
25236660|NCT02373813|50548625|FG000|Run-In Period|Decision by Sponsor|11|||
25236661|NCT02373813|50548626|FG001|Run-In Period|Decision by Sponsor|0|||
25236662|NCT02373813|50548627|FG002|Run-In Period|Decision by Sponsor|0|||
25236663|NCT02373813|50548628|FG003|Run-In Period|Decision by Sponsor|0|||
25236664|NCT02373813|50548625|FG000|Run-In Period|Protocol Violation|75|||
25236665|NCT02373813|50548626|FG001|Run-In Period|Protocol Violation|0|||
25236666|NCT02373813|50548627|FG002|Run-In Period|Protocol Violation|0|||
25236667|NCT02373813|50548628|FG003|Run-In Period|Protocol Violation|0|||
25236668|NCT02373813|50548625|FG000|Run-In Period|Lost to Follow-up|2|||
25236669|NCT02373813|50548626|FG001|Run-In Period|Lost to Follow-up|0|||
25236670|NCT02373813|50548627|FG002|Run-In Period|Lost to Follow-up|0|||
25236671|NCT02373813|50548628|FG003|Run-In Period|Lost to Follow-up|0|||
25236672|NCT02373813|50548625|FG000|Run-In Period|Adverse Event|3|||
25236673|NCT02373813|50548626|FG001|Run-In Period|Adverse Event|0|||
25319691|NCT03330106|50635357|FG001|Part B|Clinical Progression|0|||
25319692|NCT03330106|50635358|FG002|Part B|Clinical Progression|1|||
25319693|NCT03330106|50635359|FG003|Part B|Clinical Progression|1|||
25319694|NCT03330106|50635356|FG000|Part B|Symptomatic Deterioration|0|||
25236674|NCT02373813|50548627|FG002|Run-In Period|Adverse Event|0|||
25319695|NCT03330106|50635357|FG001|Part B|Symptomatic Deterioration|0|||
25319696|NCT03330106|50635358|FG002|Part B|Symptomatic Deterioration|0|||
25319697|NCT03330106|50635359|FG003|Part B|Symptomatic Deterioration|1|||
25319698|NCT03330106|50635356|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
25319699|NCT03330106|50635357|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
25319700|NCT03330106|50635358|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
25319701|NCT03330106|50635359|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
25319702|NCT03330106|50635356|FG000|Part B|Progressive Disease|0|||
25319703|NCT03330106|50635357|FG001|Part B|Progressive Disease|0|||
25319704|NCT03330106|50635358|FG002|Part B|Progressive Disease|11|||
25319705|NCT03330106|50635359|FG003|Part B|Progressive Disease|4|||
25319706|NCT03164564|50635371|FG000|Overall Study|Death|3|||
25319707|NCT03164564|50635372|FG001|Overall Study|Death|0|||
25319708|NCT03164564|50635371|FG000|Overall Study|Withdrawal by Subject|20|||
25319709|NCT03164564|50635372|FG001|Overall Study|Withdrawal by Subject|15|||
25319710|NCT03164564|50635371|FG000|Overall Study|Lost to Follow-up|2|||
25319711|NCT03164564|50635372|FG001|Overall Study|Lost to Follow-up|0|||
25319712|NCT03164564|50635371|FG000|Overall Study|Physician Decision|0|||
25319713|NCT03164564|50635372|FG001|Overall Study|Physician Decision|1|||
25319714|NCT03164564|50635371|FG000|Overall Study|Adverse Event|0|||
25319715|NCT03164564|50635372|FG001|Overall Study|Adverse Event|1|||
25319716|NCT03164564|50635371|FG000|Overall Study|Ongoing|1586|||
25319717|NCT03164564|50635372|FG001|Overall Study|Ongoing|1586|||
25319718|NCT02821754|50635392|FG000|Overall Study|Procedure not required prior to amendment change|13|||
25319719|NCT02821754|50635393|FG001|Overall Study|Procedure not required prior to amendment change|11|||
25319720|NCT02821754|50635394|FG002|Overall Study|Procedure not required prior to amendment change|0|||
25319721|NCT02821754|50635392|FG000|Overall Study|Participant's Clinical status|2|||
25319722|NCT02821754|50635393|FG001|Overall Study|Participant's Clinical status|0|||
25319723|NCT02821754|50635394|FG002|Overall Study|Participant's Clinical status|0|||
25319724|NCT02821754|50635392|FG000|Overall Study|Participant removed for noncompliance|1|||
25319725|NCT02821754|50635393|FG001|Overall Study|Participant removed for noncompliance|0|||
25319726|NCT02821754|50635394|FG002|Overall Study|Participant removed for noncompliance|0|||
25319727|NCT02821754|50635392|FG000|Overall Study|Drug not available.|0|||
25319728|NCT02821754|50635393|FG001|Overall Study|Drug not available.|0|||
25319729|NCT02821754|50635394|FG002|Overall Study|Drug not available.|1|||
25319730|NCT02821754|50635392|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
25319731|NCT02821754|50635393|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
25236675|NCT02373813|50548628|FG003|Run-In Period|Adverse Event|0|||
25236676|NCT02373813|50548625|FG000|Run-In Period|Noncompliance|1|||
25319732|NCT02821754|50635394|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
25319733|NCT02742246|50635403|FG000|Overall Study|Never initiated treatment|5|||
25319734|NCT02742246|50635404|FG001|Overall Study|Never initiated treatment|3|||
25319735|NCT02742246|50635405|FG002|Overall Study|Never initiated treatment|1|||
25319736|NCT02742246|50635403|FG000|Overall Study|dropped out during treatment|14|||
25077540|NCT02240680|50185298|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
25236677|NCT02373813|50548626|FG001|Run-In Period|Noncompliance|0|||
25236678|NCT02373813|50548627|FG002|Run-In Period|Noncompliance|0|||
25236679|NCT02373813|50548628|FG003|Run-In Period|Noncompliance|0|||
25236680|NCT02373813|50548625|FG000|Run-In Period|Ineligibility Determined|3|||
25236681|NCT02373813|50548626|FG001|Run-In Period|Ineligibility Determined|0|||
25236682|NCT02373813|50548627|FG002|Run-In Period|Ineligibility Determined|0|||
25236683|NCT02373813|50548628|FG003|Run-In Period|Ineligibility Determined|0|||
25236684|NCT02373813|50548625|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
25236685|NCT02373813|50548626|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
25236686|NCT02373813|50548627|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
25236687|NCT02373813|50548628|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
25236688|NCT02373813|50548625|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
25236689|NCT02373813|50548626|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
25236690|NCT02373813|50548627|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
25236691|NCT02373813|50548628|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
25236692|NCT02373813|50548625|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
25236693|NCT02373813|50548626|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
25236694|NCT02373813|50548627|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
25236695|NCT02373813|50548628|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
25236696|NCT02373813|50548625|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
25236697|NCT02373813|50548626|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
25236698|NCT02373813|50548627|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
25236699|NCT02373813|50548628|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
25236700|NCT01853748|50548645|FG000|Allocation|Withdrawal by Subject|1|||
25236701|NCT01853748|50548646|FG001|Allocation|Withdrawal by Subject|13|||
25236702|NCT01853748|50548645|FG000|Allocation|not sufficient to receive intervention|0|||
25236703|NCT01853748|50548646|FG001|Allocation|not sufficient to receive intervention|1|||
25236704|NCT01853748|50548645|FG000|Follow-Up|Withdrawal by Subject|7|||
25236705|NCT01853748|50548646|FG001|Follow-Up|Withdrawal by Subject|6|||
25236706|NCT01853748|50548645|FG000|Follow-Up|Adverse Event|67|||
25236707|NCT01853748|50548646|FG001|Follow-Up|Adverse Event|7|||
25236708|NCT01853748|50548645|FG000|Follow-Up|not available for data collection|16|||
25236709|NCT01853748|50548646|FG001|Follow-Up|not available for data collection|4|||
25236710|NCT03116347|50548693|FG000|Overall Study|Withdrawal by Subject|1|||
25236711|NCT03116347|50548694|FG001|Overall Study|Withdrawal by Subject|2|||
25236712|NCT00001213|50548740|FG000|Overall Study|Death|18|||
25236713|NCT00000135|50548746|FG000|Overall Study|Death|27|||
25236714|NCT00000135|50548747|FG001|Overall Study|Death|14|||
25236715|NCT00001723|50548755|FG000|Overall Study|Lack of Efficacy|6|||
25236716|NCT00001723|50548756|FG001|Overall Study|Lack of Efficacy|7|||
25236717|NCT00001723|50548755|FG000|Overall Study|Lack of family interest|4|||
25236718|NCT00001723|50548756|FG001|Overall Study|Lack of family interest|5|||
25236719|NCT00001723|50548755|FG000|Overall Study|Lost to Follow-up|2|||
25236720|NCT00001723|50548756|FG001|Overall Study|Lost to Follow-up|2|||
25236721|NCT00001723|50548755|FG000|Overall Study|medication intolerance|1|||
25236722|NCT00001723|50548756|FG001|Overall Study|medication intolerance|2|||
25236723|NCT00000378|50548778|FG000|Overall Study|Lack of Efficacy|16|||
25236724|NCT00000378|50548779|FG001|Overall Study|Lack of Efficacy|14|||
25236725|NCT01350115|50548787|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
25236726|NCT01350115|50548788|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
25236727|NCT01350115|50548787|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
25236728|NCT01350115|50548788|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
25236729|NCT01350115|50548787|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
25236730|NCT01350115|50548788|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
25236731|NCT04142983|50548796|FG000|Overall Study|Lost to Follow-up|73|||
25236732|NCT04142983|50548796|FG000|Overall Study|Withdrawal by Subject|10|||
25236733|NCT04142983|50548796|FG000|Overall Study|Physician Decision|1|||
25236734|NCT04142983|50548796|FG000|Overall Study|Adverse Event|1|||
25236735|NCT04142983|50548796|FG000|Overall Study|No longer eligible|4|||
24976826|NCT00048932|50065737|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
24976827|NCT00048932|50065735|FG000|Double Blind Period (DB)|Relocation|1|||
24976828|NCT00048932|50065736|FG001|Double Blind Period (DB)|Relocation|0|||
25236736|NCT04142983|50548796|FG000|Overall Study|Screen Failure|10|||
25236737|NCT03801031|50548803|FG000|Overall Study|Lost to Follow-up|1|||
25236738|NCT03801031|50548804|FG001|Overall Study|Lost to Follow-up|0|||
24976829|NCT00048932|50065737|FG002|Double Blind Period (DB)|Relocation|0|||
25236739|NCT03801031|50548803|FG000|Overall Study|Unable to comply|1|||
25236740|NCT03801031|50548804|FG001|Overall Study|Unable to comply|0|||
25236741|NCT03801031|50548803|FG000|Overall Study|Withdrawal by Subject|0|||
25319737|NCT02742246|50635404|FG001|Overall Study|dropped out during treatment|14|||
25236742|NCT03801031|50548804|FG001|Overall Study|Withdrawal by Subject|1|||
25236743|NCT03357952|50548812|FG000|Overall Study|Withdrawal by Subject|0|||
25236744|NCT03357952|50548813|FG001|Overall Study|Withdrawal by Subject|1|||
25236745|NCT03357952|50548812|FG000|Overall Study|Sponsor Decision|9|||
25236746|NCT03357952|50548813|FG001|Overall Study|Sponsor Decision|0|||
25236747|NCT03055858|50548819|FG000|Overall Study|Death|9|||
25236748|NCT03055858|50548819|FG000|Overall Study|Withdrawal by Subject|11|||
25236749|NCT03055858|50548819|FG000|Overall Study|Lost to Follow-up|6|||
25236750|NCT03055858|50548819|FG000|Overall Study|Missed Follow-Up Visits|18|||
25236751|NCT02773849|50548846|FG000|Overall Study|Adverse Event|3|||
25236752|NCT02773849|50548846|FG000|Overall Study|Lack of Efficacy|89|||
25236753|NCT02773849|50548846|FG000|Overall Study|Withdrawal by Subject|1|||
25236754|NCT02773849|50548846|FG000|Overall Study|Withdrawal of Consent|1|||
25236755|NCT02393716|50548854|FG000|Overall Study|Death|29|||
25236756|NCT02393716|50548854|FG000|Overall Study|Withdrawal by Subject|8|||
25236757|NCT02393716|50548854|FG000|Overall Study|Device Explanted|8|||
25236758|NCT02393716|50548854|FG000|Overall Study|Missed visit|16|||
25236759|NCT01804816|50548859|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
25236760|NCT01804816|50548859|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
25236761|NCT00584233|50548866|FG000|Overall Study|Withdrawal by Subject|5|||
25236762|NCT00584233|50548866|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
25236763|NCT00001566|50548878|FG000|Overall Study|patients' choice to discontinue protocol|3|||
25236764|NCT00001566|50548878|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
25236765|NCT00001566|50548878|FG000|Overall Study|Death|13|||
25236766|NCT00001566|50548878|FG000|Overall Study|Lost to Follow-up|1|||
25236767|NCT00001566|50548878|FG000|Overall Study|unable to complete initial apheresis|1|||
25236768|NCT00001575|50548882|FG000|Overall Study|Screening failures-Ph I portion|22|||
25236769|NCT00001575|50548882|FG000|Overall Study|Withdrawn/deaths|23|||
25236770|NCT00001596|50548888|FG000|Overall Study|Death|1|||
25236771|NCT00001596|50548889|FG001|Overall Study|Death|0|||
25236772|NCT00001596|50548888|FG000|Overall Study|Withdrawal by Subject|3|||
25236773|NCT00001596|50548889|FG001|Overall Study|Withdrawal by Subject|1|||
25236774|NCT00001596|50548888|FG000|Overall Study|Study Termination|12|||
25236775|NCT00001596|50548889|FG001|Overall Study|Study Termination|9|||
25236776|NCT00001596|50548888|FG000|Overall Study|Adverse Event|1|||
25236777|NCT00001596|50548889|FG001|Overall Study|Adverse Event|0|||
25236778|NCT01349803|50548926|FG000|Overall Study|Adverse Event|0|||
25236779|NCT01349803|50548927|FG001|Overall Study|Adverse Event|0|||
25236780|NCT01349803|50548928|FG002|Overall Study|Adverse Event|0|||
25236781|NCT01349803|50548929|FG003|Overall Study|Adverse Event|2|||
25236782|NCT01349803|50548926|FG000|Overall Study|Withdrawal by Subject|1|||
25236783|NCT01349803|50548927|FG001|Overall Study|Withdrawal by Subject|0|||
25236784|NCT01349803|50548928|FG002|Overall Study|Withdrawal by Subject|0|||
25236785|NCT01349803|50548929|FG003|Overall Study|Withdrawal by Subject|0|||
25236786|NCT01349803|50548926|FG000|Overall Study|Protocol-specified criteria|0|||
25236787|NCT01349803|50548927|FG001|Overall Study|Protocol-specified criteria|1|||
25236788|NCT01349803|50548928|FG002|Overall Study|Protocol-specified criteria|3|||
25236789|NCT01349803|50548929|FG003|Overall Study|Protocol-specified criteria|0|||
25236790|NCT04059146|50549071|FG000|Overall Study|Withdrawal by Subject|0|||
25236791|NCT04059146|50549072|FG001|Overall Study|Withdrawal by Subject|1|||
25236792|NCT03969641|50549093|FG000|Overall Study|Lost to Follow-up|5|||
25319738|NCT02742246|50635405|FG002|Overall Study|dropped out during treatment|11|||
25319739|NCT02742246|50635403|FG000|Overall Study|Death|1|||
25319740|NCT02742246|50635404|FG001|Overall Study|Death|0|||
25319741|NCT02742246|50635405|FG002|Overall Study|Death|0|||
25319742|NCT02708108|50635415|FG000|Overall Study|Death|1|||
25319743|NCT02708108|50635416|FG001|Overall Study|Death|2|||
25319744|NCT02708108|50635415|FG000|Overall Study|Regimen change|1|||
25319745|NCT02708108|50635416|FG001|Overall Study|Regimen change|0|||
25319746|NCT02708108|50635415|FG000|Overall Study|No MRD and no imaging available|0|||
25319747|NCT02708108|50635416|FG001|Overall Study|No MRD and no imaging available|1|||
25319748|NCT02619682|50635423|FG000|Overall Study|Withdrawal by Subject|3|||
25236793|NCT03969641|50549094|FG001|Overall Study|Lost to Follow-up|3|||
25236794|NCT03969641|50549093|FG000|Overall Study|Withdrawal by Subject|1|||
25236795|NCT03969641|50549094|FG001|Overall Study|Withdrawal by Subject|2|||
25236796|NCT03969641|50549093|FG000|Overall Study|Found to be ineligible|1|||
25319749|NCT02619682|50635423|FG000|Overall Study|Lack of Efficacy|8|||
25236797|NCT03969641|50549094|FG001|Overall Study|Found to be ineligible|1|||
25236798|NCT03969641|50549093|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
25236799|NCT03969641|50549094|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
25236800|NCT03969641|50549093|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
25236801|NCT03969641|50549094|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
25236802|NCT03969641|50549093|FG000|Overall Study|Elective termination|0|||
25319750|NCT02619682|50635423|FG000|Overall Study|new secondary cancer|1|||
25319751|NCT02619682|50635423|FG000|Overall Study|post surgery complications|2|||
25319752|NCT02617589|50635429|FG000|Randomization|Request to Discontinue Study Treatment|1|||
25236803|NCT03969641|50549094|FG001|Overall Study|Elective termination|1|||
25236804|NCT03721172|50549140|FG000|Placebo-controlled Phase|Adverse Event|7|||
25236805|NCT03721172|50549141|FG001|Placebo-controlled Phase|Adverse Event|7|||
25236806|NCT03721172|50549142|FG002|Placebo-controlled Phase|Adverse Event|0|||
25236807|NCT03721172|50549140|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
25236808|NCT03721172|50549141|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
25236809|NCT03721172|50549142|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
25236810|NCT03721172|50549140|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
25236811|NCT03721172|50549141|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
25236812|NCT03721172|50549142|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
25236813|NCT03721172|50549140|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
25236814|NCT03721172|50549141|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
25236815|NCT03721172|50549142|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
25236816|NCT03721172|50549140|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
25236817|NCT03721172|50549141|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
25236818|NCT03721172|50549142|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
25236819|NCT03721172|50549140|FG000|Placebo-controlled Phase|Other|3|||
25236820|NCT03721172|50549141|FG001|Placebo-controlled Phase|Other|0|||
25236821|NCT03721172|50549142|FG002|Placebo-controlled Phase|Other|0|||
25236822|NCT03721172|50549140|FG000|Apremilast Extension Phase|Adverse Event|0|||
25236823|NCT03721172|50549141|FG001|Apremilast Extension Phase|Adverse Event|0|||
25236824|NCT03721172|50549142|FG002|Apremilast Extension Phase|Adverse Event|10|||
25236825|NCT03721172|50549140|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
25236826|NCT03721172|50549141|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
25236827|NCT03721172|50549142|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
25236828|NCT03721172|50549140|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
25236829|NCT03721172|50549141|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
25236830|NCT03721172|50549142|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
25236831|NCT03721172|50549140|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
25236832|NCT03721172|50549141|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
25236833|NCT03721172|50549142|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
25236834|NCT03721172|50549140|FG000|Apremilast Extension Phase|Protocol Violation|0|||
25236835|NCT03721172|50549141|FG001|Apremilast Extension Phase|Protocol Violation|0|||
25236836|NCT03721172|50549142|FG002|Apremilast Extension Phase|Protocol Violation|1|||
25236837|NCT03721172|50549140|FG000|Apremilast Extension Phase|Physician Decision|0|||
25236838|NCT03721172|50549141|FG001|Apremilast Extension Phase|Physician Decision|0|||
25236839|NCT03721172|50549142|FG002|Apremilast Extension Phase|Physician Decision|1|||
25236840|NCT03721172|50549140|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
25236841|NCT03721172|50549141|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
25236842|NCT03721172|50549142|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
25236843|NCT03721172|50549140|FG000|Apremilast Extension Phase|Other|0|||
25236844|NCT03721172|50549141|FG001|Apremilast Extension Phase|Other|0|||
25236845|NCT03721172|50549142|FG002|Apremilast Extension Phase|Other|3|||
25236846|NCT03721172|50549140|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
25236847|NCT03721172|50549141|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
25236848|NCT03721172|50549142|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
25236849|NCT02337686|50549176|FG000|Overall Study|Adverse Event|1|||
25236850|NCT04540887|50549202|FG000|Overall Study|Withdrawal by Subject|2|||
25236851|NCT04294680|50549213|FG000|Overall Study|Withdrawal by Subject|2|||
25236852|NCT04294680|50549214|FG001|Overall Study|Withdrawal by Subject|1|||
25236853|NCT04294680|50549213|FG000|Overall Study|Follow-up visits completed outside of window|1|||
25236854|NCT04294680|50549214|FG001|Overall Study|Follow-up visits completed outside of window|0|||
25236855|NCT01350102|50549224|FG000|Overall Study|Adverse Event|0|||
25236856|NCT01350102|50549225|FG001|Overall Study|Adverse Event|0|||
25236857|NCT01350102|50549226|FG002|Overall Study|Adverse Event|1|||
25236858|NCT01350102|50549227|FG003|Overall Study|Adverse Event|0|||
25236859|NCT04059549|50549241|FG000|Overall Study|Withdrawal by Subject|2|||
25236860|NCT04059549|50549242|FG001|Overall Study|Withdrawal by Subject|0|||
25236861|NCT04041570|50549254|FG000|Overall Study|Moved from Area|0|||
25236862|NCT04041570|50549255|FG001|Overall Study|Moved from Area|2|||
25236863|NCT03879408|50549267|FG000|Overall Study|Lost to Follow-up|0|||
25236864|NCT03879408|50549268|FG001|Overall Study|Lost to Follow-up|3|||
25236865|NCT03879408|50549269|FG002|Overall Study|Lost to Follow-up|2|||
25236866|NCT03879408|50549270|FG003|Overall Study|Lost to Follow-up|1|||
25236867|NCT03879408|50549271|FG004|Overall Study|Lost to Follow-up|0|||
25236868|NCT03879408|50549267|FG000|Overall Study|Withdrawal by Subject|2|||
25236869|NCT03879408|50549268|FG001|Overall Study|Withdrawal by Subject|1|||
25236870|NCT03879408|50549269|FG002|Overall Study|Withdrawal by Subject|1|||
25236871|NCT03879408|50549270|FG003|Overall Study|Withdrawal by Subject|0|||
25236872|NCT03879408|50549271|FG004|Overall Study|Withdrawal by Subject|1|||
25236873|NCT02706873|50549291|FG000|Overall Study|Adverse Event|13|||
25236874|NCT02706873|50549292|FG001|Overall Study|Adverse Event|3|||
25236875|NCT02706873|50549293|FG002|Overall Study|Adverse Event|13|||
25236876|NCT02706873|50549294|FG003|Overall Study|Adverse Event|12|||
25236877|NCT02706873|50549291|FG000|Overall Study|Withdrawal by Subject|15|||
25236878|NCT02706873|50549292|FG001|Overall Study|Withdrawal by Subject|0|||
25236879|NCT02706873|50549293|FG002|Overall Study|Withdrawal by Subject|8|||
25236880|NCT02706873|50549294|FG003|Overall Study|Withdrawal by Subject|11|||
25236881|NCT02706873|50549291|FG000|Overall Study|Lost to Follow-up|3|||
25236882|NCT02706873|50549292|FG001|Overall Study|Lost to Follow-up|0|||
25236883|NCT02706873|50549293|FG002|Overall Study|Lost to Follow-up|4|||
25236884|NCT02706873|50549294|FG003|Overall Study|Lost to Follow-up|2|||
25236885|NCT02706873|50549291|FG000|Overall Study|Lack of Efficacy|10|||
25236886|NCT02706873|50549292|FG001|Overall Study|Lack of Efficacy|0|||
25236887|NCT02706873|50549293|FG002|Overall Study|Lack of Efficacy|0|||
25236888|NCT02706873|50549294|FG003|Overall Study|Lack of Efficacy|3|||
25236889|NCT02706873|50549291|FG000|Overall Study|Other|5|||
25236890|NCT02706873|50549292|FG001|Overall Study|Other|1|||
25236891|NCT02706873|50549293|FG002|Overall Study|Other|2|||
25236892|NCT02706873|50549294|FG003|Overall Study|Other|3|||
25236893|NCT02706873|50549291|FG000|Overall Study|Not Dosed|1|||
25236894|NCT02706873|50549292|FG001|Overall Study|Not Dosed|0|||
25236895|NCT02706873|50549293|FG002|Overall Study|Not Dosed|0|||
25236896|NCT02706873|50549294|FG003|Overall Study|Not Dosed|1|||
25236897|NCT02706873|50549291|FG000|Overall Study|Ongoing|0|||
25236898|NCT02706873|50549292|FG001|Overall Study|Ongoing|0|||
25236899|NCT02706873|50549293|FG002|Overall Study|Ongoing|0|||
25236900|NCT02706873|50549294|FG003|Overall Study|Ongoing|1|||
25236901|NCT00819780|50549314|FG000|Overall Study|Did not receive study drug|3|||
25236902|NCT00819780|50549315|FG001|Overall Study|Did not receive study drug|4|||
25236903|NCT00819780|50549314|FG000|Overall Study|Still in treatment|25|||
25236904|NCT00819780|50549315|FG001|Overall Study|Still in treatment|17|||
25236905|NCT00000620|50549454|FG000|Overall Study|Death|86|||
25236906|NCT00000620|50549455|FG001|Overall Study|Death|67|||
25236907|NCT00000620|50549456|FG002|Overall Study|Death|112|||
25236908|NCT00000620|50549457|FG003|Overall Study|Death|126|||
25236909|NCT00000620|50549458|FG004|Overall Study|Death|64|||
25236910|NCT00000620|50549459|FG005|Overall Study|Death|77|||
25236911|NCT00000620|50549460|FG006|Overall Study|Death|91|||
25236912|NCT00000620|50549461|FG007|Overall Study|Death|95|||
25236913|NCT00000620|50549454|FG000|Overall Study|Lost to Follow-up|14|||
25236914|NCT00000620|50549455|FG001|Overall Study|Lost to Follow-up|14|||
25236915|NCT00000620|50549456|FG002|Overall Study|Lost to Follow-up|14|||
25236916|NCT00000620|50549457|FG003|Overall Study|Lost to Follow-up|14|||
25236917|NCT00000620|50549458|FG004|Overall Study|Lost to Follow-up|15|||
25236918|NCT00000620|50549459|FG005|Overall Study|Lost to Follow-up|15|||
25236919|NCT00000620|50549460|FG006|Overall Study|Lost to Follow-up|13|||
25236920|NCT00000620|50549461|FG007|Overall Study|Lost to Follow-up|14|||
25236921|NCT00000620|50549454|FG000|Overall Study|Withdrawal by Subject|40|||
25236922|NCT00000620|50549455|FG001|Overall Study|Withdrawal by Subject|27|||
25236923|NCT00000620|50549456|FG002|Overall Study|Withdrawal by Subject|28|||
25236924|NCT00000620|50549457|FG003|Overall Study|Withdrawal by Subject|27|||
25236925|NCT00000620|50549458|FG004|Overall Study|Withdrawal by Subject|30|||
25236926|NCT00000620|50549459|FG005|Overall Study|Withdrawal by Subject|32|||
25236927|NCT00000620|50549460|FG006|Overall Study|Withdrawal by Subject|32|||
25236928|NCT00000620|50549461|FG007|Overall Study|Withdrawal by Subject|21|||
25236929|NCT00000620|50549454|FG000|Overall Study|missed closeout visit|22|||
25236930|NCT00000620|50549455|FG001|Overall Study|missed closeout visit|28|||
25236931|NCT00000620|50549456|FG002|Overall Study|missed closeout visit|16|||
25236932|NCT00000620|50549457|FG003|Overall Study|missed closeout visit|11|||
25236933|NCT00000620|50549458|FG004|Overall Study|missed closeout visit|26|||
25236934|NCT00000620|50549459|FG005|Overall Study|missed closeout visit|28|||
25236935|NCT00000620|50549460|FG006|Overall Study|missed closeout visit|13|||
25236936|NCT00000620|50549461|FG007|Overall Study|missed closeout visit|16|||
25236937|NCT00001262|50549524|FG000|Overall Study|Death|10|||
25236938|NCT00001262|50549525|FG001|Overall Study|Death|11|||
25236939|NCT00001262|50549526|FG002|Overall Study|Death|0|||
25236940|NCT00001262|50549524|FG000|Overall Study|Withdrawal by Subject|0|||
25236941|NCT00001262|50549525|FG001|Overall Study|Withdrawal by Subject|3|||
25236942|NCT00001262|50549526|FG002|Overall Study|Withdrawal by Subject|0|||
25236943|NCT00001277|50549543|FG000|Overall Study|Adverse Event|0|||
25236944|NCT00001277|50549544|FG001|Overall Study|Adverse Event|0|||
25236945|NCT00001277|50549545|FG002|Overall Study|Adverse Event|1|||
25236946|NCT00001277|50549543|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
25236947|NCT00001277|50549544|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
25236948|NCT00001277|50549545|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
25236949|NCT00001703|50549587|FG000|Overall Study|progressed disease|2|||
25236950|NCT00001703|50549587|FG000|Overall Study|No evidence of disease|1|||
25236951|NCT00001703|50549587|FG000|Overall Study|recurrent disease|2|||
25236952|NCT01349907|50549611|FG000|Overall Study|Adverse Event|37|||
25236953|NCT01349907|50549612|FG001|Overall Study|Adverse Event|11|||
25236954|NCT01349907|50549611|FG000|Overall Study|Treatment failure|13|||
25236955|NCT01349907|50549612|FG001|Overall Study|Treatment failure|4|||
25236956|NCT01349907|50549611|FG000|Overall Study|Lost to Follow-up|25|||
25236957|NCT01349907|50549612|FG001|Overall Study|Lost to Follow-up|6|||
25236958|NCT01349907|50549611|FG000|Overall Study|Withdrawal by Subject|30|||
25236959|NCT01349907|50549612|FG001|Overall Study|Withdrawal by Subject|8|||
25236960|NCT01349907|50549611|FG000|Overall Study|Protocol Violation|33|||
25236961|NCT01349907|50549612|FG001|Overall Study|Protocol Violation|13|||
25236962|NCT01349907|50549611|FG000|Overall Study|Administrative|1|||
25236963|NCT01349907|50549612|FG001|Overall Study|Administrative|1|||
25236964|NCT04847141|50549621|FG000|Overall Study|Adverse Event|1|||
25236965|NCT04847141|50549622|FG001|Overall Study|Adverse Event|0|||
25236966|NCT04847141|50549623|FG002|Overall Study|Adverse Event|1|||
25236967|NCT04847141|50549621|FG000|Overall Study|Withdrawal by Subject|2|||
25236968|NCT04847141|50549622|FG001|Overall Study|Withdrawal by Subject|4|||
25236969|NCT04847141|50549623|FG002|Overall Study|Withdrawal by Subject|3|||
25236970|NCT04847141|50549621|FG000|Overall Study|Lost to Follow-up|7|||
25236971|NCT04847141|50549622|FG001|Overall Study|Lost to Follow-up|5|||
25236972|NCT04847141|50549623|FG002|Overall Study|Lost to Follow-up|7|||
25236973|NCT04847141|50549621|FG000|Overall Study|Reason not Specified|0|||
25236974|NCT04847141|50549622|FG001|Overall Study|Reason not Specified|1|||
25236975|NCT04847141|50549623|FG002|Overall Study|Reason not Specified|0|||
25236976|NCT01349829|50549633|FG000|Overall Study|Lost to Follow-up|4|||
25236977|NCT01349829|50549634|FG001|Overall Study|Lost to Follow-up|8|||
25236978|NCT01349829|50549633|FG000|Overall Study|Consent withdrawal|3|||
25236979|NCT01349829|50549634|FG001|Overall Study|Consent withdrawal|8|||
25236980|NCT01349829|50549633|FG000|Overall Study|Migrated/moved|2|||
25236981|NCT01349829|50549634|FG001|Overall Study|Migrated/moved|7|||
25236982|NCT01350128|50549642|FG000|Overall Study|Withdrawal by Subject|3|||
25236983|NCT01350128|50549642|FG000|Overall Study|Protocol discontinuation criteria|8|||
25236984|NCT01350128|50549642|FG000|Overall Study|Physician Decision|1|||
25236985|NCT01350128|50549642|FG000|Overall Study|Lost to Follow-up|2|||
25236986|NCT03893825|50549722|FG000|Overall Study|Death|2|||
25236987|NCT03893825|50549723|FG001|Overall Study|Death|1|||
25236988|NCT03893825|50549722|FG000|Overall Study|Adverse Event|0|||
25236989|NCT03893825|50549723|FG001|Overall Study|Adverse Event|2|||
25236990|NCT03893825|50549722|FG000|Overall Study|Withdrawal by Subject|19|||
25236991|NCT03893825|50549723|FG001|Overall Study|Withdrawal by Subject|21|||
25236992|NCT03893825|50549722|FG000|Overall Study|Protocol deviation|1|||
25236993|NCT03893825|50549723|FG001|Overall Study|Protocol deviation|0|||
25236994|NCT03893825|50549722|FG000|Overall Study|Lost to Follow-up|10|||
25236995|NCT03893825|50549723|FG001|Overall Study|Lost to Follow-up|10|||
25236996|NCT03893825|50549722|FG000|Overall Study|Other than specified|7|||
25236997|NCT03893825|50549723|FG001|Overall Study|Other than specified|6|||
25236998|NCT03890666|50549731|FG000|Overall Study|Withdrawal by Subject|0|||
25236999|NCT03890666|50549732|FG001|Overall Study|Withdrawal by Subject|1|||
25237000|NCT03890666|50549731|FG000|Overall Study|Protocol deviation|1|||
25237001|NCT03890666|50549732|FG001|Overall Study|Protocol deviation|4|||
25237002|NCT03890666|50549731|FG000|Overall Study|Lost to Follow-up|2|||
25237003|NCT03890666|50549732|FG001|Overall Study|Lost to Follow-up|5|||
25237004|NCT03890666|50549731|FG000|Overall Study|Other than specified|1|||
25237005|NCT03890666|50549732|FG001|Overall Study|Other than specified|8|||
25237006|NCT03276572|50549786|FG000|Overall Study|In follow-up|0|||
25237007|NCT03276572|50549787|FG001|Overall Study|In follow-up|0|||
25237008|NCT03276572|50549788|FG002|Overall Study|In follow-up|0|||
25237009|NCT03276572|50549789|FG003|Overall Study|In follow-up|0|||
25237010|NCT03276572|50549790|FG004|Overall Study|In follow-up|0|||
25237011|NCT03276572|50549791|FG005|Overall Study|In follow-up|1|||
25237012|NCT03276572|50549792|FG006|Overall Study|In follow-up|1|||
25237013|NCT03276572|50549786|FG000|Overall Study|Lost to Follow-up|0|||
25237014|NCT03276572|50549787|FG001|Overall Study|Lost to Follow-up|0|||
25237015|NCT03276572|50549788|FG002|Overall Study|Lost to Follow-up|0|||
25237016|NCT03276572|50549789|FG003|Overall Study|Lost to Follow-up|0|||
25237017|NCT03276572|50549790|FG004|Overall Study|Lost to Follow-up|0|||
25237018|NCT03276572|50549791|FG005|Overall Study|Lost to Follow-up|0|||
25237019|NCT03276572|50549792|FG006|Overall Study|Lost to Follow-up|1|||
25237020|NCT03090737|50549817|FG000|Overall Study|Other reasons|1|||
25237021|NCT03090737|50549817|FG000|Overall Study|Completed treatment as per protocol|17|||
25237022|NCT03090737|50549817|FG000|Overall Study|Maximum clinical benefit|2|||
25237023|NCT03090737|50549817|FG000|Overall Study|Adverse event unrelated to study drug|7|||
25237024|NCT03090737|50549817|FG000|Overall Study|Study drug toxicity|4|||
25237025|NCT03090737|50549817|FG000|Overall Study|Disease progression|98|||
25237026|NCT03004976|50549862|FG000|Overall Study|Lost to Follow-up|7|||
25237027|NCT03004976|50549863|FG001|Overall Study|Lost to Follow-up|5|||
25237028|NCT03004976|50549862|FG000|Overall Study|Physician Decision|1|||
25237029|NCT03004976|50549863|FG001|Overall Study|Physician Decision|0|||
25237030|NCT03004976|50549862|FG000|Overall Study|Withdrawal by Subject|1|||
25319753|NCT02617589|50635430|FG001|Randomization|Request to Discontinue Study Treatment|3|||
25237031|NCT03004976|50549863|FG001|Overall Study|Withdrawal by Subject|0|||
25237032|NCT03004976|50549862|FG000|Overall Study|Death|4|||
25237033|NCT03004976|50549863|FG001|Overall Study|Death|1|||
25237034|NCT02985866|50549871|FG000|Overall Study|Poor CGM data|1|||
25237035|NCT02985866|50549872|FG001|Overall Study|Poor CGM data|1|||
25237036|NCT02762981|50549897|FG000|Overall Study|Adverse Event|2|||
25237037|NCT02762981|50549898|FG001|Overall Study|Adverse Event|3|||
25237038|NCT02762981|50549899|FG002|Overall Study|Adverse Event|1|||
25237039|NCT02762981|50549900|FG003|Overall Study|Adverse Event|1|||
25237040|NCT02762981|50549901|FG004|Overall Study|Adverse Event|3|||
25237041|NCT02762981|50549897|FG000|Overall Study|Physician Decision|0|||
25237042|NCT02762981|50549898|FG001|Overall Study|Physician Decision|1|||
25237043|NCT02762981|50549899|FG002|Overall Study|Physician Decision|0|||
25237044|NCT02762981|50549900|FG003|Overall Study|Physician Decision|0|||
25237045|NCT02762981|50549901|FG004|Overall Study|Physician Decision|1|||
25237046|NCT02762981|50549897|FG000|Overall Study|Disease progression|11|||
25237047|NCT02762981|50549898|FG001|Overall Study|Disease progression|23|||
25237048|NCT02762981|50549899|FG002|Overall Study|Disease progression|4|||
25237049|NCT02762981|50549900|FG003|Overall Study|Disease progression|10|||
25237050|NCT02762981|50549901|FG004|Overall Study|Disease progression|1|||
25237051|NCT02762981|50549897|FG000|Overall Study|Enrolled not treated|1|||
25237052|NCT02762981|50549898|FG001|Overall Study|Enrolled not treated|5|||
25237053|NCT02762981|50549899|FG002|Overall Study|Enrolled not treated|0|||
25237054|NCT02762981|50549900|FG003|Overall Study|Enrolled not treated|2|||
25237055|NCT02762981|50549901|FG004|Overall Study|Enrolled not treated|0|||
25237056|NCT02762981|50549897|FG000|Overall Study|Other|2|||
25237057|NCT02762981|50549898|FG001|Overall Study|Other|3|||
25237058|NCT02762981|50549899|FG002|Overall Study|Other|1|||
25237059|NCT02762981|50549900|FG003|Overall Study|Other|0|||
25237060|NCT02762981|50549901|FG004|Overall Study|Other|0|||
25237061|NCT02762981|50549897|FG000|Overall Study|Missing|1|||
25237062|NCT02762981|50549898|FG001|Overall Study|Missing|0|||
25237063|NCT02762981|50549899|FG002|Overall Study|Missing|0|||
25237064|NCT02762981|50549900|FG003|Overall Study|Missing|0|||
25237065|NCT02762981|50549901|FG004|Overall Study|Missing|0|||
25237066|NCT02762981|50549897|FG000|Overall Study|Withdrawal by Subject|0|||
25237067|NCT02762981|50549898|FG001|Overall Study|Withdrawal by Subject|5|||
25237068|NCT02762981|50549899|FG002|Overall Study|Withdrawal by Subject|1|||
25237069|NCT02762981|50549900|FG003|Overall Study|Withdrawal by Subject|3|||
25237070|NCT02762981|50549901|FG004|Overall Study|Withdrawal by Subject|0|||
25237071|NCT02255435|50549941|FG000|Overall Study|Patient's Limited Time Availability|0|||
25237072|NCT02255435|50549942|FG001|Overall Study|Patient's Limited Time Availability|0|||
25237073|NCT02255435|50549943|FG002|Overall Study|Patient's Limited Time Availability|0|||
25237074|NCT02255435|50549944|FG003|Overall Study|Patient's Limited Time Availability|0|||
25237075|NCT02255435|50549945|FG004|Overall Study|Patient's Limited Time Availability|0|||
25237076|NCT02255435|50549946|FG005|Overall Study|Patient's Limited Time Availability|0|||
25237077|NCT02255435|50549947|FG006|Overall Study|Patient's Limited Time Availability|0|||
25237078|NCT02255435|50549948|FG007|Overall Study|Patient's Limited Time Availability|1|||
25237079|NCT02255435|50549949|FG008|Overall Study|Patient's Limited Time Availability|0|||
25237080|NCT02255435|50549950|FG009|Overall Study|Patient's Limited Time Availability|0|||
25237081|NCT02255435|50549941|FG000|Overall Study|Withdrawal by Subject|0|||
25237082|NCT02255435|50549942|FG001|Overall Study|Withdrawal by Subject|0|||
25237083|NCT02255435|50549943|FG002|Overall Study|Withdrawal by Subject|0|||
25237084|NCT02255435|50549944|FG003|Overall Study|Withdrawal by Subject|0|||
25237085|NCT02255435|50549945|FG004|Overall Study|Withdrawal by Subject|0|||
25237086|NCT02255435|50549946|FG005|Overall Study|Withdrawal by Subject|0|||
25237087|NCT02255435|50549947|FG006|Overall Study|Withdrawal by Subject|0|||
25237088|NCT02255435|50549948|FG007|Overall Study|Withdrawal by Subject|0|||
25237089|NCT02255435|50549949|FG008|Overall Study|Withdrawal by Subject|1|||
25237090|NCT02255435|50549950|FG009|Overall Study|Withdrawal by Subject|4|||
25237091|NCT02255435|50549941|FG000|Overall Study|Administrative reasons|0|||
25237092|NCT02255435|50549942|FG001|Overall Study|Administrative reasons|0|||
25237093|NCT02255435|50549943|FG002|Overall Study|Administrative reasons|0|||
25237094|NCT02255435|50549944|FG003|Overall Study|Administrative reasons|0|||
25237095|NCT02255435|50549945|FG004|Overall Study|Administrative reasons|0|||
25237096|NCT02255435|50549946|FG005|Overall Study|Administrative reasons|0|||
25237097|NCT02255435|50549947|FG006|Overall Study|Administrative reasons|0|||
25237098|NCT02255435|50549948|FG007|Overall Study|Administrative reasons|0|||
25237099|NCT02255435|50549949|FG008|Overall Study|Administrative reasons|0|||
25237100|NCT02255435|50549950|FG009|Overall Study|Administrative reasons|2|||
24976830|NCT00048932|50065735|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
25237101|NCT00001832|50550021|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
25237102|NCT00001832|50550022|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
25237103|NCT00001832|50550023|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
25237104|NCT00001832|50550024|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
25237105|NCT00001832|50550025|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
25237106|NCT00001832|50550026|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
25237107|NCT00001832|50550027|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
25237108|NCT00001832|50550028|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
25237109|NCT00001832|50550029|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
25237110|NCT00001832|50550030|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
25237111|NCT00001832|50550031|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
25237112|NCT00001832|50550032|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
25237113|NCT00001832|50550033|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
25237114|NCT00001832|50550034|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
25237115|NCT00001832|50550035|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
25237116|NCT00001832|50550021|FG000|Treatment Period|Death during treatment|0|||
25237117|NCT00001832|50550022|FG001|Treatment Period|Death during treatment|0|||
25237118|NCT00001832|50550023|FG002|Treatment Period|Death during treatment|0|||
25237119|NCT00001832|50550024|FG003|Treatment Period|Death during treatment|0|||
25237120|NCT00001832|50550025|FG004|Treatment Period|Death during treatment|0|||
25237121|NCT00001832|50550026|FG005|Treatment Period|Death during treatment|1|||
25237122|NCT00001832|50550027|FG006|Treatment Period|Death during treatment|0|||
25237123|NCT00001832|50550028|FG007|Treatment Period|Death during treatment|0|||
25237124|NCT00001832|50550029|FG008|Treatment Period|Death during treatment|0|||
25237125|NCT00001832|50550030|FG009|Treatment Period|Death during treatment|0|||
25237126|NCT00001832|50550031|FG010|Treatment Period|Death during treatment|0|||
25237127|NCT00001832|50550032|FG011|Treatment Period|Death during treatment|0|||
25237128|NCT00001832|50550033|FG012|Treatment Period|Death during treatment|0|||
25237129|NCT00001832|50550034|FG013|Treatment Period|Death during treatment|0|||
25237130|NCT00001832|50550035|FG014|Treatment Period|Death during treatment|0|||
25237131|NCT00001832|50550021|FG000|Treatment Period|Not treated|0|||
25237132|NCT00001832|50550022|FG001|Treatment Period|Not treated|0|||
25237133|NCT00001832|50550023|FG002|Treatment Period|Not treated|0|||
25237134|NCT00001832|50550024|FG003|Treatment Period|Not treated|0|||
25237135|NCT00001832|50550025|FG004|Treatment Period|Not treated|0|||
25237136|NCT00001832|50550026|FG005|Treatment Period|Not treated|0|||
25237137|NCT00001832|50550027|FG006|Treatment Period|Not treated|0|||
25237138|NCT00001832|50550028|FG007|Treatment Period|Not treated|1|||
25237139|NCT00001832|50550029|FG008|Treatment Period|Not treated|0|||
25237140|NCT00001832|50550030|FG009|Treatment Period|Not treated|0|||
25237141|NCT00001832|50550031|FG010|Treatment Period|Not treated|0|||
25237142|NCT00001832|50550032|FG011|Treatment Period|Not treated|0|||
25237143|NCT00001832|50550033|FG012|Treatment Period|Not treated|0|||
25237144|NCT00001832|50550034|FG013|Treatment Period|Not treated|0|||
25237145|NCT00001832|50550035|FG014|Treatment Period|Not treated|0|||
25237146|NCT01349816|50550269|FG000|Overall Study|Withdrawal by Subject|4|||
25237147|NCT01349816|50550269|FG000|Overall Study|Physician Decision|1|||
25237148|NCT01349816|50550269|FG000|Overall Study|Adverse Event|14|||
25237149|NCT01349816|50550269|FG000|Overall Study|Lost to Follow-up|2|||
25237150|NCT01349816|50550269|FG000|Overall Study|Protocol Violation|1|||
25237151|NCT01349816|50550269|FG000|Overall Study|Protocol-specified criteria|8|||
25237152|NCT02971137|50550385|FG000|Overall Study|Lost to Follow-up|44|||
25237153|NCT02971137|50550386|FG001|Overall Study|Lost to Follow-up|56|||
25237154|NCT05201807|50550457|FG000|Overall Study|Adverse Event|1|||
25237155|NCT05201807|50550457|FG000|Overall Study|COVID-19 Related|1|||
25237156|NCT04978337|50550463|FG000|Overall Study|Withdrawal by Subject|0|||
25237157|NCT04978337|50550464|FG001|Overall Study|Withdrawal by Subject|1|||
25237158|NCT04828707|50550473|FG000|Overall Study|Lost to Follow-up|3|||
25237159|NCT04828707|50550474|FG001|Overall Study|Lost to Follow-up|2|||
25237160|NCT04828707|50550473|FG000|Overall Study|Withdrawal by Subject|2|||
25237161|NCT04828707|50550474|FG001|Overall Study|Withdrawal by Subject|1|||
25237162|NCT04629534|50550493|FG000|Overall Study|Physician Decision|1|||
25237163|NCT04629534|50550494|FG001|Overall Study|Physician Decision|0|||
25237164|NCT04629534|50550493|FG000|Overall Study|Protocol Violation|0|||
25237165|NCT04629534|50550494|FG001|Overall Study|Protocol Violation|2|||
25237166|NCT04481191|50550506|FG000|Overall Study|Withdrawn by parent/guardian|15|||
25237167|NCT04481191|50550507|FG001|Overall Study|Withdrawn by parent/guardian|10|||
25319754|NCT02617589|50635429|FG000|Randomization|Participant Withdrew Consent|1|||
25319755|NCT02617589|50635430|FG001|Randomization|Participant Withdrew Consent|2|||
25319756|NCT02617589|50635429|FG000|Treatment|Other Reasons|3|||
25237168|NCT03695185|50550530|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
25237169|NCT03695185|50550530|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
25237170|NCT03695185|50550530|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
25319757|NCT02617589|50635430|FG001|Treatment|Other Reasons|3|||
25319758|NCT02617589|50635429|FG000|Treatment|Poor/Non Compliance|1|||
25237171|NCT03695185|50550530|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
25237172|NCT03695185|50550530|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
25237173|NCT03695185|50550530|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
25237174|NCT03596164|50550537|FG000|Overall Study|Adverse Event|0|||
25237175|NCT03596164|50550538|FG001|Overall Study|Adverse Event|1|||
25237176|NCT03596164|50550537|FG000|Overall Study|Death|1|||
25319759|NCT02617589|50635430|FG001|Treatment|Poor/Non Compliance|1|||
25319760|NCT02617589|50635429|FG000|Treatment|Maximum Clinical Benefit|0|||
25237177|NCT03596164|50550538|FG001|Overall Study|Death|0|||
25237178|NCT03547908|50550548|FG000|Overall Study|Still On Study|115|||
25237179|NCT03547908|50550549|FG001|Overall Study|Still On Study|118|||
25237180|NCT03547908|50550548|FG000|Overall Study|Lost to Follow-up|2|||
25237181|NCT03547908|50550549|FG001|Overall Study|Lost to Follow-up|2|||
25237182|NCT03547908|50550548|FG000|Overall Study|Withdrew Consent|2|||
25237183|NCT03547908|50550549|FG001|Overall Study|Withdrew Consent|1|||
25237184|NCT03547908|50550548|FG000|Overall Study|Adverse Event|1|||
25237185|NCT03547908|50550549|FG001|Overall Study|Adverse Event|0|||
25237186|NCT03547908|50550548|FG000|Overall Study|Death|1|||
25237187|NCT03547908|50550549|FG001|Overall Study|Death|0|||
25237188|NCT03547908|50550548|FG000|Overall Study|Investigator's Discretion|0|||
25237189|NCT03547908|50550549|FG001|Overall Study|Investigator's Discretion|1|||
25319761|NCT02617589|50635430|FG001|Treatment|Maximum Clinical Benefit|2|||
25319762|NCT02617589|50635429|FG000|Treatment|Participant Withdrew Consent|2|||
25319763|NCT02617589|50635430|FG001|Treatment|Participant Withdrew Consent|6|||
25319764|NCT02617589|50635429|FG000|Treatment|Participant Request to Discontinue|12|||
25319765|NCT02617589|50635430|FG001|Treatment|Participant Request to Discontinue|21|||
25319766|NCT02617589|50635429|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
25319767|NCT02617589|50635430|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
25319768|NCT02617589|50635429|FG000|Treatment|Death|1|||
25319769|NCT02617589|50635430|FG001|Treatment|Death|1|||
25319770|NCT02617589|50635429|FG000|Treatment|Study Drug Toxicity|27|||
25319771|NCT02617589|50635430|FG001|Treatment|Study Drug Toxicity|20|||
25319772|NCT02617589|50635429|FG000|Treatment|Disease Progression|216|||
25319773|NCT02617589|50635430|FG001|Treatment|Disease Progression|136|||
25319774|NCT02471807|50635436|FG000|Overall Study|Death|14|||
25319775|NCT02471807|50635436|FG000|Overall Study|Withdrawal by Subject|2|||
25319776|NCT02471807|50635436|FG000|Overall Study|Explant|5|||
25319777|NCT02471807|50635436|FG000|Overall Study|Lost to Follow-up|1|||
25319778|NCT02364557|50635442|FG000|Overall Study|Protocol Violation|3|||
25237190|NCT03547908|50550548|FG000|Overall Study|Randomized But Never Treated|1|||
25319779|NCT02364557|50635443|FG001|Overall Study|Protocol Violation|1|||
25319780|NCT02337829|50635479|FG000|Overall Study|Death|0|||
25319781|NCT02337829|50635480|FG001|Overall Study|Death|1|||
25319782|NCT02337829|50635481|FG002|Overall Study|Death|0|||
25319783|NCT02337829|50635482|FG003|Overall Study|Death|0|||
25319784|NCT02337829|50635479|FG000|Overall Study|Study terminated by sponsor|12|||
25319785|NCT02337829|50635480|FG001|Overall Study|Study terminated by sponsor|10|||
25319786|NCT02337829|50635481|FG002|Overall Study|Study terminated by sponsor|5|||
25319787|NCT02337829|50635482|FG003|Overall Study|Study terminated by sponsor|6|||
25319788|NCT02337829|50635479|FG000|Overall Study|discontinued for other reasons|6|||
25319789|NCT02337829|50635480|FG001|Overall Study|discontinued for other reasons|3|||
25237191|NCT03547908|50550549|FG001|Overall Study|Randomized But Never Treated|0|||
25237192|NCT03240874|50550559|FG000|Overall Study|Lost to Follow-up|0|||
25237193|NCT03240874|50550560|FG001|Overall Study|Lost to Follow-up|2|||
25237194|NCT03240874|50550561|FG002|Overall Study|Lost to Follow-up|4|||
25237195|NCT03240874|50550562|FG003|Overall Study|Lost to Follow-up|1|||
25237196|NCT03173560|50550572|FG000|Overall Study|Ongoing on Treatment|38|||
25237197|NCT03173560|50550573|FG001|Overall Study|Ongoing on Treatment|50|||
25237198|NCT03173560|50550572|FG000|Overall Study|Ongoing Survival Follow-up|56|||
25237199|NCT03173560|50550573|FG001|Overall Study|Ongoing Survival Follow-up|57|||
25237200|NCT03173560|50550572|FG000|Overall Study|Lost to Follow-up|1|||
25237201|NCT03173560|50550573|FG001|Overall Study|Lost to Follow-up|4|||
25237202|NCT03173560|50550572|FG000|Overall Study|Withdrawal by Subject|10|||
25237203|NCT03173560|50550573|FG001|Overall Study|Withdrawal by Subject|5|||
25237204|NCT03173560|50550572|FG000|Overall Study|Other|0|||
25319790|NCT02337829|50635481|FG002|Overall Study|discontinued for other reasons|1|||
25319791|NCT02337829|50635482|FG003|Overall Study|discontinued for other reasons|4|||
25319792|NCT02257528|50635494|FG000|Overall Study|Never received study treatment|1|||
25319793|NCT01899326|50635505|FG000|Overall Study|Withdrawal by Subject|1|||
25319794|NCT01899326|50635505|FG000|Overall Study|Adverse Event|2|||
25319795|NCT01899326|50635505|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
25237205|NCT03173560|50550573|FG001|Overall Study|Other|1|||
25237206|NCT02990468|50550582|FG000|Phase 2: MTD|Change in treatment|0|||
25237207|NCT02990468|50550583|FG001|Phase 2: MTD|Change in treatment|0|||
25237208|NCT02990468|50550584|FG002|Phase 2: MTD|Change in treatment|1|||
25237209|NCT02899299|50550594|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
25237210|NCT02899299|50550595|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
25237211|NCT02899299|50550594|FG000|Pre-treatment|Participant withdrew consent|1|||
25237212|NCT02899299|50550595|FG001|Pre-treatment|Participant withdrew consent|11|||
25237213|NCT02899299|50550594|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
25237214|NCT02899299|50550595|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
25237215|NCT02899299|50550594|FG000|Pre-treatment|Not reported|0|||
25237216|NCT02899299|50550595|FG001|Pre-treatment|Not reported|1|||
25237217|NCT02899299|50550594|FG000|Treatment|Disease Progression|182|||
25237218|NCT02899299|50550595|FG001|Treatment|Disease Progression|44|||
25237219|NCT02899299|50550594|FG000|Treatment|Study Drug Toxicity|59|||
25237220|NCT02899299|50550595|FG001|Treatment|Study Drug Toxicity|24|||
25237221|NCT02899299|50550594|FG000|Treatment|Adverse Event unrelated to Study Drug|12|||
25237222|NCT02899299|50550595|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
25237223|NCT02899299|50550594|FG000|Treatment|Participant request to discontinue Study treatment|4|||
25237224|NCT02899299|50550595|FG001|Treatment|Participant request to discontinue Study treatment|10|||
25237225|NCT02899299|50550594|FG000|Treatment|Participant withdrew consent|6|||
25237226|NCT02899299|50550595|FG001|Treatment|Participant withdrew consent|3|||
25237227|NCT02899299|50550594|FG000|Treatment|Lost to Follow-up|0|||
25237228|NCT02899299|50550595|FG001|Treatment|Lost to Follow-up|1|||
25237229|NCT02899299|50550594|FG000|Treatment|Maximum Clinical Benefit|10|||
25237230|NCT02899299|50550595|FG001|Treatment|Maximum Clinical Benefit|2|||
25237231|NCT02899299|50550594|FG000|Treatment|Poor/Non-compliance|1|||
25237232|NCT02899299|50550595|FG001|Treatment|Poor/Non-compliance|0|||
25237233|NCT02899299|50550594|FG000|Treatment|Participant no longer meets Study criteria|4|||
25237234|NCT02899299|50550595|FG001|Treatment|Participant no longer meets Study criteria|0|||
25237235|NCT02899299|50550594|FG000|Treatment|Administrative reason by Sponsor|2|||
25237236|NCT02899299|50550595|FG001|Treatment|Administrative reason by Sponsor|0|||
25237237|NCT02899299|50550594|FG000|Treatment|Other reasons|11|||
25237238|NCT02899299|50550595|FG001|Treatment|Other reasons|2|||
25237239|NCT02899299|50550594|FG000|Treatment|Not reported: Includes participants who achieved max duration of treatment|4|||
25237240|NCT02899299|50550595|FG001|Treatment|Not reported: Includes participants who achieved max duration of treatment|189|||
25237241|NCT02855944|50550603|FG000|Period 1: Treatment|Ongoing|14|||
25237242|NCT02855944|50550604|FG001|Period 1: Treatment|Ongoing|0|||
25237243|NCT02855944|50550603|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
25237244|NCT02855944|50550604|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
25237245|NCT02855944|50550603|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
25237246|NCT02855944|50550604|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
25237247|NCT02681055|50550615|FG000|Weeks 5-12|Adverse Event|1|||
25237248|NCT02577354|50550622|FG000|Overall Study|Lack of Efficacy|4|||
25237249|NCT02577354|50550623|FG001|Overall Study|Lack of Efficacy|4|||
25237250|NCT02577354|50550622|FG000|Overall Study|Lost to Follow-up|3|||
25237251|NCT02577354|50550623|FG001|Overall Study|Lost to Follow-up|1|||
25237252|NCT02577354|50550622|FG000|Overall Study|Missed Visit|4|||
25237253|NCT02577354|50550623|FG001|Overall Study|Missed Visit|3|||
25237254|NCT02577354|50550622|FG000|Overall Study|Adverse Event|4|||
25237255|NCT02577354|50550623|FG001|Overall Study|Adverse Event|5|||
25237256|NCT02477696|50550641|FG000|Overall Study|Adverse Event|40|||
25237257|NCT02477696|50550642|FG001|Overall Study|Adverse Event|59|||
25237258|NCT02477696|50550641|FG000|Overall Study|CLL Disease Progression|82|||
25237259|NCT02477696|50550642|FG001|Overall Study|CLL Disease Progression|68|||
25237260|NCT02477696|50550641|FG000|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|2|||
25237261|NCT02477696|50550642|FG001|Overall Study|Includes Non-compliance, Relocation, Subject's Decision and Medical Monitor's Decision.|10|||
25237262|NCT02477696|50550641|FG000|Overall Study|Death|5|||
25237263|NCT02477696|50550642|FG001|Overall Study|Death|6|||
25237264|NCT02477696|50550641|FG000|Overall Study|Withdrawal by Subject|7|||
25237265|NCT02477696|50550642|FG001|Overall Study|Withdrawal by Subject|7|||
25237266|NCT02477696|50550641|FG000|Overall Study|Physician Decision|5|||
25237267|NCT02477696|50550642|FG001|Overall Study|Physician Decision|5|||
25237268|NCT02451943|50550650|FG000|Overall Study|On Treatment|4|||
25237269|NCT02451943|50550651|FG001|Overall Study|On Treatment|4|||
25237270|NCT02451943|50550650|FG000|Overall Study|Withdrawal by Subject|13|||
25237271|NCT02451943|50550651|FG001|Overall Study|Withdrawal by Subject|16|||
25237272|NCT02451943|50550650|FG000|Overall Study|Lost to Follow-up|3|||
25237273|NCT02451943|50550651|FG001|Overall Study|Lost to Follow-up|4|||
25237274|NCT02409342|50550659|FG000|Overall Study|Death|211|||
25237275|NCT02409342|50550660|FG001|Overall Study|Death|201|||
25237276|NCT02409342|50550659|FG000|Overall Study|Withdrawal by Subject|24|||
25319796|NCT01856192|50635512|FG000|Overall Study|Adverse Event|12|||
25319797|NCT01856192|50635513|FG001|Overall Study|Adverse Event|4|||
25237277|NCT02409342|50550660|FG001|Overall Study|Withdrawal by Subject|17|||
25237278|NCT02409342|50550659|FG000|Overall Study|Study Terminated By Sponsor|48|||
25237279|NCT02409342|50550660|FG001|Overall Study|Study Terminated By Sponsor|59|||
25237280|NCT02409342|50550659|FG000|Overall Study|Lost to Follow-up|3|||
25237281|NCT02409342|50550660|FG001|Overall Study|Lost to Follow-up|5|||
25237282|NCT02409342|50550659|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
25237283|NCT02409342|50550660|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
25237284|NCT02409342|50550659|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
25237285|NCT02409342|50550660|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
25237286|NCT02409342|50550659|FG000|Overall Study|Sponsor Decision|1|||
25237287|NCT02409342|50550660|FG001|Overall Study|Sponsor Decision|0|||
25237288|NCT02336503|50550676|FG000|Overall Study|Lost to Follow-up|0|||
25237289|NCT02336503|50550677|FG001|Overall Study|Lost to Follow-up|3|||
25237290|NCT02336503|50550678|FG002|Overall Study|Lost to Follow-up|0|||
25237291|NCT02336503|50550679|FG003|Overall Study|Lost to Follow-up|2|||
25237292|NCT02336503|50550676|FG000|Overall Study|Withdrawal by Subject|2|||
25237293|NCT02336503|50550677|FG001|Overall Study|Withdrawal by Subject|0|||
25237294|NCT02336503|50550678|FG002|Overall Study|Withdrawal by Subject|0|||
25237295|NCT02336503|50550679|FG003|Overall Study|Withdrawal by Subject|4|||
25237296|NCT02336503|50550676|FG000|Overall Study|Adverse Event|0|||
25237297|NCT02336503|50550677|FG001|Overall Study|Adverse Event|0|||
25237298|NCT02336503|50550678|FG002|Overall Study|Adverse Event|1|||
25237299|NCT02336503|50550679|FG003|Overall Study|Adverse Event|0|||
25237300|NCT02255409|50550695|FG000|Overall Study|Administrative Reason|3|||
25237301|NCT02255409|50550696|FG001|Overall Study|Administrative Reason|7|||
25237302|NCT02255409|50550695|FG000|Overall Study|Withdrawal by Subject|1|||
25237303|NCT02255409|50550696|FG001|Overall Study|Withdrawal by Subject|5|||
25237304|NCT02255409|50550695|FG000|Overall Study|Lost to Follow-up|10|||
25237305|NCT02255409|50550696|FG001|Overall Study|Lost to Follow-up|19|||
25237306|NCT00630032|50550727|FG000|Overall Study|Death|55|||
25237307|NCT00630032|50550728|FG001|Overall Study|Death|49|||
25237308|NCT00630032|50550727|FG000|Overall Study|Withdrawal by Subject|3|||
25237309|NCT00630032|50550728|FG001|Overall Study|Withdrawal by Subject|2|||
25237310|NCT00630032|50550727|FG000|Overall Study|Lost to Follow-up|18|||
25237311|NCT00630032|50550728|FG001|Overall Study|Lost to Follow-up|31|||
25237312|NCT00630032|50550727|FG000|Overall Study|Protocol Violation|1|||
25237313|NCT00630032|50550728|FG001|Overall Study|Protocol Violation|0|||
25237314|NCT00630032|50550727|FG000|Overall Study|Patient has moved|1|||
25237315|NCT00630032|50550728|FG001|Overall Study|Patient has moved|1|||
25237316|NCT00630032|50550727|FG000|Overall Study|Disease progression|1|||
25237317|NCT00630032|50550728|FG001|Overall Study|Disease progression|1|||
25237318|NCT00630032|50550727|FG000|Overall Study|End of monitoring in US centers|11|||
25319798|NCT01856192|50635512|FG000|Overall Study|Alternative therapy|0|||
25319799|NCT01856192|50635513|FG001|Overall Study|Alternative therapy|3|||
25319800|NCT01856192|50635512|FG000|Overall Study|Death|3|||
25319801|NCT01856192|50635513|FG001|Overall Study|Death|5|||
25319802|NCT01856192|50635512|FG000|Overall Study|Lack of Efficacy|0|||
25319803|NCT01856192|50635513|FG001|Overall Study|Lack of Efficacy|5|||
25319804|NCT01856192|50635512|FG000|Overall Study|Withdrawal by Subject|1|||
25319805|NCT01856192|50635513|FG001|Overall Study|Withdrawal by Subject|1|||
25319806|NCT01856192|50635512|FG000|Overall Study|Other diseases|1|||
25319807|NCT01856192|50635513|FG001|Overall Study|Other diseases|0|||
25319808|NCT01856192|50635512|FG000|Overall Study|Never started treatment|7|||
25319809|NCT01856192|50635513|FG001|Overall Study|Never started treatment|5|||
25319810|NCT01856192|50635512|FG000|Overall Study|Path ineligible|20|||
25319811|NCT01856192|50635513|FG001|Overall Study|Path ineligible|34|||
25319812|NCT01856192|50635512|FG000|Overall Study|Non-path ineligible|2|||
25319813|NCT01856192|50635513|FG001|Overall Study|Non-path ineligible|2|||
25319814|NCT01856192|50635512|FG000|Overall Study|Physician Decision|1|||
25319815|NCT01856192|50635513|FG001|Overall Study|Physician Decision|1|||
25319816|NCT01856192|50635512|FG000|Overall Study|Suspicion of progressive disease|1|||
25319817|NCT01856192|50635513|FG001|Overall Study|Suspicion of progressive disease|0|||
25319818|NCT01856192|50635512|FG000|Overall Study|Non-compliance|1|||
25319819|NCT01856192|50635513|FG001|Overall Study|Non-compliance|0|||
25319820|NCT01572480|50635519|FG000|Participants Enrolled|Withdrawal by Subject|1|||
25319821|NCT01572480|50635519|FG000|Drug Administration|Discontinued drug/Off Study|1|||
25319822|NCT01572480|50635519|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
25237319|NCT00630032|50550728|FG001|Overall Study|End of monitoring in US centers|11|||
25237320|NCT00465517|50550736|FG000|Overall Study|Adverse Event|7|||
25237321|NCT00465517|50550737|FG001|Overall Study|Adverse Event|3|||
25237322|NCT00465517|50550736|FG000|Overall Study|Lost to Follow-up|1|||
25237323|NCT00465517|50550737|FG001|Overall Study|Lost to Follow-up|0|||
25237324|NCT00465517|50550736|FG000|Overall Study|Withdrawal by Subject|4|||
25237325|NCT00465517|50550737|FG001|Overall Study|Withdrawal by Subject|1|||
25237326|NCT05050578|50550745|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
25319823|NCT01572480|50635519|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
25237327|NCT05050578|50550746|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
25237328|NCT05050578|50550745|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
25237329|NCT05050578|50550746|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
25237330|NCT05050578|50550745|FG000|Period 2, 30 Days|Protocol Violation|0|||
25237331|NCT05050578|50550746|FG001|Period 2, 30 Days|Protocol Violation|1|||
25237332|NCT04490278|50550755|FG000|Overall Study|Lost to Follow-up|6|||
25237333|NCT04004221|50550759|FG000|Overall Study|Death|89|||
25237334|NCT04004221|50550759|FG000|Overall Study|Withdrawal by Subject|5|||
25237335|NCT04004221|50550759|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
25237336|NCT04004221|50550759|FG000|Overall Study|Sponsor Decision|9|||
25237337|NCT04004221|50550759|FG000|Overall Study|Participant refused to enter LTE|1|||
25237338|NCT03775512|50550769|FG000|Overall Study|Death|1|||
25237339|NCT03775512|50550770|FG001|Overall Study|Death|1|||
25237340|NCT03775512|50550769|FG000|Overall Study|Withdrawal by Subject|7|||
25237341|NCT03775512|50550770|FG001|Overall Study|Withdrawal by Subject|4|||
25237342|NCT03775512|50550769|FG000|Overall Study|Lost to Follow-up|5|||
25237343|NCT03775512|50550770|FG001|Overall Study|Lost to Follow-up|5|||
25237344|NCT03775512|50550769|FG000|Overall Study|Excluded before Catheter insertion|14|||
25237345|NCT03775512|50550770|FG001|Overall Study|Excluded before Catheter insertion|5|||
25237346|NCT03775512|50550769|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
25237347|NCT03775512|50550770|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
25237348|NCT03775512|50550769|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
25237349|NCT03775512|50550770|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
25237350|NCT03620747|50550776|FG000|Overall Study|Participant decision|7|||
25237351|NCT03620747|50550776|FG000|Overall Study|Adverse Event|6|||
25237352|NCT03620747|50550776|FG000|Overall Study|Lack of Efficacy|1|||
25237353|NCT03620747|50550776|FG000|Overall Study|Poor compliance to protocol|2|||
25237354|NCT03620747|50550776|FG000|Overall Study|Other-unspecified|3|||
25237355|NCT03338790|50550801|FG000|Overall Study|Disease Progression|65|||
25237356|NCT03338790|50550802|FG001|Overall Study|Disease Progression|43|||
25237357|NCT03338790|50550803|FG002|Overall Study|Disease Progression|50|||
25237358|NCT03338790|50550804|FG003|Overall Study|Disease Progression|37|||
25237359|NCT03338790|50550801|FG000|Overall Study|Study Drug Toxicity|9|||
25237360|NCT03338790|50550802|FG001|Overall Study|Study Drug Toxicity|8|||
25319824|NCT01126190|50635526|FG000|Double-Blind Phase|Death|0|||
25319825|NCT01126190|50635527|FG001|Double-Blind Phase|Death|1|||
25319826|NCT01126190|50635528|FG002|Double-Blind Phase|Death|0|||
25319827|NCT01126190|50635526|FG000|Double-Blind Phase|Adverse Event|1|||
25319828|NCT01126190|50635527|FG001|Double-Blind Phase|Adverse Event|2|||
25319829|NCT01126190|50635528|FG002|Double-Blind Phase|Adverse Event|0|||
25319830|NCT01126190|50635526|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
25319831|NCT01126190|50635527|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
25319832|NCT01126190|50635528|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
25319833|NCT01126190|50635526|FG000|Double-Blind Phase|Request of Investigator|1|||
25319834|NCT01126190|50635527|FG001|Double-Blind Phase|Request of Investigator|0|||
25319835|NCT01126190|50635528|FG002|Double-Blind Phase|Request of Investigator|0|||
25319836|NCT01126190|50635526|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
25319837|NCT01126190|50635527|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
25319838|NCT01126190|50635528|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
25319839|NCT01126190|50635526|FG000|Double-Blind Phase|Non-compliance|1|||
25319840|NCT01126190|50635527|FG001|Double-Blind Phase|Non-compliance|0|||
25319841|NCT01126190|50635528|FG002|Double-Blind Phase|Non-compliance|0|||
25319842|NCT01126190|50635526|FG000|Double-Blind Phase|Lost to Follow-up|1|||
25319843|NCT01126190|50635527|FG001|Double-Blind Phase|Lost to Follow-up|3|||
25319844|NCT01126190|50635528|FG002|Double-Blind Phase|Lost to Follow-up|0|||
25319845|NCT01126190|50635526|FG000|Open-Label Phase|Death|0|||
25319846|NCT01126190|50635527|FG001|Open-Label Phase|Death|0|||
25319847|NCT01126190|50635528|FG002|Open-Label Phase|Death|1|||
25319848|NCT01126190|50635526|FG000|Open-Label Phase|Adverse Event|0|||
25319849|NCT01126190|50635527|FG001|Open-Label Phase|Adverse Event|0|||
25319850|NCT01126190|50635528|FG002|Open-Label Phase|Adverse Event|4|||
25319851|NCT01126190|50635526|FG000|Open-Label Phase|Withdrawal by Subject|0|||
25319852|NCT01126190|50635527|FG001|Open-Label Phase|Withdrawal by Subject|0|||
25319853|NCT01126190|50635528|FG002|Open-Label Phase|Withdrawal by Subject|6|||
25319854|NCT00939185|50635561|FG000|Overall Study|Adverse Event|3|||
25319855|NCT00939185|50635561|FG000|Overall Study|Lack of Efficacy|1|||
25319856|NCT00939185|50635561|FG000|Overall Study|Lost to Follow-up|6|||
25319857|NCT00939185|50635561|FG000|Overall Study|Other|3|||
25237361|NCT03338790|50550803|FG002|Overall Study|Study Drug Toxicity|15|||
25237362|NCT03338790|50550804|FG003|Overall Study|Study Drug Toxicity|0|||
25237363|NCT03338790|50550801|FG000|Overall Study|Death|1|||
25237364|NCT03338790|50550802|FG001|Overall Study|Death|1|||
25319858|NCT00939185|50635561|FG000|Overall Study|Withdrawal by Subject|2|||
25237365|NCT03338790|50550803|FG002|Overall Study|Death|1|||
25319859|NCT00939185|50635561|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
25319860|NCT03977155|50635568|FG000|Overall Study|Adverse Event|3|||
25319861|NCT03977155|50635569|FG001|Overall Study|Adverse Event|0|||
25237366|NCT03338790|50550804|FG003|Overall Study|Death|0|||
25237367|NCT03338790|50550801|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
25237368|NCT03338790|50550802|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
25237369|NCT03338790|50550803|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
25237370|NCT03338790|50550804|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
25237371|NCT03338790|50550801|FG000|Overall Study|Participant request to discontinue study treatment|3|||
25237372|NCT03338790|50550802|FG001|Overall Study|Participant request to discontinue study treatment|3|||
25237373|NCT03338790|50550803|FG002|Overall Study|Participant request to discontinue study treatment|2|||
25237374|NCT03338790|50550804|FG003|Overall Study|Participant request to discontinue study treatment|1|||
25237375|NCT03338790|50550801|FG000|Overall Study|Poor/non-compliance|0|||
25237376|NCT03338790|50550802|FG001|Overall Study|Poor/non-compliance|1|||
25237377|NCT03338790|50550803|FG002|Overall Study|Poor/non-compliance|0|||
25237378|NCT03338790|50550804|FG003|Overall Study|Poor/non-compliance|0|||
25237379|NCT03338790|50550801|FG000|Overall Study|Participant withdrew consent|1|||
25237380|NCT03338790|50550802|FG001|Overall Study|Participant withdrew consent|0|||
25237381|NCT03338790|50550803|FG002|Overall Study|Participant withdrew consent|1|||
25237382|NCT03338790|50550804|FG003|Overall Study|Participant withdrew consent|1|||
25237383|NCT03338790|50550801|FG000|Overall Study|Other reasons|0|||
25237384|NCT03338790|50550802|FG001|Overall Study|Other reasons|5|||
25237385|NCT03338790|50550803|FG002|Overall Study|Other reasons|0|||
25237386|NCT03338790|50550804|FG003|Overall Study|Other reasons|2|||
25237387|NCT03338790|50550801|FG000|Overall Study|Not reported|0|||
25237388|NCT03338790|50550802|FG001|Overall Study|Not reported|0|||
25237389|NCT03338790|50550803|FG002|Overall Study|Not reported|1|||
25237390|NCT03338790|50550804|FG003|Overall Study|Not reported|0|||
25237391|NCT03338790|50550801|FG000|Overall Study|Completed treatment period|1|||
25237392|NCT03338790|50550802|FG001|Overall Study|Completed treatment period|2|||
25237393|NCT03338790|50550803|FG002|Overall Study|Completed treatment period|0|||
25237394|NCT03338790|50550804|FG003|Overall Study|Completed treatment period|0|||
25237395|NCT02954536|50550831|FG000|Overall Study|Adverse Event|2|||
25237396|NCT02954536|50550831|FG000|Overall Study|Death|12|||
25237397|NCT02919670|50550837|FG000|Overall Study|Only 17 participants met compliance|43|||
25237398|NCT02919670|50550838|FG001|Overall Study|Only 17 participants met compliance|39|||
25237399|NCT02250326|50550937|FG000|Treatment Period|Death|1|||
25237400|NCT02250326|50550938|FG001|Treatment Period|Death|12|||
25237401|NCT02250326|50550939|FG002|Treatment Period|Death|2|||
25237402|NCT02250326|50550937|FG000|Treatment Period|Adverse Event|8|||
25237403|NCT02250326|50550938|FG001|Treatment Period|Adverse Event|4|||
25237404|NCT02250326|50550939|FG002|Treatment Period|Adverse Event|8|||
25237405|NCT02250326|50550937|FG000|Treatment Period|Progressive Disease|42|||
25237406|NCT02250326|50550938|FG001|Treatment Period|Progressive Disease|36|||
25237407|NCT02250326|50550939|FG002|Treatment Period|Progressive Disease|45|||
25237408|NCT02250326|50550937|FG000|Treatment Period|Symptomatic Deterioration|9|||
25237409|NCT02250326|50550938|FG001|Treatment Period|Symptomatic Deterioration|4|||
25237410|NCT02250326|50550939|FG002|Treatment Period|Symptomatic Deterioration|10|||
25237411|NCT02250326|50550937|FG000|Treatment Period|Withdrawal by Subject|11|||
25237412|NCT02250326|50550938|FG001|Treatment Period|Withdrawal by Subject|5|||
25237413|NCT02250326|50550939|FG002|Treatment Period|Withdrawal by Subject|4|||
25237414|NCT02250326|50550937|FG000|Treatment Period|Miscellaneous|8|||
25237415|NCT02250326|50550938|FG001|Treatment Period|Miscellaneous|2|||
25237416|NCT02250326|50550939|FG002|Treatment Period|Miscellaneous|7|||
25237417|NCT02250326|50550937|FG000|Treatment Period|Randomized or assigned; not treated|2|||
25237418|NCT02250326|50550938|FG001|Treatment Period|Randomized or assigned; not treated|1|||
25237419|NCT02250326|50550939|FG002|Treatment Period|Randomized or assigned; not treated|1|||
25237420|NCT02250326|50550937|FG000|Follow-Up Period|Death|46|||
25237421|NCT02250326|50550938|FG001|Follow-Up Period|Death|26|||
25237422|NCT02250326|50550939|FG002|Follow-Up Period|Death|32|||
25237423|NCT02250326|50550937|FG000|Follow-Up Period|Unknown or Missing|2|||
25237424|NCT02250326|50550938|FG001|Follow-Up Period|Unknown or Missing|3|||
25319862|NCT03977155|50635570|FG002|Overall Study|Adverse Event|0|||
25319863|NCT03977155|50635568|FG000|Overall Study|Lost to Follow-up|0|||
25319864|NCT03977155|50635569|FG001|Overall Study|Lost to Follow-up|1|||
25237425|NCT02250326|50550939|FG002|Follow-Up Period|Unknown or Missing|3|||
25237426|NCT02250326|50550937|FG000|Follow-Up Period|Lost to Follow-up|1|||
25237427|NCT02250326|50550938|FG001|Follow-Up Period|Lost to Follow-up|1|||
25237428|NCT02250326|50550939|FG002|Follow-Up Period|Lost to Follow-up|3|||
25237429|NCT01567722|50550951|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
25237430|NCT01567722|50550952|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
25237431|NCT01567722|50550953|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
25237432|NCT01567722|50550951|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
25237433|NCT01567722|50550952|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
25319865|NCT03977155|50635570|FG002|Overall Study|Lost to Follow-up|0|||
25319866|NCT03977155|50635568|FG000|Overall Study|Withdrawal by Subject|1|||
25237434|NCT01567722|50550953|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
25237435|NCT01567722|50550951|FG000|Overall Study|Protocol closure by the OCG|2|||
25237436|NCT01567722|50550952|FG001|Overall Study|Protocol closure by the OCG|0|||
25237437|NCT01567722|50550953|FG002|Overall Study|Protocol closure by the OCG|0|||
25237438|NCT01567722|50550951|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
25237439|NCT01567722|50550952|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
25237440|NCT01567722|50550953|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
25237441|NCT01349790|50550978|FG000|Overall Study|Investigator Judgement|3|||
25237442|NCT01349790|50550978|FG000|Overall Study|Death|2|||
25237443|NCT01349790|50550978|FG000|Overall Study|Withdrawal by Patient|2|||
25237444|NCT01349790|50550978|FG000|Overall Study|Adverse Event|1|||
25237445|NCT01349790|50550978|FG000|Overall Study|Lost to Follow-up|1|||
25237446|NCT01349595|50550984|FG000|Overall Study|Lack of funding|2|||
25237447|NCT01349595|50550985|FG001|Overall Study|Lack of funding|2|||
25237448|NCT01349673|50550995|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
25237449|NCT01349673|50550995|FG000|Overall Study|No Longer Qualified For Study|1|||
25237450|NCT01349673|50550995|FG000|Overall Study|Site Closure|10|||
25237451|NCT01349673|50550995|FG000|Overall Study|Withdrawal by Subject|21|||
25237452|NCT01349673|50550995|FG000|Overall Study|Lost to Follow-up|6|||
25237453|NCT01349673|50550995|FG000|Overall Study|Adverse Event|17|||
25319867|NCT03977155|50635569|FG001|Overall Study|Withdrawal by Subject|1|||
25319868|NCT03977155|50635570|FG002|Overall Study|Withdrawal by Subject|2|||
25319869|NCT03977155|50635568|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
25319870|NCT03977155|50635569|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
25319871|NCT03977155|50635570|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
25319872|NCT00930059|50635595|FG000|Overall Study|Death|1|||
25319873|NCT00930059|50635596|FG001|Overall Study|Death|0|||
25319874|NCT00930059|50635595|FG000|Overall Study|Did not meet entrance criteria|1|||
25319875|NCT00930059|50635596|FG001|Overall Study|Did not meet entrance criteria|1|||
25319876|NCT00930059|50635595|FG000|Overall Study|Withdrawal by Subject|3|||
25319877|NCT00930059|50635596|FG001|Overall Study|Withdrawal by Subject|4|||
25319878|NCT00930059|50635595|FG000|Overall Study|Other|1|||
25319879|NCT00930059|50635596|FG001|Overall Study|Other|0|||
25319880|NCT00930059|50635595|FG000|Overall Study|1 site terminated by sponsor|1|||
25319881|NCT00930059|50635596|FG001|Overall Study|1 site terminated by sponsor|1|||
25319882|NCT00930059|50635595|FG000|Overall Study|Adverse Event|1|||
25319883|NCT00930059|50635596|FG001|Overall Study|Adverse Event|6|||
25319884|NCT00772005|50635615|FG000|Overall Study|Adverse Event|9|||
25319885|NCT00772005|50635616|FG001|Overall Study|Adverse Event|14|||
25319886|NCT00772005|50635617|FG002|Overall Study|Adverse Event|10|||
25319887|NCT00772005|50635618|FG003|Overall Study|Adverse Event|13|||
25319888|NCT00772005|50635615|FG000|Overall Study|Lack of Efficacy|0|||
25319889|NCT00772005|50635616|FG001|Overall Study|Lack of Efficacy|1|||
25319890|NCT00772005|50635617|FG002|Overall Study|Lack of Efficacy|0|||
25319891|NCT00772005|50635618|FG003|Overall Study|Lack of Efficacy|0|||
25319892|NCT00772005|50635615|FG000|Overall Study|Withdrawal by Subject|3|||
25319893|NCT00772005|50635616|FG001|Overall Study|Withdrawal by Subject|7|||
25319894|NCT00772005|50635617|FG002|Overall Study|Withdrawal by Subject|10|||
25319895|NCT00772005|50635618|FG003|Overall Study|Withdrawal by Subject|2|||
25319896|NCT00772005|50635615|FG000|Overall Study|Protocol Violation|2|||
25319897|NCT00772005|50635616|FG001|Overall Study|Protocol Violation|4|||
25319898|NCT00772005|50635617|FG002|Overall Study|Protocol Violation|1|||
25319899|NCT00772005|50635618|FG003|Overall Study|Protocol Violation|6|||
25319900|NCT00772005|50635615|FG000|Overall Study|Lost to Follow-up|7|||
25319901|NCT00772005|50635616|FG001|Overall Study|Lost to Follow-up|3|||
25319902|NCT00772005|50635617|FG002|Overall Study|Lost to Follow-up|6|||
25319903|NCT00772005|50635618|FG003|Overall Study|Lost to Follow-up|3|||
25319904|NCT00772005|50635615|FG000|Overall Study|Non-compliance with study procedures|1|||
25319905|NCT00772005|50635616|FG001|Overall Study|Non-compliance with study procedures|1|||
25319906|NCT00772005|50635617|FG002|Overall Study|Non-compliance with study procedures|0|||
25319907|NCT00772005|50635618|FG003|Overall Study|Non-compliance with study procedures|1|||
25319908|NCT00772005|50635615|FG000|Overall Study|Non-compliance with drug administration|3|||
25319909|NCT00772005|50635616|FG001|Overall Study|Non-compliance with drug administration|0|||
25319910|NCT00772005|50635617|FG002|Overall Study|Non-compliance with drug administration|1|||
25237454|NCT01349673|50550995|FG000|Overall Study|Study Terminated By Sponsor|50|||
25237455|NCT01349673|50550995|FG000|Overall Study|Lack of Efficacy|8|||
25319911|NCT00772005|50635618|FG003|Overall Study|Non-compliance with drug administration|1|||
25319912|NCT00939107|50635630|FG000|Overall Study|Lost to Follow-up|14|||
25319913|NCT00939107|50635631|FG001|Overall Study|Lost to Follow-up|12|||
25319914|NCT00927485|50635639|FG000|Overall Study|Adverse Event|4|||
25319915|NCT00927485|50635640|FG001|Overall Study|Adverse Event|2|||
25237456|NCT01349660|50551104|FG000|Overall Study|Still Receiving Study Treatment|0|||
25237457|NCT01349660|50551105|FG001|Overall Study|Still Receiving Study Treatment|0|||
25237458|NCT01349660|50551106|FG002|Overall Study|Still Receiving Study Treatment|1|||
25237459|NCT01349660|50551104|FG000|Overall Study|Disease Progression|2|||
25237460|NCT01349660|50551105|FG001|Overall Study|Disease Progression|4|||
25237461|NCT01349660|50551106|FG002|Overall Study|Disease Progression|50|||
25237462|NCT01349660|50551104|FG000|Overall Study|Adverse Event|1|||
25237463|NCT01349660|50551105|FG001|Overall Study|Adverse Event|1|||
25237464|NCT01349660|50551106|FG002|Overall Study|Adverse Event|12|||
25237465|NCT01349660|50551104|FG000|Overall Study|Withdrawal by Subject|2|||
25237466|NCT01349660|50551105|FG001|Overall Study|Withdrawal by Subject|0|||
25237467|NCT01349660|50551106|FG002|Overall Study|Withdrawal by Subject|9|||
25237468|NCT01349660|50551104|FG000|Overall Study|Death|1|||
25237469|NCT01349660|50551105|FG001|Overall Study|Death|1|||
25237470|NCT01349660|50551106|FG002|Overall Study|Death|0|||
25237471|NCT01349660|50551104|FG000|Overall Study|Non-Permitted Interventions|0|||
25237472|NCT01349660|50551105|FG001|Overall Study|Non-Permitted Interventions|0|||
25237473|NCT01349660|50551106|FG002|Overall Study|Non-Permitted Interventions|2|||
25237474|NCT01349660|50551104|FG000|Overall Study|Study Compliance|0|||
25237475|NCT01349660|50551105|FG001|Overall Study|Study Compliance|0|||
25237476|NCT01349660|50551106|FG002|Overall Study|Study Compliance|1|||
25237477|NCT01349660|50551104|FG000|Overall Study|Declining Performance Status|0|||
25237478|NCT01349660|50551105|FG001|Overall Study|Declining Performance Status|0|||
25237479|NCT01349660|50551106|FG002|Overall Study|Declining Performance Status|1|||
25237480|NCT01349569|50551125|FG000|Overall Study|Lack of Efficacy|4|||
25237481|NCT04642079|50551272|FG000|Overall Study|Lost to Follow-up|2|||
25237482|NCT04642079|50551273|FG001|Overall Study|Lost to Follow-up|5|||
25237483|NCT04642079|50551274|FG002|Overall Study|Lost to Follow-up|2|||
25237484|NCT04642079|50551275|FG003|Overall Study|Lost to Follow-up|0|||
25237485|NCT04642079|50551272|FG000|Overall Study|Withdrawal by Subject|0|||
25237486|NCT04642079|50551273|FG001|Overall Study|Withdrawal by Subject|4|||
25237487|NCT04642079|50551274|FG002|Overall Study|Withdrawal by Subject|1|||
25237488|NCT04642079|50551275|FG003|Overall Study|Withdrawal by Subject|2|||
25237489|NCT04642079|50551272|FG000|Overall Study|Other|0|||
25237490|NCT04642079|50551273|FG001|Overall Study|Other|0|||
25237491|NCT04642079|50551274|FG002|Overall Study|Other|0|||
25237492|NCT04642079|50551275|FG003|Overall Study|Other|1|||
25237493|NCT04642079|50551272|FG000|Overall Study|No longer met eligibility criteria|1|||
25237494|NCT04642079|50551273|FG001|Overall Study|No longer met eligibility criteria|0|||
25237495|NCT04642079|50551274|FG002|Overall Study|No longer met eligibility criteria|1|||
25237496|NCT04642079|50551275|FG003|Overall Study|No longer met eligibility criteria|1|||
25237497|NCT04419493|50551294|FG000|Wash-out After Period 1|Adverse Event|1|||
25237498|NCT04419493|50551295|FG001|Wash-out After Period 1|Adverse Event|2|||
25237499|NCT04419493|50551296|FG002|Wash-out After Period 1|Adverse Event|1|||
25237500|NCT04419493|50551297|FG003|Wash-out After Period 1|Adverse Event|0|||
25237501|NCT04359901|50551310|FG000|Overall Study|Withdrawal by Subject|0|||
25237502|NCT04359901|50551311|FG001|Overall Study|Withdrawal by Subject|1|||
25237503|NCT04359901|50551310|FG000|Overall Study|Death|6|||
25237504|NCT04359901|50551311|FG001|Overall Study|Death|2|||
25237505|NCT04147611|50551334|FG000|Overall Study|Physician Decision|0|||
25237506|NCT04147611|50551335|FG001|Overall Study|Physician Decision|1|||
25237507|NCT03765788|50551368|FG000|Overall Study|Subject decision|2|||
25237508|NCT03765788|50551369|FG001|Overall Study|Subject decision|3|||
25237509|NCT03765788|50551368|FG000|Overall Study|Physician Decision|2|||
25237510|NCT03765788|50551369|FG001|Overall Study|Physician Decision|4|||
25237511|NCT03765788|50551368|FG000|Overall Study|Death|0|||
25237512|NCT03765788|50551369|FG001|Overall Study|Death|1|||
25237513|NCT03765788|50551368|FG000|Overall Study|Lost to Follow-up|1|||
25237514|NCT03765788|50551369|FG001|Overall Study|Lost to Follow-up|0|||
25237515|NCT03635424|50551376|FG000|Overall Study|Adverse Event|1|||
25237516|NCT03635424|50551376|FG000|Overall Study|Death|1|||
25237517|NCT03635424|50551376|FG000|Overall Study|Device not implanted|1|||
25237518|NCT03603964|50551380|FG000|Overall Study|Death|9|||
25237519|NCT03603964|50551380|FG000|Overall Study|Withdrawal by participant|7|||
25237520|NCT03603964|50551380|FG000|Overall Study|Study terminated by Sponsor|19|||
25237521|NCT03456700|50551395|FG000|Overall Study|Withdrawal by Subject|1|||
25237522|NCT03191864|50551413|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
25237523|NCT03191864|50551414|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
25237524|NCT03191864|50551415|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
25237525|NCT03191864|50551416|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
25237526|NCT03191864|50551417|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
25237527|NCT03191864|50551418|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
25237528|NCT03191864|50551413|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
25237529|NCT03191864|50551414|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
25237530|NCT03191864|50551415|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
25237531|NCT03191864|50551416|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
25237532|NCT03191864|50551417|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
25237533|NCT03191864|50551418|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
25237534|NCT03191864|50551413|FG000|Baseline Symptom Assessment|Adverse Event|0|||
25237535|NCT03191864|50551414|FG001|Baseline Symptom Assessment|Adverse Event|0|||
25237536|NCT03191864|50551415|FG002|Baseline Symptom Assessment|Adverse Event|0|||
25237537|NCT03191864|50551416|FG003|Baseline Symptom Assessment|Adverse Event|0|||
25237538|NCT03191864|50551417|FG004|Baseline Symptom Assessment|Adverse Event|0|||
25237539|NCT03191864|50551418|FG005|Baseline Symptom Assessment|Adverse Event|2|||
25237540|NCT03191864|50551413|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
25237541|NCT03191864|50551414|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
25237542|NCT03191864|50551415|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
25237543|NCT03191864|50551416|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
25237544|NCT03191864|50551417|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
25237545|NCT03191864|50551418|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
25237546|NCT03191864|50551413|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
25237547|NCT03191864|50551414|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
25237548|NCT03191864|50551415|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
25237549|NCT03191864|50551416|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
25237550|NCT03191864|50551417|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
25237551|NCT03191864|50551418|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
25237552|NCT03191864|50551413|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
25237553|NCT03191864|50551414|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
25237554|NCT03191864|50551415|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
25237555|NCT03191864|50551416|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
25237556|NCT03191864|50551417|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
25319916|NCT00927485|50635639|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
25319917|NCT00927485|50635640|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
25319918|NCT00927251|50635646|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
25319919|NCT00927095|50635653|FG000|Overall Study|Adverse Event|3|||
25319920|NCT00927095|50635654|FG001|Overall Study|Adverse Event|1|||
25319921|NCT00927095|50635655|FG002|Overall Study|Adverse Event|0|||
25319922|NCT00927095|50635653|FG000|Overall Study|Withdrawal by Subject|2|||
25319923|NCT00927095|50635654|FG001|Overall Study|Withdrawal by Subject|1|||
25319924|NCT00927095|50635655|FG002|Overall Study|Withdrawal by Subject|1|||
25319925|NCT00927095|50635653|FG000|Overall Study|Physician Decision|1|||
25319926|NCT00927095|50635654|FG001|Overall Study|Physician Decision|2|||
25319927|NCT00927095|50635655|FG002|Overall Study|Physician Decision|1|||
25319928|NCT00932165|50635663|FG000|Overall Study|Lost to Follow-up|1|||
25319929|NCT04888494|50635670|FG000|Overall Study|Lost to Follow-up|2|||
25319930|NCT04888494|50635671|FG001|Overall Study|Lost to Follow-up|3|||
25319931|NCT04888494|50635670|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
25319932|NCT04888494|50635671|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
25319933|NCT04761822|50635731|FG000|Overall Study|Adverse Event|3|||
25319934|NCT04761822|50635732|FG001|Overall Study|Adverse Event|1|||
25319935|NCT04761822|50635733|FG002|Overall Study|Adverse Event|1|||
25319936|NCT04761822|50635734|FG003|Overall Study|Adverse Event|3|||
25319937|NCT04761822|50635731|FG000|Overall Study|Lost to Follow-up|1|||
25319938|NCT04761822|50635732|FG001|Overall Study|Lost to Follow-up|0|||
25319939|NCT04761822|50635733|FG002|Overall Study|Lost to Follow-up|2|||
25319940|NCT04761822|50635734|FG003|Overall Study|Lost to Follow-up|3|||
25319941|NCT04761822|50635731|FG000|Overall Study|Physician Decision|0|||
25319942|NCT04761822|50635732|FG001|Overall Study|Physician Decision|1|||
25319943|NCT04761822|50635733|FG002|Overall Study|Physician Decision|0|||
25319944|NCT04761822|50635734|FG003|Overall Study|Physician Decision|0|||
25319945|NCT04761822|50635731|FG000|Overall Study|Withdrawal by Subject|3|||
25319946|NCT04761822|50635732|FG001|Overall Study|Withdrawal by Subject|8|||
25319947|NCT04761822|50635733|FG002|Overall Study|Withdrawal by Subject|1|||
25319948|NCT04761822|50635734|FG003|Overall Study|Withdrawal by Subject|11|||
25319949|NCT04761822|50635731|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
25319950|NCT04761822|50635732|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
25319951|NCT04761822|50635733|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
25319952|NCT04761822|50635734|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
25319953|NCT04761822|50635731|FG000|Overall Study|Participant requested unblinding|0|||
25319954|NCT04761822|50635732|FG001|Overall Study|Participant requested unblinding|0|||
25319955|NCT04761822|50635733|FG002|Overall Study|Participant requested unblinding|0|||
25319956|NCT04761822|50635734|FG003|Overall Study|Participant requested unblinding|1|||
25319957|NCT04573972|50635763|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
25319958|NCT04573972|50635764|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
25237557|NCT03191864|50551418|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
25237558|NCT03191864|50551413|FG000|Part 1 - Induction|Adverse Event|0|||
25237559|NCT03191864|50551414|FG001|Part 1 - Induction|Adverse Event|2|||
25237560|NCT03191864|50551415|FG002|Part 1 - Induction|Adverse Event|0|||
25237561|NCT03191864|50551416|FG003|Part 1 - Induction|Adverse Event|1|||
25237562|NCT03191864|50551417|FG004|Part 1 - Induction|Adverse Event|0|||
25237563|NCT03191864|50551418|FG005|Part 1 - Induction|Adverse Event|2|||
25237564|NCT03191864|50551413|FG000|Part 1 - Induction|Randomized but never dosed|0|||
25237565|NCT03191864|50551414|FG001|Part 1 - Induction|Randomized but never dosed|0|||
25237566|NCT03191864|50551415|FG002|Part 1 - Induction|Randomized but never dosed|1|||
25237567|NCT03191864|50551416|FG003|Part 1 - Induction|Randomized but never dosed|0|||
25237568|NCT03191864|50551417|FG004|Part 1 - Induction|Randomized but never dosed|0|||
25237569|NCT03191864|50551418|FG005|Part 1 - Induction|Randomized but never dosed|0|||
25237570|NCT03191864|50551413|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
25237571|NCT03191864|50551414|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
25237572|NCT03191864|50551415|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
25237573|NCT03191864|50551416|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
25237574|NCT03191864|50551417|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
25237575|NCT03191864|50551418|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
25237576|NCT03191864|50551413|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
25237577|NCT03191864|50551414|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
25237578|NCT03191864|50551415|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
25237579|NCT03191864|50551416|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
25237580|NCT03191864|50551417|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
25237581|NCT03191864|50551418|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
25237582|NCT03191864|50551413|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
25237583|NCT03191864|50551414|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
25237584|NCT03191864|50551415|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
25237585|NCT03191864|50551416|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
25237586|NCT03191864|50551417|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
25237587|NCT03191864|50551418|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
25237588|NCT03191864|50551413|FG000|Part 2 - Maintenance|Physician Decision|1|||
25237589|NCT03191864|50551414|FG001|Part 2 - Maintenance|Physician Decision|0|||
25237590|NCT03191864|50551415|FG002|Part 2 - Maintenance|Physician Decision|0|||
25237591|NCT03191864|50551416|FG003|Part 2 - Maintenance|Physician Decision|0|||
25237592|NCT03191864|50551417|FG004|Part 2 - Maintenance|Physician Decision|0|||
25237593|NCT03191864|50551418|FG005|Part 2 - Maintenance|Physician Decision|0|||
25237594|NCT03191864|50551413|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
25237595|NCT03191864|50551414|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
25237596|NCT03191864|50551415|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
25237597|NCT03191864|50551416|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
25237598|NCT03191864|50551417|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
25237599|NCT03191864|50551418|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
25237600|NCT03191864|50551413|FG000|Part 2 - Maintenance|Adverse Event|0|||
25237601|NCT03191864|50551414|FG001|Part 2 - Maintenance|Adverse Event|0|||
25237602|NCT03191864|50551415|FG002|Part 2 - Maintenance|Adverse Event|0|||
25237603|NCT03191864|50551416|FG003|Part 2 - Maintenance|Adverse Event|0|||
25237604|NCT03191864|50551417|FG004|Part 2 - Maintenance|Adverse Event|1|||
25237605|NCT03191864|50551418|FG005|Part 2 - Maintenance|Adverse Event|0|||
25237606|NCT03191864|50551413|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
25237607|NCT03191864|50551414|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
25237608|NCT03191864|50551415|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
25237609|NCT03191864|50551416|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
25237610|NCT03191864|50551417|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
25237611|NCT03191864|50551418|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
25237612|NCT03191864|50551413|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
25237613|NCT03191864|50551414|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
25237614|NCT03191864|50551415|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
25237615|NCT03191864|50551416|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
25237616|NCT03191864|50551417|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
25237617|NCT03191864|50551418|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
25237618|NCT02975882|50551450|FG000|Overall Study|Adverse Event|1|||
25237619|NCT02975882|50551451|FG001|Overall Study|Adverse Event|2|||
25237620|NCT02975882|50551452|FG002|Overall Study|Adverse Event|1|||
25319959|NCT04476043|50635785|FG000|Overall Study|Withdrawal by Subject|1|||
25319960|NCT04476043|50635786|FG001|Overall Study|Withdrawal by Subject|3|||
25237621|NCT02975882|50551453|FG003|Overall Study|Adverse Event|1|||
25237622|NCT02975882|50551450|FG000|Overall Study|Death|0|||
25237623|NCT02975882|50551451|FG001|Overall Study|Death|1|||
25237624|NCT02975882|50551452|FG002|Overall Study|Death|0|||
25237625|NCT02975882|50551453|FG003|Overall Study|Death|0|||
25237626|NCT02975882|50551450|FG000|Overall Study|Lack of Efficacy|3|||
25237627|NCT02975882|50551451|FG001|Overall Study|Lack of Efficacy|7|||
25237628|NCT02975882|50551452|FG002|Overall Study|Lack of Efficacy|4|||
25237629|NCT02975882|50551453|FG003|Overall Study|Lack of Efficacy|3|||
25237630|NCT02975882|50551450|FG000|Overall Study|Physician Decision|0|||
25237631|NCT02975882|50551451|FG001|Overall Study|Physician Decision|2|||
25237632|NCT02975882|50551452|FG002|Overall Study|Physician Decision|4|||
25237633|NCT02975882|50551453|FG003|Overall Study|Physician Decision|2|||
25237634|NCT02975882|50551450|FG000|Overall Study|Ineligible|0|||
25237635|NCT02975882|50551451|FG001|Overall Study|Ineligible|1|||
25237636|NCT02975882|50551452|FG002|Overall Study|Ineligible|0|||
25237637|NCT02975882|50551453|FG003|Overall Study|Ineligible|0|||
25237638|NCT02636725|50551499|FG000|Baseline|Adverse Event|1|||
25237639|NCT02636725|50551499|FG000|Baseline|Lack of Efficacy|2|||
25237640|NCT02573493|50551507|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
25237641|NCT02573493|50551508|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
25237642|NCT02573493|50551509|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
25237643|NCT02573493|50551510|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
25237644|NCT02327078|50551543|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
25237645|NCT02327078|50551544|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
25237646|NCT02327078|50551545|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
25237647|NCT02327078|50551546|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
25237648|NCT02327078|50551547|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
25237649|NCT02327078|50551548|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
25237650|NCT02327078|50551549|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
25237651|NCT02327078|50551550|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
25237652|NCT02327078|50551551|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
25237653|NCT02327078|50551543|FG000|Overall Study|Death|2|||
25237654|NCT02327078|50551544|FG001|Overall Study|Death|4|||
25237655|NCT02327078|50551545|FG002|Overall Study|Death|10|||
25319961|NCT04476043|50635787|FG002|Overall Study|Withdrawal by Subject|4|||
25319962|NCT04476043|50635788|FG003|Overall Study|Withdrawal by Subject|1|||
25319963|NCT04476043|50635785|FG000|Overall Study|Lost to Follow-up|1|||
25319964|NCT04476043|50635786|FG001|Overall Study|Lost to Follow-up|1|||
25319965|NCT04476043|50635787|FG002|Overall Study|Lost to Follow-up|2|||
25319966|NCT04476043|50635788|FG003|Overall Study|Lost to Follow-up|1|||
25319967|NCT04476043|50635785|FG000|Overall Study|Adverse Event|2|||
25319968|NCT04476043|50635786|FG001|Overall Study|Adverse Event|0|||
25319969|NCT04476043|50635787|FG002|Overall Study|Adverse Event|1|||
25319970|NCT04476043|50635788|FG003|Overall Study|Adverse Event|0|||
25319971|NCT04476043|50635785|FG000|Overall Study|Protocol Violation|0|||
25319972|NCT04476043|50635786|FG001|Overall Study|Protocol Violation|1|||
24976831|NCT00048932|50065736|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
24976832|NCT00048932|50065737|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
24976833|NCT00048932|50065735|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
24976834|NCT00048932|50065736|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
24976835|NCT00048932|50065737|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
24976836|NCT00048932|50065735|FG000|Double Blind Period (DB)|Pregnancy|1|||
24976837|NCT00048932|50065736|FG001|Double Blind Period (DB)|Pregnancy|0|||
25319973|NCT04476043|50635787|FG002|Overall Study|Protocol Violation|0|||
25319974|NCT04476043|50635788|FG003|Overall Study|Protocol Violation|0|||
25319975|NCT04391309|50635809|FG000|Overall Study|Death|1|||
25319976|NCT04391309|50635810|FG001|Overall Study|Death|1|||
25319977|NCT04391309|50635809|FG000|Overall Study|Lost to Follow-up|3|||
25319978|NCT04391309|50635810|FG001|Overall Study|Lost to Follow-up|2|||
25319979|NCT04391309|50635809|FG000|Overall Study|Withdrawal by Subject|2|||
25319980|NCT04391309|50635810|FG001|Overall Study|Withdrawal by Subject|2|||
25319981|NCT04202965|50635838|FG000|Overall Study|Adverse Event|3|||
25319982|NCT04202965|50635838|FG000|Overall Study|Did not meet inclusion criteria|1|||
25319983|NCT04056624|50635846|FG000|Overall Study|Withdrawal by Subject|0|||
25319984|NCT04056624|50635847|FG001|Overall Study|Withdrawal by Subject|0|||
24976838|NCT00048932|50065737|FG002|Double Blind Period (DB)|Pregnancy|0|||
24976839|NCT00048932|50065735|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
25237656|NCT02327078|50551546|FG003|Overall Study|Death|6|||
25237657|NCT02327078|50551547|FG004|Overall Study|Death|4|||
25319985|NCT04056624|50635848|FG002|Overall Study|Withdrawal by Subject|1|||
25319986|NCT04056624|50635846|FG000|Overall Study|Protocol Violation|1|||
25319987|NCT04056624|50635847|FG001|Overall Study|Protocol Violation|2|||
25319988|NCT04056624|50635848|FG002|Overall Study|Protocol Violation|0|||
25319989|NCT03870763|50635868|FG000|Overall Study|Study terminated by sponsor|0|||
25319990|NCT03870763|50635869|FG001|Overall Study|Study terminated by sponsor|2|||
25237658|NCT02327078|50551548|FG005|Overall Study|Death|3|||
25237659|NCT02327078|50551549|FG006|Overall Study|Death|2|||
25237660|NCT02327078|50551550|FG007|Overall Study|Death|51|||
25319991|NCT03870763|50635870|FG002|Overall Study|Study terminated by sponsor|0|||
25319992|NCT03870763|50635868|FG000|Overall Study|Withdrawal by Subject|0|||
25237661|NCT02327078|50551551|FG008|Overall Study|Death|97|||
25237662|NCT02327078|50551543|FG000|Overall Study|Lost to Follow-up|0|||
25237663|NCT02327078|50551544|FG001|Overall Study|Lost to Follow-up|1|||
25237664|NCT02327078|50551545|FG002|Overall Study|Lost to Follow-up|1|||
25237665|NCT02327078|50551546|FG003|Overall Study|Lost to Follow-up|0|||
25237666|NCT02327078|50551547|FG004|Overall Study|Lost to Follow-up|0|||
25237667|NCT02327078|50551548|FG005|Overall Study|Lost to Follow-up|0|||
25237668|NCT02327078|50551549|FG006|Overall Study|Lost to Follow-up|0|||
25237669|NCT02327078|50551550|FG007|Overall Study|Lost to Follow-up|2|||
25237670|NCT02327078|50551551|FG008|Overall Study|Lost to Follow-up|5|||
25237671|NCT02327078|50551543|FG000|Overall Study|Site Terminated by Sponsor|1|||
25237672|NCT02327078|50551544|FG001|Overall Study|Site Terminated by Sponsor|0|||
25237673|NCT02327078|50551545|FG002|Overall Study|Site Terminated by Sponsor|1|||
25237674|NCT02327078|50551546|FG003|Overall Study|Site Terminated by Sponsor|4|||
25237675|NCT02327078|50551547|FG004|Overall Study|Site Terminated by Sponsor|0|||
25237676|NCT02327078|50551548|FG005|Overall Study|Site Terminated by Sponsor|0|||
25237677|NCT02327078|50551549|FG006|Overall Study|Site Terminated by Sponsor|0|||
25237678|NCT02327078|50551550|FG007|Overall Study|Site Terminated by Sponsor|11|||
25237679|NCT02327078|50551551|FG008|Overall Study|Site Terminated by Sponsor|25|||
25237680|NCT02327078|50551543|FG000|Overall Study|Physician Decision|0|||
25237681|NCT02327078|50551544|FG001|Overall Study|Physician Decision|0|||
25237682|NCT02327078|50551545|FG002|Overall Study|Physician Decision|0|||
25237683|NCT02327078|50551546|FG003|Overall Study|Physician Decision|1|||
25237684|NCT02327078|50551547|FG004|Overall Study|Physician Decision|0|||
25237685|NCT02327078|50551548|FG005|Overall Study|Physician Decision|0|||
25237686|NCT02327078|50551549|FG006|Overall Study|Physician Decision|0|||
25237687|NCT02327078|50551550|FG007|Overall Study|Physician Decision|0|||
25237688|NCT02327078|50551551|FG008|Overall Study|Physician Decision|1|||
25237689|NCT02327078|50551543|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
25237690|NCT02327078|50551544|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
25237691|NCT02327078|50551545|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
25237692|NCT02327078|50551546|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
25237693|NCT02327078|50551547|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
25237694|NCT02327078|50551548|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
25237695|NCT02327078|50551549|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
25237696|NCT02327078|50551550|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
25237697|NCT02327078|50551551|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
25237698|NCT02327078|50551543|FG000|Overall Study|Reason not Specified|0|||
25237699|NCT02327078|50551544|FG001|Overall Study|Reason not Specified|0|||
25237700|NCT02327078|50551545|FG002|Overall Study|Reason not Specified|0|||
25237701|NCT02327078|50551546|FG003|Overall Study|Reason not Specified|0|||
25237702|NCT02327078|50551547|FG004|Overall Study|Reason not Specified|0|||
25237703|NCT02327078|50551548|FG005|Overall Study|Reason not Specified|0|||
25237704|NCT02327078|50551549|FG006|Overall Study|Reason not Specified|0|||
25237705|NCT02327078|50551550|FG007|Overall Study|Reason not Specified|5|||
25237706|NCT02327078|50551551|FG008|Overall Study|Reason not Specified|12|||
25237707|NCT02304458|50551594|FG000|Overall Study|Adverse Event|0|||
25237708|NCT02304458|50551595|FG001|Overall Study|Adverse Event|0|||
25237709|NCT02304458|50551596|FG002|Overall Study|Adverse Event|7|||
25237710|NCT02304458|50551597|FG003|Overall Study|Adverse Event|0|||
25237711|NCT02304458|50551598|FG004|Overall Study|Adverse Event|0|||
25237712|NCT02304458|50551599|FG005|Overall Study|Adverse Event|0|||
25237713|NCT02304458|50551600|FG006|Overall Study|Adverse Event|3|||
25237714|NCT02304458|50551601|FG007|Overall Study|Adverse Event|4|||
25237715|NCT02304458|50551594|FG000|Overall Study|Death|0|||
25237716|NCT02304458|50551595|FG001|Overall Study|Death|0|||
25237717|NCT02304458|50551596|FG002|Overall Study|Death|2|||
25237718|NCT02304458|50551597|FG003|Overall Study|Death|0|||
25237719|NCT02304458|50551598|FG004|Overall Study|Death|0|||
25237720|NCT02304458|50551599|FG005|Overall Study|Death|0|||
25237721|NCT02304458|50551600|FG006|Overall Study|Death|1|||
25237722|NCT02304458|50551601|FG007|Overall Study|Death|0|||
25237723|NCT02304458|50551594|FG000|Overall Study|Lack of Efficacy|4|||
25237724|NCT02304458|50551595|FG001|Overall Study|Lack of Efficacy|6|||
25237725|NCT02304458|50551596|FG002|Overall Study|Lack of Efficacy|38|||
25237726|NCT02304458|50551597|FG003|Overall Study|Lack of Efficacy|5|||
25237727|NCT02304458|50551598|FG004|Overall Study|Lack of Efficacy|6|||
25237728|NCT02304458|50551599|FG005|Overall Study|Lack of Efficacy|6|||
25237729|NCT02304458|50551600|FG006|Overall Study|Lack of Efficacy|21|||
25237730|NCT02304458|50551601|FG007|Overall Study|Lack of Efficacy|4|||
25237731|NCT02304458|50551594|FG000|Overall Study|Physician Decision|2|||
25237732|NCT02304458|50551595|FG001|Overall Study|Physician Decision|0|||
25237733|NCT02304458|50551596|FG002|Overall Study|Physician Decision|16|||
25237734|NCT02304458|50551597|FG003|Overall Study|Physician Decision|1|||
25237735|NCT02304458|50551598|FG004|Overall Study|Physician Decision|0|||
25237736|NCT02304458|50551599|FG005|Overall Study|Physician Decision|0|||
25237737|NCT02304458|50551600|FG006|Overall Study|Physician Decision|3|||
25237738|NCT02304458|50551601|FG007|Overall Study|Physician Decision|0|||
25237739|NCT02304458|50551594|FG000|Overall Study|Protocol Violation|0|||
25237740|NCT02304458|50551595|FG001|Overall Study|Protocol Violation|0|||
25237741|NCT02304458|50551596|FG002|Overall Study|Protocol Violation|1|||
25237742|NCT02304458|50551597|FG003|Overall Study|Protocol Violation|0|||
25237743|NCT02304458|50551598|FG004|Overall Study|Protocol Violation|0|||
25237744|NCT02304458|50551599|FG005|Overall Study|Protocol Violation|0|||
25237745|NCT02304458|50551600|FG006|Overall Study|Protocol Violation|0|||
25237746|NCT02304458|50551601|FG007|Overall Study|Protocol Violation|0|||
25237747|NCT02304458|50551594|FG000|Overall Study|Withdrawal by Subject|1|||
25237748|NCT02304458|50551595|FG001|Overall Study|Withdrawal by Subject|0|||
25237749|NCT02304458|50551596|FG002|Overall Study|Withdrawal by Subject|7|||
25237750|NCT02304458|50551597|FG003|Overall Study|Withdrawal by Subject|0|||
25237751|NCT02304458|50551598|FG004|Overall Study|Withdrawal by Subject|0|||
25237752|NCT02304458|50551599|FG005|Overall Study|Withdrawal by Subject|0|||
25237753|NCT02304458|50551600|FG006|Overall Study|Withdrawal by Subject|1|||
25237754|NCT02304458|50551601|FG007|Overall Study|Withdrawal by Subject|0|||
25237755|NCT02187224|50551637|FG000|Overall Study|Did not show up for test day|1|||
25237756|NCT02187224|50551638|FG001|Overall Study|Did not show up for test day|0|||
25237757|NCT02176226|50551648|FG000|Overall Study|Lost to Follow-up|3|||
25237758|NCT02176226|50551648|FG000|Overall Study|Withdrew prior to treatment|6|||
25237759|NCT02032823|50551654|FG000|Overall Study|Death|75|||
25237760|NCT02032823|50551655|FG001|Overall Study|Death|109|||
25237761|NCT02032823|50551654|FG000|Overall Study|Lost to Follow-up|18|||
25237762|NCT02032823|50551655|FG001|Overall Study|Lost to Follow-up|17|||
25237763|NCT02032823|50551654|FG000|Overall Study|Withdrawal by Subject|70|||
25237764|NCT02032823|50551655|FG001|Overall Study|Withdrawal by Subject|53|||
25237765|NCT02032823|50551654|FG000|Overall Study|Ongoing study at data cut-off|755|||
25237766|NCT02032823|50551655|FG001|Overall Study|Ongoing study at data cut-off|731|||
25237767|NCT02032823|50551654|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
25237768|NCT02032823|50551655|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
25237769|NCT01958021|50551663|FG000|Overall Study|Progressive disease|87|||
25237770|NCT01958021|50551664|FG001|Overall Study|Progressive disease|146|||
25319993|NCT03870763|50635869|FG001|Overall Study|Withdrawal by Subject|1|||
25319994|NCT03870763|50635870|FG002|Overall Study|Withdrawal by Subject|0|||
25319995|NCT03870763|50635868|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
25319996|NCT03870763|50635869|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
25319997|NCT03870763|50635870|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
25319998|NCT03647501|50635880|FG000|Overall Study|Lost to Follow-up|1|||
25319999|NCT03647501|50635881|FG001|Overall Study|Lost to Follow-up|1|||
25320000|NCT03647501|50635880|FG000|Overall Study|Withdrawal by Subject|0|||
25320001|NCT03647501|50635881|FG001|Overall Study|Withdrawal by Subject|1|||
25320002|NCT03587142|50635913|FG000|Overall Study|Lost to Follow-up|5|||
25320003|NCT03587142|50635914|FG001|Overall Study|Lost to Follow-up|3|||
25320004|NCT03587142|50635913|FG000|Overall Study|Did not complete the f4 visit|3|||
25320005|NCT03587142|50635914|FG001|Overall Study|Did not complete the f4 visit|7|||
25320006|NCT03493854|50635922|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
25320007|NCT03493854|50635923|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
25320008|NCT03493854|50635922|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
25320009|NCT03493854|50635923|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
25320010|NCT03493854|50635922|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
25320011|NCT03493854|50635923|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
25320012|NCT03493854|50635922|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
25320013|NCT03493854|50635923|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
25320014|NCT03493854|50635922|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
25320015|NCT03493854|50635923|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
25320016|NCT03493854|50635922|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
25320017|NCT03493854|50635923|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
25320018|NCT03493854|50635922|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
25320019|NCT03493854|50635923|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
25320020|NCT03493854|50635922|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229|||
25320021|NCT03493854|50635923|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228|||
25320022|NCT03493854|50635922|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
25237771|NCT01958021|50551663|FG000|Overall Study|Adverse Event|25|||
25237772|NCT01958021|50551664|FG001|Overall Study|Adverse Event|7|||
25237773|NCT01958021|50551663|FG000|Overall Study|Subject/guardian decision|12|||
25237774|NCT01958021|50551664|FG001|Overall Study|Subject/guardian decision|13|||
25237775|NCT01958021|50551663|FG000|Overall Study|Physician Decision|10|||
25237776|NCT01958021|50551664|FG001|Overall Study|Physician Decision|13|||
25237777|NCT01958021|50551663|FG000|Overall Study|Protocol Violation|3|||
25237778|NCT01958021|50551664|FG001|Overall Study|Protocol Violation|1|||
25237779|NCT01958021|50551663|FG000|Overall Study|Death|2|||
25237780|NCT01958021|50551664|FG001|Overall Study|Death|0|||
25237781|NCT00567580|50551673|FG000|Overall Study|Protocol Violation|28|||
25237782|NCT00567580|50551674|FG001|Overall Study|Protocol Violation|24|||
25237783|NCT00567580|50551675|FG002|Overall Study|Protocol Violation|24|||
25237784|NCT01058863|50551686|FG000|Overall Study|Lost to Follow-up|1|||
25237785|NCT01058863|50551686|FG000|Overall Study|Withdrawal by Subject|1|||
25237786|NCT01058863|50551686|FG000|Overall Study|Sponsor requested withdrawal|1|||
25237787|NCT01058863|50551686|FG000|Overall Study|Randomized in error|1|||
25237788|NCT01058395|50551701|FG000|Overall Study|Death|2|||
25237789|NCT01058395|50551702|FG001|Overall Study|Death|1|||
25237790|NCT01058395|50551701|FG000|Overall Study|Lost to Follow-up|1|||
25237791|NCT01058395|50551702|FG001|Overall Study|Lost to Follow-up|0|||
25237792|NCT01058356|50551708|FG000|Overall Study|Adverse Event|5|||
25237793|NCT01058356|50551708|FG000|Overall Study|Administration of contraindicated drugs|12|||
25237794|NCT01058356|50551708|FG000|Overall Study|Withdrawal by Subject|21|||
25237795|NCT01058356|50551708|FG000|Overall Study|Lost to Follow-up|4|||
25237796|NCT01058005|50551715|FG000|Overall Study|Adverse Event|0|||
25237797|NCT01058005|50551716|FG001|Overall Study|Adverse Event|2|||
25237798|NCT01058005|50551717|FG002|Overall Study|Adverse Event|1|||
25237799|NCT01058005|50551715|FG000|Overall Study|Physician Decision|2|||
25237800|NCT01058005|50551716|FG001|Overall Study|Physician Decision|2|||
25237801|NCT01058005|50551717|FG002|Overall Study|Physician Decision|0|||
25237802|NCT01058005|50551715|FG000|Overall Study|Withdrawal by Subject|4|||
25237803|NCT01058005|50551716|FG001|Overall Study|Withdrawal by Subject|5|||
25237804|NCT01058005|50551717|FG002|Overall Study|Withdrawal by Subject|11|||
25237805|NCT01058005|50551715|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
25237806|NCT01058005|50551716|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
25237807|NCT01058005|50551717|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
25237808|NCT01058005|50551715|FG000|Overall Study|Reason Missing|5|||
25237809|NCT01058005|50551716|FG001|Overall Study|Reason Missing|3|||
25237810|NCT01058005|50551717|FG002|Overall Study|Reason Missing|1|||
25237811|NCT01056640|50551727|FG000|Overall Study|Withdrawal by Subject|11|||
25237812|NCT01056640|50551728|FG001|Overall Study|Withdrawal by Subject|8|||
25237813|NCT01056640|50551727|FG000|Overall Study|Death|15|||
25237814|NCT01056640|50551728|FG001|Overall Study|Death|4|||
25237815|NCT01056523|50551734|FG000|Overall Study|Death|1|||
25237816|NCT01056523|50551735|FG001|Overall Study|Death|0|||
25237817|NCT01056523|50551736|FG002|Overall Study|Death|2|||
25237818|NCT01056523|50551737|FG003|Overall Study|Death|3|||
25237819|NCT01056523|50551738|FG004|Overall Study|Death|0|||
25237820|NCT01056523|50551739|FG005|Overall Study|Death|0|||
25237821|NCT01056523|50551740|FG006|Overall Study|Death|1|||
25237822|NCT01056484|50551747|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
25237823|NCT01056484|50551748|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
25237824|NCT01056484|50551747|FG000|Randomized Controlled Trial|Physician Decision|1|||
25237825|NCT01056484|50551748|FG001|Randomized Controlled Trial|Physician Decision|0|||
25237826|NCT01056484|50551747|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
25237827|NCT01056484|50551748|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
25237828|NCT01055314|50551757|FG000|Overall Study|Adverse Event|7|||
25320023|NCT03493854|50635923|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
25320024|NCT03493854|50635922|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
25320025|NCT03493854|50635923|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1|||
25320026|NCT03493854|50635922|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3|||
25320027|NCT03493854|50635923|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
25320028|NCT03493854|50635922|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1|||
24976840|NCT00048932|50065736|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
24976841|NCT00048932|50065737|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
24976842|NCT00048932|50065735|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
25237829|NCT01055314|50551758|FG001|Overall Study|Adverse Event|4|||
25237830|NCT01055314|50551757|FG000|Overall Study|Death|2|||
25237831|NCT01055314|50551758|FG001|Overall Study|Death|1|||
25237832|NCT01055314|50551757|FG000|Overall Study|Lack of Efficacy|11|||
25237833|NCT01055314|50551758|FG001|Overall Study|Lack of Efficacy|19|||
25237834|NCT01055314|50551757|FG000|Overall Study|Physician Decision|10|||
25237835|NCT01055314|50551758|FG001|Overall Study|Physician Decision|5|||
25237836|NCT01055314|50551757|FG000|Overall Study|Withdrawal by Subject|1|||
25237837|NCT01055314|50551758|FG001|Overall Study|Withdrawal by Subject|0|||
25237838|NCT01055314|50551757|FG000|Overall Study|Ineligible|3|||
25237839|NCT01055314|50551758|FG001|Overall Study|Ineligible|5|||
25237840|NCT01055314|50551757|FG000|Overall Study|Refusal of further protocol therapy|10|||
25237841|NCT01055314|50551758|FG001|Overall Study|Refusal of further protocol therapy|4|||
25237842|NCT01055314|50551757|FG000|Overall Study|No treatment|1|||
25237843|NCT01055314|50551758|FG001|Overall Study|No treatment|0|||
25237844|NCT01055197|50551767|FG000|Overall Study|Protocol Violation|7|||
25237845|NCT01055197|50551768|FG001|Overall Study|Protocol Violation|2|||
25237846|NCT01055197|50551767|FG000|Overall Study|Withdrawal by Subject|2|||
25237847|NCT01055197|50551768|FG001|Overall Study|Withdrawal by Subject|0|||
25237848|NCT01054885|50551780|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
25237849|NCT01054885|50551781|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
25237850|NCT01054885|50551782|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
25237851|NCT01054885|50551783|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
25237852|NCT01054885|50551784|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
25237853|NCT01054885|50551785|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
25320029|NCT03493854|50635923|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0|||
25320030|NCT03493854|50635922|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
25320031|NCT03493854|50635923|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0|||
25320032|NCT03493854|50635922|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|5|||
25320033|NCT03493854|50635923|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|3|||
25320034|NCT03493854|50635922|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
25320035|NCT03493854|50635923|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
25320036|NCT03493854|50635922|FG000|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18|||
25320037|NCT03493854|50635923|FG001|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16|||
25320038|NCT03188705|50635929|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
25320039|NCT03188705|50635929|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
25320040|NCT03072238|50635936|FG000|Overall Study|Withdrawal by Subject|30|||
25320041|NCT03072238|50635937|FG001|Overall Study|Withdrawal by Subject|51|||
25320042|NCT03072238|50635936|FG000|Overall Study|Lost to Follow-up|7|||
25320043|NCT03072238|50635937|FG001|Overall Study|Lost to Follow-up|4|||
25320044|NCT03072238|50635936|FG000|Overall Study|Physician Decision|1|||
25320045|NCT03072238|50635937|FG001|Overall Study|Physician Decision|3|||
25320046|NCT03072238|50635936|FG000|Overall Study|Death|139|||
25320047|NCT03072238|50635937|FG001|Overall Study|Death|121|||
25320048|NCT03072238|50635936|FG000|Overall Study|Other|0|||
25320049|NCT03072238|50635937|FG001|Overall Study|Other|1|||
25320050|NCT03072238|50635936|FG000|Overall Study|Ongoing on study|377|||
25320051|NCT03072238|50635937|FG001|Overall Study|Ongoing on study|367|||
25320052|NCT03032484|50635944|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
25320053|NCT03032484|50635945|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
25320054|NCT03032484|50635944|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
25320055|NCT03032484|50635945|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
25320056|NCT02975349|50635954|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
25320057|NCT02975349|50635955|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
25320058|NCT02975349|50635956|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
25320059|NCT02975349|50635957|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
25320060|NCT02975349|50635958|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
25320061|NCT02975349|50635959|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
25320062|NCT02975349|50635954|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
25320063|NCT02975349|50635955|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
25320064|NCT02975349|50635956|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
25320065|NCT02975349|50635957|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
25320066|NCT02975349|50635958|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
25320067|NCT02975349|50635959|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
25320068|NCT02975349|50635954|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
25320069|NCT02975349|50635955|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
25320070|NCT02975349|50635956|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
25237854|NCT01054885|50551786|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
25237855|NCT01054885|50551780|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
25237856|NCT01054885|50551781|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
25237857|NCT01054885|50551782|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
25320071|NCT02975349|50635957|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
25320072|NCT02975349|50635958|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
25320073|NCT02975349|50635959|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
25320074|NCT02975349|50635954|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
25237858|NCT01054885|50551783|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
25237859|NCT01054885|50551784|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
25237860|NCT01054885|50551785|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
25237861|NCT01054885|50551786|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
25237862|NCT01054885|50551780|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
25237863|NCT01054885|50551781|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
25237864|NCT01054885|50551782|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
25237865|NCT01054885|50551783|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
25237866|NCT01054885|50551784|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
25237867|NCT01054885|50551785|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
25237868|NCT01054885|50551786|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
25237869|NCT01054885|50551780|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
25237870|NCT01054885|50551781|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
25237871|NCT01054885|50551782|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
25237872|NCT01054885|50551783|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
25237873|NCT01054885|50551784|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
25237874|NCT01054885|50551785|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
25237875|NCT01054885|50551786|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
25237876|NCT01054885|50551780|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
25237877|NCT01054885|50551781|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
25237878|NCT01054885|50551782|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
25237879|NCT01054885|50551783|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
25237880|NCT01054885|50551784|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
25237881|NCT01054885|50551785|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
25237882|NCT01054885|50551786|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
25237883|NCT01054885|50551780|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
25237884|NCT01054885|50551781|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
25237885|NCT01054885|50551782|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
25237886|NCT01054885|50551783|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
25237887|NCT01054885|50551784|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
25237888|NCT01054885|50551785|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
25237889|NCT01054885|50551786|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
25237890|NCT01054885|50551780|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
25237891|NCT01054885|50551781|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
25237892|NCT01054885|50551782|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
25237893|NCT01054885|50551783|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
25237894|NCT01054885|50551784|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
25237895|NCT01054885|50551785|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
25237896|NCT01054885|50551786|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
25237897|NCT01054885|50551780|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
25237898|NCT01054885|50551781|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
25237899|NCT01054885|50551782|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
25237900|NCT01054885|50551783|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
25237901|NCT01054885|50551784|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
25237902|NCT01054885|50551785|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
25237903|NCT01054885|50551786|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
25237904|NCT01054885|50551780|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
25237905|NCT01054885|50551781|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
25237906|NCT01054885|50551782|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
25237907|NCT01054885|50551783|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
25237908|NCT01054885|50551784|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
25237909|NCT01054885|50551785|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
25237910|NCT01054885|50551786|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
25237911|NCT01054885|50551780|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
25237912|NCT01054885|50551781|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
25237913|NCT01054885|50551782|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
25237914|NCT01054885|50551783|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
25237915|NCT01054885|50551784|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
25237916|NCT01054885|50551785|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
25237917|NCT01054885|50551786|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
25237918|NCT01054885|50551780|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
25237919|NCT01054885|50551781|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
25237920|NCT01054885|50551782|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
25237921|NCT01054885|50551783|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
25237922|NCT01054885|50551784|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
25237923|NCT01054885|50551785|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
25237924|NCT01054885|50551786|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
25237925|NCT01054885|50551780|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
25237926|NCT01054885|50551781|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
25237927|NCT01054885|50551782|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
25237928|NCT01054885|50551783|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
25237929|NCT01054885|50551784|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
25237930|NCT01054885|50551785|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
25237931|NCT01054885|50551786|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
25237932|NCT01054885|50551780|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
25237933|NCT01054885|50551781|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
25237934|NCT01054885|50551782|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
25237935|NCT01054885|50551783|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
25237936|NCT01054885|50551784|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
25237937|NCT01054885|50551785|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
25237938|NCT01054885|50551786|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
25237939|NCT01054885|50551780|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
25237940|NCT01054885|50551781|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
25237941|NCT01054885|50551782|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
25237942|NCT01054885|50551783|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
25237943|NCT01054885|50551784|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
25237944|NCT01054885|50551785|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
25237945|NCT01054885|50551786|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
25237946|NCT01054885|50551780|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
25237947|NCT01054885|50551781|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
25237948|NCT01054885|50551782|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
25237949|NCT01054885|50551783|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
25237950|NCT01054885|50551784|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
25237951|NCT01054885|50551785|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
25237952|NCT01054885|50551786|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
25237953|NCT01054846|50551803|FG000|Overall Study|Lost to Follow-up|76|||
25237954|NCT01054846|50551804|FG001|Overall Study|Lost to Follow-up|17|||
25237955|NCT01054729|50551813|FG000|Overall Study|Randomized but Not Treated|0|||
25237956|NCT01054729|50551814|FG001|Overall Study|Randomized but Not Treated|1|||
25237957|NCT01054729|50551815|FG002|Overall Study|Randomized but Not Treated|0|||
25237958|NCT01054729|50551816|FG003|Overall Study|Randomized but Not Treated|0|||
25237959|NCT01054729|50551813|FG000|Overall Study|Adverse Event|1|||
25237960|NCT01054729|50551814|FG001|Overall Study|Adverse Event|1|||
25237961|NCT01054729|50551815|FG002|Overall Study|Adverse Event|2|||
25237962|NCT01054729|50551816|FG003|Overall Study|Adverse Event|1|||
25237963|NCT01054729|50551813|FG000|Overall Study|Withdrawal by Subject|1|||
25237964|NCT01054729|50551814|FG001|Overall Study|Withdrawal by Subject|0|||
25237965|NCT01054729|50551815|FG002|Overall Study|Withdrawal by Subject|1|||
25237966|NCT01054729|50551816|FG003|Overall Study|Withdrawal by Subject|0|||
25237967|NCT01054729|50551813|FG000|Overall Study|Lost to Follow-up|0|||
25237968|NCT01054729|50551814|FG001|Overall Study|Lost to Follow-up|1|||
25237969|NCT01054729|50551815|FG002|Overall Study|Lost to Follow-up|0|||
25237970|NCT01054729|50551816|FG003|Overall Study|Lost to Follow-up|0|||
25237971|NCT01054729|50551813|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
25237972|NCT01054729|50551814|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
25237973|NCT01054729|50551815|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
25237974|NCT01054729|50551816|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
25237975|NCT01054729|50551813|FG000|Overall Study|Non-responder|1|||
25237976|NCT01054729|50551814|FG001|Overall Study|Non-responder|0|||
25237977|NCT01054729|50551815|FG002|Overall Study|Non-responder|1|||
25237978|NCT01054729|50551816|FG003|Overall Study|Non-responder|1|||
25237979|NCT01054729|50551813|FG000|Overall Study|PEG/RBV Non-responder|1|||
25320075|NCT02975349|50635955|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
25320076|NCT02975349|50635956|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
25320077|NCT02975349|50635957|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
25237980|NCT01054729|50551814|FG001|Overall Study|PEG/RBV Non-responder|0|||
25237981|NCT01054729|50551815|FG002|Overall Study|PEG/RBV Non-responder|1|||
25237982|NCT01054729|50551816|FG003|Overall Study|PEG/RBV Non-responder|0|||
25237983|NCT01054729|50551813|FG000|Overall Study|Personal/Obligations|0|||
25237984|NCT01054729|50551814|FG001|Overall Study|Personal/Obligations|1|||
25237985|NCT01054729|50551815|FG002|Overall Study|Personal/Obligations|0|||
25320078|NCT02975349|50635958|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
25237986|NCT01054729|50551816|FG003|Overall Study|Personal/Obligations|0|||
25237987|NCT01054729|50551813|FG000|Overall Study|Subject moved|0|||
25237988|NCT01054729|50551814|FG001|Overall Study|Subject moved|0|||
25237989|NCT01054729|50551815|FG002|Overall Study|Subject moved|1|||
25237990|NCT01054729|50551816|FG003|Overall Study|Subject moved|0|||
25237991|NCT01054729|50551813|FG000|Overall Study|Lack of Efficacy|0|||
25237992|NCT01054729|50551814|FG001|Overall Study|Lack of Efficacy|0|||
25237993|NCT01054729|50551815|FG002|Overall Study|Lack of Efficacy|0|||
25237994|NCT01054729|50551816|FG003|Overall Study|Lack of Efficacy|1|||
25237995|NCT01054573|50551830|FG000|Overall Study|Adverse Event|1|||
25237996|NCT01054573|50551831|FG001|Overall Study|Adverse Event|0|||
25237997|NCT01054573|50551832|FG002|Overall Study|Adverse Event|1|||
25237998|NCT01054573|50551833|FG003|Overall Study|Adverse Event|1|||
25237999|NCT01054573|50551830|FG000|Overall Study|Lost to Follow-up|0|||
25238000|NCT01054573|50551831|FG001|Overall Study|Lost to Follow-up|2|||
25238001|NCT01054573|50551832|FG002|Overall Study|Lost to Follow-up|0|||
25238002|NCT01054573|50551833|FG003|Overall Study|Lost to Follow-up|0|||
25238003|NCT01054573|50551830|FG000|Overall Study|Withdrawal by Subject|0|||
25238004|NCT01054573|50551831|FG001|Overall Study|Withdrawal by Subject|2|||
25238005|NCT01054573|50551832|FG002|Overall Study|Withdrawal by Subject|2|||
25238006|NCT01054573|50551833|FG003|Overall Study|Withdrawal by Subject|1|||
25238007|NCT01054456|50551852|FG000|Overall Study|Other|1|||
25238008|NCT01054300|50551858|FG000|Period 1|Adverse Event|1|||
25238009|NCT01054300|50551859|FG001|Period 1|Adverse Event|0|||
25238010|NCT01054300|50551860|FG002|Period 1|Adverse Event|0|||
25238011|NCT01054300|50551861|FG003|Period 1|Adverse Event|0|||
25238012|NCT01054300|50551858|FG000|Period 2|Withdrawal by Subject|0|||
25238013|NCT01054300|50551859|FG001|Period 2|Withdrawal by Subject|0|||
25238014|NCT01054300|50551860|FG002|Period 2|Withdrawal by Subject|1|||
25238015|NCT01054300|50551861|FG003|Period 2|Withdrawal by Subject|0|||
25238016|NCT01053988|50551876|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
25238017|NCT01053988|50551877|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
25238018|NCT01053988|50551878|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
25238019|NCT01053988|50551879|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
25238020|NCT01053988|50551880|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
25238021|NCT01053988|50551881|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
24976843|NCT00048932|50065736|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
24976844|NCT00048932|50065737|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
24976845|NCT00048932|50065735|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
24976846|NCT00048932|50065736|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
24976847|NCT00048932|50065737|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
24976848|NCT00048932|50065735|FG000|Open Label Period (OL)|Death|0|||
24976849|NCT00048932|50065736|FG001|Open Label Period (OL)|Death|0|||
24976850|NCT00048932|50065737|FG002|Open Label Period (OL)|Death|25|||
24976851|NCT00048932|50065735|FG000|Open Label Period (OL)|Adverse Event|0|||
24976852|NCT00048932|50065736|FG001|Open Label Period (OL)|Adverse Event|0|||
24976853|NCT00048932|50065737|FG002|Open Label Period (OL)|Adverse Event|103|||
24976854|NCT00048932|50065735|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
24976855|NCT00048932|50065736|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
24976856|NCT00048932|50065737|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
24976857|NCT00048932|50065735|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
25238022|NCT01053988|50551876|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
25238023|NCT01053988|50551877|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
25238024|NCT01053988|50551878|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
25238025|NCT01053988|50551879|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
25238026|NCT01053988|50551880|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
25238027|NCT01053988|50551881|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
25238028|NCT01053988|50551876|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
25238029|NCT01053988|50551877|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
25238030|NCT01053988|50551878|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
25238031|NCT01053988|50551879|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
25238032|NCT01053988|50551880|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
25238033|NCT01053988|50551881|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
25238034|NCT01053988|50551876|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
25238035|NCT01053988|50551877|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
25238036|NCT01053988|50551878|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
25238037|NCT01053988|50551879|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
25238038|NCT01053988|50551880|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
25238039|NCT01053988|50551881|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
25238040|NCT01053988|50551876|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
25238041|NCT01053988|50551877|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
24976858|NCT00048932|50065736|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
25238042|NCT01053988|50551878|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
25238043|NCT01053988|50551879|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
25238044|NCT01053988|50551880|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
25238045|NCT01053988|50551881|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
25238046|NCT01053988|50551876|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
25238047|NCT01053988|50551877|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
25238048|NCT01053988|50551878|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
25238049|NCT01053988|50551879|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
25238050|NCT01053988|50551880|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
25238051|NCT01053988|50551881|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
25238052|NCT01053988|50551876|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
25238053|NCT01053988|50551877|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
25238054|NCT01053988|50551878|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
25238055|NCT01053988|50551879|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
25238056|NCT01053988|50551880|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
25238057|NCT01053988|50551881|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
25238058|NCT01053988|50551876|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
25238059|NCT01053988|50551877|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
25238060|NCT01053988|50551878|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
25238061|NCT01053988|50551879|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
25238062|NCT01053988|50551880|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
25238063|NCT01053988|50551881|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
25238064|NCT01053988|50551876|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
25238065|NCT01053988|50551877|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
25238066|NCT01053988|50551878|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
25238067|NCT01053988|50551879|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
25238068|NCT01053988|50551880|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
25238069|NCT01053988|50551881|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
25238070|NCT01053988|50551876|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
25238071|NCT01053988|50551877|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
25238072|NCT01053988|50551878|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
25238073|NCT01053988|50551879|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
25238074|NCT01053988|50551880|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
25238075|NCT01053988|50551881|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
25238076|NCT01053988|50551876|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
25238077|NCT01053988|50551877|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
25238078|NCT01053988|50551878|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
25238079|NCT01053988|50551879|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
25238080|NCT01053988|50551880|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
25238081|NCT01053988|50551881|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
25238082|NCT01053988|50551876|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
25238083|NCT01053988|50551877|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
25238084|NCT01053988|50551878|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
25238085|NCT01053988|50551879|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
25238086|NCT01053988|50551880|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
25238087|NCT01053988|50551881|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
25238088|NCT01053988|50551876|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
25238089|NCT01053988|50551877|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
25238090|NCT01053988|50551878|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
25238091|NCT01053988|50551879|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
25238092|NCT01053988|50551880|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
25238093|NCT01053988|50551881|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
25238094|NCT01053988|50551876|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
25238095|NCT01053988|50551877|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
25238096|NCT01053988|50551878|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
25238097|NCT01053988|50551879|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
25238098|NCT01053988|50551880|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
25238099|NCT01053988|50551881|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
25238100|NCT01053247|50551896|FG000|Overall Study|Withdrawal by Subject|9|||
25238101|NCT01053247|50551897|FG001|Overall Study|Withdrawal by Subject|4|||
25238102|NCT01053247|50551898|FG002|Overall Study|Withdrawal by Subject|15|||
25238103|NCT01053247|50551896|FG000|Overall Study|Lack of Efficacy|1|||
25238104|NCT01053247|50551897|FG001|Overall Study|Lack of Efficacy|0|||
25238105|NCT01053247|50551898|FG002|Overall Study|Lack of Efficacy|1|||
25238106|NCT01053247|50551896|FG000|Overall Study|Protocol Violation|2|||
25238107|NCT01053247|50551897|FG001|Overall Study|Protocol Violation|1|||
25238108|NCT01053247|50551898|FG002|Overall Study|Protocol Violation|2|||
25238109|NCT01053247|50551896|FG000|Overall Study|Lost to Follow-up|8|||
25238110|NCT01053247|50551897|FG001|Overall Study|Lost to Follow-up|5|||
25238111|NCT01053247|50551898|FG002|Overall Study|Lost to Follow-up|7|||
25238112|NCT01053247|50551896|FG000|Overall Study|Adverse Event|0|||
25238113|NCT01053247|50551897|FG001|Overall Study|Adverse Event|9|||
25238114|NCT01053247|50551898|FG002|Overall Study|Adverse Event|3|||
25238115|NCT01052779|50551908|FG000|Overall Study|Adverse Event|1|||
25238116|NCT01052779|50551909|FG001|Overall Study|Adverse Event|4|||
25238117|NCT01052779|50551908|FG000|Overall Study|Withdrawal by Subject|1|||
25238118|NCT01052779|50551909|FG001|Overall Study|Withdrawal by Subject|2|||
25238119|NCT01052779|50551908|FG000|Overall Study|Other-Protocol Violation|1|||
25238120|NCT01052779|50551909|FG001|Overall Study|Other-Protocol Violation|1|||
25238121|NCT01052779|50551908|FG000|Overall Study|Other-Surgery|0|||
25238122|NCT01052779|50551909|FG001|Overall Study|Other-Surgery|2|||
25238123|NCT01052779|50551908|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
25238124|NCT01052779|50551909|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
25238125|NCT01052662|50551918|FG000|Overall Study|Lost to Follow-up|15|||
25238126|NCT01052662|50551919|FG001|Overall Study|Lost to Follow-up|13|||
25238127|NCT01052662|50551920|FG002|Overall Study|Lost to Follow-up|18|||
25238128|NCT01052662|50551918|FG000|Overall Study|Withdrawal by Subject|3|||
25238129|NCT01052662|50551919|FG001|Overall Study|Withdrawal by Subject|2|||
25238130|NCT01052662|50551920|FG002|Overall Study|Withdrawal by Subject|1|||
25238131|NCT01052662|50551918|FG000|Overall Study|Pharmacy issue|1|||
25238132|NCT01052662|50551919|FG001|Overall Study|Pharmacy issue|3|||
25238133|NCT01052662|50551920|FG002|Overall Study|Pharmacy issue|3|||
25238134|NCT01052662|50551918|FG000|Overall Study|Adverse Event|1|||
25238135|NCT01052662|50551919|FG001|Overall Study|Adverse Event|1|||
25238136|NCT01052662|50551920|FG002|Overall Study|Adverse Event|0|||
25238137|NCT01052662|50551918|FG000|Overall Study|Legal Problem|2|||
25238138|NCT01052662|50551919|FG001|Overall Study|Legal Problem|0|||
25238139|NCT01052662|50551920|FG002|Overall Study|Legal Problem|0|||
25238140|NCT01052662|50551918|FG000|Overall Study|Administrative|0|||
25238141|NCT01052662|50551919|FG001|Overall Study|Administrative|3|||
25238142|NCT01052662|50551920|FG002|Overall Study|Administrative|0|||
25238143|NCT01052116|50551930|FG000|Overall Study|Lost to Follow-up|11|||
25238144|NCT01052116|50551931|FG001|Overall Study|Lost to Follow-up|17|||
25238145|NCT01052116|50551930|FG000|Overall Study|Withdrawal by Subject|3|||
25238146|NCT01052116|50551931|FG001|Overall Study|Withdrawal by Subject|6|||
25238147|NCT01052116|50551930|FG000|Overall Study|Spirometry not performed|0|||
25320079|NCT02975349|50635959|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
25320080|NCT02975349|50635954|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
25320081|NCT02975349|50635955|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
25320082|NCT02975349|50635956|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
25320083|NCT02975349|50635957|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
25320084|NCT02975349|50635958|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
25320085|NCT02975349|50635959|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
25320086|NCT02975349|50635954|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
25320087|NCT02975349|50635955|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
25320088|NCT02975349|50635956|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
25320089|NCT02975349|50635957|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
25320090|NCT02975349|50635958|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
25320091|NCT02975349|50635959|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
25320092|NCT02975349|50635954|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
25320093|NCT02975349|50635955|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
25320094|NCT02975349|50635956|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
25320095|NCT02975349|50635957|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
25320096|NCT02975349|50635958|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
24976859|NCT00048932|50065737|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
25238148|NCT01052116|50551931|FG001|Overall Study|Spirometry not performed|4|||
25238149|NCT01052077|50551939|FG000|Phase A|Lost to Follow-up|22|||
25238150|NCT01052077|50551940|FG001|Phase A|Lost to Follow-up|0|||
25238151|NCT01052077|50551941|FG002|Phase A|Lost to Follow-up|0|||
25238152|NCT01052077|50551942|FG003|Phase A|Lost to Follow-up|0|||
25238153|NCT01052077|50551939|FG000|Phase A|Adverse Event|32|||
25238154|NCT01052077|50551940|FG001|Phase A|Adverse Event|0|||
25238155|NCT01052077|50551941|FG002|Phase A|Adverse Event|0|||
25238156|NCT01052077|50551942|FG003|Phase A|Adverse Event|0|||
25238157|NCT01052077|50551939|FG000|Phase A|Met Withdrawal Criteria|26|||
25238158|NCT01052077|50551940|FG001|Phase A|Met Withdrawal Criteria|0|||
25238159|NCT01052077|50551941|FG002|Phase A|Met Withdrawal Criteria|0|||
25238160|NCT01052077|50551942|FG003|Phase A|Met Withdrawal Criteria|0|||
25238161|NCT01052077|50551939|FG000|Phase A|Physician Decision|10|||
25238162|NCT01052077|50551940|FG001|Phase A|Physician Decision|0|||
25238163|NCT01052077|50551941|FG002|Phase A|Physician Decision|0|||
25238164|NCT01052077|50551942|FG003|Phase A|Physician Decision|0|||
25238165|NCT01052077|50551939|FG000|Phase A|Withdrawal by Subject|29|||
25238166|NCT01052077|50551940|FG001|Phase A|Withdrawal by Subject|0|||
25238167|NCT01052077|50551941|FG002|Phase A|Withdrawal by Subject|0|||
25238168|NCT01052077|50551942|FG003|Phase A|Withdrawal by Subject|0|||
25238169|NCT01052077|50551939|FG000|Phase A|Protocol Deviation|27|||
25238170|NCT01052077|50551940|FG001|Phase A|Protocol Deviation|0|||
25238171|NCT01052077|50551941|FG002|Phase A|Protocol Deviation|0|||
25238172|NCT01052077|50551942|FG003|Phase A|Protocol Deviation|0|||
25238173|NCT01052077|50551939|FG000|Phase B|Lost to Follow-up|0|||
25238174|NCT01052077|50551940|FG001|Phase B|Lost to Follow-up|2|||
25238175|NCT01052077|50551941|FG002|Phase B|Lost to Follow-up|3|||
25238176|NCT01052077|50551942|FG003|Phase B|Lost to Follow-up|0|||
25238177|NCT01052077|50551939|FG000|Phase B|Adverse Event|0|||
25238178|NCT01052077|50551940|FG001|Phase B|Adverse Event|9|||
25238179|NCT01052077|50551941|FG002|Phase B|Adverse Event|2|||
25238180|NCT01052077|50551942|FG003|Phase B|Adverse Event|0|||
25238181|NCT01052077|50551939|FG000|Phase B|Met Withdrawal Criteria|0|||
25238182|NCT01052077|50551940|FG001|Phase B|Met Withdrawal Criteria|2|||
25238183|NCT01052077|50551941|FG002|Phase B|Met Withdrawal Criteria|1|||
25238184|NCT01052077|50551942|FG003|Phase B|Met Withdrawal Criteria|0|||
25238185|NCT01052077|50551939|FG000|Phase B|Physician Decision|0|||
25238186|NCT01052077|50551940|FG001|Phase B|Physician Decision|1|||
25238187|NCT01052077|50551941|FG002|Phase B|Physician Decision|1|||
25238188|NCT01052077|50551942|FG003|Phase B|Physician Decision|0|||
25238189|NCT01052077|50551939|FG000|Phase B|Withdrawal by Subject|0|||
25238190|NCT01052077|50551940|FG001|Phase B|Withdrawal by Subject|0|||
25238191|NCT01052077|50551941|FG002|Phase B|Withdrawal by Subject|5|||
25238192|NCT01052077|50551942|FG003|Phase B|Withdrawal by Subject|0|||
25238193|NCT01052077|50551939|FG000|Phase B|Protocol Deviation|0|||
25238194|NCT01052077|50551940|FG001|Phase B|Protocol Deviation|3|||
25238195|NCT01052077|50551941|FG002|Phase B|Protocol Deviation|4|||
25238196|NCT01052077|50551942|FG003|Phase B|Protocol Deviation|0|||
25238197|NCT01052077|50551939|FG000|Phase B|Lack of Efficacy|0|||
25238198|NCT01052077|50551940|FG001|Phase B|Lack of Efficacy|1|||
25238199|NCT01052077|50551941|FG002|Phase B|Lack of Efficacy|0|||
25238200|NCT01052077|50551942|FG003|Phase B|Lack of Efficacy|0|||
25238201|NCT01052077|50551939|FG000|Phase A+|Lost to Follow-up|0|||
25238202|NCT01052077|50551940|FG001|Phase A+|Lost to Follow-up|0|||
25238203|NCT01052077|50551941|FG002|Phase A+|Lost to Follow-up|0|||
25238204|NCT01052077|50551942|FG003|Phase A+|Lost to Follow-up|8|||
25238205|NCT01052077|50551939|FG000|Phase A+|Adverse Event|0|||
25238206|NCT01052077|50551940|FG001|Phase A+|Adverse Event|0|||
25238207|NCT01052077|50551941|FG002|Phase A+|Adverse Event|0|||
25238208|NCT01052077|50551942|FG003|Phase A+|Adverse Event|4|||
25238209|NCT01052077|50551939|FG000|Phase A+|Met Withdrawal Criteria|0|||
25238210|NCT01052077|50551940|FG001|Phase A+|Met Withdrawal Criteria|0|||
25238211|NCT01052077|50551941|FG002|Phase A+|Met Withdrawal Criteria|0|||
25238212|NCT01052077|50551942|FG003|Phase A+|Met Withdrawal Criteria|2|||
25238213|NCT01052077|50551939|FG000|Phase A+|Withdrawal by Subject|0|||
25238214|NCT01052077|50551940|FG001|Phase A+|Withdrawal by Subject|0|||
25238215|NCT01052077|50551941|FG002|Phase A+|Withdrawal by Subject|0|||
25238216|NCT01052077|50551942|FG003|Phase A+|Withdrawal by Subject|7|||
25238217|NCT01052038|50551951|FG000|Overall Study|Lost to Follow-up|2|||
25238218|NCT01052038|50551952|FG001|Overall Study|Lost to Follow-up|3|||
25238219|NCT01052038|50551953|FG002|Overall Study|Lost to Follow-up|1|||
25238220|NCT01052038|50551951|FG000|Overall Study|Protocol Violation|2|||
25238221|NCT01052038|50551952|FG001|Overall Study|Protocol Violation|3|||
25238222|NCT01052038|50551953|FG002|Overall Study|Protocol Violation|3|||
25238223|NCT01051960|50551961|FG000|Overall Study|Adverse Event|1|||
25320097|NCT02975349|50635959|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
25320098|NCT02975349|50635954|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
25320099|NCT02975349|50635955|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
24976860|NCT00048932|50065735|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
25238224|NCT01051921|50551965|FG000|Overall Study|Physician Decision|9|||
25238225|NCT01051921|50551965|FG000|Overall Study|Adverse Event|8|||
25238226|NCT01051921|50551965|FG000|Overall Study|Withdrawal by Subject|7|||
25238227|NCT01051921|50551965|FG000|Overall Study|Lost to Follow-up|4|||
25238228|NCT01051921|50551965|FG000|Overall Study|virological failure|1|||
25238229|NCT01051921|50551965|FG000|Overall Study|patient moved|1|||
25238230|NCT01051063|50551971|FG000|Overall Study|Death|2|||
25238231|NCT01051063|50551972|FG001|Overall Study|Death|2|||
25238232|NCT01051063|50551971|FG000|Overall Study|Withdrawal by Subject|1|||
25238233|NCT01051063|50551972|FG001|Overall Study|Withdrawal by Subject|1|||
25238234|NCT01051063|50551971|FG000|Overall Study|Termination of the study|5|||
25238235|NCT01051063|50551972|FG001|Overall Study|Termination of the study|0|||
25238236|NCT01051063|50551971|FG000|Overall Study|Moved from the study site area|1|||
25238237|NCT01051063|50551972|FG001|Overall Study|Moved from the study site area|0|||
25238238|NCT01051063|50551971|FG000|Overall Study|Other|1|||
25238239|NCT01051063|50551972|FG001|Overall Study|Other|0|||
25238240|NCT01051063|50551971|FG000|Overall Study|Lost to Follow-up|0|||
25238241|NCT01051063|50551972|FG001|Overall Study|Lost to Follow-up|1|||
25238242|NCT01050790|50551979|FG000|Overall Study|Adverse Event|1|||
25238243|NCT01050673|50551986|FG000|Overall Study|Physician Decision|4|||
25238244|NCT01050673|50551987|FG001|Overall Study|Physician Decision|5|||
25238245|NCT01050205|50551995|FG000|Overall Study|Lost to Follow-up|7|||
25238246|NCT01050205|50551996|FG001|Overall Study|Lost to Follow-up|1|||
25238247|NCT01050205|50551995|FG000|Overall Study|Withdrawal by Subject|1|||
25238248|NCT01050205|50551996|FG001|Overall Study|Withdrawal by Subject|1|||
25238249|NCT01050205|50551995|FG000|Overall Study|Relocated from area|1|||
25238250|NCT01050205|50551996|FG001|Overall Study|Relocated from area|2|||
25238251|NCT01050205|50551995|FG000|Overall Study|Discontinued Intervention|2|||
25238252|NCT01050205|50551996|FG001|Overall Study|Discontinued Intervention|0|||
25238253|NCT01059448|50552006|FG000|Overall Study|Adverse Event|1|||
25238254|NCT01059448|50552007|FG001|Overall Study|Adverse Event|3|||
25238255|NCT01059448|50552008|FG002|Overall Study|Adverse Event|0|||
25238256|NCT01059448|50552009|FG003|Overall Study|Adverse Event|1|||
25238257|NCT01059448|50552006|FG000|Overall Study|Withdrawal by Subject|2|||
25238258|NCT01059448|50552007|FG001|Overall Study|Withdrawal by Subject|0|||
25238259|NCT01059448|50552008|FG002|Overall Study|Withdrawal by Subject|2|||
25238260|NCT01059448|50552009|FG003|Overall Study|Withdrawal by Subject|4|||
25238261|NCT01059448|50552006|FG000|Overall Study|Disease Progression|2|||
25238262|NCT01059448|50552007|FG001|Overall Study|Disease Progression|1|||
25238263|NCT01059448|50552008|FG002|Overall Study|Disease Progression|4|||
25238264|NCT01059448|50552009|FG003|Overall Study|Disease Progression|2|||
25238265|NCT01059448|50552006|FG000|Overall Study|Administrative Decision|43|||
25238266|NCT01059448|50552007|FG001|Overall Study|Administrative Decision|49|||
25238267|NCT01059448|50552008|FG002|Overall Study|Administrative Decision|45|||
25238268|NCT01059448|50552009|FG003|Overall Study|Administrative Decision|46|||
25238269|NCT01059448|50552006|FG000|Overall Study|Lost to Follow-up|0|||
25238270|NCT01059448|50552007|FG001|Overall Study|Lost to Follow-up|0|||
25238271|NCT01059448|50552008|FG002|Overall Study|Lost to Follow-up|2|||
25238272|NCT01059448|50552009|FG003|Overall Study|Lost to Follow-up|0|||
25238273|NCT01059448|50552006|FG000|Overall Study|Death|0|||
25238274|NCT01059448|50552007|FG001|Overall Study|Death|1|||
25238275|NCT01059448|50552008|FG002|Overall Study|Death|0|||
25238276|NCT01059448|50552009|FG003|Overall Study|Death|0|||
25238277|NCT01059448|50552006|FG000|Overall Study|Other|1|||
25238278|NCT01059448|50552007|FG001|Overall Study|Other|1|||
25238279|NCT01059448|50552008|FG002|Overall Study|Other|0|||
25238280|NCT01059448|50552009|FG003|Overall Study|Other|1|||
25238281|NCT01058707|50552026|FG000|Overall Study|Disease Progression|15|||
25238282|NCT01058707|50552027|FG001|Overall Study|Disease Progression|20|||
25238283|NCT01058707|50552028|FG002|Overall Study|Disease Progression|20|||
25238284|NCT01058707|50552029|FG003|Overall Study|Disease Progression|15|||
25238285|NCT01058707|50552030|FG004|Overall Study|Disease Progression|23|||
25238286|NCT01058707|50552031|FG005|Overall Study|Disease Progression|10|||
25238287|NCT01058707|50552032|FG006|Overall Study|Disease Progression|12|||
25238288|NCT01058707|50552026|FG000|Overall Study|Adverse Event|11|||
25238289|NCT01058707|50552027|FG001|Overall Study|Adverse Event|4|||
25238290|NCT01058707|50552028|FG002|Overall Study|Adverse Event|7|||
25238291|NCT01058707|50552029|FG003|Overall Study|Adverse Event|6|||
25238292|NCT01058707|50552030|FG004|Overall Study|Adverse Event|7|||
25238293|NCT01058707|50552031|FG005|Overall Study|Adverse Event|3|||
25238294|NCT01058707|50552032|FG006|Overall Study|Adverse Event|1|||
25320100|NCT02975349|50635956|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
25320101|NCT02975349|50635957|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
25320102|NCT02975349|50635958|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
25320103|NCT02975349|50635959|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
25320104|NCT02975349|50635954|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
25320105|NCT02975349|50635955|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
25320106|NCT02975349|50635956|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
25238295|NCT01058707|50552026|FG000|Overall Study|Subject Decision|5|||
25238296|NCT01058707|50552027|FG001|Overall Study|Subject Decision|3|||
25238297|NCT01058707|50552028|FG002|Overall Study|Subject Decision|3|||
25238298|NCT01058707|50552029|FG003|Overall Study|Subject Decision|1|||
25238299|NCT01058707|50552030|FG004|Overall Study|Subject Decision|2|||
25238300|NCT01058707|50552031|FG005|Overall Study|Subject Decision|3|||
25238301|NCT01058707|50552032|FG006|Overall Study|Subject Decision|6|||
25238302|NCT01058707|50552026|FG000|Overall Study|Lost to Follow-up|0|||
25238303|NCT01058707|50552027|FG001|Overall Study|Lost to Follow-up|0|||
25238304|NCT01058707|50552028|FG002|Overall Study|Lost to Follow-up|1|||
25238305|NCT01058707|50552029|FG003|Overall Study|Lost to Follow-up|0|||
25238306|NCT01058707|50552030|FG004|Overall Study|Lost to Follow-up|0|||
25238307|NCT01058707|50552031|FG005|Overall Study|Lost to Follow-up|0|||
25238308|NCT01058707|50552032|FG006|Overall Study|Lost to Follow-up|0|||
25238309|NCT01058707|50552026|FG000|Overall Study|Reason Not Specified|0|||
25238310|NCT01058707|50552027|FG001|Overall Study|Reason Not Specified|3|||
25238311|NCT01058707|50552028|FG002|Overall Study|Reason Not Specified|2|||
25238312|NCT01058707|50552029|FG003|Overall Study|Reason Not Specified|0|||
25238313|NCT01058707|50552030|FG004|Overall Study|Reason Not Specified|7|||
25238314|NCT01058707|50552031|FG005|Overall Study|Reason Not Specified|1|||
25238315|NCT01058707|50552032|FG006|Overall Study|Reason Not Specified|7|||
25238316|NCT01054144|50552070|FG000|Overall Study|Death|2|||
25238317|NCT00105586|50552079|FG000|Overall Study|Adverse Event|4|||
25238318|NCT00105586|50552080|FG001|Overall Study|Adverse Event|3|||
25238319|NCT00105586|50552079|FG000|Overall Study|Physician Decision|13|||
25238320|NCT00105586|50552080|FG001|Overall Study|Physician Decision|13|||
25238321|NCT01059643|50552088|FG000|Overall Study|Adverse Event|3|||
25238322|NCT01059643|50552088|FG000|Overall Study|Withdrawal by Subject|2|||
25238323|NCT01059643|50552088|FG000|Overall Study|Physician Decision|1|||
25238324|NCT01059565|50552097|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
25238325|NCT01059565|50552098|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
25238326|NCT01059565|50552097|FG000|24-Week Randomized Phase|Adverse Event|5|||
25238327|NCT01059565|50552098|FG001|24-Week Randomized Phase|Adverse Event|0|||
25238328|NCT01059565|50552097|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
25238329|NCT01059565|50552098|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
25238330|NCT01059565|50552097|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
25238331|NCT01059565|50552098|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
25238332|NCT01059565|50552097|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
25238333|NCT01059565|50552098|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
25238334|NCT01059565|50552097|FG000|24-Week Open-Label Phase|Adverse Event|2|||
25238335|NCT01059565|50552098|FG001|24-Week Open-Label Phase|Adverse Event|0|||
25238336|NCT01059565|50552097|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
25238337|NCT01059565|50552098|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
25238338|NCT01059565|50552097|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
25238339|NCT01059565|50552098|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
25238340|NCT01059565|50552097|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
25238341|NCT01059565|50552098|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
25238342|NCT01059565|50552097|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
25238343|NCT01059565|50552098|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
25238344|NCT01059565|50552097|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
25238345|NCT01059565|50552098|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
25238346|NCT01059526|50552108|FG000|Overall Study|Patient enrolled but not treated|20|||
25238347|NCT01059526|50552109|FG001|Overall Study|Patient enrolled but not treated|17|||
25238348|NCT01059526|50552108|FG000|Overall Study|Adverse Event|2|||
25238349|NCT01059526|50552109|FG001|Overall Study|Adverse Event|2|||
25238350|NCT01059526|50552108|FG000|Overall Study|Protocol Violation|0|||
25238351|NCT01059526|50552109|FG001|Overall Study|Protocol Violation|1|||
25238352|NCT01059526|50552108|FG000|Overall Study|Withdrawal by Subject|3|||
25238353|NCT01059526|50552109|FG001|Overall Study|Withdrawal by Subject|1|||
25238354|NCT01059526|50552108|FG000|Overall Study|Lost to Follow-up|4|||
25238355|NCT01059526|50552109|FG001|Overall Study|Lost to Follow-up|1|||
25238356|NCT01059526|50552108|FG000|Overall Study|Patient found to be dermatographic|1|||
25238357|NCT01059526|50552109|FG001|Overall Study|Patient found to be dermatographic|0|||
25238358|NCT03277261|50552117|FG000|Overall Study|Adverse Event|17|||
25238359|NCT03277261|50552118|FG001|Overall Study|Adverse Event|1|||
25238360|NCT03277261|50552117|FG000|Overall Study|Participant Withdrawal of Consent|6|||
25238361|NCT03277261|50552118|FG001|Overall Study|Participant Withdrawal of Consent|15|||
25238362|NCT03277261|50552117|FG000|Overall Study|Investigator / Sponsor Decision|4|||
25238363|NCT03277261|50552118|FG001|Overall Study|Investigator / Sponsor Decision|2|||
25238364|NCT03277261|50552117|FG000|Overall Study|Pregnancy|2|||
25238365|NCT03277261|50552118|FG001|Overall Study|Pregnancy|0|||
25238366|NCT03277261|50552117|FG000|Overall Study|Lost to Follow-up|2|||
25238367|NCT03277261|50552118|FG001|Overall Study|Lost to Follow-up|2|||
25238368|NCT03277261|50552117|FG000|Overall Study|Lack of Efficacy|2|||
25238369|NCT03277261|50552118|FG001|Overall Study|Lack of Efficacy|2|||
25238370|NCT03277261|50552117|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
25238371|NCT03277261|50552118|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
25238372|NCT03277690|50552140|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
25238373|NCT03277690|50552141|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
25238374|NCT03277690|50552140|FG000|Dose Titration and Maintenance|Physician Decision|1|||
25238375|NCT03277690|50552141|FG001|Dose Titration and Maintenance|Physician Decision|0|||
25238376|NCT03277690|50552140|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
25238377|NCT03277690|50552141|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
25238378|NCT03277690|50552140|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
25238379|NCT03277690|50552141|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
25238380|NCT03277690|50552140|FG000|Dose Titration and Maintenance|Adverse Event|15|||
25238381|NCT03277690|50552141|FG001|Dose Titration and Maintenance|Adverse Event|0|||
25238382|NCT03277690|50552140|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
25238383|NCT03277690|50552141|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
25320107|NCT02975349|50635957|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
25320108|NCT02975349|50635958|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
25320109|NCT02975349|50635959|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
25320110|NCT02520141|50636030|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
25320111|NCT02513394|50636038|FG000|Overall Study|Withdrawal by Subject|11|||
25320112|NCT02513394|50636039|FG001|Overall Study|Withdrawal by Subject|23|||
25320113|NCT02513394|50636038|FG000|Overall Study|Ineligible|1|||
25320114|NCT02513394|50636039|FG001|Overall Study|Ineligible|0|||
25320115|NCT02329847|50636051|FG000|Overall Study|Death|4|||
25320116|NCT02329847|50636052|FG001|Overall Study|Death|4|||
25320117|NCT02329847|50636053|FG002|Overall Study|Death|22|||
25320118|NCT02329847|50636054|FG003|Overall Study|Death|12|||
25320119|NCT02329847|50636055|FG004|Overall Study|Death|20|||
25320120|NCT02329847|50636056|FG005|Overall Study|Death|13|||
25320121|NCT02329847|50636051|FG000|Overall Study|Lost to Follow-up|0|||
25320122|NCT02329847|50636052|FG001|Overall Study|Lost to Follow-up|0|||
25320123|NCT02329847|50636053|FG002|Overall Study|Lost to Follow-up|2|||
25320124|NCT02329847|50636054|FG003|Overall Study|Lost to Follow-up|3|||
25320125|NCT02329847|50636055|FG004|Overall Study|Lost to Follow-up|0|||
25320126|NCT02329847|50636056|FG005|Overall Study|Lost to Follow-up|1|||
25320127|NCT02329847|50636051|FG000|Overall Study|Physician Decision|0|||
25320128|NCT02329847|50636052|FG001|Overall Study|Physician Decision|0|||
25320129|NCT02329847|50636053|FG002|Overall Study|Physician Decision|0|||
25320130|NCT02329847|50636054|FG003|Overall Study|Physician Decision|0|||
25320131|NCT02329847|50636055|FG004|Overall Study|Physician Decision|1|||
25320132|NCT02329847|50636056|FG005|Overall Study|Physician Decision|0|||
25320133|NCT02329847|50636051|FG000|Overall Study|Withdrawal by Subject|2|||
25320134|NCT02329847|50636052|FG001|Overall Study|Withdrawal by Subject|1|||
25320135|NCT02329847|50636053|FG002|Overall Study|Withdrawal by Subject|5|||
25320136|NCT02329847|50636054|FG003|Overall Study|Withdrawal by Subject|7|||
25320137|NCT02329847|50636055|FG004|Overall Study|Withdrawal by Subject|8|||
25320138|NCT02329847|50636056|FG005|Overall Study|Withdrawal by Subject|3|||
25320139|NCT02329847|50636051|FG000|Overall Study|Other|1|||
25320140|NCT02329847|50636052|FG001|Overall Study|Other|2|||
25320141|NCT02329847|50636053|FG002|Overall Study|Other|6|||
25320142|NCT02329847|50636054|FG003|Overall Study|Other|13|||
25320143|NCT02329847|50636055|FG004|Overall Study|Other|10|||
25320144|NCT02329847|50636056|FG005|Overall Study|Other|3|||
25320145|NCT02314624|50636077|FG000|Overall Study|No participating patient|16|||
25320146|NCT02314624|50636078|FG001|Overall Study|No participating patient|13|||
25320147|NCT02314624|50636077|FG000|Overall Study|Participant withdrew|7|||
25320148|NCT02314624|50636078|FG001|Overall Study|Participant withdrew|2|||
25320149|NCT02314624|50636077|FG000|Overall Study|Lost to Follow-up|2|||
25320150|NCT02314624|50636078|FG001|Overall Study|Lost to Follow-up|5|||
25320151|NCT02314624|50636077|FG000|Overall Study|Dropped/Excluded by PI|6|||
25320152|NCT02314624|50636078|FG001|Overall Study|Dropped/Excluded by PI|6|||
25320153|NCT02017717|50636103|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
25320154|NCT02017717|50636104|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
25320155|NCT02017717|50636105|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
25320156|NCT02017717|50636106|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
25320157|NCT02017717|50636107|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
25320158|NCT02017717|50636108|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
25320159|NCT02017717|50636109|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
25320160|NCT02017717|50636110|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
25320161|NCT02017717|50636111|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
25320162|NCT02017717|50636103|FG000|Before Treatment Period|Participant request to stop therapy|0|||
25238384|NCT03277690|50552140|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
25238385|NCT03277690|50552141|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
25320163|NCT02017717|50636104|FG001|Before Treatment Period|Participant request to stop therapy|0|||
25320164|NCT02017717|50636105|FG002|Before Treatment Period|Participant request to stop therapy|0|||
25320165|NCT02017717|50636106|FG003|Before Treatment Period|Participant request to stop therapy|0|||
25320166|NCT02017717|50636107|FG004|Before Treatment Period|Participant request to stop therapy|5|||
25320167|NCT02017717|50636108|FG005|Before Treatment Period|Participant request to stop therapy|0|||
25320168|NCT02017717|50636109|FG006|Before Treatment Period|Participant request to stop therapy|0|||
25320169|NCT02017717|50636110|FG007|Before Treatment Period|Participant request to stop therapy|0|||
25238386|NCT03271021|50552150|FG000|Overall Study|Adverse Event|3|||
25238387|NCT03271021|50552151|FG001|Overall Study|Adverse Event|2|||
25238388|NCT03271021|50552150|FG000|Overall Study|Withdrawal by Subject|36|||
25238389|NCT03271021|50552151|FG001|Overall Study|Withdrawal by Subject|53|||
25238390|NCT03271021|50552150|FG000|Overall Study|Lost to Follow-up|34|||
25238391|NCT03271021|50552151|FG001|Overall Study|Lost to Follow-up|39|||
25238392|NCT03271021|50552150|FG000|Overall Study|Protocol Violation|6|||
25238393|NCT03271021|50552151|FG001|Overall Study|Protocol Violation|4|||
25238394|NCT03271021|50552150|FG000|Overall Study|Abnormal Lab Results|1|||
25238395|NCT03271021|50552151|FG001|Overall Study|Abnormal Lab Results|0|||
25238396|NCT03271021|50552150|FG000|Overall Study|Miscellaneous|9|||
25238397|NCT03271021|50552151|FG001|Overall Study|Miscellaneous|8|||
25238398|NCT01249651|50552172|FG000|Overall Study|Withdrawal by Subject|4|||
25238399|NCT01249651|50552172|FG000|Overall Study|Adverse Event|1|||
25238400|NCT01249651|50552172|FG000|Overall Study|Protocol Violation|1|||
25238401|NCT01249651|50552172|FG000|Overall Study|Sponsor Decision|1|||
25238402|NCT01249417|50552179|FG000|Randomised Population|Study treatment not received|0|||
25238403|NCT01249417|50552180|FG001|Randomised Population|Study treatment not received|0|||
25238404|NCT01249417|50552181|FG002|Randomised Population|Study treatment not received|2|||
25238405|NCT01249417|50552179|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
25238406|NCT01249417|50552180|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
25238407|NCT01249417|50552181|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
25238408|NCT01249417|50552179|FG000|Treatment Phase - ITT Population|Other|0|||
25238409|NCT01249417|50552180|FG001|Treatment Phase - ITT Population|Other|0|||
25238410|NCT01249417|50552181|FG002|Treatment Phase - ITT Population|Other|1|||
25238411|NCT01249417|50552179|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
25238412|NCT01249417|50552180|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
25238413|NCT01249417|50552181|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
25238414|NCT01249417|50552179|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
25238415|NCT01249417|50552180|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
25238416|NCT01249417|50552181|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
25238417|NCT01249417|50552179|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
25238418|NCT01249417|50552180|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
25238419|NCT01249417|50552181|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
25238420|NCT01249261|50552191|FG000|Overall Study|Withdrawal by Subject|1|||
25238421|NCT01249261|50552192|FG001|Overall Study|Withdrawal by Subject|0|||
25238422|NCT01248949|50552212|FG000|Overall Study|Lost to Follow-up|2|||
25238423|NCT01248949|50552213|FG001|Overall Study|Lost to Follow-up|2|||
25238424|NCT01248949|50552214|FG002|Overall Study|Lost to Follow-up|2|||
25238425|NCT01248949|50552215|FG003|Overall Study|Lost to Follow-up|1|||
25238426|NCT01248949|50552216|FG004|Overall Study|Lost to Follow-up|0|||
25238427|NCT01248949|50552212|FG000|Overall Study|Withdrawal by Subject|5|||
25238428|NCT01248949|50552213|FG001|Overall Study|Withdrawal by Subject|3|||
25238429|NCT01248949|50552214|FG002|Overall Study|Withdrawal by Subject|11|||
25238430|NCT01248949|50552215|FG003|Overall Study|Withdrawal by Subject|3|||
25238431|NCT01248949|50552216|FG004|Overall Study|Withdrawal by Subject|1|||
25238432|NCT01248949|50552212|FG000|Overall Study|Death|22|||
25238433|NCT01248949|50552213|FG001|Overall Study|Death|7|||
25238434|NCT01248949|50552214|FG002|Overall Study|Death|21|||
25238435|NCT01248949|50552215|FG003|Overall Study|Death|6|||
25238436|NCT01248949|50552216|FG004|Overall Study|Death|2|||
25238437|NCT01248949|50552212|FG000|Overall Study|Alternative Therapy|1|||
25238438|NCT01248949|50552213|FG001|Overall Study|Alternative Therapy|0|||
25238439|NCT01248949|50552214|FG002|Overall Study|Alternative Therapy|0|||
25238440|NCT01248949|50552215|FG003|Overall Study|Alternative Therapy|0|||
25238441|NCT01248949|50552216|FG004|Overall Study|Alternative Therapy|0|||
25238442|NCT01248949|50552212|FG000|Overall Study|Alternative Therapy.|1|||
25238443|NCT01248949|50552213|FG001|Overall Study|Alternative Therapy.|0|||
25238444|NCT01248949|50552214|FG002|Overall Study|Alternative Therapy.|0|||
25238445|NCT01248949|50552215|FG003|Overall Study|Alternative Therapy.|0|||
25238446|NCT01248949|50552216|FG004|Overall Study|Alternative Therapy.|0|||
25320170|NCT02017717|50636111|FG008|Before Treatment Period|Participant request to stop therapy|0|||
25238447|NCT01248949|50552212|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
25238448|NCT01248949|50552213|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
25238449|NCT01248949|50552214|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
25238450|NCT01248949|50552215|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
25238451|NCT01248949|50552216|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
25238452|NCT01248949|50552212|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
25238453|NCT01248949|50552213|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
25238454|NCT01248949|50552214|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
25238455|NCT01248949|50552215|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
25238456|NCT01248949|50552216|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
25238457|NCT01248949|50552212|FG000|Overall Study|Participant Went To Hospice|0|||
25238458|NCT01248949|50552213|FG001|Overall Study|Participant Went To Hospice|0|||
25238459|NCT01248949|50552214|FG002|Overall Study|Participant Went To Hospice|1|||
25238460|NCT01248949|50552215|FG003|Overall Study|Participant Went To Hospice|0|||
25238461|NCT01248949|50552216|FG004|Overall Study|Participant Went To Hospice|0|||
25238462|NCT01248949|50552212|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
25238463|NCT01248949|50552213|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
25238464|NCT01248949|50552214|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
25238465|NCT01248949|50552215|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
25238466|NCT01248949|50552216|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
25238467|NCT01248949|50552212|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
25238468|NCT01248949|50552213|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
25238469|NCT01248949|50552214|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
25238470|NCT01248949|50552215|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
25238471|NCT01248949|50552216|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
25238472|NCT01248949|50552212|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
25238473|NCT01248949|50552213|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
25238474|NCT01248949|50552214|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
25238475|NCT01248949|50552215|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
25238476|NCT01248949|50552216|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
25238477|NCT01248949|50552212|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
25238478|NCT01248949|50552213|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
25238479|NCT01248949|50552214|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
25238480|NCT01248949|50552215|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
25238481|NCT01248949|50552216|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
25238482|NCT01248793|50552230|FG000|Overall Study|Lost to Follow-up|0|||
25238483|NCT01248793|50552231|FG001|Overall Study|Lost to Follow-up|1|||
25238484|NCT01248793|50552230|FG000|Overall Study|Adverse Event|1|||
25238485|NCT01248793|50552231|FG001|Overall Study|Adverse Event|1|||
25238486|NCT01248793|50552230|FG000|Overall Study|Protocol Violation|0|||
25238487|NCT01248793|50552231|FG001|Overall Study|Protocol Violation|1|||
25238488|NCT01248793|50552230|FG000|Overall Study|Withdrawal by Subject|3|||
25238489|NCT01248793|50552231|FG001|Overall Study|Withdrawal by Subject|3|||
25238490|NCT01248364|50552241|FG000|Overall Study|Adverse Event|0|||
25238491|NCT01248364|50552242|FG001|Overall Study|Adverse Event|1|||
25238492|NCT01248364|50552243|FG002|Overall Study|Adverse Event|0|||
25238493|NCT01248364|50552244|FG003|Overall Study|Adverse Event|0|||
25238494|NCT01248130|50552256|FG000|Overall Study|Protocol Violation|1|||
25238495|NCT01248130|50552257|FG001|Overall Study|Protocol Violation|0|||
25238496|NCT01248130|50552256|FG000|Overall Study|Ineligible|1|||
25238497|NCT01248130|50552257|FG001|Overall Study|Ineligible|0|||
25238498|NCT01248013|50552263|FG000|Overall Study|Withdrawal by Subject|14|||
25238499|NCT01247350|50552272|FG000|Overall Study|Adverse Event|0|||
25238500|NCT01247350|50552273|FG001|Overall Study|Adverse Event|0|||
25238501|NCT01247350|50552274|FG002|Overall Study|Adverse Event|1|||
25238502|NCT01247350|50552275|FG003|Overall Study|Adverse Event|0|||
25238503|NCT01247350|50552276|FG004|Overall Study|Adverse Event|0|||
25238504|NCT01247350|50552272|FG000|Overall Study|Withdrawal by Subject|0|||
25238505|NCT01247350|50552273|FG001|Overall Study|Withdrawal by Subject|0|||
25238506|NCT01247350|50552274|FG002|Overall Study|Withdrawal by Subject|0|||
25238507|NCT01247350|50552275|FG003|Overall Study|Withdrawal by Subject|1|||
25238508|NCT01247350|50552276|FG004|Overall Study|Withdrawal by Subject|0|||
25238509|NCT01247350|50552272|FG000|Overall Study|Entry criteria not met|0|||
25238510|NCT01247350|50552273|FG001|Overall Study|Entry criteria not met|0|||
25238511|NCT01247350|50552274|FG002|Overall Study|Entry criteria not met|0|||
25238512|NCT01247350|50552275|FG003|Overall Study|Entry criteria not met|0|||
25238513|NCT01247350|50552276|FG004|Overall Study|Entry criteria not met|1|||
25238514|NCT01246999|50552306|FG000|Overall Study|Lost to Follow-up|0|||
25238515|NCT01246999|50552307|FG001|Overall Study|Lost to Follow-up|1|||
25238516|NCT01246999|50552308|FG002|Overall Study|Lost to Follow-up|0|||
25238517|NCT01246999|50552309|FG003|Overall Study|Lost to Follow-up|0|||
25238518|NCT01246999|50552306|FG000|Overall Study|Withdrawal by Subject|0|||
25238519|NCT01246999|50552307|FG001|Overall Study|Withdrawal by Subject|0|||
25238520|NCT01246999|50552308|FG002|Overall Study|Withdrawal by Subject|0|||
25238521|NCT01246999|50552309|FG003|Overall Study|Withdrawal by Subject|2|||
25238522|NCT01245751|50552331|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
25238523|NCT01245751|50552332|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
25238524|NCT01245751|50552333|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
25238525|NCT01245751|50552334|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
25238526|NCT01245751|50552331|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
25238527|NCT01245751|50552332|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
25238528|NCT01245751|50552333|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
25238529|NCT01245751|50552334|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
25238530|NCT01245751|50552331|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
25238531|NCT01245751|50552332|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
25238532|NCT01245751|50552333|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
25238533|NCT01245751|50552334|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
25238534|NCT01245673|50552345|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
25238535|NCT01245283|50552352|FG000|Overall Study|Lost to Follow-up|14|||
25238536|NCT01245283|50552353|FG001|Overall Study|Lost to Follow-up|11|||
25238537|NCT01245283|50552354|FG002|Overall Study|Lost to Follow-up|11|||
25238538|NCT01245049|50552367|FG000|Overall Study|Migrated/moved from study area|0|||
25238539|NCT01245049|50552368|FG001|Overall Study|Migrated/moved from study area|1|||
25238540|NCT01245049|50552367|FG000|Overall Study|Withdrawal by Subject|0|||
25238541|NCT01245049|50552368|FG001|Overall Study|Withdrawal by Subject|1|||
25238542|NCT01245049|50552367|FG000|Overall Study|Lost to Follow-up|1|||
25238543|NCT01245049|50552368|FG001|Overall Study|Lost to Follow-up|2|||
25238544|NCT01244893|50552374|FG000|Baseline|Protocol Violation|0|||
25238545|NCT01244893|50552375|FG001|Baseline|Protocol Violation|1|||
25238546|NCT01244893|50552374|FG000|1-Week Follow Up|Lost to Follow-up|1|||
25238547|NCT01244893|50552375|FG001|1-Week Follow Up|Lost to Follow-up|0|||
25238548|NCT01244815|50552390|FG000|Overall Study|Not Treated|0|||
25238549|NCT01244815|50552391|FG001|Overall Study|Not Treated|1|||
25238550|NCT01244815|50552392|FG002|Overall Study|Not Treated|0|||
25238551|NCT01244815|50552393|FG003|Overall Study|Not Treated|0|||
25238552|NCT01244815|50552390|FG000|Overall Study|Adverse Event|4|||
25238553|NCT01244815|50552391|FG001|Overall Study|Adverse Event|7|||
25238554|NCT01244815|50552392|FG002|Overall Study|Adverse Event|5|||
25238555|NCT01244815|50552393|FG003|Overall Study|Adverse Event|5|||
25238556|NCT01244815|50552390|FG000|Overall Study|Treatment Failure|0|||
25238557|NCT01244815|50552391|FG001|Overall Study|Treatment Failure|0|||
25238558|NCT01244815|50552392|FG002|Overall Study|Treatment Failure|0|||
25238559|NCT01244815|50552393|FG003|Overall Study|Treatment Failure|1|||
25238560|NCT01244815|50552390|FG000|Overall Study|Lost to Follow-up|3|||
25238561|NCT01244815|50552391|FG001|Overall Study|Lost to Follow-up|2|||
25238562|NCT01244815|50552392|FG002|Overall Study|Lost to Follow-up|3|||
25238563|NCT01244815|50552393|FG003|Overall Study|Lost to Follow-up|2|||
25238564|NCT01244815|50552390|FG000|Overall Study|Withdrawal by Subject|0|||
25238565|NCT01244815|50552391|FG001|Overall Study|Withdrawal by Subject|2|||
25238566|NCT01244815|50552392|FG002|Overall Study|Withdrawal by Subject|0|||
25238567|NCT01244815|50552393|FG003|Overall Study|Withdrawal by Subject|3|||
25238568|NCT01244815|50552390|FG000|Overall Study|Protocol Violation|7|||
25238569|NCT01244815|50552391|FG001|Overall Study|Protocol Violation|4|||
25238570|NCT01244815|50552392|FG002|Overall Study|Protocol Violation|3|||
25238571|NCT01244815|50552393|FG003|Overall Study|Protocol Violation|1|||
25238572|NCT01244815|50552390|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
25238573|NCT01244815|50552391|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
25238574|NCT01244815|50552392|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
25238575|NCT01244815|50552393|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
25238576|NCT01244425|50552405|FG000|Overall Study|Withdrawal by Subject|2|||
25238577|NCT01244425|50552406|FG001|Overall Study|Withdrawal by Subject|2|||
25238578|NCT01244425|50552405|FG000|Overall Study|Adverse Event|1|||
25238579|NCT01244425|50552406|FG001|Overall Study|Adverse Event|1|||
25238580|NCT01244191|50552422|FG000|Overall Study|Progressive disease|295|||
25238581|NCT01244191|50552423|FG001|Overall Study|Progressive disease|350|||
25238582|NCT01244191|50552422|FG000|Overall Study|Clinical disease progression|54|||
25238583|NCT01244191|50552423|FG001|Overall Study|Clinical disease progression|36|||
25238584|NCT01244191|50552422|FG000|Overall Study|Adverse Event|65|||
25238585|NCT01244191|50552423|FG001|Overall Study|Adverse Event|48|||
25238586|NCT01244191|50552422|FG000|Overall Study|Death|22|||
25238587|NCT01244191|50552423|FG001|Overall Study|Death|29|||
25238588|NCT01244191|50552422|FG000|Overall Study|Lost to Follow-up|0|||
25238589|NCT01244191|50552423|FG001|Overall Study|Lost to Follow-up|2|||
25238590|NCT01244191|50552422|FG000|Overall Study|Protocol Violation|1|||
25238591|NCT01244191|50552423|FG001|Overall Study|Protocol Violation|2|||
25238592|NCT01244191|50552422|FG000|Overall Study|Withdrawal by Subject|31|||
25238593|NCT01244191|50552423|FG001|Overall Study|Withdrawal by Subject|23|||
25238594|NCT01244191|50552422|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
25238595|NCT01244191|50552423|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
25320171|NCT02017717|50636103|FG000|Before Treatment Period|Participant withdrew consent|0|||
25320172|NCT02017717|50636104|FG001|Before Treatment Period|Participant withdrew consent|0|||
25238596|NCT01244035|50552429|FG000|Part 1: Period 1|Adverse Event|0|||
25238597|NCT01244035|50552430|FG001|Part 1: Period 1|Adverse Event|0|||
25238598|NCT01244035|50552431|FG002|Part 1: Period 1|Adverse Event|0|||
25238599|NCT01244035|50552432|FG003|Part 1: Period 1|Adverse Event|0|||
25238600|NCT01244035|50552433|FG004|Part 1: Period 1|Adverse Event|0|||
25238601|NCT01244035|50552434|FG005|Part 1: Period 1|Adverse Event|1|||
25238602|NCT01244035|50552429|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
25238603|NCT01244035|50552430|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
25238604|NCT01244035|50552431|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
25238605|NCT01244035|50552432|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
25238606|NCT01244035|50552433|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
25238607|NCT01244035|50552434|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
25238608|NCT01244035|50552429|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
25238609|NCT01244035|50552430|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
25238610|NCT01244035|50552431|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
25238611|NCT01244035|50552432|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
25238612|NCT01244035|50552433|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
25238613|NCT01244035|50552434|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
25238614|NCT01244035|50552429|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
25238615|NCT01244035|50552430|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
25238616|NCT01244035|50552431|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
25238617|NCT01244035|50552432|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
25238618|NCT01244035|50552433|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
25238619|NCT01244035|50552434|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
25238620|NCT01244035|50552429|FG000|Part 1: Period 3|Adverse Event|0|||
25238621|NCT01244035|50552430|FG001|Part 1: Period 3|Adverse Event|0|||
25238622|NCT01244035|50552431|FG002|Part 1: Period 3|Adverse Event|0|||
25238623|NCT01244035|50552432|FG003|Part 1: Period 3|Adverse Event|0|||
25238624|NCT01244035|50552433|FG004|Part 1: Period 3|Adverse Event|0|||
25238625|NCT01244035|50552434|FG005|Part 1: Period 3|Adverse Event|1|||
25238626|NCT01244035|50552429|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
25238627|NCT01244035|50552430|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
25238628|NCT01244035|50552431|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
25238629|NCT01244035|50552432|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
25238630|NCT01244035|50552433|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
25238631|NCT01244035|50552434|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
25238632|NCT01244035|50552429|FG000|Part 1: Period 3|Protocol Deviation|0|||
25238633|NCT01244035|50552430|FG001|Part 1: Period 3|Protocol Deviation|1|||
25238634|NCT01244035|50552431|FG002|Part 1: Period 3|Protocol Deviation|0|||
25238635|NCT01244035|50552432|FG003|Part 1: Period 3|Protocol Deviation|0|||
25238636|NCT01244035|50552433|FG004|Part 1: Period 3|Protocol Deviation|0|||
25238637|NCT01244035|50552434|FG005|Part 1: Period 3|Protocol Deviation|0|||
25320173|NCT02017717|50636105|FG002|Before Treatment Period|Participant withdrew consent|0|||
25238638|NCT01243762|50552470|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
25238639|NCT01243762|50552471|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
25238640|NCT01243762|50552472|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
25238641|NCT01243762|50552473|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
25238642|NCT01243762|50552474|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
25238643|NCT01243762|50552475|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
25238644|NCT01243762|50552476|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
25238645|NCT01243762|50552470|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
25238646|NCT01243762|50552471|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
25238647|NCT01243762|50552472|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
25238648|NCT01243762|50552473|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
25238649|NCT01243762|50552474|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
25238650|NCT01243762|50552475|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
25238651|NCT01243762|50552476|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
25238652|NCT01243762|50552470|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
25320174|NCT02017717|50636106|FG003|Before Treatment Period|Participant withdrew consent|0|||
25320175|NCT02017717|50636107|FG004|Before Treatment Period|Participant withdrew consent|11|||
25320176|NCT02017717|50636108|FG005|Before Treatment Period|Participant withdrew consent|0|||
25320177|NCT02017717|50636109|FG006|Before Treatment Period|Participant withdrew consent|0|||
25320178|NCT02017717|50636110|FG007|Before Treatment Period|Participant withdrew consent|0|||
25320179|NCT02017717|50636111|FG008|Before Treatment Period|Participant withdrew consent|2|||
25320180|NCT02017717|50636103|FG000|Before Treatment Period|Lost to Follow-up|0|||
25320181|NCT02017717|50636104|FG001|Before Treatment Period|Lost to Follow-up|0|||
25320182|NCT02017717|50636105|FG002|Before Treatment Period|Lost to Follow-up|0|||
25320183|NCT02017717|50636106|FG003|Before Treatment Period|Lost to Follow-up|0|||
25320184|NCT02017717|50636107|FG004|Before Treatment Period|Lost to Follow-up|1|||
25320185|NCT02017717|50636108|FG005|Before Treatment Period|Lost to Follow-up|0|||
25320186|NCT02017717|50636109|FG006|Before Treatment Period|Lost to Follow-up|0|||
25320187|NCT02017717|50636110|FG007|Before Treatment Period|Lost to Follow-up|0|||
25320188|NCT02017717|50636111|FG008|Before Treatment Period|Lost to Follow-up|0|||
25320189|NCT02017717|50636103|FG000|Before Treatment Period|Participant no longer met criteria|0|||
25238653|NCT01243762|50552471|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
25238654|NCT01243762|50552472|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
25320190|NCT02017717|50636104|FG001|Before Treatment Period|Participant no longer met criteria|0|||
25238655|NCT01243762|50552473|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
25238656|NCT01243762|50552474|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
25238657|NCT01243762|50552475|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
25238658|NCT01243762|50552476|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
25238659|NCT01243762|50552470|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
25238660|NCT01243762|50552471|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
25238661|NCT01243762|50552472|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
25238662|NCT01243762|50552473|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
25238663|NCT01243762|50552474|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
24976861|NCT00048932|50065736|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
25238664|NCT01243762|50552475|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
25238665|NCT01243762|50552476|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
25238666|NCT01243762|50552470|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
25238667|NCT01243762|50552471|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
25238668|NCT01243762|50552472|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
25238669|NCT01243762|50552473|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
25238670|NCT01243762|50552474|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
25238671|NCT01243762|50552475|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
25238672|NCT01243762|50552476|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
25238673|NCT01243762|50552470|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
25238674|NCT01243762|50552471|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
25238675|NCT01243762|50552472|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
25238676|NCT01243762|50552473|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
25238677|NCT01243762|50552474|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
25238678|NCT01243762|50552475|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
25238679|NCT01243762|50552476|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
25238680|NCT01243762|50552470|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
25238681|NCT01243762|50552471|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
25238682|NCT01243762|50552472|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
25320191|NCT02017717|50636105|FG002|Before Treatment Period|Participant no longer met criteria|0|||
25320192|NCT02017717|50636106|FG003|Before Treatment Period|Participant no longer met criteria|1|||
25320193|NCT02017717|50636107|FG004|Before Treatment Period|Participant no longer met criteria|2|||
25320194|NCT02017717|50636108|FG005|Before Treatment Period|Participant no longer met criteria|0|||
25320195|NCT02017717|50636109|FG006|Before Treatment Period|Participant no longer met criteria|0|||
25320196|NCT02017717|50636110|FG007|Before Treatment Period|Participant no longer met criteria|1|||
25320197|NCT02017717|50636111|FG008|Before Treatment Period|Participant no longer met criteria|0|||
25320198|NCT02017717|50636103|FG000|Before Treatment Period|other reason|0|||
25320199|NCT02017717|50636104|FG001|Before Treatment Period|other reason|0|||
25320200|NCT02017717|50636105|FG002|Before Treatment Period|other reason|0|||
25320201|NCT02017717|50636106|FG003|Before Treatment Period|other reason|0|||
25320202|NCT02017717|50636107|FG004|Before Treatment Period|other reason|1|||
25320203|NCT02017717|50636108|FG005|Before Treatment Period|other reason|0|||
25320204|NCT02017717|50636109|FG006|Before Treatment Period|other reason|0|||
25320205|NCT02017717|50636110|FG007|Before Treatment Period|other reason|0|||
25238683|NCT01243762|50552473|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
25238684|NCT01243762|50552474|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
25238685|NCT01243762|50552475|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
25238686|NCT01243762|50552476|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
25238687|NCT01243762|50552470|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
25238688|NCT01243762|50552471|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
25238689|NCT01243762|50552472|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
25238690|NCT01243762|50552473|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
25320206|NCT02017717|50636111|FG008|Before Treatment Period|other reason|0|||
25320207|NCT02017717|50636103|FG000|Treatment Period|Disease progression|7|||
25320208|NCT02017717|50636104|FG001|Treatment Period|Disease progression|9|||
25320209|NCT02017717|50636105|FG002|Treatment Period|Disease progression|12|||
25320210|NCT02017717|50636106|FG003|Treatment Period|Disease progression|165|||
25320211|NCT02017717|50636107|FG004|Treatment Period|Disease progression|134|||
25320212|NCT02017717|50636108|FG005|Treatment Period|Disease progression|20|||
25320213|NCT02017717|50636109|FG006|Treatment Period|Disease progression|26|||
25238691|NCT01243762|50552474|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
25238692|NCT01243762|50552475|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
25238693|NCT01243762|50552476|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
25238694|NCT01243411|50552495|FG000|Overall Study|Withdrawal by Subject|18|||
25238695|NCT01243411|50552495|FG000|Overall Study|Lost to Follow-up|10|||
25238696|NCT01243411|50552495|FG000|Overall Study|Adverse Event|5|||
25238697|NCT01243411|50552495|FG000|Overall Study|Other|8|||
25238698|NCT01243177|50552501|FG000|Overall Study|Lack of Efficacy|47|||
25320214|NCT02017717|50636110|FG007|Treatment Period|Disease progression|17|||
25320215|NCT02017717|50636111|FG008|Treatment Period|Disease progression|22|||
25320216|NCT02017717|50636103|FG000|Treatment Period|Study drug toxicity|3|||
25320217|NCT02017717|50636104|FG001|Treatment Period|Study drug toxicity|0|||
25320218|NCT02017717|50636105|FG002|Treatment Period|Study drug toxicity|1|||
25320219|NCT02017717|50636106|FG003|Treatment Period|Study drug toxicity|7|||
25320220|NCT02017717|50636107|FG004|Treatment Period|Study drug toxicity|11|||
25320221|NCT02017717|50636108|FG005|Treatment Period|Study drug toxicity|4|||
25238699|NCT01243177|50552502|FG001|Overall Study|Lack of Efficacy|31|||
25238700|NCT01243177|50552501|FG000|Overall Study|Protocol Violation|11|||
25238701|NCT01243177|50552502|FG001|Overall Study|Protocol Violation|10|||
25238702|NCT01243177|50552501|FG000|Overall Study|Lost to Follow-up|15|||
25238703|NCT01243177|50552502|FG001|Overall Study|Lost to Follow-up|18|||
25238704|NCT01243177|50552501|FG000|Overall Study|Withdrawal by Subject|46|||
25238705|NCT01243177|50552502|FG001|Overall Study|Withdrawal by Subject|38|||
25238706|NCT01243177|50552501|FG000|Overall Study|AE, serious fatal|0|||
25238707|NCT01243177|50552502|FG001|Overall Study|AE, serious fatal|1|||
25238708|NCT01243177|50552501|FG000|Overall Study|SAE, non-fatal|7|||
25238709|NCT01243177|50552502|FG001|Overall Study|SAE, non-fatal|9|||
25238710|NCT01243177|50552501|FG000|Overall Study|AE, non-serious non-fatal|40|||
25238711|NCT01243177|50552502|FG001|Overall Study|AE, non-serious non-fatal|58|||
25238712|NCT01243177|50552501|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
25238713|NCT01243177|50552502|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
25238714|NCT01243177|50552501|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
25238715|NCT01243177|50552502|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
25238716|NCT01243177|50552501|FG000|Overall Study|Other Reason|11|||
25238717|NCT01243177|50552502|FG001|Overall Study|Other Reason|12|||
25238718|NCT01242748|50552510|FG000|Overall Study|Adverse Event|10|||
25238719|NCT01242748|50552511|FG001|Overall Study|Adverse Event|5|||
25320222|NCT02017717|50636109|FG006|Treatment Period|Study drug toxicity|4|||
25320223|NCT02017717|50636110|FG007|Treatment Period|Study drug toxicity|5|||
25320224|NCT02017717|50636111|FG008|Treatment Period|Study drug toxicity|3|||
25320225|NCT02017717|50636103|FG000|Treatment Period|Death|0|||
25238720|NCT01242748|50552510|FG000|Overall Study|Lost to Follow-up|6|||
25238721|NCT01242748|50552511|FG001|Overall Study|Lost to Follow-up|2|||
25238722|NCT01242748|50552510|FG000|Overall Study|Physician Decision|3|||
25238723|NCT01242748|50552511|FG001|Overall Study|Physician Decision|2|||
25238724|NCT01242748|50552510|FG000|Overall Study|Protocol Violation|1|||
25238725|NCT01242748|50552511|FG001|Overall Study|Protocol Violation|0|||
25238726|NCT01242748|50552510|FG000|Overall Study|Withdrawal by Subject|10|||
25238727|NCT01242748|50552511|FG001|Overall Study|Withdrawal by Subject|2|||
25238728|NCT01242748|50552510|FG000|Overall Study|Miscellaneous reasons|8|||
25238729|NCT01242748|50552511|FG001|Overall Study|Miscellaneous reasons|3|||
25238730|NCT01242514|50552520|FG000|Overall Study|e.g., project closure|1042|||
25238731|NCT01242514|50552521|FG001|Overall Study|e.g., project closure|305|||
25238732|NCT01242514|50552522|FG002|Overall Study|e.g., project closure|171|||
25238733|NCT01242514|50552520|FG000|Overall Study|Subject decision|33|||
25238734|NCT01242514|50552521|FG001|Overall Study|Subject decision|8|||
25238735|NCT01242514|50552522|FG002|Overall Study|Subject decision|2|||
25238736|NCT01242514|50552520|FG000|Overall Study|Severe non-compliance to protocol|5|||
25238737|NCT01242514|50552521|FG001|Overall Study|Severe non-compliance to protocol|2|||
25238738|NCT01242514|50552522|FG002|Overall Study|Severe non-compliance to protocol|1|||
25238739|NCT01242514|50552520|FG000|Overall Study|Lack of therapeutic response|99|||
25238740|NCT01242514|50552521|FG001|Overall Study|Lack of therapeutic response|16|||
25238741|NCT01242514|50552522|FG002|Overall Study|Lack of therapeutic response|10|||
25238742|NCT01242514|50552520|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
25238743|NCT01242514|50552521|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
25238744|NCT01242514|50552522|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
25238745|NCT01242514|50552520|FG000|Overall Study|Lost to Follow-up|14|||
25238746|NCT01242514|50552521|FG001|Overall Study|Lost to Follow-up|5|||
25238747|NCT01242514|50552522|FG002|Overall Study|Lost to Follow-up|4|||
25238748|NCT01242514|50552520|FG000|Overall Study|Adverse Event|129|||
25238749|NCT01242514|50552521|FG001|Overall Study|Adverse Event|18|||
25238750|NCT01242514|50552522|FG002|Overall Study|Adverse Event|19|||
25238751|NCT01242085|50552533|FG000|Overall Study|Withdrawal by Subject|4|||
25238752|NCT01242085|50552534|FG001|Overall Study|Withdrawal by Subject|2|||
25238753|NCT01242085|50552535|FG002|Overall Study|Withdrawal by Subject|0|||
25238754|NCT01242085|50552533|FG000|Overall Study|medically unable to have surgery|4|||
25238755|NCT01242085|50552534|FG001|Overall Study|medically unable to have surgery|5|||
25238756|NCT01242085|50552535|FG002|Overall Study|medically unable to have surgery|0|||
25238757|NCT01241461|50552543|FG000|Overall Study|Progressive Disease|3|||
25238758|NCT01241461|50552544|FG001|Overall Study|Progressive Disease|6|||
25238759|NCT01240135|50552556|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
25320226|NCT02017717|50636104|FG001|Treatment Period|Death|0|||
25320227|NCT02017717|50636105|FG002|Treatment Period|Death|1|||
25320228|NCT02017717|50636106|FG003|Treatment Period|Death|0|||
25320229|NCT02017717|50636107|FG004|Treatment Period|Death|0|||
25320230|NCT02017717|50636108|FG005|Treatment Period|Death|0|||
25238760|NCT01240135|50552557|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
25238761|NCT01240135|50552556|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
25238762|NCT01240135|50552557|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
25238763|NCT01247701|50552563|FG000|Overall Study|Death|2|||
25238764|NCT01247701|50552563|FG000|Overall Study|Relapsed|8|||
25238765|NCT01248247|50552571|FG000|Overall Study|Adverse Event|2|||
25238766|NCT01248247|50552572|FG001|Overall Study|Adverse Event|4|||
25238767|NCT01248247|50552573|FG002|Overall Study|Adverse Event|4|||
25238768|NCT01248247|50552574|FG003|Overall Study|Adverse Event|2|||
25238769|NCT01248247|50552571|FG000|Overall Study|Death|0|||
25238770|NCT01248247|50552572|FG001|Overall Study|Death|1|||
25320231|NCT02017717|50636109|FG006|Treatment Period|Death|0|||
25320232|NCT02017717|50636110|FG007|Treatment Period|Death|1|||
25320233|NCT02017717|50636111|FG008|Treatment Period|Death|0|||
25320234|NCT02017717|50636103|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
25320235|NCT02017717|50636104|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
25320236|NCT02017717|50636105|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
25320237|NCT02017717|50636106|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
25320238|NCT02017717|50636107|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
25320239|NCT02017717|50636108|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
25320240|NCT02017717|50636109|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
25320241|NCT02017717|50636110|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
25320242|NCT02017717|50636111|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
25320243|NCT02017717|50636103|FG000|Treatment Period|Participant request to stop therapy|0|||
25320244|NCT02017717|50636104|FG001|Treatment Period|Participant request to stop therapy|0|||
25320245|NCT02017717|50636105|FG002|Treatment Period|Participant request to stop therapy|3|||
25320246|NCT02017717|50636106|FG003|Treatment Period|Participant request to stop therapy|4|||
25320247|NCT02017717|50636107|FG004|Treatment Period|Participant request to stop therapy|7|||
25320248|NCT02017717|50636108|FG005|Treatment Period|Participant request to stop therapy|5|||
25320249|NCT02017717|50636109|FG006|Treatment Period|Participant request to stop therapy|0|||
25320250|NCT02017717|50636110|FG007|Treatment Period|Participant request to stop therapy|2|||
25320251|NCT02017717|50636111|FG008|Treatment Period|Participant request to stop therapy|1|||
25320252|NCT02017717|50636103|FG000|Treatment Period|Participant withdrew consent|0|||
25320253|NCT02017717|50636104|FG001|Treatment Period|Participant withdrew consent|0|||
25320254|NCT02017717|50636105|FG002|Treatment Period|Participant withdrew consent|1|||
25320255|NCT02017717|50636106|FG003|Treatment Period|Participant withdrew consent|1|||
25320256|NCT02017717|50636107|FG004|Treatment Period|Participant withdrew consent|4|||
25320257|NCT02017717|50636108|FG005|Treatment Period|Participant withdrew consent|0|||
25320258|NCT02017717|50636109|FG006|Treatment Period|Participant withdrew consent|0|||
25320259|NCT02017717|50636110|FG007|Treatment Period|Participant withdrew consent|2|||
25320260|NCT02017717|50636111|FG008|Treatment Period|Participant withdrew consent|0|||
25320261|NCT02017717|50636103|FG000|Treatment Period|Participant no longer met criteria|0|||
25320262|NCT02017717|50636104|FG001|Treatment Period|Participant no longer met criteria|0|||
25320263|NCT02017717|50636105|FG002|Treatment Period|Participant no longer met criteria|0|||
25320264|NCT02017717|50636106|FG003|Treatment Period|Participant no longer met criteria|0|||
25320265|NCT02017717|50636107|FG004|Treatment Period|Participant no longer met criteria|1|||
25320266|NCT02017717|50636108|FG005|Treatment Period|Participant no longer met criteria|0|||
25320267|NCT02017717|50636109|FG006|Treatment Period|Participant no longer met criteria|0|||
25320268|NCT02017717|50636110|FG007|Treatment Period|Participant no longer met criteria|0|||
25320269|NCT02017717|50636111|FG008|Treatment Period|Participant no longer met criteria|0|||
25320270|NCT02017717|50636103|FG000|Treatment Period|other reasons|0|||
25320271|NCT02017717|50636104|FG001|Treatment Period|other reasons|0|||
25238771|NCT01248247|50552573|FG002|Overall Study|Death|4|||
25238772|NCT01248247|50552574|FG003|Overall Study|Death|7|||
25238773|NCT01248247|50552571|FG000|Overall Study|Lost to Follow-up|0|||
25238774|NCT01248247|50552572|FG001|Overall Study|Lost to Follow-up|1|||
25238775|NCT01248247|50552573|FG002|Overall Study|Lost to Follow-up|1|||
25238776|NCT01248247|50552574|FG003|Overall Study|Lost to Follow-up|0|||
25238777|NCT01248247|50552571|FG000|Overall Study|Alternative treatment|0|||
25238778|NCT01248247|50552572|FG001|Overall Study|Alternative treatment|1|||
25238779|NCT01248247|50552573|FG002|Overall Study|Alternative treatment|0|||
25238780|NCT01248247|50552574|FG003|Overall Study|Alternative treatment|0|||
25238781|NCT01248247|50552571|FG000|Overall Study|Other|2|||
25238782|NCT01248247|50552572|FG001|Overall Study|Other|8|||
25320272|NCT02017717|50636105|FG002|Treatment Period|other reasons|0|||
25320273|NCT02017717|50636106|FG003|Treatment Period|other reasons|0|||
25320274|NCT02017717|50636107|FG004|Treatment Period|other reasons|1|||
25320275|NCT02017717|50636108|FG005|Treatment Period|other reasons|0|||
25320276|NCT02017717|50636109|FG006|Treatment Period|other reasons|0|||
25320277|NCT02017717|50636110|FG007|Treatment Period|other reasons|1|||
25320278|NCT02017717|50636111|FG008|Treatment Period|other reasons|1|||
25320279|NCT02017717|50636103|FG000|Treatment Period|Maximum clinical benefit|0|||
25238783|NCT01248247|50552573|FG002|Overall Study|Other|8|||
25238784|NCT01248247|50552574|FG003|Overall Study|Other|5|||
25238785|NCT01248247|50552571|FG000|Overall Study|Progression|18|||
25238786|NCT01248247|50552572|FG001|Overall Study|Progression|27|||
25238787|NCT01248247|50552573|FG002|Overall Study|Progression|56|||
25238788|NCT01248247|50552574|FG003|Overall Study|Progression|44|||
25238789|NCT01248247|50552571|FG000|Overall Study|Refuse further treatment|0|||
25238790|NCT01248247|50552572|FG001|Overall Study|Refuse further treatment|0|||
25238791|NCT01248247|50552573|FG002|Overall Study|Refuse further treatment|1|||
25238792|NCT01248247|50552574|FG003|Overall Study|Refuse further treatment|2|||
25238793|NCT01248247|50552571|FG000|Overall Study|Complicating disease|0|||
25238794|NCT01248247|50552572|FG001|Overall Study|Complicating disease|0|||
25238795|NCT01248247|50552573|FG002|Overall Study|Complicating disease|1|||
25238796|NCT01248247|50552574|FG003|Overall Study|Complicating disease|1|||
25238797|NCT02598583|50552586|FG000|Extension Period|Withdrawal by Subject|1|||
25238798|NCT02598583|50552587|FG001|Extension Period|Withdrawal by Subject|0|||
25238799|NCT04831736|50552604|FG000|Overall Study|Withdrawal by Subject|0|||
25238800|NCT04831736|50552605|FG001|Overall Study|Withdrawal by Subject|1|||
25238801|NCT04583956|50552620|FG000|Overall Study|Death|9|||
25238802|NCT04583956|50552621|FG001|Overall Study|Death|11|||
25238803|NCT04583956|50552620|FG000|Overall Study|Lost to Follow-up|7|||
25238804|NCT04583956|50552621|FG001|Overall Study|Lost to Follow-up|9|||
25238805|NCT04583956|50552620|FG000|Overall Study|Protocol Violation|2|||
25238806|NCT04583956|50552621|FG001|Overall Study|Protocol Violation|0|||
25238807|NCT04583956|50552620|FG000|Overall Study|Withdrawal by Subject|0|||
25238808|NCT04583956|50552621|FG001|Overall Study|Withdrawal by Subject|2|||
25238809|NCT04583956|50552620|FG000|Overall Study|Randomized but not dosed|2|||
25238810|NCT04583956|50552621|FG001|Overall Study|Randomized but not dosed|3|||
25238811|NCT04583956|50552620|FG000|Overall Study|Withdrawal of consent before product administration|1|||
25238812|NCT04583956|50552621|FG001|Overall Study|Withdrawal of consent before product administration|0|||
25238813|NCT04463680|50552637|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
25238814|NCT04463680|50552637|FG000|Overall Study|Not eligible due to implant duration of use|1|||
25238815|NCT04463680|50552637|FG000|Overall Study|Withdrawal by Subject|3|||
25238816|NCT04449029|50552649|FG000|Overall Study|Adverse Event|0|||
25238817|NCT04449029|50552650|FG001|Overall Study|Adverse Event|1|||
25320280|NCT02017717|50636104|FG001|Treatment Period|Maximum clinical benefit|0|||
25320281|NCT02017717|50636105|FG002|Treatment Period|Maximum clinical benefit|0|||
25320282|NCT02017717|50636106|FG003|Treatment Period|Maximum clinical benefit|0|||
25320283|NCT02017717|50636107|FG004|Treatment Period|Maximum clinical benefit|1|||
25320284|NCT02017717|50636108|FG005|Treatment Period|Maximum clinical benefit|0|||
25320285|NCT02017717|50636109|FG006|Treatment Period|Maximum clinical benefit|0|||
25320286|NCT02017717|50636110|FG007|Treatment Period|Maximum clinical benefit|0|||
25320287|NCT02017717|50636111|FG008|Treatment Period|Maximum clinical benefit|0|||
25320288|NCT01419080|50636148|FG000|Overall Study|Withdrawal by Subject|75|||
25320289|NCT01419080|50636148|FG000|Overall Study|Death|30|||
25320290|NCT01419080|50636148|FG000|Overall Study|Lost to Follow-up|23|||
25320291|NCT01419080|50636148|FG000|Overall Study|Too Ill|3|||
25320292|NCT01164228|50636156|FG000|Overall Study|Progression|24|||
25320293|NCT01164228|50636157|FG001|Overall Study|Progression|25|||
25320294|NCT01164228|50636156|FG000|Overall Study|Adverse Event|13|||
25320295|NCT01164228|50636157|FG001|Overall Study|Adverse Event|7|||
25320296|NCT01164228|50636156|FG000|Overall Study|Death|1|||
25320297|NCT01164228|50636157|FG001|Overall Study|Death|1|||
25320298|NCT01164228|50636156|FG000|Overall Study|Withdrawal by Subject|2|||
25320299|NCT01164228|50636157|FG001|Overall Study|Withdrawal by Subject|0|||
25320300|NCT01164228|50636156|FG000|Overall Study|Physician Decision|1|||
25320301|NCT01164228|50636157|FG001|Overall Study|Physician Decision|2|||
25320302|NCT01164228|50636156|FG000|Overall Study|Symptomatic deterioration|1|||
25320303|NCT01164228|50636157|FG001|Overall Study|Symptomatic deterioration|0|||
25320304|NCT01164228|50636156|FG000|Overall Study|Never started treatment|1|||
25320305|NCT01164228|50636157|FG001|Overall Study|Never started treatment|3|||
25320306|NCT01164228|50636156|FG000|Overall Study|Ineligible|1|||
25320307|NCT01164228|50636157|FG001|Overall Study|Ineligible|0|||
25320308|NCT00554515|50636163|FG000|Overall Study|Withdrawal by Subject|3|||
25320309|NCT00554515|50636163|FG000|Overall Study|Disease progression|52|||
25320310|NCT00554515|50636163|FG000|Overall Study|Physician Decision|18|||
25320311|NCT00554515|50636163|FG000|Overall Study|Withdrawal by Subject|11|||
25320312|NCT00554515|50636163|FG000|Overall Study|Adverse Event|9|||
25320313|NCT00554515|50636163|FG000|Overall Study|Death|2|||
25238818|NCT04449029|50552651|FG002|Overall Study|Adverse Event|1|||
25238819|NCT04449029|50552652|FG003|Overall Study|Adverse Event|0|||
25238820|NCT04449029|50552653|FG004|Overall Study|Adverse Event|1|||
25238821|NCT04449029|50552654|FG005|Overall Study|Adverse Event|0|||
25320314|NCT00554515|50636163|FG000|Overall Study|Achieved Stable Disease|7|||
25320315|NCT00554515|50636163|FG000|Overall Study|Other|1|||
25320316|NCT00554515|50636163|FG000|Overall Study|Misc|15|||
25238822|NCT04449029|50552655|FG006|Overall Study|Adverse Event|1|||
25320317|NCT00049517|50636190|FG000|Induction|Disease progression|0|||
25320318|NCT00049517|50636191|FG001|Induction|Disease progression|0|||
25320319|NCT00049517|50636192|FG002|Induction|Disease progression|0|||
25238823|NCT04449029|50552656|FG007|Overall Study|Adverse Event|0|||
25238824|NCT04449029|50552649|FG000|Overall Study|Lost to Follow-up|0|||
25238825|NCT04449029|50552650|FG001|Overall Study|Lost to Follow-up|1|||
25238826|NCT04449029|50552651|FG002|Overall Study|Lost to Follow-up|0|||
25238827|NCT04449029|50552652|FG003|Overall Study|Lost to Follow-up|0|||
25238828|NCT04449029|50552653|FG004|Overall Study|Lost to Follow-up|0|||
25238829|NCT04449029|50552654|FG005|Overall Study|Lost to Follow-up|0|||
25238830|NCT04449029|50552655|FG006|Overall Study|Lost to Follow-up|0|||
25238831|NCT04449029|50552656|FG007|Overall Study|Lost to Follow-up|0|||
25238832|NCT04449029|50552649|FG000|Overall Study|Protocol Violation|0|||
25238833|NCT04449029|50552650|FG001|Overall Study|Protocol Violation|1|||
25238834|NCT04449029|50552651|FG002|Overall Study|Protocol Violation|0|||
25238835|NCT04449029|50552652|FG003|Overall Study|Protocol Violation|0|||
25238836|NCT04449029|50552653|FG004|Overall Study|Protocol Violation|0|||
25238837|NCT04449029|50552654|FG005|Overall Study|Protocol Violation|0|||
25238838|NCT04449029|50552655|FG006|Overall Study|Protocol Violation|0|||
25320320|NCT00049517|50636193|FG003|Induction|Disease progression|0|||
25320321|NCT00049517|50636194|FG004|Induction|Disease progression|18|||
25320322|NCT00049517|50636195|FG005|Induction|Disease progression|11|||
25320323|NCT00049517|50636190|FG000|Induction|Adverse Event|0|||
25320324|NCT00049517|50636191|FG001|Induction|Adverse Event|0|||
25320325|NCT00049517|50636192|FG002|Induction|Adverse Event|0|||
25238839|NCT04449029|50552656|FG007|Overall Study|Protocol Violation|0|||
25238840|NCT04449029|50552649|FG000|Overall Study|Physician Decision|0|||
25238841|NCT04449029|50552650|FG001|Overall Study|Physician Decision|0|||
25238842|NCT04449029|50552651|FG002|Overall Study|Physician Decision|0|||
25238843|NCT04449029|50552652|FG003|Overall Study|Physician Decision|0|||
25238844|NCT04449029|50552653|FG004|Overall Study|Physician Decision|0|||
25238845|NCT04449029|50552654|FG005|Overall Study|Physician Decision|1|||
25238846|NCT04449029|50552655|FG006|Overall Study|Physician Decision|0|||
25320326|NCT00049517|50636193|FG003|Induction|Adverse Event|0|||
25320327|NCT00049517|50636194|FG004|Induction|Adverse Event|5|||
25320328|NCT00049517|50636195|FG005|Induction|Adverse Event|7|||
25320329|NCT00049517|50636190|FG000|Induction|Death|0|||
24976862|NCT00048932|50065737|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
24976863|NCT00048932|50065735|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
24976864|NCT00048932|50065736|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
25238847|NCT04449029|50552656|FG007|Overall Study|Physician Decision|0|||
25238848|NCT04449029|50552649|FG000|Overall Study|Withdrawal by Subject|3|||
25238849|NCT04449029|50552650|FG001|Overall Study|Withdrawal by Subject|0|||
25238850|NCT04449029|50552651|FG002|Overall Study|Withdrawal by Subject|1|||
25238851|NCT04449029|50552652|FG003|Overall Study|Withdrawal by Subject|1|||
25238852|NCT04449029|50552653|FG004|Overall Study|Withdrawal by Subject|5|||
25238853|NCT04449029|50552654|FG005|Overall Study|Withdrawal by Subject|1|||
25238854|NCT04449029|50552655|FG006|Overall Study|Withdrawal by Subject|4|||
25238855|NCT04449029|50552656|FG007|Overall Study|Withdrawal by Subject|0|||
25238856|NCT04428333|50552686|FG000|Overall Study|Physician Decision|2|||
25238857|NCT04428333|50552687|FG001|Overall Study|Physician Decision|0|||
25238858|NCT04428333|50552686|FG000|Overall Study|Withdrawal by Subject|0|||
25238859|NCT04428333|50552687|FG001|Overall Study|Withdrawal by Subject|1|||
25238860|NCT04428333|50552686|FG000|Overall Study|In Follow-Up|5|||
25238861|NCT04428333|50552687|FG001|Overall Study|In Follow-Up|10|||
25238862|NCT04428333|50552686|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
25238863|NCT04428333|50552687|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
25238864|NCT04193202|50552695|FG000|Overall Study|Adverse Event|2|||
25238865|NCT04193202|50552696|FG001|Overall Study|Adverse Event|1|||
25238866|NCT04193202|50552695|FG000|Overall Study|Death|0|||
25238867|NCT04193202|50552696|FG001|Overall Study|Death|1|||
25238868|NCT04193202|50552695|FG000|Overall Study|Physician Decision|1|||
25238869|NCT04193202|50552696|FG001|Overall Study|Physician Decision|1|||
25238870|NCT04193202|50552695|FG000|Overall Study|Protocol Violation|2|||
25238871|NCT04193202|50552696|FG001|Overall Study|Protocol Violation|2|||
25238872|NCT04193202|50552695|FG000|Overall Study|Withdrawal by Subject|11|||
25238873|NCT04193202|50552696|FG001|Overall Study|Withdrawal by Subject|5|||
25238874|NCT04159935|50552704|FG000|Overall Study|Study terminated due to COVID-19|1|||
25238875|NCT04159935|50552705|FG001|Overall Study|Study terminated due to COVID-19|3|||
25238876|NCT04128696|50552713|FG000|Overall Study|Lost to Follow-up|0|||
25238877|NCT04128696|50552714|FG001|Overall Study|Lost to Follow-up|1|||
25238878|NCT04128696|50552713|FG000|Overall Study|Withdrawal by Subject|8|||
25238879|NCT04128696|50552714|FG001|Overall Study|Withdrawal by Subject|5|||
25238880|NCT04128696|50552713|FG000|Overall Study|In Follow-up|47|||
25238881|NCT04128696|50552714|FG001|Overall Study|In Follow-up|51|||
25320330|NCT00049517|50636191|FG001|Induction|Death|0|||
25320331|NCT00049517|50636192|FG002|Induction|Death|0|||
25238882|NCT04128696|50552713|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|52|||
25238883|NCT04128696|50552714|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|62|||
25320332|NCT00049517|50636193|FG003|Induction|Death|0|||
25320333|NCT00049517|50636194|FG004|Induction|Death|9|||
25238884|NCT03871543|50552738|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
25238885|NCT03871543|50552738|FG000|Period 1|Investigator Error|1|||
25238886|NCT03871543|50552738|FG000|Period 1|Protocol Violation|2|||
25238887|NCT03871543|50552738|FG000|Period 1|COVID-19 Related|1|||
25238888|NCT03871543|50552738|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
25238889|NCT03871543|50552738|FG000|Period 1|Withdrawal by Subject|10|||
25238890|NCT03871543|50552738|FG000|Period 2|Adverse Event|1|||
25238891|NCT03871543|50552738|FG000|Period 2|Withdrawal by Subject|1|||
25238892|NCT03843125|50552750|FG000|Overall Study|Adverse Event|17|||
25238893|NCT03843125|50552751|FG001|Overall Study|Adverse Event|13|||
25238894|NCT03843125|50552752|FG002|Overall Study|Adverse Event|5|||
25238895|NCT03843125|50552753|FG003|Overall Study|Adverse Event|9|||
25238896|NCT03843125|50552750|FG000|Overall Study|Death|0|||
25238897|NCT03843125|50552751|FG001|Overall Study|Death|6|||
25238898|NCT03843125|50552752|FG002|Overall Study|Death|2|||
25238899|NCT03843125|50552753|FG003|Overall Study|Death|0|||
25238900|NCT03843125|50552750|FG000|Overall Study|Lack of Efficacy|14|||
25320334|NCT00049517|50636195|FG005|Induction|Death|6|||
25320335|NCT00049517|50636190|FG000|Induction|Withdrawal by Subject|0|||
25320336|NCT00049517|50636191|FG001|Induction|Withdrawal by Subject|0|||
25320337|NCT00049517|50636192|FG002|Induction|Withdrawal by Subject|0|||
25320338|NCT00049517|50636193|FG003|Induction|Withdrawal by Subject|0|||
24976865|NCT00048932|50065737|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
24976866|NCT00048932|50065735|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
24976867|NCT00048932|50065736|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
24976868|NCT00048932|50065737|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
24976869|NCT00048932|50065735|FG000|Open Label Period (OL)|Pregnancy|0|||
24976870|NCT00048932|50065736|FG001|Open Label Period (OL)|Pregnancy|0|||
24976871|NCT00048932|50065737|FG002|Open Label Period (OL)|Pregnancy|6|||
24976872|NCT00048932|50065735|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
24976873|NCT00048932|50065736|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
24976874|NCT00048932|50065737|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
24976875|NCT00048932|50065735|FG000|Open Label Period (OL)|Investigator Retiring|0|||
24976876|NCT00048932|50065736|FG001|Open Label Period (OL)|Investigator Retiring|0|||
24976877|NCT00048932|50065737|FG002|Open Label Period (OL)|Investigator Retiring|2|||
24976878|NCT00048932|50065735|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
24976879|NCT00048932|50065736|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
24976880|NCT00048932|50065737|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
24976881|NCT00048932|50065735|FG000|Open Label Period (OL)|Participant Relocated|0|||
24976882|NCT00048932|50065736|FG001|Open Label Period (OL)|Participant Relocated|0|||
24976883|NCT00048932|50065737|FG002|Open Label Period (OL)|Participant Relocated|6|||
24976884|NCT00048932|50065735|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
24976885|NCT00048932|50065736|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
25320339|NCT00049517|50636194|FG004|Induction|Withdrawal by Subject|1|||
25320340|NCT00049517|50636195|FG005|Induction|Withdrawal by Subject|3|||
25320341|NCT00049517|50636190|FG000|Induction|Alternative therapy|0|||
25320342|NCT00049517|50636191|FG001|Induction|Alternative therapy|0|||
25320343|NCT00049517|50636192|FG002|Induction|Alternative therapy|0|||
25320344|NCT00049517|50636193|FG003|Induction|Alternative therapy|0|||
25320345|NCT00049517|50636194|FG004|Induction|Alternative therapy|2|||
25320346|NCT00049517|50636195|FG005|Induction|Alternative therapy|2|||
25320347|NCT00049517|50636190|FG000|Induction|Other complicating disease|0|||
25320348|NCT00049517|50636191|FG001|Induction|Other complicating disease|0|||
25320349|NCT00049517|50636192|FG002|Induction|Other complicating disease|0|||
25320350|NCT00049517|50636193|FG003|Induction|Other complicating disease|0|||
25320351|NCT00049517|50636194|FG004|Induction|Other complicating disease|3|||
25320352|NCT00049517|50636195|FG005|Induction|Other complicating disease|0|||
25320353|NCT00049517|50636190|FG000|Induction|Reasons not reported|0|||
25320354|NCT00049517|50636191|FG001|Induction|Reasons not reported|0|||
25320355|NCT00049517|50636192|FG002|Induction|Reasons not reported|0|||
25320356|NCT00049517|50636193|FG003|Induction|Reasons not reported|0|||
25320357|NCT00049517|50636194|FG004|Induction|Reasons not reported|22|||
25320358|NCT00049517|50636195|FG005|Induction|Reasons not reported|25|||
25320359|NCT00049517|50636190|FG000|Conditioning/Transplant|Disease progression|14|||
25320360|NCT00049517|50636191|FG001|Conditioning/Transplant|Disease progression|6|||
24976886|NCT00048932|50065737|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
24976887|NCT00048932|50065735|FG000|Open Label Period (OL)|Site Closure|0|||
24976888|NCT00048932|50065736|FG001|Open Label Period (OL)|Site Closure|0|||
24976889|NCT00048932|50065737|FG002|Open Label Period (OL)|Site Closure|3|||
25238901|NCT03843125|50552751|FG001|Overall Study|Lack of Efficacy|11|||
25238902|NCT03843125|50552752|FG002|Overall Study|Lack of Efficacy|9|||
25238903|NCT03843125|50552753|FG003|Overall Study|Lack of Efficacy|4|||
25238904|NCT03843125|50552750|FG000|Overall Study|Lost to Follow-up|3|||
25238905|NCT03843125|50552751|FG001|Overall Study|Lost to Follow-up|4|||
25238906|NCT03843125|50552752|FG002|Overall Study|Lost to Follow-up|0|||
25320361|NCT00049517|50636192|FG002|Conditioning/Transplant|Disease progression|10|||
25320362|NCT00049517|50636193|FG003|Conditioning/Transplant|Disease progression|6|||
25320363|NCT00049517|50636194|FG004|Conditioning/Transplant|Disease progression|0|||
25320364|NCT00049517|50636195|FG005|Conditioning/Transplant|Disease progression|0|||
25320365|NCT00049517|50636190|FG000|Conditioning/Transplant|Adverse Event|2|||
25320366|NCT00049517|50636191|FG001|Conditioning/Transplant|Adverse Event|1|||
25320367|NCT00049517|50636192|FG002|Conditioning/Transplant|Adverse Event|4|||
25320368|NCT00049517|50636193|FG003|Conditioning/Transplant|Adverse Event|8|||
25320369|NCT00049517|50636194|FG004|Conditioning/Transplant|Adverse Event|0|||
25320370|NCT00049517|50636195|FG005|Conditioning/Transplant|Adverse Event|0|||
25320371|NCT00049517|50636190|FG000|Conditioning/Transplant|Death|1|||
25320372|NCT00049517|50636191|FG001|Conditioning/Transplant|Death|0|||
25320373|NCT00049517|50636192|FG002|Conditioning/Transplant|Death|0|||
25320374|NCT00049517|50636193|FG003|Conditioning/Transplant|Death|2|||
25320375|NCT00049517|50636194|FG004|Conditioning/Transplant|Death|0|||
25320376|NCT00049517|50636195|FG005|Conditioning/Transplant|Death|0|||
25320377|NCT00049517|50636190|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
25320378|NCT00049517|50636191|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
25320379|NCT00049517|50636192|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
25320380|NCT00049517|50636193|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
25320381|NCT00049517|50636194|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
25320382|NCT00049517|50636195|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
25320383|NCT00049517|50636190|FG000|Conditioning/Transplant|Alternative therapy|4|||
25320384|NCT00049517|50636191|FG001|Conditioning/Transplant|Alternative therapy|4|||
25320385|NCT00049517|50636192|FG002|Conditioning/Transplant|Alternative therapy|2|||
25320386|NCT00049517|50636193|FG003|Conditioning/Transplant|Alternative therapy|1|||
25320387|NCT00049517|50636194|FG004|Conditioning/Transplant|Alternative therapy|1|||
25320388|NCT00049517|50636195|FG005|Conditioning/Transplant|Alternative therapy|0|||
25320389|NCT00049517|50636190|FG000|Conditioning/Transplant|Other complicating disease|2|||
25320390|NCT00049517|50636191|FG001|Conditioning/Transplant|Other complicating disease|0|||
25320391|NCT00049517|50636192|FG002|Conditioning/Transplant|Other complicating disease|0|||
25320392|NCT00049517|50636193|FG003|Conditioning/Transplant|Other complicating disease|4|||
25320393|NCT00049517|50636194|FG004|Conditioning/Transplant|Other complicating disease|0|||
25320394|NCT00049517|50636195|FG005|Conditioning/Transplant|Other complicating disease|1|||
24976890|NCT00048932|50065735|FG000|Open Label Period (OL)|Trial Terminated|0|||
24976891|NCT00048932|50065736|FG001|Open Label Period (OL)|Trial Terminated|0|||
24976892|NCT00048932|50065737|FG002|Open Label Period (OL)|Trial Terminated|1|||
24976893|NCT00048932|50065735|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
24976894|NCT00048932|50065736|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
24976895|NCT00048932|50065737|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
24976896|NCT00048932|50065735|FG000|Open Label Period (OL)|Patient Decision|0|||
24976897|NCT00048932|50065736|FG001|Open Label Period (OL)|Patient Decision|0|||
24976898|NCT00048932|50065737|FG002|Open Label Period (OL)|Patient Decision|4|||
24976899|NCT00048932|50065735|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
24976900|NCT00048932|50065736|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
24976901|NCT00048932|50065737|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
24976902|NCT00048932|50065735|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
24976903|NCT00048932|50065736|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
24976904|NCT00048932|50065737|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
24976905|NCT00048932|50065735|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
24976906|NCT00048932|50065736|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
24976907|NCT00048932|50065737|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
24976908|NCT00048932|50065735|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
24976909|NCT00048932|50065736|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
24976910|NCT00048932|50065737|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
24976911|NCT00048932|50065735|FG000|Open Label Period (OL)|Investigator Decision|0|||
24976912|NCT00048932|50065736|FG001|Open Label Period (OL)|Investigator Decision|0|||
24976913|NCT00048932|50065737|FG002|Open Label Period (OL)|Investigator Decision|4|||
24976914|NCT00048932|50065735|FG000|Open Label Period (OL)|Site Staff Issues|0|||
24976915|NCT00048932|50065736|FG001|Open Label Period (OL)|Site Staff Issues|0|||
24976916|NCT00048932|50065737|FG002|Open Label Period (OL)|Site Staff Issues|2|||
24976917|NCT00048932|50065735|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
24976918|NCT00048932|50065736|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
24976919|NCT00048932|50065737|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
24976920|NCT00048932|50065735|FG000|Open Label Period (OL)|Participant Surgery|0|||
24976921|NCT00048932|50065736|FG001|Open Label Period (OL)|Participant Surgery|0|||
24976922|NCT00048932|50065737|FG002|Open Label Period (OL)|Participant Surgery|1|||
24976923|NCT00073983|50065746|FG000|Overall Study|not evaluable|1|||
25320395|NCT00049517|50636190|FG000|Conditioning/Transplant|Reasons not reported|25|||
25320396|NCT00049517|50636191|FG001|Conditioning/Transplant|Reasons not reported|31|||
25320397|NCT00049517|50636192|FG002|Conditioning/Transplant|Reasons not reported|18|||
24976924|NCT03812679|50065752|FG000|Overall Study|Adverse Event|2|||
24976925|NCT03812679|50065752|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
24976926|NCT03812679|50065752|FG000|Overall Study|Renal transplant|1|||
24976927|NCT03812679|50065752|FG000|Overall Study|Withdrawal by Subject|1|||
24976928|NCT03812679|50065752|FG000|Overall Study|Termination of study|2|||
24976929|NCT03812679|50065752|FG000|Overall Study|Water device replacement|1|||
24976930|NCT02952820|50065759|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
24976931|NCT02952820|50065760|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
24976932|NCT02952820|50065761|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
24976933|NCT02952820|50065759|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
24976934|NCT02952820|50065760|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
24976935|NCT02952820|50065761|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
24976936|NCT02952820|50065759|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
24976937|NCT02952820|50065760|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
24976938|NCT02952820|50065761|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
24976939|NCT02952820|50065759|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
24976940|NCT02952820|50065760|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
24976941|NCT02952820|50065761|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
24976942|NCT02952820|50065759|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
24976943|NCT02952820|50065760|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
24976944|NCT02952820|50065761|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
24976945|NCT02952820|50065759|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
24976946|NCT02952820|50065760|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
24976947|NCT02952820|50065761|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
25238907|NCT03843125|50552753|FG003|Overall Study|Lost to Follow-up|2|||
25238908|NCT03843125|50552750|FG000|Overall Study|Other|12|||
25238909|NCT03843125|50552751|FG001|Overall Study|Other|14|||
25238910|NCT03843125|50552752|FG002|Overall Study|Other|3|||
25238911|NCT03843125|50552753|FG003|Overall Study|Other|4|||
25238912|NCT03843125|50552750|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
25238913|NCT03843125|50552751|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
25238914|NCT03843125|50552752|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
25238915|NCT03843125|50552753|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
25238916|NCT03843125|50552750|FG000|Overall Study|Study Terminated by Sponsor|318|||
25238917|NCT03843125|50552751|FG001|Overall Study|Study Terminated by Sponsor|318|||
25238918|NCT03843125|50552752|FG002|Overall Study|Study Terminated by Sponsor|163|||
25238919|NCT03843125|50552753|FG003|Overall Study|Study Terminated by Sponsor|163|||
25238920|NCT03843125|50552750|FG000|Overall Study|Withdrawal by Subject|23|||
25238921|NCT03843125|50552751|FG001|Overall Study|Withdrawal by Subject|12|||
25238922|NCT03843125|50552752|FG002|Overall Study|Withdrawal by Subject|6|||
25238923|NCT03843125|50552753|FG003|Overall Study|Withdrawal by Subject|9|||
25238924|NCT03843125|50552750|FG000|Overall Study|Missing data|0|||
25238925|NCT03843125|50552751|FG001|Overall Study|Missing data|1|||
25238926|NCT03843125|50552752|FG002|Overall Study|Missing data|1|||
25238927|NCT03843125|50552753|FG003|Overall Study|Missing data|0|||
25238928|NCT03695237|50552766|FG000|Overall Study|Discontinued to Restart Puberty|1|||
25238929|NCT03695237|50552767|FG001|Overall Study|Discontinued to Restart Puberty|0|||
25238930|NCT03603509|50552776|FG000|Overall Study|Lost to Follow-up|3|||
25238931|NCT03603509|50552777|FG001|Overall Study|Lost to Follow-up|4|||
25238932|NCT03439293|50552783|FG000|Overall Study|Ongoing on Treatment|15|||
25238933|NCT03439293|50552783|FG000|Overall Study|Ongoing off Treatment|19|||
25238934|NCT03439293|50552783|FG000|Overall Study|Death|18|||
25238935|NCT03439293|50552783|FG000|Overall Study|Withdrawal by Subject|7|||
25238936|NCT03439293|50552783|FG000|Overall Study|Lost to Follow-up|2|||
25238937|NCT03275285|50552799|FG000|Overall Study|Ongoing|61|||
25238938|NCT03275285|50552800|FG001|Overall Study|Ongoing|105|||
25238939|NCT03100149|50552817|FG000|Overall Study|Adverse Event|0|||
25238940|NCT03100149|50552818|FG001|Overall Study|Adverse Event|1|||
25320398|NCT00049517|50636193|FG003|Conditioning/Transplant|Reasons not reported|15|||
25238941|NCT03100149|50552819|FG002|Overall Study|Adverse Event|0|||
25238942|NCT03100149|50552817|FG000|Overall Study|Participant Moved out of Country|0|||
25238943|NCT03100149|50552818|FG001|Overall Study|Participant Moved out of Country|0|||
25238944|NCT03100149|50552819|FG002|Overall Study|Participant Moved out of Country|1|||
25238945|NCT03100149|50552817|FG000|Overall Study|Withdrawal by Subject|0|||
25238946|NCT03100149|50552818|FG001|Overall Study|Withdrawal by Subject|3|||
25238947|NCT03100149|50552819|FG002|Overall Study|Withdrawal by Subject|1|||
25238948|NCT03066258|50552832|FG000|Overall Study|Death|1|||
25238949|NCT03066258|50552833|FG001|Overall Study|Death|0|||
25238950|NCT03066258|50552834|FG002|Overall Study|Death|0|||
25238951|NCT03066258|50552835|FG003|Overall Study|Death|0|||
25238952|NCT03066258|50552836|FG004|Overall Study|Death|1|||
25238953|NCT03024255|50552852|FG000|Overall Study|Adverse Event|1|||
25238954|NCT03024255|50552853|FG001|Overall Study|Adverse Event|4|||
25238955|NCT03024255|50552854|FG002|Overall Study|Adverse Event|8|||
25238956|NCT03024255|50552855|FG003|Overall Study|Adverse Event|0|||
25238957|NCT03024255|50552852|FG000|Overall Study|Withdrawal by Subject|3|||
25238958|NCT03024255|50552853|FG001|Overall Study|Withdrawal by Subject|1|||
25238959|NCT03024255|50552854|FG002|Overall Study|Withdrawal by Subject|0|||
25238960|NCT03024255|50552855|FG003|Overall Study|Withdrawal by Subject|3|||
25238961|NCT03024255|50552852|FG000|Overall Study|Protocol Violation|0|||
25238962|NCT03024255|50552853|FG001|Overall Study|Protocol Violation|0|||
25320399|NCT00049517|50636194|FG004|Conditioning/Transplant|Reasons not reported|5|||
25320400|NCT00049517|50636195|FG005|Conditioning/Transplant|Reasons not reported|5|||
25320401|NCT00926783|50636205|FG000|Overall Study|Incomplete CFAE Procedures|3|||
25320402|NCT00926783|50636206|FG001|Overall Study|Incomplete CFAE Procedures|3|||
25320403|NCT00929669|50636212|FG000|Overall Study|elevated glucose levels|1|||
25077541|NCT02240680|50185295|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
25077542|NCT02240680|50185296|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
25077543|NCT02240680|50185297|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
25238963|NCT03024255|50552854|FG002|Overall Study|Protocol Violation|2|||
25238964|NCT03024255|50552855|FG003|Overall Study|Protocol Violation|0|||
25238965|NCT03024255|50552852|FG000|Overall Study|Lost to Follow-up|1|||
25238966|NCT03024255|50552853|FG001|Overall Study|Lost to Follow-up|2|||
25077544|NCT02240680|50185298|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
25077545|NCT02240368|50185309|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
25077546|NCT02240368|50185310|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
25077547|NCT02240368|50185311|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
25238967|NCT03024255|50552854|FG002|Overall Study|Lost to Follow-up|1|||
25238968|NCT03024255|50552855|FG003|Overall Study|Lost to Follow-up|1|||
25238969|NCT03024255|50552852|FG000|Overall Study|Lack of Efficacy|1|||
25238970|NCT03024255|50552853|FG001|Overall Study|Lack of Efficacy|0|||
25238971|NCT03024255|50552854|FG002|Overall Study|Lack of Efficacy|0|||
25238972|NCT03024255|50552855|FG003|Overall Study|Lack of Efficacy|0|||
25238973|NCT03024255|50552852|FG000|Overall Study|Protocol Noncompliance|1|||
25238974|NCT03024255|50552853|FG001|Overall Study|Protocol Noncompliance|1|||
25238975|NCT03024255|50552854|FG002|Overall Study|Protocol Noncompliance|0|||
25238976|NCT03024255|50552855|FG003|Overall Study|Protocol Noncompliance|1|||
25238977|NCT02927262|50552874|FG000|Overall Study|Adverse Event|7|||
25238978|NCT02927262|50552875|FG001|Overall Study|Adverse Event|1|||
25238979|NCT02927262|50552874|FG000|Overall Study|Death|1|||
25238980|NCT02927262|50552875|FG001|Overall Study|Death|0|||
25238981|NCT02927262|50552874|FG000|Overall Study|Withdrawal by Subject|3|||
25238982|NCT02927262|50552875|FG001|Overall Study|Withdrawal by Subject|0|||
25238983|NCT02927262|50552874|FG000|Overall Study|Disease Relapse|23|||
25238984|NCT02927262|50552875|FG001|Overall Study|Disease Relapse|18|||
25238985|NCT02927262|50552874|FG000|Overall Study|Miscellaneous|5|||
25238986|NCT02927262|50552875|FG001|Overall Study|Miscellaneous|4|||
25238987|NCT02927262|50552874|FG000|Overall Study|Ongoing|4|||
25238988|NCT02927262|50552875|FG001|Overall Study|Ongoing|0|||
25238989|NCT02743494|50552883|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
25238990|NCT02743494|50552884|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
25238991|NCT02743494|50552883|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
25238992|NCT02743494|50552884|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
25238993|NCT02743494|50552883|FG000|Treatment Period|Completed treatment|229|||
25238994|NCT02743494|50552884|FG001|Treatment Period|Completed treatment|99|||
25238995|NCT02743494|50552883|FG000|Treatment Period|Disease recurrence|149|||
25238996|NCT02743494|50552884|FG001|Treatment Period|Disease recurrence|113|||
25238997|NCT02743494|50552883|FG000|Treatment Period|Study drug toxicity|57|||
25238998|NCT02743494|50552884|FG001|Treatment Period|Study drug toxicity|8|||
25238999|NCT02743494|50552883|FG000|Treatment Period|Death|1|||
25239000|NCT02743494|50552884|FG001|Treatment Period|Death|0|||
25239001|NCT02743494|50552883|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
25239002|NCT02743494|50552884|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
25239003|NCT02743494|50552883|FG000|Treatment Period|Participant request to discontinue treatment|30|||
25239004|NCT02743494|50552884|FG001|Treatment Period|Participant request to discontinue treatment|5|||
25239005|NCT02743494|50552883|FG000|Treatment Period|Participant withdrew consent|12|||
25239006|NCT02743494|50552884|FG001|Treatment Period|Participant withdrew consent|4|||
25239007|NCT02743494|50552883|FG000|Treatment Period|Lost to Follow-up|0|||
25239008|NCT02743494|50552884|FG001|Treatment Period|Lost to Follow-up|1|||
25239009|NCT02743494|50552883|FG000|Treatment Period|Poor/Non-compliance|1|||
25239010|NCT02743494|50552884|FG001|Treatment Period|Poor/Non-compliance|0|||
25077548|NCT02240368|50185309|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
25077549|NCT02240368|50185310|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
25239011|NCT02743494|50552883|FG000|Treatment Period|Other reasons|7|||
25239012|NCT02743494|50552884|FG001|Treatment Period|Other reasons|2|||
25239013|NCT02636582|50552892|FG000|Overall Study|Surgical Pathology|1|||
25239014|NCT02636582|50552893|FG001|Overall Study|Surgical Pathology|0|||
25239015|NCT02367040|50552901|FG000|Overall Study|Lost to Follow-up|1|||
25320404|NCT00566995|50636216|FG000|Overall Study|Toxicity|4|||
25239016|NCT02367040|50552902|FG001|Overall Study|Lost to Follow-up|1|||
25239017|NCT02367040|50552901|FG000|Overall Study|Lack of Efficacy|1|||
25239018|NCT02367040|50552902|FG001|Overall Study|Lack of Efficacy|0|||
25239019|NCT02367040|50552901|FG000|Overall Study|Additional primary malignancy|0|||
25239020|NCT02367040|50552902|FG001|Overall Study|Additional primary malignancy|1|||
25239021|NCT02367040|50552901|FG000|Overall Study|AE not associated with clinical disease progression|104|||
25239022|NCT02367040|50552902|FG001|Overall Study|AE not associated with clinical disease progression|9|||
25239023|NCT02367040|50552901|FG000|Overall Study|AE associated with clinical disease progression|1|||
25239024|NCT02367040|50552902|FG001|Overall Study|AE associated with clinical disease progression|3|||
25239025|NCT02367040|50552901|FG000|Overall Study|Physician Decision|2|||
25239026|NCT02367040|50552902|FG001|Overall Study|Physician Decision|8|||
25239027|NCT02367040|50552901|FG000|Overall Study|Non-compliance with study drug|1|||
25077550|NCT02240368|50185311|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
25239028|NCT02367040|50552902|FG001|Overall Study|Non-compliance with study drug|0|||
25239029|NCT02367040|50552901|FG000|Overall Study|Failure to meet continuation criteria|1|||
25239030|NCT02367040|50552902|FG001|Overall Study|Failure to meet continuation criteria|0|||
25239031|NCT02367040|50552901|FG000|Overall Study|Switching to other therapy|2|||
25239032|NCT02367040|50552902|FG001|Overall Study|Switching to other therapy|0|||
25239033|NCT02367040|50552901|FG000|Overall Study|Withdrawal by Subject|41|||
25239034|NCT02367040|50552902|FG001|Overall Study|Withdrawal by Subject|14|||
25239035|NCT02367040|50552901|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
25239036|NCT02367040|50552902|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
25239037|NCT02367040|50552901|FG000|Overall Study|Patient decision|35|||
25239038|NCT02367040|50552902|FG001|Overall Study|Patient decision|11|||
25239039|NCT02367040|50552901|FG000|Overall Study|Required procedure failed|1|||
25239040|NCT02367040|50552902|FG001|Overall Study|Required procedure failed|0|||
25239041|NCT02367040|50552901|FG000|Overall Study|Randomized by mistake with study treatment|1|||
25239042|NCT02367040|50552902|FG001|Overall Study|Randomized by mistake with study treatment|0|||
25239043|NCT02367040|50552901|FG000|Overall Study|Protocol Violation|1|||
25239044|NCT02367040|50552902|FG001|Overall Study|Protocol Violation|0|||
25239045|NCT02367040|50552901|FG000|Overall Study|Progressive disease - radiological progression|39|||
25239046|NCT02367040|50552902|FG001|Overall Study|Progressive disease - radiological progression|67|||
25239047|NCT02367040|50552901|FG000|Overall Study|Progressive disease - clinical progression|2|||
25239048|NCT02367040|50552902|FG001|Overall Study|Progressive disease - clinical progression|6|||
25239049|NCT02367040|50552901|FG000|Overall Study|Drug not administered|3|||
25239050|NCT02367040|50552902|FG001|Overall Study|Drug not administered|2|||
25239051|NCT01886872|50552911|FG000|Overall Study|Ineligible|7|||
25239052|NCT01886872|50552912|FG001|Overall Study|Ineligible|4|||
25239053|NCT01886872|50552913|FG002|Overall Study|Ineligible|12|||
25239054|NCT01252953|50552928|FG000|Overall Study|Withdrawal by Subject|16|||
25239055|NCT01252953|50552929|FG001|Overall Study|Withdrawal by Subject|17|||
25239056|NCT01252953|50552928|FG000|Overall Study|Lost to Follow-up|22|||
25239057|NCT01252953|50552929|FG001|Overall Study|Lost to Follow-up|21|||
25239058|NCT01234480|50552936|FG000|Overall Study|Pregnancy|88|||
25239059|NCT01234480|50552936|FG000|Overall Study|>36/Normal History|50|||
25239060|NCT01234480|50552936|FG000|Overall Study|Age|3|||
25239061|NCT01234480|50552936|FG000|Overall Study|HPV Vaccine History|28|||
25239062|NCT01234480|50552936|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
25239063|NCT01234480|50552936|FG000|Overall Study|Hysterectomy|2|||
25239064|NCT01234480|50552936|FG000|Overall Study|Hysterectomy post enrollment|1|||
25239065|NCT01234480|50552936|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
25239066|NCT01234480|50552936|FG000|Overall Study|Informed Consent Form Violation|30|||
25239067|NCT01234480|50552936|FG000|Overall Study|Incorrect Visit|3|||
25239068|NCT01234480|50552936|FG000|Overall Study|No Florida Lab License|20|||
25239069|NCT01234480|50552936|FG000|Overall Study|Out of Window|42|||
25239070|NCT01234480|50552936|FG000|Overall Study|Sample Processing/Storage|92|||
25239071|NCT01234480|50552936|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
25239072|NCT01234480|50552936|FG000|Overall Study|Site/Subject non-compliance|44|||
25239073|NCT01234480|50552936|FG000|Overall Study|Missing Sample|9|||
25239074|NCT01038778|50552945|FG000|Overall Study|Withdrawal by Subject|0|||
25239075|NCT01038778|50552946|FG001|Overall Study|Withdrawal by Subject|2|||
25239076|NCT01038778|50552947|FG002|Overall Study|Withdrawal by Subject|3|||
25239077|NCT00877851|50552956|FG000|Overall Study|Lost to Follow-up|5|||
25239078|NCT00877851|50552957|FG001|Overall Study|Lost to Follow-up|5|||
25239079|NCT00877851|50552956|FG000|Overall Study|computer problem|3|||
25077551|NCT02239978|50185321|FG000|Overall Study|Withdrawal by Subject|2|||
25077552|NCT02239978|50185322|FG001|Overall Study|Withdrawal by Subject|0|||
25239080|NCT00877851|50552957|FG001|Overall Study|computer problem|0|||
25239081|NCT00877851|50552956|FG000|Overall Study|no longer interested in participating|1|||
25239082|NCT00877851|50552957|FG001|Overall Study|no longer interested in participating|0|||
25239083|NCT00846742|50552963|FG000|Overall Study|Withdrawal by Subject|1|||
25239084|NCT00837616|50552970|FG000|Overall Study|Withdrawal by Subject|0|||
25239085|NCT00837616|50552971|FG001|Overall Study|Withdrawal by Subject|1|||
25239086|NCT00697073|50552977|FG000|Overall Study|Withdrawal by Subject|2|||
25320405|NCT00566995|50636216|FG000|Overall Study|Withdrew consent|3|||
25320406|NCT00926393|50636222|FG000|Overall Study|Withdrawal by Subject|1|||
25320407|NCT00926393|50636223|FG001|Overall Study|Withdrawal by Subject|2|||
25320408|NCT00926393|50636222|FG000|Overall Study|Adverse Event|1|||
25320409|NCT00926393|50636223|FG001|Overall Study|Adverse Event|1|||
25320410|NCT00926237|50636229|FG000|Overall Study|Withdrawal by Subject|2|||
25320411|NCT00926237|50636230|FG001|Overall Study|Withdrawal by Subject|1|||
25320412|NCT00931463|50636242|FG000|Overall Study|Death|8|||
25320413|NCT00931463|50636243|FG001|Overall Study|Death|4|||
25320414|NCT00931463|50636242|FG000|Overall Study|Withdrawal by Subject|5|||
25320415|NCT00931463|50636243|FG001|Overall Study|Withdrawal by Subject|0|||
25320416|NCT00931463|50636242|FG000|Overall Study|Lost to Follow-up|4|||
25320417|NCT00931463|50636243|FG001|Overall Study|Lost to Follow-up|1|||
25320418|NCT00929201|50636249|FG000|Period 1|Withdrawal by Subject|0|||
25239087|NCT00697073|50552977|FG000|Overall Study|Pregnancy|1|||
25239088|NCT00697073|50552977|FG000|Overall Study|non compliance and other|6|||
25239089|NCT00176254|50552981|FG000|Overall Study|Lost to Follow-up|1|||
25239090|NCT04834726|50553012|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
25239091|NCT04834726|50553013|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
25239092|NCT04834726|50553014|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
25239093|NCT04834726|50553015|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
25239094|NCT04834726|50553016|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
25239095|NCT04834726|50553017|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
25239096|NCT04834726|50553018|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
25239097|NCT04834726|50553019|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
25239098|NCT04834726|50553020|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
25239099|NCT04732949|50553036|FG000|Overall Study|Withdrawal by Subject|23|||
25239100|NCT04732949|50553037|FG001|Overall Study|Withdrawal by Subject|27|||
25239101|NCT04732949|50553036|FG000|Overall Study|Protocol Violation|0|||
25239102|NCT04732949|50553037|FG001|Overall Study|Protocol Violation|1|||
25239103|NCT04732949|50553036|FG000|Overall Study|Non-compliance|0|||
25239104|NCT04732949|50553037|FG001|Overall Study|Non-compliance|2|||
25239105|NCT04732949|50553036|FG000|Overall Study|Physician Decision|2|||
25239106|NCT04732949|50553037|FG001|Overall Study|Physician Decision|1|||
25239107|NCT04732949|50553036|FG000|Overall Study|Serious adverse event (Fatal)|16|||
25239108|NCT04732949|50553037|FG001|Overall Study|Serious adverse event (Fatal)|18|||
25239109|NCT04732949|50553036|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
25239110|NCT04732949|50553037|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
25320419|NCT00929201|50636250|FG001|Period 1|Withdrawal by Subject|1|||
25320420|NCT00926003|50636260|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
25239111|NCT04732949|50553036|FG000|Overall Study|Non-serious adverse event|1|||
25239112|NCT04732949|50553037|FG001|Overall Study|Non-serious adverse event|3|||
25239113|NCT04732949|50553036|FG000|Overall Study|Lost to Follow-up|26|||
25239114|NCT04732949|50553037|FG001|Overall Study|Lost to Follow-up|27|||
25239115|NCT04732949|50553036|FG000|Overall Study|Other|6|||
25239116|NCT04732949|50553037|FG001|Overall Study|Other|3|||
25239117|NCT04235504|50553092|FG000|Study Phase|Withdrawal by Subject|5|||
25239118|NCT04235504|50553093|FG001|Study Phase|Withdrawal by Subject|2|||
25239119|NCT04235504|50553094|FG002|Study Phase|Withdrawal by Subject|0|||
25239120|NCT04235504|50553095|FG003|Study Phase|Withdrawal by Subject|0|||
25239121|NCT04235504|50553092|FG000|Continuation Phase|Withdrawal by Subject|0|||
25239122|NCT04235504|50553093|FG001|Continuation Phase|Withdrawal by Subject|4|||
25239123|NCT04235504|50553094|FG002|Continuation Phase|Withdrawal by Subject|0|||
25239124|NCT04235504|50553095|FG003|Continuation Phase|Withdrawal by Subject|0|||
25239125|NCT04235504|50553092|FG000|Continuation Phase|Adverse Event|0|||
25239126|NCT04235504|50553093|FG001|Continuation Phase|Adverse Event|1|||
25239127|NCT04235504|50553094|FG002|Continuation Phase|Adverse Event|0|||
25239128|NCT04235504|50553095|FG003|Continuation Phase|Adverse Event|0|||
25239129|NCT04235504|50553092|FG000|Continuation Phase|Physician Decision|1|||
25239130|NCT04235504|50553093|FG001|Continuation Phase|Physician Decision|2|||
25239131|NCT04235504|50553094|FG002|Continuation Phase|Physician Decision|1|||
25239132|NCT04235504|50553095|FG003|Continuation Phase|Physician Decision|0|||
25239133|NCT04172987|50553110|FG000|Lead In Period|Adverse Event|1|||
25239134|NCT04172987|50553110|FG000|Lead In Period|Protocol Violation|1|||
25239135|NCT04172987|50553110|FG000|Period 1|Physician Decision|1|||
25239136|NCT04172987|50553110|FG000|Period 2|Adverse Event|5|||
25320421|NCT00926003|50636261|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
25077553|NCT02239510|50185332|FG000|Overall Study|Lost to Follow-up|2|||
25077554|NCT02239510|50185333|FG001|Overall Study|Lost to Follow-up|1|||
25239137|NCT04172987|50553110|FG000|Period 2|Dosing Termination by Sponsor|4|||
25320422|NCT00926003|50636262|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
25320423|NCT00926003|50636260|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
25320424|NCT00926003|50636261|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
25320425|NCT00926003|50636262|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
25239138|NCT03705832|50553119|FG000|Overall Study|Physician Decision|0|||
25239139|NCT03705832|50553120|FG001|Overall Study|Physician Decision|1|||
25239140|NCT03705832|50553119|FG000|Overall Study|Withdrawal by Subject|1|||
25239141|NCT03705832|50553120|FG001|Overall Study|Withdrawal by Subject|0|||
25239142|NCT03447743|50553126|FG000|Overall Study|Withdrawal by Subject|2|||
25239143|NCT03447743|50553126|FG000|Overall Study|Lost to Follow-up|3|||
25239144|NCT03447743|50553126|FG000|Overall Study|Adverse Event|1|||
25239145|NCT03447743|50553126|FG000|Overall Study|Did not meet criteria to continue|1|||
25239146|NCT03433755|50553134|FG000|Overall Study|Lost to Follow-up|1|||
25239147|NCT03433755|50553135|FG001|Overall Study|Lost to Follow-up|0|||
25239148|NCT03433755|50553136|FG002|Overall Study|Lost to Follow-up|0|||
25239149|NCT03433755|50553137|FG003|Overall Study|Lost to Follow-up|0|||
25239150|NCT03433755|50553134|FG000|Overall Study|Decision by Sponsor|1|||
25239151|NCT03433755|50553135|FG001|Overall Study|Decision by Sponsor|0|||
25239152|NCT03433755|50553136|FG002|Overall Study|Decision by Sponsor|0|||
25239153|NCT03433755|50553137|FG003|Overall Study|Decision by Sponsor|0|||
25239154|NCT03406507|50553160|FG000|Extension Period|Lack of Efficacy|0|||
25239155|NCT03406507|50553161|FG001|Extension Period|Lack of Efficacy|1|||
25239156|NCT03283150|50553170|FG000|Overall Study|Withdrawal by Subject|6|||
25239157|NCT03283150|50553171|FG001|Overall Study|Withdrawal by Subject|0|||
25239158|NCT03283150|50553172|FG002|Overall Study|Withdrawal by Subject|0|||
25239159|NCT03218917|50553183|FG000|Overall Study|Adverse Event|3|||
25239160|NCT03218917|50553184|FG001|Overall Study|Adverse Event|3|||
25239161|NCT03218917|50553185|FG002|Overall Study|Adverse Event|2|||
25239162|NCT03218917|50553183|FG000|Overall Study|Subject withdrew consent|2|||
25239163|NCT03218917|50553184|FG001|Overall Study|Subject withdrew consent|4|||
25239164|NCT03218917|50553185|FG002|Overall Study|Subject withdrew consent|10|||
25239165|NCT03218917|50553183|FG000|Overall Study|Physician Decision|0|||
25239166|NCT03218917|50553184|FG001|Overall Study|Physician Decision|1|||
25239167|NCT03218917|50553185|FG002|Overall Study|Physician Decision|1|||
25239168|NCT03218917|50553183|FG000|Overall Study|Lost to Follow-up|1|||
25239169|NCT03218917|50553184|FG001|Overall Study|Lost to Follow-up|0|||
25239170|NCT03218917|50553185|FG002|Overall Study|Lost to Follow-up|0|||
25239171|NCT03218917|50553183|FG000|Overall Study|Reason Missing|0|||
25239172|NCT03218917|50553184|FG001|Overall Study|Reason Missing|2|||
25239173|NCT03218917|50553185|FG002|Overall Study|Reason Missing|0|||
25239174|NCT03218917|50553183|FG000|Overall Study|Death|0|||
25239175|NCT03218917|50553184|FG001|Overall Study|Death|1|||
25239176|NCT03218917|50553185|FG002|Overall Study|Death|0|||
25239177|NCT03218917|50553183|FG000|Overall Study|Non-Compliance with Study Drug|0|||
25239178|NCT03218917|50553184|FG001|Overall Study|Non-Compliance with Study Drug|1|||
25239179|NCT03218917|50553185|FG002|Overall Study|Non-Compliance with Study Drug|0|||
25239180|NCT03056040|50553196|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
25239181|NCT03056040|50553197|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
25239182|NCT03056040|50553196|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
25239183|NCT03056040|50553197|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
25239184|NCT03056040|50553196|FG000|Primary Evaluation Period|Pregnancy|0|||
25239185|NCT03056040|50553197|FG001|Primary Evaluation Period|Pregnancy|1|||
25239186|NCT03056040|50553196|FG000|Extension Period|Physician Decision|3|||
25239187|NCT03056040|50553197|FG001|Extension Period|Physician Decision|3|||
25239188|NCT03056040|50553196|FG000|Extension Period|Lost to Follow-up|0|||
25239189|NCT03056040|50553197|FG001|Extension Period|Lost to Follow-up|1|||
25239190|NCT03056040|50553196|FG000|Extension Period|Death|0|||
25239191|NCT03056040|50553197|FG001|Extension Period|Death|3|||
25239192|NCT03056040|50553196|FG000|Extension Period|Withdrawal by Subject|1|||
25239193|NCT03056040|50553197|FG001|Extension Period|Withdrawal by Subject|0|||
25239194|NCT03021499|50553208|FG000|Overall Study|Adverse Event|1|||
25239195|NCT03021499|50553209|FG001|Overall Study|Adverse Event|0|||
25239196|NCT03021499|50553208|FG000|Overall Study|Death|1|||
25239197|NCT03021499|50553209|FG001|Overall Study|Death|5|||
25239198|NCT03021499|50553208|FG000|Overall Study|Lack of Efficacy|0|||
25239199|NCT03021499|50553209|FG001|Overall Study|Lack of Efficacy|1|||
25239200|NCT03021499|50553208|FG000|Overall Study|Lost to Follow-up|1|||
25239201|NCT03021499|50553209|FG001|Overall Study|Lost to Follow-up|3|||
25239202|NCT03021499|50553208|FG000|Overall Study|Physician Decision|2|||
25239203|NCT03021499|50553209|FG001|Overall Study|Physician Decision|3|||
25239204|NCT03021499|50553208|FG000|Overall Study|Pregnancy|1|||
25239205|NCT03021499|50553209|FG001|Overall Study|Pregnancy|0|||
25239206|NCT03021499|50553208|FG000|Overall Study|Withdrawal by Subject|7|||
25239207|NCT03021499|50553209|FG001|Overall Study|Withdrawal by Subject|14|||
25239208|NCT03021499|50553208|FG000|Overall Study|Prohibited medication required|1|||
25239209|NCT03021499|50553209|FG001|Overall Study|Prohibited medication required|0|||
25239210|NCT03021499|50553208|FG000|Overall Study|Protocol non-compliance|1|||
25239211|NCT03021499|50553209|FG001|Overall Study|Protocol non-compliance|1|||
25239212|NCT03021499|50553208|FG000|Overall Study|None of the above|0|||
25239213|NCT03021499|50553209|FG001|Overall Study|None of the above|4|||
25239214|NCT03021499|50553208|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
25239215|NCT03021499|50553209|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
25239216|NCT02726581|50553238|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
25239217|NCT02726581|50553239|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
25239218|NCT02726581|50553240|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
25239219|NCT02726581|50553238|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
25239220|NCT02726581|50553239|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
25239221|NCT02726581|50553240|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
25239222|NCT02726581|50553238|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
25239223|NCT02726581|50553239|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25239224|NCT02726581|50553240|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
25239225|NCT02726581|50553238|FG000|Treatment Period|Disease progression|47|||
25239226|NCT02726581|50553239|FG001|Treatment Period|Disease progression|50|||
25239227|NCT02726581|50553240|FG002|Treatment Period|Disease progression|16|||
25239228|NCT02726581|50553238|FG000|Treatment Period|Other reasons|9|||
25239229|NCT02726581|50553239|FG001|Treatment Period|Other reasons|8|||
25239230|NCT02726581|50553240|FG002|Treatment Period|Other reasons|2|||
25239231|NCT02726581|50553238|FG000|Treatment Period|Study drug toxicity|6|||
25239232|NCT02726581|50553239|FG001|Treatment Period|Study drug toxicity|3|||
25239233|NCT02726581|50553240|FG002|Treatment Period|Study drug toxicity|2|||
25239234|NCT02726581|50553238|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
25239235|NCT02726581|50553239|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
25239236|NCT02726581|50553240|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
25239237|NCT02726581|50553238|FG000|Treatment Period|Participant withdrew consent|3|||
25239238|NCT02726581|50553239|FG001|Treatment Period|Participant withdrew consent|1|||
25239239|NCT02726581|50553240|FG002|Treatment Period|Participant withdrew consent|1|||
25239240|NCT02726581|50553238|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
25239241|NCT02726581|50553239|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
25239242|NCT02726581|50553240|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
25239243|NCT02726581|50553238|FG000|Treatment Period|Maximum clinical benefit|0|||
25239244|NCT02726581|50553239|FG001|Treatment Period|Maximum clinical benefit|2|||
25239245|NCT02726581|50553240|FG002|Treatment Period|Maximum clinical benefit|0|||
25239246|NCT02726581|50553238|FG000|Treatment Period|Death|1|||
25239247|NCT02726581|50553239|FG001|Treatment Period|Death|0|||
25239248|NCT02726581|50553240|FG002|Treatment Period|Death|0|||
25239249|NCT02726581|50553238|FG000|Treatment Period|Poor/non-compliance|1|||
25239250|NCT02726581|50553239|FG001|Treatment Period|Poor/non-compliance|0|||
25239251|NCT02726581|50553240|FG002|Treatment Period|Poor/non-compliance|0|||
25239252|NCT02726581|50553238|FG000|Treatment Period|Participant no longer meets study criteria|0|||
25239253|NCT02726581|50553239|FG001|Treatment Period|Participant no longer meets study criteria|1|||
25239254|NCT02726581|50553240|FG002|Treatment Period|Participant no longer meets study criteria|0|||
25239255|NCT02700048|50553250|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
25239256|NCT02700048|50553251|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
25239257|NCT02425904|50553268|FG000|Overall Study|Lost to Follow-up|1|||
25239258|NCT02425904|50553269|FG001|Overall Study|Lost to Follow-up|0|||
25239259|NCT02425904|50553268|FG000|Overall Study|Withdrawal by Subject|2|||
25239260|NCT02425904|50553269|FG001|Overall Study|Withdrawal by Subject|0|||
25239261|NCT02425904|50553268|FG000|Overall Study|Death|0|||
25239262|NCT02425904|50553269|FG001|Overall Study|Death|3|||
25239263|NCT02296125|50553291|FG000|Overall Study|Withdrawal by Subject|18|||
25239264|NCT02296125|50553292|FG001|Overall Study|Withdrawal by Subject|8|||
25239265|NCT02296125|50553293|FG002|Overall Study|Withdrawal by Subject|6|||
25239266|NCT02296125|50553294|FG003|Overall Study|Withdrawal by Subject|2|||
25239267|NCT02296125|50553291|FG000|Overall Study|Adverse Event|41|||
25239268|NCT02296125|50553292|FG001|Overall Study|Adverse Event|52|||
25239269|NCT02296125|50553293|FG002|Overall Study|Adverse Event|9|||
25239270|NCT02296125|50553294|FG003|Overall Study|Adverse Event|4|||
25239271|NCT02296125|50553291|FG000|Overall Study|Severe non-compliance to protocol|0|||
25239272|NCT02296125|50553292|FG001|Overall Study|Severe non-compliance to protocol|1|||
25239273|NCT02296125|50553293|FG002|Overall Study|Severe non-compliance to protocol|0|||
25239274|NCT02296125|50553294|FG003|Overall Study|Severe non-compliance to protocol|0|||
25239275|NCT02296125|50553291|FG000|Overall Study|Condition under investigation worsened|153|||
25239276|NCT02296125|50553292|FG001|Overall Study|Condition under investigation worsened|199|||
25239277|NCT02296125|50553293|FG002|Overall Study|Condition under investigation worsened|39|||
25239278|NCT02296125|50553294|FG003|Overall Study|Condition under investigation worsened|56|||
25239279|NCT02296125|50553291|FG000|Overall Study|Any reason not specifically recorded|6|||
25239280|NCT02296125|50553292|FG001|Overall Study|Any reason not specifically recorded|4|||
25239281|NCT02296125|50553293|FG002|Overall Study|Any reason not specifically recorded|2|||
25239282|NCT02296125|50553294|FG003|Overall Study|Any reason not specifically recorded|0|||
25239283|NCT02097420|50553305|FG000|Overall Study|Death|4|||
25239284|NCT02097420|50553305|FG000|Overall Study|Device explanted|3|||
25239285|NCT02097420|50553305|FG000|Overall Study|Not reached 12-month visit|7|||
25239286|NCT01964989|50553311|FG000|Overall Study|Protocol Violation|3|||
25239287|NCT01964989|50553312|FG001|Overall Study|Protocol Violation|4|||
25239288|NCT01964989|50553311|FG000|Overall Study|Administrative Reason|103|||
25239289|NCT01964989|50553312|FG001|Overall Study|Administrative Reason|95|||
25239290|NCT01964989|50553311|FG000|Overall Study|Adverse Event|0|||
25239291|NCT01964989|50553312|FG001|Overall Study|Adverse Event|1|||
25239292|NCT01964989|50553311|FG000|Overall Study|Death|1|||
25239293|NCT01964989|50553312|FG001|Overall Study|Death|3|||
25239294|NCT01964989|50553311|FG000|Overall Study|Withdrawal by Subject|156|||
25239295|NCT01964989|50553312|FG001|Overall Study|Withdrawal by Subject|160|||
25239296|NCT01964989|50553311|FG000|Overall Study|Lost to Follow-up|254|||
25239297|NCT01964989|50553312|FG001|Overall Study|Lost to Follow-up|232|||
25239298|NCT01964989|50553311|FG000|Overall Study|Other|267|||
25239299|NCT01964989|50553312|FG001|Overall Study|Other|252|||
25239300|NCT01575860|50553340|FG000|Overall Study|Withdrawal by Subject|1|||
25239301|NCT01575860|50553340|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
25239302|NCT01416831|50553347|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
25239303|NCT01416831|50553348|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
25239304|NCT01267955|50553354|FG000|Stage 1 (6 Months)|Death|3|||
25239305|NCT01267955|50553354|FG000|Stage 2 (6 Months)|Death|5|||
25239306|NCT01267955|50553354|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
25239307|NCT01064648|50553361|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
25239308|NCT01064648|50553362|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
25239309|NCT01064648|50553363|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
25239310|NCT01064648|50553364|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
25239311|NCT01064648|50553361|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
25239312|NCT01064648|50553362|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
25239313|NCT01064648|50553363|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
25239314|NCT01064648|50553364|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
25239315|NCT01064648|50553361|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
25239316|NCT01064648|50553362|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
25239317|NCT01064648|50553363|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
25239318|NCT01064648|50553364|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
25239319|NCT01064648|50553361|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
25239320|NCT01064648|50553362|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
25239321|NCT01064648|50553363|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
25239322|NCT01064648|50553364|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
25239323|NCT01064648|50553361|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
25239324|NCT01064648|50553362|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
25239325|NCT01064648|50553363|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
25239326|NCT01064648|50553364|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
25239327|NCT01064648|50553361|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
25239328|NCT01064648|50553362|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
25239329|NCT01064648|50553363|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
25239330|NCT01064648|50553364|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
25239331|NCT01064648|50553361|FG000|Phase II|Adverse Event|0|||
25239332|NCT01064648|50553362|FG001|Phase II|Adverse Event|0|||
25239333|NCT01064648|50553363|FG002|Phase II|Adverse Event|15|||
25239334|NCT01064648|50553364|FG003|Phase II|Adverse Event|8|||
25239335|NCT01064648|50553361|FG000|Phase II|Death|0|||
25239336|NCT01064648|50553362|FG001|Phase II|Death|0|||
25239337|NCT01064648|50553363|FG002|Phase II|Death|4|||
25239338|NCT01064648|50553364|FG003|Phase II|Death|5|||
25239339|NCT01064648|50553361|FG000|Phase II|Withdrawal by Subject|0|||
25239340|NCT01064648|50553362|FG001|Phase II|Withdrawal by Subject|0|||
25239341|NCT01064648|50553363|FG002|Phase II|Withdrawal by Subject|2|||
25239342|NCT01064648|50553364|FG003|Phase II|Withdrawal by Subject|5|||
25239343|NCT01064648|50553361|FG000|Phase II|Progression|0|||
25239344|NCT01064648|50553362|FG001|Phase II|Progression|0|||
25239345|NCT01064648|50553363|FG002|Phase II|Progression|21|||
25239346|NCT01064648|50553364|FG003|Phase II|Progression|27|||
25239347|NCT01064648|50553361|FG000|Phase II|Non-protocol specified|0|||
25239348|NCT01064648|50553362|FG001|Phase II|Non-protocol specified|0|||
25239349|NCT01064648|50553363|FG002|Phase II|Non-protocol specified|5|||
25239350|NCT01064648|50553364|FG003|Phase II|Non-protocol specified|3|||
25239351|NCT01064648|50553361|FG000|Phase II|Under Review|0|||
25239352|NCT01064648|50553362|FG001|Phase II|Under Review|0|||
25239353|NCT01064648|50553363|FG002|Phase II|Under Review|2|||
25239354|NCT01064648|50553364|FG003|Phase II|Under Review|0|||
25239355|NCT00542451|50553390|FG000|Overall Study|Adverse Event|31|||
25239356|NCT00542451|50553390|FG000|Overall Study|Withdrawal by Subject|30|||
25239357|NCT00542451|50553390|FG000|Overall Study|Physician Decision|4|||
25239358|NCT00542451|50553390|FG000|Overall Study|Recurrent disease|1|||
25239359|NCT00542451|50553390|FG000|Overall Study|unknown reason|1|||
25239360|NCT00542451|50553390|FG000|Overall Study|Death|2|||
25239361|NCT00542451|50553390|FG000|Overall Study|Lost to Follow-up|10|||
25239362|NCT00382070|50553399|FG000|Overall Study|No follow up data mapped to Other|17|||
25239363|NCT00382070|50553400|FG001|Overall Study|No follow up data mapped to Other|19|||
25239364|NCT00382070|50553399|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
25239365|NCT00382070|50553400|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
25239366|NCT00382070|50553399|FG000|Overall Study|No clinical assessment|9|||
25239367|NCT00382070|50553400|FG001|Overall Study|No clinical assessment|11|||
25239368|NCT02921269|50553423|FG000|Overall Study|Did not complete DLT period|1|||
25239369|NCT04303559|50553462|FG000|Overall Study|Study closed due to poor enrollment.|1|||
25239370|NCT03784820|50553468|FG000|Overall Study|Lost to Follow-up|5|||
25239371|NCT03784820|50553469|FG001|Overall Study|Lost to Follow-up|5|||
25239372|NCT03784820|50553470|FG002|Overall Study|Lost to Follow-up|3|||
25239373|NCT03784820|50553471|FG003|Overall Study|Lost to Follow-up|3|||
25239374|NCT03769675|50553479|FG000|Overall Study|Lost to Follow-up|1|||
25239375|NCT03729245|50553485|FG000|Overall Study|Lost to Follow-up|5|||
25239376|NCT03729245|50553486|FG001|Overall Study|Lost to Follow-up|6|||
25239377|NCT03729245|50553485|FG000|Overall Study|Withdrawal by Subject|16|||
25239378|NCT03729245|50553486|FG001|Overall Study|Withdrawal by Subject|19|||
25239379|NCT03729245|50553485|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
25239380|NCT03729245|50553486|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
25239381|NCT03311711|50553506|FG000|Overall Study|Death|1|||
25239382|NCT03311711|50553507|FG001|Overall Study|Death|0|||
25239383|NCT03311711|50553508|FG002|Overall Study|Death|0|||
25239384|NCT03311711|50553509|FG003|Overall Study|Death|0|||
25239385|NCT03311711|50553510|FG004|Overall Study|Death|0|||
25239386|NCT03311711|50553511|FG005|Overall Study|Death|0|||
25239387|NCT03311711|50553512|FG006|Overall Study|Death|1|||
25239388|NCT03311711|50553513|FG007|Overall Study|Death|0|||
25239389|NCT03311711|50553514|FG008|Overall Study|Death|1|||
25239390|NCT03311711|50553515|FG009|Overall Study|Death|0|||
25239391|NCT03311711|50553506|FG000|Overall Study|Death of dyad partner|0|||
25239392|NCT03311711|50553507|FG001|Overall Study|Death of dyad partner|1|||
25239393|NCT03311711|50553508|FG002|Overall Study|Death of dyad partner|0|||
25239394|NCT03311711|50553509|FG003|Overall Study|Death of dyad partner|0|||
25239395|NCT03311711|50553510|FG004|Overall Study|Death of dyad partner|0|||
25239396|NCT03311711|50553511|FG005|Overall Study|Death of dyad partner|0|||
25239397|NCT03311711|50553512|FG006|Overall Study|Death of dyad partner|0|||
25239398|NCT03311711|50553513|FG007|Overall Study|Death of dyad partner|1|||
25239399|NCT03311711|50553514|FG008|Overall Study|Death of dyad partner|0|||
25239400|NCT03311711|50553515|FG009|Overall Study|Death of dyad partner|1|||
25239401|NCT03311711|50553506|FG000|Overall Study|Lost to Follow-up|2|||
25239402|NCT03311711|50553507|FG001|Overall Study|Lost to Follow-up|2|||
25239403|NCT03311711|50553508|FG002|Overall Study|Lost to Follow-up|0|||
25239404|NCT03311711|50553509|FG003|Overall Study|Lost to Follow-up|0|||
25239405|NCT03311711|50553510|FG004|Overall Study|Lost to Follow-up|0|||
25239406|NCT03311711|50553511|FG005|Overall Study|Lost to Follow-up|0|||
25239407|NCT03311711|50553512|FG006|Overall Study|Lost to Follow-up|1|||
25239408|NCT03311711|50553513|FG007|Overall Study|Lost to Follow-up|1|||
25239409|NCT03311711|50553514|FG008|Overall Study|Lost to Follow-up|0|||
25239410|NCT03311711|50553515|FG009|Overall Study|Lost to Follow-up|0|||
25239411|NCT03311711|50553506|FG000|Overall Study|Withdrawal by Subject|1|||
25239412|NCT03311711|50553507|FG001|Overall Study|Withdrawal by Subject|1|||
25239413|NCT03311711|50553508|FG002|Overall Study|Withdrawal by Subject|0|||
25239414|NCT03311711|50553509|FG003|Overall Study|Withdrawal by Subject|0|||
25239415|NCT03311711|50553510|FG004|Overall Study|Withdrawal by Subject|0|||
25239416|NCT03311711|50553511|FG005|Overall Study|Withdrawal by Subject|0|||
25239417|NCT03311711|50553512|FG006|Overall Study|Withdrawal by Subject|3|||
25239418|NCT03311711|50553513|FG007|Overall Study|Withdrawal by Subject|3|||
25239419|NCT03311711|50553514|FG008|Overall Study|Withdrawal by Subject|0|||
25239420|NCT03311711|50553515|FG009|Overall Study|Withdrawal by Subject|0|||
25239421|NCT03270891|50553545|FG000|Overall Study|Lost to Follow-up|3|||
25239422|NCT03270891|50553546|FG001|Overall Study|Lost to Follow-up|6|||
25239423|NCT03270891|50553547|FG002|Overall Study|Lost to Follow-up|0|||
25239424|NCT03270891|50553545|FG000|Overall Study|Withdrawal by Subject|1|||
25239425|NCT03270891|50553546|FG001|Overall Study|Withdrawal by Subject|0|||
25239426|NCT03270891|50553547|FG002|Overall Study|Withdrawal by Subject|0|||
25239427|NCT03270891|50553545|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
25239428|NCT03270891|50553546|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
25239429|NCT03270891|50553547|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
25320426|NCT00928889|50636272|FG000|Overall Study|Lost to Follow-up|3|||
25320427|NCT00928889|50636273|FG001|Overall Study|Lost to Follow-up|1|||
25239430|NCT02992743|50553559|FG000|Overall Study|Withdrawal by Subject|1|||
25239431|NCT02992743|50553560|FG001|Overall Study|Withdrawal by Subject|1|||
25239432|NCT02992743|50553559|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
25239433|NCT02992743|50553560|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
25239434|NCT02992743|50553559|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
25239435|NCT02992743|50553560|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
25320428|NCT00928889|50636272|FG000|Overall Study|Protocol Violation|0|||
25239436|NCT02992743|50553559|FG000|Overall Study|No measurable disease|1|||
25239437|NCT02992743|50553560|FG001|Overall Study|No measurable disease|0|||
25239438|NCT02992743|50553559|FG000|Overall Study|Lost to Follow-up|0|||
25239439|NCT02992743|50553560|FG001|Overall Study|Lost to Follow-up|1|||
25239440|NCT02853344|50553568|FG000|Overall Study|Lost to Follow-up|1|||
25239441|NCT02853344|50553569|FG001|Overall Study|Lost to Follow-up|1|||
25239442|NCT02853344|50553568|FG000|Overall Study|Withdrawal by Subject|2|||
25239443|NCT02853344|50553569|FG001|Overall Study|Withdrawal by Subject|4|||
25239444|NCT02853344|50553568|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
25239445|NCT02853344|50553569|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
25239446|NCT02853344|50553568|FG000|Overall Study|Death|70|||
25239447|NCT02853344|50553569|FG001|Overall Study|Death|112|||
25239448|NCT02739620|50553580|FG000|Overall Study|Lost to Follow-up|3|||
25239449|NCT02739620|50553581|FG001|Overall Study|Lost to Follow-up|1|||
25239450|NCT02739620|50553580|FG000|Overall Study|Adverse Event|0|||
25239451|NCT02739620|50553581|FG001|Overall Study|Adverse Event|1|||
25239452|NCT02675426|50553590|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
25239453|NCT02675426|50553591|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
25239454|NCT02675426|50553592|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
25239455|NCT02675426|50553593|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
25239456|NCT02675426|50553590|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
25239457|NCT02675426|50553591|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
25239458|NCT02675426|50553592|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
25239459|NCT02675426|50553593|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
25239460|NCT02675426|50553590|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
25239461|NCT02675426|50553591|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
25239462|NCT02675426|50553592|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
24976948|NCT02952820|50065759|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
24976949|NCT02952820|50065760|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
24976950|NCT02952820|50065761|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
24976951|NCT02952820|50065759|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
24976952|NCT02952820|50065760|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
24976953|NCT02952820|50065761|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
25239463|NCT02675426|50553593|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
25239464|NCT02675426|50553590|FG000|Period 1: Week 1 to Week 12|Other|2|||
25239465|NCT02675426|50553591|FG001|Period 1: Week 1 to Week 12|Other|1|||
25239466|NCT02675426|50553592|FG002|Period 1: Week 1 to Week 12|Other|0|||
25239467|NCT02675426|50553593|FG003|Period 1: Week 1 to Week 12|Other|2|||
25239468|NCT02675426|50553590|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
25239469|NCT02675426|50553591|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
25239470|NCT02675426|50553592|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
25239471|NCT02675426|50553593|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
25239472|NCT02675426|50553590|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
25239473|NCT02675426|50553591|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
25239474|NCT02675426|50553592|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
25239475|NCT02675426|50553593|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
25239476|NCT02675426|50553590|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
25239477|NCT02675426|50553591|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
25239478|NCT02675426|50553592|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
25239479|NCT02675426|50553593|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
25239480|NCT02675426|50553590|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
25239481|NCT02675426|50553591|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
25239482|NCT02675426|50553592|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
25239483|NCT02675426|50553593|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
25239484|NCT02675426|50553590|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
25239485|NCT02675426|50553591|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
25239486|NCT02675426|50553592|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
25239487|NCT02675426|50553593|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
25239488|NCT02675426|50553590|FG000|Period 2: Week 12 to Week 260|Other|8|||
25239489|NCT02675426|50553591|FG001|Period 2: Week 12 to Week 260|Other|12|||
25239490|NCT02675426|50553592|FG002|Period 2: Week 12 to Week 260|Other|23|||
25239491|NCT02675426|50553593|FG003|Period 2: Week 12 to Week 260|Other|15|||
25320429|NCT00928889|50636273|FG001|Overall Study|Protocol Violation|1|||
25320430|NCT00928889|50636272|FG000|Overall Study|Adverse Event|1|||
25320431|NCT00928889|50636273|FG001|Overall Study|Adverse Event|0|||
25320432|NCT00928889|50636272|FG000|Overall Study|Other|1|||
25320433|NCT00928889|50636273|FG001|Overall Study|Other|0|||
25320434|NCT03978091|50636285|FG000|Overall Study|Lost to Follow-up|0|||
25320435|NCT03978091|50636286|FG001|Overall Study|Lost to Follow-up|0|||
25320436|NCT03978091|50636287|FG002|Overall Study|Lost to Follow-up|1|||
25320437|NCT03978091|50636288|FG003|Overall Study|Lost to Follow-up|0|||
25320438|NCT03978091|50636289|FG004|Overall Study|Lost to Follow-up|0|||
25320439|NCT03978091|50636290|FG005|Overall Study|Lost to Follow-up|0|||
25320440|NCT03978091|50636285|FG000|Overall Study|Withdrawal by Subject|0|||
25320441|NCT03978091|50636286|FG001|Overall Study|Withdrawal by Subject|0|||
25320442|NCT03978091|50636287|FG002|Overall Study|Withdrawal by Subject|0|||
25320443|NCT03978091|50636288|FG003|Overall Study|Withdrawal by Subject|1|||
25320444|NCT03978091|50636289|FG004|Overall Study|Withdrawal by Subject|1|||
25320445|NCT03978091|50636290|FG005|Overall Study|Withdrawal by Subject|0|||
25239492|NCT02091960|50553634|FG000|Overall Study|Death|7|||
25239493|NCT02091960|50553634|FG000|Overall Study|Withdrawal by Subject|1|||
25239494|NCT02091960|50553634|FG000|Overall Study|Miscellaneous Reasons|31|||
25239495|NCT02091960|50553634|FG000|Overall Study|On Study at Data Cut-off|12|||
25239496|NCT02060721|50553638|FG000|Overall Study|Lost to Follow-up|1|||
25239497|NCT02060721|50553638|FG000|Overall Study|Physician Decision|2|||
25239498|NCT02060721|50553638|FG000|Overall Study|Death|14|||
25239499|NCT02060721|50553638|FG000|Overall Study|Withdrawal by Subject|2|||
25239500|NCT02060721|50553638|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
25239501|NCT01527149|50553642|FG000|Overall Study|Death|2|||
25239502|NCT01359956|50553650|FG000|Overall Study|Death|58|||
25239503|NCT01359956|50553651|FG001|Overall Study|Death|60|||
25239504|NCT01359956|50553652|FG002|Overall Study|Death|66|||
25239505|NCT01359956|50553653|FG003|Overall Study|Death|57|||
25239506|NCT01359956|50553650|FG000|Overall Study|Lost to Follow-up|3|||
25239507|NCT01359956|50553651|FG001|Overall Study|Lost to Follow-up|4|||
25239508|NCT01359956|50553652|FG002|Overall Study|Lost to Follow-up|1|||
25239509|NCT01359956|50553653|FG003|Overall Study|Lost to Follow-up|1|||
25239510|NCT01306045|50553666|FG000|Met General Eligibility Criteria|Screen failures|193|||
25239511|NCT01306045|50553667|FG001|Met General Eligibility Criteria|Screen failures|11|||
25239512|NCT01306045|50553668|FG002|Met General Eligibility Criteria|Screen failures|8|||
25239513|NCT01356940|50553749|FG000|First Intervention (28 Days)|Adverse Event|1|||
25239514|NCT01356940|50553750|FG001|First Intervention (28 Days)|Adverse Event|0|||
25239515|NCT01356940|50553749|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
25239516|NCT01356940|50553750|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
25239517|NCT01330030|50553769|FG000|Overall Study|Lost to Follow-up|16|||
25239518|NCT01330030|50553770|FG001|Overall Study|Lost to Follow-up|17|||
25239519|NCT00477295|50553890|FG000|Overall Study|Adverse Event|31|||
25239520|NCT00477295|50553891|FG001|Overall Study|Adverse Event|35|||
25239521|NCT00477295|50553890|FG000|Overall Study|Withdrawal by Subject|35|||
25239522|NCT00477295|50553891|FG001|Overall Study|Withdrawal by Subject|24|||
25239523|NCT00477295|50553890|FG000|Overall Study|Lack of Efficacy|23|||
25239524|NCT00477295|50553891|FG001|Overall Study|Lack of Efficacy|23|||
25239525|NCT00477295|50553890|FG000|Overall Study|Protocol Violation|3|||
25239526|NCT00477295|50553891|FG001|Overall Study|Protocol Violation|8|||
25239527|NCT00477295|50553890|FG000|Overall Study|Physician Decision|4|||
25239528|NCT00477295|50553891|FG001|Overall Study|Physician Decision|5|||
25320446|NCT00564733|50636313|FG000|Overall Study|Withdrawal by Subject|4|||
25239529|NCT00477295|50553890|FG000|Overall Study|Lost to Follow-up|21|||
25239530|NCT00477295|50553891|FG001|Overall Study|Lost to Follow-up|11|||
25239531|NCT00477295|50553890|FG000|Overall Study|Other|4|||
25239532|NCT00477295|50553891|FG001|Overall Study|Other|3|||
25239533|NCT00476593|50553903|FG000|Overall Study|Lost to Follow-up|10|||
25239534|NCT00476593|50553904|FG001|Overall Study|Lost to Follow-up|2|||
25239535|NCT00476593|50553905|FG002|Overall Study|Lost to Follow-up|8|||
25239536|NCT00476593|50553906|FG003|Overall Study|Lost to Follow-up|22|||
25239537|NCT00476476|50553918|FG000|Overall Study|Adverse Event|2|||
25320447|NCT00564733|50636313|FG000|Overall Study|Ineligible|5|||
25320448|NCT00931385|50636317|FG000|Overall Study|Adverse Event|2|||
25320449|NCT00931385|50636318|FG001|Overall Study|Adverse Event|1|||
25239538|NCT00476476|50553919|FG001|Overall Study|Adverse Event|7|||
25239539|NCT00476476|50553918|FG000|Overall Study|Progressive Disease|0|||
25239540|NCT00476476|50553919|FG001|Overall Study|Progressive Disease|17|||
25239541|NCT00476086|50553924|FG000|Overall Study|Alternative therapy|1|||
25239542|NCT00476086|50553924|FG000|Overall Study|Progressive Disease|4|||
25239543|NCT00476047|50553930|FG000|Overall Study|Lost to Follow-up|1|||
25239544|NCT00476008|50553938|FG000|Overall Study|Adverse Event|4|||
25239545|NCT00476008|50553939|FG001|Overall Study|Adverse Event|4|||
25239546|NCT00476008|50553938|FG000|Overall Study|Placebo concerns|2|||
25239547|NCT00476008|50553939|FG001|Overall Study|Placebo concerns|2|||
25239548|NCT00476008|50553938|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
25239549|NCT00476008|50553939|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
25239550|NCT00476008|50553938|FG000|Overall Study|Withdrawal by Subject|0|||
25239551|NCT00476008|50553939|FG001|Overall Study|Withdrawal by Subject|1|||
25239552|NCT00476008|50553938|FG000|Overall Study|Death|1|||
25239553|NCT00476008|50553939|FG001|Overall Study|Death|0|||
25239554|NCT00475735|50553955|FG000|Treatment Period 1|Adverse Event|2|||
25239555|NCT00475735|50553956|FG001|Treatment Period 1|Adverse Event|0|||
25239556|NCT00475735|50553957|FG002|Treatment Period 1|Adverse Event|0|||
25239557|NCT00475735|50553958|FG003|Treatment Period 1|Adverse Event|0|||
25239558|NCT00475735|50553959|FG004|Treatment Period 1|Adverse Event|0|||
25239559|NCT00475735|50553960|FG005|Treatment Period 1|Adverse Event|0|||
25239560|NCT00475735|50553955|FG000|Treatment Period 1|Lack of Efficacy|1|||
25239561|NCT00475735|50553956|FG001|Treatment Period 1|Lack of Efficacy|0|||
25239562|NCT00475735|50553957|FG002|Treatment Period 1|Lack of Efficacy|0|||
25239563|NCT00475735|50553958|FG003|Treatment Period 1|Lack of Efficacy|0|||
25239564|NCT00475735|50553959|FG004|Treatment Period 1|Lack of Efficacy|0|||
25239565|NCT00475735|50553960|FG005|Treatment Period 1|Lack of Efficacy|0|||
25239566|NCT00475735|50553955|FG000|Treatment Period 1|Lost to Follow-up|0|||
25239567|NCT00475735|50553956|FG001|Treatment Period 1|Lost to Follow-up|0|||
25239568|NCT00475735|50553957|FG002|Treatment Period 1|Lost to Follow-up|0|||
25239569|NCT00475735|50553958|FG003|Treatment Period 1|Lost to Follow-up|0|||
25239570|NCT00475735|50553959|FG004|Treatment Period 1|Lost to Follow-up|0|||
25239571|NCT00475735|50553960|FG005|Treatment Period 1|Lost to Follow-up|1|||
25239572|NCT00475735|50553955|FG000|Treatment Period 1|Protocol Violation|0|||
25239573|NCT00475735|50553956|FG001|Treatment Period 1|Protocol Violation|0|||
25239574|NCT00475735|50553957|FG002|Treatment Period 1|Protocol Violation|0|||
25239575|NCT00475735|50553958|FG003|Treatment Period 1|Protocol Violation|1|||
25239576|NCT00475735|50553959|FG004|Treatment Period 1|Protocol Violation|0|||
25239577|NCT00475735|50553960|FG005|Treatment Period 1|Protocol Violation|0|||
25239578|NCT00475735|50553955|FG000|Treatment Period 1|Withdrawal by Subject|1|||
25320450|NCT00931385|50636319|FG002|Overall Study|Adverse Event|0|||
25320451|NCT00931385|50636320|FG003|Overall Study|Adverse Event|3|||
25320452|NCT00931385|50636317|FG000|Overall Study|Protocol Violation|0|||
25320453|NCT00931385|50636318|FG001|Overall Study|Protocol Violation|0|||
25320454|NCT00931385|50636319|FG002|Overall Study|Protocol Violation|1|||
25320455|NCT00931385|50636320|FG003|Overall Study|Protocol Violation|0|||
25320456|NCT00931385|50636317|FG000|Overall Study|Withdrawal by Subject|0|||
25320457|NCT00931385|50636318|FG001|Overall Study|Withdrawal by Subject|1|||
25320458|NCT00931385|50636319|FG002|Overall Study|Withdrawal by Subject|0|||
25320459|NCT00931385|50636320|FG003|Overall Study|Withdrawal by Subject|1|||
25320460|NCT00931385|50636317|FG000|Overall Study|Lost to Follow-up|0|||
25320461|NCT00931385|50636318|FG001|Overall Study|Lost to Follow-up|0|||
25320462|NCT00931385|50636319|FG002|Overall Study|Lost to Follow-up|0|||
25320463|NCT00931385|50636320|FG003|Overall Study|Lost to Follow-up|1|||
25320464|NCT00565747|50636336|FG000|Overall Study|No embryo transfer|67|||
25320465|NCT00565747|50636337|FG001|Overall Study|No embryo transfer|73|||
25320466|NCT00563797|50636345|FG000|Overall Study|Lost to Follow-up|7|||
25320467|NCT00563797|50636346|FG001|Overall Study|Lost to Follow-up|2|||
25320468|NCT00771927|50636365|FG000|Overall Study|Adverse Event|100|||
25320469|NCT00771927|50636366|FG001|Overall Study|Adverse Event|105|||
25320470|NCT00771927|50636365|FG000|Overall Study|Lack of Efficacy|70|||
25320471|NCT00771927|50636366|FG001|Overall Study|Lack of Efficacy|42|||
25320472|NCT00771927|50636365|FG000|Overall Study|Lost to Follow-up|46|||
25320473|NCT00771927|50636366|FG001|Overall Study|Lost to Follow-up|46|||
25320474|NCT00771927|50636365|FG000|Overall Study|Withdrawal by Subject|16|||
25320475|NCT00771927|50636366|FG001|Overall Study|Withdrawal by Subject|17|||
25320476|NCT00771927|50636365|FG000|Overall Study|Other reason|23|||
25320477|NCT00771927|50636366|FG001|Overall Study|Other reason|27|||
25239579|NCT00475735|50553956|FG001|Treatment Period 1|Withdrawal by Subject|1|||
25239580|NCT00475735|50553957|FG002|Treatment Period 1|Withdrawal by Subject|0|||
25239581|NCT00475735|50553958|FG003|Treatment Period 1|Withdrawal by Subject|0|||
25239582|NCT00475735|50553959|FG004|Treatment Period 1|Withdrawal by Subject|0|||
25239583|NCT00475735|50553960|FG005|Treatment Period 1|Withdrawal by Subject|0|||
25239584|NCT00475735|50553955|FG000|Treatment Period 1|DC due to AE but continuing|0|||
25320478|NCT00771849|50636374|FG000|Overall Study|Lost to Follow-up|1|||
25320479|NCT00771849|50636375|FG001|Overall Study|Lost to Follow-up|2|||
25320480|NCT00771849|50636374|FG000|Overall Study|Withdrawal by Subject|1|||
25320481|NCT00771849|50636375|FG001|Overall Study|Withdrawal by Subject|1|||
25171761|NCT02985957|50309412|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
25171762|NCT02985957|50309413|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
25171763|NCT02985957|50309414|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
25171764|NCT02985957|50309408|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
25171765|NCT02985957|50309409|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
25171766|NCT02985957|50309410|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
25320482|NCT00771849|50636374|FG000|Overall Study|Not vaccinated|0|||
25320483|NCT00771849|50636375|FG001|Overall Study|Not vaccinated|1|||
25320484|NCT00564889|50636381|FG000|Overall Study|Death|7|||
25320485|NCT00564889|50636381|FG000|Overall Study|Adverse Event|12|||
25320486|NCT00564889|50636381|FG000|Overall Study|Alternative treatment|3|||
25320487|NCT00564889|50636381|FG000|Overall Study|Disease progression|3|||
25320488|NCT00564889|50636381|FG000|Overall Study|Other, not specified|4|||
25320489|NCT00560833|50636399|FG000|Overall Study|Adverse Event|16|||
25320490|NCT00560833|50636400|FG001|Overall Study|Adverse Event|10|||
25320491|NCT00560833|50636401|FG002|Overall Study|Adverse Event|25|||
25320492|NCT00560833|50636402|FG003|Overall Study|Adverse Event|23|||
25320493|NCT00560833|50636403|FG004|Overall Study|Adverse Event|35|||
25320494|NCT00560833|50636399|FG000|Overall Study|Lost to Follow-up|0|||
25320495|NCT00560833|50636400|FG001|Overall Study|Lost to Follow-up|0|||
25320496|NCT00560833|50636401|FG002|Overall Study|Lost to Follow-up|1|||
25320497|NCT00560833|50636402|FG003|Overall Study|Lost to Follow-up|0|||
25320498|NCT00560833|50636403|FG004|Overall Study|Lost to Follow-up|0|||
25320499|NCT00560833|50636399|FG000|Overall Study|Lack of Efficacy|22|||
25320500|NCT00560833|50636400|FG001|Overall Study|Lack of Efficacy|9|||
25320501|NCT00560833|50636401|FG002|Overall Study|Lack of Efficacy|6|||
25320502|NCT00560833|50636402|FG003|Overall Study|Lack of Efficacy|4|||
25320503|NCT00560833|50636403|FG004|Overall Study|Lack of Efficacy|4|||
25320504|NCT00560833|50636399|FG000|Overall Study|Participant uncooperative|5|||
25320505|NCT00560833|50636400|FG001|Overall Study|Participant uncooperative|5|||
25320506|NCT00560833|50636401|FG002|Overall Study|Participant uncooperative|4|||
25320507|NCT00560833|50636402|FG003|Overall Study|Participant uncooperative|4|||
25320508|NCT00560833|50636403|FG004|Overall Study|Participant uncooperative|2|||
25320509|NCT00560833|50636399|FG000|Overall Study|Other|1|||
25320510|NCT00560833|50636400|FG001|Overall Study|Other|1|||
25320511|NCT00560833|50636401|FG002|Overall Study|Other|3|||
25320512|NCT00560833|50636402|FG003|Overall Study|Other|0|||
25320513|NCT00560833|50636403|FG004|Overall Study|Other|0|||
25239585|NCT00475735|50553956|FG001|Treatment Period 1|DC due to AE but continuing|0|||
25239586|NCT00475735|50553957|FG002|Treatment Period 1|DC due to AE but continuing|0|||
25239587|NCT00475735|50553958|FG003|Treatment Period 1|DC due to AE but continuing|1|||
25239588|NCT00475735|50553959|FG004|Treatment Period 1|DC due to AE but continuing|2|||
25239589|NCT00475735|50553960|FG005|Treatment Period 1|DC due to AE but continuing|2|||
25239590|NCT00475735|50553955|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
25239591|NCT00475735|50553956|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
25239592|NCT00475735|50553957|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
25239593|NCT00475735|50553958|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
25239594|NCT00475735|50553959|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
25239595|NCT00475735|50553960|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
25239596|NCT00475735|50553955|FG000|Treatment Washout|Lost to Follow-up|0|||
25239597|NCT00475735|50553956|FG001|Treatment Washout|Lost to Follow-up|1|||
25239598|NCT00475735|50553957|FG002|Treatment Washout|Lost to Follow-up|0|||
25320514|NCT00560833|50636399|FG000|Overall Study|Never received drug|0|||
25320515|NCT00560833|50636400|FG001|Overall Study|Never received drug|1|||
25320516|NCT00560833|50636401|FG002|Overall Study|Never received drug|0|||
25320517|NCT00560833|50636402|FG003|Overall Study|Never received drug|0|||
25320518|NCT00560833|50636403|FG004|Overall Study|Never received drug|1|||
25320519|NCT00771615|50636424|FG000|Overall Study|Withdrawal by Subject|0|||
25320520|NCT00771615|50636425|FG001|Overall Study|Withdrawal by Subject|1|||
25320521|NCT00771615|50636426|FG002|Overall Study|Withdrawal by Subject|0|||
25320522|NCT00771615|50636427|FG003|Overall Study|Withdrawal by Subject|0|||
25320523|NCT00771615|50636428|FG004|Overall Study|Withdrawal by Subject|0|||
25320524|NCT00771615|50636429|FG005|Overall Study|Withdrawal by Subject|0|||
25320525|NCT00771615|50636430|FG006|Overall Study|Withdrawal by Subject|0|||
25320526|NCT00771615|50636431|FG007|Overall Study|Withdrawal by Subject|1|||
25171767|NCT02985957|50309411|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
25171768|NCT02985957|50309412|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
25171769|NCT02985957|50309413|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
25171770|NCT02985957|50309414|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
25171771|NCT02985957|50309408|FG000|Treatment Period|Death|0|||
25171772|NCT02985957|50309409|FG001|Treatment Period|Death|0|||
25171773|NCT02985957|50309410|FG002|Treatment Period|Death|0|||
25171774|NCT02985957|50309411|FG003|Treatment Period|Death|0|||
25171775|NCT02985957|50309412|FG004|Treatment Period|Death|1|||
25320527|NCT00771615|50636432|FG008|Overall Study|Withdrawal by Subject|0|||
25320528|NCT00771615|50636424|FG000|Overall Study|Lost to Follow-up|1|||
25320529|NCT00771615|50636425|FG001|Overall Study|Lost to Follow-up|1|||
25320530|NCT00771615|50636426|FG002|Overall Study|Lost to Follow-up|1|||
25320531|NCT00771615|50636427|FG003|Overall Study|Lost to Follow-up|1|||
25320532|NCT00771615|50636428|FG004|Overall Study|Lost to Follow-up|0|||
25320533|NCT00771615|50636429|FG005|Overall Study|Lost to Follow-up|1|||
25320534|NCT00771615|50636430|FG006|Overall Study|Lost to Follow-up|1|||
25320535|NCT00771615|50636431|FG007|Overall Study|Lost to Follow-up|0|||
25320536|NCT00771615|50636432|FG008|Overall Study|Lost to Follow-up|0|||
25320537|NCT02723604|50636461|FG000|Overall Study|ineligible|1|||
25320538|NCT02723604|50636461|FG000|Overall Study|never received treatment|1|||
25320539|NCT00560755|50636465|FG000|Overall Study|Protocol Violation|15|||
25320540|NCT00560755|50636465|FG000|Overall Study|Withdrawal by Subject|26|||
25320541|NCT00560755|50636465|FG000|Overall Study|Lost to Follow-up|9|||
25239599|NCT00475735|50553958|FG003|Treatment Washout|Lost to Follow-up|0|||
25320542|NCT00560755|50636465|FG000|Overall Study|Adverse Event|8|||
25320543|NCT00560755|50636465|FG000|Overall Study|Physician Decision|2|||
25320544|NCT00770991|50636472|FG000|Overall Study|Physician Decision|2|||
25320545|NCT00770991|50636473|FG001|Overall Study|Physician Decision|0|||
25320546|NCT00770991|50636472|FG000|Overall Study|Withdrawal by Subject|1|||
25320547|NCT00770991|50636473|FG001|Overall Study|Withdrawal by Subject|0|||
25320548|NCT00770991|50636472|FG000|Overall Study|Adverse Event|1|||
25320549|NCT00770991|50636473|FG001|Overall Study|Adverse Event|5|||
25320550|NCT00770991|50636472|FG000|Overall Study|Pregnancy|1|||
25320551|NCT00770991|50636473|FG001|Overall Study|Pregnancy|0|||
25320552|NCT00925769|50636484|FG000|Overall Study|Major toxicity|1|||
25320553|NCT00925769|50636485|FG001|Overall Study|Major toxicity|0|||
25320554|NCT00925769|50636486|FG002|Overall Study|Major toxicity|1|||
25320555|NCT00925769|50636487|FG003|Overall Study|Major toxicity|1|||
25320556|NCT00925769|50636488|FG004|Overall Study|Major toxicity|0|||
25320557|NCT00925769|50636489|FG005|Overall Study|Major toxicity|0|||
25320558|NCT00925769|50636484|FG000|Overall Study|Disease progression|4|||
25320559|NCT00925769|50636485|FG001|Overall Study|Disease progression|5|||
25239600|NCT00475735|50553959|FG004|Treatment Washout|Lost to Follow-up|0|||
25239601|NCT00475735|50553960|FG005|Treatment Washout|Lost to Follow-up|0|||
25239602|NCT00475735|50553955|FG000|Treatment Washout|Protocol Violation|0|||
25239603|NCT00475735|50553956|FG001|Treatment Washout|Protocol Violation|1|||
25239604|NCT00475735|50553957|FG002|Treatment Washout|Protocol Violation|0|||
25239605|NCT00475735|50553958|FG003|Treatment Washout|Protocol Violation|0|||
25239606|NCT00475735|50553959|FG004|Treatment Washout|Protocol Violation|0|||
25239607|NCT00475735|50553960|FG005|Treatment Washout|Protocol Violation|0|||
25239608|NCT00475735|50553955|FG000|Treatment Period 2|Adverse Event|0|||
25239609|NCT00475735|50553956|FG001|Treatment Period 2|Adverse Event|1|||
25239610|NCT00475735|50553957|FG002|Treatment Period 2|Adverse Event|0|||
25239611|NCT00475735|50553958|FG003|Treatment Period 2|Adverse Event|2|||
25239612|NCT00475735|50553959|FG004|Treatment Period 2|Adverse Event|0|||
25239613|NCT00475735|50553960|FG005|Treatment Period 2|Adverse Event|0|||
25239614|NCT00475735|50553955|FG000|Treatment Period 2|Lack of Efficacy|0|||
25239615|NCT00475735|50553956|FG001|Treatment Period 2|Lack of Efficacy|0|||
25239616|NCT00475735|50553957|FG002|Treatment Period 2|Lack of Efficacy|0|||
25239617|NCT00475735|50553958|FG003|Treatment Period 2|Lack of Efficacy|0|||
25239618|NCT00475735|50553959|FG004|Treatment Period 2|Lack of Efficacy|0|||
25239619|NCT00475735|50553960|FG005|Treatment Period 2|Lack of Efficacy|1|||
25239620|NCT00475735|50553955|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25239621|NCT00475735|50553956|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25239622|NCT00475735|50553957|FG002|Treatment Period 2|Withdrawal by Subject|0|||
25239623|NCT00475735|50553958|FG003|Treatment Period 2|Withdrawal by Subject|0|||
25239624|NCT00475735|50553959|FG004|Treatment Period 2|Withdrawal by Subject|1|||
25239625|NCT00475735|50553960|FG005|Treatment Period 2|Withdrawal by Subject|0|||
25239626|NCT00475657|50553968|FG000|Overall Study|Death|1|||
25239627|NCT00475657|50553968|FG000|Overall Study|Sponsor's Decision|3|||
25239628|NCT00475423|50553972|FG000|Overall Study|Protocol Violation|5|||
25320560|NCT00925769|50636486|FG002|Overall Study|Disease progression|3|||
25239629|NCT00475423|50553972|FG000|Overall Study|Adverse Event|4|||
25239630|NCT00475423|50553972|FG000|Overall Study|Withdrawal by Subject|6|||
25239631|NCT00475423|50553972|FG000|Overall Study|Lack of Efficacy|8|||
25239632|NCT00475423|50553972|FG000|Overall Study|Death|1|||
25320561|NCT00925769|50636487|FG003|Overall Study|Disease progression|4|||
25320562|NCT00925769|50636488|FG004|Overall Study|Disease progression|2|||
25320563|NCT00925769|50636489|FG005|Overall Study|Disease progression|3|||
25320564|NCT00925769|50636484|FG000|Overall Study|Death|0|||
25320565|NCT00925769|50636485|FG001|Overall Study|Death|0|||
25320566|NCT00925769|50636486|FG002|Overall Study|Death|1|||
25320567|NCT00925769|50636487|FG003|Overall Study|Death|0|||
25239633|NCT00475423|50553972|FG000|Overall Study|Reason not specified|1|||
25239634|NCT00475423|50553972|FG000|Overall Study|Lost to Follow-up|7|||
25239635|NCT00475306|50553980|FG000|Overall Study|Protocol Violation|1|||
25320568|NCT00925769|50636488|FG004|Overall Study|Death|0|||
25320569|NCT00925769|50636489|FG005|Overall Study|Death|0|||
25320570|NCT00925769|50636484|FG000|Overall Study|Physician Decision|1|||
25239636|NCT00475306|50553981|FG001|Overall Study|Protocol Violation|1|||
25239637|NCT00475306|50553982|FG002|Overall Study|Protocol Violation|0|||
25239638|NCT00475306|50553983|FG003|Overall Study|Protocol Violation|1|||
25239639|NCT00475228|50553995|FG000|Overall Study|Lost to Follow-up|17|||
25239640|NCT00475228|50553996|FG001|Overall Study|Lost to Follow-up|17|||
25239641|NCT00475033|50554008|FG000|Infant Series|Failed to return|3|||
25239642|NCT00475033|50554009|FG001|Infant Series|Failed to return|4|||
25239643|NCT00475033|50554008|FG000|Infant Series|Parent or legal guardian request|1|||
25239644|NCT00475033|50554009|FG001|Infant Series|Parent or legal guardian request|5|||
25239645|NCT00475033|50554008|FG000|Infant Series|Protocol Violation|1|||
25239646|NCT00475033|50554009|FG001|Infant Series|Protocol Violation|2|||
25239647|NCT00475033|50554008|FG000|Infant Series|Lost to Follow-up|2|||
25239648|NCT00475033|50554009|FG001|Infant Series|Lost to Follow-up|0|||
25239649|NCT00475033|50554008|FG000|Infant Series|Adverse Event|0|||
25239650|NCT00475033|50554009|FG001|Infant Series|Adverse Event|2|||
25239651|NCT00475033|50554008|FG000|After the Infant Series|Adverse Event|0|||
25239652|NCT00475033|50554009|FG001|After the Infant Series|Adverse Event|4|||
25239653|NCT00475033|50554008|FG000|After the Infant Series|Parent or legal guardian request|2|||
25239654|NCT00475033|50554009|FG001|After the Infant Series|Parent or legal guardian request|2|||
25239655|NCT00475033|50554008|FG000|After the Infant Series|Failed to return|2|||
25239656|NCT00475033|50554009|FG001|After the Infant Series|Failed to return|1|||
25239657|NCT00475033|50554008|FG000|After the Infant Series|Protocol Violation|1|||
25239658|NCT00475033|50554009|FG001|After the Infant Series|Protocol Violation|0|||
25239659|NCT00475033|50554008|FG000|After the Infant Series|Lost to Follow-up|1|||
25239660|NCT00475033|50554009|FG001|After the Infant Series|Lost to Follow-up|0|||
25239661|NCT00475033|50554008|FG000|After the Infant Series|Other|0|||
25239662|NCT00475033|50554009|FG001|After the Infant Series|Other|1|||
25239663|NCT00475033|50554008|FG000|Toddler Dose|Parent or legal guardian request|2|||
25320571|NCT00925769|50636485|FG001|Overall Study|Physician Decision|0|||
25320572|NCT00925769|50636486|FG002|Overall Study|Physician Decision|0|||
25320573|NCT00925769|50636487|FG003|Overall Study|Physician Decision|0|||
25320574|NCT00925769|50636488|FG004|Overall Study|Physician Decision|0|||
25320575|NCT00925769|50636489|FG005|Overall Study|Physician Decision|0|||
25320576|NCT00925769|50636484|FG000|Overall Study|Missing documentation|0|||
25320577|NCT00925769|50636485|FG001|Overall Study|Missing documentation|1|||
25320578|NCT00925769|50636486|FG002|Overall Study|Missing documentation|0|||
25320579|NCT00925769|50636487|FG003|Overall Study|Missing documentation|0|||
25320580|NCT00925769|50636488|FG004|Overall Study|Missing documentation|0|||
25320581|NCT00925769|50636489|FG005|Overall Study|Missing documentation|0|||
25320582|NCT00925769|50636484|FG000|Overall Study|End of study visit not done|0|||
25320583|NCT00925769|50636485|FG001|Overall Study|End of study visit not done|0|||
25320584|NCT00925769|50636486|FG002|Overall Study|End of study visit not done|1|||
25320585|NCT00925769|50636487|FG003|Overall Study|End of study visit not done|0|||
25320586|NCT00925769|50636488|FG004|Overall Study|End of study visit not done|0|||
25320587|NCT00925769|50636489|FG005|Overall Study|End of study visit not done|0|||
25320588|NCT00925769|50636484|FG000|Overall Study|Participant is unable to swallow drug|0|||
25320589|NCT00925769|50636485|FG001|Overall Study|Participant is unable to swallow drug|0|||
25320590|NCT00925769|50636486|FG002|Overall Study|Participant is unable to swallow drug|0|||
25320591|NCT00925769|50636487|FG003|Overall Study|Participant is unable to swallow drug|1|||
25320592|NCT00925769|50636488|FG004|Overall Study|Participant is unable to swallow drug|0|||
25320593|NCT00925769|50636489|FG005|Overall Study|Participant is unable to swallow drug|0|||
25320594|NCT00925769|50636484|FG000|Overall Study|Adverse Event|0|||
25320595|NCT00925769|50636485|FG001|Overall Study|Adverse Event|0|||
25320596|NCT00925769|50636486|FG002|Overall Study|Adverse Event|0|||
25320597|NCT00925769|50636487|FG003|Overall Study|Adverse Event|0|||
25320598|NCT00925769|50636488|FG004|Overall Study|Adverse Event|1|||
25320599|NCT00925769|50636489|FG005|Overall Study|Adverse Event|0|||
25320600|NCT00770913|50636508|FG000|Overall Study|Adverse Event|1|||
25320601|NCT00770913|50636509|FG001|Overall Study|Adverse Event|3|||
25320602|NCT00770913|50636510|FG002|Overall Study|Adverse Event|6|||
25320603|NCT00770913|50636508|FG000|Overall Study|Refusal to continue participation|6|||
25320604|NCT00770913|50636509|FG001|Overall Study|Refusal to continue participation|4|||
25320605|NCT00770913|50636510|FG002|Overall Study|Refusal to continue participation|5|||
25239664|NCT00475033|50554009|FG001|Toddler Dose|Parent or legal guardian request|0|||
25239665|NCT00475033|50554008|FG000|Toddler Dose|Failed to return|1|||
25320606|NCT00770913|50636508|FG000|Overall Study|Physician Decision|0|||
25239666|NCT00475033|50554009|FG001|Toddler Dose|Failed to return|0|||
25320607|NCT00770913|50636509|FG001|Overall Study|Physician Decision|1|||
25320608|NCT00770913|50636510|FG002|Overall Study|Physician Decision|1|||
25320609|NCT00770913|50636508|FG000|Overall Study|Protocol Violation|3|||
25320610|NCT00770913|50636509|FG001|Overall Study|Protocol Violation|0|||
25320611|NCT00770913|50636510|FG002|Overall Study|Protocol Violation|1|||
25320612|NCT00770913|50636508|FG000|Overall Study|Incorrect drug was allocated|1|||
25320613|NCT00770913|50636509|FG001|Overall Study|Incorrect drug was allocated|0|||
25239667|NCT00475033|50554008|FG000|Toddler Dose|Lost to Follow-up|1|||
25239668|NCT00475033|50554009|FG001|Toddler Dose|Lost to Follow-up|0|||
25239669|NCT00474994|50554022|FG000|Overall Study|Patient Not treated|1|||
25239670|NCT00474994|50554022|FG000|Overall Study|Patient evaluable for toxicity only|3|||
25239671|NCT00474994|50554022|FG000|Overall Study|Patient found to be ineligible|1|||
25239672|NCT00474955|50554026|FG000|Overall Study|Adverse Event|2|||
25239673|NCT00474955|50554026|FG000|Overall Study|Drug unavailability|1|||
25239674|NCT00474955|50554026|FG000|Overall Study|Personal reasons|5|||
25239675|NCT00474487|50554034|FG000|Overall Study|Withdrawal by Subject|6|||
25239676|NCT00474487|50554035|FG001|Overall Study|Withdrawal by Subject|0|||
25239677|NCT00474487|50554036|FG002|Overall Study|Withdrawal by Subject|0|||
25239678|NCT00474487|50554037|FG003|Overall Study|Withdrawal by Subject|0|||
25239679|NCT00474487|50554034|FG000|Overall Study|Lost to Follow-up|20|||
25239680|NCT00474487|50554035|FG001|Overall Study|Lost to Follow-up|1|||
25239681|NCT00474487|50554036|FG002|Overall Study|Lost to Follow-up|7|||
25239682|NCT00474487|50554037|FG003|Overall Study|Lost to Follow-up|0|||
25239683|NCT00474487|50554034|FG000|Overall Study|Inappropriate enrollment|4|||
25239684|NCT00474487|50554035|FG001|Overall Study|Inappropriate enrollment|0|||
25239685|NCT00474487|50554036|FG002|Overall Study|Inappropriate enrollment|7|||
25239686|NCT00474487|50554037|FG003|Overall Study|Inappropriate enrollment|0|||
25239687|NCT00474487|50554034|FG000|Overall Study|Death|0|||
25239688|NCT00474487|50554035|FG001|Overall Study|Death|1|||
25239689|NCT00474487|50554036|FG002|Overall Study|Death|0|||
25239690|NCT00474487|50554037|FG003|Overall Study|Death|0|||
25239691|NCT00474253|50554049|FG000|Overall Study|Withdrew consent|2|||
25239692|NCT00474253|50554050|FG001|Overall Study|Withdrew consent|0|||
25239693|NCT00474253|50554049|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
25239694|NCT00474253|50554050|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
25239695|NCT00474253|50554049|FG000|Overall Study|Lost to Follow-up|1|||
25239696|NCT00474253|50554050|FG001|Overall Study|Lost to Follow-up|0|||
25239697|NCT00474253|50554049|FG000|Overall Study|Discharged prior to study completion|0|||
25239698|NCT00474253|50554050|FG001|Overall Study|Discharged prior to study completion|1|||
25239699|NCT00474058|50554058|FG000|Overall Study|Adverse Event|11|||
25239700|NCT00474058|50554059|FG001|Overall Study|Adverse Event|6|||
25239701|NCT00474058|50554058|FG000|Overall Study|Lack of Efficacy|0|||
25239702|NCT00474058|50554059|FG001|Overall Study|Lack of Efficacy|4|||
25239703|NCT00474058|50554058|FG000|Overall Study|Withdrawal by Subject|11|||
25239704|NCT00474058|50554059|FG001|Overall Study|Withdrawal by Subject|7|||
25239705|NCT00474058|50554058|FG000|Overall Study|Other|2|||
25239706|NCT00474058|50554059|FG001|Overall Study|Other|0|||
25239707|NCT00473824|50554067|FG000|Overall Study|Virologic Breakthrough|1|||
25239708|NCT00473824|50554068|FG001|Overall Study|Virologic Breakthrough|0|||
25239709|NCT00473824|50554067|FG000|Overall Study|Adverse Event|1|||
25239710|NCT00473824|50554068|FG001|Overall Study|Adverse Event|0|||
25239711|NCT00473824|50554067|FG000|Overall Study|Death|1|||
25239712|NCT00473824|50554068|FG001|Overall Study|Death|0|||
25239713|NCT00473824|50554067|FG000|Overall Study|Lost to Follow-up|1|||
25320614|NCT00770913|50636510|FG002|Overall Study|Incorrect drug was allocated|0|||
25320615|NCT00562861|50636520|FG000|Overall Study|Adverse Event|1|||
25320616|NCT00562861|50636521|FG001|Overall Study|Adverse Event|1|||
25320617|NCT00562861|50636520|FG000|Overall Study|Lack of Efficacy|5|||
25320618|NCT00562861|50636521|FG001|Overall Study|Lack of Efficacy|5|||
25320619|NCT00562861|50636520|FG000|Overall Study|noncompliance, moved|7|||
25320620|NCT00562861|50636521|FG001|Overall Study|noncompliance, moved|2|||
25320621|NCT00562861|50636520|FG000|Overall Study|Lost to Follow-up|7|||
25320622|NCT00562861|50636521|FG001|Overall Study|Lost to Follow-up|3|||
25320623|NCT00770679|50636527|FG000|Overall Study|Lost to Follow-up|3|||
25320624|NCT00770679|50636527|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
25320625|NCT00770601|50636531|FG000|Overall Study|Withdrawal by Subject|1|||
25320626|NCT00770367|50636537|FG000|First Intervention|Withdrawal by Subject|0|||
25320627|NCT00770367|50636538|FG001|First Intervention|Withdrawal by Subject|2|||
25320628|NCT00770367|50636537|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
25320629|NCT00770367|50636538|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
25320630|NCT00770367|50636537|FG000|Second Intervention|Lost to Follow-up|2|||
25320631|NCT00770367|50636538|FG001|Second Intervention|Lost to Follow-up|0|||
25077555|NCT02462486|50185342|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
25239714|NCT00473824|50554068|FG001|Overall Study|Lost to Follow-up|0|||
25239715|NCT00473824|50554067|FG000|Overall Study|Withdrawal by physician|1|||
25239716|NCT00473824|50554068|FG001|Overall Study|Withdrawal by physician|0|||
25239717|NCT00473746|50554079|FG000|Period 1 (Phase 1)|Adverse Event|1|||
25239718|NCT00473746|50554080|FG001|Period 1 (Phase 1)|Adverse Event|0|||
25239719|NCT00473746|50554081|FG002|Period 1 (Phase 1)|Adverse Event|0|||
25239720|NCT00473746|50554082|FG003|Period 1 (Phase 1)|Adverse Event|0|||
25239721|NCT00473746|50554083|FG004|Period 1 (Phase 1)|Adverse Event|0|||
25239722|NCT00473746|50554079|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
25239723|NCT00473746|50554080|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
25239724|NCT00473746|50554081|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
25239725|NCT00473746|50554082|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
25320632|NCT00931307|50636546|FG000|Overall Study|Lack of Efficacy|12|||
25320633|NCT00931307|50636546|FG000|Overall Study|Biomicroscopy|1|||
25239726|NCT00473746|50554083|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
25239727|NCT00473746|50554079|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
25239728|NCT00473746|50554080|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
25239729|NCT00473746|50554081|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
25239730|NCT00473746|50554082|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
25320634|NCT00930761|50636565|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
25320635|NCT00930761|50636566|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
25320636|NCT00930761|50636565|FG000|Overall Study|less than 3 music therapy sessions|0|||
25320637|NCT00930761|50636566|FG001|Overall Study|less than 3 music therapy sessions|3|||
25320638|NCT00770289|50636572|FG000|Overall Study|Other|6|||
25320639|NCT00556933|50636585|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
25320640|NCT00556933|50636586|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
25320641|NCT00556933|50636587|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
25320642|NCT00556933|50636588|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
25320643|NCT00556933|50636585|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
25320644|NCT00556933|50636586|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
25320645|NCT00556933|50636587|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
25320646|NCT00556933|50636588|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
25320647|NCT00556933|50636585|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
25320648|NCT00556933|50636586|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
25320649|NCT00556933|50636587|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
25320650|NCT00556933|50636588|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
25320651|NCT00556933|50636585|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
25320652|NCT00556933|50636586|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
25320653|NCT00556933|50636587|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
25320654|NCT00556933|50636588|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
25320655|NCT00556933|50636585|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
25320656|NCT00556933|50636586|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
25320657|NCT00556933|50636587|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
25320658|NCT00556933|50636588|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
25320659|NCT00556933|50636585|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
25320660|NCT00556933|50636586|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
25320661|NCT00556933|50636587|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
25320662|NCT00556933|50636588|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
25320663|NCT00556933|50636585|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
25320664|NCT00556933|50636586|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
25320665|NCT00556933|50636587|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
25320666|NCT00556933|50636588|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
25320667|NCT00556933|50636585|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
25320668|NCT00556933|50636586|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
25320669|NCT00556933|50636587|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
25320670|NCT00556933|50636588|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
25320671|NCT00556933|50636585|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
25320672|NCT00556933|50636586|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
25320673|NCT00556933|50636587|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
25320674|NCT00556933|50636588|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
25320675|NCT00556933|50636585|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
25320676|NCT00556933|50636586|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
25320677|NCT00556933|50636587|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
25320678|NCT00556933|50636588|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
25320679|NCT00556933|50636585|FG000|CNI Withdrawal vs. Minimization|Death|0|||
25320680|NCT00556933|50636586|FG001|CNI Withdrawal vs. Minimization|Death|0|||
25320681|NCT00556933|50636587|FG002|CNI Withdrawal vs. Minimization|Death|0|||
25320682|NCT00556933|50636588|FG003|CNI Withdrawal vs. Minimization|Death|1|||
25320683|NCT00770211|50636609|FG000|Overall Study|Lost to Follow-up|1|||
25320684|NCT00770211|50636610|FG001|Overall Study|Lost to Follow-up|0|||
25320685|NCT00770211|50636609|FG000|Overall Study|Withdrawal by Subject|0|||
25320686|NCT00770211|50636610|FG001|Overall Study|Withdrawal by Subject|2|||
25320687|NCT00928187|50636619|FG000|Overall Study|Death|1|||
25320688|NCT00928187|50636620|FG001|Overall Study|Death|2|||
25320689|NCT00928187|50636621|FG002|Overall Study|Death|3|||
25320690|NCT00928187|50636619|FG000|Overall Study|Lost to Follow-up|1|||
25320691|NCT00928187|50636620|FG001|Overall Study|Lost to Follow-up|2|||
25320692|NCT00928187|50636621|FG002|Overall Study|Lost to Follow-up|1|||
25320693|NCT00928187|50636619|FG000|Overall Study|Withdrawal by Subject|0|||
25320694|NCT00928187|50636620|FG001|Overall Study|Withdrawal by Subject|1|||
25320695|NCT00928187|50636621|FG002|Overall Study|Withdrawal by Subject|1|||
25239731|NCT00473746|50554083|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
25239732|NCT00473746|50554079|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
25239733|NCT00473746|50554080|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
25239734|NCT00473746|50554081|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
25239735|NCT00473746|50554082|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
25239736|NCT00473746|50554083|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
25239737|NCT00473746|50554079|FG000|Period 1 (Phase 1)|Reason not specified|0|||
25239738|NCT00473746|50554080|FG001|Period 1 (Phase 1)|Reason not specified|1|||
25239739|NCT00473746|50554081|FG002|Period 1 (Phase 1)|Reason not specified|0|||
25239740|NCT00473746|50554082|FG003|Period 1 (Phase 1)|Reason not specified|0|||
25239741|NCT00473746|50554083|FG004|Period 1 (Phase 1)|Reason not specified|0|||
25239742|NCT00473746|50554079|FG000|Period 2 (Phase 2)|Adverse Event|0|||
25239743|NCT00473746|50554080|FG001|Period 2 (Phase 2)|Adverse Event|0|||
25239744|NCT00473746|50554081|FG002|Period 2 (Phase 2)|Adverse Event|0|||
25239745|NCT00473746|50554082|FG003|Period 2 (Phase 2)|Adverse Event|0|||
25239746|NCT00473746|50554083|FG004|Period 2 (Phase 2)|Adverse Event|3|||
25239747|NCT00473746|50554079|FG000|Period 2 (Phase 2)|Death|0|||
25239748|NCT00473746|50554080|FG001|Period 2 (Phase 2)|Death|0|||
25320696|NCT00928187|50636619|FG000|Overall Study|Protocol Violation|0|||
25320697|NCT00928187|50636620|FG001|Overall Study|Protocol Violation|1|||
25320698|NCT00928187|50636621|FG002|Overall Study|Protocol Violation|0|||
25320699|NCT00769119|50636631|FG000|Overall Study|Voluntary discontinuation|0|||
25320700|NCT00769119|50636632|FG001|Overall Study|Voluntary discontinuation|2|||
25320701|NCT00769119|50636631|FG000|Overall Study|Adverse Event|1|||
25320702|NCT00769119|50636632|FG001|Overall Study|Adverse Event|1|||
25320703|NCT00769119|50636631|FG000|Overall Study|Disallowed medication|1|||
25320704|NCT00769119|50636632|FG001|Overall Study|Disallowed medication|0|||
25320705|NCT00927953|50636640|FG000|Overall Study|Death|2|||
25320706|NCT00927953|50636641|FG001|Overall Study|Death|1|||
25320707|NCT00768651|50636648|FG000|Overall Study|Withdrawal by Subject|1|||
25320708|NCT00756717|50636653|FG000|Overall Study|Withdrawal by Subject|2|||
25320709|NCT03962101|50636657|FG000|Overall Study|Adverse Event|1|||
25320710|NCT03962101|50636657|FG000|Overall Study|Physician Decision|2|||
25239749|NCT00473746|50554081|FG002|Period 2 (Phase 2)|Death|0|||
25239750|NCT00473746|50554082|FG003|Period 2 (Phase 2)|Death|0|||
25239751|NCT00473746|50554083|FG004|Period 2 (Phase 2)|Death|1|||
25239752|NCT00473746|50554079|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
25239753|NCT00473746|50554080|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
25239754|NCT00473746|50554081|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
25239755|NCT00473746|50554082|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
25239756|NCT00473746|50554083|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
25239757|NCT00473746|50554079|FG000|Period 2 (Phase 2)|Reason not specified|0|||
25239758|NCT00473746|50554080|FG001|Period 2 (Phase 2)|Reason not specified|0|||
25239759|NCT00473746|50554081|FG002|Period 2 (Phase 2)|Reason not specified|0|||
25239760|NCT00473746|50554082|FG003|Period 2 (Phase 2)|Reason not specified|0|||
25239761|NCT00473746|50554083|FG004|Period 2 (Phase 2)|Reason not specified|3|||
25239762|NCT00473668|50554100|FG000|Overall Study|Withdrawal by Subject|0|||
25239763|NCT00473668|50554101|FG001|Overall Study|Withdrawal by Subject|2|||
25239764|NCT00473668|50554102|FG002|Overall Study|Withdrawal by Subject|0|||
25239765|NCT00473668|50554100|FG000|Overall Study|Migrated/moved from study area|3|||
25239766|NCT00473668|50554101|FG001|Overall Study|Migrated/moved from study area|2|||
25239767|NCT00473668|50554102|FG002|Overall Study|Migrated/moved from study area|0|||
25239768|NCT00473668|50554100|FG000|Overall Study|Lost to Follow-up|0|||
25239769|NCT00473668|50554101|FG001|Overall Study|Lost to Follow-up|4|||
25239770|NCT00473668|50554102|FG002|Overall Study|Lost to Follow-up|6|||
25239771|NCT00473668|50554100|FG000|Overall Study|Other|2|||
25239772|NCT00473668|50554101|FG001|Overall Study|Other|3|||
25239773|NCT00473668|50554102|FG002|Overall Study|Other|4|||
25239774|NCT00473590|50554112|FG000|Overall Study|Adverse Event|3|||
25239775|NCT00473590|50554113|FG001|Overall Study|Adverse Event|3|||
25239776|NCT00473590|50554112|FG000|Overall Study|Death|4|||
25239777|NCT00473590|50554113|FG001|Overall Study|Death|2|||
25239778|NCT00473590|50554112|FG000|Overall Study|Progression not resulting in death|24|||
25320711|NCT03962101|50636657|FG000|Overall Study|Not related to medical events|1|||
25320712|NCT00923351|50636664|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
25239779|NCT00473590|50554113|FG001|Overall Study|Progression not resulting in death|20|||
25239780|NCT00473590|50554112|FG000|Overall Study|Non-protocol-specified therapy|7|||
25239781|NCT00473590|50554113|FG001|Overall Study|Non-protocol-specified therapy|5|||
25239782|NCT00473590|50554112|FG000|Overall Study|Physician Decision|2|||
25239783|NCT00473590|50554113|FG001|Overall Study|Physician Decision|4|||
25239784|NCT00473590|50554112|FG000|Overall Study|Withdrawal by Subject|5|||
25239785|NCT00473590|50554113|FG001|Overall Study|Withdrawal by Subject|3|||
25239786|NCT00473590|50554112|FG000|Overall Study|Other|0|||
25239787|NCT00473590|50554113|FG001|Overall Study|Other|1|||
25239788|NCT00473512|50554124|FG000|Period 1 (Phase 1)|Adverse Event|0|||
25239789|NCT00473512|50554125|FG001|Period 1 (Phase 1)|Adverse Event|0|||
25239790|NCT00473512|50554126|FG002|Period 1 (Phase 1)|Adverse Event|0|||
25320713|NCT00923351|50636665|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
25320714|NCT00923351|50636666|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
25320715|NCT00755937|50636672|FG000|Recruitment|Unknown if infliximab received|164|||
25239791|NCT00473512|50554127|FG003|Period 1 (Phase 1)|Adverse Event|5|||
25239792|NCT00473512|50554128|FG004|Period 1 (Phase 1)|Adverse Event|0|||
25239793|NCT00473512|50554124|FG000|Period 1 (Phase 1)|Death|0|||
25239794|NCT00473512|50554125|FG001|Period 1 (Phase 1)|Death|0|||
25239795|NCT00473512|50554126|FG002|Period 1 (Phase 1)|Death|0|||
25239796|NCT00473512|50554127|FG003|Period 1 (Phase 1)|Death|1|||
25239797|NCT00473512|50554128|FG004|Period 1 (Phase 1)|Death|0|||
25239798|NCT00473512|50554124|FG000|Period 1 (Phase 1)|Disease Progression|1|||
25239799|NCT00473512|50554125|FG001|Period 1 (Phase 1)|Disease Progression|1|||
25239800|NCT00473512|50554126|FG002|Period 1 (Phase 1)|Disease Progression|0|||
25239801|NCT00473512|50554127|FG003|Period 1 (Phase 1)|Disease Progression|10|||
25239802|NCT00473512|50554128|FG004|Period 1 (Phase 1)|Disease Progression|1|||
25239803|NCT00473512|50554124|FG000|Period 1 (Phase 1)|Other|0|||
25239804|NCT00473512|50554125|FG001|Period 1 (Phase 1)|Other|0|||
25239805|NCT00473512|50554126|FG002|Period 1 (Phase 1)|Other|0|||
25239806|NCT00473512|50554127|FG003|Period 1 (Phase 1)|Other|1|||
25239807|NCT00473512|50554128|FG004|Period 1 (Phase 1)|Other|0|||
25239808|NCT00473512|50554124|FG000|Period 2 (Phase 2)|Adverse Event|0|||
25239809|NCT00473512|50554125|FG001|Period 2 (Phase 2)|Adverse Event|0|||
25239810|NCT00473512|50554126|FG002|Period 2 (Phase 2)|Adverse Event|0|||
25239811|NCT00473512|50554127|FG003|Period 2 (Phase 2)|Adverse Event|1|||
25239812|NCT00473512|50554128|FG004|Period 2 (Phase 2)|Adverse Event|0|||
25239813|NCT00473512|50554124|FG000|Period 2 (Phase 2)|Death|0|||
25239814|NCT00473512|50554125|FG001|Period 2 (Phase 2)|Death|0|||
25239815|NCT00473512|50554126|FG002|Period 2 (Phase 2)|Death|0|||
25239816|NCT00473512|50554127|FG003|Period 2 (Phase 2)|Death|1|||
25239817|NCT00473512|50554128|FG004|Period 2 (Phase 2)|Death|1|||
25239818|NCT00473512|50554124|FG000|Period 2 (Phase 2)|Disease Progression|0|||
25239819|NCT00473512|50554125|FG001|Period 2 (Phase 2)|Disease Progression|2|||
25239820|NCT00473512|50554126|FG002|Period 2 (Phase 2)|Disease Progression|2|||
25239821|NCT00473512|50554127|FG003|Period 2 (Phase 2)|Disease Progression|17|||
25239822|NCT00473512|50554128|FG004|Period 2 (Phase 2)|Disease Progression|1|||
25239823|NCT00473512|50554124|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
25239824|NCT00473512|50554125|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
25239825|NCT00473512|50554126|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
25239826|NCT00473512|50554127|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
25239827|NCT00473512|50554128|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
25239828|NCT00473512|50554124|FG000|Period 2 (Phase 2)|Other|1|||
25239829|NCT00473512|50554125|FG001|Period 2 (Phase 2)|Other|0|||
25239830|NCT00473512|50554126|FG002|Period 2 (Phase 2)|Other|0|||
25239831|NCT00473512|50554127|FG003|Period 2 (Phase 2)|Other|3|||
25239832|NCT00473512|50554128|FG004|Period 2 (Phase 2)|Other|0|||
25239833|NCT00473434|50554148|FG000|Overall Study|Physician Decision|3|||
25239834|NCT00473434|50554148|FG000|Overall Study|Withdrawal by Subject|9|||
25239835|NCT00473434|50554148|FG000|Overall Study|Compliance|3|||
25239836|NCT00473434|50554148|FG000|Overall Study|Lack of Efficacy|3|||
25239837|NCT00473434|50554148|FG000|Overall Study|Adverse Event|3|||
25239838|NCT00473434|50554148|FG000|Overall Study|Patient was selling medication to others|1|||
25239839|NCT00473434|50554148|FG000|Overall Study|Safety evaluation|1|||
25239840|NCT00473434|50554148|FG000|Overall Study|Reason not specified|6|||
25239841|NCT00473434|50554148|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
25239842|NCT00473434|50554148|FG000|Overall Study|Switching to trial medication|1|||
25239843|NCT00473434|50554148|FG000|Overall Study|No longer required|1|||
25239844|NCT00473083|50554168|FG000|Overall Study|Adverse Event|1|||
25239845|NCT00473083|50554169|FG001|Overall Study|Adverse Event|0|||
25239846|NCT00473083|50554170|FG002|Overall Study|Adverse Event|0|||
25239847|NCT00472420|50554181|FG000|Induction Treatment Period|Physician Decision|9|||
25239848|NCT00472420|50554181|FG000|Induction Treatment Period|Adverse Event|3|||
25239849|NCT00472420|50554181|FG000|Induction Treatment Period|Non-compliance|1|||
25239850|NCT00472420|50554181|FG000|Induction Treatment Period|Death|3|||
25239851|NCT00472420|50554181|FG000|Follow-up Period|Death|5|||
25239852|NCT00472420|50554181|FG000|Follow-up Period|Physician Decision|9|||
25239853|NCT00472420|50554181|FG000|Follow-up Period|Lost to Follow-up|2|||
25239854|NCT00472420|50554181|FG000|Follow-up Period|Protocol Violation|1|||
25239855|NCT00472303|50554187|FG000|Titration Phase|Adverse Event|22|||
25239856|NCT00472303|50554188|FG001|Titration Phase|Adverse Event|12|||
25239857|NCT00472303|50554189|FG002|Titration Phase|Adverse Event|0|||
25239858|NCT00472303|50554187|FG000|Titration Phase|Death|4|||
25239859|NCT00472303|50554188|FG001|Titration Phase|Death|2|||
25239860|NCT00472303|50554189|FG002|Titration Phase|Death|0|||
25239861|NCT00472303|50554187|FG000|Titration Phase|Lack of Efficacy|10|||
25239862|NCT00472303|50554188|FG001|Titration Phase|Lack of Efficacy|0|||
25239863|NCT00472303|50554189|FG002|Titration Phase|Lack of Efficacy|0|||
25239864|NCT00472303|50554187|FG000|Titration Phase|Withdrawal by Subject|16|||
25239865|NCT00472303|50554188|FG001|Titration Phase|Withdrawal by Subject|13|||
25239866|NCT00472303|50554189|FG002|Titration Phase|Withdrawal by Subject|0|||
25239867|NCT00472303|50554187|FG000|Titration Phase|Trial Medication non-compliant|4|||
25239868|NCT00472303|50554188|FG001|Titration Phase|Trial Medication non-compliant|1|||
25239869|NCT00472303|50554189|FG002|Titration Phase|Trial Medication non-compliant|0|||
25239870|NCT00472303|50554187|FG000|Titration Phase|Other|3|||
25239871|NCT00472303|50554188|FG001|Titration Phase|Other|1|||
25239872|NCT00472303|50554189|FG002|Titration Phase|Other|0|||
25239873|NCT00472303|50554187|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
25239874|NCT00472303|50554188|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
25239875|NCT00472303|50554189|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
25239876|NCT00472303|50554187|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
25239877|NCT00472303|50554188|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
25239878|NCT00472303|50554189|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
25239879|NCT00472303|50554187|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
25239880|NCT00472303|50554188|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
25239881|NCT00472303|50554189|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
25239882|NCT00472303|50554187|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
25239883|NCT00472303|50554188|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
25239884|NCT00472303|50554189|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
25239885|NCT00472303|50554187|FG000|Discontinuations After Titration Phase|Other|5|||
25239886|NCT00472303|50554188|FG001|Discontinuations After Titration Phase|Other|0|||
25239887|NCT00472303|50554189|FG002|Discontinuations After Titration Phase|Other|0|||
25239888|NCT00472303|50554187|FG000|Maintenance Phase|Adverse Event|5|||
25239889|NCT00472303|50554188|FG001|Maintenance Phase|Adverse Event|6|||
25239890|NCT00472303|50554189|FG002|Maintenance Phase|Adverse Event|6|||
25239891|NCT00472303|50554187|FG000|Maintenance Phase|Death|3|||
25239892|NCT00472303|50554188|FG001|Maintenance Phase|Death|0|||
25239893|NCT00472303|50554189|FG002|Maintenance Phase|Death|2|||
25239894|NCT00472303|50554187|FG000|Maintenance Phase|Lack of Efficacy|2|||
25239895|NCT00472303|50554188|FG001|Maintenance Phase|Lack of Efficacy|2|||
25239896|NCT00472303|50554189|FG002|Maintenance Phase|Lack of Efficacy|4|||
25239897|NCT00472303|50554187|FG000|Maintenance Phase|Withdrawal by Subject|6|||
25239898|NCT00472303|50554188|FG001|Maintenance Phase|Withdrawal by Subject|7|||
25239899|NCT00472303|50554189|FG002|Maintenance Phase|Withdrawal by Subject|3|||
25239900|NCT00472303|50554187|FG000|Maintenance Phase|Trial medication non-compliant|0|||
25239901|NCT00472303|50554188|FG001|Maintenance Phase|Trial medication non-compliant|0|||
25239902|NCT00472303|50554189|FG002|Maintenance Phase|Trial medication non-compliant|1|||
25239903|NCT00472303|50554187|FG000|Maintenance Phase|Resolution of pain|0|||
25239904|NCT00472303|50554188|FG001|Maintenance Phase|Resolution of pain|0|||
25239905|NCT00472303|50554189|FG002|Maintenance Phase|Resolution of pain|1|||
25239906|NCT00472303|50554187|FG000|Maintenance Phase|Other|1|||
25239907|NCT00472303|50554188|FG001|Maintenance Phase|Other|1|||
25239908|NCT00472303|50554189|FG002|Maintenance Phase|Other|0|||
25239909|NCT00471718|50554217|FG000|Overall Study|Adverse Event|3|||
25239910|NCT00471718|50554217|FG000|Overall Study|other complicating disease|1|||
25239911|NCT00471718|50554217|FG000|Overall Study|disease progression|22|||
25239912|NCT00471718|50554217|FG000|Overall Study|Withdrawal by Subject|1|||
25239913|NCT00471445|50554227|FG000|Overall Study|Withdrawal by Subject|1|||
25239914|NCT00471445|50554228|FG001|Overall Study|Withdrawal by Subject|1|||
25239915|NCT00471445|50554227|FG000|Overall Study|Ineligible|1|||
25320716|NCT00755937|50636672|FG000|Observational Follow-up|Lost to Follow-up|148|||
25320717|NCT00755079|50636678|FG000|Overall Study|Lost to Follow-up|1|||
25320718|NCT00755079|50636679|FG001|Overall Study|Lost to Follow-up|3|||
25320719|NCT00755079|50636678|FG000|Overall Study|Adverse Event|0|||
25320720|NCT00755079|50636679|FG001|Overall Study|Adverse Event|1|||
25320721|NCT00755079|50636678|FG000|Overall Study|Withdrawal by Subject|0|||
25320722|NCT00755079|50636679|FG001|Overall Study|Withdrawal by Subject|2|||
25320723|NCT00925301|50636687|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
25320724|NCT00925301|50636688|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
25320725|NCT00925301|50636689|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
25320726|NCT00925301|50636690|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
25320727|NCT00925301|50636687|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
25320728|NCT00925301|50636688|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
25320729|NCT00925301|50636689|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
25320730|NCT00925301|50636690|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
25320731|NCT00925301|50636687|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
25320732|NCT00925301|50636688|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
25320733|NCT00925301|50636689|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
25239916|NCT00471445|50554228|FG001|Overall Study|Ineligible|0|||
25239917|NCT00471445|50554227|FG000|Overall Study|Protocol Violation|0|||
25239918|NCT00471445|50554228|FG001|Overall Study|Protocol Violation|1|||
25239919|NCT00471328|50554236|FG000|Core Phase|Adverse Event|18|||
25239920|NCT00471328|50554237|FG001|Core Phase|Adverse Event|6|||
25239921|NCT00471328|50554236|FG000|Core Phase|Death|8|||
25239922|NCT00471328|50554237|FG001|Core Phase|Death|4|||
25320734|NCT00925301|50636690|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
25239923|NCT00471328|50554236|FG000|Core Phase|Withdrawal by Subject|2|||
25239924|NCT00471328|50554237|FG001|Core Phase|Withdrawal by Subject|2|||
25239925|NCT00471328|50554236|FG000|Core Phase|Abnormal laboratory value|1|||
25239926|NCT00471328|50554237|FG001|Core Phase|Abnormal laboratory value|0|||
25239927|NCT00471328|50554236|FG000|Core Phase|Disease Progression|78|||
25239928|NCT00471328|50554237|FG001|Core Phase|Disease Progression|53|||
25239929|NCT00471328|50554236|FG000|Core Phase|Administrative Problem|0|||
25239930|NCT00471328|50554237|FG001|Core Phase|Administrative Problem|1|||
25239931|NCT00471328|50554236|FG000|Core Phase|Protocol Deviation|0|||
25239932|NCT00471328|50554237|FG001|Core Phase|Protocol Deviation|1|||
25239933|NCT00471328|50554236|FG000|Extension Phase|Adverse Event|3|||
25239934|NCT00471328|50554237|FG001|Extension Phase|Adverse Event|12|||
25239935|NCT00471328|50554236|FG000|Extension Phase|Withdrawal by Subject|0|||
25239936|NCT00471328|50554237|FG001|Extension Phase|Withdrawal by Subject|2|||
25239937|NCT00471328|50554236|FG000|Extension Phase|Death|1|||
25239938|NCT00471328|50554237|FG001|Extension Phase|Death|7|||
25239939|NCT00471328|50554236|FG000|Extension Phase|Protocol Deviation|3|||
25239940|NCT00471328|50554237|FG001|Extension Phase|Protocol Deviation|1|||
25239941|NCT00471328|50554236|FG000|Extension Phase|Treatment duration as per protocol|0|||
25239942|NCT00471328|50554237|FG001|Extension Phase|Treatment duration as per protocol|1|||
25239943|NCT00471328|50554236|FG000|Extension Phase|Disease Progression|32|||
25239944|NCT00471328|50554237|FG001|Extension Phase|Disease Progression|44|||
25239945|NCT00471328|50554236|FG000|Extension Phase|New cancer Therapy|1|||
25239946|NCT00471328|50554237|FG001|Extension Phase|New cancer Therapy|0|||
25239947|NCT00471328|50554236|FG000|Extension Phase|Administrative Problem|1|||
25239948|NCT00471328|50554237|FG001|Extension Phase|Administrative Problem|0|||
25239949|NCT00470470|50554245|FG000|Overall Study|Adverse Event|2|||
25239950|NCT00470470|50554245|FG000|Overall Study|Death|2|||
25239951|NCT00470470|50554245|FG000|Overall Study|Not treated|1|||
25239952|NCT00470275|50554249|FG000|Overall Study|Death|1|||
25239953|NCT00470275|50554249|FG000|Overall Study|Lack of Efficacy|7|||
25239954|NCT00470275|50554249|FG000|Overall Study|Withdrawal by Subject|2|||
25239955|NCT00470158|50554258|FG000|Overall Study|Death|0|||
25239956|NCT00470158|50554259|FG001|Overall Study|Death|0|||
25239957|NCT00470158|50554260|FG002|Overall Study|Death|0|||
25239958|NCT00470158|50554261|FG003|Overall Study|Death|0|||
25239959|NCT00470158|50554262|FG004|Overall Study|Death|2|||
25239960|NCT00470158|50554258|FG000|Overall Study|Lost to Follow-up|7|||
25239961|NCT00470158|50554259|FG001|Overall Study|Lost to Follow-up|8|||
25239962|NCT00470158|50554260|FG002|Overall Study|Lost to Follow-up|8|||
25239963|NCT00470158|50554261|FG003|Overall Study|Lost to Follow-up|5|||
25239964|NCT00470158|50554262|FG004|Overall Study|Lost to Follow-up|4|||
25239965|NCT00470158|50554258|FG000|Overall Study|Protocol Violation|1|||
25239966|NCT00470158|50554259|FG001|Overall Study|Protocol Violation|0|||
25239967|NCT00470158|50554260|FG002|Overall Study|Protocol Violation|0|||
25239968|NCT00470158|50554261|FG003|Overall Study|Protocol Violation|0|||
25239969|NCT00470158|50554262|FG004|Overall Study|Protocol Violation|0|||
25239970|NCT00475540|50554276|FG000|36 Months|Lost to Follow-up|4|||
25239971|NCT00475540|50554277|FG001|36 Months|Lost to Follow-up|4|||
25239972|NCT00475540|50554276|FG000|36 Months|Death|1|||
25239973|NCT00475540|50554277|FG001|36 Months|Death|2|||
25239974|NCT00475540|50554276|FG000|36 Months|Censored due to reoperation|3|||
25239975|NCT00475540|50554277|FG001|36 Months|Censored due to reoperation|0|||
25239976|NCT00472186|50554285|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
25239977|NCT00472186|50554286|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
25239978|NCT00479713|50554296|FG000|Overall Study|Adverse Event|8|||
25239979|NCT00479713|50554297|FG001|Overall Study|Adverse Event|6|||
25239980|NCT00479713|50554296|FG000|Overall Study|Death|1|||
25239981|NCT00479713|50554297|FG001|Overall Study|Death|0|||
25239982|NCT00479713|50554296|FG000|Overall Study|Lost to Follow-up|0|||
25239983|NCT00479713|50554297|FG001|Overall Study|Lost to Follow-up|1|||
25239984|NCT00479713|50554296|FG000|Overall Study|Protocol Violation|0|||
25239985|NCT00479713|50554297|FG001|Overall Study|Protocol Violation|1|||
25239986|NCT00479713|50554296|FG000|Overall Study|Withdrawal by Subject|4|||
25239987|NCT00479713|50554297|FG001|Overall Study|Withdrawal by Subject|1|||
25239988|NCT00474526|50554329|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
25239989|NCT00474526|50554330|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
25239990|NCT00474526|50554331|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
25239991|NCT00474526|50554332|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
25239992|NCT00474526|50554333|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
25239993|NCT00474526|50554334|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
25239994|NCT00474526|50554335|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
25239995|NCT00474526|50554336|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
25239996|NCT00474526|50554337|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
25239997|NCT00474526|50554338|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
25239998|NCT00474526|50554339|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
25239999|NCT00474526|50554340|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
25240000|NCT00474526|50554341|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
25240001|NCT00474526|50554342|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
25240002|NCT00474526|50554343|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
25240003|NCT00474526|50554344|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
25240004|NCT00474526|50554345|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
25240005|NCT00474526|50554329|FG000|Overall Study|Adverse Event|2|||
25240006|NCT00474526|50554330|FG001|Overall Study|Adverse Event|0|||
25240007|NCT00474526|50554331|FG002|Overall Study|Adverse Event|2|||
25240008|NCT00474526|50554332|FG003|Overall Study|Adverse Event|4|||
25240009|NCT00474526|50554333|FG004|Overall Study|Adverse Event|2|||
25240010|NCT00474526|50554334|FG005|Overall Study|Adverse Event|1|||
25240011|NCT00474526|50554335|FG006|Overall Study|Adverse Event|1|||
25240012|NCT00474526|50554336|FG007|Overall Study|Adverse Event|0|||
25240013|NCT00474526|50554337|FG008|Overall Study|Adverse Event|0|||
25240014|NCT00474526|50554338|FG009|Overall Study|Adverse Event|0|||
25240015|NCT00474526|50554339|FG010|Overall Study|Adverse Event|0|||
25240016|NCT00474526|50554340|FG011|Overall Study|Adverse Event|0|||
25240017|NCT00474526|50554341|FG012|Overall Study|Adverse Event|0|||
25240018|NCT00474526|50554342|FG013|Overall Study|Adverse Event|0|||
25240019|NCT00474526|50554343|FG014|Overall Study|Adverse Event|1|||
25240020|NCT00474526|50554344|FG015|Overall Study|Adverse Event|1|||
25240021|NCT00474526|50554345|FG016|Overall Study|Adverse Event|0|||
25240022|NCT00474526|50554329|FG000|Overall Study|Death|0|||
25240023|NCT00474526|50554330|FG001|Overall Study|Death|0|||
25240024|NCT00474526|50554331|FG002|Overall Study|Death|0|||
25240025|NCT00474526|50554332|FG003|Overall Study|Death|0|||
25077556|NCT02462486|50185343|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
25077557|NCT02462486|50185344|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
25077558|NCT02462486|50185342|FG000|Overall Study|Adverse Event|53|||
25077559|NCT02462486|50185343|FG001|Overall Study|Adverse Event|48|||
25077560|NCT02462486|50185344|FG002|Overall Study|Adverse Event|21|||
25077561|NCT02462486|50185342|FG000|Overall Study|Lack of Efficacy|6|||
25077562|NCT02462486|50185343|FG001|Overall Study|Lack of Efficacy|12|||
25077563|NCT02462486|50185344|FG002|Overall Study|Lack of Efficacy|3|||
25077564|NCT02462486|50185342|FG000|Overall Study|Lost to Follow-up|3|||
25240026|NCT00474526|50554333|FG004|Overall Study|Death|0|||
25240027|NCT00474526|50554334|FG005|Overall Study|Death|0|||
25240028|NCT00474526|50554335|FG006|Overall Study|Death|0|||
25240029|NCT00474526|50554336|FG007|Overall Study|Death|0|||
25240030|NCT00474526|50554337|FG008|Overall Study|Death|0|||
25240031|NCT00474526|50554338|FG009|Overall Study|Death|0|||
25240032|NCT00474526|50554339|FG010|Overall Study|Death|0|||
25240033|NCT00474526|50554340|FG011|Overall Study|Death|0|||
25240034|NCT00474526|50554341|FG012|Overall Study|Death|0|||
25240035|NCT00474526|50554342|FG013|Overall Study|Death|3|||
25240036|NCT00474526|50554343|FG014|Overall Study|Death|0|||
25240037|NCT00474526|50554344|FG015|Overall Study|Death|0|||
25240038|NCT00474526|50554345|FG016|Overall Study|Death|0|||
25240039|NCT00474526|50554329|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
25240040|NCT00474526|50554330|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
25240041|NCT00474526|50554331|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
25240042|NCT00474526|50554332|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
25240043|NCT00474526|50554333|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
25240044|NCT00474526|50554334|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
25240045|NCT00474526|50554335|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
25240046|NCT00474526|50554336|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
25240047|NCT00474526|50554337|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
25240048|NCT00474526|50554338|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
25240049|NCT00474526|50554339|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
25240050|NCT00474526|50554340|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
25240051|NCT00474526|50554341|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
25240052|NCT00474526|50554342|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
25240053|NCT00474526|50554343|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
25240054|NCT00474526|50554344|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
25240055|NCT00474526|50554345|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
25240056|NCT00474526|50554329|FG000|Overall Study|Lost to Follow-up|8|||
25240057|NCT00474526|50554330|FG001|Overall Study|Lost to Follow-up|6|||
25240058|NCT00474526|50554331|FG002|Overall Study|Lost to Follow-up|13|||
25240059|NCT00474526|50554332|FG003|Overall Study|Lost to Follow-up|29|||
25240060|NCT00474526|50554333|FG004|Overall Study|Lost to Follow-up|11|||
25240061|NCT00474526|50554334|FG005|Overall Study|Lost to Follow-up|5|||
25240062|NCT00474526|50554335|FG006|Overall Study|Lost to Follow-up|8|||
25240063|NCT00474526|50554336|FG007|Overall Study|Lost to Follow-up|1|||
25240064|NCT00474526|50554337|FG008|Overall Study|Lost to Follow-up|0|||
25240065|NCT00474526|50554338|FG009|Overall Study|Lost to Follow-up|6|||
25240066|NCT00474526|50554339|FG010|Overall Study|Lost to Follow-up|2|||
25077565|NCT02462486|50185343|FG001|Overall Study|Lost to Follow-up|4|||
25240067|NCT00474526|50554340|FG011|Overall Study|Lost to Follow-up|4|||
25077566|NCT02462486|50185344|FG002|Overall Study|Lost to Follow-up|2|||
25240068|NCT00474526|50554341|FG012|Overall Study|Lost to Follow-up|6|||
25240069|NCT00474526|50554342|FG013|Overall Study|Lost to Follow-up|74|||
25240070|NCT00474526|50554343|FG014|Overall Study|Lost to Follow-up|29|||
25240071|NCT00474526|50554344|FG015|Overall Study|Lost to Follow-up|4|||
25240072|NCT00474526|50554345|FG016|Overall Study|Lost to Follow-up|5|||
25240073|NCT00474526|50554329|FG000|Overall Study|Protocol Violation|2|||
25240074|NCT00474526|50554330|FG001|Overall Study|Protocol Violation|6|||
25240075|NCT00474526|50554331|FG002|Overall Study|Protocol Violation|4|||
25240076|NCT00474526|50554332|FG003|Overall Study|Protocol Violation|12|||
25240077|NCT00474526|50554333|FG004|Overall Study|Protocol Violation|3|||
25240078|NCT00474526|50554334|FG005|Overall Study|Protocol Violation|1|||
25240079|NCT00474526|50554335|FG006|Overall Study|Protocol Violation|3|||
25240080|NCT00474526|50554336|FG007|Overall Study|Protocol Violation|0|||
25240081|NCT00474526|50554337|FG008|Overall Study|Protocol Violation|0|||
25240082|NCT00474526|50554338|FG009|Overall Study|Protocol Violation|4|||
25240083|NCT00474526|50554339|FG010|Overall Study|Protocol Violation|2|||
25240084|NCT00474526|50554340|FG011|Overall Study|Protocol Violation|2|||
25240085|NCT00474526|50554341|FG012|Overall Study|Protocol Violation|4|||
25240086|NCT00474526|50554342|FG013|Overall Study|Protocol Violation|19|||
25240087|NCT00474526|50554343|FG014|Overall Study|Protocol Violation|9|||
25240088|NCT00474526|50554344|FG015|Overall Study|Protocol Violation|6|||
25240089|NCT00474526|50554345|FG016|Overall Study|Protocol Violation|2|||
25240090|NCT00474526|50554329|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
25240091|NCT00474526|50554330|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
25240092|NCT00474526|50554331|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
25240093|NCT00474526|50554332|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
25240094|NCT00474526|50554333|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
25240095|NCT00474526|50554334|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
25240096|NCT00474526|50554335|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
25240097|NCT00474526|50554336|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
25240098|NCT00474526|50554337|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
25240099|NCT00474526|50554338|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
25240100|NCT00474526|50554339|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
25240101|NCT00474526|50554340|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
25240102|NCT00474526|50554341|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
25240103|NCT00474526|50554342|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
25240104|NCT00474526|50554343|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
25240105|NCT00474526|50554344|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
25240106|NCT00474526|50554345|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
25240107|NCT00474526|50554329|FG000|Overall Study|Withdrawal by Subject|9|||
25240108|NCT00474526|50554330|FG001|Overall Study|Withdrawal by Subject|24|||
25240109|NCT00474526|50554331|FG002|Overall Study|Withdrawal by Subject|21|||
25240110|NCT00474526|50554332|FG003|Overall Study|Withdrawal by Subject|52|||
25240111|NCT00474526|50554333|FG004|Overall Study|Withdrawal by Subject|38|||
25240112|NCT00474526|50554334|FG005|Overall Study|Withdrawal by Subject|6|||
25240113|NCT00474526|50554335|FG006|Overall Study|Withdrawal by Subject|12|||
25240114|NCT00474526|50554336|FG007|Overall Study|Withdrawal by Subject|4|||
25240115|NCT00474526|50554337|FG008|Overall Study|Withdrawal by Subject|4|||
25240116|NCT00474526|50554338|FG009|Overall Study|Withdrawal by Subject|13|||
25240117|NCT00474526|50554339|FG010|Overall Study|Withdrawal by Subject|5|||
25240118|NCT00474526|50554340|FG011|Overall Study|Withdrawal by Subject|4|||
25240119|NCT00474526|50554341|FG012|Overall Study|Withdrawal by Subject|4|||
25240120|NCT00474526|50554342|FG013|Overall Study|Withdrawal by Subject|37|||
25240121|NCT00474526|50554343|FG014|Overall Study|Withdrawal by Subject|22|||
25240122|NCT00474526|50554344|FG015|Overall Study|Withdrawal by Subject|1|||
25240123|NCT00474526|50554345|FG016|Overall Study|Withdrawal by Subject|1|||
25240124|NCT00478426|50554431|FG000|Overall Study|Withdrawal by Subject|1|||
25240125|NCT00477412|50554439|FG000|Overall Study|Death|0|||
25240126|NCT00477412|50554440|FG001|Overall Study|Death|0|||
25240127|NCT00477412|50554441|FG002|Overall Study|Death|0|||
25320735|NCT00925301|50636687|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
25320736|NCT00925301|50636688|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
25320737|NCT00925301|50636689|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
25320738|NCT00925301|50636690|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
25320739|NCT00925301|50636687|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
25320740|NCT00925301|50636688|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
25320741|NCT00925301|50636689|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
25320742|NCT00925301|50636690|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
25320743|NCT00925301|50636687|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
25240128|NCT00477412|50554442|FG003|Overall Study|Death|4|||
25240129|NCT00477412|50554439|FG000|Overall Study|Lost to Follow-up|0|||
25240130|NCT00477412|50554440|FG001|Overall Study|Lost to Follow-up|0|||
25240131|NCT00477412|50554441|FG002|Overall Study|Lost to Follow-up|0|||
25240132|NCT00477412|50554442|FG003|Overall Study|Lost to Follow-up|1|||
25240133|NCT00477412|50554439|FG000|Overall Study|Withdrawal by Subject|0|||
25240134|NCT00477412|50554440|FG001|Overall Study|Withdrawal by Subject|0|||
25240135|NCT00477412|50554441|FG002|Overall Study|Withdrawal by Subject|0|||
25240136|NCT00477412|50554442|FG003|Overall Study|Withdrawal by Subject|2|||
25240137|NCT00477412|50554439|FG000|Overall Study|Second Malignancy|0|||
25240138|NCT00477412|50554440|FG001|Overall Study|Second Malignancy|0|||
25240139|NCT00477412|50554441|FG002|Overall Study|Second Malignancy|0|||
25240140|NCT00477412|50554442|FG003|Overall Study|Second Malignancy|1|||
25240141|NCT00477412|50554439|FG000|Overall Study|Adverse Event|1|||
25240142|NCT00477412|50554440|FG001|Overall Study|Adverse Event|0|||
25240143|NCT00477412|50554441|FG002|Overall Study|Adverse Event|1|||
25240144|NCT00477412|50554442|FG003|Overall Study|Adverse Event|0|||
25320744|NCT00925301|50636688|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
25320745|NCT00925301|50636689|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
25320746|NCT00925301|50636690|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
25320747|NCT00925301|50636687|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
25320748|NCT00925301|50636688|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
25320749|NCT00925301|50636689|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
25320750|NCT00925301|50636690|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
25320751|NCT00754065|50636703|FG000|Overall Study|Never received treatment|12|||
25320752|NCT00754065|50636704|FG001|Overall Study|Never received treatment|2|||
25320753|NCT00754065|50636703|FG000|Overall Study|Adverse Event|19|||
25320754|NCT00754065|50636704|FG001|Overall Study|Adverse Event|25|||
25320755|NCT00754065|50636703|FG000|Overall Study|Lost to Follow-up|7|||
25320756|NCT00754065|50636704|FG001|Overall Study|Lost to Follow-up|11|||
25320757|NCT00754065|50636703|FG000|Overall Study|Protocol Violation|12|||
25320758|NCT00754065|50636704|FG001|Overall Study|Protocol Violation|10|||
25320759|NCT00754065|50636703|FG000|Overall Study|Withdrawal by Subject|4|||
25320760|NCT00754065|50636704|FG001|Overall Study|Withdrawal by Subject|5|||
25320761|NCT00754065|50636703|FG000|Overall Study|Pregnancy|6|||
25320762|NCT00754065|50636704|FG001|Overall Study|Pregnancy|0|||
25320763|NCT00754065|50636703|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
25171776|NCT02985957|50309413|FG005|Treatment Period|Death|0|||
25171777|NCT02985957|50309414|FG006|Treatment Period|Death|0|||
25171778|NCT02985957|50309408|FG000|Treatment Period|Participant withdrew consent|0|||
25171779|NCT02985957|50309409|FG001|Treatment Period|Participant withdrew consent|0|||
25171780|NCT02985957|50309410|FG002|Treatment Period|Participant withdrew consent|0|||
25171781|NCT02985957|50309411|FG003|Treatment Period|Participant withdrew consent|1|||
25171782|NCT02985957|50309412|FG004|Treatment Period|Participant withdrew consent|3|||
25171783|NCT02985957|50309413|FG005|Treatment Period|Participant withdrew consent|0|||
25171784|NCT02985957|50309414|FG006|Treatment Period|Participant withdrew consent|1|||
25171785|NCT02985957|50309408|FG000|Treatment Period|Lost to Follow-up|0|||
25171786|NCT02985957|50309409|FG001|Treatment Period|Lost to Follow-up|0|||
25171787|NCT02985957|50309410|FG002|Treatment Period|Lost to Follow-up|0|||
25171788|NCT02985957|50309411|FG003|Treatment Period|Lost to Follow-up|0|||
25171789|NCT02985957|50309412|FG004|Treatment Period|Lost to Follow-up|1|||
25171790|NCT02985957|50309413|FG005|Treatment Period|Lost to Follow-up|0|||
25171791|NCT02985957|50309414|FG006|Treatment Period|Lost to Follow-up|0|||
25171792|NCT02985957|50309408|FG000|Treatment Period|Other reasons|0|||
25171793|NCT02985957|50309409|FG001|Treatment Period|Other reasons|0|||
25171794|NCT02985957|50309410|FG002|Treatment Period|Other reasons|1|||
25171795|NCT02985957|50309411|FG003|Treatment Period|Other reasons|3|||
25171796|NCT02985957|50309412|FG004|Treatment Period|Other reasons|6|||
25171797|NCT02985957|50309413|FG005|Treatment Period|Other reasons|0|||
25171798|NCT02985957|50309414|FG006|Treatment Period|Other reasons|1|||
25171799|NCT02985957|50309408|FG000|Treatment Period|Not reported|0|||
25171800|NCT02985957|50309409|FG001|Treatment Period|Not reported|1|||
25171801|NCT02985957|50309410|FG002|Treatment Period|Not reported|2|||
25171802|NCT02985957|50309411|FG003|Treatment Period|Not reported|5|||
25171803|NCT02985957|50309412|FG004|Treatment Period|Not reported|0|||
25171804|NCT02985957|50309413|FG005|Treatment Period|Not reported|0|||
25171805|NCT02985957|50309414|FG006|Treatment Period|Not reported|0|||
25171806|NCT02985957|50309408|FG000|Treatment Period|Maximum clinical benefit|0|||
25171807|NCT02985957|50309409|FG001|Treatment Period|Maximum clinical benefit|0|||
25171808|NCT02985957|50309410|FG002|Treatment Period|Maximum clinical benefit|1|||
25171809|NCT02985957|50309411|FG003|Treatment Period|Maximum clinical benefit|1|||
25171810|NCT02985957|50309412|FG004|Treatment Period|Maximum clinical benefit|0|||
25171811|NCT02985957|50309413|FG005|Treatment Period|Maximum clinical benefit|0|||
25171812|NCT02985957|50309414|FG006|Treatment Period|Maximum clinical benefit|2|||
25171813|NCT02985957|50309408|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
25171814|NCT02985957|50309409|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
25171815|NCT02985957|50309410|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
25171816|NCT02985957|50309411|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
25171817|NCT02985957|50309412|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
25171818|NCT02985957|50309413|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
25171819|NCT02985957|50309414|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
25171820|NCT02985957|50309408|FG000|Treatment Period|Study drug toxicity|1|||
25171821|NCT02985957|50309409|FG001|Treatment Period|Study drug toxicity|23|||
25171822|NCT02985957|50309410|FG002|Treatment Period|Study drug toxicity|20|||
25171823|NCT02985957|50309411|FG003|Treatment Period|Study drug toxicity|11|||
25171824|NCT02985957|50309412|FG004|Treatment Period|Study drug toxicity|19|||
25171825|NCT02985957|50309413|FG005|Treatment Period|Study drug toxicity|3|||
25240145|NCT01089556|50554452|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
25240146|NCT01089556|50554453|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
25240147|NCT01089556|50554454|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
25240148|NCT01089556|50554455|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
25240149|NCT01089556|50554456|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
25240150|NCT01089556|50554457|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
25240151|NCT01089556|50554452|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
25240152|NCT01089556|50554453|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
25240153|NCT01089556|50554454|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
25240154|NCT01089556|50554455|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
25240155|NCT01089556|50554456|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
25240156|NCT01089556|50554457|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
25240157|NCT01089556|50554452|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
25240158|NCT01089556|50554453|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
25240159|NCT01089556|50554454|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
25240160|NCT01089556|50554455|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
25240161|NCT01089556|50554456|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
25240162|NCT01089556|50554457|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
25240163|NCT01089556|50554452|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
25240164|NCT01089556|50554453|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
25240165|NCT01089556|50554454|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
25240166|NCT01089556|50554455|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
25240167|NCT01089556|50554456|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
25240168|NCT01089556|50554457|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
25240169|NCT01089556|50554452|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
25240170|NCT01089556|50554453|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
25240171|NCT01089556|50554454|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
25240172|NCT01089556|50554455|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
25240173|NCT01089556|50554456|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
25240174|NCT01089556|50554457|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
25240175|NCT01089556|50554452|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
25240176|NCT01089556|50554453|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
25240177|NCT01089556|50554454|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
25240178|NCT01089556|50554455|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
25240179|NCT01089556|50554456|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
25240180|NCT01089556|50554457|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
25240181|NCT01089556|50554452|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
25240182|NCT01089556|50554453|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
25240183|NCT01089556|50554454|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
25320764|NCT00754065|50636704|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
25320765|NCT04138056|50636724|FG000|Primary Study|Lost to Follow-up|3|||
25320766|NCT04138056|50636725|FG001|Primary Study|Lost to Follow-up|4|||
25320767|NCT04138056|50636726|FG002|Primary Study|Lost to Follow-up|1|||
25320768|NCT04138056|50636727|FG003|Primary Study|Lost to Follow-up|1|||
25320769|NCT04138056|50636728|FG004|Primary Study|Lost to Follow-up|4|||
25320770|NCT04138056|50636724|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
25320771|NCT04138056|50636725|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
25320772|NCT04138056|50636726|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
25320773|NCT04138056|50636727|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
25320774|NCT04138056|50636728|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
25320775|NCT04138056|50636724|FG000|Extension Study|Lost to Follow-up|1|||
25320776|NCT04138056|50636725|FG001|Extension Study|Lost to Follow-up|2|||
25320777|NCT04138056|50636726|FG002|Extension Study|Lost to Follow-up|1|||
25320778|NCT04138056|50636727|FG003|Extension Study|Lost to Follow-up|0|||
25320779|NCT04138056|50636728|FG004|Extension Study|Lost to Follow-up|1|||
25320780|NCT00753675|50636774|FG000|Overall Study|other reason|11|||
25240184|NCT01089556|50554455|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
25240185|NCT01089556|50554456|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
25240186|NCT01089556|50554457|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
25240187|NCT01089556|50554452|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
25320781|NCT00753675|50636775|FG001|Overall Study|other reason|12|||
25320782|NCT00753675|50636776|FG002|Overall Study|other reason|13|||
25320783|NCT00753675|50636774|FG000|Overall Study|Death|1|||
25320784|NCT00753675|50636775|FG001|Overall Study|Death|2|||
25320785|NCT00753675|50636776|FG002|Overall Study|Death|4|||
25240188|NCT01089556|50554453|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
25240189|NCT01089556|50554454|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
25320786|NCT00753675|50636774|FG000|Overall Study|Adverse Event|11|||
25320787|NCT00753675|50636775|FG001|Overall Study|Adverse Event|9|||
25320788|NCT00753675|50636776|FG002|Overall Study|Adverse Event|4|||
25240190|NCT01089556|50554455|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
25240191|NCT01089556|50554456|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
25240192|NCT01089556|50554457|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
25240193|NCT01089556|50554452|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
25240194|NCT01089556|50554453|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
25240195|NCT01089556|50554454|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
25240196|NCT01089556|50554455|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
25240197|NCT01089556|50554456|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
25240198|NCT01089556|50554457|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
25240199|NCT01089556|50554452|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
25240200|NCT01089556|50554453|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
25240201|NCT01089556|50554454|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
25320789|NCT00753675|50636774|FG000|Overall Study|Objective progression of disease|35|||
25320790|NCT00753675|50636775|FG001|Overall Study|Objective progression of disease|35|||
25320791|NCT00753675|50636776|FG002|Overall Study|Objective progression of disease|35|||
25320792|NCT00753675|50636774|FG000|Overall Study|Withdrawal by Subject|0|||
25320793|NCT00753675|50636775|FG001|Overall Study|Withdrawal by Subject|1|||
25320794|NCT00753675|50636776|FG002|Overall Study|Withdrawal by Subject|0|||
25320795|NCT00753675|50636774|FG000|Overall Study|Lost to Follow-up|1|||
25320796|NCT00753675|50636775|FG001|Overall Study|Lost to Follow-up|0|||
25320797|NCT00753675|50636776|FG002|Overall Study|Lost to Follow-up|0|||
25240202|NCT01089556|50554455|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
25240203|NCT01089556|50554456|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
25240204|NCT01089556|50554457|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
25240205|NCT01089556|50554452|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
25240206|NCT01089556|50554453|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
25240207|NCT01089556|50554454|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
25240208|NCT01089556|50554455|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
25240209|NCT01089556|50554456|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
25240210|NCT01089556|50554457|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
25240211|NCT01089556|50554452|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
25240212|NCT01089556|50554453|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
25240213|NCT01089556|50554454|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
25240214|NCT01089556|50554455|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
25240215|NCT01089556|50554456|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
25240216|NCT01089556|50554457|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
25240217|NCT01089556|50554452|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
25240218|NCT01089556|50554453|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
25240219|NCT01089556|50554454|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
25240220|NCT01089556|50554455|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
25240221|NCT01089556|50554456|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
25240222|NCT01089556|50554457|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
25320798|NCT00586521|50636784|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
25320799|NCT00923273|50636793|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
25320800|NCT00923273|50636794|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
25320801|NCT00923273|50636795|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
25320802|NCT00923273|50636796|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
25320803|NCT00923273|50636797|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
25320804|NCT00923273|50636793|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
25320805|NCT00923273|50636794|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
25320806|NCT00923273|50636795|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
25320807|NCT00923273|50636796|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
25320808|NCT00923273|50636797|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
25320809|NCT00923195|50636817|FG000|Overall Study|Death|0|||
25320810|NCT00923195|50636818|FG001|Overall Study|Death|1|||
25320811|NCT00753519|50636826|FG000|Overall Study|Withdrawal by Subject|0|||
25320812|NCT00753519|50636827|FG001|Overall Study|Withdrawal by Subject|2|||
25320813|NCT00919061|50636835|FG000|Overall Study|Adverse Event|1|||
25240223|NCT01089556|50554452|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
25320814|NCT00919061|50636835|FG000|Overall Study|Withdrawal by Subject|1|||
25320815|NCT00747435|50636839|FG000|Overall Study|Lost to Follow-up|2|||
25320816|NCT00747435|50636839|FG000|Overall Study|Withdrawal by Subject|3|||
25320817|NCT00747435|50636839|FG000|Overall Study|Still undergoing follow up|1|||
25240224|NCT01089556|50554453|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
25240225|NCT01089556|50554454|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
25240226|NCT01089556|50554455|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
25320818|NCT00918749|50636846|FG000|Overall Study|Adverse Event|1|||
25320819|NCT00918749|50636847|FG001|Overall Study|Adverse Event|0|||
25320820|NCT00918749|50636848|FG002|Overall Study|Adverse Event|1|||
25240227|NCT01089556|50554456|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
25240228|NCT01089556|50554457|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
25240229|NCT01089556|50554452|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
25240230|NCT01089556|50554453|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
25240231|NCT01089556|50554454|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
25240232|NCT01089556|50554455|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
25240233|NCT01089556|50554456|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
25240234|NCT01089556|50554457|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
25240235|NCT01089127|50554475|FG000|Overall Study|Adverse Event|5|||
25240236|NCT01089127|50554476|FG001|Overall Study|Adverse Event|1|||
25240237|NCT01089127|50554477|FG002|Overall Study|Adverse Event|1|||
25240238|NCT01089127|50554478|FG003|Overall Study|Adverse Event|0|||
25240239|NCT01089127|50554479|FG004|Overall Study|Adverse Event|0|||
25240240|NCT01089127|50554480|FG005|Overall Study|Adverse Event|1|||
25240241|NCT01089127|50554475|FG000|Overall Study|Subject withdrew consent|0|||
25240242|NCT01089127|50554476|FG001|Overall Study|Subject withdrew consent|1|||
25240243|NCT01089127|50554477|FG002|Overall Study|Subject withdrew consent|1|||
25240244|NCT01089127|50554478|FG003|Overall Study|Subject withdrew consent|1|||
25240245|NCT01089127|50554479|FG004|Overall Study|Subject withdrew consent|0|||
25240246|NCT01089127|50554480|FG005|Overall Study|Subject withdrew consent|2|||
25240247|NCT01089127|50554475|FG000|Overall Study|Abnormal test procedure result(s)|2|||
25240248|NCT01089127|50554476|FG001|Overall Study|Abnormal test procedure result(s)|1|||
25240249|NCT01089127|50554477|FG002|Overall Study|Abnormal test procedure result(s)|0|||
25240250|NCT01089127|50554478|FG003|Overall Study|Abnormal test procedure result(s)|0|||
25240251|NCT01089127|50554479|FG004|Overall Study|Abnormal test procedure result(s)|0|||
25240252|NCT01089127|50554480|FG005|Overall Study|Abnormal test procedure result(s)|0|||
25240253|NCT01089127|50554475|FG000|Overall Study|Lost to Follow-up|1|||
25240254|NCT01089127|50554476|FG001|Overall Study|Lost to Follow-up|1|||
25240255|NCT01089127|50554477|FG002|Overall Study|Lost to Follow-up|0|||
25240256|NCT01089127|50554478|FG003|Overall Study|Lost to Follow-up|0|||
25240257|NCT01089127|50554479|FG004|Overall Study|Lost to Follow-up|1|||
25240258|NCT01089127|50554480|FG005|Overall Study|Lost to Follow-up|0|||
25240259|NCT01089127|50554475|FG000|Overall Study|Protocol deviation|0|||
25240260|NCT01089127|50554476|FG001|Overall Study|Protocol deviation|1|||
25240261|NCT01089127|50554477|FG002|Overall Study|Protocol deviation|0|||
25240262|NCT01089127|50554478|FG003|Overall Study|Protocol deviation|0|||
25320821|NCT00918749|50636846|FG000|Overall Study|Lost to Follow-up|0|||
25240263|NCT01089127|50554479|FG004|Overall Study|Protocol deviation|1|||
25240264|NCT01089127|50554480|FG005|Overall Study|Protocol deviation|0|||
25240265|NCT01087957|50554496|FG000|Overall Study|Death|2|||
25240266|NCT01087957|50554497|FG001|Overall Study|Death|2|||
25240267|NCT01087957|50554496|FG000|Overall Study|Lost to Follow-up|3|||
25240268|NCT01087957|50554497|FG001|Overall Study|Lost to Follow-up|4|||
25240269|NCT01087957|50554496|FG000|Overall Study|Protocol Violation|13|||
25240270|NCT01087957|50554497|FG001|Overall Study|Protocol Violation|25|||
25240271|NCT01087957|50554496|FG000|Overall Study|Withdrawal by Subject|18|||
25240272|NCT01087957|50554497|FG001|Overall Study|Withdrawal by Subject|15|||
25240273|NCT01087957|50554496|FG000|Overall Study|Physician Decision|5|||
25240274|NCT01087957|50554497|FG001|Overall Study|Physician Decision|9|||
25240275|NCT01087723|50554505|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
25240276|NCT01087723|50554506|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
25240277|NCT01087723|50554505|FG000|Overall Study|Withdrawal by Subject|10|||
25240278|NCT01087723|50554506|FG001|Overall Study|Withdrawal by Subject|13|||
25240279|NCT01087723|50554505|FG000|Overall Study|Physician Decision|2|||
25240280|NCT01087723|50554506|FG001|Overall Study|Physician Decision|0|||
25240281|NCT01087723|50554505|FG000|Overall Study|Lost to Follow-up|1|||
25240282|NCT01087723|50554506|FG001|Overall Study|Lost to Follow-up|4|||
25240283|NCT01087723|50554505|FG000|Overall Study|Reason Not Specified|1|||
25240284|NCT01087723|50554506|FG001|Overall Study|Reason Not Specified|2|||
25240285|NCT01087528|50554512|FG000|Overall Study|Withdrawal by Subject|1|||
25240286|NCT01087528|50554512|FG000|Overall Study|Incomplete CE procedure|6|||
25240287|NCT01085812|50554518|FG000|Open-Label Period|Adverse Event|0|||
25240288|NCT01085812|50554519|FG001|Open-Label Period|Adverse Event|80|||
25240289|NCT01085812|50554518|FG000|Open-Label Period|Lack of Efficacy|0|||
25240290|NCT01085812|50554519|FG001|Open-Label Period|Lack of Efficacy|26|||
25240291|NCT01085812|50554518|FG000|Open-Label Period|Protocol Violation|0|||
25240292|NCT01085812|50554519|FG001|Open-Label Period|Protocol Violation|39|||
25240293|NCT01085812|50554518|FG000|Open-Label Period|Withdrawal by Subject|0|||
25240294|NCT01085812|50554519|FG001|Open-Label Period|Withdrawal by Subject|53|||
25240295|NCT01085812|50554518|FG000|Open-Label Period|Lost to Follow-up|0|||
25240296|NCT01085812|50554519|FG001|Open-Label Period|Lost to Follow-up|42|||
25240297|NCT01085812|50554518|FG000|Double-Blind Period|Adverse Event|3|||
25320822|NCT00918749|50636847|FG001|Overall Study|Lost to Follow-up|0|||
25240298|NCT01085812|50554519|FG001|Double-Blind Period|Adverse Event|8|||
25240299|NCT01085812|50554518|FG000|Double-Blind Period|Protocol Violation|2|||
25240300|NCT01085812|50554519|FG001|Double-Blind Period|Protocol Violation|7|||
25240301|NCT01085812|50554518|FG000|Double-Blind Period|Withdrawal by Subject|11|||
25240302|NCT01085812|50554519|FG001|Double-Blind Period|Withdrawal by Subject|24|||
25240303|NCT01085812|50554518|FG000|Double-Blind Period|Lost to Follow-up|5|||
25240304|NCT01085812|50554519|FG001|Double-Blind Period|Lost to Follow-up|17|||
25240305|NCT01085812|50554518|FG000|Double-Blind Period|Other Reasons|0|||
25240306|NCT01085812|50554519|FG001|Double-Blind Period|Other Reasons|2|||
25240307|NCT01085812|50554518|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
25240308|NCT01085812|50554519|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
25240309|NCT01085812|50554518|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
25240310|NCT01085812|50554519|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
25240311|NCT01085812|50554518|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
25240312|NCT01085812|50554519|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
25240313|NCT01085812|50554518|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
25240314|NCT01085812|50554519|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
25240315|NCT01085812|50554518|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
25240316|NCT01085812|50554519|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
25240317|NCT01085734|50554528|FG000|Overall Study|Adverse Event|0|||
25240318|NCT01085734|50554529|FG001|Overall Study|Adverse Event|2|||
25240319|NCT01085734|50554528|FG000|Overall Study|Death|1|||
25240320|NCT01085734|50554529|FG001|Overall Study|Death|0|||
25240321|NCT01085734|50554528|FG000|Overall Study|Lost to Follow-up|0|||
25240322|NCT01085734|50554529|FG001|Overall Study|Lost to Follow-up|1|||
25240323|NCT01085734|50554528|FG000|Overall Study|Withdrawal by Subject|0|||
25240324|NCT01085734|50554529|FG001|Overall Study|Withdrawal by Subject|1|||
25240325|NCT01084603|50554536|FG000|Baseline|Withdrawal by Subject|2|||
25240326|NCT01084603|50554536|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
25320823|NCT00918749|50636848|FG002|Overall Study|Lost to Follow-up|1|||
25320824|NCT00918749|50636846|FG000|Overall Study|Withdrawal by Subject|5|||
25320825|NCT00918749|50636847|FG001|Overall Study|Withdrawal by Subject|3|||
25320826|NCT00918749|50636848|FG002|Overall Study|Withdrawal by Subject|5|||
25240327|NCT01084603|50554536|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
25240328|NCT01084603|50554536|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
25240329|NCT01084603|50554536|FG000|Washout Period 4|Adverse Event|1|||
25240330|NCT01084174|50554551|FG000|Overall Study|gastrointestinal symptoms|1|||
25240331|NCT01084174|50554552|FG001|Overall Study|gastrointestinal symptoms|1|||
25240332|NCT01084174|50554551|FG000|Overall Study|Eosinophilic esophagitis|0|||
25240333|NCT01084174|50554552|FG001|Overall Study|Eosinophilic esophagitis|1|||
25240334|NCT01084174|50554551|FG000|Overall Study|Anaphylaxis|0|||
25240335|NCT01084174|50554552|FG001|Overall Study|Anaphylaxis|1|||
25240336|NCT01084174|50554551|FG000|Overall Study|Participant noncompliance|0|||
25240337|NCT01084174|50554552|FG001|Overall Study|Participant noncompliance|1|||
25240338|NCT01084135|50554562|FG000|20 Week|Physician Decision|0|||
25240339|NCT01084135|50554563|FG001|20 Week|Physician Decision|1|||
25240340|NCT01083316|50554571|FG000|Overall Study|Adverse Event|2|||
25240341|NCT01083316|50554571|FG000|Overall Study|Withdrawal by Subject|1|||
25240342|NCT01083160|50554576|FG000|Overall Study|Adverse Event|1|||
25240343|NCT01083121|50554580|FG000|Overall Study|Use of Humira outside the approved label|81|||
25240344|NCT01082614|50554590|FG000|Overall Study|Adverse Event|1|||
25240345|NCT01082614|50554591|FG001|Overall Study|Adverse Event|4|||
25240346|NCT01082614|50554590|FG000|Overall Study|Equipment Malfunction|0|||
25240347|NCT01082614|50554591|FG001|Overall Study|Equipment Malfunction|1|||
25240348|NCT01082614|50554590|FG000|Overall Study|Physician Decision|2|||
25240349|NCT01082614|50554591|FG001|Overall Study|Physician Decision|0|||
25240350|NCT01081873|50554597|FG000|Overall Study|Death|86|||
25240351|NCT01081873|50554597|FG000|Overall Study|Withdrawal by Subject|10|||
25240352|NCT01081873|50554597|FG000|Overall Study|Lost to Follow-up|142|||
25240353|NCT01081873|50554597|FG000|Overall Study|Progression of prostate cancer|13|||
25240354|NCT01081873|50554597|FG000|Overall Study|Other|47|||
25240355|NCT01081795|50554629|FG000|Overall Study|Adverse Event|18|||
25240356|NCT01081795|50554630|FG001|Overall Study|Adverse Event|23|||
25240357|NCT01081795|50554631|FG002|Overall Study|Adverse Event|6|||
25240358|NCT01081795|50554629|FG000|Overall Study|Lack of Efficacy|7|||
25240359|NCT01081795|50554630|FG001|Overall Study|Lack of Efficacy|5|||
25240360|NCT01081795|50554631|FG002|Overall Study|Lack of Efficacy|19|||
25240361|NCT01081795|50554629|FG000|Overall Study|Subject's schedule|1|||
25240362|NCT01081795|50554630|FG001|Overall Study|Subject's schedule|1|||
25320827|NCT00918749|50636846|FG000|Overall Study|No Study Medication Taken|1|||
25320828|NCT00918749|50636847|FG001|Overall Study|No Study Medication Taken|0|||
25240363|NCT01081795|50554631|FG002|Overall Study|Subject's schedule|2|||
25240364|NCT01081795|50554629|FG000|Overall Study|Revocation of informed consent|2|||
25240365|NCT01081795|50554630|FG001|Overall Study|Revocation of informed consent|0|||
25240366|NCT01081795|50554631|FG002|Overall Study|Revocation of informed consent|0|||
25240367|NCT01081795|50554629|FG000|Overall Study|Ineligible for participation|1|||
25240368|NCT01081795|50554630|FG001|Overall Study|Ineligible for participation|0|||
25240369|NCT01081795|50554631|FG002|Overall Study|Ineligible for participation|0|||
25240370|NCT01081795|50554629|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
25240371|NCT01081795|50554630|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
25240372|NCT01081795|50554631|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
25240373|NCT01081795|50554629|FG000|Overall Study|Using drug with restricted days of use|2|||
25240374|NCT01081795|50554630|FG001|Overall Study|Using drug with restricted days of use|3|||
25240375|NCT01081795|50554631|FG002|Overall Study|Using drug with restricted days of use|2|||
25240376|NCT01081795|50554629|FG000|Overall Study|Other|1|||
25240377|NCT01081795|50554630|FG001|Overall Study|Other|2|||
25240378|NCT01081795|50554631|FG002|Overall Study|Other|0|||
25240379|NCT01081678|50554643|FG000|Overall Study|Ineligibility Determined|0|||
25240380|NCT01081678|50554644|FG001|Overall Study|Ineligibility Determined|0|||
25240381|NCT01081678|50554645|FG002|Overall Study|Ineligibility Determined|1|||
25240382|NCT01081678|50554646|FG003|Overall Study|Ineligibility Determined|1|||
25240383|NCT01081678|50554643|FG000|Overall Study|Noncompliance|3|||
25240384|NCT01081678|50554644|FG001|Overall Study|Noncompliance|4|||
25240385|NCT01081678|50554645|FG002|Overall Study|Noncompliance|5|||
25240386|NCT01081678|50554646|FG003|Overall Study|Noncompliance|2|||
25240387|NCT01081678|50554643|FG000|Overall Study|Adverse Event|2|||
25240388|NCT01081678|50554644|FG001|Overall Study|Adverse Event|1|||
25240389|NCT01081678|50554645|FG002|Overall Study|Adverse Event|2|||
25240390|NCT01081678|50554646|FG003|Overall Study|Adverse Event|2|||
25240391|NCT01081678|50554643|FG000|Overall Study|Withdrawal by Subject|15|||
25240392|NCT01081678|50554644|FG001|Overall Study|Withdrawal by Subject|7|||
25240393|NCT01081678|50554645|FG002|Overall Study|Withdrawal by Subject|17|||
25240394|NCT01081678|50554646|FG003|Overall Study|Withdrawal by Subject|14|||
25240395|NCT01081678|50554643|FG000|Overall Study|Administrative Decision|1|||
25240396|NCT01081678|50554644|FG001|Overall Study|Administrative Decision|0|||
25240397|NCT01081678|50554645|FG002|Overall Study|Administrative Decision|0|||
25240398|NCT01081678|50554646|FG003|Overall Study|Administrative Decision|1|||
25240399|NCT01081678|50554643|FG000|Overall Study|Lost to Follow-up|4|||
25240400|NCT01081678|50554644|FG001|Overall Study|Lost to Follow-up|1|||
25240401|NCT01081678|50554645|FG002|Overall Study|Lost to Follow-up|4|||
25240402|NCT01081678|50554646|FG003|Overall Study|Lost to Follow-up|3|||
25240403|NCT01081678|50554643|FG000|Overall Study|Death|2|||
25240404|NCT01081678|50554644|FG001|Overall Study|Death|2|||
25240405|NCT01081678|50554645|FG002|Overall Study|Death|2|||
25240406|NCT01081678|50554646|FG003|Overall Study|Death|6|||
25240407|NCT01081678|50554643|FG000|Overall Study|Other|0|||
25240408|NCT01081678|50554644|FG001|Overall Study|Other|1|||
25240409|NCT01081678|50554645|FG002|Overall Study|Other|0|||
25240410|NCT01081678|50554646|FG003|Overall Study|Other|0|||
25240411|NCT01081249|50554656|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
25240412|NCT01081249|50554657|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
25240413|NCT01081132|50554665|FG000|Overall Study|Lack of Efficacy|25|||
25240414|NCT01081132|50554666|FG001|Overall Study|Lack of Efficacy|9|||
25240415|NCT01081132|50554665|FG000|Overall Study|Withdrawal by Subject|13|||
25240416|NCT01081132|50554666|FG001|Overall Study|Withdrawal by Subject|16|||
25240417|NCT01081132|50554665|FG000|Overall Study|Lost to Follow-up|4|||
25240418|NCT01081132|50554666|FG001|Overall Study|Lost to Follow-up|11|||
25240419|NCT01081132|50554665|FG000|Overall Study|Adverse Event|3|||
25240420|NCT01081132|50554666|FG001|Overall Study|Adverse Event|9|||
25240421|NCT01081132|50554665|FG000|Overall Study|Non Compliance|4|||
25240422|NCT01081132|50554666|FG001|Overall Study|Non Compliance|2|||
25240423|NCT01081132|50554665|FG000|Overall Study|Lack Of Compliance|0|||
25240424|NCT01081132|50554666|FG001|Overall Study|Lack Of Compliance|1|||
25240425|NCT01081132|50554665|FG000|Overall Study|Missed Visits|1|||
25240426|NCT01081132|50554666|FG001|Overall Study|Missed Visits|1|||
25240427|NCT01081132|50554665|FG000|Overall Study|Stopped Taking Meds|2|||
25240428|NCT01081132|50554666|FG001|Overall Study|Stopped Taking Meds|0|||
25240429|NCT01081132|50554665|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
25240430|NCT01081132|50554666|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
25240431|NCT01081132|50554665|FG000|Overall Study|Declined Taper Phase|0|||
25240432|NCT01081132|50554666|FG001|Overall Study|Declined Taper Phase|1|||
25240433|NCT01081132|50554665|FG000|Overall Study|Protocol Violation|3|||
25240434|NCT01081132|50554666|FG001|Overall Study|Protocol Violation|1|||
25320829|NCT00918749|50636848|FG002|Overall Study|No Study Medication Taken|0|||
25320830|NCT00746733|50636856|FG000|Second Intervention|Adverse Event|1|||
25240435|NCT01080625|50554675|FG000|Overall Study|Physician Decision|0|||
25240436|NCT01080625|50554676|FG001|Overall Study|Physician Decision|2|||
25240437|NCT01080625|50554677|FG002|Overall Study|Physician Decision|1|||
25240438|NCT01059903|50554687|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
25240439|NCT01059903|50554688|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
25240440|NCT00199888|50554744|FG000|Overall Study|Lost to Follow-up|1|||
25240441|NCT00199849|50554751|FG000|Overall Study|Unrelated illness or complication|0|||
25240442|NCT00199849|50554752|FG001|Overall Study|Unrelated illness or complication|1|||
25240443|NCT00199849|50554753|FG002|Overall Study|Unrelated illness or complication|0|||
25240444|NCT00199849|50554751|FG000|Overall Study|Progressive disease requiring intervention|0|||
25240445|NCT00199849|50554752|FG001|Overall Study|Progressive disease requiring intervention|0|||
25240446|NCT00199849|50554753|FG002|Overall Study|Progressive disease requiring intervention|1|||
25240447|NCT00199849|50554751|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
25240448|NCT00199849|50554752|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
25240449|NCT00199849|50554753|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
25240450|NCT00199381|50554761|FG000|Overall Study|Withdrawal by Subject|38|||
25240451|NCT00199381|50554761|FG000|Overall Study|Adverse Event|73|||
25240452|NCT00199381|50554761|FG000|Overall Study|Protocol Violation|6|||
25240453|NCT00199381|50554761|FG000|Overall Study|Lack of Efficacy|27|||
25240454|NCT00199381|50554761|FG000|Overall Study|Not including due to early termination|37|||
25240455|NCT00199381|50554761|FG000|Overall Study|Study termination by Sponsor|323|||
25240456|NCT00198133|50554767|FG000|Overall Study|Disease progression|2|||
25240457|NCT00198133|50554768|FG001|Overall Study|Disease progression|5|||
25240458|NCT00198133|50554767|FG000|Overall Study|Adverse Event|1|||
25240459|NCT00198133|50554768|FG001|Overall Study|Adverse Event|3|||
25240460|NCT00198133|50554767|FG000|Overall Study|Withdrawal by Subject|1|||
25240461|NCT00198133|50554768|FG001|Overall Study|Withdrawal by Subject|0|||
25240462|NCT00198133|50554767|FG000|Overall Study|Physician Decision|1|||
25240463|NCT00198133|50554768|FG001|Overall Study|Physician Decision|0|||
25240464|NCT00197236|50554777|FG000|Overall Study|Adverse Event|1|||
25240465|NCT00197236|50554778|FG001|Overall Study|Adverse Event|0|||
25240466|NCT00197236|50554779|FG002|Overall Study|Adverse Event|1|||
25240467|NCT00197236|50554777|FG000|Overall Study|Lost to Follow-up|5|||
25240468|NCT00197236|50554778|FG001|Overall Study|Lost to Follow-up|14|||
25240469|NCT00197236|50554779|FG002|Overall Study|Lost to Follow-up|6|||
25240470|NCT00197236|50554777|FG000|Overall Study|Protocol Violation|0|||
25240471|NCT00197236|50554778|FG001|Overall Study|Protocol Violation|0|||
25240472|NCT00197236|50554779|FG002|Overall Study|Protocol Violation|1|||
25240473|NCT00197236|50554777|FG000|Overall Study|Withdrawal by Subject|7|||
25240474|NCT00197236|50554778|FG001|Overall Study|Withdrawal by Subject|3|||
25240475|NCT00197236|50554779|FG002|Overall Study|Withdrawal by Subject|11|||
25240476|NCT00197236|50554777|FG000|Overall Study|Study drug/medication expiration|1|||
25240477|NCT00197236|50554778|FG001|Overall Study|Study drug/medication expiration|0|||
25240478|NCT00197236|50554779|FG002|Overall Study|Study drug/medication expiration|3|||
25240479|NCT00197236|50554777|FG000|Overall Study|Returned out of specified time window|0|||
25240480|NCT00197236|50554778|FG001|Overall Study|Returned out of specified time window|0|||
25240481|NCT00197236|50554779|FG002|Overall Study|Returned out of specified time window|1|||
25240482|NCT00197002|50554793|FG000|Overall Study|Adverse Event|0|||
25240483|NCT00197002|50554794|FG001|Overall Study|Adverse Event|1|||
25240484|NCT00197002|50554795|FG002|Overall Study|Adverse Event|0|||
25240485|NCT00197002|50554793|FG000|Overall Study|Protocol Violation|1|||
25240486|NCT00197002|50554794|FG001|Overall Study|Protocol Violation|0|||
25240487|NCT00197002|50554795|FG002|Overall Study|Protocol Violation|2|||
25240488|NCT00197002|50554793|FG000|Overall Study|Withdrawal by Subject|9|||
25240489|NCT00197002|50554794|FG001|Overall Study|Withdrawal by Subject|5|||
25240490|NCT00197002|50554795|FG002|Overall Study|Withdrawal by Subject|7|||
25240491|NCT00197002|50554793|FG000|Overall Study|Migrated/moved from study area|3|||
25240492|NCT00197002|50554794|FG001|Overall Study|Migrated/moved from study area|5|||
25240493|NCT00197002|50554795|FG002|Overall Study|Migrated/moved from study area|1|||
25240494|NCT00197002|50554793|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
25240495|NCT00197002|50554794|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
25240496|NCT00197002|50554795|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
25240497|NCT00197002|50554793|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
25240498|NCT00197002|50554794|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
25240499|NCT00197002|50554795|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
25240500|NCT00197002|50554793|FG000|Overall Study|Others|3|||
25240501|NCT00197002|50554794|FG001|Overall Study|Others|1|||
25240502|NCT00197002|50554795|FG002|Overall Study|Others|1|||
25240503|NCT00196105|50554809|FG000|Overall Study|Lost to Follow-up|4|||
25240504|NCT00196105|50554810|FG001|Overall Study|Lost to Follow-up|5|||
24976954|NCT02952820|50065759|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
24976955|NCT02952820|50065760|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
24976956|NCT02952820|50065761|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
24976957|NCT02952820|50065759|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
24976958|NCT02952820|50065760|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
24976959|NCT02952820|50065761|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
25240505|NCT00196105|50554811|FG002|Overall Study|Lost to Follow-up|7|||
25240506|NCT00195715|50554819|FG000|Overall Study|Adverse Event|122|||
25240507|NCT00195715|50554819|FG000|Overall Study|Withdrawal by Subject|58|||
25240508|NCT00195715|50554819|FG000|Overall Study|Lost to Follow-up|27|||
25240509|NCT00195715|50554819|FG000|Overall Study|Protocol Violation|13|||
25240510|NCT00195715|50554819|FG000|Overall Study|Lack of Efficacy|93|||
25077567|NCT02462486|50185342|FG000|Overall Study|Withdrawal by Subject|25|||
25077568|NCT02462486|50185343|FG001|Overall Study|Withdrawal by Subject|22|||
25077569|NCT02462486|50185344|FG002|Overall Study|Withdrawal by Subject|19|||
25077570|NCT02462486|50185342|FG000|Overall Study|Protocol Violation|3|||
25077571|NCT02462486|50185343|FG001|Overall Study|Protocol Violation|1|||
25077572|NCT02462486|50185344|FG002|Overall Study|Protocol Violation|1|||
25077573|NCT02462486|50185342|FG000|Overall Study|Reason not Specified|3|||
25077574|NCT02462486|50185343|FG001|Overall Study|Reason not Specified|4|||
25077575|NCT02462486|50185344|FG002|Overall Study|Reason not Specified|3|||
25077576|NCT02495948|50185352|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
25077577|NCT02495948|50185353|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
25077578|NCT02495948|50185352|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
25077579|NCT02495948|50185353|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
25077580|NCT02461628|50185362|FG000|Overall Study|Refused to complete survey|4|||
25077581|NCT02461628|50185363|FG001|Overall Study|Refused to complete survey|7|||
25077582|NCT02429791|50185371|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
25077583|NCT02429791|50185372|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
25077584|NCT02429791|50185371|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
25077585|NCT02429791|50185372|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
25077586|NCT02429791|50185371|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
25077587|NCT02429791|50185372|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
25077588|NCT02429791|50185371|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
25077589|NCT02429791|50185372|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
25077590|NCT02429791|50185371|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
25077591|NCT02429791|50185372|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
25077592|NCT02429791|50185371|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
25077593|NCT02429791|50185372|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
25077594|NCT02429791|50185371|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
25077595|NCT02429791|50185372|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
25077596|NCT02429791|50185371|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
25077597|NCT02429791|50185372|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
25077598|NCT02429791|50185371|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
25077599|NCT02429791|50185372|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
25077600|NCT02429791|50185371|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
25077601|NCT02429791|50185372|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
25077602|NCT02429791|50185371|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
25077603|NCT02429791|50185372|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
25077604|NCT02429791|50185371|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
25077605|NCT02429791|50185372|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
25077606|NCT02132611|50185385|FG000|Overall Study|Death|2|||
25240511|NCT00195715|50554819|FG000|Overall Study|Pregnancy|14|||
25240512|NCT00195715|50554819|FG000|Overall Study|Investigative site closure|8|||
25240513|NCT00195715|50554819|FG000|Overall Study|Subject moved/relocated|7|||
25240514|NCT00195715|50554819|FG000|Overall Study|Subject non-compliance|6|||
25240515|NCT00195715|50554819|FG000|Overall Study|Subject started commercial Humira|5|||
25240516|NCT00195715|50554819|FG000|Overall Study|Subject choice|3|||
25240517|NCT00195715|50554819|FG000|Overall Study|Loss of response/no improvement|3|||
25240518|NCT00195715|50554819|FG000|Overall Study|Sponsor stopped study|1|||
25240519|NCT00195715|50554819|FG000|Overall Study|Administrative reasons|2|||
25240520|NCT00195715|50554819|FG000|Overall Study|Investigator's decision|2|||
25240521|NCT00195715|50554819|FG000|Overall Study|Subject wants to get pregnant|4|||
25240522|NCT00195715|50554819|FG000|Overall Study|Use of prohibited medication|2|||
25240523|NCT00195715|50554819|FG000|Overall Study|Planned surgery|2|||
25240524|NCT00195715|50554819|FG000|Overall Study|Increased infection rate|1|||
25240525|NCT00195715|50554819|FG000|Overall Study|Ineligible|1|||
25240526|NCT00195715|50554819|FG000|Overall Study|Colonic stricture|1|||
25240527|NCT00195715|50554819|FG000|Overall Study|Sponsor discontinued trial|1|||
25240528|NCT00195715|50554819|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
25240529|NCT00195676|50554823|FG000|Period O - Open-label Treatment|Adverse Event|82|||
25240530|NCT00195676|50554823|FG000|Period O - Open-label Treatment|Death|6|||
25240531|NCT00195676|50554823|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
25240532|NCT00195676|50554823|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
25240533|NCT00195676|50554823|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
25240534|NCT00195676|50554823|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
25240535|NCT00195676|50554823|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
25077607|NCT02461160|50185402|FG000|Overall Study|Lost to Follow-up|0|||
25077608|NCT02461160|50185403|FG001|Overall Study|Lost to Follow-up|0|||
25240536|NCT00195676|50554823|FG000|Period O - Open-label Treatment|Other reasons|68|||
25320831|NCT00746733|50636857|FG001|Second Intervention|Adverse Event|0|||
25077609|NCT02461160|50185404|FG002|Overall Study|Lost to Follow-up|0|||
25077610|NCT02461160|50185405|FG003|Overall Study|Lost to Follow-up|0|||
25240537|NCT00195676|50554823|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
25240538|NCT00195676|50554823|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
25240539|NCT00195676|50554823|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
25240540|NCT00195676|50554823|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
25240541|NCT00195676|50554823|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
25240542|NCT00195676|50554823|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
25240543|NCT00195676|50554823|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
25240544|NCT00195676|50554823|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
24976960|NCT02952820|50065759|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
24976961|NCT02952820|50065760|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
24976962|NCT02952820|50065761|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
24976963|NCT02952820|50065759|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
24976964|NCT02952820|50065760|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
24976965|NCT02952820|50065761|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
24976966|NCT02952820|50065759|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
24976967|NCT02952820|50065760|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
24976968|NCT02952820|50065761|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
24976969|NCT02952820|50065759|FG000|Active Treatment Period (6 Months)|Not treated|0|||
25077611|NCT02461160|50185406|FG004|Overall Study|Lost to Follow-up|0|||
25077612|NCT02461160|50185407|FG005|Overall Study|Lost to Follow-up|0|||
25240545|NCT00195676|50554823|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
25240546|NCT00195676|50554823|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
25240547|NCT00195676|50554823|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
25240548|NCT00195676|50554823|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
25240549|NCT00195676|50554823|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
25240550|NCT00194077|50554833|FG000|Overall Study|Lack of Efficacy|22|||
25240551|NCT00194077|50554834|FG001|Overall Study|Lack of Efficacy|29|||
25240552|NCT00194077|50554833|FG000|Overall Study|Study nonadherence|1|||
25240553|NCT00194077|50554834|FG001|Overall Study|Study nonadherence|0|||
25240554|NCT00194077|50554833|FG000|Overall Study|Withdrawal by Subject|1|||
25320832|NCT00746733|50636856|FG000|Third Intervention|Withdrawal by Subject|1|||
25320833|NCT00746733|50636857|FG001|Third Intervention|Withdrawal by Subject|1|||
25320834|NCT00745875|50636872|FG000|Overall Study|Continuing study treatment|4|||
25320835|NCT00745875|50636873|FG001|Overall Study|Continuing study treatment|4|||
25320836|NCT00555217|50636881|FG000|Overall Study|Withdrawal by Subject|35|||
25077613|NCT02461160|50185408|FG006|Overall Study|Lost to Follow-up|0|||
25077614|NCT02461160|50185409|FG007|Overall Study|Lost to Follow-up|1|||
25077615|NCT02461160|50185410|FG008|Overall Study|Lost to Follow-up|0|||
25077616|NCT02461160|50185411|FG009|Overall Study|Lost to Follow-up|0|||
25077617|NCT02461160|50185412|FG010|Overall Study|Lost to Follow-up|0|||
25077618|NCT02461160|50185413|FG011|Overall Study|Lost to Follow-up|0|||
25077619|NCT02461160|50185414|FG012|Overall Study|Lost to Follow-up|0|||
25077620|NCT01653704|50185465|FG000|Overall Study|Technical failure during recording|1|||
25077621|NCT01653704|50185466|FG001|Overall Study|Technical failure during recording|1|||
25240555|NCT00194077|50554834|FG001|Overall Study|Withdrawal by Subject|1|||
25320837|NCT00555217|50636882|FG001|Overall Study|Withdrawal by Subject|31|||
25320838|NCT00555217|50636881|FG000|Overall Study|Lost to Follow-up|19|||
25320839|NCT00555217|50636882|FG001|Overall Study|Lost to Follow-up|20|||
25320840|NCT00555217|50636881|FG000|Overall Study|close out sites|21|||
25320841|NCT00555217|50636882|FG001|Overall Study|close out sites|17|||
25320842|NCT00745251|50636890|FG000|Overall Study|Adverse Event|1|||
25320843|NCT00745251|50636891|FG001|Overall Study|Adverse Event|2|||
25320844|NCT00745251|50636890|FG000|Overall Study|Withdrawal by Subject|1|||
25320845|NCT00745251|50636891|FG001|Overall Study|Withdrawal by Subject|1|||
25320846|NCT00745095|50636903|FG000|Overall Study|Declined to participate|1|||
25320847|NCT00745095|50636904|FG001|Overall Study|Declined to participate|0|||
25320848|NCT00745095|50636905|FG002|Overall Study|Declined to participate|0|||
25320849|NCT00745095|50636906|FG003|Overall Study|Declined to participate|0|||
25320850|NCT00745095|50636907|FG004|Overall Study|Declined to participate|92|||
25320851|NCT00745095|50636908|FG005|Overall Study|Declined to participate|95|||
25320852|NCT00745095|50636903|FG000|Overall Study|Ineligible due to GFR criteria|0|||
25320853|NCT00745095|50636904|FG001|Overall Study|Ineligible due to GFR criteria|2|||
25320854|NCT00745095|50636905|FG002|Overall Study|Ineligible due to GFR criteria|3|||
25320855|NCT00745095|50636906|FG003|Overall Study|Ineligible due to GFR criteria|3|||
25320856|NCT00745095|50636907|FG004|Overall Study|Ineligible due to GFR criteria|30|||
25077622|NCT01653704|50185465|FG000|Overall Study|Performance not reflective of training|1|||
25077623|NCT01653704|50185466|FG001|Overall Study|Performance not reflective of training|0|||
25320857|NCT00745095|50636908|FG005|Overall Study|Ineligible due to GFR criteria|28|||
25320858|NCT00744939|50636929|FG000|Overall Study|Withdrawal by Subject|9|||
25320859|NCT00744939|50636929|FG000|Overall Study|Protocol Violation|13|||
25320860|NCT00744939|50636929|FG000|Overall Study|Death|24|||
25320861|NCT00744939|50636929|FG000|Overall Study|distance|4|||
25320862|NCT00744939|50636929|FG000|Overall Study|Lost to Follow-up|12|||
25077624|NCT02495168|50185475|FG000|Overall Study|Other than Specified|18|||
25077625|NCT02495168|50185476|FG001|Overall Study|Other than Specified|22|||
25077626|NCT02495168|50185477|FG002|Overall Study|Other than Specified|5|||
25077627|NCT02495168|50185475|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
25077628|NCT02495168|50185476|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
25077629|NCT02495168|50185477|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
25077630|NCT02495168|50185475|FG000|Overall Study|Physician Decision|1|||
25077631|NCT02495168|50185476|FG001|Overall Study|Physician Decision|1|||
25077632|NCT02495168|50185477|FG002|Overall Study|Physician Decision|0|||
25077633|NCT02495168|50185475|FG000|Overall Study|Lost to Follow-up|10|||
25077634|NCT02495168|50185476|FG001|Overall Study|Lost to Follow-up|6|||
25077635|NCT02495168|50185477|FG002|Overall Study|Lost to Follow-up|1|||
25077636|NCT02495168|50185475|FG000|Overall Study|Withdrawal by Subject|1|||
25077637|NCT02495168|50185476|FG001|Overall Study|Withdrawal by Subject|4|||
25077638|NCT02495168|50185477|FG002|Overall Study|Withdrawal by Subject|2|||
25077639|NCT02495168|50185475|FG000|Overall Study|Protocol Violation|0|||
25077640|NCT02495168|50185476|FG001|Overall Study|Protocol Violation|10|||
25077641|NCT02495168|50185477|FG002|Overall Study|Protocol Violation|1|||
25077642|NCT02495168|50185475|FG000|Overall Study|Adverse Event|4|||
25240556|NCT00193609|50554840|FG000|Overall Study|Lack of Efficacy|2|||
25240557|NCT00193609|50554840|FG000|Overall Study|Adverse Event|2|||
25240558|NCT00193180|50554844|FG000|Overall Study|Lack of Efficacy|1|||
25240559|NCT00193180|50554844|FG000|Overall Study|Adverse Event|8|||
25240560|NCT00193180|50554844|FG000|Overall Study|Protocol Violation|1|||
25240561|NCT00193063|50554849|FG000|Overall Study|Lack of Efficacy|3|||
25240562|NCT00193063|50554849|FG000|Overall Study|Adverse Event|1|||
25240563|NCT00191854|50554856|FG000|Overall Study|Death|26|||
25240564|NCT00191854|50554857|FG001|Overall Study|Death|23|||
25240565|NCT00191854|50554858|FG002|Overall Study|Death|29|||
25240566|NCT00191854|50554856|FG000|Overall Study|Lost to Follow-up|7|||
25240567|NCT00191854|50554857|FG001|Overall Study|Lost to Follow-up|5|||
25240568|NCT00191854|50554858|FG002|Overall Study|Lost to Follow-up|5|||
25240569|NCT00191854|50554856|FG000|Overall Study|Withdrawal by Subject|4|||
25240570|NCT00191854|50554857|FG001|Overall Study|Withdrawal by Subject|2|||
25240571|NCT00191854|50554858|FG002|Overall Study|Withdrawal by Subject|3|||
25240572|NCT00191854|50554856|FG000|Overall Study|Sponsor Decision|0|||
25240573|NCT00191854|50554857|FG001|Overall Study|Sponsor Decision|0|||
25240574|NCT00191854|50554858|FG002|Overall Study|Sponsor Decision|1|||
25240575|NCT00191854|50554856|FG000|Overall Study|Screen Failure|0|||
25240576|NCT00191854|50554857|FG001|Overall Study|Screen Failure|0|||
25240577|NCT00191854|50554858|FG002|Overall Study|Screen Failure|1|||
25240578|NCT00191815|50554866|FG000|Overall Study|Adverse Event|2|||
25240579|NCT00191815|50554866|FG000|Overall Study|Disease progression or relapse|24|||
25240580|NCT00191815|50554866|FG000|Overall Study|Death|2|||
25240581|NCT00191815|50554866|FG000|Overall Study|Protocol Violation|3|||
25240582|NCT00191815|50554866|FG000|Overall Study|Physician Decision|2|||
25240583|NCT00191815|50554866|FG000|Overall Study|Withdrawal by Subject|7|||
25240584|NCT00191386|50554870|FG000|Overall Study|Adverse Event|16|||
25240585|NCT00191386|50554870|FG000|Overall Study|Lost to Follow-up|1|||
25240586|NCT00191386|50554870|FG000|Overall Study|Entry Criteria Exclusion|3|||
25240587|NCT00191386|50554870|FG000|Overall Study|Protocol Violation|18|||
25240588|NCT00191386|50554870|FG000|Overall Study|Withdrawal by Subject|96|||
25240589|NCT00191386|50554870|FG000|Overall Study|Physician Decision|11|||
25240590|NCT00191386|50554870|FG000|Overall Study|Lack of Efficacy|15|||
25240591|NCT00191308|50554874|FG000|Overall Study|Adverse Event|1|||
25240592|NCT00191269|50554880|FG000|Overall Study|Protocol Violation|0|||
25240593|NCT00191269|50554881|FG001|Overall Study|Protocol Violation|2|||
25240594|NCT00191269|50554880|FG000|Overall Study|Adverse Event|1|||
25240595|NCT00191269|50554881|FG001|Overall Study|Adverse Event|4|||
25240596|NCT00191269|50554880|FG000|Overall Study|Progression of Disease|4|||
25240597|NCT00191269|50554881|FG001|Overall Study|Progression of Disease|42|||
25240598|NCT00191269|50554880|FG000|Overall Study|Lack of Efficacy|1|||
25240599|NCT00191269|50554881|FG001|Overall Study|Lack of Efficacy|5|||
25240600|NCT00191269|50554880|FG000|Overall Study|Withdrawal by Subject|0|||
24976970|NCT02952820|50065760|FG001|Active Treatment Period (6 Months)|Not treated|0|||
25077643|NCT02495168|50185476|FG001|Overall Study|Adverse Event|8|||
25077644|NCT02495168|50185477|FG002|Overall Study|Adverse Event|3|||
25077645|NCT02495168|50185475|FG000|Overall Study|Lack of Efficacy|0|||
25077646|NCT02495168|50185476|FG001|Overall Study|Lack of Efficacy|0|||
25171826|NCT02985957|50309414|FG006|Treatment Period|Study drug toxicity|5|||
25171827|NCT02985957|50309408|FG000|Treatment Period|Disease progression|0|||
25171828|NCT02985957|50309409|FG001|Treatment Period|Disease progression|16|||
25171829|NCT02985957|50309410|FG002|Treatment Period|Disease progression|20|||
25171830|NCT02985957|50309411|FG003|Treatment Period|Disease progression|39|||
25171831|NCT02985957|50309412|FG004|Treatment Period|Disease progression|29|||
25171832|NCT02985957|50309413|FG005|Treatment Period|Disease progression|11|||
25171833|NCT02985957|50309414|FG006|Treatment Period|Disease progression|28|||
25240601|NCT00191269|50554881|FG001|Overall Study|Withdrawal by Subject|1|||
25240602|NCT00191269|50554880|FG000|Overall Study|Pathologic Aggrevation|0|||
25240603|NCT00191269|50554881|FG001|Overall Study|Pathologic Aggrevation|1|||
25240604|NCT00191269|50554880|FG000|Overall Study|Physician Decision|0|||
25240605|NCT00191269|50554881|FG001|Overall Study|Physician Decision|3|||
25240606|NCT00191191|50554890|FG000|Overall Study|Entry Criteria Exclusion|2|||
25240607|NCT00191191|50554891|FG001|Overall Study|Entry Criteria Exclusion|0|||
25240608|NCT00191191|50554890|FG000|Overall Study|Treated with Another Systemic Agent|1|||
25240609|NCT00191191|50554891|FG001|Overall Study|Treated with Another Systemic Agent|1|||
25240610|NCT00191191|50554890|FG000|Overall Study|Adverse Event|11|||
25240611|NCT00191191|50554891|FG001|Overall Study|Adverse Event|21|||
25240612|NCT00191191|50554890|FG000|Overall Study|Progressive Disease|84|||
25240613|NCT00191191|50554891|FG001|Overall Study|Progressive Disease|72|||
25240614|NCT00191191|50554890|FG000|Overall Study|Toxicity After Dose Reduction|7|||
25240615|NCT00191191|50554891|FG001|Overall Study|Toxicity After Dose Reduction|8|||
25240616|NCT00191191|50554890|FG000|Overall Study|Family/Caregiver Decision|5|||
25240617|NCT00191191|50554891|FG001|Overall Study|Family/Caregiver Decision|7|||
25240618|NCT00191191|50554890|FG000|Overall Study|Lost to Follow-up|1|||
25240619|NCT00191191|50554891|FG001|Overall Study|Lost to Follow-up|0|||
25240620|NCT00191191|50554890|FG000|Overall Study|Physician Decision|3|||
25240621|NCT00191191|50554891|FG001|Overall Study|Physician Decision|2|||
25240622|NCT00191191|50554890|FG000|Overall Study|Good Clinical Practice Violation|0|||
25240623|NCT00191191|50554891|FG001|Overall Study|Good Clinical Practice Violation|1|||
25240624|NCT00191152|50554899|FG000|Initial Treatment|Adverse Event|43|||
25240625|NCT00191152|50554900|FG001|Initial Treatment|Adverse Event|67|||
25240626|NCT00191152|50554899|FG000|Initial Treatment|Physician Decision|40|||
25240627|NCT00191152|50554900|FG001|Initial Treatment|Physician Decision|31|||
25320863|NCT00744939|50636929|FG000|Overall Study|Medical history exclusionary|1|||
25320864|NCT00744939|50636929|FG000|Overall Study|Did not receive Magnevist|7|||
25320865|NCT00744939|50636929|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
25320866|NCT00744939|50636929|FG000|Overall Study|coma|1|||
25320867|NCT00744939|50636929|FG000|Overall Study|incorrect race|1|||
25320868|NCT00744861|50636945|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
25320869|NCT00744861|50636946|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
25320870|NCT00744861|50636947|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
25320871|NCT00744861|50636948|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
25320872|NCT00744861|50636945|FG000|Feasibility Stage 1|Pregnancy|0|||
25320873|NCT00744861|50636946|FG001|Feasibility Stage 1|Pregnancy|1|||
25320874|NCT00744861|50636947|FG002|Feasibility Stage 1|Pregnancy|0|||
25320875|NCT00744861|50636948|FG003|Feasibility Stage 1|Pregnancy|0|||
25320876|NCT00744861|50636945|FG000|Pivotal Stage 2|Adverse Event|0|||
25320877|NCT00744861|50636946|FG001|Pivotal Stage 2|Adverse Event|0|||
25240628|NCT00191152|50554899|FG000|Initial Treatment|Withdrawal by Subject|40|||
25240629|NCT00191152|50554900|FG001|Initial Treatment|Withdrawal by Subject|28|||
25240630|NCT00191152|50554899|FG000|Initial Treatment|Lost to Follow-up|0|||
25240631|NCT00191152|50554900|FG001|Initial Treatment|Lost to Follow-up|6|||
25240632|NCT00191152|50554899|FG000|Initial Treatment|Other|18|||
25240633|NCT00191152|50554900|FG001|Initial Treatment|Other|21|||
25240634|NCT00191152|50554899|FG000|Crossover Treatment|Adverse Event|8|||
25240635|NCT00191152|50554900|FG001|Crossover Treatment|Adverse Event|8|||
25240636|NCT00191152|50554899|FG000|Crossover Treatment|Physician Decision|7|||
25240637|NCT00191152|50554900|FG001|Crossover Treatment|Physician Decision|7|||
25240638|NCT00191152|50554899|FG000|Crossover Treatment|Withdrawal by Subject|6|||
25240639|NCT00191152|50554900|FG001|Crossover Treatment|Withdrawal by Subject|9|||
25240640|NCT00191152|50554899|FG000|Crossover Treatment|Lost to Follow-up|2|||
25240641|NCT00191152|50554900|FG001|Crossover Treatment|Lost to Follow-up|1|||
25240642|NCT00191152|50554899|FG000|Crossover Treatment|Other|4|||
25240643|NCT00191152|50554900|FG001|Crossover Treatment|Other|3|||
25240644|NCT00190684|50554918|FG000|Overall Study|Adverse Event|86|||
25240645|NCT00190684|50554918|FG000|Overall Study|Satisfactory response|80|||
25240646|NCT00190684|50554918|FG000|Overall Study|Lack of efficacy|204|||
25240647|NCT00190684|50554918|FG000|Overall Study|Lost to Follow-up|232|||
25240648|NCT00190684|50554918|FG000|Overall Study|Patient moved|60|||
25320878|NCT00744861|50636947|FG002|Pivotal Stage 2|Adverse Event|6|||
25320879|NCT00744861|50636948|FG003|Pivotal Stage 2|Adverse Event|11|||
25320880|NCT00744861|50636945|FG000|Pivotal Stage 2|Death|0|||
25320881|NCT00744861|50636946|FG001|Pivotal Stage 2|Death|0|||
25240649|NCT00190684|50554918|FG000|Overall Study|Patient Decision|432|||
25240650|NCT00190684|50554918|FG000|Overall Study|Clinical relapse|67|||
25240651|NCT00190684|50554918|FG000|Overall Study|Sponsor's decision|17|||
25240652|NCT00190684|50554918|FG000|Overall Study|Physician Decision|84|||
25240653|NCT00190684|50554918|FG000|Overall Study|Protocol Violation|123|||
25240654|NCT00190684|50554918|FG000|Overall Study|Study Period III Completed|103|||
25240655|NCT00190684|50554918|FG000|Overall Study|Study Period V Completed|1|||
25320882|NCT00744861|50636947|FG002|Pivotal Stage 2|Death|0|||
25320883|NCT00744861|50636948|FG003|Pivotal Stage 2|Death|1|||
25240656|NCT00179959|50554929|FG000|Overall Study|Lost to Follow-up|3|||
25240657|NCT00179959|50554930|FG001|Overall Study|Lost to Follow-up|1|||
25240658|NCT00179959|50554929|FG000|Overall Study|Withdrawal by Subject|3|||
25240659|NCT00179959|50554930|FG001|Overall Study|Withdrawal by Subject|2|||
25320884|NCT00744861|50636945|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
25240660|NCT00179647|50554936|FG000|Overall Study|Adverse Event|294|||
25240661|NCT00179647|50554936|FG000|Overall Study|Lack of Efficacy|478|||
25240662|NCT00179647|50554936|FG000|Overall Study|Withdrawal by Subject|83|||
25320885|NCT00744861|50636946|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
25240663|NCT00179647|50554936|FG000|Overall Study|Lost to Follow-up|4|||
25240664|NCT00179647|50554936|FG000|Overall Study|Death|94|||
25240665|NCT00179647|50554936|FG000|Overall Study|Other|960|||
25240666|NCT00179413|50554942|FG000|Overall Study|Adverse Event|38|||
25240667|NCT00179413|50554943|FG001|Overall Study|Adverse Event|20|||
25240668|NCT00179413|50554942|FG000|Overall Study|Withdrawal by Subject|87|||
25240669|NCT00179413|50554943|FG001|Overall Study|Withdrawal by Subject|95|||
25240670|NCT00178633|50554949|FG000|Overall Study|Lost to Follow-up|6|||
25240671|NCT00178399|50554954|FG000|Overall Study|Physician Decision|4|||
25240672|NCT00178399|50554954|FG000|Overall Study|Withdrawal by Subject|8|||
25240673|NCT00178399|50554954|FG000|Overall Study|Lost to Follow-up|1|||
25240674|NCT00178126|50554961|FG000|Overall Study|Lost to Follow-up|21|||
25240675|NCT00178126|50554962|FG001|Overall Study|Lost to Follow-up|21|||
25240676|NCT00178126|50554961|FG000|Overall Study|did not receive intervention|4|||
25240677|NCT00178126|50554962|FG001|Overall Study|did not receive intervention|6|||
25240678|NCT00177307|50554968|FG000|Overall Study|Withdrawal by Subject|1|||
25240679|NCT00176644|50554972|FG000|Overall Study|Withdrawal by Subject|1|||
25240680|NCT00176605|50554980|FG000|Overall Study|Withdrawal by Subject|2|||
25320886|NCT00744861|50636947|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
25320887|NCT00744861|50636948|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
25320888|NCT00744861|50636945|FG000|Pivotal Stage 2|Physician Decision|0|||
25320889|NCT00744861|50636946|FG001|Pivotal Stage 2|Physician Decision|0|||
25320890|NCT00744861|50636947|FG002|Pivotal Stage 2|Physician Decision|3|||
25320891|NCT00744861|50636948|FG003|Pivotal Stage 2|Physician Decision|1|||
25320892|NCT00744861|50636945|FG000|Pivotal Stage 2|Protocol Violation|0|||
25320893|NCT00744861|50636946|FG001|Pivotal Stage 2|Protocol Violation|0|||
25320894|NCT00744861|50636947|FG002|Pivotal Stage 2|Protocol Violation|0|||
25320895|NCT00744861|50636948|FG003|Pivotal Stage 2|Protocol Violation|1|||
25320896|NCT00744861|50636945|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
25320897|NCT00744861|50636946|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
25320898|NCT00744861|50636947|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
25320899|NCT00744861|50636948|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
25320900|NCT00744861|50636945|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
25320901|NCT00744861|50636946|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
25320902|NCT00744861|50636947|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
25320903|NCT00744861|50636948|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
25320904|NCT03969589|50636958|FG000|Overall Study|Lost to Follow-up|3|||
25320905|NCT03969589|50636959|FG001|Overall Study|Lost to Follow-up|2|||
25320906|NCT03969589|50636958|FG000|Overall Study|Declined Follow-Up|0|||
25240681|NCT00176488|50554984|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
25240682|NCT00175825|50554992|FG000|Overall Study|Adverse Event|3|||
25320907|NCT03969589|50636959|FG001|Overall Study|Declined Follow-Up|1|||
25240683|NCT00175825|50554993|FG001|Overall Study|Adverse Event|2|||
25240684|NCT00175825|50554994|FG002|Overall Study|Adverse Event|1|||
25240685|NCT00175825|50554995|FG003|Overall Study|Adverse Event|1|||
25320908|NCT00744627|50636967|FG000|Overall Study|Adverse Event|6|||
25320909|NCT00744627|50636968|FG001|Overall Study|Adverse Event|9|||
25240686|NCT00175825|50554992|FG000|Overall Study|Lost to Follow-up|1|||
25240687|NCT00175825|50554993|FG001|Overall Study|Lost to Follow-up|2|||
25240688|NCT00175825|50554994|FG002|Overall Study|Lost to Follow-up|0|||
25240689|NCT00175825|50554995|FG003|Overall Study|Lost to Follow-up|0|||
25240690|NCT00175825|50554992|FG000|Overall Study|Withdrawal by Subject|1|||
25320910|NCT00744627|50636967|FG000|Overall Study|Lack of Efficacy|7|||
25320911|NCT00744627|50636968|FG001|Overall Study|Lack of Efficacy|3|||
25320912|NCT00744627|50636967|FG000|Overall Study|Noncompliance|0|||
25320913|NCT00744627|50636968|FG001|Overall Study|Noncompliance|1|||
25320914|NCT00744627|50636967|FG000|Overall Study|Protocol Deviations|0|||
25320915|NCT00744627|50636968|FG001|Overall Study|Protocol Deviations|2|||
25320916|NCT00744627|50636967|FG000|Overall Study|Voluntary Withdrawal|9|||
25320917|NCT00744627|50636968|FG001|Overall Study|Voluntary Withdrawal|6|||
25320918|NCT00744627|50636967|FG000|Overall Study|Lost to Follow-up|2|||
25320919|NCT00744627|50636968|FG001|Overall Study|Lost to Follow-up|1|||
25320920|NCT00744627|50636967|FG000|Overall Study|Other|1|||
25240691|NCT00175825|50554993|FG001|Overall Study|Withdrawal by Subject|0|||
25240692|NCT00175825|50554994|FG002|Overall Study|Withdrawal by Subject|0|||
25240693|NCT00175825|50554995|FG003|Overall Study|Withdrawal by Subject|0|||
25320921|NCT00744627|50636968|FG001|Overall Study|Other|0|||
25240694|NCT00174967|50555009|FG000|Overall Study|Adverse Event|1|||
25240695|NCT00174967|50555010|FG001|Overall Study|Adverse Event|2|||
25240696|NCT00174967|50555011|FG002|Overall Study|Adverse Event|2|||
25240697|NCT00174967|50555012|FG003|Overall Study|Adverse Event|1|||
25240698|NCT00174967|50555009|FG000|Overall Study|Gout Flare|0|||
25240699|NCT00174967|50555010|FG001|Overall Study|Gout Flare|0|||
25240700|NCT00174967|50555011|FG002|Overall Study|Gout Flare|0|||
25240701|NCT00174967|50555012|FG003|Overall Study|Gout Flare|1|||
25240702|NCT00174967|50555009|FG000|Overall Study|Other|0|||
25240703|NCT00174967|50555010|FG001|Overall Study|Other|1|||
25240704|NCT00174967|50555011|FG002|Overall Study|Other|0|||
25240705|NCT00174967|50555012|FG003|Overall Study|Other|0|||
25240706|NCT00174265|50555024|FG000|Overall Study|Adverse Event|7|||
25240707|NCT00174265|50555025|FG001|Overall Study|Adverse Event|4|||
25240708|NCT00174265|50555024|FG000|Overall Study|Lack of Efficacy|2|||
25240709|NCT00174265|50555025|FG001|Overall Study|Lack of Efficacy|2|||
25240710|NCT00174265|50555024|FG000|Overall Study|Withdrawal by Subject|3|||
25240711|NCT00174265|50555025|FG001|Overall Study|Withdrawal by Subject|5|||
25240712|NCT00174265|50555024|FG000|Overall Study|Lost to Follow-up|1|||
25240713|NCT00174265|50555025|FG001|Overall Study|Lost to Follow-up|0|||
25240714|NCT00174265|50555024|FG000|Overall Study|Other (Not specified)|16|||
25240715|NCT00174265|50555025|FG001|Overall Study|Other (Not specified)|10|||
25240716|NCT00172042|50555033|FG000|Overall Study|Adverse Event|27|||
25240717|NCT00172042|50555034|FG001|Overall Study|Adverse Event|13|||
25240718|NCT00172042|50555033|FG000|Overall Study|Abnormal laboratory value(s)|5|||
25240719|NCT00172042|50555034|FG001|Overall Study|Abnormal laboratory value(s)|1|||
25240720|NCT00172042|50555033|FG000|Overall Study|Abnormal test procedure(s)|0|||
25240721|NCT00172042|50555034|FG001|Overall Study|Abnormal test procedure(s)|3|||
25240722|NCT00172042|50555033|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
25240723|NCT00172042|50555034|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
25240724|NCT00172042|50555033|FG000|Overall Study|Patient no longer requires study drug|10|||
25240725|NCT00172042|50555034|FG001|Overall Study|Patient no longer requires study drug|8|||
25240726|NCT00172042|50555033|FG000|Overall Study|Protocol Violation|8|||
25240727|NCT00172042|50555034|FG001|Overall Study|Protocol Violation|7|||
25240728|NCT00172042|50555033|FG000|Overall Study|Withdrawal by Subject|37|||
25240729|NCT00172042|50555034|FG001|Overall Study|Withdrawal by Subject|25|||
25240730|NCT00172042|50555033|FG000|Overall Study|Lost to Follow-up|3|||
25240731|NCT00172042|50555034|FG001|Overall Study|Lost to Follow-up|5|||
25240732|NCT00172042|50555033|FG000|Overall Study|Administrative problems|13|||
25240733|NCT00172042|50555034|FG001|Overall Study|Administrative problems|10|||
25240734|NCT00172042|50555033|FG000|Overall Study|Death|42|||
25240735|NCT00172042|50555034|FG001|Overall Study|Death|42|||
25240736|NCT00171925|50555042|FG000|Overall Study|Adverse Event|10|||
25240737|NCT00171925|50555043|FG001|Overall Study|Adverse Event|6|||
25240738|NCT00171925|50555042|FG000|Overall Study|Protocol Violation|1|||
25320922|NCT03959137|50636974|FG000|Overall Study|Protocol Violation|6|||
25320923|NCT00562627|50636981|FG000|Overall Study|Protocol Violation|1|||
25320924|NCT00562627|50636982|FG001|Overall Study|Protocol Violation|1|||
25320925|NCT00562627|50636983|FG002|Overall Study|Protocol Violation|1|||
25320926|NCT00562159|50636993|FG000|Overall Study|Adverse Event|11|||
25240739|NCT00171925|50555043|FG001|Overall Study|Protocol Violation|1|||
25240740|NCT00171925|50555042|FG000|Overall Study|Withdrawal by Subject|6|||
25240741|NCT00171925|50555043|FG001|Overall Study|Withdrawal by Subject|9|||
25240742|NCT00171925|50555042|FG000|Overall Study|Lost to Follow-up|2|||
25240743|NCT00171925|50555043|FG001|Overall Study|Lost to Follow-up|2|||
25240744|NCT00171925|50555042|FG000|Overall Study|Administrative problems|10|||
25240745|NCT00171925|50555043|FG001|Overall Study|Administrative problems|11|||
25240746|NCT00171925|50555042|FG000|Overall Study|Death|1|||
25240747|NCT00171925|50555043|FG001|Overall Study|Death|2|||
25320927|NCT00562159|50636994|FG001|Overall Study|Adverse Event|8|||
25320928|NCT00562159|50636993|FG000|Overall Study|Lost to Follow-up|5|||
25240748|NCT00171340|50555051|FG000|Overall Study|Adverse Event|46|||
25240749|NCT00171340|50555052|FG001|Overall Study|Adverse Event|42|||
25240750|NCT00171340|50555051|FG000|Overall Study|Lack of Efficacy|29|||
25240751|NCT00171340|50555052|FG001|Overall Study|Lack of Efficacy|41|||
25240752|NCT00171340|50555051|FG000|Overall Study|Protocol Violation|7|||
25240753|NCT00171340|50555052|FG001|Overall Study|Protocol Violation|8|||
25240754|NCT00171340|50555051|FG000|Overall Study|Withdrawal by Subject|22|||
25240755|NCT00171340|50555052|FG001|Overall Study|Withdrawal by Subject|19|||
25240756|NCT00171340|50555051|FG000|Overall Study|Lost to Follow-up|0|||
25240757|NCT00171340|50555052|FG001|Overall Study|Lost to Follow-up|5|||
25240758|NCT00171340|50555051|FG000|Overall Study|Abnormal Laboratory Results|2|||
25240759|NCT00171340|50555052|FG001|Overall Study|Abnormal Laboratory Results|0|||
25320929|NCT00562159|50636994|FG001|Overall Study|Lost to Follow-up|4|||
25320930|NCT00562159|50636993|FG000|Overall Study|Withdrawal by Subject|9|||
25240760|NCT00171340|50555051|FG000|Overall Study|Abnormal Test Procedure Results|6|||
25240761|NCT00171340|50555052|FG001|Overall Study|Abnormal Test Procedure Results|11|||
25240762|NCT00171340|50555051|FG000|Overall Study|No Longer Required Study Drug|1|||
25240763|NCT00171340|50555052|FG001|Overall Study|No Longer Required Study Drug|1|||
25240764|NCT00171340|50555051|FG000|Overall Study|Administrative Problems|5|||
25240765|NCT00171340|50555052|FG001|Overall Study|Administrative Problems|2|||
25240766|NCT00171340|50555051|FG000|Overall Study|Death|6|||
25240767|NCT00171340|50555052|FG001|Overall Study|Death|6|||
25240768|NCT00171301|50555062|FG000|Overall Study|Death|1|||
25240769|NCT00171301|50555063|FG001|Overall Study|Death|2|||
25240770|NCT00171301|50555062|FG000|Overall Study|Adverse Event|1|||
25240771|NCT00171301|50555063|FG001|Overall Study|Adverse Event|2|||
25240772|NCT00171301|50555062|FG000|Overall Study|Lost to Follow-up|6|||
25240773|NCT00171301|50555063|FG001|Overall Study|Lost to Follow-up|2|||
25240774|NCT00171301|50555062|FG000|Overall Study|Protocol Violation|0|||
25240775|NCT00171301|50555063|FG001|Overall Study|Protocol Violation|2|||
25240776|NCT00171301|50555062|FG000|Overall Study|Withdrawal by Subject|0|||
25240777|NCT00171301|50555063|FG001|Overall Study|Withdrawal by Subject|1|||
25240778|NCT00171223|50555073|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
25240779|NCT00171223|50555074|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
25240780|NCT00171223|50555075|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
25240781|NCT00171223|50555073|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
25240782|NCT00171223|50555074|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
25240783|NCT00171223|50555075|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
25240784|NCT00171223|50555073|FG000|Overall Study|Abnormal Procedure|1|||
25240785|NCT00171223|50555074|FG001|Overall Study|Abnormal Procedure|0|||
25240786|NCT00171223|50555075|FG002|Overall Study|Abnormal Procedure|0|||
25240787|NCT00171223|50555073|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
25240788|NCT00171223|50555074|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
25240789|NCT00171223|50555075|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
25240790|NCT00171223|50555073|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
25240791|NCT00171223|50555074|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
25240792|NCT00171223|50555075|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
25240793|NCT00171223|50555073|FG000|Overall Study|Protocol Violation|2|||
25320931|NCT00562159|50636994|FG001|Overall Study|Withdrawal by Subject|8|||
25077647|NCT02495168|50185477|FG002|Overall Study|Lack of Efficacy|3|||
25240794|NCT00171223|50555074|FG001|Overall Study|Protocol Violation|2|||
25240795|NCT00171223|50555075|FG002|Overall Study|Protocol Violation|3|||
25240796|NCT00171223|50555073|FG000|Overall Study|Participant Withdrew Consent|12|||
25240797|NCT00171223|50555074|FG001|Overall Study|Participant Withdrew Consent|21|||
25240798|NCT00171223|50555075|FG002|Overall Study|Participant Withdrew Consent|15|||
25240799|NCT00171223|50555073|FG000|Overall Study|Lost to Follow-up|5|||
25240800|NCT00171223|50555074|FG001|Overall Study|Lost to Follow-up|2|||
25240801|NCT00171223|50555075|FG002|Overall Study|Lost to Follow-up|3|||
25240802|NCT00171223|50555073|FG000|Overall Study|Administrative Problems|4|||
25240803|NCT00171223|50555074|FG001|Overall Study|Administrative Problems|7|||
25320932|NCT00562159|50636993|FG000|Overall Study|Protocol Violation|12|||
25320933|NCT00562159|50636994|FG001|Overall Study|Protocol Violation|12|||
25077648|NCT02494778|50185485|FG000|Overall Study|Death|3|||
25240804|NCT00171223|50555075|FG002|Overall Study|Administrative Problems|6|||
25240805|NCT00171223|50555073|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
25240806|NCT00171223|50555074|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
25240807|NCT00171223|50555075|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
25240808|NCT00171223|50555073|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
25240809|NCT00171223|50555074|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
25240810|NCT00171223|50555075|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
25240811|NCT00479674|50555081|FG000|Overall Study|Adverse Event|18|||
25240812|NCT00479674|50555081|FG000|Overall Study|Withdrawal by Subject|6|||
25240813|NCT00479674|50555081|FG000|Overall Study|Physician Decision|14|||
25240814|NCT00479674|50555081|FG000|Overall Study|none provided|3|||
25240815|NCT00479401|50555088|FG000|Overall Study|Adverse Event|24|||
25320934|NCT00562159|50636993|FG000|Overall Study|Did not meet protocol eligibility|1|||
25320935|NCT00562159|50636994|FG001|Overall Study|Did not meet protocol eligibility|1|||
25320936|NCT04223778|50637003|FG000|Overall Study|Ongoing|322|||
25320937|NCT04223778|50637004|FG001|Overall Study|Ongoing|326|||
25320938|NCT04223778|50637003|FG000|Overall Study|Death|0|||
25320939|NCT04223778|50637004|FG001|Overall Study|Death|1|||
25320940|NCT04223778|50637003|FG000|Overall Study|Lost to Follow-up|1|||
25320941|NCT04223778|50637004|FG001|Overall Study|Lost to Follow-up|5|||
25240816|NCT00479401|50555089|FG001|Overall Study|Adverse Event|20|||
25240817|NCT00479401|50555090|FG002|Overall Study|Adverse Event|4|||
25240818|NCT00479401|50555088|FG000|Overall Study|Lack of Efficacy|2|||
25240819|NCT00479401|50555089|FG001|Overall Study|Lack of Efficacy|2|||
25240820|NCT00479401|50555090|FG002|Overall Study|Lack of Efficacy|4|||
25240821|NCT00479401|50555088|FG000|Overall Study|Protocol Violation|2|||
25240822|NCT00479401|50555089|FG001|Overall Study|Protocol Violation|1|||
25240823|NCT00479401|50555090|FG002|Overall Study|Protocol Violation|1|||
25240824|NCT00479401|50555088|FG000|Overall Study|Lost to Follow-up|1|||
25240825|NCT00479401|50555089|FG001|Overall Study|Lost to Follow-up|1|||
25240826|NCT00479401|50555090|FG002|Overall Study|Lost to Follow-up|1|||
25240827|NCT00479401|50555088|FG000|Overall Study|Withdrawal by Subject|16|||
25240828|NCT00479401|50555089|FG001|Overall Study|Withdrawal by Subject|10|||
25240829|NCT00479401|50555090|FG002|Overall Study|Withdrawal by Subject|2|||
25240830|NCT00479401|50555088|FG000|Overall Study|Exclusion criteria, relocation|4|||
25240831|NCT00479401|50555089|FG001|Overall Study|Exclusion criteria, relocation|3|||
25240832|NCT00479401|50555090|FG002|Overall Study|Exclusion criteria, relocation|0|||
25240833|NCT00478777|50555098|FG000|Overall Study|Adverse Event|29|||
25240834|NCT00478777|50555098|FG000|Overall Study|Lack of Efficacy|23|||
25240835|NCT00478777|50555098|FG000|Overall Study|Withdrawal by Subject|4|||
25240836|NCT00478777|50555098|FG000|Overall Study|Death|3|||
25240837|NCT00478777|50555098|FG000|Overall Study|Protocol Violation|3|||
25240838|NCT00478777|50555098|FG000|Overall Study|Lost to Follow-up|3|||
25240839|NCT00478777|50555098|FG000|Overall Study|Physician Decision|1|||
25240840|NCT00478777|50555098|FG000|Overall Study|Intolerance of therapy|1|||
25240841|NCT00478777|50555098|FG000|Overall Study|Lack of compliance|1|||
25240842|NCT00478777|50555098|FG000|Overall Study|Lymphocytes infusion|1|||
25240843|NCT00478777|50555098|FG000|Overall Study|End of therapy|2|||
25240844|NCT00478777|50555098|FG000|Overall Study|Not treated with lenalidomide|6|||
25240845|NCT00477607|50555104|FG000|Overall Study|Lost to Follow-up|7|||
25240846|NCT00477607|50555105|FG001|Overall Study|Lost to Follow-up|7|||
25240847|NCT00477490|50555116|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
25240848|NCT00477490|50555117|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
25240849|NCT00477490|50555118|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
25240850|NCT00477490|50555119|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
25240851|NCT00477490|50555120|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
25240852|NCT00477490|50555121|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
25240853|NCT00477490|50555122|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
25240854|NCT00477490|50555123|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
25240855|NCT00477490|50555124|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
25240856|NCT00477490|50555116|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
25240857|NCT00477490|50555117|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
25240858|NCT00477490|50555118|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
25240859|NCT00477490|50555119|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
25240860|NCT00477490|50555120|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
25240861|NCT00477490|50555121|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
25240862|NCT00477490|50555122|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
25240863|NCT00477490|50555123|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
25240864|NCT00477490|50555124|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
25240865|NCT00477490|50555116|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
25320942|NCT04223778|50637003|FG000|Overall Study|Physician Decision|3|||
25320943|NCT04223778|50637004|FG001|Overall Study|Physician Decision|1|||
25320944|NCT04223778|50637003|FG000|Overall Study|Withdrawal by Subject|10|||
25320945|NCT04223778|50637004|FG001|Overall Study|Withdrawal by Subject|1|||
25320946|NCT04223778|50637003|FG000|Overall Study|Lack of Efficacy|0|||
25320947|NCT04223778|50637004|FG001|Overall Study|Lack of Efficacy|2|||
25320948|NCT00921557|50637013|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
25240866|NCT00477490|50555117|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
25240867|NCT00477490|50555118|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
25320949|NCT00921557|50637014|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
25320950|NCT00921557|50637015|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
25240868|NCT00477490|50555119|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
25240869|NCT00477490|50555120|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
25240870|NCT00477490|50555121|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
25240871|NCT00477490|50555122|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
25240872|NCT00477490|50555123|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
25240873|NCT00477490|50555124|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
25320951|NCT00921557|50637013|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
25320952|NCT00921557|50637014|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
25320953|NCT00921557|50637015|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
25320954|NCT00921557|50637013|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
25320955|NCT00921557|50637014|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
25240874|NCT00477490|50555116|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
25240875|NCT00477490|50555117|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
25240876|NCT00477490|50555118|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
25240877|NCT00477490|50555119|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
25240878|NCT00477490|50555120|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
25240879|NCT00477490|50555121|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
25240880|NCT00477490|50555122|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
25240881|NCT00477490|50555123|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
25320956|NCT00921557|50637015|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
25320957|NCT00921557|50637013|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
25240882|NCT00477490|50555124|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
25240883|NCT00477490|50555116|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
25240884|NCT00477490|50555117|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
25240885|NCT00477490|50555118|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
25240886|NCT00477490|50555119|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
25320958|NCT00921557|50637014|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
25320959|NCT00921557|50637015|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
25320960|NCT00921557|50637013|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
25320961|NCT00921557|50637014|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
25320962|NCT00921557|50637015|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
25320963|NCT00550615|50637030|FG000|Overall Study|Withdrawal by Subject|0|||
25320964|NCT00550615|50637031|FG001|Overall Study|Withdrawal by Subject|0|||
25320965|NCT00550615|50637032|FG002|Overall Study|Withdrawal by Subject|2|||
25320966|NCT00550615|50637033|FG003|Overall Study|Withdrawal by Subject|3|||
25320967|NCT00550615|50637030|FG000|Overall Study|Not evaluable|0|||
25320968|NCT00550615|50637031|FG001|Overall Study|Not evaluable|0|||
25320969|NCT00550615|50637032|FG002|Overall Study|Not evaluable|2|||
25320970|NCT00550615|50637033|FG003|Overall Study|Not evaluable|7|||
25240887|NCT00477490|50555120|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
25240888|NCT00477490|50555121|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
25240889|NCT00477490|50555122|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
25240890|NCT00477490|50555123|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
25240891|NCT00477490|50555124|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
25240892|NCT00477490|50555116|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
25240893|NCT00477490|50555117|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
25240894|NCT00477490|50555118|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
25240895|NCT00477490|50555119|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
25240896|NCT00477490|50555120|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
25240897|NCT00477490|50555121|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
25240898|NCT00477490|50555122|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
25240899|NCT00477490|50555123|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
25240900|NCT00477490|50555124|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
25240901|NCT00477490|50555116|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
25240902|NCT00477490|50555117|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
25320971|NCT00744471|50637043|FG000|Overall Study|Randomized but not treated|1|||
25240903|NCT00477490|50555118|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
25240904|NCT00477490|50555119|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
25240905|NCT00477490|50555120|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
25240906|NCT00477490|50555121|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
25240907|NCT00477490|50555122|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
25240908|NCT00477490|50555123|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
25240909|NCT00477490|50555124|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
25320972|NCT00744471|50637044|FG001|Overall Study|Randomized but not treated|1|||
25320973|NCT00744471|50637045|FG002|Overall Study|Randomized but not treated|4|||
25320974|NCT00744471|50637046|FG003|Overall Study|Randomized but not treated|0|||
25320975|NCT00744471|50637043|FG000|Overall Study|Death|0|||
25320976|NCT00744471|50637044|FG001|Overall Study|Death|0|||
25320977|NCT00744471|50637045|FG002|Overall Study|Death|0|||
25240910|NCT00477490|50555116|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
25240911|NCT00477490|50555117|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
25240912|NCT00477490|50555118|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
25240913|NCT00477490|50555119|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
25240914|NCT00477490|50555120|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
25240915|NCT00477490|50555121|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
25240916|NCT00477490|50555122|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
25320978|NCT00744471|50637046|FG003|Overall Study|Death|1|||
25320979|NCT00744471|50637043|FG000|Overall Study|Adverse Event|6|||
25320980|NCT00744471|50637044|FG001|Overall Study|Adverse Event|7|||
25320981|NCT00744471|50637045|FG002|Overall Study|Adverse Event|5|||
25320982|NCT00744471|50637046|FG003|Overall Study|Adverse Event|9|||
25320983|NCT00744471|50637043|FG000|Overall Study|Withdrawal by Subject|9|||
25240917|NCT00477490|50555123|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
25320984|NCT00744471|50637044|FG001|Overall Study|Withdrawal by Subject|9|||
25320985|NCT00744471|50637045|FG002|Overall Study|Withdrawal by Subject|15|||
25320986|NCT00744471|50637046|FG003|Overall Study|Withdrawal by Subject|12|||
25240918|NCT00477490|50555124|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
25240919|NCT00477490|50555116|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
25240920|NCT00477490|50555117|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
25240921|NCT00477490|50555118|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
25240922|NCT00477490|50555119|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
25240923|NCT00477490|50555120|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
25240924|NCT00477490|50555121|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
25240925|NCT00477490|50555122|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
25240926|NCT00477490|50555123|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
25240927|NCT00477490|50555124|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
25240928|NCT00477490|50555116|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
25240929|NCT00477490|50555117|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
25240930|NCT00477490|50555118|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
25240931|NCT00477490|50555119|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
25240932|NCT00477490|50555120|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
25240933|NCT00477490|50555121|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
25240934|NCT00477490|50555122|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
25240935|NCT00477490|50555123|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
25240936|NCT00477490|50555124|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
25240937|NCT00477490|50555116|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
25240938|NCT00477490|50555117|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
25240939|NCT00477490|50555118|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
25240940|NCT00477490|50555119|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
25240941|NCT00477490|50555120|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
25240942|NCT00477490|50555121|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
25240943|NCT00477490|50555122|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
25240944|NCT00477490|50555123|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
25240945|NCT00477490|50555124|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
25240946|NCT00477490|50555116|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
25240947|NCT00477490|50555117|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
25240948|NCT00477490|50555118|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
25240949|NCT00477490|50555119|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
25240950|NCT00477490|50555120|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
25240951|NCT00477490|50555121|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
25240952|NCT00477490|50555122|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
25240953|NCT00477490|50555123|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
25240954|NCT00477490|50555124|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
25240955|NCT00477490|50555116|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
25320987|NCT00744471|50637043|FG000|Overall Study|Protocol Violation|1|||
24976971|NCT02952820|50065761|FG002|Active Treatment Period (6 Months)|Not treated|1|||
24976972|NCT00006392|50065776|FG000|Overall Study|Ineligible|11|||
24976973|NCT00006392|50065777|FG001|Overall Study|Ineligible|3|||
25240956|NCT00477490|50555117|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
25240957|NCT00477490|50555118|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
25240958|NCT00477490|50555119|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
25240959|NCT00477490|50555120|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
25240960|NCT00477490|50555121|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
25240961|NCT00477490|50555122|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
25240962|NCT00477490|50555123|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
25240963|NCT00477490|50555124|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
25240964|NCT00477490|50555116|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
25240965|NCT00477490|50555117|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
25240966|NCT00477490|50555118|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
25240967|NCT00477490|50555119|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
25240968|NCT00477490|50555120|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
25240969|NCT00477490|50555121|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
25240970|NCT00477490|50555122|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
25240971|NCT00477490|50555123|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
25240972|NCT00477490|50555124|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
25240973|NCT00477334|50555154|FG000|Overall Study|Discontinued prior to taking study drug|106|||
25240974|NCT00477334|50555155|FG001|Overall Study|Discontinued prior to taking study drug|53|||
25240975|NCT00477334|50555154|FG000|Overall Study|Adverse Event|1|||
25240976|NCT00477334|50555155|FG001|Overall Study|Adverse Event|2|||
25240977|NCT00477334|50555154|FG000|Overall Study|Withdrawal by Subject|2|||
25240978|NCT00477334|50555155|FG001|Overall Study|Withdrawal by Subject|1|||
25240979|NCT00477334|50555154|FG000|Overall Study|Lost to Follow-up|15|||
25240980|NCT00477334|50555155|FG001|Overall Study|Lost to Follow-up|4|||
25240981|NCT00477334|50555154|FG000|Overall Study|Administrative Problems|39|||
25240982|NCT00477334|50555155|FG001|Overall Study|Administrative Problems|15|||
25240983|NCT00477334|50555154|FG000|Overall Study|Protocol Violation|7|||
25240984|NCT00477334|50555155|FG001|Overall Study|Protocol Violation|1|||
25240985|NCT04971967|50555299|FG000|Overall Study|Lost to Follow-up|6|||
25240986|NCT04971967|50555300|FG001|Overall Study|Lost to Follow-up|7|||
25240987|NCT04716881|50555314|FG000|Overall Study|Adverse Event|1|||
25240988|NCT04716881|50555314|FG000|Overall Study|Lost to Follow-up|1|||
25240989|NCT04582266|50555331|FG000|Overall Study|Lost to Follow-up|7|||
25240990|NCT04582266|50555332|FG001|Overall Study|Lost to Follow-up|5|||
25240991|NCT04582266|50555331|FG000|Overall Study|Withdrawal by Subject|1|||
25240992|NCT04582266|50555332|FG001|Overall Study|Withdrawal by Subject|0|||
25240993|NCT04582266|50555331|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
25240994|NCT04582266|50555332|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
25240995|NCT04459338|50555342|FG000|Overall Study|Loss of IV during study|1|||
25240996|NCT04459338|50555343|FG001|Overall Study|Loss of IV during study|0|||
25240997|NCT04166383|50555349|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
25240998|NCT04166383|50555349|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
25240999|NCT04166383|50555349|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
25241000|NCT03908437|50555408|FG000|Overall Study|Death|0|||
25241001|NCT03908437|50555409|FG001|Overall Study|Death|1|||
25241002|NCT03908437|50555408|FG000|Overall Study|Lost to Follow-up|31|||
25241003|NCT03908437|50555409|FG001|Overall Study|Lost to Follow-up|24|||
25241004|NCT03740048|50555417|FG000|Overall Study|Withdrawal by Subject|1|||
25241005|NCT03740048|50555418|FG001|Overall Study|Withdrawal by Subject|1|||
25241006|NCT03740048|50555417|FG000|Overall Study|Death|1|||
25241007|NCT03740048|50555418|FG001|Overall Study|Death|6|||
25241008|NCT03740048|50555417|FG000|Overall Study|Switched to thrice-weekly HD|2|||
25241009|NCT03740048|50555418|FG001|Overall Study|Switched to thrice-weekly HD|0|||
25241010|NCT03740048|50555417|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
25241011|NCT03740048|50555418|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
25241012|NCT03740048|50555417|FG000|Overall Study|Lost to Follow-up|0|||
25241013|NCT03740048|50555418|FG001|Overall Study|Lost to Follow-up|1|||
25241014|NCT03740048|50555417|FG000|Overall Study|Non-compliance with HD|0|||
25320988|NCT00744471|50637044|FG001|Overall Study|Protocol Violation|4|||
25320989|NCT00744471|50637045|FG002|Overall Study|Protocol Violation|1|||
25320990|NCT00744471|50637046|FG003|Overall Study|Protocol Violation|2|||
25241015|NCT03740048|50555418|FG001|Overall Study|Non-compliance with HD|1|||
25241016|NCT03436862|50555478|FG000|Overall Study|Adverse Event|4|||
25241017|NCT03436862|50555478|FG000|Overall Study|Progressive Disease|2|||
25241018|NCT03373760|50555542|FG000|Overall Study|Adverse Event|8|||
25241019|NCT03373760|50555542|FG000|Overall Study|Disease Progression|46|||
25241020|NCT03373760|50555542|FG000|Overall Study|Death|4|||
25241021|NCT03324880|50555551|FG000|Overall Study|Adverse Event|0|||
25241022|NCT03324880|50555552|FG001|Overall Study|Adverse Event|2|||
25241023|NCT03324880|50555551|FG000|Overall Study|Withdrawal by Subject|2|||
25241024|NCT03324880|50555552|FG001|Overall Study|Withdrawal by Subject|2|||
25241025|NCT03324880|50555551|FG000|Overall Study|Lost to Follow-up|0|||
25241026|NCT03324880|50555552|FG001|Overall Study|Lost to Follow-up|1|||
25241027|NCT03324880|50555551|FG000|Overall Study|Product Recall|0|||
25241028|NCT03324880|50555552|FG001|Overall Study|Product Recall|1|||
25241029|NCT03053440|50555573|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
25241030|NCT03053440|50555574|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
25241031|NCT03053440|50555573|FG000|Overall Study|Death|18|||
25241032|NCT03053440|50555574|FG001|Overall Study|Death|14|||
25241033|NCT03053440|50555573|FG000|Overall Study|Withdrawal by Subject|9|||
25241034|NCT03053440|50555574|FG001|Overall Study|Withdrawal by Subject|8|||
25241035|NCT03053440|50555573|FG000|Overall Study|Lost to Follow-up|1|||
25241036|NCT03053440|50555574|FG001|Overall Study|Lost to Follow-up|0|||
25241037|NCT03053440|50555573|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
25241038|NCT03053440|50555574|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
25241039|NCT03053440|50555573|FG000|Overall Study|Physician Decision|2|||
25241040|NCT03053440|50555574|FG001|Overall Study|Physician Decision|1|||
25241041|NCT03053440|50555573|FG000|Overall Study|Participant Randomized but died before dosing|1|||
25241042|NCT03053440|50555574|FG001|Overall Study|Participant Randomized but died before dosing|0|||
25241043|NCT02985684|50555581|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
25241044|NCT02985684|50555581|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
25241045|NCT02985684|50555581|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
25241046|NCT02949934|50555620|FG000|Natural Drinking Period|Adverse Event|1|||
25241047|NCT02949934|50555621|FG001|Natural Drinking Period|Adverse Event|0|||
25241048|NCT02949934|50555622|FG002|Natural Drinking Period|Adverse Event|0|||
25241049|NCT02949934|50555623|FG003|Natural Drinking Period|Adverse Event|1|||
25241050|NCT02949934|50555624|FG004|Natural Drinking Period|Adverse Event|0|||
25241051|NCT02949934|50555625|FG005|Natural Drinking Period|Adverse Event|0|||
25241052|NCT02949934|50555620|FG000|Natural Drinking Period|Lost to Follow-up|0|||
25241053|NCT02949934|50555621|FG001|Natural Drinking Period|Lost to Follow-up|0|||
25241054|NCT02949934|50555622|FG002|Natural Drinking Period|Lost to Follow-up|0|||
25241055|NCT02949934|50555623|FG003|Natural Drinking Period|Lost to Follow-up|0|||
25241056|NCT02949934|50555624|FG004|Natural Drinking Period|Lost to Follow-up|1|||
25241057|NCT02949934|50555625|FG005|Natural Drinking Period|Lost to Follow-up|0|||
25241058|NCT02949934|50555620|FG000|Neuroimaging|Protocol Violation|2|||
25241059|NCT02949934|50555621|FG001|Neuroimaging|Protocol Violation|0|||
25241060|NCT02949934|50555622|FG002|Neuroimaging|Protocol Violation|0|||
25241061|NCT02949934|50555623|FG003|Neuroimaging|Protocol Violation|0|||
25241062|NCT02949934|50555624|FG004|Neuroimaging|Protocol Violation|1|||
25241063|NCT02949934|50555625|FG005|Neuroimaging|Protocol Violation|0|||
25241064|NCT02949934|50555620|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
25241065|NCT02949934|50555621|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
25241066|NCT02949934|50555622|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
25241067|NCT02949934|50555623|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
25241068|NCT02949934|50555624|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
25241069|NCT02949934|50555625|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
25241070|NCT02949934|50555620|FG000|Neuroimaging|Not scanned|0|||
25241071|NCT02949934|50555621|FG001|Neuroimaging|Not scanned|0|||
25241072|NCT02949934|50555622|FG002|Neuroimaging|Not scanned|1|||
25241073|NCT02949934|50555623|FG003|Neuroimaging|Not scanned|0|||
25241074|NCT02949934|50555624|FG004|Neuroimaging|Not scanned|0|||
25241075|NCT02949934|50555625|FG005|Neuroimaging|Not scanned|2|||
25320991|NCT00744471|50637043|FG000|Overall Study|Entered extension study|41|||
25320992|NCT00744471|50637044|FG001|Overall Study|Entered extension study|84|||
25320993|NCT00744471|50637045|FG002|Overall Study|Entered extension study|100|||
25320994|NCT00744471|50637046|FG003|Overall Study|Entered extension study|91|||
25320995|NCT00744471|50637043|FG000|Overall Study|Other|2|||
25320996|NCT00744471|50637044|FG001|Overall Study|Other|3|||
25320997|NCT00744471|50637045|FG002|Overall Study|Other|6|||
25320998|NCT00744471|50637046|FG003|Overall Study|Other|2|||
25320999|NCT00744471|50637043|FG000|Overall Study|Lack of Efficacy|83|||
25321000|NCT00744471|50637044|FG001|Overall Study|Lack of Efficacy|37|||
25321001|NCT00744471|50637045|FG002|Overall Study|Lack of Efficacy|19|||
25321002|NCT00744471|50637046|FG003|Overall Study|Lack of Efficacy|31|||
25321003|NCT00744471|50637043|FG000|Overall Study|Lost to Follow-up|0|||
25321004|NCT00744471|50637044|FG001|Overall Study|Lost to Follow-up|0|||
25241076|NCT02949934|50555620|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
25241077|NCT02949934|50555621|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
25241078|NCT02949934|50555622|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
25241079|NCT02949934|50555623|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
25241080|NCT02949934|50555624|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
24976974|NCT00006392|50065778|FG002|Overall Study|Ineligible|5|||
25241081|NCT02949934|50555625|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
25321005|NCT00744471|50637045|FG002|Overall Study|Lost to Follow-up|2|||
25321006|NCT00744471|50637046|FG003|Overall Study|Lost to Follow-up|0|||
25321007|NCT00744237|50637059|FG000|Overall Study|Lack of Efficacy|1|||
25321008|NCT00744237|50637060|FG001|Overall Study|Lack of Efficacy|1|||
25321009|NCT00744237|50637061|FG002|Overall Study|Lack of Efficacy|0|||
25321010|NCT00744237|50637059|FG000|Overall Study|Withdrawal by Subject|9|||
25321011|NCT00744237|50637060|FG001|Overall Study|Withdrawal by Subject|5|||
25321012|NCT00744237|50637061|FG002|Overall Study|Withdrawal by Subject|3|||
25321013|NCT00744237|50637059|FG000|Overall Study|Lost to Follow-up|1|||
25321014|NCT00744237|50637060|FG001|Overall Study|Lost to Follow-up|1|||
25321015|NCT00744237|50637061|FG002|Overall Study|Lost to Follow-up|1|||
25321016|NCT00744237|50637059|FG000|Overall Study|Protocol Violation|3|||
25321017|NCT00744237|50637060|FG001|Overall Study|Protocol Violation|4|||
25321018|NCT00744237|50637061|FG002|Overall Study|Protocol Violation|3|||
25321019|NCT00744237|50637059|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
25241082|NCT02949934|50555620|FG000|Bar Laboratory|Adverse Event|1|||
25241083|NCT02949934|50555621|FG001|Bar Laboratory|Adverse Event|0|||
25241084|NCT02949934|50555622|FG002|Bar Laboratory|Adverse Event|2|||
25241085|NCT02949934|50555623|FG003|Bar Laboratory|Adverse Event|0|||
25241086|NCT02949934|50555624|FG004|Bar Laboratory|Adverse Event|1|||
25241087|NCT02949934|50555625|FG005|Bar Laboratory|Adverse Event|0|||
25241088|NCT02949934|50555620|FG000|Bar Laboratory|Protocol Violation|0|||
25241089|NCT02949934|50555621|FG001|Bar Laboratory|Protocol Violation|0|||
25241090|NCT02949934|50555622|FG002|Bar Laboratory|Protocol Violation|0|||
25241091|NCT02949934|50555623|FG003|Bar Laboratory|Protocol Violation|1|||
25241092|NCT02949934|50555624|FG004|Bar Laboratory|Protocol Violation|0|||
25241093|NCT02949934|50555625|FG005|Bar Laboratory|Protocol Violation|0|||
25241094|NCT02935634|50555657|FG000|Randomization|Participant withdrew consent|0|||
25241095|NCT02935634|50555658|FG001|Randomization|Participant withdrew consent|1|||
25241096|NCT02935634|50555659|FG002|Randomization|Participant withdrew consent|0|||
25241097|NCT02935634|50555660|FG003|Randomization|Participant withdrew consent|0|||
25241098|NCT02935634|50555661|FG004|Randomization|Participant withdrew consent|0|||
25241099|NCT02935634|50555662|FG005|Randomization|Participant withdrew consent|0|||
25241100|NCT02935634|50555657|FG000|Randomization|Death|2|||
25241101|NCT02935634|50555658|FG001|Randomization|Death|1|||
25241102|NCT02935634|50555659|FG002|Randomization|Death|1|||
25241103|NCT02935634|50555660|FG003|Randomization|Death|0|||
25241104|NCT02935634|50555661|FG004|Randomization|Death|0|||
25241105|NCT02935634|50555662|FG005|Randomization|Death|0|||
25241106|NCT02935634|50555657|FG000|Randomization|Other reasons|0|||
25241107|NCT02935634|50555658|FG001|Randomization|Other reasons|2|||
25241108|NCT02935634|50555659|FG002|Randomization|Other reasons|2|||
25241109|NCT02935634|50555660|FG003|Randomization|Other reasons|0|||
25241110|NCT02935634|50555661|FG004|Randomization|Other reasons|0|||
25241111|NCT02935634|50555662|FG005|Randomization|Other reasons|0|||
25241112|NCT02935634|50555657|FG000|Treatment: Track 1|Disease progression|15|||
25241113|NCT02935634|50555658|FG001|Treatment: Track 1|Disease progression|17|||
25241114|NCT02935634|50555659|FG002|Treatment: Track 1|Disease progression|28|||
25241115|NCT02935634|50555660|FG003|Treatment: Track 1|Disease progression|4|||
25241116|NCT02935634|50555661|FG004|Treatment: Track 1|Disease progression|6|||
25241117|NCT02935634|50555662|FG005|Treatment: Track 1|Disease progression|2|||
25241118|NCT02935634|50555657|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
25241119|NCT02935634|50555658|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
25241120|NCT02935634|50555659|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
25241121|NCT02935634|50555660|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
25241122|NCT02935634|50555661|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
25241123|NCT02935634|50555662|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
25241124|NCT02935634|50555657|FG000|Treatment: Track 1|Lost to Follow-up|1|||
25321020|NCT00744237|50637060|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
25321021|NCT00744237|50637061|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
25321022|NCT00744237|50637059|FG000|Overall Study|Dosing Error|1|||
25321023|NCT00744237|50637060|FG001|Overall Study|Dosing Error|0|||
25321024|NCT00744237|50637061|FG002|Overall Study|Dosing Error|1|||
25321025|NCT00744237|50637059|FG000|Overall Study|Study Drug Error|1|||
24976975|NCT00006392|50065779|FG003|Overall Study|Ineligible|5|||
25241125|NCT02935634|50555658|FG001|Treatment: Track 1|Lost to Follow-up|0|||
25241126|NCT02935634|50555659|FG002|Treatment: Track 1|Lost to Follow-up|0|||
25241127|NCT02935634|50555660|FG003|Treatment: Track 1|Lost to Follow-up|0|||
25321026|NCT00744237|50637060|FG001|Overall Study|Study Drug Error|0|||
25321027|NCT00744237|50637061|FG002|Overall Study|Study Drug Error|0|||
25321028|NCT00744237|50637059|FG000|Overall Study|Prohibited Concomitant Medication|0|||
25241128|NCT02935634|50555661|FG004|Treatment: Track 1|Lost to Follow-up|0|||
25241129|NCT02935634|50555662|FG005|Treatment: Track 1|Lost to Follow-up|0|||
25241130|NCT02935634|50555657|FG000|Treatment: Track 1|Study drug toxicity|2|||
25241131|NCT02935634|50555658|FG001|Treatment: Track 1|Study drug toxicity|1|||
25241132|NCT02935634|50555659|FG002|Treatment: Track 1|Study drug toxicity|3|||
25321029|NCT00744237|50637060|FG001|Overall Study|Prohibited Concomitant Medication|0|||
25321030|NCT00744237|50637061|FG002|Overall Study|Prohibited Concomitant Medication|1|||
25321031|NCT00744237|50637059|FG000|Overall Study|Poor Compliance|0|||
25321032|NCT00744237|50637060|FG001|Overall Study|Poor Compliance|2|||
25321033|NCT00744237|50637061|FG002|Overall Study|Poor Compliance|0|||
25321034|NCT00744237|50637059|FG000|Overall Study|Administrative. Site Closed|1|||
25321035|NCT00744237|50637060|FG001|Overall Study|Administrative. Site Closed|1|||
25321036|NCT00744237|50637061|FG002|Overall Study|Administrative. Site Closed|1|||
25241133|NCT02935634|50555660|FG003|Treatment: Track 1|Study drug toxicity|0|||
25241134|NCT02935634|50555661|FG004|Treatment: Track 1|Study drug toxicity|0|||
25241135|NCT02935634|50555662|FG005|Treatment: Track 1|Study drug toxicity|1|||
25241136|NCT02935634|50555657|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
25241137|NCT02935634|50555658|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
25241138|NCT02935634|50555659|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
25241139|NCT02935634|50555660|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
25241140|NCT02935634|50555661|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
25241141|NCT02935634|50555662|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
25321037|NCT00744237|50637059|FG000|Overall Study|Adverse Event|9|||
25321038|NCT00744237|50637060|FG001|Overall Study|Adverse Event|13|||
25321039|NCT00744237|50637061|FG002|Overall Study|Adverse Event|5|||
25321040|NCT00743145|50637069|FG000|Overall Study|Withdrawal by Subject|1|||
25321041|NCT00743145|50637069|FG000|Overall Study|Adverse Event|2|||
25321042|NCT00743145|50637069|FG000|Overall Study|Pregnancy|1|||
25321043|NCT00920855|50637086|FG000|Overall Study|Adverse Event|1|||
25321044|NCT00920855|50637087|FG001|Overall Study|Adverse Event|1|||
25321045|NCT00920855|50637088|FG002|Overall Study|Adverse Event|4|||
25241142|NCT02935634|50555657|FG000|Treatment: Track 1|Participant withdrew consent|2|||
25241143|NCT02935634|50555658|FG001|Treatment: Track 1|Participant withdrew consent|0|||
25241144|NCT02935634|50555659|FG002|Treatment: Track 1|Participant withdrew consent|1|||
25241145|NCT02935634|50555660|FG003|Treatment: Track 1|Participant withdrew consent|0|||
25241146|NCT02935634|50555661|FG004|Treatment: Track 1|Participant withdrew consent|1|||
25241147|NCT02935634|50555662|FG005|Treatment: Track 1|Participant withdrew consent|0|||
25241148|NCT02935634|50555657|FG000|Treatment: Track 1|Other reasons|0|||
25241149|NCT02935634|50555658|FG001|Treatment: Track 1|Other reasons|0|||
25241150|NCT02935634|50555659|FG002|Treatment: Track 1|Other reasons|2|||
25241151|NCT02935634|50555660|FG003|Treatment: Track 1|Other reasons|0|||
25241152|NCT02935634|50555661|FG004|Treatment: Track 1|Other reasons|0|||
25241153|NCT02935634|50555662|FG005|Treatment: Track 1|Other reasons|0|||
25241154|NCT02935634|50555657|FG000|Treatment: Track 2|Disease progression|13|||
25241155|NCT02935634|50555658|FG001|Treatment: Track 2|Disease progression|26|||
25241156|NCT02935634|50555659|FG002|Treatment: Track 2|Disease progression|20|||
25241157|NCT02935634|50555660|FG003|Treatment: Track 2|Disease progression|5|||
25241158|NCT02935634|50555661|FG004|Treatment: Track 2|Disease progression|1|||
25241159|NCT02935634|50555662|FG005|Treatment: Track 2|Disease progression|4|||
25241160|NCT02935634|50555657|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
25241161|NCT02935634|50555658|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
25241162|NCT02935634|50555659|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
25241163|NCT02935634|50555660|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
25241164|NCT02935634|50555661|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
25241165|NCT02935634|50555662|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
25241166|NCT02935634|50555657|FG000|Treatment: Track 2|Study drug toxicity|7|||
25241167|NCT02935634|50555658|FG001|Treatment: Track 2|Study drug toxicity|3|||
25241168|NCT02935634|50555659|FG002|Treatment: Track 2|Study drug toxicity|0|||
25241169|NCT02935634|50555660|FG003|Treatment: Track 2|Study drug toxicity|0|||
25241170|NCT02935634|50555661|FG004|Treatment: Track 2|Study drug toxicity|0|||
25241171|NCT02935634|50555662|FG005|Treatment: Track 2|Study drug toxicity|0|||
25241172|NCT02935634|50555657|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
25241173|NCT02935634|50555658|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
25241174|NCT02935634|50555659|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
25241175|NCT02935634|50555660|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
25241176|NCT02935634|50555661|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
25241177|NCT02935634|50555662|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
25241178|NCT02935634|50555657|FG000|Treatment: Track 2|Participant withdrew consent|0|||
25241179|NCT02935634|50555658|FG001|Treatment: Track 2|Participant withdrew consent|1|||
25241180|NCT02935634|50555659|FG002|Treatment: Track 2|Participant withdrew consent|1|||
25241181|NCT02935634|50555660|FG003|Treatment: Track 2|Participant withdrew consent|0|||
25241182|NCT02935634|50555661|FG004|Treatment: Track 2|Participant withdrew consent|1|||
25241183|NCT02935634|50555662|FG005|Treatment: Track 2|Participant withdrew consent|0|||
25321046|NCT00920855|50637086|FG000|Overall Study|Withdrawal by Subject|2|||
25321047|NCT00920855|50637087|FG001|Overall Study|Withdrawal by Subject|1|||
25321048|NCT00920855|50637088|FG002|Overall Study|Withdrawal by Subject|6|||
25321049|NCT00920855|50637086|FG000|Overall Study|Disease progression|2|||
25241184|NCT02921256|50555692|FG000|Arm 1a v. Arm II|Adverse Event|6|||
25241185|NCT02921256|50555693|FG001|Arm 1a v. Arm II|Adverse Event|15|||
25241186|NCT02921256|50555694|FG002|Arm 1a v. Arm II|Adverse Event|0|||
25241187|NCT02921256|50555692|FG000|Arm 1a v. Arm II|Death|0|||
25321050|NCT00920855|50637087|FG001|Overall Study|Disease progression|1|||
25321051|NCT00920855|50637088|FG002|Overall Study|Disease progression|10|||
24976976|NCT00006392|50065776|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
24976977|NCT00006392|50065777|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
24976978|NCT00006392|50065778|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
24976979|NCT00006392|50065779|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
24976980|NCT00379769|50065793|FG000|Main Study|Death|57|||
24976981|NCT00379769|50065794|FG001|Main Study|Death|67|||
24976982|NCT00379769|50065795|FG002|Main Study|Death|54|||
24976983|NCT00379769|50065796|FG003|Main Study|Death|72|||
24976984|NCT00379769|50065797|FG004|Main Study|Death|0|||
24976985|NCT00379769|50065798|FG005|Main Study|Death|0|||
24976986|NCT00379769|50065793|FG000|Main Study|Adverse Event|5|||
24976987|NCT00379769|50065794|FG001|Main Study|Adverse Event|8|||
24976988|NCT00379769|50065795|FG002|Main Study|Adverse Event|10|||
24976989|NCT00379769|50065796|FG003|Main Study|Adverse Event|11|||
24976990|NCT00379769|50065797|FG004|Main Study|Adverse Event|0|||
24976991|NCT00379769|50065798|FG005|Main Study|Adverse Event|0|||
24976992|NCT00379769|50065793|FG000|Main Study|Lost to Follow-up|29|||
24976993|NCT00379769|50065794|FG001|Main Study|Lost to Follow-up|29|||
24976994|NCT00379769|50065795|FG002|Main Study|Lost to Follow-up|25|||
24976995|NCT00379769|50065796|FG003|Main Study|Lost to Follow-up|26|||
24976996|NCT00379769|50065797|FG004|Main Study|Lost to Follow-up|0|||
24976997|NCT00379769|50065798|FG005|Main Study|Lost to Follow-up|0|||
24976998|NCT00379769|50065793|FG000|Main Study|Withdrawal by Subject|46|||
24976999|NCT00379769|50065794|FG001|Main Study|Withdrawal by Subject|56|||
24977000|NCT00379769|50065795|FG002|Main Study|Withdrawal by Subject|72|||
24977001|NCT00379769|50065796|FG003|Main Study|Withdrawal by Subject|70|||
24977002|NCT00379769|50065797|FG004|Main Study|Withdrawal by Subject|0|||
24977003|NCT00379769|50065798|FG005|Main Study|Withdrawal by Subject|0|||
24977004|NCT00379769|50065793|FG000|Main Study|Moved to survival status follow-up only|27|||
24977005|NCT00379769|50065794|FG001|Main Study|Moved to survival status follow-up only|25|||
24977006|NCT00379769|50065795|FG002|Main Study|Moved to survival status follow-up only|32|||
24977007|NCT00379769|50065796|FG003|Main Study|Moved to survival status follow-up only|36|||
24977008|NCT00379769|50065797|FG004|Main Study|Moved to survival status follow-up only|0|||
24977009|NCT00379769|50065798|FG005|Main Study|Moved to survival status follow-up only|0|||
24977010|NCT00379769|50065793|FG000|Main Study|Participant moved|3|||
24977011|NCT00379769|50065794|FG001|Main Study|Participant moved|2|||
24977012|NCT00379769|50065795|FG002|Main Study|Participant moved|3|||
24977013|NCT00379769|50065796|FG003|Main Study|Participant moved|3|||
24977014|NCT00379769|50065797|FG004|Main Study|Participant moved|0|||
24977015|NCT00379769|50065798|FG005|Main Study|Participant moved|0|||
24977016|NCT00379769|50065793|FG000|Main Study|Poor compliance|3|||
24977017|NCT00379769|50065794|FG001|Main Study|Poor compliance|2|||
24977018|NCT00379769|50065795|FG002|Main Study|Poor compliance|2|||
24977019|NCT00379769|50065796|FG003|Main Study|Poor compliance|1|||
24977020|NCT00379769|50065797|FG004|Main Study|Poor compliance|0|||
24977021|NCT00379769|50065798|FG005|Main Study|Poor compliance|0|||
24977022|NCT00379769|50065793|FG000|Main Study|Prohibited glucose lowering medication|0|||
24977023|NCT00379769|50065794|FG001|Main Study|Prohibited glucose lowering medication|3|||
24977024|NCT00379769|50065795|FG002|Main Study|Prohibited glucose lowering medication|0|||
24977025|NCT00379769|50065796|FG003|Main Study|Prohibited glucose lowering medication|1|||
24977026|NCT00379769|50065797|FG004|Main Study|Prohibited glucose lowering medication|0|||
24977027|NCT00379769|50065798|FG005|Main Study|Prohibited glucose lowering medication|0|||
24977028|NCT00379769|50065793|FG000|Main Study|Site closed|4|||
24977029|NCT00379769|50065794|FG001|Main Study|Site closed|4|||
25321052|NCT00920855|50637086|FG000|Overall Study|Noncompliance to study medication|0|||
24977030|NCT00379769|50065795|FG002|Main Study|Site closed|4|||
24977031|NCT00379769|50065796|FG003|Main Study|Site closed|8|||
24977032|NCT00379769|50065797|FG004|Main Study|Site closed|0|||
24977033|NCT00379769|50065798|FG005|Main Study|Site closed|0|||
24977034|NCT00379769|50065793|FG000|Main Study|Entry criteria violation|0|||
24977035|NCT00379769|50065794|FG001|Main Study|Entry criteria violation|0|||
24977036|NCT00379769|50065795|FG002|Main Study|Entry criteria violation|1|||
24977037|NCT00379769|50065796|FG003|Main Study|Entry criteria violation|1|||
24977038|NCT00379769|50065797|FG004|Main Study|Entry criteria violation|0|||
24977039|NCT00379769|50065798|FG005|Main Study|Entry criteria violation|0|||
24977040|NCT00379769|50065793|FG000|Main Study|Participant did not take study drug|0|||
24977041|NCT00379769|50065794|FG001|Main Study|Participant did not take study drug|0|||
24977042|NCT00379769|50065795|FG002|Main Study|Participant did not take study drug|1|||
24977043|NCT00379769|50065796|FG003|Main Study|Participant did not take study drug|0|||
25241188|NCT02921256|50555693|FG001|Arm 1a v. Arm II|Death|2|||
25241189|NCT02921256|50555694|FG002|Arm 1a v. Arm II|Death|0|||
25241190|NCT02921256|50555692|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
25241191|NCT02921256|50555693|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
25077649|NCT02494778|50185485|FG000|Overall Study|Other|173|||
25077650|NCT02494778|50185485|FG000|Overall Study|Lack of Efficacy|4|||
25077651|NCT02494778|50185485|FG000|Overall Study|Adverse Event|18|||
25077652|NCT02494778|50185485|FG000|Overall Study|Withdrawal by Subject|20|||
25077653|NCT02494778|50185485|FG000|Overall Study|Lost to Follow-up|2|||
25077654|NCT02494778|50185485|FG000|Overall Study|Noncompliant with study drug admin.|1|||
25077655|NCT02493764|50185491|FG000|Overall Study|Adverse Event|2|||
25077656|NCT02493764|50185492|FG001|Overall Study|Adverse Event|2|||
25077657|NCT02493764|50185491|FG000|Overall Study|Death|44|||
25077658|NCT02493764|50185492|FG001|Overall Study|Death|58|||
25077659|NCT02493764|50185491|FG000|Overall Study|Lost to Follow-up|2|||
25077660|NCT02493764|50185492|FG001|Overall Study|Lost to Follow-up|1|||
25321053|NCT00920855|50637087|FG001|Overall Study|Noncompliance to study medication|0|||
25321054|NCT00920855|50637088|FG002|Overall Study|Noncompliance to study medication|1|||
25321055|NCT00920855|50637086|FG000|Overall Study|Response plateau; started maintenance|0|||
25321056|NCT00920855|50637087|FG001|Overall Study|Response plateau; started maintenance|0|||
25321057|NCT00920855|50637088|FG002|Overall Study|Response plateau; started maintenance|1|||
25321058|NCT00742209|50637102|FG000|Overall Study|Adverse Event|11|||
25321059|NCT00742209|50637103|FG001|Overall Study|Adverse Event|4|||
25321060|NCT00742209|50637104|FG002|Overall Study|Adverse Event|17|||
25077661|NCT02493764|50185491|FG000|Overall Study|Protocol Violation|6|||
25077662|NCT02493764|50185492|FG001|Overall Study|Protocol Violation|7|||
25077663|NCT02493764|50185491|FG000|Overall Study|Physician Decision|1|||
25077664|NCT02493764|50185492|FG001|Overall Study|Physician Decision|1|||
25077665|NCT02493764|50185491|FG000|Overall Study|Participant moved|17|||
25241192|NCT02921256|50555694|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
25241193|NCT02921256|50555692|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
25241194|NCT02921256|50555693|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
25241195|NCT02921256|50555694|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
25241196|NCT02921256|50555692|FG000|Arm 1a v. Arm II|Physician Decision|1|||
25241197|NCT02921256|50555693|FG001|Arm 1a v. Arm II|Physician Decision|1|||
25241198|NCT02921256|50555694|FG002|Arm 1a v. Arm II|Physician Decision|0|||
25241199|NCT02921256|50555692|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
25241200|NCT02921256|50555693|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
25241201|NCT02921256|50555694|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
25241202|NCT02921256|50555692|FG000|Arm Ib v Arm III|Adverse Event|9|||
25241203|NCT02921256|50555693|FG001|Arm Ib v Arm III|Adverse Event|0|||
25241204|NCT02921256|50555694|FG002|Arm Ib v Arm III|Adverse Event|4|||
25241205|NCT02921256|50555692|FG000|Arm Ib v Arm III|Death|1|||
25241206|NCT02921256|50555693|FG001|Arm Ib v Arm III|Death|0|||
25241207|NCT02921256|50555694|FG002|Arm Ib v Arm III|Death|1|||
25241208|NCT02921256|50555692|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
25241209|NCT02921256|50555693|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
25241210|NCT02921256|50555694|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
25241211|NCT02921256|50555692|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
25241212|NCT02921256|50555693|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
25241213|NCT02921256|50555694|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
25241214|NCT02921256|50555692|FG000|Arm Ib v Arm III|Physician Decision|4|||
25241215|NCT02921256|50555693|FG001|Arm Ib v Arm III|Physician Decision|0|||
25241216|NCT02921256|50555694|FG002|Arm Ib v Arm III|Physician Decision|1|||
25241217|NCT02921256|50555692|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
25241218|NCT02921256|50555693|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
25241219|NCT02921256|50555694|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
25241220|NCT02864992|50555711|FG000|Overall Study|still on treatment|15|||
25077666|NCT02493764|50185492|FG001|Overall Study|Participant moved|5|||
25241221|NCT02864992|50555712|FG001|Overall Study|still on treatment|1|||
25241222|NCT02864992|50555713|FG002|Overall Study|still on treatment|33|||
25321061|NCT00742209|50637105|FG003|Overall Study|Adverse Event|16|||
25321062|NCT00742209|50637106|FG004|Overall Study|Adverse Event|13|||
25077667|NCT02493764|50185491|FG000|Overall Study|Withdrawal parent/guardian|0|||
25077668|NCT02493764|50185492|FG001|Overall Study|Withdrawal parent/guardian|1|||
25077669|NCT02493764|50185491|FG000|Overall Study|Withdrawal by Subject|11|||
25321063|NCT00742209|50637102|FG000|Overall Study|Participant Withdrew Consent|8|||
25241223|NCT02788045|50555722|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
25241224|NCT02788045|50555723|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
25241225|NCT02788045|50555724|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
25241226|NCT02788045|50555722|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
25241227|NCT02788045|50555723|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
25241228|NCT02788045|50555724|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
25241229|NCT02788045|50555722|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
25241230|NCT02788045|50555723|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
25241231|NCT02788045|50555724|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
25241232|NCT02788045|50555722|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
25241233|NCT02788045|50555723|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
25241234|NCT02788045|50555724|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
25241235|NCT02788045|50555722|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
25241236|NCT02788045|50555723|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
25241237|NCT02788045|50555724|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
25241238|NCT02788045|50555722|FG000|Main Study (Up to Week 72)|Other|3|||
25241239|NCT02788045|50555723|FG001|Main Study (Up to Week 72)|Other|0|||
25241240|NCT02788045|50555724|FG002|Main Study (Up to Week 72)|Other|0|||
25241241|NCT02788045|50555722|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
25241242|NCT02788045|50555723|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
25241243|NCT02788045|50555724|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
25241244|NCT02788045|50555722|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
25241245|NCT02788045|50555723|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
25241246|NCT02788045|50555724|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
25241247|NCT02788045|50555722|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
25241248|NCT02788045|50555723|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
25241249|NCT02788045|50555724|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
25241250|NCT02684578|50555734|FG000|Overall Study|Withdrawal by Subject|10|||
25241251|NCT02684578|50555735|FG001|Overall Study|Withdrawal by Subject|7|||
25241252|NCT02684578|50555734|FG000|Overall Study|Lost to Follow-up|0|||
25241253|NCT02684578|50555735|FG001|Overall Study|Lost to Follow-up|3|||
25241254|NCT02684578|50555734|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
25241255|NCT02684578|50555735|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
25241256|NCT02684578|50555734|FG000|Overall Study|Missing follow-up data|0|||
25241257|NCT02684578|50555735|FG001|Overall Study|Missing follow-up data|1|||
25241258|NCT02612129|50555743|FG000|Single Dose Treatment Period|Screening Failure|1|||
25241259|NCT02612129|50555744|FG001|Single Dose Treatment Period|Screening Failure|0|||
25241260|NCT02612129|50555745|FG002|Single Dose Treatment Period|Screening Failure|0|||
25241261|NCT02612129|50555743|FG000|Continuous Treatment Period|Early Escape|0|||
25241262|NCT02612129|50555744|FG001|Continuous Treatment Period|Early Escape|2|||
25241263|NCT02612129|50555745|FG002|Continuous Treatment Period|Early Escape|0|||
25321064|NCT00742209|50637103|FG001|Overall Study|Participant Withdrew Consent|4|||
25321065|NCT00742209|50637104|FG002|Overall Study|Participant Withdrew Consent|14|||
25321066|NCT00742209|50637105|FG003|Overall Study|Participant Withdrew Consent|7|||
25321067|NCT00742209|50637106|FG004|Overall Study|Participant Withdrew Consent|4|||
25321068|NCT00742209|50637102|FG000|Overall Study|Protocol Violation|6|||
25321069|NCT00742209|50637103|FG001|Overall Study|Protocol Violation|5|||
25321070|NCT00742209|50637104|FG002|Overall Study|Protocol Violation|4|||
25321071|NCT00742209|50637105|FG003|Overall Study|Protocol Violation|5|||
25241264|NCT02612129|50555743|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
25321072|NCT00742209|50637106|FG004|Overall Study|Protocol Violation|3|||
25321073|NCT00742209|50637102|FG000|Overall Study|Lost to Follow-up|3|||
25241265|NCT02612129|50555744|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
25241266|NCT02612129|50555745|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
25241267|NCT02612129|50555743|FG000|Continuous Treatment Period|Safety Reasons|0|||
25241268|NCT02612129|50555744|FG001|Continuous Treatment Period|Safety Reasons|3|||
25241269|NCT02612129|50555745|FG002|Continuous Treatment Period|Safety Reasons|0|||
25241270|NCT02612129|50555743|FG000|Continuous Treatment Period|Death|0|||
25241271|NCT02612129|50555744|FG001|Continuous Treatment Period|Death|1|||
25241272|NCT02612129|50555745|FG002|Continuous Treatment Period|Death|0|||
25241273|NCT02612129|50555743|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
25241274|NCT02612129|50555744|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
25321074|NCT00742209|50637103|FG001|Overall Study|Lost to Follow-up|4|||
25241275|NCT02612129|50555745|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
25241276|NCT02580305|50555755|FG000|Overall Study|Adverse Event|15|||
25321075|NCT00742209|50637104|FG002|Overall Study|Lost to Follow-up|5|||
25321076|NCT00742209|50637105|FG003|Overall Study|Lost to Follow-up|5|||
25321077|NCT00742209|50637106|FG004|Overall Study|Lost to Follow-up|3|||
25241277|NCT02580305|50555756|FG001|Overall Study|Adverse Event|19|||
25241278|NCT02580305|50555757|FG002|Overall Study|Adverse Event|10|||
25241279|NCT02580305|50555755|FG000|Overall Study|Lack of Efficacy|5|||
25321078|NCT00742209|50637102|FG000|Overall Study|Lack of Efficacy|6|||
25321079|NCT00742209|50637103|FG001|Overall Study|Lack of Efficacy|1|||
25321080|NCT00742209|50637104|FG002|Overall Study|Lack of Efficacy|1|||
25241280|NCT02580305|50555756|FG001|Overall Study|Lack of Efficacy|0|||
25241281|NCT02580305|50555757|FG002|Overall Study|Lack of Efficacy|2|||
25241282|NCT02580305|50555755|FG000|Overall Study|Protocol Violation|4|||
25241283|NCT02580305|50555756|FG001|Overall Study|Protocol Violation|9|||
25241284|NCT02580305|50555757|FG002|Overall Study|Protocol Violation|6|||
25241285|NCT02580305|50555755|FG000|Overall Study|Lost to Follow-up|4|||
25241286|NCT02580305|50555756|FG001|Overall Study|Lost to Follow-up|4|||
25241287|NCT02580305|50555757|FG002|Overall Study|Lost to Follow-up|2|||
25241288|NCT02580305|50555755|FG000|Overall Study|Withdrawal by Subject|11|||
25241289|NCT02580305|50555756|FG001|Overall Study|Withdrawal by Subject|9|||
25241290|NCT02580305|50555757|FG002|Overall Study|Withdrawal by Subject|7|||
25241291|NCT02580305|50555755|FG000|Overall Study|Randomized in error and never treated|4|||
25321081|NCT00742209|50637105|FG003|Overall Study|Lack of Efficacy|3|||
25321082|NCT00742209|50637106|FG004|Overall Study|Lack of Efficacy|1|||
25321083|NCT00742209|50637102|FG000|Overall Study|Investigator Discretion|0|||
25321084|NCT00742209|50637103|FG001|Overall Study|Investigator Discretion|0|||
25321085|NCT00742209|50637104|FG002|Overall Study|Investigator Discretion|5|||
25321086|NCT00742209|50637105|FG003|Overall Study|Investigator Discretion|1|||
25321087|NCT00742209|50637106|FG004|Overall Study|Investigator Discretion|1|||
25321088|NCT00741819|50637119|FG000|Overall Study|Adverse Event|3|||
25321089|NCT00741819|50637119|FG000|Overall Study|Withdrawal by Subject|3|||
25321090|NCT00741819|50637119|FG000|Overall Study|Death|1|||
25321091|NCT00741819|50637119|FG000|Overall Study|Disease progression|1|||
25321092|NCT00924443|50637125|FG000|Overall Study|Physician Decision|2|||
25321093|NCT00924443|50637125|FG000|Overall Study|Protocol Violation|1|||
25321094|NCT00924287|50637129|FG000|Overall Study|Death|1|||
25321095|NCT00923975|50637133|FG000|Overall Study|Did not meet inclusion criteria|1|||
25321096|NCT00918203|50637169|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
25321097|NCT00918203|50637170|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
25321098|NCT00918203|50637171|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
25321099|NCT00918203|50637169|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
25321100|NCT00918203|50637170|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
25321101|NCT00918203|50637171|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
25321102|NCT00918203|50637169|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
25321103|NCT00918203|50637170|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
25321104|NCT00918203|50637171|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
25321105|NCT00918203|50637169|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
25321106|NCT00918203|50637170|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
25241292|NCT02580305|50555756|FG001|Overall Study|Randomized in error and never treated|8|||
25241293|NCT02580305|50555757|FG002|Overall Study|Randomized in error and never treated|5|||
25241294|NCT02054741|50555776|FG000|Overall Study|Protocol Violation|13|||
25241295|NCT02054741|50555777|FG001|Overall Study|Protocol Violation|2|||
25241296|NCT02054741|50555776|FG000|Overall Study|Withdrawal by Subject|10|||
25241297|NCT02054741|50555777|FG001|Overall Study|Withdrawal by Subject|5|||
25321107|NCT00918203|50637171|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
25241298|NCT02054741|50555776|FG000|Overall Study|Death|94|||
25241299|NCT02054741|50555777|FG001|Overall Study|Death|90|||
25241300|NCT02054741|50555776|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
25241301|NCT02054741|50555777|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
25241302|NCT01555463|50555785|FG000|Treatment|Adverse Event|6|||
25241303|NCT01555463|50555786|FG001|Treatment|Adverse Event|12|||
25241304|NCT01555463|50555785|FG000|Treatment|Withdrawal by Subject|24|||
25241305|NCT01555463|50555786|FG001|Treatment|Withdrawal by Subject|36|||
25241306|NCT01555463|50555785|FG000|Treatment|Lost to Follow-up|28|||
25241307|NCT01555463|50555786|FG001|Treatment|Lost to Follow-up|23|||
25241308|NCT01555463|50555785|FG000|Treatment|Protocol Violation|4|||
25241309|NCT01555463|50555786|FG001|Treatment|Protocol Violation|5|||
25241310|NCT01555463|50555785|FG000|Treatment|Other reason|2|||
25241311|NCT01555463|50555786|FG001|Treatment|Other reason|3|||
25241312|NCT01555463|50555785|FG000|Follow up|Adverse Event|2|||
25321108|NCT00918281|50637183|FG000|Overall Study|Physician Decision|29|||
25241313|NCT01555463|50555786|FG001|Follow up|Adverse Event|5|||
25241314|NCT01555463|50555785|FG000|Follow up|Death|0|||
25241315|NCT01555463|50555786|FG001|Follow up|Death|1|||
25241316|NCT01555463|50555785|FG000|Follow up|Withdrawal by Subject|22|||
25321109|NCT02770716|50637192|FG000|Overall Study|Death|101|||
25321110|NCT02770716|50637193|FG001|Overall Study|Death|45|||
25321111|NCT02770716|50637192|FG000|Overall Study|Withdrawal by Subject|4|||
25321112|NCT02770716|50637193|FG001|Overall Study|Withdrawal by Subject|2|||
25321113|NCT02770716|50637192|FG000|Overall Study|Lost to Follow-up|1|||
25241317|NCT01555463|50555786|FG001|Follow up|Withdrawal by Subject|22|||
25321114|NCT02770716|50637193|FG001|Overall Study|Lost to Follow-up|0|||
25321115|NCT02770716|50637192|FG000|Overall Study|Various reasons|6|||
25241318|NCT01555463|50555785|FG000|Follow up|Lost to Follow-up|9|||
25241319|NCT01555463|50555786|FG001|Follow up|Lost to Follow-up|10|||
25241320|NCT01555463|50555785|FG000|Follow up|Protocol Violation|2|||
25241321|NCT01555463|50555786|FG001|Follow up|Protocol Violation|4|||
25241322|NCT01555463|50555785|FG000|Follow up|Other reason|3|||
25241323|NCT01555463|50555786|FG001|Follow up|Other reason|3|||
25241324|NCT01081951|50555864|FG000|Overall Study|Death|54|||
25241325|NCT01081951|50555865|FG001|Overall Study|Death|47|||
25241326|NCT01081951|50555864|FG000|Overall Study|Withdrawal by Subject|2|||
25241327|NCT01081951|50555865|FG001|Overall Study|Withdrawal by Subject|6|||
25241328|NCT01081951|50555864|FG000|Overall Study|Allocated treatment but did not take it|0|||
25241329|NCT01081951|50555865|FG001|Overall Study|Allocated treatment but did not take it|1|||
25241330|NCT01081951|50555864|FG000|Overall Study|Lost to Follow-up|0|||
25241331|NCT01081951|50555865|FG001|Overall Study|Lost to Follow-up|1|||
25241332|NCT02277106|50555871|FG000|Stage 2|Adverse Event|0|||
25241333|NCT02277106|50555872|FG001|Stage 2|Adverse Event|0|||
25241334|NCT02277106|50555873|FG002|Stage 2|Adverse Event|1|||
25241335|NCT02215096|50555896|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
25241336|NCT02215096|50555897|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
25241337|NCT02215096|50555898|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
25241338|NCT02215096|50555899|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
25241339|NCT02215096|50555900|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
25241340|NCT02215096|50555896|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
25241341|NCT02215096|50555897|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
25241342|NCT02215096|50555898|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
25241343|NCT02215096|50555899|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
25241344|NCT02215096|50555900|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
25241345|NCT02215096|50555896|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
25241346|NCT02215096|50555897|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
25241347|NCT02215096|50555898|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
25241348|NCT02215096|50555899|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
25241349|NCT02215096|50555900|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
25241350|NCT02215096|50555896|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
25241351|NCT02215096|50555897|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
25241352|NCT02215096|50555898|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
25241353|NCT02215096|50555899|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
25321116|NCT02770716|50637193|FG001|Overall Study|Various reasons|2|||
25321117|NCT00917579|50637199|FG000|Washout >= 2 Weeks|Adverse Event|1|||
25321118|NCT00917579|50637200|FG001|Washout >= 2 Weeks|Adverse Event|0|||
25321119|NCT00917579|50637199|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
25321120|NCT00917579|50637200|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
25321121|NCT00915551|50637208|FG000|Overall Study|Withdrawal by Subject|0|||
25321122|NCT00915551|50637209|FG001|Overall Study|Withdrawal by Subject|1|||
25321123|NCT00915473|50637217|FG000|Screening|Withdrawal by Subject|1|||
25321124|NCT00915473|50637218|FG001|Screening|Withdrawal by Subject|0|||
25321125|NCT00915473|50637217|FG000|4-week Follow Up|Lost to Follow-up|1|||
25321126|NCT00915473|50637218|FG001|4-week Follow Up|Lost to Follow-up|5|||
25321127|NCT00917501|50637226|FG000|Overall Study|Lost to Follow-up|4|||
25321128|NCT00917501|50637227|FG001|Overall Study|Lost to Follow-up|1|||
25321129|NCT00917501|50637226|FG000|Overall Study|Withdrawal by Subject|3|||
25321130|NCT00917501|50637227|FG001|Overall Study|Withdrawal by Subject|1|||
25321131|NCT00917501|50637226|FG000|Overall Study|Lack of Efficacy|1|||
25321132|NCT00917501|50637227|FG001|Overall Study|Lack of Efficacy|2|||
25321133|NCT00917501|50637226|FG000|Overall Study|trouble swollowing capsules|0|||
25321134|NCT00917501|50637227|FG001|Overall Study|trouble swollowing capsules|1|||
25321135|NCT00917267|50637246|FG000|Overall Study|Adverse Event|15|||
25321136|NCT00917267|50637247|FG001|Overall Study|Adverse Event|36|||
25321137|NCT00917267|50637246|FG000|Overall Study|Physician Decision|2|||
25241354|NCT02215096|50555900|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
25321138|NCT00917267|50637247|FG001|Overall Study|Physician Decision|4|||
25321139|NCT00917267|50637246|FG000|Overall Study|Protocol Violation|9|||
25321140|NCT00917267|50637247|FG001|Overall Study|Protocol Violation|18|||
25241355|NCT02214160|50555919|FG000|Overall Study|Withdrawal by Subject|1|||
25321141|NCT00917267|50637246|FG000|Overall Study|Withdrawal by Subject|5|||
25321142|NCT00917267|50637247|FG001|Overall Study|Withdrawal by Subject|12|||
25321143|NCT00917267|50637246|FG000|Overall Study|Lost to follow up|0|||
25321144|NCT00917267|50637247|FG001|Overall Study|Lost to follow up|2|||
25321145|NCT00917267|50637246|FG000|Overall Study|Entry Criteria Not Met|1|||
25321146|NCT00917267|50637247|FG001|Overall Study|Entry Criteria Not Met|0|||
25241356|NCT02214160|50555920|FG001|Overall Study|Withdrawal by Subject|0|||
25241357|NCT02214160|50555921|FG002|Overall Study|Withdrawal by Subject|6|||
25241358|NCT02214160|50555919|FG000|Overall Study|Death|2|||
25241359|NCT02214160|50555920|FG001|Overall Study|Death|2|||
25241360|NCT02214160|50555921|FG002|Overall Study|Death|1|||
25241361|NCT02214160|50555919|FG000|Overall Study|Subject Non-Compliance|0|||
25241362|NCT02214160|50555920|FG001|Overall Study|Subject Non-Compliance|3|||
25241363|NCT02214160|50555921|FG002|Overall Study|Subject Non-Compliance|1|||
25241364|NCT02214160|50555919|FG000|Overall Study|Adverse Event|0|||
25241365|NCT02214160|50555920|FG001|Overall Study|Adverse Event|1|||
25241366|NCT02214160|50555921|FG002|Overall Study|Adverse Event|1|||
25241367|NCT02214160|50555919|FG000|Overall Study|Sponsor Decision|0|||
25241368|NCT02214160|50555920|FG001|Overall Study|Sponsor Decision|2|||
25241369|NCT02214160|50555921|FG002|Overall Study|Sponsor Decision|0|||
25241370|NCT02214160|50555919|FG000|Overall Study|Protocol Violation|1|||
25241371|NCT02214160|50555920|FG001|Overall Study|Protocol Violation|0|||
25241372|NCT02214160|50555921|FG002|Overall Study|Protocol Violation|0|||
25241373|NCT02214160|50555919|FG000|Overall Study|Physician Decision|0|||
25241374|NCT02214160|50555920|FG001|Overall Study|Physician Decision|0|||
25241375|NCT02214160|50555921|FG002|Overall Study|Physician Decision|1|||
25241376|NCT03189862|50555952|FG000|Overall Study|Withdrawal by Subject|1|||
25241377|NCT03189862|50555953|FG001|Overall Study|Withdrawal by Subject|0|||
25241378|NCT03189862|50555952|FG000|Overall Study|Lost to Follow-up|54|||
25241379|NCT03189862|50555953|FG001|Overall Study|Lost to Follow-up|62|||
25241380|NCT00107614|50555985|FG000|Overall Study|Physician Decision|10|||
25241381|NCT00107614|50555985|FG000|Overall Study|Death|2|||
25241382|NCT00107380|50555989|FG000|Overall Study|Adverse Event|7|||
25241383|NCT00107380|50555989|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
25241384|NCT00107380|50555989|FG000|Overall Study|Progression/relapse|4|||
25241385|NCT00107380|50555989|FG000|Overall Study|Death|3|||
25241386|NCT00107380|50555989|FG000|Overall Study|Other - not protocol specified|7|||
25241387|NCT00107380|50555989|FG000|Overall Study|Ineligible|2|||
25241388|NCT01340014|50555996|FG000|Period 1, First 7 Days|Adverse Event|1|||
25241389|NCT01340014|50555997|FG001|Period 1, First 7 Days|Adverse Event|0|||
25241390|NCT01340014|50555996|FG000|Period 1, First 7 Days|Personal Reasons|1|||
25241391|NCT01340014|50555997|FG001|Period 1, First 7 Days|Personal Reasons|0|||
25241392|NCT01340014|50555996|FG000|Period 2, Second 7 Days|Adverse Event|0|||
25241393|NCT01340014|50555997|FG001|Period 2, Second 7 Days|Adverse Event|1|||
25241394|NCT01339897|50556007|FG000|Overall Study|Adverse Event|1|||
25321147|NCT00917267|50637246|FG000|Overall Study|Sponsor Decision|5|||
25321148|NCT00917267|50637247|FG001|Overall Study|Sponsor Decision|5|||
25321149|NCT00917267|50637246|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
25321150|NCT00917267|50637247|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
25321151|NCT00920699|50637260|FG000|Overall Study|Withdrawal by Subject|2|||
25321152|NCT00920699|50637261|FG001|Overall Study|Withdrawal by Subject|0|||
25321153|NCT00920699|50637262|FG002|Overall Study|Withdrawal by Subject|2|||
25321154|NCT00920699|50637260|FG000|Overall Study|no longer met eligibility|0|||
25321155|NCT00920699|50637261|FG001|Overall Study|no longer met eligibility|1|||
25321156|NCT00920699|50637262|FG002|Overall Study|no longer met eligibility|0|||
25321157|NCT00920699|50637260|FG000|Overall Study|Lost to Follow-up|0|||
25321158|NCT00920699|50637261|FG001|Overall Study|Lost to Follow-up|0|||
25321159|NCT00920699|50637262|FG002|Overall Study|Lost to Follow-up|2|||
25321160|NCT03462576|50637273|FG000|Overall Study|Protocol Violation|5|||
25321161|NCT03462576|50637274|FG001|Overall Study|Protocol Violation|11|||
25321162|NCT03462576|50637275|FG002|Overall Study|Protocol Violation|7|||
25321163|NCT03462576|50637273|FG000|Overall Study|Device Malfunction|0|||
25321164|NCT03462576|50637274|FG001|Overall Study|Device Malfunction|0|||
25321165|NCT03462576|50637275|FG002|Overall Study|Device Malfunction|1|||
25241395|NCT01339897|50556008|FG001|Overall Study|Adverse Event|0|||
25241396|NCT01339897|50556009|FG002|Overall Study|Adverse Event|0|||
25241397|NCT01339897|50556010|FG003|Overall Study|Adverse Event|1|||
25241398|NCT01339429|50556022|FG000|Overall Study|Withdrawal by Subject|1|||
25321166|NCT00916721|50637285|FG000|Overall Study|Lost to Follow-up|0|||
25321167|NCT00916721|50637286|FG001|Overall Study|Lost to Follow-up|1|||
25321168|NCT00916721|50637285|FG000|Overall Study|Adverse Event|6|||
24977044|NCT00379769|50065797|FG004|Main Study|Participant did not take study drug|0|||
24977045|NCT00379769|50065798|FG005|Main Study|Participant did not take study drug|0|||
25241399|NCT01339429|50556022|FG000|Overall Study|Physician Decision|3|||
25241400|NCT01339390|50556028|FG000|Overall Study|Death|32|||
25241401|NCT01339390|50556029|FG001|Overall Study|Death|29|||
25241402|NCT01339390|50556028|FG000|Overall Study|Lost to Follow-up|125|||
25241403|NCT01339390|50556029|FG001|Overall Study|Lost to Follow-up|127|||
25241404|NCT01339273|50556037|FG000|Overall Study|Lost to Follow-up|8|||
25241405|NCT01339273|50556038|FG001|Overall Study|Lost to Follow-up|8|||
25241406|NCT01334866|50556044|FG000|Overall Study|Withdrawal by Subject|10|||
25241407|NCT01334866|50556044|FG000|Overall Study|Lost to Follow-up|3|||
25241408|NCT01334866|50556044|FG000|Overall Study|Physician Decision|3|||
25241409|NCT01334866|50556044|FG000|Overall Study|medically necessary prior to procedure|2|||
25321169|NCT00916721|50637286|FG001|Overall Study|Adverse Event|3|||
25241410|NCT01334866|50556044|FG000|Overall Study|medically necessary post-procedure|1|||
25241411|NCT01334710|50556050|FG000|Overall Study|Trial was terminated|3|||
25241412|NCT01334554|50556057|FG000|Overall Study|Adverse Event|4|||
25241413|NCT01334554|50556058|FG001|Overall Study|Adverse Event|2|||
25241414|NCT01332799|50556068|FG000|Overall Study|Insufficient funding|10|||
25241415|NCT01332799|50556069|FG001|Overall Study|Insufficient funding|10|||
25241416|NCT01332331|50556077|FG000|Overall Study|Lost to Follow-up|0|||
25241417|NCT01332331|50556078|FG001|Overall Study|Lost to Follow-up|1|||
25241418|NCT01332331|50556077|FG000|Overall Study|Adverse Event|1|||
25241419|NCT01332331|50556078|FG001|Overall Study|Adverse Event|1|||
25241420|NCT01332331|50556077|FG000|Overall Study|Physician Decision|1|||
25321170|NCT00916721|50637285|FG000|Overall Study|Withdrawal by Subject|2|||
25321171|NCT00916721|50637286|FG001|Overall Study|Withdrawal by Subject|2|||
25321172|NCT00916721|50637285|FG000|Overall Study|Protocol Violation|2|||
25321173|NCT00916721|50637286|FG001|Overall Study|Protocol Violation|4|||
25241421|NCT01332331|50556078|FG001|Overall Study|Physician Decision|0|||
25241422|NCT01332292|50556085|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
25241423|NCT01332292|50556086|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
25321174|NCT00915005|50637294|FG000|Overall Study|Withdrawal by Subject|4|||
25321175|NCT00915005|50637295|FG001|Overall Study|Withdrawal by Subject|4|||
25321176|NCT00915005|50637294|FG000|Overall Study|Patient preferred protons therapy|6|||
25321177|NCT00915005|50637295|FG001|Overall Study|Patient preferred protons therapy|0|||
25321178|NCT00915005|50637294|FG000|Overall Study|Insurance denial|3|||
25321179|NCT00915005|50637295|FG001|Overall Study|Insurance denial|15|||
25321180|NCT01143246|50637303|FG000|Overall Study|Adverse Event|24|||
25241424|NCT01332292|50556085|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
25241425|NCT01332292|50556086|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
25241426|NCT01332292|50556085|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
25241427|NCT01332292|50556086|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
25241428|NCT01332019|50556096|FG000|Overall Study|Was Not Dosed|1|||
25241429|NCT01332019|50556097|FG001|Overall Study|Was Not Dosed|0|||
25241430|NCT01332019|50556096|FG000|Overall Study|Other|16|||
25241431|NCT01332019|50556097|FG001|Overall Study|Other|18|||
25241432|NCT01332019|50556096|FG000|Overall Study|Death|2|||
25241433|NCT01332019|50556097|FG001|Overall Study|Death|1|||
25241434|NCT01332019|50556096|FG000|Overall Study|Physician Decision|4|||
25241435|NCT01332019|50556097|FG001|Overall Study|Physician Decision|3|||
25241436|NCT01332019|50556096|FG000|Overall Study|Withdrawal by Subject|73|||
25241437|NCT01332019|50556097|FG001|Overall Study|Withdrawal by Subject|71|||
25241438|NCT01332019|50556096|FG000|Overall Study|Lost to Follow-up|4|||
25241439|NCT01332019|50556097|FG001|Overall Study|Lost to Follow-up|7|||
25241440|NCT01332019|50556096|FG000|Overall Study|Adverse Event|13|||
25241441|NCT01332019|50556097|FG001|Overall Study|Adverse Event|22|||
25241442|NCT01331239|50556105|FG000|Part II: Core Study|Adverse Event|0|||
25241443|NCT01331239|50556106|FG001|Part II: Core Study|Adverse Event|3|||
25241444|NCT01331239|50556107|FG002|Part II: Core Study|Adverse Event|0|||
25241445|NCT01331239|50556105|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
25241446|NCT01331239|50556106|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
25241447|NCT01331239|50556107|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
25241448|NCT01331239|50556105|FG000|Part II: Core Study|Withdrawal by Subject|0|||
25241449|NCT01331239|50556106|FG001|Part II: Core Study|Withdrawal by Subject|2|||
25241450|NCT01331239|50556107|FG002|Part II: Core Study|Withdrawal by Subject|0|||
25241451|NCT01331239|50556105|FG000|Part II: Core Study|Administrative problems|0|||
25241452|NCT01331239|50556106|FG001|Part II: Core Study|Administrative problems|1|||
25241453|NCT01331239|50556107|FG002|Part II: Core Study|Administrative problems|0|||
25241454|NCT01331161|50556125|FG000|Overall Study|Physician Decision|1|||
25241455|NCT01331161|50556126|FG001|Overall Study|Physician Decision|0|||
25241456|NCT01331161|50556125|FG000|Overall Study|Lost to Follow-up|0|||
25241457|NCT01331161|50556126|FG001|Overall Study|Lost to Follow-up|1|||
25241458|NCT01331161|50556125|FG000|Overall Study|Pregnancy|0|||
25241459|NCT01331161|50556126|FG001|Overall Study|Pregnancy|1|||
25241460|NCT01331005|50556136|FG000|Overall Study|Lost to Follow-up|2|||
25241461|NCT01331005|50556137|FG001|Overall Study|Lost to Follow-up|1|||
25241462|NCT01331005|50556136|FG000|Overall Study|Withdrawal by Subject|2|||
25241463|NCT01331005|50556137|FG001|Overall Study|Withdrawal by Subject|3|||
25241464|NCT01330459|50556145|FG000|Overall Study|Physician Decision|0|||
25321181|NCT01143246|50637304|FG001|Overall Study|Adverse Event|28|||
25321182|NCT01143246|50637303|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
24977046|NCT00379769|50065793|FG000|Main Study|Physician Decision|2|||
25241465|NCT01330459|50556146|FG001|Overall Study|Physician Decision|2|||
25241466|NCT01330381|50556156|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
25241467|NCT01330381|50556157|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
25241468|NCT01330381|50556158|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
25241469|NCT01330381|50556156|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
25241470|NCT01330381|50556157|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
25241471|NCT01330381|50556158|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
25241472|NCT01330381|50556156|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
25241473|NCT01330381|50556157|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
25241474|NCT01330381|50556158|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
25241475|NCT01330381|50556156|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
25241476|NCT01330381|50556157|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
25241477|NCT01330381|50556158|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
25241478|NCT01330381|50556156|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
25241479|NCT01330381|50556157|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
25241480|NCT01330381|50556158|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
25241481|NCT01330381|50556156|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
25241482|NCT01330381|50556157|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
25241483|NCT01330381|50556158|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
25241484|NCT01330381|50556156|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
25241485|NCT01330381|50556157|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
25241486|NCT01330381|50556158|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
25241487|NCT01330381|50556156|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
25241488|NCT01330381|50556157|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
25241489|NCT01330381|50556158|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
25241490|NCT01330381|50556156|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
25241491|NCT01330381|50556157|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
25241492|NCT01330381|50556158|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
25241493|NCT01330381|50556156|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
25241494|NCT01330381|50556157|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
25241495|NCT01330381|50556158|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
25321183|NCT01143246|50637304|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
25321184|NCT01143246|50637303|FG000|Overall Study|Lost to Follow-up|0|||
25321185|NCT01143246|50637304|FG001|Overall Study|Lost to Follow-up|1|||
25321186|NCT01143246|50637303|FG000|Overall Study|Death|16|||
25321187|NCT01143246|50637304|FG001|Overall Study|Death|15|||
25321188|NCT01143246|50637303|FG000|Overall Study|Reason not Specified|3|||
25241496|NCT01330303|50556167|FG000|Period 1|Adverse Event|1|||
25241497|NCT01330303|50556168|FG001|Period 1|Adverse Event|0|||
25241498|NCT01330303|50556167|FG000|Period 1|Protocol Violation|0|||
25241499|NCT01330303|50556168|FG001|Period 1|Protocol Violation|1|||
25241500|NCT01330303|50556167|FG000|Period 1|Withdrawal by Subject|0|||
25241501|NCT01330303|50556168|FG001|Period 1|Withdrawal by Subject|1|||
25241502|NCT01330108|50556175|FG000|Overall Study|Withdrawal by Subject|4|||
25241503|NCT01059825|50556185|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
25241504|NCT01059825|50556186|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
25241505|NCT01059825|50556187|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
25241506|NCT01059825|50556188|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
25241507|NCT01059825|50556189|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
25241508|NCT01059825|50556190|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
25241509|NCT01059825|50556191|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
25241510|NCT01059825|50556185|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
25241511|NCT01059825|50556186|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
25241512|NCT01059825|50556187|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
25321189|NCT01143246|50637304|FG001|Overall Study|Reason not Specified|5|||
25321190|NCT00561925|50637318|FG000|14 Day Lead-In Period|Adverse Event|38|||
25321191|NCT00561925|50637319|FG001|14 Day Lead-In Period|Adverse Event|0|||
25321192|NCT00561925|50637320|FG002|14 Day Lead-In Period|Adverse Event|0|||
25321193|NCT00561925|50637321|FG003|14 Day Lead-In Period|Adverse Event|0|||
25241513|NCT01059825|50556188|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
25241514|NCT01059825|50556189|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
25241515|NCT01059825|50556190|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
25241516|NCT01059825|50556191|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
25241517|NCT01059825|50556185|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
25241518|NCT01059825|50556186|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
25241519|NCT01059825|50556187|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
25241520|NCT01059825|50556188|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
25241521|NCT01059825|50556189|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
25241522|NCT01059825|50556190|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
25321194|NCT00561925|50637322|FG004|14 Day Lead-In Period|Adverse Event|0|||
25241523|NCT01059825|50556191|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
25321195|NCT00561925|50637318|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
25321196|NCT00561925|50637319|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
25321197|NCT00561925|50637320|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
25241524|NCT01059825|50556185|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
25241525|NCT01059825|50556186|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
25241526|NCT01059825|50556187|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
25241527|NCT01059825|50556188|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
25241528|NCT01059825|50556189|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
25241529|NCT01059825|50556190|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
25241530|NCT01059825|50556191|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
25241531|NCT01059825|50556185|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
25241532|NCT01059825|50556186|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
25241533|NCT01059825|50556187|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
25241534|NCT01059825|50556188|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
25241535|NCT01059825|50556189|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
25241536|NCT01059825|50556190|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
25241537|NCT01059825|50556191|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
25241538|NCT01059825|50556185|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
25241539|NCT01059825|50556186|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
25241540|NCT01059825|50556187|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
25241541|NCT01059825|50556188|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
25241542|NCT01059825|50556189|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
25241543|NCT01059825|50556190|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
25241544|NCT01059825|50556191|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
25241545|NCT01059825|50556185|FG000|Treatment Period|Lost to Follow-up|2|||
25241546|NCT01059825|50556186|FG001|Treatment Period|Lost to Follow-up|1|||
25241547|NCT01059825|50556187|FG002|Treatment Period|Lost to Follow-up|0|||
25241548|NCT01059825|50556188|FG003|Treatment Period|Lost to Follow-up|1|||
25241549|NCT01059825|50556189|FG004|Treatment Period|Lost to Follow-up|2|||
25241550|NCT01059825|50556190|FG005|Treatment Period|Lost to Follow-up|0|||
25241551|NCT01059825|50556191|FG006|Treatment Period|Lost to Follow-up|0|||
25241552|NCT01059825|50556185|FG000|Treatment Period|Withdrawal by Subject|3|||
25241553|NCT01059825|50556186|FG001|Treatment Period|Withdrawal by Subject|0|||
25241554|NCT01059825|50556187|FG002|Treatment Period|Withdrawal by Subject|1|||
25241555|NCT01059825|50556188|FG003|Treatment Period|Withdrawal by Subject|5|||
25241556|NCT01059825|50556189|FG004|Treatment Period|Withdrawal by Subject|4|||
25241557|NCT01059825|50556190|FG005|Treatment Period|Withdrawal by Subject|1|||
25241558|NCT01059825|50556191|FG006|Treatment Period|Withdrawal by Subject|0|||
25241559|NCT01059825|50556185|FG000|Treatment Period|Other reason not specified|1|||
25241560|NCT01059825|50556186|FG001|Treatment Period|Other reason not specified|2|||
25241561|NCT01059825|50556187|FG002|Treatment Period|Other reason not specified|1|||
25241562|NCT01059825|50556188|FG003|Treatment Period|Other reason not specified|2|||
25241563|NCT01059825|50556189|FG004|Treatment Period|Other reason not specified|0|||
25241564|NCT01059825|50556190|FG005|Treatment Period|Other reason not specified|0|||
25241565|NCT01059825|50556191|FG006|Treatment Period|Other reason not specified|0|||
25241566|NCT01059825|50556185|FG000|Treatment Period|Protocol Violation|0|||
25241567|NCT01059825|50556186|FG001|Treatment Period|Protocol Violation|0|||
25241568|NCT01059825|50556187|FG002|Treatment Period|Protocol Violation|1|||
25241569|NCT01059825|50556188|FG003|Treatment Period|Protocol Violation|1|||
25241570|NCT01059825|50556189|FG004|Treatment Period|Protocol Violation|1|||
25241571|NCT01059825|50556190|FG005|Treatment Period|Protocol Violation|1|||
25241572|NCT01059825|50556191|FG006|Treatment Period|Protocol Violation|0|||
25241573|NCT01059825|50556185|FG000|Treatment Period|Adverse event related to study drug|1|||
25241574|NCT01059825|50556186|FG001|Treatment Period|Adverse event related to study drug|0|||
25241575|NCT01059825|50556187|FG002|Treatment Period|Adverse event related to study drug|1|||
25241576|NCT01059825|50556188|FG003|Treatment Period|Adverse event related to study drug|1|||
25241577|NCT01059825|50556189|FG004|Treatment Period|Adverse event related to study drug|0|||
25241578|NCT01059825|50556190|FG005|Treatment Period|Adverse event related to study drug|0|||
25241579|NCT01059825|50556191|FG006|Treatment Period|Adverse event related to study drug|0|||
25241580|NCT01059825|50556185|FG000|Treatment Period|Insufficient clinical response|3|||
25321198|NCT00561925|50637321|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
25321199|NCT00561925|50637322|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
25321200|NCT00561925|50637318|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
25241581|NCT01059825|50556186|FG001|Treatment Period|Insufficient clinical response|0|||
25241582|NCT01059825|50556187|FG002|Treatment Period|Insufficient clinical response|0|||
25241583|NCT01059825|50556188|FG003|Treatment Period|Insufficient clinical response|0|||
25241584|NCT01059825|50556189|FG004|Treatment Period|Insufficient clinical response|0|||
25241585|NCT01059825|50556190|FG005|Treatment Period|Insufficient clinical response|0|||
25241586|NCT01059825|50556191|FG006|Treatment Period|Insufficient clinical response|0|||
25241587|NCT01059825|50556185|FG000|Treatment Period|Adverse event not related to study drug|0|||
25321201|NCT00561925|50637319|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
25321202|NCT00561925|50637320|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
25321203|NCT00561925|50637321|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
25321204|NCT00561925|50637322|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
25321205|NCT00561925|50637318|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
25321206|NCT00561925|50637319|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
25321207|NCT00561925|50637320|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
25321208|NCT00561925|50637321|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
25321209|NCT00561925|50637322|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
25321210|NCT00561925|50637318|FG000|14 Day Lead-In Period|Other|5|||
25321211|NCT00561925|50637319|FG001|14 Day Lead-In Period|Other|0|||
25321212|NCT00561925|50637320|FG002|14 Day Lead-In Period|Other|0|||
25321213|NCT00561925|50637321|FG003|14 Day Lead-In Period|Other|0|||
25321214|NCT00561925|50637322|FG004|14 Day Lead-In Period|Other|0|||
25321215|NCT00561925|50637318|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
25321216|NCT00561925|50637319|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
25321217|NCT00561925|50637320|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
25241588|NCT01059825|50556186|FG001|Treatment Period|Adverse event not related to study drug|1|||
25241589|NCT01059825|50556187|FG002|Treatment Period|Adverse event not related to study drug|2|||
25321218|NCT00561925|50637321|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
25321219|NCT00561925|50637322|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
25241590|NCT01059825|50556188|FG003|Treatment Period|Adverse event not related to study drug|1|||
25241591|NCT01059825|50556189|FG004|Treatment Period|Adverse event not related to study drug|1|||
25241592|NCT01059825|50556190|FG005|Treatment Period|Adverse event not related to study drug|1|||
25241593|NCT01059825|50556191|FG006|Treatment Period|Adverse event not related to study drug|0|||
25241594|NCT01059773|50556250|FG000|Overall Study|Adverse Event|2|||
25241595|NCT01059773|50556251|FG001|Overall Study|Adverse Event|2|||
25241596|NCT01059773|50556250|FG000|Overall Study|Withdrawal by Subject|1|||
25241597|NCT01059773|50556251|FG001|Overall Study|Withdrawal by Subject|5|||
25241598|NCT01059773|50556250|FG000|Overall Study|Lost to Follow-up|1|||
25241599|NCT01059773|50556251|FG001|Overall Study|Lost to Follow-up|1|||
25241600|NCT01059773|50556250|FG000|Overall Study|Pregnancy|1|||
25241601|NCT01059773|50556251|FG001|Overall Study|Pregnancy|1|||
25321220|NCT00561925|50637318|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
25321221|NCT00561925|50637319|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
25321222|NCT00561925|50637320|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
25321223|NCT00561925|50637321|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
25321224|NCT00561925|50637322|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
25321225|NCT00561925|50637318|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
25321226|NCT00561925|50637319|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
25321227|NCT00561925|50637320|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
25321228|NCT00561925|50637321|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
25321229|NCT00561925|50637322|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
25321230|NCT00561925|50637318|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
25321231|NCT00561925|50637319|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
25321232|NCT00561925|50637320|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
25241602|NCT01059773|50556250|FG000|Overall Study|Protocol Violation|6|||
25241603|NCT01059773|50556251|FG001|Overall Study|Protocol Violation|2|||
25241604|NCT01059773|50556250|FG000|Overall Study|Physician Decision|5|||
25241605|NCT01059773|50556251|FG001|Overall Study|Physician Decision|4|||
25241606|NCT01059773|50556250|FG000|Overall Study|Lack of Efficacy|3|||
25241607|NCT01059773|50556251|FG001|Overall Study|Lack of Efficacy|3|||
25241608|NCT01059773|50556250|FG000|Overall Study|Death|0|||
25241609|NCT01059773|50556251|FG001|Overall Study|Death|1|||
25241610|NCT01059773|50556250|FG000|Overall Study|Malignancy including squamous cell skin|0|||
25241611|NCT01059773|50556251|FG001|Overall Study|Malignancy including squamous cell skin|1|||
25321233|NCT00561925|50637321|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
25241612|NCT01059773|50556250|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
25241613|NCT01059773|50556251|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
25241614|NCT01059773|50556250|FG000|Overall Study|Other|1|||
25241615|NCT01059773|50556251|FG001|Overall Study|Other|3|||
25241616|NCT01059318|50556262|FG000|Core Study (26 Week)|Adverse Event|3|||
25241617|NCT01059318|50556262|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
25241618|NCT01059318|50556262|FG000|Extension (36 Week)|Adverse Event|3|||
25241619|NCT01058655|50556273|FG000|Overall Study|Withdrawal by Subject|1|||
25241620|NCT01058655|50556274|FG001|Overall Study|Withdrawal by Subject|0|||
25321234|NCT00561925|50637322|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
25321235|NCT00561925|50637318|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
25241621|NCT01058655|50556275|FG002|Overall Study|Withdrawal by Subject|3|||
25241622|NCT01058655|50556276|FG003|Overall Study|Withdrawal by Subject|4|||
25241623|NCT01058655|50556273|FG000|Overall Study|Prolonged Treatment Delay|0|||
25241624|NCT01058655|50556274|FG001|Overall Study|Prolonged Treatment Delay|0|||
25321236|NCT00561925|50637319|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
25321237|NCT00561925|50637320|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
25321238|NCT00561925|50637321|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
25321239|NCT00561925|50637322|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
25321240|NCT00561925|50637318|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
25321241|NCT00561925|50637319|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
25321242|NCT00561925|50637320|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
25321243|NCT00561925|50637321|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
25321244|NCT00561925|50637322|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
25321245|NCT00561925|50637318|FG000|144-week Double-blind, Double-dummy|Death|0|||
25241625|NCT01058655|50556275|FG002|Overall Study|Prolonged Treatment Delay|0|||
24977047|NCT00379769|50065794|FG001|Main Study|Physician Decision|2|||
25321246|NCT00561925|50637319|FG001|144-week Double-blind, Double-dummy|Death|6|||
25321247|NCT00561925|50637320|FG002|144-week Double-blind, Double-dummy|Death|3|||
25321248|NCT00561925|50637321|FG003|144-week Double-blind, Double-dummy|Death|0|||
25321249|NCT00561925|50637322|FG004|144-week Double-blind, Double-dummy|Death|0|||
25321250|NCT00561925|50637318|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
25321251|NCT00561925|50637319|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
25321252|NCT00561925|50637320|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
25321253|NCT00561925|50637321|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
25321254|NCT00561925|50637322|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
25321255|NCT00561925|50637318|FG000|144-week Double-blind, Double-dummy|Other|0|||
25321256|NCT00561925|50637319|FG001|144-week Double-blind, Double-dummy|Other|8|||
25321257|NCT00561925|50637320|FG002|144-week Double-blind, Double-dummy|Other|11|||
25321258|NCT00561925|50637321|FG003|144-week Double-blind, Double-dummy|Other|0|||
25321259|NCT00561925|50637322|FG004|144-week Double-blind, Double-dummy|Other|0|||
25321260|NCT00561925|50637318|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
25321261|NCT00561925|50637319|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
25321262|NCT00561925|50637320|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
25321263|NCT00561925|50637321|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
25321264|NCT00561925|50637322|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
25321265|NCT00549445|50637342|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
25321266|NCT00549445|50637343|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
25321267|NCT00601107|50637353|FG000|Overall Study|Adverse Event|0|||
25321268|NCT00601107|50637354|FG001|Overall Study|Adverse Event|1|||
25321269|NCT00601107|50637355|FG002|Overall Study|Adverse Event|3|||
24977048|NCT00379769|50065795|FG002|Main Study|Physician Decision|1|||
24977049|NCT00379769|50065796|FG003|Main Study|Physician Decision|1|||
24977050|NCT00379769|50065797|FG004|Main Study|Physician Decision|0|||
24977051|NCT00379769|50065798|FG005|Main Study|Physician Decision|0|||
24977052|NCT00379769|50065793|FG000|Main Study|Participant completed study at visit 27|1|||
24977053|NCT00379769|50065794|FG001|Main Study|Participant completed study at visit 27|0|||
24977054|NCT00379769|50065795|FG002|Main Study|Participant completed study at visit 27|0|||
24977055|NCT00379769|50065796|FG003|Main Study|Participant completed study at visit 27|0|||
24977056|NCT00379769|50065797|FG004|Main Study|Participant completed study at visit 27|0|||
24977057|NCT00379769|50065798|FG005|Main Study|Participant completed study at visit 27|0|||
24977058|NCT00379769|50065793|FG000|Main Study|Personal reasons|1|||
24977059|NCT00379769|50065794|FG001|Main Study|Personal reasons|0|||
24977060|NCT00379769|50065795|FG002|Main Study|Personal reasons|0|||
25241626|NCT01058655|50556276|FG003|Overall Study|Prolonged Treatment Delay|2|||
25241627|NCT01058655|50556273|FG000|Overall Study|Symptomatic Deterioration|0|||
25241628|NCT01058655|50556274|FG001|Overall Study|Symptomatic Deterioration|0|||
25241629|NCT01058655|50556275|FG002|Overall Study|Symptomatic Deterioration|0|||
25241630|NCT01058655|50556276|FG003|Overall Study|Symptomatic Deterioration|1|||
25241631|NCT01058655|50556273|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
25241632|NCT01058655|50556274|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
25241633|NCT01058655|50556275|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
25321270|NCT00601107|50637356|FG003|Overall Study|Adverse Event|0|||
25321271|NCT00601107|50637353|FG000|Overall Study|Withdrawal by Subject|5|||
24977061|NCT00379769|50065796|FG003|Main Study|Personal reasons|0|||
24977062|NCT00379769|50065797|FG004|Main Study|Personal reasons|0|||
25241634|NCT01058655|50556276|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
25241635|NCT01058655|50556273|FG000|Overall Study|Death|0|||
25241636|NCT01058655|50556274|FG001|Overall Study|Death|1|||
25241637|NCT01058655|50556275|FG002|Overall Study|Death|1|||
25241638|NCT01058655|50556276|FG003|Overall Study|Death|0|||
25241639|NCT01058655|50556273|FG000|Overall Study|Disease Progression|1|||
25241640|NCT01058655|50556274|FG001|Overall Study|Disease Progression|2|||
25241641|NCT01058655|50556275|FG002|Overall Study|Disease Progression|4|||
25241642|NCT01058655|50556276|FG003|Overall Study|Disease Progression|24|||
25241643|NCT01058655|50556273|FG000|Overall Study|Other|0|||
25241644|NCT01058655|50556274|FG001|Overall Study|Other|0|||
25241645|NCT01058655|50556275|FG002|Overall Study|Other|0|||
25241646|NCT01058655|50556276|FG003|Overall Study|Other|4|||
25241647|NCT01058421|50556289|FG000|1 Month Outcomes|Death|10|||
25241648|NCT01058421|50556290|FG001|1 Month Outcomes|Death|6|||
25241649|NCT01058421|50556289|FG000|1 Month Outcomes|Lost to Follow-up|8|||
25241650|NCT01058421|50556290|FG001|1 Month Outcomes|Lost to Follow-up|7|||
25241651|NCT01058421|50556289|FG000|1 Month Outcomes|Remained in Hospital|5|||
25241652|NCT01058421|50556290|FG001|1 Month Outcomes|Remained in Hospital|12|||
25241653|NCT01058421|50556289|FG000|1 Month Outcomes|Remained in Other Facility|16|||
25241654|NCT01058421|50556290|FG001|1 Month Outcomes|Remained in Other Facility|17|||
25241655|NCT01058421|50556289|FG000|3 Month Outcomes|Death|3|||
25241656|NCT01058421|50556290|FG001|3 Month Outcomes|Death|5|||
25241657|NCT01058421|50556289|FG000|3 Month Outcomes|Lost to Follow-up|12|||
25241658|NCT01058421|50556290|FG001|3 Month Outcomes|Lost to Follow-up|11|||
25241659|NCT01058421|50556289|FG000|3 Month Outcomes|Remained in Hospital|0|||
25241660|NCT01058421|50556290|FG001|3 Month Outcomes|Remained in Hospital|2|||
25241661|NCT01058421|50556289|FG000|3 Month Outcomes|Remained in Other Facility|5|||
25241662|NCT01058421|50556290|FG001|3 Month Outcomes|Remained in Other Facility|8|||
25241663|NCT01058421|50556289|FG000|6 Month Outcomes|Death|2|||
25241664|NCT01058421|50556290|FG001|6 Month Outcomes|Death|2|||
25241665|NCT01058421|50556289|FG000|6 Month Outcomes|Lost to Follow-up|16|||
25241666|NCT01058421|50556290|FG001|6 Month Outcomes|Lost to Follow-up|21|||
25241667|NCT01058421|50556289|FG000|6 Month Outcomes|Remained in Other Facility|1|||
25321272|NCT00601107|50637354|FG001|Overall Study|Withdrawal by Subject|4|||
25321273|NCT00601107|50637355|FG002|Overall Study|Withdrawal by Subject|7|||
25321274|NCT00601107|50637356|FG003|Overall Study|Withdrawal by Subject|4|||
25321275|NCT00601107|50637353|FG000|Overall Study|Lost to Follow-up|3|||
25321276|NCT00601107|50637354|FG001|Overall Study|Lost to Follow-up|3|||
25321277|NCT00601107|50637355|FG002|Overall Study|Lost to Follow-up|0|||
25321278|NCT00601107|50637356|FG003|Overall Study|Lost to Follow-up|3|||
25321279|NCT00601107|50637353|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
25321280|NCT00601107|50637354|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
25321281|NCT00601107|50637355|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
25321282|NCT00601107|50637356|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
25321283|NCT00601107|50637353|FG000|Overall Study|Worsening of Psoriasis|4|||
25321284|NCT00601107|50637354|FG001|Overall Study|Worsening of Psoriasis|1|||
25321285|NCT00601107|50637355|FG002|Overall Study|Worsening of Psoriasis|1|||
25321286|NCT00601107|50637356|FG003|Overall Study|Worsening of Psoriasis|4|||
25321287|NCT00601107|50637353|FG000|Overall Study|Undefined|1|||
25321288|NCT00601107|50637354|FG001|Overall Study|Undefined|0|||
25321289|NCT00601107|50637355|FG002|Overall Study|Undefined|1|||
25321290|NCT00601107|50637356|FG003|Overall Study|Undefined|0|||
25321291|NCT00914927|50637373|FG000|Overall Study|Adverse Event|0|||
25321292|NCT00914927|50637374|FG001|Overall Study|Adverse Event|0|||
25321293|NCT00914927|50637375|FG002|Overall Study|Adverse Event|0|||
25321294|NCT00914927|50637376|FG003|Overall Study|Adverse Event|0|||
25321295|NCT00914927|50637377|FG004|Overall Study|Adverse Event|1|||
25321296|NCT00914927|50637378|FG005|Overall Study|Adverse Event|0|||
25321297|NCT00914927|50637379|FG006|Overall Study|Adverse Event|0|||
25321298|NCT00914927|50637373|FG000|Overall Study|Withdrawal by Subject|0|||
25321299|NCT00914927|50637374|FG001|Overall Study|Withdrawal by Subject|1|||
25321300|NCT00914927|50637375|FG002|Overall Study|Withdrawal by Subject|0|||
25321301|NCT00914927|50637376|FG003|Overall Study|Withdrawal by Subject|1|||
25321302|NCT00914927|50637377|FG004|Overall Study|Withdrawal by Subject|0|||
24977063|NCT00379769|50065798|FG005|Main Study|Personal reasons|0|||
25241668|NCT01058421|50556290|FG001|6 Month Outcomes|Remained in Other Facility|3|||
25241669|NCT01058304|50556298|FG000|Overall Study|Withdrawal by Subject|8|||
25241670|NCT01058304|50556299|FG001|Overall Study|Withdrawal by Subject|5|||
25241671|NCT01058304|50556298|FG000|Overall Study|Lost to Follow-up|13|||
25241672|NCT01058304|50556299|FG001|Overall Study|Lost to Follow-up|16|||
25241673|NCT01058304|50556298|FG000|Overall Study|Developed exclusion criterion|6|||
25321303|NCT00914927|50637378|FG005|Overall Study|Withdrawal by Subject|0|||
25321304|NCT00914927|50637379|FG006|Overall Study|Withdrawal by Subject|0|||
25321305|NCT00914927|50637373|FG000|Overall Study|Lost to Follow-up|0|||
25321306|NCT00914927|50637374|FG001|Overall Study|Lost to Follow-up|0|||
25241674|NCT01058304|50556299|FG001|Overall Study|Developed exclusion criterion|12|||
25241675|NCT01058265|50556307|FG000|Overall Study|Lost to Follow-up|11|||
25241676|NCT01058265|50556308|FG001|Overall Study|Lost to Follow-up|12|||
25241677|NCT01057251|50556316|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
25321307|NCT00914927|50637375|FG002|Overall Study|Lost to Follow-up|0|||
25321308|NCT00914927|50637376|FG003|Overall Study|Lost to Follow-up|1|||
25321309|NCT00914927|50637377|FG004|Overall Study|Lost to Follow-up|0|||
25321310|NCT00914927|50637378|FG005|Overall Study|Lost to Follow-up|0|||
25321311|NCT00914927|50637379|FG006|Overall Study|Lost to Follow-up|0|||
25321312|NCT00914927|50637373|FG000|Overall Study|Administrative/Other|2|||
25241678|NCT01057251|50556317|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
25241679|NCT01057251|50556316|FG000|Overall Study|Adverse Event|4|||
25241680|NCT01057251|50556317|FG001|Overall Study|Adverse Event|2|||
25241681|NCT01057251|50556316|FG000|Overall Study|Lack of Efficacy|2|||
25241682|NCT01057251|50556317|FG001|Overall Study|Lack of Efficacy|11|||
25241683|NCT01057251|50556316|FG000|Overall Study|Protocol Violation|6|||
25241684|NCT01057251|50556317|FG001|Overall Study|Protocol Violation|2|||
25241685|NCT01057251|50556316|FG000|Overall Study|Withdrawal by Subject|4|||
25241686|NCT01057251|50556317|FG001|Overall Study|Withdrawal by Subject|5|||
25241687|NCT01057251|50556316|FG000|Overall Study|Lost to Follow-up|7|||
25241688|NCT01057251|50556317|FG001|Overall Study|Lost to Follow-up|6|||
25241689|NCT01057251|50556316|FG000|Overall Study|Other Reason|1|||
25241690|NCT01057251|50556317|FG001|Overall Study|Other Reason|1|||
25241691|NCT01056822|50556325|FG000|Overall Study|Adverse Event|0|||
25241692|NCT01056822|50556326|FG001|Overall Study|Adverse Event|1|||
25241693|NCT01056822|50556325|FG000|Overall Study|Protocol Violation|6|||
25241694|NCT01056822|50556326|FG001|Overall Study|Protocol Violation|5|||
25241695|NCT01056822|50556325|FG000|Overall Study|Withdrawal by Subject|1|||
25241696|NCT01056822|50556326|FG001|Overall Study|Withdrawal by Subject|1|||
25241697|NCT01056822|50556325|FG000|Overall Study|Lost to Follow-up|1|||
25241698|NCT01056822|50556326|FG001|Overall Study|Lost to Follow-up|0|||
25241699|NCT01051791|50556333|FG000|Overall Study|Failed screening|3|||
25241700|NCT01051791|50556333|FG000|Overall Study|Withdrawal by Subject|1|||
25241701|NCT01056510|50556345|FG000|Overall Study|Dropout Before Start of Treatment|1|||
25241702|NCT01056510|50556346|FG001|Overall Study|Dropout Before Start of Treatment|1|||
25241703|NCT01056510|50556345|FG000|Overall Study|Withdrawal by Subject|4|||
25241704|NCT01056510|50556346|FG001|Overall Study|Withdrawal by Subject|2|||
25241705|NCT01056510|50556345|FG000|Overall Study|Death|29|||
25241706|NCT01056510|50556346|FG001|Overall Study|Death|34|||
25241707|NCT01056510|50556345|FG000|Overall Study|Noncompliance|1|||
25241708|NCT01056510|50556346|FG001|Overall Study|Noncompliance|3|||
25241709|NCT01056510|50556345|FG000|Overall Study|Physician Decision|4|||
25241710|NCT01056510|50556346|FG001|Overall Study|Physician Decision|5|||
25241711|NCT01056510|50556345|FG000|Overall Study|Lost to Follow-up|5|||
25241712|NCT01056510|50556346|FG001|Overall Study|Lost to Follow-up|6|||
25241713|NCT01056510|50556345|FG000|Overall Study|Other|10|||
25241714|NCT01056510|50556346|FG001|Overall Study|Other|12|||
25241715|NCT01056510|50556345|FG000|Overall Study|Missing|0|||
25241716|NCT01056510|50556346|FG001|Overall Study|Missing|1|||
25241717|NCT01051323|50556354|FG000|Overall Study|Discontinuation of treatment|103|||
25241718|NCT01051323|50556354|FG000|Overall Study|Transplantation|28|||
25241719|NCT01051323|50556354|FG000|Overall Study|Dialysis dependency|22|||
25241720|NCT01051323|50556354|FG000|Overall Study|Withdrawal by Subject|13|||
25241721|NCT01051323|50556354|FG000|Overall Study|Lost to Follow-up|31|||
25241722|NCT01051323|50556354|FG000|Overall Study|Death|129|||
25241723|NCT01051323|50556354|FG000|Overall Study|Hospitalization|28|||
25241724|NCT01051323|50556354|FG000|Overall Study|Other|148|||
25241725|NCT01051323|50556354|FG000|Overall Study|Missing|37|||
25241726|NCT01056276|50556364|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
25241727|NCT01056276|50556365|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
25241728|NCT01056276|50556364|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
25241729|NCT01056276|50556365|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
25321313|NCT00914927|50637374|FG001|Overall Study|Administrative/Other|1|||
25321314|NCT00914927|50637375|FG002|Overall Study|Administrative/Other|0|||
25241730|NCT01056276|50556364|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
25241731|NCT01056276|50556365|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
25241732|NCT01056276|50556364|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
25241733|NCT01056276|50556365|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
25241734|NCT01056276|50556364|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
25241735|NCT01056276|50556365|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
25241736|NCT01056276|50556364|FG000|Treatment Period-Cycles 1-8|Death|3|||
25241737|NCT01056276|50556365|FG001|Treatment Period-Cycles 1-8|Death|1|||
25241738|NCT01056276|50556364|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
25241739|NCT01056276|50556365|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
25321315|NCT00914927|50637376|FG003|Overall Study|Administrative/Other|0|||
25321316|NCT00914927|50637377|FG004|Overall Study|Administrative/Other|1|||
25321317|NCT00914927|50637378|FG005|Overall Study|Administrative/Other|0|||
25321318|NCT00914927|50637379|FG006|Overall Study|Administrative/Other|0|||
25321319|NCT00914849|50637406|FG000|Overall Study|Withdrawal by Subject|1|||
25321320|NCT00914849|50637407|FG001|Overall Study|Withdrawal by Subject|0|||
25321321|NCT00914849|50637406|FG000|Overall Study|Not eligible|0|||
25321322|NCT00914849|50637407|FG001|Overall Study|Not eligible|1|||
25321323|NCT00912743|50637415|FG000|Overall Study|Adverse Event|3|||
25321324|NCT00912743|50637416|FG001|Overall Study|Adverse Event|1|||
25321325|NCT00912743|50637415|FG000|Overall Study|Lack of Efficacy|9|||
25321326|NCT00912743|50637416|FG001|Overall Study|Lack of Efficacy|18|||
25321327|NCT00912743|50637415|FG000|Overall Study|Toxicity|0|||
25321328|NCT00912743|50637416|FG001|Overall Study|Toxicity|1|||
25321329|NCT00912743|50637415|FG000|Overall Study|End of treatment form was not collected|1|||
25321330|NCT00912743|50637416|FG001|Overall Study|End of treatment form was not collected|0|||
25321331|NCT00914459|50637424|FG000|Overall Study|Protocol Violation|0|||
25321332|NCT00914459|50637425|FG001|Overall Study|Protocol Violation|1|||
25321333|NCT00914459|50637424|FG000|Overall Study|Parent/Legal guardian request|1|||
25321334|NCT00914459|50637425|FG001|Overall Study|Parent/Legal guardian request|0|||
25321335|NCT00912509|50637435|FG000|Overall Study|Lost to Follow-up|1|||
25241740|NCT01056276|50556364|FG000|Maintenance Therapy|Toxicity|0|||
25241741|NCT01056276|50556365|FG001|Maintenance Therapy|Toxicity|2|||
25321336|NCT00912509|50637436|FG001|Overall Study|Lost to Follow-up|0|||
25321337|NCT00912509|50637435|FG000|Overall Study|Lack of Efficacy|4|||
25321338|NCT00912509|50637436|FG001|Overall Study|Lack of Efficacy|3|||
25321339|NCT00913835|50637456|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
25321340|NCT00913835|50637457|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
25321341|NCT00913835|50637456|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
25321342|NCT00913835|50637457|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
25321343|NCT00913835|50637456|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
25321344|NCT00913835|50637457|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
25321345|NCT00913835|50637456|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
25321346|NCT00913835|50637457|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
25321347|NCT00913835|50637456|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
25321348|NCT00913835|50637457|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
25321349|NCT00913523|50637482|FG000|Overall Study|Withdrawal by Subject|3|||
25321350|NCT00913523|50637483|FG001|Overall Study|Withdrawal by Subject|2|||
25321351|NCT00913523|50637484|FG002|Overall Study|Withdrawal by Subject|2|||
25321352|NCT00913523|50637482|FG000|Overall Study|Lost to Follow-up|1|||
25321353|NCT00913523|50637483|FG001|Overall Study|Lost to Follow-up|1|||
25321354|NCT00913523|50637484|FG002|Overall Study|Lost to Follow-up|1|||
25321355|NCT00913523|50637482|FG000|Overall Study|Adverse Event|1|||
25321356|NCT00913523|50637483|FG001|Overall Study|Adverse Event|0|||
25321357|NCT00913523|50637484|FG002|Overall Study|Adverse Event|0|||
25321358|NCT00913523|50637482|FG000|Overall Study|Protocol Violation|5|||
25321359|NCT00913523|50637483|FG001|Overall Study|Protocol Violation|8|||
25321360|NCT00913523|50637484|FG002|Overall Study|Protocol Violation|8|||
25321361|NCT00913523|50637482|FG000|Overall Study|Pregnancy|1|||
25241742|NCT01056276|50556364|FG000|Maintenance Therapy|Progressive Disease|0|||
25241743|NCT01056276|50556365|FG001|Maintenance Therapy|Progressive Disease|9|||
25241744|NCT01056276|50556364|FG000|Maintenance Therapy|Physician Decision|0|||
25241745|NCT01056276|50556365|FG001|Maintenance Therapy|Physician Decision|1|||
25241746|NCT01056276|50556364|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
25241747|NCT01056276|50556365|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
25241748|NCT01056276|50556364|FG000|Maintenance Therapy|Intercurrent Illness|0|||
25241749|NCT01056276|50556365|FG001|Maintenance Therapy|Intercurrent Illness|1|||
25241750|NCT01056276|50556364|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
25241751|NCT01056276|50556365|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
25241752|NCT01055886|50556378|FG000|Overall Study|Withdrawal by Subject|4|||
25321362|NCT00913523|50637483|FG001|Overall Study|Pregnancy|3|||
25321363|NCT00913523|50637484|FG002|Overall Study|Pregnancy|0|||
25321364|NCT00913523|50637482|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
25241753|NCT01055886|50556379|FG001|Overall Study|Withdrawal by Subject|9|||
25241754|NCT01055886|50556378|FG000|Overall Study|Lost to Follow-up|1|||
25241755|NCT01055886|50556379|FG001|Overall Study|Lost to Follow-up|1|||
25241756|NCT01055886|50556378|FG000|Overall Study|Withdrawal by PI|0|||
25241757|NCT01055886|50556379|FG001|Overall Study|Withdrawal by PI|1|||
25321365|NCT00913523|50637483|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
25241758|NCT01055613|50556387|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
25321366|NCT00913523|50637484|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
25321367|NCT00912197|50637494|FG000|Overall Study|Withdrawal by Subject|3|||
25321368|NCT00912197|50637495|FG001|Overall Study|Withdrawal by Subject|3|||
25321369|NCT00910247|50637503|FG000|Overall Study|Adverse Event|15|||
25321370|NCT00910247|50637503|FG000|Overall Study|Death|2|||
25321371|NCT00910247|50637503|FG000|Overall Study|Lost to Follow-up|10|||
25321372|NCT00910247|50637503|FG000|Overall Study|Physician Decision|3|||
25321373|NCT00910247|50637503|FG000|Overall Study|Protocol Violation|10|||
25321374|NCT00910247|50637503|FG000|Overall Study|Withdrawal by Subject|25|||
25321375|NCT00910247|50637503|FG000|Overall Study|Not collected|4|||
25321376|NCT00659334|50637514|FG000|Overall Study|Screen Failure|8|||
25321377|NCT00659334|50637515|FG001|Overall Study|Screen Failure|5|||
25321378|NCT00659334|50637516|FG002|Overall Study|Screen Failure|0|||
25321379|NCT00659334|50637517|FG003|Overall Study|Screen Failure|0|||
25321380|NCT00659334|50637518|FG004|Overall Study|Screen Failure|0|||
25321381|NCT00659334|50637519|FG005|Overall Study|Screen Failure|0|||
25241759|NCT01055613|50556388|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
25241760|NCT01055613|50556387|FG000|Overall Study|Unacceptable lens fit|1|||
25241761|NCT01055613|50556388|FG001|Overall Study|Unacceptable lens fit|0|||
25241762|NCT01055613|50556387|FG000|Overall Study|Discomfort|2|||
25241763|NCT01055613|50556388|FG001|Overall Study|Discomfort|1|||
25241764|NCT01055613|50556387|FG000|Overall Study|Lost to Follow-up|1|||
25241765|NCT01055613|50556388|FG001|Overall Study|Lost to Follow-up|1|||
25241766|NCT01055613|50556387|FG000|Overall Study|Protocol Violation|1|||
25241767|NCT01055613|50556388|FG001|Overall Study|Protocol Violation|1|||
25241768|NCT01055613|50556387|FG000|Overall Study|Subject Disinterest|1|||
25241769|NCT01055613|50556388|FG001|Overall Study|Subject Disinterest|1|||
25241770|NCT01055457|50556404|FG000|Overall Study|Lost to Follow-up|0|||
25241771|NCT01055457|50556405|FG001|Overall Study|Lost to Follow-up|1|||
25241772|NCT01055457|50556406|FG002|Overall Study|Lost to Follow-up|0|||
25241773|NCT01055457|50556407|FG003|Overall Study|Lost to Follow-up|0|||
25241774|NCT01055457|50556408|FG004|Overall Study|Lost to Follow-up|0|||
25241775|NCT01055457|50556409|FG005|Overall Study|Lost to Follow-up|1|||
25241776|NCT01055457|50556410|FG006|Overall Study|Lost to Follow-up|0|||
25241777|NCT01055457|50556411|FG007|Overall Study|Lost to Follow-up|0|||
25241778|NCT01055457|50556412|FG008|Overall Study|Lost to Follow-up|0|||
25321382|NCT00659334|50637520|FG006|Overall Study|Screen Failure|1|||
25321383|NCT00910091|50637542|FG000|Pre-assignment|Withdrawal by Subject|0|||
25321384|NCT00910091|50637543|FG001|Pre-assignment|Withdrawal by Subject|2|||
25321385|NCT00910091|50637542|FG000|Treatment and Survival|Withdrawal by Subject|3|||
25321386|NCT00910091|50637543|FG001|Treatment and Survival|Withdrawal by Subject|4|||
25321387|NCT00910091|50637542|FG000|Treatment and Survival|Adverse Event|1|||
25321388|NCT00910091|50637543|FG001|Treatment and Survival|Adverse Event|0|||
25321389|NCT00909857|50637552|FG000|Overall Study|Withdrawal by Subject|6|||
25321390|NCT00909857|50637553|FG001|Overall Study|Withdrawal by Subject|10|||
25321391|NCT00909857|50637552|FG000|Overall Study|Adverse Event|5|||
25321392|NCT00909857|50637553|FG001|Overall Study|Adverse Event|5|||
25321393|NCT00909857|50637552|FG000|Overall Study|Lost to Follow-up|2|||
25321394|NCT00909857|50637553|FG001|Overall Study|Lost to Follow-up|5|||
25321395|NCT00909857|50637552|FG000|Overall Study|Protocol Violation|2|||
25241779|NCT01055457|50556413|FG009|Overall Study|Lost to Follow-up|0|||
25241780|NCT01055457|50556404|FG000|Overall Study|Protocol Violation|0|||
25241781|NCT01055457|50556405|FG001|Overall Study|Protocol Violation|0|||
25241782|NCT01055457|50556406|FG002|Overall Study|Protocol Violation|1|||
25241783|NCT01055457|50556407|FG003|Overall Study|Protocol Violation|1|||
25241784|NCT01055457|50556408|FG004|Overall Study|Protocol Violation|1|||
25241785|NCT01055457|50556409|FG005|Overall Study|Protocol Violation|2|||
25241786|NCT01055457|50556410|FG006|Overall Study|Protocol Violation|1|||
25241787|NCT01055457|50556411|FG007|Overall Study|Protocol Violation|0|||
25241788|NCT01055457|50556412|FG008|Overall Study|Protocol Violation|0|||
25241789|NCT01055457|50556413|FG009|Overall Study|Protocol Violation|1|||
25241790|NCT01055457|50556404|FG000|Overall Study|Subject Disinterest|0|||
25241791|NCT01055457|50556405|FG001|Overall Study|Subject Disinterest|0|||
25241792|NCT01055457|50556406|FG002|Overall Study|Subject Disinterest|0|||
25241793|NCT01055457|50556407|FG003|Overall Study|Subject Disinterest|0|||
25241794|NCT01055457|50556408|FG004|Overall Study|Subject Disinterest|0|||
25241795|NCT01055457|50556409|FG005|Overall Study|Subject Disinterest|0|||
25241796|NCT01055457|50556410|FG006|Overall Study|Subject Disinterest|0|||
25241797|NCT01055457|50556411|FG007|Overall Study|Subject Disinterest|1|||
25241798|NCT01055457|50556412|FG008|Overall Study|Subject Disinterest|0|||
25241799|NCT01055457|50556413|FG009|Overall Study|Subject Disinterest|0|||
25241800|NCT01055457|50556404|FG000|Overall Study|Subject Ineligible|1|||
25241801|NCT01055457|50556405|FG001|Overall Study|Subject Ineligible|0|||
25241802|NCT01055457|50556406|FG002|Overall Study|Subject Ineligible|1|||
25241803|NCT01055457|50556407|FG003|Overall Study|Subject Ineligible|0|||
25241804|NCT01055457|50556408|FG004|Overall Study|Subject Ineligible|1|||
25241805|NCT01055457|50556409|FG005|Overall Study|Subject Ineligible|0|||
25241806|NCT01055457|50556410|FG006|Overall Study|Subject Ineligible|0|||
25321396|NCT00909857|50637553|FG001|Overall Study|Protocol Violation|1|||
25321397|NCT00909857|50637552|FG000|Overall Study|Pregnancy|1|||
25321398|NCT00909857|50637553|FG001|Overall Study|Pregnancy|0|||
25321399|NCT00909857|50637552|FG000|Overall Study|Other|1|||
25321400|NCT00909857|50637553|FG001|Overall Study|Other|0|||
25241807|NCT01055457|50556411|FG007|Overall Study|Subject Ineligible|0|||
25321401|NCT00909857|50637552|FG000|Overall Study|Did not receive study medication|19|||
25241808|NCT01055457|50556412|FG008|Overall Study|Subject Ineligible|0|||
25241809|NCT01055457|50556413|FG009|Overall Study|Subject Ineligible|0|||
25241810|NCT01055457|50556404|FG000|Overall Study|Discomfort|0|||
25241811|NCT01055457|50556405|FG001|Overall Study|Discomfort|0|||
25241812|NCT01055457|50556406|FG002|Overall Study|Discomfort|0|||
25241813|NCT01055457|50556407|FG003|Overall Study|Discomfort|0|||
25241814|NCT01055457|50556408|FG004|Overall Study|Discomfort|1|||
25241815|NCT01055457|50556409|FG005|Overall Study|Discomfort|0|||
25241816|NCT01055457|50556410|FG006|Overall Study|Discomfort|0|||
25241817|NCT01055457|50556411|FG007|Overall Study|Discomfort|0|||
25241818|NCT01055457|50556412|FG008|Overall Study|Discomfort|0|||
25241819|NCT01055457|50556413|FG009|Overall Study|Discomfort|0|||
25241820|NCT01055457|50556404|FG000|Overall Study|Pregnancy|0|||
25241821|NCT01055457|50556405|FG001|Overall Study|Pregnancy|0|||
25241822|NCT01055457|50556406|FG002|Overall Study|Pregnancy|0|||
25241823|NCT01055457|50556407|FG003|Overall Study|Pregnancy|1|||
25241824|NCT01055457|50556408|FG004|Overall Study|Pregnancy|0|||
25241825|NCT01055457|50556409|FG005|Overall Study|Pregnancy|0|||
25241826|NCT01055457|50556410|FG006|Overall Study|Pregnancy|0|||
25241827|NCT01055457|50556411|FG007|Overall Study|Pregnancy|0|||
25241828|NCT01055457|50556412|FG008|Overall Study|Pregnancy|0|||
25321402|NCT00909857|50637553|FG001|Overall Study|Did not receive study medication|24|||
25321403|NCT00911807|50637562|FG000|Overall Study|Adverse Event|2|||
25241829|NCT01055457|50556413|FG009|Overall Study|Pregnancy|0|||
25241830|NCT01055457|50556404|FG000|Overall Study|Adverse Event|0|||
25241831|NCT01055457|50556405|FG001|Overall Study|Adverse Event|0|||
25241832|NCT01055457|50556406|FG002|Overall Study|Adverse Event|0|||
25241833|NCT01055457|50556407|FG003|Overall Study|Adverse Event|1|||
25241834|NCT01055457|50556408|FG004|Overall Study|Adverse Event|0|||
25241835|NCT01055457|50556409|FG005|Overall Study|Adverse Event|0|||
25241836|NCT01055457|50556410|FG006|Overall Study|Adverse Event|0|||
25241837|NCT01055457|50556411|FG007|Overall Study|Adverse Event|0|||
25241838|NCT01055457|50556412|FG008|Overall Study|Adverse Event|0|||
25241839|NCT01055457|50556413|FG009|Overall Study|Adverse Event|0|||
25241840|NCT01055028|50556437|FG000|Screening|Screen Failure|1|||
25241841|NCT01055028|50556438|FG001|Screening|Screen Failure|1|||
25241842|NCT01055028|50556437|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
25241843|NCT01055028|50556438|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
25241844|NCT01055028|50556437|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
25241845|NCT01055028|50556438|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
25241846|NCT01055028|50556437|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
25241847|NCT01055028|50556438|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
25241848|NCT01050816|50556470|FG000|Overall Study|Lost to Follow-up|2|||
25241849|NCT01050816|50556470|FG000|Overall Study|patient's refusal|2|||
25241850|NCT01054560|50556476|FG000|Overall Study|Death|10|||
25241851|NCT01054560|50556477|FG001|Overall Study|Death|21|||
25241852|NCT01054560|50556476|FG000|Overall Study|Lost to Follow-up|2|||
25241853|NCT01054560|50556477|FG001|Overall Study|Lost to Follow-up|5|||
25241854|NCT01054560|50556476|FG000|Overall Study|Withdrawal by Subject|0|||
25241855|NCT01054560|50556477|FG001|Overall Study|Withdrawal by Subject|2|||
25241856|NCT01054560|50556476|FG000|Overall Study|Physician Decision|1|||
25241857|NCT01054560|50556477|FG001|Overall Study|Physician Decision|0|||
25241858|NCT01054443|50556489|FG000|Overall Study|Withdrawal by Subject|0|||
25241859|NCT01054443|50556490|FG001|Overall Study|Withdrawal by Subject|0|||
25241860|NCT01054443|50556491|FG002|Overall Study|Withdrawal by Subject|0|||
25241861|NCT01054443|50556492|FG003|Overall Study|Withdrawal by Subject|1|||
25241862|NCT01050543|50556507|FG000|Overall Study|Withdrawal by Subject|0|||
25241863|NCT01050543|50556508|FG001|Overall Study|Withdrawal by Subject|2|||
25241864|NCT01050543|50556507|FG000|Overall Study|Protocol Violation|0|||
25241865|NCT01050543|50556508|FG001|Overall Study|Protocol Violation|1|||
25241866|NCT01050543|50556507|FG000|Overall Study|Administrative|4|||
25241867|NCT01050543|50556508|FG001|Overall Study|Administrative|1|||
25241868|NCT01051557|50556521|FG000|Overall Study|Physician Decision|1|||
25241869|NCT01051557|50556522|FG001|Overall Study|Physician Decision|0|||
25241870|NCT01051557|50556523|FG002|Overall Study|Physician Decision|0|||
25241871|NCT01051557|50556524|FG003|Overall Study|Physician Decision|0|||
25241872|NCT01051557|50556525|FG004|Overall Study|Physician Decision|0|||
25241873|NCT01051557|50556526|FG005|Overall Study|Physician Decision|0|||
25241874|NCT01051557|50556527|FG006|Overall Study|Physician Decision|0|||
25241875|NCT01051557|50556521|FG000|Overall Study|disease progression|3|||
25241876|NCT01051557|50556522|FG001|Overall Study|disease progression|3|||
25241877|NCT01051557|50556523|FG002|Overall Study|disease progression|5|||
25241878|NCT01051557|50556524|FG003|Overall Study|disease progression|2|||
25241879|NCT01051557|50556525|FG004|Overall Study|disease progression|4|||
25241880|NCT01051557|50556526|FG005|Overall Study|disease progression|3|||
25241881|NCT01051557|50556527|FG006|Overall Study|disease progression|1|||
25321404|NCT00911807|50637563|FG001|Overall Study|Adverse Event|1|||
25241882|NCT01051557|50556521|FG000|Overall Study|Withdrawal by Subject|0|||
25241883|NCT01051557|50556522|FG001|Overall Study|Withdrawal by Subject|0|||
25241884|NCT01051557|50556523|FG002|Overall Study|Withdrawal by Subject|1|||
25241885|NCT01051557|50556524|FG003|Overall Study|Withdrawal by Subject|0|||
25241886|NCT01051557|50556525|FG004|Overall Study|Withdrawal by Subject|2|||
25241887|NCT01051557|50556526|FG005|Overall Study|Withdrawal by Subject|0|||
25241888|NCT01051557|50556527|FG006|Overall Study|Withdrawal by Subject|1|||
25241889|NCT01051557|50556521|FG000|Overall Study|Adverse Event|0|||
25241890|NCT01051557|50556522|FG001|Overall Study|Adverse Event|0|||
25241891|NCT01051557|50556523|FG002|Overall Study|Adverse Event|0|||
25241892|NCT01051557|50556524|FG003|Overall Study|Adverse Event|1|||
25241893|NCT01051557|50556525|FG004|Overall Study|Adverse Event|1|||
25241894|NCT01051557|50556526|FG005|Overall Study|Adverse Event|3|||
25241895|NCT01051557|50556527|FG006|Overall Study|Adverse Event|4|||
25241896|NCT01054170|50556546|FG000|Overall Study|Protocol Violation|1|||
25241897|NCT01054170|50556547|FG001|Overall Study|Protocol Violation|0|||
25241898|NCT01054170|50556546|FG000|Overall Study|Withdrawal by Subject|3|||
25241899|NCT01054170|50556547|FG001|Overall Study|Withdrawal by Subject|2|||
25241900|NCT01054170|50556546|FG000|Overall Study|Adverse Event|0|||
25241901|NCT01054170|50556547|FG001|Overall Study|Adverse Event|4|||
25241902|NCT01053741|50556555|FG000|2nd Study Intervention|Physician Decision|0|||
25241903|NCT01053741|50556556|FG001|2nd Study Intervention|Physician Decision|1|||
25241904|NCT01052493|50556562|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
25241905|NCT01052493|50556563|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
25241906|NCT01052493|50556564|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
25241907|NCT01052103|50556579|FG000|Overall Study|Adverse Event|10|||
25241908|NCT01052103|50556580|FG001|Overall Study|Adverse Event|6|||
25241909|NCT01052103|50556579|FG000|Overall Study|Entry Criteria Not Met|3|||
25241910|NCT01052103|50556580|FG001|Overall Study|Entry Criteria Not Met|1|||
25241911|NCT01052103|50556579|FG000|Overall Study|Lost to Follow-up|3|||
25241912|NCT01052103|50556580|FG001|Overall Study|Lost to Follow-up|5|||
25241913|NCT01052103|50556579|FG000|Overall Study|Protocol Violation|10|||
25241914|NCT01052103|50556580|FG001|Overall Study|Protocol Violation|4|||
25241915|NCT01052103|50556579|FG000|Overall Study|Scheduling conflict|2|||
25241916|NCT01052103|50556580|FG001|Overall Study|Scheduling conflict|1|||
25241917|NCT01052103|50556579|FG000|Overall Study|Sponsor Decision|2|||
25321405|NCT00911807|50637564|FG002|Overall Study|Adverse Event|5|||
25321406|NCT00911807|50637562|FG000|Overall Study|Death|0|||
25321407|NCT00911807|50637563|FG001|Overall Study|Death|0|||
25321408|NCT00911807|50637564|FG002|Overall Study|Death|1|||
25321409|NCT00911807|50637562|FG000|Overall Study|Protocol Violation|6|||
25321410|NCT00911807|50637563|FG001|Overall Study|Protocol Violation|4|||
25321411|NCT00911807|50637564|FG002|Overall Study|Protocol Violation|9|||
25321412|NCT00911807|50637562|FG000|Overall Study|Withdrawal by Subject|8|||
25321413|NCT00911807|50637563|FG001|Overall Study|Withdrawal by Subject|10|||
25241918|NCT01052103|50556580|FG001|Overall Study|Sponsor Decision|0|||
25241919|NCT01052103|50556579|FG000|Overall Study|Withdrawal by Subject|3|||
25241920|NCT01052103|50556580|FG001|Overall Study|Withdrawal by Subject|6|||
25241921|NCT01052103|50556579|FG000|Overall Study|Perceived Lack of Efficacy|1|||
25241922|NCT01052103|50556580|FG001|Overall Study|Perceived Lack of Efficacy|0|||
25321414|NCT00911807|50637564|FG002|Overall Study|Withdrawal by Subject|7|||
25321415|NCT00911807|50637562|FG000|Overall Study|Organizational reasons|1|||
25321416|NCT00911807|50637563|FG001|Overall Study|Organizational reasons|3|||
25321417|NCT00911807|50637564|FG002|Overall Study|Organizational reasons|1|||
25321418|NCT04287920|50637591|FG000|Overall Study|Lost to Follow-up|1|||
25321419|NCT04287920|50637592|FG001|Overall Study|Lost to Follow-up|1|||
25321420|NCT04287920|50637591|FG000|Overall Study|Withdrawal by Subject|0|||
25321421|NCT04287920|50637592|FG001|Overall Study|Withdrawal by Subject|3|||
25321422|NCT00909779|50637600|FG000|Overall Study|Adverse Event|53|||
25321423|NCT00909779|50637601|FG001|Overall Study|Adverse Event|55|||
25321424|NCT00909779|50637600|FG000|Overall Study|Lack of Efficacy|7|||
25241923|NCT01051986|50556589|FG000|Overall Study|Death|1|||
25241924|NCT01051986|50556590|FG001|Overall Study|Death|0|||
25241925|NCT01051986|50556589|FG000|Overall Study|Withdrawal by Subject|2|||
25241926|NCT01051986|50556590|FG001|Overall Study|Withdrawal by Subject|1|||
25241927|NCT01051986|50556589|FG000|Overall Study|Protocol Violation|2|||
25241928|NCT01051986|50556590|FG001|Overall Study|Protocol Violation|3|||
25241929|NCT00105534|50556602|FG000|Overall Study|Adverse Event|2|||
25241930|NCT00105534|50556603|FG001|Overall Study|Adverse Event|5|||
25241931|NCT00105534|50556602|FG000|Overall Study|Protocol Violation|1|||
25241932|NCT00105534|50556603|FG001|Overall Study|Protocol Violation|4|||
25241933|NCT00105534|50556602|FG000|Overall Study|Withdrawal by Subject|6|||
25241934|NCT00105534|50556603|FG001|Overall Study|Withdrawal by Subject|6|||
25241935|NCT00105534|50556602|FG000|Overall Study|Lost to Follow-up|5|||
25321425|NCT00909779|50637601|FG001|Overall Study|Lack of Efficacy|4|||
25321426|NCT00909779|50637600|FG000|Overall Study|Lost to Follow-up|19|||
25321427|NCT00909779|50637601|FG001|Overall Study|Lost to Follow-up|15|||
25321428|NCT00909779|50637600|FG000|Overall Study|Physician Decision|8|||
25321429|NCT00909779|50637601|FG001|Overall Study|Physician Decision|2|||
25321430|NCT00909779|50637600|FG000|Overall Study|Protocol Violation|2|||
25241936|NCT00105534|50556603|FG001|Overall Study|Lost to Follow-up|1|||
25241937|NCT00105534|50556602|FG000|Overall Study|Lack of Efficacy|7|||
25241938|NCT00105534|50556603|FG001|Overall Study|Lack of Efficacy|15|||
25321431|NCT00909779|50637601|FG001|Overall Study|Protocol Violation|5|||
25321432|NCT00909779|50637600|FG000|Overall Study|Withdrawal by Subject|116|||
25321433|NCT00909779|50637601|FG001|Overall Study|Withdrawal by Subject|80|||
25321434|NCT00909779|50637600|FG000|Overall Study|Site Ceasing Operation|2|||
25321435|NCT00909779|50637601|FG001|Overall Study|Site Ceasing Operation|2|||
25321436|NCT00909779|50637600|FG000|Overall Study|Medical Monitor Decision|1|||
25321437|NCT00909779|50637601|FG001|Overall Study|Medical Monitor Decision|0|||
25321438|NCT00909779|50637600|FG000|Overall Study|Noncompliance|1|||
25241939|NCT00105534|50556602|FG000|Overall Study|Treatment unmasked|1|||
25241940|NCT00105534|50556603|FG001|Overall Study|Treatment unmasked|0|||
25241941|NCT00105534|50556602|FG000|Overall Study|Other Reason|0|||
25321439|NCT00909779|50637601|FG001|Overall Study|Noncompliance|1|||
25321440|NCT00909779|50637600|FG000|Overall Study|Randomized in error|1|||
25321441|NCT00909779|50637601|FG001|Overall Study|Randomized in error|1|||
25321442|NCT00910871|50637609|FG000|Overall Study|Adverse Event|5|||
25321443|NCT00910871|50637609|FG000|Overall Study|Death|12|||
25321444|NCT00910871|50637609|FG000|Overall Study|Lost to Follow-up|8|||
25321445|NCT00910871|50637609|FG000|Overall Study|Protocol Violation|11|||
25321446|NCT00910871|50637609|FG000|Overall Study|Withdrawal by Subject|12|||
25321447|NCT00910871|50637609|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
25321448|NCT00910871|50637609|FG000|Overall Study|Undefined|1|||
25321449|NCT02631941|50637634|FG000|Overall Study|Physician Decision|0|||
25321450|NCT02631941|50637635|FG001|Overall Study|Physician Decision|1|||
25321451|NCT02631941|50637636|FG002|Overall Study|Physician Decision|0|||
25321452|NCT02631941|50637637|FG003|Overall Study|Physician Decision|0|||
25321453|NCT02631941|50637638|FG004|Overall Study|Physician Decision|0|||
25321454|NCT02631941|50637639|FG005|Overall Study|Physician Decision|0|||
25321455|NCT02631941|50637640|FG006|Overall Study|Physician Decision|0|||
25321456|NCT02631941|50637641|FG007|Overall Study|Physician Decision|0|||
25321457|NCT02631941|50637642|FG008|Overall Study|Physician Decision|0|||
25321458|NCT02631941|50637643|FG009|Overall Study|Physician Decision|0|||
25321459|NCT02631941|50637634|FG000|Overall Study|Adverse Event|0|||
25321460|NCT02631941|50637635|FG001|Overall Study|Adverse Event|1|||
25321461|NCT02631941|50637636|FG002|Overall Study|Adverse Event|0|||
25321462|NCT02631941|50637637|FG003|Overall Study|Adverse Event|0|||
25321463|NCT02631941|50637638|FG004|Overall Study|Adverse Event|0|||
25321464|NCT02631941|50637639|FG005|Overall Study|Adverse Event|0|||
25321465|NCT02631941|50637640|FG006|Overall Study|Adverse Event|0|||
25321466|NCT02631941|50637641|FG007|Overall Study|Adverse Event|0|||
25241942|NCT00105534|50556603|FG001|Overall Study|Other Reason|2|||
25241943|NCT00105183|50556612|FG000|Overall Study|Death|19|||
25241944|NCT00105183|50556613|FG001|Overall Study|Death|13|||
25241945|NCT00105183|50556614|FG002|Overall Study|Death|15|||
25241946|NCT00105183|50556612|FG000|Overall Study|Withdrawal by Subject|1|||
25241947|NCT00105183|50556613|FG001|Overall Study|Withdrawal by Subject|1|||
25241948|NCT00105183|50556614|FG002|Overall Study|Withdrawal by Subject|4|||
25241949|NCT00105183|50556612|FG000|Overall Study|Physician Decision|1|||
25241950|NCT00105183|50556613|FG001|Overall Study|Physician Decision|2|||
25241951|NCT00105183|50556614|FG002|Overall Study|Physician Decision|3|||
25241952|NCT00105183|50556612|FG000|Overall Study|Lost to Follow-up|0|||
25241953|NCT00105183|50556613|FG001|Overall Study|Lost to Follow-up|1|||
25241954|NCT00105183|50556614|FG002|Overall Study|Lost to Follow-up|1|||
25241955|NCT00105183|50556612|FG000|Overall Study|Other reason|1|||
25241956|NCT00105183|50556613|FG001|Overall Study|Other reason|2|||
25241957|NCT00105183|50556614|FG002|Overall Study|Other reason|0|||
25241958|NCT01059617|50556626|FG000|Overall Study|Other|7|||
25241959|NCT01059617|50556627|FG001|Overall Study|Other|1|||
25241960|NCT01059617|50556628|FG002|Overall Study|Other|8|||
25241961|NCT01059617|50556629|FG003|Overall Study|Other|6|||
25241962|NCT01059344|50556649|FG000|Overall Study|Adverse Event|12|||
25241963|NCT01059344|50556650|FG001|Overall Study|Adverse Event|30|||
25241964|NCT01059344|50556649|FG000|Overall Study|Withdrawal by Subject|6|||
25241965|NCT01059344|50556650|FG001|Overall Study|Withdrawal by Subject|9|||
25241966|NCT01059344|50556649|FG000|Overall Study|Lost to Follow-up|1|||
25241967|NCT01059344|50556650|FG001|Overall Study|Lost to Follow-up|1|||
25241968|NCT01059344|50556649|FG000|Overall Study|Other|3|||
25241969|NCT01059344|50556650|FG001|Overall Study|Other|6|||
25321467|NCT02631941|50637642|FG008|Overall Study|Adverse Event|0|||
25321468|NCT02631941|50637643|FG009|Overall Study|Adverse Event|0|||
24977064|NCT00379769|50065793|FG000|Main Study|Risk of heart failure|0|||
25241970|NCT01059071|50556658|FG000|Overall Study|Lack of Efficacy|1|||
25241971|NCT01059071|50556659|FG001|Overall Study|Lack of Efficacy|4|||
25241972|NCT01059071|50556660|FG002|Overall Study|Lack of Efficacy|2|||
25241973|NCT01059071|50556661|FG003|Overall Study|Lack of Efficacy|3|||
25241974|NCT01059071|50556658|FG000|Overall Study|Withdrawal by Subject|1|||
25321469|NCT02631941|50637634|FG000|Overall Study|Withdrawal by Subject|0|||
25321470|NCT02631941|50637635|FG001|Overall Study|Withdrawal by Subject|0|||
25321471|NCT02631941|50637636|FG002|Overall Study|Withdrawal by Subject|0|||
25241975|NCT01059071|50556659|FG001|Overall Study|Withdrawal by Subject|0|||
25241976|NCT01059071|50556660|FG002|Overall Study|Withdrawal by Subject|0|||
25241977|NCT01059071|50556661|FG003|Overall Study|Withdrawal by Subject|2|||
25241978|NCT01059071|50556658|FG000|Overall Study|Physician Decision|0|||
25321472|NCT02631941|50637637|FG003|Overall Study|Withdrawal by Subject|0|||
25321473|NCT02631941|50637638|FG004|Overall Study|Withdrawal by Subject|1|||
25321474|NCT02631941|50637639|FG005|Overall Study|Withdrawal by Subject|0|||
25321475|NCT02631941|50637640|FG006|Overall Study|Withdrawal by Subject|0|||
25321476|NCT02631941|50637641|FG007|Overall Study|Withdrawal by Subject|1|||
25321477|NCT02631941|50637642|FG008|Overall Study|Withdrawal by Subject|0|||
25321478|NCT02631941|50637643|FG009|Overall Study|Withdrawal by Subject|0|||
25321479|NCT02631941|50637634|FG000|Overall Study|Lost to Follow-up|0|||
25321480|NCT02631941|50637635|FG001|Overall Study|Lost to Follow-up|0|||
25321481|NCT02631941|50637636|FG002|Overall Study|Lost to Follow-up|0|||
25321482|NCT02631941|50637637|FG003|Overall Study|Lost to Follow-up|0|||
25321483|NCT02631941|50637638|FG004|Overall Study|Lost to Follow-up|0|||
25321484|NCT02631941|50637639|FG005|Overall Study|Lost to Follow-up|0|||
25321485|NCT02631941|50637640|FG006|Overall Study|Lost to Follow-up|0|||
25321486|NCT02631941|50637641|FG007|Overall Study|Lost to Follow-up|0|||
25321487|NCT02631941|50637642|FG008|Overall Study|Lost to Follow-up|1|||
25321488|NCT02631941|50637643|FG009|Overall Study|Lost to Follow-up|0|||
25321489|NCT00908375|50637655|FG000|Overall Study|Withdrawal by Subject|2|||
25321490|NCT00908375|50637656|FG001|Overall Study|Withdrawal by Subject|4|||
25321491|NCT00908375|50637655|FG000|Overall Study|Lost to Follow-up|8|||
25321492|NCT00908375|50637656|FG001|Overall Study|Lost to Follow-up|6|||
25321493|NCT00909389|50637662|FG000|Overall Study|Adverse Event|6|||
25321494|NCT00909389|50637662|FG000|Overall Study|Death|4|||
25321495|NCT00909389|50637662|FG000|Overall Study|Poor Compliance|16|||
25321496|NCT00909389|50637662|FG000|Overall Study|Lost to Follow-up|4|||
25321497|NCT00909389|50637662|FG000|Overall Study|No Information|103|||
25321498|NCT00910715|50637669|FG000|Overall Study|Lost to Follow-up|22|||
25321499|NCT00910715|50637670|FG001|Overall Study|Lost to Follow-up|26|||
25321500|NCT00910715|50637671|FG002|Overall Study|Lost to Follow-up|0|||
25321501|NCT00600483|50637751|FG000|Overall Study|Lost to Follow-up|26|||
25321502|NCT00600483|50637752|FG001|Overall Study|Lost to Follow-up|47|||
25321503|NCT00600483|50637751|FG000|Overall Study|Randomized but not treated|10|||
25321504|NCT00600483|50637752|FG001|Overall Study|Randomized but not treated|0|||
25321505|NCT00600171|50637764|FG000|Overall Study|Adverse Event|0|||
25241979|NCT01059071|50556659|FG001|Overall Study|Physician Decision|0|||
25321506|NCT00600171|50637765|FG001|Overall Study|Adverse Event|1|||
25321507|NCT00600171|50637766|FG002|Overall Study|Adverse Event|0|||
25241980|NCT01059071|50556660|FG002|Overall Study|Physician Decision|0|||
25241981|NCT01059071|50556661|FG003|Overall Study|Physician Decision|1|||
25241982|NCT01058369|50556669|FG000|Overall Study|Adverse Event|1|||
25241983|NCT01058369|50556669|FG000|Overall Study|Early termination study|1|||
25241984|NCT01057433|50556673|FG000|Overall Study|Adverse Event|1|||
25241985|NCT01057394|50556677|FG000|Overall Study|Not eligible|0|||
25241986|NCT01057394|50556678|FG001|Overall Study|Not eligible|2|||
25241987|NCT01058642|50556686|FG000|Treatment Period 1|Adverse Event|0|||
25241988|NCT01058642|50556687|FG001|Treatment Period 1|Adverse Event|1|||
25241989|NCT01058642|50556688|FG002|Treatment Period 1|Adverse Event|1|||
25241990|NCT01058642|50556689|FG003|Treatment Period 1|Adverse Event|0|||
25241991|NCT01058642|50556686|FG000|Treatment Period 1|Physician Decision|0|||
25241992|NCT01058642|50556687|FG001|Treatment Period 1|Physician Decision|0|||
25241993|NCT01058642|50556688|FG002|Treatment Period 1|Physician Decision|1|||
25241994|NCT01058642|50556689|FG003|Treatment Period 1|Physician Decision|0|||
25241995|NCT01058642|50556686|FG000|Treatment Period 1|Withdrawal by Subject|1|||
25241996|NCT01058642|50556687|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25241997|NCT01058642|50556688|FG002|Treatment Period 1|Withdrawal by Subject|0|||
25241998|NCT01058642|50556689|FG003|Treatment Period 1|Withdrawal by Subject|0|||
25241999|NCT01058642|50556686|FG000|Treatment Period 1|Lack of Efficacy|0|||
25242000|NCT01058642|50556687|FG001|Treatment Period 1|Lack of Efficacy|0|||
25242001|NCT01058642|50556688|FG002|Treatment Period 1|Lack of Efficacy|0|||
25242002|NCT01058642|50556689|FG003|Treatment Period 1|Lack of Efficacy|1|||
25242003|NCT01058642|50556686|FG000|Treatment Period 1|Protocol Violation|0|||
25242004|NCT01058642|50556687|FG001|Treatment Period 1|Protocol Violation|0|||
25242005|NCT01058642|50556688|FG002|Treatment Period 1|Protocol Violation|0|||
25321508|NCT00600171|50637767|FG003|Overall Study|Adverse Event|0|||
25242006|NCT01058642|50556689|FG003|Treatment Period 1|Protocol Violation|1|||
25242007|NCT01058642|50556686|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
25242008|NCT01058642|50556687|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
25242009|NCT01058642|50556688|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
25242010|NCT01058642|50556689|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
25242011|NCT01056653|50556700|FG000|Overall Study|Lost to Follow-up|0|||
25321509|NCT00600171|50637768|FG004|Overall Study|Adverse Event|1|||
25321510|NCT00600171|50637769|FG005|Overall Study|Adverse Event|0|||
25321511|NCT00600171|50637764|FG000|Overall Study|Lack of Efficacy|9|||
25242012|NCT01056653|50556701|FG001|Overall Study|Lost to Follow-up|0|||
25242013|NCT01056653|50556702|FG002|Overall Study|Lost to Follow-up|2|||
25242014|NCT01056536|50556714|FG000|Overall Study|Lost to Follow-up|202|||
25242015|NCT01056536|50556715|FG001|Overall Study|Lost to Follow-up|116|||
25242016|NCT01056536|50556716|FG002|Overall Study|Lost to Follow-up|248|||
25242017|NCT01056380|50556726|FG000|Overall Study|Lost to Follow-up|2|||
25321512|NCT00600171|50637765|FG001|Overall Study|Lack of Efficacy|12|||
25321513|NCT00600171|50637766|FG002|Overall Study|Lack of Efficacy|3|||
25321514|NCT00600171|50637767|FG003|Overall Study|Lack of Efficacy|5|||
25321515|NCT00600171|50637768|FG004|Overall Study|Lack of Efficacy|4|||
25321516|NCT00600171|50637769|FG005|Overall Study|Lack of Efficacy|0|||
25321517|NCT00600171|50637764|FG000|Overall Study|Protocol Violation|1|||
25321518|NCT00600171|50637765|FG001|Overall Study|Protocol Violation|2|||
25321519|NCT00600171|50637766|FG002|Overall Study|Protocol Violation|0|||
25321520|NCT00600171|50637767|FG003|Overall Study|Protocol Violation|1|||
25321521|NCT00600171|50637768|FG004|Overall Study|Protocol Violation|0|||
25321522|NCT00600171|50637769|FG005|Overall Study|Protocol Violation|0|||
25321523|NCT00600171|50637764|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
25321524|NCT00600171|50637765|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
25321525|NCT00600171|50637766|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
25321526|NCT00600171|50637767|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
25321527|NCT00600171|50637768|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
25321528|NCT00600171|50637769|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
25321529|NCT00600171|50637764|FG000|Overall Study|Withdrawal by Subject|3|||
25321530|NCT00600171|50637765|FG001|Overall Study|Withdrawal by Subject|0|||
25321531|NCT00600171|50637766|FG002|Overall Study|Withdrawal by Subject|0|||
25321532|NCT00600171|50637767|FG003|Overall Study|Withdrawal by Subject|1|||
25321533|NCT00600171|50637768|FG004|Overall Study|Withdrawal by Subject|1|||
25321534|NCT00600171|50637769|FG005|Overall Study|Withdrawal by Subject|1|||
25321535|NCT00600171|50637764|FG000|Overall Study|Physician Decision|0|||
25321536|NCT00600171|50637765|FG001|Overall Study|Physician Decision|1|||
25321537|NCT00600171|50637766|FG002|Overall Study|Physician Decision|0|||
25321538|NCT00600171|50637767|FG003|Overall Study|Physician Decision|1|||
25321539|NCT00600171|50637768|FG004|Overall Study|Physician Decision|0|||
25321540|NCT00600171|50637769|FG005|Overall Study|Physician Decision|2|||
25321541|NCT00600171|50637764|FG000|Overall Study|Lost to Follow-up|0|||
25321542|NCT00600171|50637765|FG001|Overall Study|Lost to Follow-up|0|||
25321543|NCT00600171|50637766|FG002|Overall Study|Lost to Follow-up|0|||
25321544|NCT00600171|50637767|FG003|Overall Study|Lost to Follow-up|1|||
25321545|NCT00600171|50637768|FG004|Overall Study|Lost to Follow-up|0|||
25321546|NCT00600171|50637769|FG005|Overall Study|Lost to Follow-up|0|||
25321547|NCT04035668|50637788|FG000|Overall Study|Adverse Event|3|||
25321548|NCT04035668|50637789|FG001|Overall Study|Adverse Event|4|||
25321549|NCT04035668|50637790|FG002|Overall Study|Adverse Event|2|||
25321550|NCT04035668|50637788|FG000|Overall Study|Lost to Follow-up|0|||
25321551|NCT04035668|50637789|FG001|Overall Study|Lost to Follow-up|1|||
25321552|NCT04035668|50637790|FG002|Overall Study|Lost to Follow-up|0|||
25321553|NCT04035668|50637788|FG000|Overall Study|Physician Decision|2|||
25321554|NCT04035668|50637789|FG001|Overall Study|Physician Decision|1|||
25242018|NCT01056380|50556727|FG001|Overall Study|Lost to Follow-up|3|||
25242019|NCT01055834|50556737|FG000|Treatment Period I|Adverse Event|1|||
25242020|NCT01055834|50556738|FG001|Treatment Period I|Adverse Event|0|||
25321555|NCT04035668|50637790|FG002|Overall Study|Physician Decision|1|||
25321556|NCT04035668|50637788|FG000|Overall Study|Subject Decision|2|||
25321557|NCT04035668|50637789|FG001|Overall Study|Subject Decision|2|||
25321558|NCT04035668|50637790|FG002|Overall Study|Subject Decision|0|||
25321559|NCT00885495|50637810|FG000|Overall Study|Adverse Event|1|||
25321560|NCT00885495|50637811|FG001|Overall Study|Adverse Event|2|||
25321561|NCT00885495|50637810|FG000|Overall Study|Protocol Violation|0|||
25321562|NCT00885495|50637811|FG001|Overall Study|Protocol Violation|1|||
25321563|NCT00885495|50637810|FG000|Overall Study|Withdrawal by Subject|1|||
25321564|NCT00885495|50637811|FG001|Overall Study|Withdrawal by Subject|0|||
25321565|NCT00885105|50637824|FG000|Overall Study|Withdrawal by Subject|0|||
25321566|NCT00885105|50637825|FG001|Overall Study|Withdrawal by Subject|8|||
25321567|NCT00885105|50637824|FG000|Overall Study|Adverse Event|1|||
25321568|NCT00885105|50637825|FG001|Overall Study|Adverse Event|0|||
25242021|NCT01055639|50556749|FG000|Overall Study|Adverse Event|0|||
25321569|NCT00885105|50637824|FG000|Overall Study|Protocol Violation|0|||
25321570|NCT00885105|50637825|FG001|Overall Study|Protocol Violation|2|||
25321571|NCT03945188|50637833|FG000|Overall Study|Protocol Violation|1|||
25321572|NCT03945188|50637834|FG001|Overall Study|Protocol Violation|0|||
25321573|NCT03945188|50637833|FG000|Overall Study|Disease worsening|79|||
25242022|NCT01055639|50556750|FG001|Overall Study|Adverse Event|1|||
25242023|NCT01055639|50556749|FG000|Overall Study|Lack of Efficacy|0|||
25242024|NCT01055639|50556750|FG001|Overall Study|Lack of Efficacy|1|||
25242025|NCT01055639|50556749|FG000|Overall Study|Lost to Follow-up|8|||
25242026|NCT01055639|50556750|FG001|Overall Study|Lost to Follow-up|11|||
25242027|NCT01055639|50556749|FG000|Overall Study|Protocol Violation|5|||
25242028|NCT01055639|50556750|FG001|Overall Study|Protocol Violation|5|||
25242029|NCT01055639|50556749|FG000|Overall Study|Withdrawal by Subject|8|||
25242030|NCT01055639|50556750|FG001|Overall Study|Withdrawal by Subject|11|||
25242031|NCT01055132|50556765|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
25242032|NCT01055132|50556766|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
25242033|NCT01055132|50556765|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
25242034|NCT01055132|50556766|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
25242035|NCT01054976|50556776|FG000|Overall Study|Adverse Event|16|||
25242036|NCT01054976|50556776|FG000|Overall Study|Uncooperative participations to study|7|||
25242037|NCT01054976|50556776|FG000|Overall Study|Withdrawal by Subject|4|||
25242038|NCT01054976|50556776|FG000|Overall Study|Other|8|||
25242039|NCT01053962|50556785|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
25242040|NCT01053962|50556786|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
25242041|NCT01053962|50556787|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
25242042|NCT01053962|50556788|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
25242043|NCT01053962|50556789|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
25242044|NCT01053962|50556785|FG000|Pretreatment Period|Venipuncture Failure|0|||
25242045|NCT01053962|50556786|FG001|Pretreatment Period|Venipuncture Failure|0|||
25242046|NCT01053962|50556787|FG002|Pretreatment Period|Venipuncture Failure|1|||
25242047|NCT01053962|50556788|FG003|Pretreatment Period|Venipuncture Failure|0|||
25242048|NCT01053962|50556789|FG004|Pretreatment Period|Venipuncture Failure|0|||
25242049|NCT01053962|50556785|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
25242050|NCT01053962|50556786|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
25242051|NCT01053962|50556787|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
25242052|NCT01053962|50556788|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
25242053|NCT01053962|50556789|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
25242054|NCT01053962|50556785|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
25242055|NCT01053962|50556786|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
25242056|NCT01053962|50556787|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
25321574|NCT03945188|50637834|FG001|Overall Study|Disease worsening|73|||
25321575|NCT03945188|50637833|FG000|Overall Study|Physician Decision|2|||
25321576|NCT03945188|50637834|FG001|Overall Study|Physician Decision|2|||
25321577|NCT03945188|50637833|FG000|Overall Study|Lack of Efficacy|7|||
25321578|NCT03945188|50637834|FG001|Overall Study|Lack of Efficacy|4|||
25321579|NCT03945188|50637833|FG000|Overall Study|Pregnancy|2|||
25321580|NCT03945188|50637834|FG001|Overall Study|Pregnancy|0|||
25321581|NCT03945188|50637833|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
25321582|NCT03945188|50637834|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
25321583|NCT03945188|50637833|FG000|Overall Study|Adverse Event|10|||
25321584|NCT03945188|50637834|FG001|Overall Study|Adverse Event|5|||
25321585|NCT03945188|50637833|FG000|Overall Study|Other|2|||
25321586|NCT03945188|50637834|FG001|Overall Study|Other|2|||
25321587|NCT03945188|50637833|FG000|Overall Study|Lost to Follow-up|1|||
25321588|NCT03945188|50637834|FG001|Overall Study|Lost to Follow-up|2|||
25321589|NCT00884949|50637840|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
25321590|NCT00884949|50637840|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
25321591|NCT00884793|50637853|FG000|Overall Study|Withdrawal by Subject|1|||
25321592|NCT00884325|50637859|FG000|Overall Study|Lost to Follow-up|1|||
25321593|NCT00884325|50637860|FG001|Overall Study|Lost to Follow-up|2|||
25321594|NCT00884325|50637859|FG000|Overall Study|Lack of Efficacy|0|||
25321595|NCT00884325|50637860|FG001|Overall Study|Lack of Efficacy|1|||
25321596|NCT00884325|50637859|FG000|Overall Study|Withdrawal by Subject|1|||
25321597|NCT00884325|50637860|FG001|Overall Study|Withdrawal by Subject|1|||
25321598|NCT00884325|50637859|FG000|Overall Study|Not provided|1|||
25321599|NCT00884325|50637860|FG001|Overall Study|Not provided|0|||
25321600|NCT00883779|50637868|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
25321601|NCT00883779|50637869|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
25321602|NCT00883779|50637868|FG000|Primary Study Treatment Phase|Disease progression|75|||
25321603|NCT00883779|50637869|FG001|Primary Study Treatment Phase|Disease progression|59|||
25321604|NCT00883779|50637868|FG000|Primary Study Treatment Phase|Adverse Event|16|||
25321605|NCT00883779|50637869|FG001|Primary Study Treatment Phase|Adverse Event|16|||
25321606|NCT00883779|50637868|FG000|Primary Study Treatment Phase|Death|2|||
25321607|NCT00883779|50637869|FG001|Primary Study Treatment Phase|Death|3|||
25321608|NCT00883779|50637868|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
25321609|NCT00883779|50637869|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
25321610|NCT00883779|50637868|FG000|Primary Study Treatment Phase|Other|3|||
25321611|NCT00883779|50637869|FG001|Primary Study Treatment Phase|Other|0|||
24977065|NCT00379769|50065794|FG001|Main Study|Risk of heart failure|1|||
25321612|NCT00883779|50637868|FG000|Post-Study Treatment Phase|Adverse Event|2|||
25321613|NCT00883779|50637869|FG001|Post-Study Treatment Phase|Adverse Event|3|||
25321614|NCT00883779|50637868|FG000|Post-Study Treatment Phase|Death|1|||
25321615|NCT00883779|50637869|FG001|Post-Study Treatment Phase|Death|3|||
25242057|NCT01053962|50556788|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
25242058|NCT01053962|50556789|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
25242059|NCT01053962|50556785|FG000|Treatment Period|Lack of Efficacy|0|||
25242060|NCT01053962|50556786|FG001|Treatment Period|Lack of Efficacy|0|||
25242061|NCT01053962|50556787|FG002|Treatment Period|Lack of Efficacy|0|||
25242062|NCT01053962|50556788|FG003|Treatment Period|Lack of Efficacy|0|||
25242063|NCT01053962|50556789|FG004|Treatment Period|Lack of Efficacy|1|||
25242064|NCT01053962|50556785|FG000|Treatment Period|Adverse Event|0|||
25242065|NCT01053962|50556786|FG001|Treatment Period|Adverse Event|0|||
25242066|NCT01053962|50556787|FG002|Treatment Period|Adverse Event|0|||
25321616|NCT00883779|50637868|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
25321617|NCT00883779|50637869|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
25321618|NCT00883779|50637868|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
25321619|NCT00883779|50637869|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
25321620|NCT00883779|50637868|FG000|Post-Study Treatment Phase|Disease progression|103|||
25321621|NCT00883779|50637869|FG001|Post-Study Treatment Phase|Disease progression|122|||
25321622|NCT00883779|50637868|FG000|Post-Study Treatment Phase|Other|3|||
25321623|NCT00883779|50637869|FG001|Post-Study Treatment Phase|Other|0|||
25321624|NCT00883779|50637868|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
25321625|NCT00883779|50637869|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
25321626|NCT00883779|50637868|FG000|Off-study Phase|Death|185|||
25321627|NCT00883779|50637869|FG001|Off-study Phase|Death|174|||
25321628|NCT00883779|50637868|FG000|Off-study Phase|Refused treatment|1|||
25321629|NCT00883779|50637869|FG001|Off-study Phase|Refused treatment|1|||
25321630|NCT00883779|50637868|FG000|Off-study Phase|Failure to return|5|||
25321631|NCT00883779|50637869|FG001|Off-study Phase|Failure to return|6|||
25242067|NCT01053962|50556788|FG003|Treatment Period|Adverse Event|0|||
25242068|NCT01053962|50556789|FG004|Treatment Period|Adverse Event|1|||
25242069|NCT01053962|50556785|FG000|Treatment Period|Withdrawal by Subject|0|||
25242070|NCT01053962|50556786|FG001|Treatment Period|Withdrawal by Subject|0|||
25242071|NCT01053962|50556787|FG002|Treatment Period|Withdrawal by Subject|0|||
25242072|NCT01053962|50556788|FG003|Treatment Period|Withdrawal by Subject|0|||
25242073|NCT01053962|50556789|FG004|Treatment Period|Withdrawal by Subject|1|||
25242074|NCT01053962|50556785|FG000|Treatment Period|Noncompliance with protocol|1|||
25242075|NCT01053962|50556786|FG001|Treatment Period|Noncompliance with protocol|0|||
25242076|NCT01053962|50556787|FG002|Treatment Period|Noncompliance with protocol|0|||
25242077|NCT01053962|50556788|FG003|Treatment Period|Noncompliance with protocol|0|||
25242078|NCT01053962|50556789|FG004|Treatment Period|Noncompliance with protocol|0|||
25242079|NCT01053221|50556808|FG000|Overall Study|The study was closed prematurely|5|||
25242080|NCT01053221|50556809|FG001|Overall Study|The study was closed prematurely|9|||
25242081|NCT01052012|50556821|FG000|Overall Study|Not treated|2|||
25242082|NCT01052012|50556822|FG001|Overall Study|Not treated|5|||
25242083|NCT01052012|50556823|FG002|Overall Study|Not treated|0|||
25242084|NCT01052012|50556824|FG003|Overall Study|Not treated|0|||
25242085|NCT01052012|50556825|FG004|Overall Study|Not treated|11|||
25242086|NCT01052012|50556826|FG005|Overall Study|Not treated|8|||
25242087|NCT01052012|50556821|FG000|Overall Study|Adverse Event|1|||
25242088|NCT01052012|50556822|FG001|Overall Study|Adverse Event|0|||
25242089|NCT01052012|50556823|FG002|Overall Study|Adverse Event|0|||
25242090|NCT01052012|50556824|FG003|Overall Study|Adverse Event|1|||
25242091|NCT01052012|50556825|FG004|Overall Study|Adverse Event|0|||
25242092|NCT01052012|50556826|FG005|Overall Study|Adverse Event|0|||
25242093|NCT01052012|50556821|FG000|Overall Study|Lost to Follow-up|0|||
25242094|NCT01052012|50556822|FG001|Overall Study|Lost to Follow-up|0|||
25242095|NCT01052012|50556823|FG002|Overall Study|Lost to Follow-up|0|||
25242096|NCT01052012|50556824|FG003|Overall Study|Lost to Follow-up|0|||
25242097|NCT01052012|50556825|FG004|Overall Study|Lost to Follow-up|1|||
25242098|NCT01052012|50556826|FG005|Overall Study|Lost to Follow-up|0|||
25242099|NCT01052012|50556821|FG000|Overall Study|Withdrawal by Subject|1|||
25242100|NCT01052012|50556822|FG001|Overall Study|Withdrawal by Subject|1|||
25242101|NCT01052012|50556823|FG002|Overall Study|Withdrawal by Subject|0|||
25242102|NCT01052012|50556824|FG003|Overall Study|Withdrawal by Subject|0|||
25242103|NCT01052012|50556825|FG004|Overall Study|Withdrawal by Subject|3|||
25242104|NCT01052012|50556826|FG005|Overall Study|Withdrawal by Subject|1|||
25242105|NCT01052012|50556821|FG000|Overall Study|Physician Decision|0|||
25242106|NCT01052012|50556822|FG001|Overall Study|Physician Decision|0|||
25242107|NCT01052012|50556823|FG002|Overall Study|Physician Decision|0|||
25242108|NCT01052012|50556824|FG003|Overall Study|Physician Decision|0|||
25242109|NCT01052012|50556825|FG004|Overall Study|Physician Decision|0|||
25242110|NCT01052012|50556826|FG005|Overall Study|Physician Decision|1|||
25242111|NCT01052012|50556821|FG000|Overall Study|Other|0|||
25242112|NCT01052012|50556822|FG001|Overall Study|Other|0|||
25321632|NCT00883779|50637868|FG000|Off-study Phase|Other|18|||
25321633|NCT00883779|50637869|FG001|Off-study Phase|Other|21|||
25242113|NCT01052012|50556823|FG002|Overall Study|Other|0|||
25242114|NCT01052012|50556824|FG003|Overall Study|Other|0|||
25242115|NCT01052012|50556825|FG004|Overall Study|Other|1|||
25242116|NCT01052012|50556826|FG005|Overall Study|Other|0|||
25242117|NCT01051817|50556842|FG000|Overall Study|Adverse Event|0|||
25242118|NCT01051817|50556843|FG001|Overall Study|Adverse Event|2|||
25242119|NCT01051817|50556842|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
25321634|NCT04159701|50637877|FG000|Period 1: Treatment Period|Pregnancy|1|||
25242120|NCT01051817|50556843|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
25242121|NCT01051817|50556842|FG000|Overall Study|Withdrawal by Subject|3|||
25242122|NCT01051817|50556843|FG001|Overall Study|Withdrawal by Subject|5|||
25242123|NCT01051817|50556842|FG000|Overall Study|Protocol Violation|0|||
25242124|NCT01051817|50556843|FG001|Overall Study|Protocol Violation|1|||
25242125|NCT01327846|50556853|FG000|Core Phase|Subject decision (vital status: missing)|1|||
25242126|NCT01327846|50556854|FG001|Core Phase|Subject decision (vital status: missing)|2|||
25242127|NCT01327846|50556855|FG002|Core Phase|Subject decision (vital status: missing)|2|||
25242128|NCT01327846|50556856|FG003|Core Phase|Subject decision (vital status: missing)|1|||
25242129|NCT01327846|50556853|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
25242130|NCT01327846|50556854|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
25242131|NCT01327846|50556855|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
25242132|NCT01327846|50556856|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
25242133|NCT01327846|50556853|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
25242134|NCT01327846|50556854|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
25242135|NCT01327846|50556855|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
25242136|NCT01327846|50556856|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
25242137|NCT01327846|50556853|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
25242138|NCT01327846|50556854|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
25242139|NCT01327846|50556855|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
25242140|NCT01327846|50556856|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
25242141|NCT01327846|50556853|FG000|Core Phase|Lost to Follow-up|3|||
25242142|NCT01327846|50556854|FG001|Core Phase|Lost to Follow-up|3|||
25242143|NCT01327846|50556855|FG002|Core Phase|Lost to Follow-up|4|||
25242144|NCT01327846|50556856|FG003|Core Phase|Lost to Follow-up|5|||
25242145|NCT01327846|50556853|FG000|Extension Phase|Study terminated by sponsor|1073|||
25242146|NCT01327846|50556854|FG001|Extension Phase|Study terminated by sponsor|1124|||
25242147|NCT01327846|50556855|FG002|Extension Phase|Study terminated by sponsor|1067|||
25242148|NCT01327846|50556856|FG003|Extension Phase|Study terminated by sponsor|1660|||
25242149|NCT01327846|50556853|FG000|Extension Phase|Withdrawal by Subject|20|||
25242150|NCT01327846|50556854|FG001|Extension Phase|Withdrawal by Subject|13|||
25321635|NCT04159701|50637878|FG001|Period 1: Treatment Period|Pregnancy|0|||
25321636|NCT04159701|50637877|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
25321637|NCT04159701|50637878|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
25321638|NCT04159701|50637877|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
25321639|NCT04159701|50637878|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
25321640|NCT04159701|50637877|FG000|Washout Period|site terminated by sponsor|0|||
25321641|NCT04159701|50637878|FG001|Washout Period|site terminated by sponsor|1|||
25321642|NCT04159701|50637877|FG000|Washout Period|study terminated by sponsor|10|||
25321643|NCT04159701|50637878|FG001|Washout Period|study terminated by sponsor|3|||
25321644|NCT04159701|50637877|FG000|Washout Period|Withdrawal by Subject|1|||
25321645|NCT04159701|50637878|FG001|Washout Period|Withdrawal by Subject|0|||
25321646|NCT04159701|50637877|FG000|Washout Period|Inadvertent Enrollment|1|||
25321647|NCT04159701|50637878|FG001|Washout Period|Inadvertent Enrollment|0|||
25321648|NCT04159701|50637877|FG000|Washout Period|Miscellaneous|1|||
25242151|NCT01327846|50556855|FG002|Extension Phase|Withdrawal by Subject|19|||
25242152|NCT01327846|50556856|FG003|Extension Phase|Withdrawal by Subject|37|||
25242153|NCT01327846|50556853|FG000|Extension Phase|Lost to Follow-up|4|||
25242154|NCT01327846|50556854|FG001|Extension Phase|Lost to Follow-up|3|||
25242155|NCT01327846|50556855|FG002|Extension Phase|Lost to Follow-up|4|||
25242156|NCT01327846|50556856|FG003|Extension Phase|Lost to Follow-up|7|||
25242157|NCT01327846|50556853|FG000|Extension Phase|Technical Problems|2|||
25242158|NCT01327846|50556854|FG001|Extension Phase|Technical Problems|4|||
25242159|NCT01327846|50556855|FG002|Extension Phase|Technical Problems|2|||
25242160|NCT01327846|50556856|FG003|Extension Phase|Technical Problems|2|||
25321649|NCT04159701|50637878|FG001|Washout Period|Miscellaneous|0|||
25321650|NCT04159701|50637877|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
25321651|NCT04159701|50637878|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
25321652|NCT04159701|50637877|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
25242161|NCT01051739|50556869|FG000|Overall Study|Death|3|||
25242162|NCT01051739|50556870|FG001|Overall Study|Death|3|||
25242163|NCT01051739|50556869|FG000|Overall Study|Withdrawal by Subject|25|||
25242164|NCT01051739|50556870|FG001|Overall Study|Withdrawal by Subject|10|||
25242165|NCT01051661|50556882|FG000|Overall Study|Adverse Event|1|||
25242166|NCT01051661|50556883|FG001|Overall Study|Adverse Event|1|||
25242167|NCT01051661|50556884|FG002|Overall Study|Adverse Event|1|||
25242168|NCT01051661|50556885|FG003|Overall Study|Adverse Event|1|||
25242169|NCT01051661|50556886|FG004|Overall Study|Adverse Event|0|||
25242170|NCT01051661|50556887|FG005|Overall Study|Adverse Event|0|||
25242171|NCT01051661|50556882|FG000|Overall Study|Lost to Follow-up|13|||
25242172|NCT01051661|50556883|FG001|Overall Study|Lost to Follow-up|22|||
25242173|NCT01051661|50556884|FG002|Overall Study|Lost to Follow-up|15|||
25242174|NCT01051661|50556885|FG003|Overall Study|Lost to Follow-up|17|||
25242175|NCT01051661|50556886|FG004|Overall Study|Lost to Follow-up|10|||
25242176|NCT01051661|50556887|FG005|Overall Study|Lost to Follow-up|24|||
25242177|NCT01051661|50556882|FG000|Overall Study|Migrated/moved from study area|1|||
25242178|NCT01051661|50556883|FG001|Overall Study|Migrated/moved from study area|6|||
25321653|NCT04159701|50637878|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
25321654|NCT04159701|50637877|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
25321655|NCT04159701|50637878|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
25321656|NCT04159701|50637877|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
25321657|NCT04159701|50637878|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
25321658|NCT04159701|50637877|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
25321659|NCT04159701|50637878|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
25321660|NCT00880269|50637890|FG000|Overall Study|Protocol Violation|1|||
25321661|NCT00880269|50637891|FG001|Overall Study|Protocol Violation|0|||
25321662|NCT00880269|50637890|FG000|Overall Study|Disease Progression|13|||
25321663|NCT00880269|50637891|FG001|Overall Study|Disease Progression|11|||
25321664|NCT00880269|50637890|FG000|Overall Study|New Cancer Therapy|1|||
25321665|NCT00880269|50637891|FG001|Overall Study|New Cancer Therapy|0|||
25321666|NCT00880269|50637890|FG000|Overall Study|Death|4|||
25321667|NCT00880269|50637891|FG001|Overall Study|Death|2|||
25321668|NCT00880269|50637890|FG000|Overall Study|Lost to Follow-up|0|||
25321669|NCT00880269|50637891|FG001|Overall Study|Lost to Follow-up|1|||
25321670|NCT00880269|50637890|FG000|Overall Study|Withdrawal by Subject|3|||
25321671|NCT00880269|50637891|FG001|Overall Study|Withdrawal by Subject|4|||
25321672|NCT00880269|50637890|FG000|Overall Study|Adverse Event|10|||
25321673|NCT00880269|50637891|FG001|Overall Study|Adverse Event|9|||
25321674|NCT00880191|50637899|FG000|Overall Study|Refused further treatment|4|||
25321675|NCT00880191|50637900|FG001|Overall Study|Refused further treatment|1|||
25321676|NCT00880191|50637899|FG000|Overall Study|Adverse Event|8|||
25321677|NCT00880191|50637900|FG001|Overall Study|Adverse Event|6|||
25321678|NCT00880191|50637899|FG000|Overall Study|Hospitalization/efficacy|1|||
25321679|NCT00880191|50637900|FG001|Overall Study|Hospitalization/efficacy|1|||
25321680|NCT00597519|50637906|FG000|Overall Study|Death|1|||
25321681|NCT00879333|50637912|FG000|Overall Study|Adverse Event|94|||
25321682|NCT00879333|50637913|FG001|Overall Study|Adverse Event|34|||
25321683|NCT00879333|50637912|FG000|Overall Study|Abnormal Laboratory Value|1|||
25321684|NCT00879333|50637913|FG001|Overall Study|Abnormal Laboratory Value|0|||
25321685|NCT00879333|50637912|FG000|Overall Study|Withdrawal by Subject|20|||
25242179|NCT01051661|50556884|FG002|Overall Study|Migrated/moved from study area|6|||
25242180|NCT01051661|50556885|FG003|Overall Study|Migrated/moved from study area|8|||
25321686|NCT00879333|50637913|FG001|Overall Study|Withdrawal by Subject|7|||
25321687|NCT00879333|50637912|FG000|Overall Study|Lost to Follow-up|2|||
25321688|NCT00879333|50637913|FG001|Overall Study|Lost to Follow-up|1|||
25321689|NCT00879333|50637912|FG000|Overall Study|Administrative Problems|2|||
25321690|NCT00879333|50637913|FG001|Overall Study|Administrative Problems|0|||
25321691|NCT00879333|50637912|FG000|Overall Study|Death|16|||
25321692|NCT00879333|50637913|FG001|Overall Study|Death|5|||
25321693|NCT00879333|50637912|FG000|Overall Study|Disease Progression|292|||
25321694|NCT00879333|50637913|FG001|Overall Study|Disease Progression|169|||
25321695|NCT00879333|50637912|FG000|Overall Study|Protocol Violation|1|||
25242181|NCT01051661|50556886|FG004|Overall Study|Migrated/moved from study area|7|||
25242182|NCT01051661|50556887|FG005|Overall Study|Migrated/moved from study area|3|||
25242183|NCT01051661|50556882|FG000|Overall Study|Refused blood sampling|0|||
25321696|NCT00879333|50637913|FG001|Overall Study|Protocol Violation|1|||
25321697|NCT03481556|50637925|FG000|Overall Study|Adverse Event|1|||
25321698|NCT03481556|50637926|FG001|Overall Study|Adverse Event|0|||
25321699|NCT03481556|50637927|FG002|Overall Study|Adverse Event|0|||
25242184|NCT01051661|50556883|FG001|Overall Study|Refused blood sampling|0|||
25242185|NCT01051661|50556884|FG002|Overall Study|Refused blood sampling|0|||
25242186|NCT01051661|50556885|FG003|Overall Study|Refused blood sampling|0|||
25242187|NCT01051661|50556886|FG004|Overall Study|Refused blood sampling|0|||
25242188|NCT01051661|50556887|FG005|Overall Study|Refused blood sampling|1|||
25321700|NCT03481556|50637928|FG003|Overall Study|Adverse Event|0|||
25321701|NCT03481556|50637925|FG000|Overall Study|Death|4|||
25242189|NCT01051661|50556882|FG000|Overall Study|Data not reliable|1|||
25242190|NCT01051661|50556883|FG001|Overall Study|Data not reliable|0|||
25242191|NCT01051661|50556884|FG002|Overall Study|Data not reliable|0|||
25242192|NCT01051661|50556885|FG003|Overall Study|Data not reliable|0|||
25321702|NCT03481556|50637926|FG001|Overall Study|Death|2|||
25321703|NCT03481556|50637927|FG002|Overall Study|Death|3|||
25321704|NCT03481556|50637928|FG003|Overall Study|Death|16|||
25321705|NCT03481556|50637925|FG000|Overall Study|Study Terminated by Sponsor|10|||
25321706|NCT03481556|50637926|FG001|Overall Study|Study Terminated by Sponsor|5|||
25321707|NCT03481556|50637927|FG002|Overall Study|Study Terminated by Sponsor|2|||
25321708|NCT03481556|50637928|FG003|Overall Study|Study Terminated by Sponsor|9|||
25321709|NCT00596427|50637946|FG000|Overall Study|Withdrawal by Subject|2|||
25321710|NCT00596427|50637947|FG001|Overall Study|Withdrawal by Subject|2|||
25321711|NCT00596427|50637946|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
25321712|NCT00596427|50637947|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
25242193|NCT01051661|50556886|FG004|Overall Study|Data not reliable|0|||
25242194|NCT01051661|50556887|FG005|Overall Study|Data not reliable|1|||
25242195|NCT01051661|50556882|FG000|Overall Study|Unable to attend visit(s)|2|||
25242196|NCT01051661|50556883|FG001|Overall Study|Unable to attend visit(s)|4|||
25321713|NCT00596427|50637946|FG000|Overall Study|Protocol Violation|1|||
25321714|NCT00596427|50637947|FG001|Overall Study|Protocol Violation|0|||
25321715|NCT02732210|50637956|FG000|Overall Study|Site Closed|0|||
25321716|NCT02732210|50637957|FG001|Overall Study|Site Closed|11|||
25321717|NCT02732210|50637956|FG000|Overall Study|Study Ended|13|||
25321718|NCT02732210|50637957|FG001|Overall Study|Study Ended|13|||
25321719|NCT02732210|50637956|FG000|Overall Study|Withdrawal by Subject|28|||
25321720|NCT02732210|50637957|FG001|Overall Study|Withdrawal by Subject|87|||
25321721|NCT02732210|50637956|FG000|Overall Study|Lost to Follow-up|5|||
25321722|NCT02732210|50637957|FG001|Overall Study|Lost to Follow-up|57|||
25321723|NCT02732210|50637956|FG000|Overall Study|Death|4|||
25321724|NCT02732210|50637957|FG001|Overall Study|Death|15|||
25321725|NCT02732210|50637956|FG000|Overall Study|Other|35|||
25321726|NCT02732210|50637957|FG001|Overall Study|Other|103|||
25321727|NCT02732210|50637956|FG000|Overall Study|Missing|0|||
25321728|NCT02732210|50637957|FG001|Overall Study|Missing|8|||
25321729|NCT00595959|50637963|FG000|Overall Study|Withdrawal by Subject|1|||
25242197|NCT01051661|50556884|FG002|Overall Study|Unable to attend visit(s)|2|||
25242198|NCT01051661|50556885|FG003|Overall Study|Unable to attend visit(s)|1|||
25242199|NCT01051661|50556886|FG004|Overall Study|Unable to attend visit(s)|3|||
25242200|NCT01051661|50556887|FG005|Overall Study|Unable to attend visit(s)|2|||
25242201|NCT01051661|50556882|FG000|Overall Study|Consent not received from both parents|0|||
25242202|NCT01051661|50556883|FG001|Overall Study|Consent not received from both parents|0|||
25242203|NCT01051661|50556884|FG002|Overall Study|Consent not received from both parents|0|||
25242204|NCT01051661|50556885|FG003|Overall Study|Consent not received from both parents|0|||
25242205|NCT01051661|50556886|FG004|Overall Study|Consent not received from both parents|0|||
25242206|NCT01051661|50556887|FG005|Overall Study|Consent not received from both parents|1|||
25242207|NCT01051661|50556882|FG000|Overall Study|Failure to comply with protocol|0|||
25242208|NCT01051661|50556883|FG001|Overall Study|Failure to comply with protocol|0|||
25242209|NCT01051661|50556884|FG002|Overall Study|Failure to comply with protocol|2|||
25242210|NCT01051661|50556885|FG003|Overall Study|Failure to comply with protocol|0|||
25242211|NCT01051661|50556886|FG004|Overall Study|Failure to comply with protocol|0|||
25242212|NCT01051661|50556887|FG005|Overall Study|Failure to comply with protocol|0|||
25242213|NCT01051661|50556882|FG000|Overall Study|Subject lost legal representation|0|||
25242214|NCT01051661|50556883|FG001|Overall Study|Subject lost legal representation|0|||
25242215|NCT01051661|50556884|FG002|Overall Study|Subject lost legal representation|0|||
25242216|NCT01051661|50556885|FG003|Overall Study|Subject lost legal representation|0|||
25242217|NCT01051661|50556886|FG004|Overall Study|Subject lost legal representation|1|||
25242218|NCT01051661|50556887|FG005|Overall Study|Subject lost legal representation|0|||
25242219|NCT01051661|50556882|FG000|Overall Study|Protocol Violation|0|||
25242220|NCT01051661|50556883|FG001|Overall Study|Protocol Violation|0|||
25242221|NCT01051661|50556884|FG002|Overall Study|Protocol Violation|0|||
25242222|NCT01051661|50556885|FG003|Overall Study|Protocol Violation|1|||
25242223|NCT01051661|50556886|FG004|Overall Study|Protocol Violation|2|||
25242224|NCT01051661|50556887|FG005|Overall Study|Protocol Violation|1|||
25242225|NCT01051661|50556882|FG000|Overall Study|Withdrawal by Subject|16|||
25242226|NCT01051661|50556883|FG001|Overall Study|Withdrawal by Subject|30|||
25242227|NCT01051661|50556884|FG002|Overall Study|Withdrawal by Subject|13|||
25242228|NCT01051661|50556885|FG003|Overall Study|Withdrawal by Subject|28|||
25242229|NCT01051661|50556886|FG004|Overall Study|Withdrawal by Subject|12|||
25321730|NCT00595959|50637963|FG000|Overall Study|Lost to Follow-up|1|||
25321731|NCT00436748|50638001|FG000|Overall Study|Ineligibility Determined|1|||
25321732|NCT00436748|50638002|FG001|Overall Study|Ineligibility Determined|1|||
25321733|NCT00436748|50638001|FG000|Overall Study|Adverse Event|0|||
25321734|NCT00436748|50638002|FG001|Overall Study|Adverse Event|2|||
25321735|NCT00436748|50638001|FG000|Overall Study|Consent Withdrawn|1|||
25321736|NCT00436748|50638002|FG001|Overall Study|Consent Withdrawn|4|||
25242230|NCT01051661|50556887|FG005|Overall Study|Withdrawal by Subject|34|||
25242231|NCT01051466|50556924|FG000|Overall Study|Adverse Event|1|||
25242232|NCT01051466|50556925|FG001|Overall Study|Adverse Event|0|||
25321737|NCT00436748|50638001|FG000|Overall Study|Administrative Decision|1|||
25321738|NCT00436748|50638002|FG001|Overall Study|Administrative Decision|0|||
25321739|NCT00436748|50638001|FG000|Overall Study|Lost to Follow-up|0|||
25321740|NCT00436748|50638002|FG001|Overall Study|Lost to Follow-up|1|||
25242233|NCT01051466|50556924|FG000|Overall Study|Lost to Follow-up|1|||
25242234|NCT01051466|50556925|FG001|Overall Study|Lost to Follow-up|1|||
25242235|NCT01051466|50556924|FG000|Overall Study|Withdrawal by Subject|5|||
25242236|NCT01051466|50556925|FG001|Overall Study|Withdrawal by Subject|1|||
25242237|NCT01051466|50556924|FG000|Overall Study|Entry Criteria Not Met|0|||
25242238|NCT01051466|50556925|FG001|Overall Study|Entry Criteria Not Met|3|||
25242239|NCT01051466|50556924|FG000|Overall Study|Physician Decision|1|||
25242240|NCT01051466|50556925|FG001|Overall Study|Physician Decision|0|||
25242241|NCT01051349|50556939|FG000|Overall Study|Adverse Event|88|||
25242242|NCT01051349|50556939|FG000|Overall Study|Consent Withdrawn|54|||
25242243|NCT01051349|50556939|FG000|Overall Study|Investigator Decision|6|||
25242244|NCT01051349|50556939|FG000|Overall Study|Lost to Follow-up|6|||
25242245|NCT01051349|50556939|FG000|Overall Study|Subject non-compliance|7|||
25321741|NCT00436748|50638001|FG000|Overall Study|Protocol-specified Criteria|5|||
25321742|NCT00436748|50638002|FG001|Overall Study|Protocol-specified Criteria|4|||
25321743|NCT00436748|50638001|FG000|Overall Study|Other|3|||
25242246|NCT01051349|50556939|FG000|Overall Study|Reason not Specified|12|||
25242247|NCT01050998|50556951|FG000|Overall Study|Adverse Event|1|||
25242248|NCT01050998|50556952|FG001|Overall Study|Adverse Event|0|||
25242249|NCT01050998|50556953|FG002|Overall Study|Adverse Event|1|||
25242250|NCT01050998|50556954|FG003|Overall Study|Adverse Event|0|||
25242251|NCT01050998|50556955|FG004|Overall Study|Adverse Event|2|||
25242252|NCT01050998|50556951|FG000|Overall Study|Withdrawal by Subject|0|||
25242253|NCT01050998|50556952|FG001|Overall Study|Withdrawal by Subject|0|||
25242254|NCT01050998|50556953|FG002|Overall Study|Withdrawal by Subject|0|||
25242255|NCT01050998|50556954|FG003|Overall Study|Withdrawal by Subject|1|||
25242256|NCT01050998|50556955|FG004|Overall Study|Withdrawal by Subject|3|||
25242257|NCT01050998|50556951|FG000|Overall Study|Other|3|||
25242258|NCT01050998|50556952|FG001|Overall Study|Other|2|||
25242259|NCT01050998|50556953|FG002|Overall Study|Other|1|||
25242260|NCT01050998|50556954|FG003|Overall Study|Other|1|||
25242261|NCT01050998|50556955|FG004|Overall Study|Other|5|||
25242262|NCT01050998|50556951|FG000|Overall Study|Data integrity issues|0|||
25242263|NCT01050998|50556952|FG001|Overall Study|Data integrity issues|0|||
25242264|NCT01050998|50556953|FG002|Overall Study|Data integrity issues|1|||
25242265|NCT01050998|50556954|FG003|Overall Study|Data integrity issues|1|||
25242266|NCT01050998|50556955|FG004|Overall Study|Data integrity issues|4|||
25242267|NCT00106028|50556973|FG000|Overall Study|Adverse Event|3|||
25242268|NCT00106028|50556974|FG001|Overall Study|Adverse Event|2|||
25242269|NCT00106028|50556973|FG000|Overall Study|Protocol Violation|1|||
25242270|NCT00106028|50556974|FG001|Overall Study|Protocol Violation|1|||
25242271|NCT00106028|50556973|FG000|Overall Study|Withdrawal by Subject|2|||
25242272|NCT00106028|50556974|FG001|Overall Study|Withdrawal by Subject|8|||
25242273|NCT00106028|50556973|FG000|Overall Study|Lost to Follow-up|0|||
25242274|NCT00106028|50556974|FG001|Overall Study|Lost to Follow-up|1|||
25242275|NCT01050764|50556982|FG000|Overall Study|Death, before HSCT|1|||
25242276|NCT01050764|50556982|FG000|Overall Study|Donor mobilization failure, death|1|||
25242277|NCT01050764|50556982|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
25242278|NCT01050569|50556989|FG000|Overall Study|Lost to Follow-up|20|||
25242279|NCT01050569|50556990|FG001|Overall Study|Lost to Follow-up|14|||
25242280|NCT01050569|50556991|FG002|Overall Study|Lost to Follow-up|16|||
25242281|NCT01050569|50556989|FG000|Overall Study|Withdrawal by Subject|9|||
25242282|NCT01050569|50556990|FG001|Overall Study|Withdrawal by Subject|3|||
25242283|NCT01050569|50556991|FG002|Overall Study|Withdrawal by Subject|11|||
25242284|NCT01050569|50556989|FG000|Overall Study|Lack of Efficacy|5|||
25242285|NCT01050569|50556990|FG001|Overall Study|Lack of Efficacy|4|||
25242286|NCT01050569|50556991|FG002|Overall Study|Lack of Efficacy|3|||
25242287|NCT01050569|50556989|FG000|Overall Study|Adverse Event|1|||
25242288|NCT01050569|50556990|FG001|Overall Study|Adverse Event|0|||
25242289|NCT01050569|50556991|FG002|Overall Study|Adverse Event|0|||
25242290|NCT01050569|50556989|FG000|Overall Study|Physician Decision|3|||
25242291|NCT01050569|50556990|FG001|Overall Study|Physician Decision|3|||
25242292|NCT01050569|50556991|FG002|Overall Study|Physician Decision|3|||
25242293|NCT01050530|50557005|FG000|Overall Study|Adverse Event|6|||
25242294|NCT01050530|50557006|FG001|Overall Study|Adverse Event|3|||
25242295|NCT01050530|50557005|FG000|Overall Study|Lack of Efficacy|1|||
25242296|NCT01050530|50557006|FG001|Overall Study|Lack of Efficacy|4|||
25242297|NCT01050530|50557005|FG000|Overall Study|Withdrawal by Subject|0|||
25321744|NCT00436748|50638002|FG001|Overall Study|Other|0|||
25242298|NCT01050530|50557006|FG001|Overall Study|Withdrawal by Subject|3|||
25242299|NCT01050530|50557005|FG000|Overall Study|Protocol Violation|1|||
25242300|NCT01050530|50557006|FG001|Overall Study|Protocol Violation|0|||
25321745|NCT03342404|50638010|FG000|Overall Study|Withdrawal by Subject|9|||
25242301|NCT01050257|50557015|FG000|Overall Study|Adverse Event|4|||
25242302|NCT01050257|50557016|FG001|Overall Study|Adverse Event|4|||
25321746|NCT03342404|50638011|FG001|Overall Study|Withdrawal by Subject|10|||
25242303|NCT01050257|50557017|FG002|Overall Study|Adverse Event|2|||
25242304|NCT01050257|50557015|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
25242305|NCT01050257|50557016|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
25242306|NCT01050257|50557017|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
25242307|NCT01050257|50557015|FG000|Overall Study|Withdrawal by Subject|0|||
25242308|NCT01050257|50557016|FG001|Overall Study|Withdrawal by Subject|3|||
25242309|NCT01050257|50557017|FG002|Overall Study|Withdrawal by Subject|0|||
25242310|NCT01050257|50557015|FG000|Overall Study|No reason specified|0|||
25242311|NCT01050257|50557016|FG001|Overall Study|No reason specified|0|||
25321747|NCT03342404|50638010|FG000|Overall Study|Lack of Efficacy|1|||
25321748|NCT03342404|50638011|FG001|Overall Study|Lack of Efficacy|17|||
25321749|NCT03342404|50638010|FG000|Overall Study|Adverse Event|3|||
25321750|NCT03342404|50638011|FG001|Overall Study|Adverse Event|4|||
25321751|NCT03342404|50638010|FG000|Overall Study|Noncompliance with study drug|1|||
25321752|NCT03342404|50638011|FG001|Overall Study|Noncompliance with study drug|0|||
25321753|NCT03342404|50638010|FG000|Overall Study|Other reasons|1|||
25321754|NCT03342404|50638011|FG001|Overall Study|Other reasons|0|||
25321755|NCT02703272|50638021|FG000|Overall Study|Death|4|||
25321756|NCT02703272|50638022|FG001|Overall Study|Death|9|||
25321757|NCT02703272|50638023|FG002|Overall Study|Death|19|||
25321758|NCT02703272|50638024|FG003|Overall Study|Death|10|||
25321759|NCT02703272|50638021|FG000|Overall Study|Withdrawal by Subject|0|||
25321760|NCT02703272|50638022|FG001|Overall Study|Withdrawal by Subject|0|||
25321761|NCT02703272|50638023|FG002|Overall Study|Withdrawal by Subject|4|||
25321762|NCT02703272|50638024|FG003|Overall Study|Withdrawal by Subject|2|||
25321763|NCT02703272|50638021|FG000|Overall Study|Study Terminated by Sponsor|6|||
25321764|NCT02703272|50638022|FG001|Overall Study|Study Terminated by Sponsor|1|||
25321765|NCT02703272|50638023|FG002|Overall Study|Study Terminated by Sponsor|12|||
25321766|NCT02703272|50638024|FG003|Overall Study|Study Terminated by Sponsor|4|||
25321767|NCT02703272|50638021|FG000|Overall Study|Other|1|||
25321768|NCT02703272|50638022|FG001|Overall Study|Other|0|||
25321769|NCT02703272|50638023|FG002|Overall Study|Other|0|||
25321770|NCT02703272|50638024|FG003|Overall Study|Other|0|||
25321771|NCT02568215|50638064|FG000|Overall Study|Death|1|||
25321772|NCT02568215|50638065|FG001|Overall Study|Death|2|||
25321773|NCT02568215|50638066|FG002|Overall Study|Death|0|||
25321774|NCT02568215|50638064|FG000|Overall Study|Physician Decision|2|||
25321775|NCT02568215|50638065|FG001|Overall Study|Physician Decision|2|||
25321776|NCT02568215|50638066|FG002|Overall Study|Physician Decision|2|||
25321777|NCT02568215|50638064|FG000|Overall Study|Lost to Follow-up|29|||
25321778|NCT02568215|50638065|FG001|Overall Study|Lost to Follow-up|32|||
25321779|NCT02568215|50638066|FG002|Overall Study|Lost to Follow-up|41|||
25321780|NCT02568215|50638064|FG000|Overall Study|Withdrawal by Subject|21|||
25321781|NCT02568215|50638065|FG001|Overall Study|Withdrawal by Subject|19|||
25321782|NCT02568215|50638066|FG002|Overall Study|Withdrawal by Subject|22|||
25321783|NCT02568215|50638064|FG000|Overall Study|Protocol Violation|1|||
25321784|NCT02568215|50638065|FG001|Overall Study|Protocol Violation|1|||
25321785|NCT02568215|50638066|FG002|Overall Study|Protocol Violation|0|||
25321786|NCT02568215|50638064|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
25321787|NCT02568215|50638065|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
25242312|NCT01050257|50557017|FG002|Overall Study|No reason specified|2|||
25242313|NCT01050257|50557015|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
25242314|NCT01050257|50557016|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
25242315|NCT01050257|50557017|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
25242316|NCT01050257|50557015|FG000|Overall Study|Violation criteria|0|||
25242317|NCT01050257|50557016|FG001|Overall Study|Violation criteria|1|||
25242318|NCT01050257|50557017|FG002|Overall Study|Violation criteria|0|||
25242319|NCT01050257|50557015|FG000|Overall Study|Failure to return|0|||
25242320|NCT01050257|50557016|FG001|Overall Study|Failure to return|2|||
25242321|NCT01050257|50557017|FG002|Overall Study|Failure to return|0|||
25242322|NCT01050257|50557015|FG000|Overall Study|Death|0|||
25242323|NCT01050257|50557016|FG001|Overall Study|Death|0|||
25242324|NCT01050257|50557017|FG002|Overall Study|Death|1|||
25242325|NCT01050218|50557025|FG000|Overall Study|Adverse Event|37|||
25242326|NCT01050218|50557025|FG000|Overall Study|Lack of Efficacy|8|||
25242327|NCT01050218|50557025|FG000|Overall Study|Protocol Violation|3|||
25321788|NCT02568215|50638066|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
25321789|NCT02568215|50638064|FG000|Overall Study|Other|0|||
25321790|NCT02568215|50638065|FG001|Overall Study|Other|1|||
25321791|NCT02568215|50638066|FG002|Overall Study|Other|4|||
25321792|NCT00908141|50638103|FG000|Overall Study|Withdrawal by Subject|0|||
25321793|NCT00908141|50638104|FG001|Overall Study|Withdrawal by Subject|1|||
25321794|NCT00906347|50638112|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
25321795|NCT00906347|50638113|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
25077670|NCT02493764|50185492|FG001|Overall Study|Withdrawal by Subject|7|||
25242328|NCT01050218|50557025|FG000|Overall Study|Withdrawal by Subject|18|||
25242329|NCT01050218|50557025|FG000|Overall Study|Discontinued by sponsor|18|||
25242330|NCT01050218|50557025|FG000|Overall Study|Compliance|2|||
25242331|NCT01050218|50557025|FG000|Overall Study|Failed to return|7|||
25321796|NCT00906347|50638112|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
25321797|NCT00906347|50638113|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
25321798|NCT00906347|50638112|FG000|Received Study Drug|Refused study drug|1|||
25321799|NCT00906347|50638113|FG001|Received Study Drug|Refused study drug|0|||
25321800|NCT00906347|50638112|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
25321801|NCT00906347|50638113|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
25321802|NCT00906035|50638122|FG000|Overall Study|Withdrawal by Subject|2|||
25321803|NCT00906035|50638123|FG001|Overall Study|Withdrawal by Subject|3|||
25242332|NCT01050218|50557025|FG000|Overall Study|Serious Adverse Event|1|||
25242333|NCT01050218|50557025|FG000|Overall Study|Family emergency|1|||
25242334|NCT01050062|50557031|FG000|Overall Study|Adverse Event|75|||
25242335|NCT01050062|50557032|FG001|Overall Study|Adverse Event|22|||
25242336|NCT01050062|50557031|FG000|Overall Study|Lost to Follow-up|83|||
25242337|NCT01050062|50557032|FG001|Overall Study|Lost to Follow-up|35|||
25242338|NCT01050062|50557031|FG000|Overall Study|Lack of Efficacy|22|||
25242339|NCT01050062|50557032|FG001|Overall Study|Lack of Efficacy|35|||
25242340|NCT01050062|50557031|FG000|Overall Study|Physician Decision|74|||
25321804|NCT00906035|50638124|FG002|Overall Study|Withdrawal by Subject|0|||
25321805|NCT00905489|50638132|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
25321806|NCT00905489|50638132|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
25321807|NCT00905489|50638132|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
25321808|NCT02704754|50638143|FG000|Overall Study|Lost to Follow-up|1|||
25321809|NCT02704754|50638144|FG001|Overall Study|Lost to Follow-up|1|||
25321810|NCT02704754|50638143|FG000|Overall Study|Lack of Efficacy|1|||
25321811|NCT02704754|50638144|FG001|Overall Study|Lack of Efficacy|0|||
25321812|NCT02704754|50638143|FG000|Overall Study|Withdrawal by Subject|1|||
25321813|NCT02704754|50638144|FG001|Overall Study|Withdrawal by Subject|0|||
25321814|NCT03170882|50638152|FG000|Overall Study|Death|17|||
25321815|NCT03170882|50638153|FG001|Overall Study|Death|29|||
25321816|NCT03170882|50638152|FG000|Overall Study|Lost to Follow-up|0|||
25321817|NCT03170882|50638153|FG001|Overall Study|Lost to Follow-up|1|||
25321818|NCT03170882|50638152|FG000|Overall Study|Withdrawal by Subject|4|||
25321819|NCT03170882|50638153|FG001|Overall Study|Withdrawal by Subject|7|||
25321820|NCT03170882|50638152|FG000|Overall Study|Reason not Specified|28|||
25321821|NCT03170882|50638153|FG001|Overall Study|Reason not Specified|36|||
25321822|NCT00907517|50638164|FG000|Overall Study|Progressive Disease|3|||
25321823|NCT00907517|50638165|FG001|Overall Study|Progressive Disease|3|||
25321824|NCT00907517|50638166|FG002|Overall Study|Progressive Disease|4|||
25321825|NCT00907517|50638167|FG003|Overall Study|Progressive Disease|4|||
25321826|NCT00907517|50638168|FG004|Overall Study|Progressive Disease|4|||
25321827|NCT00907517|50638164|FG000|Overall Study|Symptomatic Deterioration|0|||
25321828|NCT00907517|50638165|FG001|Overall Study|Symptomatic Deterioration|0|||
25321829|NCT00907517|50638166|FG002|Overall Study|Symptomatic Deterioration|0|||
25321830|NCT00907517|50638167|FG003|Overall Study|Symptomatic Deterioration|0|||
25321831|NCT00907517|50638168|FG004|Overall Study|Symptomatic Deterioration|1|||
25321832|NCT00905255|50638182|FG000|Overall Study|Adverse Event|7|||
25321833|NCT00905255|50638183|FG001|Overall Study|Adverse Event|5|||
25321834|NCT00905255|50638182|FG000|Overall Study|Withdrawal by Subject|5|||
25321835|NCT00905255|50638183|FG001|Overall Study|Withdrawal by Subject|4|||
25321836|NCT00905255|50638182|FG000|Overall Study|Familial and Personal Reasons|1|||
25321837|NCT00905255|50638183|FG001|Overall Study|Familial and Personal Reasons|0|||
25321838|NCT00905021|50638190|FG000|Overall Study|Adverse Event|2|||
25321839|NCT00906971|50638197|FG000|Overall Study|Withdrawal by Subject|8|||
25321840|NCT00906971|50638198|FG001|Overall Study|Withdrawal by Subject|2|||
25321841|NCT00906971|50638197|FG000|Overall Study|Lost to Follow-up|0|||
25321842|NCT00906971|50638198|FG001|Overall Study|Lost to Follow-up|1|||
25321843|NCT00903929|50638204|FG000|Overall Study|Withdrawal by Subject|0|||
25321844|NCT00903929|50638205|FG001|Overall Study|Withdrawal by Subject|0|||
25321845|NCT00903929|50638206|FG002|Overall Study|Withdrawal by Subject|1|||
25321846|NCT00903929|50638207|FG003|Overall Study|Withdrawal by Subject|2|||
25321847|NCT00903929|50638204|FG000|Overall Study|Adverse Event|0|||
25321848|NCT00903929|50638205|FG001|Overall Study|Adverse Event|0|||
25321849|NCT00903929|50638206|FG002|Overall Study|Adverse Event|0|||
25321850|NCT00903929|50638207|FG003|Overall Study|Adverse Event|1|||
25321851|NCT00903695|50638214|FG000|Overall Study|medical exclusion after 1st testing|1|||
25321852|NCT00903695|50638215|FG001|Overall Study|medical exclusion after 1st testing|0|||
25321853|NCT00903695|50638214|FG000|Overall Study|lung cancer|1|||
25321854|NCT00903695|50638215|FG001|Overall Study|lung cancer|0|||
25321855|NCT02432274|50638231|FG000|Overall Study|Radiological Disease Progression|3|||
25321856|NCT02432274|50638232|FG001|Overall Study|Radiological Disease Progression|4|||
25321857|NCT02432274|50638233|FG002|Overall Study|Radiological Disease Progression|7|||
25321858|NCT02432274|50638234|FG003|Overall Study|Radiological Disease Progression|0|||
25321859|NCT02432274|50638235|FG004|Overall Study|Radiological Disease Progression|24|||
25321860|NCT02432274|50638236|FG005|Overall Study|Radiological Disease Progression|6|||
25321861|NCT02432274|50638237|FG006|Overall Study|Radiological Disease Progression|11|||
25321862|NCT02432274|50638238|FG007|Overall Study|Radiological Disease Progression|9|||
25321863|NCT02432274|50638231|FG000|Overall Study|Clinical Disease Progression|0|||
25321864|NCT02432274|50638232|FG001|Overall Study|Clinical Disease Progression|4|||
25321865|NCT02432274|50638233|FG002|Overall Study|Clinical Disease Progression|1|||
25321866|NCT02432274|50638234|FG003|Overall Study|Clinical Disease Progression|0|||
25321867|NCT02432274|50638235|FG004|Overall Study|Clinical Disease Progression|1|||
25321868|NCT02432274|50638236|FG005|Overall Study|Clinical Disease Progression|0|||
25321869|NCT02432274|50638237|FG006|Overall Study|Clinical Disease Progression|0|||
25321870|NCT02432274|50638238|FG007|Overall Study|Clinical Disease Progression|1|||
25321871|NCT02432274|50638231|FG000|Overall Study|Adverse Event|0|||
25321872|NCT02432274|50638232|FG001|Overall Study|Adverse Event|0|||
25321873|NCT02432274|50638233|FG002|Overall Study|Adverse Event|1|||
25321874|NCT02432274|50638234|FG003|Overall Study|Adverse Event|0|||
25321875|NCT02432274|50638235|FG004|Overall Study|Adverse Event|1|||
25321876|NCT02432274|50638236|FG005|Overall Study|Adverse Event|0|||
25321877|NCT02432274|50638237|FG006|Overall Study|Adverse Event|2|||
25321878|NCT02432274|50638238|FG007|Overall Study|Adverse Event|0|||
25321879|NCT02432274|50638231|FG000|Overall Study|Withdrawal by Subject|0|||
25321880|NCT02432274|50638232|FG001|Overall Study|Withdrawal by Subject|0|||
25321881|NCT02432274|50638233|FG002|Overall Study|Withdrawal by Subject|0|||
25321882|NCT02432274|50638234|FG003|Overall Study|Withdrawal by Subject|0|||
25321883|NCT02432274|50638235|FG004|Overall Study|Withdrawal by Subject|2|||
25321884|NCT02432274|50638236|FG005|Overall Study|Withdrawal by Subject|0|||
25321885|NCT02432274|50638237|FG006|Overall Study|Withdrawal by Subject|1|||
25321886|NCT02432274|50638238|FG007|Overall Study|Withdrawal by Subject|2|||
25321887|NCT02432274|50638231|FG000|Overall Study|Participant Choice|0|||
25321888|NCT02432274|50638232|FG001|Overall Study|Participant Choice|0|||
25321889|NCT02432274|50638233|FG002|Overall Study|Participant Choice|1|||
25321890|NCT02432274|50638234|FG003|Overall Study|Participant Choice|0|||
25321891|NCT02432274|50638235|FG004|Overall Study|Participant Choice|0|||
25321892|NCT02432274|50638236|FG005|Overall Study|Participant Choice|0|||
25242341|NCT01050062|50557032|FG001|Overall Study|Physician Decision|9|||
25242342|NCT01050062|50557031|FG000|Overall Study|Others|17|||
25242343|NCT01050062|50557032|FG001|Overall Study|Others|11|||
25242344|NCT00105989|50557050|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
25242345|NCT00105989|50557051|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
25242346|NCT00105989|50557050|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
25242347|NCT00105989|50557051|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
25242348|NCT00105989|50557050|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
25242349|NCT00105989|50557051|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
25242350|NCT00105989|50557050|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
25242351|NCT00105989|50557051|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
25242352|NCT00105989|50557050|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
25242353|NCT00105989|50557051|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
25242354|NCT00105989|50557050|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
25242355|NCT00105989|50557051|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
25242356|NCT00105989|50557050|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
25242357|NCT00105989|50557051|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
25242358|NCT00105989|50557050|FG000|Acute - Open Label: Week 0-10|Death|1|||
25242359|NCT00105989|50557051|FG001|Acute - Open Label: Week 0-10|Death|0|||
25242360|NCT00105989|50557050|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
25242361|NCT00105989|50557051|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
25242362|NCT00105989|50557050|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
25242363|NCT00105989|50557051|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
25242364|NCT00105989|50557050|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
25242365|NCT00105989|50557051|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
25242366|NCT00105989|50557050|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
25242367|NCT00105989|50557051|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
25242368|NCT00105989|50557050|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
25242369|NCT00105989|50557051|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
25321893|NCT02432274|50638237|FG006|Overall Study|Participant Choice|1|||
25321894|NCT02432274|50638238|FG007|Overall Study|Participant Choice|0|||
25242370|NCT00105989|50557050|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
25321895|NCT02432274|50638231|FG000|Overall Study|Other than specified|0|||
25321896|NCT02432274|50638232|FG001|Overall Study|Other than specified|1|||
25321897|NCT02432274|50638233|FG002|Overall Study|Other than specified|0|||
25321898|NCT02432274|50638234|FG003|Overall Study|Other than specified|0|||
25242371|NCT00105989|50557051|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
25242372|NCT00105989|50557050|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
25242373|NCT00105989|50557051|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
25242374|NCT00105989|50557050|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
25242375|NCT00105989|50557051|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
25242376|NCT00105989|50557050|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
25242377|NCT00105989|50557051|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
25242378|NCT00105989|50557050|FG000|Continuation - Open Label:Week 10-34|Death|0|||
25242379|NCT00105989|50557051|FG001|Continuation - Open Label:Week 10-34|Death|0|||
25242380|NCT00105989|50557050|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
25242381|NCT00105989|50557051|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
25242382|NCT00105989|50557050|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
25242383|NCT00105989|50557051|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
25242384|NCT00105989|50557050|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
25242385|NCT00105989|50557051|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
25242386|NCT00105989|50557050|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
25242387|NCT00105989|50557051|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
25242388|NCT00105989|50557050|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
25242389|NCT00105989|50557051|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
25242390|NCT00105989|50557050|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
25242391|NCT00105989|50557051|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
25242392|NCT00105989|50557050|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
25242393|NCT00105989|50557051|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
25242394|NCT00105989|50557050|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
25242395|NCT00105989|50557051|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
25242396|NCT00105989|50557050|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
25242397|NCT00105989|50557051|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
25242398|NCT00105989|50557050|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
25242399|NCT00105989|50557051|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
25242400|NCT00105989|50557050|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
25242401|NCT00105989|50557051|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
25242402|NCT00105989|50557050|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
25242403|NCT00105989|50557051|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
25242404|NCT03277248|50557069|FG000|Overall Study|Adverse Event|3|||
25242405|NCT03277248|50557070|FG001|Overall Study|Adverse Event|1|||
25242406|NCT03277248|50557069|FG000|Overall Study|Subject Withdrawal of Consent|6|||
25242407|NCT03277248|50557070|FG001|Overall Study|Subject Withdrawal of Consent|23|||
25242408|NCT03277248|50557069|FG000|Overall Study|Investigator/Sponsor Decision|2|||
25242409|NCT03277248|50557070|FG001|Overall Study|Investigator/Sponsor Decision|2|||
25242410|NCT03277248|50557069|FG000|Overall Study|Pregnancy|4|||
25242411|NCT03277248|50557070|FG001|Overall Study|Pregnancy|1|||
25242412|NCT03277248|50557069|FG000|Overall Study|Lost to Follow-up|0|||
25242413|NCT03277248|50557070|FG001|Overall Study|Lost to Follow-up|2|||
25242414|NCT03277248|50557069|FG000|Overall Study|Lack of Efficacy|0|||
25242415|NCT03277248|50557070|FG001|Overall Study|Lack of Efficacy|2|||
25242416|NCT03277248|50557069|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
25242417|NCT03277248|50557070|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
25242418|NCT03276780|50557078|FG000|Overall Study|Withdrawal by Subject|5|||
25242419|NCT03276780|50557079|FG001|Overall Study|Withdrawal by Subject|3|||
25242420|NCT03276780|50557078|FG000|Overall Study|Lost to Follow-up|3|||
25242421|NCT03276780|50557079|FG001|Overall Study|Lost to Follow-up|5|||
25242422|NCT03276780|50557078|FG000|Overall Study|Moved out of state|1|||
25242423|NCT03276780|50557079|FG001|Overall Study|Moved out of state|1|||
25321899|NCT02432274|50638235|FG004|Overall Study|Other than specified|0|||
25321900|NCT02432274|50638236|FG005|Overall Study|Other than specified|1|||
25321901|NCT02432274|50638237|FG006|Overall Study|Other than specified|0|||
25321902|NCT02432274|50638238|FG007|Overall Study|Other than specified|1|||
25321903|NCT02432274|50638231|FG000|Overall Study|Ongoing|0|||
25321904|NCT02432274|50638232|FG001|Overall Study|Ongoing|0|||
25321905|NCT02432274|50638233|FG002|Overall Study|Ongoing|1|||
25321906|NCT02432274|50638234|FG003|Overall Study|Ongoing|1|||
25321907|NCT02432274|50638235|FG004|Overall Study|Ongoing|3|||
25321908|NCT02432274|50638236|FG005|Overall Study|Ongoing|0|||
25321909|NCT02432274|50638237|FG006|Overall Study|Ongoing|0|||
25242424|NCT03276780|50557078|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
25242425|NCT03276780|50557079|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
25321910|NCT02432274|50638238|FG007|Overall Study|Ongoing|7|||
25321911|NCT00903617|50638272|FG000|Overall Study|Adverse Event|0|||
25321912|NCT00903617|50638273|FG001|Overall Study|Adverse Event|1|||
25321913|NCT00903617|50638274|FG002|Overall Study|Adverse Event|1|||
25321914|NCT00903617|50638275|FG003|Overall Study|Adverse Event|0|||
25321915|NCT00903617|50638272|FG000|Overall Study|Protocol-defined stopping criteria|0|||
25321916|NCT00903617|50638273|FG001|Overall Study|Protocol-defined stopping criteria|2|||
25321917|NCT00903617|50638274|FG002|Overall Study|Protocol-defined stopping criteria|0|||
25321918|NCT00903617|50638275|FG003|Overall Study|Protocol-defined stopping criteria|0|||
25321919|NCT00903617|50638272|FG000|Overall Study|Lost to Follow-up|2|||
25321920|NCT00903617|50638273|FG001|Overall Study|Lost to Follow-up|0|||
25321921|NCT00903617|50638274|FG002|Overall Study|Lost to Follow-up|1|||
25321922|NCT00903617|50638275|FG003|Overall Study|Lost to Follow-up|1|||
25321923|NCT00903617|50638272|FG000|Overall Study|Withdrawal by Subject|1|||
25321924|NCT00903617|50638273|FG001|Overall Study|Withdrawal by Subject|2|||
25321925|NCT00903617|50638274|FG002|Overall Study|Withdrawal by Subject|3|||
25321926|NCT00903617|50638275|FG003|Overall Study|Withdrawal by Subject|0|||
25321927|NCT00903383|50638290|FG000|Overall Study|Adverse Event|1|||
25321928|NCT00903383|50638291|FG001|Overall Study|Adverse Event|2|||
25321929|NCT00903383|50638292|FG002|Overall Study|Adverse Event|3|||
25321930|NCT00903383|50638293|FG003|Overall Study|Adverse Event|1|||
25321931|NCT00903383|50638290|FG000|Overall Study|Physician Decision|1|||
25321932|NCT00903383|50638291|FG001|Overall Study|Physician Decision|2|||
25242426|NCT03276780|50557078|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
25242427|NCT03276780|50557079|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
25242428|NCT03271047|50557095|FG000|Phase 1b: Dose Finding Period|Death|8|||
25242429|NCT03271047|50557096|FG001|Phase 1b: Dose Finding Period|Death|8|||
25242430|NCT03271047|50557097|FG002|Phase 1b: Dose Finding Period|Death|0|||
25242431|NCT03271047|50557098|FG003|Phase 1b: Dose Finding Period|Death|0|||
25242432|NCT03271047|50557095|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
25242433|NCT03271047|50557096|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
25242434|NCT03271047|50557097|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
25242435|NCT03271047|50557098|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
25242436|NCT03271047|50557095|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
25242437|NCT03271047|50557096|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
25242438|NCT03271047|50557097|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
25242439|NCT03271047|50557098|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
25242440|NCT03271047|50557095|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
25242441|NCT03271047|50557096|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
25242442|NCT03271047|50557097|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
25242443|NCT03271047|50557098|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
25242444|NCT03271047|50557095|FG000|Randomized Phase 2 Period|Other|0|||
25242445|NCT03271047|50557096|FG001|Randomized Phase 2 Period|Other|0|||
25242446|NCT03271047|50557097|FG002|Randomized Phase 2 Period|Other|0|||
25242447|NCT03271047|50557098|FG003|Randomized Phase 2 Period|Other|1|||
25242448|NCT03271047|50557095|FG000|Randomized Phase 2 Period|Death|0|||
25242449|NCT03271047|50557096|FG001|Randomized Phase 2 Period|Death|0|||
25242450|NCT03271047|50557097|FG002|Randomized Phase 2 Period|Death|20|||
25242451|NCT03271047|50557098|FG003|Randomized Phase 2 Period|Death|21|||
25242452|NCT03271047|50557095|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
25321933|NCT00903383|50638292|FG002|Overall Study|Physician Decision|0|||
25321934|NCT00903383|50638293|FG003|Overall Study|Physician Decision|0|||
25321935|NCT00903383|50638290|FG000|Overall Study|Lost to Follow-up|0|||
25321936|NCT00903383|50638291|FG001|Overall Study|Lost to Follow-up|0|||
25321937|NCT00903383|50638292|FG002|Overall Study|Lost to Follow-up|0|||
25321938|NCT00903383|50638293|FG003|Overall Study|Lost to Follow-up|1|||
25321939|NCT00903383|50638290|FG000|Overall Study|Decision of Sponsor|1|||
25321940|NCT00903383|50638291|FG001|Overall Study|Decision of Sponsor|0|||
25321941|NCT00903383|50638292|FG002|Overall Study|Decision of Sponsor|0|||
25321942|NCT00903383|50638293|FG003|Overall Study|Decision of Sponsor|0|||
25321943|NCT00903383|50638290|FG000|Overall Study|Withdrawal by Subject|4|||
25321944|NCT00903383|50638291|FG001|Overall Study|Withdrawal by Subject|1|||
25321945|NCT00903383|50638292|FG002|Overall Study|Withdrawal by Subject|0|||
25321946|NCT00903383|50638293|FG003|Overall Study|Withdrawal by Subject|2|||
25321947|NCT00903383|50638290|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
25321948|NCT00903383|50638291|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
25321949|NCT00903383|50638292|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
25321950|NCT00903383|50638293|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
25242453|NCT03271047|50557096|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
25242454|NCT03271047|50557097|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
25242455|NCT03271047|50557098|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
25242456|NCT03271047|50557095|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
25242457|NCT03271047|50557096|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
25242458|NCT03271047|50557097|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
25321951|NCT00903383|50638290|FG000|Overall Study|Patient Decision|0|||
25321952|NCT00903383|50638291|FG001|Overall Study|Patient Decision|0|||
25242459|NCT03271047|50557098|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
25321953|NCT00903383|50638292|FG002|Overall Study|Patient Decision|0|||
25321954|NCT00903383|50638293|FG003|Overall Study|Patient Decision|1|||
25321955|NCT02314026|50638303|FG000|Overall Study|Protocol Violation|28|||
25321956|NCT01617096|50638313|FG000|Overall Study|Withdrawal by Subject|96|||
25321957|NCT01617096|50638314|FG001|Overall Study|Withdrawal by Subject|81|||
25321958|NCT01617096|50638313|FG000|Overall Study|Lost to Follow-up|37|||
25321959|NCT01617096|50638314|FG001|Overall Study|Lost to Follow-up|32|||
25321960|NCT01617096|50638313|FG000|Overall Study|Physician Decision|10|||
25321961|NCT01617096|50638314|FG001|Overall Study|Physician Decision|18|||
25321962|NCT01617096|50638313|FG000|Overall Study|Death|4|||
25321963|NCT01617096|50638314|FG001|Overall Study|Death|3|||
25321964|NCT01617096|50638313|FG000|Overall Study|Other|1|||
25321965|NCT01617096|50638314|FG001|Overall Study|Other|3|||
25321966|NCT00900731|50638343|FG000|Overall Study|Adverse Event|31|||
25321967|NCT00900731|50638344|FG001|Overall Study|Adverse Event|27|||
25321968|NCT00900731|50638343|FG000|Overall Study|Withdrawal by Subject|8|||
25321969|NCT00900731|50638344|FG001|Overall Study|Withdrawal by Subject|7|||
25321970|NCT00900731|50638343|FG000|Overall Study|Protocol Deviation|8|||
25321971|NCT00900731|50638344|FG001|Overall Study|Protocol Deviation|11|||
25321972|NCT00900731|50638343|FG000|Overall Study|Administrative Problems|5|||
25321973|NCT00900731|50638344|FG001|Overall Study|Administrative Problems|4|||
25321974|NCT00900731|50638343|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
25321975|NCT00900731|50638344|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
25321976|NCT00900731|50638343|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
25321977|NCT00900731|50638344|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
25321978|NCT00900731|50638343|FG000|Overall Study|Lost to Follow-up|2|||
25321979|NCT00900731|50638344|FG001|Overall Study|Lost to Follow-up|3|||
25321980|NCT00900731|50638343|FG000|Overall Study|Lack of Efficacy|1|||
25321981|NCT00900731|50638344|FG001|Overall Study|Lack of Efficacy|3|||
25321982|NCT00900731|50638343|FG000|Overall Study|Death|0|||
25321983|NCT00900731|50638344|FG001|Overall Study|Death|2|||
25321984|NCT03842436|50638350|FG000|Overall Study|Lost to Follow-up|1|||
25321985|NCT00602472|50638390|FG000|Overall Study|Adverse Event|5|||
25321986|NCT00602472|50638391|FG001|Overall Study|Adverse Event|23|||
25321987|NCT00602472|50638390|FG000|Overall Study|Protocol Violation|4|||
25321988|NCT00602472|50638391|FG001|Overall Study|Protocol Violation|19|||
25321989|NCT00602472|50638390|FG000|Overall Study|Withdrawal by Subject|8|||
25321990|NCT00602472|50638391|FG001|Overall Study|Withdrawal by Subject|14|||
25242460|NCT03271047|50557095|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
25242461|NCT03271047|50557096|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
25242462|NCT03271047|50557097|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
25242463|NCT03271047|50557098|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
25242464|NCT03276936|50557112|FG000|Overall Study|Adverse Event|4|||
25242465|NCT03276936|50557113|FG001|Overall Study|Adverse Event|2|||
25242466|NCT03276936|50557112|FG000|Overall Study|Lost to Follow-up|16|||
25242467|NCT03276936|50557113|FG001|Overall Study|Lost to Follow-up|13|||
25242468|NCT03276936|50557112|FG000|Overall Study|Withdrawal by Subject|30|||
25242469|NCT03276936|50557113|FG001|Overall Study|Withdrawal by Subject|20|||
25321991|NCT00602472|50638390|FG000|Overall Study|Other incl. lack of efficacy|4|||
25321992|NCT00602472|50638391|FG001|Overall Study|Other incl. lack of efficacy|2|||
25242470|NCT03276936|50557112|FG000|Overall Study|Not mentioned|6|||
25242471|NCT03276936|50557113|FG001|Overall Study|Not mentioned|3|||
25242472|NCT00106002|50557119|FG000|Overall Study|Did not take any study drug|1|||
25242473|NCT00106002|50557119|FG000|Overall Study|Ineligible after Registration|1|||
25321993|NCT00901901|50638426|FG000|Treatment Period|Adverse Event|120|||
25321994|NCT00901901|50638427|FG001|Treatment Period|Adverse Event|128|||
25321995|NCT00901901|50638426|FG000|Treatment Period|Withdrawal by Subject|26|||
25321996|NCT00901901|50638427|FG001|Treatment Period|Withdrawal by Subject|24|||
25321997|NCT00901901|50638426|FG000|Treatment Period|Physician Decision|2|||
25321998|NCT00901901|50638427|FG001|Treatment Period|Physician Decision|2|||
25321999|NCT00901901|50638426|FG000|Treatment Period|Lost to Follow-up|3|||
25322000|NCT00901901|50638427|FG001|Treatment Period|Lost to Follow-up|5|||
25322001|NCT00901901|50638426|FG000|Treatment Period|Noncompliance with study medication|4|||
25322002|NCT00901901|50638427|FG001|Treatment Period|Noncompliance with study medication|1|||
25322003|NCT00901901|50638426|FG000|Treatment Period|Missing|1|||
25322004|NCT00901901|50638427|FG001|Treatment Period|Missing|0|||
25322005|NCT00901901|50638426|FG000|Treatment Period|Never treated|0|||
25322006|NCT00901901|50638427|FG001|Treatment Period|Never treated|3|||
25322007|NCT00901901|50638426|FG000|Treatment Period|Protocol driven decision point|0|||
25322008|NCT00901901|50638427|FG001|Treatment Period|Protocol driven decision point|2|||
25322009|NCT00901901|50638426|FG000|Treatment Period|Study terminated by sponsor|2|||
24977066|NCT00379769|50065795|FG002|Main Study|Risk of heart failure|0|||
25242474|NCT00105482|50557137|FG000|Overall Study|Adverse Event|1|||
25242475|NCT00105482|50557138|FG001|Overall Study|Adverse Event|1|||
25242476|NCT00105482|50557137|FG000|Overall Study|Lost to Follow-up|26|||
25322010|NCT00901901|50638427|FG001|Treatment Period|Study terminated by sponsor|0|||
25322011|NCT00901901|50638426|FG000|Treatment Period|Protocol Violation|5|||
25322012|NCT00901901|50638427|FG001|Treatment Period|Protocol Violation|9|||
25322013|NCT00901901|50638426|FG000|Treatment Period|Switch to commercial drug|1|||
25322014|NCT00901901|50638427|FG001|Treatment Period|Switch to commercial drug|1|||
25242477|NCT00105482|50557138|FG001|Overall Study|Lost to Follow-up|17|||
25242478|NCT00105482|50557137|FG000|Overall Study|Withdrawal by Subject|0|||
25242479|NCT00105482|50557138|FG001|Overall Study|Withdrawal by Subject|1|||
25242480|NCT00105482|50557137|FG000|Overall Study|Lost Interest|29|||
25242481|NCT00105482|50557138|FG001|Overall Study|Lost Interest|32|||
25242482|NCT00105482|50557137|FG000|Overall Study|Scheduling Conflict|2|||
25242483|NCT00105482|50557138|FG001|Overall Study|Scheduling Conflict|3|||
25242484|NCT00105482|50557137|FG000|Overall Study|Withdrawn by PI|1|||
25242485|NCT00105482|50557138|FG001|Overall Study|Withdrawn by PI|1|||
25242486|NCT01327651|50557153|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
25242487|NCT01327651|50557154|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
25242488|NCT01327651|50557155|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
25242489|NCT01327651|50557156|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
25242490|NCT01327651|50557157|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
25242491|NCT01327651|50557158|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
25242492|NCT01327651|50557159|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
25242493|NCT01327651|50557160|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
25242494|NCT01327651|50557161|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
25242495|NCT01327651|50557153|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
25242496|NCT01327651|50557154|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
25242497|NCT01327651|50557155|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
25242498|NCT01327651|50557156|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
25242499|NCT01327651|50557157|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
25242500|NCT01327651|50557158|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
25242501|NCT01327651|50557159|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
25242502|NCT01327651|50557160|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
25242503|NCT01327651|50557161|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
25242504|NCT01327651|50557153|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
25242505|NCT01327651|50557154|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
25242506|NCT01327651|50557155|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
25242507|NCT01327651|50557156|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
25242508|NCT01327651|50557157|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
25242509|NCT01327651|50557158|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
25242510|NCT01327651|50557159|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
25242511|NCT01327651|50557160|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
25242512|NCT01327651|50557161|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
25242513|NCT01327651|50557153|FG000|Post Study Follow-up|Lost to Follow-up|0|||
25242514|NCT01327651|50557154|FG001|Post Study Follow-up|Lost to Follow-up|1|||
25242515|NCT01327651|50557155|FG002|Post Study Follow-up|Lost to Follow-up|1|||
25242516|NCT01327651|50557156|FG003|Post Study Follow-up|Lost to Follow-up|0|||
25242517|NCT01327651|50557157|FG004|Post Study Follow-up|Lost to Follow-up|0|||
25242518|NCT01327651|50557158|FG005|Post Study Follow-up|Lost to Follow-up|0|||
25242519|NCT01327651|50557159|FG006|Post Study Follow-up|Lost to Follow-up|4|||
25242520|NCT01327651|50557160|FG007|Post Study Follow-up|Lost to Follow-up|1|||
25242521|NCT01327651|50557161|FG008|Post Study Follow-up|Lost to Follow-up|2|||
25242522|NCT00105443|50557202|FG000|Double-Blind Treatment|Adverse Event|1|||
25242523|NCT00105443|50557203|FG001|Double-Blind Treatment|Adverse Event|0|||
25242524|NCT00105443|50557204|FG002|Double-Blind Treatment|Adverse Event|0|||
25242525|NCT00105443|50557205|FG003|Double-Blind Treatment|Adverse Event|0|||
25242526|NCT00105443|50557202|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
25242527|NCT00105443|50557203|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
25242528|NCT00105443|50557204|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
25242529|NCT00105443|50557205|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
25242530|NCT00105443|50557202|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
25242531|NCT00105443|50557203|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
25242532|NCT00105443|50557204|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
25242533|NCT00105443|50557205|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
25242534|NCT00105443|50557202|FG000|Double-Blind Treatment|Physician Decision|1|||
25242535|NCT00105443|50557203|FG001|Double-Blind Treatment|Physician Decision|0|||
25242536|NCT00105443|50557204|FG002|Double-Blind Treatment|Physician Decision|2|||
25242537|NCT00105443|50557205|FG003|Double-Blind Treatment|Physician Decision|0|||
25322015|NCT00901901|50638426|FG000|Treatment Period|Transfer to treatment continuation study|5|||
25322016|NCT00901901|50638427|FG001|Treatment Period|Transfer to treatment continuation study|2|||
25322017|NCT00901901|50638426|FG000|Follow-up Period|Death|181|||
25322018|NCT00901901|50638427|FG001|Follow-up Period|Death|208|||
25322019|NCT00901901|50638426|FG000|Follow-up Period|Protocol driven decision point|47|||
25322020|NCT00901901|50638427|FG001|Follow-up Period|Protocol driven decision point|36|||
25322021|NCT00901901|50638426|FG000|Follow-up Period|Withdrawal by Subject|6|||
25322022|NCT00901901|50638427|FG001|Follow-up Period|Withdrawal by Subject|9|||
25322023|NCT00901901|50638426|FG000|Follow-up Period|Lost to Follow-up|12|||
25322024|NCT00901901|50638427|FG001|Follow-up Period|Lost to Follow-up|8|||
25322025|NCT00901901|50638426|FG000|Follow-up Period|Missing|94|||
25322026|NCT00901901|50638427|FG001|Follow-up Period|Missing|80|||
25322027|NCT02143778|50638435|FG000|Overall Study|Withdrawal by Subject|2|||
25322028|NCT02143778|50638435|FG000|Overall Study|Device malfunction|1|||
25322029|NCT00896363|50638479|FG000|Overall Study|Adverse Event|3|||
25322030|NCT00896363|50638480|FG001|Overall Study|Adverse Event|4|||
25322031|NCT00896363|50638481|FG002|Overall Study|Adverse Event|2|||
25322032|NCT00896363|50638479|FG000|Overall Study|Lack of Efficacy|0|||
25322033|NCT00896363|50638480|FG001|Overall Study|Lack of Efficacy|2|||
25322034|NCT00896363|50638481|FG002|Overall Study|Lack of Efficacy|1|||
25322035|NCT00896363|50638479|FG000|Overall Study|Withdrawal by Subject|3|||
25322036|NCT00896363|50638480|FG001|Overall Study|Withdrawal by Subject|5|||
25322037|NCT00896363|50638481|FG002|Overall Study|Withdrawal by Subject|5|||
25322038|NCT00900029|50638497|FG000|Overall Study|Lost to Follow-up|0|||
25322039|NCT00900029|50638498|FG001|Overall Study|Lost to Follow-up|2|||
25322040|NCT00900029|50638499|FG002|Overall Study|Lost to Follow-up|1|||
25322041|NCT00900029|50638500|FG003|Overall Study|Lost to Follow-up|4|||
25322042|NCT00900029|50638501|FG004|Overall Study|Lost to Follow-up|4|||
25322043|NCT00900029|50638497|FG000|Overall Study|Withdrawal by Subject|2|||
25322044|NCT00900029|50638498|FG001|Overall Study|Withdrawal by Subject|2|||
25322045|NCT00900029|50638499|FG002|Overall Study|Withdrawal by Subject|1|||
25322046|NCT00900029|50638500|FG003|Overall Study|Withdrawal by Subject|1|||
25322047|NCT00900029|50638501|FG004|Overall Study|Withdrawal by Subject|1|||
25322048|NCT00900029|50638497|FG000|Overall Study|Adverse Event|0|||
25322049|NCT00900029|50638498|FG001|Overall Study|Adverse Event|0|||
25322050|NCT00900029|50638499|FG002|Overall Study|Adverse Event|1|||
25322051|NCT00900029|50638500|FG003|Overall Study|Adverse Event|1|||
25322052|NCT00900029|50638501|FG004|Overall Study|Adverse Event|1|||
25322053|NCT00900029|50638497|FG000|Overall Study|Death|1|||
25322054|NCT00900029|50638498|FG001|Overall Study|Death|0|||
25322055|NCT00900029|50638499|FG002|Overall Study|Death|0|||
25322056|NCT00900029|50638500|FG003|Overall Study|Death|1|||
25322057|NCT00900029|50638501|FG004|Overall Study|Death|0|||
25322058|NCT00896051|50638519|FG000|Overall Study|Adverse Event|2|||
25322059|NCT00896051|50638520|FG001|Overall Study|Adverse Event|1|||
25322060|NCT00896051|50638519|FG000|Overall Study|Lost to Follow-up|3|||
25322061|NCT00896051|50638520|FG001|Overall Study|Lost to Follow-up|2|||
25322062|NCT00896051|50638519|FG000|Overall Study|Withdrawal by Subject|3|||
25322063|NCT00896051|50638520|FG001|Overall Study|Withdrawal by Subject|2|||
25322064|NCT00896051|50638519|FG000|Overall Study|Subject noncompliant|1|||
25322065|NCT00896051|50638520|FG001|Overall Study|Subject noncompliant|3|||
25322066|NCT00896051|50638519|FG000|Overall Study|Other|1|||
25322067|NCT00896051|50638520|FG001|Overall Study|Other|1|||
25322068|NCT00894647|50638537|FG000|Overall Study|Adverse Event|5|||
25322069|NCT00894647|50638538|FG001|Overall Study|Adverse Event|4|||
25242538|NCT00105443|50557202|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
25242539|NCT00105443|50557203|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
25242540|NCT00105443|50557204|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
25242541|NCT00105443|50557205|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
25322070|NCT00894647|50638537|FG000|Overall Study|Withdrawal by Subject|4|||
25322071|NCT00894647|50638538|FG001|Overall Study|Withdrawal by Subject|4|||
25322072|NCT00894647|50638537|FG000|Overall Study|Lost to Follow-up|0|||
25322073|NCT00894647|50638538|FG001|Overall Study|Lost to Follow-up|2|||
25322074|NCT00894647|50638537|FG000|Overall Study|Non-compliance with study procedures|0|||
25322075|NCT00894647|50638538|FG001|Overall Study|Non-compliance with study procedures|2|||
25242542|NCT00105443|50557202|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
25242543|NCT00105443|50557203|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
25242544|NCT00105443|50557204|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
25242545|NCT00105443|50557205|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
25322076|NCT00894647|50638537|FG000|Overall Study|Other, not due to AE|1|||
25322077|NCT00894647|50638538|FG001|Overall Study|Other, not due to AE|2|||
25242546|NCT00105443|50557202|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
25242547|NCT00105443|50557203|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
25242548|NCT00105443|50557204|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
25242549|NCT00105443|50557205|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
25242550|NCT00105443|50557202|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
25322078|NCT00892775|50638546|FG000|Overall Study|Protocol Violation|1|||
25322079|NCT00892775|50638547|FG001|Overall Study|Protocol Violation|0|||
25322080|NCT00892775|50638546|FG000|Overall Study|Subject difficulties with blood drawing|1|||
25322081|NCT00892775|50638547|FG001|Overall Study|Subject difficulties with blood drawing|0|||
25322082|NCT00892775|50638546|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
25322083|NCT00892775|50638547|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
24977067|NCT00379769|50065796|FG003|Main Study|Risk of heart failure|0|||
25322084|NCT00892775|50638546|FG000|Overall Study|Migrated/ moved from study area|1|||
25322085|NCT00892775|50638547|FG001|Overall Study|Migrated/ moved from study area|0|||
25322086|NCT00892775|50638546|FG000|Overall Study|Withdrawal by Subject|0|||
25322087|NCT00892775|50638547|FG001|Overall Study|Withdrawal by Subject|1|||
25322088|NCT00892775|50638546|FG000|Overall Study|Lost to Follow-up|1|||
25322089|NCT00892775|50638547|FG001|Overall Study|Lost to Follow-up|0|||
25322090|NCT00895895|50638558|FG000|Period 1|Adverse Event|7|||
25322091|NCT00895895|50638559|FG001|Period 1|Adverse Event|6|||
25322092|NCT00895895|50638560|FG002|Period 1|Adverse Event|4|||
25322093|NCT00895895|50638561|FG003|Period 1|Adverse Event|6|||
25322094|NCT00895895|50638562|FG004|Period 1|Adverse Event|7|||
25322095|NCT00895895|50638558|FG000|Period 1|Death|0|||
25322096|NCT00895895|50638559|FG001|Period 1|Death|0|||
25322097|NCT00895895|50638560|FG002|Period 1|Death|0|||
25322098|NCT00895895|50638561|FG003|Period 1|Death|0|||
25322099|NCT00895895|50638562|FG004|Period 1|Death|1|||
25322100|NCT00895895|50638558|FG000|Period 1|discontinued by sponsor|2|||
25322101|NCT00895895|50638559|FG001|Period 1|discontinued by sponsor|1|||
25322102|NCT00895895|50638560|FG002|Period 1|discontinued by sponsor|2|||
25322103|NCT00895895|50638561|FG003|Period 1|discontinued by sponsor|1|||
25322104|NCT00895895|50638562|FG004|Period 1|discontinued by sponsor|1|||
25322105|NCT00895895|50638558|FG000|Period 1|failed to return|0|||
25322106|NCT00895895|50638559|FG001|Period 1|failed to return|0|||
25322107|NCT00895895|50638560|FG002|Period 1|failed to return|1|||
25322108|NCT00895895|50638561|FG003|Period 1|failed to return|0|||
25322109|NCT00895895|50638562|FG004|Period 1|failed to return|1|||
25322110|NCT00895895|50638558|FG000|Period 1|investigator request|0|||
25322111|NCT00895895|50638559|FG001|Period 1|investigator request|1|||
25322112|NCT00895895|50638560|FG002|Period 1|investigator request|0|||
25322113|NCT00895895|50638561|FG003|Period 1|investigator request|0|||
25322114|NCT00895895|50638562|FG004|Period 1|investigator request|0|||
25242551|NCT00105443|50557203|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
25242552|NCT00105443|50557204|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
25242553|NCT00105443|50557205|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
25242554|NCT00105443|50557202|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
25242555|NCT00105443|50557203|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
25242556|NCT00105443|50557204|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
25242557|NCT00105443|50557205|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
25242558|NCT00105443|50557202|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
25242559|NCT00105443|50557203|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
25242560|NCT00105443|50557204|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
25242561|NCT00105443|50557205|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
25242562|NCT00105443|50557202|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
25242563|NCT00105443|50557203|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
25242564|NCT00105443|50557204|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
25242565|NCT00105443|50557205|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
25242566|NCT00105443|50557202|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
25242567|NCT00105443|50557203|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
25242568|NCT00105443|50557204|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
25242569|NCT00105443|50557205|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
25242570|NCT00105443|50557202|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
25242571|NCT00105443|50557203|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
25242572|NCT00105443|50557204|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
25242573|NCT00105443|50557205|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
25242574|NCT00105443|50557202|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
25242575|NCT00105443|50557203|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
25242576|NCT00105443|50557204|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
25242577|NCT00105443|50557205|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
25242578|NCT00105443|50557202|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
25242579|NCT00105443|50557203|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
25322115|NCT00895895|50638558|FG000|Period 1|Lost to Follow-up|2|||
24977068|NCT00379769|50065797|FG004|Main Study|Risk of heart failure|0|||
25322116|NCT00895895|50638559|FG001|Period 1|Lost to Follow-up|1|||
25322117|NCT00895895|50638560|FG002|Period 1|Lost to Follow-up|3|||
25322118|NCT00895895|50638561|FG003|Period 1|Lost to Follow-up|2|||
25322119|NCT00895895|50638562|FG004|Period 1|Lost to Follow-up|3|||
25322120|NCT00895895|50638558|FG000|Period 1|Other|1|||
25322121|NCT00895895|50638559|FG001|Period 1|Other|2|||
25322122|NCT00895895|50638560|FG002|Period 1|Other|1|||
25322123|NCT00895895|50638561|FG003|Period 1|Other|1|||
25322124|NCT00895895|50638562|FG004|Period 1|Other|1|||
25322125|NCT00895895|50638558|FG000|Period 1|Protocol Violation|0|||
25322126|NCT00895895|50638559|FG001|Period 1|Protocol Violation|1|||
25322127|NCT00895895|50638560|FG002|Period 1|Protocol Violation|0|||
25242580|NCT00105443|50557204|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
25242581|NCT00105443|50557205|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
25242582|NCT00105443|50557202|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
25242583|NCT00105443|50557203|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
25242584|NCT00105443|50557204|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
25242585|NCT00105443|50557205|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
25242586|NCT00105443|50557202|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
25242587|NCT00105443|50557203|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
25242588|NCT00105443|50557204|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
25242589|NCT00105443|50557205|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
25322128|NCT00895895|50638561|FG003|Period 1|Protocol Violation|0|||
25322129|NCT00895895|50638562|FG004|Period 1|Protocol Violation|0|||
25322130|NCT00895895|50638558|FG000|Period 1|Withdrawal by Subject|6|||
25322131|NCT00895895|50638559|FG001|Period 1|Withdrawal by Subject|6|||
25322132|NCT00895895|50638560|FG002|Period 1|Withdrawal by Subject|8|||
25322133|NCT00895895|50638561|FG003|Period 1|Withdrawal by Subject|2|||
25322134|NCT00895895|50638562|FG004|Period 1|Withdrawal by Subject|4|||
25322135|NCT00895895|50638558|FG000|Period 1|unsatisfactory response-efficacy|2|||
25322136|NCT00895895|50638559|FG001|Period 1|unsatisfactory response-efficacy|0|||
25322137|NCT00895895|50638560|FG002|Period 1|unsatisfactory response-efficacy|0|||
25322138|NCT00895895|50638561|FG003|Period 1|unsatisfactory response-efficacy|0|||
25322139|NCT00895895|50638562|FG004|Period 1|unsatisfactory response-efficacy|0|||
25322140|NCT00895895|50638558|FG000|Period 1|randomized and not treated|1|||
25322141|NCT00895895|50638559|FG001|Period 1|randomized and not treated|3|||
25322142|NCT00895895|50638560|FG002|Period 1|randomized and not treated|1|||
25322143|NCT00895895|50638561|FG003|Period 1|randomized and not treated|1|||
25322144|NCT00895895|50638562|FG004|Period 1|randomized and not treated|2|||
25322145|NCT00895895|50638558|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
25322146|NCT00895895|50638559|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
25322147|NCT00895895|50638560|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
25322148|NCT00895895|50638561|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
25322149|NCT00895895|50638562|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
25322150|NCT00895895|50638558|FG000|After Period 1, Prior to Period 2|Other|0|||
25242590|NCT00105443|50557202|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
25242591|NCT00105443|50557203|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
25242592|NCT00105443|50557204|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
25242593|NCT00105443|50557205|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
25242594|NCT00105443|50557202|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
25242595|NCT00105443|50557203|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
25242596|NCT00105443|50557204|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
25242597|NCT00105443|50557205|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
25242598|NCT01327612|50557221|FG000|Overall Study|Withdrawal by Subject|0|||
25242599|NCT01327612|50557222|FG001|Overall Study|Withdrawal by Subject|0|||
25242600|NCT01327612|50557223|FG002|Overall Study|Withdrawal by Subject|0|||
25242601|NCT01327612|50557224|FG003|Overall Study|Withdrawal by Subject|0|||
25242602|NCT01327612|50557225|FG004|Overall Study|Withdrawal by Subject|0|||
25322151|NCT00895895|50638559|FG001|After Period 1, Prior to Period 2|Other|0|||
25322152|NCT00895895|50638560|FG002|After Period 1, Prior to Period 2|Other|1|||
25322153|NCT00895895|50638561|FG003|After Period 1, Prior to Period 2|Other|0|||
25322154|NCT00895895|50638562|FG004|After Period 1, Prior to Period 2|Other|0|||
25322155|NCT00895895|50638558|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
25322156|NCT00895895|50638559|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
25322157|NCT00895895|50638560|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
25322158|NCT00895895|50638561|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
25322159|NCT00895895|50638562|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
25322160|NCT00895895|50638558|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
25322161|NCT00895895|50638559|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
25322162|NCT00895895|50638560|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
25242603|NCT01327612|50557226|FG005|Overall Study|Withdrawal by Subject|1|||
25242604|NCT01327612|50557227|FG006|Overall Study|Withdrawal by Subject|0|||
25322163|NCT00895895|50638561|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
25322164|NCT00895895|50638562|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
25322165|NCT00895895|50638558|FG000|Period 2|Adverse Event|3|||
25322166|NCT00895895|50638559|FG001|Period 2|Adverse Event|3|||
25322167|NCT00895895|50638560|FG002|Period 2|Adverse Event|5|||
25322168|NCT00895895|50638561|FG003|Period 2|Adverse Event|2|||
25322169|NCT00895895|50638562|FG004|Period 2|Adverse Event|5|||
25322170|NCT00895895|50638558|FG000|Period 2|Death|0|||
25322171|NCT00895895|50638559|FG001|Period 2|Death|0|||
25322172|NCT00895895|50638560|FG002|Period 2|Death|1|||
25322173|NCT00895895|50638561|FG003|Period 2|Death|0|||
25322174|NCT00895895|50638562|FG004|Period 2|Death|0|||
25322175|NCT00895895|50638558|FG000|Period 2|discontinued by sponsor|44|||
25322176|NCT00895895|50638559|FG001|Period 2|discontinued by sponsor|44|||
25322177|NCT00895895|50638560|FG002|Period 2|discontinued by sponsor|38|||
25322178|NCT00895895|50638561|FG003|Period 2|discontinued by sponsor|46|||
25322179|NCT00895895|50638562|FG004|Period 2|discontinued by sponsor|37|||
25322180|NCT00895895|50638558|FG000|Period 2|failed to return|2|||
25322181|NCT00895895|50638559|FG001|Period 2|failed to return|0|||
25322182|NCT00895895|50638560|FG002|Period 2|failed to return|0|||
25322183|NCT00895895|50638561|FG003|Period 2|failed to return|0|||
25322184|NCT00895895|50638562|FG004|Period 2|failed to return|0|||
25242605|NCT01327612|50557221|FG000|Overall Study|Disease Progression|1|||
25242606|NCT01327612|50557222|FG001|Overall Study|Disease Progression|1|||
25242607|NCT01327612|50557223|FG002|Overall Study|Disease Progression|1|||
25242608|NCT01327612|50557224|FG003|Overall Study|Disease Progression|0|||
25322185|NCT00895895|50638558|FG000|Period 2|investigator request|2|||
25322186|NCT00895895|50638559|FG001|Period 2|investigator request|0|||
25322187|NCT00895895|50638560|FG002|Period 2|investigator request|0|||
25322188|NCT00895895|50638561|FG003|Period 2|investigator request|0|||
25322189|NCT00895895|50638562|FG004|Period 2|investigator request|0|||
25322190|NCT00895895|50638558|FG000|Period 2|Lost to Follow-up|1|||
25322191|NCT00895895|50638559|FG001|Period 2|Lost to Follow-up|2|||
25322192|NCT00895895|50638560|FG002|Period 2|Lost to Follow-up|1|||
25322193|NCT00895895|50638561|FG003|Period 2|Lost to Follow-up|1|||
25322194|NCT00895895|50638562|FG004|Period 2|Lost to Follow-up|0|||
25322195|NCT00895895|50638558|FG000|Period 2|Other|1|||
25322196|NCT00895895|50638559|FG001|Period 2|Other|1|||
25322197|NCT00895895|50638560|FG002|Period 2|Other|3|||
25322198|NCT00895895|50638561|FG003|Period 2|Other|1|||
24977069|NCT00379769|50065798|FG005|Main Study|Risk of heart failure|0|||
25242609|NCT01327612|50557225|FG004|Overall Study|Disease Progression|1|||
25242610|NCT01327612|50557226|FG005|Overall Study|Disease Progression|2|||
25242611|NCT01327612|50557227|FG006|Overall Study|Disease Progression|2|||
25242612|NCT01327612|50557221|FG000|Overall Study|Administrative Decision|0|||
25242613|NCT01327612|50557222|FG001|Overall Study|Administrative Decision|0|||
25242614|NCT01327612|50557223|FG002|Overall Study|Administrative Decision|0|||
25242615|NCT01327612|50557224|FG003|Overall Study|Administrative Decision|1|||
25242616|NCT01327612|50557225|FG004|Overall Study|Administrative Decision|0|||
25242617|NCT01327612|50557226|FG005|Overall Study|Administrative Decision|0|||
25242618|NCT01327612|50557227|FG006|Overall Study|Administrative Decision|0|||
25242619|NCT01327612|50557221|FG000|Overall Study|Death|0|||
25242620|NCT01327612|50557222|FG001|Overall Study|Death|0|||
25242621|NCT01327612|50557223|FG002|Overall Study|Death|0|||
25242622|NCT01327612|50557224|FG003|Overall Study|Death|0|||
25242623|NCT01327612|50557225|FG004|Overall Study|Death|1|||
25242624|NCT01327612|50557226|FG005|Overall Study|Death|0|||
25242625|NCT01327612|50557227|FG006|Overall Study|Death|0|||
25242626|NCT01327573|50557246|FG000|Overall Study|Physician Decision|3|||
25242627|NCT01327573|50557247|FG001|Overall Study|Physician Decision|1|||
25242628|NCT01327495|50557260|FG000|Overall Study|Adverse Event|2|||
25242629|NCT01327495|50557261|FG001|Overall Study|Adverse Event|1|||
25242630|NCT01327495|50557262|FG002|Overall Study|Adverse Event|1|||
25242631|NCT01327495|50557263|FG003|Overall Study|Adverse Event|0|||
25242632|NCT01327495|50557264|FG004|Overall Study|Adverse Event|0|||
25242633|NCT01327495|50557265|FG005|Overall Study|Adverse Event|2|||
25242634|NCT01327495|50557260|FG000|Overall Study|Withdrawal by Subject|0|||
25242635|NCT01327495|50557261|FG001|Overall Study|Withdrawal by Subject|1|||
25242636|NCT01327495|50557262|FG002|Overall Study|Withdrawal by Subject|1|||
25242637|NCT01327495|50557263|FG003|Overall Study|Withdrawal by Subject|0|||
25242638|NCT01327495|50557264|FG004|Overall Study|Withdrawal by Subject|1|||
25242639|NCT01327495|50557265|FG005|Overall Study|Withdrawal by Subject|0|||
25242640|NCT01327495|50557260|FG000|Overall Study|Physician Decision|0|||
25242641|NCT01327495|50557261|FG001|Overall Study|Physician Decision|0|||
25242642|NCT01327495|50557262|FG002|Overall Study|Physician Decision|0|||
25242643|NCT01327495|50557263|FG003|Overall Study|Physician Decision|0|||
25242644|NCT01327495|50557264|FG004|Overall Study|Physician Decision|2|||
25242645|NCT01327495|50557265|FG005|Overall Study|Physician Decision|0|||
25242646|NCT01327339|50557285|FG000|Overall Study|Protocol Violation|8|||
25242647|NCT01327300|50557289|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
25242648|NCT01327300|50557290|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
25242649|NCT01379521|50557308|FG000|Overall Study -Treatment Period|Adverse Event|3|||
25322199|NCT00895895|50638562|FG004|Period 2|Other|1|||
25322200|NCT00895895|50638558|FG000|Period 2|Protocol Violation|1|||
25322201|NCT00895895|50638559|FG001|Period 2|Protocol Violation|0|||
25322202|NCT00895895|50638560|FG002|Period 2|Protocol Violation|1|||
25322203|NCT00895895|50638561|FG003|Period 2|Protocol Violation|1|||
25322204|NCT00895895|50638562|FG004|Period 2|Protocol Violation|1|||
25322205|NCT00895895|50638558|FG000|Period 2|Withdrawal by Subject|0|||
25322206|NCT00895895|50638559|FG001|Period 2|Withdrawal by Subject|2|||
25322207|NCT00895895|50638560|FG002|Period 2|Withdrawal by Subject|0|||
25322208|NCT00895895|50638561|FG003|Period 2|Withdrawal by Subject|3|||
25322209|NCT00895895|50638562|FG004|Period 2|Withdrawal by Subject|5|||
25322210|NCT00895895|50638558|FG000|Period 2|unsatisfactory response-efficacy|2|||
25242650|NCT01379521|50557309|FG001|Overall Study -Treatment Period|Adverse Event|0|||
25242651|NCT01379521|50557308|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
25242652|NCT01379521|50557309|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
25242653|NCT01379521|50557308|FG000|Overall Study -Treatment Period|Disease Progression|23|||
25242654|NCT01379521|50557309|FG001|Overall Study -Treatment Period|Disease Progression|22|||
25242655|NCT01379521|50557308|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
25242656|NCT01379521|50557309|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
25242657|NCT01379521|50557308|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
25242658|NCT01379521|50557309|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
25242659|NCT01379521|50557308|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
25242660|NCT01379521|50557309|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
25242661|NCT01379521|50557308|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
25242662|NCT01379521|50557309|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
25242663|NCT01379521|50557308|FG000|Overall Study -Treatment Period|Death|2|||
25242664|NCT01379521|50557309|FG001|Overall Study -Treatment Period|Death|1|||
25322211|NCT00895895|50638559|FG001|Period 2|unsatisfactory response-efficacy|1|||
25322212|NCT00895895|50638560|FG002|Period 2|unsatisfactory response-efficacy|0|||
25322213|NCT00895895|50638561|FG003|Period 2|unsatisfactory response-efficacy|0|||
25322214|NCT00895895|50638562|FG004|Period 2|unsatisfactory response-efficacy|0|||
25322215|NCT00895661|50638580|FG000|Overall Study|Death|1|||
25322216|NCT00895661|50638580|FG000|Overall Study|reason unknown|2|||
25242665|NCT01379521|50557308|FG000|Post-Treatment Evaluations|Disease Progression|22|||
25242666|NCT01379521|50557309|FG001|Post-Treatment Evaluations|Disease Progression|20|||
25242667|NCT01379521|50557308|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
25242668|NCT01379521|50557309|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
25242669|NCT01379521|50557308|FG000|Post-Treatment Evaluations|Death|1|||
25242670|NCT01379521|50557309|FG001|Post-Treatment Evaluations|Death|0|||
25242671|NCT01371994|50557317|FG000|Overall Study|Adverse Event|3|||
25242672|NCT01371994|50557318|FG001|Overall Study|Adverse Event|6|||
25242673|NCT01371994|50557317|FG000|Overall Study|Lack of Efficacy|3|||
25242674|NCT01371994|50557318|FG001|Overall Study|Lack of Efficacy|0|||
25242675|NCT01371994|50557317|FG000|Overall Study|Withdrawal by Subject|13|||
25242676|NCT01371994|50557318|FG001|Overall Study|Withdrawal by Subject|7|||
25242677|NCT01371994|50557317|FG000|Overall Study|Lost to Follow-up|1|||
25242678|NCT01371994|50557318|FG001|Overall Study|Lost to Follow-up|1|||
25242679|NCT01371994|50557317|FG000|Overall Study|Protocol Violation|24|||
25242680|NCT01371994|50557318|FG001|Overall Study|Protocol Violation|17|||
25242681|NCT01371994|50557317|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
25242682|NCT01371994|50557318|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
25242683|NCT01371994|50557317|FG000|Overall Study|Physician Decision|1|||
25242684|NCT01371994|50557318|FG001|Overall Study|Physician Decision|1|||
25322217|NCT00895583|50638586|FG000|Overall Study|Adverse Event|28|||
25322218|NCT00895583|50638587|FG001|Overall Study|Adverse Event|4|||
25322219|NCT00895583|50638586|FG000|Overall Study|Death|2|||
25322220|NCT00895583|50638587|FG001|Overall Study|Death|1|||
25322221|NCT00895583|50638586|FG000|Overall Study|Physician Decision|3|||
25322222|NCT00895583|50638587|FG001|Overall Study|Physician Decision|1|||
25322223|NCT00895583|50638586|FG000|Overall Study|Lost to Follow-up|1|||
25322224|NCT00895583|50638587|FG001|Overall Study|Lost to Follow-up|3|||
25322225|NCT00895583|50638586|FG000|Overall Study|Protocol Violation|1|||
25322226|NCT00895583|50638587|FG001|Overall Study|Protocol Violation|0|||
25322227|NCT00895583|50638586|FG000|Overall Study|Withdrawal by Subject|4|||
25322228|NCT00895583|50638587|FG001|Overall Study|Withdrawal by Subject|2|||
25322229|NCT00895583|50638586|FG000|Overall Study|Lack of Efficacy|5|||
25322230|NCT00895583|50638587|FG001|Overall Study|Lack of Efficacy|0|||
25322231|NCT00895583|50638586|FG000|Overall Study|Other|0|||
25322232|NCT00895583|50638587|FG001|Overall Study|Other|1|||
25322233|NCT00894413|50638604|FG000|Overall Study|Physician Decision|0|||
25322234|NCT00894413|50638605|FG001|Overall Study|Physician Decision|2|||
25322235|NCT00894413|50638604|FG000|Overall Study|Adverse Event|0|||
25322236|NCT00894413|50638605|FG001|Overall Study|Adverse Event|2|||
25322237|NCT00894413|50638604|FG000|Overall Study|Withdrawal by Subject|0|||
25322238|NCT00894413|50638605|FG001|Overall Study|Withdrawal by Subject|4|||
25322239|NCT00895037|50638614|FG000|Overall Study|Death|0|||
25322240|NCT00895037|50638615|FG001|Overall Study|Death|2|||
25322241|NCT00895037|50638616|FG002|Overall Study|Death|1|||
25322242|NCT00892151|50638624|FG000|Overall Study|Protocol Violation|1|||
25322243|NCT01706705|50638628|FG000|Overall Study|Death|1|||
25322244|NCT01706705|50638628|FG000|Overall Study|Lack of Efficacy|13|||
25322245|NCT01706705|50638628|FG000|Overall Study|Non-clinical|6|||
25322246|NCT00894803|50638644|FG000|Overall Study|Death|20|||
25322247|NCT00894803|50638645|FG001|Overall Study|Death|4|||
25322248|NCT00894803|50638644|FG000|Overall Study|Lost to Follow-up|0|||
25322249|NCT00894803|50638645|FG001|Overall Study|Lost to Follow-up|1|||
25322250|NCT00601458|50638654|FG000|Overall Study|Dosing Error|1|||
25322251|NCT00601458|50638655|FG001|Overall Study|Dosing Error|0|||
25322252|NCT00601458|50638656|FG002|Overall Study|Dosing Error|0|||
25322253|NCT00601458|50638654|FG000|Overall Study|Incomplete Data|0|||
25322254|NCT00601458|50638655|FG001|Overall Study|Incomplete Data|2|||
25322255|NCT00601458|50638656|FG002|Overall Study|Incomplete Data|0|||
25322256|NCT00601458|50638654|FG000|Overall Study|Protocol Violation|3|||
25322257|NCT00601458|50638655|FG001|Overall Study|Protocol Violation|2|||
25322258|NCT00601458|50638656|FG002|Overall Study|Protocol Violation|1|||
25322259|NCT00601458|50638654|FG000|Overall Study|Early Termination|0|||
25322260|NCT00601458|50638655|FG001|Overall Study|Early Termination|1|||
25322261|NCT00601458|50638656|FG002|Overall Study|Early Termination|1|||
25322262|NCT02141282|50638668|FG000|Overall Study|Adverse event, not related to progression|8|||
25322263|NCT02141282|50638669|FG001|Overall Study|Adverse event, not related to progression|1|||
25322264|NCT02141282|50638670|FG002|Overall Study|Adverse event, not related to progression|3|||
25242685|NCT01371994|50557317|FG000|Overall Study|Miscellaneous Reasons|6|||
25242686|NCT01371994|50557318|FG001|Overall Study|Miscellaneous Reasons|4|||
25242687|NCT01371877|50557326|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
25242688|NCT01371877|50557327|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
25242689|NCT01371838|50557335|FG000|Overall Study|Withdrawal by Subject|27|||
25242690|NCT01371838|50557336|FG001|Overall Study|Withdrawal by Subject|33|||
25242691|NCT01371838|50557335|FG000|Overall Study|Lost to Follow-up|10|||
25242692|NCT01371838|50557336|FG001|Overall Study|Lost to Follow-up|20|||
25242693|NCT01371838|50557335|FG000|Overall Study|Death|3|||
25242694|NCT01371838|50557336|FG001|Overall Study|Death|4|||
25242695|NCT01371838|50557335|FG000|Overall Study|Protocol Violation|3|||
25242696|NCT01371838|50557336|FG001|Overall Study|Protocol Violation|0|||
25242697|NCT01371838|50557335|FG000|Overall Study|Investigator Decision|3|||
25242698|NCT01371838|50557336|FG001|Overall Study|Investigator Decision|8|||
25242699|NCT01371838|50557335|FG000|Overall Study|Last follow-up visit not conducted|2|||
25242700|NCT01371838|50557336|FG001|Overall Study|Last follow-up visit not conducted|0|||
25242701|NCT01371838|50557335|FG000|Overall Study|Lack of therapeutic response|0|||
25242702|NCT01371838|50557336|FG001|Overall Study|Lack of therapeutic response|1|||
25242703|NCT01371838|50557335|FG000|Overall Study|Surgery|1|||
25242704|NCT01371838|50557336|FG001|Overall Study|Surgery|0|||
25322265|NCT02141282|50638671|FG003|Overall Study|Adverse event, not related to progression|1|||
25322266|NCT02141282|50638668|FG000|Overall Study|Adverse event, related to progression|1|||
25322267|NCT02141282|50638669|FG001|Overall Study|Adverse event, related to progression|0|||
25322268|NCT02141282|50638670|FG002|Overall Study|Adverse event, related to progression|2|||
25322269|NCT02141282|50638671|FG003|Overall Study|Adverse event, related to progression|0|||
25322270|NCT02141282|50638668|FG000|Overall Study|COVID-19 infection|1|||
25322271|NCT02141282|50638669|FG001|Overall Study|COVID-19 infection|0|||
25322272|NCT02141282|50638670|FG002|Overall Study|COVID-19 infection|0|||
25322273|NCT02141282|50638671|FG003|Overall Study|COVID-19 infection|0|||
25322274|NCT02141282|50638668|FG000|Overall Study|Lost to Follow-up|0|||
25322275|NCT02141282|50638669|FG001|Overall Study|Lost to Follow-up|0|||
25322276|NCT02141282|50638670|FG002|Overall Study|Lost to Follow-up|4|||
25242705|NCT01371721|50557345|FG000|Overall Study|Adverse Event|5|||
25242706|NCT01371721|50557346|FG001|Overall Study|Adverse Event|4|||
25242707|NCT01371721|50557347|FG002|Overall Study|Adverse Event|5|||
25242708|NCT01371721|50557345|FG000|Overall Study|Protocol Violation|6|||
25242709|NCT01371721|50557346|FG001|Overall Study|Protocol Violation|4|||
25242710|NCT01371721|50557347|FG002|Overall Study|Protocol Violation|5|||
25242711|NCT01371721|50557345|FG000|Overall Study|Lost to Follow-up|8|||
25242712|NCT01371721|50557346|FG001|Overall Study|Lost to Follow-up|2|||
25242713|NCT01371721|50557347|FG002|Overall Study|Lost to Follow-up|6|||
25242714|NCT01371721|50557345|FG000|Overall Study|Withdrawal by Subject|5|||
25242715|NCT01371721|50557346|FG001|Overall Study|Withdrawal by Subject|7|||
25242716|NCT01371721|50557347|FG002|Overall Study|Withdrawal by Subject|11|||
25242717|NCT01371721|50557345|FG000|Overall Study|Other|2|||
25242718|NCT01371721|50557346|FG001|Overall Study|Other|3|||
25242719|NCT01371721|50557347|FG002|Overall Study|Other|0|||
25242720|NCT01371721|50557345|FG000|Overall Study|Lack of Efficacy|2|||
25242721|NCT01371721|50557346|FG001|Overall Study|Lack of Efficacy|4|||
25242722|NCT01371721|50557347|FG002|Overall Study|Lack of Efficacy|3|||
25242723|NCT01371721|50557345|FG000|Overall Study|Randomized but not treated|1|||
25242724|NCT01371721|50557346|FG001|Overall Study|Randomized but not treated|0|||
25242725|NCT01371721|50557347|FG002|Overall Study|Randomized but not treated|0|||
25242726|NCT01366534|50557360|FG000|Overall Study|Lost to Follow-up|1|||
25322277|NCT02141282|50638671|FG003|Overall Study|Lost to Follow-up|2|||
25322278|NCT02141282|50638668|FG000|Overall Study|Other, not specified|14|||
25242727|NCT01366534|50557361|FG001|Overall Study|Lost to Follow-up|0|||
25242728|NCT01366534|50557362|FG002|Overall Study|Lost to Follow-up|0|||
25242729|NCT01366534|50557360|FG000|Overall Study|Migrated|1|||
25242730|NCT01366534|50557361|FG001|Overall Study|Migrated|1|||
25322279|NCT02141282|50638669|FG001|Overall Study|Other, not specified|11|||
25242731|NCT01366534|50557362|FG002|Overall Study|Migrated|0|||
25242732|NCT01366534|50557360|FG000|Overall Study|Declined challenged|0|||
25242733|NCT01366534|50557361|FG001|Overall Study|Declined challenged|1|||
25322280|NCT02141282|50638670|FG002|Overall Study|Other, not specified|23|||
25242734|NCT01366534|50557362|FG002|Overall Study|Declined challenged|0|||
25242735|NCT01365910|50557370|FG000|Overall Study|Withdrawal by Subject|7|||
25242736|NCT01365910|50557370|FG000|Overall Study|disease progression|18|||
25242737|NCT01365910|50557370|FG000|Overall Study|Adverse Event|3|||
25242738|NCT01365910|50557370|FG000|Overall Study|other complicating disease|1|||
25242739|NCT01365910|50557370|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
25242740|NCT01365481|50557378|FG000|Overall Study|Adverse Event|6|||
25242741|NCT01365481|50557379|FG001|Overall Study|Adverse Event|9|||
25242742|NCT01365481|50557380|FG002|Overall Study|Adverse Event|0|||
25242743|NCT01365481|50557381|FG003|Overall Study|Adverse Event|2|||
25242744|NCT01365481|50557378|FG000|Overall Study|Withdrawal by Subject|0|||
25242745|NCT01365481|50557379|FG001|Overall Study|Withdrawal by Subject|2|||
25242746|NCT01365481|50557380|FG002|Overall Study|Withdrawal by Subject|1|||
25242747|NCT01365481|50557381|FG003|Overall Study|Withdrawal by Subject|1|||
25242748|NCT01365481|50557378|FG000|Overall Study|Lost to Follow-up|1|||
25242749|NCT01365481|50557379|FG001|Overall Study|Lost to Follow-up|1|||
25242750|NCT01365481|50557380|FG002|Overall Study|Lost to Follow-up|2|||
25242751|NCT01365481|50557381|FG003|Overall Study|Lost to Follow-up|3|||
25242752|NCT01365481|50557378|FG000|Overall Study|Abnormal laboratory value(s)|0|||
25242753|NCT01365481|50557379|FG001|Overall Study|Abnormal laboratory value(s)|1|||
25242754|NCT01365481|50557380|FG002|Overall Study|Abnormal laboratory value(s)|0|||
25242755|NCT01365481|50557381|FG003|Overall Study|Abnormal laboratory value(s)|0|||
25242756|NCT01365481|50557378|FG000|Overall Study|Administrative problems|0|||
25242757|NCT01365481|50557379|FG001|Overall Study|Administrative problems|1|||
25242758|NCT01365481|50557380|FG002|Overall Study|Administrative problems|0|||
25242759|NCT01365481|50557381|FG003|Overall Study|Administrative problems|0|||
25242760|NCT01365481|50557378|FG000|Overall Study|Protocol deviation|0|||
25242761|NCT01365481|50557379|FG001|Overall Study|Protocol deviation|1|||
25242762|NCT01365481|50557380|FG002|Overall Study|Protocol deviation|0|||
25242763|NCT01365481|50557381|FG003|Overall Study|Protocol deviation|1|||
25242764|NCT01365481|50557378|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25242765|NCT01365481|50557379|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
25242766|NCT01365481|50557380|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
25242767|NCT01365481|50557381|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
25242768|NCT01357915|50557393|FG000|Overall Study|Lost to Follow-up|3|||
25242769|NCT01357915|50557394|FG001|Overall Study|Lost to Follow-up|0|||
25242770|NCT01350973|50557403|FG000|Overall Study|Adverse Event|4|||
25242771|NCT01350973|50557404|FG001|Overall Study|Adverse Event|7|||
25242772|NCT01350973|50557405|FG002|Overall Study|Adverse Event|7|||
25242773|NCT01350973|50557403|FG000|Overall Study|Voluntary Withdrawal|2|||
25242774|NCT01350973|50557404|FG001|Overall Study|Voluntary Withdrawal|1|||
25242775|NCT01350973|50557405|FG002|Overall Study|Voluntary Withdrawal|1|||
25242776|NCT01350544|50557415|FG000|Overall Study|Administrative Withdrawal|0|||
25242777|NCT01350544|50557416|FG001|Overall Study|Administrative Withdrawal|1|||
25242778|NCT01350544|50557415|FG000|Overall Study|Death|1|||
25242779|NCT01350544|50557416|FG001|Overall Study|Death|2|||
25242780|NCT01350544|50557415|FG000|Overall Study|Moved out of LA County|2|||
25242781|NCT01350544|50557416|FG001|Overall Study|Moved out of LA County|2|||
25242782|NCT01350544|50557415|FG000|Overall Study|Medical Issues|1|||
25242783|NCT01350544|50557416|FG001|Overall Study|Medical Issues|1|||
25242784|NCT01350544|50557415|FG000|Overall Study|Withdrawal by Subject|0|||
25242785|NCT01350544|50557416|FG001|Overall Study|Withdrawal by Subject|1|||
25242786|NCT01350544|50557415|FG000|Overall Study|Incarceration|1|||
25242787|NCT01350544|50557416|FG001|Overall Study|Incarceration|0|||
25242788|NCT01350544|50557415|FG000|Overall Study|Lost to Follow-up|18|||
25242789|NCT01350544|50557416|FG001|Overall Study|Lost to Follow-up|15|||
25242790|NCT01350505|50557422|FG000|Overall Study|Lost to Follow-up|4|||
25242791|NCT01350271|50557429|FG000|Overall Study|Lost to Follow-up|21|||
25242792|NCT01350271|50557430|FG001|Overall Study|Lost to Follow-up|17|||
25242793|NCT01350271|50557431|FG002|Overall Study|Lost to Follow-up|26|||
25242794|NCT01348828|50557442|FG000|Overall Study|Death|20|||
25242795|NCT01348828|50557442|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
25242796|NCT01348828|50557442|FG000|Overall Study|Conversion|2|||
25322281|NCT02141282|50638671|FG003|Overall Study|Other, not specified|9|||
25242797|NCT01348828|50557442|FG000|Overall Study|missed visit|1|||
25242798|NCT01348789|50557446|FG000|Overall Study|Protocol Violation|2|||
25242799|NCT01348789|50557446|FG000|Overall Study|Withdrawal by Subject|2|||
25242800|NCT01342510|50557461|FG000|Overall Study|Protocol Violation|12|||
25242801|NCT01342510|50557462|FG001|Overall Study|Protocol Violation|6|||
25322282|NCT02141282|50638668|FG000|Overall Study|Progressive disease, Richter's|4|||
25322283|NCT02141282|50638669|FG001|Overall Study|Progressive disease, Richter's|1|||
25322284|NCT02141282|50638670|FG002|Overall Study|Progressive disease, Richter's|1|||
25322285|NCT02141282|50638671|FG003|Overall Study|Progressive disease, Richter's|1|||
25322286|NCT02141282|50638668|FG000|Overall Study|Progressive disease per protocol|12|||
25322287|NCT02141282|50638669|FG001|Overall Study|Progressive disease per protocol|7|||
25322288|NCT02141282|50638670|FG002|Overall Study|Progressive disease per protocol|9|||
25322289|NCT02141282|50638671|FG003|Overall Study|Progressive disease per protocol|2|||
25322290|NCT02141282|50638668|FG000|Overall Study|Stem cell transplant|1|||
25322291|NCT02141282|50638669|FG001|Overall Study|Stem cell transplant|0|||
25322292|NCT02141282|50638670|FG002|Overall Study|Stem cell transplant|1|||
25322293|NCT02141282|50638671|FG003|Overall Study|Stem cell transplant|0|||
25322294|NCT02141282|50638668|FG000|Overall Study|Study terminated by Sponsor|0|||
25322295|NCT02141282|50638669|FG001|Overall Study|Study terminated by Sponsor|1|||
25322296|NCT02141282|50638670|FG002|Overall Study|Study terminated by Sponsor|0|||
25322297|NCT02141282|50638671|FG003|Overall Study|Study terminated by Sponsor|0|||
25322298|NCT02141282|50638668|FG000|Overall Study|Subject non-compliance|0|||
25242802|NCT01342510|50557463|FG002|Overall Study|Protocol Violation|13|||
25242803|NCT01342510|50557464|FG003|Overall Study|Protocol Violation|11|||
25242804|NCT01340872|50557484|FG000|Double-blind Phase|Adverse Event|6|||
25242805|NCT01340872|50557485|FG001|Double-blind Phase|Adverse Event|4|||
25242806|NCT01340872|50557486|FG002|Double-blind Phase|Adverse Event|0|||
25242807|NCT01340872|50557487|FG003|Double-blind Phase|Adverse Event|0|||
25242808|NCT01340872|50557484|FG000|Double-blind Phase|Withdrawal by Subject|3|||
25242809|NCT01340872|50557485|FG001|Double-blind Phase|Withdrawal by Subject|5|||
25242810|NCT01340872|50557486|FG002|Double-blind Phase|Withdrawal by Subject|0|||
25242811|NCT01340872|50557487|FG003|Double-blind Phase|Withdrawal by Subject|0|||
25322299|NCT02141282|50638669|FG001|Overall Study|Subject non-compliance|0|||
25322300|NCT02141282|50638670|FG002|Overall Study|Subject non-compliance|1|||
25322301|NCT02141282|50638671|FG003|Overall Study|Subject non-compliance|0|||
25322302|NCT02141282|50638668|FG000|Overall Study|Withdrew consent|2|||
25322303|NCT02141282|50638669|FG001|Overall Study|Withdrew consent|0|||
25322304|NCT02141282|50638670|FG002|Overall Study|Withdrew consent|4|||
25322305|NCT02141282|50638671|FG003|Overall Study|Withdrew consent|0|||
25322306|NCT00003479|50638684|FG000|Overall Study|Not evaluable|3|||
25322307|NCT00891839|50638688|FG000|Overall Study|Adverse Event|2|||
25322308|NCT00891839|50638688|FG000|Overall Study|Withdrawal by Subject|2|||
25322309|NCT00891839|50638688|FG000|Overall Study|Disease progression|3|||
25322310|NCT00600756|50638694|FG000|Analysis After 6 Months|Adverse Event|43|||
25322311|NCT00600756|50638695|FG001|Analysis After 6 Months|Adverse Event|33|||
25322312|NCT00600756|50638694|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
25322313|NCT00600756|50638695|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
25322314|NCT00600756|50638694|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
25322315|NCT00600756|50638695|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
25322316|NCT00600756|50638694|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
25322317|NCT00600756|50638695|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
25322318|NCT00600756|50638694|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
25322319|NCT00600756|50638695|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
25322320|NCT00600756|50638694|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
25322321|NCT00600756|50638695|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
25322322|NCT00600756|50638694|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
25322323|NCT00600756|50638695|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
25322324|NCT00600756|50638694|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
25322325|NCT00600756|50638695|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
25322326|NCT00600756|50638694|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
25322327|NCT00600756|50638695|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
25322328|NCT00600756|50638694|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
25322329|NCT00600756|50638695|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
25322330|NCT00600756|50638694|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
25322331|NCT00600756|50638695|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
25242812|NCT01340872|50557484|FG000|Double-blind Phase|Lost to Follow-up|0|||
25242813|NCT01340872|50557485|FG001|Double-blind Phase|Lost to Follow-up|1|||
25322332|NCT00600756|50638694|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
25322333|NCT00600756|50638695|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
25322334|NCT00600756|50638694|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
25322335|NCT00600756|50638695|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
25322336|NCT00600756|50638694|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
25242814|NCT01340872|50557486|FG002|Double-blind Phase|Lost to Follow-up|0|||
25242815|NCT01340872|50557487|FG003|Double-blind Phase|Lost to Follow-up|0|||
25242816|NCT01340872|50557484|FG000|Double-blind Phase|Protocol Violation|0|||
25242817|NCT01340872|50557485|FG001|Double-blind Phase|Protocol Violation|1|||
25242818|NCT01340872|50557486|FG002|Double-blind Phase|Protocol Violation|0|||
25242819|NCT01340872|50557487|FG003|Double-blind Phase|Protocol Violation|0|||
25242820|NCT01340872|50557484|FG000|Open-label Phase|Physician Decision|0|||
25242821|NCT01340872|50557485|FG001|Open-label Phase|Physician Decision|0|||
25242822|NCT01340872|50557486|FG002|Open-label Phase|Physician Decision|2|||
25322337|NCT00600756|50638695|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
25322338|NCT00890825|50638707|FG000|Overall Study|Withdrawal by Subject|1|||
25322339|NCT00890825|50638708|FG001|Overall Study|Withdrawal by Subject|0|||
25322340|NCT00890825|50638707|FG000|Overall Study|Alive at data cut off (DCO)|13|||
25242823|NCT01340872|50557487|FG003|Open-label Phase|Physician Decision|1|||
25242824|NCT01340872|50557484|FG000|Open-label Phase|Pregnancy|0|||
25242825|NCT01340872|50557485|FG001|Open-label Phase|Pregnancy|0|||
25242826|NCT01340872|50557486|FG002|Open-label Phase|Pregnancy|1|||
25242827|NCT01340872|50557487|FG003|Open-label Phase|Pregnancy|0|||
25242828|NCT01340872|50557484|FG000|Open-label Phase|Adverse Event|0|||
25242829|NCT01340872|50557485|FG001|Open-label Phase|Adverse Event|0|||
25242830|NCT01340872|50557486|FG002|Open-label Phase|Adverse Event|8|||
25242831|NCT01340872|50557487|FG003|Open-label Phase|Adverse Event|4|||
25242832|NCT01340872|50557484|FG000|Open-label Phase|Withdrawal by Subject|0|||
25322341|NCT00890825|50638708|FG001|Overall Study|Alive at data cut off (DCO)|14|||
25322342|NCT00890201|50638716|FG000|Overall Study|Protocol Violation|5|||
25322343|NCT00890201|50638717|FG001|Overall Study|Protocol Violation|56|||
25322344|NCT00891527|50638723|FG000|Overall Study|Withdrawal by Subject|2|||
25322345|NCT03861078|50638728|FG000|Overall Study|COVID-19 shut down|4|||
25322346|NCT03861078|50638728|FG000|Overall Study|Lost to Follow-up|1|||
25322347|NCT03861078|50638728|FG000|Overall Study|Protocol Violation|2|||
25322348|NCT03861078|50638728|FG000|Overall Study|lack of venous access|1|||
25322349|NCT00891371|50638736|FG000|Pre-assignment|Inclusion/exclusion|5|||
25322350|NCT00891371|50638736|FG000|Pre-assignment|Consent withdrawal|1|||
25322351|NCT00891371|50638736|FG000|Treatment|Lack of Efficacy|5|||
25322352|NCT00891371|50638736|FG000|Treatment|Adverse Event|2|||
25322353|NCT00891371|50638736|FG000|Treatment|Death|1|||
25322354|NCT00891371|50638736|FG000|Treatment|Lost to Follow-up|1|||
25322355|NCT00890045|50638742|FG000|Overall Study|Death|0|||
25322356|NCT00890045|50638743|FG001|Overall Study|Death|1|||
25322357|NCT00890045|50638742|FG000|Overall Study|Did not receive HeRO Graft|0|||
25322358|NCT00890045|50638743|FG001|Overall Study|Did not receive HeRO Graft|2|||
25322359|NCT00890045|50638742|FG000|Overall Study|Lost to Follow-up|5|||
25322360|NCT00890045|50638743|FG001|Overall Study|Lost to Follow-up|7|||
25322361|NCT00891293|50638749|FG000|Overall Study|Adverse Event|2|||
25322362|NCT00891293|50638749|FG000|Overall Study|Protocol Violation|2|||
25322363|NCT00891293|50638749|FG000|Overall Study|Laboratory abnormality|4|||
25322364|NCT00891293|50638749|FG000|Overall Study|Lost to Follow-up|7|||
25322365|NCT00891293|50638749|FG000|Overall Study|Subject withdrew consent|7|||
25322366|NCT00891293|50638749|FG000|Overall Study|Sponsor termination|62|||
25322367|NCT00889421|50638753|FG000|Overall Study|Lack of Efficacy|3|||
25322368|NCT00889265|50638757|FG000|Overall Study|Adverse Event|1|||
25322369|NCT00889265|50638757|FG000|Overall Study|Lost to Follow-up|5|||
25322370|NCT00889265|50638757|FG000|Overall Study|Protocol Violation|1|||
25322371|NCT00603746|50638767|FG000|Overall Study|Adverse Event|2|||
25322372|NCT00603746|50638768|FG001|Overall Study|Adverse Event|3|||
25322373|NCT00603746|50638769|FG002|Overall Study|Adverse Event|0|||
25322374|NCT00603746|50638770|FG003|Overall Study|Adverse Event|1|||
25322375|NCT00603746|50638771|FG004|Overall Study|Adverse Event|0|||
25322376|NCT00603746|50638772|FG005|Overall Study|Adverse Event|4|||
25322377|NCT00603746|50638767|FG000|Overall Study|Lack of Efficacy|34|||
25322378|NCT00603746|50638768|FG001|Overall Study|Lack of Efficacy|11|||
25322379|NCT00603746|50638769|FG002|Overall Study|Lack of Efficacy|6|||
25322380|NCT00603746|50638770|FG003|Overall Study|Lack of Efficacy|11|||
25322381|NCT00603746|50638771|FG004|Overall Study|Lack of Efficacy|12|||
25322382|NCT00603746|50638772|FG005|Overall Study|Lack of Efficacy|8|||
25322383|NCT00603746|50638767|FG000|Overall Study|Protocol Violation|0|||
25242833|NCT01340872|50557485|FG001|Open-label Phase|Withdrawal by Subject|0|||
25322384|NCT00603746|50638768|FG001|Overall Study|Protocol Violation|3|||
25322385|NCT00603746|50638769|FG002|Overall Study|Protocol Violation|1|||
25242834|NCT01340872|50557486|FG002|Open-label Phase|Withdrawal by Subject|1|||
25242835|NCT01340872|50557487|FG003|Open-label Phase|Withdrawal by Subject|6|||
25322386|NCT00603746|50638770|FG003|Overall Study|Protocol Violation|0|||
25322387|NCT00603746|50638771|FG004|Overall Study|Protocol Violation|1|||
25322388|NCT00603746|50638772|FG005|Overall Study|Protocol Violation|0|||
25322389|NCT00603746|50638767|FG000|Overall Study|Lost to Follow-up|0|||
25322390|NCT00603746|50638768|FG001|Overall Study|Lost to Follow-up|1|||
25322391|NCT00603746|50638769|FG002|Overall Study|Lost to Follow-up|1|||
25322392|NCT00603746|50638770|FG003|Overall Study|Lost to Follow-up|0|||
25322393|NCT00603746|50638771|FG004|Overall Study|Lost to Follow-up|0|||
25242836|NCT01340872|50557484|FG000|Open-label Phase|Worsening of IBD|0|||
25322394|NCT00603746|50638772|FG005|Overall Study|Lost to Follow-up|0|||
25322395|NCT00603746|50638767|FG000|Overall Study|Physician Decision|1|||
25322396|NCT00603746|50638768|FG001|Overall Study|Physician Decision|0|||
25322397|NCT00603746|50638769|FG002|Overall Study|Physician Decision|0|||
25322398|NCT00603746|50638770|FG003|Overall Study|Physician Decision|0|||
25322399|NCT00603746|50638771|FG004|Overall Study|Physician Decision|1|||
25322400|NCT00603746|50638772|FG005|Overall Study|Physician Decision|0|||
25322401|NCT00603746|50638767|FG000|Overall Study|Withdrawal by Subject|1|||
25322402|NCT00603746|50638768|FG001|Overall Study|Withdrawal by Subject|0|||
25322403|NCT00603746|50638769|FG002|Overall Study|Withdrawal by Subject|0|||
25322404|NCT00603746|50638770|FG003|Overall Study|Withdrawal by Subject|1|||
25322405|NCT00603746|50638771|FG004|Overall Study|Withdrawal by Subject|3|||
25322406|NCT00603746|50638772|FG005|Overall Study|Withdrawal by Subject|1|||
25322407|NCT00888329|50638788|FG000|Overall Study|Physician Decision|6|||
25322408|NCT00888329|50638789|FG001|Overall Study|Physician Decision|9|||
25322409|NCT00603590|50638797|FG000|Overall Study|Did not attend study clinic|39|||
25322410|NCT00603590|50638798|FG001|Overall Study|Did not attend study clinic|30|||
25322411|NCT00603590|50638797|FG000|Overall Study|Refused blood test|5|||
25322412|NCT00603590|50638798|FG001|Overall Study|Refused blood test|1|||
25322413|NCT00603590|50638797|FG000|Overall Study|Patient discontinued study drug|22|||
25322414|NCT00603590|50638798|FG001|Overall Study|Patient discontinued study drug|15|||
25322415|NCT00603590|50638797|FG000|Overall Study|Adverse Event|2|||
25322416|NCT00603590|50638798|FG001|Overall Study|Adverse Event|0|||
25322417|NCT00603590|50638797|FG000|Overall Study|Lost to Follow-up|8|||
25322418|NCT00603590|50638798|FG001|Overall Study|Lost to Follow-up|4|||
25322419|NCT00603590|50638797|FG000|Overall Study|Cardiovascular event|0|||
25322420|NCT00603590|50638798|FG001|Overall Study|Cardiovascular event|1|||
25322421|NCT00888173|50638804|FG000|Overall Study|Wrong Primary|1|||
25322422|NCT00888173|50638804|FG000|Overall Study|Ineligible: required test not done|1|||
25322423|NCT00887549|50638817|FG000|Induction Therapy|Adverse Event|8|||
25322424|NCT00887549|50638817|FG000|Induction Therapy|Physician Decision|1|||
25322425|NCT00887549|50638817|FG000|Induction Therapy|Progressive Disease|13|||
25322426|NCT00887549|50638817|FG000|Induction Therapy|Death due to Study Disease|4|||
25322427|NCT00887549|50638817|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
25322428|NCT00887549|50638817|FG000|Maintenance Therapy|Adverse Event|16|||
25322429|NCT00887549|50638817|FG000|Maintenance Therapy|Physician Decision|1|||
25322430|NCT00887549|50638817|FG000|Maintenance Therapy|Progressive Disease|25|||
25322431|NCT00887549|50638817|FG000|Maintenance Therapy|Death due to adverse event|1|||
25322432|NCT00887315|50638827|FG000|Overall Study|Study termination|7|||
25322433|NCT00887315|50638828|FG001|Overall Study|Study termination|4|||
25322434|NCT03608826|50638834|FG000|Overall Study|Death|3|||
25322435|NCT03608826|50638834|FG000|Overall Study|Heart Transplant|3|||
25242837|NCT01340872|50557485|FG001|Open-label Phase|Worsening of IBD|0|||
25242838|NCT01340872|50557486|FG002|Open-label Phase|Worsening of IBD|1|||
25242839|NCT01340872|50557487|FG003|Open-label Phase|Worsening of IBD|0|||
25242840|NCT01340794|50557501|FG000|Overall Study|Withdrawal by Subject|0|||
25242841|NCT01340794|50557502|FG001|Overall Study|Withdrawal by Subject|1|||
25242842|NCT01340482|50557513|FG000|Overall Study|Adverse Event|2|||
25242843|NCT01340482|50557514|FG001|Overall Study|Adverse Event|0|||
25242844|NCT01340482|50557515|FG002|Overall Study|Adverse Event|0|||
25242845|NCT01340209|50557528|FG000|Overall Study|Adverse Event|1|||
25242846|NCT01340209|50557529|FG001|Overall Study|Adverse Event|1|||
25242847|NCT01340209|50557530|FG002|Overall Study|Adverse Event|2|||
25242848|NCT01340209|50557528|FG000|Overall Study|Protocol Violation|1|||
25242849|NCT01340209|50557529|FG001|Overall Study|Protocol Violation|2|||
25242850|NCT01340209|50557530|FG002|Overall Study|Protocol Violation|1|||
25242851|NCT01340209|50557528|FG000|Overall Study|Withdrawal by Subject|0|||
25242852|NCT01340209|50557529|FG001|Overall Study|Withdrawal by Subject|0|||
25242853|NCT01340209|50557530|FG002|Overall Study|Withdrawal by Subject|1|||
25242854|NCT01340209|50557528|FG000|Overall Study|Other reason not defined above|3|||
25242855|NCT01340209|50557529|FG001|Overall Study|Other reason not defined above|5|||
25242856|NCT01340209|50557530|FG002|Overall Study|Other reason not defined above|4|||
25242857|NCT01326910|50557540|FG000|Overall Study|Withdrawal by Subject|3|||
25242858|NCT01326910|50557541|FG001|Overall Study|Withdrawal by Subject|2|||
25242859|NCT01326910|50557540|FG000|Overall Study|Protocol Violation|1|||
25242860|NCT01326910|50557541|FG001|Overall Study|Protocol Violation|1|||
25242861|NCT01326481|50557547|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
25242862|NCT01325701|50557555|FG000|Overall Study|Adverse Event|12|||
25242863|NCT01325701|50557556|FG001|Overall Study|Adverse Event|0|||
25322436|NCT03608826|50638834|FG000|Overall Study|Physician Decision|4|||
25322437|NCT00887159|50638841|FG000|Overall Study|Disease progression|6|||
25242864|NCT01325701|50557555|FG000|Overall Study|Protocol Violation|1|||
25242865|NCT01325701|50557556|FG001|Overall Study|Protocol Violation|0|||
25242866|NCT01325701|50557555|FG000|Overall Study|Physician Decision|2|||
25242867|NCT01325701|50557556|FG001|Overall Study|Physician Decision|2|||
25242868|NCT01325701|50557555|FG000|Overall Study|Withdrawal by Subject|2|||
25242869|NCT01325701|50557556|FG001|Overall Study|Withdrawal by Subject|1|||
25242870|NCT01325701|50557555|FG000|Overall Study|Rollerover Extension Study|4|||
25242871|NCT01325701|50557556|FG001|Overall Study|Rollerover Extension Study|0|||
25242872|NCT01325623|50557563|FG000|Overall Study|Withdrawal by Subject|3|||
25242873|NCT01325584|50557600|FG000|Overall Study|Death|1|||
25242874|NCT01325428|50557604|FG000|Part A|Progressive disease according to RECIST|9|||
25242875|NCT01325428|50557604|FG000|Part A|Clinical signs, symptoms of progression|2|||
25242876|NCT01325428|50557604|FG000|Part A|Other adverse event|1|||
25242877|NCT01325428|50557604|FG000|Part A|Refused continue taking trial medication|2|||
25242878|NCT01325428|50557604|FG000|Part A|Other reason not defined above|2|||
25242879|NCT01325428|50557604|FG000|Part B|Refused continue taking trial medication|2|||
25242880|NCT01325428|50557604|FG000|Part B|Other reason not defined above|1|||
25242881|NCT01325350|50557618|FG000|Overall Study|Adverse Event|3|||
25242882|NCT01325350|50557619|FG001|Overall Study|Adverse Event|3|||
25242883|NCT01325350|50557620|FG002|Overall Study|Adverse Event|3|||
25242884|NCT01325350|50557621|FG003|Overall Study|Adverse Event|1|||
25242885|NCT01325350|50557622|FG004|Overall Study|Adverse Event|2|||
25242886|NCT01325350|50557618|FG000|Overall Study|Pregnancy|0|||
25242887|NCT01325350|50557619|FG001|Overall Study|Pregnancy|0|||
25242888|NCT01325350|50557620|FG002|Overall Study|Pregnancy|1|||
25242889|NCT01325350|50557621|FG003|Overall Study|Pregnancy|0|||
25242890|NCT01325350|50557622|FG004|Overall Study|Pregnancy|1|||
25242891|NCT01325350|50557618|FG000|Overall Study|Lost to Follow-up|1|||
25242892|NCT01325350|50557619|FG001|Overall Study|Lost to Follow-up|0|||
25242893|NCT01325350|50557620|FG002|Overall Study|Lost to Follow-up|5|||
25242894|NCT01325350|50557621|FG003|Overall Study|Lost to Follow-up|1|||
25242895|NCT01325350|50557622|FG004|Overall Study|Lost to Follow-up|5|||
25242896|NCT01325350|50557618|FG000|Overall Study|Personal Reasons|2|||
25242897|NCT01325350|50557619|FG001|Overall Study|Personal Reasons|1|||
25242898|NCT01325350|50557620|FG002|Overall Study|Personal Reasons|6|||
25242899|NCT01325350|50557621|FG003|Overall Study|Personal Reasons|5|||
25242900|NCT01325350|50557622|FG004|Overall Study|Personal Reasons|3|||
25242901|NCT01325350|50557618|FG000|Overall Study|Protocol Violation|0|||
25242902|NCT01325350|50557619|FG001|Overall Study|Protocol Violation|0|||
25242903|NCT01325350|50557620|FG002|Overall Study|Protocol Violation|0|||
25242904|NCT01325350|50557621|FG003|Overall Study|Protocol Violation|1|||
25242905|NCT01325350|50557622|FG004|Overall Study|Protocol Violation|0|||
25322438|NCT00887159|50638842|FG001|Overall Study|Disease progression|39|||
25322439|NCT00887159|50638843|FG002|Overall Study|Disease progression|33|||
25322440|NCT00887159|50638841|FG000|Overall Study|Adverse Event|3|||
25322441|NCT00887159|50638842|FG001|Overall Study|Adverse Event|4|||
25322442|NCT00887159|50638843|FG002|Overall Study|Adverse Event|17|||
25322443|NCT00887159|50638841|FG000|Overall Study|Death|2|||
25322444|NCT00887159|50638842|FG001|Overall Study|Death|2|||
25322445|NCT00887159|50638843|FG002|Overall Study|Death|0|||
25322446|NCT00887159|50638841|FG000|Overall Study|Withdrawal by Subject|4|||
25322447|NCT00887159|50638842|FG001|Overall Study|Withdrawal by Subject|4|||
25322448|NCT00887159|50638843|FG002|Overall Study|Withdrawal by Subject|2|||
25322449|NCT00887159|50638841|FG000|Overall Study|Alternative therapy|2|||
25322450|NCT00887159|50638842|FG001|Overall Study|Alternative therapy|0|||
25322451|NCT00887159|50638843|FG002|Overall Study|Alternative therapy|0|||
25322452|NCT00887159|50638841|FG000|Overall Study|Physician Decision|1|||
25322453|NCT00887159|50638842|FG001|Overall Study|Physician Decision|1|||
25322454|NCT00887159|50638843|FG002|Overall Study|Physician Decision|0|||
25322455|NCT00887159|50638841|FG000|Overall Study|Sympomatic deterioration|1|||
25322456|NCT00887159|50638842|FG001|Overall Study|Sympomatic deterioration|0|||
25322457|NCT00887159|50638843|FG002|Overall Study|Sympomatic deterioration|0|||
25322458|NCT00887159|50638841|FG000|Overall Study|Treatment delayed|1|||
25322459|NCT00887159|50638842|FG001|Overall Study|Treatment delayed|1|||
25322460|NCT00887159|50638843|FG002|Overall Study|Treatment delayed|0|||
25322461|NCT00887159|50638841|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
25322462|NCT00887159|50638842|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
25322463|NCT00887159|50638843|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
25322464|NCT00887159|50638841|FG000|Overall Study|Received more tx instead of observation|1|||
25322465|NCT00887159|50638842|FG001|Overall Study|Received more tx instead of observation|0|||
25322466|NCT00887159|50638843|FG002|Overall Study|Received more tx instead of observation|0|||
25322467|NCT00887159|50638841|FG000|Overall Study|Ineligible|5|||
25322468|NCT00887159|50638842|FG001|Overall Study|Ineligible|1|||
25242906|NCT01325350|50557618|FG000|Overall Study|Withdrawal by Subject|0|||
25242907|NCT01325350|50557619|FG001|Overall Study|Withdrawal by Subject|0|||
25242908|NCT01325350|50557620|FG002|Overall Study|Withdrawal by Subject|1|||
25242909|NCT01325350|50557621|FG003|Overall Study|Withdrawal by Subject|1|||
25242910|NCT01325350|50557622|FG004|Overall Study|Withdrawal by Subject|0|||
25242911|NCT01325350|50557618|FG000|Overall Study|Did Not Receive Treatment|0|||
25242912|NCT01325350|50557619|FG001|Overall Study|Did Not Receive Treatment|1|||
25322469|NCT00887159|50638843|FG002|Overall Study|Ineligible|0|||
25322470|NCT00887159|50638841|FG000|Overall Study|Never started assigned therapy|3|||
25322471|NCT00887159|50638842|FG001|Overall Study|Never started assigned therapy|3|||
25322472|NCT00887159|50638843|FG002|Overall Study|Never started assigned therapy|4|||
25322473|NCT00886769|50638855|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
25242913|NCT01325350|50557620|FG002|Overall Study|Did Not Receive Treatment|1|||
25242914|NCT01325350|50557621|FG003|Overall Study|Did Not Receive Treatment|0|||
25242915|NCT01325350|50557622|FG004|Overall Study|Did Not Receive Treatment|1|||
25242916|NCT01324999|50557634|FG000|Overall Study|Adverse Event|3|||
25242917|NCT01324999|50557634|FG000|Overall Study|Withdrawal by Subject|2|||
25242918|NCT01324570|50557640|FG000|Overall Study|Adverse Event|4|||
25242919|NCT01324570|50557641|FG001|Overall Study|Adverse Event|7|||
25242920|NCT01324570|50557640|FG000|Overall Study|Withdrawal by Subject|0|||
25242921|NCT01324570|50557641|FG001|Overall Study|Withdrawal by Subject|3|||
25242922|NCT01324570|50557640|FG000|Overall Study|Lack of Efficacy|0|||
25242923|NCT01324570|50557641|FG001|Overall Study|Lack of Efficacy|1|||
25242924|NCT01324570|50557640|FG000|Overall Study|Confirmed or suspected diversion|0|||
25242925|NCT01324570|50557641|FG001|Overall Study|Confirmed or suspected diversion|1|||
25242926|NCT01324570|50557640|FG000|Overall Study|Administrative|0|||
25322474|NCT00886769|50638856|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
25322475|NCT00886613|50638865|FG000|Overall Study|Protocol deviation (Part B)|1|||
25242927|NCT01324570|50557641|FG001|Overall Study|Administrative|2|||
25322476|NCT00886613|50638866|FG001|Overall Study|Protocol deviation (Part B)|0|||
25322477|NCT00886613|50638867|FG002|Overall Study|Protocol deviation (Part B)|0|||
25322478|NCT00886613|50638865|FG000|Overall Study|Lost to follow-up (Part B)|1|||
25322479|NCT00886613|50638866|FG001|Overall Study|Lost to follow-up (Part B)|0|||
25322480|NCT00886613|50638867|FG002|Overall Study|Lost to follow-up (Part B)|1|||
25322481|NCT00886613|50638865|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
25322482|NCT00886613|50638866|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
25242928|NCT01324141|50557649|FG000|Overall Study|Declined to participate before treatment started|1|||
25242929|NCT01324141|50557649|FG000|Overall Study|Disease progression on study|1|||
25322483|NCT00886613|50638867|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
25322484|NCT00886379|50638883|FG000|Overall Study|Transferred Schools|0|||
25322485|NCT00886379|50638884|FG001|Overall Study|Transferred Schools|0|||
25322486|NCT00886379|50638885|FG002|Overall Study|Transferred Schools|2|||
25322487|NCT00886379|50638886|FG003|Overall Study|Transferred Schools|1|||
25322488|NCT00886379|50638887|FG004|Overall Study|Transferred Schools|1|||
25322489|NCT00886379|50638883|FG000|Overall Study|Final blood draw not obtained|3|||
25322490|NCT00886379|50638884|FG001|Overall Study|Final blood draw not obtained|3|||
25322491|NCT00886379|50638885|FG002|Overall Study|Final blood draw not obtained|4|||
25322492|NCT00886379|50638886|FG003|Overall Study|Final blood draw not obtained|2|||
25322493|NCT00886379|50638887|FG004|Overall Study|Final blood draw not obtained|2|||
25322494|NCT00599196|50638899|FG000|Overall Study|Lack of Efficacy|22|||
25322495|NCT00599196|50638899|FG000|Overall Study|Adverse Event|93|||
25322496|NCT00599196|50638899|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
25322497|NCT00599196|50638899|FG000|Overall Study|Subject withdrew consent|43|||
25322498|NCT00599196|50638899|FG000|Overall Study|Study ended per sponsor|197|||
25322499|NCT00599196|50638899|FG000|Overall Study|Lost to Follow-up|17|||
25322500|NCT00599196|50638899|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
25322501|NCT00599196|50638899|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
25322502|NCT00599196|50638899|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
25322503|NCT00599196|50638899|FG000|Overall Study|Other: Pt Moved To Australia|1|||
25322504|NCT00599196|50638899|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
25322505|NCT00599196|50638899|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
25322506|NCT00603512|50638908|FG000|Overall Study|Adverse Event|0|||
25242930|NCT01324102|50557665|FG000|Overall Study|illness|1|||
25242931|NCT01324102|50557666|FG001|Overall Study|illness|6|||
25242932|NCT01324024|50557673|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
25242933|NCT01324024|50557674|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
25242934|NCT01323946|50557687|FG000|Overall Study|Lost to Follow-up|0|||
25242935|NCT01323946|50557688|FG001|Overall Study|Lost to Follow-up|1|||
25242936|NCT01323946|50557689|FG002|Overall Study|Lost to Follow-up|0|||
25242937|NCT01323946|50557687|FG000|Overall Study|Parents refused the last blood draw|1|||
25242938|NCT01323946|50557688|FG001|Overall Study|Parents refused the last blood draw|0|||
25242939|NCT01323946|50557689|FG002|Overall Study|Parents refused the last blood draw|0|||
25242940|NCT01323946|50557687|FG000|Overall Study|Withdrawal by Subject|2|||
25242941|NCT01323946|50557688|FG001|Overall Study|Withdrawal by Subject|2|||
25322507|NCT00603512|50638909|FG001|Overall Study|Adverse Event|2|||
25322508|NCT00603512|50638910|FG002|Overall Study|Adverse Event|4|||
25322509|NCT00603512|50638911|FG003|Overall Study|Adverse Event|4|||
25322510|NCT00603512|50638912|FG004|Overall Study|Adverse Event|2|||
25242942|NCT01323946|50557689|FG002|Overall Study|Withdrawal by Subject|0|||
25242943|NCT01323790|50557702|FG000|Overall Study|Other|3|||
25242944|NCT01323790|50557703|FG001|Overall Study|Other|2|||
25322511|NCT00603512|50638908|FG000|Overall Study|Lack of Efficacy|0|||
25322512|NCT00603512|50638909|FG001|Overall Study|Lack of Efficacy|1|||
25322513|NCT00603512|50638910|FG002|Overall Study|Lack of Efficacy|0|||
25322514|NCT00603512|50638911|FG003|Overall Study|Lack of Efficacy|0|||
25242945|NCT01323790|50557704|FG002|Overall Study|Other|1|||
25322515|NCT00603512|50638912|FG004|Overall Study|Lack of Efficacy|1|||
25322516|NCT00603512|50638908|FG000|Overall Study|Other|2|||
25242946|NCT01323790|50557702|FG000|Overall Study|Lost to Follow-up|11|||
25322517|NCT00603512|50638909|FG001|Overall Study|Other|1|||
25322518|NCT00603512|50638910|FG002|Overall Study|Other|0|||
25242947|NCT01323790|50557703|FG001|Overall Study|Lost to Follow-up|9|||
25242948|NCT01323790|50557704|FG002|Overall Study|Lost to Follow-up|9|||
25242949|NCT01323790|50557702|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
25322519|NCT00603512|50638911|FG003|Overall Study|Other|1|||
25322520|NCT00603512|50638912|FG004|Overall Study|Other|1|||
25322521|NCT00603512|50638908|FG000|Overall Study|Withdrawal by Subject|0|||
25322522|NCT00603512|50638909|FG001|Overall Study|Withdrawal by Subject|0|||
25322523|NCT00603512|50638910|FG002|Overall Study|Withdrawal by Subject|0|||
25322524|NCT00603512|50638911|FG003|Overall Study|Withdrawal by Subject|0|||
25322525|NCT00603512|50638912|FG004|Overall Study|Withdrawal by Subject|1|||
25322526|NCT00603512|50638908|FG000|Overall Study|Randomized but not treated|0|||
25322527|NCT00603512|50638909|FG001|Overall Study|Randomized but not treated|1|||
25242950|NCT01323790|50557703|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
25242951|NCT01323790|50557704|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
25242952|NCT01323790|50557702|FG000|Overall Study|Lack of Efficacy|3|||
25242953|NCT01323790|50557703|FG001|Overall Study|Lack of Efficacy|0|||
25242954|NCT01323790|50557704|FG002|Overall Study|Lack of Efficacy|3|||
25242955|NCT01323790|50557702|FG000|Overall Study|Adverse Event|11|||
25242956|NCT01323790|50557703|FG001|Overall Study|Adverse Event|24|||
25242957|NCT01323790|50557704|FG002|Overall Study|Adverse Event|12|||
25242958|NCT01323790|50557702|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
25242959|NCT01323790|50557703|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
25322528|NCT00603512|50638910|FG002|Overall Study|Randomized but not treated|1|||
25322529|NCT00603512|50638911|FG003|Overall Study|Randomized but not treated|2|||
25322530|NCT00603512|50638912|FG004|Overall Study|Randomized but not treated|0|||
25322531|NCT04242875|50638924|FG000|Overall Study|Adverse Event|2|||
25322532|NCT00603278|50638938|FG000|Overall Study|Lack of Efficacy|35|||
25322533|NCT00603278|50638939|FG001|Overall Study|Lack of Efficacy|10|||
25322534|NCT00603278|50638940|FG002|Overall Study|Lack of Efficacy|11|||
25322535|NCT00603278|50638941|FG003|Overall Study|Lack of Efficacy|8|||
25322536|NCT00603278|50638942|FG004|Overall Study|Lack of Efficacy|7|||
25322537|NCT00603278|50638943|FG005|Overall Study|Lack of Efficacy|14|||
25322538|NCT00603278|50638938|FG000|Overall Study|Adverse Event|0|||
25322539|NCT00603278|50638939|FG001|Overall Study|Adverse Event|3|||
25322540|NCT00603278|50638940|FG002|Overall Study|Adverse Event|1|||
25322541|NCT00603278|50638941|FG003|Overall Study|Adverse Event|0|||
25322542|NCT00603278|50638942|FG004|Overall Study|Adverse Event|2|||
25242960|NCT01323790|50557704|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
25242961|NCT01323790|50557702|FG000|Overall Study|Withdrawal by Subject|23|||
25242962|NCT01323790|50557703|FG001|Overall Study|Withdrawal by Subject|20|||
25242963|NCT01323790|50557704|FG002|Overall Study|Withdrawal by Subject|13|||
25242964|NCT01323790|50557702|FG000|Overall Study|Did Not Receive Treatment|2|||
25242965|NCT01323790|50557703|FG001|Overall Study|Did Not Receive Treatment|0|||
25242966|NCT01323790|50557704|FG002|Overall Study|Did Not Receive Treatment|1|||
25242967|NCT01323790|50557702|FG000|Overall Study|Severe non-compliance with protocol|2|||
25242968|NCT01323790|50557703|FG001|Overall Study|Severe non-compliance with protocol|2|||
25242969|NCT01323790|50557704|FG002|Overall Study|Severe non-compliance with protocol|2|||
25242970|NCT01323673|50557714|FG000|Overall Study|Adverse Event|0|||
25242971|NCT01323673|50557715|FG001|Overall Study|Adverse Event|1|||
25242972|NCT01323673|50557714|FG000|Overall Study|Lost to Follow-up|0|||
25242973|NCT01323673|50557715|FG001|Overall Study|Lost to Follow-up|1|||
25242974|NCT01323673|50557714|FG000|Overall Study|Protocol Violation|1|||
25242975|NCT01323673|50557715|FG001|Overall Study|Protocol Violation|0|||
25242976|NCT01323673|50557714|FG000|Overall Study|Withdrawal by Subject|2|||
25242977|NCT01323673|50557715|FG001|Overall Study|Withdrawal by Subject|3|||
25242978|NCT01323634|50557723|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
25242979|NCT01323634|50557724|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
25242980|NCT01323634|50557725|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
25242981|NCT01323634|50557723|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
25322543|NCT00603278|50638943|FG005|Overall Study|Adverse Event|1|||
25322544|NCT00603278|50638938|FG000|Overall Study|Withdrawal by Subject|2|||
25077671|NCT02460380|50185500|FG000|Overall Study|Withdrawal by Subject|10|||
25242982|NCT01323634|50557724|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
25242983|NCT01323634|50557725|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
25322545|NCT00603278|50638939|FG001|Overall Study|Withdrawal by Subject|3|||
25322546|NCT00603278|50638940|FG002|Overall Study|Withdrawal by Subject|1|||
25242984|NCT01323634|50557723|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
25242985|NCT01323634|50557724|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
25242986|NCT01323634|50557725|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
25322547|NCT00603278|50638941|FG003|Overall Study|Withdrawal by Subject|2|||
25242987|NCT01323634|50557723|FG000|2-week Run-in Period|Physician Decision|5|||
25242988|NCT01323634|50557724|FG001|2-week Run-in Period|Physician Decision|0|||
25242989|NCT01323634|50557725|FG002|2-week Run-in Period|Physician Decision|0|||
25242990|NCT01323634|50557723|FG000|2-week Run-in Period|Protocol Violation|1|||
25242991|NCT01323634|50557724|FG001|2-week Run-in Period|Protocol Violation|0|||
25242992|NCT01323634|50557725|FG002|2-week Run-in Period|Protocol Violation|0|||
25242993|NCT01323634|50557723|FG000|2-week Run-in Period|Adverse Event|1|||
25242994|NCT01323634|50557724|FG001|2-week Run-in Period|Adverse Event|0|||
25242995|NCT01323634|50557725|FG002|2-week Run-in Period|Adverse Event|0|||
25242996|NCT01323634|50557723|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
25242997|NCT01323634|50557724|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
25242998|NCT01323634|50557725|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
25242999|NCT01323634|50557723|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
25243000|NCT01323634|50557724|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
25243001|NCT01323634|50557725|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
25243002|NCT01323634|50557723|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
25243003|NCT01323634|50557724|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
25243004|NCT01323634|50557725|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
25243005|NCT01323634|50557723|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
25243006|NCT01323634|50557724|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
25243007|NCT01323634|50557725|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
25243008|NCT01323634|50557723|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
25243009|NCT01323634|50557724|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
25243010|NCT01323634|50557725|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
25243011|NCT01323634|50557723|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
25243012|NCT01323634|50557724|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
25243013|NCT01323634|50557725|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
25243014|NCT01323634|50557723|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
25243015|NCT01323634|50557724|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
25243016|NCT01323634|50557725|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
25243017|NCT01323478|50557731|FG000|Overall Study|Adverse Event|7|||
25243018|NCT01323478|50557731|FG000|Overall Study|Lack of Efficacy|4|||
25243019|NCT01323478|50557731|FG000|Overall Study|Non-compliance With Study Product|3|||
25243020|NCT01323478|50557731|FG000|Overall Study|Protocol Violation|1|||
25243021|NCT01323478|50557731|FG000|Overall Study|Withdrawal of Consent|1|||
25243022|NCT01323478|50557731|FG000|Overall Study|Administrative or Other Reasons|8|||
25243023|NCT01322386|50557737|FG000|Overall Study|Protocol Violation|0|||
25243024|NCT01322386|50557738|FG001|Overall Study|Protocol Violation|1|||
25243025|NCT01322386|50557737|FG000|Overall Study|Physician Decision|0|||
25243026|NCT01322386|50557738|FG001|Overall Study|Physician Decision|1|||
25243027|NCT01322347|50557748|FG000|Overall Study|Adverse Event|7|||
25243028|NCT01322347|50557749|FG001|Overall Study|Adverse Event|2|||
25243029|NCT01322347|50557748|FG000|Overall Study|Death|5|||
25243030|NCT01322347|50557749|FG001|Overall Study|Death|3|||
25243031|NCT01322347|50557748|FG000|Overall Study|Physician Decision|2|||
25243032|NCT01322347|50557749|FG001|Overall Study|Physician Decision|1|||
25243033|NCT01322347|50557748|FG000|Overall Study|Protocol Violation|5|||
25243034|NCT01322347|50557749|FG001|Overall Study|Protocol Violation|2|||
25243035|NCT01322347|50557748|FG000|Overall Study|Withdrawal by Subject|1|||
25243036|NCT01322347|50557749|FG001|Overall Study|Withdrawal by Subject|4|||
25243037|NCT01322347|50557748|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
25243038|NCT01322347|50557749|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
25243039|NCT01322347|50557748|FG000|Overall Study|blood transfusion|5|||
25243040|NCT01322347|50557749|FG001|Overall Study|blood transfusion|5|||
25243041|NCT01322347|50557748|FG000|Overall Study|sponsor decision|1|||
25243042|NCT01322347|50557749|FG001|Overall Study|sponsor decision|3|||
25243043|NCT01322347|50557748|FG000|Overall Study|ineligible|6|||
25243044|NCT01322347|50557749|FG001|Overall Study|ineligible|3|||
25243045|NCT01322347|50557748|FG000|Overall Study|kidney transplant|3|||
25243046|NCT01322347|50557749|FG001|Overall Study|kidney transplant|1|||
25243047|NCT01322347|50557748|FG000|Overall Study|study drug withheld > 12 wks|0|||
25243048|NCT01322347|50557749|FG001|Overall Study|study drug withheld > 12 wks|1|||
25243049|NCT01322347|50557748|FG000|Overall Study|moved/changed dialysis|2|||
25243050|NCT01322347|50557749|FG001|Overall Study|moved/changed dialysis|4|||
25243051|NCT01321879|50557756|FG000|Overall Study|Lack of Efficacy|5|||
25243052|NCT01321879|50557756|FG000|Overall Study|Adverse Event|5|||
25243053|NCT01321879|50557756|FG000|Overall Study|Death|3|||
25243054|NCT01321879|50557756|FG000|Overall Study|Withdrawal by Subject|1|||
25243055|NCT01321723|50557763|FG000|Overall Study|Adverse Event|3|||
25243056|NCT01321723|50557764|FG001|Overall Study|Adverse Event|5|||
25243057|NCT01321723|50557765|FG002|Overall Study|Adverse Event|2|||
25243058|NCT01321723|50557763|FG000|Overall Study|Withdrawal by Subject|2|||
25243059|NCT01321723|50557764|FG001|Overall Study|Withdrawal by Subject|0|||
25243060|NCT01321723|50557765|FG002|Overall Study|Withdrawal by Subject|2|||
25243061|NCT01321606|50557775|FG000|Overall Study|Lost to Follow-up|0|||
25243062|NCT01321606|50557776|FG001|Overall Study|Lost to Follow-up|0|||
25243063|NCT01321606|50557777|FG002|Overall Study|Lost to Follow-up|0|||
25243064|NCT01321606|50557778|FG003|Overall Study|Lost to Follow-up|1|||
25243065|NCT01320943|50557790|FG000|Overall Study|Lost to Follow-up|1|||
25243066|NCT01320943|50557791|FG001|Overall Study|Lost to Follow-up|0|||
25243067|NCT01320943|50557790|FG000|Overall Study|Physician Decision|0|||
25243068|NCT01320943|50557791|FG001|Overall Study|Physician Decision|1|||
25243069|NCT01320943|50557790|FG000|Overall Study|Randomized but not Treated|0|||
25243070|NCT01320943|50557791|FG001|Overall Study|Randomized but not Treated|1|||
25243071|NCT02482233|50557806|FG000|Overall Study|Lost to Follow-up|1|||
25243072|NCT02482233|50557807|FG001|Overall Study|Lost to Follow-up|1|||
25243073|NCT01320202|50557817|FG000|Overall Study|Adverse Event|5|||
25243074|NCT01320202|50557818|FG001|Overall Study|Adverse Event|5|||
25243075|NCT01320202|50557817|FG000|Overall Study|Death|5|||
25243076|NCT01320202|50557818|FG001|Overall Study|Death|3|||
25243077|NCT01320202|50557817|FG000|Overall Study|Lost to Follow-up|1|||
25322548|NCT00603278|50638942|FG004|Overall Study|Withdrawal by Subject|1|||
25322549|NCT00603278|50638943|FG005|Overall Study|Withdrawal by Subject|2|||
25322550|NCT00603278|50638938|FG000|Overall Study|Protocol Violation|3|||
25322551|NCT00603278|50638939|FG001|Overall Study|Protocol Violation|0|||
25322552|NCT00603278|50638940|FG002|Overall Study|Protocol Violation|1|||
25322553|NCT00603278|50638941|FG003|Overall Study|Protocol Violation|1|||
25322554|NCT00603278|50638942|FG004|Overall Study|Protocol Violation|0|||
25322555|NCT00603278|50638943|FG005|Overall Study|Protocol Violation|1|||
25322556|NCT00603278|50638938|FG000|Overall Study|Physician Decision|0|||
25322557|NCT00603278|50638939|FG001|Overall Study|Physician Decision|1|||
25322558|NCT00603278|50638940|FG002|Overall Study|Physician Decision|0|||
25322559|NCT00603278|50638941|FG003|Overall Study|Physician Decision|0|||
25322560|NCT00603278|50638942|FG004|Overall Study|Physician Decision|2|||
25322561|NCT00603278|50638943|FG005|Overall Study|Physician Decision|1|||
25322562|NCT00603278|50638938|FG000|Overall Study|Lost to Follow-up|1|||
25322563|NCT00603278|50638939|FG001|Overall Study|Lost to Follow-up|0|||
25322564|NCT00603278|50638940|FG002|Overall Study|Lost to Follow-up|0|||
25322565|NCT00603278|50638941|FG003|Overall Study|Lost to Follow-up|0|||
25322566|NCT00603278|50638942|FG004|Overall Study|Lost to Follow-up|1|||
25322567|NCT00603278|50638943|FG005|Overall Study|Lost to Follow-up|0|||
25322568|NCT00876447|50638959|FG000|Overall Study|Other miscellaneous reasons|3|||
25322569|NCT00876447|50638960|FG001|Overall Study|Other miscellaneous reasons|8|||
25322570|NCT00876447|50638959|FG000|Overall Study|Site closure|19|||
25322571|NCT00876447|50638960|FG001|Overall Study|Site closure|14|||
25322572|NCT00876447|50638959|FG000|Overall Study|Protocol Violation|9|||
25322573|NCT00876447|50638960|FG001|Overall Study|Protocol Violation|3|||
25322574|NCT00876447|50638959|FG000|Overall Study|Personal reasons|30|||
25322575|NCT00876447|50638960|FG001|Overall Study|Personal reasons|28|||
25322576|NCT00876447|50638959|FG000|Overall Study|Lost to Follow-up|6|||
25322577|NCT00876447|50638960|FG001|Overall Study|Lost to Follow-up|15|||
25322578|NCT00876447|50638959|FG000|Overall Study|Pregnancy|4|||
25322579|NCT00876447|50638960|FG001|Overall Study|Pregnancy|2|||
25322580|NCT00876447|50638959|FG000|Overall Study|Lack of Efficacy|5|||
25243078|NCT01320202|50557818|FG001|Overall Study|Lost to Follow-up|0|||
25243079|NCT01320202|50557817|FG000|Overall Study|Physician Decision|3|||
25243080|NCT01320202|50557818|FG001|Overall Study|Physician Decision|1|||
25243081|NCT01320202|50557817|FG000|Overall Study|Protocol Violation|2|||
25243082|NCT01320202|50557818|FG001|Overall Study|Protocol Violation|1|||
25243083|NCT01320202|50557817|FG000|Overall Study|Withdrawal by Subject|10|||
25243084|NCT01320202|50557818|FG001|Overall Study|Withdrawal by Subject|3|||
25243085|NCT01320202|50557817|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
25243086|NCT01320202|50557818|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
25243087|NCT01320202|50557817|FG000|Overall Study|kidney transplant|1|||
25243088|NCT01320202|50557818|FG001|Overall Study|kidney transplant|2|||
25243089|NCT01320202|50557817|FG000|Overall Study|blood transfusion|1|||
25243090|NCT01320202|50557818|FG001|Overall Study|blood transfusion|7|||
25243091|NCT01320202|50557817|FG000|Overall Study|moved/changed dialysis|5|||
25243092|NCT01320202|50557818|FG001|Overall Study|moved/changed dialysis|2|||
25322581|NCT00876447|50638960|FG001|Overall Study|Lack of Efficacy|3|||
25322582|NCT00876447|50638959|FG000|Overall Study|Adverse Event|4|||
25322583|NCT00876447|50638960|FG001|Overall Study|Adverse Event|8|||
25322584|NCT00598650|50638990|FG000|Overall Study|Withdrawal by Subject|3|||
25322585|NCT00598650|50638990|FG000|Overall Study|Adverse Event|18|||
25322586|NCT00598650|50638990|FG000|Overall Study|No treatment for 3 weeks|1|||
25243093|NCT01320202|50557817|FG000|Overall Study|sponsor request|2|||
25243094|NCT01320202|50557818|FG001|Overall Study|sponsor request|0|||
25243095|NCT01320202|50557817|FG000|Overall Study|ineligible|3|||
25243096|NCT01320202|50557818|FG001|Overall Study|ineligible|0|||
25243097|NCT01320202|50557817|FG000|Overall Study|regained renal function|1|||
25243098|NCT01320202|50557818|FG001|Overall Study|regained renal function|0|||
25322587|NCT00598650|50638990|FG000|Overall Study|Not eligible|1|||
25243099|NCT01319383|50557827|FG000|Overall Study|No ex vivo or in vivo response|4|||
25243100|NCT01319383|50557828|FG001|Overall Study|No ex vivo or in vivo response|0|||
25243101|NCT01319383|50557827|FG000|Overall Study|Physician Decision|3|||
25243102|NCT01319383|50557828|FG001|Overall Study|Physician Decision|0|||
25243103|NCT01319383|50557827|FG000|Overall Study|Lack of Efficacy|5|||
25243104|NCT01319383|50557828|FG001|Overall Study|Lack of Efficacy|9|||
25243105|NCT01319383|50557827|FG000|Overall Study|No in vivo response to interval doses|0|||
25243106|NCT01319383|50557828|FG001|Overall Study|No in vivo response to interval doses|1|||
25243107|NCT01316614|50557845|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
25243108|NCT01316614|50557845|FG000|Overall Study|Cytology slides not available for review|4|||
25243109|NCT01316614|50557845|FG000|Overall Study|Cystic lesion|5|||
25243110|NCT01316614|50557845|FG000|Overall Study|Inadequate number of passes|2|||
25243111|NCT01316614|50557845|FG000|Overall Study|Medically unstable|1|||
25243112|NCT01316575|50557852|FG000|Overall Study|Withdrawal by Subject|2|||
25243113|NCT01316575|50557853|FG001|Overall Study|Withdrawal by Subject|0|||
25322588|NCT00598650|50638990|FG000|Overall Study|Prohibited Concomitant Medication|2|||
25322589|NCT00598650|50638990|FG000|Overall Study|Physician Decision|2|||
25322590|NCT04249076|50638997|FG000|Overall Study|Adverse Event|1|||
25322591|NCT04249076|50638998|FG001|Overall Study|Adverse Event|1|||
25322592|NCT04249076|50638997|FG000|Overall Study|Protocol Violation|1|||
25322593|NCT04249076|50638998|FG001|Overall Study|Protocol Violation|2|||
25322594|NCT04249076|50638997|FG000|Overall Study|Lack of Efficacy|0|||
25322595|NCT04249076|50638998|FG001|Overall Study|Lack of Efficacy|1|||
25243114|NCT01316575|50557852|FG000|Overall Study|Required alternate treatment|0|||
25243115|NCT01316575|50557853|FG001|Overall Study|Required alternate treatment|1|||
25243116|NCT01315678|50557861|FG000|Overall Study|Withdrawal by Subject|7|||
25243117|NCT01315678|50557862|FG001|Overall Study|Withdrawal by Subject|3|||
25243118|NCT01315678|50557861|FG000|Overall Study|Adverse Event|3|||
25243119|NCT01315678|50557862|FG001|Overall Study|Adverse Event|1|||
25243120|NCT01315678|50557861|FG000|Overall Study|Lost to Follow-up|1|||
25243121|NCT01315678|50557862|FG001|Overall Study|Lost to Follow-up|0|||
25243122|NCT01315678|50557861|FG000|Overall Study|similar reason to those listed above|3|||
25243123|NCT01315678|50557862|FG001|Overall Study|similar reason to those listed above|2|||
25243124|NCT01315249|50557872|FG000|Overall Study|Adverse Event|22|||
25243125|NCT01315249|50557873|FG001|Overall Study|Adverse Event|26|||
25243126|NCT01315249|50557872|FG000|Overall Study|Withdrawal by Subject|11|||
25243127|NCT01315249|50557873|FG001|Overall Study|Withdrawal by Subject|10|||
25243128|NCT01315249|50557872|FG000|Overall Study|Protocol Violation|8|||
25243129|NCT01315249|50557873|FG001|Overall Study|Protocol Violation|5|||
25243130|NCT01315249|50557872|FG000|Overall Study|Abnormal test results|1|||
25243131|NCT01315249|50557873|FG001|Overall Study|Abnormal test results|2|||
25243132|NCT01315249|50557872|FG000|Overall Study|Administrative problems|1|||
25243133|NCT01315249|50557873|FG001|Overall Study|Administrative problems|0|||
25243134|NCT01315249|50557872|FG000|Overall Study|inability to use device|1|||
25243135|NCT01315249|50557873|FG001|Overall Study|inability to use device|0|||
25243136|NCT01315249|50557872|FG000|Overall Study|Lack of Efficacy|0|||
25243137|NCT01315249|50557873|FG001|Overall Study|Lack of Efficacy|1|||
25243138|NCT01315249|50557872|FG000|Overall Study|Lost to Follow-up|0|||
25243139|NCT01315249|50557873|FG001|Overall Study|Lost to Follow-up|2|||
25243140|NCT01315249|50557872|FG000|Overall Study|Death|0|||
25243141|NCT01315249|50557873|FG001|Overall Study|Death|1|||
25243142|NCT01315132|50557879|FG000|Overall Study|not treated due to disease progression|1|||
25243143|NCT01313767|50557885|FG000|Overall Study|Adverse Event|1|||
25243144|NCT01313767|50557886|FG001|Overall Study|Adverse Event|0|||
25243145|NCT01313767|50557885|FG000|Overall Study|Lost to Follow-up|1|||
25243146|NCT01313767|50557886|FG001|Overall Study|Lost to Follow-up|0|||
25243147|NCT01313767|50557885|FG000|Overall Study|Withdrawal by Subject|2|||
25243148|NCT01313767|50557886|FG001|Overall Study|Withdrawal by Subject|1|||
25243149|NCT01313767|50557885|FG000|Overall Study|Protocol Violation|3|||
25243150|NCT01313767|50557886|FG001|Overall Study|Protocol Violation|1|||
25243151|NCT01313728|50557892|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
25243152|NCT01313650|50557901|FG000|Overall Study|Adverse Event|9|||
25243153|NCT01313650|50557902|FG001|Overall Study|Adverse Event|34|||
25243154|NCT01313650|50557903|FG002|Overall Study|Adverse Event|24|||
25243155|NCT01313650|50557904|FG003|Overall Study|Adverse Event|23|||
25243156|NCT01313650|50557901|FG000|Overall Study|Lack of Efficacy|37|||
25243157|NCT01313650|50557902|FG001|Overall Study|Lack of Efficacy|20|||
25243158|NCT01313650|50557903|FG002|Overall Study|Lack of Efficacy|32|||
25243159|NCT01313650|50557904|FG003|Overall Study|Lack of Efficacy|20|||
25243160|NCT01313650|50557901|FG000|Overall Study|Lost to Follow-up|1|||
25243161|NCT01313650|50557902|FG001|Overall Study|Lost to Follow-up|0|||
25243162|NCT01313650|50557903|FG002|Overall Study|Lost to Follow-up|3|||
25243163|NCT01313650|50557904|FG003|Overall Study|Lost to Follow-up|2|||
25243164|NCT01313650|50557901|FG000|Overall Study|Withdrawal by Subject|16|||
25243165|NCT01313650|50557902|FG001|Overall Study|Withdrawal by Subject|20|||
25322596|NCT04249076|50638997|FG000|Overall Study|Withdrawal by Subject|0|||
25243166|NCT01313650|50557903|FG002|Overall Study|Withdrawal by Subject|15|||
25243167|NCT01313650|50557904|FG003|Overall Study|Withdrawal by Subject|15|||
25243168|NCT01313650|50557901|FG000|Overall Study|Protocol Violation|4|||
25243169|NCT01313650|50557902|FG001|Overall Study|Protocol Violation|7|||
25243170|NCT01313650|50557903|FG002|Overall Study|Protocol Violation|5|||
25243171|NCT01313650|50557904|FG003|Overall Study|Protocol Violation|6|||
25243172|NCT01313650|50557901|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
25243173|NCT01313650|50557902|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
25243174|NCT01313650|50557903|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
25243175|NCT01313650|50557904|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
25243176|NCT01313299|50557917|FG000|Overall Study|Adverse Event|3|||
25243177|NCT01313299|50557918|FG001|Overall Study|Adverse Event|1|||
25243178|NCT01313299|50557919|FG002|Overall Study|Adverse Event|1|||
25243179|NCT01313299|50557917|FG000|Overall Study|Lost to Follow-up|1|||
25243180|NCT01313299|50557918|FG001|Overall Study|Lost to Follow-up|0|||
25243181|NCT01313299|50557919|FG002|Overall Study|Lost to Follow-up|0|||
25243182|NCT01313299|50557917|FG000|Overall Study|Protocol Violation|2|||
25243183|NCT01313299|50557918|FG001|Overall Study|Protocol Violation|0|||
25243184|NCT01313299|50557919|FG002|Overall Study|Protocol Violation|0|||
25243185|NCT01313299|50557917|FG000|Overall Study|Withdrawal by Subject|1|||
25243186|NCT01313299|50557918|FG001|Overall Study|Withdrawal by Subject|0|||
25243187|NCT01313299|50557919|FG002|Overall Study|Withdrawal by Subject|2|||
25243188|NCT01313299|50557917|FG000|Overall Study|Family reason and moved out of state|0|||
25243189|NCT01313299|50557918|FG001|Overall Study|Family reason and moved out of state|2|||
25243190|NCT01313299|50557919|FG002|Overall Study|Family reason and moved out of state|0|||
25243191|NCT01313299|50557917|FG000|Overall Study|Lack of subject compliance|0|||
25243192|NCT01313299|50557918|FG001|Overall Study|Lack of subject compliance|0|||
25243193|NCT01313299|50557919|FG002|Overall Study|Lack of subject compliance|1|||
25243194|NCT01313221|50557930|FG000|Overall Study|Protocol Violation|0|||
25243195|NCT01313221|50557931|FG001|Overall Study|Protocol Violation|1|||
25243196|NCT01313221|50557932|FG002|Overall Study|Protocol Violation|1|||
25243197|NCT01313221|50557930|FG000|Overall Study|Non-compliance|3|||
25243198|NCT01313221|50557931|FG001|Overall Study|Non-compliance|0|||
25243199|NCT01313221|50557932|FG002|Overall Study|Non-compliance|2|||
25243200|NCT01313221|50557930|FG000|Overall Study|Withdrawal by Subject|2|||
25243201|NCT01313221|50557931|FG001|Overall Study|Withdrawal by Subject|3|||
25243202|NCT01313221|50557932|FG002|Overall Study|Withdrawal by Subject|5|||
25243203|NCT01313221|50557930|FG000|Overall Study|Requirement for alternative therapy|0|||
25243204|NCT01313221|50557931|FG001|Overall Study|Requirement for alternative therapy|1|||
25243205|NCT01313221|50557932|FG002|Overall Study|Requirement for alternative therapy|1|||
25243206|NCT01313221|50557930|FG000|Overall Study|Lost to Follow-up|6|||
25243207|NCT01313221|50557931|FG001|Overall Study|Lost to Follow-up|3|||
25243208|NCT01313221|50557932|FG002|Overall Study|Lost to Follow-up|1|||
25243209|NCT01313221|50557930|FG000|Overall Study|Other|1|||
25243210|NCT01313221|50557931|FG001|Overall Study|Other|0|||
25243211|NCT01313221|50557932|FG002|Overall Study|Other|0|||
25243212|NCT01313221|50557930|FG000|Overall Study|Adverse Event|0|||
25243213|NCT01313221|50557931|FG001|Overall Study|Adverse Event|0|||
25243214|NCT01313221|50557932|FG002|Overall Study|Adverse Event|7|||
25243215|NCT01313221|50557930|FG000|Overall Study|Disease progression|0|||
25243216|NCT01313221|50557931|FG001|Overall Study|Disease progression|0|||
25243217|NCT01313221|50557932|FG002|Overall Study|Disease progression|2|||
25243218|NCT01313221|50557930|FG000|Overall Study|Physician Decision|0|||
25243219|NCT01313221|50557931|FG001|Overall Study|Physician Decision|0|||
25243220|NCT01313221|50557932|FG002|Overall Study|Physician Decision|2|||
25243221|NCT01313221|50557930|FG000|Overall Study|Pregnancy|0|||
25243222|NCT01313221|50557931|FG001|Overall Study|Pregnancy|0|||
25243223|NCT01313221|50557932|FG002|Overall Study|Pregnancy|2|||
25243224|NCT01313182|50557942|FG000|Overall Study|Protocol Violation|66|||
25243225|NCT01313182|50557943|FG001|Overall Study|Protocol Violation|92|||
25243226|NCT01312909|50557952|FG000|Overall Study|Randomized but not treated|1|||
25243227|NCT01312909|50557953|FG001|Overall Study|Randomized but not treated|3|||
25243228|NCT01312909|50557954|FG002|Overall Study|Randomized but not treated|1|||
25243229|NCT01312909|50557952|FG000|Overall Study|Adverse Event|1|||
25243230|NCT01312909|50557953|FG001|Overall Study|Adverse Event|0|||
25243231|NCT01312909|50557954|FG002|Overall Study|Adverse Event|3|||
25243232|NCT01312909|50557952|FG000|Overall Study|Protocol Violation|2|||
25243233|NCT01312909|50557953|FG001|Overall Study|Protocol Violation|0|||
25243234|NCT01312909|50557954|FG002|Overall Study|Protocol Violation|2|||
25243235|NCT01312909|50557952|FG000|Overall Study|Other|9|||
25243236|NCT01312909|50557953|FG001|Overall Study|Other|6|||
25243237|NCT01312909|50557954|FG002|Overall Study|Other|11|||
25243238|NCT01312909|50557952|FG000|Overall Study|Withdrawal by Subject|8|||
25243239|NCT01312909|50557953|FG001|Overall Study|Withdrawal by Subject|10|||
25243240|NCT01312909|50557954|FG002|Overall Study|Withdrawal by Subject|7|||
25243241|NCT01312909|50557952|FG000|Overall Study|Lost to Follow-up|21|||
25243242|NCT01312909|50557953|FG001|Overall Study|Lost to Follow-up|17|||
25243243|NCT01312909|50557954|FG002|Overall Study|Lost to Follow-up|20|||
25243244|NCT01312909|50557952|FG000|Overall Study|Insufficient clinical response|0|||
25243245|NCT01312909|50557953|FG001|Overall Study|Insufficient clinical response|0|||
25243246|NCT01312909|50557954|FG002|Overall Study|Insufficient clinical response|1|||
25243247|NCT01312909|50557952|FG000|Overall Study|Entrance criteria not met|0|||
25243248|NCT01312909|50557953|FG001|Overall Study|Entrance criteria not met|0|||
25243249|NCT01312909|50557954|FG002|Overall Study|Entrance criteria not met|2|||
25243250|NCT01312129|50557964|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
25243251|NCT01312129|50557965|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
25322597|NCT04249076|50638998|FG001|Overall Study|Withdrawal by Subject|1|||
25322598|NCT04150107|50639006|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
25322599|NCT04150107|50639007|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
25322600|NCT04150107|50639006|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
25322601|NCT04150107|50639007|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
25322602|NCT04173494|50639017|FG000|Randomized Double-Blind Treatment Period|Adverse Event|16|||
25243252|NCT01311661|50557971|FG000|Overall Study|Adverse Event|2|||
25243253|NCT01311661|50557971|FG000|Overall Study|Protocol Violation|3|||
25243254|NCT01311661|50557971|FG000|Overall Study|Withdrawal by Subject|2|||
25243255|NCT01311505|50557983|FG000|First Intervention Period|Protocol Violation|0|||
25243256|NCT01311505|50557984|FG001|First Intervention Period|Protocol Violation|1|||
25243257|NCT01310803|50557995|FG000|Overall Study|Subject terminated by Sponsor|1|||
25322603|NCT04173494|50639018|FG001|Randomized Double-Blind Treatment Period|Adverse Event|11|||
25322604|NCT04173494|50639017|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|6|||
25322605|NCT04173494|50639018|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|5|||
25322606|NCT04173494|50639017|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|6|||
25322607|NCT04173494|50639018|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|3|||
25322608|NCT04173494|50639017|FG000|Randomized Double-Blind Treatment Period|Death|4|||
25322609|NCT04173494|50639018|FG001|Randomized Double-Blind Treatment Period|Death|3|||
25322610|NCT04173494|50639017|FG000|Randomized Double-Blind Treatment Period|Leukemic Transformation|2|||
25322611|NCT04173494|50639018|FG001|Randomized Double-Blind Treatment Period|Leukemic Transformation|2|||
25322612|NCT04173494|50639017|FG000|Randomized Double-Blind Treatment Period|Disease Progression|1|||
25322613|NCT04173494|50639018|FG001|Randomized Double-Blind Treatment Period|Disease Progression|2|||
25322614|NCT04173494|50639017|FG000|Randomized Double-Blind Treatment Period|Lost to Follow-up|1|||
25322615|NCT04173494|50639018|FG001|Randomized Double-Blind Treatment Period|Lost to Follow-up|0|||
25322616|NCT04173494|50639017|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
25322617|NCT04173494|50639018|FG001|Randomized Double-Blind Treatment Period|Physician Decision|1|||
25322618|NCT04173494|50639017|FG000|Open-Label Extended Treatment Period|Open-label treatment ongoing|52|||
25322619|NCT04173494|50639018|FG001|Open-Label Extended Treatment Period|Open-label treatment ongoing|22|||
25322620|NCT04173494|50639017|FG000|Open-Label Extended Treatment Period|Continuing in MMB extension study|24|||
25322621|NCT04173494|50639018|FG001|Open-Label Extended Treatment Period|Continuing in MMB extension study|9|||
25322622|NCT04173494|50639017|FG000|Open-Label Extended Treatment Period|Adverse Event|8|||
25322623|NCT04173494|50639018|FG001|Open-Label Extended Treatment Period|Adverse Event|1|||
25322624|NCT04173494|50639017|FG000|Open-Label Extended Treatment Period|Withdrawal by Subject|2|||
25322625|NCT04173494|50639018|FG001|Open-Label Extended Treatment Period|Withdrawal by Subject|3|||
25322626|NCT04173494|50639017|FG000|Open-Label Extended Treatment Period|Death|3|||
25322627|NCT04173494|50639018|FG001|Open-Label Extended Treatment Period|Death|1|||
25322628|NCT04173494|50639017|FG000|Open-Label Extended Treatment Period|Physician Decision|2|||
25322629|NCT04173494|50639018|FG001|Open-Label Extended Treatment Period|Physician Decision|2|||
25322630|NCT04173494|50639017|FG000|Open-Label Extended Treatment Period|Lack of Efficacy|1|||
25322631|NCT04173494|50639018|FG001|Open-Label Extended Treatment Period|Lack of Efficacy|1|||
25322632|NCT04173494|50639017|FG000|Open-Label Extended Treatment Period|Leukemic transformation|0|||
25322633|NCT04173494|50639018|FG001|Open-Label Extended Treatment Period|Leukemic transformation|1|||
25322634|NCT00875979|50639026|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
25322635|NCT00875979|50639027|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
25322636|NCT00875979|50639026|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
25322637|NCT00875979|50639027|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
25322638|NCT00875979|50639026|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
25322639|NCT00875979|50639027|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
25243258|NCT01310803|50557996|FG001|Overall Study|Subject terminated by Sponsor|0|||
25243259|NCT01310413|50558008|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
25243260|NCT01310413|50558009|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
25243261|NCT01310413|50558010|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
25243262|NCT01310413|50558011|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
25243263|NCT01310413|50558012|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
25243264|NCT01310413|50558013|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
25243265|NCT01310413|50558014|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
25243266|NCT01310413|50558008|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
25243267|NCT01310413|50558009|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
25243268|NCT01310413|50558010|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
25243269|NCT01310413|50558011|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
25243270|NCT01310413|50558012|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
25243271|NCT01310413|50558013|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
25243272|NCT01310413|50558014|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
25243273|NCT01310413|50558008|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
25243274|NCT01310413|50558009|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
25243275|NCT01310413|50558010|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
25243276|NCT01310413|50558011|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
25243277|NCT01310413|50558012|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
25243278|NCT01310413|50558013|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
25243279|NCT01310413|50558014|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
25243280|NCT01310413|50558008|FG000|Day 0 to Day 385|Other|1|||
25243281|NCT01310413|50558009|FG001|Day 0 to Day 385|Other|0|||
25243282|NCT01310413|50558010|FG002|Day 0 to Day 385|Other|3|||
25243283|NCT01310413|50558011|FG003|Day 0 to Day 385|Other|0|||
25243284|NCT01310413|50558012|FG004|Day 0 to Day 385|Other|0|||
25243285|NCT01310413|50558013|FG005|Day 0 to Day 385|Other|0|||
25243286|NCT01310413|50558014|FG006|Day 0 to Day 385|Other|0|||
25243287|NCT01310413|50558008|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
25243288|NCT01310413|50558009|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
25243289|NCT01310413|50558010|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
25243290|NCT01310413|50558011|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
25243291|NCT01310413|50558012|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
25243292|NCT01310413|50558013|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
25243293|NCT01310413|50558014|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
25243294|NCT01310413|50558008|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
25243295|NCT01310413|50558009|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
25243296|NCT01310413|50558010|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
25243297|NCT01310413|50558011|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
25243298|NCT01310413|50558012|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
25243299|NCT01310413|50558013|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
25243300|NCT01310413|50558014|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
25243301|NCT01309828|50558045|FG000|Overall Study|Adverse Event|10|||
25243302|NCT01309828|50558046|FG001|Overall Study|Adverse Event|11|||
25243303|NCT01309828|50558045|FG000|Overall Study|Voluntary Withdrawal|5|||
25243304|NCT01309828|50558046|FG001|Overall Study|Voluntary Withdrawal|4|||
25243305|NCT01309828|50558045|FG000|Overall Study|Major Protocol Deviation|0|||
25243306|NCT01309828|50558046|FG001|Overall Study|Major Protocol Deviation|1|||
25243307|NCT01309828|50558045|FG000|Overall Study|Other|1|||
25243308|NCT01309828|50558046|FG001|Overall Study|Other|0|||
25243309|NCT01309282|50558052|FG000|Overall Study|Lost to Follow-up|1|||
25243310|NCT01309243|50558058|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
25243311|NCT01309243|50558059|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
25243312|NCT01309243|50558058|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
25243313|NCT01309243|50558059|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
25243314|NCT01309243|50558058|FG000|Randomized Phase Through Week 96|Death|0|||
25243315|NCT01309243|50558059|FG001|Randomized Phase Through Week 96|Death|1|||
25243316|NCT01309243|50558058|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
25243317|NCT01309243|50558059|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
25243318|NCT01309243|50558058|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
25243319|NCT01309243|50558059|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
25243320|NCT01309243|50558058|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
25243321|NCT01309243|50558059|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
25243322|NCT01309243|50558058|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
25243323|NCT01309243|50558059|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
25243324|NCT01309243|50558058|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
25243325|NCT01309243|50558059|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
25243326|NCT01309243|50558058|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
25243327|NCT01309243|50558059|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
25322640|NCT00875979|50639026|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
25322641|NCT00875979|50639027|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
25322642|NCT00875979|50639026|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
25243328|NCT01309243|50558058|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
25243329|NCT01309243|50558059|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
25243330|NCT01309243|50558058|FG000|Extension Phase|Lost to Follow-up|6|||
25243331|NCT01309243|50558059|FG001|Extension Phase|Lost to Follow-up|0|||
25243332|NCT01309204|50558067|FG000|Overall Study|Adverse Event|48|||
25243333|NCT01309204|50558068|FG001|Overall Study|Adverse Event|58|||
25243334|NCT01309204|50558067|FG000|Overall Study|Lost to Follow-up|2|||
25243335|NCT01309204|50558068|FG001|Overall Study|Lost to Follow-up|2|||
25243336|NCT01309204|50558067|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
25243337|NCT01309204|50558068|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
25243338|NCT01309204|50558067|FG000|Overall Study|Inadequate control of IOP|4|||
25322643|NCT00875979|50639027|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
25243339|NCT01309204|50558068|FG001|Overall Study|Inadequate control of IOP|4|||
25243340|NCT01309204|50558067|FG000|Overall Study|Other|4|||
25243341|NCT01309204|50558068|FG001|Overall Study|Other|1|||
25243342|NCT01309165|50558076|FG000|Overall Study|Lost to Follow-up|4|||
25243343|NCT01309165|50558077|FG001|Overall Study|Lost to Follow-up|3|||
25243344|NCT01309165|50558076|FG000|Overall Study|Return to work|1|||
25243345|NCT01309165|50558077|FG001|Overall Study|Return to work|2|||
25243346|NCT01309165|50558076|FG000|Overall Study|Left country|0|||
25243347|NCT01309165|50558077|FG001|Overall Study|Left country|1|||
25243348|NCT01309165|50558076|FG000|Overall Study|No transportation|0|||
25243349|NCT01309165|50558077|FG001|Overall Study|No transportation|1|||
25243350|NCT01309165|50558076|FG000|Overall Study|Admitted to hospital for second stroke|1|||
25243351|NCT01309165|50558077|FG001|Overall Study|Admitted to hospital for second stroke|0|||
25243352|NCT01308853|50558084|FG000|Overall Study|Adverse Event|1|||
25243353|NCT01308853|50558084|FG000|Overall Study|Lost to Follow-up|2|||
25243354|NCT01308853|50558084|FG000|Overall Study|Insertion of permanent implants|1|||
25243355|NCT01308736|50558090|FG000|Overall Study|Did not attend a single session|6|||
25243356|NCT01308736|50558091|FG001|Overall Study|Did not attend a single session|5|||
25243357|NCT01308580|50558099|FG000|Overall Study|Lost to Follow-up|12|||
25243358|NCT01308580|50558100|FG001|Overall Study|Lost to Follow-up|7|||
25243359|NCT01308463|50558107|FG000|Overall Study|Study Discontinued|23|||
25243360|NCT01308463|50558107|FG000|Overall Study|Death|4|||
25243361|NCT01308463|50558107|FG000|Overall Study|Revision|2|||
25243362|NCT01308424|50558113|FG000|Baseline Eligibility|Screen Failures|71|||
25243363|NCT01308424|50558114|FG001|Baseline Eligibility|Screen Failures|0|||
25243364|NCT01308424|50558115|FG002|Baseline Eligibility|Screen Failures|0|||
25243365|NCT01308424|50558113|FG000|Randomization|Adverse Event|0|||
25243366|NCT01308424|50558114|FG001|Randomization|Adverse Event|1|||
25243367|NCT01308424|50558115|FG002|Randomization|Adverse Event|1|||
25243368|NCT01308424|50558113|FG000|Randomization|Lost to Follow-up|0|||
25243369|NCT01308424|50558114|FG001|Randomization|Lost to Follow-up|1|||
25243370|NCT01308424|50558115|FG002|Randomization|Lost to Follow-up|0|||
25322644|NCT00875979|50639026|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
25322645|NCT00875979|50639027|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
25322646|NCT00875979|50639026|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
25322647|NCT00875979|50639027|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
25322648|NCT00875979|50639026|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
25322649|NCT00875979|50639027|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
25322650|NCT00875979|50639026|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
25322651|NCT00875979|50639027|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
25322652|NCT00602420|50639035|FG000|Overall Study|Death|1|||
25322653|NCT00602420|50639036|FG001|Overall Study|Death|4|||
25322654|NCT00602420|50639035|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
25322655|NCT00602420|50639036|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
25322656|NCT00602420|50639035|FG000|Overall Study|Withdrawal by Subject|18|||
25322657|NCT00602420|50639036|FG001|Overall Study|Withdrawal by Subject|17|||
25322658|NCT00602420|50639035|FG000|Overall Study|Adverse Event|1|||
25322659|NCT00602420|50639036|FG001|Overall Study|Adverse Event|0|||
25322660|NCT00875667|50639050|FG000|Overall Study|Adverse Event|29|||
25322661|NCT00875667|50639051|FG001|Overall Study|Adverse Event|10|||
25322662|NCT00875667|50639050|FG000|Overall Study|Withdrawal by Subject|17|||
25322663|NCT00875667|50639051|FG001|Overall Study|Withdrawal by Subject|5|||
25243371|NCT01308424|50558113|FG000|Randomization|Physician Decision|0|||
25243372|NCT01308424|50558114|FG001|Randomization|Physician Decision|1|||
25243373|NCT01308424|50558115|FG002|Randomization|Physician Decision|1|||
25243374|NCT01307800|50558126|FG000|Overall Study|Adverse Event|9|||
25243375|NCT01307800|50558127|FG001|Overall Study|Adverse Event|8|||
25243376|NCT01307800|50558128|FG002|Overall Study|Adverse Event|10|||
25243377|NCT01307800|50558129|FG003|Overall Study|Adverse Event|14|||
25243378|NCT01307800|50558126|FG000|Overall Study|Entry Criteria Not Met|0|||
25243379|NCT01307800|50558127|FG001|Overall Study|Entry Criteria Not Met|0|||
25243380|NCT01307800|50558128|FG002|Overall Study|Entry Criteria Not Met|0|||
25243381|NCT01307800|50558129|FG003|Overall Study|Entry Criteria Not Met|2|||
25243382|NCT01307800|50558126|FG000|Overall Study|Lost to Follow-up|5|||
25243383|NCT01307800|50558127|FG001|Overall Study|Lost to Follow-up|6|||
25243384|NCT01307800|50558128|FG002|Overall Study|Lost to Follow-up|2|||
25243385|NCT01307800|50558129|FG003|Overall Study|Lost to Follow-up|8|||
25322664|NCT00875667|50639050|FG000|Overall Study|Death|7|||
25322665|NCT00875667|50639051|FG001|Overall Study|Death|2|||
25322666|NCT00875667|50639050|FG000|Overall Study|Protocol Violation|2|||
25322667|NCT00875667|50639051|FG001|Overall Study|Protocol Violation|0|||
25322668|NCT00875667|50639050|FG000|Overall Study|Disease Progression|100|||
25243386|NCT01307800|50558126|FG000|Overall Study|Perceived Lack of Efficacy|24|||
25243387|NCT01307800|50558127|FG001|Overall Study|Perceived Lack of Efficacy|23|||
25243388|NCT01307800|50558128|FG002|Overall Study|Perceived Lack of Efficacy|20|||
25243389|NCT01307800|50558129|FG003|Overall Study|Perceived Lack of Efficacy|33|||
25243390|NCT01307800|50558126|FG000|Overall Study|Protocol Violation|0|||
25243391|NCT01307800|50558127|FG001|Overall Study|Protocol Violation|3|||
25243392|NCT01307800|50558128|FG002|Overall Study|Protocol Violation|4|||
25243393|NCT01307800|50558129|FG003|Overall Study|Protocol Violation|5|||
25243394|NCT01307800|50558126|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
25243395|NCT01307800|50558127|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
25243396|NCT01307800|50558128|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
25243397|NCT01307800|50558129|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
25243398|NCT01307800|50558126|FG000|Overall Study|Sponsor Decision|6|||
25243399|NCT01307800|50558127|FG001|Overall Study|Sponsor Decision|9|||
25243400|NCT01307800|50558128|FG002|Overall Study|Sponsor Decision|12|||
25243401|NCT01307800|50558129|FG003|Overall Study|Sponsor Decision|28|||
25243402|NCT01307800|50558126|FG000|Overall Study|Withdrawal by Subject|10|||
25243403|NCT01307800|50558127|FG001|Overall Study|Withdrawal by Subject|11|||
25243404|NCT01307800|50558128|FG002|Overall Study|Withdrawal by Subject|8|||
25243405|NCT01307800|50558129|FG003|Overall Study|Withdrawal by Subject|15|||
25243406|NCT01307800|50558126|FG000|Overall Study|Participant Moved|0|||
25243407|NCT01307800|50558127|FG001|Overall Study|Participant Moved|2|||
25243408|NCT01307800|50558128|FG002|Overall Study|Participant Moved|1|||
25243409|NCT01307800|50558129|FG003|Overall Study|Participant Moved|3|||
25243410|NCT01307449|50558143|FG000|Overall Study|Adverse Event|1|||
25243411|NCT01307449|50558144|FG001|Overall Study|Adverse Event|0|||
25243412|NCT01307449|50558145|FG002|Overall Study|Adverse Event|0|||
25243413|NCT01307449|50558146|FG003|Overall Study|Adverse Event|0|||
25243414|NCT01307020|50558166|FG000|Overall Study|Lost to Follow-up|0|||
25243415|NCT01307020|50558167|FG001|Overall Study|Lost to Follow-up|0|||
25243416|NCT01307020|50558168|FG002|Overall Study|Lost to Follow-up|1|||
25243417|NCT01307020|50558169|FG003|Overall Study|Lost to Follow-up|1|||
25243418|NCT01307020|50558170|FG004|Overall Study|Lost to Follow-up|0|||
25243419|NCT01307020|50558171|FG005|Overall Study|Lost to Follow-up|0|||
25243420|NCT01307020|50558172|FG006|Overall Study|Lost to Follow-up|1|||
25243421|NCT01307020|50558173|FG007|Overall Study|Lost to Follow-up|0|||
25243422|NCT01307020|50558174|FG008|Overall Study|Lost to Follow-up|0|||
25243423|NCT01307020|50558175|FG009|Overall Study|Lost to Follow-up|0|||
25243424|NCT01307020|50558166|FG000|Overall Study|Electronic data capture failure|0|||
25243425|NCT01307020|50558167|FG001|Overall Study|Electronic data capture failure|1|||
25243426|NCT01307020|50558168|FG002|Overall Study|Electronic data capture failure|0|||
25243427|NCT01307020|50558169|FG003|Overall Study|Electronic data capture failure|0|||
25243428|NCT01307020|50558170|FG004|Overall Study|Electronic data capture failure|0|||
25243429|NCT01307020|50558171|FG005|Overall Study|Electronic data capture failure|0|||
25243430|NCT01307020|50558172|FG006|Overall Study|Electronic data capture failure|0|||
25243431|NCT01307020|50558173|FG007|Overall Study|Electronic data capture failure|0|||
25243432|NCT01307020|50558174|FG008|Overall Study|Electronic data capture failure|0|||
25243433|NCT01307020|50558175|FG009|Overall Study|Electronic data capture failure|0|||
25243434|NCT01306201|50558197|FG000|Overall Study|Arrhythmia|4|||
25243435|NCT01306201|50558197|FG000|Overall Study|Files could not be processed|3|||
25243436|NCT01306201|50558197|FG000|Overall Study|Files unreadable|3|||
25243437|NCT01306162|50558209|FG000|Period 1|Adverse Event|0|||
25243438|NCT01306162|50558210|FG001|Period 1|Adverse Event|0|||
25243439|NCT01306162|50558211|FG002|Period 1|Adverse Event|0|||
25243440|NCT01306162|50558212|FG003|Period 1|Adverse Event|1|||
25243441|NCT01306162|50558209|FG000|Washout 1|Non-compliance to protocol|0|||
25243442|NCT01306162|50558210|FG001|Washout 1|Non-compliance to protocol|1|||
25243443|NCT01306162|50558211|FG002|Washout 1|Non-compliance to protocol|0|||
25243444|NCT01306162|50558212|FG003|Washout 1|Non-compliance to protocol|0|||
25322669|NCT00875667|50639051|FG001|Overall Study|Disease Progression|49|||
25322670|NCT00875667|50639050|FG000|Overall Study|Miscellaneous|12|||
25322671|NCT00875667|50639051|FG001|Overall Study|Miscellaneous|6|||
25322672|NCT00875667|50639050|FG000|Overall Study|Randomized but no Study Drug Given|3|||
25322673|NCT00875667|50639051|FG001|Overall Study|Randomized but no Study Drug Given|1|||
25322674|NCT00602030|50639061|FG000|Lead-in Phase|Disease Progression|2|||
25322675|NCT00602030|50639062|FG001|Lead-in Phase|Disease Progression|3|||
25243445|NCT01305577|50558228|FG000|Overall Study|Adverse Event|2|||
25243446|NCT01305577|50558229|FG001|Overall Study|Adverse Event|2|||
25243447|NCT01305577|50558230|FG002|Overall Study|Adverse Event|1|||
25322676|NCT00602030|50639063|FG002|Lead-in Phase|Disease Progression|0|||
25243448|NCT01305577|50558228|FG000|Overall Study|Withdrawal by Subject|7|||
25243449|NCT01305577|50558229|FG001|Overall Study|Withdrawal by Subject|5|||
25243450|NCT01305577|50558230|FG002|Overall Study|Withdrawal by Subject|6|||
25243451|NCT01305577|50558228|FG000|Overall Study|Lost to Follow-up|4|||
25243452|NCT01305577|50558229|FG001|Overall Study|Lost to Follow-up|3|||
25243453|NCT01305577|50558230|FG002|Overall Study|Lost to Follow-up|2|||
25243454|NCT01305577|50558228|FG000|Overall Study|Protocol Deviation|0|||
25243455|NCT01305577|50558229|FG001|Overall Study|Protocol Deviation|1|||
25243456|NCT01305577|50558230|FG002|Overall Study|Protocol Deviation|1|||
25243457|NCT01304329|50558238|FG000|Third Intervention (3 Days)|Adverse Event|0|||
25322677|NCT00602030|50639064|FG003|Lead-in Phase|Disease Progression|0|||
25243458|NCT01304329|50558239|FG001|Third Intervention (3 Days)|Adverse Event|1|||
25243459|NCT01304329|50558240|FG002|Third Intervention (3 Days)|Adverse Event|0|||
25243460|NCT01304329|50558241|FG003|Third Intervention (3 Days)|Adverse Event|0|||
25243461|NCT01304329|50558242|FG004|Third Intervention (3 Days)|Adverse Event|0|||
25243462|NCT01304329|50558243|FG005|Third Intervention (3 Days)|Adverse Event|0|||
25243463|NCT01303861|50558256|FG000|Overall Study|Lost to Follow-up|34|||
25243464|NCT01303861|50558257|FG001|Overall Study|Lost to Follow-up|14|||
25243465|NCT01303861|50558258|FG002|Overall Study|Lost to Follow-up|27|||
25243466|NCT01303861|50558259|FG003|Overall Study|Lost to Follow-up|31|||
25243467|NCT01303861|50558256|FG000|Overall Study|Lack of Efficacy|3|||
25322678|NCT00602030|50639065|FG004|Lead-in Phase|Disease Progression|0|||
25243468|NCT01303861|50558257|FG001|Overall Study|Lack of Efficacy|2|||
25243469|NCT01303861|50558258|FG002|Overall Study|Lack of Efficacy|1|||
25243470|NCT01303861|50558259|FG003|Overall Study|Lack of Efficacy|0|||
25243471|NCT01303861|50558256|FG000|Overall Study|Withdrawal by Subject|16|||
25243472|NCT01303861|50558257|FG001|Overall Study|Withdrawal by Subject|8|||
25243473|NCT01303861|50558258|FG002|Overall Study|Withdrawal by Subject|8|||
25243474|NCT01303861|50558259|FG003|Overall Study|Withdrawal by Subject|23|||
25243475|NCT01303861|50558256|FG000|Overall Study|Adverse Event|4|||
25243476|NCT01303861|50558257|FG001|Overall Study|Adverse Event|1|||
25243477|NCT01303861|50558258|FG002|Overall Study|Adverse Event|0|||
25243478|NCT01303861|50558259|FG003|Overall Study|Adverse Event|5|||
25243479|NCT01303861|50558256|FG000|Overall Study|Pregnancy|1|||
25243480|NCT01303861|50558257|FG001|Overall Study|Pregnancy|0|||
25243481|NCT01303861|50558258|FG002|Overall Study|Pregnancy|0|||
25243482|NCT01303861|50558259|FG003|Overall Study|Pregnancy|0|||
25322679|NCT00602030|50639061|FG000|Lead-in Phase|Adverse Event|0|||
25322680|NCT00602030|50639062|FG001|Lead-in Phase|Adverse Event|2|||
25322681|NCT00602030|50639063|FG002|Lead-in Phase|Adverse Event|0|||
25322682|NCT00602030|50639064|FG003|Lead-in Phase|Adverse Event|0|||
25322683|NCT00602030|50639065|FG004|Lead-in Phase|Adverse Event|0|||
25322684|NCT00602030|50639061|FG000|Double-blind Phase|Disease progression|0|||
25322685|NCT00602030|50639062|FG001|Double-blind Phase|Disease progression|0|||
25322686|NCT00602030|50639063|FG002|Double-blind Phase|Disease progression|33|||
25322687|NCT00602030|50639064|FG003|Double-blind Phase|Disease progression|30|||
25322688|NCT00602030|50639065|FG004|Double-blind Phase|Disease progression|0|||
25322689|NCT00602030|50639061|FG000|Double-blind Phase|Adverse Event|0|||
25322690|NCT00602030|50639062|FG001|Double-blind Phase|Adverse Event|0|||
25322691|NCT00602030|50639063|FG002|Double-blind Phase|Adverse Event|9|||
25322692|NCT00602030|50639064|FG003|Double-blind Phase|Adverse Event|18|||
25322693|NCT00602030|50639065|FG004|Double-blind Phase|Adverse Event|0|||
25322694|NCT00602030|50639061|FG000|Double-blind Phase|Consent withdrawal|0|||
25322695|NCT00602030|50639062|FG001|Double-blind Phase|Consent withdrawal|0|||
25322696|NCT00602030|50639063|FG002|Double-blind Phase|Consent withdrawal|4|||
25322697|NCT00602030|50639064|FG003|Double-blind Phase|Consent withdrawal|3|||
25322698|NCT00602030|50639065|FG004|Double-blind Phase|Consent withdrawal|0|||
25322699|NCT00602030|50639061|FG000|Double-blind Phase|Death|0|||
25322700|NCT00602030|50639062|FG001|Double-blind Phase|Death|0|||
25322701|NCT00602030|50639063|FG002|Double-blind Phase|Death|3|||
25322702|NCT00602030|50639064|FG003|Double-blind Phase|Death|3|||
25322703|NCT00602030|50639065|FG004|Double-blind Phase|Death|0|||
25322704|NCT00602030|50639061|FG000|Double-blind Phase|Administrative decision|0|||
25322705|NCT00602030|50639062|FG001|Double-blind Phase|Administrative decision|0|||
25322706|NCT00602030|50639063|FG002|Double-blind Phase|Administrative decision|0|||
25322707|NCT00602030|50639064|FG003|Double-blind Phase|Administrative decision|2|||
25322708|NCT00602030|50639065|FG004|Double-blind Phase|Administrative decision|0|||
25322709|NCT00602030|50639061|FG000|Double-blind Phase|Ineligibility|0|||
25322710|NCT00602030|50639062|FG001|Double-blind Phase|Ineligibility|0|||
25322711|NCT00602030|50639063|FG002|Double-blind Phase|Ineligibility|0|||
25322712|NCT00602030|50639064|FG003|Double-blind Phase|Ineligibility|1|||
25322713|NCT00602030|50639065|FG004|Double-blind Phase|Ineligibility|0|||
25322714|NCT00602030|50639061|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
25322715|NCT00602030|50639062|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
25322716|NCT00602030|50639063|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
25322717|NCT00602030|50639064|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
25322718|NCT00602030|50639065|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
25322719|NCT00602030|50639061|FG000|Double-blind Phase|Reason not specified|0|||
25243483|NCT01303627|50558272|FG000|Overall Study|the failure while performing URS|0|||
25243484|NCT01303627|50558273|FG001|Overall Study|the failure while performing URS|1|||
25243485|NCT01303510|50558281|FG000|Overall Study|Lost to Follow-up|1|||
25243486|NCT01303510|50558282|FG001|Overall Study|Lost to Follow-up|0|||
25243487|NCT01303159|50558288|FG000|Overall Study|Death|16|||
25243488|NCT01303159|50558288|FG000|Overall Study|Study Termination|7|||
25243489|NCT01302964|50558294|FG000|Overall Study|Adverse Event|1|||
25322720|NCT00602030|50639062|FG001|Double-blind Phase|Reason not specified|0|||
25243490|NCT01302964|50558295|FG001|Overall Study|Adverse Event|0|||
25243491|NCT01302691|50558303|FG000|Overall Study|Adverse Event|2|||
25243492|NCT01302691|50558304|FG001|Overall Study|Adverse Event|0|||
25243493|NCT01302691|50558303|FG000|Overall Study|Death|0|||
25243494|NCT01302691|50558304|FG001|Overall Study|Death|1|||
25243495|NCT01302691|50558303|FG000|Overall Study|Lost to Follow-up|1|||
25243496|NCT01302691|50558304|FG001|Overall Study|Lost to Follow-up|0|||
25243497|NCT01302691|50558303|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
25243498|NCT01302691|50558304|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
25243499|NCT01302691|50558303|FG000|Overall Study|Physician Decision|0|||
25243500|NCT01302691|50558304|FG001|Overall Study|Physician Decision|1|||
25243501|NCT01302691|50558303|FG000|Overall Study|Protocol Violation|1|||
25243502|NCT01302691|50558304|FG001|Overall Study|Protocol Violation|0|||
25243503|NCT01302418|50558310|FG000|Overall Study|Protocol Violation|9|||
25243504|NCT01302418|50558310|FG000|Overall Study|Non-evaluable|9|||
25243505|NCT01302067|50558317|FG000|Overall Study|Death|0|||
25243506|NCT01302067|50558318|FG001|Overall Study|Death|0|||
25243507|NCT01302067|50558319|FG002|Overall Study|Death|1|||
25243508|NCT01302067|50558317|FG000|Overall Study|Physician Decision|9|||
25243509|NCT01302067|50558318|FG001|Overall Study|Physician Decision|5|||
25243510|NCT01302067|50558319|FG002|Overall Study|Physician Decision|14|||
25243511|NCT01302067|50558317|FG000|Overall Study|Lack of Efficacy|8|||
25243512|NCT01302067|50558318|FG001|Overall Study|Lack of Efficacy|4|||
25243513|NCT01302067|50558319|FG002|Overall Study|Lack of Efficacy|2|||
25243514|NCT01302067|50558317|FG000|Overall Study|Lost to Follow-up|9|||
25243515|NCT01302067|50558318|FG001|Overall Study|Lost to Follow-up|4|||
25243516|NCT01302067|50558319|FG002|Overall Study|Lost to Follow-up|15|||
25243517|NCT01302067|50558317|FG000|Overall Study|Withdrawal by Subject|13|||
25243518|NCT01302067|50558318|FG001|Overall Study|Withdrawal by Subject|6|||
25243519|NCT01302067|50558319|FG002|Overall Study|Withdrawal by Subject|10|||
25243520|NCT01302067|50558317|FG000|Overall Study|Other|1|||
25243521|NCT01302067|50558318|FG001|Overall Study|Other|1|||
25243522|NCT01302067|50558319|FG002|Overall Study|Other|3|||
25243523|NCT01302067|50558317|FG000|Overall Study|Protocol Violation|11|||
25243524|NCT01302067|50558318|FG001|Overall Study|Protocol Violation|0|||
25243525|NCT01302067|50558319|FG002|Overall Study|Protocol Violation|8|||
25243526|NCT01302067|50558317|FG000|Overall Study|Adverse Event|27|||
25322721|NCT00602030|50639063|FG002|Double-blind Phase|Reason not specified|4|||
25322722|NCT00602030|50639064|FG003|Double-blind Phase|Reason not specified|2|||
25322723|NCT00602030|50639065|FG004|Double-blind Phase|Reason not specified|0|||
25322724|NCT00602030|50639061|FG000|Crossover Phase|Disease Progression|0|||
25322725|NCT00602030|50639062|FG001|Crossover Phase|Disease Progression|0|||
25322726|NCT00602030|50639063|FG002|Crossover Phase|Disease Progression|0|||
25322727|NCT00602030|50639064|FG003|Crossover Phase|Disease Progression|0|||
25322728|NCT00602030|50639065|FG004|Crossover Phase|Disease Progression|11|||
25322729|NCT00602030|50639061|FG000|Crossover Phase|Adverse Event|0|||
25322730|NCT00602030|50639062|FG001|Crossover Phase|Adverse Event|0|||
25322731|NCT00602030|50639063|FG002|Crossover Phase|Adverse Event|0|||
25322732|NCT00602030|50639064|FG003|Crossover Phase|Adverse Event|0|||
25322733|NCT00602030|50639065|FG004|Crossover Phase|Adverse Event|3|||
25322734|NCT00602030|50639061|FG000|Crossover Phase|Consent withdrawal|0|||
25322735|NCT00602030|50639062|FG001|Crossover Phase|Consent withdrawal|0|||
25322736|NCT00602030|50639063|FG002|Crossover Phase|Consent withdrawal|0|||
25322737|NCT00602030|50639064|FG003|Crossover Phase|Consent withdrawal|0|||
25322738|NCT00602030|50639065|FG004|Crossover Phase|Consent withdrawal|2|||
25322739|NCT00549757|50639079|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
25322740|NCT00549757|50639080|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
25322741|NCT00549757|50639079|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
25322742|NCT00549757|50639080|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
25322743|NCT00549757|50639079|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
25243527|NCT01302067|50558318|FG001|Overall Study|Adverse Event|14|||
25243528|NCT01302067|50558319|FG002|Overall Study|Adverse Event|45|||
25243529|NCT01301950|50558329|FG000|Overall Study|Surgery was cancelled by patient|0|||
25322744|NCT00549757|50639080|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
25243530|NCT01301950|50558330|FG001|Overall Study|Surgery was cancelled by patient|1|||
25243531|NCT01301833|50558340|FG000|Overall Study|Adverse Event|7|||
25322745|NCT00549757|50639079|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
25322746|NCT00549757|50639080|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
25322747|NCT00549757|50639079|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
25322748|NCT00549757|50639080|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
25322749|NCT00549757|50639079|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
25322750|NCT00549757|50639080|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
25322751|NCT00549757|50639079|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
25322752|NCT00549757|50639080|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
25322753|NCT00549757|50639079|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
25322754|NCT00549757|50639080|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
25322755|NCT00549757|50639079|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
25322756|NCT00549757|50639080|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
25322757|NCT00549757|50639079|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
25322758|NCT00549757|50639080|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
25322759|NCT00549757|50639079|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
25322760|NCT00549757|50639080|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
25322761|NCT00549757|50639079|FG000|Extension Period (in Average 9 Months)|Death|143|||
25322762|NCT00549757|50639080|FG001|Extension Period (in Average 9 Months)|Death|136|||
25322763|NCT00549757|50639079|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
25322764|NCT00549757|50639080|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
25322765|NCT00549757|50639079|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
25322766|NCT00549757|50639080|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
25322767|NCT00549757|50639079|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
25322768|NCT00549757|50639080|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
25243532|NCT01301833|50558341|FG001|Overall Study|Adverse Event|5|||
25243533|NCT01301833|50558342|FG002|Overall Study|Adverse Event|5|||
25243534|NCT01301833|50558343|FG003|Overall Study|Adverse Event|5|||
25243535|NCT01301833|50558340|FG000|Overall Study|Lack of Efficacy|1|||
25243536|NCT01301833|50558341|FG001|Overall Study|Lack of Efficacy|1|||
25243537|NCT01301833|50558342|FG002|Overall Study|Lack of Efficacy|0|||
25322769|NCT00549601|50639095|FG000|Randomized|Protocol Violation|0|||
25243538|NCT01301833|50558343|FG003|Overall Study|Lack of Efficacy|0|||
25243539|NCT01301833|50558340|FG000|Overall Study|Physician Decision|3|||
25322770|NCT00549601|50639096|FG001|Randomized|Protocol Violation|0|||
25322771|NCT00549601|50639097|FG002|Randomized|Protocol Violation|1|||
25322772|NCT00549601|50639095|FG000|Randomized|Withdrawal by Subject|0|||
25322773|NCT00549601|50639096|FG001|Randomized|Withdrawal by Subject|1|||
25243540|NCT01301833|50558341|FG001|Overall Study|Physician Decision|1|||
25243541|NCT01301833|50558342|FG002|Overall Study|Physician Decision|1|||
25322774|NCT00549601|50639097|FG002|Randomized|Withdrawal by Subject|1|||
25322775|NCT00549601|50639095|FG000|Received Study Drug|Adverse Event|2|||
25322776|NCT00549601|50639096|FG001|Received Study Drug|Adverse Event|5|||
25322777|NCT00549601|50639097|FG002|Received Study Drug|Adverse Event|1|||
25322778|NCT00549601|50639095|FG000|Received Study Drug|Death|0|||
25322779|NCT00549601|50639096|FG001|Received Study Drug|Death|1|||
25322780|NCT00549601|50639097|FG002|Received Study Drug|Death|0|||
25322781|NCT00549601|50639095|FG000|Received Study Drug|Lost to Follow-up|0|||
25322782|NCT00549601|50639096|FG001|Received Study Drug|Lost to Follow-up|1|||
25322783|NCT00549601|50639097|FG002|Received Study Drug|Lost to Follow-up|1|||
25243542|NCT01301833|50558343|FG003|Overall Study|Physician Decision|0|||
25243543|NCT01301833|50558340|FG000|Overall Study|Withdrawal by Subject|3|||
25243544|NCT01301833|50558341|FG001|Overall Study|Withdrawal by Subject|1|||
25243545|NCT01301833|50558342|FG002|Overall Study|Withdrawal by Subject|1|||
25322784|NCT00549601|50639095|FG000|Received Study Drug|Protocol Violation|3|||
25322785|NCT00549601|50639096|FG001|Received Study Drug|Protocol Violation|4|||
25243546|NCT01301833|50558343|FG003|Overall Study|Withdrawal by Subject|2|||
25243547|NCT01301833|50558340|FG000|Overall Study|Personal matter|1|||
25322786|NCT00549601|50639097|FG002|Received Study Drug|Protocol Violation|1|||
25322787|NCT00549601|50639095|FG000|Received Study Drug|Withdrawal by Subject|2|||
25322788|NCT00549601|50639096|FG001|Received Study Drug|Withdrawal by Subject|0|||
25322789|NCT00549601|50639097|FG002|Received Study Drug|Withdrawal by Subject|1|||
25322790|NCT00601640|50639123|FG000|Overall Study|Withdrawal by Subject|3|||
25322791|NCT00601640|50639124|FG001|Overall Study|Withdrawal by Subject|0|||
25322792|NCT00601640|50639125|FG002|Overall Study|Withdrawal by Subject|7|||
25322793|NCT00601640|50639123|FG000|Overall Study|Death|1|||
25322794|NCT00601640|50639124|FG001|Overall Study|Death|0|||
25322795|NCT00601640|50639125|FG002|Overall Study|Death|0|||
25243548|NCT01301833|50558341|FG001|Overall Study|Personal matter|0|||
25243549|NCT01301833|50558342|FG002|Overall Study|Personal matter|0|||
25243550|NCT01301833|50558343|FG003|Overall Study|Personal matter|0|||
25243551|NCT01301092|50558356|FG000|Overall Study|Lost to Follow-up|0|||
25243552|NCT01301092|50558357|FG001|Overall Study|Lost to Follow-up|0|||
25243553|NCT01301092|50558358|FG002|Overall Study|Lost to Follow-up|1|||
25322796|NCT00601640|50639123|FG000|Overall Study|Adverse Event|0|||
25322797|NCT00601640|50639124|FG001|Overall Study|Adverse Event|4|||
25322798|NCT00601640|50639125|FG002|Overall Study|Adverse Event|2|||
25243554|NCT01300819|50558373|FG000|Overall Study|Adverse Event|9|||
25322799|NCT00601640|50639123|FG000|Overall Study|intercurrent illness|1|||
25243555|NCT01300819|50558374|FG001|Overall Study|Adverse Event|27|||
25243556|NCT01300819|50558373|FG000|Overall Study|Lack of Efficacy|2|||
25243557|NCT01300819|50558374|FG001|Overall Study|Lack of Efficacy|1|||
25243558|NCT01300819|50558373|FG000|Overall Study|Withdrawal by Subject|10|||
25243559|NCT01300819|50558374|FG001|Overall Study|Withdrawal by Subject|12|||
25243560|NCT01300819|50558373|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
25243561|NCT01300819|50558374|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
25243562|NCT01300819|50558373|FG000|Overall Study|Refusal to down titrate study drug|0|||
25243563|NCT01300819|50558374|FG001|Overall Study|Refusal to down titrate study drug|1|||
25243564|NCT01300819|50558373|FG000|Overall Study|Administrative reason|0|||
25243565|NCT01300819|50558374|FG001|Overall Study|Administrative reason|1|||
25243566|NCT01300819|50558373|FG000|Overall Study|Safety follow up not done by mistake|0|||
25243567|NCT01300819|50558374|FG001|Overall Study|Safety follow up not done by mistake|1|||
25243568|NCT01300819|50558373|FG000|Overall Study|Follow up call was not done|1|||
25243569|NCT01300819|50558374|FG001|Overall Study|Follow up call was not done|0|||
25243570|NCT01300741|50558380|FG000|Overall Study|Lens deposits|1|||
25243571|NCT01300741|50558380|FG000|Overall Study|Lost to Follow-up|1|||
25243572|NCT01300741|50558380|FG000|Overall Study|Discomfort|1|||
25243573|NCT01300546|50558388|FG000|Overall Study|Withdrawal by Subject|1|||
25243574|NCT01300546|50558389|FG001|Overall Study|Withdrawal by Subject|0|||
25243575|NCT01300546|50558388|FG000|Overall Study|Lost to Follow-up|0|||
25243576|NCT01300546|50558389|FG001|Overall Study|Lost to Follow-up|2|||
25243577|NCT01300546|50558388|FG000|Overall Study|Lack of Efficacy|0|||
25243578|NCT01300546|50558389|FG001|Overall Study|Lack of Efficacy|3|||
25322800|NCT00601640|50639124|FG001|Overall Study|intercurrent illness|0|||
25322801|NCT00601640|50639125|FG002|Overall Study|intercurrent illness|0|||
25322802|NCT00601640|50639123|FG000|Overall Study|change in eligibility status|0|||
25322803|NCT00601640|50639124|FG001|Overall Study|change in eligibility status|1|||
25322804|NCT00601640|50639125|FG002|Overall Study|change in eligibility status|1|||
25322805|NCT02805725|50639140|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
25322806|NCT02805725|50639141|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
25322807|NCT02805725|50639142|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
25322808|NCT02805725|50639143|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
25322809|NCT02805725|50639144|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
25322810|NCT02805725|50639140|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
25322811|NCT02805725|50639141|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
25322812|NCT02805725|50639142|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
25322813|NCT02805725|50639143|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
25322814|NCT02805725|50639144|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
25322815|NCT02805725|50639140|FG000|Phase II|Protocol Violation|0|||
25322816|NCT02805725|50639141|FG001|Phase II|Protocol Violation|0|||
25322817|NCT02805725|50639142|FG002|Phase II|Protocol Violation|0|||
25322818|NCT02805725|50639143|FG003|Phase II|Protocol Violation|0|||
25322819|NCT02805725|50639144|FG004|Phase II|Protocol Violation|6|||
25322820|NCT00546871|50639161|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
25322821|NCT00546871|50639162|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
25322822|NCT00546871|50639161|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
25322823|NCT00546871|50639162|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
25322824|NCT00546871|50639161|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
25322825|NCT00546871|50639162|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
25322826|NCT00546871|50639161|FG000|Study Extension Period|Protocol Violation|1|||
25322827|NCT00546871|50639162|FG001|Study Extension Period|Protocol Violation|0|||
25322828|NCT00546871|50639161|FG000|Study Extension Period|Withdrawal by Subject|0|||
25322829|NCT00546871|50639162|FG001|Study Extension Period|Withdrawal by Subject|1|||
25322830|NCT03951805|50639195|FG000|Overall Study|Adverse Event|1|||
25322831|NCT03951805|50639196|FG001|Overall Study|Adverse Event|0|||
25322832|NCT03951805|50639197|FG002|Overall Study|Adverse Event|0|||
25243579|NCT01300546|50558388|FG000|Overall Study|Adverse Event|0|||
25243580|NCT01300546|50558389|FG001|Overall Study|Adverse Event|1|||
25243581|NCT01300351|50558397|FG000|Overall Study|Did not receive treatment|2|||
25322833|NCT03951805|50639198|FG003|Overall Study|Adverse Event|0|||
25322834|NCT03944707|50639210|FG000|Overall Study|Adverse Event|0|||
25322835|NCT03944707|50639211|FG001|Overall Study|Adverse Event|2|||
25243582|NCT01300351|50558398|FG001|Overall Study|Did not receive treatment|0|||
25243583|NCT01300351|50558397|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
25322836|NCT03944707|50639210|FG000|Overall Study|Study terminated by sponsor|12|||
25322837|NCT03944707|50639211|FG001|Overall Study|Study terminated by sponsor|7|||
25322838|NCT03944707|50639210|FG000|Overall Study|Subject decision|0|||
25322839|NCT03944707|50639211|FG001|Overall Study|Subject decision|1|||
25322840|NCT00549055|50639217|FG000|Overall Study|Adverse Event|4|||
25322841|NCT00549055|50639217|FG000|Overall Study|Lack of Efficacy|18|||
25322842|NCT00549055|50639217|FG000|Overall Study|Stabilization|5|||
25243584|NCT01300351|50558398|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
25243585|NCT01300351|50558397|FG000|Overall Study|Lost to Follow-up|0|||
25243586|NCT01300351|50558398|FG001|Overall Study|Lost to Follow-up|1|||
25243587|NCT01300351|50558397|FG000|Overall Study|Adverse Event|0|||
25322843|NCT00549055|50639217|FG000|Overall Study|Progression to fibrosis|2|||
25322844|NCT00549055|50639217|FG000|Overall Study|Decrease of size|1|||
25322845|NCT00549055|50639217|FG000|Overall Study|Active choroidal neovascula increased|1|||
25322846|NCT00549055|50639217|FG000|Overall Study|Vitreous hemorrhage|1|||
25322847|NCT00549055|50639217|FG000|Overall Study|Growth choroidal neovascularisation|1|||
25243588|NCT01300351|50558398|FG001|Overall Study|Adverse Event|4|||
25243589|NCT01300351|50558397|FG000|Overall Study|Withdrawal by Subject|7|||
25243590|NCT01300351|50558398|FG001|Overall Study|Withdrawal by Subject|10|||
25243591|NCT01300234|50558406|FG000|Overall Study|Adverse Event|1|||
25243592|NCT01300234|50558407|FG001|Overall Study|Adverse Event|1|||
25243593|NCT01300234|50558406|FG000|Overall Study|Protocol Violation|2|||
25322848|NCT00549055|50639217|FG000|Overall Study|Choroidal neovascularization|1|||
25322849|NCT00549055|50639217|FG000|Overall Study|Very low visual acuity (VA)|1|||
25322850|NCT00883116|50639223|FG000|Overall Study|Adverse event unrelated to study drug|5|||
25322851|NCT00883116|50639224|FG001|Overall Study|Adverse event unrelated to study drug|10|||
25322852|NCT00883116|50639223|FG000|Overall Study|Death|6|||
25322853|NCT00883116|50639224|FG001|Overall Study|Death|2|||
25322854|NCT00883116|50639223|FG000|Overall Study|Disease progression|130|||
25322855|NCT00883116|50639224|FG001|Overall Study|Disease progression|128|||
25322856|NCT00883116|50639223|FG000|Overall Study|Lost to Follow-up|0|||
25322857|NCT00883116|50639224|FG001|Overall Study|Lost to Follow-up|1|||
25322858|NCT00883116|50639223|FG000|Overall Study|Maximum clinical benefit|13|||
25322859|NCT00883116|50639224|FG001|Overall Study|Maximum clinical benefit|46|||
25322860|NCT00883116|50639223|FG000|Overall Study|Not identified|3|||
25322861|NCT00883116|50639224|FG001|Overall Study|Not identified|6|||
25322862|NCT00883116|50639223|FG000|Overall Study|Study drug toxicity|36|||
25322863|NCT00883116|50639224|FG001|Overall Study|Study drug toxicity|16|||
25322864|NCT00883116|50639223|FG000|Overall Study|Withdrawal by Subject|14|||
25322865|NCT00883116|50639224|FG001|Overall Study|Withdrawal by Subject|8|||
25322866|NCT00883116|50639223|FG000|Overall Study|No longer meets study criteria|2|||
25322867|NCT00883116|50639224|FG001|Overall Study|No longer meets study criteria|2|||
25322868|NCT00594399|50639243|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
25322869|NCT00594399|50639244|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
25322870|NCT00594399|50639245|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
25322871|NCT00594399|50639243|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
25322872|NCT00594399|50639244|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
25322873|NCT00594399|50639245|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
25322874|NCT00594399|50639243|FG000|Initial 3 Month Counseling|Personal issues|2|||
25322875|NCT00594399|50639244|FG001|Initial 3 Month Counseling|Personal issues|0|||
25322876|NCT00594399|50639245|FG002|Initial 3 Month Counseling|Personal issues|0|||
25322877|NCT00594399|50639243|FG000|Initial 3 Month Counseling|Too busy|7|||
25322878|NCT00594399|50639244|FG001|Initial 3 Month Counseling|Too busy|1|||
25322879|NCT00594399|50639245|FG002|Initial 3 Month Counseling|Too busy|0|||
25322880|NCT00594399|50639243|FG000|Initial 3 Month Counseling|Pain|2|||
25322881|NCT00594399|50639244|FG001|Initial 3 Month Counseling|Pain|0|||
25322882|NCT00594399|50639245|FG002|Initial 3 Month Counseling|Pain|0|||
25322883|NCT00594399|50639243|FG000|Initial 3 Month Counseling|Moved|1|||
25322884|NCT00594399|50639244|FG001|Initial 3 Month Counseling|Moved|0|||
25322885|NCT00594399|50639245|FG002|Initial 3 Month Counseling|Moved|0|||
25322886|NCT00594399|50639243|FG000|Initial 3 Month Counseling|Family illness|1|||
25322887|NCT00594399|50639244|FG001|Initial 3 Month Counseling|Family illness|0|||
25322888|NCT00594399|50639245|FG002|Initial 3 Month Counseling|Family illness|0|||
25322889|NCT00594399|50639243|FG000|Rerandomization Arm 1 Only|Death|2|||
25243594|NCT01300234|50558407|FG001|Overall Study|Protocol Violation|3|||
25322890|NCT00594399|50639244|FG001|Rerandomization Arm 1 Only|Death|1|||
25322891|NCT00594399|50639245|FG002|Rerandomization Arm 1 Only|Death|0|||
25322892|NCT00594399|50639243|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
25322893|NCT00594399|50639244|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
25322894|NCT00594399|50639245|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
25322895|NCT00546715|50639255|FG000|Overall Study|Withdrawal by Subject|0|||
25322896|NCT00546715|50639256|FG001|Overall Study|Withdrawal by Subject|1|||
25322897|NCT00546715|50639257|FG002|Overall Study|Withdrawal by Subject|0|||
25322898|NCT00546715|50639258|FG003|Overall Study|Withdrawal by Subject|0|||
25243595|NCT01300234|50558406|FG000|Overall Study|Withdrawal by Subject|5|||
25243596|NCT01300234|50558407|FG001|Overall Study|Withdrawal by Subject|9|||
25322899|NCT00874029|50639268|FG000|Overall Study|Withdrawal by Subject|10|||
25322900|NCT00874029|50639268|FG000|Overall Study|Pregnancy|4|||
25322901|NCT00874029|50639268|FG000|Overall Study|Physician Decision|1|||
25322902|NCT00874029|50639268|FG000|Overall Study|Adverse Event|1|||
25322903|NCT00874029|50639268|FG000|Overall Study|Lost to Follow-up|5|||
25322904|NCT00546637|50639284|FG000|Overall Study|Adverse Event|46|||
25322905|NCT00546637|50639285|FG001|Overall Study|Adverse Event|20|||
25322906|NCT00546637|50639284|FG000|Overall Study|Lack of Efficacy|5|||
25322907|NCT00546637|50639285|FG001|Overall Study|Lack of Efficacy|5|||
25322908|NCT00546637|50639284|FG000|Overall Study|Lost to Follow-up|2|||
25322909|NCT00546637|50639285|FG001|Overall Study|Lost to Follow-up|2|||
25322910|NCT00546637|50639284|FG000|Overall Study|Other|10|||
25322911|NCT00546637|50639285|FG001|Overall Study|Other|12|||
25322912|NCT00546637|50639284|FG000|Overall Study|Withdrawal by Subject|7|||
25322913|NCT00546637|50639285|FG001|Overall Study|Withdrawal by Subject|9|||
25322914|NCT00546637|50639284|FG000|Overall Study|Randomized, but not treated|3|||
25322915|NCT00546637|50639285|FG001|Overall Study|Randomized, but not treated|1|||
25322916|NCT00546481|50639293|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
25243597|NCT01300234|50558406|FG000|Overall Study|Lost to Follow-up|14|||
25243598|NCT01300234|50558407|FG001|Overall Study|Lost to Follow-up|12|||
25243599|NCT01300234|50558406|FG000|Overall Study|Pregnancy|2|||
25243600|NCT01300234|50558407|FG001|Overall Study|Pregnancy|1|||
25243601|NCT01300234|50558406|FG000|Overall Study|Participant reached stopping critera|2|||
25243602|NCT01300234|50558407|FG001|Overall Study|Participant reached stopping critera|0|||
25243603|NCT01300234|50558406|FG000|Overall Study|Participant stopped medication|1|||
25243604|NCT01300234|50558407|FG001|Overall Study|Participant stopped medication|1|||
25322917|NCT00546481|50639294|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
25322918|NCT00546481|50639295|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
25322919|NCT00546481|50639293|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
25322920|NCT00546481|50639294|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
25322921|NCT00546481|50639295|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
25322922|NCT00546481|50639293|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
25322923|NCT00546481|50639294|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
25322924|NCT00546481|50639295|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
25322925|NCT00546481|50639293|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
25243605|NCT01300234|50558406|FG000|Overall Study|Participant refused return to hospital|1|||
25243606|NCT01300234|50558407|FG001|Overall Study|Participant refused return to hospital|0|||
25243607|NCT01299961|50558424|FG000|Overall Study|Adverse Event|3|||
25243608|NCT01299961|50558424|FG000|Overall Study|Lack of Efficacy|2|||
25243609|NCT01299961|50558424|FG000|Overall Study|Lost to Follow-up|1|||
25243610|NCT01299805|50558430|FG000|Overall Study|Adverse Event|2|||
25243611|NCT01299805|50558431|FG001|Overall Study|Adverse Event|0|||
25243612|NCT01299766|50558439|FG000|Overall Study|Death|5|||
25243613|NCT01299766|50558440|FG001|Overall Study|Death|4|||
25243614|NCT01299766|50558439|FG000|Overall Study|Withdrawal by Subject|29|||
25322926|NCT00546481|50639294|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
25243615|NCT01299766|50558440|FG001|Overall Study|Withdrawal by Subject|19|||
25243616|NCT01299727|50558449|FG000|Overall Study|Withdrawal by Subject|1|||
25243617|NCT01299727|50558450|FG001|Overall Study|Withdrawal by Subject|0|||
25243618|NCT01299727|50558451|FG002|Overall Study|Withdrawal by Subject|0|||
25243619|NCT01299727|50558449|FG000|Overall Study|Adverse Event|0|||
25243620|NCT01299727|50558450|FG001|Overall Study|Adverse Event|0|||
25243621|NCT01299727|50558451|FG002|Overall Study|Adverse Event|1|||
25243622|NCT01299727|50558449|FG000|Overall Study|Completed the Treatment Period|3|||
25243623|NCT01299727|50558450|FG001|Overall Study|Completed the Treatment Period|4|||
25243624|NCT01299727|50558451|FG002|Overall Study|Completed the Treatment Period|3|||
25243625|NCT01299571|50558459|FG000|Overall Study|Protocol Violation|107|||
25243626|NCT01299376|50558466|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
25243627|NCT01299376|50558467|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
25243628|NCT01299376|50558466|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
25243629|NCT01299376|50558467|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
25243630|NCT01299376|50558466|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
25243631|NCT01299376|50558467|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
25243632|NCT01299376|50558466|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
25322927|NCT00546481|50639295|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
25322928|NCT00546481|50639293|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
25322929|NCT00546481|50639294|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
25077672|NCT02460380|50185501|FG001|Overall Study|Withdrawal by Subject|5|||
25077673|NCT02493062|50185508|FG000|Overall Study|Physician Decision|12|||
25243633|NCT01299376|50558467|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
25243634|NCT01299376|50558466|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
25243635|NCT01299376|50558467|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
25243636|NCT01299376|50558466|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
25243637|NCT01299376|50558467|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
25243638|NCT01299376|50558466|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
25243639|NCT01299376|50558467|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
25243640|NCT01299376|50558466|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
25243641|NCT01299376|50558467|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
25243642|NCT01299376|50558466|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
25243643|NCT01299376|50558467|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
25243644|NCT01299376|50558466|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
25243645|NCT01299376|50558467|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
25243646|NCT01299376|50558466|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
25243647|NCT01299376|50558467|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
25243648|NCT01299025|50558479|FG000|Overall Study|Withdrawal by Subject|2|||
25243649|NCT01299025|50558480|FG001|Overall Study|Withdrawal by Subject|1|||
25243650|NCT01299025|50558479|FG000|Overall Study|Lost to Follow-up|1|||
25243651|NCT01299025|50558480|FG001|Overall Study|Lost to Follow-up|0|||
25243652|NCT01298596|50558488|FG000|Overall Study|Withdrawal by Subject|1|||
25243653|NCT01298596|50558489|FG001|Overall Study|Withdrawal by Subject|1|||
25243654|NCT01298596|50558488|FG000|Overall Study|Death|5|||
25243655|NCT01298596|50558489|FG001|Overall Study|Death|3|||
25243656|NCT01298596|50558488|FG000|Overall Study|Lost to Follow-up|6|||
25243657|NCT01298596|50558489|FG001|Overall Study|Lost to Follow-up|14|||
25243658|NCT01298596|50558488|FG000|Overall Study|Referred for further management|16|||
25243659|NCT01298596|50558489|FG001|Overall Study|Referred for further management|15|||
25243660|NCT01298518|50558498|FG000|Overall Study|Withdrawal by Subject|0|||
25243661|NCT01298518|50558499|FG001|Overall Study|Withdrawal by Subject|0|||
25243662|NCT01298518|50558500|FG002|Overall Study|Withdrawal by Subject|1|||
25243663|NCT01298362|50558510|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
25243664|NCT01298362|50558511|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
25243665|NCT01298323|50558521|FG000|Overall Study|Adverse Event|2|||
25243666|NCT01298323|50558522|FG001|Overall Study|Adverse Event|4|||
25243667|NCT01298323|50558521|FG000|Overall Study|Death|11|||
25243668|NCT01298323|50558522|FG001|Overall Study|Death|16|||
25243669|NCT01298323|50558521|FG000|Overall Study|Lost to Follow-up|1|||
25243670|NCT01298323|50558522|FG001|Overall Study|Lost to Follow-up|0|||
25243671|NCT01298323|50558521|FG000|Overall Study|Withdrawal by Subject|6|||
25243672|NCT01298323|50558522|FG001|Overall Study|Withdrawal by Subject|3|||
25243673|NCT01298323|50558521|FG000|Overall Study|Protocol Violation|1|||
25243674|NCT01298323|50558522|FG001|Overall Study|Protocol Violation|0|||
25243675|NCT01298323|50558521|FG000|Overall Study|Other|10|||
25243676|NCT01298323|50558522|FG001|Overall Study|Other|9|||
25243677|NCT01298323|50558521|FG000|Overall Study|Ongoing|55|||
25243678|NCT01298323|50558522|FG001|Overall Study|Ongoing|55|||
25243679|NCT01298323|50558521|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
25243680|NCT01298323|50558522|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
25243681|NCT01297504|50558528|FG000|Overall Study|Invalid Consent|1|||
25243682|NCT01297504|50558528|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
25243683|NCT01297504|50558528|FG000|Overall Study|No Study Visits|4|||
25243684|NCT01297504|50558528|FG000|Overall Study|Death|3|||
25243685|NCT01297504|50558528|FG000|Overall Study|Lost to Follow-up|43|||
25243686|NCT01297504|50558528|FG000|Overall Study|Withdrawal by Subject|9|||
25243687|NCT01297504|50558528|FG000|Overall Study|Site Closure|3|||
25243688|NCT01297504|50558528|FG000|Overall Study|Protocol Violation|3|||
25243689|NCT01297465|50558538|FG000|Overall Study|Lack of Ovarian Response|1|||
25243690|NCT01297465|50558539|FG001|Overall Study|Lack of Ovarian Response|1|||
25243691|NCT01297465|50558538|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
25243692|NCT01297465|50558539|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
25243693|NCT01297465|50558538|FG000|Overall Study|No Oocytes Retrieved|1|||
25243694|NCT01297465|50558539|FG001|Overall Study|No Oocytes Retrieved|1|||
25243695|NCT01297465|50558538|FG000|Overall Study|Poor oocyte quality|0|||
25243696|NCT01297465|50558539|FG001|Overall Study|Poor oocyte quality|1|||
25243697|NCT01297465|50558538|FG000|Overall Study|No Fertilization|6|||
25243698|NCT01297465|50558539|FG001|Overall Study|No Fertilization|4|||
25243699|NCT01297465|50558538|FG000|Overall Study|All Embryos Discarded|0|||
25243700|NCT01297465|50558539|FG001|Overall Study|All Embryos Discarded|1|||
25243701|NCT01297465|50558538|FG000|Overall Study|Intention to Freeze all Embryos|0|||
25243702|NCT01297465|50558539|FG001|Overall Study|Intention to Freeze all Embryos|1|||
24977070|NCT00379769|50065793|FG000|Main Study|Investigator refused to log temperature|0|||
25243703|NCT01297309|50558545|FG000|Overall Study|Eligibility failure|2|||
25243704|NCT01297309|50558545|FG000|Overall Study|Screen failure|2|||
25243705|NCT01297309|50558545|FG000|Overall Study|Withdrawal by Subject|5|||
25243706|NCT01297309|50558545|FG000|Overall Study|Adverse Event|1|||
25243707|NCT01297309|50558545|FG000|Overall Study|Investigator Decision|2|||
25243708|NCT01297309|50558545|FG000|Overall Study|Death|1|||
25243709|NCT01297309|50558545|FG000|Overall Study|Participant not entering extensionperiod|1|||
25243710|NCT04518462|50558552|FG000|Overall Study|Withdrawal by Subject|0|||
25243711|NCT04518462|50558553|FG001|Overall Study|Withdrawal by Subject|0|||
25322930|NCT00546481|50639295|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
25322931|NCT00546481|50639293|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
25322932|NCT00546481|50639294|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
25322933|NCT00546481|50639295|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
25322934|NCT00546481|50639293|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
25322935|NCT00546481|50639294|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
25322936|NCT00546481|50639295|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
25243712|NCT04518462|50558554|FG002|Overall Study|Withdrawal by Subject|1|||
25243713|NCT04518462|50558552|FG000|Overall Study|Physician Decision|1|||
25243714|NCT04518462|50558553|FG001|Overall Study|Physician Decision|1|||
25243715|NCT04518462|50558554|FG002|Overall Study|Physician Decision|0|||
25243716|NCT01297270|50558565|FG000|Overall Study|Adverse Event|19|||
25243717|NCT01297270|50558566|FG001|Overall Study|Adverse Event|32|||
25243718|NCT01297270|50558567|FG002|Overall Study|Adverse Event|5|||
25243719|NCT01297270|50558565|FG000|Overall Study|Lack of Efficacy|15|||
25243720|NCT01297270|50558566|FG001|Overall Study|Lack of Efficacy|17|||
25243721|NCT01297270|50558567|FG002|Overall Study|Lack of Efficacy|15|||
25243722|NCT01297270|50558565|FG000|Overall Study|Lost to Follow-up|1|||
25243723|NCT01297270|50558566|FG001|Overall Study|Lost to Follow-up|2|||
25243724|NCT01297270|50558567|FG002|Overall Study|Lost to Follow-up|1|||
25243725|NCT01297270|50558565|FG000|Overall Study|Protocol Violation|0|||
25243726|NCT01297270|50558566|FG001|Overall Study|Protocol Violation|2|||
25243727|NCT01297270|50558567|FG002|Overall Study|Protocol Violation|0|||
25243728|NCT01297270|50558565|FG000|Overall Study|Withdrawal by Subject|7|||
25243729|NCT01297270|50558566|FG001|Overall Study|Withdrawal by Subject|15|||
25243730|NCT01297270|50558567|FG002|Overall Study|Withdrawal by Subject|7|||
25243731|NCT01297270|50558565|FG000|Overall Study|Other reason not defined above|3|||
25243732|NCT01297270|50558566|FG001|Overall Study|Other reason not defined above|3|||
25243733|NCT01297270|50558567|FG002|Overall Study|Other reason not defined above|1|||
25243734|NCT01297270|50558565|FG000|Overall Study|Not treated|0|||
25243735|NCT01297270|50558566|FG001|Overall Study|Not treated|1|||
25322937|NCT00546481|50639293|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
25322938|NCT00546481|50639294|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
25322939|NCT00546481|50639295|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
25322940|NCT00546481|50639293|FG000|Maintenance Phase (CERA)|Other Reason|0|||
25322941|NCT00546481|50639294|FG001|Maintenance Phase (CERA)|Other Reason|0|||
25322942|NCT00546481|50639295|FG002|Maintenance Phase (CERA)|Other Reason|1|||
25243736|NCT01297270|50558567|FG002|Overall Study|Not treated|0|||
25243737|NCT01296568|50558575|FG000|Continued Access Phase|Lost to Follow-up|1|||
25243738|NCT01296568|50558575|FG000|Continued Access Phase|Withdrawal by Subject|1|||
25243739|NCT01296568|50558575|FG000|Continued Access Phase|Disease Progression|1|||
25243740|NCT01296412|50558583|FG000|Overall Study|Adverse Event|8|||
25243741|NCT01296412|50558584|FG001|Overall Study|Adverse Event|29|||
25243742|NCT01296412|50558583|FG000|Overall Study|Lack of Efficacy|1|||
25243743|NCT01296412|50558584|FG001|Overall Study|Lack of Efficacy|0|||
25243744|NCT01296412|50558583|FG000|Overall Study|Lost to Follow-up|10|||
25243745|NCT01296412|50558584|FG001|Overall Study|Lost to Follow-up|7|||
25243746|NCT01296412|50558583|FG000|Overall Study|Non-compliance with study drug|1|||
25243747|NCT01296412|50558584|FG001|Overall Study|Non-compliance with study drug|2|||
25243748|NCT01296412|50558583|FG000|Overall Study|Other reason not specified|20|||
25243749|NCT01296412|50558584|FG001|Overall Study|Other reason not specified|15|||
25243750|NCT01296412|50558583|FG000|Overall Study|Physician Decision|1|||
25243751|NCT01296412|50558584|FG001|Overall Study|Physician Decision|3|||
25243752|NCT01296412|50558583|FG000|Overall Study|Pregnancy|0|||
25243753|NCT01296412|50558584|FG001|Overall Study|Pregnancy|1|||
25243754|NCT01296412|50558583|FG000|Overall Study|Withdrawal by Subject|10|||
25243755|NCT01296412|50558584|FG001|Overall Study|Withdrawal by Subject|13|||
25243756|NCT01295905|50558592|FG000|Overall Study|Did not meet inclusion criteria|1|||
25243757|NCT01295905|50558593|FG001|Overall Study|Did not meet inclusion criteria|0|||
25243758|NCT01295905|50558592|FG000|Overall Study|Met exclusion criteria|1|||
25243759|NCT01295905|50558593|FG001|Overall Study|Met exclusion criteria|0|||
25243760|NCT02596035|50558602|FG000|Overall Study|Disease Progression|64|||
25243761|NCT02596035|50558603|FG001|Overall Study|Disease Progression|32|||
25243762|NCT02596035|50558604|FG002|Overall Study|Disease Progression|1|||
25243763|NCT02596035|50558602|FG000|Overall Study|study drug toxicity|12|||
25243764|NCT02596035|50558603|FG001|Overall Study|study drug toxicity|3|||
25243765|NCT02596035|50558604|FG002|Overall Study|study drug toxicity|0|||
25243766|NCT02596035|50558602|FG000|Overall Study|AE unrelated to study drug|5|||
25243767|NCT02596035|50558603|FG001|Overall Study|AE unrelated to study drug|2|||
25243768|NCT02596035|50558604|FG002|Overall Study|AE unrelated to study drug|0|||
25243769|NCT02596035|50558602|FG000|Overall Study|participant request to discontinue study treatment|2|||
25243770|NCT02596035|50558603|FG001|Overall Study|participant request to discontinue study treatment|0|||
25243771|NCT02596035|50558604|FG002|Overall Study|participant request to discontinue study treatment|0|||
25243772|NCT02596035|50558602|FG000|Overall Study|participant withdrew consent|2|||
25243773|NCT02596035|50558603|FG001|Overall Study|participant withdrew consent|2|||
25243774|NCT02596035|50558604|FG002|Overall Study|participant withdrew consent|0|||
25243775|NCT02596035|50558602|FG000|Overall Study|Poor/Non Comlpiance|0|||
25243776|NCT02596035|50558603|FG001|Overall Study|Poor/Non Comlpiance|1|||
25243777|NCT02596035|50558604|FG002|Overall Study|Poor/Non Comlpiance|0|||
25243778|NCT02596035|50558602|FG000|Overall Study|participant no longer meets study criteria|1|||
25243779|NCT02596035|50558603|FG001|Overall Study|participant no longer meets study criteria|0|||
25243780|NCT02596035|50558604|FG002|Overall Study|participant no longer meets study criteria|0|||
25243781|NCT02596035|50558602|FG000|Overall Study|other reasons|11|||
25243782|NCT02596035|50558603|FG001|Overall Study|other reasons|4|||
25322943|NCT00880698|50639307|FG000|Overall Study|Death|0|||
25243783|NCT02596035|50558604|FG002|Overall Study|other reasons|0|||
25243784|NCT02595372|50558613|FG000|Overall Study|Adverse Event|6|||
25322944|NCT00880698|50639308|FG001|Overall Study|Death|0|||
25243785|NCT02595372|50558613|FG000|Overall Study|Physician Decision|2|||
25243786|NCT02595372|50558613|FG000|Overall Study|Disease Progression|1|||
25322945|NCT00880698|50639309|FG002|Overall Study|Death|1|||
25322946|NCT00880698|50639310|FG003|Overall Study|Death|2|||
25322947|NCT00880698|50639307|FG000|Overall Study|Lost to Follow-up|1|||
25322948|NCT00880698|50639308|FG001|Overall Study|Lost to Follow-up|3|||
25322949|NCT00880698|50639309|FG002|Overall Study|Lost to Follow-up|0|||
25322950|NCT00880698|50639310|FG003|Overall Study|Lost to Follow-up|1|||
25322951|NCT00880620|50639326|FG000|Overall Study|Adverse Event|4|||
25322952|NCT00880620|50639327|FG001|Overall Study|Adverse Event|5|||
25322953|NCT00880620|50639328|FG002|Overall Study|Adverse Event|15|||
25322954|NCT00880620|50639329|FG003|Overall Study|Adverse Event|15|||
25322955|NCT00880620|50639326|FG000|Overall Study|Death|0|||
25322956|NCT00880620|50639327|FG001|Overall Study|Death|0|||
25322957|NCT00880620|50639328|FG002|Overall Study|Death|1|||
25322958|NCT00880620|50639329|FG003|Overall Study|Death|0|||
25322959|NCT00880620|50639326|FG000|Overall Study|Lack of Efficacy|12|||
25322960|NCT00880620|50639327|FG001|Overall Study|Lack of Efficacy|4|||
25322961|NCT00880620|50639328|FG002|Overall Study|Lack of Efficacy|0|||
25322962|NCT00880620|50639329|FG003|Overall Study|Lack of Efficacy|1|||
25322963|NCT00880620|50639326|FG000|Overall Study|Lost to Follow-up|0|||
25322964|NCT00880620|50639327|FG001|Overall Study|Lost to Follow-up|1|||
25322965|NCT00880620|50639328|FG002|Overall Study|Lost to Follow-up|1|||
25322966|NCT00880620|50639329|FG003|Overall Study|Lost to Follow-up|0|||
25322967|NCT00880620|50639326|FG000|Overall Study|Protocol Violation|0|||
25322968|NCT00880620|50639327|FG001|Overall Study|Protocol Violation|1|||
25322969|NCT00880620|50639328|FG002|Overall Study|Protocol Violation|0|||
25322970|NCT00880620|50639329|FG003|Overall Study|Protocol Violation|2|||
25322971|NCT00880620|50639326|FG000|Overall Study|Withdrawal by Subject|4|||
25322972|NCT00880620|50639327|FG001|Overall Study|Withdrawal by Subject|3|||
25322973|NCT00880620|50639328|FG002|Overall Study|Withdrawal by Subject|1|||
25322974|NCT00880620|50639329|FG003|Overall Study|Withdrawal by Subject|3|||
25322975|NCT00880620|50639326|FG000|Overall Study|Noncompliance|0|||
25322976|NCT00880620|50639327|FG001|Overall Study|Noncompliance|0|||
25322977|NCT00880620|50639328|FG002|Overall Study|Noncompliance|1|||
25322978|NCT00880620|50639329|FG003|Overall Study|Noncompliance|1|||
25322979|NCT00880620|50639326|FG000|Overall Study|Other|1|||
25322980|NCT00880620|50639327|FG001|Overall Study|Other|1|||
25322981|NCT00880620|50639328|FG002|Overall Study|Other|2|||
25322982|NCT00880620|50639329|FG003|Overall Study|Other|2|||
25322983|NCT00881868|50639355|FG000|Overall Study|Adverse Event|0|||
25243787|NCT01248962|50558633|FG000|Overall Study|Withdrawal by Subject|1|||
25243788|NCT01248962|50558634|FG001|Overall Study|Withdrawal by Subject|1|||
25243789|NCT01248962|50558633|FG000|Overall Study|Adverse Event|2|||
25243790|NCT01248962|50558634|FG001|Overall Study|Adverse Event|1|||
25243791|NCT01248962|50558633|FG000|Overall Study|Complete Response after 4 Cycles|1|||
25243792|NCT01248962|50558634|FG001|Overall Study|Complete Response after 4 Cycles|0|||
25243793|NCT01248962|50558633|FG000|Overall Study|Complete Response after 3 Cycles|0|||
25243794|NCT01248962|50558634|FG001|Overall Study|Complete Response after 3 Cycles|1|||
25243795|NCT01248962|50558633|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
25243796|NCT01248962|50558634|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
25243797|NCT01248455|50558641|FG000|Overall Study|switched to alternate treatment|1|||
25243798|NCT01247090|50558648|FG000|Overall Study|Physician Decision|1|||
25243799|NCT01247090|50558649|FG001|Overall Study|Physician Decision|0|||
25243800|NCT01247090|50558650|FG002|Overall Study|Physician Decision|0|||
25243801|NCT01247090|50558648|FG000|Overall Study|Withdrawal by Subject|0|||
25243802|NCT01247090|50558649|FG001|Overall Study|Withdrawal by Subject|1|||
25243803|NCT01247090|50558650|FG002|Overall Study|Withdrawal by Subject|0|||
25243804|NCT01249664|50558660|FG000|Overall Study|Withdrawal by Subject|5|||
25243805|NCT01249664|50558661|FG001|Overall Study|Withdrawal by Subject|0|||
25243806|NCT01249664|50558660|FG000|Overall Study|Adverse Event|1|||
25243807|NCT01249664|50558661|FG001|Overall Study|Adverse Event|0|||
25243808|NCT01249274|50558671|FG000|Overall Study|Lost to Follow-up|3|||
25243809|NCT01249274|50558672|FG001|Overall Study|Lost to Follow-up|4|||
25322984|NCT00881868|50639356|FG001|Overall Study|Adverse Event|1|||
25322985|NCT00881868|50639355|FG000|Overall Study|Lost to Follow-up|2|||
25322986|NCT00881868|50639356|FG001|Overall Study|Lost to Follow-up|1|||
25322987|NCT00881868|50639355|FG000|Overall Study|Physician Decision|4|||
25322988|NCT00881868|50639356|FG001|Overall Study|Physician Decision|0|||
25322989|NCT00881868|50639355|FG000|Overall Study|Protocol Violation|2|||
25322990|NCT00881868|50639356|FG001|Overall Study|Protocol Violation|0|||
25322991|NCT00881712|50639365|FG000|Overall Study|Death|1|||
25243810|NCT01249274|50558671|FG000|Overall Study|Received inpatient substance treatment|1|||
25243811|NCT01249274|50558672|FG001|Overall Study|Received inpatient substance treatment|2|||
25243812|NCT01249157|50558680|FG000|Overall Study|Withdrawal by Subject|1|||
25243813|NCT01249118|50558684|FG000|First Washout Period|Physician Decision|0|||
25243814|NCT01249118|50558685|FG001|First Washout Period|Physician Decision|1|||
25243815|NCT01249118|50558686|FG002|First Washout Period|Physician Decision|0|||
25243816|NCT01248884|50558696|FG000|Overall Study|Withdrawal by Subject|1|||
25243817|NCT01248884|50558697|FG001|Overall Study|Withdrawal by Subject|3|||
25243818|NCT01248884|50558698|FG002|Overall Study|Withdrawal by Subject|1|||
25322992|NCT00881712|50639366|FG001|Overall Study|Death|0|||
25322993|NCT00881712|50639367|FG002|Overall Study|Death|0|||
25322994|NCT00881712|50639365|FG000|Overall Study|Withdrawal by Subject|1|||
25322995|NCT00881712|50639366|FG001|Overall Study|Withdrawal by Subject|0|||
25322996|NCT00881712|50639367|FG002|Overall Study|Withdrawal by Subject|0|||
25322997|NCT03955471|50639375|FG000|Overall Study|Death|22|||
25322998|NCT03955471|50639375|FG000|Overall Study|Lost to Follow-up|1|||
25322999|NCT03955471|50639375|FG000|Overall Study|Withdrawal by Subject|6|||
25323000|NCT03955471|50639375|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
25323001|NCT00880542|50639379|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
25323002|NCT00880542|50639379|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
25323003|NCT00880542|50639379|FG000|REP: Surgical Resection|progressive disease|1|||
25323004|NCT00885534|50639383|FG000|Overall Study|Patient deemed ineligible|1|||
25323005|NCT00885378|50639389|FG000|Overall Study|Lack of Efficacy|2|||
25323006|NCT00885378|50639390|FG001|Overall Study|Lack of Efficacy|2|||
25323007|NCT00885378|50639389|FG000|Overall Study|Withdrawal by Subject|1|||
25323008|NCT00885378|50639390|FG001|Overall Study|Withdrawal by Subject|2|||
25243819|NCT01248884|50558696|FG000|Overall Study|Adverse Event|1|||
25243820|NCT01248884|50558697|FG001|Overall Study|Adverse Event|0|||
25243821|NCT01248884|50558698|FG002|Overall Study|Adverse Event|0|||
25243822|NCT01248728|50558710|FG000|Overall Study|Adverse Event|1|||
25243823|NCT01248728|50558711|FG001|Overall Study|Adverse Event|1|||
25243824|NCT01248728|50558710|FG000|Overall Study|Withdrawal by Subject|2|||
25323009|NCT00885378|50639389|FG000|Overall Study|Lost to Follow-up|1|||
25323010|NCT00885378|50639390|FG001|Overall Study|Lost to Follow-up|2|||
25243825|NCT01248728|50558711|FG001|Overall Study|Withdrawal by Subject|1|||
25243826|NCT01248728|50558710|FG000|Overall Study|Lack of Efficacy|1|||
25243827|NCT01248728|50558711|FG001|Overall Study|Lack of Efficacy|0|||
25243828|NCT01246973|50558721|FG000|Overall Study|Other|38|||
25243829|NCT01246973|50558722|FG001|Overall Study|Other|25|||
25243830|NCT01246973|50558721|FG000|Overall Study|Adverse Event|16|||
25243831|NCT01246973|50558722|FG001|Overall Study|Adverse Event|9|||
25243832|NCT01246973|50558721|FG000|Overall Study|Withdrawal by Subject|7|||
25243833|NCT01246973|50558722|FG001|Overall Study|Withdrawal by Subject|13|||
25243834|NCT01246466|50558728|FG000|Overall Study|Death|1|||
25243835|NCT01246466|50558728|FG000|Overall Study|Withdrawal by Subject|1|||
25243836|NCT01245764|50558737|FG000|Study Phase A|Other|3|||
25243837|NCT01245764|50558738|FG001|Study Phase A|Other|2|||
25243838|NCT01245764|50558739|FG002|Study Phase A|Other|3|||
25243839|NCT01245764|50558740|FG003|Study Phase A|Other|1|||
25243840|NCT01245764|50558737|FG000|Study Phase A|Protocol Violation|6|||
25323011|NCT00885378|50639389|FG000|Overall Study|Poor/Noncompliance|2|||
25323012|NCT00885378|50639390|FG001|Overall Study|Poor/Noncompliance|2|||
25323013|NCT00885378|50639389|FG000|Overall Study|Protocol Violation|2|||
25323014|NCT00885378|50639390|FG001|Overall Study|Protocol Violation|0|||
25243841|NCT01245764|50558738|FG001|Study Phase A|Protocol Violation|3|||
25243842|NCT01245764|50558739|FG002|Study Phase A|Protocol Violation|2|||
25243843|NCT01245764|50558740|FG003|Study Phase A|Protocol Violation|2|||
25323015|NCT00545779|50639396|FG000|Overall Study|Violation of selection criteria at entry|8|||
25243844|NCT01245764|50558737|FG000|Study Phase A|Lost to Follow-up|0|||
25243845|NCT01245764|50558738|FG001|Study Phase A|Lost to Follow-up|0|||
25243846|NCT01245764|50558739|FG002|Study Phase A|Lost to Follow-up|5|||
25243847|NCT01245764|50558740|FG003|Study Phase A|Lost to Follow-up|0|||
25323016|NCT00545779|50639396|FG000|Overall Study|Other protocol violation|1|||
25323017|NCT00545779|50639396|FG000|Overall Study|Did not cooperate|7|||
25323018|NCT00545779|50639396|FG000|Overall Study|Withdrawal by Subject|20|||
25323019|NCT00545779|50639396|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
25323020|NCT00545779|50639396|FG000|Overall Study|Failure to return|3|||
25323021|NCT00597714|50639406|FG000|Overall Study|Death|56|||
25323022|NCT00597714|50639407|FG001|Overall Study|Death|46|||
25323023|NCT00597714|50639408|FG002|Overall Study|Death|0|||
25243848|NCT01245140|50558760|FG000|Overall Study|Adverse Event|1|||
25243849|NCT01245140|50558761|FG001|Overall Study|Adverse Event|3|||
25243850|NCT01245140|50558760|FG000|Overall Study|Lack of Efficacy|2|||
25243851|NCT01245140|50558761|FG001|Overall Study|Lack of Efficacy|4|||
25323024|NCT00597714|50639406|FG000|Overall Study|Recipient death|0|||
25323025|NCT00597714|50639407|FG001|Overall Study|Recipient death|0|||
25323026|NCT00597714|50639408|FG002|Overall Study|Recipient death|10|||
25323027|NCT03938857|50639421|FG000|Overall Study|Physician Decision|1|||
25323028|NCT03938857|50639422|FG001|Overall Study|Physician Decision|0|||
25243852|NCT01245140|50558760|FG000|Overall Study|Protocol Violation|0|||
25243853|NCT01245140|50558761|FG001|Overall Study|Protocol Violation|1|||
25243854|NCT01245140|50558760|FG000|Overall Study|Withdrawal by Subject|0|||
25243855|NCT01245140|50558761|FG001|Overall Study|Withdrawal by Subject|1|||
25243856|NCT01245140|50558760|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
25243857|NCT01245140|50558761|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
25243858|NCT01245101|50558769|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
25243859|NCT01245101|50558770|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
25243860|NCT01245101|50558769|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
25243861|NCT01245101|50558770|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
25243862|NCT01245101|50558769|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
25243863|NCT01245101|50558770|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
25323029|NCT03938857|50639423|FG002|Overall Study|Physician Decision|0|||
25323030|NCT03938857|50639424|FG003|Overall Study|Physician Decision|0|||
25323031|NCT00884832|50639436|FG000|Overall Study|Withdrawal by Subject|0|||
25243864|NCT01245062|50558778|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
25243865|NCT01245062|50558779|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
25243866|NCT01245062|50558780|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
25323032|NCT00884832|50639437|FG001|Overall Study|Withdrawal by Subject|1|||
25323033|NCT03938545|50639447|FG000|Overall Study|Lost to Follow-up|0|||
25323034|NCT03938545|50639448|FG001|Overall Study|Lost to Follow-up|0|||
25323035|NCT03938545|50639449|FG002|Overall Study|Lost to Follow-up|0|||
25323036|NCT03938545|50639450|FG003|Overall Study|Lost to Follow-up|1|||
25323037|NCT03938545|50639447|FG000|Overall Study|Non-compliance with study drug|0|||
25323038|NCT03938545|50639448|FG001|Overall Study|Non-compliance with study drug|0|||
25323039|NCT03938545|50639449|FG002|Overall Study|Non-compliance with study drug|1|||
25323040|NCT03938545|50639450|FG003|Overall Study|Non-compliance with study drug|0|||
25323041|NCT03938545|50639447|FG000|Overall Study|Pregnancy|1|||
25323042|NCT03938545|50639448|FG001|Overall Study|Pregnancy|0|||
25323043|NCT03938545|50639449|FG002|Overall Study|Pregnancy|0|||
25323044|NCT03938545|50639450|FG003|Overall Study|Pregnancy|0|||
25323045|NCT03938545|50639447|FG000|Overall Study|Study terminated by sponsor|6|||
25323046|NCT03938545|50639448|FG001|Overall Study|Study terminated by sponsor|4|||
25323047|NCT03938545|50639449|FG002|Overall Study|Study terminated by sponsor|2|||
25323048|NCT03938545|50639450|FG003|Overall Study|Study terminated by sponsor|4|||
25323049|NCT03938545|50639447|FG000|Overall Study|Withdrawal by Subject|0|||
25323050|NCT03938545|50639448|FG001|Overall Study|Withdrawal by Subject|1|||
25323051|NCT03938545|50639449|FG002|Overall Study|Withdrawal by Subject|0|||
25323052|NCT03938545|50639450|FG003|Overall Study|Withdrawal by Subject|0|||
25323053|NCT03938545|50639447|FG000|Overall Study|Adverse Event|1|||
25323054|NCT03938545|50639448|FG001|Overall Study|Adverse Event|0|||
25323055|NCT03938545|50639449|FG002|Overall Study|Adverse Event|0|||
25243867|NCT01245062|50558778|FG000|Randomization and Crossover Phase|Physician Decision|2|||
25243868|NCT01245062|50558779|FG001|Randomization and Crossover Phase|Physician Decision|4|||
25243869|NCT01245062|50558780|FG002|Randomization and Crossover Phase|Physician Decision|0|||
25323056|NCT03938545|50639450|FG003|Overall Study|Adverse Event|0|||
25243870|NCT01245062|50558778|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
25243871|NCT01245062|50558779|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
25243872|NCT01245062|50558780|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
25243873|NCT01245062|50558778|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
25243874|NCT01245062|50558779|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
25243875|NCT01245062|50558780|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
25243876|NCT01245062|50558778|FG000|Cross-over Phase|Lost to Follow-up|0|||
25243877|NCT01245062|50558779|FG001|Cross-over Phase|Lost to Follow-up|0|||
25243878|NCT01245062|50558780|FG002|Cross-over Phase|Lost to Follow-up|1|||
25243879|NCT01245062|50558778|FG000|Cross-over Phase|Physician Decision|0|||
25243880|NCT01245062|50558779|FG001|Cross-over Phase|Physician Decision|0|||
25243881|NCT01245062|50558780|FG002|Cross-over Phase|Physician Decision|1|||
25243882|NCT01245062|50558778|FG000|Cross-over Phase|Withdrew Consent|0|||
25243883|NCT01245062|50558779|FG001|Cross-over Phase|Withdrew Consent|0|||
25243884|NCT01245062|50558780|FG002|Cross-over Phase|Withdrew Consent|4|||
25243885|NCT01245062|50558778|FG000|Cross-over Phase|Study closed/ terminated|0|||
25243886|NCT01245062|50558779|FG001|Cross-over Phase|Study closed/ terminated|0|||
25243887|NCT01245062|50558780|FG002|Cross-over Phase|Study closed/ terminated|11|||
25243888|NCT01244984|50558791|FG000|Overall Study|Adverse Event|2|||
25243889|NCT01244984|50558792|FG001|Overall Study|Adverse Event|11|||
25243890|NCT01244984|50558793|FG002|Overall Study|Adverse Event|2|||
25323057|NCT00879996|50639462|FG000|Overall Study|Lost to Follow-up|7|||
25323058|NCT00879996|50639463|FG001|Overall Study|Lost to Follow-up|6|||
25323059|NCT00879996|50639462|FG000|Overall Study|non-compliance|6|||
25323060|NCT00879996|50639463|FG001|Overall Study|non-compliance|4|||
25323061|NCT00879996|50639462|FG000|Overall Study|Physician Decision|1|||
25323062|NCT00879996|50639463|FG001|Overall Study|Physician Decision|2|||
25323063|NCT00879996|50639462|FG000|Overall Study|psychiatric problem|0|||
25243891|NCT01244984|50558791|FG000|Overall Study|Protocol Violation|1|||
25243892|NCT01244984|50558792|FG001|Overall Study|Protocol Violation|0|||
25243893|NCT01244984|50558793|FG002|Overall Study|Protocol Violation|0|||
25243894|NCT01244984|50558791|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
25243895|NCT01244984|50558792|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
25243896|NCT01244984|50558793|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
25243897|NCT01244984|50558791|FG000|Overall Study|Withdrawal by Subject|1|||
25243898|NCT01244984|50558792|FG001|Overall Study|Withdrawal by Subject|2|||
25243899|NCT01244984|50558793|FG002|Overall Study|Withdrawal by Subject|2|||
25243900|NCT01244516|50558805|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
25243901|NCT01244516|50558806|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
25243902|NCT01244516|50558807|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
25243903|NCT01244516|50558805|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
25243904|NCT01244516|50558806|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
25243905|NCT01244516|50558807|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
25243906|NCT01244516|50558805|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
25243907|NCT01244516|50558806|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
25243908|NCT01244516|50558807|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
25243909|NCT01244516|50558805|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
25243910|NCT01244516|50558806|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
25243911|NCT01244516|50558807|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
25243912|NCT01244516|50558805|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
25243913|NCT01244516|50558806|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
25243914|NCT01244516|50558807|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
25243915|NCT01244516|50558805|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
25243916|NCT01244516|50558806|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
25243917|NCT01244516|50558807|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
25243918|NCT01244516|50558805|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
25243919|NCT01244516|50558806|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
25243920|NCT01244516|50558807|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
25243921|NCT01244126|50558819|FG000|Overall Study|Protocol Violation|3|||
25243922|NCT01244126|50558820|FG001|Overall Study|Protocol Violation|3|||
25243923|NCT01244126|50558821|FG002|Overall Study|Protocol Violation|9|||
25243924|NCT01243892|50558831|FG000|Overall Study|Did not meet eligibility criteria|2|||
25243925|NCT01243892|50558832|FG001|Overall Study|Did not meet eligibility criteria|0|||
25243926|NCT01243775|50558838|FG000|Overall Study|Withdrawal by Subject|2|||
25243927|NCT01243268|50558842|FG000|Overall Study|Lost to Follow-up|4|||
25243928|NCT01243268|50558842|FG000|Overall Study|Protocol Violation|51|||
25243929|NCT01243268|50558842|FG000|Overall Study|Deviation with contract date|7|||
25243930|NCT01243268|50558842|FG000|Overall Study|Duplicate subject|2|||
25243931|NCT01242371|50558848|FG000|Overall Study|Withdrawal by Subject|2|||
25323064|NCT00879996|50639463|FG001|Overall Study|psychiatric problem|1|||
25323065|NCT00879996|50639462|FG000|Overall Study|put on parole|1|||
25323066|NCT00879996|50639463|FG001|Overall Study|put on parole|0|||
25323067|NCT00873093|50639476|FG000|Overall Study|Adverse Event|0|||
25323068|NCT00873093|50639477|FG001|Overall Study|Adverse Event|2|||
25323069|NCT00873093|50639478|FG002|Overall Study|Adverse Event|0|||
25323070|NCT00873093|50639479|FG003|Overall Study|Adverse Event|0|||
25323071|NCT00873093|50639480|FG004|Overall Study|Adverse Event|0|||
25323072|NCT00873093|50639476|FG000|Overall Study|Death|0|||
25323073|NCT00873093|50639477|FG001|Overall Study|Death|3|||
25323074|NCT00873093|50639478|FG002|Overall Study|Death|2|||
25323075|NCT00873093|50639479|FG003|Overall Study|Death|0|||
25323076|NCT00873093|50639480|FG004|Overall Study|Death|0|||
25243932|NCT01242371|50558849|FG001|Overall Study|Withdrawal by Subject|2|||
25243933|NCT01242371|50558848|FG000|Overall Study|Protocol Violation|0|||
25323077|NCT00873093|50639476|FG000|Overall Study|Physician Decision|0|||
25323078|NCT00873093|50639477|FG001|Overall Study|Physician Decision|17|||
25243934|NCT01242371|50558849|FG001|Overall Study|Protocol Violation|3|||
25243935|NCT01242176|50558855|FG000|Washout Period of 7 Days|Adverse Event|0|||
25243936|NCT01242176|50558856|FG001|Washout Period of 7 Days|Adverse Event|2|||
25243937|NCT01242176|50558855|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
25243938|NCT01242176|50558856|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
25243939|NCT01242020|50558864|FG000|Overall Study|Withdrawal by Subject|2|||
25243940|NCT01242020|50558865|FG001|Overall Study|Withdrawal by Subject|0|||
25243941|NCT01242020|50558864|FG000|Overall Study|Failed screening|1|||
25243942|NCT01242020|50558865|FG001|Overall Study|Failed screening|0|||
25243943|NCT01241786|50558871|FG000|Overall Study|Lack of Efficacy|5|||
25243944|NCT01241318|50558878|FG000|Overall Study|Woman: false pregnancies|27|||
25243945|NCT01241318|50558879|FG001|Overall Study|Woman: false pregnancies|15|||
25243946|NCT01241318|50558878|FG000|Overall Study|Woman: miscarriage/abortion|46|||
25243947|NCT01241318|50558879|FG001|Overall Study|Woman: miscarriage/abortion|38|||
25243948|NCT01241318|50558878|FG000|Overall Study|Withdrawal by Subject|175|||
25243949|NCT01241318|50558879|FG001|Overall Study|Withdrawal by Subject|46|||
25243950|NCT01241318|50558878|FG000|Overall Study|Lost to Follow-up|740|||
25243951|NCT01241318|50558879|FG001|Overall Study|Lost to Follow-up|455|||
25243952|NCT01241318|50558878|FG000|Overall Study|Death|2|||
25243953|NCT01241318|50558879|FG001|Overall Study|Death|4|||
25243954|NCT01241318|50558878|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
25243955|NCT01241318|50558879|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
25243956|NCT01241318|50558878|FG000|Overall Study|Woman: Stillborn infant|129|||
25243957|NCT01241318|50558879|FG001|Overall Study|Woman: Stillborn infant|146|||
25243958|NCT01241279|50558890|FG000|Overall Study|Lost to Follow-up|0|||
25243959|NCT01241279|50558891|FG001|Overall Study|Lost to Follow-up|1|||
25243960|NCT01241240|50558899|FG000|Overall Study|Adverse Event|5|||
25243961|NCT01241240|50558900|FG001|Overall Study|Adverse Event|4|||
25243962|NCT01241240|50558899|FG000|Overall Study|Lost to Follow-up|2|||
25243963|NCT01241240|50558900|FG001|Overall Study|Lost to Follow-up|4|||
25323079|NCT00873093|50639478|FG002|Overall Study|Physician Decision|10|||
25323080|NCT00873093|50639479|FG003|Overall Study|Physician Decision|10|||
25323081|NCT00873093|50639480|FG004|Overall Study|Physician Decision|2|||
25323082|NCT00873093|50639476|FG000|Overall Study|Withdrawal by Subject|1|||
25323083|NCT00873093|50639477|FG001|Overall Study|Withdrawal by Subject|4|||
25323084|NCT00873093|50639478|FG002|Overall Study|Withdrawal by Subject|4|||
25323085|NCT00873093|50639479|FG003|Overall Study|Withdrawal by Subject|0|||
25323086|NCT00873093|50639480|FG004|Overall Study|Withdrawal by Subject|0|||
25323087|NCT00873093|50639476|FG000|Overall Study|Ineligible|0|||
25323088|NCT00873093|50639477|FG001|Overall Study|Ineligible|1|||
25323089|NCT00873093|50639478|FG002|Overall Study|Ineligible|0|||
25323090|NCT00873093|50639479|FG003|Overall Study|Ineligible|1|||
25323091|NCT00873093|50639480|FG004|Overall Study|Ineligible|0|||
25323092|NCT00884286|50639504|FG000|Overall Study|Progressive disease|21|||
25323093|NCT00884286|50639505|FG001|Overall Study|Progressive disease|28|||
25323094|NCT00884286|50639504|FG000|Overall Study|Toxicity|4|||
25323095|NCT00884286|50639505|FG001|Overall Study|Toxicity|1|||
25323096|NCT00884286|50639504|FG000|Overall Study|Death|2|||
25323097|NCT00884286|50639505|FG001|Overall Study|Death|2|||
25323098|NCT00884286|50639504|FG000|Overall Study|Physician Decision|1|||
25323099|NCT00884286|50639505|FG001|Overall Study|Physician Decision|0|||
25323100|NCT00884286|50639504|FG000|Overall Study|Septic shock|1|||
25323101|NCT00884286|50639505|FG001|Overall Study|Septic shock|0|||
25323102|NCT00884286|50639504|FG000|Overall Study|Thrombus in right auricle|1|||
25323103|NCT00884286|50639505|FG001|Overall Study|Thrombus in right auricle|0|||
25323104|NCT00884286|50639504|FG000|Overall Study|Not treated|2|||
25323105|NCT00884286|50639505|FG001|Overall Study|Not treated|1|||
25323106|NCT00884286|50639504|FG000|Overall Study|Comprised lung carcinoma|0|||
25323107|NCT00884286|50639505|FG001|Overall Study|Comprised lung carcinoma|1|||
25243964|NCT01241240|50558899|FG000|Overall Study|Personal Reasons|1|||
25243965|NCT01241240|50558900|FG001|Overall Study|Personal Reasons|1|||
25243966|NCT01240811|50558909|FG000|Overall Study|Physician Decision|0|||
25243967|NCT01240811|50558910|FG001|Overall Study|Physician Decision|1|||
25243968|NCT01240811|50558911|FG002|Overall Study|Physician Decision|0|||
25243969|NCT01240811|50558909|FG000|Overall Study|Withdrawal by Subject|0|||
25243970|NCT01240811|50558910|FG001|Overall Study|Withdrawal by Subject|0|||
25323108|NCT00873015|50639516|FG000|Overall Study|Withdrawal by Subject|0|||
25323109|NCT00873015|50639517|FG001|Overall Study|Withdrawal by Subject|1|||
25323110|NCT00873015|50639518|FG002|Overall Study|Withdrawal by Subject|0|||
25323111|NCT00873015|50639519|FG003|Overall Study|Withdrawal by Subject|0|||
25323112|NCT03921151|50639534|FG000|Overall Study|Withdrawal by Subject|11|||
25243971|NCT01240811|50558911|FG002|Overall Study|Withdrawal by Subject|1|||
25243972|NCT01240382|50558923|FG000|Overall Study|Adverse Event|2|||
25243973|NCT01240382|50558924|FG001|Overall Study|Adverse Event|1|||
25243974|NCT01240382|50558923|FG000|Overall Study|Lack of Efficacy|0|||
25243975|NCT01240382|50558924|FG001|Overall Study|Lack of Efficacy|2|||
25323113|NCT03921151|50639535|FG001|Overall Study|Withdrawal by Subject|16|||
25243976|NCT01240382|50558923|FG000|Overall Study|Fear of adverse events|0|||
25323114|NCT00872001|50639547|FG000|Overall Study|Adverse Event|34|||
25243977|NCT01240382|50558924|FG001|Overall Study|Fear of adverse events|1|||
25243978|NCT01244828|50558930|FG000|Overall Study|Adverse Event|37|||
25243979|NCT01244828|50558930|FG000|Overall Study|Withdrawal by Subject|31|||
25243980|NCT01244828|50558930|FG000|Overall Study|Lack of Efficacy|7|||
25243981|NCT01244828|50558930|FG000|Overall Study|Lost to Follow-up|2|||
25243982|NCT01244828|50558930|FG000|Overall Study|Other reason (not specified)|1|||
25243983|NCT01249833|50558936|FG000|Overall Study|Lost to Follow-up|0|||
25243984|NCT01249833|50558937|FG001|Overall Study|Lost to Follow-up|1|||
25243985|NCT01249404|50558946|FG000|Overall Study|Study treatment not received|0|||
25243986|NCT01249404|50558947|FG001|Overall Study|Study treatment not received|1|||
25243987|NCT01249404|50558948|FG002|Overall Study|Study treatment not received|2|||
25243988|NCT01249404|50558946|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
25243989|NCT01249404|50558947|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
25243990|NCT01249404|50558948|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
25243991|NCT01249404|50558946|FG000|Overall Study|Adverse Event|2|||
25243992|NCT01249404|50558947|FG001|Overall Study|Adverse Event|2|||
25243993|NCT01249404|50558948|FG002|Overall Study|Adverse Event|2|||
25243994|NCT01249404|50558946|FG000|Overall Study|Withdrawal by Subject|2|||
25243995|NCT01249404|50558947|FG001|Overall Study|Withdrawal by Subject|2|||
25243996|NCT01249404|50558948|FG002|Overall Study|Withdrawal by Subject|0|||
25243997|NCT01249404|50558946|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
25243998|NCT01249404|50558947|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
25243999|NCT01249404|50558948|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
25244000|NCT01249404|50558946|FG000|Overall Study|Non compliance to visit schedule|0|||
25244001|NCT01249404|50558947|FG001|Overall Study|Non compliance to visit schedule|1|||
25244002|NCT01249404|50558948|FG002|Overall Study|Non compliance to visit schedule|0|||
25244003|NCT01249365|50558956|FG000|Overall Study|Lost to Follow-up|1|||
25244004|NCT01249131|50558960|FG000|Washout Period of 10 Days|Adverse Event|0|||
25244005|NCT01249131|50558961|FG001|Washout Period of 10 Days|Adverse Event|0|||
25323115|NCT00872001|50639548|FG001|Overall Study|Adverse Event|23|||
25323116|NCT00872001|50639547|FG000|Overall Study|Protocol Defined Clinical Event|5|||
25323117|NCT00872001|50639548|FG001|Overall Study|Protocol Defined Clinical Event|7|||
25323118|NCT00872001|50639547|FG000|Overall Study|Lost to Follow-up|13|||
25323119|NCT00872001|50639548|FG001|Overall Study|Lost to Follow-up|12|||
25323120|NCT00872001|50639547|FG000|Overall Study|Withdrawal by Subject|18|||
25323121|NCT00872001|50639548|FG001|Overall Study|Withdrawal by Subject|30|||
25323122|NCT00872001|50639547|FG000|Overall Study|Protocol Violation|5|||
25323123|NCT00872001|50639548|FG001|Overall Study|Protocol Violation|8|||
25323124|NCT00872001|50639547|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
25323125|NCT00872001|50639548|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
25323126|NCT00872001|50639547|FG000|Overall Study|Administrative|23|||
25323127|NCT00872001|50639548|FG001|Overall Study|Administrative|15|||
25323128|NCT00871923|50639556|FG000|Overall Study|Death|1|||
25323129|NCT00871923|50639556|FG000|Overall Study|Withdrawal by Subject|1|||
25323130|NCT03922945|50639563|FG000|Overall Study|Adverse Event|1|||
25323131|NCT03922945|50639564|FG001|Overall Study|Adverse Event|1|||
25323132|NCT03922945|50639565|FG002|Overall Study|Adverse Event|2|||
25323133|NCT03922945|50639563|FG000|Overall Study|Lost to Follow-up|13|||
25323134|NCT03922945|50639564|FG001|Overall Study|Lost to Follow-up|9|||
25323135|NCT03922945|50639565|FG002|Overall Study|Lost to Follow-up|20|||
25323136|NCT03922945|50639563|FG000|Overall Study|Lack of Efficacy|2|||
25323137|NCT03922945|50639564|FG001|Overall Study|Lack of Efficacy|0|||
25323138|NCT03922945|50639565|FG002|Overall Study|Lack of Efficacy|1|||
25323139|NCT03922945|50639563|FG000|Overall Study|Protocol Non-Compliance|0|||
25323140|NCT03922945|50639564|FG001|Overall Study|Protocol Non-Compliance|0|||
25323141|NCT03922945|50639565|FG002|Overall Study|Protocol Non-Compliance|1|||
25323142|NCT03922945|50639563|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
25323143|NCT03922945|50639564|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
25323144|NCT03922945|50639565|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
25323145|NCT03922945|50639563|FG000|Overall Study|All Other Personal Reasons|1|||
25323146|NCT03922945|50639564|FG001|Overall Study|All Other Personal Reasons|1|||
25323147|NCT03922945|50639565|FG002|Overall Study|All Other Personal Reasons|2|||
25323148|NCT03922477|50639576|FG000|Overall Study|Death|9|||
25244006|NCT01249131|50558962|FG002|Washout Period of 10 Days|Adverse Event|0|||
25323149|NCT03922477|50639576|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
25323150|NCT03922477|50639576|FG000|Overall Study|Physician Decision|1|||
25323151|NCT03922477|50639576|FG000|Overall Study|Withdrawal by Subject|2|||
25244007|NCT01249131|50558963|FG003|Washout Period of 10 Days|Adverse Event|0|||
25244008|NCT01249131|50558964|FG004|Washout Period of 10 Days|Adverse Event|1|||
25244009|NCT01249131|50558965|FG005|Washout Period of 10 Days|Adverse Event|0|||
25244010|NCT01249092|50558973|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
25244011|NCT01249092|50558973|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
25323152|NCT00867165|50639582|FG000|Overall Study|Adverse Event|3|||
25323153|NCT00867165|50639583|FG001|Overall Study|Adverse Event|0|||
25323154|NCT00867165|50639582|FG000|Overall Study|Withdrawal by Subject|1|||
25323155|NCT00867165|50639583|FG001|Overall Study|Withdrawal by Subject|0|||
25244012|NCT01248936|50558979|FG000|Overall Study|Sponsor Decision|259|||
25244013|NCT01248936|50558979|FG000|Overall Study|Progression of Disease|50|||
25244014|NCT01248936|50558979|FG000|Overall Study|Death|26|||
25244015|NCT01248936|50558979|FG000|Overall Study|Withdrawal of Consent|20|||
25244016|NCT01248936|50558979|FG000|Overall Study|Adverse Event|8|||
25244017|NCT01248936|50558979|FG000|Overall Study|Lost to Follow-up|7|||
25244018|NCT01248936|50558979|FG000|Overall Study|Refused Treatment|1|||
25244019|NCT01248936|50558979|FG000|Overall Study|Other reason|3|||
25244020|NCT01248780|50558986|FG000|Overall Study|Lack of Efficacy|2|||
25244021|NCT01248780|50558987|FG001|Overall Study|Lack of Efficacy|0|||
25244022|NCT01248780|50558986|FG000|Overall Study|Lost to Follow-up|0|||
25244023|NCT01248780|50558987|FG001|Overall Study|Lost to Follow-up|1|||
25244024|NCT01248780|50558986|FG000|Overall Study|Death|0|||
25244025|NCT01248780|50558987|FG001|Overall Study|Death|1|||
25244026|NCT01248780|50558986|FG000|Overall Study|Adverse Event|2|||
25244027|NCT01248780|50558987|FG001|Overall Study|Adverse Event|7|||
25244028|NCT01248780|50558986|FG000|Overall Study|Protocol Violation|1|||
25244029|NCT01248780|50558987|FG001|Overall Study|Protocol Violation|1|||
25244030|NCT01248780|50558986|FG000|Overall Study|Withdrawal by Subject|4|||
25244031|NCT01248780|50558987|FG001|Overall Study|Withdrawal by Subject|4|||
25244032|NCT01248780|50558986|FG000|Overall Study|Not treated|0|||
25244033|NCT01248780|50558987|FG001|Overall Study|Not treated|1|||
25244034|NCT01248468|50558996|FG000|Overall Study|Administrative problem|1|||
25244035|NCT01248468|50558997|FG001|Overall Study|Administrative problem|0|||
25244036|NCT01248468|50558998|FG002|Overall Study|Administrative problem|0|||
25244037|NCT01248468|50558996|FG000|Overall Study|Lost to Follow-up|9|||
25244038|NCT01248468|50558997|FG001|Overall Study|Lost to Follow-up|12|||
25244039|NCT01248468|50558998|FG002|Overall Study|Lost to Follow-up|4|||
25244040|NCT01248468|50558996|FG000|Overall Study|Pregnancy|1|||
25244041|NCT01248468|50558997|FG001|Overall Study|Pregnancy|0|||
25244042|NCT01248468|50558998|FG002|Overall Study|Pregnancy|0|||
25244043|NCT01248468|50558996|FG000|Overall Study|Withdrawal by Subject|4|||
25244044|NCT01248468|50558997|FG001|Overall Study|Withdrawal by Subject|2|||
25244045|NCT01248468|50558998|FG002|Overall Study|Withdrawal by Subject|0|||
25244046|NCT01247922|50559006|FG000|Overall Study|Disease progression|4|||
25244047|NCT01246206|50559010|FG000|Overall Study|Patient did not receive study regiments.|1|||
25244048|NCT01246011|50559017|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
25244049|NCT01246011|50559018|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
25244050|NCT01246011|50559019|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
25244051|NCT01246011|50559017|FG000|Overall Study|Withdrawal by Subject|0|||
25244052|NCT01246011|50559018|FG001|Overall Study|Withdrawal by Subject|0|||
25244053|NCT01246011|50559019|FG002|Overall Study|Withdrawal by Subject|1|||
25244054|NCT01244490|50559031|FG000|Overall Study|Lack of Efficacy|14|||
25323156|NCT00867087|50639589|FG000|Overall Study|Other|1|||
25323157|NCT00867087|50639589|FG000|Overall Study|Withdrawal by Subject|4|||
25323158|NCT00867087|50639589|FG000|Overall Study|Death|37|||
25323159|NCT00545233|50639595|FG000|Overall Study|Adverse Event|10|||
25244055|NCT01244490|50559032|FG001|Overall Study|Lack of Efficacy|5|||
25244056|NCT01244490|50559033|FG002|Overall Study|Lack of Efficacy|5|||
25244057|NCT01244490|50559031|FG000|Overall Study|Withdrawal by Subject|4|||
25244058|NCT01244490|50559032|FG001|Overall Study|Withdrawal by Subject|4|||
25244059|NCT01244490|50559033|FG002|Overall Study|Withdrawal by Subject|9|||
25244060|NCT01244490|50559031|FG000|Overall Study|Adverse Event|1|||
25244061|NCT01244490|50559032|FG001|Overall Study|Adverse Event|9|||
25244062|NCT01244490|50559033|FG002|Overall Study|Adverse Event|5|||
25244063|NCT01244490|50559031|FG000|Overall Study|Lost to Follow-up|0|||
25244064|NCT01244490|50559032|FG001|Overall Study|Lost to Follow-up|6|||
25244065|NCT01244490|50559033|FG002|Overall Study|Lost to Follow-up|3|||
25244066|NCT01244490|50559031|FG000|Overall Study|Other|0|||
25244067|NCT01244490|50559032|FG001|Overall Study|Other|0|||
25244068|NCT01244490|50559033|FG002|Overall Study|Other|1|||
25323160|NCT00545233|50639596|FG001|Overall Study|Adverse Event|5|||
25323161|NCT00545233|50639595|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
25244069|NCT01243944|50559043|FG000|Overall Study|Adverse Event|15|||
25244070|NCT01243944|50559044|FG001|Overall Study|Adverse Event|13|||
25244071|NCT01243944|50559043|FG000|Overall Study|Lost to Follow-up|2|||
25323162|NCT00545233|50639596|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
25323163|NCT00545233|50639595|FG000|Overall Study|Protocol Violation|2|||
25244072|NCT01243944|50559044|FG001|Overall Study|Lost to Follow-up|1|||
25244073|NCT01243944|50559043|FG000|Overall Study|Physician Decision|2|||
25244074|NCT01243944|50559044|FG001|Overall Study|Physician Decision|7|||
25244075|NCT01243944|50559043|FG000|Overall Study|Disease progression|12|||
25244076|NCT01243944|50559044|FG001|Overall Study|Disease progression|11|||
25244077|NCT01243944|50559043|FG000|Overall Study|Protocol deviation|1|||
25244078|NCT01243944|50559044|FG001|Overall Study|Protocol deviation|1|||
25244079|NCT01243944|50559043|FG000|Overall Study|Participant decision|10|||
25244080|NCT01243944|50559044|FG001|Overall Study|Participant decision|15|||
25244081|NCT01243944|50559043|FG000|Overall Study|Death|2|||
25244082|NCT01243944|50559044|FG001|Overall Study|Death|3|||
25244083|NCT01243944|50559043|FG000|Overall Study|Non-compliance with study treatment|1|||
25244084|NCT01243944|50559044|FG001|Overall Study|Non-compliance with study treatment|0|||
25244085|NCT01243242|50559053|FG000|Overall Study|Adverse Event|1|||
25244086|NCT01243242|50559054|FG001|Overall Study|Adverse Event|1|||
25244087|NCT01243242|50559053|FG000|Overall Study|Withdrawal by Subject|1|||
25244088|NCT01243242|50559054|FG001|Overall Study|Withdrawal by Subject|1|||
25244089|NCT01243242|50559053|FG000|Overall Study|Physician Decision|0|||
25244090|NCT01243242|50559054|FG001|Overall Study|Physician Decision|1|||
25244091|NCT01243242|50559053|FG000|Overall Study|sponsor decision|0|||
25244092|NCT01243242|50559054|FG001|Overall Study|sponsor decision|1|||
25244093|NCT01243242|50559053|FG000|Overall Study|non compliance|1|||
25244094|NCT01243242|50559054|FG001|Overall Study|non compliance|0|||
25244095|NCT01242813|50559060|FG000|Overall Study|Lost to Follow-up|2|||
25244096|NCT01242111|50559064|FG000|Overall Study|Adverse Event|1|||
25244097|NCT01242111|50559064|FG000|Overall Study|Withdrawal by Subject|1|||
25244098|NCT01242111|50559064|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
25244099|NCT01241604|50559068|FG000|Screening Period|Screen Failure|3|||
25244100|NCT01241604|50559069|FG001|Screening Period|Screen Failure|0|||
25244101|NCT01241604|50559070|FG002|Screening Period|Screen Failure|0|||
25244102|NCT01241292|50559079|FG000|Overall Study|Administrative Reason by Sponsor|1|||
25244103|NCT01241292|50559080|FG001|Overall Study|Administrative Reason by Sponsor|0|||
25244104|NCT01241292|50559079|FG000|Overall Study|Disease Progression|2|||
25244105|NCT01241292|50559080|FG001|Overall Study|Disease Progression|0|||
25244106|NCT01241292|50559079|FG000|Overall Study|Study Drug Toxicity|0|||
25244107|NCT01241292|50559080|FG001|Overall Study|Study Drug Toxicity|1|||
25244108|NCT01241292|50559079|FG000|Overall Study|Participant Discontinued Treatment|0|||
25244109|NCT01241292|50559080|FG001|Overall Study|Participant Discontinued Treatment|2|||
25244110|NCT01240863|50559092|FG000|Open-label Titration Period|Adverse Event|47|||
25244111|NCT01240863|50559093|FG001|Open-label Titration Period|Adverse Event|0|||
25244112|NCT01240863|50559094|FG002|Open-label Titration Period|Adverse Event|0|||
25244113|NCT01240863|50559092|FG000|Open-label Titration Period|Lack of Efficacy|19|||
25244114|NCT01240863|50559093|FG001|Open-label Titration Period|Lack of Efficacy|0|||
25244115|NCT01240863|50559094|FG002|Open-label Titration Period|Lack of Efficacy|0|||
25244116|NCT01240863|50559092|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
25244117|NCT01240863|50559093|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
25244118|NCT01240863|50559094|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
25244119|NCT01240863|50559092|FG000|Open-label Titration Period|Protocol Violation|7|||
25244120|NCT01240863|50559093|FG001|Open-label Titration Period|Protocol Violation|0|||
25244121|NCT01240863|50559094|FG002|Open-label Titration Period|Protocol Violation|0|||
25244122|NCT01240863|50559092|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
25244123|NCT01240863|50559093|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
25244124|NCT01240863|50559094|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
25244125|NCT01240863|50559092|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
25244126|NCT01240863|50559093|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
25244127|NCT01240863|50559094|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
25244128|NCT01240863|50559092|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
25244129|NCT01240863|50559093|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
25244130|NCT01240863|50559094|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
25244131|NCT01240863|50559092|FG000|Open-label Titration Period|Other|7|||
25244132|NCT01240863|50559093|FG001|Open-label Titration Period|Other|0|||
25244133|NCT01240863|50559094|FG002|Open-label Titration Period|Other|0|||
25244134|NCT01240863|50559092|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
25244135|NCT01240863|50559093|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
25244136|NCT01240863|50559094|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
25244137|NCT01240863|50559092|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
25244138|NCT01240863|50559093|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
25244139|NCT01240863|50559094|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
25244140|NCT01240863|50559092|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
25244141|NCT01240863|50559093|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
25244142|NCT01240863|50559094|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
25323164|NCT00545233|50639596|FG001|Overall Study|Protocol Violation|0|||
25323165|NCT00545233|50639595|FG000|Overall Study|Refused Treatment|9|||
25323166|NCT00545233|50639596|FG001|Overall Study|Refused Treatment|7|||
25323167|NCT00545233|50639595|FG000|Overall Study|Failure to Return|4|||
25244143|NCT01240863|50559092|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
25244144|NCT01240863|50559093|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
25244145|NCT01240863|50559094|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
25244146|NCT01240863|50559092|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
25323168|NCT00545233|50639596|FG001|Overall Study|Failure to Return|6|||
25323169|NCT00545233|50639595|FG000|Overall Study|Insufficient response|14|||
25323170|NCT00545233|50639596|FG001|Overall Study|Insufficient response|15|||
25244147|NCT01240863|50559093|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
25244148|NCT01240863|50559094|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
25244149|NCT01240863|50559092|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
25244150|NCT01240863|50559093|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
25244151|NCT01240863|50559094|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
25244152|NCT01240863|50559092|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
25244153|NCT01240863|50559093|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
25244154|NCT01240863|50559094|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
25244155|NCT01240863|50559092|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
25244156|NCT01240863|50559093|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
25244157|NCT01240863|50559094|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
25244158|NCT01240746|50559109|FG000|Overall Study|Adverse Event|2|||
25244159|NCT01240746|50559110|FG001|Overall Study|Adverse Event|0|||
25244160|NCT01240746|50559111|FG002|Overall Study|Adverse Event|10|||
25244161|NCT01240746|50559109|FG000|Overall Study|Lost to Follow-up|23|||
25244162|NCT01240746|50559110|FG001|Overall Study|Lost to Follow-up|20|||
25244163|NCT01240746|50559111|FG002|Overall Study|Lost to Follow-up|102|||
25244164|NCT01240746|50559109|FG000|Overall Study|Protocol Violation|24|||
25244165|NCT01240746|50559110|FG001|Overall Study|Protocol Violation|15|||
25323171|NCT00545233|50639595|FG000|Overall Study|Physician Decision|2|||
25323172|NCT00545233|50639596|FG001|Overall Study|Physician Decision|1|||
25323173|NCT02393248|50639628|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323174|NCT02393248|50639629|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
25323175|NCT02393248|50639630|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323176|NCT02393248|50639631|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323177|NCT02393248|50639632|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25244166|NCT01240746|50559111|FG002|Overall Study|Protocol Violation|72|||
25244167|NCT01240746|50559109|FG000|Overall Study|Withdrawal by Subject|10|||
25244168|NCT01240746|50559110|FG001|Overall Study|Withdrawal by Subject|13|||
25244169|NCT01240746|50559111|FG002|Overall Study|Withdrawal by Subject|59|||
25244170|NCT01240590|50559124|FG000|Phase I|Refused further treatment|0|||
25244171|NCT01240590|50559125|FG001|Phase I|Refused further treatment|0|||
25244172|NCT01240590|50559126|FG002|Phase I|Refused further treatment|3|||
25244173|NCT01240590|50559127|FG003|Phase I|Refused further treatment|0|||
25244174|NCT01240590|50559128|FG004|Phase I|Refused further treatment|0|||
25244175|NCT01240590|50559124|FG000|Phase II|Refused further treatment|0|||
25244176|NCT01240590|50559125|FG001|Phase II|Refused further treatment|0|||
25244177|NCT01240590|50559126|FG002|Phase II|Refused further treatment|0|||
25244178|NCT01240590|50559127|FG003|Phase II|Refused further treatment|2|||
25244179|NCT01240590|50559128|FG004|Phase II|Refused further treatment|1|||
25244180|NCT01240200|50559156|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
25244181|NCT01240200|50559157|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
25244182|NCT01356966|50559168|FG000|Overall Study|Withdrawal by Subject|1|||
25244183|NCT01356966|50559169|FG001|Overall Study|Withdrawal by Subject|2|||
25323178|NCT02393248|50639633|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
25323179|NCT02393248|50639634|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
25323180|NCT02393248|50639635|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323181|NCT02393248|50639636|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323182|NCT02393248|50639637|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323183|NCT02393248|50639638|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323184|NCT02393248|50639639|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25244184|NCT01356966|50559168|FG000|Overall Study|Physician Decision|1|||
25244185|NCT01356966|50559169|FG001|Overall Study|Physician Decision|0|||
25244186|NCT01295827|50559198|FG000|Overall Study|Adverse Event|1|||
25244187|NCT01295827|50559199|FG001|Overall Study|Adverse Event|2|||
25244188|NCT01295827|50559200|FG002|Overall Study|Adverse Event|2|||
25244189|NCT01295827|50559201|FG003|Overall Study|Adverse Event|1|||
25244190|NCT01295827|50559202|FG004|Overall Study|Adverse Event|1|||
25244191|NCT01295827|50559203|FG005|Overall Study|Adverse Event|4|||
25244192|NCT01295827|50559204|FG006|Overall Study|Adverse Event|15|||
25244193|NCT01295827|50559205|FG007|Overall Study|Adverse Event|49|||
25244194|NCT01295827|50559206|FG008|Overall Study|Adverse Event|22|||
25244195|NCT01295827|50559207|FG009|Overall Study|Adverse Event|7|||
25244196|NCT01295827|50559208|FG010|Overall Study|Adverse Event|50|||
25244197|NCT01295827|50559209|FG011|Overall Study|Adverse Event|21|||
25244198|NCT01295827|50559210|FG012|Overall Study|Adverse Event|0|||
25323185|NCT02393248|50639640|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323186|NCT02393248|50639641|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25244199|NCT01295827|50559211|FG013|Overall Study|Adverse Event|0|||
25244200|NCT01295827|50559212|FG014|Overall Study|Adverse Event|0|||
25244201|NCT01295827|50559198|FG000|Overall Study|Lost to Follow-up|0|||
25244202|NCT01295827|50559199|FG001|Overall Study|Lost to Follow-up|0|||
25244203|NCT01295827|50559200|FG002|Overall Study|Lost to Follow-up|3|||
25323187|NCT02393248|50639642|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323188|NCT02393248|50639643|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323189|NCT02393248|50639644|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323190|NCT02393248|50639645|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323191|NCT02393248|50639646|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323192|NCT02393248|50639647|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323193|NCT02393248|50639648|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323194|NCT02393248|50639649|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323195|NCT02393248|50639650|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323196|NCT02393248|50639651|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323197|NCT02393248|50639652|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
25323198|NCT02393248|50639628|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323199|NCT02393248|50639629|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
25323200|NCT02393248|50639630|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323201|NCT02393248|50639631|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323202|NCT02393248|50639632|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323203|NCT02393248|50639633|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323204|NCT02393248|50639634|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323205|NCT02393248|50639635|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323206|NCT02393248|50639636|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323207|NCT02393248|50639637|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323208|NCT02393248|50639638|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323209|NCT02393248|50639639|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323210|NCT02393248|50639640|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323211|NCT02393248|50639641|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323212|NCT02393248|50639642|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323213|NCT02393248|50639643|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323214|NCT02393248|50639644|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323215|NCT02393248|50639645|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323216|NCT02393248|50639646|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323217|NCT02393248|50639647|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25244204|NCT01295827|50559201|FG003|Overall Study|Lost to Follow-up|0|||
25244205|NCT01295827|50559202|FG004|Overall Study|Lost to Follow-up|1|||
25244206|NCT01295827|50559203|FG005|Overall Study|Lost to Follow-up|0|||
25323218|NCT02393248|50639648|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323219|NCT02393248|50639649|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323220|NCT02393248|50639650|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323221|NCT02393248|50639651|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323222|NCT02393248|50639652|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
25323223|NCT02393248|50639628|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
25323224|NCT02393248|50639629|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
25323225|NCT02393248|50639630|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
25323226|NCT02393248|50639631|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
25323227|NCT02393248|50639632|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
25323228|NCT02393248|50639633|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
25323229|NCT02393248|50639634|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
25323230|NCT02393248|50639635|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
25323231|NCT02393248|50639636|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
25323232|NCT02393248|50639637|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
25323233|NCT02393248|50639638|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
25323234|NCT02393248|50639639|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
25323235|NCT02393248|50639640|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
25323236|NCT02393248|50639641|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
25323237|NCT02393248|50639642|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
25323238|NCT02393248|50639643|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
25323239|NCT02393248|50639644|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
25323240|NCT02393248|50639645|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
25244207|NCT01295827|50559204|FG006|Overall Study|Lost to Follow-up|4|||
25244208|NCT01295827|50559205|FG007|Overall Study|Lost to Follow-up|8|||
25244209|NCT01295827|50559206|FG008|Overall Study|Lost to Follow-up|7|||
25244210|NCT01295827|50559207|FG009|Overall Study|Lost to Follow-up|4|||
25244211|NCT01295827|50559208|FG010|Overall Study|Lost to Follow-up|7|||
25244212|NCT01295827|50559209|FG011|Overall Study|Lost to Follow-up|3|||
24977071|NCT00379769|50065794|FG001|Main Study|Investigator refused to log temperature|0|||
25244213|NCT01295827|50559210|FG012|Overall Study|Lost to Follow-up|0|||
25244214|NCT01295827|50559211|FG013|Overall Study|Lost to Follow-up|0|||
25244215|NCT01295827|50559212|FG014|Overall Study|Lost to Follow-up|0|||
25244216|NCT01295827|50559198|FG000|Overall Study|Not Reported|0|||
25244217|NCT01295827|50559199|FG001|Overall Study|Not Reported|0|||
25244218|NCT01295827|50559200|FG002|Overall Study|Not Reported|0|||
25244219|NCT01295827|50559201|FG003|Overall Study|Not Reported|1|||
25244220|NCT01295827|50559202|FG004|Overall Study|Not Reported|0|||
25244221|NCT01295827|50559203|FG005|Overall Study|Not Reported|0|||
25244222|NCT01295827|50559204|FG006|Overall Study|Not Reported|24|||
25244223|NCT01295827|50559205|FG007|Overall Study|Not Reported|58|||
25244224|NCT01295827|50559206|FG008|Overall Study|Not Reported|41|||
25244225|NCT01295827|50559207|FG009|Overall Study|Not Reported|2|||
25244226|NCT01295827|50559208|FG010|Overall Study|Not Reported|23|||
25244227|NCT01295827|50559209|FG011|Overall Study|Not Reported|13|||
25244228|NCT01295827|50559210|FG012|Overall Study|Not Reported|0|||
25244229|NCT01295827|50559211|FG013|Overall Study|Not Reported|0|||
25244230|NCT01295827|50559212|FG014|Overall Study|Not Reported|0|||
25244231|NCT01295827|50559198|FG000|Overall Study|Progressive Disease|2|||
25244232|NCT01295827|50559199|FG001|Overall Study|Progressive Disease|1|||
25244233|NCT01295827|50559200|FG002|Overall Study|Progressive Disease|5|||
25244234|NCT01295827|50559201|FG003|Overall Study|Progressive Disease|2|||
25244235|NCT01295827|50559202|FG004|Overall Study|Progressive Disease|0|||
25244236|NCT01295827|50559203|FG005|Overall Study|Progressive Disease|1|||
25244237|NCT01295827|50559204|FG006|Overall Study|Progressive Disease|87|||
25244238|NCT01295827|50559205|FG007|Overall Study|Progressive Disease|144|||
25244239|NCT01295827|50559206|FG008|Overall Study|Progressive Disease|85|||
25244240|NCT01295827|50559207|FG009|Overall Study|Progressive Disease|40|||
25244241|NCT01295827|50559208|FG010|Overall Study|Progressive Disease|175|||
25323241|NCT02393248|50639646|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
25323242|NCT02393248|50639647|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
25323243|NCT02393248|50639648|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
25323244|NCT02393248|50639649|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
25323245|NCT02393248|50639650|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
25323246|NCT02393248|50639651|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
25323247|NCT02393248|50639652|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
25323248|NCT02393248|50639628|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
25323249|NCT02393248|50639629|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323250|NCT02393248|50639630|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323251|NCT02393248|50639631|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323252|NCT02393248|50639632|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323253|NCT02393248|50639633|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323254|NCT02393248|50639634|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323255|NCT02393248|50639635|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323256|NCT02393248|50639636|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323257|NCT02393248|50639637|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323258|NCT02393248|50639638|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25244242|NCT01295827|50559209|FG011|Overall Study|Progressive Disease|136|||
25244243|NCT01295827|50559210|FG012|Overall Study|Progressive Disease|0|||
25244244|NCT01295827|50559211|FG013|Overall Study|Progressive Disease|0|||
25323259|NCT02393248|50639639|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323260|NCT02393248|50639640|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323261|NCT02393248|50639641|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323262|NCT02393248|50639642|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323263|NCT02393248|50639643|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323264|NCT02393248|50639644|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323265|NCT02393248|50639645|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323266|NCT02393248|50639646|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323267|NCT02393248|50639647|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323268|NCT02393248|50639648|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323269|NCT02393248|50639649|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323270|NCT02393248|50639650|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323271|NCT02393248|50639651|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323272|NCT02393248|50639652|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
25323273|NCT02393248|50639628|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323274|NCT02393248|50639629|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323275|NCT02393248|50639630|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323276|NCT02393248|50639631|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323277|NCT02393248|50639632|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25244245|NCT01295827|50559212|FG014|Overall Study|Progressive Disease|0|||
25244246|NCT01295827|50559198|FG000|Overall Study|Screen Failure|0|||
25244247|NCT01295827|50559199|FG001|Overall Study|Screen Failure|0|||
25244248|NCT01295827|50559200|FG002|Overall Study|Screen Failure|0|||
25244249|NCT01295827|50559201|FG003|Overall Study|Screen Failure|0|||
25244250|NCT01295827|50559202|FG004|Overall Study|Screen Failure|0|||
25244251|NCT01295827|50559203|FG005|Overall Study|Screen Failure|0|||
25244252|NCT01295827|50559204|FG006|Overall Study|Screen Failure|2|||
25244253|NCT01295827|50559205|FG007|Overall Study|Screen Failure|2|||
25244254|NCT01295827|50559206|FG008|Overall Study|Screen Failure|2|||
25244255|NCT01295827|50559207|FG009|Overall Study|Screen Failure|0|||
25323278|NCT02393248|50639633|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
25323279|NCT02393248|50639634|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
25323280|NCT02393248|50639635|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323281|NCT02393248|50639636|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323282|NCT02393248|50639637|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
25323283|NCT02393248|50639638|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323284|NCT02393248|50639639|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323285|NCT02393248|50639640|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323286|NCT02393248|50639641|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323287|NCT02393248|50639642|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323288|NCT02393248|50639643|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323289|NCT02393248|50639644|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323290|NCT02393248|50639645|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323291|NCT02393248|50639646|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323292|NCT02393248|50639647|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323293|NCT02393248|50639648|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323294|NCT02393248|50639649|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323295|NCT02393248|50639650|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25244256|NCT01295827|50559208|FG010|Overall Study|Screen Failure|1|||
25323296|NCT02393248|50639651|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323297|NCT02393248|50639652|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
25323298|NCT02393248|50639628|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323299|NCT02393248|50639629|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323300|NCT02393248|50639630|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323301|NCT02393248|50639631|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323302|NCT02393248|50639632|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323303|NCT02393248|50639633|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323304|NCT02393248|50639634|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
25323305|NCT02393248|50639635|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323306|NCT02393248|50639636|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323307|NCT02393248|50639637|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323308|NCT02393248|50639638|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323309|NCT02393248|50639639|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323310|NCT02393248|50639640|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323311|NCT02393248|50639641|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323312|NCT02393248|50639642|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323313|NCT02393248|50639643|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323314|NCT02393248|50639644|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25244257|NCT01295827|50559209|FG011|Overall Study|Screen Failure|0|||
25244258|NCT01295827|50559210|FG012|Overall Study|Screen Failure|0|||
25244259|NCT01295827|50559211|FG013|Overall Study|Screen Failure|0|||
25244260|NCT01295827|50559212|FG014|Overall Study|Screen Failure|0|||
25244261|NCT01295827|50559198|FG000|Overall Study|Withdrawal by Subject|1|||
25244262|NCT01295827|50559199|FG001|Overall Study|Withdrawal by Subject|0|||
25244263|NCT01295827|50559200|FG002|Overall Study|Withdrawal by Subject|2|||
25244264|NCT01295827|50559201|FG003|Overall Study|Withdrawal by Subject|0|||
25244265|NCT01295827|50559202|FG004|Overall Study|Withdrawal by Subject|0|||
25244266|NCT01295827|50559203|FG005|Overall Study|Withdrawal by Subject|1|||
25244267|NCT01295827|50559204|FG006|Overall Study|Withdrawal by Subject|13|||
25244268|NCT01295827|50559205|FG007|Overall Study|Withdrawal by Subject|35|||
25244269|NCT01295827|50559206|FG008|Overall Study|Withdrawal by Subject|11|||
25244270|NCT01295827|50559207|FG009|Overall Study|Withdrawal by Subject|2|||
25244271|NCT01295827|50559208|FG010|Overall Study|Withdrawal by Subject|18|||
25244272|NCT01295827|50559209|FG011|Overall Study|Withdrawal by Subject|13|||
25244273|NCT01295827|50559210|FG012|Overall Study|Withdrawal by Subject|0|||
25244274|NCT01295827|50559211|FG013|Overall Study|Withdrawal by Subject|0|||
25244275|NCT01295827|50559212|FG014|Overall Study|Withdrawal by Subject|0|||
25244276|NCT01295827|50559198|FG000|Overall Study|Other|0|||
25323315|NCT02393248|50639645|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323316|NCT02393248|50639646|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323317|NCT02393248|50639647|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323318|NCT02393248|50639648|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323319|NCT02393248|50639649|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323320|NCT02393248|50639650|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323321|NCT02393248|50639651|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323322|NCT02393248|50639652|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
25323323|NCT02393248|50639628|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323324|NCT02393248|50639629|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323325|NCT02393248|50639630|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323326|NCT02393248|50639631|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323327|NCT02393248|50639632|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323328|NCT02393248|50639633|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323329|NCT02393248|50639634|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323330|NCT02393248|50639635|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323331|NCT02393248|50639636|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323332|NCT02393248|50639637|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323333|NCT02393248|50639638|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323334|NCT02393248|50639639|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
25077674|NCT02492984|50185514|FG000|Overall Study|Adverse Event|1|||
25244277|NCT01295827|50559199|FG001|Overall Study|Other|0|||
25244278|NCT01295827|50559200|FG002|Overall Study|Other|0|||
25244279|NCT01295827|50559201|FG003|Overall Study|Other|0|||
25244280|NCT01295827|50559202|FG004|Overall Study|Other|0|||
25244281|NCT01295827|50559203|FG005|Overall Study|Other|0|||
25244282|NCT01295827|50559204|FG006|Overall Study|Other|1|||
25244283|NCT01295827|50559205|FG007|Overall Study|Other|1|||
25244284|NCT01295827|50559206|FG008|Overall Study|Other|1|||
25244285|NCT01295827|50559207|FG009|Overall Study|Other|0|||
25244286|NCT01295827|50559208|FG010|Overall Study|Other|2|||
25244287|NCT01295827|50559209|FG011|Overall Study|Other|0|||
25244288|NCT01295827|50559210|FG012|Overall Study|Other|0|||
25244289|NCT01295827|50559211|FG013|Overall Study|Other|0|||
25244290|NCT01295827|50559212|FG014|Overall Study|Other|0|||
25244291|NCT01295671|50559268|FG000|Overall Study|Lost to Follow-up|4|||
25244292|NCT01295671|50559269|FG001|Overall Study|Lost to Follow-up|6|||
25244293|NCT01295671|50559270|FG002|Overall Study|Lost to Follow-up|3|||
25244294|NCT01295671|50559268|FG000|Overall Study|Withdrawal by Subject|3|||
25244295|NCT01295671|50559269|FG001|Overall Study|Withdrawal by Subject|1|||
25244296|NCT01295671|50559270|FG002|Overall Study|Withdrawal by Subject|0|||
25244297|NCT01295320|50559278|FG000|Overall Study|Adverse Event|2|||
25244298|NCT01295320|50559278|FG000|Overall Study|Lost to Follow-up|4|||
25244299|NCT01295320|50559278|FG000|Overall Study|Withdrawal by Subject|2|||
25244300|NCT01295320|50559278|FG000|Overall Study|Subject was bedridden|1|||
25244301|NCT01295320|50559278|FG000|Overall Study|Unable to travel|1|||
25244302|NCT01295281|50559284|FG000|First Intervention (7 Days)|Death|0|||
25244303|NCT01295281|50559285|FG001|First Intervention (7 Days)|Death|1|||
25244304|NCT01294696|50559293|FG000|Overall Study|Screening failures|7|||
25244305|NCT01294696|50559293|FG000|Overall Study|Protocol Violation|8|||
25244306|NCT01294696|50559293|FG000|Overall Study|Missing BPI Response|7|||
25244307|NCT01294696|50559293|FG000|Overall Study|Site closure|52|||
25244308|NCT01294579|50559298|FG000|Overall Study|Disease progression|12|||
25244309|NCT01294579|50559298|FG000|Overall Study|Adverse Event|11|||
25244310|NCT01294579|50559298|FG000|Overall Study|Study closed/terminated|3|||
25244311|NCT01294579|50559298|FG000|Overall Study|Lost to Follow-up|1|||
25244312|NCT01294579|50559298|FG000|Overall Study|Physician Decision|3|||
25244313|NCT01294579|50559298|FG000|Overall Study|Withdrawal by Subject|5|||
25244314|NCT01294462|50559304|FG000|Overall Study|Lost to Follow-up|1|||
25244315|NCT01294462|50559305|FG001|Overall Study|Lost to Follow-up|0|||
25244316|NCT01294462|50559304|FG000|Overall Study|Withdrawal by Subject|65|||
25244317|NCT01294462|50559305|FG001|Overall Study|Withdrawal by Subject|63|||
25244318|NCT01294423|50559314|FG000|Overall Study|Adverse Event|1|||
25244319|NCT01294423|50559315|FG001|Overall Study|Adverse Event|2|||
25244320|NCT01294423|50559316|FG002|Overall Study|Adverse Event|3|||
25244321|NCT01294423|50559314|FG000|Overall Study|Withdrawal by Subject|1|||
25244322|NCT01294423|50559315|FG001|Overall Study|Withdrawal by Subject|2|||
25244323|NCT01294423|50559316|FG002|Overall Study|Withdrawal by Subject|2|||
25244324|NCT01294423|50559314|FG000|Overall Study|subject no longer meets study criteria|2|||
25244325|NCT01294423|50559315|FG001|Overall Study|subject no longer meets study criteria|5|||
25323335|NCT02393248|50639640|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
25323336|NCT02393248|50639641|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
25323337|NCT02393248|50639642|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
25323338|NCT02393248|50639643|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25244326|NCT01294423|50559316|FG002|Overall Study|subject no longer meets study criteria|2|||
25244327|NCT01294423|50559314|FG000|Overall Study|poor/non-compliance|1|||
25244328|NCT01294423|50559315|FG001|Overall Study|poor/non-compliance|0|||
25244329|NCT01294423|50559316|FG002|Overall Study|poor/non-compliance|1|||
25244330|NCT01294150|50559326|FG000|Overall Study|Physician Decision|2|||
25244331|NCT01294150|50559327|FG001|Overall Study|Physician Decision|2|||
25244332|NCT01292473|50559339|FG000|Overall Study|Adverse Event|1|||
25244333|NCT01292473|50559340|FG001|Overall Study|Adverse Event|0|||
25244334|NCT01292473|50559341|FG002|Overall Study|Adverse Event|1|||
25244335|NCT01292473|50559342|FG003|Overall Study|Adverse Event|1|||
25244336|NCT01292473|50559339|FG000|Overall Study|Lost to Follow-up|1|||
25244337|NCT01292473|50559340|FG001|Overall Study|Lost to Follow-up|1|||
25244338|NCT01292473|50559341|FG002|Overall Study|Lost to Follow-up|2|||
25244339|NCT01292473|50559342|FG003|Overall Study|Lost to Follow-up|2|||
25244340|NCT01292473|50559339|FG000|Overall Study|Withdrawal by Subject|3|||
25244341|NCT01292473|50559340|FG001|Overall Study|Withdrawal by Subject|4|||
25244342|NCT01292473|50559341|FG002|Overall Study|Withdrawal by Subject|3|||
25244343|NCT01292473|50559342|FG003|Overall Study|Withdrawal by Subject|3|||
25244344|NCT01292473|50559339|FG000|Overall Study|Physician Decision|0|||
25244345|NCT01292473|50559340|FG001|Overall Study|Physician Decision|1|||
25244346|NCT01292473|50559341|FG002|Overall Study|Physician Decision|0|||
25244347|NCT01292473|50559342|FG003|Overall Study|Physician Decision|0|||
25244348|NCT01292473|50559339|FG000|Overall Study|Disease Progression|0|||
25323339|NCT02393248|50639644|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323340|NCT02393248|50639645|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323341|NCT02393248|50639646|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323342|NCT02393248|50639647|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323343|NCT02393248|50639648|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323344|NCT02393248|50639649|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323345|NCT02393248|50639650|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323346|NCT02393248|50639651|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323347|NCT02393248|50639652|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
25323348|NCT02393248|50639628|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323349|NCT02393248|50639629|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323350|NCT02393248|50639630|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323351|NCT02393248|50639631|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323352|NCT02393248|50639632|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323353|NCT02393248|50639633|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323354|NCT02393248|50639634|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323355|NCT02393248|50639635|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323356|NCT02393248|50639636|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323357|NCT02393248|50639637|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323358|NCT02393248|50639638|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
25244349|NCT01292473|50559340|FG001|Overall Study|Disease Progression|1|||
25244350|NCT01292473|50559341|FG002|Overall Study|Disease Progression|3|||
25244351|NCT01292473|50559342|FG003|Overall Study|Disease Progression|6|||
25244352|NCT01292239|50559358|FG000|Overall Study|Other|1|||
25244353|NCT01292239|50559359|FG001|Overall Study|Other|1|||
25244354|NCT01292239|50559358|FG000|Overall Study|Withdrawal by Subject|3|||
25244355|NCT01292239|50559359|FG001|Overall Study|Withdrawal by Subject|6|||
25244356|NCT01291225|50559367|FG000|Overall Study|Lost to Follow-up|85|||
25244357|NCT01291225|50559368|FG001|Overall Study|Lost to Follow-up|39|||
25244358|NCT01290796|50559378|FG000|Overall Study|Lost to Follow-up|21|||
25244359|NCT01290796|50559378|FG000|Overall Study|Withdrawal by Subject|4|||
25244360|NCT01290796|50559378|FG000|Overall Study|Physician Decision|2|||
25244361|NCT01290796|50559378|FG000|Overall Study|Secondary Surgical Intervention|2|||
25244362|NCT01290796|50559378|FG000|Overall Study|Withdrawal by Sponsor|1|||
25244363|NCT01290757|50559384|FG000|Overall Study|Adverse Event|1|||
25244364|NCT01290757|50559385|FG001|Overall Study|Adverse Event|0|||
25244365|NCT01290757|50559384|FG000|Overall Study|Protocol Violation|1|||
25244366|NCT01290757|50559385|FG001|Overall Study|Protocol Violation|1|||
25244367|NCT01290757|50559384|FG000|Overall Study|Other|0|||
25244368|NCT01290757|50559385|FG001|Overall Study|Other|1|||
25244369|NCT01290718|50559391|FG000|Overall Study|Early termination of the study|4|||
25244370|NCT01290679|50559397|FG000|Overall Study|Adverse Event|2|||
25323359|NCT02393248|50639639|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
25323360|NCT02393248|50639640|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323361|NCT02393248|50639641|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323362|NCT02393248|50639642|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323363|NCT02393248|50639643|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323364|NCT02393248|50639644|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323365|NCT02393248|50639645|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323366|NCT02393248|50639646|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323367|NCT02393248|50639647|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25244371|NCT01290679|50559398|FG001|Overall Study|Adverse Event|0|||
25244372|NCT01290679|50559397|FG000|Overall Study|Lost to Follow-up|8|||
25244373|NCT01290679|50559398|FG001|Overall Study|Lost to Follow-up|10|||
25244374|NCT01290679|50559397|FG000|Overall Study|Protocol Violation|0|||
25244375|NCT01290679|50559398|FG001|Overall Study|Protocol Violation|1|||
25244376|NCT01290679|50559397|FG000|Overall Study|Withdrawal by Subject|6|||
25244377|NCT01290679|50559398|FG001|Overall Study|Withdrawal by Subject|5|||
25244378|NCT01290679|50559397|FG000|Overall Study|Subject Entered Another Trial|0|||
25323368|NCT02393248|50639648|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323369|NCT02393248|50639649|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323370|NCT02393248|50639650|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323371|NCT02393248|50639651|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323372|NCT02393248|50639652|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
25323373|NCT02393248|50639628|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
25244379|NCT01290679|50559398|FG001|Overall Study|Subject Entered Another Trial|5|||
25244380|NCT01290601|50559406|FG000|Overall Study|Adverse Event|0|||
25244381|NCT01290601|50559407|FG001|Overall Study|Adverse Event|2|||
25244382|NCT01290601|50559408|FG002|Overall Study|Adverse Event|0|||
25244383|NCT01290601|50559409|FG003|Overall Study|Adverse Event|0|||
25244384|NCT01290601|50559406|FG000|Overall Study|Lack of Efficacy|2|||
25244385|NCT01290601|50559407|FG001|Overall Study|Lack of Efficacy|1|||
25244386|NCT01290601|50559408|FG002|Overall Study|Lack of Efficacy|0|||
25244387|NCT01290601|50559409|FG003|Overall Study|Lack of Efficacy|0|||
25244388|NCT01290601|50559406|FG000|Overall Study|Lost to Follow-up|7|||
25244389|NCT01290601|50559407|FG001|Overall Study|Lost to Follow-up|2|||
25244390|NCT01290601|50559408|FG002|Overall Study|Lost to Follow-up|0|||
25244391|NCT01290601|50559409|FG003|Overall Study|Lost to Follow-up|0|||
25244392|NCT01290601|50559406|FG000|Overall Study|Other|1|||
25244393|NCT01290601|50559407|FG001|Overall Study|Other|0|||
25244394|NCT01290601|50559408|FG002|Overall Study|Other|0|||
25244395|NCT01290601|50559409|FG003|Overall Study|Other|0|||
25244396|NCT01290601|50559406|FG000|Overall Study|Protocol Violation|1|||
25323374|NCT02393248|50639629|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
25323375|NCT02393248|50639630|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
25323376|NCT02393248|50639631|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
25323377|NCT02393248|50639632|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
25323378|NCT02393248|50639633|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
25323379|NCT02393248|50639634|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
25323380|NCT02393248|50639635|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
25323381|NCT02393248|50639636|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
25323382|NCT02393248|50639637|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
25323383|NCT02393248|50639638|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
25323384|NCT02393248|50639639|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
25323385|NCT02393248|50639640|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
25323386|NCT02393248|50639641|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
25323387|NCT02393248|50639642|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
25323388|NCT02393248|50639643|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
25323389|NCT02393248|50639644|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
25323390|NCT02393248|50639645|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
25323391|NCT02393248|50639646|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
25323392|NCT02393248|50639647|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
25323393|NCT02393248|50639648|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
25323394|NCT02393248|50639649|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
25323395|NCT02393248|50639650|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
24977072|NCT00379769|50065795|FG002|Main Study|Investigator refused to log temperature|1|||
25244397|NCT01290601|50559407|FG001|Overall Study|Protocol Violation|0|||
25244398|NCT01290601|50559408|FG002|Overall Study|Protocol Violation|0|||
25244399|NCT01290601|50559409|FG003|Overall Study|Protocol Violation|0|||
25244400|NCT01290523|50559415|FG000|Overall Study|Death|3|||
25244401|NCT01290094|50559419|FG000|Overall Study|Withdrawal by Subject|1|||
25244402|NCT01290094|50559419|FG000|Overall Study|Lost to Follow-up|5|||
25323396|NCT02393248|50639651|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
25323397|NCT02393248|50639652|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
25323398|NCT02393248|50639628|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323399|NCT02393248|50639629|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323400|NCT02393248|50639630|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323401|NCT02393248|50639631|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323402|NCT02393248|50639632|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323403|NCT02393248|50639633|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25244403|NCT01289821|50559432|FG000|Treatment Period|Withdrawal by Subject|1|||
25244404|NCT01289821|50559432|FG000|Treatment Period|Physician Decision|3|||
25323404|NCT02393248|50639634|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323405|NCT02393248|50639635|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323406|NCT02393248|50639636|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323407|NCT02393248|50639637|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323408|NCT02393248|50639638|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323409|NCT02393248|50639639|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
25323410|NCT02393248|50639640|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323411|NCT02393248|50639641|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
25323412|NCT02393248|50639642|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323413|NCT02393248|50639643|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323414|NCT02393248|50639644|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323415|NCT02393248|50639645|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323416|NCT02393248|50639646|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323417|NCT02393248|50639647|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323418|NCT02393248|50639648|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323419|NCT02393248|50639649|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323420|NCT02393248|50639650|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323421|NCT02393248|50639651|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323422|NCT02393248|50639652|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
25323423|NCT02393248|50639628|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25323424|NCT02393248|50639629|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25323425|NCT02393248|50639630|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25323426|NCT02393248|50639631|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25323427|NCT02393248|50639632|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25244405|NCT01289821|50559432|FG000|Treatment Period|Adverse Event|4|||
25244406|NCT01289821|50559432|FG000|Treatment Period|Radiological Progression|43|||
25244407|NCT01289821|50559432|FG000|Treatment Period|Clinical Progression|2|||
25323428|NCT02393248|50639633|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25323429|NCT02393248|50639634|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25323430|NCT02393248|50639635|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25323431|NCT02393248|50639636|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25323432|NCT02393248|50639637|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25323433|NCT02393248|50639638|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25323434|NCT02393248|50639639|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25323435|NCT02393248|50639640|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25244408|NCT01289821|50559432|FG000|Treatment Period|Therapeutic procedure required|1|||
25244409|NCT01289821|50559432|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
25244410|NCT01289821|50559432|FG000|Safety Follow-up Period|Protocol Violation|3|||
25244411|NCT01289821|50559432|FG000|Safety Follow-up Period|Unspecified reason|1|||
25244412|NCT01289821|50559432|FG000|Survival Follow-up Period|Protocol Violation|1|||
25244413|NCT01289821|50559432|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
25244414|NCT01289821|50559432|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
25244415|NCT01289782|50559438|FG000|Overall Study|Lost to Follow-up|14|||
25244416|NCT01289782|50559439|FG001|Overall Study|Lost to Follow-up|7|||
25244417|NCT01289782|50559438|FG000|Overall Study|Protocol Violation|1|||
25244418|NCT01289782|50559439|FG001|Overall Study|Protocol Violation|1|||
25244419|NCT01289782|50559438|FG000|Overall Study|Withdrawal by Subject|8|||
25244420|NCT01289782|50559439|FG001|Overall Study|Withdrawal by Subject|2|||
25244421|NCT01289782|50559438|FG000|Overall Study|Sponsor's Decision|1|||
25244422|NCT01289782|50559439|FG001|Overall Study|Sponsor's Decision|0|||
25244423|NCT01289782|50559438|FG000|Overall Study|Reason not specified|1|||
25244424|NCT01289782|50559439|FG001|Overall Study|Reason not specified|2|||
25244425|NCT01289353|50559445|FG000|Overall Study|Lost to Follow-up|2|||
25244426|NCT01289119|50559455|FG000|Overall Study|Adverse Event|2|||
25244427|NCT01289119|50559456|FG001|Overall Study|Adverse Event|1|||
25244428|NCT01289119|50559457|FG002|Overall Study|Adverse Event|0|||
25244429|NCT01289119|50559458|FG003|Overall Study|Adverse Event|2|||
25244430|NCT01289119|50559459|FG004|Overall Study|Adverse Event|1|||
25244431|NCT01289119|50559460|FG005|Overall Study|Adverse Event|0|||
25244432|NCT01289119|50559455|FG000|Overall Study|Major Protocol Deviation|2|||
25244433|NCT01289119|50559456|FG001|Overall Study|Major Protocol Deviation|1|||
25244434|NCT01289119|50559457|FG002|Overall Study|Major Protocol Deviation|3|||
25244435|NCT01289119|50559458|FG003|Overall Study|Major Protocol Deviation|0|||
25244436|NCT01289119|50559459|FG004|Overall Study|Major Protocol Deviation|2|||
25323436|NCT02393248|50639641|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25323437|NCT02393248|50639642|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25244437|NCT01289119|50559460|FG005|Overall Study|Major Protocol Deviation|1|||
25244438|NCT01289119|50559455|FG000|Overall Study|Lost to Follow-up|0|||
25244439|NCT01289119|50559456|FG001|Overall Study|Lost to Follow-up|3|||
25244440|NCT01289119|50559457|FG002|Overall Study|Lost to Follow-up|0|||
25244441|NCT01289119|50559458|FG003|Overall Study|Lost to Follow-up|0|||
25244442|NCT01289119|50559459|FG004|Overall Study|Lost to Follow-up|0|||
25244443|NCT01289119|50559460|FG005|Overall Study|Lost to Follow-up|1|||
25244444|NCT01289119|50559455|FG000|Overall Study|Withdrawal by Subject|4|||
25244445|NCT01289119|50559456|FG001|Overall Study|Withdrawal by Subject|2|||
25244446|NCT01289119|50559457|FG002|Overall Study|Withdrawal by Subject|4|||
25244447|NCT01289119|50559458|FG003|Overall Study|Withdrawal by Subject|3|||
25244448|NCT01289119|50559459|FG004|Overall Study|Withdrawal by Subject|1|||
25244449|NCT01289119|50559460|FG005|Overall Study|Withdrawal by Subject|1|||
25244450|NCT01289119|50559455|FG000|Overall Study|Pregnancy|0|||
25244451|NCT01289119|50559456|FG001|Overall Study|Pregnancy|1|||
25244452|NCT01289119|50559457|FG002|Overall Study|Pregnancy|0|||
25244453|NCT01289119|50559458|FG003|Overall Study|Pregnancy|0|||
25244454|NCT01289119|50559459|FG004|Overall Study|Pregnancy|0|||
25244455|NCT01289119|50559460|FG005|Overall Study|Pregnancy|0|||
25244456|NCT01289119|50559455|FG000|Overall Study|Lack of Efficacy|0|||
25244457|NCT01289119|50559456|FG001|Overall Study|Lack of Efficacy|1|||
25244458|NCT01289119|50559457|FG002|Overall Study|Lack of Efficacy|1|||
25244459|NCT01289119|50559458|FG003|Overall Study|Lack of Efficacy|1|||
25244460|NCT01289119|50559459|FG004|Overall Study|Lack of Efficacy|1|||
25244461|NCT01289119|50559460|FG005|Overall Study|Lack of Efficacy|1|||
25244462|NCT01289119|50559455|FG000|Overall Study|Other|1|||
25244463|NCT01289119|50559456|FG001|Overall Study|Other|0|||
25244464|NCT01289119|50559457|FG002|Overall Study|Other|1|||
25244465|NCT01289119|50559458|FG003|Overall Study|Other|0|||
25244466|NCT01289119|50559459|FG004|Overall Study|Other|0|||
25244467|NCT01289119|50559460|FG005|Overall Study|Other|0|||
25077675|NCT02492984|50185515|FG001|Overall Study|Adverse Event|0|||
25077676|NCT02492984|50185514|FG000|Overall Study|Protocol Violation|1|||
25077677|NCT02492984|50185515|FG001|Overall Study|Protocol Violation|0|||
25077678|NCT02492984|50185514|FG000|Overall Study|Withdrawal by Subject|1|||
25077679|NCT02492984|50185515|FG001|Overall Study|Withdrawal by Subject|0|||
25077680|NCT01680159|50185528|FG000|Screening Period|Not meet criteria for dose-up period|7|||
25077681|NCT01680159|50185528|FG000|Increased Dose Period|Adverse Event|6|||
25077682|NCT01680159|50185528|FG000|Increased Dose Period|Withdrawal by Subject|2|||
25244468|NCT01289041|50559474|FG000|Overall Study|Adverse Event|24|||
25323438|NCT02393248|50639643|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25323439|NCT02393248|50639644|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25323440|NCT02393248|50639645|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25077683|NCT02491892|50185550|FG000|Overall Study|Adverse Event|1|||
25077684|NCT02491892|50185551|FG001|Overall Study|Adverse Event|1|||
25077685|NCT02491892|50185550|FG000|Overall Study|Death|1|||
25077686|NCT02491892|50185551|FG001|Overall Study|Death|1|||
25077687|NCT02491892|50185550|FG000|Overall Study|Lack of Efficacy|37|||
25077688|NCT02491892|50185551|FG001|Overall Study|Lack of Efficacy|36|||
25077689|NCT02491892|50185550|FG000|Overall Study|Refused Treatment|1|||
25077690|NCT02491892|50185551|FG001|Overall Study|Refused Treatment|0|||
25077691|NCT02491892|50185550|FG000|Overall Study|Lost to Follow-up|1|||
25077692|NCT02491892|50185551|FG001|Overall Study|Lost to Follow-up|0|||
25077693|NCT02436356|50185567|FG000|Overall Study|Excluded by MRI Screening|0|||
25077694|NCT02436356|50185568|FG001|Overall Study|Excluded by MRI Screening|0|||
25077695|NCT02436356|50185569|FG002|Overall Study|Excluded by MRI Screening|2|||
25077696|NCT02436356|50185567|FG000|Overall Study|Lost to Follow-up|0|||
25077697|NCT02436356|50185568|FG001|Overall Study|Lost to Follow-up|1|||
25077698|NCT02436356|50185569|FG002|Overall Study|Lost to Follow-up|0|||
25077699|NCT02436356|50185567|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
25077700|NCT02436356|50185568|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
25077701|NCT02436356|50185569|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
25077702|NCT02436356|50185567|FG000|Overall Study|Excluded due to other medical conditions|3|||
25244469|NCT01289041|50559474|FG000|Overall Study|Physician Decision|1|||
25244470|NCT01289041|50559474|FG000|Overall Study|Progressive Disease|41|||
25244471|NCT01289041|50559474|FG000|Overall Study|Withdrawal by Subject|3|||
25077703|NCT02436356|50185568|FG001|Overall Study|Excluded due to other medical conditions|0|||
25077704|NCT02436356|50185569|FG002|Overall Study|Excluded due to other medical conditions|0|||
25077705|NCT02436356|50185567|FG000|Overall Study|Withdrawal by Subject|1|||
25077706|NCT02436356|50185568|FG001|Overall Study|Withdrawal by Subject|0|||
25077707|NCT02436356|50185569|FG002|Overall Study|Withdrawal by Subject|0|||
25077708|NCT02436200|50185582|FG000|Overall Study|Significant outlier|1|||
25244472|NCT01289041|50559474|FG000|Overall Study|Death|1|||
25244473|NCT01288729|50559482|FG000|Overall Study|Withdrawal by Subject|1|||
25244474|NCT01288729|50559483|FG001|Overall Study|Withdrawal by Subject|0|||
25244475|NCT01288612|50559492|FG000|Overall Study|Unable to contact|11|||
25244476|NCT01288612|50559493|FG001|Overall Study|Unable to contact|16|||
25244477|NCT01288612|50559494|FG002|Overall Study|Unable to contact|20|||
25244478|NCT01288612|50559492|FG000|Overall Study|Declined|78|||
25323441|NCT02393248|50639646|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
25323442|NCT02393248|50639647|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25323443|NCT02393248|50639648|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
25323444|NCT02393248|50639649|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
25323445|NCT02393248|50639650|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25323446|NCT02393248|50639651|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
25323447|NCT02393248|50639652|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
25323448|NCT02393248|50639628|FG000|Part 3: Combination Therapy|Death|0|||
25323449|NCT02393248|50639629|FG001|Part 3: Combination Therapy|Death|0|||
25323450|NCT02393248|50639630|FG002|Part 3: Combination Therapy|Death|0|||
25323451|NCT02393248|50639631|FG003|Part 3: Combination Therapy|Death|0|||
25323452|NCT02393248|50639632|FG004|Part 3: Combination Therapy|Death|0|||
25323453|NCT02393248|50639633|FG005|Part 3: Combination Therapy|Death|0|||
25323454|NCT02393248|50639634|FG006|Part 3: Combination Therapy|Death|0|||
25323455|NCT02393248|50639635|FG007|Part 3: Combination Therapy|Death|0|||
25323456|NCT02393248|50639636|FG008|Part 3: Combination Therapy|Death|0|||
25323457|NCT02393248|50639637|FG009|Part 3: Combination Therapy|Death|0|||
25323458|NCT02393248|50639638|FG010|Part 3: Combination Therapy|Death|0|||
25244479|NCT01288612|50559493|FG001|Overall Study|Declined|63|||
25244480|NCT01288612|50559494|FG002|Overall Study|Declined|62|||
25323459|NCT02393248|50639639|FG011|Part 3: Combination Therapy|Death|0|||
25323460|NCT02393248|50639640|FG012|Part 3: Combination Therapy|Death|0|||
25323461|NCT02393248|50639641|FG013|Part 3: Combination Therapy|Death|0|||
25323462|NCT02393248|50639642|FG014|Part 3: Combination Therapy|Death|0|||
25323463|NCT02393248|50639643|FG015|Part 3: Combination Therapy|Death|1|||
25323464|NCT02393248|50639644|FG016|Part 3: Combination Therapy|Death|7|||
25323465|NCT02393248|50639645|FG017|Part 3: Combination Therapy|Death|5|||
25323466|NCT02393248|50639646|FG018|Part 3: Combination Therapy|Death|5|||
25244481|NCT01288612|50559492|FG000|Overall Study|Unable to intubate|0|||
25244482|NCT01288612|50559493|FG001|Overall Study|Unable to intubate|3|||
25244483|NCT01288612|50559494|FG002|Overall Study|Unable to intubate|0|||
25244484|NCT01287832|50559504|FG000|Overall Study|Adverse Event|1|||
25244485|NCT01287832|50559505|FG001|Overall Study|Adverse Event|0|||
25244486|NCT01287832|50559504|FG000|Overall Study|Death|0|||
25244487|NCT01287832|50559505|FG001|Overall Study|Death|1|||
25244488|NCT01287754|50559513|FG000|Overall Study|Death|2|||
25244489|NCT01287754|50559514|FG001|Overall Study|Death|12|||
25244490|NCT01287754|50559513|FG000|Overall Study|Lost to Follow-up|1|||
25244491|NCT01287754|50559514|FG001|Overall Study|Lost to Follow-up|6|||
25244492|NCT01287754|50559513|FG000|Overall Study|Protocol Violation|0|||
25244493|NCT01287754|50559514|FG001|Overall Study|Protocol Violation|3|||
25244494|NCT01287520|50559529|FG000|Overall Study|Adverse Event|2|||
25244495|NCT01287520|50559530|FG001|Overall Study|Adverse Event|2|||
25244496|NCT01287520|50559531|FG002|Overall Study|Adverse Event|2|||
25244497|NCT01287520|50559532|FG003|Overall Study|Adverse Event|1|||
25244498|NCT01287520|50559533|FG004|Overall Study|Adverse Event|1|||
25244499|NCT01287520|50559534|FG005|Overall Study|Adverse Event|2|||
25244500|NCT01287520|50559535|FG006|Overall Study|Adverse Event|0|||
25244501|NCT01287520|50559536|FG007|Overall Study|Adverse Event|2|||
25244502|NCT01287520|50559537|FG008|Overall Study|Adverse Event|0|||
25244503|NCT01287520|50559529|FG000|Overall Study|Physician Decision|1|||
25244504|NCT01287520|50559530|FG001|Overall Study|Physician Decision|1|||
25244505|NCT01287520|50559531|FG002|Overall Study|Physician Decision|2|||
25244506|NCT01287520|50559532|FG003|Overall Study|Physician Decision|0|||
25244507|NCT01287520|50559533|FG004|Overall Study|Physician Decision|1|||
25244508|NCT01287520|50559534|FG005|Overall Study|Physician Decision|1|||
25244509|NCT01287520|50559535|FG006|Overall Study|Physician Decision|0|||
25244510|NCT01287520|50559536|FG007|Overall Study|Physician Decision|1|||
25244511|NCT01287520|50559537|FG008|Overall Study|Physician Decision|0|||
25244512|NCT01287520|50559529|FG000|Overall Study|Progressive disease|0|||
25244513|NCT01287520|50559530|FG001|Overall Study|Progressive disease|4|||
25244514|NCT01287520|50559531|FG002|Overall Study|Progressive disease|1|||
25244515|NCT01287520|50559532|FG003|Overall Study|Progressive disease|6|||
25244516|NCT01287520|50559533|FG004|Overall Study|Progressive disease|1|||
25244517|NCT01287520|50559534|FG005|Overall Study|Progressive disease|0|||
25244518|NCT01287520|50559535|FG006|Overall Study|Progressive disease|2|||
25244519|NCT01287520|50559536|FG007|Overall Study|Progressive disease|2|||
25244520|NCT01287520|50559537|FG008|Overall Study|Progressive disease|4|||
25244521|NCT01287520|50559529|FG000|Overall Study|Withdrawal by Subject|0|||
25323467|NCT02393248|50639647|FG019|Part 3: Combination Therapy|Death|3|||
25323468|NCT02393248|50639648|FG020|Part 3: Combination Therapy|Death|7|||
25323469|NCT02393248|50639649|FG021|Part 3: Combination Therapy|Death|5|||
25323470|NCT02393248|50639650|FG022|Part 3: Combination Therapy|Death|6|||
25323471|NCT02393248|50639651|FG023|Part 3: Combination Therapy|Death|3|||
25244522|NCT01287520|50559530|FG001|Overall Study|Withdrawal by Subject|0|||
25244523|NCT01287520|50559531|FG002|Overall Study|Withdrawal by Subject|0|||
25244524|NCT01287520|50559532|FG003|Overall Study|Withdrawal by Subject|0|||
25244525|NCT01287520|50559533|FG004|Overall Study|Withdrawal by Subject|0|||
25244526|NCT01287520|50559534|FG005|Overall Study|Withdrawal by Subject|1|||
25323472|NCT02393248|50639652|FG024|Part 3: Combination Therapy|Death|0|||
25323473|NCT02393248|50639628|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25323474|NCT02393248|50639629|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25323475|NCT02393248|50639630|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25323476|NCT02393248|50639631|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25323477|NCT02393248|50639632|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25323478|NCT02393248|50639633|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25323479|NCT02393248|50639634|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25323480|NCT02393248|50639635|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25323481|NCT02393248|50639636|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25323482|NCT02393248|50639637|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25323483|NCT02393248|50639638|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25323484|NCT02393248|50639639|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25323485|NCT02393248|50639640|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25323486|NCT02393248|50639641|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25323487|NCT02393248|50639642|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25323488|NCT02393248|50639643|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25323489|NCT02393248|50639644|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25244527|NCT01287520|50559535|FG006|Overall Study|Withdrawal by Subject|0|||
25244528|NCT01287520|50559536|FG007|Overall Study|Withdrawal by Subject|0|||
25244529|NCT01287520|50559537|FG008|Overall Study|Withdrawal by Subject|1|||
25244530|NCT01287403|50559586|FG000|1st Intervention (1 Day)|Adverse Event|1|||
25244531|NCT01287364|50559602|FG000|Overall Study|Adverse Event|0|||
25244532|NCT01287364|50559603|FG001|Overall Study|Adverse Event|3|||
25244533|NCT01287364|50559602|FG000|Overall Study|Protocol Violation|5|||
25244534|NCT01287364|50559603|FG001|Overall Study|Protocol Violation|5|||
25244535|NCT01287364|50559602|FG000|Overall Study|Other Reason|4|||
25244536|NCT01287364|50559603|FG001|Overall Study|Other Reason|2|||
25244537|NCT01287013|50559625|FG000|Overall Study|Non-evaluable|3|||
25244538|NCT01287013|50559626|FG001|Overall Study|Non-evaluable|5|||
25244539|NCT01287013|50559627|FG002|Overall Study|Non-evaluable|21|||
25244540|NCT01286779|50559635|FG000|Overall Study|Withdrawal by Subject|9|||
25244541|NCT01286779|50559635|FG000|Overall Study|Protocol Violation|5|||
25244542|NCT01286779|50559635|FG000|Overall Study|Physician Decision|2|||
25244543|NCT01286779|50559635|FG000|Overall Study|Participant had scheduled surgery|1|||
25244544|NCT01286779|50559635|FG000|Overall Study|Participant moved to another country|1|||
25244545|NCT01286779|50559635|FG000|Overall Study|Discontinued by sponsor|1|||
25244546|NCT01286740|50559649|FG000|Overall Study|Enrolled but not treated|1|||
25244547|NCT01286740|50559649|FG000|Overall Study|Protocol Violation|1|||
25244548|NCT01286311|50559655|FG000|Overall Study|Physician did not want outreach sent|14|||
25244549|NCT01286311|50559656|FG001|Overall Study|Physician did not want outreach sent|0|||
25244550|NCT01286077|50559664|FG000|Overall Study|Adverse Event|2|||
25323490|NCT02393248|50639645|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
25323491|NCT02393248|50639646|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
25323492|NCT02393248|50639647|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
25323493|NCT02393248|50639648|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
25323494|NCT02393248|50639649|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
25323495|NCT02393248|50639650|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
25323496|NCT02393248|50639651|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
25323497|NCT02393248|50639652|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
25323498|NCT02393248|50639628|FG000|Part 3: Combination Therapy|Disease Progression|0|||
25323499|NCT02393248|50639629|FG001|Part 3: Combination Therapy|Disease Progression|0|||
25323500|NCT02393248|50639630|FG002|Part 3: Combination Therapy|Disease Progression|0|||
25323501|NCT02393248|50639631|FG003|Part 3: Combination Therapy|Disease Progression|0|||
25323502|NCT02393248|50639632|FG004|Part 3: Combination Therapy|Disease Progression|0|||
25323503|NCT02393248|50639633|FG005|Part 3: Combination Therapy|Disease Progression|0|||
25323504|NCT02393248|50639634|FG006|Part 3: Combination Therapy|Disease Progression|0|||
25323505|NCT02393248|50639635|FG007|Part 3: Combination Therapy|Disease Progression|0|||
25323506|NCT02393248|50639636|FG008|Part 3: Combination Therapy|Disease Progression|0|||
25323507|NCT02393248|50639637|FG009|Part 3: Combination Therapy|Disease Progression|0|||
25323508|NCT02393248|50639638|FG010|Part 3: Combination Therapy|Disease Progression|0|||
25323509|NCT02393248|50639639|FG011|Part 3: Combination Therapy|Disease Progression|0|||
25244551|NCT01286077|50559665|FG001|Overall Study|Adverse Event|0|||
25244552|NCT01286077|50559664|FG000|Overall Study|Death|1|||
25244553|NCT01286077|50559665|FG001|Overall Study|Death|0|||
25244554|NCT01286077|50559664|FG000|Overall Study|Protocol Violation|1|||
25244555|NCT01286077|50559665|FG001|Overall Study|Protocol Violation|1|||
25323510|NCT02393248|50639640|FG012|Part 3: Combination Therapy|Disease Progression|0|||
25323511|NCT02393248|50639641|FG013|Part 3: Combination Therapy|Disease Progression|0|||
25323512|NCT02393248|50639642|FG014|Part 3: Combination Therapy|Disease Progression|0|||
25323513|NCT02393248|50639643|FG015|Part 3: Combination Therapy|Disease Progression|0|||
25323514|NCT02393248|50639644|FG016|Part 3: Combination Therapy|Disease Progression|0|||
25323515|NCT02393248|50639645|FG017|Part 3: Combination Therapy|Disease Progression|0|||
25323516|NCT02393248|50639646|FG018|Part 3: Combination Therapy|Disease Progression|0|||
25323517|NCT02393248|50639647|FG019|Part 3: Combination Therapy|Disease Progression|0|||
25323518|NCT02393248|50639648|FG020|Part 3: Combination Therapy|Disease Progression|2|||
25323519|NCT02393248|50639649|FG021|Part 3: Combination Therapy|Disease Progression|1|||
25323520|NCT02393248|50639650|FG022|Part 3: Combination Therapy|Disease Progression|0|||
25323521|NCT02393248|50639651|FG023|Part 3: Combination Therapy|Disease Progression|0|||
25323522|NCT02393248|50639652|FG024|Part 3: Combination Therapy|Disease Progression|0|||
25323523|NCT02393248|50639628|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323524|NCT02393248|50639629|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323525|NCT02393248|50639630|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323526|NCT02393248|50639631|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323527|NCT02393248|50639632|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323528|NCT02393248|50639633|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323529|NCT02393248|50639634|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323530|NCT02393248|50639635|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323531|NCT02393248|50639636|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323532|NCT02393248|50639637|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323533|NCT02393248|50639638|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323534|NCT02393248|50639639|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323535|NCT02393248|50639640|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323536|NCT02393248|50639641|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323537|NCT02393248|50639642|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323538|NCT02393248|50639643|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323539|NCT02393248|50639644|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323540|NCT02393248|50639645|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323541|NCT02393248|50639646|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323542|NCT02393248|50639647|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323543|NCT02393248|50639648|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
25323544|NCT02393248|50639649|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
25323545|NCT02393248|50639650|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323546|NCT02393248|50639651|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323547|NCT02393248|50639652|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
25323548|NCT02393248|50639628|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323549|NCT02393248|50639629|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323550|NCT02393248|50639630|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323551|NCT02393248|50639631|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323552|NCT02393248|50639632|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323553|NCT02393248|50639633|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323554|NCT02393248|50639634|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323555|NCT02393248|50639635|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323556|NCT02393248|50639636|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323557|NCT02393248|50639637|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323558|NCT02393248|50639638|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25244556|NCT01286077|50559664|FG000|Overall Study|Withdrawal by Subject|0|||
25244557|NCT01286077|50559665|FG001|Overall Study|Withdrawal by Subject|2|||
25244558|NCT01286077|50559664|FG000|Overall Study|Intercurrent illness|1|||
25244559|NCT01286077|50559665|FG001|Overall Study|Intercurrent illness|0|||
25244560|NCT01286077|50559664|FG000|Overall Study|Non-compliance|1|||
25244561|NCT01286077|50559665|FG001|Overall Study|Non-compliance|0|||
25244562|NCT01286077|50559664|FG000|Overall Study|The subject starts with alternative MMY|0|||
25244563|NCT01286077|50559665|FG001|Overall Study|The subject starts with alternative MMY|3|||
25244564|NCT01286077|50559664|FG000|Overall Study|Patient's decision to stop treatment|3|||
25244565|NCT01286077|50559665|FG001|Overall Study|Patient's decision to stop treatment|0|||
25244566|NCT01286077|50559664|FG000|Overall Study|Progression of disease|0|||
25244567|NCT01286077|50559665|FG001|Overall Study|Progression of disease|1|||
25244568|NCT01286077|50559664|FG000|Overall Study|refill medication not received in time|1|||
25244569|NCT01286077|50559665|FG001|Overall Study|refill medication not received in time|0|||
25244570|NCT01285960|50559671|FG000|Overall Study|Withdrawal by Subject|2|||
25244571|NCT01285960|50559671|FG000|Overall Study|Lost to Follow-up|2|||
25244572|NCT01285960|50559671|FG000|Overall Study|2 subjects received less 10 sonications|2|||
25244573|NCT01285609|50559688|FG000|Randomized|Progressive Disease|41|||
25244574|NCT01285609|50559689|FG001|Randomized|Progressive Disease|61|||
25244575|NCT01285609|50559688|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
25244576|NCT01285609|50559689|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
25323559|NCT02393248|50639639|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323560|NCT02393248|50639640|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323561|NCT02393248|50639641|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323562|NCT02393248|50639642|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323563|NCT02393248|50639643|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323564|NCT02393248|50639644|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323565|NCT02393248|50639645|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323566|NCT02393248|50639646|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323567|NCT02393248|50639647|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323568|NCT02393248|50639648|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
25323569|NCT02393248|50639649|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323570|NCT02393248|50639650|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323571|NCT02393248|50639651|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323572|NCT02393248|50639652|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
25323573|NCT02393248|50639628|FG000|Part 3: Combination Therapy|Adverse Event|0|||
25323574|NCT02393248|50639629|FG001|Part 3: Combination Therapy|Adverse Event|0|||
25323575|NCT02393248|50639630|FG002|Part 3: Combination Therapy|Adverse Event|0|||
25323576|NCT02393248|50639631|FG003|Part 3: Combination Therapy|Adverse Event|0|||
25323577|NCT02393248|50639632|FG004|Part 3: Combination Therapy|Adverse Event|0|||
25323578|NCT02393248|50639633|FG005|Part 3: Combination Therapy|Adverse Event|0|||
25323579|NCT02393248|50639634|FG006|Part 3: Combination Therapy|Adverse Event|0|||
25323580|NCT02393248|50639635|FG007|Part 3: Combination Therapy|Adverse Event|0|||
25323581|NCT02393248|50639636|FG008|Part 3: Combination Therapy|Adverse Event|0|||
25323582|NCT02393248|50639637|FG009|Part 3: Combination Therapy|Adverse Event|0|||
25323583|NCT02393248|50639638|FG010|Part 3: Combination Therapy|Adverse Event|0|||
25323584|NCT02393248|50639639|FG011|Part 3: Combination Therapy|Adverse Event|0|||
25323585|NCT02393248|50639640|FG012|Part 3: Combination Therapy|Adverse Event|0|||
25323586|NCT02393248|50639641|FG013|Part 3: Combination Therapy|Adverse Event|0|||
25323587|NCT02393248|50639642|FG014|Part 3: Combination Therapy|Adverse Event|0|||
25323588|NCT02393248|50639643|FG015|Part 3: Combination Therapy|Adverse Event|0|||
25323589|NCT02393248|50639644|FG016|Part 3: Combination Therapy|Adverse Event|0|||
25323590|NCT02393248|50639645|FG017|Part 3: Combination Therapy|Adverse Event|0|||
25323591|NCT02393248|50639646|FG018|Part 3: Combination Therapy|Adverse Event|0|||
25323592|NCT02393248|50639647|FG019|Part 3: Combination Therapy|Adverse Event|0|||
25323593|NCT02393248|50639648|FG020|Part 3: Combination Therapy|Adverse Event|0|||
25323594|NCT02393248|50639649|FG021|Part 3: Combination Therapy|Adverse Event|0|||
25323595|NCT02393248|50639650|FG022|Part 3: Combination Therapy|Adverse Event|0|||
25323596|NCT02393248|50639651|FG023|Part 3: Combination Therapy|Adverse Event|1|||
25323597|NCT02393248|50639652|FG024|Part 3: Combination Therapy|Adverse Event|0|||
25323598|NCT02393248|50639628|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323599|NCT02393248|50639629|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323600|NCT02393248|50639630|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323601|NCT02393248|50639631|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25244577|NCT01285609|50559688|FG000|Randomized|Study Drug Toxicity|13|||
25244578|NCT01285609|50559689|FG001|Randomized|Study Drug Toxicity|14|||
25244579|NCT01285609|50559688|FG000|Randomized|Death|5|||
25244580|NCT01285609|50559689|FG001|Randomized|Death|7|||
25244581|NCT01285609|50559688|FG000|Randomized|Withdrawal by Subject|8|||
25244582|NCT01285609|50559689|FG001|Randomized|Withdrawal by Subject|11|||
25244583|NCT01285609|50559688|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
25244584|NCT01285609|50559689|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
25244585|NCT01285609|50559688|FG000|Randomized|Undisclosed Reasons|1|||
25244586|NCT01285609|50559689|FG001|Randomized|Undisclosed Reasons|0|||
25244587|NCT01285609|50559688|FG000|Randomized|Randomized but not Treated|4|||
25244588|NCT01285609|50559689|FG001|Randomized|Randomized but not Treated|4|||
25244589|NCT01285609|50559688|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
25244590|NCT01285609|50559689|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
25244591|NCT01285609|50559688|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
25244592|NCT01285609|50559689|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
25244593|NCT01285609|50559688|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
25244594|NCT01285609|50559689|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
25244595|NCT01285609|50559688|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
25244596|NCT01285609|50559689|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
25244597|NCT01285609|50559688|FG000|Treated With Blinded Therapy|Death|11|||
25244598|NCT01285609|50559689|FG001|Treated With Blinded Therapy|Death|3|||
25244599|NCT01285609|50559688|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
25244600|NCT01285609|50559689|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
25244601|NCT01285609|50559688|FG000|Treated With Blinded Therapy|Not Reported|0|||
25244602|NCT01285609|50559689|FG001|Treated With Blinded Therapy|Not Reported|2|||
25244603|NCT01285609|50559688|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
25244604|NCT01285609|50559689|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
25323602|NCT02393248|50639632|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323603|NCT02393248|50639633|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25244605|NCT01285609|50559688|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
25244606|NCT01285609|50559689|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
25323604|NCT02393248|50639634|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323605|NCT02393248|50639635|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323606|NCT02393248|50639636|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323607|NCT02393248|50639637|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323608|NCT02393248|50639638|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323609|NCT02393248|50639639|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323610|NCT02393248|50639640|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323611|NCT02393248|50639641|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323612|NCT02393248|50639642|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323613|NCT02393248|50639643|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323614|NCT02393248|50639644|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323615|NCT02393248|50639645|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323616|NCT02393248|50639646|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323617|NCT02393248|50639647|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323618|NCT02393248|50639648|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323619|NCT02393248|50639649|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323620|NCT02393248|50639650|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323621|NCT02393248|50639651|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
25323622|NCT02393248|50639652|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
25323623|NCT00601484|50639715|FG000|Overall Study|Adverse Event|0|||
25323624|NCT00601484|50639716|FG001|Overall Study|Adverse Event|1|||
25323625|NCT00601484|50639715|FG000|Overall Study|Lost to Follow-up|4|||
25323626|NCT00601484|50639716|FG001|Overall Study|Lost to Follow-up|3|||
25323627|NCT00601484|50639715|FG000|Overall Study|Lack of Efficacy|0|||
25323628|NCT00601484|50639716|FG001|Overall Study|Lack of Efficacy|2|||
25323629|NCT00601484|50639715|FG000|Overall Study|Withdrawal by Subject|1|||
25323630|NCT00601484|50639716|FG001|Overall Study|Withdrawal by Subject|1|||
25323631|NCT00601484|50639715|FG000|Overall Study|Randomized, but not treated|0|||
25323632|NCT00601484|50639716|FG001|Overall Study|Randomized, but not treated|1|||
25323633|NCT00883896|50639726|FG000|Overall Study|Lost to Follow-up|0|||
25244607|NCT01285609|50559688|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
25244608|NCT01285609|50559689|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
25244609|NCT01285609|50559688|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
25244610|NCT01285609|50559689|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
25244611|NCT01285609|50559688|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
25244612|NCT01285609|50559689|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
25244613|NCT01285609|50559688|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
25244614|NCT01285609|50559689|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
25244615|NCT01285609|50559688|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
25244616|NCT01285609|50559689|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
25244617|NCT01285609|50559688|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
25244618|NCT01285609|50559689|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
25244619|NCT01285609|50559688|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
25244620|NCT01285609|50559689|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
25244621|NCT01285609|50559688|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
25323634|NCT00883896|50639727|FG001|Overall Study|Lost to Follow-up|0|||
25323635|NCT00883896|50639728|FG002|Overall Study|Lost to Follow-up|0|||
25323636|NCT00883896|50639729|FG003|Overall Study|Lost to Follow-up|2|||
25323637|NCT00883896|50639726|FG000|Overall Study|Withdrawal by Subject|5|||
25244622|NCT01285609|50559689|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
25244623|NCT01285492|50559699|FG000|Overall Study|Adverse Event|11|||
25323638|NCT00883896|50639727|FG001|Overall Study|Withdrawal by Subject|0|||
25323639|NCT00883896|50639728|FG002|Overall Study|Withdrawal by Subject|1|||
25323640|NCT00883896|50639729|FG003|Overall Study|Withdrawal by Subject|3|||
25323641|NCT00883896|50639726|FG000|Overall Study|Lack of Efficacy|0|||
25323642|NCT00883896|50639727|FG001|Overall Study|Lack of Efficacy|0|||
25323643|NCT00883896|50639728|FG002|Overall Study|Lack of Efficacy|0|||
25323644|NCT00883896|50639729|FG003|Overall Study|Lack of Efficacy|2|||
25323645|NCT00883896|50639726|FG000|Overall Study|Other|1|||
25323646|NCT00883896|50639727|FG001|Overall Study|Other|0|||
25323647|NCT00883896|50639728|FG002|Overall Study|Other|0|||
25323648|NCT00883896|50639729|FG003|Overall Study|Other|0|||
25323649|NCT03920293|50639741|FG000|Overall Study|Withdrawal by Subject|2|||
25323650|NCT03920293|50639742|FG001|Overall Study|Withdrawal by Subject|1|||
25323651|NCT03920293|50639741|FG000|Overall Study|Physician Decision|1|||
25323652|NCT03920293|50639742|FG001|Overall Study|Physician Decision|2|||
25323653|NCT03920293|50639741|FG000|Overall Study|Adverse Event|0|||
25323654|NCT03920293|50639742|FG001|Overall Study|Adverse Event|2|||
25323655|NCT03920293|50639741|FG000|Overall Study|Sponsor Decision|0|||
25323656|NCT03920293|50639742|FG001|Overall Study|Sponsor Decision|1|||
25323657|NCT03920293|50639741|FG000|Overall Study|Death|2|||
25323658|NCT03920293|50639742|FG001|Overall Study|Death|0|||
25323659|NCT03920293|50639741|FG000|Overall Study|Protocol Violation|1|||
25323660|NCT03920293|50639742|FG001|Overall Study|Protocol Violation|0|||
25323661|NCT03920293|50639741|FG000|Overall Study|Noncompliance|1|||
25323662|NCT03920293|50639742|FG001|Overall Study|Noncompliance|0|||
25323663|NCT00867009|50639748|FG000|Induction Period|Nonserious Adverse Event|5|||
25323664|NCT00867009|50639748|FG000|Induction Period|Serious Adverse Event|10|||
25323665|NCT00867009|50639748|FG000|Induction Period|Death due to serious adverse event|6|||
25323666|NCT00867009|50639748|FG000|Induction Period|Death due to Study Disease|4|||
25323667|NCT00867009|50639748|FG000|Induction Period|Protocol Violation|1|||
25323668|NCT00867009|50639748|FG000|Induction Period|Withdrawal by Subject|8|||
25323669|NCT00867009|50639748|FG000|Induction Period|Physician Decision|3|||
25323670|NCT00867009|50639748|FG000|Induction Period|Progressive Disease (PD)|25|||
25323671|NCT00867009|50639748|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
25323672|NCT00601250|50639754|FG000|Overall Study|Adverse Event|3|||
25323673|NCT00601250|50639755|FG001|Overall Study|Adverse Event|9|||
25323674|NCT00601250|50639754|FG000|Overall Study|Protocol Violation|3|||
25323675|NCT00601250|50639755|FG001|Overall Study|Protocol Violation|2|||
25323676|NCT00601250|50639754|FG000|Overall Study|Lost to Follow-up|2|||
25323677|NCT00601250|50639755|FG001|Overall Study|Lost to Follow-up|6|||
25323678|NCT00601250|50639754|FG000|Overall Study|Withdrawal by Subject|4|||
25323679|NCT00601250|50639755|FG001|Overall Study|Withdrawal by Subject|13|||
25323680|NCT00601250|50639754|FG000|Overall Study|Other incl. lack of efficacy|2|||
25244624|NCT01285492|50559700|FG001|Overall Study|Adverse Event|0|||
25244625|NCT01285492|50559699|FG000|Overall Study|Protocol Violation|3|||
25244626|NCT01285492|50559700|FG001|Overall Study|Protocol Violation|0|||
25244627|NCT01285492|50559699|FG000|Overall Study|Withdrawal by Subject|2|||
25244628|NCT01285492|50559700|FG001|Overall Study|Withdrawal by Subject|1|||
25244629|NCT01285492|50559699|FG000|Overall Study|Death|1|||
25244630|NCT01285492|50559700|FG001|Overall Study|Death|0|||
25244631|NCT01284634|50559710|FG000|Overall Study|Adverse Event|1|||
25244632|NCT01284634|50559711|FG001|Overall Study|Adverse Event|0|||
25244633|NCT01284634|50559712|FG002|Overall Study|Adverse Event|2|||
25323681|NCT00601250|50639755|FG001|Overall Study|Other incl. lack of efficacy|9|||
25323682|NCT00866775|50639763|FG000|Overall Study|Adverse Event|5|||
25323683|NCT00866775|50639764|FG001|Overall Study|Adverse Event|19|||
25323684|NCT00866775|50639763|FG000|Overall Study|Death|1|||
25323685|NCT00866775|50639764|FG001|Overall Study|Death|0|||
25323686|NCT00866775|50639763|FG000|Overall Study|Lost to Follow-up|0|||
25323687|NCT00866775|50639764|FG001|Overall Study|Lost to Follow-up|4|||
25323688|NCT00866775|50639763|FG000|Overall Study|Physician Decision|0|||
25244634|NCT01284634|50559713|FG003|Overall Study|Adverse Event|1|||
25244635|NCT01284361|50559723|FG000|Overall Study|Withdrawal by Subject|1|||
25244636|NCT01284361|50559723|FG000|Overall Study|Protocol Violation|5|||
25323689|NCT00866775|50639764|FG001|Overall Study|Physician Decision|3|||
25323690|NCT00866775|50639763|FG000|Overall Study|Protocol Violation|3|||
25323691|NCT00866775|50639764|FG001|Overall Study|Protocol Violation|4|||
25323692|NCT00866775|50639763|FG000|Overall Study|Withdrawal by Subject|4|||
25323693|NCT00866775|50639764|FG001|Overall Study|Withdrawal by Subject|4|||
25323694|NCT00866775|50639763|FG000|Overall Study|met exit criteria|23|||
25323695|NCT00866775|50639764|FG001|Overall Study|met exit criteria|17|||
25323696|NCT00866775|50639763|FG000|Overall Study|discontinued due to communication error|0|||
25323697|NCT00866775|50639764|FG001|Overall Study|discontinued due to communication error|1|||
25323698|NCT03265210|50639774|FG000|Overall Study|Withdrawal by Subject|7|||
25244637|NCT01284361|50559723|FG000|Overall Study|Adverse Event|1|||
25244638|NCT01284361|50559723|FG000|Overall Study|Lost to Follow-up|2|||
25244639|NCT01284127|50559730|FG000|Overall Study|Adverse Event|2|||
25323699|NCT03265210|50639775|FG001|Overall Study|Withdrawal by Subject|9|||
25323700|NCT03265210|50639774|FG000|Overall Study|Lost to Follow-up|2|||
25323701|NCT03265210|50639775|FG001|Overall Study|Lost to Follow-up|0|||
25323702|NCT03265210|50639774|FG000|Overall Study|Physician Decision|2|||
25323703|NCT03265210|50639775|FG001|Overall Study|Physician Decision|0|||
25323704|NCT03265210|50639774|FG000|Overall Study|Adverse Event|1|||
25323705|NCT03265210|50639775|FG001|Overall Study|Adverse Event|0|||
25323706|NCT00543985|50639781|FG000|Overall Study|Withdrawal by Subject|4|||
25323707|NCT00582556|50639796|FG000|Overall Study|Withdrawal by Subject|0|||
25323708|NCT00582556|50639797|FG001|Overall Study|Withdrawal by Subject|1|||
25323709|NCT00582556|50639798|FG002|Overall Study|Withdrawal by Subject|1|||
25323710|NCT00582556|50639796|FG000|Overall Study|Physician Decision|0|||
25323711|NCT00582556|50639797|FG001|Overall Study|Physician Decision|0|||
25323712|NCT00582556|50639798|FG002|Overall Study|Physician Decision|1|||
25323713|NCT00542269|50639810|FG000|Overall Study|Adverse Event|10|||
25323714|NCT00542269|50639811|FG001|Overall Study|Adverse Event|4|||
25323715|NCT00542269|50639812|FG002|Overall Study|Adverse Event|5|||
25323716|NCT00542269|50639810|FG000|Overall Study|Protocol Violation|1|||
25323717|NCT00542269|50639811|FG001|Overall Study|Protocol Violation|1|||
25323718|NCT00542269|50639812|FG002|Overall Study|Protocol Violation|0|||
25323719|NCT00542269|50639810|FG000|Overall Study|Withdrawal by Subject|1|||
25323720|NCT00542269|50639811|FG001|Overall Study|Withdrawal by Subject|0|||
25323721|NCT00542269|50639812|FG002|Overall Study|Withdrawal by Subject|0|||
25323722|NCT00542269|50639810|FG000|Overall Study|Administrative problems|1|||
25323723|NCT00542269|50639811|FG001|Overall Study|Administrative problems|1|||
25323724|NCT00542269|50639812|FG002|Overall Study|Administrative problems|1|||
25323725|NCT00866697|50639824|FG000|Overall Study|Study closed/terminated|156|||
25323726|NCT00866697|50639825|FG001|Overall Study|Study closed/terminated|138|||
25244640|NCT01284127|50559730|FG000|Overall Study|Withdrawal by Subject|4|||
25244641|NCT01284127|50559730|FG000|Overall Study|Physician Decision|1|||
25244642|NCT01283971|50559736|FG000|Overall Study|Adverse Event|3|||
25244643|NCT01283971|50559737|FG001|Overall Study|Adverse Event|5|||
25244644|NCT01283971|50559736|FG000|Overall Study|Insufficient therapeutic responses|3|||
25244645|NCT01283971|50559737|FG001|Overall Study|Insufficient therapeutic responses|3|||
25244646|NCT01283971|50559736|FG000|Overall Study|Protocol Violation|5|||
25244647|NCT01283971|50559737|FG001|Overall Study|Protocol Violation|1|||
25244648|NCT01283971|50559736|FG000|Overall Study|Refused treatment|3|||
25244649|NCT01283971|50559737|FG001|Overall Study|Refused treatment|1|||
25244650|NCT01283971|50559736|FG000|Overall Study|Failure to return|0|||
25244651|NCT01283971|50559737|FG001|Overall Study|Failure to return|1|||
25244652|NCT01283971|50559736|FG000|Overall Study|Administrative reasons|1|||
25244653|NCT01283971|50559737|FG001|Overall Study|Administrative reasons|1|||
25244654|NCT01283581|50559746|FG000|Overall Study|Lost to Follow-up|8|||
25244655|NCT01283581|50559747|FG001|Overall Study|Lost to Follow-up|6|||
25244656|NCT01283581|50559748|FG002|Overall Study|Lost to Follow-up|8|||
25244657|NCT01283581|50559746|FG000|Overall Study|Withdrawal by Subject|2|||
25244658|NCT01283581|50559747|FG001|Overall Study|Withdrawal by Subject|5|||
25244659|NCT01283581|50559748|FG002|Overall Study|Withdrawal by Subject|2|||
25244660|NCT01283581|50559746|FG000|Overall Study|Adverse Event|1|||
25244661|NCT01283581|50559747|FG001|Overall Study|Adverse Event|1|||
25244662|NCT01283581|50559748|FG002|Overall Study|Adverse Event|4|||
25244663|NCT01283581|50559746|FG000|Overall Study|Physician Decision|0|||
25244664|NCT01283581|50559747|FG001|Overall Study|Physician Decision|1|||
25244665|NCT01283581|50559748|FG002|Overall Study|Physician Decision|2|||
25244666|NCT01283581|50559746|FG000|Overall Study|Protocol Violation|0|||
25244667|NCT01283581|50559747|FG001|Overall Study|Protocol Violation|1|||
25323727|NCT00866697|50639824|FG000|Overall Study|Lost to Follow-up|22|||
25323728|NCT00866697|50639825|FG001|Overall Study|Lost to Follow-up|28|||
25323729|NCT00866697|50639824|FG000|Overall Study|Physician Decision|3|||
25323730|NCT00866697|50639825|FG001|Overall Study|Physician Decision|5|||
25323731|NCT00866697|50639824|FG000|Overall Study|Withdrawal by Subject|33|||
25323732|NCT00866697|50639825|FG001|Overall Study|Withdrawal by Subject|57|||
25323733|NCT00542191|50639831|FG000|Overall Study|Death|3|||
25323734|NCT00600938|50639837|FG000|Core Study|Abnormal test procedure result(s)|3|||
25323735|NCT00600938|50639838|FG001|Core Study|Abnormal test procedure result(s)|2|||
25323736|NCT00600938|50639839|FG002|Core Study|Abnormal test procedure result(s)|0|||
25244668|NCT01283581|50559748|FG002|Overall Study|Protocol Violation|2|||
25323737|NCT00600938|50639840|FG003|Core Study|Abnormal test procedure result(s)|0|||
25323738|NCT00600938|50639837|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
25323739|NCT00600938|50639838|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
25323740|NCT00600938|50639839|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
25323741|NCT00600938|50639840|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
25323742|NCT00600938|50639837|FG000|Core Study|Patient withdrew consent|7|||
25323743|NCT00600938|50639838|FG001|Core Study|Patient withdrew consent|12|||
25244669|NCT01283581|50559746|FG000|Overall Study|Noncompliance|1|||
25244670|NCT01283581|50559747|FG001|Overall Study|Noncompliance|0|||
25244671|NCT01283581|50559748|FG002|Overall Study|Noncompliance|0|||
25244672|NCT01283581|50559746|FG000|Overall Study|Investigator unblinded|0|||
25244673|NCT01283581|50559747|FG001|Overall Study|Investigator unblinded|0|||
25244674|NCT01283581|50559748|FG002|Overall Study|Investigator unblinded|1|||
25244675|NCT01283581|50559746|FG000|Overall Study|"Early termination"|0|||
25244676|NCT01283581|50559747|FG001|Overall Study|"Early termination"|0|||
25244677|NCT01283581|50559748|FG002|Overall Study|"Early termination"|1|||
25244678|NCT01283542|50559759|FG000|Main Phase|Acute or progressive vision loss|1|||
25244679|NCT01283542|50559759|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
25244680|NCT01283542|50559759|FG000|Main Phase|abnormal laboratory values|5|||
25244681|NCT01283542|50559759|FG000|Extension Phase|Physician Decision|1|||
25244682|NCT01283542|50559759|FG000|Extension Phase|Adverse Event|1|||
25244683|NCT01283542|50559759|FG000|Extension Phase|Administrative problems|1|||
25244684|NCT01283386|50559783|FG000|Overall Study|Death|2|||
25323744|NCT00600938|50639839|FG002|Core Study|Patient withdrew consent|0|||
25323745|NCT00600938|50639840|FG003|Core Study|Patient withdrew consent|0|||
25323746|NCT00600938|50639837|FG000|Core Study|Lost to Follow-up|3|||
25323747|NCT00600938|50639838|FG001|Core Study|Lost to Follow-up|2|||
25323748|NCT00600938|50639839|FG002|Core Study|Lost to Follow-up|0|||
25323749|NCT00600938|50639840|FG003|Core Study|Lost to Follow-up|0|||
25323750|NCT00600938|50639837|FG000|Core Study|Death|1|||
25323751|NCT00600938|50639838|FG001|Core Study|Death|1|||
25323752|NCT00600938|50639839|FG002|Core Study|Death|0|||
25323753|NCT00600938|50639840|FG003|Core Study|Death|0|||
25323754|NCT00600938|50639837|FG000|Core Study|Protocol Violation|1|||
25244685|NCT01283386|50559784|FG001|Overall Study|Death|0|||
25244686|NCT01283386|50559783|FG000|Overall Study|Withdrawal by Subject|2|||
25244687|NCT01283386|50559784|FG001|Overall Study|Withdrawal by Subject|1|||
25244688|NCT01283386|50559783|FG000|Overall Study|Relapse of underlying disease|1|||
25244689|NCT01283386|50559784|FG001|Overall Study|Relapse of underlying disease|3|||
25244690|NCT01283386|50559783|FG000|Overall Study|Progression of underlying disease|2|||
25244691|NCT01283386|50559784|FG001|Overall Study|Progression of underlying disease|7|||
25244692|NCT01283386|50559783|FG000|Overall Study|Reason not specified|1|||
25244693|NCT01283386|50559784|FG001|Overall Study|Reason not specified|0|||
25244694|NCT01283386|50559783|FG000|Overall Study|Protocol Violation|0|||
25244695|NCT01283386|50559784|FG001|Overall Study|Protocol Violation|1|||
25244696|NCT01283152|50559792|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
25244697|NCT01283152|50559793|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
25244698|NCT01283152|50559792|FG000|Overall Study|Refused HESA|1|||
25244699|NCT01283152|50559793|FG001|Overall Study|Refused HESA|0|||
25244700|NCT01283035|50559799|FG000|Overall Study|Subject later found ineligible|1|||
25244701|NCT01283464|50559805|FG000|Overall Study|Lost to Follow-up|0|||
25244702|NCT01283464|50559806|FG001|Overall Study|Lost to Follow-up|1|||
25244703|NCT01283464|50559805|FG000|Overall Study|Withdrawal by Subject|1|||
25244704|NCT01283464|50559806|FG001|Overall Study|Withdrawal by Subject|0|||
25244705|NCT01283464|50559805|FG000|Overall Study|Physician Decision|1|||
25244706|NCT01283464|50559806|FG001|Overall Study|Physician Decision|0|||
25244707|NCT01282801|50559814|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
25244708|NCT01282801|50559815|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
25244709|NCT01282372|50559821|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
25244710|NCT01282372|50559821|FG000|Overall Study|Lost to Follow-up|23|||
25244711|NCT01282372|50559821|FG000|Overall Study|Withdrawal by Subject|11|||
25244712|NCT01282372|50559821|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
25244713|NCT01282372|50559821|FG000|Overall Study|Death|1|||
25244714|NCT01282372|50559821|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
25244715|NCT01282372|50559821|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
25244716|NCT01282372|50559821|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
25244717|NCT01282372|50559821|FG000|Overall Study|Adverse Event|12|||
25244718|NCT01282294|50559832|FG000|Overall Study|Lost to Follow-up|14|||
25244719|NCT01282294|50559832|FG000|Overall Study|Screening failure|1|||
25244720|NCT01282294|50559832|FG000|Overall Study|Adverse Event|1|||
25244721|NCT01282294|50559832|FG000|Overall Study|Patient non-compliance|2|||
25244722|NCT01282294|50559832|FG000|Overall Study|Physician Decision|1|||
25244723|NCT01282216|50559838|FG000|Overall Study|Graft failure|0|||
25244724|NCT01282216|50559839|FG001|Overall Study|Graft failure|0|||
25244725|NCT01282216|50559840|FG002|Overall Study|Graft failure|3|||
25323755|NCT00600938|50639838|FG001|Core Study|Protocol Violation|2|||
25323756|NCT00600938|50639839|FG002|Core Study|Protocol Violation|0|||
25244726|NCT01282216|50559841|FG003|Overall Study|Graft failure|2|||
25323757|NCT00600938|50639840|FG003|Core Study|Protocol Violation|0|||
25323758|NCT00600938|50639837|FG000|Extension Study|Adverse Event|1|||
25244727|NCT01282216|50559838|FG000|Overall Study|Physician Decision|0|||
25244728|NCT01282216|50559839|FG001|Overall Study|Physician Decision|0|||
25244729|NCT01282216|50559840|FG002|Overall Study|Physician Decision|11|||
25244730|NCT01282216|50559841|FG003|Overall Study|Physician Decision|0|||
25244731|NCT01282216|50559838|FG000|Overall Study|Relapse|0|||
25244732|NCT01282216|50559839|FG001|Overall Study|Relapse|0|||
25244733|NCT01282216|50559840|FG002|Overall Study|Relapse|17|||
25244734|NCT01282216|50559841|FG003|Overall Study|Relapse|6|||
25323759|NCT00600938|50639838|FG001|Extension Study|Adverse Event|0|||
25244735|NCT01282216|50559838|FG000|Overall Study|Death|0|||
25244736|NCT01282216|50559839|FG001|Overall Study|Death|0|||
25244737|NCT01282216|50559840|FG002|Overall Study|Death|2|||
25244738|NCT01282216|50559841|FG003|Overall Study|Death|0|||
25244739|NCT01281865|50559849|FG000|Overall Study|Adverse Event|1|||
25244740|NCT01281865|50559850|FG001|Overall Study|Adverse Event|1|||
25244741|NCT01281865|50559849|FG000|Overall Study|Withdrawal by Subject|1|||
25244742|NCT01281865|50559850|FG001|Overall Study|Withdrawal by Subject|0|||
25323760|NCT00600938|50639839|FG002|Extension Study|Adverse Event|2|||
25323761|NCT00600938|50639840|FG003|Extension Study|Adverse Event|0|||
25323762|NCT00600938|50639837|FG000|Extension Study|Abnormal test procedure results|0|||
25323763|NCT00600938|50639838|FG001|Extension Study|Abnormal test procedure results|1|||
25323764|NCT00600938|50639839|FG002|Extension Study|Abnormal test procedure results|1|||
25323765|NCT00600938|50639840|FG003|Extension Study|Abnormal test procedure results|1|||
25323766|NCT00600938|50639837|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
25323767|NCT00600938|50639838|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
25323768|NCT00600938|50639839|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
25323769|NCT00600938|50639840|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
25323770|NCT00600938|50639837|FG000|Extension Study|Withdrawal by Subject|2|||
25323771|NCT00600938|50639838|FG001|Extension Study|Withdrawal by Subject|2|||
25323772|NCT00600938|50639839|FG002|Extension Study|Withdrawal by Subject|3|||
25323773|NCT00600938|50639840|FG003|Extension Study|Withdrawal by Subject|0|||
25323774|NCT00600938|50639837|FG000|Extension Study|Lost to Follow-up|1|||
25323775|NCT00600938|50639838|FG001|Extension Study|Lost to Follow-up|1|||
25323776|NCT00600938|50639839|FG002|Extension Study|Lost to Follow-up|2|||
25323777|NCT00600938|50639840|FG003|Extension Study|Lost to Follow-up|0|||
25323778|NCT00600938|50639837|FG000|Extension Study|Death|1|||
25323779|NCT00600938|50639838|FG001|Extension Study|Death|0|||
25323780|NCT00600938|50639839|FG002|Extension Study|Death|0|||
25323781|NCT00600938|50639840|FG003|Extension Study|Death|0|||
25323782|NCT00543439|50639881|FG000|Period 1|Adverse Event|0|||
25323783|NCT00543439|50639882|FG001|Period 1|Adverse Event|2|||
25323784|NCT00543439|50639883|FG002|Period 1|Adverse Event|1|||
25323785|NCT00543439|50639881|FG000|Period 1|Withdrawal by Subject|1|||
25323786|NCT00543439|50639882|FG001|Period 1|Withdrawal by Subject|1|||
25323787|NCT00543439|50639883|FG002|Period 1|Withdrawal by Subject|0|||
25323788|NCT00543439|50639881|FG000|Period 1|Physician Decision|0|||
25323789|NCT00543439|50639882|FG001|Period 1|Physician Decision|0|||
25323790|NCT00543439|50639883|FG002|Period 1|Physician Decision|1|||
25323791|NCT00543439|50639881|FG000|Period 2|Protocol Violation|1|||
25323792|NCT00543439|50639882|FG001|Period 2|Protocol Violation|0|||
25323793|NCT00543439|50639883|FG002|Period 2|Protocol Violation|1|||
25323794|NCT00543439|50639881|FG000|Period 2|Adverse Event|0|||
25323795|NCT00543439|50639882|FG001|Period 2|Adverse Event|1|||
25323796|NCT00543439|50639883|FG002|Period 2|Adverse Event|1|||
25323797|NCT00582166|50639900|FG000|Overall Study|Death|1|||
25323798|NCT00582166|50639900|FG000|Overall Study|Ineligible pathology|1|||
25323799|NCT00601172|50639906|FG000|Overall Study|Adverse Event|43|||
25323800|NCT00601172|50639907|FG001|Overall Study|Adverse Event|32|||
25323801|NCT00601172|50639906|FG000|Overall Study|Lack of Efficacy|11|||
25323802|NCT00601172|50639907|FG001|Overall Study|Lack of Efficacy|12|||
25323803|NCT00601172|50639906|FG000|Overall Study|Protocol Violation|2|||
25323804|NCT00601172|50639907|FG001|Overall Study|Protocol Violation|5|||
25323805|NCT00601172|50639906|FG000|Overall Study|Lost to Follow-up|4|||
25323806|NCT00601172|50639907|FG001|Overall Study|Lost to Follow-up|3|||
25323807|NCT00601172|50639906|FG000|Overall Study|Physician Decision|27|||
25323808|NCT00601172|50639907|FG001|Overall Study|Physician Decision|28|||
25323809|NCT00601172|50639906|FG000|Overall Study|Withdrawal by Subject|35|||
25323810|NCT00601172|50639907|FG001|Overall Study|Withdrawal by Subject|27|||
25323811|NCT00601172|50639906|FG000|Overall Study|Did not meet continuation criteria|19|||
25323812|NCT00601172|50639907|FG001|Overall Study|Did not meet continuation criteria|20|||
25323813|NCT00582010|50639916|FG000|Overall Study|Death|0|||
25323814|NCT00582010|50639917|FG001|Overall Study|Death|1|||
25323815|NCT03920215|50639931|FG000|Overall Study|Lost to Follow-up|1|||
25323816|NCT03920215|50639932|FG001|Overall Study|Lost to Follow-up|2|||
25323817|NCT03920215|50639933|FG002|Overall Study|Lost to Follow-up|0|||
25323818|NCT03920215|50639934|FG003|Overall Study|Lost to Follow-up|0|||
25323819|NCT03920215|50639931|FG000|Overall Study|Death|0|||
25323820|NCT03920215|50639932|FG001|Overall Study|Death|0|||
25323821|NCT03920215|50639933|FG002|Overall Study|Death|0|||
25323822|NCT03920215|50639934|FG003|Overall Study|Death|1|||
25323823|NCT00580840|50639944|FG000|Run-in|Adverse Event|17|||
25323824|NCT00580840|50639945|FG001|Run-in|Adverse Event|0|||
25323825|NCT00580840|50639946|FG002|Run-in|Adverse Event|0|||
25244743|NCT01281865|50559849|FG000|Overall Study|Lack of Efficacy|1|||
25244744|NCT01281865|50559850|FG001|Overall Study|Lack of Efficacy|0|||
25244745|NCT01281202|50559858|FG000|Overall Study|Adverse Event|2|||
25323826|NCT00580840|50639947|FG003|Run-in|Adverse Event|0|||
25323827|NCT00580840|50639944|FG000|Run-in|Lack of Efficacy|93|||
25323828|NCT00580840|50639945|FG001|Run-in|Lack of Efficacy|0|||
25323829|NCT00580840|50639946|FG002|Run-in|Lack of Efficacy|0|||
25244746|NCT01281202|50559859|FG001|Overall Study|Adverse Event|0|||
25244747|NCT01281202|50559858|FG000|Overall Study|Withdrawal by Subject|2|||
25244748|NCT01281202|50559859|FG001|Overall Study|Withdrawal by Subject|2|||
25244749|NCT01281202|50559858|FG000|Overall Study|Protocol Violation|11|||
25244750|NCT01281202|50559859|FG001|Overall Study|Protocol Violation|10|||
25244751|NCT01281202|50559858|FG000|Overall Study|Administrative|2|||
25244752|NCT01281202|50559859|FG001|Overall Study|Administrative|8|||
25244753|NCT01281202|50559858|FG000|Overall Study|Lost to Follow-up|11|||
25244754|NCT01281202|50559859|FG001|Overall Study|Lost to Follow-up|13|||
25244755|NCT01281202|50559858|FG000|Overall Study|Incarceration|0|||
25244756|NCT01281202|50559859|FG001|Overall Study|Incarceration|3|||
25244757|NCT01281124|50559867|FG000|Overall Study|Death|1|||
25244758|NCT01280968|50559875|FG000|Overall Study|Lost to Follow-up|8|||
25244759|NCT01280968|50559876|FG001|Overall Study|Lost to Follow-up|2|||
25244760|NCT01280968|50559875|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
25244761|NCT01280968|50559876|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
25244762|NCT01280968|50559875|FG000|Overall Study|Commuting Problems|2|||
25244763|NCT01280968|50559876|FG001|Overall Study|Commuting Problems|0|||
25244764|NCT01280968|50559875|FG000|Overall Study|Anxiety|2|||
25244765|NCT01280968|50559876|FG001|Overall Study|Anxiety|0|||
25244766|NCT01280968|50559875|FG000|Overall Study|Adverse Event|1|||
25244767|NCT01280968|50559876|FG001|Overall Study|Adverse Event|0|||
25244768|NCT01280968|50559875|FG000|Overall Study|Scheduling Conflicts|1|||
25244769|NCT01280968|50559876|FG001|Overall Study|Scheduling Conflicts|1|||
25244770|NCT01280968|50559875|FG000|Overall Study|Pre-existing Neurological Condition|1|||
25244771|NCT01280968|50559876|FG001|Overall Study|Pre-existing Neurological Condition|0|||
25244772|NCT01280968|50559875|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
25244773|NCT01280968|50559876|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
25244774|NCT01280812|50559886|FG000|Overall Study|Withdrawal by Subject|2|||
25244775|NCT01280812|50559887|FG001|Overall Study|Withdrawal by Subject|1|||
25244776|NCT01280812|50559888|FG002|Overall Study|Withdrawal by Subject|0|||
25244777|NCT01280812|50559886|FG000|Overall Study|Lost to Follow-up|1|||
25244778|NCT01280812|50559887|FG001|Overall Study|Lost to Follow-up|1|||
25244779|NCT01280812|50559888|FG002|Overall Study|Lost to Follow-up|1|||
25244780|NCT01280656|50559900|FG000|Overall Study|Adverse Event|1|||
25244781|NCT01280656|50559901|FG001|Overall Study|Adverse Event|14|||
25244782|NCT01280656|50559902|FG002|Overall Study|Adverse Event|13|||
25244783|NCT01280656|50559900|FG000|Overall Study|Lack of Efficacy|1|||
25244784|NCT01280656|50559901|FG001|Overall Study|Lack of Efficacy|22|||
25244785|NCT01280656|50559902|FG002|Overall Study|Lack of Efficacy|38|||
25244786|NCT01280656|50559900|FG000|Overall Study|Treatment shortening (RGT)|0|||
25244787|NCT01280656|50559901|FG001|Overall Study|Treatment shortening (RGT)|4|||
25244788|NCT01280656|50559902|FG002|Overall Study|Treatment shortening (RGT)|5|||
25244789|NCT01280656|50559900|FG000|Overall Study|Other|1|||
25244790|NCT01280656|50559901|FG001|Overall Study|Other|7|||
25244791|NCT01280656|50559902|FG002|Overall Study|Other|7|||
25244792|NCT01280617|50559912|FG000|Overall Study|Adverse Event|0|||
25244793|NCT01280617|50559913|FG001|Overall Study|Adverse Event|1|||
25244794|NCT01280266|50559921|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
25244795|NCT01280266|50559922|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
25244796|NCT01280266|50559921|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
25244797|NCT01280266|50559922|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
25244798|NCT01279447|50559934|FG000|Overall Study|Lost to Follow-up|3|||
25244799|NCT01279447|50559935|FG001|Overall Study|Lost to Follow-up|1|||
25323830|NCT00580840|50639947|FG003|Run-in|Lack of Efficacy|0|||
25323831|NCT00580840|50639944|FG000|Run-in|Loss of Efficacy|1|||
25323832|NCT00580840|50639945|FG001|Run-in|Loss of Efficacy|0|||
25323833|NCT00580840|50639946|FG002|Run-in|Loss of Efficacy|0|||
25323834|NCT00580840|50639947|FG003|Run-in|Loss of Efficacy|0|||
25323835|NCT00580840|50639944|FG000|Run-in|Lost to Follow-up|4|||
25323836|NCT00580840|50639945|FG001|Run-in|Lost to Follow-up|0|||
25323837|NCT00580840|50639946|FG002|Run-in|Lost to Follow-up|0|||
25323838|NCT00580840|50639947|FG003|Run-in|Lost to Follow-up|0|||
25323839|NCT00580840|50639944|FG000|Run-in|Withdrawal by Subject|5|||
25323840|NCT00580840|50639945|FG001|Run-in|Withdrawal by Subject|0|||
25323841|NCT00580840|50639946|FG002|Run-in|Withdrawal by Subject|0|||
25244800|NCT01276639|50559957|FG000|Week 0 to 16|Death|1|||
25244801|NCT01276639|50559958|FG001|Week 0 to 16|Death|0|||
25323842|NCT00580840|50639947|FG003|Run-in|Withdrawal by Subject|0|||
25323843|NCT00580840|50639944|FG000|Run-in|Other: Per Sponsor Request|2|||
25323844|NCT00580840|50639945|FG001|Run-in|Other: Per Sponsor Request|0|||
25323845|NCT00580840|50639946|FG002|Run-in|Other: Per Sponsor Request|0|||
25244802|NCT01276639|50559959|FG002|Week 0 to 16|Death|0|||
25244803|NCT01276639|50559960|FG003|Week 0 to 16|Death|0|||
25244804|NCT01276639|50559961|FG004|Week 0 to 16|Death|0|||
25244805|NCT01276639|50559957|FG000|Week 0 to 16|Adverse Event|11|||
25244806|NCT01276639|50559958|FG001|Week 0 to 16|Adverse Event|8|||
25244807|NCT01276639|50559959|FG002|Week 0 to 16|Adverse Event|11|||
25244808|NCT01276639|50559960|FG003|Week 0 to 16|Adverse Event|0|||
25323846|NCT00580840|50639947|FG003|Run-in|Other: Per Sponsor Request|0|||
25244809|NCT01276639|50559961|FG004|Week 0 to 16|Adverse Event|0|||
25244810|NCT01276639|50559957|FG000|Week 0 to 16|Lack of Efficacy|20|||
25244811|NCT01276639|50559958|FG001|Week 0 to 16|Lack of Efficacy|15|||
25244812|NCT01276639|50559959|FG002|Week 0 to 16|Lack of Efficacy|25|||
25244813|NCT01276639|50559960|FG003|Week 0 to 16|Lack of Efficacy|0|||
25244814|NCT01276639|50559961|FG004|Week 0 to 16|Lack of Efficacy|0|||
25244815|NCT01276639|50559957|FG000|Week 0 to 16|Lost to Follow-up|3|||
25244816|NCT01276639|50559958|FG001|Week 0 to 16|Lost to Follow-up|5|||
25244817|NCT01276639|50559959|FG002|Week 0 to 16|Lost to Follow-up|3|||
25244818|NCT01276639|50559960|FG003|Week 0 to 16|Lost to Follow-up|0|||
25244819|NCT01276639|50559961|FG004|Week 0 to 16|Lost to Follow-up|0|||
25244820|NCT01276639|50559957|FG000|Week 0 to 16|Withdrawal by Subject|8|||
25244821|NCT01276639|50559958|FG001|Week 0 to 16|Withdrawal by Subject|5|||
25244822|NCT01276639|50559959|FG002|Week 0 to 16|Withdrawal by Subject|4|||
25244823|NCT01276639|50559960|FG003|Week 0 to 16|Withdrawal by Subject|0|||
25244824|NCT01276639|50559961|FG004|Week 0 to 16|Withdrawal by Subject|0|||
25244825|NCT01276639|50559957|FG000|Week 0 to 16|Other|7|||
25323847|NCT00580840|50639944|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
25323848|NCT00580840|50639945|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
25323849|NCT00580840|50639946|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
25323850|NCT00580840|50639947|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
25323851|NCT00580840|50639944|FG000|Run-in|Other: Exclusionary Lab Value|1|||
25323852|NCT00580840|50639945|FG001|Run-in|Other: Exclusionary Lab Value|0|||
25323853|NCT00580840|50639946|FG002|Run-in|Other: Exclusionary Lab Value|0|||
25323854|NCT00580840|50639947|FG003|Run-in|Other: Exclusionary Lab Value|0|||
25323855|NCT00580840|50639944|FG000|Double-Blind|Adverse Event|0|||
25323856|NCT00580840|50639945|FG001|Double-Blind|Adverse Event|3|||
25323857|NCT00580840|50639946|FG002|Double-Blind|Adverse Event|4|||
25323858|NCT00580840|50639947|FG003|Double-Blind|Adverse Event|1|||
25323859|NCT00580840|50639944|FG000|Double-Blind|Loss of Efficacy|0|||
25323860|NCT00580840|50639945|FG001|Double-Blind|Loss of Efficacy|1|||
25323861|NCT00580840|50639946|FG002|Double-Blind|Loss of Efficacy|2|||
25323862|NCT00580840|50639947|FG003|Double-Blind|Loss of Efficacy|10|||
25323863|NCT00580840|50639944|FG000|Double-Blind|Lost to Follow-up|0|||
25323864|NCT00580840|50639945|FG001|Double-Blind|Lost to Follow-up|1|||
25323865|NCT00580840|50639946|FG002|Double-Blind|Lost to Follow-up|0|||
25323866|NCT00580840|50639947|FG003|Double-Blind|Lost to Follow-up|2|||
25323867|NCT00580840|50639944|FG000|Double-Blind|Withdrawal by Subject|0|||
25323868|NCT00580840|50639945|FG001|Double-Blind|Withdrawal by Subject|1|||
25323869|NCT00580840|50639946|FG002|Double-Blind|Withdrawal by Subject|2|||
25323870|NCT00580840|50639947|FG003|Double-Blind|Withdrawal by Subject|2|||
25323871|NCT00580840|50639944|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
25323872|NCT00580840|50639945|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
25323873|NCT00580840|50639946|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
25323874|NCT00580840|50639947|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
25323875|NCT00580840|50639944|FG000|Double-Blind|Other: Forbidden Medication|0|||
25323876|NCT00580840|50639945|FG001|Double-Blind|Other: Forbidden Medication|0|||
25323877|NCT00580840|50639946|FG002|Double-Blind|Other: Forbidden Medication|1|||
25323878|NCT00580840|50639947|FG003|Double-Blind|Other: Forbidden Medication|0|||
25323879|NCT00879684|50639957|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
25323880|NCT00879684|50639958|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
25323881|NCT00879684|50639959|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
25323882|NCT00879684|50639960|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
25323883|NCT00879684|50639961|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
25323884|NCT00879684|50639962|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
25323885|NCT00879684|50639963|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
25323886|NCT00879684|50639957|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
25323887|NCT00879684|50639958|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
25244826|NCT01276639|50559958|FG001|Week 0 to 16|Other|7|||
25244827|NCT01276639|50559959|FG002|Week 0 to 16|Other|2|||
25244828|NCT01276639|50559960|FG003|Week 0 to 16|Other|0|||
25323888|NCT00879684|50639959|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
25323889|NCT00879684|50639960|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
25323890|NCT00879684|50639961|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
25323891|NCT00879684|50639962|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
25323892|NCT00879684|50639963|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
25244829|NCT01276639|50559961|FG004|Week 0 to 16|Other|0|||
25244830|NCT01276639|50559957|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
25244831|NCT01276639|50559958|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
25244832|NCT01276639|50559959|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
25244833|NCT01276639|50559960|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
25323893|NCT00879684|50639957|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
25323894|NCT00879684|50639958|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
25244834|NCT01276639|50559961|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
25244835|NCT01276639|50559957|FG000|Week 16 to 52|Death|1|||
25244836|NCT01276639|50559958|FG001|Week 16 to 52|Death|0|||
25323895|NCT00879684|50639959|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
25323896|NCT00879684|50639960|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
25323897|NCT00879684|50639961|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
25323898|NCT00879684|50639962|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
25323899|NCT00879684|50639963|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
25323900|NCT00879684|50639957|FG000|Stage 1: Dose Escalation|Death|0|||
25323901|NCT00879684|50639958|FG001|Stage 1: Dose Escalation|Death|0|||
25323902|NCT00879684|50639959|FG002|Stage 1: Dose Escalation|Death|1|||
25323903|NCT00879684|50639960|FG003|Stage 1: Dose Escalation|Death|0|||
25323904|NCT00879684|50639961|FG004|Stage 1: Dose Escalation|Death|0|||
25323905|NCT00879684|50639962|FG005|Stage 1: Dose Escalation|Death|0|||
25323906|NCT00879684|50639963|FG006|Stage 1: Dose Escalation|Death|0|||
25323907|NCT00879684|50639957|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
25323908|NCT00879684|50639958|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
25323909|NCT00879684|50639959|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
25323910|NCT00879684|50639960|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
25323911|NCT00879684|50639961|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
25323912|NCT00879684|50639962|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
25323913|NCT00879684|50639963|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
25323914|NCT00879684|50639957|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
25323915|NCT00879684|50639958|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
25323916|NCT00879684|50639959|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
25323917|NCT00879684|50639960|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
25323918|NCT00879684|50639961|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
25323919|NCT00879684|50639962|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
25323920|NCT00879684|50639963|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
25323921|NCT00879684|50639957|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
25323922|NCT00879684|50639958|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
25323923|NCT00879684|50639959|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
25323924|NCT00879684|50639960|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
25323925|NCT00879684|50639961|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
25323926|NCT00879684|50639962|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
25323927|NCT00879684|50639963|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
25323928|NCT00581776|50639982|FG000|Overall Study|Disease progression or no response|3|||
25323929|NCT00883740|50639986|FG000|First Intervention|Lost to Follow-up|1|||
25323930|NCT00883740|50639987|FG001|First Intervention|Lost to Follow-up|0|||
25323931|NCT00883740|50639986|FG000|First Intervention|No longer willing to participate|2|||
25323932|NCT00883740|50639987|FG001|First Intervention|No longer willing to participate|0|||
25323933|NCT00883740|50639986|FG000|First Intervention|Protocol Violation|3|||
25323934|NCT00883740|50639987|FG001|First Intervention|Protocol Violation|6|||
25323935|NCT00883740|50639986|FG000|First Intervention|Adverse Event|1|||
25323936|NCT00883740|50639987|FG001|First Intervention|Adverse Event|2|||
25323937|NCT00883740|50639986|FG000|Second Intervention|Protocol Violation|1|||
25323938|NCT00883740|50639987|FG001|Second Intervention|Protocol Violation|0|||
25323939|NCT00883740|50639986|FG000|Second Intervention|No longer willing to participate|0|||
25323940|NCT00883740|50639987|FG001|Second Intervention|No longer willing to participate|1|||
25323941|NCT00597012|50639995|FG000|Overall Study|Death|1|||
25323942|NCT00597012|50639996|FG001|Overall Study|Death|1|||
25323943|NCT00597012|50639995|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
25323944|NCT00597012|50639996|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
25323945|NCT00597012|50639995|FG000|Overall Study|Withdrawal by Subject|7|||
25323946|NCT00597012|50639996|FG001|Overall Study|Withdrawal by Subject|4|||
25323947|NCT00597012|50639995|FG000|Overall Study|Ineligible|2|||
25323948|NCT00597012|50639996|FG001|Overall Study|Ineligible|0|||
25323949|NCT00597012|50639995|FG000|Overall Study|Lost to Follow-up|0|||
25323950|NCT00597012|50639996|FG001|Overall Study|Lost to Follow-up|2|||
25323951|NCT00542815|50640007|FG000|Overall Study|Adverse Event|19|||
25323952|NCT00542815|50640008|FG001|Overall Study|Adverse Event|6|||
25323953|NCT00542815|50640009|FG002|Overall Study|Adverse Event|9|||
25323954|NCT00542815|50640007|FG000|Overall Study|Death|10|||
25323955|NCT00542815|50640008|FG001|Overall Study|Death|7|||
25323956|NCT00542815|50640009|FG002|Overall Study|Death|3|||
25323957|NCT00542815|50640007|FG000|Overall Study|Lack of Efficacy|9|||
25323958|NCT00542815|50640008|FG001|Overall Study|Lack of Efficacy|2|||
25323959|NCT00542815|50640009|FG002|Overall Study|Lack of Efficacy|0|||
25323960|NCT00542815|50640007|FG000|Overall Study|Physician Decision|2|||
25323961|NCT00542815|50640008|FG001|Overall Study|Physician Decision|1|||
25323962|NCT00542815|50640009|FG002|Overall Study|Physician Decision|0|||
25323963|NCT00542815|50640007|FG000|Overall Study|Protocol Violation|1|||
25323964|NCT00542815|50640008|FG001|Overall Study|Protocol Violation|1|||
25323965|NCT00542815|50640009|FG002|Overall Study|Protocol Violation|2|||
25323966|NCT00542815|50640007|FG000|Overall Study|Withdrawal by Subject|41|||
25323967|NCT00542815|50640008|FG001|Overall Study|Withdrawal by Subject|5|||
25323968|NCT00542815|50640009|FG002|Overall Study|Withdrawal by Subject|8|||
25323969|NCT00542815|50640007|FG000|Overall Study|Other reasons|24|||
25323970|NCT00542815|50640008|FG001|Overall Study|Other reasons|10|||
25323971|NCT00542815|50640009|FG002|Overall Study|Other reasons|10|||
25323972|NCT00542425|50640022|FG000|Initial 24 Weeks|Administrative reasons|0|||
25323973|NCT00542425|50640023|FG001|Initial 24 Weeks|Administrative reasons|0|||
25244837|NCT01276639|50559959|FG002|Week 16 to 52|Death|0|||
25244838|NCT01276639|50559960|FG003|Week 16 to 52|Death|0|||
25244839|NCT01276639|50559961|FG004|Week 16 to 52|Death|0|||
25244840|NCT01276639|50559957|FG000|Week 16 to 52|Adverse Event|10|||
25244841|NCT01276639|50559958|FG001|Week 16 to 52|Adverse Event|13|||
25244842|NCT01276639|50559959|FG002|Week 16 to 52|Adverse Event|0|||
25244843|NCT01276639|50559960|FG003|Week 16 to 52|Adverse Event|1|||
25244844|NCT01276639|50559961|FG004|Week 16 to 52|Adverse Event|3|||
25244845|NCT01276639|50559957|FG000|Week 16 to 52|Lack of Efficacy|99|||
25244846|NCT01276639|50559958|FG001|Week 16 to 52|Lack of Efficacy|71|||
25244847|NCT01276639|50559959|FG002|Week 16 to 52|Lack of Efficacy|0|||
25244848|NCT01276639|50559960|FG003|Week 16 to 52|Lack of Efficacy|14|||
25244849|NCT01276639|50559961|FG004|Week 16 to 52|Lack of Efficacy|13|||
25244850|NCT01276639|50559957|FG000|Week 16 to 52|Lost to Follow-up|3|||
25244851|NCT01276639|50559958|FG001|Week 16 to 52|Lost to Follow-up|1|||
25244852|NCT01276639|50559959|FG002|Week 16 to 52|Lost to Follow-up|0|||
25244853|NCT01276639|50559960|FG003|Week 16 to 52|Lost to Follow-up|0|||
25244854|NCT01276639|50559961|FG004|Week 16 to 52|Lost to Follow-up|1|||
25244855|NCT01276639|50559957|FG000|Week 16 to 52|Withdrawal by Subject|4|||
25244856|NCT01276639|50559958|FG001|Week 16 to 52|Withdrawal by Subject|4|||
25244857|NCT01276639|50559959|FG002|Week 16 to 52|Withdrawal by Subject|0|||
25244858|NCT01276639|50559960|FG003|Week 16 to 52|Withdrawal by Subject|0|||
25244859|NCT01276639|50559961|FG004|Week 16 to 52|Withdrawal by Subject|1|||
25244860|NCT01276639|50559957|FG000|Week 16 to 52|Other|10|||
25244861|NCT01276639|50559958|FG001|Week 16 to 52|Other|12|||
25244862|NCT01276639|50559959|FG002|Week 16 to 52|Other|0|||
25244863|NCT01276639|50559960|FG003|Week 16 to 52|Other|1|||
25244864|NCT01276639|50559961|FG004|Week 16 to 52|Other|3|||
25244865|NCT01275625|50559976|FG000|Overall Study|Death|1|||
25244866|NCT01275625|50559976|FG000|Overall Study|Lack of Efficacy|2|||
25244867|NCT01275625|50559976|FG000|Overall Study|Lost to Follow-up|1|||
25244868|NCT01275625|50559976|FG000|Overall Study|Withdrawal by Subject|3|||
25244869|NCT01275625|50559976|FG000|Overall Study|Protocol Violation|1|||
25244870|NCT01275625|50559976|FG000|Overall Study|Adverse Event|4|||
25244871|NCT01275625|50559976|FG000|Overall Study|Other|1|||
25244872|NCT01272193|50559982|FG000|Overall Study|Adverse Event|1|||
25244873|NCT01272193|50559983|FG001|Overall Study|Adverse Event|1|||
25244874|NCT01272193|50559982|FG000|Overall Study|Lack of Efficacy|0|||
25244875|NCT01272193|50559983|FG001|Overall Study|Lack of Efficacy|3|||
25244876|NCT01272193|50559982|FG000|Overall Study|Withdrawal Criteria|1|||
25244877|NCT01272193|50559983|FG001|Overall Study|Withdrawal Criteria|1|||
25244878|NCT01272193|50559982|FG000|Overall Study|Unclassified|8|||
25244879|NCT01272193|50559983|FG001|Overall Study|Unclassified|7|||
25244880|NCT01270828|50559995|FG000|Pregabalin CR SB|Reason Unspecified|0|||
25244881|NCT01270828|50559996|FG001|Pregabalin CR SB|Reason Unspecified|0|||
25244882|NCT01270828|50559997|FG002|Pregabalin CR SB|Reason Unspecified|8|||
25244883|NCT01270828|50559995|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
25244884|NCT01270828|50559996|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
25244885|NCT01270828|50559997|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
25244886|NCT01270828|50559995|FG000|Pregabalin CR SB|Related adverse event|0|||
25244887|NCT01270828|50559996|FG001|Pregabalin CR SB|Related adverse event|0|||
25244888|NCT01270828|50559997|FG002|Pregabalin CR SB|Related adverse event|46|||
25323974|NCT00542425|50640024|FG002|Initial 24 Weeks|Administrative reasons|1|||
25323975|NCT00542425|50640025|FG003|Initial 24 Weeks|Administrative reasons|1|||
25323976|NCT00542425|50640026|FG004|Initial 24 Weeks|Administrative reasons|0|||
25323977|NCT00542425|50640022|FG000|Initial 24 Weeks|Adverse Event|0|||
25323978|NCT00542425|50640023|FG001|Initial 24 Weeks|Adverse Event|1|||
25244889|NCT01270828|50559995|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
25244890|NCT01270828|50559996|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
25244891|NCT01270828|50559997|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
25244892|NCT01270828|50559995|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
25244893|NCT01270828|50559996|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
25244894|NCT01270828|50559997|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
25244895|NCT01270828|50559995|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
25244896|NCT01270828|50559996|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
25244897|NCT01270828|50559997|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
25323979|NCT00542425|50640024|FG002|Initial 24 Weeks|Adverse Event|1|||
25244898|NCT01270828|50559995|FG000|Pregabalin CR SB|Unrelated AE|0|||
25244899|NCT01270828|50559996|FG001|Pregabalin CR SB|Unrelated AE|0|||
25244900|NCT01270828|50559997|FG002|Pregabalin CR SB|Unrelated AE|8|||
25244901|NCT01270828|50559995|FG000|Pregabalin CR SB|Protocol Violation|0|||
25244902|NCT01270828|50559996|FG001|Pregabalin CR SB|Protocol Violation|0|||
25323980|NCT00542425|50640025|FG003|Initial 24 Weeks|Adverse Event|3|||
25323981|NCT00542425|50640026|FG004|Initial 24 Weeks|Adverse Event|2|||
25323982|NCT00542425|50640022|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
25323983|NCT00542425|50640023|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
25323984|NCT00542425|50640024|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
25323985|NCT00542425|50640025|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
25323986|NCT00542425|50640026|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
25323987|NCT00542425|50640022|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
25323988|NCT00542425|50640023|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
25323989|NCT00542425|50640024|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
25244903|NCT01270828|50559997|FG002|Pregabalin CR SB|Protocol Violation|8|||
25244904|NCT01270828|50559995|FG000|Double Blind Phase|Death|0|||
25244905|NCT01270828|50559996|FG001|Double Blind Phase|Death|1|||
25244906|NCT01270828|50559997|FG002|Double Blind Phase|Death|0|||
25244907|NCT01270828|50559995|FG000|Double Blind Phase|Protocol Violation|0|||
25244908|NCT01270828|50559996|FG001|Double Blind Phase|Protocol Violation|1|||
25244909|NCT01270828|50559997|FG002|Double Blind Phase|Protocol Violation|0|||
25244910|NCT01270828|50559995|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
25244911|NCT01270828|50559996|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
25244912|NCT01270828|50559997|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
25244913|NCT01270828|50559995|FG000|Double Blind Phase|Reason Unspecified|7|||
25244914|NCT01270828|50559996|FG001|Double Blind Phase|Reason Unspecified|4|||
25244915|NCT01270828|50559997|FG002|Double Blind Phase|Reason Unspecified|0|||
25244916|NCT01270828|50559995|FG000|Double Blind Phase|Withdrawal by Subject|6|||
25244917|NCT01270828|50559996|FG001|Double Blind Phase|Withdrawal by Subject|15|||
25244918|NCT01270828|50559997|FG002|Double Blind Phase|Withdrawal by Subject|0|||
25244919|NCT01270828|50559995|FG000|Double Blind Phase|Lost to Follow-up|1|||
25244920|NCT01270828|50559996|FG001|Double Blind Phase|Lost to Follow-up|2|||
25244921|NCT01270828|50559997|FG002|Double Blind Phase|Lost to Follow-up|0|||
25244922|NCT01270828|50559995|FG000|Double Blind Phase|Lack of Efficacy|2|||
25244923|NCT01270828|50559996|FG001|Double Blind Phase|Lack of Efficacy|11|||
25244924|NCT01270828|50559997|FG002|Double Blind Phase|Lack of Efficacy|0|||
25244925|NCT01270828|50559995|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
25244926|NCT01270828|50559996|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
25244927|NCT01270828|50559997|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
25244928|NCT01270828|50559995|FG000|Double Blind Phase|Adverse event related to study drug|5|||
25244929|NCT01270828|50559996|FG001|Double Blind Phase|Adverse event related to study drug|7|||
25244930|NCT01270828|50559997|FG002|Double Blind Phase|Adverse event related to study drug|0|||
25244931|NCT01269385|50560005|FG000|Overall Study|Adverse Event|1|||
25244932|NCT01269385|50560006|FG001|Overall Study|Adverse Event|1|||
25244933|NCT01269385|50560007|FG002|Overall Study|Adverse Event|0|||
25244934|NCT01269385|50560008|FG003|Overall Study|Adverse Event|0|||
25244935|NCT01268683|50560018|FG000|Overall Study|Lost to Follow-up|1|||
25244936|NCT01268683|50560018|FG000|Overall Study|Death|1|||
25244937|NCT01268566|50560022|FG000|Overall Study|Lost to Follow-up|1|||
25244938|NCT01268566|50560022|FG000|Overall Study|Withdrawal by Subject|12|||
25244939|NCT01268566|50560022|FG000|Overall Study|Death|30|||
25244940|NCT01268488|50560026|FG000|Overall Study|Adverse Event|3|||
25244941|NCT01268488|50560026|FG000|Overall Study|Physician Decision|2|||
25244942|NCT01268098|50560033|FG000|Overall Study|Adverse Event|1|||
25244943|NCT01268098|50560034|FG001|Overall Study|Adverse Event|0|||
25323990|NCT00542425|50640025|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
25323991|NCT00542425|50640026|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
25323992|NCT00542425|50640022|FG000|Initial 24 Weeks|Non-compliance|0|||
25323993|NCT00542425|50640023|FG001|Initial 24 Weeks|Non-compliance|0|||
25244944|NCT01268059|50560044|FG000|Overall Study|Lost to Follow-up|0|||
25244945|NCT01268059|50560045|FG001|Overall Study|Lost to Follow-up|1|||
25244946|NCT01268059|50560046|FG002|Overall Study|Lost to Follow-up|0|||
25244947|NCT01268059|50560047|FG003|Overall Study|Lost to Follow-up|0|||
25244948|NCT01268059|50560044|FG000|Overall Study|Withdrawal by Subject|7|||
25244949|NCT01268059|50560045|FG001|Overall Study|Withdrawal by Subject|4|||
25244950|NCT01268059|50560046|FG002|Overall Study|Withdrawal by Subject|0|||
25244951|NCT01268059|50560047|FG003|Overall Study|Withdrawal by Subject|0|||
25244952|NCT01268059|50560044|FG000|Overall Study|Death|20|||
25244953|NCT01268059|50560045|FG001|Overall Study|Death|30|||
25244954|NCT01268059|50560046|FG002|Overall Study|Death|3|||
25244955|NCT01268059|50560047|FG003|Overall Study|Death|5|||
25323994|NCT00542425|50640024|FG002|Initial 24 Weeks|Non-compliance|0|||
25323995|NCT00542425|50640025|FG003|Initial 24 Weeks|Non-compliance|1|||
25244956|NCT01268059|50560044|FG000|Overall Study|Progression of disease|1|||
25244957|NCT01268059|50560045|FG001|Overall Study|Progression of disease|0|||
25244958|NCT01268059|50560046|FG002|Overall Study|Progression of disease|0|||
25244959|NCT01268059|50560047|FG003|Overall Study|Progression of disease|0|||
25244960|NCT01267825|50560062|FG000|Overall Study|study terminated. no data collected.|1|||
25244961|NCT01267825|50560063|FG001|Overall Study|study terminated. no data collected.|0|||
25244962|NCT01260181|50560069|FG000|Overall Study|Decision of Investigator|1|||
25244963|NCT01260142|50560079|FG000|Treatment Period 1|Study on hold|1|||
25244964|NCT01260142|50560080|FG001|Treatment Period 1|Study on hold|1|||
25244965|NCT01260142|50560081|FG002|Treatment Period 1|Study on hold|0|||
25244966|NCT01260142|50560082|FG003|Treatment Period 1|Study on hold|0|||
25244967|NCT01260142|50560083|FG004|Treatment Period 1|Study on hold|1|||
25244968|NCT01260142|50560084|FG005|Treatment Period 1|Study on hold|2|||
25244969|NCT01260142|50560079|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
25244970|NCT01260142|50560080|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
25244971|NCT01260142|50560081|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
25244972|NCT01260142|50560082|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
25244973|NCT01260142|50560083|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
25244974|NCT01260142|50560084|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
25244975|NCT01260142|50560079|FG000|Treatment Period 1|Withdrawal by Subject|0|||
25244976|NCT01260142|50560080|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25244977|NCT01260142|50560081|FG002|Treatment Period 1|Withdrawal by Subject|0|||
25244978|NCT01260142|50560082|FG003|Treatment Period 1|Withdrawal by Subject|0|||
25244979|NCT01260142|50560083|FG004|Treatment Period 1|Withdrawal by Subject|0|||
25244980|NCT01260142|50560084|FG005|Treatment Period 1|Withdrawal by Subject|1|||
25244981|NCT01259869|50560104|FG000|Overall Study|Duplicated registration|1|||
25244982|NCT01259713|50560110|FG000|Overall Study|Adverse Event|54|||
25244983|NCT01259713|50560111|FG001|Overall Study|Adverse Event|23|||
25244984|NCT01259713|50560110|FG000|Overall Study|Death Not Related to IFI|8|||
25244985|NCT01259713|50560111|FG001|Overall Study|Death Not Related to IFI|1|||
25244986|NCT01259713|50560110|FG000|Overall Study|Investigators Discretion|14|||
25244987|NCT01259713|50560111|FG001|Overall Study|Investigators Discretion|6|||
25244988|NCT01259713|50560110|FG000|Overall Study|Lack of Efficacy|2|||
25244989|NCT01259713|50560111|FG001|Overall Study|Lack of Efficacy|0|||
25244990|NCT01259713|50560110|FG000|Overall Study|Protocol Violation|5|||
25244991|NCT01259713|50560111|FG001|Overall Study|Protocol Violation|4|||
25244992|NCT01259713|50560110|FG000|Overall Study|Subject Withdrew Consent|12|||
25323996|NCT00542425|50640026|FG004|Initial 24 Weeks|Non-compliance|1|||
25323997|NCT00542425|50640022|FG000|Initial 24 Weeks|Protocol Violation|0|||
25323998|NCT00542425|50640023|FG001|Initial 24 Weeks|Protocol Violation|0|||
25323999|NCT00542425|50640024|FG002|Initial 24 Weeks|Protocol Violation|0|||
25244993|NCT01259713|50560111|FG001|Overall Study|Subject Withdrew Consent|7|||
25244994|NCT01259401|50560119|FG000|4-month Follow-up|Death|0|||
25244995|NCT01259401|50560120|FG001|4-month Follow-up|Death|1|||
25244996|NCT01259401|50560119|FG000|4-month Follow-up|Lost to Follow-up|0|||
25244997|NCT01259401|50560120|FG001|4-month Follow-up|Lost to Follow-up|1|||
25244998|NCT01313923|50560135|FG000|Overall Study|Physician Decision|3|||
25324000|NCT00542425|50640025|FG003|Initial 24 Weeks|Protocol Violation|1|||
25324001|NCT00542425|50640026|FG004|Initial 24 Weeks|Protocol Violation|0|||
25324002|NCT00542425|50640022|FG000|Initial 24 Weeks|Refusal of treatment|2|||
25324003|NCT00542425|50640023|FG001|Initial 24 Weeks|Refusal of treatment|2|||
25324004|NCT00542425|50640024|FG002|Initial 24 Weeks|Refusal of treatment|1|||
25324005|NCT00542425|50640025|FG003|Initial 24 Weeks|Refusal of treatment|4|||
25324006|NCT00542425|50640026|FG004|Initial 24 Weeks|Refusal of treatment|1|||
25324007|NCT00542425|50640022|FG000|Initial 24 Weeks|Other|0|||
25324008|NCT00542425|50640023|FG001|Initial 24 Weeks|Other|2|||
25324009|NCT00542425|50640024|FG002|Initial 24 Weeks|Other|1|||
25324010|NCT00542425|50640025|FG003|Initial 24 Weeks|Other|0|||
25324011|NCT00542425|50640026|FG004|Initial 24 Weeks|Other|0|||
25324012|NCT00542425|50640022|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
25324013|NCT00542425|50640023|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
25324014|NCT00542425|50640024|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
25324015|NCT00542425|50640025|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
25324016|NCT00542425|50640026|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
25324017|NCT00542425|50640022|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
25324018|NCT00542425|50640023|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
25324019|NCT00542425|50640024|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
25324020|NCT00542425|50640025|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
25324021|NCT00542425|50640026|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
25324022|NCT00542425|50640022|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
25324023|NCT00542425|50640023|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
25324024|NCT00542425|50640024|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
25324025|NCT00542425|50640025|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
25324026|NCT00542425|50640026|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
25324027|NCT00542425|50640022|FG000|Extended 24 Weeks of Treatment|Other|1|||
25324028|NCT00542425|50640023|FG001|Extended 24 Weeks of Treatment|Other|1|||
25324029|NCT00542425|50640024|FG002|Extended 24 Weeks of Treatment|Other|0|||
25324030|NCT00542425|50640025|FG003|Extended 24 Weeks of Treatment|Other|0|||
25324031|NCT00542425|50640026|FG004|Extended 24 Weeks of Treatment|Other|1|||
25324032|NCT00541099|50640038|FG000|Overall Study|Ineligible|3|||
25324033|NCT00580606|50640044|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
25324034|NCT00580606|50640045|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
25324035|NCT00580606|50640044|FG000|Open Label (OL)|Withdrawal by Subject|4|||
25324036|NCT00580606|50640045|FG001|Open Label (OL)|Withdrawal by Subject|6|||
25244999|NCT01313884|50560139|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
25245000|NCT01135459|50560145|FG000|Overall Study|Adverse Event|8|||
25245001|NCT01135459|50560146|FG001|Overall Study|Adverse Event|10|||
25245002|NCT01135459|50560145|FG000|Overall Study|Lack of Efficacy|3|||
25245003|NCT01135459|50560146|FG001|Overall Study|Lack of Efficacy|1|||
25245004|NCT01135459|50560145|FG000|Overall Study|Withdrawal by Subject|2|||
25245005|NCT01135459|50560146|FG001|Overall Study|Withdrawal by Subject|3|||
25245006|NCT01135459|50560145|FG000|Overall Study|Protocol Violation|5|||
25245007|NCT01135459|50560146|FG001|Overall Study|Protocol Violation|3|||
25245008|NCT01135459|50560145|FG000|Overall Study|Lost to Follow-up|2|||
25245009|NCT01135459|50560146|FG001|Overall Study|Lost to Follow-up|1|||
25245010|NCT01135459|50560145|FG000|Overall Study|Non-compliance to study procedures|0|||
25245011|NCT01135459|50560146|FG001|Overall Study|Non-compliance to study procedures|1|||
25245012|NCT01135459|50560145|FG000|Overall Study|Other than specified|1|||
25245013|NCT01135459|50560146|FG001|Overall Study|Other than specified|1|||
25245014|NCT01259284|50560155|FG000|Overall Study|Study Termination|2|||
25245015|NCT01259284|50560156|FG001|Overall Study|Study Termination|0|||
25245016|NCT01259284|50560157|FG002|Overall Study|Study Termination|0|||
25245017|NCT01259245|50560167|FG000|Overall Study|Withdrawal by Subject|27|||
25245018|NCT01259245|50560168|FG001|Overall Study|Withdrawal by Subject|24|||
25245019|NCT01259245|50560167|FG000|Overall Study|Death|1|||
25245020|NCT01259245|50560168|FG001|Overall Study|Death|2|||
25245021|NCT01259089|50560176|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
25245022|NCT01259089|50560177|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
25245023|NCT01259089|50560178|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
25245024|NCT01259089|50560179|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
25245025|NCT01259089|50560180|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
25245026|NCT01259089|50560181|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
25245027|NCT01259089|50560176|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
25245028|NCT01259089|50560177|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
25324037|NCT00580606|50640044|FG000|Open Label (OL)|Dosing Symptoms|0|||
25324038|NCT00580606|50640045|FG001|Open Label (OL)|Dosing Symptoms|1|||
25324039|NCT00580606|50640044|FG000|Open Label (OL)|Lost to Follow-up|0|||
25324040|NCT00580606|50640045|FG001|Open Label (OL)|Lost to Follow-up|1|||
25324041|NCT00580606|50640044|FG000|Open Label (OL)|Pregnancy|0|||
25324042|NCT00580606|50640045|FG001|Open Label (OL)|Pregnancy|1|||
25324043|NCT00580606|50640044|FG000|Open Label (OL)|Non-compliance|2|||
25324044|NCT00580606|50640045|FG001|Open Label (OL)|Non-compliance|0|||
25245029|NCT01259089|50560178|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
25245030|NCT01259089|50560179|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
25245031|NCT01259089|50560180|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
25245032|NCT01259089|50560181|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
25245033|NCT01259089|50560176|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
25245034|NCT01259089|50560177|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
25245035|NCT01259089|50560178|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
25245036|NCT01259089|50560179|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
25245037|NCT01259089|50560180|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
25245038|NCT01259089|50560181|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
25245039|NCT01259089|50560176|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
25324045|NCT00580606|50640044|FG000|Open Label (OL)|Physician Decision|1|||
25324046|NCT00580606|50640045|FG001|Open Label (OL)|Physician Decision|1|||
25324047|NCT00580606|50640044|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
25324048|NCT00580606|50640045|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
25324049|NCT00579982|50640059|FG000|Overall Study|Adverse Event|4|||
25077709|NCT01679613|50185586|FG000|Overall Study|other than stated above|0|||
25077710|NCT01679613|50185587|FG001|Overall Study|other than stated above|1|||
25077711|NCT01679613|50185588|FG002|Overall Study|other than stated above|2|||
25077712|NCT01679613|50185589|FG003|Overall Study|other than stated above|2|||
25077713|NCT02489630|50185598|FG000|Overall Study|Oversedation|1|||
25077714|NCT02489630|50185599|FG001|Overall Study|Oversedation|1|||
25077715|NCT02489630|50185598|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
25077716|NCT02489630|50185599|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
25077717|NCT02739347|50185607|FG000|Overall Study|Adverse Event|3|||
25077718|NCT02739347|50185608|FG001|Overall Study|Adverse Event|0|||
25077719|NCT02739347|50185607|FG000|Overall Study|Protocol Violation|0|||
25077720|NCT02739347|50185608|FG001|Overall Study|Protocol Violation|1|||
25077721|NCT02739347|50185607|FG000|Overall Study|Lost to Follow-up|0|||
25077722|NCT02739347|50185608|FG001|Overall Study|Lost to Follow-up|2|||
25077723|NCT02435966|50185617|FG000|Overall Study|Withdrawal by Subject|0|||
25077724|NCT02435966|50185618|FG001|Overall Study|Withdrawal by Subject|1|||
25077725|NCT02435966|50185619|FG002|Overall Study|Withdrawal by Subject|0|||
25077726|NCT01679301|50185627|FG000|Screening Period|screen failure|3|||
25324050|NCT00579982|50640059|FG000|Overall Study|Protocol Violation|4|||
25324051|NCT00596466|50640063|FG000|Overall Study|Lack of Efficacy|5|||
25324052|NCT00596466|50640063|FG000|Overall Study|Adverse Event|4|||
25324053|NCT00596466|50640063|FG000|Overall Study|Withdrawal by Subject|2|||
25324054|NCT00596466|50640063|FG000|Overall Study|Protocol Violation|2|||
25324055|NCT00596466|50640063|FG000|Overall Study|Unpecified|2|||
25324056|NCT00596466|50640063|FG000|Overall Study|Enrolled, not treated|2|||
25324057|NCT00596934|50640067|FG000|Overall Study|Protocol Violation|1|||
25324058|NCT00596934|50640067|FG000|Overall Study|Withdrawal by Subject|1|||
25324059|NCT03911401|50640076|FG000|Overall Study|Adverse Event|1|||
25324060|NCT03911401|50640077|FG001|Overall Study|Adverse Event|2|||
25324061|NCT03911401|50640078|FG002|Overall Study|Adverse Event|5|||
25324062|NCT03911401|50640076|FG000|Overall Study|Lack of Efficacy|1|||
25324063|NCT03911401|50640077|FG001|Overall Study|Lack of Efficacy|1|||
25324064|NCT03911401|50640078|FG002|Overall Study|Lack of Efficacy|8|||
25324065|NCT03911401|50640076|FG000|Overall Study|Physician Decision|0|||
25324066|NCT03911401|50640077|FG001|Overall Study|Physician Decision|0|||
25077727|NCT01679301|50185628|FG001|Screening Period|screen failure|0|||
25077728|NCT01679301|50185629|FG002|Screening Period|screen failure|0|||
25077729|NCT01678911|50185635|FG000|Second Intervention|Lost to Follow-up|2|||
25077730|NCT01678911|50185636|FG001|Second Intervention|Lost to Follow-up|0|||
25077731|NCT02487446|50185642|FG000|Period 1|Physician Decision|0|||
25077732|NCT02487446|50185643|FG001|Period 1|Physician Decision|1|||
25077733|NCT02487446|50185642|FG000|Period 1|Lack of Efficacy|1|||
25077734|NCT02487446|50185643|FG001|Period 1|Lack of Efficacy|0|||
25077735|NCT02487446|50185642|FG000|Period 1|Protocol deviation|3|||
25077736|NCT02487446|50185643|FG001|Period 1|Protocol deviation|2|||
25077737|NCT02487446|50185642|FG000|Period 1|Lost to Follow-up|2|||
25077738|NCT02487446|50185643|FG001|Period 1|Lost to Follow-up|0|||
25077739|NCT02487446|50185642|FG000|Period 1|Withdrawal by Subject|2|||
25077740|NCT02487446|50185643|FG001|Period 1|Withdrawal by Subject|0|||
25077741|NCT02487446|50185642|FG000|Period 1|Adverse Event|5|||
25077742|NCT02487446|50185643|FG001|Period 1|Adverse Event|5|||
25245040|NCT01259089|50560177|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
25245041|NCT01259089|50560178|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
25245042|NCT01259089|50560179|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
25324067|NCT03911401|50640078|FG002|Overall Study|Physician Decision|1|||
25324068|NCT03911401|50640076|FG000|Overall Study|Withdrawal by Subject|1|||
25324069|NCT03911401|50640077|FG001|Overall Study|Withdrawal by Subject|2|||
25324070|NCT03911401|50640078|FG002|Overall Study|Withdrawal by Subject|0|||
25324071|NCT03911401|50640076|FG000|Overall Study|Withdrawal by parent/guardian|4|||
25077743|NCT02487446|50185642|FG000|Washout|Lost to Follow-up|0|||
25077744|NCT02487446|50185643|FG001|Washout|Lost to Follow-up|2|||
25077745|NCT02487446|50185642|FG000|Washout|Withdrawal by Subject|1|||
25077746|NCT02487446|50185643|FG001|Washout|Withdrawal by Subject|4|||
25077747|NCT02487446|50185642|FG000|Washout|Adverse Event|2|||
25077748|NCT02487446|50185643|FG001|Washout|Adverse Event|2|||
25077749|NCT02487446|50185642|FG000|Period 2|Protocol deviation|0|||
25245043|NCT01259089|50560180|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
25245044|NCT01259089|50560181|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
25245045|NCT01259089|50560176|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
25245046|NCT01259089|50560177|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
25245047|NCT01259089|50560178|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
25245048|NCT01259089|50560179|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
25245049|NCT01259089|50560180|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
25245050|NCT01259089|50560181|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
25245051|NCT01259089|50560176|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
25245052|NCT01259089|50560177|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
25245053|NCT01259089|50560178|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
25245054|NCT01259089|50560179|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
25245055|NCT01259089|50560180|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
25245056|NCT01259089|50560181|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
25245057|NCT01259089|50560176|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
25245058|NCT01259089|50560177|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
25245059|NCT01259089|50560178|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
25245060|NCT01259089|50560179|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
25245061|NCT01259089|50560180|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
25245062|NCT01259089|50560181|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
25245063|NCT01259089|50560176|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
25245064|NCT01259089|50560177|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
25245065|NCT01259089|50560178|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
25245066|NCT01259089|50560179|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
25245067|NCT01259089|50560180|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
25245068|NCT01259089|50560181|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
25245069|NCT01259089|50560176|FG000|Survival Follow up for Two Years|Death|3|||
25245070|NCT01259089|50560177|FG001|Survival Follow up for Two Years|Death|2|||
25245071|NCT01259089|50560178|FG002|Survival Follow up for Two Years|Death|2|||
25245072|NCT01259089|50560179|FG003|Survival Follow up for Two Years|Death|3|||
25245073|NCT01259089|50560180|FG004|Survival Follow up for Two Years|Death|6|||
25245074|NCT01259089|50560181|FG005|Survival Follow up for Two Years|Death|13|||
25245075|NCT01259089|50560176|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
25245076|NCT01259089|50560177|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
25245077|NCT01259089|50560178|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
25245078|NCT01259089|50560179|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
25245079|NCT01259089|50560180|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
25245080|NCT01259089|50560181|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
25245081|NCT01259089|50560176|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
25245082|NCT01259089|50560177|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
25245083|NCT01259089|50560178|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
25324072|NCT03911401|50640077|FG001|Overall Study|Withdrawal by parent/guardian|4|||
25324073|NCT03911401|50640078|FG002|Overall Study|Withdrawal by parent/guardian|11|||
25324074|NCT00579670|50640091|FG000|Overall Study|Death|1|||
25324075|NCT00579670|50640092|FG001|Overall Study|Death|0|||
25324076|NCT00579670|50640093|FG002|Overall Study|Death|0|||
25324077|NCT00579670|50640094|FG003|Overall Study|Death|0|||
25324078|NCT00579670|50640095|FG004|Overall Study|Death|0|||
25324079|NCT00579670|50640091|FG000|Overall Study|Adverse Event|1|||
25245084|NCT01259089|50560179|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
25245085|NCT01259089|50560180|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
25245086|NCT01259089|50560181|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
25245087|NCT01258738|50560197|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
25245088|NCT01258738|50560198|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
25245089|NCT01258738|50560197|FG000|Double-blind Period|Withdrawal by Subject|2|||
25245090|NCT01258738|50560198|FG001|Double-blind Period|Withdrawal by Subject|2|||
25245091|NCT01258738|50560197|FG000|Double-blind Period|Protocol Violation|1|||
25245092|NCT01258738|50560198|FG001|Double-blind Period|Protocol Violation|1|||
25324080|NCT00579670|50640092|FG001|Overall Study|Adverse Event|0|||
25324081|NCT00579670|50640093|FG002|Overall Study|Adverse Event|1|||
25324082|NCT00579670|50640094|FG003|Overall Study|Adverse Event|2|||
25077750|NCT02487446|50185643|FG001|Period 2|Protocol deviation|1|||
25077751|NCT02487446|50185642|FG000|Period 2|Lost to Follow-up|1|||
25324083|NCT00579670|50640095|FG004|Overall Study|Adverse Event|0|||
25245093|NCT01258738|50560197|FG000|Double-blind Period|Adverse Event|3|||
25245094|NCT01258738|50560198|FG001|Double-blind Period|Adverse Event|1|||
25245095|NCT01258738|50560197|FG000|Open-label Period|Did not meet inclusion criteria|0|||
25245096|NCT01258738|50560198|FG001|Open-label Period|Did not meet inclusion criteria|1|||
25245097|NCT01258738|50560197|FG000|Open-label Period|Insufficient clinical response|5|||
25245098|NCT01258738|50560198|FG001|Open-label Period|Insufficient clinical response|3|||
25245099|NCT01258738|50560197|FG000|Open-label Period|Lost to Follow-up|0|||
25245100|NCT01258738|50560198|FG001|Open-label Period|Lost to Follow-up|2|||
25245101|NCT01258738|50560197|FG000|Open-label Period|Withdrawal by Subject|5|||
25245102|NCT01258738|50560198|FG001|Open-label Period|Withdrawal by Subject|6|||
25245103|NCT01258738|50560197|FG000|Open-label Period|Protocol Violation|2|||
25245104|NCT01258738|50560198|FG001|Open-label Period|Protocol Violation|2|||
25245105|NCT01258738|50560197|FG000|Open-label Period|Adverse Event|4|||
25245106|NCT01258738|50560198|FG001|Open-label Period|Adverse Event|5|||
25245107|NCT01258738|50560197|FG000|Open-label Period|Other Reasons|0|||
25245108|NCT01258738|50560198|FG001|Open-label Period|Other Reasons|1|||
25245109|NCT01258738|50560197|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
25245110|NCT01258738|50560198|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
25245111|NCT01258660|50560206|FG000|Overall Study|Adverse Event|2|||
25245112|NCT01258660|50560207|FG001|Overall Study|Adverse Event|4|||
25245113|NCT01258660|50560206|FG000|Overall Study|Withdrawal by Subject|3|||
25245114|NCT01258660|50560207|FG001|Overall Study|Withdrawal by Subject|0|||
25245115|NCT01258660|50560206|FG000|Overall Study|due to relocation|2|||
25245116|NCT01258660|50560207|FG001|Overall Study|due to relocation|0|||
25245117|NCT01258660|50560206|FG000|Overall Study|Protocol Violation|0|||
25245118|NCT01258660|50560207|FG001|Overall Study|Protocol Violation|1|||
25245119|NCT01258660|50560206|FG000|Overall Study|Invalid for primary analysis data set|4|||
25245120|NCT01258660|50560207|FG001|Overall Study|Invalid for primary analysis data set|6|||
25245121|NCT01258348|50560214|FG000|Overall Study|Adverse Event|1|||
25245122|NCT01258348|50560215|FG001|Overall Study|Adverse Event|1|||
25245123|NCT01258348|50560216|FG002|Overall Study|Adverse Event|3|||
25245124|NCT01258348|50560217|FG003|Overall Study|Adverse Event|2|||
25245125|NCT01258348|50560218|FG004|Overall Study|Adverse Event|4|||
25245126|NCT01258348|50560214|FG000|Overall Study|Progressive Disease|0|||
25245127|NCT01258348|50560215|FG001|Overall Study|Progressive Disease|3|||
25245128|NCT01258348|50560216|FG002|Overall Study|Progressive Disease|0|||
25245129|NCT01258348|50560217|FG003|Overall Study|Progressive Disease|2|||
25245130|NCT01258348|50560218|FG004|Overall Study|Progressive Disease|2|||
25245131|NCT01258348|50560214|FG000|Overall Study|Physician Decision|0|||
25245132|NCT01258348|50560215|FG001|Overall Study|Physician Decision|0|||
25245133|NCT01258348|50560216|FG002|Overall Study|Physician Decision|0|||
25245134|NCT01258348|50560217|FG003|Overall Study|Physician Decision|2|||
25245135|NCT01258348|50560218|FG004|Overall Study|Physician Decision|0|||
25245136|NCT01258348|50560214|FG000|Overall Study|Withdrawal by Subject|0|||
25245137|NCT01258348|50560215|FG001|Overall Study|Withdrawal by Subject|1|||
25245138|NCT01258348|50560216|FG002|Overall Study|Withdrawal by Subject|0|||
25245139|NCT01258348|50560217|FG003|Overall Study|Withdrawal by Subject|0|||
25245140|NCT01258348|50560218|FG004|Overall Study|Withdrawal by Subject|0|||
25245141|NCT01258075|50560234|FG000|Overall Study|Adverse Event|8|||
25245142|NCT01258075|50560235|FG001|Overall Study|Adverse Event|3|||
25245143|NCT01258075|50560234|FG000|Overall Study|Lost to Follow-up|11|||
25245144|NCT01258075|50560235|FG001|Overall Study|Lost to Follow-up|6|||
25245145|NCT01258075|50560234|FG000|Overall Study|Withdrawal by Subject|10|||
25245146|NCT01258075|50560235|FG001|Overall Study|Withdrawal by Subject|7|||
25245147|NCT01258075|50560234|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
25245148|NCT01258075|50560235|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
25245149|NCT01258075|50560234|FG000|Overall Study|Other|12|||
25245150|NCT01258075|50560235|FG001|Overall Study|Other|5|||
25245151|NCT01257568|50560241|FG000|Overall Study|Lost to Follow-up|2|||
25245152|NCT01257568|50560241|FG000|Overall Study|Withdrawal by Subject|6|||
25324084|NCT00579670|50640091|FG000|Overall Study|Lack of Efficacy|0|||
25324085|NCT00579670|50640092|FG001|Overall Study|Lack of Efficacy|0|||
25324086|NCT00579670|50640093|FG002|Overall Study|Lack of Efficacy|1|||
25324087|NCT00579670|50640094|FG003|Overall Study|Lack of Efficacy|14|||
25324088|NCT00579670|50640095|FG004|Overall Study|Lack of Efficacy|0|||
25324089|NCT00579670|50640091|FG000|Overall Study|Lost to Follow-up|0|||
25245153|NCT01257568|50560241|FG000|Overall Study|Terminated|1|||
25245154|NCT01257568|50560241|FG000|Overall Study|Component Revision|24|||
25245155|NCT01256788|50560250|FG000|Overall Study|Lost to Follow-up|5|||
25324090|NCT00579670|50640092|FG001|Overall Study|Lost to Follow-up|1|||
25324091|NCT00579670|50640093|FG002|Overall Study|Lost to Follow-up|0|||
25245156|NCT01256788|50560251|FG001|Overall Study|Lost to Follow-up|8|||
25245157|NCT01256788|50560252|FG002|Overall Study|Lost to Follow-up|3|||
25245158|NCT01256671|50560260|FG000|Overall Study|Adverse Event|29|||
25245159|NCT01256671|50560260|FG000|Overall Study|Lost to Follow-up|16|||
25324092|NCT00579670|50640094|FG003|Overall Study|Lost to Follow-up|4|||
25324093|NCT00579670|50640095|FG004|Overall Study|Lost to Follow-up|0|||
25324094|NCT00579670|50640091|FG000|Overall Study|Other|0|||
25324095|NCT00579670|50640092|FG001|Overall Study|Other|0|||
25324096|NCT00579670|50640093|FG002|Overall Study|Other|1|||
25324097|NCT00579670|50640094|FG003|Overall Study|Other|2|||
25324098|NCT00579670|50640095|FG004|Overall Study|Other|0|||
25324099|NCT00579670|50640091|FG000|Overall Study|Withdrawal by Subject|0|||
25324100|NCT00579670|50640092|FG001|Overall Study|Withdrawal by Subject|0|||
25324101|NCT00579670|50640093|FG002|Overall Study|Withdrawal by Subject|1|||
25324102|NCT00579670|50640094|FG003|Overall Study|Withdrawal by Subject|0|||
25324103|NCT00579670|50640095|FG004|Overall Study|Withdrawal by Subject|0|||
25324104|NCT03909295|50640119|FG000|Overall Study|Adverse Event|2|||
25324105|NCT03909295|50640119|FG000|Overall Study|Study terminated by sponsor|50|||
25324106|NCT00599924|50640130|FG000|Overall Study|Lack of Efficacy|3|||
25324107|NCT00599924|50640131|FG001|Overall Study|Lack of Efficacy|5|||
25324108|NCT00599924|50640132|FG002|Overall Study|Lack of Efficacy|1|||
25324109|NCT00599924|50640133|FG003|Overall Study|Lack of Efficacy|2|||
25324110|NCT00599924|50640134|FG004|Overall Study|Lack of Efficacy|3|||
25324111|NCT00599924|50640135|FG005|Overall Study|Lack of Efficacy|2|||
25324112|NCT00599924|50640136|FG006|Overall Study|Lack of Efficacy|0|||
25324113|NCT00599924|50640130|FG000|Overall Study|Adverse Event|0|||
25245160|NCT01256671|50560260|FG000|Overall Study|Withdrawal by Subject|31|||
25245161|NCT01256671|50560260|FG000|Overall Study|Physician Decision|3|||
25245162|NCT01256671|50560260|FG000|Overall Study|Lack of Efficacy|4|||
25245163|NCT01256671|50560260|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
25245164|NCT01256593|50560264|FG000|Overall Study|Protocol Violation|26|||
25245165|NCT01256593|50560264|FG000|Overall Study|No Drug Administration Information|2|||
25245166|NCT01256593|50560264|FG000|Overall Study|No Visit After Treatment|186|||
25324114|NCT00599924|50640131|FG001|Overall Study|Adverse Event|0|||
25324115|NCT00599924|50640132|FG002|Overall Study|Adverse Event|0|||
25324116|NCT00599924|50640133|FG003|Overall Study|Adverse Event|2|||
25324117|NCT00599924|50640134|FG004|Overall Study|Adverse Event|0|||
25324118|NCT00599924|50640135|FG005|Overall Study|Adverse Event|0|||
25245167|NCT01256476|50560270|FG000|Overall Study|Adverse Event|2|||
25245168|NCT01256476|50560271|FG001|Overall Study|Adverse Event|1|||
25245169|NCT01256476|50560270|FG000|Overall Study|Withdrawal by Subject|2|||
25245170|NCT01256476|50560271|FG001|Overall Study|Withdrawal by Subject|1|||
25245171|NCT01256476|50560270|FG000|Overall Study|Lost to Follow-up|1|||
25245172|NCT01256476|50560271|FG001|Overall Study|Lost to Follow-up|2|||
25245173|NCT01256476|50560270|FG000|Overall Study|Persistent ALT or AST elevation|1|||
25245174|NCT01256476|50560271|FG001|Overall Study|Persistent ALT or AST elevation|0|||
25245175|NCT01256476|50560270|FG000|Overall Study|Physician Decision|0|||
25245176|NCT01256476|50560271|FG001|Overall Study|Physician Decision|1|||
25245177|NCT01256476|50560270|FG000|Overall Study|Subject non-compliance|0|||
25324119|NCT00599924|50640136|FG006|Overall Study|Adverse Event|2|||
25324120|NCT00599924|50640130|FG000|Overall Study|Death|0|||
25324121|NCT00599924|50640131|FG001|Overall Study|Death|0|||
25324122|NCT00599924|50640132|FG002|Overall Study|Death|0|||
25324123|NCT00599924|50640133|FG003|Overall Study|Death|2|||
25324124|NCT00599924|50640134|FG004|Overall Study|Death|0|||
25324125|NCT00599924|50640135|FG005|Overall Study|Death|2|||
25324126|NCT00599924|50640136|FG006|Overall Study|Death|1|||
25324127|NCT00599924|50640130|FG000|Overall Study|Protocol Violation|0|||
25324128|NCT00599924|50640131|FG001|Overall Study|Protocol Violation|0|||
25324129|NCT00599924|50640132|FG002|Overall Study|Protocol Violation|0|||
25324130|NCT00599924|50640133|FG003|Overall Study|Protocol Violation|1|||
25324131|NCT00599924|50640134|FG004|Overall Study|Protocol Violation|0|||
25324132|NCT00599924|50640135|FG005|Overall Study|Protocol Violation|0|||
25324133|NCT00599924|50640136|FG006|Overall Study|Protocol Violation|0|||
25324134|NCT00599924|50640130|FG000|Overall Study|Withdrawal by Subject|0|||
25324135|NCT00599924|50640131|FG001|Overall Study|Withdrawal by Subject|0|||
25324136|NCT00599924|50640132|FG002|Overall Study|Withdrawal by Subject|1|||
25324137|NCT00599924|50640133|FG003|Overall Study|Withdrawal by Subject|0|||
25324138|NCT00599924|50640134|FG004|Overall Study|Withdrawal by Subject|1|||
25324139|NCT00599924|50640135|FG005|Overall Study|Withdrawal by Subject|0|||
25324140|NCT00599924|50640136|FG006|Overall Study|Withdrawal by Subject|0|||
25245178|NCT01256476|50560271|FG001|Overall Study|Subject non-compliance|1|||
25245179|NCT01256476|50560270|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
25245180|NCT01256476|50560271|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
25324141|NCT00599924|50640130|FG000|Overall Study|Other|0|||
25324142|NCT00599924|50640131|FG001|Overall Study|Other|0|||
25324143|NCT00599924|50640132|FG002|Overall Study|Other|0|||
25245181|NCT01256008|50560280|FG000|Overall Study|Lost to Follow-up|6|||
25245182|NCT01256008|50560281|FG001|Overall Study|Lost to Follow-up|4|||
25245183|NCT01256008|50560282|FG002|Overall Study|Lost to Follow-up|11|||
25245184|NCT01256008|50560280|FG000|Overall Study|Withdrawal by Subject|2|||
25324144|NCT00599924|50640133|FG003|Overall Study|Other|1|||
25324145|NCT00599924|50640134|FG004|Overall Study|Other|2|||
25324146|NCT00599924|50640135|FG005|Overall Study|Other|0|||
25324147|NCT00599924|50640136|FG006|Overall Study|Other|2|||
25324148|NCT00581542|50640159|FG000|Overall Study|they met an exclusion criteria|2|||
25324149|NCT00581542|50640160|FG001|Overall Study|they met an exclusion criteria|2|||
25245185|NCT01256008|50560281|FG001|Overall Study|Withdrawal by Subject|3|||
25245186|NCT01256008|50560282|FG002|Overall Study|Withdrawal by Subject|10|||
25245187|NCT01255423|50560294|FG000|Overall Study|Abnormal Laboratory value|3|||
25245188|NCT01255423|50560295|FG001|Overall Study|Abnormal Laboratory value|2|||
25245189|NCT01255423|50560294|FG000|Overall Study|Use of prohibited medications|0|||
25245190|NCT01255423|50560295|FG001|Overall Study|Use of prohibited medications|1|||
25245191|NCT01255306|50560303|FG000|Overall Study|Physician Decision|1|||
25245192|NCT01255306|50560304|FG001|Overall Study|Physician Decision|1|||
25245193|NCT01254721|50560315|FG000|Overall Study|Lost to Follow-up|0|||
25324150|NCT00581542|50640159|FG000|Overall Study|Lost to Follow-up|9|||
25324151|NCT00581542|50640160|FG001|Overall Study|Lost to Follow-up|21|||
25324152|NCT03912337|50640170|FG000|Overall Study|Withdrawal of Consent From Study|1|||
25324153|NCT03912337|50640171|FG001|Overall Study|Withdrawal of Consent From Study|0|||
25324154|NCT03912337|50640170|FG000|Overall Study|Lost to Follow-up|1|||
25324155|NCT03912337|50640171|FG001|Overall Study|Lost to Follow-up|1|||
25324156|NCT03912259|50640179|FG000|Overall Study|Adverse Event (AE)|2|||
25324157|NCT03912259|50640180|FG001|Overall Study|Adverse Event (AE)|4|||
25324158|NCT03912259|50640179|FG000|Overall Study|Lack of Efficacy|4|||
25324159|NCT03912259|50640180|FG001|Overall Study|Lack of Efficacy|1|||
25324160|NCT03912259|50640179|FG000|Overall Study|Withdrawal by Subject|11|||
25324161|NCT03912259|50640180|FG001|Overall Study|Withdrawal by Subject|1|||
25324162|NCT02121652|50640189|FG000|Overall Study|Lost to Follow-up|2|||
25324163|NCT02121652|50640190|FG001|Overall Study|Lost to Follow-up|1|||
25324164|NCT02121652|50640189|FG000|Overall Study|Death|1|||
25324165|NCT02121652|50640190|FG001|Overall Study|Death|0|||
25324166|NCT02121652|50640189|FG000|Overall Study|Withdrawal by Subject|3|||
25324167|NCT02121652|50640190|FG001|Overall Study|Withdrawal by Subject|3|||
25324168|NCT00595920|50640209|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
25324169|NCT00595764|50640215|FG000|Overall Study|Protocol Violation|24|||
25324170|NCT00595764|50640216|FG001|Overall Study|Protocol Violation|19|||
25324171|NCT00595764|50640215|FG000|Overall Study|Missed Medication >1 week|10|||
25324172|NCT00595764|50640216|FG001|Overall Study|Missed Medication >1 week|17|||
25324173|NCT00595764|50640215|FG000|Overall Study|Missed 3 PM visits|1|||
25324174|NCT00595764|50640216|FG001|Overall Study|Missed 3 PM visits|7|||
25324175|NCT00595764|50640215|FG000|Overall Study|Withdrawal by Subject|4|||
25324176|NCT00595764|50640216|FG001|Overall Study|Withdrawal by Subject|0|||
25324177|NCT00581308|50640236|FG000|Pre Discharge|Lost to Follow-up|1|||
25324178|NCT00581308|50640236|FG000|Pre Discharge|Device Removed|1|||
25324179|NCT00581308|50640236|FG000|Month 1|Lost to Follow-up|3|||
25324180|NCT00581308|50640236|FG000|Month 1|Withdrawal by Subject|2|||
25324181|NCT00581308|50640236|FG000|Month 1|Device Removed|2|||
25324182|NCT00581308|50640236|FG000|Month 1|Uknown|1|||
25324183|NCT00581308|50640236|FG000|Month 6|Lost to Follow-up|1|||
25324184|NCT00581308|50640236|FG000|Month 6|Withdrawal by Subject|2|||
25324185|NCT00581308|50640236|FG000|Month 12|Death|1|||
25324186|NCT00581308|50640236|FG000|Month 12|Lost to Follow-up|14|||
25324187|NCT00581308|50640236|FG000|Month 12|Withdrawal by Subject|3|||
25324188|NCT00581308|50640236|FG000|Month 12|Device Removed|1|||
25324189|NCT00581308|50640236|FG000|Month 12|Other|1|||
25324190|NCT00877890|50640245|FG000|Overall Study|Adverse Event|6|||
25324191|NCT00877890|50640246|FG001|Overall Study|Adverse Event|6|||
25324192|NCT00877890|50640245|FG000|Overall Study|Lost to Follow-up|5|||
25324193|NCT00877890|50640246|FG001|Overall Study|Lost to Follow-up|5|||
25324194|NCT00877890|50640245|FG000|Overall Study|Protocol Violation|0|||
25324195|NCT00877890|50640246|FG001|Overall Study|Protocol Violation|1|||
25324196|NCT00877890|50640245|FG000|Overall Study|Withdrawal of Consent|6|||
25324197|NCT00877890|50640246|FG001|Overall Study|Withdrawal of Consent|12|||
25324198|NCT00877890|50640245|FG000|Overall Study|Investigator Decision|0|||
25077752|NCT02487446|50185643|FG001|Period 2|Lost to Follow-up|1|||
25077753|NCT02487446|50185642|FG000|Period 2|Withdrawal by Subject|1|||
25324199|NCT00877890|50640246|FG001|Overall Study|Investigator Decision|2|||
25324200|NCT00877890|50640245|FG000|Overall Study|Loss of Glucose Control|3|||
25324201|NCT00877890|50640246|FG001|Overall Study|Loss of Glucose Control|4|||
25324202|NCT03474679|50640256|FG000|Overall Study|Death|7|||
25324203|NCT03474679|50640256|FG000|Overall Study|Withdrawal by Subject|1|||
25324204|NCT03472885|50640260|FG000|Overall Study|Adverse Event|1|||
25324205|NCT03905863|50640266|FG000|Overall Study|Adverse Event|2|||
25324206|NCT03905863|50640267|FG001|Overall Study|Adverse Event|4|||
25245194|NCT01254721|50560316|FG001|Overall Study|Lost to Follow-up|4|||
25245195|NCT01254721|50560315|FG000|Overall Study|Lack of Efficacy|4|||
25324207|NCT03905863|50640266|FG000|Overall Study|Withdrawal by Subject|2|||
25324208|NCT03905863|50640267|FG001|Overall Study|Withdrawal by Subject|2|||
25324209|NCT03905863|50640266|FG000|Overall Study|Physician Decision|0|||
25324210|NCT03905863|50640267|FG001|Overall Study|Physician Decision|3|||
25324211|NCT03905863|50640266|FG000|Overall Study|Lost to Follow-up|1|||
25324212|NCT03905863|50640267|FG001|Overall Study|Lost to Follow-up|0|||
25324213|NCT03905863|50640266|FG000|Overall Study|Protocol Violation|0|||
25324214|NCT03905863|50640267|FG001|Overall Study|Protocol Violation|2|||
25324215|NCT03905863|50640266|FG000|Overall Study|Death|0|||
25324216|NCT03905863|50640267|FG001|Overall Study|Death|1|||
25324217|NCT04067011|50640276|FG000|Overall Study|Not Treated|8|||
25324218|NCT04067011|50640277|FG001|Overall Study|Not Treated|7|||
25324219|NCT04067011|50640278|FG002|Overall Study|Not Treated|5|||
25324220|NCT04067011|50640276|FG000|Overall Study|Adverse Event|2|||
25324221|NCT04067011|50640277|FG001|Overall Study|Adverse Event|1|||
25324222|NCT04067011|50640278|FG002|Overall Study|Adverse Event|0|||
25324223|NCT04067011|50640276|FG000|Overall Study|Withdrawal by Subject|6|||
25324224|NCT04067011|50640277|FG001|Overall Study|Withdrawal by Subject|2|||
25324225|NCT04067011|50640278|FG002|Overall Study|Withdrawal by Subject|1|||
25324226|NCT04067011|50640276|FG000|Overall Study|Lost to Follow-up|0|||
25324227|NCT04067011|50640277|FG001|Overall Study|Lost to Follow-up|0|||
25324228|NCT04067011|50640278|FG002|Overall Study|Lost to Follow-up|1|||
25324229|NCT04067011|50640276|FG000|Overall Study|Physician Decision|1|||
25324230|NCT04067011|50640277|FG001|Overall Study|Physician Decision|1|||
25324231|NCT04067011|50640278|FG002|Overall Study|Physician Decision|0|||
25324232|NCT04067011|50640276|FG000|Overall Study|Other Reasons|2|||
25324233|NCT04067011|50640277|FG001|Overall Study|Other Reasons|0|||
25324234|NCT04067011|50640278|FG002|Overall Study|Other Reasons|1|||
25324235|NCT04067011|50640276|FG000|Overall Study|Missing|0|||
25324236|NCT04067011|50640277|FG001|Overall Study|Missing|2|||
25245196|NCT01254721|50560316|FG001|Overall Study|Lack of Efficacy|2|||
25245197|NCT01254721|50560315|FG000|Overall Study|Death|0|||
25245198|NCT01254721|50560316|FG001|Overall Study|Death|1|||
25245199|NCT01254721|50560315|FG000|Overall Study|technical problum|1|||
25245200|NCT01254721|50560316|FG001|Overall Study|technical problum|0|||
25245201|NCT01254721|50560315|FG000|Overall Study|Adverse Event|2|||
25245202|NCT01254721|50560316|FG001|Overall Study|Adverse Event|3|||
25245203|NCT01254721|50560315|FG000|Overall Study|Withdrawal by Subject|8|||
25245204|NCT01254721|50560316|FG001|Overall Study|Withdrawal by Subject|11|||
25245205|NCT01254721|50560315|FG000|Overall Study|Wrongly randomization|0|||
25245206|NCT01254721|50560316|FG001|Overall Study|Wrongly randomization|1|||
25245207|NCT01254643|50560322|FG000|Overall Study|Withdrawal by Subject|1|||
25245208|NCT01254604|50560328|FG000|Overall Study|Lost to Follow-up|1|||
25245209|NCT01254604|50560329|FG001|Overall Study|Lost to Follow-up|1|||
25245210|NCT01254604|50560328|FG000|Overall Study|Protocol Violation|2|||
25245211|NCT01254604|50560329|FG001|Overall Study|Protocol Violation|2|||
25245212|NCT01254604|50560328|FG000|Overall Study|Withdrawal by Subject|2|||
25245213|NCT01254604|50560329|FG001|Overall Study|Withdrawal by Subject|4|||
25245214|NCT01254604|50560328|FG000|Overall Study|Adverse Event|3|||
25245215|NCT01254604|50560329|FG001|Overall Study|Adverse Event|2|||
25245216|NCT01254565|50560341|FG000|Overall Study|Non-compliance to Study Procedures|0|||
25245217|NCT01254565|50560342|FG001|Overall Study|Non-compliance to Study Procedures|0|||
25245218|NCT01254565|50560343|FG002|Overall Study|Non-compliance to Study Procedures|0|||
25245219|NCT01254565|50560344|FG003|Overall Study|Non-compliance to Study Procedures|0|||
25245220|NCT01254565|50560345|FG004|Overall Study|Non-compliance to Study Procedures|1|||
25245221|NCT01254565|50560346|FG005|Overall Study|Non-compliance to Study Procedures|0|||
25245222|NCT01254565|50560341|FG000|Overall Study|Did not Receive Treatment|1|||
25324237|NCT04067011|50640278|FG002|Overall Study|Missing|0|||
25324238|NCT00539305|50640322|FG000|Overall Study|Adverse Event|1|||
25324239|NCT00539305|50640323|FG001|Overall Study|Adverse Event|0|||
25324240|NCT00539305|50640322|FG000|Overall Study|Substance Use|0|||
25324241|NCT00539305|50640323|FG001|Overall Study|Substance Use|1|||
25324242|NCT00539305|50640322|FG000|Overall Study|Withdrawal by Subject|0|||
25077754|NCT02487446|50185643|FG001|Period 2|Withdrawal by Subject|1|||
25245223|NCT01254565|50560342|FG001|Overall Study|Did not Receive Treatment|1|||
25245224|NCT01254565|50560343|FG002|Overall Study|Did not Receive Treatment|0|||
25324243|NCT00539305|50640323|FG001|Overall Study|Withdrawal by Subject|1|||
25324244|NCT00877032|50640355|FG000|Overall Study|Did not meet entrance criteria|0|||
25324245|NCT00877032|50640356|FG001|Overall Study|Did not meet entrance criteria|0|||
25324246|NCT00877032|50640357|FG002|Overall Study|Did not meet entrance criteria|0|||
25324247|NCT00877032|50640358|FG003|Overall Study|Did not meet entrance criteria|1|||
25245225|NCT01254565|50560344|FG003|Overall Study|Did not Receive Treatment|0|||
25245226|NCT01254565|50560345|FG004|Overall Study|Did not Receive Treatment|3|||
25245227|NCT01254565|50560346|FG005|Overall Study|Did not Receive Treatment|4|||
25245228|NCT01254565|50560341|FG000|Overall Study|Other|0|||
25245229|NCT01254565|50560342|FG001|Overall Study|Other|0|||
25245230|NCT01254565|50560343|FG002|Overall Study|Other|0|||
25245231|NCT01254565|50560344|FG003|Overall Study|Other|1|||
25245232|NCT01254565|50560345|FG004|Overall Study|Other|0|||
25245233|NCT01254565|50560346|FG005|Overall Study|Other|0|||
25245234|NCT01254409|50560364|FG000|Overall Study|Adverse Event|0|||
25245235|NCT01254409|50560365|FG001|Overall Study|Adverse Event|1|||
25245236|NCT01254409|50560366|FG002|Overall Study|Adverse Event|0|||
25245237|NCT01254409|50560367|FG003|Overall Study|Adverse Event|0|||
25245238|NCT01254331|50560380|FG000|Initial Phase|Adverse Event|3|||
25245239|NCT01254331|50560380|FG000|Initial Phase|Withdrawal by Subject|1|||
25245240|NCT01254331|50560380|FG000|Initial Phase|Pregnancy|1|||
25245241|NCT01254331|50560380|FG000|Extension Phase|Lack of Efficacy|1|||
25245242|NCT01254331|50560380|FG000|Extension Phase|Lost to Follow-up|3|||
25324248|NCT00877032|50640359|FG004|Overall Study|Did not meet entrance criteria|0|||
25324249|NCT00877032|50640360|FG005|Overall Study|Did not meet entrance criteria|0|||
25324250|NCT00877032|50640361|FG006|Overall Study|Did not meet entrance criteria|2|||
25324251|NCT00538681|50640400|FG000|Overall Study|Progressive Disease|7|||
25324252|NCT00538681|50640401|FG001|Overall Study|Progressive Disease|0|||
25324253|NCT00538681|50640402|FG002|Overall Study|Progressive Disease|1|||
25324254|NCT00538681|50640403|FG003|Overall Study|Progressive Disease|0|||
25324255|NCT00538681|50640400|FG000|Overall Study|Sponsor Decision|1|||
25324256|NCT00538681|50640401|FG001|Overall Study|Sponsor Decision|3|||
25324257|NCT00538681|50640402|FG002|Overall Study|Sponsor Decision|8|||
25324258|NCT00538681|50640403|FG003|Overall Study|Sponsor Decision|9|||
25324259|NCT00538681|50640400|FG000|Overall Study|Adverse Event|1|||
25324260|NCT00538681|50640401|FG001|Overall Study|Adverse Event|1|||
25324261|NCT00538681|50640402|FG002|Overall Study|Adverse Event|1|||
25324262|NCT00538681|50640403|FG003|Overall Study|Adverse Event|0|||
25324263|NCT00538681|50640400|FG000|Overall Study|Death|0|||
25324264|NCT00538681|50640401|FG001|Overall Study|Death|0|||
25324265|NCT00538681|50640402|FG002|Overall Study|Death|1|||
25324266|NCT00538681|50640403|FG003|Overall Study|Death|1|||
25324267|NCT00538681|50640400|FG000|Overall Study|Investigator Decision|0|||
25324268|NCT00538681|50640401|FG001|Overall Study|Investigator Decision|0|||
25324269|NCT00538681|50640402|FG002|Overall Study|Investigator Decision|0|||
25324270|NCT00538681|50640403|FG003|Overall Study|Investigator Decision|1|||
25324271|NCT00876018|50640417|FG000|Overall Study|Lost to Follow-up|0|||
25324272|NCT00876018|50640418|FG001|Overall Study|Lost to Follow-up|1|||
25324273|NCT00876018|50640419|FG002|Overall Study|Lost to Follow-up|1|||
25324274|NCT00876018|50640417|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
25324275|NCT00876018|50640418|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
25324276|NCT00876018|50640419|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
25324277|NCT03885934|50640444|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
25324278|NCT03885934|50640445|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
25324279|NCT03885934|50640446|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
25324280|NCT03885934|50640447|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
25324281|NCT03885934|50640448|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
25324282|NCT03885934|50640449|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
25324283|NCT00875706|50640466|FG000|Overall Study|Withdrawal by Subject|1|||
25324284|NCT00875706|50640467|FG001|Overall Study|Withdrawal by Subject|0|||
25324285|NCT00875706|50640468|FG002|Overall Study|Withdrawal by Subject|0|||
25324286|NCT04399889|50640479|FG000|Overall Study|Death|5|||
25324287|NCT04399889|50640480|FG001|Overall Study|Death|1|||
25324288|NCT04399889|50640481|FG002|Overall Study|Death|1|||
25324289|NCT00837265|50640496|FG000|Pilot Phase|Withdrawal by Subject|0|||
25324290|NCT00837265|50640497|FG001|Pilot Phase|Withdrawal by Subject|2|||
25324291|NCT00837265|50640498|FG002|Pilot Phase|Withdrawal by Subject|3|||
25324292|NCT00837265|50640499|FG003|Pilot Phase|Withdrawal by Subject|2|||
25324293|NCT00837265|50640500|FG004|Pilot Phase|Withdrawal by Subject|0|||
25324294|NCT00837265|50640501|FG005|Pilot Phase|Withdrawal by Subject|0|||
25324295|NCT00837265|50640502|FG006|Pilot Phase|Withdrawal by Subject|0|||
25245243|NCT01254292|50560395|FG000|Comparative Phase|Adverse Event|25|||
25245244|NCT01254292|50560396|FG001|Comparative Phase|Adverse Event|25|||
25324296|NCT00837265|50640496|FG000|Pilot Phase|Decision of the investigator|2|||
25324297|NCT00837265|50640497|FG001|Pilot Phase|Decision of the investigator|1|||
25324298|NCT00837265|50640498|FG002|Pilot Phase|Decision of the investigator|0|||
25245245|NCT01254292|50560395|FG000|Comparative Phase|Lost to Follow-up|3|||
25245246|NCT01254292|50560396|FG001|Comparative Phase|Lost to Follow-up|21|||
25245247|NCT01254292|50560395|FG000|Comparative Phase|Pregnancy|2|||
25245248|NCT01254292|50560396|FG001|Comparative Phase|Pregnancy|6|||
25324299|NCT00837265|50640499|FG003|Pilot Phase|Decision of the investigator|0|||
25324300|NCT00837265|50640500|FG004|Pilot Phase|Decision of the investigator|0|||
25245249|NCT01254292|50560395|FG000|Comparative Phase|Withdrawal by Subject|20|||
25324301|NCT00837265|50640501|FG005|Pilot Phase|Decision of the investigator|0|||
25324302|NCT00837265|50640502|FG006|Pilot Phase|Decision of the investigator|0|||
25324303|NCT00837265|50640496|FG000|Pilot Phase|Adverse Event|1|||
25324304|NCT00837265|50640497|FG001|Pilot Phase|Adverse Event|0|||
25324305|NCT00837265|50640498|FG002|Pilot Phase|Adverse Event|0|||
25324306|NCT00837265|50640499|FG003|Pilot Phase|Adverse Event|0|||
25324307|NCT00837265|50640500|FG004|Pilot Phase|Adverse Event|0|||
25324308|NCT00837265|50640501|FG005|Pilot Phase|Adverse Event|0|||
25324309|NCT00837265|50640502|FG006|Pilot Phase|Adverse Event|0|||
25324310|NCT00837265|50640496|FG000|Pilot Phase|Disease progression|0|||
25324311|NCT00837265|50640497|FG001|Pilot Phase|Disease progression|0|||
25324312|NCT00837265|50640498|FG002|Pilot Phase|Disease progression|0|||
25324313|NCT00837265|50640499|FG003|Pilot Phase|Disease progression|1|||
25324314|NCT00837265|50640500|FG004|Pilot Phase|Disease progression|0|||
25245250|NCT01254292|50560396|FG001|Comparative Phase|Withdrawal by Subject|21|||
25245251|NCT01254292|50560395|FG000|Comparative Phase|Protocol Violation|1|||
25245252|NCT01254292|50560396|FG001|Comparative Phase|Protocol Violation|2|||
25245253|NCT01254292|50560395|FG000|Comparative Phase|Wish for pregnancy|4|||
25245254|NCT01254292|50560396|FG001|Comparative Phase|Wish for pregnancy|6|||
25245255|NCT01254292|50560395|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
25245256|NCT01254292|50560396|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
25245257|NCT01254292|50560395|FG000|LCS12 Extension Phase|Adverse Event|9|||
25245258|NCT01254292|50560396|FG001|LCS12 Extension Phase|Adverse Event|0|||
25245259|NCT01254292|50560395|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
25245260|NCT01254292|50560396|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
25245261|NCT01254292|50560395|FG000|LCS12 Extension Phase|Other unknown|4|||
25245262|NCT01254292|50560396|FG001|LCS12 Extension Phase|Other unknown|0|||
25245263|NCT01254292|50560395|FG000|LCS12 Extension Phase|Pregnancy|2|||
25245264|NCT01254292|50560396|FG001|LCS12 Extension Phase|Pregnancy|0|||
25245265|NCT01254292|50560395|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
25245266|NCT01254292|50560396|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
25245267|NCT01254019|50560405|FG000|Overall Study|Adverse Event|0|||
25245268|NCT01254019|50560406|FG001|Overall Study|Adverse Event|2|||
25245269|NCT01254019|50560405|FG000|Overall Study|Protocol Violation|1|||
25245270|NCT01254019|50560406|FG001|Overall Study|Protocol Violation|0|||
25245271|NCT01254019|50560405|FG000|Overall Study|Withdrawal by Subject|0|||
25245272|NCT01254019|50560406|FG001|Overall Study|Withdrawal by Subject|2|||
25245273|NCT01253317|50560415|FG000|Overall Study|Adverse Event|2|||
25245274|NCT01253200|50560428|FG000|Overall Study|Death|1|||
25245275|NCT01253200|50560429|FG001|Overall Study|Death|0|||
25245276|NCT01253200|50560430|FG002|Overall Study|Death|0|||
25245277|NCT01253200|50560431|FG003|Overall Study|Death|0|||
25245278|NCT01253200|50560432|FG004|Overall Study|Death|0|||
25245279|NCT01253200|50560428|FG000|Overall Study|Lost to Follow-up|1|||
25245280|NCT01253200|50560429|FG001|Overall Study|Lost to Follow-up|1|||
25245281|NCT01253200|50560430|FG002|Overall Study|Lost to Follow-up|0|||
25245282|NCT01253200|50560431|FG003|Overall Study|Lost to Follow-up|0|||
25245283|NCT01253200|50560432|FG004|Overall Study|Lost to Follow-up|0|||
25245284|NCT01253200|50560428|FG000|Overall Study|Withdrawal by Subject|2|||
25245285|NCT01253200|50560429|FG001|Overall Study|Withdrawal by Subject|0|||
25245286|NCT01253200|50560430|FG002|Overall Study|Withdrawal by Subject|0|||
25245287|NCT01253200|50560431|FG003|Overall Study|Withdrawal by Subject|0|||
25245288|NCT01253200|50560432|FG004|Overall Study|Withdrawal by Subject|0|||
25245289|NCT01253200|50560428|FG000|Overall Study|Protocol Violation|1|||
25245290|NCT01253200|50560429|FG001|Overall Study|Protocol Violation|4|||
25245291|NCT01253200|50560430|FG002|Overall Study|Protocol Violation|0|||
25245292|NCT01253200|50560431|FG003|Overall Study|Protocol Violation|0|||
25245293|NCT01253200|50560432|FG004|Overall Study|Protocol Violation|5|||
25245294|NCT01253200|50560428|FG000|Overall Study|intents|10|||
25245295|NCT01253200|50560429|FG001|Overall Study|intents|10|||
25245296|NCT01253200|50560430|FG002|Overall Study|intents|1|||
25245297|NCT01253200|50560431|FG003|Overall Study|intents|3|||
25245298|NCT01253200|50560432|FG004|Overall Study|intents|0|||
25324315|NCT00837265|50640501|FG005|Pilot Phase|Disease progression|0|||
25324316|NCT00837265|50640502|FG006|Pilot Phase|Disease progression|0|||
25324317|NCT00837265|50640496|FG000|Pilot Phase|Participant left the city|0|||
25324318|NCT00837265|50640497|FG001|Pilot Phase|Participant left the city|0|||
25324319|NCT00837265|50640498|FG002|Pilot Phase|Participant left the city|0|||
25324320|NCT00837265|50640499|FG003|Pilot Phase|Participant left the city|1|||
25245299|NCT01253200|50560428|FG000|Overall Study|Attempts|6|||
25245300|NCT01253200|50560429|FG001|Overall Study|Attempts|4|||
25245301|NCT01253200|50560430|FG002|Overall Study|Attempts|1|||
25245302|NCT01253200|50560431|FG003|Overall Study|Attempts|2|||
25324321|NCT00837265|50640500|FG004|Pilot Phase|Participant left the city|0|||
25245303|NCT01253200|50560432|FG004|Overall Study|Attempts|0|||
25245304|NCT01253044|50560443|FG000|Overall Study|Lost to Follow-up|38|||
25245305|NCT01253044|50560444|FG001|Overall Study|Lost to Follow-up|29|||
25245306|NCT01252966|50560452|FG000|Overall Study|Lost to Follow-up|16|||
25245307|NCT01252966|50560453|FG001|Overall Study|Lost to Follow-up|10|||
25324322|NCT00837265|50640501|FG005|Pilot Phase|Participant left the city|0|||
25324323|NCT00837265|50640502|FG006|Pilot Phase|Participant left the city|0|||
25324324|NCT00837265|50640496|FG000|Main Phase|Withdrawal by Subject|0|||
25324325|NCT00837265|50640497|FG001|Main Phase|Withdrawal by Subject|0|||
25324326|NCT00837265|50640498|FG002|Main Phase|Withdrawal by Subject|0|||
25324327|NCT00837265|50640499|FG003|Main Phase|Withdrawal by Subject|0|||
25324328|NCT00837265|50640500|FG004|Main Phase|Withdrawal by Subject|4|||
25324329|NCT00837265|50640501|FG005|Main Phase|Withdrawal by Subject|2|||
25324330|NCT00837265|50640502|FG006|Main Phase|Withdrawal by Subject|1|||
25324331|NCT00837265|50640496|FG000|Main Phase|Decision of the investigator|0|||
25324332|NCT00837265|50640497|FG001|Main Phase|Decision of the investigator|0|||
25324333|NCT00837265|50640498|FG002|Main Phase|Decision of the investigator|0|||
25324334|NCT00837265|50640499|FG003|Main Phase|Decision of the investigator|0|||
25324335|NCT00837265|50640500|FG004|Main Phase|Decision of the investigator|0|||
25324336|NCT00837265|50640501|FG005|Main Phase|Decision of the investigator|2|||
25324337|NCT00837265|50640502|FG006|Main Phase|Decision of the investigator|1|||
25324338|NCT00837265|50640496|FG000|Main Phase|Adverse Event|0|||
25324339|NCT00837265|50640497|FG001|Main Phase|Adverse Event|0|||
25324340|NCT00837265|50640498|FG002|Main Phase|Adverse Event|0|||
25324341|NCT00837265|50640499|FG003|Main Phase|Adverse Event|0|||
25324342|NCT00837265|50640500|FG004|Main Phase|Adverse Event|0|||
25324343|NCT00837265|50640501|FG005|Main Phase|Adverse Event|1|||
25324344|NCT00837265|50640502|FG006|Main Phase|Adverse Event|0|||
25324345|NCT00837265|50640496|FG000|Main Phase|Death|0|||
25324346|NCT00837265|50640497|FG001|Main Phase|Death|0|||
25324347|NCT00837265|50640498|FG002|Main Phase|Death|0|||
25324348|NCT00837265|50640499|FG003|Main Phase|Death|0|||
25324349|NCT00837265|50640500|FG004|Main Phase|Death|2|||
25324350|NCT00837265|50640501|FG005|Main Phase|Death|0|||
25324351|NCT00837265|50640502|FG006|Main Phase|Death|1|||
25324352|NCT00837265|50640496|FG000|Main Phase|Lost to Follow-up|0|||
25324353|NCT00837265|50640497|FG001|Main Phase|Lost to Follow-up|0|||
25324354|NCT00837265|50640498|FG002|Main Phase|Lost to Follow-up|0|||
25324355|NCT00837265|50640499|FG003|Main Phase|Lost to Follow-up|0|||
25324356|NCT00837265|50640500|FG004|Main Phase|Lost to Follow-up|1|||
25324357|NCT00837265|50640501|FG005|Main Phase|Lost to Follow-up|0|||
25324358|NCT00837265|50640502|FG006|Main Phase|Lost to Follow-up|0|||
25324359|NCT00837265|50640496|FG000|Main Phase|Principal investigator resignation|0|||
25324360|NCT00837265|50640497|FG001|Main Phase|Principal investigator resignation|0|||
25324361|NCT00837265|50640498|FG002|Main Phase|Principal investigator resignation|0|||
25324362|NCT00837265|50640499|FG003|Main Phase|Principal investigator resignation|0|||
25324363|NCT00837265|50640500|FG004|Main Phase|Principal investigator resignation|2|||
25324364|NCT00837265|50640501|FG005|Main Phase|Principal investigator resignation|0|||
25324365|NCT00837265|50640502|FG006|Main Phase|Principal investigator resignation|0|||
25324366|NCT00837265|50640496|FG000|Main Phase|Participant's personal reason|0|||
25324367|NCT00837265|50640497|FG001|Main Phase|Participant's personal reason|0|||
25324368|NCT00837265|50640498|FG002|Main Phase|Participant's personal reason|0|||
25324369|NCT00837265|50640499|FG003|Main Phase|Participant's personal reason|0|||
25324370|NCT00837265|50640500|FG004|Main Phase|Participant's personal reason|1|||
25324371|NCT00837265|50640501|FG005|Main Phase|Participant's personal reason|0|||
25324372|NCT00837265|50640502|FG006|Main Phase|Participant's personal reason|0|||
25324373|NCT00594516|50640515|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
25324374|NCT00594516|50640516|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
25324375|NCT00594516|50640517|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
25324376|NCT00594516|50640515|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
25245308|NCT01252966|50560452|FG000|Overall Study|Withdrawal by Subject|7|||
25245309|NCT01252966|50560453|FG001|Overall Study|Withdrawal by Subject|3|||
25245310|NCT01252810|50560463|FG000|Overall Study|Withdrawal by Subject|4|||
25245311|NCT01252810|50560464|FG001|Overall Study|Withdrawal by Subject|1|||
25245312|NCT01252810|50560463|FG000|Overall Study|Lost to Follow-up|0|||
25245313|NCT01252810|50560464|FG001|Overall Study|Lost to Follow-up|1|||
25245314|NCT01252810|50560463|FG000|Overall Study|Physician Decision|2|||
25245315|NCT01252810|50560464|FG001|Overall Study|Physician Decision|1|||
25245316|NCT01252810|50560463|FG000|Overall Study|Various reasons|8|||
25245317|NCT01252810|50560464|FG001|Overall Study|Various reasons|0|||
25245318|NCT01252186|50560473|FG000|Overall Study|Adverse Event|9|||
25245319|NCT01252186|50560474|FG001|Overall Study|Adverse Event|6|||
25077755|NCT02487446|50185642|FG000|Period 2|Adverse Event|6|||
25245320|NCT01252186|50560475|FG002|Overall Study|Adverse Event|8|||
25245321|NCT01252186|50560473|FG000|Overall Study|Withdrawal by Subject|2|||
25245322|NCT01252186|50560474|FG001|Overall Study|Withdrawal by Subject|5|||
25324377|NCT00594516|50640516|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
25324378|NCT00594516|50640517|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
25324379|NCT00594516|50640515|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
25324380|NCT00594516|50640516|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
25324381|NCT00594516|50640517|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
25324382|NCT00594516|50640515|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
25324383|NCT00594516|50640516|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
25324384|NCT00594516|50640517|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
25324385|NCT00594516|50640515|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
25324386|NCT00594516|50640516|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
25324387|NCT00594516|50640517|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
25324388|NCT00594516|50640515|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
25324389|NCT00594516|50640516|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
25324390|NCT00594516|50640517|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
25324391|NCT00594516|50640515|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
25324392|NCT00594516|50640516|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
25324393|NCT00594516|50640517|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
25324394|NCT00594516|50640515|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
25324395|NCT00594516|50640516|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
25324396|NCT00594516|50640517|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
25324397|NCT00594516|50640515|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
25324398|NCT00594516|50640516|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
25324399|NCT00594516|50640517|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
25324400|NCT00538291|50640521|FG000|Overall Study|Adverse Event|2|||
25324401|NCT00538291|50640521|FG000|Overall Study|Withdrawal by Subject|1|||
25324402|NCT00594906|50640527|FG000|Overall Study|Physician Decision|1|||
25245323|NCT01252186|50560475|FG002|Overall Study|Withdrawal by Subject|2|||
25245324|NCT01252186|50560473|FG000|Overall Study|Physician Decision|0|||
25245325|NCT01252186|50560474|FG001|Overall Study|Physician Decision|0|||
25324403|NCT00594906|50640528|FG001|Overall Study|Physician Decision|0|||
25324404|NCT00594906|50640527|FG000|Overall Study|Physician Decision|0|||
25324405|NCT00594906|50640528|FG001|Overall Study|Physician Decision|1|||
25324406|NCT00594906|50640527|FG000|Overall Study|Death|0|||
25324407|NCT00594906|50640528|FG001|Overall Study|Death|1|||
25324408|NCT00537979|50640536|FG000|Overall Study|Adverse Event|2|||
25324409|NCT00537979|50640537|FG001|Overall Study|Adverse Event|2|||
25324410|NCT00537979|50640536|FG000|Overall Study|Withdrawal by Subject|1|||
25324411|NCT00537979|50640537|FG001|Overall Study|Withdrawal by Subject|4|||
25324412|NCT00537979|50640536|FG000|Overall Study|Lost to Follow-up|1|||
25324413|NCT00537979|50640537|FG001|Overall Study|Lost to Follow-up|4|||
25324414|NCT00537979|50640536|FG000|Overall Study|Lack of Efficacy|0|||
25324415|NCT00537979|50640537|FG001|Overall Study|Lack of Efficacy|1|||
25324416|NCT00537979|50640536|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
25324417|NCT00537979|50640537|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
25324418|NCT00537979|50640536|FG000|Overall Study|Death|0|||
25324419|NCT00537979|50640537|FG001|Overall Study|Death|3|||
25324420|NCT00537979|50640536|FG000|Overall Study|Kidney transplant|0|||
25245326|NCT01252186|50560475|FG002|Overall Study|Physician Decision|1|||
25245327|NCT01252186|50560473|FG000|Overall Study|Non-compliance|0|||
25245328|NCT01252186|50560474|FG001|Overall Study|Non-compliance|3|||
25245329|NCT01252186|50560475|FG002|Overall Study|Non-compliance|4|||
25245330|NCT01252186|50560473|FG000|Overall Study|Protocol Violation|0|||
25245331|NCT01252186|50560474|FG001|Overall Study|Protocol Violation|0|||
25245332|NCT01252186|50560475|FG002|Overall Study|Protocol Violation|1|||
25245333|NCT01252186|50560473|FG000|Overall Study|Pregnancy|2|||
25245334|NCT01252186|50560474|FG001|Overall Study|Pregnancy|2|||
25245335|NCT01252186|50560475|FG002|Overall Study|Pregnancy|0|||
25245336|NCT01252186|50560473|FG000|Overall Study|Sponsor Request|2|||
25245337|NCT01252186|50560474|FG001|Overall Study|Sponsor Request|1|||
25245338|NCT01252186|50560475|FG002|Overall Study|Sponsor Request|0|||
25245339|NCT01252186|50560473|FG000|Overall Study|Lost to Follow-up|10|||
25245340|NCT01252186|50560474|FG001|Overall Study|Lost to Follow-up|10|||
25245341|NCT01252186|50560475|FG002|Overall Study|Lost to Follow-up|11|||
25245342|NCT01252186|50560473|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
25245343|NCT01252186|50560474|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
25245344|NCT01252186|50560475|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
25245345|NCT01251952|50560510|FG000|Overall Study|Adverse Event|1|||
25245346|NCT01251367|50560514|FG000|Overall Study|Protocol Violation|1|||
25245347|NCT01251367|50560514|FG000|Overall Study|Lack of Efficacy|2|||
25245348|NCT01251367|50560514|FG000|Overall Study|Adverse Event|19|||
25245349|NCT01251367|50560514|FG000|Overall Study|Withdrawal by Subject|36|||
25245350|NCT01251367|50560514|FG000|Overall Study|Lost to Follow-up|5|||
25245351|NCT01251367|50560514|FG000|Overall Study|Subject Required Alternative Treatment|7|||
25245352|NCT01251367|50560514|FG000|Overall Study|No Study Drug Available|1|||
25324421|NCT00537979|50640537|FG001|Overall Study|Kidney transplant|3|||
25245353|NCT01251367|50560514|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
25245354|NCT01251367|50560514|FG000|Overall Study|End of Study Visit Performed in Error|1|||
25245355|NCT01250509|50560520|FG000|Overall Study|Lost to Follow-up|5|||
25245356|NCT01250509|50560521|FG001|Overall Study|Lost to Follow-up|2|||
25324422|NCT00537979|50640536|FG000|Overall Study|Heart failure|0|||
25245357|NCT01250119|50560529|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
25245358|NCT01250119|50560530|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
25245359|NCT01250119|50560529|FG000|Diagnostic Phase|Participants Not Tested|44|||
25245360|NCT01250119|50560530|FG001|Diagnostic Phase|Participants Not Tested|0|||
25245361|NCT01250119|50560529|FG000|Treatment Phase|Progressive Disease|0|||
25245362|NCT01250119|50560530|FG001|Treatment Phase|Progressive Disease|32|||
25245363|NCT01250119|50560529|FG000|Treatment Phase|Death|0|||
25245364|NCT01250119|50560530|FG001|Treatment Phase|Death|2|||
25245365|NCT01250119|50560529|FG000|Treatment Phase|Withdrawal by Subject|0|||
25245366|NCT01250119|50560530|FG001|Treatment Phase|Withdrawal by Subject|1|||
25245367|NCT01250119|50560529|FG000|Treatment Phase|Adverse Event|0|||
25245368|NCT01250119|50560530|FG001|Treatment Phase|Adverse Event|2|||
25245369|NCT01250119|50560529|FG000|Treatment Phase|Unknown reason|0|||
25245370|NCT01250119|50560530|FG001|Treatment Phase|Unknown reason|4|||
25245371|NCT01250002|50560539|FG000|Overall Study|Change to open surgical procedure|4|||
25245372|NCT01250002|50560540|FG001|Overall Study|Change to open surgical procedure|3|||
25245373|NCT01246960|50560548|FG000|Overall Study|Lost to Follow-up|3|||
25245374|NCT01246960|50560549|FG001|Overall Study|Lost to Follow-up|1|||
25245375|NCT01246960|50560548|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
25245376|NCT01246960|50560549|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
25245377|NCT01244620|50560555|FG000|Overall Study|Study terminated|4|||
25245378|NCT01244620|50560556|FG001|Overall Study|Study terminated|4|||
25245379|NCT01244620|50560557|FG002|Overall Study|Study terminated|4|||
25245380|NCT01244620|50560558|FG003|Overall Study|Study terminated|4|||
25245381|NCT01267201|50560568|FG000|First Intervention Period|Withdrawal by Subject|1|||
25245382|NCT01267201|50560569|FG001|First Intervention Period|Withdrawal by Subject|0|||
25245383|NCT01267201|50560570|FG002|First Intervention Period|Withdrawal by Subject|0|||
25245384|NCT01267201|50560571|FG003|First Intervention Period|Withdrawal by Subject|0|||
25245385|NCT01267201|50560572|FG004|First Intervention Period|Withdrawal by Subject|0|||
25245386|NCT01267201|50560573|FG005|First Intervention Period|Withdrawal by Subject|0|||
25245387|NCT01267201|50560568|FG000|Second Intervention Period|Withdrawal by Subject|0|||
25245388|NCT01267201|50560569|FG001|Second Intervention Period|Withdrawal by Subject|1|||
25245389|NCT01267201|50560570|FG002|Second Intervention Period|Withdrawal by Subject|0|||
25245390|NCT01267201|50560571|FG003|Second Intervention Period|Withdrawal by Subject|0|||
25245391|NCT01267201|50560572|FG004|Second Intervention Period|Withdrawal by Subject|0|||
25245392|NCT01267201|50560573|FG005|Second Intervention Period|Withdrawal by Subject|0|||
25245393|NCT01266967|50560583|FG000|Overall Study|Death|69|||
25245394|NCT01266967|50560584|FG001|Overall Study|Death|61|||
25245395|NCT01266967|50560583|FG000|Overall Study|Study Closed/Terminated|15|||
25245396|NCT01266967|50560584|FG001|Overall Study|Study Closed/Terminated|17|||
25245397|NCT01266967|50560583|FG000|Overall Study|Lost to Follow-up|2|||
25245398|NCT01266967|50560584|FG001|Overall Study|Lost to Follow-up|1|||
25245399|NCT01266967|50560583|FG000|Overall Study|Physician Decision|0|||
25245400|NCT01266967|50560584|FG001|Overall Study|Physician Decision|1|||
25245401|NCT01266967|50560583|FG000|Overall Study|Withdrawal by Subject|3|||
25245402|NCT01266967|50560584|FG001|Overall Study|Withdrawal by Subject|3|||
25245403|NCT01266850|50560598|FG000|Overall Study|Lost to Follow-up|19|||
25245404|NCT01266850|50560599|FG001|Overall Study|Lost to Follow-up|19|||
25245405|NCT01266850|50560600|FG002|Overall Study|Lost to Follow-up|13|||
25245406|NCT01266850|50560601|FG003|Overall Study|Lost to Follow-up|13|||
25245407|NCT01266850|50560602|FG004|Overall Study|Lost to Follow-up|12|||
25245408|NCT01266850|50560598|FG000|Overall Study|Withdrawal by Subject|8|||
25245409|NCT01266850|50560599|FG001|Overall Study|Withdrawal by Subject|9|||
25245410|NCT01266850|50560600|FG002|Overall Study|Withdrawal by Subject|6|||
25245411|NCT01266850|50560601|FG003|Overall Study|Withdrawal by Subject|9|||
25245412|NCT01266850|50560602|FG004|Overall Study|Withdrawal by Subject|12|||
25245413|NCT01266850|50560598|FG000|Overall Study|Physician Decision|3|||
25245414|NCT01266850|50560599|FG001|Overall Study|Physician Decision|6|||
25245415|NCT01266850|50560600|FG002|Overall Study|Physician Decision|4|||
25245416|NCT01266850|50560601|FG003|Overall Study|Physician Decision|4|||
25245417|NCT01266850|50560602|FG004|Overall Study|Physician Decision|3|||
25245418|NCT01266850|50560598|FG000|Overall Study|Protocol Violation|0|||
25245419|NCT01266850|50560599|FG001|Overall Study|Protocol Violation|1|||
25245420|NCT01266850|50560600|FG002|Overall Study|Protocol Violation|0|||
25245421|NCT01266850|50560601|FG003|Overall Study|Protocol Violation|1|||
25245422|NCT01266850|50560602|FG004|Overall Study|Protocol Violation|2|||
25245423|NCT01266850|50560598|FG000|Overall Study|Adverse Event|0|||
25245424|NCT01266850|50560599|FG001|Overall Study|Adverse Event|0|||
25245425|NCT01266850|50560600|FG002|Overall Study|Adverse Event|0|||
25245426|NCT01266850|50560601|FG003|Overall Study|Adverse Event|0|||
25245427|NCT01266850|50560602|FG004|Overall Study|Adverse Event|1|||
25245428|NCT01266850|50560598|FG000|Overall Study|Site Closure|0|||
25245429|NCT01266850|50560599|FG001|Overall Study|Site Closure|1|||
25245430|NCT01266850|50560600|FG002|Overall Study|Site Closure|1|||
25245431|NCT01266850|50560601|FG003|Overall Study|Site Closure|1|||
25245432|NCT01266850|50560602|FG004|Overall Study|Site Closure|0|||
25245433|NCT01266460|50560614|FG000|Overall Study|Adverse Event|3|||
25245434|NCT01266460|50560614|FG000|Overall Study|Withdrawal by Subject|5|||
25245435|NCT01266460|50560614|FG000|Overall Study|Disease Progression|18|||
25245436|NCT01266460|50560614|FG000|Overall Study|Not otherwise specified|8|||
25245437|NCT01266265|50560620|FG000|Overall Study|Death|95|||
25245438|NCT01266265|50560621|FG001|Overall Study|Death|73|||
25245439|NCT01266265|50560620|FG000|Overall Study|Lost to Follow-up|23|||
25245440|NCT01266265|50560621|FG001|Overall Study|Lost to Follow-up|28|||
25245441|NCT01266265|50560620|FG000|Overall Study|Withdrawal by Subject|13|||
25245442|NCT01266265|50560621|FG001|Overall Study|Withdrawal by Subject|11|||
25245443|NCT01266265|50560620|FG000|Overall Study|Respiratory-related adverse event|2|||
25245444|NCT01266265|50560621|FG001|Overall Study|Respiratory-related adverse event|1|||
25245445|NCT01266265|50560620|FG000|Overall Study|Transferred care to another provider|22|||
25245446|NCT01266265|50560621|FG001|Overall Study|Transferred care to another provider|28|||
25245447|NCT01266265|50560620|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
25245448|NCT01266265|50560621|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
25245449|NCT01266265|50560620|FG000|Overall Study|Enrolled in another clinical study|15|||
25245450|NCT01266265|50560621|FG001|Overall Study|Enrolled in another clinical study|26|||
25245451|NCT01266265|50560620|FG000|Overall Study|Non-compliance|8|||
25245452|NCT01266265|50560621|FG001|Overall Study|Non-compliance|5|||
25245453|NCT01266265|50560620|FG000|Overall Study|Lung transplant|6|||
25245454|NCT01266265|50560621|FG001|Overall Study|Lung transplant|5|||
25245455|NCT01266265|50560620|FG000|Overall Study|Site closed early|4|||
25245456|NCT01266265|50560621|FG001|Overall Study|Site closed early|3|||
25245457|NCT01266265|50560620|FG000|Overall Study|Clinical worsening|1|||
25245458|NCT01266265|50560621|FG001|Overall Study|Clinical worsening|1|||
25245459|NCT01266148|50560646|FG000|Overall Study|Adverse Event|2|||
25245460|NCT01266148|50560647|FG001|Overall Study|Adverse Event|0|||
25245461|NCT01266148|50560646|FG000|Overall Study|Ongoing rejection|1|||
25245462|NCT01266148|50560647|FG001|Overall Study|Ongoing rejection|0|||
25245463|NCT01266148|50560646|FG000|Overall Study|2 2R rejections|1|||
25245464|NCT01266148|50560647|FG001|Overall Study|2 2R rejections|0|||
25245465|NCT01266148|50560646|FG000|Overall Study|Death|2|||
25245466|NCT01266148|50560647|FG001|Overall Study|Death|3|||
25245467|NCT01266148|50560646|FG000|Overall Study|missing mGFR value + AE|1|||
25245468|NCT01266148|50560647|FG001|Overall Study|missing mGFR value + AE|0|||
25245469|NCT01266070|50560653|FG000|Overall Study|Adverse Event|3|||
25245470|NCT01266070|50560653|FG000|Overall Study|Protocol Violation|1|||
25245471|NCT01265992|50560657|FG000|Overall Study|Lost to Follow-up|1|||
25245472|NCT01265992|50560657|FG000|Overall Study|Withdrawal by Subject|1|||
25245473|NCT01265992|50560657|FG000|Overall Study|Adverse Event|1|||
25245474|NCT01265992|50560657|FG000|Overall Study|Administrative reasons|2|||
25245475|NCT01265992|50560657|FG000|Overall Study|Stopped treatment|3|||
25245476|NCT01265992|50560657|FG000|Overall Study|Did not receive treatment|1|||
25245477|NCT01265953|50560663|FG000|Overall Study|Non compliance|5|||
25245478|NCT01265953|50560664|FG001|Overall Study|Non compliance|3|||
25245479|NCT01265875|50560670|FG000|Overall Study|Uncooperative/unreliable|1|||
25245480|NCT01265797|50560677|FG000|Run-in Month|Withdrawal by Subject|0|||
25245481|NCT01265797|50560678|FG001|Run-in Month|Withdrawal by Subject|4|||
25245482|NCT01265797|50560677|FG000|Run-in Month|1st seizure during run-in month|0|||
25245483|NCT01265797|50560678|FG001|Run-in Month|1st seizure during run-in month|1|||
25245484|NCT01265797|50560677|FG000|Blinded Month|Lack of Efficacy|5|||
25245485|NCT01265797|50560678|FG001|Blinded Month|Lack of Efficacy|0|||
25245486|NCT01265797|50560677|FG000|Blinded Month|Lost to Follow-up|1|||
25245487|NCT01265797|50560678|FG001|Blinded Month|Lost to Follow-up|0|||
25245488|NCT01265797|50560677|FG000|Blinded Month|Protocol Violation|2|||
25245489|NCT01265797|50560678|FG001|Blinded Month|Protocol Violation|1|||
25324423|NCT00537979|50640537|FG001|Overall Study|Heart failure|1|||
25324424|NCT00537823|50640546|FG000|Overall Study|Adverse Event|2|||
25324425|NCT00537823|50640547|FG001|Overall Study|Adverse Event|0|||
25324426|NCT00537277|50640554|FG000|Overall Study|Adverse Event|1|||
25324427|NCT00537277|50640554|FG000|Overall Study|Lack of Efficacy|2|||
25324428|NCT00537277|50640554|FG000|Overall Study|Lost to Follow-up|12|||
25324429|NCT00537277|50640554|FG000|Overall Study|Protocol Violation|11|||
25077756|NCT02487446|50185643|FG001|Period 2|Adverse Event|2|||
25077757|NCT02739269|50185652|FG000|Overall Study|Protocol Violation|5|||
25077758|NCT02739269|50185653|FG001|Overall Study|Protocol Violation|0|||
25077759|NCT02739269|50185652|FG000|Overall Study|Cycle cancellation|2|||
25245490|NCT01265797|50560677|FG000|Blinded Month|Adverse Event|2|||
25245491|NCT01265797|50560678|FG001|Blinded Month|Adverse Event|0|||
25245492|NCT01265797|50560677|FG000|Blinded Month|Diary data incomplete|0|||
25245493|NCT01265797|50560678|FG001|Blinded Month|Diary data incomplete|1|||
25245494|NCT01265797|50560677|FG000|Open Label Month|Lost to Follow-up|0|||
25245495|NCT01265797|50560678|FG001|Open Label Month|Lost to Follow-up|1|||
25245496|NCT01265719|50560688|FG000|Overall Study|Does not meet entrance criteria|0|||
25245497|NCT01265719|50560689|FG001|Overall Study|Does not meet entrance criteria|3|||
25245498|NCT01265719|50560688|FG000|Overall Study|Other reasons|2|||
25245499|NCT01265719|50560689|FG001|Overall Study|Other reasons|0|||
25245500|NCT01265719|50560688|FG000|Overall Study|Withdrawal by Subject|8|||
25245501|NCT01265719|50560689|FG001|Overall Study|Withdrawal by Subject|3|||
25245502|NCT01265719|50560688|FG000|Overall Study|Lost to Follow-up|2|||
25245503|NCT01265719|50560689|FG001|Overall Study|Lost to Follow-up|7|||
25245504|NCT01265719|50560688|FG000|Overall Study|Adverse Event|2|||
25245505|NCT01265719|50560689|FG001|Overall Study|Adverse Event|0|||
25245506|NCT01265563|50560721|FG000|Overall Study|Withdrawal by Subject|0|||
25245507|NCT01265563|50560722|FG001|Overall Study|Withdrawal by Subject|1|||
25245508|NCT01265563|50560723|FG002|Overall Study|Withdrawal by Subject|1|||
25245509|NCT01265563|50560724|FG003|Overall Study|Withdrawal by Subject|0|||
25245510|NCT01265563|50560725|FG004|Overall Study|Withdrawal by Subject|2|||
25245511|NCT01265056|50560744|FG000|Initial Study Period|Withdrawal by Subject|1|||
25245512|NCT01265056|50560745|FG001|Initial Study Period|Withdrawal by Subject|1|||
25245513|NCT01265056|50560744|FG000|Initial Study Period|Withdrawal by Subject|1|||
25245514|NCT01265056|50560745|FG001|Initial Study Period|Withdrawal by Subject|1|||
25245515|NCT01265056|50560744|FG000|Follow up|Lost to Follow-up|7|||
25245516|NCT01265056|50560745|FG001|Follow up|Lost to Follow-up|3|||
25245517|NCT01264939|50560753|FG000|Overall Study|Adverse Event|1|||
25324430|NCT00537277|50640554|FG000|Overall Study|Unclassified|4|||
25324431|NCT00537277|50640554|FG000|Overall Study|Inability to tolerate trial medication|4|||
25324432|NCT00537277|50640554|FG000|Overall Study|Non-compliance with trial procedures|15|||
25324433|NCT00537199|50640558|FG000|Overall Study|Study Terminated|1|||
25324434|NCT03898063|50640564|FG000|Overall Study|Withdrawal by Subject|10|||
25324435|NCT03898063|50640565|FG001|Overall Study|Withdrawal by Subject|8|||
25324436|NCT00873912|50640573|FG000|Overall Study|Withdrawal by Subject|1|||
25324437|NCT00873912|50640574|FG001|Overall Study|Withdrawal by Subject|0|||
25324438|NCT00873912|50640573|FG000|Overall Study|Lost to Follow-up|2|||
25324439|NCT00873912|50640574|FG001|Overall Study|Lost to Follow-up|0|||
25324440|NCT03823300|50640586|FG000|Overall Study|Withdrawal by Subject|16|||
25324441|NCT03823300|50640587|FG001|Overall Study|Withdrawal by Subject|22|||
25324442|NCT03823300|50640586|FG000|Overall Study|Death|10|||
25324443|NCT03823300|50640587|FG001|Overall Study|Death|14|||
25245518|NCT01264939|50560754|FG001|Overall Study|Adverse Event|3|||
25245519|NCT01264939|50560753|FG000|Overall Study|Lost to Follow-up|0|||
25245520|NCT01264939|50560754|FG001|Overall Study|Lost to Follow-up|3|||
25245521|NCT01264939|50560753|FG000|Overall Study|Physician Decision|1|||
25245522|NCT01264939|50560754|FG001|Overall Study|Physician Decision|1|||
25245523|NCT01264939|50560753|FG000|Overall Study|Patient/Guardian Decision|8|||
25245524|NCT01264939|50560754|FG001|Overall Study|Patient/Guardian Decision|10|||
25245525|NCT01264939|50560753|FG000|Overall Study|Disease Progression|8|||
25245526|NCT01264939|50560754|FG001|Overall Study|Disease Progression|11|||
25245527|NCT01264081|50560760|FG000|Participants Screened|Screening failures|30|||
25245528|NCT01264081|50560760|FG000|Started Treatment|Withdrawal by Subject|1|||
25245529|NCT01264081|50560760|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
25245530|NCT01263925|50560766|FG000|Overall Study|Protocol Violation|1|||
25245531|NCT01263925|50560767|FG001|Overall Study|Protocol Violation|0|||
25245532|NCT01263925|50560766|FG000|Overall Study|Lack of Efficacy|0|||
25245533|NCT01263925|50560767|FG001|Overall Study|Lack of Efficacy|1|||
25245534|NCT01263925|50560766|FG000|Overall Study|Adverse Event|23|||
25245535|NCT01263925|50560767|FG001|Overall Study|Adverse Event|22|||
25245536|NCT01263925|50560766|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
25245537|NCT01263925|50560767|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
25245538|NCT01263925|50560766|FG000|Overall Study|Withdrawal by Subject|6|||
25245539|NCT01263925|50560767|FG001|Overall Study|Withdrawal by Subject|8|||
25245540|NCT01263925|50560766|FG000|Overall Study|Other|4|||
25245541|NCT01263925|50560767|FG001|Overall Study|Other|4|||
25245542|NCT01263925|50560766|FG000|Overall Study|Lost to Follow-up|3|||
25245543|NCT01263925|50560767|FG001|Overall Study|Lost to Follow-up|1|||
25245544|NCT01263925|50560766|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
25245545|NCT01263925|50560767|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
25245546|NCT01263925|50560766|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
25245547|NCT01263925|50560767|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
25245548|NCT01263925|50560766|FG000|Overall Study|AE/ Withdrawal|1|||
25324444|NCT03823300|50640586|FG000|Overall Study|Adverse Event|3|||
25324445|NCT03823300|50640587|FG001|Overall Study|Adverse Event|5|||
25324446|NCT03823300|50640586|FG000|Overall Study|Physician Decision|1|||
25324447|NCT03823300|50640587|FG001|Overall Study|Physician Decision|7|||
25324448|NCT03823300|50640586|FG000|Overall Study|Lost to Follow-up|1|||
25324449|NCT03823300|50640587|FG001|Overall Study|Lost to Follow-up|3|||
25245549|NCT01263925|50560767|FG001|Overall Study|AE/ Withdrawal|4|||
25245550|NCT01263925|50560766|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
25245551|NCT01263925|50560767|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
25245552|NCT01263925|50560766|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
25245553|NCT01263925|50560767|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
25245554|NCT01263925|50560766|FG000|Overall Study|Withdrawal/ Not specified|0|||
25245555|NCT01263925|50560767|FG001|Overall Study|Withdrawal/ Not specified|1|||
25245556|NCT01263769|50560773|FG000|Overall Study|Non-Compliant with treatment|1|||
25245557|NCT01263691|50560783|FG000|Overall Study|Lost to Follow-up|1|||
25245558|NCT01263691|50560784|FG001|Overall Study|Lost to Follow-up|0|||
25245559|NCT01263691|50560785|FG002|Overall Study|Lost to Follow-up|1|||
25245560|NCT01263691|50560786|FG003|Overall Study|Lost to Follow-up|1|||
25245561|NCT01263691|50560787|FG004|Overall Study|Lost to Follow-up|0|||
25245562|NCT01263691|50560788|FG005|Overall Study|Lost to Follow-up|0|||
25245563|NCT01263691|50560783|FG000|Overall Study|Withdrawal by Subject|1|||
25245564|NCT01263691|50560784|FG001|Overall Study|Withdrawal by Subject|0|||
25245565|NCT01263691|50560785|FG002|Overall Study|Withdrawal by Subject|0|||
25245566|NCT01263691|50560786|FG003|Overall Study|Withdrawal by Subject|0|||
25245567|NCT01263691|50560787|FG004|Overall Study|Withdrawal by Subject|0|||
25245568|NCT01263691|50560788|FG005|Overall Study|Withdrawal by Subject|0|||
25245569|NCT01263691|50560783|FG000|Overall Study|Adverse Event|1|||
25245570|NCT01263691|50560784|FG001|Overall Study|Adverse Event|0|||
25245571|NCT01263691|50560785|FG002|Overall Study|Adverse Event|0|||
25245572|NCT01263691|50560786|FG003|Overall Study|Adverse Event|0|||
25245573|NCT01263691|50560787|FG004|Overall Study|Adverse Event|0|||
25245574|NCT01263691|50560788|FG005|Overall Study|Adverse Event|0|||
25245575|NCT01263496|50560865|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
25245576|NCT01263496|50560866|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
25324450|NCT03823300|50640586|FG000|Overall Study|Protocol Violation|1|||
25324451|NCT03823300|50640587|FG001|Overall Study|Protocol Violation|1|||
25324452|NCT03823300|50640586|FG000|Overall Study|Lack of Efficacy|1|||
25324453|NCT03823300|50640587|FG001|Overall Study|Lack of Efficacy|1|||
25324454|NCT03823300|50640586|FG000|Overall Study|Not Eligible|0|||
25324455|NCT03823300|50640587|FG001|Overall Study|Not Eligible|1|||
25245577|NCT01263496|50560867|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
25324456|NCT03823300|50640586|FG000|Overall Study|Other|1|||
25324457|NCT03823300|50640587|FG001|Overall Study|Other|0|||
25324458|NCT00537745|50640593|FG000|Overall Study|Did not meet eligibility criteria|2|||
25324459|NCT00537745|50640593|FG000|Overall Study|Withdrawal by Subject|2|||
25324460|NCT00537745|50640593|FG000|Overall Study|Subject unable to provide Interlock info|1|||
25324461|NCT00874848|50640600|FG000|Overall Study|Adverse Event|13|||
25324462|NCT00874848|50640601|FG001|Overall Study|Adverse Event|2|||
25324463|NCT00874848|50640600|FG000|Overall Study|Progressive neoplastic disease|38|||
25324464|NCT00874848|50640601|FG001|Overall Study|Progressive neoplastic disease|18|||
25324465|NCT00874848|50640600|FG000|Overall Study|Withdrawal by Subject|7|||
25324466|NCT00874848|50640601|FG001|Overall Study|Withdrawal by Subject|4|||
25324467|NCT00874848|50640600|FG000|Overall Study|Noncompliance|1|||
25324468|NCT00874848|50640601|FG001|Overall Study|Noncompliance|1|||
25324469|NCT00874848|50640600|FG000|Overall Study|Failure to comply with protocol|0|||
25324470|NCT00874848|50640601|FG001|Overall Study|Failure to comply with protocol|1|||
25245578|NCT01263496|50560868|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
25245579|NCT01263496|50560869|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
25245580|NCT01263496|50560870|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
25245581|NCT01263496|50560871|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
25245582|NCT01263496|50560872|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
25245583|NCT01263496|50560873|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
25245584|NCT01263496|50560865|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
25245585|NCT01263496|50560866|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
25245586|NCT01263496|50560867|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
25245587|NCT01263496|50560868|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
25245588|NCT01263496|50560869|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
25245589|NCT01263496|50560870|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
25245590|NCT01263496|50560871|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
25245591|NCT01263496|50560872|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
25245592|NCT01263496|50560873|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
25245593|NCT01263496|50560865|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
25245594|NCT01263496|50560866|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
25245595|NCT01263496|50560867|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
25245596|NCT01263496|50560868|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
25245597|NCT01263496|50560869|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
25245598|NCT01263496|50560870|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
25245599|NCT01263496|50560871|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
25245600|NCT01263496|50560872|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
25245601|NCT01263496|50560873|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
25245602|NCT01263496|50560865|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
25245603|NCT01263496|50560866|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
25324471|NCT00874848|50640600|FG000|Overall Study|Physician Decision|0|||
25324472|NCT00874848|50640601|FG001|Overall Study|Physician Decision|2|||
25324473|NCT00578812|50640609|FG000|Overall Study|Not treated|6|||
25324474|NCT00578812|50640610|FG001|Overall Study|Not treated|7|||
25324475|NCT00536809|50640617|FG000|Phase II|Adverse Event|1|||
25245604|NCT01263496|50560867|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
25245605|NCT01263496|50560868|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
25245606|NCT01263496|50560869|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
25245607|NCT01263496|50560870|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
25245608|NCT01263496|50560871|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
25245609|NCT01263496|50560872|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
25245610|NCT01263496|50560873|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
25245611|NCT01263496|50560865|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
25245612|NCT01263496|50560866|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
25245613|NCT01263496|50560867|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
25245614|NCT01263496|50560868|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
25245615|NCT01263496|50560869|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
25245616|NCT01263496|50560870|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
25245617|NCT01263496|50560871|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
25245618|NCT01263496|50560872|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
25245619|NCT01263496|50560873|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
25245620|NCT01263496|50560865|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
25324476|NCT00536809|50640617|FG000|Phase II|Referred for surgical resection|1|||
25324477|NCT00536731|50640628|FG000|Overall Study|Adverse Event|3|||
25324478|NCT00536731|50640629|FG001|Overall Study|Adverse Event|2|||
25324479|NCT00536731|50640630|FG002|Overall Study|Adverse Event|3|||
25324480|NCT00536731|50640628|FG000|Overall Study|Withdrawal by Subject|0|||
25324481|NCT00536731|50640629|FG001|Overall Study|Withdrawal by Subject|2|||
25324482|NCT00536731|50640630|FG002|Overall Study|Withdrawal by Subject|0|||
25324483|NCT00536731|50640628|FG000|Overall Study|Intake of prohibited conc. medication|0|||
25245621|NCT01263496|50560866|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
25245622|NCT01263496|50560867|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
25245623|NCT01263496|50560868|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
25245624|NCT01263496|50560869|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
25245625|NCT01263496|50560870|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
25245626|NCT01263496|50560871|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
25245627|NCT01263496|50560872|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
25245628|NCT01263496|50560873|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
25245629|NCT01263496|50560865|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
25245630|NCT01263496|50560866|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
25245631|NCT01263496|50560867|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
25245632|NCT01263496|50560868|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
25245633|NCT01263496|50560869|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
25245634|NCT01263496|50560870|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
25245635|NCT01263496|50560871|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
25245636|NCT01263496|50560872|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
25245637|NCT01263496|50560873|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
25245638|NCT01263223|50560885|FG000|Period 2|Withdrawal by Subject|0|||
25245639|NCT01263223|50560886|FG001|Period 2|Withdrawal by Subject|1|||
25245640|NCT01263223|50560885|FG000|7-day Follow-up|Withdrawal by Subject|0|||
25245641|NCT01263223|50560886|FG001|7-day Follow-up|Withdrawal by Subject|1|||
25245642|NCT01263223|50560885|FG000|7-day Follow-up|Lost to Follow-up|1|||
25245643|NCT01263223|50560886|FG001|7-day Follow-up|Lost to Follow-up|0|||
25245644|NCT01263106|50560895|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
25245645|NCT01263106|50560896|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
25245646|NCT01263028|50560905|FG000|Overall Study|Withdrawal by Subject|1|||
25245647|NCT01263028|50560905|FG000|Overall Study|Adverse Event|1|||
25245648|NCT01263028|50560905|FG000|Overall Study|Study terminated due to low enrollment.|4|||
25245649|NCT01262989|50560909|FG000|Period 1|Lost to Follow-up|1|||
25245650|NCT01262989|50560910|FG001|Period 1|Lost to Follow-up|1|||
25245651|NCT01262989|50560909|FG000|Period 1|Intercurrent disease|0|||
25245652|NCT01262989|50560910|FG001|Period 1|Intercurrent disease|1|||
25245653|NCT01262989|50560909|FG000|Period 1|Positive answer for exclusion criteria|0|||
25245654|NCT01262989|50560910|FG001|Period 1|Positive answer for exclusion criteria|1|||
25324484|NCT00536731|50640629|FG001|Overall Study|Intake of prohibited conc. medication|0|||
25324485|NCT00536731|50640630|FG002|Overall Study|Intake of prohibited conc. medication|1|||
25324486|NCT00536731|50640628|FG000|Overall Study|Safety reasons|0|||
25324487|NCT00536731|50640629|FG001|Overall Study|Safety reasons|0|||
25324488|NCT00536731|50640630|FG002|Overall Study|Safety reasons|1|||
25077760|NCT02739269|50185653|FG001|Overall Study|Cycle cancellation|2|||
25077761|NCT02739269|50185652|FG000|Overall Study|Withdrawal by Subject|0|||
25077762|NCT02739269|50185653|FG001|Overall Study|Withdrawal by Subject|2|||
25324489|NCT00536731|50640628|FG000|Overall Study|Other|1|||
25324490|NCT00536731|50640629|FG001|Overall Study|Other|1|||
25245655|NCT01262989|50560909|FG000|Period 2|Intercurrent disease|0|||
25245656|NCT01262989|50560910|FG001|Period 2|Intercurrent disease|1|||
25245657|NCT01262872|50560924|FG000|Step 2|Death|0|||
25245658|NCT01262872|50560925|FG001|Step 2|Death|0|||
25245659|NCT01262872|50560926|FG002|Step 2|Death|0|||
25324491|NCT00536731|50640630|FG002|Overall Study|Other|0|||
25324492|NCT00536575|50640638|FG000|Overall Study|Withdrawal by Subject|1|||
25245660|NCT01262872|50560927|FG003|Step 2|Death|1|||
25324493|NCT00536575|50640638|FG000|Overall Study|Death|1|||
25324494|NCT03214250|50640649|FG000|Overall Study|Death|5|||
25324495|NCT03214250|50640650|FG001|Overall Study|Death|5|||
25324496|NCT03214250|50640651|FG002|Overall Study|Death|7|||
25245661|NCT01262872|50560928|FG004|Step 2|Death|0|||
25245662|NCT01262872|50560929|FG005|Step 2|Death|2|||
25245663|NCT01262872|50560930|FG006|Step 2|Death|2|||
25245664|NCT01262872|50560931|FG007|Step 2|Death|1|||
25245665|NCT01262872|50560924|FG000|Step 2|Protocol Violation|0|||
25245666|NCT01262872|50560925|FG001|Step 2|Protocol Violation|0|||
25324497|NCT03214250|50640652|FG003|Overall Study|Death|4|||
25324498|NCT03214250|50640653|FG004|Overall Study|Death|23|||
25324499|NCT03214250|50640654|FG005|Overall Study|Death|23|||
25324500|NCT03214250|50640655|FG006|Overall Study|Death|24|||
25324501|NCT03214250|50640649|FG000|Overall Study|Lost to Follow-up|0|||
25324502|NCT03214250|50640650|FG001|Overall Study|Lost to Follow-up|0|||
25324503|NCT03214250|50640651|FG002|Overall Study|Lost to Follow-up|0|||
25324504|NCT03214250|50640652|FG003|Overall Study|Lost to Follow-up|1|||
25324505|NCT03214250|50640653|FG004|Overall Study|Lost to Follow-up|1|||
25324506|NCT03214250|50640654|FG005|Overall Study|Lost to Follow-up|2|||
25324507|NCT03214250|50640655|FG006|Overall Study|Lost to Follow-up|0|||
25324508|NCT03214250|50640649|FG000|Overall Study|Other|0|||
25245667|NCT01262872|50560926|FG002|Step 2|Protocol Violation|1|||
25245668|NCT01262872|50560927|FG003|Step 2|Protocol Violation|0|||
25245669|NCT01262872|50560928|FG004|Step 2|Protocol Violation|0|||
25245670|NCT01262872|50560929|FG005|Step 2|Protocol Violation|0|||
25245671|NCT01262872|50560930|FG006|Step 2|Protocol Violation|3|||
25245672|NCT01262872|50560931|FG007|Step 2|Protocol Violation|1|||
25245673|NCT01262872|50560924|FG000|Step 2|Withdrawal by Subject|0|||
25245674|NCT01262872|50560925|FG001|Step 2|Withdrawal by Subject|0|||
25245675|NCT01262872|50560926|FG002|Step 2|Withdrawal by Subject|4|||
25245676|NCT01262872|50560927|FG003|Step 2|Withdrawal by Subject|6|||
25245677|NCT01262872|50560928|FG004|Step 2|Withdrawal by Subject|3|||
25245678|NCT01262872|50560929|FG005|Step 2|Withdrawal by Subject|1|||
25245679|NCT01262872|50560930|FG006|Step 2|Withdrawal by Subject|2|||
25245680|NCT01262872|50560931|FG007|Step 2|Withdrawal by Subject|1|||
25245681|NCT01262872|50560924|FG000|Step 2|Migrated/moved from study area|0|||
25245682|NCT01262872|50560925|FG001|Step 2|Migrated/moved from study area|0|||
25245683|NCT01262872|50560926|FG002|Step 2|Migrated/moved from study area|4|||
25245684|NCT01262872|50560927|FG003|Step 2|Migrated/moved from study area|3|||
25245685|NCT01262872|50560928|FG004|Step 2|Migrated/moved from study area|2|||
25245686|NCT01262872|50560929|FG005|Step 2|Migrated/moved from study area|6|||
25245687|NCT01262872|50560930|FG006|Step 2|Migrated/moved from study area|2|||
25245688|NCT01262872|50560931|FG007|Step 2|Migrated/moved from study area|3|||
25245689|NCT01262677|50560968|FG000|Overall Study|Does not meet entrance criteria|0|||
25245690|NCT01262677|50560969|FG001|Overall Study|Does not meet entrance criteria|2|||
25324509|NCT03214250|50640650|FG001|Overall Study|Other|0|||
25324510|NCT03214250|50640651|FG002|Overall Study|Other|0|||
25245691|NCT01262677|50560970|FG002|Overall Study|Does not meet entrance criteria|0|||
25245692|NCT01262677|50560968|FG000|Overall Study|Insufficient clinical response|0|||
25245693|NCT01262677|50560969|FG001|Overall Study|Insufficient clinical response|0|||
25245694|NCT01262677|50560970|FG002|Overall Study|Insufficient clinical response|1|||
25245695|NCT01262677|50560968|FG000|Overall Study|Lost to Follow-up|1|||
25245696|NCT01262677|50560969|FG001|Overall Study|Lost to Follow-up|0|||
25245697|NCT01262677|50560970|FG002|Overall Study|Lost to Follow-up|2|||
25245698|NCT01262677|50560968|FG000|Overall Study|No longer willing to participate|3|||
25245699|NCT01262677|50560969|FG001|Overall Study|No longer willing to participate|3|||
25245700|NCT01262677|50560970|FG002|Overall Study|No longer willing to participate|2|||
25245701|NCT01262677|50560968|FG000|Overall Study|Reason not provided|2|||
25245702|NCT01262677|50560969|FG001|Overall Study|Reason not provided|1|||
25245703|NCT01262677|50560970|FG002|Overall Study|Reason not provided|3|||
25245704|NCT01262677|50560968|FG000|Overall Study|Protocol Violation|0|||
25245705|NCT01262677|50560969|FG001|Overall Study|Protocol Violation|1|||
25245706|NCT01262677|50560970|FG002|Overall Study|Protocol Violation|1|||
25245707|NCT01262677|50560968|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
25245708|NCT01262677|50560969|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
25245709|NCT01262677|50560970|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
25245710|NCT01262638|50560982|FG000|Overall Study|Adverse Event|3|||
25245711|NCT01262638|50560983|FG001|Overall Study|Adverse Event|4|||
25324511|NCT03214250|50640652|FG003|Overall Study|Other|0|||
25324512|NCT03214250|50640653|FG004|Overall Study|Other|1|||
25324513|NCT03214250|50640654|FG005|Overall Study|Other|1|||
25324514|NCT03214250|50640655|FG006|Overall Study|Other|2|||
25324515|NCT03214250|50640649|FG000|Overall Study|Remains on Study|2|||
25245712|NCT01262638|50560984|FG002|Overall Study|Adverse Event|3|||
25245713|NCT01262638|50560985|FG003|Overall Study|Adverse Event|4|||
25245714|NCT01262638|50560982|FG000|Overall Study|Protocol Violation|1|||
25245715|NCT01262638|50560983|FG001|Overall Study|Protocol Violation|0|||
25245716|NCT01262638|50560984|FG002|Overall Study|Protocol Violation|0|||
25245717|NCT01262638|50560985|FG003|Overall Study|Protocol Violation|1|||
25324516|NCT03214250|50640650|FG001|Overall Study|Remains on Study|2|||
25324517|NCT03214250|50640651|FG002|Overall Study|Remains on Study|0|||
25324518|NCT03214250|50640652|FG003|Overall Study|Remains on Study|1|||
25324519|NCT03214250|50640653|FG004|Overall Study|Remains on Study|7|||
25324520|NCT03214250|50640654|FG005|Overall Study|Remains on Study|5|||
25324521|NCT03214250|50640655|FG006|Overall Study|Remains on Study|3|||
25324522|NCT03214250|50640649|FG000|Overall Study|Withdrawal by Subject|0|||
25324523|NCT03214250|50640650|FG001|Overall Study|Withdrawal by Subject|0|||
25324524|NCT03214250|50640651|FG002|Overall Study|Withdrawal by Subject|1|||
25324525|NCT03214250|50640652|FG003|Overall Study|Withdrawal by Subject|2|||
25324526|NCT03214250|50640653|FG004|Overall Study|Withdrawal by Subject|5|||
25324527|NCT03214250|50640654|FG005|Overall Study|Withdrawal by Subject|0|||
25324528|NCT03214250|50640655|FG006|Overall Study|Withdrawal by Subject|2|||
25324529|NCT00874770|50640679|FG000|Overall Study|Lack of Efficacy|2|||
25324530|NCT00874770|50640680|FG001|Overall Study|Lack of Efficacy|0|||
25324531|NCT00874770|50640681|FG002|Overall Study|Lack of Efficacy|0|||
25324532|NCT00874770|50640682|FG003|Overall Study|Lack of Efficacy|2|||
25324533|NCT00874770|50640679|FG000|Overall Study|Adverse Event|1|||
25324534|NCT00874770|50640680|FG001|Overall Study|Adverse Event|1|||
25324535|NCT00874770|50640681|FG002|Overall Study|Adverse Event|4|||
25324536|NCT00874770|50640682|FG003|Overall Study|Adverse Event|2|||
25324537|NCT00874770|50640679|FG000|Overall Study|Lost to Follow-up|1|||
25324538|NCT00874770|50640680|FG001|Overall Study|Lost to Follow-up|0|||
25324539|NCT00874770|50640681|FG002|Overall Study|Lost to Follow-up|0|||
25324540|NCT00874770|50640682|FG003|Overall Study|Lost to Follow-up|1|||
25324541|NCT00874770|50640679|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
25324542|NCT00874770|50640680|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
25324543|NCT00874770|50640681|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
25324544|NCT00874770|50640682|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
25324545|NCT00536263|50640705|FG000|Overall Study|Adverse Event|5|||
25324546|NCT00536263|50640706|FG001|Overall Study|Adverse Event|5|||
25324547|NCT00536263|50640707|FG002|Overall Study|Adverse Event|7|||
25324548|NCT00536263|50640705|FG000|Overall Study|Lost to Follow-up|3|||
25324549|NCT00536263|50640706|FG001|Overall Study|Lost to Follow-up|4|||
25324550|NCT00536263|50640707|FG002|Overall Study|Lost to Follow-up|4|||
25324551|NCT00536263|50640705|FG000|Overall Study|Subject withdrew - not treatment related|2|||
25324552|NCT00536263|50640706|FG001|Overall Study|Subject withdrew - not treatment related|0|||
25324553|NCT00536263|50640707|FG002|Overall Study|Subject withdrew - not treatment related|5|||
25324554|NCT00536263|50640705|FG000|Overall Study|Subject withdrew - treatment related|0|||
25324555|NCT00536263|50640706|FG001|Overall Study|Subject withdrew - treatment related|3|||
25324556|NCT00536263|50640707|FG002|Overall Study|Subject withdrew - treatment related|2|||
25324557|NCT00536263|50640705|FG000|Overall Study|Noncompliance with protocol|0|||
25324558|NCT00536263|50640706|FG001|Overall Study|Noncompliance with protocol|0|||
25324559|NCT00536263|50640707|FG002|Overall Study|Noncompliance with protocol|1|||
25324560|NCT00536263|50640705|FG000|Overall Study|Did not meet protocol eligibility|1|||
25324561|NCT00536263|50640706|FG001|Overall Study|Did not meet protocol eligibility|2|||
25324562|NCT00536263|50640707|FG002|Overall Study|Did not meet protocol eligibility|2|||
25324563|NCT00578344|50640715|FG000|Overall Study|Insurance problems|1|||
25324564|NCT00578344|50640715|FG000|Overall Study|Graft failure|1|||
24977073|NCT00379769|50065796|FG003|Main Study|Investigator refused to log temperature|0|||
24977074|NCT00379769|50065797|FG004|Main Study|Investigator refused to log temperature|0|||
24977075|NCT00379769|50065798|FG005|Main Study|Investigator refused to log temperature|0|||
25077763|NCT03318523|50185663|FG000|PC Period: Up to Year 1|Adverse Event|1|||
24977076|NCT00379769|50065793|FG000|Main Study|Reason unspecified|0|||
25077764|NCT03318523|50185664|FG001|PC Period: Up to Year 1|Adverse Event|0|||
25245718|NCT01262638|50560982|FG000|Overall Study|Withdrawal by Subject|2|||
25245719|NCT01262638|50560983|FG001|Overall Study|Withdrawal by Subject|1|||
25245720|NCT01262638|50560984|FG002|Overall Study|Withdrawal by Subject|0|||
25324565|NCT00873366|50640719|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
25324566|NCT00873366|50640719|FG000|Overall Study|Off tamoxifen due to side effects|2|||
25324567|NCT00873366|50640719|FG000|Overall Study|Refused to continue DM-BT testing|3|||
25077765|NCT03318523|50185665|FG002|PC Period: Up to Year 1|Adverse Event|2|||
25077766|NCT03318523|50185666|FG003|PC Period: Up to Year 1|Adverse Event|0|||
25077767|NCT03318523|50185667|FG004|PC Period: Up to Year 1|Adverse Event|0|||
25077768|NCT03318523|50185668|FG005|PC Period: Up to Year 1|Adverse Event|0|||
25077769|NCT03318523|50185669|FG006|PC Period: Up to Year 1|Adverse Event|0|||
25324568|NCT00536107|50640725|FG000|Overall Study|Death|5|||
25324569|NCT00536107|50640726|FG001|Overall Study|Death|1|||
25324570|NCT00536107|50640725|FG000|Overall Study|Incorrect enrolment|1|||
25324571|NCT00536107|50640726|FG001|Overall Study|Incorrect enrolment|0|||
25324572|NCT00536107|50640725|FG000|Overall Study|Withdrawal by Subject|0|||
25324573|NCT00536107|50640726|FG001|Overall Study|Withdrawal by Subject|1|||
25324574|NCT00536107|50640725|FG000|Overall Study|Study Termination|2|||
25324575|NCT00536107|50640726|FG001|Overall Study|Study Termination|4|||
25324576|NCT00885482|50640755|FG000|Overall Study|Pregnancy|1|||
25324577|NCT00885482|50640755|FG000|Overall Study|Lack of Efficacy|1|||
25324578|NCT00885482|50640755|FG000|Overall Study|Death|1|||
25324579|NCT00885482|50640755|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
25324580|NCT00885170|50640779|FG000|Overall Study|Adverse Event|12|||
25324581|NCT00885170|50640780|FG001|Overall Study|Adverse Event|4|||
25324582|NCT00885170|50640779|FG000|Overall Study|Excessive bone loss|6|||
25324583|NCT00885170|50640780|FG001|Overall Study|Excessive bone loss|3|||
25324584|NCT00885170|50640779|FG000|Overall Study|Lost to Follow-up|2|||
25324585|NCT00885170|50640780|FG001|Overall Study|Lost to Follow-up|1|||
25324586|NCT00885170|50640779|FG000|Overall Study|Physician Decision|2|||
25324587|NCT00885170|50640780|FG001|Overall Study|Physician Decision|1|||
25324588|NCT00885170|50640779|FG000|Overall Study|Protocol Violation|3|||
25324589|NCT00885170|50640780|FG001|Overall Study|Protocol Violation|1|||
25324590|NCT00885170|50640779|FG000|Overall Study|Withdrawal by Subject|13|||
25324591|NCT00885170|50640780|FG001|Overall Study|Withdrawal by Subject|13|||
25324592|NCT00866619|50640807|FG000|Overall Study|Adverse Event|112|||
25324593|NCT00866619|50640808|FG001|Overall Study|Adverse Event|106|||
25324594|NCT00866619|50640809|FG002|Overall Study|Adverse Event|47|||
25324595|NCT00866619|50640810|FG003|Overall Study|Adverse Event|44|||
25077770|NCT03318523|50185670|FG007|PC Period: Up to Year 1|Adverse Event|0|||
25324596|NCT00866619|50640807|FG000|Overall Study|Protocol Violation|2|||
25324597|NCT00866619|50640808|FG001|Overall Study|Protocol Violation|39|||
25324598|NCT00866619|50640809|FG002|Overall Study|Protocol Violation|2|||
24977077|NCT00379769|50065794|FG001|Main Study|Reason unspecified|0|||
24977078|NCT00379769|50065795|FG002|Main Study|Reason unspecified|1|||
24977079|NCT00379769|50065796|FG003|Main Study|Reason unspecified|0|||
25324599|NCT00866619|50640810|FG003|Overall Study|Protocol Violation|17|||
25324600|NCT00866619|50640807|FG000|Overall Study|Withdrawal by Subject|587|||
25324601|NCT00866619|50640808|FG001|Overall Study|Withdrawal by Subject|295|||
25324602|NCT00866619|50640809|FG002|Overall Study|Withdrawal by Subject|272|||
25324603|NCT00866619|50640810|FG003|Overall Study|Withdrawal by Subject|144|||
25324604|NCT00866619|50640807|FG000|Overall Study|Lost to Follow-up|1145|||
25324605|NCT00866619|50640808|FG001|Overall Study|Lost to Follow-up|830|||
25324606|NCT00866619|50640809|FG002|Overall Study|Lost to Follow-up|568|||
25324607|NCT00866619|50640810|FG003|Overall Study|Lost to Follow-up|425|||
25324608|NCT00884390|50640857|FG000|Overall Study|Adverse Event|0|||
25324609|NCT00884390|50640858|FG001|Overall Study|Adverse Event|1|||
25324610|NCT00884390|50640857|FG000|Overall Study|Lost to Follow-up|0|||
25324611|NCT00884390|50640858|FG001|Overall Study|Lost to Follow-up|1|||
25324612|NCT00884390|50640857|FG000|Overall Study|Physician Decision|2|||
25324613|NCT00884390|50640858|FG001|Overall Study|Physician Decision|1|||
25324614|NCT00884390|50640857|FG000|Overall Study|Protocol Violation|4|||
25324615|NCT00884390|50640858|FG001|Overall Study|Protocol Violation|1|||
25324616|NCT00884390|50640857|FG000|Overall Study|Withdrawal by Subject|4|||
25324617|NCT00884390|50640858|FG001|Overall Study|Withdrawal by Subject|1|||
25324618|NCT00884390|50640857|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
25324619|NCT00884390|50640858|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
25324620|NCT00884390|50640857|FG000|Overall Study|Other|11|||
25324621|NCT00884390|50640858|FG001|Overall Study|Other|1|||
25324622|NCT00872898|50640895|FG000|Part Two - Double Blind|Adverse Event|4|||
25324623|NCT00872898|50640896|FG001|Part Two - Double Blind|Adverse Event|3|||
25324624|NCT00872898|50640895|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
25324625|NCT00872898|50640896|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
25324626|NCT00872898|50640895|FG000|Part Two - Double Blind|Protocol Violation|1|||
25324627|NCT00872898|50640896|FG001|Part Two - Double Blind|Protocol Violation|0|||
25324628|NCT00872898|50640895|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
25324629|NCT00872898|50640896|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
25324630|NCT00872898|50640895|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
25324631|NCT00872898|50640896|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
25324632|NCT00872898|50640895|FG000|Part Two - Double Blind|Other reasons|2|||
25324633|NCT00872898|50640896|FG001|Part Two - Double Blind|Other reasons|0|||
25324634|NCT00884312|50640907|FG000|Overall Study|Non-fatal Progressive Disease|0|||
25324635|NCT00884312|50640908|FG001|Overall Study|Non-fatal Progressive Disease|8|||
25324636|NCT00884312|50640907|FG000|Overall Study|Fatal Progressive Disease|0|||
25324637|NCT00884312|50640908|FG001|Overall Study|Fatal Progressive Disease|1|||
25324638|NCT00884312|50640907|FG000|Overall Study|Non-fatal Adverse Event|1|||
25324639|NCT00884312|50640908|FG001|Overall Study|Non-fatal Adverse Event|0|||
25324640|NCT00884312|50640907|FG000|Overall Study|Fatal Adverse Event|1|||
25324641|NCT00884312|50640908|FG001|Overall Study|Fatal Adverse Event|4|||
25324642|NCT00884312|50640907|FG000|Overall Study|Withdrawal by Subject|0|||
25324643|NCT00884312|50640908|FG001|Overall Study|Withdrawal by Subject|6|||
25245721|NCT01262638|50560985|FG003|Overall Study|Withdrawal by Subject|1|||
25245722|NCT01262638|50560982|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
25245723|NCT01262638|50560983|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
25245724|NCT01262638|50560984|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
25245725|NCT01262638|50560985|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
25245726|NCT01262638|50560982|FG000|Overall Study|Lost to Follow-up|1|||
25245727|NCT01262638|50560983|FG001|Overall Study|Lost to Follow-up|1|||
25245728|NCT01262638|50560984|FG002|Overall Study|Lost to Follow-up|1|||
25245729|NCT01262638|50560985|FG003|Overall Study|Lost to Follow-up|1|||
25245730|NCT01262638|50560982|FG000|Overall Study|Participant Went Out of Town|0|||
25245731|NCT01262638|50560983|FG001|Overall Study|Participant Went Out of Town|0|||
25324644|NCT00884312|50640907|FG000|Overall Study|Physician Decision|0|||
25324645|NCT00884312|50640908|FG001|Overall Study|Physician Decision|1|||
25324646|NCT00884312|50640907|FG000|Overall Study|Other|0|||
25324647|NCT00884312|50640908|FG001|Overall Study|Other|4|||
25324648|NCT00884312|50640907|FG000|Overall Study|Did Not Receive Study Drug|0|||
25324649|NCT00884312|50640908|FG001|Overall Study|Did Not Receive Study Drug|1|||
25324650|NCT00534313|50640918|FG000|Short-term Period|Adverse Event|1|||
25324651|NCT00534313|50640919|FG001|Short-term Period|Adverse Event|2|||
25324652|NCT00534313|50640920|FG002|Short-term Period|Adverse Event|1|||
25324653|NCT00534313|50640921|FG003|Short-term Period|Adverse Event|3|||
25324654|NCT00534313|50640918|FG000|Short-term Period|Lack of Efficacy|3|||
25324655|NCT00534313|50640919|FG001|Short-term Period|Lack of Efficacy|4|||
25324656|NCT00534313|50640920|FG002|Short-term Period|Lack of Efficacy|0|||
25324657|NCT00534313|50640921|FG003|Short-term Period|Lack of Efficacy|3|||
25324658|NCT00534313|50640918|FG000|Short-term Period|Participant not meeting study criteria|0|||
25324659|NCT00534313|50640919|FG001|Short-term Period|Participant not meeting study criteria|0|||
25324660|NCT00534313|50640920|FG002|Short-term Period|Participant not meeting study criteria|0|||
24977080|NCT00379769|50065797|FG004|Main Study|Reason unspecified|0|||
24977081|NCT00379769|50065798|FG005|Main Study|Reason unspecified|0|||
24977082|NCT00379769|50065793|FG000|Observational Follow-up|Death|0|||
24977083|NCT00379769|50065794|FG001|Observational Follow-up|Death|0|||
24977084|NCT00379769|50065795|FG002|Observational Follow-up|Death|0|||
24977085|NCT00379769|50065796|FG003|Observational Follow-up|Death|0|||
24977086|NCT00379769|50065797|FG004|Observational Follow-up|Death|78|||
24977087|NCT00379769|50065798|FG005|Observational Follow-up|Death|70|||
24977088|NCT00379769|50065793|FG000|Observational Follow-up|Adverse Event|0|||
24977089|NCT00379769|50065794|FG001|Observational Follow-up|Adverse Event|0|||
24977090|NCT00379769|50065795|FG002|Observational Follow-up|Adverse Event|0|||
24977091|NCT00379769|50065796|FG003|Observational Follow-up|Adverse Event|0|||
24977092|NCT00379769|50065797|FG004|Observational Follow-up|Adverse Event|1|||
24977093|NCT00379769|50065798|FG005|Observational Follow-up|Adverse Event|0|||
24977094|NCT00379769|50065793|FG000|Observational Follow-up|Lost to Follow-up|0|||
24977095|NCT00379769|50065794|FG001|Observational Follow-up|Lost to Follow-up|0|||
24977096|NCT00379769|50065795|FG002|Observational Follow-up|Lost to Follow-up|0|||
24977097|NCT00379769|50065796|FG003|Observational Follow-up|Lost to Follow-up|0|||
24977098|NCT00379769|50065797|FG004|Observational Follow-up|Lost to Follow-up|25|||
24977099|NCT00379769|50065798|FG005|Observational Follow-up|Lost to Follow-up|27|||
24977100|NCT00379769|50065793|FG000|Observational Follow-up|Withdrawal by Subject|0|||
24977101|NCT00379769|50065794|FG001|Observational Follow-up|Withdrawal by Subject|0|||
24977102|NCT00379769|50065795|FG002|Observational Follow-up|Withdrawal by Subject|0|||
25077771|NCT03318523|50185671|FG008|PC Period: Up to Year 1|Adverse Event|0|||
25077772|NCT03318523|50185672|FG009|PC Period: Up to Year 1|Adverse Event|0|||
24977103|NCT00379769|50065796|FG003|Observational Follow-up|Withdrawal by Subject|0|||
24977104|NCT00379769|50065797|FG004|Observational Follow-up|Withdrawal by Subject|12|||
24977105|NCT00379769|50065798|FG005|Observational Follow-up|Withdrawal by Subject|12|||
25324661|NCT00534313|50640921|FG003|Short-term Period|Participant not meeting study criteria|1|||
25324662|NCT00534313|50640918|FG000|Short-term Period|Participant withdrew consent|2|||
25324663|NCT00534313|50640919|FG001|Short-term Period|Participant withdrew consent|0|||
25324664|NCT00534313|50640920|FG002|Short-term Period|Participant withdrew consent|0|||
25324665|NCT00534313|50640921|FG003|Short-term Period|Participant withdrew consent|2|||
25324666|NCT00534313|50640918|FG000|Short-term Period|Pregnancy|0|||
25324667|NCT00534313|50640919|FG001|Short-term Period|Pregnancy|0|||
25324668|NCT00534313|50640920|FG002|Short-term Period|Pregnancy|1|||
25324669|NCT00534313|50640921|FG003|Short-term Period|Pregnancy|0|||
25324670|NCT00534313|50640918|FG000|Long-term Period|Adverse Event|2|||
25324671|NCT00534313|50640919|FG001|Long-term Period|Adverse Event|1|||
25324672|NCT00534313|50640920|FG002|Long-term Period|Adverse Event|0|||
25324673|NCT00534313|50640921|FG003|Long-term Period|Adverse Event|1|||
25324674|NCT00534313|50640918|FG000|Long-term Period|Lack of Efficacy|14|||
25324675|NCT00534313|50640919|FG001|Long-term Period|Lack of Efficacy|10|||
25324676|NCT00534313|50640920|FG002|Long-term Period|Lack of Efficacy|14|||
25324677|NCT00534313|50640921|FG003|Long-term Period|Lack of Efficacy|12|||
25324678|NCT00534313|50640918|FG000|Long-term Period|Lost to Follow-up|1|||
25324679|NCT00534313|50640919|FG001|Long-term Period|Lost to Follow-up|2|||
24977106|NCT00379769|50065793|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
24977107|NCT00379769|50065794|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
25324680|NCT00534313|50640920|FG002|Long-term Period|Lost to Follow-up|0|||
25324681|NCT00534313|50640921|FG003|Long-term Period|Lost to Follow-up|0|||
25324682|NCT00534313|50640918|FG000|Long-term Period|Withdrawal by Subject|2|||
25324683|NCT00534313|50640919|FG001|Long-term Period|Withdrawal by Subject|2|||
25324684|NCT00534313|50640920|FG002|Long-term Period|Withdrawal by Subject|0|||
25324685|NCT00534313|50640921|FG003|Long-term Period|Withdrawal by Subject|0|||
25324686|NCT00534313|50640918|FG000|Long-term Period|No longer meets study criteria|0|||
25324687|NCT00534313|50640919|FG001|Long-term Period|No longer meets study criteria|1|||
25324688|NCT00534313|50640920|FG002|Long-term Period|No longer meets study criteria|0|||
25324689|NCT00534313|50640921|FG003|Long-term Period|No longer meets study criteria|0|||
25324690|NCT00534313|50640918|FG000|Long-term Period|Poor compliance/noncompliance|0|||
25324691|NCT00534313|50640919|FG001|Long-term Period|Poor compliance/noncompliance|1|||
25324692|NCT00534313|50640920|FG002|Long-term Period|Poor compliance/noncompliance|1|||
24977108|NCT00379769|50065795|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
24977109|NCT00379769|50065796|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
24977110|NCT00379769|50065797|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
24977111|NCT00379769|50065798|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
24977112|NCT00379769|50065793|FG000|Observational Follow-up|Physician Decision|0|||
24977113|NCT00379769|50065794|FG001|Observational Follow-up|Physician Decision|0|||
24977114|NCT00379769|50065795|FG002|Observational Follow-up|Physician Decision|0|||
24977115|NCT00379769|50065796|FG003|Observational Follow-up|Physician Decision|0|||
24977116|NCT00379769|50065797|FG004|Observational Follow-up|Physician Decision|8|||
24977117|NCT00379769|50065798|FG005|Observational Follow-up|Physician Decision|8|||
24977118|NCT00379769|50065793|FG000|Observational Follow-up|Site Closed Early|0|||
25245732|NCT01262638|50560984|FG002|Overall Study|Participant Went Out of Town|1|||
25245733|NCT01262638|50560985|FG003|Overall Study|Participant Went Out of Town|0|||
25245734|NCT01262560|50561001|FG000|Overall Study|Protocol Violation|0|||
25245735|NCT01262560|50561002|FG001|Overall Study|Protocol Violation|1|||
25245736|NCT01262560|50561003|FG002|Overall Study|Protocol Violation|2|||
25245737|NCT01262365|50561014|FG000|Overall Study|Lack of Efficacy|35|||
25245738|NCT01262365|50561015|FG001|Overall Study|Lack of Efficacy|30|||
25245739|NCT01262365|50561016|FG002|Overall Study|Lack of Efficacy|47|||
25245740|NCT01262365|50561014|FG000|Overall Study|Protocol Violation|3|||
25245741|NCT01262365|50561015|FG001|Overall Study|Protocol Violation|1|||
25245742|NCT01262365|50561016|FG002|Overall Study|Protocol Violation|1|||
25245743|NCT01262365|50561014|FG000|Overall Study|Lost to Follow-up|3|||
25245744|NCT01262365|50561015|FG001|Overall Study|Lost to Follow-up|7|||
25245745|NCT01262365|50561016|FG002|Overall Study|Lost to Follow-up|6|||
25245746|NCT01262365|50561014|FG000|Overall Study|Withdrawal by Subject|17|||
25245747|NCT01262365|50561015|FG001|Overall Study|Withdrawal by Subject|22|||
25245748|NCT01262365|50561016|FG002|Overall Study|Withdrawal by Subject|22|||
25245749|NCT01262365|50561014|FG000|Overall Study|Death|1|||
25245750|NCT01262365|50561015|FG001|Overall Study|Death|2|||
25324693|NCT00534313|50640921|FG003|Long-term Period|Poor compliance/noncompliance|0|||
25324694|NCT00534313|50640918|FG000|Long-term Period|Administrative reason by sponsor|17|||
25324695|NCT00534313|50640919|FG001|Long-term Period|Administrative reason by sponsor|15|||
25324696|NCT00534313|50640920|FG002|Long-term Period|Administrative reason by sponsor|26|||
25245751|NCT01262365|50561016|FG002|Overall Study|Death|1|||
25245752|NCT01262365|50561014|FG000|Overall Study|Adverse Event|26|||
25324697|NCT00534313|50640921|FG003|Long-term Period|Administrative reason by sponsor|18|||
25324698|NCT00534313|50640918|FG000|Long-term Period|Other|1|||
25245753|NCT01262365|50561015|FG001|Overall Study|Adverse Event|16|||
25245754|NCT01262365|50561016|FG002|Overall Study|Adverse Event|11|||
25245755|NCT01262365|50561014|FG000|Overall Study|sponsor decision|1|||
25245756|NCT01262365|50561015|FG001|Overall Study|sponsor decision|1|||
25245757|NCT01262365|50561016|FG002|Overall Study|sponsor decision|0|||
25245758|NCT01262365|50561014|FG000|Overall Study|Randomization error|1|||
25245759|NCT01262365|50561015|FG001|Overall Study|Randomization error|0|||
25245760|NCT01262365|50561016|FG002|Overall Study|Randomization error|2|||
25245761|NCT01262365|50561014|FG000|Overall Study|Non-compliance|1|||
25245762|NCT01262365|50561015|FG001|Overall Study|Non-compliance|0|||
25245763|NCT01262365|50561016|FG002|Overall Study|Non-compliance|2|||
25324699|NCT00534313|50640919|FG001|Long-term Period|Other|2|||
25324700|NCT00534313|50640920|FG002|Long-term Period|Other|2|||
25324701|NCT00534313|50640921|FG003|Long-term Period|Other|2|||
25324702|NCT02611960|50640968|FG000|Overall Study|COVID-19 Association Unspecified Adverse Event|7|||
25324703|NCT02611960|50640969|FG001|Overall Study|COVID-19 Association Unspecified Adverse Event|8|||
25324704|NCT02611960|50640968|FG000|Overall Study|Death|87|||
25324705|NCT02611960|50640969|FG001|Overall Study|Death|85|||
25324706|NCT02611960|50640968|FG000|Overall Study|Withdrawal by Subject|0|||
25324707|NCT02611960|50640969|FG001|Overall Study|Withdrawal by Subject|1|||
25324708|NCT02611960|50640968|FG000|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|1|||
25324709|NCT02611960|50640969|FG001|Overall Study|COVID-19 Association Unspecified Withdrawal By Participant|4|||
25324710|NCT02611960|50640968|FG000|Overall Study|Participants Ongoing|22|||
25324711|NCT02611960|50640969|FG001|Overall Study|Participants Ongoing|18|||
25324712|NCT03888391|50640976|FG000|Overall Study|Lost to Follow-up|15|||
25324713|NCT00594204|50640982|FG000|Overall Study|Adverse Event|15|||
25324714|NCT00594204|50640983|FG001|Overall Study|Adverse Event|3|||
25324715|NCT00594204|50640982|FG000|Overall Study|Lost to Follow-up|9|||
25324716|NCT00594204|50640983|FG001|Overall Study|Lost to Follow-up|5|||
25324717|NCT00594204|50640982|FG000|Overall Study|Withdrawal by Subject|23|||
25324718|NCT00594204|50640983|FG001|Overall Study|Withdrawal by Subject|29|||
25324719|NCT00594204|50640982|FG000|Overall Study|Other|4|||
25324720|NCT00594204|50640983|FG001|Overall Study|Other|3|||
25245764|NCT01262365|50561014|FG000|Overall Study|Suspected pregnancy|1|||
25245765|NCT01262365|50561015|FG001|Overall Study|Suspected pregnancy|0|||
25245766|NCT01262365|50561016|FG002|Overall Study|Suspected pregnancy|0|||
25245767|NCT01262365|50561014|FG000|Overall Study|Patient pregnant|1|||
25245768|NCT01262365|50561015|FG001|Overall Study|Patient pregnant|0|||
25245769|NCT01262365|50561016|FG002|Overall Study|Patient pregnant|1|||
25245770|NCT01262365|50561014|FG000|Overall Study|Toxicity related to study drug|0|||
25245771|NCT01262365|50561015|FG001|Overall Study|Toxicity related to study drug|1|||
25245772|NCT01262365|50561016|FG002|Overall Study|Toxicity related to study drug|0|||
25245773|NCT01262365|50561014|FG000|Overall Study|Cannot tolerate the protocol|0|||
25245774|NCT01262365|50561015|FG001|Overall Study|Cannot tolerate the protocol|1|||
25245775|NCT01262365|50561016|FG002|Overall Study|Cannot tolerate the protocol|0|||
25245776|NCT01262365|50561014|FG000|Overall Study|Patient unavailable|0|||
25245777|NCT01262365|50561015|FG001|Overall Study|Patient unavailable|0|||
25245778|NCT01262365|50561016|FG002|Overall Study|Patient unavailable|1|||
25245779|NCT03932812|50561026|FG000|Overall Study|Lost to Follow-up|12|||
25245780|NCT03932812|50561027|FG001|Overall Study|Lost to Follow-up|14|||
25324721|NCT00594204|50640982|FG000|Overall Study|Lack of Efficacy|3|||
25324722|NCT00594204|50640983|FG001|Overall Study|Lack of Efficacy|4|||
25324723|NCT00594204|50640982|FG000|Overall Study|Randomized but not treated|4|||
25324724|NCT00594204|50640983|FG001|Overall Study|Randomized but not treated|1|||
25324725|NCT03888235|50641001|FG000|Overall Study|Lost to Follow-up|1|||
25245781|NCT03932812|50561026|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
25245782|NCT03932812|50561027|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
25245783|NCT01262287|50561036|FG000|Overall Study|Lost to Follow-up|2|||
25324726|NCT03888235|50641002|FG001|Overall Study|Lost to Follow-up|1|||
25245784|NCT01262287|50561037|FG001|Overall Study|Lost to Follow-up|1|||
25245785|NCT01262092|50561049|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
25245786|NCT01262092|50561050|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
25245787|NCT01262092|50561049|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
25245788|NCT01262092|50561050|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
25245789|NCT01262092|50561049|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
25245790|NCT01262092|50561050|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
25245791|NCT01262092|50561049|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
25245792|NCT01262092|50561050|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
25245793|NCT01261975|50561056|FG000|Overall Study|Surgical complication|1|||
25245794|NCT01261780|50561065|FG000|Overall Study|Withdrawal by Subject|1|||
25245795|NCT01261780|50561066|FG001|Overall Study|Withdrawal by Subject|0|||
25245796|NCT01261780|50561065|FG000|Overall Study|Event not related to subject|1|||
25245797|NCT01261780|50561066|FG001|Overall Study|Event not related to subject|2|||
25245798|NCT01261624|50561074|FG000|Week 0 to Week 12|Disease Progression|1|||
25245799|NCT01261624|50561075|FG001|Week 0 to Week 12|Disease Progression|1|||
25245800|NCT01261624|50561074|FG000|Week 0 to Week 12|Insufficient Response|0|||
25245801|NCT01261624|50561075|FG001|Week 0 to Week 12|Insufficient Response|2|||
25245802|NCT01261624|50561074|FG000|Week 13 to Week 24|Insufficient Response|0|||
25245803|NCT01261624|50561075|FG001|Week 13 to Week 24|Insufficient Response|1|||
25245804|NCT03694522|50561089|FG000|Overall Study|Withdrawal by Subject|8|||
25245805|NCT03694522|50561090|FG001|Overall Study|Withdrawal by Subject|10|||
25245806|NCT03694522|50561089|FG000|Overall Study|Physician Decision|53|||
25245807|NCT03694522|50561090|FG001|Overall Study|Physician Decision|54|||
25245808|NCT03694522|50561089|FG000|Overall Study|Other|1|||
25245809|NCT03694522|50561090|FG001|Overall Study|Other|1|||
25245810|NCT03694522|50561089|FG000|Overall Study|Lost to Follow-up|0|||
25245811|NCT03694522|50561090|FG001|Overall Study|Lost to Follow-up|1|||
25245812|NCT01261390|50561100|FG000|Overall Study|Significant Concurrent Illness|1|||
25245813|NCT01261390|50561101|FG001|Overall Study|Significant Concurrent Illness|0|||
25245814|NCT01261390|50561102|FG002|Overall Study|Significant Concurrent Illness|1|||
25245815|NCT01261390|50561103|FG003|Overall Study|Significant Concurrent Illness|0|||
25245816|NCT01261390|50561100|FG000|Overall Study|Dissatisfaction with Treatment|2|||
25245817|NCT01261390|50561101|FG001|Overall Study|Dissatisfaction with Treatment|1|||
25245818|NCT01261390|50561102|FG002|Overall Study|Dissatisfaction with Treatment|1|||
25245819|NCT01261390|50561103|FG003|Overall Study|Dissatisfaction with Treatment|2|||
25245820|NCT01261390|50561100|FG000|Overall Study|Relocation|0|||
25245821|NCT01261390|50561101|FG001|Overall Study|Relocation|1|||
25324727|NCT03888235|50641003|FG002|Overall Study|Lost to Follow-up|0|||
25324728|NCT00866307|50641034|FG000|Induction|Adverse Event|5|||
25324729|NCT00866307|50641035|FG001|Induction|Adverse Event|0|||
25324730|NCT00866307|50641036|FG002|Induction|Adverse Event|0|||
25324731|NCT00866307|50641034|FG000|Induction|Death|2|||
25324732|NCT00866307|50641035|FG001|Induction|Death|0|||
25324733|NCT00866307|50641036|FG002|Induction|Death|0|||
25324734|NCT00866307|50641034|FG000|Induction|Physician Decision|5|||
25324735|NCT00866307|50641035|FG001|Induction|Physician Decision|0|||
25324736|NCT00866307|50641036|FG002|Induction|Physician Decision|0|||
25324737|NCT00866307|50641034|FG000|Induction|Progressive Disease|1|||
25324738|NCT00866307|50641035|FG001|Induction|Progressive Disease|0|||
25324739|NCT00866307|50641036|FG002|Induction|Progressive Disease|0|||
25324740|NCT00866307|50641034|FG000|Induction|Identification of Patients with Day 29 M|3|||
25324741|NCT00866307|50641035|FG001|Induction|Identification of Patients with Day 29 M|0|||
25324742|NCT00866307|50641036|FG002|Induction|Identification of Patients with Day 29 M|0|||
25324743|NCT00866307|50641034|FG000|Induction|Inadequate cytognetic samples th|1|||
25324744|NCT00866307|50641035|FG001|Induction|Inadequate cytognetic samples th|0|||
25324745|NCT00866307|50641036|FG002|Induction|Inadequate cytognetic samples th|0|||
25324746|NCT00866307|50641034|FG000|Induction|Improper post-induction consent|2|||
25324747|NCT00866307|50641035|FG001|Induction|Improper post-induction consent|0|||
25324748|NCT00866307|50641036|FG002|Induction|Improper post-induction consent|0|||
25324749|NCT00866307|50641034|FG000|Induction|Study was closed at the time|1|||
25324750|NCT00866307|50641035|FG001|Induction|Study was closed at the time|0|||
25245822|NCT01261390|50561102|FG002|Overall Study|Relocation|0|||
25245823|NCT01261390|50561103|FG003|Overall Study|Relocation|0|||
25245824|NCT01261390|50561100|FG000|Overall Study|Loss of Interest in the Study|3|||
25245825|NCT01261390|50561101|FG001|Overall Study|Loss of Interest in the Study|1|||
25245826|NCT01261390|50561102|FG002|Overall Study|Loss of Interest in the Study|0|||
25324751|NCT00866307|50641036|FG002|Induction|Study was closed at the time|0|||
25324752|NCT00866307|50641034|FG000|Consolidation/Maintenance|Adverse Event|0|||
25324753|NCT00866307|50641035|FG001|Consolidation/Maintenance|Adverse Event|0|||
25324754|NCT00866307|50641036|FG002|Consolidation/Maintenance|Adverse Event|8|||
25324755|NCT00866307|50641034|FG000|Consolidation/Maintenance|Death|0|||
25245827|NCT01261390|50561103|FG003|Overall Study|Loss of Interest in the Study|0|||
25245828|NCT01261390|50561100|FG000|Overall Study|Lost to Follow-up|1|||
25324756|NCT00866307|50641035|FG001|Consolidation/Maintenance|Death|0|||
25324757|NCT00866307|50641036|FG002|Consolidation/Maintenance|Death|1|||
25245829|NCT01261390|50561101|FG001|Overall Study|Lost to Follow-up|6|||
25245830|NCT01261390|50561102|FG002|Overall Study|Lost to Follow-up|5|||
25245831|NCT01261390|50561103|FG003|Overall Study|Lost to Follow-up|6|||
25245832|NCT03391882|50561124|FG000|Study Overall|Adverse Event|3|||
25245833|NCT03391882|50561125|FG001|Study Overall|Adverse Event|6|||
25245834|NCT03391882|50561126|FG002|Study Overall|Adverse Event|1|||
25245835|NCT03391882|50561127|FG003|Study Overall|Adverse Event|1|||
25245836|NCT03391882|50561128|FG004|Study Overall|Adverse Event|3|||
25245837|NCT03391882|50561129|FG005|Study Overall|Adverse Event|1|||
25245838|NCT03391882|50561124|FG000|Study Overall|Lack of Efficacy|13|||
25245839|NCT03391882|50561125|FG001|Study Overall|Lack of Efficacy|9|||
25245840|NCT03391882|50561126|FG002|Study Overall|Lack of Efficacy|0|||
25245841|NCT03391882|50561127|FG003|Study Overall|Lack of Efficacy|0|||
25245842|NCT03391882|50561128|FG004|Study Overall|Lack of Efficacy|0|||
25245843|NCT03391882|50561129|FG005|Study Overall|Lack of Efficacy|0|||
25245844|NCT03391882|50561124|FG000|Study Overall|Withdrawal by Subject|3|||
25245845|NCT03391882|50561125|FG001|Study Overall|Withdrawal by Subject|3|||
25245846|NCT03391882|50561126|FG002|Study Overall|Withdrawal by Subject|2|||
25245847|NCT03391882|50561127|FG003|Study Overall|Withdrawal by Subject|2|||
25245848|NCT03391882|50561128|FG004|Study Overall|Withdrawal by Subject|1|||
25245849|NCT03391882|50561129|FG005|Study Overall|Withdrawal by Subject|3|||
25245850|NCT03391882|50561124|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
25245851|NCT03391882|50561125|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
25245852|NCT03391882|50561126|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
25245853|NCT03391882|50561127|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
25245854|NCT03391882|50561128|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
25245855|NCT03391882|50561129|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
25245856|NCT03391882|50561124|FG000|Study Overall|Protocol Violation|1|||
25245857|NCT03391882|50561125|FG001|Study Overall|Protocol Violation|0|||
25245858|NCT03391882|50561126|FG002|Study Overall|Protocol Violation|0|||
25245859|NCT03391882|50561127|FG003|Study Overall|Protocol Violation|0|||
25245860|NCT03391882|50561128|FG004|Study Overall|Protocol Violation|0|||
25245861|NCT03391882|50561129|FG005|Study Overall|Protocol Violation|0|||
25245862|NCT03391882|50561124|FG000|Part A - Titration Phase|Adverse Event|3|||
25245863|NCT03391882|50561125|FG001|Part A - Titration Phase|Adverse Event|6|||
25245864|NCT03391882|50561126|FG002|Part A - Titration Phase|Adverse Event|0|||
25245865|NCT03391882|50561127|FG003|Part A - Titration Phase|Adverse Event|0|||
25245866|NCT03391882|50561128|FG004|Part A - Titration Phase|Adverse Event|0|||
25324758|NCT00866307|50641034|FG000|Consolidation/Maintenance|Physician Decision|0|||
25324759|NCT00866307|50641035|FG001|Consolidation/Maintenance|Physician Decision|3|||
25324760|NCT00866307|50641036|FG002|Consolidation/Maintenance|Physician Decision|2|||
25324761|NCT00866307|50641034|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
25324762|NCT00866307|50641035|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
25324763|NCT00866307|50641036|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
25324764|NCT00866307|50641034|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
25245867|NCT03391882|50561129|FG005|Part A - Titration Phase|Adverse Event|0|||
25245868|NCT03391882|50561124|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
25245869|NCT03391882|50561125|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
25245870|NCT03391882|50561126|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
25245871|NCT03391882|50561127|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
25245872|NCT03391882|50561128|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
25245873|NCT03391882|50561129|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
25245874|NCT03391882|50561124|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
25245875|NCT03391882|50561125|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
25245876|NCT03391882|50561126|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
25245877|NCT03391882|50561127|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
25245878|NCT03391882|50561128|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
25245879|NCT03391882|50561129|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
25245880|NCT03391882|50561124|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
25245881|NCT03391882|50561125|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
25245882|NCT03391882|50561126|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
25245883|NCT03391882|50561127|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
25245884|NCT03391882|50561128|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
25245885|NCT03391882|50561129|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
25245886|NCT03391882|50561124|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
25245887|NCT03391882|50561125|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
25245888|NCT03391882|50561126|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
25245889|NCT03391882|50561127|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
25245890|NCT03391882|50561128|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
25324765|NCT00866307|50641035|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
25245891|NCT03391882|50561129|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
25245892|NCT03391882|50561124|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
25245893|NCT03391882|50561125|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
25245894|NCT03391882|50561126|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
25245895|NCT03391882|50561127|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
25245896|NCT03391882|50561128|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
25245897|NCT03391882|50561129|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
25245898|NCT03391882|50561124|FG000|Part B - Treatment Phase|Adverse Event|0|||
25245899|NCT03391882|50561125|FG001|Part B - Treatment Phase|Adverse Event|0|||
25245900|NCT03391882|50561126|FG002|Part B - Treatment Phase|Adverse Event|1|||
25245901|NCT03391882|50561127|FG003|Part B - Treatment Phase|Adverse Event|1|||
25245902|NCT03391882|50561128|FG004|Part B - Treatment Phase|Adverse Event|3|||
25245903|NCT03391882|50561129|FG005|Part B - Treatment Phase|Adverse Event|1|||
25245904|NCT03391882|50561124|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
25245905|NCT03391882|50561125|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
25245906|NCT03391882|50561126|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
25245907|NCT03391882|50561127|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
25245908|NCT03391882|50561128|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
25245909|NCT03391882|50561129|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
25245910|NCT01261000|50561139|FG000|Overall Study|Screen failure|1|||
25245911|NCT01234402|50561172|FG000|Overall Study|Lost to Follow-up|0|||
25245912|NCT01234402|50561173|FG001|Overall Study|Lost to Follow-up|1|||
25245913|NCT01234402|50561174|FG002|Overall Study|Lost to Follow-up|3|||
25245914|NCT01234402|50561172|FG000|Overall Study|Withdrawal by Subject|1|||
25245915|NCT01234402|50561173|FG001|Overall Study|Withdrawal by Subject|3|||
25245916|NCT01234402|50561174|FG002|Overall Study|Withdrawal by Subject|4|||
25245917|NCT01234402|50561172|FG000|Overall Study|Never treated: Death|0|||
25245918|NCT01234402|50561173|FG001|Overall Study|Never treated: Death|0|||
25245919|NCT01234402|50561174|FG002|Overall Study|Never treated: Death|1|||
25324766|NCT00866307|50641036|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
25324767|NCT00866307|50641034|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
25324768|NCT00866307|50641035|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
25324769|NCT00866307|50641036|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
25324770|NCT00866307|50641034|FG000|Consolidation/Maintenance|Therapy error|0|||
25324771|NCT00866307|50641035|FG001|Consolidation/Maintenance|Therapy error|1|||
25324772|NCT00866307|50641036|FG002|Consolidation/Maintenance|Therapy error|0|||
25324773|NCT00866307|50641034|FG000|Consolidation/Maintenance|Non-compliance|0|||
25324774|NCT00866307|50641035|FG001|Consolidation/Maintenance|Non-compliance|0|||
25324775|NCT00866307|50641036|FG002|Consolidation/Maintenance|Non-compliance|1|||
25324776|NCT00866307|50641034|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
25324777|NCT00866307|50641035|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
25324778|NCT00866307|50641036|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
25324779|NCT00531427|50641044|FG000|Overall Study|Withdrawal by Subject|7|||
25324780|NCT00531427|50641045|FG001|Overall Study|Withdrawal by Subject|13|||
25324781|NCT00531427|50641044|FG000|Overall Study|Adverse Event|44|||
25324782|NCT00531427|50641045|FG001|Overall Study|Adverse Event|30|||
25324783|NCT00531427|50641044|FG000|Overall Study|Lost to Follow-up|4|||
25324784|NCT00531427|50641045|FG001|Overall Study|Lost to Follow-up|3|||
25324785|NCT00531427|50641044|FG000|Overall Study|Lack of Efficacy|14|||
25324786|NCT00531427|50641045|FG001|Overall Study|Lack of Efficacy|39|||
25324787|NCT00531427|50641044|FG000|Overall Study|Administrative|4|||
25324788|NCT00531427|50641045|FG001|Overall Study|Administrative|9|||
25324789|NCT00871728|50641052|FG000|Overall Study|Adverse Event|1|||
25324790|NCT00871728|50641052|FG000|Overall Study|Protocol Violation|7|||
25324791|NCT00871728|50641052|FG000|Overall Study|Lost to Follow-up|2|||
25324792|NCT00871728|50641052|FG000|Overall Study|Failed to Visit Hospital|4|||
25324793|NCT00871728|50641052|FG000|Overall Study|Participant Non-compliance|1|||
25324794|NCT00871728|50641052|FG000|Overall Study|Withdrawal of Informed Consent|5|||
25324795|NCT00868998|50641056|FG000|Overall Study|Screen Failure|1|||
25324796|NCT00868998|50641056|FG000|Overall Study|Withdrawal by Subject|1|||
25324797|NCT00868998|50641056|FG000|Overall Study|Progression of disease|2|||
25324798|NCT00868998|50641056|FG000|Overall Study|Death|1|||
25324799|NCT00533845|50641071|FG000|Overall Study|Physician Decision|1|||
25324800|NCT00533845|50641072|FG001|Overall Study|Physician Decision|0|||
25324801|NCT00857649|50641080|FG000|Overall Study|Adverse Event|15|||
25324802|NCT00857649|50641081|FG001|Overall Study|Adverse Event|10|||
25324803|NCT00857649|50641080|FG000|Overall Study|Non-compliance|1|||
25245920|NCT01234402|50561172|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
25324804|NCT00857649|50641081|FG001|Overall Study|Non-compliance|1|||
25324805|NCT00857649|50641080|FG000|Overall Study|Protocol Violation|2|||
25324806|NCT00857649|50641081|FG001|Overall Study|Protocol Violation|2|||
25324807|NCT00857649|50641080|FG000|Overall Study|Withdrawal of Consent|10|||
25324808|NCT00857649|50641081|FG001|Overall Study|Withdrawal of Consent|7|||
25245921|NCT01234402|50561173|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
25245922|NCT01234402|50561174|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
25324809|NCT00857649|50641080|FG000|Overall Study|Nursing Home Placement|2|||
25324810|NCT00857649|50641081|FG001|Overall Study|Nursing Home Placement|9|||
25324811|NCT00857649|50641080|FG000|Overall Study|Other Reasons|1|||
25324812|NCT00857649|50641081|FG001|Overall Study|Other Reasons|3|||
25324813|NCT00857415|50641089|FG000|Overall Study|Image acquisition failure|2|||
25324814|NCT00857415|50641090|FG001|Overall Study|Image acquisition failure|0|||
25324815|NCT00857415|50641089|FG000|Overall Study|Invalid image or not imaged|3|||
25324816|NCT00857415|50641090|FG001|Overall Study|Invalid image or not imaged|0|||
25324817|NCT00857415|50641089|FG000|Overall Study|Subject still living at end of study|110|||
25324818|NCT00857415|50641090|FG001|Overall Study|Subject still living at end of study|0|||
25324819|NCT00857415|50641089|FG000|Overall Study|Deceased with no autopsy|2|||
25324820|NCT00857415|50641090|FG001|Overall Study|Deceased with no autopsy|0|||
25324821|NCT00532441|50641096|FG000|Overall Study|Death|1|||
25324822|NCT00532441|50641097|FG001|Overall Study|Death|0|||
25324823|NCT00857259|50641118|FG000|Overall Study|Protocol Violation|1|||
25324824|NCT00857259|50641119|FG001|Overall Study|Protocol Violation|0|||
25324825|NCT00857259|50641120|FG002|Overall Study|Protocol Violation|1|||
25324826|NCT00868608|50641133|FG000|Overall Study|Withdrawal by Subject|3|||
25324827|NCT00868608|50641134|FG001|Overall Study|Withdrawal by Subject|1|||
25324828|NCT00868608|50641135|FG002|Overall Study|Withdrawal by Subject|0|||
25324829|NCT00868608|50641133|FG000|Overall Study|Lost to Follow-up|3|||
25324830|NCT00868608|50641134|FG001|Overall Study|Lost to Follow-up|0|||
25324831|NCT00868608|50641135|FG002|Overall Study|Lost to Follow-up|1|||
25324832|NCT00868608|50641133|FG000|Overall Study|Death|16|||
25324833|NCT00868608|50641134|FG001|Overall Study|Death|2|||
25245923|NCT01234402|50561172|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
25245924|NCT01234402|50561173|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
25245925|NCT01234402|50561174|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
25245926|NCT01260922|50561186|FG000|First Intervention|Withdrawal by Subject|0|||
25245927|NCT01260922|50561187|FG001|First Intervention|Withdrawal by Subject|1|||
25245928|NCT01260922|50561186|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
25245929|NCT01260922|50561187|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
25245930|NCT01260922|50561186|FG000|Second Intervention|Emesis|0|||
25245931|NCT01260922|50561187|FG001|Second Intervention|Emesis|2|||
25245932|NCT01233817|50561193|FG000|Overall Study|Lost to Follow-up|1|||
25245933|NCT01233817|50561193|FG000|Overall Study|Withdrawal by Subject|2|||
25245934|NCT01233232|50561200|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
25245935|NCT01233232|50561201|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
25245936|NCT01233232|50561202|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
25245937|NCT01233076|50561212|FG000|Period 2, One Week|Lost to Follow-up|1|||
25245938|NCT01233076|50561213|FG001|Period 2, One Week|Lost to Follow-up|0|||
25245939|NCT01212094|50561222|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
25245940|NCT01212094|50561223|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
25245941|NCT01212094|50561224|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
25245942|NCT01212094|50561222|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
25245943|NCT01212094|50561223|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
25245944|NCT01212094|50561224|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
25245945|NCT01212094|50561222|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
25245946|NCT01212094|50561223|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
25245947|NCT01212094|50561224|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
25245948|NCT01212094|50561222|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
25245949|NCT01212094|50561223|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
25245950|NCT01212094|50561224|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
25245951|NCT01212094|50561222|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
25245952|NCT01212094|50561223|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
25245953|NCT01212094|50561224|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
25245954|NCT01212094|50561222|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
25324834|NCT00868608|50641135|FG002|Overall Study|Death|4|||
25324835|NCT00868608|50641133|FG000|Overall Study|Other - Unspecified|1|||
25324836|NCT00868608|50641134|FG001|Overall Study|Other - Unspecified|0|||
25324837|NCT00868608|50641135|FG002|Overall Study|Other - Unspecified|0|||
25324838|NCT00856635|50641145|FG000|Overall Study|Lost to Follow-up|2|||
25324839|NCT00856635|50641146|FG001|Overall Study|Lost to Follow-up|5|||
25324840|NCT00856635|50641145|FG000|Overall Study|Pregnancy|1|||
25324841|NCT00856635|50641146|FG001|Overall Study|Pregnancy|0|||
25324842|NCT00856635|50641145|FG000|Overall Study|Withdrawal by Subject|3|||
25324843|NCT00856635|50641146|FG001|Overall Study|Withdrawal by Subject|1|||
25324844|NCT00856635|50641145|FG000|Overall Study|Serious Adverse Event|1|||
25324845|NCT00856635|50641146|FG001|Overall Study|Serious Adverse Event|0|||
25324846|NCT00856635|50641145|FG000|Overall Study|Other|1|||
25324847|NCT00856635|50641146|FG001|Overall Study|Other|0|||
25324848|NCT00856635|50641145|FG000|Overall Study|Discontinued at Randomization|2|||
25324849|NCT00856635|50641146|FG001|Overall Study|Discontinued at Randomization|2|||
25324850|NCT00856557|50641156|FG000|Overall Study|No patients with contextual flags|12|||
25324851|NCT00856557|50641157|FG001|Overall Study|No patients with contextual flags|16|||
25324852|NCT00856323|50641163|FG000|Overall Study|Withdrawal by Subject|2|||
25245955|NCT01212094|50561223|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
25245956|NCT01212094|50561224|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
25245957|NCT01232569|50561233|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
25324853|NCT00856245|50641171|FG000|Overall Study|Was not transplanted|5|||
25324854|NCT00855933|50641177|FG000|Overall Study|Withdrawal by Subject|0|||
25324855|NCT00855933|50641178|FG001|Overall Study|Withdrawal by Subject|1|||
25324856|NCT00871572|50641188|FG000|Overall Study|Adverse Event|0|||
25324857|NCT00871572|50641189|FG001|Overall Study|Adverse Event|2|||
25324858|NCT00871572|50641190|FG002|Overall Study|Adverse Event|0|||
25324859|NCT00871572|50641191|FG003|Overall Study|Adverse Event|3|||
25324860|NCT00871572|50641188|FG000|Overall Study|Investigator Decision|0|||
25324861|NCT00871572|50641189|FG001|Overall Study|Investigator Decision|1|||
25324862|NCT00871572|50641190|FG002|Overall Study|Investigator Decision|0|||
25324863|NCT00871572|50641191|FG003|Overall Study|Investigator Decision|1|||
25324864|NCT00871572|50641188|FG000|Overall Study|Lost to Follow-up|0|||
25324865|NCT00871572|50641189|FG001|Overall Study|Lost to Follow-up|1|||
25324866|NCT00871572|50641190|FG002|Overall Study|Lost to Follow-up|0|||
25324867|NCT00871572|50641191|FG003|Overall Study|Lost to Follow-up|1|||
25324868|NCT00871572|50641188|FG000|Overall Study|Protocol Violation|0|||
25324869|NCT00871572|50641189|FG001|Overall Study|Protocol Violation|0|||
25324870|NCT00871572|50641190|FG002|Overall Study|Protocol Violation|1|||
25324871|NCT00871572|50641191|FG003|Overall Study|Protocol Violation|1|||
25324872|NCT00871572|50641188|FG000|Overall Study|Sponsor Decision|1|||
25324873|NCT00871572|50641189|FG001|Overall Study|Sponsor Decision|0|||
25245958|NCT01232569|50561234|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
25245959|NCT01232569|50561235|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
25245960|NCT01232569|50561236|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
25324874|NCT00871572|50641190|FG002|Overall Study|Sponsor Decision|0|||
25324875|NCT00871572|50641191|FG003|Overall Study|Sponsor Decision|0|||
25324876|NCT00871572|50641188|FG000|Overall Study|Withdrawal by Subject|1|||
25324877|NCT00871572|50641189|FG001|Overall Study|Withdrawal by Subject|2|||
25324878|NCT00871572|50641190|FG002|Overall Study|Withdrawal by Subject|3|||
25324879|NCT00871572|50641191|FG003|Overall Study|Withdrawal by Subject|1|||
25324880|NCT03885661|50641203|FG000|Overall Study|Withdrawal by Subject|0|||
25324881|NCT03885661|50641204|FG001|Overall Study|Withdrawal by Subject|1|||
25324882|NCT03885661|50641203|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
25324883|NCT03885661|50641204|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
25324884|NCT00868530|50641210|FG000|Overall Study|Adverse Event|3|||
25324885|NCT00868530|50641210|FG000|Overall Study|Lost to Follow-up|1|||
25324886|NCT00855465|50641216|FG000|Treatment Period|Adverse Event|4|||
25324887|NCT00855465|50641217|FG001|Treatment Period|Adverse Event|2|||
25324888|NCT00855465|50641216|FG000|Treatment Period|Death|2|||
25324889|NCT00855465|50641217|FG001|Treatment Period|Death|2|||
25324890|NCT00855465|50641216|FG000|Treatment Period|Lack of Efficacy|2|||
25324891|NCT00855465|50641217|FG001|Treatment Period|Lack of Efficacy|1|||
25324892|NCT00855465|50641216|FG000|Treatment Period|Non-compliance|1|||
25324893|NCT00855465|50641217|FG001|Treatment Period|Non-compliance|0|||
25324894|NCT00855465|50641216|FG000|Treatment Period|Protocol Violation|2|||
25324895|NCT00855465|50641217|FG001|Treatment Period|Protocol Violation|0|||
25324896|NCT00855465|50641216|FG000|Treatment Period|Withdrawal by Subject|2|||
25324897|NCT00855465|50641217|FG001|Treatment Period|Withdrawal by Subject|0|||
25324898|NCT00855465|50641216|FG000|Treatment Period|Not treated|1|||
25324899|NCT00855465|50641217|FG001|Treatment Period|Not treated|0|||
25324900|NCT00855465|50641216|FG000|Follow-up Period (FUP)|Adverse Event|0|||
25324901|NCT00855465|50641217|FG001|Follow-up Period (FUP)|Adverse Event|1|||
25324902|NCT00855465|50641216|FG000|Follow-up Period (FUP)|Death|0|||
25245961|NCT01232569|50561233|FG000|Double-blind Treatment Period|Escape|2|||
25245962|NCT01232569|50561234|FG001|Double-blind Treatment Period|Escape|2|||
25324903|NCT00855465|50641217|FG001|Follow-up Period (FUP)|Death|1|||
25324904|NCT00855465|50641216|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
25324905|NCT00855465|50641217|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
25324906|NCT00855465|50641216|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
25324907|NCT00855465|50641217|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
25324908|NCT00855465|50641216|FG000|Follow-up Period (FUP)|Missing|1|||
25324909|NCT00855465|50641217|FG001|Follow-up Period (FUP)|Missing|0|||
25324910|NCT00598442|50641226|FG000|Overall Study|Adverse Event|3|||
25324911|NCT00598442|50641227|FG001|Overall Study|Adverse Event|0|||
25324912|NCT00598442|50641228|FG002|Overall Study|Adverse Event|0|||
25245963|NCT01232569|50561235|FG002|Double-blind Treatment Period|Escape|0|||
25245964|NCT01232569|50561236|FG003|Double-blind Treatment Period|Escape|0|||
25245965|NCT01232569|50561233|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
25245966|NCT01232569|50561234|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
25245967|NCT01232569|50561235|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
25245968|NCT01232569|50561236|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
25324913|NCT00598442|50641226|FG000|Overall Study|Death|19|||
25324914|NCT00598442|50641227|FG001|Overall Study|Death|11|||
25324915|NCT00598442|50641228|FG002|Overall Study|Death|11|||
25324916|NCT00598442|50641226|FG000|Overall Study|Lost to Follow-up|4|||
25324917|NCT00598442|50641227|FG001|Overall Study|Lost to Follow-up|3|||
25324918|NCT00598442|50641228|FG002|Overall Study|Lost to Follow-up|3|||
25324919|NCT00598442|50641226|FG000|Overall Study|Physician Decision|2|||
25324920|NCT00598442|50641227|FG001|Overall Study|Physician Decision|1|||
25324921|NCT00598442|50641228|FG002|Overall Study|Physician Decision|1|||
25324922|NCT00598442|50641226|FG000|Overall Study|Withdrawal by Subject|8|||
25245969|NCT01232569|50561233|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
25245970|NCT01232569|50561234|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
25245971|NCT01232569|50561235|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
25245972|NCT01232569|50561236|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
25245973|NCT01232569|50561233|FG000|Double-blind Treatment Period|Physician Decision|1|||
25245974|NCT01232569|50561234|FG001|Double-blind Treatment Period|Physician Decision|0|||
25245975|NCT01232569|50561235|FG002|Double-blind Treatment Period|Physician Decision|0|||
25245976|NCT01232569|50561236|FG003|Double-blind Treatment Period|Physician Decision|0|||
25245977|NCT01232569|50561233|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
25245978|NCT01232569|50561234|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
25245979|NCT01232569|50561235|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
25245980|NCT01232569|50561236|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
25245981|NCT01232569|50561233|FG000|Double-blind Treatment Period|Death|2|||
25245982|NCT01232569|50561234|FG001|Double-blind Treatment Period|Death|0|||
25245983|NCT01232569|50561235|FG002|Double-blind Treatment Period|Death|0|||
25245984|NCT01232569|50561236|FG003|Double-blind Treatment Period|Death|0|||
25245985|NCT01211665|50561247|FG000|Overall Study|Withdrawal by Subject|1|||
25245986|NCT01211665|50561248|FG001|Overall Study|Withdrawal by Subject|0|||
25245987|NCT01211665|50561247|FG000|Overall Study|Death|1|||
25324923|NCT00598442|50641227|FG001|Overall Study|Withdrawal by Subject|16|||
25324924|NCT00598442|50641228|FG002|Overall Study|Withdrawal by Subject|6|||
25324925|NCT00598442|50641226|FG000|Overall Study|Noncompliance|0|||
25324926|NCT00598442|50641227|FG001|Overall Study|Noncompliance|2|||
25324927|NCT00598442|50641228|FG002|Overall Study|Noncompliance|1|||
25324928|NCT00598442|50641226|FG000|Overall Study|Relocation|1|||
25324929|NCT00598442|50641227|FG001|Overall Study|Relocation|4|||
25324930|NCT00598442|50641228|FG002|Overall Study|Relocation|0|||
25324931|NCT00598442|50641226|FG000|Overall Study|Renal transplant|0|||
25245988|NCT01211665|50561248|FG001|Overall Study|Death|0|||
25324932|NCT00598442|50641227|FG001|Overall Study|Renal transplant|0|||
25324933|NCT00598442|50641228|FG002|Overall Study|Renal transplant|1|||
25324934|NCT00598442|50641226|FG000|Overall Study|Site closed by sponsor|5|||
25324935|NCT00598442|50641227|FG001|Overall Study|Site closed by sponsor|2|||
25324936|NCT00598442|50641228|FG002|Overall Study|Site closed by sponsor|1|||
25324937|NCT00598442|50641226|FG000|Overall Study|Started dialysis|1|||
25324938|NCT00598442|50641227|FG001|Overall Study|Started dialysis|0|||
25324939|NCT00598442|50641228|FG002|Overall Study|Started dialysis|0|||
25324940|NCT00593814|50641238|FG000|Overall Study|Death|7|||
25324941|NCT00593814|50641239|FG001|Overall Study|Death|0|||
25324942|NCT00593814|50641238|FG000|Overall Study|Withdrawal by Subject|7|||
25324943|NCT00593814|50641239|FG001|Overall Study|Withdrawal by Subject|0|||
25324944|NCT00593814|50641238|FG000|Overall Study|Lost to Follow-up|7|||
25324945|NCT00593814|50641239|FG001|Overall Study|Lost to Follow-up|0|||
25324946|NCT00593814|50641238|FG000|Overall Study|Physician Decision|3|||
25324947|NCT00593814|50641239|FG001|Overall Study|Physician Decision|0|||
25324948|NCT00855309|50641247|FG000|Overall Study|patient never recieved drug|1|||
25324949|NCT00855309|50641248|FG001|Overall Study|patient never recieved drug|0|||
25324950|NCT00532129|50641254|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
25324951|NCT00532129|50641254|FG000|Treatment Period|Physician Decision|15|||
25324952|NCT00532129|50641254|FG000|Treatment Period|Disease progression|3|||
25324953|NCT00532129|50641254|FG000|Treatment Period|Protocol Violation|1|||
25324954|NCT00532129|50641254|FG000|Treatment Period|Other|5|||
25324955|NCT00532129|50641254|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
25324956|NCT00532129|50641254|FG000|Follow-up Period|Disease progression|57|||
25324957|NCT00532129|50641254|FG000|Follow-up Period|Lost to Follow-up|1|||
25324958|NCT00532129|50641254|FG000|Follow-up Period|Other|6|||
25324959|NCT00854607|50641258|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
25324960|NCT00854373|50641271|FG000|Overall Study|Withdrawal by Subject|1|||
25324961|NCT00854373|50641272|FG001|Overall Study|Withdrawal by Subject|3|||
25324962|NCT00854373|50641271|FG000|Overall Study|Forgot to take study drug|1|||
25324963|NCT00854373|50641272|FG001|Overall Study|Forgot to take study drug|1|||
25324964|NCT00853905|50641280|FG000|Overall Study|Lost to Follow-up|1|||
25324965|NCT00853905|50641281|FG001|Overall Study|Lost to Follow-up|3|||
25324966|NCT00853905|50641280|FG000|Overall Study|Withdrawal by Subject|0|||
25324967|NCT00853905|50641281|FG001|Overall Study|Withdrawal by Subject|1|||
25324968|NCT00853905|50641280|FG000|Overall Study|never had surgery|1|||
25324969|NCT00853905|50641281|FG001|Overall Study|never had surgery|0|||
25324970|NCT00868296|50641292|FG000|Overall Study|Adverse Event|0|||
25324971|NCT00868296|50641293|FG001|Overall Study|Adverse Event|2|||
25324972|NCT00868296|50641292|FG000|Overall Study|Withdrawal by Subject|0|||
25324973|NCT00868296|50641293|FG001|Overall Study|Withdrawal by Subject|1|||
25324974|NCT00867360|50641301|FG000|Overall Study|Withdrawal by Subject|1|||
25324975|NCT00867360|50641302|FG001|Overall Study|Withdrawal by Subject|0|||
25324976|NCT00867360|50641301|FG000|Overall Study|Physician Decision|0|||
25324977|NCT00867360|50641302|FG001|Overall Study|Physician Decision|1|||
25324978|NCT00593736|50641313|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
25324979|NCT00593736|50641314|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
25324980|NCT00593736|50641315|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
25324981|NCT00593736|50641316|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
25324982|NCT00593736|50641313|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
25324983|NCT00593736|50641314|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
25324984|NCT00593736|50641315|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
25324985|NCT00593736|50641316|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
25324986|NCT00593736|50641313|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
25324987|NCT00593736|50641314|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
25245989|NCT01232491|50561256|FG000|Overall Study|Adverse Event|13|||
25245990|NCT01232491|50561257|FG001|Overall Study|Adverse Event|8|||
25245991|NCT01232491|50561256|FG000|Overall Study|Lack of Efficacy|1|||
25245992|NCT01232491|50561257|FG001|Overall Study|Lack of Efficacy|5|||
25245993|NCT01232491|50561256|FG000|Overall Study|Protocol Violation|13|||
25245994|NCT01232491|50561257|FG001|Overall Study|Protocol Violation|11|||
25245995|NCT01232491|50561256|FG000|Overall Study|Withdrawal Criteria|12|||
25245996|NCT01232491|50561257|FG001|Overall Study|Withdrawal Criteria|21|||
25245997|NCT01232491|50561256|FG000|Overall Study|Other|21|||
25245998|NCT01232491|50561257|FG001|Overall Study|Other|18|||
25245999|NCT01232452|50561265|FG000|Overall Study|Adverse Event|17|||
25246000|NCT01232452|50561266|FG001|Overall Study|Adverse Event|15|||
25246001|NCT01232452|50561265|FG000|Overall Study|Withdrawal by Subject|11|||
25246002|NCT01232452|50561266|FG001|Overall Study|Withdrawal by Subject|8|||
25246003|NCT01232452|50561265|FG000|Overall Study|Physician Decision|8|||
25324988|NCT00593736|50641315|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
25324989|NCT00593736|50641316|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
25324990|NCT00593736|50641313|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
25324991|NCT00593736|50641314|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
25324992|NCT00593736|50641315|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
25246004|NCT01232452|50561266|FG001|Overall Study|Physician Decision|12|||
25246005|NCT01232452|50561265|FG000|Overall Study|Protocol entry criterion not met|0|||
25246006|NCT01232452|50561266|FG001|Overall Study|Protocol entry criterion not met|2|||
25246007|NCT01232452|50561265|FG000|Overall Study|Sponsor Decision|3|||
25246008|NCT01232452|50561266|FG001|Overall Study|Sponsor Decision|1|||
25246009|NCT01232452|50561265|FG000|Overall Study|Protocol Violation|0|||
25324993|NCT00593736|50641316|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
25324994|NCT00593736|50641313|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
25324995|NCT00593736|50641314|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
25324996|NCT00593736|50641315|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
25246010|NCT01232452|50561266|FG001|Overall Study|Protocol Violation|1|||
25246011|NCT01211197|50561272|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
25246012|NCT01211197|50561273|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
25246013|NCT01211197|50561274|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
25246014|NCT01211197|50561275|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
25246015|NCT01211197|50561276|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
25246016|NCT01211197|50561277|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
25246017|NCT01211197|50561272|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
25246018|NCT01211197|50561273|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
25246019|NCT01211197|50561274|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
25246020|NCT01211197|50561275|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
25246021|NCT01211197|50561276|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
25246022|NCT01211197|50561277|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
25246023|NCT01232296|50561287|FG000|Overall Study|Adverse Event|24|||
25246024|NCT01232296|50561288|FG001|Overall Study|Adverse Event|12|||
25246025|NCT01232296|50561287|FG000|Overall Study|Physician Decision|1|||
25324997|NCT00593736|50641316|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
25324998|NCT00593736|50641313|FG000|Screening Period and Placebo Run-in|Various|0|||
25324999|NCT00593736|50641314|FG001|Screening Period and Placebo Run-in|Various|0|||
25325000|NCT00593736|50641315|FG002|Screening Period and Placebo Run-in|Various|0|||
25325001|NCT00593736|50641316|FG003|Screening Period and Placebo Run-in|Various|25|||
25325002|NCT00593736|50641313|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
25325003|NCT00593736|50641314|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
25325004|NCT00593736|50641315|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
25325005|NCT00593736|50641316|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
25325006|NCT00593736|50641313|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
25325007|NCT00593736|50641314|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
25325008|NCT00593736|50641315|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
25325009|NCT00593736|50641316|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
25325010|NCT00593736|50641313|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
25246026|NCT01232296|50561288|FG001|Overall Study|Physician Decision|1|||
25246027|NCT01232296|50561287|FG000|Overall Study|Progressive disease|43|||
25246028|NCT01232296|50561288|FG001|Overall Study|Progressive disease|61|||
25246029|NCT01232296|50561287|FG000|Overall Study|Study terminated by sponsor|0|||
25246030|NCT01232296|50561288|FG001|Overall Study|Study terminated by sponsor|1|||
25246031|NCT01232296|50561287|FG000|Overall Study|Technical problems|3|||
25246032|NCT01232296|50561288|FG001|Overall Study|Technical problems|0|||
25246033|NCT01232296|50561287|FG000|Overall Study|Subject/guardian decision|10|||
25246034|NCT01232296|50561288|FG001|Overall Study|Subject/guardian decision|2|||
25246035|NCT01232296|50561287|FG000|Overall Study|Death|1|||
25246036|NCT01232296|50561288|FG001|Overall Study|Death|6|||
25246037|NCT01231984|50561296|FG000|Study Period 1|Withdrawal by Subject|0|||
25246038|NCT01231984|50561297|FG001|Study Period 1|Withdrawal by Subject|0|||
25246039|NCT01231984|50561298|FG002|Study Period 1|Withdrawal by Subject|0|||
25246040|NCT01231984|50561299|FG003|Study Period 1|Withdrawal by Subject|1|||
25246041|NCT01231984|50561296|FG000|Study Period 1|Lost to Follow-up|1|||
25246042|NCT01231984|50561297|FG001|Study Period 1|Lost to Follow-up|1|||
25246043|NCT01231984|50561298|FG002|Study Period 1|Lost to Follow-up|1|||
25246044|NCT01231984|50561299|FG003|Study Period 1|Lost to Follow-up|0|||
25246045|NCT01231984|50561296|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
25246046|NCT01231984|50561297|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
25246047|NCT01231984|50561298|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
25246048|NCT01231984|50561299|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
25246049|NCT01231984|50561296|FG000|Study Period 1|Screen Failure|0|||
25246050|NCT01231984|50561297|FG001|Study Period 1|Screen Failure|0|||
25246051|NCT01231984|50561298|FG002|Study Period 1|Screen Failure|0|||
25246052|NCT01231984|50561299|FG003|Study Period 1|Screen Failure|1|||
25325011|NCT00593736|50641314|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
25325012|NCT00593736|50641315|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
25325013|NCT00593736|50641316|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
25325014|NCT00593736|50641313|FG000|Treatment Period and Placebo Run-out|Various|1|||
25325015|NCT00593736|50641314|FG001|Treatment Period and Placebo Run-out|Various|1|||
25246053|NCT01231984|50561296|FG000|Study Period 1|Non-compliance with study requirements|5|||
25246054|NCT01231984|50561297|FG001|Study Period 1|Non-compliance with study requirements|0|||
25246055|NCT01231984|50561298|FG002|Study Period 1|Non-compliance with study requirements|2|||
25246056|NCT01231984|50561299|FG003|Study Period 1|Non-compliance with study requirements|1|||
25246057|NCT01231984|50561296|FG000|Study Period 1|Protocol Violation|3|||
25246058|NCT01231984|50561297|FG001|Study Period 1|Protocol Violation|4|||
25246059|NCT01231984|50561298|FG002|Study Period 1|Protocol Violation|2|||
25246060|NCT01231984|50561299|FG003|Study Period 1|Protocol Violation|3|||
25246061|NCT01231984|50561296|FG000|Study Period 1|Adverse Event|1|||
25246062|NCT01231984|50561297|FG001|Study Period 1|Adverse Event|0|||
25246063|NCT01231984|50561298|FG002|Study Period 1|Adverse Event|0|||
25325016|NCT00593736|50641315|FG002|Treatment Period and Placebo Run-out|Various|1|||
25325017|NCT00593736|50641316|FG003|Treatment Period and Placebo Run-out|Various|0|||
25325018|NCT00883688|50641326|FG000|Overall Study|Ineligible|2|||
25325019|NCT03883477|50641332|FG000|Overall Study|Death|1|||
25325020|NCT03883477|50641333|FG001|Overall Study|Death|0|||
25325021|NCT03883477|50641332|FG000|Overall Study|Protocol Violation|0|||
25325022|NCT03883477|50641333|FG001|Overall Study|Protocol Violation|1|||
25325023|NCT00853827|50641341|FG000|Single Blind Period (1 Week)|Other|4|||
25325024|NCT00853827|50641342|FG001|Single Blind Period (1 Week)|Other|0|||
25325025|NCT00853827|50641341|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
25325026|NCT00853827|50641342|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
25325027|NCT00853827|50641341|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
25325028|NCT00853827|50641342|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
25325029|NCT00853827|50641341|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
25325030|NCT00853827|50641342|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
25325031|NCT00853827|50641341|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
25325032|NCT00853827|50641342|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
25325033|NCT00853827|50641341|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
25325034|NCT00853827|50641342|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
25325035|NCT00853827|50641341|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
25325036|NCT00853827|50641342|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
25325037|NCT00853827|50641341|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
25325038|NCT00853827|50641342|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
25325039|NCT00853827|50641341|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
25325040|NCT00853827|50641342|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
25325041|NCT00853827|50641341|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
25325042|NCT00853827|50641342|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
25325043|NCT00853827|50641341|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
25325044|NCT00853827|50641342|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
25325045|NCT00853827|50641341|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
25325046|NCT00853827|50641342|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
25246064|NCT01231984|50561299|FG003|Study Period 1|Adverse Event|0|||
25246065|NCT01231984|50561296|FG000|Study Period 1|Other|0|||
25246066|NCT01231984|50561297|FG001|Study Period 1|Other|0|||
25246067|NCT01231984|50561298|FG002|Study Period 1|Other|0|||
25246068|NCT01231984|50561299|FG003|Study Period 1|Other|1|||
25246069|NCT01231984|50561296|FG000|Study Period 2|Withdrawal by Subject|1|||
25246070|NCT01231984|50561297|FG001|Study Period 2|Withdrawal by Subject|1|||
25246071|NCT01231984|50561298|FG002|Study Period 2|Withdrawal by Subject|0|||
25246072|NCT01231984|50561299|FG003|Study Period 2|Withdrawal by Subject|0|||
25246073|NCT01231984|50561296|FG000|Study Period 2|Lost to Follow-up|1|||
25246074|NCT01231984|50561297|FG001|Study Period 2|Lost to Follow-up|0|||
25246075|NCT01231984|50561298|FG002|Study Period 2|Lost to Follow-up|0|||
25246076|NCT01231984|50561299|FG003|Study Period 2|Lost to Follow-up|3|||
25246077|NCT01231984|50561296|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
25246078|NCT01231984|50561297|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
25246079|NCT01231984|50561298|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
25246080|NCT01231984|50561299|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
25246081|NCT01210807|50561319|FG000|Overall Study|Lost to Follow-up|1|||
25246082|NCT01210807|50561320|FG001|Overall Study|Lost to Follow-up|2|||
25246083|NCT01210807|50561319|FG000|Overall Study|Not implanted bilaterally|2|||
25246084|NCT01210807|50561320|FG001|Overall Study|Not implanted bilaterally|1|||
25246085|NCT01231555|50561329|FG000|Overall Study|Study terminated|8|||
25246086|NCT01231555|50561330|FG001|Overall Study|Study terminated|5|||
25246087|NCT01231555|50561331|FG002|Overall Study|Study terminated|8|||
25246088|NCT01231555|50561329|FG000|Overall Study|Withdrawal by Subject|0|||
25325047|NCT00853827|50641341|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
25325048|NCT00853827|50641342|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
25325049|NCT00853827|50641341|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
25325050|NCT00853827|50641342|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
25246089|NCT01231555|50561330|FG001|Overall Study|Withdrawal by Subject|2|||
25246090|NCT01231555|50561331|FG002|Overall Study|Withdrawal by Subject|0|||
25246091|NCT01210690|50561339|FG000|Overall Study|Adverse Event|7|||
25246092|NCT01210690|50561339|FG000|Overall Study|Lack of Efficacy|12|||
25246093|NCT01210690|50561339|FG000|Overall Study|Lost to Follow-up|3|||
25246094|NCT01210690|50561339|FG000|Overall Study|Disease Remission|1|||
25246095|NCT01210690|50561339|FG000|Overall Study|Withdrawal by Subject|1|||
25246096|NCT01210690|50561339|FG000|Overall Study|Patient refused to swallow|1|||
25246097|NCT01210690|50561339|FG000|Overall Study|Patient could not take glucose|1|||
25246098|NCT01210651|50561346|FG000|Overall Study|Lost to Follow-up|1|||
25246099|NCT01210651|50561347|FG001|Overall Study|Lost to Follow-up|1|||
25246100|NCT01210651|50561346|FG000|Overall Study|schedule conflicts|1|||
25246101|NCT01210651|50561347|FG001|Overall Study|schedule conflicts|5|||
25246102|NCT01210651|50561346|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
25246103|NCT01210651|50561347|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
25246104|NCT01210651|50561346|FG000|Overall Study|Withdrawal by Subject|1|||
25246105|NCT01210651|50561347|FG001|Overall Study|Withdrawal by Subject|1|||
25246106|NCT01210651|50561346|FG000|Overall Study|Injury outside study|2|||
25246107|NCT01210651|50561347|FG001|Overall Study|Injury outside study|0|||
25246108|NCT01210495|50561426|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
25246109|NCT01210495|50561427|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
25246110|NCT01210495|50561428|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
25246111|NCT01210495|50561429|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
25246112|NCT01210495|50561426|FG000|Overall Study|Death|14|||
25246113|NCT01210495|50561427|FG001|Overall Study|Death|7|||
25246114|NCT01210495|50561428|FG002|Overall Study|Death|112|||
25246115|NCT01210495|50561429|FG003|Overall Study|Death|54|||
25246116|NCT01210495|50561426|FG000|Overall Study|Study Terminated by Sponsor|0|||
25246117|NCT01210495|50561427|FG001|Overall Study|Study Terminated by Sponsor|0|||
25246118|NCT01210495|50561428|FG002|Overall Study|Study Terminated by Sponsor|4|||
25246119|NCT01210495|50561429|FG003|Overall Study|Study Terminated by Sponsor|11|||
25246120|NCT01210495|50561426|FG000|Overall Study|Lost to Follow-up|0|||
25246121|NCT01210495|50561427|FG001|Overall Study|Lost to Follow-up|0|||
25246122|NCT01210495|50561428|FG002|Overall Study|Lost to Follow-up|1|||
25246123|NCT01210495|50561429|FG003|Overall Study|Lost to Follow-up|1|||
25246124|NCT01210495|50561426|FG000|Overall Study|Other unspecified|0|||
25246125|NCT01210495|50561427|FG001|Overall Study|Other unspecified|0|||
25325051|NCT00853827|50641341|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
25325052|NCT00853827|50641342|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
25325053|NCT00853827|50641341|FG000|Double Blind Period (103 Weeks)|Death|1|||
24977119|NCT00379769|50065794|FG001|Observational Follow-up|Site Closed Early|0|||
24977120|NCT00379769|50065795|FG002|Observational Follow-up|Site Closed Early|0|||
24977121|NCT00379769|50065796|FG003|Observational Follow-up|Site Closed Early|0|||
24977122|NCT00379769|50065797|FG004|Observational Follow-up|Site Closed Early|6|||
24977123|NCT00379769|50065798|FG005|Observational Follow-up|Site Closed Early|7|||
24977124|NCT00379769|50065793|FG000|Observational Follow-up|Participant Moved|0|||
24977125|NCT00379769|50065794|FG001|Observational Follow-up|Participant Moved|0|||
24977126|NCT00379769|50065795|FG002|Observational Follow-up|Participant Moved|0|||
24977127|NCT00379769|50065796|FG003|Observational Follow-up|Participant Moved|0|||
24977128|NCT00379769|50065797|FG004|Observational Follow-up|Participant Moved|0|||
24977129|NCT00379769|50065798|FG005|Observational Follow-up|Participant Moved|1|||
24977130|NCT00379769|50065793|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
24977131|NCT00379769|50065794|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
24977132|NCT00379769|50065795|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
24977133|NCT00379769|50065796|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
24977134|NCT00379769|50065797|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
24977135|NCT00379769|50065798|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
24977136|NCT00006164|50065827|FG000|Overall Study|Withdrew or lost to follow-up|70|||
24977137|NCT00006164|50065828|FG001|Overall Study|Withdrew or lost to follow-up|81|||
24977138|NCT00378599|50065834|FG000|Overall Study|Adverse Event|38|||
24977139|NCT00378599|50065834|FG000|Overall Study|Protocol Violation|2|||
24977140|NCT00378599|50065834|FG000|Overall Study|Treatment failure|7|||
24977141|NCT00378599|50065834|FG000|Overall Study|Withdrawal by Subject|5|||
24977142|NCT00378209|50065838|FG000|Overall Study|Progressive disease|11|||
25325054|NCT00853827|50641342|FG001|Double Blind Period (103 Weeks)|Death|6|||
25325055|NCT00853749|50641350|FG000|Overall Study|Lost to Follow-up|0|||
25325056|NCT00853749|50641351|FG001|Overall Study|Lost to Follow-up|1|||
25325057|NCT00592839|50641360|FG000|Overall Study|Withdrawal by Subject|1|||
25325058|NCT00592839|50641361|FG001|Overall Study|Withdrawal by Subject|1|||
25325059|NCT00592839|50641362|FG002|Overall Study|Withdrawal by Subject|3|||
25325060|NCT00592839|50641360|FG000|Overall Study|Protocol Violation|1|||
24977143|NCT00378209|50065838|FG000|Overall Study|Adverse Event|3|||
24977144|NCT00378209|50065838|FG000|Overall Study|Initiation of non-protocol therapy|3|||
24977145|NCT00378209|50065838|FG000|Overall Study|Physician Decision|3|||
25246126|NCT01210495|50561428|FG002|Overall Study|Other unspecified|6|||
25246127|NCT01210495|50561429|FG003|Overall Study|Other unspecified|0|||
25246128|NCT01231516|50561441|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
25246129|NCT01231516|50561442|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
25325061|NCT00592839|50641361|FG001|Overall Study|Protocol Violation|1|||
25325062|NCT00592839|50641362|FG002|Overall Study|Protocol Violation|2|||
25325063|NCT00592839|50641360|FG000|Overall Study|Adverse Event|0|||
25325064|NCT00592839|50641361|FG001|Overall Study|Adverse Event|1|||
25325065|NCT00592839|50641362|FG002|Overall Study|Adverse Event|0|||
25325066|NCT00592839|50641360|FG000|Overall Study|Lost to Follow-up|0|||
25325067|NCT00592839|50641361|FG001|Overall Study|Lost to Follow-up|1|||
24977146|NCT00378209|50065838|FG000|Overall Study|Death|1|||
24977147|NCT00378209|50065838|FG000|Overall Study|Treatment delay|1|||
25077773|NCT03318523|50185663|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
25325068|NCT00592839|50641362|FG002|Overall Study|Lost to Follow-up|1|||
25325069|NCT00598832|50641372|FG000|Overall Study|Lack of Efficacy|3|||
25325070|NCT00598832|50641373|FG001|Overall Study|Lack of Efficacy|7|||
25325071|NCT00598832|50641372|FG000|Overall Study|Adverse Event|6|||
25325072|NCT00598832|50641373|FG001|Overall Study|Adverse Event|2|||
25325073|NCT00598832|50641372|FG000|Overall Study|Withdrawal by Subject|25|||
25325074|NCT00598832|50641373|FG001|Overall Study|Withdrawal by Subject|36|||
25325075|NCT00598832|50641372|FG000|Overall Study|Protocol Violation|0|||
25325076|NCT00598832|50641373|FG001|Overall Study|Protocol Violation|2|||
25325077|NCT00598832|50641372|FG000|Overall Study|Lost to Follow-up|24|||
25325078|NCT00598832|50641373|FG001|Overall Study|Lost to Follow-up|29|||
25325079|NCT00598832|50641372|FG000|Overall Study|Pregnancy|2|||
25325080|NCT00598832|50641373|FG001|Overall Study|Pregnancy|2|||
25325081|NCT00598832|50641372|FG000|Overall Study|Physician Decision|1|||
25325082|NCT00598832|50641373|FG001|Overall Study|Physician Decision|4|||
25325083|NCT00598832|50641372|FG000|Overall Study|Non compliance|1|||
25325084|NCT00598832|50641373|FG001|Overall Study|Non compliance|0|||
25325085|NCT00853593|50641379|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
25325086|NCT00853593|50641379|FG000|Overall Study|Model 4396 lead not attempted|29|||
25325087|NCT00853593|50641379|FG000|Overall Study|Implant not attempted|4|||
25325088|NCT00853125|50641400|FG000|Overall Study|Study participant's donor was CMV +|1|||
25325089|NCT00530023|50641407|FG000|Overall Study|Withdrawal by Subject|0|||
25325090|NCT00530023|50641408|FG001|Overall Study|Withdrawal by Subject|1|||
25325091|NCT00529087|50641417|FG000|Overall Study|Adverse Event|10|||
25325092|NCT00529087|50641418|FG001|Overall Study|Adverse Event|13|||
25325093|NCT00529087|50641419|FG002|Overall Study|Adverse Event|4|||
25325094|NCT00529087|50641417|FG000|Overall Study|Lost to Follow-up|6|||
25325095|NCT00529087|50641418|FG001|Overall Study|Lost to Follow-up|4|||
25325096|NCT00529087|50641419|FG002|Overall Study|Lost to Follow-up|1|||
25325097|NCT00529087|50641417|FG000|Overall Study|Protocol Violation|8|||
25325098|NCT00529087|50641418|FG001|Overall Study|Protocol Violation|7|||
25325099|NCT00529087|50641419|FG002|Overall Study|Protocol Violation|6|||
25325100|NCT00529087|50641417|FG000|Overall Study|Withdrawal by Subject|3|||
25325101|NCT00529087|50641418|FG001|Overall Study|Withdrawal by Subject|3|||
25325102|NCT00529087|50641419|FG002|Overall Study|Withdrawal by Subject|3|||
25325103|NCT00529087|50641417|FG000|Overall Study|Protocol deviation|1|||
25325104|NCT00529087|50641418|FG001|Overall Study|Protocol deviation|1|||
25325105|NCT00529087|50641419|FG002|Overall Study|Protocol deviation|2|||
25325106|NCT00870870|50641454|FG000|Overall Study|Withdrawal by Subject|0|||
25325107|NCT00870870|50641455|FG001|Overall Study|Withdrawal by Subject|1|||
25325108|NCT00870870|50641456|FG002|Overall Study|Withdrawal by Subject|1|||
25325109|NCT00870870|50641457|FG003|Overall Study|Withdrawal by Subject|3|||
25325110|NCT00870870|50641454|FG000|Overall Study|Adverse Event|0|||
25325111|NCT00870870|50641455|FG001|Overall Study|Adverse Event|0|||
25325112|NCT00870870|50641456|FG002|Overall Study|Adverse Event|2|||
25325113|NCT00870870|50641457|FG003|Overall Study|Adverse Event|2|||
25325114|NCT03877237|50641474|FG000|Overall Study|Adverse Event|1|||
25325115|NCT03877237|50641475|FG001|Overall Study|Adverse Event|2|||
25325116|NCT03877237|50641474|FG000|Overall Study|Death|3|||
25325117|NCT03877237|50641475|FG001|Overall Study|Death|2|||
25325118|NCT03877237|50641474|FG000|Overall Study|Physician Decision|1|||
25325119|NCT03877237|50641475|FG001|Overall Study|Physician Decision|0|||
25325120|NCT03877237|50641474|FG000|Overall Study|Withdrawal by Subject|0|||
25325121|NCT03877237|50641475|FG001|Overall Study|Withdrawal by Subject|2|||
25325122|NCT00528931|50641481|FG000|Overall Study|Lost to Follow-up|1|||
24977148|NCT03410992|50065845|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
24977149|NCT03410992|50065846|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
24977150|NCT03410992|50065847|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
24977151|NCT03410992|50065848|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
24977152|NCT03410992|50065849|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
24977153|NCT03410992|50065850|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
24977154|NCT03410992|50065851|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
24977155|NCT03410992|50065852|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
24977156|NCT03410992|50065853|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
24977157|NCT03410992|50065854|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
24977158|NCT03410992|50065855|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
24977159|NCT03410992|50065845|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
24977160|NCT03410992|50065846|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
24977161|NCT03410992|50065847|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
24977162|NCT03410992|50065848|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
24977163|NCT03410992|50065849|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
24977164|NCT03410992|50065850|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
24977165|NCT03410992|50065851|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
24977166|NCT03410992|50065852|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
24977167|NCT03410992|50065853|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
24977168|NCT03410992|50065854|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
24977169|NCT03410992|50065855|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
24977170|NCT03410992|50065845|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
24977171|NCT03410992|50065846|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
24977172|NCT03410992|50065847|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
24977173|NCT03410992|50065848|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
24977174|NCT03410992|50065849|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
24977175|NCT03410992|50065850|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
24977176|NCT03410992|50065851|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
25325123|NCT00866814|50641486|FG000|Overall Study|Lost to Follow-up|12|||
25325124|NCT00866814|50641486|FG000|Overall Study|Adverse Event|2|||
25325125|NCT00866814|50641486|FG000|Overall Study|Physician Decision|1|||
25325126|NCT00866814|50641486|FG000|Overall Study|Death|1|||
25325127|NCT00866814|50641486|FG000|Overall Study|No longer wished to participate|1|||
25325128|NCT00866814|50641486|FG000|Overall Study|Unable to meet follow-up requirements|2|||
25325129|NCT00866814|50641486|FG000|Overall Study|Moved to area without study site|1|||
25325130|NCT00871494|50641490|FG000|Overall Study|Protocol Violation|5|||
25325131|NCT00871494|50641490|FG000|Overall Study|Lack of Efficacy|4|||
25325132|NCT00871494|50641490|FG000|Overall Study|Adverse Event|4|||
25325133|NCT00871494|50641490|FG000|Overall Study|Lost to Follow-up|1|||
25325134|NCT00529789|50641494|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
25325135|NCT00529789|50641494|FG000|Study Period II/III|Adverse Event|3|||
25325136|NCT00529789|50641494|FG000|Study Period II/III|Lack of Efficacy|2|||
25325137|NCT00529789|50641494|FG000|Study Period II/III|Withdrawal by Subject|1|||
25325138|NCT00529789|50641494|FG000|Study Period II/III|Protocol Violation|3|||
25325139|NCT00529789|50641494|FG000|Study Period II/III|Physician Decision|3|||
25325140|NCT00529789|50641494|FG000|Study Period II/III|Lost to Follow-up|3|||
25325141|NCT00529789|50641494|FG000|Study Period IV|Parent/Caregiver Decision|1|||
25325142|NCT00529789|50641494|FG000|Study Period IV|Adverse Event|1|||
25325143|NCT00529789|50641494|FG000|Study Period IV|Lack of Efficacy|1|||
25325144|NCT00529789|50641494|FG000|Study Period IV|Lost to Follow-up|3|||
25325145|NCT00577642|50641504|FG000|Overall Study|Clinical Disease Progression|1|||
25325146|NCT00866658|50641510|FG000|Overall Study|Adverse Event|5|||
25325147|NCT00866658|50641511|FG001|Overall Study|Adverse Event|14|||
24977177|NCT03410992|50065852|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
25325148|NCT00866658|50641510|FG000|Overall Study|Lack of Efficacy|2|||
25325149|NCT00866658|50641511|FG001|Overall Study|Lack of Efficacy|1|||
25325150|NCT00866658|50641510|FG000|Overall Study|Withdrawal by Subject|1|||
24977178|NCT03410992|50065853|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
24977179|NCT03410992|50065854|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
24977180|NCT03410992|50065855|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
24977181|NCT03410992|50065845|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
24977182|NCT03410992|50065846|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
24977183|NCT03410992|50065847|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
25325151|NCT00866658|50641511|FG001|Overall Study|Withdrawal by Subject|0|||
25325152|NCT00866658|50641510|FG000|Overall Study|Protocol Violation|1|||
25325153|NCT00866658|50641511|FG001|Overall Study|Protocol Violation|1|||
25325154|NCT00866658|50641510|FG000|Overall Study|Familial and Personal Reasons|4|||
24977184|NCT03410992|50065848|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
24977185|NCT03410992|50065849|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
24977186|NCT03410992|50065850|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
24977187|NCT03410992|50065851|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
24977188|NCT03410992|50065852|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
24977189|NCT03410992|50065853|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
25325155|NCT00866658|50641511|FG001|Overall Study|Familial and Personal Reasons|5|||
25325156|NCT03872453|50641521|FG000|Overall Study|Adverse Event|1|||
25325157|NCT03872453|50641522|FG001|Overall Study|Adverse Event|1|||
25325158|NCT03872453|50641523|FG002|Overall Study|Adverse Event|0|||
25325159|NCT03872453|50641524|FG003|Overall Study|Adverse Event|0|||
25325160|NCT03872453|50641521|FG000|Overall Study|Lost to Follow-up|8|||
25325161|NCT03872453|50641522|FG001|Overall Study|Lost to Follow-up|7|||
25325162|NCT03872453|50641523|FG002|Overall Study|Lost to Follow-up|4|||
25325163|NCT03872453|50641524|FG003|Overall Study|Lost to Follow-up|4|||
24977190|NCT03410992|50065854|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
24977191|NCT03410992|50065855|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
24977192|NCT03410992|50065845|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
24977193|NCT03410992|50065846|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
24977194|NCT03410992|50065847|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
24977195|NCT03410992|50065848|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
25325164|NCT03872453|50641521|FG000|Overall Study|Never Treated Migraine|19|||
25325165|NCT03872453|50641522|FG001|Overall Study|Never Treated Migraine|17|||
25325166|NCT03872453|50641523|FG002|Overall Study|Never Treated Migraine|13|||
25325167|NCT03872453|50641524|FG003|Overall Study|Never Treated Migraine|12|||
25325168|NCT03872453|50641521|FG000|Overall Study|Pregnancy|1|||
25325169|NCT03872453|50641522|FG001|Overall Study|Pregnancy|0|||
25325170|NCT03872453|50641523|FG002|Overall Study|Pregnancy|0|||
25325171|NCT03872453|50641524|FG003|Overall Study|Pregnancy|0|||
25325172|NCT03872453|50641521|FG000|Overall Study|Protocol Deviation|2|||
25325173|NCT03872453|50641522|FG001|Overall Study|Protocol Deviation|0|||
25325174|NCT03872453|50641523|FG002|Overall Study|Protocol Deviation|0|||
25325175|NCT03872453|50641524|FG003|Overall Study|Protocol Deviation|2|||
25325176|NCT03872453|50641521|FG000|Overall Study|Withdrawal by Subject|0|||
25325177|NCT03872453|50641522|FG001|Overall Study|Withdrawal by Subject|1|||
25325178|NCT03872453|50641523|FG002|Overall Study|Withdrawal by Subject|2|||
25325179|NCT03872453|50641524|FG003|Overall Study|Withdrawal by Subject|0|||
25325180|NCT03872453|50641521|FG000|Overall Study|Other Than Specified|1|||
25325181|NCT03872453|50641522|FG001|Overall Study|Other Than Specified|0|||
25325182|NCT03872453|50641523|FG002|Overall Study|Other Than Specified|0|||
25325183|NCT03872453|50641524|FG003|Overall Study|Other Than Specified|0|||
25325184|NCT00597584|50641536|FG000|Overall Study|Adverse Event|4|||
25325185|NCT00597584|50641537|FG001|Overall Study|Adverse Event|2|||
25325186|NCT00597584|50641536|FG000|Overall Study|Death|53|||
25325187|NCT00597584|50641537|FG001|Overall Study|Death|30|||
25325188|NCT00597584|50641536|FG000|Overall Study|Lack of Efficacy|1|||
25325189|NCT00597584|50641537|FG001|Overall Study|Lack of Efficacy|0|||
25325190|NCT00597584|50641536|FG000|Overall Study|Lost to Follow-up|2|||
25325191|NCT00597584|50641537|FG001|Overall Study|Lost to Follow-up|4|||
25325192|NCT00597584|50641536|FG000|Overall Study|Physician Decision|3|||
25325193|NCT00597584|50641537|FG001|Overall Study|Physician Decision|0|||
25325194|NCT00597584|50641536|FG000|Overall Study|Pregnancy|2|||
25325195|NCT00597584|50641537|FG001|Overall Study|Pregnancy|0|||
24977196|NCT03410992|50065849|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
24977197|NCT03410992|50065850|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
24977198|NCT03410992|50065851|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
24977199|NCT03410992|50065852|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
24977200|NCT03410992|50065853|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
24977201|NCT03410992|50065854|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
24977202|NCT03410992|50065855|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
24977203|NCT03410992|50065845|FG000|Week 16 Assessment|Incorrect escapers|0|||
24977204|NCT03410992|50065846|FG001|Week 16 Assessment|Incorrect escapers|6|||
24977205|NCT03410992|50065847|FG002|Week 16 Assessment|Incorrect escapers|0|||
24977206|NCT03410992|50065848|FG003|Week 16 Assessment|Incorrect escapers|0|||
24977207|NCT03410992|50065849|FG004|Week 16 Assessment|Incorrect escapers|0|||
24977208|NCT03410992|50065850|FG005|Week 16 Assessment|Incorrect escapers|0|||
24977209|NCT03410992|50065851|FG006|Week 16 Assessment|Incorrect escapers|0|||
24977210|NCT03410992|50065852|FG007|Week 16 Assessment|Incorrect escapers|0|||
24977211|NCT03410992|50065853|FG008|Week 16 Assessment|Incorrect escapers|0|||
24977212|NCT03410992|50065854|FG009|Week 16 Assessment|Incorrect escapers|0|||
24977213|NCT03410992|50065855|FG010|Week 16 Assessment|Incorrect escapers|0|||
24977214|NCT03410992|50065845|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
24977215|NCT03410992|50065846|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
24977216|NCT03410992|50065847|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
25325196|NCT00597584|50641536|FG000|Overall Study|Withdrawal by Subject|44|||
25325197|NCT00597584|50641537|FG001|Overall Study|Withdrawal by Subject|12|||
25325198|NCT00597584|50641536|FG000|Overall Study|Discontinued Dialysis|0|||
25325199|NCT00597584|50641537|FG001|Overall Study|Discontinued Dialysis|1|||
25325200|NCT00597584|50641536|FG000|Overall Study|Lost ability to consent|1|||
25325201|NCT00597584|50641537|FG001|Overall Study|Lost ability to consent|1|||
25325202|NCT00597584|50641536|FG000|Overall Study|Never dosed|1|||
25325203|NCT00597584|50641537|FG001|Overall Study|Never dosed|0|||
25325204|NCT00597584|50641536|FG000|Overall Study|Relocation|8|||
25325205|NCT00597584|50641537|FG001|Overall Study|Relocation|6|||
25325206|NCT00597584|50641536|FG000|Overall Study|Renal transplant|9|||
25325207|NCT00597584|50641537|FG001|Overall Study|Renal transplant|7|||
25325208|NCT00529633|50641545|FG000|Overall Study|Withdrawal by Subject|1|||
25325209|NCT00529633|50641546|FG001|Overall Study|Withdrawal by Subject|1|||
25325210|NCT00530335|50641552|FG000|Overall Study|Adverse Event|3|||
25325211|NCT00530335|50641552|FG000|Overall Study|Protocol Violation|1|||
25325212|NCT00530335|50641552|FG000|Overall Study|Withdrawal by Subject|1|||
25325213|NCT00530335|50641552|FG000|Overall Study|Physician Decision|1|||
25325214|NCT00712270|50641559|FG000|Overall Study|Withdrawal by Subject|11|||
25325215|NCT00712270|50641559|FG000|Overall Study|Screen Failure|3|||
25325216|NCT00530257|50641585|FG000|Overall Study|Lost to Follow-up|1|||
25325217|NCT00869778|50641595|FG000|Overall Study|Adverse Event|2|||
25325218|NCT00869778|50641596|FG001|Overall Study|Adverse Event|0|||
25325219|NCT00869778|50641597|FG002|Overall Study|Adverse Event|0|||
25325220|NCT00869778|50641595|FG000|Overall Study|Withdrawal by Subject|3|||
25325221|NCT00869778|50641596|FG001|Overall Study|Withdrawal by Subject|4|||
25325222|NCT00869778|50641597|FG002|Overall Study|Withdrawal by Subject|5|||
25325223|NCT00869778|50641595|FG000|Overall Study|Pregnancy|1|||
25325224|NCT00869778|50641596|FG001|Overall Study|Pregnancy|0|||
25325225|NCT00869778|50641597|FG002|Overall Study|Pregnancy|0|||
25325226|NCT00869778|50641595|FG000|Overall Study|Protocol Violation|5|||
25325227|NCT00869778|50641596|FG001|Overall Study|Protocol Violation|3|||
25325228|NCT00869778|50641597|FG002|Overall Study|Protocol Violation|5|||
25325229|NCT00869778|50641595|FG000|Overall Study|Unblinding|1|||
25325230|NCT00869778|50641596|FG001|Overall Study|Unblinding|0|||
25325231|NCT00869778|50641597|FG002|Overall Study|Unblinding|0|||
25325232|NCT00711958|50641628|FG000|Overall Study|Withdrawal by Subject|6|||
25325233|NCT00711958|50641629|FG001|Overall Study|Withdrawal by Subject|8|||
25325234|NCT00711958|50641628|FG000|Overall Study|Lack of Efficacy|3|||
25325235|NCT00711958|50641629|FG001|Overall Study|Lack of Efficacy|1|||
25325236|NCT00711958|50641628|FG000|Overall Study|Clinical deterioration|1|||
25325237|NCT00711958|50641629|FG001|Overall Study|Clinical deterioration|0|||
25325238|NCT00711958|50641628|FG000|Overall Study|Adverse Event|9|||
24977217|NCT03410992|50065848|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
24977218|NCT03410992|50065849|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
24977219|NCT03410992|50065850|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
25325239|NCT00711958|50641629|FG001|Overall Study|Adverse Event|7|||
25325240|NCT00711958|50641628|FG000|Overall Study|Protocol Violation|1|||
25325241|NCT00711958|50641629|FG001|Overall Study|Protocol Violation|0|||
25325242|NCT00711958|50641628|FG000|Overall Study|Lost to Follow-up|2|||
25325243|NCT00711958|50641629|FG001|Overall Study|Lost to Follow-up|2|||
25325244|NCT00711958|50641628|FG000|Overall Study|Death|10|||
25325245|NCT00711958|50641629|FG001|Overall Study|Death|5|||
25325246|NCT00711958|50641628|FG000|Overall Study|Progression of disease|1|||
25325247|NCT00711958|50641629|FG001|Overall Study|Progression of disease|0|||
25325248|NCT00711880|50641637|FG000|Overall Study|Adverse Event|11|||
25325249|NCT00711880|50641638|FG001|Overall Study|Adverse Event|2|||
25325250|NCT00711880|50641637|FG000|Overall Study|Patient non-compliance|1|||
25325251|NCT00711880|50641638|FG001|Overall Study|Patient non-compliance|0|||
25325252|NCT00711880|50641637|FG000|Overall Study|Lack of Efficacy|1|||
25325253|NCT00711880|50641638|FG001|Overall Study|Lack of Efficacy|5|||
25325254|NCT00528775|50641644|FG000|Overall Study|Other not specified|1|||
25325255|NCT00529399|50641651|FG000|Overall Study|Lost to Follow-up|1|||
25325256|NCT00529399|50641652|FG001|Overall Study|Lost to Follow-up|0|||
25325257|NCT00529399|50641653|FG002|Overall Study|Lost to Follow-up|1|||
25325258|NCT00529399|50641651|FG000|Overall Study|Withdrawal by Subject|1|||
25325259|NCT00529399|50641652|FG001|Overall Study|Withdrawal by Subject|0|||
25325260|NCT00529399|50641653|FG002|Overall Study|Withdrawal by Subject|1|||
25325261|NCT00529399|50641651|FG000|Overall Study|Non-compliant|0|||
25325262|NCT00529399|50641652|FG001|Overall Study|Non-compliant|1|||
25325263|NCT00529399|50641653|FG002|Overall Study|Non-compliant|0|||
25325264|NCT00852969|50641663|FG000|Overall Study|Adverse Event|0|||
25325265|NCT00852969|50641664|FG001|Overall Study|Adverse Event|1|||
25325266|NCT00852969|50641663|FG000|Overall Study|Lost to Follow-up|0|||
25325267|NCT00852969|50641664|FG001|Overall Study|Lost to Follow-up|1|||
25325268|NCT03870997|50641676|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
25325269|NCT03870997|50641677|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
25325270|NCT03870997|50641678|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
25325271|NCT03870997|50641679|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
25325272|NCT03870997|50641680|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
25325273|NCT03870997|50641681|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
25325274|NCT00521365|50641690|FG000|Overall Study|Adverse Event|3|||
25325275|NCT00521365|50641690|FG000|Overall Study|Lost to Follow-up|6|||
25325276|NCT00521365|50641690|FG000|Overall Study|Protocol deviation|2|||
25325277|NCT00521365|50641690|FG000|Overall Study|Drug compliance|3|||
25325278|NCT00521365|50641690|FG000|Overall Study|Usage of not allowed drugs|6|||
25325279|NCT00711802|50641702|FG000|Overall Study|Not treated (no further detail)|2|||
25325280|NCT00711802|50641703|FG001|Overall Study|Not treated (no further detail)|1|||
25325281|NCT00711802|50641704|FG002|Overall Study|Not treated (no further detail)|2|||
25325282|NCT00711802|50641705|FG003|Overall Study|Not treated (no further detail)|0|||
25325283|NCT00711802|50641706|FG004|Overall Study|Not treated (no further detail)|2|||
25325284|NCT00711802|50641707|FG005|Overall Study|Not treated (no further detail)|0|||
25325285|NCT00711802|50641708|FG006|Overall Study|Not treated (no further detail)|0|||
25325286|NCT00711802|50641709|FG007|Overall Study|Not treated (no further detail)|0|||
25325287|NCT00711802|50641702|FG000|Overall Study|Adverse Event|0|||
25325288|NCT00711802|50641703|FG001|Overall Study|Adverse Event|0|||
25325289|NCT00711802|50641704|FG002|Overall Study|Adverse Event|0|||
25325290|NCT00711802|50641705|FG003|Overall Study|Adverse Event|0|||
25325291|NCT00711802|50641706|FG004|Overall Study|Adverse Event|1|||
25325292|NCT00711802|50641707|FG005|Overall Study|Adverse Event|1|||
25325293|NCT00711802|50641708|FG006|Overall Study|Adverse Event|0|||
25325294|NCT00711802|50641709|FG007|Overall Study|Adverse Event|0|||
25325295|NCT00711802|50641702|FG000|Overall Study|Microbiological failure|0|||
25325296|NCT00711802|50641703|FG001|Overall Study|Microbiological failure|1|||
25325297|NCT00711802|50641704|FG002|Overall Study|Microbiological failure|0|||
25325298|NCT00711802|50641705|FG003|Overall Study|Microbiological failure|0|||
25325299|NCT00711802|50641706|FG004|Overall Study|Microbiological failure|0|||
25325300|NCT00711802|50641707|FG005|Overall Study|Microbiological failure|1|||
25325301|NCT00711802|50641708|FG006|Overall Study|Microbiological failure|0|||
25325302|NCT00711802|50641709|FG007|Overall Study|Microbiological failure|0|||
25325303|NCT00711802|50641702|FG000|Overall Study|Protocol Violation|0|||
25325304|NCT00711802|50641703|FG001|Overall Study|Protocol Violation|0|||
25325305|NCT00711802|50641704|FG002|Overall Study|Protocol Violation|0|||
25325306|NCT00711802|50641705|FG003|Overall Study|Protocol Violation|1|||
25325307|NCT00711802|50641706|FG004|Overall Study|Protocol Violation|0|||
25325308|NCT00711802|50641707|FG005|Overall Study|Protocol Violation|0|||
25325309|NCT00711802|50641708|FG006|Overall Study|Protocol Violation|0|||
25325310|NCT00711802|50641709|FG007|Overall Study|Protocol Violation|0|||
25325311|NCT00711802|50641702|FG000|Overall Study|Physician Decision|0|||
25325312|NCT00711802|50641703|FG001|Overall Study|Physician Decision|2|||
25325313|NCT00711802|50641704|FG002|Overall Study|Physician Decision|0|||
25325314|NCT00711802|50641705|FG003|Overall Study|Physician Decision|0|||
25325315|NCT00711802|50641706|FG004|Overall Study|Physician Decision|0|||
24977220|NCT03410992|50065851|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
24977221|NCT03410992|50065852|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
24977222|NCT03410992|50065853|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
24977223|NCT03410992|50065854|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
24977224|NCT03410992|50065855|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
24977225|NCT03410992|50065845|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
24977226|NCT03410992|50065846|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
24977227|NCT03410992|50065847|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
24977228|NCT03410992|50065848|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
24977229|NCT03410992|50065849|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
24977230|NCT03410992|50065850|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
24977231|NCT03410992|50065851|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
24977232|NCT03410992|50065852|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
24977233|NCT03410992|50065853|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
24977234|NCT03410992|50065854|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
24977235|NCT03410992|50065855|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
24977236|NCT03410992|50065845|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
25325316|NCT00711802|50641707|FG005|Overall Study|Physician Decision|0|||
25325317|NCT00711802|50641708|FG006|Overall Study|Physician Decision|0|||
25325318|NCT00711802|50641709|FG007|Overall Study|Physician Decision|0|||
25325319|NCT00711802|50641702|FG000|Overall Study|Withdrawal by Subject|0|||
25325320|NCT00711802|50641703|FG001|Overall Study|Withdrawal by Subject|1|||
25325321|NCT00711802|50641704|FG002|Overall Study|Withdrawal by Subject|0|||
25325322|NCT00711802|50641705|FG003|Overall Study|Withdrawal by Subject|1|||
25325323|NCT00711802|50641706|FG004|Overall Study|Withdrawal by Subject|0|||
25325324|NCT00711802|50641707|FG005|Overall Study|Withdrawal by Subject|0|||
25325325|NCT00711802|50641708|FG006|Overall Study|Withdrawal by Subject|0|||
25325326|NCT00711802|50641709|FG007|Overall Study|Withdrawal by Subject|0|||
25325327|NCT00711802|50641702|FG000|Overall Study|Lost to Follow-up|0|||
25325328|NCT00711802|50641703|FG001|Overall Study|Lost to Follow-up|0|||
25325329|NCT00711802|50641704|FG002|Overall Study|Lost to Follow-up|3|||
25325330|NCT00711802|50641705|FG003|Overall Study|Lost to Follow-up|1|||
25325331|NCT00711802|50641706|FG004|Overall Study|Lost to Follow-up|10|||
25325332|NCT00711802|50641707|FG005|Overall Study|Lost to Follow-up|6|||
25325333|NCT00711802|50641708|FG006|Overall Study|Lost to Follow-up|4|||
25325334|NCT00711802|50641709|FG007|Overall Study|Lost to Follow-up|2|||
25325335|NCT00711802|50641702|FG000|Overall Study|Reason not reported|0|||
25325336|NCT00711802|50641703|FG001|Overall Study|Reason not reported|1|||
25325337|NCT00711802|50641704|FG002|Overall Study|Reason not reported|1|||
25325338|NCT00711802|50641705|FG003|Overall Study|Reason not reported|0|||
25325339|NCT00711802|50641706|FG004|Overall Study|Reason not reported|1|||
25325340|NCT00711802|50641707|FG005|Overall Study|Reason not reported|0|||
25325341|NCT00711802|50641708|FG006|Overall Study|Reason not reported|1|||
25325342|NCT00711802|50641709|FG007|Overall Study|Reason not reported|0|||
25325343|NCT00851877|50641730|FG000|Phase I-1|Death|1|||
25325344|NCT00851877|50641731|FG001|Phase I-1|Death|0|||
25325345|NCT00851877|50641732|FG002|Phase I-1|Death|0|||
25325346|NCT00851877|50641730|FG000|Phase II|Withdrawal by Subject|0|||
25325347|NCT00851877|50641731|FG001|Phase II|Withdrawal by Subject|0|||
25325348|NCT00851877|50641732|FG002|Phase II|Withdrawal by Subject|3|||
25325349|NCT00882908|50641743|FG000|Overall Study|Adverse Event|0|||
25325350|NCT00882908|50641744|FG001|Overall Study|Adverse Event|0|||
25325351|NCT00882908|50641745|FG002|Overall Study|Adverse Event|1|||
25325352|NCT00882908|50641746|FG003|Overall Study|Adverse Event|0|||
25325353|NCT00882908|50641747|FG004|Overall Study|Adverse Event|1|||
25325354|NCT00882908|50641743|FG000|Overall Study|Lost to Follow-up|3|||
25325355|NCT00882908|50641744|FG001|Overall Study|Lost to Follow-up|5|||
25325356|NCT00882908|50641745|FG002|Overall Study|Lost to Follow-up|3|||
25325357|NCT00882908|50641746|FG003|Overall Study|Lost to Follow-up|1|||
25325358|NCT00882908|50641747|FG004|Overall Study|Lost to Follow-up|2|||
25325359|NCT00882908|50641743|FG000|Overall Study|Protocol Violation|0|||
25325360|NCT00882908|50641744|FG001|Overall Study|Protocol Violation|1|||
25325361|NCT00882908|50641745|FG002|Overall Study|Protocol Violation|0|||
25325362|NCT00882908|50641746|FG003|Overall Study|Protocol Violation|0|||
25325363|NCT00882908|50641747|FG004|Overall Study|Protocol Violation|0|||
25325364|NCT00882908|50641743|FG000|Overall Study|Withdrawal by Subject|0|||
25325365|NCT00882908|50641744|FG001|Overall Study|Withdrawal by Subject|0|||
25325366|NCT00882908|50641745|FG002|Overall Study|Withdrawal by Subject|3|||
25325367|NCT00882908|50641746|FG003|Overall Study|Withdrawal by Subject|5|||
25325368|NCT00882908|50641747|FG004|Overall Study|Withdrawal by Subject|2|||
25325369|NCT00882908|50641743|FG000|Overall Study|Subject reached a virologic endpoint|0|||
25246130|NCT01231516|50561441|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
25246131|NCT01231516|50561442|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
25246132|NCT01231516|50561441|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
25246133|NCT01231516|50561442|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
25246134|NCT01231516|50561441|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
25246135|NCT01231516|50561442|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
25246136|NCT01231516|50561441|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
25246137|NCT01231516|50561442|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
25246138|NCT01231516|50561441|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
25246139|NCT01231516|50561442|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
25246140|NCT01231516|50561441|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
25246141|NCT01231516|50561442|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
25246142|NCT01231516|50561441|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
25246143|NCT01231516|50561442|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
25246144|NCT01231516|50561441|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
25246145|NCT01231516|50561442|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
25246146|NCT01231516|50561441|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
25246147|NCT01231516|50561442|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
25246148|NCT01231516|50561441|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
25246149|NCT01231516|50561442|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
25246150|NCT01231516|50561441|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
25246151|NCT01231516|50561442|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
25246152|NCT01231516|50561441|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
25246153|NCT01231516|50561442|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
25246154|NCT01231516|50561441|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
25246155|NCT01231516|50561442|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
25246156|NCT01231516|50561441|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
25246157|NCT01231516|50561442|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
25246158|NCT01231516|50561441|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
25246159|NCT01231516|50561442|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
25246160|NCT01231321|50561448|FG000|Overall Study|Adverse Event|3|||
25246161|NCT01231321|50561448|FG000|Overall Study|Lack of Efficacy|2|||
25246162|NCT01210222|50561458|FG000|Overall Study|Ineligible|2|||
25246163|NCT01210222|50561458|FG000|Overall Study|Never treated|1|||
25246164|NCT01210144|50561470|FG000|Overall Study|Lack of ovarian response|1|||
25246165|NCT01210144|50561471|FG001|Overall Study|Lack of ovarian response|0|||
25246166|NCT01210144|50561470|FG000|Overall Study|No fertilization|1|||
25246167|NCT01210144|50561471|FG001|Overall Study|No fertilization|0|||
25246168|NCT01210144|50561470|FG000|Overall Study|No transfer|1|||
25246169|NCT01210144|50561471|FG001|Overall Study|No transfer|0|||
25246170|NCT01209949|50561478|FG000|Overall Study|Lost to Follow-up|3|||
25246171|NCT01209832|50561482|FG000|Period 1|Sponsor Decision and was not dosed|1|||
25246172|NCT01209832|50561482|FG000|Period 2|Sponsor Decision|1|||
25246173|NCT01230892|50561495|FG000|Overall Study|Withdrawal by Subject|1|||
25246174|NCT01230892|50561496|FG001|Overall Study|Withdrawal by Subject|1|||
25246175|NCT01230892|50561495|FG000|Overall Study|Lost to Follow-up|2|||
25246176|NCT01230892|50561496|FG001|Overall Study|Lost to Follow-up|0|||
25246177|NCT01230814|50561504|FG000|Overall Study|Lost to Follow-up|11|||
25246178|NCT01230814|50561505|FG001|Overall Study|Lost to Follow-up|3|||
25246179|NCT01230814|50561504|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
25246180|NCT01230814|50561505|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
25325370|NCT00882908|50641744|FG001|Overall Study|Subject reached a virologic endpoint|0|||
25325371|NCT00882908|50641745|FG002|Overall Study|Subject reached a virologic endpoint|0|||
25325372|NCT00882908|50641746|FG003|Overall Study|Subject reached a virologic endpoint|0|||
25325373|NCT00882908|50641747|FG004|Overall Study|Subject reached a virologic endpoint|1|||
25325374|NCT00882908|50641743|FG000|Overall Study|Study terminated in error|0|||
25325375|NCT00882908|50641744|FG001|Overall Study|Study terminated in error|0|||
25325376|NCT00882908|50641745|FG002|Overall Study|Study terminated in error|0|||
25246181|NCT01230307|50561513|FG000|Overall Study|LVAD Placement|0|||
25246182|NCT01230307|50561514|FG001|Overall Study|LVAD Placement|2|||
25246183|NCT01209598|50561522|FG000|Overall Study|Withdrawal by Subject|1|||
25325377|NCT00882908|50641746|FG003|Overall Study|Study terminated in error|1|||
25246184|NCT01209598|50561523|FG001|Overall Study|Withdrawal by Subject|0|||
25246185|NCT01209520|50561530|FG000|Overall Study|Withdrawal by Subject|3|||
25246186|NCT01209325|50561534|FG000|Overall Study|Lost to Follow-up|24|||
25246187|NCT01209325|50561534|FG000|Overall Study|Adverse Event|1|||
25246188|NCT01209325|50561534|FG000|Overall Study|Relocated|3|||
25246189|NCT01209325|50561534|FG000|Overall Study|Refusal after starting therapy|8|||
25246190|NCT01209325|50561534|FG000|Overall Study|Protocol Violation|4|||
25246191|NCT01209325|50561534|FG000|Overall Study|Refusal prior to therapy|1|||
25246192|NCT01209325|50561534|FG000|Overall Study|Incarceration|2|||
25246193|NCT01209286|50561572|FG000|Overall Study|Adverse Event|4|||
25246194|NCT01209286|50561573|FG001|Overall Study|Adverse Event|3|||
25246195|NCT01209286|50561574|FG002|Overall Study|Adverse Event|1|||
25246196|NCT01209286|50561572|FG000|Overall Study|Hematological Relapse After Remission|0|||
25246197|NCT01209286|50561573|FG001|Overall Study|Hematological Relapse After Remission|1|||
25246198|NCT01209286|50561574|FG002|Overall Study|Hematological Relapse After Remission|1|||
25246199|NCT01209286|50561572|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
25246200|NCT01209286|50561573|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
25246201|NCT01209286|50561574|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
25246202|NCT01209286|50561572|FG000|Overall Study|Physician Decision|0|||
25246203|NCT01209286|50561573|FG001|Overall Study|Physician Decision|2|||
25246204|NCT01209286|50561574|FG002|Overall Study|Physician Decision|0|||
25246205|NCT01209286|50561572|FG000|Overall Study|Other|0|||
25246206|NCT01209286|50561573|FG001|Overall Study|Other|1|||
25246207|NCT01209286|50561574|FG002|Overall Study|Other|0|||
25246208|NCT01208233|50561597|FG000|Overall Study|Adverse Event|0|||
25246209|NCT01208233|50561598|FG001|Overall Study|Adverse Event|1|||
25246210|NCT01208233|50561599|FG002|Overall Study|Adverse Event|2|||
25246211|NCT01208233|50561600|FG003|Overall Study|Adverse Event|0|||
25246212|NCT01208233|50561601|FG004|Overall Study|Adverse Event|3|||
25246213|NCT01208233|50561602|FG005|Overall Study|Adverse Event|5|||
25246214|NCT01208233|50561597|FG000|Overall Study|Death|0|||
25246215|NCT01208233|50561598|FG001|Overall Study|Death|0|||
25246216|NCT01208233|50561599|FG002|Overall Study|Death|0|||
25246217|NCT01208233|50561600|FG003|Overall Study|Death|0|||
25246218|NCT01208233|50561601|FG004|Overall Study|Death|3|||
25246219|NCT01208233|50561602|FG005|Overall Study|Death|5|||
25246220|NCT01208233|50561597|FG000|Overall Study|Did not meet entrance criteria|2|||
25246221|NCT01208233|50561598|FG001|Overall Study|Did not meet entrance criteria|1|||
25246222|NCT01208233|50561599|FG002|Overall Study|Did not meet entrance criteria|1|||
25246223|NCT01208233|50561600|FG003|Overall Study|Did not meet entrance criteria|0|||
25246224|NCT01208233|50561601|FG004|Overall Study|Did not meet entrance criteria|1|||
25246225|NCT01208233|50561602|FG005|Overall Study|Did not meet entrance criteria|0|||
25246226|NCT01208233|50561597|FG000|Overall Study|Medication error without adverse event|0|||
25246227|NCT01208233|50561598|FG001|Overall Study|Medication error without adverse event|0|||
25246228|NCT01208233|50561599|FG002|Overall Study|Medication error without adverse event|0|||
25246229|NCT01208233|50561600|FG003|Overall Study|Medication error without adverse event|0|||
25246230|NCT01208233|50561601|FG004|Overall Study|Medication error without adverse event|0|||
25246231|NCT01208233|50561602|FG005|Overall Study|Medication error without adverse event|1|||
25246232|NCT01208233|50561597|FG000|Overall Study|Study terminated by sponsor|0|||
25246233|NCT01208233|50561598|FG001|Overall Study|Study terminated by sponsor|0|||
25325378|NCT00882908|50641747|FG004|Overall Study|Study terminated in error|0|||
25325379|NCT00851799|50641763|FG000|Overall Study|Death|1|||
25325380|NCT00851799|50641764|FG001|Overall Study|Death|0|||
25325381|NCT00851799|50641765|FG002|Overall Study|Death|1|||
25325382|NCT00851799|50641763|FG000|Overall Study|Lost to Follow-up|5|||
25325383|NCT00851799|50641764|FG001|Overall Study|Lost to Follow-up|3|||
25325384|NCT00851799|50641765|FG002|Overall Study|Lost to Follow-up|10|||
25325385|NCT00851799|50641763|FG000|Overall Study|Not able to get to clinic|8|||
25325386|NCT00851799|50641764|FG001|Overall Study|Not able to get to clinic|5|||
25325387|NCT00851799|50641765|FG002|Overall Study|Not able to get to clinic|9|||
25325388|NCT00851799|50641763|FG000|Overall Study|Not willing to adhere to requirements|1|||
25325389|NCT00851799|50641764|FG001|Overall Study|Not willing to adhere to requirements|2|||
25325390|NCT00851799|50641765|FG002|Overall Study|Not willing to adhere to requirements|2|||
25325391|NCT00851799|50641763|FG000|Overall Study|Withdrew consent prior study completion|1|||
25246234|NCT01208233|50561599|FG002|Overall Study|Study terminated by sponsor|0|||
25246235|NCT01208233|50561600|FG003|Overall Study|Study terminated by sponsor|0|||
25246236|NCT01208233|50561601|FG004|Overall Study|Study terminated by sponsor|10|||
25246237|NCT01208233|50561602|FG005|Overall Study|Study terminated by sponsor|7|||
25246238|NCT01208233|50561597|FG000|Overall Study|Protocol Violation|0|||
25246239|NCT01208233|50561598|FG001|Overall Study|Protocol Violation|0|||
25246240|NCT01208233|50561599|FG002|Overall Study|Protocol Violation|0|||
25246241|NCT01208233|50561600|FG003|Overall Study|Protocol Violation|0|||
25246242|NCT01208233|50561601|FG004|Overall Study|Protocol Violation|3|||
25246243|NCT01208233|50561602|FG005|Overall Study|Protocol Violation|0|||
25325392|NCT00851799|50641764|FG001|Overall Study|Withdrew consent prior study completion|2|||
25325393|NCT00851799|50641765|FG002|Overall Study|Withdrew consent prior study completion|1|||
25246244|NCT01208233|50561597|FG000|Overall Study|Other|2|||
25246245|NCT01208233|50561598|FG001|Overall Study|Other|1|||
25246246|NCT01208233|50561599|FG002|Overall Study|Other|0|||
25246247|NCT01208233|50561600|FG003|Overall Study|Other|0|||
25246248|NCT01208233|50561601|FG004|Overall Study|Other|0|||
25246249|NCT01208233|50561602|FG005|Overall Study|Other|1|||
25246250|NCT01208233|50561597|FG000|Overall Study|Withdrawal by Subject|1|||
25246251|NCT01208233|50561598|FG001|Overall Study|Withdrawal by Subject|0|||
25246252|NCT01208233|50561599|FG002|Overall Study|Withdrawal by Subject|1|||
25246253|NCT01208233|50561600|FG003|Overall Study|Withdrawal by Subject|1|||
25246254|NCT01208233|50561601|FG004|Overall Study|Withdrawal by Subject|4|||
25246255|NCT01208233|50561602|FG005|Overall Study|Withdrawal by Subject|2|||
25246256|NCT01208038|50561622|FG000|Overall Study|Withdrawal by Subject|1|||
25246257|NCT01207687|50561626|FG000|Overall Study|Adverse Event|1|||
25246258|NCT01207687|50561626|FG000|Overall Study|Withdrawal by Subject|1|||
25246259|NCT01207453|50561638|FG000|First Intervention|Adverse Event|2|||
25246260|NCT01207453|50561639|FG001|First Intervention|Adverse Event|1|||
25246261|NCT01207453|50561638|FG000|Washout|Adverse Event|1|||
25246262|NCT01207453|50561639|FG001|Washout|Adverse Event|0|||
25246263|NCT01207453|50561638|FG000|Washout|Lost to Follow-up|1|||
25246264|NCT01207453|50561639|FG001|Washout|Lost to Follow-up|0|||
25246265|NCT01207453|50561638|FG000|2nd Intervention|Adverse Event|1|||
25246266|NCT01207453|50561639|FG001|2nd Intervention|Adverse Event|2|||
25246267|NCT01207453|50561638|FG000|2nd Intervention|Lost to Follow-up|1|||
25246268|NCT01207453|50561639|FG001|2nd Intervention|Lost to Follow-up|0|||
25246269|NCT01207414|50561650|FG000|Overall Study|Adverse Event|25|||
25246270|NCT01207414|50561651|FG001|Overall Study|Adverse Event|39|||
25325394|NCT00851799|50641763|FG000|Overall Study|Severe Debilitation|0|||
25325395|NCT00851799|50641764|FG001|Overall Study|Severe Debilitation|1|||
25325396|NCT00851799|50641765|FG002|Overall Study|Severe Debilitation|0|||
25325397|NCT00851799|50641763|FG000|Overall Study|Completed protocol due to pregnancy|0|||
25325398|NCT00851799|50641764|FG001|Overall Study|Completed protocol due to pregnancy|0|||
25325399|NCT00851799|50641765|FG002|Overall Study|Completed protocol due to pregnancy|1|||
25325400|NCT00521053|50641773|FG000|Observation Phase|Disease Progression|55|||
25325401|NCT00521053|50641773|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
25325402|NCT00521053|50641773|FG000|Observation Phase|Death|2|||
25325403|NCT00521053|50641773|FG000|Observation Phase|Adverse Event|1|||
25325404|NCT00521053|50641773|FG000|Observation Phase|Other non-study melanoma treatment|1|||
25325405|NCT00521053|50641773|FG000|Observation Phase|Physician Decision|1|||
25325406|NCT00853047|50641785|FG000|Core Phase|Participant Request|0|||
25325407|NCT00853047|50641786|FG001|Core Phase|Participant Request|0|||
25325408|NCT00853047|50641787|FG002|Core Phase|Participant Request|0|||
25325409|NCT00853047|50641788|FG003|Core Phase|Participant Request|1|||
25325410|NCT00853047|50641789|FG004|Core Phase|Participant Request|0|||
25325411|NCT00853047|50641790|FG005|Core Phase|Participant Request|0|||
25325412|NCT00853047|50641785|FG000|Open-Label Extension Phase|Participant Request|0|||
25325413|NCT00853047|50641786|FG001|Open-Label Extension Phase|Participant Request|0|||
25325414|NCT00853047|50641787|FG002|Open-Label Extension Phase|Participant Request|0|||
25325415|NCT00853047|50641788|FG003|Open-Label Extension Phase|Participant Request|0|||
25325416|NCT00853047|50641789|FG004|Open-Label Extension Phase|Participant Request|0|||
25325417|NCT00853047|50641790|FG005|Open-Label Extension Phase|Participant Request|7|||
25325418|NCT00853047|50641785|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
25325419|NCT00853047|50641786|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
25325420|NCT00853047|50641787|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
25246271|NCT01207414|50561650|FG000|Overall Study|Abnormal test procedure results|0|||
25246272|NCT01207414|50561651|FG001|Overall Study|Abnormal test procedure results|1|||
25246273|NCT01207414|50561650|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
25246274|NCT01207414|50561651|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
25246275|NCT01207414|50561650|FG000|Overall Study|Patient withdrew consent|14|||
25246276|NCT01207414|50561651|FG001|Overall Study|Patient withdrew consent|11|||
25246277|NCT01207414|50561650|FG000|Overall Study|Lost to Follow-up|15|||
25246278|NCT01207414|50561651|FG001|Overall Study|Lost to Follow-up|17|||
25246279|NCT01207414|50561650|FG000|Overall Study|Administrative problems|1|||
25246280|NCT01207414|50561651|FG001|Overall Study|Administrative problems|1|||
25246281|NCT01207414|50561650|FG000|Overall Study|Protocol deviation|12|||
25246282|NCT01207414|50561651|FG001|Overall Study|Protocol deviation|9|||
25246283|NCT01207414|50561650|FG000|Overall Study|Randomized in error|1|||
25246284|NCT01207414|50561651|FG001|Overall Study|Randomized in error|0|||
25246285|NCT01207219|50561660|FG000|Overall Study|changed diagnosis during study period|5|||
25246286|NCT01207219|50561661|FG001|Overall Study|changed diagnosis during study period|3|||
25325421|NCT00853047|50641788|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
25325422|NCT00853047|50641789|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
25325423|NCT00853047|50641790|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
25325424|NCT00853047|50641785|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
25325425|NCT00853047|50641786|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
25325426|NCT00853047|50641787|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
25246287|NCT01207219|50561662|FG002|Overall Study|changed diagnosis during study period|1|||
25246288|NCT01207219|50561660|FG000|Overall Study|Lost to Follow-up|6|||
25246289|NCT01207219|50561661|FG001|Overall Study|Lost to Follow-up|8|||
25246290|NCT01207219|50561662|FG002|Overall Study|Lost to Follow-up|6|||
25246291|NCT01206517|50561676|FG000|Overall Study|Withdrawal by Subject|0|||
25246292|NCT01206517|50561677|FG001|Overall Study|Withdrawal by Subject|0|||
25246293|NCT01206517|50561678|FG002|Overall Study|Withdrawal by Subject|2|||
25246294|NCT01206517|50561679|FG003|Overall Study|Withdrawal by Subject|0|||
25246295|NCT01206517|50561680|FG004|Overall Study|Withdrawal by Subject|1|||
25246296|NCT01206517|50561681|FG005|Overall Study|Withdrawal by Subject|0|||
25246297|NCT01206439|50561692|FG000|Overall Study|subject did not meet inclusion criteria|1|||
25246298|NCT01206322|50561698|FG000|Overall Study|Adverse Event|0|||
25246299|NCT01206322|50561699|FG001|Overall Study|Adverse Event|0|||
25246300|NCT01206322|50561700|FG002|Overall Study|Adverse Event|0|||
25246301|NCT01206322|50561701|FG003|Overall Study|Adverse Event|1|||
25325427|NCT00853047|50641788|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
25325428|NCT00853047|50641789|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
25325429|NCT00853047|50641790|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
25325430|NCT00853047|50641785|FG000|Open-Label Extension Phase|Investigator Decision|0|||
25325431|NCT00853047|50641786|FG001|Open-Label Extension Phase|Investigator Decision|0|||
25325432|NCT00853047|50641787|FG002|Open-Label Extension Phase|Investigator Decision|0|||
25325433|NCT00853047|50641788|FG003|Open-Label Extension Phase|Investigator Decision|0|||
25325434|NCT00853047|50641789|FG004|Open-Label Extension Phase|Investigator Decision|0|||
25325435|NCT00853047|50641790|FG005|Open-Label Extension Phase|Investigator Decision|1|||
25325436|NCT00853047|50641785|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
25325437|NCT00853047|50641786|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
25325438|NCT00853047|50641787|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
25325439|NCT00853047|50641788|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
25325440|NCT00853047|50641789|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
25325441|NCT00853047|50641790|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
25325442|NCT00520975|50641807|FG000|Overall Study|Disease progression|31|||
25325443|NCT00520975|50641808|FG001|Overall Study|Disease progression|23|||
25325444|NCT00520975|50641807|FG000|Overall Study|Adverse Event|7|||
25325445|NCT00520975|50641808|FG001|Overall Study|Adverse Event|10|||
25325446|NCT00520975|50641807|FG000|Overall Study|Death|0|||
25325447|NCT00520975|50641808|FG001|Overall Study|Death|2|||
25325448|NCT00520975|50641807|FG000|Overall Study|Withdrawal by Subject|3|||
25325449|NCT00520975|50641808|FG001|Overall Study|Withdrawal by Subject|5|||
25325450|NCT00520975|50641807|FG000|Overall Study|Other therapy|2|||
25325451|NCT00520975|50641808|FG001|Overall Study|Other therapy|4|||
25325452|NCT00520975|50641807|FG000|Overall Study|Other reasons|4|||
25325453|NCT00520975|50641808|FG001|Overall Study|Other reasons|2|||
25325454|NCT00520975|50641807|FG000|Overall Study|Not start protocol therapy|1|||
25325455|NCT00520975|50641808|FG001|Overall Study|Not start protocol therapy|2|||
25325456|NCT00851721|50641816|FG000|Overall Study|planned surgery|1|||
25325457|NCT00851721|50641817|FG001|Overall Study|planned surgery|0|||
25325458|NCT00851721|50641816|FG000|Overall Study|Death|1|||
25325459|NCT00851721|50641817|FG001|Overall Study|Death|0|||
25325460|NCT00851721|50641816|FG000|Overall Study|Adverse Event|0|||
25325461|NCT00851721|50641817|FG001|Overall Study|Adverse Event|1|||
25325462|NCT00520741|50641831|FG000|Overall Study|Adverse Event|16|||
25325463|NCT00520741|50641832|FG001|Overall Study|Adverse Event|56|||
25325464|NCT00520741|50641831|FG000|Overall Study|Lack of Efficacy|11|||
25325465|NCT00520741|50641832|FG001|Overall Study|Lack of Efficacy|30|||
25325466|NCT00520741|50641831|FG000|Overall Study|Withdrawal by Subject|0|||
25325467|NCT00520741|50641832|FG001|Overall Study|Withdrawal by Subject|11|||
25325468|NCT00520741|50641831|FG000|Overall Study|Protocol Violation|2|||
25325469|NCT00520741|50641832|FG001|Overall Study|Protocol Violation|15|||
25325470|NCT00520741|50641831|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
25246302|NCT01206166|50561713|FG000|Overall Study|No evaluable data|2|||
25246303|NCT01206166|50561714|FG001|Overall Study|No evaluable data|3|||
25246304|NCT01207102|50561723|FG000|Overall Study|Withdrawal by Subject|5|||
25325471|NCT00520741|50641832|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
25325472|NCT00520741|50641831|FG000|Overall Study|Lost to Follow-up|4|||
25325473|NCT00520741|50641832|FG001|Overall Study|Lost to Follow-up|4|||
25325474|NCT00520741|50641831|FG000|Overall Study|Other reasons for premature termination|0|||
25325475|NCT00520741|50641832|FG001|Overall Study|Other reasons for premature termination|6|||
25325476|NCT00882518|50641842|FG000|Overall Study|Adverse Event|9|||
25325477|NCT00882518|50641843|FG001|Overall Study|Adverse Event|18|||
25246305|NCT01207102|50561723|FG000|Overall Study|Adverse Event|2|||
25325478|NCT00882518|50641842|FG000|Overall Study|Withdrawal by Subject|9|||
25325479|NCT00882518|50641843|FG001|Overall Study|Withdrawal by Subject|13|||
25325480|NCT00882518|50641842|FG000|Overall Study|Lack of Efficacy|12|||
25325481|NCT00882518|50641843|FG001|Overall Study|Lack of Efficacy|9|||
25325482|NCT00882518|50641842|FG000|Overall Study|Severe non-compliance to protocol|3|||
25325483|NCT00882518|50641843|FG001|Overall Study|Severe non-compliance to protocol|1|||
25325484|NCT00882518|50641842|FG000|Overall Study|Incorrect enrolment|4|||
25325485|NCT00882518|50641843|FG001|Overall Study|Incorrect enrolment|2|||
25325486|NCT00882518|50641842|FG000|Overall Study|Central lab closure for National day|1|||
25325487|NCT00882518|50641843|FG001|Overall Study|Central lab closure for National day|0|||
25325488|NCT00882518|50641842|FG000|Overall Study|Allocating random number by mistake|0|||
25325489|NCT00882518|50641843|FG001|Overall Study|Allocating random number by mistake|1|||
25325490|NCT00882362|50641860|FG000|Overall Study|Adverse Event|13|||
25325491|NCT00882362|50641861|FG001|Overall Study|Adverse Event|10|||
25325492|NCT00882362|50641860|FG000|Overall Study|Withdrawal by Subject|13|||
25246306|NCT01207102|50561723|FG000|Overall Study|progression|2|||
25246307|NCT01207102|50561723|FG000|Overall Study|Withdrawal by Treating Physician|1|||
25246308|NCT01205776|50561739|FG000|Overall Study|Lost to Follow-up|53|||
25246309|NCT01205776|50561740|FG001|Overall Study|Lost to Follow-up|61|||
25325493|NCT00882362|50641861|FG001|Overall Study|Withdrawal by Subject|10|||
25325494|NCT00882362|50641860|FG000|Overall Study|Lack of Efficacy|3|||
25325495|NCT00882362|50641861|FG001|Overall Study|Lack of Efficacy|0|||
25325496|NCT00882362|50641860|FG000|Overall Study|Protocol Violation|7|||
25325497|NCT00882362|50641861|FG001|Overall Study|Protocol Violation|2|||
25325498|NCT00882362|50641860|FG000|Overall Study|Pregnancy|1|||
25325499|NCT00882362|50641861|FG001|Overall Study|Pregnancy|0|||
25246310|NCT01205776|50561739|FG000|Overall Study|Withdrawal by Subject|11|||
25246311|NCT01205776|50561740|FG001|Overall Study|Withdrawal by Subject|34|||
25246312|NCT01205581|50561752|FG000|Overall Study|Withdrawal by Subject|1|||
25246313|NCT01205581|50561753|FG001|Overall Study|Withdrawal by Subject|0|||
25246314|NCT01205581|50561754|FG002|Overall Study|Withdrawal by Subject|0|||
25246315|NCT01205581|50561755|FG003|Overall Study|Withdrawal by Subject|0|||
25246316|NCT01205581|50561756|FG004|Overall Study|Withdrawal by Subject|0|||
25246317|NCT01205581|50561757|FG005|Overall Study|Withdrawal by Subject|0|||
25246318|NCT01205269|50561788|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
25246319|NCT01205269|50561789|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
25246320|NCT01205269|50561790|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
25246321|NCT01205269|50561791|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
25246322|NCT01205269|50561792|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
25246323|NCT01205269|50561793|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
25246324|NCT01240915|50561818|FG000|Overall Study|Adverse Event|0|||
25246325|NCT01240915|50561819|FG001|Overall Study|Adverse Event|0|||
25246326|NCT01240915|50561820|FG002|Overall Study|Adverse Event|0|||
25325500|NCT00882362|50641860|FG000|Overall Study|Physician Decision|5|||
25325501|NCT00882362|50641861|FG001|Overall Study|Physician Decision|1|||
25325502|NCT00882362|50641860|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
25325503|NCT00882362|50641861|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
25325504|NCT00882362|50641860|FG000|Overall Study|change of residence or other commitments|5|||
25325505|NCT00882362|50641861|FG001|Overall Study|change of residence or other commitments|0|||
25325506|NCT00851643|50641873|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
25325507|NCT00851643|50641874|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
25325508|NCT00851643|50641875|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
25325509|NCT00851643|50641876|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
25246327|NCT01240915|50561821|FG003|Overall Study|Adverse Event|1|||
25325510|NCT00851643|50641877|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
25325511|NCT00851643|50641878|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
25325512|NCT00851643|50641873|FG000|Base Study (Up to 12 Months)|Other|0|||
25325513|NCT00851643|50641874|FG001|Base Study (Up to 12 Months)|Other|0|||
25325514|NCT00851643|50641875|FG002|Base Study (Up to 12 Months)|Other|0|||
25325515|NCT00851643|50641876|FG003|Base Study (Up to 12 Months)|Other|0|||
25325516|NCT00851643|50641877|FG004|Base Study (Up to 12 Months)|Other|0|||
25325517|NCT00851643|50641878|FG005|Base Study (Up to 12 Months)|Other|1|||
25325518|NCT00851643|50641873|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
25325519|NCT00851643|50641874|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
25325520|NCT00851643|50641875|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
25246328|NCT01240915|50561822|FG004|Overall Study|Adverse Event|0|||
25246329|NCT01240915|50561823|FG005|Overall Study|Adverse Event|2|||
25246330|NCT01240915|50561824|FG006|Overall Study|Adverse Event|0|||
25325521|NCT00851643|50641876|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
25325522|NCT00851643|50641877|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
24977237|NCT03410992|50065846|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
25325523|NCT00851643|50641878|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
25325524|NCT00851643|50641873|FG000|Extension Study (Up to 36 Months)|Moved|0|||
25325525|NCT00851643|50641874|FG001|Extension Study (Up to 36 Months)|Moved|2|||
25325526|NCT00851643|50641875|FG002|Extension Study (Up to 36 Months)|Moved|1|||
25325527|NCT00851643|50641876|FG003|Extension Study (Up to 36 Months)|Moved|1|||
25325528|NCT00851643|50641877|FG004|Extension Study (Up to 36 Months)|Moved|0|||
25325529|NCT00851643|50641878|FG005|Extension Study (Up to 36 Months)|Moved|1|||
25325530|NCT00529243|50641891|FG000|Overall Study|Adverse Event|1|||
25325531|NCT00529243|50641891|FG000|Overall Study|Death|1|||
25325532|NCT00529243|50641891|FG000|Overall Study|Relocated|1|||
25325533|NCT03728309|50641897|FG000|Overall Study|Randomized but not Treated|0|||
25246331|NCT01240915|50561825|FG007|Overall Study|Adverse Event|0|||
25246332|NCT01240915|50561826|FG008|Overall Study|Adverse Event|1|||
25246333|NCT01240915|50561818|FG000|Overall Study|Lost to Follow-up|0|||
25246334|NCT01240915|50561819|FG001|Overall Study|Lost to Follow-up|0|||
25246335|NCT01240915|50561820|FG002|Overall Study|Lost to Follow-up|0|||
25246336|NCT01240915|50561821|FG003|Overall Study|Lost to Follow-up|0|||
25246337|NCT01240915|50561822|FG004|Overall Study|Lost to Follow-up|1|||
25246338|NCT01240915|50561823|FG005|Overall Study|Lost to Follow-up|1|||
25246339|NCT01240915|50561824|FG006|Overall Study|Lost to Follow-up|0|||
25246340|NCT01240915|50561825|FG007|Overall Study|Lost to Follow-up|1|||
25246341|NCT01240915|50561826|FG008|Overall Study|Lost to Follow-up|1|||
25246342|NCT01240915|50561818|FG000|Overall Study|Withdrawal by Subject|2|||
25246343|NCT01240915|50561819|FG001|Overall Study|Withdrawal by Subject|1|||
25246344|NCT01240915|50561820|FG002|Overall Study|Withdrawal by Subject|0|||
25246345|NCT01240915|50561821|FG003|Overall Study|Withdrawal by Subject|2|||
25246346|NCT01240915|50561822|FG004|Overall Study|Withdrawal by Subject|0|||
25246347|NCT01240915|50561823|FG005|Overall Study|Withdrawal by Subject|4|||
25246348|NCT01240915|50561824|FG006|Overall Study|Withdrawal by Subject|2|||
25246349|NCT01240915|50561825|FG007|Overall Study|Withdrawal by Subject|3|||
25246350|NCT01240915|50561826|FG008|Overall Study|Withdrawal by Subject|3|||
25246351|NCT01240915|50561818|FG000|Overall Study|Other|0|||
25246352|NCT01240915|50561819|FG001|Overall Study|Other|0|||
25246353|NCT01240915|50561820|FG002|Overall Study|Other|0|||
25246354|NCT01240915|50561821|FG003|Overall Study|Other|0|||
25246355|NCT01240915|50561822|FG004|Overall Study|Other|2|||
25246356|NCT01240915|50561823|FG005|Overall Study|Other|0|||
25246357|NCT01240915|50561824|FG006|Overall Study|Other|0|||
25246358|NCT01240915|50561825|FG007|Overall Study|Other|0|||
25246359|NCT01240915|50561826|FG008|Overall Study|Other|0|||
25246360|NCT01240915|50561818|FG000|Overall Study|Insufficient Clinical Response|0|||
25246361|NCT01240915|50561819|FG001|Overall Study|Insufficient Clinical Response|0|||
25246362|NCT01240915|50561820|FG002|Overall Study|Insufficient Clinical Response|0|||
25246363|NCT01240915|50561821|FG003|Overall Study|Insufficient Clinical Response|0|||
25246364|NCT01240915|50561822|FG004|Overall Study|Insufficient Clinical Response|1|||
25246365|NCT01240915|50561823|FG005|Overall Study|Insufficient Clinical Response|3|||
25246366|NCT01240915|50561824|FG006|Overall Study|Insufficient Clinical Response|6|||
25246367|NCT01240915|50561825|FG007|Overall Study|Insufficient Clinical Response|0|||
25246368|NCT01240915|50561826|FG008|Overall Study|Insufficient Clinical Response|3|||
25246369|NCT01239745|50561848|FG000|Overall Study|Study terminated by sponsor|45|||
25246370|NCT01239745|50561848|FG000|Overall Study|Adverse Event|1|||
25246371|NCT01239472|50561854|FG000|Overall Study|Withdrawal by Subject|5|||
25246372|NCT01239472|50561855|FG001|Overall Study|Withdrawal by Subject|1|||
25246373|NCT01239472|50561854|FG000|Overall Study|Adverse Event|0|||
25246374|NCT01239472|50561855|FG001|Overall Study|Adverse Event|1|||
25246375|NCT01239472|50561854|FG000|Overall Study|Lack of Efficacy|0|||
25246376|NCT01239472|50561855|FG001|Overall Study|Lack of Efficacy|1|||
25246377|NCT01229449|50561868|FG000|Overall Study|Withdrawal by Subject|0|||
25246378|NCT01229449|50561869|FG001|Overall Study|Withdrawal by Subject|3|||
25246379|NCT01229449|50561870|FG002|Overall Study|Withdrawal by Subject|0|||
25246380|NCT01229449|50561871|FG003|Overall Study|Withdrawal by Subject|1|||
25325534|NCT03728309|50641898|FG001|Overall Study|Randomized but not Treated|1|||
25325535|NCT03728309|50641897|FG000|Overall Study|Adverse Event|0|||
25325536|NCT03728309|50641898|FG001|Overall Study|Adverse Event|1|||
25246381|NCT01229449|50561872|FG004|Overall Study|Withdrawal by Subject|1|||
25246382|NCT01229449|50561868|FG000|Overall Study|Lost to Follow-up|1|||
25246383|NCT01229449|50561869|FG001|Overall Study|Lost to Follow-up|1|||
25246384|NCT01229449|50561870|FG002|Overall Study|Lost to Follow-up|1|||
25246385|NCT01229449|50561871|FG003|Overall Study|Lost to Follow-up|0|||
25246386|NCT01229449|50561872|FG004|Overall Study|Lost to Follow-up|0|||
25246387|NCT01229449|50561868|FG000|Overall Study|Physician Decision|0|||
25246388|NCT01229449|50561869|FG001|Overall Study|Physician Decision|0|||
25246389|NCT01229449|50561870|FG002|Overall Study|Physician Decision|1|||
25246390|NCT01229449|50561871|FG003|Overall Study|Physician Decision|0|||
25246391|NCT01229449|50561872|FG004|Overall Study|Physician Decision|0|||
25246392|NCT01239316|50561884|FG000|Overall Study|Progression/Relapse|11|||
25246393|NCT01239316|50561884|FG000|Overall Study|Adverse Event|1|||
25246394|NCT01239160|50561890|FG000|Overall Study|Lost to Follow-up|3|||
25325537|NCT03728309|50641897|FG000|Overall Study|Withdrawal by Subject|2|||
25325538|NCT03728309|50641898|FG001|Overall Study|Withdrawal by Subject|8|||
25325539|NCT03728309|50641897|FG000|Overall Study|Lost to Follow-up|9|||
25325540|NCT03728309|50641898|FG001|Overall Study|Lost to Follow-up|10|||
25325541|NCT03728309|50641897|FG000|Overall Study|Protocol Deviation|0|||
25325542|NCT03728309|50641898|FG001|Overall Study|Protocol Deviation|1|||
25325543|NCT03728309|50641897|FG000|Overall Study|Due to COVID|1|||
25325544|NCT03728309|50641898|FG001|Overall Study|Due to COVID|3|||
25325545|NCT03683719|50641915|FG000|Overall Study|Lack of Efficacy|1|||
25325546|NCT03683719|50641916|FG001|Overall Study|Lack of Efficacy|3|||
25325547|NCT03683719|50641917|FG002|Overall Study|Lack of Efficacy|4|||
25325548|NCT03683719|50641918|FG003|Overall Study|Lack of Efficacy|0|||
25325549|NCT03683719|50641919|FG004|Overall Study|Lack of Efficacy|4|||
25325550|NCT03683719|50641915|FG000|Overall Study|Adverse Event|6|||
25325551|NCT03683719|50641916|FG001|Overall Study|Adverse Event|6|||
25325552|NCT03683719|50641917|FG002|Overall Study|Adverse Event|0|||
25325553|NCT03683719|50641918|FG003|Overall Study|Adverse Event|1|||
25325554|NCT03683719|50641919|FG004|Overall Study|Adverse Event|3|||
25325555|NCT03683719|50641915|FG000|Overall Study|Withdrawal by Subject|4|||
25325556|NCT03683719|50641916|FG001|Overall Study|Withdrawal by Subject|4|||
25325557|NCT03683719|50641917|FG002|Overall Study|Withdrawal by Subject|3|||
25325558|NCT03683719|50641918|FG003|Overall Study|Withdrawal by Subject|5|||
25325559|NCT03683719|50641919|FG004|Overall Study|Withdrawal by Subject|5|||
25325560|NCT03683719|50641915|FG000|Overall Study|Lost to Follow-up|1|||
25325561|NCT03683719|50641916|FG001|Overall Study|Lost to Follow-up|0|||
25325562|NCT03683719|50641917|FG002|Overall Study|Lost to Follow-up|0|||
25325563|NCT03683719|50641918|FG003|Overall Study|Lost to Follow-up|1|||
25325564|NCT03683719|50641919|FG004|Overall Study|Lost to Follow-up|1|||
25325565|NCT03683719|50641915|FG000|Overall Study|Other personal reasons|0|||
25325566|NCT03683719|50641916|FG001|Overall Study|Other personal reasons|0|||
25325567|NCT03683719|50641917|FG002|Overall Study|Other personal reasons|1|||
25325568|NCT03683719|50641918|FG003|Overall Study|Other personal reasons|0|||
25325569|NCT03683719|50641919|FG004|Overall Study|Other personal reasons|1|||
25325570|NCT00851253|50641933|FG000|Overall Study|Disease Progression|1|||
25325571|NCT00851253|50641934|FG001|Overall Study|Disease Progression|0|||
25325572|NCT00520351|50641942|FG000|First Intervention|Withdrawal by Subject|1|||
25325573|NCT00520351|50641943|FG001|First Intervention|Withdrawal by Subject|1|||
25325574|NCT00850395|50641953|FG000|Overall Study|Death|1|||
25325575|NCT00850395|50641953|FG000|Overall Study|Adverse Event|1|||
25325576|NCT00850395|50641953|FG000|Overall Study|Insufficient clinical response|3|||
25325577|NCT00850395|50641953|FG000|Overall Study|Other|5|||
25325578|NCT00520039|50641959|FG000|Overall Study|Exclusion criteria met at first visit|7|||
25325579|NCT00520039|50641960|FG001|Overall Study|Exclusion criteria met at first visit|5|||
25325580|NCT00577720|50641972|FG000|Overall Study|Adverse Event|2|||
25325581|NCT00577720|50641973|FG001|Overall Study|Adverse Event|1|||
25325582|NCT00577720|50641974|FG002|Overall Study|Adverse Event|0|||
25325583|NCT00577720|50641975|FG003|Overall Study|Adverse Event|4|||
25325584|NCT00577720|50641972|FG000|Overall Study|Lost to Follow-up|0|||
25246395|NCT01239160|50561891|FG001|Overall Study|Lost to Follow-up|5|||
25246396|NCT01239160|50561892|FG002|Overall Study|Lost to Follow-up|0|||
25246397|NCT01239160|50561890|FG000|Overall Study|Withdrawal by Subject|17|||
25246398|NCT01239160|50561891|FG001|Overall Study|Withdrawal by Subject|6|||
25246399|NCT01239160|50561892|FG002|Overall Study|Withdrawal by Subject|2|||
25246400|NCT01239160|50561890|FG000|Overall Study|Physician Decision|5|||
25246401|NCT01239160|50561891|FG001|Overall Study|Physician Decision|7|||
25246402|NCT01239160|50561892|FG002|Overall Study|Physician Decision|2|||
25246403|NCT01239160|50561890|FG000|Overall Study|Early Termination Due to Study Closure|0|||
25246404|NCT01239160|50561891|FG001|Overall Study|Early Termination Due to Study Closure|1|||
25246405|NCT01239160|50561892|FG002|Overall Study|Early Termination Due to Study Closure|6|||
25246406|NCT01239121|50561901|FG000|Overall Study|Withdrawal by Subject|2|||
25246407|NCT01239121|50561902|FG001|Overall Study|Withdrawal by Subject|4|||
25246408|NCT01239121|50561903|FG002|Overall Study|Withdrawal by Subject|0|||
25246409|NCT01239043|50561913|FG000|Overall Study|Protocol Violation|2|||
25246410|NCT01239043|50561914|FG001|Overall Study|Protocol Violation|1|||
25246411|NCT01238848|50561922|FG000|Overall Study|Physician Decision|13|||
25246412|NCT01238848|50561923|FG001|Overall Study|Physician Decision|5|||
25325585|NCT00577720|50641973|FG001|Overall Study|Lost to Follow-up|0|||
25325586|NCT00577720|50641974|FG002|Overall Study|Lost to Follow-up|1|||
25325587|NCT00577720|50641975|FG003|Overall Study|Lost to Follow-up|0|||
25325588|NCT00577720|50641972|FG000|Overall Study|Protocol Violation|0|||
25325589|NCT00577720|50641973|FG001|Overall Study|Protocol Violation|0|||
25325590|NCT00577720|50641974|FG002|Overall Study|Protocol Violation|0|||
25325591|NCT00577720|50641975|FG003|Overall Study|Protocol Violation|1|||
25246413|NCT01238575|50561931|FG000|Overall Study|Lack of Efficacy|2|||
25246414|NCT01238575|50561932|FG001|Overall Study|Lack of Efficacy|4|||
25246415|NCT01238575|50561931|FG000|Overall Study|Adverse Event|2|||
25325592|NCT00577720|50641972|FG000|Overall Study|Withdrawal by Subject|2|||
25325593|NCT00577720|50641973|FG001|Overall Study|Withdrawal by Subject|0|||
25325594|NCT00577720|50641974|FG002|Overall Study|Withdrawal by Subject|0|||
25325595|NCT00577720|50641975|FG003|Overall Study|Withdrawal by Subject|2|||
25325596|NCT00519649|50641985|FG000|Overall Study|Withdrawal by Subject|1|||
25325597|NCT00512707|50642003|FG000|Overall Study|Lost to Follow-up|5|||
25325598|NCT00512707|50642004|FG001|Overall Study|Lost to Follow-up|11|||
25325599|NCT00512707|50642003|FG000|Overall Study|Developed skin irritation|2|||
25325600|NCT00512707|50642004|FG001|Overall Study|Developed skin irritation|1|||
25325601|NCT00512707|50642003|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
25325602|NCT00512707|50642004|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
25325603|NCT00512707|50642003|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
25325604|NCT00512707|50642004|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
25325605|NCT03471767|50642012|FG000|Overall Study|Withdrawal by Subject|3|||
25325606|NCT03471767|50642013|FG001|Overall Study|Withdrawal by Subject|1|||
25325607|NCT03471767|50642012|FG000|Overall Study|Adverse Event|1|||
25325608|NCT03471767|50642013|FG001|Overall Study|Adverse Event|0|||
25325609|NCT03471767|50642012|FG000|Overall Study|Lost to Follow-up|1|||
25325610|NCT03471767|50642013|FG001|Overall Study|Lost to Follow-up|0|||
25325611|NCT03471767|50642012|FG000|Overall Study|PI Withdrawal|1|||
25325612|NCT03471767|50642013|FG001|Overall Study|PI Withdrawal|3|||
25325613|NCT00849693|50642023|FG000|Acute Treatment Phase|Adverse Event|12|||
25325614|NCT00849693|50642024|FG001|Acute Treatment Phase|Adverse Event|7|||
25325615|NCT00849693|50642025|FG002|Acute Treatment Phase|Adverse Event|6|||
25325616|NCT00849693|50642026|FG003|Acute Treatment Phase|Adverse Event|4|||
25325617|NCT00849693|50642023|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
25325618|NCT00849693|50642024|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
25325619|NCT00849693|50642025|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
25325620|NCT00849693|50642026|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
25325621|NCT00849693|50642023|FG000|Acute Treatment Phase|Protocol Violation|1|||
25325622|NCT00849693|50642024|FG001|Acute Treatment Phase|Protocol Violation|5|||
25325623|NCT00849693|50642025|FG002|Acute Treatment Phase|Protocol Violation|2|||
25325624|NCT00849693|50642026|FG003|Acute Treatment Phase|Protocol Violation|6|||
25325625|NCT00849693|50642023|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
25325626|NCT00849693|50642024|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
25325627|NCT00849693|50642025|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
25325628|NCT00849693|50642026|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
25325629|NCT00849693|50642023|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
25325630|NCT00849693|50642024|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
25325631|NCT00849693|50642025|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
25325632|NCT00849693|50642026|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
25325633|NCT00849693|50642023|FG000|Acute Treatment Phase|Physician Decision|2|||
25325634|NCT00849693|50642024|FG001|Acute Treatment Phase|Physician Decision|1|||
25325635|NCT00849693|50642025|FG002|Acute Treatment Phase|Physician Decision|2|||
25325636|NCT00849693|50642026|FG003|Acute Treatment Phase|Physician Decision|1|||
25325637|NCT00849693|50642023|FG000|Acute Treatment Phase|Sponsor decision|0|||
25325638|NCT00849693|50642024|FG001|Acute Treatment Phase|Sponsor decision|0|||
25325639|NCT00849693|50642025|FG002|Acute Treatment Phase|Sponsor decision|1|||
25325640|NCT00849693|50642026|FG003|Acute Treatment Phase|Sponsor decision|0|||
25325641|NCT00849693|50642023|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
25325642|NCT00849693|50642024|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
25246416|NCT01238575|50561932|FG001|Overall Study|Adverse Event|0|||
25246417|NCT01237951|50561938|FG000|Overall Study|Death|1|||
25246418|NCT01239394|50561942|FG000|Overall Study|Adverse Event|1|||
25246419|NCT01237678|50561949|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
25246420|NCT01237678|50561950|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
25246421|NCT01237678|50561951|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
25246422|NCT01237678|50561949|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
25325643|NCT00849693|50642025|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
25325644|NCT00849693|50642026|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
25325645|NCT00849693|50642023|FG000|Extension Phase|Adverse Event|4|||
25325646|NCT00849693|50642024|FG001|Extension Phase|Adverse Event|6|||
25325647|NCT00849693|50642025|FG002|Extension Phase|Adverse Event|3|||
25325648|NCT00849693|50642026|FG003|Extension Phase|Adverse Event|7|||
25325649|NCT00849693|50642023|FG000|Extension Phase|Lost to Follow-up|7|||
25325650|NCT00849693|50642024|FG001|Extension Phase|Lost to Follow-up|5|||
25325651|NCT00849693|50642025|FG002|Extension Phase|Lost to Follow-up|6|||
25325652|NCT00849693|50642026|FG003|Extension Phase|Lost to Follow-up|6|||
25246423|NCT01237678|50561950|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
25246424|NCT01237678|50561951|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
25325653|NCT00849693|50642023|FG000|Extension Phase|Protocol Violation|0|||
25325654|NCT00849693|50642024|FG001|Extension Phase|Protocol Violation|3|||
25325655|NCT00849693|50642025|FG002|Extension Phase|Protocol Violation|2|||
25325656|NCT00849693|50642026|FG003|Extension Phase|Protocol Violation|3|||
25325657|NCT00849693|50642023|FG000|Extension Phase|Withdrawal by Subject|6|||
25325658|NCT00849693|50642024|FG001|Extension Phase|Withdrawal by Subject|9|||
25325659|NCT00849693|50642025|FG002|Extension Phase|Withdrawal by Subject|10|||
25325660|NCT00849693|50642026|FG003|Extension Phase|Withdrawal by Subject|15|||
25325661|NCT00849693|50642023|FG000|Extension Phase|Parent or caregiver decision|9|||
25325662|NCT00849693|50642024|FG001|Extension Phase|Parent or caregiver decision|4|||
25325663|NCT00849693|50642025|FG002|Extension Phase|Parent or caregiver decision|10|||
25325664|NCT00849693|50642026|FG003|Extension Phase|Parent or caregiver decision|5|||
25325665|NCT00849693|50642023|FG000|Extension Phase|Physician Decision|1|||
25325666|NCT00849693|50642024|FG001|Extension Phase|Physician Decision|1|||
25325667|NCT00849693|50642025|FG002|Extension Phase|Physician Decision|2|||
25325668|NCT00849693|50642026|FG003|Extension Phase|Physician Decision|0|||
25325669|NCT00849693|50642023|FG000|Extension Phase|Sponsor decision|1|||
25325670|NCT00849693|50642024|FG001|Extension Phase|Sponsor decision|0|||
25325671|NCT00849693|50642025|FG002|Extension Phase|Sponsor decision|0|||
25325672|NCT00849693|50642026|FG003|Extension Phase|Sponsor decision|1|||
25325673|NCT00849693|50642023|FG000|Extension Phase|Lack of Efficacy|2|||
25325674|NCT00849693|50642024|FG001|Extension Phase|Lack of Efficacy|2|||
25325675|NCT00849693|50642025|FG002|Extension Phase|Lack of Efficacy|2|||
25325676|NCT00849693|50642026|FG003|Extension Phase|Lack of Efficacy|1|||
25325677|NCT00527605|50642050|FG000|Overall Study|Adverse Event|3|||
25325678|NCT00527605|50642051|FG001|Overall Study|Adverse Event|0|||
25325679|NCT00527605|50642050|FG000|Overall Study|Withdrawal by Subject|3|||
25325680|NCT00527605|50642051|FG001|Overall Study|Withdrawal by Subject|7|||
25325681|NCT00527605|50642050|FG000|Overall Study|Lost to Follow-up|6|||
25246425|NCT01237678|50561949|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
25246426|NCT01237678|50561950|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
25246427|NCT01237678|50561951|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
25246428|NCT01237678|50561949|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
25246429|NCT01237678|50561950|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
25246430|NCT01237678|50561951|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
25246431|NCT01237678|50561949|FG000|Phase II|Adverse Event|0|||
25246432|NCT01237678|50561950|FG001|Phase II|Adverse Event|39|||
25325682|NCT00527605|50642051|FG001|Overall Study|Lost to Follow-up|2|||
25325683|NCT00527605|50642050|FG000|Overall Study|Protocol Violation|1|||
25325684|NCT00527605|50642051|FG001|Overall Study|Protocol Violation|2|||
25325685|NCT00849381|50642057|FG000|Overall Study|Adverse Event|1|||
25325686|NCT00849381|50642057|FG000|Overall Study|Lost to Follow-up|129|||
25325687|NCT00849381|50642057|FG000|Overall Study|Protocol Violation|5|||
25325688|NCT00849381|50642057|FG000|Overall Study|Withdrawal by Subject|6|||
25325689|NCT00849381|50642057|FG000|Overall Study|Other|4|||
25325690|NCT00711412|50642061|FG000|Induction Treatment|Death|2|||
25325691|NCT00711412|50642061|FG000|Induction Treatment|Adverse Event|1|||
25325692|NCT00711412|50642061|FG000|Induction Treatment|Other|1|||
25325693|NCT00711412|50642061|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
25325694|NCT00711412|50642061|FG000|Evaluated for Combination Treatment|Death|1|||
25325695|NCT00711412|50642061|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
25325696|NCT00711412|50642061|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
25325697|NCT00711412|50642061|FG000|Combination Treatment|Progressive Disease|1|||
25325698|NCT00711412|50642061|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
25325699|NCT00711412|50642061|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
25325700|NCT00711412|50642061|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
25325701|NCT00711412|50642061|FG000|Evaluation for Response and Surgery|Death|1|||
25325702|NCT00711412|50642061|FG000|Survival Follow up Until Death|Other|12|||
25325703|NCT00577408|50642077|FG000|Overall Study|Stopped attending study visits|9|||
25325704|NCT00577408|50642078|FG001|Overall Study|Stopped attending study visits|11|||
25325705|NCT00577408|50642077|FG000|Overall Study|Continued opioid use|3|||
25325706|NCT00577408|50642078|FG001|Overall Study|Continued opioid use|2|||
25246433|NCT01237678|50561951|FG002|Phase II|Adverse Event|9|||
25246434|NCT01237678|50561949|FG000|Phase II|Death|0|||
25246435|NCT01237678|50561950|FG001|Phase II|Death|0|||
25246436|NCT01237678|50561951|FG002|Phase II|Death|2|||
25246437|NCT01237678|50561949|FG000|Phase II|Lack of Efficacy|0|||
25246438|NCT01237678|50561950|FG001|Phase II|Lack of Efficacy|25|||
25246439|NCT01237678|50561951|FG002|Phase II|Lack of Efficacy|3|||
25246440|NCT01237678|50561949|FG000|Phase II|Withdrawal by Subject|0|||
25246441|NCT01237678|50561950|FG001|Phase II|Withdrawal by Subject|1|||
25246442|NCT01237678|50561951|FG002|Phase II|Withdrawal by Subject|5|||
25246443|NCT01237678|50561949|FG000|Phase II|Completed Cycles 4-6|0|||
25246444|NCT01237678|50561950|FG001|Phase II|Completed Cycles 4-6|11|||
25246445|NCT01237678|50561951|FG002|Phase II|Completed Cycles 4-6|21|||
25325707|NCT00577408|50642077|FG000|Overall Study|Non-compliance with study meds|0|||
25325708|NCT00577408|50642078|FG001|Overall Study|Non-compliance with study meds|3|||
25325709|NCT00577408|50642077|FG000|Overall Study|Refused Oral Naltrexone|0|||
25325710|NCT00577408|50642078|FG001|Overall Study|Refused Oral Naltrexone|1|||
25325711|NCT00577408|50642077|FG000|Overall Study|Moved out of state|0|||
25325712|NCT00577408|50642078|FG001|Overall Study|Moved out of state|1|||
25325713|NCT00577408|50642077|FG000|Overall Study|Scheduling Issues|0|||
25325714|NCT00577408|50642078|FG001|Overall Study|Scheduling Issues|3|||
25325715|NCT00577408|50642077|FG000|Overall Study|Death|0|||
25325716|NCT00577408|50642078|FG001|Overall Study|Death|1|||
25325717|NCT00577408|50642077|FG000|Overall Study|Psychiatric hospitalization|0|||
25325718|NCT00577408|50642078|FG001|Overall Study|Psychiatric hospitalization|1|||
25325719|NCT00828009|50642084|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
25325720|NCT00828009|50642084|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
25325721|NCT00828009|50642084|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
25325722|NCT00828009|50642084|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
25325723|NCT00828009|50642084|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
25325724|NCT00828009|50642084|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
25325725|NCT00828009|50642084|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
25325726|NCT00828009|50642084|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
25325727|NCT00828009|50642084|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
25325728|NCT00828009|50642084|FG000|Step 2 - Maintenance Therapy|Death|1|||
25325729|NCT00828009|50642084|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
25325730|NCT00828009|50642084|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
25325731|NCT00828009|50642084|FG000|Step 2 - Maintenance Therapy|Other|1|||
25325732|NCT00713596|50642092|FG000|Overall Study|Study was terminated|2|||
25325733|NCT00713596|50642093|FG001|Overall Study|Study was terminated|3|||
25246446|NCT01237678|50561949|FG000|Phase II|Sponsor Decision/Study Closed|0|||
25246447|NCT01237678|50561950|FG001|Phase II|Sponsor Decision/Study Closed|18|||
25246448|NCT01237678|50561951|FG002|Phase II|Sponsor Decision/Study Closed|7|||
25246449|NCT01237678|50561949|FG000|Phase II|Randomized but were not treated|0|||
25246450|NCT01237678|50561950|FG001|Phase II|Randomized but were not treated|4|||
25246451|NCT01237678|50561951|FG002|Phase II|Randomized but were not treated|3|||
25246452|NCT01229371|50561974|FG000|Overall Study|Withdrawal by Subject|0|||
25246453|NCT01229371|50561975|FG001|Overall Study|Withdrawal by Subject|1|||
25246454|NCT01229371|50561976|FG002|Overall Study|Withdrawal by Subject|0|||
25325734|NCT00713596|50642094|FG002|Overall Study|Study was terminated|2|||
25325735|NCT00880568|50642111|FG000|Overall Study|Disease progression|3|||
25325736|NCT00880568|50642112|FG001|Overall Study|Disease progression|3|||
25325737|NCT00880568|50642113|FG002|Overall Study|Disease progression|3|||
25325738|NCT00880568|50642114|FG003|Overall Study|Disease progression|1|||
25325739|NCT00880568|50642115|FG004|Overall Study|Disease progression|3|||
25325740|NCT00880568|50642116|FG005|Overall Study|Disease progression|3|||
25325741|NCT00880568|50642117|FG006|Overall Study|Disease progression|5|||
25325742|NCT00880568|50642118|FG007|Overall Study|Disease progression|0|||
25325743|NCT00880568|50642119|FG008|Overall Study|Disease progression|3|||
25325744|NCT00880568|50642111|FG000|Overall Study|Adverse Event|0|||
25325745|NCT00880568|50642112|FG001|Overall Study|Adverse Event|0|||
25325746|NCT00880568|50642113|FG002|Overall Study|Adverse Event|0|||
25325747|NCT00880568|50642114|FG003|Overall Study|Adverse Event|0|||
25325748|NCT00880568|50642115|FG004|Overall Study|Adverse Event|0|||
25246455|NCT01229371|50561977|FG003|Overall Study|Withdrawal by Subject|0|||
25325749|NCT00880568|50642116|FG005|Overall Study|Adverse Event|0|||
25325750|NCT00880568|50642117|FG006|Overall Study|Adverse Event|1|||
25325751|NCT00880568|50642118|FG007|Overall Study|Adverse Event|1|||
25325752|NCT00880568|50642119|FG008|Overall Study|Adverse Event|0|||
25325753|NCT00880568|50642111|FG000|Overall Study|Withdrawal by Subject|0|||
25325754|NCT00880568|50642112|FG001|Overall Study|Withdrawal by Subject|0|||
25325755|NCT00880568|50642113|FG002|Overall Study|Withdrawal by Subject|0|||
25325756|NCT00880568|50642114|FG003|Overall Study|Withdrawal by Subject|0|||
25325757|NCT00880568|50642115|FG004|Overall Study|Withdrawal by Subject|0|||
25246456|NCT01237327|50561989|FG000|Overall Study|Protocol Violation: Core Study|1|||
25246457|NCT01237327|50561990|FG001|Overall Study|Protocol Violation: Core Study|0|||
25325758|NCT00880568|50642116|FG005|Overall Study|Withdrawal by Subject|0|||
25325759|NCT00880568|50642117|FG006|Overall Study|Withdrawal by Subject|0|||
25246458|NCT01237327|50561989|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
25246459|NCT01237327|50561990|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
25246460|NCT01237327|50561989|FG000|Overall Study|Progression of Disease: Core Study|18|||
25246461|NCT01237327|50561990|FG001|Overall Study|Progression of Disease: Core Study|22|||
25246462|NCT01237327|50561989|FG000|Overall Study|Progression of Disease: Extension Study|15|||
25246463|NCT01237327|50561990|FG001|Overall Study|Progression of Disease: Extension Study|13|||
25246464|NCT01237327|50561989|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
25246465|NCT01237327|50561990|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
25246466|NCT01237327|50561989|FG000|Overall Study|Withdrawal by Subject|1|||
25325760|NCT00880568|50642118|FG007|Overall Study|Withdrawal by Subject|1|||
25325761|NCT00880568|50642119|FG008|Overall Study|Withdrawal by Subject|0|||
25325762|NCT00881894|50642146|FG000|Overall Study|Consent withdrawn|0|||
25325763|NCT00881894|50642147|FG001|Overall Study|Consent withdrawn|1|||
25325764|NCT00881894|50642146|FG000|Overall Study|Other reasons for premature termination|1|||
25325765|NCT00881894|50642147|FG001|Overall Study|Other reasons for premature termination|2|||
25325766|NCT00711100|50642153|FG000|Overall Study|Lack of Efficacy|5|||
25325767|NCT00711100|50642153|FG000|Overall Study|Withdrawal by Subject|8|||
25325768|NCT00827931|50642171|FG000|Overall Study|Death|3|||
25325769|NCT00827931|50642172|FG001|Overall Study|Death|5|||
25325770|NCT00827931|50642171|FG000|Overall Study|Adverse Event|1|||
25325771|NCT00827931|50642172|FG001|Overall Study|Adverse Event|0|||
25325772|NCT00827931|50642171|FG000|Overall Study|Lost to Follow-up|1|||
25325773|NCT00827931|50642172|FG001|Overall Study|Lost to Follow-up|0|||
25325774|NCT00827931|50642171|FG000|Overall Study|Withdrawal by Subject|0|||
25325775|NCT00827931|50642172|FG001|Overall Study|Withdrawal by Subject|1|||
25325776|NCT00827931|50642171|FG000|Overall Study|Other|1|||
25325777|NCT00827931|50642172|FG001|Overall Study|Other|0|||
25325778|NCT00526669|50642178|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
25325779|NCT00526669|50642179|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
25325780|NCT00526669|50642178|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
25325781|NCT00526669|50642179|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
25325782|NCT00526669|50642178|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
25325783|NCT00526669|50642179|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
25325784|NCT00526669|50642178|FG000|Combined Treatment Phase|Death|0|||
25325785|NCT00526669|50642179|FG001|Combined Treatment Phase|Death|2|||
25325786|NCT00710866|50642191|FG000|Overall Study|Protocol Violation|5|||
25325787|NCT00710866|50642192|FG001|Overall Study|Protocol Violation|4|||
25325788|NCT00710866|50642191|FG000|Overall Study|Withdrawal by Subject|2|||
25325789|NCT00710866|50642192|FG001|Overall Study|Withdrawal by Subject|1|||
25325790|NCT00710866|50642191|FG000|Overall Study|Lost to Follow-up|1|||
25325791|NCT00710866|50642192|FG001|Overall Study|Lost to Follow-up|0|||
25325792|NCT00710866|50642191|FG000|Overall Study|Failed to meet eligibility|1|||
25325793|NCT00710866|50642192|FG001|Overall Study|Failed to meet eligibility|1|||
25325794|NCT00827775|50642209|FG000|Overall Study|Withdrawal by Subject|0|||
25325795|NCT00827775|50642210|FG001|Overall Study|Withdrawal by Subject|5|||
25325796|NCT00827541|50642218|FG000|Overall Study|Exitus|1|||
25325797|NCT00827541|50642219|FG001|Overall Study|Exitus|8|||
25325798|NCT00827541|50642218|FG000|Overall Study|Other|1|||
25325799|NCT00827541|50642219|FG001|Overall Study|Other|3|||
25325800|NCT00827541|50642218|FG000|Overall Study|Pathogen not susceptible|1|||
25325801|NCT00827541|50642219|FG001|Overall Study|Pathogen not susceptible|0|||
25325802|NCT00827541|50642218|FG000|Overall Study|Lack of effectiveness|1|||
25325803|NCT00827541|50642219|FG001|Overall Study|Lack of effectiveness|0|||
25325804|NCT00518323|50642229|FG000|Overall Study|Lack of Efficacy|14|||
25325805|NCT00518323|50642230|FG001|Overall Study|Lack of Efficacy|2|||
25325806|NCT00518323|50642231|FG002|Overall Study|Lack of Efficacy|4|||
25325807|NCT00518323|50642232|FG003|Overall Study|Lack of Efficacy|20|||
25325808|NCT00518323|50642229|FG000|Overall Study|Withdrawal by Subject|1|||
25325809|NCT00518323|50642230|FG001|Overall Study|Withdrawal by Subject|2|||
25325810|NCT00518323|50642231|FG002|Overall Study|Withdrawal by Subject|4|||
25325811|NCT00518323|50642232|FG003|Overall Study|Withdrawal by Subject|2|||
25325812|NCT00518323|50642229|FG000|Overall Study|Lost to Follow-up|0|||
25325813|NCT00518323|50642230|FG001|Overall Study|Lost to Follow-up|2|||
25325814|NCT00518323|50642231|FG002|Overall Study|Lost to Follow-up|1|||
25325815|NCT00518323|50642232|FG003|Overall Study|Lost to Follow-up|3|||
25325816|NCT00518323|50642229|FG000|Overall Study|Adverse Event|1|||
25325817|NCT00518323|50642230|FG001|Overall Study|Adverse Event|1|||
25325818|NCT00518323|50642231|FG002|Overall Study|Adverse Event|1|||
25325819|NCT00518323|50642232|FG003|Overall Study|Adverse Event|0|||
25325820|NCT00518323|50642229|FG000|Overall Study|Prohibited medication and others|3|||
25325821|NCT00518323|50642230|FG001|Overall Study|Prohibited medication and others|1|||
25325822|NCT00518323|50642231|FG002|Overall Study|Prohibited medication and others|1|||
25325823|NCT00518323|50642232|FG003|Overall Study|Prohibited medication and others|0|||
25325824|NCT00826449|50642244|FG000|Overall Study|Disease Progression|4|||
25246467|NCT01237327|50561990|FG001|Overall Study|Withdrawal by Subject|3|||
25325825|NCT00826449|50642244|FG000|Overall Study|Withdrawal by Subject|1|||
25325826|NCT00825825|50642249|FG000|First Medication Period (14 Days)|Adverse Event|1|||
25325827|NCT00825825|50642250|FG001|First Medication Period (14 Days)|Adverse Event|0|||
25325828|NCT00825825|50642251|FG002|First Medication Period (14 Days)|Adverse Event|0|||
25325829|NCT00825825|50642252|FG003|First Medication Period (14 Days)|Adverse Event|0|||
25325830|NCT00825825|50642253|FG004|First Medication Period (14 Days)|Adverse Event|0|||
25325831|NCT00825825|50642254|FG005|First Medication Period (14 Days)|Adverse Event|1|||
25325832|NCT00825825|50642249|FG000|First Medication Period (14 Days)|Physician Decision|2|||
25325833|NCT00825825|50642250|FG001|First Medication Period (14 Days)|Physician Decision|0|||
25325834|NCT00825825|50642251|FG002|First Medication Period (14 Days)|Physician Decision|1|||
25325835|NCT00825825|50642252|FG003|First Medication Period (14 Days)|Physician Decision|0|||
25325836|NCT00825825|50642253|FG004|First Medication Period (14 Days)|Physician Decision|0|||
25325837|NCT00825825|50642254|FG005|First Medication Period (14 Days)|Physician Decision|1|||
25325838|NCT00825825|50642249|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
25325839|NCT00825825|50642250|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
25325840|NCT00825825|50642251|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
25325841|NCT00825825|50642252|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
25325842|NCT00825825|50642253|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
25325843|NCT00825825|50642254|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
25325844|NCT00825825|50642249|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
25325845|NCT00825825|50642250|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
25325846|NCT00825825|50642251|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
25325847|NCT00825825|50642252|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
25325848|NCT00825825|50642253|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
24977238|NCT03410992|50065847|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
25246468|NCT01237327|50561989|FG000|Overall Study|Lost to Follow-up|3|||
25246469|NCT01237327|50561990|FG001|Overall Study|Lost to Follow-up|0|||
25246470|NCT01237054|50561996|FG000|Overall Study|imaging 10C0096|1|||
25246471|NCT01236352|50562033|FG000|Overall Study|Death|0|||
25246472|NCT01236352|50562034|FG001|Overall Study|Death|0|||
25246473|NCT01236352|50562035|FG002|Overall Study|Death|0|||
25246474|NCT01236352|50562036|FG003|Overall Study|Death|0|||
25246475|NCT01236352|50562037|FG004|Overall Study|Death|0|||
25246476|NCT01236352|50562038|FG005|Overall Study|Death|0|||
25246477|NCT01236352|50562039|FG006|Overall Study|Death|0|||
25246478|NCT01236352|50562040|FG007|Overall Study|Death|1|||
25246479|NCT01236352|50562041|FG008|Overall Study|Death|0|||
25246480|NCT01236352|50562042|FG009|Overall Study|Death|0|||
25246481|NCT01236352|50562043|FG010|Overall Study|Death|0|||
25246482|NCT01236352|50562033|FG000|Overall Study|Withdrawal by Subject|0|||
25246483|NCT01236352|50562034|FG001|Overall Study|Withdrawal by Subject|0|||
25246484|NCT01236352|50562035|FG002|Overall Study|Withdrawal by Subject|0|||
25246485|NCT01236352|50562036|FG003|Overall Study|Withdrawal by Subject|0|||
25246486|NCT01236352|50562037|FG004|Overall Study|Withdrawal by Subject|0|||
25246487|NCT01236352|50562038|FG005|Overall Study|Withdrawal by Subject|0|||
25246488|NCT01236352|50562039|FG006|Overall Study|Withdrawal by Subject|0|||
25246489|NCT01236352|50562040|FG007|Overall Study|Withdrawal by Subject|0|||
25246490|NCT01236352|50562041|FG008|Overall Study|Withdrawal by Subject|0|||
25246491|NCT01236352|50562042|FG009|Overall Study|Withdrawal by Subject|2|||
25246492|NCT01236352|50562043|FG010|Overall Study|Withdrawal by Subject|1|||
25246493|NCT01236352|50562033|FG000|Overall Study|Adverse Event|0|||
25246494|NCT01236352|50562034|FG001|Overall Study|Adverse Event|0|||
25246495|NCT01236352|50562035|FG002|Overall Study|Adverse Event|0|||
25246496|NCT01236352|50562036|FG003|Overall Study|Adverse Event|0|||
25246497|NCT01236352|50562037|FG004|Overall Study|Adverse Event|0|||
25246498|NCT01236352|50562038|FG005|Overall Study|Adverse Event|0|||
25246499|NCT01236352|50562039|FG006|Overall Study|Adverse Event|2|||
25246500|NCT01236352|50562040|FG007|Overall Study|Adverse Event|0|||
25246501|NCT01236352|50562041|FG008|Overall Study|Adverse Event|0|||
25246502|NCT01236352|50562042|FG009|Overall Study|Adverse Event|4|||
25246503|NCT01236352|50562043|FG010|Overall Study|Adverse Event|1|||
25246504|NCT01236352|50562033|FG000|Overall Study|Study drug toxicity|0|||
25246505|NCT01236352|50562034|FG001|Overall Study|Study drug toxicity|0|||
25246506|NCT01236352|50562035|FG002|Overall Study|Study drug toxicity|0|||
25246507|NCT01236352|50562036|FG003|Overall Study|Study drug toxicity|0|||
25325849|NCT00825825|50642254|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
25325850|NCT00825825|50642249|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
25325851|NCT00825825|50642250|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
25325852|NCT00825825|50642251|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
25325853|NCT00825825|50642252|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
25325854|NCT00825825|50642253|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
25325855|NCT00825825|50642254|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
25325856|NCT00825825|50642249|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
25325857|NCT00825825|50642250|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
25325858|NCT00825825|50642251|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
25325859|NCT00825825|50642252|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
25325860|NCT00825825|50642253|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
25325861|NCT00825825|50642254|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
25325862|NCT00825825|50642249|FG000|Third Medication Period (14 Days)|poor data quality|0|||
25325863|NCT00825825|50642250|FG001|Third Medication Period (14 Days)|poor data quality|1|||
25325864|NCT00825825|50642251|FG002|Third Medication Period (14 Days)|poor data quality|0|||
25325865|NCT00825825|50642252|FG003|Third Medication Period (14 Days)|poor data quality|0|||
25325866|NCT00825825|50642253|FG004|Third Medication Period (14 Days)|poor data quality|0|||
25325867|NCT00825825|50642254|FG005|Third Medication Period (14 Days)|poor data quality|0|||
25325868|NCT00710710|50642263|FG000|Overall Study|Consent withdrawn|2|||
25325869|NCT00710710|50642264|FG001|Overall Study|Consent withdrawn|2|||
25325870|NCT00710710|50642263|FG000|Overall Study|Protocol Violation|0|||
25325871|NCT00710710|50642264|FG001|Overall Study|Protocol Violation|1|||
25325872|NCT00710710|50642263|FG000|Overall Study|Adverse Event|3|||
25325873|NCT00710710|50642264|FG001|Overall Study|Adverse Event|3|||
25325874|NCT00710710|50642263|FG000|Overall Study|Progressive disease|40|||
25325875|NCT00710710|50642264|FG001|Overall Study|Progressive disease|38|||
25325876|NCT00880334|50642272|FG000|Randomized Phase|Physician Decision|1|||
25325877|NCT00880334|50642273|FG001|Randomized Phase|Physician Decision|0|||
25325878|NCT00880334|50642272|FG000|Randomized Phase|Withdrawal by Subject|2|||
25325879|NCT00880334|50642273|FG001|Randomized Phase|Withdrawal by Subject|1|||
25325880|NCT00880334|50642272|FG000|Randomized Phase|Inadequate Labs|1|||
25325881|NCT00880334|50642273|FG001|Randomized Phase|Inadequate Labs|1|||
25325882|NCT00880334|50642272|FG000|Randomized Phase|Brain Metastasis|0|||
25325883|NCT00880334|50642273|FG001|Randomized Phase|Brain Metastasis|1|||
25325884|NCT00880334|50642272|FG000|Randomized Phase|Crossover Participants|0|||
25325885|NCT00880334|50642273|FG001|Randomized Phase|Crossover Participants|37|||
25325886|NCT00865566|50642289|FG000|Overall Study|Death|1|||
25325887|NCT00865566|50642290|FG001|Overall Study|Death|11|||
25325888|NCT00865566|50642289|FG000|Overall Study|Lost to Follow-up|314|||
25325889|NCT00865566|50642290|FG001|Overall Study|Lost to Follow-up|315|||
25325890|NCT00865566|50642289|FG000|Overall Study|Withdrawal by Subject|45|||
25325891|NCT00865566|50642290|FG001|Overall Study|Withdrawal by Subject|65|||
25325892|NCT00865566|50642289|FG000|Overall Study|Physician Decision|0|||
25325893|NCT00865566|50642290|FG001|Overall Study|Physician Decision|1|||
25325894|NCT00865566|50642289|FG000|Overall Study|Participant relocated|78|||
25325895|NCT00865566|50642290|FG001|Overall Study|Participant relocated|107|||
25325896|NCT00865566|50642289|FG000|Overall Study|Participant unable to adhere|27|||
25325897|NCT00865566|50642290|FG001|Overall Study|Participant unable to adhere|42|||
25325898|NCT00865566|50642289|FG000|Overall Study|Other; N=245 due to early study closure|154|||
25325899|NCT00865566|50642290|FG001|Overall Study|Other; N=245 due to early study closure|139|||
25325900|NCT00865566|50642289|FG000|Overall Study|HIV infection|5|||
25325901|NCT00865566|50642290|FG001|Overall Study|HIV infection|7|||
25325902|NCT03866473|50642298|FG000|Phase 1|Death|1|||
25325903|NCT03866473|50642299|FG001|Phase 1|Death|0|||
25325904|NCT03866473|50642298|FG000|Phase 2|Death|0|||
25325905|NCT03866473|50642299|FG001|Phase 2|Death|2|||
25325906|NCT03866473|50642298|FG000|Phase 2|Dropped|1|||
25325907|NCT03866473|50642299|FG001|Phase 2|Dropped|1|||
25325908|NCT03866473|50642298|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
25325909|NCT03866473|50642299|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
25325910|NCT00525499|50642313|FG000|Overall Study|Lost to Follow-up|2|||
25325911|NCT00525499|50642314|FG001|Overall Study|Lost to Follow-up|4|||
25325912|NCT00525499|50642315|FG002|Overall Study|Lost to Follow-up|1|||
25325913|NCT00525499|50642316|FG003|Overall Study|Lost to Follow-up|4|||
25325914|NCT00525499|50642313|FG000|Overall Study|Adverse Event|0|||
25325915|NCT00525499|50642314|FG001|Overall Study|Adverse Event|1|||
25325916|NCT00525499|50642315|FG002|Overall Study|Adverse Event|0|||
25325917|NCT00525499|50642316|FG003|Overall Study|Adverse Event|1|||
25325918|NCT00525499|50642313|FG000|Overall Study|Withdrawal by Subject|5|||
25325919|NCT00525499|50642314|FG001|Overall Study|Withdrawal by Subject|1|||
25325920|NCT00525499|50642315|FG002|Overall Study|Withdrawal by Subject|5|||
25325921|NCT00525499|50642316|FG003|Overall Study|Withdrawal by Subject|2|||
25325922|NCT00525499|50642313|FG000|Overall Study|Protocol Violation|0|||
25325923|NCT00525499|50642314|FG001|Overall Study|Protocol Violation|1|||
25325924|NCT00525499|50642315|FG002|Overall Study|Protocol Violation|1|||
25325925|NCT00525499|50642316|FG003|Overall Study|Protocol Violation|0|||
25325926|NCT00824655|50642328|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
25325927|NCT00824655|50642329|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
25325928|NCT00824655|50642328|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
25325929|NCT00824655|50642329|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
25325930|NCT00525265|50642339|FG000|Overall Study|Protocol Violation|1|||
25325931|NCT00525265|50642340|FG001|Overall Study|Protocol Violation|0|||
25325932|NCT00880256|50642346|FG000|Overall Study|Lost to Follow-up|28|||
25325933|NCT03865381|50642355|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
25325934|NCT03865381|50642355|FG000|Overall Study|Withdrawal by Subject|2|||
25325935|NCT00713206|50642361|FG000|Overall Study|Lost to Follow-up|4|||
25325936|NCT00713206|50642362|FG001|Overall Study|Lost to Follow-up|4|||
25325937|NCT00713206|50642361|FG000|Overall Study|Death|1|||
25246508|NCT01236352|50562037|FG004|Overall Study|Study drug toxicity|0|||
25246509|NCT01236352|50562038|FG005|Overall Study|Study drug toxicity|1|||
25246510|NCT01236352|50562039|FG006|Overall Study|Study drug toxicity|1|||
25325938|NCT00713206|50642362|FG001|Overall Study|Death|0|||
25325939|NCT00865098|50642368|FG000|Overall Study|Progressive disease|1|||
25325940|NCT00880100|50642372|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
25325941|NCT00880100|50642372|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
25325942|NCT00880100|50642372|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
25325943|NCT00518011|50642378|FG000|Overall Study|Death|1|||
25325944|NCT00518011|50642379|FG001|Overall Study|Death|1|||
25325945|NCT00518011|50642378|FG000|Overall Study|Adverse Event|2|||
25325946|NCT00518011|50642379|FG001|Overall Study|Adverse Event|3|||
25325947|NCT00518011|50642378|FG000|Overall Study|Disease Progression|2|||
25325948|NCT00518011|50642379|FG001|Overall Study|Disease Progression|2|||
25325949|NCT00518011|50642378|FG000|Overall Study|Other Reasons|3|||
25325950|NCT00518011|50642379|FG001|Overall Study|Other Reasons|2|||
25325951|NCT00518011|50642378|FG000|Overall Study|Withdrawal by Subject|1|||
25325952|NCT00518011|50642379|FG001|Overall Study|Withdrawal by Subject|0|||
25325953|NCT00865020|50642388|FG000|Overall Study|Withdrawal by Subject|22|||
25325954|NCT00865020|50642389|FG001|Overall Study|Withdrawal by Subject|16|||
25325955|NCT00865020|50642388|FG000|Overall Study|Adverse Event|9|||
25246511|NCT01236352|50562040|FG007|Overall Study|Study drug toxicity|0|||
25246512|NCT01236352|50562041|FG008|Overall Study|Study drug toxicity|0|||
25246513|NCT01236352|50562042|FG009|Overall Study|Study drug toxicity|2|||
25246514|NCT01236352|50562043|FG010|Overall Study|Study drug toxicity|2|||
25246515|NCT01236352|50562033|FG000|Overall Study|Disease progression|1|||
25246516|NCT01236352|50562034|FG001|Overall Study|Disease progression|2|||
25246517|NCT01236352|50562035|FG002|Overall Study|Disease progression|1|||
25246518|NCT01236352|50562036|FG003|Overall Study|Disease progression|2|||
25246519|NCT01236352|50562037|FG004|Overall Study|Disease progression|2|||
25246520|NCT01236352|50562038|FG005|Overall Study|Disease progression|2|||
25246521|NCT01236352|50562039|FG006|Overall Study|Disease progression|1|||
25246522|NCT01236352|50562040|FG007|Overall Study|Disease progression|3|||
25246523|NCT01236352|50562041|FG008|Overall Study|Disease progression|2|||
25246524|NCT01236352|50562042|FG009|Overall Study|Disease progression|2|||
25246525|NCT01236352|50562043|FG010|Overall Study|Disease progression|2|||
25246526|NCT01236352|50562033|FG000|Overall Study|Poor/Non-compliance|1|||
25246527|NCT01236352|50562034|FG001|Overall Study|Poor/Non-compliance|0|||
25246528|NCT01236352|50562035|FG002|Overall Study|Poor/Non-compliance|0|||
25246529|NCT01236352|50562036|FG003|Overall Study|Poor/Non-compliance|0|||
25246530|NCT01236352|50562037|FG004|Overall Study|Poor/Non-compliance|0|||
25246531|NCT01236352|50562038|FG005|Overall Study|Poor/Non-compliance|0|||
25246532|NCT01236352|50562039|FG006|Overall Study|Poor/Non-compliance|0|||
25325956|NCT00865020|50642389|FG001|Overall Study|Adverse Event|14|||
25325957|NCT00865020|50642388|FG000|Overall Study|Abnormal test procedure result(s)|6|||
25325958|NCT00865020|50642389|FG001|Overall Study|Abnormal test procedure result(s)|8|||
25325959|NCT00865020|50642388|FG000|Overall Study|Lost to Follow-up|6|||
25325960|NCT00865020|50642389|FG001|Overall Study|Lost to Follow-up|4|||
25325961|NCT00865020|50642388|FG000|Overall Study|Protocol deviation|4|||
25325962|NCT00865020|50642389|FG001|Overall Study|Protocol deviation|1|||
25325963|NCT00865020|50642388|FG000|Overall Study|Administrative problems|0|||
25246533|NCT01236352|50562040|FG007|Overall Study|Poor/Non-compliance|0|||
25246534|NCT01236352|50562041|FG008|Overall Study|Poor/Non-compliance|0|||
25246535|NCT01236352|50562042|FG009|Overall Study|Poor/Non-compliance|0|||
25246536|NCT01236352|50562043|FG010|Overall Study|Poor/Non-compliance|0|||
25246537|NCT01236352|50562033|FG000|Overall Study|Maximum clinical benefit|1|||
25325964|NCT00865020|50642389|FG001|Overall Study|Administrative problems|2|||
25325965|NCT00865020|50642388|FG000|Overall Study|Abnormal laboratory value(s)|0|||
25325966|NCT00865020|50642389|FG001|Overall Study|Abnormal laboratory value(s)|1|||
25325967|NCT00865020|50642388|FG000|Overall Study|Death|0|||
25325968|NCT00865020|50642389|FG001|Overall Study|Death|1|||
25325969|NCT00865020|50642388|FG000|Overall Study|Randomized but discontinued|2|||
25325970|NCT00865020|50642389|FG001|Overall Study|Randomized but discontinued|4|||
25246538|NCT01236352|50562034|FG001|Overall Study|Maximum clinical benefit|1|||
25325971|NCT00517933|50642397|FG000|Period 1|Death|2|||
25325972|NCT00517933|50642398|FG001|Period 1|Death|1|||
25325973|NCT00517933|50642397|FG000|Period 1|Adverse Event|4|||
25325974|NCT00517933|50642398|FG001|Period 1|Adverse Event|4|||
25325975|NCT00517933|50642397|FG000|Period 1|Lost to Follow-up|2|||
25325976|NCT00517933|50642398|FG001|Period 1|Lost to Follow-up|0|||
25325977|NCT00517933|50642397|FG000|Period 1|Underwent lung transplant|0|||
25325978|NCT00517933|50642398|FG001|Period 1|Underwent lung transplant|1|||
25325979|NCT00517933|50642397|FG000|Period 2|Death|2|||
25325980|NCT00517933|50642398|FG001|Period 2|Death|4|||
25325981|NCT00517933|50642397|FG000|Period 2|Adverse Event|2|||
25325982|NCT00517933|50642398|FG001|Period 2|Adverse Event|4|||
25325983|NCT00517933|50642397|FG000|Period 2|Physician Decision|1|||
25325984|NCT00517933|50642398|FG001|Period 2|Physician Decision|0|||
25325985|NCT00517933|50642397|FG000|Period 2|Withdrawal by Subject|1|||
25325986|NCT00517933|50642398|FG001|Period 2|Withdrawal by Subject|3|||
25325987|NCT00517933|50642397|FG000|Period 2|Underwent lung transplant|0|||
25325988|NCT00517933|50642398|FG001|Period 2|Underwent lung transplant|2|||
25325989|NCT00701038|50642409|FG000|Overall Study|study amended pilot group of patients|4|||
25325990|NCT00701038|50642410|FG001|Overall Study|study amended pilot group of patients|4|||
25325991|NCT00857766|50642418|FG000|Overall Study|Adverse Event|13|||
25325992|NCT00857766|50642419|FG001|Overall Study|Adverse Event|12|||
25325993|NCT00857766|50642418|FG000|Overall Study|Protocol Violation|11|||
25325994|NCT00857766|50642419|FG001|Overall Study|Protocol Violation|11|||
25325995|NCT00857766|50642418|FG000|Overall Study|Lost to Follow-up|1|||
25325996|NCT00857766|50642419|FG001|Overall Study|Lost to Follow-up|0|||
25325997|NCT00857766|50642418|FG000|Overall Study|Investigator Discretion|2|||
25325998|NCT00857766|50642419|FG001|Overall Study|Investigator Discretion|3|||
25325999|NCT00857766|50642418|FG000|Overall Study|Participant Withdrew Consent|4|||
25326000|NCT00857766|50642419|FG001|Overall Study|Participant Withdrew Consent|4|||
25326001|NCT00517699|50642425|FG000|Overall Study|Withdrawal by Subject|1|||
25326002|NCT00517699|50642425|FG000|Overall Study|Lack of Efficacy|1|||
25326003|NCT00517699|50642425|FG000|Overall Study|Administrative error|1|||
25326004|NCT00517699|50642425|FG000|Overall Study|Study terminated by Sponsor|2|||
25326005|NCT00857454|50642429|FG000|Overall Study|Withdrawal by Subject|2|||
25326006|NCT00857454|50642429|FG000|Overall Study|Lost to Follow-up|1|||
25326007|NCT00857454|50642429|FG000|Overall Study|Adverse Event|2|||
25326008|NCT00857454|50642429|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
25326009|NCT00857454|50642429|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
25326010|NCT00857454|50642429|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
25326011|NCT00525031|50642435|FG000|Overall Study|Disease Progression|1|||
25326012|NCT00525031|50642436|FG001|Overall Study|Disease Progression|1|||
25326013|NCT00524485|50642443|FG000|Overall Study|Withdrawal by Subject|5|||
25326014|NCT00857220|50642447|FG000|Overall Study|Adverse Event|35|||
25326015|NCT00857220|50642447|FG000|Overall Study|Death|1|||
25326016|NCT00857220|50642447|FG000|Overall Study|Lack of Efficacy|11|||
25326017|NCT00857220|50642447|FG000|Overall Study|Lost to Follow-up|30|||
25326018|NCT00857220|50642447|FG000|Overall Study|Physician Decision|4|||
25326019|NCT00857220|50642447|FG000|Overall Study|Protocol Violation|16|||
25326020|NCT00857220|50642447|FG000|Overall Study|Withdrawal by Subject|67|||
25326021|NCT00857220|50642447|FG000|Overall Study|Clinical Hold|6|||
25326022|NCT00857220|50642447|FG000|Overall Study|Site Closed|5|||
25326023|NCT00857220|50642447|FG000|Overall Study|Miscellaneous|8|||
25326024|NCT00524173|50642453|FG000|Overall Study|Lost to Follow-up|0|||
25326025|NCT00524173|50642454|FG001|Overall Study|Lost to Follow-up|1|||
25326026|NCT00524173|50642453|FG000|Overall Study|Death|1|||
25326027|NCT00524173|50642454|FG001|Overall Study|Death|0|||
25326028|NCT00524173|50642453|FG000|Overall Study|Had not reached endpoint at study close|4|||
25326029|NCT00524173|50642454|FG001|Overall Study|Had not reached endpoint at study close|1|||
25326030|NCT00879710|50642462|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
25326031|NCT00879710|50642463|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
25326032|NCT00879710|50642464|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
25326033|NCT00879710|50642465|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
25326034|NCT00879710|50642462|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
25326035|NCT00879710|50642463|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
25326036|NCT00879710|50642464|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
25326037|NCT00879710|50642465|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
25326038|NCT00597506|50642473|FG000|Overall Study|Subject is being followed for survival|1|||
25326039|NCT00708682|50642486|FG000|Infant Series|Adverse Event|1|||
25326040|NCT00708682|50642486|FG000|Infant Series|Lost to Follow-up|4|||
25326041|NCT00708682|50642486|FG000|Infant Series|Protocol Violation|1|||
25326042|NCT00708682|50642486|FG000|Infant Series|Parent/legal guardian request|6|||
25326043|NCT00708682|50642486|FG000|Infant Series|Failed to return|2|||
25326044|NCT00708682|50642486|FG000|Infant Series|Other|19|||
25326045|NCT00708682|50642486|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
25326046|NCT00708682|50642486|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
25326047|NCT00708682|50642486|FG000|Toddler Dose|Lost to Follow-up|3|||
25326048|NCT00708682|50642486|FG000|Toddler Dose|Failed to Return|4|||
25326049|NCT00712348|50642492|FG000|Overall Study|Withdrawal by Subject|1|||
25326050|NCT00881504|50642496|FG000|Overall Study|Withdrawal by Subject|1|||
25326051|NCT01936831|50642509|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
25326052|NCT01936831|50642510|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
25326053|NCT01936831|50642511|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
25326054|NCT01936831|50642512|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
25326055|NCT01936831|50642513|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
25326056|NCT01936831|50642514|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
25326057|NCT01936831|50642515|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
25326058|NCT01936831|50642516|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
25326059|NCT01936831|50642517|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
25326060|NCT03863353|50642534|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
25326061|NCT03863353|50642535|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
25326062|NCT00523705|50642543|FG000|Overall Study|No time for study.|0|||
25326063|NCT00523705|50642544|FG001|Overall Study|No time for study.|1|||
25326064|NCT00523549|50642557|FG000|Overall Study|Adverse Event|6|||
25326065|NCT00523549|50642558|FG001|Overall Study|Adverse Event|3|||
25326066|NCT00523549|50642557|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25326067|NCT00523549|50642558|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
25326068|NCT00523549|50642557|FG000|Overall Study|Protocol Deviation|3|||
25326069|NCT00523549|50642558|FG001|Overall Study|Protocol Deviation|1|||
25326070|NCT00523549|50642557|FG000|Overall Study|Patient withdrew consent|7|||
25326071|NCT00523549|50642558|FG001|Overall Study|Patient withdrew consent|6|||
25326072|NCT00523549|50642557|FG000|Overall Study|Lost to Follow-up|3|||
25326073|NCT00523549|50642558|FG001|Overall Study|Lost to Follow-up|5|||
25326074|NCT03504085|50642566|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
25326075|NCT03504085|50642567|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
25326076|NCT03504085|50642566|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
25326077|NCT03504085|50642567|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
25326078|NCT00700102|50642575|FG000|Overall Study|Died|394|||
25326079|NCT00700102|50642576|FG001|Overall Study|Died|385|||
25326080|NCT00700102|50642575|FG000|Overall Study|Lost to Follow-up|8|||
25326081|NCT00700102|50642576|FG001|Overall Study|Lost to Follow-up|10|||
25326082|NCT00595478|50642584|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
25326083|NCT00595478|50642585|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
25326084|NCT00595478|50642584|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
25326085|NCT00595478|50642585|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
25326086|NCT00516295|50642594|FG000|Overall Study|Lack of Efficacy|2|||
25326087|NCT00516295|50642595|FG001|Overall Study|Lack of Efficacy|0|||
25246539|NCT01236352|50562035|FG002|Overall Study|Maximum clinical benefit|1|||
25246540|NCT01236352|50562036|FG003|Overall Study|Maximum clinical benefit|0|||
25246541|NCT01236352|50562037|FG004|Overall Study|Maximum clinical benefit|2|||
25246542|NCT01236352|50562038|FG005|Overall Study|Maximum clinical benefit|0|||
25246543|NCT01236352|50562039|FG006|Overall Study|Maximum clinical benefit|3|||
25246544|NCT01236352|50562040|FG007|Overall Study|Maximum clinical benefit|1|||
25246545|NCT01236352|50562041|FG008|Overall Study|Maximum clinical benefit|1|||
25246546|NCT01236352|50562042|FG009|Overall Study|Maximum clinical benefit|4|||
25246547|NCT01236352|50562043|FG010|Overall Study|Maximum clinical benefit|2|||
25246548|NCT01236352|50562033|FG000|Overall Study|Subject request to discontinue treatment|0|||
25246549|NCT01236352|50562034|FG001|Overall Study|Subject request to discontinue treatment|0|||
25246550|NCT01236352|50562035|FG002|Overall Study|Subject request to discontinue treatment|1|||
25246551|NCT01236352|50562036|FG003|Overall Study|Subject request to discontinue treatment|1|||
25246552|NCT01236352|50562037|FG004|Overall Study|Subject request to discontinue treatment|0|||
25246553|NCT01236352|50562038|FG005|Overall Study|Subject request to discontinue treatment|1|||
25246554|NCT01236352|50562039|FG006|Overall Study|Subject request to discontinue treatment|0|||
25326088|NCT00516295|50642596|FG002|Overall Study|Lack of Efficacy|0|||
25246555|NCT01236352|50562040|FG007|Overall Study|Subject request to discontinue treatment|0|||
25246556|NCT01236352|50562041|FG008|Overall Study|Subject request to discontinue treatment|0|||
25246557|NCT01236352|50562042|FG009|Overall Study|Subject request to discontinue treatment|1|||
25246558|NCT01236352|50562043|FG010|Overall Study|Subject request to discontinue treatment|4|||
25246559|NCT01236352|50562033|FG000|Overall Study|Subject to receive drug via EAP|1|||
25246560|NCT01236352|50562034|FG001|Overall Study|Subject to receive drug via EAP|1|||
25246561|NCT01236352|50562035|FG002|Overall Study|Subject to receive drug via EAP|1|||
25246562|NCT01236352|50562036|FG003|Overall Study|Subject to receive drug via EAP|0|||
25246563|NCT01236352|50562037|FG004|Overall Study|Subject to receive drug via EAP|0|||
25246564|NCT01236352|50562038|FG005|Overall Study|Subject to receive drug via EAP|0|||
25246565|NCT01236352|50562039|FG006|Overall Study|Subject to receive drug via EAP|0|||
25246566|NCT01236352|50562040|FG007|Overall Study|Subject to receive drug via EAP|2|||
25246567|NCT01236352|50562041|FG008|Overall Study|Subject to receive drug via EAP|0|||
25326089|NCT00516295|50642594|FG000|Overall Study|Ineligible|1|||
25326090|NCT00516295|50642595|FG001|Overall Study|Ineligible|0|||
25326091|NCT00516295|50642596|FG002|Overall Study|Ineligible|0|||
25326092|NCT03861559|50642606|FG000|Overall Study|Adverse Event|0|||
25326093|NCT03861559|50642607|FG001|Overall Study|Adverse Event|2|||
25326094|NCT03861559|50642606|FG000|Overall Study|Treatment failure|0|||
25326095|NCT03861559|50642607|FG001|Overall Study|Treatment failure|2|||
25246568|NCT01236352|50562042|FG009|Overall Study|Subject to receive drug via EAP|4|||
25246569|NCT01236352|50562043|FG010|Overall Study|Subject to receive drug via EAP|0|||
25246570|NCT01236352|50562033|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
25246571|NCT01236352|50562034|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
25246572|NCT01236352|50562035|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
25246573|NCT01236352|50562036|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
25246574|NCT01236352|50562037|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
25246575|NCT01236352|50562038|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
25246576|NCT01236352|50562039|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
25326096|NCT03861559|50642606|FG000|Overall Study|Noncompliance|1|||
25326097|NCT03861559|50642607|FG001|Overall Study|Noncompliance|1|||
25326098|NCT03861559|50642606|FG000|Overall Study|Did not meet eligibility requirements|1|||
25326099|NCT03861559|50642607|FG001|Overall Study|Did not meet eligibility requirements|0|||
25326100|NCT00516139|50642613|FG000|Overall Study|Adverse Event|27|||
25326101|NCT00516139|50642613|FG000|Overall Study|Lost to Follow-up|1|||
25326102|NCT00516139|50642613|FG000|Overall Study|Protocol Violation|1|||
25326103|NCT00516139|50642613|FG000|Overall Study|Withdrawal by Subject|8|||
25326104|NCT00516139|50642613|FG000|Overall Study|Lack of Efficacy|1|||
25326105|NCT00515827|50642623|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
25246577|NCT01236352|50562040|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
25246578|NCT01236352|50562041|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
25246579|NCT01236352|50562042|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
25246580|NCT01236352|50562043|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
25246581|NCT01236352|50562033|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
25246582|NCT01236352|50562034|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
25246583|NCT01236352|50562035|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
25246584|NCT01236352|50562036|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
25246585|NCT01236352|50562037|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
25246586|NCT01236352|50562038|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
25246587|NCT01236352|50562039|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
25246588|NCT01236352|50562040|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
25246589|NCT01236352|50562041|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
25246590|NCT01236352|50562042|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
25326106|NCT00515827|50642624|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
25326107|NCT00515827|50642623|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
25326108|NCT00515827|50642624|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
25326109|NCT00522457|50642632|FG000|Overall Study|Due to disease progression|16|||
25326110|NCT00522457|50642632|FG000|Overall Study|Adverse Event|2|||
25326111|NCT00856986|50642641|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
25326112|NCT00856986|50642642|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
25326113|NCT00856986|50642643|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
25326114|NCT00856986|50642644|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
25326115|NCT00856986|50642645|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
25326116|NCT00856986|50642641|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
25326117|NCT00856986|50642642|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
25326118|NCT00856986|50642643|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
25246591|NCT01236352|50562043|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
25246592|NCT01236352|50562033|FG000|Overall Study|Lack of response to drug|0|||
25246593|NCT01236352|50562034|FG001|Overall Study|Lack of response to drug|0|||
25246594|NCT01236352|50562035|FG002|Overall Study|Lack of response to drug|0|||
25246595|NCT01236352|50562036|FG003|Overall Study|Lack of response to drug|0|||
25246596|NCT01236352|50562037|FG004|Overall Study|Lack of response to drug|0|||
25246597|NCT01236352|50562038|FG005|Overall Study|Lack of response to drug|0|||
25246598|NCT01236352|50562039|FG006|Overall Study|Lack of response to drug|0|||
25246599|NCT01236352|50562040|FG007|Overall Study|Lack of response to drug|0|||
25246600|NCT01236352|50562041|FG008|Overall Study|Lack of response to drug|0|||
25246601|NCT01236352|50562042|FG009|Overall Study|Lack of response to drug|1|||
25246602|NCT01236352|50562043|FG010|Overall Study|Lack of response to drug|1|||
25246603|NCT01236352|50562033|FG000|Overall Study|Patient transferred to IST|0|||
25246604|NCT01236352|50562034|FG001|Overall Study|Patient transferred to IST|0|||
25246605|NCT01236352|50562035|FG002|Overall Study|Patient transferred to IST|0|||
25246606|NCT01236352|50562036|FG003|Overall Study|Patient transferred to IST|0|||
25326119|NCT00856986|50642644|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
25326120|NCT00856986|50642645|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
25326121|NCT00856986|50642641|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
25326122|NCT00856986|50642642|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
25326123|NCT00856986|50642643|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
25326124|NCT00856986|50642644|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
25326125|NCT00856986|50642645|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
25326126|NCT00856986|50642641|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
25326127|NCT00856986|50642642|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
25326128|NCT00856986|50642643|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
25326129|NCT00856986|50642644|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
25326130|NCT00856986|50642645|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
25326131|NCT00856986|50642641|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
25326132|NCT00856986|50642642|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
25326133|NCT00856986|50642643|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
25326134|NCT00856986|50642644|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
25326135|NCT00856986|50642645|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
25326136|NCT00856986|50642641|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
25326137|NCT00856986|50642642|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
25326138|NCT00856986|50642643|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
25326139|NCT00856986|50642644|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
25326140|NCT00856986|50642645|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
25326141|NCT00856986|50642641|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
25326142|NCT00856986|50642642|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
25326143|NCT00856986|50642643|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
25326144|NCT00856986|50642644|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
25326145|NCT00856986|50642645|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
25326146|NCT00856986|50642641|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
25326147|NCT00856986|50642642|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
25326148|NCT00856986|50642643|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
25326149|NCT00856986|50642644|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
25326150|NCT00856986|50642645|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
25326151|NCT00856986|50642641|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
25326152|NCT00856986|50642642|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
25326153|NCT00856986|50642643|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
25326154|NCT00856986|50642644|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
25326155|NCT00856986|50642645|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
25326156|NCT00856986|50642641|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
25326157|NCT00856986|50642642|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
25326158|NCT00856986|50642643|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
25326159|NCT00856986|50642644|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
25326160|NCT00856986|50642645|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
25326161|NCT00856986|50642641|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
25326162|NCT00856986|50642642|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
25326163|NCT00856986|50642643|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
25326164|NCT00856986|50642644|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
25326165|NCT00856986|50642645|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
25326166|NCT00856986|50642641|FG000|Main Period, Weeks 0-26|Unclassified|7|||
25326167|NCT00856986|50642642|FG001|Main Period, Weeks 0-26|Unclassified|6|||
25246607|NCT01236352|50562037|FG004|Overall Study|Patient transferred to IST|0|||
25246608|NCT01236352|50562038|FG005|Overall Study|Patient transferred to IST|0|||
25246609|NCT01236352|50562039|FG006|Overall Study|Patient transferred to IST|0|||
25246610|NCT01236352|50562040|FG007|Overall Study|Patient transferred to IST|0|||
25246611|NCT01236352|50562041|FG008|Overall Study|Patient transferred to IST|0|||
25246612|NCT01236352|50562042|FG009|Overall Study|Patient transferred to IST|2|||
25246613|NCT01236352|50562043|FG010|Overall Study|Patient transferred to IST|6|||
25326168|NCT00856986|50642643|FG002|Main Period, Weeks 0-26|Unclassified|7|||
25326169|NCT00856986|50642644|FG003|Main Period, Weeks 0-26|Unclassified|0|||
25326170|NCT00856986|50642645|FG004|Main Period, Weeks 0-26|Unclassified|0|||
25326171|NCT00856986|50642641|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
25246614|NCT01236118|50562070|FG000|Overall Study|Adverse Event|2|||
25246615|NCT01236118|50562071|FG001|Overall Study|Adverse Event|0|||
25246616|NCT01236118|50562072|FG002|Overall Study|Adverse Event|2|||
25246617|NCT01236118|50562070|FG000|Overall Study|Physician Decision|0|||
25246618|NCT01236118|50562071|FG001|Overall Study|Physician Decision|1|||
25246619|NCT01236118|50562072|FG002|Overall Study|Physician Decision|0|||
25246620|NCT01236118|50562070|FG000|Overall Study|Withdrawal by Subject|0|||
25246621|NCT01236118|50562071|FG001|Overall Study|Withdrawal by Subject|0|||
25246622|NCT01236118|50562072|FG002|Overall Study|Withdrawal by Subject|1|||
25326172|NCT00856986|50642642|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
25326173|NCT00856986|50642643|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
25326174|NCT00856986|50642644|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
25326175|NCT00856986|50642645|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
25326176|NCT00856986|50642641|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
25326177|NCT00856986|50642642|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
25326178|NCT00856986|50642643|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
25326179|NCT00856986|50642644|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
25326180|NCT00856986|50642645|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
25326181|NCT00856986|50642641|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
25326182|NCT00856986|50642642|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
25326183|NCT00856986|50642643|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
25326184|NCT00856986|50642644|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
25326185|NCT00856986|50642645|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
25326186|NCT00856986|50642641|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
25326187|NCT00856986|50642642|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
25326188|NCT00856986|50642643|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
25326189|NCT00856986|50642644|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
25326190|NCT00856986|50642645|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
25326191|NCT00856986|50642641|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
25326192|NCT00856986|50642642|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
25326193|NCT00856986|50642643|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
25326194|NCT00856986|50642644|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
25246623|NCT01236001|50562082|FG000|Overall Study|Adverse Event|5|||
25246624|NCT01236001|50562083|FG001|Overall Study|Adverse Event|14|||
25246625|NCT01236001|50562082|FG000|Overall Study|Lack of Efficacy|6|||
25326195|NCT00856986|50642645|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
25326196|NCT00856986|50642641|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
25326197|NCT00856986|50642642|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
25326198|NCT00856986|50642643|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
25246626|NCT01236001|50562083|FG001|Overall Study|Lack of Efficacy|6|||
25246627|NCT01236001|50562082|FG000|Overall Study|Lost to Follow-up|6|||
25246628|NCT01236001|50562083|FG001|Overall Study|Lost to Follow-up|1|||
25246629|NCT01236001|50562082|FG000|Overall Study|Incompliance|1|||
25246630|NCT01236001|50562083|FG001|Overall Study|Incompliance|0|||
25246631|NCT01236001|50562082|FG000|Overall Study|Planned Visit After End of Study|0|||
25246632|NCT01236001|50562083|FG001|Overall Study|Planned Visit After End of Study|1|||
25246633|NCT01229254|50562093|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
25246634|NCT01229254|50562094|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
25246635|NCT01229254|50562095|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
25246636|NCT01229254|50562093|FG000|Overall Study|Adverse Event|4|||
25246637|NCT01229254|50562094|FG001|Overall Study|Adverse Event|5|||
25246638|NCT01229254|50562095|FG002|Overall Study|Adverse Event|3|||
25246639|NCT01229254|50562093|FG000|Overall Study|Lost to Follow-up|3|||
25326199|NCT00856986|50642644|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
25326200|NCT00856986|50642645|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
25246640|NCT01229254|50562094|FG001|Overall Study|Lost to Follow-up|0|||
25246641|NCT01229254|50562095|FG002|Overall Study|Lost to Follow-up|1|||
25246642|NCT01229254|50562093|FG000|Overall Study|Physician Decision|0|||
25246643|NCT01229254|50562094|FG001|Overall Study|Physician Decision|3|||
25246644|NCT01229254|50562095|FG002|Overall Study|Physician Decision|0|||
25246645|NCT01229254|50562093|FG000|Overall Study|Protocol Violation|4|||
25326201|NCT00707746|50642659|FG000|Treatment Period|Adverse Event|2|||
25326202|NCT00707746|50642660|FG001|Treatment Period|Adverse Event|4|||
25326203|NCT00707746|50642659|FG000|Treatment Period|Ineligibility|0|||
25326204|NCT00707746|50642660|FG001|Treatment Period|Ineligibility|1|||
25326205|NCT00856908|50642668|FG000|Overall Study|Lost to Follow-up|1|||
25326206|NCT00856908|50642669|FG001|Overall Study|Lost to Follow-up|0|||
25326207|NCT00522379|50642680|FG000|Overall Study|Adverse Event|12|||
25326208|NCT00522379|50642681|FG001|Overall Study|Adverse Event|15|||
25326209|NCT00522379|50642682|FG002|Overall Study|Adverse Event|12|||
25326210|NCT00522379|50642683|FG003|Overall Study|Adverse Event|5|||
25326211|NCT00522379|50642684|FG004|Overall Study|Adverse Event|17|||
25326212|NCT00522379|50642680|FG000|Overall Study|Lack of Efficacy|3|||
25326213|NCT00522379|50642681|FG001|Overall Study|Lack of Efficacy|0|||
25246646|NCT01229254|50562094|FG001|Overall Study|Protocol Violation|6|||
25246647|NCT01229254|50562095|FG002|Overall Study|Protocol Violation|5|||
25246648|NCT01229254|50562093|FG000|Overall Study|Withdrawal by Subject|1|||
25246649|NCT01229254|50562094|FG001|Overall Study|Withdrawal by Subject|0|||
25246650|NCT01229254|50562095|FG002|Overall Study|Withdrawal by Subject|1|||
25326214|NCT00522379|50642682|FG002|Overall Study|Lack of Efficacy|2|||
25326215|NCT00522379|50642683|FG003|Overall Study|Lack of Efficacy|2|||
25326216|NCT00522379|50642684|FG004|Overall Study|Lack of Efficacy|7|||
25246651|NCT01229254|50562093|FG000|Overall Study|Non-compliance with Study Drug|0|||
25246652|NCT01229254|50562094|FG001|Overall Study|Non-compliance with Study Drug|1|||
25326217|NCT00522379|50642680|FG000|Overall Study|Withdrawal by Subject|2|||
25326218|NCT00522379|50642681|FG001|Overall Study|Withdrawal by Subject|3|||
25326219|NCT00522379|50642682|FG002|Overall Study|Withdrawal by Subject|1|||
25326220|NCT00522379|50642683|FG003|Overall Study|Withdrawal by Subject|2|||
25326221|NCT00522379|50642684|FG004|Overall Study|Withdrawal by Subject|0|||
25326222|NCT00522379|50642680|FG000|Overall Study|Protocol Violation|1|||
25326223|NCT00522379|50642681|FG001|Overall Study|Protocol Violation|1|||
25326224|NCT00522379|50642682|FG002|Overall Study|Protocol Violation|2|||
25326225|NCT00522379|50642683|FG003|Overall Study|Protocol Violation|0|||
25326226|NCT00522379|50642684|FG004|Overall Study|Protocol Violation|0|||
25326227|NCT00522379|50642680|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
25326228|NCT00522379|50642681|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
25326229|NCT00522379|50642682|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
25326230|NCT00522379|50642683|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
25326231|NCT00522379|50642684|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
25326232|NCT00522379|50642680|FG000|Overall Study|Lost to Follow-up|1|||
25326233|NCT00522379|50642681|FG001|Overall Study|Lost to Follow-up|0|||
25326234|NCT00522379|50642682|FG002|Overall Study|Lost to Follow-up|4|||
25326235|NCT00522379|50642683|FG003|Overall Study|Lost to Follow-up|2|||
25326236|NCT00522379|50642684|FG004|Overall Study|Lost to Follow-up|2|||
25326237|NCT00522379|50642680|FG000|Overall Study|Randomization error|0|||
25326238|NCT00522379|50642681|FG001|Overall Study|Randomization error|0|||
25326239|NCT00522379|50642682|FG002|Overall Study|Randomization error|0|||
25326240|NCT00522379|50642683|FG003|Overall Study|Randomization error|0|||
25326241|NCT00522379|50642684|FG004|Overall Study|Randomization error|1|||
25326242|NCT00522379|50642680|FG000|Overall Study|Dispensing error|1|||
25326243|NCT00522379|50642681|FG001|Overall Study|Dispensing error|0|||
25326244|NCT00522379|50642682|FG002|Overall Study|Dispensing error|0|||
25326245|NCT00522379|50642683|FG003|Overall Study|Dispensing error|1|||
25326246|NCT00522379|50642684|FG004|Overall Study|Dispensing error|0|||
25326247|NCT00522379|50642680|FG000|Overall Study|Subject Moved|1|||
25326248|NCT00522379|50642681|FG001|Overall Study|Subject Moved|1|||
25326249|NCT00522379|50642682|FG002|Overall Study|Subject Moved|0|||
25326250|NCT00522379|50642683|FG003|Overall Study|Subject Moved|0|||
25326251|NCT00522379|50642684|FG004|Overall Study|Subject Moved|0|||
25326252|NCT00522379|50642680|FG000|Overall Study|Sponsor Request|0|||
25326253|NCT00522379|50642681|FG001|Overall Study|Sponsor Request|1|||
25326254|NCT00522379|50642682|FG002|Overall Study|Sponsor Request|0|||
25326255|NCT00522379|50642683|FG003|Overall Study|Sponsor Request|0|||
25326256|NCT00522379|50642684|FG004|Overall Study|Sponsor Request|0|||
25326257|NCT00522379|50642680|FG000|Overall Study|Family Problem|0|||
25326258|NCT00522379|50642681|FG001|Overall Study|Family Problem|0|||
25326259|NCT00522379|50642682|FG002|Overall Study|Family Problem|1|||
25326260|NCT00522379|50642683|FG003|Overall Study|Family Problem|0|||
25326261|NCT00522379|50642684|FG004|Overall Study|Family Problem|0|||
25326262|NCT00522379|50642680|FG000|Overall Study|Site Closed|0|||
25326263|NCT00522379|50642681|FG001|Overall Study|Site Closed|0|||
25326264|NCT00522379|50642682|FG002|Overall Study|Site Closed|0|||
25326265|NCT00522379|50642683|FG003|Overall Study|Site Closed|1|||
25326266|NCT00522379|50642684|FG004|Overall Study|Site Closed|0|||
25326267|NCT00522379|50642680|FG000|Overall Study|Subject Withdrawal|0|||
25326268|NCT00522379|50642681|FG001|Overall Study|Subject Withdrawal|0|||
25326269|NCT00522379|50642682|FG002|Overall Study|Subject Withdrawal|0|||
25246653|NCT01229254|50562095|FG002|Overall Study|Non-compliance with Study Drug|1|||
25246654|NCT01235728|50562104|FG000|Overall Study|Protocol Violation|0|||
25246655|NCT01235728|50562105|FG001|Overall Study|Protocol Violation|0|||
25246656|NCT01235728|50562106|FG002|Overall Study|Protocol Violation|0|||
25246657|NCT01235728|50562107|FG003|Overall Study|Protocol Violation|1|||
25246658|NCT01235728|50562108|FG004|Overall Study|Protocol Violation|0|||
25246659|NCT01235728|50562109|FG005|Overall Study|Protocol Violation|0|||
25246660|NCT01235728|50562110|FG006|Overall Study|Protocol Violation|0|||
25246661|NCT01235728|50562111|FG007|Overall Study|Protocol Violation|0|||
25246662|NCT01235689|50562121|FG000|Overall Study|Adverse Event|12|||
25246663|NCT01235689|50562122|FG001|Overall Study|Adverse Event|16|||
25246664|NCT01235689|50562121|FG000|Overall Study|Lack of Efficacy|12|||
25246665|NCT01235689|50562122|FG001|Overall Study|Lack of Efficacy|5|||
25326270|NCT00522379|50642683|FG003|Overall Study|Subject Withdrawal|1|||
25326271|NCT00522379|50642684|FG004|Overall Study|Subject Withdrawal|0|||
25326272|NCT00856830|50642700|FG000|Irinotecan & Bendamustine|Death|0|||
25326273|NCT00856830|50642701|FG001|Irinotecan & Bendamustine|Death|0|||
25326274|NCT00856830|50642702|FG002|Irinotecan & Bendamustine|Death|0|||
25326275|NCT00856830|50642703|FG003|Irinotecan & Bendamustine|Death|2|||
25326276|NCT00856830|50642700|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
25326277|NCT00856830|50642701|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
25326278|NCT00856830|50642702|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
25326279|NCT00856830|50642703|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
25326280|NCT00522301|50642708|FG000|Overall Study|Withdrawal by Subject|1|||
25326281|NCT00522301|50642708|FG000|Overall Study|Adverse Event|5|||
25326282|NCT00863928|50642714|FG000|Overall Study|Protocol Violation|26|||
25326283|NCT00863928|50642715|FG001|Overall Study|Protocol Violation|0|||
25326284|NCT00863928|50642714|FG000|Overall Study|Withdrawal by Subject|3|||
25246666|NCT01235689|50562121|FG000|Overall Study|Withdrawal by Subject|3|||
25246667|NCT01235689|50562122|FG001|Overall Study|Withdrawal by Subject|4|||
25326285|NCT00863928|50642715|FG001|Overall Study|Withdrawal by Subject|0|||
25326286|NCT00863928|50642714|FG000|Overall Study|surgery cancellation|4|||
25326287|NCT00863928|50642715|FG001|Overall Study|surgery cancellation|0|||
25326288|NCT00863928|50642714|FG000|Overall Study|medication allergy|3|||
25326289|NCT00863928|50642715|FG001|Overall Study|medication allergy|0|||
25326290|NCT00856518|50642723|FG000|Overall Study|Lost to Follow-up|4|||
25326291|NCT00856518|50642724|FG001|Overall Study|Lost to Follow-up|2|||
25326292|NCT00506389|50642735|FG000|In-treatment Period|Other|3|||
25326293|NCT00506389|50642736|FG001|In-treatment Period|Other|3|||
25326294|NCT00506389|50642737|FG002|In-treatment Period|Other|4|||
25326295|NCT00506389|50642735|FG000|In-treatment Period|Lost to Follow-up|0|||
25326296|NCT00506389|50642736|FG001|In-treatment Period|Lost to Follow-up|0|||
25326297|NCT00506389|50642737|FG002|In-treatment Period|Lost to Follow-up|1|||
25326298|NCT00506389|50642735|FG000|In-treatment Period|Lack of compliance|1|||
25326299|NCT00506389|50642736|FG001|In-treatment Period|Lack of compliance|0|||
25326300|NCT00506389|50642737|FG002|In-treatment Period|Lack of compliance|0|||
25326301|NCT00506389|50642735|FG000|In-treatment Period|Reasons not related to trial|4|||
25326302|NCT00506389|50642736|FG001|In-treatment Period|Reasons not related to trial|1|||
25326303|NCT00506389|50642737|FG002|In-treatment Period|Reasons not related to trial|0|||
25326304|NCT00506389|50642735|FG000|In-treatment Period|Withdrawal by Subject|3|||
25326305|NCT00506389|50642736|FG001|In-treatment Period|Withdrawal by Subject|3|||
25326306|NCT00506389|50642737|FG002|In-treatment Period|Withdrawal by Subject|4|||
25326307|NCT00506389|50642735|FG000|In-treatment Period|Lack of Efficacy|0|||
25326308|NCT00506389|50642736|FG001|In-treatment Period|Lack of Efficacy|2|||
25326309|NCT00506389|50642737|FG002|In-treatment Period|Lack of Efficacy|0|||
25326310|NCT00506389|50642735|FG000|In-treatment Period|Adverse Event|11|||
25326311|NCT00506389|50642736|FG001|In-treatment Period|Adverse Event|5|||
25326312|NCT00506389|50642737|FG002|In-treatment Period|Adverse Event|2|||
25326313|NCT00506389|50642735|FG000|In-treatment Period|Randomized but not treated|4|||
25326314|NCT00506389|50642736|FG001|In-treatment Period|Randomized but not treated|1|||
25326315|NCT00506389|50642737|FG002|In-treatment Period|Randomized but not treated|1|||
25326316|NCT00871338|50642750|FG000|Prior to Booster|Withdrawal by Subject|1|||
25326317|NCT00871338|50642751|FG001|Prior to Booster|Withdrawal by Subject|3|||
25326318|NCT00871338|50642750|FG000|Prior to Booster|Lost to Follow-up|1|||
25246668|NCT01235689|50562121|FG000|Overall Study|Lost to Follow-up|1|||
25326319|NCT00871338|50642751|FG001|Prior to Booster|Lost to Follow-up|0|||
25326320|NCT00824421|50642760|FG000|Overall Study|Adverse Event|6|||
25326321|NCT00824421|50642761|FG001|Overall Study|Adverse Event|6|||
25326322|NCT00824421|50642762|FG002|Overall Study|Adverse Event|6|||
25326323|NCT00824421|50642760|FG000|Overall Study|Death|0|||
25326324|NCT00824421|50642761|FG001|Overall Study|Death|1|||
25326325|NCT00824421|50642762|FG002|Overall Study|Death|0|||
25326326|NCT00824421|50642760|FG000|Overall Study|Lack of Efficacy|5|||
25246669|NCT01235689|50562122|FG001|Overall Study|Lost to Follow-up|2|||
25246670|NCT01235689|50562121|FG000|Overall Study|Miscellaneous|1|||
25246671|NCT01235689|50562122|FG001|Overall Study|Miscellaneous|5|||
25246672|NCT01229176|50562136|FG000|Overall Study|Withdrawal by Subject|0|||
25246673|NCT01229176|50562137|FG001|Overall Study|Withdrawal by Subject|0|||
25246674|NCT01229176|50562138|FG002|Overall Study|Withdrawal by Subject|0|||
25246675|NCT01229176|50562139|FG003|Overall Study|Withdrawal by Subject|1|||
25246676|NCT01229176|50562140|FG004|Overall Study|Withdrawal by Subject|1|||
25246677|NCT01229176|50562141|FG005|Overall Study|Withdrawal by Subject|1|||
25246678|NCT01229176|50562142|FG006|Overall Study|Withdrawal by Subject|0|||
25246679|NCT01229176|50562143|FG007|Overall Study|Withdrawal by Subject|1|||
25246680|NCT01229176|50562136|FG000|Overall Study|Lost to Follow-up|0|||
25246681|NCT01229176|50562137|FG001|Overall Study|Lost to Follow-up|3|||
25246682|NCT01229176|50562138|FG002|Overall Study|Lost to Follow-up|0|||
25246683|NCT01229176|50562139|FG003|Overall Study|Lost to Follow-up|0|||
25246684|NCT01229176|50562140|FG004|Overall Study|Lost to Follow-up|1|||
25246685|NCT01229176|50562141|FG005|Overall Study|Lost to Follow-up|1|||
25246686|NCT01229176|50562142|FG006|Overall Study|Lost to Follow-up|0|||
25246687|NCT01229176|50562143|FG007|Overall Study|Lost to Follow-up|2|||
25246688|NCT01228747|50562163|FG000|Overall Study|Adverse Event|8|||
25246689|NCT01228747|50562164|FG001|Overall Study|Adverse Event|4|||
25246690|NCT01228747|50562163|FG000|Overall Study|Lack of Efficacy|40|||
25326327|NCT00824421|50642761|FG001|Overall Study|Lack of Efficacy|7|||
25326328|NCT00824421|50642762|FG002|Overall Study|Lack of Efficacy|4|||
25326329|NCT00824421|50642760|FG000|Overall Study|Lost to Follow-up|2|||
25326330|NCT00824421|50642761|FG001|Overall Study|Lost to Follow-up|3|||
25326331|NCT00824421|50642762|FG002|Overall Study|Lost to Follow-up|0|||
25326332|NCT00824421|50642760|FG000|Overall Study|Pregnancy|1|||
25326333|NCT00824421|50642761|FG001|Overall Study|Pregnancy|0|||
25326334|NCT00824421|50642762|FG002|Overall Study|Pregnancy|1|||
25326335|NCT00824421|50642760|FG000|Overall Study|Withdrawal by Subject|2|||
25246691|NCT01228747|50562164|FG001|Overall Study|Lack of Efficacy|27|||
25246692|NCT01228747|50562163|FG000|Overall Study|Protocol Violation|6|||
25246693|NCT01228747|50562164|FG001|Overall Study|Protocol Violation|5|||
25246694|NCT01228747|50562163|FG000|Overall Study|Lost to Follow-up|4|||
25326336|NCT00824421|50642761|FG001|Overall Study|Withdrawal by Subject|3|||
25326337|NCT00824421|50642762|FG002|Overall Study|Withdrawal by Subject|3|||
25326338|NCT00824421|50642760|FG000|Overall Study|Randomized but not Treated|1|||
25326339|NCT00824421|50642761|FG001|Overall Study|Randomized but not Treated|1|||
25326340|NCT00824421|50642762|FG002|Overall Study|Randomized but not Treated|0|||
25326341|NCT00824421|50642760|FG000|Overall Study|Other|0|||
25326342|NCT00824421|50642761|FG001|Overall Study|Other|1|||
25326343|NCT00824421|50642762|FG002|Overall Study|Other|0|||
25326344|NCT00514813|50642776|FG000|Overall Study|Study terminated|14|||
25326345|NCT00514813|50642777|FG001|Overall Study|Study terminated|74|||
25326346|NCT00514813|50642778|FG002|Overall Study|Study terminated|40|||
25326347|NCT00514813|50642779|FG003|Overall Study|Study terminated|2|||
25326348|NCT00514813|50642776|FG000|Overall Study|Adverse Event|0|||
25326349|NCT00514813|50642777|FG001|Overall Study|Adverse Event|2|||
25326350|NCT00514813|50642778|FG002|Overall Study|Adverse Event|2|||
25326351|NCT00514813|50642779|FG003|Overall Study|Adverse Event|0|||
25326352|NCT00514813|50642776|FG000|Overall Study|Protocol Violation|1|||
25326353|NCT00514813|50642777|FG001|Overall Study|Protocol Violation|0|||
25326354|NCT00514813|50642778|FG002|Overall Study|Protocol Violation|0|||
25326355|NCT00514813|50642779|FG003|Overall Study|Protocol Violation|0|||
25326356|NCT00514813|50642776|FG000|Overall Study|Withdrawal by Subject|0|||
25326357|NCT00514813|50642777|FG001|Overall Study|Withdrawal by Subject|1|||
25326358|NCT00514813|50642778|FG002|Overall Study|Withdrawal by Subject|0|||
25326359|NCT00514813|50642779|FG003|Overall Study|Withdrawal by Subject|0|||
25326360|NCT00514813|50642776|FG000|Overall Study|Lack of Efficacy|0|||
25326361|NCT00514813|50642777|FG001|Overall Study|Lack of Efficacy|1|||
25326362|NCT00514813|50642778|FG002|Overall Study|Lack of Efficacy|0|||
25326363|NCT00514813|50642779|FG003|Overall Study|Lack of Efficacy|0|||
25326364|NCT00514813|50642776|FG000|Overall Study|Kidney transplant|0|||
25326365|NCT00514813|50642777|FG001|Overall Study|Kidney transplant|6|||
25326366|NCT00514813|50642778|FG002|Overall Study|Kidney transplant|2|||
25326367|NCT00514813|50642779|FG003|Overall Study|Kidney transplant|0|||
25326368|NCT00514813|50642776|FG000|Overall Study|Death|0|||
25326369|NCT00514813|50642777|FG001|Overall Study|Death|2|||
25326370|NCT00514813|50642778|FG002|Overall Study|Death|3|||
25326371|NCT00514813|50642779|FG003|Overall Study|Death|2|||
25326372|NCT00597116|50642791|FG000|Overall Study|Adverse Event|2|||
25326373|NCT00597116|50642792|FG001|Overall Study|Adverse Event|1|||
25326374|NCT00597116|50642791|FG000|Overall Study|Withdrawal by Subject|0|||
25326375|NCT00597116|50642792|FG001|Overall Study|Withdrawal by Subject|2|||
25326376|NCT00597116|50642791|FG000|Overall Study|Physician Decision|0|||
25326377|NCT00597116|50642792|FG001|Overall Study|Physician Decision|1|||
24977239|NCT03410992|50065848|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
24977240|NCT03410992|50065849|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
25246695|NCT01228747|50562164|FG001|Overall Study|Lost to Follow-up|3|||
25246696|NCT01228747|50562163|FG000|Overall Study|Withdrawal by Subject|5|||
25246697|NCT01228747|50562164|FG001|Overall Study|Withdrawal by Subject|1|||
25246698|NCT01228747|50562163|FG000|Overall Study|Other Reason|2|||
25246699|NCT01228747|50562164|FG001|Overall Study|Other Reason|5|||
25246700|NCT01228591|50562170|FG000|Baseline|Lack of Efficacy|1|||
25246701|NCT01228591|50562171|FG001|Baseline|Lack of Efficacy|2|||
25246702|NCT01235338|50562183|FG000|Overall Study|Adverse Event|3|||
25246703|NCT01235338|50562184|FG001|Overall Study|Adverse Event|2|||
25246704|NCT01235338|50562183|FG000|Overall Study|Protocol Violation|1|||
25246705|NCT01235338|50562184|FG001|Overall Study|Protocol Violation|1|||
25246706|NCT01235338|50562183|FG000|Overall Study|Withdrawal by Subject|5|||
25246707|NCT01235338|50562184|FG001|Overall Study|Withdrawal by Subject|0|||
25246708|NCT01235338|50562183|FG000|Overall Study|Exclusion criteria violations|1|||
25246709|NCT01235338|50562184|FG001|Overall Study|Exclusion criteria violations|1|||
25246710|NCT01235338|50562183|FG000|Overall Study|Positive drug screen|0|||
25246711|NCT01235338|50562184|FG001|Overall Study|Positive drug screen|1|||
25246712|NCT01235338|50562183|FG000|Overall Study|Prohibited meds|1|||
25326378|NCT00597116|50642791|FG000|Overall Study|Death|0|||
25326379|NCT00597116|50642792|FG001|Overall Study|Death|1|||
25326380|NCT00597116|50642791|FG000|Overall Study|Lost to Follow-up|1|||
25326381|NCT00597116|50642792|FG001|Overall Study|Lost to Follow-up|0|||
25326382|NCT00597116|50642791|FG000|Overall Study|Progressive disease|11|||
25326383|NCT00597116|50642792|FG001|Overall Study|Progressive disease|6|||
25326384|NCT00514735|50642800|FG000|Overall Study|Withdrawal by Subject|13|||
25326385|NCT00514735|50642801|FG001|Overall Study|Withdrawal by Subject|5|||
25326386|NCT00514735|50642800|FG000|Overall Study|Death|1|||
25326387|NCT00514735|50642801|FG001|Overall Study|Death|0|||
25326388|NCT00514735|50642800|FG000|Overall Study|Lost to Follow-up|0|||
25326389|NCT00514735|50642801|FG001|Overall Study|Lost to Follow-up|1|||
25326390|NCT03252587|50642813|FG000|Overall Study|Adverse Event|3|||
25326391|NCT03252587|50642814|FG001|Overall Study|Adverse Event|8|||
25326392|NCT03252587|50642815|FG002|Overall Study|Adverse Event|6|||
25326393|NCT03252587|50642816|FG003|Overall Study|Adverse Event|12|||
25326394|NCT03252587|50642813|FG000|Overall Study|Lack of Efficacy|7|||
25326395|NCT03252587|50642814|FG001|Overall Study|Lack of Efficacy|2|||
25326396|NCT03252587|50642815|FG002|Overall Study|Lack of Efficacy|2|||
25326397|NCT03252587|50642816|FG003|Overall Study|Lack of Efficacy|4|||
25326398|NCT03252587|50642813|FG000|Overall Study|Lost to Follow-up|2|||
25326399|NCT03252587|50642814|FG001|Overall Study|Lost to Follow-up|0|||
25326400|NCT03252587|50642815|FG002|Overall Study|Lost to Follow-up|0|||
25326401|NCT03252587|50642816|FG003|Overall Study|Lost to Follow-up|2|||
25326402|NCT03252587|50642813|FG000|Overall Study|Pregnancy|2|||
25326403|NCT03252587|50642814|FG001|Overall Study|Pregnancy|1|||
25326404|NCT03252587|50642815|FG002|Overall Study|Pregnancy|0|||
25246713|NCT01235338|50562184|FG001|Overall Study|Prohibited meds|0|||
25246714|NCT01234675|50562192|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
25246715|NCT01234675|50562193|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
25246716|NCT01234675|50562192|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
25246717|NCT01234675|50562193|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
25246718|NCT01228318|50562201|FG000|Overall Study|Clinic no show to receive intervention|1|||
25246719|NCT01228318|50562202|FG001|Overall Study|Clinic no show to receive intervention|0|||
25326405|NCT03252587|50642816|FG003|Overall Study|Pregnancy|1|||
25326406|NCT03252587|50642813|FG000|Overall Study|Withdrawal by Subject|8|||
25326407|NCT03252587|50642814|FG001|Overall Study|Withdrawal by Subject|4|||
25326408|NCT03252587|50642815|FG002|Overall Study|Withdrawal by Subject|4|||
25326409|NCT03252587|50642816|FG003|Overall Study|Withdrawal by Subject|4|||
25326410|NCT03252587|50642813|FG000|Overall Study|Other Reasons|2|||
25326411|NCT03252587|50642814|FG001|Overall Study|Other Reasons|5|||
25326412|NCT03252587|50642815|FG002|Overall Study|Other Reasons|5|||
25326413|NCT03252587|50642816|FG003|Overall Study|Other Reasons|4|||
25326414|NCT00511147|50642829|FG000|Overall Study|Withdrawal by Subject|1|||
25326415|NCT00511147|50642829|FG000|Overall Study|Disease progression|5|||
25326416|NCT00511147|50642829|FG000|Overall Study|Required platelet transfusion|1|||
25326417|NCT00510835|50642836|FG000|Overall Study|Withdrawal by Subject|6|||
25326418|NCT00510835|50642837|FG001|Overall Study|Withdrawal by Subject|2|||
25326419|NCT00510835|50642838|FG002|Overall Study|Withdrawal by Subject|2|||
25326420|NCT00506077|50642848|FG000|Treatment Period 1|Adverse Event|2|||
25326421|NCT00506077|50642849|FG001|Treatment Period 1|Adverse Event|1|||
25326422|NCT00506077|50642848|FG000|Treatment Period 1|Lost to Follow-up|0|||
25326423|NCT00506077|50642849|FG001|Treatment Period 1|Lost to Follow-up|2|||
25326424|NCT00506077|50642848|FG000|Treatment Period 1|Withdrawal by Subject|2|||
25326425|NCT00506077|50642849|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25326426|NCT00506077|50642848|FG000|Treatment Period 2|Adverse Event|0|||
25326427|NCT00506077|50642849|FG001|Treatment Period 2|Adverse Event|1|||
25326428|NCT00506077|50642848|FG000|Treatment Period 2|Withdrawal by Subject|1|||
25326429|NCT00506077|50642849|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25246720|NCT01228318|50562201|FG000|Overall Study|Unable to contact|2|||
25246721|NCT01228318|50562202|FG001|Overall Study|Unable to contact|5|||
25326430|NCT00505921|50642855|FG000|Overall Study|Ineligible|1|||
25326431|NCT00505921|50642855|FG000|Overall Study|Failed to Mobilize|8|||
25326432|NCT00596960|50642861|FG000|Overall Study|Death|1|||
25326433|NCT00596960|50642862|FG001|Overall Study|Death|2|||
25326434|NCT00596960|50642861|FG000|Overall Study|Lost to Follow-up|6|||
25326435|NCT00596960|50642862|FG001|Overall Study|Lost to Follow-up|5|||
25326436|NCT00596960|50642861|FG000|Overall Study|Withdrawal by Subject|1|||
25326437|NCT00596960|50642862|FG001|Overall Study|Withdrawal by Subject|0|||
25326438|NCT00596960|50642861|FG000|Overall Study|Incarcerated|2|||
25326439|NCT00596960|50642862|FG001|Overall Study|Incarcerated|0|||
25326440|NCT00596960|50642861|FG000|Overall Study|Physician Decision|1|||
25326441|NCT00596960|50642862|FG001|Overall Study|Physician Decision|0|||
25326442|NCT00596960|50642861|FG000|Overall Study|Protocol Violation|0|||
25326443|NCT00596960|50642862|FG001|Overall Study|Protocol Violation|1|||
25326444|NCT00596960|50642861|FG000|Overall Study|No alcohol use data|0|||
25326445|NCT00596960|50642862|FG001|Overall Study|No alcohol use data|1|||
25326446|NCT00505765|50642871|FG000|Overall Study|Withdrawal by Subject|1|||
25326447|NCT00505765|50642872|FG001|Overall Study|Withdrawal by Subject|0|||
25326448|NCT00505765|50642873|FG002|Overall Study|Withdrawal by Subject|0|||
25326449|NCT00505765|50642871|FG000|Overall Study|Adverse Event|1|||
25326450|NCT00505765|50642872|FG001|Overall Study|Adverse Event|2|||
25326451|NCT00505765|50642873|FG002|Overall Study|Adverse Event|0|||
25326452|NCT00505765|50642871|FG000|Overall Study|Noncompliance|0|||
25326453|NCT00505765|50642872|FG001|Overall Study|Noncompliance|1|||
25326454|NCT00505765|50642873|FG002|Overall Study|Noncompliance|3|||
25326455|NCT00505687|50642881|FG000|Overall Study|Important protocol violation|2|||
25326456|NCT00505687|50642881|FG000|Overall Study|Lack of Efficacy|15|||
25326457|NCT00505687|50642881|FG000|Overall Study|Adverse Event|48|||
25326458|NCT00505687|50642881|FG000|Overall Study|Subject withdrew consent|15|||
25326459|NCT00505687|50642881|FG000|Overall Study|Lost to Follow-up|1|||
25326460|NCT00505687|50642881|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
25326461|NCT00505687|50642881|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
25326462|NCT00505687|50642881|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
25326463|NCT00505687|50642881|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
25326464|NCT00505687|50642881|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
25326465|NCT00505687|50642881|FG000|Overall Study|Other: Disease Progression|1|||
25326466|NCT00505687|50642881|FG000|Overall Study|Other: As Per Sponsor|8|||
25326467|NCT00505375|50642887|FG000|Overall Study|Death|1|||
25326468|NCT00505375|50642888|FG001|Overall Study|Death|0|||
25326469|NCT00505375|50642887|FG000|Overall Study|Withdrawal by Subject|2|||
25326470|NCT00505375|50642888|FG001|Overall Study|Withdrawal by Subject|2|||
25326471|NCT00505375|50642887|FG000|Overall Study|Lost to Follow-up|0|||
25326472|NCT00505375|50642888|FG001|Overall Study|Lost to Follow-up|2|||
25326473|NCT00505375|50642887|FG000|Overall Study|Pregnancy|1|||
25326474|NCT00505375|50642888|FG001|Overall Study|Pregnancy|0|||
25326475|NCT00505375|50642887|FG000|Overall Study|Travel issues|0|||
25326476|NCT00505375|50642888|FG001|Overall Study|Travel issues|1|||
25326477|NCT00594932|50642896|FG000|First 3 Months|Withdrawal by Subject|1|||
25326478|NCT00594932|50642897|FG001|First 3 Months|Withdrawal by Subject|3|||
25326479|NCT00594932|50642896|FG000|Final 3 Months|Withdrawal by Subject|4|||
25326480|NCT00594932|50642897|FG001|Final 3 Months|Withdrawal by Subject|3|||
25326481|NCT00504829|50642906|FG000|Overall Study|Protocol Violation|6|||
25326482|NCT00504829|50642907|FG001|Overall Study|Protocol Violation|4|||
25326483|NCT00504829|50642908|FG002|Overall Study|Protocol Violation|10|||
25326484|NCT00504595|50642920|FG000|Overall Study|Lack of Efficacy|1|||
25326485|NCT00504595|50642921|FG001|Overall Study|Lack of Efficacy|0|||
25326486|NCT00504595|50642922|FG002|Overall Study|Lack of Efficacy|0|||
25326487|NCT00504595|50642923|FG003|Overall Study|Lack of Efficacy|0|||
25326488|NCT00504595|50642920|FG000|Overall Study|Other|0|||
25326489|NCT00504595|50642921|FG001|Overall Study|Other|0|||
25326490|NCT00504595|50642922|FG002|Overall Study|Other|2|||
25326491|NCT00504595|50642923|FG003|Overall Study|Other|0|||
25326492|NCT00513409|50642935|FG000|Overall Study|Adverse Event|0|||
25326493|NCT00513409|50642936|FG001|Overall Study|Adverse Event|1|||
25326494|NCT00513409|50642935|FG000|Overall Study|Withdrawal by Subject|0|||
25326495|NCT00513409|50642936|FG001|Overall Study|Withdrawal by Subject|2|||
25246722|NCT01228318|50562201|FG000|Overall Study|Moved|0|||
25246723|NCT01228318|50562202|FG001|Overall Study|Moved|2|||
25246724|NCT01228318|50562201|FG000|Overall Study|Incarcerated|1|||
25246725|NCT01228318|50562202|FG001|Overall Study|Incarcerated|0|||
25246726|NCT01227967|50562210|FG000|Overall Study|Protocol Violation|3|||
25246727|NCT01227967|50562211|FG001|Overall Study|Protocol Violation|1|||
25246728|NCT01227967|50562210|FG000|Overall Study|Death|0|||
25077774|NCT03318523|50185664|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
25077775|NCT03318523|50185665|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
25077776|NCT03318523|50185666|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
25077777|NCT03318523|50185667|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
25077778|NCT03318523|50185668|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
25246729|NCT01227967|50562211|FG001|Overall Study|Death|1|||
25246730|NCT01227967|50562210|FG000|Overall Study|Lost to Follow-up|8|||
25246731|NCT01227967|50562211|FG001|Overall Study|Lost to Follow-up|3|||
25246732|NCT01227967|50562210|FG000|Overall Study|Withdrawal by Subject|4|||
25246733|NCT01227967|50562211|FG001|Overall Study|Withdrawal by Subject|3|||
25246734|NCT01227967|50562210|FG000|Overall Study|Physician Decision|0|||
25246735|NCT01227967|50562211|FG001|Overall Study|Physician Decision|1|||
25246736|NCT01227967|50562210|FG000|Overall Study|Never Started Treatment|0|||
25246737|NCT01227967|50562211|FG001|Overall Study|Never Started Treatment|4|||
25246738|NCT01227967|50562210|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
25246739|NCT01227967|50562211|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
25246740|NCT01227928|50562219|FG000|Overall Study|Lost to Follow-up|4|||
25326496|NCT00513409|50642935|FG000|Overall Study|Lost to Follow-up|0|||
25326497|NCT00513409|50642936|FG001|Overall Study|Lost to Follow-up|1|||
25326498|NCT00513409|50642935|FG000|Overall Study|Physician Decision|1|||
25326499|NCT00513409|50642936|FG001|Overall Study|Physician Decision|0|||
25326500|NCT00513409|50642935|FG000|Overall Study|Visit 3 not done|1|||
25326501|NCT00513409|50642936|FG001|Overall Study|Visit 3 not done|2|||
25326502|NCT03150095|50642944|FG000|Overall Study|Death|0|||
25326503|NCT03150095|50642945|FG001|Overall Study|Death|1|||
25326504|NCT03150095|50642944|FG000|Overall Study|Lost to Follow-up|1|||
25326505|NCT03150095|50642945|FG001|Overall Study|Lost to Follow-up|1|||
25246741|NCT01227928|50562220|FG001|Overall Study|Lost to Follow-up|2|||
25326506|NCT03150095|50642944|FG000|Overall Study|Withdrawal by Subject|4|||
25326507|NCT03150095|50642945|FG001|Overall Study|Withdrawal by Subject|0|||
25326508|NCT03150095|50642944|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
25326509|NCT03150095|50642945|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
25326510|NCT00705016|50642954|FG000|Overall Study|Adverse Event|6|||
25326511|NCT00705016|50642955|FG001|Overall Study|Adverse Event|11|||
25326512|NCT00705016|50642956|FG002|Overall Study|Adverse Event|10|||
25326513|NCT00705016|50642954|FG000|Overall Study|Death|5|||
25326514|NCT00705016|50642955|FG001|Overall Study|Death|7|||
25326515|NCT00705016|50642956|FG002|Overall Study|Death|5|||
25326516|NCT00705016|50642954|FG000|Overall Study|Protocol Violation|0|||
25326517|NCT00705016|50642955|FG001|Overall Study|Protocol Violation|1|||
25326518|NCT00705016|50642956|FG002|Overall Study|Protocol Violation|1|||
25326519|NCT00705016|50642954|FG000|Overall Study|Withdrawal by Subject|4|||
25326520|NCT00705016|50642955|FG001|Overall Study|Withdrawal by Subject|3|||
25326521|NCT00705016|50642956|FG002|Overall Study|Withdrawal by Subject|2|||
25326522|NCT00705016|50642954|FG000|Overall Study|Progressive Disease|33|||
25326523|NCT00705016|50642955|FG001|Overall Study|Progressive Disease|29|||
25326524|NCT00705016|50642956|FG002|Overall Study|Progressive Disease|33|||
25246742|NCT01227928|50562219|FG000|Overall Study|Withdrawal by Subject|4|||
25246743|NCT01227928|50562220|FG001|Overall Study|Withdrawal by Subject|3|||
25246744|NCT01227928|50562219|FG000|Overall Study|Death|14|||
25246745|NCT01227928|50562220|FG001|Overall Study|Death|12|||
25246746|NCT01227889|50562228|FG000|Randomized Phase (RP)|Adverse Event|13|||
25246747|NCT01227889|50562229|FG001|Randomized Phase (RP)|Adverse Event|0|||
25246748|NCT01227889|50562228|FG000|Randomized Phase (RP)|Physician Decision|13|||
25246749|NCT01227889|50562229|FG001|Randomized Phase (RP)|Physician Decision|5|||
25246750|NCT01227889|50562228|FG000|Randomized Phase (RP)|Progressive Disease|135|||
25246751|NCT01227889|50562229|FG001|Randomized Phase (RP)|Progressive Disease|52|||
25246752|NCT01227889|50562228|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
25246753|NCT01227889|50562229|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
25246754|NCT01227889|50562228|FG000|Randomized Phase (RP)|Missing|1|||
25246755|NCT01227889|50562229|FG001|Randomized Phase (RP)|Missing|3|||
25326525|NCT00705016|50642954|FG000|Overall Study|Symptomatic Deterioration|3|||
25326526|NCT00705016|50642955|FG001|Overall Study|Symptomatic Deterioration|1|||
25326527|NCT00705016|50642956|FG002|Overall Study|Symptomatic Deterioration|1|||
25326528|NCT00705016|50642954|FG000|Overall Study|Other|9|||
25326529|NCT00705016|50642955|FG001|Overall Study|Other|6|||
25326530|NCT00705016|50642956|FG002|Overall Study|Other|6|||
25326531|NCT00595868|50642966|FG000|Overall Study|Lost to Follow-up|45|||
25326532|NCT00595868|50642967|FG001|Overall Study|Lost to Follow-up|50|||
25326533|NCT00856284|50642997|FG000|Overall Study|Hyperglycemic rescue|231|||
25326534|NCT00856284|50642998|FG001|Overall Study|Hyperglycemic rescue|201|||
25326535|NCT00856284|50642999|FG002|Overall Study|Hyperglycemic rescue|235|||
25246756|NCT01227889|50562228|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
25246757|NCT01227889|50562229|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
25246758|NCT01227889|50562228|FG000|Crossover Phase|Adverse Event|0|||
25246759|NCT01227889|50562229|FG001|Crossover Phase|Adverse Event|1|||
25246760|NCT01227889|50562228|FG000|Crossover Phase|Physician Decision|0|||
25246761|NCT01227889|50562229|FG001|Crossover Phase|Physician Decision|3|||
25246762|NCT01227889|50562228|FG000|Crossover Phase|Progressive Disease|0|||
25246763|NCT01227889|50562229|FG001|Crossover Phase|Progressive Disease|31|||
25246764|NCT01227889|50562228|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
25246765|NCT01227889|50562229|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
25246766|NCT01227889|50562228|FG000|Crossover Phase|Withdrawal by Subject|0|||
25246767|NCT01227889|50562229|FG001|Crossover Phase|Withdrawal by Subject|1|||
25246768|NCT01227577|50562243|FG000|Overall Study|Protocol deviation|3|||
25246769|NCT01227577|50562243|FG000|Overall Study|Death|3|||
25246770|NCT01227577|50562243|FG000|Overall Study|Administrative problems|2|||
25246771|NCT01227577|50562243|FG000|Overall Study|Lost to Follow-up|1|||
25246772|NCT01227577|50562243|FG000|Overall Study|Withdrawal by Subject|4|||
25246773|NCT01227577|50562243|FG000|Overall Study|Lack of Efficacy|5|||
25246774|NCT01227577|50562243|FG000|Overall Study|Adverse Event|17|||
25246775|NCT01227421|50562263|FG000|Overall Study|Lost to Follow-up|6|||
25246776|NCT01227421|50562264|FG001|Overall Study|Lost to Follow-up|7|||
25246777|NCT01227421|50562265|FG002|Overall Study|Lost to Follow-up|5|||
25246778|NCT01227421|50562263|FG000|Overall Study|Adverse Event|2|||
25326536|NCT00856284|50642997|FG000|Overall Study|Adverse Event|60|||
25326537|NCT00856284|50642998|FG001|Overall Study|Adverse Event|74|||
25326538|NCT00856284|50642999|FG002|Overall Study|Adverse Event|82|||
25326539|NCT00856284|50642997|FG000|Overall Study|Major protocol deviation|24|||
25326540|NCT00856284|50642998|FG001|Overall Study|Major protocol deviation|16|||
25326541|NCT00856284|50642999|FG002|Overall Study|Major protocol deviation|15|||
25077779|NCT03318523|50185669|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
25246779|NCT01227421|50562264|FG001|Overall Study|Adverse Event|7|||
25246780|NCT01227421|50562265|FG002|Overall Study|Adverse Event|2|||
25246781|NCT01227421|50562263|FG000|Overall Study|Withdrawal by Subject|1|||
25246782|NCT01227421|50562264|FG001|Overall Study|Withdrawal by Subject|2|||
25326542|NCT00856284|50642997|FG000|Overall Study|Lost to Follow-up|20|||
25326543|NCT00856284|50642998|FG001|Overall Study|Lost to Follow-up|22|||
25326544|NCT00856284|50642999|FG002|Overall Study|Lost to Follow-up|28|||
25326545|NCT00856284|50642997|FG000|Overall Study|Voluntary withdrawal|48|||
25326546|NCT00856284|50642998|FG001|Overall Study|Voluntary withdrawal|52|||
25326547|NCT00856284|50642999|FG002|Overall Study|Voluntary withdrawal|62|||
25326548|NCT00856284|50642997|FG000|Overall Study|Pregnancy|1|||
25326549|NCT00856284|50642998|FG001|Overall Study|Pregnancy|2|||
25326550|NCT00856284|50642999|FG002|Overall Study|Pregnancy|0|||
25326551|NCT00856284|50642997|FG000|Overall Study|Investigator discretion|9|||
25326552|NCT00856284|50642998|FG001|Overall Study|Investigator discretion|8|||
25326553|NCT00856284|50642999|FG002|Overall Study|Investigator discretion|10|||
25326554|NCT00856284|50642997|FG000|Overall Study|Other|15|||
25326555|NCT00856284|50642998|FG001|Overall Study|Other|17|||
25326556|NCT00856284|50642999|FG002|Overall Study|Other|14|||
25326557|NCT00856284|50642997|FG000|Overall Study|Randomized in error|0|||
25326558|NCT00856284|50642998|FG001|Overall Study|Randomized in error|0|||
25326559|NCT00856284|50642999|FG002|Overall Study|Randomized in error|1|||
25326560|NCT00510289|50643007|FG000|Overall Study|Withdrawal by Subject|7|||
25326561|NCT00510289|50643007|FG000|Overall Study|Refused bone marrow biopsy|2|||
25326562|NCT00510289|50643007|FG000|Overall Study|Lost to Follow-up|1|||
25326563|NCT00510289|50643007|FG000|Overall Study|Progressed prior to starting drug|2|||
25326564|NCT00492115|50643014|FG000|Overall Study|Withdrawal by Subject|3|||
25326565|NCT00492115|50643015|FG001|Overall Study|Withdrawal by Subject|4|||
25326566|NCT00856206|50643023|FG000|Overall Study|Protocol Violation|6|||
25326567|NCT00856206|50643024|FG001|Overall Study|Protocol Violation|18|||
25246783|NCT01227421|50562265|FG002|Overall Study|Withdrawal by Subject|1|||
25246784|NCT01227421|50562263|FG000|Overall Study|Protocol Violation|1|||
25246785|NCT01227421|50562264|FG001|Overall Study|Protocol Violation|1|||
25246786|NCT01227421|50562265|FG002|Overall Study|Protocol Violation|2|||
25326568|NCT00856206|50643023|FG000|Overall Study|Adverse Event|10|||
25326569|NCT00856206|50643024|FG001|Overall Study|Adverse Event|46|||
25326570|NCT00856206|50643023|FG000|Overall Study|Lack of Efficacy|1|||
25326571|NCT00856206|50643024|FG001|Overall Study|Lack of Efficacy|2|||
25326572|NCT00856206|50643023|FG000|Overall Study|Withdrawal by Subject|15|||
25326573|NCT00856206|50643024|FG001|Overall Study|Withdrawal by Subject|36|||
25246787|NCT01227421|50562263|FG000|Overall Study|Randomized in error|1|||
25246788|NCT01227421|50562264|FG001|Overall Study|Randomized in error|1|||
25246789|NCT01227421|50562265|FG002|Overall Study|Randomized in error|0|||
25246790|NCT01227265|50562276|FG000|Overall Study|Did Not Receive Treatment|1|||
25246791|NCT01227265|50562277|FG001|Overall Study|Did Not Receive Treatment|2|||
25246792|NCT01227265|50562278|FG002|Overall Study|Did Not Receive Treatment|0|||
25246793|NCT01227265|50562276|FG000|Overall Study|Administrative|1|||
25246794|NCT01227265|50562277|FG001|Overall Study|Administrative|0|||
25246795|NCT01227265|50562278|FG002|Overall Study|Administrative|2|||
25246796|NCT01227265|50562276|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
25246797|NCT01227265|50562277|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
25246798|NCT01227265|50562278|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
25246799|NCT01227265|50562276|FG000|Overall Study|Protocol Violation|2|||
25246800|NCT01227265|50562277|FG001|Overall Study|Protocol Violation|1|||
25246801|NCT01227265|50562278|FG002|Overall Study|Protocol Violation|0|||
25246802|NCT01227265|50562276|FG000|Overall Study|Withdrawal by Subject|7|||
25246803|NCT01227265|50562277|FG001|Overall Study|Withdrawal by Subject|7|||
25246804|NCT01227265|50562278|FG002|Overall Study|Withdrawal by Subject|3|||
25246805|NCT01227265|50562276|FG000|Overall Study|Lost to Follow-up|2|||
25246806|NCT01227265|50562277|FG001|Overall Study|Lost to Follow-up|0|||
25246807|NCT01227265|50562278|FG002|Overall Study|Lost to Follow-up|3|||
25246808|NCT01227265|50562276|FG000|Overall Study|Adverse Event|6|||
25246809|NCT01227265|50562277|FG001|Overall Study|Adverse Event|10|||
25246810|NCT01227265|50562278|FG002|Overall Study|Adverse Event|5|||
25246811|NCT01226095|50562286|FG000|Overall Study|Poor compliance|1|||
25246812|NCT01225822|50562302|FG000|Overall Study|Adverse Event|13|||
25246813|NCT01225822|50562303|FG001|Overall Study|Adverse Event|31|||
25246814|NCT01225822|50562304|FG002|Overall Study|Adverse Event|18|||
25246815|NCT01225822|50562305|FG003|Overall Study|Adverse Event|23|||
25246816|NCT01225822|50562306|FG004|Overall Study|Adverse Event|14|||
25326574|NCT00856206|50643023|FG000|Overall Study|Lost to Follow-up|13|||
25326575|NCT00856206|50643024|FG001|Overall Study|Lost to Follow-up|39|||
25326576|NCT00856206|50643023|FG000|Overall Study|Death|2|||
25326577|NCT00856206|50643024|FG001|Overall Study|Death|2|||
25326578|NCT00856206|50643023|FG000|Overall Study|Decision by the Sponsor|4|||
25326579|NCT00856206|50643024|FG001|Overall Study|Decision by the Sponsor|8|||
25326580|NCT00856206|50643023|FG000|Overall Study|Other than specified above|3|||
25326581|NCT00856206|50643024|FG001|Overall Study|Other than specified above|10|||
25326582|NCT00593112|50643032|FG000|Overall Study|Scan Anxiety|3|||
25246817|NCT01225822|50562302|FG000|Overall Study|Protocol Violation|6|||
25246818|NCT01225822|50562303|FG001|Overall Study|Protocol Violation|8|||
25246819|NCT01225822|50562304|FG002|Overall Study|Protocol Violation|6|||
25246820|NCT01225822|50562305|FG003|Overall Study|Protocol Violation|7|||
25246821|NCT01225822|50562306|FG004|Overall Study|Protocol Violation|4|||
25246822|NCT01225822|50562302|FG000|Overall Study|Lost to Follow-up|0|||
25246823|NCT01225822|50562303|FG001|Overall Study|Lost to Follow-up|0|||
25246824|NCT01225822|50562304|FG002|Overall Study|Lost to Follow-up|0|||
25246825|NCT01225822|50562305|FG003|Overall Study|Lost to Follow-up|1|||
25246826|NCT01225822|50562306|FG004|Overall Study|Lost to Follow-up|0|||
25246827|NCT01225822|50562302|FG000|Overall Study|Withdrawal by Subject|6|||
25246828|NCT01225822|50562303|FG001|Overall Study|Withdrawal by Subject|7|||
25246829|NCT01225822|50562304|FG002|Overall Study|Withdrawal by Subject|7|||
25246830|NCT01225822|50562305|FG003|Overall Study|Withdrawal by Subject|11|||
25246831|NCT01225822|50562306|FG004|Overall Study|Withdrawal by Subject|6|||
25246832|NCT01225822|50562302|FG000|Overall Study|Other|13|||
25246833|NCT01225822|50562303|FG001|Overall Study|Other|10|||
25246834|NCT01225822|50562304|FG002|Overall Study|Other|7|||
25246835|NCT01225822|50562305|FG003|Overall Study|Other|10|||
25246836|NCT01225822|50562306|FG004|Overall Study|Other|7|||
25246837|NCT01225549|50562321|FG000|Period 4 - Washout|Disallowed medication|0|||
25246838|NCT01225549|50562322|FG001|Period 4 - Washout|Disallowed medication|1|||
25246839|NCT01225549|50562323|FG002|Period 4 - Washout|Disallowed medication|0|||
25246840|NCT01225549|50562324|FG003|Period 4 - Washout|Disallowed medication|0|||
25246841|NCT01225549|50562325|FG004|Period 4 - Washout|Disallowed medication|0|||
25246842|NCT01225549|50562326|FG005|Period 4 - Washout|Disallowed medication|0|||
25246843|NCT01225549|50562327|FG006|Period 4 - Washout|Disallowed medication|0|||
25246844|NCT01225549|50562328|FG007|Period 4 - Washout|Disallowed medication|0|||
25246845|NCT01225549|50562329|FG008|Period 4 - Washout|Disallowed medication|0|||
25246846|NCT01225549|50562330|FG009|Period 4 - Washout|Disallowed medication|0|||
25246847|NCT01225549|50562321|FG000|Period 6 - Washout|Disallowed medication|0|||
25246848|NCT01225549|50562322|FG001|Period 6 - Washout|Disallowed medication|0|||
25246849|NCT01225549|50562323|FG002|Period 6 - Washout|Disallowed medication|0|||
25246850|NCT01225549|50562324|FG003|Period 6 - Washout|Disallowed medication|1|||
25246851|NCT01225549|50562325|FG004|Period 6 - Washout|Disallowed medication|0|||
25246852|NCT01225549|50562326|FG005|Period 6 - Washout|Disallowed medication|0|||
25246853|NCT01225549|50562327|FG006|Period 6 - Washout|Disallowed medication|0|||
25246854|NCT01225549|50562328|FG007|Period 6 - Washout|Disallowed medication|0|||
25246855|NCT01225549|50562329|FG008|Period 6 - Washout|Disallowed medication|0|||
25246856|NCT01225549|50562330|FG009|Period 6 - Washout|Disallowed medication|0|||
25246857|NCT01225159|50562342|FG000|Overall Study|Change operation|1|||
25246858|NCT01225159|50562343|FG001|Overall Study|Change operation|0|||
25246859|NCT01224925|50562351|FG000|Overall Study|Lost to Follow-up|3|||
25246860|NCT01224925|50562352|FG001|Overall Study|Lost to Follow-up|2|||
25246861|NCT01223404|50562360|FG000|First Intervention (1 Day)|Adverse Event|0|||
25246862|NCT01223404|50562361|FG001|First Intervention (1 Day)|Adverse Event|0|||
25246863|NCT01223404|50562362|FG002|First Intervention (1 Day)|Adverse Event|0|||
25246864|NCT01223404|50562363|FG003|First Intervention (1 Day)|Adverse Event|1|||
25246865|NCT01223404|50562364|FG004|First Intervention (1 Day)|Adverse Event|0|||
25246866|NCT01223404|50562365|FG005|First Intervention (1 Day)|Adverse Event|0|||
25246867|NCT01223404|50562360|FG000|Second Intervention (1 Day)|Adverse Event|1|||
25246868|NCT01223404|50562361|FG001|Second Intervention (1 Day)|Adverse Event|0|||
25246869|NCT01223404|50562362|FG002|Second Intervention (1 Day)|Adverse Event|0|||
25246870|NCT01223404|50562363|FG003|Second Intervention (1 Day)|Adverse Event|0|||
25246871|NCT01223404|50562364|FG004|Second Intervention (1 Day)|Adverse Event|0|||
25246872|NCT01223404|50562365|FG005|Second Intervention (1 Day)|Adverse Event|0|||
25246873|NCT01223404|50562360|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
25246874|NCT01223404|50562361|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
25246875|NCT01223404|50562362|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
25246876|NCT01223404|50562363|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
25246877|NCT01223404|50562364|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
25246878|NCT01223404|50562365|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
25246879|NCT01223365|50562413|FG000|Open-label Titration Period|Enrolled but not treated|1|||
25326583|NCT00593112|50643033|FG001|Overall Study|Scan Anxiety|0|||
25326584|NCT00593112|50643032|FG000|Overall Study|Abnormal Scan|1|||
25326585|NCT00593112|50643033|FG001|Overall Study|Abnormal Scan|0|||
25326586|NCT00593112|50643032|FG000|Overall Study|Unreadable Scan|1|||
25326587|NCT00593112|50643033|FG001|Overall Study|Unreadable Scan|0|||
25246880|NCT01223365|50562413|FG000|Open-label Titration Period|Adverse Event|23|||
25246881|NCT01223365|50562413|FG000|Open-label Titration Period|Lack of Efficacy|3|||
25246882|NCT01223365|50562413|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
25246883|NCT01223365|50562413|FG000|Open-label Titration Period|Protocol Violation|1|||
25246884|NCT01223365|50562413|FG000|Open-label Titration Period|Lost to Follow-up|2|||
25246885|NCT01223365|50562413|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
25246886|NCT01223365|50562413|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
25246887|NCT01223365|50562413|FG000|Open-label Titration Period|Starting physical therapy|1|||
25246888|NCT01223365|50562413|FG000|Open-label Treatment Period|Adverse Event|39|||
25246889|NCT01223365|50562413|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
25326588|NCT00593112|50643032|FG000|Overall Study|Withdrawal by Subject|5|||
25326589|NCT00593112|50643033|FG001|Overall Study|Withdrawal by Subject|0|||
25326590|NCT00491179|50643041|FG000|Overall Study|Adverse Event|5|||
25326591|NCT00491179|50643042|FG001|Overall Study|Adverse Event|1|||
25326592|NCT00491179|50643041|FG000|Overall Study|Withdrawal by Subject|2|||
25326593|NCT00491179|50643042|FG001|Overall Study|Withdrawal by Subject|1|||
25326594|NCT00503581|50643051|FG000|Overall Study|Study closed|3|||
25326595|NCT00503581|50643052|FG001|Overall Study|Study closed|4|||
25326596|NCT00503581|50643053|FG002|Overall Study|Study closed|2|||
25326597|NCT00703534|50643063|FG000|Overall Study|Adverse Event|14|||
25326598|NCT00703534|50643064|FG001|Overall Study|Adverse Event|3|||
25326599|NCT00703534|50643063|FG000|Overall Study|Withdrawal by Subject|8|||
25326600|NCT00703534|50643064|FG001|Overall Study|Withdrawal by Subject|7|||
25326601|NCT00703534|50643063|FG000|Overall Study|Incorrect Enrollment|6|||
25326602|NCT00703534|50643064|FG001|Overall Study|Incorrect Enrollment|6|||
25326603|NCT00703534|50643063|FG000|Overall Study|Lost to Follow-up|1|||
25326604|NCT00703534|50643064|FG001|Overall Study|Lost to Follow-up|4|||
25326605|NCT00703534|50643063|FG000|Overall Study|Severe Non Compliance|1|||
25326606|NCT00703534|50643064|FG001|Overall Study|Severe Non Compliance|5|||
25326607|NCT00503425|50643070|FG000|Overall Study|Participant files lost|6|||
25326608|NCT00503425|50643070|FG000|Overall Study|Adverse Event|5|||
25326609|NCT00503425|50643070|FG000|Overall Study|Lack of Efficacy|25|||
25326610|NCT00503425|50643070|FG000|Overall Study|Withdrawal by Subject|8|||
25326611|NCT00503425|50643070|FG000|Overall Study|Lost to Follow-up|3|||
25326612|NCT00503425|50643070|FG000|Overall Study|Death|3|||
25326613|NCT00503425|50643070|FG000|Overall Study|Missing Data/Unknown|4|||
25326614|NCT00863772|50643078|FG000|Overall Study|Adverse Event|1|||
25326615|NCT00863772|50643079|FG001|Overall Study|Adverse Event|4|||
25326616|NCT00863772|50643080|FG002|Overall Study|Adverse Event|0|||
25326617|NCT00863772|50643078|FG000|Overall Study|Lack of Efficacy|4|||
25326618|NCT00863772|50643079|FG001|Overall Study|Lack of Efficacy|2|||
25326619|NCT00863772|50643080|FG002|Overall Study|Lack of Efficacy|4|||
25326620|NCT00863772|50643078|FG000|Overall Study|Lost to Follow-up|5|||
25326621|NCT00863772|50643079|FG001|Overall Study|Lost to Follow-up|1|||
25326622|NCT00863772|50643080|FG002|Overall Study|Lost to Follow-up|1|||
25326623|NCT00863772|50643078|FG000|Overall Study|Protocol Violation|2|||
25326624|NCT00863772|50643079|FG001|Overall Study|Protocol Violation|0|||
25326625|NCT00863772|50643080|FG002|Overall Study|Protocol Violation|2|||
25326626|NCT00863772|50643078|FG000|Overall Study|Withdrawal by Subject|4|||
25326627|NCT00863772|50643079|FG001|Overall Study|Withdrawal by Subject|7|||
25326628|NCT00863772|50643080|FG002|Overall Study|Withdrawal by Subject|5|||
25326629|NCT00863772|50643078|FG000|Overall Study|Study terminated by sponsor|44|||
25326630|NCT00863772|50643079|FG001|Overall Study|Study terminated by sponsor|45|||
25326631|NCT00863772|50643080|FG002|Overall Study|Study terminated by sponsor|36|||
25326632|NCT00863772|50643078|FG000|Overall Study|Entered extension study|6|||
25326633|NCT00863772|50643079|FG001|Overall Study|Entered extension study|4|||
25326634|NCT00863772|50643080|FG002|Overall Study|Entered extension study|9|||
25326635|NCT00863772|50643078|FG000|Overall Study|Other|1|||
25326636|NCT00863772|50643079|FG001|Overall Study|Other|2|||
25326637|NCT00863772|50643080|FG002|Overall Study|Other|4|||
25326638|NCT00863772|50643078|FG000|Overall Study|Randomized but not Treated|1|||
25326639|NCT00863772|50643079|FG001|Overall Study|Randomized but not Treated|0|||
25326640|NCT00863772|50643080|FG002|Overall Study|Randomized but not Treated|0|||
25326641|NCT00502801|50643088|FG000|Treatment Period|Withdrawal by Subject|3|||
25326642|NCT00502801|50643088|FG000|Treatment Period|Adverse Event|7|||
25326643|NCT00502801|50643088|FG000|Treatment Period|Death|14|||
25326644|NCT00502801|50643088|FG000|Treatment Period|OTHER|30|||
25326645|NCT00502801|50643088|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
25326646|NCT00502801|50643088|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
25326647|NCT00502801|50643088|FG000|End of Therapy to Test of Cure|Death|3|||
25326648|NCT00502801|50643088|FG000|End of Therapy to Test of Cure|OTHER|2|||
25326649|NCT00824265|50643094|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
25326650|NCT00824265|50643095|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
25326651|NCT00824265|50643094|FG000|Treatment Phase|Protocol Violation|1|||
25326652|NCT00824265|50643095|FG001|Treatment Phase|Protocol Violation|0|||
25326653|NCT00824265|50643094|FG000|Treatment Phase|Lost to Follow-up|1|||
25326654|NCT00824265|50643095|FG001|Treatment Phase|Lost to Follow-up|1|||
25326655|NCT00824265|50643094|FG000|Treatment Phase|Physician Decision|6|||
25326656|NCT00824265|50643095|FG001|Treatment Phase|Physician Decision|12|||
25326657|NCT00824265|50643094|FG000|Treatment Phase|Withdrawal by Subject|6|||
25326658|NCT00824265|50643095|FG001|Treatment Phase|Withdrawal by Subject|15|||
25326659|NCT00824265|50643094|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
25326660|NCT00824265|50643095|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
25326661|NCT00824265|50643094|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
25326662|NCT00824265|50643095|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
25326663|NCT00855894|50643105|FG000|Overall Study|Death|31|||
25326664|NCT00855894|50643105|FG000|Overall Study|Patient's decision|1|||
25326665|NCT00855894|50643105|FG000|Overall Study|Disease progression|1|||
25326666|NCT00855816|50643111|FG000|Overall Study|Withdrawal by Subject|22|||
25326667|NCT00855816|50643112|FG001|Overall Study|Withdrawal by Subject|15|||
25326668|NCT00855816|50643111|FG000|Overall Study|Lost to Follow-up|3|||
25326669|NCT00855816|50643112|FG001|Overall Study|Lost to Follow-up|5|||
25326670|NCT00855816|50643111|FG000|Overall Study|Death|1|||
25326671|NCT00855816|50643112|FG001|Overall Study|Death|0|||
25326672|NCT00855816|50643111|FG000|Overall Study|Became ineligible|0|||
25326673|NCT00855816|50643112|FG001|Overall Study|Became ineligible|1|||
25326674|NCT00855738|50643118|FG000|Overall Study|Lost to Follow-up|2|||
25326675|NCT00855738|50643118|FG000|Overall Study|Adverse Event|1|||
25326676|NCT00855738|50643118|FG000|Overall Study|Subject Defaulted|1|||
25326677|NCT00855738|50643118|FG000|Overall Study|Death|1|||
25326678|NCT00490945|50643129|FG000|Overall Study|Adverse Event|0|||
25326679|NCT00490945|50643130|FG001|Overall Study|Adverse Event|1|||
25326680|NCT00490945|50643131|FG002|Overall Study|Adverse Event|0|||
25326681|NCT00490945|50643132|FG003|Overall Study|Adverse Event|0|||
25326682|NCT00490945|50643133|FG004|Overall Study|Adverse Event|0|||
25326683|NCT00879398|50643151|FG000|Overall Study|Visit Stop|399|||
25326684|NCT00879398|50643151|FG000|Overall Study|Lack of Efficacy|64|||
25326685|NCT00879398|50643151|FG000|Overall Study|Adverse Event|41|||
25326686|NCT00879398|50643151|FG000|Overall Study|Other Reasons|171|||
25326687|NCT00696436|50643160|FG000|Overall Study|Adverse Event|7|||
25326688|NCT00696436|50643161|FG001|Overall Study|Adverse Event|9|||
25326689|NCT00696436|50643162|FG002|Overall Study|Adverse Event|8|||
25246890|NCT01223365|50562413|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
25246891|NCT01223365|50562413|FG000|Open-label Treatment Period|Protocol Violation|15|||
25246892|NCT01223365|50562413|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
25246893|NCT01223365|50562413|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
25246894|NCT01223365|50562413|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
25246895|NCT01223365|50562413|FG000|Open-label Treatment Period|Moved out of area|2|||
25326690|NCT00696436|50643163|FG003|Overall Study|Adverse Event|6|||
25326691|NCT00696436|50643164|FG004|Overall Study|Adverse Event|4|||
25326692|NCT00696436|50643160|FG000|Overall Study|Protocol Violation|3|||
25326693|NCT00696436|50643161|FG001|Overall Study|Protocol Violation|2|||
25326694|NCT00696436|50643162|FG002|Overall Study|Protocol Violation|2|||
25326695|NCT00696436|50643163|FG003|Overall Study|Protocol Violation|0|||
25326696|NCT00696436|50643164|FG004|Overall Study|Protocol Violation|1|||
25326697|NCT00696436|50643160|FG000|Overall Study|Lost to Follow-up|1|||
25326698|NCT00696436|50643161|FG001|Overall Study|Lost to Follow-up|6|||
25326699|NCT00696436|50643162|FG002|Overall Study|Lost to Follow-up|2|||
25326700|NCT00696436|50643163|FG003|Overall Study|Lost to Follow-up|4|||
25326701|NCT00696436|50643164|FG004|Overall Study|Lost to Follow-up|3|||
25326702|NCT00696436|50643160|FG000|Overall Study|Withdrawal by Subject|4|||
25326703|NCT00696436|50643161|FG001|Overall Study|Withdrawal by Subject|11|||
25326704|NCT00696436|50643162|FG002|Overall Study|Withdrawal by Subject|5|||
25326705|NCT00696436|50643163|FG003|Overall Study|Withdrawal by Subject|7|||
25326706|NCT00696436|50643164|FG004|Overall Study|Withdrawal by Subject|1|||
25326707|NCT00696436|50643160|FG000|Overall Study|Lack of Efficacy|3|||
25326708|NCT00696436|50643161|FG001|Overall Study|Lack of Efficacy|1|||
25326709|NCT00696436|50643162|FG002|Overall Study|Lack of Efficacy|5|||
25326710|NCT00696436|50643163|FG003|Overall Study|Lack of Efficacy|2|||
25326711|NCT00696436|50643164|FG004|Overall Study|Lack of Efficacy|4|||
25326712|NCT00696436|50643160|FG000|Overall Study|Participant Unavailability|2|||
25326713|NCT00696436|50643161|FG001|Overall Study|Participant Unavailability|0|||
25326714|NCT00696436|50643162|FG002|Overall Study|Participant Unavailability|2|||
25326715|NCT00696436|50643163|FG003|Overall Study|Participant Unavailability|1|||
25326716|NCT00696436|50643164|FG004|Overall Study|Participant Unavailability|0|||
25326717|NCT00696436|50643160|FG000|Overall Study|Administrative Error|2|||
25326718|NCT00696436|50643161|FG001|Overall Study|Administrative Error|0|||
25326719|NCT00696436|50643162|FG002|Overall Study|Administrative Error|2|||
25326720|NCT00696436|50643163|FG003|Overall Study|Administrative Error|0|||
25326721|NCT00696436|50643164|FG004|Overall Study|Administrative Error|0|||
25246896|NCT01223365|50562413|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
25246897|NCT01223365|50562413|FG000|Open-label Treatment Period|"Out of window"|1|||
25326722|NCT00696436|50643160|FG000|Overall Study|Participant Non-compliance|0|||
25326723|NCT00696436|50643161|FG001|Overall Study|Participant Non-compliance|0|||
25326724|NCT00696436|50643162|FG002|Overall Study|Participant Non-compliance|1|||
25326725|NCT00696436|50643163|FG003|Overall Study|Participant Non-compliance|2|||
25326726|NCT00696436|50643164|FG004|Overall Study|Participant Non-compliance|0|||
25326727|NCT00696436|50643160|FG000|Overall Study|Administrative Decision|1|||
25326728|NCT00696436|50643161|FG001|Overall Study|Administrative Decision|0|||
25326729|NCT00696436|50643162|FG002|Overall Study|Administrative Decision|0|||
25246898|NCT01223365|50562413|FG000|Open-label Treatment Period|Starting physical therapy|1|||
25246899|NCT01223365|50562413|FG000|Open-label Treatment Period|Physician Decision|2|||
25246900|NCT01222507|50562422|FG000|Overall Study|Physician Decision|1|||
25246901|NCT01222507|50562422|FG000|Overall Study|Withdrawal by Subject|1|||
25246902|NCT01222078|50562426|FG000|Overall Study|Early termination of the study|1|||
25246903|NCT01221727|50562433|FG000|Overall Study|Physician Decision|2|||
25246904|NCT01221727|50562434|FG001|Overall Study|Physician Decision|0|||
25246905|NCT01221727|50562433|FG000|Overall Study|Withdrawal by Subject|1|||
25246906|NCT01221727|50562434|FG001|Overall Study|Withdrawal by Subject|1|||
25246907|NCT01221181|50562446|FG000|Overall Study|Lost to Follow-up|1|||
25246908|NCT01220557|50562452|FG000|Overall Study|Lost to Follow-up|5|||
25246909|NCT01220557|50562453|FG001|Overall Study|Lost to Follow-up|3|||
25246910|NCT01220557|50562452|FG000|Overall Study|attended less than 6 lessons|1|||
25246911|NCT01220557|50562453|FG001|Overall Study|attended less than 6 lessons|2|||
25246912|NCT01220401|50562459|FG000|Overall Study|Withdrawal by Subject|2|||
25246913|NCT01220401|50562459|FG000|Overall Study|Protocol Violation|1|||
25246914|NCT01220167|50562466|FG000|Period 3|Urine positive for substance abuse|0|||
25246915|NCT01220167|50562467|FG001|Period 3|Urine positive for substance abuse|1|||
25246916|NCT01220167|50562468|FG002|Period 3|Urine positive for substance abuse|0|||
25246917|NCT01220128|50562481|FG000|Overall Study|Progressive disease|0|||
25246918|NCT01220128|50562482|FG001|Overall Study|Progressive disease|0|||
25246919|NCT01220128|50562483|FG002|Overall Study|Progressive disease|2|||
25246920|NCT01220128|50562484|FG003|Overall Study|Progressive disease|0|||
25246921|NCT01220128|50562485|FG004|Overall Study|Progressive disease|0|||
25246922|NCT01220128|50562486|FG005|Overall Study|Progressive disease|0|||
25326730|NCT00696436|50643163|FG003|Overall Study|Administrative Decision|0|||
25326731|NCT00696436|50643164|FG004|Overall Study|Administrative Decision|0|||
25326732|NCT00696436|50643160|FG000|Overall Study|Missing|0|||
25326733|NCT00696436|50643161|FG001|Overall Study|Missing|1|||
25326734|NCT00696436|50643162|FG002|Overall Study|Missing|1|||
25326735|NCT00696436|50643163|FG003|Overall Study|Missing|0|||
25326736|NCT00696436|50643164|FG004|Overall Study|Missing|0|||
25326737|NCT00878072|50643176|FG000|Overall Study|Withdrew consent|2|||
25326738|NCT00594854|50643204|FG000|Overall Study|Study terminated|7|||
25326739|NCT00594854|50643205|FG001|Overall Study|Study terminated|10|||
24977241|NCT03410992|50065850|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
24977242|NCT03410992|50065851|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
25246923|NCT01220128|50562487|FG006|Overall Study|Progressive disease|0|||
25246924|NCT01220128|50562481|FG000|Overall Study|Sponsor study termination|0|||
25326740|NCT00855582|50643214|FG000|Overall Study|Adverse Event|2|||
25326741|NCT00855582|50643215|FG001|Overall Study|Adverse Event|6|||
25246925|NCT01220128|50562482|FG001|Overall Study|Sponsor study termination|1|||
25246926|NCT01220128|50562483|FG002|Overall Study|Sponsor study termination|0|||
25326742|NCT00855582|50643216|FG002|Overall Study|Adverse Event|3|||
25326743|NCT00855582|50643214|FG000|Overall Study|Death|1|||
25326744|NCT00855582|50643215|FG001|Overall Study|Death|0|||
25326745|NCT00855582|50643216|FG002|Overall Study|Death|0|||
25326746|NCT00855582|50643214|FG000|Overall Study|Lack of Efficacy|1|||
25326747|NCT00855582|50643215|FG001|Overall Study|Lack of Efficacy|3|||
25326748|NCT00855582|50643216|FG002|Overall Study|Lack of Efficacy|8|||
25326749|NCT00855582|50643214|FG000|Overall Study|Lost to Follow-up|1|||
25326750|NCT00855582|50643215|FG001|Overall Study|Lost to Follow-up|3|||
25326751|NCT00855582|50643216|FG002|Overall Study|Lost to Follow-up|1|||
25326752|NCT00855582|50643214|FG000|Overall Study|Physician Decision|0|||
25326753|NCT00855582|50643215|FG001|Overall Study|Physician Decision|0|||
25326754|NCT00855582|50643216|FG002|Overall Study|Physician Decision|1|||
25326755|NCT00855582|50643214|FG000|Overall Study|Protocol Violation|6|||
25326756|NCT00855582|50643215|FG001|Overall Study|Protocol Violation|2|||
25326757|NCT00855582|50643216|FG002|Overall Study|Protocol Violation|6|||
25326758|NCT00855582|50643214|FG000|Overall Study|Entry Criteria Not Met|8|||
25246927|NCT01220128|50562484|FG003|Overall Study|Sponsor study termination|0|||
25246928|NCT01220128|50562485|FG004|Overall Study|Sponsor study termination|0|||
25246929|NCT01220128|50562486|FG005|Overall Study|Sponsor study termination|0|||
25246930|NCT01220128|50562487|FG006|Overall Study|Sponsor study termination|1|||
25326759|NCT00855582|50643215|FG001|Overall Study|Entry Criteria Not Met|6|||
25326760|NCT00855582|50643216|FG002|Overall Study|Entry Criteria Not Met|3|||
25326761|NCT00855582|50643214|FG000|Overall Study|Withdrawal by Subject|7|||
25246931|NCT01220128|50562481|FG000|Overall Study|Adverse event, serious fatal|2|||
25246932|NCT01220128|50562482|FG001|Overall Study|Adverse event, serious fatal|0|||
25246933|NCT01220128|50562483|FG002|Overall Study|Adverse event, serious fatal|0|||
25246934|NCT01220128|50562484|FG003|Overall Study|Adverse event, serious fatal|0|||
25246935|NCT01220128|50562485|FG004|Overall Study|Adverse event, serious fatal|0|||
25246936|NCT01220128|50562486|FG005|Overall Study|Adverse event, serious fatal|0|||
25246937|NCT01220128|50562487|FG006|Overall Study|Adverse event, serious fatal|1|||
25246938|NCT01220128|50562481|FG000|Overall Study|Adverse event, non-fatal|1|||
25326762|NCT00855582|50643215|FG001|Overall Study|Withdrawal by Subject|4|||
25326763|NCT00855582|50643216|FG002|Overall Study|Withdrawal by Subject|8|||
25326764|NCT00854724|50643229|FG000|First Intervention|Withdrawal by Subject|1|||
25326765|NCT00854724|50643230|FG001|First Intervention|Withdrawal by Subject|1|||
25326766|NCT00854724|50643229|FG000|Washout|Protocol Violation|1|||
25326767|NCT00854724|50643230|FG001|Washout|Protocol Violation|0|||
25326768|NCT00854724|50643229|FG000|Washout|Withdrawal by Subject|0|||
25326769|NCT00854724|50643230|FG001|Washout|Withdrawal by Subject|1|||
25326770|NCT00854724|50643229|FG000|Second Intervention|Protocol Violation|1|||
25326771|NCT00854724|50643230|FG001|Second Intervention|Protocol Violation|0|||
25326772|NCT00854724|50643229|FG000|Second Intervention|Physician Decision|0|||
25326773|NCT00854724|50643230|FG001|Second Intervention|Physician Decision|1|||
25326774|NCT00698932|50643268|FG000|Overall Study|Adverse Event|0|||
25326775|NCT00698932|50643269|FG001|Overall Study|Adverse Event|2|||
25326776|NCT00698932|50643268|FG000|Overall Study|Incorrect enrollment|0|||
25326777|NCT00698932|50643269|FG001|Overall Study|Incorrect enrollment|2|||
25326778|NCT00698932|50643268|FG000|Overall Study|Study specific discontinuation criteria|3|||
25326779|NCT00698932|50643269|FG001|Overall Study|Study specific discontinuation criteria|4|||
25326780|NCT00698932|50643268|FG000|Overall Study|Withdrawal by Subject|11|||
25326781|NCT00698932|50643269|FG001|Overall Study|Withdrawal by Subject|23|||
25326782|NCT00698932|50643268|FG000|Overall Study|Lost to Follow-up|6|||
25326783|NCT00698932|50643269|FG001|Overall Study|Lost to Follow-up|1|||
25326784|NCT00698932|50643268|FG000|Overall Study|Severe non-compliance to protocol|1|||
25326785|NCT00698932|50643269|FG001|Overall Study|Severe non-compliance to protocol|2|||
25326786|NCT00698932|50643268|FG000|Overall Study|Safety reasons|0|||
25326787|NCT00698932|50643269|FG001|Overall Study|Safety reasons|2|||
25326788|NCT00698932|50643268|FG000|Overall Study|Death|1|||
25326789|NCT00698932|50643269|FG001|Overall Study|Death|0|||
25326790|NCT00823719|50643277|FG000|Overall Study|Adverse Event|1|||
25326791|NCT00823719|50643278|FG001|Overall Study|Adverse Event|2|||
25326792|NCT00823719|50643277|FG000|Overall Study|Physician Decision|1|||
25326793|NCT00823719|50643278|FG001|Overall Study|Physician Decision|4|||
25326794|NCT00823719|50643277|FG000|Overall Study|Withdrawal by Subject|0|||
25326795|NCT00823719|50643278|FG001|Overall Study|Withdrawal by Subject|1|||
25326796|NCT00823719|50643277|FG000|Overall Study|Disease Progression|4|||
25326797|NCT00823719|50643278|FG001|Overall Study|Disease Progression|4|||
25326798|NCT00875420|50643291|FG000|Overall Study|Adverse Event|0|||
25326799|NCT00875420|50643292|FG001|Overall Study|Adverse Event|1|||
25326800|NCT00875420|50643293|FG002|Overall Study|Adverse Event|1|||
25326801|NCT00875420|50643294|FG003|Overall Study|Adverse Event|0|||
25326802|NCT00875420|50643295|FG004|Overall Study|Adverse Event|0|||
25326803|NCT00875420|50643291|FG000|Overall Study|Inability to complete study procedures|1|||
25326804|NCT00875420|50643292|FG001|Overall Study|Inability to complete study procedures|0|||
25326805|NCT00875420|50643293|FG002|Overall Study|Inability to complete study procedures|1|||
25326806|NCT00875420|50643294|FG003|Overall Study|Inability to complete study procedures|1|||
25326807|NCT00875420|50643295|FG004|Overall Study|Inability to complete study procedures|1|||
25326808|NCT00875420|50643291|FG000|Overall Study|Lost to Follow-up|1|||
25326809|NCT00875420|50643292|FG001|Overall Study|Lost to Follow-up|0|||
25326810|NCT00875420|50643293|FG002|Overall Study|Lost to Follow-up|0|||
25326811|NCT00875420|50643294|FG003|Overall Study|Lost to Follow-up|0|||
25326812|NCT00875420|50643295|FG004|Overall Study|Lost to Follow-up|0|||
25326813|NCT00875420|50643291|FG000|Overall Study|Personal reason|0|||
25326814|NCT00875420|50643292|FG001|Overall Study|Personal reason|0|||
25326815|NCT00875420|50643293|FG002|Overall Study|Personal reason|0|||
25326816|NCT00875420|50643294|FG003|Overall Study|Personal reason|0|||
25326817|NCT00875420|50643295|FG004|Overall Study|Personal reason|1|||
25326818|NCT00875420|50643291|FG000|Overall Study|Prohibited medication|0|||
25246939|NCT01220128|50562482|FG001|Overall Study|Adverse event, non-fatal|0|||
25246940|NCT01220128|50562483|FG002|Overall Study|Adverse event, non-fatal|0|||
25246941|NCT01220128|50562484|FG003|Overall Study|Adverse event, non-fatal|0|||
25246942|NCT01220128|50562485|FG004|Overall Study|Adverse event, non-fatal|0|||
25246943|NCT01220128|50562486|FG005|Overall Study|Adverse event, non-fatal|0|||
25246944|NCT01220128|50562487|FG006|Overall Study|Adverse event, non-fatal|3|||
25246945|NCT01220128|50562481|FG000|Overall Study|Other|0|||
25246946|NCT01220128|50562482|FG001|Overall Study|Other|0|||
25246947|NCT01220128|50562483|FG002|Overall Study|Other|1|||
25246948|NCT01220128|50562484|FG003|Overall Study|Other|0|||
25326819|NCT00875420|50643292|FG001|Overall Study|Prohibited medication|0|||
25326820|NCT00875420|50643293|FG002|Overall Study|Prohibited medication|0|||
25326821|NCT00875420|50643294|FG003|Overall Study|Prohibited medication|1|||
25326822|NCT00875420|50643295|FG004|Overall Study|Prohibited medication|0|||
25326823|NCT00875420|50643291|FG000|Overall Study|Sponsor decision|0|||
25326824|NCT00875420|50643292|FG001|Overall Study|Sponsor decision|1|||
25326825|NCT00875420|50643293|FG002|Overall Study|Sponsor decision|0|||
25326826|NCT00875420|50643294|FG003|Overall Study|Sponsor decision|0|||
25326827|NCT00875420|50643295|FG004|Overall Study|Sponsor decision|0|||
25326828|NCT00875420|50643291|FG000|Overall Study|Withdrawal by Subject|0|||
25326829|NCT00875420|50643292|FG001|Overall Study|Withdrawal by Subject|0|||
25246949|NCT01220128|50562485|FG004|Overall Study|Other|0|||
25326830|NCT00875420|50643293|FG002|Overall Study|Withdrawal by Subject|1|||
25326831|NCT00875420|50643294|FG003|Overall Study|Withdrawal by Subject|0|||
25326832|NCT00875420|50643295|FG004|Overall Study|Withdrawal by Subject|0|||
25326833|NCT00822237|50643309|FG000|Dose 1 Vaccination|Not vaccinated|3|||
25326834|NCT00822237|50643310|FG001|Dose 1 Vaccination|Not vaccinated|0|||
25326835|NCT00822237|50643309|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
25326836|NCT00822237|50643310|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
25326837|NCT00822237|50643309|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
25326838|NCT00822237|50643310|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
25326839|NCT00822237|50643309|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
25326840|NCT00822237|50643310|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
25326841|NCT00822237|50643309|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
25326842|NCT00822237|50643310|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
25326843|NCT00577096|50643317|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
25326844|NCT00577096|50643318|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
25326845|NCT00577096|50643317|FG000|Short Term Participation|Withdrawal by Subject|3|||
25326846|NCT00577096|50643318|FG001|Short Term Participation|Withdrawal by Subject|5|||
25326847|NCT00577096|50643317|FG000|Short Term Participation|Death|1|||
25326848|NCT00577096|50643318|FG001|Short Term Participation|Death|1|||
25326849|NCT00863304|50643328|FG000|Overall Study|Adverse Event|10|||
25326850|NCT00863304|50643329|FG001|Overall Study|Adverse Event|4|||
25326851|NCT00863304|50643330|FG002|Overall Study|Adverse Event|14|||
25326852|NCT00863304|50643331|FG003|Overall Study|Adverse Event|16|||
25326853|NCT00863304|50643328|FG000|Overall Study|Lost to Follow-up|1|||
25326854|NCT00863304|50643329|FG001|Overall Study|Lost to Follow-up|5|||
25326855|NCT00863304|50643330|FG002|Overall Study|Lost to Follow-up|4|||
25326856|NCT00863304|50643331|FG003|Overall Study|Lost to Follow-up|2|||
25326857|NCT00863304|50643328|FG000|Overall Study|Lack of Efficacy|57|||
25326858|NCT00863304|50643329|FG001|Overall Study|Lack of Efficacy|26|||
25326859|NCT00863304|50643330|FG002|Overall Study|Lack of Efficacy|30|||
25326860|NCT00863304|50643331|FG003|Overall Study|Lack of Efficacy|28|||
25326861|NCT00863304|50643328|FG000|Overall Study|Withdrawal by Subject|19|||
25326862|NCT00863304|50643329|FG001|Overall Study|Withdrawal by Subject|14|||
25326863|NCT00863304|50643330|FG002|Overall Study|Withdrawal by Subject|20|||
25326864|NCT00863304|50643331|FG003|Overall Study|Withdrawal by Subject|18|||
25326865|NCT00863304|50643328|FG000|Overall Study|Other|1|||
25326866|NCT00863304|50643329|FG001|Overall Study|Other|0|||
25326867|NCT00863304|50643330|FG002|Overall Study|Other|0|||
25326868|NCT00863304|50643331|FG003|Overall Study|Other|1|||
25326869|NCT00863304|50643328|FG000|Overall Study|Protocol Violation|2|||
25326870|NCT00863304|50643329|FG001|Overall Study|Protocol Violation|6|||
25326871|NCT00863304|50643330|FG002|Overall Study|Protocol Violation|2|||
25326872|NCT00863304|50643331|FG003|Overall Study|Protocol Violation|0|||
25326873|NCT00863304|50643328|FG000|Overall Study|Randomized, but not Treated|3|||
25326874|NCT00863304|50643329|FG001|Overall Study|Randomized, but not Treated|1|||
25326875|NCT00863304|50643330|FG002|Overall Study|Randomized, but not Treated|4|||
25326876|NCT00863304|50643331|FG003|Overall Study|Randomized, but not Treated|1|||
25246950|NCT01220128|50562486|FG005|Overall Study|Other|0|||
25246951|NCT01220128|50562487|FG006|Overall Study|Other|0|||
25246952|NCT01220128|50562481|FG000|Overall Study|Consent withdrawn by subject|1|||
25246953|NCT01220128|50562482|FG001|Overall Study|Consent withdrawn by subject|0|||
25246954|NCT01220128|50562483|FG002|Overall Study|Consent withdrawn by subject|0|||
25246955|NCT01220128|50562484|FG003|Overall Study|Consent withdrawn by subject|0|||
25246956|NCT01220128|50562485|FG004|Overall Study|Consent withdrawn by subject|0|||
25246957|NCT01220128|50562486|FG005|Overall Study|Consent withdrawn by subject|0|||
25246958|NCT01220128|50562487|FG006|Overall Study|Consent withdrawn by subject|0|||
25246959|NCT01219933|50562504|FG000|Overall Study|Adverse Event|8|||
25246960|NCT01219933|50562504|FG000|Overall Study|No LDA reached|5|||
25246961|NCT01219933|50562504|FG000|Overall Study|No LDA maintained|7|||
25246962|NCT01219933|50562504|FG000|Overall Study|Lost to Follow-up|3|||
25246963|NCT01219933|50562504|FG000|Overall Study|GC free|1|||
25246964|NCT01219933|50562504|FG000|Overall Study|Withdrawal by Subject|5|||
25246965|NCT01219933|50562504|FG000|Overall Study|Protocol Violation|8|||
25246966|NCT01219933|50562504|FG000|Overall Study|Lack of Efficacy|1|||
25246967|NCT01218802|50562511|FG000|Overall Study|Lost to Follow-up|5|||
25246968|NCT01218802|50562512|FG001|Overall Study|Lost to Follow-up|6|||
25326877|NCT00863304|50643328|FG000|Overall Study|Entered extension study|101|||
25326878|NCT00863304|50643329|FG001|Overall Study|Entered extension study|129|||
25326879|NCT00863304|50643330|FG002|Overall Study|Entered extension study|113|||
25326880|NCT00863304|50643331|FG003|Overall Study|Entered extension study|125|||
25326881|NCT00695110|50643343|FG000|Treatment Period 1|Adverse Event|1|||
25326882|NCT00695110|50643343|FG000|Treatment Period 1|Withdrawal by Subject|2|||
25326883|NCT00695110|50643343|FG000|Treatment Period 3|Withdrawal by Subject|1|||
25326884|NCT00695110|50643343|FG000|Treatment Period 4|Adverse Event|1|||
25326885|NCT00594386|50643350|FG000|Overall Study|Major protocol violation|2|||
25326886|NCT00594386|50643350|FG000|Overall Study|Lack of Efficacy|12|||
25326887|NCT00594386|50643350|FG000|Overall Study|Adverse Event|68|||
25326888|NCT00594386|50643350|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
25326889|NCT00594386|50643350|FG000|Overall Study|Subject withdrew consent|35|||
25326890|NCT00594386|50643350|FG000|Overall Study|Study ended per sponsor|115|||
25326891|NCT00594386|50643350|FG000|Overall Study|Lost to Follow-up|6|||
25326892|NCT00594386|50643350|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
25326893|NCT00594386|50643350|FG000|Overall Study|Other: Subject moved to Seattle|1|||
25326894|NCT00594386|50643350|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
25326895|NCT00594386|50643350|FG000|Overall Study|Other: Study terminated per investigator|2|||
25326896|NCT00594386|50643350|FG000|Overall Study|Other: Sponsor closure of study|1|||
25326897|NCT00594386|50643350|FG000|Overall Study|Other: Site terminated participation|1|||
25326898|NCT00594386|50643350|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
25326899|NCT00594386|50643350|FG000|Overall Study|Other: Loss of drivers license|1|||
25326900|NCT00862992|50643357|FG000|Overall Study|Adverse Event|2|||
25326901|NCT00862992|50643358|FG001|Overall Study|Adverse Event|1|||
25326902|NCT00862992|50643359|FG002|Overall Study|Adverse Event|1|||
25326903|NCT00862992|50643357|FG000|Overall Study|Physician Decision|1|||
25326904|NCT00862992|50643358|FG001|Overall Study|Physician Decision|0|||
25326905|NCT00862992|50643359|FG002|Overall Study|Physician Decision|0|||
25326906|NCT00862992|50643357|FG000|Overall Study|Withdrawal by Subject|0|||
25326907|NCT00862992|50643358|FG001|Overall Study|Withdrawal by Subject|0|||
25326908|NCT00862992|50643359|FG002|Overall Study|Withdrawal by Subject|2|||
25326909|NCT00694096|50643367|FG000|Overall Study|Withdrawal by Subject|5|||
25326910|NCT00854100|50643374|FG000|Overall Study|Inability to complete the study visits|0|||
25326911|NCT00854100|50643375|FG001|Overall Study|Inability to complete the study visits|0|||
25326912|NCT00854100|50643376|FG002|Overall Study|Inability to complete the study visits|1|||
25326913|NCT00854100|50643374|FG000|Overall Study|Lost to Follow-up|2|||
25326914|NCT00854100|50643375|FG001|Overall Study|Lost to Follow-up|0|||
25326915|NCT00854100|50643376|FG002|Overall Study|Lost to Follow-up|3|||
25326916|NCT00854100|50643374|FG000|Overall Study|Withdrawal by Subject|3|||
25326917|NCT00854100|50643375|FG001|Overall Study|Withdrawal by Subject|1|||
25326918|NCT00854100|50643376|FG002|Overall Study|Withdrawal by Subject|2|||
25326919|NCT00854100|50643374|FG000|Overall Study|Protocol Violation|2|||
25326920|NCT00854100|50643375|FG001|Overall Study|Protocol Violation|4|||
25326921|NCT00854100|50643376|FG002|Overall Study|Protocol Violation|3|||
25326922|NCT00854100|50643374|FG000|Overall Study|Adverse Event|2|||
25326923|NCT00854100|50643375|FG001|Overall Study|Adverse Event|1|||
25326924|NCT00854100|50643376|FG002|Overall Study|Adverse Event|2|||
25326925|NCT00509899|50643393|FG000|Overall Study|Progressive disease|1|||
25326926|NCT00509899|50643394|FG001|Overall Study|Progressive disease|3|||
25326927|NCT00509899|50643395|FG002|Overall Study|Progressive disease|5|||
25326928|NCT00509899|50643396|FG003|Overall Study|Progressive disease|1|||
25326929|NCT00509899|50643397|FG004|Overall Study|Progressive disease|0|||
25326930|NCT00509899|50643398|FG005|Overall Study|Progressive disease|1|||
25326931|NCT00509899|50643399|FG006|Overall Study|Progressive disease|0|||
25326932|NCT00509899|50643400|FG007|Overall Study|Progressive disease|0|||
25326933|NCT00509899|50643393|FG000|Overall Study|Unacceptable Toxicity|1|||
25326934|NCT00509899|50643394|FG001|Overall Study|Unacceptable Toxicity|0|||
25326935|NCT00509899|50643395|FG002|Overall Study|Unacceptable Toxicity|0|||
25326936|NCT00509899|50643396|FG003|Overall Study|Unacceptable Toxicity|2|||
25326937|NCT00509899|50643397|FG004|Overall Study|Unacceptable Toxicity|0|||
25326938|NCT00509899|50643398|FG005|Overall Study|Unacceptable Toxicity|0|||
24977243|NCT03410992|50065852|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
24977244|NCT03410992|50065853|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
24977245|NCT03410992|50065854|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
24977246|NCT03410992|50065855|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
24977247|NCT03410992|50065845|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
25077780|NCT03318523|50185670|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
25077781|NCT03318523|50185671|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
25077782|NCT03318523|50185672|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
25326939|NCT00509899|50643399|FG006|Overall Study|Unacceptable Toxicity|0|||
25326940|NCT00509899|50643400|FG007|Overall Study|Unacceptable Toxicity|0|||
25326941|NCT00509899|50643393|FG000|Overall Study|Withdrawal by Subject|6|||
25326942|NCT00509899|50643394|FG001|Overall Study|Withdrawal by Subject|2|||
25326943|NCT00509899|50643395|FG002|Overall Study|Withdrawal by Subject|3|||
25326944|NCT00509899|50643396|FG003|Overall Study|Withdrawal by Subject|0|||
25326945|NCT00509899|50643397|FG004|Overall Study|Withdrawal by Subject|3|||
25326946|NCT00509899|50643398|FG005|Overall Study|Withdrawal by Subject|2|||
25326947|NCT00509899|50643399|FG006|Overall Study|Withdrawal by Subject|0|||
25326948|NCT00509899|50643400|FG007|Overall Study|Withdrawal by Subject|0|||
25326949|NCT00509899|50643393|FG000|Overall Study|Physician Decision|4|||
25326950|NCT00509899|50643394|FG001|Overall Study|Physician Decision|2|||
25326951|NCT00509899|50643395|FG002|Overall Study|Physician Decision|7|||
25326952|NCT00509899|50643396|FG003|Overall Study|Physician Decision|0|||
25326953|NCT00509899|50643397|FG004|Overall Study|Physician Decision|1|||
25326954|NCT00509899|50643398|FG005|Overall Study|Physician Decision|4|||
25326955|NCT00509899|50643399|FG006|Overall Study|Physician Decision|0|||
25326956|NCT00509899|50643400|FG007|Overall Study|Physician Decision|0|||
25326957|NCT00509899|50643393|FG000|Overall Study|Intercurrent Illness|1|||
25326958|NCT00509899|50643394|FG001|Overall Study|Intercurrent Illness|0|||
25326959|NCT00509899|50643395|FG002|Overall Study|Intercurrent Illness|0|||
25326960|NCT00509899|50643396|FG003|Overall Study|Intercurrent Illness|1|||
25326961|NCT00509899|50643397|FG004|Overall Study|Intercurrent Illness|0|||
25326962|NCT00509899|50643398|FG005|Overall Study|Intercurrent Illness|1|||
25326963|NCT00509899|50643399|FG006|Overall Study|Intercurrent Illness|0|||
25326964|NCT00509899|50643400|FG007|Overall Study|Intercurrent Illness|0|||
25326965|NCT00509899|50643393|FG000|Overall Study|Death|2|||
25326966|NCT00509899|50643394|FG001|Overall Study|Death|2|||
25326967|NCT00509899|50643395|FG002|Overall Study|Death|3|||
25326968|NCT00509899|50643396|FG003|Overall Study|Death|0|||
25326969|NCT00509899|50643397|FG004|Overall Study|Death|1|||
25326970|NCT00509899|50643398|FG005|Overall Study|Death|1|||
25326971|NCT00509899|50643399|FG006|Overall Study|Death|1|||
25326972|NCT00509899|50643400|FG007|Overall Study|Death|1|||
25326973|NCT00509899|50643393|FG000|Overall Study|Lack of Efficacy|1|||
25326974|NCT00509899|50643394|FG001|Overall Study|Lack of Efficacy|0|||
25326975|NCT00509899|50643395|FG002|Overall Study|Lack of Efficacy|2|||
25326976|NCT00509899|50643396|FG003|Overall Study|Lack of Efficacy|0|||
25326977|NCT00509899|50643397|FG004|Overall Study|Lack of Efficacy|0|||
25326978|NCT00509899|50643398|FG005|Overall Study|Lack of Efficacy|1|||
25326979|NCT00509899|50643399|FG006|Overall Study|Lack of Efficacy|0|||
25326980|NCT00509899|50643400|FG007|Overall Study|Lack of Efficacy|0|||
25326981|NCT00862836|50643414|FG000|Overall Study|Withdrawal by Subject|1|||
25326982|NCT00820755|50643418|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
25326983|NCT00820755|50643419|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
25326984|NCT00820755|50643420|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
25326985|NCT00820755|50643418|FG000|Period 1: Combination Therapy Phase|Death|28|||
25326986|NCT00820755|50643419|FG001|Period 1: Combination Therapy Phase|Death|0|||
25326987|NCT00820755|50643420|FG002|Period 1: Combination Therapy Phase|Death|0|||
25326988|NCT00820755|50643418|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
25326989|NCT00820755|50643419|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
25326990|NCT00820755|50643420|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
25326991|NCT00820755|50643418|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
25326992|NCT00820755|50643419|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
25326993|NCT00820755|50643420|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
25326994|NCT00820755|50643418|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
25326995|NCT00820755|50643419|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
25326996|NCT00820755|50643420|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
25326997|NCT00820755|50643418|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
25326998|NCT00820755|50643419|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
25326999|NCT00820755|50643420|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
25327000|NCT00820755|50643418|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
25327001|NCT00820755|50643419|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
25327002|NCT00820755|50643420|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
25327003|NCT00820755|50643418|FG000|Period 1: Combination Therapy Phase|Other|11|||
25327004|NCT00820755|50643419|FG001|Period 1: Combination Therapy Phase|Other|0|||
25327005|NCT00820755|50643420|FG002|Period 1: Combination Therapy Phase|Other|0|||
25327006|NCT00820755|50643418|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
25327007|NCT00820755|50643419|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
25327008|NCT00820755|50643420|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
25327009|NCT00820599|50643428|FG000|Overall Study|Death|129|||
25327010|NCT00820599|50643428|FG000|Overall Study|Withdrawal by Subject|2|||
25327011|NCT00819741|50643434|FG000|Overall Study|Adverse Event|5|||
25327012|NCT00819741|50643435|FG001|Overall Study|Adverse Event|2|||
25327013|NCT00819741|50643434|FG000|Overall Study|Lack of Efficacy|0|||
25327014|NCT00819741|50643435|FG001|Overall Study|Lack of Efficacy|2|||
25327015|NCT00819741|50643434|FG000|Overall Study|Lost to Follow-up|3|||
25327016|NCT00819741|50643435|FG001|Overall Study|Lost to Follow-up|1|||
25327017|NCT00819741|50643434|FG000|Overall Study|Protocol Violation|3|||
25327018|NCT00819741|50643435|FG001|Overall Study|Protocol Violation|4|||
25327019|NCT00819741|50643434|FG000|Overall Study|Withdrawal by Subject|2|||
25327020|NCT00819741|50643435|FG001|Overall Study|Withdrawal by Subject|2|||
25327021|NCT00819741|50643434|FG000|Overall Study|Unclassified|6|||
24977248|NCT03410992|50065846|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
24977249|NCT03410992|50065847|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
25327022|NCT00819741|50643435|FG001|Overall Study|Unclassified|0|||
25327023|NCT00819741|50643434|FG000|Overall Study|Reasons unknown|3|||
25327024|NCT00819741|50643435|FG001|Overall Study|Reasons unknown|3|||
25327025|NCT00862134|50643443|FG000|Overall Study|Death|1|||
25327026|NCT00862134|50643444|FG001|Overall Study|Death|0|||
25327027|NCT00862134|50643443|FG000|Overall Study|Physician Decision|0|||
25327028|NCT00862134|50643444|FG001|Overall Study|Physician Decision|1|||
25327029|NCT00862134|50643443|FG000|Overall Study|Withdrawal by Subject|1|||
25327030|NCT00862134|50643444|FG001|Overall Study|Withdrawal by Subject|2|||
25327031|NCT00862134|50643443|FG000|Overall Study|Sponsor terminated study|5|||
25327032|NCT00862134|50643444|FG001|Overall Study|Sponsor terminated study|7|||
25327033|NCT00862134|50643443|FG000|Overall Study|Adverse Event|2|||
25327034|NCT00862134|50643444|FG001|Overall Study|Adverse Event|2|||
25327035|NCT00862134|50643443|FG000|Overall Study|Withdrew prior to dosing|2|||
25327036|NCT00862134|50643444|FG001|Overall Study|Withdrew prior to dosing|0|||
25327037|NCT00848484|50643452|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
25327038|NCT00848484|50643453|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
25327039|NCT00848484|50643452|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
25327040|NCT00848484|50643453|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
25327041|NCT00848484|50643452|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
25327042|NCT00848484|50643453|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
25327043|NCT00848484|50643452|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
25327044|NCT00848484|50643453|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
25327045|NCT00848484|50643452|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
25327046|NCT00848484|50643453|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
25327047|NCT00509821|50643461|FG000|Study Period 1 (Induction)|Death|0|||
25327048|NCT00509821|50643462|FG001|Study Period 1 (Induction)|Death|1|||
25327049|NCT00509821|50643461|FG000|Study Period 1 (Induction)|Adverse Event|0|||
25327050|NCT00509821|50643462|FG001|Study Period 1 (Induction)|Adverse Event|2|||
25327051|NCT00509821|50643461|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
25327052|NCT00509821|50643462|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
25327053|NCT00508651|50643475|FG000|Overall Study|Lost to Follow-up|3|||
25327054|NCT00508651|50643476|FG001|Overall Study|Lost to Follow-up|1|||
25327055|NCT00508651|50643475|FG000|Overall Study|Withdrawal by Subject|1|||
25327056|NCT00508651|50643476|FG001|Overall Study|Withdrawal by Subject|1|||
25327057|NCT00490555|50643486|FG000|Overall Study|noncompliant with drug administration|0|||
25327058|NCT00490555|50643487|FG001|Overall Study|noncompliant with drug administration|0|||
25327059|NCT00490555|50643488|FG002|Overall Study|noncompliant with drug administration|2|||
25327060|NCT00490555|50643489|FG003|Overall Study|noncompliant with drug administration|0|||
25246969|NCT01218802|50562511|FG000|Overall Study|Withdrawal by Subject|3|||
25246970|NCT01218802|50562512|FG001|Overall Study|Withdrawal by Subject|10|||
25246971|NCT01218802|50562511|FG000|Overall Study|Adverse Event|0|||
25246972|NCT01218802|50562512|FG001|Overall Study|Adverse Event|2|||
25246973|NCT01218802|50562511|FG000|Overall Study|Incarcerated|2|||
25246974|NCT01218802|50562512|FG001|Overall Study|Incarcerated|0|||
25246975|NCT01218646|50562522|FG000|Overall Study|Adverse Event|0|||
25246976|NCT01218646|50562523|FG001|Overall Study|Adverse Event|0|||
25246977|NCT01218646|50562524|FG002|Overall Study|Adverse Event|1|||
25246978|NCT01218646|50562525|FG003|Overall Study|Adverse Event|0|||
25246979|NCT01218646|50562522|FG000|Overall Study|Lost to Follow-up|1|||
25246980|NCT01218646|50562523|FG001|Overall Study|Lost to Follow-up|0|||
25246981|NCT01218646|50562524|FG002|Overall Study|Lost to Follow-up|0|||
25246982|NCT01218646|50562525|FG003|Overall Study|Lost to Follow-up|0|||
25246983|NCT01218646|50562522|FG000|Overall Study|Protocol Violation|0|||
25246984|NCT01218646|50562523|FG001|Overall Study|Protocol Violation|0|||
25246985|NCT01218646|50562524|FG002|Overall Study|Protocol Violation|1|||
25246986|NCT01218646|50562525|FG003|Overall Study|Protocol Violation|1|||
25246987|NCT01188772|50562539|FG000|Overall Study|Randomized but Not Treated|0|||
25246988|NCT01188772|50562540|FG001|Overall Study|Randomized but Not Treated|1|||
25246989|NCT01188772|50562541|FG002|Overall Study|Randomized but Not Treated|0|||
25246990|NCT01188772|50562542|FG003|Overall Study|Randomized but Not Treated|0|||
25246991|NCT01188772|50562539|FG000|Overall Study|Adverse Event|0|||
25246992|NCT01188772|50562540|FG001|Overall Study|Adverse Event|1|||
25246993|NCT01188772|50562541|FG002|Overall Study|Adverse Event|2|||
25246994|NCT01188772|50562542|FG003|Overall Study|Adverse Event|0|||
25246995|NCT01188772|50562539|FG000|Overall Study|Lost to Follow-up|4|||
25246996|NCT01188772|50562540|FG001|Overall Study|Lost to Follow-up|1|||
25246997|NCT01188772|50562541|FG002|Overall Study|Lost to Follow-up|1|||
25246998|NCT01188772|50562542|FG003|Overall Study|Lost to Follow-up|1|||
25246999|NCT01188772|50562539|FG000|Overall Study|Non-responder|0|||
25247000|NCT01188772|50562540|FG001|Overall Study|Non-responder|0|||
25247001|NCT01188772|50562541|FG002|Overall Study|Non-responder|3|||
25327061|NCT00501085|50643499|FG000|Overall Study|Lost to Follow-up|195|||
25077783|NCT03318523|50185663|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
25077784|NCT03318523|50185664|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
25247002|NCT01188772|50562542|FG003|Overall Study|Non-responder|0|||
25247003|NCT01188772|50562539|FG000|Overall Study|Physician Decision|0|||
25247004|NCT01188772|50562540|FG001|Overall Study|Physician Decision|0|||
25247005|NCT01188772|50562541|FG002|Overall Study|Physician Decision|1|||
25247006|NCT01188772|50562542|FG003|Overall Study|Physician Decision|0|||
25247007|NCT01188772|50562539|FG000|Overall Study|Terminated by Sponsor|0|||
25247008|NCT01188772|50562540|FG001|Overall Study|Terminated by Sponsor|0|||
25247009|NCT01188772|50562541|FG002|Overall Study|Terminated by Sponsor|1|||
25247010|NCT01188772|50562542|FG003|Overall Study|Terminated by Sponsor|0|||
25247011|NCT01188772|50562539|FG000|Overall Study|Treatment Failure|0|||
25247012|NCT01188772|50562540|FG001|Overall Study|Treatment Failure|0|||
25247013|NCT01188772|50562541|FG002|Overall Study|Treatment Failure|1|||
25247014|NCT01188772|50562542|FG003|Overall Study|Treatment Failure|0|||
25247015|NCT01188772|50562539|FG000|Overall Study|Virologic Failure|1|||
25247016|NCT01188772|50562540|FG001|Overall Study|Virologic Failure|0|||
25247017|NCT01188772|50562541|FG002|Overall Study|Virologic Failure|0|||
25247018|NCT01188772|50562542|FG003|Overall Study|Virologic Failure|0|||
25247019|NCT01188772|50562539|FG000|Overall Study|Withdrawal by Subject|0|||
25247020|NCT01188772|50562540|FG001|Overall Study|Withdrawal by Subject|0|||
25247021|NCT01188772|50562541|FG002|Overall Study|Withdrawal by Subject|2|||
25247022|NCT01188772|50562542|FG003|Overall Study|Withdrawal by Subject|0|||
25247023|NCT01188655|50562555|FG000|Overall Study|Lack of Efficacy|1|||
25247024|NCT01188655|50562555|FG000|Overall Study|Lost to Follow-up|1|||
25247025|NCT01188655|50562555|FG000|Overall Study|Other|11|||
25247026|NCT01188538|50562561|FG000|Overall Study|Lost to Follow-up|0|||
25247027|NCT01188538|50562562|FG001|Overall Study|Lost to Follow-up|1|||
25247028|NCT01188343|50562573|FG000|Overall Study|Not vaccinated|0|||
25327062|NCT00501085|50643499|FG000|Overall Study|Withdrawal by Subject|34|||
25327063|NCT00501085|50643499|FG000|Overall Study|Subject Decision|1|||
25327064|NCT00501085|50643499|FG000|Overall Study|Revision Surgery|7|||
25327065|NCT00501085|50643499|FG000|Overall Study|Explantation Surgery|26|||
25327066|NCT00501085|50643499|FG000|Overall Study|Adverse Event|4|||
25327067|NCT00501085|50643499|FG000|Overall Study|Non-Compliance|24|||
25327068|NCT00501085|50643499|FG000|Overall Study|Study closed by sponsor|109|||
25327069|NCT00501085|50643499|FG000|Overall Study|Other loss to follow-up|32|||
25327070|NCT00501007|50643503|FG000|Overall Study|Inclusion criteria not met.|29|||
25327071|NCT00501007|50643504|FG001|Overall Study|Inclusion criteria not met.|25|||
25327072|NCT00873860|50643514|FG000|Overall Study|Lost to Follow-up|1|||
25327073|NCT00873860|50643515|FG001|Overall Study|Lost to Follow-up|0|||
25327074|NCT00873860|50643516|FG002|Overall Study|Lost to Follow-up|0|||
25327075|NCT00873860|50643517|FG003|Overall Study|Lost to Follow-up|1|||
25327076|NCT00873860|50643514|FG000|Overall Study|Withdrawal by Subject|1|||
25327077|NCT00873860|50643515|FG001|Overall Study|Withdrawal by Subject|0|||
25327078|NCT00873860|50643516|FG002|Overall Study|Withdrawal by Subject|2|||
25327079|NCT00873860|50643517|FG003|Overall Study|Withdrawal by Subject|0|||
25327080|NCT00873860|50643514|FG000|Overall Study|Death|1|||
25327081|NCT00873860|50643515|FG001|Overall Study|Death|0|||
25327082|NCT00873860|50643516|FG002|Overall Study|Death|0|||
25327083|NCT00873860|50643517|FG003|Overall Study|Death|0|||
25327084|NCT00873860|50643514|FG000|Overall Study|Other|1|||
25327085|NCT00873860|50643515|FG001|Overall Study|Other|0|||
25327086|NCT00873860|50643516|FG002|Overall Study|Other|1|||
25327087|NCT00873860|50643517|FG003|Overall Study|Other|0|||
25327088|NCT03853291|50643540|FG000|Overall Study|Lost to Follow-up|1|||
25327089|NCT03853291|50643541|FG001|Overall Study|Lost to Follow-up|2|||
25327090|NCT03853291|50643542|FG002|Overall Study|Lost to Follow-up|0|||
25327091|NCT03853291|50643543|FG003|Overall Study|Lost to Follow-up|0|||
25327092|NCT03853291|50643544|FG004|Overall Study|Lost to Follow-up|0|||
25327093|NCT03853291|50643545|FG005|Overall Study|Lost to Follow-up|0|||
25327094|NCT03853291|50643540|FG000|Overall Study|Determined to be ineligible|1|||
25327095|NCT03853291|50643541|FG001|Overall Study|Determined to be ineligible|1|||
25327096|NCT03853291|50643542|FG002|Overall Study|Determined to be ineligible|0|||
25327097|NCT03853291|50643543|FG003|Overall Study|Determined to be ineligible|0|||
25327098|NCT03853291|50643544|FG004|Overall Study|Determined to be ineligible|0|||
25327099|NCT03853291|50643545|FG005|Overall Study|Determined to be ineligible|0|||
25327100|NCT03853213|50643558|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
25327101|NCT03853213|50643559|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
25327102|NCT03853213|50643558|FG000|Overall Study|Other (e.g., too busy)|0|||
25327103|NCT03853213|50643559|FG001|Overall Study|Other (e.g., too busy)|2|||
25327104|NCT02666105|50643585|FG000|Overall Study|Death|1|||
25327105|NCT00819585|50643604|FG000|Core Study|Adverse Event|2|||
25327106|NCT00819585|50643605|FG001|Core Study|Adverse Event|1|||
25327107|NCT00819585|50643606|FG002|Core Study|Adverse Event|1|||
25327108|NCT00819585|50643607|FG003|Core Study|Adverse Event|4|||
25327109|NCT00819585|50643608|FG004|Core Study|Adverse Event|1|||
25327110|NCT00819585|50643609|FG005|Core Study|Adverse Event|0|||
25327111|NCT00819585|50643610|FG006|Core Study|Adverse Event|2|||
25247029|NCT01188343|50562574|FG001|Overall Study|Not vaccinated|2|||
25247030|NCT01188343|50562575|FG002|Overall Study|Not vaccinated|1|||
25247031|NCT01188343|50562573|FG000|Overall Study|Withdrawal by Subject|1|||
25327112|NCT00819585|50643611|FG007|Core Study|Adverse Event|0|||
25327113|NCT00819585|50643612|FG008|Core Study|Adverse Event|0|||
25327114|NCT00819585|50643613|FG009|Core Study|Adverse Event|0|||
25327115|NCT00819585|50643614|FG010|Core Study|Adverse Event|0|||
25327116|NCT00819585|50643604|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
25327117|NCT00819585|50643605|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
25327118|NCT00819585|50643606|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
25327119|NCT00819585|50643607|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
25247032|NCT01188343|50562574|FG001|Overall Study|Withdrawal by Subject|24|||
25247033|NCT01188343|50562575|FG002|Overall Study|Withdrawal by Subject|0|||
25247034|NCT01188226|50562586|FG000|Overall Study|Withdrawal by Subject|4|||
25247035|NCT01218100|50562604|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
25247036|NCT01218100|50562605|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
25247037|NCT01218100|50562606|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
25247038|NCT01218100|50562607|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
25247039|NCT01218100|50562604|FG000|Overall Study|Adverse Event|4|||
25247040|NCT01218100|50562605|FG001|Overall Study|Adverse Event|6|||
25247041|NCT01218100|50562606|FG002|Overall Study|Adverse Event|6|||
25247042|NCT01218100|50562607|FG003|Overall Study|Adverse Event|7|||
25247043|NCT01218100|50562604|FG000|Overall Study|Lack of Efficacy|9|||
25247044|NCT01218100|50562605|FG001|Overall Study|Lack of Efficacy|6|||
25247045|NCT01218100|50562606|FG002|Overall Study|Lack of Efficacy|5|||
25247046|NCT01218100|50562607|FG003|Overall Study|Lack of Efficacy|12|||
25247047|NCT01218100|50562604|FG000|Overall Study|Protocol Violation|0|||
25247048|NCT01218100|50562605|FG001|Overall Study|Protocol Violation|0|||
25247049|NCT01218100|50562606|FG002|Overall Study|Protocol Violation|1|||
25327120|NCT00819585|50643608|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
25327121|NCT00819585|50643609|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
25327122|NCT00819585|50643610|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
25327123|NCT00819585|50643611|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
25327124|NCT00819585|50643612|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
25327125|NCT00819585|50643613|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
25327126|NCT00819585|50643614|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
25327127|NCT00819585|50643604|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
25327128|NCT00819585|50643605|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
25327129|NCT00819585|50643606|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
25327130|NCT00819585|50643607|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
25327131|NCT00819585|50643608|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
25247050|NCT01218100|50562607|FG003|Overall Study|Protocol Violation|1|||
25247051|NCT01218100|50562604|FG000|Overall Study|Withdrawal by Subject|5|||
25247052|NCT01218100|50562605|FG001|Overall Study|Withdrawal by Subject|2|||
25247053|NCT01218100|50562606|FG002|Overall Study|Withdrawal by Subject|6|||
25247054|NCT01218100|50562607|FG003|Overall Study|Withdrawal by Subject|7|||
25247055|NCT01218100|50562604|FG000|Overall Study|Lost to Follow-up|3|||
25247056|NCT01218100|50562605|FG001|Overall Study|Lost to Follow-up|8|||
25247057|NCT01218100|50562606|FG002|Overall Study|Lost to Follow-up|2|||
25247058|NCT01218100|50562607|FG003|Overall Study|Lost to Follow-up|1|||
25247059|NCT01218100|50562604|FG000|Overall Study|Other Reason|2|||
25247060|NCT01218100|50562605|FG001|Overall Study|Other Reason|2|||
25247061|NCT01218100|50562606|FG002|Overall Study|Other Reason|6|||
25247062|NCT01218100|50562607|FG003|Overall Study|Other Reason|4|||
25247063|NCT01187953|50562653|FG000|Overall Study|Death|11|||
25247064|NCT01187953|50562654|FG001|Overall Study|Death|13|||
25247065|NCT01187953|50562653|FG000|Overall Study|Adverse Event|1|||
25247066|NCT01187953|50562654|FG001|Overall Study|Adverse Event|2|||
25247067|NCT01187953|50562653|FG000|Overall Study|Lost to Follow-up|0|||
25247068|NCT01187953|50562654|FG001|Overall Study|Lost to Follow-up|3|||
25247069|NCT01187953|50562653|FG000|Overall Study|Withdrawal by Subject|3|||
25247070|NCT01187953|50562654|FG001|Overall Study|Withdrawal by Subject|3|||
25247071|NCT01217944|50562670|FG000|Overall Study|Protocol Violation|1|||
25327132|NCT00819585|50643609|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
25327133|NCT00819585|50643610|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
25327134|NCT00819585|50643611|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
25327135|NCT00819585|50643612|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
25327136|NCT00819585|50643613|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
25327137|NCT00819585|50643614|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
25327138|NCT00819585|50643604|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
25327139|NCT00819585|50643605|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
25327140|NCT00819585|50643606|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
25327141|NCT00819585|50643607|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
25327142|NCT00819585|50643608|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
25327143|NCT00819585|50643609|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
25327144|NCT00819585|50643610|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
25327145|NCT00819585|50643611|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
25247072|NCT01217944|50562671|FG001|Overall Study|Protocol Violation|1|||
25247073|NCT01217944|50562672|FG002|Overall Study|Protocol Violation|0|||
25247074|NCT01217944|50562670|FG000|Overall Study|Lost to Follow-up|3|||
25247075|NCT01217944|50562671|FG001|Overall Study|Lost to Follow-up|1|||
25247076|NCT01217944|50562672|FG002|Overall Study|Lost to Follow-up|0|||
25327146|NCT00819585|50643612|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
25327147|NCT00819585|50643613|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
25327148|NCT00819585|50643614|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
25327149|NCT00819585|50643604|FG000|Core Study|Subject Withdrew Consent|0|||
25327150|NCT00819585|50643605|FG001|Core Study|Subject Withdrew Consent|3|||
25327151|NCT00819585|50643606|FG002|Core Study|Subject Withdrew Consent|2|||
25327152|NCT00819585|50643607|FG003|Core Study|Subject Withdrew Consent|1|||
25327153|NCT00819585|50643608|FG004|Core Study|Subject Withdrew Consent|0|||
25327154|NCT00819585|50643609|FG005|Core Study|Subject Withdrew Consent|0|||
25327155|NCT00819585|50643610|FG006|Core Study|Subject Withdrew Consent|3|||
25327156|NCT00819585|50643611|FG007|Core Study|Subject Withdrew Consent|0|||
25327157|NCT00819585|50643612|FG008|Core Study|Subject Withdrew Consent|0|||
25327158|NCT00819585|50643613|FG009|Core Study|Subject Withdrew Consent|0|||
25327159|NCT00819585|50643614|FG010|Core Study|Subject Withdrew Consent|0|||
25327160|NCT00819585|50643604|FG000|Core Study|Lost to Follow-up|2|||
25327161|NCT00819585|50643605|FG001|Core Study|Lost to Follow-up|1|||
25327162|NCT00819585|50643606|FG002|Core Study|Lost to Follow-up|2|||
25327163|NCT00819585|50643607|FG003|Core Study|Lost to Follow-up|0|||
25327164|NCT00819585|50643608|FG004|Core Study|Lost to Follow-up|1|||
25327165|NCT00819585|50643609|FG005|Core Study|Lost to Follow-up|1|||
25327166|NCT00819585|50643610|FG006|Core Study|Lost to Follow-up|1|||
25327167|NCT00819585|50643611|FG007|Core Study|Lost to Follow-up|0|||
25327168|NCT00819585|50643612|FG008|Core Study|Lost to Follow-up|0|||
25327169|NCT00819585|50643613|FG009|Core Study|Lost to Follow-up|0|||
25327170|NCT00819585|50643614|FG010|Core Study|Lost to Follow-up|0|||
25327171|NCT00819585|50643604|FG000|Core Study|Administrative Problems|0|||
25327172|NCT00819585|50643605|FG001|Core Study|Administrative Problems|0|||
25327173|NCT00819585|50643606|FG002|Core Study|Administrative Problems|0|||
25327174|NCT00819585|50643607|FG003|Core Study|Administrative Problems|0|||
25327175|NCT00819585|50643608|FG004|Core Study|Administrative Problems|0|||
25327176|NCT00819585|50643609|FG005|Core Study|Administrative Problems|0|||
25327177|NCT00819585|50643610|FG006|Core Study|Administrative Problems|2|||
25327178|NCT00819585|50643611|FG007|Core Study|Administrative Problems|0|||
25327179|NCT00819585|50643612|FG008|Core Study|Administrative Problems|0|||
25247077|NCT01217944|50562670|FG000|Overall Study|Withdrawal by Subject|1|||
25247078|NCT01217944|50562671|FG001|Overall Study|Withdrawal by Subject|2|||
25247079|NCT01217944|50562672|FG002|Overall Study|Withdrawal by Subject|0|||
25327180|NCT00819585|50643613|FG009|Core Study|Administrative Problems|0|||
25327181|NCT00819585|50643614|FG010|Core Study|Administrative Problems|0|||
25327182|NCT00819585|50643604|FG000|Core Study|Death|0|||
25327183|NCT00819585|50643605|FG001|Core Study|Death|0|||
25327184|NCT00819585|50643606|FG002|Core Study|Death|0|||
25327185|NCT00819585|50643607|FG003|Core Study|Death|0|||
25327186|NCT00819585|50643608|FG004|Core Study|Death|0|||
25327187|NCT00819585|50643609|FG005|Core Study|Death|0|||
25327188|NCT00819585|50643610|FG006|Core Study|Death|1|||
25327189|NCT00819585|50643611|FG007|Core Study|Death|0|||
25327190|NCT00819585|50643612|FG008|Core Study|Death|0|||
25247080|NCT01217944|50562670|FG000|Overall Study|Lack of Efficacy|1|||
25247081|NCT01217944|50562671|FG001|Overall Study|Lack of Efficacy|0|||
25247082|NCT01217944|50562672|FG002|Overall Study|Lack of Efficacy|0|||
25247083|NCT01187446|50562684|FG000|Overall Study|Patient started non-protocol therapy|0|||
25247084|NCT01187446|50562685|FG001|Overall Study|Patient started non-protocol therapy|1|||
25247085|NCT01187407|50562695|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
25247086|NCT01187407|50562696|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
25247087|NCT01187407|50562697|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
25247088|NCT01187407|50562698|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
25247089|NCT01187407|50562699|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
25247090|NCT01187407|50562695|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
25247091|NCT01187407|50562696|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
25247092|NCT01187407|50562697|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
25327191|NCT00819585|50643613|FG009|Core Study|Death|0|||
25327192|NCT00819585|50643614|FG010|Core Study|Death|0|||
25327193|NCT00819585|50643604|FG000|Core Study|Protocol Violation|0|||
25247093|NCT01187407|50562698|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
25327194|NCT00819585|50643605|FG001|Core Study|Protocol Violation|0|||
25327195|NCT00819585|50643606|FG002|Core Study|Protocol Violation|1|||
25327196|NCT00819585|50643607|FG003|Core Study|Protocol Violation|0|||
25327197|NCT00819585|50643608|FG004|Core Study|Protocol Violation|0|||
25327198|NCT00819585|50643609|FG005|Core Study|Protocol Violation|1|||
25327199|NCT00819585|50643610|FG006|Core Study|Protocol Violation|3|||
25327200|NCT00819585|50643611|FG007|Core Study|Protocol Violation|0|||
25327201|NCT00819585|50643612|FG008|Core Study|Protocol Violation|0|||
25327202|NCT00819585|50643613|FG009|Core Study|Protocol Violation|0|||
25327203|NCT00819585|50643614|FG010|Core Study|Protocol Violation|0|||
25327204|NCT00819585|50643604|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
25327205|NCT00819585|50643605|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
25327206|NCT00819585|50643606|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
25327207|NCT00819585|50643607|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
25327208|NCT00819585|50643608|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
25327209|NCT00819585|50643609|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
25327210|NCT00819585|50643610|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
25327211|NCT00819585|50643611|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
25327212|NCT00819585|50643612|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
25327213|NCT00819585|50643613|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
25327214|NCT00819585|50643614|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
25327215|NCT00819585|50643604|FG000|Extension Study|Subject Withdrew Consent|0|||
25327216|NCT00819585|50643605|FG001|Extension Study|Subject Withdrew Consent|0|||
25327217|NCT00819585|50643606|FG002|Extension Study|Subject Withdrew Consent|0|||
25327218|NCT00819585|50643607|FG003|Extension Study|Subject Withdrew Consent|0|||
25327219|NCT00819585|50643608|FG004|Extension Study|Subject Withdrew Consent|0|||
25327220|NCT00819585|50643609|FG005|Extension Study|Subject Withdrew Consent|0|||
25327221|NCT00819585|50643610|FG006|Extension Study|Subject Withdrew Consent|0|||
25327222|NCT00819585|50643611|FG007|Extension Study|Subject Withdrew Consent|0|||
25327223|NCT00819585|50643612|FG008|Extension Study|Subject Withdrew Consent|3|||
25327224|NCT00819585|50643613|FG009|Extension Study|Subject Withdrew Consent|0|||
25327225|NCT00819585|50643614|FG010|Extension Study|Subject Withdrew Consent|1|||
25327226|NCT00819585|50643604|FG000|Extension Study|Lost to Follow-up|0|||
25327227|NCT00819585|50643605|FG001|Extension Study|Lost to Follow-up|0|||
25327228|NCT00819585|50643606|FG002|Extension Study|Lost to Follow-up|0|||
25327229|NCT00819585|50643607|FG003|Extension Study|Lost to Follow-up|0|||
25327230|NCT00819585|50643608|FG004|Extension Study|Lost to Follow-up|0|||
25327231|NCT00819585|50643609|FG005|Extension Study|Lost to Follow-up|0|||
25327232|NCT00819585|50643610|FG006|Extension Study|Lost to Follow-up|0|||
25327233|NCT00819585|50643611|FG007|Extension Study|Lost to Follow-up|0|||
25327234|NCT00819585|50643612|FG008|Extension Study|Lost to Follow-up|2|||
25327235|NCT00819585|50643613|FG009|Extension Study|Lost to Follow-up|1|||
25327236|NCT00819585|50643614|FG010|Extension Study|Lost to Follow-up|1|||
25327237|NCT00819585|50643604|FG000|Extension Study|Death|0|||
25327238|NCT00819585|50643605|FG001|Extension Study|Death|0|||
25327239|NCT00819585|50643606|FG002|Extension Study|Death|0|||
25327240|NCT00819585|50643607|FG003|Extension Study|Death|0|||
25327241|NCT00819585|50643608|FG004|Extension Study|Death|0|||
25327242|NCT00819585|50643609|FG005|Extension Study|Death|0|||
25327243|NCT00819585|50643610|FG006|Extension Study|Death|0|||
25327244|NCT00819585|50643611|FG007|Extension Study|Death|0|||
25327245|NCT00819585|50643612|FG008|Extension Study|Death|2|||
25327246|NCT00819585|50643613|FG009|Extension Study|Death|0|||
25327247|NCT00819585|50643614|FG010|Extension Study|Death|0|||
25327248|NCT00508261|50643646|FG000|Overall Study|Other|0|||
25327249|NCT00508261|50643647|FG001|Overall Study|Other|1|||
25327250|NCT00508261|50643648|FG002|Overall Study|Other|1|||
25327251|NCT00508261|50643649|FG003|Overall Study|Other|0|||
25327252|NCT00508261|50643646|FG000|Overall Study|Serious Adverse Event|0|||
25327253|NCT00508261|50643647|FG001|Overall Study|Serious Adverse Event|1|||
25327254|NCT00508261|50643648|FG002|Overall Study|Serious Adverse Event|0|||
25327255|NCT00508261|50643649|FG003|Overall Study|Serious Adverse Event|0|||
25327256|NCT00508261|50643646|FG000|Overall Study|Withdrawal by Subject|3|||
25327257|NCT00508261|50643647|FG001|Overall Study|Withdrawal by Subject|4|||
25327258|NCT00508261|50643648|FG002|Overall Study|Withdrawal by Subject|4|||
25327259|NCT00508261|50643649|FG003|Overall Study|Withdrawal by Subject|0|||
25327260|NCT00508261|50643646|FG000|Overall Study|Migrated/ moved from study area|0|||
25327261|NCT00508261|50643647|FG001|Overall Study|Migrated/ moved from study area|1|||
25327262|NCT00508261|50643648|FG002|Overall Study|Migrated/ moved from study area|0|||
25327263|NCT00508261|50643649|FG003|Overall Study|Migrated/ moved from study area|0|||
25327264|NCT00508261|50643646|FG000|Overall Study|Lost to Follow-up|0|||
25327265|NCT00508261|50643647|FG001|Overall Study|Lost to Follow-up|1|||
25327266|NCT00508261|50643648|FG002|Overall Study|Lost to Follow-up|1|||
25327267|NCT00508261|50643649|FG003|Overall Study|Lost to Follow-up|1|||
25327268|NCT00819039|50643688|FG000|Overall Study|Physician Decision|1|||
25327269|NCT00819039|50643689|FG001|Overall Study|Physician Decision|0|||
25327270|NCT00819039|50643690|FG002|Overall Study|Physician Decision|1|||
25327271|NCT00819039|50643688|FG000|Overall Study|Protocol Violation|1|||
25327272|NCT00819039|50643689|FG001|Overall Study|Protocol Violation|0|||
25327273|NCT00819039|50643690|FG002|Overall Study|Protocol Violation|0|||
25327274|NCT00500539|50643700|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
25327275|NCT00500539|50643700|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
25327276|NCT00500539|50643700|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
25327277|NCT00500539|50643700|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
25327278|NCT00500539|50643700|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
25327279|NCT00500539|50643700|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
25327280|NCT00500539|50643700|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
25327281|NCT00500539|50643700|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
25327282|NCT00500539|50643700|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
25327283|NCT00500539|50643700|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
25247094|NCT01187407|50562699|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
25247095|NCT01187407|50562695|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
25247096|NCT01187407|50562696|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
25247097|NCT01187407|50562697|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
25327284|NCT00500539|50643700|FG000|Follow-up Period (16 Weeks)|Death|1|||
25327285|NCT00500539|50643700|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
25327286|NCT00500539|50643700|FG000|Follow-up Period (16 Weeks)|Missing|3|||
25327287|NCT00818883|50643709|FG000|Overall Study|Adverse Event|28|||
25247098|NCT01187407|50562698|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
25247099|NCT01187407|50562699|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
25247100|NCT01187407|50562695|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
25247101|NCT01187407|50562696|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
25247102|NCT01187407|50562697|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
25247103|NCT01187407|50562698|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
25247104|NCT01187407|50562699|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
25247105|NCT01187407|50562695|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
25247106|NCT01187407|50562696|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
25247107|NCT01187407|50562697|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
25247108|NCT01187407|50562698|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
25247109|NCT01187407|50562699|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
25247110|NCT01187407|50562695|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
25247111|NCT01187407|50562696|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
25247112|NCT01187407|50562697|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
25327288|NCT00818883|50643710|FG001|Overall Study|Adverse Event|19|||
25327289|NCT00818883|50643709|FG000|Overall Study|Protocol Violation|2|||
25327290|NCT00818883|50643710|FG001|Overall Study|Protocol Violation|2|||
25327291|NCT00818883|50643709|FG000|Overall Study|Lost to Follow-up|3|||
25327292|NCT00818883|50643710|FG001|Overall Study|Lost to Follow-up|2|||
25327293|NCT00818883|50643709|FG000|Overall Study|Withdrawal by Subject|16|||
25327294|NCT00818883|50643710|FG001|Overall Study|Withdrawal by Subject|14|||
25327295|NCT00818883|50643709|FG000|Overall Study|Lack of Efficacy|0|||
25327296|NCT00818883|50643710|FG001|Overall Study|Lack of Efficacy|2|||
25247113|NCT01187407|50562698|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
25247114|NCT01187407|50562699|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
25247115|NCT01187407|50562695|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
25247116|NCT01187407|50562696|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
25247117|NCT01187407|50562697|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
25247118|NCT01187407|50562698|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
25247119|NCT01187407|50562699|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
25247120|NCT01187407|50562695|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
25247121|NCT01187407|50562696|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
25247122|NCT01187407|50562697|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
25247123|NCT01187407|50562698|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
25247124|NCT01187407|50562699|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
25247125|NCT01187407|50562695|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
25247126|NCT01187407|50562696|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
25327297|NCT00818883|50643709|FG000|Overall Study|Other|2|||
25327298|NCT00818883|50643710|FG001|Overall Study|Other|7|||
25327299|NCT00508027|50643716|FG000|Dose Level 1|Lost to Follow-up|4|||
25327300|NCT00508027|50643716|FG000|Dose Level 1|Withdrawal by Subject|2|||
25327301|NCT00508027|50643716|FG000|Dose Level 1|Physician Decision|2|||
25327302|NCT00508027|50643716|FG000|Dose Level 2|Lost to Follow-up|2|||
25327303|NCT00508027|50643716|FG000|Dose Level 2|Withdrawal by Subject|2|||
25327304|NCT00500149|50643745|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
25327305|NCT00500149|50643746|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
25327306|NCT00500149|50643745|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
25327307|NCT00500149|50643746|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
25327308|NCT00500149|50643745|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
25327309|NCT00500149|50643746|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
25247127|NCT01187407|50562697|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
25247128|NCT01187407|50562698|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
25327310|NCT00500149|50643745|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
25247129|NCT01187407|50562699|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
25247130|NCT01187407|50562695|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
25247131|NCT01187407|50562696|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
25247132|NCT01187407|50562697|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
25247133|NCT01187407|50562698|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
25247134|NCT01187407|50562699|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
25247135|NCT01187407|50562695|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
25247136|NCT01187407|50562696|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
25247137|NCT01187407|50562697|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
25247138|NCT01187407|50562698|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
25247139|NCT01187407|50562699|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
25247140|NCT01187407|50562695|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
25247141|NCT01187407|50562696|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
25247142|NCT01187407|50562697|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
25247143|NCT01187407|50562698|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
25247144|NCT01187407|50562699|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
25247145|NCT01187407|50562695|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
25247146|NCT01187407|50562696|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
25247147|NCT01187407|50562697|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
25247148|NCT01187407|50562698|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
25247149|NCT01187407|50562699|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
25247150|NCT01187407|50562695|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
25247151|NCT01187407|50562696|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
25247152|NCT01187407|50562697|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
25247153|NCT01187407|50562698|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
25247154|NCT01187407|50562699|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
25247155|NCT01186978|50562716|FG000|Overall Study|Withdrawal by Subject|1|||
25247156|NCT01186939|50562720|FG000|Overall Study|Death|7|||
25247157|NCT01186939|50562720|FG000|Overall Study|Withdrawal by Subject|2|||
25247158|NCT01186939|50562720|FG000|Overall Study|No longer receiving clinical benefit|17|||
25247159|NCT01186939|50562720|FG000|Overall Study|Program closed|5|||
25247160|NCT01186939|50562720|FG000|Overall Study|Sponsor decision|4|||
25247161|NCT01186939|50562720|FG000|Overall Study|Started additional treatment|1|||
25247162|NCT01186939|50562720|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
25247163|NCT01186939|50562720|FG000|Overall Study|Myocardial infarction|1|||
25327311|NCT00500149|50643746|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
25327312|NCT00500149|50643745|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
25327313|NCT00500149|50643746|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
25327314|NCT00500149|50643745|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
25327315|NCT00500149|50643746|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
25327316|NCT00500149|50643745|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
25327317|NCT00500149|50643746|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
25327318|NCT00489853|50643752|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
25327319|NCT00489853|50643753|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
25327320|NCT00489853|50643754|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
25327321|NCT00489853|50643752|FG000|Wash-out Period 1|Adverse Event|0|||
25327322|NCT00489853|50643753|FG001|Wash-out Period 1|Adverse Event|1|||
25327323|NCT00489853|50643754|FG002|Wash-out Period 1|Adverse Event|1|||
25327324|NCT00489853|50643752|FG000|Wash-out Period 1|Protocol Violation|0|||
25327325|NCT00489853|50643753|FG001|Wash-out Period 1|Protocol Violation|1|||
25327326|NCT00489853|50643754|FG002|Wash-out Period 1|Protocol Violation|1|||
25327327|NCT00489853|50643752|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
25327328|NCT00489853|50643753|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
24977250|NCT03410992|50065848|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
25247164|NCT01186939|50562720|FG000|Overall Study|Bone marrow transplant|1|||
25247165|NCT01186939|50562720|FG000|Overall Study|Transformation to AML|1|||
25247166|NCT04938648|50562745|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
25247167|NCT04938648|50562746|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
25247168|NCT04938648|50562745|FG000|Overall Study|Patient too ill|0|||
25247169|NCT04938648|50562746|FG001|Overall Study|Patient too ill|1|||
25247170|NCT04938648|50562745|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
25247171|NCT04938648|50562746|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
25247172|NCT04938648|50562745|FG000|Overall Study|Patient did not have memory problems|1|||
25247173|NCT04938648|50562746|FG001|Overall Study|Patient did not have memory problems|1|||
25247174|NCT04938648|50562745|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
25247175|NCT04938648|50562746|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
25247176|NCT04938648|50562745|FG000|Overall Study|Care partner could not be reached|0|||
25247177|NCT04938648|50562746|FG001|Overall Study|Care partner could not be reached|1|||
25247178|NCT04938648|50562745|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
25247179|NCT04938648|50562746|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
25247180|NCT04938648|50562745|FG000|Overall Study|Withdrawal by Subject|2|||
25247181|NCT04938648|50562746|FG001|Overall Study|Withdrawal by Subject|1|||
25247182|NCT02128113|50562787|FG000|Overall Study|Withdrawal by Subject|3|||
25247183|NCT02128113|50562788|FG001|Overall Study|Withdrawal by Subject|1|||
25247184|NCT02128113|50562789|FG002|Overall Study|Withdrawal by Subject|0|||
25247185|NCT02128113|50562787|FG000|Overall Study|Protocol Violation|0|||
25247186|NCT02128113|50562788|FG001|Overall Study|Protocol Violation|1|||
25247187|NCT02128113|50562789|FG002|Overall Study|Protocol Violation|0|||
25247188|NCT02128113|50562787|FG000|Overall Study|Surgery cancelled|0|||
25247189|NCT02128113|50562788|FG001|Overall Study|Surgery cancelled|1|||
25247190|NCT02128113|50562789|FG002|Overall Study|Surgery cancelled|0|||
25247191|NCT02128113|50562787|FG000|Overall Study|Adverse Event|0|||
25247192|NCT02128113|50562788|FG001|Overall Study|Adverse Event|0|||
25247193|NCT02128113|50562789|FG002|Overall Study|Adverse Event|1|||
25247194|NCT01658826|50562803|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
25247195|NCT01658826|50562804|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
25247196|NCT01658826|50562803|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
25247197|NCT01658826|50562804|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
25247198|NCT01658826|50562803|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
25247199|NCT01658826|50562804|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
25247200|NCT01658826|50562803|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
25247201|NCT01658826|50562804|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
25247202|NCT01658826|50562803|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
25247203|NCT01658826|50562804|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
25247204|NCT01658826|50562803|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
25247205|NCT01658826|50562804|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
25247206|NCT01658826|50562803|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
25247207|NCT01658826|50562804|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
25247208|NCT01658826|50562803|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
25327329|NCT00489853|50643754|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
25327330|NCT00489853|50643752|FG000|Wash-out Period 2|Adverse Event|1|||
25327331|NCT00489853|50643753|FG001|Wash-out Period 2|Adverse Event|1|||
25327332|NCT00489853|50643754|FG002|Wash-out Period 2|Adverse Event|0|||
25327333|NCT00489853|50643752|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
25327334|NCT00489853|50643753|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
25327335|NCT00489853|50643754|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
25327336|NCT00489853|50643752|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
25327337|NCT00489853|50643753|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
25327338|NCT00489853|50643754|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
25327339|NCT03686423|50643762|FG000|Overall Study|Withdrawal by Subject|9|||
25327340|NCT03686423|50643762|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
25327341|NCT00499681|50643768|FG000|Overall Study|toxicity|0|||
25327342|NCT00499681|50643769|FG001|Overall Study|toxicity|1|||
25327343|NCT00499681|50643768|FG000|Overall Study|disease progression|0|||
25327344|NCT00499681|50643769|FG001|Overall Study|disease progression|1|||
25327345|NCT00875810|50643780|FG000|Overall Study|Withdrawal by Subject|1|||
25327346|NCT00875810|50643780|FG000|Overall Study|Physician Decision|3|||
25327347|NCT00875810|50643780|FG000|Overall Study|Lost to Follow-up|39|||
25327348|NCT00875810|50643780|FG000|Overall Study|Patient enroled but not implanted|2|||
25327349|NCT00875810|50643780|FG000|Overall Study|Device explanted|1|||
25327350|NCT00499603|50643786|FG000|Overall Study|Adverse Event|0|||
25327351|NCT00499603|50643787|FG001|Overall Study|Adverse Event|1|||
25327352|NCT00810069|50643806|FG000|Lead-in Period I|Adverse Event|43|||
25327353|NCT00810069|50643807|FG001|Lead-in Period I|Adverse Event|0|||
25327354|NCT00810069|50643808|FG002|Lead-in Period I|Adverse Event|0|||
25327355|NCT00810069|50643806|FG000|Lead-in Period I|Lack of Efficacy|1|||
25327356|NCT00810069|50643807|FG001|Lead-in Period I|Lack of Efficacy|0|||
25327357|NCT00810069|50643808|FG002|Lead-in Period I|Lack of Efficacy|0|||
25327358|NCT00810069|50643806|FG000|Lead-in Period I|Lost to Follow-up|19|||
25327359|NCT00810069|50643807|FG001|Lead-in Period I|Lost to Follow-up|0|||
25327360|NCT00810069|50643808|FG002|Lead-in Period I|Lost to Follow-up|0|||
25327361|NCT00810069|50643806|FG000|Lead-in Period I|Physician Decision|1|||
25327362|NCT00810069|50643807|FG001|Lead-in Period I|Physician Decision|0|||
25327363|NCT00810069|50643808|FG002|Lead-in Period I|Physician Decision|0|||
25327364|NCT00810069|50643806|FG000|Lead-in Period I|Protocol Violation|1|||
25327365|NCT00810069|50643807|FG001|Lead-in Period I|Protocol Violation|0|||
25327366|NCT00810069|50643808|FG002|Lead-in Period I|Protocol Violation|0|||
25327367|NCT00810069|50643806|FG000|Lead-in Period I|Withdrawal by Subject|46|||
25327368|NCT00810069|50643807|FG001|Lead-in Period I|Withdrawal by Subject|0|||
25327369|NCT00810069|50643808|FG002|Lead-in Period I|Withdrawal by Subject|0|||
25327370|NCT00810069|50643806|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
25327371|NCT00810069|50643807|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
25327372|NCT00810069|50643808|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
25327373|NCT00810069|50643806|FG000|Lead-in Period I|Randomization criteria not met|158|||
25327374|NCT00810069|50643807|FG001|Lead-in Period I|Randomization criteria not met|0|||
25327375|NCT00810069|50643808|FG002|Lead-in Period I|Randomization criteria not met|0|||
25327376|NCT00810069|50643806|FG000|Double-Blind Period II|Adverse Event|0|||
25327377|NCT00810069|50643807|FG001|Double-Blind Period II|Adverse Event|9|||
25327378|NCT00810069|50643808|FG002|Double-Blind Period II|Adverse Event|8|||
25327379|NCT00810069|50643806|FG000|Double-Blind Period II|Lack of Efficacy|0|||
25247209|NCT01658826|50562804|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
25247210|NCT01658826|50562803|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
25247211|NCT01658826|50562804|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
25247212|NCT01186744|50562820|FG000|Overall Study|Lack of Efficacy|156|||
25247213|NCT01186744|50562821|FG001|Overall Study|Lack of Efficacy|99|||
25247214|NCT01186744|50562822|FG002|Overall Study|Lack of Efficacy|0|||
25247215|NCT01186744|50562823|FG003|Overall Study|Lack of Efficacy|2|||
25247216|NCT01186744|50562824|FG004|Overall Study|Lack of Efficacy|2|||
25247217|NCT01186744|50562825|FG005|Overall Study|Lack of Efficacy|5|||
25247218|NCT01186744|50562820|FG000|Overall Study|Protocol Violation|1|||
25247219|NCT01186744|50562821|FG001|Overall Study|Protocol Violation|2|||
25247220|NCT01186744|50562822|FG002|Overall Study|Protocol Violation|0|||
25247221|NCT01186744|50562823|FG003|Overall Study|Protocol Violation|1|||
25247222|NCT01186744|50562824|FG004|Overall Study|Protocol Violation|1|||
25247223|NCT01186744|50562825|FG005|Overall Study|Protocol Violation|2|||
25247224|NCT01186744|50562820|FG000|Overall Study|Lost to Follow-up|15|||
25247225|NCT01186744|50562821|FG001|Overall Study|Lost to Follow-up|16|||
25327380|NCT00810069|50643807|FG001|Double-Blind Period II|Lack of Efficacy|7|||
25327381|NCT00810069|50643808|FG002|Double-Blind Period II|Lack of Efficacy|12|||
25327382|NCT00810069|50643806|FG000|Double-Blind Period II|Lost to Follow-up|0|||
25327383|NCT00810069|50643807|FG001|Double-Blind Period II|Lost to Follow-up|9|||
25327384|NCT00810069|50643808|FG002|Double-Blind Period II|Lost to Follow-up|9|||
25247226|NCT01186744|50562822|FG002|Overall Study|Lost to Follow-up|2|||
25247227|NCT01186744|50562823|FG003|Overall Study|Lost to Follow-up|1|||
25327385|NCT00810069|50643806|FG000|Double-Blind Period II|Physician Decision|0|||
25327386|NCT00810069|50643807|FG001|Double-Blind Period II|Physician Decision|0|||
25327387|NCT00810069|50643808|FG002|Double-Blind Period II|Physician Decision|1|||
25327388|NCT00810069|50643806|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
25327389|NCT00810069|50643807|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
25247228|NCT01186744|50562824|FG004|Overall Study|Lost to Follow-up|1|||
25247229|NCT01186744|50562825|FG005|Overall Study|Lost to Follow-up|4|||
25247230|NCT01186744|50562820|FG000|Overall Study|Screen failure|1|||
25247231|NCT01186744|50562821|FG001|Overall Study|Screen failure|1|||
25247232|NCT01186744|50562822|FG002|Overall Study|Screen failure|0|||
25247233|NCT01186744|50562823|FG003|Overall Study|Screen failure|1|||
25247234|NCT01186744|50562824|FG004|Overall Study|Screen failure|0|||
25247235|NCT01186744|50562825|FG005|Overall Study|Screen failure|0|||
25247236|NCT01186744|50562820|FG000|Overall Study|Withdrawal by Subject|14|||
25247237|NCT01186744|50562821|FG001|Overall Study|Withdrawal by Subject|10|||
25247238|NCT01186744|50562822|FG002|Overall Study|Withdrawal by Subject|2|||
25247239|NCT01186744|50562823|FG003|Overall Study|Withdrawal by Subject|5|||
25247240|NCT01186744|50562824|FG004|Overall Study|Withdrawal by Subject|0|||
25247241|NCT01186744|50562825|FG005|Overall Study|Withdrawal by Subject|6|||
25247242|NCT01186744|50562820|FG000|Overall Study|Study terminated by Sponsor|1|||
25247243|NCT01186744|50562821|FG001|Overall Study|Study terminated by Sponsor|0|||
25247244|NCT01186744|50562822|FG002|Overall Study|Study terminated by Sponsor|0|||
25247245|NCT01186744|50562823|FG003|Overall Study|Study terminated by Sponsor|0|||
25327390|NCT00810069|50643808|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
25327391|NCT00810069|50643806|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
25327392|NCT00810069|50643807|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
25327393|NCT00810069|50643808|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
25327394|NCT00810069|50643806|FG000|Double-Blind Period II|Clinical relapse|0|||
25327395|NCT00810069|50643807|FG001|Double-Blind Period II|Clinical relapse|3|||
25327396|NCT00810069|50643808|FG002|Double-Blind Period II|Clinical relapse|0|||
25327397|NCT00810069|50643806|FG000|Double-Blind Period II|Protocol Violation|0|||
25327398|NCT00810069|50643807|FG001|Double-Blind Period II|Protocol Violation|7|||
25327399|NCT00810069|50643808|FG002|Double-Blind Period II|Protocol Violation|6|||
25327400|NCT00489541|50643819|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
25327401|NCT00489541|50643820|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
25327402|NCT00489541|50643819|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
25327403|NCT00489541|50643820|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
25327404|NCT00489541|50643819|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
25327405|NCT00489541|50643820|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
25327406|NCT00489541|50643819|FG000|12-Month Clinical Follow-up|Death|3|||
25327407|NCT00489541|50643820|FG001|12-Month Clinical Follow-up|Death|2|||
25327408|NCT00489541|50643819|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
25327409|NCT00489541|50643820|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
25327410|NCT00489541|50643819|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
25327411|NCT00489541|50643820|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
25327412|NCT00809835|50643830|FG000|Overall Study|Lost to Follow-up|7|||
25327413|NCT00809835|50643831|FG001|Overall Study|Lost to Follow-up|6|||
25327414|NCT00809835|50643832|FG002|Overall Study|Lost to Follow-up|10|||
25327415|NCT00809835|50643833|FG003|Overall Study|Lost to Follow-up|2|||
25327416|NCT00809835|50643830|FG000|Overall Study|Withdrawal by Subject|1|||
25247246|NCT01186744|50562824|FG004|Overall Study|Study terminated by Sponsor|0|||
25247247|NCT01186744|50562825|FG005|Overall Study|Study terminated by Sponsor|0|||
25247248|NCT01186744|50562820|FG000|Overall Study|Other|9|||
25247249|NCT01186744|50562821|FG001|Overall Study|Other|10|||
25247250|NCT01186744|50562822|FG002|Overall Study|Other|1|||
25247251|NCT01186744|50562823|FG003|Overall Study|Other|2|||
25247252|NCT01186744|50562824|FG004|Overall Study|Other|1|||
25327417|NCT00809835|50643831|FG001|Overall Study|Withdrawal by Subject|1|||
25327418|NCT00809835|50643832|FG002|Overall Study|Withdrawal by Subject|1|||
25327419|NCT00809835|50643833|FG003|Overall Study|Withdrawal by Subject|0|||
24977251|NCT03410992|50065849|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
25247253|NCT01186744|50562825|FG005|Overall Study|Other|5|||
25247254|NCT01186744|50562820|FG000|Overall Study|Adverse Event|10|||
25247255|NCT01186744|50562821|FG001|Overall Study|Adverse Event|14|||
25247256|NCT01186744|50562822|FG002|Overall Study|Adverse Event|1|||
25247257|NCT01186744|50562823|FG003|Overall Study|Adverse Event|0|||
25247258|NCT01186744|50562824|FG004|Overall Study|Adverse Event|1|||
25327420|NCT00853242|50643850|FG000|Overall Study|Adverse Event|0|||
25327421|NCT00853242|50643851|FG001|Overall Study|Adverse Event|1|||
25327422|NCT00853242|50643852|FG002|Overall Study|Adverse Event|1|||
25327423|NCT00853242|50643853|FG003|Overall Study|Adverse Event|0|||
25327424|NCT00853242|50643854|FG004|Overall Study|Adverse Event|3|||
25327425|NCT00853242|50643855|FG005|Overall Study|Adverse Event|1|||
25327426|NCT00853242|50643856|FG006|Overall Study|Adverse Event|1|||
25327427|NCT00853242|50643850|FG000|Overall Study|Noncompliant|0|||
25327428|NCT00853242|50643851|FG001|Overall Study|Noncompliant|0|||
25327429|NCT00853242|50643852|FG002|Overall Study|Noncompliant|0|||
25327430|NCT00853242|50643853|FG003|Overall Study|Noncompliant|0|||
25327431|NCT00853242|50643854|FG004|Overall Study|Noncompliant|1|||
25327432|NCT00853242|50643855|FG005|Overall Study|Noncompliant|0|||
25327433|NCT00853242|50643856|FG006|Overall Study|Noncompliant|0|||
25327434|NCT00853242|50643850|FG000|Overall Study|Withdrawal by Subject|1|||
25327435|NCT00853242|50643851|FG001|Overall Study|Withdrawal by Subject|2|||
25327436|NCT00853242|50643852|FG002|Overall Study|Withdrawal by Subject|0|||
25327437|NCT00853242|50643853|FG003|Overall Study|Withdrawal by Subject|4|||
25327438|NCT00853242|50643854|FG004|Overall Study|Withdrawal by Subject|0|||
25327439|NCT00853242|50643855|FG005|Overall Study|Withdrawal by Subject|0|||
25327440|NCT00853242|50643856|FG006|Overall Study|Withdrawal by Subject|2|||
25327441|NCT00853242|50643850|FG000|Overall Study|Other|2|||
25327442|NCT00853242|50643851|FG001|Overall Study|Other|0|||
25327443|NCT00853242|50643852|FG002|Overall Study|Other|2|||
25327444|NCT00853242|50643853|FG003|Overall Study|Other|0|||
25327445|NCT00853242|50643854|FG004|Overall Study|Other|0|||
25327446|NCT00853242|50643855|FG005|Overall Study|Other|1|||
25327447|NCT00853242|50643856|FG006|Overall Study|Other|2|||
25327448|NCT00848250|50643880|FG000|Overall Study|surgery was completed without cardiopulm|0|||
25327449|NCT00848250|50643881|FG001|Overall Study|surgery was completed without cardiopulm|1|||
25327450|NCT00809757|50643891|FG000|Overall Study|Adverse Event|2|||
25327451|NCT00809757|50643892|FG001|Overall Study|Adverse Event|3|||
25327452|NCT00809757|50643893|FG002|Overall Study|Adverse Event|3|||
25327453|NCT00809757|50643891|FG000|Overall Study|Lost to Follow-up|0|||
25327454|NCT00809757|50643892|FG001|Overall Study|Lost to Follow-up|0|||
25327455|NCT00809757|50643893|FG002|Overall Study|Lost to Follow-up|1|||
25327456|NCT00809757|50643891|FG000|Overall Study|Protocol Violation|1|||
25327457|NCT00809757|50643892|FG001|Overall Study|Protocol Violation|1|||
25327458|NCT00809757|50643893|FG002|Overall Study|Protocol Violation|1|||
25327459|NCT00809757|50643891|FG000|Overall Study|Withdrawal by Subject|2|||
25327460|NCT00809757|50643892|FG001|Overall Study|Withdrawal by Subject|1|||
25327461|NCT00809757|50643893|FG002|Overall Study|Withdrawal by Subject|3|||
25327462|NCT00809757|50643891|FG000|Overall Study|Subject Uncooperative|1|||
25327463|NCT00809757|50643892|FG001|Overall Study|Subject Uncooperative|0|||
25327464|NCT00809757|50643893|FG002|Overall Study|Subject Uncooperative|2|||
25327465|NCT00809757|50643891|FG000|Overall Study|Noncompliance with Medication|0|||
25327466|NCT00809757|50643892|FG001|Overall Study|Noncompliance with Medication|0|||
25327467|NCT00809757|50643893|FG002|Overall Study|Noncompliance with Medication|1|||
25327468|NCT00594464|50643907|FG000|Overall Study|Withdrawal by Subject|1|||
25327469|NCT00594464|50643907|FG000|Overall Study|Delay in operation|2|||
25327470|NCT00809445|50643920|FG000|1 Month Follow-up|Lost contact|1|||
25327471|NCT00809445|50643921|FG001|1 Month Follow-up|Lost contact|2|||
25327472|NCT00809445|50643922|FG002|1 Month Follow-up|Lost contact|1|||
25327473|NCT00809445|50643920|FG000|1 Month Follow-up|Withdrew consent|1|||
25247259|NCT01186744|50562825|FG005|Overall Study|Adverse Event|4|||
25247260|NCT01186744|50562820|FG000|Overall Study|Death|1|||
25247261|NCT01186744|50562821|FG001|Overall Study|Death|0|||
25247262|NCT01186744|50562822|FG002|Overall Study|Death|0|||
25247263|NCT01186744|50562823|FG003|Overall Study|Death|0|||
25247264|NCT01186744|50562824|FG004|Overall Study|Death|0|||
25247265|NCT01186744|50562825|FG005|Overall Study|Death|0|||
25247266|NCT01185964|50562863|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
25247267|NCT01185964|50562864|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
25247268|NCT01185964|50562865|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
25247269|NCT01185964|50562866|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
25327474|NCT00809445|50643921|FG001|1 Month Follow-up|Withdrew consent|1|||
25327475|NCT00809445|50643922|FG002|1 Month Follow-up|Withdrew consent|1|||
25327476|NCT00809445|50643920|FG000|1 Month Follow-up|Death|0|||
25327477|NCT00809445|50643921|FG001|1 Month Follow-up|Death|1|||
25327478|NCT00809445|50643922|FG002|1 Month Follow-up|Death|1|||
25327479|NCT00809445|50643920|FG000|1 Month Follow-up|Incarcerated|0|||
25327480|NCT00809445|50643921|FG001|1 Month Follow-up|Incarcerated|0|||
25327481|NCT00809445|50643922|FG002|1 Month Follow-up|Incarcerated|1|||
25247270|NCT01185964|50562863|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
25247271|NCT01185964|50562864|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
25247272|NCT01185964|50562865|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
25327482|NCT00809445|50643920|FG000|6 Month Follow-up|Lost contact|16|||
25327483|NCT00809445|50643921|FG001|6 Month Follow-up|Lost contact|14|||
25327484|NCT00809445|50643922|FG002|6 Month Follow-up|Lost contact|14|||
25327485|NCT00809445|50643920|FG000|6 Month Follow-up|Death|2|||
25327486|NCT00809445|50643921|FG001|6 Month Follow-up|Death|1|||
25327487|NCT00809445|50643922|FG002|6 Month Follow-up|Death|1|||
25327488|NCT00809445|50643920|FG000|6 Month Follow-up|Incarcerated|6|||
25327489|NCT00809445|50643921|FG001|6 Month Follow-up|Incarcerated|8|||
25327490|NCT00809445|50643922|FG002|6 Month Follow-up|Incarcerated|8|||
25327491|NCT00809445|50643920|FG000|6 Month Follow-up|Withdrew consent|0|||
25327492|NCT00809445|50643921|FG001|6 Month Follow-up|Withdrew consent|0|||
25327493|NCT00809445|50643922|FG002|6 Month Follow-up|Withdrew consent|1|||
25327494|NCT00593918|50643945|FG000|Overall Study|Withdrawal by Subject|5|||
25327495|NCT00593918|50643946|FG001|Overall Study|Withdrawal by Subject|24|||
25327496|NCT00593840|50643952|FG000|Overall Study|Withdrawal by Subject|1|||
25327497|NCT00499369|50643961|FG000|Overall Study|Adverse Event|2|||
25327498|NCT00499369|50643962|FG001|Overall Study|Adverse Event|2|||
25327499|NCT00499369|50643963|FG002|Overall Study|Adverse Event|3|||
25327500|NCT00499369|50643964|FG003|Overall Study|Adverse Event|1|||
25247273|NCT01185964|50562866|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
25247274|NCT01185964|50562863|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
25247275|NCT01185964|50562864|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
25247276|NCT01185964|50562865|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
25247277|NCT01185964|50562866|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
25327501|NCT00499369|50643965|FG004|Overall Study|Adverse Event|2|||
25327502|NCT00499369|50643961|FG000|Overall Study|Withdrawal by Subject|0|||
25327503|NCT00499369|50643962|FG001|Overall Study|Withdrawal by Subject|1|||
25327504|NCT00499369|50643963|FG002|Overall Study|Withdrawal by Subject|1|||
25327505|NCT00499369|50643964|FG003|Overall Study|Withdrawal by Subject|0|||
25327506|NCT00499369|50643965|FG004|Overall Study|Withdrawal by Subject|0|||
25327507|NCT00499369|50643961|FG000|Overall Study|Progression|10|||
25327508|NCT00499369|50643962|FG001|Overall Study|Progression|12|||
25327509|NCT00499369|50643963|FG002|Overall Study|Progression|9|||
25327510|NCT00499369|50643964|FG003|Overall Study|Progression|6|||
25327511|NCT00499369|50643965|FG004|Overall Study|Progression|10|||
25327512|NCT00499369|50643961|FG000|Overall Study|Death|0|||
25327513|NCT00499369|50643962|FG001|Overall Study|Death|1|||
25327514|NCT00499369|50643963|FG002|Overall Study|Death|0|||
25327515|NCT00499369|50643964|FG003|Overall Study|Death|0|||
25327516|NCT00499369|50643965|FG004|Overall Study|Death|0|||
25327517|NCT00499369|50643961|FG000|Overall Study|Not protocol specified|2|||
25327518|NCT00499369|50643962|FG001|Overall Study|Not protocol specified|0|||
25327519|NCT00499369|50643963|FG002|Overall Study|Not protocol specified|3|||
25327520|NCT00499369|50643964|FG003|Overall Study|Not protocol specified|1|||
25327521|NCT00499369|50643965|FG004|Overall Study|Not protocol specified|0|||
25327522|NCT00499369|50643961|FG000|Overall Study|Ineligible|2|||
25247278|NCT01185964|50562863|FG000|Phase 1b and Phase 2|Adverse Event|1|||
25327523|NCT00499369|50643962|FG001|Overall Study|Ineligible|2|||
25327524|NCT00499369|50643963|FG002|Overall Study|Ineligible|1|||
25327525|NCT00499369|50643964|FG003|Overall Study|Ineligible|1|||
25327526|NCT00499369|50643965|FG004|Overall Study|Ineligible|0|||
25327527|NCT00869258|50643977|FG000|Overall Study|Physician Decision|1|||
25327528|NCT00693784|50643981|FG000|Overall Study|Lost to Follow-up|2|||
25327529|NCT00693784|50643981|FG000|Overall Study|Withdrawal by Subject|2|||
25247279|NCT01185964|50562864|FG001|Phase 1b and Phase 2|Adverse Event|0|||
25247280|NCT01185964|50562865|FG002|Phase 1b and Phase 2|Adverse Event|2|||
25247281|NCT01185964|50562866|FG003|Phase 1b and Phase 2|Adverse Event|0|||
25247282|NCT01185964|50562863|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
25247283|NCT01185964|50562864|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
25247284|NCT01185964|50562865|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
25247285|NCT01185964|50562866|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
25247286|NCT01185964|50562863|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
25247287|NCT01185964|50562864|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
25247288|NCT01185964|50562865|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
25247289|NCT01185964|50562866|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
25247290|NCT01185964|50562863|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
25247291|NCT01185964|50562864|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
25327530|NCT00693706|50643987|FG000|Overall Study|Protocol Violation|0|||
25327531|NCT00693706|50643988|FG001|Overall Study|Protocol Violation|1|||
25327532|NCT00488683|50643997|FG000|Overall Study|Withdrawal by Subject|1|||
25327533|NCT00488683|50643998|FG001|Overall Study|Withdrawal by Subject|2|||
25327534|NCT00488683|50643999|FG002|Overall Study|Withdrawal by Subject|2|||
25327535|NCT00488683|50643997|FG000|Overall Study|Lost to Follow-up|5|||
25327536|NCT00488683|50643998|FG001|Overall Study|Lost to Follow-up|3|||
25327537|NCT00488683|50643999|FG002|Overall Study|Lost to Follow-up|0|||
25327538|NCT00488683|50643997|FG000|Overall Study|Protocol Violation|5|||
25327539|NCT00488683|50643998|FG001|Overall Study|Protocol Violation|1|||
25327540|NCT00488683|50643999|FG002|Overall Study|Protocol Violation|0|||
25327541|NCT00488683|50643997|FG000|Overall Study|Unable to Classify|1|||
25327542|NCT00488683|50643998|FG001|Overall Study|Unable to Classify|0|||
25247292|NCT01185964|50562865|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
25247293|NCT01185964|50562866|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
25247294|NCT01185964|50562863|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
25247295|NCT01185964|50562864|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
25247296|NCT01185964|50562865|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
25247297|NCT01185964|50562866|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
25247298|NCT01217476|50562884|FG000|Overall Study|Adverse Event|6|||
25327543|NCT00488683|50643999|FG002|Overall Study|Unable to Classify|0|||
25327544|NCT00693472|50644033|FG000|Part 1|Adverse Event|1|||
25327545|NCT00693472|50644034|FG001|Part 1|Adverse Event|1|||
25327546|NCT00693472|50644035|FG002|Part 1|Adverse Event|0|||
25327547|NCT00693472|50644036|FG003|Part 1|Adverse Event|0|||
25327548|NCT00693472|50644033|FG000|Part 1|Lost to Follow-up|0|||
25327549|NCT00693472|50644034|FG001|Part 1|Lost to Follow-up|1|||
25247299|NCT01217476|50562885|FG001|Overall Study|Adverse Event|1|||
25247300|NCT01217476|50562884|FG000|Overall Study|Physician Decision|0|||
25247301|NCT01217476|50562885|FG001|Overall Study|Physician Decision|1|||
25247302|NCT01217476|50562884|FG000|Overall Study|Withdrawal by Subject|3|||
25247303|NCT01217476|50562885|FG001|Overall Study|Withdrawal by Subject|3|||
25247304|NCT01217476|50562884|FG000|Overall Study|Surgery on the Target Limb|0|||
25247305|NCT01217476|50562885|FG001|Overall Study|Surgery on the Target Limb|2|||
25247306|NCT01217476|50562884|FG000|Overall Study|Protocol Deviation|1|||
25247307|NCT01217476|50562885|FG001|Overall Study|Protocol Deviation|0|||
25247308|NCT01217476|50562884|FG000|Overall Study|Other|2|||
25247309|NCT01217476|50562885|FG001|Overall Study|Other|0|||
25327550|NCT00693472|50644035|FG002|Part 1|Lost to Follow-up|0|||
25327551|NCT00693472|50644036|FG003|Part 1|Lost to Follow-up|0|||
25327552|NCT00693472|50644033|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
25327553|NCT00693472|50644034|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
25327554|NCT00693472|50644035|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
25327555|NCT00693472|50644036|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
25327556|NCT00693472|50644033|FG000|Part 2|Adverse Event|0|||
25327557|NCT00693472|50644034|FG001|Part 2|Adverse Event|0|||
25327558|NCT00693472|50644035|FG002|Part 2|Adverse Event|1|||
25327559|NCT00693472|50644036|FG003|Part 2|Adverse Event|0|||
25327560|NCT00693472|50644033|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
25327561|NCT00693472|50644034|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
25327562|NCT00693472|50644035|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
25327563|NCT00693472|50644036|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
25327564|NCT00498433|50644049|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
25327565|NCT00498433|50644050|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
25327566|NCT00498433|50644051|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
25327567|NCT00498433|50644049|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
25327568|NCT00498433|50644050|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
25327569|NCT00498433|50644051|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
25327570|NCT00498433|50644049|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
25327571|NCT00498433|50644050|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
25327572|NCT00498433|50644051|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
25327573|NCT00498433|50644049|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
25327574|NCT00498433|50644050|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
25327575|NCT00498433|50644051|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
25327576|NCT00498355|50644068|FG000|Overall Study|Lost to Follow-up|1|||
25327577|NCT04327271|50644075|FG000|Overall Study|Death|1|||
25327578|NCT04327271|50644076|FG001|Overall Study|Death|0|||
25327579|NCT04327271|50644075|FG000|Overall Study|Withdrawal by Subject|1|||
25327580|NCT04327271|50644076|FG001|Overall Study|Withdrawal by Subject|0|||
25327581|NCT04327271|50644075|FG000|Overall Study|randomization error (data capture)|4|||
25327582|NCT04327271|50644076|FG001|Overall Study|randomization error (data capture)|3|||
25327583|NCT00688636|50644093|FG000|Overall Study|Adverse Event|2|||
25327584|NCT00688636|50644094|FG001|Overall Study|Adverse Event|1|||
25327585|NCT00870740|50644106|FG000|Overall Study|Adverse Event|2|||
25327586|NCT00870740|50644107|FG001|Overall Study|Adverse Event|1|||
25327587|NCT00870740|50644108|FG002|Overall Study|Adverse Event|3|||
25247310|NCT01217437|50562906|FG000|Overall Study|Adverse Event|0|||
25327588|NCT00870740|50644109|FG003|Overall Study|Adverse Event|2|||
25327589|NCT00870740|50644110|FG004|Overall Study|Adverse Event|1|||
25327590|NCT00870740|50644111|FG005|Overall Study|Adverse Event|6|||
25327591|NCT00870740|50644106|FG000|Overall Study|Consent Withdrawn|6|||
25247311|NCT01217437|50562907|FG001|Overall Study|Adverse Event|8|||
25247312|NCT01217437|50562906|FG000|Overall Study|Death|5|||
25247313|NCT01217437|50562907|FG001|Overall Study|Death|0|||
25327592|NCT00870740|50644107|FG001|Overall Study|Consent Withdrawn|3|||
25327593|NCT00870740|50644108|FG002|Overall Study|Consent Withdrawn|4|||
25327594|NCT00870740|50644109|FG003|Overall Study|Consent Withdrawn|6|||
25327595|NCT00870740|50644110|FG004|Overall Study|Consent Withdrawn|6|||
25327596|NCT00870740|50644111|FG005|Overall Study|Consent Withdrawn|5|||
25327597|NCT00870740|50644106|FG000|Overall Study|Investigator Decision|2|||
25327598|NCT00870740|50644107|FG001|Overall Study|Investigator Decision|0|||
25327599|NCT00870740|50644108|FG002|Overall Study|Investigator Decision|1|||
25327600|NCT00870740|50644109|FG003|Overall Study|Investigator Decision|0|||
25327601|NCT00870740|50644110|FG004|Overall Study|Investigator Decision|0|||
25327602|NCT00870740|50644111|FG005|Overall Study|Investigator Decision|0|||
25327603|NCT00870740|50644106|FG000|Overall Study|Subject Non-compliance|0|||
25327604|NCT00870740|50644107|FG001|Overall Study|Subject Non-compliance|0|||
25327605|NCT00870740|50644108|FG002|Overall Study|Subject Non-compliance|0|||
25327606|NCT00870740|50644109|FG003|Overall Study|Subject Non-compliance|0|||
25327607|NCT00870740|50644110|FG004|Overall Study|Subject Non-compliance|0|||
25327608|NCT00870740|50644111|FG005|Overall Study|Subject Non-compliance|1|||
25327609|NCT00870740|50644106|FG000|Overall Study|Death|0|||
25247314|NCT01217437|50562906|FG000|Overall Study|Lack of Efficacy|29|||
25247315|NCT01217437|50562907|FG001|Overall Study|Lack of Efficacy|25|||
25247316|NCT01217437|50562906|FG000|Overall Study|Physician Decision|8|||
25247317|NCT01217437|50562907|FG001|Overall Study|Physician Decision|5|||
25247318|NCT01217437|50562906|FG000|Overall Study|Withdrawal by Subject|0|||
25247319|NCT01217437|50562907|FG001|Overall Study|Withdrawal by Subject|2|||
25247320|NCT01217437|50562906|FG000|Overall Study|Ineligible|1|||
25247321|NCT01217437|50562907|FG001|Overall Study|Ineligible|1|||
25247322|NCT01217047|50562917|FG000|Overall Study|Lost to Follow-up|0|||
25247323|NCT01217047|50562918|FG001|Overall Study|Lost to Follow-up|1|||
25247324|NCT01217047|50562919|FG002|Overall Study|Lost to Follow-up|0|||
25247325|NCT01185340|50562931|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
25247326|NCT01185340|50562932|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
25247327|NCT01185340|50562933|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
25247328|NCT01185340|50562934|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
25247329|NCT01185340|50562931|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
25247330|NCT01185340|50562932|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
25247331|NCT01185340|50562933|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
25247332|NCT01185340|50562934|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
25247333|NCT01185340|50562931|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
25247334|NCT01185340|50562932|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
25247335|NCT01185340|50562933|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
25247336|NCT01185340|50562934|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
25247337|NCT01185340|50562931|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
25247338|NCT01185340|50562932|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
25247339|NCT01185340|50562933|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
25247340|NCT01185340|50562934|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
25247341|NCT01185340|50562931|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
25247342|NCT01185340|50562932|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
25247343|NCT01185340|50562933|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
25247344|NCT01185340|50562934|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
25247345|NCT01185340|50562931|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
25247346|NCT01185340|50562932|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
25247347|NCT01185340|50562933|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
25247348|NCT01185340|50562934|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
25247349|NCT01185340|50562931|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
25247350|NCT01185340|50562932|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
25247351|NCT01185340|50562933|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
25247352|NCT01185340|50562934|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
25247353|NCT01185340|50562931|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
25247354|NCT01185340|50562932|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
25247355|NCT01185340|50562933|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
25247356|NCT01185340|50562934|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
25247357|NCT01185340|50562931|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
25247358|NCT01185340|50562932|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
25247359|NCT01185340|50562933|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
25247360|NCT01185340|50562934|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
25247361|NCT01185340|50562931|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
25247362|NCT01185340|50562932|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
25327610|NCT00870740|50644107|FG001|Overall Study|Death|0|||
25247363|NCT01185340|50562933|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
25247364|NCT01185340|50562934|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
25327611|NCT00870740|50644108|FG002|Overall Study|Death|0|||
25327612|NCT00870740|50644109|FG003|Overall Study|Death|0|||
25327613|NCT00870740|50644110|FG004|Overall Study|Death|1|||
25327614|NCT00870740|50644111|FG005|Overall Study|Death|0|||
25327615|NCT00870740|50644106|FG000|Overall Study|Other|2|||
25247365|NCT01185340|50562931|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
25247366|NCT01185340|50562932|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
25327616|NCT00870740|50644107|FG001|Overall Study|Other|5|||
25327617|NCT00870740|50644108|FG002|Overall Study|Other|2|||
25327618|NCT00870740|50644109|FG003|Overall Study|Other|4|||
25327619|NCT00870740|50644110|FG004|Overall Study|Other|3|||
25327620|NCT00870740|50644111|FG005|Overall Study|Other|5|||
25327621|NCT00869024|50644138|FG000|Overall Study|Death|2|||
25327622|NCT00869024|50644139|FG001|Overall Study|Death|3|||
25327623|NCT00869024|50644138|FG000|Overall Study|Lost to Follow-up|0|||
25327624|NCT00869024|50644139|FG001|Overall Study|Lost to Follow-up|1|||
25327625|NCT00869024|50644138|FG000|Overall Study|Protocol Violation|0|||
25327626|NCT00869024|50644139|FG001|Overall Study|Protocol Violation|1|||
25327627|NCT00506779|50644147|FG000|Overall Study|Withdrawal by Subject|1|||
25327628|NCT00506779|50644148|FG001|Overall Study|Withdrawal by Subject|0|||
25327629|NCT00506779|50644149|FG002|Overall Study|Withdrawal by Subject|1|||
25327630|NCT00506779|50644150|FG003|Overall Study|Withdrawal by Subject|0|||
25327631|NCT00506779|50644147|FG000|Overall Study|Adverse Event|0|||
25327632|NCT00506779|50644148|FG001|Overall Study|Adverse Event|1|||
25327633|NCT00506779|50644149|FG002|Overall Study|Adverse Event|1|||
25327634|NCT00506779|50644150|FG003|Overall Study|Adverse Event|1|||
25327635|NCT00488293|50644163|FG000|Overall Study|Lost to Follow-up|28|||
25327636|NCT00488293|50644164|FG001|Overall Study|Lost to Follow-up|25|||
25327637|NCT00488293|50644163|FG000|Overall Study|Withdrawal by Subject|5|||
25077785|NCT03318523|50185665|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
25077786|NCT03318523|50185666|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
25077787|NCT03318523|50185667|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
25077788|NCT03318523|50185668|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
25077789|NCT03318523|50185669|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
25077790|NCT03318523|50185670|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
25077791|NCT03318523|50185671|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
25077792|NCT03318523|50185672|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
25077793|NCT03318523|50185663|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
25077794|NCT03318523|50185664|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
25247367|NCT01185340|50562933|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
25247368|NCT01185340|50562934|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
25327638|NCT00488293|50644164|FG001|Overall Study|Withdrawal by Subject|3|||
25327639|NCT00488293|50644163|FG000|Overall Study|Death|2|||
25327640|NCT00488293|50644164|FG001|Overall Study|Death|1|||
25327641|NCT00488293|50644163|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
25327642|NCT00488293|50644164|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
25327643|NCT00868790|50644170|FG000|Period 1|Adverse Event|1|||
25327644|NCT00868790|50644171|FG001|Period 1|Adverse Event|0|||
25327645|NCT00868790|50644172|FG002|Period 1|Adverse Event|0|||
25327646|NCT00868790|50644173|FG003|Period 1|Adverse Event|0|||
25327647|NCT00868790|50644174|FG004|Period 1|Adverse Event|0|||
25327648|NCT00868790|50644175|FG005|Period 1|Adverse Event|0|||
25327649|NCT00868790|50644176|FG006|Period 1|Adverse Event|0|||
25327650|NCT00868790|50644177|FG007|Period 1|Adverse Event|3|||
25327651|NCT00868790|50644178|FG008|Period 1|Adverse Event|1|||
25327652|NCT00868790|50644179|FG009|Period 1|Adverse Event|0|||
25327653|NCT00868790|50644180|FG010|Period 1|Adverse Event|0|||
25327654|NCT00868790|50644181|FG011|Period 1|Adverse Event|0|||
25327655|NCT00868790|50644182|FG012|Period 1|Adverse Event|0|||
25327656|NCT00868790|50644183|FG013|Period 1|Adverse Event|1|||
25327657|NCT00868790|50644170|FG000|Period 1|Protocol Violation|1|||
25327658|NCT00868790|50644171|FG001|Period 1|Protocol Violation|0|||
25327659|NCT00868790|50644172|FG002|Period 1|Protocol Violation|0|||
25327660|NCT00868790|50644173|FG003|Period 1|Protocol Violation|0|||
25247369|NCT01185340|50562931|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
25247370|NCT01185340|50562932|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
25247371|NCT01185340|50562933|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
25247372|NCT01185340|50562934|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
25247373|NCT01185340|50562931|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
25327661|NCT00868790|50644174|FG004|Period 1|Protocol Violation|0|||
25327662|NCT00868790|50644175|FG005|Period 1|Protocol Violation|0|||
25327663|NCT00868790|50644176|FG006|Period 1|Protocol Violation|0|||
25327664|NCT00868790|50644177|FG007|Period 1|Protocol Violation|0|||
25327665|NCT00868790|50644178|FG008|Period 1|Protocol Violation|0|||
25327666|NCT00868790|50644179|FG009|Period 1|Protocol Violation|0|||
25327667|NCT00868790|50644180|FG010|Period 1|Protocol Violation|0|||
25327668|NCT00868790|50644181|FG011|Period 1|Protocol Violation|0|||
25327669|NCT00868790|50644182|FG012|Period 1|Protocol Violation|0|||
25327670|NCT00868790|50644183|FG013|Period 1|Protocol Violation|0|||
25327671|NCT00868790|50644170|FG000|Period 1|Withdrawal by Subject|0|||
25327672|NCT00868790|50644171|FG001|Period 1|Withdrawal by Subject|1|||
25327673|NCT00868790|50644172|FG002|Period 1|Withdrawal by Subject|0|||
25327674|NCT00868790|50644173|FG003|Period 1|Withdrawal by Subject|0|||
25327675|NCT00868790|50644174|FG004|Period 1|Withdrawal by Subject|0|||
25327676|NCT00868790|50644175|FG005|Period 1|Withdrawal by Subject|0|||
25327677|NCT00868790|50644176|FG006|Period 1|Withdrawal by Subject|0|||
25327678|NCT00868790|50644177|FG007|Period 1|Withdrawal by Subject|0|||
25327679|NCT00868790|50644178|FG008|Period 1|Withdrawal by Subject|0|||
25327680|NCT00868790|50644179|FG009|Period 1|Withdrawal by Subject|0|||
25327681|NCT00868790|50644180|FG010|Period 1|Withdrawal by Subject|0|||
25327682|NCT00868790|50644181|FG011|Period 1|Withdrawal by Subject|0|||
25327683|NCT00868790|50644182|FG012|Period 1|Withdrawal by Subject|0|||
25327684|NCT00868790|50644183|FG013|Period 1|Withdrawal by Subject|1|||
25327685|NCT00868790|50644170|FG000|Period 1|Abnormal Triglycerides|0|||
25327686|NCT00868790|50644171|FG001|Period 1|Abnormal Triglycerides|0|||
25327687|NCT00868790|50644172|FG002|Period 1|Abnormal Triglycerides|0|||
25327688|NCT00868790|50644173|FG003|Period 1|Abnormal Triglycerides|0|||
25327689|NCT00868790|50644174|FG004|Period 1|Abnormal Triglycerides|1|||
25327690|NCT00868790|50644175|FG005|Period 1|Abnormal Triglycerides|0|||
25327691|NCT00868790|50644176|FG006|Period 1|Abnormal Triglycerides|0|||
25327692|NCT00868790|50644177|FG007|Period 1|Abnormal Triglycerides|0|||
25327693|NCT00868790|50644178|FG008|Period 1|Abnormal Triglycerides|0|||
25327694|NCT00868790|50644179|FG009|Period 1|Abnormal Triglycerides|0|||
25327695|NCT00868790|50644180|FG010|Period 1|Abnormal Triglycerides|0|||
25327696|NCT00868790|50644181|FG011|Period 1|Abnormal Triglycerides|0|||
25327697|NCT00868790|50644182|FG012|Period 1|Abnormal Triglycerides|0|||
25327698|NCT00868790|50644183|FG013|Period 1|Abnormal Triglycerides|0|||
25327699|NCT00868790|50644170|FG000|Period 1|Lost to Follow-up|0|||
25327700|NCT00868790|50644171|FG001|Period 1|Lost to Follow-up|0|||
25327701|NCT00868790|50644172|FG002|Period 1|Lost to Follow-up|0|||
25327702|NCT00868790|50644173|FG003|Period 1|Lost to Follow-up|0|||
25327703|NCT00868790|50644174|FG004|Period 1|Lost to Follow-up|0|||
25327704|NCT00868790|50644175|FG005|Period 1|Lost to Follow-up|1|||
25327705|NCT00868790|50644176|FG006|Period 1|Lost to Follow-up|0|||
25327706|NCT00868790|50644177|FG007|Period 1|Lost to Follow-up|0|||
25327707|NCT00868790|50644178|FG008|Period 1|Lost to Follow-up|0|||
25327708|NCT00868790|50644179|FG009|Period 1|Lost to Follow-up|0|||
25327709|NCT00868790|50644180|FG010|Period 1|Lost to Follow-up|0|||
25327710|NCT00868790|50644181|FG011|Period 1|Lost to Follow-up|0|||
25327711|NCT00868790|50644182|FG012|Period 1|Lost to Follow-up|0|||
25327712|NCT00868790|50644183|FG013|Period 1|Lost to Follow-up|0|||
25327713|NCT00868790|50644170|FG000|Period 2|Adverse Event|0|||
25327714|NCT00868790|50644171|FG001|Period 2|Adverse Event|0|||
25327715|NCT00868790|50644172|FG002|Period 2|Adverse Event|0|||
25327716|NCT00868790|50644173|FG003|Period 2|Adverse Event|0|||
25327717|NCT00868790|50644174|FG004|Period 2|Adverse Event|0|||
25327718|NCT00868790|50644175|FG005|Period 2|Adverse Event|0|||
25327719|NCT00868790|50644176|FG006|Period 2|Adverse Event|0|||
25327720|NCT00868790|50644177|FG007|Period 2|Adverse Event|0|||
25327721|NCT00868790|50644178|FG008|Period 2|Adverse Event|1|||
25327722|NCT00868790|50644179|FG009|Period 2|Adverse Event|0|||
25327723|NCT00868790|50644180|FG010|Period 2|Adverse Event|0|||
25327724|NCT00868790|50644181|FG011|Period 2|Adverse Event|0|||
25327725|NCT00868790|50644182|FG012|Period 2|Adverse Event|0|||
25327726|NCT00868790|50644183|FG013|Period 2|Adverse Event|0|||
25247374|NCT01185340|50562932|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
25247375|NCT01185340|50562933|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
25247376|NCT01185340|50562934|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
25247377|NCT01185340|50562931|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
25247378|NCT01185340|50562932|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
25247379|NCT01185340|50562933|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
25247380|NCT01185340|50562934|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
25247381|NCT01216189|50562948|FG000|Overall Study|Lost to Follow-up|21|||
25247382|NCT01216189|50562949|FG001|Overall Study|Lost to Follow-up|3|||
25247383|NCT01216189|50562948|FG000|Overall Study|Death|4|||
25327727|NCT00868790|50644170|FG000|Period 2|Lost to Follow-up|0|||
25327728|NCT00868790|50644171|FG001|Period 2|Lost to Follow-up|1|||
25327729|NCT00868790|50644172|FG002|Period 2|Lost to Follow-up|0|||
25327730|NCT00868790|50644173|FG003|Period 2|Lost to Follow-up|0|||
25327731|NCT00868790|50644174|FG004|Period 2|Lost to Follow-up|0|||
25327732|NCT00868790|50644175|FG005|Period 2|Lost to Follow-up|1|||
25247384|NCT01216189|50562949|FG001|Overall Study|Death|2|||
25247385|NCT01185301|50562959|FG000|Overall Study|Adverse Event|3|||
25247386|NCT01185301|50562960|FG001|Overall Study|Adverse Event|0|||
25327733|NCT00868790|50644176|FG006|Period 2|Lost to Follow-up|0|||
25327734|NCT00868790|50644177|FG007|Period 2|Lost to Follow-up|0|||
25327735|NCT00868790|50644178|FG008|Period 2|Lost to Follow-up|0|||
25327736|NCT00868790|50644179|FG009|Period 2|Lost to Follow-up|0|||
25327737|NCT00868790|50644180|FG010|Period 2|Lost to Follow-up|0|||
25327738|NCT00868790|50644181|FG011|Period 2|Lost to Follow-up|0|||
25327739|NCT00868790|50644182|FG012|Period 2|Lost to Follow-up|0|||
25327740|NCT00868790|50644183|FG013|Period 2|Lost to Follow-up|0|||
25327741|NCT00868790|50644170|FG000|Period 2|Withdrawal by Subject|0|||
25327742|NCT00868790|50644171|FG001|Period 2|Withdrawal by Subject|0|||
25327743|NCT00868790|50644172|FG002|Period 2|Withdrawal by Subject|0|||
25327744|NCT00868790|50644173|FG003|Period 2|Withdrawal by Subject|0|||
25327745|NCT00868790|50644174|FG004|Period 2|Withdrawal by Subject|0|||
25247387|NCT01185301|50562961|FG002|Overall Study|Adverse Event|2|||
25247388|NCT01185301|50562962|FG003|Overall Study|Adverse Event|3|||
25247389|NCT01185301|50562959|FG000|Overall Study|Withdrawal by Subject|7|||
25247390|NCT01185301|50562960|FG001|Overall Study|Withdrawal by Subject|5|||
25247391|NCT01185301|50562961|FG002|Overall Study|Withdrawal by Subject|2|||
25247392|NCT01185301|50562962|FG003|Overall Study|Withdrawal by Subject|3|||
25327746|NCT00868790|50644175|FG005|Period 2|Withdrawal by Subject|0|||
25327747|NCT00868790|50644176|FG006|Period 2|Withdrawal by Subject|0|||
25327748|NCT00868790|50644177|FG007|Period 2|Withdrawal by Subject|0|||
25327749|NCT00868790|50644178|FG008|Period 2|Withdrawal by Subject|1|||
25327750|NCT00868790|50644179|FG009|Period 2|Withdrawal by Subject|0|||
25327751|NCT00868790|50644180|FG010|Period 2|Withdrawal by Subject|0|||
25327752|NCT00868790|50644181|FG011|Period 2|Withdrawal by Subject|0|||
25327753|NCT00868790|50644182|FG012|Period 2|Withdrawal by Subject|0|||
25327754|NCT00868790|50644183|FG013|Period 2|Withdrawal by Subject|1|||
25327755|NCT00868790|50644170|FG000|Period 3|Adverse Event|0|||
25327756|NCT00868790|50644171|FG001|Period 3|Adverse Event|0|||
25327757|NCT00868790|50644172|FG002|Period 3|Adverse Event|0|||
25327758|NCT00868790|50644173|FG003|Period 3|Adverse Event|0|||
25327759|NCT00868790|50644174|FG004|Period 3|Adverse Event|0|||
25327760|NCT00868790|50644175|FG005|Period 3|Adverse Event|0|||
25327761|NCT00868790|50644176|FG006|Period 3|Adverse Event|0|||
25327762|NCT00868790|50644177|FG007|Period 3|Adverse Event|0|||
25327763|NCT00868790|50644178|FG008|Period 3|Adverse Event|0|||
25327764|NCT00868790|50644179|FG009|Period 3|Adverse Event|1|||
25327765|NCT00868790|50644180|FG010|Period 3|Adverse Event|0|||
25327766|NCT00868790|50644181|FG011|Period 3|Adverse Event|0|||
25327767|NCT00868790|50644182|FG012|Period 3|Adverse Event|0|||
25327768|NCT00868790|50644183|FG013|Period 3|Adverse Event|0|||
25327769|NCT00868790|50644170|FG000|Period 3|Protocol Violation|0|||
25327770|NCT00868790|50644171|FG001|Period 3|Protocol Violation|0|||
25327771|NCT00868790|50644172|FG002|Period 3|Protocol Violation|0|||
25327772|NCT00868790|50644173|FG003|Period 3|Protocol Violation|0|||
25327773|NCT00868790|50644174|FG004|Period 3|Protocol Violation|0|||
25327774|NCT00868790|50644175|FG005|Period 3|Protocol Violation|0|||
25327775|NCT00868790|50644176|FG006|Period 3|Protocol Violation|0|||
25327776|NCT00868790|50644177|FG007|Period 3|Protocol Violation|0|||
25327777|NCT00868790|50644178|FG008|Period 3|Protocol Violation|0|||
25327778|NCT00868790|50644179|FG009|Period 3|Protocol Violation|0|||
25327779|NCT00868790|50644180|FG010|Period 3|Protocol Violation|1|||
25327780|NCT00868790|50644181|FG011|Period 3|Protocol Violation|0|||
25327781|NCT00868790|50644182|FG012|Period 3|Protocol Violation|0|||
25327782|NCT00868790|50644183|FG013|Period 3|Protocol Violation|0|||
25327783|NCT00868790|50644170|FG000|Period 3|Study Terminated by Sponsor|0|||
25327784|NCT00868790|50644171|FG001|Period 3|Study Terminated by Sponsor|0|||
25327785|NCT00868790|50644172|FG002|Period 3|Study Terminated by Sponsor|0|||
25327786|NCT00868790|50644173|FG003|Period 3|Study Terminated by Sponsor|1|||
25327787|NCT00868790|50644174|FG004|Period 3|Study Terminated by Sponsor|0|||
25327788|NCT00868790|50644175|FG005|Period 3|Study Terminated by Sponsor|0|||
25327789|NCT00868790|50644176|FG006|Period 3|Study Terminated by Sponsor|0|||
25327790|NCT00868790|50644177|FG007|Period 3|Study Terminated by Sponsor|0|||
25327791|NCT00868790|50644178|FG008|Period 3|Study Terminated by Sponsor|0|||
25327792|NCT00868790|50644179|FG009|Period 3|Study Terminated by Sponsor|0|||
25327793|NCT00868790|50644180|FG010|Period 3|Study Terminated by Sponsor|0|||
25247393|NCT01185301|50562959|FG000|Overall Study|Lost to Follow-up|2|||
25327794|NCT00868790|50644181|FG011|Period 3|Study Terminated by Sponsor|0|||
25327795|NCT00868790|50644182|FG012|Period 3|Study Terminated by Sponsor|0|||
25327796|NCT00868790|50644183|FG013|Period 3|Study Terminated by Sponsor|0|||
25327797|NCT00868790|50644170|FG000|Period 4|Adverse Event|0|||
25327798|NCT00868790|50644171|FG001|Period 4|Adverse Event|0|||
25327799|NCT00868790|50644172|FG002|Period 4|Adverse Event|0|||
25327800|NCT00868790|50644173|FG003|Period 4|Adverse Event|0|||
25327801|NCT00868790|50644174|FG004|Period 4|Adverse Event|0|||
25327802|NCT00868790|50644175|FG005|Period 4|Adverse Event|0|||
25327803|NCT00868790|50644176|FG006|Period 4|Adverse Event|0|||
25327804|NCT00868790|50644177|FG007|Period 4|Adverse Event|1|||
25327805|NCT00868790|50644178|FG008|Period 4|Adverse Event|0|||
25327806|NCT00868790|50644179|FG009|Period 4|Adverse Event|0|||
25247394|NCT01185301|50562960|FG001|Overall Study|Lost to Follow-up|0|||
25247395|NCT01185301|50562961|FG002|Overall Study|Lost to Follow-up|0|||
25247396|NCT01185301|50562962|FG003|Overall Study|Lost to Follow-up|1|||
25327807|NCT00868790|50644180|FG010|Period 4|Adverse Event|1|||
25327808|NCT00868790|50644181|FG011|Period 4|Adverse Event|0|||
25327809|NCT00868790|50644182|FG012|Period 4|Adverse Event|1|||
25327810|NCT00868790|50644183|FG013|Period 4|Adverse Event|0|||
25327811|NCT00868790|50644170|FG000|Period 4|Lost to Follow-up|0|||
25327812|NCT00868790|50644171|FG001|Period 4|Lost to Follow-up|0|||
25327813|NCT00868790|50644172|FG002|Period 4|Lost to Follow-up|0|||
25327814|NCT00868790|50644173|FG003|Period 4|Lost to Follow-up|0|||
25327815|NCT00868790|50644174|FG004|Period 4|Lost to Follow-up|0|||
25247397|NCT01185301|50562959|FG000|Overall Study|Other Reason|3|||
25247398|NCT01185301|50562960|FG001|Overall Study|Other Reason|2|||
25247399|NCT01185301|50562961|FG002|Overall Study|Other Reason|2|||
25247400|NCT01185301|50562962|FG003|Overall Study|Other Reason|2|||
25247401|NCT01216072|50562974|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
25247402|NCT01216072|50562975|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
25247403|NCT01216072|50562974|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
25247404|NCT01216072|50562975|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
25247405|NCT01216072|50562974|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
25247406|NCT01216072|50562975|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
25327816|NCT00868790|50644175|FG005|Period 4|Lost to Follow-up|0|||
25327817|NCT00868790|50644176|FG006|Period 4|Lost to Follow-up|0|||
25327818|NCT00868790|50644177|FG007|Period 4|Lost to Follow-up|1|||
25327819|NCT00868790|50644178|FG008|Period 4|Lost to Follow-up|0|||
25327820|NCT00868790|50644179|FG009|Period 4|Lost to Follow-up|0|||
25327821|NCT00868790|50644180|FG010|Period 4|Lost to Follow-up|0|||
25327822|NCT00868790|50644181|FG011|Period 4|Lost to Follow-up|0|||
25327823|NCT00868790|50644182|FG012|Period 4|Lost to Follow-up|0|||
25327824|NCT00868790|50644183|FG013|Period 4|Lost to Follow-up|0|||
25327825|NCT00868790|50644170|FG000|Period 4|Study Terminated by Sponsor|2|||
25327826|NCT00868790|50644171|FG001|Period 4|Study Terminated by Sponsor|0|||
25327827|NCT00868790|50644172|FG002|Period 4|Study Terminated by Sponsor|0|||
25327828|NCT00868790|50644173|FG003|Period 4|Study Terminated by Sponsor|0|||
25327829|NCT00868790|50644174|FG004|Period 4|Study Terminated by Sponsor|0|||
25327830|NCT00868790|50644175|FG005|Period 4|Study Terminated by Sponsor|0|||
25327831|NCT00868790|50644176|FG006|Period 4|Study Terminated by Sponsor|0|||
25327832|NCT00868790|50644177|FG007|Period 4|Study Terminated by Sponsor|1|||
25327833|NCT00868790|50644178|FG008|Period 4|Study Terminated by Sponsor|2|||
25327834|NCT00868790|50644179|FG009|Period 4|Study Terminated by Sponsor|0|||
25327835|NCT00868790|50644180|FG010|Period 4|Study Terminated by Sponsor|2|||
25327836|NCT00868790|50644181|FG011|Period 4|Study Terminated by Sponsor|1|||
25327837|NCT00868790|50644182|FG012|Period 4|Study Terminated by Sponsor|0|||
25327838|NCT00868790|50644183|FG013|Period 4|Study Terminated by Sponsor|1|||
25327839|NCT00868790|50644170|FG000|Period 4|Abnormal ALT/AST|0|||
25327840|NCT00868790|50644171|FG001|Period 4|Abnormal ALT/AST|0|||
25327841|NCT00868790|50644172|FG002|Period 4|Abnormal ALT/AST|1|||
25247407|NCT01216072|50562974|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
25247408|NCT01216072|50562975|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
25247409|NCT01216072|50562974|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
25247410|NCT01216072|50562975|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
25247411|NCT01216072|50562974|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
25247412|NCT01216072|50562975|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
25247413|NCT01216072|50562974|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
25247414|NCT01216072|50562975|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
25247415|NCT01216072|50562974|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
25247416|NCT01216072|50562975|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
25247417|NCT01216072|50562974|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
25247418|NCT01216072|50562975|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
25247419|NCT01216072|50562974|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
25247420|NCT01216072|50562975|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
25247421|NCT01184989|50562984|FG000|Overall Study|Adverse Event|11|||
25247422|NCT01184989|50562984|FG000|Overall Study|Withdrawal by Subject|1|||
25247423|NCT01215955|50562992|FG000|Overall Study|Adverse Event|1|||
25247424|NCT01215955|50562993|FG001|Overall Study|Adverse Event|4|||
25247425|NCT01215955|50562994|FG002|Overall Study|Adverse Event|2|||
25247426|NCT01215955|50562995|FG003|Overall Study|Adverse Event|3|||
25247427|NCT01215955|50562992|FG000|Overall Study|Death|2|||
25247428|NCT01215955|50562993|FG001|Overall Study|Death|0|||
25247429|NCT01215955|50562994|FG002|Overall Study|Death|1|||
25247430|NCT01215955|50562995|FG003|Overall Study|Death|3|||
25247431|NCT01215955|50562992|FG000|Overall Study|Entry Criteria Not Met|1|||
25247432|NCT01215955|50562993|FG001|Overall Study|Entry Criteria Not Met|3|||
25327842|NCT00868790|50644173|FG003|Period 4|Abnormal ALT/AST|0|||
25327843|NCT00868790|50644174|FG004|Period 4|Abnormal ALT/AST|0|||
25327844|NCT00868790|50644175|FG005|Period 4|Abnormal ALT/AST|0|||
25247433|NCT01215955|50562994|FG002|Overall Study|Entry Criteria Not Met|4|||
25247434|NCT01215955|50562995|FG003|Overall Study|Entry Criteria Not Met|7|||
25247435|NCT01215955|50562992|FG000|Overall Study|Lack of Efficacy|1|||
25247436|NCT01215955|50562993|FG001|Overall Study|Lack of Efficacy|2|||
25247437|NCT01215955|50562994|FG002|Overall Study|Lack of Efficacy|1|||
25327845|NCT00868790|50644176|FG006|Period 4|Abnormal ALT/AST|0|||
25327846|NCT00868790|50644177|FG007|Period 4|Abnormal ALT/AST|0|||
25327847|NCT00868790|50644178|FG008|Period 4|Abnormal ALT/AST|0|||
25247438|NCT01215955|50562995|FG003|Overall Study|Lack of Efficacy|0|||
25247439|NCT01215955|50562992|FG000|Overall Study|Lost to Follow-up|4|||
25247440|NCT01215955|50562993|FG001|Overall Study|Lost to Follow-up|4|||
25247441|NCT01215955|50562994|FG002|Overall Study|Lost to Follow-up|8|||
25247442|NCT01215955|50562995|FG003|Overall Study|Lost to Follow-up|9|||
25247443|NCT01215955|50562992|FG000|Overall Study|Physician Decision|4|||
25247444|NCT01215955|50562993|FG001|Overall Study|Physician Decision|10|||
25247445|NCT01215955|50562994|FG002|Overall Study|Physician Decision|8|||
25247446|NCT01215955|50562995|FG003|Overall Study|Physician Decision|11|||
25247447|NCT01215955|50562992|FG000|Overall Study|Protocol Violation|17|||
25247448|NCT01215955|50562993|FG001|Overall Study|Protocol Violation|13|||
25247449|NCT01215955|50562994|FG002|Overall Study|Protocol Violation|8|||
25247450|NCT01215955|50562995|FG003|Overall Study|Protocol Violation|8|||
25247451|NCT01215955|50562992|FG000|Overall Study|Sponsor Decision|1|||
25247452|NCT01215955|50562993|FG001|Overall Study|Sponsor Decision|2|||
25247453|NCT01215955|50562994|FG002|Overall Study|Sponsor Decision|0|||
25327848|NCT00868790|50644179|FG009|Period 4|Abnormal ALT/AST|0|||
25327849|NCT00868790|50644180|FG010|Period 4|Abnormal ALT/AST|0|||
25327850|NCT00868790|50644181|FG011|Period 4|Abnormal ALT/AST|0|||
25327851|NCT00868790|50644182|FG012|Period 4|Abnormal ALT/AST|0|||
25327852|NCT00868790|50644183|FG013|Period 4|Abnormal ALT/AST|0|||
25327853|NCT00868790|50644170|FG000|Post-study|Withdrawal by Subject|0|||
25327854|NCT00868790|50644171|FG001|Post-study|Withdrawal by Subject|0|||
25327855|NCT00868790|50644172|FG002|Post-study|Withdrawal by Subject|0|||
25327856|NCT00868790|50644173|FG003|Post-study|Withdrawal by Subject|0|||
25327857|NCT00868790|50644174|FG004|Post-study|Withdrawal by Subject|1|||
25327858|NCT00868790|50644175|FG005|Post-study|Withdrawal by Subject|0|||
25327859|NCT00868790|50644176|FG006|Post-study|Withdrawal by Subject|0|||
25327860|NCT00868790|50644177|FG007|Post-study|Withdrawal by Subject|0|||
25327861|NCT00868790|50644178|FG008|Post-study|Withdrawal by Subject|0|||
25327862|NCT00868790|50644179|FG009|Post-study|Withdrawal by Subject|0|||
25327863|NCT00868790|50644180|FG010|Post-study|Withdrawal by Subject|0|||
25327864|NCT00868790|50644181|FG011|Post-study|Withdrawal by Subject|0|||
25327865|NCT00868790|50644182|FG012|Post-study|Withdrawal by Subject|0|||
25327866|NCT00868790|50644183|FG013|Post-study|Withdrawal by Subject|0|||
25247454|NCT01215955|50562995|FG003|Overall Study|Sponsor Decision|1|||
25247455|NCT01215955|50562992|FG000|Overall Study|Withdrawal by Subject|14|||
25247456|NCT01215955|50562993|FG001|Overall Study|Withdrawal by Subject|15|||
25247457|NCT01215955|50562994|FG002|Overall Study|Withdrawal by Subject|13|||
25247458|NCT01215955|50562995|FG003|Overall Study|Withdrawal by Subject|9|||
25247459|NCT01215955|50562992|FG000|Overall Study|Quality Issues|0|||
25327867|NCT00868790|50644170|FG000|Post-study|Excluded Medication|0|||
25327868|NCT00868790|50644171|FG001|Post-study|Excluded Medication|0|||
25327869|NCT00868790|50644172|FG002|Post-study|Excluded Medication|0|||
25247460|NCT01215955|50562993|FG001|Overall Study|Quality Issues|0|||
25247461|NCT01215955|50562994|FG002|Overall Study|Quality Issues|3|||
25247462|NCT01215955|50562995|FG003|Overall Study|Quality Issues|2|||
25327870|NCT00868790|50644173|FG003|Post-study|Excluded Medication|0|||
25327871|NCT00868790|50644174|FG004|Post-study|Excluded Medication|0|||
25327872|NCT00868790|50644175|FG005|Post-study|Excluded Medication|0|||
25327873|NCT00868790|50644176|FG006|Post-study|Excluded Medication|0|||
25327874|NCT00868790|50644177|FG007|Post-study|Excluded Medication|2|||
25247463|NCT01215916|50563034|FG000|Overall Study|Progressive Disease|0|||
25247464|NCT01215916|50563035|FG001|Overall Study|Progressive Disease|2|||
25247465|NCT01215916|50563036|FG002|Overall Study|Progressive Disease|1|||
25077795|NCT03318523|50185665|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
25077796|NCT03318523|50185666|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
25077797|NCT03318523|50185667|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
25077798|NCT03318523|50185668|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
25077799|NCT03318523|50185669|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
25247466|NCT01215916|50563037|FG003|Overall Study|Progressive Disease|2|||
25247467|NCT01215916|50563038|FG004|Overall Study|Progressive Disease|5|||
25247468|NCT01215916|50563039|FG005|Overall Study|Progressive Disease|4|||
25247469|NCT01215916|50563040|FG006|Overall Study|Progressive Disease|5|||
25247470|NCT01215916|50563041|FG007|Overall Study|Progressive Disease|3|||
25247471|NCT01215916|50563042|FG008|Overall Study|Progressive Disease|1|||
25247472|NCT01215916|50563034|FG000|Overall Study|Adverse Event|1|||
25247473|NCT01215916|50563035|FG001|Overall Study|Adverse Event|1|||
25247474|NCT01215916|50563036|FG002|Overall Study|Adverse Event|0|||
25247475|NCT01215916|50563037|FG003|Overall Study|Adverse Event|1|||
25247476|NCT01215916|50563038|FG004|Overall Study|Adverse Event|0|||
25247477|NCT01215916|50563039|FG005|Overall Study|Adverse Event|0|||
25247478|NCT01215916|50563040|FG006|Overall Study|Adverse Event|3|||
25247479|NCT01215916|50563041|FG007|Overall Study|Adverse Event|0|||
25247480|NCT01215916|50563042|FG008|Overall Study|Adverse Event|0|||
25247481|NCT01215916|50563034|FG000|Overall Study|Withdrawal by Subject|0|||
25247482|NCT01215916|50563035|FG001|Overall Study|Withdrawal by Subject|1|||
25247483|NCT01215916|50563036|FG002|Overall Study|Withdrawal by Subject|1|||
25247484|NCT01215916|50563037|FG003|Overall Study|Withdrawal by Subject|2|||
25247485|NCT01215916|50563038|FG004|Overall Study|Withdrawal by Subject|0|||
25247486|NCT01215916|50563039|FG005|Overall Study|Withdrawal by Subject|0|||
25247487|NCT01215916|50563040|FG006|Overall Study|Withdrawal by Subject|1|||
25327875|NCT00868790|50644178|FG008|Post-study|Excluded Medication|0|||
25327876|NCT00868790|50644179|FG009|Post-study|Excluded Medication|1|||
25327877|NCT00868790|50644180|FG010|Post-study|Excluded Medication|0|||
25327878|NCT00868790|50644181|FG011|Post-study|Excluded Medication|0|||
25327879|NCT00868790|50644182|FG012|Post-study|Excluded Medication|0|||
25327880|NCT00868790|50644183|FG013|Post-study|Excluded Medication|0|||
25327881|NCT00496483|50644199|FG000|Overall Study|Not dosed|9|||
25327882|NCT00496483|50644199|FG000|Overall Study|Adverse Event|2|||
25327883|NCT00496483|50644199|FG000|Overall Study|Lack of Efficacy|1|||
25327884|NCT03528551|50644209|FG000|Overall Study|Lost to Follow-up|0|||
25327885|NCT03528551|50644210|FG001|Overall Study|Lost to Follow-up|1|||
25327886|NCT03528551|50644211|FG002|Overall Study|Lost to Follow-up|0|||
25327887|NCT03528551|50644209|FG000|Overall Study|Transferred to other arm/group|2|||
25327888|NCT03528551|50644210|FG001|Overall Study|Transferred to other arm/group|3|||
25327889|NCT03528551|50644211|FG002|Overall Study|Transferred to other arm/group|0|||
25327890|NCT03528551|50644209|FG000|Overall Study|Withdrawal by parent/guardian|0|||
25327891|NCT03528551|50644210|FG001|Overall Study|Withdrawal by parent/guardian|5|||
25327892|NCT03528551|50644211|FG002|Overall Study|Withdrawal by parent/guardian|0|||
25327893|NCT03528551|50644209|FG000|Overall Study|Protocol Violation|0|||
25327894|NCT03528551|50644210|FG001|Overall Study|Protocol Violation|3|||
25327895|NCT03528551|50644211|FG002|Overall Study|Protocol Violation|0|||
25327896|NCT03528551|50644209|FG000|Overall Study|Withdrawal by Subject|0|||
25327897|NCT03528551|50644210|FG001|Overall Study|Withdrawal by Subject|7|||
25327898|NCT03528551|50644211|FG002|Overall Study|Withdrawal by Subject|0|||
25327899|NCT00487981|50644220|FG000|Overall Study|Hypothyroidism diagnosis|1|||
25327900|NCT00861744|50644228|FG000|Overall Study|Adverse Event|0|||
25327901|NCT00861744|50644229|FG001|Overall Study|Adverse Event|0|||
25327902|NCT00861744|50644230|FG002|Overall Study|Adverse Event|0|||
25327903|NCT00861744|50644231|FG003|Overall Study|Adverse Event|1|||
25327904|NCT00861744|50644228|FG000|Overall Study|Lost to Follow-up|7|||
25327905|NCT00861744|50644229|FG001|Overall Study|Lost to Follow-up|19|||
25327906|NCT00861744|50644230|FG002|Overall Study|Lost to Follow-up|17|||
25327907|NCT00861744|50644231|FG003|Overall Study|Lost to Follow-up|12|||
25327908|NCT00861744|50644228|FG000|Overall Study|Withdrawal by Subject|10|||
25327909|NCT00861744|50644229|FG001|Overall Study|Withdrawal by Subject|6|||
25327910|NCT00861744|50644230|FG002|Overall Study|Withdrawal by Subject|6|||
25327911|NCT00861744|50644231|FG003|Overall Study|Withdrawal by Subject|19|||
25327912|NCT00861744|50644228|FG000|Overall Study|Protocol Violation|0|||
25327913|NCT00861744|50644229|FG001|Overall Study|Protocol Violation|1|||
25327914|NCT00861744|50644230|FG002|Overall Study|Protocol Violation|0|||
25247488|NCT01215916|50563041|FG007|Overall Study|Withdrawal by Subject|0|||
25247489|NCT01215916|50563042|FG008|Overall Study|Withdrawal by Subject|0|||
25247490|NCT01215916|50563034|FG000|Overall Study|Death|0|||
25247491|NCT01215916|50563035|FG001|Overall Study|Death|1|||
25327915|NCT00861744|50644231|FG003|Overall Study|Protocol Violation|0|||
25327916|NCT00861744|50644228|FG000|Overall Study|Migration from study area|0|||
25327917|NCT00861744|50644229|FG001|Overall Study|Migration from study area|3|||
25327918|NCT00861744|50644230|FG002|Overall Study|Migration from study area|1|||
25327919|NCT00861744|50644231|FG003|Overall Study|Migration from study area|0|||
25327920|NCT00861744|50644228|FG000|Overall Study|Blood draws|0|||
25327921|NCT00861744|50644229|FG001|Overall Study|Blood draws|0|||
25327922|NCT00861744|50644230|FG002|Overall Study|Blood draws|0|||
25327923|NCT00861744|50644231|FG003|Overall Study|Blood draws|1|||
25327924|NCT00603239|50644243|FG000|Overall Study|Adverse Event|4|||
25327925|NCT00603239|50644244|FG001|Overall Study|Adverse Event|1|||
25327926|NCT00603239|50644243|FG000|Overall Study|Entry criteria not met|0|||
25327927|NCT00603239|50644244|FG001|Overall Study|Entry criteria not met|1|||
25327928|NCT00603239|50644243|FG000|Overall Study|Loss of glucose control|3|||
25327929|NCT00603239|50644244|FG001|Overall Study|Loss of glucose control|0|||
25327930|NCT00603239|50644243|FG000|Overall Study|Lost to Follow-up|2|||
25327931|NCT00603239|50644244|FG001|Overall Study|Lost to Follow-up|1|||
25327932|NCT00603239|50644243|FG000|Overall Study|Physician Decision|2|||
25327933|NCT00603239|50644244|FG001|Overall Study|Physician Decision|0|||
25327934|NCT00603239|50644243|FG000|Overall Study|Protocol Violation|2|||
25327935|NCT00603239|50644244|FG001|Overall Study|Protocol Violation|0|||
25327936|NCT00603239|50644243|FG000|Overall Study|Subject decision|2|||
25327937|NCT00603239|50644244|FG001|Overall Study|Subject decision|1|||
25327938|NCT00852930|50644253|FG000|Overall Study|Withdrawal by Subject|1|||
25327939|NCT00852930|50644254|FG001|Overall Study|Withdrawal by Subject|1|||
25327940|NCT00852930|50644255|FG002|Overall Study|Withdrawal by Subject|1|||
25327941|NCT00852930|50644253|FG000|Overall Study|Physician Decision|0|||
25327942|NCT00852930|50644254|FG001|Overall Study|Physician Decision|0|||
25327943|NCT00852930|50644255|FG002|Overall Study|Physician Decision|1|||
25327944|NCT00852540|50644266|FG000|Overall Study|Adverse Event|10|||
25327945|NCT00852540|50644267|FG001|Overall Study|Adverse Event|3|||
25327946|NCT00852540|50644266|FG000|Overall Study|Lack of Efficacy|15|||
25327947|NCT00852540|50644267|FG001|Overall Study|Lack of Efficacy|3|||
25327948|NCT00852540|50644266|FG000|Overall Study|Protocol Violation|1|||
25327949|NCT00852540|50644267|FG001|Overall Study|Protocol Violation|2|||
25327950|NCT00852540|50644266|FG000|Overall Study|Lost to Follow-up|2|||
25327951|NCT00852540|50644267|FG001|Overall Study|Lost to Follow-up|3|||
25327952|NCT00852540|50644266|FG000|Overall Study|Investigator Discretion|2|||
25327953|NCT00852540|50644267|FG001|Overall Study|Investigator Discretion|3|||
25327954|NCT00852540|50644266|FG000|Overall Study|Withdrawal by Subject|3|||
25327955|NCT00852540|50644267|FG001|Overall Study|Withdrawal by Subject|1|||
25327956|NCT00852540|50644266|FG000|Overall Study|Did Not Receive Study Drug|3|||
25327957|NCT00852540|50644267|FG001|Overall Study|Did Not Receive Study Drug|3|||
25327958|NCT00861198|50644274|FG000|Overall Study|SpyGlass Failed|5|||
25327959|NCT00847704|50644278|FG000|Overall Study|Withdrawal by Subject|1|||
25327960|NCT00860574|50644282|FG000|Overall Study|Death|2|||
25327961|NCT00860574|50644282|FG000|Overall Study|Relapse|1|||
25327962|NCT00496015|50644291|FG000|Overall Study|Other|1|||
25327963|NCT00496015|50644292|FG001|Overall Study|Other|0|||
25327964|NCT00496015|50644293|FG002|Overall Study|Other|0|||
25327965|NCT00496015|50644294|FG003|Overall Study|Other|1|||
25327966|NCT00496015|50644295|FG004|Overall Study|Other|0|||
25327967|NCT00487825|50644317|FG000|Overall Study|Adverse Event|2|||
25327968|NCT00487825|50644318|FG001|Overall Study|Adverse Event|2|||
25327969|NCT00487825|50644317|FG000|Overall Study|Lack of Efficacy|1|||
25327970|NCT00487825|50644318|FG001|Overall Study|Lack of Efficacy|1|||
25327971|NCT00487825|50644317|FG000|Overall Study|Other|3|||
25327972|NCT00487825|50644318|FG001|Overall Study|Other|2|||
25327973|NCT00487747|50644324|FG000|Overall Study|Adverse Event|1|||
25327974|NCT00487747|50644324|FG000|Overall Study|Lost to Follow-up|9|||
25327975|NCT00487747|50644324|FG000|Overall Study|Lack of Efficacy|1|||
25327976|NCT00487435|50644328|FG000|Overall Study|Adverse Event|146|||
25327977|NCT00487435|50644328|FG000|Overall Study|Death|2|||
25327978|NCT00487435|50644328|FG000|Overall Study|Lack of Efficacy|33|||
25327979|NCT00487435|50644328|FG000|Overall Study|Lost to Follow-up|54|||
25327980|NCT00487435|50644328|FG000|Overall Study|Pregnancy|2|||
25327981|NCT00487435|50644328|FG000|Overall Study|Withdrawal by Subject|132|||
25247492|NCT01215916|50563036|FG002|Overall Study|Death|0|||
24977252|NCT03410992|50065850|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
25247493|NCT01215916|50563037|FG003|Overall Study|Death|0|||
25247494|NCT01215916|50563038|FG004|Overall Study|Death|1|||
25247495|NCT01215916|50563039|FG005|Overall Study|Death|0|||
25247496|NCT01215916|50563040|FG006|Overall Study|Death|0|||
25247497|NCT01215916|50563041|FG007|Overall Study|Death|0|||
25247498|NCT01215916|50563042|FG008|Overall Study|Death|1|||
25247499|NCT01215916|50563034|FG000|Overall Study|Physician Decision|0|||
25247500|NCT01215916|50563035|FG001|Overall Study|Physician Decision|0|||
25247501|NCT01215916|50563036|FG002|Overall Study|Physician Decision|1|||
25247502|NCT01215916|50563037|FG003|Overall Study|Physician Decision|1|||
25247503|NCT01215916|50563038|FG004|Overall Study|Physician Decision|0|||
25247504|NCT01215916|50563039|FG005|Overall Study|Physician Decision|0|||
25247505|NCT01215916|50563040|FG006|Overall Study|Physician Decision|0|||
25247506|NCT01215916|50563041|FG007|Overall Study|Physician Decision|0|||
25247507|NCT01215916|50563042|FG008|Overall Study|Physician Decision|0|||
25327982|NCT00487435|50644328|FG000|Overall Study|Resolution Of Pain|1|||
25327983|NCT00487435|50644328|FG000|Overall Study|Study Medication Non-Compliant|32|||
25327984|NCT00487435|50644328|FG000|Overall Study|Other|83|||
25327985|NCT00487279|50644334|FG000|Overall Study|Death|1|||
25327986|NCT00487279|50644335|FG001|Overall Study|Death|0|||
25327987|NCT00487279|50644334|FG000|Overall Study|Withdrawal by Subject|0|||
25327988|NCT00487279|50644335|FG001|Overall Study|Withdrawal by Subject|2|||
25327989|NCT00495625|50644341|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
25327990|NCT00847626|50644356|FG000|Overall Study|Adverse Event|10|||
25327991|NCT00847626|50644357|FG001|Overall Study|Adverse Event|10|||
25327992|NCT00847626|50644358|FG002|Overall Study|Adverse Event|6|||
25327993|NCT00847626|50644359|FG003|Overall Study|Adverse Event|19|||
25327994|NCT00847626|50644360|FG004|Overall Study|Adverse Event|11|||
25327995|NCT00847626|50644361|FG005|Overall Study|Adverse Event|22|||
25327996|NCT00847626|50644362|FG006|Overall Study|Adverse Event|4|||
25327997|NCT00847626|50644363|FG007|Overall Study|Adverse Event|6|||
25327998|NCT00847626|50644364|FG008|Overall Study|Adverse Event|3|||
25327999|NCT00847626|50644365|FG009|Overall Study|Adverse Event|6|||
25328000|NCT00847626|50644366|FG010|Overall Study|Adverse Event|6|||
25328001|NCT00847626|50644356|FG000|Overall Study|Protocol Violation|2|||
25328002|NCT00847626|50644357|FG001|Overall Study|Protocol Violation|1|||
25328003|NCT00847626|50644358|FG002|Overall Study|Protocol Violation|2|||
25328004|NCT00847626|50644359|FG003|Overall Study|Protocol Violation|1|||
25328005|NCT00847626|50644360|FG004|Overall Study|Protocol Violation|1|||
25328006|NCT00847626|50644361|FG005|Overall Study|Protocol Violation|1|||
25328007|NCT00847626|50644362|FG006|Overall Study|Protocol Violation|1|||
25328008|NCT00847626|50644363|FG007|Overall Study|Protocol Violation|1|||
25328009|NCT00847626|50644364|FG008|Overall Study|Protocol Violation|0|||
25328010|NCT00847626|50644365|FG009|Overall Study|Protocol Violation|1|||
25328011|NCT00847626|50644366|FG010|Overall Study|Protocol Violation|1|||
25328012|NCT00847626|50644356|FG000|Overall Study|Lost to Follow-up|0|||
25328013|NCT00847626|50644357|FG001|Overall Study|Lost to Follow-up|1|||
25328014|NCT00847626|50644358|FG002|Overall Study|Lost to Follow-up|1|||
25328015|NCT00847626|50644359|FG003|Overall Study|Lost to Follow-up|1|||
25328016|NCT00847626|50644360|FG004|Overall Study|Lost to Follow-up|0|||
25328017|NCT00847626|50644361|FG005|Overall Study|Lost to Follow-up|3|||
25328018|NCT00847626|50644362|FG006|Overall Study|Lost to Follow-up|1|||
25328019|NCT00847626|50644363|FG007|Overall Study|Lost to Follow-up|3|||
25328020|NCT00847626|50644364|FG008|Overall Study|Lost to Follow-up|1|||
25328021|NCT00847626|50644365|FG009|Overall Study|Lost to Follow-up|0|||
25328022|NCT00847626|50644366|FG010|Overall Study|Lost to Follow-up|1|||
25328023|NCT00847626|50644356|FG000|Overall Study|Withdrawal by Subject|5|||
25328024|NCT00847626|50644357|FG001|Overall Study|Withdrawal by Subject|5|||
25328025|NCT00847626|50644358|FG002|Overall Study|Withdrawal by Subject|3|||
25328026|NCT00847626|50644359|FG003|Overall Study|Withdrawal by Subject|8|||
25328027|NCT00847626|50644360|FG004|Overall Study|Withdrawal by Subject|12|||
25328028|NCT00847626|50644361|FG005|Overall Study|Withdrawal by Subject|9|||
25328029|NCT00847626|50644362|FG006|Overall Study|Withdrawal by Subject|8|||
25328030|NCT00847626|50644363|FG007|Overall Study|Withdrawal by Subject|4|||
25328031|NCT00847626|50644364|FG008|Overall Study|Withdrawal by Subject|4|||
25328032|NCT00847626|50644365|FG009|Overall Study|Withdrawal by Subject|5|||
25328033|NCT00847626|50644366|FG010|Overall Study|Withdrawal by Subject|2|||
25328034|NCT00847626|50644356|FG000|Overall Study|Lack of Efficacy|3|||
25328035|NCT00847626|50644357|FG001|Overall Study|Lack of Efficacy|1|||
25328036|NCT00847626|50644358|FG002|Overall Study|Lack of Efficacy|0|||
25328037|NCT00847626|50644359|FG003|Overall Study|Lack of Efficacy|1|||
25328038|NCT00847626|50644360|FG004|Overall Study|Lack of Efficacy|2|||
25328039|NCT00847626|50644361|FG005|Overall Study|Lack of Efficacy|0|||
24995117|NCT03015532|50085972|FG006|Overall Study|Withdrawal by Subject|1|||
25247508|NCT01184872|50563068|FG000|Overall Study|Adverse Event|3|||
25247509|NCT01184872|50563069|FG001|Overall Study|Adverse Event|4|||
25247510|NCT01184872|50563068|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
25247511|NCT01184872|50563069|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
25247512|NCT01184872|50563068|FG000|Overall Study|Withdrawal by Subject|2|||
25247513|NCT01184872|50563069|FG001|Overall Study|Withdrawal by Subject|0|||
25247514|NCT01184872|50563068|FG000|Overall Study|Lost to Follow-up|0|||
25247515|NCT01184872|50563069|FG001|Overall Study|Lost to Follow-up|1|||
25247516|NCT01184872|50563068|FG000|Overall Study|Administrative problems|1|||
25247517|NCT01184872|50563069|FG001|Overall Study|Administrative problems|1|||
25247518|NCT01184872|50563068|FG000|Overall Study|Protocol deviation|1|||
25247519|NCT01184872|50563069|FG001|Overall Study|Protocol deviation|0|||
25328040|NCT00847626|50644362|FG006|Overall Study|Lack of Efficacy|6|||
25328041|NCT00847626|50644363|FG007|Overall Study|Lack of Efficacy|2|||
25328042|NCT00847626|50644364|FG008|Overall Study|Lack of Efficacy|5|||
25328043|NCT00847626|50644365|FG009|Overall Study|Lack of Efficacy|1|||
25328044|NCT00847626|50644366|FG010|Overall Study|Lack of Efficacy|7|||
25328045|NCT00847626|50644356|FG000|Overall Study|Other|1|||
25328046|NCT00847626|50644357|FG001|Overall Study|Other|5|||
25328047|NCT00847626|50644358|FG002|Overall Study|Other|4|||
25328048|NCT00847626|50644359|FG003|Overall Study|Other|1|||
25247520|NCT01215721|50563075|FG000|Overall Study|Adverse Event|2|||
25247521|NCT01184326|50563082|FG000|Overall Study|Adverse Event|1|||
25247522|NCT01184326|50563083|FG001|Overall Study|Adverse Event|2|||
25247523|NCT01184326|50563084|FG002|Overall Study|Adverse Event|0|||
25247524|NCT01184326|50563082|FG000|Overall Study|Death|0|||
25247525|NCT01184326|50563083|FG001|Overall Study|Death|0|||
25247526|NCT01184326|50563084|FG002|Overall Study|Death|1|||
25247527|NCT01184326|50563082|FG000|Overall Study|Withdrawal by Subject|0|||
25247528|NCT01184326|50563083|FG001|Overall Study|Withdrawal by Subject|0|||
25247529|NCT01184326|50563084|FG002|Overall Study|Withdrawal by Subject|1|||
25247530|NCT01184326|50563082|FG000|Overall Study|Physician Decision|1|||
25247531|NCT01184326|50563083|FG001|Overall Study|Physician Decision|1|||
25247532|NCT01184326|50563084|FG002|Overall Study|Physician Decision|0|||
25247533|NCT01184326|50563082|FG000|Overall Study|Disease Progression|1|||
25247534|NCT01184326|50563083|FG001|Overall Study|Disease Progression|3|||
25247535|NCT01184326|50563084|FG002|Overall Study|Disease Progression|12|||
25247536|NCT01215253|50563097|FG000|Overall Study|Withdrawal by Subject|57|||
25328049|NCT00847626|50644360|FG004|Overall Study|Other|2|||
25328050|NCT00847626|50644361|FG005|Overall Study|Other|2|||
25328051|NCT00847626|50644362|FG006|Overall Study|Other|2|||
25328052|NCT00847626|50644363|FG007|Overall Study|Other|3|||
25328053|NCT00847626|50644364|FG008|Overall Study|Other|1|||
25328054|NCT00847626|50644365|FG009|Overall Study|Other|1|||
25328055|NCT00847626|50644366|FG010|Overall Study|Other|3|||
25328056|NCT00851682|50644395|FG000|Overall Study|screen failure|5|||
25328057|NCT00851682|50644396|FG001|Overall Study|screen failure|0|||
25328058|NCT00860262|50644405|FG000|Overall Study|Adverse Event|9|||
25328059|NCT00860262|50644406|FG001|Overall Study|Adverse Event|6|||
25328060|NCT00860262|50644407|FG002|Overall Study|Adverse Event|7|||
25328061|NCT00860262|50644405|FG000|Overall Study|Protocol Violation|0|||
25328062|NCT00860262|50644406|FG001|Overall Study|Protocol Violation|1|||
25328063|NCT00860262|50644407|FG002|Overall Study|Protocol Violation|0|||
25328064|NCT00860262|50644405|FG000|Overall Study|Lost to Follow-up|2|||
25328065|NCT00860262|50644406|FG001|Overall Study|Lost to Follow-up|0|||
25328066|NCT00860262|50644407|FG002|Overall Study|Lost to Follow-up|1|||
25328067|NCT00860262|50644405|FG000|Overall Study|Withdrawal by Subject|4|||
25328068|NCT00860262|50644406|FG001|Overall Study|Withdrawal by Subject|8|||
25328069|NCT00860262|50644407|FG002|Overall Study|Withdrawal by Subject|6|||
25328070|NCT00860262|50644405|FG000|Overall Study|Lack of Efficacy|0|||
25328071|NCT00860262|50644406|FG001|Overall Study|Lack of Efficacy|4|||
25328072|NCT00860262|50644407|FG002|Overall Study|Lack of Efficacy|3|||
25328073|NCT00860262|50644405|FG000|Overall Study|Other|5|||
25328074|NCT00860262|50644406|FG001|Overall Study|Other|3|||
25328075|NCT00860262|50644407|FG002|Overall Study|Other|1|||
25328076|NCT00860028|50644419|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
25328077|NCT00860028|50644420|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
25247537|NCT01215253|50563098|FG001|Overall Study|Withdrawal by Subject|35|||
25247538|NCT01215253|50563097|FG000|Overall Study|Physician Decision|9|||
25328078|NCT00859638|50644430|FG000|Overall Study|Lost to Follow-up|6|||
25328079|NCT00859638|50644431|FG001|Overall Study|Lost to Follow-up|1|||
25328080|NCT00859638|50644430|FG000|Overall Study|Withdrawal by Subject|3|||
25328081|NCT00859638|50644431|FG001|Overall Study|Withdrawal by Subject|2|||
25328082|NCT00859638|50644430|FG000|Overall Study|Ill health|1|||
25328083|NCT00859638|50644431|FG001|Overall Study|Ill health|1|||
25247539|NCT01215253|50563098|FG001|Overall Study|Physician Decision|12|||
25247540|NCT01215253|50563097|FG000|Overall Study|Lost to Follow-up|6|||
25247541|NCT01215253|50563098|FG001|Overall Study|Lost to Follow-up|4|||
25247542|NCT01215253|50563097|FG000|Overall Study|Other|14|||
25328084|NCT00846846|50644437|FG000|Overall Study|Death|56|||
25247543|NCT01215253|50563098|FG001|Overall Study|Other|12|||
25247544|NCT01184053|50563105|FG000|Overall Study|progression while on treatment|3|||
25247545|NCT01183975|50563110|FG000|Overall Study|Lost to Follow-up|73|||
25247546|NCT01183858|50563116|FG000|Overall Study|Death not related to Progressive Disease|5|||
25247547|NCT01183858|50563117|FG001|Overall Study|Death not related to Progressive Disease|6|||
25247548|NCT01183858|50563116|FG000|Overall Study|Adverse Event|14|||
25247549|NCT01183858|50563117|FG001|Overall Study|Adverse Event|11|||
25247550|NCT01183858|50563116|FG000|Overall Study|Investigator's Decision|0|||
25247551|NCT01183858|50563117|FG001|Overall Study|Investigator's Decision|3|||
25247552|NCT01183858|50563116|FG000|Overall Study|Insufficient Therapeutic Response|2|||
25247553|NCT01183858|50563117|FG001|Overall Study|Insufficient Therapeutic Response|0|||
25247554|NCT01183858|50563116|FG000|Overall Study|Refused Treatment|1|||
25247555|NCT01183858|50563117|FG001|Overall Study|Refused Treatment|4|||
25247556|NCT01183858|50563116|FG000|Overall Study|Withdrew Consent|4|||
25247557|NCT01183858|50563117|FG001|Overall Study|Withdrew Consent|4|||
25247558|NCT01183858|50563116|FG000|Overall Study|Discontinued Smoking|3|||
25247559|NCT01183858|50563117|FG001|Overall Study|Discontinued Smoking|1|||
25247560|NCT01183858|50563116|FG000|Overall Study|Protocol Violation|1|||
25247561|NCT01183858|50563117|FG001|Overall Study|Protocol Violation|0|||
25247562|NCT01183858|50563116|FG000|Overall Study|Administrative/Other|6|||
25247563|NCT01183858|50563117|FG001|Overall Study|Administrative/Other|6|||
25247564|NCT01183858|50563116|FG000|Overall Study|Progressive Disease|112|||
25247565|NCT01183858|50563117|FG001|Overall Study|Progressive Disease|115|||
25247566|NCT01183858|50563116|FG000|Overall Study|Death related to Progressive Disease|4|||
25247567|NCT01183858|50563117|FG001|Overall Study|Death related to Progressive Disease|5|||
25247568|NCT01183858|50563116|FG000|Overall Study|Lost to Follow-up|1|||
25247569|NCT01183858|50563117|FG001|Overall Study|Lost to Follow-up|1|||
25247570|NCT01215175|50563128|FG000|Overall Study|Lost to Follow-up|0|||
25247571|NCT01215175|50563129|FG001|Overall Study|Lost to Follow-up|1|||
25247572|NCT01215175|50563130|FG002|Overall Study|Lost to Follow-up|0|||
25247573|NCT01215175|50563131|FG003|Overall Study|Lost to Follow-up|1|||
25247574|NCT01215175|50563132|FG004|Overall Study|Lost to Follow-up|0|||
25247575|NCT01215097|50563146|FG000|Overall Study|Adverse Event|1|||
25247576|NCT01215097|50563147|FG001|Overall Study|Adverse Event|3|||
25247577|NCT01215097|50563146|FG000|Overall Study|Protocol Violation|0|||
25247578|NCT01215097|50563147|FG001|Overall Study|Protocol Violation|2|||
25247579|NCT01215097|50563146|FG000|Overall Study|Lost to Follow-up|2|||
25247580|NCT01215097|50563147|FG001|Overall Study|Lost to Follow-up|0|||
25247581|NCT01215097|50563146|FG000|Overall Study|Withdrawal by Subject|6|||
25247582|NCT01215097|50563147|FG001|Overall Study|Withdrawal by Subject|3|||
25247583|NCT01215097|50563146|FG000|Overall Study|Lack of Efficacy|0|||
25077800|NCT03318523|50185670|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
25247584|NCT01215097|50563147|FG001|Overall Study|Lack of Efficacy|3|||
25247585|NCT01215097|50563146|FG000|Overall Study|patient's refusal to come|2|||
25247586|NCT01215097|50563147|FG001|Overall Study|patient's refusal to come|2|||
25247587|NCT01215097|50563146|FG000|Overall Study|patient's private reason|1|||
25247588|NCT01215097|50563147|FG001|Overall Study|patient's private reason|1|||
25247589|NCT03303339|50563165|FG000|Overall Study|Death|2|||
25247590|NCT03303339|50563166|FG001|Overall Study|Death|2|||
25247591|NCT03303339|50563167|FG002|Overall Study|Death|2|||
25247592|NCT03303339|50563168|FG003|Overall Study|Death|1|||
25247593|NCT03303339|50563169|FG004|Overall Study|Death|4|||
25247594|NCT03303339|50563170|FG005|Overall Study|Death|2|||
25247595|NCT03303339|50563171|FG006|Overall Study|Death|2|||
25247596|NCT03303339|50563172|FG007|Overall Study|Death|2|||
25247597|NCT03303339|50563173|FG008|Overall Study|Death|3|||
25247598|NCT03303339|50563174|FG009|Overall Study|Death|3|||
25328085|NCT00846846|50644437|FG000|Overall Study|Withdrawal by Subject|19|||
25328086|NCT00846768|50644441|FG000|Overall Study|Adverse Event|0|||
25328087|NCT00846768|50644442|FG001|Overall Study|Adverse Event|1|||
25328088|NCT00846768|50644443|FG002|Overall Study|Adverse Event|0|||
25328089|NCT00846768|50644444|FG003|Overall Study|Adverse Event|0|||
25328090|NCT00863798|50644457|FG000|Overall Study|Adverse Event|5|||
25328091|NCT00863798|50644458|FG001|Overall Study|Adverse Event|2|||
25328092|NCT00863798|50644459|FG002|Overall Study|Adverse Event|4|||
25328093|NCT00863798|50644457|FG000|Overall Study|Participant failed to return|2|||
25328094|NCT00863798|50644458|FG001|Overall Study|Participant failed to return|1|||
25328095|NCT00863798|50644459|FG002|Overall Study|Participant failed to return|0|||
25247599|NCT03303339|50563175|FG010|Overall Study|Death|4|||
25247600|NCT03303339|50563176|FG011|Overall Study|Death|24|||
25247601|NCT03303339|50563165|FG000|Overall Study|Study Terminated by Sponsor|0|||
25247602|NCT03303339|50563166|FG001|Overall Study|Study Terminated by Sponsor|0|||
25247603|NCT03303339|50563167|FG002|Overall Study|Study Terminated by Sponsor|0|||
25328096|NCT00863798|50644457|FG000|Overall Study|Investigator request|1|||
25328097|NCT00863798|50644458|FG001|Overall Study|Investigator request|2|||
25247604|NCT03303339|50563168|FG003|Overall Study|Study Terminated by Sponsor|0|||
25247605|NCT03303339|50563169|FG004|Overall Study|Study Terminated by Sponsor|0|||
25247606|NCT03303339|50563170|FG005|Overall Study|Study Terminated by Sponsor|0|||
25328098|NCT00863798|50644459|FG002|Overall Study|Investigator request|1|||
25328099|NCT00863798|50644457|FG000|Overall Study|Lack of Efficacy|4|||
25328100|NCT00863798|50644458|FG001|Overall Study|Lack of Efficacy|3|||
25328101|NCT00863798|50644459|FG002|Overall Study|Lack of Efficacy|6|||
25328102|NCT00863798|50644457|FG000|Overall Study|Lost to Follow-up|6|||
25328103|NCT00863798|50644458|FG001|Overall Study|Lost to Follow-up|9|||
25328104|NCT00863798|50644459|FG002|Overall Study|Lost to Follow-up|5|||
25328105|NCT00863798|50644457|FG000|Overall Study|Other|2|||
25328106|NCT00863798|50644458|FG001|Overall Study|Other|3|||
25328107|NCT00863798|50644459|FG002|Overall Study|Other|1|||
25328108|NCT00863798|50644457|FG000|Overall Study|Protocol Violation|0|||
25328109|NCT00863798|50644458|FG001|Overall Study|Protocol Violation|1|||
25328110|NCT00863798|50644459|FG002|Overall Study|Protocol Violation|1|||
25328111|NCT00863798|50644457|FG000|Overall Study|Withdrawal by Subject|8|||
25328112|NCT00863798|50644458|FG001|Overall Study|Withdrawal by Subject|7|||
25328113|NCT00863798|50644459|FG002|Overall Study|Withdrawal by Subject|4|||
25328114|NCT00863798|50644457|FG000|Overall Study|Randomized not treated|4|||
25328115|NCT00863798|50644458|FG001|Overall Study|Randomized not treated|2|||
25328116|NCT00863798|50644459|FG002|Overall Study|Randomized not treated|3|||
25328117|NCT00859014|50644467|FG000|Overall Study|Death|4|||
25328118|NCT00859014|50644467|FG000|Overall Study|Lost to Follow-up|1|||
25328119|NCT00593606|50644471|FG000|Overall Study|Adverse Event|13|||
25328120|NCT00593606|50644471|FG000|Overall Study|Withdrawal by Subject|1|||
25328121|NCT00593606|50644471|FG000|Overall Study|Protocol Violation|3|||
25328122|NCT00593606|50644471|FG000|Overall Study|Lost to Follow-up|2|||
25328123|NCT00593606|50644471|FG000|Overall Study|Run-In Failure|5|||
25328124|NCT00593606|50644471|FG000|Overall Study|Screen Failure|3|||
25328125|NCT00870584|50644477|FG000|Overall Study|Adverse Event|3|||
25328126|NCT00870584|50644478|FG001|Overall Study|Adverse Event|3|||
25328127|NCT00870584|50644477|FG000|Overall Study|Withdrawal by Subject|6|||
25328128|NCT00870584|50644478|FG001|Overall Study|Withdrawal by Subject|7|||
25328129|NCT00870584|50644477|FG000|Overall Study|Lost to Follow-up|5|||
25328130|NCT00870584|50644478|FG001|Overall Study|Lost to Follow-up|1|||
25328131|NCT00870584|50644477|FG000|Overall Study|Protocol Deviation|2|||
25328132|NCT00870584|50644478|FG001|Overall Study|Protocol Deviation|2|||
25328133|NCT00870194|50644486|FG000|Overall Study|Adverse Event|10|||
25328134|NCT00870194|50644487|FG001|Overall Study|Adverse Event|5|||
25328135|NCT00870194|50644486|FG000|Overall Study|Lack of Efficacy|0|||
25328136|NCT00870194|50644487|FG001|Overall Study|Lack of Efficacy|1|||
25328137|NCT00870194|50644486|FG000|Overall Study|Lost to Follow-up|2|||
25328138|NCT00870194|50644487|FG001|Overall Study|Lost to Follow-up|0|||
25328139|NCT00870194|50644486|FG000|Overall Study|Physician Decision|3|||
25328140|NCT00870194|50644487|FG001|Overall Study|Physician Decision|1|||
25328141|NCT00870194|50644486|FG000|Overall Study|Protocol Violation|3|||
25328142|NCT00870194|50644487|FG001|Overall Study|Protocol Violation|3|||
25328143|NCT00870194|50644486|FG000|Overall Study|Entry Criteria Not Met|1|||
25328144|NCT00870194|50644487|FG001|Overall Study|Entry Criteria Not Met|2|||
25328145|NCT00870194|50644486|FG000|Overall Study|Subject Decision|7|||
25328146|NCT00870194|50644487|FG001|Overall Study|Subject Decision|2|||
25328147|NCT00690430|50644495|FG000|Core Phase|Abnormal Laboratory value|0|||
25328148|NCT00690430|50644496|FG001|Core Phase|Abnormal Laboratory value|1|||
25328149|NCT00690430|50644497|FG002|Core Phase|Abnormal Laboratory value|0|||
25328150|NCT00690430|50644495|FG000|Core Phase|Adverse Event|5|||
25328151|NCT00690430|50644496|FG001|Core Phase|Adverse Event|1|||
25328152|NCT00690430|50644497|FG002|Core Phase|Adverse Event|0|||
25328153|NCT00690430|50644495|FG000|Core Phase|Death|0|||
25328154|NCT00690430|50644496|FG001|Core Phase|Death|2|||
25328155|NCT00690430|50644497|FG002|Core Phase|Death|0|||
25328156|NCT00690430|50644495|FG000|Core Phase|Protocol Violation|1|||
25328157|NCT00690430|50644496|FG001|Core Phase|Protocol Violation|0|||
25328158|NCT00690430|50644497|FG002|Core Phase|Protocol Violation|0|||
25328159|NCT00690430|50644495|FG000|Core Phase|Withdrawal by Subject|3|||
25328160|NCT00690430|50644496|FG001|Core Phase|Withdrawal by Subject|3|||
25328161|NCT00690430|50644497|FG002|Core Phase|Withdrawal by Subject|0|||
25328162|NCT00690430|50644495|FG000|Core Phase|Subject no longer requires study drug|1|||
25328163|NCT00690430|50644496|FG001|Core Phase|Subject no longer requires study drug|0|||
25328164|NCT00690430|50644497|FG002|Core Phase|Subject no longer requires study drug|0|||
25328165|NCT00690430|50644495|FG000|Core Phase|Lack of Efficacy|8|||
25328166|NCT00690430|50644496|FG001|Core Phase|Lack of Efficacy|10|||
25328167|NCT00690430|50644497|FG002|Core Phase|Lack of Efficacy|0|||
25328168|NCT00690430|50644495|FG000|Core Phase|Administrative Problems|0|||
25328169|NCT00690430|50644496|FG001|Core Phase|Administrative Problems|1|||
25328170|NCT00690430|50644497|FG002|Core Phase|Administrative Problems|0|||
25328171|NCT00690430|50644495|FG000|Core Phase|Early Termination|0|||
25328172|NCT00690430|50644496|FG001|Core Phase|Early Termination|5|||
25328173|NCT00690430|50644497|FG002|Core Phase|Early Termination|0|||
25328174|NCT00690430|50644495|FG000|Extension Phase|Lack of Efficacy|3|||
25328175|NCT00690430|50644496|FG001|Extension Phase|Lack of Efficacy|1|||
25328176|NCT00690430|50644497|FG002|Extension Phase|Lack of Efficacy|4|||
25328177|NCT00690430|50644495|FG000|Extension Phase|Abnormal Lab Values|1|||
25328178|NCT00690430|50644496|FG001|Extension Phase|Abnormal Lab Values|0|||
25328179|NCT00690430|50644497|FG002|Extension Phase|Abnormal Lab Values|0|||
25328180|NCT00690430|50644495|FG000|Extension Phase|Abnormal test procedure results|1|||
25328181|NCT00690430|50644496|FG001|Extension Phase|Abnormal test procedure results|0|||
25328182|NCT00690430|50644497|FG002|Extension Phase|Abnormal test procedure results|0|||
25247607|NCT03303339|50563171|FG006|Overall Study|Study Terminated by Sponsor|0|||
25247608|NCT03303339|50563172|FG007|Overall Study|Study Terminated by Sponsor|0|||
25247609|NCT03303339|50563173|FG008|Overall Study|Study Terminated by Sponsor|1|||
25247610|NCT03303339|50563174|FG009|Overall Study|Study Terminated by Sponsor|0|||
25328183|NCT00690430|50644495|FG000|Extension Phase|Administrative Problems|0|||
25328184|NCT00690430|50644496|FG001|Extension Phase|Administrative Problems|1|||
25328185|NCT00690430|50644497|FG002|Extension Phase|Administrative Problems|1|||
25328186|NCT00690430|50644495|FG000|Extension Phase|Adverse Event|2|||
25328187|NCT00690430|50644496|FG001|Extension Phase|Adverse Event|1|||
25328188|NCT00690430|50644497|FG002|Extension Phase|Adverse Event|2|||
25328189|NCT00690430|50644495|FG000|Extension Phase|Death|1|||
25328190|NCT00690430|50644496|FG001|Extension Phase|Death|1|||
25328191|NCT00690430|50644497|FG002|Extension Phase|Death|1|||
25328192|NCT00690430|50644495|FG000|Extension Phase|Withdrawal by Subject|0|||
25328193|NCT00690430|50644496|FG001|Extension Phase|Withdrawal by Subject|0|||
25328194|NCT00690430|50644497|FG002|Extension Phase|Withdrawal by Subject|2|||
25328195|NCT00690430|50644495|FG000|Extension Phase|Early Termination|10|||
25328196|NCT00690430|50644496|FG001|Extension Phase|Early Termination|1|||
25328197|NCT00690430|50644497|FG002|Extension Phase|Early Termination|3|||
25328198|NCT00863330|50644506|FG000|Overall Study|study terminated early due to administra|6|||
25328199|NCT00688324|50644510|FG000|Overall Study|Withdrawal by Subject|2|||
25328200|NCT00688324|50644510|FG000|Overall Study|Physician Decision|5|||
25328201|NCT00688324|50644510|FG000|Overall Study|Lost to Follow-up|1|||
25328202|NCT00862940|50644517|FG000|Overall Study|Adverse Event|15|||
25328203|NCT00862940|50644518|FG001|Overall Study|Adverse Event|12|||
25328204|NCT00862940|50644517|FG000|Overall Study|Lack of Efficacy|1|||
25328205|NCT00862940|50644518|FG001|Overall Study|Lack of Efficacy|3|||
25328206|NCT00862940|50644517|FG000|Overall Study|Protocol Violation|2|||
25328207|NCT00862940|50644518|FG001|Overall Study|Protocol Violation|5|||
25328208|NCT00862940|50644517|FG000|Overall Study|Withdrawal by Subject|4|||
25328209|NCT00862940|50644518|FG001|Overall Study|Withdrawal by Subject|6|||
25328210|NCT00862940|50644517|FG000|Overall Study|Non-compliance|4|||
25328211|NCT00862940|50644518|FG001|Overall Study|Non-compliance|0|||
25328212|NCT00862940|50644517|FG000|Overall Study|Lost to Follow-up|0|||
25247611|NCT03303339|50563175|FG010|Overall Study|Study Terminated by Sponsor|1|||
25247612|NCT03303339|50563176|FG011|Overall Study|Study Terminated by Sponsor|1|||
25247613|NCT03303339|50563165|FG000|Overall Study|Withdrawal by Subject|1|||
25247614|NCT03303339|50563166|FG001|Overall Study|Withdrawal by Subject|0|||
25247615|NCT03303339|50563167|FG002|Overall Study|Withdrawal by Subject|0|||
25247616|NCT03303339|50563168|FG003|Overall Study|Withdrawal by Subject|0|||
25247617|NCT03303339|50563169|FG004|Overall Study|Withdrawal by Subject|0|||
25247618|NCT03303339|50563170|FG005|Overall Study|Withdrawal by Subject|1|||
25247619|NCT03303339|50563171|FG006|Overall Study|Withdrawal by Subject|1|||
25247620|NCT03303339|50563172|FG007|Overall Study|Withdrawal by Subject|0|||
25247621|NCT03303339|50563173|FG008|Overall Study|Withdrawal by Subject|0|||
25247622|NCT03303339|50563174|FG009|Overall Study|Withdrawal by Subject|0|||
25247623|NCT03303339|50563175|FG010|Overall Study|Withdrawal by Subject|0|||
25328213|NCT00862940|50644518|FG001|Overall Study|Lost to Follow-up|1|||
25328214|NCT00862940|50644517|FG000|Overall Study|Administrative or other reason(s)|4|||
25328215|NCT00862940|50644518|FG001|Overall Study|Administrative or other reason(s)|3|||
25328216|NCT00868166|50644526|FG000|Overall Study|Death|58|||
25328217|NCT00868166|50644527|FG001|Overall Study|Death|65|||
25328218|NCT00868166|50644526|FG000|Overall Study|Withdrawal by Subject|33|||
25328219|NCT00868166|50644527|FG001|Overall Study|Withdrawal by Subject|25|||
25247624|NCT03303339|50563176|FG011|Overall Study|Withdrawal by Subject|2|||
25247625|NCT03303339|50563165|FG000|Overall Study|Physician Decision|0|||
25247626|NCT03303339|50563166|FG001|Overall Study|Physician Decision|0|||
25247627|NCT03303339|50563167|FG002|Overall Study|Physician Decision|0|||
25247628|NCT03303339|50563168|FG003|Overall Study|Physician Decision|0|||
25247629|NCT03303339|50563169|FG004|Overall Study|Physician Decision|1|||
25247630|NCT03303339|50563170|FG005|Overall Study|Physician Decision|0|||
25328220|NCT00868166|50644526|FG000|Overall Study|Protocol Violation|1|||
25328221|NCT00868166|50644527|FG001|Overall Study|Protocol Violation|0|||
25328222|NCT00868166|50644526|FG000|Overall Study|Lost to Follow-up|1|||
25328223|NCT00868166|50644527|FG001|Overall Study|Lost to Follow-up|3|||
25328224|NCT00868166|50644526|FG000|Overall Study|Adverse Event|9|||
25247631|NCT03303339|50563171|FG006|Overall Study|Physician Decision|0|||
25328225|NCT00868166|50644527|FG001|Overall Study|Adverse Event|10|||
25328226|NCT00868166|50644526|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
25328227|NCT00868166|50644527|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
25328228|NCT00868166|50644526|FG000|Overall Study|Non-compliance with IMP|1|||
25328229|NCT00868166|50644527|FG001|Overall Study|Non-compliance with IMP|1|||
25247632|NCT03303339|50563172|FG007|Overall Study|Physician Decision|0|||
25247633|NCT03303339|50563173|FG008|Overall Study|Physician Decision|0|||
25247634|NCT03303339|50563174|FG009|Overall Study|Physician Decision|0|||
25247635|NCT03303339|50563175|FG010|Overall Study|Physician Decision|0|||
25247636|NCT03303339|50563176|FG011|Overall Study|Physician Decision|0|||
25247637|NCT03303339|50563165|FG000|Overall Study|Safety/Non-compliance|0|||
25247638|NCT03303339|50563166|FG001|Overall Study|Safety/Non-compliance|0|||
25247639|NCT03303339|50563167|FG002|Overall Study|Safety/Non-compliance|0|||
25247640|NCT03303339|50563168|FG003|Overall Study|Safety/Non-compliance|0|||
25247641|NCT03303339|50563169|FG004|Overall Study|Safety/Non-compliance|0|||
25247642|NCT03303339|50563170|FG005|Overall Study|Safety/Non-compliance|0|||
25247643|NCT03303339|50563171|FG006|Overall Study|Safety/Non-compliance|0|||
25328230|NCT00858780|50644533|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
25328231|NCT00858780|50644534|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
25328232|NCT00858780|50644535|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
25328233|NCT00858780|50644536|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
25328234|NCT00858780|50644537|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
25328235|NCT00858780|50644533|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
25328236|NCT00858780|50644534|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
25328237|NCT00858780|50644535|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
25328238|NCT00858780|50644536|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
25328239|NCT00858780|50644537|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
25328240|NCT00858780|50644533|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
25328241|NCT00858780|50644534|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
25328242|NCT00858780|50644535|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
25328243|NCT00858780|50644536|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
25328244|NCT00858780|50644537|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
25328245|NCT00858780|50644533|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
25328246|NCT00858780|50644534|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
25328247|NCT00858780|50644535|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
25328248|NCT00858780|50644536|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
25328249|NCT00858780|50644537|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
25328250|NCT00858780|50644533|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
25328251|NCT00858780|50644534|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
25328252|NCT00858780|50644535|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
25328253|NCT00858780|50644536|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
25328254|NCT00858780|50644537|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
25328255|NCT00858780|50644533|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
25328256|NCT00858780|50644534|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
25328257|NCT00858780|50644535|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
25328258|NCT00858780|50644536|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
25328259|NCT00858780|50644537|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
25328260|NCT00850200|50644547|FG000|Overall Study|Physician Decision|2|||
25328261|NCT00850200|50644547|FG000|Overall Study|Did not recieve treatment|2|||
25328262|NCT00850200|50644547|FG000|Overall Study|Withdrawal by Subject|1|||
25328263|NCT00858234|50644554|FG000|Overall Study|Adverse Event|6|||
25328264|NCT00858234|50644554|FG000|Overall Study|Progressive disease|2|||
25328265|NCT00858234|50644554|FG000|Overall Study|Status unknown|1|||
25328266|NCT00862082|50644560|FG000|Overall Study|Sponsor decision to terminate the study|5|||
25328267|NCT00862082|50644561|FG001|Overall Study|Sponsor decision to terminate the study|0|||
25328268|NCT00862082|50644560|FG000|Overall Study|Withdrawal by Subject|0|||
25328269|NCT00862082|50644561|FG001|Overall Study|Withdrawal by Subject|1|||
25328270|NCT00849186|50644574|FG000|Overall Study|Adverse Event|2|||
25328271|NCT00849186|50644574|FG000|Overall Study|Withdrawal by Subject|1|||
25077801|NCT03318523|50185671|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
25077802|NCT03318523|50185672|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
25077803|NCT03318523|50185663|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
25077804|NCT03318523|50185664|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
25077805|NCT03318523|50185665|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
25247644|NCT03303339|50563172|FG007|Overall Study|Safety/Non-compliance|0|||
25247645|NCT03303339|50563173|FG008|Overall Study|Safety/Non-compliance|0|||
25247646|NCT03303339|50563174|FG009|Overall Study|Safety/Non-compliance|0|||
25247647|NCT03303339|50563175|FG010|Overall Study|Safety/Non-compliance|0|||
25247648|NCT03303339|50563176|FG011|Overall Study|Safety/Non-compliance|1|||
25247649|NCT01183780|50563221|FG000|Overall Study|Withdrawal by Subject|25|||
25328272|NCT00849186|50644574|FG000|Overall Study|not treated|6|||
25328273|NCT00849186|50644574|FG000|Overall Study|Other|1|||
25328274|NCT00692770|50644581|FG000|Overall Study|Protocol Violation|2|||
25328275|NCT00692770|50644582|FG001|Overall Study|Protocol Violation|7|||
25328276|NCT00692770|50644581|FG000|Overall Study|Withdrawal by Subject|97|||
25328277|NCT00692770|50644582|FG001|Overall Study|Withdrawal by Subject|36|||
25328278|NCT00692770|50644581|FG000|Overall Study|Adverse Event|136|||
25328279|NCT00692770|50644582|FG001|Overall Study|Adverse Event|41|||
25328280|NCT00692770|50644581|FG000|Overall Study|Death|10|||
25328281|NCT00692770|50644582|FG001|Overall Study|Death|5|||
25328282|NCT00692770|50644581|FG000|Overall Study|Lost to Follow-up|7|||
25247650|NCT01183780|50563222|FG001|Overall Study|Withdrawal by Subject|14|||
25247651|NCT01183780|50563221|FG000|Overall Study|Lost to Follow-up|6|||
25247652|NCT01183780|50563222|FG001|Overall Study|Lost to Follow-up|11|||
25247653|NCT01183468|50563232|FG000|Overall Study|Lost to Follow-up|2|||
25247654|NCT01183468|50563233|FG001|Overall Study|Lost to Follow-up|1|||
25247655|NCT01183468|50563234|FG002|Overall Study|Lost to Follow-up|0|||
25247656|NCT01183468|50563235|FG003|Overall Study|Lost to Follow-up|0|||
25247657|NCT01183468|50563232|FG000|Overall Study|Physician Decision|1|||
25247658|NCT01183468|50563233|FG001|Overall Study|Physician Decision|0|||
25247659|NCT01183468|50563234|FG002|Overall Study|Physician Decision|0|||
25247660|NCT01183468|50563235|FG003|Overall Study|Physician Decision|0|||
25247661|NCT01183468|50563232|FG000|Overall Study|Withdrawal by Subject|0|||
25247662|NCT01183468|50563233|FG001|Overall Study|Withdrawal by Subject|1|||
25247663|NCT01183468|50563234|FG002|Overall Study|Withdrawal by Subject|0|||
25247664|NCT01183468|50563235|FG003|Overall Study|Withdrawal by Subject|0|||
25247665|NCT01183390|50563245|FG000|First Intervention|Adverse Event|0|||
25247666|NCT01183390|50563246|FG001|First Intervention|Adverse Event|1|||
25247667|NCT01214668|50563258|FG000|Overall Study|Adverse Event|0|||
25247668|NCT01214668|50563259|FG001|Overall Study|Adverse Event|1|||
25247669|NCT01214668|50563260|FG002|Overall Study|Adverse Event|0|||
25247670|NCT01214668|50563261|FG003|Overall Study|Adverse Event|2|||
25328283|NCT00692770|50644582|FG001|Overall Study|Lost to Follow-up|3|||
25328284|NCT00692770|50644581|FG000|Overall Study|Non-compliant with study medication|11|||
25328285|NCT00692770|50644582|FG001|Overall Study|Non-compliant with study medication|5|||
25328286|NCT00692770|50644581|FG000|Overall Study|Progression by clinical judgment|2|||
25328287|NCT00692770|50644582|FG001|Overall Study|Progression by clinical judgment|3|||
25328288|NCT00692770|50644581|FG000|Overall Study|Physician decision not protocol driven|10|||
25328289|NCT00692770|50644582|FG001|Overall Study|Physician decision not protocol driven|14|||
25328290|NCT00692770|50644581|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
25328291|NCT00692770|50644582|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
25328292|NCT00692770|50644581|FG000|Overall Study|Protocol driven decision point|3|||
25328293|NCT00692770|50644582|FG001|Overall Study|Protocol driven decision point|7|||
25328294|NCT00692770|50644581|FG000|Overall Study|Completed all planned assessments|79|||
25328295|NCT00692770|50644582|FG001|Overall Study|Completed all planned assessments|101|||
25328296|NCT00692770|50644581|FG000|Overall Study|Radiological and clinical progression|8|||
25328297|NCT00692770|50644582|FG001|Overall Study|Radiological and clinical progression|8|||
25328298|NCT00692770|50644581|FG000|Overall Study|Clinical endpoint reached|16|||
25328299|NCT00692770|50644582|FG001|Overall Study|Clinical endpoint reached|43|||
25328300|NCT00692770|50644581|FG000|Overall Study|Study terminated by sponsor|2|||
25328301|NCT00692770|50644582|FG001|Overall Study|Study terminated by sponsor|2|||
25328302|NCT00692770|50644581|FG000|Overall Study|Randomized but not treated|3|||
25328303|NCT00692770|50644582|FG001|Overall Study|Randomized but not treated|4|||
25328304|NCT00849108|50644597|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
25328305|NCT00849108|50644598|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
25328306|NCT00849108|50644597|FG000|Cohort 2 Efficacy|Adverse Event|0|||
25328307|NCT00849108|50644598|FG001|Cohort 2 Efficacy|Adverse Event|1|||
25328308|NCT00849108|50644597|FG000|Cohort 2 Efficacy|Other|0|||
25328309|NCT00849108|50644598|FG001|Cohort 2 Efficacy|Other|9|||
25328310|NCT00867308|50644608|FG000|Overall Study|Death|1|||
25328311|NCT00867308|50644609|FG001|Overall Study|Death|0|||
25328312|NCT00867308|50644608|FG000|Overall Study|Adverse Event|1|||
25328313|NCT00867308|50644609|FG001|Overall Study|Adverse Event|4|||
25328314|NCT00867308|50644608|FG000|Overall Study|Lack of Efficacy|6|||
25328315|NCT00867308|50644609|FG001|Overall Study|Lack of Efficacy|12|||
25328316|NCT00867308|50644608|FG000|Overall Study|Withdrawal by Subject|1|||
25247671|NCT01214668|50563262|FG004|Overall Study|Adverse Event|1|||
25247672|NCT01214668|50563263|FG005|Overall Study|Adverse Event|1|||
25247673|NCT01214668|50563258|FG000|Overall Study|Death|0|||
25247674|NCT01214668|50563259|FG001|Overall Study|Death|0|||
25328317|NCT00867308|50644609|FG001|Overall Study|Withdrawal by Subject|2|||
25328318|NCT00866918|50644617|FG000|Overall Study|Death|1|||
25328319|NCT00866918|50644618|FG001|Overall Study|Death|5|||
25328320|NCT00866918|50644617|FG000|Overall Study|Lack of Efficacy|1|||
25328321|NCT00866918|50644618|FG001|Overall Study|Lack of Efficacy|1|||
25328322|NCT00866918|50644617|FG000|Overall Study|Physician Decision|10|||
25328323|NCT00866918|50644618|FG001|Overall Study|Physician Decision|2|||
25247675|NCT01214668|50563260|FG002|Overall Study|Death|1|||
25328324|NCT00866918|50644617|FG000|Overall Study|Ineligible|2|||
25328325|NCT00866918|50644618|FG001|Overall Study|Ineligible|4|||
25328326|NCT00866918|50644617|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
25247676|NCT01214668|50563261|FG003|Overall Study|Death|0|||
25247677|NCT01214668|50563262|FG004|Overall Study|Death|0|||
25247678|NCT01214668|50563263|FG005|Overall Study|Death|0|||
25247679|NCT01214668|50563258|FG000|Overall Study|Progressive Disease|4|||
25328327|NCT00866918|50644618|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
25328328|NCT00866918|50644617|FG000|Overall Study|Secondary malignancy|1|||
25328329|NCT00866918|50644618|FG001|Overall Study|Secondary malignancy|0|||
25328330|NCT03158285|50644627|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
25328331|NCT03158285|50644628|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
25328332|NCT03158285|50644629|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
25328333|NCT03158285|50644627|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
25328334|NCT03158285|50644628|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
25328335|NCT03158285|50644629|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
25328336|NCT03158285|50644627|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
25247680|NCT01214668|50563259|FG001|Overall Study|Progressive Disease|2|||
25247681|NCT01214668|50563260|FG002|Overall Study|Progressive Disease|5|||
25247682|NCT01214668|50563261|FG003|Overall Study|Progressive Disease|4|||
25247683|NCT01214668|50563262|FG004|Overall Study|Progressive Disease|4|||
25077806|NCT03318523|50185666|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
25077807|NCT03318523|50185667|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
25247684|NCT01214668|50563263|FG005|Overall Study|Progressive Disease|5|||
25247685|NCT01214668|50563258|FG000|Overall Study|Withdrawal by Subject|0|||
25247686|NCT01214668|50563259|FG001|Overall Study|Withdrawal by Subject|0|||
25247687|NCT01214668|50563260|FG002|Overall Study|Withdrawal by Subject|0|||
25247688|NCT01214668|50563261|FG003|Overall Study|Withdrawal by Subject|0|||
25247689|NCT01214668|50563262|FG004|Overall Study|Withdrawal by Subject|1|||
25247690|NCT01214668|50563263|FG005|Overall Study|Withdrawal by Subject|0|||
25247691|NCT01191268|50563281|FG000|Overall Study|Withdrawal by Subject|19|||
25247692|NCT01191268|50563282|FG001|Overall Study|Withdrawal by Subject|25|||
25247693|NCT01191268|50563283|FG002|Overall Study|Withdrawal by Subject|21|||
25247694|NCT01191268|50563281|FG000|Overall Study|Adverse Event|21|||
25247695|NCT01191268|50563282|FG001|Overall Study|Adverse Event|13|||
25247696|NCT01191268|50563283|FG002|Overall Study|Adverse Event|8|||
25247697|NCT01191268|50563281|FG000|Overall Study|Physician Decision|6|||
25247698|NCT01191268|50563282|FG001|Overall Study|Physician Decision|8|||
25247699|NCT01191268|50563283|FG002|Overall Study|Physician Decision|9|||
25077808|NCT03318523|50185668|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
25247700|NCT01191268|50563281|FG000|Overall Study|Lost to Follow-up|8|||
25247701|NCT01191268|50563282|FG001|Overall Study|Lost to Follow-up|5|||
25328337|NCT03158285|50644628|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
25247702|NCT01191268|50563283|FG002|Overall Study|Lost to Follow-up|9|||
25247703|NCT01191268|50563281|FG000|Overall Study|Entry Criteria Not Met|3|||
25247704|NCT01191268|50563282|FG001|Overall Study|Entry Criteria Not Met|1|||
25247705|NCT01191268|50563283|FG002|Overall Study|Entry Criteria Not Met|1|||
25247706|NCT01191268|50563281|FG000|Overall Study|Death|0|||
25247707|NCT01191268|50563282|FG001|Overall Study|Death|1|||
25247708|NCT01191268|50563283|FG002|Overall Study|Death|3|||
25247709|NCT01191268|50563281|FG000|Overall Study|Protocol Violation|1|||
25328338|NCT03158285|50644629|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
25328339|NCT03158285|50644627|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
25328340|NCT03158285|50644628|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
25328341|NCT03158285|50644629|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
25328342|NCT03158285|50644627|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
25328343|NCT03158285|50644628|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
25328344|NCT03158285|50644629|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
25328345|NCT03158285|50644627|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
25328346|NCT03158285|50644628|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
25328347|NCT03158285|50644629|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
25328348|NCT03158285|50644627|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
25328349|NCT03158285|50644628|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
25247710|NCT01191268|50563282|FG001|Overall Study|Protocol Violation|0|||
25247711|NCT01191268|50563283|FG002|Overall Study|Protocol Violation|1|||
25247712|NCT01191268|50563281|FG000|Overall Study|Sponsor Decision|0|||
25247713|NCT01191268|50563282|FG001|Overall Study|Sponsor Decision|2|||
25328350|NCT03158285|50644629|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
25247714|NCT01191268|50563283|FG002|Overall Study|Sponsor Decision|0|||
25247715|NCT01191190|50563292|FG000|Overall Study|Withdrawal by Subject|1|||
25247716|NCT05751629|50563296|FG000|Overall Study|Withdrawal by Subject|6|||
25247717|NCT05751629|50563296|FG000|Overall Study|Death|25|||
25247718|NCT05751629|50563296|FG000|Overall Study|Study Site Closed|9|||
25328351|NCT03158285|50644627|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
25328352|NCT03158285|50644628|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
25328353|NCT03158285|50644629|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
25328354|NCT03158285|50644627|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
25328355|NCT03158285|50644628|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
25328356|NCT03158285|50644629|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
25328357|NCT03158285|50644627|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
25328358|NCT03158285|50644628|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
25247719|NCT05751629|50563296|FG000|Overall Study|Physician Decision|1|||
25247720|NCT05306977|50563300|FG000|Overall Study|Withdrawal by Subject|1|||
25247721|NCT05086276|50563306|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
25247722|NCT05086276|50563307|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
25247723|NCT04870710|50563313|FG000|Overall Study|Lost to Follow-up|3|||
25247724|NCT04858802|50563319|FG000|Overall Study|Lost to Follow-up|1|||
25247725|NCT04858802|50563320|FG001|Overall Study|Lost to Follow-up|1|||
25247726|NCT04858802|50563319|FG000|Overall Study|Withdrawal by Subject|1|||
25247727|NCT04858802|50563320|FG001|Overall Study|Withdrawal by Subject|1|||
25247728|NCT04562090|50563359|FG000|Overall Study|Withdrawal by Subject|3|||
25247729|NCT04562090|50563360|FG001|Overall Study|Withdrawal by Subject|4|||
25247730|NCT04562090|50563359|FG000|Overall Study|Protocol Violation|2|||
25247731|NCT04562090|50563360|FG001|Overall Study|Protocol Violation|0|||
25247732|NCT04562090|50563359|FG000|Overall Study|Lack of Efficacy|0|||
25247733|NCT04562090|50563360|FG001|Overall Study|Lack of Efficacy|1|||
25247734|NCT04562090|50563359|FG000|Overall Study|Adverse Event|1|||
25328359|NCT03158285|50644629|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
25328360|NCT03158285|50644627|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
25328361|NCT03158285|50644628|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
25328362|NCT03158285|50644629|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
25328363|NCT03158285|50644627|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
25328364|NCT03158285|50644628|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
25328365|NCT03158285|50644629|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
25328366|NCT03158285|50644627|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
25328367|NCT03158285|50644628|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
25328368|NCT03158285|50644629|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
25247735|NCT04562090|50563360|FG001|Overall Study|Adverse Event|4|||
25247736|NCT04562090|50563359|FG000|Overall Study|Miscellaneous|0|||
25247737|NCT04562090|50563360|FG001|Overall Study|Miscellaneous|3|||
25247738|NCT04557189|50563371|FG000|Overall Study|Adverse Event|0|||
25247739|NCT04557189|50563372|FG001|Overall Study|Adverse Event|1|||
25247740|NCT04557189|50563371|FG000|Overall Study|Lost to Follow-up|1|||
25247741|NCT04557189|50563372|FG001|Overall Study|Lost to Follow-up|1|||
25247742|NCT04557189|50563371|FG000|Overall Study|Withdrawal by Subject|2|||
25328369|NCT03158285|50644627|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
25328370|NCT03158285|50644628|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
25328371|NCT03158285|50644629|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
25328372|NCT03158285|50644627|FG000|Active Treatment Period: Week 52-100|Death|1|||
25247743|NCT04557189|50563372|FG001|Overall Study|Withdrawal by Subject|1|||
25247744|NCT04557189|50563371|FG000|Overall Study|Reason not Specified|3|||
25247745|NCT04557189|50563372|FG001|Overall Study|Reason not Specified|6|||
25247746|NCT04530838|50563385|FG000|Overall Study|Other|2|||
25247747|NCT04530838|50563386|FG001|Overall Study|Other|1|||
25247748|NCT04530838|50563387|FG002|Overall Study|Other|0|||
25247749|NCT04530838|50563385|FG000|Overall Study|Physician Decision|0|||
25328373|NCT03158285|50644628|FG001|Active Treatment Period: Week 52-100|Death|0|||
25328374|NCT03158285|50644629|FG002|Active Treatment Period: Week 52-100|Death|0|||
25328375|NCT03158285|50644627|FG000|Active Treatment Period: Week 52-100|Other|4|||
25328376|NCT03158285|50644628|FG001|Active Treatment Period: Week 52-100|Other|1|||
25328377|NCT03158285|50644629|FG002|Active Treatment Period: Week 52-100|Other|0|||
25328378|NCT00861692|50644642|FG000|Overall Study|Death|6|||
25247750|NCT04530838|50563386|FG001|Overall Study|Physician Decision|0|||
25247751|NCT04530838|50563387|FG002|Overall Study|Physician Decision|1|||
25328379|NCT00602927|50644648|FG000|Period 1: 13 Days|Protocol Violation|2|||
25328380|NCT00602927|50644649|FG001|Period 1: 13 Days|Protocol Violation|4|||
25328381|NCT00602927|50644648|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
25328382|NCT00602927|50644649|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
25328383|NCT00602927|50644648|FG000|Period 1: 13 Days|Time|1|||
25328384|NCT00602927|50644649|FG001|Period 1: 13 Days|Time|0|||
25328385|NCT00602927|50644648|FG000|Period 1: 13 Days|Claustrophobia|0|||
25328386|NCT00602927|50644649|FG001|Period 1: 13 Days|Claustrophobia|1|||
25328387|NCT00602927|50644648|FG000|Period 2: 14 Days|Protocol Violation|0|||
25328388|NCT00602927|50644649|FG001|Period 2: 14 Days|Protocol Violation|2|||
25328389|NCT00602927|50644648|FG000|Period 3: 13 Days|Protocol Violation|0|||
25247752|NCT04530838|50563385|FG000|Overall Study|Death|0|||
25247753|NCT04530838|50563386|FG001|Overall Study|Death|0|||
25328390|NCT00602927|50644649|FG001|Period 3: 13 Days|Protocol Violation|1|||
25328391|NCT00602927|50644648|FG000|Period 3: 13 Days|MRI data quality|2|||
25328392|NCT00602927|50644649|FG001|Period 3: 13 Days|MRI data quality|2|||
25328393|NCT00602537|50644657|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
25328394|NCT00602537|50644658|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
25328395|NCT00602537|50644657|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
25328396|NCT00602537|50644658|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
25328397|NCT00602537|50644657|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
25328398|NCT00602537|50644658|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
25328399|NCT00602537|50644657|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
25328400|NCT00602537|50644658|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
25328401|NCT00602537|50644657|FG000|Follow Up Study Comparison|Adverse Event|1|||
25328402|NCT00602537|50644658|FG001|Follow Up Study Comparison|Adverse Event|0|||
25328403|NCT00602537|50644657|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
25328404|NCT00602537|50644658|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
25328405|NCT00602537|50644657|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
25328406|NCT00602537|50644658|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
25328407|NCT00861614|50644666|FG000|Overall Study|Disease Progression|182|||
25328408|NCT00861614|50644667|FG001|Overall Study|Disease Progression|263|||
25328409|NCT00861614|50644666|FG000|Overall Study|Study Drug Toxicity|79|||
25328410|NCT00861614|50644667|FG001|Overall Study|Study Drug Toxicity|6|||
25328411|NCT00861614|50644666|FG000|Overall Study|Death|32|||
25328412|NCT00861614|50644667|FG001|Overall Study|Death|19|||
25328413|NCT00861614|50644666|FG000|Overall Study|Adverse Event|27|||
25328414|NCT00861614|50644667|FG001|Overall Study|Adverse Event|23|||
25328415|NCT00861614|50644666|FG000|Overall Study|Withdrawal by Subject|34|||
25328416|NCT00861614|50644667|FG001|Overall Study|Withdrawal by Subject|35|||
25328417|NCT00861614|50644666|FG000|Overall Study|Other|17|||
25328418|NCT00861614|50644667|FG001|Overall Study|Other|22|||
25328419|NCT00485173|50644675|FG000|Overall Study|Death|4|||
25328420|NCT00485173|50644676|FG001|Overall Study|Death|3|||
25247754|NCT04530838|50563387|FG002|Overall Study|Death|1|||
25328421|NCT00485173|50644675|FG000|Overall Study|Lost to Follow-up|32|||
25328422|NCT00485173|50644676|FG001|Overall Study|Lost to Follow-up|61|||
25328423|NCT00495469|50644689|FG000|Overall Study|Adverse Event|0|||
25247755|NCT04530838|50563385|FG000|Overall Study|Adverse Event|0|||
25328424|NCT00495469|50644690|FG001|Overall Study|Adverse Event|1|||
25328425|NCT00495469|50644691|FG002|Overall Study|Adverse Event|3|||
25328426|NCT00495469|50644692|FG003|Overall Study|Adverse Event|0|||
25328427|NCT00495469|50644693|FG004|Overall Study|Adverse Event|1|||
25328428|NCT00495469|50644694|FG005|Overall Study|Adverse Event|1|||
25328429|NCT00495469|50644695|FG006|Overall Study|Adverse Event|1|||
25247756|NCT04530838|50563386|FG001|Overall Study|Adverse Event|1|||
25247757|NCT04530838|50563387|FG002|Overall Study|Adverse Event|0|||
25247758|NCT04530838|50563385|FG000|Overall Study|No longer meets eligibility criteria|1|||
25247759|NCT04530838|50563386|FG001|Overall Study|No longer meets eligibility criteria|0|||
25247760|NCT04530838|50563387|FG002|Overall Study|No longer meets eligibility criteria|2|||
25247761|NCT04530838|50563385|FG000|Overall Study|Withdrawal by parent/guardian|5|||
25247762|NCT04530838|50563386|FG001|Overall Study|Withdrawal by parent/guardian|2|||
25247763|NCT04530838|50563387|FG002|Overall Study|Withdrawal by parent/guardian|2|||
25247764|NCT04424901|50563401|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
25247765|NCT04424901|50563402|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
25247766|NCT04410445|50563410|FG000|Overall Study|Lost to Follow-up|3|||
25247767|NCT04410445|50563411|FG001|Overall Study|Lost to Follow-up|9|||
25247768|NCT04410445|50563410|FG000|Overall Study|Withdrawal by Subject|27|||
25247769|NCT04410445|50563411|FG001|Overall Study|Withdrawal by Subject|15|||
25247770|NCT04062448|50563440|FG000|Overall Study|Lost to Follow-up|1|||
25247771|NCT04062448|50563440|FG000|Overall Study|Withdrawal by Subject|1|||
25247772|NCT04062448|50563440|FG000|Overall Study|Ongoing|14|||
25247773|NCT03970733|50563447|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
25247774|NCT03970733|50563448|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
25247775|NCT03970733|50563449|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
25247776|NCT03970733|50563450|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
25247777|NCT03970733|50563451|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
25247778|NCT03970733|50563447|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
25247779|NCT03970733|50563448|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
25247780|NCT03970733|50563449|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
25247781|NCT03970733|50563450|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
25247782|NCT03970733|50563451|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
25247783|NCT03970733|50563447|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
25247784|NCT03970733|50563448|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
25247785|NCT03970733|50563449|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
25247786|NCT03970733|50563450|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
25247787|NCT03970733|50563451|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
25247788|NCT03970733|50563447|FG000|Main Study Phase (18 Months)|Other|1|||
25247789|NCT03970733|50563448|FG001|Main Study Phase (18 Months)|Other|1|||
25247790|NCT03970733|50563449|FG002|Main Study Phase (18 Months)|Other|0|||
25247791|NCT03970733|50563450|FG003|Main Study Phase (18 Months)|Other|0|||
25247792|NCT03970733|50563451|FG004|Main Study Phase (18 Months)|Other|0|||
25247793|NCT03970733|50563447|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
25247794|NCT03970733|50563448|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
25247795|NCT03970733|50563449|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
25247796|NCT03970733|50563450|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
25247797|NCT03970733|50563451|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
25247798|NCT03921411|50563463|FG000|Overall Study|Withdrawal by Subject|1|||
25247799|NCT03921411|50563463|FG000|Overall Study|Protocol Deviation|2|||
25247800|NCT03921411|50563463|FG000|Overall Study|Enrolled, but never treated|2|||
25247801|NCT03728582|50563467|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
25247802|NCT03728582|50563468|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
25247803|NCT03728582|50563467|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
25247804|NCT03728582|50563468|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
25247805|NCT03416179|50563487|FG000|Overall Study|Death|90|||
25247806|NCT03416179|50563488|FG001|Overall Study|Death|87|||
25247807|NCT03416179|50563489|FG002|Overall Study|Death|117|||
25247808|NCT03416179|50563490|FG003|Overall Study|Death|113|||
25247809|NCT03416179|50563487|FG000|Overall Study|Withdrawal by Subject|15|||
25247810|NCT03416179|50563488|FG001|Overall Study|Withdrawal by Subject|20|||
25247811|NCT03416179|50563489|FG002|Overall Study|Withdrawal by Subject|6|||
25247812|NCT03416179|50563490|FG003|Overall Study|Withdrawal by Subject|9|||
25247813|NCT03416179|50563487|FG000|Overall Study|Lost to Follow-up|1|||
25247814|NCT03416179|50563488|FG001|Overall Study|Lost to Follow-up|1|||
25247815|NCT03416179|50563489|FG002|Overall Study|Lost to Follow-up|0|||
25247816|NCT03416179|50563490|FG003|Overall Study|Lost to Follow-up|3|||
25247817|NCT03416179|50563487|FG000|Overall Study|Study participation terminated by Sponsor|93|||
25247818|NCT03416179|50563488|FG001|Overall Study|Study participation terminated by Sponsor|91|||
25247819|NCT03416179|50563489|FG002|Overall Study|Study participation terminated by Sponsor|26|||
25247820|NCT03416179|50563490|FG003|Overall Study|Study participation terminated by Sponsor|31|||
25247821|NCT03416179|50563487|FG000|Overall Study|Other|2|||
25247822|NCT03416179|50563488|FG001|Overall Study|Other|3|||
25247823|NCT03416179|50563489|FG002|Overall Study|Other|1|||
25247824|NCT03416179|50563490|FG003|Overall Study|Other|0|||
25247825|NCT03186638|50563502|FG000|Overall Study|Withdrawal by Subject|4|||
25247826|NCT03186638|50563503|FG001|Overall Study|Withdrawal by Subject|4|||
25247827|NCT03186638|50563502|FG000|Overall Study|Withdrawn due to medical problem|3|||
25247828|NCT03186638|50563503|FG001|Overall Study|Withdrawn due to medical problem|2|||
25247829|NCT03186638|50563502|FG000|Overall Study|Lost to Follow-up|1|||
25247830|NCT03186638|50563503|FG001|Overall Study|Lost to Follow-up|0|||
25247831|NCT03043872|50563525|FG000|Overall Study|Withdrawal by Subject|6|||
25247832|NCT03043872|50563526|FG001|Overall Study|Withdrawal by Subject|6|||
25247833|NCT03043872|50563527|FG002|Overall Study|Withdrawal by Subject|15|||
25247834|NCT03043872|50563525|FG000|Overall Study|Lost to Follow-up|2|||
25247835|NCT03043872|50563526|FG001|Overall Study|Lost to Follow-up|1|||
25247836|NCT03043872|50563527|FG002|Overall Study|Lost to Follow-up|1|||
25247837|NCT03043872|50563525|FG000|Overall Study|Death|270|||
25247838|NCT03043872|50563526|FG001|Overall Study|Death|269|||
25247839|NCT03043872|50563527|FG002|Overall Study|Death|296|||
25247840|NCT02932332|50563571|FG000|Overall Study|Withdrawal by Subject|1|||
25328430|NCT00495469|50644689|FG000|Overall Study|Lost to Follow-up|1|||
25328431|NCT00495469|50644690|FG001|Overall Study|Lost to Follow-up|1|||
25328432|NCT00495469|50644691|FG002|Overall Study|Lost to Follow-up|3|||
25328433|NCT00495469|50644692|FG003|Overall Study|Lost to Follow-up|1|||
25328434|NCT00495469|50644693|FG004|Overall Study|Lost to Follow-up|0|||
25328435|NCT00495469|50644694|FG005|Overall Study|Lost to Follow-up|0|||
25328436|NCT00495469|50644695|FG006|Overall Study|Lost to Follow-up|0|||
25328437|NCT00495469|50644689|FG000|Overall Study|Protocol Violation|0|||
25328438|NCT00495469|50644690|FG001|Overall Study|Protocol Violation|0|||
25328439|NCT00495469|50644691|FG002|Overall Study|Protocol Violation|0|||
25328440|NCT00495469|50644692|FG003|Overall Study|Protocol Violation|0|||
25328441|NCT00495469|50644693|FG004|Overall Study|Protocol Violation|1|||
25328442|NCT00495469|50644694|FG005|Overall Study|Protocol Violation|2|||
25328443|NCT00495469|50644695|FG006|Overall Study|Protocol Violation|0|||
25328444|NCT00495469|50644689|FG000|Overall Study|Withdrawal by Subject|5|||
25328445|NCT00495469|50644690|FG001|Overall Study|Withdrawal by Subject|3|||
25328446|NCT00495469|50644691|FG002|Overall Study|Withdrawal by Subject|1|||
25328447|NCT00495469|50644692|FG003|Overall Study|Withdrawal by Subject|3|||
25328448|NCT00495469|50644693|FG004|Overall Study|Withdrawal by Subject|3|||
25328449|NCT00495469|50644694|FG005|Overall Study|Withdrawal by Subject|2|||
25328450|NCT00495469|50644695|FG006|Overall Study|Withdrawal by Subject|3|||
25328451|NCT00495469|50644689|FG000|Overall Study|Lack of Efficacy|0|||
25328452|NCT00495469|50644690|FG001|Overall Study|Lack of Efficacy|0|||
25328453|NCT00495469|50644691|FG002|Overall Study|Lack of Efficacy|0|||
25328454|NCT00495469|50644692|FG003|Overall Study|Lack of Efficacy|0|||
25328455|NCT00495469|50644693|FG004|Overall Study|Lack of Efficacy|0|||
25328456|NCT00495469|50644694|FG005|Overall Study|Lack of Efficacy|0|||
25328457|NCT00495469|50644695|FG006|Overall Study|Lack of Efficacy|1|||
25328458|NCT00495469|50644689|FG000|Overall Study|Liver function test abnormality|0|||
25328459|NCT00495469|50644690|FG001|Overall Study|Liver function test abnormality|1|||
25328460|NCT00495469|50644691|FG002|Overall Study|Liver function test abnormality|0|||
25328461|NCT00495469|50644692|FG003|Overall Study|Liver function test abnormality|0|||
25328462|NCT00495469|50644693|FG004|Overall Study|Liver function test abnormality|0|||
25328463|NCT00495469|50644694|FG005|Overall Study|Liver function test abnormality|0|||
25328464|NCT00495469|50644695|FG006|Overall Study|Liver function test abnormality|0|||
25328465|NCT00495469|50644689|FG000|Overall Study|ST depression at randomisation in ECG|0|||
25328466|NCT00495469|50644690|FG001|Overall Study|ST depression at randomisation in ECG|1|||
25328467|NCT00495469|50644691|FG002|Overall Study|ST depression at randomisation in ECG|0|||
25328468|NCT00495469|50644692|FG003|Overall Study|ST depression at randomisation in ECG|0|||
25328469|NCT00495469|50644693|FG004|Overall Study|ST depression at randomisation in ECG|0|||
25328470|NCT00495469|50644694|FG005|Overall Study|ST depression at randomisation in ECG|0|||
25328471|NCT00495469|50644695|FG006|Overall Study|ST depression at randomisation in ECG|0|||
25328472|NCT00861380|50644725|FG000|Overall Study|Withdrawal Information not recorded|8427|||
25328473|NCT00861380|50644726|FG001|Overall Study|Withdrawal Information not recorded|9112|||
25328474|NCT00861380|50644727|FG002|Overall Study|Withdrawal Information not recorded|8872|||
25328475|NCT00861380|50644728|FG003|Overall Study|Withdrawal Information not recorded|3689|||
25328476|NCT00861380|50644729|FG004|Overall Study|Withdrawal Information not recorded|1812|||
25328477|NCT00861380|50644730|FG005|Overall Study|Withdrawal Information not recorded|6249|||
25247841|NCT02932332|50563572|FG001|Overall Study|Withdrawal by Subject|1|||
25247842|NCT02932332|50563573|FG002|Overall Study|Withdrawal by Subject|0|||
25247843|NCT02932332|50563574|FG003|Overall Study|Withdrawal by Subject|1|||
25247844|NCT02932332|50563571|FG000|Overall Study|Chest pain|0|||
25247845|NCT02932332|50563572|FG001|Overall Study|Chest pain|0|||
25247846|NCT02932332|50563573|FG002|Overall Study|Chest pain|0|||
25247847|NCT02932332|50563574|FG003|Overall Study|Chest pain|1|||
25247848|NCT02932332|50563571|FG000|Overall Study|Not Dyspneic cough|1|||
25247849|NCT02932332|50563572|FG001|Overall Study|Not Dyspneic cough|2|||
25247850|NCT02932332|50563573|FG002|Overall Study|Not Dyspneic cough|1|||
25328478|NCT00861380|50644731|FG006|Overall Study|Withdrawal Information not recorded|3020|||
25328479|NCT00495391|50644766|FG000|Overall Study|Lack of Efficacy|34|||
25328480|NCT00495391|50644767|FG001|Overall Study|Lack of Efficacy|18|||
25328481|NCT00495391|50644766|FG000|Overall Study|Withdrawal by Subject|2|||
25328482|NCT00495391|50644767|FG001|Overall Study|Withdrawal by Subject|3|||
25247851|NCT02932332|50563574|FG003|Overall Study|Not Dyspneic cough|0|||
25247852|NCT02820623|50563608|FG000|Overall Study|Withdrawal by Subject|1|||
25247853|NCT02820623|50563609|FG001|Overall Study|Withdrawal by Subject|3|||
25247854|NCT02820623|50563610|FG002|Overall Study|Withdrawal by Subject|3|||
25247855|NCT02820623|50563608|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
25247856|NCT02820623|50563609|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
25247857|NCT02820623|50563610|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
25247858|NCT02820623|50563608|FG000|Overall Study|Therapist unable to enroll clients|1|||
25247859|NCT02820623|50563609|FG001|Overall Study|Therapist unable to enroll clients|1|||
25247860|NCT02820623|50563610|FG002|Overall Study|Therapist unable to enroll clients|3|||
25247861|NCT02820623|50563608|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
25247862|NCT02820623|50563609|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
25247863|NCT02820623|50563610|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
25247864|NCT02774005|50563618|FG000|Overall Study|Adverse Event|8|||
25247865|NCT02774005|50563618|FG000|Overall Study|Withdrawal by Subject|23|||
25247866|NCT02774005|50563618|FG000|Overall Study|Lost to Follow-up|7|||
25247867|NCT02774005|50563618|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
25247868|NCT02774005|50563618|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
25247869|NCT02774005|50563618|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
25247870|NCT02774005|50563618|FG000|Overall Study|Death|1|||
25247871|NCT02774005|50563618|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
25247872|NCT02774005|50563618|FG000|Overall Study|Lack of compliance with study medication|4|||
25247873|NCT02774005|50563618|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
25247874|NCT02774005|50563618|FG000|Overall Study|another study|1|||
25328483|NCT00869960|50644773|FG000|Overall Study|Lost to Follow-up|2|||
25328484|NCT00494299|50644779|FG000|Overall Study|Adverse Event|93|||
25328485|NCT00494299|50644780|FG001|Overall Study|Adverse Event|13|||
25328486|NCT00494299|50644779|FG000|Overall Study|Lost to Follow-up|1|||
25328487|NCT00494299|50644780|FG001|Overall Study|Lost to Follow-up|0|||
25328488|NCT00494299|50644779|FG000|Overall Study|Physician Decision|0|||
25328489|NCT00494299|50644780|FG001|Overall Study|Physician Decision|2|||
25328490|NCT00494299|50644779|FG000|Overall Study|Protocol Violation|1|||
25328491|NCT00494299|50644780|FG001|Overall Study|Protocol Violation|2|||
25328492|NCT00494299|50644779|FG000|Overall Study|Withdrawal by Subject|8|||
25328493|NCT00494299|50644780|FG001|Overall Study|Withdrawal by Subject|3|||
25328494|NCT00494299|50644779|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
25328495|NCT00494299|50644780|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
25328496|NCT00494299|50644779|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
25328497|NCT00494299|50644780|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
25328498|NCT00494299|50644779|FG000|Overall Study|Site Closed by Sponsor|6|||
25328499|NCT00494299|50644780|FG001|Overall Study|Site Closed by Sponsor|0|||
25328500|NCT00494299|50644779|FG000|Overall Study|Protocol Driven Decision Point|11|||
25328501|NCT00494299|50644780|FG001|Overall Study|Protocol Driven Decision Point|22|||
25328502|NCT00593684|50644788|FG000|Overall Study|Death|2|||
25328503|NCT00593684|50644789|FG001|Overall Study|Death|1|||
25328504|NCT02963831|50644799|FG000|Overall Study|Progressive Disease|3|||
25328505|NCT02963831|50644800|FG001|Overall Study|Progressive Disease|3|||
25328506|NCT02963831|50644801|FG002|Overall Study|Progressive Disease|16|||
25328507|NCT02963831|50644802|FG003|Overall Study|Progressive Disease|27|||
25328508|NCT02963831|50644799|FG000|Overall Study|Withdrawal by Subject|1|||
25328509|NCT02963831|50644800|FG001|Overall Study|Withdrawal by Subject|0|||
25328510|NCT02963831|50644801|FG002|Overall Study|Withdrawal by Subject|2|||
25328511|NCT02963831|50644802|FG003|Overall Study|Withdrawal by Subject|4|||
25328512|NCT02963831|50644799|FG000|Overall Study|Adverse Event|0|||
25328513|NCT02963831|50644800|FG001|Overall Study|Adverse Event|1|||
25328514|NCT02963831|50644801|FG002|Overall Study|Adverse Event|1|||
25328515|NCT02963831|50644802|FG003|Overall Study|Adverse Event|2|||
25328516|NCT02963831|50644799|FG000|Overall Study|Death|0|||
25328517|NCT02963831|50644800|FG001|Overall Study|Death|0|||
25328518|NCT02963831|50644801|FG002|Overall Study|Death|0|||
25247875|NCT02774005|50563618|FG000|Overall Study|cardiologist imposed travel restriction|1|||
25247876|NCT01975428|50563652|FG000|Overall Study|Lost to Follow-up|17|||
25328519|NCT02963831|50644802|FG003|Overall Study|Death|2|||
25328520|NCT00859898|50644817|FG000|Overall Study|Lack of Efficacy|0|||
25328521|NCT00859898|50644818|FG001|Overall Study|Lack of Efficacy|1|||
25328522|NCT00859898|50644819|FG002|Overall Study|Lack of Efficacy|1|||
25328523|NCT00859898|50644817|FG000|Overall Study|Adverse Event|4|||
25328524|NCT00859898|50644818|FG001|Overall Study|Adverse Event|9|||
25328525|NCT00859898|50644819|FG002|Overall Study|Adverse Event|8|||
25328526|NCT00859898|50644817|FG000|Overall Study|Withdrawal by Subject|11|||
25328527|NCT00859898|50644818|FG001|Overall Study|Withdrawal by Subject|8|||
25328528|NCT00859898|50644819|FG002|Overall Study|Withdrawal by Subject|11|||
25328529|NCT00859898|50644817|FG000|Overall Study|Death|0|||
25328530|NCT00859898|50644818|FG001|Overall Study|Death|0|||
25328531|NCT00859898|50644819|FG002|Overall Study|Death|1|||
25328532|NCT00859898|50644817|FG000|Overall Study|Lost to Follow-up|10|||
25328533|NCT00859898|50644818|FG001|Overall Study|Lost to Follow-up|11|||
25328534|NCT00859898|50644819|FG002|Overall Study|Lost to Follow-up|5|||
25328535|NCT00859898|50644817|FG000|Overall Study|poor/non-compliance|2|||
25328536|NCT00859898|50644818|FG001|Overall Study|poor/non-compliance|0|||
25328537|NCT00859898|50644819|FG002|Overall Study|poor/non-compliance|0|||
25328538|NCT00859898|50644817|FG000|Overall Study|No longer meets criteria|0|||
25328539|NCT00859898|50644818|FG001|Overall Study|No longer meets criteria|1|||
25328540|NCT00859898|50644819|FG002|Overall Study|No longer meets criteria|0|||
25328541|NCT00859898|50644817|FG000|Overall Study|non-specified|1|||
25328542|NCT00859898|50644818|FG001|Overall Study|non-specified|1|||
25328543|NCT00859898|50644819|FG002|Overall Study|non-specified|1|||
25328544|NCT00859586|50644828|FG000|Overall Study|Donors|4|||
25328545|NCT00494221|50644835|FG000|Overall Study|Death|15|||
25328546|NCT00494221|50644836|FG001|Overall Study|Death|9|||
25328547|NCT00494221|50644837|FG002|Overall Study|Death|14|||
25328548|NCT00494221|50644835|FG000|Overall Study|Withdrawal by Subject|1|||
25328549|NCT00494221|50644836|FG001|Overall Study|Withdrawal by Subject|2|||
25247877|NCT01975428|50563653|FG001|Overall Study|Lost to Follow-up|4|||
25247878|NCT01975428|50563652|FG000|Overall Study|Withdrawal by Subject|3|||
25247879|NCT01975428|50563653|FG001|Overall Study|Withdrawal by Subject|10|||
25247880|NCT01047540|50563694|FG000|Overall Study|Protocol Violation|1|||
25247881|NCT01047540|50563695|FG001|Overall Study|Protocol Violation|0|||
25247882|NCT01047540|50563696|FG002|Overall Study|Protocol Violation|0|||
25247883|NCT01047540|50563697|FG003|Overall Study|Protocol Violation|0|||
25247884|NCT01047540|50563698|FG004|Overall Study|Protocol Violation|0|||
25247885|NCT01047540|50563694|FG000|Overall Study|Lost to Follow-up|1|||
25247886|NCT01047540|50563695|FG001|Overall Study|Lost to Follow-up|0|||
25247887|NCT01047540|50563696|FG002|Overall Study|Lost to Follow-up|0|||
25247888|NCT01047540|50563697|FG003|Overall Study|Lost to Follow-up|0|||
25247889|NCT01047540|50563698|FG004|Overall Study|Lost to Follow-up|0|||
25247890|NCT01047540|50563694|FG000|Overall Study|Withdrawal by Subject|1|||
25247891|NCT01047540|50563695|FG001|Overall Study|Withdrawal by Subject|0|||
25247892|NCT01047540|50563696|FG002|Overall Study|Withdrawal by Subject|3|||
25247893|NCT01047540|50563697|FG003|Overall Study|Withdrawal by Subject|0|||
25247894|NCT01047540|50563698|FG004|Overall Study|Withdrawal by Subject|1|||
25247895|NCT01047540|50563694|FG000|Overall Study|Pregnancy|1|||
25247896|NCT01047540|50563695|FG001|Overall Study|Pregnancy|0|||
25247897|NCT01047540|50563696|FG002|Overall Study|Pregnancy|0|||
25247898|NCT01047540|50563697|FG003|Overall Study|Pregnancy|0|||
25247899|NCT01047540|50563698|FG004|Overall Study|Pregnancy|0|||
25247900|NCT01047540|50563694|FG000|Overall Study|Adverse Event|1|||
25247901|NCT01047540|50563695|FG001|Overall Study|Adverse Event|0|||
25247902|NCT01047540|50563696|FG002|Overall Study|Adverse Event|0|||
25247903|NCT01047540|50563697|FG003|Overall Study|Adverse Event|0|||
25247904|NCT01047540|50563698|FG004|Overall Study|Adverse Event|0|||
25247905|NCT00521222|50563714|FG000|Overall Study|Lost to Follow-up|0|||
25247906|NCT00521222|50563715|FG001|Overall Study|Lost to Follow-up|0|||
25247907|NCT00521222|50563716|FG002|Overall Study|Lost to Follow-up|1|||
25247908|NCT00521222|50563717|FG003|Overall Study|Lost to Follow-up|1|||
25247909|NCT00521222|50563714|FG000|Overall Study|Withdrawal by Subject|0|||
25247910|NCT00521222|50563715|FG001|Overall Study|Withdrawal by Subject|0|||
25247911|NCT00521222|50563716|FG002|Overall Study|Withdrawal by Subject|2|||
25247912|NCT00521222|50563717|FG003|Overall Study|Withdrawal by Subject|0|||
25247913|NCT00521222|50563714|FG000|Overall Study|Physician Decision|0|||
25247914|NCT00521222|50563715|FG001|Overall Study|Physician Decision|1|||
25247915|NCT00521222|50563716|FG002|Overall Study|Physician Decision|0|||
24995118|NCT03015532|50085973|FG007|Overall Study|Withdrawal by Subject|0|||
25247916|NCT00521222|50563717|FG003|Overall Study|Physician Decision|1|||
25247917|NCT00378482|50563727|FG000|Overall Study|Lost to Follow-up|1|||
25247918|NCT00378482|50563727|FG000|Overall Study|Lack of Efficacy|8|||
25247919|NCT00378482|50563727|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
25247920|NCT00378482|50563727|FG000|Overall Study|Withdrawal by Subject|4|||
25328550|NCT00494221|50644837|FG002|Overall Study|Withdrawal by Subject|0|||
25328551|NCT00857948|50644849|FG000|Overall Study|Withdrawal by Subject|2|||
25328552|NCT00857948|50644850|FG001|Overall Study|Withdrawal by Subject|0|||
25247921|NCT00378482|50563727|FG000|Overall Study|Adverse Event|9|||
25247922|NCT01214629|50563755|FG000|Overall Study|Progressive Disease|1|||
25247923|NCT01214629|50563756|FG001|Overall Study|Progressive Disease|1|||
25247924|NCT01214629|50563757|FG002|Overall Study|Progressive Disease|0|||
25247925|NCT01214629|50563758|FG003|Overall Study|Progressive Disease|1|||
25247926|NCT01214629|50563759|FG004|Overall Study|Progressive Disease|2|||
25247927|NCT01214629|50563760|FG005|Overall Study|Progressive Disease|3|||
25247928|NCT01214629|50563761|FG006|Overall Study|Progressive Disease|1|||
25247929|NCT01214629|50563762|FG007|Overall Study|Progressive Disease|1|||
25247930|NCT01214629|50563763|FG008|Overall Study|Progressive Disease|1|||
25247931|NCT01214629|50563764|FG009|Overall Study|Progressive Disease|5|||
25247932|NCT01214629|50563765|FG010|Overall Study|Progressive Disease|1|||
25247933|NCT01214629|50563755|FG000|Overall Study|Adverse Event|0|||
25247934|NCT01214629|50563756|FG001|Overall Study|Adverse Event|0|||
25247935|NCT01214629|50563757|FG002|Overall Study|Adverse Event|0|||
25247936|NCT01214629|50563758|FG003|Overall Study|Adverse Event|1|||
25247937|NCT01214629|50563759|FG004|Overall Study|Adverse Event|0|||
25247938|NCT01214629|50563760|FG005|Overall Study|Adverse Event|1|||
25247939|NCT01214629|50563761|FG006|Overall Study|Adverse Event|0|||
25247940|NCT01214629|50563762|FG007|Overall Study|Adverse Event|0|||
25247941|NCT01214629|50563763|FG008|Overall Study|Adverse Event|0|||
25247942|NCT01214629|50563764|FG009|Overall Study|Adverse Event|1|||
25247943|NCT01214629|50563765|FG010|Overall Study|Adverse Event|0|||
25247944|NCT01214629|50563755|FG000|Overall Study|Physician Decision|0|||
25247945|NCT01214629|50563756|FG001|Overall Study|Physician Decision|0|||
25247946|NCT01214629|50563757|FG002|Overall Study|Physician Decision|0|||
25247947|NCT01214629|50563758|FG003|Overall Study|Physician Decision|0|||
25247948|NCT01214629|50563759|FG004|Overall Study|Physician Decision|0|||
25247949|NCT01214629|50563760|FG005|Overall Study|Physician Decision|0|||
25247950|NCT01214629|50563761|FG006|Overall Study|Physician Decision|0|||
25247951|NCT01214629|50563762|FG007|Overall Study|Physician Decision|0|||
25247952|NCT01214629|50563763|FG008|Overall Study|Physician Decision|0|||
25247953|NCT01214629|50563764|FG009|Overall Study|Physician Decision|0|||
25247954|NCT01214629|50563765|FG010|Overall Study|Physician Decision|1|||
25247955|NCT01214629|50563755|FG000|Overall Study|Withdrawal by Subject|0|||
25247956|NCT01214629|50563756|FG001|Overall Study|Withdrawal by Subject|0|||
25247957|NCT01214629|50563757|FG002|Overall Study|Withdrawal by Subject|0|||
25247958|NCT01214629|50563758|FG003|Overall Study|Withdrawal by Subject|0|||
25247959|NCT01214629|50563759|FG004|Overall Study|Withdrawal by Subject|0|||
25247960|NCT01214629|50563760|FG005|Overall Study|Withdrawal by Subject|0|||
25247961|NCT01214629|50563761|FG006|Overall Study|Withdrawal by Subject|0|||
25247962|NCT01214629|50563762|FG007|Overall Study|Withdrawal by Subject|0|||
25247963|NCT01214629|50563763|FG008|Overall Study|Withdrawal by Subject|0|||
25247964|NCT01214629|50563764|FG009|Overall Study|Withdrawal by Subject|1|||
25247965|NCT01214629|50563765|FG010|Overall Study|Withdrawal by Subject|0|||
25247966|NCT01214434|50563805|FG000|Overall Study|Withdrawal by Subject|1|||
25247967|NCT01214434|50563806|FG001|Overall Study|Withdrawal by Subject|0|||
25247968|NCT01214434|50563805|FG000|Overall Study|Lost to Follow-up|2|||
25247969|NCT01214434|50563806|FG001|Overall Study|Lost to Follow-up|2|||
25247970|NCT01214434|50563805|FG000|Overall Study|Site error|1|||
25247971|NCT01214434|50563806|FG001|Overall Study|Site error|0|||
25247972|NCT01214395|50563812|FG000|Overall Study|All patients had infection|5|||
25247973|NCT01214239|50563819|FG000|Overall Study|Adverse Event|3|||
25247974|NCT01214239|50563820|FG001|Overall Study|Adverse Event|4|||
25247975|NCT01214239|50563819|FG000|Overall Study|Protocol Violation|2|||
25247976|NCT01214239|50563820|FG001|Overall Study|Protocol Violation|1|||
25328553|NCT00857948|50644851|FG002|Overall Study|Withdrawal by Subject|0|||
25328554|NCT00857948|50644852|FG003|Overall Study|Withdrawal by Subject|0|||
25328555|NCT00857948|50644849|FG000|Overall Study|Protocol Violation|1|||
25328556|NCT00857948|50644850|FG001|Overall Study|Protocol Violation|0|||
25328557|NCT00857948|50644851|FG002|Overall Study|Protocol Violation|1|||
25328558|NCT00857948|50644852|FG003|Overall Study|Protocol Violation|0|||
25328559|NCT00866606|50644862|FG000|Overall Study|Lost to Follow-up|3|||
25328560|NCT00866606|50644862|FG000|Overall Study|Adverse Event|1|||
25328561|NCT00857792|50644866|FG000|Overall Study|inadequate image quality for analysis|12|||
25328562|NCT00601835|50644872|FG000|Overall Study|Withdrawal by Subject|9|||
25077809|NCT03318523|50185669|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
25247977|NCT01214239|50563819|FG000|Overall Study|Lost to Follow-up|1|||
25247978|NCT01214239|50563820|FG001|Overall Study|Lost to Follow-up|1|||
25247979|NCT01214239|50563819|FG000|Overall Study|Withdrawal by Subject|4|||
25247980|NCT01214239|50563820|FG001|Overall Study|Withdrawal by Subject|9|||
25247981|NCT01214239|50563819|FG000|Overall Study|Lack of Efficacy|1|||
25328563|NCT00601835|50644873|FG001|Overall Study|Withdrawal by Subject|6|||
25328564|NCT00601835|50644872|FG000|Overall Study|Physician Decision|1|||
25247982|NCT01214239|50563820|FG001|Overall Study|Lack of Efficacy|2|||
25247983|NCT01214239|50563819|FG000|Overall Study|patient's private reason|1|||
25247984|NCT01214239|50563820|FG001|Overall Study|patient's private reason|1|||
25328565|NCT00601835|50644873|FG001|Overall Study|Physician Decision|0|||
25328566|NCT00601835|50644872|FG000|Overall Study|Lost to Follow-up|37|||
25328567|NCT00601835|50644873|FG001|Overall Study|Lost to Follow-up|5|||
25328568|NCT00601835|50644872|FG000|Overall Study|Adverse Event|1|||
25328569|NCT00601835|50644873|FG001|Overall Study|Adverse Event|1|||
25328570|NCT00601835|50644872|FG000|Overall Study|Relocate|12|||
25328571|NCT00601835|50644873|FG001|Overall Study|Relocate|2|||
25328572|NCT00857246|50644879|FG000|Induction Regimen|Adverse Event|1|||
25328573|NCT00857246|50644879|FG000|Induction Regimen|disease-related complications|1|||
25328574|NCT00857246|50644879|FG000|Induction Regimen|Withdrawal by Subject|1|||
25247985|NCT01214200|50563826|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
25247986|NCT01214200|50563826|FG000|Overall Study|Withdrawal by Subject|2|||
25247987|NCT01214044|50563832|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
25328575|NCT00857246|50644879|FG000|Surgery (Curative)|disease progression|6|||
25328576|NCT00857246|50644879|FG000|ChemoRT|Withdrawal by Subject|1|||
25328577|NCT00857246|50644879|FG000|ChemoRT|Adverse Event|2|||
25328578|NCT00856856|50644886|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
25328579|NCT00856856|50644886|FG000|4-year Clinical Follow-up|Missed visit|1|||
25328580|NCT00493285|50644901|FG000|Overall Study|Lost to Follow-up|0|||
25328581|NCT00493285|50644902|FG001|Overall Study|Lost to Follow-up|0|||
25328582|NCT00493285|50644903|FG002|Overall Study|Lost to Follow-up|0|||
25328583|NCT00493285|50644904|FG003|Overall Study|Lost to Follow-up|0|||
25328584|NCT00493285|50644905|FG004|Overall Study|Lost to Follow-up|1|||
25328585|NCT00493285|50644906|FG005|Overall Study|Lost to Follow-up|0|||
25328586|NCT00856778|50644920|FG000|Overall Study|Adverse Event|7|||
25328587|NCT00856778|50644920|FG000|Overall Study|Withdrawal by Subject|10|||
25328588|NCT00856778|50644920|FG000|Overall Study|Study deviation|2|||
25328589|NCT00856778|50644920|FG000|Overall Study|Lost to Follow-up|5|||
25328590|NCT00603473|50644924|FG000|Overall Study|Adverse Event|4|||
25328591|NCT00603473|50644924|FG000|Overall Study|Lack of Efficacy|4|||
25328592|NCT00603473|50644924|FG000|Overall Study|Protocol Violation|1|||
25247988|NCT01214044|50563832|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
25247989|NCT01214044|50563832|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
25247990|NCT01214044|50563832|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
25247991|NCT01214044|50563832|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
25247992|NCT01214044|50563832|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
25247993|NCT01213966|50563844|FG000|Overall Study|Protocol Violation|1|||
25247994|NCT01213966|50563845|FG001|Overall Study|Protocol Violation|0|||
25247995|NCT01213966|50563846|FG002|Overall Study|Protocol Violation|3|||
25247996|NCT01213966|50563847|FG003|Overall Study|Protocol Violation|1|||
25247997|NCT01213264|50563860|FG000|Overall Study|Adverse Event|1|||
25247998|NCT01213264|50563861|FG001|Overall Study|Adverse Event|0|||
25247999|NCT01213264|50563862|FG002|Overall Study|Adverse Event|0|||
25248000|NCT01213264|50563860|FG000|Overall Study|Lost to Follow-up|1|||
25248001|NCT01213264|50563861|FG001|Overall Study|Lost to Follow-up|2|||
25328593|NCT00486889|50644928|FG000|Overall Study|Death|3|||
25328594|NCT00486889|50644928|FG000|Overall Study|Non-compliant|2|||
25328595|NCT00486889|50644928|FG000|Overall Study|Withdrawal by Subject|6|||
25328596|NCT00486811|50644935|FG000|Overall Study|Adverse Event|28|||
25328597|NCT00486811|50644936|FG001|Overall Study|Adverse Event|60|||
25328598|NCT00486811|50644937|FG002|Overall Study|Adverse Event|135|||
25328599|NCT00486811|50644935|FG000|Overall Study|Lack of Efficacy|34|||
25328600|NCT00486811|50644936|FG001|Overall Study|Lack of Efficacy|14|||
25328601|NCT00486811|50644937|FG002|Overall Study|Lack of Efficacy|7|||
25248002|NCT01213264|50563862|FG002|Overall Study|Lost to Follow-up|6|||
25248003|NCT01212991|50563875|FG000|Double-blind|Lost to Follow-up|8|||
25248004|NCT01212991|50563876|FG001|Double-blind|Lost to Follow-up|4|||
25248005|NCT01212991|50563877|FG002|Double-blind|Lost to Follow-up|0|||
25248006|NCT01212991|50563875|FG000|Double-blind|Death|699|||
25248007|NCT01212991|50563876|FG001|Double-blind|Death|550|||
25248008|NCT01212991|50563877|FG002|Double-blind|Death|0|||
25248009|NCT01212991|50563875|FG000|Double-blind|Withdrawal by Subject|16|||
25248010|NCT01212991|50563876|FG001|Double-blind|Withdrawal by Subject|19|||
25248011|NCT01212991|50563877|FG002|Double-blind|Withdrawal by Subject|0|||
25248012|NCT01212991|50563875|FG000|Double-blind|Other|7|||
25248013|NCT01212991|50563876|FG001|Double-blind|Other|0|||
25248014|NCT01212991|50563877|FG002|Double-blind|Other|0|||
25248015|NCT01212991|50563875|FG000|Double-blind|Sponsor decision|142|||
25248016|NCT01212991|50563876|FG001|Double-blind|Sponsor decision|38|||
25248017|NCT01212991|50563877|FG002|Double-blind|Sponsor decision|0|||
25328602|NCT00486811|50644935|FG000|Overall Study|Lost to Follow-up|4|||
25328603|NCT00486811|50644936|FG001|Overall Study|Lost to Follow-up|6|||
25328604|NCT00486811|50644937|FG002|Overall Study|Lost to Follow-up|4|||
25328605|NCT00486811|50644935|FG000|Overall Study|Withdrawal by Subject|33|||
25328606|NCT00486811|50644936|FG001|Overall Study|Withdrawal by Subject|44|||
25328607|NCT00486811|50644937|FG002|Overall Study|Withdrawal by Subject|58|||
25328608|NCT00486811|50644935|FG000|Overall Study|Study drug non-compliant|5|||
25328609|NCT00486811|50644936|FG001|Overall Study|Study drug non-compliant|6|||
25328610|NCT00486811|50644937|FG002|Overall Study|Study drug non-compliant|3|||
25328611|NCT00486811|50644935|FG000|Overall Study|All other|18|||
25248018|NCT01212991|50563875|FG000|Open-label|Death|0|||
25248019|NCT01212991|50563876|FG001|Open-label|Death|0|||
25248020|NCT01212991|50563877|FG002|Open-label|Death|166|||
25248021|NCT01212991|50563875|FG000|Open-label|Lost to Follow-up|0|||
25248022|NCT01212991|50563876|FG001|Open-label|Lost to Follow-up|0|||
25328612|NCT00486811|50644936|FG001|Overall Study|All other|11|||
25328613|NCT00486811|50644937|FG002|Overall Study|All other|7|||
25328614|NCT00486265|50644945|FG000|Overall Study|Adverse Event|1|||
25328615|NCT00486265|50644945|FG000|Overall Study|Lack of Efficacy|8|||
25328616|NCT02151604|50644949|FG000|Overall Study|Lost to Follow-up|3|||
25328617|NCT02151604|50644949|FG000|Overall Study|Withdrawal by Subject|2|||
25328618|NCT02151604|50644949|FG000|Overall Study|Physician Decision|3|||
25328619|NCT02151604|50644949|FG000|Overall Study|Death|1|||
25328620|NCT00466921|50644954|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
25328621|NCT00466921|50644954|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
25328622|NCT00466921|50644954|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
25328623|NCT00466921|50644954|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
25328624|NCT00466921|50644954|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
25328625|NCT00466921|50644954|FG000|Follow up for a Minimum of 1 Year|Death|6|||
25328626|NCT00601523|50644960|FG000|Overall Study|Adverse Event|42|||
25328627|NCT00601523|50644961|FG001|Overall Study|Adverse Event|14|||
25328628|NCT00601523|50644960|FG000|Overall Study|Lack of Efficacy|3|||
25328629|NCT00601523|50644961|FG001|Overall Study|Lack of Efficacy|0|||
25328630|NCT00601523|50644960|FG000|Overall Study|Protocol Violation|5|||
25328631|NCT00601523|50644961|FG001|Overall Study|Protocol Violation|1|||
25328632|NCT00601523|50644960|FG000|Overall Study|Lost to Follow-up|0|||
25328633|NCT00601523|50644961|FG001|Overall Study|Lost to Follow-up|1|||
25328634|NCT00601523|50644960|FG000|Overall Study|Withdrawal by Subject|18|||
25328635|NCT00601523|50644961|FG001|Overall Study|Withdrawal by Subject|9|||
25328636|NCT00601523|50644960|FG000|Overall Study|Other|9|||
25328637|NCT00601523|50644961|FG001|Overall Study|Other|1|||
25328638|NCT00466687|50644967|FG000|Overall Study|Adverse Event|1|||
25248023|NCT01212991|50563877|FG002|Open-label|Lost to Follow-up|5|||
25328639|NCT00466687|50644967|FG000|Overall Study|Other complicating illness|3|||
25248024|NCT01212991|50563875|FG000|Open-label|Withdrawal by Subject|0|||
25248025|NCT01212991|50563876|FG001|Open-label|Withdrawal by Subject|0|||
25248026|NCT01212991|50563877|FG002|Open-label|Withdrawal by Subject|7|||
25248027|NCT01212991|50563875|FG000|Open-label|Sponsor decision|0|||
25248028|NCT01212991|50563876|FG001|Open-label|Sponsor decision|0|||
25248029|NCT01212991|50563877|FG002|Open-label|Sponsor decision|53|||
25248030|NCT01212991|50563875|FG000|Open-label|Other|0|||
25328640|NCT00466687|50644967|FG000|Overall Study|Withdrawal by Subject|1|||
25328641|NCT00466687|50644967|FG000|Overall Study|Disease progression|29|||
25328642|NCT00465985|50644989|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
25328643|NCT00465985|50644990|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
25328644|NCT00465985|50644989|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
25328645|NCT00465985|50644990|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
25248031|NCT01212991|50563876|FG001|Open-label|Other|0|||
25248032|NCT01212991|50563877|FG002|Open-label|Other|3|||
25248033|NCT01212757|50563888|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
25248034|NCT01212757|50563889|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
25248035|NCT01212757|50563890|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
25248036|NCT01212757|50563891|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25248037|NCT01212757|50563892|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25248038|NCT01212757|50563893|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25248039|NCT01212757|50563894|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25248040|NCT01212757|50563895|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25248041|NCT01212757|50563896|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
25248042|NCT01212757|50563888|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
25248043|NCT01212757|50563889|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
25248044|NCT01212757|50563890|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
25248045|NCT01212757|50563891|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25328646|NCT00465985|50644989|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
25328647|NCT00465985|50644990|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
25328648|NCT00465985|50644989|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
25328649|NCT00465985|50644990|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
25248046|NCT01212757|50563892|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25248047|NCT01212757|50563893|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25248048|NCT01212757|50563894|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25328650|NCT00454051|50645001|FG000|Overall Study|Adverse Event|1|||
25328651|NCT00454051|50645002|FG001|Overall Study|Adverse Event|2|||
25248049|NCT01212757|50563895|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25248050|NCT01212757|50563896|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
25248051|NCT01212757|50563888|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
25248052|NCT01212757|50563889|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
25248053|NCT01212757|50563890|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
25248054|NCT01212757|50563891|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
25248055|NCT01212757|50563892|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
25248056|NCT01212757|50563893|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
25248057|NCT01212757|50563894|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
25248058|NCT01212757|50563895|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
25248059|NCT01212757|50563896|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
25248060|NCT01212757|50563888|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
25328652|NCT00454051|50645001|FG000|Overall Study|Withdrawal by Subject|1|||
25328653|NCT00454051|50645002|FG001|Overall Study|Withdrawal by Subject|0|||
25328654|NCT00454051|50645001|FG000|Overall Study|Protocol Violation|1|||
25328655|NCT00454051|50645002|FG001|Overall Study|Protocol Violation|1|||
25328656|NCT00484939|50645010|FG000|Overall Study|Death|9|||
25328657|NCT00484939|50645011|FG001|Overall Study|Death|13|||
25328658|NCT00484939|50645010|FG000|Overall Study|Adverse Event|22|||
25328659|NCT00484939|50645011|FG001|Overall Study|Adverse Event|12|||
25328660|NCT00484939|50645010|FG000|Overall Study|Patient Withdrew Consent|19|||
25328661|NCT00484939|50645011|FG001|Overall Study|Patient Withdrew Consent|10|||
25328662|NCT00484939|50645010|FG000|Overall Study|Protocol Violation|3|||
25328663|NCT00484939|50645011|FG001|Overall Study|Protocol Violation|3|||
25328664|NCT00484939|50645010|FG000|Overall Study|Lost to Follow-up|0|||
25328665|NCT00484939|50645011|FG001|Overall Study|Lost to Follow-up|3|||
25328666|NCT00484939|50645010|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
25328667|NCT00484939|50645011|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
25328668|NCT00484939|50645010|FG000|Overall Study|Disease progression|67|||
25328669|NCT00484939|50645011|FG001|Overall Study|Disease progression|88|||
25328670|NCT00484939|50645010|FG000|Overall Study|Screen Failure|2|||
25328671|NCT00484939|50645011|FG001|Overall Study|Screen Failure|2|||
25328672|NCT00484939|50645010|FG000|Overall Study|Reason Not Specified|11|||
25328673|NCT00484939|50645011|FG001|Overall Study|Reason Not Specified|6|||
25328674|NCT00453973|50645019|FG000|Overall Study|Adverse Event|4|||
25328675|NCT00453973|50645020|FG001|Overall Study|Adverse Event|9|||
25328676|NCT00453973|50645019|FG000|Overall Study|Withdrawal by Subject|7|||
25328677|NCT00453973|50645020|FG001|Overall Study|Withdrawal by Subject|6|||
25328678|NCT00453973|50645019|FG000|Overall Study|PI Decision|0|||
25328679|NCT00453973|50645020|FG001|Overall Study|PI Decision|2|||
25328680|NCT00453973|50645019|FG000|Overall Study|Relocation|1|||
25248061|NCT01212757|50563889|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
25248062|NCT01212757|50563890|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
25328681|NCT00453973|50645020|FG001|Overall Study|Relocation|0|||
25328682|NCT00453973|50645019|FG000|Overall Study|Renal transplant|1|||
25328683|NCT00453973|50645020|FG001|Overall Study|Renal transplant|1|||
25328684|NCT00453973|50645019|FG000|Overall Study|Site closed by sponsor|3|||
25328685|NCT00453973|50645020|FG001|Overall Study|Site closed by sponsor|0|||
25328686|NCT00453973|50645019|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
25328687|NCT00453973|50645020|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
25328688|NCT00465361|50645026|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
25328689|NCT00464815|50645032|FG000|Overall Study|Withdrawal by Subject|6|||
25328690|NCT00464815|50645033|FG001|Overall Study|Withdrawal by Subject|3|||
25328691|NCT00464737|50645042|FG000|Overall Study|Adverse Event|12|||
25328692|NCT00464737|50645043|FG001|Overall Study|Adverse Event|17|||
25328693|NCT00464737|50645044|FG002|Overall Study|Adverse Event|33|||
25248063|NCT01212757|50563891|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
25248064|NCT01212757|50563892|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
25248065|NCT01212757|50563893|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
25248066|NCT01212757|50563894|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
25248067|NCT01212757|50563895|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
25248068|NCT01212757|50563896|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
25248069|NCT01212757|50563888|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
25248070|NCT01212757|50563889|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
25248071|NCT01212757|50563890|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
25248072|NCT01212757|50563891|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25248073|NCT01212757|50563892|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25248074|NCT01212757|50563893|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25248075|NCT01212757|50563894|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25248076|NCT01212757|50563895|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25248077|NCT01212757|50563896|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
25248078|NCT01212757|50563888|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25248079|NCT01212757|50563889|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
25248080|NCT01212757|50563890|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
25328694|NCT00464737|50645042|FG000|Overall Study|Lack of Efficacy|7|||
25328695|NCT00464737|50645043|FG001|Overall Study|Lack of Efficacy|7|||
25328696|NCT00464737|50645044|FG002|Overall Study|Lack of Efficacy|4|||
25328697|NCT00464737|50645042|FG000|Overall Study|Withdrawal by Subject|5|||
25328698|NCT00464737|50645043|FG001|Overall Study|Withdrawal by Subject|3|||
25328699|NCT00464737|50645044|FG002|Overall Study|Withdrawal by Subject|5|||
25328700|NCT00464737|50645042|FG000|Overall Study|Protocol Violation|1|||
25328701|NCT00464737|50645043|FG001|Overall Study|Protocol Violation|1|||
25248081|NCT01212757|50563891|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25248082|NCT01212757|50563892|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25248083|NCT01212757|50563893|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25248084|NCT01212757|50563894|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25248085|NCT01212757|50563895|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25248086|NCT01212757|50563896|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
25248087|NCT01212757|50563888|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
25248088|NCT01212757|50563889|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
25248089|NCT01212757|50563890|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
25248090|NCT01212757|50563891|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
25248091|NCT01212757|50563892|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
25248092|NCT01212757|50563893|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
25248093|NCT01212757|50563894|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
25248094|NCT01212757|50563895|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
25248095|NCT01212757|50563896|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
25248096|NCT01212757|50563888|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
25248097|NCT01212757|50563889|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
25248098|NCT01212757|50563890|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
25328702|NCT00464737|50645044|FG002|Overall Study|Protocol Violation|5|||
25328703|NCT00464737|50645042|FG000|Overall Study|Non-compliance|0|||
25328704|NCT00464737|50645043|FG001|Overall Study|Non-compliance|1|||
25328705|NCT00464737|50645044|FG002|Overall Study|Non-compliance|1|||
25328706|NCT00464737|50645042|FG000|Overall Study|Lost to Follow-up|5|||
25328707|NCT00464737|50645043|FG001|Overall Study|Lost to Follow-up|2|||
25248099|NCT01212757|50563891|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
25248100|NCT01212757|50563892|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
25328708|NCT00464737|50645044|FG002|Overall Study|Lost to Follow-up|5|||
25328709|NCT00464737|50645042|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
25328710|NCT00464737|50645043|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
25328711|NCT00464737|50645044|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
25328712|NCT00464737|50645042|FG000|Overall Study|Other: Subject left town; family illness|1|||
25328713|NCT00464737|50645043|FG001|Overall Study|Other: Subject left town; family illness|0|||
25328714|NCT00464737|50645044|FG002|Overall Study|Other: Subject left town; family illness|0|||
25328715|NCT00464737|50645042|FG000|Overall Study|Other: Study demands too great|0|||
25328716|NCT00464737|50645043|FG001|Overall Study|Other: Study demands too great|1|||
25328717|NCT00464737|50645044|FG002|Overall Study|Other: Study demands too great|0|||
25328718|NCT00464737|50645042|FG000|Overall Study|Other: Personal family reasons|0|||
25328719|NCT00464737|50645043|FG001|Overall Study|Other: Personal family reasons|0|||
25328720|NCT00464737|50645044|FG002|Overall Study|Other: Personal family reasons|1|||
25328721|NCT00464737|50645042|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
25328722|NCT00464737|50645043|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
25328723|NCT00464737|50645044|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
25328724|NCT00453349|50645054|FG000|Randomized|Adverse Event|12|||
25328725|NCT00453349|50645055|FG001|Randomized|Adverse Event|11|||
25328726|NCT00453349|50645054|FG000|Randomized|Lack of Efficacy|2|||
25328727|NCT00453349|50645055|FG001|Randomized|Lack of Efficacy|1|||
25328728|NCT00453349|50645054|FG000|Randomized|Lost to Follow-up|7|||
25328729|NCT00453349|50645055|FG001|Randomized|Lost to Follow-up|5|||
25328730|NCT00453349|50645054|FG000|Randomized|Protocol Violation|1|||
25328731|NCT00453349|50645055|FG001|Randomized|Protocol Violation|1|||
25328732|NCT00453349|50645054|FG000|Randomized|Withdrawal by Subject|3|||
25328733|NCT00453349|50645055|FG001|Randomized|Withdrawal by Subject|5|||
25328734|NCT00453349|50645054|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
25328735|NCT00453349|50645055|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
25328736|NCT00453349|50645054|FG000|Completed Study|Adverse Event|12|||
25248101|NCT01212757|50563893|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
25248102|NCT01212757|50563894|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
25328737|NCT00453349|50645055|FG001|Completed Study|Adverse Event|11|||
25328738|NCT00453349|50645054|FG000|Completed Study|Lack of Efficacy|2|||
25248103|NCT01212757|50563895|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
25248104|NCT01212757|50563896|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
25248105|NCT01212757|50563888|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
25248106|NCT01212757|50563889|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
25248107|NCT01212757|50563890|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
25248108|NCT01212757|50563891|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
25248109|NCT01212757|50563892|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
25248110|NCT01212757|50563893|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
25248111|NCT01212757|50563894|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
25248112|NCT01212757|50563895|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
25248113|NCT01212757|50563896|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
25248114|NCT01212757|50563888|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
25248115|NCT01212757|50563889|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
25248116|NCT01212757|50563890|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
25248117|NCT01212757|50563891|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
25248118|NCT01212757|50563892|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
25248119|NCT01212757|50563893|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
25248120|NCT01212757|50563894|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
25248121|NCT01212757|50563895|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
25248122|NCT01212757|50563896|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
25248123|NCT01212757|50563888|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
25248124|NCT01212757|50563889|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
25248125|NCT01212757|50563890|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
25248126|NCT01212757|50563891|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
25248127|NCT01212757|50563892|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
25248128|NCT01212757|50563893|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
25248129|NCT01212757|50563894|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
25248130|NCT01212757|50563895|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
25248131|NCT01212757|50563896|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
25248132|NCT01212757|50563888|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
25248133|NCT01212757|50563889|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
25248134|NCT01212757|50563890|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
25248135|NCT01212757|50563891|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
25248136|NCT01212757|50563892|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
25248137|NCT01212757|50563893|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
25248138|NCT01212757|50563894|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
25328739|NCT00453349|50645055|FG001|Completed Study|Lack of Efficacy|1|||
25328740|NCT00453349|50645054|FG000|Completed Study|Lost to Follow-up|7|||
25328741|NCT00453349|50645055|FG001|Completed Study|Lost to Follow-up|5|||
25328742|NCT00453349|50645054|FG000|Completed Study|Protocol Violation|1|||
25328743|NCT00453349|50645055|FG001|Completed Study|Protocol Violation|1|||
25328744|NCT00453349|50645054|FG000|Completed Study|Withdrawal by Subject|3|||
25328745|NCT00453349|50645055|FG001|Completed Study|Withdrawal by Subject|5|||
25248139|NCT01212757|50563895|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
25248140|NCT01212757|50563896|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
25248141|NCT01212757|50563888|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
25248142|NCT01212757|50563889|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
25248143|NCT01212757|50563890|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
25248144|NCT01212757|50563891|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
25248145|NCT01212757|50563892|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
25248146|NCT01212757|50563893|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
25248147|NCT01212757|50563894|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
25248148|NCT01212757|50563895|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
25248149|NCT01212757|50563896|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
25248150|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
25248151|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
25248152|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
25248153|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
25248154|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
25248155|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
25248156|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
25248157|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
25328746|NCT00453349|50645054|FG000|Completed Study|Lost to follow up after study treatment|2|||
25328747|NCT00453349|50645055|FG001|Completed Study|Lost to follow up after study treatment|11|||
25328748|NCT00464269|50645065|FG000|Overall Study|Lack of Efficacy|1|||
25328749|NCT00464269|50645066|FG001|Overall Study|Lack of Efficacy|0|||
25328750|NCT00464269|50645067|FG002|Overall Study|Lack of Efficacy|0|||
25328751|NCT00464269|50645068|FG003|Overall Study|Lack of Efficacy|0|||
25328752|NCT00464269|50645065|FG000|Overall Study|Lost to Follow-up|0|||
25328753|NCT00464269|50645066|FG001|Overall Study|Lost to Follow-up|4|||
25328754|NCT00464269|50645067|FG002|Overall Study|Lost to Follow-up|0|||
25328755|NCT00464269|50645068|FG003|Overall Study|Lost to Follow-up|1|||
25328756|NCT00464269|50645065|FG000|Overall Study|Withdrawal by Subject|0|||
25328757|NCT00464269|50645066|FG001|Overall Study|Withdrawal by Subject|2|||
25328758|NCT00464269|50645067|FG002|Overall Study|Withdrawal by Subject|1|||
25328759|NCT00464269|50645068|FG003|Overall Study|Withdrawal by Subject|1|||
25328760|NCT00464269|50645065|FG000|Overall Study|Other reason|3|||
25328761|NCT00464269|50645066|FG001|Overall Study|Other reason|3|||
25328762|NCT00464269|50645067|FG002|Overall Study|Other reason|1|||
25328763|NCT00464269|50645068|FG003|Overall Study|Other reason|1|||
25328764|NCT00464269|50645065|FG000|Overall Study|AE, serious fatal|0|||
25328765|NCT00464269|50645066|FG001|Overall Study|AE, serious fatal|0|||
25248158|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
25248159|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
25248160|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
25248161|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
25248162|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
25248163|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
25328766|NCT00464269|50645067|FG002|Overall Study|AE, serious fatal|1|||
25328767|NCT00464269|50645068|FG003|Overall Study|AE, serious fatal|1|||
25328768|NCT00464269|50645065|FG000|Overall Study|SAE, non-fatal|0|||
25328769|NCT00464269|50645066|FG001|Overall Study|SAE, non-fatal|0|||
25328770|NCT00464269|50645067|FG002|Overall Study|SAE, non-fatal|0|||
25328771|NCT00464269|50645068|FG003|Overall Study|SAE, non-fatal|1|||
25328772|NCT00464269|50645065|FG000|Overall Study|AE, non-serious non-fatal|2|||
25328773|NCT00464269|50645066|FG001|Overall Study|AE, non-serious non-fatal|8|||
25328774|NCT00464269|50645067|FG002|Overall Study|AE, non-serious non-fatal|3|||
25328775|NCT00464269|50645068|FG003|Overall Study|AE, non-serious non-fatal|4|||
25328776|NCT00464269|50645065|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
25328777|NCT00464269|50645066|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
25328778|NCT00464269|50645067|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
25328779|NCT00464269|50645068|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
25328780|NCT00484315|50645082|FG000|12-Month Clinical Follow-up|Death|6|||
25328781|NCT00484315|50645083|FG001|12-Month Clinical Follow-up|Death|2|||
25328782|NCT00484315|50645082|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
25328783|NCT00484315|50645083|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
25328784|NCT00484315|50645082|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
25248164|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
25248165|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
25248166|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
25248167|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
25248168|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
25248169|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
25248170|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
25248171|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
25248172|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
25248173|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
25248174|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
25248175|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
25248176|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
25248177|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
25248178|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
25248179|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
25248180|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
25248181|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
25248182|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
25248183|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
25248184|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
25248185|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
25248186|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
25248187|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
25248188|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
25248189|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
25248190|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
25248191|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
25248192|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
25248193|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
25248194|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
25248195|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
25248196|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
25248197|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
25248198|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
25248199|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
25248200|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
25248201|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
25248202|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
25328785|NCT00484315|50645083|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
25248203|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
25248204|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
25248205|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
25248206|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
25248207|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
25248208|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
25248209|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
25248210|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
25248211|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
25248212|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
25248213|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
25248214|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
25248215|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
25248216|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
25248217|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
25248218|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
25248219|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
25248220|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
25248221|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
25248222|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
25248223|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
25248224|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
25248225|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
25248226|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
25248227|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
25248228|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
25248229|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
25248230|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
25248231|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
25248232|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
25248233|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
25248234|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
25248235|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
25248236|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
25248237|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
25248238|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
25248239|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
25248240|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
25248241|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
25248242|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
25248243|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
25248244|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
25328786|NCT00484315|50645082|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
25328787|NCT00484315|50645083|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
25328788|NCT00484315|50645082|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
25328789|NCT00484315|50645083|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
25328790|NCT00484315|50645082|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
25328791|NCT00484315|50645083|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
25328792|NCT00484315|50645082|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
25328793|NCT00484315|50645083|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
25328794|NCT00463801|50645089|FG000|Overall Study|Protocol Violation|1|||
25328795|NCT00463801|50645089|FG000|Overall Study|Lack of Efficacy|2|||
25328796|NCT00463801|50645089|FG000|Overall Study|Adverse Event|4|||
25328797|NCT00463801|50645089|FG000|Overall Study|Lost to Follow-up|5|||
25328798|NCT00463801|50645089|FG000|Overall Study|No longer require therapy|1|||
25328799|NCT00463567|50645100|FG000|Overall Study|Adverse Event|29|||
25328800|NCT00463567|50645101|FG001|Overall Study|Adverse Event|26|||
25328801|NCT00463567|50645102|FG002|Overall Study|Adverse Event|17|||
25328802|NCT00463567|50645103|FG003|Overall Study|Adverse Event|46|||
25328803|NCT00463567|50645104|FG004|Overall Study|Adverse Event|10|||
25248245|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
25248246|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
25248247|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
25248248|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
25248249|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
25248250|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
25248251|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
25248252|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
25248253|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
25248254|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
25248255|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
25248256|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
25248257|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
25248258|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
25248259|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
25248260|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
25248261|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
25248262|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
25248263|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
25248264|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
25248265|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
25248266|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
25248267|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
25248268|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
25248269|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
25248270|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
25248271|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
25248272|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
25248273|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
25248274|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
25248275|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
25248276|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
25248277|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
25248278|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
25248279|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
25248280|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
25248281|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
25248282|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
25248283|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
25248284|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
25248285|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
25248286|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
25248287|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
25248288|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
25248289|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
25248290|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
25248291|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
25248292|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
25248293|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
25248294|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
25248295|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
25248296|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
25248297|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
25248298|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
25248299|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
25328804|NCT00463567|50645105|FG005|Overall Study|Adverse Event|10|||
25328805|NCT00463567|50645106|FG006|Overall Study|Adverse Event|4|||
25328806|NCT00463567|50645100|FG000|Overall Study|Withdrawal by Subject|29|||
25328807|NCT00463567|50645101|FG001|Overall Study|Withdrawal by Subject|22|||
25328808|NCT00463567|50645102|FG002|Overall Study|Withdrawal by Subject|20|||
25328809|NCT00463567|50645103|FG003|Overall Study|Withdrawal by Subject|37|||
25328810|NCT00463567|50645104|FG004|Overall Study|Withdrawal by Subject|6|||
25328811|NCT00463567|50645105|FG005|Overall Study|Withdrawal by Subject|5|||
25328812|NCT00463567|50645106|FG006|Overall Study|Withdrawal by Subject|1|||
25328813|NCT00463567|50645100|FG000|Overall Study|Protocol Deviation|13|||
25328814|NCT00463567|50645101|FG001|Overall Study|Protocol Deviation|9|||
25328815|NCT00463567|50645102|FG002|Overall Study|Protocol Deviation|14|||
25328816|NCT00463567|50645103|FG003|Overall Study|Protocol Deviation|11|||
25328817|NCT00463567|50645104|FG004|Overall Study|Protocol Deviation|1|||
25328818|NCT00463567|50645105|FG005|Overall Study|Protocol Deviation|1|||
25328819|NCT00463567|50645106|FG006|Overall Study|Protocol Deviation|2|||
25248300|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
25248301|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
25248302|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
25248303|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
25248304|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
25248305|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
25248306|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
25248307|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
25248308|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
25328820|NCT00463567|50645100|FG000|Overall Study|Lost to Follow-up|12|||
25328821|NCT00463567|50645101|FG001|Overall Study|Lost to Follow-up|6|||
25328822|NCT00463567|50645102|FG002|Overall Study|Lost to Follow-up|13|||
25328823|NCT00463567|50645103|FG003|Overall Study|Lost to Follow-up|8|||
25328824|NCT00463567|50645104|FG004|Overall Study|Lost to Follow-up|1|||
25328825|NCT00463567|50645105|FG005|Overall Study|Lost to Follow-up|1|||
25328826|NCT00463567|50645106|FG006|Overall Study|Lost to Follow-up|1|||
25328827|NCT00463567|50645100|FG000|Overall Study|Administrative problems|5|||
25328828|NCT00463567|50645101|FG001|Overall Study|Administrative problems|3|||
25328829|NCT00463567|50645102|FG002|Overall Study|Administrative problems|6|||
25328830|NCT00463567|50645103|FG003|Overall Study|Administrative problems|9|||
25328831|NCT00463567|50645104|FG004|Overall Study|Administrative problems|3|||
25328832|NCT00463567|50645105|FG005|Overall Study|Administrative problems|2|||
25328833|NCT00463567|50645106|FG006|Overall Study|Administrative problems|2|||
25328834|NCT00463567|50645100|FG000|Overall Study|Lack of Efficacy|4|||
25328835|NCT00463567|50645101|FG001|Overall Study|Lack of Efficacy|9|||
25248309|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
25248310|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
25248311|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
25328836|NCT00463567|50645102|FG002|Overall Study|Lack of Efficacy|9|||
25328837|NCT00463567|50645103|FG003|Overall Study|Lack of Efficacy|17|||
25328838|NCT00463567|50645104|FG004|Overall Study|Lack of Efficacy|1|||
25328839|NCT00463567|50645105|FG005|Overall Study|Lack of Efficacy|0|||
25248312|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
25328840|NCT00463567|50645106|FG006|Overall Study|Lack of Efficacy|1|||
25328841|NCT00463567|50645100|FG000|Overall Study|Abnormal lab value(s)|1|||
25328842|NCT00463567|50645101|FG001|Overall Study|Abnormal lab value(s)|1|||
25328843|NCT00463567|50645102|FG002|Overall Study|Abnormal lab value(s)|2|||
25328844|NCT00463567|50645103|FG003|Overall Study|Abnormal lab value(s)|1|||
25328845|NCT00463567|50645104|FG004|Overall Study|Abnormal lab value(s)|1|||
25328846|NCT00463567|50645105|FG005|Overall Study|Abnormal lab value(s)|0|||
25328847|NCT00463567|50645106|FG006|Overall Study|Abnormal lab value(s)|0|||
25328848|NCT00463567|50645100|FG000|Overall Study|Abnormal test procedure result(s)|1|||
25328849|NCT00463567|50645101|FG001|Overall Study|Abnormal test procedure result(s)|1|||
25328850|NCT00463567|50645102|FG002|Overall Study|Abnormal test procedure result(s)|6|||
25328851|NCT00463567|50645103|FG003|Overall Study|Abnormal test procedure result(s)|2|||
25248313|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
25248314|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
25328852|NCT00463567|50645104|FG004|Overall Study|Abnormal test procedure result(s)|0|||
25328853|NCT00463567|50645105|FG005|Overall Study|Abnormal test procedure result(s)|2|||
25328854|NCT00463567|50645106|FG006|Overall Study|Abnormal test procedure result(s)|0|||
25328855|NCT00463567|50645100|FG000|Overall Study|Death|1|||
25328856|NCT00463567|50645101|FG001|Overall Study|Death|0|||
25328857|NCT00463567|50645102|FG002|Overall Study|Death|2|||
25328858|NCT00463567|50645103|FG003|Overall Study|Death|0|||
25328859|NCT00463567|50645104|FG004|Overall Study|Death|0|||
25328860|NCT00463567|50645105|FG005|Overall Study|Death|0|||
25328861|NCT00463567|50645106|FG006|Overall Study|Death|0|||
25328862|NCT00484159|50645131|FG000|Overall Study|Lost to Follow-up|1|||
25328863|NCT00484159|50645132|FG001|Overall Study|Lost to Follow-up|1|||
25328864|NCT00484159|50645133|FG002|Overall Study|Lost to Follow-up|0|||
25328865|NCT00462865|50645141|FG000|Overall Study|Adverse Event|1|||
25328866|NCT03839641|50645147|FG000|Overall Study|Withdrawal by Subject|1|||
25328867|NCT03839641|50645148|FG001|Overall Study|Withdrawal by Subject|1|||
25328868|NCT00462709|50645156|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
25328869|NCT00462709|50645156|FG000|Overall Study|Lost to Follow-up|10|||
25248315|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
25248316|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
25248317|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
25248318|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
25248319|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
25248320|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
25248321|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
25248322|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
25328870|NCT00462709|50645156|FG000|Overall Study|Withdrawal by Subject|8|||
25328871|NCT00462709|50645156|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
25328872|NCT00462709|50645156|FG000|Overall Study|Death|2|||
25328873|NCT00462709|50645156|FG000|Overall Study|Logistical reasons|2|||
25328874|NCT00462709|50645156|FG000|Overall Study|Physician Decision|1|||
25328875|NCT00462709|50645156|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
25328876|NCT00461305|50645162|FG000|Treatment|Adverse Event|26|||
25328877|NCT00461305|50645163|FG001|Treatment|Adverse Event|3|||
25328878|NCT00461305|50645162|FG000|Treatment|Lost to Follow-up|4|||
25328879|NCT00461305|50645163|FG001|Treatment|Lost to Follow-up|2|||
25328880|NCT00461305|50645162|FG000|Treatment|Protocol Violation|13|||
25328881|NCT00461305|50645163|FG001|Treatment|Protocol Violation|2|||
25328882|NCT00461305|50645162|FG000|Treatment|Withdrawal by Subject|48|||
25328883|NCT00461305|50645163|FG001|Treatment|Withdrawal by Subject|2|||
25328884|NCT00461305|50645162|FG000|Treatment|Never dispensed|5|||
25328885|NCT00461305|50645163|FG001|Treatment|Never dispensed|0|||
25328886|NCT00461305|50645162|FG000|Treatment|Study drug not taken|1|||
25248323|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
25328887|NCT00461305|50645163|FG001|Treatment|Study drug not taken|0|||
25248324|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
25248325|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
25248326|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
25248327|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
25248328|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
25248329|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
25248330|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
25248331|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
25248332|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
25248333|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
25248334|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
25248335|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
25248336|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
25248337|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
25248338|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
25248339|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
25328888|NCT00461305|50645162|FG000|Treatment|Partially missing diary|2|||
25328889|NCT00461305|50645163|FG001|Treatment|Partially missing diary|0|||
25328890|NCT00461305|50645162|FG000|Treatment|Other (missing drug etc)|2|||
25328891|NCT00461305|50645163|FG001|Treatment|Other (missing drug etc)|0|||
25328892|NCT00461305|50645162|FG000|Continued Treatment|Adverse Event|26|||
25248340|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
25328893|NCT00461305|50645163|FG001|Continued Treatment|Adverse Event|0|||
25328894|NCT00461305|50645162|FG000|Continued Treatment|Lost to Follow-up|4|||
25328895|NCT00461305|50645163|FG001|Continued Treatment|Lost to Follow-up|0|||
25328896|NCT00461305|50645162|FG000|Continued Treatment|Protocol Violation|13|||
25328897|NCT00461305|50645163|FG001|Continued Treatment|Protocol Violation|0|||
25328898|NCT00461305|50645162|FG000|Continued Treatment|Withdrawal by Subject|48|||
25328899|NCT00461305|50645163|FG001|Continued Treatment|Withdrawal by Subject|0|||
25328900|NCT00461305|50645162|FG000|Continued Treatment|Partially missing diary|2|||
25328901|NCT00461305|50645163|FG001|Continued Treatment|Partially missing diary|0|||
25328902|NCT00461305|50645162|FG000|Continued Treatment|Other (missing drug etc)|2|||
25328903|NCT00461305|50645163|FG001|Continued Treatment|Other (missing drug etc)|0|||
25328904|NCT00856544|50645174|FG000|Overall Study|Randomized but not treated|3|||
25328905|NCT00856544|50645175|FG001|Overall Study|Randomized but not treated|0|||
25328906|NCT00856544|50645176|FG002|Overall Study|Randomized but not treated|0|||
25328907|NCT00856544|50645177|FG003|Overall Study|Randomized but not treated|0|||
25328908|NCT00856544|50645174|FG000|Overall Study|Death|0|||
25328909|NCT00856544|50645175|FG001|Overall Study|Death|2|||
25328910|NCT00856544|50645176|FG002|Overall Study|Death|0|||
25328911|NCT00856544|50645177|FG003|Overall Study|Death|0|||
25328912|NCT00856544|50645174|FG000|Overall Study|Adverse Event|20|||
25328913|NCT00856544|50645175|FG001|Overall Study|Adverse Event|29|||
25328914|NCT00856544|50645176|FG002|Overall Study|Adverse Event|2|||
24977253|NCT03410992|50065851|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
24977254|NCT03410992|50065852|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
24977255|NCT03410992|50065853|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
24977256|NCT03410992|50065854|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
24977257|NCT03410992|50065855|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
24977258|NCT03410992|50065845|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
24977259|NCT03410992|50065846|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
24977260|NCT03410992|50065847|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
24977261|NCT03410992|50065848|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
24977262|NCT03410992|50065849|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
24977263|NCT03410992|50065850|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
24977264|NCT03410992|50065851|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
24977265|NCT03410992|50065852|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
24977266|NCT03410992|50065853|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
24977267|NCT03410992|50065854|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
24977268|NCT03410992|50065855|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
24977269|NCT03410992|50065845|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
24977270|NCT03410992|50065846|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
24977271|NCT03410992|50065847|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
25248341|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
25248342|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
25248343|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
25248344|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
25248345|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
25248346|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
25248347|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
25248348|NCT01212757|50563888|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
25248349|NCT01212757|50563889|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
25248350|NCT01212757|50563890|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
25248351|NCT01212757|50563891|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
25248352|NCT01212757|50563892|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
25248353|NCT01212757|50563893|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
25248354|NCT01212757|50563894|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
25248355|NCT01212757|50563895|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
25248356|NCT01212757|50563896|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
25248357|NCT01190410|50563916|FG000|Overall Study|Adverse Event|0|||
25248358|NCT01190410|50563917|FG001|Overall Study|Adverse Event|3|||
25248359|NCT01190410|50563916|FG000|Overall Study|Lack of Efficacy|0|||
25248360|NCT01190410|50563917|FG001|Overall Study|Lack of Efficacy|2|||
25248361|NCT01190410|50563916|FG000|Overall Study|Withdrawal by Subject|0|||
25328915|NCT00856544|50645177|FG003|Overall Study|Adverse Event|3|||
25328916|NCT00856544|50645174|FG000|Overall Study|Lack of Efficacy|16|||
25328917|NCT00856544|50645175|FG001|Overall Study|Lack of Efficacy|12|||
25328918|NCT00856544|50645176|FG002|Overall Study|Lack of Efficacy|3|||
25328919|NCT00856544|50645177|FG003|Overall Study|Lack of Efficacy|3|||
25328920|NCT00856544|50645174|FG000|Overall Study|Other|9|||
25328921|NCT00856544|50645175|FG001|Overall Study|Other|16|||
25328922|NCT00856544|50645176|FG002|Overall Study|Other|1|||
25248362|NCT01190410|50563917|FG001|Overall Study|Withdrawal by Subject|2|||
25248363|NCT01190410|50563916|FG000|Overall Study|Administrative decision|1|||
25248364|NCT01190410|50563917|FG001|Overall Study|Administrative decision|0|||
25248365|NCT01190410|50563916|FG000|Overall Study|PI discretion|0|||
25248366|NCT01190410|50563917|FG001|Overall Study|PI discretion|2|||
25248367|NCT01190254|50563932|FG000|Overall Study|Adverse Event|3|||
25248368|NCT01190254|50563933|FG001|Overall Study|Adverse Event|6|||
25248369|NCT01190254|50563934|FG002|Overall Study|Adverse Event|8|||
25248370|NCT01190254|50563932|FG000|Overall Study|Lack of Efficacy|7|||
25248371|NCT01190254|50563933|FG001|Overall Study|Lack of Efficacy|4|||
25248372|NCT01190254|50563934|FG002|Overall Study|Lack of Efficacy|5|||
25328923|NCT00856544|50645177|FG003|Overall Study|Other|6|||
25328924|NCT00856544|50645174|FG000|Overall Study|Lost to Follow-up|1|||
25328925|NCT00856544|50645175|FG001|Overall Study|Lost to Follow-up|2|||
25328926|NCT00856544|50645176|FG002|Overall Study|Lost to Follow-up|2|||
25328927|NCT00856544|50645177|FG003|Overall Study|Lost to Follow-up|0|||
25328928|NCT00856544|50645174|FG000|Overall Study|Withdrawal by Subject|8|||
25328929|NCT00856544|50645175|FG001|Overall Study|Withdrawal by Subject|5|||
25328930|NCT00856544|50645176|FG002|Overall Study|Withdrawal by Subject|0|||
25328931|NCT00856544|50645177|FG003|Overall Study|Withdrawal by Subject|1|||
25328932|NCT00856388|50645199|FG000|Overall Study|Other|1|||
25328933|NCT00848354|50645206|FG000|Phase 1|Adverse Event|5|||
25328934|NCT00848354|50645207|FG001|Phase 1|Adverse Event|4|||
25328935|NCT00848354|50645206|FG000|Phase 1|Discontinuation of study by sponsor|2|||
25328936|NCT00848354|50645207|FG001|Phase 1|Discontinuation of study by sponsor|1|||
25328937|NCT00848354|50645206|FG000|Phase 1|Failed to return|0|||
25328938|NCT00848354|50645207|FG001|Phase 1|Failed to return|1|||
25328939|NCT00848354|50645206|FG000|Phase 1|Lost to Follow-up|1|||
25328940|NCT00848354|50645207|FG001|Phase 1|Lost to Follow-up|1|||
25328941|NCT00848354|50645206|FG000|Phase 1|Unspecified Reason|1|||
25328942|NCT00848354|50645207|FG001|Phase 1|Unspecified Reason|1|||
25328943|NCT00848354|50645206|FG000|Phase 1|Protocol Violation|1|||
25328944|NCT00848354|50645207|FG001|Phase 1|Protocol Violation|1|||
25328945|NCT00848354|50645206|FG000|Phase 1|Withdrawal by Subject|2|||
25328946|NCT00848354|50645207|FG001|Phase 1|Withdrawal by Subject|4|||
25328947|NCT00848354|50645206|FG000|Phase 1|Lack of Efficacy|0|||
25328948|NCT00848354|50645207|FG001|Phase 1|Lack of Efficacy|1|||
25328949|NCT00848354|50645206|FG000|Phase 2 Year 1|Adverse Event|7|||
25328950|NCT00848354|50645207|FG001|Phase 2 Year 1|Adverse Event|2|||
25328951|NCT00848354|50645206|FG000|Phase 2 Year 1|Death|1|||
25328952|NCT00848354|50645207|FG001|Phase 2 Year 1|Death|0|||
25328953|NCT00848354|50645206|FG000|Phase 2 Year 1|Failed to Return|1|||
25328954|NCT00848354|50645207|FG001|Phase 2 Year 1|Failed to Return|1|||
25328955|NCT00848354|50645206|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
25328956|NCT00848354|50645207|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
25328957|NCT00848354|50645206|FG000|Phase 2 Year 1|Unspecified Reason|3|||
25328958|NCT00848354|50645207|FG001|Phase 2 Year 1|Unspecified Reason|0|||
25328959|NCT00848354|50645206|FG000|Phase 2 Year 1|Protocol Violation|4|||
25328960|NCT00848354|50645207|FG001|Phase 2 Year 1|Protocol Violation|1|||
25328961|NCT00848354|50645206|FG000|Phase 2 Year 1|Subject Request|1|||
25328962|NCT00848354|50645207|FG001|Phase 2 Year 1|Subject Request|2|||
25328963|NCT00848354|50645206|FG000|Phase 2 Year 2|Adverse Event|12|||
25328964|NCT00848354|50645207|FG001|Phase 2 Year 2|Adverse Event|2|||
24977272|NCT03410992|50065848|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
24977273|NCT03410992|50065849|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
25328965|NCT00848354|50645206|FG000|Phase 2 Year 2|Death|2|||
25328966|NCT00848354|50645207|FG001|Phase 2 Year 2|Death|0|||
25328967|NCT00848354|50645206|FG000|Phase 2 Year 2|Failed to return|3|||
25328968|NCT00848354|50645207|FG001|Phase 2 Year 2|Failed to return|0|||
25328969|NCT00848354|50645206|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
25328970|NCT00848354|50645207|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
25328971|NCT00848354|50645206|FG000|Phase 2 Year 2|Unspecified Reason|1|||
25328972|NCT00848354|50645207|FG001|Phase 2 Year 2|Unspecified Reason|0|||
25328973|NCT00848354|50645206|FG000|Phase 2 Year 2|Protocol Violation|1|||
25328974|NCT00848354|50645207|FG001|Phase 2 Year 2|Protocol Violation|1|||
25328975|NCT00848354|50645206|FG000|Phase 2 Year 2|Subject Request|1|||
25328976|NCT00848354|50645207|FG001|Phase 2 Year 2|Subject Request|1|||
25328977|NCT00848354|50645206|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
25328978|NCT00848354|50645207|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
25328979|NCT00848198|50645217|FG000|Overall Study|Incomplete Case Report Forms|15|||
25328980|NCT00848120|50645225|FG000|Overall Study|Adverse Event|1|||
24977274|NCT03410992|50065850|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
25248373|NCT01190254|50563932|FG000|Overall Study|Lost to Follow-up|4|||
25328981|NCT00600821|50645231|FG000|Overall Study|Death|45|||
25328982|NCT00600821|50645232|FG001|Overall Study|Death|46|||
25328983|NCT00600821|50645231|FG000|Overall Study|Lost to Follow-up|2|||
25328984|NCT00600821|50645232|FG001|Overall Study|Lost to Follow-up|2|||
25328985|NCT00600821|50645231|FG000|Overall Study|Withdrawal by Subject|1|||
25328986|NCT00600821|50645232|FG001|Overall Study|Withdrawal by Subject|1|||
25328987|NCT00600821|50645231|FG000|Overall Study|Terminated by sponsor|8|||
25328988|NCT00600821|50645232|FG001|Overall Study|Terminated by sponsor|6|||
25328989|NCT00600821|50645231|FG000|Overall Study|Objective progression or relapse|0|||
25328990|NCT00600821|50645232|FG001|Overall Study|Objective progression or relapse|1|||
25328991|NCT00600821|50645231|FG000|Overall Study|Randomized but not treated|0|||
25328992|NCT00600821|50645232|FG001|Overall Study|Randomized but not treated|1|||
25328993|NCT00600821|50645231|FG000|Overall Study|Other|2|||
25328994|NCT00600821|50645232|FG001|Overall Study|Other|3|||
25328995|NCT00592904|50645244|FG000|Overall Study|Adverse Event|15|||
25328996|NCT00592904|50645245|FG001|Overall Study|Adverse Event|25|||
25328997|NCT00592904|50645246|FG002|Overall Study|Adverse Event|13|||
25328998|NCT00592904|50645247|FG003|Overall Study|Adverse Event|5|||
25328999|NCT00592904|50645244|FG000|Overall Study|Protocol Violation|1|||
25248374|NCT01190254|50563933|FG001|Overall Study|Lost to Follow-up|2|||
25248375|NCT01190254|50563934|FG002|Overall Study|Lost to Follow-up|0|||
25248376|NCT01190254|50563932|FG000|Overall Study|Withdrawal by Subject|4|||
25248377|NCT01190254|50563933|FG001|Overall Study|Withdrawal by Subject|5|||
25248378|NCT01190254|50563934|FG002|Overall Study|Withdrawal by Subject|7|||
25248379|NCT01190254|50563932|FG000|Overall Study|Protocol Violation|2|||
25248380|NCT01190254|50563933|FG001|Overall Study|Protocol Violation|0|||
25248381|NCT01190254|50563934|FG002|Overall Study|Protocol Violation|2|||
25248382|NCT01190254|50563932|FG000|Overall Study|Did not meet protocol eligibility|1|||
25248383|NCT01190254|50563933|FG001|Overall Study|Did not meet protocol eligibility|0|||
25248384|NCT01190254|50563934|FG002|Overall Study|Did not meet protocol eligibility|0|||
25248385|NCT01190839|50563944|FG000|Overall Study|Adverse Event|32|||
25248386|NCT01190839|50563945|FG001|Overall Study|Adverse Event|41|||
25248387|NCT01190839|50563944|FG000|Overall Study|Protocol Violation|2|||
25248388|NCT01190839|50563945|FG001|Overall Study|Protocol Violation|2|||
25248389|NCT01190839|50563944|FG000|Overall Study|Lost to Follow-up|7|||
25248390|NCT01190839|50563945|FG001|Overall Study|Lost to Follow-up|1|||
25248391|NCT01190839|50563944|FG000|Overall Study|Death|1|||
25248392|NCT01190839|50563945|FG001|Overall Study|Death|0|||
25248393|NCT01190839|50563944|FG000|Overall Study|Trial stopped by Sponsor|71|||
25248394|NCT01190839|50563945|FG001|Overall Study|Trial stopped by Sponsor|68|||
25248395|NCT01190839|50563944|FG000|Overall Study|Undefined|35|||
25248396|NCT01190839|50563945|FG001|Overall Study|Undefined|31|||
25248397|NCT01190839|50563944|FG000|Overall Study|Randomized but not treated|2|||
25248398|NCT01190839|50563945|FG001|Overall Study|Randomized but not treated|4|||
25248399|NCT01190215|50563955|FG000|Up to Month 6|Lost to Follow-up|2|||
25248400|NCT01190215|50563956|FG001|Up to Month 6|Lost to Follow-up|0|||
25248401|NCT01190449|50563964|FG000|Overall Study|Ineligible|0|||
25329000|NCT00592904|50645245|FG001|Overall Study|Protocol Violation|1|||
25329001|NCT00592904|50645246|FG002|Overall Study|Protocol Violation|0|||
25329002|NCT00592904|50645247|FG003|Overall Study|Protocol Violation|1|||
25329003|NCT00592904|50645244|FG000|Overall Study|Withdrawal by Subject|4|||
25329004|NCT00592904|50645245|FG001|Overall Study|Withdrawal by Subject|16|||
25329005|NCT00592904|50645246|FG002|Overall Study|Withdrawal by Subject|1|||
25329006|NCT00592904|50645247|FG003|Overall Study|Withdrawal by Subject|2|||
25329007|NCT00592904|50645244|FG000|Overall Study|Lack of Efficacy|2|||
25329008|NCT00592904|50645245|FG001|Overall Study|Lack of Efficacy|7|||
25329009|NCT00592904|50645246|FG002|Overall Study|Lack of Efficacy|2|||
25329010|NCT00592904|50645247|FG003|Overall Study|Lack of Efficacy|3|||
25329011|NCT00592904|50645244|FG000|Overall Study|Physician Decision|0|||
25248402|NCT01190449|50563965|FG001|Overall Study|Ineligible|4|||
25329012|NCT00592904|50645245|FG001|Overall Study|Physician Decision|3|||
25329013|NCT00592904|50645246|FG002|Overall Study|Physician Decision|1|||
25329014|NCT00592904|50645247|FG003|Overall Study|Physician Decision|0|||
25329015|NCT00592904|50645244|FG000|Overall Study|Other|3|||
25248403|NCT01190176|50563971|FG000|Overall Study|Withdrawal by Subject|1|||
25248404|NCT01190176|50563971|FG000|Overall Study|Lost to Follow-up|1|||
25248405|NCT01190098|50563977|FG000|Overall Study|Adverse Event|2|||
25248406|NCT01190098|50563978|FG001|Overall Study|Adverse Event|0|||
25248407|NCT01190098|50563977|FG000|Overall Study|Patient coomorbidity|0|||
25248408|NCT01190098|50563978|FG001|Overall Study|Patient coomorbidity|1|||
25329016|NCT00592904|50645245|FG001|Overall Study|Other|3|||
25329017|NCT00592904|50645246|FG002|Overall Study|Other|0|||
25329018|NCT00592904|50645247|FG003|Overall Study|Other|0|||
25329019|NCT00855920|50645260|FG000|Overall Study|Protocol Violation|0|||
25329020|NCT00855920|50645261|FG001|Overall Study|Protocol Violation|0|||
25248409|NCT01190098|50563977|FG000|Overall Study|Lack of transportation|1|||
25248410|NCT01190098|50563978|FG001|Overall Study|Lack of transportation|0|||
25248411|NCT01190098|50563977|FG000|Overall Study|Other|0|||
25248412|NCT01190098|50563978|FG001|Overall Study|Other|1|||
25248413|NCT01190020|50563986|FG000|Overall Study|Adverse Event|2|||
25248414|NCT01190020|50563987|FG001|Overall Study|Adverse Event|0|||
25248415|NCT01190020|50563986|FG000|Overall Study|Lost to Follow-up|2|||
25329021|NCT00855920|50645262|FG002|Overall Study|Protocol Violation|2|||
25248416|NCT01190020|50563987|FG001|Overall Study|Lost to Follow-up|0|||
25329022|NCT00855920|50645260|FG000|Overall Study|Adverse Event|2|||
25329023|NCT00855920|50645261|FG001|Overall Study|Adverse Event|1|||
25329024|NCT00855920|50645262|FG002|Overall Study|Adverse Event|1|||
25329025|NCT00855920|50645260|FG000|Overall Study|Lack of Efficacy|2|||
25329026|NCT00855920|50645261|FG001|Overall Study|Lack of Efficacy|2|||
25329027|NCT00855920|50645262|FG002|Overall Study|Lack of Efficacy|2|||
25329028|NCT00855920|50645260|FG000|Overall Study|Withdrawal by Subject|2|||
25329029|NCT00855920|50645261|FG001|Overall Study|Withdrawal by Subject|3|||
25248417|NCT01190020|50563986|FG000|Overall Study|Withdrawal by Subject|3|||
25248418|NCT01190020|50563987|FG001|Overall Study|Withdrawal by Subject|0|||
25248419|NCT01189435|50563993|FG000|Overall Study|Withdrawal by Subject|1|||
25248420|NCT01189435|50563993|FG000|Overall Study|Physician Decision|1|||
25248421|NCT01165996|50563997|FG000|Overall Study|Death|1|||
25248422|NCT01165996|50563997|FG000|Overall Study|Physician Decision|1|||
25248423|NCT01165684|50564004|FG000|Overall Study|Adverse Event|1|||
25248424|NCT01165684|50564005|FG001|Overall Study|Adverse Event|1|||
25248425|NCT01165684|50564004|FG000|Overall Study|Lack of Efficacy|2|||
25329030|NCT00855920|50645262|FG002|Overall Study|Withdrawal by Subject|2|||
25329031|NCT00855920|50645260|FG000|Overall Study|Lost to Follow-up|1|||
25329032|NCT00855920|50645261|FG001|Overall Study|Lost to Follow-up|0|||
25329033|NCT00855920|50645262|FG002|Overall Study|Lost to Follow-up|2|||
25329034|NCT00855920|50645260|FG000|Overall Study|Death|0|||
25329035|NCT00855920|50645261|FG001|Overall Study|Death|1|||
25329036|NCT00855920|50645262|FG002|Overall Study|Death|0|||
25329037|NCT00855920|50645260|FG000|Overall Study|Decision by the sponsor|0|||
25329038|NCT00855920|50645261|FG001|Overall Study|Decision by the sponsor|1|||
25329039|NCT00855920|50645262|FG002|Overall Study|Decision by the sponsor|1|||
25329040|NCT00855920|50645260|FG000|Overall Study|Other than specified above|1|||
25329041|NCT00855920|50645261|FG001|Overall Study|Other than specified above|1|||
25329042|NCT00855920|50645262|FG002|Overall Study|Other than specified above|1|||
25329043|NCT00848042|50645273|FG000|Overall Study|Death|1|||
25329044|NCT00848042|50645274|FG001|Overall Study|Death|2|||
25329045|NCT00848042|50645275|FG002|Overall Study|Death|0|||
25329046|NCT00848042|50645273|FG000|Overall Study|Other Therapy|3|||
25329047|NCT00848042|50645274|FG001|Overall Study|Other Therapy|0|||
25329048|NCT00848042|50645275|FG002|Overall Study|Other Therapy|0|||
25329049|NCT00847886|50645285|FG000|Overall Study|Adverse Event|0|||
25329050|NCT00847886|50645286|FG001|Overall Study|Adverse Event|1|||
25329051|NCT00847808|50645292|FG000|Overall Study|Adverse Event|7|||
25248426|NCT01165684|50564005|FG001|Overall Study|Lack of Efficacy|1|||
25248427|NCT01165684|50564004|FG000|Overall Study|Protocol Violation|7|||
25248428|NCT01165684|50564005|FG001|Overall Study|Protocol Violation|15|||
25248429|NCT01165684|50564004|FG000|Overall Study|Withdrawal Criteria|2|||
25248430|NCT01165684|50564005|FG001|Overall Study|Withdrawal Criteria|13|||
25329052|NCT00847808|50645292|FG000|Overall Study|Protocol Violation|1|||
25329053|NCT00847808|50645292|FG000|Overall Study|Lost to Follow-up|1|||
25329054|NCT00847808|50645292|FG000|Overall Study|Withdrawal by Subject|4|||
25329055|NCT00847808|50645292|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
25329056|NCT00847808|50645292|FG000|Overall Study|Participant Took Excluded Medication|1|||
25329057|NCT00600353|50645298|FG000|Overall Study|history of malignancy within 5 years|1|||
25329058|NCT00600353|50645299|FG001|Overall Study|history of malignancy within 5 years|0|||
25329059|NCT00600353|50645298|FG000|Overall Study|History of prepartive regimen|0|||
25329060|NCT00600353|50645299|FG001|Overall Study|History of prepartive regimen|1|||
25329061|NCT00691210|50645313|FG000|Overall Study|Progression of Disease|0|||
25329062|NCT00691210|50645314|FG001|Overall Study|Progression of Disease|0|||
25248431|NCT01165684|50564004|FG000|Overall Study|Unclassified|16|||
25248432|NCT01165684|50564005|FG001|Overall Study|Unclassified|22|||
25248433|NCT01189201|50564011|FG000|Overall Study|Adverse Event|1|||
25248434|NCT01188967|50564028|FG000|Overall Study|Withdrawal by Subject|1|||
25329063|NCT00691210|50645315|FG002|Overall Study|Progression of Disease|0|||
25329064|NCT00691210|50645316|FG003|Overall Study|Progression of Disease|2|||
25329065|NCT00691210|50645317|FG004|Overall Study|Progression of Disease|0|||
25329066|NCT00691210|50645318|FG005|Overall Study|Progression of Disease|0|||
25329067|NCT00691210|50645319|FG006|Overall Study|Progression of Disease|0|||
25329068|NCT00691210|50645320|FG007|Overall Study|Progression of Disease|0|||
25329069|NCT00691210|50645313|FG000|Overall Study|Lack of Efficacy|0|||
25329070|NCT00691210|50645314|FG001|Overall Study|Lack of Efficacy|0|||
25329071|NCT00691210|50645315|FG002|Overall Study|Lack of Efficacy|0|||
24900719|NCT00785213|49994730|FG000|Quinine Sulfate Alone|Adverse Event|4|||
24900720|NCT00785213|49994730|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
25248435|NCT01188967|50564029|FG001|Overall Study|Withdrawal by Subject|1|||
25248436|NCT01188967|50564028|FG000|Overall Study|Physician Decision|1|||
25248437|NCT01188967|50564029|FG001|Overall Study|Physician Decision|1|||
25248438|NCT01188967|50564028|FG000|Overall Study|Lost to Follow-up|3|||
25248439|NCT01188967|50564029|FG001|Overall Study|Lost to Follow-up|2|||
25248440|NCT01188811|50564039|FG000|Overall Study|Withdrawal by Subject|0|||
25248441|NCT01188811|50564040|FG001|Overall Study|Withdrawal by Subject|2|||
25248442|NCT01188811|50564039|FG000|Overall Study|Adverse Event|6|||
25248443|NCT01188811|50564040|FG001|Overall Study|Adverse Event|0|||
25248444|NCT01183234|50564048|FG000|First Intervention|Adverse Event|1|||
25248445|NCT01183234|50564049|FG001|First Intervention|Adverse Event|0|||
25248446|NCT01165216|50564057|FG000|Overall Study|Adverse Event|6|||
25248447|NCT01165216|50564058|FG001|Overall Study|Adverse Event|3|||
25248448|NCT01165216|50564057|FG000|Overall Study|Withdrawal by Subject|1|||
25248449|NCT01165216|50564058|FG001|Overall Study|Withdrawal by Subject|1|||
25248450|NCT01165216|50564057|FG000|Overall Study|Disease progression|1|||
25248451|NCT01165216|50564058|FG001|Overall Study|Disease progression|3|||
25248452|NCT04545476|50564083|FG000|Overall Study|Lost to Follow-up|1|||
25248453|NCT04545476|50564084|FG001|Overall Study|Lost to Follow-up|1|||
25248454|NCT04545476|50564085|FG002|Overall Study|Lost to Follow-up|0|||
25248455|NCT04545476|50564086|FG003|Overall Study|Lost to Follow-up|0|||
25248456|NCT01969838|50564101|FG000|Double-blind Phase|Adverse Event|10|||
25248457|NCT01969838|50564102|FG001|Double-blind Phase|Adverse Event|4|||
25248458|NCT01969838|50564103|FG002|Double-blind Phase|Adverse Event|0|||
25248459|NCT01969838|50564104|FG003|Double-blind Phase|Adverse Event|0|||
25248460|NCT01969838|50564101|FG000|Double-blind Phase|Death|5|||
25248461|NCT01969838|50564102|FG001|Double-blind Phase|Death|2|||
25248462|NCT01969838|50564103|FG002|Double-blind Phase|Death|0|||
25248463|NCT01969838|50564104|FG003|Double-blind Phase|Death|0|||
25248464|NCT01969838|50564101|FG000|Double-blind Phase|Physician Decision|5|||
25248465|NCT01969838|50564102|FG001|Double-blind Phase|Physician Decision|1|||
25248466|NCT01969838|50564103|FG002|Double-blind Phase|Physician Decision|0|||
25248467|NCT01969838|50564104|FG003|Double-blind Phase|Physician Decision|0|||
25248468|NCT01969838|50564101|FG000|Double-blind Phase|Subject Decision|4|||
25329072|NCT00691210|50645316|FG003|Overall Study|Lack of Efficacy|1|||
25329073|NCT00691210|50645317|FG004|Overall Study|Lack of Efficacy|0|||
25329074|NCT00691210|50645318|FG005|Overall Study|Lack of Efficacy|1|||
25329075|NCT00691210|50645319|FG006|Overall Study|Lack of Efficacy|0|||
25329076|NCT00691210|50645320|FG007|Overall Study|Lack of Efficacy|0|||
25329077|NCT00691132|50645340|FG000|Overall Study|Adverse Event|2|||
25329078|NCT00691132|50645341|FG001|Overall Study|Adverse Event|3|||
25329079|NCT00691132|50645340|FG000|Overall Study|Withdrawal by Subject|10|||
25329080|NCT00691132|50645341|FG001|Overall Study|Withdrawal by Subject|10|||
25329081|NCT00855218|50645363|FG000|Overall Study|Adverse Event|43|||
25329082|NCT00855218|50645364|FG001|Overall Study|Adverse Event|27|||
24900721|NCT00577317|49994739|FG000|Overall Study|Study Terminated|0|||
24900722|NCT00577317|49994740|FG001|Overall Study|Study Terminated|2|||
25329083|NCT00855218|50645363|FG000|Overall Study|Withdrawal by Subject|10|||
25329084|NCT00855218|50645364|FG001|Overall Study|Withdrawal by Subject|6|||
24900723|NCT00734162|49994750|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
24900724|NCT00734162|49994751|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
24900725|NCT00734162|49994752|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
24900726|NCT00734162|49994753|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
25248469|NCT01969838|50564102|FG001|Double-blind Phase|Subject Decision|2|||
25248470|NCT01969838|50564103|FG002|Double-blind Phase|Subject Decision|0|||
25329085|NCT00855218|50645363|FG000|Overall Study|Physician Decision|18|||
25329086|NCT00855218|50645364|FG001|Overall Study|Physician Decision|11|||
25329087|NCT00855218|50645363|FG000|Overall Study|Lost to Follow-up|0|||
25248471|NCT01969838|50564104|FG003|Double-blind Phase|Subject Decision|0|||
25248472|NCT01969838|50564101|FG000|Double-blind Phase|Disease Progression|2|||
25248473|NCT01969838|50564102|FG001|Double-blind Phase|Disease Progression|0|||
25248474|NCT01969838|50564103|FG002|Double-blind Phase|Disease Progression|0|||
25248475|NCT01969838|50564104|FG003|Double-blind Phase|Disease Progression|0|||
25248476|NCT01969838|50564101|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
25329088|NCT00855218|50645364|FG001|Overall Study|Lost to Follow-up|1|||
25329089|NCT00855218|50645363|FG000|Overall Study|Protocol Violation|5|||
25329090|NCT00855218|50645364|FG001|Overall Study|Protocol Violation|9|||
25329091|NCT00855218|50645363|FG000|Overall Study|non-compliant with study drug|3|||
25329092|NCT00855218|50645364|FG001|Overall Study|non-compliant with study drug|1|||
25329093|NCT00855218|50645363|FG000|Overall Study|patient convenience|2|||
25248477|NCT01969838|50564102|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
25248478|NCT01969838|50564103|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
25248479|NCT01969838|50564104|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
25248480|NCT01969838|50564101|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
25248481|NCT01969838|50564102|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
25248482|NCT01969838|50564103|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
25248483|NCT01969838|50564104|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
25248484|NCT01969838|50564101|FG000|Open-label Phase|Adverse Event|0|||
25248485|NCT01969838|50564102|FG001|Open-label Phase|Adverse Event|0|||
25248486|NCT01969838|50564103|FG002|Open-label Phase|Adverse Event|37|||
25248487|NCT01969838|50564104|FG003|Open-label Phase|Adverse Event|49|||
25248488|NCT01969838|50564101|FG000|Open-label Phase|Disease Progression|0|||
25248489|NCT01969838|50564102|FG001|Open-label Phase|Disease Progression|0|||
25248490|NCT01969838|50564103|FG002|Open-label Phase|Disease Progression|26|||
25248491|NCT01969838|50564104|FG003|Open-label Phase|Disease Progression|27|||
25248492|NCT01969838|50564101|FG000|Open-label Phase|Lack of Efficacy|0|||
25248493|NCT01969838|50564102|FG001|Open-label Phase|Lack of Efficacy|0|||
25248494|NCT01969838|50564103|FG002|Open-label Phase|Lack of Efficacy|17|||
25248495|NCT01969838|50564104|FG003|Open-label Phase|Lack of Efficacy|19|||
25248496|NCT01969838|50564101|FG000|Open-label Phase|Subject Decision|0|||
25248497|NCT01969838|50564102|FG001|Open-label Phase|Subject Decision|0|||
25248498|NCT01969838|50564103|FG002|Open-label Phase|Subject Decision|14|||
25248499|NCT01969838|50564104|FG003|Open-label Phase|Subject Decision|15|||
25248500|NCT01969838|50564101|FG000|Open-label Phase|Death|0|||
25248501|NCT01969838|50564102|FG001|Open-label Phase|Death|0|||
25248502|NCT01969838|50564103|FG002|Open-label Phase|Death|13|||
25248503|NCT01969838|50564104|FG003|Open-label Phase|Death|11|||
25248504|NCT01969838|50564101|FG000|Open-label Phase|Physician Decision|0|||
25248505|NCT01969838|50564102|FG001|Open-label Phase|Physician Decision|0|||
25248506|NCT01969838|50564103|FG002|Open-label Phase|Physician Decision|9|||
25248507|NCT01969838|50564104|FG003|Open-label Phase|Physician Decision|14|||
25248508|NCT01969838|50564101|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
25248509|NCT01969838|50564102|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
25248510|NCT01969838|50564103|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
25248511|NCT01969838|50564104|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
25248512|NCT01165177|50564115|FG000|Overall Study|Serious Adverse Event|227|||
25248513|NCT01165177|50564116|FG001|Overall Study|Serious Adverse Event|235|||
25248514|NCT01165177|50564115|FG000|Overall Study|Withdrawal by Subject|368|||
25248515|NCT01165177|50564116|FG001|Overall Study|Withdrawal by Subject|354|||
25248516|NCT01165177|50564115|FG000|Overall Study|Protocol Violation|19|||
25248517|NCT01165177|50564116|FG001|Overall Study|Protocol Violation|21|||
25248518|NCT01165177|50564115|FG000|Overall Study|Non-serious adverse event|30|||
25248519|NCT01165177|50564116|FG001|Overall Study|Non-serious adverse event|18|||
25248520|NCT01165177|50564115|FG000|Overall Study|Other unspecified reasons|47|||
25248521|NCT01165177|50564116|FG001|Overall Study|Other unspecified reasons|35|||
25248522|NCT01165177|50564115|FG000|Overall Study|Suspected HZ episode|0|||
25248523|NCT01165177|50564116|FG001|Overall Study|Suspected HZ episode|2|||
25248524|NCT01165177|50564115|FG000|Overall Study|Lost to Follow-up|183|||
25248525|NCT01165177|50564116|FG001|Overall Study|Lost to Follow-up|194|||
25248526|NCT01165177|50564115|FG000|Overall Study|Migrated/ moved from study area|48|||
25248527|NCT01165177|50564116|FG001|Overall Study|Migrated/ moved from study area|43|||
25248528|NCT01165138|50564133|FG000|Overall Study|Adverse Event|0|||
25248529|NCT01165138|50564134|FG001|Overall Study|Adverse Event|1|||
25248530|NCT01165138|50564135|FG002|Overall Study|Adverse Event|0|||
25248531|NCT01165138|50564136|FG003|Overall Study|Adverse Event|2|||
25248532|NCT01165138|50564133|FG000|Overall Study|Lack of Efficacy|0|||
24900727|NCT00734162|49994750|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
24900728|NCT00734162|49994751|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
25248533|NCT01165138|50564134|FG001|Overall Study|Lack of Efficacy|32|||
25248534|NCT01165138|50564135|FG002|Overall Study|Lack of Efficacy|6|||
25248535|NCT01165138|50564136|FG003|Overall Study|Lack of Efficacy|7|||
25248536|NCT01165138|50564133|FG000|Overall Study|Protocol Violation|0|||
25248537|NCT01165138|50564134|FG001|Overall Study|Protocol Violation|7|||
25329094|NCT00855218|50645364|FG001|Overall Study|patient convenience|0|||
25248538|NCT01165138|50564135|FG002|Overall Study|Protocol Violation|0|||
25248539|NCT01165138|50564136|FG003|Overall Study|Protocol Violation|2|||
25248540|NCT01165138|50564133|FG000|Overall Study|Lost to Follow-up|0|||
25248541|NCT01165138|50564134|FG001|Overall Study|Lost to Follow-up|0|||
25248542|NCT01165138|50564135|FG002|Overall Study|Lost to Follow-up|1|||
25248543|NCT01165138|50564136|FG003|Overall Study|Lost to Follow-up|2|||
25248544|NCT01165138|50564133|FG000|Overall Study|Physician Decision|0|||
25248545|NCT01165138|50564134|FG001|Overall Study|Physician Decision|6|||
25248546|NCT01165138|50564135|FG002|Overall Study|Physician Decision|7|||
25248547|NCT01165138|50564136|FG003|Overall Study|Physician Decision|6|||
25248548|NCT01165138|50564133|FG000|Overall Study|Withdrawal by Subject|0|||
25248549|NCT01165138|50564134|FG001|Overall Study|Withdrawal by Subject|6|||
25248550|NCT01165138|50564135|FG002|Overall Study|Withdrawal by Subject|6|||
25248551|NCT01165138|50564136|FG003|Overall Study|Withdrawal by Subject|3|||
25248552|NCT01165021|50564144|FG000|Overall Study|Death|1|||
25248553|NCT01182844|50564150|FG000|Overall Study|Withdrawal by Subject|0|||
25329095|NCT00855218|50645363|FG000|Overall Study|technical problems|2|||
25329096|NCT00855218|50645364|FG001|Overall Study|technical problems|1|||
25329097|NCT00855218|50645363|FG000|Overall Study|Still treated with study medication|0|||
25329098|NCT00855218|50645364|FG001|Overall Study|Still treated with study medication|1|||
25329099|NCT00855218|50645363|FG000|Overall Study|Untreatable disease progression|54|||
25329100|NCT00855218|50645364|FG001|Overall Study|Untreatable disease progression|67|||
25329101|NCT00855218|50645363|FG000|Overall Study|Second malignancy|0|||
25329102|NCT00855218|50645364|FG001|Overall Study|Second malignancy|1|||
25329103|NCT00855218|50645363|FG000|Overall Study|Progression measurement proven|7|||
25329104|NCT00855218|50645364|FG001|Overall Study|Progression measurement proven|15|||
25329105|NCT00855218|50645363|FG000|Overall Study|Clinical endpoint reached|10|||
25329106|NCT00855218|50645364|FG001|Overall Study|Clinical endpoint reached|13|||
25329107|NCT01063348|50645372|FG000|Overall Study|Lost to Follow-up|3|||
25329108|NCT01063348|50645373|FG001|Overall Study|Lost to Follow-up|10|||
25329109|NCT00855062|50645381|FG000|Step1|Early Study Closure|5|||
25329110|NCT00855062|50645382|FG001|Step1|Early Study Closure|7|||
25329111|NCT00855062|50645381|FG000|Step1|Adverse Event|1|||
25329112|NCT00855062|50645382|FG001|Step1|Adverse Event|1|||
25329113|NCT00855062|50645381|FG000|Step1|Protocol Violation|1|||
25248554|NCT01182844|50564151|FG001|Overall Study|Withdrawal by Subject|2|||
25248555|NCT01164865|50564159|FG000|Overall Study|Lost to Follow-up|2|||
25248556|NCT01164865|50564160|FG001|Overall Study|Lost to Follow-up|1|||
25248557|NCT01164475|50564168|FG000|Overall Study|Lack of Efficacy|1|||
25248558|NCT01164475|50564169|FG001|Overall Study|Lack of Efficacy|0|||
25248559|NCT01164475|50564168|FG000|Overall Study|Other|0|||
25248560|NCT01164475|50564169|FG001|Overall Study|Other|1|||
25248561|NCT01164475|50564168|FG000|Overall Study|Progressive disease|0|||
25248562|NCT01164475|50564169|FG001|Overall Study|Progressive disease|1|||
25248563|NCT01164475|50564168|FG000|Overall Study|Protocol Violation|1|||
25248564|NCT01164475|50564169|FG001|Overall Study|Protocol Violation|0|||
25248565|NCT01164007|50564175|FG000|Overall Study|Adverse Event|5|||
25248566|NCT01164007|50564175|FG000|Overall Study|Progression of Disease|30|||
25248567|NCT01164007|50564175|FG000|Overall Study|Protocol Violation|1|||
25248568|NCT01164007|50564175|FG000|Overall Study|Withdrawal by Subject|1|||
25248569|NCT01164007|50564175|FG000|Overall Study|Medical Decision|3|||
25248570|NCT01163851|50564181|FG000|Overall Study|Site Closure|0|||
25248571|NCT01163851|50564182|FG001|Overall Study|Site Closure|1|||
25248572|NCT01163851|50564181|FG000|Overall Study|Enrolled but not treated|1|||
25248573|NCT01163851|50564182|FG001|Overall Study|Enrolled but not treated|0|||
25248574|NCT01163617|50564188|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
25329114|NCT00855062|50645382|FG001|Step1|Protocol Violation|0|||
25329115|NCT00855062|50645381|FG000|Step1|Pregnancy|1|||
25329116|NCT00855062|50645382|FG001|Step1|Pregnancy|0|||
25329117|NCT00855062|50645381|FG000|Step1|Withdrawal by Subject|2|||
25329118|NCT00855062|50645382|FG001|Step1|Withdrawal by Subject|3|||
25329119|NCT00855062|50645381|FG000|Step2|Early Study Closure|6|||
25329120|NCT00855062|50645382|FG001|Step2|Early Study Closure|2|||
24900729|NCT00734162|49994752|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
25248575|NCT01163617|50564189|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
25248576|NCT01163617|50564190|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
25248577|NCT01163617|50564191|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
25248578|NCT01163617|50564192|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
25248579|NCT01163617|50564193|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
25248580|NCT01163617|50564194|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
25329121|NCT00855062|50645381|FG000|Step2|Adverse Event|0|||
25329122|NCT00855062|50645382|FG001|Step2|Adverse Event|3|||
25329123|NCT00855062|50645381|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
25329124|NCT00855062|50645382|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
25329125|NCT00854906|50645388|FG000|Overall Study|One person had no ocular history|1|||
25329126|NCT00854828|50645399|FG000|Overall Study|Death|1|||
25329127|NCT00854828|50645400|FG001|Overall Study|Death|0|||
25329128|NCT00854828|50645401|FG002|Overall Study|Death|0|||
25329129|NCT00854828|50645402|FG003|Overall Study|Death|0|||
25329130|NCT00854828|50645399|FG000|Overall Study|Withdrawal by Subject|1|||
25329131|NCT00854828|50645400|FG001|Overall Study|Withdrawal by Subject|1|||
25329132|NCT00854828|50645401|FG002|Overall Study|Withdrawal by Subject|0|||
25329133|NCT00854828|50645402|FG003|Overall Study|Withdrawal by Subject|9|||
25329134|NCT00854828|50645399|FG000|Overall Study|Missed 24mo visit|1|||
25248581|NCT01163617|50564195|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
25248582|NCT01163617|50564188|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
25248583|NCT01163617|50564189|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
25248584|NCT01163617|50564190|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
25248585|NCT01163617|50564191|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
25248586|NCT01163617|50564192|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
25248587|NCT01163617|50564193|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
25248588|NCT01163617|50564194|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
25248589|NCT01163617|50564195|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
25248590|NCT01163617|50564188|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
25248591|NCT01163617|50564189|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
25248592|NCT01163617|50564190|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
25248593|NCT01163617|50564191|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
25248594|NCT01163617|50564192|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
25248595|NCT01163617|50564193|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
25248596|NCT01163617|50564194|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
25248597|NCT01163617|50564195|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
25248598|NCT01182337|50564217|FG000|Overall Study|Withdrawal by Subject|3|||
25248599|NCT01182337|50564218|FG001|Overall Study|Withdrawal by Subject|1|||
25248600|NCT01182337|50564217|FG000|Overall Study|Lost to Follow-up|0|||
25248601|NCT01182337|50564218|FG001|Overall Study|Lost to Follow-up|1|||
25248602|NCT01182298|50564225|FG000|Overall Study|Lack of Efficacy|4|||
25248603|NCT01182298|50564225|FG000|Overall Study|Withdrawal by Subject|2|||
25248604|NCT01163266|50564232|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
25248605|NCT01163266|50564233|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
25248606|NCT01163266|50564234|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
25248607|NCT01163266|50564232|FG000|Overall Study|Lack of Efficacy|1|||
25248608|NCT01163266|50564233|FG001|Overall Study|Lack of Efficacy|3|||
25248609|NCT01163266|50564234|FG002|Overall Study|Lack of Efficacy|1|||
25248610|NCT01163266|50564232|FG000|Overall Study|Noncompliance with Study Drug|0|||
25248611|NCT01163266|50564233|FG001|Overall Study|Noncompliance with Study Drug|2|||
25248612|NCT01163266|50564234|FG002|Overall Study|Noncompliance with Study Drug|0|||
25248613|NCT01163266|50564232|FG000|Overall Study|Protocol Deviations|2|||
25248614|NCT01163266|50564233|FG001|Overall Study|Protocol Deviations|2|||
25248615|NCT01163266|50564234|FG002|Overall Study|Protocol Deviations|5|||
25248616|NCT01163266|50564232|FG000|Overall Study|Withdrawal of Consent|5|||
25248617|NCT01163266|50564233|FG001|Overall Study|Withdrawal of Consent|7|||
25248618|NCT01163266|50564234|FG002|Overall Study|Withdrawal of Consent|3|||
25248619|NCT01163266|50564232|FG000|Overall Study|Lost to Follow-up|7|||
25248620|NCT01163266|50564233|FG001|Overall Study|Lost to Follow-up|7|||
25248621|NCT01163266|50564234|FG002|Overall Study|Lost to Follow-up|10|||
25329135|NCT00854828|50645400|FG001|Overall Study|Missed 24mo visit|1|||
25329136|NCT00854828|50645401|FG002|Overall Study|Missed 24mo visit|8|||
25329137|NCT00854828|50645402|FG003|Overall Study|Missed 24mo visit|8|||
25329138|NCT00847730|50645412|FG000|Overall Study|Multiple interruptions in therapy|8|||
25329139|NCT00600119|50645422|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
25329140|NCT00600119|50645423|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
25329141|NCT00600119|50645424|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
25329142|NCT00600119|50645425|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
25248622|NCT01163266|50564232|FG000|Overall Study|Other|1|||
25248623|NCT01163266|50564233|FG001|Overall Study|Other|1|||
25248624|NCT01163266|50564234|FG002|Overall Study|Other|2|||
25248625|NCT01163149|50564292|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
25329143|NCT00600119|50645426|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
25329144|NCT00600119|50645427|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
25329145|NCT00600119|50645422|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
25329146|NCT00600119|50645423|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
24900730|NCT00734162|49994753|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
25248626|NCT01163149|50564293|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
25329147|NCT00600119|50645424|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
25329148|NCT00600119|50645425|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
25329149|NCT00600119|50645426|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
25248627|NCT01163149|50564294|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
25248628|NCT01163149|50564292|FG000|Extension Treatment Period|Adverse Event|0|||
25248629|NCT01163149|50564293|FG001|Extension Treatment Period|Adverse Event|1|||
25329150|NCT00600119|50645427|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
25329151|NCT00600119|50645422|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
25329152|NCT00600119|50645423|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
25329153|NCT00600119|50645424|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
25329154|NCT00600119|50645425|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
25329155|NCT00600119|50645426|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
25248630|NCT01163149|50564294|FG002|Extension Treatment Period|Adverse Event|0|||
25248631|NCT01163149|50564292|FG000|Extension Treatment Period|Noncompliance|0|||
25248632|NCT01163149|50564293|FG001|Extension Treatment Period|Noncompliance|0|||
25248633|NCT01163149|50564294|FG002|Extension Treatment Period|Noncompliance|1|||
25248634|NCT01163032|50564319|FG000|Randomization Phase|Withdrawal by Subject|2|||
25248635|NCT01163032|50564320|FG001|Randomization Phase|Withdrawal by Subject|3|||
25248636|NCT01163032|50564321|FG002|Randomization Phase|Withdrawal by Subject|0|||
25248637|NCT01163032|50564319|FG000|Randomization Phase|Adverse Event|3|||
25248638|NCT01163032|50564320|FG001|Randomization Phase|Adverse Event|3|||
25248639|NCT01163032|50564321|FG002|Randomization Phase|Adverse Event|0|||
25248640|NCT01163032|50564319|FG000|Randomization Phase|Protocol Violation|0|||
25248641|NCT01163032|50564320|FG001|Randomization Phase|Protocol Violation|1|||
25248642|NCT01163032|50564321|FG002|Randomization Phase|Protocol Violation|0|||
25248643|NCT01163032|50564319|FG000|Randomization Phase|Various*|5|||
25248644|NCT01163032|50564320|FG001|Randomization Phase|Various*|4|||
25248645|NCT01163032|50564321|FG002|Randomization Phase|Various*|0|||
25248646|NCT01163032|50564319|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
25248647|NCT01163032|50564320|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
25248648|NCT01163032|50564321|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
25329156|NCT00600119|50645427|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
25329157|NCT00600119|50645422|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
25329158|NCT00600119|50645423|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
25329159|NCT00600119|50645424|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
25329160|NCT00600119|50645425|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
25329161|NCT00600119|50645426|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
25329162|NCT00600119|50645427|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
25329163|NCT00600119|50645422|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
25329164|NCT00600119|50645423|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
25329165|NCT00600119|50645424|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
25329166|NCT00600119|50645425|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
25329167|NCT00600119|50645426|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
25329168|NCT00600119|50645427|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
25329169|NCT00600119|50645422|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
25329170|NCT00600119|50645423|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
25329171|NCT00600119|50645424|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
25329172|NCT00600119|50645425|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
25329173|NCT00600119|50645426|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
25329174|NCT00600119|50645427|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
25329175|NCT00600119|50645422|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
25329176|NCT00600119|50645423|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
25329177|NCT00600119|50645424|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
25329178|NCT00600119|50645425|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
25329179|NCT00600119|50645426|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
25329180|NCT00600119|50645427|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
25329181|NCT00600119|50645422|FG000|Double-blind Treatment Period|Other|0|||
25329182|NCT00600119|50645423|FG001|Double-blind Treatment Period|Other|0|||
25329183|NCT00600119|50645424|FG002|Double-blind Treatment Period|Other|0|||
25329184|NCT00600119|50645425|FG003|Double-blind Treatment Period|Other|0|||
25329185|NCT00600119|50645426|FG004|Double-blind Treatment Period|Other|2|||
25329186|NCT00600119|50645427|FG005|Double-blind Treatment Period|Other|1|||
25329187|NCT00600119|50645422|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
25329188|NCT00600119|50645423|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
25329189|NCT00600119|50645424|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
25329190|NCT00600119|50645425|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
25329191|NCT00600119|50645426|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
25329192|NCT00600119|50645427|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
25248649|NCT01163032|50564319|FG000|Open Label Extension Phase|Adverse Event|0|||
25248650|NCT01163032|50564320|FG001|Open Label Extension Phase|Adverse Event|0|||
25248651|NCT01163032|50564321|FG002|Open Label Extension Phase|Adverse Event|3|||
25329193|NCT00600119|50645422|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
25329194|NCT00600119|50645423|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
25329195|NCT00600119|50645424|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
25329196|NCT00600119|50645425|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
25329197|NCT00600119|50645426|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
25329198|NCT00600119|50645427|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
25329199|NCT00600119|50645422|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
25329200|NCT00600119|50645423|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
25329201|NCT00600119|50645424|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
25329202|NCT00600119|50645425|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
25329203|NCT00600119|50645426|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
25329204|NCT00600119|50645427|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
25329205|NCT00600119|50645422|FG000|Double-blind Treatment Period|Physician Decision|2|||
25329206|NCT00600119|50645423|FG001|Double-blind Treatment Period|Physician Decision|0|||
25329207|NCT00600119|50645424|FG002|Double-blind Treatment Period|Physician Decision|0|||
25329208|NCT00600119|50645425|FG003|Double-blind Treatment Period|Physician Decision|0|||
25329209|NCT00600119|50645426|FG004|Double-blind Treatment Period|Physician Decision|0|||
25329210|NCT00600119|50645427|FG005|Double-blind Treatment Period|Physician Decision|0|||
25329211|NCT00600119|50645422|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
25329212|NCT00600119|50645423|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
25329213|NCT00600119|50645424|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
25329214|NCT00600119|50645425|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
25329215|NCT00600119|50645426|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
25329216|NCT00600119|50645427|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
25329217|NCT00600119|50645422|FG000|Double-blind Treatment Period|Adverse Event|1|||
25329218|NCT00600119|50645423|FG001|Double-blind Treatment Period|Adverse Event|1|||
25329219|NCT00600119|50645424|FG002|Double-blind Treatment Period|Adverse Event|0|||
25329220|NCT00600119|50645425|FG003|Double-blind Treatment Period|Adverse Event|1|||
25329221|NCT00600119|50645426|FG004|Double-blind Treatment Period|Adverse Event|2|||
25329222|NCT00600119|50645427|FG005|Double-blind Treatment Period|Adverse Event|10|||
25329223|NCT00600119|50645422|FG000|Follow-up Period|Adverse Event|0|||
25329224|NCT00600119|50645423|FG001|Follow-up Period|Adverse Event|0|||
25329225|NCT00600119|50645424|FG002|Follow-up Period|Adverse Event|0|||
25329226|NCT00600119|50645425|FG003|Follow-up Period|Adverse Event|0|||
25329227|NCT00600119|50645426|FG004|Follow-up Period|Adverse Event|0|||
25329228|NCT00600119|50645427|FG005|Follow-up Period|Adverse Event|1|||
25329229|NCT00600119|50645422|FG000|Follow-up Period|Other|1|||
25329230|NCT00600119|50645423|FG001|Follow-up Period|Other|0|||
25329231|NCT00600119|50645424|FG002|Follow-up Period|Other|0|||
25329232|NCT00600119|50645425|FG003|Follow-up Period|Other|0|||
25329233|NCT00600119|50645426|FG004|Follow-up Period|Other|0|||
25329234|NCT00600119|50645427|FG005|Follow-up Period|Other|0|||
25329235|NCT00866294|50645444|FG000|Overall Study|Adverse Event|12|||
25329236|NCT00866294|50645445|FG001|Overall Study|Adverse Event|13|||
25329237|NCT00866294|50645446|FG002|Overall Study|Adverse Event|9|||
25329238|NCT00866294|50645444|FG000|Overall Study|Lack of Efficacy|7|||
25329239|NCT00866294|50645445|FG001|Overall Study|Lack of Efficacy|1|||
25329240|NCT00866294|50645446|FG002|Overall Study|Lack of Efficacy|0|||
25329241|NCT00866294|50645444|FG000|Overall Study|Protocol Violation|2|||
25329242|NCT00866294|50645445|FG001|Overall Study|Protocol Violation|0|||
25329243|NCT00866294|50645446|FG002|Overall Study|Protocol Violation|0|||
25329244|NCT00866294|50645444|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
25329245|NCT00866294|50645445|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
25329246|NCT00866294|50645446|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
25329247|NCT00866294|50645444|FG000|Overall Study|Lost to Follow-up|1|||
25329248|NCT00866294|50645445|FG001|Overall Study|Lost to Follow-up|3|||
25329249|NCT00866294|50645446|FG002|Overall Study|Lost to Follow-up|0|||
25329250|NCT00866294|50645444|FG000|Overall Study|Physician Decision|6|||
25329251|NCT00866294|50645445|FG001|Overall Study|Physician Decision|2|||
25329252|NCT00866294|50645446|FG002|Overall Study|Physician Decision|1|||
24900731|NCT00734162|49994750|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
24900732|NCT00734162|49994751|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
25329253|NCT00854360|50645466|FG000|Overall Study|Adverse Event|0|||
25329254|NCT00854360|50645467|FG001|Overall Study|Adverse Event|1|||
25329255|NCT00854360|50645468|FG002|Overall Study|Adverse Event|2|||
25329256|NCT00854360|50645469|FG003|Overall Study|Adverse Event|6|||
25329257|NCT00854360|50645466|FG000|Overall Study|Withdrawal by Subject|0|||
25329258|NCT00854360|50645467|FG001|Overall Study|Withdrawal by Subject|0|||
25329259|NCT00854360|50645468|FG002|Overall Study|Withdrawal by Subject|0|||
25329260|NCT00854360|50645469|FG003|Overall Study|Withdrawal by Subject|1|||
25329261|NCT00854360|50645466|FG000|Overall Study|Pregnancy|0|||
25329262|NCT00854360|50645467|FG001|Overall Study|Pregnancy|1|||
25329263|NCT00854360|50645468|FG002|Overall Study|Pregnancy|0|||
25329264|NCT00854360|50645469|FG003|Overall Study|Pregnancy|0|||
25329265|NCT00854360|50645466|FG000|Overall Study|Lack of Efficacy|2|||
25329266|NCT00854360|50645467|FG001|Overall Study|Lack of Efficacy|1|||
25329267|NCT00854360|50645468|FG002|Overall Study|Lack of Efficacy|0|||
25329268|NCT00854360|50645469|FG003|Overall Study|Lack of Efficacy|0|||
25329269|NCT00854360|50645466|FG000|Overall Study|Other|0|||
25329270|NCT00854360|50645467|FG001|Overall Study|Other|0|||
25248652|NCT01163032|50564319|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
25248653|NCT01163032|50564320|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
25248654|NCT01163032|50564321|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
25248655|NCT01163032|50564319|FG000|Open Label Extension Phase|Protocol Violation|0|||
25248656|NCT01163032|50564320|FG001|Open Label Extension Phase|Protocol Violation|0|||
25329271|NCT00854360|50645468|FG002|Overall Study|Other|0|||
25329272|NCT00854360|50645469|FG003|Overall Study|Other|3|||
25329273|NCT00853970|50645481|FG000|Overall Study|Withdrawal by Subject|2|||
25329274|NCT00853970|50645482|FG001|Overall Study|Withdrawal by Subject|1|||
25329275|NCT00853970|50645481|FG000|Overall Study|Cancelled surgery|4|||
25329276|NCT00853970|50645482|FG001|Overall Study|Cancelled surgery|2|||
25248657|NCT01163032|50564321|FG002|Open Label Extension Phase|Protocol Violation|1|||
25248658|NCT01163032|50564319|FG000|Open Label Extension Phase|Study Termination|0|||
25248659|NCT01163032|50564320|FG001|Open Label Extension Phase|Study Termination|0|||
25248660|NCT01163032|50564321|FG002|Open Label Extension Phase|Study Termination|7|||
25248661|NCT01163032|50564319|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
25248662|NCT01163032|50564320|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
25248663|NCT01163032|50564321|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
25248664|NCT01162486|50564334|FG000|Overall Study|low ANC|1|||
25329277|NCT00865904|50645510|FG000|Overall Study|Randomized but not Treated|2|||
25329278|NCT00865904|50645511|FG001|Overall Study|Randomized but not Treated|0|||
25329279|NCT00865904|50645512|FG002|Overall Study|Randomized but not Treated|0|||
25329280|NCT00865904|50645513|FG003|Overall Study|Randomized but not Treated|1|||
25329281|NCT00865904|50645514|FG004|Overall Study|Randomized but not Treated|1|||
25329282|NCT00599339|50645530|FG000|Overall Study|Adverse Event|79|||
25329283|NCT00599339|50645530|FG000|Overall Study|Withdrawal by Subject|137|||
25329284|NCT00599339|50645530|FG000|Overall Study|Other Reason|179|||
25329285|NCT00599339|50645530|FG000|Overall Study|Lost to Follow-up|221|||
25329286|NCT00599339|50645530|FG000|Overall Study|No valid data consent|36|||
25329287|NCT00599339|50645530|FG000|Overall Study|Study Termination Status Unknown|12|||
25329288|NCT00599027|50645554|FG000|Overall Study|Withdrawal by Subject|1|||
25329289|NCT00599027|50645555|FG001|Overall Study|Withdrawal by Subject|1|||
25329290|NCT00599027|50645554|FG000|Overall Study|Adverse Event|0|||
25329291|NCT00599027|50645555|FG001|Overall Study|Adverse Event|1|||
25329292|NCT00599027|50645554|FG000|Overall Study|Treatment Failure|0|||
25329293|NCT00599027|50645555|FG001|Overall Study|Treatment Failure|1|||
25329294|NCT02881151|50645570|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
25329295|NCT00689728|50645578|FG000|Double-Blind Treatment|Adverse Event|1|||
25329296|NCT00689728|50645579|FG001|Double-Blind Treatment|Adverse Event|0|||
25329297|NCT00689728|50645580|FG002|Double-Blind Treatment|Adverse Event|0|||
25329298|NCT00689728|50645578|FG000|Double-Blind Treatment|Protocol Violation|0|||
25329299|NCT00689728|50645579|FG001|Double-Blind Treatment|Protocol Violation|0|||
25329300|NCT00689728|50645580|FG002|Double-Blind Treatment|Protocol Violation|1|||
25329301|NCT00689728|50645578|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
25329302|NCT00689728|50645579|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
25329303|NCT00689728|50645580|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
25329304|NCT00689728|50645578|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
25329305|NCT00689728|50645579|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
25329306|NCT00689728|50645580|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
25077810|NCT03318523|50185670|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
25248665|NCT01162486|50564335|FG001|Overall Study|low ANC|0|||
25248666|NCT01162486|50564336|FG002|Overall Study|low ANC|0|||
24900733|NCT00734162|49994752|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
24900734|NCT00734162|49994753|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
25248667|NCT01162486|50564337|FG003|Overall Study|low ANC|0|||
25329307|NCT00689728|50645578|FG000|Rescue|Adverse Event|0|||
25329308|NCT00689728|50645579|FG001|Rescue|Adverse Event|1|||
25329309|NCT00689728|50645580|FG002|Rescue|Adverse Event|0|||
25329310|NCT00689728|50645578|FG000|Rescue|Withdrawal by Subject|1|||
25329311|NCT00689728|50645579|FG001|Rescue|Withdrawal by Subject|1|||
24900735|NCT00734162|49994750|FG000|Open-Label Phase|Withdrew Consent|1|||
25248668|NCT01162486|50564338|FG004|Overall Study|low ANC|0|||
25248669|NCT01162486|50564334|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
25329312|NCT00689728|50645580|FG002|Rescue|Withdrawal by Subject|1|||
25329313|NCT00689728|50645578|FG000|Optional Follow-Up|Adverse Event|1|||
25329314|NCT00689728|50645579|FG001|Optional Follow-Up|Adverse Event|0|||
25329315|NCT00689728|50645580|FG002|Optional Follow-Up|Adverse Event|0|||
25329316|NCT00689728|50645578|FG000|Optional Follow-Up|Lack of Efficacy|0|||
25329317|NCT00689728|50645579|FG001|Optional Follow-Up|Lack of Efficacy|1|||
25329318|NCT00689728|50645580|FG002|Optional Follow-Up|Lack of Efficacy|1|||
25248670|NCT01162486|50564335|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
25248671|NCT01162486|50564336|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
25248672|NCT01162486|50564337|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
25248673|NCT01162486|50564338|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
25329319|NCT00689728|50645578|FG000|Optional Follow-Up|Lost to Follow-up|0|||
25329320|NCT00689728|50645579|FG001|Optional Follow-Up|Lost to Follow-up|1|||
25329321|NCT00689728|50645580|FG002|Optional Follow-Up|Lost to Follow-up|1|||
25329322|NCT00689728|50645578|FG000|Optional Follow-Up|Protocol Violation|0|||
25329323|NCT00689728|50645579|FG001|Optional Follow-Up|Protocol Violation|0|||
25329324|NCT00689728|50645580|FG002|Optional Follow-Up|Protocol Violation|1|||
24900736|NCT00734162|49994751|FG001|Open-Label Phase|Withdrew Consent|0|||
24900737|NCT00734162|49994752|FG002|Open-Label Phase|Withdrew Consent|1|||
25329325|NCT00689728|50645578|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
25329326|NCT00689728|50645579|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
25329327|NCT00689728|50645580|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
25329328|NCT00691054|50645609|FG000|Overall Study|Withdrawal by Subject|1|||
25329329|NCT00598871|50645617|FG000|Overall Study|Adverse Event|0|||
25329330|NCT00598871|50645618|FG001|Overall Study|Adverse Event|1|||
25329331|NCT00690820|50645626|FG000|Period 1|Withdrawal by Subject|0|||
25329332|NCT00690820|50645627|FG001|Period 1|Withdrawal by Subject|1|||
25329333|NCT00689338|50645633|FG000|Overall Study|Death|65|||
25329334|NCT00689338|50645633|FG000|Overall Study|Adverse Event|13|||
25329335|NCT00689338|50645633|FG000|Overall Study|Insufficient Clinical Response|1|||
25329336|NCT00689338|50645633|FG000|Overall Study|Lack of Efficacy|6|||
25329337|NCT00689338|50645633|FG000|Overall Study|Other|8|||
25329338|NCT00689338|50645633|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
25329339|NCT00689338|50645633|FG000|Overall Study|Lost to Follow-up|5|||
25329340|NCT00689338|50645633|FG000|Overall Study|Withdrawal by Subject|3|||
25329341|NCT00689338|50645633|FG000|Overall Study|Protocol Violation|15|||
25329342|NCT00686998|50645640|FG000|Overall Study|Adverse Event|3|||
25329343|NCT00686998|50645641|FG001|Overall Study|Adverse Event|2|||
25329344|NCT00686998|50645642|FG002|Overall Study|Adverse Event|1|||
25329345|NCT00686998|50645640|FG000|Overall Study|Withdrawal by Subject|2|||
24900738|NCT00734162|49994753|FG003|Open-Label Phase|Withdrew Consent|1|||
24900739|NCT00734162|49994750|FG000|Open-Label Phase|Lost to Follow-up|1|||
24900740|NCT00734162|49994751|FG001|Open-Label Phase|Lost to Follow-up|2|||
24900741|NCT00734162|49994752|FG002|Open-Label Phase|Lost to Follow-up|0|||
24900742|NCT00734162|49994753|FG003|Open-Label Phase|Lost to Follow-up|1|||
24900743|NCT00734162|49994750|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
24900744|NCT00734162|49994751|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
24900745|NCT00734162|49994752|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
24900746|NCT00734162|49994753|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
24900747|NCT00790751|49994771|FG000|Overall Study|Protocol non-compliance|16|||
24900748|NCT00790751|49994772|FG001|Overall Study|Protocol non-compliance|16|||
24900749|NCT00790751|49994773|FG002|Overall Study|Protocol non-compliance|10|||
24900750|NCT00790751|49994774|FG003|Overall Study|Protocol non-compliance|11|||
24900751|NCT00790751|49994771|FG000|Overall Study|Lost to Follow-up|4|||
24900752|NCT00790751|49994772|FG001|Overall Study|Lost to Follow-up|9|||
25248674|NCT01162486|50564334|FG000|Overall Study|elevated LFTs|0|||
25248675|NCT01162486|50564335|FG001|Overall Study|elevated LFTs|0|||
25248676|NCT01162486|50564336|FG002|Overall Study|elevated LFTs|1|||
25248677|NCT01162486|50564337|FG003|Overall Study|elevated LFTs|0|||
25248678|NCT01162486|50564338|FG004|Overall Study|elevated LFTs|0|||
25248679|NCT01162486|50564334|FG000|Overall Study|Pregnancy|0|||
25248680|NCT01162486|50564335|FG001|Overall Study|Pregnancy|0|||
25248681|NCT01162486|50564336|FG002|Overall Study|Pregnancy|0|||
25248682|NCT01162486|50564337|FG003|Overall Study|Pregnancy|1|||
25248683|NCT01162486|50564338|FG004|Overall Study|Pregnancy|0|||
25248684|NCT01162135|50564354|FG000|Overall Study|Withdrawal by Subject|1|||
25248685|NCT01162135|50564354|FG000|Overall Study|Severe back pain|1|||
25248686|NCT01162135|50564354|FG000|Overall Study|Ineligible|1|||
25248687|NCT01161628|50564358|FG000|Overall Study|Death|6|||
25248688|NCT01161628|50564358|FG000|Overall Study|Lack of Efficacy|2|||
25248689|NCT01161472|50564362|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
25329346|NCT00686998|50645641|FG001|Overall Study|Withdrawal by Subject|1|||
24900753|NCT00790751|49994773|FG002|Overall Study|Lost to Follow-up|4|||
24900754|NCT00790751|49994774|FG003|Overall Study|Lost to Follow-up|5|||
24900755|NCT00790751|49994771|FG000|Overall Study|Adverse Event|5|||
25248690|NCT01161472|50564363|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
25248691|NCT01161472|50564364|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
25329347|NCT00686998|50645642|FG002|Overall Study|Withdrawal by Subject|2|||
25329348|NCT00686998|50645640|FG000|Overall Study|Lack of Efficacy|7|||
25329349|NCT00686998|50645641|FG001|Overall Study|Lack of Efficacy|5|||
25329350|NCT00686998|50645642|FG002|Overall Study|Lack of Efficacy|0|||
25329351|NCT00686998|50645640|FG000|Overall Study|Other|0|||
25329352|NCT00686998|50645641|FG001|Overall Study|Other|0|||
25329353|NCT00686998|50645642|FG002|Overall Study|Other|1|||
25329354|NCT00686998|50645640|FG000|Overall Study|Safety Reasons|1|||
25329355|NCT00686998|50645641|FG001|Overall Study|Safety Reasons|0|||
25329356|NCT00686998|50645642|FG002|Overall Study|Safety Reasons|0|||
25329357|NCT00848718|50645663|FG000|Overall Study|Adverse Event|2|||
25329358|NCT00848718|50645664|FG001|Overall Study|Adverse Event|2|||
25329359|NCT00848718|50645665|FG002|Overall Study|Adverse Event|1|||
25329360|NCT00848718|50645666|FG003|Overall Study|Adverse Event|1|||
25329361|NCT00848718|50645667|FG004|Overall Study|Adverse Event|1|||
25329362|NCT00848718|50645668|FG005|Overall Study|Adverse Event|0|||
25329363|NCT00848718|50645669|FG006|Overall Study|Adverse Event|0|||
25329364|NCT00848718|50645670|FG007|Overall Study|Adverse Event|1|||
25329365|NCT00848718|50645671|FG008|Overall Study|Adverse Event|1|||
25329366|NCT00848718|50645672|FG009|Overall Study|Adverse Event|0|||
25329367|NCT00848718|50645673|FG010|Overall Study|Adverse Event|0|||
25329368|NCT00848718|50645674|FG011|Overall Study|Adverse Event|0|||
25329369|NCT00848718|50645675|FG012|Overall Study|Adverse Event|2|||
25329370|NCT00848718|50645663|FG000|Overall Study|Lack of Efficacy|0|||
25329371|NCT00848718|50645664|FG001|Overall Study|Lack of Efficacy|0|||
25329372|NCT00848718|50645665|FG002|Overall Study|Lack of Efficacy|1|||
25329373|NCT00848718|50645666|FG003|Overall Study|Lack of Efficacy|0|||
25329374|NCT00848718|50645667|FG004|Overall Study|Lack of Efficacy|0|||
25329375|NCT00848718|50645668|FG005|Overall Study|Lack of Efficacy|0|||
25329376|NCT00848718|50645669|FG006|Overall Study|Lack of Efficacy|1|||
25329377|NCT00848718|50645670|FG007|Overall Study|Lack of Efficacy|0|||
25329378|NCT00848718|50645671|FG008|Overall Study|Lack of Efficacy|0|||
25329379|NCT00848718|50645672|FG009|Overall Study|Lack of Efficacy|0|||
25329380|NCT00848718|50645673|FG010|Overall Study|Lack of Efficacy|0|||
25329381|NCT00848718|50645674|FG011|Overall Study|Lack of Efficacy|0|||
25329382|NCT00848718|50645675|FG012|Overall Study|Lack of Efficacy|0|||
25329383|NCT00848718|50645663|FG000|Overall Study|Physician Decision|0|||
25329384|NCT00848718|50645664|FG001|Overall Study|Physician Decision|1|||
25329385|NCT00848718|50645665|FG002|Overall Study|Physician Decision|0|||
25329386|NCT00848718|50645666|FG003|Overall Study|Physician Decision|0|||
25329387|NCT00848718|50645667|FG004|Overall Study|Physician Decision|1|||
25329388|NCT00848718|50645668|FG005|Overall Study|Physician Decision|1|||
25329389|NCT00848718|50645669|FG006|Overall Study|Physician Decision|0|||
25329390|NCT00848718|50645670|FG007|Overall Study|Physician Decision|0|||
25329391|NCT00848718|50645671|FG008|Overall Study|Physician Decision|1|||
25329392|NCT00848718|50645672|FG009|Overall Study|Physician Decision|2|||
25329393|NCT00848718|50645673|FG010|Overall Study|Physician Decision|0|||
25329394|NCT00848718|50645674|FG011|Overall Study|Physician Decision|0|||
25329395|NCT00848718|50645675|FG012|Overall Study|Physician Decision|1|||
25329396|NCT00848718|50645663|FG000|Overall Study|Progressive disease before treatment|1|||
25329397|NCT00848718|50645664|FG001|Overall Study|Progressive disease before treatment|5|||
25329398|NCT00848718|50645665|FG002|Overall Study|Progressive disease before treatment|1|||
25329399|NCT00848718|50645666|FG003|Overall Study|Progressive disease before treatment|3|||
25329400|NCT00848718|50645667|FG004|Overall Study|Progressive disease before treatment|4|||
25329401|NCT00848718|50645668|FG005|Overall Study|Progressive disease before treatment|4|||
25329402|NCT00848718|50645669|FG006|Overall Study|Progressive disease before treatment|2|||
25329403|NCT00848718|50645670|FG007|Overall Study|Progressive disease before treatment|1|||
25329404|NCT00848718|50645671|FG008|Overall Study|Progressive disease before treatment|2|||
25329405|NCT00848718|50645672|FG009|Overall Study|Progressive disease before treatment|7|||
25329406|NCT00848718|50645673|FG010|Overall Study|Progressive disease before treatment|3|||
25329407|NCT00848718|50645674|FG011|Overall Study|Progressive disease before treatment|6|||
25329408|NCT00848718|50645675|FG012|Overall Study|Progressive disease before treatment|2|||
25329409|NCT00848718|50645663|FG000|Overall Study|Protocol Violation|0|||
25329410|NCT00848718|50645664|FG001|Overall Study|Protocol Violation|1|||
25329411|NCT00848718|50645665|FG002|Overall Study|Protocol Violation|0|||
25329412|NCT00848718|50645666|FG003|Overall Study|Protocol Violation|0|||
25329413|NCT00848718|50645667|FG004|Overall Study|Protocol Violation|0|||
25329414|NCT00848718|50645668|FG005|Overall Study|Protocol Violation|0|||
25329415|NCT00848718|50645669|FG006|Overall Study|Protocol Violation|0|||
25329416|NCT00848718|50645670|FG007|Overall Study|Protocol Violation|1|||
25329417|NCT00848718|50645671|FG008|Overall Study|Protocol Violation|0|||
25329418|NCT00848718|50645672|FG009|Overall Study|Protocol Violation|0|||
25329419|NCT00848718|50645673|FG010|Overall Study|Protocol Violation|0|||
25329420|NCT00848718|50645674|FG011|Overall Study|Protocol Violation|0|||
25329421|NCT00848718|50645675|FG012|Overall Study|Protocol Violation|1|||
25329422|NCT00848718|50645663|FG000|Overall Study|Withdrawal by Subject|1|||
25329423|NCT00848718|50645664|FG001|Overall Study|Withdrawal by Subject|0|||
25329424|NCT00848718|50645665|FG002|Overall Study|Withdrawal by Subject|0|||
25329425|NCT00848718|50645666|FG003|Overall Study|Withdrawal by Subject|1|||
25329426|NCT00848718|50645667|FG004|Overall Study|Withdrawal by Subject|0|||
25329427|NCT00848718|50645668|FG005|Overall Study|Withdrawal by Subject|0|||
25329428|NCT00848718|50645669|FG006|Overall Study|Withdrawal by Subject|0|||
25329429|NCT00848718|50645670|FG007|Overall Study|Withdrawal by Subject|0|||
25329430|NCT00848718|50645671|FG008|Overall Study|Withdrawal by Subject|0|||
25329431|NCT00848718|50645672|FG009|Overall Study|Withdrawal by Subject|0|||
25248692|NCT01161472|50564365|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
25248693|NCT01161043|50564375|FG000|Overall Study|Withdrawal by Subject|3|||
25248694|NCT01160770|50564379|FG000|Overall Study|Adverse Event|10|||
25248695|NCT01160770|50564379|FG000|Overall Study|Protocol Violation|2|||
25248696|NCT01160770|50564379|FG000|Overall Study|Subject/parent/caregiver request|33|||
25248697|NCT01160770|50564379|FG000|Overall Study|Physician Decision|1|||
25248698|NCT01160770|50564379|FG000|Overall Study|Lost to Follow-up|7|||
25248699|NCT01160770|50564379|FG000|Overall Study|Study termination or sponsor request|1|||
25248700|NCT01160770|50564379|FG000|Overall Study|Death|9|||
25248701|NCT01160770|50564379|FG000|Overall Study|Lack of Efficacy|15|||
25248702|NCT01160770|50564379|FG000|Overall Study|Other Reasons|1|||
25329432|NCT00848718|50645673|FG010|Overall Study|Withdrawal by Subject|1|||
25329433|NCT00848718|50645674|FG011|Overall Study|Withdrawal by Subject|0|||
25329434|NCT00848718|50645675|FG012|Overall Study|Withdrawal by Subject|0|||
25329435|NCT00848718|50645663|FG000|Overall Study|Progressive disease during treatment|3|||
25329436|NCT00848718|50645664|FG001|Overall Study|Progressive disease during treatment|0|||
25329437|NCT00848718|50645665|FG002|Overall Study|Progressive disease during treatment|3|||
25329438|NCT00848718|50645666|FG003|Overall Study|Progressive disease during treatment|0|||
25329439|NCT00848718|50645667|FG004|Overall Study|Progressive disease during treatment|0|||
25329440|NCT00848718|50645668|FG005|Overall Study|Progressive disease during treatment|0|||
25329441|NCT00848718|50645669|FG006|Overall Study|Progressive disease during treatment|0|||
25329442|NCT00848718|50645670|FG007|Overall Study|Progressive disease during treatment|2|||
25329443|NCT00848718|50645671|FG008|Overall Study|Progressive disease during treatment|0|||
25329444|NCT00848718|50645672|FG009|Overall Study|Progressive disease during treatment|0|||
25329445|NCT00848718|50645673|FG010|Overall Study|Progressive disease during treatment|0|||
25329446|NCT00848718|50645674|FG011|Overall Study|Progressive disease during treatment|0|||
25329447|NCT00848718|50645675|FG012|Overall Study|Progressive disease during treatment|2|||
25329448|NCT00883337|50645712|FG000|Core Treatment Period|Adverse Event|9|||
25329449|NCT00883337|50645713|FG001|Core Treatment Period|Adverse Event|12|||
25329450|NCT00883337|50645714|FG002|Core Treatment Period|Adverse Event|22|||
25329451|NCT00883337|50645712|FG000|Core Treatment Period|Lack of Efficacy|7|||
25329452|NCT00883337|50645713|FG001|Core Treatment Period|Lack of Efficacy|4|||
25329453|NCT00883337|50645714|FG002|Core Treatment Period|Lack of Efficacy|2|||
25329454|NCT00883337|50645712|FG000|Core Treatment Period|Lost to Follow-up|1|||
25329455|NCT00883337|50645713|FG001|Core Treatment Period|Lost to Follow-up|1|||
25329456|NCT00883337|50645714|FG002|Core Treatment Period|Lost to Follow-up|0|||
25329457|NCT00883337|50645712|FG000|Core Treatment Period|Withdrawal by Subject|2|||
25329458|NCT00883337|50645713|FG001|Core Treatment Period|Withdrawal by Subject|2|||
25329459|NCT00883337|50645714|FG002|Core Treatment Period|Withdrawal by Subject|6|||
25329460|NCT00883337|50645712|FG000|Core Treatment Period|Wish to be pregnant|1|||
25329461|NCT00883337|50645713|FG001|Core Treatment Period|Wish to be pregnant|2|||
25329462|NCT00883337|50645714|FG002|Core Treatment Period|Wish to be pregnant|1|||
25329463|NCT00883337|50645712|FG000|Core Treatment Period|Poor compliance to protocol|0|||
25329464|NCT00883337|50645713|FG001|Core Treatment Period|Poor compliance to protocol|0|||
25329465|NCT00883337|50645714|FG002|Core Treatment Period|Poor compliance to protocol|1|||
25329466|NCT00883337|50645712|FG000|Core Treatment Period|Other than above|0|||
25329467|NCT00883337|50645713|FG001|Core Treatment Period|Other than above|1|||
25329468|NCT00883337|50645714|FG002|Core Treatment Period|Other than above|1|||
25329469|NCT00883337|50645712|FG000|Extension Treatment Period|Adverse Event|8|||
25329470|NCT00883337|50645713|FG001|Extension Treatment Period|Adverse Event|5|||
25329471|NCT00883337|50645714|FG002|Extension Treatment Period|Adverse Event|5|||
25329472|NCT00883337|50645712|FG000|Extension Treatment Period|Lack of Efficacy|8|||
25329473|NCT00883337|50645713|FG001|Extension Treatment Period|Lack of Efficacy|8|||
25329474|NCT00883337|50645714|FG002|Extension Treatment Period|Lack of Efficacy|8|||
24900756|NCT00790751|49994772|FG001|Overall Study|Adverse Event|3|||
24900757|NCT00790751|49994773|FG002|Overall Study|Adverse Event|5|||
24900758|NCT00790751|49994774|FG003|Overall Study|Adverse Event|4|||
25329475|NCT00883337|50645712|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
25248703|NCT01160614|50564385|FG000|Overall Study|Withdrawal by Subject|0|||
25248704|NCT01160614|50564386|FG001|Overall Study|Withdrawal by Subject|2|||
25248705|NCT01159912|50564413|FG000|Overall Study|Adverse Event|2|||
25329476|NCT00883337|50645713|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
25329477|NCT00883337|50645714|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
25329478|NCT00883337|50645712|FG000|Extension Treatment Period|Lost to Follow-up|1|||
25329479|NCT00883337|50645713|FG001|Extension Treatment Period|Lost to Follow-up|0|||
25329480|NCT00883337|50645714|FG002|Extension Treatment Period|Lost to Follow-up|0|||
25329481|NCT00883337|50645712|FG000|Extension Treatment Period|Other than above|10|||
25329482|NCT00883337|50645713|FG001|Extension Treatment Period|Other than above|9|||
25329483|NCT00883337|50645714|FG002|Extension Treatment Period|Other than above|5|||
25248706|NCT01159912|50564414|FG001|Overall Study|Adverse Event|2|||
25248707|NCT01159912|50564415|FG002|Overall Study|Adverse Event|3|||
25329484|NCT00838110|50645730|FG000|Overall Study|Death|0|||
25329485|NCT00838110|50645731|FG001|Overall Study|Death|0|||
25329486|NCT00838110|50645732|FG002|Overall Study|Death|1|||
25329487|NCT00838110|50645733|FG003|Overall Study|Death|2|||
25329488|NCT00838110|50645730|FG000|Overall Study|Adverse Event|11|||
25329489|NCT00838110|50645731|FG001|Overall Study|Adverse Event|10|||
25329490|NCT00838110|50645732|FG002|Overall Study|Adverse Event|8|||
25329491|NCT00838110|50645733|FG003|Overall Study|Adverse Event|7|||
25329492|NCT00838110|50645730|FG000|Overall Study|Withdrawal by Subject|5|||
25329493|NCT00838110|50645731|FG001|Overall Study|Withdrawal by Subject|6|||
25329494|NCT00838110|50645732|FG002|Overall Study|Withdrawal by Subject|3|||
25329495|NCT00838110|50645733|FG003|Overall Study|Withdrawal by Subject|4|||
25329496|NCT00838110|50645730|FG000|Overall Study|Other|3|||
25329497|NCT00838110|50645731|FG001|Overall Study|Other|3|||
25329498|NCT00838110|50645732|FG002|Overall Study|Other|3|||
25329499|NCT00838110|50645733|FG003|Overall Study|Other|2|||
25329500|NCT00838110|50645730|FG000|Overall Study|Protocol Violation|0|||
25329501|NCT00838110|50645731|FG001|Overall Study|Protocol Violation|2|||
24900759|NCT00790751|49994771|FG000|Overall Study|Requirement for restricted medication|0|||
24900760|NCT00790751|49994772|FG001|Overall Study|Requirement for restricted medication|2|||
24900761|NCT00790751|49994773|FG002|Overall Study|Requirement for restricted medication|0|||
24900762|NCT00790751|49994774|FG003|Overall Study|Requirement for restricted medication|0|||
24900763|NCT00790751|49994771|FG000|Overall Study|Death|0|||
24900764|NCT00790751|49994772|FG001|Overall Study|Death|0|||
25329502|NCT00838110|50645732|FG002|Overall Study|Protocol Violation|1|||
25329503|NCT00838110|50645733|FG003|Overall Study|Protocol Violation|1|||
25329504|NCT00838110|50645730|FG000|Overall Study|Lost to Follow-up|3|||
25329505|NCT00838110|50645731|FG001|Overall Study|Lost to Follow-up|0|||
25329506|NCT00838110|50645732|FG002|Overall Study|Lost to Follow-up|0|||
25329507|NCT00838110|50645733|FG003|Overall Study|Lost to Follow-up|0|||
25329508|NCT00838110|50645730|FG000|Overall Study|Did not meet eligibility criteria|0|||
25329509|NCT00838110|50645731|FG001|Overall Study|Did not meet eligibility criteria|0|||
25329510|NCT00838110|50645732|FG002|Overall Study|Did not meet eligibility criteria|1|||
25329511|NCT00838110|50645733|FG003|Overall Study|Did not meet eligibility criteria|2|||
25329512|NCT00838110|50645730|FG000|Overall Study|Randomized but not treated|0|||
25329513|NCT00838110|50645731|FG001|Overall Study|Randomized but not treated|1|||
25329514|NCT00838110|50645732|FG002|Overall Study|Randomized but not treated|0|||
25329515|NCT00838110|50645733|FG003|Overall Study|Randomized but not treated|0|||
25329516|NCT00837876|50645743|FG000|Overall Study|Death|2|||
25329517|NCT00837876|50645743|FG000|Overall Study|Adverse Event|7|||
25329518|NCT00837876|50645743|FG000|Overall Study|Physician Decision|1|||
25329519|NCT00837876|50645743|FG000|Overall Study|Withdrawal by Subject|3|||
25329520|NCT00837876|50645743|FG000|Overall Study|disease progression|24|||
25329521|NCT02637713|50645747|FG000|Overall Study|Screen Failure|2|||
25329522|NCT00686920|50645753|FG000|Overall Study|Death|45|||
25329523|NCT00686920|50645754|FG001|Overall Study|Death|14|||
25329524|NCT00686920|50645753|FG000|Overall Study|Liver Transplant|23|||
25329525|NCT00686920|50645754|FG001|Overall Study|Liver Transplant|8|||
25329526|NCT00686920|50645753|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
25329527|NCT00686920|50645754|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
25329528|NCT00686920|50645753|FG000|Overall Study|Withdrawal by Subject|23|||
24900765|NCT00790751|49994773|FG002|Overall Study|Death|1|||
24900766|NCT00790751|49994774|FG003|Overall Study|Death|0|||
24900767|NCT00790751|49994771|FG000|Overall Study|Physician Decision|0|||
24900768|NCT00790751|49994772|FG001|Overall Study|Physician Decision|0|||
24900769|NCT00790751|49994773|FG002|Overall Study|Physician Decision|0|||
24900770|NCT00790751|49994774|FG003|Overall Study|Physician Decision|1|||
24900771|NCT00784979|49994784|FG000|Overall Study|incomplete data|6|||
24900772|NCT00738920|49994791|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
24900773|NCT00738920|49994792|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
24900774|NCT00738920|49994793|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
24900775|NCT00738920|49994791|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
24900776|NCT00738920|49994792|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
24900777|NCT00738920|49994793|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
24900778|NCT00738920|49994791|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
24900779|NCT00738920|49994792|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
24900780|NCT00738920|49994793|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
25077811|NCT03318523|50185671|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
25329529|NCT00686920|50645754|FG001|Overall Study|Withdrawal by Subject|5|||
25329530|NCT00686920|50645753|FG000|Overall Study|Protocol Violation|2|||
25329531|NCT00686920|50645754|FG001|Overall Study|Protocol Violation|1|||
25329532|NCT00686920|50645753|FG000|Overall Study|Adverse Event|10|||
25329533|NCT00686920|50645754|FG001|Overall Study|Adverse Event|2|||
25329534|NCT00686920|50645753|FG000|Overall Study|Personal Reason|0|||
25329535|NCT00686920|50645754|FG001|Overall Study|Personal Reason|1|||
25329536|NCT00686920|50645753|FG000|Overall Study|Lost to Follow-up|15|||
25329537|NCT00686920|50645754|FG001|Overall Study|Lost to Follow-up|3|||
25329538|NCT00686920|50645753|FG000|Overall Study|Moved to Another State|1|||
25329539|NCT00686920|50645754|FG001|Overall Study|Moved to Another State|0|||
25329540|NCT00686920|50645753|FG000|Overall Study|Transferred to Nursing Home|1|||
25329541|NCT00686920|50645754|FG001|Overall Study|Transferred to Nursing Home|0|||
25329542|NCT00686920|50645753|FG000|Overall Study|Noncompliance|9|||
25329543|NCT00686920|50645754|FG001|Overall Study|Noncompliance|0|||
25329544|NCT00686920|50645753|FG000|Overall Study|Principal Investigator Decision|2|||
25329545|NCT00686920|50645754|FG001|Overall Study|Principal Investigator Decision|0|||
25329546|NCT00845832|50645763|FG000|Treatment Period|Adverse Event|0|||
25329547|NCT00845832|50645764|FG001|Treatment Period|Adverse Event|2|||
25329548|NCT00845832|50645765|FG002|Treatment Period|Adverse Event|0|||
25329549|NCT00845832|50645763|FG000|Treatment Period|Protocol Violation|1|||
25329550|NCT00845832|50645764|FG001|Treatment Period|Protocol Violation|1|||
25329551|NCT00845832|50645765|FG002|Treatment Period|Protocol Violation|0|||
25329552|NCT00845832|50645763|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
25329553|NCT00845832|50645764|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
25329554|NCT00845832|50645765|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
25329555|NCT00845832|50645763|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
25329556|NCT00845832|50645764|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
25329557|NCT00845832|50645765|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
25329558|NCT00591864|50645773|FG000|Overall Study|Incomplete Imaging|5|||
25329559|NCT00885755|50645781|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
25329560|NCT00885755|50645782|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
25329561|NCT00885755|50645783|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
25329562|NCT00885755|50645781|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
25329563|NCT00885755|50645782|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
25329564|NCT00885755|50645783|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
25329565|NCT00885755|50645781|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
25329566|NCT00885755|50645782|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
25329567|NCT00885755|50645783|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
25329568|NCT00885755|50645781|FG000|Part I: Trastuzumab+Taxane|Death|0|||
25329569|NCT00885755|50645782|FG001|Part I: Trastuzumab+Taxane|Death|0|||
25329570|NCT00885755|50645783|FG002|Part I: Trastuzumab+Taxane|Death|1|||
25329571|NCT00885755|50645781|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
25329572|NCT00885755|50645782|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
25329573|NCT00885755|50645783|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
25329574|NCT00837486|50645793|FG000|Blinded-treatment Phase|Physician Decision|1|||
25329575|NCT00837486|50645794|FG001|Blinded-treatment Phase|Physician Decision|0|||
25329576|NCT00837486|50645793|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
25248708|NCT01159912|50564413|FG000|Overall Study|Lack of Efficacy|23|||
25248709|NCT01159912|50564414|FG001|Overall Study|Lack of Efficacy|15|||
25248710|NCT01159912|50564415|FG002|Overall Study|Lack of Efficacy|14|||
25248711|NCT01159912|50564413|FG000|Overall Study|Protocol Violation|1|||
25248712|NCT01159912|50564414|FG001|Overall Study|Protocol Violation|2|||
25248713|NCT01159912|50564415|FG002|Overall Study|Protocol Violation|3|||
25248714|NCT01159912|50564413|FG000|Overall Study|Lost to Follow-up|4|||
25248715|NCT01159912|50564414|FG001|Overall Study|Lost to Follow-up|0|||
25248716|NCT01159912|50564415|FG002|Overall Study|Lost to Follow-up|0|||
25248717|NCT01159912|50564413|FG000|Overall Study|Physician Decision|0|||
25248718|NCT01159912|50564414|FG001|Overall Study|Physician Decision|0|||
25248719|NCT01159912|50564415|FG002|Overall Study|Physician Decision|3|||
25248720|NCT01159912|50564413|FG000|Overall Study|Withdrawal by Subject|10|||
25248721|NCT01159912|50564414|FG001|Overall Study|Withdrawal by Subject|3|||
25248722|NCT01159912|50564415|FG002|Overall Study|Withdrawal by Subject|3|||
25248723|NCT01159600|50564431|FG000|Overall Study|Not treated|0|||
25248724|NCT01159600|50564432|FG001|Overall Study|Not treated|0|||
25248725|NCT01159600|50564433|FG002|Overall Study|Not treated|1|||
25248726|NCT01159600|50564434|FG003|Overall Study|Not treated|0|||
25248727|NCT01159600|50564435|FG004|Overall Study|Not treated|0|||
25248728|NCT01159600|50564436|FG005|Overall Study|Not treated|1|||
25329577|NCT00837486|50645794|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
25329578|NCT00837486|50645793|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
25329579|NCT00837486|50645794|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
25329580|NCT00837486|50645793|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
25329581|NCT00837486|50645794|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
25329582|NCT00845676|50645802|FG000|Overall Study|Virologic breakthrough at week 20|1|||
25248729|NCT01159600|50564437|FG006|Overall Study|Not treated|2|||
25248730|NCT01159600|50564438|FG007|Overall Study|Not treated|2|||
25248731|NCT01159600|50564431|FG000|Overall Study|Adverse Event|7|||
25248732|NCT01159600|50564432|FG001|Overall Study|Adverse Event|2|||
25329583|NCT00845676|50645802|FG000|Overall Study|Adverse Event|1|||
25329584|NCT00883181|50645807|FG000|Overall Study|Hematological Adverse Event|26|||
25329585|NCT00883181|50645807|FG000|Overall Study|Non-hematological Adverse Event|55|||
25329586|NCT00883181|50645807|FG000|Overall Study|Disease Progression|94|||
25248733|NCT01159600|50564433|FG002|Overall Study|Adverse Event|5|||
25248734|NCT01159600|50564434|FG003|Overall Study|Adverse Event|1|||
25329587|NCT00883181|50645807|FG000|Overall Study|Administrative Reason|24|||
25329588|NCT00883181|50645807|FG000|Overall Study|Withdrawal by Subject|4|||
25329589|NCT00883181|50645807|FG000|Overall Study|Death|31|||
25329590|NCT00883181|50645807|FG000|Overall Study|Other|38|||
25329591|NCT00883181|50645807|FG000|Overall Study|Protocol Deviation|3|||
25329592|NCT00883181|50645807|FG000|Overall Study|Noncompliance|3|||
25329593|NCT00845520|50645827|FG000|Overall Study|Death|1|||
25329594|NCT00845520|50645828|FG001|Overall Study|Death|2|||
25329595|NCT00845520|50645829|FG002|Overall Study|Death|0|||
25329596|NCT00845520|50645827|FG000|Overall Study|Lost to Follow-up|1|||
25329597|NCT00845520|50645828|FG001|Overall Study|Lost to Follow-up|0|||
25329598|NCT00845520|50645829|FG002|Overall Study|Lost to Follow-up|0|||
25329599|NCT00845520|50645827|FG000|Overall Study|Adverse Event|0|||
25329600|NCT00845520|50645828|FG001|Overall Study|Adverse Event|0|||
25329601|NCT00845520|50645829|FG002|Overall Study|Adverse Event|1|||
25248735|NCT01159600|50564435|FG004|Overall Study|Adverse Event|8|||
25248736|NCT01159600|50564436|FG005|Overall Study|Adverse Event|6|||
25248737|NCT01159600|50564437|FG006|Overall Study|Adverse Event|7|||
25248738|NCT01159600|50564438|FG007|Overall Study|Adverse Event|5|||
25248739|NCT01159600|50564431|FG000|Overall Study|Lack of Efficacy|0|||
25248740|NCT01159600|50564432|FG001|Overall Study|Lack of Efficacy|0|||
25248741|NCT01159600|50564433|FG002|Overall Study|Lack of Efficacy|0|||
25248742|NCT01159600|50564434|FG003|Overall Study|Lack of Efficacy|0|||
25329602|NCT00844896|50645845|FG000|Overall Study|Lost to Follow-up|12|||
25329603|NCT00844896|50645846|FG001|Overall Study|Lost to Follow-up|16|||
25329604|NCT00844896|50645845|FG000|Overall Study|Parents did not have time to complete|0|||
25329605|NCT00844896|50645846|FG001|Overall Study|Parents did not have time to complete|1|||
25329606|NCT00827502|50645853|FG000|Overall Study|randomized but not treated|11|||
25329607|NCT00827502|50645853|FG000|Overall Study|Adverse Event|1|||
25329608|NCT00827502|50645853|FG000|Overall Study|Lost to Follow-up|4|||
25329609|NCT00827502|50645853|FG000|Overall Study|Withdrawal by Subject|5|||
25329610|NCT00837330|50645859|FG000|Overall Study|Lost to Follow-up|1|||
25329611|NCT00837330|50645860|FG001|Overall Study|Lost to Follow-up|3|||
25329612|NCT00837096|50645868|FG000|Overall Study|Physician Decision|1|||
25329613|NCT00837096|50645869|FG001|Overall Study|Physician Decision|1|||
25329614|NCT00837096|50645868|FG000|Overall Study|Not reported|9|||
25329615|NCT00837096|50645869|FG001|Overall Study|Not reported|8|||
25329616|NCT00885677|50645877|FG000|Overall Study|Death|40|||
25329617|NCT00885677|50645878|FG001|Overall Study|Death|34|||
25329618|NCT00885677|50645877|FG000|Overall Study|Lost to Follow-up|15|||
25329619|NCT00885677|50645878|FG001|Overall Study|Lost to Follow-up|13|||
25329620|NCT00885677|50645877|FG000|Overall Study|Protocol Violation|54|||
25329621|NCT00885677|50645878|FG001|Overall Study|Protocol Violation|54|||
25329622|NCT00885677|50645877|FG000|Overall Study|premature study closure|41|||
25329623|NCT00885677|50645878|FG001|Overall Study|premature study closure|44|||
25329624|NCT00885677|50645877|FG000|Overall Study|device/lead revision or replacement|7|||
25329625|NCT00885677|50645878|FG001|Overall Study|device/lead revision or replacement|6|||
25329626|NCT00885677|50645877|FG000|Overall Study|Heart transplantation|1|||
25329627|NCT00885677|50645878|FG001|Overall Study|Heart transplantation|0|||
25329628|NCT00885677|50645877|FG000|Overall Study|Inclusion/exclusion not met|25|||
25329629|NCT00885677|50645878|FG001|Overall Study|Inclusion/exclusion not met|27|||
25329630|NCT00885365|50645886|FG000|4 Weeks ON Treatment|Adverse Event|2|||
25329631|NCT00885365|50645887|FG001|4 Weeks ON Treatment|Adverse Event|4|||
25329632|NCT00885365|50645886|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
25329633|NCT00885365|50645887|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
25329634|NCT00885365|50645886|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
25329635|NCT00885365|50645887|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
25329636|NCT00827112|50645895|FG000|Overall Study|Adverse Event|2|||
25329637|NCT00827112|50645896|FG001|Overall Study|Adverse Event|0|||
25329638|NCT00827112|50645895|FG000|Overall Study|Lack of Efficacy|2|||
25329639|NCT00827112|50645896|FG001|Overall Study|Lack of Efficacy|0|||
25329640|NCT00827112|50645895|FG000|Overall Study|Lost to Follow-up|3|||
25329641|NCT00827112|50645896|FG001|Overall Study|Lost to Follow-up|2|||
25329642|NCT00827112|50645895|FG000|Overall Study|Pregnancy|0|||
25329643|NCT00827112|50645896|FG001|Overall Study|Pregnancy|1|||
25329644|NCT00827112|50645895|FG000|Overall Study|Protocol Violation|0|||
25329645|NCT00827112|50645896|FG001|Overall Study|Protocol Violation|2|||
25248743|NCT01159600|50564435|FG004|Overall Study|Lack of Efficacy|2|||
25248744|NCT01159600|50564436|FG005|Overall Study|Lack of Efficacy|0|||
25248745|NCT01159600|50564437|FG006|Overall Study|Lack of Efficacy|0|||
25329646|NCT00827112|50645895|FG000|Overall Study|Withdrawal by Subject|2|||
25329647|NCT00827112|50645896|FG001|Overall Study|Withdrawal by Subject|1|||
25329648|NCT00827112|50645895|FG000|Overall Study|Randomized but not treated|5|||
25329649|NCT00827112|50645896|FG001|Overall Study|Randomized but not treated|3|||
25329650|NCT00827112|50645895|FG000|Overall Study|Other|1|||
25329651|NCT00827112|50645896|FG001|Overall Study|Other|3|||
25329652|NCT00689104|50645906|FG000|Overall Study|Eligibility criterion not met|5|||
25329653|NCT00689104|50645907|FG001|Overall Study|Eligibility criterion not met|8|||
25329654|NCT00689104|50645908|FG002|Overall Study|Eligibility criterion not met|0|||
25248746|NCT01159600|50564438|FG007|Overall Study|Lack of Efficacy|1|||
25248747|NCT01159600|50564431|FG000|Overall Study|Non compliant with protocol|2|||
25248748|NCT01159600|50564432|FG001|Overall Study|Non compliant with protocol|1|||
25248749|NCT01159600|50564433|FG002|Overall Study|Non compliant with protocol|0|||
25248750|NCT01159600|50564434|FG003|Overall Study|Non compliant with protocol|0|||
25248751|NCT01159600|50564435|FG004|Overall Study|Non compliant with protocol|2|||
25248752|NCT01159600|50564436|FG005|Overall Study|Non compliant with protocol|0|||
25248753|NCT01159600|50564437|FG006|Overall Study|Non compliant with protocol|2|||
25248754|NCT01159600|50564438|FG007|Overall Study|Non compliant with protocol|0|||
25248755|NCT01159600|50564431|FG000|Overall Study|Lost to Follow-up|2|||
25248756|NCT01159600|50564432|FG001|Overall Study|Lost to Follow-up|3|||
25248757|NCT01159600|50564433|FG002|Overall Study|Lost to Follow-up|4|||
25248758|NCT01159600|50564434|FG003|Overall Study|Lost to Follow-up|3|||
25248759|NCT01159600|50564435|FG004|Overall Study|Lost to Follow-up|3|||
25248760|NCT01159600|50564436|FG005|Overall Study|Lost to Follow-up|0|||
25248761|NCT01159600|50564437|FG006|Overall Study|Lost to Follow-up|3|||
25248762|NCT01159600|50564438|FG007|Overall Study|Lost to Follow-up|2|||
25248763|NCT01159600|50564431|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
25248764|NCT01159600|50564432|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
25248765|NCT01159600|50564433|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
25248766|NCT01159600|50564434|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
25248767|NCT01159600|50564435|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
25248768|NCT01159600|50564436|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
25248769|NCT01159600|50564437|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
25248770|NCT01159600|50564438|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
25248771|NCT01159600|50564431|FG000|Overall Study|Other reason not defined above|3|||
25248772|NCT01159600|50564432|FG001|Overall Study|Other reason not defined above|0|||
25248773|NCT01159600|50564433|FG002|Overall Study|Other reason not defined above|4|||
25248774|NCT01159600|50564434|FG003|Overall Study|Other reason not defined above|2|||
25248775|NCT01159600|50564435|FG004|Overall Study|Other reason not defined above|5|||
25248776|NCT01159600|50564436|FG005|Overall Study|Other reason not defined above|7|||
25248777|NCT01159600|50564437|FG006|Overall Study|Other reason not defined above|3|||
25248778|NCT01159600|50564438|FG007|Overall Study|Other reason not defined above|3|||
25248779|NCT01159171|50564457|FG000|Overall Study|Adverse Event|11|||
25248780|NCT01159171|50564457|FG000|Overall Study|Progression of Disease|28|||
25248781|NCT01159171|50564457|FG000|Overall Study|Protocol Violation|1|||
25248782|NCT01159171|50564457|FG000|Overall Study|Need for Surgery|5|||
25248783|NCT01159171|50564457|FG000|Overall Study|Medical Decision|4|||
25248784|NCT01159171|50564457|FG000|Overall Study|Death|1|||
25248785|NCT01158118|50564464|FG000|Overall Study|Screen failure|1|||
25248786|NCT01158118|50564465|FG001|Overall Study|Screen failure|0|||
25248787|NCT01158118|50564464|FG000|Overall Study|Donor match was a screen failure|0|||
25248788|NCT01158118|50564465|FG001|Overall Study|Donor match was a screen failure|1|||
25248789|NCT01158118|50564464|FG000|Overall Study|Suffered stroke prior to transplant|0|||
25248790|NCT01158118|50564465|FG001|Overall Study|Suffered stroke prior to transplant|1|||
25248791|NCT01158118|50564464|FG000|Overall Study|Death|0|||
25248792|NCT01158118|50564465|FG001|Overall Study|Death|1|||
25248793|NCT01157845|50564471|FG000|Overall Study|Lost to Follow-up|5|||
25248794|NCT01157845|50564471|FG000|Overall Study|Withdrawal by Subject|12|||
25248795|NCT01157845|50564471|FG000|Overall Study|Physician Decision|3|||
25248796|NCT01157845|50564471|FG000|Overall Study|Protocol Violation|13|||
25248797|NCT01157845|50564471|FG000|Overall Study|Study was ended|1|||
25248798|NCT01157845|50564471|FG000|Overall Study|Device malfunction|1|||
25248799|NCT01157377|50564482|FG000|Overall Study|Lost to Follow-up|0|||
25248800|NCT01157377|50564483|FG001|Overall Study|Lost to Follow-up|0|||
25248801|NCT01157377|50564484|FG002|Overall Study|Lost to Follow-up|1|||
25248802|NCT01157377|50564485|FG003|Overall Study|Lost to Follow-up|0|||
25248803|NCT01157377|50564486|FG004|Overall Study|Lost to Follow-up|1|||
25248804|NCT01157377|50564487|FG005|Overall Study|Lost to Follow-up|1|||
25248805|NCT01157377|50564488|FG006|Overall Study|Lost to Follow-up|0|||
25248806|NCT01157377|50564482|FG000|Overall Study|Personal Reasons|2|||
25248807|NCT01157377|50564483|FG001|Overall Study|Personal Reasons|1|||
25248808|NCT01157377|50564484|FG002|Overall Study|Personal Reasons|0|||
25248809|NCT01157377|50564485|FG003|Overall Study|Personal Reasons|1|||
25248810|NCT01157377|50564486|FG004|Overall Study|Personal Reasons|0|||
25248811|NCT01157377|50564487|FG005|Overall Study|Personal Reasons|0|||
25248812|NCT01157377|50564488|FG006|Overall Study|Personal Reasons|0|||
25248813|NCT01157377|50564482|FG000|Overall Study|Protocol Violation|0|||
25248814|NCT01157377|50564483|FG001|Overall Study|Protocol Violation|0|||
25248815|NCT01157377|50564484|FG002|Overall Study|Protocol Violation|0|||
25248816|NCT01157377|50564485|FG003|Overall Study|Protocol Violation|0|||
25248817|NCT01157377|50564486|FG004|Overall Study|Protocol Violation|0|||
25248818|NCT01157377|50564487|FG005|Overall Study|Protocol Violation|1|||
25248819|NCT01157377|50564488|FG006|Overall Study|Protocol Violation|0|||
25248820|NCT01157377|50564482|FG000|Overall Study|Lack of Efficacy|0|||
25248821|NCT01157377|50564483|FG001|Overall Study|Lack of Efficacy|0|||
25248822|NCT01157377|50564484|FG002|Overall Study|Lack of Efficacy|0|||
25248823|NCT01157377|50564485|FG003|Overall Study|Lack of Efficacy|0|||
25248824|NCT01157377|50564486|FG004|Overall Study|Lack of Efficacy|0|||
25248825|NCT01157377|50564487|FG005|Overall Study|Lack of Efficacy|0|||
25248826|NCT01157377|50564488|FG006|Overall Study|Lack of Efficacy|1|||
25248827|NCT01157377|50564482|FG000|Overall Study|Other Miscellaneous Reasons|0|||
25248828|NCT01157377|50564483|FG001|Overall Study|Other Miscellaneous Reasons|2|||
25248829|NCT01157377|50564484|FG002|Overall Study|Other Miscellaneous Reasons|0|||
25248830|NCT01157377|50564485|FG003|Overall Study|Other Miscellaneous Reasons|0|||
25248831|NCT01157377|50564486|FG004|Overall Study|Other Miscellaneous Reasons|1|||
25248832|NCT01157377|50564487|FG005|Overall Study|Other Miscellaneous Reasons|1|||
25248833|NCT01157377|50564488|FG006|Overall Study|Other Miscellaneous Reasons|1|||
25248834|NCT01157182|50564506|FG000|Washout of 28 Days|Adverse Event|2|||
25248835|NCT01157182|50564507|FG001|Washout of 28 Days|Adverse Event|0|||
25248836|NCT01157065|50564515|FG000|Overall Study|Death|0|||
25248837|NCT01157065|50564516|FG001|Overall Study|Death|1|||
25248838|NCT01156792|50564522|FG000|Overall Study|Adverse Event|1|||
25248839|NCT01156792|50564522|FG000|Overall Study|Lack of Efficacy|36|||
25248840|NCT01156792|50564522|FG000|Overall Study|Protocol Violation|6|||
25248841|NCT01156792|50564522|FG000|Overall Study|Lost to Follow-up|3|||
25248842|NCT01156792|50564522|FG000|Overall Study|Physician Decision|3|||
25248843|NCT01156792|50564522|FG000|Overall Study|Withdrawal by Subject|9|||
25248844|NCT01156792|50564522|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
25248845|NCT01156714|50564540|FG000|Overall Study|Withdrawal by Subject|9|||
25248846|NCT01156714|50564541|FG001|Overall Study|Withdrawal by Subject|4|||
25248847|NCT01156714|50564542|FG002|Overall Study|Withdrawal by Subject|3|||
25248848|NCT01156675|50564556|FG000|Overall Study|Death|5|||
25248849|NCT01156675|50564557|FG001|Overall Study|Death|3|||
25248850|NCT01156675|50564558|FG002|Overall Study|Death|0|||
25248851|NCT01156675|50564556|FG000|Overall Study|No data|29|||
25248852|NCT01156675|50564557|FG001|Overall Study|No data|22|||
25248853|NCT01156675|50564558|FG002|Overall Study|No data|2|||
25248854|NCT01156480|50564569|FG000|Overall Study|change in diagnosis|0|||
25248855|NCT01156480|50564570|FG001|Overall Study|change in diagnosis|1|||
25248856|NCT01156363|50564578|FG000|Overall Study|Adverse Event|6|||
25329655|NCT00689104|50645909|FG003|Overall Study|Eligibility criterion not met|4|||
25329656|NCT00689104|50645906|FG000|Overall Study|Adverse Event|13|||
25329657|NCT00689104|50645907|FG001|Overall Study|Adverse Event|25|||
25329658|NCT00689104|50645908|FG002|Overall Study|Adverse Event|16|||
25329659|NCT00689104|50645909|FG003|Overall Study|Adverse Event|24|||
25329660|NCT00689104|50645906|FG000|Overall Study|Lack of Efficacy|5|||
25329661|NCT00689104|50645907|FG001|Overall Study|Lack of Efficacy|6|||
25329662|NCT00689104|50645908|FG002|Overall Study|Lack of Efficacy|2|||
25329663|NCT00689104|50645909|FG003|Overall Study|Lack of Efficacy|3|||
25329664|NCT00689104|50645906|FG000|Overall Study|Withdrawal by Subject|12|||
25329665|NCT00689104|50645907|FG001|Overall Study|Withdrawal by Subject|11|||
25329666|NCT00689104|50645908|FG002|Overall Study|Withdrawal by Subject|18|||
25329667|NCT00689104|50645909|FG003|Overall Study|Withdrawal by Subject|11|||
25329668|NCT00689104|50645906|FG000|Overall Study|Lost to Follow-up|4|||
25329669|NCT00689104|50645907|FG001|Overall Study|Lost to Follow-up|3|||
25329670|NCT00689104|50645908|FG002|Overall Study|Lost to Follow-up|2|||
25329671|NCT00689104|50645909|FG003|Overall Study|Lost to Follow-up|5|||
25329672|NCT00689104|50645906|FG000|Overall Study|Protocol Violation|2|||
25329673|NCT00689104|50645907|FG001|Overall Study|Protocol Violation|3|||
25329674|NCT00689104|50645908|FG002|Overall Study|Protocol Violation|5|||
25329675|NCT00689104|50645909|FG003|Overall Study|Protocol Violation|3|||
25329676|NCT00689104|50645906|FG000|Overall Study|Randomized but never received study drug|2|||
25329677|NCT00689104|50645907|FG001|Overall Study|Randomized but never received study drug|1|||
25329678|NCT00689104|50645908|FG002|Overall Study|Randomized but never received study drug|1|||
25329679|NCT00689104|50645909|FG003|Overall Study|Randomized but never received study drug|0|||
25329680|NCT00689104|50645906|FG000|Overall Study|Physician Decision|1|||
25329681|NCT00689104|50645907|FG001|Overall Study|Physician Decision|0|||
25329682|NCT00689104|50645908|FG002|Overall Study|Physician Decision|0|||
25329683|NCT00689104|50645909|FG003|Overall Study|Physician Decision|0|||
25329684|NCT00689104|50645906|FG000|Overall Study|Non-compliance with study procedures|0|||
25329685|NCT00689104|50645907|FG001|Overall Study|Non-compliance with study procedures|0|||
25329686|NCT00689104|50645908|FG002|Overall Study|Non-compliance with study procedures|1|||
25329687|NCT00689104|50645909|FG003|Overall Study|Non-compliance with study procedures|0|||
25329688|NCT00689026|50645921|FG000|Overall Study|Withdrawal by Subject|13|||
25248857|NCT01156363|50564578|FG000|Overall Study|Insufficient Therapeutic Response|5|||
25248858|NCT01156363|50564578|FG000|Overall Study|Failure to Return|1|||
25248859|NCT01156363|50564578|FG000|Overall Study|Refused Treatment|4|||
25248860|NCT01156363|50564578|FG000|Overall Study|Other|6|||
25248861|NCT01156051|50564591|FG000|Overall Study|Lost to Follow-up|1|||
25248862|NCT01156051|50564592|FG001|Overall Study|Lost to Follow-up|0|||
25329689|NCT00689026|50645922|FG001|Overall Study|Withdrawal by Subject|6|||
25329690|NCT00598559|50645931|FG000|Overall Study|Adverse Event|11|||
25329691|NCT00598559|50645932|FG001|Overall Study|Adverse Event|7|||
25329692|NCT00598559|50645933|FG002|Overall Study|Adverse Event|0|||
25248863|NCT01156051|50564591|FG000|Overall Study|patient not compliant with protocol|0|||
25248864|NCT01156051|50564592|FG001|Overall Study|patient not compliant with protocol|1|||
25248865|NCT01156012|50564600|FG000|Overall Study|Adverse Event|3|||
25248866|NCT01156012|50564601|FG001|Overall Study|Adverse Event|1|||
25248867|NCT01156012|50564600|FG000|Overall Study|Lost to Follow-up|1|||
25248868|NCT01156012|50564601|FG001|Overall Study|Lost to Follow-up|0|||
25248869|NCT01156012|50564600|FG000|Overall Study|Withdrawal by Subject|1|||
25248870|NCT01156012|50564601|FG001|Overall Study|Withdrawal by Subject|0|||
25248871|NCT01156012|50564600|FG000|Overall Study|use of commercial drug instead of study|0|||
25248872|NCT01156012|50564601|FG001|Overall Study|use of commercial drug instead of study|1|||
25248873|NCT01156012|50564600|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
25248874|NCT01156012|50564601|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
25248875|NCT01155661|50564607|FG000|Overall Study|Adverse Event|101|||
25248876|NCT01155661|50564607|FG000|Overall Study|Death|1|||
25248877|NCT01155661|50564607|FG000|Overall Study|Lack of Efficacy|32|||
25248878|NCT01155661|50564607|FG000|Overall Study|Lost to Follow-up|22|||
25248879|NCT01155661|50564607|FG000|Overall Study|Physician Decision|3|||
25248880|NCT01155661|50564607|FG000|Overall Study|Protocol Violation|35|||
25248881|NCT01155661|50564607|FG000|Overall Study|Withdrawal by Subject|73|||
25248882|NCT01155661|50564607|FG000|Overall Study|Sponsor Decision|13|||
25248883|NCT01155583|50564622|FG000|Phase I|Screen failure - did not start treatment|0|||
25248884|NCT01155583|50564623|FG001|Phase I|Screen failure - did not start treatment|0|||
25248885|NCT01155583|50564624|FG002|Phase I|Screen failure - did not start treatment|0|||
25248886|NCT01155583|50564625|FG003|Phase I|Screen failure - did not start treatment|0|||
25248887|NCT01155583|50564626|FG004|Phase I|Screen failure - did not start treatment|1|||
25329693|NCT00598559|50645931|FG000|Overall Study|Withdrawal by Subject|2|||
25329694|NCT00598559|50645932|FG001|Overall Study|Withdrawal by Subject|2|||
25329695|NCT00598559|50645933|FG002|Overall Study|Withdrawal by Subject|0|||
25329696|NCT00598559|50645931|FG000|Overall Study|Protocol Non-compliance|1|||
25329697|NCT00598559|50645932|FG001|Overall Study|Protocol Non-compliance|0|||
25329698|NCT00598559|50645933|FG002|Overall Study|Protocol Non-compliance|0|||
25329699|NCT00598559|50645931|FG000|Overall Study|Early discharge from hospital|9|||
25329700|NCT00598559|50645932|FG001|Overall Study|Early discharge from hospital|12|||
25329701|NCT00598559|50645933|FG002|Overall Study|Early discharge from hospital|3|||
25329702|NCT00598559|50645931|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
25329703|NCT00598559|50645932|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
25329704|NCT00598559|50645933|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
25329705|NCT00686686|50645941|FG000|Overall Study|Non-compliance|1|||
25329706|NCT00686686|50645941|FG000|Overall Study|Adverse Event|2|||
25329707|NCT00686686|50645941|FG000|Overall Study|Lost to Follow-up|3|||
25329708|NCT04160195|50645947|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
25329709|NCT04160195|50645948|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
25329710|NCT00686374|50645956|FG000|Overall Study|Lack of Efficacy|10|||
25329711|NCT00686374|50645956|FG000|Overall Study|Adverse Event|8|||
25329712|NCT00686374|50645956|FG000|Overall Study|Withdrew consent|5|||
25329713|NCT00686374|50645956|FG000|Overall Study|Lost to Follow-up|1|||
24977275|NCT03410992|50065851|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
24977276|NCT03410992|50065852|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
25248888|NCT01155583|50564627|FG005|Phase I|Screen failure - did not start treatment|0|||
25248889|NCT01155583|50564628|FG006|Phase I|Screen failure - did not start treatment|0|||
25248890|NCT01155583|50564629|FG007|Phase I|Screen failure - did not start treatment|2|||
25329714|NCT00686374|50645956|FG000|Overall Study|Missing reason|33|||
25329715|NCT00686374|50645956|FG000|Overall Study|Other, not specified|4|||
25329716|NCT00571948|50645962|FG000|Overall Study|Lost to Follow-up|2|||
25329717|NCT00571948|50645963|FG001|Overall Study|Lost to Follow-up|0|||
25329718|NCT00571948|50645962|FG000|Overall Study|Withdrawal by Subject|1|||
25329719|NCT00571948|50645963|FG001|Overall Study|Withdrawal by Subject|2|||
24900781|NCT00738920|49994791|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
24900782|NCT00738920|49994792|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
24900783|NCT00738920|49994793|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
24900784|NCT00738920|49994791|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
24900785|NCT00738920|49994792|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
24900786|NCT00738920|49994793|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
24900787|NCT00738920|49994791|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
24900788|NCT00738920|49994792|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
24900789|NCT00738920|49994793|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
24900790|NCT00738920|49994791|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
24900791|NCT00738920|49994792|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
24900792|NCT00738920|49994793|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
24900793|NCT00738920|49994791|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
24900794|NCT00738920|49994792|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
25329720|NCT00571948|50645962|FG000|Overall Study|Protocol Violation|3|||
25329721|NCT00571948|50645963|FG001|Overall Study|Protocol Violation|3|||
25329722|NCT00571948|50645962|FG000|Overall Study|infant refused study meal|3|||
25329723|NCT00571948|50645963|FG001|Overall Study|infant refused study meal|4|||
25329724|NCT00571948|50645962|FG000|Overall Study|Parent were afraid of blood colection|2|||
25329725|NCT00571948|50645963|FG001|Overall Study|Parent were afraid of blood colection|5|||
25329726|NCT00684424|50645969|FG000|Overall Study|Adverse Event|1|||
25329727|NCT00684424|50645969|FG000|Overall Study|Lost to Follow-up|2|||
25329728|NCT00684424|50645969|FG000|Overall Study|Other|2|||
25329729|NCT00685750|50645981|FG000|Overall Study|Tumor sampling failure|0|||
25329730|NCT00685750|50645982|FG001|Overall Study|Tumor sampling failure|0|||
25329731|NCT00685750|50645983|FG002|Overall Study|Tumor sampling failure|1|||
25329732|NCT00685750|50645984|FG003|Overall Study|Tumor sampling failure|0|||
25329733|NCT00685750|50645985|FG004|Overall Study|Tumor sampling failure|0|||
25329734|NCT00685750|50645986|FG005|Overall Study|Tumor sampling failure|0|||
25329735|NCT00685750|50645987|FG006|Overall Study|Tumor sampling failure|0|||
25329736|NCT00685750|50645981|FG000|Overall Study|Patient didn't receive the treatment|0|||
25329737|NCT00685750|50645982|FG001|Overall Study|Patient didn't receive the treatment|0|||
25329738|NCT00685750|50645983|FG002|Overall Study|Patient didn't receive the treatment|0|||
25329739|NCT00685750|50645984|FG003|Overall Study|Patient didn't receive the treatment|0|||
25329740|NCT00685750|50645985|FG004|Overall Study|Patient didn't receive the treatment|0|||
25329741|NCT00685750|50645986|FG005|Overall Study|Patient didn't receive the treatment|0|||
25329742|NCT00685750|50645987|FG006|Overall Study|Patient didn't receive the treatment|1|||
25329743|NCT00685750|50645981|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
25329744|NCT00685750|50645982|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
25329745|NCT00685750|50645983|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
25329746|NCT00685750|50645984|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
25329747|NCT00685750|50645985|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
25329748|NCT00685750|50645986|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
25329749|NCT00685750|50645987|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
25329750|NCT00576628|50646007|FG000|Overall Study|Adverse Event|11|||
25329751|NCT00576628|50646007|FG000|Overall Study|Death|2|||
25329752|NCT00576628|50646007|FG000|Overall Study|Failure to return|1|||
25329753|NCT00576628|50646007|FG000|Overall Study|Refused Treatment|8|||
25329754|NCT00576628|50646007|FG000|Overall Study|Pregnancy|1|||
25329755|NCT00576628|50646007|FG000|Overall Study|RBC transfusion|1|||
25329756|NCT00576628|50646007|FG000|Overall Study|Progression of Kidney Disease|1|||
25329757|NCT00576628|50646007|FG000|Overall Study|Progression of Renal Failure|1|||
25329758|NCT00576628|50646007|FG000|Overall Study|The patient move into other town|1|||
25329759|NCT00576628|50646007|FG000|Overall Study|Transplantation|1|||
25329760|NCT00576628|50646007|FG000|Overall Study|Dialysis|15|||
25329761|NCT00683878|50646015|FG000|Overall Study|Lack of Efficacy|3|||
25329762|NCT00683878|50646016|FG001|Overall Study|Lack of Efficacy|0|||
25329763|NCT00683878|50646017|FG002|Overall Study|Lack of Efficacy|1|||
25329764|NCT00683878|50646015|FG000|Overall Study|Adverse Event|4|||
25329765|NCT00683878|50646016|FG001|Overall Study|Adverse Event|3|||
25329766|NCT00683878|50646017|FG002|Overall Study|Adverse Event|3|||
25329767|NCT00683878|50646015|FG000|Overall Study|Withdrawal by Subject|9|||
25329768|NCT00683878|50646016|FG001|Overall Study|Withdrawal by Subject|8|||
25329769|NCT00683878|50646017|FG002|Overall Study|Withdrawal by Subject|6|||
25329770|NCT00683878|50646015|FG000|Overall Study|Death|0|||
25329771|NCT00683878|50646016|FG001|Overall Study|Death|1|||
25329772|NCT00683878|50646017|FG002|Overall Study|Death|0|||
25329773|NCT00683878|50646015|FG000|Overall Study|Lost to Follow-up|4|||
25329774|NCT00683878|50646016|FG001|Overall Study|Lost to Follow-up|2|||
25329775|NCT00683878|50646017|FG002|Overall Study|Lost to Follow-up|4|||
25329776|NCT00683878|50646015|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
25329777|NCT00683878|50646016|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
25329778|NCT00683878|50646017|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
25329779|NCT00884741|50646028|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
25329780|NCT00884741|50646029|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
25329781|NCT00884741|50646030|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
25329782|NCT00884741|50646031|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
25329783|NCT00884741|50646028|FG000|Step 1 Registration: Tissue Screening|Death|3|||
25329784|NCT00884741|50646029|FG001|Step 1 Registration: Tissue Screening|Death|0|||
25329785|NCT00884741|50646030|FG002|Step 1 Registration: Tissue Screening|Death|0|||
25329786|NCT00884741|50646031|FG003|Step 1 Registration: Tissue Screening|Death|0|||
25329787|NCT00884741|50646028|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
25329788|NCT00884741|50646029|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
25329789|NCT00884741|50646030|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
25329790|NCT00884741|50646031|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
25329791|NCT00884741|50646028|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
25329792|NCT00884741|50646029|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
25329793|NCT00884741|50646030|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
25329794|NCT00884741|50646031|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
25248891|NCT01155583|50564630|FG008|Phase I|Screen failure - did not start treatment|0|||
25248892|NCT01155583|50564622|FG000|Phase I|Withdrawal by Subject|0|||
25248893|NCT01155583|50564623|FG001|Phase I|Withdrawal by Subject|0|||
25248894|NCT01155583|50564624|FG002|Phase I|Withdrawal by Subject|0|||
25248895|NCT01155583|50564625|FG003|Phase I|Withdrawal by Subject|0|||
25248896|NCT01155583|50564626|FG004|Phase I|Withdrawal by Subject|0|||
25248897|NCT01155583|50564627|FG005|Phase I|Withdrawal by Subject|0|||
25248898|NCT01155583|50564628|FG006|Phase I|Withdrawal by Subject|0|||
25248899|NCT01155583|50564629|FG007|Phase I|Withdrawal by Subject|1|||
25248900|NCT01155583|50564630|FG008|Phase I|Withdrawal by Subject|0|||
25248901|NCT01155466|50564651|FG000|Overall Study|Adverse Event|13|||
25248902|NCT01155466|50564652|FG001|Overall Study|Adverse Event|15|||
25248903|NCT01155466|50564653|FG002|Overall Study|Adverse Event|6|||
25248904|NCT01155466|50564654|FG003|Overall Study|Adverse Event|17|||
25329795|NCT00884741|50646028|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
25329796|NCT00884741|50646029|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
25329797|NCT00884741|50646030|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
25329798|NCT00884741|50646031|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
25329799|NCT00884741|50646028|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
25329800|NCT00884741|50646029|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
25329801|NCT00884741|50646030|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
25329802|NCT00884741|50646031|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
25329803|NCT00884741|50646028|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
25329804|NCT00884741|50646029|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
25329805|NCT00884741|50646030|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
25329806|NCT00884741|50646031|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
25329807|NCT00884741|50646028|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
25329808|NCT00884741|50646029|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
25329809|NCT00884741|50646030|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
25329810|NCT00884741|50646031|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
25329811|NCT00884741|50646028|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
25329812|NCT00884741|50646029|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
25329813|NCT00884741|50646030|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
25329814|NCT00884741|50646031|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
25329815|NCT00884741|50646028|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
25329816|NCT00884741|50646029|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
25329817|NCT00884741|50646030|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
25329818|NCT00884741|50646031|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
24900795|NCT00738920|49994793|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
24900796|NCT00738920|49994791|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
24900797|NCT00738920|49994792|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
24900798|NCT00738920|49994793|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
24900799|NCT00738920|49994791|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
24900800|NCT00738920|49994792|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
24900801|NCT00738920|49994793|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
24900802|NCT00582972|49994801|FG000|Overall Study|Protocol Violation|2|||
24900803|NCT04319718|49994808|FG000|Overall Study|Adverse Event|0|||
24900804|NCT04319718|49994809|FG001|Overall Study|Adverse Event|2|||
24900805|NCT04319718|49994808|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
24900806|NCT04319718|49994809|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
25329819|NCT00884741|50646028|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
25329820|NCT00884741|50646029|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
25329821|NCT00884741|50646030|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
24900807|NCT04372602|49994817|FG000|Overall Study|Withdrawal by Subject|1|||
24900808|NCT04372602|49994818|FG001|Overall Study|Withdrawal by Subject|1|||
24900809|NCT04372602|49994817|FG000|Overall Study|Adverse Event|0|||
24900810|NCT04372602|49994818|FG001|Overall Study|Adverse Event|1|||
24900811|NCT04372602|49994817|FG000|Overall Study|Transitioned to comfort care|0|||
24900812|NCT04372602|49994818|FG001|Overall Study|Transitioned to comfort care|1|||
25248905|NCT01155466|50564655|FG004|Overall Study|Adverse Event|18|||
25248906|NCT01155466|50564651|FG000|Overall Study|Lost to Follow-up|0|||
25248907|NCT01155466|50564652|FG001|Overall Study|Lost to Follow-up|0|||
25248908|NCT01155466|50564653|FG002|Overall Study|Lost to Follow-up|0|||
25248909|NCT01155466|50564654|FG003|Overall Study|Lost to Follow-up|0|||
25248910|NCT01155466|50564655|FG004|Overall Study|Lost to Follow-up|2|||
25248911|NCT01155466|50564651|FG000|Overall Study|Withdrawal by Subject|7|||
25248912|NCT01155466|50564652|FG001|Overall Study|Withdrawal by Subject|5|||
24900813|NCT00733304|49994827|FG000|Overall Study|Adverse Event|3|||
25329822|NCT00884741|50646031|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
25329823|NCT00884741|50646028|FG000|Randomization|Protocol Violation|0|||
25329824|NCT00884741|50646029|FG001|Randomization|Protocol Violation|0|||
25329825|NCT00884741|50646030|FG002|Randomization|Protocol Violation|8|||
25329826|NCT00884741|50646031|FG003|Randomization|Protocol Violation|8|||
25329827|NCT00598481|50646038|FG000|Treatment|Physician Decision|1|||
25329828|NCT00880763|50646049|FG000|Extension Period (Part 2)|Adverse Event|0|||
25329829|NCT00880763|50646050|FG001|Extension Period (Part 2)|Adverse Event|0|||
25329830|NCT00880763|50646051|FG002|Extension Period (Part 2)|Adverse Event|1|||
25329831|NCT00880763|50646052|FG003|Extension Period (Part 2)|Adverse Event|1|||
25329832|NCT00880763|50646049|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
25248913|NCT01155466|50564653|FG002|Overall Study|Withdrawal by Subject|9|||
25248914|NCT01155466|50564654|FG003|Overall Study|Withdrawal by Subject|4|||
25248915|NCT01155466|50564655|FG004|Overall Study|Withdrawal by Subject|4|||
25248916|NCT01155466|50564651|FG000|Overall Study|Protocol Violation|0|||
25248917|NCT01155466|50564652|FG001|Overall Study|Protocol Violation|0|||
25248918|NCT01155466|50564653|FG002|Overall Study|Protocol Violation|2|||
25329833|NCT00880763|50646050|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
25329834|NCT00880763|50646051|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
25329835|NCT00880763|50646052|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
25329836|NCT00880763|50646049|FG000|Extension Period (Part 2)|Physician Decision|0|||
25329837|NCT00880763|50646050|FG001|Extension Period (Part 2)|Physician Decision|1|||
25248919|NCT01155466|50564654|FG003|Overall Study|Protocol Violation|0|||
25248920|NCT01155466|50564655|FG004|Overall Study|Protocol Violation|1|||
25329838|NCT00880763|50646051|FG002|Extension Period (Part 2)|Physician Decision|1|||
25329839|NCT00880763|50646052|FG003|Extension Period (Part 2)|Physician Decision|0|||
25329840|NCT00880763|50646049|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
25329841|NCT00880763|50646050|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
25329842|NCT00880763|50646051|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
25329843|NCT00880763|50646052|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
25329844|NCT00884273|50646064|FG000|Overall Study|Adverse Event|0|||
25329845|NCT00884273|50646065|FG001|Overall Study|Adverse Event|2|||
25329846|NCT00884273|50646064|FG000|Overall Study|Protocol Violation|1|||
25329847|NCT00884273|50646065|FG001|Overall Study|Protocol Violation|3|||
25329848|NCT00884273|50646064|FG000|Overall Study|Practical reasons|1|||
25329849|NCT00884273|50646065|FG001|Overall Study|Practical reasons|0|||
25329850|NCT00884117|50646071|FG000|Overall Study|Adverse Event|2|||
25329851|NCT00884117|50646071|FG000|Overall Study|Withdrawal by Subject|89|||
25329852|NCT00884117|50646071|FG000|Overall Study|Death|3|||
25329853|NCT00884117|50646071|FG000|Overall Study|Lost to Follow-up|143|||
25329854|NCT00884117|50646071|FG000|Overall Study|Other|12|||
25329855|NCT00884039|50646090|FG000|Overall Study|Withdrawal by Subject|0|||
25248921|NCT01155466|50564651|FG000|Overall Study|Administrative|0|||
25248922|NCT01155466|50564652|FG001|Overall Study|Administrative|3|||
25248923|NCT01155466|50564653|FG002|Overall Study|Administrative|0|||
25248924|NCT01155466|50564654|FG003|Overall Study|Administrative|0|||
25248925|NCT01155466|50564655|FG004|Overall Study|Administrative|0|||
25248926|NCT01155466|50564651|FG000|Overall Study|Randomized not treated|2|||
25248927|NCT01155466|50564652|FG001|Overall Study|Randomized not treated|2|||
25248928|NCT01155466|50564653|FG002|Overall Study|Randomized not treated|3|||
25248929|NCT01155466|50564654|FG003|Overall Study|Randomized not treated|0|||
25248930|NCT01155466|50564655|FG004|Overall Study|Randomized not treated|2|||
25329856|NCT00884039|50646091|FG001|Overall Study|Withdrawal by Subject|1|||
25329857|NCT00884039|50646090|FG000|Overall Study|Lack of Efficacy|2|||
25329858|NCT00884039|50646091|FG001|Overall Study|Lack of Efficacy|0|||
25329859|NCT00835770|50646099|FG000|Overall Study|MS Relapse|17|||
25329860|NCT00835770|50646100|FG001|Overall Study|MS Relapse|23|||
25329861|NCT00835770|50646099|FG000|Overall Study|MS Progression|14|||
25329862|NCT00835770|50646100|FG001|Overall Study|MS Progression|9|||
25329863|NCT00835770|50646099|FG000|Overall Study|Adverse Event|113|||
25329864|NCT00835770|50646100|FG001|Overall Study|Adverse Event|124|||
25329865|NCT00835770|50646099|FG000|Overall Study|Lost to Follow-up|22|||
25329866|NCT00835770|50646100|FG001|Overall Study|Lost to Follow-up|19|||
25077812|NCT03318523|50185672|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
25248931|NCT01155388|50564669|FG000|Overall Study|Adverse Event|1|||
25248932|NCT01155388|50564670|FG001|Overall Study|Adverse Event|0|||
25248933|NCT01154452|50564681|FG000|Phase Ib|Not Treated|1|||
25248934|NCT01154452|50564682|FG001|Phase Ib|Not Treated|0|||
25248935|NCT01154452|50564683|FG002|Phase Ib|Not Treated|0|||
25248936|NCT01154452|50564684|FG003|Phase Ib|Not Treated|0|||
25248937|NCT01154452|50564681|FG000|Phase Ib|Adverse Event|2|||
25329867|NCT00835770|50646099|FG000|Overall Study|Consent Withdrawn|144|||
25329868|NCT00835770|50646100|FG001|Overall Study|Consent Withdrawn|156|||
25248938|NCT01154452|50564682|FG001|Phase Ib|Adverse Event|1|||
25248939|NCT01154452|50564683|FG002|Phase Ib|Adverse Event|0|||
25248940|NCT01154452|50564684|FG003|Phase Ib|Adverse Event|0|||
25248941|NCT01154452|50564681|FG000|Phase II|Withdrawal by Subject|0|||
25329869|NCT00835770|50646099|FG000|Overall Study|Investigator Decision|42|||
25329870|NCT00835770|50646100|FG001|Overall Study|Investigator Decision|42|||
25329871|NCT00835770|50646099|FG000|Overall Study|Participant Non-Compliance|11|||
25329872|NCT00835770|50646100|FG001|Overall Study|Participant Non-Compliance|9|||
25329873|NCT00835770|50646099|FG000|Overall Study|Death|4|||
25329874|NCT00835770|50646100|FG001|Overall Study|Death|6|||
25329875|NCT00835770|50646099|FG000|Overall Study|Other|115|||
25329876|NCT00835770|50646100|FG001|Overall Study|Other|104|||
25329877|NCT00835770|50646099|FG000|Overall Study|Other|2|||
25329878|NCT00835770|50646100|FG001|Overall Study|Other|1|||
25329879|NCT00880685|50646112|FG000|Memantine 10mg|Lost to Follow-up|2|||
25329880|NCT00880685|50646112|FG000|Memantine 20mg|Withdrawal by Subject|1|||
25329881|NCT00835380|50646119|FG000|Overall Study|Withdrawal by Subject|2|||
25329882|NCT00880607|50646125|FG000|Overall Study|Physician Decision|2|||
25329883|NCT00880607|50646126|FG001|Overall Study|Physician Decision|2|||
25329884|NCT00880607|50646125|FG000|Overall Study|Protocol Violation|2|||
25329885|NCT00880607|50646126|FG001|Overall Study|Protocol Violation|1|||
25329886|NCT00880607|50646125|FG000|Overall Study|surgery did not extend past L1 level|3|||
25329887|NCT00880607|50646126|FG001|Overall Study|surgery did not extend past L1 level|0|||
25329888|NCT00835068|50646136|FG000|Overall Study|Death|1|||
25248942|NCT01154452|50564682|FG001|Phase II|Withdrawal by Subject|0|||
25248943|NCT01154452|50564683|FG002|Phase II|Withdrawal by Subject|1|||
25248944|NCT01154452|50564684|FG003|Phase II|Withdrawal by Subject|2|||
25329889|NCT00835068|50646137|FG001|Overall Study|Death|0|||
25329890|NCT00835068|50646136|FG000|Overall Study|Adverse Event|0|||
25329891|NCT00835068|50646137|FG001|Overall Study|Adverse Event|1|||
25329892|NCT00835068|50646136|FG000|Overall Study|Other|8|||
25329893|NCT00835068|50646137|FG001|Overall Study|Other|0|||
25329894|NCT00835068|50646136|FG000|Overall Study|Withdrawal by Subject|1|||
25329895|NCT00835068|50646137|FG001|Overall Study|Withdrawal by Subject|0|||
25329896|NCT00834912|50646149|FG000|Treatment Period 1|Adverse Event|0|||
25329897|NCT00834912|50646150|FG001|Treatment Period 1|Adverse Event|1|||
25329898|NCT00834912|50646151|FG002|Treatment Period 1|Adverse Event|0|||
25329899|NCT00834912|50646152|FG003|Treatment Period 1|Adverse Event|1|||
25329900|NCT00834912|50646153|FG004|Treatment Period 1|Adverse Event|0|||
25329901|NCT00834912|50646154|FG005|Treatment Period 1|Adverse Event|0|||
25329902|NCT00834912|50646149|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25329903|NCT00834912|50646150|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25329904|NCT00834912|50646151|FG002|Treatment Period 2|Withdrawal by Subject|1|||
25329905|NCT00834912|50646152|FG003|Treatment Period 2|Withdrawal by Subject|0|||
25329906|NCT00834912|50646153|FG004|Treatment Period 2|Withdrawal by Subject|1|||
25329907|NCT00834912|50646154|FG005|Treatment Period 2|Withdrawal by Subject|0|||
25329908|NCT00883493|50646164|FG000|Overall Study|Adverse Event|11|||
25329909|NCT00883493|50646165|FG001|Overall Study|Adverse Event|12|||
25329910|NCT00883493|50646164|FG000|Overall Study|Lack of Efficacy|4|||
25329911|NCT00883493|50646165|FG001|Overall Study|Lack of Efficacy|3|||
25329912|NCT00883493|50646164|FG000|Overall Study|Lost to Follow-up|7|||
25248945|NCT01154452|50564681|FG000|Phase II|Adverse Event|0|||
25248946|NCT01154452|50564682|FG001|Phase II|Adverse Event|0|||
24900814|NCT00733304|49994828|FG001|Overall Study|Adverse Event|0|||
24900815|NCT00733304|49994829|FG002|Overall Study|Adverse Event|0|||
24977277|NCT03410992|50065853|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
25248947|NCT01154452|50564683|FG002|Phase II|Adverse Event|4|||
25248948|NCT01154452|50564684|FG003|Phase II|Adverse Event|4|||
25248949|NCT01154296|50564699|FG000|Randomization and Intervention|Decided to decline|1|||
25248950|NCT01154296|50564700|FG001|Randomization and Intervention|Decided to decline|1|||
25248951|NCT01154296|50564699|FG000|Randomization and Intervention|Declined by staff|1|||
25248952|NCT01154296|50564700|FG001|Randomization and Intervention|Declined by staff|0|||
25248953|NCT01154296|50564699|FG000|Randomization and Intervention|Did not return|1|||
25248954|NCT01154296|50564700|FG001|Randomization and Intervention|Did not return|0|||
25248955|NCT01154296|50564699|FG000|Randomization and Intervention|Left before test|0|||
25248956|NCT01154296|50564700|FG001|Randomization and Intervention|Left before test|1|||
25248957|NCT01154296|50564699|FG000|Randomization and Intervention|Left clinic early|2|||
25248958|NCT01154296|50564700|FG001|Randomization and Intervention|Left clinic early|0|||
25248959|NCT01154296|50564699|FG000|6-month Follow-up|Lost contact|269|||
25248960|NCT01154296|50564700|FG001|6-month Follow-up|Lost contact|275|||
25248961|NCT01154296|50564699|FG000|6-month Follow-up|Incarcerated|37|||
25248962|NCT01154296|50564700|FG001|6-month Follow-up|Incarcerated|32|||
25248963|NCT01154296|50564699|FG000|6-month Follow-up|Withdrew consent|14|||
25248964|NCT01154296|50564700|FG001|6-month Follow-up|Withdrew consent|15|||
25248965|NCT01154296|50564699|FG000|6-month Follow-up|Death|3|||
25329913|NCT00883493|50646165|FG001|Overall Study|Lost to Follow-up|6|||
25329914|NCT00883493|50646164|FG000|Overall Study|Withdrawal by Subject|11|||
25329915|NCT00883493|50646165|FG001|Overall Study|Withdrawal by Subject|20|||
25329916|NCT00883493|50646164|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
25329917|NCT00883493|50646165|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
25329918|NCT00883493|50646164|FG000|Overall Study|Study specific disc. criteria|2|||
25329919|NCT00883493|50646165|FG001|Overall Study|Study specific disc. criteria|0|||
25329920|NCT00883493|50646164|FG000|Overall Study|Other|5|||
25329921|NCT00883493|50646165|FG001|Overall Study|Other|3|||
25329922|NCT04887922|50646180|FG000|1st Randomization|Decided not to have surgery|0|||
25329923|NCT04887922|50646181|FG001|1st Randomization|Decided not to have surgery|1|||
25329924|NCT04887922|50646182|FG002|1st Randomization|Decided not to have surgery|0|||
25329925|NCT04887922|50646183|FG003|1st Randomization|Decided not to have surgery|0|||
25329926|NCT04887922|50646184|FG004|1st Randomization|Decided not to have surgery|0|||
25329927|NCT04771403|50646207|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
25329928|NCT04771403|50646208|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
25329929|NCT04771403|50646207|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
25329930|NCT04771403|50646208|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
25329931|NCT04771403|50646207|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
25329932|NCT04771403|50646208|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
25329933|NCT04771403|50646207|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
25329934|NCT04771403|50646208|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
25329935|NCT04771403|50646207|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
25329936|NCT04771403|50646208|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
25329937|NCT04771403|50646207|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
25329938|NCT04771403|50646208|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
25329939|NCT04771403|50646207|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
25329940|NCT04771403|50646208|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
25329941|NCT04771403|50646207|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
25329942|NCT04771403|50646208|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
25329943|NCT04698525|50646217|FG000|Overall Study|Lost to Follow-up|1|||
25329944|NCT04698525|50646218|FG001|Overall Study|Lost to Follow-up|2|||
25329945|NCT04698525|50646217|FG000|Overall Study|Three suffered of Covid-19|2|||
25329946|NCT04698525|50646218|FG001|Overall Study|Three suffered of Covid-19|1|||
25329947|NCT04510675|50646232|FG000|Overall Study|Withdrawal by Subject|5|||
25329948|NCT04228783|50646254|FG000|Overall Study|Adverse Event|1|||
25329949|NCT04228783|50646255|FG001|Overall Study|Adverse Event|0|||
25329950|NCT04228783|50646256|FG002|Overall Study|Adverse Event|2|||
25329951|NCT04228783|50646257|FG003|Overall Study|Adverse Event|0|||
25329952|NCT04228783|50646258|FG004|Overall Study|Adverse Event|0|||
25329953|NCT04228783|50646259|FG005|Overall Study|Adverse Event|1|||
25329954|NCT04228783|50646254|FG000|Overall Study|Death|0|||
25329955|NCT04228783|50646255|FG001|Overall Study|Death|0|||
25329956|NCT04228783|50646256|FG002|Overall Study|Death|0|||
25329957|NCT04228783|50646257|FG003|Overall Study|Death|0|||
25329958|NCT04228783|50646258|FG004|Overall Study|Death|1|||
25329959|NCT04228783|50646259|FG005|Overall Study|Death|0|||
25329960|NCT04228783|50646254|FG000|Overall Study|Lost to Follow-up|36|||
25329961|NCT04228783|50646255|FG001|Overall Study|Lost to Follow-up|36|||
25329962|NCT04228783|50646256|FG002|Overall Study|Lost to Follow-up|28|||
25329963|NCT04228783|50646257|FG003|Overall Study|Lost to Follow-up|6|||
25329964|NCT04228783|50646258|FG004|Overall Study|Lost to Follow-up|14|||
25329965|NCT04228783|50646259|FG005|Overall Study|Lost to Follow-up|3|||
25329966|NCT04228783|50646254|FG000|Overall Study|Physician Decision|1|||
25329967|NCT04228783|50646255|FG001|Overall Study|Physician Decision|2|||
25329968|NCT04228783|50646256|FG002|Overall Study|Physician Decision|0|||
25329969|NCT04228783|50646257|FG003|Overall Study|Physician Decision|0|||
25329970|NCT04228783|50646258|FG004|Overall Study|Physician Decision|0|||
25329971|NCT04228783|50646259|FG005|Overall Study|Physician Decision|0|||
25329972|NCT04228783|50646254|FG000|Overall Study|Protocol Violation|0|||
24900816|NCT00733304|49994827|FG000|Overall Study|Lack of Efficacy|0|||
24900817|NCT00733304|49994828|FG001|Overall Study|Lack of Efficacy|0|||
24900818|NCT00733304|49994829|FG002|Overall Study|Lack of Efficacy|2|||
24900819|NCT00733304|49994827|FG000|Overall Study|Lost to Follow-up|0|||
24900820|NCT00733304|49994828|FG001|Overall Study|Lost to Follow-up|1|||
24900821|NCT00733304|49994829|FG002|Overall Study|Lost to Follow-up|0|||
24900822|NCT00733304|49994827|FG000|Overall Study|Physician Decision|3|||
24900823|NCT00733304|49994828|FG001|Overall Study|Physician Decision|1|||
24900824|NCT00733304|49994829|FG002|Overall Study|Physician Decision|3|||
24900825|NCT00733304|49994827|FG000|Overall Study|Withdrawal by Subject|1|||
25248966|NCT01154296|50564700|FG001|6-month Follow-up|Death|2|||
24900826|NCT00733304|49994828|FG001|Overall Study|Withdrawal by Subject|1|||
24900827|NCT00733304|49994829|FG002|Overall Study|Withdrawal by Subject|0|||
24900828|NCT00711243|49994843|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
25329973|NCT04228783|50646255|FG001|Overall Study|Protocol Violation|0|||
25329974|NCT04228783|50646256|FG002|Overall Study|Protocol Violation|0|||
25329975|NCT04228783|50646257|FG003|Overall Study|Protocol Violation|1|||
25248967|NCT01154296|50564699|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
25248968|NCT01154296|50564700|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
25248969|NCT01154218|50564706|FG000|Third Intervention Period|Adverse Event|0|||
25248970|NCT01154218|50564707|FG001|Third Intervention Period|Adverse Event|1|||
25248971|NCT01154218|50564708|FG002|Third Intervention Period|Adverse Event|0|||
25248972|NCT01154218|50564709|FG003|Third Intervention Period|Adverse Event|0|||
25329976|NCT04228783|50646258|FG004|Overall Study|Protocol Violation|0|||
25329977|NCT04228783|50646259|FG005|Overall Study|Protocol Violation|0|||
25329978|NCT04228783|50646254|FG000|Overall Study|Withdrawal by Subject|6|||
25329979|NCT04228783|50646255|FG001|Overall Study|Withdrawal by Subject|10|||
25329980|NCT04228783|50646256|FG002|Overall Study|Withdrawal by Subject|19|||
25329981|NCT04228783|50646257|FG003|Overall Study|Withdrawal by Subject|1|||
25329982|NCT04228783|50646258|FG004|Overall Study|Withdrawal by Subject|2|||
25329983|NCT04228783|50646259|FG005|Overall Study|Withdrawal by Subject|0|||
25329984|NCT04228783|50646254|FG000|Overall Study|Other|4|||
25329985|NCT04228783|50646255|FG001|Overall Study|Other|3|||
25329986|NCT04228783|50646256|FG002|Overall Study|Other|2|||
25329987|NCT04228783|50646257|FG003|Overall Study|Other|1|||
25329988|NCT04228783|50646258|FG004|Overall Study|Other|0|||
25329989|NCT04228783|50646259|FG005|Overall Study|Other|0|||
25329990|NCT03950674|50646275|FG000|Overall Study|Death|3|||
25329991|NCT03950674|50646276|FG001|Overall Study|Death|7|||
25329992|NCT03950674|50646275|FG000|Overall Study|Ongoing in Study|22|||
25329993|NCT03950674|50646276|FG001|Overall Study|Ongoing in Study|8|||
25329994|NCT03702621|50646285|FG000|Overall Study|Physician Decision|6|||
25329995|NCT03702621|50646286|FG001|Overall Study|Physician Decision|6|||
25329996|NCT03577990|50646294|FG000|Overall Study|Lost to Follow-up|4|||
25329997|NCT03577990|50646295|FG001|Overall Study|Lost to Follow-up|6|||
25329998|NCT03577990|50646294|FG000|Overall Study|Withdrawal by Subject|4|||
25329999|NCT03577990|50646295|FG001|Overall Study|Withdrawal by Subject|7|||
25330000|NCT03565497|50646305|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
25330001|NCT03565497|50646306|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
25330002|NCT03565497|50646307|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
25330003|NCT03565497|50646305|FG000|Overall Study|Lost to Follow-up|1|||
25330004|NCT03565497|50646306|FG001|Overall Study|Lost to Follow-up|1|||
25330005|NCT03565497|50646307|FG002|Overall Study|Lost to Follow-up|2|||
25330006|NCT03565497|50646305|FG000|Overall Study|Withdrawal by Subject|1|||
25330007|NCT03565497|50646306|FG001|Overall Study|Withdrawal by Subject|1|||
25330008|NCT03565497|50646307|FG002|Overall Study|Withdrawal by Subject|1|||
25330009|NCT03362931|50646315|FG000|Overall Study|Adverse Event|1|||
25330010|NCT03362931|50646315|FG000|Overall Study|Death|2|||
25330011|NCT03360019|50646322|FG000|Overall Study|Withdrawal by Subject|2|||
25330012|NCT03360019|50646323|FG001|Overall Study|Withdrawal by Subject|0|||
25248973|NCT01154218|50564706|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
25248974|NCT01154218|50564707|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
25248975|NCT01154218|50564708|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
25248976|NCT01154218|50564709|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
25248977|NCT01154218|50564706|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
25248978|NCT01154218|50564707|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
25248979|NCT01154218|50564708|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
25248980|NCT01154218|50564709|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
25248981|NCT01154140|50564734|FG000|Overall Study|Death|71|||
25248982|NCT01154140|50564735|FG001|Overall Study|Death|81|||
25248983|NCT01154140|50564734|FG000|Overall Study|Lost to Follow-up|4|||
25248984|NCT01154140|50564735|FG001|Overall Study|Lost to Follow-up|5|||
25248985|NCT01154140|50564734|FG000|Overall Study|Withdrawal by Subject|12|||
25248986|NCT01154140|50564735|FG001|Overall Study|Withdrawal by Subject|13|||
25248987|NCT01154140|50564734|FG000|Overall Study|Other|3|||
25248988|NCT01154140|50564735|FG001|Overall Study|Other|1|||
25248989|NCT01154140|50564734|FG000|Overall Study|Randomized but not treated|1|||
25248990|NCT01154140|50564735|FG001|Overall Study|Randomized but not treated|2|||
25248991|NCT01154101|50564746|FG000|Overall Study|Adverse Event|0|||
25248992|NCT01154101|50564747|FG001|Overall Study|Adverse Event|2|||
25248993|NCT01154101|50564748|FG002|Overall Study|Adverse Event|1|||
25248994|NCT01154101|50564749|FG003|Overall Study|Adverse Event|1|||
25248995|NCT01154101|50564750|FG004|Overall Study|Adverse Event|0|||
25248996|NCT01154101|50564746|FG000|Overall Study|Lost to Follow-up|0|||
25248997|NCT01154101|50564747|FG001|Overall Study|Lost to Follow-up|1|||
25248998|NCT01154101|50564748|FG002|Overall Study|Lost to Follow-up|0|||
25330013|NCT03360019|50646324|FG002|Overall Study|Withdrawal by Subject|0|||
25330014|NCT03360019|50646322|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
25248999|NCT01154101|50564749|FG003|Overall Study|Lost to Follow-up|1|||
25330015|NCT03360019|50646323|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
25330016|NCT03360019|50646324|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
25249000|NCT01154101|50564750|FG004|Overall Study|Lost to Follow-up|0|||
25249001|NCT01154101|50564746|FG000|Overall Study|Withdrawal by Subject|0|||
25249002|NCT01154101|50564747|FG001|Overall Study|Withdrawal by Subject|1|||
25249003|NCT01154101|50564748|FG002|Overall Study|Withdrawal by Subject|2|||
25249004|NCT01154101|50564749|FG003|Overall Study|Withdrawal by Subject|0|||
25249005|NCT01154101|50564750|FG004|Overall Study|Withdrawal by Subject|1|||
25249006|NCT01153984|50564767|FG000|Overall Study|Withdrawal by Subject|1|||
25249007|NCT01153984|50564767|FG000|Overall Study|Adverse Event|1|||
25249008|NCT01153633|50564773|FG000|Overall Study|Protocol Violation|1|||
25249009|NCT01153633|50564774|FG001|Overall Study|Protocol Violation|1|||
25249010|NCT01153633|50564773|FG000|Overall Study|Therapeutic failure|3|||
25249011|NCT01153633|50564774|FG001|Overall Study|Therapeutic failure|3|||
25249012|NCT01153516|50564784|FG000|Overall Study|Both subjects refused surgery|2|||
25249013|NCT01153516|50564785|FG001|Overall Study|Both subjects refused surgery|0|||
25249014|NCT01153321|50564793|FG000|Overall Study|Development of study withdrawal criteria|0|||
25249015|NCT01153321|50564794|FG001|Overall Study|Development of study withdrawal criteria|1|||
25249016|NCT01153321|50564793|FG000|Overall Study|Withdrawal by Subject|0|||
25330017|NCT03260894|50646338|FG000|Overall Study|Death|6|||
25330018|NCT03260894|50646339|FG001|Overall Study|Death|8|||
25330019|NCT03260894|50646338|FG000|Overall Study|Withdrawal by Subject|4|||
25330020|NCT03260894|50646339|FG001|Overall Study|Withdrawal by Subject|11|||
25330021|NCT03260894|50646338|FG000|Overall Study|On-going at clinical cut off date|36|||
25330022|NCT03260894|50646339|FG001|Overall Study|On-going at clinical cut off date|31|||
25330023|NCT03245008|50646350|FG000|Overall Study|Adverse Event|15|||
25330024|NCT03245008|50646351|FG001|Overall Study|Adverse Event|18|||
25330025|NCT03245008|50646352|FG002|Overall Study|Adverse Event|15|||
25330026|NCT03245008|50646353|FG003|Overall Study|Adverse Event|0|||
25330027|NCT03245008|50646354|FG004|Overall Study|Adverse Event|1|||
25330028|NCT03245008|50646350|FG000|Overall Study|Lack of Efficacy|0|||
25330029|NCT03245008|50646351|FG001|Overall Study|Lack of Efficacy|1|||
25330030|NCT03245008|50646352|FG002|Overall Study|Lack of Efficacy|0|||
25330031|NCT03245008|50646353|FG003|Overall Study|Lack of Efficacy|0|||
25330032|NCT03245008|50646354|FG004|Overall Study|Lack of Efficacy|0|||
25330033|NCT03245008|50646350|FG000|Overall Study|Lost to Follow-up|4|||
25330034|NCT03245008|50646351|FG001|Overall Study|Lost to Follow-up|1|||
25249017|NCT01153321|50564794|FG001|Overall Study|Withdrawal by Subject|1|||
25330035|NCT03245008|50646352|FG002|Overall Study|Lost to Follow-up|0|||
25330036|NCT03245008|50646353|FG003|Overall Study|Lost to Follow-up|0|||
25330037|NCT03245008|50646354|FG004|Overall Study|Lost to Follow-up|1|||
25330038|NCT03245008|50646350|FG000|Overall Study|Physician Decision|1|||
25330039|NCT03245008|50646351|FG001|Overall Study|Physician Decision|3|||
25330040|NCT03245008|50646352|FG002|Overall Study|Physician Decision|4|||
25330041|NCT03245008|50646353|FG003|Overall Study|Physician Decision|0|||
25330042|NCT03245008|50646354|FG004|Overall Study|Physician Decision|0|||
25330043|NCT03245008|50646350|FG000|Overall Study|Protocol Violation|0|||
25330044|NCT03245008|50646351|FG001|Overall Study|Protocol Violation|1|||
25330045|NCT03245008|50646352|FG002|Overall Study|Protocol Violation|0|||
25330046|NCT03245008|50646353|FG003|Overall Study|Protocol Violation|0|||
25330047|NCT03245008|50646354|FG004|Overall Study|Protocol Violation|0|||
25330048|NCT03245008|50646350|FG000|Overall Study|Withdrawal by Subject|20|||
25249018|NCT01153321|50564793|FG000|Overall Study|Adverse Event|1|||
25249019|NCT01153321|50564794|FG001|Overall Study|Adverse Event|1|||
25249020|NCT01153009|50564804|FG000|Overall Study|Adverse Event|4|||
25249021|NCT01153009|50564805|FG001|Overall Study|Adverse Event|14|||
25249022|NCT01153009|50564806|FG002|Overall Study|Adverse Event|14|||
25249023|NCT01153009|50564807|FG003|Overall Study|Adverse Event|10|||
25249024|NCT01153009|50564804|FG000|Overall Study|Lack of Efficacy|9|||
25249025|NCT01153009|50564805|FG001|Overall Study|Lack of Efficacy|0|||
25249026|NCT01153009|50564806|FG002|Overall Study|Lack of Efficacy|2|||
25249027|NCT01153009|50564807|FG003|Overall Study|Lack of Efficacy|1|||
25249028|NCT01153009|50564804|FG000|Overall Study|Noncompliance with Study Medication|1|||
25249029|NCT01153009|50564805|FG001|Overall Study|Noncompliance with Study Medication|3|||
25249030|NCT01153009|50564806|FG002|Overall Study|Noncompliance with Study Medication|4|||
25249031|NCT01153009|50564807|FG003|Overall Study|Noncompliance with Study Medication|1|||
25249032|NCT01153009|50564804|FG000|Overall Study|Protocol Deviations|4|||
25249033|NCT01153009|50564805|FG001|Overall Study|Protocol Deviations|3|||
25249034|NCT01153009|50564806|FG002|Overall Study|Protocol Deviations|3|||
25249035|NCT01153009|50564807|FG003|Overall Study|Protocol Deviations|2|||
25249036|NCT01153009|50564804|FG000|Overall Study|Withdrawal of Consent|5|||
25249037|NCT01153009|50564805|FG001|Overall Study|Withdrawal of Consent|5|||
25330049|NCT03245008|50646351|FG001|Overall Study|Withdrawal by Subject|19|||
25330050|NCT03245008|50646352|FG002|Overall Study|Withdrawal by Subject|11|||
25330051|NCT03245008|50646353|FG003|Overall Study|Withdrawal by Subject|0|||
25330052|NCT03245008|50646354|FG004|Overall Study|Withdrawal by Subject|0|||
25330053|NCT03245008|50646350|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
25330054|NCT03245008|50646351|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
25330055|NCT03245008|50646352|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
25330056|NCT03245008|50646353|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
25330057|NCT03245008|50646354|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
25249038|NCT01153009|50564806|FG002|Overall Study|Withdrawal of Consent|4|||
25249039|NCT01153009|50564807|FG003|Overall Study|Withdrawal of Consent|6|||
25249040|NCT01153009|50564804|FG000|Overall Study|Lost to Follow-up|8|||
25249041|NCT01153009|50564805|FG001|Overall Study|Lost to Follow-up|8|||
25249042|NCT01153009|50564806|FG002|Overall Study|Lost to Follow-up|11|||
25249043|NCT01153009|50564807|FG003|Overall Study|Lost to Follow-up|15|||
25249044|NCT01153009|50564804|FG000|Overall Study|Other|1|||
25249045|NCT01153009|50564805|FG001|Overall Study|Other|1|||
25249046|NCT01153009|50564806|FG002|Overall Study|Other|3|||
25249047|NCT01153009|50564807|FG003|Overall Study|Other|2|||
25249048|NCT01152814|50564817|FG000|Overall Study|Lost to Follow-up|2|||
25249049|NCT01152580|50564823|FG000|Overall Study|Withdrawal by Subject|0|||
25249050|NCT01152580|50564824|FG001|Overall Study|Withdrawal by Subject|1|||
25249051|NCT01152385|50564834|FG000|Overall Study|Withdrawal by Subject|3|||
25249052|NCT01152385|50564835|FG001|Overall Study|Withdrawal by Subject|1|||
25249053|NCT01152385|50564836|FG002|Overall Study|Withdrawal by Subject|1|||
25249054|NCT01152385|50564837|FG003|Overall Study|Withdrawal by Subject|1|||
25249055|NCT01152385|50564834|FG000|Overall Study|Protocol Violation|0|||
25249056|NCT01152385|50564835|FG001|Overall Study|Protocol Violation|0|||
25330058|NCT03245008|50646350|FG000|Overall Study|Failure to meet randomization criteria|0|||
25330059|NCT03245008|50646351|FG001|Overall Study|Failure to meet randomization criteria|1|||
25330060|NCT03245008|50646352|FG002|Overall Study|Failure to meet randomization criteria|0|||
25330061|NCT03245008|50646353|FG003|Overall Study|Failure to meet randomization criteria|1|||
25330062|NCT03245008|50646354|FG004|Overall Study|Failure to meet randomization criteria|0|||
25330063|NCT03203473|50646376|FG000|Induction Phase|Never started primary treatment|2|||
25330064|NCT03203473|50646377|FG001|Induction Phase|Never started primary treatment|0|||
25330065|NCT03203473|50646378|FG002|Induction Phase|Never started primary treatment|0|||
25330066|NCT03203473|50646376|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
25249057|NCT01152385|50564836|FG002|Overall Study|Protocol Violation|0|||
25249058|NCT01152385|50564837|FG003|Overall Study|Protocol Violation|1|||
25249059|NCT01152385|50564834|FG000|Overall Study|Adverse Event|1|||
25249060|NCT01152385|50564835|FG001|Overall Study|Adverse Event|1|||
25249061|NCT01152385|50564836|FG002|Overall Study|Adverse Event|0|||
25249062|NCT01152385|50564837|FG003|Overall Study|Adverse Event|0|||
25249063|NCT01152385|50564834|FG000|Overall Study|Study-specific withdrawal criteria|1|||
25249064|NCT01152385|50564835|FG001|Overall Study|Study-specific withdrawal criteria|1|||
25249065|NCT01152385|50564836|FG002|Overall Study|Study-specific withdrawal criteria|2|||
25249066|NCT01152385|50564837|FG003|Overall Study|Study-specific withdrawal criteria|0|||
25249067|NCT01152385|50564834|FG000|Overall Study|Other|4|||
25249068|NCT01152385|50564835|FG001|Overall Study|Other|3|||
25249069|NCT01152385|50564836|FG002|Overall Study|Other|2|||
25249070|NCT01152385|50564837|FG003|Overall Study|Other|3|||
25249071|NCT01152190|50564853|FG000|Overall Study|Adverse Event|2|||
25249072|NCT01152190|50564854|FG001|Overall Study|Adverse Event|4|||
25249073|NCT01152190|50564853|FG000|Overall Study|Death|1|||
25249074|NCT01152190|50564854|FG001|Overall Study|Death|0|||
25249075|NCT01152190|50564853|FG000|Overall Study|Protocol Violation|1|||
25249076|NCT01152190|50564854|FG001|Overall Study|Protocol Violation|1|||
25249077|NCT01152190|50564853|FG000|Overall Study|Withdrawal by Subject|1|||
25249078|NCT01152190|50564854|FG001|Overall Study|Withdrawal by Subject|3|||
25249079|NCT01151410|50564862|FG000|Overall Study|Withdrawal by Subject|3|||
25249080|NCT01151410|50564863|FG001|Overall Study|Withdrawal by Subject|5|||
25249081|NCT01151410|50564862|FG000|Overall Study|Lost to Follow-up|3|||
25249082|NCT01151410|50564863|FG001|Overall Study|Lost to Follow-up|4|||
25249083|NCT01151410|50564862|FG000|Overall Study|Adverse Event|1|||
25249084|NCT01151410|50564863|FG001|Overall Study|Adverse Event|2|||
25249085|NCT01151410|50564862|FG000|Overall Study|Protocol deviation|2|||
25249086|NCT01151410|50564863|FG001|Overall Study|Protocol deviation|1|||
25249087|NCT01151410|50564862|FG000|Overall Study|Administrative problems|1|||
25249088|NCT01151410|50564863|FG001|Overall Study|Administrative problems|1|||
25249089|NCT01151410|50564862|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25249090|NCT01151410|50564863|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
25249091|NCT01151410|50564862|FG000|Overall Study|Abnormal laboratory value(s)|0|||
25249092|NCT01151410|50564863|FG001|Overall Study|Abnormal laboratory value(s)|1|||
25249093|NCT01151215|50564872|FG000|Overall Study|Worsening of condition under study|1|||
24900829|NCT00711243|49994844|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
24900830|NCT00711243|49994845|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
24977278|NCT03410992|50065854|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
25249094|NCT01151215|50564873|FG001|Overall Study|Worsening of condition under study|1|||
25249095|NCT01151215|50564874|FG002|Overall Study|Worsening of condition under study|1|||
25249096|NCT01151215|50564872|FG000|Overall Study|Death|16|||
25249097|NCT01151215|50564873|FG001|Overall Study|Death|20|||
25249098|NCT01151215|50564874|FG002|Overall Study|Death|11|||
25249099|NCT01151215|50564872|FG000|Overall Study|Lost to Follow-up|0|||
25330067|NCT03203473|50646377|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
25330068|NCT03203473|50646378|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
25330069|NCT03203473|50646376|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
25330070|NCT03203473|50646377|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
25330071|NCT03203473|50646378|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
25330072|NCT03203473|50646376|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
25330073|NCT03203473|50646377|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
25330074|NCT03203473|50646378|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
25330075|NCT03203473|50646376|FG000|Arm Allocation Phase|started salvage therapy|0|||
25330076|NCT03203473|50646377|FG001|Arm Allocation Phase|started salvage therapy|5|||
25330077|NCT03203473|50646378|FG002|Arm Allocation Phase|started salvage therapy|0|||
25330078|NCT03203473|50646376|FG000|Arm Allocation Phase|Disease progression|0|||
25330079|NCT03203473|50646377|FG001|Arm Allocation Phase|Disease progression|0|||
25330080|NCT03203473|50646378|FG002|Arm Allocation Phase|Disease progression|37|||
25330081|NCT03203473|50646376|FG000|Arm Allocation Phase|Adverse Event|0|||
25330082|NCT03203473|50646377|FG001|Arm Allocation Phase|Adverse Event|0|||
25330083|NCT03203473|50646378|FG002|Arm Allocation Phase|Adverse Event|11|||
25330084|NCT03203473|50646376|FG000|Arm Allocation Phase|Physician Decision|0|||
25330085|NCT03203473|50646377|FG001|Arm Allocation Phase|Physician Decision|0|||
25330086|NCT03203473|50646378|FG002|Arm Allocation Phase|Physician Decision|3|||
25330087|NCT03203473|50646376|FG000|Arm Allocation Phase|Death|0|||
25330088|NCT03203473|50646377|FG001|Arm Allocation Phase|Death|0|||
25330089|NCT03203473|50646378|FG002|Arm Allocation Phase|Death|1|||
25330090|NCT03203473|50646376|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
25330091|NCT03203473|50646377|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
25330092|NCT03203473|50646378|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
25330093|NCT03203473|50646376|FG000|Arm Allocation Phase|Intercurrent illness|0|||
25330094|NCT03203473|50646377|FG001|Arm Allocation Phase|Intercurrent illness|0|||
25330095|NCT03203473|50646378|FG002|Arm Allocation Phase|Intercurrent illness|1|||
25330096|NCT03203473|50646376|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
25330097|NCT03203473|50646377|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
25330098|NCT03203473|50646378|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
25330099|NCT03191786|50646391|FG000|Overall Study|Death|236|||
25330100|NCT03191786|50646392|FG001|Overall Study|Death|127|||
25249100|NCT01151215|50564873|FG001|Overall Study|Lost to Follow-up|0|||
25249101|NCT01151215|50564874|FG002|Overall Study|Lost to Follow-up|3|||
25249102|NCT01151215|50564872|FG000|Overall Study|Withdrawal by Subject|3|||
25249103|NCT01151215|50564873|FG001|Overall Study|Withdrawal by Subject|1|||
25249104|NCT01151215|50564874|FG002|Overall Study|Withdrawal by Subject|2|||
25249105|NCT01151215|50564872|FG000|Overall Study|Disease progression|0|||
25249106|NCT01151215|50564873|FG001|Overall Study|Disease progression|1|||
25249107|NCT01151215|50564874|FG002|Overall Study|Disease progression|1|||
25249108|NCT01151215|50564872|FG000|Overall Study|Safety as judged by the investigator|0|||
25249109|NCT01151215|50564873|FG001|Overall Study|Safety as judged by the investigator|0|||
25330101|NCT03191786|50646391|FG000|Overall Study|Lost to Follow-up|9|||
25330102|NCT03191786|50646392|FG001|Overall Study|Lost to Follow-up|3|||
25330103|NCT03191786|50646391|FG000|Overall Study|Physician Decision|1|||
25330104|NCT03191786|50646392|FG001|Overall Study|Physician Decision|0|||
25330105|NCT03191786|50646391|FG000|Overall Study|Study Terminated By Sponsor|15|||
25330106|NCT03191786|50646392|FG001|Overall Study|Study Terminated By Sponsor|5|||
25330107|NCT03191786|50646391|FG000|Overall Study|Withdrawal by Subject|26|||
25330108|NCT03191786|50646392|FG001|Overall Study|Withdrawal by Subject|16|||
25330109|NCT03158051|50646400|FG000|Overall Study|Lost to Follow-up|41|||
24900831|NCT00711243|49994846|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
24900832|NCT00711243|49994847|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
24900833|NCT00711243|49994848|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
24900834|NCT00711243|49994843|FG000|Reached First Response/4 Cycles|Death|0|||
24900835|NCT00711243|49994844|FG001|Reached First Response/4 Cycles|Death|0|||
24900836|NCT00711243|49994845|FG002|Reached First Response/4 Cycles|Death|0|||
24900837|NCT00711243|49994846|FG003|Reached First Response/4 Cycles|Death|0|||
24900838|NCT00711243|49994847|FG004|Reached First Response/4 Cycles|Death|0|||
24900839|NCT00711243|49994848|FG005|Reached First Response/4 Cycles|Death|2|||
24900840|NCT00711243|49994843|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
25249110|NCT01151215|50564874|FG002|Overall Study|Safety as judged by the investigator|1|||
25249111|NCT01151137|50564884|FG000|Overall Study|Death|15|||
25249112|NCT01151137|50564885|FG001|Overall Study|Death|27|||
25249113|NCT01151137|50564884|FG000|Overall Study|Lost to Follow-up|1|||
25249114|NCT01151137|50564885|FG001|Overall Study|Lost to Follow-up|1|||
25249115|NCT01151098|50564891|FG000|Overall Study|Adverse Event|82|||
25330110|NCT03158051|50646401|FG001|Overall Study|Lost to Follow-up|47|||
25330111|NCT03158051|50646400|FG000|Overall Study|Physician Decision|6|||
25330112|NCT03158051|50646401|FG001|Overall Study|Physician Decision|7|||
25330113|NCT03158051|50646400|FG000|Overall Study|Withdrawal by Subject|24|||
25330114|NCT03158051|50646401|FG001|Overall Study|Withdrawal by Subject|15|||
25330115|NCT03158051|50646400|FG000|Overall Study|Death|0|||
25330116|NCT03158051|50646401|FG001|Overall Study|Death|1|||
25330117|NCT03051659|50646418|FG000|Treatment Period|Withdrawal by Subject|0|||
25330118|NCT03051659|50646419|FG001|Treatment Period|Withdrawal by Subject|2|||
25330119|NCT03051659|50646418|FG000|Survival Follow-up|Lost to Follow-up|23|||
25330120|NCT03051659|50646419|FG001|Survival Follow-up|Lost to Follow-up|22|||
25330121|NCT02971761|50646425|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
25330122|NCT02724878|50646429|FG000|Overall Study|Still on Active Therapy|15|||
25330123|NCT02724878|50646429|FG000|Overall Study|Disease Progression|31|||
25330124|NCT02724878|50646429|FG000|Overall Study|Toxicity|5|||
25249116|NCT01151098|50564891|FG000|Overall Study|Lost to Follow-up|6|||
25249117|NCT01151098|50564891|FG000|Overall Study|Lack of Efficacy|15|||
25249118|NCT01151098|50564891|FG000|Overall Study|Protocol Violation|1|||
25249119|NCT01151098|50564891|FG000|Overall Study|Miscellaneous|13|||
25249120|NCT01151020|50564895|FG000|Overall Study|Death|25|||
25249121|NCT01151020|50564895|FG000|Overall Study|Conversion to open repair|1|||
25249122|NCT01151020|50564895|FG000|Overall Study|Lost to Follow-up|4|||
25249123|NCT01151020|50564895|FG000|Overall Study|Withdrawal by Subject|22|||
25249124|NCT01151020|50564895|FG000|Overall Study|Patients did not receive the device|2|||
25330125|NCT02724878|50646429|FG000|Overall Study|Death|1|||
24900841|NCT00711243|49994844|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
24900842|NCT00711243|49994845|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
24900843|NCT00711243|49994846|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
24900844|NCT00711243|49994847|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
24900845|NCT00711243|49994848|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
24900846|NCT00711243|49994843|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
24900847|NCT00711243|49994844|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
24900848|NCT00711243|49994845|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
24900849|NCT00711243|49994846|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
24900850|NCT00711243|49994847|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
24900851|NCT00711243|49994848|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
24900852|NCT00711243|49994843|FG000|Treated Cycle 5 After First Response|Death|0|||
24900853|NCT00711243|49994844|FG001|Treated Cycle 5 After First Response|Death|0|||
24900854|NCT00711243|49994845|FG002|Treated Cycle 5 After First Response|Death|0|||
24900855|NCT00711243|49994846|FG003|Treated Cycle 5 After First Response|Death|0|||
24900856|NCT00711243|49994847|FG004|Treated Cycle 5 After First Response|Death|0|||
24900857|NCT00711243|49994848|FG005|Treated Cycle 5 After First Response|Death|2|||
24900858|NCT00711243|49994843|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
24900859|NCT00711243|49994844|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
24900860|NCT00711243|49994845|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
24900861|NCT00711243|49994846|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
24900862|NCT00711243|49994847|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
24900863|NCT00711243|49994848|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
24900864|NCT00711243|49994843|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
24900865|NCT00711243|49994844|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
24900866|NCT00711243|49994845|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
24900867|NCT00711243|49994846|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
24900868|NCT00711243|49994847|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
24900869|NCT00711243|49994848|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
24900870|NCT00733226|49994866|FG000|Overall Study|Withdrawal by Subject|1|||
24900871|NCT00733226|49994867|FG001|Overall Study|Withdrawal by Subject|0|||
24900872|NCT00733226|49994866|FG000|Overall Study|Lost to Follow-up|2|||
24900873|NCT00733226|49994867|FG001|Overall Study|Lost to Follow-up|0|||
24900874|NCT00733226|49994866|FG000|Overall Study|moved to another place|2|||
24900875|NCT00733226|49994867|FG001|Overall Study|moved to another place|0|||
24900876|NCT00732992|49994875|FG000|Overall Study|Adverse Event|1|||
24900877|NCT00732992|49994876|FG001|Overall Study|Adverse Event|1|||
24900878|NCT00732992|49994875|FG000|Overall Study|Objective Progression or Relapse|3|||
24900879|NCT00732992|49994876|FG001|Overall Study|Objective Progression or Relapse|5|||
24900880|NCT00732992|49994875|FG000|Overall Study|Global Deterioration of Health Status|1|||
24900881|NCT00732992|49994876|FG001|Overall Study|Global Deterioration of Health Status|0|||
24900882|NCT00732992|49994875|FG000|Overall Study|Withdrawal by Subject|1|||
24900883|NCT00732992|49994876|FG001|Overall Study|Withdrawal by Subject|0|||
24900884|NCT00732758|49994885|FG000|Overall Study|Lost to Follow-up|8|||
24900885|NCT00732758|49994886|FG001|Overall Study|Lost to Follow-up|16|||
25249125|NCT01150474|50564901|FG000|Overall Study|Withdrawal by Subject|5|||
25249126|NCT01150474|50564902|FG001|Overall Study|Withdrawal by Subject|2|||
25249127|NCT01150474|50564901|FG000|Overall Study|Cancer found|1|||
25249128|NCT01150474|50564902|FG001|Overall Study|Cancer found|0|||
25249129|NCT01150474|50564901|FG000|Overall Study|Multiple Studies|0|||
25330126|NCT02724878|50646429|FG000|Overall Study|Withdrawal by Subject|4|||
25330127|NCT02724878|50646429|FG000|Overall Study|Lost to Follow-up|2|||
25330128|NCT02724878|50646429|FG000|Overall Study|Protocol Violation|1|||
25249130|NCT01150474|50564902|FG001|Overall Study|Multiple Studies|1|||
25249131|NCT01150474|50564901|FG000|Overall Study|Rectotomy|1|||
25249132|NCT01150474|50564902|FG001|Overall Study|Rectotomy|0|||
25249133|NCT01150474|50564901|FG000|Overall Study|Drug did not arrive in time|1|||
25249134|NCT01150474|50564902|FG001|Overall Study|Drug did not arrive in time|0|||
25249135|NCT01150474|50564901|FG000|Overall Study|Drug not administered|1|||
25249136|NCT01150474|50564902|FG001|Overall Study|Drug not administered|0|||
25249137|NCT01150474|50564901|FG000|Overall Study|Surgery Changed|1|||
25249138|NCT01150474|50564902|FG001|Overall Study|Surgery Changed|0|||
25249139|NCT01150357|50564911|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
25249140|NCT01150357|50564912|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
25249141|NCT01150357|50564913|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
25249142|NCT01150357|50564911|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
25249143|NCT01150357|50564912|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
25249144|NCT01150357|50564913|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
25249145|NCT01150357|50564911|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
25249146|NCT01150357|50564912|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
25249147|NCT01150357|50564913|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
25249148|NCT01150357|50564911|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
25249149|NCT01150357|50564912|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
25249150|NCT01150357|50564913|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
25249151|NCT01150357|50564911|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
25249152|NCT01150357|50564912|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
25249153|NCT01150357|50564913|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
25249154|NCT01150357|50564911|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
25249155|NCT01150357|50564912|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
25249156|NCT01150357|50564913|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
25249157|NCT01150357|50564911|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
25249158|NCT01150357|50564912|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
24900886|NCT00699153|49994894|FG000|Overall Study|Lost to Follow-up|1|||
24900887|NCT00699153|49994895|FG001|Overall Study|Lost to Follow-up|0|||
24900888|NCT00699153|49994894|FG000|Overall Study|Adverse Event|0|||
24900889|NCT00699153|49994895|FG001|Overall Study|Adverse Event|2|||
24900890|NCT00699153|49994894|FG000|Overall Study|Protocol Violation|1|||
24900891|NCT00699153|49994895|FG001|Overall Study|Protocol Violation|0|||
24900892|NCT00699153|49994894|FG000|Overall Study|Travel Problem|1|||
24900893|NCT00699153|49994895|FG001|Overall Study|Travel Problem|0|||
24900894|NCT00698997|49994903|FG000|Overall Study|Lost to Follow-up|3|||
24900895|NCT00698997|49994904|FG001|Overall Study|Lost to Follow-up|0|||
24900896|NCT00698997|49994903|FG000|Overall Study|Withdrawal by Subject|7|||
24900897|NCT00698997|49994904|FG001|Overall Study|Withdrawal by Subject|27|||
24900898|NCT00711087|49994913|FG000|Overall Study|Lost to Follow-up|1|||
24900899|NCT00711087|49994914|FG001|Overall Study|Lost to Follow-up|0|||
24900900|NCT00738530|49994922|FG000|Overall Study|Death|220|||
24900901|NCT00738530|49994923|FG001|Overall Study|Death|224|||
24900902|NCT00738530|49994922|FG000|Overall Study|Lost to Follow-up|8|||
25330129|NCT02724878|50646429|FG000|Overall Study|Ineligible for Study Drug|5|||
25330130|NCT02724878|50646429|FG000|Overall Study|not started|1|||
25330131|NCT02600507|50646436|FG000|Overall Study|Adverse Event|3|||
25330132|NCT02600507|50646437|FG001|Overall Study|Adverse Event|15|||
24900903|NCT00738530|49994923|FG001|Overall Study|Lost to Follow-up|6|||
25249159|NCT01150357|50564913|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
25249160|NCT01150123|50564963|FG000|Overall Study|Withdrawal by Subject|1|||
25249161|NCT01150123|50564964|FG001|Overall Study|Withdrawal by Subject|1|||
25330133|NCT02600507|50646438|FG002|Overall Study|Adverse Event|5|||
25330134|NCT02600507|50646436|FG000|Overall Study|Lack of Efficacy|3|||
25330135|NCT02600507|50646437|FG001|Overall Study|Lack of Efficacy|8|||
25330136|NCT02600507|50646438|FG002|Overall Study|Lack of Efficacy|5|||
25330137|NCT02600507|50646436|FG000|Overall Study|Lost to Follow-up|3|||
25330138|NCT02600507|50646437|FG001|Overall Study|Lost to Follow-up|5|||
25330139|NCT02600507|50646438|FG002|Overall Study|Lost to Follow-up|2|||
25330140|NCT02600507|50646436|FG000|Overall Study|Protocol Violation|12|||
25330141|NCT02600507|50646437|FG001|Overall Study|Protocol Violation|4|||
25330142|NCT02600507|50646438|FG002|Overall Study|Protocol Violation|4|||
25330143|NCT02600507|50646436|FG000|Overall Study|Physician Decision|1|||
25330144|NCT02600507|50646437|FG001|Overall Study|Physician Decision|0|||
25249162|NCT01150123|50564965|FG002|Overall Study|Withdrawal by Subject|2|||
25249163|NCT01150123|50564966|FG003|Overall Study|Withdrawal by Subject|1|||
25330145|NCT02600507|50646438|FG002|Overall Study|Physician Decision|1|||
24900904|NCT00738530|49994922|FG000|Overall Study|Withdrawal by Subject|6|||
24900905|NCT00738530|49994923|FG001|Overall Study|Withdrawal by Subject|8|||
25330146|NCT02600507|50646436|FG000|Overall Study|Withdrawal by Subject|7|||
25330147|NCT02600507|50646437|FG001|Overall Study|Withdrawal by Subject|11|||
25330148|NCT02600507|50646438|FG002|Overall Study|Withdrawal by Subject|7|||
25330149|NCT02600507|50646436|FG000|Overall Study|Other|0|||
25249164|NCT01150123|50564967|FG004|Overall Study|Withdrawal by Subject|1|||
25249165|NCT01150123|50564968|FG005|Overall Study|Withdrawal by Subject|1|||
25249166|NCT01150123|50564969|FG006|Overall Study|Withdrawal by Subject|0|||
25330150|NCT02600507|50646437|FG001|Overall Study|Other|1|||
25330151|NCT02600507|50646438|FG002|Overall Study|Other|1|||
25330152|NCT02578680|50646448|FG000|Overall Study|Death|124|||
25330153|NCT02578680|50646449|FG001|Overall Study|Death|104|||
25330154|NCT02578680|50646448|FG000|Overall Study|Protocol Violation|1|||
25330155|NCT02578680|50646449|FG001|Overall Study|Protocol Violation|1|||
24900906|NCT00711009|49994931|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
24900907|NCT00711009|49994932|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
24900908|NCT00711009|49994931|FG000|Overall Study|Withdrawal by Subject|4|||
24900909|NCT00711009|49994932|FG001|Overall Study|Withdrawal by Subject|2|||
24900910|NCT00711009|49994931|FG000|Overall Study|Lost to Follow-up|3|||
24900911|NCT00711009|49994932|FG001|Overall Study|Lost to Follow-up|9|||
24900912|NCT00711009|49994931|FG000|Overall Study|Participant Noncompliant|0|||
24900913|NCT00711009|49994932|FG001|Overall Study|Participant Noncompliant|1|||
24900914|NCT00711009|49994931|FG000|Overall Study|Virologic Failure|2|||
24900915|NCT00711009|49994932|FG001|Overall Study|Virologic Failure|1|||
24900916|NCT00711009|49994931|FG000|Overall Study|Pregnancy|1|||
24900917|NCT00711009|49994932|FG001|Overall Study|Pregnancy|0|||
24900918|NCT00711009|49994931|FG000|Overall Study|Site closing|0|||
24900919|NCT00711009|49994932|FG001|Overall Study|Site closing|1|||
24900920|NCT00711009|49994931|FG000|Overall Study|Dose adjustment|1|||
24900921|NCT00711009|49994932|FG001|Overall Study|Dose adjustment|0|||
24900922|NCT00577005|49994940|FG000|Overall Study|Lost to Follow-up|3|||
24900923|NCT00577005|49994941|FG001|Overall Study|Lost to Follow-up|2|||
24900924|NCT00577005|49994940|FG000|Overall Study|Withdrawal by Subject|2|||
24900925|NCT00577005|49994941|FG001|Overall Study|Withdrawal by Subject|1|||
24900926|NCT00576927|49994952|FG000|Clinical Assessment|Lack of Efficacy|24|||
24900927|NCT00576927|49994952|FG000|Clinical Assessment|Death|1|||
24900928|NCT00576927|49994952|FG000|Clinical Assessment|Withdrawal by Subject|10|||
24900929|NCT00576927|49994952|FG000|Clinical Assessment|Physician Decision|1|||
24900930|NCT00576927|49994952|FG000|Baseline|Physician Decision|9|||
25249167|NCT01150123|50564970|FG007|Overall Study|Withdrawal by Subject|3|||
25249168|NCT01150123|50564971|FG008|Overall Study|Withdrawal by Subject|2|||
25249169|NCT01150123|50564972|FG009|Overall Study|Withdrawal by Subject|0|||
25249170|NCT01150123|50564973|FG010|Overall Study|Withdrawal by Subject|1|||
25249171|NCT01150123|50564974|FG011|Overall Study|Withdrawal by Subject|0|||
25249172|NCT01150123|50564975|FG012|Overall Study|Withdrawal by Subject|1|||
25249173|NCT01150123|50564976|FG013|Overall Study|Withdrawal by Subject|0|||
25249174|NCT01150123|50564977|FG014|Overall Study|Withdrawal by Subject|0|||
25249175|NCT01150123|50564978|FG015|Overall Study|Withdrawal by Subject|1|||
25249176|NCT01150123|50564979|FG016|Overall Study|Withdrawal by Subject|0|||
25249177|NCT01150123|50564980|FG017|Overall Study|Withdrawal by Subject|1|||
25249178|NCT01150123|50564963|FG000|Overall Study|Lost to Follow-up|2|||
25249179|NCT01150123|50564964|FG001|Overall Study|Lost to Follow-up|1|||
25249180|NCT01150123|50564965|FG002|Overall Study|Lost to Follow-up|2|||
25249181|NCT01150123|50564966|FG003|Overall Study|Lost to Follow-up|2|||
25249182|NCT01150123|50564967|FG004|Overall Study|Lost to Follow-up|2|||
25249183|NCT01150123|50564968|FG005|Overall Study|Lost to Follow-up|5|||
25249184|NCT01150123|50564969|FG006|Overall Study|Lost to Follow-up|0|||
25249185|NCT01150123|50564970|FG007|Overall Study|Lost to Follow-up|0|||
25330156|NCT02578680|50646448|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
25330157|NCT02578680|50646449|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
25330158|NCT02578680|50646448|FG000|Overall Study|Withdrawal by Subject|8|||
25330159|NCT02578680|50646449|FG001|Overall Study|Withdrawal by Subject|5|||
25330160|NCT02578680|50646448|FG000|Overall Study|Ongoing in Study|276|||
25330161|NCT02578680|50646449|FG001|Overall Study|Ongoing in Study|96|||
25330162|NCT02385266|50646457|FG000|Overall Study|Withdrawal by Subject|1|||
25330163|NCT02385266|50646458|FG001|Overall Study|Withdrawal by Subject|3|||
25330164|NCT02379988|50646464|FG000|Overall Study|Not eligible|1|||
25330165|NCT02006069|50646479|FG000|Overall Study|MPP other programming|239|||
25330166|NCT02006069|50646480|FG001|Overall Study|MPP other programming|0|||
25330167|NCT02006069|50646479|FG000|Overall Study|RV only pacing|0|||
25330168|NCT02006069|50646480|FG001|Overall Study|RV only pacing|3|||
24900931|NCT00576927|49994952|FG000|Baseline|Medication Change by PCP of subject|1|||
24900932|NCT00576927|49994952|FG000|Baseline|Withdrawal by Subject|3|||
25330169|NCT01985867|50646488|FG000|Overall Study|Lost to Follow-up|3|||
25330170|NCT01985867|50646489|FG001|Overall Study|Lost to Follow-up|4|||
24900933|NCT00576927|49994952|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
25249186|NCT01150123|50564971|FG008|Overall Study|Lost to Follow-up|3|||
25249187|NCT01150123|50564972|FG009|Overall Study|Lost to Follow-up|1|||
25249188|NCT01150123|50564973|FG010|Overall Study|Lost to Follow-up|1|||
25249189|NCT01150123|50564974|FG011|Overall Study|Lost to Follow-up|1|||
25249190|NCT01150123|50564975|FG012|Overall Study|Lost to Follow-up|2|||
25330171|NCT01985867|50646488|FG000|Overall Study|Adverse Event|3|||
25330172|NCT01985867|50646489|FG001|Overall Study|Adverse Event|2|||
25330173|NCT01985867|50646488|FG000|Overall Study|Lack of Efficacy|1|||
25330174|NCT01985867|50646489|FG001|Overall Study|Lack of Efficacy|0|||
25330175|NCT01946139|50646495|FG000|Overall Study|Withdrawal by Subject|8|||
25330176|NCT01946139|50646495|FG000|Overall Study|ineligible|8|||
25330177|NCT01946139|50646495|FG000|Overall Study|Specimens not available|4|||
25330178|NCT01367002|50646501|FG000|Overall Study|Withdrawal by Subject|1|||
25330179|NCT01367002|50646502|FG001|Overall Study|Withdrawal by Subject|0|||
25330180|NCT01367002|50646501|FG000|Overall Study|Physician Decision|0|||
25330181|NCT01367002|50646502|FG001|Overall Study|Physician Decision|2|||
25330182|NCT00858273|50646510|FG000|Overall Study|Protocol Violation|3|||
25330183|NCT00858273|50646511|FG001|Overall Study|Protocol Violation|5|||
25330184|NCT00844428|50646542|FG000|Screening Period|Screen Failure|3|||
25330185|NCT00844428|50646542|FG000|Extension Treatment Period|Death|1|||
25330186|NCT00844428|50646542|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
25249191|NCT01150123|50564976|FG013|Overall Study|Lost to Follow-up|0|||
25249192|NCT01150123|50564977|FG014|Overall Study|Lost to Follow-up|0|||
25249193|NCT01150123|50564978|FG015|Overall Study|Lost to Follow-up|0|||
25249194|NCT01150123|50564979|FG016|Overall Study|Lost to Follow-up|0|||
25249195|NCT01150123|50564980|FG017|Overall Study|Lost to Follow-up|0|||
25249196|NCT01149655|50565039|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
25330187|NCT00834834|50646548|FG000|Overall Study|Withdrawal by Subject|4|||
25330188|NCT00834834|50646549|FG001|Overall Study|Withdrawal by Subject|3|||
25330189|NCT00834366|50646557|FG000|Treatment Period 1|Adverse Event|1|||
25330190|NCT00834366|50646558|FG001|Treatment Period 1|Adverse Event|1|||
25330191|NCT00844194|50646566|FG000|Overall Study|Adverse Event|17|||
25330192|NCT00844194|50646567|FG001|Overall Study|Adverse Event|5|||
25330193|NCT00844194|50646566|FG000|Overall Study|Protocol Violation|1|||
25330194|NCT00844194|50646567|FG001|Overall Study|Protocol Violation|1|||
25330195|NCT00844194|50646566|FG000|Overall Study|Lost to Follow-up|1|||
25330196|NCT00844194|50646567|FG001|Overall Study|Lost to Follow-up|1|||
25330197|NCT00844194|50646566|FG000|Overall Study|Withdrawal by Subject|2|||
25330198|NCT00844194|50646567|FG001|Overall Study|Withdrawal by Subject|1|||
25330199|NCT00844194|50646566|FG000|Overall Study|Lack of Efficacy|3|||
25249197|NCT01149655|50565040|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
25330200|NCT00844194|50646567|FG001|Overall Study|Lack of Efficacy|0|||
25330201|NCT00844194|50646566|FG000|Overall Study|Other reason (not specified)|1|||
25330202|NCT00844194|50646567|FG001|Overall Study|Other reason (not specified)|0|||
25330203|NCT00826176|50646579|FG000|Overall Study|Lost to Follow-up|1|||
25330204|NCT00826176|50646580|FG001|Overall Study|Lost to Follow-up|0|||
25330205|NCT00826176|50646579|FG000|Overall Study|Subject Withdrew Consent|3|||
25330206|NCT00826176|50646580|FG001|Overall Study|Subject Withdrew Consent|0|||
25330207|NCT00826176|50646579|FG000|Overall Study|Administrative|9|||
25330208|NCT00826176|50646580|FG001|Overall Study|Administrative|0|||
25330209|NCT00878969|50646589|FG000|Overall Study|Physician Decision|5|||
25330210|NCT00878969|50646590|FG001|Overall Study|Physician Decision|3|||
25330211|NCT00878969|50646591|FG002|Overall Study|Physician Decision|2|||
25330212|NCT00878969|50646589|FG000|Overall Study|Withdrawal by Subject|1|||
25330213|NCT00878969|50646590|FG001|Overall Study|Withdrawal by Subject|6|||
25330214|NCT00878969|50646591|FG002|Overall Study|Withdrawal by Subject|3|||
25330215|NCT00878969|50646589|FG000|Overall Study|kidney transplant|2|||
25330216|NCT00878969|50646590|FG001|Overall Study|kidney transplant|3|||
25330217|NCT00878969|50646591|FG002|Overall Study|kidney transplant|2|||
25330218|NCT00878969|50646589|FG000|Overall Study|Adverse Event|3|||
25330219|NCT00878969|50646590|FG001|Overall Study|Adverse Event|1|||
25330220|NCT00878969|50646591|FG002|Overall Study|Adverse Event|2|||
25330221|NCT00878969|50646589|FG000|Overall Study|Lost to Follow-up|2|||
25330222|NCT00878969|50646590|FG001|Overall Study|Lost to Follow-up|1|||
25330223|NCT00878969|50646591|FG002|Overall Study|Lost to Follow-up|0|||
25249198|NCT01149655|50565041|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
25249199|NCT01149655|50565042|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
25249200|NCT01149655|50565039|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
25249201|NCT01149655|50565040|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
25330224|NCT00878969|50646589|FG000|Overall Study|Protocol Violation|2|||
25249202|NCT01149655|50565041|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
25330225|NCT00878969|50646590|FG001|Overall Study|Protocol Violation|0|||
25330226|NCT00878969|50646591|FG002|Overall Study|Protocol Violation|0|||
25330227|NCT00878969|50646589|FG000|Overall Study|Death|0|||
25330228|NCT00878969|50646590|FG001|Overall Study|Death|0|||
25330229|NCT00878969|50646591|FG002|Overall Study|Death|2|||
25330230|NCT00878969|50646589|FG000|Overall Study|Pregnancy|0|||
25330231|NCT00878969|50646590|FG001|Overall Study|Pregnancy|1|||
25330232|NCT00878969|50646591|FG002|Overall Study|Pregnancy|0|||
25330233|NCT00843726|50646605|FG000|Overall Study|Death|1|||
25330234|NCT00843726|50646606|FG001|Overall Study|Death|0|||
25330235|NCT00843726|50646605|FG000|Overall Study|Withdrawal by Subject|0|||
25330236|NCT00843726|50646606|FG001|Overall Study|Withdrawal by Subject|1|||
25330237|NCT00843492|50646615|FG000|Overall Study|Adverse Event|0|||
25330238|NCT00843492|50646616|FG001|Overall Study|Adverse Event|3|||
25330239|NCT00843492|50646615|FG000|Overall Study|Lost to Follow-up|4|||
25330240|NCT00843492|50646616|FG001|Overall Study|Lost to Follow-up|4|||
25330241|NCT00843492|50646615|FG000|Overall Study|Withdrawal by Subject|0|||
25330242|NCT00843492|50646616|FG001|Overall Study|Withdrawal by Subject|4|||
25330243|NCT00843492|50646615|FG000|Overall Study|Immobilization Stopped|1|||
25330244|NCT00843492|50646616|FG001|Overall Study|Immobilization Stopped|0|||
25330245|NCT00843492|50646615|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
25330246|NCT00843492|50646616|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
25330247|NCT00843492|50646615|FG000|Overall Study|Orthopedic Surgery|0|||
25330248|NCT00843492|50646616|FG001|Overall Study|Orthopedic Surgery|2|||
25330249|NCT00843492|50646615|FG000|Overall Study|Visit Not Performed|1|||
25330250|NCT00843492|50646616|FG001|Overall Study|Visit Not Performed|0|||
25330251|NCT00843492|50646615|FG000|Overall Study|Deep-vein Thrombosis|1|||
25330252|NCT00843492|50646616|FG001|Overall Study|Deep-vein Thrombosis|0|||
25330253|NCT00833976|50646622|FG000|Overall Study|Withdrawal by Subject|5|||
25330254|NCT00833976|50646622|FG000|Overall Study|Lost to Follow-up|4|||
25330255|NCT00833976|50646622|FG000|Overall Study|Did not meet eligibility criteria|41|||
25330256|NCT00833976|50646622|FG000|Overall Study|Physician Decision|1|||
25330257|NCT00833898|50646628|FG000|Overall Study|Withdrawal by Subject|33|||
25330258|NCT00833898|50646629|FG001|Overall Study|Withdrawal by Subject|27|||
25330259|NCT00833898|50646628|FG000|Overall Study|Lost to Follow-up|7|||
25330260|NCT00833898|50646629|FG001|Overall Study|Lost to Follow-up|7|||
25330261|NCT00833898|50646628|FG000|Overall Study|Patient did not receive transplant|0|||
25330262|NCT00833898|50646629|FG001|Overall Study|Patient did not receive transplant|2|||
25330263|NCT00825162|50646638|FG000|Overall Study|Withdrawal by Subject|11|||
25330264|NCT00825162|50646639|FG001|Overall Study|Withdrawal by Subject|13|||
25330265|NCT00825162|50646640|FG002|Overall Study|Withdrawal by Subject|3|||
25330266|NCT00825162|50646638|FG000|Overall Study|Lost to Follow-up|9|||
25330267|NCT00825162|50646639|FG001|Overall Study|Lost to Follow-up|6|||
25330268|NCT00825162|50646640|FG002|Overall Study|Lost to Follow-up|3|||
25330269|NCT00825162|50646638|FG000|Overall Study|Physician Decision|2|||
25330270|NCT00825162|50646639|FG001|Overall Study|Physician Decision|0|||
25330271|NCT00825162|50646640|FG002|Overall Study|Physician Decision|0|||
25330272|NCT00825162|50646638|FG000|Overall Study|Move away from the study area|1|||
25330273|NCT00825162|50646639|FG001|Overall Study|Move away from the study area|0|||
25330274|NCT00825162|50646640|FG002|Overall Study|Move away from the study area|0|||
25330275|NCT00825162|50646638|FG000|Overall Study|Unable to attend the study visit|5|||
25330276|NCT00825162|50646639|FG001|Overall Study|Unable to attend the study visit|2|||
25330277|NCT00825162|50646640|FG002|Overall Study|Unable to attend the study visit|0|||
25330278|NCT00824850|50646655|FG000|Overall Study|Withdrawal by Subject|0|||
25330279|NCT00824850|50646656|FG001|Overall Study|Withdrawal by Subject|1|||
25330280|NCT00596687|50646670|FG000|Overall Study|< 24 hours of insulin treatment|8|||
25330281|NCT00596687|50646671|FG001|Overall Study|< 24 hours of insulin treatment|6|||
25330282|NCT00596687|50646670|FG000|Overall Study|continuous insulin infusion during TPN|2|||
25330283|NCT00596687|50646671|FG001|Overall Study|continuous insulin infusion during TPN|1|||
25330284|NCT00596687|50646670|FG000|Overall Study|Withdrawal by Subject|3|||
25330285|NCT00596687|50646671|FG001|Overall Study|Withdrawal by Subject|1|||
25330286|NCT00596687|50646670|FG000|Overall Study|cancelled surgery|1|||
25330287|NCT00596687|50646671|FG001|Overall Study|cancelled surgery|1|||
25330288|NCT00824772|50646677|FG000|Overall Study|Withdrawal by Subject|8|||
25249203|NCT01149655|50565042|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
25249204|NCT01149655|50565039|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
25249205|NCT01149655|50565040|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
25249206|NCT01149655|50565041|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
25249207|NCT01149655|50565042|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
25249208|NCT01149655|50565039|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
25330289|NCT00824616|50646683|FG000|Overall Study|Adverse Event|2|||
25330290|NCT00824616|50646684|FG001|Overall Study|Adverse Event|1|||
25249209|NCT01149655|50565040|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
25249210|NCT01149655|50565041|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
25249211|NCT01149655|50565042|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
25249212|NCT01149655|50565039|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
25249213|NCT01149655|50565040|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
25249214|NCT01149655|50565041|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
25249215|NCT01149655|50565042|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
25249216|NCT01149655|50565039|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
25330291|NCT00824616|50646683|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
25330292|NCT00824616|50646684|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
25330293|NCT00824616|50646683|FG000|Overall Study|Hyperglycemia|1|||
25330294|NCT00824616|50646684|FG001|Overall Study|Hyperglycemia|1|||
25330295|NCT00824616|50646683|FG000|Overall Study|Lack of Efficacy|2|||
25330296|NCT00824616|50646684|FG001|Overall Study|Lack of Efficacy|1|||
25330297|NCT00824616|50646683|FG000|Overall Study|Lost to Follow-up|0|||
25330298|NCT00824616|50646684|FG001|Overall Study|Lost to Follow-up|1|||
25330299|NCT00824616|50646683|FG000|Overall Study|Withdrawal by Subject|1|||
25249217|NCT01149655|50565040|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
25249218|NCT01149655|50565041|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
25249219|NCT01149655|50565042|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
25249220|NCT01149655|50565039|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
25249221|NCT01149655|50565040|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
25249222|NCT01149655|50565041|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
25249223|NCT01149655|50565042|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
25330300|NCT00824616|50646684|FG001|Overall Study|Withdrawal by Subject|1|||
25330301|NCT00824382|50646694|FG000|Overall Study|Adverse Event|4|||
25330302|NCT00824382|50646695|FG001|Overall Study|Adverse Event|1|||
25330303|NCT00824382|50646696|FG002|Overall Study|Adverse Event|1|||
25330304|NCT00824382|50646697|FG003|Overall Study|Adverse Event|4|||
25330305|NCT00824382|50646694|FG000|Overall Study|Protocol Violation|1|||
25330306|NCT00824382|50646695|FG001|Overall Study|Protocol Violation|0|||
25330307|NCT00824382|50646696|FG002|Overall Study|Protocol Violation|0|||
25330308|NCT00824382|50646697|FG003|Overall Study|Protocol Violation|1|||
25330309|NCT00824382|50646694|FG000|Overall Study|Investigator's decision|0|||
25330310|NCT00824382|50646695|FG001|Overall Study|Investigator's decision|1|||
25330311|NCT00824382|50646696|FG002|Overall Study|Investigator's decision|2|||
25330312|NCT00824382|50646697|FG003|Overall Study|Investigator's decision|0|||
25330313|NCT00833040|50646709|FG000|Overall Study|Adverse Event|0|||
25330314|NCT00833040|50646710|FG001|Overall Study|Adverse Event|0|||
25330315|NCT00833040|50646711|FG002|Overall Study|Adverse Event|0|||
25330316|NCT00833040|50646712|FG003|Overall Study|Adverse Event|0|||
25330317|NCT00833040|50646713|FG004|Overall Study|Adverse Event|0|||
25330318|NCT00833040|50646714|FG005|Overall Study|Adverse Event|1|||
25330319|NCT00843024|50646723|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
25330320|NCT00843024|50646724|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
25330321|NCT00843024|50646725|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
24900934|NCT00576927|49994952|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
24900935|NCT00576927|49994952|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
24900936|NCT00576927|49994952|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
24900937|NCT00576927|49994952|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
24900938|NCT00698841|49994958|FG000|Overall Study|Withdrawal by Subject|2|||
24900939|NCT00698841|49994958|FG000|Overall Study|Adverse Event|3|||
24900940|NCT00698841|49994958|FG000|Overall Study|Disease progression|7|||
24900941|NCT00698841|49994958|FG000|Overall Study|Failure to meet eligibility criteria|2|||
24900942|NCT00698841|49994958|FG000|Overall Study|Study drug toxicity|2|||
24900943|NCT00698841|49994958|FG000|Overall Study|Other|2|||
24900944|NCT00577395|49994964|FG000|Overall Study|Study was terminated early by Sponsor|7|||
24900945|NCT00577395|49994965|FG001|Overall Study|Study was terminated early by Sponsor|6|||
24900946|NCT00738374|49994974|FG000|Induction Treatment Phase|Adverse Event|14|||
24900947|NCT00738374|49994975|FG001|Induction Treatment Phase|Adverse Event|0|||
24900948|NCT00738374|49994976|FG002|Induction Treatment Phase|Adverse Event|0|||
24900949|NCT00738374|49994977|FG003|Induction Treatment Phase|Adverse Event|0|||
24900950|NCT00738374|49994974|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
24900951|NCT00738374|49994975|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
24900952|NCT00738374|49994976|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
24900953|NCT00738374|49994977|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
24900954|NCT00738374|49994974|FG000|Induction Treatment Phase|Physician Decision|2|||
24900955|NCT00738374|49994975|FG001|Induction Treatment Phase|Physician Decision|0|||
24900956|NCT00738374|49994976|FG002|Induction Treatment Phase|Physician Decision|0|||
24900957|NCT00738374|49994977|FG003|Induction Treatment Phase|Physician Decision|0|||
24900958|NCT00738374|49994974|FG000|Induction Treatment Phase|Protocol Violation|2|||
24900959|NCT00738374|49994975|FG001|Induction Treatment Phase|Protocol Violation|0|||
24900960|NCT00738374|49994976|FG002|Induction Treatment Phase|Protocol Violation|0|||
24900961|NCT00738374|49994977|FG003|Induction Treatment Phase|Protocol Violation|0|||
24900962|NCT00738374|49994974|FG000|Induction Treatment Phase|Non-compliance|1|||
24900963|NCT00738374|49994975|FG001|Induction Treatment Phase|Non-compliance|0|||
24900964|NCT00738374|49994976|FG002|Induction Treatment Phase|Non-compliance|0|||
24900965|NCT00738374|49994977|FG003|Induction Treatment Phase|Non-compliance|0|||
24900966|NCT00738374|49994974|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
24900967|NCT00738374|49994975|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
24900968|NCT00738374|49994976|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
24900969|NCT00738374|49994977|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
25249224|NCT01149655|50565039|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
25330322|NCT00843024|50646726|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
25330323|NCT00843024|50646727|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
25330324|NCT00843024|50646728|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
25330325|NCT00843024|50646723|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
25330326|NCT00843024|50646724|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
25330327|NCT00843024|50646725|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
25330328|NCT00843024|50646726|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
25330329|NCT00843024|50646727|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
25330330|NCT00843024|50646728|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
25330331|NCT00843024|50646723|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
25330332|NCT00843024|50646724|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
25330333|NCT00843024|50646725|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
25330334|NCT00843024|50646726|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
25330335|NCT00843024|50646727|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
25330336|NCT00843024|50646728|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
25330337|NCT00843024|50646723|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
25330338|NCT00843024|50646724|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
25330339|NCT00843024|50646725|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
25330340|NCT00843024|50646726|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
25330341|NCT00843024|50646727|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
25330342|NCT00843024|50646728|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
25330343|NCT00843024|50646723|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
25330344|NCT00843024|50646724|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
25330345|NCT00843024|50646725|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
25330346|NCT00843024|50646726|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
25330347|NCT00843024|50646727|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
25330348|NCT00843024|50646728|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
25330349|NCT00843024|50646723|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
25330350|NCT00843024|50646724|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
25330351|NCT00843024|50646725|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
25330352|NCT00843024|50646726|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
25330353|NCT00843024|50646727|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
25330354|NCT00843024|50646728|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
25330355|NCT00843024|50646723|FG000|Single-blind Placebo Run-In Phase|Other|0|||
25330356|NCT00843024|50646724|FG001|Single-blind Placebo Run-In Phase|Other|1|||
25330357|NCT00843024|50646725|FG002|Single-blind Placebo Run-In Phase|Other|0|||
25330358|NCT00843024|50646726|FG003|Single-blind Placebo Run-In Phase|Other|0|||
25330359|NCT00843024|50646727|FG004|Single-blind Placebo Run-In Phase|Other|0|||
25330360|NCT00843024|50646728|FG005|Single-blind Placebo Run-In Phase|Other|0|||
25330361|NCT00843024|50646723|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
25330362|NCT00843024|50646724|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
25330363|NCT00843024|50646725|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
25330364|NCT00843024|50646726|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
25330365|NCT00843024|50646727|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
25330366|NCT00843024|50646728|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
25330367|NCT00843024|50646723|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
25330368|NCT00843024|50646724|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
25330369|NCT00843024|50646725|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
25330370|NCT00843024|50646726|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
25330371|NCT00843024|50646727|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
25330372|NCT00843024|50646728|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
25330373|NCT00843024|50646723|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
25330374|NCT00843024|50646724|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
25330375|NCT00843024|50646725|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
25330376|NCT00843024|50646726|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
25330377|NCT00843024|50646727|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
25330378|NCT00843024|50646728|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
25330379|NCT00843024|50646723|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
25330380|NCT00843024|50646724|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
25330381|NCT00843024|50646725|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
25330382|NCT00843024|50646726|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
25330383|NCT00843024|50646727|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
25330384|NCT00843024|50646728|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
25330385|NCT00843024|50646723|FG000|Double-blind Treatment Phase|Physician Decision|0|||
25330386|NCT00843024|50646724|FG001|Double-blind Treatment Phase|Physician Decision|0|||
25330387|NCT00843024|50646725|FG002|Double-blind Treatment Phase|Physician Decision|0|||
25330388|NCT00843024|50646726|FG003|Double-blind Treatment Phase|Physician Decision|3|||
25330389|NCT00843024|50646727|FG004|Double-blind Treatment Phase|Physician Decision|1|||
24977279|NCT03410992|50065855|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
24977280|NCT00377819|50065887|FG000|Overall Study|Adverse Event|2|||
25330390|NCT00843024|50646728|FG005|Double-blind Treatment Phase|Physician Decision|1|||
24977281|NCT00377819|50065888|FG001|Overall Study|Adverse Event|3|||
25330391|NCT00843024|50646723|FG000|Double-blind Treatment Phase|Adverse Event|0|||
25330392|NCT00843024|50646724|FG001|Double-blind Treatment Phase|Adverse Event|0|||
25330393|NCT00843024|50646725|FG002|Double-blind Treatment Phase|Adverse Event|0|||
25330394|NCT00843024|50646726|FG003|Double-blind Treatment Phase|Adverse Event|0|||
25330395|NCT00843024|50646727|FG004|Double-blind Treatment Phase|Adverse Event|1|||
25330396|NCT00843024|50646728|FG005|Double-blind Treatment Phase|Adverse Event|1|||
25330397|NCT00843024|50646723|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
25330398|NCT00843024|50646724|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
25330399|NCT00843024|50646725|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
25330400|NCT00843024|50646726|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
25330401|NCT00843024|50646727|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
25330402|NCT00843024|50646728|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
25330403|NCT00832650|50646744|FG000|Overall Study|Randomized but not treated|0|||
25330404|NCT00832650|50646745|FG001|Overall Study|Randomized but not treated|0|||
25330405|NCT00832650|50646746|FG002|Overall Study|Randomized but not treated|1|||
25330406|NCT00595517|50646754|FG000|Overall Study|Adverse Event|6|||
25330407|NCT00595517|50646754|FG000|Overall Study|Withdrawal by Subject|4|||
25330408|NCT00595517|50646754|FG000|Overall Study|Protocol Violation|2|||
25330409|NCT00595517|50646754|FG000|Overall Study|Recurrence of ulcer|5|||
25330410|NCT00595517|50646754|FG000|Overall Study|usage of prohibited treatment|1|||
25330411|NCT00595517|50646754|FG000|Overall Study|No intention to attend regularly|1|||
25330412|NCT00823836|50646760|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
25330413|NCT00823836|50646761|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
25330414|NCT00823836|50646760|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
25330415|NCT00823836|50646761|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
25330416|NCT00823836|50646760|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
25330417|NCT00823836|50646761|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
25330418|NCT00823836|50646760|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
25330419|NCT00823836|50646761|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
25249225|NCT01149655|50565040|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
25249226|NCT01149655|50565041|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
25249227|NCT01149655|50565042|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
25249228|NCT01149655|50565039|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
25249229|NCT01149655|50565040|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
25249230|NCT01149655|50565041|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
25249231|NCT01149655|50565042|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
25249232|NCT01149655|50565039|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
25249233|NCT01149655|50565040|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
25249234|NCT01149655|50565041|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
25249235|NCT01149655|50565042|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
25249236|NCT01149655|50565039|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
25249237|NCT01149655|50565040|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
25249238|NCT01149655|50565041|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
25249239|NCT01149655|50565042|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
25249240|NCT01149655|50565039|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
25249241|NCT01149655|50565040|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
25249242|NCT01149655|50565041|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
25249243|NCT01149655|50565042|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
25249244|NCT01149655|50565039|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
25249245|NCT01149655|50565040|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
25249246|NCT01149655|50565041|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
25249247|NCT01149655|50565042|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
25249248|NCT01149655|50565039|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
25249249|NCT01149655|50565040|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
25249250|NCT01149655|50565041|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
25330420|NCT00823836|50646760|FG000|Long-term Phase|Adverse Event|3|||
25330421|NCT00823836|50646761|FG001|Long-term Phase|Adverse Event|2|||
25330422|NCT00823836|50646760|FG000|Long-term Phase|Physician Decision|1|||
25330423|NCT00823836|50646761|FG001|Long-term Phase|Physician Decision|2|||
25330424|NCT00823836|50646760|FG000|Long-term Phase|Withdrawal by Subject|1|||
25330425|NCT00823836|50646761|FG001|Long-term Phase|Withdrawal by Subject|1|||
25249251|NCT01149655|50565042|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
25249252|NCT01149655|50565039|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
25330426|NCT00879437|50646770|FG000|Overall Study|Protocol Violation|0|||
25330427|NCT00879437|50646771|FG001|Overall Study|Protocol Violation|1|||
25330428|NCT00879437|50646770|FG000|Overall Study|Death|1|||
25249253|NCT01149655|50565040|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
25330429|NCT00879437|50646771|FG001|Overall Study|Death|0|||
25330430|NCT00877799|50646784|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
25330431|NCT00877799|50646785|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
25249254|NCT01149655|50565041|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
25249255|NCT01149655|50565042|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
25249256|NCT01149655|50565039|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
25249257|NCT01149655|50565040|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
25249258|NCT01149655|50565041|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
25249259|NCT01149655|50565042|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
25249260|NCT01149538|50565052|FG000|Overall Study|Lost to Follow-up|0|||
25249261|NCT01149538|50565053|FG001|Overall Study|Lost to Follow-up|1|||
25330432|NCT00877799|50646786|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
25330433|NCT00877799|50646787|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
25330434|NCT00877799|50646788|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
25330435|NCT00877799|50646784|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
25330436|NCT00877799|50646785|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
25330437|NCT00877799|50646786|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
25330438|NCT00877799|50646787|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
25330439|NCT00877799|50646788|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
25330440|NCT00877799|50646784|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
25330441|NCT00877799|50646785|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
25330442|NCT00877799|50646786|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
25330443|NCT00877799|50646787|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
25330444|NCT00877799|50646788|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
25330445|NCT00877799|50646784|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
25330446|NCT00877799|50646785|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
25330447|NCT00877799|50646786|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
25330448|NCT00877799|50646787|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
25330449|NCT00877799|50646788|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
25330450|NCT00877799|50646784|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
25330451|NCT00877799|50646785|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
25330452|NCT00877799|50646786|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
25330453|NCT00877799|50646787|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
25330454|NCT00877799|50646788|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
25330455|NCT00595127|50646799|FG000|Overall Study|Death|6|||
25330456|NCT00595127|50646799|FG000|Overall Study|Relapsed|3|||
25330457|NCT00595127|50646799|FG000|Overall Study|joined another trial|1|||
25330458|NCT00877487|50646803|FG000|Open-label Treatment Phase|Adverse Event|1|||
25330459|NCT00877487|50646804|FG001|Open-label Treatment Phase|Adverse Event|0|||
25330460|NCT00877487|50646803|FG000|Open-label Treatment Phase|Protocol Violation|3|||
25330461|NCT00877487|50646804|FG001|Open-label Treatment Phase|Protocol Violation|0|||
25330462|NCT00877487|50646803|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
25330463|NCT00877487|50646804|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
25330464|NCT00877487|50646803|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
25330465|NCT00877487|50646804|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
25330466|NCT00877487|50646803|FG000|Open-label Treatment Phase|Out of country for business|1|||
25330467|NCT00877487|50646804|FG001|Open-label Treatment Phase|Out of country for business|0|||
25330468|NCT00877487|50646803|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
25330469|NCT00877487|50646804|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
25330470|NCT00877487|50646803|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
25330471|NCT00877487|50646804|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
25330472|NCT00877487|50646803|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
25330473|NCT00877487|50646804|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
24977282|NCT00377819|50065887|FG000|Overall Study|Withdrawal by Subject|10|||
24977283|NCT00377819|50065888|FG001|Overall Study|Withdrawal by Subject|4|||
24977284|NCT00377819|50065887|FG000|Overall Study|Death|0|||
24977285|NCT00377819|50065888|FG001|Overall Study|Death|1|||
24977286|NCT00377819|50065887|FG000|Overall Study|Lost to Follow-up|0|||
24977287|NCT00377819|50065888|FG001|Overall Study|Lost to Follow-up|1|||
24977288|NCT00377819|50065887|FG000|Overall Study|Protocol Violation|1|||
24977289|NCT00377819|50065888|FG001|Overall Study|Protocol Violation|1|||
24977290|NCT03419962|50065894|FG000|Overall Study|Change to other medication|1|||
25249262|NCT01149538|50565052|FG000|Overall Study|Withdrawal by Subject|5|||
24977291|NCT03419962|50065894|FG000|Overall Study|Refusal of continuing with trial drug|1|||
24977292|NCT03419962|50065894|FG000|Overall Study|Lost to Follow-up|3|||
24977293|NCT03419962|50065894|FG000|Overall Study|Difficulty in inhaling the doses|1|||
24977294|NCT03419962|50065894|FG000|Overall Study|Missing completion data|31|||
24977295|NCT00377429|50065898|FG000|Overall Study|Withdrawal by Subject|5|||
24977296|NCT00377429|50065898|FG000|Overall Study|Adverse Event|8|||
24977297|NCT00377429|50065898|FG000|Overall Study|Physician Decision|1|||
25249263|NCT01149538|50565053|FG001|Overall Study|Withdrawal by Subject|3|||
25249264|NCT01149460|50565061|FG000|Overall Study|Withdrawal by Subject|0|||
24977298|NCT00377429|50065898|FG000|Overall Study|Patient non-compliance|1|||
24977299|NCT00376961|50065902|FG000|Initial Registration|Adverse Event|1|||
24977300|NCT00376961|50065903|FG001|Initial Registration|Adverse Event|0|||
24977301|NCT00376961|50065902|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
24977302|NCT00376961|50065903|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
25330474|NCT00877487|50646803|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
25330475|NCT00877487|50646804|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
25330476|NCT00878501|50646813|FG000|Overall Study|Adverse Event|11|||
25330477|NCT00878501|50646814|FG001|Overall Study|Adverse Event|3|||
25330478|NCT00878501|50646815|FG002|Overall Study|Adverse Event|3|||
25330479|NCT00878501|50646813|FG000|Overall Study|Lack of Efficacy|2|||
25330480|NCT00878501|50646814|FG001|Overall Study|Lack of Efficacy|1|||
25330481|NCT00878501|50646815|FG002|Overall Study|Lack of Efficacy|0|||
25330482|NCT00878501|50646813|FG000|Overall Study|Withdrawal by Subject|2|||
25330483|NCT00878501|50646814|FG001|Overall Study|Withdrawal by Subject|1|||
25330484|NCT00878501|50646815|FG002|Overall Study|Withdrawal by Subject|2|||
25330485|NCT00878501|50646813|FG000|Overall Study|Protocol Violation|0|||
25330486|NCT00878501|50646814|FG001|Overall Study|Protocol Violation|0|||
25330487|NCT00878501|50646815|FG002|Overall Study|Protocol Violation|1|||
25330488|NCT00878501|50646813|FG000|Overall Study|Incorrect enrolment|1|||
25330489|NCT00878501|50646814|FG001|Overall Study|Incorrect enrolment|2|||
25330490|NCT00878501|50646815|FG002|Overall Study|Incorrect enrolment|0|||
25330491|NCT00878501|50646813|FG000|Overall Study|Intake of prohibited concom. medication|0|||
25330492|NCT00878501|50646814|FG001|Overall Study|Intake of prohibited concom. medication|0|||
25330493|NCT00878501|50646815|FG002|Overall Study|Intake of prohibited concom. medication|1|||
25330494|NCT00878501|50646813|FG000|Overall Study|Mis-randomisation of patient|1|||
25330495|NCT00878501|50646814|FG001|Overall Study|Mis-randomisation of patient|0|||
25330496|NCT00878501|50646815|FG002|Overall Study|Mis-randomisation of patient|0|||
25330497|NCT00878501|50646813|FG000|Overall Study|Administrative|0|||
25330498|NCT00878501|50646814|FG001|Overall Study|Administrative|0|||
25330499|NCT00878501|50646815|FG002|Overall Study|Administrative|1|||
25249265|NCT01149460|50565062|FG001|Overall Study|Withdrawal by Subject|2|||
25249266|NCT01149421|50565071|FG000|Overall Study|Adverse Event|22|||
25249267|NCT01149421|50565072|FG001|Overall Study|Adverse Event|6|||
25330500|NCT00882713|50646823|FG000|Overall Study|Adverse Event|2|||
25330501|NCT00882713|50646823|FG000|Overall Study|Death|3|||
25330502|NCT00882713|50646823|FG000|Overall Study|Administrative reasons|4|||
24900970|NCT00738374|49994974|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
24900971|NCT00738374|49994975|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
24900972|NCT00738374|49994976|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
24900973|NCT00738374|49994977|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
24900974|NCT00738374|49994974|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
24900975|NCT00738374|49994975|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
24900976|NCT00738374|49994976|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
24900977|NCT00738374|49994977|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
24900978|NCT00738374|49994974|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
24900979|NCT00738374|49994975|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
24900980|NCT00738374|49994976|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
24900981|NCT00738374|49994977|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
24900982|NCT00738374|49994974|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
24900983|NCT00738374|49994975|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
24900984|NCT00738374|49994976|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
24900985|NCT00738374|49994977|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
24900986|NCT00738374|49994974|FG000|Maintenance Treatment/Observation Phase|Other|0|||
24900987|NCT00738374|49994975|FG001|Maintenance Treatment/Observation Phase|Other|1|||
24900988|NCT00738374|49994976|FG002|Maintenance Treatment/Observation Phase|Other|0|||
24900989|NCT00738374|49994977|FG003|Maintenance Treatment/Observation Phase|Other|0|||
24900990|NCT00697593|49994986|FG000|Overall Study|Adverse Event|3|||
24977303|NCT00376961|50065902|FG000|Initial Registration|Progression/relapse|1|||
24977304|NCT00376961|50065903|FG001|Initial Registration|Progression/relapse|0|||
24977305|NCT00376961|50065902|FG000|Initial Registration|Ineligible|3|||
25249268|NCT01149421|50565073|FG002|Overall Study|Adverse Event|11|||
25249269|NCT01149421|50565071|FG000|Overall Study|Withdrawal by Subject|20|||
25249270|NCT01149421|50565072|FG001|Overall Study|Withdrawal by Subject|12|||
25249271|NCT01149421|50565073|FG002|Overall Study|Withdrawal by Subject|13|||
25249272|NCT01149421|50565071|FG000|Overall Study|Sponsor Decision|0|||
25249273|NCT01149421|50565072|FG001|Overall Study|Sponsor Decision|1|||
25330503|NCT00882713|50646823|FG000|Overall Study|refused treatment/withdrew consent|4|||
25330504|NCT00882713|50646823|FG000|Overall Study|Blood transfusion|2|||
25330505|NCT00882713|50646823|FG000|Overall Study|Insufficient therapeutic response|3|||
25330506|NCT00882713|50646823|FG000|Overall Study|Failure to return|2|||
25330507|NCT00882713|50646823|FG000|Overall Study|Other - Reasons|2|||
25330508|NCT00809133|50646842|FG000|Overall Study|Progressive disease|2|||
25330509|NCT00809133|50646843|FG001|Overall Study|Progressive disease|5|||
25330510|NCT00809133|50646844|FG002|Overall Study|Progressive disease|5|||
25330511|NCT00809133|50646845|FG003|Overall Study|Progressive disease|3|||
25330512|NCT00809133|50646846|FG004|Overall Study|Progressive disease|4|||
25330513|NCT00809133|50646847|FG005|Overall Study|Progressive disease|1|||
25330514|NCT00809133|50646848|FG006|Overall Study|Progressive disease|3|||
25330515|NCT00809133|50646849|FG007|Overall Study|Progressive disease|3|||
25330516|NCT00809133|50646850|FG008|Overall Study|Progressive disease|3|||
25330517|NCT00809133|50646851|FG009|Overall Study|Progressive disease|9|||
25330518|NCT00809133|50646852|FG010|Overall Study|Progressive disease|5|||
25330519|NCT00809133|50646853|FG011|Overall Study|Progressive disease|7|||
25330520|NCT00809133|50646854|FG012|Overall Study|Progressive disease|5|||
25330521|NCT00809133|50646855|FG013|Overall Study|Progressive disease|4|||
25330522|NCT00809133|50646842|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
25330523|NCT00809133|50646843|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
25249274|NCT01149421|50565073|FG002|Overall Study|Sponsor Decision|1|||
25249275|NCT01149421|50565071|FG000|Overall Study|Lost to Follow-up|2|||
25249276|NCT01149421|50565072|FG001|Overall Study|Lost to Follow-up|4|||
25249277|NCT01149421|50565073|FG002|Overall Study|Lost to Follow-up|5|||
25249278|NCT01149421|50565071|FG000|Overall Study|Physician Decision|5|||
25249279|NCT01149421|50565072|FG001|Overall Study|Physician Decision|3|||
25249280|NCT01149421|50565073|FG002|Overall Study|Physician Decision|6|||
25249281|NCT01149421|50565071|FG000|Overall Study|Entry Criteria Not Met|1|||
25249282|NCT01149421|50565072|FG001|Overall Study|Entry Criteria Not Met|1|||
25249283|NCT01149421|50565073|FG002|Overall Study|Entry Criteria Not Met|2|||
25249284|NCT01149421|50565071|FG000|Overall Study|Protocol Violation|2|||
25249285|NCT01149421|50565072|FG001|Overall Study|Protocol Violation|2|||
25249286|NCT01149421|50565073|FG002|Overall Study|Protocol Violation|6|||
25249287|NCT01149343|50565091|FG000|Overall Study|Withdrawal by Subject|1|||
25249288|NCT01149343|50565092|FG001|Overall Study|Withdrawal by Subject|1|||
25249289|NCT01149343|50565093|FG002|Overall Study|Withdrawal by Subject|1|||
25249290|NCT01149343|50565094|FG003|Overall Study|Withdrawal by Subject|5|||
25249291|NCT01149343|50565091|FG000|Overall Study|Death|10|||
25249292|NCT01149343|50565092|FG001|Overall Study|Death|13|||
25249293|NCT01149343|50565093|FG002|Overall Study|Death|18|||
25249294|NCT01149343|50565094|FG003|Overall Study|Death|18|||
25249295|NCT01149343|50565091|FG000|Overall Study|Lost to Follow-up|1|||
25249296|NCT01149343|50565092|FG001|Overall Study|Lost to Follow-up|0|||
25249297|NCT01149343|50565093|FG002|Overall Study|Lost to Follow-up|0|||
25249298|NCT01149343|50565094|FG003|Overall Study|Lost to Follow-up|1|||
25249299|NCT01149343|50565091|FG000|Overall Study|Other|8|||
25249300|NCT01149343|50565092|FG001|Overall Study|Other|10|||
25249301|NCT01149343|50565093|FG002|Overall Study|Other|2|||
25249302|NCT01149343|50565094|FG003|Overall Study|Other|14|||
25249303|NCT01149343|50565091|FG000|Overall Study|Sponsor study termination|0|||
25249304|NCT01149343|50565092|FG001|Overall Study|Sponsor study termination|0|||
25249305|NCT01149343|50565093|FG002|Overall Study|Sponsor study termination|0|||
25249306|NCT01149343|50565094|FG003|Overall Study|Sponsor study termination|2|||
25249307|NCT01149343|50565091|FG000|Overall Study|Recurrence / Progressive disease|0|||
25249308|NCT01149343|50565092|FG001|Overall Study|Recurrence / Progressive disease|0|||
25249309|NCT01149343|50565093|FG002|Overall Study|Recurrence / Progressive disease|1|||
25330524|NCT00809133|50646844|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
25249310|NCT01149343|50565094|FG003|Overall Study|Recurrence / Progressive disease|0|||
25249311|NCT01149148|50565110|FG000|Overall Study|Lost to Follow-up|1|||
25249312|NCT01149148|50565111|FG001|Overall Study|Lost to Follow-up|2|||
25249313|NCT01149148|50565110|FG000|Overall Study|Death|1|||
25249314|NCT01149148|50565111|FG001|Overall Study|Death|0|||
25249315|NCT01148017|50565122|FG000|Overall Study|Withdrawal by Subject|31|||
25249316|NCT01148017|50565123|FG001|Overall Study|Withdrawal by Subject|14|||
25249317|NCT01148017|50565124|FG002|Overall Study|Withdrawal by Subject|0|||
25249318|NCT01148017|50565125|FG003|Overall Study|Withdrawal by Subject|0|||
25249319|NCT01148017|50565122|FG000|Overall Study|Lost to Follow-up|23|||
25249320|NCT01148017|50565123|FG001|Overall Study|Lost to Follow-up|10|||
25249321|NCT01148017|50565124|FG002|Overall Study|Lost to Follow-up|0|||
25249322|NCT01148017|50565125|FG003|Overall Study|Lost to Follow-up|0|||
25249323|NCT01148017|50565122|FG000|Overall Study|Inappropriate enrollment|1|||
25249324|NCT01148017|50565123|FG001|Overall Study|Inappropriate enrollment|0|||
25249325|NCT01148017|50565124|FG002|Overall Study|Inappropriate enrollment|0|||
25249326|NCT01148017|50565125|FG003|Overall Study|Inappropriate enrollment|0|||
25249327|NCT01148017|50565122|FG000|Overall Study|Administrative reason|22|||
25249328|NCT01148017|50565123|FG001|Overall Study|Administrative reason|9|||
25249329|NCT01148017|50565124|FG002|Overall Study|Administrative reason|0|||
25249330|NCT01148017|50565125|FG003|Overall Study|Administrative reason|0|||
25249331|NCT01148017|50565122|FG000|Overall Study|Unable to classify|3|||
25249332|NCT01148017|50565123|FG001|Overall Study|Unable to classify|1|||
25330525|NCT00809133|50646845|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
25330526|NCT00809133|50646846|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
25330527|NCT00809133|50646847|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
25249333|NCT01148017|50565124|FG002|Overall Study|Unable to classify|0|||
25249334|NCT01148017|50565125|FG003|Overall Study|Unable to classify|0|||
25249335|NCT01147900|50565139|FG000|At Year 10|Lost to Follow-up|0|||
25249336|NCT01147900|50565140|FG001|At Year 10|Lost to Follow-up|1|||
25249337|NCT01147900|50565141|FG002|At Year 10|Lost to Follow-up|0|||
25249338|NCT01147744|50565156|FG000|Overall Study|Protocol Violation|1|||
25249339|NCT01147744|50565157|FG001|Overall Study|Protocol Violation|0|||
25249340|NCT01147744|50565158|FG002|Overall Study|Protocol Violation|1|||
25249341|NCT01147744|50565159|FG003|Overall Study|Protocol Violation|0|||
25249342|NCT01147744|50565160|FG004|Overall Study|Protocol Violation|1|||
25249343|NCT01147744|50565161|FG005|Overall Study|Protocol Violation|3|||
25249344|NCT01147744|50565162|FG006|Overall Study|Protocol Violation|1|||
25249345|NCT01147744|50565156|FG000|Overall Study|Physician Decision|0|||
25249346|NCT01147744|50565157|FG001|Overall Study|Physician Decision|1|||
25249347|NCT01147744|50565158|FG002|Overall Study|Physician Decision|1|||
25249348|NCT01147744|50565159|FG003|Overall Study|Physician Decision|0|||
25249349|NCT01147744|50565160|FG004|Overall Study|Physician Decision|0|||
25249350|NCT01147744|50565161|FG005|Overall Study|Physician Decision|0|||
25249351|NCT01147744|50565162|FG006|Overall Study|Physician Decision|1|||
25249352|NCT01147744|50565156|FG000|Overall Study|Lack of Efficacy|11|||
25249353|NCT01147744|50565157|FG001|Overall Study|Lack of Efficacy|11|||
25249354|NCT01147744|50565158|FG002|Overall Study|Lack of Efficacy|9|||
25249355|NCT01147744|50565159|FG003|Overall Study|Lack of Efficacy|11|||
25249356|NCT01147744|50565160|FG004|Overall Study|Lack of Efficacy|13|||
25330528|NCT00809133|50646848|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
25330529|NCT00809133|50646849|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
25330530|NCT00809133|50646850|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
25330531|NCT00809133|50646851|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
25330532|NCT00809133|50646852|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
25330533|NCT00809133|50646853|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
25330534|NCT00809133|50646854|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
25330535|NCT00809133|50646855|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
25330536|NCT00809133|50646842|FG000|Overall Study|Other adverse event|1|||
25249357|NCT01147744|50565161|FG005|Overall Study|Lack of Efficacy|8|||
25249358|NCT01147744|50565162|FG006|Overall Study|Lack of Efficacy|7|||
25249359|NCT01147744|50565156|FG000|Overall Study|Adverse Event|1|||
25249360|NCT01147744|50565157|FG001|Overall Study|Adverse Event|2|||
25249361|NCT01147744|50565158|FG002|Overall Study|Adverse Event|3|||
25249362|NCT01147744|50565159|FG003|Overall Study|Adverse Event|0|||
25249363|NCT01147744|50565160|FG004|Overall Study|Adverse Event|2|||
25249364|NCT01147744|50565161|FG005|Overall Study|Adverse Event|1|||
25249365|NCT01147744|50565162|FG006|Overall Study|Adverse Event|2|||
25249366|NCT01147744|50565156|FG000|Overall Study|Withdrawal by Subject|8|||
25249367|NCT01147744|50565157|FG001|Overall Study|Withdrawal by Subject|4|||
25249368|NCT01147744|50565158|FG002|Overall Study|Withdrawal by Subject|2|||
25249369|NCT01147744|50565159|FG003|Overall Study|Withdrawal by Subject|2|||
25249370|NCT01147744|50565160|FG004|Overall Study|Withdrawal by Subject|2|||
25249371|NCT01147744|50565161|FG005|Overall Study|Withdrawal by Subject|5|||
25249372|NCT01147744|50565162|FG006|Overall Study|Withdrawal by Subject|2|||
25249373|NCT01147744|50565156|FG000|Overall Study|Lost to Follow-up|0|||
25249374|NCT01147744|50565157|FG001|Overall Study|Lost to Follow-up|1|||
25249375|NCT01147744|50565158|FG002|Overall Study|Lost to Follow-up|0|||
25249376|NCT01147744|50565159|FG003|Overall Study|Lost to Follow-up|0|||
25249377|NCT01147744|50565160|FG004|Overall Study|Lost to Follow-up|0|||
25249378|NCT01147744|50565161|FG005|Overall Study|Lost to Follow-up|0|||
25249379|NCT01147744|50565162|FG006|Overall Study|Lost to Follow-up|0|||
25249380|NCT01147744|50565156|FG000|Overall Study|Sponsor decision to amend protocol|7|||
25249381|NCT01147744|50565157|FG001|Overall Study|Sponsor decision to amend protocol|4|||
25249382|NCT01147744|50565158|FG002|Overall Study|Sponsor decision to amend protocol|2|||
25249383|NCT01147744|50565159|FG003|Overall Study|Sponsor decision to amend protocol|5|||
25249384|NCT01147744|50565160|FG004|Overall Study|Sponsor decision to amend protocol|7|||
25249385|NCT01147744|50565161|FG005|Overall Study|Sponsor decision to amend protocol|2|||
25249386|NCT01147744|50565162|FG006|Overall Study|Sponsor decision to amend protocol|6|||
25249387|NCT01147744|50565156|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
25249388|NCT01147744|50565157|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
25249389|NCT01147744|50565158|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
25249390|NCT01147744|50565159|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
25330537|NCT00809133|50646843|FG001|Overall Study|Other adverse event|1|||
25249391|NCT01147744|50565160|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
25249392|NCT01147744|50565161|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
25249393|NCT01147744|50565162|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
25249394|NCT01147471|50565186|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
25249395|NCT01147471|50565187|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
25249396|NCT01147471|50565186|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
25330538|NCT00809133|50646844|FG002|Overall Study|Other adverse event|1|||
25330539|NCT00809133|50646845|FG003|Overall Study|Other adverse event|0|||
25249397|NCT01147471|50565187|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
25249398|NCT01147471|50565186|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
25249399|NCT01147471|50565187|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
25249400|NCT01147471|50565186|FG000|3 Month Follow Up|Lost to Follow-up|1|||
25249401|NCT01147471|50565187|FG001|3 Month Follow Up|Lost to Follow-up|1|||
25249402|NCT01147471|50565186|FG000|3 Month Follow Up|Physician Decision|0|||
25249403|NCT01147471|50565187|FG001|3 Month Follow Up|Physician Decision|1|||
25249404|NCT01147471|50565186|FG000|6 Month Follow Up|Lost to Follow-up|4|||
25249405|NCT01147471|50565187|FG001|6 Month Follow Up|Lost to Follow-up|2|||
25249406|NCT01147393|50565193|FG000|Dose Level 1|Dose limiting Toxicity|2|||
25249407|NCT01147393|50565193|FG000|Dose Level -1|Dose Limited Toxicity|1|||
25249408|NCT01146652|50565200|FG000|Overall Study|Adverse Event|506|||
25249409|NCT01146652|50565201|FG001|Overall Study|Adverse Event|15|||
25249410|NCT01146652|50565200|FG000|Overall Study|Lack of Efficacy|91|||
25249411|NCT01146652|50565201|FG001|Overall Study|Lack of Efficacy|7|||
25249412|NCT01146652|50565200|FG000|Overall Study|Poor compliance to protocol|38|||
25249413|NCT01146652|50565201|FG001|Overall Study|Poor compliance to protocol|1|||
25249414|NCT01146652|50565200|FG000|Overall Study|Other unspecified reasons|314|||
25249415|NCT01146652|50565201|FG001|Overall Study|Other unspecified reasons|22|||
25249416|NCT01146652|50565200|FG000|Overall Study|Enrolled but not treated|2|||
25249417|NCT01146652|50565201|FG001|Overall Study|Enrolled but not treated|0|||
25249418|NCT01146613|50565216|FG000|Overall Study|Lost to Follow-up|3|||
25249419|NCT01146613|50565217|FG001|Overall Study|Lost to Follow-up|8|||
25249420|NCT01146613|50565216|FG000|Overall Study|Lack of Efficacy|0|||
25249421|NCT01146613|50565217|FG001|Overall Study|Lack of Efficacy|1|||
25249422|NCT01146613|50565216|FG000|Overall Study|Death|1|||
25249423|NCT01146613|50565217|FG001|Overall Study|Death|0|||
25249424|NCT01146613|50565216|FG000|Overall Study|Physician Decision|1|||
25249425|NCT01146613|50565217|FG001|Overall Study|Physician Decision|0|||
25249426|NCT01146613|50565216|FG000|Overall Study|Withdrawal by Subject|0|||
25249427|NCT01146613|50565217|FG001|Overall Study|Withdrawal by Subject|3|||
25249428|NCT01146613|50565216|FG000|Overall Study|schedule conflict|1|||
25249429|NCT01146613|50565217|FG001|Overall Study|schedule conflict|0|||
25249430|NCT01146613|50565216|FG000|Overall Study|Outpatient detox|1|||
25249431|NCT01146613|50565217|FG001|Overall Study|Outpatient detox|0|||
25249432|NCT01145755|50565226|FG000|Overall Study|Adverse Event|2|||
25249433|NCT01145755|50565227|FG001|Overall Study|Adverse Event|4|||
25249434|NCT01145755|50565228|FG002|Overall Study|Adverse Event|2|||
25249435|NCT01145755|50565226|FG000|Overall Study|Withdrawal by Subject|2|||
25249436|NCT01145755|50565227|FG001|Overall Study|Withdrawal by Subject|2|||
25249437|NCT01145755|50565228|FG002|Overall Study|Withdrawal by Subject|2|||
25249438|NCT01145755|50565226|FG000|Overall Study|Lost to Follow-up|2|||
25249439|NCT01145755|50565227|FG001|Overall Study|Lost to Follow-up|3|||
25249440|NCT01145755|50565228|FG002|Overall Study|Lost to Follow-up|1|||
25249441|NCT01145755|50565226|FG000|Overall Study|Protocol Violation|0|||
25249442|NCT01145755|50565227|FG001|Overall Study|Protocol Violation|3|||
25249443|NCT01145755|50565228|FG002|Overall Study|Protocol Violation|1|||
25249444|NCT01145755|50565226|FG000|Overall Study|Study Closure|14|||
25249445|NCT01145755|50565227|FG001|Overall Study|Study Closure|14|||
25249446|NCT01145755|50565228|FG002|Overall Study|Study Closure|17|||
25249447|NCT01145755|50565226|FG000|Overall Study|Lack of Efficacy|0|||
25249448|NCT01145755|50565227|FG001|Overall Study|Lack of Efficacy|1|||
25249449|NCT01145755|50565228|FG002|Overall Study|Lack of Efficacy|0|||
25249450|NCT01145755|50565226|FG000|Overall Study|Patient could not swollow medication|0|||
25249451|NCT01145755|50565227|FG001|Overall Study|Patient could not swollow medication|0|||
25249452|NCT01145755|50565228|FG002|Overall Study|Patient could not swollow medication|1|||
25249453|NCT01145755|50565226|FG000|Overall Study|Withdrawal by Subject|0|||
25249454|NCT01145755|50565227|FG001|Overall Study|Withdrawal by Subject|0|||
25249455|NCT01145755|50565228|FG002|Overall Study|Withdrawal by Subject|1|||
25249456|NCT01145755|50565226|FG000|Overall Study|Positive urine ethanol|0|||
25249457|NCT01145755|50565227|FG001|Overall Study|Positive urine ethanol|1|||
25330540|NCT00809133|50646846|FG004|Overall Study|Other adverse event|0|||
25330541|NCT00809133|50646847|FG005|Overall Study|Other adverse event|3|||
25330542|NCT00809133|50646848|FG006|Overall Study|Other adverse event|2|||
24900991|NCT00697593|49994986|FG000|Overall Study|Protocol Violation|1|||
25249458|NCT01145755|50565228|FG002|Overall Study|Positive urine ethanol|0|||
25249459|NCT01145560|50565239|FG000|Overall Study|Withdrawal by Subject|2|||
25249460|NCT01145560|50565240|FG001|Overall Study|Withdrawal by Subject|1|||
25249461|NCT01145560|50565241|FG002|Overall Study|Withdrawal by Subject|0|||
25249462|NCT01145560|50565239|FG000|Overall Study|Lost to Follow-up|1|||
25249463|NCT01145560|50565240|FG001|Overall Study|Lost to Follow-up|1|||
25249464|NCT01145560|50565241|FG002|Overall Study|Lost to Follow-up|1|||
25249465|NCT01145560|50565239|FG000|Overall Study|No study drug by 24h after organ failure|1|||
25249466|NCT01145560|50565240|FG001|Overall Study|No study drug by 24h after organ failure|0|||
25249467|NCT01145560|50565241|FG002|Overall Study|No study drug by 24h after organ failure|0|||
25249468|NCT01145560|50565239|FG000|Overall Study|Accidental unblinding of study treatment|0|||
25330543|NCT00809133|50646849|FG007|Overall Study|Other adverse event|4|||
25249469|NCT01145560|50565240|FG001|Overall Study|Accidental unblinding of study treatment|1|||
25249470|NCT01145560|50565241|FG002|Overall Study|Accidental unblinding of study treatment|0|||
25249471|NCT01145560|50565239|FG000|Overall Study|False insurance information|0|||
25249472|NCT01145560|50565240|FG001|Overall Study|False insurance information|1|||
25249473|NCT01145560|50565241|FG002|Overall Study|False insurance information|0|||
25249474|NCT01145560|50565239|FG000|Overall Study|Withdrawal of therapy|0|||
25249475|NCT01145560|50565240|FG001|Overall Study|Withdrawal of therapy|0|||
25249476|NCT01145560|50565241|FG002|Overall Study|Withdrawal of therapy|1|||
25249477|NCT01145482|50565251|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
25249478|NCT01145482|50565252|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
25249479|NCT01145053|50565258|FG000|Overall Study|Adverse Event|22|||
25249480|NCT01145053|50565258|FG000|Overall Study|Lost to Follow-up|28|||
25249481|NCT01145053|50565258|FG000|Overall Study|Withdrawal by Subject|25|||
25249482|NCT01145053|50565258|FG000|Overall Study|Other|18|||
25249483|NCT01144663|50565266|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
25249484|NCT01144663|50565267|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
25249485|NCT01144663|50565268|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
25249486|NCT01144663|50565269|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
25249487|NCT01144663|50565266|FG000|Primary Vaccination Phase|Adverse Event|1|||
25249488|NCT01144663|50565267|FG001|Primary Vaccination Phase|Adverse Event|0|||
25249489|NCT01144663|50565268|FG002|Primary Vaccination Phase|Adverse Event|0|||
25249490|NCT01144663|50565269|FG003|Primary Vaccination Phase|Adverse Event|1|||
25249491|NCT01144663|50565266|FG000|Primary Vaccination Phase|Protocol Violation|2|||
25249492|NCT01144663|50565267|FG001|Primary Vaccination Phase|Protocol Violation|0|||
25249493|NCT01144663|50565268|FG002|Primary Vaccination Phase|Protocol Violation|1|||
25249494|NCT01144663|50565269|FG003|Primary Vaccination Phase|Protocol Violation|0|||
25249495|NCT01144663|50565266|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
25249496|NCT01144663|50565267|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
25249497|NCT01144663|50565268|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
25249498|NCT01144663|50565269|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
25249499|NCT01144663|50565266|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
25249500|NCT01144663|50565267|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
25249501|NCT01144663|50565268|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
25249502|NCT01144663|50565269|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
25249503|NCT01144663|50565266|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
25249504|NCT01144663|50565267|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
25249505|NCT01144663|50565268|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
25249506|NCT01144663|50565269|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
25249507|NCT01144663|50565266|FG000|Primary Vaccination Phase|Other|0|||
25249508|NCT01144663|50565267|FG001|Primary Vaccination Phase|Other|1|||
25249509|NCT01144663|50565268|FG002|Primary Vaccination Phase|Other|0|||
25249510|NCT01144663|50565269|FG003|Primary Vaccination Phase|Other|2|||
25249511|NCT01144663|50565266|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
25249512|NCT01144663|50565267|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
25249513|NCT01144663|50565268|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
25249514|NCT01144663|50565269|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
25249515|NCT01144663|50565266|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
25249516|NCT01144663|50565267|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
25249517|NCT01144663|50565268|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
25249518|NCT01144663|50565269|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
25249519|NCT01144663|50565266|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
25249520|NCT01144663|50565267|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
25249521|NCT01144663|50565268|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
25249522|NCT01144663|50565269|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
25249523|NCT01144663|50565266|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
25249524|NCT01144663|50565267|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
25249525|NCT01144663|50565268|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
25249526|NCT01144663|50565269|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
25249527|NCT01144663|50565266|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
25249528|NCT01144663|50565267|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
25249529|NCT01144663|50565268|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
25249530|NCT01144663|50565269|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
25249531|NCT01144663|50565266|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
25249532|NCT01144663|50565267|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
25249533|NCT01144663|50565268|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
25249534|NCT01144663|50565269|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
25249535|NCT01143337|50565281|FG000|Overall Study|Adverse Event|3|||
25249536|NCT01143337|50565282|FG001|Overall Study|Adverse Event|9|||
25249537|NCT01143337|50565283|FG002|Overall Study|Adverse Event|5|||
25249538|NCT01143337|50565281|FG000|Overall Study|Lack of Efficacy|6|||
25249539|NCT01143337|50565282|FG001|Overall Study|Lack of Efficacy|2|||
25249540|NCT01143337|50565283|FG002|Overall Study|Lack of Efficacy|1|||
25249541|NCT01143337|50565281|FG000|Overall Study|Protocol Violation|1|||
25249542|NCT01143337|50565282|FG001|Overall Study|Protocol Violation|0|||
25249543|NCT01143337|50565283|FG002|Overall Study|Protocol Violation|0|||
25249544|NCT01143337|50565281|FG000|Overall Study|Withdrawal by Subject|0|||
25249545|NCT01143337|50565282|FG001|Overall Study|Withdrawal by Subject|0|||
25330544|NCT00809133|50646850|FG008|Overall Study|Other adverse event|0|||
25330545|NCT00809133|50646851|FG009|Overall Study|Other adverse event|0|||
25330546|NCT00809133|50646852|FG010|Overall Study|Other adverse event|1|||
25330547|NCT00809133|50646853|FG011|Overall Study|Other adverse event|1|||
25330548|NCT00809133|50646854|FG012|Overall Study|Other adverse event|0|||
25330549|NCT00809133|50646855|FG013|Overall Study|Other adverse event|1|||
25330550|NCT00809133|50646842|FG000|Overall Study|Lost to Follow-up|0|||
25330551|NCT00809133|50646843|FG001|Overall Study|Lost to Follow-up|0|||
25330552|NCT00809133|50646844|FG002|Overall Study|Lost to Follow-up|0|||
25330553|NCT00809133|50646845|FG003|Overall Study|Lost to Follow-up|0|||
25330554|NCT00809133|50646846|FG004|Overall Study|Lost to Follow-up|0|||
25330555|NCT00809133|50646847|FG005|Overall Study|Lost to Follow-up|1|||
25249546|NCT01143337|50565283|FG002|Overall Study|Withdrawal by Subject|1|||
25249547|NCT01143337|50565281|FG000|Overall Study|Other reason|0|||
25249548|NCT01143337|50565282|FG001|Overall Study|Other reason|0|||
25249549|NCT01143337|50565283|FG002|Overall Study|Other reason|5|||
25330556|NCT00809133|50646848|FG006|Overall Study|Lost to Follow-up|0|||
25330557|NCT00809133|50646849|FG007|Overall Study|Lost to Follow-up|0|||
25330558|NCT00809133|50646850|FG008|Overall Study|Lost to Follow-up|0|||
25330559|NCT00809133|50646851|FG009|Overall Study|Lost to Follow-up|0|||
25330560|NCT00809133|50646852|FG010|Overall Study|Lost to Follow-up|0|||
25330561|NCT00809133|50646853|FG011|Overall Study|Lost to Follow-up|0|||
25330562|NCT00809133|50646854|FG012|Overall Study|Lost to Follow-up|0|||
25330563|NCT00809133|50646855|FG013|Overall Study|Lost to Follow-up|0|||
25330564|NCT00809133|50646842|FG000|Overall Study|Consent withdrawn|0|||
25330565|NCT00809133|50646843|FG001|Overall Study|Consent withdrawn|0|||
25330566|NCT00809133|50646844|FG002|Overall Study|Consent withdrawn|0|||
25330567|NCT00809133|50646845|FG003|Overall Study|Consent withdrawn|0|||
25330568|NCT00809133|50646846|FG004|Overall Study|Consent withdrawn|1|||
25330569|NCT00809133|50646847|FG005|Overall Study|Consent withdrawn|0|||
25330570|NCT00809133|50646848|FG006|Overall Study|Consent withdrawn|0|||
25330571|NCT00809133|50646849|FG007|Overall Study|Consent withdrawn|0|||
25330572|NCT00809133|50646850|FG008|Overall Study|Consent withdrawn|0|||
25330573|NCT00809133|50646851|FG009|Overall Study|Consent withdrawn|0|||
25330574|NCT00809133|50646852|FG010|Overall Study|Consent withdrawn|0|||
25330575|NCT00809133|50646853|FG011|Overall Study|Consent withdrawn|0|||
25330576|NCT00809133|50646854|FG012|Overall Study|Consent withdrawn|0|||
25330577|NCT00809133|50646855|FG013|Overall Study|Consent withdrawn|0|||
25330578|NCT00809133|50646842|FG000|Overall Study|Other not mentioned above|0|||
25330579|NCT00809133|50646843|FG001|Overall Study|Other not mentioned above|1|||
25330580|NCT00809133|50646844|FG002|Overall Study|Other not mentioned above|0|||
25330581|NCT00809133|50646845|FG003|Overall Study|Other not mentioned above|0|||
25330582|NCT00809133|50646846|FG004|Overall Study|Other not mentioned above|0|||
25330583|NCT00809133|50646847|FG005|Overall Study|Other not mentioned above|1|||
25330584|NCT00809133|50646848|FG006|Overall Study|Other not mentioned above|0|||
25330585|NCT00809133|50646849|FG007|Overall Study|Other not mentioned above|0|||
25330586|NCT00809133|50646850|FG008|Overall Study|Other not mentioned above|0|||
25330587|NCT00809133|50646851|FG009|Overall Study|Other not mentioned above|0|||
25330588|NCT00809133|50646852|FG010|Overall Study|Other not mentioned above|0|||
25330589|NCT00809133|50646853|FG011|Overall Study|Other not mentioned above|0|||
25330590|NCT00809133|50646854|FG012|Overall Study|Other not mentioned above|0|||
25330591|NCT00809133|50646855|FG013|Overall Study|Other not mentioned above|0|||
25330592|NCT00882557|50646900|FG000|Overall Study|Withdrawal by Subject|1|||
25330593|NCT00882557|50646901|FG001|Overall Study|Withdrawal by Subject|0|||
25330594|NCT00882557|50646900|FG000|Overall Study|Trouble with Vein Access|1|||
25330595|NCT00882557|50646901|FG001|Overall Study|Trouble with Vein Access|0|||
25249550|NCT01143259|50565300|FG000|Overall Study|Withdrawal by Subject|3|||
25330596|NCT00882557|50646900|FG000|Overall Study|Randomized Not Treated|0|||
25249551|NCT01143259|50565301|FG001|Overall Study|Withdrawal by Subject|2|||
25330597|NCT00882557|50646901|FG001|Overall Study|Randomized Not Treated|1|||
25330598|NCT00808899|50646907|FG000|Overall Study|Death|1|||
25330599|NCT00808899|50646907|FG000|Overall Study|Physician Decision|3|||
25330600|NCT00808665|50646913|FG000|Overall Study|Withdrawal by Subject|1|||
25330601|NCT00808665|50646914|FG001|Overall Study|Withdrawal by Subject|0|||
25330602|NCT00808665|50646913|FG000|Overall Study|only required minimally invasive surgery|1|||
25330603|NCT00808665|50646914|FG001|Overall Study|only required minimally invasive surgery|0|||
25249552|NCT01143259|50565300|FG000|Overall Study|Protocol Violation|13|||
25249553|NCT01143259|50565301|FG001|Overall Study|Protocol Violation|9|||
25330604|NCT00808665|50646913|FG000|Overall Study|surgery cancelled|1|||
25330605|NCT00808665|50646914|FG001|Overall Study|surgery cancelled|0|||
25330606|NCT00808665|50646913|FG000|Overall Study|required an additional procedure|0|||
25330607|NCT00808665|50646914|FG001|Overall Study|required an additional procedure|1|||
25330608|NCT00808665|50646913|FG000|Overall Study|Physician Decision|3|||
25330609|NCT00808665|50646914|FG001|Overall Study|Physician Decision|1|||
25330610|NCT00808665|50646913|FG000|Overall Study|Medication stopped by resident|0|||
25330611|NCT00808665|50646914|FG001|Overall Study|Medication stopped by resident|1|||
25330612|NCT00808509|50646922|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
25330613|NCT00808509|50646923|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
25330614|NCT00808509|50646922|FG000|Randomized Phase|Reduced methotrexate dose|1|||
25330615|NCT00808509|50646923|FG001|Randomized Phase|Reduced methotrexate dose|2|||
25330616|NCT00808509|50646922|FG000|Randomized Phase|Patient refused rescue therapy|0|||
25330617|NCT00808509|50646923|FG001|Randomized Phase|Patient refused rescue therapy|3|||
25330618|NCT00807885|50646940|FG000|Overall Study|Lost to Follow-up|0|||
25330619|NCT00807885|50646941|FG001|Overall Study|Lost to Follow-up|0|||
25330620|NCT00807885|50646942|FG002|Overall Study|Lost to Follow-up|0|||
25330621|NCT00807885|50646943|FG003|Overall Study|Lost to Follow-up|0|||
25330622|NCT00807885|50646944|FG004|Overall Study|Lost to Follow-up|0|||
25330623|NCT00807885|50646945|FG005|Overall Study|Lost to Follow-up|1|||
25249554|NCT01143259|50565300|FG000|Overall Study|Screen Failure|7|||
25249555|NCT01143259|50565301|FG001|Overall Study|Screen Failure|9|||
25249556|NCT01142908|50565309|FG000|Overall Study|Lost to Follow-up|19|||
25249557|NCT01142908|50565310|FG001|Overall Study|Lost to Follow-up|13|||
25249558|NCT01142908|50565309|FG000|Overall Study|Death|1|||
25249559|NCT01142908|50565310|FG001|Overall Study|Death|4|||
25249560|NCT01142908|50565309|FG000|Overall Study|Excluded - did not meet criteria|9|||
25249561|NCT01142908|50565310|FG001|Overall Study|Excluded - did not meet criteria|5|||
25249562|NCT01142908|50565309|FG000|Overall Study|Withdrawal by Subject|3|||
25249563|NCT01142908|50565310|FG001|Overall Study|Withdrawal by Subject|0|||
25249564|NCT01142791|50565316|FG000|Overall Study|Alternative Treatment|1|||
25249565|NCT01142791|50565317|FG001|Overall Study|Alternative Treatment|0|||
25249566|NCT01142791|50565316|FG000|Overall Study|Lost to Follow-up|1|||
25249567|NCT01142791|50565317|FG001|Overall Study|Lost to Follow-up|0|||
25249568|NCT01142791|50565316|FG000|Overall Study|Withdrawal by Subject|5|||
25249569|NCT01142791|50565317|FG001|Overall Study|Withdrawal by Subject|0|||
25249570|NCT01142791|50565316|FG000|Overall Study|Received only 1 sonication|0|||
25249571|NCT01142791|50565317|FG001|Overall Study|Received only 1 sonication|6|||
25249572|NCT01142596|50565323|FG000|Overall Study|Withdrawal by Subject|9|||
25249573|NCT01142596|50565324|FG001|Overall Study|Withdrawal by Subject|35|||
25249574|NCT01142596|50565323|FG000|Overall Study|Adverse Event|8|||
25249575|NCT01142596|50565324|FG001|Overall Study|Adverse Event|35|||
25249576|NCT01142596|50565323|FG000|Overall Study|Lack of Efficacy|5|||
25249577|NCT01142596|50565324|FG001|Overall Study|Lack of Efficacy|9|||
25249578|NCT01142596|50565323|FG000|Overall Study|Lost to Follow-up|2|||
25249579|NCT01142596|50565324|FG001|Overall Study|Lost to Follow-up|3|||
25249580|NCT01142596|50565323|FG000|Overall Study|Other reason (not specified)|5|||
25249581|NCT01142596|50565324|FG001|Overall Study|Other reason (not specified)|4|||
25249582|NCT01142128|50565334|FG000|Overall Study|Physician Decision|1|||
25249583|NCT01142128|50565334|FG000|Overall Study|Lost to Follow-up|1|||
25249584|NCT01142128|50565334|FG000|Overall Study|Withdrawal by Subject|2|||
25249585|NCT01142089|50565346|FG000|Overall Study|Physician Decision|1|||
25249586|NCT01142089|50565347|FG001|Overall Study|Physician Decision|0|||
25249587|NCT01142089|50565346|FG000|Overall Study|Withdrawal by Subject|1|||
25249588|NCT01142089|50565347|FG001|Overall Study|Withdrawal by Subject|2|||
25249589|NCT01142089|50565346|FG000|Overall Study|Use of prohibited medications|0|||
25249590|NCT01142089|50565347|FG001|Overall Study|Use of prohibited medications|1|||
25249591|NCT01142089|50565346|FG000|Overall Study|Noncompliance with study procedures|2|||
25249592|NCT01142089|50565347|FG001|Overall Study|Noncompliance with study procedures|1|||
25249593|NCT01142089|50565346|FG000|Overall Study|Patient required rescue medication|8|||
25249594|NCT01142089|50565347|FG001|Overall Study|Patient required rescue medication|17|||
25249595|NCT01141660|50565355|FG000|Overall Study|Physician Decision|0|||
25249596|NCT01141660|50565356|FG001|Overall Study|Physician Decision|12|||
25249597|NCT01140880|50565364|FG000|Overall Study|Death|0|||
25249598|NCT01140880|50565365|FG001|Overall Study|Death|1|||
25249599|NCT01140880|50565364|FG000|Overall Study|Withdrawal by Subject|6|||
25249600|NCT01140880|50565365|FG001|Overall Study|Withdrawal by Subject|3|||
25249601|NCT01140880|50565364|FG000|Overall Study|Lost to Follow-up|8|||
25249602|NCT01140880|50565365|FG001|Overall Study|Lost to Follow-up|10|||
25330624|NCT00807885|50646946|FG006|Overall Study|Lost to Follow-up|0|||
25330625|NCT00807885|50646947|FG007|Overall Study|Lost to Follow-up|0|||
25330626|NCT00807885|50646948|FG008|Overall Study|Lost to Follow-up|0|||
25330627|NCT00807573|50646968|FG000|Overall Study|Withdrawal by Subject|1|||
25330628|NCT00807573|50646968|FG000|Overall Study|Adverse Event|1|||
25330629|NCT00842712|50646979|FG000|Safety Run-in Part|Adverse Event|0|||
25330630|NCT00842712|50646980|FG001|Safety Run-in Part|Adverse Event|1|||
25249603|NCT01140880|50565364|FG000|Overall Study|Protocol Violation|0|||
25249604|NCT01140880|50565365|FG001|Overall Study|Protocol Violation|30|||
25249605|NCT01140646|50565371|FG000|Overall Study|Adverse Event|4|||
25249606|NCT01140646|50565371|FG000|Overall Study|Refused Further Treatment|5|||
25249607|NCT01140568|50565375|FG000|Overall Study|disease progression|31|||
25249608|NCT01140568|50565375|FG000|Overall Study|Withdrawal by Subject|1|||
25249609|NCT01140568|50565375|FG000|Overall Study|Screen Fail|4|||
25249610|NCT01140451|50565381|FG000|Overall Study|Withdrawal by Subject|26|||
25249611|NCT01140451|50565382|FG001|Overall Study|Withdrawal by Subject|33|||
25249612|NCT01140451|50565381|FG000|Overall Study|Adverse Event|2|||
25330631|NCT00842712|50646981|FG002|Safety Run-in Part|Adverse Event|0|||
25330632|NCT00842712|50646982|FG003|Safety Run-in Part|Adverse Event|0|||
25330633|NCT00842712|50646983|FG004|Safety Run-in Part|Adverse Event|0|||
25330634|NCT00842712|50646984|FG005|Safety Run-in Part|Adverse Event|0|||
25330635|NCT00842712|50646985|FG006|Safety Run-in Part|Adverse Event|0|||
25330636|NCT00842712|50646979|FG000|Safety Run-in Part|Progressive disease|3|||
25330637|NCT00842712|50646980|FG001|Safety Run-in Part|Progressive disease|1|||
25330638|NCT00842712|50646981|FG002|Safety Run-in Part|Progressive disease|0|||
25330639|NCT00842712|50646982|FG003|Safety Run-in Part|Progressive disease|1|||
25330640|NCT00842712|50646983|FG004|Safety Run-in Part|Progressive disease|0|||
25330641|NCT00842712|50646984|FG005|Safety Run-in Part|Progressive disease|0|||
25330642|NCT00842712|50646985|FG006|Safety Run-in Part|Progressive disease|0|||
25330643|NCT00842712|50646979|FG000|Randomized Part|Randomized but not treated|0|||
25330644|NCT00842712|50646980|FG001|Randomized Part|Randomized but not treated|0|||
25330645|NCT00842712|50646981|FG002|Randomized Part|Randomized but not treated|0|||
25330646|NCT00842712|50646982|FG003|Randomized Part|Randomized but not treated|0|||
25330647|NCT00842712|50646983|FG004|Randomized Part|Randomized but not treated|0|||
25330648|NCT00842712|50646984|FG005|Randomized Part|Randomized but not treated|1|||
25330649|NCT00842712|50646985|FG006|Randomized Part|Randomized but not treated|4|||
25330650|NCT00842712|50646979|FG000|Randomized Part|Ongoing at cut-off date|0|||
25330651|NCT00842712|50646980|FG001|Randomized Part|Ongoing at cut-off date|0|||
25330652|NCT00842712|50646981|FG002|Randomized Part|Ongoing at cut-off date|0|||
25330653|NCT00842712|50646982|FG003|Randomized Part|Ongoing at cut-off date|0|||
25330654|NCT00842712|50646983|FG004|Randomized Part|Ongoing at cut-off date|0|||
25330655|NCT00842712|50646984|FG005|Randomized Part|Ongoing at cut-off date|0|||
25330656|NCT00842712|50646985|FG006|Randomized Part|Ongoing at cut-off date|2|||
25330657|NCT00842244|50647001|FG000|Overall Study|Death|3|||
25330658|NCT00842244|50647001|FG000|Overall Study|Withdrawal by Subject|1|||
25330659|NCT00842244|50647001|FG000|Overall Study|Other|17|||
25330660|NCT00832416|50647012|FG000|Overall Study|Lack of Efficacy|17|||
25330661|NCT00832416|50647013|FG001|Overall Study|Lack of Efficacy|15|||
25330662|NCT00832416|50647014|FG002|Overall Study|Lack of Efficacy|13|||
25330663|NCT00832416|50647015|FG003|Overall Study|Lack of Efficacy|52|||
25330664|NCT00832416|50647012|FG000|Overall Study|Withdrawal by Subject|5|||
25330665|NCT00832416|50647013|FG001|Overall Study|Withdrawal by Subject|7|||
25330666|NCT00832416|50647014|FG002|Overall Study|Withdrawal by Subject|2|||
25249613|NCT01140451|50565382|FG001|Overall Study|Adverse Event|6|||
25249614|NCT01140451|50565381|FG000|Overall Study|Physician Decision|5|||
25249615|NCT01140451|50565382|FG001|Overall Study|Physician Decision|3|||
25249616|NCT01140451|50565381|FG000|Overall Study|Lost to Follow-up|2|||
25249617|NCT01140451|50565382|FG001|Overall Study|Lost to Follow-up|0|||
25249618|NCT01140451|50565381|FG000|Overall Study|Participants Planning Pregnancy|3|||
25249619|NCT01140451|50565382|FG001|Overall Study|Participants Planning Pregnancy|0|||
25249620|NCT01140061|50565399|FG000|Part I|Adverse Event|1|||
25249621|NCT01140061|50565400|FG001|Part I|Adverse Event|0|||
25249622|NCT01140061|50565401|FG002|Part I|Adverse Event|0|||
25249623|NCT01140061|50565402|FG003|Part I|Adverse Event|0|||
25249624|NCT01140061|50565403|FG004|Part I|Adverse Event|0|||
25249625|NCT01140061|50565404|FG005|Part I|Adverse Event|0|||
25249626|NCT01140061|50565405|FG006|Part I|Adverse Event|0|||
25249627|NCT01140061|50565406|FG007|Part I|Adverse Event|0|||
25249628|NCT01140061|50565407|FG008|Part I|Adverse Event|0|||
25249629|NCT01140061|50565408|FG009|Part I|Adverse Event|0|||
25249630|NCT01140061|50565399|FG000|Extension|Laboratory Adverse Event|0|||
25249631|NCT01140061|50565400|FG001|Extension|Laboratory Adverse Event|0|||
25330667|NCT00832416|50647015|FG003|Overall Study|Withdrawal by Subject|10|||
24900992|NCT00697593|49994986|FG000|Overall Study|Lack of Efficacy|3|||
25249632|NCT01140061|50565401|FG002|Extension|Laboratory Adverse Event|0|||
25249633|NCT01140061|50565402|FG003|Extension|Laboratory Adverse Event|0|||
25249634|NCT01140061|50565403|FG004|Extension|Laboratory Adverse Event|0|||
25249635|NCT01140061|50565404|FG005|Extension|Laboratory Adverse Event|0|||
25249636|NCT01140061|50565405|FG006|Extension|Laboratory Adverse Event|0|||
25330668|NCT00832416|50647012|FG000|Overall Study|Physician Decision|2|||
25330669|NCT00832416|50647013|FG001|Overall Study|Physician Decision|12|||
25330670|NCT00832416|50647014|FG002|Overall Study|Physician Decision|5|||
25330671|NCT00832416|50647015|FG003|Overall Study|Physician Decision|10|||
25330672|NCT00832416|50647012|FG000|Overall Study|Administrative|0|||
25330673|NCT00832416|50647013|FG001|Overall Study|Administrative|0|||
25249637|NCT01140061|50565406|FG007|Extension|Laboratory Adverse Event|0|||
25330674|NCT00832416|50647014|FG002|Overall Study|Administrative|0|||
25330675|NCT00832416|50647015|FG003|Overall Study|Administrative|1|||
25249638|NCT01140061|50565407|FG008|Extension|Laboratory Adverse Event|0|||
25249639|NCT01140061|50565408|FG009|Extension|Laboratory Adverse Event|1|||
25249640|NCT01139164|50565426|FG000|Overall Study|Withdrawn prior to study start|0|||
25249641|NCT01139164|50565427|FG001|Overall Study|Withdrawn prior to study start|2|||
25249642|NCT01139164|50565428|FG002|Overall Study|Withdrawn prior to study start|0|||
25249643|NCT01139125|50565436|FG000|Overall Study|Withdrawal by Subject|1|||
25249644|NCT01139047|50565440|FG000|Overall Study|Withdrawal by Subject|1|||
25249645|NCT01139008|50565447|FG000|Overall Study|Withdrawal by Subject|5|||
25249646|NCT01139008|50565447|FG000|Overall Study|Non-compliant, lost product|1|||
25249647|NCT01138657|50565456|FG000|Overall Study|Adverse Event|3|||
25249648|NCT01138657|50565457|FG001|Overall Study|Adverse Event|10|||
25249649|NCT01138657|50565456|FG000|Overall Study|Lack of Efficacy|2|||
25249650|NCT01138657|50565457|FG001|Overall Study|Lack of Efficacy|1|||
25249651|NCT01138657|50565456|FG000|Overall Study|Lost to Follow-up|0|||
25249652|NCT01138657|50565457|FG001|Overall Study|Lost to Follow-up|3|||
25249653|NCT01138657|50565456|FG000|Overall Study|Miscellaneous Reasons|3|||
25249654|NCT01138657|50565457|FG001|Overall Study|Miscellaneous Reasons|4|||
25249655|NCT01138501|50565465|FG000|Overall Study|Protocol Violation|2|||
25249656|NCT01138501|50565465|FG000|Overall Study|Withdrawal by Subject|3|||
25249657|NCT01138150|50565471|FG000|Overall Study|blood unable to be processed|0|||
25249658|NCT01138150|50565472|FG001|Overall Study|blood unable to be processed|1|||
25249659|NCT01138150|50565471|FG000|Overall Study|Physician Decision|1|||
25249660|NCT01138150|50565472|FG001|Overall Study|Physician Decision|0|||
25330676|NCT00832416|50647012|FG000|Overall Study|Adverse Event|21|||
25330677|NCT00832416|50647013|FG001|Overall Study|Adverse Event|19|||
25330678|NCT00832416|50647014|FG002|Overall Study|Adverse Event|41|||
25330679|NCT00832416|50647015|FG003|Overall Study|Adverse Event|10|||
25330680|NCT00832416|50647012|FG000|Overall Study|Death|1|||
25330681|NCT00832416|50647013|FG001|Overall Study|Death|0|||
25330682|NCT00832416|50647014|FG002|Overall Study|Death|0|||
25330683|NCT00832416|50647015|FG003|Overall Study|Death|0|||
25330684|NCT00841776|50647027|FG000|Overall Study|Lack of Efficacy|0|||
25330685|NCT00841776|50647028|FG001|Overall Study|Lack of Efficacy|1|||
25330686|NCT00841776|50647027|FG000|Overall Study|Lost to Follow-up|2|||
25330687|NCT00841776|50647028|FG001|Overall Study|Lost to Follow-up|1|||
25330688|NCT00841776|50647027|FG000|Overall Study|Withdrawal by Subject|0|||
25330689|NCT00841776|50647028|FG001|Overall Study|Withdrawal by Subject|1|||
25330690|NCT00683800|50647036|FG000|Overall Study|Adverse Event|195|||
25330691|NCT00683800|50647037|FG001|Overall Study|Adverse Event|102|||
25330692|NCT00683800|50647036|FG000|Overall Study|Death|0|||
25330693|NCT00683800|50647037|FG001|Overall Study|Death|1|||
25330694|NCT00683800|50647036|FG000|Overall Study|Lost to Follow-up|57|||
25330695|NCT00683800|50647037|FG001|Overall Study|Lost to Follow-up|44|||
25330696|NCT00683800|50647036|FG000|Overall Study|Other|5|||
25330697|NCT00683800|50647037|FG001|Overall Study|Other|2|||
25330698|NCT00683800|50647036|FG000|Overall Study|Protocol Violation|13|||
25330699|NCT00683800|50647037|FG001|Overall Study|Protocol Violation|16|||
25330700|NCT00683800|50647036|FG000|Overall Study|Withdrawal by Subject|66|||
25330701|NCT00683800|50647037|FG001|Overall Study|Withdrawal by Subject|64|||
25330702|NCT00683800|50647036|FG000|Overall Study|Lack of Efficacy|61|||
25330703|NCT00683800|50647037|FG001|Overall Study|Lack of Efficacy|104|||
25330704|NCT00683800|50647036|FG000|Overall Study|Randomized, not treated|35|||
25330705|NCT00683800|50647037|FG001|Overall Study|Randomized, not treated|33|||
25330706|NCT00683644|50647045|FG000|Overall Study|Withdrawal by Subject|4|||
25330707|NCT00683644|50647046|FG001|Overall Study|Withdrawal by Subject|2|||
25330708|NCT00683644|50647045|FG000|Overall Study|Lost to Follow-up|1|||
25330709|NCT00683644|50647046|FG001|Overall Study|Lost to Follow-up|4|||
25330710|NCT00683644|50647045|FG000|Overall Study|Adverse Event|1|||
25330711|NCT00683644|50647046|FG001|Overall Study|Adverse Event|2|||
25249661|NCT01138111|50565488|FG000|Overall Study|Withdrawal by Subject|5|||
25249662|NCT01138111|50565488|FG000|Overall Study|Adverse Event|1|||
25249663|NCT01138111|50565488|FG000|Overall Study|Death|1|||
25249664|NCT01138111|50565488|FG000|Overall Study|Lost to Follow-up|2|||
25249665|NCT01137955|50565519|FG000|Overall Study|Withdrawal by Subject|5|||
25330712|NCT00683644|50647045|FG000|Overall Study|Low copper, other health problems,|7|||
25330713|NCT00683644|50647046|FG001|Overall Study|Low copper, other health problems,|6|||
25330714|NCT00685360|50647059|FG000|Overall Study|Lost to Follow-up|0|||
25330715|NCT00685360|50647060|FG001|Overall Study|Lost to Follow-up|1|||
25330716|NCT00685360|50647061|FG002|Overall Study|Lost to Follow-up|2|||
25249666|NCT01137955|50565520|FG001|Overall Study|Withdrawal by Subject|4|||
25249667|NCT01137682|50565530|FG000|Overall Study|Adverse Event-CORE|2|||
25249668|NCT01137682|50565531|FG001|Overall Study|Adverse Event-CORE|4|||
25249669|NCT01137682|50565532|FG002|Overall Study|Adverse Event-CORE|0|||
25330717|NCT00685360|50647059|FG000|Overall Study|Adverse Event|4|||
25330718|NCT00685360|50647060|FG001|Overall Study|Adverse Event|6|||
25330719|NCT00685360|50647061|FG002|Overall Study|Adverse Event|4|||
25330720|NCT00685360|50647059|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
25330721|NCT00685360|50647060|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
25330722|NCT00685360|50647061|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
25249670|NCT01137682|50565530|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
25249671|NCT01137682|50565531|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
25249672|NCT01137682|50565532|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
25249673|NCT01137682|50565530|FG000|Overall Study|Administrative problems-CORE|2|||
25249674|NCT01137682|50565531|FG001|Overall Study|Administrative problems-CORE|1|||
25249675|NCT01137682|50565532|FG002|Overall Study|Administrative problems-CORE|0|||
25249676|NCT01137682|50565530|FG000|Overall Study|Protocol Violation-CORE|0|||
25249677|NCT01137682|50565531|FG001|Overall Study|Protocol Violation-CORE|1|||
25249678|NCT01137682|50565532|FG002|Overall Study|Protocol Violation-CORE|1|||
25249679|NCT01137682|50565530|FG000|Overall Study|Adverse Event-Extension|4|||
25249680|NCT01137682|50565531|FG001|Overall Study|Adverse Event-Extension|8|||
25249681|NCT01137682|50565532|FG002|Overall Study|Adverse Event-Extension|7|||
25249682|NCT01137682|50565530|FG000|Overall Study|Lack of Efficacy-Extension|15|||
25249683|NCT01137682|50565531|FG001|Overall Study|Lack of Efficacy-Extension|9|||
25249684|NCT01137682|50565532|FG002|Overall Study|Lack of Efficacy-Extension|13|||
25249685|NCT01137682|50565530|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
25249686|NCT01137682|50565531|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
25249687|NCT01137682|50565532|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
25249688|NCT01137682|50565530|FG000|Overall Study|Lost to Follow Up-Extension|0|||
25249689|NCT01137682|50565531|FG001|Overall Study|Lost to Follow Up-Extension|1|||
25249690|NCT01137682|50565532|FG002|Overall Study|Lost to Follow Up-Extension|0|||
25249691|NCT01137682|50565530|FG000|Overall Study|Administrative problems-Extension|0|||
25249692|NCT01137682|50565531|FG001|Overall Study|Administrative problems-Extension|2|||
25249693|NCT01137682|50565532|FG002|Overall Study|Administrative problems-Extension|0|||
25249694|NCT01137682|50565530|FG000|Overall Study|Death-Extension|2|||
25249695|NCT01137682|50565531|FG001|Overall Study|Death-Extension|0|||
25330723|NCT00685360|50647059|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
25330724|NCT00685360|50647060|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
25330725|NCT00685360|50647061|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
25330726|NCT00685360|50647059|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
25330727|NCT00685360|50647060|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
25330728|NCT00685360|50647061|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
25330729|NCT00685360|50647059|FG000|Overall Study|Protocol Deviation|0|||
25330730|NCT00685360|50647060|FG001|Overall Study|Protocol Deviation|1|||
25330731|NCT00685360|50647061|FG002|Overall Study|Protocol Deviation|1|||
25330732|NCT00684814|50647069|FG000|Washout Period of 7 Days|Adverse Event|1|||
25330733|NCT00684814|50647070|FG001|Washout Period of 7 Days|Adverse Event|2|||
25330734|NCT00684814|50647069|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
25330735|NCT00684814|50647070|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
25330736|NCT00684814|50647069|FG000|Second Intervention|Adverse Event|1|||
25330737|NCT00684814|50647070|FG001|Second Intervention|Adverse Event|0|||
25330738|NCT00576472|50647091|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
25330739|NCT00576472|50647092|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
25330740|NCT00576472|50647093|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
25330741|NCT00576472|50647094|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
25330742|NCT00576472|50647095|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
25330743|NCT00576472|50647096|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
25330744|NCT00576472|50647097|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
25330745|NCT00576472|50647098|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
25330746|NCT00576472|50647099|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
25330747|NCT00576472|50647100|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
25330748|NCT00576472|50647101|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
25330749|NCT00576472|50647102|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
25330750|NCT00576472|50647103|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
25330751|NCT00576472|50647104|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
25330752|NCT00576472|50647105|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
25330753|NCT00576472|50647091|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
25330754|NCT00576472|50647092|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
25330755|NCT00576472|50647093|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
25330756|NCT00576472|50647094|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
25330757|NCT00576472|50647095|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
25330758|NCT00576472|50647096|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
25330759|NCT00576472|50647097|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
25330760|NCT00576472|50647098|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
24977306|NCT00376961|50065903|FG001|Initial Registration|Ineligible|0|||
25249696|NCT01137682|50565532|FG002|Overall Study|Death-Extension|0|||
25249697|NCT01137682|50565530|FG000|Overall Study|Protocol Violation-Extension|2|||
25249698|NCT01137682|50565531|FG001|Overall Study|Protocol Violation-Extension|1|||
25249699|NCT01137682|50565532|FG002|Overall Study|Protocol Violation-Extension|0|||
25330761|NCT00576472|50647099|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
25330762|NCT00576472|50647100|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
25330763|NCT00576472|50647101|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
25330764|NCT00576472|50647102|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
25330765|NCT00576472|50647103|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
25330766|NCT00576472|50647104|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
25330767|NCT00576472|50647105|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
25330768|NCT00576472|50647091|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
25330769|NCT00576472|50647092|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
25330770|NCT00576472|50647093|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
25330771|NCT00576472|50647094|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
25330772|NCT00576472|50647095|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
25330773|NCT00576472|50647096|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
25330774|NCT00576472|50647097|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
25249700|NCT01137682|50565530|FG000|Overall Study|Did not enter extension|2|||
25249701|NCT01137682|50565531|FG001|Overall Study|Did not enter extension|3|||
25330775|NCT00576472|50647098|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
25330776|NCT00576472|50647099|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
25330777|NCT00576472|50647100|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
25330778|NCT00576472|50647101|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
25330779|NCT00576472|50647102|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
25330780|NCT00576472|50647103|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
25330781|NCT00576472|50647104|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
25330782|NCT00576472|50647105|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
25330783|NCT00576472|50647091|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
25330784|NCT00576472|50647092|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
25330785|NCT00576472|50647093|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
25330786|NCT00576472|50647094|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
25330787|NCT00576472|50647095|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
25330788|NCT00576472|50647096|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
25330789|NCT00576472|50647097|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
25330790|NCT00576472|50647098|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
25330791|NCT00576472|50647099|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
25330792|NCT00576472|50647100|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
25330793|NCT00576472|50647101|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
25330794|NCT00576472|50647102|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
25330795|NCT00576472|50647103|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
25330796|NCT00576472|50647104|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
25330797|NCT00576472|50647105|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
25330798|NCT00576472|50647091|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
25330799|NCT00576472|50647092|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
25330800|NCT00576472|50647093|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
25330801|NCT00576472|50647094|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
25330802|NCT00576472|50647095|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
25330803|NCT00576472|50647096|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
25330804|NCT00576472|50647097|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
25330805|NCT00576472|50647098|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
25330806|NCT00576472|50647099|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
25330807|NCT00576472|50647100|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
25330808|NCT00576472|50647101|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
25330809|NCT00576472|50647102|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
25330810|NCT00576472|50647103|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
25330811|NCT00576472|50647104|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
25330812|NCT00576472|50647105|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
25330813|NCT00576472|50647091|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
25330814|NCT00576472|50647092|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
25330815|NCT00576472|50647093|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
25330816|NCT00576472|50647094|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
25330817|NCT00576472|50647095|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
25249702|NCT01137682|50565532|FG002|Overall Study|Did not enter extension|2|||
25249703|NCT01137682|50565530|FG000|Overall Study|Did not receive treatment in extension|0|||
25249704|NCT01137682|50565531|FG001|Overall Study|Did not receive treatment in extension|0|||
25249705|NCT01137682|50565532|FG002|Overall Study|Did not receive treatment in extension|1|||
25249706|NCT03452397|50565548|FG000|Overall Study|Adverse Event|1|||
25249707|NCT03452397|50565549|FG001|Overall Study|Adverse Event|0|||
25330818|NCT00576472|50647096|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
25330819|NCT00576472|50647097|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
25330820|NCT00576472|50647098|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
25330821|NCT00576472|50647099|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
25330822|NCT00576472|50647100|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
25249708|NCT03452397|50565550|FG002|Overall Study|Adverse Event|0|||
25330823|NCT00576472|50647101|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
25330824|NCT00576472|50647102|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
25330825|NCT00576472|50647103|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
25330826|NCT00576472|50647104|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
25330827|NCT00576472|50647105|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
25330828|NCT00576472|50647091|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
25330829|NCT00576472|50647092|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
25330830|NCT00576472|50647093|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
25330831|NCT00576472|50647094|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
25249709|NCT03452397|50565551|FG003|Overall Study|Adverse Event|0|||
25249710|NCT03452397|50565548|FG000|Overall Study|Administrative reason|0|||
25249711|NCT03452397|50565549|FG001|Overall Study|Administrative reason|0|||
25249712|NCT03452397|50565550|FG002|Overall Study|Administrative reason|1|||
25249713|NCT03452397|50565551|FG003|Overall Study|Administrative reason|1|||
25249714|NCT03452397|50565548|FG000|Overall Study|Withdrawal by Subject|0|||
25249715|NCT03452397|50565549|FG001|Overall Study|Withdrawal by Subject|0|||
25249716|NCT03452397|50565550|FG002|Overall Study|Withdrawal by Subject|1|||
25249717|NCT03452397|50565551|FG003|Overall Study|Withdrawal by Subject|0|||
25249718|NCT00199875|50565585|FG000|Overall Study|Withdrawal by Subject|0|||
25249719|NCT00199875|50565586|FG001|Overall Study|Withdrawal by Subject|0|||
25249720|NCT00199875|50565587|FG002|Overall Study|Withdrawal by Subject|0|||
25330832|NCT00576472|50647095|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
25330833|NCT00576472|50647096|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
25330834|NCT00576472|50647097|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
25330835|NCT00576472|50647098|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
25330836|NCT00576472|50647099|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
25330837|NCT00576472|50647100|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
25330838|NCT00576472|50647101|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
25330839|NCT00576472|50647102|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
25330840|NCT00576472|50647103|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
25330841|NCT00576472|50647104|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
25330842|NCT00576472|50647105|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
25330843|NCT00576472|50647091|FG000|MPH Cross Over Phase|Physician Decision|0|||
25330844|NCT00576472|50647092|FG001|MPH Cross Over Phase|Physician Decision|0|||
25330845|NCT00576472|50647093|FG002|MPH Cross Over Phase|Physician Decision|0|||
25330846|NCT00576472|50647094|FG003|MPH Cross Over Phase|Physician Decision|0|||
25330847|NCT00576472|50647095|FG004|MPH Cross Over Phase|Physician Decision|0|||
25330848|NCT00576472|50647096|FG005|MPH Cross Over Phase|Physician Decision|0|||
25330849|NCT00576472|50647097|FG006|MPH Cross Over Phase|Physician Decision|4|||
25249721|NCT00199875|50565588|FG003|Overall Study|Withdrawal by Subject|0|||
25249722|NCT00199875|50565589|FG004|Overall Study|Withdrawal by Subject|1|||
25330850|NCT00576472|50647098|FG007|MPH Cross Over Phase|Physician Decision|0|||
25330851|NCT00576472|50647099|FG008|MPH Cross Over Phase|Physician Decision|0|||
25330852|NCT00576472|50647100|FG009|MPH Cross Over Phase|Physician Decision|0|||
25330853|NCT00576472|50647101|FG010|MPH Cross Over Phase|Physician Decision|0|||
25330854|NCT00576472|50647102|FG011|MPH Cross Over Phase|Physician Decision|0|||
25330855|NCT00576472|50647103|FG012|MPH Cross Over Phase|Physician Decision|0|||
25330856|NCT00576472|50647104|FG013|MPH Cross Over Phase|Physician Decision|0|||
25330857|NCT00576472|50647105|FG014|MPH Cross Over Phase|Physician Decision|0|||
25330858|NCT00576472|50647091|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
25330859|NCT00576472|50647092|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
25330860|NCT00576472|50647093|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
25330861|NCT00576472|50647094|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
25330862|NCT00576472|50647095|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
25330863|NCT00576472|50647096|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
25330864|NCT00576472|50647097|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
24900993|NCT00697593|49994986|FG000|Overall Study|Suspension of the study by sponsor|12|||
25249723|NCT00199836|50565601|FG000|Overall Study|Progressive Disease|5|||
25249724|NCT00199836|50565601|FG000|Overall Study|Death|1|||
25249725|NCT00199797|50565606|FG000|Overall Study|Progressive Disease|1|||
25249726|NCT00199797|50565606|FG000|Overall Study|Adverse Event|1|||
25249727|NCT00199797|50565606|FG000|Overall Study|Physician Decision|1|||
25249728|NCT01137604|50565615|FG000|Overall Study|Adverse Event|3|||
25249729|NCT01137604|50565616|FG001|Overall Study|Adverse Event|6|||
25249730|NCT01137604|50565617|FG002|Overall Study|Adverse Event|9|||
25249731|NCT01137604|50565618|FG003|Overall Study|Adverse Event|9|||
25249732|NCT01137604|50565615|FG000|Overall Study|Participant Choice|0|||
25330865|NCT00576472|50647098|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
24900994|NCT00697515|49994990|FG000|Dose Optimization Period|Adverse Event|4|||
25249733|NCT01137604|50565616|FG001|Overall Study|Participant Choice|2|||
25249734|NCT01137604|50565617|FG002|Overall Study|Participant Choice|2|||
25249735|NCT01137604|50565618|FG003|Overall Study|Participant Choice|0|||
25249736|NCT01137604|50565615|FG000|Overall Study|Withdrawal of consent|0|||
25249737|NCT01137604|50565616|FG001|Overall Study|Withdrawal of consent|0|||
25249738|NCT01137604|50565617|FG002|Overall Study|Withdrawal of consent|0|||
25249739|NCT01137604|50565618|FG003|Overall Study|Withdrawal of consent|2|||
25249740|NCT01137604|50565615|FG000|Overall Study|Clinical progression/deterioration|1|||
25249741|NCT01137604|50565616|FG001|Overall Study|Clinical progression/deterioration|2|||
25249742|NCT01137604|50565617|FG002|Overall Study|Clinical progression/deterioration|2|||
25330866|NCT00576472|50647099|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
25330867|NCT00576472|50647100|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
25330868|NCT00576472|50647101|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
25330869|NCT00576472|50647102|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
25330870|NCT00576472|50647103|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
25330871|NCT00576472|50647104|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
25330872|NCT00576472|50647105|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
25330873|NCT00576472|50647091|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
25330874|NCT00576472|50647092|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
25330875|NCT00576472|50647093|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
25330876|NCT00576472|50647094|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
25330877|NCT00576472|50647095|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
25330878|NCT00576472|50647096|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
25330879|NCT00576472|50647097|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
25330880|NCT00576472|50647098|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
25330881|NCT00576472|50647099|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
25330882|NCT00576472|50647100|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
25249743|NCT01137604|50565618|FG003|Overall Study|Clinical progression/deterioration|0|||
25249744|NCT00198822|50565631|FG000|Overall Study|Lost to Follow-up|14|||
25249745|NCT00198822|50565632|FG001|Overall Study|Lost to Follow-up|20|||
25249746|NCT00198822|50565633|FG002|Overall Study|Lost to Follow-up|21|||
25330883|NCT00576472|50647101|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
25330884|NCT00576472|50647102|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
25330885|NCT00576472|50647103|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
25330886|NCT00576472|50647104|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
25330887|NCT00576472|50647105|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
25330888|NCT00576472|50647091|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
25330889|NCT00576472|50647092|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
25330890|NCT00576472|50647093|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
25330891|NCT00576472|50647094|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
25330892|NCT00576472|50647095|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
25330893|NCT00576472|50647096|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
25330894|NCT00576472|50647097|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
25330895|NCT00576472|50647098|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
25330896|NCT00576472|50647099|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
25330897|NCT00576472|50647100|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
25330898|NCT00576472|50647101|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
25330899|NCT00576472|50647102|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
25330900|NCT00576472|50647103|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
25330901|NCT00576472|50647104|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
25330902|NCT00576472|50647105|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
25249747|NCT01137292|50565641|FG000|Overall Study|Death|30|||
25249748|NCT01137292|50565641|FG000|Overall Study|Adverse Event|3|||
25249749|NCT01137292|50565641|FG000|Overall Study|Lack of Efficacy|13|||
25249750|NCT01137292|50565641|FG000|Overall Study|Lost to Follow-up|1|||
25249751|NCT01137292|50565641|FG000|Overall Study|Other|7|||
25249752|NCT00197496|50565647|FG000|Baseline to Discharge|not interested|1|||
25249753|NCT00197496|50565648|FG001|Baseline to Discharge|not interested|0|||
25249754|NCT00197496|50565647|FG000|Baseline to Discharge|MRSA|1|||
25249755|NCT00197496|50565648|FG001|Baseline to Discharge|MRSA|0|||
25249756|NCT00197496|50565647|FG000|Baseline to Discharge|Physician Decision|0|||
25249757|NCT00197496|50565648|FG001|Baseline to Discharge|Physician Decision|1|||
25249758|NCT00197496|50565647|FG000|Baseline to Discharge|Protocol Violation|0|||
25249759|NCT00197496|50565648|FG001|Baseline to Discharge|Protocol Violation|1|||
25249760|NCT00197496|50565647|FG000|Follow-up|Lost to Follow-up|2|||
25249761|NCT00197496|50565648|FG001|Follow-up|Lost to Follow-up|1|||
25249762|NCT00197145|50565656|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
25249763|NCT00197145|50565657|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
25249764|NCT00197145|50565656|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
25249765|NCT00197145|50565657|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
25249766|NCT00197145|50565656|FG000|Period 1: Randomized Treatment Phase|Other|2|||
25330903|NCT00576472|50647091|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
25249767|NCT00197145|50565657|FG001|Period 1: Randomized Treatment Phase|Other|2|||
25249768|NCT00197145|50565656|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
25249769|NCT00197145|50565657|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
25249770|NCT00197145|50565656|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
25249771|NCT00197145|50565657|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
25249772|NCT00197145|50565656|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
25249773|NCT00197145|50565657|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
25249774|NCT00197145|50565656|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
25249775|NCT00197145|50565657|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
25249776|NCT00197145|50565656|FG000|Period 2 : Open Label Phase|Other|1|||
25249777|NCT00197145|50565657|FG001|Period 2 : Open Label Phase|Other|0|||
25249778|NCT01136785|50565666|FG000|Overall Study|Protocol Violation|2|||
25249779|NCT01136785|50565667|FG001|Overall Study|Protocol Violation|1|||
25249780|NCT00197106|50565679|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
25249781|NCT00197106|50565680|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
25249782|NCT00197106|50565681|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
25249783|NCT00197106|50565679|FG000|Overall Treatment Period|Lack of Efficacy|0|||
25249784|NCT00197106|50565680|FG001|Overall Treatment Period|Lack of Efficacy|1|||
25249785|NCT00197106|50565681|FG002|Overall Treatment Period|Lack of Efficacy|0|||
25249786|NCT00197106|50565679|FG000|Overall Treatment Period|Lost to Follow-up|0|||
25330904|NCT00576472|50647092|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
25330905|NCT00576472|50647093|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
25330906|NCT00576472|50647094|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
25330907|NCT00576472|50647095|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
25330908|NCT00576472|50647096|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
25330909|NCT00576472|50647097|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
25249787|NCT00197106|50565680|FG001|Overall Treatment Period|Lost to Follow-up|0|||
25249788|NCT00197106|50565681|FG002|Overall Treatment Period|Lost to Follow-up|2|||
25330910|NCT00576472|50647098|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
25330911|NCT00576472|50647099|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
25330912|NCT00576472|50647100|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
25330913|NCT00576472|50647101|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
25330914|NCT00576472|50647102|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
25330915|NCT00576472|50647103|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
25330916|NCT00576472|50647104|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
25330917|NCT00576472|50647105|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
25330918|NCT00576472|50647091|FG000|MPH Home Maintenance Phase|Side effects|0|||
25330919|NCT00576472|50647092|FG001|MPH Home Maintenance Phase|Side effects|0|||
25330920|NCT00576472|50647093|FG002|MPH Home Maintenance Phase|Side effects|0|||
25330921|NCT00576472|50647094|FG003|MPH Home Maintenance Phase|Side effects|0|||
25330922|NCT00576472|50647095|FG004|MPH Home Maintenance Phase|Side effects|0|||
25330923|NCT00576472|50647096|FG005|MPH Home Maintenance Phase|Side effects|0|||
25249789|NCT00197106|50565679|FG000|Overall Treatment Period|Protocol Violation|0|||
25249790|NCT00197106|50565680|FG001|Overall Treatment Period|Protocol Violation|0|||
25249791|NCT00197106|50565681|FG002|Overall Treatment Period|Protocol Violation|2|||
25249792|NCT00197106|50565679|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
25249793|NCT00197106|50565680|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
25249794|NCT00197106|50565681|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
25249795|NCT01136746|50565689|FG000|Overall Study|Lost to Follow-up|0|||
25249796|NCT01136746|50565690|FG001|Overall Study|Lost to Follow-up|2|||
25249797|NCT01136746|50565689|FG000|Overall Study|Protocol Violation|2|||
25249798|NCT01136746|50565690|FG001|Overall Study|Protocol Violation|1|||
25249799|NCT01136746|50565689|FG000|Overall Study|Death|1|||
25249800|NCT01136746|50565690|FG001|Overall Study|Death|0|||
25249801|NCT01136356|50565696|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
25249802|NCT01136356|50565697|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
25249803|NCT01136356|50565696|FG000|First 18-day Withdrawal|Physician Decision|1|||
25249804|NCT01136356|50565697|FG001|First 18-day Withdrawal|Physician Decision|0|||
25249805|NCT01136356|50565696|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
25249806|NCT01136356|50565697|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
25249807|NCT00196326|50565702|FG000|Overall Study|Did not meet protocol requirements|64|||
25249808|NCT00196326|50565702|FG000|Overall Study|Non-compliance with the protocol|81|||
25249809|NCT00196326|50565702|FG000|Overall Study|Physician Decision|3|||
25249810|NCT00196326|50565702|FG000|Overall Study|Withdrawal by Subject|225|||
25249811|NCT00196326|50565702|FG000|Overall Study|Adverse Event|253|||
25249812|NCT00196326|50565702|FG000|Overall Study|Pregnancy|34|||
25249813|NCT00196326|50565702|FG000|Overall Study|Lost to Follow-up|304|||
25249814|NCT00196326|50565702|FG000|Overall Study|Other|22|||
25249815|NCT00195663|50565709|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
25249816|NCT00195663|50565710|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
25249817|NCT00195663|50565711|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
25249818|NCT00195663|50565709|FG000|2-year Double-blind Treatment Period|Death|0|||
25249819|NCT00195663|50565710|FG001|2-year Double-blind Treatment Period|Death|2|||
25249820|NCT00195663|50565711|FG002|2-year Double-blind Treatment Period|Death|0|||
25330924|NCT00576472|50647097|FG006|MPH Home Maintenance Phase|Side effects|0|||
25330925|NCT00576472|50647098|FG007|MPH Home Maintenance Phase|Side effects|0|||
25330926|NCT00576472|50647099|FG008|MPH Home Maintenance Phase|Side effects|0|||
25330927|NCT00576472|50647100|FG009|MPH Home Maintenance Phase|Side effects|0|||
25330928|NCT00576472|50647101|FG010|MPH Home Maintenance Phase|Side effects|0|||
25330929|NCT00576472|50647102|FG011|MPH Home Maintenance Phase|Side effects|0|||
25330930|NCT00576472|50647103|FG012|MPH Home Maintenance Phase|Side effects|0|||
25330931|NCT00576472|50647104|FG013|MPH Home Maintenance Phase|Side effects|0|||
25249821|NCT00195663|50565709|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
25249822|NCT00195663|50565710|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
25330932|NCT00576472|50647105|FG014|MPH Home Maintenance Phase|Side effects|8|||
25330933|NCT00576472|50647091|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
25330934|NCT00576472|50647092|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
25330935|NCT00576472|50647093|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
25330936|NCT00576472|50647094|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
25330937|NCT00576472|50647095|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
25249823|NCT00195663|50565711|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
25249824|NCT00195663|50565709|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
25249825|NCT00195663|50565710|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
25249826|NCT00195663|50565711|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
25249827|NCT00195663|50565709|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
25249828|NCT00195663|50565710|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
25249829|NCT00195663|50565711|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
25249830|NCT00195663|50565709|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
25249831|NCT00195663|50565710|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
25249832|NCT00195663|50565711|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
25249833|NCT00195663|50565709|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
25249834|NCT00195663|50565710|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
25249835|NCT00195663|50565711|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
25249836|NCT00195663|50565709|FG000|2-year Double-blind Treatment Period|Recovery|1|||
25249837|NCT00195663|50565710|FG001|2-year Double-blind Treatment Period|Recovery|0|||
25249838|NCT00195663|50565711|FG002|2-year Double-blind Treatment Period|Recovery|1|||
25249839|NCT00195663|50565709|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
25249840|NCT00195663|50565710|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
25249841|NCT00195663|50565711|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
25249842|NCT00195663|50565709|FG000|Open-Label Extension Period|Adverse Event|21|||
25249843|NCT00195663|50565710|FG001|Open-Label Extension Period|Adverse Event|32|||
25249844|NCT00195663|50565711|FG002|Open-Label Extension Period|Adverse Event|36|||
25249845|NCT00195663|50565709|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
25249846|NCT00195663|50565710|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
25249847|NCT00195663|50565711|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
25249848|NCT00195663|50565709|FG000|Open-Label Extension Period|Recovery|0|||
25249849|NCT00195663|50565710|FG001|Open-Label Extension Period|Recovery|2|||
25249850|NCT00195663|50565711|FG002|Open-Label Extension Period|Recovery|2|||
25249851|NCT00195663|50565709|FG000|Open-Label Extension Period|Protocol Violation|3|||
25249852|NCT00195663|50565710|FG001|Open-Label Extension Period|Protocol Violation|4|||
25249853|NCT00195663|50565711|FG002|Open-Label Extension Period|Protocol Violation|4|||
25249854|NCT00195663|50565709|FG000|Open-Label Extension Period|Death|2|||
25249855|NCT00195663|50565710|FG001|Open-Label Extension Period|Death|2|||
25249856|NCT00195663|50565711|FG002|Open-Label Extension Period|Death|2|||
25249857|NCT00195663|50565709|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
25330938|NCT00576472|50647096|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
25330939|NCT00576472|50647097|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
25330940|NCT00576472|50647098|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
25330941|NCT00576472|50647099|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
25330942|NCT00576472|50647100|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
25330943|NCT00576472|50647101|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
25330944|NCT00576472|50647102|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
25330945|NCT00576472|50647103|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
25330946|NCT00576472|50647104|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
25330947|NCT00576472|50647105|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
25330948|NCT00576472|50647091|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
25330949|NCT00576472|50647092|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
24900995|NCT00697515|49994991|FG001|Dose Optimization Period|Adverse Event|0|||
24900996|NCT00697515|49994990|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
24900997|NCT00697515|49994991|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
25249858|NCT00195663|50565710|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
25330950|NCT00576472|50647093|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
25330951|NCT00576472|50647094|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
25330952|NCT00576472|50647095|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
25330953|NCT00576472|50647096|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
25249859|NCT00195663|50565711|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
25249860|NCT00195663|50565709|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
25249861|NCT00195663|50565710|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
25249862|NCT00195663|50565711|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
25249863|NCT00195663|50565709|FG000|Open-Label Extension Period|Administrative reasons|11|||
25249864|NCT00195663|50565710|FG001|Open-Label Extension Period|Administrative reasons|11|||
25330954|NCT00576472|50647097|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
25330955|NCT00576472|50647098|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
25330956|NCT00576472|50647099|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
25330957|NCT00576472|50647100|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
25249865|NCT00195663|50565711|FG002|Open-Label Extension Period|Administrative reasons|13|||
25249866|NCT01135498|50565729|FG000|Overall Study|Adverse Event|20|||
25249867|NCT01135498|50565729|FG000|Overall Study|Progressive disease|38|||
25330958|NCT00576472|50647101|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
25330959|NCT00576472|50647102|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
25330960|NCT00576472|50647103|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
25330961|NCT00576472|50647104|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
25330962|NCT00576472|50647105|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
25330963|NCT00576472|50647091|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
25330964|NCT00576472|50647092|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
25330965|NCT00576472|50647093|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
25330966|NCT00576472|50647094|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
25330967|NCT00576472|50647095|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
25330968|NCT00576472|50647096|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
25330969|NCT00576472|50647097|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
25330970|NCT00576472|50647098|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
25330971|NCT00576472|50647099|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
25330972|NCT00576472|50647100|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
25330973|NCT00576472|50647101|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
25330974|NCT00576472|50647102|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
25330975|NCT00576472|50647103|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
25330976|NCT00576472|50647104|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
25330977|NCT00576472|50647105|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
25330978|NCT00823212|50647138|FG000|Overall Study|Death|8|||
25330979|NCT00823212|50647139|FG001|Overall Study|Death|10|||
25330980|NCT00823212|50647138|FG000|Overall Study|Withdrawal by Subject|6|||
25330981|NCT00823212|50647139|FG001|Overall Study|Withdrawal by Subject|1|||
25330982|NCT00823212|50647138|FG000|Overall Study|Incarcerated|0|||
25330983|NCT00823212|50647139|FG001|Overall Study|Incarcerated|1|||
25330984|NCT00823212|50647138|FG000|Overall Study|Missed 12-month visit|21|||
25330985|NCT00823212|50647139|FG001|Overall Study|Missed 12-month visit|21|||
25330986|NCT00807495|50647152|FG000|Overall Study|Adverse Event|6|||
25330987|NCT00807495|50647153|FG001|Overall Study|Adverse Event|3|||
25330988|NCT00807495|50647154|FG002|Overall Study|Adverse Event|1|||
25330989|NCT00807495|50647155|FG003|Overall Study|Adverse Event|1|||
25330990|NCT00807495|50647156|FG004|Overall Study|Adverse Event|2|||
25330991|NCT00807495|50647152|FG000|Overall Study|Withdrawal by Patient|2|||
25330992|NCT00807495|50647153|FG001|Overall Study|Withdrawal by Patient|0|||
25330993|NCT00807495|50647154|FG002|Overall Study|Withdrawal by Patient|1|||
25330994|NCT00807495|50647155|FG003|Overall Study|Withdrawal by Patient|0|||
25330995|NCT00807495|50647156|FG004|Overall Study|Withdrawal by Patient|0|||
25330996|NCT00807495|50647152|FG000|Overall Study|Reason Not Specified|0|||
25330997|NCT00807495|50647153|FG001|Overall Study|Reason Not Specified|3|||
25330998|NCT00807495|50647154|FG002|Overall Study|Reason Not Specified|2|||
25330999|NCT00807495|50647155|FG003|Overall Study|Reason Not Specified|0|||
25331000|NCT00807495|50647156|FG004|Overall Study|Reason Not Specified|3|||
25331001|NCT00576316|50647168|FG000|Overall Study|Adverse Event|9|||
25331002|NCT00576316|50647168|FG000|Overall Study|Withdrawal by Subject|2|||
25331003|NCT00576316|50647168|FG000|Overall Study|Protocol Violation|9|||
25331004|NCT00823134|50647172|FG000|Overall Study|Invalid measurement|1|||
25331005|NCT00831792|50647177|FG000|Overall Study|Not Eligible|3|||
25331006|NCT00831792|50647177|FG000|Overall Study|Adverse Event|1|||
25331007|NCT00831792|50647177|FG000|Overall Study|Death|1|||
25331008|NCT00831792|50647177|FG000|Overall Study|Lack of Efficacy|1|||
25331009|NCT00575380|50647183|FG000|Overall Study|Withdrawal by Subject|1|||
25331010|NCT00575380|50647184|FG001|Overall Study|Withdrawal by Subject|0|||
25331011|NCT00575380|50647183|FG000|Overall Study|Adverse Event|0|||
25249868|NCT01135498|50565729|FG000|Overall Study|Investigator judgement|25|||
25331012|NCT00575380|50647184|FG001|Overall Study|Adverse Event|1|||
25331013|NCT00575380|50647183|FG000|Overall Study|Various|0|||
25331014|NCT00575380|50647184|FG001|Overall Study|Various|2|||
25331015|NCT00840996|50647192|FG000|Overall Study|Withdrawal by Subject|1|||
25331016|NCT00840996|50647193|FG001|Overall Study|Withdrawal by Subject|0|||
25331017|NCT00680914|50647201|FG000|Overall Study|Consent withdrawal|6|||
25331018|NCT00680914|50647202|FG001|Overall Study|Consent withdrawal|3|||
25249869|NCT01135498|50565729|FG000|Overall Study|Withdrawal by Subject|4|||
25249870|NCT01135498|50565729|FG000|Overall Study|Death|1|||
25331019|NCT00680914|50647201|FG000|Overall Study|Lost to Follow-up|4|||
25331020|NCT00680914|50647202|FG001|Overall Study|Lost to Follow-up|0|||
25331021|NCT00680914|50647201|FG000|Overall Study|serious adverse event (SAE)|0|||
25331022|NCT00680914|50647202|FG001|Overall Study|serious adverse event (SAE)|1|||
25331023|NCT00680836|50647210|FG000|Overall Study|Withdrawal by Subject|3|||
25331024|NCT00680836|50647211|FG001|Overall Study|Withdrawal by Subject|0|||
25331025|NCT00680836|50647210|FG000|Overall Study|Lost to Follow-up|3|||
25331026|NCT00680836|50647211|FG001|Overall Study|Lost to Follow-up|1|||
25331027|NCT00680836|50647210|FG000|Overall Study|Physician Decision|2|||
25331028|NCT00680836|50647211|FG001|Overall Study|Physician Decision|1|||
25331029|NCT00679432|50647222|FG000|Overall Study|Adverse Event|5|||
25331030|NCT00679432|50647223|FG001|Overall Study|Adverse Event|6|||
25331031|NCT00679432|50647224|FG002|Overall Study|Adverse Event|10|||
25331032|NCT00679432|50647225|FG003|Overall Study|Adverse Event|7|||
25331033|NCT00679432|50647222|FG000|Overall Study|Protocol Violation|1|||
25331034|NCT00679432|50647223|FG001|Overall Study|Protocol Violation|1|||
25331035|NCT00679432|50647224|FG002|Overall Study|Protocol Violation|2|||
25331036|NCT00679432|50647225|FG003|Overall Study|Protocol Violation|1|||
25331037|NCT00679432|50647222|FG000|Overall Study|Withdrawal by Subject|8|||
25331038|NCT00679432|50647223|FG001|Overall Study|Withdrawal by Subject|11|||
25331039|NCT00679432|50647224|FG002|Overall Study|Withdrawal by Subject|10|||
25331040|NCT00679432|50647225|FG003|Overall Study|Withdrawal by Subject|9|||
25331041|NCT00679432|50647222|FG000|Overall Study|Lost to Follow-up|1|||
25331042|NCT00679432|50647223|FG001|Overall Study|Lost to Follow-up|5|||
25331043|NCT00679432|50647224|FG002|Overall Study|Lost to Follow-up|4|||
25331044|NCT00679432|50647225|FG003|Overall Study|Lost to Follow-up|2|||
25331045|NCT00679432|50647222|FG000|Overall Study|Physician Decision|3|||
25331046|NCT00679432|50647223|FG001|Overall Study|Physician Decision|2|||
25331047|NCT00679432|50647224|FG002|Overall Study|Physician Decision|2|||
25331048|NCT00679432|50647225|FG003|Overall Study|Physician Decision|2|||
25331049|NCT00679432|50647222|FG000|Overall Study|Sponsor decision|1|||
25331050|NCT00679432|50647223|FG001|Overall Study|Sponsor decision|0|||
25331051|NCT00679432|50647224|FG002|Overall Study|Sponsor decision|0|||
25331052|NCT00679432|50647225|FG003|Overall Study|Sponsor decision|0|||
25331053|NCT00679432|50647222|FG000|Overall Study|Lack of Efficacy|13|||
25331054|NCT00679432|50647223|FG001|Overall Study|Lack of Efficacy|9|||
25331055|NCT00679432|50647224|FG002|Overall Study|Lack of Efficacy|14|||
25331056|NCT00679432|50647225|FG003|Overall Study|Lack of Efficacy|8|||
25331057|NCT00679432|50647222|FG000|Overall Study|Infectious colitis, normal histology|5|||
25331058|NCT00679432|50647223|FG001|Overall Study|Infectious colitis, normal histology|4|||
25331059|NCT00679432|50647224|FG002|Overall Study|Infectious colitis, normal histology|8|||
25331060|NCT00679432|50647225|FG003|Overall Study|Infectious colitis, normal histology|3|||
24900998|NCT00697515|49994990|FG000|Dose Optimization Period|Lost to Follow-up|2|||
24900999|NCT00697515|49994991|FG001|Dose Optimization Period|Lost to Follow-up|0|||
24901000|NCT00697515|49994990|FG000|Dose Optimization Period|sponsor request|2|||
24977307|NCT00376961|50065902|FG000|Maintenance|Adverse Event|0|||
25249871|NCT01135498|50565729|FG000|Overall Study|Ongoing at time of analysis|2|||
25249872|NCT00195507|50565736|FG000|Overall Study|Adverse Event|24|||
25249873|NCT00195507|50565737|FG001|Overall Study|Adverse Event|13|||
25249874|NCT00195507|50565736|FG000|Overall Study|Death|0|||
25249875|NCT00195507|50565737|FG001|Overall Study|Death|1|||
25249876|NCT00195507|50565736|FG000|Overall Study|Failed to Return|4|||
25249877|NCT00195507|50565737|FG001|Overall Study|Failed to Return|3|||
25249878|NCT00195507|50565736|FG000|Overall Study|Physician Decision|1|||
25249879|NCT00195507|50565737|FG001|Overall Study|Physician Decision|2|||
25249880|NCT00195507|50565736|FG000|Overall Study|Lost to Follow-up|3|||
25249881|NCT00195507|50565737|FG001|Overall Study|Lost to Follow-up|2|||
25249882|NCT00195507|50565736|FG000|Overall Study|Protocol Violation|5|||
25249883|NCT00195507|50565737|FG001|Overall Study|Protocol Violation|4|||
25249884|NCT00195507|50565736|FG000|Overall Study|Lack of Efficacy|40|||
25249885|NCT00195507|50565737|FG001|Overall Study|Lack of Efficacy|67|||
25249886|NCT00195507|50565736|FG000|Overall Study|Withdrawal by Subject|16|||
25249887|NCT00195507|50565737|FG001|Overall Study|Withdrawal by Subject|23|||
25249888|NCT00195507|50565736|FG000|Overall Study|Protocol Deviation|6|||
25249889|NCT00195507|50565737|FG001|Overall Study|Protocol Deviation|3|||
25249890|NCT01134562|50565748|FG000|Overall Study|Adverse Event|0|||
25249891|NCT01134562|50565749|FG001|Overall Study|Adverse Event|1|||
25249892|NCT01134562|50565750|FG002|Overall Study|Adverse Event|0|||
25249893|NCT01134562|50565751|FG003|Overall Study|Adverse Event|0|||
25249894|NCT01134562|50565752|FG004|Overall Study|Adverse Event|0|||
25249895|NCT00195429|50565779|FG000|Overall Study|Adverse Event|2|||
25331061|NCT00679432|50647222|FG000|Overall Study|Randomization error, return to prior Rx|0|||
25331062|NCT00679432|50647223|FG001|Overall Study|Randomization error, return to prior Rx|0|||
25249896|NCT00195429|50565780|FG001|Overall Study|Adverse Event|4|||
25331063|NCT00679432|50647224|FG002|Overall Study|Randomization error, return to prior Rx|3|||
25331064|NCT00679432|50647225|FG003|Overall Study|Randomization error, return to prior Rx|0|||
25331065|NCT00679354|50647235|FG000|Overall Study|Death|3|||
25331066|NCT00679354|50647235|FG000|Overall Study|Lack of Efficacy|22|||
25331067|NCT00679354|50647235|FG000|Overall Study|Physician Decision|4|||
25331068|NCT00679354|50647235|FG000|Overall Study|Ineligible|1|||
25331069|NCT00822900|50647242|FG000|Overall Study|Withdrawal by Subject|14|||
25331070|NCT00822900|50647243|FG001|Overall Study|Withdrawal by Subject|14|||
25331071|NCT00822900|50647242|FG000|Overall Study|Lost to Follow-up|9|||
25331072|NCT00822900|50647243|FG001|Overall Study|Lost to Follow-up|9|||
25331073|NCT00822900|50647242|FG000|Overall Study|Death|83|||
25331074|NCT00822900|50647243|FG001|Overall Study|Death|69|||
25331075|NCT00822900|50647242|FG000|Overall Study|Became a ward of the state|2|||
25331076|NCT00822900|50647243|FG001|Overall Study|Became a ward of the state|1|||
25331077|NCT00682786|50647251|FG000|Overall Study|Withdrawal by Subject|2|||
25331078|NCT00682786|50647252|FG001|Overall Study|Withdrawal by Subject|2|||
25331079|NCT00682786|50647251|FG000|Overall Study|Did not receive irinotecan|0|||
25331080|NCT00682786|50647252|FG001|Overall Study|Did not receive irinotecan|1|||
25331081|NCT00840450|50647264|FG000|Overall Study|Adverse Event|1|||
25331082|NCT00840450|50647264|FG000|Overall Study|Lack of Efficacy|2|||
25331083|NCT00840294|50647270|FG000|Overall Study|Withdrawal by Subject|2|||
25331084|NCT00840294|50647271|FG001|Overall Study|Withdrawal by Subject|1|||
25331085|NCT00840294|50647270|FG000|Overall Study|Protocol Violation|1|||
25331086|NCT00840294|50647271|FG001|Overall Study|Protocol Violation|3|||
25331087|NCT00840294|50647270|FG000|Overall Study|Illness|0|||
25331088|NCT00840294|50647271|FG001|Overall Study|Illness|1|||
25331089|NCT00679042|50647277|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
25249897|NCT00195429|50565779|FG000|Overall Study|Lack of Efficacy|2|||
25249898|NCT00195429|50565780|FG001|Overall Study|Lack of Efficacy|1|||
25249899|NCT00195429|50565779|FG000|Overall Study|Lost to Follow-up|1|||
25249900|NCT00195429|50565780|FG001|Overall Study|Lost to Follow-up|0|||
25249901|NCT00195351|50565788|FG000|Overall Study|Lost to Follow-up|9|||
25249902|NCT00195351|50565789|FG001|Overall Study|Lost to Follow-up|9|||
25249903|NCT00195351|50565788|FG000|Overall Study|Withdrawal by Subject|6|||
25331090|NCT00679042|50647277|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
25331091|NCT00679042|50647277|FG000|5-Year Follow Up|Death|1|||
25331092|NCT00679042|50647277|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
25331093|NCT00679042|50647277|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
25331094|NCT00680368|50647281|FG000|Overall Study|not supervised, not eligible|15|||
25331095|NCT00680056|50647289|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
25331096|NCT00680056|50647290|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
25331097|NCT00680056|50647289|FG000|Second Intervention|Protocol Violation|3|||
25331098|NCT00680056|50647290|FG001|Second Intervention|Protocol Violation|1|||
25331099|NCT00680992|50647300|FG000|Overall Study|Complete Resection (as per protocol)|25|||
25331100|NCT00680992|50647301|FG001|Overall Study|Complete Resection (as per protocol)|121|||
25331101|NCT00680992|50647302|FG002|Overall Study|Complete Resection (as per protocol)|0|||
25331102|NCT00680992|50647300|FG000|Overall Study|Administrative Decision|83|||
25331103|NCT00680992|50647301|FG001|Overall Study|Administrative Decision|42|||
25331104|NCT00680992|50647302|FG002|Overall Study|Administrative Decision|5|||
25331105|NCT00680992|50647300|FG000|Overall Study|End of Trial|32|||
25331106|NCT00680992|50647301|FG001|Overall Study|End of Trial|12|||
25331107|NCT00680992|50647302|FG002|Overall Study|End of Trial|3|||
25331108|NCT00680992|50647300|FG000|Overall Study|Withdrawal by Subject|33|||
25331109|NCT00680992|50647301|FG001|Overall Study|Withdrawal by Subject|11|||
25331110|NCT00680992|50647302|FG002|Overall Study|Withdrawal by Subject|1|||
25331111|NCT00680992|50647300|FG000|Overall Study|Adverse Event|21|||
25331112|NCT00680992|50647301|FG001|Overall Study|Adverse Event|19|||
25331113|NCT00680992|50647302|FG002|Overall Study|Adverse Event|1|||
25331114|NCT00680992|50647300|FG000|Overall Study|Other|19|||
25331115|NCT00680992|50647301|FG001|Overall Study|Other|14|||
25331116|NCT00680992|50647302|FG002|Overall Study|Other|1|||
25331117|NCT00680992|50647300|FG000|Overall Study|Disease Progression|21|||
25331118|NCT00680992|50647301|FG001|Overall Study|Disease Progression|9|||
25331119|NCT00680992|50647302|FG002|Overall Study|Disease Progression|0|||
25331120|NCT00680992|50647300|FG000|Overall Study|Lost to Follow-up|12|||
25331121|NCT00680992|50647301|FG001|Overall Study|Lost to Follow-up|14|||
25331122|NCT00680992|50647302|FG002|Overall Study|Lost to Follow-up|0|||
25249904|NCT00195351|50565789|FG001|Overall Study|Withdrawal by Subject|3|||
25249905|NCT00195351|50565788|FG000|Overall Study|Protocol Deviation|3|||
25331123|NCT00680992|50647300|FG000|Overall Study|Noncompliance|4|||
25331124|NCT00680992|50647301|FG001|Overall Study|Noncompliance|6|||
25331125|NCT00680992|50647302|FG002|Overall Study|Noncompliance|0|||
25331126|NCT00680992|50647300|FG000|Overall Study|Requirement for Alternative Therapy|8|||
25331127|NCT00680992|50647301|FG001|Overall Study|Requirement for Alternative Therapy|2|||
25331128|NCT00680992|50647302|FG002|Overall Study|Requirement for Alternative Therapy|0|||
25331129|NCT00680992|50647300|FG000|Overall Study|Pregnancy|5|||
25331130|NCT00680992|50647301|FG001|Overall Study|Pregnancy|0|||
25331131|NCT00680992|50647302|FG002|Overall Study|Pregnancy|1|||
25331132|NCT00680992|50647300|FG000|Overall Study|Death|5|||
25249906|NCT00195351|50565789|FG001|Overall Study|Protocol Deviation|2|||
25331133|NCT00680992|50647301|FG001|Overall Study|Death|1|||
25331134|NCT00680992|50647302|FG002|Overall Study|Death|0|||
25331135|NCT00680992|50647300|FG000|Overall Study|Ineligibility Determined|0|||
25331136|NCT00680992|50647301|FG001|Overall Study|Ineligibility Determined|1|||
25331137|NCT00680992|50647302|FG002|Overall Study|Ineligibility Determined|0|||
25331138|NCT00805389|50647316|FG000|Overall Study|Adverse Event|0|||
25331139|NCT00805389|50647317|FG001|Overall Study|Adverse Event|0|||
25331140|NCT00805389|50647318|FG002|Overall Study|Adverse Event|1|||
25331141|NCT00805389|50647319|FG003|Overall Study|Adverse Event|2|||
25331142|NCT00805389|50647320|FG004|Overall Study|Adverse Event|0|||
25331143|NCT00805389|50647316|FG000|Overall Study|Lost to Follow-up|4|||
25249907|NCT00195351|50565788|FG000|Overall Study|Death|3|||
25249908|NCT00195351|50565789|FG001|Overall Study|Death|1|||
25249909|NCT00195351|50565788|FG000|Overall Study|Lack of Efficacy|0|||
25249910|NCT00195351|50565789|FG001|Overall Study|Lack of Efficacy|1|||
25249911|NCT00195273|50565797|FG000|Overall Study|Adverse Event|9|||
25249912|NCT00195273|50565798|FG001|Overall Study|Adverse Event|9|||
25249913|NCT00195273|50565797|FG000|Overall Study|Protocol deviation|0|||
25249914|NCT00195273|50565798|FG001|Overall Study|Protocol deviation|1|||
25249915|NCT00195273|50565797|FG000|Overall Study|Lack of Efficacy|3|||
25249916|NCT00195273|50565798|FG001|Overall Study|Lack of Efficacy|1|||
25331144|NCT00805389|50647317|FG001|Overall Study|Lost to Follow-up|3|||
25331145|NCT00805389|50647318|FG002|Overall Study|Lost to Follow-up|6|||
25331146|NCT00805389|50647319|FG003|Overall Study|Lost to Follow-up|10|||
25249917|NCT00195273|50565797|FG000|Overall Study|Procedural complications|9|||
25331147|NCT00805389|50647320|FG004|Overall Study|Lost to Follow-up|9|||
25331148|NCT00805389|50647316|FG000|Overall Study|Protocol Violation|0|||
25331149|NCT00805389|50647317|FG001|Overall Study|Protocol Violation|0|||
25331150|NCT00805389|50647318|FG002|Overall Study|Protocol Violation|1|||
25331151|NCT00805389|50647319|FG003|Overall Study|Protocol Violation|0|||
25331152|NCT00805389|50647320|FG004|Overall Study|Protocol Violation|0|||
25331153|NCT00805389|50647316|FG000|Overall Study|Withdrawal by Subject|3|||
25331154|NCT00805389|50647317|FG001|Overall Study|Withdrawal by Subject|2|||
25331155|NCT00805389|50647318|FG002|Overall Study|Withdrawal by Subject|4|||
25331156|NCT00805389|50647319|FG003|Overall Study|Withdrawal by Subject|5|||
25331157|NCT00805389|50647320|FG004|Overall Study|Withdrawal by Subject|4|||
25331158|NCT00678886|50647344|FG000|Overall Study|Withdrawal by Subject|0|||
25331159|NCT00678886|50647345|FG001|Overall Study|Withdrawal by Subject|0|||
25331160|NCT00678886|50647346|FG002|Overall Study|Withdrawal by Subject|4|||
25331161|NCT00678886|50647347|FG003|Overall Study|Withdrawal by Subject|6|||
25331162|NCT00678886|50647344|FG000|Overall Study|Physician Decision|0|||
25331163|NCT00678886|50647345|FG001|Overall Study|Physician Decision|0|||
25331164|NCT00678886|50647346|FG002|Overall Study|Physician Decision|1|||
25331165|NCT00678886|50647347|FG003|Overall Study|Physician Decision|1|||
25331166|NCT00678886|50647344|FG000|Overall Study|Lost to Follow-up|0|||
25331167|NCT00678886|50647345|FG001|Overall Study|Lost to Follow-up|0|||
25331168|NCT00678886|50647346|FG002|Overall Study|Lost to Follow-up|3|||
25331169|NCT00678886|50647347|FG003|Overall Study|Lost to Follow-up|2|||
25331170|NCT00678886|50647344|FG000|Overall Study|Other|0|||
25331171|NCT00678886|50647345|FG001|Overall Study|Other|0|||
25331172|NCT00678886|50647346|FG002|Overall Study|Other|1|||
25331173|NCT00678886|50647347|FG003|Overall Study|Other|0|||
25331174|NCT00804843|50647358|FG000|Overall Study|Protocol Violation|1|||
25331175|NCT00804843|50647359|FG001|Overall Study|Protocol Violation|0|||
25331176|NCT00804843|50647358|FG000|Overall Study|Adverse Event|8|||
25331177|NCT00804843|50647359|FG001|Overall Study|Adverse Event|5|||
25331178|NCT00804843|50647358|FG000|Overall Study|Withdrawal by Subject|1|||
25331179|NCT00804843|50647359|FG001|Overall Study|Withdrawal by Subject|2|||
25331180|NCT00822120|50647368|FG000|Initial Registration|Adverse Event|1|||
25331181|NCT00822120|50647369|FG001|Initial Registration|Adverse Event|0|||
25331182|NCT00822120|50647370|FG002|Initial Registration|Adverse Event|0|||
25331183|NCT00822120|50647371|FG003|Initial Registration|Adverse Event|0|||
25331184|NCT00822120|50647372|FG004|Initial Registration|Adverse Event|0|||
25331185|NCT00822120|50647373|FG005|Initial Registration|Adverse Event|0|||
25331186|NCT00822120|50647368|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
25331187|NCT00822120|50647369|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
25331188|NCT00822120|50647370|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
25331189|NCT00822120|50647371|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
25331190|NCT00822120|50647372|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
25331191|NCT00822120|50647373|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
25331192|NCT00822120|50647368|FG000|Initial Registration|Reasons not Protocol Specified|2|||
25331193|NCT00822120|50647369|FG001|Initial Registration|Reasons not Protocol Specified|0|||
25249918|NCT00195273|50565798|FG001|Overall Study|Procedural complications|3|||
25249919|NCT00193479|50565804|FG000|Induction Chemotherapy|Adverse Event|2|||
25249920|NCT00193479|50565804|FG000|Induction Chemotherapy|Disease Progression|1|||
25331194|NCT00822120|50647370|FG002|Initial Registration|Reasons not Protocol Specified|0|||
25331195|NCT00822120|50647371|FG003|Initial Registration|Reasons not Protocol Specified|0|||
25331196|NCT00822120|50647372|FG004|Initial Registration|Reasons not Protocol Specified|0|||
25331197|NCT00822120|50647373|FG005|Initial Registration|Reasons not Protocol Specified|0|||
25331198|NCT00822120|50647368|FG000|Initial Registration|Ineligible|22|||
25331199|NCT00822120|50647369|FG001|Initial Registration|Ineligible|1|||
25331200|NCT00822120|50647370|FG002|Initial Registration|Ineligible|0|||
25331201|NCT00822120|50647371|FG003|Initial Registration|Ineligible|0|||
25331202|NCT00822120|50647372|FG004|Initial Registration|Ineligible|0|||
25331203|NCT00822120|50647373|FG005|Initial Registration|Ineligible|0|||
25249921|NCT00193479|50565804|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
25249922|NCT00193479|50565804|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
25249923|NCT00193206|50565808|FG000|Preoperative Therapy|Lack of Efficacy|2|||
25249924|NCT00193206|50565808|FG000|Preoperative Therapy|Adverse Event|2|||
25331204|NCT00822120|50647368|FG000|PET-directed Therapy|Adverse Event|0|||
25249925|NCT00193206|50565808|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
25249926|NCT00193206|50565808|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
25249927|NCT00193206|50565808|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
25331205|NCT00822120|50647369|FG001|PET-directed Therapy|Adverse Event|0|||
25331206|NCT00822120|50647370|FG002|PET-directed Therapy|Adverse Event|0|||
25331207|NCT00822120|50647371|FG003|PET-directed Therapy|Adverse Event|1|||
25331208|NCT00822120|50647372|FG004|PET-directed Therapy|Adverse Event|0|||
25331209|NCT00822120|50647373|FG005|PET-directed Therapy|Adverse Event|0|||
25331210|NCT00822120|50647368|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
25331211|NCT00822120|50647369|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
25331212|NCT00822120|50647370|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
25331213|NCT00822120|50647371|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
25331214|NCT00822120|50647372|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
25331215|NCT00822120|50647373|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
25331216|NCT00822120|50647368|FG000|PET-directed Therapy|Death|0|||
25331217|NCT00822120|50647369|FG001|PET-directed Therapy|Death|0|||
25331218|NCT00822120|50647370|FG002|PET-directed Therapy|Death|0|||
25331219|NCT00822120|50647371|FG003|PET-directed Therapy|Death|2|||
25331220|NCT00822120|50647372|FG004|PET-directed Therapy|Death|0|||
25331221|NCT00822120|50647373|FG005|PET-directed Therapy|Death|0|||
25331222|NCT00822120|50647368|FG000|PET-directed Therapy|Protocol Violation|0|||
25331223|NCT00822120|50647369|FG001|PET-directed Therapy|Protocol Violation|0|||
25331224|NCT00822120|50647370|FG002|PET-directed Therapy|Protocol Violation|0|||
25331225|NCT00822120|50647371|FG003|PET-directed Therapy|Protocol Violation|6|||
25331226|NCT00822120|50647372|FG004|PET-directed Therapy|Protocol Violation|0|||
25331227|NCT00822120|50647373|FG005|PET-directed Therapy|Protocol Violation|0|||
25331228|NCT00804687|50647394|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
25331229|NCT00804687|50647395|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
25331230|NCT00804687|50647396|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
25331231|NCT00804687|50647397|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
25331232|NCT00804687|50647398|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
25331233|NCT00804687|50647399|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
25331234|NCT00804687|50647394|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
25331235|NCT00804687|50647395|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
25331236|NCT00804687|50647396|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
25331237|NCT00804687|50647397|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
25331238|NCT00804687|50647398|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
25331239|NCT00804687|50647399|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
25331240|NCT00804687|50647394|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
25331241|NCT00804687|50647395|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
25331242|NCT00804687|50647396|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
25331243|NCT00804687|50647397|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
25331244|NCT00804687|50647398|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
25331245|NCT00804687|50647399|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
25331246|NCT00804687|50647394|FG000|Period 5: Treatment Period|Positive drug test|1|||
25331247|NCT00804687|50647395|FG001|Period 5: Treatment Period|Positive drug test|0|||
25331248|NCT00804687|50647396|FG002|Period 5: Treatment Period|Positive drug test|0|||
25331249|NCT00804687|50647397|FG003|Period 5: Treatment Period|Positive drug test|0|||
25249928|NCT00193206|50565808|FG000|Postoperative Therapy|Physician Decision|3|||
25331250|NCT00804687|50647398|FG004|Period 5: Treatment Period|Positive drug test|0|||
25331251|NCT00804687|50647399|FG005|Period 5: Treatment Period|Positive drug test|0|||
25331252|NCT00678652|50647411|FG000|Overall Study|Protocol Violation|2|||
25331253|NCT00678652|50647412|FG001|Overall Study|Protocol Violation|0|||
25249929|NCT00193206|50565808|FG000|Postoperative Therapy|Intercurrent Illness|2|||
25249930|NCT00193206|50565808|FG000|Postoperative Therapy|Lack of Efficacy|1|||
25331254|NCT00678652|50647413|FG002|Overall Study|Protocol Violation|0|||
25331255|NCT00678652|50647414|FG003|Overall Study|Protocol Violation|0|||
25331256|NCT00678652|50647411|FG000|Overall Study|Pregnancy|0|||
25331257|NCT00678652|50647412|FG001|Overall Study|Pregnancy|0|||
25331258|NCT00678652|50647413|FG002|Overall Study|Pregnancy|1|||
25249931|NCT00193206|50565808|FG000|Postoperative Therapy|Protocol Violation|1|||
25249932|NCT00193050|50565812|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
25249933|NCT00193050|50565812|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
25249934|NCT00193050|50565812|FG000|Neoadjuvant Treatment|Physician Decision|2|||
25249935|NCT00193050|50565812|FG000|Neoadjuvant Treatment|Adverse Event|2|||
25249936|NCT00193050|50565812|FG000|Adjuvant|Physician Decision|5|||
25249937|NCT00193050|50565812|FG000|Adjuvant|Intercurrent Hospitalization|3|||
25249938|NCT00193050|50565812|FG000|Adjuvant|Lack of Efficacy|2|||
25249939|NCT00192504|50565821|FG000|Overall Study|Lost to Follow-up|1|||
25249940|NCT00192504|50565822|FG001|Overall Study|Lost to Follow-up|0|||
25249941|NCT00192504|50565823|FG002|Overall Study|Lost to Follow-up|0|||
25249942|NCT00192504|50565824|FG003|Overall Study|Lost to Follow-up|0|||
25249943|NCT00192504|50565821|FG000|Overall Study|Dosing window missed|0|||
25331259|NCT00678652|50647414|FG003|Overall Study|Pregnancy|0|||
25331260|NCT00678652|50647411|FG000|Overall Study|Relocation|1|||
25331261|NCT00678652|50647412|FG001|Overall Study|Relocation|0|||
25331262|NCT00678652|50647413|FG002|Overall Study|Relocation|0|||
25331263|NCT00678652|50647414|FG003|Overall Study|Relocation|0|||
25331264|NCT00840060|50647435|FG000|Overall Study|Withdrawal by Subject|1|||
25331265|NCT00840060|50647436|FG001|Overall Study|Withdrawal by Subject|0|||
25331266|NCT00840060|50647435|FG000|Overall Study|Change in emotional/behavioral status|0|||
25249944|NCT00192504|50565822|FG001|Overall Study|Dosing window missed|0|||
25249945|NCT00192504|50565823|FG002|Overall Study|Dosing window missed|1|||
25249946|NCT00192504|50565824|FG003|Overall Study|Dosing window missed|0|||
25249947|NCT00192114|50565834|FG000|Overall Study|Objective Tumor Progression|19|||
25249948|NCT00192114|50565834|FG000|Overall Study|Adverse Event|2|||
25249949|NCT00192114|50565834|FG000|Overall Study|Clinical Progression|2|||
25249950|NCT00192114|50565834|FG000|Overall Study|Death|1|||
25249951|NCT00192075|50565840|FG000|Overall Study|Disease Progression|23|||
25249952|NCT00192075|50565841|FG001|Overall Study|Disease Progression|6|||
25249953|NCT00192075|50565840|FG000|Overall Study|Adverse Event|1|||
25249954|NCT00192075|50565841|FG001|Overall Study|Adverse Event|3|||
25249955|NCT00192075|50565840|FG000|Overall Study|Death|0|||
25249956|NCT00192075|50565841|FG001|Overall Study|Death|1|||
25249957|NCT00192075|50565840|FG000|Overall Study|Lack of Efficacy|0|||
25249958|NCT00192075|50565841|FG001|Overall Study|Lack of Efficacy|0|||
25249959|NCT00192075|50565840|FG000|Overall Study|Physician Decision|3|||
25331267|NCT00840060|50647436|FG001|Overall Study|Change in emotional/behavioral status|1|||
25331268|NCT00574912|50647442|FG000|Overall Study|Could not place IV lines.|3|||
25249960|NCT00192075|50565841|FG001|Overall Study|Physician Decision|0|||
25249961|NCT00192075|50565840|FG000|Overall Study|Withdrawal by Subject|5|||
25249962|NCT00192075|50565841|FG001|Overall Study|Withdrawal by Subject|5|||
25249963|NCT00192075|50565840|FG000|Overall Study|Patient Non-Compliance|0|||
25249964|NCT00192075|50565841|FG001|Overall Study|Patient Non-Compliance|1|||
25331269|NCT00574912|50647442|FG000|Overall Study|scheduling conflicts|3|||
25331270|NCT00574912|50647442|FG000|Overall Study|Physician Decision|2|||
25331271|NCT00674128|50647456|FG000|Overall Study|Withdrawal by Subject|25|||
25331272|NCT00674128|50647457|FG001|Overall Study|Withdrawal by Subject|23|||
25249965|NCT00192075|50565840|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
25331273|NCT00804141|50647463|FG000|Overall Study|Adverse Event|157|||
25331274|NCT00804141|50647463|FG000|Overall Study|Death|4|||
25331275|NCT00804141|50647463|FG000|Overall Study|Failed to return|96|||
25331276|NCT00804141|50647463|FG000|Overall Study|Investigator request|8|||
25331277|NCT00804141|50647463|FG000|Overall Study|Protocol Violation|85|||
25331278|NCT00804141|50647463|FG000|Overall Study|Withdrawal by Subject|131|||
25331279|NCT00804141|50647463|FG000|Overall Study|Lack of Efficacy|46|||
25331280|NCT00804141|50647463|FG000|Overall Study|Other than specified|30|||
25331281|NCT00804141|50647463|FG000|Overall Study|Enrolled but not treated|6|||
25331282|NCT00677092|50647467|FG000|Overall Study|Adverse Event|1|||
25331283|NCT00677092|50647467|FG000|Overall Study|Lost to Follow-up|1|||
25331284|NCT00677092|50647467|FG000|Overall Study|Withdrawal by Subject|3|||
25331285|NCT00677092|50647467|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
25331286|NCT00677014|50647475|FG000|Overall Study|Lost to Follow-up|20|||
25331287|NCT00677014|50647476|FG001|Overall Study|Lost to Follow-up|12|||
25249966|NCT00192075|50565841|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
25249967|NCT00192075|50565840|FG000|Overall Study|Other|5|||
25249968|NCT00192075|50565841|FG001|Overall Study|Other|2|||
25249969|NCT00192036|50565852|FG000|Overall Study|Protocol Violation|3|||
25249970|NCT00192036|50565852|FG000|Overall Study|Adverse Event|6|||
25249971|NCT00192036|50565852|FG000|Overall Study|Patient/Physician Perception|1|||
25331288|NCT00677014|50647477|FG002|Overall Study|Lost to Follow-up|24|||
25331289|NCT00677014|50647475|FG000|Overall Study|Death|6|||
25331290|NCT00677014|50647476|FG001|Overall Study|Death|15|||
25331291|NCT00677014|50647477|FG002|Overall Study|Death|7|||
25331292|NCT00677014|50647475|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
25331293|NCT00677014|50647476|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
25331294|NCT00677014|50647477|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
25331295|NCT00839436|50647488|FG000|Overall Study|Developed exclusionary condition|1|||
25331296|NCT00839436|50647489|FG001|Overall Study|Developed exclusionary condition|0|||
25331297|NCT00839436|50647490|FG002|Overall Study|Developed exclusionary condition|0|||
25331298|NCT00839436|50647488|FG000|Overall Study|Withdrawal by Subject|0|||
25331299|NCT00839436|50647489|FG001|Overall Study|Withdrawal by Subject|1|||
25331300|NCT00839436|50647490|FG002|Overall Study|Withdrawal by Subject|0|||
25331301|NCT00839436|50647488|FG000|Overall Study|Study drug no longer available|0|||
25331302|NCT00839436|50647489|FG001|Overall Study|Study drug no longer available|0|||
25331303|NCT00839436|50647490|FG002|Overall Study|Study drug no longer available|1|||
25331304|NCT00675766|50647511|FG000|Overall Study|Lost to Follow-up|6|||
25331305|NCT00675766|50647512|FG001|Overall Study|Lost to Follow-up|5|||
25331306|NCT00675766|50647513|FG002|Overall Study|Lost to Follow-up|21|||
25331307|NCT00675766|50647514|FG003|Overall Study|Lost to Follow-up|26|||
25331308|NCT00673894|50647526|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
25331309|NCT00673894|50647527|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
25331310|NCT00673894|50647526|FG000|First Intervention 4 Weeks|Adverse Event|1|||
25331311|NCT00673894|50647527|FG001|First Intervention 4 Weeks|Adverse Event|0|||
25331312|NCT00674986|50647535|FG000|Overall Study|Adverse Event|2|||
25331313|NCT00674986|50647536|FG001|Overall Study|Adverse Event|1|||
25331314|NCT00674986|50647535|FG000|Overall Study|Subject withdrew consent|12|||
25331315|NCT00674986|50647536|FG001|Overall Study|Subject withdrew consent|19|||
25331316|NCT00674986|50647535|FG000|Overall Study|Lost to Follow-up|25|||
25331317|NCT00674986|50647536|FG001|Overall Study|Lost to Follow-up|53|||
25331318|NCT00674986|50647535|FG000|Overall Study|Other reasons|4|||
25331319|NCT00674986|50647536|FG001|Overall Study|Other reasons|8|||
25331320|NCT00673816|50647543|FG000|Overall Study|Adverse Event|1|||
25331321|NCT00673816|50647543|FG000|Overall Study|Withdrawal by Subject|1|||
25331322|NCT00673660|50647548|FG000|Overall Study|Lost to Follow-up|107|||
25331323|NCT00672958|50647559|FG000|Overall Study|Adverse Event|11|||
25331324|NCT00672958|50647560|FG001|Overall Study|Adverse Event|9|||
25331325|NCT00672958|50647559|FG000|Overall Study|Lack of Efficacy|6|||
25331326|NCT00672958|50647560|FG001|Overall Study|Lack of Efficacy|11|||
25331327|NCT00672958|50647559|FG000|Overall Study|Non-compliance with study drug|2|||
25331328|NCT00672958|50647560|FG001|Overall Study|Non-compliance with study drug|3|||
25331329|NCT00672958|50647559|FG000|Overall Study|Protocol deviations|11|||
25331330|NCT00672958|50647560|FG001|Overall Study|Protocol deviations|5|||
25331331|NCT00672958|50647559|FG000|Overall Study|Voluntary withdrawal|12|||
25331332|NCT00672958|50647560|FG001|Overall Study|Voluntary withdrawal|8|||
25331333|NCT00672958|50647559|FG000|Overall Study|Lost to Follow-up|22|||
25331334|NCT00672958|50647560|FG001|Overall Study|Lost to Follow-up|17|||
25331335|NCT00672958|50647559|FG000|Overall Study|Reason not specified|0|||
25331336|NCT00672958|50647560|FG001|Overall Study|Reason not specified|3|||
25331337|NCT00672646|50647569|FG000|Overall Study|Lost to Follow-up|0|||
25331338|NCT00672646|50647570|FG001|Overall Study|Lost to Follow-up|1|||
25331339|NCT00672646|50647571|FG002|Overall Study|Lost to Follow-up|2|||
25331340|NCT00672646|50647569|FG000|Overall Study|Withdrawal by Subject|0|||
25331341|NCT00672646|50647570|FG001|Overall Study|Withdrawal by Subject|0|||
25331342|NCT00672646|50647571|FG002|Overall Study|Withdrawal by Subject|1|||
25331343|NCT00672490|50647581|FG000|Overall Study|Withdrawal by Subject|8|||
25331344|NCT00672490|50647582|FG001|Overall Study|Withdrawal by Subject|8|||
25331345|NCT00672490|50647581|FG000|Overall Study|Lack of Compliance|2|||
25331346|NCT00672490|50647582|FG001|Overall Study|Lack of Compliance|7|||
25331347|NCT00672490|50647581|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
25249972|NCT00192036|50565852|FG000|Overall Study|Objective Tumor Progression|4|||
25249973|NCT00192036|50565852|FG000|Overall Study|Clinical Disease Progression|1|||
25249974|NCT00192036|50565852|FG000|Overall Study|Death|1|||
25249975|NCT00192036|50565852|FG000|Overall Study|Unknown or Not Specified|5|||
25249976|NCT00191724|50565861|FG000|Overall Study|Adverse Event|0|||
25249977|NCT00191724|50565862|FG001|Overall Study|Adverse Event|0|||
25249978|NCT00191724|50565863|FG002|Overall Study|Adverse Event|1|||
25249979|NCT00191724|50565864|FG003|Overall Study|Adverse Event|0|||
25249980|NCT00191724|50565865|FG004|Overall Study|Adverse Event|0|||
25249981|NCT00191724|50565861|FG000|Overall Study|Lost to Follow-up|1|||
25249982|NCT00191724|50565862|FG001|Overall Study|Lost to Follow-up|1|||
25249983|NCT00191724|50565863|FG002|Overall Study|Lost to Follow-up|0|||
25331348|NCT00672490|50647582|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
25331349|NCT00672490|50647581|FG000|Overall Study|Adverse Event|5|||
25331350|NCT00672490|50647582|FG001|Overall Study|Adverse Event|8|||
25331351|NCT00672490|50647581|FG000|Overall Study|Violation of Concomitant Medicine|1|||
25249984|NCT00191724|50565864|FG003|Overall Study|Lost to Follow-up|2|||
25249985|NCT00191724|50565865|FG004|Overall Study|Lost to Follow-up|3|||
25249986|NCT00191724|50565861|FG000|Overall Study|Withdrawal by Subject|0|||
25331352|NCT00672490|50647582|FG001|Overall Study|Violation of Concomitant Medicine|0|||
25331353|NCT00672490|50647581|FG000|Overall Study|Intolerance|0|||
25331354|NCT00672490|50647582|FG001|Overall Study|Intolerance|2|||
25331355|NCT00672490|50647581|FG000|Overall Study|Lost to Follow-up|1|||
25331356|NCT00672490|50647582|FG001|Overall Study|Lost to Follow-up|5|||
25331357|NCT00672490|50647581|FG000|Overall Study|No reason was provided|6|||
25249987|NCT00191724|50565862|FG001|Overall Study|Withdrawal by Subject|0|||
25249988|NCT00191724|50565863|FG002|Overall Study|Withdrawal by Subject|0|||
25249989|NCT00191724|50565864|FG003|Overall Study|Withdrawal by Subject|1|||
25249990|NCT00191724|50565865|FG004|Overall Study|Withdrawal by Subject|0|||
25249991|NCT00191646|50565879|FG000|Overall Study|Toxicity|26|||
25249992|NCT00191646|50565880|FG001|Overall Study|Toxicity|37|||
25249993|NCT00191646|50565879|FG000|Overall Study|Disease Progression|5|||
25249994|NCT00191646|50565880|FG001|Overall Study|Disease Progression|6|||
25249995|NCT00191646|50565879|FG000|Overall Study|Physician Decision|20|||
25249996|NCT00191646|50565880|FG001|Overall Study|Physician Decision|11|||
25249997|NCT00191646|50565879|FG000|Overall Study|Withdrawal by Subject|58|||
25249998|NCT00191646|50565880|FG001|Overall Study|Withdrawal by Subject|39|||
25249999|NCT00191646|50565879|FG000|Overall Study|Protocol Violation|5|||
25250000|NCT00191646|50565880|FG001|Overall Study|Protocol Violation|7|||
25250001|NCT00191646|50565879|FG000|Overall Study|Death|6|||
25250002|NCT00191646|50565880|FG001|Overall Study|Death|8|||
25250003|NCT00191646|50565879|FG000|Overall Study|Other|33|||
25250004|NCT00191646|50565880|FG001|Overall Study|Other|34|||
25250005|NCT00191646|50565879|FG000|Overall Study|Missing Data|18|||
25331358|NCT00672490|50647582|FG001|Overall Study|No reason was provided|2|||
25331359|NCT00670930|50647590|FG000|Overall Study|Adminstrative Problem|0|||
25331360|NCT00670930|50647591|FG001|Overall Study|Adminstrative Problem|1|||
25331361|NCT00670930|50647590|FG000|Overall Study|Lost to Follow-up|1|||
25331362|NCT00670930|50647591|FG001|Overall Study|Lost to Follow-up|0|||
25331363|NCT00670540|50647597|FG000|Overall Study|ineligible|17|||
25331364|NCT00670540|50647597|FG000|Overall Study|not living in France|348|||
25331365|NCT00670540|50647597|FG000|Overall Study|refused to participate|189|||
25331366|NCT00670540|50647597|FG000|Overall Study|controls randomised for no follow up|2770|||
25331367|NCT00670540|50647597|FG000|Overall Study|missing information inclusion criteria|1|||
25331368|NCT00591786|50647611|FG000|Overall Study|Withdrawal of Informed Consent|0|||
25331369|NCT00591786|50647612|FG001|Overall Study|Withdrawal of Informed Consent|0|||
25331370|NCT00591786|50647613|FG002|Overall Study|Withdrawal of Informed Consent|1|||
25331371|NCT00591786|50647614|FG003|Overall Study|Withdrawal of Informed Consent|0|||
25250006|NCT00191646|50565880|FG001|Overall Study|Missing Data|11|||
25250007|NCT00191451|50565897|FG000|Overall Study|Withdrawal by Subject|2|||
25250008|NCT00191451|50565898|FG001|Overall Study|Withdrawal by Subject|3|||
25250009|NCT00191451|50565899|FG002|Overall Study|Withdrawal by Subject|5|||
25250010|NCT00191451|50565897|FG000|Overall Study|Physician Decision|2|||
25250011|NCT00191451|50565898|FG001|Overall Study|Physician Decision|9|||
25331372|NCT00591786|50647615|FG004|Overall Study|Withdrawal of Informed Consent|0|||
25331373|NCT00591786|50647616|FG005|Overall Study|Withdrawal of Informed Consent|0|||
25331374|NCT00591786|50647617|FG006|Overall Study|Withdrawal of Informed Consent|0|||
25331375|NCT00591786|50647618|FG007|Overall Study|Withdrawal of Informed Consent|0|||
25331376|NCT00591786|50647619|FG008|Overall Study|Withdrawal of Informed Consent|0|||
25331377|NCT00591786|50647620|FG009|Overall Study|Withdrawal of Informed Consent|0|||
25331378|NCT00674362|50647644|FG000|Double Blind|Adverse Event|6|||
25331379|NCT00674362|50647645|FG001|Double Blind|Adverse Event|6|||
25331380|NCT00674362|50647644|FG000|Double Blind|Lack of Efficacy|2|||
25331381|NCT00674362|50647645|FG001|Double Blind|Lack of Efficacy|6|||
25331382|NCT00674362|50647644|FG000|Double Blind|Loss of efficacy|0|||
25331383|NCT00674362|50647645|FG001|Double Blind|Loss of efficacy|1|||
25331384|NCT00674362|50647644|FG000|Double Blind|Withdrawal by Subject|4|||
25331385|NCT00674362|50647645|FG001|Double Blind|Withdrawal by Subject|3|||
25331386|NCT00674362|50647644|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
25331387|NCT00674362|50647645|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
25331388|NCT00674362|50647644|FG000|Double Blind|Other: Surgery|0|||
25331389|NCT00674362|50647645|FG001|Double Blind|Other: Surgery|1|||
25331390|NCT00674362|50647644|FG000|Open Label|Adverse Event|1|||
25331391|NCT00674362|50647645|FG001|Open Label|Adverse Event|0|||
24901001|NCT00697515|49994991|FG001|Dose Optimization Period|sponsor request|0|||
25250012|NCT00191451|50565899|FG002|Overall Study|Physician Decision|6|||
25250013|NCT00191451|50565897|FG000|Overall Study|Sponsor Decision|1|||
25250014|NCT00191451|50565898|FG001|Overall Study|Sponsor Decision|0|||
25250015|NCT00191451|50565899|FG002|Overall Study|Sponsor Decision|0|||
25250016|NCT00191451|50565897|FG000|Overall Study|Ineligible|0|||
25331392|NCT00674362|50647644|FG000|Open Label|Other: Subject moved to extension study|1|||
25331393|NCT00674362|50647645|FG001|Open Label|Other: Subject moved to extension study|0|||
25331394|NCT00820950|50647657|FG000|Overall Study|Scheduling Conflict|0|||
25250017|NCT00191451|50565898|FG001|Overall Study|Ineligible|1|||
25250018|NCT00191451|50565899|FG002|Overall Study|Ineligible|0|||
25250019|NCT00191451|50565897|FG000|Overall Study|Reason Not Specified|2|||
25250020|NCT00191451|50565898|FG001|Overall Study|Reason Not Specified|1|||
25250021|NCT00191451|50565899|FG002|Overall Study|Reason Not Specified|3|||
25250022|NCT00191334|50565907|FG000|Overall Study|Adverse Event|4|||
25331395|NCT00820950|50647658|FG001|Overall Study|Scheduling Conflict|0|||
25331396|NCT00820950|50647659|FG002|Overall Study|Scheduling Conflict|0|||
25331397|NCT00820950|50647660|FG003|Overall Study|Scheduling Conflict|0|||
25331398|NCT00820950|50647661|FG004|Overall Study|Scheduling Conflict|0|||
25250023|NCT00191334|50565907|FG000|Overall Study|Disease Progression or Relapse|8|||
25250024|NCT00191334|50565907|FG000|Overall Study|Physician Decision|1|||
25250025|NCT00191334|50565907|FG000|Overall Study|Withdrawal by Subject|4|||
25250026|NCT00191139|50565913|FG000|Overall Study|Adverse Event|2|||
25250027|NCT00191139|50565914|FG001|Overall Study|Adverse Event|6|||
25250028|NCT00191139|50565913|FG000|Overall Study|Death|2|||
25250029|NCT00191139|50565914|FG001|Overall Study|Death|0|||
25250030|NCT00191139|50565913|FG000|Overall Study|Withdrawal by Subject|0|||
25250031|NCT00191139|50565914|FG001|Overall Study|Withdrawal by Subject|3|||
25331399|NCT00820950|50647662|FG005|Overall Study|Scheduling Conflict|0|||
25331400|NCT00820950|50647663|FG006|Overall Study|Scheduling Conflict|1|||
25331401|NCT00820950|50647664|FG007|Overall Study|Scheduling Conflict|1|||
25331402|NCT00820950|50647665|FG008|Overall Study|Scheduling Conflict|0|||
25331403|NCT00820950|50647666|FG009|Overall Study|Scheduling Conflict|0|||
25331404|NCT00820950|50647657|FG000|Overall Study|Protocol Violation|1|||
25331405|NCT00820950|50647658|FG001|Overall Study|Protocol Violation|1|||
25331406|NCT00820950|50647659|FG002|Overall Study|Protocol Violation|0|||
25331407|NCT00820950|50647660|FG003|Overall Study|Protocol Violation|0|||
25331408|NCT00820950|50647661|FG004|Overall Study|Protocol Violation|0|||
25331409|NCT00820950|50647662|FG005|Overall Study|Protocol Violation|0|||
25331410|NCT00820950|50647663|FG006|Overall Study|Protocol Violation|0|||
25331411|NCT00820950|50647664|FG007|Overall Study|Protocol Violation|0|||
25331412|NCT00820950|50647665|FG008|Overall Study|Protocol Violation|0|||
25331413|NCT00820950|50647666|FG009|Overall Study|Protocol Violation|0|||
25331414|NCT00670306|50647706|FG000|Overall Study|Adverse Event|8|||
25331415|NCT00670306|50647706|FG000|Overall Study|Lack of Efficacy|10|||
25331416|NCT00670306|50647706|FG000|Overall Study|Withdrawal by Subject|9|||
25331417|NCT00670306|50647706|FG000|Overall Study|Physician Decision|1|||
25331418|NCT00670306|50647706|FG000|Overall Study|Lost to Follow-up|8|||
25331419|NCT00670306|50647706|FG000|Overall Study|incl/excl criterias did not meet|19|||
25331420|NCT00672256|50647710|FG000|Overall Study|PI dropped, bad data|44|||
25331421|NCT00591630|50647718|FG000|Overall Study|Death|0|||
25331422|NCT00591630|50647719|FG001|Overall Study|Death|0|||
25331423|NCT00591630|50647720|FG002|Overall Study|Death|1|||
25331424|NCT00591630|50647721|FG003|Overall Study|Death|0|||
25331425|NCT00670228|50647733|FG000|Overall Study|Adverse Event|1|||
25331426|NCT00670228|50647734|FG001|Overall Study|Adverse Event|0|||
25331427|NCT00670228|50647733|FG000|Overall Study|Death or MACE|0|||
25331428|NCT00670228|50647734|FG001|Overall Study|Death or MACE|1|||
25331429|NCT00670228|50647733|FG000|Overall Study|Not treated|2|||
25331430|NCT00670228|50647734|FG001|Overall Study|Not treated|2|||
25331431|NCT00670228|50647733|FG000|Overall Study|Not meeting the selection criteria|2|||
25331432|NCT00670228|50647734|FG001|Overall Study|Not meeting the selection criteria|0|||
25331433|NCT00570778|50647740|FG000|Overall Study|Protocol deviation|2|||
25331434|NCT00570778|50647741|FG001|Overall Study|Protocol deviation|1|||
25331435|NCT00570778|50647742|FG002|Overall Study|Protocol deviation|2|||
25331436|NCT00570778|50647743|FG003|Overall Study|Protocol deviation|2|||
25331437|NCT00570778|50647740|FG000|Overall Study|Adverse Event|0|||
25331438|NCT00570778|50647741|FG001|Overall Study|Adverse Event|1|||
25331439|NCT00570778|50647742|FG002|Overall Study|Adverse Event|4|||
25331440|NCT00570778|50647743|FG003|Overall Study|Adverse Event|1|||
25331441|NCT00570778|50647740|FG000|Overall Study|Subject withdrew consent|0|||
25331442|NCT00570778|50647741|FG001|Overall Study|Subject withdrew consent|1|||
25331443|NCT00570778|50647742|FG002|Overall Study|Subject withdrew consent|0|||
25331444|NCT00570778|50647743|FG003|Overall Study|Subject withdrew consent|1|||
25331445|NCT00570778|50647740|FG000|Overall Study|Abnormal test procedure|1|||
25331446|NCT00570778|50647741|FG001|Overall Study|Abnormal test procedure|0|||
25331447|NCT00570778|50647742|FG002|Overall Study|Abnormal test procedure|0|||
25331448|NCT00570778|50647743|FG003|Overall Study|Abnormal test procedure|0|||
25331449|NCT00570778|50647740|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25250032|NCT00191139|50565913|FG000|Overall Study|Disease Progression|0|||
25250033|NCT00191139|50565914|FG001|Overall Study|Disease Progression|1|||
25331450|NCT00570778|50647741|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
25331451|NCT00570778|50647742|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
25331452|NCT00570778|50647743|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
25331453|NCT00570778|50647740|FG000|Overall Study|Lost to Follow-up|0|||
25331454|NCT00570778|50647741|FG001|Overall Study|Lost to Follow-up|0|||
25331455|NCT00570778|50647742|FG002|Overall Study|Lost to Follow-up|1|||
25331456|NCT00570778|50647743|FG003|Overall Study|Lost to Follow-up|0|||
25331457|NCT00570778|50647740|FG000|Overall Study|Subject no longer requires study drug|0|||
25331458|NCT00570778|50647741|FG001|Overall Study|Subject no longer requires study drug|1|||
25331459|NCT00570778|50647742|FG002|Overall Study|Subject no longer requires study drug|0|||
25331460|NCT00570778|50647743|FG003|Overall Study|Subject no longer requires study drug|0|||
25331461|NCT00668746|50647755|FG000|Overall Study|Lost to Follow-up|2|||
25331462|NCT00668746|50647756|FG001|Overall Study|Lost to Follow-up|1|||
25331463|NCT00878189|50647774|FG000|Overall Study|Death|0|||
25331464|NCT00878189|50647775|FG001|Overall Study|Death|1|||
25331465|NCT00878189|50647776|FG002|Overall Study|Death|0|||
25250034|NCT00191139|50565913|FG000|Overall Study|Other|1|||
25331466|NCT00878189|50647777|FG003|Overall Study|Death|1|||
25331467|NCT00878189|50647778|FG004|Overall Study|Death|0|||
25331468|NCT00878189|50647779|FG005|Overall Study|Death|0|||
25331469|NCT00878189|50647780|FG006|Overall Study|Death|0|||
25331470|NCT00878189|50647781|FG007|Overall Study|Death|0|||
25331471|NCT00878189|50647782|FG008|Overall Study|Death|1|||
25331472|NCT00878189|50647774|FG000|Overall Study|Participant Refused to Follow-up|0|||
25331473|NCT00878189|50647775|FG001|Overall Study|Participant Refused to Follow-up|0|||
25331474|NCT00878189|50647776|FG002|Overall Study|Participant Refused to Follow-up|0|||
25331475|NCT00878189|50647777|FG003|Overall Study|Participant Refused to Follow-up|0|||
25331476|NCT00878189|50647778|FG004|Overall Study|Participant Refused to Follow-up|0|||
25331477|NCT00878189|50647779|FG005|Overall Study|Participant Refused to Follow-up|4|||
25331478|NCT00878189|50647780|FG006|Overall Study|Participant Refused to Follow-up|0|||
25331479|NCT00878189|50647781|FG007|Overall Study|Participant Refused to Follow-up|0|||
25331480|NCT00878189|50647782|FG008|Overall Study|Participant Refused to Follow-up|0|||
25331481|NCT00878189|50647774|FG000|Overall Study|Other|3|||
25331482|NCT00878189|50647775|FG001|Overall Study|Other|2|||
25331483|NCT00878189|50647776|FG002|Overall Study|Other|4|||
25331484|NCT00878189|50647777|FG003|Overall Study|Other|7|||
25331485|NCT00878189|50647778|FG004|Overall Study|Other|4|||
25331486|NCT00878189|50647779|FG005|Overall Study|Other|18|||
25331487|NCT00878189|50647780|FG006|Overall Study|Other|15|||
25331488|NCT00878189|50647781|FG007|Overall Study|Other|3|||
25331489|NCT00878189|50647782|FG008|Overall Study|Other|4|||
25331490|NCT00878189|50647774|FG000|Overall Study|Lost to Follow-up|0|||
25331491|NCT00878189|50647775|FG001|Overall Study|Lost to Follow-up|0|||
25331492|NCT00878189|50647776|FG002|Overall Study|Lost to Follow-up|0|||
25331493|NCT00878189|50647777|FG003|Overall Study|Lost to Follow-up|0|||
25331494|NCT00878189|50647778|FG004|Overall Study|Lost to Follow-up|0|||
25250035|NCT00191139|50565914|FG001|Overall Study|Other|2|||
25250036|NCT00190983|50565920|FG000|Overall Study|Inevaluable (never treated)|2|||
25250037|NCT00190749|50565926|FG000|Overall Study|Lost to Follow-up|8|||
25250038|NCT00190749|50565927|FG001|Overall Study|Lost to Follow-up|11|||
25331495|NCT00878189|50647779|FG005|Overall Study|Lost to Follow-up|1|||
25331496|NCT00878189|50647780|FG006|Overall Study|Lost to Follow-up|1|||
25331497|NCT00878189|50647781|FG007|Overall Study|Lost to Follow-up|0|||
25250039|NCT00190749|50565926|FG000|Overall Study|Withdrawal by Subject|10|||
25250040|NCT00190749|50565927|FG001|Overall Study|Withdrawal by Subject|6|||
25250041|NCT00190749|50565926|FG000|Overall Study|Protocol Violation|5|||
25250042|NCT00190749|50565927|FG001|Overall Study|Protocol Violation|4|||
25250043|NCT00190749|50565926|FG000|Overall Study|Adverse Event|0|||
25250044|NCT00190749|50565927|FG001|Overall Study|Adverse Event|5|||
25250045|NCT00190749|50565926|FG000|Overall Study|Lack of Efficacy|2|||
25250046|NCT00190749|50565927|FG001|Overall Study|Lack of Efficacy|3|||
25250047|NCT00190749|50565926|FG000|Overall Study|Reason Not Specified|0|||
25250048|NCT00190749|50565927|FG001|Overall Study|Reason Not Specified|2|||
25250049|NCT00190749|50565926|FG000|Overall Study|Sponsor Decision|1|||
25250050|NCT00190749|50565927|FG001|Overall Study|Sponsor Decision|0|||
25250051|NCT00190671|50565935|FG000|Overall Study|Satisfactory Response|4|||
25250052|NCT00190671|50565936|FG001|Overall Study|Satisfactory Response|7|||
25250053|NCT00190671|50565935|FG000|Overall Study|Lack of Efficacy|19|||
25250054|NCT00190671|50565936|FG001|Overall Study|Lack of Efficacy|24|||
25250055|NCT00190671|50565935|FG000|Overall Study|Death from Study Disease|1|||
25250056|NCT00190671|50565936|FG001|Overall Study|Death from Study Disease|1|||
25250057|NCT00190671|50565935|FG000|Overall Study|Adverse Event|3|||
25250058|NCT00190671|50565936|FG001|Overall Study|Adverse Event|2|||
25250059|NCT00190671|50565935|FG000|Overall Study|Clinical Relapse|0|||
25250060|NCT00190671|50565936|FG001|Overall Study|Clinical Relapse|1|||
25250061|NCT00190671|50565935|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
25250062|NCT00190671|50565936|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
25250063|NCT00190671|50565935|FG000|Overall Study|Death from Other Causes|0|||
25250064|NCT00190671|50565936|FG001|Overall Study|Death from Other Causes|2|||
25250065|NCT00190671|50565935|FG000|Overall Study|Protocol Violation|0|||
25250066|NCT00190671|50565936|FG001|Overall Study|Protocol Violation|1|||
25250067|NCT00190671|50565935|FG000|Overall Study|Withdrawal by Subject|0|||
25250068|NCT00190671|50565936|FG001|Overall Study|Withdrawal by Subject|2|||
25331498|NCT00878189|50647782|FG008|Overall Study|Lost to Follow-up|0|||
25331499|NCT00878189|50647774|FG000|Overall Study|Objection Progression or Relapse|0|||
25331500|NCT00878189|50647775|FG001|Overall Study|Objection Progression or Relapse|0|||
25331501|NCT00878189|50647776|FG002|Overall Study|Objection Progression or Relapse|0|||
25331502|NCT00878189|50647777|FG003|Overall Study|Objection Progression or Relapse|0|||
25331503|NCT00878189|50647778|FG004|Overall Study|Objection Progression or Relapse|0|||
25331504|NCT00878189|50647779|FG005|Overall Study|Objection Progression or Relapse|0|||
25331505|NCT00878189|50647780|FG006|Overall Study|Objection Progression or Relapse|0|||
25250069|NCT00477165|50565958|FG000|Overall Study|Adverse Event|7|||
25250070|NCT00477165|50565959|FG001|Overall Study|Adverse Event|2|||
25250071|NCT00476229|50565965|FG000|Overall Study|Progressive shortness of breath|1|||
25331506|NCT00878189|50647781|FG007|Overall Study|Objection Progression or Relapse|0|||
25331507|NCT00878189|50647782|FG008|Overall Study|Objection Progression or Relapse|3|||
25331508|NCT00668200|50647816|FG000|Overall Study|Withdrawal by Subject|2|||
25331509|NCT00668200|50647816|FG000|Overall Study|Lost to Follow-up|1|||
25331510|NCT00838578|50647820|FG000|Overall Study|Protocol Violation|2|||
25331511|NCT00829296|50647830|FG000|Overall Study|Adverse Event|5|||
25331512|NCT00829296|50647831|FG001|Overall Study|Adverse Event|4|||
25331513|NCT00881621|50647837|FG000|Overall Study|Physician Decision|34|||
25331514|NCT00818766|50647843|FG000|Overall Study|Could not be Contacted on Day 28|11|||
25331515|NCT00818766|50647844|FG001|Overall Study|Could not be Contacted on Day 28|10|||
25331516|NCT00818766|50647843|FG000|Overall Study|Death|1|||
25331517|NCT00818766|50647844|FG001|Overall Study|Death|0|||
25331518|NCT00818766|50647843|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
25331519|NCT00818766|50647844|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
25331520|NCT00667888|50647852|FG000|Overall Study|Death|1|||
25331521|NCT00667888|50647853|FG001|Overall Study|Death|1|||
25331522|NCT00667888|50647852|FG000|Overall Study|Withdrawal by Subject|6|||
25331523|NCT00667888|50647853|FG001|Overall Study|Withdrawal by Subject|3|||
25331524|NCT00667888|50647852|FG000|Overall Study|Proceed with other treatment|3|||
25331525|NCT00667888|50647853|FG001|Overall Study|Proceed with other treatment|3|||
25331526|NCT00667888|50647852|FG000|Overall Study|Ineligible after SIM|0|||
25331527|NCT00667888|50647853|FG001|Overall Study|Ineligible after SIM|2|||
25331528|NCT00594815|50647859|FG000|Overall Study|Never Treated|3|||
25331529|NCT00594815|50647859|FG000|Overall Study|Withdrawal by Subject|2|||
25331530|NCT00594815|50647859|FG000|Overall Study|Toxicity|4|||
25331531|NCT00820248|50647865|FG000|Overall Study|No treated|4|||
25331532|NCT00820248|50647866|FG001|Overall Study|No treated|1|||
25331533|NCT00820170|50647877|FG000|Overall Study|Adverse Event|0|||
25331534|NCT00820170|50647878|FG001|Overall Study|Adverse Event|0|||
25331535|NCT00820170|50647879|FG002|Overall Study|Adverse Event|0|||
25331536|NCT00820170|50647880|FG003|Overall Study|Adverse Event|0|||
25331537|NCT00820170|50647881|FG004|Overall Study|Adverse Event|2|||
25331538|NCT00820170|50647877|FG000|Overall Study|Progressive Disease|0|||
24901002|NCT00697515|49994990|FG000|Dose Optimization Period|called to active duty|1|||
24901003|NCT00697515|49994991|FG001|Dose Optimization Period|called to active duty|0|||
24901004|NCT00697515|49994990|FG000|Dose Optimization Period|elevated QTc|1|||
24901005|NCT00697515|49994991|FG001|Dose Optimization Period|elevated QTc|0|||
24901006|NCT00697515|49994990|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
24901007|NCT00697515|49994991|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
24901008|NCT00697515|49994990|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
24901009|NCT00697515|49994991|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
25250072|NCT00476151|50565971|FG000|Overall Study|Adverse Event|0|||
25250073|NCT00476151|50565972|FG001|Overall Study|Adverse Event|2|||
25250074|NCT00476151|50565971|FG000|Overall Study|Protocol Violation|1|||
25250075|NCT00476151|50565972|FG001|Overall Study|Protocol Violation|3|||
25250076|NCT00476151|50565971|FG000|Overall Study|Withdrawal by Subject|2|||
25250077|NCT00476151|50565972|FG001|Overall Study|Withdrawal by Subject|0|||
25250078|NCT00476151|50565971|FG000|Overall Study|Physician Decision|0|||
25250079|NCT00476151|50565972|FG001|Overall Study|Physician Decision|2|||
25250080|NCT00475644|50565978|FG000|Overall Study|Protocol Violation|13|||
25250081|NCT00474903|50565985|FG000|Overall Study|Protocol Violation|1|||
25250082|NCT00474903|50565986|FG001|Overall Study|Protocol Violation|5|||
25250083|NCT00474903|50565987|FG002|Overall Study|Protocol Violation|2|||
25250084|NCT01134055|50566002|FG000|Overall Study|Adverse Event|5|||
25250085|NCT01134055|50566003|FG001|Overall Study|Adverse Event|2|||
25250086|NCT01134055|50566004|FG002|Overall Study|Adverse Event|2|||
25250087|NCT01134055|50566005|FG003|Overall Study|Adverse Event|2|||
25250088|NCT01134055|50566006|FG004|Overall Study|Adverse Event|5|||
25250089|NCT01134055|50566007|FG005|Overall Study|Adverse Event|7|||
25250090|NCT01134055|50566008|FG006|Overall Study|Adverse Event|2|||
25250091|NCT01134055|50566002|FG000|Overall Study|Lost to Follow-up|0|||
25250092|NCT01134055|50566003|FG001|Overall Study|Lost to Follow-up|1|||
25250093|NCT01134055|50566004|FG002|Overall Study|Lost to Follow-up|0|||
25250094|NCT01134055|50566005|FG003|Overall Study|Lost to Follow-up|1|||
25250095|NCT01134055|50566006|FG004|Overall Study|Lost to Follow-up|0|||
25250096|NCT01134055|50566007|FG005|Overall Study|Lost to Follow-up|0|||
25331539|NCT00820170|50647878|FG001|Overall Study|Progressive Disease|0|||
25331540|NCT00820170|50647879|FG002|Overall Study|Progressive Disease|0|||
25331541|NCT00820170|50647880|FG003|Overall Study|Progressive Disease|0|||
25250097|NCT01134055|50566008|FG006|Overall Study|Lost to Follow-up|0|||
25331542|NCT00820170|50647881|FG004|Overall Study|Progressive Disease|2|||
25331543|NCT00818454|50647898|FG000|Treatment Period 1|Adverse Event|0|||
25331544|NCT00818454|50647899|FG001|Treatment Period 1|Adverse Event|1|||
25331545|NCT00818454|50647900|FG002|Treatment Period 1|Adverse Event|0|||
25331546|NCT00818454|50647901|FG003|Treatment Period 1|Adverse Event|0|||
25250098|NCT01134055|50566002|FG000|Overall Study|Withdrawal by Subject|3|||
25250099|NCT01134055|50566003|FG001|Overall Study|Withdrawal by Subject|3|||
25250100|NCT01134055|50566004|FG002|Overall Study|Withdrawal by Subject|1|||
25250101|NCT01134055|50566005|FG003|Overall Study|Withdrawal by Subject|2|||
25250102|NCT01134055|50566006|FG004|Overall Study|Withdrawal by Subject|0|||
25250103|NCT01134055|50566007|FG005|Overall Study|Withdrawal by Subject|0|||
25250104|NCT01134055|50566008|FG006|Overall Study|Withdrawal by Subject|8|||
25250105|NCT01134055|50566002|FG000|Overall Study|Protocol Violation|0|||
25250106|NCT01134055|50566003|FG001|Overall Study|Protocol Violation|0|||
25250107|NCT01134055|50566004|FG002|Overall Study|Protocol Violation|0|||
25250108|NCT01134055|50566005|FG003|Overall Study|Protocol Violation|1|||
25250109|NCT01134055|50566006|FG004|Overall Study|Protocol Violation|1|||
25250110|NCT01134055|50566007|FG005|Overall Study|Protocol Violation|0|||
25250111|NCT01134055|50566008|FG006|Overall Study|Protocol Violation|0|||
25250112|NCT01134055|50566002|FG000|Overall Study|Physician Decision|0|||
25250113|NCT01134055|50566003|FG001|Overall Study|Physician Decision|0|||
25250114|NCT01134055|50566004|FG002|Overall Study|Physician Decision|0|||
25250115|NCT01134055|50566005|FG003|Overall Study|Physician Decision|0|||
25250116|NCT01134055|50566006|FG004|Overall Study|Physician Decision|0|||
25250117|NCT01134055|50566007|FG005|Overall Study|Physician Decision|0|||
25250118|NCT01134055|50566008|FG006|Overall Study|Physician Decision|1|||
25250119|NCT00474708|50566032|FG000|Overall Study|Lack of Efficacy|11|||
25250120|NCT00474708|50566033|FG001|Overall Study|Lack of Efficacy|5|||
25250121|NCT00474708|50566032|FG000|Overall Study|Suicide ideation/behavior|0|||
25250122|NCT00474708|50566033|FG001|Overall Study|Suicide ideation/behavior|1|||
25250123|NCT00474708|50566032|FG000|Overall Study|Withdrawal by Subject|7|||
25250124|NCT00474708|50566033|FG001|Overall Study|Withdrawal by Subject|0|||
25250125|NCT00474708|50566032|FG000|Overall Study|Lack of compliance|12|||
25250126|NCT00474708|50566033|FG001|Overall Study|Lack of compliance|4|||
25250127|NCT00474708|50566032|FG000|Overall Study|Lost to Follow-up|18|||
25250128|NCT00474708|50566033|FG001|Overall Study|Lost to Follow-up|9|||
25250129|NCT00474708|50566032|FG000|Overall Study|Physician Decision|9|||
25250130|NCT00474708|50566033|FG001|Overall Study|Physician Decision|6|||
25250131|NCT00474240|50566045|FG000|Overall Study|Withdrawal by Subject|1|||
25250132|NCT00474240|50566046|FG001|Overall Study|Withdrawal by Subject|1|||
25250133|NCT00474240|50566047|FG002|Overall Study|Withdrawal by Subject|0|||
25250134|NCT00474240|50566048|FG003|Overall Study|Withdrawal by Subject|2|||
25250135|NCT00474240|50566049|FG004|Overall Study|Withdrawal by Subject|3|||
25250136|NCT00474240|50566050|FG005|Overall Study|Withdrawal by Subject|1|||
25250137|NCT00474240|50566045|FG000|Overall Study|Adverse Event|0|||
25250138|NCT00474240|50566046|FG001|Overall Study|Adverse Event|0|||
25250139|NCT00474240|50566047|FG002|Overall Study|Adverse Event|9|||
25250140|NCT00474240|50566048|FG003|Overall Study|Adverse Event|14|||
25250141|NCT00474240|50566049|FG004|Overall Study|Adverse Event|5|||
25250142|NCT00474240|50566050|FG005|Overall Study|Adverse Event|16|||
25250143|NCT00474240|50566045|FG000|Overall Study|Removed due to lab value|0|||
25250144|NCT00474240|50566046|FG001|Overall Study|Removed due to lab value|0|||
25250145|NCT00474240|50566047|FG002|Overall Study|Removed due to lab value|0|||
25331547|NCT00818454|50647898|FG000|Treatment Period 1|Other|3|||
25331548|NCT00818454|50647899|FG001|Treatment Period 1|Other|0|||
25331549|NCT00818454|50647900|FG002|Treatment Period 1|Other|0|||
25331550|NCT00818454|50647901|FG003|Treatment Period 1|Other|0|||
25331551|NCT00818454|50647898|FG000|Washout Period of 1 Week|Adverse Event|1|||
25331552|NCT00818454|50647899|FG001|Washout Period of 1 Week|Adverse Event|1|||
25331553|NCT00818454|50647900|FG002|Washout Period of 1 Week|Adverse Event|0|||
25331554|NCT00818454|50647901|FG003|Washout Period of 1 Week|Adverse Event|0|||
25331555|NCT00818454|50647898|FG000|Washout Period of 1 Week|Protocol Violation|2|||
25331556|NCT00818454|50647899|FG001|Washout Period of 1 Week|Protocol Violation|0|||
25331557|NCT00818454|50647900|FG002|Washout Period of 1 Week|Protocol Violation|0|||
25331558|NCT00818454|50647901|FG003|Washout Period of 1 Week|Protocol Violation|0|||
25331559|NCT00818454|50647898|FG000|Washout Period of 1 Week|Other|1|||
25331560|NCT00818454|50647899|FG001|Washout Period of 1 Week|Other|2|||
25331561|NCT00818454|50647900|FG002|Washout Period of 1 Week|Other|0|||
24977308|NCT00376961|50065903|FG001|Maintenance|Adverse Event|1|||
24977309|NCT00376961|50065902|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
24977310|NCT00376961|50065903|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
24977311|NCT00376961|50065902|FG000|Maintenance|Progression/relapse|0|||
25250146|NCT00474240|50566048|FG003|Overall Study|Removed due to lab value|0|||
25250147|NCT00474240|50566049|FG004|Overall Study|Removed due to lab value|0|||
25250148|NCT00474240|50566050|FG005|Overall Study|Removed due to lab value|1|||
25250149|NCT00473889|50566066|FG000|Overall Study|Did not receive study medication|1|||
25250150|NCT00473889|50566067|FG001|Overall Study|Did not receive study medication|4|||
25250151|NCT00473889|50566066|FG000|Overall Study|Adverse Event|30|||
25250152|NCT00473889|50566067|FG001|Overall Study|Adverse Event|17|||
25250153|NCT00473889|50566066|FG000|Overall Study|Protocol Violation|4|||
25250154|NCT00473889|50566067|FG001|Overall Study|Protocol Violation|2|||
25250155|NCT00473889|50566066|FG000|Overall Study|Lack of Efficacy|28|||
25331562|NCT00818454|50647901|FG003|Washout Period of 1 Week|Other|0|||
25250156|NCT00473889|50566067|FG001|Overall Study|Lack of Efficacy|29|||
25250157|NCT00473889|50566066|FG000|Overall Study|Lost to Follow-up|2|||
25250158|NCT00473889|50566067|FG001|Overall Study|Lost to Follow-up|1|||
25250159|NCT00473889|50566066|FG000|Overall Study|Physician Decision|10|||
25331563|NCT00818454|50647898|FG000|Treatment Period 2|Other|2|||
25250160|NCT00473889|50566067|FG001|Overall Study|Physician Decision|5|||
25250161|NCT00473889|50566066|FG000|Overall Study|Trial Terminated|3|||
25331564|NCT00818454|50647899|FG001|Treatment Period 2|Other|1|||
25331565|NCT00818454|50647900|FG002|Treatment Period 2|Other|0|||
25331566|NCT00818454|50647901|FG003|Treatment Period 2|Other|0|||
25331567|NCT00818454|50647898|FG000|Treatment Period 3|Adverse Event|0|||
25331568|NCT00818454|50647899|FG001|Treatment Period 3|Adverse Event|0|||
25331569|NCT00818454|50647900|FG002|Treatment Period 3|Adverse Event|0|||
25331570|NCT00818454|50647901|FG003|Treatment Period 3|Adverse Event|1|||
25331571|NCT00828984|50647914|FG000|Overall Study|Adverse Event|2|||
25331572|NCT00828984|50647915|FG001|Overall Study|Adverse Event|3|||
25331573|NCT00828984|50647916|FG002|Overall Study|Adverse Event|0|||
25331574|NCT00828984|50647914|FG000|Overall Study|Lost to Follow-up|5|||
25331575|NCT00828984|50647915|FG001|Overall Study|Lost to Follow-up|3|||
25331576|NCT00828984|50647916|FG002|Overall Study|Lost to Follow-up|1|||
25331577|NCT00828984|50647914|FG000|Overall Study|Withdrawal by Subject|4|||
25331578|NCT00828984|50647915|FG001|Overall Study|Withdrawal by Subject|4|||
25331579|NCT00828984|50647916|FG002|Overall Study|Withdrawal by Subject|4|||
25331580|NCT00828984|50647914|FG000|Overall Study|Ineligable|1|||
25331581|NCT00828984|50647915|FG001|Overall Study|Ineligable|2|||
25331582|NCT00828984|50647916|FG002|Overall Study|Ineligable|0|||
25331583|NCT00828984|50647914|FG000|Overall Study|Medical Contraindication|0|||
25331584|NCT00828984|50647915|FG001|Overall Study|Medical Contraindication|1|||
25331585|NCT00828984|50647916|FG002|Overall Study|Medical Contraindication|0|||
25331586|NCT00828984|50647914|FG000|Overall Study|Noncompliant|1|||
25331587|NCT00828984|50647915|FG001|Overall Study|Noncompliant|2|||
25331588|NCT00828984|50647916|FG002|Overall Study|Noncompliant|3|||
25331589|NCT00828984|50647914|FG000|Overall Study|ConMed|1|||
25331590|NCT00828984|50647915|FG001|Overall Study|ConMed|1|||
25331591|NCT00828984|50647916|FG002|Overall Study|ConMed|1|||
25331592|NCT00828750|50647924|FG000|Overall Study|Lack of Efficacy|3|||
25331593|NCT00828750|50647924|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
25331594|NCT00667810|50647933|FG000|Overall Study|Adverse Event|13|||
25331595|NCT00667810|50647934|FG001|Overall Study|Adverse Event|14|||
25331596|NCT00667810|50647935|FG002|Overall Study|Adverse Event|19|||
25331597|NCT00667810|50647936|FG003|Overall Study|Adverse Event|1|||
25331598|NCT00667810|50647933|FG000|Overall Study|Death|1|||
25331599|NCT00667810|50647934|FG001|Overall Study|Death|1|||
25331600|NCT00667810|50647935|FG002|Overall Study|Death|3|||
25331601|NCT00667810|50647936|FG003|Overall Study|Death|0|||
25331602|NCT00667810|50647933|FG000|Overall Study|Lack of Efficacy|1|||
25331603|NCT00667810|50647934|FG001|Overall Study|Lack of Efficacy|0|||
25331604|NCT00667810|50647935|FG002|Overall Study|Lack of Efficacy|2|||
25331605|NCT00667810|50647936|FG003|Overall Study|Lack of Efficacy|0|||
25331606|NCT00667810|50647933|FG000|Overall Study|Lost to Follow-up|1|||
25331607|NCT00667810|50647934|FG001|Overall Study|Lost to Follow-up|4|||
25331608|NCT00667810|50647935|FG002|Overall Study|Lost to Follow-up|2|||
25331609|NCT00667810|50647936|FG003|Overall Study|Lost to Follow-up|0|||
25331610|NCT00667810|50647933|FG000|Overall Study|Physician Decision|1|||
25331611|NCT00667810|50647934|FG001|Overall Study|Physician Decision|1|||
25331612|NCT00667810|50647935|FG002|Overall Study|Physician Decision|2|||
25331613|NCT00667810|50647936|FG003|Overall Study|Physician Decision|0|||
25250162|NCT00473889|50566067|FG001|Overall Study|Trial Terminated|6|||
25250163|NCT00473889|50566066|FG000|Overall Study|Withdrawal by Subject|5|||
25250164|NCT00473889|50566067|FG001|Overall Study|Withdrawal by Subject|0|||
25250165|NCT00473694|50566077|FG000|Overall Study|Adverse Event|0|||
25250166|NCT00473694|50566078|FG001|Overall Study|Adverse Event|1|||
25250167|NCT00473694|50566079|FG002|Overall Study|Adverse Event|0|||
25250168|NCT00473694|50566080|FG003|Overall Study|Adverse Event|0|||
25250169|NCT00473694|50566077|FG000|Overall Study|Participants did not receive treatment|11|||
25250170|NCT00473694|50566078|FG001|Overall Study|Participants did not receive treatment|3|||
25250171|NCT00473694|50566079|FG002|Overall Study|Participants did not receive treatment|5|||
25250172|NCT00473694|50566080|FG003|Overall Study|Participants did not receive treatment|6|||
25250173|NCT00473694|50566077|FG000|Overall Study|Lost to Follow-up|0|||
25250174|NCT00473694|50566078|FG001|Overall Study|Lost to Follow-up|0|||
25250175|NCT00473694|50566079|FG002|Overall Study|Lost to Follow-up|0|||
25250176|NCT00473694|50566080|FG003|Overall Study|Lost to Follow-up|1|||
25250177|NCT00473655|50566096|FG000|Overall Study|Lost to Follow-up|9|||
25250178|NCT00473655|50566097|FG001|Overall Study|Lost to Follow-up|5|||
25250179|NCT00473655|50566098|FG002|Overall Study|Lost to Follow-up|8|||
25331614|NCT00667810|50647933|FG000|Overall Study|Protocol Violation|0|||
25331615|NCT00667810|50647934|FG001|Overall Study|Protocol Violation|2|||
25331616|NCT00667810|50647935|FG002|Overall Study|Protocol Violation|0|||
25331617|NCT00667810|50647936|FG003|Overall Study|Protocol Violation|0|||
25331618|NCT00667810|50647933|FG000|Overall Study|Withdrawal by Subject|14|||
25331619|NCT00667810|50647934|FG001|Overall Study|Withdrawal by Subject|20|||
25331620|NCT00667810|50647935|FG002|Overall Study|Withdrawal by Subject|29|||
25331621|NCT00667810|50647936|FG003|Overall Study|Withdrawal by Subject|1|||
25331622|NCT00667810|50647933|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
25331623|NCT00667810|50647934|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
25331624|NCT00667810|50647935|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
25331625|NCT00667810|50647936|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
25331626|NCT00667810|50647933|FG000|Overall Study|Failed to Return|0|||
25331627|NCT00667810|50647934|FG001|Overall Study|Failed to Return|0|||
25331628|NCT00667810|50647935|FG002|Overall Study|Failed to Return|2|||
25331629|NCT00667810|50647936|FG003|Overall Study|Failed to Return|0|||
25331630|NCT00667810|50647933|FG000|Overall Study|Loss of Caregiver|0|||
25331631|NCT00667810|50647934|FG001|Overall Study|Loss of Caregiver|1|||
25331632|NCT00667810|50647935|FG002|Overall Study|Loss of Caregiver|3|||
25331633|NCT00667810|50647936|FG003|Overall Study|Loss of Caregiver|0|||
25331634|NCT00667810|50647933|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
25331635|NCT00667810|50647934|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
25331636|NCT00667810|50647935|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
25331637|NCT00667810|50647936|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
25331638|NCT00667810|50647933|FG000|Overall Study|Other|6|||
25331639|NCT00667810|50647934|FG001|Overall Study|Other|6|||
25331640|NCT00667810|50647935|FG002|Overall Study|Other|5|||
25331641|NCT00667810|50647936|FG003|Overall Study|Other|0|||
25331642|NCT00819390|50647955|FG000|Overall Study|Lost to Follow-up|1|||
25331643|NCT00819390|50647956|FG001|Overall Study|Lost to Follow-up|1|||
25331644|NCT00819390|50647957|FG002|Overall Study|Lost to Follow-up|0|||
25331645|NCT00819390|50647958|FG003|Overall Study|Lost to Follow-up|0|||
25331646|NCT00819390|50647955|FG000|Overall Study|Withdrawal by Subject|2|||
25331647|NCT00819390|50647956|FG001|Overall Study|Withdrawal by Subject|0|||
25331648|NCT00819390|50647957|FG002|Overall Study|Withdrawal by Subject|0|||
25331649|NCT00819390|50647958|FG003|Overall Study|Withdrawal by Subject|0|||
25331650|NCT00819390|50647955|FG000|Overall Study|Adverse Event|0|||
25331651|NCT00819390|50647956|FG001|Overall Study|Adverse Event|0|||
25331652|NCT00819390|50647957|FG002|Overall Study|Adverse Event|1|||
25250180|NCT00473382|50566109|FG000|Core Study|Adverse Event|3|||
25250181|NCT00473382|50566110|FG001|Core Study|Adverse Event|1|||
25250182|NCT00473382|50566111|FG002|Core Study|Adverse Event|1|||
25250183|NCT00473382|50566109|FG000|Core Study|Death|3|||
25250184|NCT00473382|50566110|FG001|Core Study|Death|5|||
25250185|NCT00473382|50566111|FG002|Core Study|Death|10|||
25250186|NCT00473382|50566109|FG000|Core Study|Lost to Follow-up|3|||
25250187|NCT00473382|50566110|FG001|Core Study|Lost to Follow-up|3|||
25250188|NCT00473382|50566111|FG002|Core Study|Lost to Follow-up|3|||
25250189|NCT00473382|50566109|FG000|Core Study|Physician Decision|1|||
25250190|NCT00473382|50566110|FG001|Core Study|Physician Decision|2|||
25250191|NCT00473382|50566111|FG002|Core Study|Physician Decision|2|||
25250192|NCT00473382|50566109|FG000|Core Study|Subject non-compliance|5|||
25250193|NCT00473382|50566110|FG001|Core Study|Subject non-compliance|2|||
25250194|NCT00473382|50566111|FG002|Core Study|Subject non-compliance|1|||
25250195|NCT00473382|50566109|FG000|Core Study|Subject needed other treatment|1|||
25250196|NCT00473382|50566110|FG001|Core Study|Subject needed other treatment|3|||
25250197|NCT00473382|50566111|FG002|Core Study|Subject needed other treatment|2|||
25250198|NCT00473382|50566109|FG000|Core Study|Subject's decision|12|||
25250199|NCT00473382|50566110|FG001|Core Study|Subject's decision|11|||
25331653|NCT00819390|50647958|FG003|Overall Study|Adverse Event|0|||
25331654|NCT00876395|50647973|FG000|Overall Study|Untreated|8|||
25331655|NCT00876395|50647974|FG001|Overall Study|Untreated|1|||
25331656|NCT00876395|50647973|FG000|Overall Study|Adverse Event|63|||
25331657|NCT00876395|50647974|FG001|Overall Study|Adverse Event|11|||
25331658|NCT00876395|50647973|FG000|Overall Study|Abnormal test procedure result(s)|1|||
25331659|NCT00876395|50647974|FG001|Overall Study|Abnormal test procedure result(s)|0|||
24901010|NCT00697515|49994990|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
24901011|NCT00697515|49994991|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
24901012|NCT00697515|49994990|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
25250200|NCT00473382|50566111|FG002|Core Study|Subject's decision|10|||
24901013|NCT00697515|49994991|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
25250201|NCT00473382|50566109|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
25250202|NCT00473382|50566110|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
25250203|NCT00473382|50566111|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
25331660|NCT00876395|50647973|FG000|Overall Study|Disease progression|259|||
25331661|NCT00876395|50647974|FG001|Overall Study|Disease progression|162|||
25331662|NCT00876395|50647973|FG000|Overall Study|New cancer therapy|25|||
25250204|NCT00473382|50566109|FG000|Open-label Extension Through Month 48|Death|1|||
25250205|NCT00473382|50566110|FG001|Open-label Extension Through Month 48|Death|3|||
25250206|NCT00473382|50566111|FG002|Open-label Extension Through Month 48|Death|3|||
25250207|NCT00473382|50566109|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
25331663|NCT00876395|50647974|FG001|Overall Study|New cancer therapy|7|||
25331664|NCT00876395|50647973|FG000|Overall Study|Protocol Violation|5|||
25331665|NCT00876395|50647974|FG001|Overall Study|Protocol Violation|2|||
25331666|NCT00876395|50647973|FG000|Overall Study|Withdrawal by Subject|66|||
25331667|NCT00876395|50647974|FG001|Overall Study|Withdrawal by Subject|33|||
25331668|NCT00876395|50647973|FG000|Overall Study|Lost to Follow-up|2|||
25331669|NCT00876395|50647974|FG001|Overall Study|Lost to Follow-up|0|||
25250208|NCT00473382|50566110|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
25250209|NCT00473382|50566111|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
25250210|NCT00473382|50566109|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
25250211|NCT00473382|50566110|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
25250212|NCT00473382|50566111|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
25250213|NCT00473382|50566109|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
25250214|NCT00473382|50566110|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
25250215|NCT00473382|50566111|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
25250216|NCT00473382|50566109|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
25250217|NCT00473382|50566110|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
25250218|NCT00473382|50566111|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
25250219|NCT00473382|50566109|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
25331670|NCT00876395|50647973|FG000|Overall Study|Administrative problems|39|||
25331671|NCT00876395|50647974|FG001|Overall Study|Administrative problems|23|||
25331672|NCT00876395|50647973|FG000|Overall Study|Death|12|||
25331673|NCT00876395|50647974|FG001|Overall Study|Death|0|||
25331674|NCT00594659|50647988|FG000|Overall Study|Lost to Follow-up|13|||
25331675|NCT00594659|50647989|FG001|Overall Study|Lost to Follow-up|9|||
25331676|NCT00594659|50647990|FG002|Overall Study|Lost to Follow-up|7|||
25331677|NCT00667732|50648000|FG000|Run -In (8 Weeks)|Adverse Event|4|||
25331678|NCT00667732|50648001|FG001|Run -In (8 Weeks)|Adverse Event|0|||
25331679|NCT00667732|50648002|FG002|Run -In (8 Weeks)|Adverse Event|0|||
25331680|NCT00667732|50648000|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
25331681|NCT00667732|50648001|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
25331682|NCT00667732|50648002|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
25331683|NCT00667732|50648000|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
25331684|NCT00667732|50648001|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
25331685|NCT00667732|50648002|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
25331686|NCT00671788|50648012|FG000|Overall Study|Adverse Event|8|||
25331687|NCT00671788|50648012|FG000|Overall Study|Refused further treatment|3|||
25331688|NCT00671788|50648012|FG000|Overall Study|Ineligible|1|||
25331689|NCT00671788|50648012|FG000|Overall Study|MD Decision|1|||
25331690|NCT00671788|50648012|FG000|Overall Study|Other|1|||
25331691|NCT00875615|50648016|FG000|Overall Study|Withdrawal by Subject|1|||
25331692|NCT00597701|50648022|FG000|Overall Study|Withdrawal by Subject|5|||
25331693|NCT00597701|50648023|FG001|Overall Study|Withdrawal by Subject|5|||
25331694|NCT00597701|50648022|FG000|Overall Study|Death|0|||
25331695|NCT00597701|50648023|FG001|Overall Study|Death|1|||
25331696|NCT00597701|50648022|FG000|Overall Study|Physician Decision|2|||
25331697|NCT00597701|50648023|FG001|Overall Study|Physician Decision|0|||
25331698|NCT00597701|50648022|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
25331699|NCT00597701|50648023|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
25331700|NCT00671554|50648029|FG000|Overall Study|Disease progression|3|||
25331701|NCT00667576|50648039|FG000|Overall Study|Withdrawal by Subject|1|||
25331702|NCT00667576|50648040|FG001|Overall Study|Withdrawal by Subject|0|||
25331703|NCT00667576|50648041|FG002|Overall Study|Withdrawal by Subject|1|||
25331704|NCT00667576|50648042|FG003|Overall Study|Withdrawal by Subject|1|||
25331705|NCT00667576|50648043|FG004|Overall Study|Withdrawal by Subject|1|||
25250220|NCT00473382|50566110|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
25250221|NCT00473382|50566111|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
25250222|NCT00473382|50566109|FG000|Open-label Extension Through Month 60|Death|1|||
25250223|NCT00473382|50566110|FG001|Open-label Extension Through Month 60|Death|7|||
25250224|NCT00473382|50566111|FG002|Open-label Extension Through Month 60|Death|4|||
25250225|NCT00473382|50566109|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
25250226|NCT00473382|50566110|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
25250227|NCT00473382|50566111|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
25331706|NCT00667576|50648039|FG000|Overall Study|Adverse Event|1|||
25331707|NCT00667576|50648040|FG001|Overall Study|Adverse Event|1|||
25331708|NCT00667576|50648041|FG002|Overall Study|Adverse Event|0|||
25331709|NCT00667576|50648042|FG003|Overall Study|Adverse Event|0|||
25331710|NCT00667576|50648043|FG004|Overall Study|Adverse Event|0|||
25331711|NCT00667576|50648039|FG000|Overall Study|Lost to Follow-up|0|||
25331712|NCT00667576|50648040|FG001|Overall Study|Lost to Follow-up|0|||
25331713|NCT00667576|50648041|FG002|Overall Study|Lost to Follow-up|1|||
25331714|NCT00667576|50648042|FG003|Overall Study|Lost to Follow-up|0|||
25250228|NCT00473382|50566109|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
25250229|NCT00473382|50566110|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
25250230|NCT00473382|50566111|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
25250231|NCT00473382|50566109|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
25331715|NCT00667576|50648043|FG004|Overall Study|Lost to Follow-up|0|||
25331716|NCT00667576|50648039|FG000|Overall Study|Protocol Violation|0|||
25331717|NCT00667576|50648040|FG001|Overall Study|Protocol Violation|0|||
25331718|NCT00667576|50648041|FG002|Overall Study|Protocol Violation|0|||
25250232|NCT00473382|50566110|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
25250233|NCT00473382|50566111|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
25250234|NCT00473382|50566109|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
25250235|NCT00473382|50566110|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
25250236|NCT00473382|50566111|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
25250237|NCT00473265|50566137|FG000|Overall Study|Unrelated adverse event|5|||
25250238|NCT00473265|50566137|FG000|Overall Study|Off treatment early|15|||
25250239|NCT00472641|50566141|FG000|Overall Study|Lack of Efficacy|3|||
25250240|NCT00472641|50566141|FG000|Overall Study|Adverse Event|3|||
25250241|NCT00472641|50566141|FG000|Overall Study|Lost to Follow-up|1|||
25250242|NCT01133977|50566150|FG000|Overall Study|Adverse Event|0|||
25250243|NCT01133977|50566151|FG001|Overall Study|Adverse Event|0|||
25250244|NCT01133977|50566152|FG002|Overall Study|Adverse Event|1|||
25331719|NCT00667576|50648042|FG003|Overall Study|Protocol Violation|1|||
25331720|NCT00667576|50648043|FG004|Overall Study|Protocol Violation|0|||
25331721|NCT00667576|50648039|FG000|Overall Study|Physician Decision|0|||
25250245|NCT01133977|50566153|FG003|Overall Study|Adverse Event|0|||
25250246|NCT01133977|50566154|FG004|Overall Study|Adverse Event|0|||
25250247|NCT01133977|50566150|FG000|Overall Study|Death|1|||
25250248|NCT01133977|50566151|FG001|Overall Study|Death|1|||
25250249|NCT01133977|50566152|FG002|Overall Study|Death|1|||
25250250|NCT01133977|50566153|FG003|Overall Study|Death|7|||
25250251|NCT01133977|50566154|FG004|Overall Study|Death|3|||
25250252|NCT01133977|50566150|FG000|Overall Study|Started a New Line of Therapy|2|||
25250253|NCT01133977|50566151|FG001|Overall Study|Started a New Line of Therapy|6|||
24977312|NCT00376961|50065903|FG001|Maintenance|Progression/relapse|18|||
24977313|NCT00376961|50065902|FG000|Maintenance|Ineligible|0|||
24977314|NCT00376961|50065903|FG001|Maintenance|Ineligible|3|||
24977315|NCT03418324|50065913|FG000|Overall Study|Death|0|||
25077813|NCT03318523|50185663|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
25077814|NCT03318523|50185664|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
25077815|NCT03318523|50185665|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
24901014|NCT00738062|49995000|FG000|Open Label Treatment|Lack of Efficacy|5|||
24901015|NCT00738062|49995001|FG001|Open Label Treatment|Lack of Efficacy|0|||
24901016|NCT00738062|49995002|FG002|Open Label Treatment|Lack of Efficacy|0|||
24901017|NCT00738062|49995000|FG000|Open Label Treatment|Adverse Event|11|||
24901018|NCT00738062|49995001|FG001|Open Label Treatment|Adverse Event|0|||
25077816|NCT03318523|50185666|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
25077817|NCT03318523|50185667|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
25077818|NCT03318523|50185668|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
25077819|NCT03318523|50185669|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
25077820|NCT03318523|50185670|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
25077821|NCT03318523|50185671|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
25077822|NCT03318523|50185672|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
25077823|NCT03318523|50185663|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
25077824|NCT03318523|50185664|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
25077825|NCT03318523|50185665|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
25077826|NCT03318523|50185666|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
25077827|NCT03318523|50185667|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
25077828|NCT03318523|50185668|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
25077829|NCT03318523|50185669|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
25250254|NCT01133977|50566152|FG002|Overall Study|Started a New Line of Therapy|4|||
25250255|NCT01133977|50566153|FG003|Overall Study|Started a New Line of Therapy|25|||
25331722|NCT00667576|50648040|FG001|Overall Study|Physician Decision|0|||
24901019|NCT00738062|49995002|FG002|Open Label Treatment|Adverse Event|0|||
24901020|NCT00738062|49995000|FG000|Open Label Treatment|Protocol Violation|2|||
24901021|NCT00738062|49995001|FG001|Open Label Treatment|Protocol Violation|0|||
24901022|NCT00738062|49995002|FG002|Open Label Treatment|Protocol Violation|0|||
24901023|NCT00738062|49995000|FG000|Open Label Treatment|Withdrawal by Subject|9|||
24901024|NCT00738062|49995001|FG001|Open Label Treatment|Withdrawal by Subject|0|||
24901025|NCT00738062|49995002|FG002|Open Label Treatment|Withdrawal by Subject|0|||
24901026|NCT00738062|49995000|FG000|Open Label Treatment|Investigator Decision|1|||
24901027|NCT00738062|49995001|FG001|Open Label Treatment|Investigator Decision|0|||
24901028|NCT00738062|49995002|FG002|Open Label Treatment|Investigator Decision|0|||
24901029|NCT00738062|49995000|FG000|Open-Label Extension|Adverse Event|5|||
24901030|NCT00738062|49995001|FG001|Open-Label Extension|Adverse Event|0|||
24977316|NCT03418324|50065914|FG001|Overall Study|Death|1|||
25077830|NCT03318523|50185670|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
25250256|NCT01133977|50566154|FG004|Overall Study|Started a New Line of Therapy|33|||
25250257|NCT01133977|50566150|FG000|Overall Study|Lost to Follow-up|0|||
25250258|NCT01133977|50566151|FG001|Overall Study|Lost to Follow-up|0|||
25331723|NCT00667576|50648041|FG002|Overall Study|Physician Decision|0|||
25250259|NCT01133977|50566152|FG002|Overall Study|Lost to Follow-up|0|||
25250260|NCT01133977|50566153|FG003|Overall Study|Lost to Follow-up|2|||
25250261|NCT01133977|50566154|FG004|Overall Study|Lost to Follow-up|1|||
25250262|NCT01133977|50566150|FG000|Overall Study|Withdrawal by Subject|0|||
25250263|NCT01133977|50566151|FG001|Overall Study|Withdrawal by Subject|0|||
25250264|NCT01133977|50566152|FG002|Overall Study|Withdrawal by Subject|0|||
25250265|NCT01133977|50566153|FG003|Overall Study|Withdrawal by Subject|5|||
25250266|NCT01133977|50566154|FG004|Overall Study|Withdrawal by Subject|1|||
25250267|NCT01133821|50566171|FG000|Overall Study|Lost to Follow-up|8|||
25250268|NCT01133821|50566172|FG001|Overall Study|Lost to Follow-up|11|||
25250269|NCT01133821|50566171|FG000|Overall Study|Withdrawal by Subject|8|||
25250270|NCT01133821|50566172|FG001|Overall Study|Withdrawal by Subject|3|||
25250271|NCT01133821|50566171|FG000|Overall Study|preferred other treatment|1|||
25250272|NCT01133821|50566172|FG001|Overall Study|preferred other treatment|1|||
25250273|NCT01133821|50566171|FG000|Overall Study|Protocol Violation|0|||
25250274|NCT01133821|50566172|FG001|Overall Study|Protocol Violation|1|||
25250275|NCT01133821|50566171|FG000|Overall Study|Refused participation|1|||
25250276|NCT01133821|50566172|FG001|Overall Study|Refused participation|3|||
25250277|NCT00472446|50566182|FG000|Overall Study|Protocol Violation|0|||
25250278|NCT00472446|50566183|FG001|Overall Study|Protocol Violation|0|||
25250279|NCT00472446|50566184|FG002|Overall Study|Protocol Violation|0|||
25250280|NCT00472446|50566185|FG003|Overall Study|Protocol Violation|1|||
25250281|NCT00472446|50566182|FG000|Overall Study|Reintervention|0|||
25250282|NCT00472446|50566183|FG001|Overall Study|Reintervention|0|||
25250283|NCT00472446|50566184|FG002|Overall Study|Reintervention|1|||
25250284|NCT00472446|50566185|FG003|Overall Study|Reintervention|1|||
25250285|NCT00472446|50566182|FG000|Overall Study|Questionnaires not returned|5|||
25250286|NCT00472446|50566183|FG001|Overall Study|Questionnaires not returned|6|||
25250287|NCT00472446|50566184|FG002|Overall Study|Questionnaires not returned|6|||
25250288|NCT00472446|50566185|FG003|Overall Study|Questionnaires not returned|4|||
25250289|NCT00472290|50566195|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
25250290|NCT00472290|50566195|FG000|Overall Study|Protocol Specified Criteria|7|||
25250291|NCT00472290|50566195|FG000|Overall Study|Administrative Decision|37|||
25250292|NCT00472290|50566195|FG000|Overall Study|Death|3|||
25250293|NCT00472290|50566195|FG000|Overall Study|Lost to Follow-up|1|||
25250294|NCT00472290|50566195|FG000|Overall Study|Lack of Efficacy|1|||
25250295|NCT00472290|50566195|FG000|Overall Study|Disease Progression|4|||
25250296|NCT00472290|50566195|FG000|Overall Study|Withdrawal by Subject|5|||
25250297|NCT00472290|50566195|FG000|Overall Study|Adverse Event|6|||
25250298|NCT00472290|50566195|FG000|Overall Study|Requirement for alternative therapy|7|||
25250299|NCT01133704|50566201|FG000|Overall Study|Death|44|||
25250300|NCT01133704|50566202|FG001|Overall Study|Death|26|||
25250301|NCT01133704|50566201|FG000|Overall Study|Patient refused to continue|4|||
25250302|NCT01133704|50566202|FG001|Overall Study|Patient refused to continue|0|||
25250303|NCT01133704|50566201|FG000|Overall Study|Study Closure|1|||
25250304|NCT01133704|50566202|FG001|Overall Study|Study Closure|0|||
25250305|NCT01133665|50566208|FG000|Overall Study|Physician Decision|2|||
25250306|NCT01133626|50566215|FG000|Overall Study|Adverse Event|0|||
25250307|NCT01133626|50566216|FG001|Overall Study|Adverse Event|1|||
25250308|NCT01133626|50566217|FG002|Overall Study|Adverse Event|0|||
25250309|NCT01133626|50566215|FG000|Overall Study|Withdrawal by Subject|1|||
25250310|NCT01133626|50566216|FG001|Overall Study|Withdrawal by Subject|2|||
25250311|NCT01133626|50566217|FG002|Overall Study|Withdrawal by Subject|2|||
25250312|NCT01133626|50566215|FG000|Overall Study|Other|0|||
25250313|NCT01133626|50566216|FG001|Overall Study|Other|2|||
25250314|NCT01133626|50566217|FG002|Overall Study|Other|0|||
25250315|NCT01133392|50566227|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
25250316|NCT01133392|50566228|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
25331724|NCT00667576|50648042|FG003|Overall Study|Physician Decision|1|||
24977317|NCT03418324|50065913|FG000|Overall Study|Physician Decision|1|||
25250317|NCT01133392|50566227|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
25250318|NCT01133392|50566228|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
25250319|NCT00471354|50566234|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
25250320|NCT00471354|50566234|FG000|Overall Study|Adverse Event|13|||
24977318|NCT03418324|50065914|FG001|Overall Study|Physician Decision|1|||
25250321|NCT00471354|50566234|FG000|Overall Study|Protocol Violation|12|||
25250322|NCT00471354|50566234|FG000|Overall Study|Withdrawal by Subject|1|||
25250323|NCT00471354|50566234|FG000|Overall Study|Physician Decision|4|||
25250324|NCT00471354|50566234|FG000|Overall Study|Sponsor Decision|1|||
25250325|NCT00471354|50566234|FG000|Overall Study|Lost to Follow-up|3|||
25250326|NCT00471354|50566234|FG000|Overall Study|Lack of Efficacy|5|||
25250327|NCT00471354|50566234|FG000|Overall Study|Patient/Caregiver Decision|12|||
25250328|NCT00471315|50566238|FG000|Overall Study|Adverse Event|7|||
25250329|NCT00471315|50566238|FG000|Overall Study|Withdrawal by Subject|1|||
25250330|NCT00471237|50566249|FG000|Overall Study|Adverse Event|6|||
25250331|NCT00471237|50566250|FG001|Overall Study|Adverse Event|5|||
25250332|NCT00471237|50566251|FG002|Overall Study|Adverse Event|4|||
25250333|NCT00471237|50566252|FG003|Overall Study|Adverse Event|8|||
25250334|NCT00471237|50566253|FG004|Overall Study|Adverse Event|7|||
25250335|NCT00471237|50566254|FG005|Overall Study|Adverse Event|5|||
25250336|NCT00471237|50566255|FG006|Overall Study|Adverse Event|0|||
25250337|NCT00471237|50566249|FG000|Overall Study|Lost to Follow-up|1|||
25250338|NCT00471237|50566250|FG001|Overall Study|Lost to Follow-up|1|||
25250339|NCT00471237|50566251|FG002|Overall Study|Lost to Follow-up|0|||
25250340|NCT00471237|50566252|FG003|Overall Study|Lost to Follow-up|2|||
25250341|NCT00471237|50566253|FG004|Overall Study|Lost to Follow-up|3|||
25250342|NCT00471237|50566254|FG005|Overall Study|Lost to Follow-up|0|||
25250343|NCT00471237|50566255|FG006|Overall Study|Lost to Follow-up|0|||
25250344|NCT00471237|50566249|FG000|Overall Study|Protocol Violation|3|||
25250345|NCT00471237|50566250|FG001|Overall Study|Protocol Violation|6|||
25331725|NCT00667576|50648043|FG004|Overall Study|Physician Decision|0|||
25250346|NCT00471237|50566251|FG002|Overall Study|Protocol Violation|3|||
25250347|NCT00471237|50566252|FG003|Overall Study|Protocol Violation|2|||
25250348|NCT00471237|50566253|FG004|Overall Study|Protocol Violation|2|||
25250349|NCT00471237|50566254|FG005|Overall Study|Protocol Violation|4|||
25331726|NCT00667576|50648039|FG000|Overall Study|Missed Visit|0|||
25331727|NCT00667576|50648040|FG001|Overall Study|Missed Visit|0|||
25331728|NCT00667576|50648041|FG002|Overall Study|Missed Visit|0|||
25331729|NCT00667576|50648042|FG003|Overall Study|Missed Visit|1|||
25331730|NCT00667576|50648043|FG004|Overall Study|Missed Visit|0|||
25331731|NCT00666718|50648057|FG000|Overall Study|Adverse Event|0|||
25331732|NCT00666718|50648058|FG001|Overall Study|Adverse Event|1|||
25331733|NCT00666718|50648057|FG000|Overall Study|Death|1|||
25250350|NCT00471237|50566255|FG006|Overall Study|Protocol Violation|1|||
25250351|NCT00471237|50566249|FG000|Overall Study|Withdrawal by Subject|8|||
25250352|NCT00471237|50566250|FG001|Overall Study|Withdrawal by Subject|6|||
25250353|NCT00471237|50566251|FG002|Overall Study|Withdrawal by Subject|5|||
25250354|NCT00471237|50566252|FG003|Overall Study|Withdrawal by Subject|8|||
25250355|NCT00471237|50566253|FG004|Overall Study|Withdrawal by Subject|7|||
25250356|NCT00471237|50566254|FG005|Overall Study|Withdrawal by Subject|4|||
25250357|NCT00471237|50566255|FG006|Overall Study|Withdrawal by Subject|2|||
25250358|NCT00471237|50566249|FG000|Overall Study|Sponsor terminated study|20|||
25250359|NCT00471237|50566250|FG001|Overall Study|Sponsor terminated study|23|||
25250360|NCT00471237|50566251|FG002|Overall Study|Sponsor terminated study|19|||
25250361|NCT00471237|50566252|FG003|Overall Study|Sponsor terminated study|22|||
25250362|NCT00471237|50566253|FG004|Overall Study|Sponsor terminated study|18|||
25250363|NCT00471237|50566254|FG005|Overall Study|Sponsor terminated study|24|||
25250364|NCT00471237|50566255|FG006|Overall Study|Sponsor terminated study|0|||
25250365|NCT00471237|50566249|FG000|Overall Study|Non-compliance|0|||
25250366|NCT00471237|50566250|FG001|Overall Study|Non-compliance|1|||
25331734|NCT00666718|50648058|FG001|Overall Study|Death|0|||
25331735|NCT00666718|50648057|FG000|Overall Study|Lost to Follow-up|1|||
25331736|NCT00666718|50648058|FG001|Overall Study|Lost to Follow-up|0|||
25331737|NCT00666718|50648057|FG000|Overall Study|Entry Criteria Not Met|2|||
25331738|NCT00666718|50648058|FG001|Overall Study|Entry Criteria Not Met|0|||
25331739|NCT00666718|50648057|FG000|Overall Study|Protocol Violation|1|||
25331740|NCT00666718|50648058|FG001|Overall Study|Protocol Violation|3|||
25331741|NCT00666718|50648057|FG000|Overall Study|Withdrawal by Subject|7|||
25250367|NCT00471237|50566251|FG002|Overall Study|Non-compliance|0|||
25250368|NCT00471237|50566252|FG003|Overall Study|Non-compliance|1|||
25250369|NCT00471237|50566253|FG004|Overall Study|Non-compliance|0|||
25250370|NCT00471237|50566254|FG005|Overall Study|Non-compliance|0|||
25250371|NCT00471237|50566255|FG006|Overall Study|Non-compliance|0|||
25250372|NCT00471237|50566249|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
25250373|NCT00471237|50566250|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
25250374|NCT00471237|50566251|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
25250375|NCT00471237|50566252|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
25250376|NCT00471237|50566253|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
25250377|NCT00471237|50566254|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
25250378|NCT00471237|50566255|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
25250379|NCT00471237|50566249|FG000|Overall Study|Early stopping due to non-efficacy|1|||
25331742|NCT00666718|50648058|FG001|Overall Study|Withdrawal by Subject|12|||
25331743|NCT00666718|50648057|FG000|Overall Study|Physician Decision|0|||
25331744|NCT00666718|50648058|FG001|Overall Study|Physician Decision|2|||
25250380|NCT00471237|50566250|FG001|Overall Study|Early stopping due to non-efficacy|0|||
25250381|NCT00471237|50566251|FG002|Overall Study|Early stopping due to non-efficacy|0|||
25250382|NCT00471237|50566252|FG003|Overall Study|Early stopping due to non-efficacy|0|||
25250383|NCT00471237|50566253|FG004|Overall Study|Early stopping due to non-efficacy|1|||
25250384|NCT00471237|50566254|FG005|Overall Study|Early stopping due to non-efficacy|0|||
25250385|NCT00471237|50566255|FG006|Overall Study|Early stopping due to non-efficacy|0|||
25250386|NCT00471237|50566249|FG000|Overall Study|Participant planned to travel to abraod|1|||
25250387|NCT00471237|50566250|FG001|Overall Study|Participant planned to travel to abraod|0|||
25250388|NCT00471237|50566251|FG002|Overall Study|Participant planned to travel to abraod|0|||
25331745|NCT00667420|50648064|FG000|Overall Study|Adverse Event|2|||
25250389|NCT00471237|50566252|FG003|Overall Study|Participant planned to travel to abraod|0|||
25250390|NCT00471237|50566253|FG004|Overall Study|Participant planned to travel to abraod|0|||
25250391|NCT00471237|50566254|FG005|Overall Study|Participant planned to travel to abraod|1|||
25250392|NCT00471237|50566255|FG006|Overall Study|Participant planned to travel to abraod|0|||
25250393|NCT00471237|50566249|FG000|Overall Study|High parathyroid hormone|0|||
25250394|NCT00471237|50566250|FG001|Overall Study|High parathyroid hormone|0|||
25250395|NCT00471237|50566251|FG002|Overall Study|High parathyroid hormone|1|||
25250396|NCT00471237|50566252|FG003|Overall Study|High parathyroid hormone|0|||
25250397|NCT00471237|50566253|FG004|Overall Study|High parathyroid hormone|0|||
25250398|NCT00471237|50566254|FG005|Overall Study|High parathyroid hormone|0|||
25250399|NCT00471237|50566255|FG006|Overall Study|High parathyroid hormone|0|||
25250400|NCT00471237|50566249|FG000|Overall Study|Participant lost medication|0|||
25250401|NCT00471237|50566250|FG001|Overall Study|Participant lost medication|0|||
25250402|NCT00471237|50566251|FG002|Overall Study|Participant lost medication|0|||
25250403|NCT00471237|50566252|FG003|Overall Study|Participant lost medication|0|||
25250404|NCT00471237|50566253|FG004|Overall Study|Participant lost medication|1|||
25250405|NCT00471237|50566254|FG005|Overall Study|Participant lost medication|0|||
25250406|NCT00471237|50566255|FG006|Overall Study|Participant lost medication|0|||
25250407|NCT00471237|50566249|FG000|Overall Study|Administration of prohibited medicine|0|||
25250408|NCT00471237|50566250|FG001|Overall Study|Administration of prohibited medicine|0|||
25250409|NCT00471237|50566251|FG002|Overall Study|Administration of prohibited medicine|0|||
25250410|NCT00471237|50566252|FG003|Overall Study|Administration of prohibited medicine|0|||
25250411|NCT00471237|50566253|FG004|Overall Study|Administration of prohibited medicine|1|||
25250412|NCT00471237|50566254|FG005|Overall Study|Administration of prohibited medicine|0|||
25250413|NCT00471237|50566255|FG006|Overall Study|Administration of prohibited medicine|0|||
25250414|NCT00471237|50566249|FG000|Overall Study|Participant shifted residence|0|||
25250415|NCT00471237|50566250|FG001|Overall Study|Participant shifted residence|0|||
25250416|NCT00471237|50566251|FG002|Overall Study|Participant shifted residence|0|||
25250417|NCT00471237|50566252|FG003|Overall Study|Participant shifted residence|0|||
25250418|NCT00471237|50566253|FG004|Overall Study|Participant shifted residence|1|||
25250419|NCT00471237|50566254|FG005|Overall Study|Participant shifted residence|0|||
25250420|NCT00471237|50566255|FG006|Overall Study|Participant shifted residence|0|||
25250421|NCT00471237|50566249|FG000|Overall Study|Participant's decision|0|||
25331746|NCT00667420|50648064|FG000|Overall Study|Lack of Efficacy|5|||
25331747|NCT00667420|50648064|FG000|Overall Study|Physician Decision|1|||
25331748|NCT00667420|50648064|FG000|Overall Study|Withdrawal by Subject|2|||
25331749|NCT00853658|50648072|FG000|Overall Study|Death|713|||
25250422|NCT00471237|50566250|FG001|Overall Study|Participant's decision|0|||
25250423|NCT00471237|50566251|FG002|Overall Study|Participant's decision|0|||
25250424|NCT00471237|50566252|FG003|Overall Study|Participant's decision|0|||
25331750|NCT00853658|50648073|FG001|Overall Study|Death|768|||
25331751|NCT00853658|50648074|FG002|Overall Study|Death|753|||
25331752|NCT00853658|50648072|FG000|Overall Study|Lost to Follow-up|11|||
25331753|NCT00853658|50648073|FG001|Overall Study|Lost to Follow-up|6|||
25331754|NCT00853658|50648074|FG002|Overall Study|Lost to Follow-up|11|||
25331755|NCT00853658|50648072|FG000|Overall Study|H.A. Request|26|||
25331756|NCT00853658|50648073|FG001|Overall Study|H.A. Request|23|||
25331757|NCT00853658|50648074|FG002|Overall Study|H.A. Request|19|||
25331758|NCT00853658|50648072|FG000|Overall Study|IRB request|0|||
25331759|NCT00853658|50648073|FG001|Overall Study|IRB request|0|||
25331760|NCT00853658|50648074|FG002|Overall Study|IRB request|2|||
25331761|NCT00853658|50648072|FG000|Overall Study|Vital Status known (alive) at study end|2|||
25331762|NCT00853658|50648073|FG001|Overall Study|Vital Status known (alive) at study end|3|||
25331763|NCT00853658|50648074|FG002|Overall Study|Vital Status known (alive) at study end|3|||
25331764|NCT00853658|50648072|FG000|Overall Study|Vital Status unknown at study end|1|||
25331765|NCT00853658|50648073|FG001|Overall Study|Vital Status unknown at study end|1|||
25331766|NCT00853658|50648074|FG002|Overall Study|Vital Status unknown at study end|0|||
25331767|NCT00853658|50648072|FG000|Overall Study|Vital Status at study end N/A|8|||
25331768|NCT00853658|50648073|FG001|Overall Study|Vital Status at study end N/A|10|||
25331769|NCT00853658|50648074|FG002|Overall Study|Vital Status at study end N/A|10|||
25331770|NCT00853658|50648072|FG000|Overall Study|Patient's request|21|||
25331771|NCT00853658|50648073|FG001|Overall Study|Patient's request|17|||
25331772|NCT00853658|50648074|FG002|Overall Study|Patient's request|11|||
25331773|NCT00853658|50648072|FG000|Overall Study|Missing study completion information|5|||
25250425|NCT00471237|50566253|FG004|Overall Study|Participant's decision|0|||
25250426|NCT00471237|50566254|FG005|Overall Study|Participant's decision|1|||
25250427|NCT00471237|50566255|FG006|Overall Study|Participant's decision|0|||
25250428|NCT00471081|50566277|FG000|Active Phase|Protocol Violation|1|||
25250429|NCT00471081|50566278|FG001|Active Phase|Protocol Violation|1|||
25331774|NCT00853658|50648073|FG001|Overall Study|Missing study completion information|4|||
25331775|NCT00853658|50648074|FG002|Overall Study|Missing study completion information|6|||
25331776|NCT00666562|50648085|FG000|Overall Study|Withdrawal by Subject|0|||
25331777|NCT00666562|50648086|FG001|Overall Study|Withdrawal by Subject|1|||
25331778|NCT00666562|50648087|FG002|Overall Study|Withdrawal by Subject|0|||
25250430|NCT00471081|50566277|FG000|Active Phase|Withdrawal by Subject|0|||
25331779|NCT00666562|50648085|FG000|Overall Study|Concomitant Medication|0|||
25331780|NCT00666562|50648086|FG001|Overall Study|Concomitant Medication|1|||
25331781|NCT00666562|50648087|FG002|Overall Study|Concomitant Medication|0|||
25331782|NCT00666328|50648102|FG000|Overall Study|Death|2|||
25331783|NCT00666328|50648102|FG000|Overall Study|Lost to Follow-up|2|||
25331784|NCT00666328|50648102|FG000|Overall Study|No longer met eligibility criteria|1|||
25331785|NCT00853580|50648110|FG000|Overall Study|Lost to Follow-up|3|||
25331786|NCT00853580|50648111|FG001|Overall Study|Lost to Follow-up|5|||
25331787|NCT00853580|50648110|FG000|Overall Study|Protocol Violation|2|||
25331788|NCT00853580|50648111|FG001|Overall Study|Protocol Violation|1|||
25331789|NCT00853580|50648110|FG000|Overall Study|Withdrawal by Subject|2|||
25331790|NCT00853580|50648111|FG001|Overall Study|Withdrawal by Subject|8|||
25331791|NCT00853580|50648110|FG000|Overall Study|Commenced contraindicated therapy|0|||
25331792|NCT00853580|50648111|FG001|Overall Study|Commenced contraindicated therapy|2|||
25331793|NCT00865514|50648117|FG000|Overall Study|Infusion cost exceeded funding|2|||
25331794|NCT00865280|50648124|FG000|Overall Study|Withdrawal by Subject|4|||
25331795|NCT00865280|50648125|FG001|Overall Study|Withdrawal by Subject|1|||
25331796|NCT00865280|50648124|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
25331797|NCT00865280|50648125|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
25331798|NCT00865280|50648124|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
25331799|NCT00865280|50648125|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
25331800|NCT00865280|50648124|FG000|Overall Study|Exclusion Condition|1|||
25331801|NCT00865280|50648125|FG001|Overall Study|Exclusion Condition|0|||
25331802|NCT00865280|50648124|FG000|Overall Study|Adverse Event|0|||
25250431|NCT00471081|50566278|FG001|Active Phase|Withdrawal by Subject|3|||
25250432|NCT00471081|50566277|FG000|Active Phase|Lost to Follow-up|0|||
25250433|NCT00471081|50566278|FG001|Active Phase|Lost to Follow-up|1|||
25250434|NCT00471081|50566277|FG000|Active Phase|Lost health plan/insurance|1|||
25250435|NCT00471081|50566278|FG001|Active Phase|Lost health plan/insurance|8|||
25250436|NCT00471081|50566277|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
25250437|NCT00471081|50566278|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
25250438|NCT00471081|50566277|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
25250439|NCT00471081|50566278|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
25250440|NCT00471081|50566277|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
25250441|NCT00471081|50566278|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
25250442|NCT00470847|50566285|FG000|Overall Study|Pt still receiving treatment|1|||
25250443|NCT00470535|50566291|FG000|Overall Study|Disease Progression|13|||
25250444|NCT00470535|50566291|FG000|Overall Study|Withdrawal by Subject|1|||
25250445|NCT00470535|50566291|FG000|Overall Study|Adverse Event|1|||
25250446|NCT00470535|50566291|FG000|Overall Study|Death|1|||
25250447|NCT00470535|50566291|FG000|Overall Study|Other|2|||
25250448|NCT00470418|50566297|FG000|Overall Study|Withdrawal by Subject|1|||
25250449|NCT00470418|50566298|FG001|Overall Study|Withdrawal by Subject|0|||
25250450|NCT01133275|50566304|FG000|Overall Study|Withdrawal by Subject|1|||
25250451|NCT01133275|50566304|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
25250452|NCT00470184|50566308|FG000|Overall Study|Not Treated(became ineligible)|4|||
25250453|NCT00470184|50566308|FG000|Overall Study|Not treated (other)|1|||
25250454|NCT00470184|50566308|FG000|Overall Study|disease Progression|4|||
25250455|NCT00470184|50566308|FG000|Overall Study|Adverse Event|3|||
25250456|NCT00470184|50566308|FG000|Overall Study|Withdrawal by Subject|4|||
25250457|NCT00470184|50566308|FG000|Overall Study|other|5|||
25250458|NCT00470184|50566308|FG000|Overall Study|recurrence|1|||
25250459|NCT00470067|50566313|FG000|Overall Study|Death|1|||
25250460|NCT00470067|50566313|FG000|Overall Study|Disease Progression|6|||
25250461|NCT00475020|50566317|FG000|Overall Study|Physician Decision|3|||
25250462|NCT00475020|50566317|FG000|Overall Study|Insurance Denial|1|||
25250463|NCT00475020|50566317|FG000|Overall Study|Donor not able to donate the last minute|1|||
25250464|NCT02484456|50566323|FG000|Washout Period|Withdrawal by Subject|0|||
25250465|NCT02484456|50566324|FG001|Washout Period|Withdrawal by Subject|1|||
25250466|NCT02484456|50566323|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
25250467|NCT02484456|50566324|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
25331803|NCT00865280|50648125|FG001|Overall Study|Adverse Event|1|||
25331804|NCT00865124|50648134|FG000|Overall Study|Physician Decision|2|||
25250468|NCT02484456|50566323|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
25250469|NCT02484456|50566324|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
25250470|NCT02484456|50566323|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
25250471|NCT02484456|50566324|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
25250472|NCT01132807|50566331|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
25331805|NCT00865124|50648135|FG001|Overall Study|Physician Decision|1|||
25331806|NCT00865124|50648136|FG002|Overall Study|Physician Decision|0|||
25331807|NCT00865124|50648134|FG000|Overall Study|Withdrawn consent|2|||
25331808|NCT00865124|50648135|FG001|Overall Study|Withdrawn consent|0|||
25250473|NCT01132807|50566332|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
25250474|NCT01132807|50566333|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
25331809|NCT00865124|50648136|FG002|Overall Study|Withdrawn consent|0|||
25331810|NCT00871715|50648147|FG000|Overall Study|Withdrawal by Subject|6|||
25331811|NCT00871715|50648148|FG001|Overall Study|Withdrawal by Subject|10|||
25331812|NCT00871715|50648149|FG002|Overall Study|Withdrawal by Subject|15|||
25331813|NCT00871715|50648147|FG000|Overall Study|Physician Decision|6|||
25331814|NCT00871715|50648148|FG001|Overall Study|Physician Decision|0|||
25250475|NCT01132807|50566331|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
25250476|NCT01132807|50566332|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
25250477|NCT01132807|50566333|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
25250478|NCT01132651|50566343|FG000|Overall Study|Lost to Follow-up|1|||
25250479|NCT01132651|50566344|FG001|Overall Study|Lost to Follow-up|1|||
25250480|NCT01089543|50566354|FG000|Overall Study|Withdrawal by Subject|2|||
25250481|NCT01089543|50566355|FG001|Overall Study|Withdrawal by Subject|3|||
25250482|NCT01089543|50566356|FG002|Overall Study|Withdrawal by Subject|3|||
25250483|NCT01089543|50566357|FG003|Overall Study|Withdrawal by Subject|1|||
25250484|NCT01089543|50566354|FG000|Overall Study|Physician Decision|1|||
25250485|NCT01089543|50566355|FG001|Overall Study|Physician Decision|0|||
25250486|NCT01089543|50566356|FG002|Overall Study|Physician Decision|0|||
25250487|NCT01089543|50566357|FG003|Overall Study|Physician Decision|1|||
25250488|NCT01089543|50566354|FG000|Overall Study|Adverse Event|0|||
25250489|NCT01089543|50566355|FG001|Overall Study|Adverse Event|1|||
25250490|NCT01089543|50566356|FG002|Overall Study|Adverse Event|0|||
25250491|NCT01089543|50566357|FG003|Overall Study|Adverse Event|0|||
25250492|NCT01089504|50566369|FG000|Overall Study|Lost to Follow-up|1|||
25250493|NCT01089504|50566370|FG001|Overall Study|Lost to Follow-up|1|||
25250494|NCT01089504|50566369|FG000|Overall Study|Withdrawal by Subject|2|||
25250495|NCT01089504|50566370|FG001|Overall Study|Withdrawal by Subject|0|||
25250496|NCT01088997|50566378|FG000|Overall Study|Physician Decision|1|||
25250497|NCT01088997|50566379|FG001|Overall Study|Physician Decision|1|||
25250498|NCT01088997|50566378|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
25250499|NCT01088997|50566379|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
25331815|NCT00871715|50648149|FG002|Overall Study|Physician Decision|2|||
25331816|NCT00871715|50648147|FG000|Overall Study|Lost to Follow-up|3|||
25331817|NCT00871715|50648148|FG001|Overall Study|Lost to Follow-up|6|||
25331818|NCT00871715|50648149|FG002|Overall Study|Lost to Follow-up|9|||
25331819|NCT00819234|50648158|FG000|Overall Study|Withdrawal by Subject|8|||
25331820|NCT00819234|50648159|FG001|Overall Study|Withdrawal by Subject|13|||
24901031|NCT00738062|49995002|FG002|Open-Label Extension|Adverse Event|0|||
24901032|NCT00738062|49995000|FG000|Open-Label Extension|Physician Decision|1|||
24901033|NCT00738062|49995001|FG001|Open-Label Extension|Physician Decision|0|||
24901034|NCT00738062|49995002|FG002|Open-Label Extension|Physician Decision|0|||
24901035|NCT00738062|49995000|FG000|Open-Label Extension|Lack of Efficacy|2|||
24901036|NCT00738062|49995001|FG001|Open-Label Extension|Lack of Efficacy|0|||
24901037|NCT00738062|49995002|FG002|Open-Label Extension|Lack of Efficacy|0|||
24901038|NCT00738062|49995000|FG000|Open-Label Extension|Withdrawal by Subject|6|||
24901039|NCT00738062|49995001|FG001|Open-Label Extension|Withdrawal by Subject|0|||
24901040|NCT00738062|49995002|FG002|Open-Label Extension|Withdrawal by Subject|0|||
24901041|NCT00738062|49995000|FG000|Open-Label Extension|Protocol Violation|1|||
24901042|NCT00738062|49995001|FG001|Open-Label Extension|Protocol Violation|0|||
24901043|NCT00738062|49995002|FG002|Open-Label Extension|Protocol Violation|0|||
24901044|NCT00738062|49995000|FG000|Open-Label Extension|Study Terminated|2|||
24901045|NCT00738062|49995001|FG001|Open-Label Extension|Study Terminated|0|||
24901046|NCT00738062|49995002|FG002|Open-Label Extension|Study Terminated|0|||
24901047|NCT04245345|49995011|FG000|Overall Study|Death|1|||
24901048|NCT04245345|49995011|FG000|Overall Study|Exited prior to implant|5|||
24901049|NCT04245345|49995011|FG000|Overall Study|Exited prior to 1-month|9|||
24901050|NCT04245345|49995011|FG000|Overall Study|Missed 1-month visit|3|||
24901051|NCT04245345|49995011|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
24901052|NCT04245345|49995011|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
24901053|NCT00698685|49995017|FG000|Overall Study|Sister withdrew as donor|1|||
24901054|NCT00698685|49995017|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
24901055|NCT00737672|49995023|FG000|Overall Study|Graft Abandonment|48|||
24901056|NCT00737672|49995024|FG001|Overall Study|Graft Abandonment|56|||
24901057|NCT00737672|49995023|FG000|Overall Study|Death|23|||
24901058|NCT00737672|49995024|FG001|Overall Study|Death|22|||
25331821|NCT00819234|50648160|FG002|Overall Study|Withdrawal by Subject|6|||
25331822|NCT00819234|50648161|FG003|Overall Study|Withdrawal by Subject|3|||
25331823|NCT00819234|50648162|FG004|Overall Study|Withdrawal by Subject|0|||
24901059|NCT00737672|49995023|FG000|Overall Study|Withdrawal by Subject|1|||
24901060|NCT00737672|49995024|FG001|Overall Study|Withdrawal by Subject|2|||
24901061|NCT00737672|49995023|FG000|Overall Study|Lost to Follow-up|1|||
25250500|NCT01088997|50566378|FG000|Overall Study|Excluded prior to receiving drug|1|||
25250501|NCT01088997|50566379|FG001|Overall Study|Excluded prior to receiving drug|1|||
24901062|NCT00737672|49995024|FG001|Overall Study|Lost to Follow-up|0|||
25250502|NCT01088529|50566390|FG000|Overall Study|Did not receive study treatment|0|||
25250503|NCT01088529|50566391|FG001|Overall Study|Did not receive study treatment|1|||
25250504|NCT01087944|50566397|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
25250505|NCT01087944|50566398|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
25250506|NCT01087944|50566397|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
25250507|NCT01087944|50566398|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
25250508|NCT01132612|50566407|FG000|Overall Study|Death|0|||
25250509|NCT01132612|50566408|FG001|Overall Study|Death|0|||
25250510|NCT01132612|50566409|FG002|Overall Study|Death|1|||
25250511|NCT01132612|50566407|FG000|Overall Study|Protocol deviation|0|||
25250512|NCT01132612|50566408|FG001|Overall Study|Protocol deviation|0|||
25250513|NCT01132612|50566409|FG002|Overall Study|Protocol deviation|3|||
25331824|NCT00819234|50648163|FG005|Overall Study|Withdrawal by Subject|4|||
25331825|NCT00819234|50648164|FG006|Overall Study|Withdrawal by Subject|4|||
25331826|NCT00819234|50648165|FG007|Overall Study|Withdrawal by Subject|8|||
25331827|NCT00819234|50648166|FG008|Overall Study|Withdrawal by Subject|5|||
25331828|NCT00819234|50648167|FG009|Overall Study|Withdrawal by Subject|3|||
25331829|NCT00819234|50648158|FG000|Overall Study|Adverse Event|0|||
25331830|NCT00819234|50648159|FG001|Overall Study|Adverse Event|0|||
25331831|NCT00819234|50648160|FG002|Overall Study|Adverse Event|1|||
25331832|NCT00819234|50648161|FG003|Overall Study|Adverse Event|0|||
25331833|NCT00819234|50648162|FG004|Overall Study|Adverse Event|0|||
25331834|NCT00819234|50648163|FG005|Overall Study|Adverse Event|2|||
25331835|NCT00819234|50648164|FG006|Overall Study|Adverse Event|0|||
25331836|NCT00819234|50648165|FG007|Overall Study|Adverse Event|0|||
25331837|NCT00819234|50648166|FG008|Overall Study|Adverse Event|0|||
25331838|NCT00819234|50648167|FG009|Overall Study|Adverse Event|0|||
25331839|NCT00819234|50648158|FG000|Overall Study|Physician Decision|0|||
25331840|NCT00819234|50648159|FG001|Overall Study|Physician Decision|0|||
25331841|NCT00819234|50648160|FG002|Overall Study|Physician Decision|0|||
25331842|NCT00819234|50648161|FG003|Overall Study|Physician Decision|1|||
25331843|NCT00819234|50648162|FG004|Overall Study|Physician Decision|0|||
25331844|NCT00819234|50648163|FG005|Overall Study|Physician Decision|0|||
25331845|NCT00819234|50648164|FG006|Overall Study|Physician Decision|0|||
25331846|NCT00819234|50648165|FG007|Overall Study|Physician Decision|0|||
25331847|NCT00819234|50648166|FG008|Overall Study|Physician Decision|0|||
25331848|NCT00819234|50648167|FG009|Overall Study|Physician Decision|2|||
25331849|NCT00819234|50648158|FG000|Overall Study|Protocol Violation|0|||
25331850|NCT00819234|50648159|FG001|Overall Study|Protocol Violation|0|||
25331851|NCT00819234|50648160|FG002|Overall Study|Protocol Violation|1|||
25331852|NCT00819234|50648161|FG003|Overall Study|Protocol Violation|0|||
25331853|NCT00819234|50648162|FG004|Overall Study|Protocol Violation|0|||
25331854|NCT00819234|50648163|FG005|Overall Study|Protocol Violation|0|||
25250514|NCT01132612|50566407|FG000|Overall Study|Lost to Follow-up|2|||
25331855|NCT00819234|50648164|FG006|Overall Study|Protocol Violation|0|||
25331856|NCT00819234|50648165|FG007|Overall Study|Protocol Violation|0|||
25331857|NCT00819234|50648166|FG008|Overall Study|Protocol Violation|0|||
25331858|NCT00819234|50648167|FG009|Overall Study|Protocol Violation|0|||
25331859|NCT00819234|50648158|FG000|Overall Study|Lost to Follow-up|2|||
25331860|NCT00819234|50648159|FG001|Overall Study|Lost to Follow-up|2|||
25250515|NCT01132612|50566408|FG001|Overall Study|Lost to Follow-up|2|||
25250516|NCT01132612|50566409|FG002|Overall Study|Lost to Follow-up|7|||
25331861|NCT00819234|50648160|FG002|Overall Study|Lost to Follow-up|0|||
25331862|NCT00819234|50648161|FG003|Overall Study|Lost to Follow-up|2|||
25331863|NCT00819234|50648162|FG004|Overall Study|Lost to Follow-up|1|||
25331864|NCT00819234|50648163|FG005|Overall Study|Lost to Follow-up|1|||
25331865|NCT00819234|50648164|FG006|Overall Study|Lost to Follow-up|1|||
25331866|NCT00819234|50648165|FG007|Overall Study|Lost to Follow-up|1|||
25331867|NCT00819234|50648166|FG008|Overall Study|Lost to Follow-up|1|||
25331868|NCT00819234|50648167|FG009|Overall Study|Lost to Follow-up|2|||
25331869|NCT00667342|50648225|FG000|Overall Study|Protocol Violation|1|||
25331870|NCT00667342|50648226|FG001|Overall Study|Protocol Violation|0|||
25331871|NCT00667342|50648227|FG002|Overall Study|Protocol Violation|0|||
25331872|NCT00667342|50648225|FG000|Overall Study|Withdrawal by Subject|1|||
25331873|NCT00667342|50648226|FG001|Overall Study|Withdrawal by Subject|0|||
25331874|NCT00667342|50648227|FG002|Overall Study|Withdrawal by Subject|0|||
25331875|NCT00667342|50648225|FG000|Overall Study|Physician Decision|3|||
25331876|NCT00667342|50648226|FG001|Overall Study|Physician Decision|0|||
25250517|NCT01132612|50566407|FG000|Overall Study|Adverse Event|5|||
25250518|NCT01132612|50566408|FG001|Overall Study|Adverse Event|2|||
25250519|NCT01132612|50566409|FG002|Overall Study|Adverse Event|15|||
25250520|NCT01132612|50566407|FG000|Overall Study|Withdrawal by Subject|5|||
25331877|NCT00667342|50648227|FG002|Overall Study|Physician Decision|0|||
25331878|NCT00667342|50648225|FG000|Overall Study|Relapse or tumor progression|9|||
25331879|NCT00667342|50648226|FG001|Overall Study|Relapse or tumor progression|0|||
25331880|NCT00667342|50648227|FG002|Overall Study|Relapse or tumor progression|7|||
25331881|NCT00667342|50648225|FG000|Overall Study|Adverse Event|0|||
25331882|NCT00667342|50648226|FG001|Overall Study|Adverse Event|0|||
25250521|NCT01132612|50566408|FG001|Overall Study|Withdrawal by Subject|8|||
25250522|NCT01132612|50566409|FG002|Overall Study|Withdrawal by Subject|19|||
25250523|NCT01132612|50566407|FG000|Overall Study|Administrative problems|5|||
25331883|NCT00667342|50648227|FG002|Overall Study|Adverse Event|1|||
25331884|NCT00667342|50648225|FG000|Overall Study|Ineligible|0|||
25331885|NCT00667342|50648226|FG001|Overall Study|Ineligible|0|||
25331886|NCT00667342|50648227|FG002|Overall Study|Ineligible|1|||
25331887|NCT00871403|50648244|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
25331888|NCT00871403|50648245|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
25331889|NCT00871403|50648246|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
25331890|NCT00871403|50648244|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
25331891|NCT00871403|50648245|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
25331892|NCT00871403|50648246|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
25331893|NCT00871403|50648244|FG000|Combination Treatment Phase|Adverse Event|0|||
25331894|NCT00871403|50648245|FG001|Combination Treatment Phase|Adverse Event|17|||
25331895|NCT00871403|50648246|FG002|Combination Treatment Phase|Adverse Event|2|||
25331896|NCT00871403|50648244|FG000|Combination Treatment Phase|Disease Progression|0|||
25331897|NCT00871403|50648245|FG001|Combination Treatment Phase|Disease Progression|8|||
25250524|NCT01132612|50566408|FG001|Overall Study|Administrative problems|1|||
25250525|NCT01132612|50566409|FG002|Overall Study|Administrative problems|52|||
25331898|NCT00871403|50648246|FG002|Combination Treatment Phase|Disease Progression|5|||
25331899|NCT00871403|50648244|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
25331900|NCT00871403|50648245|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
25331901|NCT00871403|50648246|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
25331902|NCT00871403|50648244|FG000|Combination Treatment Phase|Physician Decision|0|||
25331903|NCT00871403|50648245|FG001|Combination Treatment Phase|Physician Decision|1|||
25250526|NCT01132612|50566407|FG000|Overall Study|Lack of Efficacy|23|||
25250527|NCT01132612|50566408|FG001|Overall Study|Lack of Efficacy|22|||
25250528|NCT01132612|50566409|FG002|Overall Study|Lack of Efficacy|73|||
25250529|NCT01132495|50566421|FG000|Overall Study|Various reasons|40|||
25250530|NCT01132495|50566422|FG001|Overall Study|Various reasons|38|||
25250531|NCT01132495|50566423|FG002|Overall Study|Various reasons|20|||
25250532|NCT01132495|50566424|FG003|Overall Study|Various reasons|12|||
25331904|NCT00871403|50648246|FG002|Combination Treatment Phase|Physician Decision|3|||
25331905|NCT00871403|50648244|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
25250533|NCT01087905|50566443|FG000|Overall Study|Lost to Follow-up|24|||
25250534|NCT01087905|50566444|FG001|Overall Study|Lost to Follow-up|28|||
25250535|NCT01087905|50566445|FG002|Overall Study|Lost to Follow-up|18|||
25250536|NCT01087905|50566446|FG003|Overall Study|Lost to Follow-up|31|||
25250537|NCT01087905|50566447|FG004|Overall Study|Lost to Follow-up|27|||
25250538|NCT01087905|50566448|FG005|Overall Study|Lost to Follow-up|25|||
25250539|NCT01087905|50566449|FG006|Overall Study|Lost to Follow-up|20|||
25250540|NCT01087905|50566450|FG007|Overall Study|Lost to Follow-up|24|||
25250541|NCT01087905|50566443|FG000|Overall Study|Withdrawal by Subject|5|||
25250542|NCT01087905|50566444|FG001|Overall Study|Withdrawal by Subject|4|||
25250543|NCT01087905|50566445|FG002|Overall Study|Withdrawal by Subject|4|||
25250544|NCT01087905|50566446|FG003|Overall Study|Withdrawal by Subject|5|||
25331906|NCT00871403|50648245|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
25331907|NCT00871403|50648246|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
25331908|NCT00871403|50648244|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
25331909|NCT00871403|50648245|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
25331910|NCT00871403|50648246|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
25331911|NCT00853112|50648260|FG000|Overall Study|Randomized but not treated|0|||
25331912|NCT00853112|50648261|FG001|Overall Study|Randomized but not treated|1|||
25331913|NCT00853112|50648262|FG002|Overall Study|Randomized but not treated|0|||
25331914|NCT00853112|50648263|FG003|Overall Study|Randomized but not treated|2|||
25331915|NCT00853112|50648264|FG004|Overall Study|Randomized but not treated|0|||
25331916|NCT00853112|50648265|FG005|Overall Study|Randomized but not treated|0|||
25331917|NCT00853112|50648266|FG006|Overall Study|Randomized but not treated|1|||
25331918|NCT00460603|50648294|FG000|Phase 1|Death|1|||
25331919|NCT00460603|50648295|FG001|Phase 1|Death|0|||
25331920|NCT00460603|50648296|FG002|Phase 1|Death|0|||
25331921|NCT00460603|50648297|FG003|Phase 1|Death|2|||
25331922|NCT00460603|50648298|FG004|Phase 1|Death|0|||
25331923|NCT00460603|50648299|FG005|Phase 1|Death|0|||
25331924|NCT00460603|50648300|FG006|Phase 1|Death|0|||
25331925|NCT00460603|50648301|FG007|Phase 1|Death|0|||
25331926|NCT00460603|50648302|FG008|Phase 1|Death|1|||
25331927|NCT00460603|50648303|FG009|Phase 1|Death|0|||
25331928|NCT00460603|50648304|FG010|Phase 1|Death|0|||
25331929|NCT00460603|50648305|FG011|Phase 1|Death|0|||
25250545|NCT01087905|50566447|FG004|Overall Study|Withdrawal by Subject|4|||
25331930|NCT00460603|50648294|FG000|Phase 1|Adverse Event|3|||
25331931|NCT00460603|50648295|FG001|Phase 1|Adverse Event|1|||
25250546|NCT01087905|50566448|FG005|Overall Study|Withdrawal by Subject|3|||
25250547|NCT01087905|50566449|FG006|Overall Study|Withdrawal by Subject|3|||
25250548|NCT01087905|50566450|FG007|Overall Study|Withdrawal by Subject|5|||
25250549|NCT01087788|50566469|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
25331932|NCT00460603|50648296|FG002|Phase 1|Adverse Event|1|||
25331933|NCT00460603|50648297|FG003|Phase 1|Adverse Event|2|||
25331934|NCT00460603|50648298|FG004|Phase 1|Adverse Event|0|||
25331935|NCT00460603|50648299|FG005|Phase 1|Adverse Event|0|||
25331936|NCT00460603|50648300|FG006|Phase 1|Adverse Event|3|||
25331937|NCT00460603|50648301|FG007|Phase 1|Adverse Event|0|||
25331938|NCT00460603|50648302|FG008|Phase 1|Adverse Event|4|||
25331939|NCT00460603|50648303|FG009|Phase 1|Adverse Event|0|||
25331940|NCT00460603|50648304|FG010|Phase 1|Adverse Event|0|||
25331941|NCT00460603|50648305|FG011|Phase 1|Adverse Event|0|||
25331942|NCT00460603|50648294|FG000|Phase 1|Lack of Efficacy|1|||
25331943|NCT00460603|50648295|FG001|Phase 1|Lack of Efficacy|0|||
25331944|NCT00460603|50648296|FG002|Phase 1|Lack of Efficacy|1|||
25331945|NCT00460603|50648297|FG003|Phase 1|Lack of Efficacy|2|||
25331946|NCT00460603|50648298|FG004|Phase 1|Lack of Efficacy|2|||
25331947|NCT00460603|50648299|FG005|Phase 1|Lack of Efficacy|2|||
25331948|NCT00460603|50648300|FG006|Phase 1|Lack of Efficacy|2|||
25331949|NCT00460603|50648301|FG007|Phase 1|Lack of Efficacy|2|||
25331950|NCT00460603|50648302|FG008|Phase 1|Lack of Efficacy|11|||
25331951|NCT00460603|50648303|FG009|Phase 1|Lack of Efficacy|0|||
25331952|NCT00460603|50648304|FG010|Phase 1|Lack of Efficacy|0|||
25331953|NCT00460603|50648305|FG011|Phase 1|Lack of Efficacy|0|||
25331954|NCT00460603|50648294|FG000|Phase 1|Withdrawal by Subject|1|||
25331955|NCT00460603|50648295|FG001|Phase 1|Withdrawal by Subject|2|||
25331956|NCT00460603|50648296|FG002|Phase 1|Withdrawal by Subject|1|||
25331957|NCT00460603|50648297|FG003|Phase 1|Withdrawal by Subject|1|||
25331958|NCT00460603|50648298|FG004|Phase 1|Withdrawal by Subject|3|||
25331959|NCT00460603|50648299|FG005|Phase 1|Withdrawal by Subject|0|||
25331960|NCT00460603|50648300|FG006|Phase 1|Withdrawal by Subject|1|||
24901063|NCT00737672|49995023|FG000|Overall Study|Miscellaneous|7|||
24901064|NCT00737672|49995024|FG001|Overall Study|Miscellaneous|1|||
24901065|NCT00737672|49995023|FG000|Overall Study|Physician Decision|0|||
24901066|NCT00737672|49995024|FG001|Overall Study|Physician Decision|2|||
24901067|NCT00737438|49995030|FG000|Overall Study|Withdrawal by Subject|2|||
24901068|NCT00737438|49995030|FG000|Overall Study|Patient ineligible|1|||
24901069|NCT00737282|49995036|FG000|Overall Study|Study prematurely terminated|175|||
24901070|NCT03884478|49995045|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
24901071|NCT03884478|49995046|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
24901072|NCT03884478|49995047|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
24901073|NCT03884478|49995045|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
24901074|NCT03884478|49995046|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
24901075|NCT03884478|49995047|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
24901076|NCT03884478|49995045|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
24901077|NCT03884478|49995046|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
24901078|NCT03884478|49995047|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
24901079|NCT03884478|49995045|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
24901080|NCT03884478|49995046|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
24901081|NCT03884478|49995047|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
25250550|NCT01087788|50566470|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
25250551|NCT01087788|50566471|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
25250552|NCT01087788|50566469|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
25250553|NCT01087788|50566470|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
25250554|NCT01087788|50566471|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
25250555|NCT01087788|50566469|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
25250556|NCT01087788|50566470|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
25250557|NCT01087788|50566471|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
25250558|NCT01087788|50566469|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
25250559|NCT01087788|50566470|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
25250560|NCT01087788|50566471|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
25250561|NCT01087788|50566469|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
25250562|NCT01087788|50566470|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
25250563|NCT01087788|50566471|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
25250564|NCT01087788|50566469|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
25250565|NCT01087788|50566470|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
25250566|NCT01087788|50566471|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
25250567|NCT01087788|50566469|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
25250568|NCT01087788|50566470|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
25250569|NCT01087788|50566471|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
25331961|NCT00460603|50648301|FG007|Phase 1|Withdrawal by Subject|0|||
25331962|NCT00460603|50648302|FG008|Phase 1|Withdrawal by Subject|2|||
25331963|NCT00460603|50648303|FG009|Phase 1|Withdrawal by Subject|0|||
25250570|NCT01087788|50566469|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
25250571|NCT01087788|50566470|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
25250572|NCT01087788|50566471|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
25250573|NCT01087788|50566469|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
25331964|NCT00460603|50648304|FG010|Phase 1|Withdrawal by Subject|0|||
25331965|NCT00460603|50648305|FG011|Phase 1|Withdrawal by Subject|0|||
25331966|NCT00460603|50648294|FG000|Phase 1|Other|0|||
25331967|NCT00460603|50648295|FG001|Phase 1|Other|3|||
25331968|NCT00460603|50648296|FG002|Phase 1|Other|1|||
25331969|NCT00460603|50648297|FG003|Phase 1|Other|1|||
25331970|NCT00460603|50648298|FG004|Phase 1|Other|1|||
25331971|NCT00460603|50648299|FG005|Phase 1|Other|2|||
25331972|NCT00460603|50648300|FG006|Phase 1|Other|0|||
25331973|NCT00460603|50648301|FG007|Phase 1|Other|1|||
25331974|NCT00460603|50648302|FG008|Phase 1|Other|0|||
25331975|NCT00460603|50648303|FG009|Phase 1|Other|0|||
25331976|NCT00460603|50648304|FG010|Phase 1|Other|0|||
25331977|NCT00460603|50648305|FG011|Phase 1|Other|0|||
25331978|NCT00460603|50648294|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
25331979|NCT00460603|50648295|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
25331980|NCT00460603|50648296|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
25331981|NCT00460603|50648297|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
25331982|NCT00460603|50648298|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
25331983|NCT00460603|50648299|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
25331984|NCT00460603|50648300|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
25331985|NCT00460603|50648301|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
25331986|NCT00460603|50648302|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
25331987|NCT00460603|50648303|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
25331988|NCT00460603|50648304|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
25331989|NCT00460603|50648305|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
25331990|NCT00460603|50648294|FG000|Phase 2|Adverse Event|0|||
25331991|NCT00460603|50648295|FG001|Phase 2|Adverse Event|0|||
25331992|NCT00460603|50648296|FG002|Phase 2|Adverse Event|0|||
25331993|NCT00460603|50648297|FG003|Phase 2|Adverse Event|0|||
25331994|NCT00460603|50648298|FG004|Phase 2|Adverse Event|0|||
25331995|NCT00460603|50648299|FG005|Phase 2|Adverse Event|0|||
25331996|NCT00460603|50648300|FG006|Phase 2|Adverse Event|0|||
25331997|NCT00460603|50648301|FG007|Phase 2|Adverse Event|0|||
25331998|NCT00460603|50648302|FG008|Phase 2|Adverse Event|0|||
25331999|NCT00460603|50648303|FG009|Phase 2|Adverse Event|12|||
25332000|NCT00460603|50648304|FG010|Phase 2|Adverse Event|9|||
25332001|NCT00460603|50648305|FG011|Phase 2|Adverse Event|10|||
25332002|NCT00460603|50648294|FG000|Phase 2|Death|0|||
25332003|NCT00460603|50648295|FG001|Phase 2|Death|0|||
25332004|NCT00460603|50648296|FG002|Phase 2|Death|0|||
25332005|NCT00460603|50648297|FG003|Phase 2|Death|0|||
25332006|NCT00460603|50648298|FG004|Phase 2|Death|0|||
25332007|NCT00460603|50648299|FG005|Phase 2|Death|0|||
25332008|NCT00460603|50648300|FG006|Phase 2|Death|0|||
25332009|NCT00460603|50648301|FG007|Phase 2|Death|0|||
25250574|NCT01087788|50566470|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
25250575|NCT01087788|50566471|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
25250576|NCT01087788|50566469|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
25250577|NCT01087788|50566470|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
25250578|NCT01087788|50566471|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
25250579|NCT01087788|50566469|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
25250580|NCT01087788|50566470|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
25250581|NCT01087788|50566471|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
25250582|NCT01087788|50566469|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
25250583|NCT01087788|50566470|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
25332010|NCT00460603|50648302|FG008|Phase 2|Death|0|||
25332011|NCT00460603|50648303|FG009|Phase 2|Death|4|||
25332012|NCT00460603|50648304|FG010|Phase 2|Death|2|||
25332013|NCT00460603|50648305|FG011|Phase 2|Death|2|||
25332014|NCT00460603|50648294|FG000|Phase 2|Protocol Violation|0|||
25332015|NCT00460603|50648295|FG001|Phase 2|Protocol Violation|0|||
25332016|NCT00460603|50648296|FG002|Phase 2|Protocol Violation|0|||
25332017|NCT00460603|50648297|FG003|Phase 2|Protocol Violation|0|||
24901082|NCT00582816|49995068|FG000|Overall Study|Engraftment Failure|3|||
24901083|NCT00737048|49995075|FG000|Overall Study|Physician Decision|0|||
24901084|NCT00737048|49995076|FG001|Overall Study|Physician Decision|0|||
25250584|NCT01087788|50566471|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
25250585|NCT01087788|50566469|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
25250586|NCT01087788|50566470|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
25332018|NCT00460603|50648298|FG004|Phase 2|Protocol Violation|0|||
25332019|NCT00460603|50648299|FG005|Phase 2|Protocol Violation|0|||
25332020|NCT00460603|50648300|FG006|Phase 2|Protocol Violation|0|||
25332021|NCT00460603|50648301|FG007|Phase 2|Protocol Violation|0|||
25332022|NCT00460603|50648302|FG008|Phase 2|Protocol Violation|0|||
25332023|NCT00460603|50648303|FG009|Phase 2|Protocol Violation|1|||
24901085|NCT00737048|49995077|FG002|Overall Study|Physician Decision|1|||
25250587|NCT01087788|50566471|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
25332024|NCT00460603|50648304|FG010|Phase 2|Protocol Violation|1|||
25332025|NCT00460603|50648305|FG011|Phase 2|Protocol Violation|0|||
25332026|NCT00460603|50648294|FG000|Phase 2|Lost to Follow-up|0|||
25332027|NCT00460603|50648295|FG001|Phase 2|Lost to Follow-up|0|||
25332028|NCT00460603|50648296|FG002|Phase 2|Lost to Follow-up|0|||
25332029|NCT00460603|50648297|FG003|Phase 2|Lost to Follow-up|0|||
25250588|NCT01087788|50566469|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
25250589|NCT01087788|50566470|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
25250590|NCT01087788|50566471|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
25250591|NCT01087788|50566469|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
25250592|NCT01087788|50566470|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
25250593|NCT01087788|50566471|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
25250594|NCT01087788|50566469|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
25250595|NCT01087788|50566470|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
25250596|NCT01087788|50566471|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
25250597|NCT01087788|50566469|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
25250598|NCT01087788|50566470|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
25250599|NCT01087788|50566471|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
25250600|NCT01087788|50566469|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
25250601|NCT01087788|50566470|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
25250602|NCT01087788|50566471|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
25250603|NCT01087788|50566469|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
25250604|NCT01087788|50566470|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
25250605|NCT01087788|50566471|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
25250606|NCT01087788|50566469|FG000|24-weeks Dose-blind Period|Patient moved|0|||
25250607|NCT01087788|50566470|FG001|24-weeks Dose-blind Period|Patient moved|0|||
25250608|NCT01087788|50566471|FG002|24-weeks Dose-blind Period|Patient moved|1|||
25250609|NCT01087788|50566469|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
25250610|NCT01087788|50566470|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
25250611|NCT01087788|50566471|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
25250612|NCT01087788|50566469|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
25250613|NCT01087788|50566470|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
25250614|NCT01087788|50566471|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
25250615|NCT01087788|50566469|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
25250616|NCT01087788|50566470|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
25250617|NCT01087788|50566471|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
25250618|NCT01087788|50566469|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
25250619|NCT01087788|50566470|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
25332030|NCT00460603|50648298|FG004|Phase 2|Lost to Follow-up|0|||
25332031|NCT00460603|50648299|FG005|Phase 2|Lost to Follow-up|0|||
25332032|NCT00460603|50648300|FG006|Phase 2|Lost to Follow-up|0|||
25332033|NCT00460603|50648301|FG007|Phase 2|Lost to Follow-up|0|||
25332034|NCT00460603|50648302|FG008|Phase 2|Lost to Follow-up|0|||
25332035|NCT00460603|50648303|FG009|Phase 2|Lost to Follow-up|1|||
25332036|NCT00460603|50648304|FG010|Phase 2|Lost to Follow-up|0|||
25332037|NCT00460603|50648305|FG011|Phase 2|Lost to Follow-up|0|||
25332038|NCT00460603|50648294|FG000|Phase 2|Other|0|||
25332039|NCT00460603|50648295|FG001|Phase 2|Other|0|||
25332040|NCT00460603|50648296|FG002|Phase 2|Other|0|||
25332041|NCT00460603|50648297|FG003|Phase 2|Other|0|||
25332042|NCT00460603|50648298|FG004|Phase 2|Other|0|||
24901086|NCT00737048|49995075|FG000|Overall Study|Adverse Event|0|||
24901087|NCT00737048|49995076|FG001|Overall Study|Adverse Event|1|||
24901088|NCT00737048|49995077|FG002|Overall Study|Adverse Event|0|||
24901089|NCT00737048|49995075|FG000|Overall Study|Worsening of the symptoms|3|||
24901090|NCT00737048|49995076|FG001|Overall Study|Worsening of the symptoms|5|||
24901091|NCT00737048|49995077|FG002|Overall Study|Worsening of the symptoms|3|||
24901092|NCT00731822|49995087|FG000|Overall Study|Adverse Event|2|||
24901093|NCT00731822|49995088|FG001|Overall Study|Adverse Event|1|||
24901094|NCT00731822|49995087|FG000|Overall Study|Protocol Violation|1|||
24901095|NCT00731822|49995088|FG001|Overall Study|Protocol Violation|0|||
24901096|NCT00731822|49995087|FG000|Overall Study|Lost to Follow-up|1|||
24901097|NCT00731822|49995088|FG001|Overall Study|Lost to Follow-up|0|||
24901098|NCT00731666|49995094|FG000|Overall Study|Adverse Event|2|||
24901099|NCT00731666|49995094|FG000|Overall Study|Lost to Follow-up|8|||
24901100|NCT00731666|49995094|FG000|Overall Study|Withdrawal by Subject|2|||
24901101|NCT00731120|49995101|FG000|Overall Study|Adverse Event|7|||
24901102|NCT00731120|49995102|FG001|Overall Study|Adverse Event|6|||
24901103|NCT00731120|49995103|FG002|Overall Study|Adverse Event|8|||
24901104|NCT00731120|49995101|FG000|Overall Study|Lack of Efficacy|4|||
24901105|NCT00731120|49995102|FG001|Overall Study|Lack of Efficacy|5|||
24901106|NCT00731120|49995103|FG002|Overall Study|Lack of Efficacy|4|||
24901107|NCT00731120|49995101|FG000|Overall Study|Noncompliance with Study Drug|3|||
25250620|NCT01087788|50566471|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
25250621|NCT01087788|50566469|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
25250622|NCT01087788|50566470|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
25332043|NCT00460603|50648299|FG005|Phase 2|Other|0|||
25332044|NCT00460603|50648300|FG006|Phase 2|Other|0|||
25332045|NCT00460603|50648301|FG007|Phase 2|Other|0|||
24901108|NCT00731120|49995102|FG001|Overall Study|Noncompliance with Study Drug|3|||
25332046|NCT00460603|50648302|FG008|Phase 2|Other|0|||
25332047|NCT00460603|50648303|FG009|Phase 2|Other|6|||
25332048|NCT00460603|50648304|FG010|Phase 2|Other|16|||
25250623|NCT01087788|50566471|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
25250624|NCT01087788|50566469|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
25250625|NCT01087788|50566470|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
25250626|NCT01087788|50566471|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
24901109|NCT00731120|49995103|FG002|Overall Study|Noncompliance with Study Drug|1|||
24901110|NCT00731120|49995101|FG000|Overall Study|Protocol Deviations|1|||
24901111|NCT00731120|49995102|FG001|Overall Study|Protocol Deviations|6|||
24901112|NCT00731120|49995103|FG002|Overall Study|Protocol Deviations|1|||
24901113|NCT00731120|49995101|FG000|Overall Study|Withdrawal of Consent|13|||
24901114|NCT00731120|49995102|FG001|Overall Study|Withdrawal of Consent|8|||
24901115|NCT00731120|49995103|FG002|Overall Study|Withdrawal of Consent|4|||
24901116|NCT00731120|49995101|FG000|Overall Study|Lost to Follow-up|10|||
24901117|NCT00731120|49995102|FG001|Overall Study|Lost to Follow-up|15|||
24901118|NCT00731120|49995103|FG002|Overall Study|Lost to Follow-up|17|||
24901119|NCT00731120|49995101|FG000|Overall Study|Other|4|||
24901120|NCT00731120|49995102|FG001|Overall Study|Other|0|||
24901121|NCT00731120|49995103|FG002|Overall Study|Other|1|||
24901122|NCT00731042|49995113|FG000|Second Intervention|Did not meet inclusion criteria|0|||
24901123|NCT00731042|49995114|FG001|Second Intervention|Did not meet inclusion criteria|2|||
24901124|NCT00726986|49995120|FG000|Induction Phase|Adverse Event|4|||
24901125|NCT00726986|49995120|FG000|Induction Phase|Withdrawal by Subject|2|||
24901126|NCT00726986|49995120|FG000|Induction Phase|Death|2|||
24901127|NCT00726986|49995120|FG000|Induction Phase|Lack of Efficacy|5|||
24901128|NCT00726986|49995120|FG000|Induction Phase|Secondary Disease|2|||
24901129|NCT00726986|49995120|FG000|Maintenance Phase|Adverse Event|1|||
24901130|NCT00726986|49995120|FG000|Maintenance Phase|Lack of Efficacy|2|||
24901131|NCT00696657|49995133|FG000|Overall Study|Protocol Violation|0|||
24901132|NCT00696657|49995134|FG001|Overall Study|Protocol Violation|0|||
24901133|NCT00696657|49995135|FG002|Overall Study|Protocol Violation|0|||
24901134|NCT00696657|49995136|FG003|Overall Study|Protocol Violation|0|||
24901135|NCT00696657|49995137|FG004|Overall Study|Protocol Violation|0|||
24901136|NCT00696657|49995138|FG005|Overall Study|Protocol Violation|1|||
24901137|NCT00696657|49995139|FG006|Overall Study|Protocol Violation|0|||
24901138|NCT00696657|49995140|FG007|Overall Study|Protocol Violation|0|||
24901139|NCT00696657|49995141|FG008|Overall Study|Protocol Violation|1|||
24901140|NCT00696657|49995133|FG000|Overall Study|Lack of Efficacy|0|||
24901141|NCT00696657|49995134|FG001|Overall Study|Lack of Efficacy|1|||
24901142|NCT00696657|49995135|FG002|Overall Study|Lack of Efficacy|0|||
24901143|NCT00696657|49995136|FG003|Overall Study|Lack of Efficacy|0|||
24901144|NCT00696657|49995137|FG004|Overall Study|Lack of Efficacy|0|||
24901145|NCT00696657|49995138|FG005|Overall Study|Lack of Efficacy|0|||
25250627|NCT01087788|50566469|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
25250628|NCT01087788|50566470|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
25250629|NCT01087788|50566471|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
25250630|NCT01087788|50566469|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
25250631|NCT01087788|50566470|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
25250632|NCT01087788|50566471|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
25250633|NCT01087788|50566469|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
25250634|NCT01087788|50566470|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
25332049|NCT00460603|50648305|FG011|Phase 2|Other|7|||
25332050|NCT00460603|50648294|FG000|Phase 2|Objective Progression or Relapse|0|||
25332051|NCT00460603|50648295|FG001|Phase 2|Objective Progression or Relapse|0|||
25332052|NCT00460603|50648296|FG002|Phase 2|Objective Progression or Relapse|0|||
25332053|NCT00460603|50648297|FG003|Phase 2|Objective Progression or Relapse|0|||
25332054|NCT00460603|50648298|FG004|Phase 2|Objective Progression or Relapse|0|||
25250635|NCT01087788|50566471|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
25332055|NCT00460603|50648299|FG005|Phase 2|Objective Progression or Relapse|0|||
25332056|NCT00460603|50648300|FG006|Phase 2|Objective Progression or Relapse|0|||
25332057|NCT00460603|50648301|FG007|Phase 2|Objective Progression or Relapse|0|||
25332058|NCT00460603|50648302|FG008|Phase 2|Objective Progression or Relapse|0|||
24901146|NCT00696657|49995139|FG006|Overall Study|Lack of Efficacy|0|||
24901147|NCT00696657|49995140|FG007|Overall Study|Lack of Efficacy|0|||
24901148|NCT00696657|49995141|FG008|Overall Study|Lack of Efficacy|0|||
24901149|NCT00696657|49995133|FG000|Overall Study|Withdrawal criteria|1|||
24901150|NCT00696657|49995134|FG001|Overall Study|Withdrawal criteria|3|||
24901151|NCT00696657|49995135|FG002|Overall Study|Withdrawal criteria|2|||
24901152|NCT00696657|49995136|FG003|Overall Study|Withdrawal criteria|2|||
24901153|NCT00696657|49995137|FG004|Overall Study|Withdrawal criteria|0|||
24901154|NCT00696657|49995138|FG005|Overall Study|Withdrawal criteria|0|||
24901155|NCT00696657|49995139|FG006|Overall Study|Withdrawal criteria|1|||
24901156|NCT00696657|49995140|FG007|Overall Study|Withdrawal criteria|1|||
24901157|NCT00696657|49995141|FG008|Overall Study|Withdrawal criteria|2|||
24901158|NCT00696657|49995133|FG000|Overall Study|Unclassified|0|||
24901159|NCT00696657|49995134|FG001|Overall Study|Unclassified|1|||
24901160|NCT00696657|49995135|FG002|Overall Study|Unclassified|3|||
25250636|NCT01087788|50566469|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
25332059|NCT00460603|50648303|FG009|Phase 2|Objective Progression or Relapse|9|||
25332060|NCT00460603|50648304|FG010|Phase 2|Objective Progression or Relapse|10|||
25332061|NCT00460603|50648305|FG011|Phase 2|Objective Progression or Relapse|17|||
25332062|NCT00460603|50648294|FG000|Phase 2|Global Deterioration of Health Status|0|||
25332063|NCT00460603|50648295|FG001|Phase 2|Global Deterioration of Health Status|0|||
25332064|NCT00460603|50648296|FG002|Phase 2|Global Deterioration of Health Status|0|||
25332065|NCT00460603|50648297|FG003|Phase 2|Global Deterioration of Health Status|0|||
25332066|NCT00460603|50648298|FG004|Phase 2|Global Deterioration of Health Status|0|||
25332067|NCT00460603|50648299|FG005|Phase 2|Global Deterioration of Health Status|0|||
25332068|NCT00460603|50648300|FG006|Phase 2|Global Deterioration of Health Status|0|||
25332069|NCT00460603|50648301|FG007|Phase 2|Global Deterioration of Health Status|0|||
25332070|NCT00460603|50648302|FG008|Phase 2|Global Deterioration of Health Status|0|||
25332071|NCT00460603|50648303|FG009|Phase 2|Global Deterioration of Health Status|0|||
25332072|NCT00460603|50648304|FG010|Phase 2|Global Deterioration of Health Status|1|||
25332073|NCT00460603|50648305|FG011|Phase 2|Global Deterioration of Health Status|0|||
25332074|NCT00460603|50648294|FG000|Phase 2|Withdrawal by Subject|0|||
25332075|NCT00460603|50648295|FG001|Phase 2|Withdrawal by Subject|0|||
25332076|NCT00460603|50648296|FG002|Phase 2|Withdrawal by Subject|0|||
25332077|NCT00460603|50648297|FG003|Phase 2|Withdrawal by Subject|0|||
25332078|NCT00460603|50648298|FG004|Phase 2|Withdrawal by Subject|0|||
25332079|NCT00460603|50648299|FG005|Phase 2|Withdrawal by Subject|0|||
25332080|NCT00460603|50648300|FG006|Phase 2|Withdrawal by Subject|0|||
25332081|NCT00460603|50648301|FG007|Phase 2|Withdrawal by Subject|0|||
25332082|NCT00460603|50648302|FG008|Phase 2|Withdrawal by Subject|0|||
25332083|NCT00460603|50648303|FG009|Phase 2|Withdrawal by Subject|5|||
25332084|NCT00460603|50648304|FG010|Phase 2|Withdrawal by Subject|4|||
25332085|NCT00460603|50648305|FG011|Phase 2|Withdrawal by Subject|5|||
25332086|NCT00460603|50648294|FG000|Phase 2|Randomized, but not treated|0|||
25332087|NCT00460603|50648295|FG001|Phase 2|Randomized, but not treated|0|||
25332088|NCT00460603|50648296|FG002|Phase 2|Randomized, but not treated|0|||
25332089|NCT00460603|50648297|FG003|Phase 2|Randomized, but not treated|0|||
25332090|NCT00460603|50648298|FG004|Phase 2|Randomized, but not treated|0|||
25332091|NCT00460603|50648299|FG005|Phase 2|Randomized, but not treated|0|||
25332092|NCT00460603|50648300|FG006|Phase 2|Randomized, but not treated|0|||
25250637|NCT01087788|50566470|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
25250638|NCT01087788|50566471|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
25250639|NCT01087788|50566469|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
25250640|NCT01087788|50566470|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
25332093|NCT00460603|50648301|FG007|Phase 2|Randomized, but not treated|0|||
25332094|NCT00460603|50648302|FG008|Phase 2|Randomized, but not treated|0|||
25250641|NCT01087788|50566471|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
25250642|NCT01087788|50566469|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
25250643|NCT01087788|50566470|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
25250644|NCT01087788|50566471|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
25250645|NCT01087788|50566469|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
25250646|NCT01087788|50566470|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
25250647|NCT01087788|50566471|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
25250648|NCT01086969|50566483|FG000|Overall Study|Withdrawal by Subject|1|||
25250649|NCT01086969|50566484|FG001|Overall Study|Withdrawal by Subject|2|||
25332095|NCT00460603|50648303|FG009|Phase 2|Randomized, but not treated|3|||
25332096|NCT00460603|50648304|FG010|Phase 2|Randomized, but not treated|0|||
25250650|NCT01086969|50566485|FG002|Overall Study|Withdrawal by Subject|0|||
25250651|NCT01086423|50566496|FG000|Overall Study|Protocol Violation|0|||
25250652|NCT01086423|50566497|FG001|Overall Study|Protocol Violation|0|||
25332097|NCT00460603|50648305|FG011|Phase 2|Randomized, but not treated|0|||
25332098|NCT00662038|50648331|FG000|Overall Study|Reason not specified|3|||
25332099|NCT00662038|50648331|FG000|Overall Study|Withdrawn consent|22|||
25332100|NCT00662038|50648331|FG000|Overall Study|Withdrawal by Subject|83|||
25332101|NCT00662038|50648331|FG000|Overall Study|Sponsor decision|1|||
25332102|NCT00662038|50648331|FG000|Overall Study|Physician Decision|19|||
25332103|NCT00662038|50648331|FG000|Overall Study|Lung transplantation|44|||
25332104|NCT00662038|50648331|FG000|Overall Study|Lost to Follow-up|1|||
25332105|NCT00662038|50648331|FG000|Overall Study|Death|95|||
25332106|NCT00662038|50648331|FG000|Overall Study|Adverse Event|358|||
25332107|NCT00662038|50648331|FG000|Overall Study|Continued treatment|5|||
25332108|NCT00819156|50648341|FG000|Overall Study|Adverse Event|1|||
25250653|NCT01086423|50566498|FG002|Overall Study|Protocol Violation|1|||
25332109|NCT00819156|50648342|FG001|Overall Study|Adverse Event|4|||
25332110|NCT00819156|50648343|FG002|Overall Study|Adverse Event|2|||
25332111|NCT00819156|50648344|FG003|Overall Study|Adverse Event|1|||
25332112|NCT00819156|50648345|FG004|Overall Study|Adverse Event|2|||
25332113|NCT00819156|50648346|FG005|Overall Study|Adverse Event|3|||
25332114|NCT00819156|50648341|FG000|Overall Study|Withdrawal by Subject|0|||
25332115|NCT00819156|50648342|FG001|Overall Study|Withdrawal by Subject|3|||
25250654|NCT01086423|50566496|FG000|Overall Study|Migrated/moved from study area|2|||
25250655|NCT01086423|50566497|FG001|Overall Study|Migrated/moved from study area|0|||
25250656|NCT01086423|50566498|FG002|Overall Study|Migrated/moved from study area|4|||
25250657|NCT01086423|50566496|FG000|Overall Study|Adverse event, fatal|1|||
25250658|NCT01086423|50566497|FG001|Overall Study|Adverse event, fatal|1|||
25250659|NCT01086423|50566498|FG002|Overall Study|Adverse event, fatal|0|||
25250660|NCT01086423|50566496|FG000|Overall Study|Adverse event, non-fatal|2|||
25250661|NCT01086423|50566497|FG001|Overall Study|Adverse event, non-fatal|1|||
25250662|NCT01086423|50566498|FG002|Overall Study|Adverse event, non-fatal|0|||
25250663|NCT01086423|50566496|FG000|Overall Study|Withdrawal by Subject|5|||
25250664|NCT01086423|50566497|FG001|Overall Study|Withdrawal by Subject|1|||
25250665|NCT01086423|50566498|FG002|Overall Study|Withdrawal by Subject|3|||
25250666|NCT01086423|50566496|FG000|Overall Study|Lost to Follow-up|0|||
25250667|NCT01086423|50566497|FG001|Overall Study|Lost to Follow-up|0|||
25332116|NCT00819156|50648343|FG002|Overall Study|Withdrawal by Subject|2|||
25332117|NCT00819156|50648344|FG003|Overall Study|Withdrawal by Subject|0|||
25332118|NCT00819156|50648345|FG004|Overall Study|Withdrawal by Subject|1|||
25332119|NCT00819156|50648346|FG005|Overall Study|Withdrawal by Subject|0|||
25332120|NCT00819156|50648341|FG000|Overall Study|Protocol Violation|1|||
25332121|NCT00819156|50648342|FG001|Overall Study|Protocol Violation|0|||
25332122|NCT00819156|50648343|FG002|Overall Study|Protocol Violation|1|||
25332123|NCT00819156|50648344|FG003|Overall Study|Protocol Violation|0|||
25332124|NCT00819156|50648345|FG004|Overall Study|Protocol Violation|0|||
25332125|NCT00819156|50648346|FG005|Overall Study|Protocol Violation|1|||
25332126|NCT00819156|50648341|FG000|Overall Study|Lost to Follow-up|0|||
25332127|NCT00819156|50648342|FG001|Overall Study|Lost to Follow-up|1|||
25332128|NCT00819156|50648343|FG002|Overall Study|Lost to Follow-up|0|||
25332129|NCT00819156|50648344|FG003|Overall Study|Lost to Follow-up|0|||
25250668|NCT01086423|50566498|FG002|Overall Study|Lost to Follow-up|1|||
25332130|NCT00819156|50648345|FG004|Overall Study|Lost to Follow-up|0|||
25250669|NCT01086150|50566509|FG000|Overall Study|Withdrawal by Subject|0|||
25250670|NCT01086150|50566510|FG001|Overall Study|Withdrawal by Subject|4|||
25332131|NCT00819156|50648346|FG005|Overall Study|Lost to Follow-up|2|||
25332132|NCT00819156|50648341|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
25332133|NCT00819156|50648342|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
25332134|NCT00819156|50648343|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
25332135|NCT00819156|50648344|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
25332136|NCT00819156|50648345|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
25332137|NCT00819156|50648346|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
25332138|NCT00819156|50648341|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
25332139|NCT00819156|50648342|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
25332140|NCT00819156|50648343|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
25332141|NCT00819156|50648344|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
25332142|NCT00819156|50648345|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
25332143|NCT00819156|50648346|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
25332144|NCT00819156|50648341|FG000|Overall Study|Prostate-specific antigen progression|0|||
25332145|NCT00819156|50648342|FG001|Overall Study|Prostate-specific antigen progression|0|||
25332146|NCT00819156|50648343|FG002|Overall Study|Prostate-specific antigen progression|0|||
25332147|NCT00819156|50648344|FG003|Overall Study|Prostate-specific antigen progression|0|||
25332148|NCT00819156|50648345|FG004|Overall Study|Prostate-specific antigen progression|1|||
25332149|NCT00819156|50648346|FG005|Overall Study|Prostate-specific antigen progression|0|||
25332150|NCT00459979|50648368|FG000|Overall Study|Withdrawal by Subject|1|||
25332151|NCT00459979|50648368|FG000|Overall Study|Protocol Violation|1|||
25332152|NCT00851786|50648374|FG000|Overall Study|Withdrawal by Subject|0|||
25332153|NCT00851786|50648375|FG001|Overall Study|Withdrawal by Subject|1|||
25332154|NCT00851786|50648374|FG000|Overall Study|Protocol Violation|0|||
25332155|NCT00851786|50648375|FG001|Overall Study|Protocol Violation|1|||
25332156|NCT00851786|50648374|FG000|Overall Study|Lost to Follow-up|1|||
25332157|NCT00851786|50648375|FG001|Overall Study|Lost to Follow-up|0|||
25332158|NCT00851786|50648374|FG000|Overall Study|Incarceration|1|||
25332159|NCT00851786|50648375|FG001|Overall Study|Incarceration|0|||
25332160|NCT00851786|50648374|FG000|Overall Study|Site Closure|1|||
25332161|NCT00851786|50648375|FG001|Overall Study|Site Closure|0|||
25332162|NCT00851786|50648374|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
25332163|NCT00851786|50648375|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
25332164|NCT00665626|50648383|FG000|Overall Study|Lack of Efficacy|8|||
25332165|NCT00665626|50648384|FG001|Overall Study|Lack of Efficacy|5|||
25332166|NCT00665626|50648383|FG000|Overall Study|Lost to Follow-up|0|||
25332167|NCT00665626|50648384|FG001|Overall Study|Lost to Follow-up|2|||
25332168|NCT00665626|50648383|FG000|Overall Study|Withdrawal by Subject|0|||
25332169|NCT00665626|50648384|FG001|Overall Study|Withdrawal by Subject|1|||
25332170|NCT00665626|50648383|FG000|Overall Study|Protocol Violation|0|||
25332171|NCT00665626|50648384|FG001|Overall Study|Protocol Violation|2|||
25332172|NCT00665626|50648383|FG000|Overall Study|Adverse Event|1|||
25332173|NCT00665626|50648384|FG001|Overall Study|Adverse Event|9|||
25250671|NCT01086150|50566511|FG002|Overall Study|Withdrawal by Subject|1|||
25250672|NCT01086150|50566509|FG000|Overall Study|Lost to Follow-up|0|||
25332174|NCT00665626|50648383|FG000|Overall Study|Due to exclusion criteria|0|||
25332175|NCT00665626|50648384|FG001|Overall Study|Due to exclusion criteria|1|||
24901161|NCT00696657|49995136|FG003|Overall Study|Unclassified|2|||
24901162|NCT00696657|49995137|FG004|Overall Study|Unclassified|4|||
24901163|NCT00696657|49995138|FG005|Overall Study|Unclassified|2|||
24901164|NCT00696657|49995139|FG006|Overall Study|Unclassified|0|||
24901165|NCT00696657|49995140|FG007|Overall Study|Unclassified|0|||
24901166|NCT00696657|49995141|FG008|Overall Study|Unclassified|1|||
24901167|NCT00696657|49995133|FG000|Overall Study|Adverse Event|0|||
24901168|NCT00696657|49995134|FG001|Overall Study|Adverse Event|0|||
24901169|NCT00696657|49995135|FG002|Overall Study|Adverse Event|3|||
24901170|NCT00696657|49995136|FG003|Overall Study|Adverse Event|7|||
24901171|NCT00696657|49995137|FG004|Overall Study|Adverse Event|6|||
24901172|NCT00696657|49995138|FG005|Overall Study|Adverse Event|9|||
24901173|NCT00696657|49995139|FG006|Overall Study|Adverse Event|14|||
24901174|NCT00696657|49995140|FG007|Overall Study|Adverse Event|2|||
24901175|NCT00696657|49995141|FG008|Overall Study|Adverse Event|5|||
24901176|NCT00730886|49995163|FG000|Overall Study|Lost to Follow-up|1|||
24901177|NCT00730886|49995164|FG001|Overall Study|Lost to Follow-up|0|||
24901178|NCT00730886|49995163|FG000|Overall Study|Physician Decision|1|||
24901179|NCT00730886|49995164|FG001|Overall Study|Physician Decision|0|||
24901180|NCT00726752|49995170|FG000|Overall Study|Lack of Efficacy|6|||
24901181|NCT00730028|49995188|FG000|Overall Study|Adverse Event|23|||
24901182|NCT00730028|49995189|FG001|Overall Study|Adverse Event|26|||
24901183|NCT00730028|49995190|FG002|Overall Study|Adverse Event|16|||
24901184|NCT00730028|49995191|FG003|Overall Study|Adverse Event|20|||
24901185|NCT00730028|49995192|FG004|Overall Study|Adverse Event|43|||
24901186|NCT00730028|49995188|FG000|Overall Study|Lost to Follow-up|13|||
24901187|NCT00730028|49995189|FG001|Overall Study|Lost to Follow-up|26|||
24901188|NCT00730028|49995190|FG002|Overall Study|Lost to Follow-up|22|||
24901189|NCT00730028|49995191|FG003|Overall Study|Lost to Follow-up|26|||
24901190|NCT00730028|49995192|FG004|Overall Study|Lost to Follow-up|25|||
24901191|NCT00730028|49995188|FG000|Overall Study|Protocol Violation|6|||
24901192|NCT00730028|49995189|FG001|Overall Study|Protocol Violation|1|||
24901193|NCT00730028|49995190|FG002|Overall Study|Protocol Violation|1|||
24901194|NCT00730028|49995191|FG003|Overall Study|Protocol Violation|2|||
24901195|NCT00730028|49995192|FG004|Overall Study|Protocol Violation|0|||
24901196|NCT00730028|49995188|FG000|Overall Study|Withdrawal by Subject|9|||
24901197|NCT00730028|49995189|FG001|Overall Study|Withdrawal by Subject|5|||
24901198|NCT00730028|49995190|FG002|Overall Study|Withdrawal by Subject|4|||
24901199|NCT00730028|49995191|FG003|Overall Study|Withdrawal by Subject|5|||
24901200|NCT00730028|49995192|FG004|Overall Study|Withdrawal by Subject|9|||
24901201|NCT00730028|49995188|FG000|Overall Study|Physician Decision|3|||
24901202|NCT00730028|49995189|FG001|Overall Study|Physician Decision|3|||
24901203|NCT00730028|49995190|FG002|Overall Study|Physician Decision|2|||
24901204|NCT00730028|49995191|FG003|Overall Study|Physician Decision|3|||
24901205|NCT00730028|49995192|FG004|Overall Study|Physician Decision|2|||
24901206|NCT00730028|49995188|FG000|Overall Study|Treatment Failure|5|||
24901207|NCT00730028|49995189|FG001|Overall Study|Treatment Failure|5|||
24901208|NCT00730028|49995190|FG002|Overall Study|Treatment Failure|0|||
24901209|NCT00730028|49995191|FG003|Overall Study|Treatment Failure|0|||
24901210|NCT00730028|49995192|FG004|Overall Study|Treatment Failure|1|||
24901211|NCT00730028|49995188|FG000|Overall Study|Randomization Error|1|||
25250673|NCT01086150|50566510|FG001|Overall Study|Lost to Follow-up|1|||
25250674|NCT01086150|50566511|FG002|Overall Study|Lost to Follow-up|0|||
25250675|NCT01086150|50566509|FG000|Overall Study|Screen Failure|0|||
25250676|NCT01086150|50566510|FG001|Overall Study|Screen Failure|1|||
25250677|NCT01086150|50566511|FG002|Overall Study|Screen Failure|0|||
25250678|NCT01086033|50566519|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
25250679|NCT01086033|50566519|FG000|Overall Study|Lost to Follow-up|86|||
25250680|NCT01086033|50566519|FG000|Overall Study|Adverse Event|42|||
25250681|NCT01086033|50566519|FG000|Overall Study|Withdrawal by Subject|41|||
25250682|NCT01086033|50566519|FG000|Overall Study|Other|14|||
25250683|NCT01086033|50566519|FG000|Overall Study|Other|13|||
25250684|NCT01086033|50566519|FG000|Overall Study|AE and Withdrew Consent|5|||
24901212|NCT00730028|49995189|FG001|Overall Study|Randomization Error|0|||
24901213|NCT00730028|49995190|FG002|Overall Study|Randomization Error|0|||
24901214|NCT00730028|49995191|FG003|Overall Study|Randomization Error|0|||
24901215|NCT00730028|49995192|FG004|Overall Study|Randomization Error|2|||
24901216|NCT00736502|49995204|FG000|Overall Study|Adverse Event|22|||
24901217|NCT00736502|49995204|FG000|Overall Study|Lack of Efficacy|16|||
24901218|NCT00736502|49995204|FG000|Overall Study|Lost to Follow-up|27|||
24901219|NCT00729560|49995208|FG000|Overall Study|Withdrawal by Subject|3|||
25250685|NCT01086033|50566519|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
25250686|NCT01086033|50566519|FG000|Overall Study|Withdrew consent and Other Reason|4|||
25250687|NCT01086033|50566519|FG000|Overall Study|AE and Lack of Efficacy|4|||
24901220|NCT00736190|49995212|FG000|Overall Study|Pregnancy|1|||
24901221|NCT00736190|49995212|FG000|Overall Study|Withdrawal by Subject|1|||
24901222|NCT00736190|49995212|FG000|Overall Study|Adverse Event|1|||
24901223|NCT00729326|49995218|FG000|Overall Study|Lost to Follow-up|2|||
25332176|NCT00665626|50648383|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
25332177|NCT00665626|50648384|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
25332178|NCT00665626|50648383|FG000|Overall Study|Unably to comply with dosing regimen|0|||
25332179|NCT00665626|50648384|FG001|Overall Study|Unably to comply with dosing regimen|1|||
25332180|NCT00665626|50648383|FG000|Overall Study|Death|1|||
25332181|NCT00665626|50648384|FG001|Overall Study|Death|0|||
25332182|NCT00828672|50648392|FG000|Study Treatment|Lost to Follow-up|1|||
25332183|NCT00828672|50648393|FG001|Study Treatment|Lost to Follow-up|0|||
25332184|NCT00828672|50648392|FG000|Study Treatment|Adverse Event|0|||
24901224|NCT00729326|49995219|FG001|Overall Study|Lost to Follow-up|0|||
24901225|NCT00729326|49995218|FG000|Overall Study|Physician Decision|0|||
24901226|NCT00729326|49995219|FG001|Overall Study|Physician Decision|1|||
24901227|NCT00729326|49995218|FG000|Overall Study|Protocol Violation|3|||
24901228|NCT00729326|49995219|FG001|Overall Study|Protocol Violation|2|||
24901229|NCT00729326|49995218|FG000|Overall Study|Subject Decision|4|||
24901230|NCT00729326|49995219|FG001|Overall Study|Subject Decision|4|||
24901231|NCT00729326|49995218|FG000|Overall Study|Sponsor Decision|1|||
24901232|NCT00729326|49995219|FG001|Overall Study|Sponsor Decision|2|||
24901233|NCT00729248|49995225|FG000|Overall Study|Physician Decision|2|||
24901234|NCT00696423|49995232|FG000|Overall Study|Lost to Follow-up|0|||
24977319|NCT00376259|50065922|FG000|Overall Study|Sponsor request - study termination|21|||
24977320|NCT00376259|50065923|FG001|Overall Study|Sponsor request - study termination|21|||
24977321|NCT00376259|50065922|FG000|Overall Study|Patient request|1|||
24977322|NCT00376259|50065923|FG001|Overall Study|Patient request|0|||
24977323|NCT03410056|50065933|FG000|Overall Study|Decision by Sponsor|0|||
24977324|NCT03410056|50065934|FG001|Overall Study|Decision by Sponsor|0|||
24977325|NCT03410056|50065935|FG002|Overall Study|Decision by Sponsor|3|||
24977326|NCT03410056|50065936|FG003|Overall Study|Decision by Sponsor|0|||
24977327|NCT03410056|50065937|FG004|Overall Study|Decision by Sponsor|0|||
24977328|NCT03410056|50065938|FG005|Overall Study|Decision by Sponsor|0|||
24977329|NCT03410056|50065939|FG006|Overall Study|Decision by Sponsor|0|||
24977330|NCT03410056|50065933|FG000|Overall Study|Withdrawal by Subject|0|||
24977331|NCT03410056|50065934|FG001|Overall Study|Withdrawal by Subject|2|||
24977332|NCT03410056|50065935|FG002|Overall Study|Withdrawal by Subject|5|||
24977333|NCT03410056|50065936|FG003|Overall Study|Withdrawal by Subject|5|||
24977334|NCT03410056|50065937|FG004|Overall Study|Withdrawal by Subject|0|||
24977335|NCT03410056|50065938|FG005|Overall Study|Withdrawal by Subject|0|||
24977336|NCT03410056|50065939|FG006|Overall Study|Withdrawal by Subject|0|||
24977337|NCT03409666|50065957|FG000|Overall Study|Physician Decision|0|||
24977338|NCT03409666|50065958|FG001|Overall Study|Physician Decision|1|||
24977339|NCT03409666|50065957|FG000|Overall Study|Protocol Violation|0|||
24977340|NCT03409666|50065958|FG001|Overall Study|Protocol Violation|3|||
24977341|NCT03440944|50065966|FG000|Overall Study|Physician Decision|1|||
24977342|NCT03440944|50065967|FG001|Overall Study|Physician Decision|0|||
24977343|NCT03440944|50065966|FG000|Overall Study|No Acceptable Vasculature|0|||
24977344|NCT03440944|50065967|FG001|Overall Study|No Acceptable Vasculature|1|||
24977345|NCT00365105|50065976|FG000|Overall Study|Protocol Violation|5|||
24977346|NCT00365105|50065977|FG001|Overall Study|Protocol Violation|8|||
24977347|NCT00399893|50065985|FG000|Overall Study|Withdrawal by Subject|1|||
24977348|NCT00399893|50065986|FG001|Overall Study|Withdrawal by Subject|0|||
24977349|NCT00048542|50065996|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
24977350|NCT00048542|50065997|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
24977351|NCT00048542|50065998|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
24977352|NCT00048542|50065999|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
24977353|NCT00048542|50066000|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
24977354|NCT00048542|50066001|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
24977355|NCT00048542|50066002|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
24977356|NCT00048542|50066003|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
24977357|NCT00048542|50065996|FG000|Double-Blind Phase|Protocol Violation|0|||
25077831|NCT03318523|50185671|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
25077832|NCT03318523|50185672|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
24977358|NCT00048542|50065997|FG001|Double-Blind Phase|Protocol Violation|0|||
24977359|NCT00048542|50065998|FG002|Double-Blind Phase|Protocol Violation|1|||
24977360|NCT00048542|50065999|FG003|Double-Blind Phase|Protocol Violation|0|||
24977361|NCT00048542|50066000|FG004|Double-Blind Phase|Protocol Violation|0|||
24977362|NCT00048542|50066001|FG005|Double-Blind Phase|Protocol Violation|0|||
24977363|NCT00048542|50066002|FG006|Double-Blind Phase|Protocol Violation|0|||
24901235|NCT00696423|49995233|FG001|Overall Study|Lost to Follow-up|5|||
24977364|NCT00048542|50066003|FG007|Double-Blind Phase|Protocol Violation|0|||
24977365|NCT00048542|50065996|FG000|Double-Blind Phase|Sponsor request or decision|2|||
24977366|NCT00048542|50065997|FG001|Double-Blind Phase|Sponsor request or decision|0|||
24977367|NCT00048542|50065998|FG002|Double-Blind Phase|Sponsor request or decision|0|||
24977368|NCT00048542|50065999|FG003|Double-Blind Phase|Sponsor request or decision|0|||
24977369|NCT00048542|50066000|FG004|Double-Blind Phase|Sponsor request or decision|0|||
24901236|NCT00736034|49995239|FG000|Overall Study|Adverse Event|2|||
24901237|NCT00576693|49995245|FG000|Overall Study|Lost to Follow-up|7|||
25332185|NCT00828672|50648393|FG001|Study Treatment|Adverse Event|1|||
25332186|NCT00828672|50648392|FG000|Study Treatment|Complete response, no surgery|1|||
25332187|NCT00828672|50648393|FG001|Study Treatment|Complete response, no surgery|1|||
25332188|NCT00828672|50648392|FG000|Post-surgery (<30 Days)|No central review materials|0|||
25332189|NCT00828672|50648393|FG001|Post-surgery (<30 Days)|No central review materials|1|||
25332190|NCT00873119|50648401|FG000|Overall Study|Patient request|4|||
25332191|NCT00873119|50648402|FG001|Overall Study|Patient request|2|||
25332192|NCT00873119|50648401|FG000|Overall Study|Adverse Event|8|||
25332193|NCT00873119|50648402|FG001|Overall Study|Adverse Event|0|||
25332194|NCT00873119|50648401|FG000|Overall Study|Progressive disease|26|||
25332195|NCT00873119|50648402|FG001|Overall Study|Progressive disease|18|||
25332196|NCT00873119|50648401|FG000|Overall Study|Death|2|||
25332197|NCT00873119|50648402|FG001|Overall Study|Death|1|||
25332198|NCT00873119|50648401|FG000|Overall Study|Other|2|||
25332199|NCT00873119|50648402|FG001|Overall Study|Other|5|||
25332200|NCT00873119|50648401|FG000|Overall Study|Not treated|2|||
25332201|NCT00873119|50648402|FG001|Overall Study|Not treated|0|||
25332202|NCT00661726|50648408|FG000|Overall Study|Adverse Event|1|||
25332203|NCT00865046|50648415|FG000|Overall Study|Lost to Follow-up|1|||
25332204|NCT00865046|50648416|FG001|Overall Study|Lost to Follow-up|4|||
25332205|NCT00865046|50648417|FG002|Overall Study|Lost to Follow-up|0|||
25332206|NCT00865046|50648415|FG000|Overall Study|Death|0|||
25332207|NCT00865046|50648416|FG001|Overall Study|Death|1|||
25332208|NCT00865046|50648417|FG002|Overall Study|Death|1|||
25332209|NCT00865046|50648415|FG000|Overall Study|Withdrawal by Subject|5|||
25332210|NCT00865046|50648416|FG001|Overall Study|Withdrawal by Subject|0|||
25332211|NCT00865046|50648417|FG002|Overall Study|Withdrawal by Subject|0|||
25332212|NCT00828516|50648425|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
25332213|NCT00665392|50648429|FG000|Overall Study|not treated|1|||
25332214|NCT00851630|50648436|FG000|Overall Study|Death|2|||
25332215|NCT00851630|50648437|FG001|Overall Study|Death|1|||
25332216|NCT00851630|50648436|FG000|Overall Study|Clinical failure|0|||
25332217|NCT00851630|50648437|FG001|Overall Study|Clinical failure|1|||
25332218|NCT00459667|50648446|FG000|Overall Study|Adverse Event|9|||
25332219|NCT00459667|50648447|FG001|Overall Study|Adverse Event|12|||
25332220|NCT00459667|50648448|FG002|Overall Study|Adverse Event|8|||
25332221|NCT00459667|50648446|FG000|Overall Study|Lost to Follow-up|5|||
25332222|NCT00459667|50648447|FG001|Overall Study|Lost to Follow-up|9|||
25332223|NCT00459667|50648448|FG002|Overall Study|Lost to Follow-up|3|||
25332224|NCT00459667|50648446|FG000|Overall Study|Pregnancy|1|||
25332225|NCT00459667|50648447|FG001|Overall Study|Pregnancy|1|||
25332226|NCT00459667|50648448|FG002|Overall Study|Pregnancy|1|||
25332227|NCT00459667|50648446|FG000|Overall Study|Protocol Violation|1|||
25332228|NCT00459667|50648447|FG001|Overall Study|Protocol Violation|0|||
25332229|NCT00459667|50648448|FG002|Overall Study|Protocol Violation|0|||
25332230|NCT00459667|50648446|FG000|Overall Study|Withdrawal by Subject|3|||
25332231|NCT00459667|50648447|FG001|Overall Study|Withdrawal by Subject|5|||
25332232|NCT00459667|50648448|FG002|Overall Study|Withdrawal by Subject|5|||
25332233|NCT00459667|50648446|FG000|Overall Study|Other disease modifying treatment|1|||
25332234|NCT00459667|50648447|FG001|Overall Study|Other disease modifying treatment|2|||
25332235|NCT00459667|50648448|FG002|Overall Study|Other disease modifying treatment|1|||
25332236|NCT00459667|50648446|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
25332237|NCT00459667|50648447|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
25332238|NCT00459667|50648448|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
25332239|NCT00459667|50648446|FG000|Overall Study|No treatment administered|6|||
25332240|NCT00459667|50648447|FG001|Overall Study|No treatment administered|3|||
25332241|NCT00459667|50648448|FG002|Overall Study|No treatment administered|1|||
25332242|NCT00828204|50648458|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
25332243|NCT00828204|50648459|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
25332244|NCT00828204|50648458|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
25332245|NCT00828204|50648459|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
25332246|NCT00828204|50648458|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
25332247|NCT00828204|50648459|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
25332248|NCT00828204|50648458|FG000|Main Study: After Study Restart|Adverse Event|0|||
25332249|NCT00828204|50648459|FG001|Main Study: After Study Restart|Adverse Event|2|||
25332250|NCT00828204|50648458|FG000|Main Study: After Study Restart|Noncompliance|0|||
25332251|NCT00828204|50648459|FG001|Main Study: After Study Restart|Noncompliance|1|||
25332252|NCT00828204|50648458|FG000|Extension Study|Lost to Follow-up|0|||
25332253|NCT00828204|50648459|FG001|Extension Study|Lost to Follow-up|1|||
25332254|NCT00828204|50648458|FG000|Extension Study|Physician Decision|0|||
25332255|NCT00828204|50648459|FG001|Extension Study|Physician Decision|2|||
25332256|NCT00851552|50648466|FG000|Overall Study|Death|2|||
25332257|NCT00851552|50648466|FG000|Overall Study|Adverse Event|1|||
25332258|NCT00851552|50648466|FG000|Overall Study|Disease Progression|4|||
25332259|NCT00459355|50648472|FG000|Overall Study|Subject no longer met inc criteria|20|||
25332260|NCT00459355|50648473|FG001|Overall Study|Subject no longer met inc criteria|18|||
25332261|NCT00459043|50648485|FG000|Overall Study|Withdrawal by Subject|1|||
25332262|NCT00459043|50648486|FG001|Overall Study|Withdrawal by Subject|0|||
25332263|NCT00817206|50648494|FG000|Overall Study|Adverse Event|10|||
25332264|NCT00817206|50648495|FG001|Overall Study|Adverse Event|3|||
25332265|NCT00817206|50648494|FG000|Overall Study|Protocol Violation|0|||
25332266|NCT00817206|50648495|FG001|Overall Study|Protocol Violation|2|||
25332267|NCT00817206|50648494|FG000|Overall Study|Lost to Follow-up|0|||
25332268|NCT00817206|50648495|FG001|Overall Study|Lost to Follow-up|1|||
25332269|NCT00817206|50648494|FG000|Overall Study|Death|2|||
25332270|NCT00817206|50648495|FG001|Overall Study|Death|0|||
25332271|NCT00817206|50648494|FG000|Overall Study|Withdrawal by Subject|7|||
25332272|NCT00817206|50648495|FG001|Overall Study|Withdrawal by Subject|3|||
25332273|NCT00817206|50648494|FG000|Overall Study|Physician Decision|2|||
25332274|NCT00817206|50648495|FG001|Overall Study|Physician Decision|0|||
25332275|NCT00665002|50648501|FG000|Overall Study|Progression/relapse during treatment|11|||
25332276|NCT00665002|50648501|FG000|Overall Study|Cytogenetic resistance|1|||
25332277|NCT03847987|50648507|FG000|Overall Study|Lost to Follow-up|1|||
25332278|NCT03847987|50648508|FG001|Overall Study|Lost to Follow-up|0|||
25332279|NCT03847987|50648507|FG000|Overall Study|Adverse Event|2|||
25332280|NCT03847987|50648508|FG001|Overall Study|Adverse Event|0|||
25332281|NCT00660010|50648525|FG000|Overall Study|Withdrawal by Subject|2|||
25332282|NCT00660010|50648525|FG000|Overall Study|Lost to Follow-up|3|||
25332283|NCT00660010|50648525|FG000|Overall Study|Adverse Event|1|||
25332284|NCT00660010|50648525|FG000|Overall Study|Noncompliance with visit schedule|3|||
25332285|NCT00873041|50648532|FG000|Core Study|Adverse Event|2|||
25332286|NCT00873041|50648533|FG001|Core Study|Adverse Event|3|||
25332287|NCT00873041|50648534|FG002|Core Study|Adverse Event|1|||
25332288|NCT00873041|50648532|FG000|Core Study|Withdrawal by Subject|1|||
24901238|NCT00576693|49995246|FG001|Overall Study|Lost to Follow-up|11|||
24901239|NCT00576693|49995245|FG000|Overall Study|Withdrawal by Subject|3|||
24901240|NCT00576693|49995246|FG001|Overall Study|Withdrawal by Subject|13|||
24901241|NCT00698451|49995252|FG000|Overall Study|Adverse Event|22|||
24901242|NCT00698451|49995252|FG000|Overall Study|Physician Decision|2|||
24901243|NCT00698451|49995252|FG000|Overall Study|Protocol Violation|6|||
24901244|NCT00698451|49995252|FG000|Overall Study|Withdrawal by Subject|6|||
24901245|NCT00698451|49995252|FG000|Overall Study|Disease progression|3|||
24901246|NCT00697827|49995258|FG000|Overall Study|enrolled but not treated|2|||
24901247|NCT00697827|49995259|FG001|Overall Study|enrolled but not treated|1|||
24901248|NCT00728936|49995272|FG000|Overall Study|Withdrawal by Subject|0|||
24901249|NCT00728936|49995273|FG001|Overall Study|Withdrawal by Subject|0|||
24901250|NCT00728936|49995274|FG002|Overall Study|Withdrawal by Subject|0|||
24901251|NCT00728936|49995275|FG003|Overall Study|Withdrawal by Subject|0|||
24901252|NCT00728936|49995276|FG004|Overall Study|Withdrawal by Subject|0|||
24901253|NCT00728936|49995277|FG005|Overall Study|Withdrawal by Subject|1|||
24901254|NCT00728936|49995278|FG006|Overall Study|Withdrawal by Subject|0|||
24901255|NCT00693693|49995297|FG000|Overall Study|Lost to Follow-up|1|||
24901256|NCT00693693|49995298|FG001|Overall Study|Lost to Follow-up|1|||
24901257|NCT00693693|49995299|FG002|Overall Study|Lost to Follow-up|2|||
24901258|NCT00728468|49995307|FG000|Overall Study|Enrolled but not treated|1|||
24901259|NCT00728468|49995307|FG000|Overall Study|Death|1|||
24901260|NCT00728468|49995307|FG000|Overall Study|Protocol Violation|4|||
24901261|NCT00728468|49995307|FG000|Overall Study|Objective progression or relapse|9|||
24901262|NCT00728468|49995307|FG000|Overall Study|Study terminated by sponsor|1|||
24901263|NCT00727844|49995313|FG000|Initial Randomization|Physician Decision|2|||
24901264|NCT00727844|49995314|FG001|Initial Randomization|Physician Decision|0|||
24901265|NCT00727844|49995315|FG002|Initial Randomization|Physician Decision|0|||
24901266|NCT00727844|49995316|FG003|Initial Randomization|Physician Decision|0|||
24901267|NCT00735878|49995324|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
24901268|NCT00735878|49995325|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
24901269|NCT00735878|49995326|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
24901270|NCT00695955|49995337|FG000|Cohort 1|Adverse Event|26|||
24901271|NCT00695955|49995337|FG000|Cohort 1|Protocol Violation|2|||
25332289|NCT00873041|50648533|FG001|Core Study|Withdrawal by Subject|2|||
24901272|NCT00695955|49995337|FG000|Cohort 1|Lost to Follow-up|30|||
24901273|NCT00695955|49995337|FG000|Cohort 1|Withdrawal by Subject|25|||
25332290|NCT00873041|50648534|FG002|Core Study|Withdrawal by Subject|2|||
25332291|NCT00873041|50648532|FG000|Core Study|Lost to Follow-up|3|||
25332292|NCT00873041|50648533|FG001|Core Study|Lost to Follow-up|1|||
24901274|NCT00695955|49995337|FG000|Cohort 1|Lack of Efficacy|3|||
24901275|NCT00695955|49995337|FG000|Cohort 1|Other|16|||
24901276|NCT00695955|49995337|FG000|Cohort 2|Adverse Event|24|||
24901277|NCT00695955|49995337|FG000|Cohort 2|Protocol Violation|5|||
24901278|NCT00695955|49995337|FG000|Cohort 2|Lost to Follow-up|38|||
24901279|NCT00695955|49995337|FG000|Cohort 2|Withdrawal by Subject|28|||
24901280|NCT00695955|49995337|FG000|Cohort 2|Lack of Efficacy|4|||
24901281|NCT00695955|49995337|FG000|Cohort 2|Other|5|||
25332293|NCT00873041|50648534|FG002|Core Study|Lost to Follow-up|0|||
25332294|NCT00873041|50648532|FG000|Core Study|Abnormal laboratory value|0|||
25332295|NCT00873041|50648533|FG001|Core Study|Abnormal laboratory value|0|||
25332296|NCT00873041|50648534|FG002|Core Study|Abnormal laboratory value|1|||
25332297|NCT00873041|50648532|FG000|Core Study|Protocol deviation|1|||
25332298|NCT00873041|50648533|FG001|Core Study|Protocol deviation|0|||
25332299|NCT00873041|50648534|FG002|Core Study|Protocol deviation|1|||
25332300|NCT00873041|50648532|FG000|Extension Study|Adverse Event|1|||
25332301|NCT00873041|50648533|FG001|Extension Study|Adverse Event|0|||
25332302|NCT00873041|50648534|FG002|Extension Study|Adverse Event|1|||
25332303|NCT00873041|50648532|FG000|Extension Study|Administrative reasons|0|||
25332304|NCT00873041|50648533|FG001|Extension Study|Administrative reasons|0|||
25332305|NCT00873041|50648534|FG002|Extension Study|Administrative reasons|1|||
25332306|NCT00458341|50648551|FG000|Cycle 1|Adverse Event|1|||
25332307|NCT00458341|50648552|FG001|Cycle 1|Adverse Event|0|||
25332308|NCT00816036|50648560|FG000|Overall Study|Death|47|||
25332309|NCT00816036|50648561|FG001|Overall Study|Death|28|||
25332310|NCT00816036|50648560|FG000|Overall Study|Lost to Follow-up|75|||
25332311|NCT00816036|50648561|FG001|Overall Study|Lost to Follow-up|57|||
25332312|NCT00816036|50648560|FG000|Overall Study|Withdrawal by Subject|54|||
25332313|NCT00816036|50648561|FG001|Overall Study|Withdrawal by Subject|23|||
25332314|NCT00664534|50648569|FG000|Overall Study|Adverse Event|2|||
25332315|NCT00664534|50648570|FG001|Overall Study|Adverse Event|3|||
25332316|NCT00664534|50648569|FG000|Overall Study|Lost to Follow-up|6|||
25332317|NCT00664534|50648570|FG001|Overall Study|Lost to Follow-up|10|||
25332318|NCT00664534|50648569|FG000|Overall Study|Protocol Violation|10|||
25332319|NCT00664534|50648570|FG001|Overall Study|Protocol Violation|8|||
25332320|NCT00664534|50648569|FG000|Overall Study|Withdrawal by Subject|7|||
25332321|NCT00664534|50648570|FG001|Overall Study|Withdrawal by Subject|6|||
25332322|NCT00664534|50648569|FG000|Overall Study|Physician Decision|8|||
25332323|NCT00664534|50648570|FG001|Overall Study|Physician Decision|0|||
25332324|NCT00664534|50648569|FG000|Overall Study|Sponsor decision|8|||
25332325|NCT00664534|50648570|FG001|Overall Study|Sponsor decision|6|||
24901282|NCT00693225|49995345|FG000|Overall Study|Lost to Follow-up|1|||
25250688|NCT01086033|50566519|FG000|Overall Study|Death|1|||
25250689|NCT01086033|50566519|FG000|Overall Study|AE and Lost to Follow-up|1|||
25250690|NCT01086033|50566519|FG000|Overall Study|AE and Other Reason|1|||
25250691|NCT01086033|50566519|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
25250692|NCT01085682|50566528|FG000|Overall Study|Withdrawal by Subject|25|||
25250693|NCT01085682|50566529|FG001|Overall Study|Withdrawal by Subject|25|||
25250694|NCT01085214|50566535|FG000|Overall Study|Alternate treatment required|1|||
25250695|NCT01085136|50566539|FG000|Part A|Other Adverse event|223|||
24901283|NCT00693225|49995346|FG001|Overall Study|Lost to Follow-up|2|||
24901284|NCT00693225|49995345|FG000|Overall Study|Adverse Event|1|||
24901285|NCT00693225|49995346|FG001|Overall Study|Adverse Event|3|||
24901286|NCT00735644|49995357|FG000|Overall Study|Did not receive study vaccine|0|||
24901287|NCT00735644|49995358|FG001|Overall Study|Did not receive study vaccine|1|||
24901288|NCT00735644|49995359|FG002|Overall Study|Did not receive study vaccine|0|||
24901289|NCT00735644|49995360|FG003|Overall Study|Did not receive study vaccine|0|||
24901290|NCT00735644|49995361|FG004|Overall Study|Did not receive study vaccine|0|||
24901291|NCT00735644|49995357|FG000|Overall Study|Withdrawal by Subject|0|||
24901292|NCT00735644|49995358|FG001|Overall Study|Withdrawal by Subject|1|||
24901293|NCT00735644|49995359|FG002|Overall Study|Withdrawal by Subject|1|||
24901294|NCT00735644|49995360|FG003|Overall Study|Withdrawal by Subject|1|||
24901295|NCT00735644|49995361|FG004|Overall Study|Withdrawal by Subject|0|||
24901296|NCT03718299|49995380|FG000|Overall Study|Adverse Event|1|||
24901297|NCT03718299|49995380|FG000|Overall Study|Withdrawal by Subject|6|||
24901298|NCT03718299|49995380|FG000|Overall Study|Physician Decision|2|||
24901299|NCT03718299|49995380|FG000|Overall Study|Lost to Follow-up|1|||
24901300|NCT00724958|49995384|FG000|Overall Study|Adverse Event|28|||
24901301|NCT00724958|49995384|FG000|Overall Study|Loss of Response|40|||
24901302|NCT00724958|49995384|FG000|Overall Study|No Response|18|||
24901303|NCT00724958|49995384|FG000|Overall Study|Remission|7|||
24901304|NCT00724958|49995384|FG000|Overall Study|Other Reason|76|||
24901305|NCT00724958|49995384|FG000|Overall Study|No documentation for end of therapy|13|||
24901306|NCT00695565|49995390|FG000|Overall Study|Lost to Follow-up|4|||
24901307|NCT00695565|49995391|FG001|Overall Study|Lost to Follow-up|4|||
24901308|NCT00695565|49995390|FG000|Overall Study|Adverse Event|3|||
24901309|NCT00695565|49995391|FG001|Overall Study|Adverse Event|1|||
24901310|NCT00695565|49995390|FG000|Overall Study|Protocol Violation|3|||
24901311|NCT00695565|49995391|FG001|Overall Study|Protocol Violation|1|||
25332326|NCT00594035|50648578|FG000|Overall Study|Lost to Follow-up|1|||
24901312|NCT00695565|49995390|FG000|Overall Study|Withdrawal by Subject|1|||
24901313|NCT00695565|49995391|FG001|Overall Study|Withdrawal by Subject|1|||
24901314|NCT00695565|49995390|FG000|Overall Study|Lack of Efficacy|1|||
25250696|NCT01085136|50566540|FG001|Part A|Other Adverse event|0|||
25250697|NCT01085136|50566541|FG002|Part A|Other Adverse event|0|||
24901315|NCT00695565|49995391|FG001|Overall Study|Lack of Efficacy|1|||
24901316|NCT00695565|49995390|FG000|Overall Study|Subject did not follow instructions|1|||
25332327|NCT00594035|50648579|FG001|Overall Study|Lost to Follow-up|1|||
25332328|NCT00594035|50648578|FG000|Overall Study|Withdrawal by Subject|1|||
25332329|NCT00594035|50648579|FG001|Overall Study|Withdrawal by Subject|0|||
25250698|NCT01085136|50566539|FG000|Part A|Protocol Violation|3|||
25250699|NCT01085136|50566540|FG001|Part A|Protocol Violation|0|||
25250700|NCT01085136|50566541|FG002|Part A|Protocol Violation|0|||
25332330|NCT00594035|50648578|FG000|Overall Study|Subject transferred to nursing home|0|||
25332331|NCT00594035|50648579|FG001|Overall Study|Subject transferred to nursing home|1|||
25332332|NCT00594035|50648578|FG000|Overall Study|Subject couldn't return due to job|0|||
25332333|NCT00594035|50648579|FG001|Overall Study|Subject couldn't return due to job|1|||
25332334|NCT00570310|50648587|FG000|Overall Study|Adverse Event|1|||
25332335|NCT00570310|50648588|FG001|Overall Study|Adverse Event|2|||
25332336|NCT00570310|50648587|FG000|Overall Study|Lack of Efficacy|1|||
25332337|NCT00570310|50648588|FG001|Overall Study|Lack of Efficacy|4|||
25332338|NCT00664066|50648594|FG000|Overall Study|Study terminated|3|||
25332339|NCT00814710|50648600|FG000|Overall Study|Adverse Event|1|||
25250701|NCT01085136|50566539|FG000|Part A|Lost to Follow-up|3|||
25250702|NCT01085136|50566540|FG001|Part A|Lost to Follow-up|0|||
25250703|NCT01085136|50566541|FG002|Part A|Lost to Follow-up|0|||
25250704|NCT01085136|50566539|FG000|Part A|Refusal to continue trial medication|64|||
25250705|NCT01085136|50566540|FG001|Part A|Refusal to continue trial medication|0|||
25250706|NCT01085136|50566541|FG002|Part A|Refusal to continue trial medication|0|||
25250707|NCT01085136|50566539|FG000|Part A|Other reason not defined above|30|||
25250708|NCT01085136|50566540|FG001|Part A|Other reason not defined above|0|||
25250709|NCT01085136|50566541|FG002|Part A|Other reason not defined above|0|||
25250710|NCT01085136|50566539|FG000|Part B|Other AE|0|||
25332340|NCT00814710|50648601|FG001|Overall Study|Adverse Event|0|||
25332341|NCT00814710|50648600|FG000|Overall Study|Lost to Follow-up|7|||
25332342|NCT00814710|50648601|FG001|Overall Study|Lost to Follow-up|3|||
25332343|NCT00871169|50648607|FG000|Overall Study|Protocol Violation|1|||
25332344|NCT00871169|50648607|FG000|Overall Study|Patient did not receive study treatment|2|||
25332345|NCT00814632|50648611|FG000|Overall Study|Lack of Efficacy|2|||
25332346|NCT00851318|50648619|FG000|Overall Study|Withdrawal by Subject|7|||
25332347|NCT00851318|50648620|FG001|Overall Study|Withdrawal by Subject|1|||
25332348|NCT00851318|50648621|FG002|Overall Study|Withdrawal by Subject|5|||
25332349|NCT00851318|50648622|FG003|Overall Study|Withdrawal by Subject|3|||
24901317|NCT00695565|49995391|FG001|Overall Study|Subject did not follow instructions|1|||
24901318|NCT00727532|49995397|FG000|Overall Study|Adverse Event|1|||
24901319|NCT00727532|49995397|FG000|Overall Study|Withdrawal by Subject|1|||
25250711|NCT01085136|50566540|FG001|Part B|Other AE|29|||
25250712|NCT01085136|50566541|FG002|Part B|Other AE|8|||
25250713|NCT01085136|50566539|FG000|Part B|Refusal to continue trial medication|0|||
25250714|NCT01085136|50566540|FG001|Part B|Refusal to continue trial medication|12|||
25250715|NCT01085136|50566541|FG002|Part B|Refusal to continue trial medication|7|||
24901320|NCT00721214|49995401|FG000|Overall Study|Chose another center for transplant|1|||
24901321|NCT00721214|49995401|FG000|Overall Study|Death|3|||
24901322|NCT00720902|49995407|FG000|Overall Study|Withdrawal by Subject|1|||
24901323|NCT00720902|49995408|FG001|Overall Study|Withdrawal by Subject|0|||
24901324|NCT00720902|49995407|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
24901325|NCT00720902|49995408|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
24901326|NCT00695019|49995417|FG000|Overall Study|Withdrawal by Subject|8|||
24901327|NCT00695019|49995418|FG001|Overall Study|Withdrawal by Subject|6|||
24901328|NCT00695019|49995419|FG002|Overall Study|Withdrawal by Subject|4|||
24901329|NCT00695019|49995417|FG000|Overall Study|Protocol Violation|1|||
24901330|NCT00695019|49995418|FG001|Overall Study|Protocol Violation|3|||
24901331|NCT00695019|49995419|FG002|Overall Study|Protocol Violation|1|||
24901332|NCT00695019|49995417|FG000|Overall Study|Lack of Efficacy|0|||
24901333|NCT00695019|49995418|FG001|Overall Study|Lack of Efficacy|0|||
24901334|NCT00695019|49995419|FG002|Overall Study|Lack of Efficacy|1|||
24901335|NCT00695019|49995417|FG000|Overall Study|Various|4|||
24901336|NCT00695019|49995418|FG001|Overall Study|Various|5|||
24901337|NCT00695019|49995419|FG002|Overall Study|Various|4|||
24901338|NCT00694707|49995432|FG000|Overall Study|Did Not Receive Treatment|0|||
24901339|NCT00694707|49995433|FG001|Overall Study|Did Not Receive Treatment|0|||
24901340|NCT00694707|49995434|FG002|Overall Study|Did Not Receive Treatment|1|||
24901341|NCT00694707|49995435|FG003|Overall Study|Did Not Receive Treatment|1|||
24901342|NCT00694707|49995436|FG004|Overall Study|Did Not Receive Treatment|1|||
24901343|NCT00694707|49995432|FG000|Overall Study|Adverse Event|22|||
25250716|NCT01085136|50566539|FG000|Part B|Not treated|0|||
25250717|NCT01085136|50566540|FG001|Part B|Not treated|4|||
25250718|NCT01085136|50566541|FG002|Part B|Not treated|8|||
25332350|NCT00851318|50648619|FG000|Overall Study|Adverse Event|13|||
25332351|NCT00851318|50648620|FG001|Overall Study|Adverse Event|2|||
25332352|NCT00851318|50648621|FG002|Overall Study|Adverse Event|9|||
24901344|NCT00694707|49995433|FG001|Overall Study|Adverse Event|14|||
24901345|NCT00694707|49995434|FG002|Overall Study|Adverse Event|8|||
24901346|NCT00694707|49995435|FG003|Overall Study|Adverse Event|12|||
24901347|NCT00694707|49995436|FG004|Overall Study|Adverse Event|13|||
24901348|NCT00694707|49995432|FG000|Overall Study|Insufficient Therapeutic Response|33|||
24901349|NCT00694707|49995433|FG001|Overall Study|Insufficient Therapeutic Response|18|||
25332353|NCT00851318|50648622|FG003|Overall Study|Adverse Event|12|||
25250719|NCT01085136|50566539|FG000|Part B|Other reason not defined above|0|||
25250720|NCT01085136|50566540|FG001|Part B|Other reason not defined above|6|||
25250721|NCT01085136|50566541|FG002|Part B|Other reason not defined above|3|||
25250722|NCT01084707|50566551|FG000|Overall Study|Withdrawal by Subject|6|||
25250723|NCT01084668|50566563|FG000|Overall Study|Lack of Efficacy|5|||
25250724|NCT01084668|50566563|FG000|Overall Study|Withdrawal by Subject|2|||
25250725|NCT01084668|50566563|FG000|Overall Study|Pregnancy|1|||
25250726|NCT01084668|50566563|FG000|Overall Study|Non-compliance|1|||
25250727|NCT01084551|50566572|FG000|Overall Study|Adverse Event|2|||
25250728|NCT01084551|50566573|FG001|Overall Study|Adverse Event|9|||
25332354|NCT00851318|50648619|FG000|Overall Study|Pregnancy|0|||
25332355|NCT00851318|50648620|FG001|Overall Study|Pregnancy|0|||
25332356|NCT00851318|50648621|FG002|Overall Study|Pregnancy|1|||
25332357|NCT00851318|50648622|FG003|Overall Study|Pregnancy|1|||
25332358|NCT00851318|50648619|FG000|Overall Study|Lack of Efficacy|8|||
25332359|NCT00851318|50648620|FG001|Overall Study|Lack of Efficacy|2|||
25332360|NCT00851318|50648621|FG002|Overall Study|Lack of Efficacy|4|||
25332361|NCT00851318|50648622|FG003|Overall Study|Lack of Efficacy|2|||
25332362|NCT00851318|50648619|FG000|Overall Study|Non-compliance with Study Procedures|2|||
25332363|NCT00851318|50648620|FG001|Overall Study|Non-compliance with Study Procedures|0|||
25332364|NCT00851318|50648621|FG002|Overall Study|Non-compliance with Study Procedures|1|||
25332365|NCT00851318|50648622|FG003|Overall Study|Non-compliance with Study Procedures|0|||
25332366|NCT00851318|50648619|FG000|Overall Study|Physician Decision|0|||
25332367|NCT00851318|50648620|FG001|Overall Study|Physician Decision|0|||
25332368|NCT00851318|50648621|FG002|Overall Study|Physician Decision|1|||
25332369|NCT00851318|50648622|FG003|Overall Study|Physician Decision|1|||
25332370|NCT00593957|50648635|FG000|Overall Study|Physician Decision|0|||
25332371|NCT00593957|50648636|FG001|Overall Study|Physician Decision|1|||
25332372|NCT00593957|50648637|FG002|Overall Study|Physician Decision|2|||
25332373|NCT00870233|50648659|FG000|Overall Study|Withdrawal by Subject|18|||
25332374|NCT00870233|50648659|FG000|Overall Study|Did not undergo laparotomy|3|||
25332375|NCT00870233|50648659|FG000|Overall Study|Incompatible internet browser|2|||
25332376|NCT00870233|50648659|FG000|Overall Study|Death|1|||
25332377|NCT00851084|50648666|FG000|Overall Study|Randomized but not treated|1|||
25332378|NCT00851084|50648667|FG001|Overall Study|Randomized but not treated|0|||
25332379|NCT00851084|50648666|FG000|Overall Study|Adverse Event|26|||
25332380|NCT00851084|50648667|FG001|Overall Study|Adverse Event|36|||
25332381|NCT00851084|50648666|FG000|Overall Study|Disease progression|52|||
25332382|NCT00851084|50648667|FG001|Overall Study|Disease progression|47|||
25332383|NCT00851084|50648666|FG000|Overall Study|Poor compliance to protocol|1|||
25332384|NCT00851084|50648667|FG001|Overall Study|Poor compliance to protocol|1|||
25332385|NCT00851084|50648666|FG000|Overall Study|Physician Decision|13|||
25332386|NCT00851084|50648667|FG001|Overall Study|Physician Decision|14|||
25332387|NCT00851084|50648666|FG000|Overall Study|Consent withdrawn|0|||
25332388|NCT00851084|50648667|FG001|Overall Study|Consent withdrawn|2|||
25332389|NCT00851084|50648666|FG000|Overall Study|Withdrawal by Subject|11|||
25332390|NCT00851084|50648667|FG001|Overall Study|Withdrawal by Subject|12|||
25332391|NCT00851084|50648666|FG000|Overall Study|Metastatic surgery|6|||
25332392|NCT00851084|50648667|FG001|Overall Study|Metastatic surgery|6|||
25332393|NCT00851084|50648666|FG000|Overall Study|Other|7|||
25250729|NCT01084551|50566574|FG002|Overall Study|Adverse Event|4|||
25250730|NCT01084551|50566572|FG000|Overall Study|Lack of Efficacy|2|||
25250731|NCT01084551|50566573|FG001|Overall Study|Lack of Efficacy|0|||
25250732|NCT01084551|50566574|FG002|Overall Study|Lack of Efficacy|1|||
25250733|NCT01084551|50566572|FG000|Overall Study|Withdrawal by Subject|2|||
25250734|NCT01084551|50566573|FG001|Overall Study|Withdrawal by Subject|1|||
25250735|NCT01084551|50566574|FG002|Overall Study|Withdrawal by Subject|0|||
25250736|NCT01084551|50566572|FG000|Overall Study|Protocol Violation|2|||
25250737|NCT01084551|50566573|FG001|Overall Study|Protocol Violation|4|||
25250738|NCT01084551|50566574|FG002|Overall Study|Protocol Violation|0|||
25250739|NCT01084551|50566572|FG000|Overall Study|Lost to Follow-up|0|||
25250740|NCT01084551|50566573|FG001|Overall Study|Lost to Follow-up|0|||
25250741|NCT01084551|50566574|FG002|Overall Study|Lost to Follow-up|3|||
25250742|NCT01084551|50566572|FG000|Overall Study|Physician Decision|1|||
25250743|NCT01084551|50566573|FG001|Overall Study|Physician Decision|0|||
25250744|NCT01084551|50566574|FG002|Overall Study|Physician Decision|0|||
25332394|NCT00851084|50648667|FG001|Overall Study|Other|1|||
25332395|NCT00845858|50648678|FG000|Overall Study|Withdrawal by Subject|5|||
25332396|NCT00845858|50648679|FG001|Overall Study|Withdrawal by Subject|1|||
25077833|NCT03318523|50185663|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
25250745|NCT01084005|50566584|FG000|Overall Study|Adverse Event|1|||
25250746|NCT01084005|50566585|FG001|Overall Study|Adverse Event|8|||
25250747|NCT01084005|50566584|FG000|Overall Study|Protocol Violation|3|||
25250748|NCT01084005|50566585|FG001|Overall Study|Protocol Violation|7|||
25250749|NCT01084005|50566584|FG000|Overall Study|Withdrawal by Subject|1|||
25332397|NCT00845858|50648680|FG002|Overall Study|Withdrawal by Subject|1|||
25332398|NCT00845858|50648678|FG000|Overall Study|Adverse Event|3|||
25332399|NCT00845858|50648679|FG001|Overall Study|Adverse Event|8|||
25332400|NCT00845858|50648680|FG002|Overall Study|Adverse Event|4|||
25332401|NCT00845858|50648678|FG000|Overall Study|Protocol Violation|0|||
25332402|NCT00845858|50648679|FG001|Overall Study|Protocol Violation|0|||
25332403|NCT00845858|50648680|FG002|Overall Study|Protocol Violation|1|||
25332404|NCT00845858|50648678|FG000|Overall Study|not eligible|0|||
25332405|NCT00845858|50648679|FG001|Overall Study|not eligible|3|||
25332406|NCT00845858|50648680|FG002|Overall Study|not eligible|2|||
25332407|NCT00850538|50648691|FG000|Overall Study|unable/unwilling to complete MRI|13|||
25332408|NCT00850538|50648691|FG000|Overall Study|specimen missed due to scheduling error|14|||
25332409|NCT00850538|50648691|FG000|Overall Study|specimen unusable|7|||
25332410|NCT00850538|50648691|FG000|Overall Study|Withdrawal by Subject|3|||
25250750|NCT01084005|50566585|FG001|Overall Study|Withdrawal by Subject|1|||
25250751|NCT01083810|50566594|FG000|Overall Study|Lost to Follow-up|23|||
25250752|NCT01083810|50566595|FG001|Overall Study|Lost to Follow-up|11|||
25250753|NCT01083810|50566596|FG002|Overall Study|Lost to Follow-up|4|||
25250754|NCT01083810|50566594|FG000|Overall Study|Adverse Event|15|||
25250755|NCT01083810|50566595|FG001|Overall Study|Adverse Event|11|||
25250756|NCT01083810|50566596|FG002|Overall Study|Adverse Event|4|||
25250757|NCT01083810|50566594|FG000|Overall Study|Withdrawal by Subject|7|||
25332411|NCT00850538|50648691|FG000|Overall Study|radiology error|2|||
25332412|NCT00850538|50648691|FG000|Overall Study|Protocol Violation|2|||
25332413|NCT00850460|50648697|FG000|Overall Study|Lost to Follow-up|4|||
25332414|NCT00850460|50648698|FG001|Overall Study|Lost to Follow-up|4|||
25332415|NCT00661492|50648706|FG000|Overall Study|Adverse Event|16|||
25332416|NCT00661492|50648707|FG001|Overall Study|Adverse Event|13|||
25332417|NCT00661492|50648706|FG000|Overall Study|Disease Progression|44|||
25332418|NCT00661492|50648707|FG001|Overall Study|Disease Progression|14|||
25332419|NCT00661492|50648706|FG000|Overall Study|Patient Request|6|||
25332420|NCT00661492|50648707|FG001|Overall Study|Patient Request|1|||
25332421|NCT00661492|50648706|FG000|Overall Study|Investigator Request|1|||
25332422|NCT00661492|50648707|FG001|Overall Study|Investigator Request|0|||
25332423|NCT00661492|50648706|FG000|Overall Study|Lost to Follow-up|0|||
25332424|NCT00661492|50648707|FG001|Overall Study|Lost to Follow-up|1|||
25332425|NCT00661492|50648706|FG000|Overall Study|Other|1|||
25332426|NCT00661492|50648707|FG001|Overall Study|Other|0|||
25332427|NCT00850070|50648715|FG000|Overall Study|Lack of Efficacy|1|||
25332428|NCT00850070|50648716|FG001|Overall Study|Lack of Efficacy|1|||
25332429|NCT00850070|50648715|FG000|Overall Study|Adverse Event|2|||
25332430|NCT00850070|50648716|FG001|Overall Study|Adverse Event|0|||
25332431|NCT00592358|50648727|FG000|Overall Study|Withdrawal by Subject|2|||
25332432|NCT00592358|50648727|FG000|Overall Study|Adverse Event|1|||
25332433|NCT00592358|50648727|FG000|Overall Study|Lack of Efficacy|2|||
25332434|NCT00592358|50648727|FG000|Overall Study|Inability to swallow pills|1|||
25332435|NCT00814320|50648733|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
25332436|NCT00814320|50648734|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
25250758|NCT01083810|50566595|FG001|Overall Study|Withdrawal by Subject|2|||
25250759|NCT01083810|50566596|FG002|Overall Study|Withdrawal by Subject|4|||
25250760|NCT01083810|50566594|FG000|Overall Study|Reason not reported|6|||
25250761|NCT01083810|50566595|FG001|Overall Study|Reason not reported|1|||
25250762|NCT01083810|50566596|FG002|Overall Study|Reason not reported|1|||
25250763|NCT01083810|50566594|FG000|Overall Study|Non-compliance|4|||
25250764|NCT01083810|50566595|FG001|Overall Study|Non-compliance|7|||
25250765|NCT01083810|50566596|FG002|Overall Study|Non-compliance|2|||
25250766|NCT01083810|50566594|FG000|Overall Study|Simplification|4|||
25250767|NCT01083810|50566595|FG001|Overall Study|Simplification|1|||
25250768|NCT01083810|50566596|FG002|Overall Study|Simplification|0|||
25250769|NCT01083810|50566594|FG000|Overall Study|Death|2|||
24977370|NCT00048542|50066001|FG005|Double-Blind Phase|Sponsor request or decision|0|||
25250770|NCT01083810|50566595|FG001|Overall Study|Death|2|||
25250771|NCT01083810|50566596|FG002|Overall Study|Death|3|||
25250772|NCT01083810|50566594|FG000|Overall Study|Co-morbidities|1|||
25250773|NCT01083810|50566595|FG001|Overall Study|Co-morbidities|0|||
25250774|NCT01083810|50566596|FG002|Overall Study|Co-morbidities|0|||
25250775|NCT01083810|50566594|FG000|Overall Study|Participation in study|1|||
25250776|NCT01083810|50566595|FG001|Overall Study|Participation in study|0|||
25250777|NCT01083810|50566596|FG002|Overall Study|Participation in study|0|||
25250778|NCT01083810|50566594|FG000|Overall Study|Therapy break|1|||
25250779|NCT01083810|50566595|FG001|Overall Study|Therapy break|2|||
25250780|NCT01083810|50566596|FG002|Overall Study|Therapy break|2|||
25250781|NCT01083810|50566594|FG000|Overall Study|Virologic failure|1|||
25250782|NCT01083810|50566595|FG001|Overall Study|Virologic failure|8|||
25250783|NCT01083810|50566596|FG002|Overall Study|Virologic failure|0|||
25332437|NCT00814320|50648733|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
25250784|NCT01083771|50566602|FG000|Overall Study|non-compliant|2|||
25332438|NCT00814320|50648734|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
25332439|NCT00814320|50648733|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
25332440|NCT00814320|50648734|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
25332441|NCT00814320|50648733|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
25250785|NCT01083771|50566602|FG000|Overall Study|Withdrawal by Subject|3|||
25332442|NCT00814320|50648734|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
25332443|NCT00814320|50648733|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
25332444|NCT00814320|50648734|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
25332445|NCT00814320|50648733|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
25332446|NCT00814320|50648734|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
25332447|NCT00814320|50648733|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
25332448|NCT00814320|50648734|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
25332449|NCT00814320|50648733|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
25332450|NCT00814320|50648734|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
25332451|NCT00814320|50648733|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
25332452|NCT00814320|50648734|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
25332453|NCT00814320|50648733|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
25332454|NCT00814320|50648734|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
25332455|NCT00869999|50648757|FG000|Overall Study|Withdrawal by Subject|1|||
25332456|NCT00869999|50648757|FG000|Overall Study|removed prior to starting therapy|1|||
25332457|NCT00570232|50648761|FG000|Overall Study|Adverse Event|10|||
24901350|NCT00694707|49995434|FG002|Overall Study|Insufficient Therapeutic Response|17|||
24901351|NCT00694707|49995435|FG003|Overall Study|Insufficient Therapeutic Response|15|||
25077834|NCT03318523|50185664|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
25077835|NCT03318523|50185665|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
25077836|NCT03318523|50185666|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
25077837|NCT03318523|50185667|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
25077838|NCT03318523|50185668|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
25077839|NCT03318523|50185669|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
25250786|NCT01083693|50566609|FG000|Overall Study|Adverse Event|1|||
25250787|NCT01083693|50566610|FG001|Overall Study|Adverse Event|1|||
25250788|NCT01083693|50566611|FG002|Overall Study|Adverse Event|0|||
25250789|NCT01083693|50566609|FG000|Overall Study|Lost to Follow-up|2|||
25250790|NCT01083693|50566610|FG001|Overall Study|Lost to Follow-up|0|||
25250791|NCT01083693|50566611|FG002|Overall Study|Lost to Follow-up|2|||
25250792|NCT01083693|50566609|FG000|Overall Study|Lack of effectiveness|13|||
25250793|NCT01083693|50566610|FG001|Overall Study|Lack of effectiveness|2|||
25250794|NCT01083693|50566611|FG002|Overall Study|Lack of effectiveness|2|||
25250795|NCT01083693|50566609|FG000|Overall Study|Patient Moved|0|||
25250796|NCT01083693|50566610|FG001|Overall Study|Patient Moved|1|||
25250797|NCT01083693|50566611|FG002|Overall Study|Patient Moved|0|||
25250798|NCT01083693|50566609|FG000|Overall Study|Complete remission|0|||
25250799|NCT01083693|50566610|FG001|Overall Study|Complete remission|1|||
25250800|NCT01083693|50566611|FG002|Overall Study|Complete remission|0|||
25250801|NCT01083693|50566609|FG000|Overall Study|Other medical condition/surgery|1|||
25250802|NCT01083693|50566610|FG001|Overall Study|Other medical condition/surgery|1|||
25250803|NCT01083693|50566611|FG002|Overall Study|Other medical condition/surgery|0|||
25250804|NCT01083693|50566609|FG000|Overall Study|Withdrawal by Subject|3|||
25250805|NCT01083693|50566610|FG001|Overall Study|Withdrawal by Subject|0|||
25250806|NCT01083693|50566611|FG002|Overall Study|Withdrawal by Subject|2|||
25250807|NCT01083693|50566609|FG000|Overall Study|Reason unknown|0|||
25250808|NCT01083693|50566610|FG001|Overall Study|Reason unknown|0|||
25250809|NCT01083693|50566611|FG002|Overall Study|Reason unknown|1|||
25250810|NCT01083576|50566625|FG000|Overall Study|Treatment Failure|6|||
25250811|NCT01083576|50566626|FG001|Overall Study|Treatment Failure|1|||
25250812|NCT01083186|50566633|FG000|Overall Study|Lost to Follow-up|48|||
25250813|NCT01083186|50566633|FG000|Overall Study|Consent Withdrawal|7|||
25250814|NCT01083186|50566633|FG000|Overall Study|Death|3|||
25250815|NCT01083186|50566633|FG000|Overall Study|Adverse Event|3|||
25250816|NCT01083186|50566633|FG000|Overall Study|Lack of Efficacy|2|||
25250817|NCT01083186|50566633|FG000|Overall Study|Hemodialysis Initiation|28|||
25250818|NCT01083186|50566633|FG000|Overall Study|Administrative Reasons|2|||
25250819|NCT01083186|50566633|FG000|Overall Study|Non-compliance to Study Treatment|1|||
25250820|NCT01082640|50566660|FG000|Overall Study|Adverse Event|9|||
25250821|NCT01082640|50566661|FG001|Overall Study|Adverse Event|5|||
25250822|NCT01082640|50566662|FG002|Overall Study|Adverse Event|3|||
25250823|NCT01082640|50566660|FG000|Overall Study|Withdrawal by Subject|3|||
25332458|NCT00570232|50648761|FG000|Overall Study|discontinued due to medical condition|3|||
25332459|NCT00570232|50648761|FG000|Overall Study|discontinued due to recurrence|8|||
24977371|NCT00048542|50066002|FG006|Double-Blind Phase|Sponsor request or decision|0|||
25250824|NCT01082640|50566661|FG001|Overall Study|Withdrawal by Subject|3|||
25250825|NCT01082640|50566662|FG002|Overall Study|Withdrawal by Subject|2|||
25250826|NCT01082640|50566660|FG000|Overall Study|Major protocol deviation|3|||
25077840|NCT03318523|50185670|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
25250827|NCT01082640|50566661|FG001|Overall Study|Major protocol deviation|3|||
25250828|NCT01082640|50566662|FG002|Overall Study|Major protocol deviation|0|||
25250829|NCT01082640|50566660|FG000|Overall Study|Lost to Follow-up|0|||
25250830|NCT01082640|50566661|FG001|Overall Study|Lost to Follow-up|3|||
25250831|NCT01082640|50566662|FG002|Overall Study|Lost to Follow-up|0|||
25077841|NCT03318523|50185671|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
25077842|NCT03318523|50185672|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
25077843|NCT01678209|50185699|FG000|Overall Study|could not scan twice|1|||
25077844|NCT01678209|50185700|FG001|Overall Study|could not scan twice|1|||
25077845|NCT01678209|50185701|FG002|Overall Study|could not scan twice|1|||
25077846|NCT01678209|50185699|FG000|Overall Study|scheduling conflicts|0|||
25077847|NCT01678209|50185700|FG001|Overall Study|scheduling conflicts|0|||
25077848|NCT01678209|50185701|FG002|Overall Study|scheduling conflicts|1|||
25077849|NCT01678209|50185699|FG000|Overall Study|screen fail|16|||
25077850|NCT01678209|50185700|FG001|Overall Study|screen fail|17|||
25077851|NCT01678209|50185701|FG002|Overall Study|screen fail|16|||
25077852|NCT02239120|50185711|FG000|Overall Study|Death|56|||
25077853|NCT02239120|50185712|FG001|Overall Study|Death|58|||
25077854|NCT02239120|50185711|FG000|Overall Study|Lost to Follow-up|19|||
25250832|NCT01082640|50566660|FG000|Overall Study|Other|2|||
25250833|NCT01082640|50566661|FG001|Overall Study|Other|1|||
25250834|NCT01082640|50566662|FG002|Overall Study|Other|3|||
25250835|NCT01082367|50566675|FG000|Double-blind Period|Administrative problems|0|||
25250836|NCT01082367|50566676|FG001|Double-blind Period|Administrative problems|1|||
25250837|NCT01082367|50566675|FG000|Double-blind Period|Lack of Efficacy|5|||
25077855|NCT02239120|50185712|FG001|Overall Study|Lost to Follow-up|14|||
25077856|NCT01603407|50185721|FG000|Overall Study|Adverse Event|1|||
25077857|NCT01603407|50185722|FG001|Overall Study|Adverse Event|1|||
25077858|NCT01603407|50185723|FG002|Overall Study|Adverse Event|1|||
25077859|NCT01603407|50185721|FG000|Overall Study|Protocol Violation|2|||
25077860|NCT01603407|50185722|FG001|Overall Study|Protocol Violation|2|||
25077861|NCT01603407|50185723|FG002|Overall Study|Protocol Violation|0|||
25077862|NCT01603407|50185721|FG000|Overall Study|Withdrawal by Subject|8|||
25077863|NCT01603407|50185722|FG001|Overall Study|Withdrawal by Subject|5|||
25250838|NCT01082367|50566676|FG001|Double-blind Period|Lack of Efficacy|11|||
25250839|NCT01082367|50566675|FG000|Double-blind Period|Adverse Event|0|||
25250840|NCT01082367|50566676|FG001|Double-blind Period|Adverse Event|1|||
25332460|NCT00570232|50648761|FG000|Overall Study|discontinued due to noncompliance|2|||
25332461|NCT00809328|50648765|FG000|Overall Study|Lack of Efficacy|18|||
25332462|NCT00809328|50648765|FG000|Overall Study|Adverse Event|6|||
25332463|NCT00809328|50648765|FG000|Overall Study|Protocol Violation|3|||
25332464|NCT00809328|50648765|FG000|Overall Study|Withdrawal by Subject|2|||
25332465|NCT00868517|50648772|FG000|Overall Study|Withdrawal by Subject|3|||
25332466|NCT00868517|50648773|FG001|Overall Study|Withdrawal by Subject|3|||
25332467|NCT00868517|50648774|FG002|Overall Study|Withdrawal by Subject|2|||
25332468|NCT00868517|50648772|FG000|Overall Study|Protocol Violation|1|||
25332469|NCT00868517|50648773|FG001|Overall Study|Protocol Violation|1|||
25332470|NCT00868517|50648774|FG002|Overall Study|Protocol Violation|0|||
25332471|NCT00868439|50648784|FG000|Overall Study|Adverse Event|4|||
25332472|NCT00868439|50648785|FG001|Overall Study|Adverse Event|3|||
25332473|NCT00868439|50648784|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
25332474|NCT00868439|50648785|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
25332475|NCT00868439|50648784|FG000|Overall Study|Death|0|||
25332476|NCT00868439|50648785|FG001|Overall Study|Death|1|||
25332477|NCT00868439|50648784|FG000|Overall Study|Protocol Violation|1|||
25332478|NCT00868439|50648785|FG001|Overall Study|Protocol Violation|1|||
25332479|NCT00868439|50648784|FG000|Overall Study|Physician Decision|1|||
25332480|NCT00868439|50648785|FG001|Overall Study|Physician Decision|0|||
25332481|NCT00868439|50648784|FG000|Overall Study|Withdrawal by Subject|0|||
25332482|NCT00868439|50648785|FG001|Overall Study|Withdrawal by Subject|1|||
25332483|NCT00814164|50648791|FG000|Overall Study|Progression|7|||
25332484|NCT00814164|50648791|FG000|Overall Study|not stated|7|||
25332485|NCT00814164|50648791|FG000|Overall Study|Death|5|||
25332486|NCT00659230|50648797|FG000|Overall Study|Lost to Follow-up|2|||
25077864|NCT01603407|50185723|FG002|Overall Study|Withdrawal by Subject|7|||
25332487|NCT00659230|50648798|FG001|Overall Study|Lost to Follow-up|5|||
25332488|NCT00659230|50648797|FG000|Overall Study|Lost source documentation|5|||
25332489|NCT00659230|50648798|FG001|Overall Study|Lost source documentation|4|||
25332490|NCT00659230|50648797|FG000|Overall Study|Did not return post-randomization|2|||
25077865|NCT01603407|50185721|FG000|Overall Study|Lost to Follow-up|0|||
25250841|NCT01082367|50566675|FG000|Follow-up (F-U) Period|Administrative problems|1|||
25332491|NCT00659230|50648798|FG001|Overall Study|Did not return post-randomization|3|||
25332492|NCT00809094|50648806|FG000|Overall Study|Lost to Follow-up|0|||
25332493|NCT00809094|50648807|FG001|Overall Study|Lost to Follow-up|1|||
25332494|NCT00658996|50648813|FG000|First Intervention|Positive slit lamp finding|1|||
25332495|NCT00658996|50648814|FG001|First Intervention|Positive slit lamp finding|0|||
25332496|NCT00658996|50648813|FG000|First Intervention|Lack of lenses|0|||
25077866|NCT01603407|50185722|FG001|Overall Study|Lost to Follow-up|3|||
25077867|NCT01603407|50185723|FG002|Overall Study|Lost to Follow-up|2|||
25077868|NCT02235454|50185753|FG000|Overall Study|Withdrawal by Subject|2|||
25077869|NCT02235298|50185759|FG000|Overall Study|Lost to Follow-up|6|||
25250842|NCT01082367|50566676|FG001|Follow-up (F-U) Period|Administrative problems|0|||
25250843|NCT01082367|50566675|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
25332497|NCT00658996|50648814|FG001|First Intervention|Lack of lenses|1|||
25332498|NCT00658996|50648813|FG000|Crossover Period|Physician Decision|1|||
25332499|NCT00658996|50648814|FG001|Crossover Period|Physician Decision|0|||
25332500|NCT00658996|50648813|FG000|Crossover Period|Ineligible|1|||
25332501|NCT00658996|50648814|FG001|Crossover Period|Ineligible|1|||
25332502|NCT00658996|50648813|FG000|Second Intervention|Developed a stye on upper lid|1|||
25332503|NCT00658996|50648814|FG001|Second Intervention|Developed a stye on upper lid|0|||
25332504|NCT00658996|50648813|FG000|Second Intervention|Positive slit lamp finding|0|||
25332505|NCT00658996|50648814|FG001|Second Intervention|Positive slit lamp finding|1|||
25332506|NCT00867815|50648820|FG000|Overall Study|Lost to Follow-up|1|||
25332507|NCT00452413|50648827|FG000|Overall Study|Progressive Disease|4|||
25332508|NCT00452413|50648828|FG001|Overall Study|Progressive Disease|11|||
25332509|NCT00452413|50648829|FG002|Overall Study|Progressive Disease|30|||
25332510|NCT00452413|50648827|FG000|Overall Study|Withdrawal by Subject|0|||
25332511|NCT00452413|50648828|FG001|Overall Study|Withdrawal by Subject|1|||
25332512|NCT00452413|50648829|FG002|Overall Study|Withdrawal by Subject|4|||
25332513|NCT00452413|50648827|FG000|Overall Study|Adverse Event|0|||
25332514|NCT00452413|50648828|FG001|Overall Study|Adverse Event|0|||
25077870|NCT02235298|50185760|FG001|Overall Study|Lost to Follow-up|5|||
25077871|NCT02235298|50185759|FG000|Overall Study|Adverse Event|2|||
25077872|NCT02235298|50185760|FG001|Overall Study|Adverse Event|2|||
25077873|NCT02235298|50185759|FG000|Overall Study|Withdrawal by Subject|0|||
25077874|NCT02235298|50185760|FG001|Overall Study|Withdrawal by Subject|1|||
25077875|NCT02234596|50185766|FG000|Overall Study|Participant not treated|2|||
25077876|NCT02234362|50185770|FG000|Overall Study|Not eligible after first screening visit|17|||
25077877|NCT02234362|50185770|FG000|Overall Study|Lost to Follow-up|6|||
25077878|NCT02234362|50185770|FG000|Overall Study|Withdrawal by Subject|3|||
25077879|NCT02234284|50185776|FG000|Overall Study|Death|4|||
25077880|NCT02234284|50185777|FG001|Overall Study|Death|2|||
25077881|NCT02234284|50185776|FG000|Overall Study|Withdrawal by Subject|1|||
25250844|NCT01082367|50566676|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
25250845|NCT01082367|50566675|FG000|Follow-up (F-U) Period|Adverse Event|0|||
25250846|NCT01082367|50566676|FG001|Follow-up (F-U) Period|Adverse Event|1|||
25250847|NCT01082211|50566686|FG000|Overall Study|Protocol Violation|4|||
25250848|NCT01082211|50566686|FG000|Overall Study|No protocol treatment received|3|||
25250849|NCT01081665|50566693|FG000|Overall Study|Death|41|||
25250850|NCT01081665|50566693|FG000|Overall Study|Lost to Follow-up|18|||
25250851|NCT01081665|50566693|FG000|Overall Study|Withdrawal by Subject|17|||
25250852|NCT01081665|50566693|FG000|Overall Study|Change of dialysis unit|10|||
25250853|NCT01081665|50566693|FG000|Overall Study|Regulation of iPTH|5|||
25250854|NCT01081665|50566693|FG000|Overall Study|Change in renal replacement therapy|2|||
25250855|NCT01081665|50566693|FG000|Overall Study|Adverse Event|1|||
25250856|NCT01081665|50566693|FG000|Overall Study|Lack of Efficacy|1|||
25250857|NCT01081626|50566699|FG000|Overall Study|Dosing error|1|||
25250858|NCT01081626|50566700|FG001|Overall Study|Dosing error|1|||
25250859|NCT01081626|50566699|FG000|Overall Study|Missing Estradiol|25|||
25250860|NCT01081626|50566700|FG001|Overall Study|Missing Estradiol|28|||
25250861|NCT01081626|50566699|FG000|Overall Study|Low antral follicle count|1|||
25250862|NCT01081626|50566700|FG001|Overall Study|Low antral follicle count|0|||
25250863|NCT01081626|50566699|FG000|Overall Study|Overstimulation|0|||
25250864|NCT01081626|50566700|FG001|Overall Study|Overstimulation|1|||
25250865|NCT01081626|50566699|FG000|Overall Study|Lost to Follow-up|0|||
25250866|NCT01081626|50566700|FG001|Overall Study|Lost to Follow-up|1|||
25250867|NCT01081626|50566699|FG000|Overall Study|Other|33|||
25250868|NCT01081626|50566700|FG001|Overall Study|Other|30|||
25250869|NCT01080768|50566708|FG000|Overall Study|Protocol Deviation|2|||
25250870|NCT01080768|50566709|FG001|Overall Study|Protocol Deviation|1|||
25250871|NCT01080300|50566717|FG000|Overall Study|Adverse Event|49|||
25250872|NCT01080300|50566718|FG001|Overall Study|Adverse Event|35|||
25250873|NCT01080300|50566717|FG000|Overall Study|Lack of Efficacy|12|||
25250874|NCT01080300|50566718|FG001|Overall Study|Lack of Efficacy|15|||
25250875|NCT01080300|50566717|FG000|Overall Study|Protocol Violation|7|||
25250876|NCT01080300|50566718|FG001|Overall Study|Protocol Violation|13|||
25250877|NCT01080300|50566717|FG000|Overall Study|Lost to Follow-up|10|||
25332515|NCT00452413|50648829|FG002|Overall Study|Adverse Event|5|||
25332516|NCT00452413|50648827|FG000|Overall Study|Physician Decision|0|||
25332517|NCT00452413|50648828|FG001|Overall Study|Physician Decision|0|||
25332518|NCT00452413|50648829|FG002|Overall Study|Physician Decision|4|||
25332519|NCT00452413|50648827|FG000|Overall Study|Death due to study disease|0|||
25332520|NCT00452413|50648828|FG001|Overall Study|Death due to study disease|0|||
25077882|NCT02234284|50185777|FG001|Overall Study|Withdrawal by Subject|0|||
25250878|NCT01080300|50566718|FG001|Overall Study|Lost to Follow-up|6|||
25250879|NCT01080300|50566717|FG000|Overall Study|Death|0|||
25250880|NCT01080300|50566718|FG001|Overall Study|Death|1|||
25250881|NCT01080300|50566717|FG000|Overall Study|Withdrawal by Subject|12|||
25250882|NCT01080300|50566718|FG001|Overall Study|Withdrawal by Subject|28|||
25250883|NCT01080300|50566717|FG000|Overall Study|Reasons not specified|4|||
25250884|NCT01080300|50566718|FG001|Overall Study|Reasons not specified|6|||
25250885|NCT01085097|50566729|FG000|Overall Study|Adverse Event|0|||
25250886|NCT01085097|50566730|FG001|Overall Study|Adverse Event|0|||
25250887|NCT01085097|50566731|FG002|Overall Study|Adverse Event|2|||
25250888|NCT01085097|50566729|FG000|Overall Study|Treatment failure|2|||
25250889|NCT01085097|50566730|FG001|Overall Study|Treatment failure|0|||
25250890|NCT01085097|50566731|FG002|Overall Study|Treatment failure|0|||
25250891|NCT03450629|50566745|FG000|Overall Study|Adverse Event|15|||
25250892|NCT03450629|50566746|FG001|Overall Study|Adverse Event|14|||
25250893|NCT03450629|50566745|FG000|Overall Study|Physician Decision|2|||
25332521|NCT00452413|50648829|FG002|Overall Study|Death due to study disease|2|||
25332522|NCT00452413|50648827|FG000|Overall Study|Death due to adverse event (AE)|0|||
25332523|NCT00452413|50648828|FG001|Overall Study|Death due to adverse event (AE)|0|||
25332524|NCT00452413|50648829|FG002|Overall Study|Death due to adverse event (AE)|1|||
25332525|NCT00452413|50648827|FG000|Overall Study|On treatment|0|||
25332526|NCT00452413|50648828|FG001|Overall Study|On treatment|0|||
25332527|NCT00452413|50648829|FG002|Overall Study|On treatment|3|||
25332528|NCT00867503|50648838|FG000|Overall Study|Withdrawal by Subject|1|||
25332529|NCT00867113|50648844|FG000|Treatment Period|Adverse Event|15|||
25332530|NCT00867113|50648844|FG000|Treatment Period|Death|2|||
25332531|NCT00867113|50648844|FG000|Treatment Period|Withdrawal by Subject|19|||
25332532|NCT00867113|50648844|FG000|Treatment Period|Lost to Follow-up|3|||
25332533|NCT00867113|50648844|FG000|Treatment Period|Administrative problems|1|||
25250894|NCT03450629|50566746|FG001|Overall Study|Physician Decision|2|||
25250895|NCT03450629|50566745|FG000|Overall Study|Lack of Efficacy|2|||
25250896|NCT03450629|50566746|FG001|Overall Study|Lack of Efficacy|0|||
25250897|NCT03450629|50566745|FG000|Overall Study|Lost to Follow-up|4|||
25332534|NCT00867113|50648844|FG000|Treatment Period|Disease progression/relapse|1|||
25332535|NCT00867113|50648844|FG000|Treatment Period|Protocol Violation|4|||
25332536|NCT00867113|50648844|FG000|Post Treatment After Survival Follow-up|Death|1|||
25332537|NCT00867113|50648844|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
25332538|NCT00867113|50648844|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
25332539|NCT00867113|50648844|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
25332540|NCT00451555|50648851|FG000|Overall Study|Protocol Violation|2|||
25332541|NCT00451555|50648852|FG001|Overall Study|Protocol Violation|2|||
25332542|NCT00451555|50648851|FG000|Overall Study|Adverse Event|3|||
25332543|NCT00451555|50648852|FG001|Overall Study|Adverse Event|1|||
25332544|NCT00451555|50648851|FG000|Overall Study|Withdrawal by Subject|6|||
25332545|NCT00451555|50648852|FG001|Overall Study|Withdrawal by Subject|0|||
25332546|NCT00451555|50648851|FG000|Overall Study|Physician Decision|2|||
25250898|NCT03450629|50566746|FG001|Overall Study|Lost to Follow-up|2|||
25250899|NCT03450629|50566745|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
25250900|NCT03450629|50566746|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
25250901|NCT03450629|50566745|FG000|Overall Study|Non-Compliance With Study Drug|2|||
25250902|NCT03450629|50566746|FG001|Overall Study|Non-Compliance With Study Drug|1|||
25250903|NCT03450629|50566745|FG000|Overall Study|Protocol Violation|11|||
24901352|NCT00694707|49995436|FG004|Overall Study|Insufficient Therapeutic Response|10|||
24901353|NCT00694707|49995432|FG000|Overall Study|Protocol Violation|1|||
24901354|NCT00694707|49995433|FG001|Overall Study|Protocol Violation|2|||
25250904|NCT03450629|50566746|FG001|Overall Study|Protocol Violation|8|||
25250905|NCT03450629|50566745|FG000|Overall Study|Withdrawal by Subject|12|||
25250906|NCT03450629|50566746|FG001|Overall Study|Withdrawal by Subject|6|||
25250907|NCT00198029|50566752|FG000|Overall Study|Withdrawal by Subject|4|||
25250908|NCT00197054|50566759|FG000|Overall Study|Withdrawal by Subject|9|||
25250909|NCT00197054|50566760|FG001|Overall Study|Withdrawal by Subject|3|||
25250910|NCT00197054|50566761|FG002|Overall Study|Withdrawal by Subject|3|||
25250911|NCT00197054|50566759|FG000|Overall Study|Moved from area|7|||
25332547|NCT00451555|50648852|FG001|Overall Study|Physician Decision|1|||
25332548|NCT00808236|50648869|FG000|Overall Study|Was not resuscitated|50|||
24901355|NCT00694707|49995434|FG002|Overall Study|Protocol Violation|1|||
24901356|NCT00694707|49995435|FG003|Overall Study|Protocol Violation|3|||
25332549|NCT00808236|50648870|FG001|Overall Study|Was not resuscitated|56|||
25332550|NCT00808236|50648869|FG000|Overall Study|Pre-defined exclusion|13|||
25332551|NCT00808236|50648870|FG001|Overall Study|Pre-defined exclusion|3|||
25332552|NCT00808236|50648869|FG000|Overall Study|Lost to Follow-up|1|||
25332553|NCT00808236|50648870|FG001|Overall Study|Lost to Follow-up|1|||
25332554|NCT00808236|50648869|FG000|Overall Study|Physician Decision|0|||
25332555|NCT00808236|50648870|FG001|Overall Study|Physician Decision|1|||
24901357|NCT00694707|49995436|FG004|Overall Study|Protocol Violation|1|||
24901358|NCT00694707|49995432|FG000|Overall Study|Withdrawal of Consent|14|||
24901359|NCT00694707|49995433|FG001|Overall Study|Withdrawal of Consent|18|||
25250912|NCT00197054|50566760|FG001|Overall Study|Moved from area|14|||
25250913|NCT00197054|50566761|FG002|Overall Study|Moved from area|9|||
25250914|NCT00197054|50566759|FG000|Overall Study|Lost to Follow-up|1|||
25332556|NCT00808236|50648869|FG000|Overall Study|Death|18|||
25332557|NCT00808236|50648870|FG001|Overall Study|Death|30|||
25332558|NCT00867035|50648878|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
25332559|NCT00867035|50648879|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
25332560|NCT00867035|50648878|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
25250915|NCT00197054|50566760|FG001|Overall Study|Lost to Follow-up|4|||
25250916|NCT00197054|50566761|FG002|Overall Study|Lost to Follow-up|0|||
25250917|NCT00197015|50566782|FG000|Overall Study|Adverse Event|3|||
25332561|NCT00867035|50648879|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
25332562|NCT00663208|50648892|FG000|Treatment Period|Lost to Follow-up|0|||
25332563|NCT00663208|50648893|FG001|Treatment Period|Lost to Follow-up|1|||
25332564|NCT00663208|50648894|FG002|Treatment Period|Lost to Follow-up|0|||
25250918|NCT00197015|50566783|FG001|Overall Study|Adverse Event|0|||
25250919|NCT00197015|50566784|FG002|Overall Study|Adverse Event|1|||
25250920|NCT00197015|50566782|FG000|Overall Study|Protocol Violation|0|||
25250921|NCT00197015|50566783|FG001|Overall Study|Protocol Violation|3|||
25250922|NCT00197015|50566784|FG002|Overall Study|Protocol Violation|3|||
25250923|NCT00197015|50566782|FG000|Overall Study|Withdrawal by Subject|17|||
25250924|NCT00197015|50566783|FG001|Overall Study|Withdrawal by Subject|37|||
25250925|NCT00197015|50566784|FG002|Overall Study|Withdrawal by Subject|34|||
25250926|NCT00197015|50566782|FG000|Overall Study|Lost to Follow-up|28|||
25250927|NCT00197015|50566783|FG001|Overall Study|Lost to Follow-up|46|||
25250928|NCT00197015|50566784|FG002|Overall Study|Lost to Follow-up|37|||
25250929|NCT00197015|50566782|FG000|Overall Study|Other|2|||
25250930|NCT00197015|50566783|FG001|Overall Study|Other|3|||
25332565|NCT00663208|50648895|FG003|Treatment Period|Lost to Follow-up|0|||
25332566|NCT00663208|50648896|FG004|Treatment Period|Lost to Follow-up|0|||
25332567|NCT00663208|50648897|FG005|Treatment Period|Lost to Follow-up|0|||
25250931|NCT00197015|50566784|FG002|Overall Study|Other|2|||
25250932|NCT00196976|50566806|FG000|Primary Study|Migrated from study area|0|||
25250933|NCT00196976|50566807|FG001|Primary Study|Migrated from study area|0|||
25250934|NCT00196976|50566808|FG002|Primary Study|Migrated from study area|0|||
25250935|NCT00196976|50566809|FG003|Primary Study|Migrated from study area|0|||
25250936|NCT00196976|50566810|FG004|Primary Study|Migrated from study area|0|||
25250937|NCT00196976|50566811|FG005|Primary Study|Migrated from study area|0|||
25250938|NCT00196976|50566812|FG006|Primary Study|Migrated from study area|0|||
25250939|NCT00196976|50566813|FG007|Primary Study|Migrated from study area|1|||
25250940|NCT00196976|50566814|FG008|Primary Study|Migrated from study area|0|||
25250941|NCT00196976|50566815|FG009|Primary Study|Migrated from study area|0|||
25250942|NCT00196976|50566816|FG010|Primary Study|Migrated from study area|0|||
25332568|NCT00663208|50648898|FG006|Treatment Period|Lost to Follow-up|0|||
25250943|NCT00196976|50566817|FG011|Primary Study|Migrated from study area|0|||
25250944|NCT00196976|50566818|FG012|Primary Study|Migrated from study area|0|||
25250945|NCT00196976|50566819|FG013|Primary Study|Migrated from study area|0|||
25250946|NCT00196976|50566806|FG000|Primary Study|Protocol Violation|0|||
25250947|NCT00196976|50566807|FG001|Primary Study|Protocol Violation|1|||
25250948|NCT00196976|50566808|FG002|Primary Study|Protocol Violation|1|||
25250949|NCT00196976|50566809|FG003|Primary Study|Protocol Violation|0|||
25250950|NCT00196976|50566810|FG004|Primary Study|Protocol Violation|0|||
25332569|NCT00663208|50648892|FG000|Follow-up Period|Lost to Follow-up|2|||
24901360|NCT00694707|49995434|FG002|Overall Study|Withdrawal of Consent|22|||
24901361|NCT00694707|49995435|FG003|Overall Study|Withdrawal of Consent|16|||
25250951|NCT00196976|50566811|FG005|Primary Study|Protocol Violation|0|||
25250952|NCT00196976|50566812|FG006|Primary Study|Protocol Violation|0|||
25250953|NCT00196976|50566813|FG007|Primary Study|Protocol Violation|0|||
25250954|NCT00196976|50566814|FG008|Primary Study|Protocol Violation|0|||
25250955|NCT00196976|50566815|FG009|Primary Study|Protocol Violation|0|||
25250956|NCT00196976|50566816|FG010|Primary Study|Protocol Violation|0|||
25250957|NCT00196976|50566817|FG011|Primary Study|Protocol Violation|0|||
25250958|NCT00196976|50566818|FG012|Primary Study|Protocol Violation|0|||
25250959|NCT00196976|50566819|FG013|Primary Study|Protocol Violation|0|||
25250960|NCT00196976|50566806|FG000|Primary Study|Withdrawal by Subject|1|||
25250961|NCT00196976|50566807|FG001|Primary Study|Withdrawal by Subject|0|||
25250962|NCT00196976|50566808|FG002|Primary Study|Withdrawal by Subject|1|||
25250963|NCT00196976|50566809|FG003|Primary Study|Withdrawal by Subject|1|||
25250964|NCT00196976|50566810|FG004|Primary Study|Withdrawal by Subject|2|||
25250965|NCT00196976|50566811|FG005|Primary Study|Withdrawal by Subject|1|||
25250966|NCT00196976|50566812|FG006|Primary Study|Withdrawal by Subject|0|||
25250967|NCT00196976|50566813|FG007|Primary Study|Withdrawal by Subject|0|||
25250968|NCT00196976|50566814|FG008|Primary Study|Withdrawal by Subject|0|||
25250969|NCT00196976|50566815|FG009|Primary Study|Withdrawal by Subject|1|||
25077883|NCT02234284|50185776|FG000|Overall Study|Lost to Follow-up|20|||
25077884|NCT02234284|50185777|FG001|Overall Study|Lost to Follow-up|7|||
25250970|NCT00196976|50566816|FG010|Primary Study|Withdrawal by Subject|0|||
25250971|NCT00196976|50566817|FG011|Primary Study|Withdrawal by Subject|0|||
25077885|NCT02233738|50185789|FG000|Overall Study|Lost to Follow-up|5|||
25250972|NCT00196976|50566818|FG012|Primary Study|Withdrawal by Subject|0|||
25250973|NCT00196976|50566819|FG013|Primary Study|Withdrawal by Subject|0|||
25250974|NCT00196976|50566806|FG000|Primary Study|Lost to Follow-up|0|||
25250975|NCT00196976|50566807|FG001|Primary Study|Lost to Follow-up|0|||
25332570|NCT00663208|50648893|FG001|Follow-up Period|Lost to Follow-up|0|||
25332571|NCT00663208|50648894|FG002|Follow-up Period|Lost to Follow-up|3|||
25332572|NCT00663208|50648895|FG003|Follow-up Period|Lost to Follow-up|2|||
25332573|NCT00663208|50648896|FG004|Follow-up Period|Lost to Follow-up|0|||
25332574|NCT00663208|50648897|FG005|Follow-up Period|Lost to Follow-up|0|||
25332575|NCT00663208|50648898|FG006|Follow-up Period|Lost to Follow-up|0|||
25332576|NCT00663208|50648892|FG000|Follow-up Period|Other reason|1|||
25332577|NCT00663208|50648893|FG001|Follow-up Period|Other reason|0|||
25332578|NCT00663208|50648894|FG002|Follow-up Period|Other reason|0|||
25332579|NCT00663208|50648895|FG003|Follow-up Period|Other reason|0|||
25332580|NCT00663208|50648896|FG004|Follow-up Period|Other reason|0|||
25250976|NCT00196976|50566808|FG002|Primary Study|Lost to Follow-up|0|||
25250977|NCT00196976|50566809|FG003|Primary Study|Lost to Follow-up|0|||
25250978|NCT00196976|50566810|FG004|Primary Study|Lost to Follow-up|1|||
25250979|NCT00196976|50566811|FG005|Primary Study|Lost to Follow-up|1|||
25250980|NCT00196976|50566812|FG006|Primary Study|Lost to Follow-up|0|||
25250981|NCT00196976|50566813|FG007|Primary Study|Lost to Follow-up|2|||
25250982|NCT00196976|50566814|FG008|Primary Study|Lost to Follow-up|0|||
25250983|NCT00196976|50566815|FG009|Primary Study|Lost to Follow-up|0|||
25250984|NCT00196976|50566816|FG010|Primary Study|Lost to Follow-up|0|||
25250985|NCT00196976|50566817|FG011|Primary Study|Lost to Follow-up|0|||
25250986|NCT00196976|50566818|FG012|Primary Study|Lost to Follow-up|0|||
25250987|NCT00196976|50566819|FG013|Primary Study|Lost to Follow-up|0|||
25250988|NCT00196976|50566806|FG000|Primary Study|Other|0|||
25250989|NCT00196976|50566807|FG001|Primary Study|Other|0|||
25332581|NCT00663208|50648897|FG005|Follow-up Period|Other reason|0|||
25332582|NCT00663208|50648898|FG006|Follow-up Period|Other reason|1|||
25332583|NCT00810810|50648920|FG000|Overall Study|Withdrawal by Subject|0|||
25332584|NCT00810810|50648921|FG001|Overall Study|Withdrawal by Subject|8|||
25332585|NCT00810810|50648922|FG002|Overall Study|Withdrawal by Subject|10|||
25332586|NCT00810810|50648923|FG003|Overall Study|Withdrawal by Subject|8|||
25332587|NCT00810810|50648920|FG000|Overall Study|Physician Decision|0|||
25332588|NCT00810810|50648921|FG001|Overall Study|Physician Decision|3|||
25332589|NCT00810810|50648922|FG002|Overall Study|Physician Decision|1|||
25332590|NCT00810810|50648923|FG003|Overall Study|Physician Decision|5|||
25332591|NCT00661258|50648935|FG000|Overall Study|Death|1|||
25332592|NCT00661258|50648936|FG001|Overall Study|Death|0|||
25332593|NCT00661258|50648935|FG000|Overall Study|caught by police and in detox center|2|||
25332594|NCT00661258|50648936|FG001|Overall Study|caught by police and in detox center|1|||
25332595|NCT00871871|50648944|FG000|Part I|Adverse Event|0|||
25332596|NCT00871871|50648945|FG001|Part I|Adverse Event|2|||
25332597|NCT00871871|50648946|FG002|Part I|Adverse Event|0|||
25332598|NCT00871871|50648947|FG003|Part I|Adverse Event|0|||
25332599|NCT00871871|50648944|FG000|Part I|Withdrawal by Subject|3|||
25332600|NCT00871871|50648945|FG001|Part I|Withdrawal by Subject|0|||
25332601|NCT00871871|50648946|FG002|Part I|Withdrawal by Subject|0|||
25332602|NCT00871871|50648947|FG003|Part I|Withdrawal by Subject|0|||
25332603|NCT00871871|50648944|FG000|Part I|Laboratory abnormality|0|||
25332604|NCT00871871|50648945|FG001|Part I|Laboratory abnormality|1|||
25332605|NCT00871871|50648946|FG002|Part I|Laboratory abnormality|0|||
25332606|NCT00871871|50648947|FG003|Part I|Laboratory abnormality|0|||
25332607|NCT00871871|50648944|FG000|Part II|Lack of Efficacy|0|||
25332608|NCT00871871|50648945|FG001|Part II|Lack of Efficacy|0|||
25332609|NCT00871871|50648946|FG002|Part II|Lack of Efficacy|1|||
25332610|NCT00871871|50648947|FG003|Part II|Lack of Efficacy|0|||
25332611|NCT00871871|50648944|FG000|Part II|Withdrawal by Subject|0|||
25332612|NCT00871871|50648945|FG001|Part II|Withdrawal by Subject|0|||
25332613|NCT00871871|50648946|FG002|Part II|Withdrawal by Subject|2|||
25332614|NCT00871871|50648947|FG003|Part II|Withdrawal by Subject|1|||
25332615|NCT00871871|50648944|FG000|Part II|Adverse Event|0|||
25332616|NCT00871871|50648945|FG001|Part II|Adverse Event|0|||
25332617|NCT00871871|50648946|FG002|Part II|Adverse Event|1|||
25332618|NCT00871871|50648947|FG003|Part II|Adverse Event|2|||
25332619|NCT00871871|50648944|FG000|Part II|Protocol Violation|0|||
25332620|NCT00871871|50648945|FG001|Part II|Protocol Violation|0|||
25332621|NCT00871871|50648946|FG002|Part II|Protocol Violation|0|||
25332622|NCT00871871|50648947|FG003|Part II|Protocol Violation|1|||
25332623|NCT00849680|50648965|FG000|Overall Study|Adverse Event|0|||
25332624|NCT00849680|50648966|FG001|Overall Study|Adverse Event|0|||
25332625|NCT00849680|50648967|FG002|Overall Study|Adverse Event|0|||
25332626|NCT00849680|50648968|FG003|Overall Study|Adverse Event|0|||
25332627|NCT00849680|50648969|FG004|Overall Study|Adverse Event|0|||
25332628|NCT00849680|50648970|FG005|Overall Study|Adverse Event|0|||
24901362|NCT00694707|49995436|FG004|Overall Study|Withdrawal of Consent|15|||
25332629|NCT00849680|50648971|FG006|Overall Study|Adverse Event|2|||
25250990|NCT00196976|50566808|FG002|Primary Study|Other|2|||
25332630|NCT00849680|50648972|FG007|Overall Study|Adverse Event|0|||
25332631|NCT00849680|50648965|FG000|Overall Study|Lost to Follow-up|7|||
25332632|NCT00849680|50648966|FG001|Overall Study|Lost to Follow-up|3|||
25332633|NCT00849680|50648967|FG002|Overall Study|Lost to Follow-up|12|||
25250991|NCT00196976|50566809|FG003|Primary Study|Other|0|||
25250992|NCT00196976|50566810|FG004|Primary Study|Other|0|||
25332634|NCT00849680|50648968|FG003|Overall Study|Lost to Follow-up|11|||
25332635|NCT00849680|50648969|FG004|Overall Study|Lost to Follow-up|8|||
25332636|NCT00849680|50648970|FG005|Overall Study|Lost to Follow-up|11|||
25332637|NCT00849680|50648971|FG006|Overall Study|Lost to Follow-up|12|||
25332638|NCT00849680|50648972|FG007|Overall Study|Lost to Follow-up|5|||
25332639|NCT00849680|50648965|FG000|Overall Study|Subject moved|1|||
25250993|NCT00196976|50566811|FG005|Primary Study|Other|0|||
25250994|NCT00196976|50566812|FG006|Primary Study|Other|0|||
25332640|NCT00849680|50648966|FG001|Overall Study|Subject moved|0|||
25250995|NCT00196976|50566813|FG007|Primary Study|Other|0|||
25250996|NCT00196976|50566814|FG008|Primary Study|Other|0|||
25250997|NCT00196976|50566815|FG009|Primary Study|Other|0|||
25250998|NCT00196976|50566816|FG010|Primary Study|Other|0|||
25250999|NCT00196976|50566817|FG011|Primary Study|Other|0|||
25251000|NCT00196976|50566818|FG012|Primary Study|Other|0|||
25251001|NCT00196976|50566819|FG013|Primary Study|Other|0|||
25332641|NCT00849680|50648967|FG002|Overall Study|Subject moved|3|||
24901363|NCT00694707|49995432|FG000|Overall Study|Lost to Follow-up|0|||
25251002|NCT00196976|50566806|FG000|Booster Study|Withdrawal by Subject|0|||
25251003|NCT00196976|50566807|FG001|Booster Study|Withdrawal by Subject|0|||
25251004|NCT00196976|50566808|FG002|Booster Study|Withdrawal by Subject|0|||
25251005|NCT00196976|50566809|FG003|Booster Study|Withdrawal by Subject|0|||
25251006|NCT00196976|50566810|FG004|Booster Study|Withdrawal by Subject|0|||
25251007|NCT00196976|50566811|FG005|Booster Study|Withdrawal by Subject|0|||
25251008|NCT00196976|50566812|FG006|Booster Study|Withdrawal by Subject|0|||
25251009|NCT00196976|50566813|FG007|Booster Study|Withdrawal by Subject|0|||
25251010|NCT00196976|50566814|FG008|Booster Study|Withdrawal by Subject|0|||
25251011|NCT00196976|50566815|FG009|Booster Study|Withdrawal by Subject|0|||
25251012|NCT00196976|50566816|FG010|Booster Study|Withdrawal by Subject|1|||
25251013|NCT00196976|50566817|FG011|Booster Study|Withdrawal by Subject|0|||
25251014|NCT00196976|50566818|FG012|Booster Study|Withdrawal by Subject|0|||
25251015|NCT00196976|50566819|FG013|Booster Study|Withdrawal by Subject|0|||
25251016|NCT00196976|50566806|FG000|Booster Study|Lost to Follow-up|0|||
25251017|NCT00196976|50566807|FG001|Booster Study|Lost to Follow-up|0|||
25251018|NCT00196976|50566808|FG002|Booster Study|Lost to Follow-up|0|||
24901364|NCT00694707|49995433|FG001|Overall Study|Lost to Follow-up|1|||
24901365|NCT00694707|49995434|FG002|Overall Study|Lost to Follow-up|2|||
24901366|NCT00694707|49995435|FG003|Overall Study|Lost to Follow-up|0|||
24901367|NCT00694707|49995436|FG004|Overall Study|Lost to Follow-up|0|||
24901368|NCT00694707|49995432|FG000|Overall Study|Jeopardizing Parole Status|1|||
24901369|NCT00694707|49995433|FG001|Overall Study|Jeopardizing Parole Status|0|||
24901370|NCT00694707|49995434|FG002|Overall Study|Jeopardizing Parole Status|0|||
24901371|NCT00694707|49995435|FG003|Overall Study|Jeopardizing Parole Status|0|||
24901372|NCT00694707|49995436|FG004|Overall Study|Jeopardizing Parole Status|0|||
24901373|NCT00694707|49995432|FG000|Overall Study|Death in the Family|1|||
24901374|NCT00694707|49995433|FG001|Overall Study|Death in the Family|0|||
24901375|NCT00694707|49995434|FG002|Overall Study|Death in the Family|0|||
24901376|NCT00694707|49995435|FG003|Overall Study|Death in the Family|0|||
24901377|NCT00694707|49995436|FG004|Overall Study|Death in the Family|0|||
24901378|NCT00694707|49995432|FG000|Overall Study|Arrest by Police|0|||
24901379|NCT00694707|49995433|FG001|Overall Study|Arrest by Police|1|||
24901380|NCT00694707|49995434|FG002|Overall Study|Arrest by Police|0|||
24901381|NCT00694707|49995435|FG003|Overall Study|Arrest by Police|0|||
24901382|NCT00694707|49995436|FG004|Overall Study|Arrest by Police|0|||
24901383|NCT00694707|49995432|FG000|Overall Study|Administrative Reasons|0|||
24901384|NCT00694707|49995433|FG001|Overall Study|Administrative Reasons|1|||
24901385|NCT00694707|49995434|FG002|Overall Study|Administrative Reasons|0|||
24901386|NCT00694707|49995435|FG003|Overall Study|Administrative Reasons|2|||
24901387|NCT00694707|49995436|FG004|Overall Study|Administrative Reasons|0|||
24901388|NCT00694707|49995432|FG000|Overall Study|Notification of Past Head Injury|0|||
24901389|NCT00694707|49995433|FG001|Overall Study|Notification of Past Head Injury|0|||
24901390|NCT00694707|49995434|FG002|Overall Study|Notification of Past Head Injury|0|||
24901391|NCT00694707|49995435|FG003|Overall Study|Notification of Past Head Injury|1|||
24901392|NCT00694707|49995436|FG004|Overall Study|Notification of Past Head Injury|0|||
24901393|NCT00692913|49995450|FG000|Overall Study|Adverse Event|8|||
25077886|NCT02233738|50185790|FG001|Overall Study|Lost to Follow-up|12|||
25251019|NCT00196976|50566809|FG003|Booster Study|Lost to Follow-up|0|||
25251020|NCT00196976|50566810|FG004|Booster Study|Lost to Follow-up|0|||
25251021|NCT00196976|50566811|FG005|Booster Study|Lost to Follow-up|0|||
25251022|NCT00196976|50566812|FG006|Booster Study|Lost to Follow-up|0|||
25251023|NCT00196976|50566813|FG007|Booster Study|Lost to Follow-up|0|||
25251024|NCT00196976|50566814|FG008|Booster Study|Lost to Follow-up|0|||
25332642|NCT00849680|50648968|FG003|Overall Study|Subject moved|1|||
25332643|NCT00849680|50648969|FG004|Overall Study|Subject moved|0|||
24901394|NCT00692913|49995451|FG001|Overall Study|Adverse Event|4|||
24901395|NCT00692913|49995450|FG000|Overall Study|Lost to Follow-up|3|||
24901396|NCT00692913|49995451|FG001|Overall Study|Lost to Follow-up|5|||
24901397|NCT00692913|49995450|FG000|Overall Study|Physician Decision|2|||
24901398|NCT00692913|49995451|FG001|Overall Study|Physician Decision|0|||
25251025|NCT00196976|50566815|FG009|Booster Study|Lost to Follow-up|0|||
25251026|NCT00196976|50566816|FG010|Booster Study|Lost to Follow-up|1|||
25251027|NCT00196976|50566817|FG011|Booster Study|Lost to Follow-up|2|||
25332644|NCT00849680|50648970|FG005|Overall Study|Subject moved|2|||
25251028|NCT00196976|50566818|FG012|Booster Study|Lost to Follow-up|0|||
25251029|NCT00196976|50566819|FG013|Booster Study|Lost to Follow-up|0|||
25251030|NCT00196313|50566861|FG000|Overall Study|Protocol Violation|2|||
25251031|NCT00196313|50566862|FG001|Overall Study|Protocol Violation|3|||
25332645|NCT00849680|50648971|FG006|Overall Study|Subject moved|2|||
25332646|NCT00849680|50648972|FG007|Overall Study|Subject moved|2|||
25332647|NCT00849680|50648965|FG000|Overall Study|Withdrawal by Subject|2|||
25332648|NCT00849680|50648966|FG001|Overall Study|Withdrawal by Subject|0|||
25332649|NCT00849680|50648967|FG002|Overall Study|Withdrawal by Subject|0|||
25332650|NCT00849680|50648968|FG003|Overall Study|Withdrawal by Subject|2|||
25332651|NCT00849680|50648969|FG004|Overall Study|Withdrawal by Subject|2|||
25332652|NCT00849680|50648970|FG005|Overall Study|Withdrawal by Subject|2|||
25332653|NCT00849680|50648971|FG006|Overall Study|Withdrawal by Subject|1|||
25332654|NCT00849680|50648972|FG007|Overall Study|Withdrawal by Subject|1|||
25332655|NCT00849680|50648965|FG000|Overall Study|Subject unable to comply with protocol|1|||
25332656|NCT00849680|50648966|FG001|Overall Study|Subject unable to comply with protocol|0|||
25332657|NCT00849680|50648967|FG002|Overall Study|Subject unable to comply with protocol|0|||
25332658|NCT00849680|50648968|FG003|Overall Study|Subject unable to comply with protocol|0|||
25332659|NCT00849680|50648969|FG004|Overall Study|Subject unable to comply with protocol|0|||
25332660|NCT00849680|50648970|FG005|Overall Study|Subject unable to comply with protocol|0|||
25332661|NCT00849680|50648971|FG006|Overall Study|Subject unable to comply with protocol|0|||
25332662|NCT00849680|50648972|FG007|Overall Study|Subject unable to comply with protocol|0|||
25332663|NCT00810342|50648992|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
25332664|NCT00810342|50648993|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
25332665|NCT00810342|50648992|FG000|Month 1 Follow-up|Pregnancy|1|||
25332666|NCT00810342|50648993|FG001|Month 1 Follow-up|Pregnancy|0|||
25332667|NCT00810342|50648992|FG000|6-month Follow-up|Lost to Follow-up|18|||
25332668|NCT00810342|50648993|FG001|6-month Follow-up|Lost to Follow-up|6|||
25332669|NCT00810342|50648992|FG000|6-month Follow-up|Pregnancy|6|||
25332670|NCT00810342|50648993|FG001|6-month Follow-up|Pregnancy|2|||
25332671|NCT00810342|50648992|FG000|12-month Followup|Pregnancy|9|||
25332672|NCT00810342|50648993|FG001|12-month Followup|Pregnancy|10|||
25332673|NCT00810342|50648992|FG000|12-month Followup|Lost to Follow-up|3|||
25332674|NCT00810342|50648993|FG001|12-month Followup|Lost to Follow-up|1|||
25332675|NCT00849524|50649001|FG000|Overall Study|Lack of Efficacy|3|||
25332676|NCT00808080|50649005|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
25332677|NCT00866723|50649010|FG000|Overall Study|Withdrawal by Subject|1|||
25332678|NCT00866723|50649010|FG000|Overall Study|Disease Progression|4|||
25332679|NCT00849290|50649014|FG000|Overall Study|Adverse Event|3|||
25332680|NCT00849290|50649014|FG000|Overall Study|Death|14|||
25332681|NCT00849290|50649014|FG000|Overall Study|Withdrawal by Subject|11|||
25332682|NCT00849290|50649014|FG000|Overall Study|Lost to Follow-up|2|||
25332683|NCT00849290|50649014|FG000|Overall Study|Protocol Violation|5|||
25332684|NCT00849290|50649014|FG000|Overall Study|Disease Progression|20|||
25332685|NCT00849212|50649018|FG000|Overall Study|Lack of Efficacy|1|||
25332686|NCT00849212|50649018|FG000|Overall Study|Withdrawal by Subject|3|||
25332687|NCT00849212|50649018|FG000|Overall Study|Adverse Event|2|||
25251032|NCT00196313|50566861|FG000|Overall Study|Withdrawal by Subject|3|||
25251033|NCT00196313|50566862|FG001|Overall Study|Withdrawal by Subject|1|||
25251034|NCT00196313|50566861|FG000|Overall Study|Adverse Event|3|||
25251035|NCT00196313|50566862|FG001|Overall Study|Adverse Event|1|||
25251036|NCT00196313|50566861|FG000|Overall Study|Subject Pregnant|1|||
25251037|NCT00196313|50566862|FG001|Overall Study|Subject Pregnant|1|||
25251038|NCT00196313|50566861|FG000|Overall Study|Lost to Follow-up|2|||
25251039|NCT00196313|50566862|FG001|Overall Study|Lost to Follow-up|2|||
25251040|NCT00196196|50566869|FG000|Overall Study|Withdrawal by Subject|2|||
25251041|NCT00196196|50566869|FG000|Overall Study|Did not have required condition (hydroce|5|||
25251042|NCT00195650|50566873|FG000|Overall Study|Adverse Event|194|||
25332688|NCT00849212|50649018|FG000|Overall Study|Miscellaneous|1|||
25332689|NCT00810264|50649022|FG000|Overall Study|Lost to Follow-up|191|||
25332690|NCT00810264|50649022|FG000|Overall Study|Withdrawal by subject or physician|721|||
25332691|NCT00810264|50649022|FG000|Overall Study|Death|641|||
25332692|NCT00849056|50649032|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
25251043|NCT00195650|50566873|FG000|Overall Study|Lack of Efficacy|99|||
25251044|NCT00195650|50566873|FG000|Overall Study|Withdrawal by Subject|67|||
25332693|NCT00849056|50649033|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
25332694|NCT00849056|50649032|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
25332695|NCT00849056|50649033|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
25332696|NCT00849056|50649032|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
25332697|NCT00849056|50649033|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
25332698|NCT00849056|50649032|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
25251045|NCT00195650|50566873|FG000|Overall Study|Lost to Follow-up|44|||
25251046|NCT00195650|50566873|FG000|Overall Study|Death|23|||
25251047|NCT00195650|50566873|FG000|Overall Study|Protocol Violation|15|||
25251048|NCT00195650|50566873|FG000|Overall Study|Administrative reasons|83|||
25251049|NCT00195494|50566879|FG000|Year 1|Adverse Event|0|||
25251050|NCT00195494|50566880|FG001|Year 1|Adverse Event|0|||
25251051|NCT00195494|50566881|FG002|Year 1|Adverse Event|0|||
25251052|NCT00195494|50566882|FG003|Year 1|Adverse Event|0|||
25251053|NCT00195494|50566883|FG004|Year 1|Adverse Event|34|||
25251054|NCT00195494|50566884|FG005|Year 1|Adverse Event|27|||
25251055|NCT00195494|50566879|FG000|Year 1|System Toxicity|0|||
25251056|NCT00195494|50566880|FG001|Year 1|System Toxicity|0|||
25251057|NCT00195494|50566881|FG002|Year 1|System Toxicity|0|||
25251058|NCT00195494|50566882|FG003|Year 1|System Toxicity|0|||
25332699|NCT00849056|50649033|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
25332700|NCT00849056|50649032|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
25332701|NCT00849056|50649033|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
25332702|NCT00849056|50649032|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
25332703|NCT00849056|50649033|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
25332704|NCT00849056|50649032|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
25332705|NCT00849056|50649033|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
25332706|NCT00849056|50649032|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
25332707|NCT00849056|50649033|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
25332708|NCT00849056|50649032|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
25332709|NCT00849056|50649033|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
25332710|NCT00849056|50649032|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
25332711|NCT00849056|50649033|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
25332712|NCT00849056|50649032|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
25332713|NCT00849056|50649033|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
25332714|NCT00849056|50649032|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
25332715|NCT00849056|50649033|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
25332716|NCT00849056|50649032|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
25332717|NCT00849056|50649033|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
25332718|NCT00849056|50649032|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
25332719|NCT00849056|50649033|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
25332720|NCT00849056|50649032|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
25332721|NCT00849056|50649033|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
25332722|NCT00849056|50649032|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
25332723|NCT00849056|50649033|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
25332724|NCT00837434|50649041|FG000|Overall Study|Physician Decision|3|||
25332725|NCT00837434|50649042|FG001|Overall Study|Physician Decision|0|||
25332726|NCT00837434|50649041|FG000|Overall Study|Lost to Follow-up|1|||
25332727|NCT00837434|50649042|FG001|Overall Study|Lost to Follow-up|1|||
25332728|NCT00837434|50649041|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
25332729|NCT00837434|50649042|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
25332730|NCT00837434|50649041|FG000|Overall Study|Noncompliant|2|||
25332731|NCT00837434|50649042|FG001|Overall Study|Noncompliant|0|||
25332732|NCT00837434|50649041|FG000|Overall Study|Baseline assessments not done in time|1|||
25332733|NCT00837434|50649042|FG001|Overall Study|Baseline assessments not done in time|0|||
25332734|NCT00837434|50649041|FG000|Overall Study|Unable to obtain study drug|1|||
25332735|NCT00837434|50649042|FG001|Overall Study|Unable to obtain study drug|0|||
25332736|NCT00827918|50649051|FG000|Overall Study|Adverse Event|4|||
25332737|NCT00827918|50649052|FG001|Overall Study|Adverse Event|0|||
25332738|NCT00827918|50649053|FG002|Overall Study|Adverse Event|0|||
25332739|NCT00827918|50649051|FG000|Overall Study|Lack of Efficacy|16|||
25332740|NCT00827918|50649052|FG001|Overall Study|Lack of Efficacy|4|||
25332741|NCT00827918|50649053|FG002|Overall Study|Lack of Efficacy|15|||
25332742|NCT00827918|50649051|FG000|Overall Study|Physician Decision|1|||
25332743|NCT00827918|50649052|FG001|Overall Study|Physician Decision|0|||
25332744|NCT00827918|50649053|FG002|Overall Study|Physician Decision|0|||
25332745|NCT00827918|50649051|FG000|Overall Study|Pregnancy|0|||
25332746|NCT00827918|50649052|FG001|Overall Study|Pregnancy|1|||
25332747|NCT00827918|50649053|FG002|Overall Study|Pregnancy|0|||
25332748|NCT00827918|50649051|FG000|Overall Study|Progressive Disease|1|||
25332749|NCT00827918|50649052|FG001|Overall Study|Progressive Disease|1|||
25332750|NCT00827918|50649053|FG002|Overall Study|Progressive Disease|0|||
25332751|NCT00827918|50649051|FG000|Overall Study|Protocol Violation|0|||
25332752|NCT00827918|50649052|FG001|Overall Study|Protocol Violation|1|||
25332753|NCT00827918|50649053|FG002|Overall Study|Protocol Violation|0|||
25332754|NCT00827918|50649051|FG000|Overall Study|Withdrawal by Subject|6|||
24901399|NCT00692913|49995450|FG000|Overall Study|Protocol Violation|1|||
25251059|NCT00195494|50566883|FG004|Year 1|System Toxicity|0|||
25332755|NCT00827918|50649052|FG001|Overall Study|Withdrawal by Subject|2|||
25332756|NCT00827918|50649053|FG002|Overall Study|Withdrawal by Subject|6|||
25332757|NCT00813150|50649063|FG000|Treatment Period|Adverse Event|16|||
25251060|NCT00195494|50566884|FG005|Year 1|System Toxicity|1|||
25251061|NCT00195494|50566879|FG000|Year 1|Lack of Efficacy|0|||
25251062|NCT00195494|50566880|FG001|Year 1|Lack of Efficacy|0|||
25251063|NCT00195494|50566881|FG002|Year 1|Lack of Efficacy|0|||
25332758|NCT00813150|50649064|FG001|Treatment Period|Adverse Event|15|||
25332759|NCT00813150|50649063|FG000|Treatment Period|Death|2|||
25332760|NCT00813150|50649064|FG001|Treatment Period|Death|0|||
25332761|NCT00813150|50649063|FG000|Treatment Period|Progressive disease|1|||
25332762|NCT00813150|50649064|FG001|Treatment Period|Progressive disease|0|||
25332763|NCT00813150|50649063|FG000|Treatment Period|Complete response|0|||
25332764|NCT00813150|50649064|FG001|Treatment Period|Complete response|1|||
25332765|NCT00813150|50649063|FG000|Treatment Period|Stable disease|1|||
25332766|NCT00813150|50649064|FG001|Treatment Period|Stable disease|2|||
25332767|NCT00813150|50649063|FG000|Treatment Period|Protocol Violation|3|||
25332768|NCT00813150|50649064|FG001|Treatment Period|Protocol Violation|4|||
25332769|NCT00813150|50649063|FG000|Treatment Period|Withdrawal by Subject|5|||
25332770|NCT00813150|50649064|FG001|Treatment Period|Withdrawal by Subject|3|||
25332771|NCT00813150|50649063|FG000|Treatment Period|Non compliance|0|||
25332772|NCT00813150|50649064|FG001|Treatment Period|Non compliance|1|||
25332773|NCT00813150|50649063|FG000|Treatment Period|Reason not specified|3|||
25332774|NCT00813150|50649064|FG001|Treatment Period|Reason not specified|4|||
25332775|NCT00813150|50649063|FG000|Treatment Period|Data not available|1|||
25332776|NCT00813150|50649064|FG001|Treatment Period|Data not available|2|||
25332777|NCT00813150|50649063|FG000|Long Term Follow-up|Death|0|||
25332778|NCT00813150|50649064|FG001|Long Term Follow-up|Death|4|||
25332779|NCT00813150|50649063|FG000|Long Term Follow-up|Other|0|||
25332780|NCT00813150|50649064|FG001|Long Term Follow-up|Other|3|||
25332781|NCT00813150|50649063|FG000|Long Term Follow-up|Lost to Follow-up|2|||
25332782|NCT00813150|50649064|FG001|Long Term Follow-up|Lost to Follow-up|0|||
25332783|NCT00813150|50649063|FG000|Long Term Follow-up|Progression/Relapse|22|||
25332784|NCT00813150|50649064|FG001|Long Term Follow-up|Progression/Relapse|24|||
25332785|NCT00807846|50649072|FG000|Overall Study|Adverse Event|5|||
25332786|NCT00807846|50649073|FG001|Overall Study|Adverse Event|0|||
25332787|NCT00807846|50649072|FG000|Overall Study|Lack of Efficacy|2|||
25332788|NCT00807846|50649073|FG001|Overall Study|Lack of Efficacy|0|||
25332789|NCT00807846|50649072|FG000|Overall Study|Protocol Violation|2|||
25332790|NCT00807846|50649073|FG001|Overall Study|Protocol Violation|1|||
25332791|NCT00807846|50649072|FG000|Overall Study|Withdrawal by Subject|2|||
25332792|NCT00807846|50649073|FG001|Overall Study|Withdrawal by Subject|1|||
25332793|NCT00807846|50649072|FG000|Overall Study|Other|1|||
25332794|NCT00807846|50649073|FG001|Overall Study|Other|2|||
25332795|NCT00810108|50649081|FG000|Overall Study|Withdrawal by Subject|1|||
25332796|NCT00810108|50649082|FG001|Overall Study|Withdrawal by Subject|0|||
25332797|NCT00827606|50649089|FG000|Overall Study|Protocol Violation|4|||
25332798|NCT00827606|50649090|FG001|Overall Study|Protocol Violation|3|||
25332799|NCT00827606|50649089|FG000|Overall Study|Lost to Follow-up|3|||
25332800|NCT00827606|50649090|FG001|Overall Study|Lost to Follow-up|1|||
25332801|NCT00827606|50649089|FG000|Overall Study|Withdrawal by Subject|7|||
25332802|NCT00827606|50649090|FG001|Overall Study|Withdrawal by Subject|6|||
25332803|NCT00827606|50649089|FG000|Overall Study|Pregnancy|0|||
25332804|NCT00827606|50649090|FG001|Overall Study|Pregnancy|1|||
25332805|NCT00827606|50649089|FG000|Overall Study|Other|5|||
25332806|NCT00827606|50649090|FG001|Overall Study|Other|13|||
25332807|NCT00827606|50649089|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
25332808|NCT00827606|50649090|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
25332809|NCT00827606|50649089|FG000|Overall Study|Adverse Event|4|||
25332810|NCT00827606|50649090|FG001|Overall Study|Adverse Event|2|||
25332811|NCT00663052|50649104|FG000|Overall Study|Adverse Event|6|||
25332812|NCT00663052|50649105|FG001|Overall Study|Adverse Event|3|||
25332813|NCT00663052|50649104|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
25332814|NCT00663052|50649105|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
25332815|NCT00663052|50649104|FG000|Overall Study|Protocol Violation|1|||
25332816|NCT00663052|50649105|FG001|Overall Study|Protocol Violation|0|||
25332817|NCT00663052|50649104|FG000|Overall Study|Withdrawal by Subject|2|||
25332818|NCT00663052|50649105|FG001|Overall Study|Withdrawal by Subject|5|||
25332819|NCT00663052|50649104|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
25332820|NCT00663052|50649105|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
25332821|NCT00663052|50649104|FG000|Overall Study|Other|0|||
25332822|NCT00663052|50649105|FG001|Overall Study|Other|1|||
25332823|NCT00827372|50649111|FG000|Overall Study|Adverse Event|5|||
25332824|NCT00827372|50649111|FG000|Overall Study|Lack of Efficacy|3|||
25332825|NCT00826748|50649119|FG000|Overall Study|Withdrawal by Subject|0|||
25332826|NCT00826748|50649120|FG001|Overall Study|Withdrawal by Subject|0|||
25332827|NCT00826748|50649121|FG002|Overall Study|Withdrawal by Subject|2|||
25332828|NCT00826748|50649119|FG000|Overall Study|Physician Decision|0|||
25332829|NCT00826748|50649120|FG001|Overall Study|Physician Decision|0|||
25332830|NCT00826748|50649121|FG002|Overall Study|Physician Decision|1|||
25332831|NCT00826748|50649119|FG000|Overall Study|Samples Did Not pass QC|0|||
25332832|NCT00826748|50649120|FG001|Overall Study|Samples Did Not pass QC|0|||
25332833|NCT00826748|50649121|FG002|Overall Study|Samples Did Not pass QC|1|||
25332834|NCT00806988|50649131|FG000|Overall Study|Death|15|||
25332835|NCT00806988|50649132|FG001|Overall Study|Death|16|||
25332836|NCT00806988|50649131|FG000|Overall Study|Withdrawal by Subject|8|||
25332837|NCT00806988|50649132|FG001|Overall Study|Withdrawal by Subject|8|||
25332838|NCT00806988|50649131|FG000|Overall Study|Lost to Follow-up|4|||
25332839|NCT00806988|50649132|FG001|Overall Study|Lost to Follow-up|19|||
25332840|NCT00807144|50649140|FG000|Overall Study|Lost to Follow-up|0|||
25332841|NCT00807144|50649141|FG001|Overall Study|Lost to Follow-up|1|||
25332842|NCT00591006|50649147|FG000|Overall Study|Withdrawal by Subject|0|||
25332843|NCT00591006|50649148|FG001|Overall Study|Withdrawal by Subject|0|||
25332844|NCT00591006|50649149|FG002|Overall Study|Withdrawal by Subject|0|||
25332845|NCT00591006|50649150|FG003|Overall Study|Withdrawal by Subject|0|||
25332846|NCT00591006|50649151|FG004|Overall Study|Withdrawal by Subject|0|||
25332847|NCT00591006|50649152|FG005|Overall Study|Withdrawal by Subject|0|||
25332848|NCT00591006|50649153|FG006|Overall Study|Withdrawal by Subject|0|||
25332849|NCT00591006|50649154|FG007|Overall Study|Withdrawal by Subject|0|||
25332850|NCT00591006|50649155|FG008|Overall Study|Withdrawal by Subject|0|||
25332851|NCT00591006|50649156|FG009|Overall Study|Withdrawal by Subject|0|||
25332852|NCT00591006|50649157|FG010|Overall Study|Withdrawal by Subject|0|||
25251064|NCT00195494|50566882|FG003|Year 1|Lack of Efficacy|0|||
25332853|NCT00591006|50649158|FG011|Overall Study|Withdrawal by Subject|0|||
25332854|NCT00591006|50649159|FG012|Overall Study|Withdrawal by Subject|0|||
25332855|NCT00591006|50649160|FG013|Overall Study|Withdrawal by Subject|0|||
25332856|NCT00591006|50649161|FG014|Overall Study|Withdrawal by Subject|0|||
25332857|NCT00591006|50649162|FG015|Overall Study|Withdrawal by Subject|1|||
25332858|NCT00591006|50649163|FG016|Overall Study|Withdrawal by Subject|0|||
25332859|NCT00591006|50649164|FG017|Overall Study|Withdrawal by Subject|0|||
25251065|NCT00195494|50566883|FG004|Year 1|Lack of Efficacy|24|||
25251066|NCT00195494|50566884|FG005|Year 1|Lack of Efficacy|9|||
25251067|NCT00195494|50566879|FG000|Year 1|Compliance|0|||
25251068|NCT00195494|50566880|FG001|Year 1|Compliance|0|||
25251069|NCT00195494|50566881|FG002|Year 1|Compliance|0|||
25251070|NCT00195494|50566882|FG003|Year 1|Compliance|0|||
25332860|NCT00591006|50649165|FG018|Overall Study|Withdrawal by Subject|0|||
25332861|NCT00591006|50649166|FG019|Overall Study|Withdrawal by Subject|0|||
25332862|NCT00591006|50649167|FG020|Overall Study|Withdrawal by Subject|0|||
25332863|NCT00591006|50649168|FG021|Overall Study|Withdrawal by Subject|0|||
25332864|NCT00591006|50649169|FG022|Overall Study|Withdrawal by Subject|0|||
25332865|NCT00591006|50649170|FG023|Overall Study|Withdrawal by Subject|1|||
25332866|NCT00591006|50649147|FG000|Overall Study|Adverse Event|0|||
25332867|NCT00591006|50649148|FG001|Overall Study|Adverse Event|0|||
25332868|NCT00591006|50649149|FG002|Overall Study|Adverse Event|0|||
25332869|NCT00591006|50649150|FG003|Overall Study|Adverse Event|0|||
25332870|NCT00591006|50649151|FG004|Overall Study|Adverse Event|0|||
25332871|NCT00591006|50649152|FG005|Overall Study|Adverse Event|0|||
25332872|NCT00591006|50649153|FG006|Overall Study|Adverse Event|0|||
25332873|NCT00591006|50649154|FG007|Overall Study|Adverse Event|0|||
25332874|NCT00591006|50649155|FG008|Overall Study|Adverse Event|0|||
25332875|NCT00591006|50649156|FG009|Overall Study|Adverse Event|0|||
25332876|NCT00591006|50649157|FG010|Overall Study|Adverse Event|0|||
25332877|NCT00591006|50649158|FG011|Overall Study|Adverse Event|0|||
25332878|NCT00591006|50649159|FG012|Overall Study|Adverse Event|0|||
25332879|NCT00591006|50649160|FG013|Overall Study|Adverse Event|0|||
25332880|NCT00591006|50649161|FG014|Overall Study|Adverse Event|0|||
25332881|NCT00591006|50649162|FG015|Overall Study|Adverse Event|0|||
25332882|NCT00591006|50649163|FG016|Overall Study|Adverse Event|0|||
25332883|NCT00591006|50649164|FG017|Overall Study|Adverse Event|0|||
25332884|NCT00591006|50649165|FG018|Overall Study|Adverse Event|0|||
25332885|NCT00591006|50649166|FG019|Overall Study|Adverse Event|0|||
25332886|NCT00591006|50649167|FG020|Overall Study|Adverse Event|0|||
25332887|NCT00591006|50649168|FG021|Overall Study|Adverse Event|0|||
25332888|NCT00591006|50649169|FG022|Overall Study|Adverse Event|1|||
25251071|NCT00195494|50566883|FG004|Year 1|Compliance|5|||
25332889|NCT00591006|50649170|FG023|Overall Study|Adverse Event|0|||
25332890|NCT00844844|50649187|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
25332891|NCT00844844|50649187|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
25332892|NCT00844844|50649187|FG000|Extension Treatment Period|Adverse Event|2|||
25332893|NCT00844844|50649187|FG000|Post Treatment Period|Withdrawal by Subject|1|||
25332894|NCT00660790|50649191|FG000|Baseline to 3 Months|Death|1|||
25332895|NCT00660790|50649191|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
25332896|NCT00660790|50649191|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
25332897|NCT00836810|50649197|FG000|Overall Study|New diagnosis|1|||
25332898|NCT00836810|50649198|FG001|Overall Study|New diagnosis|0|||
25332899|NCT00658684|50649207|FG000|Overall Study|Adverse Event|10|||
25332900|NCT00658684|50649208|FG001|Overall Study|Adverse Event|8|||
25332901|NCT00658684|50649209|FG002|Overall Study|Adverse Event|2|||
25332902|NCT00658684|50649210|FG003|Overall Study|Adverse Event|0|||
25332903|NCT00658684|50649207|FG000|Overall Study|Withdrawal by Subject|6|||
24901400|NCT00692913|49995451|FG001|Overall Study|Protocol Violation|1|||
24901401|NCT00692913|49995450|FG000|Overall Study|Withdrawal by Subject|15|||
25251072|NCT00195494|50566884|FG005|Year 1|Compliance|1|||
25251073|NCT00195494|50566879|FG000|Year 1|Lost to Follow-up|0|||
25251074|NCT00195494|50566880|FG001|Year 1|Lost to Follow-up|0|||
25251075|NCT00195494|50566881|FG002|Year 1|Lost to Follow-up|0|||
25251076|NCT00195494|50566882|FG003|Year 1|Lost to Follow-up|0|||
25251077|NCT00195494|50566883|FG004|Year 1|Lost to Follow-up|1|||
25251078|NCT00195494|50566884|FG005|Year 1|Lost to Follow-up|0|||
25251079|NCT00195494|50566879|FG000|Year 1|Missed >4 consecutive doses|0|||
25251080|NCT00195494|50566880|FG001|Year 1|Missed >4 consecutive doses|0|||
25251081|NCT00195494|50566881|FG002|Year 1|Missed >4 consecutive doses|0|||
25251082|NCT00195494|50566882|FG003|Year 1|Missed >4 consecutive doses|0|||
25332904|NCT00658684|50649208|FG001|Overall Study|Withdrawal by Subject|4|||
25332905|NCT00658684|50649209|FG002|Overall Study|Withdrawal by Subject|1|||
25332906|NCT00658684|50649210|FG003|Overall Study|Withdrawal by Subject|1|||
25332907|NCT00658684|50649207|FG000|Overall Study|Lack of Efficacy|1|||
25332908|NCT00658684|50649208|FG001|Overall Study|Lack of Efficacy|1|||
25332909|NCT00658684|50649209|FG002|Overall Study|Lack of Efficacy|0|||
25332910|NCT00658684|50649210|FG003|Overall Study|Lack of Efficacy|0|||
25332911|NCT00658684|50649207|FG000|Overall Study|Protocol Violation|1|||
25332912|NCT00658684|50649208|FG001|Overall Study|Protocol Violation|1|||
25332913|NCT00658684|50649209|FG002|Overall Study|Protocol Violation|0|||
25332914|NCT00658684|50649210|FG003|Overall Study|Protocol Violation|0|||
25332915|NCT00658684|50649207|FG000|Overall Study|Pregnancy|1|||
25332916|NCT00658684|50649208|FG001|Overall Study|Pregnancy|1|||
25332917|NCT00658684|50649209|FG002|Overall Study|Pregnancy|0|||
25251083|NCT00195494|50566883|FG004|Year 1|Missed >4 consecutive doses|3|||
25251084|NCT00195494|50566884|FG005|Year 1|Missed >4 consecutive doses|2|||
25332918|NCT00658684|50649210|FG003|Overall Study|Pregnancy|0|||
25332919|NCT00660400|50649220|FG000|Overall Study|Lack of insurance approval|1|||
25332920|NCT00660400|50649220|FG000|Overall Study|Suboptimal organ function|1|||
25332921|NCT00660400|50649220|FG000|Overall Study|Intracranial hemorrhage|1|||
25332922|NCT00660400|50649220|FG000|Overall Study|Withdrawal by Subject|1|||
25332923|NCT00826514|50649226|FG000|Overall Study|Adverse Event|1|||
25332924|NCT00826514|50649227|FG001|Overall Study|Adverse Event|1|||
25332925|NCT00826514|50649226|FG000|Overall Study|Lack of Efficacy|0|||
25332926|NCT00826514|50649227|FG001|Overall Study|Lack of Efficacy|1|||
25332927|NCT00826514|50649226|FG000|Overall Study|Withdrawal by Subject|2|||
25332928|NCT00826514|50649227|FG001|Overall Study|Withdrawal by Subject|3|||
25332929|NCT00826280|50649236|FG000|Overall Study|Randomized but drug not received|1|||
25332930|NCT00826280|50649237|FG001|Overall Study|Randomized but drug not received|0|||
25332931|NCT00826280|50649238|FG002|Overall Study|Randomized but drug not received|1|||
25332932|NCT00826280|50649236|FG000|Overall Study|Adverse Event|1|||
25332933|NCT00826280|50649237|FG001|Overall Study|Adverse Event|3|||
25332934|NCT00826280|50649238|FG002|Overall Study|Adverse Event|0|||
25332935|NCT00826280|50649236|FG000|Overall Study|Lost to Follow-up|0|||
25332936|NCT00826280|50649237|FG001|Overall Study|Lost to Follow-up|1|||
25332937|NCT00826280|50649238|FG002|Overall Study|Lost to Follow-up|0|||
25332938|NCT00826280|50649236|FG000|Overall Study|Sponsor discontinued subject or study|1|||
25332939|NCT00826280|50649237|FG001|Overall Study|Sponsor discontinued subject or study|0|||
25332940|NCT00826280|50649238|FG002|Overall Study|Sponsor discontinued subject or study|0|||
25332941|NCT00826280|50649236|FG000|Overall Study|Reversible ischemic defect not present|43|||
25332942|NCT00826280|50649237|FG001|Overall Study|Reversible ischemic defect not present|40|||
25332943|NCT00826280|50649238|FG002|Overall Study|Reversible ischemic defect not present|44|||
25332944|NCT00826280|50649236|FG000|Overall Study|Interpretation Failure|1|||
25332945|NCT00826280|50649237|FG001|Overall Study|Interpretation Failure|0|||
25332946|NCT00826280|50649238|FG002|Overall Study|Interpretation Failure|0|||
25332947|NCT00826280|50649236|FG000|Overall Study|Machine Failure|1|||
25332948|NCT00826280|50649237|FG001|Overall Study|Machine Failure|1|||
25332949|NCT00826280|50649238|FG002|Overall Study|Machine Failure|0|||
25332950|NCT00826280|50649236|FG000|Overall Study|One or more non-interpretable scan|0|||
25332951|NCT00826280|50649237|FG001|Overall Study|One or more non-interpretable scan|1|||
25332952|NCT00826280|50649238|FG002|Overall Study|One or more non-interpretable scan|1|||
25332953|NCT00864851|50649249|FG000|Overall Study|Withdrawal by Subject|0|||
25332954|NCT00864851|50649250|FG001|Overall Study|Withdrawal by Subject|1|||
25332955|NCT00864851|50649251|FG002|Overall Study|Withdrawal by Subject|0|||
25332956|NCT00864851|50649249|FG000|Overall Study|Physician Decision|1|||
25332957|NCT00864851|50649250|FG001|Overall Study|Physician Decision|0|||
25332958|NCT00864851|50649251|FG002|Overall Study|Physician Decision|0|||
24901402|NCT00692913|49995451|FG001|Overall Study|Withdrawal by Subject|20|||
25332959|NCT00864851|50649249|FG000|Overall Study|Death|1|||
25332960|NCT00864851|50649250|FG001|Overall Study|Death|0|||
25332961|NCT00864851|50649251|FG002|Overall Study|Death|0|||
25332962|NCT00864851|50649249|FG000|Overall Study|Patient uncooperative|1|||
25332963|NCT00864851|50649250|FG001|Overall Study|Patient uncooperative|0|||
25332964|NCT00864851|50649251|FG002|Overall Study|Patient uncooperative|0|||
25332965|NCT00857207|50649263|FG000|Overall Study|Withdrawal by Subject|13|||
25332966|NCT00857207|50649264|FG001|Overall Study|Withdrawal by Subject|0|||
25251085|NCT00195494|50566879|FG000|Year 1|Protocol deviation|0|||
25251086|NCT00195494|50566880|FG001|Year 1|Protocol deviation|0|||
25251087|NCT00195494|50566881|FG002|Year 1|Protocol deviation|0|||
25332967|NCT00857207|50649263|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
25332968|NCT00857207|50649264|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
25332969|NCT00857207|50649263|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
25332970|NCT00857207|50649264|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
25332971|NCT00836498|50649273|FG000|Overall Study|Adverse Event|1|||
25332972|NCT00836498|50649274|FG001|Overall Study|Adverse Event|0|||
25332973|NCT00836498|50649273|FG000|Overall Study|Lost to Follow-up|1|||
25332974|NCT00836498|50649274|FG001|Overall Study|Lost to Follow-up|0|||
25332975|NCT00836498|50649273|FG000|Overall Study|Withdrawal by Subject|2|||
25332976|NCT00836498|50649274|FG001|Overall Study|Withdrawal by Subject|1|||
25332977|NCT00856973|50649284|FG000|Overall Study|Adverse Event|5|||
25332978|NCT00856973|50649285|FG001|Overall Study|Adverse Event|5|||
25332979|NCT00856973|50649286|FG002|Overall Study|Adverse Event|3|||
25332980|NCT00856973|50649284|FG000|Overall Study|Lost to Follow-up|6|||
25332981|NCT00856973|50649285|FG001|Overall Study|Lost to Follow-up|3|||
25332982|NCT00856973|50649286|FG002|Overall Study|Lost to Follow-up|5|||
25332983|NCT00856973|50649284|FG000|Overall Study|Physician Decision|0|||
25332984|NCT00856973|50649285|FG001|Overall Study|Physician Decision|3|||
25332985|NCT00856973|50649286|FG002|Overall Study|Physician Decision|1|||
25332986|NCT00856973|50649284|FG000|Overall Study|Protocol Violation|1|||
25251088|NCT00195494|50566882|FG003|Year 1|Protocol deviation|0|||
25251089|NCT00195494|50566883|FG004|Year 1|Protocol deviation|2|||
25251090|NCT00195494|50566884|FG005|Year 1|Protocol deviation|3|||
25251091|NCT00195494|50566879|FG000|Year 1|Physician Decision|0|||
25251092|NCT00195494|50566880|FG001|Year 1|Physician Decision|0|||
25251093|NCT00195494|50566881|FG002|Year 1|Physician Decision|0|||
25251094|NCT00195494|50566882|FG003|Year 1|Physician Decision|0|||
25332987|NCT00856973|50649285|FG001|Overall Study|Protocol Violation|2|||
25332988|NCT00856973|50649286|FG002|Overall Study|Protocol Violation|1|||
25332989|NCT00856973|50649284|FG000|Overall Study|Withdrawal by Subject|13|||
25332990|NCT00856973|50649285|FG001|Overall Study|Withdrawal by Subject|16|||
25332991|NCT00856973|50649286|FG002|Overall Study|Withdrawal by Subject|15|||
25332992|NCT00856973|50649284|FG000|Overall Study|Other|11|||
25332993|NCT00856973|50649285|FG001|Overall Study|Other|12|||
25332994|NCT00856973|50649286|FG002|Overall Study|Other|13|||
25332995|NCT00844532|50649298|FG000|Overall Study|Death|16|||
25332996|NCT00844532|50649298|FG000|Overall Study|Withdrawal by Subject|16|||
25332997|NCT00844532|50649298|FG000|Overall Study|Lost to Follow-up|7|||
25332998|NCT00805194|50649304|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
25332999|NCT00805194|50649305|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
25333000|NCT00805194|50649304|FG000|Overall Study|Worsening or AE of underlying disease|64|||
25333001|NCT00805194|50649305|FG001|Overall Study|Worsening or AE of underlying disease|70|||
25251095|NCT00195494|50566883|FG004|Year 1|Physician Decision|1|||
25251096|NCT00195494|50566884|FG005|Year 1|Physician Decision|0|||
25333002|NCT00805194|50649304|FG000|Overall Study|Other AE|84|||
25333003|NCT00805194|50649305|FG001|Overall Study|Other AE|73|||
25333004|NCT00805194|50649304|FG000|Overall Study|Protocol Violation|9|||
25333005|NCT00805194|50649305|FG001|Overall Study|Protocol Violation|9|||
25077887|NCT02233738|50185789|FG000|Overall Study|Death|0|||
25333006|NCT00805194|50649304|FG000|Overall Study|Lost to Follow-up|5|||
25333007|NCT00805194|50649305|FG001|Overall Study|Lost to Follow-up|5|||
25333008|NCT00805194|50649304|FG000|Overall Study|Withdrawal by Subject|60|||
25333009|NCT00805194|50649305|FG001|Overall Study|Withdrawal by Subject|42|||
25333010|NCT00805194|50649304|FG000|Overall Study|Not treated|3|||
25333011|NCT00805194|50649305|FG001|Overall Study|Not treated|4|||
25333012|NCT00805194|50649304|FG000|Overall Study|Reasons other than stated above|20|||
25333013|NCT00805194|50649305|FG001|Overall Study|Reasons other than stated above|16|||
25333014|NCT00836186|50649316|FG000|Overall Study|Blood could not be drawn|1|||
25333015|NCT00657046|50649324|FG000|Overall Study|Adverse Event|1|||
25333016|NCT00657046|50649325|FG001|Overall Study|Adverse Event|1|||
24901403|NCT00694551|49995460|FG000|Overall Study|Disease Progression|1|||
24901404|NCT00694551|49995461|FG001|Overall Study|Disease Progression|0|||
24901405|NCT00694551|49995462|FG002|Overall Study|Disease Progression|1|||
24901406|NCT00689871|49995475|FG000|Overall Study|Lost to Follow-up|123|||
24901407|NCT00689871|49995476|FG001|Overall Study|Lost to Follow-up|13|||
25333017|NCT00657046|50649326|FG002|Overall Study|Adverse Event|0|||
25333018|NCT00657046|50649324|FG000|Overall Study|Protocol Violation|2|||
24901408|NCT00689871|49995477|FG002|Overall Study|Lost to Follow-up|37|||
24901409|NCT00689871|49995478|FG003|Overall Study|Lost to Follow-up|1|||
24901410|NCT00689871|49995475|FG000|Overall Study|Explanted of All Study Devices|36|||
25077888|NCT02233738|50185790|FG001|Overall Study|Death|1|||
25251097|NCT00195494|50566879|FG000|Year 1|Withdrawal by Subject|0|||
25251098|NCT00195494|50566880|FG001|Year 1|Withdrawal by Subject|0|||
25251099|NCT00195494|50566881|FG002|Year 1|Withdrawal by Subject|0|||
25333019|NCT00657046|50649325|FG001|Overall Study|Protocol Violation|2|||
25333020|NCT00657046|50649326|FG002|Overall Study|Protocol Violation|0|||
25333021|NCT00657046|50649324|FG000|Overall Study|Withdrawal by Subject|1|||
25333022|NCT00657046|50649325|FG001|Overall Study|Withdrawal by Subject|0|||
25333023|NCT00657046|50649326|FG002|Overall Study|Withdrawal by Subject|0|||
25333024|NCT00657046|50649324|FG000|Overall Study|Death|0|||
25333025|NCT00657046|50649325|FG001|Overall Study|Death|0|||
25333026|NCT00657046|50649326|FG002|Overall Study|Death|1|||
25333027|NCT00657046|50649324|FG000|Overall Study|Surgery|0|||
25333028|NCT00657046|50649325|FG001|Overall Study|Surgery|0|||
25333029|NCT00657046|50649326|FG002|Overall Study|Surgery|1|||
25333030|NCT00856661|50649336|FG000|Overall Study|Death|15|||
25333031|NCT00856661|50649337|FG001|Overall Study|Death|18|||
25333032|NCT00856661|50649336|FG000|Overall Study|Protocol Violation|2|||
25333033|NCT00856661|50649337|FG001|Overall Study|Protocol Violation|1|||
25333034|NCT00856661|50649336|FG000|Overall Study|Withdrawal by Subject|1|||
25333035|NCT00856661|50649337|FG001|Overall Study|Withdrawal by Subject|2|||
25333036|NCT00856661|50649336|FG000|Overall Study|Lost to Follow-up|1|||
25333037|NCT00856661|50649337|FG001|Overall Study|Lost to Follow-up|3|||
25333038|NCT00856661|50649336|FG000|Overall Study|Physician Judgement|8|||
25251100|NCT00195494|50566882|FG003|Year 1|Withdrawal by Subject|0|||
25251101|NCT00195494|50566883|FG004|Year 1|Withdrawal by Subject|8|||
25251102|NCT00195494|50566884|FG005|Year 1|Withdrawal by Subject|9|||
25251103|NCT00195494|50566879|FG000|Year 1|Protocol Violation|0|||
25251104|NCT00195494|50566880|FG001|Year 1|Protocol Violation|0|||
25251105|NCT00195494|50566881|FG002|Year 1|Protocol Violation|0|||
25333039|NCT00856661|50649337|FG001|Overall Study|Physician Judgement|5|||
25333040|NCT00844376|50649343|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
25333041|NCT00844376|50649344|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
25333042|NCT00658606|50649352|FG000|Overall Study|Adverse Event|2|||
25333043|NCT00658606|50649353|FG001|Overall Study|Adverse Event|1|||
25333044|NCT00658606|50649352|FG000|Overall Study|Lack of Efficacy|6|||
25333045|NCT00658606|50649353|FG001|Overall Study|Lack of Efficacy|3|||
25333046|NCT00658606|50649352|FG000|Overall Study|Lost to Follow-up|1|||
25333047|NCT00658606|50649353|FG001|Overall Study|Lost to Follow-up|0|||
25333048|NCT00658606|50649352|FG000|Overall Study|Withdrawal by Subject|7|||
25333049|NCT00658606|50649353|FG001|Overall Study|Withdrawal by Subject|16|||
25333050|NCT00658606|50649352|FG000|Overall Study|Lack of Compliance|0|||
25333051|NCT00658606|50649353|FG001|Overall Study|Lack of Compliance|3|||
25333052|NCT00589290|50649359|FG000|Overall Study|Withdrawal by Subject|1|||
25333053|NCT00843518|50649367|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
25333054|NCT00843518|50649368|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
25333055|NCT00843518|50649367|FG000|Period 2 (Double-blind Treatment)|Death|0|||
25333056|NCT00843518|50649368|FG001|Period 2 (Double-blind Treatment)|Death|1|||
25333057|NCT00843518|50649367|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
25333058|NCT00843518|50649368|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
25333059|NCT00843518|50649367|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
25333060|NCT00843518|50649368|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
25333061|NCT00843518|50649367|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
25333062|NCT00843518|50649368|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
25251106|NCT00195494|50566882|FG003|Year 1|Protocol Violation|0|||
25251107|NCT00195494|50566883|FG004|Year 1|Protocol Violation|1|||
25251108|NCT00195494|50566884|FG005|Year 1|Protocol Violation|1|||
25251109|NCT00195494|50566879|FG000|Year 2|Adverse Event|3|||
25251110|NCT00195494|50566880|FG001|Year 2|Adverse Event|7|||
25251111|NCT00195494|50566881|FG002|Year 2|Adverse Event|5|||
25251112|NCT00195494|50566882|FG003|Year 2|Adverse Event|9|||
25251113|NCT00195494|50566883|FG004|Year 2|Adverse Event|0|||
25251114|NCT00195494|50566884|FG005|Year 2|Adverse Event|0|||
25251115|NCT00195494|50566879|FG000|Year 2|Lack of Efficacy|0|||
25251116|NCT00195494|50566880|FG001|Year 2|Lack of Efficacy|1|||
25251117|NCT00195494|50566881|FG002|Year 2|Lack of Efficacy|7|||
25251118|NCT00195494|50566882|FG003|Year 2|Lack of Efficacy|7|||
25251119|NCT00195494|50566883|FG004|Year 2|Lack of Efficacy|0|||
25333063|NCT00843518|50649367|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
25333064|NCT00843518|50649368|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
25333065|NCT00843518|50649367|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
25333066|NCT00843518|50649368|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
25333067|NCT00843284|50649378|FG000|Overall Study|Adverse Event|39|||
25333068|NCT00843284|50649378|FG000|Overall Study|Lack of Efficacy|5|||
25333069|NCT00843284|50649378|FG000|Overall Study|Lost to Follow-up|11|||
25333070|NCT00843284|50649378|FG000|Overall Study|Other|10|||
25333071|NCT00843284|50649378|FG000|Overall Study|Withdrawal by Subject|4|||
25333072|NCT00843284|50649378|FG000|Overall Study|Death|3|||
25333073|NCT00652834|50649395|FG000|Overall Study|Withdrawal by Subject|3|||
25333074|NCT00652834|50649395|FG000|Overall Study|Lost to Follow-up|2|||
25333075|NCT00825812|50649403|FG000|Overall Study|Never entered follow up|0|||
25333076|NCT00825812|50649404|FG001|Overall Study|Never entered follow up|0|||
25251120|NCT00195494|50566884|FG005|Year 2|Lack of Efficacy|0|||
25251121|NCT00195494|50566879|FG000|Year 2|Compliance|1|||
25251122|NCT00195494|50566880|FG001|Year 2|Compliance|0|||
25251123|NCT00195494|50566881|FG002|Year 2|Compliance|0|||
25251124|NCT00195494|50566882|FG003|Year 2|Compliance|2|||
25251125|NCT00195494|50566883|FG004|Year 2|Compliance|0|||
25251126|NCT00195494|50566884|FG005|Year 2|Compliance|0|||
25251127|NCT00195494|50566879|FG000|Year 2|Lost to Follow-up|0|||
25251128|NCT00195494|50566880|FG001|Year 2|Lost to Follow-up|0|||
25251129|NCT00195494|50566881|FG002|Year 2|Lost to Follow-up|1|||
25251130|NCT00195494|50566882|FG003|Year 2|Lost to Follow-up|1|||
25251131|NCT00195494|50566883|FG004|Year 2|Lost to Follow-up|0|||
25251132|NCT00195494|50566884|FG005|Year 2|Lost to Follow-up|0|||
25251133|NCT00195494|50566879|FG000|Year 2|Missed >4 consecutive doses|1|||
25251134|NCT00195494|50566880|FG001|Year 2|Missed >4 consecutive doses|1|||
25251135|NCT00195494|50566881|FG002|Year 2|Missed >4 consecutive doses|1|||
25333077|NCT00825812|50649405|FG002|Overall Study|Never entered follow up|0|||
25333078|NCT00825812|50649406|FG003|Overall Study|Never entered follow up|1|||
25333079|NCT00825812|50649403|FG000|Overall Study|Adverse Event|0|||
25333080|NCT00825812|50649404|FG001|Overall Study|Adverse Event|0|||
25333081|NCT00825812|50649405|FG002|Overall Study|Adverse Event|0|||
25333082|NCT00825812|50649406|FG003|Overall Study|Adverse Event|1|||
25333083|NCT00825812|50649403|FG000|Overall Study|Subject withdrew consent|0|||
25333084|NCT00825812|50649404|FG001|Overall Study|Subject withdrew consent|0|||
25333085|NCT00825812|50649405|FG002|Overall Study|Subject withdrew consent|3|||
25333086|NCT00825812|50649406|FG003|Overall Study|Subject withdrew consent|2|||
25333087|NCT00825812|50649403|FG000|Overall Study|Non-compliance with protocol|0|||
25333088|NCT00825812|50649404|FG001|Overall Study|Non-compliance with protocol|0|||
25333089|NCT00825812|50649405|FG002|Overall Study|Non-compliance with protocol|0|||
25333090|NCT00825812|50649406|FG003|Overall Study|Non-compliance with protocol|1|||
25333091|NCT00825812|50649403|FG000|Overall Study|Administrative|0|||
25333092|NCT00825812|50649404|FG001|Overall Study|Administrative|1|||
25333093|NCT00825812|50649405|FG002|Overall Study|Administrative|3|||
25333094|NCT00825812|50649406|FG003|Overall Study|Administrative|5|||
25251136|NCT00195494|50566882|FG003|Year 2|Missed >4 consecutive doses|0|||
25251137|NCT00195494|50566883|FG004|Year 2|Missed >4 consecutive doses|0|||
25251138|NCT00195494|50566884|FG005|Year 2|Missed >4 consecutive doses|0|||
25251139|NCT00195494|50566879|FG000|Year 2|Protocol deviation|0|||
25251140|NCT00195494|50566880|FG001|Year 2|Protocol deviation|1|||
25251141|NCT00195494|50566881|FG002|Year 2|Protocol deviation|0|||
25251142|NCT00195494|50566882|FG003|Year 2|Protocol deviation|0|||
25251143|NCT00195494|50566883|FG004|Year 2|Protocol deviation|0|||
25251144|NCT00195494|50566884|FG005|Year 2|Protocol deviation|0|||
25251145|NCT00195494|50566879|FG000|Year 2|Physician Decision|1|||
25251146|NCT00195494|50566880|FG001|Year 2|Physician Decision|1|||
25251147|NCT00195494|50566881|FG002|Year 2|Physician Decision|0|||
25251148|NCT00195494|50566882|FG003|Year 2|Physician Decision|0|||
25251149|NCT00195494|50566883|FG004|Year 2|Physician Decision|0|||
25251150|NCT00195494|50566884|FG005|Year 2|Physician Decision|0|||
25251151|NCT00195494|50566879|FG000|Year 2|Withdrawal by Subject|1|||
25251152|NCT00195494|50566880|FG001|Year 2|Withdrawal by Subject|5|||
25251153|NCT00195494|50566881|FG002|Year 2|Withdrawal by Subject|4|||
25251154|NCT00195494|50566882|FG003|Year 2|Withdrawal by Subject|3|||
25251155|NCT00195494|50566883|FG004|Year 2|Withdrawal by Subject|0|||
25251156|NCT00195494|50566884|FG005|Year 2|Withdrawal by Subject|0|||
25251157|NCT00195494|50566879|FG000|Year 2|System toxicity|0|||
25251158|NCT00195494|50566880|FG001|Year 2|System toxicity|0|||
25251159|NCT00195494|50566881|FG002|Year 2|System toxicity|0|||
25251160|NCT00195494|50566882|FG003|Year 2|System toxicity|1|||
25251161|NCT00195494|50566883|FG004|Year 2|System toxicity|0|||
25251162|NCT00195494|50566884|FG005|Year 2|System toxicity|0|||
25251163|NCT00194987|50566902|FG000|Overall Study|Withdrawal by Subject|0|||
25251164|NCT00194987|50566903|FG001|Overall Study|Withdrawal by Subject|3|||
25251165|NCT00194792|50566911|FG000|Overall Study|Withdrawal by Subject|1|||
25251166|NCT00194675|50566926|FG000|Overall Study|Lost to Follow-up|1|||
25251167|NCT00194675|50566927|FG001|Overall Study|Lost to Follow-up|1|||
25251168|NCT00194675|50566926|FG000|Overall Study|lack of interest|1|||
25251169|NCT00194675|50566927|FG001|Overall Study|lack of interest|1|||
25333095|NCT00824720|50649419|FG000|Overall Study|failed plug insertion|3|||
25333096|NCT00824720|50649420|FG001|Overall Study|failed plug insertion|1|||
25333097|NCT00824720|50649421|FG002|Overall Study|failed plug insertion|0|||
25333098|NCT00824720|50649419|FG000|Overall Study|Protocol Violation|0|||
25333099|NCT00824720|50649420|FG001|Overall Study|Protocol Violation|0|||
24901411|NCT00689871|49995476|FG001|Overall Study|Explanted of All Study Devices|25|||
24901412|NCT00689871|49995477|FG002|Overall Study|Explanted of All Study Devices|29|||
25251170|NCT00194675|50566926|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
25251171|NCT00194675|50566927|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
25251172|NCT00194675|50566926|FG000|Overall Study|Protocol Violation|1|||
25251173|NCT00194675|50566927|FG001|Overall Study|Protocol Violation|0|||
25251174|NCT00194675|50566926|FG000|Overall Study|Death|1|||
25251175|NCT00194675|50566927|FG001|Overall Study|Death|0|||
25251176|NCT00194012|50566937|FG000|Randomized Phase|Lack of Efficacy|8|||
25251177|NCT00194012|50566938|FG001|Randomized Phase|Lack of Efficacy|18|||
25251178|NCT00194012|50566937|FG000|Randomized Phase|Study nonadherence|2|||
25251179|NCT00194012|50566938|FG001|Randomized Phase|Study nonadherence|1|||
25251180|NCT00194012|50566937|FG000|Randomized Phase|Withdrawal by Subject|3|||
25251181|NCT00194012|50566938|FG001|Randomized Phase|Withdrawal by Subject|3|||
25251182|NCT00194012|50566937|FG000|Randomized Phase|Adverse Event|2|||
25251183|NCT00194012|50566938|FG001|Randomized Phase|Adverse Event|1|||
25251184|NCT00194012|50566937|FG000|Randomized Phase|Participant reported having a rash|1|||
25251185|NCT00194012|50566938|FG001|Randomized Phase|Participant reported having a rash|0|||
25251186|NCT00194012|50566937|FG000|Randomized Phase|Emesis and enuresis|0|||
25251187|NCT00194012|50566938|FG001|Randomized Phase|Emesis and enuresis|1|||
25251188|NCT00194012|50566937|FG000|Randomized Phase|Oral/nasal twitching|0|||
25251189|NCT00194012|50566938|FG001|Randomized Phase|Oral/nasal twitching|1|||
25251190|NCT00194012|50566937|FG000|Open Label Extension (OLE)|Weight Gain|1|||
25251191|NCT00194012|50566938|FG001|Open Label Extension (OLE)|Weight Gain|0|||
25251192|NCT00194012|50566937|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
25251193|NCT00194012|50566938|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
25333100|NCT00824720|50649421|FG002|Overall Study|Protocol Violation|1|||
25333101|NCT03704064|50649431|FG000|Overall Study|Lost to Follow-up|8|||
25333102|NCT03704064|50649432|FG001|Overall Study|Lost to Follow-up|4|||
25333103|NCT03704064|50649431|FG000|Overall Study|Withdrawal by Subject|1|||
25333104|NCT03704064|50649432|FG001|Overall Study|Withdrawal by Subject|1|||
25333105|NCT03704064|50649431|FG000|Overall Study|No longer available for study visits|0|||
25333106|NCT03704064|50649432|FG001|Overall Study|No longer available for study visits|1|||
25333107|NCT03704064|50649431|FG000|Overall Study|Censoring event|1|||
25333108|NCT03704064|50649432|FG001|Overall Study|Censoring event|0|||
25333109|NCT00824564|50649440|FG000|Overall Study|Lost to Follow-up|5|||
25333110|NCT00824564|50649441|FG001|Overall Study|Lost to Follow-up|7|||
25333111|NCT00824564|50649440|FG000|Overall Study|Withdrawal by Subject|1|||
25333112|NCT00824564|50649441|FG001|Overall Study|Withdrawal by Subject|1|||
25333113|NCT00824564|50649440|FG000|Overall Study|Other|1|||
25333114|NCT00824564|50649441|FG001|Overall Study|Other|2|||
25333115|NCT00824564|50649440|FG000|Overall Study|Randomized, but not treated|1|||
25333116|NCT00824564|50649441|FG001|Overall Study|Randomized, but not treated|0|||
25333117|NCT00658528|50649449|FG000|Overall Study|Adverse Event|5|||
25333118|NCT00658528|50649450|FG001|Overall Study|Adverse Event|7|||
25333119|NCT00658528|50649449|FG000|Overall Study|Lost to Follow-up|14|||
25333120|NCT00658528|50649450|FG001|Overall Study|Lost to Follow-up|22|||
25333121|NCT00658528|50649449|FG000|Overall Study|Withdrawal by Subject|8|||
25333122|NCT00658528|50649450|FG001|Overall Study|Withdrawal by Subject|6|||
25333123|NCT00658528|50649449|FG000|Overall Study|Withdrawal of consent|5|||
25333124|NCT00658528|50649450|FG001|Overall Study|Withdrawal of consent|6|||
25333125|NCT00658528|50649449|FG000|Overall Study|Other|8|||
25333126|NCT00658528|50649450|FG001|Overall Study|Other|4|||
25333127|NCT02864394|50649458|FG000|Overall Study|Death|135|||
25333128|NCT02864394|50649459|FG001|Overall Study|Death|150|||
25333129|NCT02864394|50649458|FG000|Overall Study|Withdrawal by Subject|1|||
25333130|NCT02864394|50649459|FG001|Overall Study|Withdrawal by Subject|9|||
25333131|NCT02864394|50649458|FG000|Overall Study|Ongoing In Study|77|||
25333132|NCT02864394|50649459|FG001|Overall Study|Ongoing In Study|53|||
25333133|NCT00856583|50649467|FG000|Overall Study|Lack of Efficacy|389|||
25333134|NCT00856583|50649468|FG001|Overall Study|Lack of Efficacy|377|||
25333135|NCT00856583|50649467|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
25333136|NCT00856583|50649468|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
25333137|NCT00856583|50649467|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
25333138|NCT00856583|50649468|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
25333139|NCT00856583|50649467|FG000|Overall Study|Non-compliance|305|||
25333140|NCT00856583|50649468|FG001|Overall Study|Non-compliance|262|||
25333141|NCT00856583|50649467|FG000|Overall Study|Withdrawal by Subject|1092|||
25333142|NCT00856583|50649468|FG001|Overall Study|Withdrawal by Subject|919|||
25333143|NCT00856583|50649467|FG000|Overall Study|Physician Decision|59|||
25333144|NCT00856583|50649468|FG001|Overall Study|Physician Decision|82|||
25333145|NCT00856583|50649467|FG000|Overall Study|Pregnancy|14|||
25333146|NCT00856583|50649468|FG001|Overall Study|Pregnancy|5|||
25333147|NCT00856583|50649467|FG000|Overall Study|Other|92|||
25333148|NCT00856583|50649468|FG001|Overall Study|Other|104|||
25333149|NCT00856583|50649467|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
25333150|NCT00856583|50649468|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
25333151|NCT00856349|50649474|FG000|Overall Study|Death|418|||
25077889|NCT02233738|50185789|FG000|Overall Study|Withdrawal by Subject|0|||
25333152|NCT00856349|50649474|FG000|Overall Study|Withdrawal by Subject|116|||
25077890|NCT02233738|50185790|FG001|Overall Study|Withdrawal by Subject|1|||
25251194|NCT00194012|50566937|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
25251195|NCT00194012|50566938|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
25251196|NCT00194012|50566937|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
25251197|NCT00194012|50566938|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
25333153|NCT00856349|50649474|FG000|Overall Study|Lost to Follow-up|91|||
25333154|NCT00856349|50649474|FG000|Overall Study|Protocol Violation|38|||
25077891|NCT02233738|50185789|FG000|Overall Study|Did not return after Baseline|3|||
25251198|NCT00192647|50566952|FG000|Overall Study|Death|1|||
25251199|NCT00192647|50566953|FG001|Overall Study|Death|1|||
25333155|NCT00856349|50649474|FG000|Overall Study|Physician Decision|13|||
25251200|NCT00192647|50566952|FG000|Overall Study|Adverse Event|35|||
25251201|NCT00192647|50566953|FG001|Overall Study|Adverse Event|29|||
25251202|NCT00192647|50566952|FG000|Overall Study|Laboratory Test Abnormality|4|||
25251203|NCT00192647|50566953|FG001|Overall Study|Laboratory Test Abnormality|2|||
25251204|NCT00192647|50566952|FG000|Overall Study|Insufficient Therapeutic Response|53|||
25251205|NCT00192647|50566953|FG001|Overall Study|Insufficient Therapeutic Response|83|||
25251206|NCT00192647|50566952|FG000|Overall Study|Entry Criteria Violation|6|||
25251207|NCT00192647|50566953|FG001|Overall Study|Entry Criteria Violation|6|||
25251208|NCT00192647|50566952|FG000|Overall Study|Protocol Violation|3|||
25251209|NCT00192647|50566953|FG001|Overall Study|Protocol Violation|1|||
25333156|NCT00856349|50649474|FG000|Overall Study|Subject relocation|104|||
25333157|NCT00856349|50649474|FG000|Overall Study|Device explant|33|||
25333158|NCT00856349|50649474|FG000|Overall Study|Site closure|78|||
25333159|NCT00856349|50649474|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
25333160|NCT00803244|50649482|FG000|Overall Study|Adverse Event|1|||
25333161|NCT00803244|50649483|FG001|Overall Study|Adverse Event|2|||
25333162|NCT00803244|50649482|FG000|Overall Study|Withdrawal by Subject|2|||
25333163|NCT00803244|50649483|FG001|Overall Study|Withdrawal by Subject|3|||
25333164|NCT00803244|50649482|FG000|Overall Study|Any other reason not above-mentioned|4|||
25333165|NCT00803244|50649483|FG001|Overall Study|Any other reason not above-mentioned|10|||
25333166|NCT04060212|50649489|FG000|Overall Study|Withdrawal by Subject|7|||
25333167|NCT00804570|50649495|FG000|Overall Study|Adverse Event|14|||
25333168|NCT00804570|50649496|FG001|Overall Study|Adverse Event|7|||
25333169|NCT00804570|50649495|FG000|Overall Study|Lack of Efficacy|0|||
25333170|NCT00804570|50649496|FG001|Overall Study|Lack of Efficacy|1|||
25333171|NCT00804570|50649495|FG000|Overall Study|Lost to Follow-up|18|||
25333172|NCT00804570|50649496|FG001|Overall Study|Lost to Follow-up|21|||
25333173|NCT00804570|50649495|FG000|Overall Study|Entry criteria not met|5|||
25333174|NCT00804570|50649496|FG001|Overall Study|Entry criteria not met|5|||
25333175|NCT00804570|50649495|FG000|Overall Study|Protocol Violation|12|||
25333176|NCT00804570|50649496|FG001|Overall Study|Protocol Violation|16|||
25333177|NCT00804570|50649495|FG000|Overall Study|Physician Decision|1|||
25333178|NCT00804570|50649496|FG001|Overall Study|Physician Decision|2|||
25333179|NCT00804570|50649495|FG000|Overall Study|Sponsor decision|1|||
25333180|NCT00804570|50649496|FG001|Overall Study|Sponsor decision|4|||
25333181|NCT00804570|50649495|FG000|Overall Study|Withdrawal by Subject|21|||
25333182|NCT00804570|50649496|FG001|Overall Study|Withdrawal by Subject|38|||
25333183|NCT00824408|50649508|FG000|Run-in Phase|Progressive disease|4|||
25333184|NCT00824408|50649509|FG001|Run-in Phase|Progressive disease|4|||
25333185|NCT00824408|50649510|FG002|Run-in Phase|Progressive disease|0|||
25251210|NCT00192647|50566952|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
25251211|NCT00192647|50566953|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
25251212|NCT00192647|50566952|FG000|Overall Study|Failure to Return|11|||
25251213|NCT00192647|50566953|FG001|Overall Study|Failure to Return|13|||
25251214|NCT00192647|50566952|FG000|Overall Study|Other/Administrative|5|||
25251215|NCT00192647|50566953|FG001|Overall Study|Other/Administrative|3|||
25251216|NCT00192296|50566963|FG000|Overall Study|Withdrawal by Subject|0|||
25251217|NCT00192296|50566964|FG001|Overall Study|Withdrawal by Subject|1|||
25251218|NCT00192296|50566965|FG002|Overall Study|Withdrawal by Subject|0|||
25251219|NCT00192296|50566966|FG003|Overall Study|Withdrawal by Subject|0|||
25251220|NCT00192023|50566978|FG000|Period III - Double-Blind|Adverse Event|3|||
25251221|NCT00192023|50566979|FG001|Period III - Double-Blind|Adverse Event|0|||
25251222|NCT00192023|50566978|FG000|Period III - Double-Blind|Physician Decision|2|||
25251223|NCT00192023|50566979|FG001|Period III - Double-Blind|Physician Decision|0|||
25251224|NCT00192023|50566978|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
25251225|NCT00192023|50566979|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
25251226|NCT00192023|50566978|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
25251227|NCT00192023|50566979|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
25251228|NCT00192023|50566978|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
25251229|NCT00192023|50566979|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
25251230|NCT00192023|50566978|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
25333186|NCT00824408|50649511|FG003|Run-in Phase|Progressive disease|0|||
25333187|NCT00824408|50649512|FG004|Run-in Phase|Progressive disease|0|||
25251231|NCT00192023|50566979|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
25251232|NCT00192023|50566978|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
25251233|NCT00192023|50566979|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
25251234|NCT00192023|50566978|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
25251235|NCT00192023|50566979|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
25251236|NCT00192023|50566978|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
25333188|NCT00824408|50649508|FG000|Run-in Phase|Adverse Event|1|||
25333189|NCT00824408|50649509|FG001|Run-in Phase|Adverse Event|1|||
25333190|NCT00824408|50649510|FG002|Run-in Phase|Adverse Event|0|||
25333191|NCT00824408|50649511|FG003|Run-in Phase|Adverse Event|0|||
25251237|NCT00192023|50566979|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
25251238|NCT00192023|50566978|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
25251239|NCT00192023|50566979|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
25251240|NCT00191984|50566985|FG000|Overall Study|Disease Progression|21|||
25251241|NCT00191984|50566985|FG000|Overall Study|Adverse Event|4|||
25251242|NCT00191984|50566985|FG000|Overall Study|Death|2|||
25251243|NCT00191984|50566985|FG000|Overall Study|Entry Criteria Exclusion|1|||
25251244|NCT00191984|50566985|FG000|Overall Study|Withdrawal by Subject|7|||
25251245|NCT00191984|50566985|FG000|Overall Study|Physician Decision|4|||
25251246|NCT00191906|50566993|FG000|Study Period II|Adverse Event|0|||
25251247|NCT00191906|50566994|FG001|Study Period II|Adverse Event|1|||
25251248|NCT00191906|50566995|FG002|Study Period II|Adverse Event|0|||
25251249|NCT00191906|50566996|FG003|Study Period II|Adverse Event|0|||
25251250|NCT00191906|50566993|FG000|Study Period II|Withdrawal by Subject|0|||
25251251|NCT00191906|50566994|FG001|Study Period II|Withdrawal by Subject|3|||
25251252|NCT00191906|50566995|FG002|Study Period II|Withdrawal by Subject|0|||
25251253|NCT00191906|50566996|FG003|Study Period II|Withdrawal by Subject|0|||
25251254|NCT00191906|50566993|FG000|Study Period II|Parent/Caregiver Decision|0|||
25251255|NCT00191906|50566994|FG001|Study Period II|Parent/Caregiver Decision|1|||
25251256|NCT00191906|50566995|FG002|Study Period II|Parent/Caregiver Decision|0|||
25251257|NCT00191906|50566996|FG003|Study Period II|Parent/Caregiver Decision|0|||
25251258|NCT00191906|50566993|FG000|Study Period II|Entry Criteria Exclusion|0|||
25251259|NCT00191906|50566994|FG001|Study Period II|Entry Criteria Exclusion|0|||
25251260|NCT00191906|50566995|FG002|Study Period II|Entry Criteria Exclusion|1|||
25251261|NCT00191906|50566996|FG003|Study Period II|Entry Criteria Exclusion|0|||
25251262|NCT00191906|50566993|FG000|Study Period III|Adverse Event|1|||
25251263|NCT00191906|50566994|FG001|Study Period III|Adverse Event|0|||
25251264|NCT00191906|50566995|FG002|Study Period III|Adverse Event|0|||
25251265|NCT00191906|50566996|FG003|Study Period III|Adverse Event|0|||
25251266|NCT00191906|50566993|FG000|Study Period III|Lost to Follow-up|0|||
25251267|NCT00191906|50566994|FG001|Study Period III|Lost to Follow-up|1|||
25251268|NCT00191906|50566995|FG002|Study Period III|Lost to Follow-up|0|||
25251269|NCT00191906|50566996|FG003|Study Period III|Lost to Follow-up|0|||
25251270|NCT00191906|50566993|FG000|Study Period III|Parent/Caregiver Decision|1|||
25251271|NCT00191906|50566994|FG001|Study Period III|Parent/Caregiver Decision|0|||
25251272|NCT00191906|50566995|FG002|Study Period III|Parent/Caregiver Decision|0|||
25251273|NCT00191906|50566996|FG003|Study Period III|Parent/Caregiver Decision|0|||
25251274|NCT00191906|50566993|FG000|Study Period III|Lack of Efficacy|3|||
25251275|NCT00191906|50566994|FG001|Study Period III|Lack of Efficacy|3|||
25251276|NCT00191906|50566995|FG002|Study Period III|Lack of Efficacy|0|||
25251277|NCT00191906|50566996|FG003|Study Period III|Lack of Efficacy|0|||
25251278|NCT00191789|50567012|FG000|Overall Study|Adverse Event|5|||
25251279|NCT00191789|50567012|FG000|Overall Study|Patient: Satisfactory Response|5|||
25251280|NCT00191789|50567012|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
25251281|NCT00191789|50567012|FG000|Overall Study|Withdrawal by Subject|4|||
25251282|NCT00191789|50567012|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
25251283|NCT00191789|50567012|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
25251284|NCT00191789|50567012|FG000|Overall Study|Death - Not Study-Drug Related|1|||
25251285|NCT00191282|50567018|FG000|Overall Study|Adverse Event|5|||
25251286|NCT00191282|50567019|FG001|Overall Study|Adverse Event|6|||
25251287|NCT00191282|50567018|FG000|Overall Study|Death|51|||
25251288|NCT00191282|50567019|FG001|Overall Study|Death|51|||
25251289|NCT00191282|50567018|FG000|Overall Study|Lack of Efficacy|11|||
25251290|NCT00191282|50567019|FG001|Overall Study|Lack of Efficacy|6|||
25251291|NCT00191282|50567018|FG000|Overall Study|Noncompliance|14|||
25251292|NCT00191282|50567019|FG001|Overall Study|Noncompliance|17|||
25251293|NCT00191282|50567018|FG000|Overall Study|Patient moved|11|||
25251294|NCT00191282|50567019|FG001|Overall Study|Patient moved|14|||
25251295|NCT00191282|50567018|FG000|Overall Study|Withdrawal by Subject|59|||
25251296|NCT00191282|50567019|FG001|Overall Study|Withdrawal by Subject|44|||
25251297|NCT00191282|50567018|FG000|Overall Study|Physician Decision|18|||
25251298|NCT00191282|50567019|FG001|Overall Study|Physician Decision|15|||
25251299|NCT00191282|50567018|FG000|Overall Study|Protocol entry criteria not met|14|||
25251300|NCT00191282|50567019|FG001|Overall Study|Protocol entry criteria not met|9|||
25251301|NCT00191282|50567018|FG000|Overall Study|Protocol Violation|9|||
25251302|NCT00191282|50567019|FG001|Overall Study|Protocol Violation|12|||
25251303|NCT00191282|50567018|FG000|Overall Study|Severity of outcome|2|||
25251304|NCT00191282|50567019|FG001|Overall Study|Severity of outcome|5|||
25251305|NCT00191282|50567018|FG000|Overall Study|Sponsor's decision|2|||
25251306|NCT00191282|50567019|FG001|Overall Study|Sponsor's decision|2|||
25251307|NCT00191282|50567018|FG000|Overall Study|Lost to Follow-up|24|||
25251308|NCT00191282|50567019|FG001|Overall Study|Lost to Follow-up|31|||
25251309|NCT00191165|50567027|FG000|Overall Study|Adverse Event|2|||
25251310|NCT00191165|50567028|FG001|Overall Study|Adverse Event|0|||
25251311|NCT00191165|50567027|FG000|Overall Study|Protocol Violation|0|||
25251312|NCT00191165|50567028|FG001|Overall Study|Protocol Violation|1|||
25251313|NCT00191165|50567027|FG000|Overall Study|Participant Moved Away|0|||
25251314|NCT00191165|50567028|FG001|Overall Study|Participant Moved Away|1|||
25251315|NCT00190775|50567036|FG000|Overall Study|Adverse Event|57|||
25251316|NCT00190775|50567037|FG001|Overall Study|Adverse Event|22|||
25333192|NCT00824408|50649512|FG004|Run-in Phase|Adverse Event|0|||
25333193|NCT00824408|50649508|FG000|Run-in Phase|Refused to continue medication|1|||
25333194|NCT00824408|50649509|FG001|Run-in Phase|Refused to continue medication|0|||
25333195|NCT00824408|50649510|FG002|Run-in Phase|Refused to continue medication|0|||
25333196|NCT00824408|50649511|FG003|Run-in Phase|Refused to continue medication|0|||
25333197|NCT00824408|50649512|FG004|Run-in Phase|Refused to continue medication|0|||
25333198|NCT00824408|50649508|FG000|Run-in Phase|Other reason not defined above|0|||
25333199|NCT00824408|50649509|FG001|Run-in Phase|Other reason not defined above|1|||
25333200|NCT00824408|50649510|FG002|Run-in Phase|Other reason not defined above|0|||
25333201|NCT00824408|50649511|FG003|Run-in Phase|Other reason not defined above|0|||
25333202|NCT00824408|50649512|FG004|Run-in Phase|Other reason not defined above|0|||
25333203|NCT00824408|50649508|FG000|Randomized Phase|Not treated|0|||
25333204|NCT00824408|50649509|FG001|Randomized Phase|Not treated|0|||
25333205|NCT00824408|50649510|FG002|Randomized Phase|Not treated|1|||
25333206|NCT00824408|50649511|FG003|Randomized Phase|Not treated|1|||
25333207|NCT00824408|50649512|FG004|Randomized Phase|Not treated|1|||
25333208|NCT00824408|50649508|FG000|Randomized Phase|Progressive disease|0|||
25333209|NCT00824408|50649509|FG001|Randomized Phase|Progressive disease|0|||
25333210|NCT00824408|50649510|FG002|Randomized Phase|Progressive disease|25|||
25333211|NCT00824408|50649511|FG003|Randomized Phase|Progressive disease|36|||
25333212|NCT00824408|50649512|FG004|Randomized Phase|Progressive disease|34|||
25333213|NCT00824408|50649508|FG000|Randomized Phase|Adverse Event|0|||
25333214|NCT00824408|50649509|FG001|Randomized Phase|Adverse Event|0|||
25333215|NCT00824408|50649510|FG002|Randomized Phase|Adverse Event|4|||
25333216|NCT00824408|50649511|FG003|Randomized Phase|Adverse Event|5|||
25333217|NCT00824408|50649512|FG004|Randomized Phase|Adverse Event|5|||
25333218|NCT00824408|50649508|FG000|Randomized Phase|Refused to continue medication|0|||
25333219|NCT00824408|50649509|FG001|Randomized Phase|Refused to continue medication|0|||
25333220|NCT00824408|50649510|FG002|Randomized Phase|Refused to continue medication|2|||
25333221|NCT00824408|50649511|FG003|Randomized Phase|Refused to continue medication|2|||
25333222|NCT00824408|50649512|FG004|Randomized Phase|Refused to continue medication|2|||
25333223|NCT00824408|50649508|FG000|Randomized Phase|Other reason not defined above|0|||
25333224|NCT00824408|50649509|FG001|Randomized Phase|Other reason not defined above|0|||
25333225|NCT00824408|50649510|FG002|Randomized Phase|Other reason not defined above|4|||
25333226|NCT00824408|50649511|FG003|Randomized Phase|Other reason not defined above|2|||
25333227|NCT00824408|50649512|FG004|Randomized Phase|Other reason not defined above|4|||
25333228|NCT00866333|50649533|FG000|Overall Study|Withdrawal of consent|0|||
25333229|NCT00866333|50649534|FG001|Overall Study|Withdrawal of consent|1|||
25333230|NCT00866333|50649535|FG002|Overall Study|Withdrawal of consent|2|||
25333231|NCT00866333|50649533|FG000|Overall Study|Reason not Specified|3|||
25333232|NCT00866333|50649534|FG001|Overall Study|Reason not Specified|1|||
25333233|NCT00866333|50649535|FG002|Overall Study|Reason not Specified|1|||
25333234|NCT00866333|50649533|FG000|Overall Study|Study Terminated by Sponsor|2|||
25333235|NCT00866333|50649534|FG001|Overall Study|Study Terminated by Sponsor|5|||
25333236|NCT00866333|50649535|FG002|Overall Study|Study Terminated by Sponsor|9|||
25333237|NCT00834080|50649543|FG000|Overall Study|Adverse Event|7|||
25333238|NCT00834080|50649543|FG000|Overall Study|Lost to Follow-up|7|||
25333239|NCT00834080|50649543|FG000|Overall Study|Withdrawal by Subject|5|||
25333240|NCT00834080|50649543|FG000|Overall Study|Other - Pregnancy|1|||
25333241|NCT00834080|50649543|FG000|Overall Study|Other - False positive tests of the UDS|1|||
25333242|NCT00834080|50649543|FG000|Overall Study|Physician Decision|1|||
25333243|NCT00834080|50649543|FG000|Overall Study|Subject Relocated|1|||
24901413|NCT00689871|49995478|FG003|Overall Study|Explanted of All Study Devices|3|||
25251317|NCT00190775|50567036|FG000|Overall Study|Satisfactory Response|1|||
25251318|NCT00190775|50567037|FG001|Overall Study|Satisfactory Response|0|||
25251319|NCT00190775|50567036|FG000|Overall Study|Lack of Efficacy|28|||
25251320|NCT00190775|50567037|FG001|Overall Study|Lack of Efficacy|32|||
25251321|NCT00190775|50567036|FG000|Overall Study|Lost to Follow-up|31|||
25251322|NCT00190775|50567037|FG001|Overall Study|Lost to Follow-up|23|||
25251323|NCT00190775|50567036|FG000|Overall Study|Participant Moved|0|||
25333244|NCT00823472|50649549|FG000|Overall Study|Physician Decision|24|||
25333245|NCT00823472|50649550|FG001|Overall Study|Physician Decision|28|||
25333246|NCT00856193|50649556|FG000|Period 2|Abnormal test procedure results|0|||
25333247|NCT00856193|50649557|FG001|Period 2|Abnormal test procedure results|1|||
25333248|NCT00856193|50649556|FG000|Period 2|Lost to Follow-up|0|||
25333249|NCT00856193|50649557|FG001|Period 2|Lost to Follow-up|1|||
25333250|NCT00652366|50649568|FG000|Overall Study|Adverse Event|8|||
25333251|NCT00652366|50649569|FG001|Overall Study|Adverse Event|4|||
25333252|NCT00652366|50649570|FG002|Overall Study|Adverse Event|7|||
25333253|NCT00652366|50649571|FG003|Overall Study|Adverse Event|17|||
25333254|NCT00652366|50649572|FG004|Overall Study|Adverse Event|13|||
24977372|NCT00048542|50066003|FG007|Double-Blind Phase|Sponsor request or decision|0|||
25333255|NCT00652366|50649568|FG000|Overall Study|Death|5|||
25333256|NCT00652366|50649569|FG001|Overall Study|Death|4|||
25251324|NCT00190775|50567037|FG001|Overall Study|Participant Moved|1|||
25251325|NCT00190775|50567036|FG000|Overall Study|Withdrawal by Subject|24|||
25251326|NCT00190775|50567037|FG001|Overall Study|Withdrawal by Subject|13|||
25251327|NCT00190775|50567036|FG000|Overall Study|Sponsor Decision|1|||
25251328|NCT00190775|50567037|FG001|Overall Study|Sponsor Decision|0|||
25251329|NCT00190775|50567036|FG000|Overall Study|Physician Decision|3|||
25251330|NCT00190775|50567037|FG001|Overall Study|Physician Decision|0|||
25251331|NCT00190775|50567036|FG000|Overall Study|Noncompliance|3|||
25251332|NCT00190775|50567037|FG001|Overall Study|Noncompliance|5|||
25251333|NCT00190775|50567036|FG000|Overall Study|Protocol Violation|0|||
25251334|NCT00190775|50567037|FG001|Overall Study|Protocol Violation|1|||
25251335|NCT00190775|50567036|FG000|Overall Study|Exclusion Criteria Met|1|||
25251336|NCT00190775|50567037|FG001|Overall Study|Exclusion Criteria Met|3|||
25251337|NCT00199901|50567052|FG000|Overall Study|Protocol Violation|2|||
25251338|NCT00199901|50567053|FG001|Overall Study|Protocol Violation|0|||
25251339|NCT00199901|50567052|FG000|Overall Study|Withdrawal by Subject|1|||
25251340|NCT00199901|50567053|FG001|Overall Study|Withdrawal by Subject|0|||
25251341|NCT00199901|50567052|FG000|Overall Study|Progressive Disease|24|||
25251342|NCT00199901|50567053|FG001|Overall Study|Progressive Disease|24|||
25251343|NCT00198107|50567063|FG000|Double-Blind Period|Adverse Event|1|||
25251344|NCT00198107|50567064|FG001|Double-Blind Period|Adverse Event|1|||
25251345|NCT00198107|50567065|FG002|Double-Blind Period|Adverse Event|0|||
25251346|NCT00198107|50567063|FG000|Double-Blind Period|Lack of Efficacy|2|||
25251347|NCT00198107|50567064|FG001|Double-Blind Period|Lack of Efficacy|0|||
25251348|NCT00198107|50567065|FG002|Double-Blind Period|Lack of Efficacy|0|||
25251349|NCT00198107|50567063|FG000|Double-Blind Period|Lost to Follow-up|2|||
25251350|NCT00198107|50567064|FG001|Double-Blind Period|Lost to Follow-up|1|||
25251351|NCT00198107|50567065|FG002|Double-Blind Period|Lost to Follow-up|0|||
25251352|NCT00198107|50567063|FG000|Double-Blind Period|Physician Decision|1|||
25251353|NCT00198107|50567064|FG001|Double-Blind Period|Physician Decision|0|||
25251354|NCT00198107|50567065|FG002|Double-Blind Period|Physician Decision|0|||
25251355|NCT00198107|50567063|FG000|Double-Blind Period|Withdrawal by Subject|0|||
25251356|NCT00198107|50567064|FG001|Double-Blind Period|Withdrawal by Subject|1|||
25251357|NCT00198107|50567065|FG002|Double-Blind Period|Withdrawal by Subject|0|||
25251358|NCT00198107|50567063|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
25251359|NCT00198107|50567064|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
25251360|NCT00198107|50567065|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
25251361|NCT00179660|50567073|FG000|Overall Study|Adverse Event|7|||
25251362|NCT00179660|50567073|FG000|Overall Study|Lack of therapeutic effect|28|||
25251363|NCT00179660|50567073|FG000|Overall Study|Withdrawal by Subject|2|||
25251364|NCT00179660|50567073|FG000|Overall Study|Lost to Follow-up|1|||
25251365|NCT00179660|50567073|FG000|Overall Study|Death|3|||
25251366|NCT00179660|50567073|FG000|Overall Study|Other - Unspecified|9|||
25251367|NCT00178256|50567077|FG000|Overall Study|Adverse Event|2|||
25251368|NCT00178256|50567078|FG001|Overall Study|Adverse Event|0|||
25251369|NCT00178256|50567079|FG002|Overall Study|Adverse Event|0|||
25251370|NCT00178256|50567080|FG003|Overall Study|Adverse Event|0|||
25251371|NCT00178256|50567077|FG000|Overall Study|Death|0|||
25251372|NCT00178256|50567078|FG001|Overall Study|Death|1|||
25251373|NCT00178256|50567079|FG002|Overall Study|Death|0|||
25251374|NCT00178256|50567080|FG003|Overall Study|Death|1|||
25251375|NCT00178256|50567077|FG000|Overall Study|Cancer progression|2|||
25251376|NCT00178256|50567078|FG001|Overall Study|Cancer progression|0|||
25251377|NCT00178256|50567079|FG002|Overall Study|Cancer progression|0|||
25251378|NCT00178256|50567080|FG003|Overall Study|Cancer progression|1|||
25251379|NCT00177164|50567089|FG000|Overall Study|Protocol Violation|0|||
25251380|NCT00177164|50567090|FG001|Overall Study|Protocol Violation|7|||
25251381|NCT00177164|50567089|FG000|Overall Study|Lost to Follow-up|4|||
25251382|NCT00177164|50567090|FG001|Overall Study|Lost to Follow-up|5|||
25251383|NCT00177164|50567089|FG000|Overall Study|increase in alcohol and drug use|1|||
25251384|NCT00177164|50567090|FG001|Overall Study|increase in alcohol and drug use|2|||
25251385|NCT00177164|50567089|FG000|Overall Study|Adverse Event|1|||
25251386|NCT00177164|50567090|FG001|Overall Study|Adverse Event|0|||
25251387|NCT00177164|50567089|FG000|Overall Study|discharge from hospital|1|||
25251388|NCT00177164|50567090|FG001|Overall Study|discharge from hospital|0|||
25251389|NCT00177164|50567089|FG000|Overall Study|Lack of Efficacy|2|||
25251390|NCT00177164|50567090|FG001|Overall Study|Lack of Efficacy|1|||
25251391|NCT00177164|50567089|FG000|Overall Study|Pregnancy|0|||
25251392|NCT00177164|50567090|FG001|Overall Study|Pregnancy|1|||
25251393|NCT02489942|50567113|FG000|Overall Study|Request by patient|602|||
25251394|NCT02489942|50567113|FG000|Overall Study|Improvement/remission|157|||
25251395|NCT02489942|50567113|FG000|Overall Study|No change/Progressive disease|263|||
25251396|NCT02489942|50567113|FG000|Overall Study|Adverse Event|522|||
25251397|NCT02489942|50567113|FG000|Overall Study|Other personal reasons|1218|||
25251398|NCT02489942|50567113|FG000|Overall Study|Lost to Follow-up|456|||
25251399|NCT02489942|50567113|FG000|Overall Study|Not continuously investigated|7|||
25251400|NCT02489942|50567113|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
25251401|NCT02489942|50567113|FG000|Overall Study|Multiple registration|1|||
25251402|NCT02489942|50567113|FG000|Overall Study|No patient visit after entry|100|||
25333257|NCT00652366|50649570|FG002|Overall Study|Death|1|||
25333258|NCT00652366|50649571|FG003|Overall Study|Death|8|||
25333259|NCT00652366|50649572|FG004|Overall Study|Death|5|||
25333260|NCT00652366|50649568|FG000|Overall Study|Lack of Efficacy|84|||
25333261|NCT00652366|50649569|FG001|Overall Study|Lack of Efficacy|58|||
25333262|NCT00652366|50649570|FG002|Overall Study|Lack of Efficacy|53|||
25333263|NCT00652366|50649571|FG003|Overall Study|Lack of Efficacy|133|||
25251403|NCT02489942|50567113|FG000|Overall Study|No treatment with Jardiance|2|||
25251404|NCT02489942|50567113|FG000|Overall Study|Patient received Jardiance before registration|1|||
25251405|NCT02489942|50567113|FG000|Overall Study|No CRF collected|86|||
25251406|NCT00176462|50567119|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
25251407|NCT00176462|50567120|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
25251408|NCT00176462|50567119|FG000|Induction (4 Weeks)|Death|1|||
25251409|NCT00176462|50567120|FG001|Induction (4 Weeks)|Death|2|||
25333264|NCT00652366|50649572|FG004|Overall Study|Lack of Efficacy|13|||
25333265|NCT00652366|50649568|FG000|Overall Study|Violation of Selection Criteria|0|||
25251410|NCT00176462|50567119|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
25251411|NCT00176462|50567120|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
25333266|NCT00652366|50649569|FG001|Overall Study|Violation of Selection Criteria|0|||
25333267|NCT00652366|50649570|FG002|Overall Study|Violation of Selection Criteria|1|||
25333268|NCT00652366|50649571|FG003|Overall Study|Violation of Selection Criteria|0|||
25333269|NCT00652366|50649572|FG004|Overall Study|Violation of Selection Criteria|0|||
25333270|NCT00652366|50649568|FG000|Overall Study|Protocol Violation|1|||
25333271|NCT00652366|50649569|FG001|Overall Study|Protocol Violation|0|||
25333272|NCT00652366|50649570|FG002|Overall Study|Protocol Violation|0|||
25333273|NCT00652366|50649571|FG003|Overall Study|Protocol Violation|0|||
25333274|NCT00652366|50649572|FG004|Overall Study|Protocol Violation|0|||
25333275|NCT00652366|50649568|FG000|Overall Study|Refused treatment|3|||
25333276|NCT00652366|50649569|FG001|Overall Study|Refused treatment|7|||
25333277|NCT00652366|50649570|FG002|Overall Study|Refused treatment|6|||
25333278|NCT00652366|50649571|FG003|Overall Study|Refused treatment|17|||
25333279|NCT00652366|50649572|FG004|Overall Study|Refused treatment|5|||
25333280|NCT00652366|50649568|FG000|Overall Study|Other|5|||
25333281|NCT00652366|50649569|FG001|Overall Study|Other|2|||
25333282|NCT00652366|50649570|FG002|Overall Study|Other|3|||
25333283|NCT00652366|50649571|FG003|Overall Study|Other|4|||
25333284|NCT00652366|50649572|FG004|Overall Study|Other|0|||
25333285|NCT00841568|50649586|FG000|Overall Study|Adverse Event|1|||
25333286|NCT00841568|50649586|FG000|Overall Study|Death|1|||
25333287|NCT00841568|50649586|FG000|Overall Study|Withdrawal by Subject|2|||
25333288|NCT00841568|50649586|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
25333289|NCT00855959|50649594|FG000|Overall Study|Adverse Event|2|||
25333290|NCT00855959|50649594|FG000|Overall Study|Lost to Follow-up|2|||
24901414|NCT00689871|49995475|FG000|Overall Study|Withdrawal by Subject|13|||
24901415|NCT00689871|49995476|FG001|Overall Study|Withdrawal by Subject|3|||
24901416|NCT00689871|49995477|FG002|Overall Study|Withdrawal by Subject|4|||
24901417|NCT00689871|49995478|FG003|Overall Study|Withdrawal by Subject|1|||
24901418|NCT00689871|49995475|FG000|Overall Study|Death|1|||
24901419|NCT00689871|49995476|FG001|Overall Study|Death|10|||
24901420|NCT00689871|49995477|FG002|Overall Study|Death|2|||
24901421|NCT00689871|49995478|FG003|Overall Study|Death|2|||
24901422|NCT00689871|49995475|FG000|Overall Study|Physician Decision|2|||
24901423|NCT00689871|49995476|FG001|Overall Study|Physician Decision|1|||
24901424|NCT00689871|49995477|FG002|Overall Study|Physician Decision|1|||
25251412|NCT00176462|50567119|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
25251413|NCT00176462|50567120|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
25251414|NCT00176462|50567119|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
25251415|NCT00176462|50567120|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
25251416|NCT00176462|50567119|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
25251417|NCT00176462|50567120|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
25251418|NCT00176462|50567119|FG000|Consolidation (12 Weeks)|Not documented|0|||
25251419|NCT00176462|50567120|FG001|Consolidation (12 Weeks)|Not documented|1|||
25251420|NCT00176462|50567119|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
25333291|NCT00855959|50649594|FG000|Overall Study|Withdrawal by Subject|3|||
25333292|NCT00855959|50649594|FG000|Overall Study|Pregnancy|1|||
25333293|NCT00855959|50649594|FG000|Overall Study|Incorrect enrolment|1|||
25333294|NCT00841100|50649598|FG000|Phase 1 (28 Days)|Adverse Event|1|||
25333295|NCT00841100|50649598|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
25333296|NCT00651820|50649602|FG000|Overall Study|Lost to Follow-up|2|||
25333297|NCT00866177|50649608|FG000|Overall Study|Withdrawal by Subject|1|||
25333298|NCT00866177|50649608|FG000|Overall Study|Not Treated|151|||
25333299|NCT00833924|50649612|FG000|Overall Study|Death|21|||
25333300|NCT00833924|50649612|FG000|Overall Study|Conversion|2|||
25333301|NCT00833924|50649612|FG000|Overall Study|Lost to Follow-up|2|||
25333302|NCT00833924|50649612|FG000|Overall Study|Withdrawal by Subject|13|||
24901425|NCT00689871|49995478|FG003|Overall Study|Physician Decision|0|||
24901426|NCT00793793|49995500|FG000|Overall Study|Adverse Event|0|||
24901427|NCT00793793|49995501|FG001|Overall Study|Adverse Event|0|||
25251421|NCT00176462|50567120|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
25251422|NCT00176462|50567119|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
25251423|NCT00176462|50567120|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
25251424|NCT00175019|50567130|FG000|Overall Study|Adverse Event|54|||
25251425|NCT00175019|50567131|FG001|Overall Study|Adverse Event|22|||
25251426|NCT00175019|50567132|FG002|Overall Study|Adverse Event|2|||
25251427|NCT00175019|50567130|FG000|Overall Study|Protocol Violation|6|||
25251428|NCT00175019|50567131|FG001|Overall Study|Protocol Violation|3|||
25251429|NCT00175019|50567132|FG002|Overall Study|Protocol Violation|3|||
25251430|NCT00175019|50567130|FG000|Overall Study|Lost to Follow-up|42|||
25251431|NCT00175019|50567131|FG001|Overall Study|Lost to Follow-up|39|||
25251432|NCT00175019|50567132|FG002|Overall Study|Lost to Follow-up|9|||
25251433|NCT00175019|50567130|FG000|Overall Study|Did not continue under Amendment 4|1|||
25251434|NCT00175019|50567131|FG001|Overall Study|Did not continue under Amendment 4|1|||
25251435|NCT00175019|50567132|FG002|Overall Study|Did not continue under Amendment 4|2|||
25251436|NCT00175019|50567130|FG000|Overall Study|Personal Reason(s)|39|||
25251437|NCT00175019|50567131|FG001|Overall Study|Personal Reason(s)|31|||
25251438|NCT00175019|50567132|FG002|Overall Study|Personal Reason(s)|8|||
25251439|NCT00175019|50567130|FG000|Overall Study|Therapeutic Failure|10|||
25251440|NCT00175019|50567131|FG001|Overall Study|Therapeutic Failure|38|||
25251441|NCT00175019|50567132|FG002|Overall Study|Therapeutic Failure|22|||
25251442|NCT00175019|50567130|FG000|Overall Study|Gout Flare|2|||
25251443|NCT00175019|50567131|FG001|Overall Study|Gout Flare|3|||
25251444|NCT00175019|50567132|FG002|Overall Study|Gout Flare|0|||
25251445|NCT00175019|50567130|FG000|Overall Study|Reason Not Specified|40|||
25251446|NCT00175019|50567131|FG001|Overall Study|Reason Not Specified|34|||
25251447|NCT00175019|50567132|FG002|Overall Study|Reason Not Specified|11|||
25251448|NCT00174941|50567143|FG000|Overall Study|Adverse Event|1|||
25251449|NCT00174941|50567144|FG001|Overall Study|Adverse Event|10|||
25251450|NCT00174941|50567145|FG002|Overall Study|Adverse Event|2|||
25251451|NCT00174941|50567146|FG003|Overall Study|Adverse Event|13|||
25251452|NCT00174941|50567143|FG000|Overall Study|Protocol Violation|0|||
25251453|NCT00174941|50567144|FG001|Overall Study|Protocol Violation|1|||
25251454|NCT00174941|50567145|FG002|Overall Study|Protocol Violation|0|||
25251455|NCT00174941|50567146|FG003|Overall Study|Protocol Violation|1|||
25251456|NCT00174941|50567143|FG000|Overall Study|Lost to Follow-up|0|||
25251457|NCT00174941|50567144|FG001|Overall Study|Lost to Follow-up|3|||
25251458|NCT00174941|50567145|FG002|Overall Study|Lost to Follow-up|2|||
25251459|NCT00174941|50567146|FG003|Overall Study|Lost to Follow-up|5|||
25251460|NCT00174941|50567143|FG000|Overall Study|Personal Reason(s)|0|||
25251461|NCT00174941|50567144|FG001|Overall Study|Personal Reason(s)|14|||
25251462|NCT00174941|50567145|FG002|Overall Study|Personal Reason(s)|8|||
25251463|NCT00174941|50567146|FG003|Overall Study|Personal Reason(s)|22|||
25251464|NCT00174941|50567143|FG000|Overall Study|Gout Flare|0|||
25333303|NCT00833924|50649612|FG000|Overall Study|In study follow-up|71|||
25333304|NCT00840086|50649616|FG000|Overall Study|Adverse Event|1|||
25333305|NCT00840086|50649616|FG000|Overall Study|Protocol Violation|2|||
25333306|NCT00840086|50649616|FG000|Overall Study|Lost to Follow-up|1|||
25333307|NCT00822926|50649625|FG000|Second Injection Visit|Lost to Follow-up|1|||
25333308|NCT00822926|50649626|FG001|Second Injection Visit|Lost to Follow-up|0|||
25333309|NCT00822926|50649625|FG000|Second Injection Visit|Withdrawal by Subject|0|||
24901428|NCT00793793|49995502|FG002|Overall Study|Adverse Event|1|||
24901429|NCT00793793|49995503|FG003|Overall Study|Adverse Event|1|||
24901430|NCT00793793|49995504|FG004|Overall Study|Adverse Event|0|||
24901431|NCT00793793|49995505|FG005|Overall Study|Adverse Event|1|||
24901432|NCT00793793|49995506|FG006|Overall Study|Adverse Event|2|||
24901433|NCT00793793|49995507|FG007|Overall Study|Adverse Event|0|||
24901434|NCT00793793|49995508|FG008|Overall Study|Adverse Event|0|||
24901435|NCT00793793|49995509|FG009|Overall Study|Adverse Event|0|||
24901436|NCT00793793|49995510|FG010|Overall Study|Adverse Event|0|||
24901437|NCT00793793|49995511|FG011|Overall Study|Adverse Event|2|||
24901438|NCT00793793|49995500|FG000|Overall Study|Protocol Violation|0|||
24901439|NCT00793793|49995501|FG001|Overall Study|Protocol Violation|0|||
24901440|NCT00793793|49995502|FG002|Overall Study|Protocol Violation|0|||
25251465|NCT00174941|50567144|FG001|Overall Study|Gout Flare|4|||
25251466|NCT00174941|50567145|FG002|Overall Study|Gout Flare|4|||
25251467|NCT00174941|50567146|FG003|Overall Study|Gout Flare|8|||
25251468|NCT00174941|50567143|FG000|Overall Study|Reason Not Specified|1|||
25251469|NCT00174941|50567144|FG001|Overall Study|Reason Not Specified|6|||
25251470|NCT00174941|50567145|FG002|Overall Study|Reason Not Specified|2|||
25251471|NCT00174941|50567146|FG003|Overall Study|Reason Not Specified|9|||
25251472|NCT00171704|50567158|FG000|Overall Study|Adverse Event|24|||
25251473|NCT00171704|50567159|FG001|Overall Study|Adverse Event|33|||
25251474|NCT00171704|50567158|FG000|Overall Study|Disease Progression|14|||
25251475|NCT00171704|50567159|FG001|Overall Study|Disease Progression|9|||
25251476|NCT00171704|50567158|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
24901441|NCT00793793|49995503|FG003|Overall Study|Protocol Violation|1|||
24901442|NCT00793793|49995504|FG004|Overall Study|Protocol Violation|0|||
24901443|NCT00793793|49995505|FG005|Overall Study|Protocol Violation|0|||
25333310|NCT00822926|50649626|FG001|Second Injection Visit|Withdrawal by Subject|1|||
25333311|NCT00822770|50649637|FG000|Overall Study|Not treated|1|||
25333312|NCT00822770|50649638|FG001|Overall Study|Not treated|0|||
25333313|NCT00822770|50649637|FG000|Overall Study|Complication/Incomplete treatment|1|||
25333314|NCT00822770|50649638|FG001|Overall Study|Complication/Incomplete treatment|0|||
25333315|NCT00822770|50649637|FG000|Overall Study|Death|1|||
25333316|NCT00822770|50649638|FG001|Overall Study|Death|1|||
25333317|NCT02842086|50649646|FG000|Overall Study|Randomized but Never Treated|6|||
25333318|NCT02842086|50649647|FG001|Overall Study|Randomized but Never Treated|6|||
25333319|NCT02842086|50649646|FG000|Overall Study|Still in Double-Blind Phase|7|||
25333320|NCT02842086|50649647|FG001|Overall Study|Still in Double-Blind Phase|3|||
25333321|NCT02842086|50649646|FG000|Overall Study|Adverse Event|18|||
25333322|NCT02842086|50649647|FG001|Overall Study|Adverse Event|20|||
25333323|NCT02842086|50649646|FG000|Overall Study|Death|3|||
25333324|NCT02842086|50649647|FG001|Overall Study|Death|3|||
25333325|NCT02842086|50649646|FG000|Overall Study|Investigator's Discretion|9|||
25333326|NCT02842086|50649647|FG001|Overall Study|Investigator's Discretion|13|||
25333327|NCT02842086|50649646|FG000|Overall Study|Non-Compliance with Study Drug|9|||
25333328|NCT02842086|50649647|FG001|Overall Study|Non-Compliance with Study Drug|8|||
25333329|NCT02842086|50649646|FG000|Overall Study|Protocol Violation|8|||
25333330|NCT02842086|50649647|FG001|Overall Study|Protocol Violation|4|||
25333331|NCT02842086|50649646|FG000|Overall Study|Withdrew Consent|205|||
25333332|NCT02842086|50649647|FG001|Overall Study|Withdrew Consent|194|||
25333333|NCT02842086|50649646|FG000|Overall Study|Lost to Follow-up|274|||
25333334|NCT02842086|50649647|FG001|Overall Study|Lost to Follow-up|236|||
25333335|NCT02842086|50649646|FG000|Overall Study|HIV-1 Infection|5|||
25333336|NCT02842086|50649647|FG001|Overall Study|HIV-1 Infection|6|||
25333337|NCT00822692|50649655|FG000|Overall Study|Lost to Follow-up|17|||
25333338|NCT00822692|50649656|FG001|Overall Study|Lost to Follow-up|25|||
25333339|NCT00806442|50649662|FG000|Overall Study|Lost to Follow-up|3|||
25333340|NCT00806442|50649663|FG001|Overall Study|Lost to Follow-up|2|||
25333341|NCT00806442|50649662|FG000|Overall Study|Withdrawal by Subject|1|||
25333342|NCT00806442|50649663|FG001|Overall Study|Withdrawal by Subject|5|||
25251477|NCT00171704|50567159|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
25251478|NCT00171704|50567158|FG000|Overall Study|Administrative Problems|2|||
25251479|NCT00171704|50567159|FG001|Overall Study|Administrative Problems|1|||
25251480|NCT00171704|50567158|FG000|Overall Study|Death|2|||
25333343|NCT00821678|50649673|FG000|Overall Study|Withdrawal by Subject|8|||
25333344|NCT00821678|50649674|FG001|Overall Study|Withdrawal by Subject|0|||
25333345|NCT00821678|50649673|FG000|Overall Study|Lost to Follow-up|13|||
25333346|NCT00821678|50649674|FG001|Overall Study|Lost to Follow-up|12|||
24901444|NCT00793793|49995506|FG006|Overall Study|Protocol Violation|0|||
24901445|NCT00793793|49995507|FG007|Overall Study|Protocol Violation|0|||
24901446|NCT00793793|49995508|FG008|Overall Study|Protocol Violation|0|||
24901447|NCT00793793|49995509|FG009|Overall Study|Protocol Violation|0|||
24901448|NCT00793793|49995510|FG010|Overall Study|Protocol Violation|0|||
24901449|NCT00793793|49995511|FG011|Overall Study|Protocol Violation|0|||
24901450|NCT00793793|49995500|FG000|Overall Study|Lost to Follow-up|0|||
24901451|NCT00793793|49995501|FG001|Overall Study|Lost to Follow-up|0|||
24901452|NCT00793793|49995502|FG002|Overall Study|Lost to Follow-up|1|||
24901453|NCT00793793|49995503|FG003|Overall Study|Lost to Follow-up|0|||
24901454|NCT00793793|49995504|FG004|Overall Study|Lost to Follow-up|0|||
24901455|NCT00793793|49995505|FG005|Overall Study|Lost to Follow-up|0|||
24901456|NCT00793793|49995506|FG006|Overall Study|Lost to Follow-up|0|||
25251481|NCT00171704|50567159|FG001|Overall Study|Death|2|||
25251482|NCT00171704|50567158|FG000|Overall Study|Withdrawal by Subject|1|||
25251483|NCT00171704|50567159|FG001|Overall Study|Withdrawal by Subject|3|||
25251484|NCT00171704|50567158|FG000|Overall Study|Protocol Violation|0|||
25251485|NCT00171704|50567159|FG001|Overall Study|Protocol Violation|1|||
25251486|NCT00171314|50567167|FG000|Overall Study|Adverse Event|44|||
25251487|NCT00171314|50567168|FG001|Overall Study|Adverse Event|41|||
25251488|NCT00171314|50567167|FG000|Overall Study|Lack of Efficacy|19|||
25251489|NCT00171314|50567168|FG001|Overall Study|Lack of Efficacy|14|||
25251490|NCT00171314|50567167|FG000|Overall Study|Withdrawal by Subject|9|||
25251491|NCT00171314|50567168|FG001|Overall Study|Withdrawal by Subject|6|||
25333347|NCT00821678|50649673|FG000|Overall Study|Death|0|||
25333348|NCT00821678|50649674|FG001|Overall Study|Death|2|||
25333349|NCT00839852|50649682|FG000|Overall Study|Adverse Event|10|||
25333350|NCT00839852|50649682|FG000|Overall Study|Insufficient Therapeutic Response|3|||
25333351|NCT00839852|50649682|FG000|Overall Study|Protocol Violation|9|||
25333352|NCT00839852|50649682|FG000|Overall Study|Withdrawal of Consent|16|||
25333353|NCT00839852|50649682|FG000|Overall Study|Lost to Follow-up|7|||
25333354|NCT00839852|50649682|FG000|Overall Study|Lack of Compliance While in Jail|1|||
24901457|NCT00793793|49995507|FG007|Overall Study|Lost to Follow-up|0|||
24901458|NCT00793793|49995508|FG008|Overall Study|Lost to Follow-up|1|||
25251492|NCT00171314|50567167|FG000|Overall Study|Abnormal Test Procedure Results|9|||
24901459|NCT00793793|49995509|FG009|Overall Study|Lost to Follow-up|3|||
25333355|NCT00839852|50649682|FG000|Overall Study|Pregnancy|1|||
25333356|NCT00833690|50649689|FG000|Overall Study|Withdrawal by Subject|1|||
25333357|NCT00833690|50649690|FG001|Overall Study|Withdrawal by Subject|0|||
25251493|NCT00171314|50567168|FG001|Overall Study|Abnormal Test Procedure Results|3|||
25251494|NCT00171314|50567167|FG000|Overall Study|Protocol Violation|3|||
25251495|NCT00171314|50567168|FG001|Overall Study|Protocol Violation|7|||
25251496|NCT00171314|50567167|FG000|Overall Study|Administrative Problems|4|||
25251497|NCT00171314|50567168|FG001|Overall Study|Administrative Problems|3|||
25251498|NCT00171314|50567167|FG000|Overall Study|Lost to Follow-up|1|||
25251499|NCT00171314|50567168|FG001|Overall Study|Lost to Follow-up|3|||
25251500|NCT00171314|50567167|FG000|Overall Study|Death|2|||
25251501|NCT00171314|50567168|FG001|Overall Study|Death|1|||
25251502|NCT00171158|50567174|FG000|Core Study|Death|27|||
25333358|NCT00833690|50649691|FG002|Overall Study|Withdrawal by Subject|0|||
25333359|NCT00833690|50649689|FG000|Overall Study|Discontinued study drug|3|||
25333360|NCT00833690|50649690|FG001|Overall Study|Discontinued study drug|2|||
25333361|NCT00833690|50649691|FG002|Overall Study|Discontinued study drug|0|||
25333362|NCT00820898|50649699|FG000|Overall Study|Inelgible - wrong primary site|1|||
25333363|NCT00865709|50649711|FG000|Treatment|Adverse Event|9|||
25333364|NCT00865709|50649712|FG001|Treatment|Adverse Event|6|||
25333365|NCT00865709|50649711|FG000|Treatment|Withdrawal by Subject|10|||
25333366|NCT00865709|50649712|FG001|Treatment|Withdrawal by Subject|7|||
25333367|NCT00865709|50649711|FG000|Treatment|Physician Decision|3|||
25333368|NCT00865709|50649712|FG001|Treatment|Physician Decision|2|||
25333369|NCT00865709|50649711|FG000|Treatment|Surgery|8|||
25333370|NCT00865709|50649712|FG001|Treatment|Surgery|3|||
25333371|NCT00839306|50649722|FG000|Overall Study|Adverse Event|3|||
25333372|NCT00839306|50649723|FG001|Overall Study|Adverse Event|5|||
25333373|NCT00839306|50649722|FG000|Overall Study|Lost to Follow-up|6|||
25333374|NCT00839306|50649723|FG001|Overall Study|Lost to Follow-up|9|||
25333375|NCT00839306|50649722|FG000|Overall Study|Withdrawal by Subject|5|||
25333376|NCT00839306|50649723|FG001|Overall Study|Withdrawal by Subject|7|||
25333377|NCT00839306|50649722|FG000|Overall Study|Lack of Efficacy|5|||
25333378|NCT00839306|50649723|FG001|Overall Study|Lack of Efficacy|4|||
25333379|NCT00839306|50649722|FG000|Overall Study|Other|6|||
25333380|NCT00839306|50649723|FG001|Overall Study|Other|18|||
25333381|NCT00839072|50649730|FG000|First Intervention Period|Withdrawal by Subject|1|||
25333382|NCT00839072|50649731|FG001|First Intervention Period|Withdrawal by Subject|0|||
25333383|NCT00839072|50649730|FG000|First Intervention Period|Adverse Event|1|||
25333384|NCT00839072|50649731|FG001|First Intervention Period|Adverse Event|1|||
25333385|NCT00839072|50649730|FG000|Second Intervention Period|Withdrawal by Subject|1|||
25333386|NCT00839072|50649731|FG001|Second Intervention Period|Withdrawal by Subject|0|||
25333387|NCT00855803|50649737|FG000|Overall Study|Death|2|||
25333388|NCT00855803|50649737|FG000|Overall Study|Lost to Follow-up|2|||
25333389|NCT00855803|50649737|FG000|Overall Study|Technical inability to undergo procedure|2|||
25333390|NCT00855803|50649737|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
25333391|NCT00855803|50649737|FG000|Overall Study|Withdrawal by Subject|3|||
25333392|NCT00855803|50649737|FG000|Overall Study|Physician Decision|3|||
25333393|NCT03553836|50649743|FG000|Overall Study|Ongoing in Study|460|||
25251503|NCT00171158|50567174|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
25333394|NCT03553836|50649744|FG001|Overall Study|Ongoing in Study|459|||
25333395|NCT03553836|50649743|FG000|Overall Study|Withdrawal by Subject|9|||
25333396|NCT03553836|50649744|FG001|Overall Study|Withdrawal by Subject|10|||
25333397|NCT03553836|50649743|FG000|Overall Study|Lost to Follow-up|1|||
25333398|NCT03553836|50649744|FG001|Overall Study|Lost to Follow-up|3|||
25333399|NCT03553836|50649743|FG000|Overall Study|Death|17|||
25333400|NCT03553836|50649744|FG001|Overall Study|Death|17|||
25333401|NCT00838916|50649753|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
25333402|NCT00838916|50649754|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
25333403|NCT00838916|50649753|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
25251504|NCT00171158|50567174|FG000|Core Study|Protocol Violation|4|||
25251505|NCT00171158|50567174|FG000|Core Study|Administrative problems|1|||
25251506|NCT00171158|50567174|FG000|Core Study|Adverse event, non-fatal|21|||
25333404|NCT00838916|50649754|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
25251507|NCT00171158|50567174|FG000|Core Study|Consent withdrawn by subject|6|||
25251508|NCT00171158|50567174|FG000|Core Study|No longer required drug (BMT)|14|||
25333405|NCT00838916|50649753|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
25333406|NCT00838916|50649754|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
25333407|NCT00838916|50649753|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
25333408|NCT00838916|50649754|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
25333409|NCT00838916|50649753|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
25333410|NCT00838916|50649754|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
25251509|NCT00171158|50567174|FG000|Core Study|Abnormal Laboratory Values|2|||
25333411|NCT00838916|50649753|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
25333412|NCT00838916|50649754|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
25333413|NCT00838916|50649753|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
25333414|NCT00838916|50649754|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
25251510|NCT00171158|50567174|FG000|Core Study|Lost to Follow-up|1|||
25251511|NCT00171158|50567174|FG000|E2 Extension|Other|7|||
25333415|NCT00838916|50649753|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
25333416|NCT00838916|50649754|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
25333417|NCT00838916|50649753|FG000|Treatment Period (156 Weeks)|Missing|3|||
25333418|NCT00838916|50649754|FG001|Treatment Period (156 Weeks)|Missing|1|||
25333419|NCT00838916|50649753|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
25333420|NCT00838916|50649754|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
25251512|NCT00170846|50567181|FG000|Overall Study|Subject withdrew Informed Consent|5|||
25251513|NCT00170846|50567182|FG001|Overall Study|Subject withdrew Informed Consent|12|||
25251514|NCT00170846|50567183|FG002|Overall Study|Subject withdrew Informed Consent|8|||
25251515|NCT00170846|50567181|FG000|Overall Study|Lost to Follow-up|6|||
25251516|NCT00170846|50567182|FG001|Overall Study|Lost to Follow-up|3|||
25251517|NCT00170846|50567183|FG002|Overall Study|Lost to Follow-up|2|||
25251518|NCT00170846|50567181|FG000|Overall Study|Death|0|||
25251519|NCT00170846|50567182|FG001|Overall Study|Death|3|||
25251520|NCT00170846|50567183|FG002|Overall Study|Death|3|||
25251521|NCT00170846|50567181|FG000|Overall Study|Reason Missing|0|||
25333421|NCT00838916|50649753|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
25333422|NCT00838916|50649754|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
25333423|NCT00838916|50649753|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
25333424|NCT00838916|50649754|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
25333425|NCT00838916|50649753|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
25333426|NCT00838916|50649754|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
25333427|NCT00838916|50649753|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
25333428|NCT00838916|50649754|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
25333429|NCT00838916|50649753|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
25333430|NCT00838916|50649754|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
25333431|NCT00838916|50649753|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
25333432|NCT00838916|50649754|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
25333433|NCT00838916|50649753|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
25251522|NCT00170846|50567182|FG001|Overall Study|Reason Missing|1|||
25251523|NCT00170846|50567183|FG002|Overall Study|Reason Missing|0|||
25251524|NCT00479882|50567195|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
25251525|NCT00479882|50567196|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
25251526|NCT00479882|50567197|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
25251527|NCT00479882|50567198|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
25251528|NCT00479882|50567195|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
25251529|NCT00479882|50567196|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
25251530|NCT00479882|50567197|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
25251531|NCT00479882|50567198|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
25251532|NCT00479882|50567195|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
25251533|NCT00479882|50567196|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
25251534|NCT00479882|50567197|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
25251535|NCT00479882|50567198|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
25333434|NCT00838916|50649754|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
25333435|NCT00838916|50649753|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
25333436|NCT00838916|50649754|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
25333437|NCT00838916|50649753|FG000|Follow-up Period (8 Weeks)|Missing|3|||
25333438|NCT00838916|50649754|FG001|Follow-up Period (8 Weeks)|Missing|0|||
25333439|NCT00838682|50649762|FG000|Overall Study|Lost to Follow-up|21|||
25333440|NCT00838682|50649763|FG001|Overall Study|Lost to Follow-up|14|||
25251536|NCT00479882|50567195|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
25333441|NCT00838682|50649762|FG000|Overall Study|detection of exclusion criteria|4|||
25333442|NCT00838682|50649763|FG001|Overall Study|detection of exclusion criteria|3|||
25333443|NCT00838682|50649762|FG000|Overall Study|Protocol Violation|0|||
25333444|NCT00838682|50649763|FG001|Overall Study|Protocol Violation|1|||
25333445|NCT00838682|50649762|FG000|Overall Study|Withdrawal by Subject|0|||
25333446|NCT00838682|50649763|FG001|Overall Study|Withdrawal by Subject|1|||
25333447|NCT00820040|50649769|FG000|Overall Study|Death|1|||
25333448|NCT00820040|50649769|FG000|Overall Study|Sponsor terminated study|1|||
25333449|NCT00820040|50649769|FG000|Overall Study|Screen failure|1|||
25333450|NCT00803712|50649775|FG000|Overall Study|Noncompliance|3|||
25333451|NCT00803712|50649776|FG001|Overall Study|Noncompliance|0|||
25333452|NCT00803712|50649775|FG000|Overall Study|Adverse Event|5|||
25333453|NCT00803712|50649776|FG001|Overall Study|Adverse Event|0|||
25251537|NCT00479882|50567196|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
24901460|NCT00793793|49995510|FG010|Overall Study|Lost to Follow-up|1|||
25251538|NCT00479882|50567197|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
25251539|NCT00479882|50567198|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
25251540|NCT00479882|50567195|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
25333454|NCT00803712|50649775|FG000|Overall Study|Death|8|||
25333455|NCT00803712|50649776|FG001|Overall Study|Death|7|||
25333456|NCT00803712|50649775|FG000|Overall Study|Lost to Follow-up|3|||
25333457|NCT00803712|50649776|FG001|Overall Study|Lost to Follow-up|1|||
25333458|NCT00803712|50649775|FG000|Overall Study|Withdrawal by Subject|2|||
25333459|NCT00803712|50649776|FG001|Overall Study|Withdrawal by Subject|4|||
25333460|NCT00803712|50649775|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
25333461|NCT00803712|50649776|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
25333462|NCT00803712|50649775|FG000|Overall Study|Protocol criteria (other)|0|||
25333463|NCT00803712|50649776|FG001|Overall Study|Protocol criteria (other)|2|||
25333464|NCT00803712|50649775|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
25333465|NCT00803712|50649776|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
25333466|NCT00803712|50649775|FG000|Overall Study|Administrative decision|2|||
25333467|NCT00803712|50649776|FG001|Overall Study|Administrative decision|3|||
25333468|NCT00803712|50649775|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
25333469|NCT00803712|50649776|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
25333470|NCT00591344|50649784|FG000|Overall Study|Transportation issues|1|||
25333471|NCT00591344|50649785|FG001|Overall Study|Transportation issues|0|||
25333472|NCT00591344|50649784|FG000|Overall Study|Moved out of state|1|||
25333473|NCT00591344|50649785|FG001|Overall Study|Moved out of state|0|||
25333474|NCT00591344|50649784|FG000|Overall Study|Medical complications|1|||
25333475|NCT00591344|50649785|FG001|Overall Study|Medical complications|3|||
25333476|NCT00591344|50649784|FG000|Overall Study|Underwent DBS|2|||
25333477|NCT00591344|50649785|FG001|Overall Study|Underwent DBS|2|||
25333478|NCT00591344|50649784|FG000|Overall Study|Death|0|||
25333479|NCT00591344|50649785|FG001|Overall Study|Death|1|||
25333480|NCT00591344|50649784|FG000|Overall Study|Lost to Follow-up|0|||
25333481|NCT00591344|50649785|FG001|Overall Study|Lost to Follow-up|1|||
25333482|NCT00591344|50649784|FG000|Overall Study|Did not want to come off medication|0|||
25333483|NCT00591344|50649785|FG001|Overall Study|Did not want to come off medication|1|||
25333484|NCT00803634|50649797|FG000|Overall Study|Withdrew Consent|1|||
25333485|NCT00803634|50649798|FG001|Overall Study|Withdrew Consent|0|||
25333486|NCT00803634|50649797|FG000|Overall Study|Lost to Follow-up|2|||
25333487|NCT00803634|50649798|FG001|Overall Study|Lost to Follow-up|3|||
25333488|NCT00803634|50649797|FG000|Overall Study|Death|3|||
25333489|NCT00803634|50649798|FG001|Overall Study|Death|2|||
25333490|NCT00838526|50649807|FG000|Overall Study|Adverse Event|3|||
25333491|NCT00838526|50649808|FG001|Overall Study|Adverse Event|12|||
25333492|NCT00838526|50649807|FG000|Overall Study|Lost to Follow-up|4|||
25333493|NCT00838526|50649808|FG001|Overall Study|Lost to Follow-up|12|||
25251541|NCT00479882|50567196|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
25251542|NCT00479882|50567197|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
25251543|NCT00479882|50567198|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
25251544|NCT00479882|50567195|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
25251545|NCT00479882|50567196|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
25251546|NCT00479882|50567197|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
25251547|NCT00479882|50567198|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
25333494|NCT00838526|50649807|FG000|Overall Study|Withdrawal by Subject|4|||
25333495|NCT00838526|50649808|FG001|Overall Study|Withdrawal by Subject|5|||
25333496|NCT00838526|50649807|FG000|Overall Study|Lack of Efficacy|2|||
25333497|NCT00838526|50649808|FG001|Overall Study|Lack of Efficacy|3|||
25333498|NCT00838526|50649807|FG000|Overall Study|Other|11|||
25333499|NCT00838526|50649808|FG001|Overall Study|Other|7|||
25333500|NCT00818246|50649827|FG000|Overall Study|Impossible to match pictures|5|||
25333501|NCT00818168|50649831|FG000|Overall Study|Lack of Efficacy|18|||
25333502|NCT00818168|50649831|FG000|Overall Study|Pregnancy|2|||
25333503|NCT00818168|50649831|FG000|Overall Study|Withdrawal by Subject|16|||
25333504|NCT00818168|50649831|FG000|Overall Study|Lost to Follow-up|7|||
25333505|NCT00818168|50649831|FG000|Overall Study|Adverse Event|19|||
25333506|NCT00818168|50649831|FG000|Overall Study|Reason for Non-completion Not reported|6|||
25333507|NCT00818168|50649831|FG000|Overall Study|Participant Moved|2|||
25333508|NCT00817778|50649837|FG000|Overall Study|Adverse Event|1|||
25333509|NCT00817778|50649838|FG001|Overall Study|Adverse Event|0|||
25333510|NCT00817778|50649837|FG000|Overall Study|Withdrawal by Subject|1|||
25333511|NCT00817778|50649838|FG001|Overall Study|Withdrawal by Subject|1|||
25333512|NCT00817778|50649837|FG000|Overall Study|Protocol Violation|0|||
25077892|NCT02233738|50185790|FG001|Overall Study|Did not return after Baseline|2|||
25251548|NCT00479882|50567195|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
25251549|NCT00479882|50567196|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
25333513|NCT00817778|50649838|FG001|Overall Study|Protocol Violation|1|||
25333514|NCT00817778|50649837|FG000|Overall Study|Study-specific discontinuation criteria|0|||
25333515|NCT00817778|50649838|FG001|Overall Study|Study-specific discontinuation criteria|1|||
25333516|NCT00817778|50649837|FG000|Overall Study|Poor venous access|1|||
25333517|NCT00817778|50649838|FG001|Overall Study|Poor venous access|0|||
25333518|NCT00813098|50649847|FG000|Overall Study|Adverse Event|2|||
25333519|NCT00813098|50649848|FG001|Overall Study|Adverse Event|4|||
25333520|NCT00813098|50649849|FG002|Overall Study|Adverse Event|1|||
25333521|NCT00813098|50649847|FG000|Overall Study|Withdrawal by Subject|0|||
25333522|NCT00813098|50649848|FG001|Overall Study|Withdrawal by Subject|1|||
25251550|NCT00479882|50567197|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
25251551|NCT00479882|50567198|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
25251552|NCT00479882|50567195|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
25251553|NCT00479882|50567196|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
25251554|NCT00479882|50567197|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
25251555|NCT00479882|50567198|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
25251556|NCT00479882|50567195|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
25251557|NCT00479882|50567196|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
25251558|NCT00479882|50567197|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
25251559|NCT00479882|50567198|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
25251560|NCT00479882|50567195|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
25333523|NCT00813098|50649849|FG002|Overall Study|Withdrawal by Subject|0|||
24901461|NCT00793793|49995511|FG011|Overall Study|Lost to Follow-up|0|||
24901462|NCT00793793|49995500|FG000|Overall Study|Withdrawal by Subject|0|||
24901463|NCT00793793|49995501|FG001|Overall Study|Withdrawal by Subject|0|||
24901464|NCT00793793|49995502|FG002|Overall Study|Withdrawal by Subject|0|||
24901465|NCT00793793|49995503|FG003|Overall Study|Withdrawal by Subject|0|||
24901466|NCT00793793|49995504|FG004|Overall Study|Withdrawal by Subject|1|||
24901467|NCT00793793|49995505|FG005|Overall Study|Withdrawal by Subject|0|||
24901468|NCT00793793|49995506|FG006|Overall Study|Withdrawal by Subject|0|||
24901469|NCT00793793|49995507|FG007|Overall Study|Withdrawal by Subject|0|||
24901470|NCT00793793|49995508|FG008|Overall Study|Withdrawal by Subject|1|||
24901471|NCT00793793|49995509|FG009|Overall Study|Withdrawal by Subject|0|||
24901472|NCT00793793|49995510|FG010|Overall Study|Withdrawal by Subject|0|||
24901473|NCT00793793|49995511|FG011|Overall Study|Withdrawal by Subject|0|||
24901474|NCT00793793|49995500|FG000|Overall Study|reason not specified|0|||
24901475|NCT00793793|49995501|FG001|Overall Study|reason not specified|1|||
24901476|NCT00793793|49995502|FG002|Overall Study|reason not specified|0|||
24901477|NCT00793793|49995503|FG003|Overall Study|reason not specified|1|||
24901478|NCT00793793|49995504|FG004|Overall Study|reason not specified|1|||
24901479|NCT00793793|49995505|FG005|Overall Study|reason not specified|1|||
24901480|NCT00793793|49995506|FG006|Overall Study|reason not specified|2|||
24901481|NCT00793793|49995507|FG007|Overall Study|reason not specified|0|||
24901482|NCT00793793|49995508|FG008|Overall Study|reason not specified|7|||
24901483|NCT00793793|49995509|FG009|Overall Study|reason not specified|6|||
24901484|NCT00793793|49995510|FG010|Overall Study|reason not specified|2|||
24901485|NCT00793793|49995511|FG011|Overall Study|reason not specified|4|||
24901486|NCT00776789|49995559|FG000|Overall Study|Consent refusal|2|||
24901487|NCT00776789|49995560|FG001|Overall Study|Consent refusal|2|||
24901488|NCT00776789|49995559|FG000|Overall Study|Poor quality video|1|||
24901489|NCT00776789|49995560|FG001|Overall Study|Poor quality video|1|||
24901490|NCT00776555|49995570|FG000|Overall Study|Study terminated|3|||
24901491|NCT00776555|49995571|FG001|Overall Study|Study terminated|0|||
24901492|NCT00720434|49995581|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
24901493|NCT00720434|49995582|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
24901494|NCT00720434|49995583|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
24901495|NCT00720434|49995584|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
24901496|NCT00720434|49995581|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
24901497|NCT00720434|49995582|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
24901498|NCT00720434|49995583|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
24901499|NCT00720434|49995584|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
24901500|NCT00720434|49995581|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
24901501|NCT00720434|49995582|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
24901502|NCT00720434|49995583|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
25333524|NCT00813098|50649847|FG000|Overall Study|Inability to complete study procedures|1|||
25333525|NCT00813098|50649848|FG001|Overall Study|Inability to complete study procedures|0|||
25333526|NCT00813098|50649849|FG002|Overall Study|Inability to complete study procedures|0|||
25333527|NCT00813098|50649847|FG000|Overall Study|Lost to Follow-up|0|||
25333528|NCT00813098|50649848|FG001|Overall Study|Lost to Follow-up|1|||
25333529|NCT00813098|50649849|FG002|Overall Study|Lost to Follow-up|0|||
25333530|NCT00813098|50649847|FG000|Overall Study|Protocol Violation|0|||
25333531|NCT00813098|50649848|FG001|Overall Study|Protocol Violation|0|||
25333532|NCT00813098|50649849|FG002|Overall Study|Protocol Violation|1|||
24901503|NCT00720434|49995584|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
24901504|NCT00720434|49995581|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
24901505|NCT00720434|49995582|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
24901506|NCT00720434|49995583|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
24901507|NCT00720434|49995584|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
24901508|NCT00720434|49995581|FG000|Open-Label Period (Week 5-72)|Other|4|||
25251561|NCT00479882|50567196|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
25333533|NCT00813098|50649847|FG000|Overall Study|Principal Investigator decision|0|||
25333534|NCT00813098|50649848|FG001|Overall Study|Principal Investigator decision|1|||
25333535|NCT00813098|50649849|FG002|Overall Study|Principal Investigator decision|0|||
25333536|NCT00813098|50649847|FG000|Overall Study|Withdrew Consent|0|||
25333537|NCT00813098|50649848|FG001|Overall Study|Withdrew Consent|1|||
25333538|NCT00813098|50649849|FG002|Overall Study|Withdrew Consent|0|||
25333539|NCT00796653|50649861|FG000|Overall Study|Adverse Event|19|||
25333540|NCT00796653|50649862|FG001|Overall Study|Adverse Event|16|||
25333541|NCT00796653|50649863|FG002|Overall Study|Adverse Event|16|||
25333542|NCT00796653|50649864|FG003|Overall Study|Adverse Event|16|||
25333543|NCT00796653|50649861|FG000|Overall Study|Lost to Follow-up|2|||
25333544|NCT00796653|50649862|FG001|Overall Study|Lost to Follow-up|1|||
25333545|NCT00796653|50649863|FG002|Overall Study|Lost to Follow-up|2|||
25333546|NCT00796653|50649864|FG003|Overall Study|Lost to Follow-up|3|||
25333547|NCT00796653|50649861|FG000|Overall Study|Withdrawal by Subject|16|||
25251562|NCT00479882|50567197|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
25251563|NCT00479882|50567198|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
25251564|NCT00479882|50567195|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
25251565|NCT00479882|50567196|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
25251566|NCT00479882|50567197|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
25251567|NCT00479882|50567198|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
25251568|NCT00479882|50567195|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
25251569|NCT00479882|50567196|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
25251570|NCT00479882|50567197|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
25251571|NCT00479882|50567198|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
25251572|NCT00479882|50567195|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
25251573|NCT00479882|50567196|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
25333548|NCT00796653|50649862|FG001|Overall Study|Withdrawal by Subject|8|||
25333549|NCT00796653|50649863|FG002|Overall Study|Withdrawal by Subject|8|||
25333550|NCT00796653|50649864|FG003|Overall Study|Withdrawal by Subject|13|||
25333551|NCT00796653|50649861|FG000|Overall Study|Lack of Efficacy|8|||
25333552|NCT00796653|50649862|FG001|Overall Study|Lack of Efficacy|1|||
25333553|NCT00796653|50649863|FG002|Overall Study|Lack of Efficacy|3|||
25333554|NCT00796653|50649864|FG003|Overall Study|Lack of Efficacy|2|||
25333555|NCT00796653|50649861|FG000|Overall Study|Non compliance with protocol|2|||
25333556|NCT00796653|50649862|FG001|Overall Study|Non compliance with protocol|2|||
25333557|NCT00796653|50649863|FG002|Overall Study|Non compliance with protocol|0|||
25333558|NCT00796653|50649864|FG003|Overall Study|Non compliance with protocol|2|||
25333559|NCT00796653|50649861|FG000|Overall Study|Other reason not described above|4|||
25333560|NCT00796653|50649862|FG001|Overall Study|Other reason not described above|9|||
25333561|NCT00796653|50649863|FG002|Overall Study|Other reason not described above|7|||
25333562|NCT00796653|50649864|FG003|Overall Study|Other reason not described above|4|||
25333563|NCT00806286|50649885|FG000|Overall Study|Adverse Event|5|||
25333564|NCT00806286|50649886|FG001|Overall Study|Adverse Event|2|||
25333565|NCT00806286|50649887|FG002|Overall Study|Adverse Event|0|||
25333566|NCT00806286|50649885|FG000|Overall Study|Disease progression|31|||
25333567|NCT00806286|50649886|FG001|Overall Study|Disease progression|38|||
25333568|NCT00806286|50649887|FG002|Overall Study|Disease progression|1|||
25333569|NCT00806286|50649885|FG000|Overall Study|Death|1|||
25333570|NCT00806286|50649886|FG001|Overall Study|Death|6|||
25333571|NCT00806286|50649887|FG002|Overall Study|Death|0|||
25251574|NCT00479882|50567197|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
25251575|NCT00479882|50567198|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
25251576|NCT00479882|50567195|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
25251577|NCT00479882|50567196|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
25251578|NCT00479882|50567197|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
25251579|NCT00479882|50567198|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
25251580|NCT00479765|50567224|FG000|Overall Study|study terminated|4|||
25251581|NCT00479687|50567230|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
25251582|NCT00479687|50567231|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
25251583|NCT00479687|50567232|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
25251584|NCT00479687|50567230|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
25251585|NCT00479687|50567231|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
25333572|NCT00806286|50649885|FG000|Overall Study|Lost to Follow-up|0|||
25333573|NCT00806286|50649886|FG001|Overall Study|Lost to Follow-up|1|||
25333574|NCT00806286|50649887|FG002|Overall Study|Lost to Follow-up|0|||
25251586|NCT00479687|50567232|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
25333575|NCT00806286|50649885|FG000|Overall Study|Withdrawal by Subject|8|||
25333576|NCT00806286|50649886|FG001|Overall Study|Withdrawal by Subject|3|||
25333577|NCT00806286|50649887|FG002|Overall Study|Withdrawal by Subject|1|||
25333578|NCT00806286|50649885|FG000|Overall Study|Physician Decision|2|||
25333579|NCT00806286|50649886|FG001|Overall Study|Physician Decision|2|||
25333580|NCT00806286|50649887|FG002|Overall Study|Physician Decision|0|||
25251587|NCT00479687|50567230|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
25251588|NCT00479687|50567231|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
24901509|NCT00720434|49995582|FG001|Open-Label Period (Week 5-72)|Other|3|||
24901510|NCT00720434|49995583|FG002|Open-Label Period (Week 5-72)|Other|3|||
24901511|NCT00720434|49995584|FG003|Open-Label Period (Week 5-72)|Other|2|||
25333581|NCT00806286|50649885|FG000|Overall Study|Due to a variety of reasons|7|||
25333582|NCT00806286|50649886|FG001|Overall Study|Due to a variety of reasons|2|||
25333583|NCT00806286|50649887|FG002|Overall Study|Due to a variety of reasons|1|||
25333584|NCT00590538|50649895|FG000|Overall Study|Study terminated before completed|2|||
25333585|NCT00796419|50649901|FG000|Overall Study|Death|0|||
25333586|NCT00796419|50649902|FG001|Overall Study|Death|1|||
25333587|NCT00796107|50649908|FG000|Overall Study|Lack of Efficacy|1|||
25333588|NCT00796107|50649908|FG000|Overall Study|Progressive Disease|5|||
25333589|NCT00795951|50649912|FG000|Overall Study|Lost to Follow-up|1|||
25333590|NCT00795951|50649912|FG000|Overall Study|Withdrawal by Subject|1|||
25333591|NCT00795717|50649919|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
25333592|NCT00795717|50649920|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
24901512|NCT00776009|49995600|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
24901513|NCT00776009|49995601|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
24901514|NCT00776009|49995602|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
24901515|NCT00776009|49995603|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
24901516|NCT00776009|49995604|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
24901517|NCT00776009|49995605|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
24901518|NCT00776009|49995600|FG000|Period 1: First Intervention|Protocol Violation|0|||
24901519|NCT00776009|49995601|FG001|Period 1: First Intervention|Protocol Violation|1|||
24901520|NCT00776009|49995602|FG002|Period 1: First Intervention|Protocol Violation|0|||
24901521|NCT00776009|49995603|FG003|Period 1: First Intervention|Protocol Violation|0|||
24901522|NCT00776009|49995604|FG004|Period 1: First Intervention|Protocol Violation|1|||
25251589|NCT00479687|50567232|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
25251590|NCT00479687|50567230|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
25251591|NCT00479687|50567231|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
25251592|NCT00479687|50567232|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
25251593|NCT00479687|50567230|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
25251594|NCT00479687|50567231|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
25251595|NCT00479687|50567232|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
25251596|NCT00479687|50567230|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
25251597|NCT00479687|50567231|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
25251598|NCT00479687|50567232|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
25251599|NCT00479687|50567230|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
25251600|NCT00479687|50567231|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
25251601|NCT00479687|50567232|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
25251602|NCT00479687|50567230|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
25251603|NCT00479687|50567231|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
25251604|NCT00479687|50567232|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
25251605|NCT00479687|50567230|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
25251606|NCT00479687|50567231|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
25251607|NCT00479687|50567232|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
25251608|NCT00479336|50567243|FG000|Overall Study|Adverse Event|1|||
25251609|NCT00479336|50567244|FG001|Overall Study|Adverse Event|1|||
25251610|NCT00479336|50567245|FG002|Overall Study|Adverse Event|1|||
25251611|NCT00479336|50567246|FG003|Overall Study|Adverse Event|3|||
25251612|NCT00479336|50567243|FG000|Overall Study|Lack of Efficacy|1|||
25251613|NCT00479336|50567244|FG001|Overall Study|Lack of Efficacy|0|||
25251614|NCT00479336|50567245|FG002|Overall Study|Lack of Efficacy|0|||
25251615|NCT00479336|50567246|FG003|Overall Study|Lack of Efficacy|0|||
25251616|NCT00479336|50567243|FG000|Overall Study|Protocol Violation|0|||
25251617|NCT00479336|50567244|FG001|Overall Study|Protocol Violation|1|||
25251618|NCT00479336|50567245|FG002|Overall Study|Protocol Violation|0|||
25251619|NCT00479336|50567246|FG003|Overall Study|Protocol Violation|0|||
25251620|NCT00479336|50567243|FG000|Overall Study|Withdrawal by Subject|1|||
25251621|NCT00479336|50567244|FG001|Overall Study|Withdrawal by Subject|2|||
25251622|NCT00479336|50567245|FG002|Overall Study|Withdrawal by Subject|0|||
25251623|NCT00479336|50567246|FG003|Overall Study|Withdrawal by Subject|0|||
25251624|NCT00479336|50567243|FG000|Overall Study|Physician Decision|0|||
25333593|NCT00795717|50649919|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
25333594|NCT00795717|50649920|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
25251625|NCT00479336|50567244|FG001|Overall Study|Physician Decision|1|||
25251626|NCT00479336|50567245|FG002|Overall Study|Physician Decision|0|||
25251627|NCT00479336|50567246|FG003|Overall Study|Physician Decision|2|||
25333595|NCT00795717|50649919|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
24901523|NCT00776009|49995605|FG005|Period 1: First Intervention|Protocol Violation|0|||
25333596|NCT00795717|50649920|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
25333597|NCT00795717|50649919|FG000|Phase II|too busy|0|||
25333598|NCT00795717|50649920|FG001|Phase II|too busy|1|||
25333599|NCT00805740|50649929|FG000|Overall Study|Death|7|||
25333600|NCT00805740|50649930|FG001|Overall Study|Death|4|||
25333601|NCT00805740|50649929|FG000|Overall Study|Withdrawal by Subject|1|||
25333602|NCT00805740|50649930|FG001|Overall Study|Withdrawal by Subject|0|||
25333603|NCT00805740|50649929|FG000|Overall Study|Lost to Follow-up|1|||
25333604|NCT00805740|50649930|FG001|Overall Study|Lost to Follow-up|0|||
25333605|NCT00805740|50649929|FG000|Overall Study|Randomized, but not treated|2|||
25333606|NCT00805740|50649930|FG001|Overall Study|Randomized, but not treated|0|||
25333607|NCT00795639|50649938|FG000|Overall Study|Death|1|||
25333608|NCT00795639|50649939|FG001|Overall Study|Death|6|||
25333609|NCT00795639|50649938|FG000|Overall Study|Withdrawal by Subject|1|||
25251628|NCT00479336|50567243|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
25251629|NCT00479336|50567244|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
25251630|NCT00479336|50567245|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
25251631|NCT00479336|50567246|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
25251632|NCT00478244|50567256|FG000|Overall Study|Did not receive transplant|1|||
25251633|NCT00478205|50567262|FG000|Overall Study|Adverse Event|182|||
25333610|NCT00795639|50649939|FG001|Overall Study|Withdrawal by Subject|3|||
25333611|NCT00795639|50649938|FG000|Overall Study|Pregnancy|1|||
25333612|NCT00795639|50649939|FG001|Overall Study|Pregnancy|0|||
25333613|NCT00795639|50649938|FG000|Overall Study|Adverse Event|5|||
25333614|NCT00795639|50649939|FG001|Overall Study|Adverse Event|2|||
25333615|NCT00795639|50649938|FG000|Overall Study|Other|0|||
25333616|NCT00795639|50649939|FG001|Overall Study|Other|2|||
25333617|NCT00795639|50649938|FG000|Overall Study|Terminated by sponsor|13|||
25333618|NCT00795639|50649939|FG001|Overall Study|Terminated by sponsor|12|||
25333619|NCT00795639|50649938|FG000|Overall Study|Randomized and not treated|0|||
25333620|NCT00795639|50649939|FG001|Overall Study|Randomized and not treated|1|||
25333621|NCT00589602|50649945|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
25333622|NCT00794157|50649954|FG000|Overall Study|Adverse Event|4|||
25333623|NCT00794157|50649955|FG001|Overall Study|Adverse Event|1|||
25251634|NCT00478205|50567263|FG001|Overall Study|Adverse Event|39|||
25251635|NCT00478205|50567262|FG000|Overall Study|Medication Non-compliance|9|||
25251636|NCT00478205|50567263|FG001|Overall Study|Medication Non-compliance|4|||
25251637|NCT00478205|50567262|FG000|Overall Study|Protocol Violation|15|||
25251638|NCT00478205|50567263|FG001|Overall Study|Protocol Violation|5|||
25251639|NCT00478205|50567262|FG000|Overall Study|Request of Investigator or Sponsor|4|||
25251640|NCT00478205|50567263|FG001|Overall Study|Request of Investigator or Sponsor|5|||
25251641|NCT00478205|50567262|FG000|Overall Study|Withdrawal by Subject|61|||
25251642|NCT00478205|50567263|FG001|Overall Study|Withdrawal by Subject|22|||
25251643|NCT00478205|50567262|FG000|Overall Study|Lack of Efficacy|1|||
25251644|NCT00478205|50567263|FG001|Overall Study|Lack of Efficacy|0|||
25251645|NCT00478205|50567262|FG000|Overall Study|Other|24|||
25251646|NCT00478205|50567263|FG001|Overall Study|Other|12|||
25251647|NCT00477971|50567271|FG000|Overall Study|Disease progression|6|||
25251648|NCT00477971|50567272|FG001|Overall Study|Disease progression|0|||
25251649|NCT00477971|50567271|FG000|Overall Study|Withdrawal by Subject|3|||
25251650|NCT00477971|50567272|FG001|Overall Study|Withdrawal by Subject|1|||
25251651|NCT00477971|50567271|FG000|Overall Study|Adverse Event|3|||
25251652|NCT00477971|50567272|FG001|Overall Study|Adverse Event|0|||
25251653|NCT00477971|50567271|FG000|Overall Study|Death|2|||
25251654|NCT00477971|50567272|FG001|Overall Study|Death|4|||
25251655|NCT00477971|50567271|FG000|Overall Study|Alternative treatment|3|||
25251656|NCT00477971|50567272|FG001|Overall Study|Alternative treatment|1|||
25251657|NCT00477464|50567278|FG000|Overall Study|Lost to Follow-up|1|||
25251658|NCT00477464|50567278|FG000|Overall Study|Death|36|||
25251659|NCT00477464|50567278|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
25251660|NCT00477386|50567286|FG000|Overall Study|Adverse Event|4|||
25251661|NCT00477386|50567287|FG001|Overall Study|Adverse Event|8|||
25251662|NCT00477386|50567286|FG000|Overall Study|Disease progression, relapse|3|||
25251663|NCT00477386|50567287|FG001|Overall Study|Disease progression, relapse|4|||
25251664|NCT00477386|50567286|FG000|Overall Study|Disease progression, refractory|1|||
25251665|NCT00477386|50567287|FG001|Overall Study|Disease progression, refractory|3|||
25251666|NCT00477386|50567286|FG000|Overall Study|Other|1|||
25251667|NCT00477386|50567287|FG001|Overall Study|Other|2|||
25251668|NCT00477386|50567286|FG000|Overall Study|Physician Decision|1|||
25251669|NCT00477386|50567287|FG001|Overall Study|Physician Decision|0|||
25333624|NCT00794157|50649956|FG002|Overall Study|Adverse Event|8|||
25251670|NCT00477386|50567286|FG000|Overall Study|Withdrawal by Subject|1|||
25333625|NCT00794157|50649954|FG000|Overall Study|Subject withdrew consent|2|||
25333626|NCT00794157|50649955|FG001|Overall Study|Subject withdrew consent|0|||
25333627|NCT00794157|50649956|FG002|Overall Study|Subject withdrew consent|3|||
25251671|NCT00477386|50567287|FG001|Overall Study|Withdrawal by Subject|0|||
25251672|NCT00477269|50567295|FG000|Core Study|Adverse Event|6|||
25251673|NCT00477269|50567296|FG001|Core Study|Adverse Event|4|||
25251674|NCT00477269|50567297|FG002|Core Study|Adverse Event|0|||
25251675|NCT00477269|50567295|FG000|Core Study|Death|3|||
25251676|NCT00477269|50567296|FG001|Core Study|Death|3|||
25251677|NCT00477269|50567297|FG002|Core Study|Death|0|||
25251678|NCT00477269|50567295|FG000|Core Study|Withdrawn Consent|0|||
25251679|NCT00477269|50567296|FG001|Core Study|Withdrawn Consent|1|||
25251680|NCT00477269|50567297|FG002|Core Study|Withdrawn Consent|0|||
25251681|NCT00477269|50567295|FG000|Open Label Extension|Adverse Event|0|||
25251682|NCT00477269|50567296|FG001|Open Label Extension|Adverse Event|0|||
25251683|NCT00477269|50567297|FG002|Open Label Extension|Adverse Event|4|||
25251684|NCT00477269|50567295|FG000|Open Label Extension|Abnormal laboratory values|0|||
25251685|NCT00477269|50567296|FG001|Open Label Extension|Abnormal laboratory values|0|||
25251686|NCT00477269|50567297|FG002|Open Label Extension|Abnormal laboratory values|1|||
25251687|NCT00477269|50567295|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
25251688|NCT00477269|50567296|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
25251689|NCT00477269|50567297|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
25251690|NCT00477269|50567295|FG000|Open Label Extension|Adminiatrative problems|0|||
25251691|NCT00477269|50567296|FG001|Open Label Extension|Adminiatrative problems|0|||
25251692|NCT00477269|50567297|FG002|Open Label Extension|Adminiatrative problems|2|||
25251693|NCT00477269|50567295|FG000|Open Label Extension|Death|0|||
25251694|NCT00477269|50567296|FG001|Open Label Extension|Death|0|||
25251695|NCT00477269|50567297|FG002|Open Label Extension|Death|4|||
25251696|NCT00477152|50567305|FG000|Overall Study|Parent withdrew consent|2|||
25251697|NCT00477152|50567305|FG000|Overall Study|Adverse Event|1|||
25251698|NCT00476996|50567312|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
25251699|NCT00476996|50567313|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
25251700|NCT00476996|50567314|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
25251701|NCT00476996|50567315|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
25251702|NCT00476996|50567312|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
25251703|NCT00476996|50567313|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
25251704|NCT00476996|50567314|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
25251705|NCT00476996|50567315|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
25251706|NCT00476996|50567312|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
25251707|NCT00476996|50567313|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
25251708|NCT00476996|50567314|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
25251709|NCT00476996|50567315|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
25251710|NCT00476996|50567312|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
25251711|NCT00476996|50567313|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
25251712|NCT00476996|50567314|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
25251713|NCT00476996|50567315|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
25251714|NCT00476996|50567312|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
25251715|NCT00476996|50567313|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
25251716|NCT00476996|50567314|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
25251717|NCT00476996|50567315|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
25251718|NCT00476996|50567312|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
25251719|NCT00476996|50567313|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
25251720|NCT00476996|50567314|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
25251721|NCT00476996|50567315|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
25251722|NCT00476996|50567312|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
25251723|NCT00476996|50567313|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
25251724|NCT00476996|50567314|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
25251725|NCT00476996|50567315|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
25251726|NCT00476996|50567312|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
25251727|NCT00476996|50567313|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
25251728|NCT00476996|50567314|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
25251729|NCT00476996|50567315|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
25251730|NCT00476996|50567312|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
25251731|NCT00476996|50567313|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
25251732|NCT00476996|50567314|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
25251733|NCT00476996|50567315|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
25251734|NCT00476996|50567312|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
25251735|NCT00476996|50567313|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
25251736|NCT00476996|50567314|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
25251737|NCT00476996|50567315|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
25251738|NCT00476996|50567312|FG000|OLE Phase (From Week 48)|Death|0|||
25251739|NCT00476996|50567313|FG001|OLE Phase (From Week 48)|Death|0|||
25251740|NCT00476996|50567314|FG002|OLE Phase (From Week 48)|Death|0|||
25251741|NCT00476996|50567315|FG003|OLE Phase (From Week 48)|Death|7|||
25333628|NCT00794157|50649954|FG000|Overall Study|Lost to Follow-up|2|||
25333629|NCT00794157|50649955|FG001|Overall Study|Lost to Follow-up|0|||
25251742|NCT00476996|50567312|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
25251743|NCT00476996|50567313|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
25251744|NCT00476996|50567314|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
25333630|NCT00794157|50649956|FG002|Overall Study|Lost to Follow-up|1|||
25333631|NCT00794157|50649954|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25333632|NCT00794157|50649955|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
25333633|NCT00794157|50649956|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
25333634|NCT00794157|50649954|FG000|Overall Study|Administrative problems|1|||
25333635|NCT00794157|50649955|FG001|Overall Study|Administrative problems|7|||
25333636|NCT00794157|50649956|FG002|Overall Study|Administrative problems|4|||
25333637|NCT00794157|50649954|FG000|Overall Study|Abnormal test procedure result(s)|0|||
25333638|NCT00794157|50649955|FG001|Overall Study|Abnormal test procedure result(s)|1|||
25333639|NCT00794157|50649956|FG002|Overall Study|Abnormal test procedure result(s)|0|||
25333640|NCT00794157|50649954|FG000|Overall Study|Protocol deviation|0|||
25333641|NCT00794157|50649955|FG001|Overall Study|Protocol deviation|1|||
25333642|NCT00794157|50649956|FG002|Overall Study|Protocol deviation|1|||
25333643|NCT00588237|50649964|FG000|Overall Study|Evaluable for toxicity only|3|||
25333644|NCT00588237|50649964|FG000|Overall Study|Patien not treated|1|||
25333645|NCT00790023|50649971|FG000|Overall Study|Adverse Event|2|||
25333646|NCT00790023|50649972|FG001|Overall Study|Adverse Event|1|||
25333647|NCT00790023|50649973|FG002|Overall Study|Adverse Event|4|||
25333648|NCT00790023|50649971|FG000|Overall Study|Protocol Violation|2|||
25333649|NCT00790023|50649972|FG001|Overall Study|Protocol Violation|4|||
25333650|NCT00790023|50649973|FG002|Overall Study|Protocol Violation|2|||
25333651|NCT00790023|50649971|FG000|Overall Study|Withdrawal by Subject|2|||
25333652|NCT00790023|50649972|FG001|Overall Study|Withdrawal by Subject|0|||
25333653|NCT00790023|50649973|FG002|Overall Study|Withdrawal by Subject|6|||
25333654|NCT00790023|50649971|FG000|Overall Study|Lost to Follow-up|0|||
25333655|NCT00790023|50649972|FG001|Overall Study|Lost to Follow-up|0|||
25333656|NCT00790023|50649973|FG002|Overall Study|Lost to Follow-up|1|||
25333657|NCT00790023|50649971|FG000|Overall Study|Other|5|||
25333658|NCT00790023|50649972|FG001|Overall Study|Other|5|||
25333659|NCT00790023|50649973|FG002|Overall Study|Other|8|||
25333660|NCT00588822|50649982|FG000|Overall Study|progression of disease|8|||
25333661|NCT00589914|50649988|FG000|Overall Study|Adverse Event|19|||
25333662|NCT00589914|50649989|FG001|Overall Study|Adverse Event|10|||
25333663|NCT00589914|50649988|FG000|Overall Study|Death|2|||
25333664|NCT00589914|50649989|FG001|Overall Study|Death|0|||
25333665|NCT00589914|50649988|FG000|Overall Study|Lack of Efficacy|40|||
25333666|NCT00589914|50649989|FG001|Overall Study|Lack of Efficacy|43|||
25333667|NCT00589914|50649988|FG000|Overall Study|Lost to Follow-up|11|||
25333668|NCT00589914|50649989|FG001|Overall Study|Lost to Follow-up|18|||
25333669|NCT00589914|50649988|FG000|Overall Study|Pregnancy|1|||
25333670|NCT00589914|50649989|FG001|Overall Study|Pregnancy|0|||
25333671|NCT00589914|50649988|FG000|Overall Study|Withdrawal by Subject|55|||
25333672|NCT00589914|50649989|FG001|Overall Study|Withdrawal by Subject|49|||
25333673|NCT00589914|50649988|FG000|Overall Study|Other|22|||
25333674|NCT00589914|50649989|FG001|Overall Study|Other|17|||
25333675|NCT00789555|50649998|FG000|Overall Study|Protocol Amendment|78|||
25333676|NCT00789555|50649999|FG001|Overall Study|Protocol Amendment|76|||
25333677|NCT00789555|50650000|FG002|Overall Study|Protocol Amendment|80|||
25333678|NCT00789555|50649998|FG000|Overall Study|Adverse Event|17|||
25333679|NCT00789555|50649999|FG001|Overall Study|Adverse Event|7|||
25333680|NCT00789555|50650000|FG002|Overall Study|Adverse Event|10|||
25333681|NCT00789555|50649998|FG000|Overall Study|Lost to Follow-up|9|||
24901524|NCT00776009|49995600|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
25251745|NCT00476996|50567315|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
25251746|NCT00476996|50567312|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
25251747|NCT00476996|50567313|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
25251748|NCT00476996|50567314|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
25251749|NCT00476996|50567315|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
25251750|NCT00476996|50567312|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
25251751|NCT00476996|50567313|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
25251752|NCT00476996|50567314|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
25251753|NCT00476996|50567315|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
25333682|NCT00789555|50649999|FG001|Overall Study|Lost to Follow-up|10|||
25333683|NCT00789555|50650000|FG002|Overall Study|Lost to Follow-up|18|||
25333684|NCT00789555|50649998|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
25333685|NCT00789555|50649999|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
25333686|NCT00789555|50650000|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
25333687|NCT00789555|50649998|FG000|Overall Study|Treatment failure|11|||
25333688|NCT00789555|50649999|FG001|Overall Study|Treatment failure|8|||
25333689|NCT00789555|50650000|FG002|Overall Study|Treatment failure|12|||
25333690|NCT00789555|50649998|FG000|Overall Study|Protocol Violation|6|||
25333691|NCT00789555|50649999|FG001|Overall Study|Protocol Violation|9|||
25333692|NCT00789555|50650000|FG002|Overall Study|Protocol Violation|13|||
25333693|NCT00451321|50650016|FG000|Overall Study|Lost to Follow-up|3|||
25333694|NCT00451321|50650017|FG001|Overall Study|Lost to Follow-up|3|||
25333695|NCT00451321|50650018|FG002|Overall Study|Lost to Follow-up|1|||
25333696|NCT00451321|50650019|FG003|Overall Study|Lost to Follow-up|3|||
25333697|NCT00451321|50650020|FG004|Overall Study|Lost to Follow-up|0|||
25333698|NCT00451321|50650021|FG005|Overall Study|Lost to Follow-up|1|||
25171834|NCT02985957|50309408|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
25171835|NCT02985957|50309409|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
25171836|NCT02985957|50309410|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
25171837|NCT02985957|50309411|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
25171838|NCT02985957|50309412|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
25171839|NCT02985957|50309413|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
25171840|NCT02985957|50309414|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
25171841|NCT02985957|50309408|FG000|Treatment Period|Poor/Non-Compliance|0|||
25171842|NCT02985957|50309409|FG001|Treatment Period|Poor/Non-Compliance|0|||
25171843|NCT02985957|50309410|FG002|Treatment Period|Poor/Non-Compliance|0|||
25171844|NCT02985957|50309411|FG003|Treatment Period|Poor/Non-Compliance|0|||
25171845|NCT02985957|50309412|FG004|Treatment Period|Poor/Non-Compliance|1|||
25171846|NCT02985957|50309413|FG005|Treatment Period|Poor/Non-Compliance|1|||
25171847|NCT02985957|50309414|FG006|Treatment Period|Poor/Non-Compliance|0|||
25171848|NCT02985957|50309408|FG000|Treatment Period|Continuing in Treatment Period|0|||
25171849|NCT02985957|50309409|FG001|Treatment Period|Continuing in Treatment Period|1|||
25171850|NCT02985957|50309410|FG002|Treatment Period|Continuing in Treatment Period|0|||
25171851|NCT02985957|50309411|FG003|Treatment Period|Continuing in Treatment Period|4|||
25171852|NCT02985957|50309412|FG004|Treatment Period|Continuing in Treatment Period|4|||
25171853|NCT02985957|50309413|FG005|Treatment Period|Continuing in Treatment Period|0|||
25171854|NCT02985957|50309414|FG006|Treatment Period|Continuing in Treatment Period|0|||
25171855|NCT02818920|50309436|FG000|Overall Study|Unresectable|4|||
25171856|NCT02818920|50309436|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
25171857|NCT02818920|50309436|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
25171858|NCT02818920|50309436|FG000|Overall Study|Adverse Event|3|||
25171859|NCT02818920|50309436|FG000|Overall Study|Developed Other Disease|1|||
24901525|NCT00776009|49995601|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
24901526|NCT00776009|49995602|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
25171860|NCT02818920|50309436|FG000|Overall Study|Refused Further Treatment|1|||
25171861|NCT01454401|50309462|FG000|Overall Study|Death|1|||
25171862|NCT01454401|50309462|FG000|Overall Study|hospitalised|1|||
25171863|NCT01454401|50309462|FG000|Overall Study|osteomyelitis|2|||
25171864|NCT01454401|50309462|FG000|Overall Study|non-adherence|1|||
25171865|NCT01344018|50309468|FG000|Overall Study|Death|22|||
25171866|NCT01344018|50309469|FG001|Overall Study|Death|25|||
25171867|NCT01344018|50309468|FG000|Overall Study|Lost to Follow-up|4|||
25171868|NCT01344018|50309469|FG001|Overall Study|Lost to Follow-up|7|||
25171869|NCT01320085|50309478|FG000|Overall Study|Treatment Ongoing|0|||
25171870|NCT01320085|50309479|FG001|Overall Study|Treatment Ongoing|13|||
25171871|NCT01320085|50309480|FG002|Overall Study|Treatment Ongoing|2|||
25171872|NCT01320085|50309478|FG000|Overall Study|Disease Progression|26|||
25333699|NCT00451321|50650022|FG006|Overall Study|Lost to Follow-up|0|||
25333700|NCT00451321|50650023|FG007|Overall Study|Lost to Follow-up|0|||
25333701|NCT00451321|50650016|FG000|Overall Study|Withdrawal by Subject|3|||
25333702|NCT00451321|50650017|FG001|Overall Study|Withdrawal by Subject|1|||
25333703|NCT00451321|50650018|FG002|Overall Study|Withdrawal by Subject|0|||
25333704|NCT00451321|50650019|FG003|Overall Study|Withdrawal by Subject|4|||
25333705|NCT00451321|50650020|FG004|Overall Study|Withdrawal by Subject|0|||
25333706|NCT00451321|50650021|FG005|Overall Study|Withdrawal by Subject|0|||
25333707|NCT00451321|50650022|FG006|Overall Study|Withdrawal by Subject|0|||
25333708|NCT00451321|50650023|FG007|Overall Study|Withdrawal by Subject|0|||
25333709|NCT00451321|50650016|FG000|Overall Study|Study closed/terminated|1|||
25333710|NCT00451321|50650017|FG001|Overall Study|Study closed/terminated|1|||
25333711|NCT00451321|50650018|FG002|Overall Study|Study closed/terminated|17|||
25333712|NCT00451321|50650019|FG003|Overall Study|Study closed/terminated|5|||
25333713|NCT00451321|50650020|FG004|Overall Study|Study closed/terminated|7|||
25333714|NCT00451321|50650021|FG005|Overall Study|Study closed/terminated|7|||
25333715|NCT00451321|50650022|FG006|Overall Study|Study closed/terminated|5|||
25333716|NCT00451321|50650023|FG007|Overall Study|Study closed/terminated|3|||
25333717|NCT00451321|50650016|FG000|Overall Study|Sponsor decision to amend protocol|0|||
25333718|NCT00451321|50650017|FG001|Overall Study|Sponsor decision to amend protocol|0|||
25333719|NCT00451321|50650018|FG002|Overall Study|Sponsor decision to amend protocol|0|||
25333720|NCT00451321|50650019|FG003|Overall Study|Sponsor decision to amend protocol|0|||
25333721|NCT00451321|50650020|FG004|Overall Study|Sponsor decision to amend protocol|0|||
25333722|NCT00451321|50650021|FG005|Overall Study|Sponsor decision to amend protocol|1|||
24901527|NCT00776009|49995603|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
25171873|NCT01320085|50309479|FG001|Overall Study|Disease Progression|86|||
25171874|NCT01320085|50309480|FG002|Overall Study|Disease Progression|16|||
25333723|NCT00451321|50650022|FG006|Overall Study|Sponsor decision to amend protocol|1|||
25333724|NCT00451321|50650023|FG007|Overall Study|Sponsor decision to amend protocol|3|||
25333725|NCT00802464|50650049|FG000|Month 0 - Month 8|Adverse Event|0|||
25333726|NCT00802464|50650050|FG001|Month 0 - Month 8|Adverse Event|1|||
25333727|NCT00802464|50650051|FG002|Month 0 - Month 8|Adverse Event|1|||
25333728|NCT00802464|50650052|FG003|Month 0 - Month 8|Adverse Event|2|||
25333729|NCT00802464|50650049|FG000|Month 0 - Month 8|Protocol Violation|0|||
25333730|NCT00802464|50650050|FG001|Month 0 - Month 8|Protocol Violation|0|||
25333731|NCT00802464|50650051|FG002|Month 0 - Month 8|Protocol Violation|1|||
25333732|NCT00802464|50650052|FG003|Month 0 - Month 8|Protocol Violation|0|||
25333733|NCT00802464|50650049|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
25333734|NCT00802464|50650050|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
25333735|NCT00802464|50650051|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
25333736|NCT00802464|50650052|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
25333737|NCT00802464|50650049|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
25333738|NCT00802464|50650050|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
25333739|NCT00802464|50650051|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
25333740|NCT00802464|50650052|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
25333741|NCT00802464|50650049|FG000|Month 0 - Month 8|Other|0|||
25333742|NCT00802464|50650050|FG001|Month 0 - Month 8|Other|0|||
25333743|NCT00802464|50650051|FG002|Month 0 - Month 8|Other|1|||
25333744|NCT00802464|50650052|FG003|Month 0 - Month 8|Other|0|||
25333745|NCT00802464|50650049|FG000|Month 8 - Month 14|Adverse Event|0|||
25333746|NCT00802464|50650050|FG001|Month 8 - Month 14|Adverse Event|1|||
25333747|NCT00802464|50650051|FG002|Month 8 - Month 14|Adverse Event|0|||
25333748|NCT00802464|50650052|FG003|Month 8 - Month 14|Adverse Event|0|||
25333749|NCT00802464|50650049|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
25333750|NCT00802464|50650050|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
25333751|NCT00802464|50650051|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
25333752|NCT00802464|50650052|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
25333753|NCT00802464|50650049|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
25333754|NCT00802464|50650050|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
25333755|NCT00802464|50650051|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
25333756|NCT00802464|50650052|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
25333757|NCT00450619|50650066|FG000|Overall Study|refused treatment after randomization|2|||
25333758|NCT00450619|50650067|FG001|Overall Study|refused treatment after randomization|0|||
25333759|NCT00450619|50650066|FG000|Overall Study|did not progress; refused further trmt|1|||
25333760|NCT00450619|50650067|FG001|Overall Study|did not progress; refused further trmt|1|||
25333761|NCT00450619|50650066|FG000|Overall Study|Adverse Event|1|||
25333762|NCT00450619|50650067|FG001|Overall Study|Adverse Event|0|||
25333763|NCT00802074|50650080|FG000|Overall Study|Adverse Event|1|||
25333764|NCT00802074|50650081|FG001|Overall Study|Adverse Event|1|||
25333765|NCT00802074|50650082|FG002|Overall Study|Adverse Event|1|||
25333766|NCT00802074|50650083|FG003|Overall Study|Adverse Event|0|||
25333767|NCT00802074|50650084|FG004|Overall Study|Adverse Event|0|||
25333768|NCT00802074|50650085|FG005|Overall Study|Adverse Event|0|||
25333769|NCT00802074|50650080|FG000|Overall Study|Withdrawal by Subject|1|||
25251754|NCT00476996|50567312|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
25251755|NCT00476996|50567313|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
25251756|NCT00476996|50567314|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
25251757|NCT00476996|50567315|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
25251758|NCT00476957|50567326|FG000|Overall Study|Lost to Follow-up|176|||
25251759|NCT00476957|50567327|FG001|Overall Study|Lost to Follow-up|193|||
25251760|NCT00475865|50567336|FG000|Overall Study|Adverse Event|0|||
25251761|NCT00475865|50567337|FG001|Overall Study|Adverse Event|3|||
25251762|NCT00475865|50567338|FG002|Overall Study|Adverse Event|4|||
25251763|NCT00475865|50567336|FG000|Overall Study|Lack of Efficacy|1|||
25251764|NCT00475865|50567337|FG001|Overall Study|Lack of Efficacy|0|||
25251765|NCT00475865|50567338|FG002|Overall Study|Lack of Efficacy|0|||
25251766|NCT00475865|50567336|FG000|Overall Study|Progressive disease|0|||
25251767|NCT00475865|50567337|FG001|Overall Study|Progressive disease|1|||
25251768|NCT00475865|50567338|FG002|Overall Study|Progressive disease|2|||
25251769|NCT00475865|50567336|FG000|Overall Study|Participant did not wish to continue|1|||
25251770|NCT00475865|50567337|FG001|Overall Study|Participant did not wish to continue|0|||
25251771|NCT00475865|50567338|FG002|Overall Study|Participant did not wish to continue|0|||
25251772|NCT00475865|50567336|FG000|Overall Study|Other than above|0|||
25251773|NCT00475865|50567337|FG001|Overall Study|Other than above|1|||
25251774|NCT00475865|50567338|FG002|Overall Study|Other than above|0|||
25333770|NCT00802074|50650081|FG001|Overall Study|Withdrawal by Subject|0|||
25333771|NCT00802074|50650082|FG002|Overall Study|Withdrawal by Subject|0|||
25333772|NCT00802074|50650083|FG003|Overall Study|Withdrawal by Subject|0|||
25333773|NCT00802074|50650084|FG004|Overall Study|Withdrawal by Subject|0|||
25333774|NCT00802074|50650085|FG005|Overall Study|Withdrawal by Subject|0|||
25333775|NCT00450385|50650102|FG000|Overall Study|Death|3|||
25333776|NCT00450385|50650102|FG000|Overall Study|Protocol Violation|1|||
25333777|NCT00450385|50650102|FG000|Overall Study|Withdrawal by Subject|2|||
25251775|NCT00475709|50567348|FG000|Overall Study|Did not meet eligibility criteria|8|||
25251776|NCT00475709|50567348|FG000|Overall Study|Death|41|||
25251777|NCT00475709|50567348|FG000|Overall Study|Device Explant|6|||
25251778|NCT00475709|50567348|FG000|Overall Study|Lost to Follow-up|21|||
25251779|NCT00475670|50567354|FG000|Overall Study|Death|0|||
25251780|NCT00475670|50567355|FG001|Overall Study|Death|1|||
25251781|NCT00475670|50567354|FG000|Overall Study|Lack of Efficacy|3|||
25251782|NCT00475670|50567355|FG001|Overall Study|Lack of Efficacy|34|||
25251783|NCT00475670|50567354|FG000|Overall Study|Refused treatment|0|||
25251784|NCT00475670|50567355|FG001|Overall Study|Refused treatment|2|||
25251785|NCT00475670|50567354|FG000|Overall Study|Failure to Return|0|||
25251786|NCT00475670|50567355|FG001|Overall Study|Failure to Return|1|||
25251787|NCT00475670|50567354|FG000|Overall Study|Other|0|||
25251788|NCT00475670|50567355|FG001|Overall Study|Other|3|||
25251789|NCT00474968|50567363|FG000|Overall Study|Withdrawal by Subject|8|||
25251790|NCT00474968|50567364|FG001|Overall Study|Withdrawal by Subject|7|||
25251791|NCT00474968|50567363|FG000|Overall Study|Protocol Violation|9|||
25251792|NCT00474968|50567364|FG001|Overall Study|Protocol Violation|8|||
25251793|NCT00474968|50567363|FG000|Overall Study|Sample not collected|1|||
25251794|NCT00474968|50567364|FG001|Overall Study|Sample not collected|1|||
25333778|NCT00450385|50650102|FG000|Overall Study|Lack of Efficacy|2|||
25333779|NCT00450385|50650102|FG000|Overall Study|Adverse Event|1|||
25333780|NCT00450385|50650102|FG000|Overall Study|Physician Decision|1|||
25333781|NCT00450385|50650102|FG000|Overall Study|Other|3|||
25333782|NCT00588354|50650109|FG000|Baseline to 2 Weeks|Adverse Event|1|||
25333783|NCT00588354|50650110|FG001|Baseline to 2 Weeks|Adverse Event|0|||
25333784|NCT00588354|50650109|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
25333785|NCT00588354|50650110|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
25333786|NCT00588354|50650109|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
25333787|NCT00588354|50650110|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
25333788|NCT00449761|50650117|FG000|Overall Study|Disease progression|12|||
25333789|NCT00449761|50650117|FG000|Overall Study|Death|5|||
25333790|NCT00449761|50650117|FG000|Overall Study|New cancer therapy|1|||
25333791|NCT00800982|50650124|FG000|Overall Study|Lost to Follow-up|1|||
25333792|NCT00800982|50650125|FG001|Overall Study|Lost to Follow-up|2|||
25333793|NCT00800982|50650124|FG000|Overall Study|Withdrawal by Subject|0|||
25333794|NCT00800982|50650125|FG001|Overall Study|Withdrawal by Subject|1|||
25333795|NCT00800982|50650124|FG000|Overall Study|Patient moved out of state|1|||
25333796|NCT00800982|50650125|FG001|Overall Study|Patient moved out of state|0|||
25333797|NCT00830960|50650137|FG000|Overall Study|Death|5|||
25333798|NCT00830960|50650138|FG001|Overall Study|Death|4|||
25333799|NCT00830960|50650139|FG002|Overall Study|Death|3|||
25333800|NCT00830960|50650140|FG003|Overall Study|Death|2|||
25333801|NCT00830960|50650141|FG004|Overall Study|Death|6|||
25333802|NCT00830960|50650142|FG005|Overall Study|Death|1|||
25333803|NCT00830960|50650137|FG000|Overall Study|Lost to Follow-up|1|||
25333804|NCT00830960|50650138|FG001|Overall Study|Lost to Follow-up|1|||
25251795|NCT00474929|50567375|FG000|Overall Study|Withdrawal by Subject|0|||
25251796|NCT00474929|50567376|FG001|Overall Study|Withdrawal by Subject|1|||
25251797|NCT00474929|50567377|FG002|Overall Study|Withdrawal by Subject|0|||
25251798|NCT00474929|50567378|FG003|Overall Study|Withdrawal by Subject|0|||
25333805|NCT00830960|50650139|FG002|Overall Study|Lost to Follow-up|1|||
25333806|NCT00830960|50650140|FG003|Overall Study|Lost to Follow-up|0|||
25333807|NCT00830960|50650141|FG004|Overall Study|Lost to Follow-up|0|||
25333808|NCT00830960|50650142|FG005|Overall Study|Lost to Follow-up|1|||
25333809|NCT00830960|50650137|FG000|Overall Study|Withdrawal by Subject|19|||
25333810|NCT00830960|50650138|FG001|Overall Study|Withdrawal by Subject|19|||
25333811|NCT00830960|50650139|FG002|Overall Study|Withdrawal by Subject|18|||
25251799|NCT00474929|50567379|FG004|Overall Study|Withdrawal by Subject|0|||
25251800|NCT00474929|50567375|FG000|Overall Study|Unrelated medical condition|0|||
25251801|NCT00474929|50567376|FG001|Overall Study|Unrelated medical condition|0|||
25251802|NCT00474929|50567377|FG002|Overall Study|Unrelated medical condition|1|||
25251803|NCT00474929|50567378|FG003|Overall Study|Unrelated medical condition|0|||
25333812|NCT00830960|50650140|FG003|Overall Study|Withdrawal by Subject|23|||
25333813|NCT00830960|50650141|FG004|Overall Study|Withdrawal by Subject|16|||
25333814|NCT00830960|50650142|FG005|Overall Study|Withdrawal by Subject|21|||
25333815|NCT00830960|50650137|FG000|Overall Study|Sponsor Decision|1|||
25333816|NCT00830960|50650138|FG001|Overall Study|Sponsor Decision|2|||
25333817|NCT00830960|50650139|FG002|Overall Study|Sponsor Decision|3|||
25333818|NCT00830960|50650140|FG003|Overall Study|Sponsor Decision|4|||
25333819|NCT00830960|50650141|FG004|Overall Study|Sponsor Decision|5|||
25333820|NCT00830960|50650142|FG005|Overall Study|Sponsor Decision|7|||
25333821|NCT00830960|50650137|FG000|Overall Study|No study drug received|7|||
25333822|NCT00830960|50650138|FG001|Overall Study|No study drug received|2|||
25251804|NCT00474929|50567379|FG004|Overall Study|Unrelated medical condition|0|||
25251805|NCT00474929|50567375|FG000|Overall Study|Physician Decision|0|||
25251806|NCT00474929|50567376|FG001|Overall Study|Physician Decision|0|||
25333823|NCT00830960|50650139|FG002|Overall Study|No study drug received|4|||
25333824|NCT00830960|50650140|FG003|Overall Study|No study drug received|3|||
25333825|NCT00830960|50650141|FG004|Overall Study|No study drug received|5|||
25333826|NCT00830960|50650142|FG005|Overall Study|No study drug received|7|||
25333827|NCT00830804|50650179|FG000|Overall Study|Lost to Follow-up|4|||
25333828|NCT00830804|50650179|FG000|Overall Study|Death|1|||
25333829|NCT00830804|50650179|FG000|Overall Study|Unable to get to clinic|7|||
25251807|NCT00474929|50567377|FG002|Overall Study|Physician Decision|1|||
25251808|NCT00474929|50567378|FG003|Overall Study|Physician Decision|2|||
25251809|NCT00474929|50567379|FG004|Overall Study|Physician Decision|0|||
25251810|NCT00474812|50567392|FG000|Overall Study|Withdrawal by Subject|5|||
25251811|NCT00474812|50567392|FG000|Overall Study|No Initiation of treatment|2|||
25333830|NCT00830804|50650179|FG000|Overall Study|Consent withdrawn|2|||
25333831|NCT00830804|50650179|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
25333832|NCT00789477|50650189|FG000|Overall Study|Withdrawal by Subject|2|||
25333833|NCT00789477|50650190|FG001|Overall Study|Withdrawal by Subject|1|||
25333834|NCT00789477|50650191|FG002|Overall Study|Withdrawal by Subject|3|||
25333835|NCT00789477|50650192|FG003|Overall Study|Withdrawal by Subject|2|||
25333836|NCT00789477|50650193|FG004|Overall Study|Withdrawal by Subject|3|||
25333837|NCT00789477|50650189|FG000|Overall Study|Protocol Violation|1|||
25333838|NCT00789477|50650190|FG001|Overall Study|Protocol Violation|0|||
25333839|NCT00789477|50650191|FG002|Overall Study|Protocol Violation|0|||
25333840|NCT00789477|50650192|FG003|Overall Study|Protocol Violation|1|||
25333841|NCT00789477|50650193|FG004|Overall Study|Protocol Violation|0|||
25333842|NCT00789477|50650189|FG000|Overall Study|Adverse Event|3|||
25333843|NCT00789477|50650190|FG001|Overall Study|Adverse Event|3|||
25333844|NCT00789477|50650191|FG002|Overall Study|Adverse Event|1|||
25333845|NCT00789477|50650192|FG003|Overall Study|Adverse Event|0|||
25333846|NCT00789477|50650193|FG004|Overall Study|Adverse Event|0|||
25333847|NCT00789477|50650189|FG000|Overall Study|Death|1|||
25333848|NCT00789477|50650190|FG001|Overall Study|Death|1|||
25333849|NCT00789477|50650191|FG002|Overall Study|Death|2|||
25333850|NCT00789477|50650192|FG003|Overall Study|Death|2|||
25333851|NCT00789477|50650193|FG004|Overall Study|Death|0|||
25333852|NCT00789477|50650189|FG000|Overall Study|Lost to Follow-up|0|||
25333853|NCT00789477|50650190|FG001|Overall Study|Lost to Follow-up|1|||
25333854|NCT00789477|50650191|FG002|Overall Study|Lost to Follow-up|4|||
25333855|NCT00789477|50650192|FG003|Overall Study|Lost to Follow-up|2|||
25333856|NCT00789477|50650193|FG004|Overall Study|Lost to Follow-up|4|||
25333857|NCT00789477|50650189|FG000|Overall Study|Lack of Efficacy|2|||
25333858|NCT00789477|50650190|FG001|Overall Study|Lack of Efficacy|0|||
25333859|NCT00789477|50650191|FG002|Overall Study|Lack of Efficacy|0|||
25333860|NCT00789477|50650192|FG003|Overall Study|Lack of Efficacy|0|||
25333861|NCT00789477|50650193|FG004|Overall Study|Lack of Efficacy|0|||
25333862|NCT00789477|50650189|FG000|Overall Study|Other|2|||
25333863|NCT00789477|50650190|FG001|Overall Study|Other|0|||
25333864|NCT00789477|50650191|FG002|Overall Study|Other|1|||
25333865|NCT00789477|50650192|FG003|Overall Study|Other|3|||
25333866|NCT00789477|50650193|FG004|Overall Study|Other|0|||
25333867|NCT00796614|50650211|FG000|Overall Study|Adverse Event|1|||
25333868|NCT00796614|50650212|FG001|Overall Study|Adverse Event|2|||
25333869|NCT00796614|50650213|FG002|Overall Study|Adverse Event|0|||
25333870|NCT00796614|50650214|FG003|Overall Study|Adverse Event|0|||
25251812|NCT00474383|50567396|FG000|Main Study|Adverse Event|11|||
25251813|NCT00474383|50567397|FG001|Main Study|Adverse Event|0|||
25251814|NCT00474383|50567396|FG000|Main Study|Symptomatic Deterioration|1|||
25251815|NCT00474383|50567397|FG001|Main Study|Symptomatic Deterioration|0|||
25251816|NCT00474383|50567396|FG000|Main Study|Progressive Disease|23|||
25333871|NCT00796614|50650211|FG000|Overall Study|Protocol Violation|0|||
25333872|NCT00796614|50650212|FG001|Overall Study|Protocol Violation|0|||
25333873|NCT00796614|50650213|FG002|Overall Study|Protocol Violation|2|||
25333874|NCT00796614|50650214|FG003|Overall Study|Protocol Violation|0|||
25333875|NCT00796614|50650211|FG000|Overall Study|Lost to Follow-up|2|||
25333876|NCT00796614|50650212|FG001|Overall Study|Lost to Follow-up|2|||
25333877|NCT00796614|50650213|FG002|Overall Study|Lost to Follow-up|1|||
25333878|NCT00796614|50650214|FG003|Overall Study|Lost to Follow-up|0|||
25333879|NCT00796614|50650211|FG000|Overall Study|Withdrawal by Subject|1|||
25333880|NCT00796614|50650212|FG001|Overall Study|Withdrawal by Subject|0|||
25333881|NCT00796614|50650213|FG002|Overall Study|Withdrawal by Subject|0|||
25333882|NCT00796614|50650214|FG003|Overall Study|Withdrawal by Subject|1|||
25333883|NCT00796614|50650211|FG000|Overall Study|Other than stated|1|||
25333884|NCT00796614|50650212|FG001|Overall Study|Other than stated|0|||
25333885|NCT00796614|50650213|FG002|Overall Study|Other than stated|0|||
25333886|NCT00796614|50650214|FG003|Overall Study|Other than stated|0|||
25333887|NCT00448747|50650226|FG000|Overall Study|collapsed veins|1|||
25333888|NCT00448747|50650227|FG001|Overall Study|collapsed veins|0|||
25333889|NCT00830180|50650243|FG000|Overall Study|Adverse Event|6|||
25333890|NCT00830180|50650243|FG000|Overall Study|Death|11|||
25333891|NCT00830180|50650243|FG000|Overall Study|Insufficient clinical response|1|||
25333892|NCT00830180|50650243|FG000|Overall Study|Withdrawal by Subject|5|||
25251817|NCT00474383|50567397|FG001|Main Study|Progressive Disease|0|||
25333893|NCT00830180|50650243|FG000|Overall Study|Progressive disease|2|||
25333894|NCT00830180|50650243|FG000|Overall Study|Other - Unspecified|1|||
25333895|NCT00863681|50650252|FG000|Overall Study|Other|2|||
25333896|NCT00863681|50650253|FG001|Overall Study|Other|0|||
25333897|NCT00863681|50650254|FG002|Overall Study|Other|0|||
25333898|NCT00863681|50650252|FG000|Overall Study|Missing|1|||
25333899|NCT00863681|50650253|FG001|Overall Study|Missing|0|||
25333900|NCT00863681|50650254|FG002|Overall Study|Missing|0|||
25333901|NCT00863681|50650252|FG000|Overall Study|Death|40|||
25333902|NCT00863681|50650253|FG001|Overall Study|Death|23|||
25333903|NCT00863681|50650254|FG002|Overall Study|Death|6|||
25333904|NCT00863681|50650252|FG000|Overall Study|Withdrawal by Subject|12|||
25251818|NCT00474383|50567396|FG000|Main Study|Other|1|||
25251819|NCT00474383|50567397|FG001|Main Study|Other|0|||
25251820|NCT00474383|50567396|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
25251821|NCT00474383|50567397|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
25251822|NCT00474383|50567396|FG000|Extension|Progressive Disease|0|||
25251823|NCT00474383|50567397|FG001|Extension|Progressive Disease|5|||
25251824|NCT00474266|50567405|FG000|Overall Study|Withdrawal by Subject|7|||
25333905|NCT00863681|50650253|FG001|Overall Study|Withdrawal by Subject|5|||
25333906|NCT00863681|50650254|FG002|Overall Study|Withdrawal by Subject|2|||
25333907|NCT00863681|50650252|FG000|Overall Study|Protocol Violation|2|||
25333908|NCT00863681|50650253|FG001|Overall Study|Protocol Violation|0|||
25333909|NCT00863681|50650254|FG002|Overall Study|Protocol Violation|0|||
25333910|NCT00863681|50650252|FG000|Overall Study|Lost to Follow-up|3|||
25333911|NCT00863681|50650253|FG001|Overall Study|Lost to Follow-up|0|||
25333912|NCT00863681|50650254|FG002|Overall Study|Lost to Follow-up|3|||
25333913|NCT00863681|50650252|FG000|Overall Study|Adverse Event|28|||
25333914|NCT00863681|50650253|FG001|Overall Study|Adverse Event|10|||
25333915|NCT00863681|50650254|FG002|Overall Study|Adverse Event|6|||
24901528|NCT00776009|49995604|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
24901529|NCT00776009|49995605|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
24901530|NCT00776009|49995600|FG000|Period 2: Second Intervention|Protocol Violation|1|||
24901531|NCT00776009|49995601|FG001|Period 2: Second Intervention|Protocol Violation|0|||
24901532|NCT00776009|49995602|FG002|Period 2: Second Intervention|Protocol Violation|1|||
24901533|NCT00776009|49995603|FG003|Period 2: Second Intervention|Protocol Violation|0|||
24901534|NCT00776009|49995604|FG004|Period 2: Second Intervention|Protocol Violation|0|||
24901535|NCT00776009|49995605|FG005|Period 2: Second Intervention|Protocol Violation|0|||
24901536|NCT00776009|49995600|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
24901537|NCT00776009|49995601|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
24901538|NCT00776009|49995602|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
24901539|NCT00776009|49995603|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
24901540|NCT00776009|49995604|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
24901541|NCT00776009|49995605|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
24901542|NCT00694161|49995613|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
24901543|NCT00694161|49995613|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
24901544|NCT00694161|49995613|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
24901545|NCT00720356|49995617|FG000|Registration to Study|Determined to have methylated MGMT|67|||
24901546|NCT00720356|49995617|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
24901547|NCT00720356|49995617|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
24901548|NCT00720356|49995617|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
24901549|NCT00720356|49995617|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
24901550|NCT00720356|49995617|FG000|Follow up Until Death|Withdrawal by Subject|1|||
24901551|NCT00720356|49995617|FG000|Follow up Until Death|Alive at last data collection|4|||
24901552|NCT00720278|49995624|FG000|Overall Study|Adverse Event|5|||
24901553|NCT00720278|49995625|FG001|Overall Study|Adverse Event|3|||
24901554|NCT00720278|49995626|FG002|Overall Study|Adverse Event|4|||
24901555|NCT00720278|49995624|FG000|Overall Study|Withdrawal by Subject|0|||
24901556|NCT00720278|49995625|FG001|Overall Study|Withdrawal by Subject|1|||
24901557|NCT00720278|49995626|FG002|Overall Study|Withdrawal by Subject|0|||
24901558|NCT00720278|49995624|FG000|Overall Study|Lost to Follow-up|0|||
24901559|NCT00720278|49995625|FG001|Overall Study|Lost to Follow-up|0|||
24901560|NCT00720278|49995626|FG002|Overall Study|Lost to Follow-up|1|||
24901561|NCT00720278|49995624|FG000|Overall Study|Non-compliance|1|||
24901562|NCT00720278|49995625|FG001|Overall Study|Non-compliance|0|||
24901563|NCT00720278|49995626|FG002|Overall Study|Non-compliance|0|||
24977373|NCT00048542|50065996|FG000|Double-Blind Phase|Randomized in error|1|||
25333916|NCT00863681|50650252|FG000|Overall Study|Lack of Efficacy|2|||
25333917|NCT00863681|50650253|FG001|Overall Study|Lack of Efficacy|2|||
24901564|NCT00720278|49995624|FG000|Overall Study|eligibility criteria violation|1|||
25251825|NCT00474266|50567406|FG001|Overall Study|Withdrawal by Subject|20|||
25251826|NCT00474266|50567407|FG002|Overall Study|Withdrawal by Subject|4|||
24901565|NCT00720278|49995625|FG001|Overall Study|eligibility criteria violation|0|||
24901566|NCT00720278|49995626|FG002|Overall Study|eligibility criteria violation|1|||
25251827|NCT00474266|50567408|FG003|Overall Study|Withdrawal by Subject|7|||
25251828|NCT00473564|50567421|FG000|Overall Study|robot surgery aborted in OR|23|||
25333918|NCT00863681|50650254|FG002|Overall Study|Lack of Efficacy|1|||
25251829|NCT00472199|50567427|FG000|Overall Study|Adverse Event|19|||
25251830|NCT00472199|50567428|FG001|Overall Study|Adverse Event|23|||
25333919|NCT00863681|50650252|FG000|Overall Study|Non-compliance with study drug|1|||
25333920|NCT00863681|50650253|FG001|Overall Study|Non-compliance with study drug|3|||
25333921|NCT00863681|50650254|FG002|Overall Study|Non-compliance with study drug|0|||
25333922|NCT00789321|50650264|FG000|Overall Study|Adverse Event|0|||
25333923|NCT00789321|50650265|FG001|Overall Study|Adverse Event|1|||
25333924|NCT00811928|50650273|FG000|Overall Study|AEs and SAEs Including Death|7|||
25333925|NCT00811928|50650274|FG001|Overall Study|AEs and SAEs Including Death|11|||
25333926|NCT00811928|50650273|FG000|Overall Study|Withdrawal by Subject|18|||
24901567|NCT00720122|49995634|FG000|Overall Study|Lost to Follow-up|1|||
24901568|NCT00720122|49995634|FG000|Overall Study|Physician Decision|1|||
24901569|NCT00720122|49995634|FG000|Overall Study|Withdrawal by Subject|7|||
24901570|NCT00717860|49995640|FG000|Overall Study|Clinical adverse experience|5|||
24901571|NCT00717860|49995641|FG001|Overall Study|Clinical adverse experience|9|||
24901572|NCT00717860|49995640|FG000|Overall Study|Laboratory adverse experience|2|||
24901573|NCT00717860|49995641|FG001|Overall Study|Laboratory adverse experience|2|||
24901574|NCT00717860|49995640|FG000|Overall Study|Lack of Efficacy|7|||
24901575|NCT00717860|49995641|FG001|Overall Study|Lack of Efficacy|13|||
24901576|NCT00717860|49995640|FG000|Overall Study|Discontinued for other reason|6|||
24901577|NCT00717860|49995641|FG001|Overall Study|Discontinued for other reason|1|||
24901578|NCT00717860|49995640|FG000|Overall Study|Withdrew consent|7|||
24901579|NCT00717860|49995641|FG001|Overall Study|Withdrew consent|3|||
24901580|NCT00717314|49995649|FG000|Overall Study|Adverse Event|3|||
24901581|NCT00717314|49995650|FG001|Overall Study|Adverse Event|2|||
24901582|NCT00717314|49995649|FG000|Overall Study|Protocol Violation|1|||
24901583|NCT00717314|49995650|FG001|Overall Study|Protocol Violation|0|||
24901584|NCT00717314|49995649|FG000|Overall Study|Lost to Follow-up|1|||
24901585|NCT00717314|49995650|FG001|Overall Study|Lost to Follow-up|5|||
24901586|NCT00717314|49995649|FG000|Overall Study|Withdrawal by Subject|1|||
24901587|NCT00717314|49995650|FG001|Overall Study|Withdrawal by Subject|3|||
24901588|NCT00689793|49995658|FG000|Overall Study|Lost to Follow-up|4|||
24901589|NCT00689793|49995659|FG001|Overall Study|Lost to Follow-up|5|||
24901590|NCT00723944|49995669|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
24901591|NCT00723944|49995670|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
24901592|NCT00723944|49995669|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
24901593|NCT00723944|49995670|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
24901594|NCT00723944|49995669|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
24901595|NCT00723944|49995670|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
24901596|NCT00689481|49995678|FG000|Overall Study|Adverse Event|7|||
24901597|NCT00689481|49995679|FG001|Overall Study|Adverse Event|1|||
24901598|NCT00689481|49995678|FG000|Overall Study|Lost to Follow-up|4|||
24901599|NCT00689481|49995679|FG001|Overall Study|Lost to Follow-up|3|||
24901600|NCT00689481|49995678|FG000|Overall Study|Lack of Efficacy|4|||
24901601|NCT00689481|49995679|FG001|Overall Study|Lack of Efficacy|3|||
24901602|NCT00689481|49995678|FG000|Overall Study|Non-compliance with study treatment|1|||
24901603|NCT00689481|49995679|FG001|Overall Study|Non-compliance with study treatment|1|||
25333927|NCT00811928|50650274|FG001|Overall Study|Withdrawal by Subject|12|||
25333928|NCT00811928|50650273|FG000|Overall Study|Did Not Take Study Drug|3|||
24901604|NCT00689481|49995678|FG000|Overall Study|Withdrawal by Subject|8|||
24901605|NCT00689481|49995679|FG001|Overall Study|Withdrawal by Subject|4|||
24901606|NCT00689481|49995678|FG000|Overall Study|Excluded medication started during study|0|||
24901607|NCT00689481|49995679|FG001|Overall Study|Excluded medication started during study|1|||
24901608|NCT00689481|49995678|FG000|Overall Study|Subject early term, left on vacation|0|||
24901609|NCT00689481|49995679|FG001|Overall Study|Subject early term, left on vacation|1|||
24977374|NCT00048542|50065997|FG001|Double-Blind Phase|Randomized in error|0|||
25251831|NCT00472199|50567427|FG000|Overall Study|Lack of Efficacy|4|||
25251832|NCT00472199|50567428|FG001|Overall Study|Lack of Efficacy|25|||
25251833|NCT00472199|50567427|FG000|Overall Study|Lost to Follow-up|2|||
25251834|NCT00472199|50567428|FG001|Overall Study|Lost to Follow-up|4|||
25251835|NCT00472199|50567427|FG000|Overall Study|Protocol Violation|3|||
25251836|NCT00472199|50567428|FG001|Overall Study|Protocol Violation|2|||
25251837|NCT00472199|50567427|FG000|Overall Study|Withdrawal by Subject|6|||
25251838|NCT00472199|50567428|FG001|Overall Study|Withdrawal by Subject|5|||
25333929|NCT00811928|50650274|FG001|Overall Study|Did Not Take Study Drug|0|||
25333930|NCT00811928|50650273|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
25333931|NCT00811928|50650274|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
25251839|NCT00472199|50567427|FG000|Overall Study|personal reason|0|||
24901610|NCT00688701|49995688|FG000|Overall Study|Adverse Event|1|||
24901611|NCT00688701|49995689|FG001|Overall Study|Adverse Event|0|||
24901612|NCT00688701|49995690|FG002|Overall Study|Adverse Event|5|||
24901613|NCT00688701|49995691|FG003|Overall Study|Adverse Event|3|||
24901614|NCT00688701|49995688|FG000|Overall Study|Lack of Efficacy|0|||
24901615|NCT00688701|49995689|FG001|Overall Study|Lack of Efficacy|1|||
24901616|NCT00688701|49995690|FG002|Overall Study|Lack of Efficacy|0|||
25251840|NCT00472199|50567428|FG001|Overall Study|personal reason|1|||
25333932|NCT00811928|50650273|FG000|Overall Study|Investigator Decision|2|||
25333933|NCT00811928|50650274|FG001|Overall Study|Investigator Decision|1|||
25333934|NCT00811928|50650273|FG000|Overall Study|Poor Compliance|2|||
25333935|NCT00811928|50650274|FG001|Overall Study|Poor Compliance|5|||
25333936|NCT00788775|50650282|FG000|Overall Study|Progressive Disease|8|||
25333937|NCT00788775|50650283|FG001|Overall Study|Progressive Disease|6|||
25333938|NCT00788775|50650282|FG000|Overall Study|Withdrawal by Subject|0|||
25333939|NCT00788775|50650283|FG001|Overall Study|Withdrawal by Subject|2|||
25333940|NCT00788775|50650282|FG000|Overall Study|Patient Non-Compliance|1|||
25333941|NCT00788775|50650283|FG001|Overall Study|Patient Non-Compliance|0|||
25333942|NCT00788775|50650282|FG000|Overall Study|Patient's measurable disease resected.|1|||
25251841|NCT00472199|50567427|FG000|Overall Study|patient was asymptomatic|1|||
25251842|NCT00472199|50567428|FG001|Overall Study|patient was asymptomatic|0|||
25251843|NCT00472082|50567434|FG000|Overall Study|Study prematurely terminated|5|||
25251844|NCT00471887|50567438|FG000|Overall Study|Adverse Event|9|||
25251845|NCT00471536|50567442|FG000|Overall Study|Withdrawal by Subject|1|||
25251846|NCT00470834|50567448|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
25251847|NCT00470834|50567449|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
25251848|NCT00470834|50567448|FG000|Treatment Period (18 Months)|Adverse Event|7|||
25251849|NCT00470834|50567449|FG001|Treatment Period (18 Months)|Adverse Event|6|||
25251850|NCT00470834|50567448|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
25251851|NCT00470834|50567449|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
25251852|NCT00470834|50567448|FG000|Treatment Period (18 Months)|Physician Decision|4|||
25251853|NCT00470834|50567449|FG001|Treatment Period (18 Months)|Physician Decision|4|||
25251854|NCT00470834|50567448|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
25333943|NCT00788775|50650283|FG001|Overall Study|Patient's measurable disease resected.|0|||
25333944|NCT00448669|50650291|FG000|Overall Study|Lost to Follow-up|52|||
25333945|NCT00448669|50650292|FG001|Overall Study|Lost to Follow-up|63|||
25333946|NCT00448669|50650291|FG000|Overall Study|Withdrawal by Subject|90|||
25333947|NCT00448669|50650292|FG001|Overall Study|Withdrawal by Subject|74|||
25333948|NCT00448669|50650291|FG000|Overall Study|Relocated|49|||
25333949|NCT00448669|50650292|FG001|Overall Study|Relocated|36|||
25333950|NCT00448669|50650291|FG000|Overall Study|Were withdrawn by investigator|10|||
25333951|NCT00448669|50650292|FG001|Overall Study|Were withdrawn by investigator|6|||
25333952|NCT00448669|50650291|FG000|Overall Study|Death|2|||
25333953|NCT00448669|50650292|FG001|Overall Study|Death|4|||
25333954|NCT00448669|50650291|FG000|Overall Study|Had other reasons|5|||
25333955|NCT00448669|50650292|FG001|Overall Study|Had other reasons|6|||
25333956|NCT00448669|50650291|FG000|Overall Study|HIV-infected at enrollment|1|||
25333957|NCT00448669|50650292|FG001|Overall Study|HIV-infected at enrollment|2|||
25333958|NCT00448669|50650291|FG000|Overall Study|Never started drug|9|||
25333959|NCT00448669|50650292|FG001|Overall Study|Never started drug|7|||
25333960|NCT00591734|50650300|FG000|Overall Study|Lack of Efficacy|35|||
25333961|NCT00591734|50650300|FG000|Overall Study|Adverse Event|5|||
25333962|NCT00591734|50650300|FG000|Overall Study|Physician Decision|5|||
25333963|NCT00591734|50650300|FG000|Overall Study|Intercurrent Illness|8|||
25333964|NCT00788697|50650304|FG000|Overall Study|No study drug administered|12|||
25333965|NCT00788697|50650304|FG000|Overall Study|Training Patients|74|||
25333966|NCT00788697|50650304|FG000|Overall Study|no truth standard procedure available|5|||
25333967|NCT00788697|50650304|FG000|Overall Study|Technically inadequate truth standard|1|||
25333968|NCT00788697|50650304|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
25333969|NCT00848549|50650318|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
25333970|NCT00848549|50650319|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
25333971|NCT00848549|50650318|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
25333972|NCT00848549|50650319|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
25333973|NCT00848549|50650318|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
25251855|NCT00470834|50567449|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
25251856|NCT00470834|50567448|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
25251857|NCT00470834|50567449|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
25251858|NCT00470834|50567448|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
25333974|NCT00848549|50650319|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
25333975|NCT00848549|50650318|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
25333976|NCT00848549|50650319|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
25333977|NCT00848549|50650318|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
25251859|NCT00470834|50567449|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
25251860|NCT00470834|50567448|FG000|Treatment Period (18 Months)|Non-compliance|1|||
25333978|NCT00848549|50650319|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
24901617|NCT00688701|49995691|FG003|Overall Study|Lack of Efficacy|0|||
25251861|NCT00470834|50567449|FG001|Treatment Period (18 Months)|Non-compliance|0|||
25251862|NCT00470834|50567448|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
25251863|NCT00470834|50567449|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
25251864|NCT00470834|50567448|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
25251865|NCT00470834|50567449|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
25251866|NCT00470834|50567448|FG000|Extension Period (24 Months)|Adverse Event|3|||
25251867|NCT00470834|50567449|FG001|Extension Period (24 Months)|Adverse Event|4|||
25333979|NCT00848549|50650318|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
25333980|NCT00848549|50650319|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
25333981|NCT00848549|50650318|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
25333982|NCT00848549|50650319|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
25333983|NCT00848549|50650318|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
25333984|NCT00848549|50650319|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
25333985|NCT00848549|50650318|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
25333986|NCT00848549|50650319|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
25333987|NCT00848549|50650318|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
25333988|NCT00848549|50650319|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
25333989|NCT00848549|50650318|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
25333990|NCT00848549|50650319|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
25333991|NCT00848549|50650318|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
25333992|NCT00848549|50650319|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
25333993|NCT00848549|50650318|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
25333994|NCT00848549|50650319|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
25333995|NCT00848549|50650318|FG000|E2090-E044-314 (Extension Study)|Other|5|||
25333996|NCT00848549|50650319|FG001|E2090-E044-314 (Extension Study)|Other|6|||
25333997|NCT00788151|50650329|FG000|Overall Study|Other adverse event|0|||
25333998|NCT00788151|50650330|FG001|Overall Study|Other adverse event|2|||
25333999|NCT00788151|50650329|FG000|Overall Study|Protocol Violation|0|||
25334000|NCT00788151|50650330|FG001|Overall Study|Protocol Violation|1|||
25334001|NCT00788151|50650329|FG000|Overall Study|Withdrawal by Subject|13|||
25334002|NCT00788151|50650330|FG001|Overall Study|Withdrawal by Subject|6|||
25334003|NCT00788151|50650329|FG000|Overall Study|Enrolled but not treated|1|||
25334004|NCT00788151|50650330|FG001|Overall Study|Enrolled but not treated|1|||
25251868|NCT00470834|50567448|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
25251869|NCT00470834|50567449|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
25251870|NCT00470834|50567448|FG000|Extension Period (24 Months)|Physician Decision|4|||
25251871|NCT00470834|50567449|FG001|Extension Period (24 Months)|Physician Decision|3|||
25251872|NCT00470834|50567448|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
25251873|NCT00470834|50567449|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
25251874|NCT00470834|50567448|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
25251875|NCT00470834|50567449|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
25251876|NCT00470834|50567448|FG000|Extension Period (24 Months)|Non-compliance|0|||
25251877|NCT00470834|50567449|FG001|Extension Period (24 Months)|Non-compliance|1|||
25251878|NCT00470834|50567448|FG000|Extension Period (24 Months)|Disease Progression|0|||
25251879|NCT00470834|50567449|FG001|Extension Period (24 Months)|Disease Progression|1|||
25251880|NCT00470366|50567455|FG000|Overall Study|Adverse Event|3|||
25251881|NCT00470366|50567455|FG000|Overall Study|Poor compliance|1|||
25251882|NCT00470093|50567459|FG000|Overall Study|Adverse Event|2|||
25251883|NCT00470054|50567463|FG000|Overall Study|Ineligible|1|||
25334005|NCT00788073|50650338|FG000|STX209 Then Placebo|Adverse Event|1|||
25334006|NCT00788073|50650339|FG001|STX209 Then Placebo|Adverse Event|0|||
25334007|NCT00788073|50650338|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
25334008|NCT00788073|50650339|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
25334009|NCT00788073|50650338|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
25334010|NCT00788073|50650339|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
25334011|NCT00788073|50650338|FG000|STX209 Then Placebo|unable to return due to travel|0|||
25334012|NCT00788073|50650339|FG001|STX209 Then Placebo|unable to return due to travel|1|||
25334013|NCT00788073|50650338|FG000|Placebo Then STX209|Adverse Event|2|||
25334014|NCT00788073|50650339|FG001|Placebo Then STX209|Adverse Event|0|||
25334015|NCT00788073|50650338|FG000|Placebo Then STX209|Protocol Violation|0|||
25334016|NCT00788073|50650339|FG001|Placebo Then STX209|Protocol Violation|1|||
25334017|NCT00848393|50650348|FG000|Overall Study|Protocol Violation|0|||
25334018|NCT00848393|50650349|FG001|Overall Study|Protocol Violation|0|||
25171875|NCT01320085|50309478|FG000|Overall Study|Adverse Event|12|||
25171876|NCT01320085|50309479|FG001|Overall Study|Adverse Event|14|||
25171877|NCT01320085|50309480|FG002|Overall Study|Adverse Event|5|||
25171878|NCT01320085|50309478|FG000|Overall Study|Withdrawal by Subject|2|||
25171879|NCT01320085|50309479|FG001|Overall Study|Withdrawal by Subject|4|||
25171880|NCT01320085|50309480|FG002|Overall Study|Withdrawal by Subject|1|||
25171881|NCT01320085|50309478|FG000|Overall Study|Protocol Deviation|1|||
25171882|NCT01320085|50309479|FG001|Overall Study|Protocol Deviation|0|||
25171883|NCT01320085|50309480|FG002|Overall Study|Protocol Deviation|1|||
25171884|NCT01755767|50309515|FG000|Overall Study|Progressive Disease|8|||
25171885|NCT01755767|50309516|FG001|Overall Study|Progressive Disease|7|||
25171886|NCT01755767|50309517|FG002|Overall Study|Progressive Disease|91|||
25171887|NCT01755767|50309518|FG003|Overall Study|Progressive Disease|43|||
25334019|NCT00848393|50650350|FG002|Overall Study|Protocol Violation|1|||
25334020|NCT00848393|50650348|FG000|Overall Study|surgical complications unrelated to stud|0|||
25334021|NCT00848393|50650349|FG001|Overall Study|surgical complications unrelated to stud|0|||
25334022|NCT00848393|50650350|FG002|Overall Study|surgical complications unrelated to stud|2|||
25334023|NCT00815516|50650364|FG000|Overall Study|Death|3|||
25334024|NCT00815516|50650365|FG001|Overall Study|Death|1|||
25334025|NCT00815516|50650364|FG000|Overall Study|Physician Decision|1|||
25334026|NCT00815516|50650365|FG001|Overall Study|Physician Decision|0|||
25334027|NCT00787917|50650373|FG000|Blinded Treatment|Adverse Event|1|||
25334028|NCT00787917|50650374|FG001|Blinded Treatment|Adverse Event|0|||
25334029|NCT00787917|50650373|FG000|Blinded Treatment|Lack of Efficacy|1|||
25334030|NCT00787917|50650374|FG001|Blinded Treatment|Lack of Efficacy|0|||
25334031|NCT00787917|50650373|FG000|Blinded Treatment|Administrative problems|3|||
25334032|NCT00787917|50650374|FG001|Blinded Treatment|Administrative problems|2|||
25334033|NCT00787917|50650373|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
25334034|NCT00787917|50650374|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
25334035|NCT00787917|50650373|FG000|Open Label|Administrative problems|3|||
25334036|NCT00787917|50650374|FG001|Open Label|Administrative problems|0|||
25334037|NCT00814892|50650382|FG000|Overall Study|Disease Progression|1|||
25334038|NCT00814892|50650382|FG000|Overall Study|Study Termination|1|||
25334039|NCT00787839|50650386|FG000|Overall Study|Failure to have the OGTT was most common|404|||
25334040|NCT00829244|50650409|FG000|Overall Study|Adverse Event|1|||
25334041|NCT00829244|50650410|FG001|Overall Study|Adverse Event|3|||
25334042|NCT00829244|50650409|FG000|Overall Study|Protocol Violation|1|||
25334043|NCT00829244|50650410|FG001|Overall Study|Protocol Violation|0|||
25334044|NCT00829244|50650409|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
25334045|NCT00829244|50650410|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
25334046|NCT00829244|50650409|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
25334047|NCT00829244|50650410|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
25334048|NCT00829244|50650409|FG000|Overall Study|No fertilization|2|||
25334049|NCT00829244|50650410|FG001|Overall Study|No fertilization|2|||
25334050|NCT00829244|50650409|FG000|Overall Study|All embryos discarded|0|||
25334051|NCT00829244|50650410|FG001|Overall Study|All embryos discarded|3|||
25334052|NCT00829244|50650409|FG000|Overall Study|No embryo cleavage|0|||
25334053|NCT00829244|50650410|FG001|Overall Study|No embryo cleavage|2|||
25334054|NCT00787605|50650418|FG000|Overall Study|Administrative Problems|3|||
25334055|NCT00787605|50650419|FG001|Overall Study|Administrative Problems|0|||
25334056|NCT00787605|50650418|FG000|Overall Study|Adverse Event|14|||
25334057|NCT00787605|50650419|FG001|Overall Study|Adverse Event|25|||
25334058|NCT00787605|50650418|FG000|Overall Study|Lost to Follow-up|3|||
25334059|NCT00787605|50650419|FG001|Overall Study|Lost to Follow-up|6|||
25334060|NCT00787605|50650418|FG000|Overall Study|Protocol Violation|7|||
25334061|NCT00787605|50650419|FG001|Overall Study|Protocol Violation|3|||
25334062|NCT00787605|50650418|FG000|Overall Study|Withdrawal by Subject|6|||
25334063|NCT00787605|50650419|FG001|Overall Study|Withdrawal by Subject|13|||
25334064|NCT00787605|50650418|FG000|Overall Study|Lack of Efficacy|13|||
25334065|NCT00787605|50650419|FG001|Overall Study|Lack of Efficacy|9|||
25334066|NCT00448591|50650425|FG000|Overall Study|Withdrawal by Subject|178|||
25334067|NCT00448591|50650425|FG000|Overall Study|Progressive Disease|1382|||
25334068|NCT00448591|50650425|FG000|Overall Study|Adverse Event|382|||
25334069|NCT00448591|50650425|FG000|Overall Study|Protocol Violation|41|||
25334070|NCT00448591|50650425|FG000|Overall Study|Lost to Follow-up|19|||
25334071|NCT00448591|50650425|FG000|Overall Study|Treatment Regimen Completed|70|||
25334072|NCT00448591|50650425|FG000|Overall Study|Other|154|||
25334073|NCT00448591|50650425|FG000|Overall Study|Termination of Study|70|||
25334074|NCT00651664|50650441|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
25334075|NCT00651664|50650442|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
25334076|NCT00651664|50650443|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
25334077|NCT00651664|50650444|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
25334078|NCT00651664|50650445|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
25334079|NCT00651664|50650446|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
25334080|NCT00651664|50650447|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
25334081|NCT00651664|50650448|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
25334082|NCT00651664|50650449|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
25334083|NCT00651664|50650450|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
25334084|NCT00651664|50650441|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
25334085|NCT00651664|50650442|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
25334086|NCT00651664|50650443|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
25334087|NCT00651664|50650444|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
25334088|NCT00651664|50650445|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
25334089|NCT00651664|50650446|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
25334090|NCT00651664|50650447|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
25334091|NCT00651664|50650448|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
25334092|NCT00651664|50650449|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
25334093|NCT00651664|50650450|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
25334094|NCT00651664|50650441|FG000|Overall Study|Progressive Disease|3|||
25334095|NCT00651664|50650442|FG001|Overall Study|Progressive Disease|3|||
25334096|NCT00651664|50650443|FG002|Overall Study|Progressive Disease|3|||
25334097|NCT00651664|50650444|FG003|Overall Study|Progressive Disease|12|||
25334098|NCT00651664|50650445|FG004|Overall Study|Progressive Disease|4|||
25334099|NCT00651664|50650446|FG005|Overall Study|Progressive Disease|1|||
25334100|NCT00651664|50650447|FG006|Overall Study|Progressive Disease|3|||
25334101|NCT00651664|50650448|FG007|Overall Study|Progressive Disease|6|||
25334102|NCT00651664|50650449|FG008|Overall Study|Progressive Disease|5|||
25334103|NCT00651664|50650450|FG009|Overall Study|Progressive Disease|5|||
25334104|NCT00651664|50650441|FG000|Overall Study|Patient Declined Further Treatment|0|||
25334105|NCT00651664|50650442|FG001|Overall Study|Patient Declined Further Treatment|0|||
25334106|NCT00651664|50650443|FG002|Overall Study|Patient Declined Further Treatment|0|||
25334107|NCT00651664|50650444|FG003|Overall Study|Patient Declined Further Treatment|1|||
25334108|NCT00651664|50650445|FG004|Overall Study|Patient Declined Further Treatment|1|||
25334109|NCT00651664|50650446|FG005|Overall Study|Patient Declined Further Treatment|1|||
25334110|NCT00651664|50650447|FG006|Overall Study|Patient Declined Further Treatment|0|||
25334111|NCT00651664|50650448|FG007|Overall Study|Patient Declined Further Treatment|0|||
25334112|NCT00651664|50650449|FG008|Overall Study|Patient Declined Further Treatment|0|||
25334113|NCT00651664|50650450|FG009|Overall Study|Patient Declined Further Treatment|1|||
25334114|NCT00651664|50650441|FG000|Overall Study|Symptomatic Deterioration|0|||
25334115|NCT00651664|50650442|FG001|Overall Study|Symptomatic Deterioration|0|||
25334116|NCT00651664|50650443|FG002|Overall Study|Symptomatic Deterioration|0|||
25334117|NCT00651664|50650444|FG003|Overall Study|Symptomatic Deterioration|1|||
25334118|NCT00651664|50650445|FG004|Overall Study|Symptomatic Deterioration|0|||
25334119|NCT00651664|50650446|FG005|Overall Study|Symptomatic Deterioration|0|||
25334120|NCT00651664|50650447|FG006|Overall Study|Symptomatic Deterioration|1|||
25334121|NCT00651664|50650448|FG007|Overall Study|Symptomatic Deterioration|0|||
25334122|NCT00651664|50650449|FG008|Overall Study|Symptomatic Deterioration|1|||
25334123|NCT00651664|50650450|FG009|Overall Study|Symptomatic Deterioration|0|||
25334124|NCT00651664|50650441|FG000|Overall Study|Reason not Specified|0|||
25334125|NCT00651664|50650442|FG001|Overall Study|Reason not Specified|0|||
25334126|NCT00651664|50650443|FG002|Overall Study|Reason not Specified|0|||
25334127|NCT00651664|50650444|FG003|Overall Study|Reason not Specified|0|||
25334128|NCT00651664|50650445|FG004|Overall Study|Reason not Specified|0|||
25334129|NCT00651664|50650446|FG005|Overall Study|Reason not Specified|0|||
25334130|NCT00651664|50650447|FG006|Overall Study|Reason not Specified|1|||
25334131|NCT00651664|50650448|FG007|Overall Study|Reason not Specified|0|||
25334132|NCT00651664|50650449|FG008|Overall Study|Reason not Specified|0|||
25334133|NCT00651664|50650450|FG009|Overall Study|Reason not Specified|0|||
25334134|NCT00787527|50650476|FG000|Overall Study|Toxicity|3|||
25334135|NCT00787137|50650487|FG000|Overall Study|Study Termination|0|||
25334136|NCT00787137|50650488|FG001|Overall Study|Study Termination|0|||
25334137|NCT00787137|50650489|FG002|Overall Study|Study Termination|1|||
25334138|NCT00448435|50650497|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
25334139|NCT00448435|50650498|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
25334140|NCT00448279|50650509|FG000|Overall Study|Lost to Follow-up|2|||
25334141|NCT00448279|50650510|FG001|Overall Study|Lost to Follow-up|2|||
25334142|NCT00448279|50650509|FG000|Overall Study|Adverse Event|1|||
25334143|NCT00448279|50650510|FG001|Overall Study|Adverse Event|1|||
25334144|NCT00448279|50650509|FG000|Overall Study|Disease progression|16|||
25334145|NCT00448279|50650510|FG001|Overall Study|Disease progression|18|||
25334146|NCT00448279|50650509|FG000|Overall Study|Withdrawal by Subject|4|||
25334147|NCT00448279|50650510|FG001|Overall Study|Withdrawal by Subject|3|||
25334148|NCT00448279|50650509|FG000|Overall Study|Other|6|||
25334149|NCT00448279|50650510|FG001|Overall Study|Other|4|||
25334150|NCT00448279|50650509|FG000|Overall Study|Protocol Violation|0|||
25334151|NCT00448279|50650510|FG001|Overall Study|Protocol Violation|1|||
25334152|NCT00448123|50650518|FG000|Overall Study|Lost to Follow-up|9|||
25334153|NCT00448123|50650519|FG001|Overall Study|Lost to Follow-up|6|||
25251884|NCT00474188|50567467|FG000|Overall Study|Withdrawal by Subject|1|||
25251885|NCT00474188|50567467|FG000|Overall Study|Study discontinued by sponsor|5|||
25251886|NCT00475982|50567472|FG000|Overall Study|surgery rescheduled|7|||
25251887|NCT00475982|50567473|FG001|Overall Study|surgery rescheduled|3|||
25251888|NCT01089647|50567481|FG000|Overall Study|Lost to Follow-up|2|||
25251889|NCT01089647|50567482|FG001|Overall Study|Lost to Follow-up|2|||
25251890|NCT01089647|50567481|FG000|Overall Study|Withdrawal by Subject|2|||
25334154|NCT00448123|50650518|FG000|Overall Study|Physician Decision|6|||
25334155|NCT00448123|50650519|FG001|Overall Study|Physician Decision|6|||
25334156|NCT00447499|50650528|FG000|Overall Study|Adverse Event|1|||
25334157|NCT00447499|50650528|FG000|Overall Study|Patient Decision|4|||
25334158|NCT00447499|50650528|FG000|Overall Study|Sponsor Decision|1|||
25334159|NCT00447499|50650528|FG000|Overall Study|Physician Decision|1|||
25251891|NCT01089647|50567482|FG001|Overall Study|Withdrawal by Subject|1|||
25251892|NCT01089647|50567481|FG000|Overall Study|Adverse Event|0|||
25334160|NCT00800436|50650541|FG000|Overall Study|Withdrawal by Subject|0|||
25334161|NCT00800436|50650542|FG001|Overall Study|Withdrawal by Subject|0|||
25334162|NCT00800436|50650543|FG002|Overall Study|Withdrawal by Subject|1|||
25334163|NCT00800436|50650544|FG003|Overall Study|Withdrawal by Subject|1|||
24977375|NCT00048542|50065998|FG002|Double-Blind Phase|Randomized in error|0|||
25334164|NCT00800436|50650545|FG004|Overall Study|Withdrawal by Subject|0|||
25334165|NCT00800436|50650546|FG005|Overall Study|Withdrawal by Subject|0|||
25334166|NCT00800436|50650547|FG006|Overall Study|Withdrawal by Subject|0|||
25334167|NCT00655564|50650563|FG000|Overall Study|Adverse Event|1|||
25334168|NCT00655564|50650563|FG000|Overall Study|Lost to Follow-up|1|||
25334169|NCT00655564|50650563|FG000|Overall Study|Desired Alternate Therapy|1|||
25334170|NCT00447421|50650568|FG000|Overall Study|Lack of Efficacy|1|||
25334171|NCT00447421|50650568|FG000|Overall Study|Adverse Event|3|||
25334172|NCT00447421|50650568|FG000|Overall Study|Sponsor Decision|2|||
25334173|NCT00651118|50650576|FG000|Overall Study|Adverse Event|4|||
25334174|NCT00651118|50650577|FG001|Overall Study|Adverse Event|0|||
25334175|NCT00651118|50650578|FG002|Overall Study|Adverse Event|1|||
25334176|NCT00651118|50650579|FG003|Overall Study|Adverse Event|1|||
25334177|NCT00651118|50650576|FG000|Overall Study|Protocol Violation|2|||
25334178|NCT00651118|50650577|FG001|Overall Study|Protocol Violation|2|||
25334179|NCT00651118|50650578|FG002|Overall Study|Protocol Violation|6|||
25334180|NCT00651118|50650579|FG003|Overall Study|Protocol Violation|2|||
25334181|NCT00651118|50650576|FG000|Overall Study|Lost to Follow-up|2|||
25334182|NCT00651118|50650577|FG001|Overall Study|Lost to Follow-up|0|||
25334183|NCT00651118|50650578|FG002|Overall Study|Lost to Follow-up|1|||
25334184|NCT00651118|50650579|FG003|Overall Study|Lost to Follow-up|2|||
25334185|NCT00651118|50650576|FG000|Overall Study|administrative|1|||
25334186|NCT00651118|50650577|FG001|Overall Study|administrative|4|||
25334187|NCT00651118|50650578|FG002|Overall Study|administrative|2|||
25334188|NCT00651118|50650579|FG003|Overall Study|administrative|1|||
25334189|NCT00651118|50650576|FG000|Overall Study|Withdrawal by Subject|0|||
25334190|NCT00651118|50650577|FG001|Overall Study|Withdrawal by Subject|1|||
25334191|NCT00651118|50650578|FG002|Overall Study|Withdrawal by Subject|1|||
25334192|NCT00651118|50650579|FG003|Overall Study|Withdrawal by Subject|1|||
25334193|NCT00447265|50650592|FG000|Overall Study|Physician Decision|1|||
25334194|NCT00447265|50650593|FG001|Overall Study|Physician Decision|0|||
25334195|NCT00657358|50650597|FG000|Overall Study|Lack of Efficacy|6|||
25334196|NCT00457639|50650602|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
25334197|NCT00457639|50650603|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
25334198|NCT00457639|50650602|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
25334199|NCT00457639|50650603|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
25334200|NCT00457639|50650602|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
25334201|NCT00457639|50650603|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
25334202|NCT00800202|50650611|FG000|Overall Study|Adverse Event|7|||
25334203|NCT00800202|50650612|FG001|Overall Study|Adverse Event|6|||
25334204|NCT00800202|50650611|FG000|Overall Study|Death|1|||
25334205|NCT00800202|50650612|FG001|Overall Study|Death|0|||
25334206|NCT00800202|50650611|FG000|Overall Study|Other|5|||
25334207|NCT00800202|50650612|FG001|Overall Study|Other|0|||
25334208|NCT00800202|50650611|FG000|Overall Study|Disease Progression|54|||
25334209|NCT00800202|50650612|FG001|Overall Study|Disease Progression|18|||
25334210|NCT00655486|50650618|FG000|Overall Study|Adverse Event|10|||
25334211|NCT00655486|50650618|FG000|Overall Study|Lack of Efficacy|8|||
25334212|NCT00655486|50650618|FG000|Overall Study|Withdrawal by Subject|4|||
25334213|NCT00655486|50650618|FG000|Overall Study|Protocol Violation|1|||
25334214|NCT00655486|50650618|FG000|Overall Study|Unsatisfactory compliance|2|||
25334215|NCT00655486|50650618|FG000|Overall Study|Other: Pregnancy|1|||
25334216|NCT00655486|50650618|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
25334217|NCT00655486|50650618|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
25334218|NCT00457249|50650624|FG000|Overall Study|Lost to Follow-up|3|||
25334219|NCT00457249|50650625|FG001|Overall Study|Lost to Follow-up|0|||
25334220|NCT00457249|50650624|FG000|Overall Study|Protocol Violation|4|||
25334221|NCT00457249|50650625|FG001|Overall Study|Protocol Violation|1|||
25334222|NCT00457249|50650624|FG000|Overall Study|Withdrawal by Subject|3|||
25334223|NCT00457249|50650625|FG001|Overall Study|Withdrawal by Subject|1|||
25334224|NCT00457249|50650624|FG000|Overall Study|Serious Adverse Events|2|||
25334225|NCT00457249|50650625|FG001|Overall Study|Serious Adverse Events|0|||
25334226|NCT00457015|50650635|FG000|Overall Study|Left study site against medical advice|0|||
25077893|NCT02232880|50185958|FG000|Overall Study|study stopped prior to randomization|1|||
25334227|NCT00457015|50650636|FG001|Overall Study|Left study site against medical advice|1|||
25334228|NCT00654940|50650644|FG000|Period 1|Adverse Event|0|||
25334229|NCT00654940|50650645|FG001|Period 1|Adverse Event|1|||
25334230|NCT00654940|50650644|FG000|Period 1|Intolerable Pain Level|1|||
25334231|NCT00654940|50650645|FG001|Period 1|Intolerable Pain Level|0|||
25334232|NCT00588666|50650657|FG000|Overall Study|Adverse Event|4|||
25334233|NCT00793182|50650672|FG000|Overall Study|Adverse Event|0|||
24977376|NCT00048542|50065999|FG003|Double-Blind Phase|Randomized in error|0|||
25334234|NCT00793182|50650673|FG001|Overall Study|Adverse Event|1|||
25334235|NCT00793104|50650679|FG000|Overall Study|Lost to Follow-up|1|||
25334236|NCT00446797|50650685|FG000|Overall Study|Lack of Efficacy|0|||
25334237|NCT00446797|50650686|FG001|Overall Study|Lack of Efficacy|2|||
25334238|NCT00446797|50650685|FG000|Overall Study|Lost to Follow-up|5|||
25334239|NCT00446797|50650686|FG001|Overall Study|Lost to Follow-up|3|||
25334240|NCT00446797|50650685|FG000|Overall Study|Withdrawal by Subject|2|||
25334241|NCT00446797|50650686|FG001|Overall Study|Withdrawal by Subject|2|||
25334242|NCT00446797|50650685|FG000|Overall Study|Protocol Violation|1|||
25334243|NCT00446797|50650686|FG001|Overall Study|Protocol Violation|3|||
25334244|NCT00446797|50650685|FG000|Overall Study|subject entered at another site|0|||
25334245|NCT00446797|50650686|FG001|Overall Study|subject entered at another site|1|||
25334246|NCT00446797|50650685|FG000|Overall Study|did not meet entrance criteria|0|||
25334247|NCT00446797|50650686|FG001|Overall Study|did not meet entrance criteria|1|||
25334248|NCT00855335|50650697|FG000|Overall Study|Lost to Follow-up|0|||
25334249|NCT00855335|50650698|FG001|Overall Study|Lost to Follow-up|0|||
25334250|NCT00855335|50650699|FG002|Overall Study|Lost to Follow-up|3|||
24901618|NCT00688701|49995688|FG000|Overall Study|Withdrawal by Subject|3|||
24901619|NCT00688701|49995689|FG001|Overall Study|Withdrawal by Subject|3|||
24901620|NCT00688701|49995690|FG002|Overall Study|Withdrawal by Subject|4|||
24901621|NCT00688701|49995691|FG003|Overall Study|Withdrawal by Subject|8|||
24901622|NCT00688701|49995688|FG000|Overall Study|Poor compliance to protocol|0|||
24901623|NCT00688701|49995689|FG001|Overall Study|Poor compliance to protocol|1|||
24901624|NCT00688701|49995690|FG002|Overall Study|Poor compliance to protocol|1|||
24901625|NCT00688701|49995691|FG003|Overall Study|Poor compliance to protocol|0|||
24901626|NCT00688623|49995711|FG000|Overall Study|Adverse Event|22|||
24901627|NCT00688623|49995711|FG000|Overall Study|abnormal lab value|1|||
24901628|NCT00688623|49995711|FG000|Overall Study|Withdrawal by Subject|4|||
24901629|NCT00688623|49995711|FG000|Overall Study|Death|3|||
24901630|NCT00688623|49995711|FG000|Overall Study|disease progression|23|||
24901631|NCT00688623|49995711|FG000|Overall Study|Protocol Violation|2|||
24901632|NCT00717236|49995717|FG000|Double-Blind Period|Adverse Event|33|||
24901633|NCT00717236|49995718|FG001|Double-Blind Period|Adverse Event|6|||
24901634|NCT00717236|49995717|FG000|Double-Blind Period|Lack of Efficacy|6|||
24901635|NCT00717236|49995718|FG001|Double-Blind Period|Lack of Efficacy|6|||
24901636|NCT00717236|49995717|FG000|Double-Blind Period|Lost to Follow-up|3|||
24901637|NCT00717236|49995718|FG001|Double-Blind Period|Lost to Follow-up|5|||
24901638|NCT00717236|49995717|FG000|Double-Blind Period|Withdrawal by Subject|10|||
24901639|NCT00717236|49995718|FG001|Double-Blind Period|Withdrawal by Subject|2|||
24901640|NCT00717236|49995717|FG000|Double-Blind Period|Loss of efficacy|3|||
24901641|NCT00717236|49995718|FG001|Double-Blind Period|Loss of efficacy|0|||
24901642|NCT00717236|49995717|FG000|Double-Blind Period|Other: Death|1|||
24901643|NCT00717236|49995718|FG001|Double-Blind Period|Other: Death|0|||
24901644|NCT00717236|49995717|FG000|Double-Blind Period|Other: Pregnancy|1|||
24901645|NCT00717236|49995718|FG001|Double-Blind Period|Other: Pregnancy|0|||
24901646|NCT00717236|49995717|FG000|Double-Blind Period|Other: Protocol Violation|2|||
24901647|NCT00717236|49995718|FG001|Double-Blind Period|Other: Protocol Violation|0|||
24901648|NCT00717236|49995717|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
24901649|NCT00717236|49995718|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
24977377|NCT00048542|50066000|FG004|Double-Blind Phase|Randomized in error|0|||
25251893|NCT01089647|50567482|FG001|Overall Study|Adverse Event|1|||
25251894|NCT01089608|50567490|FG000|Overall Study|Adverse Event|0|||
25251895|NCT01089608|50567491|FG001|Overall Study|Adverse Event|4|||
25251896|NCT01089608|50567490|FG000|Overall Study|Lost to Follow-up|0|||
25251897|NCT01089608|50567491|FG001|Overall Study|Lost to Follow-up|2|||
25251898|NCT01089413|50567500|FG000|Overall Study|Lost to Follow-up|1|||
25251899|NCT01089413|50567500|FG000|Overall Study|Progressive Disease|93|||
25251900|NCT01089413|50567500|FG000|Overall Study|Participant Withdrew Consent|1|||
25251901|NCT01089413|50567500|FG000|Overall Study|Unacceptable Toxicity|12|||
25251902|NCT01089413|50567500|FG000|Overall Study|Death|10|||
25251903|NCT01089413|50567500|FG000|Overall Study|Metastasectomy|13|||
25251904|NCT01089413|50567500|FG000|Overall Study|Other|71|||
25251905|NCT01089023|50567510|FG000|Overall Study|Lost to Follow-up|3|||
25251906|NCT01089023|50567510|FG000|Overall Study|Adverse Event|1|||
25251907|NCT01089023|50567510|FG000|Overall Study|Withdrawal by Subject|1|||
25251908|NCT01089023|50567510|FG000|Overall Study|Protocol Violation|1|||
25334251|NCT00855335|50650700|FG003|Overall Study|Lost to Follow-up|1|||
25334252|NCT00855335|50650701|FG004|Overall Study|Lost to Follow-up|0|||
25334253|NCT00855335|50650697|FG000|Overall Study|Withdrawal by Subject|0|||
25334254|NCT00855335|50650698|FG001|Overall Study|Withdrawal by Subject|0|||
25251909|NCT01089023|50567510|FG000|Overall Study|Lack of Efficacy|1|||
25334255|NCT00855335|50650699|FG002|Overall Study|Withdrawal by Subject|0|||
25334256|NCT00855335|50650700|FG003|Overall Study|Withdrawal by Subject|1|||
24901650|NCT00717236|49995717|FG000|Double-Blind Period|Other: Site withdrew|2|||
24901651|NCT00717236|49995718|FG001|Double-Blind Period|Other: Site withdrew|0|||
24901652|NCT00717236|49995717|FG000|Double-Blind Period|Other: Screening failure|1|||
24901653|NCT00717236|49995718|FG001|Double-Blind Period|Other: Screening failure|0|||
24901654|NCT00717236|49995717|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
25251910|NCT01088984|50567516|FG000|Phase 1|Death|2|||
25251911|NCT01088984|50567517|FG001|Phase 1|Death|1|||
25334257|NCT00855335|50650701|FG004|Overall Study|Withdrawal by Subject|0|||
25251912|NCT01088984|50567516|FG000|Phase 1|Disease Progression|2|||
25251913|NCT01088984|50567517|FG001|Phase 1|Disease Progression|4|||
25334258|NCT00855335|50650697|FG000|Overall Study|Adverse Event|2|||
25251914|NCT01088984|50567516|FG000|Phase 1|Other|1|||
25251915|NCT01088984|50567517|FG001|Phase 1|Other|1|||
25251916|NCT01088984|50567516|FG000|Phase 2|Death|0|||
25251917|NCT01088984|50567517|FG001|Phase 2|Death|5|||
25251918|NCT01088984|50567516|FG000|Phase 2|Withdrawal by Subject|0|||
25251919|NCT01088984|50567517|FG001|Phase 2|Withdrawal by Subject|1|||
25251920|NCT01088984|50567516|FG000|Phase 2|DIsease Progression|0|||
25334259|NCT00855335|50650698|FG001|Overall Study|Adverse Event|0|||
25334260|NCT00855335|50650699|FG002|Overall Study|Adverse Event|0|||
25334261|NCT00855335|50650700|FG003|Overall Study|Adverse Event|0|||
25334262|NCT00855335|50650701|FG004|Overall Study|Adverse Event|0|||
25334263|NCT00855335|50650697|FG000|Overall Study|Physician Decision|1|||
25334264|NCT00855335|50650698|FG001|Overall Study|Physician Decision|1|||
25334265|NCT00855335|50650699|FG002|Overall Study|Physician Decision|0|||
25334266|NCT00855335|50650700|FG003|Overall Study|Physician Decision|0|||
25334267|NCT00855335|50650701|FG004|Overall Study|Physician Decision|0|||
25334268|NCT00855335|50650697|FG000|Overall Study|Other|2|||
25334269|NCT00855335|50650698|FG001|Overall Study|Other|1|||
25334270|NCT00855335|50650699|FG002|Overall Study|Other|2|||
25334271|NCT00855335|50650700|FG003|Overall Study|Other|5|||
25334272|NCT00855335|50650701|FG004|Overall Study|Other|1|||
25334273|NCT00799422|50650726|FG000|First Week of Wear|Lost to Follow-up|0|||
25334274|NCT00799422|50650727|FG001|First Week of Wear|Lost to Follow-up|0|||
25334275|NCT00799422|50650728|FG002|First Week of Wear|Lost to Follow-up|1|||
25334276|NCT00799422|50650729|FG003|First Week of Wear|Lost to Follow-up|0|||
25334277|NCT00799422|50650730|FG004|First Week of Wear|Lost to Follow-up|0|||
25334278|NCT00799422|50650731|FG005|First Week of Wear|Lost to Follow-up|0|||
25334279|NCT00799422|50650726|FG000|First Week of Wear|Adverse Event|0|||
25334280|NCT00799422|50650727|FG001|First Week of Wear|Adverse Event|0|||
25334281|NCT00799422|50650728|FG002|First Week of Wear|Adverse Event|0|||
25251921|NCT01088984|50567517|FG001|Phase 2|DIsease Progression|25|||
25251922|NCT01088984|50567516|FG000|Phase 2|Other|0|||
25251923|NCT01088984|50567517|FG001|Phase 2|Other|1|||
25251924|NCT01088438|50567528|FG000|Overall Study|Withdrawal by Subject|11|||
25251925|NCT01088438|50567529|FG001|Overall Study|Withdrawal by Subject|6|||
25251926|NCT01088438|50567528|FG000|Overall Study|Lost to Follow-up|18|||
25251927|NCT01088438|50567529|FG001|Overall Study|Lost to Follow-up|30|||
25251928|NCT01088243|50567537|FG000|Overall Study|Adverse Event|1|||
25251929|NCT01088243|50567538|FG001|Overall Study|Adverse Event|0|||
25251930|NCT01088048|50567554|FG000|Overall Study|Adverse Event|7|||
25251931|NCT01088048|50567555|FG001|Overall Study|Adverse Event|9|||
25251932|NCT01088048|50567556|FG002|Overall Study|Adverse Event|7|||
25251933|NCT01088048|50567557|FG003|Overall Study|Adverse Event|5|||
25251934|NCT01088048|50567558|FG004|Overall Study|Adverse Event|6|||
25251935|NCT01088048|50567559|FG005|Overall Study|Adverse Event|3|||
25251936|NCT01088048|50567560|FG006|Overall Study|Adverse Event|3|||
25251937|NCT01088048|50567561|FG007|Overall Study|Adverse Event|0|||
25251938|NCT01088048|50567562|FG008|Overall Study|Adverse Event|2|||
25251939|NCT01088048|50567563|FG009|Overall Study|Adverse Event|2|||
25251940|NCT01088048|50567554|FG000|Overall Study|Withdrew Consent|1|||
25251941|NCT01088048|50567555|FG001|Overall Study|Withdrew Consent|1|||
25251942|NCT01088048|50567556|FG002|Overall Study|Withdrew Consent|1|||
25251943|NCT01088048|50567557|FG003|Overall Study|Withdrew Consent|1|||
25251944|NCT01088048|50567558|FG004|Overall Study|Withdrew Consent|2|||
25251945|NCT01088048|50567559|FG005|Overall Study|Withdrew Consent|1|||
25251946|NCT01088048|50567560|FG006|Overall Study|Withdrew Consent|0|||
25251947|NCT01088048|50567561|FG007|Overall Study|Withdrew Consent|2|||
25251948|NCT01088048|50567562|FG008|Overall Study|Withdrew Consent|2|||
25251949|NCT01088048|50567563|FG009|Overall Study|Withdrew Consent|1|||
25251950|NCT01088048|50567554|FG000|Overall Study|Concomitant Medication Prohibited|1|||
25251951|NCT01088048|50567555|FG001|Overall Study|Concomitant Medication Prohibited|0|||
25251952|NCT01088048|50567556|FG002|Overall Study|Concomitant Medication Prohibited|0|||
25251953|NCT01088048|50567557|FG003|Overall Study|Concomitant Medication Prohibited|0|||
25334282|NCT00799422|50650729|FG003|First Week of Wear|Adverse Event|1|||
25334283|NCT00799422|50650730|FG004|First Week of Wear|Adverse Event|0|||
25334284|NCT00799422|50650731|FG005|First Week of Wear|Adverse Event|0|||
25334285|NCT00593489|50650741|FG000|Allocation|did not attend workshop; allocation not|2|||
25251954|NCT01088048|50567558|FG004|Overall Study|Concomitant Medication Prohibited|0|||
25251955|NCT01088048|50567559|FG005|Overall Study|Concomitant Medication Prohibited|0|||
25251956|NCT01088048|50567560|FG006|Overall Study|Concomitant Medication Prohibited|0|||
25251957|NCT01088048|50567561|FG007|Overall Study|Concomitant Medication Prohibited|0|||
25251958|NCT01088048|50567562|FG008|Overall Study|Concomitant Medication Prohibited|0|||
25251959|NCT01088048|50567563|FG009|Overall Study|Concomitant Medication Prohibited|0|||
25251960|NCT01088048|50567554|FG000|Overall Study|Investigator Request|2|||
25334286|NCT00593489|50650742|FG001|Allocation|did not attend workshop; allocation not|1|||
25334287|NCT00446641|50650752|FG000|Overall Study|Withdrawal by Subject|8|||
25251961|NCT01088048|50567555|FG001|Overall Study|Investigator Request|2|||
25251962|NCT01088048|50567556|FG002|Overall Study|Investigator Request|0|||
25251963|NCT01088048|50567557|FG003|Overall Study|Investigator Request|0|||
25251964|NCT01088048|50567558|FG004|Overall Study|Investigator Request|3|||
25251965|NCT01088048|50567559|FG005|Overall Study|Investigator Request|1|||
25251966|NCT01088048|50567560|FG006|Overall Study|Investigator Request|1|||
25251967|NCT01088048|50567561|FG007|Overall Study|Investigator Request|0|||
25251968|NCT01088048|50567562|FG008|Overall Study|Investigator Request|0|||
25251969|NCT01088048|50567563|FG009|Overall Study|Investigator Request|0|||
25251970|NCT01088048|50567554|FG000|Overall Study|Patient Non-compliance|0|||
25251971|NCT01088048|50567555|FG001|Overall Study|Patient Non-compliance|1|||
25251972|NCT01088048|50567556|FG002|Overall Study|Patient Non-compliance|0|||
25251973|NCT01088048|50567557|FG003|Overall Study|Patient Non-compliance|0|||
25251974|NCT01088048|50567558|FG004|Overall Study|Patient Non-compliance|0|||
25251975|NCT01088048|50567559|FG005|Overall Study|Patient Non-compliance|0|||
25251976|NCT01088048|50567560|FG006|Overall Study|Patient Non-compliance|0|||
25251977|NCT01088048|50567561|FG007|Overall Study|Patient Non-compliance|0|||
25251978|NCT01088048|50567562|FG008|Overall Study|Patient Non-compliance|0|||
25251979|NCT01088048|50567563|FG009|Overall Study|Patient Non-compliance|0|||
25251980|NCT01088048|50567554|FG000|Overall Study|Disease Progression|7|||
25251981|NCT01088048|50567555|FG001|Overall Study|Disease Progression|4|||
25251982|NCT01088048|50567556|FG002|Overall Study|Disease Progression|3|||
25251983|NCT01088048|50567557|FG003|Overall Study|Disease Progression|5|||
25251984|NCT01088048|50567558|FG004|Overall Study|Disease Progression|3|||
25251985|NCT01088048|50567559|FG005|Overall Study|Disease Progression|3|||
25251986|NCT01088048|50567560|FG006|Overall Study|Disease Progression|2|||
25251987|NCT01088048|50567561|FG007|Overall Study|Disease Progression|1|||
25251988|NCT01088048|50567562|FG008|Overall Study|Disease Progression|0|||
25251989|NCT01088048|50567563|FG009|Overall Study|Disease Progression|0|||
25251990|NCT01088048|50567554|FG000|Overall Study|Death|1|||
25251991|NCT01088048|50567555|FG001|Overall Study|Death|5|||
25251992|NCT01088048|50567556|FG002|Overall Study|Death|3|||
25251993|NCT01088048|50567557|FG003|Overall Study|Death|3|||
25251994|NCT01088048|50567558|FG004|Overall Study|Death|1|||
25251995|NCT01088048|50567559|FG005|Overall Study|Death|3|||
25251996|NCT01088048|50567560|FG006|Overall Study|Death|0|||
25251997|NCT01088048|50567561|FG007|Overall Study|Death|0|||
25251998|NCT01088048|50567562|FG008|Overall Study|Death|3|||
25251999|NCT01088048|50567563|FG009|Overall Study|Death|1|||
25252000|NCT01088048|50567554|FG000|Overall Study|Other|3|||
25252001|NCT01088048|50567555|FG001|Overall Study|Other|5|||
25252002|NCT01088048|50567556|FG002|Overall Study|Other|0|||
25252003|NCT01088048|50567557|FG003|Overall Study|Other|0|||
25252004|NCT01088048|50567558|FG004|Overall Study|Other|2|||
25252005|NCT01088048|50567559|FG005|Overall Study|Other|0|||
25252006|NCT01088048|50567560|FG006|Overall Study|Other|0|||
25252007|NCT01088048|50567561|FG007|Overall Study|Other|2|||
25252008|NCT01088048|50567562|FG008|Overall Study|Other|0|||
25252009|NCT01088048|50567563|FG009|Overall Study|Other|0|||
25252010|NCT01087970|50567596|FG000|Overall Study|Protocol Violation|2|||
25334288|NCT00446641|50650753|FG001|Overall Study|Withdrawal by Subject|3|||
25334289|NCT00446641|50650752|FG000|Overall Study|poor compliance|8|||
25334290|NCT00446641|50650753|FG001|Overall Study|poor compliance|6|||
25334291|NCT00446641|50650752|FG000|Overall Study|Lost to Follow-up|1|||
25334292|NCT00446641|50650753|FG001|Overall Study|Lost to Follow-up|1|||
25334293|NCT00646282|50650761|FG000|Overall Study|Protocol terminated|4|||
25334294|NCT00646282|50650762|FG001|Overall Study|Protocol terminated|4|||
25334295|NCT00792636|50650771|FG000|Overall Study|Protocol Violation|17|||
25334296|NCT00792636|50650772|FG001|Overall Study|Protocol Violation|23|||
25334297|NCT00792636|50650773|FG002|Overall Study|Protocol Violation|20|||
25334298|NCT00792636|50650771|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
25334299|NCT00792636|50650772|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
25334300|NCT00792636|50650773|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
25334301|NCT00792636|50650771|FG000|Overall Study|Lost to Follow-up|13|||
24901655|NCT00717236|49995718|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
25252011|NCT01087814|50567603|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
25334302|NCT00792636|50650772|FG001|Overall Study|Lost to Follow-up|19|||
25334303|NCT00792636|50650773|FG002|Overall Study|Lost to Follow-up|14|||
25334304|NCT00792636|50650771|FG000|Overall Study|Withdrew Consent|10|||
25252012|NCT01087814|50567604|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
25252013|NCT01087814|50567603|FG000|Second Intervention (5 Days)|Physician Decision|1|||
25252014|NCT01087814|50567604|FG001|Second Intervention (5 Days)|Physician Decision|0|||
25252015|NCT01087775|50567610|FG000|Overall Study|failed inclusion criteria|2|||
25252016|NCT01087502|50567617|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
25252017|NCT01087502|50567618|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
25252018|NCT01087502|50567617|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
25252019|NCT01087502|50567618|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
25334305|NCT00792636|50650772|FG001|Overall Study|Withdrew Consent|13|||
25334306|NCT00792636|50650773|FG002|Overall Study|Withdrew Consent|9|||
25334307|NCT00792636|50650771|FG000|Overall Study|Lack of Efficacy|3|||
25334308|NCT00792636|50650772|FG001|Overall Study|Lack of Efficacy|4|||
25334309|NCT00792636|50650773|FG002|Overall Study|Lack of Efficacy|13|||
25334310|NCT00792636|50650771|FG000|Overall Study|Adverse Event|4|||
25334311|NCT00792636|50650772|FG001|Overall Study|Adverse Event|2|||
25334312|NCT00792636|50650773|FG002|Overall Study|Adverse Event|3|||
25334313|NCT00792636|50650771|FG000|Overall Study|Investigator Discretion|2|||
25334314|NCT00792636|50650772|FG001|Overall Study|Investigator Discretion|0|||
25334315|NCT00792636|50650773|FG002|Overall Study|Investigator Discretion|2|||
25334316|NCT00446563|50650785|FG000|Overall Study|Adverse Event|4|||
25334317|NCT00446563|50650786|FG001|Overall Study|Adverse Event|3|||
25334318|NCT00446563|50650785|FG000|Overall Study|Abnormal laboratory value(s)|0|||
25252020|NCT01087502|50567617|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
25334319|NCT00446563|50650786|FG001|Overall Study|Abnormal laboratory value(s)|1|||
25334320|NCT00446563|50650785|FG000|Overall Study|Abnormal test procedure result(s)|1|||
25334321|NCT00446563|50650786|FG001|Overall Study|Abnormal test procedure result(s)|0|||
25334322|NCT00446563|50650785|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25334323|NCT00446563|50650786|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
25334324|NCT00446563|50650785|FG000|Overall Study|Withdrawal by Subject|2|||
25334325|NCT00446563|50650786|FG001|Overall Study|Withdrawal by Subject|1|||
25334326|NCT00446563|50650785|FG000|Overall Study|Administrative problems|0|||
25334327|NCT00446563|50650786|FG001|Overall Study|Administrative problems|1|||
25334328|NCT00650806|50650796|FG000|Overall Study|Adverse Event|0|||
24901656|NCT00717236|49995717|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
24901657|NCT00717236|49995718|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
24901658|NCT00717236|49995717|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
24901659|NCT00717236|49995718|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
24901660|NCT00717236|49995717|FG000|Double-Blind Period|Other: History of cancer|1|||
24901661|NCT00717236|49995718|FG001|Double-Blind Period|Other: History of cancer|0|||
24901662|NCT00717236|49995717|FG000|Double-Blind Period|Other: Sponsor request|1|||
24901663|NCT00717236|49995718|FG001|Double-Blind Period|Other: Sponsor request|0|||
24901664|NCT00717236|49995717|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
24901665|NCT00717236|49995718|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
24901666|NCT00717236|49995717|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
24901667|NCT00717236|49995718|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
24901668|NCT00717236|49995717|FG000|Double-Blind Period|Other: Subject moved|1|||
24901669|NCT00717236|49995718|FG001|Double-Blind Period|Other: Subject moved|1|||
24901670|NCT00717236|49995717|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
24901671|NCT00717236|49995718|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
24901672|NCT00717236|49995717|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
24901673|NCT00717236|49995718|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
24901674|NCT00717236|49995717|FG000|Double-Blind Period|Other: Transportation problems|0|||
24901675|NCT00717236|49995718|FG001|Double-Blind Period|Other: Transportation problems|1|||
24901676|NCT00717236|49995717|FG000|Double-Blind Period|Other: Investigator Decision|0|||
24901677|NCT00717236|49995718|FG001|Double-Blind Period|Other: Investigator Decision|1|||
24901678|NCT00717236|49995717|FG000|Open-Label Period|Adverse Event|29|||
24901679|NCT00717236|49995718|FG001|Open-Label Period|Adverse Event|4|||
24901680|NCT00717236|49995717|FG000|Open-Label Period|Lack of Efficacy|30|||
24901681|NCT00717236|49995718|FG001|Open-Label Period|Lack of Efficacy|8|||
24901682|NCT00717236|49995717|FG000|Open-Label Period|Lost to Follow-up|28|||
24901683|NCT00717236|49995718|FG001|Open-Label Period|Lost to Follow-up|4|||
24901684|NCT00717236|49995717|FG000|Open-Label Period|Withdrawal by Subject|20|||
25252021|NCT01087502|50567618|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
25252022|NCT01087502|50567617|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
25252023|NCT01087502|50567618|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
25252024|NCT01087502|50567617|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
25252025|NCT01087502|50567618|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
25252026|NCT01087502|50567617|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
25252027|NCT01087502|50567618|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
25252028|NCT01087502|50567617|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
25252029|NCT01087502|50567618|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
25252030|NCT01087502|50567617|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
25334329|NCT00650806|50650797|FG001|Overall Study|Adverse Event|5|||
25334330|NCT00650806|50650798|FG002|Overall Study|Adverse Event|3|||
25334331|NCT00650806|50650799|FG003|Overall Study|Adverse Event|4|||
25334332|NCT00650806|50650796|FG000|Overall Study|Lost to Follow-up|7|||
25334333|NCT00650806|50650797|FG001|Overall Study|Lost to Follow-up|6|||
25334334|NCT00650806|50650798|FG002|Overall Study|Lost to Follow-up|11|||
24901685|NCT00717236|49995718|FG001|Open-Label Period|Withdrawal by Subject|2|||
24901686|NCT00717236|49995717|FG000|Open-Label Period|Loss of Efficacy|6|||
24901687|NCT00717236|49995718|FG001|Open-Label Period|Loss of Efficacy|1|||
24901688|NCT00717236|49995717|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
25252031|NCT01087502|50567618|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
25252032|NCT01087502|50567617|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
25252033|NCT01087502|50567618|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
25252034|NCT01087502|50567617|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
25252035|NCT01087502|50567618|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
25252036|NCT01087502|50567617|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
25252037|NCT01087502|50567618|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
25252038|NCT01087502|50567617|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
25252039|NCT01087502|50567618|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
25252040|NCT01086410|50567630|FG000|Overall Study|Adverse Event|1|||
25252041|NCT01086410|50567631|FG001|Overall Study|Adverse Event|0|||
25252042|NCT01086410|50567632|FG002|Overall Study|Adverse Event|0|||
25252043|NCT01086410|50567633|FG003|Overall Study|Adverse Event|2|||
25252044|NCT01086410|50567630|FG000|Overall Study|Lack of Efficacy|1|||
25252045|NCT01086410|50567631|FG001|Overall Study|Lack of Efficacy|1|||
25252046|NCT01086410|50567632|FG002|Overall Study|Lack of Efficacy|0|||
25252047|NCT01086410|50567633|FG003|Overall Study|Lack of Efficacy|0|||
25252048|NCT01086410|50567630|FG000|Overall Study|Protocol Violation|1|||
25252049|NCT01086410|50567631|FG001|Overall Study|Protocol Violation|1|||
25252050|NCT01086410|50567632|FG002|Overall Study|Protocol Violation|0|||
25252051|NCT01086410|50567633|FG003|Overall Study|Protocol Violation|0|||
25252052|NCT01086410|50567630|FG000|Overall Study|Lost to Follow-up|0|||
25252053|NCT01086410|50567631|FG001|Overall Study|Lost to Follow-up|0|||
25252054|NCT01086410|50567632|FG002|Overall Study|Lost to Follow-up|1|||
25252055|NCT01086410|50567633|FG003|Overall Study|Lost to Follow-up|0|||
25252056|NCT04553679|50567645|FG000|Overall Study|Withdrawal by Subject|2|||
25252057|NCT04553679|50567646|FG001|Overall Study|Withdrawal by Subject|0|||
25252058|NCT04553679|50567645|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
25252059|NCT04553679|50567646|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
25252060|NCT01086215|50567660|FG000|Overall Study|Death|14|||
25252061|NCT01086215|50567661|FG001|Overall Study|Death|8|||
25334335|NCT00650806|50650799|FG003|Overall Study|Lost to Follow-up|10|||
25334336|NCT00650806|50650796|FG000|Overall Study|Protocol Violation|0|||
25334337|NCT00650806|50650797|FG001|Overall Study|Protocol Violation|0|||
25334338|NCT00650806|50650798|FG002|Overall Study|Protocol Violation|0|||
25334339|NCT00650806|50650799|FG003|Overall Study|Protocol Violation|1|||
25334340|NCT00650806|50650796|FG000|Overall Study|Pregnancy|0|||
25334341|NCT00650806|50650797|FG001|Overall Study|Pregnancy|0|||
25252062|NCT01086215|50567662|FG002|Overall Study|Death|8|||
25252063|NCT01086215|50567663|FG003|Overall Study|Death|1|||
25252064|NCT01086215|50567660|FG000|Overall Study|Lost to Follow-up|22|||
25252065|NCT01086215|50567661|FG001|Overall Study|Lost to Follow-up|39|||
25252066|NCT01086215|50567662|FG002|Overall Study|Lost to Follow-up|18|||
25252067|NCT01086215|50567663|FG003|Overall Study|Lost to Follow-up|2|||
25252068|NCT01085591|50567676|FG000|Overall Study|Adverse Event|0|||
25334342|NCT00650806|50650798|FG002|Overall Study|Pregnancy|0|||
25334343|NCT00650806|50650799|FG003|Overall Study|Pregnancy|1|||
25334344|NCT00650806|50650796|FG000|Overall Study|Withdrawal by Subject|7|||
25334345|NCT00650806|50650797|FG001|Overall Study|Withdrawal by Subject|5|||
25334346|NCT00650806|50650798|FG002|Overall Study|Withdrawal by Subject|8|||
25334347|NCT00650806|50650799|FG003|Overall Study|Withdrawal by Subject|6|||
25334348|NCT00650806|50650796|FG000|Overall Study|Noncompliance with study drug regimen|1|||
25334349|NCT00650806|50650797|FG001|Overall Study|Noncompliance with study drug regimen|1|||
25334350|NCT00650806|50650798|FG002|Overall Study|Noncompliance with study drug regimen|0|||
25334351|NCT00650806|50650799|FG003|Overall Study|Noncompliance with study drug regimen|0|||
25334352|NCT00650806|50650796|FG000|Overall Study|Study terminated by sponsor|2|||
25252069|NCT01085591|50567677|FG001|Overall Study|Adverse Event|1|||
25252070|NCT01085591|50567678|FG002|Overall Study|Adverse Event|3|||
25252071|NCT01085591|50567676|FG000|Overall Study|Physician Decision|1|||
25252072|NCT01085591|50567677|FG001|Overall Study|Physician Decision|0|||
25252073|NCT01085591|50567678|FG002|Overall Study|Physician Decision|1|||
25252074|NCT01085591|50567676|FG000|Overall Study|Withdrawal by Subject|0|||
25252075|NCT01085591|50567677|FG001|Overall Study|Withdrawal by Subject|2|||
25252076|NCT01085591|50567678|FG002|Overall Study|Withdrawal by Subject|1|||
25334353|NCT00650806|50650797|FG001|Overall Study|Study terminated by sponsor|3|||
25334354|NCT00650806|50650798|FG002|Overall Study|Study terminated by sponsor|5|||
25334355|NCT00650806|50650799|FG003|Overall Study|Study terminated by sponsor|4|||
25334356|NCT00650806|50650796|FG000|Overall Study|Other|1|||
25252077|NCT01085591|50567676|FG000|Overall Study|Lost to Follow-up|0|||
25252078|NCT01085591|50567677|FG001|Overall Study|Lost to Follow-up|1|||
25252079|NCT01085591|50567678|FG002|Overall Study|Lost to Follow-up|1|||
25252080|NCT01085591|50567676|FG000|Overall Study|Protocol Violation|1|||
25252081|NCT01085591|50567677|FG001|Overall Study|Protocol Violation|1|||
25334357|NCT00650806|50650797|FG001|Overall Study|Other|1|||
24977378|NCT00048542|50066001|FG005|Double-Blind Phase|Randomized in error|0|||
25334358|NCT00650806|50650798|FG002|Overall Study|Other|2|||
25334359|NCT00650806|50650799|FG003|Overall Study|Other|0|||
25334360|NCT00863057|50650815|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
25334361|NCT00863057|50650816|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
25334362|NCT00863057|50650817|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
25334363|NCT00863057|50650818|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
25334364|NCT00863057|50650815|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
24901689|NCT00717236|49995718|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
24901690|NCT00717236|49995717|FG000|Open-Label Period|Other: Lack of Compliance|1|||
24901691|NCT00717236|49995718|FG001|Open-Label Period|Other: Lack of Compliance|1|||
24901692|NCT00717236|49995717|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
24901693|NCT00717236|49995718|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
24901694|NCT00717236|49995717|FG000|Open-Label Period|Other: Moved|1|||
24901695|NCT00717236|49995718|FG001|Open-Label Period|Other: Moved|0|||
24901696|NCT00717236|49995717|FG000|Open-Label Period|Other: Investigator Decision|1|||
24901697|NCT00717236|49995718|FG001|Open-Label Period|Other: Investigator Decision|0|||
24901698|NCT00717236|49995717|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
24901699|NCT00717236|49995718|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
24901700|NCT00717236|49995717|FG000|Open-Label Period|Other: Sponsor Request|3|||
24901701|NCT00717236|49995718|FG001|Open-Label Period|Other: Sponsor Request|0|||
25252082|NCT01085591|50567678|FG002|Overall Study|Protocol Violation|1|||
25252083|NCT01085591|50567676|FG000|Overall Study|Other|0|||
25252084|NCT01085591|50567677|FG001|Overall Study|Other|1|||
25252085|NCT01085591|50567678|FG002|Overall Study|Other|0|||
25252086|NCT01085591|50567676|FG000|Overall Study|Not Properly Consented|1|||
25252087|NCT01085591|50567677|FG001|Overall Study|Not Properly Consented|0|||
24901702|NCT00717236|49995717|FG000|Open-Label Period|Other: Cataract Surgery|1|||
24901703|NCT00717236|49995718|FG001|Open-Label Period|Other: Cataract Surgery|0|||
24901704|NCT00717236|49995717|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
24901705|NCT00717236|49995718|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
24901706|NCT00717236|49995717|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
24901707|NCT00717236|49995718|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
24901708|NCT00717236|49995717|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
24901709|NCT00717236|49995718|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
24901710|NCT00719810|49995729|FG000|Overall Study|Adverse Event|0|||
24901711|NCT00719810|49995730|FG001|Overall Study|Adverse Event|2|||
24901712|NCT00719810|49995731|FG002|Overall Study|Adverse Event|3|||
24901713|NCT00719810|49995729|FG000|Overall Study|Lost to Follow-up|2|||
24901714|NCT00719810|49995730|FG001|Overall Study|Lost to Follow-up|0|||
24901715|NCT00719810|49995731|FG002|Overall Study|Lost to Follow-up|3|||
24901716|NCT00719810|49995729|FG000|Overall Study|Physician Decision|0|||
24901717|NCT00719810|49995730|FG001|Overall Study|Physician Decision|1|||
24901718|NCT00719810|49995731|FG002|Overall Study|Physician Decision|0|||
24901719|NCT00719810|49995729|FG000|Overall Study|Withdrawal by Subject|1|||
24901720|NCT00719810|49995730|FG001|Overall Study|Withdrawal by Subject|1|||
24901721|NCT00719810|49995731|FG002|Overall Study|Withdrawal by Subject|2|||
25252088|NCT01085591|50567678|FG002|Overall Study|Not Properly Consented|0|||
25252089|NCT01085357|50567689|FG000|Overall Study|Adverse Event|1|||
25252090|NCT01085357|50567690|FG001|Overall Study|Adverse Event|1|||
25252091|NCT01085357|50567689|FG000|Overall Study|Subject Decision|4|||
25252092|NCT01085357|50567690|FG001|Overall Study|Subject Decision|3|||
25252093|NCT01085357|50567689|FG000|Overall Study|Investigator Decision|1|||
25252094|NCT01085357|50567690|FG001|Overall Study|Investigator Decision|1|||
25252095|NCT01085357|50567689|FG000|Overall Study|Death|11|||
25252096|NCT01085357|50567690|FG001|Overall Study|Death|1|||
25252097|NCT01085357|50567689|FG000|Overall Study|Lost to Follow-up|2|||
25252098|NCT01085357|50567690|FG001|Overall Study|Lost to Follow-up|0|||
24901722|NCT00719732|49995739|FG000|Overall Study|Lost to Follow-up|20|||
24901723|NCT00719732|49995739|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
24901724|NCT00719732|49995739|FG000|Overall Study|Illness not associated with device|1|||
24901725|NCT00723710|49995743|FG000|Overall Study|Disease progression|48|||
24901726|NCT00723710|49995743|FG000|Overall Study|Adverse Event|88|||
24901727|NCT00723710|49995743|FG000|Overall Study|Withdrawal by Subject|36|||
24901728|NCT00723710|49995743|FG000|Overall Study|Physician Decision|2|||
24901729|NCT00688545|49995749|FG000|Overall Study|Lost to Follow-up|1|||
24901730|NCT00688545|49995750|FG001|Overall Study|Lost to Follow-up|4|||
24901731|NCT00688545|49995749|FG000|Overall Study|Insurance/cost of drug|0|||
24901732|NCT00688545|49995750|FG001|Overall Study|Insurance/cost of drug|1|||
24901733|NCT00688545|49995749|FG000|Overall Study|Withdrawal by Subject|2|||
25252099|NCT01085201|50567701|FG000|Overall Study|Scheduling conflict|1|||
25334365|NCT00863057|50650816|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
25334366|NCT00863057|50650817|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
24901734|NCT00688545|49995750|FG001|Overall Study|Withdrawal by Subject|3|||
24901735|NCT00688545|49995749|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
24901736|NCT00688545|49995750|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
25252100|NCT01085201|50567702|FG001|Overall Study|Scheduling conflict|0|||
25252101|NCT01085201|50567703|FG002|Overall Study|Scheduling conflict|1|||
25334367|NCT00863057|50650818|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
25334368|NCT00863057|50650815|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
25334369|NCT00863057|50650816|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
25334370|NCT00863057|50650817|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
25334371|NCT00863057|50650818|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
25334372|NCT00863057|50650815|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
25334373|NCT00863057|50650816|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
25334374|NCT00863057|50650817|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
25334375|NCT00863057|50650818|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
25334376|NCT00829166|50650836|FG000|Overall Study|Death|305|||
25334377|NCT00829166|50650837|FG001|Overall Study|Death|333|||
25252102|NCT01085201|50567704|FG003|Overall Study|Scheduling conflict|0|||
25252103|NCT01085201|50567705|FG004|Overall Study|Scheduling conflict|0|||
25334378|NCT00829166|50650836|FG000|Overall Study|Lost to Follow-up|5|||
25334379|NCT00829166|50650837|FG001|Overall Study|Lost to Follow-up|4|||
25334380|NCT00829166|50650836|FG000|Overall Study|Physician's Decision|4|||
25334381|NCT00829166|50650837|FG001|Overall Study|Physician's Decision|3|||
25334382|NCT00829166|50650836|FG000|Overall Study|Subject's Decision|41|||
25334383|NCT00829166|50650837|FG001|Overall Study|Subject's Decision|55|||
25252104|NCT01085201|50567701|FG000|Overall Study|Unknown- no study drug|2|||
25252105|NCT01085201|50567702|FG001|Overall Study|Unknown- no study drug|0|||
25252106|NCT01085201|50567703|FG002|Overall Study|Unknown- no study drug|0|||
25252107|NCT01085201|50567704|FG003|Overall Study|Unknown- no study drug|0|||
25252108|NCT01085201|50567705|FG004|Overall Study|Unknown- no study drug|0|||
25252109|NCT01085201|50567701|FG000|Overall Study|Fond ineligible after consent|0|||
25252110|NCT01085201|50567702|FG001|Overall Study|Fond ineligible after consent|1|||
25252111|NCT01085201|50567703|FG002|Overall Study|Fond ineligible after consent|1|||
25252112|NCT01085201|50567704|FG003|Overall Study|Fond ineligible after consent|0|||
25252113|NCT01085201|50567705|FG004|Overall Study|Fond ineligible after consent|0|||
25252114|NCT01085084|50567725|FG000|Overall Study|Withdrawal by Subject|1|||
25252115|NCT01085084|50567726|FG001|Overall Study|Withdrawal by Subject|0|||
25252116|NCT01085084|50567727|FG002|Overall Study|Withdrawal by Subject|0|||
25252117|NCT01085084|50567725|FG000|Overall Study|Lost to Follow-up|2|||
25252118|NCT01085084|50567726|FG001|Overall Study|Lost to Follow-up|1|||
25252119|NCT01085084|50567727|FG002|Overall Study|Lost to Follow-up|1|||
25252120|NCT01085084|50567725|FG000|Overall Study|Adverse Event|4|||
25252121|NCT01085084|50567726|FG001|Overall Study|Adverse Event|3|||
25252122|NCT01085084|50567727|FG002|Overall Study|Adverse Event|6|||
25252123|NCT01085084|50567725|FG000|Overall Study|Treatment Failure|0|||
25252124|NCT01085084|50567726|FG001|Overall Study|Treatment Failure|1|||
25252125|NCT01085084|50567727|FG002|Overall Study|Treatment Failure|2|||
25252126|NCT01085045|50567735|FG000|Part A|Withdrawal by Subject|4|||
25252127|NCT01085045|50567735|FG000|Part A|Adverse Event|6|||
25334384|NCT00829166|50650836|FG000|Overall Study|Sponsor's Decision|137|||
25334385|NCT00829166|50650837|FG001|Overall Study|Sponsor's Decision|98|||
25334386|NCT00829166|50650836|FG000|Overall Study|Reason Not Specified|3|||
25334387|NCT00829166|50650837|FG001|Overall Study|Reason Not Specified|3|||
25334388|NCT00799266|50650846|FG000|Overall Study|Adverse Event|0|||
25334389|NCT00799266|50650847|FG001|Overall Study|Adverse Event|1|||
25334390|NCT00799266|50650846|FG000|Overall Study|Subject withdrew consent|3|||
25334391|NCT00799266|50650847|FG001|Overall Study|Subject withdrew consent|0|||
25334392|NCT00650104|50650853|FG000|Overall Study|Adverse Event|17|||
25334393|NCT00650104|50650853|FG000|Overall Study|Death|2|||
25334394|NCT00650104|50650853|FG000|Overall Study|Withdrawal by Subject|11|||
25334395|NCT00650104|50650853|FG000|Overall Study|Physician Decision|7|||
25334396|NCT00650104|50650853|FG000|Overall Study|Lost to Follow-up|1|||
25334397|NCT00650104|50650853|FG000|Overall Study|Non-compliance|2|||
25334398|NCT00650104|50650853|FG000|Overall Study|Sponsor Terminated Dosing|1|||
25334399|NCT00654238|50650857|FG000|Overall Study|Screen Failures|4|||
25334400|NCT00862979|50650864|FG000|Overall Study|Adverse Event|6|||
25334401|NCT00862979|50650865|FG001|Overall Study|Adverse Event|3|||
25334402|NCT00862979|50650864|FG000|Overall Study|Protocol Violation|0|||
25334403|NCT00862979|50650865|FG001|Overall Study|Protocol Violation|1|||
25334404|NCT00862979|50650864|FG000|Overall Study|Patient withdrew consent|2|||
25334405|NCT00862979|50650865|FG001|Overall Study|Patient withdrew consent|1|||
25334406|NCT00862979|50650864|FG000|Overall Study|Administrative problems|0|||
25252128|NCT01085045|50567735|FG000|Part A|Protocol Violation|1|||
25252129|NCT01085045|50567735|FG000|Part A|Protocol Specified Criteria|7|||
25252130|NCT01085045|50567735|FG000|Part B|Withdrawal by Subject|2|||
25252131|NCT01085045|50567735|FG000|Part B|Protocol Specified Criteria|6|||
25252132|NCT01085045|50567735|FG000|Part B|Lost to Follow-up|1|||
25252133|NCT01085045|50567735|FG000|Part B|Adverse Event|6|||
25334407|NCT00862979|50650865|FG001|Overall Study|Administrative problems|1|||
25334408|NCT00862979|50650864|FG000|Overall Study|Death|0|||
25334409|NCT00862979|50650865|FG001|Overall Study|Death|1|||
25334410|NCT00483379|50650873|FG000|Treatment Period|Adverse Event|1|||
25334411|NCT00483379|50650874|FG001|Treatment Period|Adverse Event|0|||
25334412|NCT00483379|50650873|FG000|Treatment Period|Withdrawal by Subject|1|||
25334413|NCT00483379|50650874|FG001|Treatment Period|Withdrawal by Subject|0|||
25334414|NCT00446251|50650882|FG000|Overall Study|On-study Transplants|2|||
25334415|NCT00446251|50650882|FG000|Overall Study|Rituximab Infusion Reaction|2|||
25334416|NCT00446251|50650882|FG000|Overall Study|Lost to Follow-up|1|||
25334417|NCT00796224|50650888|FG000|Overall Study|Adverse Event|1|||
25334418|NCT00796224|50650889|FG001|Overall Study|Adverse Event|0|||
25334419|NCT00796224|50650888|FG000|Overall Study|Protocol Violation|0|||
25334420|NCT00796224|50650889|FG001|Overall Study|Protocol Violation|1|||
25334421|NCT00791934|50650897|FG000|Overall Study|Withdrawal by Subject|2|||
25334422|NCT00791934|50650897|FG000|Overall Study|Did not consent for extended follow-up|13|||
25334423|NCT00848081|50650903|FG000|Overall Study|Adverse Event|6|||
25334424|NCT00848081|50650904|FG001|Overall Study|Adverse Event|7|||
25334425|NCT00848081|50650903|FG000|Overall Study|Protocol Violation|8|||
25334426|NCT00848081|50650904|FG001|Overall Study|Protocol Violation|5|||
25334427|NCT00848081|50650903|FG000|Overall Study|Lost to Follow-up|1|||
25334428|NCT00848081|50650904|FG001|Overall Study|Lost to Follow-up|0|||
25334429|NCT00848081|50650903|FG000|Overall Study|Physician Decision|0|||
25334430|NCT00848081|50650904|FG001|Overall Study|Physician Decision|3|||
25334431|NCT00848081|50650903|FG000|Overall Study|Withdrawal by Subject|5|||
25334432|NCT00848081|50650904|FG001|Overall Study|Withdrawal by Subject|3|||
25252134|NCT01084772|50567757|FG000|Baseline|Withdrawal by Subject|7|||
25252135|NCT01084772|50567758|FG001|Baseline|Withdrawal by Subject|6|||
25252136|NCT01084772|50567757|FG000|3 Months|Death|1|||
25252137|NCT01084772|50567758|FG001|3 Months|Death|0|||
25252138|NCT01084772|50567757|FG000|3 Months|Study Termination|2|||
25252139|NCT01084772|50567758|FG001|3 Months|Study Termination|2|||
25252140|NCT01084772|50567757|FG000|1 Year|Withdrawal by Subject|0|||
25252141|NCT01084772|50567758|FG001|1 Year|Withdrawal by Subject|1|||
25252142|NCT01084772|50567757|FG000|1 Year|Lost to Follow-up|3|||
25252143|NCT01084772|50567758|FG001|1 Year|Lost to Follow-up|0|||
25252144|NCT01084772|50567757|FG000|1 Year|Study Termination|0|||
25252145|NCT01084772|50567758|FG001|1 Year|Study Termination|7|||
25252146|NCT01084772|50567757|FG000|2 Years|Withdrawal by Subject|1|||
25334433|NCT00654004|50650912|FG000|Overall Study|Lost to Follow-up|1|||
25334434|NCT00654004|50650913|FG001|Overall Study|Lost to Follow-up|0|||
25334435|NCT00791778|50650921|FG000|Double-blind Treatment|Adverse Event|49|||
25334436|NCT00791778|50650922|FG001|Double-blind Treatment|Adverse Event|9|||
25334437|NCT00791778|50650921|FG000|Double-blind Treatment|Physician Decision|6|||
25334438|NCT00791778|50650922|FG001|Double-blind Treatment|Physician Decision|26|||
25334439|NCT00791778|50650921|FG000|Double-blind Treatment|Protocol Violation|0|||
25334440|NCT00791778|50650922|FG001|Double-blind Treatment|Protocol Violation|4|||
25334441|NCT00791778|50650921|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
25334442|NCT00791778|50650922|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
25334443|NCT00791778|50650921|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
25334444|NCT00791778|50650922|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
25334445|NCT00791778|50650921|FG000|Follow-up|Withdrawal by Subject|3|||
25334446|NCT00791778|50650922|FG001|Follow-up|Withdrawal by Subject|0|||
25334447|NCT00791778|50650921|FG000|Follow-up|Lost to Follow-up|2|||
25334448|NCT00791778|50650922|FG001|Follow-up|Lost to Follow-up|1|||
25334449|NCT00798174|50650928|FG000|Overall Study|inability to implant azygos coil|3|||
25334450|NCT00798174|50650929|FG001|Overall Study|inability to implant azygos coil|3|||
25334451|NCT00798174|50650928|FG000|Overall Study|Inability to sedate for DFT testing|1|||
25334452|NCT00798174|50650929|FG001|Overall Study|Inability to sedate for DFT testing|0|||
25334453|NCT00798096|50650933|FG000|Overall Study|Ongoing|2|||
25334454|NCT00795600|50650939|FG000|Overall Study|Adverse Event|1|||
25334455|NCT00795600|50650940|FG001|Overall Study|Adverse Event|1|||
25334456|NCT00795600|50650939|FG000|Overall Study|Protocol Violation|1|||
25334457|NCT00795600|50650940|FG001|Overall Study|Protocol Violation|2|||
25334458|NCT00795600|50650939|FG000|Overall Study|Withdrawal by Subject|1|||
25334459|NCT00795600|50650940|FG001|Overall Study|Withdrawal by Subject|0|||
25334460|NCT00795600|50650939|FG000|Overall Study|Unclassified|1|||
25334461|NCT00795600|50650940|FG001|Overall Study|Unclassified|1|||
25334462|NCT00795132|50650946|FG000|Overall Study|Death|1|||
25334463|NCT00795132|50650946|FG000|Overall Study|Relapse|2|||
25334464|NCT00647296|50650962|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
25252147|NCT01084772|50567758|FG001|2 Years|Withdrawal by Subject|0|||
25252148|NCT01084772|50567757|FG000|2 Years|Lost to Follow-up|5|||
25334465|NCT00647296|50650963|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
25334466|NCT00647296|50650964|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
25334467|NCT00647296|50650965|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
25334468|NCT00647296|50650962|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
25334469|NCT00647296|50650963|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
25334470|NCT00647296|50650964|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
25334471|NCT00647296|50650965|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
24901737|NCT00688467|49995760|FG000|Treatment Period 1|Adverse Event|2|||
25252149|NCT01084772|50567758|FG001|2 Years|Lost to Follow-up|2|||
25252150|NCT01084772|50567757|FG000|2 Years|Study Termination|3|||
25334472|NCT00647296|50650962|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
25334473|NCT00647296|50650963|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
25334474|NCT00647296|50650964|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
25252151|NCT01084772|50567758|FG001|2 Years|Study Termination|2|||
25252152|NCT00179673|50567764|FG000|Overall Study|Adverse Event|7|||
25252153|NCT00179673|50567764|FG000|Overall Study|Lack of Efficacy|15|||
25334475|NCT00647296|50650965|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
25334476|NCT00647296|50650962|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
25334477|NCT00647296|50650963|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
25334478|NCT00647296|50650964|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
25334479|NCT00647296|50650965|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
25334480|NCT00647296|50650962|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
25334481|NCT00647296|50650963|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
25334482|NCT00647296|50650964|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
25334483|NCT00647296|50650965|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
25334484|NCT00647296|50650962|FG000|Part 2: 4-week Placebo Washout|Death|3|||
25334485|NCT00647296|50650963|FG001|Part 2: 4-week Placebo Washout|Death|0|||
25334486|NCT00647296|50650964|FG002|Part 2: 4-week Placebo Washout|Death|0|||
25334487|NCT00647296|50650965|FG003|Part 2: 4-week Placebo Washout|Death|0|||
25334488|NCT00647296|50650962|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
25334489|NCT00647296|50650963|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
25334490|NCT00647296|50650964|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
25334491|NCT00647296|50650965|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
25334492|NCT00647296|50650962|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
25334493|NCT00647296|50650963|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
25334494|NCT00647296|50650964|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
25334495|NCT00647296|50650965|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
25334496|NCT00647296|50650962|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
25334497|NCT00647296|50650963|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
25334498|NCT00647296|50650964|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
25334499|NCT00647296|50650965|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
25334500|NCT00647296|50650962|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
25334501|NCT00647296|50650963|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
25334502|NCT00647296|50650964|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
25334503|NCT00647296|50650965|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
25334504|NCT00647296|50650962|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
25334505|NCT00647296|50650963|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
25334506|NCT00647296|50650964|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
25334507|NCT00647296|50650965|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
25334508|NCT00644878|50650987|FG000|Overall Study|Adverse Event|2|||
24901738|NCT00688467|49995761|FG001|Treatment Period 1|Adverse Event|1|||
24901739|NCT00688467|49995760|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
24901740|NCT00688467|49995761|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
25252154|NCT00179673|50567764|FG000|Overall Study|Withdrawal by Subject|3|||
25252155|NCT00179673|50567764|FG000|Overall Study|Death|4|||
24901741|NCT00688467|49995760|FG000|Treatment Period 2|Protocol Violation|0|||
24901742|NCT00688467|49995761|FG001|Treatment Period 2|Protocol Violation|1|||
24901743|NCT00688467|49995760|FG000|Treatment Period 2|Adverse Event|0|||
24901744|NCT00688467|49995761|FG001|Treatment Period 2|Adverse Event|1|||
24901745|NCT00688155|49995771|FG000|Overall Study|Withdrawal by Subject|2|||
24901746|NCT00688155|49995772|FG001|Overall Study|Withdrawal by Subject|2|||
24901747|NCT00688155|49995773|FG002|Overall Study|Withdrawal by Subject|1|||
24901748|NCT00688155|49995774|FG003|Overall Study|Withdrawal by Subject|1|||
24901749|NCT00690573|49995784|FG000|Overall Study|Lack of Efficacy|8|||
24901750|NCT00690573|49995784|FG000|Overall Study|Withdrawal by Subject|1|||
24901751|NCT00719264|49995790|FG000|Overall Study|Adverse Event|41|||
24901752|NCT00719264|49995791|FG001|Overall Study|Adverse Event|49|||
24901753|NCT00719264|49995790|FG000|Overall Study|Death|13|||
24901754|NCT00719264|49995791|FG001|Overall Study|Death|10|||
24901755|NCT00719264|49995790|FG000|Overall Study|Administrative Problems|6|||
25252156|NCT00179673|50567764|FG000|Overall Study|Other Observations and options|14|||
25252157|NCT01084655|50567771|FG000|Overall Study|Radiographic disease progression|3|||
25252158|NCT01084655|50567772|FG001|Overall Study|Radiographic disease progression|2|||
25252159|NCT01084655|50567773|FG002|Overall Study|Radiographic disease progression|8|||
25252160|NCT01084655|50567771|FG000|Overall Study|Withdrawal by Subject|1|||
25252161|NCT01084655|50567772|FG001|Overall Study|Withdrawal by Subject|0|||
24901756|NCT00719264|49995791|FG001|Overall Study|Administrative Problems|4|||
24901757|NCT00719264|49995790|FG000|Overall Study|Lost to Follow-up|1|||
24901758|NCT00719264|49995791|FG001|Overall Study|Lost to Follow-up|1|||
24901759|NCT00719264|49995790|FG000|Overall Study|Withdrawal by Subject|12|||
25334509|NCT00644878|50650987|FG000|Overall Study|Abnormal laboratory value|3|||
25334510|NCT00644878|50650987|FG000|Overall Study|Protocol deviation|2|||
25334511|NCT00644878|50650987|FG000|Overall Study|Treatment duration completed as per protocol|11|||
25334512|NCT00646906|50650995|FG000|Crossover Period 1|Withdrawal by Subject|1|||
25334513|NCT00646906|50650996|FG001|Crossover Period 1|Withdrawal by Subject|0|||
25334514|NCT00646906|50650997|FG002|Crossover Period 1|Withdrawal by Subject|0|||
25334515|NCT00646906|50650998|FG003|Crossover Period 1|Withdrawal by Subject|0|||
25334516|NCT00646906|50650999|FG004|Crossover Period 1|Withdrawal by Subject|0|||
25334517|NCT00646906|50651000|FG005|Crossover Period 1|Withdrawal by Subject|1|||
25334518|NCT00646906|50651001|FG006|Crossover Period 1|Withdrawal by Subject|0|||
25334519|NCT00646906|50650995|FG000|Crossover Period 2|Withdrawal by Subject|0|||
25334520|NCT00646906|50650996|FG001|Crossover Period 2|Withdrawal by Subject|1|||
25334521|NCT00646906|50650997|FG002|Crossover Period 2|Withdrawal by Subject|2|||
25334522|NCT00646906|50650998|FG003|Crossover Period 2|Withdrawal by Subject|1|||
24901760|NCT00719264|49995791|FG001|Overall Study|Withdrawal by Subject|7|||
24901761|NCT00719264|49995790|FG000|Overall Study|Protocol Deviation|1|||
24901762|NCT00719264|49995791|FG001|Overall Study|Protocol Deviation|3|||
24901763|NCT00719264|49995790|FG000|Overall Study|New Cancer Therapy|4|||
24901764|NCT00719264|49995791|FG001|Overall Study|New Cancer Therapy|2|||
24901765|NCT00719264|49995790|FG000|Overall Study|Disease Progression|104|||
24901766|NCT00719264|49995791|FG001|Overall Study|Disease Progression|107|||
24901767|NCT00687609|49995797|FG000|Overall Study|Physician Decision|1|||
24901768|NCT00687609|49995797|FG000|Overall Study|Withdrawal by Subject|2|||
24901769|NCT00723554|49995801|FG000|Overall Study|Adverse Event|12|||
24901770|NCT00723554|49995801|FG000|Overall Study|Investigator's judgement|5|||
24901771|NCT00723554|49995801|FG000|Overall Study|Inhaled medication other than iloprost|4|||
24901772|NCT00723554|49995801|FG000|Overall Study|Withdrawal of consent|3|||
24901773|NCT00723554|49995801|FG000|Overall Study|Other|3|||
24901774|NCT00723554|49995801|FG000|Overall Study|Lost to Follow-up|1|||
24901775|NCT00723554|49995801|FG000|Overall Study|Non-compliance|1|||
24901776|NCT00687219|49995807|FG000|Overall Study|Adverse Event|8|||
24901777|NCT00687219|49995807|FG000|Overall Study|Discontinuance criteria met|7|||
24901778|NCT00687219|49995807|FG000|Overall Study|HCV-RNA positive conversion|34|||
24901779|NCT00687219|49995807|FG000|Overall Study|Withdrawal by Subject|1|||
24901780|NCT00687219|49995807|FG000|Overall Study|Lack of Efficacy|1|||
24901781|NCT00723398|49995816|FG000|Overall Study|Withdrawal by Subject|2|||
24901782|NCT00723398|49995817|FG001|Overall Study|Withdrawal by Subject|6|||
24901783|NCT00723398|49995818|FG002|Overall Study|Withdrawal by Subject|4|||
24901784|NCT00723398|49995819|FG003|Overall Study|Withdrawal by Subject|4|||
24901785|NCT00723398|49995820|FG004|Overall Study|Withdrawal by Subject|4|||
24901786|NCT00723398|49995816|FG000|Overall Study|Protocol Violation|2|||
24901787|NCT00723398|49995817|FG001|Overall Study|Protocol Violation|1|||
24901788|NCT00723398|49995818|FG002|Overall Study|Protocol Violation|5|||
24901789|NCT00723398|49995819|FG003|Overall Study|Protocol Violation|0|||
24901790|NCT00723398|49995820|FG004|Overall Study|Protocol Violation|0|||
24901791|NCT00723398|49995816|FG000|Overall Study|Physician Decision|2|||
24901792|NCT00723398|49995817|FG001|Overall Study|Physician Decision|2|||
24901793|NCT00723398|49995818|FG002|Overall Study|Physician Decision|5|||
24901794|NCT00723398|49995819|FG003|Overall Study|Physician Decision|0|||
24901795|NCT00723398|49995820|FG004|Overall Study|Physician Decision|1|||
24901796|NCT00723398|49995816|FG000|Overall Study|Adverse Event|0|||
24901797|NCT00723398|49995817|FG001|Overall Study|Adverse Event|5|||
24901798|NCT00723398|49995818|FG002|Overall Study|Adverse Event|3|||
24901799|NCT00723398|49995819|FG003|Overall Study|Adverse Event|1|||
24977379|NCT00048542|50066002|FG006|Double-Blind Phase|Randomized in error|0|||
25077894|NCT02896855|50185964|FG000|Overall Study|Death|50|||
25252162|NCT01084655|50567773|FG002|Overall Study|Withdrawal by Subject|4|||
25252163|NCT01084655|50567771|FG000|Overall Study|Adverse Event|2|||
25252164|NCT01084655|50567772|FG001|Overall Study|Adverse Event|1|||
25252165|NCT01084655|50567773|FG002|Overall Study|Adverse Event|2|||
25252166|NCT01084655|50567771|FG000|Overall Study|Other|0|||
25252167|NCT01084655|50567772|FG001|Overall Study|Other|3|||
25252168|NCT01084655|50567773|FG002|Overall Study|Other|2|||
25252169|NCT01084655|50567771|FG000|Overall Study|Symptomatic deterioration|0|||
25252170|NCT01084655|50567772|FG001|Overall Study|Symptomatic deterioration|0|||
25252171|NCT01084655|50567773|FG002|Overall Study|Symptomatic deterioration|2|||
25252172|NCT01084655|50567771|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
25334523|NCT00646906|50650999|FG004|Crossover Period 2|Withdrawal by Subject|0|||
25334524|NCT00646906|50651000|FG005|Crossover Period 2|Withdrawal by Subject|0|||
24901800|NCT00723398|49995820|FG004|Overall Study|Adverse Event|4|||
24901801|NCT00723398|49995816|FG000|Overall Study|Lost to Follow-up|0|||
24901802|NCT00723398|49995817|FG001|Overall Study|Lost to Follow-up|1|||
24901803|NCT00723398|49995818|FG002|Overall Study|Lost to Follow-up|0|||
24901804|NCT00723398|49995819|FG003|Overall Study|Lost to Follow-up|0|||
24901805|NCT00723398|49995820|FG004|Overall Study|Lost to Follow-up|0|||
24901806|NCT00716456|49995835|FG000|Overall Study|Adverse Event|0|||
24901807|NCT00716456|49995836|FG001|Overall Study|Adverse Event|2|||
24901808|NCT00716456|49995837|FG002|Overall Study|Adverse Event|0|||
25334525|NCT00646906|50651001|FG006|Crossover Period 2|Withdrawal by Subject|0|||
25334526|NCT00646906|50650995|FG000|Crossover Period 2|Physician Decision|0|||
25334527|NCT00646906|50650996|FG001|Crossover Period 2|Physician Decision|0|||
25334528|NCT00646906|50650997|FG002|Crossover Period 2|Physician Decision|0|||
25334529|NCT00646906|50650998|FG003|Crossover Period 2|Physician Decision|0|||
25334530|NCT00646906|50650999|FG004|Crossover Period 2|Physician Decision|0|||
25334531|NCT00646906|50651000|FG005|Crossover Period 2|Physician Decision|0|||
25334532|NCT00646906|50651001|FG006|Crossover Period 2|Physician Decision|1|||
25334533|NCT00642772|50651014|FG000|Overall Study|Lost to Follow-up|3|||
25334534|NCT00642772|50651014|FG000|Overall Study|Withdrawal by Subject|7|||
25334535|NCT00446095|50651023|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
25334536|NCT00446095|50651024|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
25334537|NCT00446095|50651025|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
25334538|NCT00446095|50651026|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
25334539|NCT00446095|50651027|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
25334540|NCT00446095|50651023|FG000|Phase II (8 Weeks)|Adverse Event|0|||
25334541|NCT00446095|50651024|FG001|Phase II (8 Weeks)|Adverse Event|1|||
25334542|NCT00446095|50651025|FG002|Phase II (8 Weeks)|Adverse Event|1|||
25334543|NCT00446095|50651026|FG003|Phase II (8 Weeks)|Adverse Event|0|||
25334544|NCT00446095|50651027|FG004|Phase II (8 Weeks)|Adverse Event|0|||
25334545|NCT00446095|50651023|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
25334546|NCT00446095|50651024|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
25334547|NCT00446095|50651025|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
25334548|NCT00446095|50651026|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
25334549|NCT00446095|50651027|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
25334550|NCT00446095|50651023|FG000|Phase II (8 Weeks)|Physician Decision|1|||
25334551|NCT00446095|50651024|FG001|Phase II (8 Weeks)|Physician Decision|0|||
25334552|NCT00446095|50651025|FG002|Phase II (8 Weeks)|Physician Decision|0|||
25334553|NCT00446095|50651026|FG003|Phase II (8 Weeks)|Physician Decision|0|||
25334554|NCT00446095|50651027|FG004|Phase II (8 Weeks)|Physician Decision|0|||
25334555|NCT00446095|50651023|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
25334556|NCT00446095|50651024|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
25334557|NCT00446095|50651025|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
25334558|NCT00446095|50651026|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
25334559|NCT00446095|50651027|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
25334560|NCT00446095|50651023|FG000|Phase II (8 Weeks)|Ongoing|0|||
25334561|NCT00446095|50651024|FG001|Phase II (8 Weeks)|Ongoing|0|||
25334562|NCT00446095|50651025|FG002|Phase II (8 Weeks)|Ongoing|1|||
25334563|NCT00446095|50651026|FG003|Phase II (8 Weeks)|Ongoing|0|||
25334564|NCT00446095|50651027|FG004|Phase II (8 Weeks)|Ongoing|0|||
25334565|NCT00446095|50651023|FG000|Phase I (28 Days)|Adverse Event|0|||
24901809|NCT00684645|49995845|FG000|Overall Study|Death|2|||
24901810|NCT00684645|49995845|FG000|Overall Study|Progressive disease|67|||
24901811|NCT00684645|49995845|FG000|Overall Study|Adverse Event|27|||
24901812|NCT00684645|49995845|FG000|Overall Study|Lost to Follow-up|3|||
24901813|NCT00684645|49995845|FG000|Overall Study|Other|15|||
24901814|NCT00716144|49995853|FG000|Overall Study|Withdrawal by Subject|4|||
24901815|NCT00716144|49995854|FG001|Overall Study|Withdrawal by Subject|2|||
24901816|NCT00716144|49995855|FG002|Overall Study|Withdrawal by Subject|6|||
24901817|NCT00716144|49995856|FG003|Overall Study|Withdrawal by Subject|6|||
24901818|NCT00716144|49995853|FG000|Overall Study|Lost to Follow-up|2|||
24901819|NCT00716144|49995854|FG001|Overall Study|Lost to Follow-up|2|||
24901820|NCT00716144|49995855|FG002|Overall Study|Lost to Follow-up|1|||
24901821|NCT00716144|49995856|FG003|Overall Study|Lost to Follow-up|2|||
24901822|NCT00716144|49995853|FG000|Overall Study|Adverse Event|0|||
24901823|NCT00716144|49995854|FG001|Overall Study|Adverse Event|0|||
25252173|NCT01084655|50567772|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
25252174|NCT01084655|50567773|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
25252175|NCT01084538|50567785|FG000|Overall Study|Drug not available|30|||
25252176|NCT01084538|50567785|FG000|Overall Study|Adverse Event|9|||
25252177|NCT01084538|50567785|FG000|Overall Study|Kidney transplant|6|||
25252178|NCT01084538|50567785|FG000|Overall Study|Serious Adverse Event|3|||
25252179|NCT01084538|50567785|FG000|Overall Study|Lack of effectiveness|2|||
25252180|NCT01084538|50567785|FG000|Overall Study|Patient noncompliance|2|||
25252181|NCT01084538|50567785|FG000|Overall Study|Hyperphosphatemia|2|||
25334566|NCT00446095|50651024|FG001|Phase I (28 Days)|Adverse Event|0|||
25334567|NCT00446095|50651025|FG002|Phase I (28 Days)|Adverse Event|0|||
25334568|NCT00446095|50651026|FG003|Phase I (28 Days)|Adverse Event|1|||
25334569|NCT00446095|50651027|FG004|Phase I (28 Days)|Adverse Event|0|||
25334570|NCT00446095|50651023|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
24901824|NCT00716144|49995855|FG002|Overall Study|Adverse Event|0|||
24901825|NCT00716144|49995856|FG003|Overall Study|Adverse Event|2|||
25334571|NCT00446095|50651024|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
25334572|NCT00446095|50651025|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
25334573|NCT00446095|50651026|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
25334574|NCT00446095|50651027|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
25334575|NCT00829010|50651043|FG000|Overall Study|Adverse Event|1|||
25334576|NCT00829010|50651044|FG001|Overall Study|Adverse Event|0|||
25252182|NCT01084538|50567785|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
25252183|NCT01084538|50567785|FG000|Overall Study|Change of residence|2|||
25334577|NCT00829010|50651045|FG002|Overall Study|Adverse Event|0|||
25334578|NCT00829010|50651046|FG003|Overall Study|Adverse Event|0|||
25334579|NCT00829010|50651047|FG004|Overall Study|Adverse Event|0|||
25252184|NCT01084538|50567785|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
25252185|NCT01084538|50567785|FG000|Overall Study|Reason unknown|8|||
25252186|NCT01083680|50567789|FG000|Overall Study|Lost to Follow-up|2758|||
25252187|NCT01083680|50567789|FG000|Overall Study|Withdrawal by Subject|1086|||
25252188|NCT00179517|50567795|FG000|Overall Study|Withdrawal by Subject|2|||
25252189|NCT00179517|50567796|FG001|Overall Study|Withdrawal by Subject|1|||
25252190|NCT01083641|50567802|FG000|Overall Study|Withdrawal by Subject|2|||
25252191|NCT00179010|50567808|FG000|Overall Study|Muscle probe defective|1|||
25252192|NCT00179010|50567809|FG001|Overall Study|Muscle probe defective|1|||
25252193|NCT00179010|50567808|FG000|Overall Study|Failure to place arterial line|0|||
25252194|NCT00179010|50567809|FG001|Overall Study|Failure to place arterial line|1|||
25252195|NCT01083602|50567816|FG000|Overall Study|Adverse Event|11|||
25252196|NCT01083602|50567816|FG000|Overall Study|New Cancer Therapy|2|||
25252197|NCT01083602|50567816|FG000|Overall Study|Death|1|||
25252198|NCT01083602|50567816|FG000|Overall Study|Withdrawal by Subject|5|||
25252199|NCT01083602|50567816|FG000|Overall Study|Lack of Efficacy|36|||
25252200|NCT00178464|50567820|FG000|Overall Study|Withdrawal by Subject|1|||
25252201|NCT00178464|50567820|FG000|Overall Study|Physician Decision|1|||
25252202|NCT01083485|50567826|FG000|Overall Study|Adverse Event|0|||
25252203|NCT01083485|50567827|FG001|Overall Study|Adverse Event|1|||
25252204|NCT01083485|50567826|FG000|Overall Study|Protocol Violation|1|||
25252205|NCT01083485|50567827|FG001|Overall Study|Protocol Violation|0|||
25252206|NCT01083485|50567826|FG000|Overall Study|Withdrawal by Subject|5|||
25252207|NCT01083485|50567827|FG001|Overall Study|Withdrawal by Subject|2|||
25334580|NCT00829010|50651043|FG000|Overall Study|Withdrawal by Subject|0|||
25334581|NCT00829010|50651044|FG001|Overall Study|Withdrawal by Subject|1|||
25334582|NCT00829010|50651045|FG002|Overall Study|Withdrawal by Subject|1|||
25334583|NCT00829010|50651046|FG003|Overall Study|Withdrawal by Subject|0|||
25252208|NCT01083485|50567826|FG000|Overall Study|Other|1|||
25252209|NCT01083485|50567827|FG001|Overall Study|Other|0|||
25252210|NCT01083173|50567835|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
25252211|NCT01083173|50567836|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
25334584|NCT00829010|50651047|FG004|Overall Study|Withdrawal by Subject|2|||
25334585|NCT00829010|50651043|FG000|Overall Study|Lost to Follow-up|1|||
25334586|NCT00829010|50651044|FG001|Overall Study|Lost to Follow-up|0|||
25334587|NCT00829010|50651045|FG002|Overall Study|Lost to Follow-up|2|||
25334588|NCT00829010|50651046|FG003|Overall Study|Lost to Follow-up|0|||
25334589|NCT00829010|50651047|FG004|Overall Study|Lost to Follow-up|0|||
25334590|NCT00829010|50651043|FG000|Overall Study|Fatality|5|||
25334591|NCT00829010|50651044|FG001|Overall Study|Fatality|4|||
25334592|NCT00829010|50651045|FG002|Overall Study|Fatality|0|||
25334593|NCT00829010|50651046|FG003|Overall Study|Fatality|3|||
25334594|NCT00829010|50651047|FG004|Overall Study|Fatality|0|||
25334595|NCT00829010|50651043|FG000|Overall Study|Migrated/Moved from study area|3|||
25334596|NCT00829010|50651044|FG001|Overall Study|Migrated/Moved from study area|4|||
25334597|NCT00829010|50651045|FG002|Overall Study|Migrated/Moved from study area|0|||
25334598|NCT00829010|50651046|FG003|Overall Study|Migrated/Moved from study area|5|||
24901826|NCT00716144|49995853|FG000|Overall Study|Non-compliance|1|||
24901827|NCT00716144|49995854|FG001|Overall Study|Non-compliance|0|||
24901828|NCT00716144|49995855|FG002|Overall Study|Non-compliance|0|||
25252212|NCT01083173|50567835|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
25334599|NCT00829010|50651047|FG004|Overall Study|Migrated/Moved from study area|0|||
24901829|NCT00716144|49995856|FG003|Overall Study|Non-compliance|0|||
24901830|NCT00716144|49995853|FG000|Overall Study|Protocol Violation|2|||
24901831|NCT00716144|49995854|FG001|Overall Study|Protocol Violation|0|||
24901832|NCT00716144|49995855|FG002|Overall Study|Protocol Violation|1|||
24901833|NCT00716144|49995856|FG003|Overall Study|Protocol Violation|0|||
24901834|NCT00716144|49995853|FG000|Overall Study|Physician Decision|0|||
24901835|NCT00716144|49995854|FG001|Overall Study|Physician Decision|1|||
24901836|NCT00716144|49995855|FG002|Overall Study|Physician Decision|2|||
24901837|NCT00716144|49995856|FG003|Overall Study|Physician Decision|2|||
24901838|NCT00716144|49995853|FG000|Overall Study|Intercurrent illness|0|||
25252213|NCT01083173|50567836|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
25334600|NCT00644332|50651059|FG000|Overall Study|Adverse Event|11|||
24901839|NCT00716144|49995854|FG001|Overall Study|Intercurrent illness|0|||
25252214|NCT01083173|50567835|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
25252215|NCT01083173|50567836|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
25252216|NCT01083173|50567835|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
25334601|NCT00644332|50651059|FG000|Overall Study|Withdrawal by Subject|6|||
25334602|NCT00644332|50651059|FG000|Overall Study|Completion Status Unknown|2|||
25334603|NCT00644332|50651059|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
25252217|NCT01083173|50567836|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
25252218|NCT01083173|50567835|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
25252219|NCT01083173|50567836|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
25252220|NCT01083173|50567835|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
25252221|NCT01083173|50567836|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
25252222|NCT01083173|50567835|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
25252223|NCT01083173|50567836|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
25252224|NCT01083173|50567835|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
25252225|NCT01083173|50567836|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
25252226|NCT01083173|50567835|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
25252227|NCT01083173|50567836|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
25252228|NCT01083173|50567835|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
25252229|NCT01083173|50567836|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
25252230|NCT01083173|50567835|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
25252231|NCT01083173|50567836|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
25252232|NCT00177294|50567847|FG000|Overall Study|Withdrawal by Subject|7|||
25252233|NCT00177294|50567848|FG001|Overall Study|Withdrawal by Subject|5|||
25252234|NCT01082081|50567857|FG000|Overall Study|Lost to Follow-up|0|||
25252235|NCT01082081|50567858|FG001|Overall Study|Lost to Follow-up|0|||
25252236|NCT01082081|50567859|FG002|Overall Study|Lost to Follow-up|1|||
25252237|NCT01082081|50567857|FG000|Overall Study|Withdrawal by Subject|0|||
25252238|NCT01082081|50567858|FG001|Overall Study|Withdrawal by Subject|0|||
25252239|NCT01082081|50567859|FG002|Overall Study|Withdrawal by Subject|1|||
25252240|NCT01082081|50567857|FG000|Overall Study|Other Reason|0|||
25252241|NCT01082081|50567858|FG001|Overall Study|Other Reason|1|||
25252242|NCT01082081|50567859|FG002|Overall Study|Other Reason|0|||
25252243|NCT00177216|50567870|FG000|Overall Study|Withdrawal by Subject|6|||
25252244|NCT00177216|50567871|FG001|Overall Study|Withdrawal by Subject|3|||
25252245|NCT00177216|50567872|FG002|Overall Study|Withdrawal by Subject|1|||
25252246|NCT01081886|50567886|FG000|Overall Study|Study termination|11|||
25252247|NCT01081886|50567887|FG001|Overall Study|Study termination|13|||
25252248|NCT01081769|50567895|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
25252249|NCT01081769|50567896|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
25252250|NCT01081769|50567895|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
25252251|NCT01081769|50567896|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
25252252|NCT01081769|50567895|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
25252253|NCT01081769|50567896|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
25252254|NCT01081769|50567895|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
25252255|NCT01081769|50567896|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
25252256|NCT01081769|50567895|FG000|CORE Intent-To-Treat|Adverse Event|14|||
25252257|NCT01081769|50567896|FG001|CORE Intent-To-Treat|Adverse Event|11|||
25252258|NCT01081769|50567895|FG000|CORE Intent-To-Treat|Death|1|||
25252259|NCT01081769|50567896|FG001|CORE Intent-To-Treat|Death|1|||
25252260|NCT01081769|50567895|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
25252261|NCT01081769|50567896|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
25252262|NCT01081769|50567895|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
25252263|NCT01081769|50567896|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
25252264|NCT01081769|50567895|FG000|CORE Intent-To-Treat|Pregnancy|1|||
25252265|NCT01081769|50567896|FG001|CORE Intent-To-Treat|Pregnancy|0|||
25252266|NCT01081769|50567895|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
25252267|NCT01081769|50567896|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
25252268|NCT01081769|50567895|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
25252269|NCT01081769|50567896|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
25252270|NCT01081769|50567895|FG000|CORE Intent-To-Treat|Other|0|||
25252271|NCT01081769|50567896|FG001|CORE Intent-To-Treat|Other|1|||
25252272|NCT01081769|50567895|FG000|CORE Intent-To-Treat|Ineligibility|3|||
25252273|NCT01081769|50567896|FG001|CORE Intent-To-Treat|Ineligibility|4|||
25252274|NCT01081769|50567895|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
24901840|NCT00716144|49995855|FG002|Overall Study|Intercurrent illness|1|||
24901841|NCT00716144|49995856|FG003|Overall Study|Intercurrent illness|0|||
24901842|NCT00716144|49995853|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
25252275|NCT01081769|50567896|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
25252276|NCT01081769|50567895|FG000|CORE Intent-To-Treat|Patient Moved|2|||
25252277|NCT01081769|50567896|FG001|CORE Intent-To-Treat|Patient Moved|2|||
25252278|NCT01081301|50567902|FG000|Overall Study|Bereaved|3|||
25252279|NCT01081301|50567902|FG000|Overall Study|Too busy|5|||
25252280|NCT01081301|50567902|FG000|Overall Study|Patient too ill|2|||
25252281|NCT01081301|50567902|FG000|Overall Study|Lost to Follow-up|4|||
25252282|NCT00174954|50567923|FG000|Overall Study|Adverse Event|2|||
25252283|NCT00174954|50567923|FG000|Overall Study|No tophi found in MRI|1|||
25252284|NCT00174954|50567923|FG000|Overall Study|Physician Decision|1|||
25252285|NCT01081145|50567927|FG000|Open-Label Phase|Lack of Efficacy|56|||
25252286|NCT01081145|50567928|FG001|Open-Label Phase|Lack of Efficacy|0|||
25252287|NCT01081145|50567927|FG000|Open-Label Phase|Response criteria not met|46|||
25252288|NCT01081145|50567928|FG001|Open-Label Phase|Response criteria not met|0|||
25252289|NCT01081145|50567927|FG000|Open-Label Phase|Adverse Event|42|||
25252290|NCT01081145|50567928|FG001|Open-Label Phase|Adverse Event|0|||
25252291|NCT01081145|50567927|FG000|Open-Label Phase|Withdrawal by Subject|41|||
25252292|NCT01081145|50567928|FG001|Open-Label Phase|Withdrawal by Subject|0|||
25252293|NCT01081145|50567927|FG000|Open-Label Phase|Other|12|||
25252294|NCT01081145|50567928|FG001|Open-Label Phase|Other|0|||
25252295|NCT01081145|50567927|FG000|Open-Label Phase|Lost to Follow-up|11|||
25252296|NCT01081145|50567928|FG001|Open-Label Phase|Lost to Follow-up|0|||
25252297|NCT01081145|50567927|FG000|Open-Label Phase|Protocol Violation|4|||
25252298|NCT01081145|50567928|FG001|Open-Label Phase|Protocol Violation|0|||
25252299|NCT01081145|50567927|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
25252300|NCT01081145|50567928|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
25252301|NCT01081145|50567927|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
25252302|NCT01081145|50567928|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
25252303|NCT01081145|50567927|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
25252304|NCT01081145|50567928|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
25252305|NCT01081145|50567927|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
25252306|NCT01081145|50567928|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
25334604|NCT00644332|50651059|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
25334605|NCT00445939|50651066|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
25334606|NCT00445939|50651067|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
25334607|NCT00445939|50651068|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
25334608|NCT00445939|50651069|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
25334609|NCT00445939|50651066|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
25334610|NCT00445939|50651067|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
25334611|NCT00445939|50651068|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
25334612|NCT00445939|50651069|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
25334613|NCT00482053|50651089|FG000|Inter-treatment Period|Disease progression|1|||
25252307|NCT01081145|50567927|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
25252308|NCT01081145|50567928|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
25252309|NCT01081145|50567927|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
25252310|NCT01081145|50567928|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
25252311|NCT01081145|50567927|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
25252312|NCT01081145|50567928|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
25252313|NCT00174915|50567941|FG000|Overall Study|Lost to Follow-up|19|||
25252314|NCT00174915|50567942|FG001|Overall Study|Lost to Follow-up|17|||
25252315|NCT00174915|50567943|FG002|Overall Study|Lost to Follow-up|9|||
25252316|NCT00174915|50567944|FG003|Overall Study|Lost to Follow-up|17|||
25252317|NCT00174915|50567945|FG004|Overall Study|Lost to Follow-up|10|||
25252318|NCT00174915|50567941|FG000|Overall Study|Adverse Event|18|||
25334614|NCT00455923|50651095|FG000|Overall Study|Pregnancy|0|||
25334615|NCT00455923|50651096|FG001|Overall Study|Pregnancy|2|||
25334616|NCT00455923|50651095|FG000|Overall Study|Other|3|||
25334617|NCT00455923|50651096|FG001|Overall Study|Other|1|||
25334618|NCT00642616|50651106|FG000|Overall Study|Adverse Event|2|||
25334619|NCT00642616|50651107|FG001|Overall Study|Adverse Event|0|||
25334620|NCT00642616|50651108|FG002|Overall Study|Adverse Event|1|||
25334621|NCT00642616|50651109|FG003|Overall Study|Adverse Event|0|||
25334622|NCT00642616|50651106|FG000|Overall Study|Study Terminated by Sponsor|7|||
25334623|NCT00642616|50651107|FG001|Overall Study|Study Terminated by Sponsor|6|||
25334624|NCT00642616|50651108|FG002|Overall Study|Study Terminated by Sponsor|4|||
25334625|NCT00642616|50651109|FG003|Overall Study|Study Terminated by Sponsor|5|||
25334626|NCT00642616|50651106|FG000|Overall Study|Withdrawal by Subject|0|||
25334627|NCT00642616|50651107|FG001|Overall Study|Withdrawal by Subject|1|||
25334628|NCT00642616|50651108|FG002|Overall Study|Withdrawal by Subject|1|||
25334629|NCT00642616|50651109|FG003|Overall Study|Withdrawal by Subject|1|||
25334630|NCT00642616|50651106|FG000|Overall Study|Protocol Violation|0|||
25334631|NCT00642616|50651107|FG001|Overall Study|Protocol Violation|0|||
25334632|NCT00642616|50651108|FG002|Overall Study|Protocol Violation|2|||
25252319|NCT00174915|50567942|FG001|Overall Study|Adverse Event|16|||
25252320|NCT00174915|50567943|FG002|Overall Study|Adverse Event|11|||
25334633|NCT00642616|50651109|FG003|Overall Study|Protocol Violation|0|||
25334634|NCT00642616|50651106|FG000|Overall Study|Physician Decision|0|||
25252321|NCT00174915|50567944|FG003|Overall Study|Adverse Event|18|||
25252322|NCT00174915|50567945|FG004|Overall Study|Adverse Event|5|||
25252323|NCT00174915|50567941|FG000|Overall Study|Personal Reason(s)|16|||
25252324|NCT00174915|50567942|FG001|Overall Study|Personal Reason(s)|16|||
25334635|NCT00642616|50651107|FG001|Overall Study|Physician Decision|0|||
25334636|NCT00642616|50651108|FG002|Overall Study|Physician Decision|1|||
25334637|NCT00642616|50651109|FG003|Overall Study|Physician Decision|1|||
25334638|NCT03844945|50651125|FG000|Overall Study|Adverse Event|1|||
25334639|NCT03844945|50651126|FG001|Overall Study|Adverse Event|1|||
25334640|NCT03844945|50651127|FG002|Overall Study|Adverse Event|4|||
25334641|NCT03844945|50651128|FG003|Overall Study|Adverse Event|0|||
25334642|NCT03844945|50651125|FG000|Overall Study|Withdrawal by Subject|0|||
25334643|NCT03844945|50651126|FG001|Overall Study|Withdrawal by Subject|0|||
25334644|NCT03844945|50651127|FG002|Overall Study|Withdrawal by Subject|1|||
25334645|NCT03844945|50651128|FG003|Overall Study|Withdrawal by Subject|0|||
25334646|NCT03844945|50651125|FG000|Overall Study|Lack of Efficacy|0|||
25334647|NCT03844945|50651126|FG001|Overall Study|Lack of Efficacy|0|||
25334648|NCT03844945|50651127|FG002|Overall Study|Lack of Efficacy|0|||
25334649|NCT03844945|50651128|FG003|Overall Study|Lack of Efficacy|1|||
25334650|NCT00445549|50651138|FG000|Overall Study|progressive disease|12|||
25334651|NCT00445003|50651145|FG000|Overall Study|Death|1|||
25334652|NCT00445003|50651146|FG001|Overall Study|Death|2|||
25334653|NCT00445003|50651147|FG002|Overall Study|Death|1|||
25334654|NCT00445003|50651145|FG000|Overall Study|Missed Visit|3|||
25334655|NCT00445003|50651146|FG001|Overall Study|Missed Visit|5|||
25334656|NCT00445003|50651147|FG002|Overall Study|Missed Visit|1|||
25334657|NCT00445003|50651145|FG000|Overall Study|Dropped|1|||
25334658|NCT00445003|50651146|FG001|Overall Study|Dropped|3|||
25334659|NCT00445003|50651147|FG002|Overall Study|Dropped|2|||
25334660|NCT00811070|50651161|FG000|Overall Study|Death|0|||
25334661|NCT00811070|50651162|FG001|Overall Study|Death|0|||
25334662|NCT00811070|50651163|FG002|Overall Study|Death|0|||
25334663|NCT00811070|50651164|FG003|Overall Study|Death|2|||
25334664|NCT00811070|50651165|FG004|Overall Study|Death|5|||
25334665|NCT00811070|50651166|FG005|Overall Study|Death|0|||
25334666|NCT00811070|50651161|FG000|Overall Study|Other|1|||
25334667|NCT00811070|50651162|FG001|Overall Study|Other|0|||
25334668|NCT00811070|50651163|FG002|Overall Study|Other|0|||
25334669|NCT00811070|50651164|FG003|Overall Study|Other|0|||
25334670|NCT00811070|50651165|FG004|Overall Study|Other|0|||
25334671|NCT00811070|50651166|FG005|Overall Study|Other|0|||
25334672|NCT00811070|50651161|FG000|Overall Study|Withdrawal by Subject|0|||
25334673|NCT00811070|50651162|FG001|Overall Study|Withdrawal by Subject|1|||
25334674|NCT00811070|50651163|FG002|Overall Study|Withdrawal by Subject|0|||
25334675|NCT00811070|50651164|FG003|Overall Study|Withdrawal by Subject|0|||
25334676|NCT00811070|50651165|FG004|Overall Study|Withdrawal by Subject|0|||
25334677|NCT00811070|50651166|FG005|Overall Study|Withdrawal by Subject|0|||
25334678|NCT00811070|50651161|FG000|Overall Study|Physician Decision|0|||
25334679|NCT00811070|50651162|FG001|Overall Study|Physician Decision|0|||
25334680|NCT00811070|50651163|FG002|Overall Study|Physician Decision|0|||
25334681|NCT00811070|50651164|FG003|Overall Study|Physician Decision|0|||
25334682|NCT00811070|50651165|FG004|Overall Study|Physician Decision|0|||
25334683|NCT00811070|50651166|FG005|Overall Study|Physician Decision|1|||
25334684|NCT00642460|50651184|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
25334685|NCT00642460|50651185|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
25334686|NCT00642460|50651186|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
25334687|NCT00642460|50651187|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
25334688|NCT00642460|50651188|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
25334689|NCT00642460|50651189|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
25334690|NCT00642460|50651184|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
25334691|NCT00642460|50651185|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
25334692|NCT00642460|50651186|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
25334693|NCT00642460|50651187|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
25334694|NCT00642460|50651188|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
25334695|NCT00642460|50651189|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
25334696|NCT00642460|50651184|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
25334697|NCT00642460|50651185|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
25334698|NCT00642460|50651186|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
25334699|NCT00642460|50651187|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
25334700|NCT00642460|50651188|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
25334701|NCT00642460|50651189|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
25334702|NCT00642460|50651184|FG000|Part II: Open-Label Up to Week 92|Death|0|||
25334703|NCT00642460|50651185|FG001|Part II: Open-Label Up to Week 92|Death|1|||
25334704|NCT00642460|50651186|FG002|Part II: Open-Label Up to Week 92|Death|0|||
25334705|NCT00642460|50651187|FG003|Part II: Open-Label Up to Week 92|Death|2|||
25334706|NCT00642460|50651188|FG004|Part II: Open-Label Up to Week 92|Death|0|||
25334707|NCT00642460|50651189|FG005|Part II: Open-Label Up to Week 92|Death|0|||
25334708|NCT00642460|50651184|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
25334709|NCT00642460|50651185|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
25334710|NCT00642460|50651186|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
25334711|NCT00642460|50651187|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
25334712|NCT00642460|50651188|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
25334713|NCT00642460|50651189|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
25334714|NCT00642460|50651184|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
25334715|NCT00642460|50651185|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
25334716|NCT00642460|50651186|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
25334717|NCT00642460|50651187|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
25334718|NCT00642460|50651188|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
25334719|NCT00642460|50651189|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
25334720|NCT00642460|50651184|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
25334721|NCT00642460|50651185|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
25334722|NCT00642460|50651186|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
25334723|NCT00642460|50651187|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
25334724|NCT00642460|50651188|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
25334725|NCT00642460|50651189|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
25334726|NCT00642460|50651184|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
25334727|NCT00642460|50651185|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
25334728|NCT00642460|50651186|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
25334729|NCT00642460|50651187|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
25334730|NCT00642460|50651188|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
25334731|NCT00642460|50651189|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
25334732|NCT00642460|50651184|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
25334733|NCT00642460|50651185|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
25334734|NCT00642460|50651186|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
25334735|NCT00642460|50651187|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
25334736|NCT00642460|50651188|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
25334737|NCT00642460|50651189|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
25334738|NCT00642460|50651184|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
25334739|NCT00642460|50651185|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
25334740|NCT00642460|50651186|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
25334741|NCT00642460|50651187|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
25334742|NCT00642460|50651188|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
25334743|NCT00642460|50651189|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
25334744|NCT00642460|50651184|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
25334745|NCT00642460|50651185|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
25334746|NCT00642460|50651186|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
25334747|NCT00642460|50651187|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
25334748|NCT00642460|50651188|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
25334749|NCT00642460|50651189|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
25334750|NCT00642460|50651184|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
25334751|NCT00642460|50651185|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
25334752|NCT00642460|50651186|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
25334753|NCT00642460|50651187|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
25334754|NCT00642460|50651188|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
25334755|NCT00642460|50651189|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
25334756|NCT00642460|50651184|FG000|Part III: Open-Label Up to Week 260|Other|0|||
25334757|NCT00642460|50651185|FG001|Part III: Open-Label Up to Week 260|Other|0|||
25334758|NCT00642460|50651186|FG002|Part III: Open-Label Up to Week 260|Other|0|||
25334759|NCT00642460|50651187|FG003|Part III: Open-Label Up to Week 260|Other|0|||
25334760|NCT00642460|50651188|FG004|Part III: Open-Label Up to Week 260|Other|2|||
25334761|NCT00642460|50651189|FG005|Part III: Open-Label Up to Week 260|Other|2|||
25334762|NCT00642460|50651184|FG000|Part III: Open-Label Up to Week 260|Death|0|||
25252325|NCT00174915|50567943|FG002|Overall Study|Personal Reason(s)|9|||
25252326|NCT00174915|50567944|FG003|Overall Study|Personal Reason(s)|9|||
25252327|NCT00174915|50567945|FG004|Overall Study|Personal Reason(s)|9|||
25252328|NCT00174915|50567941|FG000|Overall Study|Other|15|||
25252329|NCT00174915|50567942|FG001|Overall Study|Other|8|||
25252330|NCT00174915|50567943|FG002|Overall Study|Other|6|||
25252331|NCT00174915|50567944|FG003|Overall Study|Other|5|||
25252332|NCT00174915|50567945|FG004|Overall Study|Other|3|||
25252333|NCT00174915|50567941|FG000|Overall Study|Gout Flare|13|||
25252334|NCT00174915|50567942|FG001|Overall Study|Gout Flare|6|||
25252335|NCT00174915|50567943|FG002|Overall Study|Gout Flare|8|||
25252336|NCT00174915|50567944|FG003|Overall Study|Gout Flare|1|||
25252337|NCT00174915|50567945|FG004|Overall Study|Gout Flare|0|||
25252338|NCT00174915|50567941|FG000|Overall Study|Protocol Violation|6|||
25252339|NCT00174915|50567942|FG001|Overall Study|Protocol Violation|3|||
25252340|NCT00174915|50567943|FG002|Overall Study|Protocol Violation|3|||
25252341|NCT00174915|50567944|FG003|Overall Study|Protocol Violation|6|||
25252342|NCT00174915|50567945|FG004|Overall Study|Protocol Violation|3|||
25252343|NCT00174915|50567941|FG000|Overall Study|Therapeutic Failure|6|||
25252344|NCT00174915|50567942|FG001|Overall Study|Therapeutic Failure|3|||
25252345|NCT00174915|50567943|FG002|Overall Study|Therapeutic Failure|2|||
25252346|NCT00174915|50567944|FG003|Overall Study|Therapeutic Failure|1|||
25334763|NCT00642460|50651185|FG001|Part III: Open-Label Up to Week 260|Death|0|||
25334764|NCT00642460|50651186|FG002|Part III: Open-Label Up to Week 260|Death|0|||
25334765|NCT00642460|50651187|FG003|Part III: Open-Label Up to Week 260|Death|0|||
25334766|NCT00642460|50651188|FG004|Part III: Open-Label Up to Week 260|Death|0|||
25334767|NCT00642460|50651189|FG005|Part III: Open-Label Up to Week 260|Death|3|||
25334768|NCT00642460|50651184|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
25334769|NCT00642460|50651185|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
25252347|NCT00174915|50567945|FG004|Overall Study|Therapeutic Failure|3|||
25252348|NCT01080716|50567961|FG000|Part 1|Physician Decision|1|||
25252349|NCT01080716|50567962|FG001|Part 1|Physician Decision|0|||
25252350|NCT01080716|50567963|FG002|Part 1|Physician Decision|0|||
25252351|NCT01080716|50567964|FG003|Part 1|Physician Decision|0|||
25334770|NCT00642460|50651186|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
25334771|NCT00642460|50651187|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
25334772|NCT00642460|50651188|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
25334773|NCT00642460|50651189|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
25334774|NCT00642460|50651184|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
25334775|NCT00642460|50651185|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
25334776|NCT00642460|50651186|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
25334777|NCT00642460|50651187|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
25334778|NCT00642460|50651188|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
25334779|NCT00642460|50651189|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
25334780|NCT00814658|50651201|FG000|Overall Study|Lost to Follow-up|0|||
25334781|NCT00814658|50651202|FG001|Overall Study|Lost to Follow-up|1|||
25334782|NCT00814658|50651201|FG000|Overall Study|Physician Decision|1|||
25334783|NCT00814658|50651202|FG001|Overall Study|Physician Decision|0|||
25252352|NCT00172185|50567982|FG000|Overall Study|Adverse Event|0|||
25252353|NCT00172185|50567983|FG001|Overall Study|Adverse Event|1|||
25252354|NCT00172185|50567984|FG002|Overall Study|Adverse Event|3|||
25334784|NCT00814658|50651201|FG000|Overall Study|Adverse Event|3|||
25334785|NCT00814658|50651202|FG001|Overall Study|Adverse Event|3|||
25334786|NCT00642304|50651218|FG000|Overall Study|Adverse Event|1|||
25334787|NCT00642304|50651218|FG000|Overall Study|Death|1|||
25334788|NCT00642304|50651218|FG000|Overall Study|Blood transfusion|2|||
25334789|NCT00642304|50651218|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
25334790|NCT00642304|50651218|FG000|Overall Study|Transplantation|1|||
25334791|NCT00814580|50651224|FG000|Overall Study|Adverse Event|6|||
25334792|NCT00814580|50651225|FG001|Overall Study|Adverse Event|15|||
25334793|NCT00814580|50651224|FG000|Overall Study|Lack of Efficacy|18|||
25334794|NCT00814580|50651225|FG001|Overall Study|Lack of Efficacy|25|||
25334795|NCT00814580|50651224|FG000|Overall Study|Protocol Violation|2|||
25334796|NCT00814580|50651225|FG001|Overall Study|Protocol Violation|0|||
25334797|NCT00814580|50651224|FG000|Overall Study|Withdrawal by Subject|2|||
25334798|NCT00814580|50651225|FG001|Overall Study|Withdrawal by Subject|2|||
25334799|NCT00814580|50651224|FG000|Overall Study|Other|1|||
25334800|NCT00814580|50651225|FG001|Overall Study|Other|3|||
25334801|NCT00814580|50651224|FG000|Overall Study|Did Not Take Drug|2|||
25334802|NCT00814580|50651225|FG001|Overall Study|Did Not Take Drug|2|||
25334803|NCT00643162|50651245|FG000|Overall Study|Withdrawal by Subject|1|||
25334804|NCT00643162|50651246|FG001|Overall Study|Withdrawal by Subject|1|||
25334805|NCT00643006|50651254|FG000|Overall Study|Lost to Follow-up|5|||
25334806|NCT00643006|50651255|FG001|Overall Study|Lost to Follow-up|4|||
25334807|NCT00814502|50651265|FG000|Overall Study|Adverse Event|1|||
25334808|NCT00814502|50651266|FG001|Overall Study|Adverse Event|0|||
25334809|NCT00814502|50651265|FG000|Overall Study|Withdrawal by Subject|0|||
25334810|NCT00814502|50651266|FG001|Overall Study|Withdrawal by Subject|2|||
25334811|NCT00653224|50651276|FG000|Overall Study|Adverse Event|2|||
25334812|NCT00653224|50651277|FG001|Overall Study|Adverse Event|1|||
25334813|NCT00653224|50651276|FG000|Overall Study|Lack of Efficacy|1|||
24901843|NCT00716144|49995854|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
24901844|NCT00716144|49995855|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
24901845|NCT00716144|49995856|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
24901846|NCT00716144|49995853|FG000|Overall Study|Adverse event: left foot pain|0|||
24901847|NCT00716144|49995854|FG001|Overall Study|Adverse event: left foot pain|1|||
24901848|NCT00716144|49995855|FG002|Overall Study|Adverse event: left foot pain|0|||
25252355|NCT00172185|50567985|FG003|Overall Study|Adverse Event|4|||
25334814|NCT00653224|50651277|FG001|Overall Study|Lack of Efficacy|2|||
25334815|NCT00653224|50651276|FG000|Overall Study|Loss of efficacy|1|||
25334816|NCT00653224|50651277|FG001|Overall Study|Loss of efficacy|0|||
25334817|NCT00653224|50651276|FG000|Overall Study|Lost to Follow-up|1|||
24901849|NCT00716144|49995856|FG003|Overall Study|Adverse event: left foot pain|0|||
25252356|NCT00172185|50567982|FG000|Overall Study|Physician Decision|0|||
25334818|NCT00653224|50651277|FG001|Overall Study|Lost to Follow-up|0|||
25334819|NCT00653224|50651276|FG000|Overall Study|Other|2|||
25252357|NCT00172185|50567983|FG001|Overall Study|Physician Decision|0|||
25252358|NCT00172185|50567984|FG002|Overall Study|Physician Decision|1|||
25334820|NCT00653224|50651277|FG001|Overall Study|Other|4|||
25334821|NCT00444925|50651286|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
25334822|NCT00444925|50651287|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
25334823|NCT00444925|50651288|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
25334824|NCT00444925|50651286|FG000|Double-blind Treatment Period|Death|2|||
25334825|NCT00444925|50651287|FG001|Double-blind Treatment Period|Death|0|||
25334826|NCT00444925|50651288|FG002|Double-blind Treatment Period|Death|0|||
25334827|NCT00444925|50651286|FG000|Double-blind Treatment Period|Adverse Event|6|||
25334828|NCT00444925|50651287|FG001|Double-blind Treatment Period|Adverse Event|28|||
25334829|NCT00444925|50651288|FG002|Double-blind Treatment Period|Adverse Event|44|||
25334830|NCT00444925|50651286|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
25334831|NCT00444925|50651287|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
25334832|NCT00444925|50651288|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
25334833|NCT00444925|50651286|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
25334834|NCT00444925|50651287|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
25334835|NCT00444925|50651288|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
25334836|NCT00444925|50651286|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
25334837|NCT00444925|50651287|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
25334838|NCT00444925|50651288|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
25334839|NCT00444925|50651286|FG000|Double-blind Treatment Period|Other|7|||
25334840|NCT00444925|50651287|FG001|Double-blind Treatment Period|Other|7|||
25334841|NCT00444925|50651288|FG002|Double-blind Treatment Period|Other|12|||
25334842|NCT00641056|50651298|FG000|Overall Study|Adverse Event|12|||
25334843|NCT00641056|50651299|FG001|Overall Study|Adverse Event|2|||
25334844|NCT00641056|50651298|FG000|Overall Study|Lost to Follow-up|2|||
25334845|NCT00641056|50651299|FG001|Overall Study|Lost to Follow-up|1|||
25334846|NCT00641056|50651298|FG000|Overall Study|Physician Decision|3|||
25334847|NCT00641056|50651299|FG001|Overall Study|Physician Decision|1|||
25334848|NCT00641056|50651298|FG000|Overall Study|Protocol Violation|2|||
25334849|NCT00641056|50651299|FG001|Overall Study|Protocol Violation|0|||
25334850|NCT00641056|50651298|FG000|Overall Study|Entry Criteria Not Met|3|||
25334851|NCT00641056|50651299|FG001|Overall Study|Entry Criteria Not Met|0|||
25334852|NCT00641056|50651298|FG000|Overall Study|Subject Decision|6|||
25334853|NCT00641056|50651299|FG001|Overall Study|Subject Decision|19|||
25334854|NCT00641056|50651298|FG000|Overall Study|Sponsor Decision|1|||
25334855|NCT00641056|50651299|FG001|Overall Study|Sponsor Decision|2|||
25334856|NCT00814346|50651311|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
25334857|NCT00814346|50651312|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
25334858|NCT00814346|50651311|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
25334859|NCT00814346|50651312|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
25334860|NCT00814346|50651311|FG000|Open Phase (17 Months)|Adverse Event|5|||
25334861|NCT00814346|50651312|FG001|Open Phase (17 Months)|Adverse Event|0|||
25334862|NCT00814346|50651311|FG000|Open Phase (17 Months)|Consent|2|||
25334863|NCT00814346|50651312|FG001|Open Phase (17 Months)|Consent|0|||
25334864|NCT00814346|50651311|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
25334865|NCT00814346|50651312|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
25334866|NCT00814346|50651311|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
25334867|NCT00814346|50651312|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
25334868|NCT00569374|50651331|FG000|Overall Study|Withdrawal by Subject|4|||
25334869|NCT00828464|50651335|FG000|Overall Study|Withdrawal by Subject|1|||
25334870|NCT00810602|50651339|FG000|Overall Study|Withdrawal by Subject|8|||
25334871|NCT00810602|50651340|FG001|Overall Study|Withdrawal by Subject|3|||
25334872|NCT00791700|50651348|FG000|Overall Study|Insufficient clinical response|1|||
25334873|NCT00791700|50651349|FG001|Overall Study|Insufficient clinical response|4|||
25334874|NCT00791700|50651350|FG002|Overall Study|Insufficient clinical response|1|||
25334875|NCT00791700|50651351|FG003|Overall Study|Insufficient clinical response|8|||
25334876|NCT00791700|50651348|FG000|Overall Study|No longer willing to participate|1|||
25334877|NCT00791700|50651349|FG001|Overall Study|No longer willing to participate|1|||
25334878|NCT00791700|50651350|FG002|Overall Study|No longer willing to participate|0|||
25334879|NCT00791700|50651351|FG003|Overall Study|No longer willing to participate|8|||
25334880|NCT00791700|50651348|FG000|Overall Study|Non-compliance with study treatment|0|||
25334881|NCT00791700|50651349|FG001|Overall Study|Non-compliance with study treatment|2|||
25334882|NCT00791700|50651350|FG002|Overall Study|Non-compliance with study treatment|0|||
25334883|NCT00791700|50651351|FG003|Overall Study|Non-compliance with study treatment|4|||
25334884|NCT00791700|50651348|FG000|Overall Study|Withdrawn due to pregnancy|0|||
24977380|NCT00048542|50066003|FG007|Double-Blind Phase|Randomized in error|0|||
25334885|NCT00791700|50651349|FG001|Overall Study|Withdrawn due to pregnancy|0|||
25334886|NCT00791700|50651350|FG002|Overall Study|Withdrawn due to pregnancy|0|||
25334887|NCT00791700|50651351|FG003|Overall Study|Withdrawn due to pregnancy|1|||
25334888|NCT00791700|50651348|FG000|Overall Study|Other|0|||
25334889|NCT00791700|50651349|FG001|Overall Study|Other|1|||
25334890|NCT00791700|50651350|FG002|Overall Study|Other|0|||
25334891|NCT00791700|50651351|FG003|Overall Study|Other|1|||
25334892|NCT00791700|50651348|FG000|Overall Study|Death|0|||
25334893|NCT00791700|50651349|FG001|Overall Study|Death|0|||
25334894|NCT00791700|50651350|FG002|Overall Study|Death|0|||
25334895|NCT00791700|50651351|FG003|Overall Study|Death|1|||
25334896|NCT00791700|50651348|FG000|Overall Study|Lost to Follow-up|4|||
25334897|NCT00791700|50651349|FG001|Overall Study|Lost to Follow-up|3|||
24901850|NCT00716144|49995853|FG000|Overall Study|Clinical Depression|0|||
24901851|NCT00716144|49995854|FG001|Overall Study|Clinical Depression|1|||
24901852|NCT00716144|49995855|FG002|Overall Study|Clinical Depression|0|||
24901853|NCT00716144|49995856|FG003|Overall Study|Clinical Depression|0|||
24901854|NCT00576381|49995866|FG000|Overall Study|Reoperation|3|||
24901855|NCT00576381|49995866|FG000|Overall Study|Adverse Event|4|||
24901856|NCT00684567|49995870|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
24901857|NCT00684567|49995870|FG000|Monotherapy Period|Adverse Event|2|||
24901858|NCT00684567|49995870|FG000|Monotherapy Period|Death|1|||
24901859|NCT00684567|49995870|FG000|Monotherapy Period|Progression of primary disease|11|||
24901860|NCT00684411|49995874|FG000|Overall Study|New Primary Cancer|1|||
24901861|NCT00684411|49995874|FG000|Overall Study|Disease Progression|10|||
24901862|NCT00684411|49995874|FG000|Overall Study|Adverse Event|1|||
24901863|NCT00686829|49995878|FG000|Overall Study|Adverse Event|5|||
25252359|NCT00172185|50567985|FG003|Overall Study|Physician Decision|0|||
25252360|NCT00172185|50567982|FG000|Overall Study|SPONSOR Decision|0|||
25252361|NCT00172185|50567983|FG001|Overall Study|SPONSOR Decision|1|||
24901864|NCT00686829|49995878|FG000|Overall Study|Lack of Efficacy|6|||
24901865|NCT00686829|49995878|FG000|Overall Study|Lost to Follow-up|4|||
24901866|NCT00686829|49995878|FG000|Overall Study|Withdrawal by Subject|14|||
24901867|NCT00686829|49995878|FG000|Overall Study|Protocol Violation|3|||
24901868|NCT00686829|49995878|FG000|Overall Study|Sponsor discontinued VCV|47|||
24901869|NCT00687297|49995884|FG000|Randomization|Withdrawal by Subject|2|||
24901870|NCT00687297|49995885|FG001|Randomization|Withdrawal by Subject|0|||
24901871|NCT00687297|49995884|FG000|Randomization|Withdrew before treatment, ineligible|1|||
24901872|NCT00687297|49995885|FG001|Randomization|Withdrew before treatment, ineligible|1|||
24901873|NCT00687297|49995884|FG000|Induction|Withdrawal by Subject|4|||
24901874|NCT00687297|49995885|FG001|Induction|Withdrawal by Subject|4|||
24901875|NCT00687297|49995884|FG000|Induction|Adverse Event|16|||
24901876|NCT00687297|49995885|FG001|Induction|Adverse Event|15|||
24901877|NCT00687297|49995884|FG000|Induction|Death|7|||
24901878|NCT00687297|49995885|FG001|Induction|Death|11|||
24901879|NCT00687297|49995884|FG000|Induction|Lack of Efficacy|17|||
24901880|NCT00687297|49995885|FG001|Induction|Lack of Efficacy|21|||
24901881|NCT00687297|49995884|FG000|Induction|Ineligible|0|||
24901882|NCT00687297|49995885|FG001|Induction|Ineligible|1|||
24901883|NCT00687297|49995884|FG000|Induction|Patient Noncompliance|1|||
24977381|NCT00048542|50065996|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
25077895|NCT02896855|50185965|FG001|Overall Study|Death|40|||
25252362|NCT00172185|50567984|FG002|Overall Study|SPONSOR Decision|0|||
25252363|NCT00172185|50567985|FG003|Overall Study|SPONSOR Decision|0|||
25252364|NCT00172185|50567982|FG000|Overall Study|Withdrawal by Subject|0|||
25252365|NCT00172185|50567983|FG001|Overall Study|Withdrawal by Subject|0|||
25252366|NCT00172185|50567984|FG002|Overall Study|Withdrawal by Subject|1|||
25252367|NCT00172185|50567985|FG003|Overall Study|Withdrawal by Subject|0|||
25252368|NCT01080326|50567999|FG000|Overall Study|Patient deterioration prior to procedure|3|||
25252369|NCT01080326|50567999|FG000|Overall Study|Surgeon decision|1|||
25252370|NCT00171951|50568003|FG000|Overall Study|Adverse Event|1|||
25252371|NCT00171951|50568003|FG000|Overall Study|Abnormal Laboratory Values|2|||
25252372|NCT00171951|50568003|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
25252373|NCT00171951|50568003|FG000|Overall Study|Participants Withdrew Consent|3|||
25252374|NCT00171951|50568003|FG000|Overall Study|New Cancer Therapy|5|||
25252375|NCT00171951|50568003|FG000|Overall Study|Reason not Specified|2|||
25252376|NCT01080131|50568012|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
25252377|NCT01080131|50568013|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
25334898|NCT00791700|50651350|FG002|Overall Study|Lost to Follow-up|4|||
25334899|NCT00791700|50651351|FG003|Overall Study|Lost to Follow-up|6|||
25334900|NCT00791700|50651348|FG000|Overall Study|Adverse Event|0|||
25334901|NCT00791700|50651349|FG001|Overall Study|Adverse Event|0|||
25334902|NCT00791700|50651350|FG002|Overall Study|Adverse Event|1|||
25334903|NCT00791700|50651351|FG003|Overall Study|Adverse Event|1|||
25334904|NCT00810368|50651374|FG000|Overall Study|Lost to Follow-up|4|||
25334905|NCT00810368|50651375|FG001|Overall Study|Lost to Follow-up|2|||
24901884|NCT00687297|49995885|FG001|Induction|Patient Noncompliance|0|||
24901885|NCT00687297|49995884|FG000|Induction|Physician Decision|0|||
24901886|NCT00687297|49995885|FG001|Induction|Physician Decision|2|||
24901887|NCT00687297|49995884|FG000|Induction|Other|0|||
24901888|NCT00687297|49995885|FG001|Induction|Other|1|||
24901889|NCT00684177|49995895|FG000|Overall Study|Adverse Event|4|||
24901890|NCT00684177|49995896|FG001|Overall Study|Adverse Event|3|||
24901891|NCT00684177|49995895|FG000|Overall Study|Lack of Efficacy|10|||
25252378|NCT01080131|50568012|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
25252379|NCT01080131|50568013|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
25252380|NCT01080131|50568012|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
25334906|NCT00810368|50651374|FG000|Overall Study|Lack of Efficacy|2|||
25334907|NCT00810368|50651375|FG001|Overall Study|Lack of Efficacy|0|||
25334908|NCT00628108|50651385|FG000|Overall Study|Adverse Event|0|||
25334909|NCT00628108|50651386|FG001|Overall Study|Adverse Event|3|||
25334910|NCT00628108|50651385|FG000|Overall Study|Withdrawal by Subject|1|||
25334911|NCT00628108|50651386|FG001|Overall Study|Withdrawal by Subject|0|||
25334912|NCT00628030|50651394|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
25334913|NCT00628030|50651395|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
25334914|NCT00628030|50651394|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
25334915|NCT00628030|50651395|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
25334916|NCT00628030|50651394|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
25334917|NCT00628030|50651395|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
25334918|NCT00591578|50651404|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
25334919|NCT00591578|50651405|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
25334920|NCT00591578|50651406|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
25334921|NCT00591578|50651404|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
25334922|NCT00591578|50651405|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
25334923|NCT00591578|50651406|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
25334924|NCT00591578|50651404|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
25334925|NCT00591578|50651405|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
25334926|NCT00591578|50651406|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
25334927|NCT00591578|50651404|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
25334928|NCT00591578|50651405|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
25334929|NCT00591578|50651406|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
25334930|NCT00591578|50651404|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
25334931|NCT00591578|50651405|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
25334932|NCT00591578|50651406|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
25334933|NCT00591578|50651404|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
25334934|NCT00591578|50651405|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
25334935|NCT00591578|50651406|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
25334936|NCT00591578|50651404|FG000|Double-Blind Treatment Phase|Other|4|||
25334937|NCT00591578|50651405|FG001|Double-Blind Treatment Phase|Other|9|||
25334938|NCT00591578|50651406|FG002|Double-Blind Treatment Phase|Other|4|||
25334939|NCT00591578|50651404|FG000|Open-Label Extension Phase|Adverse Event|3|||
25334940|NCT00591578|50651405|FG001|Open-Label Extension Phase|Adverse Event|5|||
25334941|NCT00591578|50651406|FG002|Open-Label Extension Phase|Adverse Event|0|||
25334942|NCT00591578|50651404|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
25252381|NCT01080131|50568013|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
25252382|NCT01080131|50568012|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
25252383|NCT01080131|50568013|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
25252384|NCT01080131|50568012|FG000|Core Study (0- 12 Weeks)|Death|1|||
25252385|NCT01080131|50568013|FG001|Core Study (0- 12 Weeks)|Death|0|||
25252386|NCT01080131|50568012|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
25252387|NCT01080131|50568013|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
25252388|NCT01080131|50568012|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
25252389|NCT01080131|50568013|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
25252390|NCT01080131|50568012|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
25252391|NCT01080131|50568013|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
25252392|NCT01080131|50568012|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
25252393|NCT01080131|50568013|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
25252394|NCT01080131|50568012|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
25252395|NCT01080131|50568013|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
25252396|NCT01080131|50568012|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
25252397|NCT01080131|50568013|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
25252398|NCT01080131|50568012|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
25334943|NCT00591578|50651405|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
25334944|NCT00591578|50651406|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
25334945|NCT00591578|50651404|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
25334946|NCT00591578|50651405|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
25334947|NCT00591578|50651406|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
25334948|NCT00591578|50651404|FG000|Open-Label Extension Phase|Other|1|||
25334949|NCT00591578|50651405|FG001|Open-Label Extension Phase|Other|0|||
25334950|NCT00591578|50651406|FG002|Open-Label Extension Phase|Other|0|||
25334951|NCT00797862|50651418|FG000|Overall Study|Adverse Event|86|||
25334952|NCT00797862|50651419|FG001|Overall Study|Adverse Event|44|||
25334953|NCT00797862|50651420|FG002|Overall Study|Adverse Event|58|||
24901892|NCT00684177|49995896|FG001|Overall Study|Lack of Efficacy|15|||
25334954|NCT00797862|50651418|FG000|Overall Study|Abnormal Test Procedure Result|0|||
25334955|NCT00797862|50651419|FG001|Overall Study|Abnormal Test Procedure Result|1|||
25334956|NCT00797862|50651420|FG002|Overall Study|Abnormal Test Procedure Result|1|||
25334957|NCT00797862|50651418|FG000|Overall Study|Lack of Efficacy|1|||
25334958|NCT00797862|50651419|FG001|Overall Study|Lack of Efficacy|7|||
25334959|NCT00797862|50651420|FG002|Overall Study|Lack of Efficacy|6|||
25334960|NCT00797862|50651418|FG000|Overall Study|No longer required study medication|1|||
25334961|NCT00797862|50651419|FG001|Overall Study|No longer required study medication|0|||
25334962|NCT00797862|50651420|FG002|Overall Study|No longer required study medication|0|||
25334963|NCT00797862|50651418|FG000|Overall Study|Withdrawal by Subject|14|||
25334964|NCT00797862|50651419|FG001|Overall Study|Withdrawal by Subject|7|||
25334965|NCT00797862|50651420|FG002|Overall Study|Withdrawal by Subject|7|||
25334966|NCT00797862|50651418|FG000|Overall Study|Lost to Follow-up|11|||
25334967|NCT00797862|50651419|FG001|Overall Study|Lost to Follow-up|0|||
25334968|NCT00797862|50651420|FG002|Overall Study|Lost to Follow-up|5|||
25334969|NCT00797862|50651418|FG000|Overall Study|Administrative Problem|4|||
25334970|NCT00797862|50651419|FG001|Overall Study|Administrative Problem|0|||
25334971|NCT00797862|50651420|FG002|Overall Study|Administrative Problem|0|||
25334972|NCT00797862|50651418|FG000|Overall Study|Protocol Violation|4|||
25334973|NCT00797862|50651419|FG001|Overall Study|Protocol Violation|6|||
25334974|NCT00797862|50651420|FG002|Overall Study|Protocol Violation|8|||
25334975|NCT00797862|50651418|FG000|Overall Study|Mis-randomized|3|||
25334976|NCT00797862|50651419|FG001|Overall Study|Mis-randomized|3|||
25334977|NCT00797862|50651420|FG002|Overall Study|Mis-randomized|1|||
25334978|NCT00794820|50651428|FG000|Overall Study|Adverse Event|11|||
25334979|NCT00794820|50651428|FG000|Overall Study|Secondary Malignancies|2|||
25334980|NCT00794820|50651428|FG000|Overall Study|Resistant Disease|2|||
25334981|NCT00794820|50651428|FG000|Overall Study|Ineligible/Screen Failure|1|||
25334982|NCT00455533|50651434|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
25334983|NCT00455533|50651435|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
25334984|NCT00455533|50651436|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
25334985|NCT00455533|50651434|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
25334986|NCT00455533|50651435|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
25334987|NCT00455533|50651436|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
25334988|NCT00455533|50651434|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
25334989|NCT00455533|50651435|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
25334990|NCT00455533|50651436|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
25334991|NCT00455533|50651434|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
25334992|NCT00455533|50651435|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
25252399|NCT01080131|50568013|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
25252400|NCT01080131|50568012|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
25252401|NCT01080131|50568013|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
25252402|NCT00171873|50568039|FG000|Overall Study|Withdrawal by Subject|4|||
25252403|NCT00171873|50568040|FG001|Overall Study|Withdrawal by Subject|2|||
25252404|NCT00171873|50568039|FG000|Overall Study|Adverse Event|5|||
25252405|NCT00171873|50568040|FG001|Overall Study|Adverse Event|0|||
25252406|NCT00171873|50568039|FG000|Overall Study|Switched to Octreotide|0|||
25252407|NCT00171873|50568040|FG001|Overall Study|Switched to Octreotide|1|||
25252408|NCT00171834|50568053|FG000|Overall Study|Adverse Event|2|||
25252409|NCT00171834|50568054|FG001|Overall Study|Adverse Event|1|||
25334993|NCT00455533|50651436|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
25334994|NCT00455533|50651434|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
25334995|NCT00455533|50651435|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
25334996|NCT00455533|50651436|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
25334997|NCT00455533|50651434|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
25334998|NCT00455533|50651435|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
24901893|NCT00684177|49995895|FG000|Overall Study|Protocol Violation|1|||
24901894|NCT00684177|49995896|FG001|Overall Study|Protocol Violation|0|||
24901895|NCT00684177|49995895|FG000|Overall Study|Lost to Follow-up|2|||
25252410|NCT00171834|50568055|FG002|Overall Study|Adverse Event|3|||
25252411|NCT00171834|50568056|FG003|Overall Study|Adverse Event|2|||
25252412|NCT00171834|50568057|FG004|Overall Study|Adverse Event|2|||
25252413|NCT00171834|50568058|FG005|Overall Study|Adverse Event|15|||
25252414|NCT00171834|50568059|FG006|Overall Study|Adverse Event|1|||
25252415|NCT00171834|50568053|FG000|Overall Study|Withdrawal by Subject|0|||
25252416|NCT00171834|50568054|FG001|Overall Study|Withdrawal by Subject|2|||
25252417|NCT00171834|50568055|FG002|Overall Study|Withdrawal by Subject|0|||
25252418|NCT00171834|50568056|FG003|Overall Study|Withdrawal by Subject|1|||
25252419|NCT00171834|50568057|FG004|Overall Study|Withdrawal by Subject|1|||
25252420|NCT00171834|50568058|FG005|Overall Study|Withdrawal by Subject|1|||
25252421|NCT00171834|50568059|FG006|Overall Study|Withdrawal by Subject|0|||
25252422|NCT00171834|50568053|FG000|Overall Study|Death from study indication|0|||
25252423|NCT00171834|50568054|FG001|Overall Study|Death from study indication|1|||
25252424|NCT00171834|50568055|FG002|Overall Study|Death from study indication|0|||
25252425|NCT00171834|50568056|FG003|Overall Study|Death from study indication|0|||
25334999|NCT00455533|50651436|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
24901896|NCT00684177|49995896|FG001|Overall Study|Lost to Follow-up|1|||
25335000|NCT00455533|50651434|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
25252426|NCT00171834|50568057|FG004|Overall Study|Death from study indication|1|||
25252427|NCT00171834|50568058|FG005|Overall Study|Death from study indication|0|||
25252428|NCT00171834|50568059|FG006|Overall Study|Death from study indication|0|||
25252429|NCT00171834|50568053|FG000|Overall Study|Disease Progression|4|||
25252430|NCT00171834|50568054|FG001|Overall Study|Disease Progression|8|||
25252431|NCT00171834|50568055|FG002|Overall Study|Disease Progression|8|||
25252432|NCT00171834|50568056|FG003|Overall Study|Disease Progression|9|||
25252433|NCT00171834|50568057|FG004|Overall Study|Disease Progression|2|||
25252434|NCT00171834|50568058|FG005|Overall Study|Disease Progression|18|||
25252435|NCT00171834|50568059|FG006|Overall Study|Disease Progression|3|||
25252436|NCT00171834|50568053|FG000|Overall Study|Treatment Duration Completed|0|||
25252437|NCT00171834|50568054|FG001|Overall Study|Treatment Duration Completed|0|||
25252438|NCT00171834|50568055|FG002|Overall Study|Treatment Duration Completed|1|||
25252439|NCT00171834|50568056|FG003|Overall Study|Treatment Duration Completed|0|||
25252440|NCT00171834|50568057|FG004|Overall Study|Treatment Duration Completed|2|||
25252441|NCT00171834|50568058|FG005|Overall Study|Treatment Duration Completed|1|||
25252442|NCT00171834|50568059|FG006|Overall Study|Treatment Duration Completed|0|||
25252443|NCT00171249|50568089|FG000|Overall Study|Withdrawal by Subject|2|||
25335001|NCT00455533|50651435|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
25335002|NCT00455533|50651436|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
25335003|NCT00455533|50651434|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
25335004|NCT00455533|50651435|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
25335005|NCT00455533|50651436|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
25335006|NCT00455533|50651434|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
25335007|NCT00455533|50651435|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
25335008|NCT00455533|50651436|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
25252444|NCT00171249|50568090|FG001|Overall Study|Withdrawal by Subject|0|||
25335009|NCT00455533|50651434|FG000|Period Two: Randomized Period|Death|0|||
25335010|NCT00455533|50651435|FG001|Period Two: Randomized Period|Death|0|||
25335011|NCT00455533|50651436|FG002|Period Two: Randomized Period|Death|3|||
25335012|NCT00455533|50651434|FG000|Period Two: Randomized Period|Disease Progression|0|||
25335013|NCT00455533|50651435|FG001|Period Two: Randomized Period|Disease Progression|1|||
25335014|NCT00455533|50651436|FG002|Period Two: Randomized Period|Disease Progression|1|||
25335015|NCT00455533|50651434|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
25335016|NCT00455533|50651435|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
25335017|NCT00455533|50651436|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
25335018|NCT00455533|50651434|FG000|Period Two: Randomized Period|Other - need reasons|0|||
25335019|NCT00455533|50651435|FG001|Period Two: Randomized Period|Other - need reasons|1|||
25335020|NCT00455533|50651436|FG002|Period Two: Randomized Period|Other - need reasons|0|||
25252445|NCT00171249|50568091|FG002|Overall Study|Withdrawal by Subject|0|||
25252446|NCT00171249|50568092|FG003|Overall Study|Withdrawal by Subject|6|||
25252447|NCT00171249|50568093|FG004|Overall Study|Withdrawal by Subject|0|||
25252448|NCT00171249|50568094|FG005|Overall Study|Withdrawal by Subject|0|||
25252449|NCT00171249|50568095|FG006|Overall Study|Withdrawal by Subject|0|||
25252450|NCT00171249|50568089|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
25252451|NCT00171249|50568090|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
25335021|NCT00455533|50651434|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
25335022|NCT00455533|50651435|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
25335023|NCT00455533|50651436|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
25335024|NCT00455533|50651434|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
25335025|NCT00455533|50651435|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
25335026|NCT00455533|50651436|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
25335027|NCT00627094|50651446|FG000|Overall Study|Adverse Event|8|||
25335028|NCT00627094|50651447|FG001|Overall Study|Adverse Event|7|||
25335029|NCT00627094|50651446|FG000|Overall Study|Lost to Follow-up|1|||
25335030|NCT00627094|50651447|FG001|Overall Study|Lost to Follow-up|0|||
25335031|NCT00627094|50651446|FG000|Overall Study|Withdrawal by Subject|1|||
25335032|NCT00627094|50651447|FG001|Overall Study|Withdrawal by Subject|1|||
25335033|NCT00627094|50651446|FG000|Overall Study|ulcer healed|1|||
25335034|NCT00627094|50651447|FG001|Overall Study|ulcer healed|7|||
25335035|NCT00627094|50651446|FG000|Overall Study|Other reason|1|||
25335036|NCT00627094|50651447|FG001|Overall Study|Other reason|0|||
25335037|NCT00642850|50651455|FG000|Overall Study|Death|7|||
25335038|NCT00642850|50651455|FG000|Overall Study|Adverse Event|2|||
25252452|NCT00171249|50568091|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
25252453|NCT00171249|50568092|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
25252454|NCT00171249|50568093|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
25252455|NCT00171249|50568094|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
25252456|NCT00171249|50568095|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
25335039|NCT00642850|50651455|FG000|Overall Study|Lack of Efficacy|1|||
25335040|NCT00642850|50651455|FG000|Overall Study|Protocol Violation|2|||
25335041|NCT00642850|50651455|FG000|Overall Study|Kidney transplantation|8|||
25335042|NCT00642850|50651455|FG000|Overall Study|Blood transfusion|6|||
25335043|NCT00642850|50651455|FG000|Overall Study|Other reasons|7|||
25335044|NCT00455455|50651459|FG000|Washout|Withdrawal by Subject|0|||
25335045|NCT00455455|50651460|FG001|Washout|Withdrawal by Subject|1|||
25335046|NCT00455455|50651459|FG000|Washout|Withdrawal by Subject|1|||
25335047|NCT00455455|50651460|FG001|Washout|Withdrawal by Subject|0|||
25335048|NCT03840811|50651472|FG000|Overall Study|Lost to Follow-up|0|||
25335049|NCT03840811|50651473|FG001|Overall Study|Lost to Follow-up|0|||
25335050|NCT03840811|50651474|FG002|Overall Study|Lost to Follow-up|1|||
25335051|NCT00640510|50651484|FG000|Overall Study|Lack of Efficacy|0|||
25335052|NCT00640510|50651485|FG001|Overall Study|Lack of Efficacy|1|||
25335053|NCT00640510|50651484|FG000|Overall Study|Protocol Violation|1|||
25335054|NCT00640510|50651485|FG001|Overall Study|Protocol Violation|0|||
25335055|NCT00640510|50651484|FG000|Overall Study|Physician Decision|0|||
25335056|NCT00640510|50651485|FG001|Overall Study|Physician Decision|1|||
25335057|NCT00813800|50651491|FG000|Overall Study|Screen Failure after Consent|2|||
25335058|NCT00813800|50651491|FG000|Overall Study|Adverse Event|1|||
25335059|NCT00813800|50651491|FG000|Overall Study|Worsening of depression|2|||
25335060|NCT00813800|50651491|FG000|Overall Study|Physician Decision|1|||
25335061|NCT00627016|50651497|FG000|Overall Study|Adverse Event|1|||
25335062|NCT00627016|50651498|FG001|Overall Study|Adverse Event|1|||
25335063|NCT00627016|50651497|FG000|Overall Study|Protocol Violation|0|||
25335064|NCT00627016|50651498|FG001|Overall Study|Protocol Violation|2|||
25335065|NCT00627016|50651497|FG000|Overall Study|Lost to Follow-up|0|||
25335066|NCT00627016|50651498|FG001|Overall Study|Lost to Follow-up|1|||
25335067|NCT00627016|50651497|FG000|Overall Study|Withdrawal by Subject|2|||
24901897|NCT00684177|49995895|FG000|Overall Study|Physician Decision|2|||
24901898|NCT00684177|49995896|FG001|Overall Study|Physician Decision|0|||
24901899|NCT00684177|49995895|FG000|Overall Study|Withdrawal by Subject|1|||
24901900|NCT00684177|49995896|FG001|Overall Study|Withdrawal by Subject|2|||
24901901|NCT00684177|49995895|FG000|Overall Study|Other|1|||
24901902|NCT00684177|49995896|FG001|Overall Study|Other|2|||
24901903|NCT00684021|49995906|FG000|Overall Study|MRI Contraindicated|1|||
24901904|NCT00684021|49995907|FG001|Overall Study|MRI Contraindicated|1|||
24901905|NCT00684021|49995908|FG002|Overall Study|MRI Contraindicated|1|||
24901906|NCT00684021|49995909|FG003|Overall Study|MRI Contraindicated|0|||
24901907|NCT00684021|49995906|FG000|Overall Study|MRI not performed|0|||
24901908|NCT00684021|49995907|FG001|Overall Study|MRI not performed|1|||
24901909|NCT00684021|49995908|FG002|Overall Study|MRI not performed|1|||
24901910|NCT00684021|49995909|FG003|Overall Study|MRI not performed|2|||
24901911|NCT00684021|49995906|FG000|Overall Study|Death|1|||
24901912|NCT00684021|49995907|FG001|Overall Study|Death|0|||
24901913|NCT00684021|49995908|FG002|Overall Study|Death|0|||
24901914|NCT00684021|49995909|FG003|Overall Study|Death|0|||
24901915|NCT00686595|49995919|FG000|Overall Study|Adverse Event|3|||
24901916|NCT00686595|49995919|FG000|Overall Study|Protocol Violation|1|||
24901917|NCT00686595|49995919|FG000|Overall Study|Lost to Follow-up|1|||
24901918|NCT00686595|49995919|FG000|Overall Study|Lack of Efficacy|1|||
24901919|NCT00686595|49995919|FG000|Overall Study|Poor Compliance|1|||
24901920|NCT00576303|49995923|FG000|Dose Titration Period|Early withdrawal|17|||
24901921|NCT00576303|49995923|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
24901922|NCT00576303|49995923|FG000|Long Term Safety Period|Early withdrawal|16|||
24901923|NCT00686517|49995930|FG000|Treatment|Serious Adverse Event|1|||
24901924|NCT00686517|49995931|FG001|Treatment|Serious Adverse Event|2|||
24901925|NCT00686517|49995932|FG002|Treatment|Serious Adverse Event|1|||
24901926|NCT00686517|49995930|FG000|Treatment|Adverse Event|2|||
24901927|NCT00686517|49995931|FG001|Treatment|Adverse Event|0|||
24901928|NCT00686517|49995932|FG002|Treatment|Adverse Event|0|||
25252457|NCT00171249|50568089|FG000|Overall Study|Death|7|||
25252458|NCT00171249|50568090|FG001|Overall Study|Death|1|||
25252459|NCT00171249|50568091|FG002|Overall Study|Death|0|||
25252460|NCT00171249|50568092|FG003|Overall Study|Death|4|||
25252461|NCT00171249|50568093|FG004|Overall Study|Death|0|||
25252462|NCT00171249|50568094|FG005|Overall Study|Death|3|||
25252463|NCT00171249|50568095|FG006|Overall Study|Death|1|||
25252464|NCT00171249|50568089|FG000|Overall Study|Other|10|||
25252465|NCT00171249|50568090|FG001|Overall Study|Other|0|||
25252466|NCT00171249|50568091|FG002|Overall Study|Other|0|||
25252467|NCT00171249|50568092|FG003|Overall Study|Other|43|||
25252468|NCT00171249|50568093|FG004|Overall Study|Other|0|||
25252469|NCT00171249|50568094|FG005|Overall Study|Other|2|||
24901929|NCT00686517|49995930|FG000|Treatment|Poor Protocol Compliance|1|||
24901930|NCT00686517|49995931|FG001|Treatment|Poor Protocol Compliance|0|||
24901931|NCT00686517|49995932|FG002|Treatment|Poor Protocol Compliance|0|||
24901932|NCT00686517|49995930|FG000|Treatment|Protocol Violation|2|||
24901933|NCT00686517|49995931|FG001|Treatment|Protocol Violation|1|||
24901934|NCT00686517|49995932|FG002|Treatment|Protocol Violation|0|||
24901935|NCT00686205|49995942|FG000|Overall Study|Protocol Violation|127|||
24901936|NCT00686205|49995943|FG001|Overall Study|Protocol Violation|0|||
25252470|NCT00171249|50568095|FG006|Overall Study|Other|0|||
25335068|NCT00627016|50651498|FG001|Overall Study|Withdrawal by Subject|1|||
25335069|NCT00627016|50651497|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
25335070|NCT00627016|50651498|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
25335071|NCT00627016|50651497|FG000|Overall Study|Lack of Efficacy|1|||
25335072|NCT00627016|50651498|FG001|Overall Study|Lack of Efficacy|0|||
25335073|NCT00627016|50651497|FG000|Overall Study|Placed on Excluded Drugs|1|||
25335074|NCT00627016|50651498|FG001|Overall Study|Placed on Excluded Drugs|0|||
25335075|NCT00627016|50651497|FG000|Overall Study|Pregnancy|1|||
25335076|NCT00627016|50651498|FG001|Overall Study|Pregnancy|0|||
25335077|NCT00794664|50651506|FG000|Treatment Period|Withdrawal by Subject|0|||
25252471|NCT00171249|50568089|FG000|Overall Study|No Longer Requires Study Drug|4|||
25252472|NCT00171249|50568090|FG001|Overall Study|No Longer Requires Study Drug|0|||
25252473|NCT00171249|50568091|FG002|Overall Study|No Longer Requires Study Drug|0|||
25252474|NCT00171249|50568092|FG003|Overall Study|No Longer Requires Study Drug|3|||
25252475|NCT00171249|50568093|FG004|Overall Study|No Longer Requires Study Drug|0|||
25252476|NCT00171249|50568094|FG005|Overall Study|No Longer Requires Study Drug|5|||
25252477|NCT00171249|50568095|FG006|Overall Study|No Longer Requires Study Drug|0|||
25252478|NCT00171249|50568089|FG000|Overall Study|Administrative Problems|1|||
25252479|NCT00171249|50568090|FG001|Overall Study|Administrative Problems|0|||
25252480|NCT00171249|50568091|FG002|Overall Study|Administrative Problems|0|||
25252481|NCT00171249|50568092|FG003|Overall Study|Administrative Problems|2|||
25252482|NCT00171249|50568093|FG004|Overall Study|Administrative Problems|0|||
25252483|NCT00171249|50568094|FG005|Overall Study|Administrative Problems|0|||
25252484|NCT00171249|50568095|FG006|Overall Study|Administrative Problems|0|||
25252485|NCT00171249|50568089|FG000|Overall Study|Adverse Event|3|||
25252486|NCT00171249|50568090|FG001|Overall Study|Adverse Event|1|||
25252487|NCT00171249|50568091|FG002|Overall Study|Adverse Event|0|||
25252488|NCT00171249|50568092|FG003|Overall Study|Adverse Event|15|||
25252489|NCT00171249|50568093|FG004|Overall Study|Adverse Event|0|||
25252490|NCT00171249|50568094|FG005|Overall Study|Adverse Event|2|||
25252491|NCT00171249|50568095|FG006|Overall Study|Adverse Event|0|||
25252492|NCT00171249|50568089|FG000|Overall Study|Lost to Follow-up|5|||
25252493|NCT00171249|50568090|FG001|Overall Study|Lost to Follow-up|0|||
25252494|NCT00171249|50568091|FG002|Overall Study|Lost to Follow-up|0|||
25252495|NCT00171249|50568092|FG003|Overall Study|Lost to Follow-up|9|||
25252496|NCT00171249|50568093|FG004|Overall Study|Lost to Follow-up|0|||
25252497|NCT00171249|50568094|FG005|Overall Study|Lost to Follow-up|0|||
25252498|NCT00171249|50568095|FG006|Overall Study|Lost to Follow-up|0|||
25252499|NCT01085630|50568106|FG000|Overall Study|Insufficient data|1|||
25252500|NCT01085630|50568107|FG001|Overall Study|Insufficient data|0|||
25252501|NCT01085630|50568106|FG000|Overall Study|Ineligible|3|||
25252502|NCT01085630|50568107|FG001|Overall Study|Ineligible|0|||
25252503|NCT00171210|50568115|FG000|Overall Study|Adverse Event|16|||
25252504|NCT00171210|50568116|FG001|Overall Study|Adverse Event|27|||
25252505|NCT00171210|50568115|FG000|Overall Study|Abnormal laboratory value(s)|6|||
25252506|NCT00171210|50568116|FG001|Overall Study|Abnormal laboratory value(s)|3|||
25252507|NCT00171210|50568115|FG000|Overall Study|Abnormal test procedure result(s)|0|||
25252508|NCT00171210|50568116|FG001|Overall Study|Abnormal test procedure result(s)|1|||
25252509|NCT00171210|50568115|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
25252510|NCT00171210|50568116|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
25252511|NCT00171210|50568115|FG000|Overall Study|Protocol Violation|0|||
25252512|NCT00171210|50568116|FG001|Overall Study|Protocol Violation|2|||
25252513|NCT00171210|50568115|FG000|Overall Study|Withdrawal by Subject|32|||
25252514|NCT00171210|50568116|FG001|Overall Study|Withdrawal by Subject|30|||
25252515|NCT00171210|50568115|FG000|Overall Study|Lost to Follow-up|1|||
25252516|NCT00171210|50568116|FG001|Overall Study|Lost to Follow-up|0|||
25335078|NCT00794664|50651507|FG001|Treatment Period|Withdrawal by Subject|2|||
25335079|NCT00794664|50651506|FG000|Treatment Period|Protocol non-compliance|0|||
25335080|NCT00794664|50651507|FG001|Treatment Period|Protocol non-compliance|1|||
25335081|NCT00794664|50651506|FG000|Treatment Period|Other|0|||
25335082|NCT00794664|50651507|FG001|Treatment Period|Other|1|||
25335083|NCT00794664|50651506|FG000|Treatment Period|Adverse Event|1|||
25335084|NCT00794664|50651507|FG001|Treatment Period|Adverse Event|8|||
25252517|NCT00171210|50568115|FG000|Overall Study|Administrative problems|1|||
25252518|NCT00171210|50568116|FG001|Overall Study|Administrative problems|1|||
25252519|NCT00171210|50568115|FG000|Overall Study|Death|2|||
25252520|NCT00171210|50568116|FG001|Overall Study|Death|3|||
25252521|NCT00171210|50568115|FG000|Overall Study|Stopped at end of core|0|||
25252522|NCT00171210|50568116|FG001|Overall Study|Stopped at end of core|32|||
25252523|NCT00171210|50568115|FG000|Overall Study|Stopped at end of extension 1|0|||
25335085|NCT00794664|50651506|FG000|Follow-up Period|Other|1|||
25335086|NCT00794664|50651507|FG001|Follow-up Period|Other|2|||
25252524|NCT00171210|50568116|FG001|Overall Study|Stopped at end of extension 1|1|||
25252525|NCT00171054|50568124|FG000|Overall Study|Protocol Violation|1|||
25252526|NCT00171054|50568125|FG001|Overall Study|Protocol Violation|2|||
25252527|NCT00171054|50568124|FG000|Overall Study|Patient withdrew consent|1|||
25335087|NCT00794664|50651506|FG000|Follow-up Period|Withdrawal by Subject|0|||
25335088|NCT00794664|50651507|FG001|Follow-up Period|Withdrawal by Subject|2|||
25335089|NCT00794664|50651506|FG000|Follow-up Period|Protocol non-compliance|0|||
25335090|NCT00794664|50651507|FG001|Follow-up Period|Protocol non-compliance|1|||
25252528|NCT00171054|50568125|FG001|Overall Study|Patient withdrew consent|0|||
25252529|NCT00171054|50568124|FG000|Overall Study|Lost to Follow-up|0|||
25252530|NCT00171054|50568125|FG001|Overall Study|Lost to Follow-up|1|||
25252531|NCT00171054|50568124|FG000|Overall Study|Adverse Event|8|||
25252532|NCT00171054|50568125|FG001|Overall Study|Adverse Event|8|||
25252533|NCT00171054|50568124|FG000|Overall Study|Condition no longer required study drug|0|||
25252534|NCT00171054|50568125|FG001|Overall Study|Condition no longer required study drug|1|||
25252535|NCT01084694|50568133|FG000|Overall Study|Withdrawal by Subject|2|||
25252536|NCT01084694|50568134|FG001|Overall Study|Withdrawal by Subject|1|||
25335091|NCT00444535|50651513|FG000|Overall Study|Withdrawal by Subject|5|||
25335092|NCT00444535|50651513|FG000|Overall Study|Physician Decision|5|||
25335093|NCT00444535|50651513|FG000|Overall Study|progressive disease|1|||
25335094|NCT00444535|50651513|FG000|Overall Study|Adverse Event|2|||
25335095|NCT00847613|50651521|FG000|Overall Study|Ongoing at cut-off date|250|||
25335096|NCT00847613|50651522|FG001|Overall Study|Ongoing at cut-off date|265|||
25335097|NCT00847613|50651523|FG002|Overall Study|Ongoing at cut-off date|64|||
24901937|NCT00686205|49995942|FG000|Overall Study|Withdrawal by Subject|2|||
24901938|NCT00686205|49995943|FG001|Overall Study|Withdrawal by Subject|0|||
24901939|NCT00686205|49995942|FG000|Overall Study|Specimen handling procedure altered|5878|||
24901940|NCT00686205|49995943|FG001|Overall Study|Specimen handling procedure altered|0|||
24901941|NCT00686205|49995942|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
24901942|NCT00686205|49995943|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
24901943|NCT00571701|49995951|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
24901944|NCT00571701|49995952|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
24901945|NCT00571701|49995951|FG000|First Intervention 12 Months|Death|1|||
24901946|NCT00571701|49995952|FG001|First Intervention 12 Months|Death|0|||
24901947|NCT00571701|49995951|FG000|Second Intervention 12 Months|Adverse Event|0|||
24901948|NCT00571701|49995952|FG001|Second Intervention 12 Months|Adverse Event|1|||
24901949|NCT00571701|49995951|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
24901950|NCT00571701|49995952|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
24901951|NCT00686127|49995978|FG000|Overall Study|Withdrawal by Subject|14|||
24901952|NCT00686127|49995979|FG001|Overall Study|Withdrawal by Subject|6|||
24901953|NCT00718718|49995992|FG000|Prior to Week 12|Adverse Event|0|||
24901954|NCT00718718|49995993|FG001|Prior to Week 12|Adverse Event|0|||
24901955|NCT00718718|49995994|FG002|Prior to Week 12|Adverse Event|0|||
24901956|NCT00718718|49995995|FG003|Prior to Week 12|Adverse Event|0|||
24901957|NCT00718718|49995996|FG004|Prior to Week 12|Adverse Event|0|||
24901958|NCT00718718|49995997|FG005|Prior to Week 12|Adverse Event|0|||
24901959|NCT00718718|49995998|FG006|Prior to Week 12|Adverse Event|0|||
24901960|NCT00718718|49995999|FG007|Prior to Week 12|Adverse Event|1|||
24901961|NCT00718718|49996000|FG008|Prior to Week 12|Adverse Event|1|||
24901962|NCT00718718|49996001|FG009|Prior to Week 12|Adverse Event|0|||
24901963|NCT00718718|49995992|FG000|Prior to Week 12|Withdrawal by Subject|0|||
24901964|NCT00718718|49995993|FG001|Prior to Week 12|Withdrawal by Subject|0|||
24901965|NCT00718718|49995994|FG002|Prior to Week 12|Withdrawal by Subject|0|||
24901966|NCT00718718|49995995|FG003|Prior to Week 12|Withdrawal by Subject|0|||
24901967|NCT00718718|49995996|FG004|Prior to Week 12|Withdrawal by Subject|3|||
24901968|NCT00718718|49995997|FG005|Prior to Week 12|Withdrawal by Subject|0|||
24901969|NCT00718718|49995998|FG006|Prior to Week 12|Withdrawal by Subject|1|||
25252537|NCT01084694|50568133|FG000|Overall Study|Death|2|||
25252538|NCT01084694|50568134|FG001|Overall Study|Death|12|||
25252539|NCT01084694|50568133|FG000|Overall Study|eligibility not maintained|2|||
25252540|NCT01084694|50568134|FG001|Overall Study|eligibility not maintained|7|||
25252541|NCT00479856|50568148|FG000|Overall Study|Adverse Event|1|||
25252542|NCT00479856|50568148|FG000|Overall Study|Withdrawal by Subject|1|||
25252543|NCT00479856|50568148|FG000|Overall Study|Physician Decision|1|||
25252544|NCT00479466|50568158|FG000|Overall Study|Adverse Event|5|||
25252545|NCT00479466|50568159|FG001|Overall Study|Adverse Event|1|||
25252546|NCT00479466|50568160|FG002|Overall Study|Adverse Event|0|||
25252547|NCT00479466|50568161|FG003|Overall Study|Adverse Event|1|||
25252548|NCT00479466|50568162|FG004|Overall Study|Adverse Event|2|||
25252549|NCT00479466|50568163|FG005|Overall Study|Adverse Event|0|||
25252550|NCT00479466|50568158|FG000|Overall Study|Hyperglycemia|0|||
25252551|NCT00479466|50568159|FG001|Overall Study|Hyperglycemia|0|||
25252552|NCT00479466|50568160|FG002|Overall Study|Hyperglycemia|0|||
25252553|NCT00479466|50568161|FG003|Overall Study|Hyperglycemia|0|||
25252554|NCT00479466|50568162|FG004|Overall Study|Hyperglycemia|0|||
25252555|NCT00479466|50568163|FG005|Overall Study|Hyperglycemia|1|||
25252556|NCT00479466|50568158|FG000|Overall Study|Lack of Efficacy|2|||
25252557|NCT00479466|50568159|FG001|Overall Study|Lack of Efficacy|0|||
25335098|NCT00847613|50651524|FG003|Overall Study|Ongoing at cut-off date|64|||
25335099|NCT00847613|50651521|FG000|Overall Study|Death|1|||
25335100|NCT00847613|50651522|FG001|Overall Study|Death|1|||
24901970|NCT00718718|49995999|FG007|Prior to Week 12|Withdrawal by Subject|1|||
24901971|NCT00718718|49996000|FG008|Prior to Week 12|Withdrawal by Subject|1|||
24901972|NCT00718718|49996001|FG009|Prior to Week 12|Withdrawal by Subject|0|||
24901973|NCT00718718|49995992|FG000|Prior to Week 12|Other|1|||
25252558|NCT00479466|50568160|FG002|Overall Study|Lack of Efficacy|1|||
25252559|NCT00479466|50568161|FG003|Overall Study|Lack of Efficacy|0|||
25252560|NCT00479466|50568162|FG004|Overall Study|Lack of Efficacy|0|||
25252561|NCT00479466|50568163|FG005|Overall Study|Lack of Efficacy|0|||
25252562|NCT00479466|50568158|FG000|Overall Study|Lost to Follow-up|0|||
25252563|NCT00479466|50568159|FG001|Overall Study|Lost to Follow-up|1|||
25252564|NCT00479466|50568160|FG002|Overall Study|Lost to Follow-up|1|||
25252565|NCT00479466|50568161|FG003|Overall Study|Lost to Follow-up|0|||
25252566|NCT00479466|50568162|FG004|Overall Study|Lost to Follow-up|2|||
25252567|NCT00479466|50568163|FG005|Overall Study|Lost to Follow-up|2|||
25252568|NCT00479466|50568158|FG000|Overall Study|Physician Decision|2|||
25252569|NCT00479466|50568159|FG001|Overall Study|Physician Decision|1|||
25252570|NCT00479466|50568160|FG002|Overall Study|Physician Decision|1|||
25252571|NCT00479466|50568161|FG003|Overall Study|Physician Decision|0|||
25252572|NCT00479466|50568162|FG004|Overall Study|Physician Decision|0|||
25252573|NCT00479466|50568163|FG005|Overall Study|Physician Decision|0|||
25252574|NCT00479466|50568158|FG000|Overall Study|Pregnancy|0|||
25335101|NCT00847613|50651523|FG002|Overall Study|Death|0|||
25335102|NCT00847613|50651524|FG003|Overall Study|Death|0|||
25335103|NCT00847613|50651521|FG000|Overall Study|Adverse Event|36|||
25335104|NCT00847613|50651522|FG001|Overall Study|Adverse Event|26|||
25335105|NCT00847613|50651523|FG002|Overall Study|Adverse Event|5|||
25335106|NCT00847613|50651524|FG003|Overall Study|Adverse Event|6|||
25252575|NCT00479466|50568159|FG001|Overall Study|Pregnancy|0|||
25252576|NCT00479466|50568160|FG002|Overall Study|Pregnancy|0|||
25252577|NCT00479466|50568161|FG003|Overall Study|Pregnancy|0|||
25252578|NCT00479466|50568162|FG004|Overall Study|Pregnancy|1|||
25252579|NCT00479466|50568163|FG005|Overall Study|Pregnancy|0|||
25252580|NCT00479466|50568158|FG000|Overall Study|Protocol Violation|1|||
25252581|NCT00479466|50568159|FG001|Overall Study|Protocol Violation|0|||
25252582|NCT00479466|50568160|FG002|Overall Study|Protocol Violation|0|||
25252583|NCT00479466|50568161|FG003|Overall Study|Protocol Violation|0|||
25252584|NCT00479466|50568162|FG004|Overall Study|Protocol Violation|0|||
25252585|NCT00479466|50568163|FG005|Overall Study|Protocol Violation|0|||
25252586|NCT00479466|50568158|FG000|Overall Study|Withdrawal by Subject|3|||
25252587|NCT00479466|50568159|FG001|Overall Study|Withdrawal by Subject|5|||
25252588|NCT00479466|50568160|FG002|Overall Study|Withdrawal by Subject|0|||
25252589|NCT00479466|50568161|FG003|Overall Study|Withdrawal by Subject|2|||
25252590|NCT00479466|50568162|FG004|Overall Study|Withdrawal by Subject|3|||
25252591|NCT00479466|50568163|FG005|Overall Study|Withdrawal by Subject|1|||
25335107|NCT00847613|50651521|FG000|Overall Study|Lack of Efficacy|7|||
25335108|NCT00847613|50651522|FG001|Overall Study|Lack of Efficacy|3|||
25335109|NCT00847613|50651523|FG002|Overall Study|Lack of Efficacy|3|||
25335110|NCT00847613|50651524|FG003|Overall Study|Lack of Efficacy|1|||
25335111|NCT00847613|50651521|FG000|Overall Study|Study terminated by Sponsor|1|||
24901974|NCT00718718|49995993|FG001|Prior to Week 12|Other|0|||
24901975|NCT00718718|49995994|FG002|Prior to Week 12|Other|1|||
24901976|NCT00718718|49995995|FG003|Prior to Week 12|Other|0|||
25335112|NCT00847613|50651522|FG001|Overall Study|Study terminated by Sponsor|0|||
25335113|NCT00847613|50651523|FG002|Overall Study|Study terminated by Sponsor|2|||
25335114|NCT00847613|50651524|FG003|Overall Study|Study terminated by Sponsor|1|||
25335115|NCT00847613|50651521|FG000|Overall Study|Lost to Follow-up|5|||
25335116|NCT00847613|50651522|FG001|Overall Study|Lost to Follow-up|0|||
25335117|NCT00847613|50651523|FG002|Overall Study|Lost to Follow-up|0|||
25335118|NCT00847613|50651524|FG003|Overall Study|Lost to Follow-up|3|||
25335119|NCT00847613|50651521|FG000|Overall Study|Protocol Violation|6|||
25335120|NCT00847613|50651522|FG001|Overall Study|Protocol Violation|6|||
25335121|NCT00847613|50651523|FG002|Overall Study|Protocol Violation|3|||
25335122|NCT00847613|50651524|FG003|Overall Study|Protocol Violation|1|||
24901977|NCT00718718|49995996|FG004|Prior to Week 12|Other|0|||
24901978|NCT00718718|49995997|FG005|Prior to Week 12|Other|0|||
24901979|NCT00718718|49995998|FG006|Prior to Week 12|Other|0|||
24901980|NCT00718718|49995999|FG007|Prior to Week 12|Other|0|||
24901981|NCT00718718|49996000|FG008|Prior to Week 12|Other|0|||
24901982|NCT00718718|49996001|FG009|Prior to Week 12|Other|0|||
24901983|NCT00718718|49995992|FG000|Week 12 to End of Study|Adverse Event|0|||
24901984|NCT00718718|49995993|FG001|Week 12 to End of Study|Adverse Event|0|||
24901985|NCT00718718|49995994|FG002|Week 12 to End of Study|Adverse Event|0|||
24901986|NCT00718718|49995995|FG003|Week 12 to End of Study|Adverse Event|0|||
25335123|NCT00847613|50651521|FG000|Overall Study|Pregnancy|1|||
25335124|NCT00847613|50651522|FG001|Overall Study|Pregnancy|1|||
25335125|NCT00847613|50651523|FG002|Overall Study|Pregnancy|0|||
25335126|NCT00847613|50651524|FG003|Overall Study|Pregnancy|0|||
24901987|NCT00718718|49995996|FG004|Week 12 to End of Study|Adverse Event|0|||
24901988|NCT00718718|49995997|FG005|Week 12 to End of Study|Adverse Event|0|||
24901989|NCT00718718|49995998|FG006|Week 12 to End of Study|Adverse Event|0|||
25252592|NCT00479388|50568179|FG000|Overall Study|Adverse Event|90|||
25252593|NCT00479388|50568180|FG001|Overall Study|Adverse Event|45|||
25252594|NCT00479388|50568179|FG000|Overall Study|Lost to Follow-up|0|||
25252595|NCT00479388|50568180|FG001|Overall Study|Lost to Follow-up|2|||
25252596|NCT00479388|50568179|FG000|Overall Study|Protocol Violation|10|||
25335127|NCT00847613|50651521|FG000|Overall Study|Site closure|1|||
25252597|NCT00479388|50568180|FG001|Overall Study|Protocol Violation|9|||
25252598|NCT00479388|50568179|FG000|Overall Study|Withdrawal by Subject|32|||
25252599|NCT00479388|50568180|FG001|Overall Study|Withdrawal by Subject|17|||
25252600|NCT00479232|50568188|FG000|Overall Study|Adverse Event|0|||
25252601|NCT00479232|50568189|FG001|Overall Study|Adverse Event|0|||
25252602|NCT00479232|50568190|FG002|Overall Study|Adverse Event|5|||
25252603|NCT00479232|50568191|FG003|Overall Study|Adverse Event|0|||
24901990|NCT00718718|49995999|FG007|Week 12 to End of Study|Adverse Event|1|||
24901991|NCT00718718|49996000|FG008|Week 12 to End of Study|Adverse Event|0|||
24901992|NCT00718718|49996001|FG009|Week 12 to End of Study|Adverse Event|0|||
24901993|NCT00718718|49995992|FG000|Week 12 to End of Study|Death|0|||
24901994|NCT00718718|49995993|FG001|Week 12 to End of Study|Death|0|||
24901995|NCT00718718|49995994|FG002|Week 12 to End of Study|Death|0|||
24901996|NCT00718718|49995995|FG003|Week 12 to End of Study|Death|0|||
24901997|NCT00718718|49995996|FG004|Week 12 to End of Study|Death|0|||
24901998|NCT00718718|49995997|FG005|Week 12 to End of Study|Death|1|||
24901999|NCT00718718|49995998|FG006|Week 12 to End of Study|Death|0|||
24902000|NCT00718718|49995999|FG007|Week 12 to End of Study|Death|0|||
24902001|NCT00718718|49996000|FG008|Week 12 to End of Study|Death|0|||
24902002|NCT00718718|49996001|FG009|Week 12 to End of Study|Death|0|||
24902003|NCT00718718|49995992|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
24902004|NCT00718718|49995993|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
24902005|NCT00718718|49995994|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
25335128|NCT00847613|50651522|FG001|Overall Study|Site closure|0|||
25335129|NCT00847613|50651523|FG002|Overall Study|Site closure|0|||
25335130|NCT00847613|50651524|FG003|Overall Study|Site closure|1|||
25335131|NCT00847613|50651521|FG000|Overall Study|Withdrawal by Subject|8|||
25335132|NCT00847613|50651522|FG001|Overall Study|Withdrawal by Subject|11|||
25335133|NCT00847613|50651523|FG002|Overall Study|Withdrawal by Subject|2|||
25335134|NCT00847613|50651524|FG003|Overall Study|Withdrawal by Subject|2|||
25335135|NCT00847613|50651521|FG000|Overall Study|Participant moved|4|||
25335136|NCT00847613|50651522|FG001|Overall Study|Participant moved|1|||
25335137|NCT00847613|50651523|FG002|Overall Study|Participant moved|0|||
25335138|NCT00847613|50651524|FG003|Overall Study|Participant moved|0|||
25335139|NCT00847613|50651521|FG000|Overall Study|Sponsor request|0|||
25335140|NCT00847613|50651522|FG001|Overall Study|Sponsor request|1|||
25335141|NCT00847613|50651523|FG002|Overall Study|Sponsor request|0|||
25335142|NCT00847613|50651524|FG003|Overall Study|Sponsor request|0|||
25335143|NCT00847613|50651521|FG000|Overall Study|Randomized, but not treated|0|||
25335144|NCT00847613|50651522|FG001|Overall Study|Randomized, but not treated|3|||
25335145|NCT00847613|50651523|FG002|Overall Study|Randomized, but not treated|0|||
25335146|NCT00847613|50651524|FG003|Overall Study|Randomized, but not treated|0|||
25335147|NCT00847613|50651521|FG000|Overall Study|Other|1|||
25335148|NCT00847613|50651522|FG001|Overall Study|Other|1|||
25335149|NCT00847613|50651523|FG002|Overall Study|Other|2|||
25335150|NCT00847613|50651524|FG003|Overall Study|Other|0|||
25335151|NCT00794196|50651543|FG000|Overall Study|Lost to Follow-up|5|||
25335152|NCT00794196|50651544|FG001|Overall Study|Lost to Follow-up|23|||
25335153|NCT00807092|50651552|FG000|Overall Study|Adverse Event|0|||
25335154|NCT00807092|50651553|FG001|Overall Study|Adverse Event|1|||
25335155|NCT00807092|50651552|FG000|Overall Study|Protocol Violation|0|||
25335156|NCT00807092|50651553|FG001|Overall Study|Protocol Violation|2|||
25335157|NCT00807092|50651552|FG000|Overall Study|Withdrawal by Subject|1|||
25335158|NCT00807092|50651553|FG001|Overall Study|Withdrawal by Subject|0|||
25335159|NCT00807092|50651552|FG000|Overall Study|CGMS data collection failed|0|||
25335160|NCT00807092|50651553|FG001|Overall Study|CGMS data collection failed|1|||
25335161|NCT00794118|50651559|FG000|Overall Study|Lost to Follow-up|16|||
25335162|NCT00794118|50651559|FG000|Overall Study|Withdrawal by Subject|9|||
25335163|NCT00794118|50651559|FG000|Overall Study|Changed hospital center|2|||
25335164|NCT00640042|50651563|FG000|Enrollment|Did not receive study drug|83|||
25335165|NCT00807014|50651569|FG000|Overall Study|Participant Considered Disease Cured|13|||
25335166|NCT00807014|50651570|FG001|Overall Study|Participant Considered Disease Cured|2|||
25335167|NCT00807014|50651569|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
24902006|NCT00718718|49995995|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
24902007|NCT00718718|49995996|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
24902008|NCT00718718|49995997|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
25252604|NCT00479232|50568192|FG004|Overall Study|Adverse Event|0|||
25252605|NCT00479232|50568193|FG005|Overall Study|Adverse Event|10|||
25252606|NCT00479232|50568188|FG000|Overall Study|Deviation from Protocol|0|||
25335168|NCT00807014|50651570|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
25335169|NCT00807014|50651569|FG000|Overall Study|Protocol Violation|2|||
25335170|NCT00807014|50651570|FG001|Overall Study|Protocol Violation|8|||
25335171|NCT00807014|50651569|FG000|Overall Study|Adverse Event|0|||
25335172|NCT00807014|50651570|FG001|Overall Study|Adverse Event|2|||
25335173|NCT00807014|50651569|FG000|Overall Study|Lost to Follow-up|9|||
25335174|NCT00807014|50651570|FG001|Overall Study|Lost to Follow-up|7|||
25335175|NCT00807014|50651569|FG000|Overall Study|Recovery|1|||
25335176|NCT00807014|50651570|FG001|Overall Study|Recovery|0|||
25252607|NCT00479232|50568189|FG001|Overall Study|Deviation from Protocol|0|||
25252608|NCT00479232|50568190|FG002|Overall Study|Deviation from Protocol|1|||
25252609|NCT00479232|50568191|FG003|Overall Study|Deviation from Protocol|0|||
25252610|NCT00479232|50568192|FG004|Overall Study|Deviation from Protocol|0|||
25252611|NCT00479232|50568193|FG005|Overall Study|Deviation from Protocol|0|||
25252612|NCT00479232|50568188|FG000|Overall Study|Lack of Efficacy|0|||
25252613|NCT00479232|50568189|FG001|Overall Study|Lack of Efficacy|0|||
25252614|NCT00479232|50568190|FG002|Overall Study|Lack of Efficacy|2|||
25252615|NCT00479232|50568191|FG003|Overall Study|Lack of Efficacy|0|||
25335177|NCT00807014|50651569|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
25335178|NCT00807014|50651570|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
25335179|NCT00847535|50651576|FG000|Overall Study|Withdrawal by Subject|2|||
25335180|NCT00847535|50651577|FG001|Overall Study|Withdrawal by Subject|1|||
25335181|NCT00847535|50651578|FG002|Overall Study|Withdrawal by Subject|1|||
25335182|NCT00847535|50651576|FG000|Overall Study|Lost to Follow-up|0|||
25335183|NCT00847535|50651577|FG001|Overall Study|Lost to Follow-up|1|||
25335184|NCT00847535|50651578|FG002|Overall Study|Lost to Follow-up|0|||
25335185|NCT00592631|50651585|FG000|Overall Study|Lost to Follow-up|0|||
25335186|NCT00592631|50651586|FG001|Overall Study|Lost to Follow-up|2|||
25335187|NCT00791388|50651597|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
25335188|NCT00791388|50651598|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
25335189|NCT00791388|50651599|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
25335190|NCT00791388|50651600|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
25335191|NCT00791388|50651601|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
25335192|NCT00791388|50651597|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
25335193|NCT00791388|50651598|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
25335194|NCT00791388|50651599|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
25335195|NCT00791388|50651600|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
25335196|NCT00791388|50651601|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
25335197|NCT00791388|50651597|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
25335198|NCT00791388|50651598|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
25335199|NCT00791388|50651599|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
25335200|NCT00791388|50651600|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
25335201|NCT00791388|50651601|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
25335202|NCT00794040|50651615|FG000|Overall Study|Withdrawal by Subject|3|||
25335203|NCT00794040|50651616|FG001|Overall Study|Withdrawal by Subject|4|||
25335204|NCT00794040|50651615|FG000|Overall Study|Physician Decision|0|||
25335205|NCT00794040|50651616|FG001|Overall Study|Physician Decision|1|||
25335206|NCT00813488|50651622|FG000|Titration Period 1|Adverse Event|6|||
25335207|NCT00813488|50651623|FG001|Titration Period 1|Adverse Event|1|||
25335208|NCT00813488|50651622|FG000|Titration Period 1|Lack of Efficacy|9|||
25335209|NCT00813488|50651623|FG001|Titration Period 1|Lack of Efficacy|7|||
25335210|NCT00813488|50651622|FG000|Titration Period 1|Withdrawal by Subject|2|||
25335211|NCT00813488|50651623|FG001|Titration Period 1|Withdrawal by Subject|2|||
25335212|NCT00813488|50651622|FG000|Titration Period 1|Protocol Violation|4|||
25335213|NCT00813488|50651623|FG001|Titration Period 1|Protocol Violation|3|||
25335214|NCT00813488|50651622|FG000|Titration Period 1|Non-compliance to study medication|4|||
25335215|NCT00813488|50651623|FG001|Titration Period 1|Non-compliance to study medication|1|||
25335216|NCT00813488|50651622|FG000|Titration Period 1|Non-compliance to study procedures|2|||
25335217|NCT00813488|50651623|FG001|Titration Period 1|Non-compliance to study procedures|2|||
25335218|NCT00813488|50651622|FG000|Titration Period 1|Technical Difficulties|0|||
25335219|NCT00813488|50651623|FG001|Titration Period 1|Technical Difficulties|1|||
25335220|NCT00813488|50651622|FG000|Titration Period 2|Adverse Event|2|||
25335221|NCT00813488|50651623|FG001|Titration Period 2|Adverse Event|3|||
25335222|NCT00813488|50651622|FG000|Titration Period 2|Lack of Efficacy|8|||
25335223|NCT00813488|50651623|FG001|Titration Period 2|Lack of Efficacy|4|||
25335224|NCT00813488|50651622|FG000|Titration Period 2|Protocol Violation|3|||
25335225|NCT00813488|50651623|FG001|Titration Period 2|Protocol Violation|2|||
25335226|NCT00813488|50651622|FG000|Titration Period 2|Lost to Follow-up|1|||
25335227|NCT00813488|50651623|FG001|Titration Period 2|Lost to Follow-up|0|||
25335228|NCT00813488|50651622|FG000|Titration Period 2|Non-compliance with study procedures|2|||
25335229|NCT00813488|50651623|FG001|Titration Period 2|Non-compliance with study procedures|1|||
25335230|NCT00813488|50651622|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
25335231|NCT00813488|50651623|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
25335232|NCT00813488|50651622|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
25335233|NCT00813488|50651623|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
25335234|NCT00813488|50651622|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
25335235|NCT00813488|50651623|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
24902009|NCT00718718|49995998|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
25252616|NCT00479232|50568192|FG004|Overall Study|Lack of Efficacy|0|||
25335236|NCT00813488|50651622|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
25252617|NCT00479232|50568193|FG005|Overall Study|Lack of Efficacy|4|||
25252618|NCT00479232|50568188|FG000|Overall Study|Physician Decision|0|||
25252619|NCT00479232|50568189|FG001|Overall Study|Physician Decision|0|||
25252620|NCT00479232|50568190|FG002|Overall Study|Physician Decision|2|||
25252621|NCT00479232|50568191|FG003|Overall Study|Physician Decision|0|||
25252622|NCT00479232|50568192|FG004|Overall Study|Physician Decision|0|||
25252623|NCT00479232|50568193|FG005|Overall Study|Physician Decision|1|||
25252624|NCT00479232|50568188|FG000|Overall Study|Progressive Disease|3|||
25252625|NCT00479232|50568189|FG001|Overall Study|Progressive Disease|1|||
25252626|NCT00479232|50568190|FG002|Overall Study|Progressive Disease|12|||
25252627|NCT00479232|50568191|FG003|Overall Study|Progressive Disease|3|||
25252628|NCT00479232|50568192|FG004|Overall Study|Progressive Disease|3|||
25252629|NCT00479232|50568193|FG005|Overall Study|Progressive Disease|12|||
25252630|NCT00479232|50568188|FG000|Overall Study|Withdrew Consent|0|||
25252631|NCT00479232|50568189|FG001|Overall Study|Withdrew Consent|2|||
25252632|NCT00479232|50568190|FG002|Overall Study|Withdrew Consent|6|||
25252633|NCT00479232|50568191|FG003|Overall Study|Withdrew Consent|0|||
25335237|NCT00813488|50651623|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
25335238|NCT00813488|50651622|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
25335239|NCT00813488|50651623|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
25335240|NCT00813488|50651622|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
25335241|NCT00813488|50651623|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
25335242|NCT00813488|50651622|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
25335243|NCT00813488|50651623|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
25335244|NCT00813488|50651622|FG000|Double-blind Treatment Period 2|Other|1|||
25335245|NCT00813488|50651623|FG001|Double-blind Treatment Period 2|Other|0|||
25335246|NCT00813488|50651622|FG000|Open-label Extension|Adverse Event|1|||
25335247|NCT00813488|50651623|FG001|Open-label Extension|Adverse Event|2|||
25335248|NCT00813488|50651622|FG000|Open-label Extension|Lack of Efficacy|3|||
25335249|NCT00813488|50651623|FG001|Open-label Extension|Lack of Efficacy|0|||
25335250|NCT00813488|50651622|FG000|Open-label Extension|Withdrawal by Subject|0|||
25335251|NCT00813488|50651623|FG001|Open-label Extension|Withdrawal by Subject|2|||
25335252|NCT00813488|50651622|FG000|Open-label Extension|Protocol Violation|1|||
25335253|NCT00813488|50651623|FG001|Open-label Extension|Protocol Violation|2|||
25335254|NCT00813488|50651622|FG000|Open-label Extension|Non-compliance study medication|4|||
25335255|NCT00813488|50651623|FG001|Open-label Extension|Non-compliance study medication|0|||
25335256|NCT00813488|50651622|FG000|Open-label Extension|Non-compliance study procedures|2|||
25335257|NCT00813488|50651623|FG001|Open-label Extension|Non-compliance study procedures|1|||
25335258|NCT00813488|50651622|FG000|Open-label Extension|Other|1|||
25335259|NCT00813488|50651623|FG001|Open-label Extension|Other|0|||
25335260|NCT00797316|50651635|FG000|Overall Study|Administrative problems|1|||
25335261|NCT00797316|50651636|FG001|Overall Study|Administrative problems|0|||
25335262|NCT00797316|50651635|FG000|Overall Study|Adverse Event|5|||
25335263|NCT00797316|50651636|FG001|Overall Study|Adverse Event|3|||
25335264|NCT00797316|50651635|FG000|Overall Study|Lost to Follow-up|4|||
25335265|NCT00797316|50651636|FG001|Overall Study|Lost to Follow-up|8|||
25335266|NCT00797316|50651635|FG000|Overall Study|Protocol Deviation|1|||
25335267|NCT00797316|50651636|FG001|Overall Study|Protocol Deviation|2|||
25335268|NCT00797316|50651635|FG000|Overall Study|Patient withdrew consent|12|||
25335269|NCT00797316|50651636|FG001|Overall Study|Patient withdrew consent|6|||
25335270|NCT00797316|50651635|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
25335271|NCT00797316|50651636|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
25335272|NCT00587964|50651642|FG000|Overall Study|Withdrawal by Subject|1|||
25335273|NCT00587964|50651642|FG000|Overall Study|Lost to Follow-up|1|||
25335274|NCT00587964|50651642|FG000|Overall Study|Patient found to be ineligible|1|||
25335275|NCT00587964|50651642|FG000|Overall Study|Patient did not receive intervention|5|||
25335276|NCT00587964|50651642|FG000|Overall Study|Progression of Disease|4|||
25335277|NCT00590954|50651646|FG000|Overall Study|Inevaluable|2|||
25335278|NCT00791076|50651652|FG000|Overall Study|Study was terminated,PI left institution|8|||
25335279|NCT00590720|50651660|FG000|Overall Study|Lost to Follow-up|1|||
25335280|NCT00590720|50651661|FG001|Overall Study|Lost to Follow-up|0|||
25335281|NCT00590720|50651660|FG000|Overall Study|Withdrawal by Subject|0|||
25335282|NCT00590720|50651661|FG001|Overall Study|Withdrawal by Subject|1|||
25335283|NCT00625378|50651669|FG000|Overall Study|Adverse Event|22|||
25335284|NCT00625378|50651670|FG001|Overall Study|Adverse Event|0|||
25335285|NCT00625378|50651669|FG000|Overall Study|Withdrawal by Subject|16|||
25252634|NCT00479232|50568192|FG004|Overall Study|Withdrew Consent|1|||
25335286|NCT00625378|50651670|FG001|Overall Study|Withdrawal by Subject|0|||
25335287|NCT00625378|50651669|FG000|Overall Study|Death|38|||
25335288|NCT00625378|50651670|FG001|Overall Study|Death|0|||
25335289|NCT00625378|50651669|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
25335290|NCT00625378|50651670|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
25335291|NCT00625378|50651669|FG000|Overall Study|Lost to Follow-up|17|||
25335292|NCT00625378|50651670|FG001|Overall Study|Lost to Follow-up|0|||
24977382|NCT00048542|50065997|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
25252635|NCT00479232|50568193|FG005|Overall Study|Withdrew Consent|3|||
25252636|NCT00478881|50568213|FG000|Overall Study|Adverse Event|31|||
25252637|NCT00478881|50568214|FG001|Overall Study|Adverse Event|12|||
25335293|NCT00625378|50651669|FG000|Overall Study|Non-compliant with study medication|3|||
25335294|NCT00625378|50651670|FG001|Overall Study|Non-compliant with study medication|0|||
25252638|NCT00478881|50568213|FG000|Overall Study|Lack of Efficacy|0|||
25252639|NCT00478881|50568214|FG001|Overall Study|Lack of Efficacy|3|||
25252640|NCT00478881|50568213|FG000|Overall Study|Lost to Follow-up|0|||
25252641|NCT00478881|50568214|FG001|Overall Study|Lost to Follow-up|1|||
25252642|NCT00478881|50568213|FG000|Overall Study|Protocol Violation|2|||
25252643|NCT00478881|50568214|FG001|Overall Study|Protocol Violation|2|||
25252644|NCT00478881|50568213|FG000|Overall Study|Withdrawal by Subject|6|||
25252645|NCT00478881|50568214|FG001|Overall Study|Withdrawal by Subject|2|||
25252646|NCT00478881|50568213|FG000|Overall Study|Non-Compliance with Study Medication|0|||
25335295|NCT00625378|50651669|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
25335296|NCT00625378|50651670|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
25335297|NCT00625378|50651669|FG000|Overall Study|Medical decision|1|||
25335298|NCT00625378|50651670|FG001|Overall Study|Medical decision|0|||
25335299|NCT00625378|50651669|FG000|Overall Study|Multiple toxicities|1|||
25335300|NCT00625378|50651670|FG001|Overall Study|Multiple toxicities|0|||
25335301|NCT00625378|50651669|FG000|Overall Study|New cancer|1|||
25335302|NCT00625378|50651670|FG001|Overall Study|New cancer|0|||
25335303|NCT00625378|50651669|FG000|Overall Study|PTA program|2|||
25335304|NCT00625378|50651670|FG001|Overall Study|PTA program|0|||
25335305|NCT00625378|50651669|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
25335306|NCT00625378|50651670|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
25335307|NCT00625378|50651669|FG000|Overall Study|Sponsor decision|1|||
25335308|NCT00625378|50651670|FG001|Overall Study|Sponsor decision|0|||
25335309|NCT00625378|50651669|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
25335310|NCT00625378|50651670|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
25335311|NCT00625378|50651669|FG000|Overall Study|Switch to commercial drug|6|||
25335312|NCT00625378|50651670|FG001|Overall Study|Switch to commercial drug|1|||
25335313|NCT00625378|50651669|FG000|Overall Study|Missing|2|||
25335314|NCT00625378|50651670|FG001|Overall Study|Missing|0|||
25335315|NCT00625378|50651669|FG000|Overall Study|End of treatment not available|2|||
25335316|NCT00625378|50651670|FG001|Overall Study|End of treatment not available|0|||
25335317|NCT00625378|50651669|FG000|Overall Study|Never treated|2|||
25335318|NCT00625378|50651670|FG001|Overall Study|Never treated|0|||
25335319|NCT00806624|50651679|FG000|Overall Study|Adverse Event|2|||
25335320|NCT00806624|50651680|FG001|Overall Study|Adverse Event|8|||
25335321|NCT00806624|50651681|FG002|Overall Study|Adverse Event|0|||
25335322|NCT00806624|50651679|FG000|Overall Study|Death|0|||
25335323|NCT00806624|50651680|FG001|Overall Study|Death|1|||
25335324|NCT00806624|50651681|FG002|Overall Study|Death|1|||
25335325|NCT00806624|50651679|FG000|Overall Study|Lost to Follow-up|1|||
25335326|NCT00806624|50651680|FG001|Overall Study|Lost to Follow-up|0|||
25252647|NCT00478881|50568214|FG001|Overall Study|Non-Compliance with Study Medication|2|||
25252648|NCT00478647|50568220|FG000|Overall Study|Adverse Event|1|||
25252649|NCT00478647|50568220|FG000|Overall Study|Withdrawal by Subject|1|||
25252650|NCT00478608|50568224|FG000|Overall Study|Adverse Event|1|||
25252651|NCT00478608|50568224|FG000|Overall Study|Serious Adverse Event|14|||
25252652|NCT00478608|50568224|FG000|Overall Study|Withdrawal by Subject|2|||
25252653|NCT00478608|50568224|FG000|Overall Study|Protocol Violation|3|||
25252654|NCT00478257|50568230|FG000|Overall Study|Withdrawal by Subject|8|||
25252655|NCT00478257|50568231|FG001|Overall Study|Withdrawal by Subject|3|||
25252656|NCT00478140|50568237|FG000|Overall Study|Clinical Disease Progression|1|||
25252657|NCT00478023|50568246|FG000|Overall Study|Adverse Event|11|||
25252658|NCT00478023|50568247|FG001|Overall Study|Adverse Event|7|||
25252659|NCT00478023|50568248|FG002|Overall Study|Adverse Event|8|||
25252660|NCT00478023|50568249|FG003|Overall Study|Adverse Event|14|||
25252661|NCT00478023|50568250|FG004|Overall Study|Adverse Event|6|||
25252662|NCT00478023|50568246|FG000|Overall Study|Death|1|||
25252663|NCT00478023|50568247|FG001|Overall Study|Death|0|||
25252664|NCT00478023|50568248|FG002|Overall Study|Death|0|||
25252665|NCT00478023|50568249|FG003|Overall Study|Death|0|||
25252666|NCT00478023|50568250|FG004|Overall Study|Death|0|||
25252667|NCT00478023|50568246|FG000|Overall Study|Lack of Efficacy|11|||
25252668|NCT00478023|50568247|FG001|Overall Study|Lack of Efficacy|10|||
25252669|NCT00478023|50568248|FG002|Overall Study|Lack of Efficacy|4|||
25335327|NCT00806624|50651681|FG002|Overall Study|Lost to Follow-up|1|||
25252670|NCT00478023|50568249|FG003|Overall Study|Lack of Efficacy|5|||
25252671|NCT00478023|50568250|FG004|Overall Study|Lack of Efficacy|41|||
25252672|NCT00478023|50568246|FG000|Overall Study|Lost to Follow-up|3|||
25252673|NCT00478023|50568247|FG001|Overall Study|Lost to Follow-up|1|||
25252674|NCT00478023|50568248|FG002|Overall Study|Lost to Follow-up|1|||
25252675|NCT00478023|50568249|FG003|Overall Study|Lost to Follow-up|1|||
25252676|NCT00478023|50568250|FG004|Overall Study|Lost to Follow-up|0|||
25252677|NCT00478023|50568246|FG000|Overall Study|Withdrawal by Subject|2|||
25335328|NCT00806624|50651679|FG000|Overall Study|Withdrawal by Subject|6|||
25335329|NCT00806624|50651680|FG001|Overall Study|Withdrawal by Subject|3|||
25335330|NCT00806624|50651681|FG002|Overall Study|Withdrawal by Subject|3|||
25335331|NCT00806624|50651679|FG000|Overall Study|discontinued before start of treatment|0|||
25335332|NCT00806624|50651680|FG001|Overall Study|discontinued before start of treatment|0|||
25335333|NCT00806624|50651681|FG002|Overall Study|discontinued before start of treatment|1|||
25335334|NCT00806546|50651689|FG000|Overall Study|Enrolled, not treated|35|||
25335335|NCT00806546|50651689|FG000|Overall Study|Lost to Follow-up|32|||
25335336|NCT00806546|50651689|FG000|Overall Study|Adverse Event|74|||
25335337|NCT00806546|50651689|FG000|Overall Study|Withdrawal by Subject|75|||
24902010|NCT00718718|49995999|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
24902011|NCT00718718|49996000|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
24902012|NCT00718718|49996001|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
24902013|NCT00718718|49995992|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
24902014|NCT00718718|49995993|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
24902015|NCT00718718|49995994|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
24902016|NCT00718718|49995995|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
24902017|NCT00718718|49995996|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
24902018|NCT00718718|49995997|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
24902019|NCT00718718|49995998|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
24902020|NCT00718718|49995999|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
24902021|NCT00718718|49996000|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
24902022|NCT00718718|49996001|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
24902023|NCT00718718|49995992|FG000|Week 12 to End of Study|Other|0|||
24902024|NCT00718718|49995993|FG001|Week 12 to End of Study|Other|1|||
24902025|NCT00718718|49995994|FG002|Week 12 to End of Study|Other|0|||
24902026|NCT00718718|49995995|FG003|Week 12 to End of Study|Other|1|||
24902027|NCT00718718|49995996|FG004|Week 12 to End of Study|Other|0|||
24902028|NCT00718718|49995997|FG005|Week 12 to End of Study|Other|0|||
24902029|NCT00718718|49995998|FG006|Week 12 to End of Study|Other|1|||
24902030|NCT00718718|49995999|FG007|Week 12 to End of Study|Other|0|||
24902031|NCT00718718|49996000|FG008|Week 12 to End of Study|Other|0|||
24902032|NCT00718718|49996001|FG009|Week 12 to End of Study|Other|0|||
24902033|NCT00683787|49996030|FG000|Overall Study|Progression|3|||
24902034|NCT00683787|49996031|FG001|Overall Study|Progression|3|||
24902035|NCT00683787|49996032|FG002|Overall Study|Progression|0|||
24902036|NCT00683787|49996030|FG000|Overall Study|Adverse Event|0|||
24902037|NCT00683787|49996031|FG001|Overall Study|Adverse Event|0|||
24902038|NCT00683787|49996032|FG002|Overall Study|Adverse Event|2|||
24902039|NCT00723008|49996042|FG000|Enrollment|Lost to Follow-up|1|||
24902040|NCT00723008|49996043|FG001|Enrollment|Lost to Follow-up|0|||
24902041|NCT00723008|49996042|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
24902042|NCT00723008|49996043|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
24902043|NCT00723008|49996042|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
24902044|NCT00723008|49996043|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
24902045|NCT00723008|49996042|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
24902046|NCT00723008|49996043|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
24902047|NCT00723008|49996042|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
24902048|NCT00723008|49996043|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
24902049|NCT00723008|49996042|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
24902050|NCT00723008|49996043|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
24902051|NCT00718640|49996057|FG000|Overall Study|Adverse Event|4|||
24902052|NCT00718640|49996057|FG000|Overall Study|Death|1|||
24902053|NCT00718640|49996057|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
24902054|NCT00715910|49996065|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
24902055|NCT00715910|49996066|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
24902056|NCT00715910|49996067|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
24902057|NCT00715910|49996068|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
24902058|NCT00715910|49996069|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
24902059|NCT00715910|49996070|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
24902060|NCT00715910|49996065|FG000|Booster and ESFU Phase|Other|0|||
24902061|NCT00715910|49996066|FG001|Booster and ESFU Phase|Other|0|||
24902062|NCT00715910|49996067|FG002|Booster and ESFU Phase|Other|0|||
24902063|NCT00715910|49996068|FG003|Booster and ESFU Phase|Other|5|||
25252678|NCT00478023|50568247|FG001|Overall Study|Withdrawal by Subject|3|||
25252679|NCT00478023|50568248|FG002|Overall Study|Withdrawal by Subject|2|||
25252680|NCT00478023|50568249|FG003|Overall Study|Withdrawal by Subject|4|||
25252681|NCT00478023|50568250|FG004|Overall Study|Withdrawal by Subject|5|||
25252682|NCT00478023|50568246|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
25252683|NCT00478023|50568247|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
25252684|NCT00478023|50568248|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
25252685|NCT00478023|50568249|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
25252686|NCT00478023|50568250|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
25252687|NCT00477750|50568262|FG000|Overall Study|Currently Receiving Treatment|11|||
24902064|NCT00715910|49996069|FG004|Booster and ESFU Phase|Other|1|||
25252688|NCT00477672|50568271|FG000|Overall Study|Adverse Event|3|||
24902065|NCT00715910|49996070|FG005|Booster and ESFU Phase|Other|0|||
24902066|NCT00715676|49996089|FG000|Overall Study|Adverse Event|3|||
24902067|NCT00715676|49996090|FG001|Overall Study|Adverse Event|5|||
25335338|NCT00806546|50651689|FG000|Overall Study|Protocol Violation|49|||
25335339|NCT00806546|50651689|FG000|Overall Study|Various|42|||
25335340|NCT00624832|50651697|FG000|Overall Study|Adverse Event|0|||
25335341|NCT00624832|50651698|FG001|Overall Study|Adverse Event|1|||
25335342|NCT00624832|50651699|FG002|Overall Study|Adverse Event|0|||
25335343|NCT00624832|50651700|FG003|Overall Study|Adverse Event|1|||
25335344|NCT00624832|50651697|FG000|Overall Study|Abnormal Laboratory Value|2|||
25335345|NCT00624832|50651698|FG001|Overall Study|Abnormal Laboratory Value|0|||
25335346|NCT00624832|50651699|FG002|Overall Study|Abnormal Laboratory Value|0|||
25335347|NCT00624832|50651700|FG003|Overall Study|Abnormal Laboratory Value|0|||
25335348|NCT00633880|50651712|FG000|Open Label Titration|Lack of Efficacy|1|||
25335349|NCT00633880|50651713|FG001|Open Label Titration|Lack of Efficacy|0|||
25335350|NCT00633880|50651714|FG002|Open Label Titration|Lack of Efficacy|0|||
25335351|NCT00633880|50651712|FG000|Open Label Titration|Adverse Event|13|||
25335352|NCT00633880|50651713|FG001|Open Label Titration|Adverse Event|0|||
25335353|NCT00633880|50651714|FG002|Open Label Titration|Adverse Event|0|||
25335354|NCT00633880|50651712|FG000|Open Label Titration|Treatment Failure|55|||
25335355|NCT00633880|50651713|FG001|Open Label Titration|Treatment Failure|0|||
25335356|NCT00633880|50651714|FG002|Open Label Titration|Treatment Failure|0|||
25335357|NCT00633880|50651712|FG000|Open Label Titration|Protocol Violation|6|||
25335358|NCT00633880|50651713|FG001|Open Label Titration|Protocol Violation|0|||
25335359|NCT00633880|50651714|FG002|Open Label Titration|Protocol Violation|0|||
25335360|NCT00633880|50651712|FG000|Open Label Titration|Physician Decision|1|||
25335361|NCT00633880|50651713|FG001|Open Label Titration|Physician Decision|0|||
25335362|NCT00633880|50651714|FG002|Open Label Titration|Physician Decision|0|||
25335363|NCT00633880|50651712|FG000|Open Label Titration|Withdrawal by Subject|4|||
25335364|NCT00633880|50651713|FG001|Open Label Titration|Withdrawal by Subject|0|||
25335365|NCT00633880|50651714|FG002|Open Label Titration|Withdrawal by Subject|0|||
25335366|NCT00590564|50651721|FG000|Overall Study|Withdrawal by Subject|4|||
25335367|NCT00590564|50651721|FG000|Overall Study|Lost to Follow-up|6|||
25335368|NCT00590564|50651721|FG000|Overall Study|Protocol Violation|1|||
25335369|NCT00590564|50651721|FG000|Overall Study|Patient Found to be Ineligible|1|||
25335370|NCT00590564|50651721|FG000|Overall Study|Patient Non-compliance|6|||
25335371|NCT00631696|50651727|FG000|Overall Study|Entered, not randomized to treatment|1|||
25335372|NCT00631696|50651728|FG001|Overall Study|Entered, not randomized to treatment|1|||
25335373|NCT00631696|50651727|FG000|Overall Study|Discontinued after database release date|1|||
25335374|NCT00631696|50651728|FG001|Overall Study|Discontinued after database release date|0|||
25335375|NCT00631696|50651727|FG000|Overall Study|Follow up after database release date|1|||
25252689|NCT00477672|50568272|FG001|Overall Study|Adverse Event|5|||
25252690|NCT00477672|50568273|FG002|Overall Study|Adverse Event|6|||
25252691|NCT00477672|50568271|FG000|Overall Study|Death|0|||
25335376|NCT00631696|50651728|FG001|Overall Study|Follow up after database release date|0|||
25335377|NCT00631696|50651727|FG000|Overall Study|Lost to Follow-up|7|||
25335378|NCT00631696|50651728|FG001|Overall Study|Lost to Follow-up|10|||
25335379|NCT00631696|50651727|FG000|Overall Study|Withdrawal by Subject|2|||
25335380|NCT00631696|50651728|FG001|Overall Study|Withdrawal by Subject|9|||
25335381|NCT00631696|50651727|FG000|Overall Study|Other|8|||
25335382|NCT00631696|50651728|FG001|Overall Study|Other|8|||
25335383|NCT00631696|50651727|FG000|Overall Study|Protocol Violation|9|||
25335384|NCT00631696|50651728|FG001|Overall Study|Protocol Violation|9|||
25335385|NCT00631696|50651727|FG000|Overall Study|Study terminated by sponsor|3|||
25335386|NCT00631696|50651728|FG001|Overall Study|Study terminated by sponsor|3|||
25335387|NCT00631696|50651727|FG000|Overall Study|Adverse Event|5|||
25335388|NCT00631696|50651728|FG001|Overall Study|Adverse Event|0|||
25335389|NCT00631540|50651734|FG000|Overall Study|Withdrawal by Subject|5|||
25335390|NCT00631540|50651734|FG000|Overall Study|Death|4|||
25335391|NCT00631540|50651734|FG000|Overall Study|Lost to Follow-up|2|||
25335392|NCT00631540|50651734|FG000|Overall Study|Core Lab Data Unavailable|3|||
25335393|NCT00630916|50651738|FG000|Overall Study|Death|110|||
25335394|NCT00630916|50651738|FG000|Overall Study|Explant|8|||
25077896|NCT02896855|50185964|FG000|Overall Study|Lost to Follow-up|15|||
25252692|NCT00477672|50568272|FG001|Overall Study|Death|1|||
25252693|NCT00477672|50568273|FG002|Overall Study|Death|0|||
25252694|NCT00477672|50568271|FG000|Overall Study|Disease progression|0|||
25252695|NCT00477672|50568272|FG001|Overall Study|Disease progression|1|||
25252696|NCT00477672|50568273|FG002|Overall Study|Disease progression|0|||
25252697|NCT00477672|50568271|FG000|Overall Study|Physician Decision|1|||
25335395|NCT00630916|50651738|FG000|Overall Study|Lost to Follow-up|5|||
25335396|NCT00630916|50651738|FG000|Overall Study|Withdrawal by Subject|30|||
25335397|NCT00630916|50651738|FG000|Overall Study|Protocol Violation|7|||
25335398|NCT00630916|50651738|FG000|Overall Study|Physician Decision|47|||
25335399|NCT00630916|50651738|FG000|Overall Study|Lack of Efficacy|3|||
25335400|NCT00630292|50651742|FG000|Overall Study|Withdrawal by Subject|1|||
25335401|NCT00626548|50651748|FG000|Overall Study|Adverse Event|164|||
25335402|NCT00626548|50651749|FG001|Overall Study|Adverse Event|44|||
25252698|NCT00477672|50568272|FG001|Overall Study|Physician Decision|0|||
25252699|NCT00477672|50568273|FG002|Overall Study|Physician Decision|0|||
25252700|NCT00477672|50568271|FG000|Overall Study|Protocol noncompliance|0|||
25252701|NCT00477672|50568272|FG001|Overall Study|Protocol noncompliance|2|||
25252702|NCT00477672|50568273|FG002|Overall Study|Protocol noncompliance|0|||
25252703|NCT00477672|50568271|FG000|Overall Study|Consent withdrawn|2|||
25252704|NCT00477672|50568272|FG001|Overall Study|Consent withdrawn|5|||
25252705|NCT00477672|50568273|FG002|Overall Study|Consent withdrawn|10|||
25252706|NCT00477672|50568271|FG000|Overall Study|Discretion of Sponsor|1|||
25252707|NCT00477672|50568272|FG001|Overall Study|Discretion of Sponsor|2|||
25252708|NCT00477672|50568273|FG002|Overall Study|Discretion of Sponsor|0|||
25252709|NCT00477633|50568281|FG000|Overall Study|Did not receive treatment|23|||
25252710|NCT00477633|50568281|FG000|Overall Study|Adverse Event|143|||
25252711|NCT00477633|50568281|FG000|Overall Study|Pregnancy|23|||
25252712|NCT00477633|50568281|FG000|Overall Study|Lost to Follow-up|271|||
25252713|NCT00477633|50568281|FG000|Overall Study|Withdrawal by Subject|149|||
25252714|NCT00477633|50568281|FG000|Overall Study|Protocol Violation|25|||
25252715|NCT00477633|50568281|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
25252716|NCT01131676|50568297|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
25252717|NCT01131676|50568298|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
25252718|NCT01131676|50568299|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
25252719|NCT01131676|50568297|FG000|Discontinuation From Treatment|Not treated|4|||
25252720|NCT01131676|50568298|FG001|Discontinuation From Treatment|Not treated|2|||
25252721|NCT01131676|50568299|FG002|Discontinuation From Treatment|Not treated|2|||
25252722|NCT01131676|50568297|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
25252723|NCT01131676|50568298|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
25252724|NCT01131676|50568299|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
25252725|NCT01131676|50568297|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
25252726|NCT01131676|50568298|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
25252727|NCT01131676|50568299|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
25252728|NCT01131676|50568297|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
25252729|NCT01131676|50568298|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
25252730|NCT01131676|50568299|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
25252731|NCT01131676|50568297|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
25252732|NCT01131676|50568298|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
25252733|NCT01131676|50568299|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
25252734|NCT01131676|50568297|FG000|Discontinuation From Treatment|Other than those specified|162|||
25252735|NCT01131676|50568298|FG001|Discontinuation From Treatment|Other than those specified|142|||
25252736|NCT01131676|50568299|FG002|Discontinuation From Treatment|Other than those specified|125|||
25252737|NCT01131676|50568297|FG000|Discontinuation From Treatment|Adverse Event|303|||
25252738|NCT01131676|50568298|FG001|Discontinuation From Treatment|Adverse Event|267|||
25252739|NCT01131676|50568299|FG002|Discontinuation From Treatment|Adverse Event|273|||
25252740|NCT01131676|50568297|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
25252741|NCT01131676|50568298|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
25252742|NCT01131676|50568299|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
25252743|NCT01131676|50568297|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
25252744|NCT01131676|50568298|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
25252745|NCT01131676|50568299|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
25252746|NCT01131676|50568297|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
25252747|NCT01131676|50568298|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
25252748|NCT01131676|50568299|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
25252749|NCT01131676|50568297|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
25252750|NCT01131676|50568298|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
25252751|NCT01131676|50568299|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
25252752|NCT01131676|50568297|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
25252753|NCT01131676|50568298|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
25252754|NCT01131676|50568299|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
25252755|NCT01131676|50568297|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
25252756|NCT01131676|50568298|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
25252757|NCT01131676|50568299|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
25252758|NCT01131520|50568321|FG000|Overall Study|Computer problem|1|||
25252759|NCT01131520|50568322|FG001|Overall Study|Computer problem|0|||
25252760|NCT01131520|50568321|FG000|Overall Study|Counselor not available|0|||
25252761|NCT01131520|50568322|FG001|Overall Study|Counselor not available|3|||
25252762|NCT01131520|50568321|FG000|Overall Study|Subject changed history after enrollment|0|||
25252763|NCT01131520|50568322|FG001|Overall Study|Subject changed history after enrollment|1|||
25252764|NCT01131325|50568328|FG000|Overall Study|Adverse Event|1|||
25077897|NCT02896855|50185965|FG001|Overall Study|Lost to Follow-up|9|||
25252765|NCT01131325|50568328|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
25252766|NCT01131130|50568332|FG000|Period 1 - Baseline|Pregnancy|1|||
25252767|NCT01131130|50568332|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
25252768|NCT01130974|50568342|FG000|Overall Study|Protocol Violation|10|||
25252769|NCT01130974|50568343|FG001|Overall Study|Protocol Violation|10|||
25252770|NCT01130974|50568342|FG000|Overall Study|Withdrawal by Subject|0|||
25252771|NCT01130974|50568343|FG001|Overall Study|Withdrawal by Subject|1|||
25252772|NCT01130974|50568342|FG000|Overall Study|Ineligibility criteria|5|||
25252773|NCT01130974|50568343|FG001|Overall Study|Ineligibility criteria|2|||
25252774|NCT01130272|50568355|FG000|Overall Study|Adverse Event|2|||
25252775|NCT01130272|50568356|FG001|Overall Study|Adverse Event|5|||
25252776|NCT01130272|50568357|FG002|Overall Study|Adverse Event|6|||
25252777|NCT01130272|50568358|FG003|Overall Study|Adverse Event|22|||
25252778|NCT01130272|50568359|FG004|Overall Study|Adverse Event|7|||
25252779|NCT01130272|50568355|FG000|Overall Study|IVRS-confirmed constipation|0|||
25252780|NCT01130272|50568356|FG001|Overall Study|IVRS-confirmed constipation|1|||
25335403|NCT00626548|50651748|FG000|Overall Study|Withdrawal by Subject|42|||
25335404|NCT00626548|50651749|FG001|Overall Study|Withdrawal by Subject|46|||
25335405|NCT00626548|50651748|FG000|Overall Study|Protocol Violation|4|||
25335406|NCT00626548|50651749|FG001|Overall Study|Protocol Violation|11|||
25335407|NCT00626548|50651748|FG000|Overall Study|Lost to Follow-up|2|||
25335408|NCT00626548|50651749|FG001|Overall Study|Lost to Follow-up|2|||
25335409|NCT00626548|50651748|FG000|Overall Study|Other termination reason|493|||
25335410|NCT00626548|50651749|FG001|Overall Study|Other termination reason|613|||
25335411|NCT00847379|50651758|FG000|Overall Study|Study terminated by Sponsor|59|||
25335412|NCT00847379|50651759|FG001|Overall Study|Study terminated by Sponsor|57|||
25335413|NCT00847379|50651760|FG002|Overall Study|Study terminated by Sponsor|57|||
25335414|NCT00847301|50651770|FG000|Overall Study|Adverse Event|35|||
25252781|NCT01130272|50568357|FG002|Overall Study|IVRS-confirmed constipation|1|||
25252782|NCT01130272|50568358|FG003|Overall Study|IVRS-confirmed constipation|2|||
25252783|NCT01130272|50568359|FG004|Overall Study|IVRS-confirmed constipation|0|||
25252784|NCT01130272|50568355|FG000|Overall Study|Rescue medications due to diarrhea|3|||
25335415|NCT00847301|50651770|FG000|Overall Study|Switch to other anticoagulants|16|||
25335416|NCT00847301|50651770|FG000|Overall Study|Lost to Follow-up|1|||
25335417|NCT00847301|50651770|FG000|Overall Study|No prescription after hospital discharge|1|||
25335418|NCT00847301|50651770|FG000|Overall Study|Other reason not defined above|1|||
25335419|NCT00624520|50651776|FG000|Overall Study|Withdrawal by Subject|12|||
25335420|NCT00624520|50651777|FG001|Overall Study|Withdrawal by Subject|7|||
25335421|NCT00624520|50651776|FG000|Overall Study|Death|0|||
25335422|NCT00624520|50651777|FG001|Overall Study|Death|1|||
25335423|NCT00847145|50651791|FG000|Overall Study|AE or Death|0|||
25335424|NCT00847145|50651792|FG001|Overall Study|AE or Death|1|||
25335425|NCT00847145|50651793|FG002|Overall Study|AE or Death|1|||
25335426|NCT00847145|50651794|FG003|Overall Study|AE or Death|0|||
25335427|NCT00847145|50651795|FG004|Overall Study|AE or Death|0|||
25335428|NCT00847145|50651796|FG005|Overall Study|AE or Death|0|||
25335429|NCT00847145|50651797|FG006|Overall Study|AE or Death|0|||
25252785|NCT01130272|50568356|FG001|Overall Study|Rescue medications due to diarrhea|5|||
25252786|NCT01130272|50568357|FG002|Overall Study|Rescue medications due to diarrhea|8|||
25252787|NCT01130272|50568358|FG003|Overall Study|Rescue medications due to diarrhea|8|||
25252788|NCT01130272|50568359|FG004|Overall Study|Rescue medications due to diarrhea|6|||
25252789|NCT01130272|50568355|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
25252790|NCT01130272|50568356|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
25252791|NCT01130272|50568357|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
25335430|NCT00847145|50651798|FG007|Overall Study|AE or Death|0|||
25335431|NCT00847145|50651791|FG000|Overall Study|Withdrawal by Subject|3|||
25335432|NCT00847145|50651792|FG001|Overall Study|Withdrawal by Subject|4|||
25335433|NCT00847145|50651793|FG002|Overall Study|Withdrawal by Subject|6|||
25335434|NCT00847145|50651794|FG003|Overall Study|Withdrawal by Subject|1|||
25335435|NCT00847145|50651795|FG004|Overall Study|Withdrawal by Subject|0|||
25335436|NCT00847145|50651796|FG005|Overall Study|Withdrawal by Subject|0|||
25335437|NCT00847145|50651797|FG006|Overall Study|Withdrawal by Subject|1|||
25335438|NCT00847145|50651798|FG007|Overall Study|Withdrawal by Subject|1|||
25335439|NCT00847145|50651791|FG000|Overall Study|Lost to Follow-up|3|||
25335440|NCT00847145|50651792|FG001|Overall Study|Lost to Follow-up|1|||
25335441|NCT00847145|50651793|FG002|Overall Study|Lost to Follow-up|1|||
25335442|NCT00847145|50651794|FG003|Overall Study|Lost to Follow-up|0|||
25252792|NCT01130272|50568358|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
25335443|NCT00847145|50651795|FG004|Overall Study|Lost to Follow-up|4|||
25252793|NCT01130272|50568359|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
25252794|NCT01130272|50568355|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
25252795|NCT01130272|50568356|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
25335444|NCT00847145|50651796|FG005|Overall Study|Lost to Follow-up|4|||
25335445|NCT00847145|50651797|FG006|Overall Study|Lost to Follow-up|8|||
25335446|NCT00847145|50651798|FG007|Overall Study|Lost to Follow-up|2|||
25335447|NCT00847145|50651791|FG000|Overall Study|Inappropriate enrollment|0|||
25335448|NCT00847145|50651792|FG001|Overall Study|Inappropriate enrollment|0|||
25335449|NCT00847145|50651793|FG002|Overall Study|Inappropriate enrollment|0|||
25335450|NCT00847145|50651794|FG003|Overall Study|Inappropriate enrollment|0|||
25335451|NCT00847145|50651795|FG004|Overall Study|Inappropriate enrollment|1|||
25335452|NCT00847145|50651796|FG005|Overall Study|Inappropriate enrollment|0|||
25335453|NCT00847145|50651797|FG006|Overall Study|Inappropriate enrollment|0|||
25335454|NCT00847145|50651798|FG007|Overall Study|Inappropriate enrollment|0|||
25335455|NCT00847145|50651791|FG000|Overall Study|Protocol Violation|0|||
25335456|NCT00847145|50651792|FG001|Overall Study|Protocol Violation|0|||
25335457|NCT00847145|50651793|FG002|Overall Study|Protocol Violation|3|||
25335458|NCT00847145|50651794|FG003|Overall Study|Protocol Violation|0|||
25335459|NCT00847145|50651795|FG004|Overall Study|Protocol Violation|1|||
25335460|NCT00847145|50651796|FG005|Overall Study|Protocol Violation|0|||
25335461|NCT00847145|50651797|FG006|Overall Study|Protocol Violation|0|||
25335462|NCT00847145|50651798|FG007|Overall Study|Protocol Violation|1|||
25335463|NCT00846521|50651825|FG000|Overall Study|Withdrawal by Subject|5|||
25335464|NCT00846521|50651825|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
25335465|NCT00846521|50651825|FG000|Overall Study|Protocol Violation|1|||
25335466|NCT00862823|50651829|FG000|First Intervention|Withdrawal by Subject|1|||
25335467|NCT00862823|50651830|FG001|First Intervention|Withdrawal by Subject|1|||
25335468|NCT00790842|50651838|FG000|Dose Level 1|Adverse Event|1|||
25335469|NCT00790842|50651839|FG001|Dose Level 1|Adverse Event|0|||
25335470|NCT00790842|50651840|FG002|Dose Level 1|Adverse Event|0|||
25335471|NCT00790842|50651841|FG003|Dose Level 1|Adverse Event|2|||
25335472|NCT00790842|50651842|FG004|Dose Level 1|Adverse Event|0|||
25335473|NCT00790842|50651843|FG005|Dose Level 1|Adverse Event|0|||
25335474|NCT00790842|50651844|FG006|Dose Level 1|Adverse Event|0|||
25335475|NCT00790842|50651845|FG007|Dose Level 1|Adverse Event|1|||
25335476|NCT00790842|50651846|FG008|Dose Level 1|Adverse Event|0|||
25335477|NCT00790842|50651847|FG009|Dose Level 1|Adverse Event|0|||
25335478|NCT00790842|50651848|FG010|Dose Level 1|Adverse Event|0|||
25335479|NCT00790842|50651838|FG000|Dose Level 1|Physician Decision|1|||
25335480|NCT00790842|50651839|FG001|Dose Level 1|Physician Decision|0|||
25335481|NCT00790842|50651840|FG002|Dose Level 1|Physician Decision|0|||
25335482|NCT00790842|50651841|FG003|Dose Level 1|Physician Decision|0|||
25335483|NCT00790842|50651842|FG004|Dose Level 1|Physician Decision|0|||
24902068|NCT00715676|49996091|FG002|Overall Study|Adverse Event|21|||
25252796|NCT01130272|50568357|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
25252797|NCT01130272|50568358|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
25252798|NCT01130272|50568359|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
25252799|NCT01130272|50568355|FG000|Overall Study|Protocol Violation|0|||
25252800|NCT01130272|50568356|FG001|Overall Study|Protocol Violation|0|||
25252801|NCT01130272|50568357|FG002|Overall Study|Protocol Violation|3|||
25252802|NCT01130272|50568358|FG003|Overall Study|Protocol Violation|5|||
25252803|NCT01130272|50568359|FG004|Overall Study|Protocol Violation|5|||
25252804|NCT01130272|50568355|FG000|Overall Study|Lost to Follow-up|4|||
25252805|NCT01130272|50568356|FG001|Overall Study|Lost to Follow-up|3|||
25252806|NCT01130272|50568357|FG002|Overall Study|Lost to Follow-up|4|||
25252807|NCT01130272|50568358|FG003|Overall Study|Lost to Follow-up|7|||
25252808|NCT01130272|50568359|FG004|Overall Study|Lost to Follow-up|6|||
25252809|NCT01130272|50568355|FG000|Overall Study|Withdrawal by Subject|4|||
25252810|NCT01130272|50568356|FG001|Overall Study|Withdrawal by Subject|11|||
25252811|NCT01130272|50568357|FG002|Overall Study|Withdrawal by Subject|10|||
25252812|NCT01130272|50568358|FG003|Overall Study|Withdrawal by Subject|9|||
25252813|NCT01130272|50568359|FG004|Overall Study|Withdrawal by Subject|8|||
25252814|NCT01130272|50568355|FG000|Overall Study|Physician Decision|1|||
25252815|NCT01130272|50568356|FG001|Overall Study|Physician Decision|1|||
25252816|NCT01130272|50568357|FG002|Overall Study|Physician Decision|0|||
25252817|NCT01130272|50568358|FG003|Overall Study|Physician Decision|1|||
25252818|NCT01130272|50568359|FG004|Overall Study|Physician Decision|2|||
25252819|NCT01130272|50568355|FG000|Overall Study|Sponsor decision|6|||
25252820|NCT01130272|50568356|FG001|Overall Study|Sponsor decision|15|||
25252821|NCT01130272|50568357|FG002|Overall Study|Sponsor decision|16|||
25252822|NCT01130272|50568358|FG003|Overall Study|Sponsor decision|13|||
25252823|NCT01130272|50568359|FG004|Overall Study|Sponsor decision|16|||
25252824|NCT01130272|50568355|FG000|Overall Study|Study arm discontinued|38|||
25335484|NCT00790842|50651843|FG005|Dose Level 1|Physician Decision|0|||
25335485|NCT00790842|50651844|FG006|Dose Level 1|Physician Decision|0|||
25252825|NCT01130272|50568356|FG001|Overall Study|Study arm discontinued|0|||
25252826|NCT01130272|50568357|FG002|Overall Study|Study arm discontinued|0|||
25252827|NCT01130272|50568358|FG003|Overall Study|Study arm discontinued|0|||
25335486|NCT00790842|50651845|FG007|Dose Level 1|Physician Decision|1|||
25335487|NCT00790842|50651846|FG008|Dose Level 1|Physician Decision|0|||
25335488|NCT00790842|50651847|FG009|Dose Level 1|Physician Decision|0|||
25335489|NCT00790842|50651848|FG010|Dose Level 1|Physician Decision|0|||
25335490|NCT00790842|50651838|FG000|Dose Level 1|Withdrawal by Subject|1|||
25252828|NCT01130272|50568359|FG004|Overall Study|Study arm discontinued|0|||
25252829|NCT01129960|50568375|FG000|Overall Study|Withdrawal by Subject|3|||
25335491|NCT00790842|50651839|FG001|Dose Level 1|Withdrawal by Subject|0|||
25335492|NCT00790842|50651840|FG002|Dose Level 1|Withdrawal by Subject|0|||
25335493|NCT00790842|50651841|FG003|Dose Level 1|Withdrawal by Subject|0|||
25335494|NCT00790842|50651842|FG004|Dose Level 1|Withdrawal by Subject|0|||
25335495|NCT00790842|50651843|FG005|Dose Level 1|Withdrawal by Subject|0|||
25335496|NCT00790842|50651844|FG006|Dose Level 1|Withdrawal by Subject|0|||
25335497|NCT00790842|50651845|FG007|Dose Level 1|Withdrawal by Subject|0|||
25335498|NCT00790842|50651846|FG008|Dose Level 1|Withdrawal by Subject|0|||
25335499|NCT00790842|50651847|FG009|Dose Level 1|Withdrawal by Subject|0|||
25335500|NCT00790842|50651848|FG010|Dose Level 1|Withdrawal by Subject|0|||
25335501|NCT00790842|50651838|FG000|Dose Level 2|Death|0|||
25335502|NCT00790842|50651839|FG001|Dose Level 2|Death|1|||
25335503|NCT00790842|50651840|FG002|Dose Level 2|Death|0|||
25335504|NCT00790842|50651841|FG003|Dose Level 2|Death|0|||
25335505|NCT00790842|50651842|FG004|Dose Level 2|Death|1|||
25335506|NCT00790842|50651843|FG005|Dose Level 2|Death|0|||
25335507|NCT00790842|50651844|FG006|Dose Level 2|Death|0|||
25335508|NCT00790842|50651845|FG007|Dose Level 2|Death|0|||
25335509|NCT00790842|50651846|FG008|Dose Level 2|Death|0|||
25335510|NCT00790842|50651847|FG009|Dose Level 2|Death|0|||
25335511|NCT00790842|50651848|FG010|Dose Level 2|Death|0|||
25252830|NCT01129960|50568376|FG001|Overall Study|Withdrawal by Subject|0|||
25252831|NCT01129960|50568377|FG002|Overall Study|Withdrawal by Subject|3|||
25252832|NCT01129960|50568378|FG003|Overall Study|Withdrawal by Subject|2|||
25252833|NCT01129960|50568375|FG000|Overall Study|Lack of Efficacy|1|||
25252834|NCT01129960|50568376|FG001|Overall Study|Lack of Efficacy|1|||
25252835|NCT01129960|50568377|FG002|Overall Study|Lack of Efficacy|1|||
25252836|NCT01129960|50568378|FG003|Overall Study|Lack of Efficacy|1|||
25252837|NCT01129960|50568375|FG000|Overall Study|Adverse Event|23|||
25335512|NCT00790842|50651838|FG000|Dose Level 2|Physician Decision|0|||
25335513|NCT00790842|50651839|FG001|Dose Level 2|Physician Decision|1|||
25335514|NCT00790842|50651840|FG002|Dose Level 2|Physician Decision|0|||
25335515|NCT00790842|50651841|FG003|Dose Level 2|Physician Decision|0|||
25335516|NCT00790842|50651842|FG004|Dose Level 2|Physician Decision|0|||
25335517|NCT00790842|50651843|FG005|Dose Level 2|Physician Decision|0|||
25335518|NCT00790842|50651844|FG006|Dose Level 2|Physician Decision|0|||
25335519|NCT00790842|50651845|FG007|Dose Level 2|Physician Decision|0|||
25335520|NCT00790842|50651846|FG008|Dose Level 2|Physician Decision|0|||
25335521|NCT00790842|50651847|FG009|Dose Level 2|Physician Decision|0|||
25252838|NCT01129960|50568376|FG001|Overall Study|Adverse Event|16|||
25252839|NCT01129960|50568377|FG002|Overall Study|Adverse Event|16|||
25252840|NCT01129960|50568378|FG003|Overall Study|Adverse Event|7|||
25252841|NCT01129960|50568375|FG000|Overall Study|Protocol Violation|1|||
25252842|NCT01129960|50568376|FG001|Overall Study|Protocol Violation|2|||
25252843|NCT01129960|50568377|FG002|Overall Study|Protocol Violation|3|||
25252844|NCT01129960|50568378|FG003|Overall Study|Protocol Violation|0|||
25252845|NCT01129960|50568375|FG000|Overall Study|Lost to Follow-up|0|||
25335522|NCT00790842|50651848|FG010|Dose Level 2|Physician Decision|0|||
25335523|NCT00790842|50651838|FG000|Dose Level 2|Withdrawal by Subject|0|||
25335524|NCT00790842|50651839|FG001|Dose Level 2|Withdrawal by Subject|1|||
25335525|NCT00790842|50651840|FG002|Dose Level 2|Withdrawal by Subject|0|||
25335526|NCT00790842|50651841|FG003|Dose Level 2|Withdrawal by Subject|0|||
25335527|NCT00790842|50651842|FG004|Dose Level 2|Withdrawal by Subject|0|||
25335528|NCT00790842|50651843|FG005|Dose Level 2|Withdrawal by Subject|0|||
25335529|NCT00790842|50651844|FG006|Dose Level 2|Withdrawal by Subject|0|||
25335530|NCT00790842|50651845|FG007|Dose Level 2|Withdrawal by Subject|0|||
25335531|NCT00790842|50651846|FG008|Dose Level 2|Withdrawal by Subject|0|||
25077898|NCT02896855|50185964|FG000|Overall Study|Withdrawal by Subject|7|||
25335532|NCT00790842|50651847|FG009|Dose Level 2|Withdrawal by Subject|0|||
25335533|NCT00790842|50651848|FG010|Dose Level 2|Withdrawal by Subject|0|||
25335534|NCT00790842|50651838|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
25335535|NCT00790842|50651839|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
25335536|NCT00790842|50651840|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
25335537|NCT00790842|50651841|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
25335538|NCT00790842|50651842|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
25335539|NCT00790842|50651843|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
25252846|NCT01129960|50568376|FG001|Overall Study|Lost to Follow-up|2|||
25252847|NCT01129960|50568377|FG002|Overall Study|Lost to Follow-up|3|||
25252848|NCT01129960|50568378|FG003|Overall Study|Lost to Follow-up|3|||
25252849|NCT01129960|50568375|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
25335540|NCT00790842|50651844|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
25335541|NCT00790842|50651845|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
25335542|NCT00790842|50651846|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
25335543|NCT00790842|50651847|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
25335544|NCT00790842|50651848|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
25335545|NCT00790842|50651838|FG000|Dose Level 3|Adverse Event|0|||
25335546|NCT00790842|50651839|FG001|Dose Level 3|Adverse Event|0|||
25335547|NCT00790842|50651840|FG002|Dose Level 3|Adverse Event|1|||
25252850|NCT01129960|50568376|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
25252851|NCT01129960|50568377|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
25252852|NCT01129960|50568378|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
25252853|NCT01129960|50568375|FG000|Overall Study|Physician Decision|1|||
25252854|NCT01129960|50568376|FG001|Overall Study|Physician Decision|0|||
25252855|NCT01129960|50568377|FG002|Overall Study|Physician Decision|0|||
25252856|NCT01129960|50568378|FG003|Overall Study|Physician Decision|0|||
25252857|NCT01129960|50568375|FG000|Overall Study|Pregnancy|1|||
25252858|NCT01129960|50568376|FG001|Overall Study|Pregnancy|0|||
25252859|NCT01129960|50568377|FG002|Overall Study|Pregnancy|0|||
25252860|NCT01129960|50568378|FG003|Overall Study|Pregnancy|0|||
25252861|NCT01129921|50568390|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
25252862|NCT01129921|50568391|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
25252863|NCT01129921|50568390|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
25252864|NCT01129921|50568391|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
25252865|NCT01129921|50568390|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
25252866|NCT01129921|50568391|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
25252867|NCT01129921|50568390|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
25252868|NCT01129921|50568391|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
25335548|NCT00790842|50651841|FG003|Dose Level 3|Adverse Event|0|||
25335549|NCT00790842|50651842|FG004|Dose Level 3|Adverse Event|0|||
25335550|NCT00790842|50651843|FG005|Dose Level 3|Adverse Event|0|||
25335551|NCT00790842|50651844|FG006|Dose Level 3|Adverse Event|0|||
25335552|NCT00790842|50651845|FG007|Dose Level 3|Adverse Event|0|||
25335553|NCT00790842|50651846|FG008|Dose Level 3|Adverse Event|0|||
25335554|NCT00790842|50651847|FG009|Dose Level 3|Adverse Event|0|||
25335555|NCT00790842|50651848|FG010|Dose Level 3|Adverse Event|0|||
25335556|NCT00790842|50651838|FG000|Dose Level 3|Withdrawal by Subject|0|||
25335557|NCT00790842|50651839|FG001|Dose Level 3|Withdrawal by Subject|0|||
25335558|NCT00790842|50651840|FG002|Dose Level 3|Withdrawal by Subject|3|||
25335559|NCT00790842|50651841|FG003|Dose Level 3|Withdrawal by Subject|0|||
25335560|NCT00790842|50651842|FG004|Dose Level 3|Withdrawal by Subject|0|||
25335561|NCT00790842|50651843|FG005|Dose Level 3|Withdrawal by Subject|0|||
25335562|NCT00790842|50651844|FG006|Dose Level 3|Withdrawal by Subject|0|||
25335563|NCT00790842|50651845|FG007|Dose Level 3|Withdrawal by Subject|0|||
25335564|NCT00790842|50651846|FG008|Dose Level 3|Withdrawal by Subject|0|||
25335565|NCT00790842|50651847|FG009|Dose Level 3|Withdrawal by Subject|2|||
25335566|NCT00790842|50651848|FG010|Dose Level 3|Withdrawal by Subject|0|||
25335567|NCT00790842|50651838|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
25335568|NCT00790842|50651839|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
25335569|NCT00790842|50651840|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
25335570|NCT00790842|50651841|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
25335571|NCT00790842|50651842|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
25335572|NCT00790842|50651843|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
25335573|NCT00790842|50651844|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
25335574|NCT00790842|50651845|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
25335575|NCT00790842|50651846|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
25335576|NCT00790842|50651847|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
25335577|NCT00790842|50651848|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
25335578|NCT00790842|50651838|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
25335579|NCT00790842|50651839|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
25335580|NCT00790842|50651840|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
25335581|NCT00790842|50651841|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
25335582|NCT00790842|50651842|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
25335583|NCT00790842|50651843|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
25335584|NCT00790842|50651844|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
25335585|NCT00790842|50651845|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
25335586|NCT00790842|50651846|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
25335587|NCT00790842|50651847|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
25335588|NCT00790842|50651848|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
25335589|NCT00790842|50651838|FG000|Dose Level 4|Adverse Event|0|||
25335590|NCT00790842|50651839|FG001|Dose Level 4|Adverse Event|0|||
25335591|NCT00790842|50651840|FG002|Dose Level 4|Adverse Event|0|||
25335592|NCT00790842|50651841|FG003|Dose Level 4|Adverse Event|0|||
25335593|NCT00790842|50651842|FG004|Dose Level 4|Adverse Event|0|||
25335594|NCT00790842|50651843|FG005|Dose Level 4|Adverse Event|0|||
25252869|NCT01129882|50568401|FG000|Overall Study|Adverse Event|39|||
25252870|NCT01129882|50568401|FG000|Overall Study|Death|6|||
25335595|NCT00790842|50651844|FG006|Dose Level 4|Adverse Event|1|||
25335596|NCT00790842|50651845|FG007|Dose Level 4|Adverse Event|0|||
25335597|NCT00790842|50651846|FG008|Dose Level 4|Adverse Event|0|||
25335598|NCT00790842|50651847|FG009|Dose Level 4|Adverse Event|0|||
25335599|NCT00790842|50651848|FG010|Dose Level 4|Adverse Event|0|||
25335600|NCT00790842|50651838|FG000|Dose Level 4|Physician Decision|0|||
25335601|NCT00790842|50651839|FG001|Dose Level 4|Physician Decision|0|||
25335602|NCT00790842|50651840|FG002|Dose Level 4|Physician Decision|0|||
25335603|NCT00790842|50651841|FG003|Dose Level 4|Physician Decision|0|||
25335604|NCT00790842|50651842|FG004|Dose Level 4|Physician Decision|0|||
25335605|NCT00790842|50651843|FG005|Dose Level 4|Physician Decision|0|||
25335606|NCT00790842|50651844|FG006|Dose Level 4|Physician Decision|1|||
25335607|NCT00790842|50651845|FG007|Dose Level 4|Physician Decision|0|||
25335608|NCT00790842|50651846|FG008|Dose Level 4|Physician Decision|0|||
25335609|NCT00790842|50651847|FG009|Dose Level 4|Physician Decision|0|||
25252871|NCT01129882|50568401|FG000|Overall Study|Lack of Efficacy|5|||
25252872|NCT01129882|50568401|FG000|Overall Study|Lost to Follow-up|13|||
25335610|NCT00790842|50651848|FG010|Dose Level 4|Physician Decision|1|||
25335611|NCT00790842|50651838|FG000|Dose Level 4|Withdrawal by Subject|0|||
25335612|NCT00790842|50651839|FG001|Dose Level 4|Withdrawal by Subject|0|||
25335613|NCT00790842|50651840|FG002|Dose Level 4|Withdrawal by Subject|0|||
25335614|NCT00790842|50651841|FG003|Dose Level 4|Withdrawal by Subject|0|||
25335615|NCT00790842|50651842|FG004|Dose Level 4|Withdrawal by Subject|0|||
25335616|NCT00790842|50651843|FG005|Dose Level 4|Withdrawal by Subject|0|||
25335617|NCT00790842|50651844|FG006|Dose Level 4|Withdrawal by Subject|0|||
25335618|NCT00790842|50651845|FG007|Dose Level 4|Withdrawal by Subject|0|||
25335619|NCT00790842|50651846|FG008|Dose Level 4|Withdrawal by Subject|0|||
25335620|NCT00790842|50651847|FG009|Dose Level 4|Withdrawal by Subject|0|||
25335621|NCT00790842|50651848|FG010|Dose Level 4|Withdrawal by Subject|1|||
25335622|NCT00790842|50651838|FG000|Expansion Cohort|Adverse Event|0|||
25335623|NCT00790842|50651839|FG001|Expansion Cohort|Adverse Event|0|||
25252873|NCT01129882|50568401|FG000|Overall Study|Physician Decision|27|||
25252874|NCT01129882|50568401|FG000|Overall Study|Protocol Deviation|3|||
25252875|NCT01129882|50568401|FG000|Overall Study|Withdrawal Criteria Met|19|||
25252876|NCT01129882|50568401|FG000|Overall Study|Trial Termination by Sponsor|6|||
25252877|NCT01129882|50568401|FG000|Overall Study|Withdrawal by Subject|160|||
25252878|NCT01129102|50568408|FG000|Overall Study|No study drug treatment|2|||
25252879|NCT01129102|50568409|FG001|Overall Study|No study drug treatment|3|||
25252880|NCT01129102|50568410|FG002|Overall Study|No study drug treatment|1|||
25252881|NCT01129102|50568408|FG000|Overall Study|Withdrawal by Subject|2|||
25252882|NCT01129102|50568409|FG001|Overall Study|Withdrawal by Subject|0|||
25252883|NCT01129102|50568410|FG002|Overall Study|Withdrawal by Subject|3|||
25252884|NCT01129102|50568408|FG000|Overall Study|Protocol Violation|0|||
25252885|NCT01129102|50568409|FG001|Overall Study|Protocol Violation|1|||
25252886|NCT01129102|50568410|FG002|Overall Study|Protocol Violation|1|||
25252887|NCT01129102|50568408|FG000|Overall Study|Pregnancy|0|||
25252888|NCT01129102|50568409|FG001|Overall Study|Pregnancy|0|||
25252889|NCT01129102|50568410|FG002|Overall Study|Pregnancy|1|||
25252890|NCT01129102|50568408|FG000|Overall Study|Adverse Event|2|||
25252891|NCT01129102|50568409|FG001|Overall Study|Adverse Event|2|||
25252892|NCT01129102|50568410|FG002|Overall Study|Adverse Event|1|||
25252893|NCT01129102|50568408|FG000|Overall Study|Lost to Follow-up|2|||
25252894|NCT01129102|50568409|FG001|Overall Study|Lost to Follow-up|0|||
25252895|NCT01129102|50568410|FG002|Overall Study|Lost to Follow-up|0|||
25252896|NCT01129024|50568417|FG000|Overall Study|Physician Decision|5|||
25252897|NCT01129024|50568417|FG000|Overall Study|Study Terminated by Sponsor|8|||
25252898|NCT01129024|50568417|FG000|Overall Study|Withdrawal by Subject|2|||
25252899|NCT01129024|50568417|FG000|Overall Study|Lack of Efficacy|3|||
25252900|NCT01129024|50568417|FG000|Overall Study|Needed a Platelet Transfusion|1|||
25252901|NCT01128946|50568421|FG000|Period I|Protocol Violation|0|||
25252902|NCT01128946|50568422|FG001|Period I|Protocol Violation|1|||
25252903|NCT01128946|50568423|FG002|Period I|Protocol Violation|0|||
25252904|NCT01128946|50568424|FG003|Period I|Protocol Violation|0|||
25252905|NCT01128946|50568421|FG000|Period I|Withdrawal by Subject|0|||
25252906|NCT01128946|50568422|FG001|Period I|Withdrawal by Subject|0|||
25335624|NCT00790842|50651840|FG002|Expansion Cohort|Adverse Event|0|||
25335625|NCT00790842|50651841|FG003|Expansion Cohort|Adverse Event|0|||
25335626|NCT00790842|50651842|FG004|Expansion Cohort|Adverse Event|0|||
25335627|NCT00790842|50651843|FG005|Expansion Cohort|Adverse Event|0|||
25252907|NCT01128946|50568423|FG002|Period I|Withdrawal by Subject|1|||
25252908|NCT01128946|50568424|FG003|Period I|Withdrawal by Subject|1|||
25252909|NCT01128946|50568421|FG000|Period II|Protocol Violation|0|||
25252910|NCT01128946|50568422|FG001|Period II|Protocol Violation|1|||
25252911|NCT01128946|50568423|FG002|Period II|Protocol Violation|0|||
25252912|NCT01128946|50568424|FG003|Period II|Protocol Violation|0|||
25252913|NCT01128946|50568421|FG000|Period II|Withdrawal by Subject|0|||
25252914|NCT01128946|50568422|FG001|Period II|Withdrawal by Subject|0|||
25252915|NCT01128946|50568423|FG002|Period II|Withdrawal by Subject|0|||
25252916|NCT01128946|50568424|FG003|Period II|Withdrawal by Subject|1|||
25335628|NCT00790842|50651844|FG006|Expansion Cohort|Adverse Event|1|||
25335629|NCT00790842|50651845|FG007|Expansion Cohort|Adverse Event|0|||
25335630|NCT00790842|50651846|FG008|Expansion Cohort|Adverse Event|0|||
25335631|NCT00790842|50651847|FG009|Expansion Cohort|Adverse Event|0|||
25335632|NCT00790842|50651848|FG010|Expansion Cohort|Adverse Event|0|||
25335633|NCT00790842|50651838|FG000|Expansion Cohort|Death|0|||
25335634|NCT00790842|50651839|FG001|Expansion Cohort|Death|0|||
25335635|NCT00790842|50651840|FG002|Expansion Cohort|Death|2|||
25335636|NCT00790842|50651841|FG003|Expansion Cohort|Death|0|||
25335637|NCT00790842|50651842|FG004|Expansion Cohort|Death|0|||
25335638|NCT00790842|50651843|FG005|Expansion Cohort|Death|0|||
25335639|NCT00790842|50651844|FG006|Expansion Cohort|Death|0|||
25335640|NCT00790842|50651845|FG007|Expansion Cohort|Death|0|||
25335641|NCT00790842|50651846|FG008|Expansion Cohort|Death|0|||
25335642|NCT00790842|50651847|FG009|Expansion Cohort|Death|0|||
25335643|NCT00790842|50651848|FG010|Expansion Cohort|Death|0|||
25335644|NCT00790842|50651838|FG000|Expansion Cohort|Physician Decision|0|||
25335645|NCT00790842|50651839|FG001|Expansion Cohort|Physician Decision|0|||
25335646|NCT00790842|50651840|FG002|Expansion Cohort|Physician Decision|1|||
25335647|NCT00790842|50651841|FG003|Expansion Cohort|Physician Decision|0|||
25335648|NCT00790842|50651842|FG004|Expansion Cohort|Physician Decision|0|||
25335649|NCT00790842|50651843|FG005|Expansion Cohort|Physician Decision|0|||
25252917|NCT01128946|50568421|FG000|Period III|Protocol Violation|1|||
25252918|NCT01128946|50568422|FG001|Period III|Protocol Violation|0|||
25252919|NCT01128946|50568423|FG002|Period III|Protocol Violation|0|||
25252920|NCT01128946|50568424|FG003|Period III|Protocol Violation|0|||
25335650|NCT00790842|50651844|FG006|Expansion Cohort|Physician Decision|0|||
25335651|NCT00790842|50651845|FG007|Expansion Cohort|Physician Decision|0|||
25335652|NCT00790842|50651846|FG008|Expansion Cohort|Physician Decision|0|||
25335653|NCT00790842|50651847|FG009|Expansion Cohort|Physician Decision|0|||
25335654|NCT00790842|50651848|FG010|Expansion Cohort|Physician Decision|0|||
25335655|NCT00790842|50651838|FG000|Expansion Cohort|Withdrawal by Subject|0|||
25335656|NCT00790842|50651839|FG001|Expansion Cohort|Withdrawal by Subject|0|||
25335657|NCT00790842|50651840|FG002|Expansion Cohort|Withdrawal by Subject|3|||
25335658|NCT00790842|50651841|FG003|Expansion Cohort|Withdrawal by Subject|0|||
25335659|NCT00790842|50651842|FG004|Expansion Cohort|Withdrawal by Subject|0|||
25335660|NCT00790842|50651843|FG005|Expansion Cohort|Withdrawal by Subject|0|||
25335661|NCT00790842|50651844|FG006|Expansion Cohort|Withdrawal by Subject|0|||
25335662|NCT00790842|50651845|FG007|Expansion Cohort|Withdrawal by Subject|0|||
25335663|NCT00790842|50651846|FG008|Expansion Cohort|Withdrawal by Subject|0|||
25335664|NCT00790842|50651847|FG009|Expansion Cohort|Withdrawal by Subject|0|||
25335665|NCT00790842|50651848|FG010|Expansion Cohort|Withdrawal by Subject|0|||
25335666|NCT00790842|50651838|FG000|Expansion Cohort|Study Closure|0|||
25077899|NCT02896855|50185965|FG001|Overall Study|Withdrawal by Subject|4|||
25077900|NCT02232802|50185976|FG000|Period 1|Sponsor request|1|||
25077901|NCT02232802|50185977|FG001|Period 1|Sponsor request|0|||
25077902|NCT02232802|50185976|FG000|Period 1|Adverse Event|1|||
25077903|NCT02232802|50185977|FG001|Period 1|Adverse Event|1|||
25077904|NCT02434328|50185985|FG000|Overall Study|Adverse Event|9|||
25077905|NCT02434328|50185986|FG001|Overall Study|Adverse Event|4|||
25077906|NCT02434328|50185985|FG000|Overall Study|Lack of Efficacy|0|||
25077907|NCT02434328|50185986|FG001|Overall Study|Lack of Efficacy|2|||
25077908|NCT02434328|50185985|FG000|Overall Study|Physician Decision|0|||
25077909|NCT02434328|50185986|FG001|Overall Study|Physician Decision|1|||
25077910|NCT02434328|50185985|FG000|Overall Study|Withdrawal by Subject|12|||
25077911|NCT02434328|50185986|FG001|Overall Study|Withdrawal by Subject|21|||
25077912|NCT02434328|50185985|FG000|Overall Study|Death|4|||
25077913|NCT02434328|50185986|FG001|Overall Study|Death|7|||
25077914|NCT02434328|50185985|FG000|Overall Study|Lost to Follow-up|1|||
25077915|NCT02434328|50185986|FG001|Overall Study|Lost to Follow-up|6|||
25077916|NCT02434328|50185985|FG000|Overall Study|Other|4|||
25077917|NCT02434328|50185986|FG001|Overall Study|Other|1|||
25077918|NCT02660229|50185995|FG000|Overall Study|Adverse Event|2|||
24902069|NCT00715676|49996089|FG000|Overall Study|Withdrawal by Subject|1|||
25077919|NCT02660229|50185996|FG001|Overall Study|Adverse Event|0|||
25252921|NCT01128595|50568435|FG000|Treatment Period 3|Withdrawal by Subject|0|||
25252922|NCT01128595|50568436|FG001|Treatment Period 3|Withdrawal by Subject|1|||
25252923|NCT01128595|50568437|FG002|Treatment Period 3|Withdrawal by Subject|0|||
24902070|NCT00715676|49996090|FG001|Overall Study|Withdrawal by Subject|3|||
24902071|NCT00715676|49996091|FG002|Overall Study|Withdrawal by Subject|8|||
25252924|NCT01128595|50568438|FG003|Treatment Period 3|Withdrawal by Subject|0|||
25252925|NCT01129336|50568451|FG000|Overall Study|Protocol Violation|1|||
25252926|NCT01129336|50568452|FG001|Overall Study|Protocol Violation|0|||
25252927|NCT01129336|50568451|FG000|Overall Study|Disease Progression|1|||
25077920|NCT02660229|50185995|FG000|Overall Study|Withdrawal by Subject|0|||
25077921|NCT02660229|50185996|FG001|Overall Study|Withdrawal by Subject|1|||
25252928|NCT01129336|50568452|FG001|Overall Study|Disease Progression|4|||
25252929|NCT01129336|50568451|FG000|Overall Study|Lost to Follow-up|1|||
25077922|NCT02232178|50186005|FG000|Overall Study|Lost to Follow-up|0|||
25077923|NCT02232178|50186006|FG001|Overall Study|Lost to Follow-up|1|||
25077924|NCT02232178|50186007|FG002|Overall Study|Lost to Follow-up|0|||
25252930|NCT01129336|50568452|FG001|Overall Study|Lost to Follow-up|0|||
25252931|NCT01129336|50568451|FG000|Overall Study|Withdrawal by Subject|7|||
25252932|NCT01129336|50568452|FG001|Overall Study|Withdrawal by Subject|4|||
25335667|NCT00790842|50651839|FG001|Expansion Cohort|Study Closure|0|||
25335668|NCT00790842|50651840|FG002|Expansion Cohort|Study Closure|1|||
25252933|NCT01129336|50568451|FG000|Overall Study|Adverse Event|0|||
25252934|NCT01129336|50568452|FG001|Overall Study|Adverse Event|1|||
25252935|NCT01129336|50568451|FG000|Overall Study|Missing Study Completion Status|2|||
25252936|NCT01129336|50568452|FG001|Overall Study|Missing Study Completion Status|3|||
25252937|NCT01129336|50568451|FG000|Overall Study|Death|0|||
25252938|NCT01129336|50568452|FG001|Overall Study|Death|4|||
25252939|NCT01128400|50568461|FG000|Overall Study|Lost to Follow-up|1|||
25252940|NCT01128400|50568462|FG001|Overall Study|Lost to Follow-up|0|||
25252941|NCT01128400|50568463|FG002|Overall Study|Lost to Follow-up|1|||
25252942|NCT01128400|50568461|FG000|Overall Study|Screening failure|1|||
25252943|NCT01128400|50568462|FG001|Overall Study|Screening failure|0|||
25252944|NCT01128400|50568463|FG002|Overall Study|Screening failure|0|||
25252945|NCT01128400|50568461|FG000|Overall Study|were not invited to participate on taste|0|||
25252946|NCT01128400|50568462|FG001|Overall Study|were not invited to participate on taste|0|||
25252947|NCT01128400|50568463|FG002|Overall Study|were not invited to participate on taste|15|||
25252948|NCT01128400|50568461|FG000|Overall Study|Excluded due to sinus problems|0|||
25335669|NCT00790842|50651841|FG003|Expansion Cohort|Study Closure|0|||
25335670|NCT00790842|50651842|FG004|Expansion Cohort|Study Closure|0|||
25335671|NCT00790842|50651843|FG005|Expansion Cohort|Study Closure|0|||
25335672|NCT00790842|50651844|FG006|Expansion Cohort|Study Closure|0|||
25335673|NCT00790842|50651845|FG007|Expansion Cohort|Study Closure|0|||
24902072|NCT00715676|49996089|FG000|Overall Study|Lost to Follow-up|1|||
24902073|NCT00715676|49996090|FG001|Overall Study|Lost to Follow-up|2|||
24902074|NCT00715676|49996091|FG002|Overall Study|Lost to Follow-up|1|||
24902075|NCT00715676|49996089|FG000|Overall Study|Terminated by Sponsor|1|||
24902076|NCT00715676|49996090|FG001|Overall Study|Terminated by Sponsor|0|||
24902077|NCT00715676|49996091|FG002|Overall Study|Terminated by Sponsor|0|||
24902078|NCT00715676|49996089|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
24902079|NCT00715676|49996090|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
24902080|NCT00715676|49996091|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
24902081|NCT00715676|49996089|FG000|Overall Study|Use of Exclusionary Medication|0|||
25335674|NCT00790842|50651846|FG008|Expansion Cohort|Study Closure|0|||
25335675|NCT00790842|50651847|FG009|Expansion Cohort|Study Closure|0|||
25335676|NCT00790842|50651848|FG010|Expansion Cohort|Study Closure|0|||
25335677|NCT00574288|50651903|FG000|Overall Study|Adverse Event|2|||
25335678|NCT00574288|50651904|FG001|Overall Study|Adverse Event|0|||
25335679|NCT00574288|50651905|FG002|Overall Study|Adverse Event|0|||
25335680|NCT00574288|50651906|FG003|Overall Study|Adverse Event|0|||
25335681|NCT00574288|50651907|FG004|Overall Study|Adverse Event|1|||
25335682|NCT00574288|50651908|FG005|Overall Study|Adverse Event|0|||
25335683|NCT00574288|50651909|FG006|Overall Study|Adverse Event|0|||
25335684|NCT00574288|50651903|FG000|Overall Study|Death|0|||
25335685|NCT00574288|50651904|FG001|Overall Study|Death|0|||
24902082|NCT00715676|49996090|FG001|Overall Study|Use of Exclusionary Medication|0|||
24902083|NCT00715676|49996091|FG002|Overall Study|Use of Exclusionary Medication|1|||
24902084|NCT00715676|49996089|FG000|Overall Study|Elevated Blood Glucose|0|||
24902085|NCT00715676|49996090|FG001|Overall Study|Elevated Blood Glucose|1|||
24902086|NCT00715676|49996091|FG002|Overall Study|Elevated Blood Glucose|0|||
24902087|NCT00718328|49996101|FG000|Overall Study|Lost to Follow-up|1|||
24902088|NCT00718328|49996102|FG001|Overall Study|Lost to Follow-up|0|||
24902089|NCT00715520|49996111|FG000|Overall Study|Screen failure|8|||
24902090|NCT00715520|49996112|FG001|Overall Study|Screen failure|1|||
24902091|NCT00715520|49996113|FG002|Overall Study|Screen failure|1|||
24902092|NCT00715520|49996111|FG000|Overall Study|Withdrawal by Subject|2|||
24902093|NCT00715520|49996112|FG001|Overall Study|Withdrawal by Subject|0|||
24902094|NCT00715520|49996113|FG002|Overall Study|Withdrawal by Subject|1|||
24902095|NCT00790205|49996123|FG000|Overall Study|Lost to Follow-up|61|||
24902096|NCT00790205|49996124|FG001|Overall Study|Lost to Follow-up|71|||
24902097|NCT00790205|49996123|FG000|Overall Study|Withdrawal by Subject|299|||
24902098|NCT00790205|49996124|FG001|Overall Study|Withdrawal by Subject|363|||
24902099|NCT00715208|49996132|FG000|Overall Study|Withdrawal by Subject|1|||
24902100|NCT00715208|49996133|FG001|Overall Study|Withdrawal by Subject|1|||
24902101|NCT00715208|49996132|FG000|Overall Study|Adverse Event|0|||
24902102|NCT00715208|49996133|FG001|Overall Study|Adverse Event|6|||
24902103|NCT00715208|49996132|FG000|Overall Study|Lack of Efficacy|0|||
24902104|NCT00715208|49996133|FG001|Overall Study|Lack of Efficacy|2|||
24902105|NCT00775463|49996141|FG000|Overall Study|Withdrawal by Subject|0|||
24902106|NCT00775463|49996142|FG001|Overall Study|Withdrawal by Subject|1|||
25077925|NCT02232178|50186005|FG000|Overall Study|ineligibility|0|||
25252949|NCT01128400|50568462|FG001|Overall Study|Excluded due to sinus problems|1|||
25252950|NCT01128400|50568463|FG002|Overall Study|Excluded due to sinus problems|0|||
25252951|NCT01128361|50568473|FG000|Overall Study|Lost to Follow-up|0|||
25335686|NCT00574288|50651905|FG002|Overall Study|Death|0|||
25335687|NCT00574288|50651906|FG003|Overall Study|Death|0|||
25335688|NCT00574288|50651907|FG004|Overall Study|Death|0|||
25335689|NCT00574288|50651908|FG005|Overall Study|Death|25|||
24902107|NCT00775463|49996141|FG000|Overall Study|Adverse Event|7|||
24902108|NCT00775463|49996142|FG001|Overall Study|Adverse Event|9|||
25335690|NCT00574288|50651909|FG006|Overall Study|Death|21|||
25335691|NCT00574288|50651903|FG000|Overall Study|Lost to Follow-up|0|||
25335692|NCT00574288|50651904|FG001|Overall Study|Lost to Follow-up|0|||
25335693|NCT00574288|50651905|FG002|Overall Study|Lost to Follow-up|0|||
25335694|NCT00574288|50651906|FG003|Overall Study|Lost to Follow-up|0|||
25335695|NCT00574288|50651907|FG004|Overall Study|Lost to Follow-up|0|||
25335696|NCT00574288|50651908|FG005|Overall Study|Lost to Follow-up|1|||
25335697|NCT00574288|50651909|FG006|Overall Study|Lost to Follow-up|2|||
25335698|NCT00574288|50651903|FG000|Overall Study|Study Terminated By Sponsor|0|||
25335699|NCT00574288|50651904|FG001|Overall Study|Study Terminated By Sponsor|0|||
25335700|NCT00574288|50651905|FG002|Overall Study|Study Terminated By Sponsor|0|||
25335701|NCT00574288|50651906|FG003|Overall Study|Study Terminated By Sponsor|0|||
25335702|NCT00574288|50651907|FG004|Overall Study|Study Terminated By Sponsor|0|||
25335703|NCT00574288|50651908|FG005|Overall Study|Study Terminated By Sponsor|0|||
24902109|NCT00775463|49996141|FG000|Overall Study|Protocol Violation|2|||
25077926|NCT02232178|50186006|FG001|Overall Study|ineligibility|0|||
25077927|NCT02232178|50186007|FG002|Overall Study|ineligibility|1|||
25077928|NCT02232178|50186005|FG000|Overall Study|surgical complication|1|||
25077929|NCT02232178|50186006|FG001|Overall Study|surgical complication|0|||
25077930|NCT02232178|50186007|FG002|Overall Study|surgical complication|0|||
25077931|NCT01678131|50186018|FG000|Overall Study|Adverse Event|0|||
25077932|NCT01678131|50186019|FG001|Overall Study|Adverse Event|1|||
25077933|NCT01678131|50186020|FG002|Overall Study|Adverse Event|0|||
25077934|NCT01678131|50186018|FG000|Overall Study|Withdrawal by Subject|0|||
25077935|NCT01678131|50186019|FG001|Overall Study|Withdrawal by Subject|0|||
25077936|NCT01678131|50186020|FG002|Overall Study|Withdrawal by Subject|2|||
25077937|NCT02231164|50186030|FG000|Overall Study|Adverse Event|1|||
25077938|NCT02231164|50186031|FG001|Overall Study|Adverse Event|1|||
25077939|NCT02231164|50186030|FG000|Overall Study|Lack of Efficacy|4|||
25077940|NCT02231164|50186031|FG001|Overall Study|Lack of Efficacy|3|||
25077941|NCT02231164|50186030|FG000|Overall Study|Withdrawal by Subject|1|||
25077942|NCT02231164|50186031|FG001|Overall Study|Withdrawal by Subject|2|||
25077943|NCT02457182|50186039|FG000|Overall Study|Lost to Follow-up|1|||
25077944|NCT02457182|50186040|FG001|Overall Study|Lost to Follow-up|0|||
25077945|NCT02230384|50186048|FG000|Phase 1|Lost to Follow-up|1|||
25077946|NCT02230384|50186049|FG001|Phase 1|Lost to Follow-up|0|||
24902110|NCT00775463|49996142|FG001|Overall Study|Protocol Violation|2|||
24902111|NCT00775463|49996141|FG000|Overall Study|Lost to Follow-up|1|||
24902112|NCT00775463|49996142|FG001|Overall Study|Lost to Follow-up|0|||
24902113|NCT00775463|49996141|FG000|Overall Study|Lack of Efficacy|1|||
24902114|NCT00775463|49996142|FG001|Overall Study|Lack of Efficacy|1|||
24902115|NCT00587795|49996157|FG000|Overall Study|Withdrawal by Subject|1|||
24902116|NCT00587795|49996158|FG001|Overall Study|Withdrawal by Subject|0|||
24902117|NCT00587639|49996164|FG000|Overall Study|Withdrawal by Subject|1|||
24902118|NCT00774995|49996172|FG000|Overall Study|Protocol Violation|0|||
24902119|NCT00774995|49996173|FG001|Overall Study|Protocol Violation|0|||
24902120|NCT00774995|49996174|FG002|Overall Study|Protocol Violation|1|||
24902121|NCT00774995|49996175|FG003|Overall Study|Protocol Violation|0|||
24902122|NCT00713648|49996185|FG000|Overall Study|Adverse Event|1|||
25077947|NCT02230384|50186048|FG000|Phase 1|Physician Decision|0|||
25252952|NCT01128361|50568474|FG001|Overall Study|Lost to Follow-up|1|||
25252953|NCT01128361|50568473|FG000|Overall Study|Withdrawal by Subject|5|||
25252954|NCT01128361|50568474|FG001|Overall Study|Withdrawal by Subject|2|||
25252955|NCT01128244|50568480|FG000|Overall Study|Adverse Event|1|||
25252956|NCT01128244|50568480|FG000|Overall Study|Scheduling conflict|2|||
25252957|NCT01127893|50568488|FG000|Overall Study|Study Termination by the Sponsor|1|||
25252958|NCT01126879|50568494|FG000|Overall Study|Progressive Disease|3|||
25252959|NCT01126879|50568495|FG001|Overall Study|Progressive Disease|1|||
25252960|NCT01126879|50568494|FG000|Overall Study|Withdrawal by Subject|1|||
25252961|NCT01126879|50568495|FG001|Overall Study|Withdrawal by Subject|0|||
25252962|NCT01126879|50568494|FG000|Overall Study|Adverse Event|0|||
25252963|NCT01126879|50568495|FG001|Overall Study|Adverse Event|1|||
25252964|NCT01126879|50568494|FG000|Overall Study|Physician Decision|1|||
25252965|NCT01126879|50568495|FG001|Overall Study|Physician Decision|0|||
25252966|NCT01126060|50568503|FG000|Overall Study|Protocol Violation|0|||
25252967|NCT01126060|50568504|FG001|Overall Study|Protocol Violation|2|||
25252968|NCT01125748|50568512|FG000|Overall Study|Adverse Event|0|||
25252969|NCT01125748|50568513|FG001|Overall Study|Adverse Event|2|||
25252970|NCT01125748|50568512|FG000|Overall Study|Lost to Follow-up|0|||
25252971|NCT01125748|50568513|FG001|Overall Study|Lost to Follow-up|1|||
25252972|NCT01125748|50568512|FG000|Overall Study|Physician Decision|8|||
25252973|NCT01125748|50568513|FG001|Overall Study|Physician Decision|7|||
25252974|NCT01125748|50568512|FG000|Overall Study|Patient Decision to Withdraw|2|||
25077948|NCT02230384|50186049|FG001|Phase 1|Physician Decision|1|||
25077949|NCT02230384|50186048|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
25077950|NCT02230384|50186049|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
25252975|NCT01125748|50568513|FG001|Overall Study|Patient Decision to Withdraw|4|||
25335704|NCT00574288|50651909|FG006|Overall Study|Study Terminated By Sponsor|5|||
24902123|NCT00713648|49996185|FG000|Overall Study|Unclassified|2|||
25077951|NCT02230384|50186048|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
25077952|NCT02230384|50186049|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
25077953|NCT02230384|50186048|FG000|Phase 2 - Switch|Adverse Event|2|||
25077954|NCT02230384|50186049|FG001|Phase 2 - Switch|Adverse Event|0|||
25077955|NCT02738801|50186065|FG000|Overall Study|Adverse Event|1|||
25077956|NCT02738801|50186066|FG001|Overall Study|Adverse Event|1|||
25077957|NCT02738801|50186065|FG000|Overall Study|Withdrawal by Subject|0|||
25077958|NCT02738801|50186066|FG001|Overall Study|Withdrawal by Subject|1|||
25077959|NCT02230306|50186082|FG000|Overall Study|Did not receive study treatment|1|||
25335705|NCT00574288|50651903|FG000|Overall Study|Progressive Disease|17|||
25335706|NCT00574288|50651904|FG001|Overall Study|Progressive Disease|2|||
25335707|NCT00574288|50651905|FG002|Overall Study|Progressive Disease|3|||
25335708|NCT00574288|50651906|FG003|Overall Study|Progressive Disease|2|||
25335709|NCT00574288|50651907|FG004|Overall Study|Progressive Disease|1|||
25335710|NCT00574288|50651908|FG005|Overall Study|Progressive Disease|0|||
25335711|NCT00574288|50651909|FG006|Overall Study|Progressive Disease|0|||
25335712|NCT00574288|50651903|FG000|Overall Study|Other|1|||
25335713|NCT00574288|50651904|FG001|Overall Study|Other|1|||
25335714|NCT00574288|50651905|FG002|Overall Study|Other|0|||
25252976|NCT01125514|50568519|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
25252977|NCT01125514|50568519|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
25252978|NCT01125514|50568519|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
25252979|NCT01125514|50568519|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
25252980|NCT01125514|50568519|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
25252981|NCT01125514|50568519|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
25335715|NCT00574288|50651906|FG003|Overall Study|Other|0|||
25335716|NCT00574288|50651907|FG004|Overall Study|Other|0|||
25335717|NCT00574288|50651908|FG005|Overall Study|Other|0|||
25335718|NCT00574288|50651909|FG006|Overall Study|Other|0|||
25335719|NCT00790452|50651937|FG000|Overall Study|Drug supply issue|1|||
25252982|NCT01125358|50568537|FG000|Overall Study|Adverse Event|3|||
25252983|NCT01125358|50568538|FG001|Overall Study|Adverse Event|0|||
25252984|NCT01125358|50568539|FG002|Overall Study|Adverse Event|0|||
25252985|NCT01125358|50568540|FG003|Overall Study|Adverse Event|2|||
25252986|NCT01125358|50568537|FG000|Overall Study|Perceived Lack of Efficacy|6|||
25252987|NCT01125358|50568538|FG001|Overall Study|Perceived Lack of Efficacy|3|||
25252988|NCT01125358|50568539|FG002|Overall Study|Perceived Lack of Efficacy|7|||
25252989|NCT01125358|50568540|FG003|Overall Study|Perceived Lack of Efficacy|4|||
25252990|NCT01125358|50568537|FG000|Overall Study|Protocol Violation|1|||
25252991|NCT01125358|50568538|FG001|Overall Study|Protocol Violation|0|||
25252992|NCT01125358|50568539|FG002|Overall Study|Protocol Violation|0|||
25252993|NCT01125358|50568540|FG003|Overall Study|Protocol Violation|0|||
25252994|NCT01125358|50568537|FG000|Overall Study|Sponsor Decision|0|||
25252995|NCT01125358|50568538|FG001|Overall Study|Sponsor Decision|0|||
25335720|NCT00790452|50651938|FG001|Overall Study|Drug supply issue|0|||
25335721|NCT00626392|50651950|FG000|Run-in Period|Adverse Event|0|||
25335722|NCT00626392|50651951|FG001|Run-in Period|Adverse Event|0|||
25335723|NCT00626392|50651952|FG002|Run-in Period|Adverse Event|1|||
25335724|NCT00626392|50651953|FG003|Run-in Period|Adverse Event|0|||
25335725|NCT00626392|50651954|FG004|Run-in Period|Adverse Event|1|||
25335726|NCT00626392|50651955|FG005|Run-in Period|Adverse Event|0|||
25335727|NCT00626392|50651950|FG000|Run-in Period|Withdrawal by Subject|0|||
25335728|NCT00626392|50651951|FG001|Run-in Period|Withdrawal by Subject|1|||
25335729|NCT00626392|50651952|FG002|Run-in Period|Withdrawal by Subject|1|||
25335730|NCT00626392|50651953|FG003|Run-in Period|Withdrawal by Subject|1|||
25335731|NCT00626392|50651954|FG004|Run-in Period|Withdrawal by Subject|3|||
25335732|NCT00626392|50651955|FG005|Run-in Period|Withdrawal by Subject|1|||
25335733|NCT00626392|50651950|FG000|Run-in Period|Noncompliance|1|||
25335734|NCT00626392|50651951|FG001|Run-in Period|Noncompliance|0|||
25335735|NCT00626392|50651952|FG002|Run-in Period|Noncompliance|1|||
25335736|NCT00626392|50651953|FG003|Run-in Period|Noncompliance|0|||
25335737|NCT00626392|50651954|FG004|Run-in Period|Noncompliance|0|||
25077960|NCT01680861|50186088|FG000|Early Post-transplant Period|Protocol Violation|1|||
25077961|NCT01680861|50186089|FG001|Early Post-transplant Period|Protocol Violation|1|||
25252996|NCT01125358|50568539|FG002|Overall Study|Sponsor Decision|1|||
25335738|NCT00626392|50651955|FG005|Run-in Period|Noncompliance|0|||
25335739|NCT00626392|50651950|FG000|Coadministration Period|Adverse Event|3|||
25335740|NCT00626392|50651951|FG001|Coadministration Period|Adverse Event|1|||
25335741|NCT00626392|50651952|FG002|Coadministration Period|Adverse Event|7|||
25335742|NCT00626392|50651953|FG003|Coadministration Period|Adverse Event|4|||
25252997|NCT01125358|50568540|FG003|Overall Study|Sponsor Decision|1|||
25252998|NCT01125358|50568537|FG000|Overall Study|Withdrawal by Subject|2|||
25335743|NCT00626392|50651954|FG004|Coadministration Period|Adverse Event|3|||
25335744|NCT00626392|50651955|FG005|Coadministration Period|Adverse Event|4|||
25335745|NCT00626392|50651950|FG000|Coadministration Period|Withdrawal by Subject|1|||
25335746|NCT00626392|50651951|FG001|Coadministration Period|Withdrawal by Subject|1|||
25335747|NCT00626392|50651952|FG002|Coadministration Period|Withdrawal by Subject|0|||
25335748|NCT00626392|50651953|FG003|Coadministration Period|Withdrawal by Subject|1|||
25335749|NCT00626392|50651954|FG004|Coadministration Period|Withdrawal by Subject|0|||
25335750|NCT00626392|50651955|FG005|Coadministration Period|Withdrawal by Subject|1|||
25335751|NCT00626392|50651950|FG000|Coadministration Period|Protocol Violation|0|||
25335752|NCT00626392|50651951|FG001|Coadministration Period|Protocol Violation|1|||
25335753|NCT00626392|50651952|FG002|Coadministration Period|Protocol Violation|0|||
25335754|NCT00626392|50651953|FG003|Coadministration Period|Protocol Violation|1|||
25335755|NCT00626392|50651954|FG004|Coadministration Period|Protocol Violation|1|||
25335756|NCT00626392|50651955|FG005|Coadministration Period|Protocol Violation|0|||
25335757|NCT00626392|50651950|FG000|Coadministration Period|Other|0|||
25335758|NCT00626392|50651951|FG001|Coadministration Period|Other|2|||
25335759|NCT00626392|50651952|FG002|Coadministration Period|Other|3|||
25335760|NCT00626392|50651953|FG003|Coadministration Period|Other|1|||
25335761|NCT00626392|50651954|FG004|Coadministration Period|Other|1|||
25335762|NCT00626392|50651955|FG005|Coadministration Period|Other|1|||
25335763|NCT00624286|50651963|FG000|Overall Study|Protocol Deviation|7|||
25335764|NCT00624286|50651964|FG001|Overall Study|Protocol Deviation|9|||
25335765|NCT00624286|50651963|FG000|Overall Study|Adverse Event|6|||
25335766|NCT00624286|50651964|FG001|Overall Study|Adverse Event|3|||
25335767|NCT00624286|50651963|FG000|Overall Study|Withdrawal by Subject|5|||
25335768|NCT00624286|50651964|FG001|Overall Study|Withdrawal by Subject|4|||
25335769|NCT00624286|50651963|FG000|Overall Study|Lost to Follow-up|3|||
25335770|NCT00624286|50651964|FG001|Overall Study|Lost to Follow-up|2|||
25335771|NCT00624286|50651963|FG000|Overall Study|Administrative problems|3|||
25335772|NCT00624286|50651964|FG001|Overall Study|Administrative problems|0|||
25335773|NCT00624286|50651963|FG000|Overall Study|Lack of Efficacy|1|||
25335774|NCT00624286|50651964|FG001|Overall Study|Lack of Efficacy|6|||
25335775|NCT00624286|50651963|FG000|Overall Study|Not stated|0|||
24902124|NCT00713648|49996185|FG000|Overall Study|According to Protocol|2|||
24902125|NCT00713648|49996185|FG000|Overall Study|Development of antibodies|3|||
24902126|NCT00768053|49996189|FG000|Overall Study|Adverse Event|10|||
24902127|NCT00768053|49996189|FG000|Overall Study|Lost to Follow-up|1|||
24902128|NCT00683475|49996195|FG000|Overall Study|Withdrawal by Subject|1|||
24902129|NCT00683475|49996196|FG001|Overall Study|Withdrawal by Subject|0|||
24902130|NCT00683475|49996195|FG000|Overall Study|Never Treated: Adverse Event|2|||
24902131|NCT00683475|49996196|FG001|Overall Study|Never Treated: Adverse Event|3|||
24902132|NCT00683475|49996195|FG000|Overall Study|Never Treated: Progressive Disease|1|||
24902133|NCT00683475|49996196|FG001|Overall Study|Never Treated: Progressive Disease|0|||
24902134|NCT00685035|49996203|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
24902135|NCT00685035|49996204|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
24902136|NCT00773747|49996230|FG000|Overall Study|Lack of Efficacy|112|||
24902137|NCT00773747|49996231|FG001|Overall Study|Lack of Efficacy|144|||
24902138|NCT00773747|49996230|FG000|Overall Study|Physician Decision|26|||
24902139|NCT00773747|49996231|FG001|Overall Study|Physician Decision|18|||
24902140|NCT00773747|49996230|FG000|Overall Study|Lost to Follow-up|0|||
24902141|NCT00773747|49996231|FG001|Overall Study|Lost to Follow-up|1|||
24902142|NCT00773747|49996230|FG000|Overall Study|Protocol Violation|2|||
24902143|NCT00773747|49996231|FG001|Overall Study|Protocol Violation|2|||
25335776|NCT00624286|50651964|FG001|Overall Study|Not stated|1|||
24902144|NCT00773747|49996230|FG000|Overall Study|Withdrawal by Subject|89|||
24902145|NCT00773747|49996231|FG001|Overall Study|Withdrawal by Subject|61|||
24902146|NCT00773747|49996230|FG000|Overall Study|Adverse Event|61|||
24902147|NCT00773747|49996231|FG001|Overall Study|Adverse Event|62|||
24902148|NCT00773747|49996230|FG000|Overall Study|Death|5|||
24902149|NCT00773747|49996231|FG001|Overall Study|Death|8|||
24902150|NCT00773747|49996230|FG000|Overall Study|Not Treated|2|||
24902151|NCT00773747|49996231|FG001|Overall Study|Not Treated|0|||
24902152|NCT00784277|49996241|FG000|IR Treatment|Adverse Event|4|||
24902153|NCT00784277|49996242|FG001|IR Treatment|Adverse Event|8|||
24902154|NCT00784277|49996243|FG002|IR Treatment|Adverse Event|19|||
24902155|NCT00784277|49996244|FG003|IR Treatment|Adverse Event|35|||
24902156|NCT00784277|49996245|FG004|IR Treatment|Adverse Event|0|||
24902157|NCT00784277|49996246|FG005|IR Treatment|Adverse Event|0|||
24902158|NCT00784277|49996247|FG006|IR Treatment|Adverse Event|0|||
24902159|NCT00784277|49996241|FG000|IR Treatment|Lack of Efficacy|4|||
24902160|NCT00784277|49996242|FG001|IR Treatment|Lack of Efficacy|4|||
24902161|NCT00784277|49996243|FG002|IR Treatment|Lack of Efficacy|1|||
24902162|NCT00784277|49996244|FG003|IR Treatment|Lack of Efficacy|0|||
24902163|NCT00784277|49996245|FG004|IR Treatment|Lack of Efficacy|0|||
24902164|NCT00784277|49996246|FG005|IR Treatment|Lack of Efficacy|0|||
24902165|NCT00784277|49996247|FG006|IR Treatment|Lack of Efficacy|0|||
24902166|NCT00784277|49996241|FG000|IR Treatment|Lost to Follow-up|1|||
24902167|NCT00784277|49996242|FG001|IR Treatment|Lost to Follow-up|0|||
24902168|NCT00784277|49996243|FG002|IR Treatment|Lost to Follow-up|1|||
25335777|NCT00624286|50651963|FG000|Overall Study|Abnormal test procedure result(s)|0|||
25335778|NCT00624286|50651964|FG001|Overall Study|Abnormal test procedure result(s)|1|||
25335779|NCT00624286|50651963|FG000|Overall Study|Death|0|||
25335780|NCT00624286|50651964|FG001|Overall Study|Death|1|||
25335781|NCT00624052|50651974|FG000|Overall Study|Adverse Event|7|||
25335782|NCT00624052|50651975|FG001|Overall Study|Adverse Event|6|||
25335783|NCT00624052|50651976|FG002|Overall Study|Adverse Event|0|||
25335784|NCT00624052|50651977|FG003|Overall Study|Adverse Event|3|||
25335785|NCT00624052|50651974|FG000|Overall Study|Lack of Efficacy|1|||
25335786|NCT00624052|50651975|FG001|Overall Study|Lack of Efficacy|1|||
25335787|NCT00624052|50651976|FG002|Overall Study|Lack of Efficacy|0|||
25335788|NCT00624052|50651977|FG003|Overall Study|Lack of Efficacy|0|||
25335789|NCT00624052|50651974|FG000|Overall Study|Lost to Follow-up|2|||
25335790|NCT00624052|50651975|FG001|Overall Study|Lost to Follow-up|3|||
25335791|NCT00624052|50651976|FG002|Overall Study|Lost to Follow-up|1|||
24902169|NCT00784277|49996244|FG003|IR Treatment|Lost to Follow-up|0|||
24902170|NCT00784277|49996245|FG004|IR Treatment|Lost to Follow-up|0|||
24902171|NCT00784277|49996246|FG005|IR Treatment|Lost to Follow-up|0|||
24902172|NCT00784277|49996247|FG006|IR Treatment|Lost to Follow-up|0|||
24902173|NCT00784277|49996241|FG000|IR Treatment|Withdrawal by Subject|5|||
24902174|NCT00784277|49996242|FG001|IR Treatment|Withdrawal by Subject|1|||
24902175|NCT00784277|49996243|FG002|IR Treatment|Withdrawal by Subject|4|||
24902176|NCT00784277|49996244|FG003|IR Treatment|Withdrawal by Subject|6|||
24902177|NCT00784277|49996245|FG004|IR Treatment|Withdrawal by Subject|0|||
24902178|NCT00784277|49996246|FG005|IR Treatment|Withdrawal by Subject|0|||
24902179|NCT00784277|49996247|FG006|IR Treatment|Withdrawal by Subject|0|||
24902180|NCT00784277|49996241|FG000|IR Treatment|Resolution Of Pain|0|||
24902181|NCT00784277|49996242|FG001|IR Treatment|Resolution Of Pain|1|||
24902182|NCT00784277|49996243|FG002|IR Treatment|Resolution Of Pain|0|||
24902183|NCT00784277|49996244|FG003|IR Treatment|Resolution Of Pain|0|||
24902184|NCT00784277|49996245|FG004|IR Treatment|Resolution Of Pain|0|||
24902185|NCT00784277|49996246|FG005|IR Treatment|Resolution Of Pain|0|||
24902186|NCT00784277|49996247|FG006|IR Treatment|Resolution Of Pain|0|||
24902187|NCT00784277|49996241|FG000|IR Treatment|Other|2|||
24902188|NCT00784277|49996242|FG001|IR Treatment|Other|3|||
24902189|NCT00784277|49996243|FG002|IR Treatment|Other|3|||
24902190|NCT00784277|49996244|FG003|IR Treatment|Other|2|||
24902191|NCT00784277|49996245|FG004|IR Treatment|Other|0|||
24902192|NCT00784277|49996246|FG005|IR Treatment|Other|0|||
24902193|NCT00784277|49996247|FG006|IR Treatment|Other|0|||
24902194|NCT00784277|49996241|FG000|ER Treatment|Adverse Event|0|||
24902195|NCT00784277|49996242|FG001|ER Treatment|Adverse Event|0|||
24902196|NCT00784277|49996243|FG002|ER Treatment|Adverse Event|0|||
24902197|NCT00784277|49996244|FG003|ER Treatment|Adverse Event|0|||
24902198|NCT00784277|49996245|FG004|ER Treatment|Adverse Event|1|||
24902199|NCT00784277|49996246|FG005|ER Treatment|Adverse Event|7|||
24902200|NCT00784277|49996247|FG006|ER Treatment|Adverse Event|7|||
24902201|NCT00784277|49996241|FG000|ER Treatment|Lack of Efficacy|0|||
24902202|NCT00784277|49996242|FG001|ER Treatment|Lack of Efficacy|0|||
24902203|NCT00784277|49996243|FG002|ER Treatment|Lack of Efficacy|0|||
24902204|NCT00784277|49996244|FG003|ER Treatment|Lack of Efficacy|0|||
24902205|NCT00784277|49996245|FG004|ER Treatment|Lack of Efficacy|3|||
24902206|NCT00784277|49996246|FG005|ER Treatment|Lack of Efficacy|4|||
24902207|NCT00784277|49996247|FG006|ER Treatment|Lack of Efficacy|0|||
24902208|NCT00784277|49996241|FG000|ER Treatment|Lost to Follow-up|0|||
24902209|NCT00784277|49996242|FG001|ER Treatment|Lost to Follow-up|0|||
24902210|NCT00784277|49996243|FG002|ER Treatment|Lost to Follow-up|0|||
24902211|NCT00784277|49996244|FG003|ER Treatment|Lost to Follow-up|0|||
24902212|NCT00784277|49996245|FG004|ER Treatment|Lost to Follow-up|0|||
25335792|NCT00624052|50651977|FG003|Overall Study|Lost to Follow-up|0|||
25335793|NCT00624052|50651974|FG000|Overall Study|Non compliant with the protocol|2|||
25335794|NCT00624052|50651975|FG001|Overall Study|Non compliant with the protocol|1|||
25335795|NCT00624052|50651976|FG002|Overall Study|Non compliant with the protocol|1|||
25335796|NCT00624052|50651977|FG003|Overall Study|Non compliant with the protocol|1|||
25335797|NCT00624052|50651974|FG000|Overall Study|Consent withdrawn|3|||
25335798|NCT00624052|50651975|FG001|Overall Study|Consent withdrawn|1|||
25335799|NCT00624052|50651976|FG002|Overall Study|Consent withdrawn|1|||
25335800|NCT00624052|50651977|FG003|Overall Study|Consent withdrawn|0|||
24902213|NCT00784277|49996246|FG005|ER Treatment|Lost to Follow-up|2|||
24902214|NCT00784277|49996247|FG006|ER Treatment|Lost to Follow-up|0|||
24902215|NCT00784277|49996241|FG000|ER Treatment|Withdrawal by Subject|0|||
24902216|NCT00784277|49996242|FG001|ER Treatment|Withdrawal by Subject|0|||
24977383|NCT00048542|50065998|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
25335801|NCT00624052|50651974|FG000|Overall Study|Changed job/ran out if meds|0|||
24902217|NCT00784277|49996243|FG002|ER Treatment|Withdrawal by Subject|0|||
24902218|NCT00784277|49996244|FG003|ER Treatment|Withdrawal by Subject|0|||
24902219|NCT00784277|49996245|FG004|ER Treatment|Withdrawal by Subject|2|||
24902220|NCT00784277|49996246|FG005|ER Treatment|Withdrawal by Subject|5|||
24902221|NCT00784277|49996247|FG006|ER Treatment|Withdrawal by Subject|3|||
25335802|NCT00624052|50651975|FG001|Overall Study|Changed job/ran out if meds|2|||
25335803|NCT00624052|50651976|FG002|Overall Study|Changed job/ran out if meds|0|||
25335804|NCT00624052|50651977|FG003|Overall Study|Changed job/ran out if meds|0|||
25335805|NCT00785577|50651996|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
25335806|NCT00785577|50651997|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
25335807|NCT00785577|50651998|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
25335808|NCT00785577|50651999|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
25335809|NCT00785577|50652000|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
25335810|NCT00785577|50651996|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
25335811|NCT00785577|50651997|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
25335812|NCT00785577|50651998|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
25335813|NCT00785577|50651999|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
25335814|NCT00785577|50652000|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
25335815|NCT00785577|50651996|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
25335816|NCT00785577|50651997|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
25335817|NCT00785577|50651998|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
25335818|NCT00785577|50651999|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
25335819|NCT00785577|50652000|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
25335820|NCT00785577|50651996|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
25335821|NCT00785577|50651997|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
25335822|NCT00785577|50651998|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
25335823|NCT00785577|50651999|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
25335824|NCT00785577|50652000|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
25335825|NCT00785577|50651996|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
25335826|NCT00785577|50651997|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
25335827|NCT00785577|50651998|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
25335828|NCT00785577|50651999|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
25335829|NCT00785577|50652000|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
25335830|NCT00785577|50651996|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
25335831|NCT00785577|50651997|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
25335832|NCT00785577|50651998|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
25335833|NCT00785577|50651999|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
25335834|NCT00785577|50652000|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
25335835|NCT00785577|50651996|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
25335836|NCT00785577|50651997|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
25335837|NCT00785577|50651998|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
25335838|NCT00785577|50651999|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
25335839|NCT00785577|50652000|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
25335840|NCT00785577|50651996|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
25335841|NCT00785577|50651997|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
25335842|NCT00785577|50651998|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
25335843|NCT00785577|50651999|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
25335844|NCT00785577|50652000|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
25335845|NCT00785577|50651996|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
25335846|NCT00785577|50651997|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
25335847|NCT00785577|50651998|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
25335848|NCT00785577|50651999|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
25335849|NCT00785577|50652000|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
25335850|NCT00785577|50651996|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
25335851|NCT00785577|50651997|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
25335852|NCT00785577|50651998|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
25335853|NCT00785577|50651999|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
25335854|NCT00785577|50652000|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
25335855|NCT00789828|50652024|FG000|Core Period (48 Weeks)|Administrative problems|0|||
25335856|NCT00789828|50652025|FG001|Core Period (48 Weeks)|Administrative problems|1|||
25335857|NCT00789828|50652024|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
25335858|NCT00789828|50652025|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
25335859|NCT00789828|50652024|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
25335860|NCT00789828|50652025|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
25335861|NCT00789828|50652024|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
25335862|NCT00789828|50652025|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
25077962|NCT02229214|50186099|FG000|Overall Study|Adverse Event|2|||
25252999|NCT01125358|50568538|FG001|Overall Study|Withdrawal by Subject|1|||
25253000|NCT01125358|50568539|FG002|Overall Study|Withdrawal by Subject|1|||
25253001|NCT01125358|50568540|FG003|Overall Study|Withdrawal by Subject|1|||
25253002|NCT01125046|50568550|FG000|First 6 Months of Treatment|Death|1|||
25253003|NCT01125046|50568550|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
25253004|NCT01125046|50568550|FG000|First 6 Months of Treatment|Non-compliance|1|||
25253005|NCT01125046|50568550|FG000|First 6 Months of Treatment|Surgery|1|||
25253006|NCT01125046|50568550|FG000|First 6 Months of Treatment|Progressive Disease|7|||
25335863|NCT00789828|50652024|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
25335864|NCT00789828|50652025|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
25253007|NCT01125046|50568550|FG000|First 6 Months of Treatment|Adverse Event|2|||
25253008|NCT01125046|50568550|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
25253009|NCT01125046|50568550|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
25253010|NCT01125046|50568550|FG000|Follow-up/Data Cut Off Point|Death|29|||
25253011|NCT01125046|50568550|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
25253012|NCT01124734|50568554|FG000|Overall Study|Disease progression|13|||
25253013|NCT01124734|50568554|FG000|Overall Study|Adverse Event|1|||
25253014|NCT01124734|50568554|FG000|Overall Study|Withdrawal by Subject|1|||
25253015|NCT01124734|50568554|FG000|Overall Study|Elected for alternative treatment|2|||
25253016|NCT01124617|50568565|FG000|Overall Study|Adverse Event|5|||
25253017|NCT01124617|50568566|FG001|Overall Study|Adverse Event|2|||
25253018|NCT01124617|50568565|FG000|Overall Study|Lack of Efficacy|2|||
25253019|NCT01124617|50568566|FG001|Overall Study|Lack of Efficacy|1|||
25253020|NCT01124617|50568565|FG000|Overall Study|Protocol Violation|1|||
25335865|NCT00789828|50652024|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
25335866|NCT00789828|50652025|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
25335867|NCT00789828|50652024|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
25335868|NCT00789828|50652025|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
25335869|NCT00789828|50652024|FG000|Open-label Extension Period (4 Years)|Death|1|||
25335870|NCT00789828|50652025|FG001|Open-label Extension Period (4 Years)|Death|0|||
25335871|NCT00789828|50652024|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
25335872|NCT00789828|50652025|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
25335873|NCT00789828|50652024|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
25335874|NCT00789828|50652025|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
25335875|NCT00790296|50652036|FG000|Overall Study|Did not meet study eligibility criteria|1|||
25335876|NCT00790296|50652037|FG001|Overall Study|Did not meet study eligibility criteria|1|||
25335877|NCT00790296|50652036|FG000|Overall Study|Adverse Event|0|||
25335878|NCT00790296|50652037|FG001|Overall Study|Adverse Event|1|||
25335879|NCT00623194|50652043|FG000|Overall Study|Lack of Efficacy|1|||
25335880|NCT00623194|50652043|FG000|Overall Study|Protocol Violation|3|||
25335881|NCT00623194|50652043|FG000|Overall Study|Unclassified|1|||
25335882|NCT00784368|50652050|FG000|Overall Study|Physician Decision|0|||
25335883|NCT00784368|50652051|FG001|Overall Study|Physician Decision|0|||
25335884|NCT00784368|50652052|FG002|Overall Study|Physician Decision|6|||
25335885|NCT00784368|50652050|FG000|Overall Study|Lack of Efficacy|2|||
25335886|NCT00784368|50652051|FG001|Overall Study|Lack of Efficacy|0|||
25335887|NCT00784368|50652052|FG002|Overall Study|Lack of Efficacy|1|||
25335888|NCT00784368|50652050|FG000|Overall Study|Adverse Event|6|||
25335889|NCT00784368|50652051|FG001|Overall Study|Adverse Event|9|||
25335890|NCT00784368|50652052|FG002|Overall Study|Adverse Event|2|||
25335891|NCT00784368|50652050|FG000|Overall Study|Diagnosis of fever|0|||
25335892|NCT00784368|50652051|FG001|Overall Study|Diagnosis of fever|0|||
25335893|NCT00784368|50652052|FG002|Overall Study|Diagnosis of fever|1|||
25335894|NCT00784368|50652050|FG000|Overall Study|Worsening of complications|0|||
25335895|NCT00784368|50652051|FG001|Overall Study|Worsening of complications|0|||
25335896|NCT00784368|50652052|FG002|Overall Study|Worsening of complications|1|||
25335897|NCT00784368|50652050|FG000|Overall Study|Worsening of symptoms|0|||
25253021|NCT01124617|50568566|FG001|Overall Study|Protocol Violation|1|||
25253022|NCT01124617|50568565|FG000|Overall Study|Withdrawal by Subject|9|||
25335898|NCT00784368|50652051|FG001|Overall Study|Worsening of symptoms|1|||
25335899|NCT00784368|50652052|FG002|Overall Study|Worsening of symptoms|0|||
25335900|NCT00784368|50652050|FG000|Overall Study|Withdrawal of informed consent|0|||
25335901|NCT00784368|50652051|FG001|Overall Study|Withdrawal of informed consent|1|||
25335902|NCT00784368|50652052|FG002|Overall Study|Withdrawal of informed consent|0|||
25335903|NCT00622726|50652065|FG000|March, 2008 to August, 2010|Death|5|||
25335904|NCT00622726|50652066|FG001|March, 2008 to August, 2010|Death|2|||
25335905|NCT00622726|50652065|FG000|August, 2010 to April, 2013|Death|1|||
25335906|NCT00622726|50652066|FG001|August, 2010 to April, 2013|Death|5|||
25335907|NCT00623428|50652078|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
24902222|NCT00784277|49996241|FG000|ER Treatment|Study Medication Non-Compliant|0|||
24902223|NCT00784277|49996242|FG001|ER Treatment|Study Medication Non-Compliant|0|||
24902224|NCT00784277|49996243|FG002|ER Treatment|Study Medication Non-Compliant|0|||
24902225|NCT00784277|49996244|FG003|ER Treatment|Study Medication Non-Compliant|0|||
25077963|NCT02229214|50186100|FG001|Overall Study|Adverse Event|0|||
25253023|NCT01124617|50568566|FG001|Overall Study|Withdrawal by Subject|1|||
25253024|NCT01124617|50568565|FG000|Overall Study|Other|2|||
25253025|NCT01124617|50568566|FG001|Overall Study|Other|1|||
25253026|NCT01124422|50568574|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
25253027|NCT01124422|50568575|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
25253028|NCT01124422|50568576|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
25253029|NCT01124422|50568574|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
25335908|NCT00623428|50652079|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
25335909|NCT00623428|50652078|FG000|Treatment Period|Death|0|||
25253030|NCT01124422|50568575|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
25253031|NCT01124422|50568576|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
25335910|NCT00623428|50652079|FG001|Treatment Period|Death|1|||
25335911|NCT00623428|50652078|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
25335912|NCT00623428|50652079|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
25335913|NCT00623428|50652078|FG000|Treatment Period|Insufficient therapeutic response|0|||
25335914|NCT00623428|50652079|FG001|Treatment Period|Insufficient therapeutic response|2|||
25335915|NCT00623428|50652078|FG000|Treatment Period|Other|0|||
25335916|NCT00623428|50652079|FG001|Treatment Period|Other|1|||
25335917|NCT00623428|50652078|FG000|Treatment Period|Withdrawal by Subject|0|||
25335918|NCT00623428|50652079|FG001|Treatment Period|Withdrawal by Subject|1|||
25335919|NCT00623428|50652078|FG000|Follow-up Period|Relapse post-treatment|11|||
25335920|NCT00623428|50652079|FG001|Follow-up Period|Relapse post-treatment|3|||
25335921|NCT00623428|50652078|FG000|Follow-up Period|Failure to return|10|||
25335922|NCT00623428|50652079|FG001|Follow-up Period|Failure to return|2|||
25335923|NCT00623428|50652078|FG000|Follow-up Period|Patient withdrew consent|5|||
25335924|NCT00623428|50652079|FG001|Follow-up Period|Patient withdrew consent|4|||
25253032|NCT01124422|50568574|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
25253033|NCT01124422|50568575|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
25253034|NCT01124422|50568576|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
25253035|NCT01124422|50568574|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
25253036|NCT01124422|50568575|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
25253037|NCT01124422|50568576|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
25253038|NCT01124422|50568574|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
25253039|NCT01124422|50568575|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
25253040|NCT01124422|50568576|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
25253041|NCT01124422|50568574|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
25253042|NCT01124422|50568575|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
25253043|NCT01124422|50568576|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
25335925|NCT00623428|50652078|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
25335926|NCT00623428|50652079|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
25335927|NCT00623428|50652078|FG000|Follow-up Period|Did not cooperate|0|||
25335928|NCT00623428|50652079|FG001|Follow-up Period|Did not cooperate|3|||
25335929|NCT00623428|50652078|FG000|Follow-up Period|Reason not specified|1|||
25335930|NCT00623428|50652079|FG001|Follow-up Period|Reason not specified|1|||
25335931|NCT00623428|50652078|FG000|Follow-up Period|Death|0|||
25335932|NCT00623428|50652079|FG001|Follow-up Period|Death|1|||
25335933|NCT00784134|50652087|FG000|Overall Study|Lost to Follow-up|3|||
25335934|NCT00784134|50652088|FG001|Overall Study|Lost to Follow-up|6|||
25335935|NCT00776100|50652096|FG000|Overall Study|Disease Progression|1|||
25335936|NCT00776100|50652097|FG001|Overall Study|Disease Progression|0|||
25335937|NCT00783432|50652105|FG000|Overall Study|Adverse Event|22|||
25335938|NCT00783432|50652106|FG001|Overall Study|Adverse Event|17|||
25335939|NCT00783432|50652105|FG000|Overall Study|Lack of Efficacy|20|||
25335940|NCT00783432|50652106|FG001|Overall Study|Lack of Efficacy|21|||
25335941|NCT00783432|50652105|FG000|Overall Study|Lost to Follow-up|11|||
25335942|NCT00783432|50652106|FG001|Overall Study|Lost to Follow-up|6|||
25253044|NCT01124422|50568574|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
25253045|NCT01124422|50568575|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
25253046|NCT01124422|50568576|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
25253047|NCT01124422|50568574|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
25253048|NCT01124422|50568575|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
25253049|NCT01124422|50568576|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
25253050|NCT01124422|50568574|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
25253051|NCT01124422|50568575|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
25253052|NCT01124422|50568576|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
25253053|NCT01124422|50568574|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
25335943|NCT00783432|50652105|FG000|Overall Study|Withdrawal by Subject|23|||
25335944|NCT00783432|50652106|FG001|Overall Study|Withdrawal by Subject|20|||
25335945|NCT00783432|50652105|FG000|Overall Study|subject moved|3|||
25335946|NCT00783432|50652106|FG001|Overall Study|subject moved|5|||
25335947|NCT00783432|50652105|FG000|Overall Study|Protocol Violation|6|||
25335948|NCT00783432|50652106|FG001|Overall Study|Protocol Violation|9|||
25335949|NCT00783198|50652115|FG000|Overall Study|Adverse Event|15|||
25335950|NCT00783198|50652116|FG001|Overall Study|Adverse Event|19|||
25335951|NCT00783198|50652117|FG002|Overall Study|Adverse Event|3|||
25335952|NCT00783198|50652115|FG000|Overall Study|Lost to Follow-up|11|||
25335953|NCT00783198|50652116|FG001|Overall Study|Lost to Follow-up|1|||
25335954|NCT00783198|50652117|FG002|Overall Study|Lost to Follow-up|7|||
25335955|NCT00783198|50652115|FG000|Overall Study|Withdrawal by Subject|22|||
25335956|NCT00783198|50652116|FG001|Overall Study|Withdrawal by Subject|14|||
25335957|NCT00783198|50652117|FG002|Overall Study|Withdrawal by Subject|20|||
25335958|NCT00783198|50652115|FG000|Overall Study|Noncompliance with protocol|7|||
25335959|NCT00783198|50652116|FG001|Overall Study|Noncompliance with protocol|7|||
25335960|NCT00783198|50652117|FG002|Overall Study|Noncompliance with protocol|10|||
25335961|NCT00783198|50652115|FG000|Overall Study|Did not meet protocol eligibility|0|||
25335962|NCT00783198|50652116|FG001|Overall Study|Did not meet protocol eligibility|1|||
25335963|NCT00783198|50652117|FG002|Overall Study|Did not meet protocol eligibility|0|||
25335964|NCT00783198|50652115|FG000|Overall Study|Administrative|2|||
25335965|NCT00783198|50652116|FG001|Overall Study|Administrative|1|||
25335966|NCT00783198|50652117|FG002|Overall Study|Administrative|2|||
25335967|NCT00789360|50652127|FG000|Overall Study|Protocol Violation|3|||
25335968|NCT00789360|50652128|FG001|Overall Study|Protocol Violation|1|||
25335969|NCT00782496|50652137|FG000|Overall Study|Lost to Follow-up|14|||
25335970|NCT00782496|50652138|FG001|Overall Study|Lost to Follow-up|15|||
25335971|NCT00782418|50652145|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
25335972|NCT00782418|50652146|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
25335973|NCT00782418|50652147|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
25335974|NCT00782418|50652148|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
25335975|NCT00782418|50652149|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
25335976|NCT00782418|50652150|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
25335977|NCT00782418|50652151|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
25335978|NCT00782418|50652145|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
25335979|NCT00782418|50652146|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
25335980|NCT00782418|50652147|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
25335981|NCT00782418|50652148|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
25335982|NCT00782418|50652149|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
25335983|NCT00782418|50652150|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
25335984|NCT00782418|50652151|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
25335985|NCT00782340|50652168|FG000|Open Label Titration|Adverse Event|12|||
25335986|NCT00782340|50652169|FG001|Open Label Titration|Adverse Event|0|||
25335987|NCT00782340|50652170|FG002|Open Label Titration|Adverse Event|0|||
25335988|NCT00782340|50652168|FG000|Open Label Titration|Treatment failure|50|||
25335989|NCT00782340|50652169|FG001|Open Label Titration|Treatment failure|0|||
25335990|NCT00782340|50652170|FG002|Open Label Titration|Treatment failure|0|||
25335991|NCT00782340|50652168|FG000|Open Label Titration|Protocol Violation|5|||
25335992|NCT00782340|50652169|FG001|Open Label Titration|Protocol Violation|0|||
25335993|NCT00782340|50652170|FG002|Open Label Titration|Protocol Violation|0|||
25335994|NCT00782340|50652168|FG000|Open Label Titration|Withdrawal by Subject|5|||
25335995|NCT00782340|50652169|FG001|Open Label Titration|Withdrawal by Subject|0|||
25335996|NCT00782340|50652170|FG002|Open Label Titration|Withdrawal by Subject|0|||
25335997|NCT00782340|50652168|FG000|Open Label Titration|Enrollment capped|16|||
25335998|NCT00782340|50652169|FG001|Open Label Titration|Enrollment capped|0|||
25335999|NCT00782340|50652170|FG002|Open Label Titration|Enrollment capped|0|||
25336000|NCT00782340|50652168|FG000|Open Label Titration|Did not meet responder criteria|2|||
25336001|NCT00782340|50652169|FG001|Open Label Titration|Did not meet responder criteria|0|||
25336002|NCT00782340|50652170|FG002|Open Label Titration|Did not meet responder criteria|0|||
25336003|NCT00782340|50652168|FG000|Open Label Titration|Lost to Follow-up|5|||
25336004|NCT00782340|50652169|FG001|Open Label Titration|Lost to Follow-up|0|||
25336005|NCT00782340|50652170|FG002|Open Label Titration|Lost to Follow-up|0|||
25336006|NCT00782340|50652168|FG000|Open Label Titration|Randomized in error|6|||
25336007|NCT00782340|50652169|FG001|Open Label Titration|Randomized in error|0|||
25336008|NCT00782340|50652170|FG002|Open Label Titration|Randomized in error|0|||
25336009|NCT00774852|50652179|FG000|Overall Study|Adverse Event|9|||
25336010|NCT00774852|50652180|FG001|Overall Study|Adverse Event|6|||
25336011|NCT00774852|50652179|FG000|Overall Study|Death|2|||
25336012|NCT00774852|50652180|FG001|Overall Study|Death|1|||
25336013|NCT00774852|50652179|FG000|Overall Study|Lack of Efficacy|3|||
25336014|NCT00774852|50652180|FG001|Overall Study|Lack of Efficacy|7|||
25336015|NCT00774852|50652179|FG000|Overall Study|Lost to Follow-up|9|||
25336016|NCT00774852|50652180|FG001|Overall Study|Lost to Follow-up|5|||
25336017|NCT00774852|50652179|FG000|Overall Study|Physician Decision|2|||
25336018|NCT00774852|50652180|FG001|Overall Study|Physician Decision|6|||
25336019|NCT00774852|50652179|FG000|Overall Study|Pregnancy|1|||
25336020|NCT00774852|50652180|FG001|Overall Study|Pregnancy|2|||
25253054|NCT01124422|50568575|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
25253055|NCT01124422|50568576|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
25253056|NCT01124149|50568583|FG000|Acute Phase|Withdrawal by Subject|22|||
25253057|NCT01124149|50568583|FG000|Acute Phase|Adverse Event|21|||
25253058|NCT01124149|50568583|FG000|Acute Phase|Lack of Efficacy|17|||
25253059|NCT01124149|50568583|FG000|Acute Phase|Protocol Violation|14|||
25253060|NCT01124149|50568583|FG000|Acute Phase|Lost to Follow-up|2|||
24977384|NCT00048542|50065999|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
25253061|NCT01124149|50568583|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
25253062|NCT01124149|50568583|FG000|Acute Phase|Sponsor request|1|||
25253063|NCT01124149|50568583|FG000|Acute Phase|UC symptoms not ameliorated|1|||
25336021|NCT00774852|50652179|FG000|Overall Study|Withdrawal by Subject|2|||
25336022|NCT00774852|50652180|FG001|Overall Study|Withdrawal by Subject|2|||
25336023|NCT00774852|50652179|FG000|Overall Study|Non-responder|15|||
25336024|NCT00774852|50652180|FG001|Overall Study|Non-responder|11|||
25253064|NCT01124149|50568583|FG000|Acute Phase|Non-compliance|1|||
25253065|NCT01124149|50568583|FG000|Acute Phase|Low hemoglobin|1|||
25253066|NCT01124149|50568583|FG000|Acute Phase|Travelling to another country|1|||
25253067|NCT01124149|50568583|FG000|Acute Phase|Sponsor decision|1|||
25253068|NCT01124149|50568583|FG000|Maintenance Phase|Lack of Efficacy|40|||
25253069|NCT01124149|50568583|FG000|Maintenance Phase|Adverse Event|24|||
25253070|NCT01124149|50568583|FG000|Maintenance Phase|Lost to Follow-up|15|||
25253071|NCT01124149|50568583|FG000|Maintenance Phase|Withdrawal by Subject|10|||
25336025|NCT00774852|50652179|FG000|Overall Study|Subject non-compliance|0|||
25336026|NCT00774852|50652180|FG001|Overall Study|Subject non-compliance|1|||
25336027|NCT00774852|50652179|FG000|Overall Study|Protocol Violation|1|||
25336028|NCT00774852|50652180|FG001|Overall Study|Protocol Violation|0|||
25336029|NCT00774852|50652179|FG000|Overall Study|Subject received prohibited medication|1|||
25336030|NCT00774852|50652180|FG001|Overall Study|Subject received prohibited medication|0|||
25336031|NCT00774306|50652200|FG000|Overall Study|Adverse Event|3|||
25336032|NCT00774306|50652201|FG001|Overall Study|Adverse Event|0|||
25336033|NCT00774306|50652202|FG002|Overall Study|Adverse Event|0|||
25336034|NCT00774306|50652203|FG003|Overall Study|Adverse Event|0|||
25336035|NCT00774306|50652200|FG000|Overall Study|Protocol Violation|2|||
25336036|NCT00774306|50652201|FG001|Overall Study|Protocol Violation|0|||
25336037|NCT00774306|50652202|FG002|Overall Study|Protocol Violation|3|||
25336038|NCT00774306|50652203|FG003|Overall Study|Protocol Violation|0|||
25336039|NCT00774306|50652200|FG000|Overall Study|Withdrawal by Subject|6|||
25336040|NCT00774306|50652201|FG001|Overall Study|Withdrawal by Subject|1|||
25336041|NCT00774306|50652202|FG002|Overall Study|Withdrawal by Subject|1|||
25336042|NCT00774306|50652203|FG003|Overall Study|Withdrawal by Subject|0|||
25336043|NCT00774306|50652200|FG000|Overall Study|Lost to Follow-up|6|||
25336044|NCT00774306|50652201|FG001|Overall Study|Lost to Follow-up|0|||
25336045|NCT00774306|50652202|FG002|Overall Study|Lost to Follow-up|4|||
25336046|NCT00774306|50652203|FG003|Overall Study|Lost to Follow-up|5|||
25336047|NCT00774306|50652200|FG000|Overall Study|Death|1|||
25336048|NCT00774306|50652201|FG001|Overall Study|Death|1|||
25336049|NCT00774306|50652202|FG002|Overall Study|Death|0|||
25336050|NCT00774306|50652203|FG003|Overall Study|Death|0|||
25336051|NCT00781326|50652213|FG000|Phase I|Adverse Event|1|||
25336052|NCT00781326|50652213|FG000|Phase I|Withdrawal by Subject|1|||
25336053|NCT00781326|50652213|FG000|Phase I|Physician Decision|2|||
25336054|NCT00787800|50652219|FG000|Overall Study|Withdrawal by Subject|3|||
25336055|NCT00787800|50652220|FG001|Overall Study|Withdrawal by Subject|5|||
25336056|NCT00787800|50652219|FG000|Overall Study|Death|0|||
25336057|NCT00787800|50652220|FG001|Overall Study|Death|2|||
25336058|NCT00773838|50652227|FG000|Overall Study|Adverse Event|29|||
25336059|NCT00773838|50652227|FG000|Overall Study|Lost to Follow-up|1|||
25336060|NCT00773838|50652227|FG000|Overall Study|Physician Decision|8|||
25253072|NCT01124149|50568583|FG000|Maintenance Phase|Protocol Violation|5|||
25253073|NCT01124149|50568583|FG000|Maintenance Phase|Coordinator error|1|||
25253074|NCT01124149|50568583|FG000|Maintenance Phase|Non-compliance|1|||
25253075|NCT01123642|50568590|FG000|Overall Study|Lost to Follow-up|23|||
25253076|NCT01123642|50568590|FG000|Overall Study|Withdrawal by Subject|9|||
25253077|NCT01123642|50568590|FG000|Overall Study|ineligible at baseline assessment|36|||
25253078|NCT01122862|50568595|FG000|Period 1|Protocol Violation|0|||
25253079|NCT01122862|50568596|FG001|Period 1|Protocol Violation|1|||
25253080|NCT01122862|50568597|FG002|Period 1|Protocol Violation|0|||
25253081|NCT01122862|50568595|FG000|Period 2|Adverse Event|0|||
25253082|NCT01122862|50568596|FG001|Period 2|Adverse Event|0|||
25253083|NCT01122862|50568597|FG002|Period 2|Adverse Event|1|||
25253084|NCT01122394|50568608|FG000|Overall Study|Withdrawal by Subject|1|||
25253085|NCT01122394|50568609|FG001|Overall Study|Withdrawal by Subject|1|||
25253086|NCT01122394|50568608|FG000|Overall Study|Lost to Follow-up|2|||
25336061|NCT00773838|50652227|FG000|Overall Study|Progressive Disease|82|||
25336062|NCT00773838|50652227|FG000|Overall Study|Protocol Violation|2|||
25336063|NCT00773838|50652227|FG000|Overall Study|Withdrawal by Subject|21|||
25336064|NCT00787644|50652233|FG000|Overall Study|Lost to Follow-up|1|||
25336065|NCT00787644|50652234|FG001|Overall Study|Lost to Follow-up|1|||
25336066|NCT00787644|50652233|FG000|Overall Study|Withdrawal by Subject|1|||
25336067|NCT00787644|50652234|FG001|Overall Study|Withdrawal by Subject|1|||
25336068|NCT00787566|50652243|FG000|Overall Study|AE related to chemotherapy|0|||
25253087|NCT01122394|50568609|FG001|Overall Study|Lost to Follow-up|2|||
25336069|NCT00787566|50652244|FG001|Overall Study|AE related to chemotherapy|1|||
25336070|NCT00787566|50652245|FG002|Overall Study|AE related to chemotherapy|0|||
25336071|NCT00787254|50652255|FG000|Overall Study|Adverse Event|24|||
25336072|NCT00787254|50652256|FG001|Overall Study|Adverse Event|23|||
25336073|NCT00787254|50652255|FG000|Overall Study|Protocol Violation|26|||
25336074|NCT00787254|50652256|FG001|Overall Study|Protocol Violation|23|||
25336075|NCT00787254|50652255|FG000|Overall Study|Withdrawal by Subject|16|||
25336076|NCT00787254|50652256|FG001|Overall Study|Withdrawal by Subject|11|||
25336077|NCT00787254|50652255|FG000|Overall Study|Lack of Efficacy|4|||
25253088|NCT01122394|50568608|FG000|Overall Study|Adverse Event|0|||
25253089|NCT01122394|50568609|FG001|Overall Study|Adverse Event|1|||
25336078|NCT00787254|50652256|FG001|Overall Study|Lack of Efficacy|15|||
25336079|NCT00787254|50652255|FG000|Overall Study|NSAIDs discontinuation|1|||
25336080|NCT00787254|50652256|FG001|Overall Study|NSAIDs discontinuation|2|||
25336081|NCT00787254|50652255|FG000|Overall Study|Institution closed|1|||
25336082|NCT00787254|50652256|FG001|Overall Study|Institution closed|0|||
25336083|NCT00787254|50652255|FG000|Overall Study|Physician Decision|4|||
25336084|NCT00787254|50652256|FG001|Overall Study|Physician Decision|8|||
25336085|NCT00625846|50652266|FG000|Overall Study|Withdrawal by Subject|2|||
25336086|NCT00625846|50652267|FG001|Overall Study|Withdrawal by Subject|0|||
25336087|NCT00625846|50652268|FG002|Overall Study|Withdrawal by Subject|1|||
25336088|NCT00625846|50652269|FG003|Overall Study|Withdrawal by Subject|2|||
25336089|NCT00773292|50652283|FG000|Treatment 48 Weeks|Adverse Event|1|||
25336090|NCT00773292|50652283|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
25336091|NCT00786864|50652289|FG000|Overall Study|Lost to Follow-up|0|||
25336092|NCT00786864|50652290|FG001|Overall Study|Lost to Follow-up|1|||
25336093|NCT00786864|50652289|FG000|Overall Study|Sustained serious back injury|1|||
25336094|NCT00786864|50652290|FG001|Overall Study|Sustained serious back injury|0|||
25336095|NCT00621322|50652302|FG000|Overall Study|Lost to Follow-up|0|||
25336096|NCT00621322|50652303|FG001|Overall Study|Lost to Follow-up|0|||
25336097|NCT00621322|50652304|FG002|Overall Study|Lost to Follow-up|0|||
25336098|NCT00621322|50652305|FG003|Overall Study|Lost to Follow-up|0|||
25336099|NCT00621322|50652306|FG004|Overall Study|Lost to Follow-up|1|||
25336100|NCT00621322|50652307|FG005|Overall Study|Lost to Follow-up|0|||
25336101|NCT00621322|50652302|FG000|Overall Study|Physician Decision|0|||
25336102|NCT00621322|50652303|FG001|Overall Study|Physician Decision|0|||
25336103|NCT00621322|50652304|FG002|Overall Study|Physician Decision|1|||
25336104|NCT00621322|50652305|FG003|Overall Study|Physician Decision|1|||
25336105|NCT00621322|50652306|FG004|Overall Study|Physician Decision|0|||
25336106|NCT00621322|50652307|FG005|Overall Study|Physician Decision|0|||
25336107|NCT00621322|50652302|FG000|Overall Study|Withdrawal by Subject|0|||
25336108|NCT00621322|50652303|FG001|Overall Study|Withdrawal by Subject|0|||
25336109|NCT00621322|50652304|FG002|Overall Study|Withdrawal by Subject|0|||
25253090|NCT01121926|50568617|FG000|First Intervention Period|Adverse Event|1|||
25253091|NCT01121926|50568618|FG001|First Intervention Period|Adverse Event|0|||
25253092|NCT01121926|50568617|FG000|Washout Period|Adverse Event|0|||
25336110|NCT00621322|50652305|FG003|Overall Study|Withdrawal by Subject|1|||
25336111|NCT00621322|50652306|FG004|Overall Study|Withdrawal by Subject|0|||
25336112|NCT00621322|50652307|FG005|Overall Study|Withdrawal by Subject|2|||
25336113|NCT00621322|50652302|FG000|Overall Study|Migrated/moved from study area|1|||
25336114|NCT00621322|50652303|FG001|Overall Study|Migrated/moved from study area|0|||
25336115|NCT00621322|50652304|FG002|Overall Study|Migrated/moved from study area|1|||
25336116|NCT00621322|50652305|FG003|Overall Study|Migrated/moved from study area|1|||
25336117|NCT00621322|50652306|FG004|Overall Study|Migrated/moved from study area|0|||
25336118|NCT00621322|50652307|FG005|Overall Study|Migrated/moved from study area|2|||
25336119|NCT00853385|50652326|FG000|Overall Study|Death|0|||
25336120|NCT00853385|50652327|FG001|Overall Study|Death|0|||
25336121|NCT00853385|50652328|FG002|Overall Study|Death|0|||
25336122|NCT00853385|50652329|FG003|Overall Study|Death|0|||
25336123|NCT00853385|50652330|FG004|Overall Study|Death|1|||
25336124|NCT00853385|50652326|FG000|Overall Study|Adverse Event|24|||
25336125|NCT00853385|50652327|FG001|Overall Study|Adverse Event|24|||
25336126|NCT00853385|50652328|FG002|Overall Study|Adverse Event|2|||
25336127|NCT00853385|50652329|FG003|Overall Study|Adverse Event|5|||
24902226|NCT00784277|49996245|FG004|ER Treatment|Study Medication Non-Compliant|2|||
24902227|NCT00784277|49996246|FG005|ER Treatment|Study Medication Non-Compliant|3|||
24902228|NCT00784277|49996247|FG006|ER Treatment|Study Medication Non-Compliant|3|||
24902229|NCT00784277|49996241|FG000|ER Treatment|Other|0|||
24977385|NCT00048542|50066000|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
25253093|NCT01121926|50568618|FG001|Washout Period|Adverse Event|1|||
25253094|NCT01121926|50568617|FG000|Washout Period|Positive pregnancy test|0|||
25253095|NCT01121926|50568618|FG001|Washout Period|Positive pregnancy test|1|||
25253096|NCT01121575|50568630|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
25253097|NCT01121575|50568631|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
25336128|NCT00853385|50652330|FG004|Overall Study|Adverse Event|22|||
25336129|NCT00853385|50652326|FG000|Overall Study|Lack of Efficacy|6|||
25336130|NCT00853385|50652327|FG001|Overall Study|Lack of Efficacy|7|||
25336131|NCT00853385|50652328|FG002|Overall Study|Lack of Efficacy|3|||
25336132|NCT00853385|50652329|FG003|Overall Study|Lack of Efficacy|3|||
25336133|NCT00853385|50652330|FG004|Overall Study|Lack of Efficacy|6|||
25336134|NCT00853385|50652326|FG000|Overall Study|Lost to Follow-up|2|||
25336135|NCT00853385|50652327|FG001|Overall Study|Lost to Follow-up|1|||
24902230|NCT00784277|49996242|FG001|ER Treatment|Other|0|||
24902231|NCT00784277|49996243|FG002|ER Treatment|Other|0|||
24902232|NCT00784277|49996244|FG003|ER Treatment|Other|0|||
25253098|NCT01121575|50568632|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
25336136|NCT00853385|50652328|FG002|Overall Study|Lost to Follow-up|0|||
25336137|NCT00853385|50652329|FG003|Overall Study|Lost to Follow-up|0|||
24902233|NCT00784277|49996245|FG004|ER Treatment|Other|1|||
25253099|NCT01121575|50568633|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
25253100|NCT01121575|50568634|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
25253101|NCT01121575|50568635|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
25253102|NCT01121575|50568630|FG000|Overall Study|Unspecified Reasons|8|||
25253103|NCT01121575|50568631|FG001|Overall Study|Unspecified Reasons|6|||
25253104|NCT01121575|50568632|FG002|Overall Study|Unspecified Reasons|7|||
25253105|NCT01121575|50568633|FG003|Overall Study|Unspecified Reasons|5|||
25336138|NCT00853385|50652330|FG004|Overall Study|Lost to Follow-up|0|||
25336139|NCT00853385|50652326|FG000|Overall Study|Withdrawal by Subject|4|||
25336140|NCT00853385|50652327|FG001|Overall Study|Withdrawal by Subject|2|||
25336141|NCT00853385|50652328|FG002|Overall Study|Withdrawal by Subject|0|||
25336142|NCT00853385|50652329|FG003|Overall Study|Withdrawal by Subject|1|||
25336143|NCT00853385|50652330|FG004|Overall Study|Withdrawal by Subject|1|||
25336144|NCT00853385|50652326|FG000|Overall Study|Other|18|||
25336145|NCT00853385|50652327|FG001|Overall Study|Other|9|||
25336146|NCT00853385|50652328|FG002|Overall Study|Other|4|||
25336147|NCT00853385|50652329|FG003|Overall Study|Other|4|||
25336148|NCT00853385|50652330|FG004|Overall Study|Other|12|||
25336149|NCT00622336|50652352|FG000|Treatment Phase|Progression of Disease|181|||
25336150|NCT00622336|50652352|FG000|Treatment Phase|Adverse Event|46|||
25336151|NCT00622336|50652352|FG000|Treatment Phase|Other|40|||
25336152|NCT00622336|50652352|FG000|Treatment Phase|Death|14|||
25336153|NCT00622336|50652352|FG000|Treatment Phase|Lack of therapeutic effect|13|||
25336154|NCT00622336|50652352|FG000|Treatment Phase|Withdrawal by Subject|13|||
25336155|NCT00622336|50652352|FG000|Treatment Phase|Lost to Follow-up|2|||
25336156|NCT00622336|50652352|FG000|Extension Phase|Adverse Event|2|||
25336157|NCT00622336|50652352|FG000|Extension Phase|Progressive Disease|6|||
25336158|NCT00622336|50652352|FG000|Extension Phase|Lack of therapeutic effect|2|||
24902234|NCT00784277|49996246|FG005|ER Treatment|Other|3|||
24902235|NCT00784277|49996247|FG006|ER Treatment|Other|2|||
24902236|NCT00682929|49996263|FG000|Overall Study|Adverse Event|4|||
24902237|NCT00682929|49996264|FG001|Overall Study|Adverse Event|1|||
24902238|NCT00682929|49996265|FG002|Overall Study|Adverse Event|1|||
24902239|NCT00682929|49996263|FG000|Overall Study|Withdrawal by Subject|1|||
24902240|NCT00682929|49996264|FG001|Overall Study|Withdrawal by Subject|2|||
24902241|NCT00682929|49996265|FG002|Overall Study|Withdrawal by Subject|1|||
24902242|NCT00682929|49996263|FG000|Overall Study|dosing compliance < 80%|0|||
24902243|NCT00682929|49996264|FG001|Overall Study|dosing compliance < 80%|2|||
24902244|NCT00682929|49996265|FG002|Overall Study|dosing compliance < 80%|0|||
24902245|NCT00682929|49996263|FG000|Overall Study|lag in DEA renewal|1|||
24902246|NCT00682929|49996264|FG001|Overall Study|lag in DEA renewal|0|||
24902247|NCT00682929|49996265|FG002|Overall Study|lag in DEA renewal|0|||
24902248|NCT00680745|49996277|FG000|Overall Study|Withdrawal by Subject|8|||
24902249|NCT00680745|49996278|FG001|Overall Study|Withdrawal by Subject|3|||
24902250|NCT00680745|49996279|FG002|Overall Study|Withdrawal by Subject|2|||
24902251|NCT00680745|49996280|FG003|Overall Study|Withdrawal by Subject|8|||
24902252|NCT00680745|49996277|FG000|Overall Study|Lost to Follow-up|0|||
24902253|NCT00680745|49996278|FG001|Overall Study|Lost to Follow-up|1|||
24902254|NCT00680745|49996279|FG002|Overall Study|Lost to Follow-up|1|||
24902255|NCT00680745|49996280|FG003|Overall Study|Lost to Follow-up|0|||
24902256|NCT00680745|49996277|FG000|Overall Study|Death|1|||
24902257|NCT00680745|49996278|FG001|Overall Study|Death|0|||
24902258|NCT00680745|49996279|FG002|Overall Study|Death|1|||
24902259|NCT00680745|49996280|FG003|Overall Study|Death|0|||
24902260|NCT00680745|49996277|FG000|Overall Study|Adverse Event|5|||
24902261|NCT00680745|49996278|FG001|Overall Study|Adverse Event|3|||
25253106|NCT01121575|50568634|FG004|Overall Study|Unspecified Reasons|13|||
25336159|NCT00622336|50652352|FG000|Extension Phase|Withdrawal by Subject|1|||
25336160|NCT00622336|50652352|FG000|Extension Phase|Lost to Follow-up|1|||
25336161|NCT00622336|50652352|FG000|Extension Phase|Other|9|||
25336162|NCT00779766|50652360|FG000|Month 24|Serious Adverse Event|2|||
25336163|NCT00779766|50652361|FG001|Month 24|Serious Adverse Event|3|||
24902262|NCT00680745|49996279|FG002|Overall Study|Adverse Event|3|||
24902263|NCT00680745|49996280|FG003|Overall Study|Adverse Event|3|||
24902264|NCT00680745|49996277|FG000|Overall Study|Poor/Non-compliance|0|||
24902265|NCT00680745|49996278|FG001|Overall Study|Poor/Non-compliance|3|||
24902266|NCT00680745|49996279|FG002|Overall Study|Poor/Non-compliance|0|||
24902267|NCT00680745|49996280|FG003|Overall Study|Poor/Non-compliance|0|||
24902268|NCT00680745|49996277|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
24902269|NCT00680745|49996278|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
25253107|NCT01121575|50568635|FG005|Overall Study|Unspecified Reasons|10|||
25336164|NCT00779766|50652360|FG000|Month 24|Adverse Event|3|||
25336165|NCT00779766|50652361|FG001|Month 24|Adverse Event|3|||
25336166|NCT00779766|50652360|FG000|Month 24|Protocol Violation|3|||
25336167|NCT00779766|50652361|FG001|Month 24|Protocol Violation|1|||
25336168|NCT00779766|50652360|FG000|Month 24|Withdrawal by Subject|159|||
24902270|NCT00680745|49996279|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
24902271|NCT00680745|49996280|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
24902272|NCT00680745|49996277|FG000|Overall Study|False Treatment|0|||
25253108|NCT01121575|50568630|FG000|Overall Study|Death|6|||
25253109|NCT01121575|50568631|FG001|Overall Study|Death|0|||
24902273|NCT00680745|49996278|FG001|Overall Study|False Treatment|1|||
24902274|NCT00680745|49996279|FG002|Overall Study|False Treatment|3|||
24977386|NCT00048542|50066001|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
24977387|NCT00048542|50066002|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
24977388|NCT00048542|50066003|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
24977389|NCT00048542|50065996|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
24977390|NCT00048542|50065997|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
24977391|NCT00048542|50065998|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
24977392|NCT00048542|50065999|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
24977393|NCT00048542|50066000|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
24977394|NCT00048542|50066001|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
24977395|NCT00048542|50066002|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
24977396|NCT00048542|50066003|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
24977397|NCT00048542|50065996|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
24977398|NCT00048542|50065997|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
24977399|NCT00048542|50065998|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
24977400|NCT00048542|50065999|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
24977401|NCT00048542|50066000|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
24977402|NCT00048542|50066001|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
24977403|NCT00048542|50066002|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
24977404|NCT00048542|50066003|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
24977405|NCT00048542|50065996|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
24977406|NCT00048542|50065997|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
24977407|NCT00048542|50065998|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
24977408|NCT00048542|50065999|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
24977409|NCT00048542|50066000|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
24977410|NCT00048542|50066001|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
24977411|NCT00048542|50066002|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
24977412|NCT00048542|50066003|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
25253110|NCT01121575|50568632|FG002|Overall Study|Death|0|||
25253111|NCT01121575|50568633|FG003|Overall Study|Death|1|||
25253112|NCT01121575|50568634|FG004|Overall Study|Death|7|||
24902275|NCT00680745|49996280|FG003|Overall Study|False Treatment|0|||
24902276|NCT00680121|49996293|FG000|Overall Study|Lost to Follow-up|27|||
24902277|NCT00680121|49996294|FG001|Overall Study|Lost to Follow-up|23|||
24902278|NCT00767819|49996303|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
25253113|NCT01121575|50568635|FG005|Overall Study|Death|1|||
25253114|NCT01121536|50568658|FG000|Overall Study|Adverse Event|63|||
25253115|NCT01121536|50568658|FG000|Overall Study|Lack of Efficacy|35|||
25253116|NCT01121536|50568658|FG000|Overall Study|Withdrawal by Subject|65|||
25253117|NCT01121536|50568658|FG000|Overall Study|Protocol Violation|20|||
25253118|NCT01121536|50568658|FG000|Overall Study|Noncompliance with study medication|12|||
25253119|NCT01121536|50568658|FG000|Overall Study|Noncompliance with study procedures|9|||
25253120|NCT01121536|50568658|FG000|Overall Study|Lost to Follow-up|39|||
25253121|NCT01121536|50568658|FG000|Overall Study|Other|118|||
25253122|NCT01121263|50568664|FG000|Overall Study|Death|3|||
25253123|NCT01121263|50568665|FG001|Overall Study|Death|2|||
25253124|NCT01121263|50568664|FG000|Overall Study|Lost to Follow-up|22|||
25253125|NCT01121263|50568665|FG001|Overall Study|Lost to Follow-up|12|||
25253126|NCT01121263|50568664|FG000|Overall Study|Withdrawal by Subject|0|||
25253127|NCT01121263|50568665|FG001|Overall Study|Withdrawal by Subject|1|||
25253128|NCT01121185|50568675|FG000|Overall Study|Not infused|0|||
25253129|NCT01121185|50568676|FG001|Overall Study|Not infused|1|||
25253130|NCT01121185|50568675|FG000|Overall Study|Not transplanted|1|||
25336169|NCT00779766|50652361|FG001|Month 24|Withdrawal by Subject|127|||
25336170|NCT00779766|50652360|FG000|Month 24|Migrated/moved from study area|138|||
25336171|NCT00779766|50652361|FG001|Month 24|Migrated/moved from study area|162|||
25336172|NCT00779766|50652360|FG000|Month 24|Lost to Follow-up|9|||
25336173|NCT00779766|50652361|FG001|Month 24|Lost to Follow-up|9|||
25336174|NCT00779766|50652360|FG000|Month 24|Other|18|||
25336175|NCT00779766|50652361|FG001|Month 24|Other|27|||
25336176|NCT00779766|50652360|FG000|Month 48|Withdrawal by Subject|68|||
24902279|NCT00767819|49996304|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
24902280|NCT00767819|49996305|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
24902281|NCT00767819|49996303|FG000|Overall Study|Withdrawal by Subject|1|||
24902282|NCT00767819|49996304|FG001|Overall Study|Withdrawal by Subject|1|||
24902283|NCT00767819|49996305|FG002|Overall Study|Withdrawal by Subject|0|||
24902284|NCT00767819|49996303|FG000|Overall Study|Administrative problems|0|||
24902285|NCT00767819|49996304|FG001|Overall Study|Administrative problems|1|||
24902286|NCT00767819|49996305|FG002|Overall Study|Administrative problems|0|||
24902287|NCT00767819|49996303|FG000|Overall Study|Death|2|||
24902288|NCT00767819|49996304|FG001|Overall Study|Death|3|||
24902289|NCT00767819|49996305|FG002|Overall Study|Death|0|||
25253131|NCT01121185|50568676|FG001|Overall Study|Not transplanted|0|||
25336177|NCT00779766|50652361|FG001|Month 48|Withdrawal by Subject|63|||
25336178|NCT00779766|50652360|FG000|Month 48|Migrated/moved from study area|76|||
25336179|NCT00779766|50652361|FG001|Month 48|Migrated/moved from study area|75|||
25336180|NCT00779766|50652360|FG000|Month 48|Lost to Follow-up|29|||
25336181|NCT00779766|50652361|FG001|Month 48|Lost to Follow-up|30|||
25336182|NCT00779766|50652360|FG000|Month 48|Other|1|||
25336183|NCT00779766|50652361|FG001|Month 48|Other|0|||
25336184|NCT00779766|50652360|FG000|Month 72|Withdrawal by Subject|55|||
25336185|NCT00779766|50652361|FG001|Month 72|Withdrawal by Subject|71|||
25336186|NCT00779766|50652360|FG000|Month 72|Migrated/moved from study area|124|||
25336187|NCT00779766|50652361|FG001|Month 72|Migrated/moved from study area|109|||
25336188|NCT00779766|50652360|FG000|Month 72|Lost to Follow-up|6|||
25336189|NCT00779766|50652361|FG001|Month 72|Lost to Follow-up|8|||
25336190|NCT00779766|50652360|FG000|Month 72|Other|0|||
25336191|NCT00779766|50652361|FG001|Month 72|Other|1|||
25336192|NCT00846365|50652371|FG000|Overall Study|Adverse Event|20|||
25336193|NCT00846365|50652372|FG001|Overall Study|Adverse Event|30|||
25336194|NCT00846365|50652373|FG002|Overall Study|Adverse Event|11|||
25336195|NCT00846365|50652371|FG000|Overall Study|Protocol Violation|5|||
25336196|NCT00846365|50652372|FG001|Overall Study|Protocol Violation|4|||
25336197|NCT00846365|50652373|FG002|Overall Study|Protocol Violation|0|||
25336198|NCT00846365|50652371|FG000|Overall Study|Lost to Follow-up|8|||
25336199|NCT00846365|50652372|FG001|Overall Study|Lost to Follow-up|2|||
25336200|NCT00846365|50652373|FG002|Overall Study|Lost to Follow-up|5|||
25336201|NCT00846365|50652371|FG000|Overall Study|Withdrawal by Subject|11|||
25336202|NCT00846365|50652372|FG001|Overall Study|Withdrawal by Subject|11|||
25336203|NCT00846365|50652373|FG002|Overall Study|Withdrawal by Subject|9|||
25336204|NCT00846365|50652371|FG000|Overall Study|Pregnancy|1|||
25336205|NCT00846365|50652372|FG001|Overall Study|Pregnancy|0|||
25336206|NCT00846365|50652373|FG002|Overall Study|Pregnancy|0|||
25336207|NCT00846365|50652371|FG000|Overall Study|Lack of Efficacy|1|||
25336208|NCT00846365|50652372|FG001|Overall Study|Lack of Efficacy|1|||
25336209|NCT00846365|50652373|FG002|Overall Study|Lack of Efficacy|2|||
25336210|NCT00846365|50652371|FG000|Overall Study|Other|9|||
25336211|NCT00846365|50652372|FG001|Overall Study|Other|1|||
25336212|NCT00846365|50652373|FG002|Overall Study|Other|6|||
25336213|NCT00779142|50652381|FG000|Overall Study|Screen Failures|3|||
25336214|NCT00622180|50652386|FG000|Overall Study|Lost to Follow-up|1|||
25336215|NCT00622180|50652387|FG001|Overall Study|Lost to Follow-up|2|||
25077964|NCT02229214|50186099|FG000|Overall Study|Withdrawal by Subject|4|||
25253132|NCT01121146|50568684|FG000|Overall Study|Death|17|||
25253133|NCT01121146|50568685|FG001|Overall Study|Death|15|||
25253134|NCT01121146|50568684|FG000|Overall Study|Adverse Event|2|||
25253135|NCT01121146|50568685|FG001|Overall Study|Adverse Event|11|||
25253136|NCT01121146|50568684|FG000|Overall Study|Lost to Follow-up|7|||
25253137|NCT01121146|50568685|FG001|Overall Study|Lost to Follow-up|16|||
25253138|NCT01120756|50568694|FG000|Overall Study|Withdrawal by Subject|1|||
25253139|NCT01120756|50568695|FG001|Overall Study|Withdrawal by Subject|1|||
25253140|NCT01120717|50568703|FG000|Overall Study|Withdrawal by Subject|11|||
25253141|NCT01120717|50568704|FG001|Overall Study|Withdrawal by Subject|6|||
25253142|NCT01120717|50568703|FG000|Overall Study|Adverse Event|10|||
25253143|NCT01120717|50568704|FG001|Overall Study|Adverse Event|6|||
25253144|NCT01120717|50568703|FG000|Overall Study|Protocol Deviation|2|||
25253145|NCT01120717|50568704|FG001|Overall Study|Protocol Deviation|5|||
25253146|NCT01120717|50568703|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
25253147|NCT01120717|50568704|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
25253148|NCT01120717|50568703|FG000|Overall Study|Lost to Follow-up|2|||
25253149|NCT01120717|50568704|FG001|Overall Study|Lost to Follow-up|3|||
25253150|NCT01120717|50568703|FG000|Overall Study|Death|3|||
25253151|NCT01120717|50568704|FG001|Overall Study|Death|1|||
25253152|NCT01120717|50568703|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
25253153|NCT01120717|50568704|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
25253154|NCT01120600|50568712|FG000|Overall Study|Adverse Event|7|||
25336216|NCT00773136|50652393|FG000|Overall Study|Physician Decision|2|||
25077965|NCT02229214|50186100|FG001|Overall Study|Withdrawal by Subject|0|||
25253155|NCT01120600|50568713|FG001|Overall Study|Adverse Event|7|||
25253156|NCT01120600|50568712|FG000|Overall Study|Excessive Bone Loss|0|||
25253157|NCT01120600|50568713|FG001|Overall Study|Excessive Bone Loss|4|||
25253158|NCT01120600|50568712|FG000|Overall Study|Lost to Follow-up|1|||
25253159|NCT01120600|50568713|FG001|Overall Study|Lost to Follow-up|3|||
25336217|NCT00853307|50652400|FG000|Overall Study|Adverse Event|1|||
25336218|NCT00853307|50652401|FG001|Overall Study|Adverse Event|2|||
25336219|NCT00853307|50652400|FG000|Overall Study|Withdrawal by Subject|1|||
25336220|NCT00853307|50652401|FG001|Overall Study|Withdrawal by Subject|2|||
25336221|NCT00853307|50652400|FG000|Overall Study|Reason Not Specified|0|||
25336222|NCT00853307|50652401|FG001|Overall Study|Reason Not Specified|1|||
25336223|NCT00778830|50652409|FG000|Overall Study|Ongoing at data cut-off|0|||
25336224|NCT00778830|50652410|FG001|Overall Study|Ongoing at data cut-off|1|||
25336225|NCT00772668|50652416|FG000|Overall Study|Physician Decision|3|||
25336226|NCT00786474|50652423|FG000|Overall Study|Death|5|||
25336227|NCT00786474|50652424|FG001|Overall Study|Death|4|||
25336228|NCT00786474|50652423|FG000|Overall Study|Withdrawal by Subject|23|||
25336229|NCT00786474|50652424|FG001|Overall Study|Withdrawal by Subject|31|||
25336230|NCT00786474|50652423|FG000|Overall Study|Lost to Follow-up|3|||
25336231|NCT00786474|50652424|FG001|Overall Study|Lost to Follow-up|3|||
25336232|NCT00786474|50652423|FG000|Overall Study|Physician Decision|2|||
25336233|NCT00786474|50652424|FG001|Overall Study|Physician Decision|1|||
25336234|NCT00786474|50652423|FG000|Overall Study|Other|4|||
25336235|NCT00786474|50652424|FG001|Overall Study|Other|4|||
25336236|NCT00784875|50652434|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
25336237|NCT00784875|50652435|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
25336238|NCT00784875|50652436|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
25336239|NCT00784875|50652437|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
25336240|NCT00784875|50652434|FG000|Period A - Baseline|Adverse Event|0|||
25336241|NCT00784875|50652435|FG001|Period A - Baseline|Adverse Event|0|||
25336242|NCT00784875|50652436|FG002|Period A - Baseline|Adverse Event|0|||
25336243|NCT00784875|50652437|FG003|Period A - Baseline|Adverse Event|8|||
25336244|NCT00784875|50652434|FG000|Period A - Baseline|Protocol Violation|0|||
25336245|NCT00784875|50652435|FG001|Period A - Baseline|Protocol Violation|0|||
25336246|NCT00784875|50652436|FG002|Period A - Baseline|Protocol Violation|0|||
25336247|NCT00784875|50652437|FG003|Period A - Baseline|Protocol Violation|25|||
25336248|NCT00784875|50652434|FG000|Period A - Baseline|Withdrawal by Subject|0|||
25336249|NCT00784875|50652435|FG001|Period A - Baseline|Withdrawal by Subject|0|||
25336250|NCT00784875|50652436|FG002|Period A - Baseline|Withdrawal by Subject|0|||
25336251|NCT00784875|50652437|FG003|Period A - Baseline|Withdrawal by Subject|27|||
25336252|NCT00784875|50652434|FG000|Period A - Baseline|Physician Decision|0|||
25336253|NCT00784875|50652435|FG001|Period A - Baseline|Physician Decision|0|||
25336254|NCT00784875|50652436|FG002|Period A - Baseline|Physician Decision|0|||
25336255|NCT00784875|50652437|FG003|Period A - Baseline|Physician Decision|2|||
25336256|NCT00784875|50652434|FG000|Period A - Baseline|Sponsor Decision|0|||
25336257|NCT00784875|50652435|FG001|Period A - Baseline|Sponsor Decision|0|||
25336258|NCT00784875|50652436|FG002|Period A - Baseline|Sponsor Decision|0|||
25336259|NCT00784875|50652437|FG003|Period A - Baseline|Sponsor Decision|113|||
25336260|NCT00784875|50652434|FG000|Period A - Baseline|Lost to Follow-up|0|||
25336261|NCT00784875|50652435|FG001|Period A - Baseline|Lost to Follow-up|0|||
25336262|NCT00784875|50652436|FG002|Period A - Baseline|Lost to Follow-up|0|||
25336263|NCT00784875|50652437|FG003|Period A - Baseline|Lost to Follow-up|2|||
25336264|NCT00784875|50652434|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
25336265|NCT00784875|50652435|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
25336266|NCT00784875|50652436|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
25336267|NCT00784875|50652437|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
25336268|NCT00784875|50652434|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
25336269|NCT00784875|50652435|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
25336270|NCT00784875|50652436|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
25336271|NCT00784875|50652437|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
25336272|NCT00784875|50652434|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
25336273|NCT00784875|50652435|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
25336274|NCT00784875|50652436|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
25336275|NCT00784875|50652437|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
25336276|NCT00784875|50652434|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
25336277|NCT00784875|50652435|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
25336278|NCT00784875|50652436|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
25336279|NCT00784875|50652437|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
25336280|NCT00784875|50652434|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
25336281|NCT00784875|50652435|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
25336282|NCT00784875|50652436|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
25336283|NCT00784875|50652437|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
25336284|NCT00784875|50652434|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
25336285|NCT00784875|50652435|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
25336286|NCT00784875|50652436|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
25336287|NCT00784875|50652437|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
25336288|NCT00784875|50652434|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
25336289|NCT00784875|50652435|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
25336290|NCT00784875|50652436|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
25336291|NCT00784875|50652437|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
25336292|NCT00784875|50652434|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
25336293|NCT00784875|50652435|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
24977413|NCT00048542|50065996|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
24977414|NCT00048542|50065997|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
24977415|NCT00048542|50065998|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
25336294|NCT00784875|50652436|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
25336295|NCT00784875|50652437|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
25336296|NCT00784875|50652434|FG000|Period C|Adverse Event|1|||
25336297|NCT00784875|50652435|FG001|Period C|Adverse Event|0|||
25336298|NCT00784875|50652436|FG002|Period C|Adverse Event|4|||
25336299|NCT00784875|50652437|FG003|Period C|Adverse Event|2|||
25336300|NCT00784875|50652434|FG000|Period C|Protocol Violation|0|||
25336301|NCT00784875|50652435|FG001|Period C|Protocol Violation|0|||
25336302|NCT00784875|50652436|FG002|Period C|Protocol Violation|1|||
25336303|NCT00784875|50652437|FG003|Period C|Protocol Violation|2|||
25336304|NCT00784875|50652434|FG000|Period C|Lack of Efficacy|0|||
25336305|NCT00784875|50652435|FG001|Period C|Lack of Efficacy|0|||
25336306|NCT00784875|50652436|FG002|Period C|Lack of Efficacy|1|||
25336307|NCT00784875|50652437|FG003|Period C|Lack of Efficacy|0|||
25336308|NCT00784875|50652434|FG000|Period C|Withdrawal by Subject|1|||
25336309|NCT00784875|50652435|FG001|Period C|Withdrawal by Subject|1|||
25336310|NCT00784875|50652436|FG002|Period C|Withdrawal by Subject|2|||
25336311|NCT00784875|50652437|FG003|Period C|Withdrawal by Subject|0|||
25336312|NCT00784875|50652434|FG000|Period C|Physician Decision|0|||
25336313|NCT00784875|50652435|FG001|Period C|Physician Decision|0|||
25336314|NCT00784875|50652436|FG002|Period C|Physician Decision|1|||
25336315|NCT00784875|50652437|FG003|Period C|Physician Decision|1|||
25336316|NCT00784875|50652434|FG000|Period C|Sponsor Decision|5|||
25336317|NCT00784875|50652435|FG001|Period C|Sponsor Decision|5|||
25336318|NCT00784875|50652436|FG002|Period C|Sponsor Decision|4|||
25336319|NCT00784875|50652437|FG003|Period C|Sponsor Decision|2|||
25336320|NCT00784875|50652434|FG000|Period D|Adverse Event|0|||
25336321|NCT00784875|50652435|FG001|Period D|Adverse Event|2|||
25336322|NCT00784875|50652436|FG002|Period D|Adverse Event|2|||
25336323|NCT00784875|50652437|FG003|Period D|Adverse Event|0|||
25336324|NCT00784875|50652434|FG000|Period D|Protocol Violation|1|||
25336325|NCT00784875|50652435|FG001|Period D|Protocol Violation|0|||
25336326|NCT00784875|50652436|FG002|Period D|Protocol Violation|0|||
25336327|NCT00784875|50652437|FG003|Period D|Protocol Violation|0|||
25336328|NCT00784875|50652434|FG000|Period D|Withdrawal by Subject|2|||
25336329|NCT00784875|50652435|FG001|Period D|Withdrawal by Subject|0|||
25336330|NCT00784875|50652436|FG002|Period D|Withdrawal by Subject|2|||
25336331|NCT00784875|50652437|FG003|Period D|Withdrawal by Subject|0|||
25336332|NCT00784875|50652434|FG000|Period D|Physician Decision|0|||
25336333|NCT00784875|50652435|FG001|Period D|Physician Decision|1|||
25336334|NCT00784875|50652436|FG002|Period D|Physician Decision|0|||
25336335|NCT00784875|50652437|FG003|Period D|Physician Decision|0|||
25336336|NCT00784875|50652434|FG000|Period D|Sponsor Decision|1|||
25336337|NCT00784875|50652435|FG001|Period D|Sponsor Decision|1|||
25336338|NCT00784875|50652436|FG002|Period D|Sponsor Decision|1|||
25336339|NCT00784875|50652437|FG003|Period D|Sponsor Decision|0|||
25253160|NCT01120600|50568712|FG000|Overall Study|Physician Decision|1|||
25253161|NCT01120600|50568713|FG001|Overall Study|Physician Decision|3|||
25253162|NCT01120600|50568712|FG000|Overall Study|Protocol Violation|0|||
25253163|NCT01120600|50568713|FG001|Overall Study|Protocol Violation|4|||
25336340|NCT00784875|50652434|FG000|Period D|Lost to Follow-up|1|||
25336341|NCT00784875|50652435|FG001|Period D|Lost to Follow-up|0|||
25336342|NCT00784875|50652436|FG002|Period D|Lost to Follow-up|1|||
25336343|NCT00784875|50652437|FG003|Period D|Lost to Follow-up|1|||
25336344|NCT00592553|50652463|FG000|Overall Study|Protocol Noncompliance|1|||
25336345|NCT00592553|50652464|FG001|Overall Study|Protocol Noncompliance|0|||
25336346|NCT00592553|50652465|FG002|Overall Study|Protocol Noncompliance|0|||
25336347|NCT00853229|50652475|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
24902290|NCT00767819|49996303|FG000|Overall Study|Adverse Event|2|||
25253164|NCT01120600|50568712|FG000|Overall Study|Withdrawal by Subject|10|||
25253165|NCT01120600|50568713|FG001|Overall Study|Withdrawal by Subject|11|||
25253166|NCT01120210|50568721|FG000|MAIN INFUSION|Adverse Event|1|||
25253167|NCT01120210|50568722|FG001|MAIN INFUSION|Adverse Event|0|||
25253168|NCT01120210|50568721|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
25253169|NCT01120210|50568722|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
25253170|NCT01120093|50568728|FG000|Treatment Period 1|Adverse Event|0|||
25253171|NCT01120093|50568729|FG001|Treatment Period 1|Adverse Event|0|||
25336348|NCT00853229|50652476|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
25336349|NCT00853151|50652488|FG000|Overall Study|Adverse Event|1|||
25336350|NCT00853151|50652489|FG001|Overall Study|Adverse Event|4|||
25336351|NCT00853151|50652490|FG002|Overall Study|Adverse Event|2|||
25336352|NCT00853151|50652491|FG003|Overall Study|Adverse Event|0|||
25336353|NCT00853151|50652488|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
24902291|NCT00767819|49996304|FG001|Overall Study|Adverse Event|0|||
24902292|NCT00767819|49996305|FG002|Overall Study|Adverse Event|0|||
25253172|NCT01120093|50568730|FG002|Treatment Period 1|Adverse Event|1|||
25253173|NCT01120093|50568731|FG003|Treatment Period 1|Adverse Event|0|||
25253174|NCT01120093|50568732|FG004|Treatment Period 1|Adverse Event|1|||
25336354|NCT00853151|50652489|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
25336355|NCT00853151|50652490|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
25336356|NCT00853151|50652491|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
25336357|NCT00853151|50652488|FG000|Overall Study|Lost to Follow-up|2|||
25336358|NCT00853151|50652489|FG001|Overall Study|Lost to Follow-up|0|||
25336359|NCT00853151|50652490|FG002|Overall Study|Lost to Follow-up|3|||
25336360|NCT00853151|50652491|FG003|Overall Study|Lost to Follow-up|0|||
25336361|NCT00853151|50652488|FG000|Overall Study|Death|1|||
25336362|NCT00853151|50652489|FG001|Overall Study|Death|0|||
25336363|NCT00853151|50652490|FG002|Overall Study|Death|0|||
25336364|NCT00853151|50652491|FG003|Overall Study|Death|1|||
25336365|NCT00853151|50652488|FG000|Overall Study|Protocol Violation|0|||
25336366|NCT00853151|50652489|FG001|Overall Study|Protocol Violation|0|||
25336367|NCT00853151|50652490|FG002|Overall Study|Protocol Violation|0|||
25336368|NCT00853151|50652491|FG003|Overall Study|Protocol Violation|1|||
25336369|NCT00853151|50652488|FG000|Overall Study|Withdrawal by Subject|5|||
25336370|NCT00853151|50652489|FG001|Overall Study|Withdrawal by Subject|4|||
25336371|NCT00853151|50652490|FG002|Overall Study|Withdrawal by Subject|2|||
25336372|NCT00853151|50652491|FG003|Overall Study|Withdrawal by Subject|1|||
25336373|NCT00853151|50652488|FG000|Overall Study|Physician Decision|0|||
25336374|NCT00853151|50652489|FG001|Overall Study|Physician Decision|2|||
25336375|NCT00853151|50652490|FG002|Overall Study|Physician Decision|1|||
25336376|NCT00853151|50652491|FG003|Overall Study|Physician Decision|0|||
25336377|NCT00853151|50652488|FG000|Overall Study|Sponsor Decision|0|||
25336378|NCT00853151|50652489|FG001|Overall Study|Sponsor Decision|3|||
25336379|NCT00853151|50652490|FG002|Overall Study|Sponsor Decision|0|||
25336380|NCT00853151|50652491|FG003|Overall Study|Sponsor Decision|0|||
25336381|NCT00853073|50652506|FG000|Overall Study|Withdrawal by Subject|3|||
25336382|NCT00853073|50652507|FG001|Overall Study|Withdrawal by Subject|2|||
25336383|NCT00846053|50652515|FG000|Overall Study|Physician Decision|3|||
25336384|NCT00846053|50652516|FG001|Overall Study|Physician Decision|0|||
25336385|NCT00845897|50652527|FG000|Overall Study|Lost to Follow-up|1|||
25336386|NCT00845897|50652528|FG001|Overall Study|Lost to Follow-up|1|||
25336387|NCT00845897|50652529|FG002|Overall Study|Lost to Follow-up|0|||
25336388|NCT00845897|50652527|FG000|Overall Study|Withdrawal by Subject|0|||
25336389|NCT00845897|50652528|FG001|Overall Study|Withdrawal by Subject|3|||
25336390|NCT00845897|50652529|FG002|Overall Study|Withdrawal by Subject|2|||
25336391|NCT00845897|50652527|FG000|Overall Study|Ulcer did not heal|1|||
25336392|NCT00845897|50652528|FG001|Overall Study|Ulcer did not heal|0|||
25336393|NCT00845897|50652529|FG002|Overall Study|Ulcer did not heal|1|||
25336394|NCT00845897|50652527|FG000|Overall Study|Too ill to participate|0|||
25336395|NCT00845897|50652528|FG001|Overall Study|Too ill to participate|1|||
25336396|NCT00845897|50652529|FG002|Overall Study|Too ill to participate|0|||
25253175|NCT01120093|50568728|FG000|Treatment Period 1|Withdrawal by Subject|0|||
25253176|NCT01120093|50568729|FG001|Treatment Period 1|Withdrawal by Subject|1|||
25253177|NCT01120093|50568730|FG002|Treatment Period 1|Withdrawal by Subject|0|||
25253178|NCT01120093|50568731|FG003|Treatment Period 1|Withdrawal by Subject|0|||
25253179|NCT01120093|50568732|FG004|Treatment Period 1|Withdrawal by Subject|0|||
25253180|NCT01120093|50568728|FG000|Treatment Period 2|Adverse Event|0|||
25253181|NCT01120093|50568729|FG001|Treatment Period 2|Adverse Event|0|||
25253182|NCT01120093|50568730|FG002|Treatment Period 2|Adverse Event|0|||
25253183|NCT01120093|50568731|FG003|Treatment Period 2|Adverse Event|1|||
25253184|NCT01120093|50568732|FG004|Treatment Period 2|Adverse Event|0|||
25253185|NCT01120093|50568728|FG000|Treatment Period 2|Withdrawal by Subject|0|||
25253186|NCT01120093|50568729|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25253187|NCT01120093|50568730|FG002|Treatment Period 2|Withdrawal by Subject|0|||
25253188|NCT01120093|50568731|FG003|Treatment Period 2|Withdrawal by Subject|0|||
25253189|NCT01120093|50568732|FG004|Treatment Period 2|Withdrawal by Subject|1|||
25253190|NCT01120093|50568728|FG000|Treatment Period 3|Lack of Efficacy|0|||
25253191|NCT01120093|50568729|FG001|Treatment Period 3|Lack of Efficacy|0|||
25336397|NCT00862277|50652540|FG000|Overall Study|Protocol Violation|1|||
25336398|NCT00862277|50652541|FG001|Overall Study|Protocol Violation|2|||
25336399|NCT00862277|50652542|FG002|Overall Study|Protocol Violation|5|||
25336400|NCT00852995|50652555|FG000|Overall Study|Adverse Event|1|||
25336401|NCT00852995|50652556|FG001|Overall Study|Adverse Event|0|||
25336402|NCT00852995|50652557|FG002|Overall Study|Adverse Event|4|||
25336403|NCT00852995|50652558|FG003|Overall Study|Adverse Event|0|||
25336404|NCT00852995|50652559|FG004|Overall Study|Adverse Event|0|||
25336405|NCT00852995|50652555|FG000|Overall Study|Lost to Follow-up|0|||
25336406|NCT00852995|50652556|FG001|Overall Study|Lost to Follow-up|1|||
25253192|NCT01120093|50568730|FG002|Treatment Period 3|Lack of Efficacy|0|||
25253193|NCT01120093|50568731|FG003|Treatment Period 3|Lack of Efficacy|1|||
25253194|NCT01120093|50568732|FG004|Treatment Period 3|Lack of Efficacy|0|||
25253195|NCT01120093|50568728|FG000|Treatment Period 3|Adverse Event|0|||
25253196|NCT01120093|50568729|FG001|Treatment Period 3|Adverse Event|0|||
25253197|NCT01120093|50568730|FG002|Treatment Period 3|Adverse Event|0|||
25336407|NCT00852995|50652557|FG002|Overall Study|Lost to Follow-up|1|||
25336408|NCT00852995|50652558|FG003|Overall Study|Lost to Follow-up|0|||
25336409|NCT00852995|50652559|FG004|Overall Study|Lost to Follow-up|0|||
25336410|NCT00852995|50652555|FG000|Overall Study|Withdrawal by Subject|4|||
25336411|NCT00852995|50652556|FG001|Overall Study|Withdrawal by Subject|0|||
25336412|NCT00852995|50652557|FG002|Overall Study|Withdrawal by Subject|0|||
25336413|NCT00852995|50652558|FG003|Overall Study|Withdrawal by Subject|1|||
25336414|NCT00852995|50652559|FG004|Overall Study|Withdrawal by Subject|2|||
25336415|NCT00852995|50652555|FG000|Overall Study|Non-Compliance|0|||
25336416|NCT00852995|50652556|FG001|Overall Study|Non-Compliance|0|||
25336417|NCT00852995|50652557|FG002|Overall Study|Non-Compliance|0|||
25336418|NCT00852995|50652558|FG003|Overall Study|Non-Compliance|2|||
25336419|NCT00852995|50652559|FG004|Overall Study|Non-Compliance|0|||
25336420|NCT00852995|50652555|FG000|Overall Study|Progressive Disease|1|||
25336421|NCT00852995|50652556|FG001|Overall Study|Progressive Disease|0|||
25336422|NCT00852995|50652557|FG002|Overall Study|Progressive Disease|0|||
25336423|NCT00852995|50652558|FG003|Overall Study|Progressive Disease|2|||
25336424|NCT00852995|50652559|FG004|Overall Study|Progressive Disease|1|||
25336425|NCT00852995|50652555|FG000|Overall Study|Physician Decision|1|||
25336426|NCT00852995|50652556|FG001|Overall Study|Physician Decision|0|||
25336427|NCT00852995|50652557|FG002|Overall Study|Physician Decision|0|||
25336428|NCT00852995|50652558|FG003|Overall Study|Physician Decision|0|||
25336429|NCT00852995|50652559|FG004|Overall Study|Physician Decision|0|||
25336430|NCT00852995|50652555|FG000|Overall Study|Protocol Violation|0|||
25253198|NCT01120093|50568731|FG003|Treatment Period 3|Adverse Event|0|||
25253199|NCT01120093|50568732|FG004|Treatment Period 3|Adverse Event|1|||
25253200|NCT01120093|50568728|FG000|Treatment Period 3|Withdrawal by Subject|0|||
25253201|NCT01120093|50568729|FG001|Treatment Period 3|Withdrawal by Subject|0|||
25253202|NCT01120093|50568730|FG002|Treatment Period 3|Withdrawal by Subject|1|||
25336431|NCT00852995|50652556|FG001|Overall Study|Protocol Violation|0|||
25336432|NCT00852995|50652557|FG002|Overall Study|Protocol Violation|0|||
25336433|NCT00852995|50652558|FG003|Overall Study|Protocol Violation|0|||
25253203|NCT01120093|50568731|FG003|Treatment Period 3|Withdrawal by Subject|0|||
25253204|NCT01120093|50568732|FG004|Treatment Period 3|Withdrawal by Subject|0|||
25253205|NCT01120093|50568728|FG000|Treatment Period 4|Adverse Event|1|||
25253206|NCT01120093|50568729|FG001|Treatment Period 4|Adverse Event|0|||
25253207|NCT01120093|50568730|FG002|Treatment Period 4|Adverse Event|0|||
25253208|NCT01120093|50568731|FG003|Treatment Period 4|Adverse Event|0|||
25253209|NCT01120093|50568732|FG004|Treatment Period 4|Adverse Event|0|||
25253210|NCT01120093|50568728|FG000|Treatment Period 5|Adverse Event|0|||
25253211|NCT01120093|50568729|FG001|Treatment Period 5|Adverse Event|1|||
25253212|NCT01120093|50568730|FG002|Treatment Period 5|Adverse Event|0|||
25253213|NCT01120093|50568731|FG003|Treatment Period 5|Adverse Event|1|||
25253214|NCT01120093|50568732|FG004|Treatment Period 5|Adverse Event|0|||
25253215|NCT01119937|50568746|FG000|Overall Study|Adverse Event|11|||
25253216|NCT01119937|50568747|FG001|Overall Study|Adverse Event|5|||
25253217|NCT01119937|50568746|FG000|Overall Study|Protocol deviation|3|||
25336434|NCT00852995|50652559|FG004|Overall Study|Protocol Violation|1|||
25336435|NCT00852995|50652555|FG000|Overall Study|Moved Out of Area|1|||
25336436|NCT00852995|50652556|FG001|Overall Study|Moved Out of Area|0|||
25336437|NCT00852995|50652557|FG002|Overall Study|Moved Out of Area|0|||
25336438|NCT00852995|50652558|FG003|Overall Study|Moved Out of Area|0|||
25336439|NCT00852995|50652559|FG004|Overall Study|Moved Out of Area|0|||
25336440|NCT00592319|50652578|FG000|Overall Study|Lost to Follow-up|0|||
25336441|NCT00592319|50652579|FG001|Overall Study|Lost to Follow-up|3|||
25336442|NCT00862121|50652589|FG000|Overall Study|Adverse Event|1|||
25336443|NCT00862121|50652590|FG001|Overall Study|Adverse Event|2|||
25336444|NCT00862121|50652589|FG000|Overall Study|Lack of Efficacy|0|||
25336445|NCT00862121|50652590|FG001|Overall Study|Lack of Efficacy|3|||
25336446|NCT00862121|50652589|FG000|Overall Study|Protocol Violation|0|||
25336447|NCT00862121|50652590|FG001|Overall Study|Protocol Violation|1|||
25336448|NCT00862121|50652589|FG000|Overall Study|Exclusion criterion violation|0|||
25336449|NCT00862121|50652590|FG001|Overall Study|Exclusion criterion violation|1|||
25336450|NCT00862121|50652589|FG000|Overall Study|Incorrect randomisation|0|||
25336451|NCT00862121|50652590|FG001|Overall Study|Incorrect randomisation|1|||
25336452|NCT00784719|50652603|FG000|Overall Study|Adverse Event|0|||
25253218|NCT01119937|50568747|FG001|Overall Study|Protocol deviation|1|||
25253219|NCT01119937|50568746|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
25253220|NCT01119937|50568747|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
25336453|NCT00784719|50652604|FG001|Overall Study|Adverse Event|2|||
25336454|NCT00784719|50652605|FG002|Overall Study|Adverse Event|0|||
25336455|NCT00784719|50652606|FG003|Overall Study|Adverse Event|0|||
25336456|NCT00784719|50652607|FG004|Overall Study|Adverse Event|1|||
25336457|NCT00784719|50652608|FG005|Overall Study|Adverse Event|1|||
25336458|NCT00784719|50652609|FG006|Overall Study|Adverse Event|1|||
25336459|NCT00784719|50652603|FG000|Overall Study|Lost to Follow-up|0|||
25336460|NCT00784719|50652604|FG001|Overall Study|Lost to Follow-up|0|||
25336461|NCT00784719|50652605|FG002|Overall Study|Lost to Follow-up|0|||
25336462|NCT00784719|50652606|FG003|Overall Study|Lost to Follow-up|0|||
25336463|NCT00784719|50652607|FG004|Overall Study|Lost to Follow-up|1|||
25253221|NCT01119937|50568746|FG000|Overall Study|Withdrawal by Subject|2|||
25253222|NCT01119937|50568747|FG001|Overall Study|Withdrawal by Subject|1|||
25253223|NCT01119898|50568755|FG000|Overall Study|Adverse Event|4|||
25253224|NCT01119898|50568756|FG001|Overall Study|Adverse Event|5|||
25336464|NCT00784719|50652608|FG005|Overall Study|Lost to Follow-up|1|||
25336465|NCT00784719|50652609|FG006|Overall Study|Lost to Follow-up|0|||
25336466|NCT00784719|50652603|FG000|Overall Study|Other|2|||
25336467|NCT00784719|50652604|FG001|Overall Study|Other|1|||
25253225|NCT01119898|50568755|FG000|Overall Study|Withdrawal by Subject|1|||
25253226|NCT01119898|50568756|FG001|Overall Study|Withdrawal by Subject|4|||
25253227|NCT01119898|50568755|FG000|Overall Study|Lack of Efficacy|0|||
24902293|NCT00767819|49996303|FG000|Overall Study|Abnormal lab values|1|||
24902294|NCT00767819|49996304|FG001|Overall Study|Abnormal lab values|0|||
24902295|NCT00767819|49996305|FG002|Overall Study|Abnormal lab values|0|||
24902296|NCT00767819|49996303|FG000|Overall Study|Lost to Follow-up|1|||
24902297|NCT00767819|49996304|FG001|Overall Study|Lost to Follow-up|0|||
24902298|NCT00767819|49996305|FG002|Overall Study|Lost to Follow-up|0|||
24902299|NCT00584870|49996316|FG000|Overall Study|Adverse Event|4|||
24902300|NCT00584870|49996317|FG001|Overall Study|Adverse Event|3|||
24902301|NCT00584870|49996318|FG002|Overall Study|Adverse Event|2|||
24902302|NCT00584870|49996316|FG000|Overall Study|Lost to Follow-up|4|||
24902303|NCT00584870|49996317|FG001|Overall Study|Lost to Follow-up|1|||
24902304|NCT00584870|49996318|FG002|Overall Study|Lost to Follow-up|1|||
24902305|NCT00584870|49996316|FG000|Overall Study|Lack of Efficacy|7|||
24902306|NCT00584870|49996317|FG001|Overall Study|Lack of Efficacy|14|||
24902307|NCT00584870|49996318|FG002|Overall Study|Lack of Efficacy|8|||
24902308|NCT00584870|49996316|FG000|Overall Study|Withdrawal by Subject|10|||
24902309|NCT00584870|49996317|FG001|Overall Study|Withdrawal by Subject|5|||
24902310|NCT00584870|49996318|FG002|Overall Study|Withdrawal by Subject|3|||
24902311|NCT00584870|49996316|FG000|Overall Study|Protocol Violation|1|||
24902312|NCT00584870|49996317|FG001|Overall Study|Protocol Violation|1|||
24902313|NCT00584870|49996318|FG002|Overall Study|Protocol Violation|2|||
24902314|NCT00584870|49996316|FG000|Overall Study|Did not met entrance criteria|1|||
24902315|NCT00584870|49996317|FG001|Overall Study|Did not met entrance criteria|0|||
24902316|NCT00584870|49996318|FG002|Overall Study|Did not met entrance criteria|0|||
24902317|NCT00584870|49996316|FG000|Overall Study|Other|2|||
24902318|NCT00584870|49996317|FG001|Overall Study|Other|0|||
24902319|NCT00584870|49996318|FG002|Overall Study|Other|0|||
25077966|NCT02228980|50186112|FG000|Overall Study|Adverse Event|14|||
25253228|NCT01119898|50568756|FG001|Overall Study|Lack of Efficacy|2|||
25253229|NCT01119898|50568755|FG000|Overall Study|Protocol Violation|1|||
25253230|NCT01119898|50568756|FG001|Overall Study|Protocol Violation|1|||
25253231|NCT01119898|50568755|FG000|Overall Study|Medical procedure|1|||
25253232|NCT01119898|50568756|FG001|Overall Study|Medical procedure|0|||
25253233|NCT01119898|50568755|FG000|Overall Study|Randomized in error did not participate|1|||
25253234|NCT01119898|50568756|FG001|Overall Study|Randomized in error did not participate|0|||
25253235|NCT01119859|50568764|FG000|Overall Study|Adverse Event|9|||
25253236|NCT01119859|50568765|FG001|Overall Study|Adverse Event|10|||
25253237|NCT01119859|50568764|FG000|Overall Study|Death|2|||
25253238|NCT01119859|50568765|FG001|Overall Study|Death|0|||
25253239|NCT01119859|50568764|FG000|Overall Study|Insufficient therapeutic response|7|||
25336468|NCT00784719|50652605|FG002|Overall Study|Other|1|||
25336469|NCT00784719|50652606|FG003|Overall Study|Other|0|||
25336470|NCT00784719|50652607|FG004|Overall Study|Other|2|||
25336471|NCT00784719|50652608|FG005|Overall Study|Other|1|||
25336472|NCT00784719|50652609|FG006|Overall Study|Other|3|||
25336473|NCT00784719|50652603|FG000|Overall Study|Withdrawal by Subject|1|||
25336474|NCT00784719|50652604|FG001|Overall Study|Withdrawal by Subject|0|||
25336475|NCT00784719|50652605|FG002|Overall Study|Withdrawal by Subject|0|||
25336476|NCT00784719|50652606|FG003|Overall Study|Withdrawal by Subject|0|||
25336477|NCT00784719|50652607|FG004|Overall Study|Withdrawal by Subject|2|||
25336478|NCT00784719|50652608|FG005|Overall Study|Withdrawal by Subject|0|||
25336479|NCT00784719|50652609|FG006|Overall Study|Withdrawal by Subject|1|||
25336480|NCT00852917|50652629|FG000|Overall Study|Adverse Event|13|||
25336481|NCT00852917|50652630|FG001|Overall Study|Adverse Event|20|||
25336482|NCT00852917|50652631|FG002|Overall Study|Adverse Event|35|||
25336483|NCT00852917|50652632|FG003|Overall Study|Adverse Event|17|||
24902320|NCT00584870|49996316|FG000|Overall Study|Randomized but not treated|0|||
24902321|NCT00584870|49996317|FG001|Overall Study|Randomized but not treated|1|||
24902322|NCT00584870|49996318|FG002|Overall Study|Randomized but not treated|2|||
24902323|NCT00679341|49996328|FG000|Overall Study|Disease progression|42|||
24902324|NCT00679341|49996329|FG001|Overall Study|Disease progression|36|||
24902325|NCT00679341|49996328|FG000|Overall Study|Adverse Event|5|||
24902326|NCT00679341|49996329|FG001|Overall Study|Adverse Event|6|||
24902327|NCT00679341|49996328|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
24902328|NCT00679341|49996329|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
24902329|NCT00679341|49996328|FG000|Overall Study|Death|1|||
24902330|NCT00679341|49996329|FG001|Overall Study|Death|1|||
24902331|NCT00679341|49996328|FG000|Overall Study|Other|1|||
24902332|NCT00679341|49996329|FG001|Overall Study|Other|0|||
24902333|NCT00679341|49996328|FG000|Overall Study|Physician Decision|1|||
24902334|NCT00679341|49996329|FG001|Overall Study|Physician Decision|0|||
24902335|NCT00679341|49996328|FG000|Overall Study|Not treated|0|||
24902336|NCT00679341|49996329|FG001|Overall Study|Not treated|2|||
24902337|NCT00679341|49996328|FG000|Overall Study|Physician/patient decision to withdraw|0|||
24902338|NCT00679341|49996329|FG001|Overall Study|Physician/patient decision to withdraw|6|||
25253240|NCT01119859|50568765|FG001|Overall Study|Insufficient therapeutic response|14|||
25253241|NCT01119859|50568764|FG000|Overall Study|Refused treatment|3|||
25253242|NCT01119859|50568765|FG001|Overall Study|Refused treatment|6|||
25253243|NCT01119859|50568764|FG000|Overall Study|Failure to return|3|||
25253244|NCT01119859|50568765|FG001|Overall Study|Failure to return|0|||
25253245|NCT01119703|50568773|FG000|Overall Study|Adverse Event|0|||
25253246|NCT01119703|50568774|FG001|Overall Study|Adverse Event|1|||
25253247|NCT01119625|50568781|FG000|Overall Study|Lost to Follow-up|1|||
25253248|NCT01119625|50568782|FG001|Overall Study|Lost to Follow-up|2|||
25253249|NCT01119625|50568781|FG000|Overall Study|Withdrawal by Subject|2|||
25253250|NCT01119625|50568782|FG001|Overall Study|Withdrawal by Subject|1|||
25253251|NCT01119625|50568781|FG000|Overall Study|Other|0|||
25253252|NCT01119625|50568782|FG001|Overall Study|Other|1|||
25253253|NCT01119118|50568788|FG000|Overall Study|Adverse Event|1|||
25253254|NCT01119001|50568792|FG000|Overall Study|Withdrawal by Subject|2|||
25253255|NCT01118962|50568798|FG000|Overall Study|Adverse Event|2|||
25336484|NCT00852917|50652629|FG000|Overall Study|Lack of Efficacy|21|||
25336485|NCT00852917|50652630|FG001|Overall Study|Lack of Efficacy|11|||
25336486|NCT00852917|50652631|FG002|Overall Study|Lack of Efficacy|11|||
25336487|NCT00852917|50652632|FG003|Overall Study|Lack of Efficacy|47|||
25336488|NCT00852917|50652629|FG000|Overall Study|Withdrawal by Subject|4|||
25336489|NCT00852917|50652630|FG001|Overall Study|Withdrawal by Subject|8|||
25336490|NCT00852917|50652631|FG002|Overall Study|Withdrawal by Subject|10|||
25336491|NCT00852917|50652632|FG003|Overall Study|Withdrawal by Subject|9|||
25336492|NCT00852917|50652629|FG000|Overall Study|Physician Decision|6|||
25336493|NCT00852917|50652630|FG001|Overall Study|Physician Decision|7|||
25336494|NCT00852917|50652631|FG002|Overall Study|Physician Decision|2|||
25336495|NCT00852917|50652632|FG003|Overall Study|Physician Decision|19|||
25336496|NCT00852917|50652629|FG000|Overall Study|Death|0|||
25336497|NCT00852917|50652630|FG001|Overall Study|Death|0|||
25336498|NCT00852917|50652631|FG002|Overall Study|Death|0|||
25336499|NCT00852917|50652632|FG003|Overall Study|Death|1|||
25336500|NCT00845429|50652645|FG000|Overall Study|Protocol Violation|5|||
25336501|NCT00845429|50652646|FG001|Overall Study|Protocol Violation|4|||
25336502|NCT00845429|50652647|FG002|Overall Study|Protocol Violation|7|||
25253256|NCT01118962|50568798|FG000|Overall Study|Lack of Efficacy|1|||
25253257|NCT01118962|50568798|FG000|Overall Study|Protocol Violation|1|||
25253258|NCT01118962|50568798|FG000|Overall Study|Withdrawal by Subject|4|||
25253259|NCT01118962|50568798|FG000|Overall Study|Pregnancy|1|||
25253260|NCT01118962|50568798|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
25253261|NCT01118728|50568802|FG000|Overall Study|Adverse Event|17|||
25253262|NCT01118728|50568802|FG000|Overall Study|Lack of Efficacy|27|||
25253263|NCT01118728|50568802|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
25253264|NCT01118728|50568802|FG000|Overall Study|Withdrawal by Subject|3|||
25253265|NCT01118728|50568802|FG000|Overall Study|Lost to Follow-up|4|||
25336503|NCT00845429|50652645|FG000|Overall Study|Lost to Follow-up|7|||
25336504|NCT00845429|50652646|FG001|Overall Study|Lost to Follow-up|9|||
25336505|NCT00845429|50652647|FG002|Overall Study|Lost to Follow-up|10|||
25336506|NCT00845429|50652645|FG000|Overall Study|Withdrawal by Subject|2|||
25336507|NCT00845429|50652646|FG001|Overall Study|Withdrawal by Subject|2|||
25336508|NCT00845429|50652647|FG002|Overall Study|Withdrawal by Subject|2|||
25336509|NCT00845429|50652645|FG000|Overall Study|Serious adverse event|0|||
25336510|NCT00845429|50652646|FG001|Overall Study|Serious adverse event|0|||
25336511|NCT00845429|50652647|FG002|Overall Study|Serious adverse event|1|||
25336512|NCT00593333|50652657|FG000|Overall Study|Lost to Follow-up|10|||
25336513|NCT00593333|50652658|FG001|Overall Study|Lost to Follow-up|11|||
25336514|NCT00844883|50652664|FG000|Overall Study|Bridged to liver transplant|3|||
25336515|NCT00844883|50652664|FG000|Overall Study|Bridged to resection|1|||
25336516|NCT00851903|50652668|FG000|Overall Study|Withdrawal by Subject|2|||
25336517|NCT00587457|50652675|FG000|Overall Study|Adverse Event|1|||
25336518|NCT00587457|50652676|FG001|Overall Study|Adverse Event|2|||
25336519|NCT00587457|50652677|FG002|Overall Study|Adverse Event|1|||
25336520|NCT00587457|50652675|FG000|Overall Study|Disease progression|2|||
25336521|NCT00587457|50652676|FG001|Overall Study|Disease progression|0|||
25336522|NCT00587457|50652677|FG002|Overall Study|Disease progression|2|||
25336523|NCT00587457|50652675|FG000|Overall Study|Initiation of alternative therapy|0|||
25336524|NCT00587457|50652676|FG001|Overall Study|Initiation of alternative therapy|1|||
25336525|NCT00587457|50652677|FG002|Overall Study|Initiation of alternative therapy|0|||
25336526|NCT00587457|50652675|FG000|Overall Study|Undefined|0|||
24902339|NCT00679263|49996339|FG000|Visit 2/Dose 1|Adverse Event|1|||
25253266|NCT01118455|50568808|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
25253267|NCT01118455|50568809|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
25253268|NCT01118377|50568823|FG000|Overall Study|Did Not Receive Study Medication|1|||
25336527|NCT00587457|50652676|FG001|Overall Study|Undefined|0|||
25336528|NCT00587457|50652677|FG002|Overall Study|Undefined|1|||
25336529|NCT00587457|50652675|FG000|Overall Study|Development of neutralizing Abs|0|||
25336530|NCT00587457|50652676|FG001|Overall Study|Development of neutralizing Abs|0|||
25336531|NCT00587457|50652677|FG002|Overall Study|Development of neutralizing Abs|1|||
25336532|NCT00851747|50652688|FG000|Overall Study|Physician Decision|6|||
25336533|NCT00851747|50652689|FG001|Overall Study|Physician Decision|6|||
25336534|NCT00851747|50652690|FG002|Overall Study|Physician Decision|6|||
25336535|NCT00767325|50652697|FG000|Overall Study|Lack of Efficacy|2|||
25336536|NCT00767325|50652697|FG000|Overall Study|Adverse Event|7|||
25336537|NCT00767325|50652697|FG000|Overall Study|Lost to Follow-up|3|||
25336538|NCT00767325|50652697|FG000|Overall Study|No longer met study criteria|2|||
25336539|NCT00767325|50652697|FG000|Overall Study|Missed visit due to family reasons|1|||
25336540|NCT00851591|50652703|FG000|Overall Study|Withdrawal by Subject|2|||
25336541|NCT00851591|50652704|FG001|Overall Study|Withdrawal by Subject|0|||
25336542|NCT00861341|50652710|FG000|Overall Study|Withdrawal by Subject|2|||
25336543|NCT00766467|50652716|FG000|Overall Study|Withdrawal by Subject|7|||
25336544|NCT00766467|50652717|FG001|Overall Study|Withdrawal by Subject|2|||
25336545|NCT00766467|50652716|FG000|Overall Study|Adverse Event|1|||
25336546|NCT00766467|50652717|FG001|Overall Study|Adverse Event|1|||
25336547|NCT00766467|50652716|FG000|Overall Study|Protocol Violation|2|||
25336548|NCT00766467|50652717|FG001|Overall Study|Protocol Violation|4|||
25336549|NCT00766467|50652716|FG000|Overall Study|Tumor Progression on Study|0|||
25336550|NCT00766467|50652717|FG001|Overall Study|Tumor Progression on Study|1|||
25336551|NCT00766467|50652716|FG000|Overall Study|Physician Decision|1|||
25336552|NCT00766467|50652717|FG001|Overall Study|Physician Decision|0|||
25336553|NCT00850499|50652725|FG000|Overall Study|Adverse Event|3|||
25336554|NCT00850499|50652726|FG001|Overall Study|Adverse Event|1|||
25336555|NCT00850499|50652725|FG000|Overall Study|Lack of Efficacy|0|||
25336556|NCT00850499|50652726|FG001|Overall Study|Lack of Efficacy|1|||
25336557|NCT00860951|50652732|FG000|Overall Study|Withdrawal by Subject|2|||
25336558|NCT00860951|50652732|FG000|Overall Study|Lost to Follow-up|5|||
25336559|NCT00844805|50652750|FG000|Treatment Phase|Adverse Event|5|||
25336560|NCT00844805|50652751|FG001|Treatment Phase|Adverse Event|1|||
25336561|NCT00844805|50652752|FG002|Treatment Phase|Adverse Event|0|||
24902340|NCT00679263|49996340|FG001|Visit 2/Dose 1|Adverse Event|0|||
24902341|NCT00679263|49996341|FG002|Visit 2/Dose 1|Adverse Event|0|||
24902342|NCT00679263|49996339|FG000|Visit 2/Dose 1|subject not compliance|1|||
24902343|NCT00679263|49996340|FG001|Visit 2/Dose 1|subject not compliance|1|||
24902344|NCT00679263|49996341|FG002|Visit 2/Dose 1|subject not compliance|0|||
24902345|NCT00680043|49996352|FG000|Overall Study|Withdrawal by Subject|1|||
24902346|NCT00680043|49996353|FG001|Overall Study|Withdrawal by Subject|0|||
24902347|NCT00680043|49996354|FG002|Overall Study|Withdrawal by Subject|0|||
24902348|NCT00680043|49996352|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
24902349|NCT00680043|49996353|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
24902350|NCT00680043|49996354|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
24902351|NCT00680043|49996352|FG000|Overall Study|Renal Transplant|1|||
24902352|NCT00680043|49996353|FG001|Overall Study|Renal Transplant|0|||
24902353|NCT00680043|49996354|FG002|Overall Study|Renal Transplant|4|||
24902354|NCT00682539|49996365|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
24902355|NCT00682539|49996366|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
24902356|NCT00682539|49996367|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
24902357|NCT00682539|49996365|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
24902358|NCT00682539|49996366|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
24902359|NCT00682539|49996367|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
24902360|NCT00682461|49996377|FG000|Overall Study|Adverse Event|5|||
25336562|NCT00844805|50652753|FG003|Treatment Phase|Adverse Event|0|||
25336563|NCT00844805|50652750|FG000|Treatment Phase|Withdrawal by Subject|3|||
25336564|NCT00844805|50652751|FG001|Treatment Phase|Withdrawal by Subject|4|||
24902361|NCT00682461|49996378|FG001|Overall Study|Adverse Event|7|||
24902362|NCT00682461|49996377|FG000|Overall Study|Lost to Follow-up|8|||
24902363|NCT00682461|49996378|FG001|Overall Study|Lost to Follow-up|5|||
24902364|NCT00682461|49996377|FG000|Overall Study|Withdrawal by Subject|12|||
24902365|NCT00682461|49996378|FG001|Overall Study|Withdrawal by Subject|19|||
24902366|NCT00679029|49996385|FG000|Overall Study|Adverse Event|3|||
25253269|NCT01118377|50568823|FG000|Overall Study|Death|38|||
25253270|NCT01118377|50568823|FG000|Overall Study|Failure to Return|3|||
25253271|NCT01118299|50568829|FG000|Overall Study|Death|7|||
25253272|NCT01118299|50568830|FG001|Overall Study|Death|5|||
25253273|NCT01118299|50568829|FG000|Overall Study|Withdrawal by Subject|8|||
25253274|NCT01118299|50568830|FG001|Overall Study|Withdrawal by Subject|8|||
25253275|NCT01118299|50568829|FG000|Overall Study|Lost to Follow-up|2|||
25253276|NCT01118299|50568830|FG001|Overall Study|Lost to Follow-up|1|||
25253277|NCT01118299|50568829|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
25253278|NCT01118299|50568830|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
25253279|NCT01118143|50568837|FG000|Overall Study|Withdrawal by Subject|2|||
25253280|NCT01118143|50568838|FG001|Overall Study|Withdrawal by Subject|5|||
25253281|NCT01117987|50568848|FG000|Overall Study|Protocol deviation|0|||
25336565|NCT00844805|50652752|FG002|Treatment Phase|Withdrawal by Subject|0|||
25336566|NCT00844805|50652753|FG003|Treatment Phase|Withdrawal by Subject|0|||
25336567|NCT00844805|50652750|FG000|Treatment Phase|Noncompliance With Protocol|1|||
25336568|NCT00844805|50652751|FG001|Treatment Phase|Noncompliance With Protocol|0|||
25336569|NCT00844805|50652752|FG002|Treatment Phase|Noncompliance With Protocol|0|||
25253282|NCT01117987|50568849|FG001|Overall Study|Protocol deviation|1|||
25336570|NCT00844805|50652753|FG003|Treatment Phase|Noncompliance With Protocol|0|||
25336571|NCT00844805|50652750|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
25336572|NCT00844805|50652751|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
25336573|NCT00844805|50652752|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
25336574|NCT00844805|50652753|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
25336575|NCT00844805|50652750|FG000|Follow-Up Phase|Adverse Event|0|||
25336576|NCT00844805|50652751|FG001|Follow-Up Phase|Adverse Event|0|||
25336577|NCT00844805|50652752|FG002|Follow-Up Phase|Adverse Event|1|||
25336578|NCT00844805|50652753|FG003|Follow-Up Phase|Adverse Event|0|||
25336579|NCT00844805|50652750|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
25336580|NCT00844805|50652751|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
25336581|NCT00844805|50652752|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
25336582|NCT00844805|50652753|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
25336583|NCT00844805|50652750|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
25336584|NCT00844805|50652751|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
25336585|NCT00844805|50652752|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
25336586|NCT00844805|50652753|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
25336587|NCT00844805|50652750|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
25336588|NCT00844805|50652751|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
25336589|NCT00844805|50652752|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
25336590|NCT00844805|50652753|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
25336591|NCT00844805|50652750|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
25336592|NCT00844805|50652751|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
25336593|NCT00844805|50652752|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
25336594|NCT00844805|50652753|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
25336595|NCT00765999|50652764|FG000|Overall Study|Adverse Event|203|||
25336596|NCT00765999|50652764|FG000|Overall Study|Insufficient Therapeutic Response|100|||
25336597|NCT00765999|50652764|FG000|Overall Study|Protocol Violation|95|||
25336598|NCT00765999|50652764|FG000|Overall Study|Consent Withdrawn|202|||
25336599|NCT00765999|50652764|FG000|Overall Study|Lost to Follow-up|131|||
25336600|NCT00765999|50652764|FG000|Overall Study|Study Terminated by Sponsor|2|||
25253283|NCT01117987|50568848|FG000|Overall Study|Subject no longer requires study drug|1|||
25253284|NCT01117987|50568849|FG001|Overall Study|Subject no longer requires study drug|0|||
25253285|NCT01117987|50568848|FG000|Overall Study|Lost to Follow-up|1|||
25253286|NCT01117987|50568849|FG001|Overall Study|Lost to Follow-up|1|||
25253287|NCT01117987|50568848|FG000|Overall Study|Abnormal test procedure result|2|||
25253288|NCT01117987|50568849|FG001|Overall Study|Abnormal test procedure result|0|||
25253289|NCT01117987|50568848|FG000|Overall Study|Lack of Efficacy|3|||
25253290|NCT01117987|50568849|FG001|Overall Study|Lack of Efficacy|4|||
25253291|NCT01117987|50568848|FG000|Overall Study|Death|5|||
25253292|NCT01117987|50568849|FG001|Overall Study|Death|10|||
25253293|NCT01117987|50568848|FG000|Overall Study|Withdrawal by Subject|5|||
25253294|NCT01117987|50568849|FG001|Overall Study|Withdrawal by Subject|10|||
25253295|NCT01117987|50568848|FG000|Overall Study|Adverse Event|19|||
25253296|NCT01117987|50568849|FG001|Overall Study|Adverse Event|26|||
25253297|NCT01117987|50568848|FG000|Overall Study|Administrative problems|25|||
25253298|NCT01117987|50568849|FG001|Overall Study|Administrative problems|22|||
25253299|NCT01117870|50568857|FG000|Overall Study|Inability to place needle|1|||
25253300|NCT01117870|50568858|FG001|Overall Study|Inability to place needle|0|||
25253301|NCT01117792|50568868|FG000|Overall Study|Death|1|||
25253302|NCT01117792|50568868|FG000|Overall Study|Adverse Event|3|||
25253303|NCT02219490|50568872|FG000|Overall Study|Adverse Event|24|||
25253304|NCT02219490|50568872|FG000|Overall Study|Withdrew consent|96|||
25253305|NCT02219490|50568872|FG000|Overall Study|Lost to Follow-up|126|||
25253306|NCT02219490|50568872|FG000|Overall Study|COVID-19 infection|2|||
25253307|NCT02219490|50568872|FG000|Overall Study|COVID-19 logistical restrictions|33|||
25253308|NCT02219490|50568872|FG000|Overall Study|Other, not specified|57|||
25253309|NCT01117480|50568880|FG000|Overall Study|Protocol Violation|8|||
25253310|NCT01117480|50568880|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
25253311|NCT01117051|50568886|FG000|Overall Study|Withdrawal by Subject|5|||
25253312|NCT01117051|50568887|FG001|Overall Study|Withdrawal by Subject|3|||
25253313|NCT01117051|50568886|FG000|Overall Study|Adverse Event|4|||
25253314|NCT01117051|50568887|FG001|Overall Study|Adverse Event|3|||
25253315|NCT01117051|50568886|FG000|Overall Study|Lost to Follow-up|0|||
25253316|NCT01117051|50568887|FG001|Overall Study|Lost to Follow-up|1|||
25253317|NCT01117051|50568886|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
25253318|NCT01117051|50568887|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
25253319|NCT01117051|50568886|FG000|Overall Study|Sponsor's decision|3|||
25253320|NCT01117051|50568887|FG001|Overall Study|Sponsor's decision|1|||
25336601|NCT00765999|50652764|FG000|Overall Study|Other Miscellaneous Reasons|51|||
25336602|NCT00765843|50652773|FG000|Overall Study|Lost to Follow-up|1|||
25336603|NCT00765843|50652774|FG001|Overall Study|Lost to Follow-up|3|||
25336604|NCT00765843|50652775|FG002|Overall Study|Lost to Follow-up|2|||
25336605|NCT00765843|50652773|FG000|Overall Study|did not return to receive intervention|0|||
25336606|NCT00765843|50652774|FG001|Overall Study|did not return to receive intervention|1|||
25253321|NCT01117051|50568886|FG000|Overall Study|Surgical procedure|0|||
25253322|NCT01117051|50568887|FG001|Overall Study|Surgical procedure|1|||
25253323|NCT01117051|50568886|FG000|Overall Study|Randomized by mistake|0|||
25253324|NCT01117051|50568887|FG001|Overall Study|Randomized by mistake|1|||
25253325|NCT01117051|50568886|FG000|Overall Study|Convenience issue|1|||
25253326|NCT01117051|50568887|FG001|Overall Study|Convenience issue|0|||
25253327|NCT02211417|50568896|FG000|Overall Study|Withdrawal by Subject|11|||
25253328|NCT02211417|50568897|FG001|Overall Study|Withdrawal by Subject|8|||
25253329|NCT02211417|50568896|FG000|Overall Study|Protocol Violation|1|||
25336607|NCT00765843|50652775|FG002|Overall Study|did not return to receive intervention|0|||
25336608|NCT00765843|50652773|FG000|Overall Study|Adverse Event|0|||
25336609|NCT00765843|50652774|FG001|Overall Study|Adverse Event|0|||
25336610|NCT00765843|50652775|FG002|Overall Study|Adverse Event|1|||
25336611|NCT00765063|50652783|FG000|Overall Study|Lack of Efficacy|5|||
25336612|NCT00765063|50652783|FG000|Overall Study|Withdrawal by Subject|1|||
25336613|NCT00765063|50652783|FG000|Overall Study|Other|16|||
25336614|NCT00765063|50652783|FG000|Overall Study|Protocol Violation|6|||
25336615|NCT00765063|50652783|FG000|Overall Study|Adverse Event|4|||
25336616|NCT00764751|50652789|FG000|Overall Study|Adverse Event|1|||
25336617|NCT00764751|50652790|FG001|Overall Study|Adverse Event|1|||
25336618|NCT00764751|50652789|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
25336619|NCT00764751|50652790|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
25336620|NCT00764673|50652801|FG000|Overall Study|Death|1|||
25336621|NCT00764673|50652801|FG000|Overall Study|Lost to Follow-up|3|||
25336622|NCT00764673|50652801|FG000|Overall Study|Withdrawal by Subject|6|||
25336623|NCT00764673|50652801|FG000|Overall Study|Revision of Device|2|||
25336624|NCT00764517|50652807|FG000|Overall Study|Adverse Event|9|||
25336625|NCT00764517|50652808|FG001|Overall Study|Adverse Event|3|||
25336626|NCT00764517|50652807|FG000|Overall Study|Death|3|||
25336627|NCT00764517|50652808|FG001|Overall Study|Death|11|||
25336628|NCT00764517|50652807|FG000|Overall Study|Physician Decision|3|||
25336629|NCT00764517|50652808|FG001|Overall Study|Physician Decision|0|||
25336630|NCT00764361|50652816|FG000|Overall Study|Withdrawal by Subject|2|||
25336631|NCT00764361|50652817|FG001|Overall Study|Withdrawal by Subject|3|||
25336632|NCT00764361|50652816|FG000|Overall Study|Adverse Event|0|||
25336633|NCT00764361|50652817|FG001|Overall Study|Adverse Event|1|||
25336634|NCT00763971|50652826|FG000|Overall Study|Adverse Event|5|||
25336635|NCT00763971|50652827|FG001|Overall Study|Adverse Event|2|||
25336636|NCT00763971|50652828|FG002|Overall Study|Adverse Event|4|||
25336637|NCT00763971|50652826|FG000|Overall Study|Protocol Violation|3|||
25336638|NCT00763971|50652827|FG001|Overall Study|Protocol Violation|3|||
25336639|NCT00763971|50652828|FG002|Overall Study|Protocol Violation|2|||
25336640|NCT00763971|50652826|FG000|Overall Study|Withdrawal by Subject|4|||
25336641|NCT00763971|50652827|FG001|Overall Study|Withdrawal by Subject|5|||
25336642|NCT00763971|50652828|FG002|Overall Study|Withdrawal by Subject|5|||
25336643|NCT00763971|50652826|FG000|Overall Study|Lost to Follow-up|0|||
25336644|NCT00763971|50652827|FG001|Overall Study|Lost to Follow-up|1|||
25336645|NCT00763971|50652828|FG002|Overall Study|Lost to Follow-up|0|||
25336646|NCT00763971|50652826|FG000|Overall Study|Lack of Efficacy|11|||
25336647|NCT00763971|50652827|FG001|Overall Study|Lack of Efficacy|22|||
25336648|NCT00763971|50652828|FG002|Overall Study|Lack of Efficacy|54|||
25336649|NCT00763971|50652826|FG000|Overall Study|Unable to swallow capsule|2|||
25336650|NCT00763971|50652827|FG001|Overall Study|Unable to swallow capsule|1|||
25336651|NCT00763971|50652828|FG002|Overall Study|Unable to swallow capsule|1|||
25336652|NCT00763971|50652826|FG000|Overall Study|Personal reason|3|||
25336653|NCT00763971|50652827|FG001|Overall Study|Personal reason|0|||
25336654|NCT00763971|50652828|FG002|Overall Study|Personal reason|0|||
25336655|NCT00763971|50652826|FG000|Overall Study|Exclusion criteria met|1|||
25336656|NCT00763971|50652827|FG001|Overall Study|Exclusion criteria met|0|||
25336657|NCT00763971|50652828|FG002|Overall Study|Exclusion criteria met|0|||
25336658|NCT00763971|50652826|FG000|Overall Study|Sponsor decision|1|||
25336659|NCT00763971|50652827|FG001|Overall Study|Sponsor decision|0|||
25336660|NCT00763971|50652828|FG002|Overall Study|Sponsor decision|0|||
25336661|NCT00763971|50652826|FG000|Overall Study|Due to holiday season|2|||
25336662|NCT00763971|50652827|FG001|Overall Study|Due to holiday season|0|||
25253330|NCT02211417|50568897|FG001|Overall Study|Protocol Violation|0|||
25253331|NCT02211417|50568896|FG000|Overall Study|Pregnancy|0|||
25253332|NCT02211417|50568897|FG001|Overall Study|Pregnancy|1|||
25253333|NCT02211417|50568896|FG000|Overall Study|Lost to Follow-up|2|||
25253334|NCT02211417|50568897|FG001|Overall Study|Lost to Follow-up|3|||
25336663|NCT00763971|50652828|FG002|Overall Study|Due to holiday season|1|||
25336664|NCT00763971|50652826|FG000|Overall Study|Randomization error|0|||
25336665|NCT00763971|50652827|FG001|Overall Study|Randomization error|0|||
25336666|NCT00763971|50652828|FG002|Overall Study|Randomization error|1|||
25336667|NCT00763971|50652826|FG000|Overall Study|Medical monitor decision|0|||
25336668|NCT00763971|50652827|FG001|Overall Study|Medical monitor decision|0|||
25336669|NCT00763971|50652828|FG002|Overall Study|Medical monitor decision|1|||
25336670|NCT00763971|50652826|FG000|Overall Study|Moved to another country|0|||
25336671|NCT00763971|50652827|FG001|Overall Study|Moved to another country|1|||
25336672|NCT00763971|50652828|FG002|Overall Study|Moved to another country|0|||
25336673|NCT00763971|50652826|FG000|Overall Study|Subject wanted dose reduction|0|||
25336674|NCT00763971|50652827|FG001|Overall Study|Subject wanted dose reduction|1|||
25336675|NCT00763971|50652828|FG002|Overall Study|Subject wanted dose reduction|0|||
25336676|NCT00763971|50652826|FG000|Overall Study|Lack of availability|0|||
25336677|NCT00763971|50652827|FG001|Overall Study|Lack of availability|1|||
25336678|NCT00763971|50652828|FG002|Overall Study|Lack of availability|0|||
25336679|NCT00763971|50652826|FG000|Overall Study|Performed final visit on phone|0|||
25336680|NCT00763971|50652827|FG001|Overall Study|Performed final visit on phone|1|||
25336681|NCT00763971|50652828|FG002|Overall Study|Performed final visit on phone|0|||
25336682|NCT00763971|50652826|FG000|Overall Study|Participation in 489-326 required|1|||
25336683|NCT00763971|50652827|FG001|Overall Study|Participation in 489-326 required|0|||
25336684|NCT00763971|50652828|FG002|Overall Study|Participation in 489-326 required|0|||
25336685|NCT00763815|50652838|FG000|Overall Study|Adverse Event|14|||
25336686|NCT00763815|50652839|FG001|Overall Study|Adverse Event|29|||
25336687|NCT00763815|50652838|FG000|Overall Study|Lack of Efficacy|10|||
25336688|NCT00763815|50652839|FG001|Overall Study|Lack of Efficacy|11|||
25336689|NCT00763815|50652838|FG000|Overall Study|Poor Compliance to Protocol|6|||
25336690|NCT00763815|50652839|FG001|Overall Study|Poor Compliance to Protocol|6|||
24902367|NCT00679029|49996385|FG000|Overall Study|Withdrawal by Subject|1|||
24902368|NCT00679029|49996385|FG000|Overall Study|Lost to Follow-up|1|||
24902369|NCT00677235|49996391|FG000|Overall Study|Withdrawal by Subject|1|||
24902370|NCT00677235|49996392|FG001|Overall Study|Withdrawal by Subject|1|||
24902371|NCT00677235|49996391|FG000|Overall Study|Lost to Follow-up|2|||
24902372|NCT00677235|49996392|FG001|Overall Study|Lost to Follow-up|1|||
24902373|NCT00677235|49996391|FG000|Overall Study|Death|37|||
24902374|NCT00677235|49996392|FG001|Overall Study|Death|36|||
24902375|NCT00677235|49996391|FG000|Overall Study|Adverse Experience|1|||
24902376|NCT00677235|49996392|FG001|Overall Study|Adverse Experience|0|||
25253335|NCT02211417|50568896|FG000|Overall Study|Adverse Event|1|||
25253336|NCT02211417|50568897|FG001|Overall Study|Adverse Event|4|||
25253337|NCT01117012|50568910|FG000|Overall Study|Adverse Event|0|||
25253338|NCT01117012|50568911|FG001|Overall Study|Adverse Event|1|||
25253339|NCT01117012|50568910|FG000|Overall Study|Death|1|||
25253340|NCT01117012|50568911|FG001|Overall Study|Death|1|||
24902377|NCT00676689|49996398|FG000|Overall Study|Screen Failure|2|||
24902378|NCT00676689|49996398|FG000|Overall Study|Death|2|||
24902379|NCT00676689|49996398|FG000|Overall Study|Lost to Follow-up|4|||
24902380|NCT00676689|49996398|FG000|Overall Study|Physician Decision|1|||
24902381|NCT00676689|49996398|FG000|Overall Study|Withdrawal by Subject|3|||
24902382|NCT00676689|49996398|FG000|Overall Study|Continuing FU|49|||
24902383|NCT00678795|49996404|FG000|Overall Study|Adverse Event|7|||
25253341|NCT01117012|50568910|FG000|Overall Study|Withdrawal by Subject|3|||
25253342|NCT01117012|50568911|FG001|Overall Study|Withdrawal by Subject|0|||
25253343|NCT01117012|50568910|FG000|Overall Study|Undefined|4|||
25253344|NCT01117012|50568911|FG001|Overall Study|Undefined|3|||
25253345|NCT01116739|50568919|FG000|Overall Study|Child had 2 years of HS|110|||
25253346|NCT01116739|50568920|FG001|Overall Study|Child had 2 years of HS|128|||
25253347|NCT01116739|50568919|FG000|Overall Study|Withdrawal by Subject|6|||
25253348|NCT01116739|50568920|FG001|Overall Study|Withdrawal by Subject|0|||
25253349|NCT01116739|50568919|FG000|Overall Study|child too young|2|||
25253350|NCT01116739|50568920|FG001|Overall Study|child too young|6|||
25253351|NCT01116739|50568919|FG000|Overall Study|child not enrolled in head start|10|||
25253352|NCT01116739|50568920|FG001|Overall Study|child not enrolled in head start|2|||
25253353|NCT01116739|50568919|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
25253354|NCT01116739|50568920|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
25253355|NCT01116544|50568928|FG000|Overall Study|Protocol Violation|1|||
25253356|NCT01116544|50568929|FG001|Overall Study|Protocol Violation|0|||
25253357|NCT01116544|50568928|FG000|Overall Study|Withdrawal by Subject|1|||
25253358|NCT01116544|50568929|FG001|Overall Study|Withdrawal by Subject|1|||
25253359|NCT01116427|50568937|FG000|Core Phase|Adverse Event|0|||
25253360|NCT01116427|50568938|FG001|Core Phase|Adverse Event|1|||
25253361|NCT01116427|50568937|FG000|Core Phase|Lost to Follow-up|1|||
25253362|NCT01116427|50568938|FG001|Core Phase|Lost to Follow-up|0|||
25336691|NCT00763815|50652838|FG000|Overall Study|Lost to Follow-up|2|||
24902384|NCT00678795|49996405|FG001|Overall Study|Adverse Event|3|||
24902385|NCT00678795|49996404|FG000|Overall Study|Withdrawal by Subject|3|||
24902386|NCT00678795|49996405|FG001|Overall Study|Withdrawal by Subject|0|||
24902387|NCT00678795|49996404|FG000|Overall Study|Protocol Violation|0|||
24902388|NCT00678795|49996405|FG001|Overall Study|Protocol Violation|1|||
24902389|NCT00678795|49996404|FG000|Overall Study|Lost to Follow-up|0|||
25253363|NCT01116427|50568937|FG000|Core Phase|Withdrawal by Subject|3|||
25253364|NCT01116427|50568938|FG001|Core Phase|Withdrawal by Subject|0|||
25253365|NCT01116427|50568937|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
25253366|NCT01116427|50568938|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
25253367|NCT01116427|50568937|FG000|Extension Phase|Adverse Event|1|||
25336692|NCT00763815|50652839|FG001|Overall Study|Lost to Follow-up|4|||
25336693|NCT00763815|50652838|FG000|Overall Study|Early Termination|1|||
25336694|NCT00763815|50652839|FG001|Overall Study|Early Termination|0|||
25336695|NCT00763815|50652838|FG000|Overall Study|Familial and Personal Reasons|9|||
25336696|NCT00763815|50652839|FG001|Overall Study|Familial and Personal Reasons|16|||
25336697|NCT00763815|50652838|FG000|Overall Study|Physician Decision|1|||
25253368|NCT01116427|50568938|FG001|Extension Phase|Adverse Event|1|||
25253369|NCT01116427|50568937|FG000|Extension Phase|Lost to Follow-up|2|||
25253370|NCT01116427|50568938|FG001|Extension Phase|Lost to Follow-up|0|||
25253371|NCT01116427|50568937|FG000|Extension Phase|Withdrawal by Subject|5|||
25253372|NCT01116427|50568938|FG001|Extension Phase|Withdrawal by Subject|1|||
25253373|NCT01116427|50568937|FG000|Extension Phase|Not using appropriate birth control|1|||
25253374|NCT01116427|50568938|FG001|Extension Phase|Not using appropriate birth control|0|||
25253375|NCT01116232|50568948|FG000|Overall Study|Progressive diease|4|||
25253376|NCT01115998|50568957|FG000|Overall Study|Lost to Follow-up|6|||
25336698|NCT00763815|50652839|FG001|Overall Study|Physician Decision|0|||
25336699|NCT00763815|50652838|FG000|Overall Study|Withdrawal by Subject|7|||
25336700|NCT00763815|50652839|FG001|Overall Study|Withdrawal by Subject|12|||
25336701|NCT00763815|50652838|FG000|Overall Study|Protocol Violation|2|||
25336702|NCT00763815|50652839|FG001|Overall Study|Protocol Violation|5|||
25336703|NCT00763815|50652838|FG000|Overall Study|Sponsor's Decision|0|||
25336704|NCT00763815|50652839|FG001|Overall Study|Sponsor's Decision|1|||
25336705|NCT00763269|50652847|FG000|Overall Study|Lost to Follow-up|12|||
25336706|NCT00763269|50652848|FG001|Overall Study|Lost to Follow-up|13|||
25336707|NCT00763035|50652854|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
25336708|NCT00763035|50652855|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
25336709|NCT00763035|50652854|FG000|First Intervention|Adverse Event|0|||
25336710|NCT00763035|50652855|FG001|First Intervention|Adverse Event|1|||
25336711|NCT00763035|50652854|FG000|Second Intervention|Adverse Event|1|||
25336712|NCT00763035|50652855|FG001|Second Intervention|Adverse Event|0|||
25336713|NCT00763035|50652854|FG000|Second Intervention|Physician Decision|2|||
25336714|NCT00763035|50652855|FG001|Second Intervention|Physician Decision|0|||
25336715|NCT00844649|50652863|FG000|Overall Study|Progressive Disease|196|||
25336716|NCT00844649|50652864|FG001|Overall Study|Progressive Disease|245|||
25336717|NCT00844649|50652863|FG000|Overall Study|Adverse Event|128|||
25336718|NCT00844649|50652864|FG001|Overall Study|Adverse Event|73|||
25336719|NCT00844649|50652863|FG000|Overall Study|Physician Decision|25|||
25336720|NCT00844649|50652864|FG001|Overall Study|Physician Decision|18|||
25336721|NCT00844649|50652863|FG000|Overall Study|Protocol Violation|10|||
25336722|NCT00844649|50652864|FG001|Overall Study|Protocol Violation|6|||
25336723|NCT00844649|50652863|FG000|Overall Study|Withdrawal by Subject|28|||
25336724|NCT00844649|50652864|FG001|Overall Study|Withdrawal by Subject|39|||
25336725|NCT00844649|50652863|FG000|Overall Study|Other|7|||
25336726|NCT00844649|50652864|FG001|Overall Study|Other|10|||
25336727|NCT00844649|50652863|FG000|Overall Study|Withdrew prior to starting treatment|11|||
25336728|NCT00844649|50652864|FG001|Overall Study|Withdrew prior to starting treatment|27|||
25336729|NCT00762723|50652875|FG000|Overall Study|Study Terminated slow enrollement|5|||
25336730|NCT00762723|50652876|FG001|Overall Study|Study Terminated slow enrollement|5|||
25336731|NCT00762723|50652877|FG002|Overall Study|Study Terminated slow enrollement|3|||
25336732|NCT00850343|50652889|FG000|Overall Study|Withdrawal by Subject|11|||
25336733|NCT00850343|50652890|FG001|Overall Study|Withdrawal by Subject|0|||
25336734|NCT00850343|50652891|FG002|Overall Study|Withdrawal by Subject|3|||
25336735|NCT00850343|50652892|FG003|Overall Study|Withdrawal by Subject|2|||
25336736|NCT00850343|50652889|FG000|Overall Study|Adverse Event|15|||
25336737|NCT00850343|50652890|FG001|Overall Study|Adverse Event|2|||
25336738|NCT00850343|50652891|FG002|Overall Study|Adverse Event|6|||
25336739|NCT00850343|50652892|FG003|Overall Study|Adverse Event|6|||
25253377|NCT01115998|50568958|FG001|Overall Study|Lost to Follow-up|6|||
25253378|NCT01205230|50568966|FG000|Overall Study|Adverse Event|4|||
25253379|NCT01205230|50568967|FG001|Overall Study|Adverse Event|0|||
25253380|NCT01205230|50568966|FG000|Overall Study|Physician Decision|1|||
25253381|NCT01205230|50568967|FG001|Overall Study|Physician Decision|0|||
25253382|NCT01205152|50568978|FG000|Overall Study|Death|1|||
25253383|NCT01205035|50568986|FG000|Overall Study|Withdrawal by Subject|1|||
25253384|NCT01205035|50568987|FG001|Overall Study|Withdrawal by Subject|0|||
25253385|NCT01205035|50568986|FG000|Overall Study|Physician Decision|1|||
25253386|NCT01205035|50568987|FG001|Overall Study|Physician Decision|0|||
25253387|NCT01204918|50568996|FG000|Overall Study|Withdrawal by Subject|4|||
25253388|NCT01204918|50568997|FG001|Overall Study|Withdrawal by Subject|10|||
25253389|NCT01204918|50568998|FG002|Overall Study|Withdrawal by Subject|5|||
25253390|NCT01204294|50569013|FG000|Overall Study|Adverse Event|2|||
25253391|NCT01204294|50569014|FG001|Overall Study|Adverse Event|6|||
25336740|NCT00850343|50652889|FG000|Overall Study|Pregnancy|0|||
25336741|NCT00850343|50652890|FG001|Overall Study|Pregnancy|0|||
25336742|NCT00850343|50652891|FG002|Overall Study|Pregnancy|0|||
25336743|NCT00850343|50652892|FG003|Overall Study|Pregnancy|1|||
25336744|NCT00850343|50652889|FG000|Overall Study|Lack of Efficacy|17|||
25336745|NCT00850343|50652890|FG001|Overall Study|Lack of Efficacy|0|||
25336746|NCT00850343|50652891|FG002|Overall Study|Lack of Efficacy|3|||
25336747|NCT00850343|50652892|FG003|Overall Study|Lack of Efficacy|2|||
25336748|NCT00850343|50652889|FG000|Overall Study|Non-compliance with Study Procedures|1|||
25336749|NCT00850343|50652890|FG001|Overall Study|Non-compliance with Study Procedures|0|||
25336750|NCT00850343|50652891|FG002|Overall Study|Non-compliance with Study Procedures|1|||
25336751|NCT00850343|50652892|FG003|Overall Study|Non-compliance with Study Procedures|1|||
25336752|NCT00850343|50652889|FG000|Overall Study|Physician Decision|2|||
25336753|NCT00850343|50652890|FG001|Overall Study|Physician Decision|1|||
25253392|NCT01204294|50569015|FG002|Overall Study|Adverse Event|0|||
25253393|NCT01204294|50569016|FG003|Overall Study|Adverse Event|7|||
25253394|NCT01204294|50569017|FG004|Overall Study|Adverse Event|1|||
25253395|NCT01204294|50569018|FG005|Overall Study|Adverse Event|4|||
25253396|NCT01204294|50569019|FG006|Overall Study|Adverse Event|0|||
25253397|NCT01204294|50569013|FG000|Overall Study|Protocol Violation|1|||
25253398|NCT01204294|50569014|FG001|Overall Study|Protocol Violation|0|||
25253399|NCT01204294|50569015|FG002|Overall Study|Protocol Violation|2|||
25253400|NCT01204294|50569016|FG003|Overall Study|Protocol Violation|1|||
25253401|NCT01204294|50569017|FG004|Overall Study|Protocol Violation|0|||
25336754|NCT00850343|50652891|FG002|Overall Study|Physician Decision|1|||
25336755|NCT00850343|50652892|FG003|Overall Study|Physician Decision|1|||
25336756|NCT00849875|50652905|FG000|Overall Study|Death|28|||
25336757|NCT00849875|50652905|FG000|Overall Study|Ongoing (unknown completion status)|11|||
25336758|NCT00849875|50652905|FG000|Overall Study|Others|6|||
25336759|NCT00849875|50652905|FG000|Overall Study|Lost to Follow-up|2|||
25336760|NCT00844415|50652916|FG000|Overall Study|Withdrawal by Subject|1|||
25336761|NCT00843635|50652924|FG000|Overall Study|Adverse Event|2|||
25336762|NCT00843635|50652925|FG001|Overall Study|Adverse Event|2|||
25336763|NCT00843635|50652926|FG002|Overall Study|Adverse Event|0|||
25336764|NCT00843167|50652940|FG000|Treatment Period|Adverse Event|1|||
25336765|NCT00843167|50652941|FG001|Treatment Period|Adverse Event|5|||
25336766|NCT00843167|50652940|FG000|Treatment Period|Withdrawal by Subject|2|||
25336767|NCT00843167|50652941|FG001|Treatment Period|Withdrawal by Subject|3|||
25336768|NCT00849017|50652954|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
25336769|NCT00849017|50652955|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
25336770|NCT00849017|50652956|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
25336771|NCT00849017|50652954|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
25336772|NCT00849017|50652955|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
25336773|NCT00849017|50652956|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
25336774|NCT00849017|50652954|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
25336775|NCT00849017|50652955|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
25336776|NCT00849017|50652956|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
25336777|NCT00849017|50652954|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
25336778|NCT00849017|50652955|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
25336779|NCT00849017|50652956|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
25336780|NCT00849017|50652954|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
25336781|NCT00849017|50652955|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
25336782|NCT00849017|50652956|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
25336783|NCT00849017|50652954|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
25336784|NCT00849017|50652955|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
25336785|NCT00849017|50652956|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
25336786|NCT00849017|50652954|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
25336787|NCT00849017|50652955|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
25336788|NCT00849017|50652956|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
25336789|NCT00849017|50652954|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
25336790|NCT00849017|50652955|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
25336791|NCT00849017|50652956|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
25336792|NCT00849017|50652954|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
25336793|NCT00849017|50652955|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
25336794|NCT00849017|50652956|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
25336795|NCT00849017|50652954|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
25336796|NCT00849017|50652955|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
25336797|NCT00849017|50652956|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
25336798|NCT00849017|50652954|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
25336799|NCT00849017|50652955|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
25336800|NCT00849017|50652956|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
25336801|NCT00849017|50652954|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
25336802|NCT00849017|50652955|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
25336803|NCT00849017|50652956|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
25336804|NCT00849017|50652954|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
25336805|NCT00849017|50652955|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
25336806|NCT00849017|50652956|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
25336807|NCT00849017|50652954|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
25253402|NCT01204294|50569018|FG005|Overall Study|Protocol Violation|0|||
25253403|NCT01204294|50569019|FG006|Overall Study|Protocol Violation|0|||
25336808|NCT00849017|50652955|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
25336809|NCT00849017|50652956|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
25336810|NCT00849017|50652954|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
25336811|NCT00849017|50652955|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
25336812|NCT00849017|50652956|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
25336813|NCT00849017|50652954|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
25336814|NCT00849017|50652955|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
25336815|NCT00849017|50652956|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
25336816|NCT00849017|50652954|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
25336817|NCT00849017|50652955|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
25336818|NCT00849017|50652956|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
25336819|NCT00849017|50652954|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
25336820|NCT00849017|50652955|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
25336821|NCT00849017|50652956|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
25336822|NCT00849017|50652954|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
25336823|NCT00849017|50652955|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
25336824|NCT00849017|50652956|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
25336825|NCT00842543|50652972|FG000|Overall Study|Withdrawal by Subject|2|||
25336826|NCT00842543|50652973|FG001|Overall Study|Withdrawal by Subject|0|||
25336827|NCT00842543|50652974|FG002|Overall Study|Withdrawal by Subject|3|||
25336828|NCT00842543|50652975|FG003|Overall Study|Withdrawal by Subject|4|||
25336829|NCT00785928|50652994|FG000|Treatment Phase|Adverse Event|1|||
25336830|NCT00785928|50652995|FG001|Treatment Phase|Adverse Event|1|||
25336831|NCT00785928|50652996|FG002|Treatment Phase|Adverse Event|2|||
25336832|NCT00785928|50652997|FG003|Treatment Phase|Adverse Event|0|||
25336833|NCT00785928|50652998|FG004|Treatment Phase|Adverse Event|0|||
25336834|NCT00785928|50652999|FG005|Treatment Phase|Adverse Event|0|||
25336835|NCT00785928|50653000|FG006|Treatment Phase|Adverse Event|2|||
25336836|NCT00785928|50652994|FG000|Treatment Phase|Inadequate Response|0|||
25336837|NCT00785928|50652995|FG001|Treatment Phase|Inadequate Response|1|||
25336838|NCT00785928|50652996|FG002|Treatment Phase|Inadequate Response|0|||
25253404|NCT01204294|50569013|FG000|Overall Study|Withdrawal by Subject|0|||
25253405|NCT01204294|50569014|FG001|Overall Study|Withdrawal by Subject|2|||
25253406|NCT01204294|50569015|FG002|Overall Study|Withdrawal by Subject|2|||
25253407|NCT01204294|50569016|FG003|Overall Study|Withdrawal by Subject|1|||
25336839|NCT00785928|50652997|FG003|Treatment Phase|Inadequate Response|0|||
25253408|NCT01204294|50569017|FG004|Overall Study|Withdrawal by Subject|1|||
25253409|NCT01204294|50569018|FG005|Overall Study|Withdrawal by Subject|1|||
25253410|NCT01204294|50569019|FG006|Overall Study|Withdrawal by Subject|2|||
25253411|NCT01204294|50569013|FG000|Overall Study|Lack of Efficacy|0|||
25253412|NCT01204294|50569014|FG001|Overall Study|Lack of Efficacy|0|||
25253413|NCT01204294|50569015|FG002|Overall Study|Lack of Efficacy|0|||
25336840|NCT00785928|50652998|FG004|Treatment Phase|Inadequate Response|0|||
25336841|NCT00785928|50652999|FG005|Treatment Phase|Inadequate Response|0|||
25336842|NCT00785928|50653000|FG006|Treatment Phase|Inadequate Response|0|||
25336843|NCT00785928|50652994|FG000|Treatment Phase|Lack of Efficacy|0|||
25336844|NCT00785928|50652995|FG001|Treatment Phase|Lack of Efficacy|1|||
25336845|NCT00785928|50652996|FG002|Treatment Phase|Lack of Efficacy|1|||
25336846|NCT00785928|50652997|FG003|Treatment Phase|Lack of Efficacy|0|||
25336847|NCT00785928|50652998|FG004|Treatment Phase|Lack of Efficacy|0|||
25336848|NCT00785928|50652999|FG005|Treatment Phase|Lack of Efficacy|0|||
25336849|NCT00785928|50653000|FG006|Treatment Phase|Lack of Efficacy|0|||
25336850|NCT00785928|50652994|FG000|Treatment Phase|Physician Decision|0|||
25336851|NCT00785928|50652995|FG001|Treatment Phase|Physician Decision|0|||
25336852|NCT00785928|50652996|FG002|Treatment Phase|Physician Decision|0|||
24902390|NCT00678795|49996405|FG001|Overall Study|Lost to Follow-up|1|||
24902391|NCT00678795|49996404|FG000|Overall Study|Lack of Efficacy|1|||
24902392|NCT00678795|49996405|FG001|Overall Study|Lack of Efficacy|1|||
24902393|NCT00678639|49996413|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
24902394|NCT00678639|49996414|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
24902395|NCT00678561|49996464|FG000|Overall Study|Adverse Event|0|||
24902396|NCT00678561|49996465|FG001|Overall Study|Adverse Event|1|||
24902397|NCT00678561|49996466|FG002|Overall Study|Adverse Event|1|||
25253414|NCT01204294|50569016|FG003|Overall Study|Lack of Efficacy|2|||
25336853|NCT00785928|50652997|FG003|Treatment Phase|Physician Decision|0|||
25336854|NCT00785928|50652998|FG004|Treatment Phase|Physician Decision|1|||
25336855|NCT00785928|50652999|FG005|Treatment Phase|Physician Decision|0|||
25336856|NCT00785928|50653000|FG006|Treatment Phase|Physician Decision|0|||
25253415|NCT01204294|50569017|FG004|Overall Study|Lack of Efficacy|0|||
25253416|NCT01204294|50569018|FG005|Overall Study|Lack of Efficacy|0|||
25336857|NCT00785928|50652994|FG000|Treatment Phase|Sponsor Decision|1|||
25336858|NCT00785928|50652995|FG001|Treatment Phase|Sponsor Decision|0|||
25336859|NCT00785928|50652996|FG002|Treatment Phase|Sponsor Decision|0|||
25336860|NCT00785928|50652997|FG003|Treatment Phase|Sponsor Decision|0|||
25336861|NCT00785928|50652998|FG004|Treatment Phase|Sponsor Decision|0|||
25336862|NCT00785928|50652999|FG005|Treatment Phase|Sponsor Decision|0|||
25336863|NCT00785928|50653000|FG006|Treatment Phase|Sponsor Decision|1|||
25336864|NCT00785928|50652994|FG000|Treatment Phase|Withdrawal by Subject|1|||
25336865|NCT00785928|50652995|FG001|Treatment Phase|Withdrawal by Subject|2|||
25336866|NCT00785928|50652996|FG002|Treatment Phase|Withdrawal by Subject|0|||
25336867|NCT00785928|50652997|FG003|Treatment Phase|Withdrawal by Subject|0|||
25336868|NCT00785928|50652998|FG004|Treatment Phase|Withdrawal by Subject|1|||
25336869|NCT00785928|50652999|FG005|Treatment Phase|Withdrawal by Subject|0|||
25336870|NCT00785928|50653000|FG006|Treatment Phase|Withdrawal by Subject|0|||
25336871|NCT00842309|50653040|FG000|Overall Study|Withdrawal by Subject|3|||
25336872|NCT00842309|50653041|FG001|Overall Study|Withdrawal by Subject|1|||
25336873|NCT00842153|50653049|FG000|Overall Study|Adverse Event|0|||
25336874|NCT00842153|50653050|FG001|Overall Study|Adverse Event|1|||
25336875|NCT00842153|50653049|FG000|Overall Study|Lost to Follow-up|1|||
25336876|NCT00842153|50653050|FG001|Overall Study|Lost to Follow-up|2|||
25336877|NCT00762411|50653058|FG000|Initial Treatment|Death|7|||
25336878|NCT00762411|50653059|FG001|Initial Treatment|Death|6|||
25336879|NCT00762411|50653058|FG000|Initial Treatment|Adverse Event|132|||
25336880|NCT00762411|50653059|FG001|Initial Treatment|Adverse Event|40|||
25336881|NCT00762411|50653058|FG000|Initial Treatment|Protocol Violation|4|||
25336882|NCT00762411|50653059|FG001|Initial Treatment|Protocol Violation|1|||
25336883|NCT00762411|50653058|FG000|Initial Treatment|Withdrawal by Subject|65|||
25336884|NCT00762411|50653059|FG001|Initial Treatment|Withdrawal by Subject|52|||
25336885|NCT00762411|50653058|FG000|Initial Treatment|Physician Decision|1|||
25336886|NCT00762411|50653059|FG001|Initial Treatment|Physician Decision|0|||
25336887|NCT00762411|50653058|FG000|Initial Treatment|Sponsor Decision|293|||
25336888|NCT00762411|50653059|FG001|Initial Treatment|Sponsor Decision|401|||
25336889|NCT00762411|50653058|FG000|Initial Treatment|Lost to Follow-up|5|||
25336890|NCT00762411|50653059|FG001|Initial Treatment|Lost to Follow-up|0|||
25336891|NCT00762411|50653058|FG000|Initial Treatment|Caregiver Decision|21|||
25336892|NCT00762411|50653059|FG001|Initial Treatment|Caregiver Decision|16|||
25336893|NCT00762411|50653058|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
25336894|NCT00762411|50653059|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
25336895|NCT00762411|50653058|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
25336896|NCT00762411|50653059|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
25336897|NCT00762411|50653058|FG000|Delayed Start|Adverse Event|0|||
25336898|NCT00762411|50653059|FG001|Delayed Start|Adverse Event|4|||
25336899|NCT00762411|50653058|FG000|Delayed Start|Protocol Violation|0|||
25336900|NCT00762411|50653059|FG001|Delayed Start|Protocol Violation|1|||
25336901|NCT00762411|50653058|FG000|Delayed Start|Sponsor Decision|16|||
25336902|NCT00762411|50653059|FG001|Delayed Start|Sponsor Decision|20|||
25336903|NCT00762411|50653058|FG000|Delayed Start|Caregiver Decision|1|||
25336904|NCT00762411|50653059|FG001|Delayed Start|Caregiver Decision|1|||
25336905|NCT00762411|50653058|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
25253417|NCT01204294|50569019|FG006|Overall Study|Lack of Efficacy|0|||
25253418|NCT01204294|50569013|FG000|Overall Study|Other (house moving)|0|||
25253419|NCT01204294|50569014|FG001|Overall Study|Other (house moving)|0|||
25253420|NCT01204294|50569015|FG002|Overall Study|Other (house moving)|1|||
25253421|NCT01204294|50569016|FG003|Overall Study|Other (house moving)|0|||
25253422|NCT01204294|50569017|FG004|Overall Study|Other (house moving)|0|||
25253423|NCT01204294|50569018|FG005|Overall Study|Other (house moving)|0|||
25253424|NCT01204294|50569019|FG006|Overall Study|Other (house moving)|0|||
25253425|NCT01182181|50569037|FG000|First Intervention|Adverse Event|1|||
25253426|NCT01182181|50569038|FG001|First Intervention|Adverse Event|0|||
25253427|NCT01182181|50569037|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
25253428|NCT01182181|50569038|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
25253429|NCT01181986|50569046|FG000|Phase 1|Lost to Follow-up|0|||
25253430|NCT01181986|50569047|FG001|Phase 1|Lost to Follow-up|1|||
25253431|NCT01181986|50569048|FG002|Phase 1|Lost to Follow-up|1|||
25253432|NCT01181986|50569046|FG000|Phase 1|Adverse Event|0|||
25253433|NCT01181986|50569047|FG001|Phase 1|Adverse Event|0|||
25253434|NCT01181986|50569048|FG002|Phase 1|Adverse Event|1|||
25253435|NCT01181986|50569046|FG000|Phase 1|Protocol Violation|1|||
25336906|NCT00762411|50653059|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
25336907|NCT00762411|50653058|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
25336908|NCT00762411|50653059|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
25336909|NCT00762411|50653058|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
25336910|NCT00762411|50653059|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
25336911|NCT00762411|50653058|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
25336912|NCT00762411|50653059|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
25336913|NCT00762411|50653058|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
25336914|NCT00762411|50653059|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
25336915|NCT00762411|50653058|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
25253436|NCT01181986|50569047|FG001|Phase 1|Protocol Violation|0|||
25253437|NCT01181986|50569048|FG002|Phase 1|Protocol Violation|0|||
25253438|NCT01181986|50569046|FG000|Phase 2|Adverse Event|0|||
25253439|NCT01181986|50569047|FG001|Phase 2|Adverse Event|3|||
25336916|NCT00762411|50653059|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
25336917|NCT00761865|50653071|FG000|Overall Study|Lost to Follow-up|8|||
25336918|NCT00761865|50653072|FG001|Overall Study|Lost to Follow-up|7|||
25336919|NCT00841763|50653080|FG000|Overall Study|Withdrawal by Subject|60|||
25336920|NCT00841763|50653081|FG001|Overall Study|Withdrawal by Subject|17|||
25336921|NCT00841763|50653082|FG002|Overall Study|Withdrawal by Subject|4|||
25253440|NCT01181986|50569048|FG002|Phase 2|Adverse Event|0|||
25253441|NCT01181986|50569046|FG000|Phase 2|Medical condition|0|||
25253442|NCT01181986|50569047|FG001|Phase 2|Medical condition|1|||
25253443|NCT01181986|50569048|FG002|Phase 2|Medical condition|0|||
25253444|NCT01181167|50569064|FG000|Overall Study|Adverse Event|11|||
25253445|NCT01181167|50569065|FG001|Overall Study|Adverse Event|21|||
25253446|NCT01181167|50569064|FG000|Overall Study|Lost to Follow-up|1|||
24902398|NCT00678561|49996467|FG003|Overall Study|Adverse Event|0|||
24902399|NCT00678561|49996468|FG004|Overall Study|Adverse Event|1|||
25253447|NCT01181167|50569065|FG001|Overall Study|Lost to Follow-up|0|||
25253448|NCT01181167|50569064|FG000|Overall Study|Physician Decision|2|||
25253449|NCT01181167|50569065|FG001|Overall Study|Physician Decision|3|||
25253450|NCT01181167|50569064|FG000|Overall Study|Protocol Violation|3|||
25253451|NCT01181167|50569065|FG001|Overall Study|Protocol Violation|0|||
25253452|NCT01181167|50569064|FG000|Overall Study|Withdrawal by Subject|6|||
25253453|NCT01181167|50569065|FG001|Overall Study|Withdrawal by Subject|8|||
25253454|NCT01181128|50569074|FG000|Overall Study|Withdrawal by Subject|2|||
25253455|NCT01181128|50569075|FG001|Overall Study|Withdrawal by Subject|2|||
25253456|NCT01181128|50569076|FG002|Overall Study|Withdrawal by Subject|0|||
25253457|NCT01181128|50569074|FG000|Overall Study|Death|1|||
25336922|NCT00841763|50653083|FG003|Overall Study|Withdrawal by Subject|1|||
25336923|NCT00841763|50653080|FG000|Overall Study|Adverse Event|9|||
25336924|NCT00841763|50653081|FG001|Overall Study|Adverse Event|10|||
25336925|NCT00841763|50653082|FG002|Overall Study|Adverse Event|3|||
25336926|NCT00841763|50653083|FG003|Overall Study|Adverse Event|2|||
25336927|NCT00841763|50653080|FG000|Overall Study|Lost to Follow-up|63|||
25336928|NCT00841763|50653081|FG001|Overall Study|Lost to Follow-up|25|||
25336929|NCT00841763|50653082|FG002|Overall Study|Lost to Follow-up|0|||
25253458|NCT01181128|50569075|FG001|Overall Study|Death|0|||
25253459|NCT01181128|50569076|FG002|Overall Study|Death|0|||
25253460|NCT01181128|50569074|FG000|Overall Study|Physician Decision|2|||
25253461|NCT01181128|50569075|FG001|Overall Study|Physician Decision|0|||
25253462|NCT01181128|50569076|FG002|Overall Study|Physician Decision|0|||
25253463|NCT01181128|50569074|FG000|Overall Study|Adverse Event|0|||
25253464|NCT01181128|50569075|FG001|Overall Study|Adverse Event|2|||
25253465|NCT01181128|50569076|FG002|Overall Study|Adverse Event|0|||
25253466|NCT01181128|50569074|FG000|Overall Study|Other|1|||
25253467|NCT01181128|50569075|FG001|Overall Study|Other|1|||
25253468|NCT01181128|50569076|FG002|Overall Study|Other|1|||
25253469|NCT01203787|50569098|FG000|Overall Study|Death|12|||
25253470|NCT01203787|50569099|FG001|Overall Study|Death|10|||
25253471|NCT01203787|50569098|FG000|Overall Study|Withdrawal by Subject|6|||
25253472|NCT01203787|50569099|FG001|Overall Study|Withdrawal by Subject|2|||
25253473|NCT01203787|50569098|FG000|Overall Study|Lost to Follow-up|2|||
25253474|NCT01203787|50569099|FG001|Overall Study|Lost to Follow-up|0|||
25253475|NCT01203787|50569098|FG000|Overall Study|Adverse Event|11|||
25253476|NCT01203787|50569099|FG001|Overall Study|Adverse Event|15|||
25253477|NCT01181011|50569107|FG000|Overall Study|Adverse Event|2|||
25253478|NCT01181011|50569107|FG000|Overall Study|Lost to Follow-up|1|||
25253479|NCT01180777|50569116|FG000|Overall Study|Protocol Violation|6|||
25253480|NCT01180777|50569116|FG000|Overall Study|Poor lens fit|4|||
25253481|NCT01180777|50569116|FG000|Overall Study|Lost to Follow-up|1|||
25253482|NCT01180777|50569116|FG000|Overall Study|Adverse Event|1|||
25253483|NCT01648023|50569124|FG000|Overall Study|Screen Fail Post Randomization|1|||
25253484|NCT01648023|50569125|FG001|Overall Study|Screen Fail Post Randomization|2|||
25253485|NCT02756208|50569139|FG000|Overall Study|Withdrawal by Subject|1|||
25253486|NCT02756208|50569140|FG001|Overall Study|Withdrawal by Subject|0|||
25253487|NCT02756208|50569141|FG002|Overall Study|Withdrawal by Subject|1|||
25336930|NCT00841763|50653083|FG003|Overall Study|Lost to Follow-up|0|||
25336931|NCT00841763|50653080|FG000|Overall Study|Protocol Violation|20|||
25336932|NCT00841763|50653081|FG001|Overall Study|Protocol Violation|3|||
24902400|NCT00678561|49996469|FG005|Overall Study|Adverse Event|0|||
24902401|NCT00678561|49996470|FG006|Overall Study|Adverse Event|0|||
25253488|NCT02756208|50569142|FG003|Overall Study|Withdrawal by Subject|3|||
25253489|NCT02756208|50569139|FG000|Overall Study|Lost to Follow-up|3|||
25253490|NCT02756208|50569140|FG001|Overall Study|Lost to Follow-up|1|||
25253491|NCT02756208|50569141|FG002|Overall Study|Lost to Follow-up|1|||
25253492|NCT02756208|50569142|FG003|Overall Study|Lost to Follow-up|1|||
25253493|NCT02756208|50569139|FG000|Overall Study|Physician Decision|1|||
25253494|NCT02756208|50569140|FG001|Overall Study|Physician Decision|0|||
25253495|NCT02756208|50569141|FG002|Overall Study|Physician Decision|0|||
25253496|NCT02756208|50569142|FG003|Overall Study|Physician Decision|0|||
25253497|NCT02756208|50569139|FG000|Overall Study|Protocol Violation|0|||
25253498|NCT02756208|50569140|FG001|Overall Study|Protocol Violation|1|||
25336933|NCT00841763|50653082|FG002|Overall Study|Protocol Violation|1|||
25336934|NCT00841763|50653083|FG003|Overall Study|Protocol Violation|0|||
25336935|NCT00841763|50653080|FG000|Overall Study|Administrative Reasons|3|||
25336936|NCT00841763|50653081|FG001|Overall Study|Administrative Reasons|1|||
25336937|NCT00841763|50653082|FG002|Overall Study|Administrative Reasons|0|||
25336938|NCT00841763|50653083|FG003|Overall Study|Administrative Reasons|0|||
25336939|NCT00841763|50653080|FG000|Overall Study|Unable to Classify|7|||
25336940|NCT00841763|50653081|FG001|Overall Study|Unable to Classify|1|||
25336941|NCT00841763|50653082|FG002|Overall Study|Unable to Classify|0|||
25336942|NCT00841763|50653083|FG003|Overall Study|Unable to Classify|0|||
25336943|NCT00838331|50653128|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
25336944|NCT00785538|50653136|FG000|Treatment Period|Adverse Event|1|||
25336945|NCT00785538|50653137|FG001|Treatment Period|Adverse Event|2|||
25336946|NCT00785538|50653138|FG002|Treatment Period|Adverse Event|2|||
25336947|NCT00785538|50653139|FG003|Treatment Period|Adverse Event|0|||
25336948|NCT00785538|50653136|FG000|Treatment Period|Withdrawal by Subject|0|||
25336949|NCT00785538|50653137|FG001|Treatment Period|Withdrawal by Subject|0|||
25336950|NCT00785538|50653138|FG002|Treatment Period|Withdrawal by Subject|0|||
25336951|NCT00785538|50653139|FG003|Treatment Period|Withdrawal by Subject|1|||
25336952|NCT00860405|50653152|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
25336953|NCT00860405|50653153|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
25336954|NCT00838097|50653159|FG000|Overall Study|Ineligibility determined|6|||
25336955|NCT00838097|50653159|FG000|Overall Study|Adverse Event|2|||
25336956|NCT00838097|50653159|FG000|Overall Study|Withdrawal by Subject|3|||
25336957|NCT00838097|50653159|FG000|Overall Study|Requirement for alternative therapy|2|||
25336958|NCT00838097|50653159|FG000|Overall Study|Physician Decision|4|||
25336959|NCT00838097|50653159|FG000|Overall Study|Lost to Follow-up|11|||
25336960|NCT00838097|50653159|FG000|Overall Study|Death|6|||
25336961|NCT00838097|50653159|FG000|Overall Study|Protocol-specified criteria|142|||
25336962|NCT00840827|50653163|FG000|Overall Study|Adverse Event|1|||
25336963|NCT00840827|50653163|FG000|Overall Study|Lack of Efficacy|4|||
25336964|NCT00840827|50653163|FG000|Overall Study|Physician Decision|1|||
25336965|NCT00860249|50653170|FG000|Overall Study|trial was terminated prior to completion|21|||
25336966|NCT00860249|50653171|FG001|Overall Study|trial was terminated prior to completion|18|||
25336967|NCT00860249|50653172|FG002|Overall Study|trial was terminated prior to completion|21|||
25253499|NCT02756208|50569141|FG002|Overall Study|Protocol Violation|0|||
25253500|NCT02756208|50569142|FG003|Overall Study|Protocol Violation|0|||
25253501|NCT02756013|50569152|FG000|Overall Study|Adverse Event|1|||
25253502|NCT02756013|50569152|FG000|Overall Study|Hypersensitivity|1|||
25253503|NCT01202773|50569159|FG000|Overall Study|Adverse Event|4|||
25253504|NCT01202773|50569160|FG001|Overall Study|Adverse Event|5|||
25253505|NCT01202773|50569161|FG002|Overall Study|Adverse Event|5|||
25336968|NCT00840749|50653182|FG000|Overall Study|Death|1|||
25336969|NCT00840749|50653183|FG001|Overall Study|Death|2|||
25336970|NCT00840749|50653182|FG000|Overall Study|not treated on study arm|11|||
25336971|NCT00840749|50653183|FG001|Overall Study|not treated on study arm|11|||
25336972|NCT00840749|50653182|FG000|Overall Study|study closed|19|||
25336973|NCT00840749|50653183|FG001|Overall Study|study closed|14|||
25336974|NCT00859937|50653191|FG000|Overall Study|Protocol Violation|1|||
25336975|NCT00859937|50653192|FG001|Overall Study|Protocol Violation|0|||
25336976|NCT00592007|50653198|FG000|Overall Study|Withdrawal by Subject|1|||
25336977|NCT00592007|50653198|FG000|Overall Study|patient ineligible (out of lab range)|1|||
25336978|NCT00591851|50653202|FG000|Overall Study|Withdrawal by Subject|3|||
25336979|NCT00591851|50653202|FG000|Overall Study|Adverse Event|2|||
25336980|NCT00591851|50653202|FG000|Overall Study|Progressive Disease|1|||
25336981|NCT00837473|50653206|FG000|Overall Study|Lost to Follow-up|1|||
25336982|NCT00837473|50653206|FG000|Overall Study|Withdrawal by Subject|2|||
25336983|NCT00839423|50653214|FG000|Overall Study|Adverse Event|4|||
25336984|NCT00839423|50653215|FG001|Overall Study|Adverse Event|3|||
25336985|NCT00839423|50653216|FG002|Overall Study|Adverse Event|7|||
25336986|NCT00839423|50653217|FG003|Overall Study|Adverse Event|16|||
25336987|NCT00839423|50653214|FG000|Overall Study|Lack of Efficacy|6|||
25077967|NCT02228980|50186113|FG001|Overall Study|Adverse Event|0|||
25253506|NCT01202773|50569159|FG000|Overall Study|Lack of Efficacy|5|||
25253507|NCT01202773|50569160|FG001|Overall Study|Lack of Efficacy|4|||
25336988|NCT00839423|50653215|FG001|Overall Study|Lack of Efficacy|6|||
25336989|NCT00839423|50653216|FG002|Overall Study|Lack of Efficacy|3|||
25336990|NCT00839423|50653217|FG003|Overall Study|Lack of Efficacy|2|||
25336991|NCT00839423|50653214|FG000|Overall Study|Non-compliance|0|||
25336992|NCT00839423|50653215|FG001|Overall Study|Non-compliance|0|||
25336993|NCT00839423|50653216|FG002|Overall Study|Non-compliance|0|||
25336994|NCT00839423|50653217|FG003|Overall Study|Non-compliance|1|||
25336995|NCT00839423|50653214|FG000|Overall Study|Protocol Violation|0|||
25336996|NCT00839423|50653215|FG001|Overall Study|Protocol Violation|1|||
25336997|NCT00839423|50653216|FG002|Overall Study|Protocol Violation|2|||
25336998|NCT00839423|50653217|FG003|Overall Study|Protocol Violation|0|||
25336999|NCT00839423|50653214|FG000|Overall Study|Withdrawal of consent|4|||
25253508|NCT01202773|50569161|FG002|Overall Study|Lack of Efficacy|9|||
25337000|NCT00839423|50653215|FG001|Overall Study|Withdrawal of consent|0|||
25337001|NCT00839423|50653216|FG002|Overall Study|Withdrawal of consent|4|||
25337002|NCT00839423|50653217|FG003|Overall Study|Withdrawal of consent|1|||
25253509|NCT01202773|50569159|FG000|Overall Study|Entry Criteria Not Met|2|||
25253510|NCT01202773|50569160|FG001|Overall Study|Entry Criteria Not Met|0|||
25253511|NCT01202773|50569161|FG002|Overall Study|Entry Criteria Not Met|1|||
25253512|NCT01202773|50569159|FG000|Overall Study|Lost to Follow-up|1|||
25253513|NCT01202773|50569160|FG001|Overall Study|Lost to Follow-up|2|||
25253514|NCT01202773|50569161|FG002|Overall Study|Lost to Follow-up|2|||
25253515|NCT01202773|50569159|FG000|Overall Study|Withdrawal by Subject|13|||
25253516|NCT01202773|50569160|FG001|Overall Study|Withdrawal by Subject|6|||
25337003|NCT00839423|50653214|FG000|Overall Study|Lost to Follow-up|1|||
25337004|NCT00839423|50653215|FG001|Overall Study|Lost to Follow-up|0|||
25337005|NCT00839423|50653216|FG002|Overall Study|Lost to Follow-up|1|||
25337006|NCT00839423|50653217|FG003|Overall Study|Lost to Follow-up|0|||
25337007|NCT00839423|50653214|FG000|Overall Study|Administrative or other reasons|3|||
25337008|NCT00839423|50653215|FG001|Overall Study|Administrative or other reasons|0|||
25337009|NCT00839423|50653216|FG002|Overall Study|Administrative or other reasons|1|||
25337010|NCT00839423|50653217|FG003|Overall Study|Administrative or other reasons|0|||
25337011|NCT00837161|50653227|FG000|Overall Study|refused hysterectomy|2|||
25337012|NCT00859547|50653231|FG000|Overall Study|Lost to Follow-up|1|||
25337013|NCT00859547|50653231|FG000|Overall Study|Parent withdrew consent|1|||
25337014|NCT00859469|50653235|FG000|Overall Study|Adverse Event|2|||
25337015|NCT00859469|50653235|FG000|Overall Study|Lack of Efficacy|9|||
25337016|NCT00859469|50653235|FG000|Overall Study|Withdrawal by Subject|1|||
25337017|NCT00859469|50653235|FG000|Overall Study|Death|16|||
25337018|NCT00859313|50653239|FG000|Overall Study|Lack of Efficacy|2|||
25337019|NCT00859313|50653239|FG000|Overall Study|Adverse Event|1|||
25337020|NCT00859313|50653239|FG000|Overall Study|staff error|1|||
25337021|NCT00771810|50653246|FG000|Overall Study|Adverse Event|3|||
25337022|NCT00771810|50653247|FG001|Overall Study|Adverse Event|0|||
25337023|NCT00771810|50653248|FG002|Overall Study|Adverse Event|2|||
25337024|NCT00771810|50653246|FG000|Overall Study|Lost to Follow-up|0|||
25337025|NCT00771810|50653247|FG001|Overall Study|Lost to Follow-up|0|||
25337026|NCT00771810|50653248|FG002|Overall Study|Lost to Follow-up|1|||
25337027|NCT00771810|50653246|FG000|Overall Study|Physician Decision|1|||
25337028|NCT00771810|50653247|FG001|Overall Study|Physician Decision|2|||
25337029|NCT00771810|50653248|FG002|Overall Study|Physician Decision|2|||
25337030|NCT00771810|50653246|FG000|Overall Study|Protocol Violation|0|||
25337031|NCT00771810|50653247|FG001|Overall Study|Protocol Violation|1|||
25337032|NCT00771810|50653248|FG002|Overall Study|Protocol Violation|1|||
25337033|NCT00771810|50653246|FG000|Overall Study|Withdrawal by Subject|1|||
25337034|NCT00771810|50653247|FG001|Overall Study|Withdrawal by Subject|2|||
25337035|NCT00771810|50653248|FG002|Overall Study|Withdrawal by Subject|0|||
25337036|NCT00771810|50653246|FG000|Overall Study|Other|0|||
25337037|NCT00771810|50653247|FG001|Overall Study|Other|0|||
25337038|NCT00771810|50653248|FG002|Overall Study|Other|1|||
25337039|NCT00836927|50653262|FG000|Overall Study|Progressive disease|2|||
25337040|NCT00836927|50653263|FG001|Overall Study|Progressive disease|0|||
25337041|NCT00836927|50653264|FG002|Overall Study|Progressive disease|0|||
25337042|NCT00836927|50653265|FG003|Overall Study|Progressive disease|1|||
25253517|NCT01202773|50569161|FG002|Overall Study|Withdrawal by Subject|5|||
25253518|NCT01202773|50569159|FG000|Overall Study|Physician Decision|2|||
25253519|NCT01202773|50569160|FG001|Overall Study|Physician Decision|0|||
25253520|NCT01202773|50569161|FG002|Overall Study|Physician Decision|0|||
25253521|NCT01202773|50569159|FG000|Overall Study|Protocol Violation|11|||
25253522|NCT01202773|50569160|FG001|Overall Study|Protocol Violation|6|||
25253523|NCT01202773|50569161|FG002|Overall Study|Protocol Violation|10|||
25253524|NCT01202773|50569159|FG000|Overall Study|Sponsor Decision|19|||
25253525|NCT01202773|50569160|FG001|Overall Study|Sponsor Decision|20|||
25253526|NCT01202773|50569161|FG002|Overall Study|Sponsor Decision|23|||
25337043|NCT00836927|50653266|FG004|Overall Study|Progressive disease|1|||
25337044|NCT00836927|50653262|FG000|Overall Study|Withdrawal by Subject|1|||
25337045|NCT00836927|50653263|FG001|Overall Study|Withdrawal by Subject|0|||
25337046|NCT00836927|50653264|FG002|Overall Study|Withdrawal by Subject|0|||
25337047|NCT00836927|50653265|FG003|Overall Study|Withdrawal by Subject|0|||
25337048|NCT00836927|50653266|FG004|Overall Study|Withdrawal by Subject|0|||
25337049|NCT00771030|50653287|FG000|Overall Study|Adverse Event|0|||
25337050|NCT00771030|50653288|FG001|Overall Study|Adverse Event|1|||
25337051|NCT00771030|50653289|FG002|Overall Study|Adverse Event|0|||
25337052|NCT00771030|50653290|FG003|Overall Study|Adverse Event|0|||
25337053|NCT00771030|50653291|FG004|Overall Study|Adverse Event|0|||
25337054|NCT00771030|50653292|FG005|Overall Study|Adverse Event|0|||
25337055|NCT00771030|50653293|FG006|Overall Study|Adverse Event|0|||
25337056|NCT00768300|50653316|FG000|Overall Study|Randomized but not treated|1|||
25253527|NCT01180660|50569181|FG000|Overall Study|Changed to open surgery|1|||
25253528|NCT01180660|50569182|FG001|Overall Study|Changed to open surgery|0|||
25253529|NCT01202227|50569188|FG000|Overall Study|Adverse Event|16|||
25337057|NCT00768300|50653317|FG001|Overall Study|Randomized but not treated|1|||
25253530|NCT01202227|50569188|FG000|Overall Study|Withdrawal by Subject|2|||
25253531|NCT01202227|50569188|FG000|Overall Study|Lack of Efficacy|1|||
25253532|NCT01202188|50569197|FG000|Overall Study|Protocol deviation|14|||
25253533|NCT01202188|50569198|FG001|Overall Study|Protocol deviation|8|||
25253534|NCT01202188|50569199|FG002|Overall Study|Protocol deviation|12|||
25253535|NCT01202188|50569200|FG003|Overall Study|Protocol deviation|10|||
25253536|NCT01202188|50569201|FG004|Overall Study|Protocol deviation|11|||
25253537|NCT01202188|50569197|FG000|Overall Study|Subject withdrew consent|12|||
25253538|NCT01202188|50569198|FG001|Overall Study|Subject withdrew consent|13|||
25253539|NCT01202188|50569199|FG002|Overall Study|Subject withdrew consent|22|||
25337058|NCT00768300|50653316|FG000|Overall Study|Adverse Event|10|||
25337059|NCT00768300|50653317|FG001|Overall Study|Adverse Event|2|||
25337060|NCT00768300|50653316|FG000|Overall Study|Protocol Violation|6|||
25337061|NCT00768300|50653317|FG001|Overall Study|Protocol Violation|1|||
25337062|NCT00768300|50653316|FG000|Overall Study|Withdrawal by Subject|13|||
25337063|NCT00768300|50653317|FG001|Overall Study|Withdrawal by Subject|7|||
25337064|NCT00768300|50653316|FG000|Overall Study|Physician Decision|2|||
25337065|NCT00768300|50653317|FG001|Overall Study|Physician Decision|3|||
25337066|NCT00768300|50653316|FG000|Overall Study|Study discontinued by Sponsor|271|||
25337067|NCT00768300|50653317|FG001|Overall Study|Study discontinued by Sponsor|140|||
25337068|NCT00768300|50653316|FG000|Overall Study|Death|21|||
25337069|NCT00768300|50653317|FG001|Overall Study|Death|5|||
25337070|NCT00768300|50653316|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
25337071|NCT00768300|50653317|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
25337072|NCT00768300|50653316|FG000|Overall Study|Screen failure following randomization|1|||
25337073|NCT00768300|50653317|FG001|Overall Study|Screen failure following randomization|0|||
25253540|NCT01202188|50569200|FG003|Overall Study|Subject withdrew consent|11|||
25253541|NCT01202188|50569201|FG004|Overall Study|Subject withdrew consent|13|||
25253542|NCT01202188|50569197|FG000|Overall Study|Adverse Event|5|||
25253543|NCT01202188|50569198|FG001|Overall Study|Adverse Event|23|||
25253544|NCT01202188|50569199|FG002|Overall Study|Adverse Event|13|||
25253545|NCT01202188|50569200|FG003|Overall Study|Adverse Event|10|||
25337074|NCT00768300|50653316|FG000|Overall Study|Received lung transplant|1|||
25337075|NCT00768300|50653317|FG001|Overall Study|Received lung transplant|1|||
25337076|NCT00768300|50653316|FG000|Overall Study|Lost to Follow-up|0|||
25337077|NCT00768300|50653317|FG001|Overall Study|Lost to Follow-up|1|||
25337078|NCT00768300|50653316|FG000|Overall Study|Began prohibited concomitant medication|0|||
25337079|NCT00768300|50653317|FG001|Overall Study|Began prohibited concomitant medication|1|||
25337080|NCT00768300|50653316|FG000|Overall Study|Treated but never dosed with Study drug|1|||
25337081|NCT00768300|50653317|FG001|Overall Study|Treated but never dosed with Study drug|0|||
25337082|NCT00768300|50653316|FG000|Overall Study|Missing data|1|||
25337083|NCT00768300|50653317|FG001|Overall Study|Missing data|0|||
25337084|NCT00768222|50653325|FG000|Overall Study|Lost to Follow-up|1|||
25337085|NCT00768222|50653326|FG001|Overall Study|Lost to Follow-up|1|||
25337086|NCT00768222|50653325|FG000|Overall Study|Withdrawal by Subject|3|||
25337087|NCT00768222|50653326|FG001|Overall Study|Withdrawal by Subject|1|||
25337088|NCT00768222|50653325|FG000|Overall Study|Protocol Violation|0|||
24902402|NCT00678561|49996471|FG007|Overall Study|Adverse Event|0|||
24902403|NCT00678561|49996464|FG000|Overall Study|Protocol Violation|0|||
25253546|NCT01202188|50569201|FG004|Overall Study|Adverse Event|10|||
25253547|NCT01202188|50569197|FG000|Overall Study|Administrative problems|3|||
25253548|NCT01202188|50569198|FG001|Overall Study|Administrative problems|2|||
25253549|NCT01202188|50569199|FG002|Overall Study|Administrative problems|1|||
25253550|NCT01202188|50569200|FG003|Overall Study|Administrative problems|1|||
25253551|NCT01202188|50569201|FG004|Overall Study|Administrative problems|2|||
25253552|NCT01202188|50569197|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
25253553|NCT01202188|50569198|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
25253554|NCT01202188|50569199|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
25253555|NCT01202188|50569200|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
25253556|NCT01202188|50569201|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
25253557|NCT01202188|50569197|FG000|Overall Study|Lost to Follow-up|1|||
25253558|NCT01202188|50569198|FG001|Overall Study|Lost to Follow-up|1|||
25253559|NCT01202188|50569199|FG002|Overall Study|Lost to Follow-up|0|||
25253560|NCT01202188|50569200|FG003|Overall Study|Lost to Follow-up|4|||
25253561|NCT01202188|50569201|FG004|Overall Study|Lost to Follow-up|1|||
25337089|NCT00768222|50653326|FG001|Overall Study|Protocol Violation|2|||
25337090|NCT00768144|50653332|FG000|Overall Study|Adverse Event|13|||
25337091|NCT00768144|50653332|FG000|Overall Study|Progressive Disease|21|||
25337092|NCT00768144|50653332|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
24902404|NCT00678561|49996465|FG001|Overall Study|Protocol Violation|0|||
25253562|NCT01202188|50569197|FG000|Overall Study|Death|1|||
25253563|NCT01202188|50569198|FG001|Overall Study|Death|1|||
25253564|NCT01202188|50569199|FG002|Overall Study|Death|1|||
25337093|NCT00768144|50653332|FG000|Overall Study|Pt Withdrew Consent|1|||
25337094|NCT00784836|50653336|FG000|Overall Study|Early Study Termination|3|||
25337095|NCT00784758|50653342|FG000|Overall Study|Withdrawal by Subject|3|||
25337096|NCT00784758|50653343|FG001|Overall Study|Withdrawal by Subject|0|||
25253565|NCT01202188|50569200|FG003|Overall Study|Death|1|||
25253566|NCT01202188|50569201|FG004|Overall Study|Death|0|||
25253567|NCT01202188|50569197|FG000|Overall Study|Abnormal test procedure result (s)|0|||
25253568|NCT01202188|50569198|FG001|Overall Study|Abnormal test procedure result (s)|0|||
25253569|NCT01202188|50569199|FG002|Overall Study|Abnormal test procedure result (s)|2|||
25253570|NCT01202188|50569200|FG003|Overall Study|Abnormal test procedure result (s)|0|||
25253571|NCT01202188|50569201|FG004|Overall Study|Abnormal test procedure result (s)|0|||
25253572|NCT01201915|50569222|FG000|Overall Study|Adverse Event|2|||
25253573|NCT01201915|50569223|FG001|Overall Study|Adverse Event|1|||
25337097|NCT00784758|50653342|FG000|Overall Study|Adverse Event|1|||
25337098|NCT00784758|50653343|FG001|Overall Study|Adverse Event|0|||
25337099|NCT00768066|50653354|FG000|Overall Study|Did not receive study product injection.|3|||
25337100|NCT00768066|50653355|FG001|Overall Study|Did not receive study product injection.|3|||
25337101|NCT00768066|50653356|FG002|Overall Study|Did not receive study product injection.|0|||
25337102|NCT00767676|50653364|FG000|Overall Study|Investigator error|54|||
25337103|NCT00767520|50653370|FG000|Overall Study|Participants still on treatment|11|||
25337104|NCT00767520|50653371|FG001|Overall Study|Participants still on treatment|15|||
25337105|NCT00767520|50653370|FG000|Overall Study|Randomized in error and Never treated|0|||
25337106|NCT00767520|50653371|FG001|Overall Study|Randomized in error and Never treated|2|||
25337107|NCT00838565|50653383|FG000|Overall Study|Withdrawal by Subject|0|||
25337108|NCT00838565|50653384|FG001|Overall Study|Withdrawal by Subject|0|||
25337109|NCT00838565|50653385|FG002|Overall Study|Withdrawal by Subject|1|||
25337110|NCT00838565|50653386|FG003|Overall Study|Withdrawal by Subject|0|||
25337111|NCT00838565|50653387|FG004|Overall Study|Withdrawal by Subject|0|||
25337112|NCT00838565|50653388|FG005|Overall Study|Withdrawal by Subject|2|||
25337113|NCT00838565|50653383|FG000|Overall Study|Other|0|||
25337114|NCT00838565|50653384|FG001|Overall Study|Other|2|||
25337115|NCT00838565|50653385|FG002|Overall Study|Other|0|||
25253574|NCT01201915|50569224|FG002|Overall Study|Adverse Event|1|||
25253575|NCT01201915|50569222|FG000|Overall Study|Lost to Follow-up|0|||
25337116|NCT00838565|50653386|FG003|Overall Study|Other|0|||
25337117|NCT00838565|50653387|FG004|Overall Study|Other|0|||
25337118|NCT00838565|50653388|FG005|Overall Study|Other|0|||
25337119|NCT00838565|50653383|FG000|Overall Study|Randomized but not Treated|0|||
25337120|NCT00838565|50653384|FG001|Overall Study|Randomized but not Treated|1|||
25337121|NCT00838565|50653385|FG002|Overall Study|Randomized but not Treated|0|||
25337122|NCT00838565|50653386|FG003|Overall Study|Randomized but not Treated|0|||
25337123|NCT00838565|50653387|FG004|Overall Study|Randomized but not Treated|0|||
25337124|NCT00838565|50653388|FG005|Overall Study|Randomized but not Treated|0|||
25337125|NCT00858845|50653409|FG000|Overall Study|Patient underwent heart transplant.|0|||
25337126|NCT00858845|50653410|FG001|Overall Study|Patient underwent heart transplant.|1|||
25337127|NCT00770562|50653418|FG000|Overall Study|Did not take treatment|1|||
25337128|NCT00770562|50653419|FG001|Overall Study|Did not take treatment|1|||
25337129|NCT00836693|50653428|FG000|Overall Study|Adverse Event|4|||
25337130|NCT00836693|50653429|FG001|Overall Study|Adverse Event|1|||
25337131|NCT00836693|50653428|FG000|Overall Study|Sponsor Decision|0|||
25337132|NCT00836693|50653429|FG001|Overall Study|Sponsor Decision|1|||
25337133|NCT00836693|50653428|FG000|Overall Study|Physician Decision|2|||
25337134|NCT00836693|50653429|FG001|Overall Study|Physician Decision|0|||
25337135|NCT00836693|50653428|FG000|Overall Study|Withdrawal by Subject|9|||
25337136|NCT00836693|50653429|FG001|Overall Study|Withdrawal by Subject|4|||
25253576|NCT01201915|50569223|FG001|Overall Study|Lost to Follow-up|4|||
25253577|NCT01201915|50569224|FG002|Overall Study|Lost to Follow-up|0|||
25253578|NCT01201915|50569222|FG000|Overall Study|Physician Decision|3|||
25253579|NCT01201915|50569223|FG001|Overall Study|Physician Decision|0|||
25253580|NCT01201915|50569224|FG002|Overall Study|Physician Decision|0|||
25253581|NCT01201915|50569222|FG000|Overall Study|Subject Decision|3|||
25253582|NCT01201915|50569223|FG001|Overall Study|Subject Decision|3|||
25253583|NCT01201915|50569224|FG002|Overall Study|Subject Decision|5|||
25253584|NCT01201915|50569222|FG000|Overall Study|Target Lesion Progression|0|||
25253585|NCT01201915|50569223|FG001|Overall Study|Target Lesion Progression|3|||
25337137|NCT00836693|50653428|FG000|Overall Study|Protocol Violation|1|||
25337138|NCT00836693|50653429|FG001|Overall Study|Protocol Violation|0|||
25337139|NCT00836693|50653428|FG000|Overall Study|Lost to Follow-up|1|||
25337140|NCT00836693|50653429|FG001|Overall Study|Lost to Follow-up|0|||
25337141|NCT00770484|50653437|FG000|Overall Study|Withdrawal by Subject|1|||
25337142|NCT00770484|50653438|FG001|Overall Study|Withdrawal by Subject|0|||
25337143|NCT00835679|50653448|FG000|Overall Study|Withdrawal by Subject|1|||
25337144|NCT00835679|50653449|FG001|Overall Study|Withdrawal by Subject|0|||
25253586|NCT01201915|50569224|FG002|Overall Study|Target Lesion Progression|0|||
25337145|NCT00835679|50653450|FG002|Overall Study|Withdrawal by Subject|0|||
25337146|NCT00835679|50653451|FG003|Overall Study|Withdrawal by Subject|0|||
25253587|NCT01179919|50569232|FG000|Overall Study|Protocol Violation|1|||
25253588|NCT01179919|50569232|FG000|Overall Study|Adverse Event|1|||
25253589|NCT01201798|50569238|FG000|Overall Study|Adverse Event|2|||
25337147|NCT00766506|50653467|FG000|Overall Study|Use rescue medication after 3 hours|3|||
25337148|NCT00766506|50653468|FG001|Overall Study|Use rescue medication after 3 hours|0|||
25337149|NCT00766506|50653467|FG000|Overall Study|Other|2|||
25337150|NCT00766506|50653468|FG001|Overall Study|Other|2|||
25337151|NCT00770328|50653476|FG000|Overall Study|Adverse Event|11|||
25337152|NCT00770328|50653477|FG001|Overall Study|Adverse Event|2|||
25337153|NCT00770328|50653476|FG000|Overall Study|Lost to Follow-up|2|||
25337154|NCT00770328|50653477|FG001|Overall Study|Lost to Follow-up|2|||
25337155|NCT00766038|50653485|FG000|Overall Study|Lost to Follow-up|15|||
25337156|NCT00766038|50653486|FG001|Overall Study|Lost to Follow-up|14|||
25337157|NCT00765882|50653497|FG000|Overall Study|Adverse Event|10|||
25337158|NCT00765882|50653498|FG001|Overall Study|Adverse Event|21|||
25337159|NCT00765882|50653499|FG002|Overall Study|Adverse Event|20|||
25337160|NCT00765882|50653497|FG000|Overall Study|Lack of Efficacy|4|||
25337161|NCT00765882|50653498|FG001|Overall Study|Lack of Efficacy|0|||
25337162|NCT00765882|50653499|FG002|Overall Study|Lack of Efficacy|1|||
25337163|NCT00765882|50653497|FG000|Overall Study|Protocol Violation|4|||
25253590|NCT01201798|50569239|FG001|Overall Study|Adverse Event|0|||
25253591|NCT01201798|50569238|FG000|Overall Study|Lost to Follow-up|3|||
25253592|NCT01201798|50569239|FG001|Overall Study|Lost to Follow-up|5|||
25337164|NCT00765882|50653498|FG001|Overall Study|Protocol Violation|3|||
25337165|NCT00765882|50653499|FG002|Overall Study|Protocol Violation|1|||
25337166|NCT00765882|50653497|FG000|Overall Study|Withdrawal by Subject|2|||
25337167|NCT00765882|50653498|FG001|Overall Study|Withdrawal by Subject|6|||
25337168|NCT00765882|50653499|FG002|Overall Study|Withdrawal by Subject|6|||
25337169|NCT00765882|50653497|FG000|Overall Study|Lost to Follow-up|1|||
25337170|NCT00765882|50653498|FG001|Overall Study|Lost to Follow-up|9|||
25337171|NCT00765882|50653499|FG002|Overall Study|Lost to Follow-up|6|||
25337172|NCT00765882|50653497|FG000|Overall Study|Other Reason|3|||
25337173|NCT00765882|50653498|FG001|Overall Study|Other Reason|1|||
25337174|NCT00765882|50653499|FG002|Overall Study|Other Reason|2|||
25337175|NCT00769860|50653509|FG000|Overall Study|Withdrawal by Subject|2|||
25337176|NCT00769860|50653510|FG001|Overall Study|Withdrawal by Subject|0|||
25337177|NCT00858143|50653516|FG000|Overall Study|Adverse Event|16|||
25337178|NCT00858143|50653516|FG000|Overall Study|Lack of Efficacy|4|||
25337179|NCT00858143|50653516|FG000|Overall Study|Death|7|||
25337180|NCT00858143|50653516|FG000|Overall Study|Other|23|||
25337181|NCT00828113|50653522|FG000|Overall Study|Withdrawal by Subject|27|||
25337182|NCT00828113|50653523|FG001|Overall Study|Withdrawal by Subject|26|||
25337183|NCT00828113|50653522|FG000|Overall Study|Lost to Follow-up|3|||
25337184|NCT00828113|50653523|FG001|Overall Study|Lost to Follow-up|5|||
25337185|NCT00769704|50653531|FG000|Overall Study|Lost to Follow-up|3|||
25337186|NCT00769704|50653532|FG001|Overall Study|Lost to Follow-up|2|||
25337187|NCT00769704|50653531|FG000|Overall Study|Death|95|||
25337188|NCT00769704|50653532|FG001|Overall Study|Death|190|||
25337189|NCT00769704|50653531|FG000|Overall Study|Withdrawal by Subject|12|||
25337190|NCT00769704|50653532|FG001|Overall Study|Withdrawal by Subject|5|||
25337191|NCT00769704|50653531|FG000|Overall Study|Other|1|||
25337192|NCT00769704|50653532|FG001|Overall Study|Other|2|||
25337193|NCT00818753|50653542|FG000|Overall Study|Protocol Violation|1|||
25337194|NCT00818753|50653543|FG001|Overall Study|Protocol Violation|0|||
25337195|NCT00818753|50653544|FG002|Overall Study|Protocol Violation|0|||
25337196|NCT00818753|50653542|FG000|Overall Study|Other reason (not specified)|0|||
25253593|NCT01201798|50569238|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
25337197|NCT00818753|50653543|FG001|Overall Study|Other reason (not specified)|0|||
25337198|NCT00818753|50653544|FG002|Overall Study|Other reason (not specified)|1|||
25337199|NCT00818753|50653542|FG000|Overall Study|Randomised and not treated|2|||
25337200|NCT00818753|50653543|FG001|Overall Study|Randomised and not treated|0|||
25337201|NCT00818753|50653544|FG002|Overall Study|Randomised and not treated|0|||
25337202|NCT00765726|50653552|FG000|Overall Study|Withdrawal by Subject|1|||
25337203|NCT00765726|50653552|FG000|Overall Study|Discontinuation of study by sponsor|8|||
24977416|NCT00048542|50065999|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
24977417|NCT00048542|50066000|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
25253594|NCT01201798|50569239|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
25253595|NCT01201798|50569238|FG000|Overall Study|Noncompliance|1|||
25253596|NCT01201798|50569239|FG001|Overall Study|Noncompliance|0|||
25253597|NCT01201798|50569238|FG000|Overall Study|Protocol Violation|1|||
25253598|NCT01201798|50569239|FG001|Overall Study|Protocol Violation|1|||
25253599|NCT01201798|50569238|FG000|Overall Study|Treatment Failure|1|||
25253600|NCT01201798|50569239|FG001|Overall Study|Treatment Failure|8|||
25253601|NCT01201759|50569247|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
25253602|NCT01201759|50569248|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
25253603|NCT01201759|50569247|FG000|Visit 3 - Washout|Adverse Event|0|||
25253604|NCT01201759|50569248|FG001|Visit 3 - Washout|Adverse Event|3|||
25253605|NCT01201759|50569247|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
25337204|NCT00765336|50653558|FG000|Overall Study|Protocol Violation|4|||
25337205|NCT00765336|50653559|FG001|Overall Study|Protocol Violation|2|||
25337206|NCT00765336|50653558|FG000|Overall Study|Withdrawal by Subject|6|||
25337207|NCT00765336|50653559|FG001|Overall Study|Withdrawal by Subject|4|||
25337208|NCT00765336|50653558|FG000|Overall Study|Lost to Follow-up|7|||
25337209|NCT00765336|50653559|FG001|Overall Study|Lost to Follow-up|9|||
25337210|NCT00765336|50653558|FG000|Overall Study|Adverse Event|2|||
25337211|NCT00765336|50653559|FG001|Overall Study|Adverse Event|1|||
25337212|NCT00818519|50653567|FG000|Overall Study|Adverse Event|2|||
25337213|NCT00818519|50653568|FG001|Overall Study|Adverse Event|2|||
25337214|NCT00818519|50653567|FG000|Overall Study|Lost to Follow-up|4|||
25337215|NCT00818519|50653568|FG001|Overall Study|Lost to Follow-up|6|||
25077968|NCT02228980|50186114|FG002|Overall Study|Adverse Event|0|||
25077969|NCT02228980|50186115|FG003|Overall Study|Adverse Event|0|||
25077970|NCT02228980|50186112|FG000|Overall Study|Protocol Violation|7|||
25077971|NCT02228980|50186113|FG001|Overall Study|Protocol Violation|0|||
25077972|NCT02228980|50186114|FG002|Overall Study|Protocol Violation|0|||
25253606|NCT01201759|50569248|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
25253607|NCT01201759|50569247|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
25253608|NCT01201759|50569248|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
25253609|NCT01200589|50569258|FG000|Overall Study|Withdrawal by Subject|13|||
25253610|NCT01200589|50569259|FG001|Overall Study|Withdrawal by Subject|11|||
25253611|NCT01200589|50569258|FG000|Overall Study|Physician Decision|2|||
25253612|NCT01200589|50569259|FG001|Overall Study|Physician Decision|2|||
25253613|NCT01200589|50569258|FG000|Overall Study|Lost to Follow-up|5|||
25253614|NCT01200589|50569259|FG001|Overall Study|Lost to Follow-up|4|||
25253615|NCT01200589|50569258|FG000|Overall Study|Study terminated|170|||
25253616|NCT01200589|50569259|FG001|Overall Study|Study terminated|172|||
25253617|NCT01200511|50569265|FG000|Overall Study|Lost to Follow-up|3|||
25253618|NCT01200511|50569265|FG000|Overall Study|Withdrawal by Subject|1|||
25253619|NCT01200511|50569265|FG000|Overall Study|Adverse Event|1|||
25253620|NCT01179334|50569273|FG000|Treatment Period|Adverse Event|1|||
25253621|NCT01179334|50569274|FG001|Treatment Period|Adverse Event|0|||
25253622|NCT01179334|50569273|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
25253623|NCT01179334|50569274|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
25253624|NCT01179334|50569273|FG000|Long-term Extension (LTE) Period|Death|3|||
25253625|NCT01179334|50569274|FG001|Long-term Extension (LTE) Period|Death|0|||
25253626|NCT01179334|50569273|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
25253627|NCT01179334|50569274|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
25253628|NCT01178671|50569282|FG000|Overall Study|Adverse Event|4|||
25253629|NCT01178671|50569283|FG001|Overall Study|Adverse Event|6|||
25253630|NCT01178671|50569282|FG000|Overall Study|Protocol Violation|1|||
25253631|NCT01178671|50569283|FG001|Overall Study|Protocol Violation|1|||
25253632|NCT01178671|50569282|FG000|Overall Study|Lack of Efficacy|0|||
25253633|NCT01178671|50569283|FG001|Overall Study|Lack of Efficacy|1|||
25253634|NCT01178671|50569282|FG000|Overall Study|Lost to Follow-up|3|||
25253635|NCT01178671|50569283|FG001|Overall Study|Lost to Follow-up|1|||
25253636|NCT01178671|50569282|FG000|Overall Study|Physician Decision|4|||
25253637|NCT01178671|50569283|FG001|Overall Study|Physician Decision|6|||
25253638|NCT01178125|50569289|FG000|Overall Study|Lost to Follow-up|397|||
25253639|NCT01178125|50569289|FG000|Overall Study|Adverse Event|244|||
25253640|NCT01178125|50569289|FG000|Overall Study|Withdrawal by Subject|209|||
25253641|NCT01178125|50569289|FG000|Overall Study|Noncompliance|184|||
25253642|NCT01178125|50569289|FG000|Overall Study|Pregnancy|55|||
25253643|NCT01178125|50569289|FG000|Overall Study|Other Reason|39|||
25253644|NCT01178125|50569289|FG000|Overall Study|Sponsor Decision|28|||
25253645|NCT01178125|50569289|FG000|Overall Study|Protocol Violation|17|||
25253646|NCT01178125|50569289|FG000|Overall Study|Investigator Decision|5|||
25253647|NCT01178086|50569311|FG000|Overall Study|Participant refusal|7|||
25253648|NCT01178086|50569311|FG000|Overall Study|Physician Decision|44|||
25253649|NCT01178086|50569311|FG000|Overall Study|Switch to other CLL therapy|113|||
25253650|NCT01178086|50569311|FG000|Overall Study|Death|59|||
25253651|NCT01178086|50569311|FG000|Overall Study|Other unspecified|89|||
25253652|NCT01178086|50569311|FG000|Overall Study|Excluded from EAS|20|||
25253653|NCT01177969|50569319|FG000|Overall Study|Protocol Violation|2|||
25253654|NCT01177969|50569320|FG001|Overall Study|Protocol Violation|1|||
25253655|NCT01177969|50569319|FG000|Overall Study|Withdrawal by Subject|1|||
25253656|NCT01177969|50569320|FG001|Overall Study|Withdrawal by Subject|2|||
25253657|NCT01177813|50569331|FG000|Overall Study|Adverse Event|8|||
25253658|NCT01177813|50569332|FG001|Overall Study|Adverse Event|2|||
25253659|NCT01177813|50569333|FG002|Overall Study|Adverse Event|4|||
25253660|NCT01177813|50569334|FG003|Overall Study|Adverse Event|6|||
25253661|NCT01177813|50569335|FG004|Overall Study|Adverse Event|3|||
25253662|NCT01177813|50569331|FG000|Overall Study|Lack of Efficacy|1|||
25253663|NCT01177813|50569332|FG001|Overall Study|Lack of Efficacy|0|||
25077973|NCT02228980|50186115|FG003|Overall Study|Protocol Violation|0|||
25253664|NCT01177813|50569333|FG002|Overall Study|Lack of Efficacy|0|||
25253665|NCT01177813|50569334|FG003|Overall Study|Lack of Efficacy|0|||
25253666|NCT01177813|50569335|FG004|Overall Study|Lack of Efficacy|0|||
25337216|NCT00818519|50653567|FG000|Overall Study|Protocol Violation|2|||
25077974|NCT02228980|50186112|FG000|Overall Study|Withdrawal by Subject|3|||
25077975|NCT02228980|50186113|FG001|Overall Study|Withdrawal by Subject|3|||
25253667|NCT01177813|50569331|FG000|Overall Study|Protocol Violation|3|||
25253668|NCT01177813|50569332|FG001|Overall Study|Protocol Violation|2|||
25253669|NCT01177813|50569333|FG002|Overall Study|Protocol Violation|2|||
25253670|NCT01177813|50569334|FG003|Overall Study|Protocol Violation|0|||
25253671|NCT01177813|50569335|FG004|Overall Study|Protocol Violation|1|||
25253672|NCT01177813|50569331|FG000|Overall Study|Lost to Follow-up|12|||
25253673|NCT01177813|50569332|FG001|Overall Study|Lost to Follow-up|5|||
25253674|NCT01177813|50569333|FG002|Overall Study|Lost to Follow-up|6|||
25253675|NCT01177813|50569334|FG003|Overall Study|Lost to Follow-up|3|||
25253676|NCT01177813|50569335|FG004|Overall Study|Lost to Follow-up|0|||
25253677|NCT01177813|50569331|FG000|Overall Study|Withdrawal by Subject|12|||
25253678|NCT01177813|50569332|FG001|Overall Study|Withdrawal by Subject|7|||
25253679|NCT01177813|50569333|FG002|Overall Study|Withdrawal by Subject|6|||
25253680|NCT01177813|50569334|FG003|Overall Study|Withdrawal by Subject|5|||
25253681|NCT01177813|50569335|FG004|Overall Study|Withdrawal by Subject|3|||
25253682|NCT01177813|50569331|FG000|Overall Study|Other reason not defined above|5|||
25253683|NCT01177813|50569332|FG001|Overall Study|Other reason not defined above|2|||
25253684|NCT01177813|50569333|FG002|Overall Study|Other reason not defined above|2|||
25253685|NCT01177813|50569334|FG003|Overall Study|Other reason not defined above|3|||
25253686|NCT01177813|50569335|FG004|Overall Study|Other reason not defined above|2|||
25253687|NCT01200394|50569349|FG000|Overall Study|Adverse Event|0|||
25253688|NCT01200394|50569350|FG001|Overall Study|Adverse Event|14|||
25253689|NCT01200394|50569349|FG000|Overall Study|Death|1|||
25253690|NCT01200394|50569350|FG001|Overall Study|Death|0|||
25253691|NCT01200394|50569349|FG000|Overall Study|Lost to Follow-up|0|||
25253692|NCT01200394|50569350|FG001|Overall Study|Lost to Follow-up|1|||
25253693|NCT01200394|50569349|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
25253694|NCT01200394|50569350|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
25253695|NCT01200394|50569349|FG000|Overall Study|Protocol Violation|0|||
25253696|NCT01200394|50569350|FG001|Overall Study|Protocol Violation|3|||
25253697|NCT01200394|50569349|FG000|Overall Study|Withdrawal by Subject|0|||
25253698|NCT01200394|50569350|FG001|Overall Study|Withdrawal by Subject|5|||
25253699|NCT01200394|50569349|FG000|Overall Study|Other|0|||
25253700|NCT01200394|50569350|FG001|Overall Study|Other|1|||
25253701|NCT01200355|50569359|FG000|Overall Study|Death|7|||
25253702|NCT01200355|50569360|FG001|Overall Study|Death|2|||
25253703|NCT01200238|50569368|FG000|Overall Study|Adverse Event|2|||
25253704|NCT01200238|50569369|FG001|Overall Study|Adverse Event|1|||
25253705|NCT01200238|50569368|FG000|Overall Study|Progressive Disease|5|||
25253706|NCT01200238|50569369|FG001|Overall Study|Progressive Disease|8|||
25253707|NCT01200238|50569368|FG000|Overall Study|Withdrawal by Subject|0|||
25253708|NCT01200238|50569369|FG001|Overall Study|Withdrawal by Subject|1|||
25253709|NCT01199731|50569378|FG000|Overall Study|Adverse Event|0|||
25253710|NCT01199731|50569379|FG001|Overall Study|Adverse Event|1|||
25253711|NCT01199731|50569380|FG002|Overall Study|Adverse Event|0|||
25253712|NCT01199731|50569378|FG000|Overall Study|Study closed/terminated|7|||
25253713|NCT01199731|50569379|FG001|Overall Study|Study closed/terminated|9|||
25253714|NCT01199731|50569380|FG002|Overall Study|Study closed/terminated|7|||
25253715|NCT01199731|50569378|FG000|Overall Study|Lost to Follow-up|0|||
25253716|NCT01199731|50569379|FG001|Overall Study|Lost to Follow-up|0|||
25253717|NCT01199731|50569380|FG002|Overall Study|Lost to Follow-up|2|||
25253718|NCT01199731|50569378|FG000|Overall Study|Physician Decision|0|||
25253719|NCT01199731|50569379|FG001|Overall Study|Physician Decision|1|||
25253720|NCT01199731|50569380|FG002|Overall Study|Physician Decision|1|||
25253721|NCT01199731|50569378|FG000|Overall Study|Withdrawal by Subject|2|||
25253722|NCT01199731|50569379|FG001|Overall Study|Withdrawal by Subject|0|||
25253723|NCT01199731|50569380|FG002|Overall Study|Withdrawal by Subject|0|||
25337217|NCT00818519|50653568|FG001|Overall Study|Protocol Violation|1|||
25337218|NCT00818519|50653567|FG000|Overall Study|Pregnancy|0|||
25337219|NCT00818519|50653568|FG001|Overall Study|Pregnancy|1|||
25337220|NCT00818519|50653567|FG000|Overall Study|Withdrawal by Subject|4|||
25337221|NCT00818519|50653568|FG001|Overall Study|Withdrawal by Subject|9|||
25337222|NCT00818519|50653567|FG000|Overall Study|participant recovered completely|1|||
25337223|NCT00818519|50653568|FG001|Overall Study|participant recovered completely|0|||
25337224|NCT00818519|50653567|FG000|Overall Study|participant will leave for long tme|1|||
25337225|NCT00818519|50653568|FG001|Overall Study|participant will leave for long tme|0|||
25337226|NCT00827567|50653574|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
25337227|NCT00765102|50653578|FG000|Overall Study|Progressive disease|18|||
25337228|NCT00765102|50653578|FG000|Overall Study|Adverse Event|6|||
25337229|NCT00765102|50653578|FG000|Overall Study|Physician Decision|4|||
25253724|NCT01199263|50569390|FG000|Overall Study|Ineligible|0|||
25253725|NCT01199263|50569391|FG001|Overall Study|Ineligible|2|||
25253726|NCT01199263|50569390|FG000|Overall Study|Never Treated|6|||
25253727|NCT01199263|50569391|FG001|Overall Study|Never Treated|0|||
25253728|NCT01199068|50569402|FG000|Overall Study|Unacceptable toxicity|0|||
25253729|NCT01199068|50569403|FG001|Overall Study|Unacceptable toxicity|0|||
25253730|NCT01199068|50569404|FG002|Overall Study|Unacceptable toxicity|2|||
25253731|NCT01199068|50569402|FG000|Overall Study|Progressive disease|3|||
24977418|NCT00048542|50066001|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
25253732|NCT01199068|50569403|FG001|Overall Study|Progressive disease|3|||
25253733|NCT01199068|50569404|FG002|Overall Study|Progressive disease|6|||
25253734|NCT01199068|50569402|FG000|Overall Study|Withdrawal by Subject|0|||
25253735|NCT01199068|50569403|FG001|Overall Study|Withdrawal by Subject|0|||
25253736|NCT01199068|50569404|FG002|Overall Study|Withdrawal by Subject|1|||
25253737|NCT01198873|50569421|FG000|Overall Study|Adverse Event|4|||
25253738|NCT01198873|50569422|FG001|Overall Study|Adverse Event|7|||
25253739|NCT01198873|50569421|FG000|Overall Study|Study closure|29|||
25253740|NCT01198873|50569422|FG001|Overall Study|Study closure|23|||
25253741|NCT01198873|50569421|FG000|Overall Study|Other than above|4|||
25253742|NCT01198873|50569422|FG001|Overall Study|Other than above|2|||
25253743|NCT01198795|50569428|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
25253744|NCT01198795|50569428|FG000|Overall Study|Withdrawal by Subject|17|||
25253745|NCT01198795|50569428|FG000|Overall Study|Lost to Follow-up|15|||
25253746|NCT01198795|50569428|FG000|Overall Study|Adverse Event|9|||
25253747|NCT01198795|50569428|FG000|Overall Study|Lack of Efficacy|5|||
25253748|NCT01198795|50569428|FG000|Overall Study|Protocol Violation|2|||
25253749|NCT01198795|50569428|FG000|Overall Study|Other Reason|4|||
25253750|NCT01198756|50569436|FG000|Overall Study|Adverse Event|0|||
25253751|NCT01198756|50569437|FG001|Overall Study|Adverse Event|0|||
25253752|NCT01198756|50569438|FG002|Overall Study|Adverse Event|0|||
25253753|NCT01198756|50569439|FG003|Overall Study|Adverse Event|1|||
25253754|NCT01198756|50569436|FG000|Overall Study|Protocol Violation|0|||
25253755|NCT01198756|50569437|FG001|Overall Study|Protocol Violation|0|||
25253756|NCT01198756|50569438|FG002|Overall Study|Protocol Violation|0|||
25253757|NCT01198756|50569439|FG003|Overall Study|Protocol Violation|2|||
25253758|NCT01198756|50569436|FG000|Overall Study|Withdrawal by Subject|9|||
25253759|NCT01198756|50569437|FG001|Overall Study|Withdrawal by Subject|4|||
25253760|NCT01198756|50569438|FG002|Overall Study|Withdrawal by Subject|7|||
25253761|NCT01198756|50569439|FG003|Overall Study|Withdrawal by Subject|5|||
25253762|NCT01198756|50569436|FG000|Overall Study|Lost to Follow-up|29|||
25253763|NCT01198756|50569437|FG001|Overall Study|Lost to Follow-up|36|||
25253764|NCT01198756|50569438|FG002|Overall Study|Lost to Follow-up|23|||
25253765|NCT01198756|50569439|FG003|Overall Study|Lost to Follow-up|18|||
25253766|NCT01198600|50569456|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
25253767|NCT01198600|50569457|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
25253768|NCT01198600|50569458|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
25253769|NCT01198600|50569459|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
25253770|NCT01198600|50569456|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
25253771|NCT01198600|50569457|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
25253772|NCT01198600|50569458|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
25253773|NCT01198600|50569459|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
25253774|NCT01198600|50569456|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
25253775|NCT01198600|50569457|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
25253776|NCT01198600|50569458|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
25253777|NCT01198600|50569459|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
25253778|NCT01198600|50569456|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
25253779|NCT01198600|50569457|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
25253780|NCT01198600|50569458|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
25337230|NCT00765102|50653578|FG000|Overall Study|Withdrawal by Subject|2|||
25337231|NCT00765102|50653578|FG000|Overall Study|Protocol Violation|1|||
25337232|NCT00809354|50653594|FG000|Overall Study|Adverse Event|32|||
25337233|NCT00809354|50653595|FG001|Overall Study|Adverse Event|45|||
25337234|NCT00809354|50653596|FG002|Overall Study|Adverse Event|37|||
25337235|NCT00809354|50653597|FG003|Overall Study|Adverse Event|53|||
25337236|NCT00809354|50653598|FG004|Overall Study|Adverse Event|26|||
25337237|NCT00809354|50653599|FG005|Overall Study|Adverse Event|33|||
25337238|NCT00809354|50653600|FG006|Overall Study|Adverse Event|44|||
25337239|NCT00809354|50653601|FG007|Overall Study|Adverse Event|40|||
25337240|NCT00809354|50653602|FG008|Overall Study|Adverse Event|46|||
25337241|NCT00809354|50653603|FG009|Overall Study|Adverse Event|26|||
25337242|NCT00809354|50653594|FG000|Overall Study|Lack of Efficacy|23|||
25337243|NCT00809354|50653595|FG001|Overall Study|Lack of Efficacy|23|||
25337244|NCT00809354|50653596|FG002|Overall Study|Lack of Efficacy|22|||
25337245|NCT00809354|50653597|FG003|Overall Study|Lack of Efficacy|15|||
25337246|NCT00809354|50653598|FG004|Overall Study|Lack of Efficacy|40|||
25337247|NCT00809354|50653599|FG005|Overall Study|Lack of Efficacy|19|||
25337248|NCT00809354|50653600|FG006|Overall Study|Lack of Efficacy|21|||
25337249|NCT00809354|50653601|FG007|Overall Study|Lack of Efficacy|15|||
25337250|NCT00809354|50653602|FG008|Overall Study|Lack of Efficacy|18|||
25253781|NCT01198600|50569459|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
25253782|NCT01198600|50569456|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
25253783|NCT01198600|50569457|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
25253784|NCT01198600|50569458|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
25337251|NCT00809354|50653603|FG009|Overall Study|Lack of Efficacy|38|||
25337252|NCT00809354|50653594|FG000|Overall Study|Lost to Follow-up|10|||
25337253|NCT00809354|50653595|FG001|Overall Study|Lost to Follow-up|11|||
25337254|NCT00809354|50653596|FG002|Overall Study|Lost to Follow-up|8|||
25337255|NCT00809354|50653597|FG003|Overall Study|Lost to Follow-up|13|||
25337256|NCT00809354|50653598|FG004|Overall Study|Lost to Follow-up|6|||
25337257|NCT00809354|50653599|FG005|Overall Study|Lost to Follow-up|2|||
25337258|NCT00809354|50653600|FG006|Overall Study|Lost to Follow-up|0|||
25337259|NCT00809354|50653601|FG007|Overall Study|Lost to Follow-up|5|||
25337260|NCT00809354|50653602|FG008|Overall Study|Lost to Follow-up|4|||
25337261|NCT00809354|50653603|FG009|Overall Study|Lost to Follow-up|0|||
25337262|NCT00809354|50653594|FG000|Overall Study|Protocol Violation|7|||
25337263|NCT00809354|50653595|FG001|Overall Study|Protocol Violation|14|||
25337264|NCT00809354|50653596|FG002|Overall Study|Protocol Violation|14|||
25337265|NCT00809354|50653597|FG003|Overall Study|Protocol Violation|12|||
25337266|NCT00809354|50653598|FG004|Overall Study|Protocol Violation|14|||
25337267|NCT00809354|50653599|FG005|Overall Study|Protocol Violation|6|||
25337268|NCT00809354|50653600|FG006|Overall Study|Protocol Violation|4|||
25337269|NCT00809354|50653601|FG007|Overall Study|Protocol Violation|6|||
25337270|NCT00809354|50653602|FG008|Overall Study|Protocol Violation|9|||
25337271|NCT00809354|50653603|FG009|Overall Study|Protocol Violation|3|||
25337272|NCT00809354|50653594|FG000|Overall Study|Withdrawal by Subject|32|||
25337273|NCT00809354|50653595|FG001|Overall Study|Withdrawal by Subject|27|||
25337274|NCT00809354|50653596|FG002|Overall Study|Withdrawal by Subject|31|||
25337275|NCT00809354|50653597|FG003|Overall Study|Withdrawal by Subject|33|||
25337276|NCT00809354|50653598|FG004|Overall Study|Withdrawal by Subject|34|||
25337277|NCT00809354|50653599|FG005|Overall Study|Withdrawal by Subject|29|||
25337278|NCT00809354|50653600|FG006|Overall Study|Withdrawal by Subject|27|||
25337279|NCT00809354|50653601|FG007|Overall Study|Withdrawal by Subject|19|||
25337280|NCT00809354|50653602|FG008|Overall Study|Withdrawal by Subject|18|||
25337281|NCT00809354|50653603|FG009|Overall Study|Withdrawal by Subject|20|||
25337282|NCT00809354|50653594|FG000|Overall Study|Other|10|||
25337283|NCT00809354|50653595|FG001|Overall Study|Other|2|||
25337284|NCT00809354|50653596|FG002|Overall Study|Other|7|||
25337285|NCT00809354|50653597|FG003|Overall Study|Other|10|||
25337286|NCT00809354|50653598|FG004|Overall Study|Other|5|||
25337287|NCT00809354|50653599|FG005|Overall Study|Other|3|||
25337288|NCT00809354|50653600|FG006|Overall Study|Other|2|||
25337289|NCT00809354|50653601|FG007|Overall Study|Other|3|||
25337290|NCT00809354|50653602|FG008|Overall Study|Other|4|||
25337291|NCT00809354|50653603|FG009|Overall Study|Other|3|||
25337292|NCT00809354|50653594|FG000|Overall Study|Study terminated by sponsor|138|||
25337293|NCT00809354|50653595|FG001|Overall Study|Study terminated by sponsor|134|||
25337294|NCT00809354|50653596|FG002|Overall Study|Study terminated by sponsor|129|||
25337295|NCT00809354|50653597|FG003|Overall Study|Study terminated by sponsor|120|||
25337296|NCT00809354|50653598|FG004|Overall Study|Study terminated by sponsor|126|||
25337297|NCT00809354|50653599|FG005|Overall Study|Study terminated by sponsor|133|||
25337298|NCT00809354|50653600|FG006|Overall Study|Study terminated by sponsor|124|||
25337299|NCT00809354|50653601|FG007|Overall Study|Study terminated by sponsor|148|||
25337300|NCT00809354|50653602|FG008|Overall Study|Study terminated by sponsor|127|||
25337301|NCT00809354|50653603|FG009|Overall Study|Study terminated by sponsor|135|||
25337302|NCT00809354|50653594|FG000|Overall Study|Withdrawn due to pregnancy|0|||
25337303|NCT00809354|50653595|FG001|Overall Study|Withdrawn due to pregnancy|1|||
25337304|NCT00809354|50653596|FG002|Overall Study|Withdrawn due to pregnancy|0|||
25337305|NCT00809354|50653597|FG003|Overall Study|Withdrawn due to pregnancy|0|||
25337306|NCT00809354|50653598|FG004|Overall Study|Withdrawn due to pregnancy|0|||
25337307|NCT00809354|50653599|FG005|Overall Study|Withdrawn due to pregnancy|0|||
25337308|NCT00809354|50653600|FG006|Overall Study|Withdrawn due to pregnancy|0|||
25337309|NCT00809354|50653601|FG007|Overall Study|Withdrawn due to pregnancy|0|||
25337310|NCT00809354|50653602|FG008|Overall Study|Withdrawn due to pregnancy|0|||
25337311|NCT00809354|50653603|FG009|Overall Study|Withdrawn due to pregnancy|0|||
25337312|NCT00809354|50653594|FG000|Overall Study|Randomized but not Treated|3|||
25337313|NCT00809354|50653595|FG001|Overall Study|Randomized but not Treated|1|||
25337314|NCT00809354|50653596|FG002|Overall Study|Randomized but not Treated|6|||
25337315|NCT00809354|50653597|FG003|Overall Study|Randomized but not Treated|0|||
25337316|NCT00809354|50653598|FG004|Overall Study|Randomized but not Treated|5|||
25337317|NCT00809354|50653599|FG005|Overall Study|Randomized but not Treated|0|||
25337318|NCT00809354|50653600|FG006|Overall Study|Randomized but not Treated|1|||
25337319|NCT00809354|50653601|FG007|Overall Study|Randomized but not Treated|1|||
25337320|NCT00809354|50653602|FG008|Overall Study|Randomized but not Treated|2|||
25337321|NCT00809354|50653603|FG009|Overall Study|Randomized but not Treated|1|||
24902405|NCT00678561|49996466|FG002|Overall Study|Protocol Violation|0|||
25337322|NCT00809354|50653594|FG000|Overall Study|Death|0|||
25337323|NCT00809354|50653595|FG001|Overall Study|Death|0|||
25337324|NCT00809354|50653596|FG002|Overall Study|Death|0|||
25337325|NCT00809354|50653597|FG003|Overall Study|Death|0|||
25337326|NCT00809354|50653598|FG004|Overall Study|Death|0|||
25337327|NCT00809354|50653599|FG005|Overall Study|Death|0|||
25337328|NCT00809354|50653600|FG006|Overall Study|Death|0|||
25337329|NCT00809354|50653601|FG007|Overall Study|Death|1|||
25337330|NCT00809354|50653602|FG008|Overall Study|Death|0|||
25337331|NCT00809354|50653603|FG009|Overall Study|Death|0|||
25337332|NCT00834899|50653632|FG000|Overall Study|Withdrawal by Subject|1|||
25337333|NCT00834899|50653633|FG001|Overall Study|Withdrawal by Subject|1|||
25337334|NCT00764946|50653642|FG000|Overall Study|Lack of Efficacy|1|||
25337335|NCT00764946|50653643|FG001|Overall Study|Lack of Efficacy|0|||
25337336|NCT00764946|50653644|FG002|Overall Study|Lack of Efficacy|0|||
25337337|NCT00764946|50653642|FG000|Overall Study|Lost to Follow-up|3|||
25337338|NCT00764946|50653643|FG001|Overall Study|Lost to Follow-up|4|||
25337339|NCT00764946|50653644|FG002|Overall Study|Lost to Follow-up|0|||
25337340|NCT00764946|50653642|FG000|Overall Study|Physician Decision|2|||
25337341|NCT00764946|50653643|FG001|Overall Study|Physician Decision|4|||
25337342|NCT00764946|50653644|FG002|Overall Study|Physician Decision|0|||
25337343|NCT00764946|50653642|FG000|Overall Study|Adverse Event|3|||
25337344|NCT00764946|50653643|FG001|Overall Study|Adverse Event|2|||
25337345|NCT00764946|50653644|FG002|Overall Study|Adverse Event|1|||
25337346|NCT00764946|50653642|FG000|Overall Study|Withdrawal by Subject|3|||
25337347|NCT00764946|50653643|FG001|Overall Study|Withdrawal by Subject|6|||
25337348|NCT00764946|50653644|FG002|Overall Study|Withdrawal by Subject|2|||
25337349|NCT00764946|50653642|FG000|Overall Study|Never Treated|1|||
25337350|NCT00764946|50653643|FG001|Overall Study|Never Treated|1|||
25253785|NCT01198600|50569459|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
25253786|NCT01198600|50569456|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
25253787|NCT01198600|50569457|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
25253788|NCT01198600|50569458|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
25253789|NCT01198600|50569459|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
25253790|NCT01198600|50569456|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
25253791|NCT01198600|50569457|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
25253792|NCT01198600|50569458|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
25253793|NCT01198600|50569459|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
25253794|NCT01198132|50569469|FG000|Overall Study|Withdrawal by Subject|4|||
25253795|NCT01198132|50569470|FG001|Overall Study|Withdrawal by Subject|5|||
25253796|NCT01198132|50569469|FG000|Overall Study|Physician Decision|5|||
25253797|NCT01198132|50569470|FG001|Overall Study|Physician Decision|4|||
25253798|NCT01198132|50569469|FG000|Overall Study|Other Unspecified|3|||
25253799|NCT01198132|50569470|FG001|Overall Study|Other Unspecified|6|||
25253800|NCT01198132|50569469|FG000|Overall Study|Lack of Efficacy|2|||
25253801|NCT01198132|50569470|FG001|Overall Study|Lack of Efficacy|3|||
25253802|NCT01198132|50569469|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
25253803|NCT01198132|50569470|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
25253804|NCT01198132|50569469|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
25253805|NCT01198132|50569470|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
25253806|NCT01198132|50569469|FG000|Overall Study|Adverse Event|0|||
25253807|NCT01198132|50569470|FG001|Overall Study|Adverse Event|1|||
25253808|NCT01198132|50569469|FG000|Overall Study|Protocol Violation|1|||
25253809|NCT01198132|50569470|FG001|Overall Study|Protocol Violation|0|||
25253810|NCT01197508|50569482|FG000|Overall Study|Withdrawal by Subject|8|||
25253811|NCT01197508|50569483|FG001|Overall Study|Withdrawal by Subject|7|||
25253812|NCT01197508|50569484|FG002|Overall Study|Withdrawal by Subject|15|||
25253813|NCT01197508|50569485|FG003|Overall Study|Withdrawal by Subject|4|||
25253814|NCT01197508|50569482|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
25337351|NCT00764946|50653644|FG002|Overall Study|Never Treated|1|||
25337352|NCT00764868|50653658|FG000|Overall Study|Adverse Event|18|||
25337353|NCT00764868|50653658|FG000|Overall Study|Withdrawal by Subject|31|||
25337354|NCT00764868|50653658|FG000|Overall Study|Non-compliance|16|||
25337355|NCT00764868|50653658|FG000|Overall Study|Lost to Follow-up|25|||
25337356|NCT00764868|50653658|FG000|Overall Study|Lack of Efficacy|5|||
25337357|NCT00764868|50653658|FG000|Overall Study|Subject moved|7|||
25337358|NCT00764868|50653658|FG000|Overall Study|Pregnancy|3|||
25337359|NCT00764868|50653658|FG000|Overall Study|Prohibited medication|1|||
25337360|NCT00764868|50653658|FG000|Overall Study|Out of town|1|||
25337361|NCT00764868|50653658|FG000|Overall Study|Misuse and compliance of study drug|1|||
25337362|NCT00764868|50653658|FG000|Overall Study|Subject sent to boarding school|1|||
25337363|NCT00764868|50653658|FG000|Overall Study|Met an exclusion criteria|1|||
25337364|NCT00764868|50653658|FG000|Overall Study|Positive drug screen|2|||
24977419|NCT00048542|50066002|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
25253815|NCT01197508|50569483|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
25253816|NCT01197508|50569484|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
25253817|NCT01197508|50569485|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
25253818|NCT01197508|50569482|FG000|Overall Study|Adverse Event|10|||
25253819|NCT01197508|50569483|FG001|Overall Study|Adverse Event|13|||
25253820|NCT01197508|50569484|FG002|Overall Study|Adverse Event|23|||
25253821|NCT01197508|50569485|FG003|Overall Study|Adverse Event|3|||
25253822|NCT01197508|50569482|FG000|Overall Study|Severe non-compliance to protocol|0|||
25253823|NCT01197508|50569483|FG001|Overall Study|Severe non-compliance to protocol|3|||
25337365|NCT00764868|50653658|FG000|Overall Study|Sponsor requested withdrawal|1|||
25337366|NCT00764790|50653665|FG000|Overall Study|Protocol Violation|0|||
25337367|NCT00764790|50653666|FG001|Overall Study|Protocol Violation|0|||
25337368|NCT00764790|50653667|FG002|Overall Study|Protocol Violation|1|||
25337369|NCT00764790|50653665|FG000|Overall Study|Withdrawal by Subject|10|||
25337370|NCT00764790|50653666|FG001|Overall Study|Withdrawal by Subject|12|||
25337371|NCT00764790|50653667|FG002|Overall Study|Withdrawal by Subject|6|||
25337372|NCT00764790|50653665|FG000|Overall Study|Lost to Follow-up|28|||
25337373|NCT00764790|50653666|FG001|Overall Study|Lost to Follow-up|29|||
25337374|NCT00764790|50653667|FG002|Overall Study|Lost to Follow-up|23|||
25337375|NCT00756444|50653677|FG000|Overall Study|Adverse Event|1|||
25337376|NCT00756444|50653678|FG001|Overall Study|Adverse Event|1|||
25337377|NCT00756444|50653677|FG000|Overall Study|Withdrawal by Subject|6|||
25337378|NCT00756444|50653678|FG001|Overall Study|Withdrawal by Subject|8|||
25337379|NCT00756444|50653677|FG000|Overall Study|Lost to Follow-up|0|||
25337380|NCT00756444|50653678|FG001|Overall Study|Lost to Follow-up|1|||
25337381|NCT00756444|50653677|FG000|Overall Study|Death|5|||
25337382|NCT00756444|50653678|FG001|Overall Study|Death|4|||
25337383|NCT00756444|50653677|FG000|Overall Study|Disease Progression|2|||
25337384|NCT00756444|50653678|FG001|Overall Study|Disease Progression|7|||
25337385|NCT00756444|50653677|FG000|Overall Study|Ineligibility Determined|1|||
25337386|NCT00756444|50653678|FG001|Overall Study|Ineligibility Determined|0|||
25337387|NCT00769002|50653689|FG000|Overall Study|Study was not completed, no data|9|||
25337388|NCT00769002|50653690|FG001|Overall Study|Study was not completed, no data|9|||
25337389|NCT00753012|50653697|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
25337390|NCT00753012|50653698|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
25337391|NCT00753012|50653697|FG000|Overall Study|Adverse Event|2|||
25337392|NCT00753012|50653698|FG001|Overall Study|Adverse Event|0|||
25253824|NCT01197508|50569484|FG002|Overall Study|Severe non-compliance to protocol|1|||
25253825|NCT01197508|50569485|FG003|Overall Study|Severe non-compliance to protocol|3|||
25253826|NCT01197508|50569482|FG000|Overall Study|Condition under investigation worsened|1|||
25253827|NCT01197508|50569483|FG001|Overall Study|Condition under investigation worsened|1|||
25253828|NCT01197508|50569484|FG002|Overall Study|Condition under investigation worsened|1|||
25253829|NCT01197508|50569485|FG003|Overall Study|Condition under investigation worsened|1|||
25337393|NCT00753012|50653697|FG000|Overall Study|Withdrawal by Subject|0|||
25337394|NCT00753012|50653698|FG001|Overall Study|Withdrawal by Subject|1|||
25337395|NCT00753012|50653697|FG000|Overall Study|Lost to Follow-up|4|||
25337396|NCT00753012|50653698|FG001|Overall Study|Lost to Follow-up|0|||
25337397|NCT00753012|50653697|FG000|Overall Study|Confounded endpoint data|1|||
25337398|NCT00753012|50653698|FG001|Overall Study|Confounded endpoint data|0|||
25337399|NCT00806156|50653707|FG000|Overall Study|Death|35|||
25337400|NCT00806156|50653708|FG001|Overall Study|Death|95|||
25077976|NCT02228980|50186114|FG002|Overall Study|Withdrawal by Subject|2|||
25077977|NCT02228980|50186115|FG003|Overall Study|Withdrawal by Subject|3|||
25077978|NCT02228590|50186129|FG000|Overall Study|Withdrawal by Subject|1|||
25077979|NCT02227108|50186134|FG000|Overall Study|Did not receive treatment|2|||
25253830|NCT01197508|50569482|FG000|Overall Study|Lack of Efficacy|1|||
25253831|NCT01197508|50569483|FG001|Overall Study|Lack of Efficacy|2|||
25253832|NCT01197508|50569484|FG002|Overall Study|Lack of Efficacy|2|||
25253833|NCT01197508|50569485|FG003|Overall Study|Lack of Efficacy|1|||
25337401|NCT00806156|50653707|FG000|Overall Study|Did not meet eligibility criteria|1|||
25337402|NCT00806156|50653708|FG001|Overall Study|Did not meet eligibility criteria|0|||
25337403|NCT00806156|50653707|FG000|Overall Study|Study terminated by Sponsor|2|||
25337404|NCT00806156|50653708|FG001|Overall Study|Study terminated by Sponsor|40|||
25253834|NCT01197508|50569482|FG000|Overall Study|Study-specific withdrawal criteria|0|||
25337405|NCT00806156|50653707|FG000|Overall Study|Consent withdrawn by subject|1|||
25337406|NCT00806156|50653708|FG001|Overall Study|Consent withdrawn by subject|3|||
25337407|NCT00806156|50653707|FG000|Overall Study|Lost to Follow-up|0|||
25337408|NCT00806156|50653708|FG001|Overall Study|Lost to Follow-up|1|||
25337409|NCT00764478|50653729|FG000|Overall Study|Adverse Event|1|||
25337410|NCT00764478|50653730|FG001|Overall Study|Adverse Event|1|||
25337411|NCT00764478|50653731|FG002|Overall Study|Adverse Event|1|||
25337412|NCT00764478|50653729|FG000|Overall Study|Withdrawal by Subject|7|||
25253835|NCT01197508|50569483|FG001|Overall Study|Study-specific withdrawal criteria|0|||
25253836|NCT01197508|50569484|FG002|Overall Study|Study-specific withdrawal criteria|1|||
25253837|NCT01197508|50569485|FG003|Overall Study|Study-specific withdrawal criteria|2|||
25253838|NCT01197508|50569482|FG000|Overall Study|Lost to Follow-up|1|||
25253839|NCT01197508|50569483|FG001|Overall Study|Lost to Follow-up|1|||
25337413|NCT00764478|50653730|FG001|Overall Study|Withdrawal by Subject|12|||
24902406|NCT00678561|49996467|FG003|Overall Study|Protocol Violation|0|||
25253840|NCT01197508|50569484|FG002|Overall Study|Lost to Follow-up|2|||
25253841|NCT01197508|50569485|FG003|Overall Study|Lost to Follow-up|0|||
25253842|NCT01197508|50569482|FG000|Overall Study|Other|2|||
25253843|NCT01197508|50569483|FG001|Overall Study|Other|3|||
25253844|NCT01197508|50569484|FG002|Overall Study|Other|2|||
25253845|NCT01197508|50569485|FG003|Overall Study|Other|2|||
25253846|NCT01196416|50569502|FG000|Overall Study|Withdrawal by Subject|2|||
25253847|NCT01196104|50569508|FG000|Overall Study|Lost to Follow-up|1|||
25253848|NCT01196104|50569509|FG001|Overall Study|Lost to Follow-up|0|||
25253849|NCT01196104|50569508|FG000|Overall Study|Physician Decision|0|||
25337414|NCT00764478|50653731|FG002|Overall Study|Withdrawal by Subject|1|||
25337415|NCT00764478|50653729|FG000|Overall Study|Lost to Follow-up|7|||
25337416|NCT00764478|50653730|FG001|Overall Study|Lost to Follow-up|8|||
25337417|NCT00764478|50653731|FG002|Overall Study|Lost to Follow-up|5|||
25337418|NCT00764478|50653729|FG000|Overall Study|Protocol Violation|0|||
25337419|NCT00764478|50653730|FG001|Overall Study|Protocol Violation|1|||
25337420|NCT00764478|50653731|FG002|Overall Study|Protocol Violation|1|||
25337421|NCT00805766|50653739|FG000|Screening Period|Adverse Event|1|||
25337422|NCT00805766|50653739|FG000|Screening Period|Lack of Efficacy|2|||
25337423|NCT00805766|50653739|FG000|Screening Period|Pregnancy|1|||
25337424|NCT00805766|50653739|FG000|Screening Period|Responder|2|||
25337425|NCT00805766|50653739|FG000|Increased Dose Period|Adverse Event|4|||
25337426|NCT00805766|50653739|FG000|Increased Dose Period|Lack of Efficacy|7|||
25337427|NCT00805766|50653739|FG000|Increased Dose Period|Pregnancy|1|||
25337428|NCT00805766|50653739|FG000|Increased Dose Period|Withdrawal by Subject|1|||
25337429|NCT00805532|50653749|FG000|Overall Study|invalid data|0|||
25337430|NCT00805532|50653750|FG001|Overall Study|invalid data|1|||
25337431|NCT00764322|50653760|FG000|Overall Study|Withdrawal by Subject|11|||
25337432|NCT00764322|50653760|FG000|Overall Study|No CYP2D6 genotyping|9|||
25253850|NCT01196104|50569509|FG001|Overall Study|Physician Decision|1|||
25253851|NCT01196104|50569508|FG000|Overall Study|Withdrawal by Subject|3|||
25253852|NCT01196104|50569509|FG001|Overall Study|Withdrawal by Subject|3|||
25253853|NCT01196104|50569508|FG000|Overall Study|Various|0|||
25253854|NCT01196104|50569509|FG001|Overall Study|Various|1|||
25253855|NCT01196026|50569527|FG000|Overall Study|Withdrawal by Subject|1|||
25253856|NCT01196026|50569528|FG001|Overall Study|Withdrawal by Subject|4|||
25253857|NCT01196026|50569529|FG002|Overall Study|Withdrawal by Subject|0|||
25253858|NCT01196026|50569530|FG003|Overall Study|Withdrawal by Subject|0|||
25253859|NCT01196026|50569531|FG004|Overall Study|Withdrawal by Subject|0|||
25253860|NCT01196026|50569532|FG005|Overall Study|Withdrawal by Subject|0|||
25253861|NCT01196026|50569527|FG000|Overall Study|Lost to Follow-up|0|||
25253862|NCT01196026|50569528|FG001|Overall Study|Lost to Follow-up|3|||
25253863|NCT01196026|50569529|FG002|Overall Study|Lost to Follow-up|0|||
25253864|NCT01196026|50569530|FG003|Overall Study|Lost to Follow-up|0|||
25253865|NCT01196026|50569531|FG004|Overall Study|Lost to Follow-up|1|||
25253866|NCT01196026|50569532|FG005|Overall Study|Lost to Follow-up|0|||
25253867|NCT01196026|50569527|FG000|Overall Study|Other|0|||
25253868|NCT01196026|50569528|FG001|Overall Study|Other|1|||
25253869|NCT01196026|50569529|FG002|Overall Study|Other|0|||
25253870|NCT01196026|50569530|FG003|Overall Study|Other|0|||
25253871|NCT01196026|50569531|FG004|Overall Study|Other|0|||
25253872|NCT01196026|50569532|FG005|Overall Study|Other|0|||
25253873|NCT01195948|50569555|FG000|Overall Study|Lost to Follow-up|0|||
25253874|NCT01195948|50569556|FG001|Overall Study|Lost to Follow-up|1|||
25253875|NCT01195948|50569557|FG002|Overall Study|Lost to Follow-up|2|||
25253876|NCT01195831|50569570|FG000|Overall Study|Lost to Follow-up|2|||
25253877|NCT01195831|50569571|FG001|Overall Study|Lost to Follow-up|4|||
25253878|NCT01195831|50569570|FG000|Overall Study|Withdrawal by Subject|2|||
25253879|NCT01195831|50569571|FG001|Overall Study|Withdrawal by Subject|2|||
25253880|NCT01195831|50569570|FG000|Overall Study|Adverse Event|4|||
25253881|NCT01195831|50569571|FG001|Overall Study|Adverse Event|2|||
25253882|NCT01195831|50569570|FG000|Overall Study|Protocol Violation|0|||
25253883|NCT01195831|50569571|FG001|Overall Study|Protocol Violation|2|||
25253884|NCT01195675|50569577|FG000|Overall Study|Adverse Event|1|||
25253885|NCT01195675|50569577|FG000|Overall Study|Withdrawal by Subject|2|||
25253886|NCT01195636|50569594|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
25253887|NCT01195636|50569595|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
25337433|NCT00752856|50653779|FG000|Overall Study|randomized but did not do viral kinetics|0|||
25337434|NCT00752856|50653780|FG001|Overall Study|randomized but did not do viral kinetics|1|||
25253888|NCT01195636|50569594|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
25253889|NCT01195636|50569595|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
25253890|NCT01195636|50569594|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
25253891|NCT01195636|50569595|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
25253892|NCT01195636|50569594|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
25253893|NCT01195636|50569595|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
25253894|NCT01195636|50569594|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
25253895|NCT01195636|50569595|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
25253896|NCT01195636|50569594|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
25253897|NCT01195636|50569595|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
25253898|NCT01195636|50569594|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
25253899|NCT01195636|50569595|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
25253900|NCT01195636|50569594|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
25253901|NCT01195636|50569595|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
25253902|NCT01195363|50569603|FG000|Overall Study|Lost to Follow-up|7|||
25253903|NCT01195363|50569604|FG001|Overall Study|Lost to Follow-up|4|||
25337435|NCT00755196|50653786|FG000|Overall Study|Lost to Follow-up|1|||
25337436|NCT00755196|50653786|FG000|Overall Study|Lack of Efficiency|1|||
25337437|NCT00805142|50653793|FG000|Titration Period|Adverse Event|3|||
25337438|NCT00805142|50653794|FG001|Titration Period|Adverse Event|3|||
25337439|NCT00805142|50653793|FG000|Titration Period|Lack of Efficacy|1|||
25337440|NCT00805142|50653794|FG001|Titration Period|Lack of Efficacy|1|||
25337441|NCT00805142|50653793|FG000|Titration Period|Lost to Follow-up|0|||
25337442|NCT00805142|50653794|FG001|Titration Period|Lost to Follow-up|1|||
25337443|NCT00805142|50653793|FG000|Titration Period|Disease Progression|2|||
25337444|NCT00805142|50653794|FG001|Titration Period|Disease Progression|1|||
25337445|NCT00805142|50653793|FG000|Titration Period|Withdrawal of consent|0|||
25337446|NCT00805142|50653794|FG001|Titration Period|Withdrawal of consent|1|||
25337447|NCT00805142|50653793|FG000|Titration Period|Other|0|||
25337448|NCT00805142|50653794|FG001|Titration Period|Other|3|||
25253904|NCT01195363|50569603|FG000|Overall Study|Adverse Event|3|||
25253905|NCT01195363|50569604|FG001|Overall Study|Adverse Event|1|||
25253906|NCT01195363|50569603|FG000|Overall Study|Lack of Efficacy|0|||
25253907|NCT01195363|50569604|FG001|Overall Study|Lack of Efficacy|4|||
25253908|NCT01195363|50569603|FG000|Overall Study|incarceration|1|||
25337449|NCT00805142|50653793|FG000|Maintenance Period|Adverse Event|0|||
25337450|NCT00805142|50653794|FG001|Maintenance Period|Adverse Event|1|||
25253909|NCT01195363|50569604|FG001|Overall Study|incarceration|0|||
25253910|NCT01195090|50569612|FG000|Overall Study|Adverse Event|1|||
25337451|NCT00805142|50653793|FG000|Maintenance Period|Other|0|||
25337452|NCT00805142|50653794|FG001|Maintenance Period|Other|1|||
25337453|NCT00761631|50653811|FG000|Overall Study|Parent/legal guardian request|8|||
25337454|NCT00761631|50653812|FG001|Overall Study|Parent/legal guardian request|3|||
25337455|NCT00761631|50653813|FG002|Overall Study|Parent/legal guardian request|8|||
25337456|NCT00761631|50653814|FG003|Overall Study|Parent/legal guardian request|0|||
25337457|NCT00761631|50653815|FG004|Overall Study|Parent/legal guardian request|5|||
25337458|NCT00761631|50653816|FG005|Overall Study|Parent/legal guardian request|0|||
25337459|NCT00761631|50653811|FG000|Overall Study|Lost to Follow-up|2|||
25337460|NCT00761631|50653812|FG001|Overall Study|Lost to Follow-up|4|||
25337461|NCT00761631|50653813|FG002|Overall Study|Lost to Follow-up|7|||
25337462|NCT00761631|50653814|FG003|Overall Study|Lost to Follow-up|1|||
25337463|NCT00761631|50653815|FG004|Overall Study|Lost to Follow-up|6|||
25337464|NCT00761631|50653816|FG005|Overall Study|Lost to Follow-up|1|||
25337465|NCT00761631|50653811|FG000|Overall Study|Protocol Violation|2|||
25337466|NCT00761631|50653812|FG001|Overall Study|Protocol Violation|0|||
25337467|NCT00761631|50653813|FG002|Overall Study|Protocol Violation|0|||
25337468|NCT00761631|50653814|FG003|Overall Study|Protocol Violation|1|||
25337469|NCT00761631|50653815|FG004|Overall Study|Protocol Violation|5|||
25337470|NCT00761631|50653816|FG005|Overall Study|Protocol Violation|1|||
25337471|NCT00761631|50653811|FG000|Overall Study|Randomized, not treated|1|||
25337472|NCT00761631|50653812|FG001|Overall Study|Randomized, not treated|0|||
25337473|NCT00761631|50653813|FG002|Overall Study|Randomized, not treated|0|||
25337474|NCT00761631|50653814|FG003|Overall Study|Randomized, not treated|0|||
25337475|NCT00761631|50653815|FG004|Overall Study|Randomized, not treated|0|||
25337476|NCT00761631|50653816|FG005|Overall Study|Randomized, not treated|0|||
25337477|NCT00761631|50653811|FG000|Overall Study|Failed to return|1|||
25337478|NCT00761631|50653812|FG001|Overall Study|Failed to return|0|||
25337479|NCT00761631|50653813|FG002|Overall Study|Failed to return|1|||
25337480|NCT00761631|50653814|FG003|Overall Study|Failed to return|1|||
25337481|NCT00761631|50653815|FG004|Overall Study|Failed to return|5|||
25337482|NCT00761631|50653816|FG005|Overall Study|Failed to return|2|||
25337483|NCT00761631|50653811|FG000|Overall Study|Physician Decision|1|||
25337484|NCT00761631|50653812|FG001|Overall Study|Physician Decision|0|||
25337485|NCT00761631|50653813|FG002|Overall Study|Physician Decision|0|||
25337486|NCT00761631|50653814|FG003|Overall Study|Physician Decision|0|||
25337487|NCT00761631|50653815|FG004|Overall Study|Physician Decision|0|||
25337488|NCT00761631|50653816|FG005|Overall Study|Physician Decision|0|||
25337489|NCT00761631|50653811|FG000|Overall Study|Other|0|||
25337490|NCT00761631|50653812|FG001|Overall Study|Other|0|||
25337491|NCT00761631|50653813|FG002|Overall Study|Other|0|||
25253911|NCT01195090|50569613|FG001|Overall Study|Adverse Event|2|||
25337492|NCT00761631|50653814|FG003|Overall Study|Other|0|||
25337493|NCT00761631|50653815|FG004|Overall Study|Other|1|||
25337494|NCT00761631|50653816|FG005|Overall Study|Other|1|||
25337495|NCT00763698|50653839|FG000|Overall Study|Unsuccessful Implant|5|||
25337496|NCT00763698|50653839|FG000|Overall Study|Death|4|||
25253912|NCT01195090|50569612|FG000|Overall Study|Lost to Follow-up|2|||
25337497|NCT00763698|50653839|FG000|Overall Study|Withdrawal by Subject|1|||
25337498|NCT00763386|50653846|FG000|Overall Study|Adverse Event|43|||
25337499|NCT00763386|50653847|FG001|Overall Study|Adverse Event|33|||
25337500|NCT00763386|50653846|FG000|Overall Study|Death|1|||
25337501|NCT00763386|50653847|FG001|Overall Study|Death|2|||
25337502|NCT00763386|50653846|FG000|Overall Study|Lost to Follow-up|3|||
25337503|NCT00763386|50653847|FG001|Overall Study|Lost to Follow-up|3|||
25337504|NCT00763386|50653846|FG000|Overall Study|Withdrawal by Subject|0|||
25337505|NCT00763386|50653847|FG001|Overall Study|Withdrawal by Subject|1|||
25253913|NCT01195090|50569613|FG001|Overall Study|Lost to Follow-up|2|||
25337506|NCT00763386|50653846|FG000|Overall Study|CRF missing|0|||
25337507|NCT00763386|50653847|FG001|Overall Study|CRF missing|1|||
25337508|NCT00763386|50653846|FG000|Overall Study|Study Prosthesis Removed|1|||
25337509|NCT00763386|50653847|FG001|Overall Study|Study Prosthesis Removed|0|||
25253914|NCT01195090|50569612|FG000|Overall Study|Protocol Violation|3|||
25253915|NCT01195090|50569613|FG001|Overall Study|Protocol Violation|4|||
25337510|NCT00761319|50653855|FG000|Overall Study|Protocol Violation|21|||
25337511|NCT00761319|50653856|FG001|Overall Study|Protocol Violation|14|||
25337512|NCT00761319|50653855|FG000|Overall Study|Adverse Event|11|||
25337513|NCT00761319|50653856|FG001|Overall Study|Adverse Event|7|||
25337514|NCT00761319|50653855|FG000|Overall Study|Withdrawal by Subject|8|||
25337515|NCT00761319|50653856|FG001|Overall Study|Withdrawal by Subject|7|||
25337516|NCT00761319|50653855|FG000|Overall Study|Noncompliance|4|||
25337517|NCT00761319|50653856|FG001|Overall Study|Noncompliance|3|||
25337518|NCT00761319|50653855|FG000|Overall Study|Lost to Follow-up|1|||
25337519|NCT00761319|50653856|FG001|Overall Study|Lost to Follow-up|1|||
25337520|NCT00761319|50653855|FG000|Overall Study|Nonspecified|2|||
25337521|NCT00761319|50653856|FG001|Overall Study|Nonspecified|2|||
25337522|NCT00761319|50653855|FG000|Overall Study|Missing|1|||
25253916|NCT01194973|50569619|FG000|Screening Period|Screen Failure|3|||
25253917|NCT01194973|50569619|FG000|26 Week Treatment Period|Adverse Event|1|||
25253918|NCT01194973|50569619|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
25253919|NCT01194973|50569619|FG000|26 Week Treatment Period|Pregnancy|1|||
25253920|NCT02218697|50569625|FG000|Overall Study|Adverse Event|0|||
25253921|NCT02218697|50569626|FG001|Overall Study|Adverse Event|2|||
25337523|NCT00761319|50653856|FG001|Overall Study|Missing|0|||
25337524|NCT00762996|50653862|FG000|Period One|Protocol Violation|0|||
25337525|NCT00762996|50653863|FG001|Period One|Protocol Violation|0|||
25337526|NCT00762996|50653864|FG002|Period One|Protocol Violation|1|||
25337527|NCT00762996|50653865|FG003|Period One|Protocol Violation|0|||
25337528|NCT00762996|50653862|FG000|Period One|ineligible|0|||
25337529|NCT00762996|50653863|FG001|Period One|ineligible|0|||
25337530|NCT00762996|50653864|FG002|Period One|ineligible|1|||
25337531|NCT00762996|50653865|FG003|Period One|ineligible|1|||
25337532|NCT00762996|50653862|FG000|Period One|Adverse Event|0|||
25337533|NCT00762996|50653863|FG001|Period One|Adverse Event|0|||
25337534|NCT00762996|50653864|FG002|Period One|Adverse Event|1|||
25337535|NCT00762996|50653865|FG003|Period One|Adverse Event|0|||
25337536|NCT00762996|50653862|FG000|Period One|Withdrawal by Subject|0|||
25253922|NCT02218697|50569625|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
25253923|NCT02218697|50569626|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
25337537|NCT00762996|50653863|FG001|Period One|Withdrawal by Subject|0|||
25337538|NCT00762996|50653864|FG002|Period One|Withdrawal by Subject|1|||
25337539|NCT00762996|50653865|FG003|Period One|Withdrawal by Subject|0|||
25337540|NCT00762606|50653875|FG000|Overall Study|Lost to Follow-up|18|||
25337541|NCT00762606|50653876|FG001|Overall Study|Lost to Follow-up|13|||
25337542|NCT00818441|50653884|FG000|Overall Study|Death|69|||
25337543|NCT00818441|50653885|FG001|Overall Study|Death|26|||
25337544|NCT00818441|50653884|FG000|Overall Study|Other|5|||
25337545|NCT00818441|50653885|FG001|Overall Study|Other|0|||
25337546|NCT00818441|50653884|FG000|Overall Study|Lost to Follow-up|2|||
25337547|NCT00818441|50653885|FG001|Overall Study|Lost to Follow-up|1|||
25337548|NCT00818441|50653884|FG000|Overall Study|Withdrawal by Subject|2|||
25337549|NCT00818441|50653885|FG001|Overall Study|Withdrawal by Subject|0|||
25337550|NCT00818441|50653884|FG000|Overall Study|Adverse Event|0|||
25337551|NCT00818441|50653885|FG001|Overall Study|Adverse Event|1|||
25337552|NCT00818441|50653884|FG000|Overall Study|Study terminated by sponsor|11|||
25337553|NCT00818441|50653885|FG001|Overall Study|Study terminated by sponsor|2|||
25337554|NCT00826943|50653892|FG000|Overall Study|Withdrawal by Subject|0|||
25337555|NCT00826943|50653893|FG001|Overall Study|Withdrawal by Subject|0|||
25337556|NCT00826943|50653894|FG002|Overall Study|Withdrawal by Subject|0|||
25337557|NCT00826943|50653895|FG003|Overall Study|Withdrawal by Subject|0|||
25337558|NCT00826943|50653896|FG004|Overall Study|Withdrawal by Subject|1|||
25337559|NCT00826943|50653897|FG005|Overall Study|Withdrawal by Subject|0|||
25337560|NCT00834041|50653907|FG000|Overall Study|Withdrawal by Subject|1|||
25337561|NCT00834041|50653908|FG001|Overall Study|Withdrawal by Subject|0|||
25337562|NCT00834041|50653907|FG000|Overall Study|Lost to Follow-up|0|||
25337563|NCT00834041|50653908|FG001|Overall Study|Lost to Follow-up|1|||
25337564|NCT00760929|50653918|FG000|Overall Study|Adverse Event|2|||
25337565|NCT00760929|50653919|FG001|Overall Study|Adverse Event|0|||
25077980|NCT02227108|50186134|FG000|Overall Study|Other|3|||
25077981|NCT02227108|50186134|FG000|Overall Study|Progressive disease|17|||
25253924|NCT02218697|50569625|FG000|Overall Study|Withdrawal by Subject|2|||
25337566|NCT00760929|50653920|FG002|Overall Study|Adverse Event|6|||
25337567|NCT00760929|50653921|FG003|Overall Study|Adverse Event|10|||
25337568|NCT00760929|50653918|FG000|Overall Study|Lack of Efficacy|0|||
25253925|NCT02218697|50569626|FG001|Overall Study|Withdrawal by Subject|3|||
25337569|NCT00760929|50653919|FG001|Overall Study|Lack of Efficacy|2|||
25253926|NCT01177540|50569634|FG000|Overall Study|Adverse Event|1|||
25253927|NCT01177540|50569635|FG001|Overall Study|Adverse Event|0|||
25337570|NCT00760929|50653920|FG002|Overall Study|Lack of Efficacy|1|||
25337571|NCT00760929|50653921|FG003|Overall Study|Lack of Efficacy|0|||
25337572|NCT00760929|50653918|FG000|Overall Study|Withdrawal by Subject|1|||
25337573|NCT00760929|50653919|FG001|Overall Study|Withdrawal by Subject|0|||
25337574|NCT00760929|50653920|FG002|Overall Study|Withdrawal by Subject|9|||
25337575|NCT00760929|50653921|FG003|Overall Study|Withdrawal by Subject|1|||
25337576|NCT00760929|50653918|FG000|Overall Study|Lost to Follow-up|0|||
25337577|NCT00760929|50653919|FG001|Overall Study|Lost to Follow-up|0|||
25337578|NCT00760929|50653920|FG002|Overall Study|Lost to Follow-up|1|||
25337579|NCT00760929|50653921|FG003|Overall Study|Lost to Follow-up|0|||
25337580|NCT00760929|50653918|FG000|Overall Study|Progression of Disease|21|||
25337581|NCT00760929|50653919|FG001|Overall Study|Progression of Disease|26|||
25337582|NCT00760929|50653920|FG002|Overall Study|Progression of Disease|38|||
25337583|NCT00760929|50653921|FG003|Overall Study|Progression of Disease|42|||
25337584|NCT00760929|50653918|FG000|Overall Study|Other|2|||
25337585|NCT00760929|50653919|FG001|Overall Study|Other|0|||
25337586|NCT00760929|50653920|FG002|Overall Study|Other|2|||
25337587|NCT00760929|50653921|FG003|Overall Study|Other|1|||
25337588|NCT00760929|50653918|FG000|Overall Study|Death|0|||
25337589|NCT00760929|50653919|FG001|Overall Study|Death|0|||
25337590|NCT00760929|50653920|FG002|Overall Study|Death|1|||
25337591|NCT00760929|50653921|FG003|Overall Study|Death|0|||
25337592|NCT00760929|50653918|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
25337593|NCT00760929|50653919|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
25337594|NCT00760929|50653920|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
25337595|NCT00760929|50653921|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
25337596|NCT00818207|50653932|FG000|Overall Study|Adverse Event|6|||
25337597|NCT00818207|50653933|FG001|Overall Study|Adverse Event|0|||
25337598|NCT00818207|50653932|FG000|Overall Study|Lost to Follow-up|160|||
25337599|NCT00818207|50653933|FG001|Overall Study|Lost to Follow-up|146|||
25337600|NCT00818207|50653932|FG000|Overall Study|Multiple reasons|11|||
25337601|NCT00818207|50653933|FG001|Overall Study|Multiple reasons|12|||
25337602|NCT00818207|50653932|FG000|Overall Study|Withdrawal by Subject|42|||
25337603|NCT00818207|50653933|FG001|Overall Study|Withdrawal by Subject|104|||
25337604|NCT00818207|50653932|FG000|Overall Study|Death|3|||
25337605|NCT00818207|50653933|FG001|Overall Study|Death|5|||
25337606|NCT00760617|50653942|FG000|Overall Study|Adverse Event|5|||
25337607|NCT00760617|50653943|FG001|Overall Study|Adverse Event|2|||
25337608|NCT00760617|50653944|FG002|Overall Study|Adverse Event|0|||
25337609|NCT00760617|50653942|FG000|Overall Study|Lost to Follow-up|0|||
25337610|NCT00760617|50653943|FG001|Overall Study|Lost to Follow-up|0|||
25337611|NCT00760617|50653944|FG002|Overall Study|Lost to Follow-up|5|||
25337612|NCT00760383|50653954|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
25337613|NCT00760383|50653955|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
25337614|NCT00759915|50653963|FG000|Overall Study|Withdrawal by Subject|1|||
25337615|NCT00759915|50653964|FG001|Overall Study|Withdrawal by Subject|0|||
25337616|NCT00759915|50653963|FG000|Overall Study|Adverse Event|0|||
25337617|NCT00759915|50653964|FG001|Overall Study|Adverse Event|1|||
25337618|NCT00759759|50653972|FG000|Overall Study|didn't return for period 2|1|||
25337619|NCT00759759|50653973|FG001|Overall Study|didn't return for period 2|0|||
25337620|NCT00759759|50653972|FG000|Overall Study|Didn't receive drug in period 2|1|||
24902407|NCT00678561|49996468|FG004|Overall Study|Protocol Violation|1|||
24902408|NCT00678561|49996469|FG005|Overall Study|Protocol Violation|1|||
24902409|NCT00678561|49996470|FG006|Overall Study|Protocol Violation|0|||
24902410|NCT00678561|49996471|FG007|Overall Study|Protocol Violation|0|||
25337621|NCT00759759|50653973|FG001|Overall Study|Didn't receive drug in period 2|0|||
25337622|NCT00759759|50653972|FG000|Overall Study|Withdrawal by Subject|2|||
25337623|NCT00759759|50653973|FG001|Overall Study|Withdrawal by Subject|1|||
25337624|NCT00759681|50653981|FG000|Overall Study|Death|2|||
25337625|NCT00759681|50653982|FG001|Overall Study|Death|5|||
25337626|NCT00759681|50653981|FG000|Overall Study|Lost to Follow-up|8|||
25337627|NCT00759681|50653982|FG001|Overall Study|Lost to Follow-up|5|||
25337628|NCT00826241|50653989|FG000|Overall Study|Withdrawal from Follow-up|1|||
25337629|NCT00826241|50653989|FG000|Overall Study|Withdrew consent|2|||
25337630|NCT00826241|50653989|FG000|Overall Study|Death|4|||
25337631|NCT00826241|50653989|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
25337632|NCT00826241|50653989|FG000|Overall Study|Non-compliance|1|||
25337633|NCT00826241|50653989|FG000|Overall Study|Progression of disease|1|||
25337634|NCT00826241|50653989|FG000|Overall Study|Patient refused follow-up|3|||
25337635|NCT00826241|50653989|FG000|Overall Study|Lost to Follow-up|9|||
25337636|NCT00826241|50653989|FG000|Overall Study|Could not obtain records|1|||
25337637|NCT00826241|50653989|FG000|Overall Study|Screen failure|2|||
25337638|NCT00826241|50653989|FG000|Overall Study|Pt unable to proceed to registration|1|||
25337639|NCT00826241|50653989|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
25337640|NCT00758589|50653997|FG000|Overall Study|Adverse Event|3|||
25337641|NCT00758589|50653998|FG001|Overall Study|Adverse Event|2|||
24902411|NCT00678561|49996464|FG000|Overall Study|Withdrawal by Subject|0|||
25337642|NCT00758589|50653999|FG002|Overall Study|Adverse Event|5|||
25337643|NCT00758589|50654000|FG003|Overall Study|Adverse Event|4|||
25337644|NCT00758589|50653997|FG000|Overall Study|Withdrawal by Subject|0|||
25337645|NCT00758589|50653998|FG001|Overall Study|Withdrawal by Subject|1|||
25337646|NCT00758589|50653999|FG002|Overall Study|Withdrawal by Subject|1|||
25337647|NCT00758589|50654000|FG003|Overall Study|Withdrawal by Subject|1|||
25337648|NCT00758589|50653997|FG000|Overall Study|Palm stopped to work|0|||
25337649|NCT00758589|50653998|FG001|Overall Study|Palm stopped to work|0|||
25337650|NCT00758589|50653999|FG002|Overall Study|Palm stopped to work|0|||
25337651|NCT00758589|50654000|FG003|Overall Study|Palm stopped to work|1|||
25337652|NCT00833417|50654012|FG000|Overall Study|Adverse Event|5|||
25337653|NCT00833417|50654013|FG001|Overall Study|Adverse Event|16|||
25337654|NCT00833417|50654012|FG000|Overall Study|Death|1|||
25337655|NCT00833417|50654013|FG001|Overall Study|Death|3|||
25337656|NCT00833417|50654012|FG000|Overall Study|Lost to Follow-up|1|||
25337657|NCT00833417|50654013|FG001|Overall Study|Lost to Follow-up|2|||
25337658|NCT00833417|50654012|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
25337659|NCT00833417|50654013|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
25337660|NCT00833417|50654012|FG000|Overall Study|Patient Decision to Withdraw|4|||
25337661|NCT00833417|50654013|FG001|Overall Study|Patient Decision to Withdraw|23|||
25337662|NCT00833417|50654012|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
25337663|NCT00833417|50654013|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
25337664|NCT00833417|50654012|FG000|Overall Study|Disease Progression|18|||
25337665|NCT00833417|50654013|FG001|Overall Study|Disease Progression|17|||
25337666|NCT00833417|50654012|FG000|Overall Study|Reason Not Specified|0|||
25337667|NCT00833417|50654013|FG001|Overall Study|Reason Not Specified|1|||
25337668|NCT00762372|50654023|FG000|Overall Study|Adverse Event|1|||
25337669|NCT00762372|50654024|FG001|Overall Study|Adverse Event|0|||
25253928|NCT01177384|50569643|FG000|Overall Study|Adverse Event|6|||
25253929|NCT01177384|50569644|FG001|Overall Study|Adverse Event|4|||
25253930|NCT01177384|50569643|FG000|Overall Study|Lack of Efficacy|0|||
25253931|NCT01177384|50569644|FG001|Overall Study|Lack of Efficacy|1|||
25253932|NCT01177384|50569643|FG000|Overall Study|Lost to Follow-up|3|||
25253933|NCT01177384|50569644|FG001|Overall Study|Lost to Follow-up|4|||
25337670|NCT00762372|50654025|FG002|Overall Study|Adverse Event|0|||
25337671|NCT00833261|50654039|FG000|Overall Study|Withdrawal by Subject|4|||
25337672|NCT00833105|50654043|FG000|Overall Study|Withdrawal by Subject|1|||
25337673|NCT00833105|50654043|FG000|Overall Study|Adverse Event|2|||
25337674|NCT00833027|50654049|FG000|Overall Study|Adverse Event|33|||
25337675|NCT00833027|50654049|FG000|Overall Study|Death|1|||
25337676|NCT00833027|50654049|FG000|Overall Study|Lack of Efficacy|12|||
25337677|NCT00833027|50654049|FG000|Overall Study|Lost to Follow-up|24|||
25337678|NCT00833027|50654049|FG000|Overall Study|Protocol Violation|115|||
25337679|NCT00833027|50654049|FG000|Overall Study|Withdrawal by Subject|16|||
25337680|NCT00833027|50654049|FG000|Overall Study|Missing|10|||
25337681|NCT00752622|50654053|FG000|Induction Phase|Adverse Event|3|||
25337682|NCT00752622|50654053|FG000|Induction Phase|Other|3|||
25337683|NCT00752622|50654053|FG000|Induction Phase|Non-responder|14|||
25337684|NCT00752622|50654053|FG000|Induction Phase|Withdrawal by Subject|1|||
25337685|NCT00752622|50654053|FG000|Induction Phase|Premature study termination|14|||
25337686|NCT00752622|50654053|FG000|Observational Phase|Premature Study Termination|36|||
25253934|NCT01177384|50569643|FG000|Overall Study|Physician Decision|0|||
25253935|NCT01177384|50569644|FG001|Overall Study|Physician Decision|3|||
25253936|NCT01177384|50569643|FG000|Overall Study|Protocol Violation|0|||
25253937|NCT01177384|50569644|FG001|Overall Study|Protocol Violation|2|||
25253938|NCT01177384|50569643|FG000|Overall Study|Withdrawal by Subject|5|||
25253939|NCT01177384|50569644|FG001|Overall Study|Withdrawal by Subject|12|||
25253940|NCT01194154|50569652|FG000|Overall Study|Adverse Event|12|||
25253941|NCT01194154|50569653|FG001|Overall Study|Adverse Event|7|||
25253942|NCT01194154|50569652|FG000|Overall Study|Lost to Follow-up|2|||
25253943|NCT01194154|50569653|FG001|Overall Study|Lost to Follow-up|3|||
25253944|NCT01194154|50569652|FG000|Overall Study|Protocol Violation|0|||
25253945|NCT01194154|50569653|FG001|Overall Study|Protocol Violation|1|||
25253946|NCT01194154|50569652|FG000|Overall Study|Withdrawal by Subject|5|||
25253947|NCT01194154|50569653|FG001|Overall Study|Withdrawal by Subject|6|||
25253948|NCT01194154|50569652|FG000|Overall Study|Blood pressure increase|5|||
25253949|NCT01194154|50569653|FG001|Overall Study|Blood pressure increase|3|||
25337687|NCT00752622|50654053|FG000|Observational Phase|Non-responder|2|||
25337688|NCT00752622|50654053|FG000|Observational Phase|Withdrawal by Subject|2|||
25337689|NCT00752622|50654053|FG000|Observational Phase|Adverse Event|1|||
25337690|NCT00752622|50654053|FG000|Observational Phase|Other|2|||
25337691|NCT00752622|50654053|FG000|Interventional Phase|Non-responder|2|||
25253950|NCT01194154|50569652|FG000|Overall Study|Hemoglobin decrease|0|||
25253951|NCT01194154|50569653|FG001|Overall Study|Hemoglobin decrease|1|||
25253952|NCT01194154|50569652|FG000|Overall Study|Hemoglobin increase|12|||
25253953|NCT01194154|50569653|FG001|Overall Study|Hemoglobin increase|3|||
25253954|NCT01194154|50569652|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
25337692|NCT00752622|50654053|FG000|Interventional Phase|Physician Decision|1|||
25337693|NCT00752622|50654053|FG000|Interventional Phase|Premature Study Termination|5|||
25337694|NCT00754650|50654058|FG000|Overall Study|Disease Progression|2|||
25337695|NCT00761748|50654062|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
25253955|NCT01194154|50569653|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
25253956|NCT01194154|50569652|FG000|Overall Study|Treatment with prohibited medication|4|||
25253957|NCT01194154|50569653|FG001|Overall Study|Treatment with prohibited medication|5|||
25253958|NCT01194154|50569652|FG000|Overall Study|Other|4|||
25253959|NCT01194154|50569653|FG001|Overall Study|Other|0|||
25253960|NCT01194154|50569652|FG000|Overall Study|Did not receive study medication|2|||
25253961|NCT01194154|50569653|FG001|Overall Study|Did not receive study medication|4|||
25337696|NCT00761748|50654063|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
25337697|NCT00761748|50654062|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
25253962|NCT01193920|50569680|FG000|Overall Study|Withdrawal by Subject|1|||
25253963|NCT01193920|50569681|FG001|Overall Study|Withdrawal by Subject|0|||
25253964|NCT01193920|50569682|FG002|Overall Study|Withdrawal by Subject|5|||
25253965|NCT01193920|50569683|FG003|Overall Study|Withdrawal by Subject|1|||
25253966|NCT01193920|50569684|FG004|Overall Study|Withdrawal by Subject|3|||
25253967|NCT01193920|50569685|FG005|Overall Study|Withdrawal by Subject|1|||
25253968|NCT01193920|50569686|FG006|Overall Study|Withdrawal by Subject|3|||
25253969|NCT01193920|50569687|FG007|Overall Study|Withdrawal by Subject|0|||
25253970|NCT01193920|50569688|FG008|Overall Study|Withdrawal by Subject|1|||
25253971|NCT01193920|50569689|FG009|Overall Study|Withdrawal by Subject|0|||
25253972|NCT01193920|50569680|FG000|Overall Study|Lost to Follow-up|1|||
25253973|NCT01193920|50569681|FG001|Overall Study|Lost to Follow-up|0|||
25253974|NCT01193920|50569682|FG002|Overall Study|Lost to Follow-up|1|||
25253975|NCT01193920|50569683|FG003|Overall Study|Lost to Follow-up|1|||
25253976|NCT01193920|50569684|FG004|Overall Study|Lost to Follow-up|3|||
25253977|NCT01193920|50569685|FG005|Overall Study|Lost to Follow-up|3|||
25253978|NCT01193920|50569686|FG006|Overall Study|Lost to Follow-up|1|||
25253979|NCT01193920|50569687|FG007|Overall Study|Lost to Follow-up|0|||
25253980|NCT01193920|50569688|FG008|Overall Study|Lost to Follow-up|2|||
25253981|NCT01193920|50569689|FG009|Overall Study|Lost to Follow-up|3|||
25253982|NCT01193920|50569680|FG000|Overall Study|Protocol Violation|1|||
25253983|NCT01193920|50569681|FG001|Overall Study|Protocol Violation|0|||
25253984|NCT01193920|50569682|FG002|Overall Study|Protocol Violation|0|||
25253985|NCT01193920|50569683|FG003|Overall Study|Protocol Violation|0|||
25253986|NCT01193920|50569684|FG004|Overall Study|Protocol Violation|0|||
25253987|NCT01193920|50569685|FG005|Overall Study|Protocol Violation|0|||
25253988|NCT01193920|50569686|FG006|Overall Study|Protocol Violation|0|||
25253989|NCT01193920|50569687|FG007|Overall Study|Protocol Violation|0|||
25253990|NCT01193920|50569688|FG008|Overall Study|Protocol Violation|0|||
25253991|NCT01193920|50569689|FG009|Overall Study|Protocol Violation|0|||
25253992|NCT01193920|50569680|FG000|Overall Study|Death|0|||
25253993|NCT01193920|50569681|FG001|Overall Study|Death|0|||
25253994|NCT01193920|50569682|FG002|Overall Study|Death|0|||
25253995|NCT01193920|50569683|FG003|Overall Study|Death|1|||
25253996|NCT01193920|50569684|FG004|Overall Study|Death|0|||
25253997|NCT01193920|50569685|FG005|Overall Study|Death|0|||
25253998|NCT01193920|50569686|FG006|Overall Study|Death|2|||
25337698|NCT00761748|50654063|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
25337699|NCT00825305|50654071|FG000|Overall Study|Adverse Event|1|||
25337700|NCT00825305|50654072|FG001|Overall Study|Adverse Event|1|||
25337701|NCT00825305|50654071|FG000|Overall Study|Withdrawal by Subject|6|||
25337702|NCT00825305|50654072|FG001|Overall Study|Withdrawal by Subject|12|||
25337703|NCT00825305|50654071|FG000|Overall Study|Inappropriate inclusion|1|||
25337704|NCT00825305|50654072|FG001|Overall Study|Inappropriate inclusion|0|||
25337705|NCT00825305|50654071|FG000|Overall Study|Protocol Violation|9|||
25337706|NCT00825305|50654072|FG001|Overall Study|Protocol Violation|9|||
25337707|NCT00825305|50654071|FG000|Overall Study|Can not be classified|0|||
25337708|NCT00825305|50654072|FG001|Overall Study|Can not be classified|1|||
25337709|NCT00754572|50654078|FG000|Overall Study|Adverse Event|19|||
25337710|NCT00754572|50654078|FG000|Overall Study|Other|39|||
25337711|NCT00754572|50654078|FG000|Overall Study|Protocol Violation|3|||
25337712|NCT00754572|50654078|FG000|Overall Study|Withdrawal by Subject|3|||
25337713|NCT00754572|50654078|FG000|Overall Study|Lack of Efficacy|2|||
25253999|NCT01193920|50569687|FG007|Overall Study|Death|3|||
25254000|NCT01193920|50569688|FG008|Overall Study|Death|2|||
25254001|NCT01193920|50569689|FG009|Overall Study|Death|4|||
25254002|NCT01193920|50569680|FG000|Overall Study|Unable to classify|0|||
25254003|NCT01193920|50569681|FG001|Overall Study|Unable to classify|0|||
25254004|NCT01193920|50569682|FG002|Overall Study|Unable to classify|0|||
25254005|NCT01193920|50569683|FG003|Overall Study|Unable to classify|1|||
25254006|NCT01193920|50569684|FG004|Overall Study|Unable to classify|0|||
25337714|NCT00754572|50654078|FG000|Overall Study|Death|1|||
25337715|NCT00754572|50654078|FG000|Overall Study|Administrative Reason|3|||
25337716|NCT00754572|50654078|FG000|Overall Study|Lost to Follow-up|1|||
25254007|NCT01193920|50569685|FG005|Overall Study|Unable to classify|0|||
25337717|NCT00824993|50654084|FG000|Overall Study|Withdrawal by Subject|1|||
25254008|NCT01193920|50569686|FG006|Overall Study|Unable to classify|0|||
25254009|NCT01193920|50569687|FG007|Overall Study|Unable to classify|1|||
25254010|NCT01193920|50569688|FG008|Overall Study|Unable to classify|0|||
25254011|NCT01193920|50569689|FG009|Overall Study|Unable to classify|0|||
25337718|NCT00824993|50654085|FG001|Overall Study|Withdrawal by Subject|1|||
25337719|NCT00824993|50654084|FG000|Overall Study|Malignancy Relapse|9|||
25337720|NCT00824993|50654085|FG001|Overall Study|Malignancy Relapse|10|||
25337721|NCT00824993|50654084|FG000|Overall Study|Rapid Bone Loss|0|||
25337722|NCT00824993|50654085|FG001|Overall Study|Rapid Bone Loss|1|||
25337723|NCT00824993|50654084|FG000|Overall Study|Non-Compliant|2|||
25337724|NCT00824993|50654085|FG001|Overall Study|Non-Compliant|1|||
25337725|NCT00824993|50654084|FG000|Overall Study|Insurance Issue|2|||
25337726|NCT00824993|50654085|FG001|Overall Study|Insurance Issue|1|||
25337727|NCT00824993|50654084|FG000|Overall Study|Death|0|||
25337728|NCT00824993|50654085|FG001|Overall Study|Death|3|||
25337729|NCT00832091|50654093|FG000|Overall Study|Adverse Event|1|||
25337730|NCT00832091|50654094|FG001|Overall Study|Adverse Event|1|||
25337731|NCT00832091|50654093|FG000|Overall Study|Protocol Violation|1|||
25337732|NCT00832091|50654094|FG001|Overall Study|Protocol Violation|0|||
25337733|NCT00832091|50654093|FG000|Overall Study|Withdrawal by Subject|2|||
25337734|NCT00832091|50654094|FG001|Overall Study|Withdrawal by Subject|1|||
25337735|NCT00832091|50654093|FG000|Overall Study|Prohibited Medication|1|||
25337736|NCT00832091|50654094|FG001|Overall Study|Prohibited Medication|0|||
25337737|NCT00754338|50654104|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
25337738|NCT00754338|50654105|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
25337739|NCT00754338|50654106|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
25337740|NCT00754338|50654107|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
25337741|NCT00754338|50654104|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
25337742|NCT00754338|50654105|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
25337743|NCT00754338|50654106|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
25337744|NCT00754338|50654107|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
25337745|NCT00761514|50654119|FG000|Overall Study|Adverse Event|1|||
25337746|NCT00761514|50654119|FG000|Overall Study|Withdrawal by Subject|2|||
25337747|NCT00761514|50654119|FG000|Overall Study|Lost to Follow-up|1|||
25337748|NCT00761514|50654119|FG000|Overall Study|Health insurance didn't cover study drug|1|||
25337749|NCT00761514|50654119|FG000|Overall Study|Problem complying with study visit|1|||
25337750|NCT00761514|50654119|FG000|Overall Study|Unable to pay for medications|1|||
25337751|NCT00831779|50654125|FG000|Overall Study|Lost to Follow-up|1|||
25337752|NCT00831779|50654126|FG001|Overall Study|Lost to Follow-up|0|||
25337753|NCT00831779|50654125|FG000|Overall Study|No longer met criteria|0|||
25337754|NCT00831779|50654126|FG001|Overall Study|No longer met criteria|1|||
25337755|NCT00758043|50654136|FG000|Overall Study|Adverse Event|1|||
25337756|NCT00758043|50654137|FG001|Overall Study|Adverse Event|20|||
25337757|NCT00758043|50654138|FG002|Overall Study|Adverse Event|12|||
25337758|NCT00758043|50654139|FG003|Overall Study|Adverse Event|62|||
25337759|NCT00758043|50654136|FG000|Overall Study|Lack of Efficacy|0|||
25337760|NCT00758043|50654137|FG001|Overall Study|Lack of Efficacy|6|||
25337761|NCT00758043|50654138|FG002|Overall Study|Lack of Efficacy|18|||
25337762|NCT00758043|50654139|FG003|Overall Study|Lack of Efficacy|12|||
25337763|NCT00758043|50654136|FG000|Overall Study|Refused Further Treatment|0|||
25337764|NCT00758043|50654137|FG001|Overall Study|Refused Further Treatment|11|||
25337765|NCT00758043|50654138|FG002|Overall Study|Refused Further Treatment|5|||
25337766|NCT00758043|50654139|FG003|Overall Study|Refused Further Treatment|8|||
25337767|NCT00758043|50654136|FG000|Overall Study|Lost to Follow-up|0|||
25337768|NCT00758043|50654137|FG001|Overall Study|Lost to Follow-up|2|||
25337769|NCT00758043|50654138|FG002|Overall Study|Lost to Follow-up|2|||
25337770|NCT00758043|50654139|FG003|Overall Study|Lost to Follow-up|5|||
25337771|NCT00758043|50654136|FG000|Overall Study|Withdrawal by Subject|0|||
25337772|NCT00758043|50654137|FG001|Overall Study|Withdrawal by Subject|1|||
25337773|NCT00758043|50654138|FG002|Overall Study|Withdrawal by Subject|1|||
25337774|NCT00758043|50654139|FG003|Overall Study|Withdrawal by Subject|4|||
25337775|NCT00758043|50654136|FG000|Overall Study|Required Prohibited Medication|0|||
25337776|NCT00758043|50654137|FG001|Overall Study|Required Prohibited Medication|0|||
25337777|NCT00758043|50654138|FG002|Overall Study|Required Prohibited Medication|1|||
25337778|NCT00758043|50654139|FG003|Overall Study|Required Prohibited Medication|3|||
25337779|NCT00758043|50654136|FG000|Overall Study|Non-Compliant With study Drug|0|||
25337780|NCT00758043|50654137|FG001|Overall Study|Non-Compliant With study Drug|0|||
25337781|NCT00758043|50654138|FG002|Overall Study|Non-Compliant With study Drug|0|||
25337782|NCT00758043|50654139|FG003|Overall Study|Non-Compliant With study Drug|1|||
25337783|NCT00758043|50654136|FG000|Overall Study|Other Reasons|0|||
25077982|NCT02227108|50186134|FG000|Overall Study|Initiation of alternative therapy|2|||
25337784|NCT00758043|50654137|FG001|Overall Study|Other Reasons|1|||
25337785|NCT00758043|50654138|FG002|Overall Study|Other Reasons|0|||
25337786|NCT00758043|50654139|FG003|Overall Study|Other Reasons|5|||
25337787|NCT00831701|50654157|FG000|Overall Study|Withdrawal by Subject|2|||
25337788|NCT00831701|50654158|FG001|Overall Study|Withdrawal by Subject|0|||
25337789|NCT00831701|50654157|FG000|Overall Study|Stone expulsion before first medication|2|||
25337790|NCT00831701|50654158|FG001|Overall Study|Stone expulsion before first medication|2|||
25337791|NCT00831701|50654157|FG000|Overall Study|Lost to Follow-up|1|||
25337792|NCT00831701|50654158|FG001|Overall Study|Lost to Follow-up|3|||
25254012|NCT01193686|50569714|FG000|Overall Study|Withdrawal by Subject|4|||
25337793|NCT00752895|50654166|FG000|Overall Study|Withdrawal by Subject|8|||
25337794|NCT00752895|50654167|FG001|Overall Study|Withdrawal by Subject|3|||
25337795|NCT00831389|50654175|FG000|Overall Study|Withdrawal by Subject|0|||
25337796|NCT00831389|50654176|FG001|Overall Study|Withdrawal by Subject|1|||
25337797|NCT00831311|50654184|FG000|Overall Study|Definitive Contraindication|3|||
25337798|NCT00831311|50654185|FG001|Overall Study|Definitive Contraindication|3|||
25337799|NCT00831311|50654184|FG000|Overall Study|Lost to Follow-up|3|||
25337800|NCT00831311|50654185|FG001|Overall Study|Lost to Follow-up|0|||
25337801|NCT00831311|50654184|FG000|Overall Study|Physician Decision|0|||
25337802|NCT00831311|50654185|FG001|Overall Study|Physician Decision|1|||
25337803|NCT00831311|50654184|FG000|Overall Study|Withdrawal by Subject|6|||
25337804|NCT00831311|50654185|FG001|Overall Study|Withdrawal by Subject|4|||
25337805|NCT00831233|50654194|FG000|Overall Study|Adverse Event|0|||
25337806|NCT00831233|50654195|FG001|Overall Study|Adverse Event|1|||
25337807|NCT00831233|50654194|FG000|Overall Study|Protocol Violation|1|||
24902412|NCT00678561|49996465|FG001|Overall Study|Withdrawal by Subject|0|||
24902413|NCT00678561|49996466|FG002|Overall Study|Withdrawal by Subject|0|||
24902414|NCT00678561|49996467|FG003|Overall Study|Withdrawal by Subject|0|||
24902415|NCT00678561|49996468|FG004|Overall Study|Withdrawal by Subject|0|||
24902416|NCT00678561|49996469|FG005|Overall Study|Withdrawal by Subject|0|||
24902417|NCT00678561|49996470|FG006|Overall Study|Withdrawal by Subject|0|||
24902418|NCT00678561|49996471|FG007|Overall Study|Withdrawal by Subject|1|||
24902419|NCT00676143|49996498|FG000|Overall Study|Adverse Event|34|||
24902420|NCT00676143|49996499|FG001|Overall Study|Adverse Event|60|||
24902421|NCT00676143|49996498|FG000|Overall Study|Death|4|||
24902422|NCT00676143|49996499|FG001|Overall Study|Death|4|||
24902423|NCT00676143|49996498|FG000|Overall Study|Lack of Efficacy|0|||
24902424|NCT00676143|49996499|FG001|Overall Study|Lack of Efficacy|6|||
24902425|NCT00676143|49996498|FG000|Overall Study|Lost to Follow-up|0|||
24902426|NCT00676143|49996499|FG001|Overall Study|Lost to Follow-up|13|||
24902427|NCT00676143|49996498|FG000|Overall Study|Physician Decision|5|||
24902428|NCT00676143|49996499|FG001|Overall Study|Physician Decision|8|||
24902429|NCT00676143|49996498|FG000|Overall Study|Protocol Violation|4|||
24902430|NCT00676143|49996499|FG001|Overall Study|Protocol Violation|8|||
24902431|NCT00676143|49996498|FG000|Overall Study|Withdrawal by Subject|24|||
24902432|NCT00676143|49996499|FG001|Overall Study|Withdrawal by Subject|42|||
24902433|NCT00676143|49996498|FG000|Overall Study|Discontinuation of study by sponsor|65|||
24902434|NCT00676143|49996499|FG001|Overall Study|Discontinuation of study by sponsor|88|||
24902435|NCT00676143|49996498|FG000|Overall Study|Failed to return|2|||
24902436|NCT00676143|49996499|FG001|Overall Study|Failed to return|1|||
24902437|NCT00676143|49996498|FG000|Overall Study|Loss of caregiver|5|||
24902438|NCT00676143|49996499|FG001|Overall Study|Loss of caregiver|3|||
25077983|NCT02227108|50186134|FG000|Overall Study|Investigator discretion|1|||
25254013|NCT01193686|50569715|FG001|Overall Study|Withdrawal by Subject|1|||
25254014|NCT01193686|50569714|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
25254015|NCT01193686|50569715|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
25254016|NCT01193608|50569728|FG000|Overall Study|Other|0|||
25254017|NCT01193608|50569729|FG001|Overall Study|Other|1|||
25254018|NCT01193608|50569730|FG002|Overall Study|Other|0|||
25254019|NCT01193608|50569731|FG003|Overall Study|Other|0|||
25254020|NCT01193608|50569732|FG004|Overall Study|Other|0|||
25254021|NCT01193608|50569733|FG005|Overall Study|Other|0|||
25254022|NCT01193608|50569728|FG000|Overall Study|Withdrawal by Subject|0|||
25254023|NCT01193608|50569729|FG001|Overall Study|Withdrawal by Subject|1|||
25254024|NCT01193608|50569730|FG002|Overall Study|Withdrawal by Subject|2|||
25254025|NCT01193608|50569731|FG003|Overall Study|Withdrawal by Subject|3|||
25254026|NCT01193608|50569732|FG004|Overall Study|Withdrawal by Subject|3|||
25254027|NCT01193608|50569733|FG005|Overall Study|Withdrawal by Subject|0|||
25254028|NCT01193608|50569728|FG000|Overall Study|Lost to Follow-up|0|||
25254029|NCT01193608|50569729|FG001|Overall Study|Lost to Follow-up|0|||
25254030|NCT01193608|50569730|FG002|Overall Study|Lost to Follow-up|0|||
25254031|NCT01193608|50569731|FG003|Overall Study|Lost to Follow-up|0|||
25254032|NCT01193608|50569732|FG004|Overall Study|Lost to Follow-up|1|||
25337808|NCT00831233|50654195|FG001|Overall Study|Protocol Violation|0|||
25337809|NCT00831233|50654194|FG000|Overall Study|Selection Criteria Not Met|2|||
24902439|NCT00676143|49996498|FG000|Overall Study|Other|11|||
24902440|NCT00676143|49996499|FG001|Overall Study|Other|20|||
24902441|NCT00676143|49996498|FG000|Overall Study|Participant participation unknown|1|||
24902442|NCT00676143|49996499|FG001|Overall Study|Participant participation unknown|4|||
24902443|NCT00676143|49996498|FG000|Overall Study|Vasogenic edema recurrence|1|||
24902444|NCT00676143|49996499|FG001|Overall Study|Vasogenic edema recurrence|3|||
24902445|NCT00675597|49996524|FG000|Overall Study|Withdrawal by Subject|3|||
25254033|NCT01193608|50569733|FG005|Overall Study|Lost to Follow-up|2|||
24902446|NCT00675441|49996532|FG000|Overall Study|Withdrawal by Subject|2|||
24902447|NCT00675441|49996532|FG000|Overall Study|Death|1|||
25254034|NCT01193608|50569728|FG000|Overall Study|Adverse Event|0|||
25337810|NCT00831233|50654195|FG001|Overall Study|Selection Criteria Not Met|0|||
25337811|NCT00761280|50654212|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
25254035|NCT01193608|50569729|FG001|Overall Study|Adverse Event|0|||
25254036|NCT01193608|50569730|FG002|Overall Study|Adverse Event|0|||
25337812|NCT00761280|50654213|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
25337813|NCT00761280|50654212|FG000|Randomization to First Dose|Sponsor decision|1|||
25337814|NCT00761280|50654213|FG001|Randomization to First Dose|Sponsor decision|0|||
25337815|NCT00761280|50654212|FG000|Randomization to First Dose|Other|1|||
25337816|NCT00761280|50654213|FG001|Randomization to First Dose|Other|0|||
25337817|NCT00761280|50654212|FG000|First Dose to End of Study|End of trial|5|||
25337818|NCT00761280|50654213|FG001|First Dose to End of Study|End of trial|5|||
25337819|NCT00761280|50654212|FG000|First Dose to End of Study|Progressive disease|5|||
25337820|NCT00761280|50654213|FG001|First Dose to End of Study|Progressive disease|3|||
25337821|NCT00761280|50654212|FG000|First Dose to End of Study|Sponsor decision|1|||
25337822|NCT00761280|50654213|FG001|First Dose to End of Study|Sponsor decision|2|||
25337823|NCT00761280|50654212|FG000|First Dose to End of Study|Death|1|||
25337824|NCT00761280|50654213|FG001|First Dose to End of Study|Death|0|||
25337825|NCT00761280|50654212|FG000|First Dose to End of Study|Lost to Follow-up|0|||
25337826|NCT00761280|50654213|FG001|First Dose to End of Study|Lost to Follow-up|1|||
25337827|NCT00824369|50654225|FG000|Overall Study|Nolonger willing to participate in study|1|||
25337828|NCT00824369|50654226|FG001|Overall Study|Nolonger willing to participate in study|0|||
25337829|NCT00824369|50654227|FG002|Overall Study|Nolonger willing to participate in study|1|||
25077984|NCT02227108|50186134|FG000|Overall Study|Adverse Event|6|||
25077985|NCT03564145|50186138|FG000|Overall Study|Adverse Event|4|||
25077986|NCT03564145|50186138|FG000|Overall Study|Lost to Follow-up|21|||
25077987|NCT03564145|50186138|FG000|Overall Study|Protocol Violation|2|||
25077988|NCT03564145|50186138|FG000|Overall Study|Withdrawal by Subject|48|||
25077989|NCT03564145|50186138|FG000|Overall Study|Study Terminated by Sponsor|146|||
25077990|NCT03564145|50186138|FG000|Overall Study|Physician Decision|1|||
25077991|NCT03564145|50186138|FG000|Overall Study|Other Than Specified|1|||
25077992|NCT03564145|50186138|FG000|Overall Study|Pregnancy|1|||
25077993|NCT02226562|50186144|FG000|Overall Study|Lost to Follow-up|0|||
25077994|NCT02226562|50186145|FG001|Overall Study|Lost to Follow-up|1|||
25254037|NCT01193608|50569731|FG003|Overall Study|Adverse Event|0|||
25337830|NCT00824369|50654228|FG003|Overall Study|Nolonger willing to participate in study|2|||
25337831|NCT00824369|50654229|FG004|Overall Study|Nolonger willing to participate in study|0|||
25337832|NCT00824369|50654230|FG005|Overall Study|Nolonger willing to participate in study|1|||
25337833|NCT00824369|50654225|FG000|Overall Study|Lost to Follow-up|0|||
25337834|NCT00824369|50654226|FG001|Overall Study|Lost to Follow-up|0|||
25337835|NCT00824369|50654227|FG002|Overall Study|Lost to Follow-up|0|||
25337836|NCT00824369|50654228|FG003|Overall Study|Lost to Follow-up|0|||
25337837|NCT00824369|50654229|FG004|Overall Study|Lost to Follow-up|1|||
25337838|NCT00824369|50654230|FG005|Overall Study|Lost to Follow-up|0|||
25337839|NCT00824291|50654246|FG000|Overall Study|Adverse Event|15|||
25337840|NCT00824291|50654247|FG001|Overall Study|Adverse Event|6|||
24902448|NCT00674973|49996547|FG000|Overall Study|Insufficient Therapeutic Response|77|||
24902449|NCT00674973|49996548|FG001|Overall Study|Insufficient Therapeutic Response|72|||
24902450|NCT00674973|49996547|FG000|Overall Study|Refused Treatment|1|||
24902451|NCT00674973|49996548|FG001|Overall Study|Refused Treatment|5|||
24902452|NCT00674973|49996547|FG000|Overall Study|Failure to Return|1|||
24902453|NCT00674973|49996548|FG001|Overall Study|Failure to Return|0|||
24902454|NCT00674973|49996547|FG000|Overall Study|Adverse Event|2|||
24902455|NCT00674973|49996548|FG001|Overall Study|Adverse Event|9|||
24902456|NCT00674973|49996547|FG000|Overall Study|Death|19|||
24902457|NCT00674973|49996548|FG001|Overall Study|Death|15|||
24902458|NCT00674973|49996547|FG000|Overall Study|Protocol Violation|0|||
24902459|NCT00674973|49996548|FG001|Overall Study|Protocol Violation|1|||
24902460|NCT00673179|49996556|FG000|Overall Study|Toxicity/Complications|3|||
24902461|NCT00673179|49996557|FG001|Overall Study|Toxicity/Complications|0|||
25254038|NCT01193608|50569732|FG004|Overall Study|Adverse Event|1|||
25337841|NCT00824291|50654246|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
25254039|NCT01193608|50569733|FG005|Overall Study|Adverse Event|0|||
25254040|NCT01177228|50569756|FG000|Overall Study|Positive tuberculosis test|0|||
25254041|NCT01177228|50569757|FG001|Overall Study|Positive tuberculosis test|1|||
25254042|NCT01177228|50569758|FG002|Overall Study|Positive tuberculosis test|0|||
25254043|NCT01177228|50569759|FG003|Overall Study|Positive tuberculosis test|0|||
25254044|NCT01177228|50569756|FG000|Overall Study|Worsening disease activity|1|||
25254045|NCT01177228|50569757|FG001|Overall Study|Worsening disease activity|0|||
25254046|NCT01177228|50569758|FG002|Overall Study|Worsening disease activity|0|||
25254047|NCT01177228|50569759|FG003|Overall Study|Worsening disease activity|0|||
25254048|NCT01177228|50569756|FG000|Overall Study|Withdrawal by Subject|0|||
24902462|NCT00584012|49996563|FG000|Overall Study|Withdrawal by Subject|1|||
24902463|NCT00674817|49996567|FG000|Period 1|Withdrawal by Subject|2|||
24902464|NCT00674817|49996567|FG000|Period 1|Protocol Violation|1|||
25077995|NCT02456636|50186179|FG000|Overall Study|Death|0|||
25077996|NCT02456636|50186180|FG001|Overall Study|Death|3|||
25077997|NCT02456636|50186181|FG002|Overall Study|Death|0|||
25337842|NCT00824291|50654247|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
25337843|NCT00824291|50654246|FG000|Overall Study|Lost to Follow-up|11|||
25337844|NCT00824291|50654247|FG001|Overall Study|Lost to Follow-up|9|||
25337845|NCT00824291|50654246|FG000|Overall Study|Non-compliance|1|||
25337846|NCT00824291|50654247|FG001|Overall Study|Non-compliance|1|||
25337847|NCT00824291|50654246|FG000|Overall Study|Protocol Violation|4|||
25337848|NCT00824291|50654247|FG001|Overall Study|Protocol Violation|1|||
25337849|NCT00824291|50654246|FG000|Overall Study|Withdrawal by Subject|14|||
25337850|NCT00824291|50654247|FG001|Overall Study|Withdrawal by Subject|8|||
25337851|NCT00824291|50654246|FG000|Overall Study|Lack of Efficacy|7|||
25337852|NCT00824291|50654247|FG001|Overall Study|Lack of Efficacy|8|||
25337853|NCT00824291|50654246|FG000|Overall Study|Participant on prohibited medication|1|||
25254049|NCT01177228|50569757|FG001|Overall Study|Withdrawal by Subject|1|||
25254050|NCT01177228|50569758|FG002|Overall Study|Withdrawal by Subject|0|||
25254051|NCT01177228|50569759|FG003|Overall Study|Withdrawal by Subject|0|||
25254052|NCT01193530|50569776|FG000|Overall Study|Withdrawal by Subject|2|||
25254053|NCT01193530|50569777|FG001|Overall Study|Withdrawal by Subject|2|||
25254054|NCT01193530|50569776|FG000|Overall Study|Began Contraindicated Therapy|1|||
25254055|NCT01193530|50569777|FG001|Overall Study|Began Contraindicated Therapy|0|||
25254056|NCT01193530|50569776|FG000|Overall Study|Lost Light Box|0|||
25254057|NCT01193530|50569777|FG001|Overall Study|Lost Light Box|1|||
25254058|NCT01193530|50569776|FG000|Overall Study|Returned home - out of state|0|||
25254059|NCT01193530|50569777|FG001|Overall Study|Returned home - out of state|1|||
25254060|NCT01193530|50569776|FG000|Overall Study|Non-Compliance|0|||
25254061|NCT01193530|50569777|FG001|Overall Study|Non-Compliance|1|||
25254062|NCT00107172|50569785|FG000|Overall Study|Withdrawal by Subject|1|||
25254063|NCT00107172|50569786|FG001|Overall Study|Withdrawal by Subject|0|||
25254064|NCT00107172|50569785|FG000|Overall Study|Death|0|||
25254065|NCT00107172|50569786|FG001|Overall Study|Death|2|||
25254066|NCT00107172|50569785|FG000|Overall Study|Other Reason|4|||
25254067|NCT00107172|50569786|FG001|Overall Study|Other Reason|3|||
25254068|NCT01680965|50569800|FG000|Overall Study|Death|0|||
25254069|NCT01680965|50569801|FG001|Overall Study|Death|0|||
25254070|NCT01680965|50569802|FG002|Overall Study|Death|0|||
25254071|NCT01680965|50569803|FG003|Overall Study|Death|6|||
25254072|NCT01339923|50569818|FG000|Overall Study|Adverse Event|1|||
25254073|NCT01339923|50569819|FG001|Overall Study|Adverse Event|1|||
25254074|NCT01339923|50569820|FG002|Overall Study|Adverse Event|1|||
25254075|NCT01339923|50569821|FG003|Overall Study|Adverse Event|0|||
25254076|NCT01339923|50569822|FG004|Overall Study|Adverse Event|0|||
25254077|NCT01339923|50569823|FG005|Overall Study|Adverse Event|0|||
25254078|NCT01339923|50569824|FG006|Overall Study|Adverse Event|1|||
25254079|NCT01339923|50569818|FG000|Overall Study|Inappropriate Enrollment|1|||
25254080|NCT01339923|50569819|FG001|Overall Study|Inappropriate Enrollment|0|||
25254081|NCT01339923|50569820|FG002|Overall Study|Inappropriate Enrollment|0|||
25254082|NCT01339923|50569821|FG003|Overall Study|Inappropriate Enrollment|0|||
25254083|NCT01339923|50569822|FG004|Overall Study|Inappropriate Enrollment|0|||
25254084|NCT01339923|50569823|FG005|Overall Study|Inappropriate Enrollment|1|||
25254085|NCT01339923|50569824|FG006|Overall Study|Inappropriate Enrollment|0|||
25337854|NCT00824291|50654247|FG001|Overall Study|Participant on prohibited medication|0|||
24902465|NCT00674817|49996567|FG000|Period 3|Adverse Event|1|||
24902466|NCT00674817|49996567|FG000|Period 3|Protocol Violation|1|||
24902467|NCT00674817|49996567|FG000|Period 4|Adverse Event|1|||
24902468|NCT00672633|49996583|FG000|Overall Study|Withdrawal by Subject|0|||
24902469|NCT00672633|49996584|FG001|Overall Study|Withdrawal by Subject|1|||
24902470|NCT00672555|49996590|FG000|Overall Study|Lost to Follow-up|4|||
24902471|NCT00672555|49996590|FG000|Overall Study|Did not want to answer questionnaire|2|||
24902472|NCT00672477|49996596|FG000|Overall Study|Adverse Event|10|||
24902473|NCT00672477|49996597|FG001|Overall Study|Adverse Event|7|||
24902474|NCT00672477|49996596|FG000|Overall Study|Death|7|||
24902475|NCT00672477|49996597|FG001|Overall Study|Death|11|||
24902476|NCT00672477|49996596|FG000|Overall Study|Physician Decision|2|||
24902477|NCT00672477|49996597|FG001|Overall Study|Physician Decision|0|||
24902478|NCT00672477|49996596|FG000|Overall Study|Protocol Violation|1|||
24902479|NCT00672477|49996597|FG001|Overall Study|Protocol Violation|1|||
24902480|NCT00672477|49996596|FG000|Overall Study|Withdrawal by Subject|5|||
24902481|NCT00672477|49996597|FG001|Overall Study|Withdrawal by Subject|3|||
24902482|NCT00672477|49996596|FG000|Overall Study|Lack of Efficacy|1|||
25254086|NCT01339923|50569818|FG000|Overall Study|Lost to Follow-up|4|||
25337855|NCT00804986|50654259|FG000|Overall Study|Adverse Event|0|||
25337856|NCT00804986|50654260|FG001|Overall Study|Adverse Event|1|||
25337857|NCT00804986|50654261|FG002|Overall Study|Adverse Event|2|||
25337858|NCT00804986|50654262|FG003|Overall Study|Adverse Event|1|||
25337859|NCT00804986|50654263|FG004|Overall Study|Adverse Event|3|||
25254087|NCT01339923|50569819|FG001|Overall Study|Lost to Follow-up|4|||
25254088|NCT01339923|50569820|FG002|Overall Study|Lost to Follow-up|0|||
25254089|NCT01339923|50569821|FG003|Overall Study|Lost to Follow-up|3|||
25254090|NCT01339923|50569822|FG004|Overall Study|Lost to Follow-up|1|||
25254091|NCT01339923|50569823|FG005|Overall Study|Lost to Follow-up|1|||
25337860|NCT00804986|50654264|FG005|Overall Study|Adverse Event|0|||
25337861|NCT00804986|50654259|FG000|Overall Study|Lack of Efficacy|0|||
25337862|NCT00804986|50654260|FG001|Overall Study|Lack of Efficacy|0|||
25337863|NCT00804986|50654261|FG002|Overall Study|Lack of Efficacy|0|||
25337864|NCT00804986|50654262|FG003|Overall Study|Lack of Efficacy|1|||
25337865|NCT00804986|50654263|FG004|Overall Study|Lack of Efficacy|0|||
25337866|NCT00804986|50654264|FG005|Overall Study|Lack of Efficacy|3|||
25337867|NCT00804986|50654259|FG000|Overall Study|Lost to Follow-up|0|||
25337868|NCT00804986|50654260|FG001|Overall Study|Lost to Follow-up|0|||
25337869|NCT00804986|50654261|FG002|Overall Study|Lost to Follow-up|0|||
25337870|NCT00804986|50654262|FG003|Overall Study|Lost to Follow-up|1|||
25337871|NCT00804986|50654263|FG004|Overall Study|Lost to Follow-up|1|||
25337872|NCT00804986|50654264|FG005|Overall Study|Lost to Follow-up|3|||
25337873|NCT00804986|50654259|FG000|Overall Study|Protocol Violation|0|||
25337874|NCT00804986|50654260|FG001|Overall Study|Protocol Violation|1|||
25337875|NCT00804986|50654261|FG002|Overall Study|Protocol Violation|0|||
25337876|NCT00804986|50654262|FG003|Overall Study|Protocol Violation|1|||
25337877|NCT00804986|50654263|FG004|Overall Study|Protocol Violation|0|||
25337878|NCT00804986|50654264|FG005|Overall Study|Protocol Violation|0|||
25337879|NCT00804986|50654259|FG000|Overall Study|Withdrawal by Subject|0|||
25337880|NCT00804986|50654260|FG001|Overall Study|Withdrawal by Subject|3|||
25337881|NCT00804986|50654261|FG002|Overall Study|Withdrawal by Subject|0|||
25337882|NCT00804986|50654262|FG003|Overall Study|Withdrawal by Subject|3|||
25337883|NCT00804986|50654263|FG004|Overall Study|Withdrawal by Subject|5|||
25337884|NCT00804986|50654264|FG005|Overall Study|Withdrawal by Subject|3|||
25337885|NCT00804986|50654259|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
25337886|NCT00804986|50654260|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
25337887|NCT00804986|50654261|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
25337888|NCT00804986|50654262|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
25337889|NCT00804986|50654263|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
25254092|NCT01339923|50569824|FG006|Overall Study|Lost to Follow-up|5|||
25254093|NCT01339923|50569818|FG000|Overall Study|Protocol Violation|0|||
25254094|NCT01339923|50569819|FG001|Overall Study|Protocol Violation|0|||
25254095|NCT01339923|50569820|FG002|Overall Study|Protocol Violation|0|||
25254096|NCT01339923|50569821|FG003|Overall Study|Protocol Violation|0|||
25254097|NCT01339923|50569822|FG004|Overall Study|Protocol Violation|0|||
25254098|NCT01339923|50569823|FG005|Overall Study|Protocol Violation|3|||
25254099|NCT01339923|50569824|FG006|Overall Study|Protocol Violation|1|||
25337890|NCT00804986|50654264|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
25337891|NCT00804986|50654259|FG000|Overall Study|Sponsor Decision|0|||
25337892|NCT00804986|50654260|FG001|Overall Study|Sponsor Decision|1|||
25337893|NCT00804986|50654261|FG002|Overall Study|Sponsor Decision|0|||
25337894|NCT00804986|50654262|FG003|Overall Study|Sponsor Decision|0|||
25337895|NCT00804986|50654263|FG004|Overall Study|Sponsor Decision|0|||
25337896|NCT00804986|50654264|FG005|Overall Study|Sponsor Decision|0|||
25337897|NCT00804986|50654259|FG000|Overall Study|Physician Decision|1|||
25337898|NCT00804986|50654260|FG001|Overall Study|Physician Decision|0|||
25337899|NCT00804986|50654261|FG002|Overall Study|Physician Decision|0|||
25337900|NCT00804986|50654262|FG003|Overall Study|Physician Decision|0|||
25337901|NCT00804986|50654263|FG004|Overall Study|Physician Decision|0|||
25337902|NCT00804986|50654264|FG005|Overall Study|Physician Decision|0|||
25337903|NCT00752232|50654285|FG000|Overall Study|Protocol Violation|0|||
24902483|NCT00672477|49996597|FG001|Overall Study|Lack of Efficacy|1|||
25254100|NCT01339923|50569818|FG000|Overall Study|Unable to Classify|1|||
25254101|NCT01339923|50569819|FG001|Overall Study|Unable to Classify|0|||
25254102|NCT01339923|50569820|FG002|Overall Study|Unable to Classify|1|||
25254103|NCT01339923|50569821|FG003|Overall Study|Unable to Classify|0|||
25254104|NCT01339923|50569822|FG004|Overall Study|Unable to Classify|0|||
25254105|NCT01339923|50569823|FG005|Overall Study|Unable to Classify|1|||
25254106|NCT01339923|50569824|FG006|Overall Study|Unable to Classify|5|||
25337904|NCT00752232|50654286|FG001|Overall Study|Protocol Violation|0|||
25337905|NCT00752232|50654287|FG002|Overall Study|Protocol Violation|0|||
25337906|NCT00752232|50654288|FG003|Overall Study|Protocol Violation|0|||
25337907|NCT00752232|50654289|FG004|Overall Study|Protocol Violation|0|||
25337908|NCT00752232|50654290|FG005|Overall Study|Protocol Violation|1|||
25337909|NCT00752232|50654291|FG006|Overall Study|Protocol Violation|0|||
25337910|NCT00752232|50654285|FG000|Overall Study|Caregiver request|2|||
25337911|NCT00752232|50654286|FG001|Overall Study|Caregiver request|0|||
25337912|NCT00752232|50654287|FG002|Overall Study|Caregiver request|0|||
24902484|NCT00672477|49996596|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
25254107|NCT01339923|50569818|FG000|Overall Study|Withdrawal by Subject|7|||
25337913|NCT00752232|50654288|FG003|Overall Study|Caregiver request|0|||
25337914|NCT00752232|50654289|FG004|Overall Study|Caregiver request|1|||
25337915|NCT00752232|50654290|FG005|Overall Study|Caregiver request|0|||
25337916|NCT00752232|50654291|FG006|Overall Study|Caregiver request|0|||
25254108|NCT01339923|50569819|FG001|Overall Study|Withdrawal by Subject|11|||
25254109|NCT01339923|50569820|FG002|Overall Study|Withdrawal by Subject|6|||
25254110|NCT01339923|50569821|FG003|Overall Study|Withdrawal by Subject|1|||
25337917|NCT00752232|50654285|FG000|Overall Study|Investigator request|0|||
25254111|NCT01339923|50569822|FG004|Overall Study|Withdrawal by Subject|4|||
25337918|NCT00752232|50654286|FG001|Overall Study|Investigator request|0|||
25337919|NCT00752232|50654287|FG002|Overall Study|Investigator request|0|||
25337920|NCT00752232|50654288|FG003|Overall Study|Investigator request|0|||
25337921|NCT00752232|50654289|FG004|Overall Study|Investigator request|1|||
25337922|NCT00752232|50654290|FG005|Overall Study|Investigator request|0|||
25337923|NCT00752232|50654291|FG006|Overall Study|Investigator request|0|||
25337924|NCT00752232|50654285|FG000|Overall Study|Subject request|0|||
25337925|NCT00752232|50654286|FG001|Overall Study|Subject request|0|||
25337926|NCT00752232|50654287|FG002|Overall Study|Subject request|1|||
25337927|NCT00752232|50654288|FG003|Overall Study|Subject request|0|||
25337928|NCT00752232|50654289|FG004|Overall Study|Subject request|0|||
25337929|NCT00752232|50654290|FG005|Overall Study|Subject request|0|||
25337930|NCT00752232|50654291|FG006|Overall Study|Subject request|0|||
25337931|NCT00752232|50654285|FG000|Overall Study|Group home admission|0|||
25337932|NCT00752232|50654286|FG001|Overall Study|Group home admission|0|||
25337933|NCT00752232|50654287|FG002|Overall Study|Group home admission|0|||
25337934|NCT00752232|50654288|FG003|Overall Study|Group home admission|1|||
25337935|NCT00752232|50654289|FG004|Overall Study|Group home admission|0|||
25337936|NCT00752232|50654290|FG005|Overall Study|Group home admission|0|||
25337937|NCT00752232|50654291|FG006|Overall Study|Group home admission|0|||
25337938|NCT00752232|50654285|FG000|Overall Study|Caregiver could not attend the subject|0|||
25337939|NCT00752232|50654286|FG001|Overall Study|Caregiver could not attend the subject|0|||
25337940|NCT00752232|50654287|FG002|Overall Study|Caregiver could not attend the subject|0|||
25337941|NCT00752232|50654288|FG003|Overall Study|Caregiver could not attend the subject|0|||
25337942|NCT00752232|50654289|FG004|Overall Study|Caregiver could not attend the subject|1|||
25337943|NCT00752232|50654290|FG005|Overall Study|Caregiver could not attend the subject|0|||
25337944|NCT00752232|50654291|FG006|Overall Study|Caregiver could not attend the subject|0|||
25337945|NCT00760266|50654310|FG000|Overall Study|Adverse Event|13|||
25337946|NCT00760266|50654311|FG001|Overall Study|Adverse Event|7|||
25337947|NCT00760266|50654310|FG000|Overall Study|Abnormal laboratory value(s)|1|||
25337948|NCT00760266|50654311|FG001|Overall Study|Abnormal laboratory value(s)|0|||
25337949|NCT00760266|50654310|FG000|Overall Study|Abnormal test procedure result(s)|1|||
25337950|NCT00760266|50654311|FG001|Overall Study|Abnormal test procedure result(s)|0|||
25337951|NCT00760266|50654310|FG000|Overall Study|Lack of Efficacy|2|||
25337952|NCT00760266|50654311|FG001|Overall Study|Lack of Efficacy|2|||
25337953|NCT00760266|50654310|FG000|Overall Study|Protocol deviation|2|||
25337954|NCT00760266|50654311|FG001|Overall Study|Protocol deviation|4|||
25337955|NCT00760266|50654310|FG000|Overall Study|Patient withdrew consent|3|||
25337956|NCT00760266|50654311|FG001|Overall Study|Patient withdrew consent|3|||
25337957|NCT00760266|50654310|FG000|Overall Study|Lost to Follow-up|2|||
25337958|NCT00760266|50654311|FG001|Overall Study|Lost to Follow-up|1|||
25337959|NCT00760266|50654310|FG000|Overall Study|Administrative Problems|0|||
25337960|NCT00760266|50654311|FG001|Overall Study|Administrative Problems|1|||
25337961|NCT00753714|50654319|FG000|Overall Study|Lack of Efficacy|21|||
25337962|NCT00753714|50654320|FG001|Overall Study|Lack of Efficacy|34|||
25337963|NCT00753714|50654319|FG000|Overall Study|Adverse Event|26|||
25337964|NCT00753714|50654320|FG001|Overall Study|Adverse Event|18|||
25337965|NCT00753714|50654319|FG000|Overall Study|Protocol Violation|1|||
25337966|NCT00753714|50654320|FG001|Overall Study|Protocol Violation|0|||
25337967|NCT00753714|50654319|FG000|Overall Study|Lost to Follow-up|0|||
25337968|NCT00753714|50654320|FG001|Overall Study|Lost to Follow-up|1|||
25337969|NCT00753714|50654319|FG000|Overall Study|Withdrawal by Subject|2|||
25254112|NCT01339923|50569823|FG005|Overall Study|Withdrawal by Subject|3|||
25254113|NCT01339923|50569824|FG006|Overall Study|Withdrawal by Subject|2|||
25254114|NCT01380093|50569857|FG000|Naloxone Challenge Phase|Screen failures|21|||
25254115|NCT01380093|50569858|FG001|Naloxone Challenge Phase|Screen failures|0|||
25254116|NCT01380093|50569859|FG002|Naloxone Challenge Phase|Screen failures|0|||
25254117|NCT01380093|50569860|FG003|Naloxone Challenge Phase|Screen failures|0|||
25254118|NCT01380093|50569861|FG004|Naloxone Challenge Phase|Screen failures|0|||
25254119|NCT01380093|50569862|FG005|Naloxone Challenge Phase|Screen failures|0|||
25254120|NCT01380093|50569863|FG006|Naloxone Challenge Phase|Screen failures|0|||
25254121|NCT01380093|50569864|FG007|Naloxone Challenge Phase|Screen failures|0|||
25337970|NCT00753714|50654320|FG001|Overall Study|Withdrawal by Subject|1|||
25337971|NCT00753714|50654319|FG000|Overall Study|Death|3|||
25337972|NCT00753714|50654320|FG001|Overall Study|Death|3|||
25337973|NCT00753714|50654319|FG000|Overall Study|Other|7|||
25337974|NCT00753714|50654320|FG001|Overall Study|Other|5|||
25337975|NCT00759954|50654331|FG000|Overall Study|Personal reason|1|||
25337976|NCT00759954|50654332|FG001|Overall Study|Personal reason|0|||
25337977|NCT00759954|50654331|FG000|Overall Study|Adverse Event|1|||
25337978|NCT00759954|50654332|FG001|Overall Study|Adverse Event|2|||
25337979|NCT00804908|50654341|FG000|Overall Study|Other|115|||
25337980|NCT00804908|50654342|FG001|Overall Study|Other|116|||
25337981|NCT00804908|50654343|FG002|Overall Study|Other|114|||
25254122|NCT01380093|50569865|FG008|Naloxone Challenge Phase|Screen failures|0|||
25337982|NCT00808808|50654354|FG000|Overall Study|Vaccinated; survey not completed|131|||
25337983|NCT00808808|50654355|FG001|Overall Study|Vaccinated; survey not completed|169|||
25337984|NCT00808808|50654356|FG002|Overall Study|Vaccinated; survey not completed|302|||
25337985|NCT00808808|50654354|FG000|Overall Study|Employee was not vaccinated.|2686|||
25337986|NCT00808808|50654355|FG001|Overall Study|Employee was not vaccinated.|2268|||
25337987|NCT00808808|50654356|FG002|Overall Study|Employee was not vaccinated.|2255|||
25337988|NCT00589784|50654372|FG000|Overall Study|Withdrawal by Subject|0|||
25337989|NCT00589784|50654373|FG001|Overall Study|Withdrawal by Subject|6|||
25337990|NCT00589784|50654372|FG000|Overall Study|Patient inevaluable|1|||
25337991|NCT00589784|50654373|FG001|Overall Study|Patient inevaluable|0|||
25337992|NCT00589784|50654372|FG000|Overall Study|Adverse Event|0|||
25337993|NCT00589784|50654373|FG001|Overall Study|Adverse Event|4|||
25337994|NCT00759876|50654378|FG000|Overall Study|Sponsor terminated study early|36|||
25337995|NCT00823979|50654385|FG000|Overall Study|Lack of Efficacy|13|||
25337996|NCT00823979|50654386|FG001|Overall Study|Lack of Efficacy|16|||
25337997|NCT00823979|50654387|FG002|Overall Study|Lack of Efficacy|9|||
25337998|NCT00823979|50654385|FG000|Overall Study|Lost to Follow-up|2|||
25337999|NCT00823979|50654386|FG001|Overall Study|Lost to Follow-up|1|||
25338000|NCT00823979|50654387|FG002|Overall Study|Lost to Follow-up|0|||
25338001|NCT00823979|50654385|FG000|Overall Study|Withdrawal by Subject|2|||
25338002|NCT00823979|50654386|FG001|Overall Study|Withdrawal by Subject|3|||
25338003|NCT00823979|50654387|FG002|Overall Study|Withdrawal by Subject|2|||
25338004|NCT00823979|50654385|FG000|Overall Study|Protocol Violation|1|||
25338005|NCT00823979|50654386|FG001|Overall Study|Protocol Violation|1|||
25338006|NCT00823979|50654387|FG002|Overall Study|Protocol Violation|0|||
25338007|NCT00823979|50654385|FG000|Overall Study|Pregnancy|0|||
25338008|NCT00823979|50654386|FG001|Overall Study|Pregnancy|1|||
25338009|NCT00823979|50654387|FG002|Overall Study|Pregnancy|0|||
25338010|NCT00823979|50654385|FG000|Overall Study|Adverse Event|0|||
25338011|NCT00823979|50654386|FG001|Overall Study|Adverse Event|2|||
25338012|NCT00823979|50654387|FG002|Overall Study|Adverse Event|4|||
25338013|NCT00823979|50654385|FG000|Overall Study|Other|2|||
25338014|NCT00823979|50654386|FG001|Overall Study|Other|0|||
25338015|NCT00823979|50654387|FG002|Overall Study|Other|1|||
25338016|NCT00823979|50654385|FG000|Overall Study|Randomized but not Treated|4|||
25338017|NCT00823979|50654386|FG001|Overall Study|Randomized but not Treated|3|||
25338018|NCT00823979|50654387|FG002|Overall Study|Randomized but not Treated|1|||
25338019|NCT00823979|50654385|FG000|Overall Study|Study Terminated by Sponsor|5|||
25338020|NCT00823979|50654386|FG001|Overall Study|Study Terminated by Sponsor|5|||
25338021|NCT00823979|50654387|FG002|Overall Study|Study Terminated by Sponsor|7|||
25338022|NCT00823901|50654397|FG000|Overall Study|Adverse Event|1|||
25338023|NCT00823901|50654398|FG001|Overall Study|Adverse Event|1|||
25338024|NCT00823901|50654397|FG000|Overall Study|Lack of Efficacy|1|||
25338025|NCT00823901|50654398|FG001|Overall Study|Lack of Efficacy|0|||
25338026|NCT00823901|50654397|FG000|Overall Study|Lost to Follow-up|2|||
25338027|NCT00823901|50654398|FG001|Overall Study|Lost to Follow-up|1|||
25338028|NCT00823823|50654406|FG000|Overall Study|Lost to Follow-up|3|||
25338029|NCT00823823|50654407|FG001|Overall Study|Lost to Follow-up|1|||
25338030|NCT00823823|50654406|FG000|Overall Study|Protocol Violation|5|||
25338031|NCT00823823|50654407|FG001|Overall Study|Protocol Violation|5|||
25338032|NCT00759564|50654427|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
25338033|NCT00759564|50654428|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
25338034|NCT00759564|50654429|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
25338035|NCT00759564|50654430|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
25338036|NCT00759564|50654431|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
25338037|NCT00816023|50654467|FG000|Overall Study|Lost to Follow-up|1|||
25338038|NCT00816023|50654468|FG001|Overall Study|Lost to Follow-up|1|||
25338039|NCT00816023|50654469|FG002|Overall Study|Lost to Follow-up|0|||
25338040|NCT00816023|50654470|FG003|Overall Study|Lost to Follow-up|0|||
25338041|NCT00816023|50654467|FG000|Overall Study|Withdrawal by Subject|1|||
25338042|NCT00816023|50654468|FG001|Overall Study|Withdrawal by Subject|0|||
24902485|NCT00672477|49996597|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
24902486|NCT00674661|49996605|FG000|Overall Study|Other|5|||
24902487|NCT00674661|49996606|FG001|Overall Study|Other|7|||
24902488|NCT00674661|49996605|FG000|Overall Study|Lost to Follow-up|6|||
24902489|NCT00674661|49996606|FG001|Overall Study|Lost to Follow-up|3|||
24902490|NCT00674661|49996605|FG000|Overall Study|Withdrawal by Subject|0|||
24902491|NCT00674661|49996606|FG001|Overall Study|Withdrawal by Subject|5|||
25338043|NCT00816023|50654469|FG002|Overall Study|Withdrawal by Subject|0|||
25338044|NCT00816023|50654470|FG003|Overall Study|Withdrawal by Subject|0|||
25338045|NCT00816023|50654467|FG000|Overall Study|Physician Decision|0|||
24902492|NCT00671931|49996617|FG000|Overall Study|Physician Decision|1|||
24902493|NCT00671931|49996618|FG001|Overall Study|Physician Decision|0|||
25338046|NCT00816023|50654468|FG001|Overall Study|Physician Decision|0|||
25338047|NCT00816023|50654469|FG002|Overall Study|Physician Decision|1|||
25338048|NCT00816023|50654470|FG003|Overall Study|Physician Decision|0|||
25338049|NCT00816023|50654467|FG000|Overall Study|assessments complete prior to window|1|||
25338050|NCT00816023|50654468|FG001|Overall Study|assessments complete prior to window|1|||
25338051|NCT00816023|50654469|FG002|Overall Study|assessments complete prior to window|2|||
25338052|NCT00816023|50654470|FG003|Overall Study|assessments complete prior to window|1|||
25338053|NCT00816023|50654467|FG000|Overall Study|Randomized Not Treated|6|||
25338054|NCT00816023|50654468|FG001|Overall Study|Randomized Not Treated|4|||
25338055|NCT00816023|50654469|FG002|Overall Study|Randomized Not Treated|6|||
25338056|NCT00816023|50654470|FG003|Overall Study|Randomized Not Treated|11|||
25338057|NCT00759174|50654482|FG000|Overall Study|Other|0|||
25338058|NCT00759174|50654483|FG001|Overall Study|Other|2|||
25338059|NCT00815633|50654490|FG000|Overall Study|study terminated|1|||
25338060|NCT00830765|50654496|FG000|Overall Study|Protocol Violation|3|||
24902494|NCT00671931|49996619|FG002|Overall Study|Physician Decision|0|||
24902495|NCT00671931|49996620|FG003|Overall Study|Physician Decision|2|||
24902496|NCT00671931|49996621|FG004|Overall Study|Physician Decision|1|||
24902497|NCT00673881|49996637|FG000|Overall Study|Withdrawal by Subject|1|||
24902498|NCT00671853|49996643|FG000|Overall Study|Lack of Efficacy|3|||
24902499|NCT00671853|49996644|FG001|Overall Study|Lack of Efficacy|7|||
24902500|NCT00671853|49996643|FG000|Overall Study|Adverse Event|7|||
24902501|NCT00671853|49996644|FG001|Overall Study|Adverse Event|1|||
24902502|NCT00671853|49996643|FG000|Overall Study|Withdrawal by Subject|1|||
24902503|NCT00671853|49996644|FG001|Overall Study|Withdrawal by Subject|5|||
24902504|NCT00671853|49996643|FG000|Overall Study|Lost to Follow-up|8|||
24902505|NCT00671853|49996644|FG001|Overall Study|Lost to Follow-up|8|||
24902506|NCT00671853|49996643|FG000|Overall Study|Physician Decision|0|||
24902507|NCT00671853|49996644|FG001|Overall Study|Physician Decision|2|||
24902508|NCT00671853|49996643|FG000|Overall Study|Non-adherence with study procedures|1|||
24902509|NCT00671853|49996644|FG001|Overall Study|Non-adherence with study procedures|4|||
24902510|NCT00570921|49996652|FG000|Overall Study|Protocol Violation|1|||
24902511|NCT00570921|49996652|FG000|Overall Study|Physician Decision|1|||
24902512|NCT00670449|49996660|FG000|Overall Study|Adverse Event|6|||
24902513|NCT00670449|49996661|FG001|Overall Study|Adverse Event|2|||
24902514|NCT00670449|49996662|FG002|Overall Study|Adverse Event|8|||
24902515|NCT00670449|49996663|FG003|Overall Study|Adverse Event|5|||
24902516|NCT00670449|49996660|FG000|Overall Study|Protocol Deviation|1|||
24902517|NCT00670449|49996661|FG001|Overall Study|Protocol Deviation|2|||
24902518|NCT00670449|49996662|FG002|Overall Study|Protocol Deviation|0|||
24902519|NCT00670449|49996663|FG003|Overall Study|Protocol Deviation|1|||
24902520|NCT00670449|49996660|FG000|Overall Study|Administrative Problems|0|||
24902521|NCT00670449|49996661|FG001|Overall Study|Administrative Problems|2|||
24902522|NCT00670449|49996662|FG002|Overall Study|Administrative Problems|0|||
24902523|NCT00670449|49996663|FG003|Overall Study|Administrative Problems|1|||
24902524|NCT00670449|49996660|FG000|Overall Study|Subject Withdrew Consent|0|||
24902525|NCT00670449|49996661|FG001|Overall Study|Subject Withdrew Consent|2|||
24902526|NCT00670449|49996662|FG002|Overall Study|Subject Withdrew Consent|0|||
24902527|NCT00670449|49996663|FG003|Overall Study|Subject Withdrew Consent|1|||
24902528|NCT00670449|49996660|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
24902529|NCT00670449|49996661|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
24902530|NCT00670449|49996662|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
24902531|NCT00670449|49996663|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
24902532|NCT00670449|49996660|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
24902533|NCT00670449|49996661|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
24902534|NCT00670449|49996662|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
24902535|NCT00670449|49996663|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
24902536|NCT00668733|49996674|FG000|Overall Study|Lost to Follow-up|2|||
24902537|NCT00668733|49996675|FG001|Overall Study|Lost to Follow-up|3|||
24902538|NCT00668733|49996674|FG000|Overall Study|Withdrawal by Subject|0|||
24977420|NCT00048542|50066003|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
24977421|NCT00048542|50065996|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
24977422|NCT00048542|50065997|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
24977423|NCT00048542|50065998|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
24977424|NCT00048542|50065999|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
24977425|NCT00048542|50066000|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
24977426|NCT00048542|50066001|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
25338061|NCT00830765|50654497|FG001|Overall Study|Protocol Violation|2|||
25338062|NCT00830375|50654503|FG000|Overall Study|Lost to Follow-up|1|||
24902539|NCT00668733|49996675|FG001|Overall Study|Withdrawal by Subject|4|||
24902540|NCT00673257|49996681|FG000|Overall Study|Withdrawal by Subject|4|||
24902541|NCT00673257|49996681|FG000|Overall Study|Unable to obtain specimen|1|||
24902542|NCT00667875|49996688|FG000|Overall Study|Adverse Event|0|||
24902543|NCT00667875|49996689|FG001|Overall Study|Adverse Event|2|||
24902544|NCT00667875|49996690|FG002|Overall Study|Adverse Event|6|||
24902545|NCT00667875|49996688|FG000|Overall Study|Withdrawal by Subject|10|||
24902546|NCT00667875|49996689|FG001|Overall Study|Withdrawal by Subject|9|||
24902547|NCT00667875|49996690|FG002|Overall Study|Withdrawal by Subject|7|||
24902548|NCT03468998|49996710|FG000|Overall Study|Withdrawal by Subject|1|||
24902549|NCT03468998|49996711|FG001|Overall Study|Withdrawal by Subject|1|||
25338063|NCT00803270|50654509|FG000|Overall Study|Lost to Follow-up|1|||
25338064|NCT00803270|50654510|FG001|Overall Study|Lost to Follow-up|2|||
25338065|NCT00751998|50654516|FG000|Overall Study|Lost to Follow-up|7|||
25338066|NCT00751998|50654516|FG000|Overall Study|Death|11|||
25338067|NCT00751998|50654516|FG000|Overall Study|Withdrawal by Subject|2|||
25338068|NCT00803738|50654522|FG000|Overall Study|Adverse Event|3|||
25338069|NCT00803738|50654523|FG001|Overall Study|Adverse Event|5|||
25338070|NCT00803738|50654522|FG000|Overall Study|Lost to Follow-up|4|||
25338071|NCT00803738|50654523|FG001|Overall Study|Lost to Follow-up|4|||
25338072|NCT00803738|50654522|FG000|Overall Study|Protocol Violation|18|||
25338073|NCT00803738|50654523|FG001|Overall Study|Protocol Violation|10|||
25338074|NCT00803738|50654522|FG000|Overall Study|Withdrawal by Subject|1|||
25338075|NCT00803738|50654523|FG001|Overall Study|Withdrawal by Subject|4|||
25338076|NCT00803738|50654522|FG000|Overall Study|Lack of Efficacy|10|||
25338077|NCT00803738|50654523|FG001|Overall Study|Lack of Efficacy|16|||
25338078|NCT00803738|50654522|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
25338079|NCT00803738|50654523|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
25338080|NCT00803738|50654522|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
25338081|NCT00803738|50654523|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
25338082|NCT00758706|50654531|FG000|Overall Study|Adverse Event|4|||
25338083|NCT00758706|50654532|FG001|Overall Study|Adverse Event|4|||
24902550|NCT03468998|49996712|FG002|Overall Study|Withdrawal by Subject|0|||
24902551|NCT03468998|49996713|FG003|Overall Study|Withdrawal by Subject|4|||
24902552|NCT03468998|49996714|FG004|Overall Study|Withdrawal by Subject|1|||
24902553|NCT03468998|49996715|FG005|Overall Study|Withdrawal by Subject|0|||
24902554|NCT00667251|49996729|FG000|Overall Study|Adverse Event|13|||
24902555|NCT00667251|49996730|FG001|Overall Study|Adverse Event|4|||
24902556|NCT00667251|49996729|FG000|Overall Study|Withdrawal by Subject|6|||
24902557|NCT00667251|49996730|FG001|Overall Study|Withdrawal by Subject|2|||
24902558|NCT00667251|49996729|FG000|Overall Study|Other/missing|46|||
24902559|NCT00667251|49996730|FG001|Overall Study|Other/missing|84|||
24902560|NCT00667251|49996729|FG000|Overall Study|Intercurrent Illness|4|||
24902561|NCT00667251|49996730|FG001|Overall Study|Intercurrent Illness|3|||
24902562|NCT00667251|49996729|FG000|Overall Study|Symptomatic progression|1|||
24902563|NCT00667251|49996730|FG001|Overall Study|Symptomatic progression|2|||
24902564|NCT00669903|49996748|FG000|Overall Study|Adverse Event|0|||
24902565|NCT00669903|49996749|FG001|Overall Study|Adverse Event|1|||
24902566|NCT00669903|49996750|FG002|Overall Study|Adverse Event|3|||
24902567|NCT00669903|49996751|FG003|Overall Study|Adverse Event|1|||
24902568|NCT00669903|49996748|FG000|Overall Study|Withdrawal by Subject|0|||
24902569|NCT00669903|49996749|FG001|Overall Study|Withdrawal by Subject|2|||
24902570|NCT00669903|49996750|FG002|Overall Study|Withdrawal by Subject|2|||
24902571|NCT00669903|49996751|FG003|Overall Study|Withdrawal by Subject|2|||
24902572|NCT00669903|49996748|FG000|Overall Study|Lost to Follow-up|1|||
24902573|NCT00669903|49996749|FG001|Overall Study|Lost to Follow-up|1|||
24902574|NCT00669903|49996750|FG002|Overall Study|Lost to Follow-up|0|||
24902575|NCT00669903|49996751|FG003|Overall Study|Lost to Follow-up|1|||
24902576|NCT00669903|49996748|FG000|Overall Study|Protocol Violation|0|||
24902577|NCT00669903|49996749|FG001|Overall Study|Protocol Violation|1|||
24902578|NCT00669903|49996750|FG002|Overall Study|Protocol Violation|0|||
24902579|NCT00669903|49996751|FG003|Overall Study|Protocol Violation|0|||
24902580|NCT03759392|49996763|FG000|Overall Study|Adverse Event|12|||
24902581|NCT03759392|49996764|FG001|Overall Study|Adverse Event|4|||
24902582|NCT03759392|49996763|FG000|Overall Study|Death|2|||
24902583|NCT03759392|49996764|FG001|Overall Study|Death|1|||
24902584|NCT03759392|49996763|FG000|Overall Study|Withdrawal by Subject|2|||
24902585|NCT03759392|49996764|FG001|Overall Study|Withdrawal by Subject|0|||
24902586|NCT03759392|49996763|FG000|Overall Study|Protocol Violation|2|||
24902587|NCT03759392|49996764|FG001|Overall Study|Protocol Violation|0|||
24902588|NCT03759392|49996763|FG000|Overall Study|Physician Decision|0|||
24902589|NCT03759392|49996764|FG001|Overall Study|Physician Decision|1|||
24902590|NCT03759392|49996763|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
24902591|NCT03759392|49996764|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
24902592|NCT03759392|49996763|FG000|Overall Study|No longer able to take medicines|1|||
24902593|NCT03759392|49996764|FG001|Overall Study|No longer able to take medicines|0|||
24902594|NCT03759392|49996763|FG000|Overall Study|Stopped taking study drug|1|||
24902595|NCT03759392|49996764|FG001|Overall Study|Stopped taking study drug|0|||
24902596|NCT00667719|49996770|FG000|Overall Study|Adverse Event|39|||
25338084|NCT00591266|50654541|FG000|Overall Study|Adverse Event|2|||
25338085|NCT00591266|50654542|FG001|Overall Study|Adverse Event|2|||
25338086|NCT00591266|50654543|FG002|Overall Study|Adverse Event|3|||
25338087|NCT00591266|50654541|FG000|Overall Study|Lost to Follow-up|0|||
25338088|NCT00591266|50654542|FG001|Overall Study|Lost to Follow-up|1|||
24902597|NCT00667719|49996770|FG000|Overall Study|Abnormal Test Procedure|1|||
24902598|NCT00667719|49996770|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
24902599|NCT00667719|49996770|FG000|Overall Study|Protocol Violation|3|||
24902600|NCT00667719|49996770|FG000|Overall Study|Withdrawal by Subject|17|||
24902601|NCT00667719|49996770|FG000|Overall Study|Lost to Follow-up|8|||
25338089|NCT00591266|50654543|FG002|Overall Study|Lost to Follow-up|0|||
25338090|NCT00591266|50654541|FG000|Overall Study|Protocol Violation|0|||
25338091|NCT00591266|50654542|FG001|Overall Study|Protocol Violation|0|||
25338092|NCT00591266|50654543|FG002|Overall Study|Protocol Violation|1|||
25338093|NCT00591266|50654541|FG000|Overall Study|Withdrawal by Subject|6|||
25338094|NCT00591266|50654542|FG001|Overall Study|Withdrawal by Subject|2|||
25338095|NCT00591266|50654543|FG002|Overall Study|Withdrawal by Subject|5|||
25338096|NCT00591266|50654541|FG000|Overall Study|Lack of Efficacy|0|||
25338097|NCT00591266|50654542|FG001|Overall Study|Lack of Efficacy|2|||
25338098|NCT00591266|50654543|FG002|Overall Study|Lack of Efficacy|0|||
25338099|NCT00591266|50654541|FG000|Overall Study|Other|1|||
25338100|NCT00591266|50654542|FG001|Overall Study|Other|4|||
25338101|NCT00591266|50654543|FG002|Overall Study|Other|5|||
25338102|NCT00758394|50654555|FG000|2nd Intervention Order|Lost to Follow-up|0|||
25338103|NCT00758394|50654556|FG001|2nd Intervention Order|Lost to Follow-up|1|||
25338104|NCT00758394|50654557|FG002|2nd Intervention Order|Lost to Follow-up|0|||
25338105|NCT00758394|50654558|FG003|2nd Intervention Order|Lost to Follow-up|0|||
25338106|NCT00758394|50654555|FG000|3rd Intervention|Lost to Follow-up|1|||
25338107|NCT00758394|50654556|FG001|3rd Intervention|Lost to Follow-up|0|||
25338108|NCT00758394|50654557|FG002|3rd Intervention|Lost to Follow-up|0|||
25338109|NCT00758394|50654558|FG003|3rd Intervention|Lost to Follow-up|1|||
25338110|NCT04450394|50654571|FG000|Overall Study|Adverse Event|2|||
25338111|NCT04450394|50654572|FG001|Overall Study|Adverse Event|0|||
25338112|NCT04450394|50654573|FG002|Overall Study|Adverse Event|0|||
25338113|NCT04450394|50654571|FG000|Overall Study|Death|0|||
25338114|NCT04450394|50654572|FG001|Overall Study|Death|1|||
25338115|NCT04450394|50654573|FG002|Overall Study|Death|0|||
25338116|NCT04450394|50654571|FG000|Overall Study|Lost to Follow-up|0|||
25338117|NCT04450394|50654572|FG001|Overall Study|Lost to Follow-up|3|||
25338118|NCT04450394|50654573|FG002|Overall Study|Lost to Follow-up|0|||
25338119|NCT04450394|50654571|FG000|Overall Study|Physician Decision|0|||
25338120|NCT04450394|50654572|FG001|Overall Study|Physician Decision|1|||
25338121|NCT04450394|50654573|FG002|Overall Study|Physician Decision|0|||
25338122|NCT04450394|50654571|FG000|Overall Study|Protocol Violation|2|||
25338123|NCT04450394|50654572|FG001|Overall Study|Protocol Violation|0|||
25254123|NCT01380093|50569857|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
25254124|NCT01380093|50569858|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
25254125|NCT01380093|50569859|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
25338124|NCT04450394|50654573|FG002|Overall Study|Protocol Violation|0|||
25338125|NCT04450394|50654571|FG000|Overall Study|Withdrawal by Subject|6|||
25338126|NCT04450394|50654572|FG001|Overall Study|Withdrawal by Subject|9|||
25338127|NCT04450394|50654573|FG002|Overall Study|Withdrawal by Subject|0|||
25338128|NCT00758160|50654580|FG000|Overall Study|No Longer Requires Study Medication|4|||
25254126|NCT01380093|50569860|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
25254127|NCT01380093|50569861|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
25254128|NCT01380093|50569862|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
25254129|NCT01380093|50569863|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
25254130|NCT01380093|50569864|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
25254131|NCT01380093|50569865|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
25254132|NCT01380093|50569857|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
25254133|NCT01380093|50569858|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
25254134|NCT01380093|50569859|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
25254135|NCT01380093|50569860|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
25254136|NCT01380093|50569861|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
25254137|NCT01380093|50569862|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
25254138|NCT01380093|50569863|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
25254139|NCT01380093|50569864|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
25254140|NCT01380093|50569865|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
25254141|NCT01380093|50569857|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
25254142|NCT01380093|50569858|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
25254143|NCT01380093|50569859|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
25254144|NCT01380093|50569860|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
25254145|NCT01380093|50569861|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
25254146|NCT01380093|50569862|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
25338129|NCT00758160|50654580|FG000|Overall Study|Administration Problems|3|||
25338130|NCT00758160|50654580|FG000|Overall Study|Adverse Event|15|||
25338131|NCT00758160|50654580|FG000|Overall Study|Lack of Efficacy|10|||
25338132|NCT00758160|50654580|FG000|Overall Study|Lost to Follow-up|14|||
25338133|NCT00758160|50654580|FG000|Overall Study|Protocol Violation|12|||
25338134|NCT00758160|50654580|FG000|Overall Study|Withdrawal by Subject|8|||
25338135|NCT00757848|50654590|FG000|Overall Study|Voluntary discontinuation|1|||
25338136|NCT00757848|50654591|FG001|Overall Study|Voluntary discontinuation|0|||
25338137|NCT00757848|50654590|FG000|Overall Study|Adverse Event|1|||
25338138|NCT00757848|50654591|FG001|Overall Study|Adverse Event|2|||
25338139|NCT00757848|50654590|FG000|Overall Study|Incorrect enrolment|1|||
25338140|NCT00757848|50654591|FG001|Overall Study|Incorrect enrolment|0|||
25338141|NCT00751296|50654597|FG000|Overall Study|Adverse Event|2|||
25338142|NCT00751140|50654601|FG000|Overall Study|benign angioma excluded from analysis|1|||
25338143|NCT00751881|50654612|FG000|Core Treatment Period|Not treated|1|||
25338144|NCT00751881|50654613|FG001|Core Treatment Period|Not treated|1|||
25338145|NCT00751881|50654614|FG002|Core Treatment Period|Not treated|2|||
25338146|NCT00751881|50654612|FG000|Core Treatment Period|Adverse Event|26|||
25338147|NCT00751881|50654613|FG001|Core Treatment Period|Adverse Event|54|||
25338148|NCT00751881|50654614|FG002|Core Treatment Period|Adverse Event|58|||
25338149|NCT00751881|50654612|FG000|Core Treatment Period|Lack of Efficacy|37|||
25338150|NCT00751881|50654613|FG001|Core Treatment Period|Lack of Efficacy|30|||
25338151|NCT00751881|50654614|FG002|Core Treatment Period|Lack of Efficacy|20|||
25338152|NCT00751881|50654612|FG000|Core Treatment Period|Poor compliance to protocol|15|||
25338153|NCT00751881|50654613|FG001|Core Treatment Period|Poor compliance to protocol|3|||
25338154|NCT00751881|50654614|FG002|Core Treatment Period|Poor compliance to protocol|4|||
25338155|NCT00751881|50654612|FG000|Core Treatment Period|Lost to Follow-up|6|||
25338156|NCT00751881|50654613|FG001|Core Treatment Period|Lost to Follow-up|4|||
25338157|NCT00751881|50654614|FG002|Core Treatment Period|Lost to Follow-up|3|||
25338158|NCT00751881|50654612|FG000|Core Treatment Period|Other: protocol deviation|3|||
25338159|NCT00751881|50654613|FG001|Core Treatment Period|Other: protocol deviation|3|||
25338160|NCT00751881|50654614|FG002|Core Treatment Period|Other: protocol deviation|7|||
25338161|NCT00751881|50654612|FG000|Core Treatment Period|Other: wish to parent|5|||
25338162|NCT00751881|50654613|FG001|Core Treatment Period|Other: wish to parent|7|||
25338163|NCT00751881|50654614|FG002|Core Treatment Period|Other: wish to parent|4|||
25338164|NCT00751881|50654612|FG000|Core Treatment Period|Other: personal/family constraints|6|||
25338165|NCT00751881|50654613|FG001|Core Treatment Period|Other: personal/family constraints|7|||
25338166|NCT00751881|50654614|FG002|Core Treatment Period|Other: personal/family constraints|10|||
25338167|NCT00751881|50654612|FG000|Core Treatment Period|Other: MS treatment change|6|||
25338168|NCT00751881|50654613|FG001|Core Treatment Period|Other: MS treatment change|4|||
25338169|NCT00751881|50654614|FG002|Core Treatment Period|Other: MS treatment change|4|||
25338170|NCT00751881|50654612|FG000|Core Treatment Period|Other: tolerability complaints|2|||
25338171|NCT00751881|50654613|FG001|Core Treatment Period|Other: tolerability complaints|0|||
25338172|NCT00751881|50654614|FG002|Core Treatment Period|Other: tolerability complaints|0|||
25338173|NCT00751881|50654612|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
25338174|NCT00751881|50654613|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
25338175|NCT00751881|50654614|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
25338176|NCT00751881|50654612|FG000|Extension Study Period|Adverse Event|18|||
25338177|NCT00751881|50654613|FG001|Extension Study Period|Adverse Event|20|||
25338178|NCT00751881|50654614|FG002|Extension Study Period|Adverse Event|21|||
25338179|NCT00751881|50654612|FG000|Extension Study Period|Lack of Efficacy|14|||
24902602|NCT00669669|49996779|FG000|Overall Study|To late to start treatment|1|||
24902603|NCT00467779|49996798|FG000|Stage 1|Adverse Event|1|||
24902604|NCT00467779|49996799|FG001|Stage 1|Adverse Event|0|||
24902605|NCT00467779|49996800|FG002|Stage 1|Adverse Event|0|||
24902606|NCT00467779|49996801|FG003|Stage 1|Adverse Event|0|||
24902607|NCT00467779|49996802|FG004|Stage 1|Adverse Event|0|||
24902608|NCT00467779|49996803|FG005|Stage 1|Adverse Event|1|||
24902609|NCT00467779|49996804|FG006|Stage 1|Adverse Event|2|||
24902610|NCT00467779|49996805|FG007|Stage 1|Adverse Event|1|||
24902611|NCT00467779|49996806|FG008|Stage 1|Adverse Event|0|||
24902612|NCT00467779|49996807|FG009|Stage 1|Adverse Event|0|||
24902613|NCT00467779|49996808|FG010|Stage 1|Adverse Event|0|||
24902614|NCT00467779|49996809|FG011|Stage 1|Adverse Event|0|||
24902615|NCT00467779|49996810|FG012|Stage 1|Adverse Event|0|||
24902616|NCT00467779|49996811|FG013|Stage 1|Adverse Event|0|||
24902617|NCT00467779|49996812|FG014|Stage 1|Adverse Event|0|||
24902618|NCT00467779|49996798|FG000|Stage 1|Disease Progression|2|||
24902619|NCT00467779|49996799|FG001|Stage 1|Disease Progression|2|||
24902620|NCT00467779|49996800|FG002|Stage 1|Disease Progression|2|||
24902621|NCT00467779|49996801|FG003|Stage 1|Disease Progression|3|||
24902622|NCT00467779|49996802|FG004|Stage 1|Disease Progression|2|||
24902623|NCT00467779|49996803|FG005|Stage 1|Disease Progression|2|||
24902624|NCT00467779|49996804|FG006|Stage 1|Disease Progression|4|||
24977427|NCT00048542|50066002|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
25338180|NCT00751881|50654613|FG001|Extension Study Period|Lack of Efficacy|10|||
25338181|NCT00751881|50654614|FG002|Extension Study Period|Lack of Efficacy|20|||
25338182|NCT00751881|50654612|FG000|Extension Study Period|Lost to Follow-up|4|||
25338183|NCT00751881|50654613|FG001|Extension Study Period|Lost to Follow-up|9|||
25338184|NCT00751881|50654614|FG002|Extension Study Period|Lost to Follow-up|6|||
25338185|NCT00751881|50654612|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
24902625|NCT00467779|49996805|FG007|Stage 1|Disease Progression|5|||
24902626|NCT00467779|49996806|FG008|Stage 1|Disease Progression|0|||
24902627|NCT00467779|49996807|FG009|Stage 1|Disease Progression|0|||
24902628|NCT00467779|49996808|FG010|Stage 1|Disease Progression|0|||
24902629|NCT00467779|49996809|FG011|Stage 1|Disease Progression|0|||
24902630|NCT00467779|49996810|FG012|Stage 1|Disease Progression|0|||
25338186|NCT00751881|50654613|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
25338187|NCT00751881|50654614|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
25338188|NCT00751881|50654612|FG000|Extension Study Period|Other than specified above|26|||
25338189|NCT00751881|50654613|FG001|Extension Study Period|Other than specified above|30|||
25338190|NCT00751881|50654614|FG002|Extension Study Period|Other than specified above|18|||
25338191|NCT00747474|50654628|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
25338192|NCT00747474|50654629|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
25338193|NCT00747474|50654630|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
25338194|NCT00747474|50654631|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
25338195|NCT00747474|50654632|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
25338196|NCT00747474|50654633|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
25338197|NCT00747474|50654634|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
25338198|NCT00747474|50654635|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
25338199|NCT00747474|50654636|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
25338200|NCT00747474|50654637|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
25338201|NCT00747474|50654638|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
25338202|NCT00747474|50654639|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
25338203|NCT00830063|50654648|FG000|Overall Study|Adverse Event|7|||
25338204|NCT00830063|50654649|FG001|Overall Study|Adverse Event|13|||
25338205|NCT00830063|50654650|FG002|Overall Study|Adverse Event|16|||
25338206|NCT00830063|50654651|FG003|Overall Study|Adverse Event|13|||
25338207|NCT00830063|50654648|FG000|Overall Study|Death|1|||
25338208|NCT00830063|50654649|FG001|Overall Study|Death|0|||
25338209|NCT00830063|50654650|FG002|Overall Study|Death|0|||
25338210|NCT00830063|50654651|FG003|Overall Study|Death|0|||
25338211|NCT00830063|50654648|FG000|Overall Study|Lost to Follow-up|0|||
25338212|NCT00830063|50654649|FG001|Overall Study|Lost to Follow-up|0|||
25338213|NCT00830063|50654650|FG002|Overall Study|Lost to Follow-up|3|||
25338214|NCT00830063|50654651|FG003|Overall Study|Lost to Follow-up|1|||
25338215|NCT00830063|50654648|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
25338216|NCT00830063|50654649|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
25338217|NCT00830063|50654650|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
25338218|NCT00830063|50654651|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
25338219|NCT00830063|50654648|FG000|Overall Study|Lack of Efficacy|51|||
25338220|NCT00830063|50654649|FG001|Overall Study|Lack of Efficacy|23|||
25338221|NCT00830063|50654650|FG002|Overall Study|Lack of Efficacy|25|||
25338222|NCT00830063|50654651|FG003|Overall Study|Lack of Efficacy|32|||
25338223|NCT00830063|50654648|FG000|Overall Study|Other|5|||
25338224|NCT00830063|50654649|FG001|Overall Study|Other|5|||
25338225|NCT00830063|50654650|FG002|Overall Study|Other|8|||
25338226|NCT00830063|50654651|FG003|Overall Study|Other|6|||
25338227|NCT00830063|50654648|FG000|Overall Study|Withdrawal by Subject|16|||
25338228|NCT00830063|50654649|FG001|Overall Study|Withdrawal by Subject|10|||
25338229|NCT00830063|50654650|FG002|Overall Study|Withdrawal by Subject|16|||
24902631|NCT00467779|49996811|FG013|Stage 1|Disease Progression|0|||
24902632|NCT00467779|49996812|FG014|Stage 1|Disease Progression|0|||
24902633|NCT00467779|49996798|FG000|Stage 1|Unspecified Reason|1|||
24902634|NCT00467779|49996799|FG001|Stage 1|Unspecified Reason|0|||
24902635|NCT00467779|49996800|FG002|Stage 1|Unspecified Reason|1|||
24902636|NCT00467779|49996801|FG003|Stage 1|Unspecified Reason|0|||
24902637|NCT00467779|49996802|FG004|Stage 1|Unspecified Reason|1|||
24902638|NCT00467779|49996803|FG005|Stage 1|Unspecified Reason|2|||
24902639|NCT00467779|49996804|FG006|Stage 1|Unspecified Reason|0|||
24902640|NCT00467779|49996805|FG007|Stage 1|Unspecified Reason|0|||
24902641|NCT00467779|49996806|FG008|Stage 1|Unspecified Reason|0|||
24902642|NCT00467779|49996807|FG009|Stage 1|Unspecified Reason|0|||
24902643|NCT00467779|49996808|FG010|Stage 1|Unspecified Reason|0|||
24902644|NCT00467779|49996809|FG011|Stage 1|Unspecified Reason|0|||
24902645|NCT00467779|49996810|FG012|Stage 1|Unspecified Reason|0|||
24902646|NCT00467779|49996811|FG013|Stage 1|Unspecified Reason|0|||
24902647|NCT00467779|49996812|FG014|Stage 1|Unspecified Reason|0|||
24902648|NCT00467779|49996798|FG000|Stage 1|Physician Decision|0|||
24902649|NCT00467779|49996799|FG001|Stage 1|Physician Decision|1|||
24902650|NCT00467779|49996800|FG002|Stage 1|Physician Decision|0|||
24902651|NCT00467779|49996801|FG003|Stage 1|Physician Decision|0|||
24902652|NCT00467779|49996802|FG004|Stage 1|Physician Decision|0|||
24902653|NCT00467779|49996803|FG005|Stage 1|Physician Decision|0|||
24902654|NCT00467779|49996804|FG006|Stage 1|Physician Decision|0|||
24902655|NCT00467779|49996805|FG007|Stage 1|Physician Decision|0|||
25338230|NCT00830063|50654651|FG003|Overall Study|Withdrawal by Subject|13|||
25338231|NCT00830063|50654648|FG000|Overall Study|Protocol Violation|1|||
25338232|NCT00830063|50654649|FG001|Overall Study|Protocol Violation|0|||
25338233|NCT00830063|50654650|FG002|Overall Study|Protocol Violation|3|||
25338234|NCT00830063|50654651|FG003|Overall Study|Protocol Violation|2|||
24902656|NCT00467779|49996806|FG008|Stage 1|Physician Decision|0|||
24902657|NCT00467779|49996807|FG009|Stage 1|Physician Decision|0|||
25338235|NCT00830063|50654648|FG000|Overall Study|Randomized But Not Treated|0|||
25338236|NCT00830063|50654649|FG001|Overall Study|Randomized But Not Treated|2|||
25338237|NCT00830063|50654650|FG002|Overall Study|Randomized But Not Treated|0|||
25338238|NCT00830063|50654651|FG003|Overall Study|Randomized But Not Treated|2|||
25338239|NCT00750438|50654665|FG000|Overall Study|Protocol Violation|4|||
25338240|NCT00750438|50654666|FG001|Overall Study|Protocol Violation|1|||
25338241|NCT00750438|50654665|FG000|Overall Study|Physician Decision|2|||
25338242|NCT00750438|50654666|FG001|Overall Study|Physician Decision|2|||
25338243|NCT00750438|50654665|FG000|Overall Study|Withdrawal by Subject|1|||
25338244|NCT00750438|50654666|FG001|Overall Study|Withdrawal by Subject|1|||
25338245|NCT00586326|50654672|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
25338246|NCT00586326|50654672|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
25338247|NCT00586326|50654672|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
25338248|NCT00586326|50654672|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
25338249|NCT00586326|50654672|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
25338250|NCT00586326|50654672|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
25338251|NCT00586326|50654672|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
25338252|NCT00586326|50654672|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
25338253|NCT00586326|50654672|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
25338254|NCT00586326|50654672|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
25338255|NCT00586326|50654672|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
25338256|NCT00586326|50654672|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
25338257|NCT00586326|50654672|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
25338258|NCT00586326|50654672|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
25338259|NCT00586326|50654672|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
25338260|NCT00586326|50654672|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
25338261|NCT00586326|50654672|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
25338262|NCT00751101|50654682|FG000|Overall Study|Withdrawal by Subject|1|||
25338263|NCT00751101|50654683|FG001|Overall Study|Withdrawal by Subject|0|||
25338264|NCT00751101|50654682|FG000|Overall Study|No HFS / Never Started Patch/|0|||
25254147|NCT01380093|50569863|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
25254148|NCT01380093|50569864|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
25254149|NCT01380093|50569865|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
25254150|NCT01380093|50569857|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
25254151|NCT01380093|50569858|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
25254152|NCT01380093|50569859|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
25254153|NCT01380093|50569860|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
25254154|NCT01380093|50569861|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
25338265|NCT00751101|50654683|FG001|Overall Study|No HFS / Never Started Patch/|4|||
25338266|NCT00751101|50654682|FG000|Overall Study|Never began capecitabine|1|||
25338267|NCT00751101|50654683|FG001|Overall Study|Never began capecitabine|0|||
25338268|NCT00751101|50654682|FG000|Overall Study|Physician Decision|0|||
25338269|NCT00751101|50654683|FG001|Overall Study|Physician Decision|1|||
25338270|NCT00750204|50654695|FG000|Overall Study|study halted prematurely|1|||
25338271|NCT00750204|50654696|FG001|Overall Study|study halted prematurely|1|||
25338272|NCT00751023|50654704|FG000|Overall Study|Lost to Follow-up|11|||
25338273|NCT00751023|50654705|FG001|Overall Study|Lost to Follow-up|7|||
25338274|NCT00591773|50654714|FG000|Overall Study|Adverse Event|9|||
25338275|NCT00591773|50654715|FG001|Overall Study|Adverse Event|9|||
25338276|NCT00591773|50654716|FG002|Overall Study|Adverse Event|6|||
25338277|NCT00591773|50654714|FG000|Overall Study|Protocol Violation|2|||
25338278|NCT00591773|50654715|FG001|Overall Study|Protocol Violation|3|||
25338279|NCT00591773|50654716|FG002|Overall Study|Protocol Violation|0|||
25338280|NCT00591773|50654714|FG000|Overall Study|Lost to Follow-up|1|||
25338281|NCT00591773|50654715|FG001|Overall Study|Lost to Follow-up|4|||
25338282|NCT00591773|50654716|FG002|Overall Study|Lost to Follow-up|1|||
25338283|NCT00591773|50654714|FG000|Overall Study|Withdrawal by Subject|2|||
25338284|NCT00591773|50654715|FG001|Overall Study|Withdrawal by Subject|5|||
25338285|NCT00591773|50654716|FG002|Overall Study|Withdrawal by Subject|3|||
25338286|NCT00591773|50654714|FG000|Overall Study|Lack of Efficacy|1|||
25338287|NCT00591773|50654715|FG001|Overall Study|Lack of Efficacy|2|||
25338288|NCT00591773|50654716|FG002|Overall Study|Lack of Efficacy|2|||
25338289|NCT00591773|50654714|FG000|Overall Study|Other|1|||
25338290|NCT00591773|50654715|FG001|Overall Study|Other|1|||
25338291|NCT00591773|50654716|FG002|Overall Study|Other|4|||
25338292|NCT00750867|50654724|FG000|Overall Study|Adverse Event|2|||
25338293|NCT00744042|50654728|FG000|Overall Study|Withdrawal by Subject|1|||
25338294|NCT00829829|50654741|FG000|Overall Study|Protocol Violation|0|||
25338295|NCT00829829|50654742|FG001|Overall Study|Protocol Violation|3|||
25338296|NCT00829829|50654743|FG002|Overall Study|Protocol Violation|0|||
25338297|NCT00829829|50654741|FG000|Overall Study|Adverse Event|4|||
25338298|NCT00829829|50654742|FG001|Overall Study|Adverse Event|4|||
25338299|NCT00829829|50654743|FG002|Overall Study|Adverse Event|3|||
25338300|NCT00829829|50654741|FG000|Overall Study|Withdrawal by Subject|8|||
25338301|NCT00829829|50654742|FG001|Overall Study|Withdrawal by Subject|4|||
25338302|NCT00829829|50654743|FG002|Overall Study|Withdrawal by Subject|2|||
25338303|NCT00829829|50654741|FG000|Overall Study|Decision by the Sponsor|1|||
25338304|NCT00829829|50654742|FG001|Overall Study|Decision by the Sponsor|0|||
25338305|NCT00829829|50654743|FG002|Overall Study|Decision by the Sponsor|2|||
25338306|NCT00829829|50654741|FG000|Overall Study|Lost to Follow-up|7|||
25338307|NCT00829829|50654742|FG001|Overall Study|Lost to Follow-up|3|||
25338308|NCT00829829|50654743|FG002|Overall Study|Lost to Follow-up|3|||
25338309|NCT00829829|50654741|FG000|Overall Study|Other than specified above|2|||
25338310|NCT00829829|50654742|FG001|Overall Study|Other than specified above|2|||
25338311|NCT00829829|50654743|FG002|Overall Study|Other than specified above|1|||
25338312|NCT00823199|50654752|FG000|Overall Study|Withdrawal by Subject|2|||
25338313|NCT00829439|50654757|FG000|Overall Study|Adverse Event|0|||
25338314|NCT00829439|50654758|FG001|Overall Study|Adverse Event|0|||
25338315|NCT00829439|50654759|FG002|Overall Study|Adverse Event|1|||
25338316|NCT00829439|50654760|FG003|Overall Study|Adverse Event|0|||
25338317|NCT00749775|50654764|FG000|Overall Study|Protocol Violation|24|||
25338318|NCT00749775|50654764|FG000|Overall Study|Lost to Follow-up|36|||
25338319|NCT00749775|50654764|FG000|Overall Study|No visit after first day of treatment|44|||
25338320|NCT00749775|50654764|FG000|Overall Study|No drug administration|3|||
25338321|NCT00829283|50654780|FG000|Overall Study|Lost to Follow-up|7|||
25338322|NCT00829283|50654781|FG001|Overall Study|Lost to Follow-up|25|||
25338323|NCT00821873|50654787|FG000|Overall Study|Lost to Follow-up|4|||
25338324|NCT00749463|50654794|FG000|Overall Study|Adverse Event|0|||
25338325|NCT00749463|50654795|FG001|Overall Study|Adverse Event|4|||
25338326|NCT00749463|50654796|FG002|Overall Study|Adverse Event|1|||
25338327|NCT00749463|50654794|FG000|Overall Study|Withdrawal by Subject|1|||
25338328|NCT00749463|50654795|FG001|Overall Study|Withdrawal by Subject|0|||
25338329|NCT00749463|50654796|FG002|Overall Study|Withdrawal by Subject|0|||
25338330|NCT00821327|50654804|FG000|Overall Study|Adverse Event|13|||
25254155|NCT01380093|50569862|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
25254156|NCT01380093|50569863|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
25254157|NCT01380093|50569864|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
25254158|NCT01380093|50569865|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
25254159|NCT01380093|50569857|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
25254160|NCT01380093|50569858|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
25338331|NCT00821327|50654804|FG000|Overall Study|Patient Request|1|||
25338332|NCT00821327|50654804|FG000|Overall Study|Investigator Request|2|||
25338333|NCT00821327|50654804|FG000|Overall Study|Sponsor Request|1|||
25338334|NCT00821327|50654804|FG000|Overall Study|Disease Progression|13|||
25338335|NCT00821327|50654804|FG000|Overall Study|Other/Unknown|5|||
25338336|NCT00821093|50654810|FG000|Overall Study|Adverse Event|20|||
25338337|NCT00821093|50654811|FG001|Overall Study|Adverse Event|12|||
25338338|NCT00821093|50654810|FG000|Overall Study|Withdrawal by Subject|9|||
25338339|NCT00821093|50654811|FG001|Overall Study|Withdrawal by Subject|13|||
25338340|NCT00821093|50654810|FG000|Overall Study|Lost to Follow-up|9|||
25338341|NCT00821093|50654811|FG001|Overall Study|Lost to Follow-up|3|||
25338342|NCT00821093|50654810|FG000|Overall Study|Protocol deviation|3|||
25338343|NCT00821093|50654811|FG001|Overall Study|Protocol deviation|6|||
25338344|NCT00821093|50654810|FG000|Overall Study|Abnormal laboratory value(s)|2|||
25254161|NCT01380093|50569859|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
25254162|NCT01380093|50569860|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
25254163|NCT01380093|50569861|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
25254164|NCT01380093|50569862|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
25254165|NCT01380093|50569863|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
25254166|NCT01380093|50569864|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
25254167|NCT01380093|50569865|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
25254168|NCT01380093|50569857|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
25254169|NCT01380093|50569858|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
25254170|NCT01380093|50569859|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
25254171|NCT01380093|50569860|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
25254172|NCT01380093|50569861|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
25254173|NCT01380093|50569862|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
25254174|NCT01380093|50569863|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
25254175|NCT01380093|50569864|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
25338345|NCT00821093|50654811|FG001|Overall Study|Abnormal laboratory value(s)|0|||
25338346|NCT00821093|50654810|FG000|Overall Study|Lack of Efficacy|2|||
25338347|NCT00821093|50654811|FG001|Overall Study|Lack of Efficacy|2|||
25338348|NCT00821093|50654810|FG000|Overall Study|Death|2|||
25338349|NCT00821093|50654811|FG001|Overall Study|Death|1|||
25338350|NCT00821093|50654810|FG000|Overall Study|Abnormal test procedure result(s)|1|||
25338351|NCT00821093|50654811|FG001|Overall Study|Abnormal test procedure result(s)|1|||
25338352|NCT00821093|50654810|FG000|Overall Study|Administrative problems|1|||
25338353|NCT00821093|50654811|FG001|Overall Study|Administrative problems|2|||
25338354|NCT00821015|50654817|FG000|Overall Study|Lost to Follow-up|12|||
25338355|NCT00814463|50654821|FG000|Overall Study|Lost to Follow-up|1|||
25338356|NCT00743652|50654831|FG000|Overall Study|Parent/Legal Guardian Request|3|||
25338357|NCT00743652|50654832|FG001|Overall Study|Parent/Legal Guardian Request|2|||
25338358|NCT00743652|50654833|FG002|Overall Study|Parent/Legal Guardian Request|2|||
25338359|NCT00743652|50654834|FG003|Overall Study|Parent/Legal Guardian Request|2|||
25338360|NCT00743652|50654835|FG004|Overall Study|Parent/Legal Guardian Request|0|||
25338361|NCT00743652|50654831|FG000|Overall Study|Adverse Event|3|||
25338362|NCT00743652|50654832|FG001|Overall Study|Adverse Event|0|||
25338363|NCT00743652|50654833|FG002|Overall Study|Adverse Event|0|||
25338364|NCT00743652|50654834|FG003|Overall Study|Adverse Event|0|||
25338365|NCT00743652|50654835|FG004|Overall Study|Adverse Event|0|||
25338366|NCT00743652|50654831|FG000|Overall Study|Death|2|||
25338367|NCT00743652|50654832|FG001|Overall Study|Death|0|||
25338368|NCT00743652|50654833|FG002|Overall Study|Death|0|||
25338369|NCT00743652|50654834|FG003|Overall Study|Death|0|||
25338370|NCT00743652|50654835|FG004|Overall Study|Death|0|||
25338371|NCT00743652|50654831|FG000|Overall Study|Investigator Request|0|||
25338372|NCT00743652|50654832|FG001|Overall Study|Investigator Request|0|||
25338373|NCT00743652|50654833|FG002|Overall Study|Investigator Request|0|||
25338374|NCT00743652|50654834|FG003|Overall Study|Investigator Request|2|||
25338375|NCT00743652|50654835|FG004|Overall Study|Investigator Request|0|||
25338376|NCT00743652|50654831|FG000|Overall Study|Other|1|||
25338377|NCT00743652|50654832|FG001|Overall Study|Other|1|||
25338378|NCT00743652|50654833|FG002|Overall Study|Other|0|||
25338379|NCT00743652|50654834|FG003|Overall Study|Other|0|||
25338380|NCT00743652|50654835|FG004|Overall Study|Other|0|||
25338381|NCT00743652|50654831|FG000|Overall Study|Lost to Follow-up|1|||
25338382|NCT00743652|50654832|FG001|Overall Study|Lost to Follow-up|0|||
25338383|NCT00743652|50654833|FG002|Overall Study|Lost to Follow-up|0|||
25338384|NCT00743652|50654834|FG003|Overall Study|Lost to Follow-up|0|||
25338385|NCT00743652|50654835|FG004|Overall Study|Lost to Follow-up|0|||
25338386|NCT00748215|50654853|FG000|Overall Study|Withdrawal by Subject|7|||
25338387|NCT00748215|50654854|FG001|Overall Study|Withdrawal by Subject|7|||
25338388|NCT00748215|50654853|FG000|Overall Study|Treatment change|2|||
25338389|NCT00748215|50654854|FG001|Overall Study|Treatment change|1|||
25338390|NCT00748215|50654853|FG000|Overall Study|Change in patient condition|0|||
25338391|NCT00748215|50654854|FG001|Overall Study|Change in patient condition|3|||
25338392|NCT00748215|50654853|FG000|Overall Study|Non-compliant|0|||
25338393|NCT00748215|50654854|FG001|Overall Study|Non-compliant|2|||
25338394|NCT00748215|50654853|FG000|Overall Study|Adverse Event|0|||
25338395|NCT00748215|50654854|FG001|Overall Study|Adverse Event|5|||
25338396|NCT00749892|50654860|FG000|Overall Study|Withdrawal by Subject|3|||
25338397|NCT00749580|50654866|FG000|Overall Study|Lost to Follow-up|4|||
25338398|NCT00749580|50654867|FG001|Overall Study|Lost to Follow-up|8|||
25338399|NCT00749580|50654866|FG000|Overall Study|Adverse Event|0|||
25338400|NCT00749580|50654867|FG001|Overall Study|Adverse Event|1|||
25338401|NCT00747006|50654876|FG000|Overall Study|Adverse Event|1|||
25338402|NCT00747006|50654877|FG001|Overall Study|Adverse Event|0|||
25338403|NCT00747006|50654878|FG002|Overall Study|Adverse Event|0|||
25338404|NCT00747006|50654876|FG000|Overall Study|Lost to Follow-up|0|||
25338405|NCT00747006|50654877|FG001|Overall Study|Lost to Follow-up|1|||
25338406|NCT00747006|50654878|FG002|Overall Study|Lost to Follow-up|0|||
25338407|NCT00747006|50654876|FG000|Overall Study|Physician Decision|2|||
25338408|NCT00747006|50654877|FG001|Overall Study|Physician Decision|0|||
25338409|NCT00747006|50654878|FG002|Overall Study|Physician Decision|1|||
25338410|NCT00743340|50654889|FG000|Overall Study|Study medication non-compliance|1|||
25338411|NCT00743340|50654889|FG000|Overall Study|Lost to Follow-up|1|||
25338412|NCT00743340|50654889|FG000|Overall Study|Withdrawal from the Study|5|||
25338413|NCT00743340|50654889|FG000|Overall Study|Protocol Violation|1|||
25338414|NCT00743340|50654889|FG000|Overall Study|Virologic failure|8|||
25338415|NCT00743340|50654889|FG000|Overall Study|Pregnancy|1|||
25338416|NCT00743340|50654889|FG000|Overall Study|Rolled over to other Gilead Study|23|||
25338417|NCT00743340|50654889|FG000|Overall Study|Participant Relocated|1|||
25338418|NCT00749190|50654900|FG000|Overall Study|Adverse Event|0|||
25338419|NCT00749190|50654901|FG001|Overall Study|Adverse Event|2|||
25338420|NCT00749190|50654902|FG002|Overall Study|Adverse Event|0|||
25077998|NCT02456636|50186179|FG000|Overall Study|Pregnancy|1|||
25338421|NCT00749190|50654903|FG003|Overall Study|Adverse Event|4|||
25338422|NCT00749190|50654904|FG004|Overall Study|Adverse Event|0|||
25338423|NCT00749190|50654905|FG005|Overall Study|Adverse Event|3|||
25338424|NCT00749190|50654906|FG006|Overall Study|Adverse Event|0|||
25338425|NCT00749190|50654900|FG000|Overall Study|Lack of Efficacy|3|||
25338426|NCT00749190|50654901|FG001|Overall Study|Lack of Efficacy|1|||
25338427|NCT00749190|50654902|FG002|Overall Study|Lack of Efficacy|1|||
25338428|NCT00749190|50654903|FG003|Overall Study|Lack of Efficacy|0|||
25338429|NCT00749190|50654904|FG004|Overall Study|Lack of Efficacy|0|||
25338430|NCT00749190|50654905|FG005|Overall Study|Lack of Efficacy|1|||
25338431|NCT00749190|50654906|FG006|Overall Study|Lack of Efficacy|0|||
25338432|NCT00749190|50654900|FG000|Overall Study|Withdrawal by Subject|2|||
25338433|NCT00749190|50654901|FG001|Overall Study|Withdrawal by Subject|1|||
25338434|NCT00749190|50654902|FG002|Overall Study|Withdrawal by Subject|0|||
25338435|NCT00749190|50654903|FG003|Overall Study|Withdrawal by Subject|0|||
25338436|NCT00749190|50654904|FG004|Overall Study|Withdrawal by Subject|0|||
25338437|NCT00749190|50654905|FG005|Overall Study|Withdrawal by Subject|1|||
25338438|NCT00749190|50654906|FG006|Overall Study|Withdrawal by Subject|0|||
25338439|NCT00749190|50654900|FG000|Overall Study|Protocol Violation|0|||
25338440|NCT00749190|50654901|FG001|Overall Study|Protocol Violation|1|||
25338441|NCT00749190|50654902|FG002|Overall Study|Protocol Violation|0|||
25338442|NCT00749190|50654903|FG003|Overall Study|Protocol Violation|0|||
25338443|NCT00749190|50654904|FG004|Overall Study|Protocol Violation|0|||
25338444|NCT00749190|50654905|FG005|Overall Study|Protocol Violation|0|||
25338445|NCT00749190|50654906|FG006|Overall Study|Protocol Violation|1|||
25338446|NCT00749190|50654900|FG000|Overall Study|Other reason not defined above|0|||
25338447|NCT00749190|50654901|FG001|Overall Study|Other reason not defined above|0|||
25338448|NCT00749190|50654902|FG002|Overall Study|Other reason not defined above|0|||
25338449|NCT00749190|50654903|FG003|Overall Study|Other reason not defined above|1|||
25338450|NCT00749190|50654904|FG004|Overall Study|Other reason not defined above|0|||
25338451|NCT00749190|50654905|FG005|Overall Study|Other reason not defined above|0|||
25338452|NCT00749190|50654906|FG006|Overall Study|Other reason not defined above|0|||
25338453|NCT00748566|50654927|FG000|Overall Study|Adverse Event|49|||
25338454|NCT00748566|50654927|FG000|Overall Study|Death|1|||
25338455|NCT00748566|50654927|FG000|Overall Study|Lack of Efficacy|12|||
25338456|NCT00748566|50654927|FG000|Overall Study|Lost to Follow-up|1|||
25338457|NCT00748566|50654927|FG000|Overall Study|Protocol Violation|13|||
25338458|NCT00748566|50654927|FG000|Overall Study|Withdrawal by Subject|22|||
25338459|NCT00748566|50654927|FG000|Overall Study|Study terminated by sponsor|5|||
25338460|NCT00748566|50654927|FG000|Overall Study|Other|9|||
25338461|NCT00743106|50654933|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
25338462|NCT00743106|50654934|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
25338463|NCT00738699|50654942|FG000|Overall Study|Withdrawal by Subject|5|||
25338464|NCT00738699|50654943|FG001|Overall Study|Withdrawal by Subject|0|||
25338465|NCT00738699|50654942|FG000|Overall Study|Lost to Follow-up|1|||
25338466|NCT00738699|50654943|FG001|Overall Study|Lost to Follow-up|0|||
25338467|NCT00738699|50654942|FG000|Overall Study|Death|144|||
25338468|NCT00738699|50654943|FG001|Overall Study|Death|68|||
25338469|NCT00738699|50654942|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
25338470|NCT00738699|50654943|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
25254176|NCT01380093|50569865|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
25254177|NCT01380093|50569857|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
25254178|NCT01380093|50569858|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
25254179|NCT01380093|50569859|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
25254180|NCT01380093|50569860|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
25254181|NCT01380093|50569861|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
25254182|NCT01380093|50569862|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
25254183|NCT01380093|50569863|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
25254184|NCT01380093|50569864|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
25254185|NCT01380093|50569865|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
25254186|NCT01380093|50569857|FG000|Treatment Phase: Second Intervention|Other|0|||
25254187|NCT01380093|50569858|FG001|Treatment Phase: Second Intervention|Other|0|||
25254188|NCT01380093|50569859|FG002|Treatment Phase: Second Intervention|Other|0|||
25254189|NCT01380093|50569860|FG003|Treatment Phase: Second Intervention|Other|1|||
25254190|NCT01380093|50569861|FG004|Treatment Phase: Second Intervention|Other|0|||
25254191|NCT01380093|50569862|FG005|Treatment Phase: Second Intervention|Other|0|||
25254192|NCT01380093|50569863|FG006|Treatment Phase: Second Intervention|Other|0|||
25254193|NCT01380093|50569864|FG007|Treatment Phase: Second Intervention|Other|0|||
25254194|NCT01380093|50569865|FG008|Treatment Phase: Second Intervention|Other|0|||
25254195|NCT01380093|50569857|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
25254196|NCT01380093|50569858|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
25254197|NCT01380093|50569859|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
25338471|NCT00738699|50654942|FG000|Overall Study|Other|2|||
25338472|NCT00738699|50654943|FG001|Overall Study|Other|0|||
25338473|NCT00814307|50654953|FG000|Overall Study|Randomized but not treated|1|||
25338474|NCT00814307|50654954|FG001|Overall Study|Randomized but not treated|0|||
25338475|NCT00814307|50654955|FG002|Overall Study|Randomized but not treated|0|||
25254198|NCT01380093|50569860|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
25338476|NCT00814307|50654956|FG003|Overall Study|Randomized but not treated|0|||
25338477|NCT00814307|50654953|FG000|Overall Study|Adverse Event|3|||
25338478|NCT00814307|50654954|FG001|Overall Study|Adverse Event|9|||
25338479|NCT00814307|50654955|FG002|Overall Study|Adverse Event|3|||
25338480|NCT00814307|50654956|FG003|Overall Study|Adverse Event|2|||
25338481|NCT00814307|50654953|FG000|Overall Study|Lack of Efficacy|1|||
25254199|NCT01380093|50569861|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
25338482|NCT00814307|50654954|FG001|Overall Study|Lack of Efficacy|1|||
25338483|NCT00814307|50654955|FG002|Overall Study|Lack of Efficacy|3|||
25338484|NCT00814307|50654956|FG003|Overall Study|Lack of Efficacy|4|||
25338485|NCT00814307|50654953|FG000|Overall Study|Other|1|||
25338486|NCT00814307|50654954|FG001|Overall Study|Other|2|||
25338487|NCT00814307|50654955|FG002|Overall Study|Other|0|||
25338488|NCT00814307|50654956|FG003|Overall Study|Other|1|||
25338489|NCT00814307|50654953|FG000|Overall Study|Protocol Violation|2|||
25338490|NCT00814307|50654954|FG001|Overall Study|Protocol Violation|8|||
25338491|NCT00814307|50654955|FG002|Overall Study|Protocol Violation|1|||
25338492|NCT00814307|50654956|FG003|Overall Study|Protocol Violation|1|||
25338493|NCT00814307|50654953|FG000|Overall Study|Withdrawal by Subject|4|||
25338494|NCT00814307|50654954|FG001|Overall Study|Withdrawal by Subject|6|||
25338495|NCT00814307|50654955|FG002|Overall Study|Withdrawal by Subject|0|||
25338496|NCT00814307|50654956|FG003|Overall Study|Withdrawal by Subject|2|||
24902658|NCT00467779|49996808|FG010|Stage 1|Physician Decision|0|||
24902659|NCT00467779|49996809|FG011|Stage 1|Physician Decision|0|||
24902660|NCT00467779|49996810|FG012|Stage 1|Physician Decision|0|||
24902661|NCT00467779|49996811|FG013|Stage 1|Physician Decision|0|||
24902662|NCT00467779|49996812|FG014|Stage 1|Physician Decision|0|||
24902663|NCT00467779|49996798|FG000|Stage 1|Withdrawal by Subject|0|||
24902664|NCT00467779|49996799|FG001|Stage 1|Withdrawal by Subject|0|||
24902665|NCT00467779|49996800|FG002|Stage 1|Withdrawal by Subject|0|||
25254200|NCT01380093|50569862|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
25254201|NCT01380093|50569863|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
25254202|NCT01380093|50569864|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
25254203|NCT01380093|50569865|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
25254204|NCT01380093|50569857|FG000|Treatment Phase: Third Intervention|Other|0|||
25254205|NCT01380093|50569858|FG001|Treatment Phase: Third Intervention|Other|0|||
25254206|NCT01380093|50569859|FG002|Treatment Phase: Third Intervention|Other|0|||
25254207|NCT01380093|50569860|FG003|Treatment Phase: Third Intervention|Other|0|||
25254208|NCT01380093|50569861|FG004|Treatment Phase: Third Intervention|Other|0|||
25254209|NCT01380093|50569862|FG005|Treatment Phase: Third Intervention|Other|0|||
25254210|NCT01380093|50569863|FG006|Treatment Phase: Third Intervention|Other|0|||
25254211|NCT01380093|50569864|FG007|Treatment Phase: Third Intervention|Other|0|||
25254212|NCT01380093|50569865|FG008|Treatment Phase: Third Intervention|Other|1|||
25254213|NCT01379937|50569883|FG000|Overall Study|Protocol Violation|0|||
25254214|NCT01379937|50569884|FG001|Overall Study|Protocol Violation|0|||
25254215|NCT01379937|50569885|FG002|Overall Study|Protocol Violation|0|||
25254216|NCT01379937|50569886|FG003|Overall Study|Protocol Violation|1|||
25254217|NCT01379937|50569883|FG000|Overall Study|Consent withdrawal|0|||
25254218|NCT01379937|50569884|FG001|Overall Study|Consent withdrawal|1|||
25254219|NCT01379937|50569885|FG002|Overall Study|Consent withdrawal|0|||
25254220|NCT01379937|50569886|FG003|Overall Study|Consent withdrawal|0|||
25254221|NCT01379937|50569883|FG000|Overall Study|Lost to Follow-up|1|||
25254222|NCT01379937|50569884|FG001|Overall Study|Lost to Follow-up|2|||
25254223|NCT01379937|50569885|FG002|Overall Study|Lost to Follow-up|2|||
25254224|NCT01379937|50569886|FG003|Overall Study|Lost to Follow-up|0|||
25254225|NCT01379781|50569912|FG000|Overall Study|Lost to Follow-up|11|||
25254226|NCT01379781|50569913|FG001|Overall Study|Lost to Follow-up|8|||
25254227|NCT01379703|50569919|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
25254228|NCT01379703|50569920|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
25254229|NCT01379703|50569921|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
25254230|NCT01379703|50569919|FG000|Study Start Through 9 Months|Adverse Event|0|||
25254231|NCT01379703|50569920|FG001|Study Start Through 9 Months|Adverse Event|14|||
25254232|NCT01379703|50569921|FG002|Study Start Through 9 Months|Adverse Event|10|||
25254233|NCT01379703|50569919|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
25254234|NCT01379703|50569920|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
25254235|NCT01379703|50569921|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
25254236|NCT01379703|50569919|FG000|Study Start Through 9 Months|Treatment Failure|0|||
25254237|NCT01379703|50569920|FG001|Study Start Through 9 Months|Treatment Failure|2|||
25254238|NCT01379703|50569921|FG002|Study Start Through 9 Months|Treatment Failure|2|||
25338497|NCT00814307|50654953|FG000|Overall Study|Death|0|||
25338498|NCT00814307|50654954|FG001|Overall Study|Death|1|||
25338499|NCT00814307|50654955|FG002|Overall Study|Death|0|||
25254239|NCT01379703|50569919|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
25254240|NCT01379703|50569920|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
25254241|NCT01379703|50569921|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
25254242|NCT01379703|50569919|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
25254243|NCT01379703|50569920|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
25338500|NCT00814307|50654956|FG003|Overall Study|Death|0|||
25338501|NCT00748098|50654968|FG000|First Treatment Intervention Period|Adverse Event|1|||
25338502|NCT00748098|50654969|FG001|First Treatment Intervention Period|Adverse Event|1|||
24902666|NCT00467779|49996801|FG003|Stage 1|Withdrawal by Subject|0|||
24902667|NCT00467779|49996802|FG004|Stage 1|Withdrawal by Subject|0|||
25338503|NCT00748098|50654968|FG000|First Treatment Intervention Period|Protocol Violation|1|||
25338504|NCT00748098|50654969|FG001|First Treatment Intervention Period|Protocol Violation|0|||
25338505|NCT00748098|50654968|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
25338506|NCT00748098|50654969|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
25338507|NCT00748098|50654968|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
25254244|NCT01379703|50569921|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
25254245|NCT01379703|50569919|FG000|Study Start Through 9 Months|Medication not available|0|||
25254246|NCT01379703|50569920|FG001|Study Start Through 9 Months|Medication not available|2|||
25254247|NCT01379703|50569921|FG002|Study Start Through 9 Months|Medication not available|1|||
25254248|NCT01379703|50569919|FG000|Study Start Through 9 Months|Poor general condition|0|||
25254249|NCT01379703|50569920|FG001|Study Start Through 9 Months|Poor general condition|1|||
25254250|NCT01379703|50569921|FG002|Study Start Through 9 Months|Poor general condition|0|||
25254251|NCT01379703|50569919|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
25254252|NCT01379703|50569920|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
25254253|NCT01379703|50569921|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
25254254|NCT01379703|50569919|FG000|Study Start Through 9 Months|Reason unknown|2|||
25254255|NCT01379703|50569920|FG001|Study Start Through 9 Months|Reason unknown|31|||
25254256|NCT01379703|50569921|FG002|Study Start Through 9 Months|Reason unknown|24|||
25254257|NCT01379703|50569919|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
25254258|NCT01379703|50569920|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
25254259|NCT01379703|50569921|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
25254260|NCT01379703|50569919|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
25254261|NCT01379703|50569920|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
25254262|NCT01379703|50569921|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
25254263|NCT01379703|50569919|FG000|9 Months Through 18 Months|Adverse Event|0|||
25254264|NCT01379703|50569920|FG001|9 Months Through 18 Months|Adverse Event|6|||
25254265|NCT01379703|50569921|FG002|9 Months Through 18 Months|Adverse Event|0|||
25254266|NCT01379703|50569919|FG000|9 Months Through 18 Months|Treatment failure|0|||
25254267|NCT01379703|50569920|FG001|9 Months Through 18 Months|Treatment failure|5|||
25254268|NCT01379703|50569921|FG002|9 Months Through 18 Months|Treatment failure|0|||
25254269|NCT01379703|50569919|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
25254270|NCT01379703|50569920|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
25254271|NCT01379703|50569921|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
25254272|NCT01379703|50569919|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
25254273|NCT01379703|50569920|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
25254274|NCT01379703|50569921|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
25254275|NCT01379703|50569919|FG000|9 Months Through 18 Months|Fatigue|0|||
25254276|NCT01379703|50569920|FG001|9 Months Through 18 Months|Fatigue|1|||
25254277|NCT01379703|50569921|FG002|9 Months Through 18 Months|Fatigue|0|||
25254278|NCT01379703|50569919|FG000|9 Months Through 18 Months|Reason Unknown|0|||
25254279|NCT01379703|50569920|FG001|9 Months Through 18 Months|Reason Unknown|23|||
25254280|NCT01379703|50569921|FG002|9 Months Through 18 Months|Reason Unknown|0|||
25254281|NCT01335477|50569932|FG000|Overall Study|Adverse Event|30|||
25338508|NCT00748098|50654969|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
25338509|NCT00748098|50654968|FG000|First Taper Period|Protocol Violation|1|||
25338510|NCT00748098|50654969|FG001|First Taper Period|Protocol Violation|0|||
25338511|NCT00748098|50654968|FG000|First Taper Period|Withdrawal by Subject|2|||
25338512|NCT00748098|50654969|FG001|First Taper Period|Withdrawal by Subject|0|||
25338513|NCT00748098|50654968|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
25338514|NCT00748098|50654969|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
25338515|NCT00748098|50654968|FG000|1-Week Washout Period|Adverse Event|0|||
25338516|NCT00748098|50654969|FG001|1-Week Washout Period|Adverse Event|1|||
25338517|NCT00748098|50654968|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
25338518|NCT00748098|50654969|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
25338519|NCT00748098|50654968|FG000|Second Treatment Intervention Period|Adverse Event|4|||
25338520|NCT00748098|50654969|FG001|Second Treatment Intervention Period|Adverse Event|1|||
25338521|NCT00748098|50654968|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
25338522|NCT00748098|50654969|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
25338523|NCT00748098|50654968|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
25338524|NCT00748098|50654969|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
25338525|NCT00813995|50654978|FG000|Overall Study|Clinical adverse event|9|||
25338526|NCT00813995|50654979|FG001|Overall Study|Clinical adverse event|3|||
25338527|NCT00813995|50654978|FG000|Overall Study|Laboratory adverse event|0|||
25338528|NCT00813995|50654979|FG001|Overall Study|Laboratory adverse event|2|||
25338529|NCT00813995|50654978|FG000|Overall Study|Lack of Efficacy|1|||
25338530|NCT00813995|50654979|FG001|Overall Study|Lack of Efficacy|0|||
25338531|NCT00813995|50654978|FG000|Overall Study|Lost to Follow-up|4|||
25338532|NCT00813995|50654979|FG001|Overall Study|Lost to Follow-up|2|||
25338533|NCT00813995|50654978|FG000|Overall Study|Other reason|2|||
25338534|NCT00813995|50654979|FG001|Overall Study|Other reason|2|||
25077999|NCT02456636|50186180|FG001|Overall Study|Pregnancy|3|||
25338535|NCT00813995|50654978|FG000|Overall Study|Protocol Violation|3|||
25338536|NCT00813995|50654979|FG001|Overall Study|Protocol Violation|2|||
25338537|NCT00813995|50654978|FG000|Overall Study|Subject moved|4|||
25338538|NCT00813995|50654979|FG001|Overall Study|Subject moved|0|||
25338539|NCT00813995|50654978|FG000|Overall Study|Withdrawal by Subject|0|||
25338540|NCT00813995|50654979|FG001|Overall Study|Withdrawal by Subject|5|||
25338541|NCT00737529|50654989|FG000|Overall Study|Disease Progression|95|||
25338542|NCT00737529|50654989|FG000|Overall Study|Adverse Event|24|||
25338543|NCT00737529|50654989|FG000|Overall Study|Withdrawal by Subject|5|||
25338544|NCT00737529|50654989|FG000|Overall Study|Death|4|||
25338545|NCT00737529|50654989|FG000|Overall Study|Protocol Violation|1|||
25338546|NCT00737529|50654989|FG000|Overall Study|Other|4|||
25338547|NCT00813917|50654995|FG000|Overall Study|Adverse Event|0|||
25338548|NCT00813917|50654996|FG001|Overall Study|Adverse Event|1|||
25338549|NCT00813917|50654995|FG000|Overall Study|Withdrawal by Subject|3|||
25338550|NCT00813917|50654996|FG001|Overall Study|Withdrawal by Subject|4|||
25338551|NCT00813917|50654995|FG000|Overall Study|Lost to Follow-up|3|||
25338552|NCT00813917|50654996|FG001|Overall Study|Lost to Follow-up|1|||
25338553|NCT00737061|50655002|FG000|Waiting Period|Lost to Follow-up|6|||
25338554|NCT00737061|50655002|FG000|Waiting Period|Withdrawal by Subject|1|||
25338555|NCT00737061|50655002|FG000|Waiting Period|Bilateral placement failure|34|||
25338556|NCT00737061|50655002|FG000|Waiting Period|Deemed patent following HSG|26|||
25338557|NCT00737061|50655002|FG000|Waiting Period|Alternative contraception failure|3|||
25338558|NCT00737061|50655002|FG000|Waiting Period|Elected surgical tubal ligation|5|||
25338559|NCT00737061|50655002|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
25338560|NCT00737061|50655002|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
25338561|NCT00737061|50655002|FG000|1 Year Wearing Period|Discontinued reilance|3|||
25338562|NCT00737061|50655002|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
25338563|NCT00585975|50655008|FG000|Overall Study|Withdrawal by Subject|3|||
25338564|NCT00585975|50655009|FG001|Overall Study|Withdrawal by Subject|3|||
25338565|NCT00585975|50655008|FG000|Overall Study|Lost to Follow-up|2|||
25338566|NCT00585975|50655009|FG001|Overall Study|Lost to Follow-up|1|||
25338567|NCT00585975|50655008|FG000|Overall Study|Enrollment met/over-enrolled|10|||
25338568|NCT00585975|50655009|FG001|Overall Study|Enrollment met/over-enrolled|9|||
25338569|NCT00585585|50655015|FG000|Overall Study|Adverse Event|1|||
25338570|NCT00734097|50655019|FG000|Screening|Protocol Violation|12|||
25338571|NCT00734097|50655019|FG000|Screening|Withdrawal by Subject|5|||
25338572|NCT00734097|50655019|FG000|Screening|Lost to Follow-up|2|||
25254282|NCT01335477|50569933|FG001|Overall Study|Adverse Event|42|||
25254283|NCT01335477|50569932|FG000|Overall Study|Non compliant with protocol|0|||
25254284|NCT01335477|50569933|FG001|Overall Study|Non compliant with protocol|2|||
25254285|NCT01335477|50569932|FG000|Overall Study|Lost to Follow-up|1|||
25254286|NCT01335477|50569933|FG001|Overall Study|Lost to Follow-up|2|||
25254287|NCT01335477|50569932|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
25254288|NCT01335477|50569933|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
25254289|NCT01335477|50569932|FG000|Overall Study|Not treated|1|||
25254290|NCT01335477|50569933|FG001|Overall Study|Not treated|2|||
25254291|NCT01335477|50569932|FG000|Overall Study|Reason other than those stated above|2|||
25254292|NCT01335477|50569933|FG001|Overall Study|Reason other than those stated above|2|||
25254293|NCT01371825|50569939|FG000|Overall Study|Death|4|||
25254294|NCT01371747|50569949|FG000|Overall Study|Adverse Event|4|||
25254295|NCT01371747|50569950|FG001|Overall Study|Adverse Event|2|||
25254296|NCT01371747|50569951|FG002|Overall Study|Adverse Event|7|||
25254297|NCT01371747|50569952|FG003|Overall Study|Adverse Event|2|||
25254298|NCT01371747|50569953|FG004|Overall Study|Adverse Event|2|||
25254299|NCT01371747|50569954|FG005|Overall Study|Adverse Event|2|||
25254300|NCT01371747|50569949|FG000|Overall Study|Death|1|||
25254301|NCT01371747|50569950|FG001|Overall Study|Death|0|||
25254302|NCT01371747|50569951|FG002|Overall Study|Death|4|||
25254303|NCT01371747|50569952|FG003|Overall Study|Death|1|||
25254304|NCT01371747|50569953|FG004|Overall Study|Death|2|||
25254305|NCT01371747|50569954|FG005|Overall Study|Death|0|||
25254306|NCT01371747|50569949|FG000|Overall Study|Abnormal Renal Function|0|||
25254307|NCT01371747|50569950|FG001|Overall Study|Abnormal Renal Function|2|||
25254308|NCT01371747|50569951|FG002|Overall Study|Abnormal Renal Function|0|||
25254309|NCT01371747|50569952|FG003|Overall Study|Abnormal Renal Function|1|||
25254310|NCT01371747|50569953|FG004|Overall Study|Abnormal Renal Function|0|||
25254311|NCT01371747|50569954|FG005|Overall Study|Abnormal Renal Function|1|||
25254312|NCT01371747|50569949|FG000|Overall Study|High Serum Potassium Results|1|||
25338573|NCT00734097|50655019|FG000|Screening|Unconfirmed pregnancy|1|||
25338574|NCT00734097|50655019|FG000|Open Label|Lost to Follow-up|7|||
25338575|NCT00734097|50655019|FG000|Open Label|Withdrawal by Subject|5|||
25338576|NCT00734097|50655019|FG000|Open Label|Protocol Violation|4|||
25338577|NCT00819767|50655025|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25338578|NCT00819767|50655026|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
25338579|NCT00733005|50655034|FG000|Overall Study|Adverse Event|0|||
24902668|NCT00467779|49996803|FG005|Stage 1|Withdrawal by Subject|0|||
25254313|NCT01371747|50569950|FG001|Overall Study|High Serum Potassium Results|1|||
25338580|NCT00733005|50655035|FG001|Overall Study|Adverse Event|1|||
25254314|NCT01371747|50569951|FG002|Overall Study|High Serum Potassium Results|1|||
25254315|NCT01371747|50569952|FG003|Overall Study|High Serum Potassium Results|2|||
25254316|NCT01371747|50569953|FG004|Overall Study|High Serum Potassium Results|0|||
25254317|NCT01371747|50569954|FG005|Overall Study|High Serum Potassium Results|2|||
25254318|NCT01371747|50569949|FG000|Overall Study|Low Serum Potassium Results|1|||
25254319|NCT01371747|50569950|FG001|Overall Study|Low Serum Potassium Results|1|||
25254320|NCT01371747|50569951|FG002|Overall Study|Low Serum Potassium Results|1|||
25338581|NCT00733005|50655034|FG000|Overall Study|Treatment Failure|0|||
25338582|NCT00733005|50655035|FG001|Overall Study|Treatment Failure|1|||
25338583|NCT00733005|50655034|FG000|Overall Study|Withdrawal by Subject|0|||
25338584|NCT00733005|50655035|FG001|Overall Study|Withdrawal by Subject|1|||
25338585|NCT00733005|50655034|FG000|Overall Study|Protocol Violation|2|||
25338586|NCT00733005|50655035|FG001|Overall Study|Protocol Violation|0|||
25338587|NCT00812981|50655043|FG000|Overall Study|Other|0|||
25338588|NCT00812981|50655044|FG001|Overall Study|Other|1|||
25338589|NCT00732615|50655052|FG000|Overall Study|Withdrawal by Subject|3|||
25338590|NCT00732615|50655053|FG001|Overall Study|Withdrawal by Subject|1|||
25338591|NCT00732615|50655052|FG000|Overall Study|Lost to Follow-up|0|||
25338592|NCT00732615|50655053|FG001|Overall Study|Lost to Follow-up|1|||
25338593|NCT00732615|50655052|FG000|Overall Study|Adverse Event|0|||
25338594|NCT00732615|50655053|FG001|Overall Study|Adverse Event|2|||
25338595|NCT00732615|50655052|FG000|Overall Study|Physician Decision|3|||
25338596|NCT00732615|50655053|FG001|Overall Study|Physician Decision|0|||
25338597|NCT00732615|50655052|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
25338598|NCT00732615|50655053|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
25338599|NCT00732381|50655062|FG000|Overall Study|Adverse Event|1|||
25338600|NCT00732381|50655063|FG001|Overall Study|Adverse Event|0|||
25338601|NCT00732381|50655062|FG000|Overall Study|Treatment Failure|1|||
25338602|NCT00732381|50655063|FG001|Overall Study|Treatment Failure|1|||
25338603|NCT00732303|50655069|FG000|Overall Study|Study Terminated|2|||
25338604|NCT00813761|50655075|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
25338605|NCT00813761|50655076|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
25338606|NCT00813761|50655077|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
25338607|NCT00813761|50655078|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
25338608|NCT00813761|50655075|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
25338609|NCT00813761|50655076|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
25338610|NCT00813761|50655077|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
25338611|NCT00813761|50655078|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
25338612|NCT00813761|50655075|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
25338613|NCT00813761|50655076|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
25338614|NCT00813761|50655077|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
25338615|NCT00813761|50655078|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
25338616|NCT00813761|50655075|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
25338617|NCT00813761|50655076|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
25338618|NCT00813761|50655077|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
25338619|NCT00813761|50655078|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
25338620|NCT00813761|50655075|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
25338621|NCT00813761|50655076|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
25338622|NCT00813761|50655077|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
25338623|NCT00813761|50655078|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
25338624|NCT00813761|50655075|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
25338625|NCT00813761|50655076|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
25338626|NCT00813761|50655077|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
25338627|NCT00813761|50655078|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
25338628|NCT00813761|50655075|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
25338629|NCT00813761|50655076|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
25338630|NCT00813761|50655077|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
25338631|NCT00813761|50655078|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
25338632|NCT00813761|50655075|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
25338633|NCT00813761|50655076|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
25338634|NCT00813761|50655077|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
25338635|NCT00813761|50655078|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
25254321|NCT01371747|50569952|FG003|Overall Study|Low Serum Potassium Results|1|||
25254322|NCT01371747|50569953|FG004|Overall Study|Low Serum Potassium Results|0|||
25254323|NCT01371747|50569954|FG005|Overall Study|Low Serum Potassium Results|3|||
25254324|NCT01371747|50569949|FG000|Overall Study|Protocol Violation|0|||
25254325|NCT01371747|50569950|FG001|Overall Study|Protocol Violation|0|||
25254326|NCT01371747|50569951|FG002|Overall Study|Protocol Violation|1|||
25254327|NCT01371747|50569952|FG003|Overall Study|Protocol Violation|0|||
25338636|NCT00813761|50655075|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
25338637|NCT00813761|50655076|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
25338638|NCT00813761|50655077|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
25338639|NCT00813761|50655078|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
25338640|NCT00813761|50655075|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
25338641|NCT00813761|50655076|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
25338642|NCT00813761|50655077|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
25338643|NCT00813761|50655078|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
25338644|NCT00813761|50655075|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
25338645|NCT00813761|50655076|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
25338646|NCT00813761|50655077|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
25338647|NCT00813761|50655078|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
25338648|NCT00813761|50655075|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
25338649|NCT00813761|50655076|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
25338650|NCT00813761|50655077|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
25338651|NCT00813761|50655078|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
25338652|NCT00732069|50655094|FG000|Washout After First Study Drug|Adverse Event|1|||
25338653|NCT00732069|50655095|FG001|Washout After First Study Drug|Adverse Event|0|||
25338654|NCT00732069|50655096|FG002|Washout After First Study Drug|Adverse Event|0|||
25338655|NCT00732069|50655097|FG003|Washout After First Study Drug|Adverse Event|0|||
25338656|NCT00732069|50655098|FG004|Washout After First Study Drug|Adverse Event|0|||
25338657|NCT00732069|50655099|FG005|Washout After First Study Drug|Adverse Event|0|||
25338658|NCT00731679|50655109|FG000|Overall Study|Adverse Event|7|||
25338659|NCT00731679|50655110|FG001|Overall Study|Adverse Event|8|||
25338660|NCT00731679|50655109|FG000|Overall Study|Withdrawal by Subject|8|||
25338661|NCT00731679|50655110|FG001|Overall Study|Withdrawal by Subject|8|||
25254328|NCT01371747|50569953|FG004|Overall Study|Protocol Violation|0|||
25254329|NCT01371747|50569954|FG005|Overall Study|Protocol Violation|0|||
25254330|NCT01371747|50569949|FG000|Overall Study|Non-Compliance|3|||
25254331|NCT01371747|50569950|FG001|Overall Study|Non-Compliance|4|||
25254332|NCT01371747|50569951|FG002|Overall Study|Non-Compliance|3|||
25254333|NCT01371747|50569952|FG003|Overall Study|Non-Compliance|0|||
25254334|NCT01371747|50569953|FG004|Overall Study|Non-Compliance|0|||
25254335|NCT01371747|50569954|FG005|Overall Study|Non-Compliance|1|||
25254336|NCT01371747|50569949|FG000|Overall Study|Physician Decision|0|||
25254337|NCT01371747|50569950|FG001|Overall Study|Physician Decision|0|||
25254338|NCT01371747|50569951|FG002|Overall Study|Physician Decision|0|||
25254339|NCT01371747|50569952|FG003|Overall Study|Physician Decision|0|||
25254340|NCT01371747|50569953|FG004|Overall Study|Physician Decision|1|||
25254341|NCT01371747|50569954|FG005|Overall Study|Physician Decision|0|||
25338662|NCT00731679|50655109|FG000|Overall Study|Lost to Follow-up|7|||
25338663|NCT00731679|50655110|FG001|Overall Study|Lost to Follow-up|8|||
25338664|NCT00731679|50655109|FG000|Overall Study|Noncompliance|0|||
25338665|NCT00731679|50655110|FG001|Overall Study|Noncompliance|1|||
25338666|NCT00731679|50655109|FG000|Overall Study|Pregnancy|0|||
25338667|NCT00731679|50655110|FG001|Overall Study|Pregnancy|1|||
25338668|NCT00731133|50655116|FG000|Overall Study|Withdrawal by Subject|10|||
25338669|NCT00730275|50655124|FG000|Overall Study|Withdrawal by Subject|0|||
25338670|NCT00730275|50655125|FG001|Overall Study|Withdrawal by Subject|0|||
25338671|NCT00730275|50655126|FG002|Overall Study|Withdrawal by Subject|0|||
25338672|NCT00730275|50655127|FG003|Overall Study|Withdrawal by Subject|1|||
25338673|NCT00730041|50655145|FG000|Overall Study|Lost to Follow-up|0|||
25338674|NCT00730041|50655146|FG001|Overall Study|Lost to Follow-up|2|||
25338675|NCT00729651|50655154|FG000|Overall Study|Withdrawal by Subject|5|||
25338676|NCT00729651|50655155|FG001|Overall Study|Withdrawal by Subject|6|||
25338677|NCT00729651|50655154|FG000|Overall Study|Lost to Follow-up|5|||
25338678|NCT00729651|50655155|FG001|Overall Study|Lost to Follow-up|4|||
25338679|NCT00729651|50655154|FG000|Overall Study|Protocol Violation|0|||
25338680|NCT00729651|50655155|FG001|Overall Study|Protocol Violation|1|||
25338681|NCT00729651|50655154|FG000|Overall Study|Adverse Event|7|||
25338682|NCT00729651|50655155|FG001|Overall Study|Adverse Event|3|||
25338683|NCT00729651|50655154|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
25338684|NCT00729651|50655155|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
25338685|NCT00729651|50655154|FG000|Overall Study|Subject's private reason|2|||
25254342|NCT01371747|50569949|FG000|Overall Study|Withdrawal by Subject|6|||
25254343|NCT01371747|50569950|FG001|Overall Study|Withdrawal by Subject|12|||
25254344|NCT01371747|50569951|FG002|Overall Study|Withdrawal by Subject|5|||
25254345|NCT01371747|50569952|FG003|Overall Study|Withdrawal by Subject|2|||
25254346|NCT01371747|50569953|FG004|Overall Study|Withdrawal by Subject|2|||
25254347|NCT01371747|50569954|FG005|Overall Study|Withdrawal by Subject|4|||
25338686|NCT00729651|50655155|FG001|Overall Study|Subject's private reason|0|||
25338687|NCT00729183|50655163|FG000|Overall Study|Adverse Event|11|||
25338688|NCT00729183|50655164|FG001|Overall Study|Adverse Event|5|||
25338689|NCT00729183|50655163|FG000|Overall Study|Lack of Efficacy|0|||
25338690|NCT00729183|50655164|FG001|Overall Study|Lack of Efficacy|1|||
25338691|NCT00729183|50655163|FG000|Overall Study|Lost to Follow-up|3|||
25338692|NCT00729183|50655164|FG001|Overall Study|Lost to Follow-up|1|||
25338693|NCT00729183|50655163|FG000|Overall Study|Physician Decision|1|||
25338694|NCT00729183|50655164|FG001|Overall Study|Physician Decision|1|||
25254348|NCT01371747|50569949|FG000|Overall Study|Other Reasons|2|||
25254349|NCT01371747|50569950|FG001|Overall Study|Other Reasons|1|||
25338695|NCT00729183|50655163|FG000|Overall Study|Protocol Violation|1|||
25338696|NCT00729183|50655164|FG001|Overall Study|Protocol Violation|0|||
25338697|NCT00729183|50655163|FG000|Overall Study|Withdrawal by Subject|9|||
25338698|NCT00729183|50655164|FG001|Overall Study|Withdrawal by Subject|7|||
25338699|NCT00811733|50655172|FG000|Overall Study|Investigator Discretion|10|||
25338700|NCT00811733|50655173|FG001|Overall Study|Investigator Discretion|8|||
25338701|NCT00811733|50655172|FG000|Overall Study|Withdrawal by Subject|1|||
25338702|NCT00811733|50655173|FG001|Overall Study|Withdrawal by Subject|2|||
25338703|NCT00728949|50655181|FG000|Overall Study|Adverse Event|8|||
25338704|NCT00728949|50655182|FG001|Overall Study|Adverse Event|0|||
25338705|NCT00728949|50655181|FG000|Overall Study|Withdrawal by Subject|2|||
25338706|NCT00728949|50655182|FG001|Overall Study|Withdrawal by Subject|2|||
25338707|NCT00728949|50655181|FG000|Overall Study|Abnormal Lab Results|0|||
25338708|NCT00728949|50655182|FG001|Overall Study|Abnormal Lab Results|2|||
25338709|NCT00728949|50655181|FG000|Overall Study|On treatment at cutoff date|1|||
25338710|NCT00728949|50655182|FG001|Overall Study|On treatment at cutoff date|0|||
25338711|NCT00728481|50655190|FG000|Overall Study|Withdrawal by Subject|0|||
25338712|NCT00728481|50655191|FG001|Overall Study|Withdrawal by Subject|1|||
25338713|NCT00728481|50655190|FG000|Overall Study|Adverse Event|0|||
25338714|NCT00728481|50655191|FG001|Overall Study|Adverse Event|1|||
25338715|NCT00728481|50655190|FG000|Overall Study|Study medication non-compliance|0|||
25338716|NCT00728481|50655191|FG001|Overall Study|Study medication non-compliance|2|||
25338717|NCT00728481|50655190|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
25338718|NCT00728481|50655191|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
25338719|NCT00811655|50655197|FG000|Overall Study|Physician Decision|1|||
25338720|NCT00727311|50655201|FG000|Overall Study|Did not receive drug|316|||
25338721|NCT00727311|50655201|FG000|Overall Study|Missing end of therapy data|205|||
25338722|NCT00727311|50655201|FG000|Overall Study|Adverse Event|58|||
25338723|NCT00727311|50655201|FG000|Overall Study|Lack of Efficacy|242|||
25338724|NCT00727311|50655201|FG000|Overall Study|Lost to Follow-up|73|||
25338725|NCT00727311|50655201|FG000|Overall Study|Withdrawal by Subject|77|||
25338726|NCT00727311|50655201|FG000|Overall Study|Other|97|||
25338727|NCT00727311|50655201|FG000|Overall Study|Multiple reasons|39|||
25338728|NCT00726999|50655207|FG000|Overall Study|Physician Decision|0|||
25338729|NCT00726999|50655208|FG001|Overall Study|Physician Decision|1|||
25338730|NCT00726999|50655207|FG000|Overall Study|Withdrawal by Subject|2|||
25338731|NCT00726999|50655208|FG001|Overall Study|Withdrawal by Subject|0|||
25338732|NCT00726999|50655207|FG000|Overall Study|Protocol Violation|1|||
25338733|NCT00726999|50655208|FG001|Overall Study|Protocol Violation|0|||
25338734|NCT00585351|50655222|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
25338735|NCT00585351|50655223|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
25338736|NCT00585351|50655224|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
25338737|NCT00585351|50655225|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
25338738|NCT00585351|50655226|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
25338739|NCT00585351|50655227|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
25338740|NCT00585351|50655228|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
25338741|NCT00585351|50655229|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
25338742|NCT00585351|50655222|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
25338743|NCT00585351|50655223|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
25338744|NCT00585351|50655224|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
25338745|NCT00585351|50655225|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
25338746|NCT00585351|50655226|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
25338747|NCT00585351|50655227|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
25338748|NCT00585351|50655228|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
25338749|NCT00585351|50655229|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
25338750|NCT00585351|50655222|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
25338751|NCT00585351|50655223|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
25338752|NCT00585351|50655224|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
25338753|NCT00585351|50655225|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
25338754|NCT00585351|50655226|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
25338755|NCT00585351|50655227|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
25338756|NCT00585351|50655228|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
25338757|NCT00585351|50655229|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
25338758|NCT00585351|50655222|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
25338759|NCT00585351|50655223|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
25338760|NCT00585351|50655224|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
25338761|NCT00585351|50655225|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
25338762|NCT00585351|50655226|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
25338763|NCT00585351|50655227|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
25338764|NCT00585351|50655228|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
25338765|NCT00585351|50655229|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
25338766|NCT00585351|50655222|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
25338767|NCT00585351|50655223|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
25338768|NCT00585351|50655224|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
25338769|NCT00585351|50655225|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
25338770|NCT00585351|50655226|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
25338771|NCT00585351|50655227|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
25338772|NCT00585351|50655228|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
25338773|NCT00585351|50655229|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
25338774|NCT00585351|50655222|FG000|Enrollment Period (Intervention)|Death|0|||
25338775|NCT00585351|50655223|FG001|Enrollment Period (Intervention)|Death|0|||
25338776|NCT00585351|50655224|FG002|Enrollment Period (Intervention)|Death|0|||
25338777|NCT00585351|50655225|FG003|Enrollment Period (Intervention)|Death|0|||
25338778|NCT00585351|50655226|FG004|Enrollment Period (Intervention)|Death|1|||
25338779|NCT00585351|50655227|FG005|Enrollment Period (Intervention)|Death|0|||
25338780|NCT00585351|50655228|FG006|Enrollment Period (Intervention)|Death|1|||
25338781|NCT00585351|50655229|FG007|Enrollment Period (Intervention)|Death|0|||
25254350|NCT01371747|50569951|FG002|Overall Study|Other Reasons|2|||
25254351|NCT01371747|50569952|FG003|Overall Study|Other Reasons|0|||
25254352|NCT01371747|50569953|FG004|Overall Study|Other Reasons|0|||
25338782|NCT00585351|50655222|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
25338783|NCT00585351|50655223|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
25338784|NCT00585351|50655224|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
25338785|NCT00585351|50655225|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
25338786|NCT00585351|50655226|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
25338787|NCT00585351|50655227|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
25338788|NCT00585351|50655228|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
25338789|NCT00585351|50655229|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
25338790|NCT00726609|50655243|FG000|Overall Study|Adverse Event|10|||
25338791|NCT00726609|50655243|FG000|Overall Study|Withdrawal by Subject|2|||
25338792|NCT00726609|50655243|FG000|Overall Study|Lack of Efficacy|25|||
25338793|NCT00726609|50655243|FG000|Overall Study|Other|16|||
25338794|NCT00726609|50655243|FG000|Overall Study|Missing|42|||
25338795|NCT00726609|50655243|FG000|Overall Study|Other|3|||
25254353|NCT01371747|50569954|FG005|Overall Study|Other Reasons|1|||
25254354|NCT01371708|50569989|FG000|Overall Study|Insufficient clinical response|3|||
25254355|NCT01371708|50569990|FG001|Overall Study|Insufficient clinical response|2|||
25338796|NCT00726453|50655249|FG000|Primary Enrollment Group|Death|18|||
25338797|NCT00726453|50655250|FG001|Primary Enrollment Group|Death|0|||
25338798|NCT00726453|50655249|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
25338799|NCT00726453|50655250|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
25338800|NCT00726453|50655249|FG000|38 mm Length Group|Death|0|||
25338801|NCT00726453|50655250|FG001|38 mm Length Group|Death|3|||
25338802|NCT00726063|50655257|FG000|Overall Study|Adverse Event|9|||
25338803|NCT00726063|50655258|FG001|Overall Study|Adverse Event|7|||
25338804|NCT00808028|50655268|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
25338805|NCT00808028|50655269|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
25338806|NCT00808028|50655270|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
25338807|NCT00808028|50655271|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
25338808|NCT00808028|50655268|FG000|Stage 1 (6 Months)|Other|1|||
25338809|NCT00808028|50655269|FG001|Stage 1 (6 Months)|Other|0|||
24902669|NCT00467779|49996804|FG006|Stage 1|Withdrawal by Subject|1|||
24902670|NCT00467779|49996805|FG007|Stage 1|Withdrawal by Subject|1|||
24902671|NCT00467779|49996806|FG008|Stage 1|Withdrawal by Subject|0|||
24902672|NCT00467779|49996807|FG009|Stage 1|Withdrawal by Subject|0|||
25254356|NCT01371708|50569991|FG002|Overall Study|Insufficient clinical response|0|||
25254357|NCT01371708|50569989|FG000|Overall Study|Lost to Follow-up|5|||
25254358|NCT01371708|50569990|FG001|Overall Study|Lost to Follow-up|9|||
25254359|NCT01371708|50569991|FG002|Overall Study|Lost to Follow-up|7|||
25254360|NCT01371708|50569989|FG000|Overall Study|Protocol Violation|2|||
25254361|NCT01371708|50569990|FG001|Overall Study|Protocol Violation|1|||
25254362|NCT01371708|50569991|FG002|Overall Study|Protocol Violation|2|||
25254363|NCT01371708|50569989|FG000|Overall Study|No longer willing to participate|7|||
25254364|NCT01371708|50569990|FG001|Overall Study|No longer willing to participate|7|||
25254365|NCT01371708|50569991|FG002|Overall Study|No longer willing to participate|13|||
25254366|NCT01371708|50569989|FG000|Overall Study|Medication error/not related to AE|0|||
25254367|NCT01371708|50569990|FG001|Overall Study|Medication error/not related to AE|1|||
25254368|NCT01371708|50569991|FG002|Overall Study|Medication error/not related to AE|0|||
25254369|NCT01371708|50569989|FG000|Overall Study|Other|3|||
25254370|NCT01371708|50569990|FG001|Overall Study|Other|2|||
25254371|NCT01371708|50569991|FG002|Overall Study|Other|4|||
25254372|NCT01371708|50569989|FG000|Overall Study|Adverse Event|5|||
25254373|NCT01371708|50569990|FG001|Overall Study|Adverse Event|8|||
25338810|NCT00808028|50655270|FG002|Stage 1 (6 Months)|Other|2|||
25338811|NCT00808028|50655271|FG003|Stage 1 (6 Months)|Other|4|||
25338812|NCT00808028|50655268|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
25338813|NCT00808028|50655269|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
25338814|NCT00808028|50655270|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
25338815|NCT00808028|50655271|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
25338816|NCT00808028|50655268|FG000|Stage 1 (6 Months)|Adverse Event|0|||
25338817|NCT00808028|50655269|FG001|Stage 1 (6 Months)|Adverse Event|0|||
25338818|NCT00808028|50655270|FG002|Stage 1 (6 Months)|Adverse Event|1|||
25338819|NCT00808028|50655271|FG003|Stage 1 (6 Months)|Adverse Event|2|||
25338820|NCT00808028|50655268|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
25338821|NCT00808028|50655269|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
24977428|NCT00048542|50066003|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
24977429|NCT00048542|50065996|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
24977430|NCT00048542|50065997|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
24977431|NCT00048542|50065998|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
24977432|NCT00048542|50065999|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
24977433|NCT00048542|50066000|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
24977434|NCT00048542|50066001|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
25254374|NCT01371708|50569991|FG002|Overall Study|Adverse Event|12|||
25254375|NCT01371708|50569989|FG000|Overall Study|Started but did not receive treatment|1|||
25338822|NCT00808028|50655270|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
25338823|NCT00808028|50655271|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
25338824|NCT00808028|50655268|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
25338825|NCT00808028|50655269|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
25338826|NCT00808028|50655270|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
25338827|NCT00808028|50655271|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
25338828|NCT00808028|50655268|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
25338829|NCT00808028|50655269|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
25338830|NCT00808028|50655270|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
25338831|NCT00808028|50655271|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
25338832|NCT00808028|50655268|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
25338833|NCT00808028|50655269|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
25338834|NCT00808028|50655270|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
25338835|NCT00808028|50655271|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
25338836|NCT00808028|50655268|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
25338837|NCT00808028|50655269|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
25338838|NCT00808028|50655270|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
25338839|NCT00808028|50655271|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
25338840|NCT00808028|50655268|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
25338841|NCT00808028|50655269|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
25338842|NCT00808028|50655270|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
25338843|NCT00808028|50655271|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
25338844|NCT00808028|50655268|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
25338845|NCT00808028|50655269|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
25338846|NCT00808028|50655270|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
25338847|NCT00808028|50655271|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
24977435|NCT00048542|50066002|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
25254376|NCT01371708|50569990|FG001|Overall Study|Started but did not receive treatment|0|||
25254377|NCT01371708|50569991|FG002|Overall Study|Started but did not receive treatment|1|||
25254378|NCT01335399|50570003|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
25254379|NCT01335399|50570004|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
25254380|NCT01335399|50570003|FG000|Pre-treatment Period|Participant request to discontinue|0|||
25254381|NCT01335399|50570004|FG001|Pre-treatment Period|Participant request to discontinue|1|||
25254382|NCT01335399|50570003|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
25254383|NCT01335399|50570004|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
25254384|NCT01335399|50570003|FG000|Pre-treatment Period|Consent withdrawal|3|||
25254385|NCT01335399|50570004|FG001|Pre-treatment Period|Consent withdrawal|0|||
25254386|NCT01335399|50570003|FG000|Treatment Period|Disease progression|117|||
25254387|NCT01335399|50570004|FG001|Treatment Period|Disease progression|145|||
25254388|NCT01335399|50570003|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
25338848|NCT00808028|50655268|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
25338849|NCT00808028|50655269|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
25338850|NCT00808028|50655270|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
25338851|NCT00808028|50655271|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
25338852|NCT00808028|50655268|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
25338853|NCT00808028|50655269|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
25338854|NCT00808028|50655270|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
25338855|NCT00808028|50655271|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
25254389|NCT01335399|50570004|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
25254390|NCT01335399|50570003|FG000|Treatment Period|Study drug toxicity|52|||
25254391|NCT01335399|50570004|FG001|Treatment Period|Study drug toxicity|64|||
25254392|NCT01335399|50570003|FG000|Treatment Period|Participant request to discontinue|30|||
25254393|NCT01335399|50570004|FG001|Treatment Period|Participant request to discontinue|22|||
25254394|NCT01335399|50570003|FG000|Treatment Period|Other reasons|30|||
25254395|NCT01335399|50570004|FG001|Treatment Period|Other reasons|30|||
25254396|NCT01335399|50570003|FG000|Treatment Period|Consent withdrawal|10|||
25254397|NCT01335399|50570004|FG001|Treatment Period|Consent withdrawal|7|||
25254398|NCT01335399|50570003|FG000|Treatment Period|Death|7|||
25338856|NCT00808028|50655268|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
25338857|NCT00808028|50655269|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
25254399|NCT01335399|50570004|FG001|Treatment Period|Death|6|||
25254400|NCT01335399|50570003|FG000|Treatment Period|Poor/Non-compliance|3|||
25338858|NCT00808028|50655270|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
25338859|NCT00808028|50655271|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
25338860|NCT00808028|50655268|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
25338861|NCT00808028|50655269|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
25338862|NCT00808028|50655270|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
25338863|NCT00808028|50655271|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
25338864|NCT00809783|50655294|FG000|Overall Study|Death|1|||
25338865|NCT00809783|50655295|FG001|Overall Study|Death|0|||
25338866|NCT00809783|50655296|FG002|Overall Study|Death|0|||
25338867|NCT00809783|50655294|FG000|Overall Study|Adverse Event|34|||
25338868|NCT00809783|50655295|FG001|Overall Study|Adverse Event|52|||
25338869|NCT00809783|50655296|FG002|Overall Study|Adverse Event|71|||
25338870|NCT00809783|50655294|FG000|Overall Study|Lack of Efficacy|39|||
25338871|NCT00809783|50655295|FG001|Overall Study|Lack of Efficacy|52|||
25338872|NCT00809783|50655296|FG002|Overall Study|Lack of Efficacy|63|||
24902673|NCT00467779|49996808|FG010|Stage 1|Withdrawal by Subject|0|||
24902674|NCT00467779|49996809|FG011|Stage 1|Withdrawal by Subject|0|||
24902675|NCT00467779|49996810|FG012|Stage 1|Withdrawal by Subject|0|||
24902676|NCT00467779|49996811|FG013|Stage 1|Withdrawal by Subject|0|||
24902677|NCT00467779|49996812|FG014|Stage 1|Withdrawal by Subject|0|||
24902678|NCT00467779|49996798|FG000|Stage 1A|Adverse Event|0|||
24902679|NCT00467779|49996799|FG001|Stage 1A|Adverse Event|0|||
24902680|NCT00467779|49996800|FG002|Stage 1A|Adverse Event|0|||
24902681|NCT00467779|49996801|FG003|Stage 1A|Adverse Event|0|||
24902682|NCT00467779|49996802|FG004|Stage 1A|Adverse Event|0|||
24902683|NCT00467779|49996803|FG005|Stage 1A|Adverse Event|0|||
24902684|NCT00467779|49996804|FG006|Stage 1A|Adverse Event|0|||
24902685|NCT00467779|49996805|FG007|Stage 1A|Adverse Event|0|||
24902686|NCT00467779|49996806|FG008|Stage 1A|Adverse Event|0|||
24902687|NCT00467779|49996807|FG009|Stage 1A|Adverse Event|0|||
24902688|NCT00467779|49996808|FG010|Stage 1A|Adverse Event|0|||
24902689|NCT00467779|49996809|FG011|Stage 1A|Adverse Event|0|||
24902690|NCT00467779|49996810|FG012|Stage 1A|Adverse Event|1|||
24902691|NCT00467779|49996811|FG013|Stage 1A|Adverse Event|0|||
24902692|NCT00467779|49996812|FG014|Stage 1A|Adverse Event|0|||
24902693|NCT00467779|49996798|FG000|Stage 1A|Death|0|||
24902694|NCT00467779|49996799|FG001|Stage 1A|Death|0|||
24902695|NCT00467779|49996800|FG002|Stage 1A|Death|0|||
24902696|NCT00467779|49996801|FG003|Stage 1A|Death|0|||
24902697|NCT00467779|49996802|FG004|Stage 1A|Death|0|||
24902698|NCT00467779|49996803|FG005|Stage 1A|Death|0|||
24902699|NCT00467779|49996804|FG006|Stage 1A|Death|0|||
24902700|NCT00467779|49996805|FG007|Stage 1A|Death|0|||
24902701|NCT00467779|49996806|FG008|Stage 1A|Death|0|||
24902702|NCT00467779|49996807|FG009|Stage 1A|Death|0|||
24902703|NCT00467779|49996808|FG010|Stage 1A|Death|0|||
24902704|NCT00467779|49996809|FG011|Stage 1A|Death|1|||
24902705|NCT00467779|49996810|FG012|Stage 1A|Death|1|||
24902706|NCT00467779|49996811|FG013|Stage 1A|Death|0|||
24902707|NCT00467779|49996812|FG014|Stage 1A|Death|0|||
24902708|NCT00467779|49996798|FG000|Stage 1A|Disease Progression|0|||
24902709|NCT00467779|49996799|FG001|Stage 1A|Disease Progression|0|||
24902710|NCT00467779|49996800|FG002|Stage 1A|Disease Progression|0|||
25254401|NCT01335399|50570004|FG001|Treatment Period|Poor/Non-compliance|4|||
25078000|NCT02456636|50186181|FG002|Overall Study|Pregnancy|5|||
25254402|NCT01335399|50570003|FG000|Treatment Period|Lost to Follow-up|2|||
25338873|NCT00809783|50655294|FG000|Overall Study|Lost to Follow-up|0|||
25338874|NCT00809783|50655295|FG001|Overall Study|Lost to Follow-up|3|||
25338875|NCT00809783|50655296|FG002|Overall Study|Lost to Follow-up|4|||
25338876|NCT00809783|50655294|FG000|Overall Study|Withdrawal by Subject|47|||
24902711|NCT00467779|49996801|FG003|Stage 1A|Disease Progression|0|||
24902712|NCT00467779|49996802|FG004|Stage 1A|Disease Progression|0|||
25254403|NCT01335399|50570004|FG001|Treatment Period|Lost to Follow-up|2|||
24902713|NCT00467779|49996803|FG005|Stage 1A|Disease Progression|0|||
24902714|NCT00467779|49996804|FG006|Stage 1A|Disease Progression|0|||
24902715|NCT00467779|49996805|FG007|Stage 1A|Disease Progression|0|||
24902716|NCT00467779|49996806|FG008|Stage 1A|Disease Progression|0|||
24902717|NCT00467779|49996807|FG009|Stage 1A|Disease Progression|2|||
25254404|NCT01335399|50570003|FG000|Treatment Period|Maximum clinical benefit|1|||
25254405|NCT01335399|50570004|FG001|Treatment Period|Maximum clinical benefit|1|||
25254406|NCT01335399|50570003|FG000|Treatment Period|No longer meet study criteria|1|||
25254407|NCT01335399|50570004|FG001|Treatment Period|No longer meet study criteria|1|||
25254408|NCT01335399|50570003|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
25254409|NCT01335399|50570004|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
25254410|NCT01366521|50570014|FG000|Overall Study|Adverse Event|1|||
25254411|NCT01366521|50570015|FG001|Overall Study|Adverse Event|0|||
25254412|NCT01366521|50570016|FG002|Overall Study|Adverse Event|0|||
25254413|NCT01366521|50570017|FG003|Overall Study|Adverse Event|0|||
25254414|NCT01366521|50570014|FG000|Overall Study|Protocol Violation|0|||
25254415|NCT01366521|50570015|FG001|Overall Study|Protocol Violation|0|||
25254416|NCT01366521|50570016|FG002|Overall Study|Protocol Violation|1|||
25254417|NCT01366521|50570017|FG003|Overall Study|Protocol Violation|0|||
25254418|NCT01366521|50570014|FG000|Overall Study|Physician Decision|0|||
25254419|NCT01366521|50570015|FG001|Overall Study|Physician Decision|0|||
25254420|NCT01366521|50570016|FG002|Overall Study|Physician Decision|1|||
25338877|NCT00809783|50655295|FG001|Overall Study|Withdrawal by Subject|72|||
25338878|NCT00809783|50655296|FG002|Overall Study|Withdrawal by Subject|64|||
25338879|NCT00809783|50655294|FG000|Overall Study|Protocol Violation|2|||
25338880|NCT00809783|50655295|FG001|Overall Study|Protocol Violation|6|||
25338881|NCT00809783|50655296|FG002|Overall Study|Protocol Violation|5|||
25338882|NCT00809783|50655294|FG000|Overall Study|Randomized, but not treated|3|||
25338883|NCT00809783|50655295|FG001|Overall Study|Randomized, but not treated|0|||
25338884|NCT00809783|50655296|FG002|Overall Study|Randomized, but not treated|2|||
25338885|NCT00809783|50655294|FG000|Overall Study|Study Terminated by Sponsor|378|||
25338886|NCT00809783|50655295|FG001|Overall Study|Study Terminated by Sponsor|626|||
25338887|NCT00809783|50655296|FG002|Overall Study|Study Terminated by Sponsor|565|||
25338888|NCT00809783|50655294|FG000|Overall Study|Other|21|||
25338889|NCT00809783|50655295|FG001|Overall Study|Other|21|||
25338890|NCT00809783|50655296|FG002|Overall Study|Other|16|||
25338891|NCT00809471|50655307|FG000|Overall Study|Protocol non-compliance|15|||
25338892|NCT00809471|50655308|FG001|Overall Study|Protocol non-compliance|15|||
25338893|NCT00809471|50655309|FG002|Overall Study|Protocol non-compliance|6|||
25338894|NCT00809471|50655307|FG000|Overall Study|Lost to Follow-up|4|||
25338895|NCT00809471|50655308|FG001|Overall Study|Lost to Follow-up|2|||
25338896|NCT00809471|50655309|FG002|Overall Study|Lost to Follow-up|9|||
25338897|NCT00809471|50655307|FG000|Overall Study|Adverse Event|0|||
25338898|NCT00809471|50655308|FG001|Overall Study|Adverse Event|2|||
25338899|NCT00809471|50655309|FG002|Overall Study|Adverse Event|2|||
25338900|NCT00809471|50655307|FG000|Overall Study|Requirement for restricted medication|1|||
25338901|NCT00809471|50655308|FG001|Overall Study|Requirement for restricted medication|1|||
25338902|NCT00809471|50655309|FG002|Overall Study|Requirement for restricted medication|0|||
25338903|NCT00807248|50655321|FG000|Overall Study|Adverse Event|1|||
25338904|NCT00807248|50655322|FG001|Overall Study|Adverse Event|2|||
25338905|NCT00807248|50655323|FG002|Overall Study|Adverse Event|2|||
24902718|NCT00467779|49996808|FG010|Stage 1A|Disease Progression|2|||
24902719|NCT00467779|49996809|FG011|Stage 1A|Disease Progression|5|||
24902720|NCT00467779|49996810|FG012|Stage 1A|Disease Progression|2|||
24902721|NCT00467779|49996811|FG013|Stage 1A|Disease Progression|0|||
24902722|NCT00467779|49996812|FG014|Stage 1A|Disease Progression|0|||
24902723|NCT00467779|49996798|FG000|Stage 1A|Physician Decision|0|||
24902724|NCT00467779|49996799|FG001|Stage 1A|Physician Decision|0|||
24902725|NCT00467779|49996800|FG002|Stage 1A|Physician Decision|0|||
24902726|NCT00467779|49996801|FG003|Stage 1A|Physician Decision|0|||
24902727|NCT00467779|49996802|FG004|Stage 1A|Physician Decision|0|||
24902728|NCT00467779|49996803|FG005|Stage 1A|Physician Decision|0|||
24902729|NCT00467779|49996804|FG006|Stage 1A|Physician Decision|0|||
24902730|NCT00467779|49996805|FG007|Stage 1A|Physician Decision|0|||
24902731|NCT00467779|49996806|FG008|Stage 1A|Physician Decision|0|||
24902732|NCT00467779|49996807|FG009|Stage 1A|Physician Decision|1|||
24902733|NCT00467779|49996808|FG010|Stage 1A|Physician Decision|0|||
24977436|NCT00048542|50066003|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
24977437|NCT00048542|50065996|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
25078001|NCT02456636|50186179|FG000|Overall Study|Physician Decision|4|||
25254421|NCT01366521|50570017|FG003|Overall Study|Physician Decision|0|||
25254422|NCT01366521|50570014|FG000|Overall Study|Withdrawal by Subject|0|||
25254423|NCT01366521|50570015|FG001|Overall Study|Withdrawal by Subject|1|||
25338906|NCT00807248|50655324|FG003|Overall Study|Adverse Event|6|||
25338907|NCT00807248|50655321|FG000|Overall Study|Lack of Efficacy|14|||
24902734|NCT00467779|49996809|FG011|Stage 1A|Physician Decision|0|||
24902735|NCT00467779|49996810|FG012|Stage 1A|Physician Decision|0|||
24977438|NCT00048542|50065997|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
25254424|NCT01366521|50570016|FG002|Overall Study|Withdrawal by Subject|0|||
25254425|NCT01366521|50570017|FG003|Overall Study|Withdrawal by Subject|0|||
25338908|NCT00807248|50655322|FG001|Overall Study|Lack of Efficacy|4|||
25338909|NCT00807248|50655323|FG002|Overall Study|Lack of Efficacy|8|||
25338910|NCT00807248|50655324|FG003|Overall Study|Lack of Efficacy|3|||
25254426|NCT01335009|50570031|FG000|Overall Study|Too ill to travel to study sites|1|||
25254427|NCT01335009|50570032|FG001|Overall Study|Too ill to travel to study sites|0|||
25254428|NCT01335009|50570031|FG000|Overall Study|Death|28|||
25254429|NCT01335009|50570032|FG001|Overall Study|Death|32|||
25254430|NCT01335009|50570031|FG000|Overall Study|Withdrawal by Subject|1|||
25254431|NCT01335009|50570032|FG001|Overall Study|Withdrawal by Subject|1|||
25254432|NCT01335009|50570031|FG000|Overall Study|Lost to Follow-up|1|||
25254433|NCT01335009|50570032|FG001|Overall Study|Lost to Follow-up|0|||
25338911|NCT00807248|50655321|FG000|Overall Study|Protocol Violation|0|||
25338912|NCT00807248|50655322|FG001|Overall Study|Protocol Violation|1|||
25338913|NCT00807248|50655323|FG002|Overall Study|Protocol Violation|1|||
25338914|NCT00807248|50655324|FG003|Overall Study|Protocol Violation|0|||
25338915|NCT00807248|50655321|FG000|Overall Study|Withdrawal of Consent|5|||
25338916|NCT00807248|50655322|FG001|Overall Study|Withdrawal of Consent|5|||
25254434|NCT01366443|50570047|FG000|Overall Study|Lost to Follow-up|2|||
25254435|NCT01366443|50570047|FG000|Overall Study|Under 18 yo|1|||
25254436|NCT01332630|50570052|FG000|Overall Study|Withdrawal by Subject|3|||
25254437|NCT01366209|50570058|FG000|Overall Study|Adverse Event|6|||
25254438|NCT01366209|50570059|FG001|Overall Study|Adverse Event|7|||
25254439|NCT01366209|50570058|FG000|Overall Study|Withdrawal by Subject|4|||
25254440|NCT01366209|50570059|FG001|Overall Study|Withdrawal by Subject|4|||
25254441|NCT01366209|50570058|FG000|Overall Study|Death|12|||
25254442|NCT01366209|50570059|FG001|Overall Study|Death|19|||
25254443|NCT01366209|50570058|FG000|Overall Study|Lung transplantation|6|||
25254444|NCT01366209|50570059|FG001|Overall Study|Lung transplantation|1|||
25254445|NCT01366209|50570058|FG000|Overall Study|Lost to Follow-up|2|||
25254446|NCT01366209|50570059|FG001|Overall Study|Lost to Follow-up|1|||
25254447|NCT01366209|50570058|FG000|Overall Study|Physician Decision|1|||
25254448|NCT01366209|50570059|FG001|Overall Study|Physician Decision|0|||
25338917|NCT00807248|50655323|FG002|Overall Study|Withdrawal of Consent|5|||
25338918|NCT00807248|50655324|FG003|Overall Study|Withdrawal of Consent|5|||
24902736|NCT00467779|49996811|FG013|Stage 1A|Physician Decision|0|||
24902737|NCT00467779|49996812|FG014|Stage 1A|Physician Decision|0|||
24902738|NCT00467779|49996798|FG000|Stage 1A|Withdrawal by Subject|0|||
24902739|NCT00467779|49996799|FG001|Stage 1A|Withdrawal by Subject|0|||
24902740|NCT00467779|49996800|FG002|Stage 1A|Withdrawal by Subject|0|||
24902741|NCT00467779|49996801|FG003|Stage 1A|Withdrawal by Subject|0|||
24902742|NCT00467779|49996802|FG004|Stage 1A|Withdrawal by Subject|0|||
24902743|NCT00467779|49996803|FG005|Stage 1A|Withdrawal by Subject|0|||
24902744|NCT00467779|49996804|FG006|Stage 1A|Withdrawal by Subject|0|||
24902745|NCT00467779|49996805|FG007|Stage 1A|Withdrawal by Subject|0|||
24902746|NCT00467779|49996806|FG008|Stage 1A|Withdrawal by Subject|0|||
24902747|NCT00467779|49996807|FG009|Stage 1A|Withdrawal by Subject|0|||
24902748|NCT00467779|49996808|FG010|Stage 1A|Withdrawal by Subject|1|||
24902749|NCT00467779|49996809|FG011|Stage 1A|Withdrawal by Subject|1|||
24902750|NCT00467779|49996810|FG012|Stage 1A|Withdrawal by Subject|1|||
24902751|NCT00467779|49996811|FG013|Stage 1A|Withdrawal by Subject|0|||
24902752|NCT00467779|49996812|FG014|Stage 1A|Withdrawal by Subject|0|||
24902753|NCT00467779|49996798|FG000|Stage 1A|Unspecified Reason|0|||
24902754|NCT00467779|49996799|FG001|Stage 1A|Unspecified Reason|0|||
24902755|NCT00467779|49996800|FG002|Stage 1A|Unspecified Reason|0|||
24902756|NCT00467779|49996801|FG003|Stage 1A|Unspecified Reason|0|||
24902757|NCT00467779|49996802|FG004|Stage 1A|Unspecified Reason|0|||
24902758|NCT00467779|49996803|FG005|Stage 1A|Unspecified Reason|0|||
24902759|NCT00467779|49996804|FG006|Stage 1A|Unspecified Reason|0|||
24902760|NCT00467779|49996805|FG007|Stage 1A|Unspecified Reason|0|||
24902761|NCT00467779|49996806|FG008|Stage 1A|Unspecified Reason|0|||
24902762|NCT00467779|49996807|FG009|Stage 1A|Unspecified Reason|0|||
24902763|NCT00467779|49996808|FG010|Stage 1A|Unspecified Reason|0|||
24902764|NCT00467779|49996809|FG011|Stage 1A|Unspecified Reason|1|||
24902765|NCT00467779|49996810|FG012|Stage 1A|Unspecified Reason|1|||
24902766|NCT00467779|49996811|FG013|Stage 1A|Unspecified Reason|0|||
24902767|NCT00467779|49996812|FG014|Stage 1A|Unspecified Reason|0|||
24902768|NCT00467779|49996798|FG000|Stage 2|Adverse Event|0|||
25078002|NCT02456636|50186180|FG001|Overall Study|Physician Decision|5|||
24902769|NCT00467779|49996799|FG001|Stage 2|Adverse Event|0|||
24902770|NCT00467779|49996800|FG002|Stage 2|Adverse Event|0|||
24902771|NCT00467779|49996801|FG003|Stage 2|Adverse Event|0|||
24902772|NCT00467779|49996802|FG004|Stage 2|Adverse Event|0|||
24902773|NCT00467779|49996803|FG005|Stage 2|Adverse Event|0|||
24902774|NCT00467779|49996804|FG006|Stage 2|Adverse Event|0|||
24902775|NCT00467779|49996805|FG007|Stage 2|Adverse Event|0|||
24902776|NCT00467779|49996806|FG008|Stage 2|Adverse Event|1|||
24902777|NCT00467779|49996807|FG009|Stage 2|Adverse Event|0|||
24902778|NCT00467779|49996808|FG010|Stage 2|Adverse Event|0|||
24902779|NCT00467779|49996809|FG011|Stage 2|Adverse Event|0|||
24902780|NCT00467779|49996810|FG012|Stage 2|Adverse Event|0|||
24902781|NCT00467779|49996811|FG013|Stage 2|Adverse Event|0|||
25254449|NCT01366209|50570058|FG000|Overall Study|Sponsors decision|0|||
25254450|NCT01366209|50570059|FG001|Overall Study|Sponsors decision|1|||
25338919|NCT00807248|50655321|FG000|Overall Study|Lost to Follow-up|1|||
25338920|NCT00807248|50655322|FG001|Overall Study|Lost to Follow-up|0|||
25338921|NCT00807248|50655323|FG002|Overall Study|Lost to Follow-up|0|||
25338922|NCT00807248|50655324|FG003|Overall Study|Lost to Follow-up|0|||
25338923|NCT00807248|50655321|FG000|Overall Study|Other Reason|0|||
25338924|NCT00807248|50655322|FG001|Overall Study|Other Reason|0|||
25338925|NCT00807248|50655323|FG002|Overall Study|Other Reason|2|||
25338926|NCT00807248|50655324|FG003|Overall Study|Other Reason|0|||
25338927|NCT00589628|50655336|FG000|Overall Study|Lost to Follow-up|0|||
25338928|NCT00589628|50655337|FG001|Overall Study|Lost to Follow-up|1|||
25338929|NCT00588848|50655345|FG000|Overall Study|Physician Decision|0|||
25338930|NCT00588848|50655346|FG001|Overall Study|Physician Decision|3|||
25338931|NCT00797108|50655357|FG000|Overall Study|Adverse Event|1|||
25338932|NCT00797108|50655358|FG001|Overall Study|Adverse Event|0|||
25338933|NCT00797108|50655359|FG002|Overall Study|Adverse Event|3|||
25338934|NCT00797108|50655357|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
25338935|NCT00797108|50655358|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
25338936|NCT00797108|50655359|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
25338937|NCT00797108|50655357|FG000|Overall Study|Global Deterioration of Health Status|0|||
25338938|NCT00797108|50655358|FG001|Overall Study|Global Deterioration of Health Status|1|||
25338939|NCT00797108|50655359|FG002|Overall Study|Global Deterioration of Health Status|0|||
25338940|NCT00797108|50655357|FG000|Overall Study|Lack of Efficacy|1|||
25338941|NCT00797108|50655358|FG001|Overall Study|Lack of Efficacy|0|||
25338942|NCT00797108|50655359|FG002|Overall Study|Lack of Efficacy|1|||
25338943|NCT00797108|50655357|FG000|Overall Study|Other|0|||
25338944|NCT00797108|50655358|FG001|Overall Study|Other|0|||
25338945|NCT00797108|50655359|FG002|Overall Study|Other|2|||
25338946|NCT00797108|50655357|FG000|Overall Study|Randomized but not Treated|2|||
25338947|NCT00797108|50655358|FG001|Overall Study|Randomized but not Treated|0|||
25338948|NCT00797108|50655359|FG002|Overall Study|Randomized but not Treated|0|||
25338949|NCT00742560|50655372|FG000|Overall Study|Adverse Event|0|||
25338950|NCT00742560|50655373|FG001|Overall Study|Adverse Event|0|||
25338951|NCT00742560|50655374|FG002|Overall Study|Adverse Event|1|||
25338952|NCT00742560|50655375|FG003|Overall Study|Adverse Event|1|||
25338953|NCT00742560|50655376|FG004|Overall Study|Adverse Event|1|||
25338954|NCT00742560|50655372|FG000|Overall Study|Death|0|||
25338955|NCT00742560|50655373|FG001|Overall Study|Death|2|||
25338956|NCT00742560|50655374|FG002|Overall Study|Death|0|||
25338957|NCT00742560|50655375|FG003|Overall Study|Death|2|||
25338958|NCT00742560|50655376|FG004|Overall Study|Death|3|||
25338959|NCT00742560|50655372|FG000|Overall Study|Subject's Decision|1|||
25338960|NCT00742560|50655373|FG001|Overall Study|Subject's Decision|0|||
25338961|NCT00742560|50655374|FG002|Overall Study|Subject's Decision|2|||
25338962|NCT00742560|50655375|FG003|Overall Study|Subject's Decision|3|||
24902782|NCT00467779|49996812|FG014|Stage 2|Adverse Event|0|||
25254451|NCT01366209|50570058|FG000|Overall Study|Withdrew consent|4|||
25254452|NCT01366209|50570059|FG001|Overall Study|Withdrew consent|3|||
25254453|NCT01365546|50570065|FG000|Overall Study|Withdrawal by Subject|1|||
25254454|NCT01365546|50570065|FG000|Overall Study|Screen failure|9|||
25254455|NCT01365546|50570065|FG000|Overall Study|Study termination|1|||
25254456|NCT01365507|50570075|FG000|Overall Study|Withdrawal Criteria|8|||
25254457|NCT01365507|50570076|FG001|Overall Study|Withdrawal Criteria|5|||
25254458|NCT01365507|50570075|FG000|Overall Study|Unclassified|1|||
25254459|NCT01365507|50570076|FG001|Overall Study|Unclassified|4|||
25254460|NCT01365468|50570100|FG000|Overall Study|Physician Decision|1|||
25254461|NCT01365468|50570101|FG001|Overall Study|Physician Decision|0|||
25254462|NCT01365468|50570100|FG000|Overall Study|Disease progression|1|||
25254463|NCT01365468|50570101|FG001|Overall Study|Disease progression|0|||
25254464|NCT01365468|50570100|FG000|Overall Study|Lost to Follow-up|2|||
25254465|NCT01365468|50570101|FG001|Overall Study|Lost to Follow-up|0|||
25254466|NCT01357980|50570112|FG000|Overall Study|Lack of Efficacy|0|||
25254467|NCT01357980|50570113|FG001|Overall Study|Lack of Efficacy|1|||
25254468|NCT01357980|50570114|FG002|Overall Study|Lack of Efficacy|0|||
25254469|NCT01357980|50570115|FG003|Overall Study|Lack of Efficacy|0|||
25254470|NCT01357980|50570112|FG000|Overall Study|Consent withdrawn|0|||
25254471|NCT01357980|50570113|FG001|Overall Study|Consent withdrawn|0|||
25254472|NCT01357980|50570114|FG002|Overall Study|Consent withdrawn|1|||
25338963|NCT00742560|50655376|FG004|Overall Study|Subject's Decision|3|||
25338964|NCT00742560|50655372|FG000|Overall Study|Investigator's Decision|0|||
25338965|NCT00742560|50655373|FG001|Overall Study|Investigator's Decision|0|||
24902783|NCT00467779|49996798|FG000|Stage 2|Death|0|||
24902784|NCT00467779|49996799|FG001|Stage 2|Death|0|||
25254473|NCT01357980|50570115|FG003|Overall Study|Consent withdrawn|0|||
25254474|NCT01332318|50570129|FG000|Overall Study|Adverse Event|0|||
25254475|NCT01332318|50570130|FG001|Overall Study|Adverse Event|3|||
25254476|NCT01332318|50570131|FG002|Overall Study|Adverse Event|0|||
25254477|NCT01332318|50570132|FG003|Overall Study|Adverse Event|0|||
25254478|NCT01332318|50570129|FG000|Overall Study|Withdrawal by Subject|1|||
25338966|NCT00742560|50655374|FG002|Overall Study|Investigator's Decision|4|||
25338967|NCT00742560|50655375|FG003|Overall Study|Investigator's Decision|1|||
25338968|NCT00742560|50655376|FG004|Overall Study|Investigator's Decision|0|||
25338969|NCT00742560|50655372|FG000|Overall Study|Disease Progression|1|||
25338970|NCT00742560|50655373|FG001|Overall Study|Disease Progression|0|||
25338971|NCT00742560|50655374|FG002|Overall Study|Disease Progression|5|||
24902785|NCT00467779|49996800|FG002|Stage 2|Death|0|||
24902786|NCT00467779|49996801|FG003|Stage 2|Death|0|||
24902787|NCT00467779|49996802|FG004|Stage 2|Death|0|||
24902788|NCT00467779|49996803|FG005|Stage 2|Death|0|||
24902789|NCT00467779|49996804|FG006|Stage 2|Death|0|||
24902790|NCT00467779|49996805|FG007|Stage 2|Death|0|||
24902791|NCT00467779|49996806|FG008|Stage 2|Death|1|||
24902792|NCT00467779|49996807|FG009|Stage 2|Death|0|||
24902793|NCT00467779|49996808|FG010|Stage 2|Death|0|||
24902794|NCT00467779|49996809|FG011|Stage 2|Death|0|||
24902795|NCT00467779|49996810|FG012|Stage 2|Death|0|||
24902796|NCT00467779|49996811|FG013|Stage 2|Death|0|||
24902797|NCT00467779|49996812|FG014|Stage 2|Death|0|||
24902798|NCT00467779|49996798|FG000|Stage 2|Disease Progression|0|||
24902799|NCT00467779|49996799|FG001|Stage 2|Disease Progression|0|||
24902800|NCT00467779|49996800|FG002|Stage 2|Disease Progression|0|||
24902801|NCT00467779|49996801|FG003|Stage 2|Disease Progression|0|||
24902802|NCT00467779|49996802|FG004|Stage 2|Disease Progression|0|||
24902803|NCT00467779|49996803|FG005|Stage 2|Disease Progression|0|||
24902804|NCT00467779|49996804|FG006|Stage 2|Disease Progression|0|||
24902805|NCT00467779|49996805|FG007|Stage 2|Disease Progression|0|||
24902806|NCT00467779|49996806|FG008|Stage 2|Disease Progression|16|||
24902807|NCT00467779|49996807|FG009|Stage 2|Disease Progression|0|||
24902808|NCT00467779|49996808|FG010|Stage 2|Disease Progression|0|||
24902809|NCT00467779|49996809|FG011|Stage 2|Disease Progression|0|||
24902810|NCT00467779|49996810|FG012|Stage 2|Disease Progression|0|||
24902811|NCT00467779|49996811|FG013|Stage 2|Disease Progression|0|||
24902812|NCT00467779|49996812|FG014|Stage 2|Disease Progression|0|||
24902813|NCT00467779|49996798|FG000|Stage 2|Unspecified Reason|0|||
24902814|NCT00467779|49996799|FG001|Stage 2|Unspecified Reason|0|||
24902815|NCT00467779|49996800|FG002|Stage 2|Unspecified Reason|0|||
24902816|NCT00467779|49996801|FG003|Stage 2|Unspecified Reason|0|||
24902817|NCT00467779|49996802|FG004|Stage 2|Unspecified Reason|0|||
24902818|NCT00467779|49996803|FG005|Stage 2|Unspecified Reason|0|||
24902819|NCT00467779|49996804|FG006|Stage 2|Unspecified Reason|0|||
24902820|NCT00467779|49996805|FG007|Stage 2|Unspecified Reason|0|||
24902821|NCT00467779|49996806|FG008|Stage 2|Unspecified Reason|3|||
24902822|NCT00467779|49996807|FG009|Stage 2|Unspecified Reason|0|||
24902823|NCT00467779|49996808|FG010|Stage 2|Unspecified Reason|0|||
24902824|NCT00467779|49996809|FG011|Stage 2|Unspecified Reason|0|||
24902825|NCT00467779|49996810|FG012|Stage 2|Unspecified Reason|0|||
24902826|NCT00467779|49996811|FG013|Stage 2|Unspecified Reason|0|||
24902827|NCT00467779|49996812|FG014|Stage 2|Unspecified Reason|0|||
24902828|NCT00467779|49996798|FG000|Stage 2A|Adverse Event|0|||
24902829|NCT00467779|49996799|FG001|Stage 2A|Adverse Event|0|||
24902830|NCT00467779|49996800|FG002|Stage 2A|Adverse Event|0|||
24902831|NCT00467779|49996801|FG003|Stage 2A|Adverse Event|0|||
24902832|NCT00467779|49996802|FG004|Stage 2A|Adverse Event|0|||
24902833|NCT00467779|49996803|FG005|Stage 2A|Adverse Event|0|||
24902834|NCT00467779|49996804|FG006|Stage 2A|Adverse Event|0|||
24902835|NCT00467779|49996805|FG007|Stage 2A|Adverse Event|0|||
24902836|NCT00467779|49996806|FG008|Stage 2A|Adverse Event|0|||
25254479|NCT01332318|50570130|FG001|Overall Study|Withdrawal by Subject|1|||
25254480|NCT01332318|50570131|FG002|Overall Study|Withdrawal by Subject|0|||
25254481|NCT01332318|50570132|FG003|Overall Study|Withdrawal by Subject|1|||
25254482|NCT01332318|50570129|FG000|Overall Study|Protocol Violation|1|||
25254483|NCT01332318|50570130|FG001|Overall Study|Protocol Violation|0|||
25254484|NCT01332318|50570131|FG002|Overall Study|Protocol Violation|1|||
24902837|NCT00467779|49996807|FG009|Stage 2A|Adverse Event|0|||
25254485|NCT01332318|50570132|FG003|Overall Study|Protocol Violation|1|||
25254486|NCT01331109|50570147|FG000|Overall Study|Adverse Event|6|||
25254487|NCT01331109|50570147|FG000|Overall Study|Lack of Efficacy|2|||
24902838|NCT00467779|49996808|FG010|Stage 2A|Adverse Event|0|||
24902839|NCT00467779|49996809|FG011|Stage 2A|Adverse Event|0|||
24902840|NCT00467779|49996810|FG012|Stage 2A|Adverse Event|0|||
24902841|NCT00467779|49996811|FG013|Stage 2A|Adverse Event|2|||
24902842|NCT00467779|49996812|FG014|Stage 2A|Adverse Event|0|||
24902843|NCT00467779|49996798|FG000|Stage 2A|Death|0|||
24902844|NCT00467779|49996799|FG001|Stage 2A|Death|0|||
24902845|NCT00467779|49996800|FG002|Stage 2A|Death|0|||
24902846|NCT00467779|49996801|FG003|Stage 2A|Death|0|||
24902847|NCT00467779|49996802|FG004|Stage 2A|Death|0|||
24902848|NCT00467779|49996803|FG005|Stage 2A|Death|0|||
24902849|NCT00467779|49996804|FG006|Stage 2A|Death|0|||
24902850|NCT00467779|49996805|FG007|Stage 2A|Death|0|||
24902851|NCT00467779|49996806|FG008|Stage 2A|Death|0|||
24902852|NCT00467779|49996807|FG009|Stage 2A|Death|0|||
24902853|NCT00467779|49996808|FG010|Stage 2A|Death|0|||
24902854|NCT00467779|49996809|FG011|Stage 2A|Death|0|||
24902855|NCT00467779|49996810|FG012|Stage 2A|Death|0|||
24902856|NCT00467779|49996811|FG013|Stage 2A|Death|1|||
24902857|NCT00467779|49996812|FG014|Stage 2A|Death|0|||
25254488|NCT01331109|50570147|FG000|Overall Study|Protocol Violation|3|||
25254489|NCT01331109|50570147|FG000|Overall Study|Withdrawal by Subject|7|||
25338972|NCT00742560|50655375|FG003|Overall Study|Disease Progression|17|||
25338973|NCT00742560|50655376|FG004|Overall Study|Disease Progression|16|||
25338974|NCT00742560|50655372|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
25338975|NCT00742560|50655373|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
25338976|NCT00742560|50655374|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
25338977|NCT00742560|50655375|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
25338978|NCT00742560|50655376|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
25338979|NCT00742560|50655372|FG000|Overall Study|Other|0|||
25338980|NCT00742560|50655373|FG001|Overall Study|Other|1|||
25338981|NCT00742560|50655374|FG002|Overall Study|Other|8|||
25338982|NCT00742560|50655375|FG003|Overall Study|Other|9|||
25338983|NCT00742560|50655376|FG004|Overall Study|Other|9|||
25338984|NCT00742560|50655372|FG000|Overall Study|MIssing|0|||
25338985|NCT00742560|50655373|FG001|Overall Study|MIssing|0|||
25338986|NCT00742560|50655374|FG002|Overall Study|MIssing|0|||
25338987|NCT00742560|50655375|FG003|Overall Study|MIssing|0|||
25338988|NCT00742560|50655376|FG004|Overall Study|MIssing|1|||
25338989|NCT00740220|50655407|FG000|Overall Study|screen failures (non-COPD patients)|9|||
25338990|NCT00796718|50655411|FG000|Overall Study|Adverse Event|2|||
25338991|NCT00796718|50655411|FG000|Overall Study|Exclusion Criteria|1|||
25338992|NCT00796718|50655411|FG000|Overall Study|Lost to Follow-up|5|||
25338993|NCT00796718|50655411|FG000|Overall Study|Withdrawal by Informed Consent|1|||
25338994|NCT00809159|50655419|FG000|Part 1|Adverse Event|1|||
25338995|NCT00809159|50655420|FG001|Part 1|Adverse Event|1|||
25338996|NCT00809159|50655421|FG002|Part 1|Adverse Event|0|||
25338997|NCT00809159|50655422|FG003|Part 1|Adverse Event|0|||
25338998|NCT00809159|50655423|FG004|Part 1|Adverse Event|0|||
25338999|NCT00809159|50655424|FG005|Part 1|Adverse Event|0|||
25339000|NCT00809159|50655419|FG000|Part 1|Lost to Follow-up|1|||
25339001|NCT00809159|50655420|FG001|Part 1|Lost to Follow-up|0|||
25339002|NCT00809159|50655421|FG002|Part 1|Lost to Follow-up|0|||
25339003|NCT00809159|50655422|FG003|Part 1|Lost to Follow-up|0|||
25339004|NCT00809159|50655423|FG004|Part 1|Lost to Follow-up|0|||
25339005|NCT00809159|50655424|FG005|Part 1|Lost to Follow-up|0|||
25339006|NCT00809159|50655419|FG000|Part 1|Withdrawal by Subject|3|||
25339007|NCT00809159|50655420|FG001|Part 1|Withdrawal by Subject|1|||
25339008|NCT00809159|50655421|FG002|Part 1|Withdrawal by Subject|0|||
25339009|NCT00809159|50655422|FG003|Part 1|Withdrawal by Subject|0|||
25339010|NCT00809159|50655423|FG004|Part 1|Withdrawal by Subject|0|||
25339011|NCT00809159|50655424|FG005|Part 1|Withdrawal by Subject|0|||
25339012|NCT00809159|50655419|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
25339013|NCT00809159|50655420|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
25339014|NCT00809159|50655421|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
25339015|NCT00809159|50655422|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
25339016|NCT00809159|50655423|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
25339017|NCT00809159|50655424|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
25339018|NCT00809159|50655419|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
25339019|NCT00809159|50655420|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
25339020|NCT00809159|50655421|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
25339021|NCT00809159|50655422|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
25339022|NCT00809159|50655423|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
25339023|NCT00809159|50655424|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
25339024|NCT00809159|50655419|FG000|Part 1 and 2|Administrative problems|0|||
25339025|NCT00809159|50655420|FG001|Part 1 and 2|Administrative problems|0|||
25254490|NCT01331109|50570147|FG000|Overall Study|Lost to Follow-up|1|||
25254491|NCT01331109|50570147|FG000|Overall Study|Study Terminated by Sponsor|38|||
25254492|NCT01357551|50570153|FG000|Overall Study|Withdrawal by Subject|6|||
25254493|NCT01357551|50570154|FG001|Overall Study|Withdrawal by Subject|4|||
25254494|NCT01357551|50570153|FG000|Overall Study|Death|0|||
25254495|NCT01357551|50570154|FG001|Overall Study|Death|1|||
25254496|NCT01357551|50570153|FG000|Overall Study|Lost to Follow-up|16|||
25254497|NCT01357551|50570154|FG001|Overall Study|Lost to Follow-up|6|||
25254498|NCT01357239|50570167|FG000|Stratum: All Patients|Adverse Event|0|||
25254499|NCT01357239|50570168|FG001|Stratum: All Patients|Adverse Event|0|||
25339026|NCT00809159|50655421|FG002|Part 1 and 2|Administrative problems|0|||
25339027|NCT00809159|50655422|FG003|Part 1 and 2|Administrative problems|1|||
25339028|NCT00809159|50655423|FG004|Part 1 and 2|Administrative problems|0|||
25339029|NCT00809159|50655424|FG005|Part 1 and 2|Administrative problems|0|||
25339030|NCT00809159|50655419|FG000|Part 1 and 2|Adverse Event|0|||
25339031|NCT00809159|50655420|FG001|Part 1 and 2|Adverse Event|0|||
25339032|NCT00809159|50655421|FG002|Part 1 and 2|Adverse Event|1|||
25339033|NCT00809159|50655422|FG003|Part 1 and 2|Adverse Event|0|||
25339034|NCT00809159|50655423|FG004|Part 1 and 2|Adverse Event|1|||
25339035|NCT00809159|50655424|FG005|Part 1 and 2|Adverse Event|1|||
25254500|NCT01357239|50570169|FG002|Stratum: All Patients|Adverse Event|1|||
25254501|NCT01357239|50570170|FG003|Stratum: All Patients|Adverse Event|1|||
25254502|NCT01357239|50570167|FG000|Stratum: All Patients|Subject withdrew consent|0|||
25339036|NCT00809159|50655419|FG000|Part 1 and 2|Lost to Follow-up|0|||
25339037|NCT00809159|50655420|FG001|Part 1 and 2|Lost to Follow-up|0|||
25339038|NCT00809159|50655421|FG002|Part 1 and 2|Lost to Follow-up|1|||
25254503|NCT01357239|50570168|FG001|Stratum: All Patients|Subject withdrew consent|0|||
25254504|NCT01357239|50570169|FG002|Stratum: All Patients|Subject withdrew consent|1|||
25339039|NCT00809159|50655422|FG003|Part 1 and 2|Lost to Follow-up|1|||
25339040|NCT00809159|50655423|FG004|Part 1 and 2|Lost to Follow-up|0|||
25339041|NCT00809159|50655424|FG005|Part 1 and 2|Lost to Follow-up|0|||
25339042|NCT00809159|50655419|FG000|Part 1 and 2|Withdrawal by Subject|0|||
25339043|NCT00809159|50655420|FG001|Part 1 and 2|Withdrawal by Subject|0|||
25339044|NCT00809159|50655421|FG002|Part 1 and 2|Withdrawal by Subject|4|||
25339045|NCT00809159|50655422|FG003|Part 1 and 2|Withdrawal by Subject|0|||
25339046|NCT00809159|50655423|FG004|Part 1 and 2|Withdrawal by Subject|0|||
25339047|NCT00809159|50655424|FG005|Part 1 and 2|Withdrawal by Subject|1|||
25339048|NCT00745368|50655438|FG000|Overall Study|Unable to provide sample|3|||
25339049|NCT00589472|50655442|FG000|Overall Study|Adverse Event|1|||
25339050|NCT00811577|50655448|FG000|Overall Study|Lost to Follow-up|7|||
25339051|NCT00811577|50655449|FG001|Overall Study|Lost to Follow-up|1|||
25339052|NCT00811577|50655448|FG000|Overall Study|Withdrawal by Subject|3|||
25339053|NCT00811577|50655449|FG001|Overall Study|Withdrawal by Subject|0|||
25339054|NCT00802178|50655498|FG000|Overall Study|Lack of Efficacy|36|||
25339055|NCT00802178|50655498|FG000|Overall Study|Insufficient tolerability (IT)|17|||
25339056|NCT00802178|50655498|FG000|Overall Study|Withdrawal by Subject|18|||
25339057|NCT00802178|50655498|FG000|Overall Study|Other|32|||
25339058|NCT00802178|50655498|FG000|Overall Study|Lack of efficacy and patient wish|1|||
25339059|NCT00802178|50655498|FG000|Overall Study|IT and patient wish|8|||
25339060|NCT00802178|50655498|FG000|Overall Study|Patients wish and other reason|1|||
25339061|NCT00744978|50655504|FG000|Period 1|Lost to Follow-up|1|||
25339062|NCT00744978|50655505|FG001|Period 1|Lost to Follow-up|0|||
25339063|NCT00744978|50655504|FG000|Period 1|Withdrawal by Subject|0|||
25339064|NCT00744978|50655505|FG001|Period 1|Withdrawal by Subject|2|||
25339065|NCT00744978|50655504|FG000|Period 1|Other|0|||
25339066|NCT00744978|50655505|FG001|Period 1|Other|2|||
25339067|NCT00744978|50655504|FG000|Period 1|Adverse Event|4|||
25339068|NCT00744978|50655505|FG001|Period 1|Adverse Event|0|||
25339069|NCT00744978|50655504|FG000|Period 1|Randomized but not Treated|1|||
25339070|NCT00744978|50655505|FG001|Period 1|Randomized but not Treated|1|||
25339071|NCT00744978|50655504|FG000|Period 2|Adverse Event|0|||
25339072|NCT00744978|50655505|FG001|Period 2|Adverse Event|1|||
25339073|NCT00739908|50655513|FG000|Overall Study|Adverse Event|5|||
25339074|NCT00739908|50655514|FG001|Overall Study|Adverse Event|6|||
25339075|NCT00739908|50655513|FG000|Overall Study|Withdrawal by Subject|4|||
25339076|NCT00739908|50655514|FG001|Overall Study|Withdrawal by Subject|2|||
25339077|NCT00739908|50655513|FG000|Overall Study|Lost to Follow-up|14|||
25339078|NCT00739908|50655514|FG001|Overall Study|Lost to Follow-up|9|||
25339079|NCT00739908|50655513|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
25339080|NCT00739908|50655514|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
25339081|NCT00739908|50655513|FG000|Overall Study|Non-Compliance With Study Medication|0|||
25339082|NCT00739908|50655514|FG001|Overall Study|Non-Compliance With Study Medication|3|||
25254505|NCT01357239|50570170|FG003|Stratum: All Patients|Subject withdrew consent|1|||
25254506|NCT01357239|50570167|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
25254507|NCT01357239|50570168|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
25254508|NCT01357239|50570169|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
25254509|NCT01357239|50570170|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
25254510|NCT01357239|50570167|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
25254511|NCT01357239|50570168|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
25254512|NCT01357239|50570169|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
25254513|NCT01357239|50570170|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
25254514|NCT01357239|50570167|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
25254515|NCT01357239|50570168|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
25254516|NCT01357239|50570169|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
25254517|NCT01357239|50570170|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
25254518|NCT01357161|50570186|FG000|Part 1 (Open Label Run-in)|Death|5|||
25254519|NCT01357161|50570187|FG001|Part 1 (Open Label Run-in)|Death|0|||
25254520|NCT01357161|50570188|FG002|Part 1 (Open Label Run-in)|Death|0|||
25254521|NCT01357161|50570186|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
25254522|NCT01357161|50570187|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
25254523|NCT01357161|50570188|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
25254524|NCT01357161|50570186|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
25254525|NCT01357161|50570187|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
25254526|NCT01357161|50570188|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
25339083|NCT00739908|50655513|FG000|Overall Study|Lack of Efficacy|0|||
25339084|NCT00739908|50655514|FG001|Overall Study|Lack of Efficacy|1|||
25339085|NCT00739908|50655513|FG000|Overall Study|Relocation|0|||
25339086|NCT00739908|50655514|FG001|Overall Study|Relocation|1|||
25254527|NCT01357161|50570186|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
25339087|NCT00739596|50655524|FG000|Overall Study|Adverse Event|12|||
25339088|NCT00739596|50655525|FG001|Overall Study|Adverse Event|6|||
25339089|NCT00739596|50655524|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
24902858|NCT00467779|49996798|FG000|Stage 2A|Disease Progression|0|||
24902859|NCT00467779|49996799|FG001|Stage 2A|Disease Progression|0|||
24902860|NCT00467779|49996800|FG002|Stage 2A|Disease Progression|0|||
24902861|NCT00467779|49996801|FG003|Stage 2A|Disease Progression|0|||
24902862|NCT00467779|49996802|FG004|Stage 2A|Disease Progression|0|||
24902863|NCT00467779|49996803|FG005|Stage 2A|Disease Progression|0|||
24902864|NCT00467779|49996804|FG006|Stage 2A|Disease Progression|0|||
24902865|NCT00467779|49996805|FG007|Stage 2A|Disease Progression|0|||
24902866|NCT00467779|49996806|FG008|Stage 2A|Disease Progression|0|||
24902867|NCT00467779|49996807|FG009|Stage 2A|Disease Progression|0|||
24902868|NCT00467779|49996808|FG010|Stage 2A|Disease Progression|0|||
25339090|NCT00739596|50655525|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
25339091|NCT00739596|50655524|FG000|Overall Study|Patient Withdrew Consent|8|||
24902869|NCT00467779|49996809|FG011|Stage 2A|Disease Progression|0|||
24902870|NCT00467779|49996810|FG012|Stage 2A|Disease Progression|0|||
24902871|NCT00467779|49996811|FG013|Stage 2A|Disease Progression|10|||
25339092|NCT00739596|50655525|FG001|Overall Study|Patient Withdrew Consent|8|||
25339093|NCT00739596|50655524|FG000|Overall Study|Lost to Follow-up|0|||
24902872|NCT00467779|49996812|FG014|Stage 2A|Disease Progression|0|||
24902873|NCT00467779|49996798|FG000|Stage 2A|Unspecified Reason|0|||
24902874|NCT00467779|49996799|FG001|Stage 2A|Unspecified Reason|0|||
24902875|NCT00467779|49996800|FG002|Stage 2A|Unspecified Reason|0|||
24902876|NCT00467779|49996801|FG003|Stage 2A|Unspecified Reason|0|||
24902877|NCT00467779|49996802|FG004|Stage 2A|Unspecified Reason|0|||
24902878|NCT00467779|49996803|FG005|Stage 2A|Unspecified Reason|0|||
24902879|NCT00467779|49996804|FG006|Stage 2A|Unspecified Reason|0|||
24902880|NCT00467779|49996805|FG007|Stage 2A|Unspecified Reason|0|||
24902881|NCT00467779|49996806|FG008|Stage 2A|Unspecified Reason|0|||
24902882|NCT00467779|49996807|FG009|Stage 2A|Unspecified Reason|0|||
24902883|NCT00467779|49996808|FG010|Stage 2A|Unspecified Reason|0|||
24902884|NCT00467779|49996809|FG011|Stage 2A|Unspecified Reason|0|||
24902885|NCT00467779|49996810|FG012|Stage 2A|Unspecified Reason|0|||
24902886|NCT00467779|49996811|FG013|Stage 2A|Unspecified Reason|7|||
24902887|NCT00467779|49996812|FG014|Stage 2A|Unspecified Reason|0|||
24902888|NCT00467779|49996798|FG000|Stage 2A|Withdrawal by Subject|0|||
24902889|NCT00467779|49996799|FG001|Stage 2A|Withdrawal by Subject|0|||
25339094|NCT00739596|50655525|FG001|Overall Study|Lost to Follow-up|2|||
25339095|NCT00739596|50655524|FG000|Overall Study|Protocol Deviation|1|||
25339096|NCT00739596|50655525|FG001|Overall Study|Protocol Deviation|1|||
25339097|NCT00742326|50655533|FG000|Overall Study|Physician Decision|0|||
25339098|NCT00742326|50655534|FG001|Overall Study|Physician Decision|1|||
25339099|NCT00741936|50655542|FG000|Overall Study|Lost to Follow-up|1|||
24902890|NCT00467779|49996800|FG002|Stage 2A|Withdrawal by Subject|0|||
24902891|NCT00467779|49996801|FG003|Stage 2A|Withdrawal by Subject|0|||
24902892|NCT00467779|49996802|FG004|Stage 2A|Withdrawal by Subject|0|||
24902893|NCT00467779|49996803|FG005|Stage 2A|Withdrawal by Subject|0|||
24902894|NCT00467779|49996804|FG006|Stage 2A|Withdrawal by Subject|0|||
24902895|NCT00467779|49996805|FG007|Stage 2A|Withdrawal by Subject|0|||
24902896|NCT00467779|49996806|FG008|Stage 2A|Withdrawal by Subject|0|||
24902897|NCT00467779|49996807|FG009|Stage 2A|Withdrawal by Subject|0|||
24902898|NCT00467779|49996808|FG010|Stage 2A|Withdrawal by Subject|0|||
24902899|NCT00467779|49996809|FG011|Stage 2A|Withdrawal by Subject|0|||
24902900|NCT00467779|49996810|FG012|Stage 2A|Withdrawal by Subject|0|||
24902901|NCT00467779|49996811|FG013|Stage 2A|Withdrawal by Subject|1|||
24902902|NCT00467779|49996812|FG014|Stage 2A|Withdrawal by Subject|0|||
24902903|NCT00467779|49996798|FG000|Stage 3|Adverse Event|0|||
24902904|NCT00467779|49996799|FG001|Stage 3|Adverse Event|0|||
24902905|NCT00467779|49996800|FG002|Stage 3|Adverse Event|0|||
24902906|NCT00467779|49996801|FG003|Stage 3|Adverse Event|0|||
24902907|NCT00467779|49996802|FG004|Stage 3|Adverse Event|0|||
24977439|NCT00048542|50065998|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
24977440|NCT00048542|50065999|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
25339100|NCT00741936|50655543|FG001|Overall Study|Lost to Follow-up|1|||
25339101|NCT00741936|50655542|FG000|Overall Study|Adverse Event|3|||
24902908|NCT00467779|49996803|FG005|Stage 3|Adverse Event|0|||
24902909|NCT00467779|49996804|FG006|Stage 3|Adverse Event|0|||
24902910|NCT00467779|49996805|FG007|Stage 3|Adverse Event|0|||
24902911|NCT00467779|49996806|FG008|Stage 3|Adverse Event|0|||
24902912|NCT00467779|49996807|FG009|Stage 3|Adverse Event|0|||
24902913|NCT00467779|49996808|FG010|Stage 3|Adverse Event|0|||
25339102|NCT00741936|50655543|FG001|Overall Study|Adverse Event|4|||
24902914|NCT00467779|49996809|FG011|Stage 3|Adverse Event|0|||
24902915|NCT00467779|49996810|FG012|Stage 3|Adverse Event|0|||
24902916|NCT00467779|49996811|FG013|Stage 3|Adverse Event|0|||
24902917|NCT00467779|49996812|FG014|Stage 3|Adverse Event|2|||
24902918|NCT00467779|49996798|FG000|Stage 3|Death|0|||
24902919|NCT00467779|49996799|FG001|Stage 3|Death|0|||
24902920|NCT00467779|49996800|FG002|Stage 3|Death|0|||
24902921|NCT00467779|49996801|FG003|Stage 3|Death|0|||
24902922|NCT00467779|49996802|FG004|Stage 3|Death|0|||
24902923|NCT00467779|49996803|FG005|Stage 3|Death|0|||
25339103|NCT00741936|50655542|FG000|Overall Study|Pregnancy|0|||
25339104|NCT00741936|50655543|FG001|Overall Study|Pregnancy|1|||
24902924|NCT00467779|49996804|FG006|Stage 3|Death|0|||
24902925|NCT00467779|49996805|FG007|Stage 3|Death|0|||
24902926|NCT00467779|49996806|FG008|Stage 3|Death|0|||
24902927|NCT00467779|49996807|FG009|Stage 3|Death|0|||
24902928|NCT00467779|49996808|FG010|Stage 3|Death|0|||
24902929|NCT00467779|49996809|FG011|Stage 3|Death|0|||
24902930|NCT00467779|49996810|FG012|Stage 3|Death|0|||
24902931|NCT00467779|49996811|FG013|Stage 3|Death|0|||
24902932|NCT00467779|49996812|FG014|Stage 3|Death|1|||
24902933|NCT00467779|49996798|FG000|Stage 3|Disease Progression|0|||
24902934|NCT00467779|49996799|FG001|Stage 3|Disease Progression|0|||
24902935|NCT00467779|49996800|FG002|Stage 3|Disease Progression|0|||
24902936|NCT00467779|49996801|FG003|Stage 3|Disease Progression|0|||
24902937|NCT00467779|49996802|FG004|Stage 3|Disease Progression|0|||
24902938|NCT00467779|49996803|FG005|Stage 3|Disease Progression|0|||
24902939|NCT00467779|49996804|FG006|Stage 3|Disease Progression|0|||
24902940|NCT00467779|49996805|FG007|Stage 3|Disease Progression|0|||
24902941|NCT00467779|49996806|FG008|Stage 3|Disease Progression|0|||
24902942|NCT00467779|49996807|FG009|Stage 3|Disease Progression|0|||
24902943|NCT00467779|49996808|FG010|Stage 3|Disease Progression|0|||
24902944|NCT00467779|49996809|FG011|Stage 3|Disease Progression|0|||
24902945|NCT00467779|49996810|FG012|Stage 3|Disease Progression|0|||
24902946|NCT00467779|49996811|FG013|Stage 3|Disease Progression|0|||
24902947|NCT00467779|49996812|FG014|Stage 3|Disease Progression|9|||
24902948|NCT00467779|49996798|FG000|Stage 3|Unspecified Reason|0|||
24902949|NCT00467779|49996799|FG001|Stage 3|Unspecified Reason|0|||
24902950|NCT00467779|49996800|FG002|Stage 3|Unspecified Reason|0|||
24902951|NCT00467779|49996801|FG003|Stage 3|Unspecified Reason|0|||
24902952|NCT00467779|49996802|FG004|Stage 3|Unspecified Reason|0|||
24902953|NCT00467779|49996803|FG005|Stage 3|Unspecified Reason|0|||
24902954|NCT00467779|49996804|FG006|Stage 3|Unspecified Reason|0|||
24902955|NCT00467779|49996805|FG007|Stage 3|Unspecified Reason|0|||
24902956|NCT00467779|49996806|FG008|Stage 3|Unspecified Reason|0|||
24902957|NCT00467779|49996807|FG009|Stage 3|Unspecified Reason|0|||
24902958|NCT00467779|49996808|FG010|Stage 3|Unspecified Reason|0|||
24902959|NCT00467779|49996809|FG011|Stage 3|Unspecified Reason|0|||
24902960|NCT00467779|49996810|FG012|Stage 3|Unspecified Reason|0|||
24902961|NCT00467779|49996811|FG013|Stage 3|Unspecified Reason|0|||
24902962|NCT00467779|49996812|FG014|Stage 3|Unspecified Reason|5|||
24902963|NCT00570687|49996852|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902964|NCT00570687|49996853|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902965|NCT00570687|49996854|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902966|NCT00570687|49996855|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902967|NCT00570687|49996856|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
24902968|NCT00570687|49996857|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
24902969|NCT00570687|49996858|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
24902970|NCT00570687|49996859|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
24902971|NCT00570687|49996860|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
24902972|NCT00570687|49996861|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
24902973|NCT00570687|49996852|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902974|NCT00570687|49996853|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902975|NCT00570687|49996854|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902976|NCT00570687|49996855|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902977|NCT00570687|49996856|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902978|NCT00570687|49996857|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902979|NCT00570687|49996858|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902980|NCT00570687|49996859|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902981|NCT00570687|49996860|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
24902982|NCT00570687|49996861|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902983|NCT00570687|49996852|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902984|NCT00570687|49996853|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902985|NCT00570687|49996854|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902986|NCT00570687|49996855|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902987|NCT00570687|49996856|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902988|NCT00570687|49996857|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902989|NCT00570687|49996858|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
24902990|NCT00570687|49996859|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902991|NCT00570687|49996860|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902992|NCT00570687|49996861|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
24902993|NCT03836677|49996875|FG000|Period 1|Adverse Event|0|||
24902994|NCT03836677|49996876|FG001|Period 1|Adverse Event|1|||
24902995|NCT03836677|49996875|FG000|Period 2|Severe non-compliance to protocol|1|||
24902996|NCT03836677|49996876|FG001|Period 2|Severe non-compliance to protocol|0|||
24902997|NCT00434161|49996907|FG000|Overall Study|Adverse Event|5|||
24902998|NCT00434161|49996908|FG001|Overall Study|Adverse Event|1|||
24902999|NCT00434161|49996909|FG002|Overall Study|Adverse Event|4|||
24903000|NCT00434161|49996907|FG000|Overall Study|Lost to Follow-up|0|||
24903001|NCT00434161|49996908|FG001|Overall Study|Lost to Follow-up|1|||
24903002|NCT00434161|49996909|FG002|Overall Study|Lost to Follow-up|0|||
24903003|NCT00434161|49996907|FG000|Overall Study|Death|1|||
24903004|NCT00434161|49996908|FG001|Overall Study|Death|0|||
24903005|NCT00434161|49996909|FG002|Overall Study|Death|1|||
24903006|NCT00434161|49996907|FG000|Overall Study|Non-Compliance|1|||
24903007|NCT00434161|49996908|FG001|Overall Study|Non-Compliance|1|||
24903008|NCT00434161|49996909|FG002|Overall Study|Non-Compliance|0|||
25339105|NCT00741936|50655542|FG000|Overall Study|Protocol Violation|2|||
25339106|NCT00741936|50655543|FG001|Overall Study|Protocol Violation|0|||
25339107|NCT00741936|50655542|FG000|Overall Study|Lack of Efficacy|0|||
25339108|NCT00741936|50655543|FG001|Overall Study|Lack of Efficacy|2|||
25339109|NCT00741936|50655542|FG000|Overall Study|Low compliance|3|||
25339110|NCT00741936|50655543|FG001|Overall Study|Low compliance|0|||
25339111|NCT00811187|50655551|FG000|Overall Study|Unable to place device / procedure abort|3|||
25339112|NCT00811187|50655552|FG001|Overall Study|Unable to place device / procedure abort|3|||
25339113|NCT00591149|50655558|FG000|Overall Study|Adverse Event|4|||
25339114|NCT00591149|50655558|FG000|Overall Study|Withdrawal by Subject|1|||
25339115|NCT00735072|50655564|FG000|Overall Study|interrupted study med during ARV change|1|||
25339116|NCT00735072|50655565|FG001|Overall Study|interrupted study med during ARV change|0|||
25339117|NCT00735072|50655564|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
25339118|NCT00735072|50655565|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
25339119|NCT00810641|50655576|FG000|Overall Study|Withdrawal by Subject|0|||
25339120|NCT00810641|50655577|FG001|Overall Study|Withdrawal by Subject|1|||
25339121|NCT00810641|50655578|FG002|Overall Study|Withdrawal by Subject|2|||
25339122|NCT00793598|50655591|FG000|Overall Study|Patient Request|0|||
25339123|NCT00793598|50655592|FG001|Overall Study|Patient Request|1|||
25339124|NCT00793598|50655593|FG002|Overall Study|Patient Request|0|||
25339125|NCT00793598|50655594|FG003|Overall Study|Patient Request|0|||
25339126|NCT00793598|50655595|FG004|Overall Study|Patient Request|0|||
25339127|NCT00793598|50655596|FG005|Overall Study|Patient Request|0|||
25339128|NCT00793598|50655597|FG006|Overall Study|Patient Request|0|||
25339129|NCT00793598|50655598|FG007|Overall Study|Patient Request|0|||
25339130|NCT00793598|50655591|FG000|Overall Study|Protocol Violation|0|||
25339131|NCT00793598|50655592|FG001|Overall Study|Protocol Violation|0|||
25339132|NCT00793598|50655593|FG002|Overall Study|Protocol Violation|0|||
25339133|NCT00793598|50655594|FG003|Overall Study|Protocol Violation|0|||
25339134|NCT00793598|50655595|FG004|Overall Study|Protocol Violation|0|||
25339135|NCT00793598|50655596|FG005|Overall Study|Protocol Violation|0|||
25339136|NCT00793598|50655597|FG006|Overall Study|Protocol Violation|0|||
25339137|NCT00793598|50655598|FG007|Overall Study|Protocol Violation|1|||
25339138|NCT00793598|50655591|FG000|Overall Study|Subject not dosed|0|||
25339139|NCT00793598|50655592|FG001|Overall Study|Subject not dosed|0|||
25339140|NCT00793598|50655593|FG002|Overall Study|Subject not dosed|0|||
25339141|NCT00793598|50655594|FG003|Overall Study|Subject not dosed|0|||
25339142|NCT00793598|50655595|FG004|Overall Study|Subject not dosed|0|||
25339143|NCT00793598|50655596|FG005|Overall Study|Subject not dosed|1|||
25339144|NCT00793598|50655597|FG006|Overall Study|Subject not dosed|0|||
25339145|NCT00793598|50655598|FG007|Overall Study|Subject not dosed|0|||
25339146|NCT00796562|50655620|FG000|Overall Study|Death|49|||
25339147|NCT00801632|50655624|FG000|Overall Study|Re-transplant|1|||
25339148|NCT00806819|50655630|FG000|Overall Study|progressive disease (modified RECIST )|217|||
25339149|NCT00806819|50655631|FG001|Overall Study|progressive disease (modified RECIST )|216|||
25339150|NCT00806819|50655630|FG000|Overall Study|Worsening or AE of underlying disease|18|||
25339151|NCT00806819|50655631|FG001|Overall Study|Worsening or AE of underlying disease|25|||
25339152|NCT00806819|50655630|FG000|Overall Study|Other AE|38|||
25339153|NCT00806819|50655631|FG001|Overall Study|Other AE|40|||
25339154|NCT00806819|50655630|FG000|Overall Study|Protocol Violation|9|||
25339155|NCT00806819|50655631|FG001|Overall Study|Protocol Violation|4|||
24903009|NCT00434161|49996907|FG000|Overall Study|Withdrawal by Subject|2|||
25339156|NCT00806819|50655630|FG000|Overall Study|Lost to Follow-up|1|||
25339157|NCT00806819|50655631|FG001|Overall Study|Lost to Follow-up|0|||
25339158|NCT00806819|50655630|FG000|Overall Study|Withdrawal by Subject|32|||
25339159|NCT00806819|50655631|FG001|Overall Study|Withdrawal by Subject|29|||
24903010|NCT00434161|49996908|FG001|Overall Study|Withdrawal by Subject|0|||
24903011|NCT00434161|49996909|FG002|Overall Study|Withdrawal by Subject|3|||
24903012|NCT00434161|49996907|FG000|Overall Study|Logistical error study assessments|1|||
25339160|NCT00806819|50655630|FG000|Overall Study|Not treated|6|||
25339161|NCT00806819|50655631|FG001|Overall Study|Not treated|3|||
25339162|NCT00806819|50655630|FG000|Overall Study|Reasons other than stated above|25|||
25339163|NCT00806819|50655631|FG001|Overall Study|Reasons other than stated above|41|||
25339164|NCT00801242|50655638|FG000|Overall Study|Adverse Event|10|||
25339165|NCT00801242|50655638|FG000|Overall Study|Withdrawal by Subject|13|||
25339166|NCT00801242|50655638|FG000|Overall Study|Protocol Violation|5|||
25339167|NCT00801242|50655638|FG000|Overall Study|Physician Decision|3|||
25339168|NCT00801242|50655638|FG000|Overall Study|Lost to Follow-up|1|||
24903013|NCT00434161|49996908|FG001|Overall Study|Logistical error study assessments|0|||
24903014|NCT00434161|49996909|FG002|Overall Study|Logistical error study assessments|3|||
24903015|NCT00441103|49996926|FG000|Overall Study|Adverse Event|2|||
24903016|NCT00441103|49996927|FG001|Overall Study|Adverse Event|1|||
24903017|NCT00441103|49996926|FG000|Overall Study|Death|1|||
24903018|NCT00441103|49996927|FG001|Overall Study|Death|0|||
24903019|NCT00441103|49996926|FG000|Overall Study|Disease Progression|2|||
24903020|NCT00441103|49996927|FG001|Overall Study|Disease Progression|0|||
24903021|NCT00441103|49996926|FG000|Overall Study|Lost to Follow-up|1|||
24903022|NCT00441103|49996927|FG001|Overall Study|Lost to Follow-up|0|||
24903023|NCT00441103|49996926|FG000|Overall Study|Protocol Violation|1|||
24903024|NCT00441103|49996927|FG001|Overall Study|Protocol Violation|0|||
24903025|NCT00441103|49996926|FG000|Overall Study|Participant unable to use Rebiject II|1|||
24903026|NCT00441103|49996927|FG001|Overall Study|Participant unable to use Rebiject II|0|||
24903027|NCT00441103|49996926|FG000|Overall Study|Participant refused MRI|1|||
24903028|NCT00441103|49996927|FG001|Overall Study|Participant refused MRI|0|||
24903029|NCT00441103|49996926|FG000|Overall Study|Inclusion criteria absent|1|||
24903030|NCT00441103|49996927|FG001|Overall Study|Inclusion criteria absent|0|||
24903031|NCT00441103|49996926|FG000|Overall Study|Non-compliant|0|||
24903032|NCT00441103|49996927|FG001|Overall Study|Non-compliant|1|||
24903033|NCT00441103|49996926|FG000|Overall Study|Participant decided to withdraw|1|||
24903034|NCT00441103|49996927|FG001|Overall Study|Participant decided to withdraw|0|||
24903035|NCT00441103|49996926|FG000|Overall Study|Participant's reason|0|||
24903036|NCT00441103|49996927|FG001|Overall Study|Participant's reason|1|||
24903037|NCT00441103|49996926|FG000|Overall Study|Participant decided to stop|0|||
24903038|NCT00441103|49996927|FG001|Overall Study|Participant decided to stop|1|||
24903039|NCT00433771|49996934|FG000|Overall Study|screen fail|14|||
24903040|NCT00433771|49996934|FG000|Overall Study|Treated and later found to be ineligible|2|||
24903041|NCT00433771|49996934|FG000|Overall Study|Death|2|||
24903042|NCT00433771|49996934|FG000|Overall Study|Failure to deploy stent|1|||
24903043|NCT00433537|49996938|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
24903044|NCT00433537|49996939|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
24903045|NCT00433537|49996940|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
24903046|NCT00433537|49996938|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
24903047|NCT00433537|49996939|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
24903048|NCT00433537|49996940|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
24903049|NCT00433537|49996938|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
24903050|NCT00433537|49996939|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
24903051|NCT00433537|49996940|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
24903052|NCT00433537|49996938|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
24903053|NCT00433537|49996939|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
24903054|NCT00433537|49996940|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
24903055|NCT00433537|49996938|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
24903056|NCT00433537|49996939|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
24903057|NCT00433537|49996940|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
24903058|NCT00433537|49996938|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
24903059|NCT00433537|49996939|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
24903060|NCT00433537|49996940|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
24903061|NCT00433537|49996938|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
24903062|NCT00433537|49996939|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
24903063|NCT00433537|49996940|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
24903064|NCT00433537|49996938|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
24903065|NCT00433537|49996939|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
24903066|NCT00433537|49996940|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
24903067|NCT00433537|49996938|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
24903068|NCT00433537|49996939|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
24903069|NCT00433537|49996940|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
24903070|NCT00570765|49996950|FG000|DB Phase|Withdrawal by Subject|1|||
24903071|NCT00570765|49996951|FG001|DB Phase|Withdrawal by Subject|0|||
24903072|NCT00570765|49996952|FG002|DB Phase|Withdrawal by Subject|0|||
24903073|NCT00570765|49996953|FG003|DB Phase|Withdrawal by Subject|0|||
24903074|NCT00570765|49996950|FG000|DB Phase|Protocol Violation|0|||
24903075|NCT00570765|49996951|FG001|DB Phase|Protocol Violation|1|||
24903076|NCT00570765|49996952|FG002|DB Phase|Protocol Violation|0|||
24903077|NCT00570765|49996953|FG003|DB Phase|Protocol Violation|0|||
25078003|NCT02456636|50186181|FG002|Overall Study|Physician Decision|4|||
24903078|NCT00570765|49996950|FG000|DB Phase|Adverse Event|3|||
24903079|NCT00570765|49996951|FG001|DB Phase|Adverse Event|6|||
24903080|NCT00570765|49996952|FG002|DB Phase|Adverse Event|0|||
24903081|NCT00570765|49996953|FG003|DB Phase|Adverse Event|0|||
24903082|NCT00570765|49996950|FG000|DB Phase|Did Not Receive Study Drug|0|||
24903083|NCT00570765|49996951|FG001|DB Phase|Did Not Receive Study Drug|0|||
24903084|NCT00570765|49996952|FG002|DB Phase|Did Not Receive Study Drug|1|||
24903085|NCT00570765|49996953|FG003|DB Phase|Did Not Receive Study Drug|0|||
24977441|NCT00048542|50066000|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
24903086|NCT00570765|49996950|FG000|LTSE Phase|Withdrawal by Subject|0|||
24903087|NCT00570765|49996951|FG001|LTSE Phase|Withdrawal by Subject|0|||
24903088|NCT00570765|49996952|FG002|LTSE Phase|Withdrawal by Subject|0|||
24903089|NCT00570765|49996953|FG003|LTSE Phase|Withdrawal by Subject|1|||
24903090|NCT00570765|49996950|FG000|LTSE Phase|Adverse Event|0|||
24903091|NCT00570765|49996951|FG001|LTSE Phase|Adverse Event|0|||
24903092|NCT00570765|49996952|FG002|LTSE Phase|Adverse Event|0|||
24903093|NCT00570765|49996953|FG003|LTSE Phase|Adverse Event|7|||
24903094|NCT00570765|49996950|FG000|LTSE Phase|Physician Decision|0|||
24903095|NCT00570765|49996951|FG001|LTSE Phase|Physician Decision|0|||
24903096|NCT00570765|49996952|FG002|LTSE Phase|Physician Decision|0|||
24903097|NCT00570765|49996953|FG003|LTSE Phase|Physician Decision|4|||
24903098|NCT00667563|49996964|FG000|Overall Study|Protocol Violation|24|||
24903099|NCT00667095|49996970|FG000|Overall Study|Withdrawal by Subject|0|||
24903100|NCT00667095|49996971|FG001|Overall Study|Withdrawal by Subject|1|||
24903101|NCT00433381|49996979|FG000|Overall Study|Ineligible / no protocol treatment|3|||
24903102|NCT00433381|49996980|FG001|Overall Study|Ineligible / no protocol treatment|3|||
24903103|NCT00667017|49996994|FG000|Overall Study|Withdrawal by Subject|1|||
24903104|NCT00666705|49996998|FG000|Overall Study|Withdrawal by Subject|1|||
24903105|NCT00433147|49997011|FG000|Overall Study|Adverse Event|0|||
24903106|NCT00433147|49997012|FG001|Overall Study|Adverse Event|1|||
24903107|NCT00433147|49997013|FG002|Overall Study|Adverse Event|0|||
24977442|NCT00048542|50066001|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
24977443|NCT00048542|50066002|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
25078004|NCT02456636|50186179|FG000|Overall Study|Withdrawal by Subject|13|||
24903108|NCT00433147|49997014|FG003|Overall Study|Adverse Event|0|||
24903109|NCT00666237|49997026|FG000|Overall Study|Death|5|||
24903110|NCT00666237|49997027|FG001|Overall Study|Death|5|||
24903111|NCT00666237|49997026|FG000|Overall Study|Lost to Follow-up|29|||
24903112|NCT00666237|49997027|FG001|Overall Study|Lost to Follow-up|25|||
24903113|NCT00662025|49997033|FG000|Overall Study|Objective progression or relapse|51|||
24903114|NCT00662025|49997033|FG000|Overall Study|Adverse Event|7|||
24903115|NCT00662025|49997033|FG000|Overall Study|Withdrawal by Subject|1|||
24903116|NCT00662025|49997033|FG000|Overall Study|Results of other clinical study|2|||
24903117|NCT00662025|49997033|FG000|Overall Study|Target lesion cannot be evaluated|1|||
24903118|NCT00662025|49997033|FG000|Overall Study|Domestic circumstances|1|||
24903119|NCT00440947|49997037|FG000|36-Week Induction Phase|Adverse Event|16|||
24903120|NCT00440947|49997038|FG001|36-Week Induction Phase|Adverse Event|0|||
24903121|NCT00440947|49997039|FG002|36-Week Induction Phase|Adverse Event|0|||
24903122|NCT00440947|49997040|FG003|36-Week Induction Phase|Adverse Event|0|||
24903123|NCT00440947|49997041|FG004|36-Week Induction Phase|Adverse Event|0|||
24903124|NCT00440947|49997037|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
24903125|NCT00440947|49997038|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
24903126|NCT00440947|49997039|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
24903127|NCT00440947|49997040|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
24903128|NCT00440947|49997041|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
24903129|NCT00440947|49997037|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
24903130|NCT00440947|49997038|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
24903131|NCT00440947|49997039|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
24903132|NCT00440947|49997040|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
24903133|NCT00440947|49997041|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
24903134|NCT00440947|49997037|FG000|36-Week Induction Phase|Non-compliance|10|||
24903135|NCT00440947|49997038|FG001|36-Week Induction Phase|Non-compliance|0|||
24903136|NCT00440947|49997039|FG002|36-Week Induction Phase|Non-compliance|0|||
24903137|NCT00440947|49997040|FG003|36-Week Induction Phase|Non-compliance|0|||
24903138|NCT00440947|49997041|FG004|36-Week Induction Phase|Non-compliance|0|||
24903139|NCT00440947|49997037|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
24903140|NCT00440947|49997038|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
24903141|NCT00440947|49997039|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
24903142|NCT00440947|49997040|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
24903143|NCT00440947|49997041|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
24903144|NCT00440947|49997037|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
24903145|NCT00440947|49997038|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
24903146|NCT00440947|49997039|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
24903147|NCT00440947|49997040|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
24903148|NCT00440947|49997041|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
24903149|NCT00440947|49997037|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
24903150|NCT00440947|49997038|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
24903151|NCT00440947|49997039|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
24977444|NCT00048542|50066003|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
24903152|NCT00440947|49997040|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
24903153|NCT00440947|49997041|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
24903154|NCT00440947|49997037|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
24903155|NCT00440947|49997038|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
24903156|NCT00440947|49997039|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
24903157|NCT00440947|49997040|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
24903158|NCT00440947|49997041|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
24903159|NCT00440947|49997037|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
24903160|NCT00440947|49997038|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
24903161|NCT00440947|49997039|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
24903162|NCT00440947|49997040|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
24903163|NCT00440947|49997041|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
24903164|NCT00440947|49997037|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
24903165|NCT00440947|49997038|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
24903166|NCT00440947|49997039|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
24903167|NCT00440947|49997040|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
24903168|NCT00440947|49997041|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
24903169|NCT00440947|49997037|FG000|36-Week Induction Phase|Incarceration|3|||
24903170|NCT00440947|49997038|FG001|36-Week Induction Phase|Incarceration|0|||
24903171|NCT00440947|49997039|FG002|36-Week Induction Phase|Incarceration|0|||
24903172|NCT00440947|49997040|FG003|36-Week Induction Phase|Incarceration|0|||
24903173|NCT00440947|49997041|FG004|36-Week Induction Phase|Incarceration|0|||
24903174|NCT00440947|49997037|FG000|36-Week Induction Phase|Pregnancy|1|||
24903175|NCT00440947|49997038|FG001|36-Week Induction Phase|Pregnancy|0|||
24903176|NCT00440947|49997039|FG002|36-Week Induction Phase|Pregnancy|0|||
24903177|NCT00440947|49997040|FG003|36-Week Induction Phase|Pregnancy|0|||
24903178|NCT00440947|49997041|FG004|36-Week Induction Phase|Pregnancy|0|||
24903179|NCT00440947|49997037|FG000|48-Week Randomization Phase|Adverse Event|0|||
24903180|NCT00440947|49997038|FG001|48-Week Randomization Phase|Adverse Event|2|||
24903181|NCT00440947|49997039|FG002|48-Week Randomization Phase|Adverse Event|5|||
24903182|NCT00440947|49997040|FG003|48-Week Randomization Phase|Adverse Event|0|||
24903183|NCT00440947|49997041|FG004|48-Week Randomization Phase|Adverse Event|0|||
24903184|NCT00440947|49997037|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
24903185|NCT00440947|49997038|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
24903186|NCT00440947|49997039|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
24903187|NCT00440947|49997040|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
24903188|NCT00440947|49997041|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
24903189|NCT00440947|49997037|FG000|48-Week Randomization Phase|Non-compliance|0|||
24903190|NCT00440947|49997038|FG001|48-Week Randomization Phase|Non-compliance|3|||
24903191|NCT00440947|49997039|FG002|48-Week Randomization Phase|Non-compliance|4|||
24903192|NCT00440947|49997040|FG003|48-Week Randomization Phase|Non-compliance|0|||
24903193|NCT00440947|49997041|FG004|48-Week Randomization Phase|Non-compliance|0|||
25339169|NCT00801242|50655638|FG000|Overall Study|Miscellaneous reasons|20|||
25339170|NCT00800540|50655651|FG000|Period One: 6 Weeks|Noncompliance|1|||
25339171|NCT00800540|50655652|FG001|Period One: 6 Weeks|Noncompliance|0|||
25339172|NCT00800540|50655651|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
25339173|NCT00800540|50655652|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
25339174|NCT00800540|50655651|FG000|Period 2: 6 Weeks|Adverse Event|0|||
25339175|NCT00800540|50655652|FG001|Period 2: 6 Weeks|Adverse Event|1|||
25339176|NCT00800384|50655660|FG000|Overall Study|Withdrawal by Subject|24|||
25339177|NCT00800384|50655661|FG001|Overall Study|Withdrawal by Subject|17|||
25339178|NCT00800384|50655660|FG000|Overall Study|Lost to Follow-up|17|||
25339179|NCT00800384|50655661|FG001|Overall Study|Lost to Follow-up|26|||
25339180|NCT00796328|50655668|FG000|Overall Study|experienced hypotension requiring tx|6|||
25339181|NCT00588692|50655674|FG000|Overall Study|Withdrawal by Subject|4|||
25339182|NCT00588692|50655675|FG001|Overall Study|Withdrawal by Subject|2|||
25339183|NCT00588692|50655674|FG000|Overall Study|Hip Surgery|0|||
25339184|NCT00588692|50655675|FG001|Overall Study|Hip Surgery|1|||
25339185|NCT00588692|50655674|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
25339186|NCT00588692|50655675|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
25339187|NCT00588692|50655674|FG000|Overall Study|Cancer|1|||
25339188|NCT00588692|50655675|FG001|Overall Study|Cancer|0|||
25339189|NCT00588692|50655674|FG000|Overall Study|Death|1|||
25339190|NCT00588692|50655675|FG001|Overall Study|Death|0|||
25339191|NCT00588146|50655683|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
25339192|NCT00588146|50655684|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
25339193|NCT00795704|50655692|FG000|Overall Study|Withdrawal by Subject|3|||
24903194|NCT00440947|49997037|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
25339194|NCT00795704|50655693|FG001|Overall Study|Withdrawal by Subject|2|||
25339195|NCT00795704|50655692|FG000|Overall Study|Adverse Event|1|||
25339196|NCT00795704|50655693|FG001|Overall Study|Adverse Event|1|||
25339197|NCT00444457|50655703|FG000|Infant Series|Other|0|||
25339198|NCT00444457|50655704|FG001|Infant Series|Other|1|||
25339199|NCT00444457|50655705|FG002|Infant Series|Other|0|||
25339200|NCT00444457|50655706|FG003|Infant Series|Other|0|||
25339201|NCT00444457|50655703|FG000|Infant Series|Parent or legal guardian request|18|||
25339202|NCT00444457|50655704|FG001|Infant Series|Parent or legal guardian request|29|||
25339203|NCT00444457|50655705|FG002|Infant Series|Parent or legal guardian request|34|||
25339204|NCT00444457|50655706|FG003|Infant Series|Parent or legal guardian request|14|||
25339205|NCT00444457|50655703|FG000|Infant Series|Lost to Follow-up|10|||
25339206|NCT00444457|50655704|FG001|Infant Series|Lost to Follow-up|11|||
25339207|NCT00444457|50655705|FG002|Infant Series|Lost to Follow-up|7|||
25339208|NCT00444457|50655706|FG003|Infant Series|Lost to Follow-up|6|||
25339209|NCT00444457|50655703|FG000|Infant Series|Protocol Violation|16|||
25339210|NCT00444457|50655704|FG001|Infant Series|Protocol Violation|8|||
25339211|NCT00444457|50655705|FG002|Infant Series|Protocol Violation|6|||
25339212|NCT00444457|50655706|FG003|Infant Series|Protocol Violation|3|||
25339213|NCT00444457|50655703|FG000|Infant Series|Failed to return|5|||
25339214|NCT00444457|50655704|FG001|Infant Series|Failed to return|4|||
25339215|NCT00444457|50655705|FG002|Infant Series|Failed to return|4|||
25339216|NCT00444457|50655706|FG003|Infant Series|Failed to return|2|||
25339217|NCT00444457|50655703|FG000|Infant Series|Investigator request|4|||
25339218|NCT00444457|50655704|FG001|Infant Series|Investigator request|3|||
25339219|NCT00444457|50655705|FG002|Infant Series|Investigator request|3|||
25339220|NCT00444457|50655706|FG003|Infant Series|Investigator request|2|||
25339221|NCT00444457|50655703|FG000|Infant Series|Other|0|||
25339222|NCT00444457|50655704|FG001|Infant Series|Other|2|||
25339223|NCT00444457|50655705|FG002|Infant Series|Other|4|||
25339224|NCT00444457|50655706|FG003|Infant Series|Other|0|||
25339225|NCT00444457|50655703|FG000|Infant Series|Adverse Event|1|||
25339226|NCT00444457|50655704|FG001|Infant Series|Adverse Event|2|||
25339227|NCT00444457|50655705|FG002|Infant Series|Adverse Event|2|||
25339228|NCT00444457|50655706|FG003|Infant Series|Adverse Event|0|||
25339229|NCT00444457|50655703|FG000|Infant Series|Death|0|||
25339230|NCT00444457|50655704|FG001|Infant Series|Death|1|||
25339231|NCT00444457|50655705|FG002|Infant Series|Death|1|||
25339232|NCT00444457|50655706|FG003|Infant Series|Death|1|||
25339233|NCT00444457|50655703|FG000|After Infant Series|Other|0|||
25339234|NCT00444457|50655704|FG001|After Infant Series|Other|1|||
25339235|NCT00444457|50655705|FG002|After Infant Series|Other|1|||
25339236|NCT00444457|50655706|FG003|After Infant Series|Other|1|||
25339237|NCT00444457|50655703|FG000|After Infant Series|Parent or legal guardian request|4|||
25339238|NCT00444457|50655704|FG001|After Infant Series|Parent or legal guardian request|11|||
25339239|NCT00444457|50655705|FG002|After Infant Series|Parent or legal guardian request|6|||
25339240|NCT00444457|50655706|FG003|After Infant Series|Parent or legal guardian request|3|||
25339241|NCT00444457|50655703|FG000|After Infant Series|Failed to return|7|||
25339242|NCT00444457|50655704|FG001|After Infant Series|Failed to return|6|||
25339243|NCT00444457|50655705|FG002|After Infant Series|Failed to return|5|||
25339244|NCT00444457|50655706|FG003|After Infant Series|Failed to return|1|||
25339245|NCT00444457|50655703|FG000|After Infant Series|Lost to Follow-up|5|||
25339246|NCT00444457|50655704|FG001|After Infant Series|Lost to Follow-up|5|||
25339247|NCT00444457|50655705|FG002|After Infant Series|Lost to Follow-up|5|||
25339248|NCT00444457|50655706|FG003|After Infant Series|Lost to Follow-up|2|||
25339249|NCT00444457|50655703|FG000|After Infant Series|Protocol Violation|2|||
25339250|NCT00444457|50655704|FG001|After Infant Series|Protocol Violation|4|||
25339251|NCT00444457|50655705|FG002|After Infant Series|Protocol Violation|2|||
25339252|NCT00444457|50655706|FG003|After Infant Series|Protocol Violation|2|||
25339253|NCT00444457|50655703|FG000|After Infant Series|Adverse Event|2|||
25339254|NCT00444457|50655704|FG001|After Infant Series|Adverse Event|2|||
25339255|NCT00444457|50655705|FG002|After Infant Series|Adverse Event|0|||
24903195|NCT00440947|49997038|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
24903196|NCT00440947|49997039|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
24903197|NCT00440947|49997040|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
24903198|NCT00440947|49997041|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
24903199|NCT00440947|49997037|FG000|48-Week Randomization Phase|Protocol Violation|0|||
24903200|NCT00440947|49997038|FG001|48-Week Randomization Phase|Protocol Violation|0|||
24903201|NCT00440947|49997039|FG002|48-Week Randomization Phase|Protocol Violation|1|||
25339256|NCT00444457|50655706|FG003|After Infant Series|Adverse Event|0|||
24903202|NCT00440947|49997040|FG003|48-Week Randomization Phase|Protocol Violation|0|||
24903203|NCT00440947|49997041|FG004|48-Week Randomization Phase|Protocol Violation|0|||
24903204|NCT00440947|49997037|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
24903205|NCT00440947|49997038|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
24903206|NCT00440947|49997039|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
24903207|NCT00440947|49997040|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
25339257|NCT00444457|50655703|FG000|After Infant Series|Investigator request|0|||
25339258|NCT00444457|50655704|FG001|After Infant Series|Investigator request|0|||
25339259|NCT00444457|50655705|FG002|After Infant Series|Investigator request|0|||
25339260|NCT00444457|50655706|FG003|After Infant Series|Investigator request|1|||
25339261|NCT00444457|50655703|FG000|After Infant Series|Other|0|||
25339262|NCT00444457|50655704|FG001|After Infant Series|Other|1|||
25339263|NCT00444457|50655705|FG002|After Infant Series|Other|0|||
25339264|NCT00444457|50655706|FG003|After Infant Series|Other|0|||
25339265|NCT00444457|50655703|FG000|Toddler Dose|Lost to Follow-up|4|||
25339266|NCT00444457|50655704|FG001|Toddler Dose|Lost to Follow-up|1|||
25339267|NCT00444457|50655705|FG002|Toddler Dose|Lost to Follow-up|1|||
25339268|NCT00444457|50655706|FG003|Toddler Dose|Lost to Follow-up|3|||
25339269|NCT00444457|50655703|FG000|Toddler Dose|Failed to return|2|||
25339270|NCT00444457|50655704|FG001|Toddler Dose|Failed to return|2|||
25339271|NCT00444457|50655705|FG002|Toddler Dose|Failed to return|1|||
25339272|NCT00444457|50655706|FG003|Toddler Dose|Failed to return|3|||
25339273|NCT00444457|50655703|FG000|Toddler Dose|Parent or legal guardian request|0|||
25339274|NCT00444457|50655704|FG001|Toddler Dose|Parent or legal guardian request|3|||
25339275|NCT00444457|50655705|FG002|Toddler Dose|Parent or legal guardian request|2|||
25339276|NCT00444457|50655706|FG003|Toddler Dose|Parent or legal guardian request|1|||
25339277|NCT00444457|50655703|FG000|Toddler Dose|Protocol Violation|1|||
25339278|NCT00444457|50655704|FG001|Toddler Dose|Protocol Violation|0|||
25339279|NCT00444457|50655705|FG002|Toddler Dose|Protocol Violation|0|||
25339280|NCT00444457|50655706|FG003|Toddler Dose|Protocol Violation|1|||
25339281|NCT00799058|50655730|FG000|Overall Study|Withdrawal by Subject|2|||
25339282|NCT00799058|50655731|FG001|Overall Study|Withdrawal by Subject|2|||
25339283|NCT00799058|50655732|FG002|Overall Study|Withdrawal by Subject|2|||
25339284|NCT00799058|50655730|FG000|Overall Study|Lost to Follow-up|1|||
25339285|NCT00799058|50655731|FG001|Overall Study|Lost to Follow-up|2|||
25339286|NCT00799058|50655732|FG002|Overall Study|Lost to Follow-up|1|||
25339287|NCT00799058|50655730|FG000|Overall Study|Adverse Event|0|||
25339288|NCT00799058|50655731|FG001|Overall Study|Adverse Event|2|||
25339289|NCT00799058|50655732|FG002|Overall Study|Adverse Event|0|||
25339290|NCT00799058|50655730|FG000|Overall Study|Pregnancy|1|||
25339291|NCT00799058|50655731|FG001|Overall Study|Pregnancy|0|||
25339292|NCT00799058|50655732|FG002|Overall Study|Pregnancy|0|||
25339293|NCT00799058|50655730|FG000|Overall Study|Not adherent|3|||
25339294|NCT00799058|50655731|FG001|Overall Study|Not adherent|2|||
25339295|NCT00799058|50655732|FG002|Overall Study|Not adherent|1|||
25339296|NCT00799058|50655730|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
25339297|NCT00799058|50655731|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
25339298|NCT00799058|50655732|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
24903208|NCT00440947|49997041|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
24903209|NCT00440947|49997037|FG000|48-Week Randomization Phase|Pregnancy|0|||
24903210|NCT00440947|49997038|FG001|48-Week Randomization Phase|Pregnancy|0|||
24903211|NCT00440947|49997039|FG002|48-Week Randomization Phase|Pregnancy|1|||
24903212|NCT00440947|49997040|FG003|48-Week Randomization Phase|Pregnancy|0|||
24903213|NCT00440947|49997041|FG004|48-Week Randomization Phase|Pregnancy|0|||
24903214|NCT00440947|49997037|FG000|48-Week Randomization Phase|Incarceration|0|||
24903215|NCT00440947|49997038|FG001|48-Week Randomization Phase|Incarceration|3|||
24903216|NCT00440947|49997039|FG002|48-Week Randomization Phase|Incarceration|0|||
24903217|NCT00440947|49997040|FG003|48-Week Randomization Phase|Incarceration|0|||
24903218|NCT00440947|49997041|FG004|48-Week Randomization Phase|Incarceration|0|||
24903219|NCT00440947|49997037|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
24903220|NCT00440947|49997038|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
24903221|NCT00440947|49997039|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
24903222|NCT00440947|49997040|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
24903223|NCT00440947|49997041|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
24903224|NCT00440947|49997037|FG000|48-Week Randomization Phase|Physician Decision|0|||
24903225|NCT00440947|49997038|FG001|48-Week Randomization Phase|Physician Decision|2|||
24903226|NCT00440947|49997039|FG002|48-Week Randomization Phase|Physician Decision|0|||
24903227|NCT00440947|49997040|FG003|48-Week Randomization Phase|Physician Decision|0|||
24903228|NCT00440947|49997041|FG004|48-Week Randomization Phase|Physician Decision|0|||
24903229|NCT00440947|49997037|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
24903230|NCT00440947|49997038|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
24903231|NCT00440947|49997039|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
24903232|NCT00440947|49997040|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
24903233|NCT00440947|49997041|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
24903234|NCT00440947|49997037|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
24903235|NCT00440947|49997038|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
24977445|NCT00048542|50065996|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
25339299|NCT00799058|50655730|FG000|Overall Study|IP dispensing error|1|||
25339300|NCT00799058|50655731|FG001|Overall Study|IP dispensing error|0|||
25339301|NCT00799058|50655732|FG002|Overall Study|IP dispensing error|0|||
25339302|NCT00799058|50655730|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
25339303|NCT00799058|50655731|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
25339304|NCT00799058|50655732|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
25339305|NCT00799058|50655730|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
25339306|NCT00799058|50655731|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
24903236|NCT00440947|49997039|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
24903237|NCT00440947|49997040|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
24903238|NCT00440947|49997041|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
24903239|NCT00440947|49997037|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
24903240|NCT00440947|49997038|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
24903241|NCT00440947|49997039|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
24903242|NCT00440947|49997040|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
24903243|NCT00440947|49997041|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
24903244|NCT00440947|49997037|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
24903245|NCT00440947|49997038|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
24903246|NCT00440947|49997039|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
24903247|NCT00440947|49997040|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
24903248|NCT00440947|49997041|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
24903249|NCT00440947|49997037|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
24903250|NCT00440947|49997038|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
24903251|NCT00440947|49997039|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
24903252|NCT00440947|49997040|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
24903253|NCT00440947|49997041|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
24903254|NCT00440947|49997037|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
24903255|NCT00440947|49997038|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
24903256|NCT00440947|49997039|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
24903257|NCT00440947|49997040|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
24903258|NCT00440947|49997041|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
24903259|NCT00440947|49997037|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
24903260|NCT00440947|49997038|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
24903261|NCT00440947|49997039|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
24903262|NCT00440947|49997040|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
24903263|NCT00440947|49997041|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
24903264|NCT00440947|49997037|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
24903265|NCT00440947|49997038|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
24903266|NCT00440947|49997039|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
24903267|NCT00440947|49997040|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
25254528|NCT01357161|50570187|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
25339307|NCT00799058|50655732|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
25339308|NCT00799058|50655730|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
25339309|NCT00799058|50655731|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
25339310|NCT00799058|50655732|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
25339311|NCT00799058|50655730|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
25339312|NCT00799058|50655731|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
25339313|NCT00799058|50655732|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
25339314|NCT00725985|50655745|FG000|ITP- Treatment Disposition|Adverse Event|20|||
25339315|NCT00725985|50655746|FG001|ITP- Treatment Disposition|Adverse Event|10|||
25339316|NCT00725985|50655747|FG002|ITP- Treatment Disposition|Adverse Event|5|||
25339317|NCT00725985|50655748|FG003|ITP- Treatment Disposition|Adverse Event|0|||
25339318|NCT00725985|50655749|FG004|ITP- Treatment Disposition|Adverse Event|0|||
25339319|NCT00725985|50655750|FG005|ITP- Treatment Disposition|Adverse Event|0|||
25339320|NCT00725985|50655751|FG006|ITP- Treatment Disposition|Adverse Event|0|||
25339321|NCT00725985|50655752|FG007|ITP- Treatment Disposition|Adverse Event|0|||
25339322|NCT00725985|50655753|FG008|ITP- Treatment Disposition|Adverse Event|0|||
25339323|NCT00725985|50655754|FG009|ITP- Treatment Disposition|Adverse Event|0|||
25339324|NCT00725985|50655755|FG010|ITP- Treatment Disposition|Adverse Event|0|||
25339325|NCT00725985|50655756|FG011|ITP- Treatment Disposition|Adverse Event|0|||
25339326|NCT00725985|50655745|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
25339327|NCT00725985|50655746|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
25339328|NCT00725985|50655747|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
25339329|NCT00725985|50655748|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
25339330|NCT00725985|50655749|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
25339331|NCT00725985|50655750|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
24977446|NCT00048542|50065997|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
25254529|NCT01357161|50570188|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
25254530|NCT01357161|50570186|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
25254531|NCT01357161|50570187|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
25254532|NCT01357161|50570188|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
25254533|NCT01357161|50570186|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
25254534|NCT01357161|50570187|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
25254535|NCT01357161|50570188|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
25254536|NCT01357161|50570186|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
24903268|NCT00440947|49997041|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
24903269|NCT00440947|49997037|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
24903270|NCT00440947|49997038|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
24903271|NCT00440947|49997039|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
24903272|NCT00440947|49997040|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
24903273|NCT00440947|49997041|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
24903274|NCT00440947|49997037|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
24903275|NCT00440947|49997038|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
24903276|NCT00440947|49997039|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
24903277|NCT00440947|49997040|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
24903278|NCT00440947|49997041|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
24903279|NCT00440947|49997037|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
24903280|NCT00440947|49997038|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
24903281|NCT00440947|49997039|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
24903282|NCT00440947|49997040|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
24903283|NCT00440947|49997041|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
24903284|NCT00440947|49997037|FG000|Optional 60-Week Extension Phase|Other|0|||
24903285|NCT00440947|49997038|FG001|Optional 60-Week Extension Phase|Other|0|||
24903286|NCT00440947|49997039|FG002|Optional 60-Week Extension Phase|Other|0|||
24903287|NCT00440947|49997040|FG003|Optional 60-Week Extension Phase|Other|1|||
24903288|NCT00440947|49997041|FG004|Optional 60-Week Extension Phase|Other|0|||
24903289|NCT00440947|49997037|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
24903290|NCT00440947|49997038|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
24903291|NCT00440947|49997039|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
24903292|NCT00440947|49997040|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
24903293|NCT00440947|49997041|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
24903294|NCT00440947|49997037|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
24903295|NCT00440947|49997038|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
24903296|NCT00440947|49997039|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
24903297|NCT00440947|49997040|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
24903298|NCT00440947|49997041|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
24903299|NCT00664521|49997064|FG000|Overall Study|Adverse Event|4|||
24903300|NCT00664521|49997065|FG001|Overall Study|Adverse Event|1|||
24903301|NCT00664521|49997064|FG000|Overall Study|Lost to Follow-up|1|||
24903302|NCT00664521|49997065|FG001|Overall Study|Lost to Follow-up|0|||
24903303|NCT00664521|49997064|FG000|Overall Study|Other|1|||
24903304|NCT00664521|49997065|FG001|Overall Study|Other|0|||
24903305|NCT00664209|49997071|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
24903306|NCT00664209|49997071|FG000|Study Treatment Period|Physician Decision|4|||
25339332|NCT00725985|50655751|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
25339333|NCT00725985|50655752|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
25339334|NCT00725985|50655753|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
25339335|NCT00725985|50655754|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
25339336|NCT00725985|50655755|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
25339337|NCT00725985|50655756|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
25339338|NCT00725985|50655745|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
25339339|NCT00725985|50655746|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
25339340|NCT00725985|50655747|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
24903307|NCT00664209|49997071|FG000|Study Treatment Period|Withdrawal by Subject|2|||
24903308|NCT00440557|49997079|FG000|Overall Study|Withdrawal by Subject|10|||
24903309|NCT00440557|49997080|FG001|Overall Study|Withdrawal by Subject|5|||
24903310|NCT00440557|49997081|FG002|Overall Study|Withdrawal by Subject|11|||
24903311|NCT00440557|49997079|FG000|Overall Study|Lost to Follow-up|1|||
24903312|NCT00440557|49997080|FG001|Overall Study|Lost to Follow-up|2|||
24903313|NCT00440557|49997081|FG002|Overall Study|Lost to Follow-up|6|||
24903314|NCT00440557|49997079|FG000|Overall Study|Adverse Event|3|||
24903315|NCT00440557|49997080|FG001|Overall Study|Adverse Event|3|||
24903316|NCT00440557|49997081|FG002|Overall Study|Adverse Event|5|||
24903317|NCT00440557|49997079|FG000|Overall Study|Death|2|||
24903318|NCT00440557|49997080|FG001|Overall Study|Death|6|||
24903319|NCT00440557|49997081|FG002|Overall Study|Death|3|||
24903320|NCT00440557|49997079|FG000|Overall Study|Began Dialysis|4|||
24977447|NCT00048542|50065998|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
24977448|NCT00048542|50065999|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
25339341|NCT00725985|50655748|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
24903321|NCT00440557|49997080|FG001|Overall Study|Began Dialysis|1|||
24903322|NCT00440557|49997081|FG002|Overall Study|Began Dialysis|4|||
25339342|NCT00725985|50655749|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
24903323|NCT00440557|49997079|FG000|Overall Study|Principal Investigator decision|0|||
24903324|NCT00440557|49997080|FG001|Overall Study|Principal Investigator decision|3|||
24903325|NCT00440557|49997081|FG002|Overall Study|Principal Investigator decision|1|||
24903326|NCT00440557|49997079|FG000|Overall Study|Patient moved|1|||
24903327|NCT00440557|49997080|FG001|Overall Study|Patient moved|2|||
24903328|NCT00440557|49997081|FG002|Overall Study|Patient moved|1|||
24903329|NCT00440557|49997079|FG000|Overall Study|Principal Investigator's office closed|3|||
24903330|NCT00440557|49997080|FG001|Overall Study|Principal Investigator's office closed|6|||
24903331|NCT00440557|49997081|FG002|Overall Study|Principal Investigator's office closed|4|||
24903332|NCT00440557|49997079|FG000|Overall Study|Patient transferred to nursing home|0|||
24903333|NCT00440557|49997080|FG001|Overall Study|Patient transferred to nursing home|1|||
24903334|NCT00440557|49997081|FG002|Overall Study|Patient transferred to nursing home|0|||
24903335|NCT00440557|49997079|FG000|Overall Study|Patient had surgery|1|||
24903336|NCT00440557|49997080|FG001|Overall Study|Patient had surgery|0|||
24903337|NCT00440557|49997081|FG002|Overall Study|Patient had surgery|0|||
24903338|NCT00582608|49997141|FG000|Overall Study|Not Treated|7|||
24903339|NCT00582608|49997141|FG000|Overall Study|Patient Ineligible|1|||
24903340|NCT00582608|49997141|FG000|Overall Study|Lack of accrual|4|||
24903341|NCT03014570|49997147|FG000|Overall Study|COVID-19 Restrictions|38|||
24903342|NCT03014570|49997148|FG001|Overall Study|COVID-19 Restrictions|24|||
24903343|NCT03014570|49997147|FG000|Overall Study|Death|70|||
24903344|NCT03014570|49997148|FG001|Overall Study|Death|79|||
24903345|NCT03014570|49997147|FG000|Overall Study|Transfer from facility|11|||
24903346|NCT03014570|49997148|FG001|Overall Study|Transfer from facility|14|||
24903347|NCT03014570|49997147|FG000|Overall Study|Hospitalized|5|||
24903348|NCT03014570|49997148|FG001|Overall Study|Hospitalized|3|||
24903349|NCT03014570|49997147|FG000|Overall Study|Transfer within facility|1|||
24903350|NCT03014570|49997148|FG001|Overall Study|Transfer within facility|0|||
25254537|NCT01357161|50570187|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
25254538|NCT01357161|50570188|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
25254539|NCT01357161|50570186|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
25254540|NCT01357161|50570187|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
25254541|NCT01357161|50570188|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
25254542|NCT01357161|50570186|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
25339343|NCT00725985|50655750|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
25339344|NCT00725985|50655751|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
25339345|NCT00725985|50655752|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
25339346|NCT00725985|50655753|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
25339347|NCT00725985|50655754|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
25339348|NCT00725985|50655755|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
25339349|NCT00725985|50655756|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
25339350|NCT00725985|50655745|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
25339351|NCT00725985|50655746|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
25339352|NCT00725985|50655747|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
25339353|NCT00725985|50655748|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
25339354|NCT00725985|50655749|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
25339355|NCT00725985|50655750|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
25339356|NCT00725985|50655751|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
25339357|NCT00725985|50655752|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
25339358|NCT00725985|50655753|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
25339359|NCT00725985|50655754|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
25339360|NCT00725985|50655755|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
25339361|NCT00725985|50655756|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
25339362|NCT00725985|50655745|FG000|ITP- Treatment Disposition|Other|50|||
25339363|NCT00725985|50655746|FG001|ITP- Treatment Disposition|Other|38|||
25339364|NCT00725985|50655747|FG002|ITP- Treatment Disposition|Other|24|||
25339365|NCT00725985|50655748|FG003|ITP- Treatment Disposition|Other|0|||
25339366|NCT00725985|50655749|FG004|ITP- Treatment Disposition|Other|0|||
25339367|NCT00725985|50655750|FG005|ITP- Treatment Disposition|Other|0|||
25339368|NCT00725985|50655751|FG006|ITP- Treatment Disposition|Other|0|||
25339369|NCT00725985|50655752|FG007|ITP- Treatment Disposition|Other|0|||
25339370|NCT00725985|50655753|FG008|ITP- Treatment Disposition|Other|0|||
25339371|NCT00725985|50655754|FG009|ITP- Treatment Disposition|Other|0|||
25339372|NCT00725985|50655755|FG010|ITP- Treatment Disposition|Other|0|||
25339373|NCT00725985|50655756|FG011|ITP- Treatment Disposition|Other|0|||
24903351|NCT03014570|49997147|FG000|Overall Study|Site refusal|0|||
24903352|NCT03014570|49997148|FG001|Overall Study|Site refusal|11|||
24903353|NCT00427999|49997155|FG000|Overall Study|Adverse Event|6|||
24903354|NCT00427999|49997155|FG000|Overall Study|Abnormal laboratory values|1|||
24903355|NCT00427999|49997155|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
25254543|NCT01357161|50570187|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
25254544|NCT01357161|50570188|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
24903356|NCT00427999|49997155|FG000|Overall Study|Protocol Violation|2|||
25254545|NCT01357161|50570186|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
25339374|NCT00725985|50655745|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
25339375|NCT00725985|50655746|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
24903357|NCT00427999|49997155|FG000|Overall Study|Withdrawal by Subject|9|||
24903358|NCT00427999|49997155|FG000|Overall Study|Death|1|||
24903359|NCT00661713|49997168|FG000|Overall Study|Death|1|||
24903360|NCT00661713|49997169|FG001|Overall Study|Death|0|||
24903361|NCT00661713|49997170|FG002|Overall Study|Death|0|||
24903362|NCT00661713|49997171|FG003|Overall Study|Death|0|||
24903363|NCT00661713|49997172|FG004|Overall Study|Death|1|||
24903364|NCT00661713|49997173|FG005|Overall Study|Death|0|||
24903365|NCT00661713|49997174|FG006|Overall Study|Death|0|||
24903366|NCT00661713|49997175|FG007|Overall Study|Death|0|||
24903367|NCT00661713|49997168|FG000|Overall Study|Unable to Classify|1|||
24903368|NCT00661713|49997169|FG001|Overall Study|Unable to Classify|0|||
24903369|NCT00661713|49997170|FG002|Overall Study|Unable to Classify|0|||
24903370|NCT00661713|49997171|FG003|Overall Study|Unable to Classify|0|||
24903371|NCT00661713|49997172|FG004|Overall Study|Unable to Classify|0|||
24903372|NCT00661713|49997173|FG005|Overall Study|Unable to Classify|0|||
24903373|NCT00661713|49997174|FG006|Overall Study|Unable to Classify|0|||
24903374|NCT00661713|49997175|FG007|Overall Study|Unable to Classify|0|||
24903375|NCT00661713|49997168|FG000|Overall Study|Protocol Violation|1|||
24903376|NCT00661713|49997169|FG001|Overall Study|Protocol Violation|6|||
25339376|NCT00725985|50655747|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
25339377|NCT00725985|50655748|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
24903377|NCT00661713|49997170|FG002|Overall Study|Protocol Violation|3|||
25339378|NCT00725985|50655749|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
24903378|NCT00661713|49997171|FG003|Overall Study|Protocol Violation|3|||
24903379|NCT00661713|49997172|FG004|Overall Study|Protocol Violation|0|||
24903380|NCT00661713|49997173|FG005|Overall Study|Protocol Violation|2|||
24903381|NCT00661713|49997174|FG006|Overall Study|Protocol Violation|2|||
24903382|NCT00661713|49997175|FG007|Overall Study|Protocol Violation|1|||
24903383|NCT00661713|49997168|FG000|Overall Study|Withdrawal by Subject|11|||
24903384|NCT00661713|49997169|FG001|Overall Study|Withdrawal by Subject|25|||
24903385|NCT00661713|49997170|FG002|Overall Study|Withdrawal by Subject|12|||
24903386|NCT00661713|49997171|FG003|Overall Study|Withdrawal by Subject|21|||
24903387|NCT00661713|49997172|FG004|Overall Study|Withdrawal by Subject|12|||
24903388|NCT00661713|49997173|FG005|Overall Study|Withdrawal by Subject|26|||
24903389|NCT00661713|49997174|FG006|Overall Study|Withdrawal by Subject|45|||
24903390|NCT00661713|49997175|FG007|Overall Study|Withdrawal by Subject|9|||
24903391|NCT00661713|49997168|FG000|Overall Study|Lost to Follow-up|2|||
24903392|NCT00661713|49997169|FG001|Overall Study|Lost to Follow-up|7|||
24903393|NCT00661713|49997170|FG002|Overall Study|Lost to Follow-up|2|||
24903394|NCT00661713|49997171|FG003|Overall Study|Lost to Follow-up|2|||
24903395|NCT00661713|49997172|FG004|Overall Study|Lost to Follow-up|5|||
24903396|NCT00661713|49997173|FG005|Overall Study|Lost to Follow-up|7|||
24903397|NCT00661713|49997174|FG006|Overall Study|Lost to Follow-up|14|||
24903398|NCT00661713|49997175|FG007|Overall Study|Lost to Follow-up|1|||
24903399|NCT00661713|49997168|FG000|Overall Study|Administrative Reason|0|||
24903400|NCT00661713|49997169|FG001|Overall Study|Administrative Reason|1|||
24903401|NCT00661713|49997170|FG002|Overall Study|Administrative Reason|0|||
24903402|NCT00661713|49997171|FG003|Overall Study|Administrative Reason|2|||
24903403|NCT00661713|49997172|FG004|Overall Study|Administrative Reason|2|||
24903404|NCT00661713|49997173|FG005|Overall Study|Administrative Reason|2|||
24903405|NCT00661713|49997174|FG006|Overall Study|Administrative Reason|1|||
25339379|NCT00725985|50655750|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
25339380|NCT00725985|50655751|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
25339381|NCT00725985|50655752|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
25339382|NCT00725985|50655753|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
25339383|NCT00725985|50655754|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
25339384|NCT00725985|50655755|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
25339385|NCT00725985|50655756|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
25339386|NCT00725985|50655745|FG000|OLMP (Up to 96 Weeks)|Death|0|||
25339387|NCT00725985|50655746|FG001|OLMP (Up to 96 Weeks)|Death|0|||
25339388|NCT00725985|50655747|FG002|OLMP (Up to 96 Weeks)|Death|0|||
25339389|NCT00725985|50655748|FG003|OLMP (Up to 96 Weeks)|Death|0|||
25339390|NCT00725985|50655749|FG004|OLMP (Up to 96 Weeks)|Death|1|||
25339391|NCT00725985|50655750|FG005|OLMP (Up to 96 Weeks)|Death|0|||
25339392|NCT00725985|50655751|FG006|OLMP (Up to 96 Weeks)|Death|0|||
25339393|NCT00725985|50655752|FG007|OLMP (Up to 96 Weeks)|Death|0|||
24903406|NCT00661713|49997175|FG007|Overall Study|Administrative Reason|0|||
24903407|NCT00661713|49997168|FG000|Overall Study|Adverse Event|0|||
24903408|NCT00661713|49997169|FG001|Overall Study|Adverse Event|0|||
24903409|NCT00661713|49997170|FG002|Overall Study|Adverse Event|0|||
24903410|NCT00661713|49997171|FG003|Overall Study|Adverse Event|0|||
24903411|NCT00661713|49997172|FG004|Overall Study|Adverse Event|0|||
24903412|NCT00661713|49997173|FG005|Overall Study|Adverse Event|0|||
25339394|NCT00725985|50655753|FG008|OLMP (Up to 96 Weeks)|Death|0|||
25339395|NCT00725985|50655754|FG009|OLMP (Up to 96 Weeks)|Death|0|||
24903413|NCT00661713|49997174|FG006|Overall Study|Adverse Event|1|||
24903414|NCT00661713|49997175|FG007|Overall Study|Adverse Event|0|||
24903415|NCT00661713|49997168|FG000|Overall Study|Inappropriate Enrollment|0|||
25339396|NCT00725985|50655755|FG010|OLMP (Up to 96 Weeks)|Death|0|||
25339397|NCT00725985|50655756|FG011|OLMP (Up to 96 Weeks)|Death|0|||
25339398|NCT00725985|50655745|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
25339399|NCT00725985|50655746|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
25339400|NCT00725985|50655747|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
25339401|NCT00725985|50655748|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
25339402|NCT00725985|50655749|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
25339403|NCT00725985|50655750|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
25339404|NCT00725985|50655751|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
25339405|NCT00725985|50655752|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
25339406|NCT00725985|50655753|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
24903416|NCT00661713|49997169|FG001|Overall Study|Inappropriate Enrollment|0|||
24903417|NCT00661713|49997170|FG002|Overall Study|Inappropriate Enrollment|0|||
24903418|NCT00661713|49997171|FG003|Overall Study|Inappropriate Enrollment|0|||
24903419|NCT00661713|49997172|FG004|Overall Study|Inappropriate Enrollment|0|||
24903420|NCT00661713|49997173|FG005|Overall Study|Inappropriate Enrollment|0|||
24903421|NCT00661713|49997174|FG006|Overall Study|Inappropriate Enrollment|1|||
24903422|NCT00661713|49997175|FG007|Overall Study|Inappropriate Enrollment|0|||
24903423|NCT03835975|49997200|FG000|Overall Study|Lost to Follow-up|1|||
24903424|NCT03835975|49997201|FG001|Overall Study|Lost to Follow-up|1|||
24903425|NCT03835975|49997202|FG002|Overall Study|Lost to Follow-up|0|||
24903426|NCT03835975|49997203|FG003|Overall Study|Lost to Follow-up|0|||
24903427|NCT03835975|49997204|FG004|Overall Study|Lost to Follow-up|0|||
24903428|NCT03835975|49997200|FG000|Overall Study|No longer met eligibility criteria|0|||
24903429|NCT03835975|49997201|FG001|Overall Study|No longer met eligibility criteria|1|||
24903430|NCT03835975|49997202|FG002|Overall Study|No longer met eligibility criteria|0|||
24903431|NCT03835975|49997203|FG003|Overall Study|No longer met eligibility criteria|0|||
24903432|NCT03835975|49997204|FG004|Overall Study|No longer met eligibility criteria|0|||
24903433|NCT03835975|49997200|FG000|Overall Study|Protocol Violation|1|||
24903434|NCT03835975|49997201|FG001|Overall Study|Protocol Violation|1|||
24903435|NCT03835975|49997202|FG002|Overall Study|Protocol Violation|2|||
24903436|NCT03835975|49997203|FG003|Overall Study|Protocol Violation|0|||
24903437|NCT03835975|49997204|FG004|Overall Study|Protocol Violation|0|||
25254546|NCT01357161|50570187|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
25254547|NCT01357161|50570188|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
25254548|NCT01357161|50570186|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
25254549|NCT01357161|50570187|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
25254550|NCT01357161|50570188|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
25254551|NCT01351350|50570201|FG000|Overall Study|Disease Progression|5|||
25254552|NCT01351350|50570202|FG001|Overall Study|Disease Progression|13|||
25339407|NCT00725985|50655754|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
25339408|NCT00725985|50655755|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
25339409|NCT00725985|50655756|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
25339410|NCT00725985|50655745|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
25339411|NCT00725985|50655746|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
25339412|NCT00725985|50655747|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
25339413|NCT00725985|50655748|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
25339414|NCT00725985|50655749|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
25339415|NCT00725985|50655750|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
25339416|NCT00725985|50655751|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
25339417|NCT00725985|50655752|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
25339418|NCT00725985|50655753|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
24903438|NCT03835975|49997200|FG000|Overall Study|Withdrawal by Subject|1|||
24903439|NCT03835975|49997201|FG001|Overall Study|Withdrawal by Subject|0|||
24903440|NCT03835975|49997202|FG002|Overall Study|Withdrawal by Subject|1|||
24903441|NCT03835975|49997203|FG003|Overall Study|Withdrawal by Subject|1|||
24903442|NCT03835975|49997204|FG004|Overall Study|Withdrawal by Subject|0|||
25254553|NCT01351350|50570203|FG002|Overall Study|Disease Progression|6|||
25254554|NCT01351350|50570204|FG003|Overall Study|Disease Progression|8|||
25254555|NCT01351350|50570205|FG004|Overall Study|Disease Progression|5|||
25254556|NCT01351350|50570201|FG000|Overall Study|Adverse Event|1|||
25254557|NCT01351350|50570202|FG001|Overall Study|Adverse Event|10|||
25254558|NCT01351350|50570203|FG002|Overall Study|Adverse Event|1|||
25254559|NCT01351350|50570204|FG003|Overall Study|Adverse Event|2|||
25254560|NCT01351350|50570205|FG004|Overall Study|Adverse Event|0|||
25254561|NCT01351350|50570201|FG000|Overall Study|Participant Decision|2|||
25254562|NCT01351350|50570202|FG001|Overall Study|Participant Decision|6|||
25254563|NCT01351350|50570203|FG002|Overall Study|Participant Decision|3|||
25254564|NCT01351350|50570204|FG003|Overall Study|Participant Decision|3|||
25254565|NCT01351350|50570205|FG004|Overall Study|Participant Decision|2|||
25254566|NCT01351350|50570201|FG000|Overall Study|Enrolled but not Treated|0|||
25254567|NCT01351350|50570202|FG001|Overall Study|Enrolled but not Treated|0|||
25339419|NCT00725985|50655754|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
25339420|NCT00725985|50655755|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
25254568|NCT01351350|50570203|FG002|Overall Study|Enrolled but not Treated|1|||
25254569|NCT01351350|50570204|FG003|Overall Study|Enrolled but not Treated|0|||
24903443|NCT00427921|49997218|FG000|Overall Study|Adverse Event|26|||
24903444|NCT00427921|49997218|FG000|Overall Study|Withdrawal by Subject|4|||
24903445|NCT00427921|49997218|FG000|Overall Study|Lost to Follow-up|2|||
24903446|NCT00427921|49997218|FG000|Overall Study|Other reason not specified|10|||
24903447|NCT00427921|49997218|FG000|Overall Study|Adverse Event + Hospitalization|1|||
24903448|NCT00427921|49997218|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
24903449|NCT00427921|49997218|FG000|Overall Study|Adverse Event + No Response|1|||
24903450|NCT00427921|49997218|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
24903451|NCT00427921|49997218|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
24903452|NCT00427921|49997218|FG000|Overall Study|Adverse Event + Lost Response|1|||
24903453|NCT00427921|49997218|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
24903454|NCT00427921|49997218|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
24903455|NCT00432991|49997224|FG000|Overall Study|Protocol Violation|7|||
24903456|NCT00432991|49997225|FG001|Overall Study|Protocol Violation|12|||
24903457|NCT00432835|49997233|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
24903458|NCT00432835|49997234|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
24903459|NCT00580970|49997242|FG000|Pre-treatment|Non-compliance|1|||
24903460|NCT00580970|49997242|FG000|Treatment (Lovastatin)|Non-compliance|6|||
24903461|NCT00580970|49997242|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
24903462|NCT00580970|49997242|FG000|Treatment (Lovastatin)|Physician Decision|4|||
24903463|NCT00580970|49997242|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
24903464|NCT00580970|49997242|FG000|Treatment (Lovastatin)|Death|1|||
24903465|NCT00665925|49997250|FG000|Overall Study|Lack of Efficacy|10|||
24903466|NCT00665925|49997251|FG001|Overall Study|Lack of Efficacy|8|||
24903467|NCT00665925|49997252|FG002|Overall Study|Lack of Efficacy|9|||
24903468|NCT00665925|49997253|FG003|Overall Study|Lack of Efficacy|8|||
24903469|NCT00665925|49997250|FG000|Overall Study|Lost to Follow-up|1|||
24903470|NCT00665925|49997251|FG001|Overall Study|Lost to Follow-up|2|||
24903471|NCT00665925|49997252|FG002|Overall Study|Lost to Follow-up|2|||
24903472|NCT00665925|49997253|FG003|Overall Study|Lost to Follow-up|2|||
24903473|NCT00665925|49997250|FG000|Overall Study|Withdrawal by Subject|2|||
24903474|NCT00665925|49997251|FG001|Overall Study|Withdrawal by Subject|2|||
24903475|NCT00665925|49997252|FG002|Overall Study|Withdrawal by Subject|3|||
24903476|NCT00665925|49997253|FG003|Overall Study|Withdrawal by Subject|2|||
24903477|NCT00665925|49997250|FG000|Overall Study|Physician Decision|0|||
24903478|NCT00665925|49997251|FG001|Overall Study|Physician Decision|0|||
24903479|NCT00665925|49997252|FG002|Overall Study|Physician Decision|1|||
24903480|NCT00665925|49997253|FG003|Overall Study|Physician Decision|2|||
24903481|NCT00665925|49997250|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
24903482|NCT00665925|49997251|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
24903483|NCT00665925|49997252|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
24903484|NCT00665925|49997253|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
24903485|NCT00665925|49997250|FG000|Overall Study|Adverse Event|1|||
24903486|NCT00665925|49997251|FG001|Overall Study|Adverse Event|5|||
24977449|NCT00048542|50066000|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
24977450|NCT00048542|50066001|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
24977451|NCT00048542|50066002|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
24977452|NCT00048542|50066003|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
24977453|NCT00048542|50065996|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
24977454|NCT00048542|50065997|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
24977455|NCT00048542|50065998|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
24977456|NCT00048542|50065999|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
24977457|NCT00048542|50066000|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
24977458|NCT00048542|50066001|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
24977459|NCT00048542|50066002|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
24977460|NCT00048542|50066003|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
24977461|NCT00048542|50065996|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
24977462|NCT00048542|50065997|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
24977463|NCT00048542|50065998|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
24977464|NCT00048542|50065999|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
24977465|NCT00048542|50066000|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
24977466|NCT00048542|50066001|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
24977467|NCT00048542|50066002|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
24977468|NCT00048542|50066003|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
24977469|NCT03814590|50066046|FG000|Overall Study|Adverse Event|0|||
24903487|NCT00665925|49997252|FG002|Overall Study|Adverse Event|10|||
24903488|NCT00665925|49997253|FG003|Overall Study|Adverse Event|5|||
24903489|NCT00665925|49997250|FG000|Overall Study|Enrolled by mistake|0|||
24903490|NCT00665925|49997251|FG001|Overall Study|Enrolled by mistake|0|||
24903491|NCT00665925|49997252|FG002|Overall Study|Enrolled by mistake|0|||
24903492|NCT00665925|49997253|FG003|Overall Study|Enrolled by mistake|1|||
24903493|NCT00665925|49997250|FG000|Overall Study|Due to exclusion criteria|1|||
24903494|NCT00665925|49997251|FG001|Overall Study|Due to exclusion criteria|0|||
24903495|NCT00665925|49997252|FG002|Overall Study|Due to exclusion criteria|0|||
24903496|NCT00665925|49997253|FG003|Overall Study|Due to exclusion criteria|0|||
24903497|NCT00426751|49997266|FG000|Overall Study|Adverse Event|8|||
24903498|NCT00426751|49997267|FG001|Overall Study|Adverse Event|1|||
24903499|NCT00426751|49997266|FG000|Overall Study|Lost to Follow-up|7|||
24903500|NCT00426751|49997267|FG001|Overall Study|Lost to Follow-up|6|||
24903501|NCT00426751|49997266|FG000|Overall Study|Consent Withdrawn|0|||
24903502|NCT00426751|49997267|FG001|Overall Study|Consent Withdrawn|1|||
24903503|NCT00426751|49997266|FG000|Overall Study|Other Reasons|7|||
24903504|NCT00426751|49997267|FG001|Overall Study|Other Reasons|12|||
24903505|NCT00440401|49997275|FG000|Overall Study|Adverse Event|2|||
24903506|NCT00440401|49997276|FG001|Overall Study|Adverse Event|1|||
24903507|NCT00440401|49997275|FG000|Overall Study|Other|2|||
24903508|NCT00440401|49997276|FG001|Overall Study|Other|5|||
24903509|NCT02598960|49997295|FG000|Treatment Period|Disease Progression|4|||
24903510|NCT02598960|49997296|FG001|Treatment Period|Disease Progression|4|||
24903511|NCT02598960|49997297|FG002|Treatment Period|Disease Progression|4|||
24903512|NCT02598960|49997298|FG003|Treatment Period|Disease Progression|6|||
24903513|NCT02598960|49997299|FG004|Treatment Period|Disease Progression|8|||
24903514|NCT02598960|49997300|FG005|Treatment Period|Disease Progression|2|||
24903515|NCT02598960|49997301|FG006|Treatment Period|Disease Progression|2|||
24903516|NCT02598960|49997302|FG007|Treatment Period|Disease Progression|3|||
24903517|NCT02598960|49997303|FG008|Treatment Period|Disease Progression|7|||
24903518|NCT02598960|49997304|FG009|Treatment Period|Disease Progression|9|||
24903519|NCT02598960|49997305|FG010|Treatment Period|Disease Progression|7|||
24903520|NCT02598960|49997306|FG011|Treatment Period|Disease Progression|143|||
24903521|NCT02598960|49997307|FG012|Treatment Period|Disease Progression|23|||
24903522|NCT02598960|49997295|FG000|Treatment Period|Study drug toxicity|0|||
24903523|NCT02598960|49997296|FG001|Treatment Period|Study drug toxicity|0|||
24903524|NCT02598960|49997297|FG002|Treatment Period|Study drug toxicity|0|||
24903525|NCT02598960|49997298|FG003|Treatment Period|Study drug toxicity|0|||
24903526|NCT02598960|49997299|FG004|Treatment Period|Study drug toxicity|0|||
24903527|NCT02598960|49997300|FG005|Treatment Period|Study drug toxicity|0|||
24903528|NCT02598960|49997301|FG006|Treatment Period|Study drug toxicity|0|||
24903529|NCT02598960|49997302|FG007|Treatment Period|Study drug toxicity|0|||
24903530|NCT02598960|49997303|FG008|Treatment Period|Study drug toxicity|0|||
24903531|NCT02598960|49997304|FG009|Treatment Period|Study drug toxicity|1|||
24903532|NCT02598960|49997305|FG010|Treatment Period|Study drug toxicity|0|||
24903533|NCT02598960|49997306|FG011|Treatment Period|Study drug toxicity|3|||
24903534|NCT02598960|49997307|FG012|Treatment Period|Study drug toxicity|0|||
24903535|NCT02598960|49997295|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
24903536|NCT02598960|49997296|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
24903537|NCT02598960|49997297|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
24903538|NCT02598960|49997298|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
24903539|NCT02598960|49997299|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
24903540|NCT02598960|49997300|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
24903541|NCT02598960|49997301|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
24903542|NCT02598960|49997302|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
24903543|NCT02598960|49997303|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
24903544|NCT02598960|49997304|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
24903545|NCT02598960|49997305|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
24903546|NCT02598960|49997306|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
24903547|NCT02598960|49997307|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
24903548|NCT02598960|49997295|FG000|Treatment Period|participant request to discontinue|0|||
24903549|NCT02598960|49997296|FG001|Treatment Period|participant request to discontinue|1|||
24903550|NCT02598960|49997297|FG002|Treatment Period|participant request to discontinue|0|||
24903551|NCT02598960|49997298|FG003|Treatment Period|participant request to discontinue|0|||
24903552|NCT02598960|49997299|FG004|Treatment Period|participant request to discontinue|1|||
24903553|NCT02598960|49997300|FG005|Treatment Period|participant request to discontinue|0|||
24903554|NCT02598960|49997301|FG006|Treatment Period|participant request to discontinue|0|||
24903555|NCT02598960|49997302|FG007|Treatment Period|participant request to discontinue|0|||
24903556|NCT02598960|49997303|FG008|Treatment Period|participant request to discontinue|0|||
24903557|NCT02598960|49997304|FG009|Treatment Period|participant request to discontinue|0|||
24903558|NCT02598960|49997305|FG010|Treatment Period|participant request to discontinue|1|||
24903559|NCT02598960|49997306|FG011|Treatment Period|participant request to discontinue|4|||
24903560|NCT02598960|49997307|FG012|Treatment Period|participant request to discontinue|0|||
24903561|NCT02598960|49997295|FG000|Treatment Period|participant withdrew consent|0|||
24903562|NCT02598960|49997296|FG001|Treatment Period|participant withdrew consent|0|||
25254570|NCT01351350|50570205|FG004|Overall Study|Enrolled but not Treated|0|||
24903563|NCT02598960|49997297|FG002|Treatment Period|participant withdrew consent|0|||
25254571|NCT01350999|50570233|FG000|Overall Study|Adverse Event|4|||
25254572|NCT01350999|50570234|FG001|Overall Study|Adverse Event|9|||
25254573|NCT01350999|50570235|FG002|Overall Study|Adverse Event|10|||
25254574|NCT01350999|50570233|FG000|Overall Study|Voluntary withdrawal|3|||
25254575|NCT01350999|50570234|FG001|Overall Study|Voluntary withdrawal|4|||
25339421|NCT00725985|50655756|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
25339422|NCT00725985|50655745|FG000|OLMP (Up to 96 Weeks)|Other|0|||
25339423|NCT00725985|50655746|FG001|OLMP (Up to 96 Weeks)|Other|0|||
25339424|NCT00725985|50655747|FG002|OLMP (Up to 96 Weeks)|Other|0|||
25339425|NCT00725985|50655748|FG003|OLMP (Up to 96 Weeks)|Other|15|||
25339426|NCT00725985|50655749|FG004|OLMP (Up to 96 Weeks)|Other|20|||
25339427|NCT00725985|50655750|FG005|OLMP (Up to 96 Weeks)|Other|44|||
25339428|NCT00725985|50655751|FG006|OLMP (Up to 96 Weeks)|Other|0|||
25339429|NCT00725985|50655752|FG007|OLMP (Up to 96 Weeks)|Other|0|||
25339430|NCT00725985|50655753|FG008|OLMP (Up to 96 Weeks)|Other|0|||
25339431|NCT00725985|50655754|FG009|OLMP (Up to 96 Weeks)|Other|0|||
25339432|NCT00725985|50655755|FG010|OLMP (Up to 96 Weeks)|Other|0|||
25339433|NCT00725985|50655756|FG011|OLMP (Up to 96 Weeks)|Other|0|||
25339434|NCT00725985|50655745|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
25339435|NCT00725985|50655746|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
25339436|NCT00725985|50655747|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
25339437|NCT00725985|50655748|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
25339438|NCT00725985|50655749|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
25339439|NCT00725985|50655750|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
25339440|NCT00725985|50655751|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
25339441|NCT00725985|50655752|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
25339442|NCT00725985|50655753|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
25339443|NCT00725985|50655754|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
25339444|NCT00725985|50655755|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
25339445|NCT00725985|50655756|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
25339446|NCT00725985|50655745|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
25339447|NCT00725985|50655746|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
25339448|NCT00725985|50655747|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
25339449|NCT00725985|50655748|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
25339450|NCT00725985|50655749|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
25339451|NCT00725985|50655750|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
25339452|NCT00725985|50655751|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
25339453|NCT00725985|50655752|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
25339454|NCT00725985|50655753|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
25339455|NCT00725985|50655754|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
25339456|NCT00725985|50655755|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
25339457|NCT00725985|50655756|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
25339458|NCT00725985|50655745|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
25339459|NCT00725985|50655746|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
25339460|NCT00725985|50655747|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
25339461|NCT00725985|50655748|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
25339462|NCT00725985|50655749|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
25339463|NCT00725985|50655750|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
25339464|NCT00725985|50655751|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
25339465|NCT00725985|50655752|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
25339466|NCT00725985|50655753|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
25339467|NCT00725985|50655754|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
25339468|NCT00725985|50655755|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
25339469|NCT00725985|50655756|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
25339470|NCT00725985|50655745|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
25339471|NCT00725985|50655746|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
25339472|NCT00725985|50655747|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
25339473|NCT00725985|50655748|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
25339474|NCT00725985|50655749|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
25339475|NCT00725985|50655750|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
25339476|NCT00725985|50655751|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
25339477|NCT00725985|50655752|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
25339478|NCT00725985|50655753|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
25254576|NCT01350999|50570235|FG002|Overall Study|Voluntary withdrawal|6|||
25254577|NCT01350999|50570233|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
25254578|NCT01350999|50570234|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
25254579|NCT01350999|50570235|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
25254580|NCT01330914|50570254|FG000|Overall Study|Withdrawal by Subject|4|||
25339479|NCT00725985|50655754|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
25339480|NCT00725985|50655755|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
25339481|NCT00725985|50655756|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
25254581|NCT01330914|50570254|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
25254582|NCT01350804|50570262|FG000|Core Study|Withdrawal by Subject|11|||
24903564|NCT02598960|49997298|FG003|Treatment Period|participant withdrew consent|0|||
24903565|NCT02598960|49997299|FG004|Treatment Period|participant withdrew consent|0|||
24903566|NCT02598960|49997300|FG005|Treatment Period|participant withdrew consent|0|||
24903567|NCT02598960|49997301|FG006|Treatment Period|participant withdrew consent|0|||
24903568|NCT02598960|49997302|FG007|Treatment Period|participant withdrew consent|0|||
24903569|NCT02598960|49997303|FG008|Treatment Period|participant withdrew consent|0|||
24977470|NCT03814590|50066047|FG001|Overall Study|Adverse Event|0|||
24977471|NCT03814590|50066048|FG002|Overall Study|Adverse Event|0|||
24977472|NCT03814590|50066049|FG003|Overall Study|Adverse Event|0|||
24977473|NCT03814590|50066050|FG004|Overall Study|Adverse Event|0|||
24977474|NCT03814590|50066051|FG005|Overall Study|Adverse Event|1|||
24977475|NCT03814590|50066052|FG006|Overall Study|Adverse Event|1|||
25339482|NCT00793910|50655784|FG000|Overall Study|discarded study pills|0|||
25339483|NCT00793910|50655785|FG001|Overall Study|discarded study pills|1|||
25339484|NCT00793910|50655784|FG000|Overall Study|did not pick up medications|1|||
25339485|NCT00793910|50655785|FG001|Overall Study|did not pick up medications|1|||
25339486|NCT00793910|50655784|FG000|Overall Study|ineligible based on entry criteria|2|||
25339487|NCT00793910|50655785|FG001|Overall Study|ineligible based on entry criteria|3|||
25339488|NCT00793910|50655784|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
25339489|NCT00793910|50655785|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
25339490|NCT00793910|50655784|FG000|Overall Study|Withdrawal by Subject|0|||
25339491|NCT00793910|50655785|FG001|Overall Study|Withdrawal by Subject|1|||
25339492|NCT00444145|50655791|FG000|Overall Study|Withdrawal by Subject|2|||
25339493|NCT00444145|50655791|FG000|Overall Study|Lost to Follow-up|1|||
25339494|NCT00444145|50655791|FG000|Overall Study|non-compliant|11|||
25339495|NCT00444145|50655791|FG000|Overall Study|Screen Failures|5|||
25339496|NCT00725283|50655795|FG000|Overall Study|Missing Code|3|||
25339497|NCT00725283|50655795|FG000|Overall Study|Death|5|||
25339498|NCT00725283|50655795|FG000|Overall Study|Other|6|||
25339499|NCT00725283|50655795|FG000|Overall Study|Withdrawal by Subject|10|||
25339500|NCT00444067|50655801|FG000|Overall Study|Lost to Follow-up|0|||
25339501|NCT00444067|50655802|FG001|Overall Study|Lost to Follow-up|1|||
25339502|NCT00789854|50655811|FG000|Overall Study|Adverse Event|28|||
25339503|NCT00789854|50655812|FG001|Overall Study|Adverse Event|23|||
25339504|NCT00789854|50655813|FG002|Overall Study|Adverse Event|18|||
25339505|NCT00789854|50655811|FG000|Overall Study|Lost to Follow-up|1|||
25339506|NCT00789854|50655812|FG001|Overall Study|Lost to Follow-up|1|||
25339507|NCT00789854|50655813|FG002|Overall Study|Lost to Follow-up|4|||
25339508|NCT00789854|50655811|FG000|Overall Study|Withdrawal by Subject|9|||
25339509|NCT00789854|50655812|FG001|Overall Study|Withdrawal by Subject|6|||
25339510|NCT00789854|50655813|FG002|Overall Study|Withdrawal by Subject|17|||
25339511|NCT00789854|50655811|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
25339512|NCT00789854|50655812|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
25339513|NCT00789854|50655813|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
25339514|NCT00789854|50655811|FG000|Overall Study|Severe non-compliance to the protocol|3|||
25339515|NCT00789854|50655812|FG001|Overall Study|Severe non-compliance to the protocol|0|||
25339516|NCT00789854|50655813|FG002|Overall Study|Severe non-compliance to the protocol|0|||
25339517|NCT00789854|50655811|FG000|Overall Study|Safety reasons|0|||
25339518|NCT00789854|50655812|FG001|Overall Study|Safety reasons|0|||
25339519|NCT00789854|50655813|FG002|Overall Study|Safety reasons|2|||
25339520|NCT00789854|50655811|FG000|Overall Study|Other|6|||
25339521|NCT00789854|50655812|FG001|Overall Study|Other|0|||
25339522|NCT00789854|50655813|FG002|Overall Study|Other|5|||
25339523|NCT00725205|50655821|FG000|Overall Study|Adverse Event|22|||
25339524|NCT00725205|50655821|FG000|Overall Study|Investigator Discontinued|1|||
25339525|NCT00725205|50655821|FG000|Overall Study|Non-compliance With Protocol|14|||
25339526|NCT00725205|50655821|FG000|Overall Study|Other|8|||
25339527|NCT00725205|50655821|FG000|Overall Study|Protocol Defined Clinical Event|1|||
25339528|NCT00725205|50655821|FG000|Overall Study|Treatment Failure|41|||
25339529|NCT00443755|50655827|FG000|Overall Study|Withdrawal by Subject|2|||
25339530|NCT00443755|50655828|FG001|Overall Study|Withdrawal by Subject|1|||
25339531|NCT00724971|50655834|FG000|Overall Study|Adverse Event|5|||
25339532|NCT00724971|50655834|FG000|Overall Study|Withdrawal by Subject|1|||
25339533|NCT00443599|50655840|FG000|Overall Study|Physician Decision|2|||
25339534|NCT00443599|50655841|FG001|Overall Study|Physician Decision|1|||
25339535|NCT00443599|50655840|FG000|Overall Study|Death|1|||
25339536|NCT00443599|50655841|FG001|Overall Study|Death|1|||
25339537|NCT00443599|50655840|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
25339538|NCT00443599|50655841|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
25339539|NCT00455143|50655847|FG000|Overall Study|Physician Decision|1|||
25339540|NCT00455143|50655847|FG000|Overall Study|Withdrawal by Subject|1|||
25339541|NCT00455143|50655847|FG000|Overall Study|Staff was not avail to follow patient|2|||
25339542|NCT00455143|50655847|FG000|Overall Study|No longer met Inclusion Criteria|1|||
25339543|NCT00455143|50655847|FG000|Overall Study|Surgical time, staff not available|1|||
24903570|NCT02598960|49997304|FG009|Treatment Period|participant withdrew consent|0|||
24903571|NCT02598960|49997305|FG010|Treatment Period|participant withdrew consent|0|||
25339544|NCT00454987|50655855|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
25339545|NCT00454987|50655856|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
25339546|NCT00454987|50655857|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
25339547|NCT00454987|50655855|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
25339548|NCT00454987|50655856|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
25339549|NCT00454987|50655857|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
25339550|NCT00454987|50655855|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
25339551|NCT00454987|50655856|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
25339552|NCT00454987|50655857|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
25339553|NCT00724893|50655868|FG000|Overall Study|Adverse Event|76|||
25339554|NCT00724893|50655869|FG001|Overall Study|Adverse Event|142|||
25339555|NCT00724893|50655868|FG000|Overall Study|Withdrawal by Subject|0|||
25339556|NCT00724893|50655869|FG001|Overall Study|Withdrawal by Subject|1|||
25339557|NCT00724893|50655868|FG000|Overall Study|Lack of virologic response|94|||
25339558|NCT00724893|50655869|FG001|Overall Study|Lack of virologic response|202|||
25339559|NCT00724893|50655868|FG000|Overall Study|Reason not specified|193|||
25339560|NCT00724893|50655869|FG001|Overall Study|Reason not specified|7|||
25339561|NCT00724893|50655868|FG000|Overall Study|Patient choice|0|||
25339562|NCT00724893|50655869|FG001|Overall Study|Patient choice|26|||
25339563|NCT00724893|50655868|FG000|Overall Study|Geographic reasons|0|||
25339564|NCT00724893|50655869|FG001|Overall Study|Geographic reasons|11|||
25339565|NCT00724893|50655868|FG000|Overall Study|Incarceration|0|||
25339566|NCT00724893|50655869|FG001|Overall Study|Incarceration|9|||
25339567|NCT00724893|50655868|FG000|Overall Study|Substance abuse|0|||
25339568|NCT00724893|50655869|FG001|Overall Study|Substance abuse|3|||
25339569|NCT00724893|50655868|FG000|Overall Study|Financial reasons|0|||
25339570|NCT00724893|50655869|FG001|Overall Study|Financial reasons|2|||
25339571|NCT00724893|50655868|FG000|Overall Study|Assigned shorter treatment|0|||
25339572|NCT00724893|50655869|FG001|Overall Study|Assigned shorter treatment|2|||
25339573|NCT00724893|50655868|FG000|Overall Study|Lost to Follow-up|0|||
25339574|NCT00724893|50655869|FG001|Overall Study|Lost to Follow-up|52|||
25339575|NCT00724893|50655868|FG000|Overall Study|Unknown, missing data|1|||
25339576|NCT00724893|50655869|FG001|Overall Study|Unknown, missing data|1|||
25339577|NCT00789698|50655894|FG000|Overall Study|Lack of Efficacy|10|||
25339578|NCT00789698|50655895|FG001|Overall Study|Lack of Efficacy|4|||
25339579|NCT00789698|50655896|FG002|Overall Study|Lack of Efficacy|5|||
25339580|NCT00789698|50655897|FG003|Overall Study|Lack of Efficacy|18|||
25339581|NCT00789698|50655894|FG000|Overall Study|Adverse Event|5|||
25339582|NCT00789698|50655895|FG001|Overall Study|Adverse Event|5|||
25339583|NCT00789698|50655896|FG002|Overall Study|Adverse Event|3|||
25339584|NCT00789698|50655897|FG003|Overall Study|Adverse Event|4|||
25339585|NCT00789698|50655894|FG000|Overall Study|Lost to Follow-up|5|||
25339586|NCT00789698|50655895|FG001|Overall Study|Lost to Follow-up|5|||
25339587|NCT00789698|50655896|FG002|Overall Study|Lost to Follow-up|2|||
25339588|NCT00789698|50655897|FG003|Overall Study|Lost to Follow-up|9|||
25339589|NCT00789698|50655894|FG000|Overall Study|Protocol Violation|6|||
25339590|NCT00789698|50655895|FG001|Overall Study|Protocol Violation|1|||
25339591|NCT00789698|50655896|FG002|Overall Study|Protocol Violation|2|||
25339592|NCT00789698|50655897|FG003|Overall Study|Protocol Violation|1|||
25339593|NCT00789698|50655894|FG000|Overall Study|Withdrawal by Subject|14|||
25339594|NCT00789698|50655895|FG001|Overall Study|Withdrawal by Subject|15|||
25339595|NCT00789698|50655896|FG002|Overall Study|Withdrawal by Subject|12|||
25339596|NCT00789698|50655897|FG003|Overall Study|Withdrawal by Subject|19|||
25339597|NCT00789698|50655894|FG000|Overall Study|Administrative|0|||
25339598|NCT00789698|50655895|FG001|Overall Study|Administrative|3|||
25339599|NCT00789698|50655896|FG002|Overall Study|Administrative|3|||
25339600|NCT00789698|50655897|FG003|Overall Study|Administrative|1|||
24903572|NCT02598960|49997306|FG011|Treatment Period|participant withdrew consent|3|||
25254583|NCT01350804|50570263|FG001|Core Study|Withdrawal by Subject|17|||
25254584|NCT01350804|50570264|FG002|Core Study|Withdrawal by Subject|16|||
25254585|NCT01350804|50570265|FG003|Core Study|Withdrawal by Subject|7|||
25254586|NCT01350804|50570262|FG000|Core Study|Study terminated by Sponsor|0|||
25254587|NCT01350804|50570263|FG001|Core Study|Study terminated by Sponsor|0|||
25254588|NCT01350804|50570264|FG002|Core Study|Study terminated by Sponsor|0|||
25254589|NCT01350804|50570265|FG003|Core Study|Study terminated by Sponsor|2|||
24903573|NCT02598960|49997307|FG012|Treatment Period|participant withdrew consent|0|||
25339601|NCT00724815|50655908|FG000|Overall Study|Randomized, not treated|31|||
25339602|NCT00724815|50655909|FG001|Overall Study|Randomized, not treated|30|||
25339603|NCT00724815|50655908|FG000|Overall Study|Adverse Event|5|||
25339604|NCT00724815|50655909|FG001|Overall Study|Adverse Event|3|||
25339605|NCT00724815|50655908|FG000|Overall Study|Lost to Follow-up|4|||
25254590|NCT01350804|50570262|FG000|Core Study|Protocol deviation|1|||
25254591|NCT01350804|50570263|FG001|Core Study|Protocol deviation|0|||
25339606|NCT00724815|50655909|FG001|Overall Study|Lost to Follow-up|1|||
25339607|NCT00724815|50655908|FG000|Overall Study|Other Various|3|||
25339608|NCT00724815|50655909|FG001|Overall Study|Other Various|5|||
25339609|NCT00454909|50655918|FG000|Overall Study|Withdrawal by Subject|1|||
25339610|NCT00454909|50655919|FG001|Overall Study|Withdrawal by Subject|0|||
25339611|NCT00454909|50655920|FG002|Overall Study|Withdrawal by Subject|0|||
25339612|NCT00454909|50655918|FG000|Overall Study|Migrated/moved from study area|0|||
25339613|NCT00454909|50655919|FG001|Overall Study|Migrated/moved from study area|0|||
25339614|NCT00454909|50655920|FG002|Overall Study|Migrated/moved from study area|1|||
25339615|NCT00454909|50655918|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
25339616|NCT00454909|50655919|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
25339617|NCT00454909|50655920|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
25339618|NCT00454909|50655918|FG000|Overall Study|Others|1|||
25339619|NCT00454909|50655919|FG001|Overall Study|Others|0|||
25339620|NCT00454909|50655920|FG002|Overall Study|Others|0|||
25339621|NCT00798590|50655931|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
25339622|NCT00798590|50655932|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
25339623|NCT00481195|50655940|FG000|Overall Study|Adverse Event|16|||
25339624|NCT00481195|50655941|FG001|Overall Study|Adverse Event|11|||
25339625|NCT00481195|50655940|FG000|Overall Study|Lack of Efficacy|1|||
25339626|NCT00481195|50655941|FG001|Overall Study|Lack of Efficacy|3|||
25339627|NCT00481195|50655940|FG000|Overall Study|Lost to Follow-up|4|||
25339628|NCT00481195|50655941|FG001|Overall Study|Lost to Follow-up|6|||
25339629|NCT00481195|50655940|FG000|Overall Study|Physician Decision|3|||
25339630|NCT00481195|50655941|FG001|Overall Study|Physician Decision|1|||
25339631|NCT00481195|50655940|FG000|Overall Study|Protocol Violation|10|||
25339632|NCT00481195|50655941|FG001|Overall Study|Protocol Violation|7|||
25339633|NCT00481195|50655940|FG000|Overall Study|Withdrawal by Subject|3|||
25339634|NCT00481195|50655941|FG001|Overall Study|Withdrawal by Subject|9|||
25339635|NCT00481195|50655940|FG000|Overall Study|Miscellaneous|2|||
25339636|NCT00481195|50655941|FG001|Overall Study|Miscellaneous|2|||
25339637|NCT00454363|50655958|FG000|Overall Study|Adverse Event|1|||
25339638|NCT00454363|50655959|FG001|Overall Study|Adverse Event|2|||
25339639|NCT00454363|50655958|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
25339640|NCT00454363|50655959|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
25339641|NCT00454207|50655966|FG000|Overall Study|Adverse Event|3|||
25339642|NCT00454207|50655967|FG001|Overall Study|Adverse Event|1|||
25339643|NCT00454207|50655966|FG000|Overall Study|Lack of Efficacy|1|||
25339644|NCT00454207|50655967|FG001|Overall Study|Lack of Efficacy|0|||
25339645|NCT00454207|50655966|FG000|Overall Study|Protocol Violation|0|||
25339646|NCT00454207|50655967|FG001|Overall Study|Protocol Violation|1|||
25339647|NCT00738894|50655987|FG000|Overall Study|Lost to Follow-up|23|||
25339648|NCT00738894|50655988|FG001|Overall Study|Lost to Follow-up|13|||
25339649|NCT00738894|50655987|FG000|Overall Study|Withdrawal by Subject|10|||
25339650|NCT00738894|50655988|FG001|Overall Study|Withdrawal by Subject|15|||
25339651|NCT00738894|50655987|FG000|Overall Study|Physician Decision|4|||
25339652|NCT00738894|50655988|FG001|Overall Study|Physician Decision|5|||
25339653|NCT00738894|50655987|FG000|Overall Study|Death|2|||
25339654|NCT00738894|50655988|FG001|Overall Study|Death|0|||
25339655|NCT00480493|50655996|FG000|Overall Study|moved|2|||
25339656|NCT00480493|50655997|FG001|Overall Study|moved|7|||
25339657|NCT00734994|50656005|FG000|Overall Study|Withdrawal by Subject|1|||
25339658|NCT00798434|50656012|FG000|Double-Blind|Adverse Event|22|||
25339659|NCT00798434|50656013|FG001|Double-Blind|Adverse Event|46|||
25339660|NCT00798434|50656012|FG000|Double-Blind|Death|0|||
25339661|NCT00798434|50656013|FG001|Double-Blind|Death|1|||
25339662|NCT00798434|50656012|FG000|Double-Blind|Lost to Follow-up|1|||
25339663|NCT00798434|50656013|FG001|Double-Blind|Lost to Follow-up|0|||
25339664|NCT00798434|50656012|FG000|Double-Blind|Lack of Efficacy|8|||
25339665|NCT00798434|50656013|FG001|Double-Blind|Lack of Efficacy|12|||
25339666|NCT00798434|50656012|FG000|Double-Blind|Withdrawal by Subject|17|||
25339667|NCT00798434|50656013|FG001|Double-Blind|Withdrawal by Subject|14|||
25339668|NCT00798434|50656012|FG000|Double-Blind|Protocol Violation|1|||
25339669|NCT00798434|50656013|FG001|Double-Blind|Protocol Violation|4|||
25339670|NCT00798434|50656012|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
25339671|NCT00798434|50656013|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
24903574|NCT02598960|49997295|FG000|Treatment Period|No longer meets study criteria|0|||
24903575|NCT02598960|49997296|FG001|Treatment Period|No longer meets study criteria|0|||
25339672|NCT00798434|50656012|FG000|Double-Blind|Other|1|||
25339673|NCT00798434|50656013|FG001|Double-Blind|Other|0|||
25339674|NCT00798434|50656012|FG000|Double-Blind|Not Treated|3|||
25339675|NCT00798434|50656013|FG001|Double-Blind|Not Treated|6|||
25339676|NCT00798434|50656012|FG000|Open-Label|Adverse Event|33|||
25339677|NCT00798434|50656013|FG001|Open-Label|Adverse Event|11|||
25339678|NCT00798434|50656012|FG000|Open-Label|Lack of Efficacy|5|||
25339679|NCT00798434|50656013|FG001|Open-Label|Lack of Efficacy|11|||
24903576|NCT02598960|49997297|FG002|Treatment Period|No longer meets study criteria|0|||
25339680|NCT00798434|50656012|FG000|Open-Label|Withdrawal by Subject|2|||
25339681|NCT00798434|50656013|FG001|Open-Label|Withdrawal by Subject|7|||
25339682|NCT00798434|50656012|FG000|Open-Label|Protocol Violation|1|||
24903577|NCT02598960|49997298|FG003|Treatment Period|No longer meets study criteria|0|||
25339683|NCT00798434|50656013|FG001|Open-Label|Protocol Violation|0|||
25339684|NCT00798434|50656012|FG000|Open-Label|Other|1|||
25339685|NCT00798434|50656013|FG001|Open-Label|Other|2|||
25339686|NCT00798434|50656012|FG000|Open-Label|Not Treated|0|||
25339687|NCT00798434|50656013|FG001|Open-Label|Not Treated|1|||
25339688|NCT00724503|50656026|FG000|Overall Study|Lost to Follow-up|4|||
25339689|NCT00724503|50656027|FG001|Overall Study|Lost to Follow-up|8|||
25339690|NCT00724503|50656026|FG000|Overall Study|Withdrawal by Subject|11|||
25339691|NCT00724503|50656027|FG001|Overall Study|Withdrawal by Subject|23|||
25339692|NCT00724503|50656026|FG000|Overall Study|Death|190|||
25339693|NCT00724503|50656027|FG001|Overall Study|Death|182|||
25339694|NCT00724503|50656026|FG000|Overall Study|Adverse Event|1|||
25339695|NCT00724503|50656027|FG001|Overall Study|Adverse Event|0|||
25339696|NCT00724503|50656026|FG000|Overall Study|Not otherwise specified|4|||
25339697|NCT00724503|50656027|FG001|Overall Study|Not otherwise specified|7|||
25339698|NCT00791648|50656037|FG000|Overall Study|Physician Decision|0|||
25339699|NCT00791648|50656038|FG001|Overall Study|Physician Decision|1|||
25339700|NCT00791648|50656037|FG000|Overall Study|Withdrawal by Subject|0|||
25339701|NCT00791648|50656038|FG001|Overall Study|Withdrawal by Subject|1|||
25339702|NCT00791492|50656046|FG000|Overall Study|Withdrawal by Subject|1|||
25339703|NCT00791492|50656047|FG001|Overall Study|Withdrawal by Subject|2|||
25339704|NCT00791492|50656046|FG000|Overall Study|Liver transplantation|5|||
25339705|NCT00791492|50656047|FG001|Overall Study|Liver transplantation|1|||
25339706|NCT00723957|50656055|FG000|Overall Study|Adverse event unrelated to study drug|1|||
25339707|NCT00723957|50656056|FG001|Overall Study|Adverse event unrelated to study drug|4|||
25339708|NCT00723957|50656055|FG000|Overall Study|Death|3|||
25339709|NCT00723957|50656056|FG001|Overall Study|Death|4|||
25339710|NCT00723957|50656055|FG000|Overall Study|Disease progression|27|||
25339711|NCT00723957|50656056|FG001|Overall Study|Disease progression|25|||
25339712|NCT00723957|50656055|FG000|Overall Study|Maximum clinical benefit|4|||
25339713|NCT00723957|50656056|FG001|Overall Study|Maximum clinical benefit|5|||
25339714|NCT00723957|50656055|FG000|Overall Study|Investigator decision|1|||
25339715|NCT00723957|50656056|FG001|Overall Study|Investigator decision|1|||
25339716|NCT00723957|50656055|FG000|Overall Study|Study drug toxicity|4|||
25339717|NCT00723957|50656056|FG001|Overall Study|Study drug toxicity|6|||
25339718|NCT00723957|50656055|FG000|Overall Study|Withdrawal by Subject|7|||
25339719|NCT00723957|50656056|FG001|Overall Study|Withdrawal by Subject|5|||
25339720|NCT00723957|50656055|FG000|Overall Study|Reason not analyzed|1|||
25339721|NCT00723957|50656056|FG001|Overall Study|Reason not analyzed|0|||
25339722|NCT00723957|50656055|FG000|Overall Study|Never received treatment|3|||
25339723|NCT00723957|50656056|FG001|Overall Study|Never received treatment|3|||
25339724|NCT00723801|50656064|FG000|Overall Study|Lost to Follow-up|1|||
25339725|NCT00723801|50656065|FG001|Overall Study|Lost to Follow-up|2|||
25339726|NCT00723801|50656064|FG000|Overall Study|Protocol Violation|2|||
25339727|NCT00723801|50656065|FG001|Overall Study|Protocol Violation|1|||
25339728|NCT00797966|50656075|FG000|Phase A|Lost to Follow-up|0|||
25339729|NCT00797966|50656076|FG001|Phase A|Lost to Follow-up|0|||
25339730|NCT00797966|50656077|FG002|Phase A|Lost to Follow-up|0|||
25339731|NCT00797966|50656078|FG003|Phase A|Lost to Follow-up|0|||
25339732|NCT00797966|50656079|FG004|Phase A|Lost to Follow-up|33|||
25339733|NCT00797966|50656080|FG005|Phase A|Lost to Follow-up|0|||
25339734|NCT00797966|50656075|FG000|Phase A|Adverse Event|0|||
25339735|NCT00797966|50656076|FG001|Phase A|Adverse Event|0|||
25339736|NCT00797966|50656077|FG002|Phase A|Adverse Event|0|||
25339737|NCT00797966|50656078|FG003|Phase A|Adverse Event|0|||
25339738|NCT00797966|50656079|FG004|Phase A|Adverse Event|46|||
25339739|NCT00797966|50656080|FG005|Phase A|Adverse Event|0|||
25339740|NCT00797966|50656075|FG000|Phase A|Met withdrawal criteria|0|||
25339741|NCT00797966|50656076|FG001|Phase A|Met withdrawal criteria|0|||
25339742|NCT00797966|50656077|FG002|Phase A|Met withdrawal criteria|0|||
25339743|NCT00797966|50656078|FG003|Phase A|Met withdrawal criteria|0|||
25339744|NCT00797966|50656079|FG004|Phase A|Met withdrawal criteria|4|||
25339745|NCT00797966|50656080|FG005|Phase A|Met withdrawal criteria|0|||
25339746|NCT00797966|50656075|FG000|Phase A|Physician Decision|0|||
25339747|NCT00797966|50656076|FG001|Phase A|Physician Decision|0|||
25339748|NCT00797966|50656077|FG002|Phase A|Physician Decision|0|||
25339749|NCT00797966|50656078|FG003|Phase A|Physician Decision|0|||
25339750|NCT00797966|50656079|FG004|Phase A|Physician Decision|13|||
25339751|NCT00797966|50656080|FG005|Phase A|Physician Decision|0|||
25339752|NCT00797966|50656075|FG000|Phase A|Withdrawal by Subject|0|||
25339753|NCT00797966|50656076|FG001|Phase A|Withdrawal by Subject|0|||
25339754|NCT00797966|50656077|FG002|Phase A|Withdrawal by Subject|0|||
25339755|NCT00797966|50656078|FG003|Phase A|Withdrawal by Subject|0|||
25339756|NCT00797966|50656079|FG004|Phase A|Withdrawal by Subject|33|||
25339757|NCT00797966|50656080|FG005|Phase A|Withdrawal by Subject|0|||
25339758|NCT00797966|50656075|FG000|Phase A|Protocol deviation|0|||
25339759|NCT00797966|50656076|FG001|Phase A|Protocol deviation|0|||
25339760|NCT00797966|50656077|FG002|Phase A|Protocol deviation|0|||
25339761|NCT00797966|50656078|FG003|Phase A|Protocol deviation|0|||
25339762|NCT00797966|50656079|FG004|Phase A|Protocol deviation|56|||
25339763|NCT00797966|50656080|FG005|Phase A|Protocol deviation|0|||
25339764|NCT00797966|50656075|FG000|Phase B|Lost to Follow-up|0|||
25339765|NCT00797966|50656076|FG001|Phase B|Lost to Follow-up|1|||
25339766|NCT00797966|50656077|FG002|Phase B|Lost to Follow-up|3|||
25339767|NCT00797966|50656078|FG003|Phase B|Lost to Follow-up|0|||
25339768|NCT00797966|50656079|FG004|Phase B|Lost to Follow-up|0|||
25339769|NCT00797966|50656080|FG005|Phase B|Lost to Follow-up|0|||
25339770|NCT00797966|50656075|FG000|Phase B|Adverse Event|2|||
25339771|NCT00797966|50656076|FG001|Phase B|Adverse Event|1|||
25339772|NCT00797966|50656077|FG002|Phase B|Adverse Event|3|||
25339773|NCT00797966|50656078|FG003|Phase B|Adverse Event|1|||
25339774|NCT00797966|50656079|FG004|Phase B|Adverse Event|0|||
25339775|NCT00797966|50656080|FG005|Phase B|Adverse Event|0|||
25339776|NCT00797966|50656075|FG000|Phase B|Met Withdrawal Criteria|3|||
25339777|NCT00797966|50656076|FG001|Phase B|Met Withdrawal Criteria|3|||
25339778|NCT00797966|50656077|FG002|Phase B|Met Withdrawal Criteria|6|||
25339779|NCT00797966|50656078|FG003|Phase B|Met Withdrawal Criteria|1|||
25339780|NCT00797966|50656079|FG004|Phase B|Met Withdrawal Criteria|0|||
25339781|NCT00797966|50656080|FG005|Phase B|Met Withdrawal Criteria|0|||
25339782|NCT00797966|50656075|FG000|Phase B|Physician Decision|1|||
25339783|NCT00797966|50656076|FG001|Phase B|Physician Decision|0|||
25339784|NCT00797966|50656077|FG002|Phase B|Physician Decision|3|||
25339785|NCT00797966|50656078|FG003|Phase B|Physician Decision|1|||
25339786|NCT00797966|50656079|FG004|Phase B|Physician Decision|0|||
25339787|NCT00797966|50656080|FG005|Phase B|Physician Decision|0|||
25339788|NCT00797966|50656075|FG000|Phase B|Withdrawal by Subject|1|||
25339789|NCT00797966|50656076|FG001|Phase B|Withdrawal by Subject|4|||
25339790|NCT00797966|50656077|FG002|Phase B|Withdrawal by Subject|3|||
25339791|NCT00797966|50656078|FG003|Phase B|Withdrawal by Subject|3|||
25339792|NCT00797966|50656079|FG004|Phase B|Withdrawal by Subject|0|||
25339793|NCT00797966|50656080|FG005|Phase B|Withdrawal by Subject|0|||
25339794|NCT00797966|50656075|FG000|Phase B|Protocol Deviation|4|||
25339795|NCT00797966|50656076|FG001|Phase B|Protocol Deviation|8|||
25339796|NCT00797966|50656077|FG002|Phase B|Protocol Deviation|2|||
25339797|NCT00797966|50656078|FG003|Phase B|Protocol Deviation|6|||
25339798|NCT00797966|50656079|FG004|Phase B|Protocol Deviation|0|||
25339799|NCT00797966|50656080|FG005|Phase B|Protocol Deviation|0|||
25339800|NCT00797966|50656075|FG000|Phase B|Lack of Efficacy|0|||
25339801|NCT00797966|50656076|FG001|Phase B|Lack of Efficacy|1|||
25339802|NCT00797966|50656077|FG002|Phase B|Lack of Efficacy|1|||
25339803|NCT00797966|50656078|FG003|Phase B|Lack of Efficacy|4|||
25339804|NCT00797966|50656079|FG004|Phase B|Lack of Efficacy|0|||
25339805|NCT00797966|50656080|FG005|Phase B|Lack of Efficacy|0|||
25339806|NCT00797966|50656075|FG000|Phase A+|Lost to Follow-up|0|||
25339807|NCT00797966|50656076|FG001|Phase A+|Lost to Follow-up|0|||
25339808|NCT00797966|50656077|FG002|Phase A+|Lost to Follow-up|0|||
25339809|NCT00797966|50656078|FG003|Phase A+|Lost to Follow-up|0|||
25339810|NCT00797966|50656079|FG004|Phase A+|Lost to Follow-up|0|||
25339811|NCT00797966|50656080|FG005|Phase A+|Lost to Follow-up|9|||
25339812|NCT00797966|50656075|FG000|Phase A+|Met withdrawal criteria|0|||
25339813|NCT00797966|50656076|FG001|Phase A+|Met withdrawal criteria|0|||
25339814|NCT00797966|50656077|FG002|Phase A+|Met withdrawal criteria|0|||
25339815|NCT00797966|50656078|FG003|Phase A+|Met withdrawal criteria|0|||
25339816|NCT00797966|50656079|FG004|Phase A+|Met withdrawal criteria|0|||
25339817|NCT00797966|50656080|FG005|Phase A+|Met withdrawal criteria|5|||
25339818|NCT00797966|50656075|FG000|Phase A+|Withdrawal by Subject|0|||
25339819|NCT00797966|50656076|FG001|Phase A+|Withdrawal by Subject|0|||
25339820|NCT00797966|50656077|FG002|Phase A+|Withdrawal by Subject|0|||
24903578|NCT02598960|49997299|FG004|Treatment Period|No longer meets study criteria|0|||
24903579|NCT02598960|49997300|FG005|Treatment Period|No longer meets study criteria|0|||
24903580|NCT02598960|49997301|FG006|Treatment Period|No longer meets study criteria|0|||
24903581|NCT02598960|49997302|FG007|Treatment Period|No longer meets study criteria|0|||
24903582|NCT02598960|49997303|FG008|Treatment Period|No longer meets study criteria|0|||
24903583|NCT02598960|49997304|FG009|Treatment Period|No longer meets study criteria|0|||
24977476|NCT03814590|50066053|FG007|Overall Study|Adverse Event|1|||
25254592|NCT01350804|50570264|FG002|Core Study|Protocol deviation|1|||
25254593|NCT01350804|50570265|FG003|Core Study|Protocol deviation|0|||
25254594|NCT01350804|50570262|FG000|Core Study|Physician Decision|1|||
25254595|NCT01350804|50570263|FG001|Core Study|Physician Decision|0|||
25254596|NCT01350804|50570264|FG002|Core Study|Physician Decision|1|||
25254597|NCT01350804|50570265|FG003|Core Study|Physician Decision|3|||
25254598|NCT01350804|50570262|FG000|Core Study|Lost to Follow-up|3|||
25254599|NCT01350804|50570263|FG001|Core Study|Lost to Follow-up|0|||
25254600|NCT01350804|50570264|FG002|Core Study|Lost to Follow-up|2|||
25254601|NCT01350804|50570265|FG003|Core Study|Lost to Follow-up|1|||
25254602|NCT01350804|50570262|FG000|Core Study|Lack of Efficacy|16|||
25254603|NCT01350804|50570263|FG001|Core Study|Lack of Efficacy|19|||
25254604|NCT01350804|50570264|FG002|Core Study|Lack of Efficacy|18|||
25339821|NCT00797966|50656078|FG003|Phase A+|Withdrawal by Subject|0|||
25339822|NCT00797966|50656079|FG004|Phase A+|Withdrawal by Subject|0|||
25339823|NCT00797966|50656080|FG005|Phase A+|Withdrawal by Subject|6|||
25339824|NCT00797966|50656075|FG000|Phase A+|Adverse Event|0|||
25339825|NCT00797966|50656076|FG001|Phase A+|Adverse Event|0|||
25339826|NCT00797966|50656077|FG002|Phase A+|Adverse Event|0|||
25339827|NCT00797966|50656078|FG003|Phase A+|Adverse Event|0|||
24903584|NCT02598960|49997305|FG010|Treatment Period|No longer meets study criteria|0|||
24903585|NCT02598960|49997306|FG011|Treatment Period|No longer meets study criteria|1|||
24903586|NCT02598960|49997307|FG012|Treatment Period|No longer meets study criteria|0|||
24903587|NCT02598960|49997295|FG000|Treatment Period|Other Reasons|0|||
24903588|NCT02598960|49997296|FG001|Treatment Period|Other Reasons|0|||
24903589|NCT02598960|49997297|FG002|Treatment Period|Other Reasons|0|||
24903590|NCT02598960|49997298|FG003|Treatment Period|Other Reasons|0|||
24903591|NCT02598960|49997299|FG004|Treatment Period|Other Reasons|0|||
24903592|NCT02598960|49997300|FG005|Treatment Period|Other Reasons|0|||
24903593|NCT02598960|49997301|FG006|Treatment Period|Other Reasons|0|||
24903594|NCT02598960|49997302|FG007|Treatment Period|Other Reasons|0|||
24903595|NCT02598960|49997303|FG008|Treatment Period|Other Reasons|0|||
24903596|NCT02598960|49997304|FG009|Treatment Period|Other Reasons|0|||
24903597|NCT02598960|49997305|FG010|Treatment Period|Other Reasons|0|||
24903598|NCT02598960|49997306|FG011|Treatment Period|Other Reasons|0|||
24903599|NCT02598960|49997307|FG012|Treatment Period|Other Reasons|1|||
24903600|NCT02598960|49997295|FG000|Participants Entering Follow Up Period|Death|1|||
24903601|NCT02598960|49997296|FG001|Participants Entering Follow Up Period|Death|0|||
24903602|NCT02598960|49997297|FG002|Participants Entering Follow Up Period|Death|0|||
24903603|NCT02598960|49997298|FG003|Participants Entering Follow Up Period|Death|0|||
24903604|NCT02598960|49997299|FG004|Participants Entering Follow Up Period|Death|0|||
24903605|NCT02598960|49997300|FG005|Participants Entering Follow Up Period|Death|0|||
24903606|NCT02598960|49997301|FG006|Participants Entering Follow Up Period|Death|0|||
24903607|NCT02598960|49997302|FG007|Participants Entering Follow Up Period|Death|0|||
24903608|NCT02598960|49997303|FG008|Participants Entering Follow Up Period|Death|0|||
24903609|NCT02598960|49997304|FG009|Participants Entering Follow Up Period|Death|1|||
24903610|NCT02598960|49997305|FG010|Participants Entering Follow Up Period|Death|0|||
24903611|NCT02598960|49997306|FG011|Participants Entering Follow Up Period|Death|11|||
24903612|NCT02598960|49997307|FG012|Participants Entering Follow Up Period|Death|2|||
24903613|NCT02598960|49997295|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
24903614|NCT02598960|49997296|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
24903615|NCT02598960|49997297|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
24903616|NCT02598960|49997298|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
24903617|NCT02598960|49997299|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
24903618|NCT02598960|49997300|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
24903619|NCT02598960|49997301|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
24903620|NCT02598960|49997302|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
24977477|NCT03814590|50066054|FG008|Overall Study|Adverse Event|0|||
24977478|NCT03814590|50066055|FG009|Overall Study|Adverse Event|0|||
24977479|NCT03814590|50066056|FG010|Overall Study|Adverse Event|1|||
24977480|NCT03814590|50066057|FG011|Overall Study|Adverse Event|0|||
24977481|NCT03814590|50066058|FG012|Overall Study|Adverse Event|3|||
24977482|NCT03814590|50066059|FG013|Overall Study|Adverse Event|0|||
24977483|NCT03814590|50066046|FG000|Overall Study|Lost to Follow-up|0|||
24977484|NCT03814590|50066047|FG001|Overall Study|Lost to Follow-up|2|||
24977485|NCT03814590|50066048|FG002|Overall Study|Lost to Follow-up|1|||
24977486|NCT03814590|50066049|FG003|Overall Study|Lost to Follow-up|0|||
24977487|NCT03814590|50066050|FG004|Overall Study|Lost to Follow-up|1|||
24977488|NCT03814590|50066051|FG005|Overall Study|Lost to Follow-up|1|||
24977489|NCT03814590|50066052|FG006|Overall Study|Lost to Follow-up|1|||
24977490|NCT03814590|50066053|FG007|Overall Study|Lost to Follow-up|1|||
24977491|NCT03814590|50066054|FG008|Overall Study|Lost to Follow-up|0|||
24977492|NCT03814590|50066055|FG009|Overall Study|Lost to Follow-up|0|||
24977493|NCT03814590|50066056|FG010|Overall Study|Lost to Follow-up|1|||
24977494|NCT03814590|50066057|FG011|Overall Study|Lost to Follow-up|0|||
24977495|NCT03814590|50066058|FG012|Overall Study|Lost to Follow-up|0|||
24977496|NCT03814590|50066059|FG013|Overall Study|Lost to Follow-up|1|||
24977497|NCT03814590|50066046|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
24977498|NCT03814590|50066047|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
24977499|NCT03814590|50066048|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
24977500|NCT03814590|50066049|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
24977501|NCT03814590|50066050|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
24977502|NCT03814590|50066051|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
24903621|NCT02598960|49997303|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
24977503|NCT03814590|50066052|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
24977504|NCT03814590|50066053|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
24903622|NCT02598960|49997304|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
24977505|NCT03814590|50066054|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
24977506|NCT03814590|50066055|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
24995119|NCT00047463|50085995|FG000|Overall Study|Withdrawal by Subject|0|||
24903623|NCT02598960|49997305|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
24903624|NCT02598960|49997306|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
24903625|NCT02598960|49997307|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
24903626|NCT02598960|49997295|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
24903627|NCT02598960|49997296|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
24903628|NCT02598960|49997297|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
24903629|NCT02598960|49997298|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
24903630|NCT02598960|49997299|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
24903631|NCT02598960|49997300|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
24903632|NCT02598960|49997301|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
24903633|NCT02598960|49997302|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
24903634|NCT02598960|49997303|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
24903635|NCT02598960|49997304|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
24903636|NCT02598960|49997305|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
24903637|NCT02598960|49997306|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
24903638|NCT02598960|49997307|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
24903639|NCT02598960|49997295|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
24903640|NCT02598960|49997296|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
24903641|NCT02598960|49997297|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
24903642|NCT02598960|49997298|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
24903643|NCT02598960|49997299|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
24977507|NCT03814590|50066056|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
25339828|NCT00797966|50656079|FG004|Phase A+|Adverse Event|0|||
25339829|NCT00797966|50656080|FG005|Phase A+|Adverse Event|4|||
25339830|NCT00797966|50656075|FG000|Phase A+|Protocol deviation|0|||
25339831|NCT00797966|50656076|FG001|Phase A+|Protocol deviation|0|||
25339832|NCT00797966|50656077|FG002|Phase A+|Protocol deviation|0|||
25339833|NCT00797966|50656078|FG003|Phase A+|Protocol deviation|0|||
25339834|NCT00797966|50656079|FG004|Phase A+|Protocol deviation|0|||
25339835|NCT00797966|50656080|FG005|Phase A+|Protocol deviation|4|||
25339836|NCT00723489|50656096|FG000|Overall Study|Physician Decision|0|||
25339837|NCT00723489|50656097|FG001|Overall Study|Physician Decision|1|||
25339838|NCT00723489|50656098|FG002|Overall Study|Physician Decision|0|||
25339839|NCT00723489|50656099|FG003|Overall Study|Physician Decision|0|||
25339840|NCT00723489|50656096|FG000|Overall Study|Pregnancy|0|||
25339841|NCT00723489|50656097|FG001|Overall Study|Pregnancy|0|||
25339842|NCT00723489|50656098|FG002|Overall Study|Pregnancy|0|||
25339843|NCT00723489|50656099|FG003|Overall Study|Pregnancy|1|||
25339844|NCT00723489|50656096|FG000|Overall Study|Withdrawal by Subject|0|||
25339845|NCT00723489|50656097|FG001|Overall Study|Withdrawal by Subject|0|||
25339846|NCT00723489|50656098|FG002|Overall Study|Withdrawal by Subject|0|||
25339847|NCT00723489|50656099|FG003|Overall Study|Withdrawal by Subject|1|||
25339848|NCT00723489|50656096|FG000|Overall Study|Seropositive at baseline|1|||
25339849|NCT00723489|50656097|FG001|Overall Study|Seropositive at baseline|0|||
25339850|NCT00723489|50656098|FG002|Overall Study|Seropositive at baseline|0|||
25339851|NCT00723489|50656099|FG003|Overall Study|Seropositive at baseline|0|||
25339852|NCT00723489|50656096|FG000|Overall Study|Prohibited Medication|0|||
25339853|NCT00723489|50656097|FG001|Overall Study|Prohibited Medication|0|||
25339854|NCT00723489|50656098|FG002|Overall Study|Prohibited Medication|0|||
25339855|NCT00723489|50656099|FG003|Overall Study|Prohibited Medication|1|||
25339856|NCT00723489|50656096|FG000|Overall Study|Samples Collected Out of Window|0|||
24977508|NCT03814590|50066057|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
24977509|NCT03814590|50066058|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
25254605|NCT01350804|50570265|FG003|Core Study|Lack of Efficacy|5|||
25254606|NCT01350804|50570262|FG000|Core Study|Death|1|||
25254607|NCT01350804|50570263|FG001|Core Study|Death|1|||
25254608|NCT01350804|50570264|FG002|Core Study|Death|1|||
25254609|NCT01350804|50570265|FG003|Core Study|Death|0|||
25254610|NCT01350804|50570262|FG000|Core Study|Adverse Event|8|||
25254611|NCT01350804|50570263|FG001|Core Study|Adverse Event|10|||
25254612|NCT01350804|50570264|FG002|Core Study|Adverse Event|8|||
25254613|NCT01350804|50570265|FG003|Core Study|Adverse Event|8|||
25254614|NCT01350804|50570262|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
25254615|NCT01350804|50570263|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
25254616|NCT01350804|50570264|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
25254617|NCT01350804|50570265|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
25254618|NCT01350804|50570262|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
25254619|NCT01350804|50570263|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
25254620|NCT01350804|50570264|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
25254621|NCT01350804|50570265|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
24903644|NCT02598960|49997300|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
24903645|NCT02598960|49997301|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
24903646|NCT02598960|49997302|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
24903647|NCT02598960|49997303|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
24903648|NCT02598960|49997304|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
24903649|NCT02598960|49997305|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
24903650|NCT02598960|49997306|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
24903651|NCT02598960|49997307|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
24903652|NCT02598960|49997295|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
24903653|NCT02598960|49997296|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
24903654|NCT02598960|49997297|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
24903655|NCT02598960|49997298|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
24903656|NCT02598960|49997299|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
24903657|NCT02598960|49997300|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
24903658|NCT02598960|49997301|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
24903659|NCT02598960|49997302|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
24903660|NCT02598960|49997303|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
24977510|NCT03814590|50066059|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
24977511|NCT03814590|50066046|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
25339857|NCT00723489|50656097|FG001|Overall Study|Samples Collected Out of Window|3|||
25339858|NCT00723489|50656098|FG002|Overall Study|Samples Collected Out of Window|0|||
25339859|NCT00723489|50656099|FG003|Overall Study|Samples Collected Out of Window|0|||
25339860|NCT00587990|50656112|FG000|Overall Study|Death|0|||
25339861|NCT00587990|50656113|FG001|Overall Study|Death|0|||
25339862|NCT00587990|50656114|FG002|Overall Study|Death|1|||
25339863|NCT00723255|50656122|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
25339864|NCT00723255|50656122|FG000|Overall Study|Ineligible: Second primary|1|||
25339865|NCT00723255|50656122|FG000|Overall Study|Ineligible: Wrong Primary|2|||
25339866|NCT00791258|50656138|FG000|Overall Study|Adverse Event|87|||
25339867|NCT00791258|50656138|FG000|Overall Study|Lost to Follow-up|18|||
25339868|NCT00791258|50656138|FG000|Overall Study|Protocol Violation|109|||
25339869|NCT00791258|50656138|FG000|Overall Study|Withdrawal by Subject|40|||
25339870|NCT00791258|50656138|FG000|Overall Study|Did not take medication for >3 days|1|||
25339871|NCT00791258|50656138|FG000|Overall Study|subject left area|2|||
25339872|NCT00791258|50656138|FG000|Overall Study|non-compliance|3|||
25339873|NCT00791258|50656138|FG000|Overall Study|Subject incarcerated|1|||
25339874|NCT00791258|50656138|FG000|Overall Study|Subject required restricted medication|1|||
25339875|NCT00791258|50656138|FG000|Overall Study|Lack of Efficacy|1|||
25339876|NCT00808067|50656144|FG000|Overall Study|Major/minor bleed|30|||
25339877|NCT00808067|50656145|FG001|Overall Study|Major/minor bleed|44|||
25339878|NCT00808067|50656144|FG000|Overall Study|Outcome event - other|33|||
25339879|NCT00808067|50656145|FG001|Overall Study|Outcome event - other|25|||
25339880|NCT00808067|50656144|FG000|Overall Study|Adverse Event|111|||
25339881|NCT00808067|50656145|FG001|Overall Study|Adverse Event|121|||
25339882|NCT00808067|50656144|FG000|Overall Study|Hospitalization (not including surgery)|18|||
25339883|NCT00808067|50656145|FG001|Overall Study|Hospitalization (not including surgery)|17|||
25339884|NCT00808067|50656144|FG000|Overall Study|Hospitalization due to surgery|37|||
25339885|NCT00808067|50656145|FG001|Overall Study|Hospitalization due to surgery|40|||
25339886|NCT00808067|50656144|FG000|Overall Study|Reduced creatinine clearance|53|||
25339887|NCT00808067|50656145|FG001|Overall Study|Reduced creatinine clearance|55|||
25339888|NCT00808067|50656144|FG000|Overall Study|Elevated LFT results|7|||
25339889|NCT00808067|50656145|FG001|Overall Study|Elevated LFT results|3|||
25339890|NCT00808067|50656144|FG000|Overall Study|Patient refused to take study medication|65|||
25339891|NCT00808067|50656145|FG001|Overall Study|Patient refused to take study medication|76|||
25339892|NCT00808067|50656144|FG000|Overall Study|Missing|1|||
25339893|NCT00808067|50656145|FG001|Overall Study|Missing|0|||
25339894|NCT00808067|50656144|FG000|Overall Study|Death|1|||
25339895|NCT00808067|50656145|FG001|Overall Study|Death|1|||
25339896|NCT00808067|50656144|FG000|Overall Study|Procedure|6|||
25339897|NCT00808067|50656145|FG001|Overall Study|Procedure|7|||
25339898|NCT00808067|50656144|FG000|Overall Study|Withdrawal by Subject|21|||
25339899|NCT00808067|50656145|FG001|Overall Study|Withdrawal by Subject|25|||
25339900|NCT00808067|50656144|FG000|Overall Study|Site closed|4|||
25339901|NCT00808067|50656145|FG001|Overall Study|Site closed|3|||
25339902|NCT00808067|50656144|FG000|Overall Study|Physician Decision|47|||
25339903|NCT00808067|50656145|FG001|Overall Study|Physician Decision|38|||
25339904|NCT00808067|50656144|FG000|Overall Study|Protocol Violation|3|||
25339905|NCT00808067|50656145|FG001|Overall Study|Protocol Violation|11|||
25339906|NCT00808067|50656144|FG000|Overall Study|Patient elected|7|||
25339907|NCT00808067|50656145|FG001|Overall Study|Patient elected|9|||
25339908|NCT00808067|50656144|FG000|Overall Study|Site closed for cause|19|||
25339909|NCT00808067|50656145|FG001|Overall Study|Site closed for cause|19|||
25339910|NCT00808067|50656144|FG000|Overall Study|Other reason not defined above|5|||
24903661|NCT02598960|49997304|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
24903662|NCT02598960|49997305|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
24903663|NCT02598960|49997306|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
24903664|NCT02598960|49997307|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
24903665|NCT00426361|49997338|FG000|Overall Study|Lost to Follow-up|3|||
24903666|NCT00426361|49997339|FG001|Overall Study|Lost to Follow-up|2|||
24903667|NCT00426361|49997340|FG002|Overall Study|Lost to Follow-up|5|||
24903668|NCT00426361|49997338|FG000|Overall Study|Withdrawal by Subject|1|||
24903669|NCT00426361|49997339|FG001|Overall Study|Withdrawal by Subject|3|||
24903670|NCT00426361|49997340|FG002|Overall Study|Withdrawal by Subject|0|||
24977512|NCT03814590|50066047|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
24977513|NCT03814590|50066048|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
24977514|NCT03814590|50066049|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
24977515|NCT03814590|50066050|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
24977516|NCT03814590|50066051|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
24977517|NCT03814590|50066052|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
24977518|NCT03814590|50066053|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
24977519|NCT03814590|50066054|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
25254622|NCT01350804|50570262|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
24903671|NCT00665847|49997348|FG000|Overall Study|Adverse Event|8|||
24903672|NCT00665847|49997348|FG000|Overall Study|Withdrawal by Subject|2|||
24903673|NCT00665847|49997348|FG000|Overall Study|Subject non-compliant|8|||
24903674|NCT00665847|49997348|FG000|Overall Study|Subject reached a virologic endpoint|4|||
24903675|NCT00665847|49997348|FG000|Overall Study|Resistance to TMC125|1|||
24903676|NCT00665847|49997348|FG000|Overall Study|Subject ineligible to continue the trial|1|||
24903677|NCT00665847|49997348|FG000|Overall Study|Switch to Commercial Medication|1|||
24903678|NCT00426127|49997352|FG000|Overall Study|Adverse Event|1|||
24903679|NCT00426127|49997352|FG000|Overall Study|Removed due to disease progression|1|||
24903680|NCT00425503|49997356|FG000|Overall Study|Adverse Event|2|||
24903681|NCT00425503|49997356|FG000|Overall Study|Protocol Violation|1|||
24903682|NCT00425269|49997362|FG000|Overall Study|Pregnancy|5|||
24903683|NCT00425269|49997363|FG001|Overall Study|Pregnancy|7|||
24903684|NCT00425269|49997362|FG000|Overall Study|Lost to Follow-up|9|||
24903685|NCT00425269|49997363|FG001|Overall Study|Lost to Follow-up|9|||
24903686|NCT00425269|49997362|FG000|Overall Study|moved or medical reason|5|||
24903687|NCT00425269|49997363|FG001|Overall Study|moved or medical reason|4|||
24903688|NCT00430573|49997369|FG000|Overall Study|Withdrawal by Subject|5|||
24903689|NCT02075840|49997393|FG000|Overall Study|Withdrawal by Subject|13|||
24903690|NCT02075840|49997394|FG001|Overall Study|Withdrawal by Subject|22|||
24903691|NCT02075840|49997393|FG000|Overall Study|Reason not specified|1|||
24903692|NCT02075840|49997394|FG001|Overall Study|Reason not specified|0|||
24903693|NCT02075840|49997393|FG000|Overall Study|Adverse Event|0|||
24903694|NCT02075840|49997394|FG001|Overall Study|Adverse Event|2|||
24903695|NCT02075840|49997393|FG000|Overall Study|Death|35|||
24903696|NCT02075840|49997394|FG001|Overall Study|Death|40|||
24903697|NCT02075840|49997393|FG000|Overall Study|Lost to Follow-up|3|||
24903698|NCT02075840|49997394|FG001|Overall Study|Lost to Follow-up|2|||
24903699|NCT02075840|49997393|FG000|Overall Study|Physician Decision|1|||
24903700|NCT02075840|49997394|FG001|Overall Study|Physician Decision|3|||
24903701|NCT02075840|49997393|FG000|Overall Study|Ongoing at CCOD|99|||
24903702|NCT02075840|49997394|FG001|Overall Study|Ongoing at CCOD|82|||
24903703|NCT00430495|49997404|FG000|Overall Study|Adverse Event|2|||
24903704|NCT00430495|49997405|FG001|Overall Study|Adverse Event|3|||
24903705|NCT00430495|49997406|FG002|Overall Study|Adverse Event|2|||
24903706|NCT00430495|49997407|FG003|Overall Study|Adverse Event|0|||
24903707|NCT00430495|49997404|FG000|Overall Study|Death|0|||
25254623|NCT01350804|50570263|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
25254624|NCT01350804|50570264|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
25254625|NCT01350804|50570265|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
24903708|NCT00430495|49997405|FG001|Overall Study|Death|0|||
24903709|NCT00430495|49997406|FG002|Overall Study|Death|1|||
24903710|NCT00430495|49997407|FG003|Overall Study|Death|0|||
24903711|NCT00430495|49997404|FG000|Overall Study|Lost to Follow-up|0|||
25254626|NCT01350804|50570262|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
25254627|NCT01350804|50570263|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
25254628|NCT01350804|50570264|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
25254629|NCT01350804|50570265|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
25254630|NCT01350804|50570262|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
25254631|NCT01350804|50570263|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
25254632|NCT01350804|50570264|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
25339911|NCT00808067|50656145|FG001|Overall Study|Other reason not defined above|5|||
25339912|NCT00808067|50656144|FG000|Overall Study|Excluded from analysis|13|||
25339913|NCT00808067|50656145|FG001|Overall Study|Excluded from analysis|19|||
24903712|NCT00430495|49997405|FG001|Overall Study|Lost to Follow-up|1|||
24903713|NCT00430495|49997406|FG002|Overall Study|Lost to Follow-up|4|||
24903714|NCT00430495|49997407|FG003|Overall Study|Lost to Follow-up|0|||
24903715|NCT00430495|49997404|FG000|Overall Study|Protocol Violation|1|||
24903716|NCT00430495|49997405|FG001|Overall Study|Protocol Violation|0|||
24903717|NCT00430495|49997406|FG002|Overall Study|Protocol Violation|1|||
24903718|NCT00430495|49997407|FG003|Overall Study|Protocol Violation|0|||
24903719|NCT00430495|49997404|FG000|Overall Study|Disease Progression|1|||
24903720|NCT00430495|49997405|FG001|Overall Study|Disease Progression|1|||
24903721|NCT00430495|49997406|FG002|Overall Study|Disease Progression|0|||
24903722|NCT00430495|49997407|FG003|Overall Study|Disease Progression|0|||
24903723|NCT00430495|49997404|FG000|Overall Study|Other|8|||
24903724|NCT00430495|49997405|FG001|Overall Study|Other|2|||
24903725|NCT00430495|49997406|FG002|Overall Study|Other|5|||
24903726|NCT00430495|49997407|FG003|Overall Study|Other|4|||
24903727|NCT00430495|49997404|FG000|Overall Study|Randomized but not Treated|2|||
24903728|NCT00430495|49997405|FG001|Overall Study|Randomized but not Treated|0|||
24903729|NCT00430495|49997406|FG002|Overall Study|Randomized but not Treated|0|||
24903730|NCT00430495|49997407|FG003|Overall Study|Randomized but not Treated|0|||
24903731|NCT00425113|49997419|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
25339914|NCT00723021|50656151|FG000|Intervention Period 4|Adverse Event|0|||
25339915|NCT00723021|50656152|FG001|Intervention Period 4|Adverse Event|0|||
25339916|NCT00723021|50656153|FG002|Intervention Period 4|Adverse Event|0|||
25339917|NCT00723021|50656154|FG003|Intervention Period 4|Adverse Event|0|||
25339918|NCT00723021|50656155|FG004|Intervention Period 4|Adverse Event|1|||
25339919|NCT00721227|50656176|FG000|Overall Study|Lost to Follow-up|3|||
25339920|NCT00721227|50656177|FG001|Overall Study|Lost to Follow-up|0|||
25339921|NCT00721227|50656176|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
25339922|NCT00721227|50656177|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
25339923|NCT00807599|50656185|FG000|Overall Study|Not treated on protocol study|0|||
25339924|NCT00807599|50656186|FG001|Overall Study|Not treated on protocol study|0|||
25339925|NCT00807599|50656187|FG002|Overall Study|Not treated on protocol study|2|||
25254633|NCT01350804|50570265|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
25254634|NCT01350804|50570262|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
25254635|NCT01350804|50570263|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
25254636|NCT01350804|50570264|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
25254637|NCT01350804|50570265|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
25254638|NCT01350492|50570287|FG000|Intervention|Lost to Follow-up|2|||
25254639|NCT01350492|50570288|FG001|Intervention|Lost to Follow-up|5|||
25254640|NCT01350492|50570287|FG000|Intervention|Withdrawal by Subject|3|||
25254641|NCT01350492|50570288|FG001|Intervention|Withdrawal by Subject|1|||
25254642|NCT01350492|50570287|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
25254643|NCT01350492|50570288|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
25254644|NCT01350492|50570287|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
25254645|NCT01350492|50570288|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
25254646|NCT02270957|50570296|FG000|Overall Study|Lack of Efficacy|2|||
25254647|NCT02270957|50570297|FG001|Overall Study|Lack of Efficacy|4|||
25254648|NCT02270957|50570296|FG000|Overall Study|Adverse Event|2|||
25254649|NCT02270957|50570297|FG001|Overall Study|Adverse Event|0|||
25254650|NCT01350414|50570304|FG000|Overall Study|Lost to Follow-up|13|||
25254651|NCT01350414|50570304|FG000|Overall Study|Withdrawal by Subject|4|||
25254652|NCT01350414|50570304|FG000|Overall Study|Physician Decision|2|||
25254653|NCT01350336|50570314|FG000|Overall Study|Lost to Follow-up|31|||
25254654|NCT01350336|50570314|FG000|Overall Study|Withdrawal by Subject|14|||
25254655|NCT01350336|50570314|FG000|Overall Study|Physician Decision|8|||
25254656|NCT01350336|50570314|FG000|Overall Study|Death|4|||
25254657|NCT01349049|50570372|FG000|Overall Study|Disease progression|3|||
25254658|NCT01349049|50570373|FG001|Overall Study|Disease progression|5|||
25254659|NCT01349049|50570374|FG002|Overall Study|Disease progression|3|||
25254660|NCT01349049|50570375|FG003|Overall Study|Disease progression|2|||
25339926|NCT00807599|50656185|FG000|Overall Study|Adverse Event|0|||
25339927|NCT00807599|50656186|FG001|Overall Study|Adverse Event|0|||
25339928|NCT00807599|50656187|FG002|Overall Study|Adverse Event|5|||
25339929|NCT00807599|50656185|FG000|Overall Study|Inadequate response to induction|0|||
24903732|NCT00425113|49997420|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
24903733|NCT00425113|49997419|FG000|Overall Study|diagnosis of abdominal TB|0|||
24903734|NCT00425113|49997420|FG001|Overall Study|diagnosis of abdominal TB|1|||
24903735|NCT00425113|49997419|FG000|Overall Study|missing study drug more than 14 days|0|||
24903736|NCT00425113|49997420|FG001|Overall Study|missing study drug more than 14 days|1|||
24903737|NCT00425113|49997419|FG000|Overall Study|Withdrawal by Subject|1|||
25254661|NCT01349049|50570376|FG004|Overall Study|Disease progression|2|||
25254662|NCT01349049|50570377|FG005|Overall Study|Disease progression|2|||
25254663|NCT01349049|50570378|FG006|Overall Study|Disease progression|3|||
24903738|NCT00425113|49997420|FG001|Overall Study|Withdrawal by Subject|0|||
24903739|NCT00440011|49997429|FG000|Overall Study|Adverse Event|2|||
24903740|NCT00440011|49997430|FG001|Overall Study|Adverse Event|0|||
24903741|NCT00440011|49997429|FG000|Overall Study|Lost to Follow-up|0|||
24903742|NCT00440011|49997430|FG001|Overall Study|Lost to Follow-up|2|||
24903743|NCT00440011|49997429|FG000|Overall Study|Protocol Violation|1|||
24903744|NCT00440011|49997430|FG001|Overall Study|Protocol Violation|1|||
24903745|NCT00440011|49997429|FG000|Overall Study|Withdrawal by Subject|1|||
24903746|NCT00440011|49997430|FG001|Overall Study|Withdrawal by Subject|0|||
24903747|NCT00663117|49997467|FG000|Overall Study|Lack of Efficacy|1|||
24903748|NCT00663117|49997468|FG001|Overall Study|Lack of Efficacy|0|||
24903749|NCT00570141|49997489|FG000|Overall Study|Adverse Event|1|||
24903750|NCT00570141|49997489|FG000|Overall Study|Missed visits|1|||
24903751|NCT00570141|49997489|FG000|Overall Study|Lost to Follow-up|1|||
24903752|NCT00579254|49997493|FG000|Overall Study|Lost to Follow-up|39|||
24903753|NCT00579254|49997493|FG000|Overall Study|Discontinued when study terminated|73|||
24903754|NCT00661089|49997499|FG000|Overall Study|1 subject withdrawal|0|||
24903755|NCT00661089|49997500|FG001|Overall Study|1 subject withdrawal|1|||
24903756|NCT00661089|49997499|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
24903757|NCT00661089|49997500|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
24903758|NCT00582426|49997513|FG000|Overall Study|Lost to Follow-up|0|||
24903759|NCT00582426|49997514|FG001|Overall Study|Lost to Follow-up|2|||
24903760|NCT00582426|49997513|FG000|Overall Study|Adverse Event|4|||
24903761|NCT00582426|49997514|FG001|Overall Study|Adverse Event|2|||
24903762|NCT00582426|49997513|FG000|Overall Study|Protocol Violation|6|||
24903763|NCT00582426|49997514|FG001|Overall Study|Protocol Violation|2|||
24903764|NCT00582426|49997513|FG000|Overall Study|Death|4|||
24903765|NCT00582426|49997514|FG001|Overall Study|Death|3|||
24903766|NCT00582426|49997513|FG000|Overall Study|Withdrawal by Subject|3|||
24903767|NCT00582426|49997514|FG001|Overall Study|Withdrawal by Subject|2|||
24903768|NCT00582426|49997513|FG000|Overall Study|Disease Progression|2|||
24903769|NCT00582426|49997514|FG001|Overall Study|Disease Progression|2|||
24903770|NCT00582426|49997513|FG000|Overall Study|Use of illicit drugs|1|||
24903771|NCT00582426|49997514|FG001|Overall Study|Use of illicit drugs|0|||
24903772|NCT02387970|49997522|FG000|Overall Study|Did not complete 1-year follow up|1|||
24903773|NCT02387970|49997523|FG001|Overall Study|Did not complete 1-year follow up|2|||
24903774|NCT00580034|49997529|FG000|Overall Study|Toxicity|10|||
24903775|NCT00580034|49997530|FG001|Overall Study|Toxicity|0|||
24903776|NCT00773513|49997536|FG000|Overall Study|Renal Transplant|254|||
24903777|NCT00773513|49997537|FG001|Overall Study|Renal Transplant|263|||
24903778|NCT00773513|49997536|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
24903779|NCT00773513|49997537|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
24903780|NCT00773513|49997536|FG000|Overall Study|Withdrew Consent|68|||
24903781|NCT00773513|49997537|FG001|Overall Study|Withdrew Consent|69|||
24903782|NCT00773513|49997536|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
24903783|NCT00773513|49997537|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
24903784|NCT00773513|49997536|FG000|Overall Study|Failure to Return|22|||
24903785|NCT00773513|49997537|FG001|Overall Study|Failure to Return|8|||
24903786|NCT00773513|49997536|FG000|Overall Study|Insufficient Therapeutic Response|1|||
24903787|NCT00773513|49997537|FG001|Overall Study|Insufficient Therapeutic Response|18|||
24903788|NCT00773513|49997536|FG000|Overall Study|Reason Not Specified|159|||
24903789|NCT00773513|49997537|FG001|Overall Study|Reason Not Specified|126|||
24903790|NCT00773513|49997536|FG000|Overall Study|Death|531|||
24903791|NCT00773513|49997537|FG001|Overall Study|Death|545|||
24977520|NCT03814590|50066055|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
24977521|NCT03814590|50066056|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
24977522|NCT03814590|50066057|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
24977523|NCT03814590|50066058|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
24977524|NCT03814590|50066059|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
24977525|NCT03814590|50066046|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
24977526|NCT03814590|50066047|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
24977527|NCT03814590|50066048|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
24977528|NCT03814590|50066049|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
24977529|NCT03814590|50066050|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
24977530|NCT03814590|50066051|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
24977531|NCT03814590|50066052|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
24977532|NCT03814590|50066053|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
24977533|NCT03814590|50066054|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
24977534|NCT03814590|50066055|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
24977535|NCT03814590|50066056|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
24977536|NCT03814590|50066057|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
24977537|NCT03814590|50066058|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
24977538|NCT03814590|50066059|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
24903792|NCT00581828|49997543|FG000|Overall Study|Protocol Violation|1|||
24903793|NCT00767039|49997549|FG000|Overall Study|Death|5|||
24903794|NCT00767039|49997550|FG001|Overall Study|Death|2|||
24903795|NCT00662649|49997560|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
24903796|NCT00662649|49997561|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
24903797|NCT00662649|49997562|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
24903798|NCT00662649|49997563|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
24903799|NCT00662649|49997564|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
24903800|NCT00662649|49997560|FG000|Core Study (24 Months)|Adverse Event|22|||
24903801|NCT00662649|49997561|FG001|Core Study (24 Months)|Adverse Event|13|||
24903802|NCT00662649|49997562|FG002|Core Study (24 Months)|Adverse Event|18|||
24903803|NCT00662649|49997563|FG003|Core Study (24 Months)|Adverse Event|0|||
24903804|NCT00662649|49997564|FG004|Core Study (24 Months)|Adverse Event|0|||
25078005|NCT02456636|50186180|FG001|Overall Study|Withdrawal by Subject|14|||
25254664|NCT01349049|50570379|FG007|Overall Study|Disease progression|2|||
25254665|NCT01349049|50570380|FG008|Overall Study|Disease progression|33|||
25254666|NCT01349049|50570372|FG000|Overall Study|Adverse Event|0|||
25254667|NCT01349049|50570373|FG001|Overall Study|Adverse Event|1|||
25339930|NCT00807599|50656186|FG001|Overall Study|Inadequate response to induction|0|||
25339931|NCT00807599|50656187|FG002|Overall Study|Inadequate response to induction|9|||
25254668|NCT01349049|50570374|FG002|Overall Study|Adverse Event|0|||
25254669|NCT01349049|50570375|FG003|Overall Study|Adverse Event|0|||
25254670|NCT01349049|50570376|FG004|Overall Study|Adverse Event|0|||
25254671|NCT01349049|50570377|FG005|Overall Study|Adverse Event|3|||
25254672|NCT01349049|50570378|FG006|Overall Study|Adverse Event|1|||
25254673|NCT01349049|50570379|FG007|Overall Study|Adverse Event|0|||
25254674|NCT01349049|50570380|FG008|Overall Study|Adverse Event|4|||
25254675|NCT01349049|50570372|FG000|Overall Study|Physician Decision|0|||
25254676|NCT01349049|50570373|FG001|Overall Study|Physician Decision|1|||
25254677|NCT01349049|50570374|FG002|Overall Study|Physician Decision|0|||
25254678|NCT01349049|50570375|FG003|Overall Study|Physician Decision|0|||
25254679|NCT01349049|50570376|FG004|Overall Study|Physician Decision|0|||
25254680|NCT01349049|50570377|FG005|Overall Study|Physician Decision|0|||
25254681|NCT01349049|50570378|FG006|Overall Study|Physician Decision|0|||
25254682|NCT01349049|50570379|FG007|Overall Study|Physician Decision|0|||
25254683|NCT01349049|50570380|FG008|Overall Study|Physician Decision|2|||
25254684|NCT01349049|50570372|FG000|Overall Study|Protocol Violation|0|||
25254685|NCT01349049|50570373|FG001|Overall Study|Protocol Violation|0|||
25254686|NCT01349049|50570374|FG002|Overall Study|Protocol Violation|0|||
25254687|NCT01349049|50570375|FG003|Overall Study|Protocol Violation|0|||
25254688|NCT01349049|50570376|FG004|Overall Study|Protocol Violation|0|||
25254689|NCT01349049|50570377|FG005|Overall Study|Protocol Violation|0|||
25254690|NCT01349049|50570378|FG006|Overall Study|Protocol Violation|0|||
25254691|NCT01349049|50570379|FG007|Overall Study|Protocol Violation|0|||
25254692|NCT01349049|50570380|FG008|Overall Study|Protocol Violation|1|||
25254693|NCT01349049|50570372|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
25254694|NCT01349049|50570373|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
25254695|NCT01349049|50570374|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
25254696|NCT01349049|50570375|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
25254697|NCT01349049|50570376|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
25254698|NCT01349049|50570377|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
25254699|NCT01349049|50570378|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
25254700|NCT01349049|50570379|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
25254701|NCT01349049|50570380|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
25254702|NCT01349049|50570372|FG000|Overall Study|Other|0|||
25339932|NCT00807599|50656185|FG000|Overall Study|Withdrawal by Subject|0|||
25339933|NCT00807599|50656186|FG001|Overall Study|Withdrawal by Subject|0|||
25339934|NCT00807599|50656187|FG002|Overall Study|Withdrawal by Subject|1|||
25339935|NCT00721149|50656193|FG000|Overall Study|Physician Decision|1|||
25339936|NCT00788372|50656197|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
25339937|NCT00788372|50656197|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
25339938|NCT00788372|50656197|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
25339939|NCT00788372|50656197|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
25339940|NCT00788372|50656197|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
25339941|NCT00788372|50656197|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
25339942|NCT00788372|50656197|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
24903805|NCT00662649|49997560|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
24903806|NCT00662649|49997561|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
24903807|NCT00662649|49997562|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
25254703|NCT01349049|50570373|FG001|Overall Study|Other|0|||
25254704|NCT01349049|50570374|FG002|Overall Study|Other|0|||
25254705|NCT01349049|50570375|FG003|Overall Study|Other|0|||
25254706|NCT01349049|50570376|FG004|Overall Study|Other|0|||
25254707|NCT01349049|50570377|FG005|Overall Study|Other|1|||
25254708|NCT01349049|50570378|FG006|Overall Study|Other|0|||
25254709|NCT01349049|50570379|FG007|Overall Study|Other|0|||
24903808|NCT00662649|49997563|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
24903809|NCT00662649|49997564|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
24903810|NCT00662649|49997560|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
24903811|NCT00662649|49997561|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
24903812|NCT00662649|49997562|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
24903813|NCT00662649|49997563|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
24903814|NCT00662649|49997564|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
24903815|NCT00662649|49997560|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
24903816|NCT00662649|49997561|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
24903817|NCT00662649|49997562|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
24903818|NCT00662649|49997563|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
24903819|NCT00662649|49997564|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
24903820|NCT00662649|49997560|FG000|Core Study (24 Months)|Protocol Violation|5|||
24903821|NCT00662649|49997561|FG001|Core Study (24 Months)|Protocol Violation|5|||
25339943|NCT00738582|50656201|FG000|Combination Therapy|Completed Combination Therapy|1|||
25339944|NCT00738582|50656202|FG001|Combination Therapy|Completed Combination Therapy|0|||
25339945|NCT00738582|50656201|FG000|Combination Therapy|Physician Decision|1|||
25339946|NCT00738582|50656202|FG001|Combination Therapy|Physician Decision|0|||
25339947|NCT00738582|50656201|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
25339948|NCT00738582|50656202|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
25339949|NCT00738582|50656201|FG000|Combination Therapy|Other|5|||
25339950|NCT00738582|50656202|FG001|Combination Therapy|Other|0|||
25339951|NCT00738582|50656201|FG000|Combination Therapy|Adverse Event|16|||
25339952|NCT00738582|50656202|FG001|Combination Therapy|Adverse Event|0|||
25339953|NCT00738582|50656201|FG000|Combination Therapy|Progressive Disease|9|||
25339954|NCT00738582|50656202|FG001|Combination Therapy|Progressive Disease|0|||
25339955|NCT00738582|50656201|FG000|Maintenance Therapy|Other|0|||
25339956|NCT00738582|50656202|FG001|Maintenance Therapy|Other|2|||
25339957|NCT00738582|50656201|FG000|Maintenance Therapy|Adverse Event|0|||
25339958|NCT00738582|50656202|FG001|Maintenance Therapy|Adverse Event|6|||
25339959|NCT00738582|50656201|FG000|Maintenance Therapy|Progressive Disease|0|||
25339960|NCT00738582|50656202|FG001|Maintenance Therapy|Progressive Disease|47|||
25339961|NCT00738582|50656201|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
24903822|NCT00662649|49997562|FG002|Core Study (24 Months)|Protocol Violation|4|||
24903823|NCT00662649|49997563|FG003|Core Study (24 Months)|Protocol Violation|0|||
24903824|NCT00662649|49997564|FG004|Core Study (24 Months)|Protocol Violation|0|||
24903825|NCT00662649|49997560|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
24903826|NCT00662649|49997561|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
24903827|NCT00662649|49997562|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
24903828|NCT00662649|49997563|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
24903829|NCT00662649|49997564|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
24903830|NCT00662649|49997560|FG000|Core Study (24 Months)|Death|1|||
24903831|NCT00662649|49997561|FG001|Core Study (24 Months)|Death|0|||
24903832|NCT00662649|49997562|FG002|Core Study (24 Months)|Death|2|||
24977539|NCT03814590|50066046|FG000|Overall Study|UNKNOWN REASON|0|||
24977540|NCT03814590|50066047|FG001|Overall Study|UNKNOWN REASON|0|||
24977541|NCT03814590|50066048|FG002|Overall Study|UNKNOWN REASON|0|||
24977542|NCT03814590|50066049|FG003|Overall Study|UNKNOWN REASON|0|||
24977543|NCT03814590|50066050|FG004|Overall Study|UNKNOWN REASON|0|||
24977544|NCT03814590|50066051|FG005|Overall Study|UNKNOWN REASON|0|||
24977545|NCT03814590|50066052|FG006|Overall Study|UNKNOWN REASON|0|||
24977546|NCT03814590|50066053|FG007|Overall Study|UNKNOWN REASON|1|||
24977547|NCT03814590|50066054|FG008|Overall Study|UNKNOWN REASON|0|||
24977548|NCT03814590|50066055|FG009|Overall Study|UNKNOWN REASON|0|||
24977549|NCT03814590|50066056|FG010|Overall Study|UNKNOWN REASON|0|||
24977550|NCT03814590|50066057|FG011|Overall Study|UNKNOWN REASON|0|||
24977551|NCT03814590|50066058|FG012|Overall Study|UNKNOWN REASON|0|||
24977552|NCT03814590|50066059|FG013|Overall Study|UNKNOWN REASON|0|||
24977553|NCT00048074|50066102|FG000|Overall Study|Adverse Event|46|||
24977554|NCT00048074|50066103|FG001|Overall Study|Adverse Event|41|||
24977555|NCT00048074|50066104|FG002|Overall Study|Adverse Event|53|||
24977556|NCT00048074|50066102|FG000|Overall Study|Death|3|||
24977557|NCT00048074|50066103|FG001|Overall Study|Death|3|||
25339962|NCT00738582|50656202|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
25339963|NCT00720759|50656213|FG000|Overall Study|Lost to Follow-up|0|||
25339964|NCT00720759|50656214|FG001|Overall Study|Lost to Follow-up|1|||
25339965|NCT00720759|50656215|FG002|Overall Study|Lost to Follow-up|1|||
25339966|NCT00720759|50656216|FG003|Overall Study|Lost to Follow-up|0|||
24903833|NCT00662649|49997563|FG003|Core Study (24 Months)|Death|0|||
24903834|NCT00662649|49997564|FG004|Core Study (24 Months)|Death|0|||
24977558|NCT00048074|50066104|FG002|Overall Study|Death|2|||
24903835|NCT00662649|49997560|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
24977559|NCT00048074|50066102|FG000|Overall Study|Lost to Follow-up|2|||
24977560|NCT00048074|50066103|FG001|Overall Study|Lost to Follow-up|6|||
24977561|NCT00048074|50066104|FG002|Overall Study|Lost to Follow-up|6|||
24977562|NCT00048074|50066102|FG000|Overall Study|Withdrawal by Subject|28|||
24903836|NCT00662649|49997561|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
24903837|NCT00662649|49997562|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
24903838|NCT00662649|49997563|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
24903839|NCT00662649|49997564|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
24903840|NCT00662649|49997560|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
24903841|NCT00662649|49997561|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
24903842|NCT00662649|49997562|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
24903843|NCT00662649|49997563|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
24903844|NCT00662649|49997564|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
24903845|NCT00662649|49997560|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
24903846|NCT00662649|49997561|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
24903847|NCT00662649|49997562|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
24903848|NCT00662649|49997563|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
24903849|NCT00662649|49997564|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
24903850|NCT00662649|49997560|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
24903851|NCT00662649|49997561|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
24903852|NCT00662649|49997562|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
24903853|NCT00662649|49997563|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
24903854|NCT00662649|49997564|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
24903855|NCT00662649|49997560|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
24903856|NCT00662649|49997561|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
24903857|NCT00662649|49997562|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
24903858|NCT00662649|49997563|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
24903859|NCT00662649|49997564|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
24903860|NCT00662649|49997560|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
24903861|NCT00662649|49997561|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
24903862|NCT00662649|49997562|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
24903863|NCT00662649|49997563|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
24903864|NCT00662649|49997564|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
24903865|NCT00662649|49997560|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
24903866|NCT00662649|49997561|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
24903867|NCT00662649|49997562|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
24903868|NCT00662649|49997563|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
24903869|NCT00662649|49997564|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
24903870|NCT00662649|49997560|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
24903871|NCT00662649|49997561|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
24903872|NCT00662649|49997562|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
24903873|NCT00662649|49997563|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
24903874|NCT00662649|49997564|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
25339967|NCT00720213|50656226|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
25339968|NCT00720213|50656227|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
25339969|NCT00720213|50656228|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
25339970|NCT00810407|50656236|FG000|Overall Study|Protocol Violation|3|||
25339971|NCT00810407|50656236|FG000|Overall Study|No Visit After First Day of Treatment|3|||
25339972|NCT00720057|50656242|FG000|Overall Study|Lost to Follow-up|0|||
25254710|NCT01349049|50570380|FG008|Overall Study|Other|4|||
25254711|NCT01349049|50570372|FG000|Overall Study|Death|0|||
25254712|NCT01349049|50570373|FG001|Overall Study|Death|0|||
25254713|NCT01349049|50570374|FG002|Overall Study|Death|0|||
25254714|NCT01349049|50570375|FG003|Overall Study|Death|0|||
25254715|NCT01349049|50570376|FG004|Overall Study|Death|0|||
25254716|NCT01349049|50570377|FG005|Overall Study|Death|0|||
24903875|NCT00662649|49997560|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
24903876|NCT00662649|49997561|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
24903877|NCT00662649|49997562|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
24903878|NCT00662649|49997563|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
24903879|NCT00662649|49997564|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
24903880|NCT00766493|49997578|FG000|30 Days Post-Procedure|Discontinued|7|||
25254717|NCT01349049|50570378|FG006|Overall Study|Death|0|||
25254718|NCT01349049|50570379|FG007|Overall Study|Death|1|||
25254719|NCT01349049|50570380|FG008|Overall Study|Death|5|||
25254720|NCT01349049|50570372|FG000|Overall Study|Non-compliance|0|||
25254721|NCT01349049|50570373|FG001|Overall Study|Non-compliance|0|||
25254722|NCT01349049|50570374|FG002|Overall Study|Non-compliance|0|||
25339973|NCT00720057|50656243|FG001|Overall Study|Lost to Follow-up|2|||
25254723|NCT01349049|50570375|FG003|Overall Study|Non-compliance|1|||
25254724|NCT01349049|50570376|FG004|Overall Study|Non-compliance|0|||
25254725|NCT01349049|50570377|FG005|Overall Study|Non-compliance|0|||
25339974|NCT00720057|50656242|FG000|Overall Study|Protocol Violation|1|||
25339975|NCT00720057|50656243|FG001|Overall Study|Protocol Violation|0|||
25339976|NCT00720057|50656242|FG000|Overall Study|Withdrawal by Subject|0|||
25339977|NCT00720057|50656243|FG001|Overall Study|Withdrawal by Subject|1|||
25339978|NCT00790868|50656251|FG000|Overall Study|Withdrawal by Subject|4|||
25339979|NCT00790868|50656252|FG001|Overall Study|Withdrawal by Subject|5|||
25339980|NCT00790868|50656251|FG000|Overall Study|Lost to Follow-up|2|||
25339981|NCT00790868|50656252|FG001|Overall Study|Lost to Follow-up|12|||
25339982|NCT00719901|50656260|FG000|Overall Study|Adverse Event|5|||
25339983|NCT00719901|50656260|FG000|Overall Study|Withdrawal by Subject|1|||
25339984|NCT00719901|50656260|FG000|Overall Study|Alternate Treatment|1|||
25339985|NCT00719901|50656260|FG000|Overall Study|Disease Progression|3|||
24903881|NCT00766493|49997578|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
24903882|NCT00766493|49997578|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
24903883|NCT03070392|49997584|FG000|Overall Study|Not Treated|7|||
24903884|NCT03070392|49997585|FG001|Overall Study|Not Treated|0|||
24903885|NCT03070392|49997586|FG002|Overall Study|Not Treated|3|||
24903886|NCT03070392|49997587|FG003|Overall Study|Not Treated|12|||
24903887|NCT03070392|49997584|FG000|Overall Study|Death|3|||
24903888|NCT03070392|49997585|FG001|Overall Study|Death|0|||
24903889|NCT03070392|49997586|FG002|Overall Study|Death|0|||
24903890|NCT03070392|49997587|FG003|Overall Study|Death|1|||
24903891|NCT03070392|49997584|FG000|Overall Study|Withdrawal by Subject|7|||
24903892|NCT03070392|49997585|FG001|Overall Study|Withdrawal by Subject|0|||
24903893|NCT03070392|49997586|FG002|Overall Study|Withdrawal by Subject|0|||
24903894|NCT03070392|49997587|FG003|Overall Study|Withdrawal by Subject|3|||
24903895|NCT03070392|49997584|FG000|Overall Study|Physician Decision|1|||
24903896|NCT03070392|49997585|FG001|Overall Study|Physician Decision|0|||
24903897|NCT03070392|49997586|FG002|Overall Study|Physician Decision|0|||
24903898|NCT03070392|49997587|FG003|Overall Study|Physician Decision|2|||
24903899|NCT03070392|49997584|FG000|Overall Study|Progressive Disease|154|||
24903900|NCT03070392|49997585|FG001|Overall Study|Progressive Disease|6|||
24903901|NCT03070392|49997586|FG002|Overall Study|Progressive Disease|2|||
24903902|NCT03070392|49997587|FG003|Overall Study|Progressive Disease|70|||
24903903|NCT03070392|49997584|FG000|Overall Study|Adverse Event|6|||
24903904|NCT03070392|49997585|FG001|Overall Study|Adverse Event|1|||
24903905|NCT03070392|49997586|FG002|Overall Study|Adverse Event|1|||
24903906|NCT03070392|49997587|FG003|Overall Study|Adverse Event|3|||
24903907|NCT03070392|49997584|FG000|Overall Study|Alternate anticancer treatment|1|||
24903908|NCT03070392|49997585|FG001|Overall Study|Alternate anticancer treatment|0|||
24903909|NCT03070392|49997586|FG002|Overall Study|Alternate anticancer treatment|0|||
24903910|NCT03070392|49997587|FG003|Overall Study|Alternate anticancer treatment|1|||
24903911|NCT03070392|49997584|FG000|Overall Study|Ongoing|73|||
24903912|NCT03070392|49997585|FG001|Overall Study|Ongoing|0|||
24903913|NCT03070392|49997586|FG002|Overall Study|Ongoing|0|||
24903914|NCT03070392|49997587|FG003|Overall Study|Ongoing|11|||
24903915|NCT00784043|49997595|FG000|Overall Study|Withdrawal by Subject|8|||
24903916|NCT00784043|49997596|FG001|Overall Study|Withdrawal by Subject|5|||
24903917|NCT00784043|49997595|FG000|Overall Study|Protocol Terminated|23|||
24903918|NCT00784043|49997596|FG001|Overall Study|Protocol Terminated|1|||
25339986|NCT00719901|50656260|FG000|Overall Study|Availability of Study Drug|1|||
25339987|NCT00807365|50656264|FG000|Overall Study|Study Terminated|5|||
25339988|NCT00719355|50656270|FG000|Overall Study|Death|0|||
25339989|NCT00719355|50656271|FG001|Overall Study|Death|1|||
25339990|NCT00719355|50656270|FG000|Overall Study|Medical|14|||
25339991|NCT00719355|50656271|FG001|Overall Study|Medical|5|||
25339992|NCT00719355|50656270|FG000|Overall Study|Compliance|4|||
25339993|NCT00719355|50656271|FG001|Overall Study|Compliance|6|||
25339994|NCT00719355|50656270|FG000|Overall Study|Moved|0|||
25339995|NCT00719355|50656271|FG001|Overall Study|Moved|1|||
25339996|NCT00590759|50656277|FG000|Overall Study|Death|52|||
25339997|NCT00590759|50656277|FG000|Overall Study|Lost to Follow-up|28|||
25339998|NCT00734604|50656287|FG000|Overall Study|Adverse Event|0|||
24903919|NCT00773279|49997602|FG000|Period 1|Adverse Event|2|||
24903920|NCT00773279|49997603|FG001|Period 1|Adverse Event|1|||
24903921|NCT00773279|49997602|FG000|Period 1|Lack of Efficacy|0|||
24903922|NCT00773279|49997603|FG001|Period 1|Lack of Efficacy|2|||
24977563|NCT00048074|50066103|FG001|Overall Study|Withdrawal by Subject|30|||
25339999|NCT00734604|50656288|FG001|Overall Study|Adverse Event|2|||
25340000|NCT00734604|50656289|FG002|Overall Study|Adverse Event|0|||
25340001|NCT00734604|50656290|FG003|Overall Study|Adverse Event|2|||
24903923|NCT00773279|49997602|FG000|Period 1|Unclassified|5|||
24903924|NCT00773279|49997603|FG001|Period 1|Unclassified|1|||
24903925|NCT00773279|49997602|FG000|Period 2|Adverse Event|0|||
24903926|NCT00773279|49997603|FG001|Period 2|Adverse Event|1|||
24903927|NCT00773279|49997602|FG000|Period 2|Lack of Efficacy|1|||
24903928|NCT00773279|49997603|FG001|Period 2|Lack of Efficacy|0|||
24903929|NCT00773279|49997602|FG000|Period 2|Protocol Violation|0|||
24903930|NCT00773279|49997603|FG001|Period 2|Protocol Violation|3|||
24903931|NCT00773279|49997602|FG000|Period 2|Unclassified|2|||
24903932|NCT00773279|49997603|FG001|Period 2|Unclassified|2|||
25340002|NCT00734604|50656291|FG004|Overall Study|Adverse Event|1|||
24903933|NCT00766415|49997612|FG000|Overall Study|Withdrawal by Subject|0|||
24903934|NCT00766415|49997613|FG001|Overall Study|Withdrawal by Subject|1|||
24903935|NCT00772967|49997619|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
24903936|NCT00772967|49997620|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
24903937|NCT00772967|49997621|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
24903938|NCT00772967|49997622|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
24903939|NCT00772967|49997623|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
24903940|NCT00772967|49997624|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
24903941|NCT00772967|49997619|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
24903942|NCT00772967|49997620|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
24903943|NCT00772967|49997621|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
24903944|NCT00772967|49997622|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
24903945|NCT00772967|49997623|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
24903946|NCT00772967|49997624|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
24903947|NCT00772967|49997619|FG000|Crossover Treatment 3|Adverse Event|0|||
24977564|NCT00048074|50066104|FG002|Overall Study|Withdrawal by Subject|35|||
24977565|NCT00048074|50066102|FG000|Overall Study|Protocol Violation|1|||
24977566|NCT00048074|50066103|FG001|Overall Study|Protocol Violation|3|||
24977567|NCT00048074|50066104|FG002|Overall Study|Protocol Violation|0|||
24977568|NCT00048074|50066102|FG000|Overall Study|Study participation was terminated|0|||
24977569|NCT00048074|50066103|FG001|Overall Study|Study participation was terminated|1|||
24977570|NCT00048074|50066104|FG002|Overall Study|Study participation was terminated|0|||
25340003|NCT00734604|50656292|FG005|Overall Study|Adverse Event|1|||
25340004|NCT00734604|50656287|FG000|Overall Study|Serious Adverse Event|1|||
25340005|NCT00734604|50656288|FG001|Overall Study|Serious Adverse Event|0|||
25340006|NCT00734604|50656289|FG002|Overall Study|Serious Adverse Event|1|||
25340007|NCT00734604|50656290|FG003|Overall Study|Serious Adverse Event|2|||
25340008|NCT00734604|50656291|FG004|Overall Study|Serious Adverse Event|0|||
25340009|NCT00734604|50656292|FG005|Overall Study|Serious Adverse Event|1|||
25340010|NCT00734604|50656287|FG000|Overall Study|Lost to Follow-up|1|||
25340011|NCT00734604|50656288|FG001|Overall Study|Lost to Follow-up|2|||
25340012|NCT00734604|50656289|FG002|Overall Study|Lost to Follow-up|2|||
25340013|NCT00734604|50656290|FG003|Overall Study|Lost to Follow-up|4|||
25340014|NCT00734604|50656291|FG004|Overall Study|Lost to Follow-up|2|||
25340015|NCT00734604|50656292|FG005|Overall Study|Lost to Follow-up|3|||
25340016|NCT00734604|50656287|FG000|Overall Study|Physician Decision|0|||
25340017|NCT00734604|50656288|FG001|Overall Study|Physician Decision|1|||
25340018|NCT00734604|50656289|FG002|Overall Study|Physician Decision|1|||
25340019|NCT00734604|50656290|FG003|Overall Study|Physician Decision|0|||
25340020|NCT00734604|50656291|FG004|Overall Study|Physician Decision|0|||
25340021|NCT00734604|50656292|FG005|Overall Study|Physician Decision|0|||
25340022|NCT00734604|50656287|FG000|Overall Study|Protocol Violation|0|||
25340023|NCT00734604|50656288|FG001|Overall Study|Protocol Violation|2|||
25340024|NCT00734604|50656289|FG002|Overall Study|Protocol Violation|0|||
25340025|NCT00734604|50656290|FG003|Overall Study|Protocol Violation|0|||
25340026|NCT00734604|50656291|FG004|Overall Study|Protocol Violation|1|||
25340027|NCT00734604|50656292|FG005|Overall Study|Protocol Violation|0|||
25340028|NCT00734604|50656287|FG000|Overall Study|Sponsor Decision|1|||
25340029|NCT00734604|50656288|FG001|Overall Study|Sponsor Decision|2|||
25340030|NCT00734604|50656289|FG002|Overall Study|Sponsor Decision|1|||
25340031|NCT00734604|50656290|FG003|Overall Study|Sponsor Decision|0|||
25340032|NCT00734604|50656291|FG004|Overall Study|Sponsor Decision|2|||
25340033|NCT00734604|50656292|FG005|Overall Study|Sponsor Decision|0|||
25340034|NCT00734604|50656287|FG000|Overall Study|Withdrawal by Subject|0|||
25340035|NCT00734604|50656288|FG001|Overall Study|Withdrawal by Subject|2|||
25340036|NCT00734604|50656289|FG002|Overall Study|Withdrawal by Subject|0|||
25340037|NCT00734604|50656290|FG003|Overall Study|Withdrawal by Subject|1|||
25340038|NCT00734604|50656291|FG004|Overall Study|Withdrawal by Subject|2|||
25340039|NCT00734604|50656292|FG005|Overall Study|Withdrawal by Subject|1|||
25340040|NCT00734604|50656287|FG000|Overall Study|Lack of Efficacy|0|||
25340041|NCT00734604|50656288|FG001|Overall Study|Lack of Efficacy|1|||
25340042|NCT00734604|50656289|FG002|Overall Study|Lack of Efficacy|1|||
25340043|NCT00734604|50656290|FG003|Overall Study|Lack of Efficacy|0|||
25340044|NCT00734604|50656291|FG004|Overall Study|Lack of Efficacy|0|||
24977571|NCT00048074|50066102|FG000|Overall Study|Husband ill|0|||
25340045|NCT00734604|50656292|FG005|Overall Study|Lack of Efficacy|0|||
25340046|NCT00590681|50656303|FG000|Overall Study|Withdrawal by Subject|7|||
25340047|NCT00590681|50656303|FG000|Overall Study|Adverse Event|8|||
25340048|NCT00590681|50656303|FG000|Overall Study|Death|3|||
25340049|NCT00590681|50656303|FG000|Overall Study|Lost to Follow-up|1|||
24903948|NCT00772967|49997620|FG001|Crossover Treatment 3|Adverse Event|0|||
24903949|NCT00772967|49997621|FG002|Crossover Treatment 3|Adverse Event|0|||
24977572|NCT00048074|50066103|FG001|Overall Study|Husband ill|1|||
24977573|NCT00048074|50066104|FG002|Overall Study|Husband ill|0|||
24977574|NCT00048074|50066102|FG000|Overall Study|Poor compliance|0|||
25340050|NCT00590681|50656303|FG000|Overall Study|disease progression|1|||
25340051|NCT00727272|50656307|FG000|Washout Period A|Adverse Event|0|||
25340052|NCT00727272|50656308|FG001|Washout Period A|Adverse Event|0|||
24903950|NCT00772967|49997622|FG003|Crossover Treatment 3|Adverse Event|0|||
24903951|NCT00772967|49997623|FG004|Crossover Treatment 3|Adverse Event|1|||
24903952|NCT00772967|49997624|FG005|Crossover Treatment 3|Adverse Event|0|||
24903953|NCT00662259|49997647|FG000|Overall Study|Adverse Event|2|||
24903954|NCT00662259|49997648|FG001|Overall Study|Adverse Event|0|||
24903955|NCT00660699|49997654|FG000|Overall Study|Withdrawal by Subject|2|||
24903956|NCT00582114|49997660|FG000|Overall Study|Death|4|||
24903957|NCT00582114|49997661|FG001|Overall Study|Death|4|||
24903958|NCT00582114|49997660|FG000|Overall Study|Kidney Transplant|3|||
24903959|NCT00582114|49997661|FG001|Overall Study|Kidney Transplant|1|||
24903960|NCT00582114|49997660|FG000|Overall Study|Lost to Follow-up|7|||
24903961|NCT00582114|49997661|FG001|Overall Study|Lost to Follow-up|6|||
24903962|NCT00582114|49997660|FG000|Overall Study|Withdrawal by Subject|8|||
24903963|NCT00582114|49997661|FG001|Overall Study|Withdrawal by Subject|16|||
24903964|NCT00582114|49997660|FG000|Overall Study|Adverse Event|1|||
24903965|NCT00582114|49997661|FG001|Overall Study|Adverse Event|1|||
24903966|NCT00582114|49997660|FG000|Overall Study|Physician Decision|0|||
24903967|NCT00582114|49997661|FG001|Overall Study|Physician Decision|6|||
24903968|NCT00582114|49997660|FG000|Overall Study|Stopped by data safety monitoring board|19|||
24903969|NCT00582114|49997661|FG001|Overall Study|Stopped by data safety monitoring board|20|||
24903970|NCT00582036|49997669|FG000|Overall Study|Withdrawal by Subject|0|||
24903971|NCT00582036|49997670|FG001|Overall Study|Withdrawal by Subject|1|||
24903972|NCT00581360|49997676|FG000|Overall Study|Withdrawal by Subject|1|||
24903973|NCT00660387|49997682|FG000|Overall Study|Adverse Event|1|||
24903974|NCT00660387|49997683|FG001|Overall Study|Adverse Event|2|||
24903975|NCT00660387|49997682|FG000|Overall Study|Lack of Efficacy|0|||
24903976|NCT00660387|49997683|FG001|Overall Study|Lack of Efficacy|1|||
24903977|NCT00660387|49997682|FG000|Overall Study|Protocol Violation|1|||
24903978|NCT00660387|49997683|FG001|Overall Study|Protocol Violation|0|||
24903979|NCT00582738|49997691|FG000|Overall Study|Administrative Problems|7|||
24903980|NCT00582738|49997692|FG001|Overall Study|Administrative Problems|8|||
24903981|NCT00582738|49997691|FG000|Overall Study|Adverse Event|0|||
24903982|NCT00582738|49997692|FG001|Overall Study|Adverse Event|5|||
24903983|NCT00582738|49997691|FG000|Overall Study|Graft Lost|0|||
24903984|NCT00582738|49997692|FG001|Overall Study|Graft Lost|1|||
24903985|NCT00582738|49997691|FG000|Overall Study|Other|1|||
24903986|NCT00582738|49997692|FG001|Overall Study|Other|0|||
24903987|NCT00582738|49997691|FG000|Overall Study|Protocol Violation|1|||
24903988|NCT00582738|49997692|FG001|Overall Study|Protocol Violation|1|||
24903989|NCT00582738|49997691|FG000|Overall Study|Withdrawal by Subject|0|||
24903990|NCT00582738|49997692|FG001|Overall Study|Withdrawal by Subject|3|||
24903991|NCT00772889|49997707|FG000|Overall Study|Adverse Event|7|||
25340053|NCT00727272|50656309|FG002|Washout Period A|Adverse Event|1|||
25340054|NCT00727272|50656307|FG000|Washout Period B|Withdrawal by Subject|0|||
25340055|NCT00727272|50656308|FG001|Washout Period B|Withdrawal by Subject|0|||
25340056|NCT00727272|50656309|FG002|Washout Period B|Withdrawal by Subject|1|||
25340057|NCT00805025|50656319|FG000|Overall Study|Screened but not enrolled/treated|42|||
25340058|NCT00805025|50656319|FG000|Overall Study|Adverse Event|4|||
25340059|NCT00805025|50656319|FG000|Overall Study|Withdrawal by Subject|2|||
25340060|NCT00805025|50656319|FG000|Overall Study|Physician Decision|1|||
25340061|NCT00734214|50656325|FG000|Overall Study|Withdrawal by Subject|3|||
25340062|NCT00734214|50656326|FG001|Overall Study|Withdrawal by Subject|4|||
25340063|NCT00734214|50656325|FG000|Overall Study|MD withdrawal|1|||
25340064|NCT00734214|50656326|FG001|Overall Study|MD withdrawal|0|||
25340065|NCT00787202|50656337|FG000|Overall Study|Adverse Event|3|||
25340066|NCT00787202|50656338|FG001|Overall Study|Adverse Event|2|||
25340067|NCT00787202|50656339|FG002|Overall Study|Adverse Event|0|||
25340068|NCT00787202|50656340|FG003|Overall Study|Adverse Event|0|||
25340069|NCT00787202|50656341|FG004|Overall Study|Adverse Event|2|||
25340070|NCT00787202|50656337|FG000|Overall Study|Lack of Efficacy|5|||
25340071|NCT00787202|50656338|FG001|Overall Study|Lack of Efficacy|6|||
25340072|NCT00787202|50656339|FG002|Overall Study|Lack of Efficacy|5|||
25340073|NCT00787202|50656340|FG003|Overall Study|Lack of Efficacy|2|||
24903992|NCT00772889|49997708|FG001|Overall Study|Adverse Event|4|||
24903993|NCT00772889|49997709|FG002|Overall Study|Adverse Event|0|||
24903994|NCT00772889|49997707|FG000|Overall Study|Withdrawal by Subject|9|||
24903995|NCT00772889|49997708|FG001|Overall Study|Withdrawal by Subject|8|||
24903996|NCT00772889|49997709|FG002|Overall Study|Withdrawal by Subject|9|||
24903997|NCT00772889|49997707|FG000|Overall Study|Lost to Follow-up|6|||
24903998|NCT00772889|49997708|FG001|Overall Study|Lost to Follow-up|6|||
24903999|NCT00772889|49997709|FG002|Overall Study|Lost to Follow-up|7|||
24904000|NCT01247324|49997719|FG000|Overall Study|Death|1|||
24904001|NCT01247324|49997720|FG001|Overall Study|Death|0|||
24904002|NCT01247324|49997719|FG000|Overall Study|Physician Decision|0|||
25340074|NCT00787202|50656341|FG004|Overall Study|Lack of Efficacy|1|||
25340075|NCT00787202|50656337|FG000|Overall Study|Lost to Follow-up|1|||
25340076|NCT00787202|50656338|FG001|Overall Study|Lost to Follow-up|0|||
25340077|NCT00787202|50656339|FG002|Overall Study|Lost to Follow-up|0|||
25340078|NCT00787202|50656340|FG003|Overall Study|Lost to Follow-up|0|||
25340079|NCT00787202|50656341|FG004|Overall Study|Lost to Follow-up|0|||
25340080|NCT00787202|50656337|FG000|Overall Study|Withdrawal by Subject|2|||
25340081|NCT00787202|50656338|FG001|Overall Study|Withdrawal by Subject|2|||
25340082|NCT00787202|50656339|FG002|Overall Study|Withdrawal by Subject|2|||
25340083|NCT00787202|50656340|FG003|Overall Study|Withdrawal by Subject|0|||
25340084|NCT00787202|50656341|FG004|Overall Study|Withdrawal by Subject|0|||
25340085|NCT00787202|50656337|FG000|Overall Study|Protocol Violation|2|||
25340086|NCT00787202|50656338|FG001|Overall Study|Protocol Violation|1|||
25340087|NCT00787202|50656339|FG002|Overall Study|Protocol Violation|0|||
25340088|NCT00787202|50656340|FG003|Overall Study|Protocol Violation|0|||
25340089|NCT00787202|50656341|FG004|Overall Study|Protocol Violation|1|||
25340090|NCT00787202|50656337|FG000|Overall Study|Randomized, not treated|1|||
25340091|NCT00787202|50656338|FG001|Overall Study|Randomized, not treated|0|||
24904003|NCT01247324|49997720|FG001|Overall Study|Physician Decision|1|||
24904004|NCT01247324|49997719|FG000|Overall Study|Non-compliance with study drug|3|||
24904005|NCT01247324|49997720|FG001|Overall Study|Non-compliance with study drug|0|||
24904006|NCT01247324|49997719|FG000|Overall Study|Lack of Efficacy|12|||
24904007|NCT01247324|49997720|FG001|Overall Study|Lack of Efficacy|8|||
24904008|NCT01247324|49997719|FG000|Overall Study|Non-compliance|2|||
24904009|NCT01247324|49997720|FG001|Overall Study|Non-compliance|0|||
25340092|NCT00787202|50656339|FG002|Overall Study|Randomized, not treated|0|||
25340093|NCT00787202|50656340|FG003|Overall Study|Randomized, not treated|0|||
25340094|NCT00787202|50656341|FG004|Overall Study|Randomized, not treated|0|||
25340095|NCT04033367|50656359|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
25340096|NCT04033367|50656360|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
25340097|NCT04033367|50656359|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
25340098|NCT04033367|50656360|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
25340099|NCT04033367|50656359|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
25340100|NCT04033367|50656360|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
25340101|NCT04033367|50656359|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
25340102|NCT04033367|50656360|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
25340103|NCT00733980|50656372|FG000|Overall Study|Adverse Event|5|||
25340104|NCT00733980|50656373|FG001|Overall Study|Adverse Event|2|||
24904010|NCT01247324|49997719|FG000|Overall Study|Pregnancy|2|||
24904011|NCT01247324|49997720|FG001|Overall Study|Pregnancy|3|||
24904012|NCT01247324|49997719|FG000|Overall Study|Protocol Violation|1|||
24904013|NCT01247324|49997720|FG001|Overall Study|Protocol Violation|2|||
24904014|NCT01247324|49997719|FG000|Overall Study|Reason not specified|11|||
24904015|NCT01247324|49997720|FG001|Overall Study|Reason not specified|8|||
24904016|NCT01247324|49997719|FG000|Overall Study|Consent withdrawn by participant|13|||
24904017|NCT01247324|49997720|FG001|Overall Study|Consent withdrawn by participant|8|||
24904018|NCT01247324|49997719|FG000|Overall Study|Adverse Event|25|||
24904019|NCT01247324|49997720|FG001|Overall Study|Adverse Event|13|||
25171888|NCT01755767|50309515|FG000|Overall Study|Clinical Disease Progression|4|||
25171889|NCT01755767|50309516|FG001|Overall Study|Clinical Disease Progression|2|||
25171890|NCT01755767|50309517|FG002|Overall Study|Clinical Disease Progression|29|||
25340105|NCT00733980|50656372|FG000|Overall Study|Lack of Efficacy|0|||
24904020|NCT01247324|49997719|FG000|Overall Study|Lost to Follow-up|1|||
24904021|NCT01247324|49997720|FG001|Overall Study|Lost to Follow-up|1|||
24904022|NCT00772577|49997729|FG000|Overall Study|Adverse Event|6|||
24904023|NCT00772577|49997730|FG001|Overall Study|Adverse Event|3|||
24904024|NCT00772577|49997729|FG000|Overall Study|Abnormal laboratory values|0|||
24904025|NCT00772577|49997730|FG001|Overall Study|Abnormal laboratory values|1|||
24904026|NCT00772577|49997729|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
24904027|NCT00772577|49997730|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
24904028|NCT00772577|49997729|FG000|Overall Study|Patient withdrew consent|8|||
24904029|NCT00772577|49997730|FG001|Overall Study|Patient withdrew consent|5|||
24904030|NCT00772577|49997729|FG000|Overall Study|Lost to Follow-up|4|||
25340106|NCT00733980|50656373|FG001|Overall Study|Lack of Efficacy|1|||
25340107|NCT00733980|50656372|FG000|Overall Study|Protocol Violation|2|||
25340108|NCT00733980|50656373|FG001|Overall Study|Protocol Violation|1|||
25340109|NCT00733980|50656372|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
25340110|NCT00733980|50656373|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
25340111|NCT00733980|50656372|FG000|Overall Study|Lost to Follow-up|6|||
25340112|NCT00733980|50656373|FG001|Overall Study|Lost to Follow-up|11|||
25340113|NCT00733980|50656372|FG000|Overall Study|Physician Decision|2|||
25340114|NCT00733980|50656373|FG001|Overall Study|Physician Decision|3|||
24904031|NCT00772577|49997730|FG001|Overall Study|Lost to Follow-up|3|||
24904032|NCT00772577|49997729|FG000|Overall Study|Administrative problems|2|||
24904033|NCT00772577|49997730|FG001|Overall Study|Administrative problems|1|||
24904034|NCT00772577|49997729|FG000|Overall Study|Protocol Deviation|3|||
25340115|NCT00733980|50656372|FG000|Overall Study|Withdrawal by Subject|6|||
25340116|NCT00733980|50656373|FG001|Overall Study|Withdrawal by Subject|2|||
25340117|NCT00806585|50656385|FG000|Overall Study|Study terminated by Sponsor|0|||
25340118|NCT00806585|50656386|FG001|Overall Study|Study terminated by Sponsor|0|||
25340119|NCT00806585|50656387|FG002|Overall Study|Study terminated by Sponsor|1|||
24904035|NCT00772577|49997730|FG001|Overall Study|Protocol Deviation|2|||
24904036|NCT02345850|49997739|FG000|Overall Study|Not transplanted|10|||
24904037|NCT02345850|49997740|FG001|Overall Study|Not transplanted|5|||
24904038|NCT02345850|49997741|FG002|Overall Study|Not transplanted|4|||
24904039|NCT02345850|49997739|FG000|Overall Study|Lost to Follow-up|2|||
24904040|NCT02345850|49997740|FG001|Overall Study|Lost to Follow-up|3|||
24904041|NCT02345850|49997741|FG002|Overall Study|Lost to Follow-up|2|||
24904042|NCT02345850|49997739|FG000|Overall Study|Withdrawal by Subject|1|||
24904043|NCT02345850|49997740|FG001|Overall Study|Withdrawal by Subject|0|||
24904044|NCT02345850|49997741|FG002|Overall Study|Withdrawal by Subject|0|||
24904045|NCT00659607|49997749|FG000|Overall Study|No blood pressure recorded|147|||
24904046|NCT00659607|49997749|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
24904047|NCT00659607|49997749|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
24904048|NCT00659607|49997749|FG000|Overall Study|No recorded efficacy data|15|||
24904049|NCT00659607|49997749|FG000|Overall Study|Inconsistent BP measuring date|2|||
24904050|NCT02848092|49997757|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
24904051|NCT02848092|49997758|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
24904052|NCT02848092|49997757|FG000|1-month Post-training Follow-up|Adverse Event|2|||
24904053|NCT02848092|49997758|FG001|1-month Post-training Follow-up|Adverse Event|1|||
24904054|NCT02848092|49997757|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
24904055|NCT02848092|49997758|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
24904056|NCT02848092|49997757|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
24904057|NCT02848092|49997758|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
24904058|NCT02848092|49997757|FG000|1-month Post-training Follow-up|fatigue|0|||
24904059|NCT02848092|49997758|FG001|1-month Post-training Follow-up|fatigue|1|||
24904060|NCT02848092|49997757|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
24904061|NCT02848092|49997758|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
24904062|NCT02848092|49997757|FG000|6-month Post-training Follow-up|Adverse Event|1|||
24904063|NCT02848092|49997758|FG001|6-month Post-training Follow-up|Adverse Event|1|||
24904064|NCT02848092|49997757|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
24904065|NCT02848092|49997758|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
24904066|NCT02848092|49997757|FG000|6-month Post-training Follow-up|frustrated with task|1|||
24904067|NCT02848092|49997758|FG001|6-month Post-training Follow-up|frustrated with task|0|||
24904068|NCT02848092|49997757|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
24904069|NCT02848092|49997758|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
24904070|NCT02848092|49997757|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
24904071|NCT02848092|49997758|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
24904072|NCT00660309|49997766|FG000|Overall Study|Adverse Event|2|||
24904073|NCT00660309|49997767|FG001|Overall Study|Adverse Event|0|||
24904074|NCT00660309|49997766|FG000|Overall Study|Withdrawal by Subject|0|||
24904075|NCT00660309|49997767|FG001|Overall Study|Withdrawal by Subject|3|||
24904076|NCT00581100|49997776|FG000|Overall Study|Death|1|||
24904077|NCT00581100|49997777|FG001|Overall Study|Death|0|||
24904078|NCT00581100|49997776|FG000|Overall Study|Adverse Event|2|||
24904079|NCT00581100|49997777|FG001|Overall Study|Adverse Event|1|||
24904080|NCT00581100|49997776|FG000|Overall Study|Withdrawal by Subject|1|||
24904081|NCT00581100|49997777|FG001|Overall Study|Withdrawal by Subject|4|||
24904082|NCT00581100|49997776|FG000|Overall Study|Other|3|||
24904083|NCT00581100|49997777|FG001|Overall Study|Other|0|||
25340120|NCT00806585|50656388|FG003|Overall Study|Study terminated by Sponsor|2|||
25340121|NCT00806585|50656389|FG004|Overall Study|Study terminated by Sponsor|0|||
25340122|NCT00806585|50656385|FG000|Overall Study|Protocol Violation|3|||
25340123|NCT00806585|50656386|FG001|Overall Study|Protocol Violation|1|||
25340124|NCT00806585|50656387|FG002|Overall Study|Protocol Violation|2|||
25340125|NCT00806585|50656388|FG003|Overall Study|Protocol Violation|0|||
25340126|NCT00806585|50656389|FG004|Overall Study|Protocol Violation|0|||
25340127|NCT00806585|50656385|FG000|Overall Study|Physician Decision|0|||
25340128|NCT00806585|50656386|FG001|Overall Study|Physician Decision|2|||
25340129|NCT00806585|50656387|FG002|Overall Study|Physician Decision|3|||
25340130|NCT00806585|50656388|FG003|Overall Study|Physician Decision|0|||
25340131|NCT00806585|50656389|FG004|Overall Study|Physician Decision|1|||
25340132|NCT00806585|50656385|FG000|Overall Study|Lost to Follow-up|2|||
24904084|NCT00579098|49997785|FG000|Overall Study|Lost to Follow-up|2|||
24904085|NCT00579098|49997786|FG001|Overall Study|Lost to Follow-up|0|||
24904086|NCT00579098|49997785|FG000|Overall Study|Adverse Event|2|||
24904087|NCT00579098|49997786|FG001|Overall Study|Adverse Event|3|||
24904088|NCT00579098|49997785|FG000|Overall Study|Withdrawal by Subject|2|||
24904089|NCT00579098|49997786|FG001|Overall Study|Withdrawal by Subject|3|||
24904090|NCT00579098|49997785|FG000|Overall Study|AF returned after ablation|3|||
24904091|NCT00579098|49997786|FG001|Overall Study|AF returned after ablation|2|||
24904092|NCT00772109|49997796|FG000|Overall Study|Serious adverse event|1|||
25340133|NCT00806585|50656386|FG001|Overall Study|Lost to Follow-up|1|||
25340134|NCT00806585|50656387|FG002|Overall Study|Lost to Follow-up|2|||
25340135|NCT00806585|50656388|FG003|Overall Study|Lost to Follow-up|2|||
25340136|NCT00806585|50656389|FG004|Overall Study|Lost to Follow-up|5|||
24904093|NCT00772109|49997797|FG001|Overall Study|Serious adverse event|0|||
24904094|NCT00772109|49997798|FG002|Overall Study|Serious adverse event|1|||
24904095|NCT00772109|49997799|FG003|Overall Study|Serious adverse event|0|||
24904096|NCT00772109|49997796|FG000|Overall Study|Protocol Violation|5|||
24904097|NCT00772109|49997797|FG001|Overall Study|Protocol Violation|8|||
24904098|NCT00772109|49997798|FG002|Overall Study|Protocol Violation|7|||
24904099|NCT00772109|49997799|FG003|Overall Study|Protocol Violation|6|||
24904100|NCT00772109|49997796|FG000|Overall Study|Lost to Follow-up|7|||
24904101|NCT00772109|49997797|FG001|Overall Study|Lost to Follow-up|3|||
24904102|NCT00772109|49997798|FG002|Overall Study|Lost to Follow-up|5|||
24904103|NCT00772109|49997799|FG003|Overall Study|Lost to Follow-up|9|||
24904104|NCT00772109|49997796|FG000|Overall Study|Withdrawal by Subject|8|||
24904105|NCT00772109|49997797|FG001|Overall Study|Withdrawal by Subject|8|||
24904106|NCT00772109|49997798|FG002|Overall Study|Withdrawal by Subject|6|||
24904107|NCT00772109|49997799|FG003|Overall Study|Withdrawal by Subject|16|||
24904108|NCT00772031|49997811|FG000|Overall Study|Early termination of trial|12|||
24904109|NCT00772031|49997812|FG001|Overall Study|Early termination of trial|10|||
24904110|NCT00772031|49997811|FG000|Overall Study|Lost to Follow-up|20|||
24904111|NCT00772031|49997812|FG001|Overall Study|Lost to Follow-up|33|||
24904112|NCT00580866|49997826|FG000|Overall Study|Lost to Follow-up|2|||
24904113|NCT00580866|49997827|FG001|Overall Study|Lost to Follow-up|2|||
24904114|NCT00771953|49997835|FG000|Overall Study|Adverse Event|5|||
24904115|NCT00771953|49997836|FG001|Overall Study|Adverse Event|3|||
24904116|NCT00771953|49997835|FG000|Overall Study|Death|2|||
24904117|NCT00771953|49997836|FG001|Overall Study|Death|2|||
24904118|NCT00771953|49997835|FG000|Overall Study|Progression before active Tx|1|||
24904119|NCT00771953|49997836|FG001|Overall Study|Progression before active Tx|2|||
24904120|NCT00771953|49997835|FG000|Overall Study|Sponsor decision|1|||
24904121|NCT00771953|49997836|FG001|Overall Study|Sponsor decision|0|||
24904122|NCT00771953|49997835|FG000|Overall Study|Other complicating disease|1|||
24904123|NCT00771953|49997836|FG001|Overall Study|Other complicating disease|0|||
24904124|NCT00771953|49997835|FG000|Overall Study|Withdrawal by Subject|0|||
24904125|NCT00771953|49997836|FG001|Overall Study|Withdrawal by Subject|3|||
24904126|NCT00621244|49997848|FG000|Overall Study|Withdrawal by Subject|7|||
24904127|NCT00621244|49997849|FG001|Overall Study|Withdrawal by Subject|3|||
24904128|NCT00621244|49997850|FG002|Overall Study|Withdrawal by Subject|3|||
24904129|NCT00621244|49997851|FG003|Overall Study|Withdrawal by Subject|3|||
24904130|NCT00621244|49997848|FG000|Overall Study|Disease progression|44|||
25078006|NCT02456636|50186181|FG002|Overall Study|Withdrawal by Subject|16|||
25078007|NCT02456636|50186179|FG000|Overall Study|Lost to Follow-up|50|||
25078008|NCT02456636|50186180|FG001|Overall Study|Lost to Follow-up|44|||
25078009|NCT02456636|50186181|FG002|Overall Study|Lost to Follow-up|50|||
25078010|NCT02226172|50186189|FG000|Overall Study|Participant refused further follow-up|4|||
25078011|NCT02226172|50186189|FG000|Overall Study|Other|5|||
25078012|NCT02226172|50186189|FG000|Overall Study|Death|1|||
25078013|NCT02226172|50186189|FG000|Overall Study|Study terminated by sponsor|1|||
25078014|NCT02226172|50186189|FG000|Overall Study|Adverse Event|6|||
25078015|NCT01676961|50186193|FG000|Overall Study|Death|3|||
25078016|NCT01676961|50186193|FG000|Overall Study|Lost to Follow-up|1|||
25078017|NCT01676961|50186193|FG000|Overall Study|Withdrawal by Subject|1|||
25078018|NCT01676727|50186215|FG000|Overall Study|Death|18|||
25078019|NCT01676727|50186215|FG000|Overall Study|Withdrawal by Subject|6|||
25078020|NCT01676727|50186215|FG000|Overall Study|Screening failure|5|||
25078021|NCT01676727|50186215|FG000|Overall Study|Not willing to attend 1-year visit|2|||
25078022|NCT01676727|50186215|FG000|Overall Study|Valve explanted|1|||
25078023|NCT03745651|50186223|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
25078024|NCT03745651|50186224|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
25078025|NCT03745651|50186225|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
25078026|NCT03745651|50186226|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
25340137|NCT00806585|50656385|FG000|Overall Study|Lack of Efficacy|1|||
24904131|NCT00621244|49997849|FG001|Overall Study|Disease progression|20|||
24904132|NCT00621244|49997850|FG002|Overall Study|Disease progression|20|||
24904133|NCT00621244|49997851|FG003|Overall Study|Disease progression|15|||
24904134|NCT00621244|49997848|FG000|Overall Study|Death|3|||
24904135|NCT00621244|49997849|FG001|Overall Study|Death|3|||
24904136|NCT00621244|49997850|FG002|Overall Study|Death|1|||
24904137|NCT00621244|49997851|FG003|Overall Study|Death|1|||
24904138|NCT00621244|49997848|FG000|Overall Study|Adverse Event|27|||
25078027|NCT03745651|50186227|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
25078028|NCT03745651|50186228|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
25078029|NCT03745651|50186229|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
25078030|NCT03745651|50186223|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
24904139|NCT00621244|49997849|FG001|Overall Study|Adverse Event|7|||
24904140|NCT00621244|49997850|FG002|Overall Study|Adverse Event|9|||
24904141|NCT00621244|49997851|FG003|Overall Study|Adverse Event|2|||
24904142|NCT00621244|49997848|FG000|Overall Study|Administrative problems|5|||
24904143|NCT00621244|49997849|FG001|Overall Study|Administrative problems|1|||
24904144|NCT00621244|49997850|FG002|Overall Study|Administrative problems|0|||
24904145|NCT00621244|49997851|FG003|Overall Study|Administrative problems|2|||
24904146|NCT00659529|49997925|FG000|Overall Study|Withdrawal by Subject|4|||
24904147|NCT00659529|49997925|FG000|Overall Study|Protocol Violation|3|||
24904148|NCT00659529|49997925|FG000|Overall Study|Screen failure|9|||
24904149|NCT00578942|49997929|FG000|Overall Study|Lost to Follow-up|1|||
24904150|NCT00765245|49997935|FG000|Overall Study|disease progression|3|||
24904151|NCT00765245|49997936|FG001|Overall Study|disease progression|2|||
24904152|NCT00765245|49997935|FG000|Overall Study|Withdrawal by Subject|3|||
24904153|NCT00765245|49997936|FG001|Overall Study|Withdrawal by Subject|0|||
24904154|NCT00765245|49997935|FG000|Overall Study|Adverse Event|5|||
24904155|NCT00765245|49997936|FG001|Overall Study|Adverse Event|0|||
24904156|NCT00765245|49997935|FG000|Overall Study|Physician Decision|1|||
24904157|NCT00765245|49997936|FG001|Overall Study|Physician Decision|0|||
24904158|NCT00765245|49997935|FG000|Overall Study|Death|1|||
24904159|NCT00765245|49997936|FG001|Overall Study|Death|0|||
24904160|NCT00782795|49997944|FG000|Overall Study|Withdrawal by Subject|1|||
24904161|NCT00782795|49997945|FG001|Overall Study|Withdrawal by Subject|2|||
24904162|NCT00656799|49997951|FG000|Overall Study|Death|2|||
24904163|NCT00764699|49997955|FG000|Overall Study|PI left and study terminated|3|||
24904164|NCT00782717|49997961|FG000|Overall Study|Adverse Event|2|||
24904165|NCT00782717|49997962|FG001|Overall Study|Adverse Event|5|||
24904166|NCT00782717|49997961|FG000|Overall Study|Patient decision unrelated to AE|6|||
24904167|NCT00782717|49997962|FG001|Overall Study|Patient decision unrelated to AE|3|||
24904168|NCT00782717|49997961|FG000|Overall Study|Noncompliance|2|||
24904169|NCT00782717|49997962|FG001|Overall Study|Noncompliance|1|||
24904170|NCT00782717|49997961|FG000|Overall Study|Treatment failure|3|||
24904171|NCT00782717|49997962|FG001|Overall Study|Treatment failure|14|||
24904172|NCT00782717|49997961|FG000|Overall Study|Enrollment close prior to surgery|1|||
24904173|NCT00782717|49997962|FG001|Overall Study|Enrollment close prior to surgery|0|||
24904174|NCT00782717|49997961|FG000|Overall Study|Did not meet entrance criteria|1|||
24904175|NCT00782717|49997962|FG001|Overall Study|Did not meet entrance criteria|3|||
24904176|NCT00782717|49997961|FG000|Overall Study|Exited in error|0|||
24904177|NCT00782717|49997962|FG001|Overall Study|Exited in error|2|||
24904178|NCT00656175|49997970|FG000|Overall Study|Adverse Event|1|||
24904179|NCT00656175|49997971|FG001|Overall Study|Adverse Event|0|||
25340138|NCT00806585|50656386|FG001|Overall Study|Lack of Efficacy|0|||
25340139|NCT00806585|50656387|FG002|Overall Study|Lack of Efficacy|0|||
25340140|NCT00806585|50656388|FG003|Overall Study|Lack of Efficacy|0|||
25340141|NCT00806585|50656389|FG004|Overall Study|Lack of Efficacy|0|||
25340142|NCT00806585|50656385|FG000|Overall Study|Adverse Event|1|||
25340143|NCT00806585|50656386|FG001|Overall Study|Adverse Event|5|||
25078031|NCT03745651|50186224|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
25078032|NCT03745651|50186225|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
25078033|NCT03745651|50186226|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25078034|NCT03745651|50186227|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25078035|NCT03745651|50186228|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25078036|NCT03745651|50186229|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
25078037|NCT03745651|50186223|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
25078038|NCT03745651|50186224|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
25078039|NCT03745651|50186225|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
25078040|NCT03745651|50186226|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
25078041|NCT03745651|50186227|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
25078042|NCT03745651|50186228|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
25078043|NCT03745651|50186229|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
25078044|NCT03745651|50186223|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
25078045|NCT03745651|50186224|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
25078046|NCT03745651|50186225|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
25078047|NCT03745651|50186226|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
25340144|NCT00806585|50656387|FG002|Overall Study|Adverse Event|3|||
25340145|NCT00806585|50656388|FG003|Overall Study|Adverse Event|4|||
25340146|NCT00806585|50656389|FG004|Overall Study|Adverse Event|2|||
24904180|NCT00656175|49997970|FG000|Overall Study|Transportation issues|0|||
24904181|NCT00656175|49997971|FG001|Overall Study|Transportation issues|1|||
24904182|NCT00620776|49997979|FG000|Overall Study|Did not receive treatment|3|||
24904183|NCT00620776|49997980|FG001|Overall Study|Did not receive treatment|5|||
24904184|NCT00620776|49997979|FG000|Overall Study|Adverse Event|2|||
24904185|NCT00620776|49997980|FG001|Overall Study|Adverse Event|3|||
24904186|NCT00620776|49997979|FG000|Overall Study|Lack of Efficacy|2|||
24904187|NCT00620776|49997980|FG001|Overall Study|Lack of Efficacy|1|||
24904188|NCT00620776|49997979|FG000|Overall Study|Lost to Follow-up|2|||
25254726|NCT01349049|50570378|FG006|Overall Study|Non-compliance|0|||
25254727|NCT01349049|50570379|FG007|Overall Study|Non-compliance|0|||
25254728|NCT01349049|50570380|FG008|Overall Study|Non-compliance|0|||
24904189|NCT00620776|49997980|FG001|Overall Study|Lost to Follow-up|5|||
25340147|NCT00806585|50656385|FG000|Overall Study|Withdrawal by Subject|10|||
25340148|NCT00806585|50656386|FG001|Overall Study|Withdrawal by Subject|8|||
25340149|NCT00806585|50656387|FG002|Overall Study|Withdrawal by Subject|9|||
25340150|NCT00806585|50656388|FG003|Overall Study|Withdrawal by Subject|3|||
25340151|NCT00806585|50656389|FG004|Overall Study|Withdrawal by Subject|11|||
25340152|NCT00806585|50656385|FG000|Overall Study|Completion status unknown|15|||
25340153|NCT00806585|50656386|FG001|Overall Study|Completion status unknown|14|||
25340154|NCT00806585|50656387|FG002|Overall Study|Completion status unknown|12|||
25340155|NCT00806585|50656388|FG003|Overall Study|Completion status unknown|4|||
25340156|NCT00806585|50656389|FG004|Overall Study|Completion status unknown|12|||
25340157|NCT00480025|50656403|FG000|Overall Study|Protocol Violation|12|||
25340158|NCT00480025|50656404|FG001|Overall Study|Protocol Violation|7|||
25340159|NCT00480025|50656403|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
25340160|NCT00480025|50656404|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
25340161|NCT00480025|50656403|FG000|Overall Study|Disease Progression / Recurrence|449|||
25340162|NCT00480025|50656404|FG001|Overall Study|Disease Progression / Recurrence|224|||
25340163|NCT00480025|50656403|FG000|Overall Study|Adverse Event|44|||
25340164|NCT00480025|50656404|FG001|Overall Study|Adverse Event|12|||
25340165|NCT00480025|50656403|FG000|Overall Study|Other|70|||
25340166|NCT00480025|50656404|FG001|Overall Study|Other|29|||
25340167|NCT00480025|50656403|FG000|Overall Study|SAE including intercurrent illness|76|||
25340168|NCT00480025|50656404|FG001|Overall Study|SAE including intercurrent illness|42|||
25340169|NCT00806351|50656418|FG000|Overall Study|Death|5|||
25254729|NCT01349049|50570372|FG000|Overall Study|Withdrawal by Subject|0|||
24977575|NCT00048074|50066103|FG001|Overall Study|Poor compliance|1|||
24977576|NCT00048074|50066104|FG002|Overall Study|Poor compliance|0|||
24977577|NCT00048074|50066102|FG000|Overall Study|Out of station|0|||
25254730|NCT01349049|50570373|FG001|Overall Study|Withdrawal by Subject|0|||
25254731|NCT01349049|50570374|FG002|Overall Study|Withdrawal by Subject|0|||
25340170|NCT00806351|50656419|FG001|Overall Study|Death|4|||
25340171|NCT00733902|50656429|FG000|Overall Study|Death|0|||
25340172|NCT00733902|50656430|FG001|Overall Study|Death|0|||
25340173|NCT00733902|50656431|FG002|Overall Study|Death|0|||
25340174|NCT00733902|50656432|FG003|Overall Study|Death|1|||
25340175|NCT00733902|50656429|FG000|Overall Study|Adverse Event|3|||
25340176|NCT00733902|50656430|FG001|Overall Study|Adverse Event|4|||
25340177|NCT00733902|50656431|FG002|Overall Study|Adverse Event|7|||
25340178|NCT00733902|50656432|FG003|Overall Study|Adverse Event|11|||
25340179|NCT00733902|50656429|FG000|Overall Study|Lack of Efficacy|56|||
25340180|NCT00733902|50656430|FG001|Overall Study|Lack of Efficacy|21|||
25340181|NCT00733902|50656431|FG002|Overall Study|Lack of Efficacy|34|||
25340182|NCT00733902|50656432|FG003|Overall Study|Lack of Efficacy|23|||
25340183|NCT00733902|50656429|FG000|Overall Study|Protocol Violation|4|||
25340184|NCT00733902|50656430|FG001|Overall Study|Protocol Violation|6|||
25340185|NCT00733902|50656431|FG002|Overall Study|Protocol Violation|3|||
25340186|NCT00733902|50656432|FG003|Overall Study|Protocol Violation|3|||
25340187|NCT00733902|50656429|FG000|Overall Study|Withdrawal by Subject|10|||
25340188|NCT00733902|50656430|FG001|Overall Study|Withdrawal by Subject|5|||
25340189|NCT00733902|50656431|FG002|Overall Study|Withdrawal by Subject|4|||
25340190|NCT00733902|50656432|FG003|Overall Study|Withdrawal by Subject|16|||
25340191|NCT00733902|50656429|FG000|Overall Study|Entered extension study|89|||
25340192|NCT00733902|50656430|FG001|Overall Study|Entered extension study|124|||
25340193|NCT00733902|50656431|FG002|Overall Study|Entered extension study|111|||
24904190|NCT00620776|49997979|FG000|Overall Study|Withdrawal by Subject|3|||
24904191|NCT00620776|49997980|FG001|Overall Study|Withdrawal by Subject|2|||
24904192|NCT00656019|49997990|FG000|Overall Study|Not Eligible|10|||
24904193|NCT00656019|49997991|FG001|Overall Study|Not Eligible|0|||
24904194|NCT00656019|49997992|FG002|Overall Study|Not Eligible|0|||
24904195|NCT00656019|49997993|FG003|Overall Study|Not Eligible|0|||
24904196|NCT00656019|49997990|FG000|Overall Study|Withdrawal by Subject|2|||
24904197|NCT00656019|49997991|FG001|Overall Study|Withdrawal by Subject|0|||
24904198|NCT00656019|49997992|FG002|Overall Study|Withdrawal by Subject|0|||
24977578|NCT00048074|50066103|FG001|Overall Study|Out of station|1|||
24977579|NCT00048074|50066104|FG002|Overall Study|Out of station|1|||
24977580|NCT00048074|50066102|FG000|Overall Study|Social reasons|1|||
25254732|NCT01349049|50570375|FG003|Overall Study|Withdrawal by Subject|0|||
25254733|NCT01349049|50570376|FG004|Overall Study|Withdrawal by Subject|0|||
25254734|NCT01349049|50570377|FG005|Overall Study|Withdrawal by Subject|0|||
25254735|NCT01349049|50570378|FG006|Overall Study|Withdrawal by Subject|0|||
25254736|NCT01349049|50570379|FG007|Overall Study|Withdrawal by Subject|0|||
25340194|NCT00733902|50656432|FG003|Overall Study|Entered extension study|109|||
25340195|NCT00733902|50656429|FG000|Overall Study|Randomized but not treated|2|||
24904199|NCT00656019|49997993|FG003|Overall Study|Withdrawal by Subject|0|||
24977581|NCT00048074|50066103|FG001|Overall Study|Social reasons|0|||
24977582|NCT00048074|50066104|FG002|Overall Study|Social reasons|0|||
25254737|NCT01349049|50570380|FG008|Overall Study|Withdrawal by Subject|6|||
25340196|NCT00733902|50656430|FG001|Overall Study|Randomized but not treated|2|||
24904200|NCT00656019|49997990|FG000|Overall Study|Lost to Follow-up|2|||
24904201|NCT00656019|49997991|FG001|Overall Study|Lost to Follow-up|1|||
24904202|NCT00656019|49997992|FG002|Overall Study|Lost to Follow-up|0|||
24904203|NCT00656019|49997993|FG003|Overall Study|Lost to Follow-up|0|||
24904204|NCT00782483|49998003|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
24904205|NCT00782171|49998009|FG000|Overall Study|Lost to Follow-up|2|||
24904206|NCT00782171|49998010|FG001|Overall Study|Lost to Follow-up|2|||
24904207|NCT00782171|49998009|FG000|Overall Study|Withdrawal by Subject|2|||
24904208|NCT00782171|49998010|FG001|Overall Study|Withdrawal by Subject|1|||
24904209|NCT00782171|49998009|FG000|Overall Study|complications|3|||
24904210|NCT00782171|49998010|FG001|Overall Study|complications|1|||
24904211|NCT00782171|49998009|FG000|Overall Study|others|7|||
24904212|NCT00782171|49998010|FG001|Overall Study|others|9|||
24904213|NCT00782171|49998009|FG000|Overall Study|not eligible|8|||
24904214|NCT00782171|49998010|FG001|Overall Study|not eligible|6|||
24904215|NCT00764465|49998022|FG000|Overall Study|Adverse Event|2|||
24904216|NCT00764465|49998023|FG001|Overall Study|Adverse Event|0|||
24904217|NCT00764465|49998024|FG002|Overall Study|Adverse Event|0|||
24904218|NCT00764465|49998025|FG003|Overall Study|Adverse Event|1|||
24904219|NCT00764465|49998026|FG004|Overall Study|Adverse Event|1|||
24904220|NCT00764465|49998027|FG005|Overall Study|Adverse Event|1|||
24904221|NCT00764465|49998022|FG000|Overall Study|Withdrawal by Subject|0|||
24904222|NCT00764465|49998023|FG001|Overall Study|Withdrawal by Subject|1|||
24904223|NCT00764465|49998024|FG002|Overall Study|Withdrawal by Subject|1|||
24904224|NCT00764465|49998025|FG003|Overall Study|Withdrawal by Subject|0|||
24904225|NCT00764465|49998026|FG004|Overall Study|Withdrawal by Subject|0|||
24904226|NCT00764465|49998027|FG005|Overall Study|Withdrawal by Subject|0|||
24904227|NCT00655863|49998047|FG000|Overall Study|Lost to Follow-up|0|||
24904228|NCT00655863|49998048|FG001|Overall Study|Lost to Follow-up|0|||
24904229|NCT00655863|49998049|FG002|Overall Study|Lost to Follow-up|1|||
24904230|NCT00781937|49998059|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
24904231|NCT00781937|49998060|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
24904232|NCT00781937|49998059|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
24904233|NCT00781937|49998060|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
24904234|NCT00781937|49998059|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
24904235|NCT00781937|49998060|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
24904236|NCT00781937|49998059|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
24904237|NCT00781937|49998060|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
24904238|NCT00781937|49998059|FG000|Main Trial Period Through Week 56|Unclassified|10|||
24904239|NCT00781937|49998060|FG001|Main Trial Period Through Week 56|Unclassified|15|||
24904240|NCT00781937|49998059|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
24904241|NCT00781937|49998060|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
24904242|NCT00781937|49998059|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
24904243|NCT00781937|49998060|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
24904244|NCT00659373|49998068|FG000|Overall Study|Withdrawal by Subject|3|||
24904245|NCT00659373|49998069|FG001|Overall Study|Withdrawal by Subject|5|||
24904246|NCT00659373|49998068|FG000|Overall Study|Assessment Missed|2|||
24904247|NCT00659373|49998069|FG001|Overall Study|Assessment Missed|2|||
24904248|NCT00439777|49998077|FG000|Treatment Period|Death|29|||
24904249|NCT00439777|49998078|FG001|Treatment Period|Death|21|||
24904250|NCT00439777|49998077|FG000|Treatment Period|Study terminated by sponsor|125|||
24904251|NCT00439777|49998078|FG001|Treatment Period|Study terminated by sponsor|132|||
24904252|NCT00439777|49998077|FG000|Treatment Period|Site closed by investigator|0|||
24904253|NCT00439777|49998078|FG001|Treatment Period|Site closed by investigator|1|||
24904254|NCT00439777|49998077|FG000|Treatment Period|Did not take study treatment|7|||
24904255|NCT00439777|49998078|FG001|Treatment Period|Did not take study treatment|8|||
24904256|NCT00439777|49998077|FG000|Treatment Period|Adverse Event|111|||
24904257|NCT00439777|49998078|FG001|Treatment Period|Adverse Event|92|||
24904258|NCT00439777|49998077|FG000|Treatment Period|Protocol Violation|23|||
24904259|NCT00439777|49998078|FG001|Treatment Period|Protocol Violation|30|||
24904260|NCT00439777|49998077|FG000|Treatment Period|Withdrawal by Subject|66|||
24904261|NCT00439777|49998078|FG001|Treatment Period|Withdrawal by Subject|118|||
24904262|NCT00439777|49998077|FG000|Treatment Period|Lack of Efficacy|1|||
24904263|NCT00439777|49998078|FG001|Treatment Period|Lack of Efficacy|4|||
24904264|NCT00439777|49998077|FG000|Treatment Period|Lost to Follow-up|8|||
24904265|NCT00439777|49998078|FG001|Treatment Period|Lost to Follow-up|10|||
24977583|NCT03831191|50066116|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
24904266|NCT00439777|49998077|FG000|Treatment Period|Protocol driven decision point|1|||
24904267|NCT00439777|49998078|FG001|Treatment Period|Protocol driven decision point|3|||
24904268|NCT00439777|49998077|FG000|Treatment Period|Physician Decision|7|||
24904269|NCT00439777|49998078|FG001|Treatment Period|Physician Decision|18|||
24904270|NCT00439777|49998077|FG000|Treatment Period|Clinical endpoint reached|26|||
24904271|NCT00439777|49998078|FG001|Treatment Period|Clinical endpoint reached|13|||
24904272|NCT00439777|49998077|FG000|Treatment Period|Technical problems|3|||
24904273|NCT00439777|49998078|FG001|Treatment Period|Technical problems|1|||
24904274|NCT00439777|49998077|FG000|Treatment Period|Participant convenience|12|||
24904275|NCT00439777|49998078|FG001|Treatment Period|Participant convenience|8|||
24904276|NCT00439777|49998077|FG000|Observational Period|Protocol Violation|0|||
24904277|NCT00439777|49998078|FG001|Observational Period|Protocol Violation|2|||
24904278|NCT00439777|49998077|FG000|Observational Period|Withdrawal by Subject|9|||
24904279|NCT00439777|49998078|FG001|Observational Period|Withdrawal by Subject|5|||
24904280|NCT00439777|49998077|FG000|Observational Period|Lost to Follow-up|1|||
24904281|NCT00439777|49998078|FG001|Observational Period|Lost to Follow-up|11|||
24904282|NCT00439777|49998077|FG000|Observational Period|Death|27|||
24904283|NCT00439777|49998078|FG001|Observational Period|Death|20|||
24904284|NCT00439777|49998077|FG000|Observational Period|Study terminated by sponsor|3|||
24904285|NCT00439777|49998078|FG001|Observational Period|Study terminated by sponsor|1|||
24904286|NCT00439777|49998077|FG000|Observational Period|Protocol driven decision point|0|||
24904287|NCT00439777|49998078|FG001|Observational Period|Protocol driven decision point|1|||
24904288|NCT00439777|49998077|FG000|Observational Period|Lack of Efficacy|1|||
24904289|NCT00439777|49998078|FG001|Observational Period|Lack of Efficacy|0|||
24904290|NCT00439777|49998077|FG000|Observational Period|Technical problems|0|||
24904291|NCT00439777|49998078|FG001|Observational Period|Technical problems|1|||
24904292|NCT00620854|49998090|FG000|Washout 1|Withdrawal by Subject|0|||
24904293|NCT00620854|49998091|FG001|Washout 1|Withdrawal by Subject|0|||
24904294|NCT00620854|49998092|FG002|Washout 1|Withdrawal by Subject|1|||
24904295|NCT00620854|49998093|FG003|Washout 1|Withdrawal by Subject|1|||
24904296|NCT00620854|49998094|FG004|Washout 1|Withdrawal by Subject|0|||
24904297|NCT00620854|49998095|FG005|Washout 1|Withdrawal by Subject|0|||
24904298|NCT00430027|49998106|FG000|Overall Study|Study terminated|8|||
24904299|NCT00429793|49998110|FG000|Overall Study|Improper pre-protocol treatment|3|||
24904300|NCT00429793|49998110|FG000|Overall Study|Required test not done|1|||
24904301|NCT00429793|49998110|FG000|Overall Study|Never treated|1|||
24904302|NCT00429793|49998110|FG000|Overall Study|Non-measurable|1|||
24904303|NCT00424645|49998121|FG000|Overall Study|Death|1|||
24904304|NCT00424645|49998122|FG001|Overall Study|Death|0|||
24904305|NCT00763451|49998132|FG000|Overall Study|Adverse Event|4|||
24904306|NCT00763451|49998133|FG001|Overall Study|Adverse Event|6|||
24904307|NCT00763451|49998134|FG002|Overall Study|Adverse Event|19|||
24904308|NCT00763451|49998135|FG003|Overall Study|Adverse Event|14|||
24904309|NCT00763451|49998132|FG000|Overall Study|Lack of Efficacy|1|||
24904310|NCT00763451|49998133|FG001|Overall Study|Lack of Efficacy|4|||
24904311|NCT00763451|49998134|FG002|Overall Study|Lack of Efficacy|3|||
24904312|NCT00763451|49998135|FG003|Overall Study|Lack of Efficacy|2|||
24904313|NCT00763451|49998132|FG000|Overall Study|Withdrawal by Subject|1|||
24904314|NCT00763451|49998133|FG001|Overall Study|Withdrawal by Subject|6|||
24904315|NCT00763451|49998134|FG002|Overall Study|Withdrawal by Subject|9|||
24904316|NCT00763451|49998135|FG003|Overall Study|Withdrawal by Subject|7|||
24904317|NCT00763451|49998132|FG000|Overall Study|Protocol Violation|0|||
24904318|NCT00763451|49998133|FG001|Overall Study|Protocol Violation|0|||
24904319|NCT00763451|49998134|FG002|Overall Study|Protocol Violation|1|||
24904320|NCT00763451|49998135|FG003|Overall Study|Protocol Violation|0|||
24904321|NCT00763451|49998132|FG000|Overall Study|Poor Compliance to Protocol|1|||
24904322|NCT00763451|49998133|FG001|Overall Study|Poor Compliance to Protocol|1|||
24904323|NCT00763451|49998134|FG002|Overall Study|Poor Compliance to Protocol|2|||
24904324|NCT00763451|49998135|FG003|Overall Study|Poor Compliance to Protocol|2|||
24904325|NCT00763451|49998132|FG000|Overall Study|Familial and Personal Reasons|5|||
24904326|NCT00763451|49998133|FG001|Overall Study|Familial and Personal Reasons|3|||
24904327|NCT00763451|49998134|FG002|Overall Study|Familial and Personal Reasons|5|||
24904328|NCT00763451|49998135|FG003|Overall Study|Familial and Personal Reasons|4|||
24904329|NCT00763451|49998132|FG000|Overall Study|Randomized but not Treated|1|||
24904330|NCT00763451|49998133|FG001|Overall Study|Randomized but not Treated|1|||
24904331|NCT00763451|49998134|FG002|Overall Study|Randomized but not Treated|0|||
24904332|NCT00763451|49998135|FG003|Overall Study|Randomized but not Treated|0|||
24904333|NCT00763451|49998132|FG000|Overall Study|Study Site Reason|0|||
24904334|NCT00763451|49998133|FG001|Overall Study|Study Site Reason|1|||
24904335|NCT00763451|49998134|FG002|Overall Study|Study Site Reason|1|||
24904336|NCT00763451|49998135|FG003|Overall Study|Study Site Reason|1|||
24904337|NCT00762762|49998148|FG000|Overall Study|Did not return for appointments|6|||
24904338|NCT00762762|49998149|FG001|Overall Study|Did not return for appointments|8|||
24904339|NCT00424489|49998157|FG000|Overall Study|Death|3|||
24904340|NCT00578864|49998163|FG000|Overall Study|Death|1|||
24904341|NCT00578864|49998164|FG001|Overall Study|Death|0|||
24904342|NCT00770315|49998187|FG000|Overall Study|Adverse Event|11|||
24904343|NCT00770315|49998188|FG001|Overall Study|Adverse Event|17|||
24904344|NCT00770315|49998189|FG002|Overall Study|Adverse Event|16|||
24904345|NCT00770315|49998190|FG003|Overall Study|Adverse Event|6|||
24904346|NCT00770315|49998187|FG000|Overall Study|Lost to Follow-up|9|||
24904347|NCT00770315|49998188|FG001|Overall Study|Lost to Follow-up|5|||
24904348|NCT00770315|49998189|FG002|Overall Study|Lost to Follow-up|10|||
24904349|NCT00770315|49998190|FG003|Overall Study|Lost to Follow-up|3|||
24904350|NCT00770315|49998187|FG000|Overall Study|Withdrawal by Subject|13|||
24904351|NCT00770315|49998188|FG001|Overall Study|Withdrawal by Subject|17|||
24904352|NCT00770315|49998189|FG002|Overall Study|Withdrawal by Subject|24|||
24904353|NCT00770315|49998190|FG003|Overall Study|Withdrawal by Subject|20|||
24904354|NCT00770315|49998187|FG000|Overall Study|Noncompliance with Protocol|7|||
24904355|NCT00770315|49998188|FG001|Overall Study|Noncompliance with Protocol|4|||
24904356|NCT00770315|49998189|FG002|Overall Study|Noncompliance with Protocol|7|||
24904357|NCT00770315|49998190|FG003|Overall Study|Noncompliance with Protocol|9|||
24904358|NCT00587171|49998202|FG000|Overall Study|Lost to Follow-up|1|||
24904359|NCT00587171|49998203|FG001|Overall Study|Lost to Follow-up|1|||
24904360|NCT00763139|49998209|FG000|Overall Study|Adverse Event|4|||
24904361|NCT00763139|49998210|FG001|Overall Study|Adverse Event|2|||
24904362|NCT00763139|49998209|FG000|Overall Study|Withdrawal by Subject|0|||
24904363|NCT00763139|49998210|FG001|Overall Study|Withdrawal by Subject|1|||
24904364|NCT00763139|49998209|FG000|Overall Study|med change not allowed by protocol|1|||
24904365|NCT00763139|49998210|FG001|Overall Study|med change not allowed by protocol|0|||
24904366|NCT01366092|49998221|FG000|Overall Study|Progressive cGVHD|2|||
24904367|NCT01366092|49998221|FG000|Overall Study|Physician Decision|1|||
24904368|NCT01366092|49998221|FG000|Overall Study|Withdrawal by Subject|1|||
24904369|NCT00781859|49998227|FG000|Overall Study|Adverse Event|2|||
24904370|NCT00781859|49998228|FG001|Overall Study|Adverse Event|2|||
24904371|NCT00781859|49998227|FG000|Overall Study|Withdrawal by Subject|8|||
24904372|NCT00781859|49998228|FG001|Overall Study|Withdrawal by Subject|4|||
24904373|NCT00781859|49998227|FG000|Overall Study|Lost to Follow-up|6|||
24904374|NCT00781859|49998228|FG001|Overall Study|Lost to Follow-up|3|||
24904375|NCT00781859|49998227|FG000|Overall Study|Death|3|||
24904376|NCT00781859|49998228|FG001|Overall Study|Death|0|||
24904377|NCT00580788|49998238|FG000|Overall Study|Adverse Event|0|||
24904378|NCT00580788|49998239|FG001|Overall Study|Adverse Event|0|||
24904379|NCT00580788|49998240|FG002|Overall Study|Adverse Event|0|||
24904380|NCT00580788|49998241|FG003|Overall Study|Adverse Event|1|||
24904381|NCT00417079|49998260|FG000|Overall Study|Disease progression|267|||
24904382|NCT00417079|49998261|FG001|Overall Study|Disease progression|180|||
24904383|NCT00417079|49998260|FG000|Overall Study|Adverse Event|32|||
24904384|NCT00417079|49998261|FG001|Overall Study|Adverse Event|67|||
24904385|NCT00417079|49998260|FG000|Overall Study|Non-compliance to protocol|0|||
24904386|NCT00417079|49998261|FG001|Overall Study|Non-compliance to protocol|1|||
24904387|NCT00417079|49998260|FG000|Overall Study|Lost to Follow-up|2|||
24904388|NCT00417079|49998261|FG001|Overall Study|Lost to Follow-up|0|||
24904389|NCT00417079|49998260|FG000|Overall Study|Withdrawal by Subject|17|||
24904390|NCT00417079|49998261|FG001|Overall Study|Withdrawal by Subject|8|||
24904391|NCT00417079|49998260|FG000|Overall Study|Not treated|6|||
24904392|NCT00417079|49998261|FG001|Overall Study|Not treated|7|||
24904393|NCT00417079|49998260|FG000|Overall Study|Screened failure|2|||
24904394|NCT00417079|49998261|FG001|Overall Study|Screened failure|1|||
24904395|NCT00417079|49998260|FG000|Overall Study|Investigator's decision|1|||
24904396|NCT00417079|49998261|FG001|Overall Study|Investigator's decision|4|||
24904397|NCT00417079|49998260|FG000|Overall Study|Non-confirmed Disease progression|1|||
24904398|NCT00417079|49998261|FG001|Overall Study|Non-confirmed Disease progression|1|||
24904399|NCT00417079|49998260|FG000|Overall Study|Clinical deterioration|1|||
24904400|NCT00417079|49998261|FG001|Overall Study|Clinical deterioration|0|||
24904401|NCT00417079|49998260|FG000|Overall Study|Screening error|2|||
24904402|NCT00417079|49998261|FG001|Overall Study|Screening error|1|||
24904403|NCT00417079|49998260|FG000|Overall Study|Withdrawal by subject's family|0|||
24904404|NCT00417079|49998261|FG001|Overall Study|Withdrawal by subject's family|1|||
24904405|NCT00417079|49998260|FG000|Overall Study|Patient unable to come to the clinic|0|||
24904406|NCT00417079|49998261|FG001|Overall Study|Patient unable to come to the clinic|1|||
24904407|NCT00417079|49998260|FG000|Overall Study|abnormal liver function tests|0|||
24904408|NCT00417079|49998261|FG001|Overall Study|abnormal liver function tests|1|||
24904409|NCT00429169|49998269|FG000|Overall Study|Lost to Follow-up|0|||
24904410|NCT00429169|49998270|FG001|Overall Study|Lost to Follow-up|1|||
24904411|NCT00429169|49998269|FG000|Overall Study|Ineligibility discovered after entry|2|||
24904412|NCT00429169|49998270|FG001|Overall Study|Ineligibility discovered after entry|1|||
24904413|NCT00416455|49998280|FG000|Overall Study|PET / CT not done|3|||
24904414|NCT00416455|49998281|FG001|Overall Study|PET / CT not done|5|||
24904415|NCT00416455|49998280|FG000|Overall Study|PET / CT poor quality|2|||
24904416|NCT00416455|49998281|FG001|Overall Study|PET / CT poor quality|1|||
24904417|NCT00416455|49998280|FG000|Overall Study|Inadequate pathology|11|||
24904418|NCT00416455|49998281|FG001|Overall Study|Inadequate pathology|2|||
25078048|NCT03745651|50186227|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
24904419|NCT00415909|49998298|FG000|Overall Study|Withdrawal by Subject|2|||
24904420|NCT00415909|49998298|FG000|Overall Study|Death|1|||
24904421|NCT00415597|49998302|FG000|Enrollment|Withdrawal by Subject|1|||
24904422|NCT00415597|49998302|FG000|Enrollment|Protocol Violation|1|||
24904423|NCT00415597|49998302|FG000|Treatment|Adverse Event|110|||
24904424|NCT00415597|49998302|FG000|Treatment|Lack of Efficacy|39|||
24904425|NCT00415597|49998302|FG000|Treatment|Protocol Violation|67|||
25254738|NCT01348854|50570414|FG000|Overall Study|Lost to Follow-up|2|||
24904426|NCT00415597|49998302|FG000|Treatment|Physician Decision|3|||
24904427|NCT00415597|49998302|FG000|Treatment|Withdrawal by Subject|51|||
24904428|NCT00415597|49998302|FG000|Treatment|Lost to Follow-up|28|||
24904429|NCT00415597|49998302|FG000|Treatment|Drug Screen|2|||
24904430|NCT00415597|49998302|FG000|Treatment|Administrative|3|||
24904431|NCT00415597|49998302|FG000|Treatment|Sponsor Decision|1|||
24904432|NCT00415597|49998302|FG000|Treatment|Multiple Reasons|1|||
24904433|NCT00620542|49998308|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
24904434|NCT00620542|49998309|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
24904435|NCT00620542|49998310|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
24904436|NCT00620542|49998311|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
24904437|NCT00620542|49998308|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
24904438|NCT00620542|49998309|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
24904439|NCT00620542|49998310|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
24904440|NCT00620542|49998311|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
24904441|NCT00620542|49998308|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
24904442|NCT00620542|49998309|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
24904443|NCT00620542|49998310|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
24904444|NCT00620542|49998311|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
24904445|NCT00620542|49998308|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
24904446|NCT00620542|49998309|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
24904447|NCT00620542|49998310|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
24904448|NCT00620542|49998311|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
24904449|NCT00620542|49998308|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
24904450|NCT00620542|49998309|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
25340197|NCT00733902|50656431|FG002|Overall Study|Randomized but not treated|2|||
25340198|NCT00733902|50656432|FG003|Overall Study|Randomized but not treated|1|||
24904451|NCT00620542|49998310|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
24904452|NCT00620542|49998311|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
24904453|NCT00620542|49998308|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
24904454|NCT00620542|49998309|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
24904455|NCT00620542|49998310|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
24904456|NCT00620542|49998311|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
24904457|NCT00620542|49998308|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
24904458|NCT00620542|49998309|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
24904459|NCT00620542|49998310|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
24904460|NCT00620542|49998311|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
24904461|NCT00620542|49998308|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
24904462|NCT00620542|49998309|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
24904463|NCT00620542|49998310|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
24904464|NCT00620542|49998311|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
24904465|NCT00620542|49998308|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
24904466|NCT00620542|49998309|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
24977584|NCT03831191|50066117|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
24977585|NCT03831191|50066118|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
24977586|NCT03831191|50066119|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
24977587|NCT03831191|50066120|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
24977588|NCT03831191|50066121|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
24977589|NCT03831191|50066122|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
24977590|NCT03831191|50066123|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
24977591|NCT03831191|50066124|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
24977592|NCT03831191|50066125|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
24977593|NCT03831191|50066126|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
24977594|NCT03831191|50066127|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
24977595|NCT03831191|50066128|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
24977596|NCT03831191|50066129|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
24904467|NCT00620542|49998310|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
24904468|NCT00620542|49998311|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
24904469|NCT00620542|49998308|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
24904470|NCT00620542|49998309|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
24904471|NCT00620542|49998310|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
24904472|NCT00620542|49998311|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
24904473|NCT00620542|49998308|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
24904474|NCT00620542|49998309|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
24977597|NCT03831191|50066130|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
24977598|NCT03831191|50066116|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
24977599|NCT03831191|50066117|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
24977600|NCT03831191|50066118|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
24977601|NCT03831191|50066119|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
24904475|NCT00620542|49998310|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
24904476|NCT00620542|49998311|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
24977602|NCT03831191|50066120|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
24977603|NCT03831191|50066121|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
24904477|NCT00620542|49998308|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
24904478|NCT00620542|49998309|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
24904479|NCT00620542|49998310|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
24904480|NCT00620542|49998311|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
24904481|NCT00620542|49998308|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
24904482|NCT00620542|49998309|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
24904483|NCT00620542|49998310|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
24904484|NCT00620542|49998311|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
24904485|NCT00620542|49998308|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
24904486|NCT00620542|49998309|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
24904487|NCT00620542|49998310|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
24904488|NCT00620542|49998311|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
24904489|NCT00620542|49998308|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
24904490|NCT00620542|49998309|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
24904491|NCT00620542|49998310|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
24904492|NCT00620542|49998311|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
24904493|NCT05096208|49998323|FG000|Overall Study|Lost to Follow-up|3|||
24904494|NCT05096208|49998324|FG001|Overall Study|Lost to Follow-up|5|||
24904495|NCT05096208|49998325|FG002|Overall Study|Lost to Follow-up|5|||
24904496|NCT05096208|49998326|FG003|Overall Study|Lost to Follow-up|2|||
24904497|NCT05096208|49998323|FG000|Overall Study|Withdrawal by Subject|0|||
24904498|NCT05096208|49998324|FG001|Overall Study|Withdrawal by Subject|1|||
24904499|NCT05096208|49998325|FG002|Overall Study|Withdrawal by Subject|2|||
24904500|NCT05096208|49998326|FG003|Overall Study|Withdrawal by Subject|3|||
24904501|NCT05096208|49998323|FG000|Overall Study|No longer met eligibility criteria|1|||
24904502|NCT05096208|49998324|FG001|Overall Study|No longer met eligibility criteria|0|||
24904503|NCT05096208|49998325|FG002|Overall Study|No longer met eligibility criteria|0|||
24904504|NCT05096208|49998326|FG003|Overall Study|No longer met eligibility criteria|0|||
24904505|NCT05096208|49998323|FG000|Overall Study|Other|0|||
24904506|NCT05096208|49998324|FG001|Overall Study|Other|0|||
24904507|NCT05096208|49998325|FG002|Overall Study|Other|1|||
24904508|NCT05096208|49998326|FG003|Overall Study|Other|0|||
24904509|NCT04555616|49998345|FG000|Overall Study|Death|1|||
24904510|NCT04555616|49998346|FG001|Overall Study|Death|0|||
24904511|NCT04555616|49998347|FG002|Overall Study|Death|1|||
24904512|NCT04555616|49998345|FG000|Overall Study|Withdrawal by Subject|2|||
24904513|NCT04555616|49998346|FG001|Overall Study|Withdrawal by Subject|1|||
24904514|NCT04555616|49998347|FG002|Overall Study|Withdrawal by Subject|0|||
24904515|NCT04177758|49998371|FG000|Overall Study|Lost to Follow-up|19|||
24904516|NCT04177758|49998372|FG001|Overall Study|Lost to Follow-up|11|||
24904517|NCT04003103|49998381|FG000|Overall Study|Death|1|||
24904518|NCT04003103|49998382|FG001|Overall Study|Death|0|||
24904519|NCT04003103|49998383|FG002|Overall Study|Death|0|||
24904520|NCT04003103|49998381|FG000|Overall Study|Lost to Follow-up|4|||
24904521|NCT04003103|49998382|FG001|Overall Study|Lost to Follow-up|3|||
24904522|NCT04003103|49998383|FG002|Overall Study|Lost to Follow-up|2|||
24904523|NCT04003103|49998381|FG000|Overall Study|Withdrawal by Subject|10|||
24904524|NCT04003103|49998382|FG001|Overall Study|Withdrawal by Subject|1|||
24904525|NCT04003103|49998383|FG002|Overall Study|Withdrawal by Subject|1|||
24904526|NCT04003103|49998381|FG000|Overall Study|Status not recorded|0|||
24904527|NCT04003103|49998382|FG001|Overall Study|Status not recorded|2|||
24904528|NCT04003103|49998383|FG002|Overall Study|Status not recorded|0|||
24904529|NCT03921528|49998432|FG000|Overall Study|Withdrawal by Subject|0|||
24904530|NCT03921528|49998433|FG001|Overall Study|Withdrawal by Subject|1|||
24904531|NCT03921528|49998434|FG002|Overall Study|Withdrawal by Subject|0|||
24904532|NCT03921528|49998435|FG003|Overall Study|Withdrawal by Subject|0|||
24904533|NCT03921528|49998436|FG004|Overall Study|Withdrawal by Subject|0|||
24904534|NCT03832322|49998454|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
24904535|NCT03832322|49998455|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
24904536|NCT03642990|49998471|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
24904537|NCT03642990|49998471|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
24904538|NCT03639311|49998477|FG000|Overall Study|Ongoing at the time of analysis|88|||
24904539|NCT03639311|49998478|FG001|Overall Study|Ongoing at the time of analysis|0|||
24904540|NCT03639311|49998477|FG000|Overall Study|Lost to Follow-up|1|||
24904541|NCT03639311|49998478|FG001|Overall Study|Lost to Follow-up|0|||
24904542|NCT03639311|49998477|FG000|Overall Study|Adverse Event|1|||
24904543|NCT03639311|49998478|FG001|Overall Study|Adverse Event|0|||
24904544|NCT03633825|49998489|FG000|Enrollment|Did not post on network|5066|||
24904545|NCT03633825|49998490|FG001|Enrollment|Did not post on network|5080|||
24904546|NCT03633825|49998489|FG000|Enrollment|Post not classified as crisis|13967|||
24904547|NCT03633825|49998490|FG001|Enrollment|Post not classified as crisis|13757|||
24904548|NCT03633825|49998489|FG000|Follow up|Lost to Follow-up|478|||
24904549|NCT03633825|49998490|FG001|Follow up|Lost to Follow-up|450|||
24904550|NCT03465540|49998502|FG000|Overall Study|Withdrawal by Subject|0|||
24904551|NCT03465540|49998503|FG001|Overall Study|Withdrawal by Subject|0|||
25254739|NCT01348854|50570415|FG001|Overall Study|Lost to Follow-up|1|||
24904552|NCT03465540|49998504|FG002|Overall Study|Withdrawal by Subject|1|||
24904553|NCT03465540|49998505|FG003|Overall Study|Withdrawal by Subject|1|||
24904554|NCT03465540|49998506|FG004|Overall Study|Withdrawal by Subject|1|||
24904555|NCT03465540|49998507|FG005|Overall Study|Withdrawal by Subject|0|||
24904556|NCT03465540|49998502|FG000|Overall Study|Lost to Follow-up|0|||
24904557|NCT03465540|49998503|FG001|Overall Study|Lost to Follow-up|1|||
24904558|NCT03465540|49998504|FG002|Overall Study|Lost to Follow-up|0|||
24904559|NCT03465540|49998505|FG003|Overall Study|Lost to Follow-up|0|||
24904560|NCT03465540|49998506|FG004|Overall Study|Lost to Follow-up|1|||
24904561|NCT03465540|49998507|FG005|Overall Study|Lost to Follow-up|0|||
24904562|NCT03465540|49998502|FG000|Overall Study|Death|1|||
24904563|NCT03465540|49998503|FG001|Overall Study|Death|1|||
24904564|NCT03465540|49998504|FG002|Overall Study|Death|0|||
24904565|NCT03465540|49998505|FG003|Overall Study|Death|2|||
24904566|NCT03465540|49998506|FG004|Overall Study|Death|0|||
24904567|NCT03465540|49998507|FG005|Overall Study|Death|2|||
24904568|NCT03465540|49998502|FG000|Overall Study|Protocol specified criteria|0|||
24904569|NCT03465540|49998503|FG001|Overall Study|Protocol specified criteria|2|||
24904570|NCT03465540|49998504|FG002|Overall Study|Protocol specified criteria|2|||
24904571|NCT03465540|49998505|FG003|Overall Study|Protocol specified criteria|0|||
24904572|NCT03465540|49998506|FG004|Overall Study|Protocol specified criteria|2|||
24904573|NCT03465540|49998507|FG005|Overall Study|Protocol specified criteria|0|||
24904574|NCT03246061|49998532|FG000|Overall Study|Still in follow-up|15|||
24904575|NCT03246061|49998533|FG001|Overall Study|Still in follow-up|21|||
24904576|NCT03055832|49998566|FG000|Week 2|Withdrawal by Subject|1|||
24904577|NCT03055832|49998567|FG001|Week 2|Withdrawal by Subject|0|||
24904578|NCT03052049|49998587|FG000|Overall Study|Withdrawal by Subject|2|||
24904579|NCT02771275|49998612|FG000|Overall Study|Reoperation|2|||
24977604|NCT03831191|50066122|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
24977605|NCT03831191|50066123|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
24977606|NCT03831191|50066124|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
24977607|NCT03831191|50066125|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
24977608|NCT03831191|50066126|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
24977609|NCT03831191|50066127|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
24977610|NCT03831191|50066128|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
24977611|NCT03831191|50066129|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
24977612|NCT03831191|50066130|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
24977613|NCT03831191|50066116|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
24977614|NCT03831191|50066117|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
24977615|NCT03831191|50066118|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
24977616|NCT03831191|50066119|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
24977617|NCT03831191|50066120|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
24977618|NCT03831191|50066121|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
24977619|NCT03831191|50066122|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
24977620|NCT03831191|50066123|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
24977621|NCT03831191|50066124|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
24977622|NCT03831191|50066125|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
24977623|NCT03831191|50066126|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
24977624|NCT03831191|50066127|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
24977625|NCT03831191|50066128|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
24904580|NCT02771275|49998612|FG000|Overall Study|On Study|11|||
24904581|NCT02768870|49998616|FG000|Overall Study|Not Implanted with Device|2|||
24904582|NCT02768870|49998616|FG000|Overall Study|Death|1|||
24904583|NCT02768870|49998616|FG000|Overall Study|Reoperation|4|||
24904584|NCT02768870|49998616|FG000|Overall Study|On Study|19|||
24904585|NCT02750618|49998620|FG000|Overall Study|Withdrawal by Subject|1|||
24904586|NCT02537431|49998624|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
24904587|NCT02526160|49998630|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
24904588|NCT02526160|49998631|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
24904589|NCT02526160|49998630|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
24904590|NCT02526160|49998631|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
24904591|NCT02526160|49998630|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
24904592|NCT02526160|49998631|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
24904593|NCT02526160|49998630|FG000|Open-Label Treatment Extension Period I|Death|0|||
24904594|NCT02526160|49998631|FG001|Open-Label Treatment Extension Period I|Death|1|||
24977626|NCT03831191|50066129|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
25078049|NCT03745651|50186228|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
24904595|NCT02526160|49998630|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
24904596|NCT02526160|49998631|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
24904597|NCT02526160|49998630|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
24977627|NCT03831191|50066130|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
24977628|NCT03831191|50066116|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
24977629|NCT03831191|50066117|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
25254740|NCT01348854|50570414|FG000|Overall Study|Withdrawal by Subject|1|||
24904598|NCT02526160|49998631|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
24904599|NCT02526160|49998630|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
24904600|NCT02526160|49998631|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
24904601|NCT02526160|49998630|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
24904602|NCT02526160|49998631|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
24904603|NCT02432196|49998642|FG000|Overall Study|Not Implanted with Device|1|||
24904604|NCT02432196|49998642|FG000|Overall Study|Death|2|||
24904605|NCT02432196|49998642|FG000|Overall Study|Reoperation|3|||
24904606|NCT02432196|49998642|FG000|Overall Study|On Study|20|||
24904607|NCT02157610|49998666|FG000|Overall Study|Death|4|||
24904608|NCT02157610|49998667|FG001|Overall Study|Death|4|||
24904609|NCT01511250|49998710|FG000|Overall Study|Withdrawal of Consent|1|||
24904610|NCT01511250|49998711|FG001|Overall Study|Withdrawal of Consent|0|||
24904611|NCT01511250|49998712|FG002|Overall Study|Withdrawal of Consent|0|||
24904612|NCT01511250|49998713|FG003|Overall Study|Withdrawal of Consent|0|||
24904613|NCT01511250|49998714|FG004|Overall Study|Withdrawal of Consent|0|||
24904614|NCT01511250|49998715|FG005|Overall Study|Withdrawal of Consent|0|||
24904615|NCT01511250|49998716|FG006|Overall Study|Withdrawal of Consent|0|||
24904616|NCT01511250|49998717|FG007|Overall Study|Withdrawal of Consent|1|||
24904617|NCT01511250|49998718|FG008|Overall Study|Withdrawal of Consent|1|||
24904618|NCT01511250|49998719|FG009|Overall Study|Withdrawal of Consent|0|||
24904619|NCT01511250|49998710|FG000|Overall Study|Sponsor/Investigator Decision|1|||
24904620|NCT01511250|49998711|FG001|Overall Study|Sponsor/Investigator Decision|0|||
24904621|NCT01511250|49998712|FG002|Overall Study|Sponsor/Investigator Decision|0|||
24904622|NCT01511250|49998713|FG003|Overall Study|Sponsor/Investigator Decision|0|||
24904623|NCT01511250|49998714|FG004|Overall Study|Sponsor/Investigator Decision|0|||
24904624|NCT01511250|49998715|FG005|Overall Study|Sponsor/Investigator Decision|0|||
24904625|NCT01511250|49998716|FG006|Overall Study|Sponsor/Investigator Decision|0|||
24904626|NCT01511250|49998717|FG007|Overall Study|Sponsor/Investigator Decision|0|||
24904627|NCT01511250|49998718|FG008|Overall Study|Sponsor/Investigator Decision|0|||
24904628|NCT01511250|49998719|FG009|Overall Study|Sponsor/Investigator Decision|0|||
24904629|NCT01511250|49998710|FG000|Overall Study|Lost to Follow-up|7|||
24904630|NCT01511250|49998711|FG001|Overall Study|Lost to Follow-up|3|||
24904631|NCT01511250|49998712|FG002|Overall Study|Lost to Follow-up|3|||
24904632|NCT01511250|49998713|FG003|Overall Study|Lost to Follow-up|3|||
24904633|NCT01511250|49998714|FG004|Overall Study|Lost to Follow-up|0|||
24904634|NCT01511250|49998715|FG005|Overall Study|Lost to Follow-up|0|||
24904635|NCT01511250|49998716|FG006|Overall Study|Lost to Follow-up|2|||
24904636|NCT01511250|49998717|FG007|Overall Study|Lost to Follow-up|3|||
25340199|NCT00790790|50656445|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
25340200|NCT00790790|50656446|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
25340201|NCT00790790|50656447|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
25340202|NCT00790790|50656445|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
25340203|NCT00790790|50656446|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
25340204|NCT00790790|50656447|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
24904637|NCT01511250|49998718|FG008|Overall Study|Lost to Follow-up|13|||
24904638|NCT01511250|49998719|FG009|Overall Study|Lost to Follow-up|5|||
24904639|NCT01511250|49998710|FG000|Overall Study|Protocol Violation|0|||
24904640|NCT01511250|49998711|FG001|Overall Study|Protocol Violation|2|||
24904641|NCT01511250|49998712|FG002|Overall Study|Protocol Violation|1|||
24904642|NCT01511250|49998713|FG003|Overall Study|Protocol Violation|0|||
25340205|NCT00790790|50656445|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
25340206|NCT00790790|50656446|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
25340207|NCT00790790|50656447|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
25340208|NCT00790790|50656445|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
25340209|NCT00790790|50656446|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
25340210|NCT00790790|50656447|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
25340211|NCT00790790|50656445|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
25340212|NCT00790790|50656446|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
25340213|NCT00790790|50656447|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
25340214|NCT00719043|50656467|FG000|Overall Study|Adverse Event|5|||
25340215|NCT00719043|50656468|FG001|Overall Study|Adverse Event|1|||
25340216|NCT00719043|50656469|FG002|Overall Study|Adverse Event|2|||
25340217|NCT00719043|50656470|FG003|Overall Study|Adverse Event|2|||
25340218|NCT00719043|50656471|FG004|Overall Study|Adverse Event|1|||
25340219|NCT00719043|50656472|FG005|Overall Study|Adverse Event|4|||
25340220|NCT00719043|50656473|FG006|Overall Study|Adverse Event|4|||
25340221|NCT00719043|50656467|FG000|Overall Study|Lost to Follow-up|14|||
25340222|NCT00719043|50656468|FG001|Overall Study|Lost to Follow-up|10|||
25340223|NCT00719043|50656469|FG002|Overall Study|Lost to Follow-up|8|||
24904643|NCT01511250|49998714|FG004|Overall Study|Protocol Violation|0|||
24904644|NCT01511250|49998715|FG005|Overall Study|Protocol Violation|0|||
24904645|NCT01511250|49998716|FG006|Overall Study|Protocol Violation|0|||
24904646|NCT01511250|49998717|FG007|Overall Study|Protocol Violation|0|||
24904647|NCT01511250|49998718|FG008|Overall Study|Protocol Violation|0|||
24904648|NCT01511250|49998719|FG009|Overall Study|Protocol Violation|0|||
24904649|NCT01424566|49998741|FG000|Single-blind Treatment|Adverse Event|71|||
24904650|NCT01424566|49998742|FG001|Single-blind Treatment|Adverse Event|0|||
24904651|NCT01424566|49998743|FG002|Single-blind Treatment|Adverse Event|0|||
24904652|NCT01424566|49998741|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
24904653|NCT01424566|49998742|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
24904654|NCT01424566|49998743|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
24904655|NCT01424566|49998741|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
24904656|NCT01424566|49998742|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
24904657|NCT01424566|49998743|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
24904658|NCT01424566|49998741|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
24977630|NCT03831191|50066118|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
24977631|NCT03831191|50066119|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
24977632|NCT03831191|50066120|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
24977633|NCT03831191|50066121|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
24977634|NCT03831191|50066122|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
24977635|NCT03831191|50066123|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
24977636|NCT03831191|50066124|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
24977637|NCT03831191|50066125|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
24977638|NCT03831191|50066126|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
24977639|NCT03831191|50066127|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
24977640|NCT03831191|50066128|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
24977641|NCT03831191|50066129|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
24977642|NCT03831191|50066130|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
24977643|NCT03831191|50066116|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
24977644|NCT03831191|50066117|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
24977645|NCT03831191|50066118|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
24977646|NCT03831191|50066119|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
24977647|NCT03831191|50066120|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
24977648|NCT03831191|50066121|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
24977649|NCT03831191|50066122|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
24977650|NCT03831191|50066123|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
24977651|NCT03831191|50066124|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
24977652|NCT03831191|50066125|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
24977653|NCT03831191|50066126|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
24977654|NCT03831191|50066127|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
24977655|NCT03831191|50066128|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
24977656|NCT03831191|50066129|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
24977657|NCT03831191|50066130|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
24977658|NCT03831191|50066116|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
24977659|NCT03831191|50066117|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
24977660|NCT03831191|50066118|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
24977661|NCT03831191|50066119|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
24977662|NCT03831191|50066120|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
24977663|NCT03831191|50066121|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
24977664|NCT03831191|50066122|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
24977665|NCT03831191|50066123|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
24977666|NCT03831191|50066124|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
24977667|NCT03831191|50066125|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
24977668|NCT03831191|50066126|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
24977669|NCT03831191|50066127|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
24904659|NCT01424566|49998742|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
24904660|NCT01424566|49998743|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
24904661|NCT01424566|49998741|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
24904662|NCT01424566|49998742|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
24904663|NCT01424566|49998743|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
24904664|NCT01424566|49998741|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
24904665|NCT01424566|49998742|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
24904666|NCT01424566|49998743|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
24904667|NCT01424566|49998741|FG000|Double-blind Treatment|Adverse Event|0|||
24904668|NCT01424566|49998742|FG001|Double-blind Treatment|Adverse Event|21|||
24904669|NCT01424566|49998743|FG002|Double-blind Treatment|Adverse Event|13|||
24904670|NCT01424566|49998741|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
24977670|NCT03831191|50066128|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
24977671|NCT03831191|50066129|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
24977672|NCT03831191|50066130|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
24977673|NCT03831191|50066116|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
25078050|NCT03745651|50186229|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
25078051|NCT03745651|50186223|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
24904671|NCT01424566|49998742|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
24904672|NCT01424566|49998743|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
24904673|NCT01424566|49998741|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
24904674|NCT01424566|49998742|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
24904675|NCT01424566|49998743|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
24904676|NCT01424566|49998741|FG000|Double-blind Treatment|Lack of Efficacy|0|||
24904677|NCT01424566|49998742|FG001|Double-blind Treatment|Lack of Efficacy|1|||
24904678|NCT01424566|49998743|FG002|Double-blind Treatment|Lack of Efficacy|1|||
24904679|NCT01361607|49998752|FG000|Overall Study|Adverse Event|38|||
24904680|NCT01361607|49998753|FG001|Overall Study|Adverse Event|29|||
24904681|NCT01361607|49998752|FG000|Overall Study|Withdrawal by Subject|19|||
24904682|NCT01361607|49998753|FG001|Overall Study|Withdrawal by Subject|8|||
24977674|NCT03831191|50066117|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
24977675|NCT03831191|50066118|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
24977676|NCT03831191|50066119|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
24977677|NCT03831191|50066120|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
24977678|NCT03831191|50066121|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
24977679|NCT03831191|50066122|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
24977680|NCT03831191|50066123|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
24977681|NCT03831191|50066124|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
24977682|NCT03831191|50066125|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
24977683|NCT03831191|50066126|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
24904683|NCT01361607|49998752|FG000|Overall Study|Withdrawal by Investigator|5|||
24904684|NCT01361607|49998753|FG001|Overall Study|Withdrawal by Investigator|3|||
24904685|NCT01361607|49998752|FG000|Overall Study|Lost to Follow-up|1|||
24904686|NCT01361607|49998753|FG001|Overall Study|Lost to Follow-up|0|||
24904687|NCT01361607|49998752|FG000|Overall Study|Met Withdrawal Criteria|1|||
24904688|NCT01361607|49998753|FG001|Overall Study|Met Withdrawal Criteria|1|||
24904689|NCT01337089|49998760|FG000|Overall Study|Adverse Event|237|||
24904690|NCT01337089|49998760|FG000|Overall Study|Withdrawal by Subject|129|||
24904691|NCT01337089|49998760|FG000|Overall Study|Withdrawal by Investigator|33|||
24904692|NCT01337089|49998760|FG000|Overall Study|Met Withdrawal Criteria|3|||
24904693|NCT01337089|49998760|FG000|Overall Study|Lost to Follow-up|2|||
24904694|NCT00114530|49998774|FG000|Overall Study|Death|3|||
24904695|NCT00114530|49998775|FG001|Overall Study|Death|11|||
24904696|NCT00114530|49998774|FG000|Overall Study|Lost to Follow-up|1|||
24904697|NCT00114530|49998775|FG001|Overall Study|Lost to Follow-up|1|||
24904698|NCT00114530|49998774|FG000|Overall Study|Physician Decision|1|||
24904699|NCT00114530|49998775|FG001|Overall Study|Physician Decision|1|||
24904700|NCT00114530|49998774|FG000|Overall Study|Withdrawal by Subject|2|||
24904701|NCT00114530|49998775|FG001|Overall Study|Withdrawal by Subject|6|||
24904702|NCT00114530|49998774|FG000|Overall Study|Breast Cancer|1|||
24904703|NCT00114530|49998775|FG001|Overall Study|Breast Cancer|0|||
24904704|NCT00114530|49998774|FG000|Overall Study|Subject decision after endpoint failure|0|||
24904705|NCT00114530|49998775|FG001|Overall Study|Subject decision after endpoint failure|1|||
24904706|NCT00114530|49998774|FG000|Overall Study|Ineligible|1|||
24904707|NCT00114530|49998775|FG001|Overall Study|Ineligible|0|||
24904708|NCT00618982|49998798|FG000|Overall Study|Adverse Event|23|||
24977684|NCT03831191|50066127|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
24977685|NCT03831191|50066128|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
24977686|NCT03831191|50066129|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
24977687|NCT03831191|50066130|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
24977688|NCT03831191|50066116|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
24977689|NCT03831191|50066117|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
24977690|NCT03831191|50066118|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
24977691|NCT03831191|50066119|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
24977692|NCT03831191|50066120|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
24977693|NCT03831191|50066121|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
24977694|NCT03831191|50066122|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
24977695|NCT03831191|50066123|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
24977696|NCT03831191|50066124|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
25254741|NCT01348854|50570415|FG001|Overall Study|Withdrawal by Subject|0|||
25254742|NCT01348776|50570421|FG000|Overall Study|Lost to Follow-up|3|||
24904709|NCT00618982|49998798|FG000|Overall Study|Withdrawal by Subject|1|||
25254743|NCT01348698|50570434|FG000|Overall Study|Does not meet lesion size criteria|1|||
24904710|NCT00618982|49998798|FG000|Overall Study|Protocol Violation|1|||
24904711|NCT00618982|49998798|FG000|Overall Study|ongoing, still treated with study med.|25|||
24904712|NCT00578786|49998808|FG000|Overall Study|Adverse Event|27|||
24904713|NCT00578786|49998809|FG001|Overall Study|Adverse Event|37|||
24904714|NCT00578786|49998810|FG002|Overall Study|Adverse Event|17|||
24904715|NCT00578786|49998808|FG000|Overall Study|Lack of Efficacy|2|||
24904716|NCT00578786|49998809|FG001|Overall Study|Lack of Efficacy|5|||
24904717|NCT00578786|49998810|FG002|Overall Study|Lack of Efficacy|2|||
24904718|NCT00578786|49998808|FG000|Overall Study|Early Escape from Prior Study|2|||
24904719|NCT00578786|49998809|FG001|Overall Study|Early Escape from Prior Study|1|||
24904720|NCT00578786|49998810|FG002|Overall Study|Early Escape from Prior Study|2|||
24904721|NCT00578786|49998808|FG000|Overall Study|Withdrawal by Subject|7|||
24904722|NCT00578786|49998809|FG001|Overall Study|Withdrawal by Subject|8|||
24904723|NCT00578786|49998810|FG002|Overall Study|Withdrawal by Subject|5|||
24904724|NCT00578786|49998808|FG000|Overall Study|Protocol Violation|0|||
24904725|NCT00578786|49998809|FG001|Overall Study|Protocol Violation|3|||
24904726|NCT00578786|49998810|FG002|Overall Study|Protocol Violation|1|||
24904727|NCT00578786|49998808|FG000|Overall Study|Physician Decision|1|||
24904728|NCT00578786|49998809|FG001|Overall Study|Physician Decision|0|||
24904729|NCT00578786|49998810|FG002|Overall Study|Physician Decision|1|||
24904730|NCT00578786|49998808|FG000|Overall Study|Sponsor Decision|0|||
24904731|NCT00578786|49998809|FG001|Overall Study|Sponsor Decision|0|||
24904732|NCT00578786|49998810|FG002|Overall Study|Sponsor Decision|1|||
24904733|NCT00578786|49998808|FG000|Overall Study|Lost to Follow-up|0|||
24904734|NCT00578786|49998809|FG001|Overall Study|Lost to Follow-up|4|||
24904735|NCT00578786|49998810|FG002|Overall Study|Lost to Follow-up|0|||
24904736|NCT00578786|49998808|FG000|Overall Study|Pregnancy|0|||
24904737|NCT00578786|49998809|FG001|Overall Study|Pregnancy|1|||
24904738|NCT00578786|49998810|FG002|Overall Study|Pregnancy|0|||
24904739|NCT00578786|49998808|FG000|Overall Study|Not Otherwise Specified|0|||
25340224|NCT00719043|50656470|FG003|Overall Study|Lost to Follow-up|9|||
25340225|NCT00719043|50656471|FG004|Overall Study|Lost to Follow-up|10|||
24904740|NCT00578786|49998809|FG001|Overall Study|Not Otherwise Specified|4|||
24904741|NCT00578786|49998810|FG002|Overall Study|Not Otherwise Specified|1|||
24904742|NCT00578786|49998808|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
24904743|NCT00578786|49998809|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
24904744|NCT00578786|49998810|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
24904745|NCT00424255|49998830|FG000|Overall Study|Death|115|||
24904746|NCT00424255|49998831|FG001|Overall Study|Death|111|||
24904747|NCT00424255|49998830|FG000|Overall Study|Lost to Follow-up|26|||
24904748|NCT00424255|49998831|FG001|Overall Study|Lost to Follow-up|20|||
24904749|NCT00424255|49998830|FG000|Overall Study|Protocol Violation|0|||
24904750|NCT00424255|49998831|FG001|Overall Study|Protocol Violation|1|||
25254744|NCT01348698|50570434|FG000|Overall Study|Death|3|||
24904751|NCT00424255|49998830|FG000|Overall Study|Withdrawal by Subject|34|||
24977697|NCT03831191|50066125|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
24977698|NCT03831191|50066126|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
24977699|NCT03831191|50066127|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
24977700|NCT03831191|50066128|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
24977701|NCT03831191|50066129|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
24977702|NCT03831191|50066130|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
24977703|NCT03831191|50066116|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
24977704|NCT03831191|50066117|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
24977705|NCT03831191|50066118|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
24977706|NCT03831191|50066119|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
24977707|NCT03831191|50066120|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
24977708|NCT03831191|50066121|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
24977709|NCT03831191|50066122|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
24977710|NCT03831191|50066123|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
24977711|NCT03831191|50066124|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
24977712|NCT03831191|50066125|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
24977713|NCT03831191|50066126|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
24977714|NCT03831191|50066127|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
24977715|NCT03831191|50066128|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
24977716|NCT03831191|50066129|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
24977717|NCT03831191|50066130|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
24977718|NCT03831191|50066116|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
24977719|NCT03831191|50066117|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
25254745|NCT01348698|50570434|FG000|Overall Study|PI decision to close study|68|||
25254746|NCT01348542|50570440|FG000|Overall Study|Withdrawal by Subject|3|||
25254747|NCT01348542|50570441|FG001|Overall Study|Withdrawal by Subject|0|||
24977720|NCT03831191|50066118|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
24977721|NCT03831191|50066119|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
25254748|NCT01346709|50570447|FG000|Overall Study|Protocol Violation|35|||
25254749|NCT01346709|50570447|FG000|Overall Study|Lost to Follow-up|31|||
25254750|NCT01346709|50570447|FG000|Overall Study|Missing data in candidate risk factor|285|||
25254751|NCT01346592|50570454|FG000|Overall Study|Lost to Follow-up|62|||
25254752|NCT01346592|50570455|FG001|Overall Study|Lost to Follow-up|29|||
24904752|NCT00424255|49998831|FG001|Overall Study|Withdrawal by Subject|38|||
24904753|NCT00424255|49998830|FG000|Overall Study|Physician Decision|3|||
24904754|NCT00424255|49998831|FG001|Overall Study|Physician Decision|7|||
24904755|NCT00424255|49998830|FG000|Overall Study|Cognitive Disturbance|1|||
25340226|NCT00719043|50656472|FG005|Overall Study|Lost to Follow-up|9|||
25340227|NCT00719043|50656473|FG006|Overall Study|Lost to Follow-up|9|||
25340228|NCT00719043|50656467|FG000|Overall Study|Protocol Violation|0|||
24904756|NCT00424255|49998831|FG001|Overall Study|Cognitive Disturbance|0|||
24904757|NCT00424255|49998830|FG000|Overall Study|Non-compliance by Participants|1|||
24904758|NCT00424255|49998831|FG001|Overall Study|Non-compliance by Participants|0|||
24904759|NCT00424255|49998830|FG000|Overall Study|Fatigue|1|||
24904760|NCT00424255|49998831|FG001|Overall Study|Fatigue|0|||
24904761|NCT00424255|49998830|FG000|Overall Study|Disease Progression|0|||
24904762|NCT00424255|49998831|FG001|Overall Study|Disease Progression|2|||
25254753|NCT01346592|50570456|FG002|Overall Study|Lost to Follow-up|29|||
25254754|NCT01346592|50570454|FG000|Overall Study|Protocol Violation|2|||
25254755|NCT01346592|50570455|FG001|Overall Study|Protocol Violation|1|||
25254756|NCT01346592|50570456|FG002|Overall Study|Protocol Violation|0|||
25254757|NCT01346592|50570454|FG000|Overall Study|Death|1|||
24904763|NCT00424255|49998830|FG000|Overall Study|Sponsor Terminated Study|161|||
24904764|NCT00424255|49998831|FG001|Overall Study|Sponsor Terminated Study|167|||
24904765|NCT00620074|49998837|FG000|Overall Study|Adverse Event|1|||
24904766|NCT00424177|49998841|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
24904767|NCT00424177|49998841|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
24904768|NCT00424177|49998841|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
24904769|NCT00424177|49998841|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
24904770|NCT00424177|49998841|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
24904771|NCT00424177|49998841|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
24904772|NCT00424177|49998841|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
24904773|NCT00424177|49998841|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
25254758|NCT01346592|50570455|FG001|Overall Study|Death|3|||
25254759|NCT01346592|50570456|FG002|Overall Study|Death|4|||
25254760|NCT01346592|50570454|FG000|Overall Study|Adverse Event|0|||
25340229|NCT00719043|50656468|FG001|Overall Study|Protocol Violation|0|||
25340230|NCT00719043|50656469|FG002|Overall Study|Protocol Violation|0|||
25340231|NCT00719043|50656470|FG003|Overall Study|Protocol Violation|0|||
25340232|NCT00719043|50656471|FG004|Overall Study|Protocol Violation|0|||
25340233|NCT00719043|50656472|FG005|Overall Study|Protocol Violation|1|||
25340234|NCT00719043|50656473|FG006|Overall Study|Protocol Violation|0|||
25340235|NCT00719043|50656467|FG000|Overall Study|Other|1|||
25340236|NCT00719043|50656468|FG001|Overall Study|Other|0|||
25340237|NCT00719043|50656469|FG002|Overall Study|Other|1|||
25340238|NCT00719043|50656470|FG003|Overall Study|Other|2|||
25340239|NCT00719043|50656471|FG004|Overall Study|Other|0|||
25340240|NCT00719043|50656472|FG005|Overall Study|Other|2|||
25340241|NCT00719043|50656473|FG006|Overall Study|Other|1|||
25340242|NCT00719043|50656467|FG000|Overall Study|Withdrawal by Subject|12|||
25340243|NCT00719043|50656468|FG001|Overall Study|Withdrawal by Subject|14|||
25340244|NCT00719043|50656469|FG002|Overall Study|Withdrawal by Subject|9|||
25340245|NCT00719043|50656470|FG003|Overall Study|Withdrawal by Subject|10|||
25340246|NCT00719043|50656471|FG004|Overall Study|Withdrawal by Subject|16|||
25340247|NCT00719043|50656472|FG005|Overall Study|Withdrawal by Subject|18|||
25340248|NCT00719043|50656473|FG006|Overall Study|Withdrawal by Subject|14|||
25340249|NCT00786422|50656501|FG000|Rivaroxaban Treatment|Death|2|||
25340250|NCT00786422|50656501|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
25340251|NCT00786422|50656501|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
25340252|NCT00786422|50656501|FG000|Rivaroxaban Treatment|Physician Decision|1|||
25340253|NCT00786422|50656501|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
25340254|NCT00786422|50656501|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
25340255|NCT00786422|50656501|FG000|Rivaroxaban Treatment|Adverse Event|2|||
25340256|NCT00786422|50656501|FG000|Follow-up Period|Death|1|||
25340257|NCT00786422|50656501|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
25340258|NCT00718887|50656509|FG000|Overall Study|Withdrawal by Subject|3|||
25340259|NCT00718887|50656510|FG001|Overall Study|Withdrawal by Subject|2|||
25340260|NCT00718887|50656509|FG000|Overall Study|Not identified|2|||
25340261|NCT00718887|50656510|FG001|Overall Study|Not identified|7|||
25340262|NCT00786188|50656524|FG000|Overall Study|Adverse Event|3|||
25340263|NCT00786188|50656525|FG001|Overall Study|Adverse Event|1|||
24977722|NCT03831191|50066120|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
25254761|NCT01346592|50570455|FG001|Overall Study|Adverse Event|1|||
25254762|NCT01346592|50570456|FG002|Overall Study|Adverse Event|0|||
25254763|NCT01346592|50570454|FG000|Overall Study|Withdrawal by Subject|77|||
25254764|NCT01346592|50570455|FG001|Overall Study|Withdrawal by Subject|51|||
25340264|NCT00786188|50656524|FG000|Overall Study|Withdrawal by Subject|2|||
25340265|NCT00786188|50656525|FG001|Overall Study|Withdrawal by Subject|0|||
25340266|NCT00790556|50656533|FG000|Treatment Period 1|Physician Decision|1|||
25340267|NCT00790556|50656534|FG001|Treatment Period 1|Physician Decision|0|||
25340268|NCT00790556|50656533|FG000|Treatment Period 1|Withdrawal by Subject|1|||
25340269|NCT00790556|50656534|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25340270|NCT00733824|50656545|FG000|Phase I|Withdrawal by Subject|1|||
25340271|NCT00733824|50656546|FG001|Phase I|Withdrawal by Subject|0|||
24904774|NCT00424177|49998841|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
24904775|NCT00424177|49998841|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
24904776|NCT00618826|49998853|FG000|Overall Study|Adverse Event|1|||
24904777|NCT00578448|49998858|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
24904778|NCT00578448|49998858|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
24904779|NCT00578448|49998858|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
24904780|NCT00578448|49998858|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
24904781|NCT00578318|49998866|FG000|Overall Study|Lost to Follow-up|2|||
24904782|NCT00578318|49998867|FG001|Overall Study|Lost to Follow-up|0|||
24904783|NCT00578318|49998866|FG000|Overall Study|Physician Decision|1|||
24904784|NCT00578318|49998867|FG001|Overall Study|Physician Decision|0|||
24904785|NCT00618748|49998876|FG000|Overall Study|Adverse Event|4|||
24904786|NCT00618748|49998877|FG001|Overall Study|Adverse Event|3|||
24904787|NCT00618748|49998878|FG002|Overall Study|Adverse Event|8|||
24904788|NCT00618748|49998876|FG000|Overall Study|Physician Decision|3|||
24904789|NCT00618748|49998877|FG001|Overall Study|Physician Decision|1|||
24904790|NCT00618748|49998878|FG002|Overall Study|Physician Decision|1|||
24904791|NCT00618748|49998876|FG000|Overall Study|Withdrawal by Subject|4|||
24904792|NCT00618748|49998877|FG001|Overall Study|Withdrawal by Subject|1|||
24904793|NCT00618748|49998878|FG002|Overall Study|Withdrawal by Subject|5|||
24904794|NCT00658359|49998889|FG000|Overall Study|Death|3|||
24904795|NCT00658359|49998890|FG001|Overall Study|Death|1|||
24904796|NCT00658359|49998891|FG002|Overall Study|Death|2|||
24904797|NCT00658359|49998889|FG000|Overall Study|Adverse Event|13|||
24904798|NCT00658359|49998890|FG001|Overall Study|Adverse Event|6|||
24904799|NCT00658359|49998891|FG002|Overall Study|Adverse Event|9|||
24904800|NCT00658359|49998889|FG000|Overall Study|Protocol Violation|1|||
24904801|NCT00658359|49998890|FG001|Overall Study|Protocol Violation|0|||
24904802|NCT00658359|49998891|FG002|Overall Study|Protocol Violation|0|||
24904803|NCT00658359|49998889|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
24904804|NCT00658359|49998890|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
24904805|NCT00658359|49998891|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
24904806|NCT00658359|49998889|FG000|Overall Study|Withdrawal by Subject|7|||
24904807|NCT00658359|49998890|FG001|Overall Study|Withdrawal by Subject|4|||
24904808|NCT00658359|49998891|FG002|Overall Study|Withdrawal by Subject|2|||
24904809|NCT00658359|49998889|FG000|Overall Study|Lost to Follow-up|2|||
24904810|NCT00658359|49998890|FG001|Overall Study|Lost to Follow-up|2|||
24904811|NCT00658359|49998891|FG002|Overall Study|Lost to Follow-up|4|||
24904812|NCT00658359|49998889|FG000|Overall Study|Lack of Efficacy|0|||
24904813|NCT00658359|49998890|FG001|Overall Study|Lack of Efficacy|1|||
24904814|NCT00658359|49998891|FG002|Overall Study|Lack of Efficacy|0|||
25340272|NCT00733824|50656547|FG002|Phase I|Withdrawal by Subject|0|||
25340273|NCT00733824|50656548|FG003|Phase I|Withdrawal by Subject|0|||
25340274|NCT00733824|50656549|FG004|Phase I|Withdrawal by Subject|0|||
25340275|NCT00718809|50656565|FG000|Overall Study|Disease progression|9|||
25340276|NCT00718809|50656566|FG001|Overall Study|Disease progression|7|||
25340277|NCT00718809|50656565|FG000|Overall Study|Adverse Event|1|||
25340278|NCT00718809|50656566|FG001|Overall Study|Adverse Event|1|||
25340279|NCT00718809|50656565|FG000|Overall Study|Withdrawal by Subject|0|||
25340280|NCT00718809|50656566|FG001|Overall Study|Withdrawal by Subject|1|||
24904815|NCT00619918|49998903|FG000|Overall Study|Withdrawal by Subject|4|||
24904816|NCT00619918|49998904|FG001|Overall Study|Withdrawal by Subject|3|||
24904817|NCT00619918|49998903|FG000|Overall Study|Physician Decision|8|||
24904818|NCT00619918|49998904|FG001|Overall Study|Physician Decision|8|||
24904819|NCT00619918|49998903|FG000|Overall Study|Transfer to outside facility|3|||
24904820|NCT00619918|49998904|FG001|Overall Study|Transfer to outside facility|3|||
24904821|NCT00619918|49998903|FG000|Overall Study|Left before receiving first dose|5|||
24904822|NCT00619918|49998904|FG001|Overall Study|Left before receiving first dose|8|||
24904823|NCT01005914|49998910|FG000|Overall Study|Adverse Event|4|||
24904824|NCT01005914|49998910|FG000|Overall Study|Death|4|||
24904825|NCT01005914|49998910|FG000|Overall Study|Lack of Efficacy|1|||
24904826|NCT01005914|49998910|FG000|Overall Study|Withdrawal by Subject|1|||
24904827|NCT00618514|49998921|FG000|Overall Study|Lost to Follow-up|11|||
24904828|NCT00618514|49998922|FG001|Overall Study|Lost to Follow-up|12|||
24904829|NCT00618514|49998923|FG002|Overall Study|Lost to Follow-up|4|||
25078052|NCT03745651|50186224|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
25078053|NCT03745651|50186225|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
25340281|NCT00718809|50656565|FG000|Overall Study|Lost to Follow-up|1|||
25340282|NCT00718809|50656566|FG001|Overall Study|Lost to Follow-up|0|||
25340283|NCT00718809|50656565|FG000|Overall Study|Noncompliance|1|||
24904830|NCT00655629|49998931|FG000|Overall Study|Adverse Event|4|||
24904831|NCT00655629|49998932|FG001|Overall Study|Adverse Event|1|||
24904832|NCT00655629|49998931|FG000|Overall Study|Lack of Efficacy|2|||
24904833|NCT00655629|49998932|FG001|Overall Study|Lack of Efficacy|12|||
24904834|NCT00655629|49998931|FG000|Overall Study|Lost to Follow-up|4|||
24904835|NCT00655629|49998932|FG001|Overall Study|Lost to Follow-up|3|||
24904836|NCT00655629|49998931|FG000|Overall Study|Protocol Violation|5|||
24904837|NCT00655629|49998932|FG001|Overall Study|Protocol Violation|3|||
24904838|NCT00655629|49998931|FG000|Overall Study|consent withdrawn|6|||
24904839|NCT00655629|49998932|FG001|Overall Study|consent withdrawn|4|||
24904840|NCT00578292|49998938|FG000|Overall Study|Death|1|||
24904841|NCT00578292|49998938|FG000|Overall Study|Graft failure|2|||
24904842|NCT00570063|49998944|FG000|Overall Study|Adverse Event|4|||
24904843|NCT00570063|49998945|FG001|Overall Study|Adverse Event|1|||
24904844|NCT00570063|49998944|FG000|Overall Study|Lack of Efficacy|0|||
24904845|NCT00570063|49998945|FG001|Overall Study|Lack of Efficacy|1|||
24904846|NCT00570063|49998944|FG000|Overall Study|Withdrawal by Subject|4|||
24904847|NCT00570063|49998945|FG001|Overall Study|Withdrawal by Subject|3|||
24904848|NCT00570063|49998944|FG000|Overall Study|Sponsor's Decision|7|||
24904849|NCT00570063|49998945|FG001|Overall Study|Sponsor's Decision|3|||
24904850|NCT00577772|49998962|FG000|Overall Study|Lost to Follow-up|0|||
24904851|NCT00577772|49998963|FG001|Overall Study|Lost to Follow-up|1|||
24904852|NCT00578136|49998971|FG000|Overall Study|Not given intervention|1|||
24904853|NCT00578136|49998972|FG001|Overall Study|Not given intervention|1|||
24904854|NCT00655551|49998981|FG000|All Periods Combined|Adverse Event|0|||
24904855|NCT00655551|49998982|FG001|All Periods Combined|Adverse Event|3|||
24904856|NCT00655551|49998983|FG002|All Periods Combined|Adverse Event|4|||
24904857|NCT00655551|49998981|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
24904858|NCT00655551|49998982|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
24904859|NCT00655551|49998983|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
24904860|NCT00655551|49998981|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
24904861|NCT00655551|49998982|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
24904862|NCT00655551|49998983|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
24904863|NCT00655551|49998981|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
24904864|NCT00655551|49998982|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
24904865|NCT00655551|49998983|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
24904866|NCT00312728|49998991|FG000|Overall Study|Progressive disease|53|||
24904867|NCT00312728|49998991|FG000|Overall Study|Adverse Event|32|||
24904868|NCT00312728|49998991|FG000|Overall Study|Withdrawal by Subject|10|||
24904869|NCT00312728|49998991|FG000|Overall Study|Required non-protocol cancer treatment|2|||
24904870|NCT00312728|49998991|FG000|Overall Study|Protocol Violation|2|||
24904871|NCT00312728|49998991|FG000|Overall Study|Other|10|||
24904872|NCT00312728|49998991|FG000|Overall Study|Other|1|||
24904873|NCT00577824|49998998|FG000|Overall Study|Adverse Event|6|||
24904874|NCT00577824|49998999|FG001|Overall Study|Adverse Event|18|||
25340284|NCT00718809|50656566|FG001|Overall Study|Noncompliance|0|||
25340285|NCT00585039|50656574|FG000|Overall Study|medication spilled|2|||
25340286|NCT00585039|50656575|FG001|Overall Study|medication spilled|0|||
25340287|NCT00806195|50656587|FG000|Overall Study|Death|6|||
25340288|NCT00806195|50656588|FG001|Overall Study|Death|0|||
25340289|NCT00806195|50656589|FG002|Overall Study|Death|1|||
25340290|NCT00806195|50656590|FG003|Overall Study|Death|0|||
25340291|NCT00806195|50656587|FG000|Overall Study|Adverse Event|25|||
25340292|NCT00806195|50656588|FG001|Overall Study|Adverse Event|5|||
25340293|NCT00806195|50656589|FG002|Overall Study|Adverse Event|11|||
24904875|NCT00577824|49999000|FG002|Overall Study|Adverse Event|1|||
24904876|NCT00577824|49998998|FG000|Overall Study|Patient decision|0|||
24904877|NCT00577824|49998999|FG001|Overall Study|Patient decision|1|||
24977723|NCT03831191|50066121|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
24977724|NCT03831191|50066122|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
24977725|NCT03831191|50066123|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
24977726|NCT03831191|50066124|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
25254765|NCT01346592|50570456|FG002|Overall Study|Withdrawal by Subject|38|||
25254766|NCT01346592|50570454|FG000|Overall Study|Inappropriate enrollment|3|||
25254767|NCT01346592|50570455|FG001|Overall Study|Inappropriate enrollment|1|||
25254768|NCT01346592|50570456|FG002|Overall Study|Inappropriate enrollment|1|||
25254769|NCT01346592|50570454|FG000|Overall Study|Administrative reason|1|||
25254770|NCT01346592|50570455|FG001|Overall Study|Administrative reason|0|||
25254771|NCT01346592|50570456|FG002|Overall Study|Administrative reason|0|||
25254772|NCT01346592|50570454|FG000|Overall Study|Unable to Classify|7|||
25340294|NCT00806195|50656590|FG003|Overall Study|Adverse Event|2|||
24977727|NCT03831191|50066125|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
25340295|NCT00806195|50656587|FG000|Overall Study|Withdrawal by Subject|119|||
24904878|NCT00577824|49999000|FG002|Overall Study|Patient decision|1|||
24904879|NCT00577824|49998998|FG000|Overall Study|Protocol Violation|1|||
24904880|NCT00577824|49998999|FG001|Overall Study|Protocol Violation|1|||
24904881|NCT00577824|49999000|FG002|Overall Study|Protocol Violation|0|||
24904882|NCT00617344|49999011|FG000|Overall Study|Serious adverse event|1|||
24904883|NCT00617344|49999012|FG001|Overall Study|Serious adverse event|0|||
24904884|NCT00617344|49999013|FG002|Overall Study|Serious adverse event|0|||
24904885|NCT00617344|49999011|FG000|Overall Study|Other Adverse Event|1|||
24904886|NCT00617344|49999012|FG001|Overall Study|Other Adverse Event|1|||
25254773|NCT01346592|50570455|FG001|Overall Study|Unable to Classify|3|||
25340296|NCT00806195|50656588|FG001|Overall Study|Withdrawal by Subject|31|||
25340297|NCT00806195|50656589|FG002|Overall Study|Withdrawal by Subject|76|||
25340298|NCT00806195|50656590|FG003|Overall Study|Withdrawal by Subject|35|||
25340299|NCT00806195|50656587|FG000|Overall Study|Lost to Follow-up|217|||
24904887|NCT00617344|49999013|FG002|Overall Study|Other Adverse Event|0|||
24904888|NCT00617344|49999011|FG000|Overall Study|Protocol Violation|10|||
24904889|NCT00617344|49999012|FG001|Overall Study|Protocol Violation|8|||
24904890|NCT00617344|49999013|FG002|Overall Study|Protocol Violation|5|||
24904891|NCT00617344|49999011|FG000|Overall Study|Lost to Follow-up|5|||
24904892|NCT00617344|49999012|FG001|Overall Study|Lost to Follow-up|4|||
24904893|NCT00617344|49999013|FG002|Overall Study|Lost to Follow-up|1|||
24904894|NCT00617344|49999011|FG000|Overall Study|Withdrawal by Subject|8|||
25340300|NCT00806195|50656588|FG001|Overall Study|Lost to Follow-up|66|||
25340301|NCT00806195|50656589|FG002|Overall Study|Lost to Follow-up|90|||
25340302|NCT00806195|50656590|FG003|Overall Study|Lost to Follow-up|34|||
25340303|NCT00806195|50656587|FG000|Overall Study|Inappropriate Enrollment|0|||
24904895|NCT00617344|49999012|FG001|Overall Study|Withdrawal by Subject|9|||
24904896|NCT00617344|49999013|FG002|Overall Study|Withdrawal by Subject|2|||
24904897|NCT00654381|49999081|FG000|1st Stage|Adverse Event|3|||
24904898|NCT00654381|49999082|FG001|1st Stage|Adverse Event|3|||
24904899|NCT00654381|49999083|FG002|1st Stage|Adverse Event|3|||
24904900|NCT00654381|49999084|FG003|1st Stage|Adverse Event|3|||
24904901|NCT00654381|49999085|FG004|1st Stage|Adverse Event|2|||
24904902|NCT00654381|49999086|FG005|1st Stage|Adverse Event|1|||
24904903|NCT00654381|49999081|FG000|1st Stage|Withdrawal by Subject|0|||
24904904|NCT00654381|49999082|FG001|1st Stage|Withdrawal by Subject|0|||
24904905|NCT00654381|49999083|FG002|1st Stage|Withdrawal by Subject|0|||
24904906|NCT00654381|49999084|FG003|1st Stage|Withdrawal by Subject|1|||
24904907|NCT00654381|49999085|FG004|1st Stage|Withdrawal by Subject|0|||
24904908|NCT00654381|49999086|FG005|1st Stage|Withdrawal by Subject|1|||
24904909|NCT00654381|49999081|FG000|1st Stage|Investigator's decision|0|||
24904910|NCT00654381|49999082|FG001|1st Stage|Investigator's decision|0|||
24904911|NCT00654381|49999083|FG002|1st Stage|Investigator's decision|0|||
24904912|NCT00654381|49999084|FG003|1st Stage|Investigator's decision|1|||
24904913|NCT00654381|49999085|FG004|1st Stage|Investigator's decision|0|||
24904914|NCT00654381|49999086|FG005|1st Stage|Investigator's decision|0|||
24904915|NCT00654381|49999081|FG000|2nd Stage|Adverse Event|2|||
24904916|NCT00654381|49999082|FG001|2nd Stage|Adverse Event|0|||
24904917|NCT00654381|49999083|FG002|2nd Stage|Adverse Event|2|||
25340304|NCT00806195|50656588|FG001|Overall Study|Inappropriate Enrollment|1|||
25340305|NCT00806195|50656589|FG002|Overall Study|Inappropriate Enrollment|0|||
25340306|NCT00806195|50656590|FG003|Overall Study|Inappropriate Enrollment|0|||
25340307|NCT00806195|50656587|FG000|Overall Study|Administrative Reason|113|||
25340308|NCT00806195|50656588|FG001|Overall Study|Administrative Reason|35|||
25340309|NCT00806195|50656589|FG002|Overall Study|Administrative Reason|66|||
25340310|NCT00806195|50656590|FG003|Overall Study|Administrative Reason|26|||
25340311|NCT00806195|50656587|FG000|Overall Study|Protocol Violation|34|||
25340312|NCT00806195|50656588|FG001|Overall Study|Protocol Violation|24|||
25340313|NCT00806195|50656589|FG002|Overall Study|Protocol Violation|26|||
25340314|NCT00806195|50656590|FG003|Overall Study|Protocol Violation|9|||
25340315|NCT00733746|50656602|FG000|Overall Study|Ineligible|5|||
25340316|NCT00718419|50656608|FG000|Overall Study|Adverse Event|2|||
25340317|NCT00718419|50656609|FG001|Overall Study|Adverse Event|1|||
25340318|NCT00718419|50656608|FG000|Overall Study|Physician Decision|1|||
25340319|NCT00718419|50656609|FG001|Overall Study|Physician Decision|6|||
25340320|NCT00718419|50656608|FG000|Overall Study|Sponsor decision|0|||
25340321|NCT00718419|50656609|FG001|Overall Study|Sponsor decision|1|||
25340322|NCT00718419|50656608|FG000|Overall Study|Withdrawal by Subject|0|||
25340323|NCT00718419|50656609|FG001|Overall Study|Withdrawal by Subject|5|||
25340324|NCT00718419|50656608|FG000|Overall Study|Progressive Disease|7|||
25340325|NCT00718419|50656609|FG001|Overall Study|Progressive Disease|25|||
25340326|NCT00718419|50656608|FG000|Overall Study|Death Due to Progressive Disease|2|||
25340327|NCT00718419|50656609|FG001|Overall Study|Death Due to Progressive Disease|0|||
25340328|NCT00718419|50656608|FG000|Overall Study|Death Due to Study Drug Related|0|||
25340329|NCT00718419|50656609|FG001|Overall Study|Death Due to Study Drug Related|1|||
24904918|NCT00654381|49999084|FG003|2nd Stage|Adverse Event|3|||
24904919|NCT00654381|49999085|FG004|2nd Stage|Adverse Event|7|||
24904920|NCT00654381|49999086|FG005|2nd Stage|Adverse Event|2|||
24904921|NCT00654381|49999081|FG000|2nd Stage|Withdrawal by Subject|0|||
25340330|NCT00718419|50656608|FG000|Overall Study|Death Due to Adverse Events|1|||
25340331|NCT00718419|50656609|FG001|Overall Study|Death Due to Adverse Events|0|||
25340332|NCT00717249|50656617|FG000|Overall Study|Lens Discomfort|4|||
25340333|NCT00717249|50656618|FG001|Overall Study|Lens Discomfort|1|||
25340334|NCT00717249|50656617|FG000|Overall Study|Unsatisfactory visual Response|0|||
25340335|NCT00717249|50656618|FG001|Overall Study|Unsatisfactory visual Response|2|||
24904922|NCT00654381|49999082|FG001|2nd Stage|Withdrawal by Subject|0|||
24904923|NCT00654381|49999083|FG002|2nd Stage|Withdrawal by Subject|0|||
24904924|NCT00654381|49999084|FG003|2nd Stage|Withdrawal by Subject|0|||
24904925|NCT00654381|49999085|FG004|2nd Stage|Withdrawal by Subject|1|||
24904926|NCT00654381|49999086|FG005|2nd Stage|Withdrawal by Subject|1|||
24904927|NCT00654381|49999081|FG000|2nd Stage|Investigator's decision|0|||
24904928|NCT00654381|49999082|FG001|2nd Stage|Investigator's decision|0|||
25340336|NCT00717249|50656617|FG000|Overall Study|Adverse Event|4|||
25340337|NCT00717249|50656618|FG001|Overall Study|Adverse Event|2|||
24904929|NCT00654381|49999083|FG002|2nd Stage|Investigator's decision|1|||
24904930|NCT00654381|49999084|FG003|2nd Stage|Investigator's decision|1|||
24904931|NCT00654381|49999085|FG004|2nd Stage|Investigator's decision|0|||
24904932|NCT00654381|49999086|FG005|2nd Stage|Investigator's decision|0|||
24904933|NCT00654381|49999081|FG000|Extension Stage|Adverse Event|1|||
24904934|NCT00654381|49999082|FG001|Extension Stage|Adverse Event|2|||
24904935|NCT00654381|49999083|FG002|Extension Stage|Adverse Event|9|||
24904936|NCT00654381|49999084|FG003|Extension Stage|Adverse Event|7|||
24904937|NCT00654381|49999085|FG004|Extension Stage|Adverse Event|1|||
24904938|NCT00654381|49999086|FG005|Extension Stage|Adverse Event|1|||
24904939|NCT00654381|49999081|FG000|Extension Stage|Protocol Violation|0|||
24904940|NCT00654381|49999082|FG001|Extension Stage|Protocol Violation|0|||
24904941|NCT00654381|49999083|FG002|Extension Stage|Protocol Violation|0|||
24904942|NCT00654381|49999084|FG003|Extension Stage|Protocol Violation|1|||
24904943|NCT00654381|49999085|FG004|Extension Stage|Protocol Violation|0|||
24904944|NCT00654381|49999086|FG005|Extension Stage|Protocol Violation|0|||
24904945|NCT00654381|49999081|FG000|Extension Stage|Lack of Efficacy|0|||
24904946|NCT00654381|49999082|FG001|Extension Stage|Lack of Efficacy|0|||
24904947|NCT00654381|49999083|FG002|Extension Stage|Lack of Efficacy|1|||
24904948|NCT00654381|49999084|FG003|Extension Stage|Lack of Efficacy|0|||
24904949|NCT00654381|49999085|FG004|Extension Stage|Lack of Efficacy|0|||
24904950|NCT00654381|49999086|FG005|Extension Stage|Lack of Efficacy|0|||
24904951|NCT00654381|49999081|FG000|Extension Stage|Withdrawal by Subject|0|||
24904952|NCT00654381|49999082|FG001|Extension Stage|Withdrawal by Subject|0|||
24904953|NCT00654381|49999083|FG002|Extension Stage|Withdrawal by Subject|1|||
24904954|NCT00654381|49999084|FG003|Extension Stage|Withdrawal by Subject|1|||
24904955|NCT00654381|49999085|FG004|Extension Stage|Withdrawal by Subject|1|||
24904956|NCT00654381|49999086|FG005|Extension Stage|Withdrawal by Subject|1|||
24904957|NCT00654381|49999081|FG000|Extension Stage|Closure of the trial site|0|||
24904958|NCT00654381|49999082|FG001|Extension Stage|Closure of the trial site|0|||
24904959|NCT00654381|49999083|FG002|Extension Stage|Closure of the trial site|0|||
24904960|NCT00654381|49999084|FG003|Extension Stage|Closure of the trial site|0|||
24904961|NCT00654381|49999085|FG004|Extension Stage|Closure of the trial site|1|||
24904962|NCT00654381|49999086|FG005|Extension Stage|Closure of the trial site|1|||
24904963|NCT00657267|49999103|FG000|Overall Study|Progressive disease|45|||
24904964|NCT00657267|49999103|FG000|Overall Study|Adverse Event|9|||
24904965|NCT00653991|49999111|FG000|3 Month Follow-up|Participant would not respond|150|||
24904966|NCT00653991|49999112|FG001|3 Month Follow-up|Participant would not respond|157|||
24904967|NCT00653991|49999111|FG000|6 Month Follow-up|Participant would not respond|133|||
24904968|NCT00653991|49999112|FG001|6 Month Follow-up|Participant would not respond|141|||
24904969|NCT00652899|49999120|FG000|Overall Study|Death|1|||
24904970|NCT00652899|49999120|FG000|Overall Study|Treating physician decision|1|||
24904971|NCT00617890|49999132|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
24904972|NCT00617890|49999133|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
24904973|NCT00617890|49999134|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
24904974|NCT00617890|49999135|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
24904975|NCT00617890|49999132|FG000|Overall Study|Lack of Efficacy|23|||
24904976|NCT00617890|49999133|FG001|Overall Study|Lack of Efficacy|26|||
24904977|NCT00617890|49999134|FG002|Overall Study|Lack of Efficacy|30|||
24904978|NCT00617890|49999135|FG003|Overall Study|Lack of Efficacy|97|||
24904979|NCT00617890|49999132|FG000|Overall Study|Lost to Follow-up|0|||
24904980|NCT00617890|49999133|FG001|Overall Study|Lost to Follow-up|0|||
24904981|NCT00617890|49999134|FG002|Overall Study|Lost to Follow-up|1|||
24904982|NCT00617890|49999135|FG003|Overall Study|Lost to Follow-up|2|||
24904983|NCT00617890|49999132|FG000|Overall Study|Withdrawal by Subject|4|||
25078054|NCT03745651|50186226|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
25254774|NCT01346592|50570456|FG002|Overall Study|Unable to Classify|6|||
25254775|NCT01346514|50570483|FG000|Overall Study|Lost to Follow-up|19|||
25254776|NCT01346514|50570484|FG001|Overall Study|Lost to Follow-up|30|||
25254777|NCT01346514|50570483|FG000|Overall Study|Withdrawal by Subject|7|||
25254778|NCT01346514|50570484|FG001|Overall Study|Withdrawal by Subject|3|||
25254779|NCT01346514|50570483|FG000|Overall Study|Death|3|||
25254780|NCT01346514|50570484|FG001|Overall Study|Death|4|||
24904984|NCT00617890|49999133|FG001|Overall Study|Withdrawal by Subject|1|||
24904985|NCT00617890|49999134|FG002|Overall Study|Withdrawal by Subject|0|||
24904986|NCT00617890|49999135|FG003|Overall Study|Withdrawal by Subject|2|||
24904987|NCT00617890|49999132|FG000|Overall Study|Protocol Violation|2|||
24904988|NCT00617890|49999133|FG001|Overall Study|Protocol Violation|1|||
24904989|NCT00617890|49999134|FG002|Overall Study|Protocol Violation|0|||
24904990|NCT00617890|49999135|FG003|Overall Study|Protocol Violation|0|||
25254781|NCT01193335|50570494|FG000|After Infant Series|Lost to Follow-up|1|||
24904991|NCT00617890|49999132|FG000|Overall Study|Adverse Event|1|||
24904992|NCT00617890|49999133|FG001|Overall Study|Adverse Event|0|||
24904993|NCT00617890|49999134|FG002|Overall Study|Adverse Event|3|||
24904994|NCT00617890|49999135|FG003|Overall Study|Adverse Event|8|||
25254782|NCT01193335|50570495|FG001|After Infant Series|Lost to Follow-up|2|||
24904995|NCT00617890|49999132|FG000|Overall Study|Not treated|1|||
24904996|NCT00617890|49999133|FG001|Overall Study|Not treated|0|||
24904997|NCT00617890|49999134|FG002|Overall Study|Not treated|1|||
24904998|NCT00617890|49999135|FG003|Overall Study|Not treated|1|||
24904999|NCT00712166|49999150|FG000|Overall Study|Noncompliance|0|||
24905000|NCT00712166|49999151|FG001|Overall Study|Noncompliance|1|||
24905001|NCT00652743|49999162|FG000|Months 12-18|Lost to Follow-up|1|||
24905002|NCT00652743|49999163|FG001|Months 12-18|Lost to Follow-up|2|||
24905003|NCT00652743|49999164|FG002|Months 12-18|Lost to Follow-up|7|||
24905004|NCT00652743|49999162|FG000|Months 24-30|Other|5|||
24905005|NCT00652743|49999163|FG001|Months 24-30|Other|1|||
24905006|NCT00652743|49999164|FG002|Months 24-30|Other|11|||
24905007|NCT00652743|49999162|FG000|Months 36-42|Serious Adverse Events|0|||
24905008|NCT00652743|49999163|FG001|Months 36-42|Serious Adverse Events|1|||
24905009|NCT00652743|49999164|FG002|Months 36-42|Serious Adverse Events|1|||
24905010|NCT00652743|49999162|FG000|Months 36-42|Withdrawal by Subject|1|||
24905011|NCT00652743|49999163|FG001|Months 36-42|Withdrawal by Subject|1|||
24905012|NCT00652743|49999164|FG002|Months 36-42|Withdrawal by Subject|0|||
24905013|NCT00652743|49999162|FG000|Months 36-42|Lost to Follow-up|0|||
24905014|NCT00652743|49999163|FG001|Months 36-42|Lost to Follow-up|1|||
24905015|NCT00652743|49999164|FG002|Months 36-42|Lost to Follow-up|0|||
24905016|NCT00652743|49999162|FG000|Months 36-42|Migrated/moved from study area|1|||
24905017|NCT00652743|49999163|FG001|Months 36-42|Migrated/moved from study area|0|||
24905018|NCT00652743|49999164|FG002|Months 36-42|Migrated/moved from study area|0|||
24905019|NCT00652743|49999162|FG000|Months 36-42|Other|4|||
24905020|NCT00652743|49999163|FG001|Months 36-42|Other|2|||
24905021|NCT00652743|49999164|FG002|Months 36-42|Other|8|||
24905022|NCT00712010|49999175|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
24905023|NCT00653523|49999191|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
24905024|NCT00653523|49999191|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
24905025|NCT00653523|49999191|FG000|Overall Study|Adverse Event|7|||
24905026|NCT00653523|49999191|FG000|Overall Study|Withdrawal by Subject|6|||
25340338|NCT00717249|50656617|FG000|Overall Study|Lost to Follow-up|2|||
25340339|NCT00717249|50656618|FG001|Overall Study|Lost to Follow-up|0|||
24905027|NCT00653523|49999191|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
25340340|NCT00717249|50656617|FG000|Overall Study|Withdrawal by Subject|1|||
25340341|NCT00717249|50656618|FG001|Overall Study|Withdrawal by Subject|2|||
25340342|NCT00717249|50656617|FG000|Overall Study|Pregnancy|6|||
25340343|NCT00717249|50656618|FG001|Overall Study|Pregnancy|3|||
25340344|NCT00717249|50656617|FG000|Overall Study|Protocol Violation|0|||
25340345|NCT00717249|50656618|FG001|Overall Study|Protocol Violation|2|||
24905028|NCT00653523|49999191|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
24905029|NCT02717442|49999197|FG000|Overall Study|Study Terminated by Sponsor|31|||
24905030|NCT02717442|49999198|FG001|Overall Study|Study Terminated by Sponsor|29|||
24905031|NCT02717442|49999197|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
24905032|NCT02717442|49999198|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
24905033|NCT02717442|49999197|FG000|Overall Study|Other - Not Specified|2|||
24905034|NCT02717442|49999198|FG001|Overall Study|Other - Not Specified|0|||
24905035|NCT00616018|49999211|FG000|Overall Study|Protocol Violation|3|||
24905036|NCT00424021|49999220|FG000|NCT00046319 Study Period|Adverse Event|1|||
24905037|NCT00424021|49999221|FG001|NCT00046319 Study Period|Adverse Event|0|||
24905038|NCT00424021|49999222|FG002|NCT00046319 Study Period|Adverse Event|1|||
24905039|NCT00424021|49999223|FG003|NCT00046319 Study Period|Adverse Event|1|||
24905040|NCT00424021|49999220|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
24905041|NCT00424021|49999221|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
24905042|NCT00424021|49999222|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
24905043|NCT00424021|49999223|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
24905044|NCT00424021|49999220|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
24905045|NCT00424021|49999221|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
24905046|NCT00424021|49999222|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
24905047|NCT00424021|49999223|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
24905048|NCT00424021|49999220|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
24905049|NCT00424021|49999221|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
24905050|NCT00424021|49999222|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
25078055|NCT03745651|50186227|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
24905051|NCT00424021|49999223|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
24905052|NCT00424021|49999220|FG000|AMB-220-E Study Period|Adverse Event|1|||
24905053|NCT00424021|49999221|FG001|AMB-220-E Study Period|Adverse Event|1|||
24905054|NCT00424021|49999222|FG002|AMB-220-E Study Period|Adverse Event|3|||
25078056|NCT03745651|50186228|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
25340346|NCT00717249|50656617|FG000|Overall Study|Subject became Ineligible|1|||
25340347|NCT00717249|50656618|FG001|Overall Study|Subject became Ineligible|1|||
24905055|NCT00424021|49999223|FG003|AMB-220-E Study Period|Adverse Event|7|||
24905056|NCT00424021|49999220|FG000|AMB-220-E Study Period|Death|0|||
24905057|NCT00424021|49999221|FG001|AMB-220-E Study Period|Death|0|||
24905058|NCT00424021|49999222|FG002|AMB-220-E Study Period|Death|1|||
24905059|NCT00424021|49999223|FG003|AMB-220-E Study Period|Death|1|||
24905060|NCT00424021|49999220|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
24905061|NCT00424021|49999221|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
24905062|NCT00424021|49999222|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
24905063|NCT00424021|49999223|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
24905064|NCT00424021|49999220|FG000|AMB-220-E Study Period|Physician Decision|0|||
24905065|NCT00424021|49999221|FG001|AMB-220-E Study Period|Physician Decision|0|||
24905066|NCT00424021|49999222|FG002|AMB-220-E Study Period|Physician Decision|0|||
24905067|NCT00424021|49999223|FG003|AMB-220-E Study Period|Physician Decision|1|||
24905068|NCT00617734|49999242|FG000|Overall Study|Withdrew Consent|2|||
24905069|NCT00617734|49999243|FG001|Overall Study|Withdrew Consent|0|||
24905070|NCT00617734|49999242|FG000|Overall Study|Adverse Event|4|||
24905071|NCT00617734|49999243|FG001|Overall Study|Adverse Event|1|||
24905072|NCT00617734|49999242|FG000|Overall Study|Protocol Violation|1|||
24905073|NCT00617734|49999243|FG001|Overall Study|Protocol Violation|0|||
24905074|NCT00617734|49999242|FG000|Overall Study|Found Ineligible After Randomization|1|||
24905075|NCT00617734|49999243|FG001|Overall Study|Found Ineligible After Randomization|4|||
24905076|NCT00617734|49999242|FG000|Overall Study|Lost to Follow-up|0|||
24977728|NCT03831191|50066126|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
24977729|NCT03831191|50066127|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
24977730|NCT03831191|50066128|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
24977731|NCT03831191|50066129|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
24977732|NCT03831191|50066130|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
24977733|NCT00005906|50066163|FG000|Overall Study|Lack of Efficacy|3|||
24977734|NCT00066690|50066170|FG000|Overall Study|Adverse Event|145|||
24977735|NCT00066690|50066171|FG001|Overall Study|Adverse Event|58|||
24905077|NCT00617734|49999243|FG001|Overall Study|Lost to Follow-up|1|||
24905078|NCT00577460|49999252|FG000|Overall Study|Adverse Event|11|||
24905079|NCT00577460|49999253|FG001|Overall Study|Adverse Event|7|||
24905080|NCT00577460|49999254|FG002|Overall Study|Adverse Event|14|||
24905081|NCT00577460|49999252|FG000|Overall Study|Protocol Violation|0|||
24905082|NCT00577460|49999253|FG001|Overall Study|Protocol Violation|1|||
24905083|NCT00577460|49999254|FG002|Overall Study|Protocol Violation|1|||
24905084|NCT00577460|49999252|FG000|Overall Study|Lost to Follow-up|0|||
24905085|NCT00577460|49999253|FG001|Overall Study|Lost to Follow-up|3|||
24905086|NCT00577460|49999254|FG002|Overall Study|Lost to Follow-up|4|||
24905087|NCT00577460|49999252|FG000|Overall Study|Withdrawal by Subject|5|||
24905088|NCT00577460|49999253|FG001|Overall Study|Withdrawal by Subject|5|||
24905089|NCT00577460|49999254|FG002|Overall Study|Withdrawal by Subject|6|||
24905090|NCT00577460|49999252|FG000|Overall Study|Other|0|||
24905091|NCT00577460|49999253|FG001|Overall Study|Other|3|||
24905092|NCT00577460|49999254|FG002|Overall Study|Other|2|||
24905093|NCT00415519|49999271|FG000|Overall Study|Adverse Event|1|||
24905094|NCT00415519|49999272|FG001|Overall Study|Adverse Event|0|||
24905095|NCT00415519|49999271|FG000|Overall Study|Withdrawal by Subject|2|||
24905096|NCT00415519|49999272|FG001|Overall Study|Withdrawal by Subject|0|||
24905097|NCT00415519|49999271|FG000|Overall Study|Patient's convenience|1|||
24905098|NCT00415519|49999272|FG001|Overall Study|Patient's convenience|0|||
24905099|NCT00423943|49999280|FG000|Overall Study|Withdrawal by Subject|3|||
24977736|NCT00066690|50066172|FG002|Overall Study|Adverse Event|126|||
24977737|NCT00066690|50066170|FG000|Overall Study|Death|3|||
24977738|NCT00066690|50066171|FG001|Overall Study|Death|0|||
24977739|NCT00066690|50066172|FG002|Overall Study|Death|2|||
24977740|NCT00066690|50066170|FG000|Overall Study|Lack of Efficacy|114|||
24977741|NCT00066690|50066171|FG001|Overall Study|Lack of Efficacy|110|||
24977742|NCT00066690|50066172|FG002|Overall Study|Lack of Efficacy|76|||
24977743|NCT00066690|50066170|FG000|Overall Study|Lost to Follow-up|40|||
24977744|NCT00066690|50066171|FG001|Overall Study|Lost to Follow-up|21|||
24977745|NCT00066690|50066172|FG002|Overall Study|Lost to Follow-up|29|||
24977746|NCT00066690|50066170|FG000|Overall Study|Withdrawal by Subject|50|||
24977747|NCT00066690|50066171|FG001|Overall Study|Withdrawal by Subject|55|||
24977748|NCT00066690|50066172|FG002|Overall Study|Withdrawal by Subject|49|||
25078057|NCT03745651|50186229|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
24905100|NCT00423943|49999281|FG001|Overall Study|Withdrawal by Subject|1|||
24905101|NCT00428389|49999289|FG000|Core Phase|Adverse Event|6|||
24905102|NCT00428389|49999290|FG001|Core Phase|Adverse Event|4|||
24905103|NCT00428389|49999289|FG000|Core Phase|Lack of Efficacy|2|||
24977749|NCT00066690|50066170|FG000|Overall Study|Treatment Ongoing|246|||
24977750|NCT00066690|50066171|FG001|Overall Study|Treatment Ongoing|278|||
24977751|NCT00066690|50066172|FG002|Overall Study|Treatment Ongoing|282|||
24905104|NCT00428389|49999290|FG001|Core Phase|Lack of Efficacy|0|||
24905105|NCT00428389|49999289|FG000|Core Phase|Abnormal test procedure result(s)|0|||
24977752|NCT03409276|50066188|FG000|Overall Study|Withdrawal by Subject|0|||
24905106|NCT00428389|49999290|FG001|Core Phase|Abnormal test procedure result(s)|1|||
24905107|NCT00428389|49999289|FG000|Core Phase|Withdrawal by Subject|3|||
24905108|NCT00428389|49999290|FG001|Core Phase|Withdrawal by Subject|4|||
24905109|NCT00428389|49999289|FG000|Core Phase|Protocol deviation|0|||
24905110|NCT00428389|49999290|FG001|Core Phase|Protocol deviation|2|||
24905111|NCT00428389|49999289|FG000|Extension Phase|Adverse Event|17|||
24905112|NCT00428389|49999290|FG001|Extension Phase|Adverse Event|11|||
24905113|NCT00428389|49999289|FG000|Extension Phase|Lack of Efficacy|4|||
24905114|NCT00428389|49999290|FG001|Extension Phase|Lack of Efficacy|3|||
24905115|NCT00428389|49999289|FG000|Extension Phase|Withdrawal by Subject|6|||
24905116|NCT00428389|49999290|FG001|Extension Phase|Withdrawal by Subject|6|||
25340348|NCT00717249|50656617|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
25340349|NCT00717249|50656618|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
25340350|NCT00717249|50656617|FG000|Overall Study|Gastric Surgery|0|||
25340351|NCT00717249|50656618|FG001|Overall Study|Gastric Surgery|1|||
25340352|NCT00717249|50656617|FG000|Overall Study|Diagnosed with Diabetes|1|||
25340353|NCT00717249|50656618|FG001|Overall Study|Diagnosed with Diabetes|0|||
25340354|NCT00717249|50656617|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
25340355|NCT00717249|50656618|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
24905117|NCT00428389|49999289|FG000|Extension Phase|Lost to Follow-up|0|||
25254783|NCT01193335|50570494|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
25254784|NCT01193335|50570495|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
25254785|NCT01193335|50570494|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
25254786|NCT01193335|50570495|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
25254787|NCT01193335|50570494|FG000|1-Year Follow-up|Lost to Follow-up|4|||
25254788|NCT01193335|50570495|FG001|1-Year Follow-up|Lost to Follow-up|0|||
25254789|NCT01193335|50570494|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
25254790|NCT01193335|50570495|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
25254791|NCT01193335|50570494|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
25254792|NCT01193335|50570495|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
25254793|NCT01342887|50570517|FG000|Overall Study|Death|2|||
25254794|NCT01342341|50570523|FG000|Overall Study|Lost to Follow-up|4|||
25254795|NCT01342341|50570524|FG001|Overall Study|Lost to Follow-up|4|||
25254796|NCT01340664|50570533|FG000|Overall Study|Adverse Event|0|||
25254797|NCT01340664|50570534|FG001|Overall Study|Adverse Event|1|||
25254798|NCT01340664|50570535|FG002|Overall Study|Adverse Event|7|||
25254799|NCT01340664|50570533|FG000|Overall Study|Lost to Follow-up|2|||
25254800|NCT01340664|50570534|FG001|Overall Study|Lost to Follow-up|0|||
25254801|NCT01340664|50570535|FG002|Overall Study|Lost to Follow-up|2|||
25254802|NCT01340664|50570533|FG000|Overall Study|Withdrawal by Subject|2|||
25254803|NCT01340664|50570534|FG001|Overall Study|Withdrawal by Subject|4|||
25254804|NCT01340664|50570535|FG002|Overall Study|Withdrawal by Subject|0|||
25254805|NCT01340664|50570533|FG000|Overall Study|Glycemic withdrawal criteria|2|||
25254806|NCT01340664|50570534|FG001|Overall Study|Glycemic withdrawal criteria|0|||
25254807|NCT01340664|50570535|FG002|Overall Study|Glycemic withdrawal criteria|0|||
25254808|NCT01340664|50570533|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
25254809|NCT01340664|50570534|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
25254810|NCT01340664|50570535|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
25254811|NCT01340664|50570533|FG000|Overall Study|Other|1|||
25254812|NCT01340664|50570534|FG001|Overall Study|Other|2|||
25254813|NCT01340664|50570535|FG002|Overall Study|Other|2|||
25254814|NCT01340625|50570545|FG000|First Intervention|Adverse Event|1|||
25254815|NCT01340625|50570546|FG001|First Intervention|Adverse Event|0|||
25254816|NCT01340625|50570545|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
25254817|NCT01340625|50570546|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
25254818|NCT01340196|50570552|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
25254819|NCT01327599|50570561|FG000|Overall Study|Adverse Event|1|||
25254820|NCT01327599|50570561|FG000|Overall Study|Could Not Attend Visit|1|||
25254821|NCT01327599|50570561|FG000|Overall Study|Withdrawal of Consent|1|||
25254822|NCT01193257|50570567|FG000|Overall Study|Death|202|||
25254823|NCT01193257|50570568|FG001|Overall Study|Death|391|||
25254824|NCT01193257|50570567|FG000|Overall Study|Study termination by sponsor|0|||
25254825|NCT01193257|50570568|FG001|Overall Study|Study termination by sponsor|3|||
25340356|NCT00717249|50656617|FG000|Overall Study|Subject relocated|1|||
25340357|NCT00717249|50656618|FG001|Overall Study|Subject relocated|0|||
25340358|NCT00717249|50656617|FG000|Overall Study|Headaches|1|||
25254826|NCT01193257|50570567|FG000|Overall Study|Withdrawal by Subject|26|||
25254827|NCT01193257|50570568|FG001|Overall Study|Withdrawal by Subject|86|||
25254828|NCT01193257|50570567|FG000|Overall Study|Lost to Follow-up|2|||
25254829|NCT01193257|50570568|FG001|Overall Study|Lost to Follow-up|3|||
25254830|NCT01193257|50570567|FG000|Overall Study|Unblinded due to futility|135|||
25254831|NCT01193257|50570568|FG001|Overall Study|Unblinded due to futility|251|||
25340359|NCT00717249|50656618|FG001|Overall Study|Headaches|0|||
24905118|NCT00428389|49999290|FG001|Extension Phase|Lost to Follow-up|3|||
24905119|NCT00428389|49999289|FG000|Extension Phase|Death|1|||
24905120|NCT00428389|49999290|FG001|Extension Phase|Death|0|||
25254832|NCT01193218|50570579|FG000|0-12 Weeks|Adverse Event|6|||
25254833|NCT01193218|50570580|FG001|0-12 Weeks|Adverse Event|0|||
25254834|NCT01193218|50570581|FG002|0-12 Weeks|Adverse Event|1|||
25340360|NCT00727194|50656624|FG000|Screening Period|Low QMG scores|0|||
24905121|NCT00428389|49999289|FG000|Extension Phase|Protocol Violation|3|||
25340361|NCT00727194|50656625|FG001|Screening Period|Low QMG scores|0|||
25340362|NCT00727194|50656626|FG002|Screening Period|Low QMG scores|6|||
25340363|NCT00727194|50656624|FG000|Screening Period|Lacked AChR antibodies|0|||
25340364|NCT00727194|50656625|FG001|Screening Period|Lacked AChR antibodies|0|||
24905122|NCT00428389|49999290|FG001|Extension Phase|Protocol Violation|2|||
24905123|NCT00428389|49999289|FG000|Extension Phase|Administrative problems|1|||
24905124|NCT00428389|49999290|FG001|Extension Phase|Administrative problems|1|||
24905125|NCT00616642|49999298|FG000|Overall Study|Withdrawal by Subject|0|||
25340365|NCT00727194|50656626|FG002|Screening Period|Lacked AChR antibodies|5|||
25340366|NCT00727194|50656624|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
25340367|NCT00727194|50656625|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
24905126|NCT00616642|49999299|FG001|Overall Study|Withdrawal by Subject|1|||
24905127|NCT00406315|49999305|FG000|Overall Study|Death|1|||
24905128|NCT00406315|49999305|FG000|Overall Study|Adverse Event|39|||
24905129|NCT00406315|49999305|FG000|Overall Study|Laboratory Abnormality|4|||
24905130|NCT00406315|49999305|FG000|Overall Study|Lack of Efficacy|13|||
24905131|NCT00406315|49999305|FG000|Overall Study|Other|33|||
24905132|NCT00406315|49999305|FG000|Overall Study|Lost to Follow-up|21|||
24905133|NCT00406315|49999305|FG000|Overall Study|Withdrawal by Subject|30|||
24905134|NCT00711594|49999313|FG000|Overall Study|Progressive disease|2|||
24905135|NCT00711594|49999314|FG001|Overall Study|Progressive disease|2|||
24905136|NCT00711594|49999315|FG002|Overall Study|Progressive disease|6|||
24905137|NCT00711594|49999316|FG003|Overall Study|Progressive disease|44|||
24905138|NCT00711594|49999313|FG000|Overall Study|Other Adverse Event|1|||
24905139|NCT00711594|49999314|FG001|Overall Study|Other Adverse Event|0|||
24905140|NCT00711594|49999315|FG002|Overall Study|Other Adverse Event|0|||
24905141|NCT00711594|49999316|FG003|Overall Study|Other Adverse Event|16|||
24905142|NCT00711594|49999313|FG000|Overall Study|Withdrawal by Subject|0|||
24905143|NCT00711594|49999314|FG001|Overall Study|Withdrawal by Subject|1|||
24905144|NCT00711594|49999315|FG002|Overall Study|Withdrawal by Subject|0|||
24905145|NCT00711594|49999316|FG003|Overall Study|Withdrawal by Subject|2|||
24905146|NCT00710762|49999330|FG000|Overall Study|Progressive disease|27|||
24905147|NCT00710762|49999331|FG001|Overall Study|Progressive disease|30|||
24905148|NCT00710762|49999330|FG000|Overall Study|Adverse Event other disease worsening|2|||
24905149|NCT00710762|49999331|FG001|Overall Study|Adverse Event other disease worsening|1|||
24905150|NCT00710762|49999330|FG000|Overall Study|Other Adverse Event|7|||
24905151|NCT00710762|49999331|FG001|Overall Study|Other Adverse Event|7|||
24905152|NCT00710762|49999330|FG000|Overall Study|Lost to Follow-up|1|||
24905153|NCT00710762|49999331|FG001|Overall Study|Lost to Follow-up|0|||
24905154|NCT00710762|49999330|FG000|Overall Study|Reason other than listed above|2|||
24905155|NCT00710762|49999331|FG001|Overall Study|Reason other than listed above|2|||
24905156|NCT00573430|49999340|FG000|Overall Study|Incorrect enrollment of randomization|0|||
24905157|NCT00573430|49999341|FG001|Overall Study|Incorrect enrollment of randomization|4|||
24905158|NCT00573430|49999342|FG002|Overall Study|Incorrect enrollment of randomization|3|||
24905159|NCT00573430|49999340|FG000|Overall Study|Adverse Event|0|||
24905160|NCT00573430|49999341|FG001|Overall Study|Adverse Event|0|||
24905161|NCT00573430|49999342|FG002|Overall Study|Adverse Event|2|||
24905162|NCT00573430|49999340|FG000|Overall Study|Withdrawal by Subject|1|||
24905163|NCT00573430|49999341|FG001|Overall Study|Withdrawal by Subject|0|||
24905164|NCT00573430|49999342|FG002|Overall Study|Withdrawal by Subject|1|||
24905165|NCT00573430|49999340|FG000|Overall Study|Protocol Violation|0|||
24905166|NCT00573430|49999341|FG001|Overall Study|Protocol Violation|1|||
24905167|NCT00573430|49999342|FG002|Overall Study|Protocol Violation|1|||
24905168|NCT00573430|49999340|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
24905169|NCT00573430|49999341|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
24905170|NCT00573430|49999342|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
24905171|NCT00711516|49999352|FG000|Overall Study|Adverse Event|1|||
24905172|NCT00711516|49999353|FG001|Overall Study|Adverse Event|1|||
24905173|NCT00711516|49999352|FG000|Overall Study|Withdrawal by Subject|0|||
24905174|NCT00711516|49999353|FG001|Overall Study|Withdrawal by Subject|1|||
24905175|NCT00711516|49999352|FG000|Overall Study|Protocol Violation|0|||
24905176|NCT00711516|49999353|FG001|Overall Study|Protocol Violation|1|||
24905177|NCT00615550|49999361|FG000|Overall Study|Lost to Follow-up|6|||
24905178|NCT00615550|49999362|FG001|Overall Study|Lost to Follow-up|1|||
24905179|NCT00186888|49999371|FG000|Overall Study|Toxicity|0|||
24905180|NCT00186888|49999372|FG001|Overall Study|Toxicity|1|||
24905181|NCT00186888|49999373|FG002|Overall Study|Toxicity|0|||
24905182|NCT00186888|49999371|FG000|Overall Study|Relapse or progression of disease|4|||
24905183|NCT00186888|49999372|FG001|Overall Study|Relapse or progression of disease|2|||
24905184|NCT00186888|49999373|FG002|Overall Study|Relapse or progression of disease|0|||
25340368|NCT00727194|50656626|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
25340369|NCT00727194|50656624|FG000|Screening Period|Severe infections|0|||
24905185|NCT00577382|49999410|FG000|Overall Study|Adverse Event|0|||
24905186|NCT00577382|49999411|FG001|Overall Study|Adverse Event|6|||
24905187|NCT00577382|49999410|FG000|Overall Study|Withdrawal by Subject|0|||
24905188|NCT00577382|49999411|FG001|Overall Study|Withdrawal by Subject|1|||
24905189|NCT00577382|49999410|FG000|Overall Study|Progressive Disease|17|||
24905190|NCT00577382|49999411|FG001|Overall Study|Progressive Disease|19|||
24905191|NCT00577382|49999410|FG000|Overall Study|Intercurrent Illness|1|||
24905192|NCT00577382|49999411|FG001|Overall Study|Intercurrent Illness|2|||
24905193|NCT00577382|49999410|FG000|Overall Study|Death|1|||
24905194|NCT00577382|49999411|FG001|Overall Study|Death|1|||
24905195|NCT00577382|49999410|FG000|Overall Study|Lost to Follow-up|2|||
24905196|NCT00577382|49999411|FG001|Overall Study|Lost to Follow-up|2|||
24905197|NCT00614926|49999419|FG000|Overall Study|Burden of travel|1|||
24905198|NCT00614926|49999420|FG001|Overall Study|Burden of travel|0|||
24905199|NCT00614926|49999419|FG000|Overall Study|Adverse Event|3|||
24905200|NCT00614926|49999420|FG001|Overall Study|Adverse Event|0|||
24905201|NCT00423319|49999433|FG000|Overall Study|Death|2|||
24905202|NCT00423319|49999434|FG001|Overall Study|Death|0|||
24905203|NCT00423319|49999433|FG000|Overall Study|Adverse Event|93|||
24905204|NCT00423319|49999434|FG001|Overall Study|Adverse Event|112|||
24905205|NCT00423319|49999433|FG000|Overall Study|Withdrawal by Subject|86|||
24905206|NCT00423319|49999434|FG001|Overall Study|Withdrawal by Subject|99|||
24905207|NCT00423319|49999433|FG000|Overall Study|Lost to Follow-up|4|||
24905208|NCT00423319|49999434|FG001|Overall Study|Lost to Follow-up|3|||
24905209|NCT00423319|49999433|FG000|Overall Study|Poor compliance or noncompliance|1|||
24905210|NCT00423319|49999434|FG001|Overall Study|Poor compliance or noncompliance|1|||
24905211|NCT00423319|49999433|FG000|Overall Study|No longer meets study criteria|15|||
24905212|NCT00423319|49999434|FG001|Overall Study|No longer meets study criteria|15|||
24905213|NCT00423319|49999433|FG000|Overall Study|Other|23|||
24905214|NCT00423319|49999434|FG001|Overall Study|Other|22|||
24905215|NCT00710684|49999444|FG000|Overall Study|Adverse Event|11|||
24905216|NCT00710684|49999445|FG001|Overall Study|Adverse Event|19|||
24905217|NCT00710684|49999446|FG002|Overall Study|Adverse Event|16|||
24905218|NCT00710684|49999444|FG000|Overall Study|Lack of Efficacy|4|||
24905219|NCT00710684|49999445|FG001|Overall Study|Lack of Efficacy|3|||
24905220|NCT00710684|49999446|FG002|Overall Study|Lack of Efficacy|5|||
24905221|NCT00710684|49999444|FG000|Overall Study|Protocol Violation|5|||
24905222|NCT00710684|49999445|FG001|Overall Study|Protocol Violation|5|||
24905223|NCT00710684|49999446|FG002|Overall Study|Protocol Violation|5|||
24905224|NCT00710684|49999444|FG000|Overall Study|Lost to Follow-up|4|||
24905225|NCT00710684|49999445|FG001|Overall Study|Lost to Follow-up|6|||
24905226|NCT00710684|49999446|FG002|Overall Study|Lost to Follow-up|7|||
24905227|NCT00710684|49999444|FG000|Overall Study|Physician Decision|0|||
24905228|NCT00710684|49999445|FG001|Overall Study|Physician Decision|2|||
24905229|NCT00710684|49999446|FG002|Overall Study|Physician Decision|4|||
24905230|NCT00710684|49999444|FG000|Overall Study|Withdrawal by Subject|24|||
24905231|NCT00710684|49999445|FG001|Overall Study|Withdrawal by Subject|18|||
24905232|NCT00710684|49999446|FG002|Overall Study|Withdrawal by Subject|11|||
24905233|NCT00710684|49999444|FG000|Overall Study|Missing|1|||
24905234|NCT00710684|49999445|FG001|Overall Study|Missing|0|||
24905235|NCT00710684|49999446|FG002|Overall Study|Missing|0|||
24905236|NCT00710684|49999444|FG000|Overall Study|Did not continue after week 24|25|||
24905237|NCT00710684|49999445|FG001|Overall Study|Did not continue after week 24|21|||
24905238|NCT00710684|49999446|FG002|Overall Study|Did not continue after week 24|16|||
24905239|NCT00710606|49999462|FG000|Overall Study|Adverse Event|0|||
24905240|NCT00710606|49999463|FG001|Overall Study|Adverse Event|2|||
24905241|NCT00713544|49999477|FG000|Overall Study|Adverse Event|5|||
24905242|NCT00713544|49999478|FG001|Overall Study|Adverse Event|3|||
24905243|NCT00713544|49999479|FG002|Overall Study|Adverse Event|7|||
24905244|NCT00713544|49999480|FG003|Overall Study|Adverse Event|7|||
24905245|NCT00713544|49999481|FG004|Overall Study|Adverse Event|3|||
24905246|NCT00713544|49999482|FG005|Overall Study|Adverse Event|5|||
24905247|NCT00713544|49999477|FG000|Overall Study|Withdrawal by Subject|2|||
24905248|NCT00713544|49999478|FG001|Overall Study|Withdrawal by Subject|0|||
24905249|NCT00713544|49999479|FG002|Overall Study|Withdrawal by Subject|3|||
24905250|NCT00713544|49999480|FG003|Overall Study|Withdrawal by Subject|2|||
24905251|NCT00713544|49999481|FG004|Overall Study|Withdrawal by Subject|3|||
24977753|NCT03409276|50066189|FG001|Overall Study|Withdrawal by Subject|0|||
24977754|NCT03409276|50066190|FG002|Overall Study|Withdrawal by Subject|0|||
24905252|NCT00713544|49999482|FG005|Overall Study|Withdrawal by Subject|1|||
24905253|NCT00713544|49999477|FG000|Overall Study|Protocol Violation|0|||
24905254|NCT00713544|49999478|FG001|Overall Study|Protocol Violation|0|||
24905255|NCT00713544|49999479|FG002|Overall Study|Protocol Violation|0|||
24905256|NCT00713544|49999480|FG003|Overall Study|Protocol Violation|0|||
24905257|NCT00713544|49999481|FG004|Overall Study|Protocol Violation|0|||
24905258|NCT00713544|49999482|FG005|Overall Study|Protocol Violation|1|||
24905259|NCT00713544|49999477|FG000|Overall Study|Physician Decision|0|||
24905260|NCT00713544|49999478|FG001|Overall Study|Physician Decision|0|||
24905261|NCT00713544|49999479|FG002|Overall Study|Physician Decision|0|||
24977755|NCT03409276|50066191|FG003|Overall Study|Withdrawal by Subject|0|||
24905262|NCT00713544|49999480|FG003|Overall Study|Physician Decision|0|||
24905263|NCT00713544|49999481|FG004|Overall Study|Physician Decision|0|||
24905264|NCT00713544|49999482|FG005|Overall Study|Physician Decision|2|||
24905265|NCT00713544|49999477|FG000|Overall Study|Lack of Efficacy|0|||
24905266|NCT00713544|49999478|FG001|Overall Study|Lack of Efficacy|1|||
24905267|NCT00713544|49999479|FG002|Overall Study|Lack of Efficacy|0|||
24905268|NCT00713544|49999480|FG003|Overall Study|Lack of Efficacy|1|||
24905269|NCT00713544|49999481|FG004|Overall Study|Lack of Efficacy|1|||
24905270|NCT00713544|49999482|FG005|Overall Study|Lack of Efficacy|0|||
24905271|NCT00713544|49999477|FG000|Overall Study|Lost to Follow-up|0|||
24905272|NCT00713544|49999478|FG001|Overall Study|Lost to Follow-up|0|||
24905273|NCT00713544|49999479|FG002|Overall Study|Lost to Follow-up|1|||
24905274|NCT00713544|49999480|FG003|Overall Study|Lost to Follow-up|0|||
24905275|NCT00713544|49999481|FG004|Overall Study|Lost to Follow-up|0|||
24905276|NCT00713544|49999482|FG005|Overall Study|Lost to Follow-up|0|||
24905277|NCT00713544|49999477|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
24905278|NCT00713544|49999478|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
24905279|NCT00713544|49999479|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
24905280|NCT00713544|49999480|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
24905281|NCT00713544|49999481|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
24905282|NCT00713544|49999482|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
24905283|NCT00713544|49999477|FG000|Overall Study|Incorrect enrollment|0|||
24905284|NCT00713544|49999478|FG001|Overall Study|Incorrect enrollment|1|||
24905285|NCT00713544|49999479|FG002|Overall Study|Incorrect enrollment|0|||
24905286|NCT00713544|49999480|FG003|Overall Study|Incorrect enrollment|0|||
24905287|NCT00713544|49999481|FG004|Overall Study|Incorrect enrollment|0|||
24905288|NCT00713544|49999482|FG005|Overall Study|Incorrect enrollment|0|||
24905289|NCT00713544|49999477|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
24905290|NCT00713544|49999478|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
24905291|NCT00713544|49999479|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
24905292|NCT00713544|49999480|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
24905293|NCT00713544|49999481|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
24905294|NCT00713544|49999482|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
24905295|NCT00415363|49999498|FG000|Overall Study|Withdrawal by Subject|4|||
24905296|NCT00415363|49999499|FG001|Overall Study|Withdrawal by Subject|4|||
24905297|NCT00415363|49999498|FG000|Overall Study|Adverse Event|4|||
24905298|NCT00415363|49999499|FG001|Overall Study|Adverse Event|4|||
24905299|NCT00415363|49999498|FG000|Overall Study|Lost to Follow-up|2|||
24905300|NCT00415363|49999499|FG001|Overall Study|Lost to Follow-up|1|||
24905301|NCT00415363|49999498|FG000|Overall Study|Physician Decision|3|||
24905302|NCT00415363|49999499|FG001|Overall Study|Physician Decision|1|||
24905303|NCT00415363|49999498|FG000|Overall Study|Death|16|||
24905304|NCT00415363|49999499|FG001|Overall Study|Death|12|||
24905305|NCT00415363|49999498|FG000|Overall Study|Progressive disease|26|||
24905306|NCT00415363|49999499|FG001|Overall Study|Progressive disease|32|||
24905307|NCT00415051|49999506|FG000|Overall Study|Protocol Violation|1|||
24905308|NCT00713258|49999512|FG000|Overall Study|Adverse Event|2|||
24905309|NCT00713258|49999513|FG001|Overall Study|Adverse Event|4|||
24905310|NCT00713258|49999512|FG000|Overall Study|Non-Compliance|2|||
24905311|NCT00713258|49999513|FG001|Overall Study|Non-Compliance|1|||
24905312|NCT00713258|49999512|FG000|Overall Study|Other|1|||
24905313|NCT00713258|49999513|FG001|Overall Study|Other|1|||
24905314|NCT00710034|49999521|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
24905315|NCT00710034|49999522|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
24905316|NCT00710034|49999521|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
25254835|NCT01193218|50570582|FG003|0-12 Weeks|Adverse Event|0|||
25254836|NCT01193218|50570583|FG004|0-12 Weeks|Adverse Event|0|||
25254837|NCT01193218|50570584|FG005|0-12 Weeks|Adverse Event|2|||
25254838|NCT01193218|50570585|FG006|0-12 Weeks|Adverse Event|2|||
25254839|NCT01193218|50570586|FG007|0-12 Weeks|Adverse Event|0|||
24977756|NCT03409276|50066192|FG004|Overall Study|Withdrawal by Subject|1|||
25254840|NCT01193218|50570579|FG000|0-12 Weeks|Protocol Violation|0|||
25254841|NCT01193218|50570580|FG001|0-12 Weeks|Protocol Violation|0|||
25254842|NCT01193218|50570581|FG002|0-12 Weeks|Protocol Violation|0|||
25254843|NCT01193218|50570582|FG003|0-12 Weeks|Protocol Violation|0|||
25254844|NCT01193218|50570583|FG004|0-12 Weeks|Protocol Violation|1|||
25254845|NCT01193218|50570584|FG005|0-12 Weeks|Protocol Violation|1|||
25254846|NCT01193218|50570585|FG006|0-12 Weeks|Protocol Violation|0|||
24905317|NCT00710034|49999522|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
24905318|NCT00710034|49999521|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
25254847|NCT01193218|50570586|FG007|0-12 Weeks|Protocol Violation|0|||
25254848|NCT01193218|50570579|FG000|0-12 Weeks|Withdrawal by Subject|3|||
24905319|NCT00710034|49999522|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
24905320|NCT00710034|49999521|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
24905321|NCT00710034|49999522|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
24905322|NCT00710034|49999521|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
24905323|NCT00710034|49999522|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
24905324|NCT00710034|49999521|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
24977757|NCT03409276|50066188|FG000|Overall Study|Lost to Follow-up|0|||
25254849|NCT01193218|50570580|FG001|0-12 Weeks|Withdrawal by Subject|0|||
25254850|NCT01193218|50570581|FG002|0-12 Weeks|Withdrawal by Subject|2|||
24905325|NCT00710034|49999522|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
24905326|NCT00710034|49999521|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
24905327|NCT00710034|49999522|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
24905328|NCT00710034|49999521|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
24905329|NCT00710034|49999522|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
24905330|NCT00710034|49999521|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
24905331|NCT00710034|49999522|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
24905332|NCT00710034|49999521|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
24905333|NCT00710034|49999522|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
24905334|NCT00710034|49999521|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
24905335|NCT00710034|49999522|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
25340370|NCT00727194|50656625|FG001|Screening Period|Severe infections|0|||
25340371|NCT00727194|50656626|FG002|Screening Period|Severe infections|2|||
25340372|NCT00727194|50656624|FG000|Screening Period|History of thymoma|0|||
25340373|NCT00727194|50656625|FG001|Screening Period|History of thymoma|0|||
25340374|NCT00727194|50656626|FG002|Screening Period|History of thymoma|1|||
25340375|NCT00727194|50656624|FG000|Treatment Period 2|Lack of Efficacy|0|||
25340376|NCT00727194|50656625|FG001|Treatment Period 2|Lack of Efficacy|1|||
25340377|NCT00727194|50656626|FG002|Treatment Period 2|Lack of Efficacy|0|||
25340378|NCT00717093|50656642|FG000|Overall Study|Adverse Event|19|||
25340379|NCT00717093|50656643|FG001|Overall Study|Adverse Event|9|||
25340380|NCT00717093|50656642|FG000|Overall Study|Lack of Efficacy|3|||
25340381|NCT00717093|50656643|FG001|Overall Study|Lack of Efficacy|13|||
25340382|NCT00717093|50656642|FG000|Overall Study|Lost to Follow-up|9|||
25340383|NCT00717093|50656643|FG001|Overall Study|Lost to Follow-up|6|||
25340384|NCT00717093|50656642|FG000|Overall Study|Withdrawal by Subject|12|||
25340385|NCT00717093|50656643|FG001|Overall Study|Withdrawal by Subject|19|||
25340386|NCT00717093|50656642|FG000|Overall Study|Other|0|||
25340387|NCT00717093|50656643|FG001|Overall Study|Other|1|||
25340388|NCT00717093|50656642|FG000|Overall Study|Randomized but not treated|1|||
25340389|NCT00717093|50656643|FG001|Overall Study|Randomized but not treated|0|||
25340390|NCT00716859|50656651|FG000|Overall Study|Adverse Event|4|||
25340391|NCT00716859|50656652|FG001|Overall Study|Adverse Event|1|||
25340392|NCT00716859|50656651|FG000|Overall Study|Lack of Efficacy|3|||
25340393|NCT00716859|50656652|FG001|Overall Study|Lack of Efficacy|0|||
25340394|NCT00716859|50656651|FG000|Overall Study|Withdrawal by Subject|1|||
25340395|NCT00716859|50656652|FG001|Overall Study|Withdrawal by Subject|3|||
25340396|NCT00716859|50656651|FG000|Overall Study|Not treated|1|||
25340397|NCT00716859|50656652|FG001|Overall Study|Not treated|1|||
25340398|NCT00589121|50656660|FG000|Overall Study|Protocol Violation|2|||
25340399|NCT00589121|50656661|FG001|Overall Study|Protocol Violation|6|||
25340400|NCT00589121|50656660|FG000|Overall Study|No protocol treatment received|0|||
25340401|NCT00589121|50656661|FG001|Overall Study|No protocol treatment received|1|||
25340402|NCT00590135|50656670|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
25340403|NCT00589667|50656675|FG000|Overall Study|Adverse Event|2|||
25340404|NCT00589667|50656675|FG000|Overall Study|Withdrawal by Subject|1|||
25340405|NCT00737568|50656681|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
25340406|NCT00737568|50656682|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
25340407|NCT00737568|50656681|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
25340408|NCT00737568|50656682|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
25340409|NCT00737568|50656681|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
25340410|NCT00737568|50656682|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
25340411|NCT00737568|50656681|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
25340412|NCT00737568|50656682|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
25340413|NCT00737568|50656681|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
25340414|NCT00737568|50656682|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
25340415|NCT00737568|50656681|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
25340416|NCT00737568|50656682|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
25340417|NCT00737568|50656681|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
25340418|NCT00737568|50656682|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
25340419|NCT00737568|50656681|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
25340420|NCT00737568|50656682|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
25340421|NCT00737568|50656681|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
25340422|NCT00737568|50656682|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
25340423|NCT00737100|50656691|FG000|Overall Study|Adverse Event|6|||
25340424|NCT00737100|50656692|FG001|Overall Study|Adverse Event|5|||
25340425|NCT00737100|50656693|FG002|Overall Study|Adverse Event|3|||
24905336|NCT00414973|49999532|FG000|Overall Study|Withdrawal by Subject|14|||
24905337|NCT00414973|49999533|FG001|Overall Study|Withdrawal by Subject|4|||
25340426|NCT00737100|50656691|FG000|Overall Study|Lost to Follow-up|0|||
25340427|NCT00737100|50656692|FG001|Overall Study|Lost to Follow-up|1|||
25340428|NCT00737100|50656693|FG002|Overall Study|Lost to Follow-up|0|||
25340429|NCT00737100|50656691|FG000|Overall Study|Withdrawal by Subject|0|||
25340430|NCT00737100|50656692|FG001|Overall Study|Withdrawal by Subject|0|||
25340431|NCT00737100|50656693|FG002|Overall Study|Withdrawal by Subject|3|||
25340432|NCT00737100|50656691|FG000|Overall Study|Reason discontinued not explained above|1|||
25340433|NCT00737100|50656692|FG001|Overall Study|Reason discontinued not explained above|1|||
25340434|NCT00737100|50656693|FG002|Overall Study|Reason discontinued not explained above|1|||
25340435|NCT00732498|50656703|FG000|Overall Study|Ineligible|1|||
25340436|NCT00732498|50656703|FG000|Overall Study|Adverse Event|2|||
25340437|NCT00732498|50656703|FG000|Overall Study|Physician Decision|3|||
25340438|NCT00726882|50656707|FG000|Overall Study|Withdrawal by Subject|5|||
24905338|NCT00414973|49999534|FG002|Overall Study|Withdrawal by Subject|1|||
24977758|NCT03409276|50066189|FG001|Overall Study|Lost to Follow-up|0|||
24977759|NCT03409276|50066190|FG002|Overall Study|Lost to Follow-up|0|||
24977760|NCT03409276|50066191|FG003|Overall Study|Lost to Follow-up|2|||
24977761|NCT03409276|50066192|FG004|Overall Study|Lost to Follow-up|2|||
24977762|NCT00004562|50066210|FG000|Overall Study|Lost to Follow-up|102|||
24977763|NCT00004562|50066211|FG001|Overall Study|Lost to Follow-up|91|||
24977764|NCT00004412|50066220|FG000|Randomized Period|Moved to Crossover Period|3|||
24977765|NCT00004412|50066221|FG001|Randomized Period|Moved to Crossover Period|0|||
24977766|NCT00004412|50066222|FG002|Randomized Period|Moved to Crossover Period|0|||
24977767|NCT03440320|50066232|FG000|Overall Study|Withdrawal by Subject|0|||
24977768|NCT03440320|50066233|FG001|Overall Study|Withdrawal by Subject|1|||
24977769|NCT00004088|50066241|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
24977770|NCT00004088|50066241|FG000|Overall Study|Withdrawal by Subject|1|||
24977771|NCT00004088|50066241|FG000|Overall Study|Protocol Violation|3|||
24977772|NCT00004088|50066241|FG000|Overall Study|Physician Decision|1|||
24977773|NCT03439072|50066245|FG000|Overall Study|Withdrawal by Subject|2|||
24977774|NCT03439072|50066246|FG001|Overall Study|Withdrawal by Subject|3|||
24977775|NCT03439072|50066245|FG000|Overall Study|Physician Decision|0|||
24977776|NCT03439072|50066246|FG001|Overall Study|Physician Decision|1|||
24977777|NCT00078312|50066252|FG000|Overall Study|Adverse Event|43|||
24977778|NCT00078312|50066252|FG000|Overall Study|Lack of Efficacy|15|||
24977779|NCT00078312|50066252|FG000|Overall Study|Lost to Follow-up|41|||
24977780|NCT00078312|50066252|FG000|Overall Study|Physician Decision|9|||
24977781|NCT00078312|50066252|FG000|Overall Study|Protocol Violation|3|||
24977782|NCT00078312|50066252|FG000|Overall Study|Withdrawal by Subject|33|||
24977783|NCT00078312|50066252|FG000|Overall Study|Miscellaneous|33|||
24977784|NCT00003896|50066256|FG000|Overall Study|Adverse Event|16|||
24977785|NCT00003896|50066256|FG000|Overall Study|Withdrawal by Subject|1|||
24977786|NCT00003896|50066256|FG000|Overall Study|Lack of Efficacy|1|||
24977787|NCT00003896|50066256|FG000|Overall Study|Death|3|||
24977788|NCT00003896|50066256|FG000|Overall Study|not protocol specified|3|||
24905339|NCT00414973|49999535|FG003|Overall Study|Withdrawal by Subject|0|||
24905340|NCT00414973|49999532|FG000|Overall Study|Adverse Event|10|||
24905341|NCT00414973|49999533|FG001|Overall Study|Adverse Event|0|||
24905342|NCT00414973|49999534|FG002|Overall Study|Adverse Event|1|||
24905343|NCT00414973|49999535|FG003|Overall Study|Adverse Event|0|||
24905344|NCT00414973|49999532|FG000|Overall Study|Protocol Violation|3|||
24905345|NCT00414973|49999533|FG001|Overall Study|Protocol Violation|4|||
24905346|NCT00414973|49999534|FG002|Overall Study|Protocol Violation|0|||
24905347|NCT00414973|49999535|FG003|Overall Study|Protocol Violation|0|||
24905348|NCT00414973|49999532|FG000|Overall Study|Lost to Follow-up|0|||
24905349|NCT00414973|49999533|FG001|Overall Study|Lost to Follow-up|2|||
24905350|NCT00414973|49999534|FG002|Overall Study|Lost to Follow-up|0|||
24905351|NCT00414973|49999535|FG003|Overall Study|Lost to Follow-up|0|||
24905352|NCT00414973|49999532|FG000|Overall Study|Sponsor Decision|1|||
24905353|NCT00414973|49999533|FG001|Overall Study|Sponsor Decision|0|||
24905354|NCT00414973|49999534|FG002|Overall Study|Sponsor Decision|0|||
24905355|NCT00414973|49999535|FG003|Overall Study|Sponsor Decision|0|||
24905356|NCT00414973|49999532|FG000|Overall Study|Death|0|||
24905357|NCT00414973|49999533|FG001|Overall Study|Death|0|||
24905358|NCT00414973|49999534|FG002|Overall Study|Death|1|||
24905359|NCT00414973|49999535|FG003|Overall Study|Death|0|||
24905360|NCT00423085|49999548|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
24905361|NCT00423085|49999549|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
24977789|NCT00003896|50066256|FG000|Overall Study|ineligible|5|||
24977790|NCT00003830|50066263|FG000|Overall Study|No follow up data|3|||
24977791|NCT00003830|50066264|FG001|Overall Study|No follow up data|0|||
24977792|NCT00003830|50066263|FG000|Overall Study|Sentinel node positive patients|829|||
24977793|NCT00003830|50066264|FG001|Overall Study|Sentinel node positive patients|793|||
24977794|NCT03407482|50066272|FG000|Overall Study|Adverse Event|12|||
25340439|NCT00726882|50656707|FG000|Overall Study|Lost to Follow-up|7|||
24977795|NCT03407482|50066272|FG000|Overall Study|Disease Relapse|1|||
25340440|NCT00726882|50656707|FG000|Overall Study|Other|10|||
24905362|NCT00423085|49999550|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
24905363|NCT00423085|49999551|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
24905364|NCT00423085|49999548|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
25340441|NCT00790400|50656715|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
25340442|NCT00790400|50656716|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
25340443|NCT00790400|50656715|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
25340444|NCT00790400|50656716|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
25340445|NCT00790400|50656715|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
25340446|NCT00790400|50656716|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
25340447|NCT00790400|50656715|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
25340448|NCT00790400|50656716|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
25340449|NCT00790400|50656715|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
25340450|NCT00790400|50656716|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
25340451|NCT00790400|50656715|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
25340452|NCT00790400|50656716|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
25340453|NCT00790400|50656715|FG000|Double-blind Period (Core Phase)|Death|1|||
25340454|NCT00790400|50656716|FG001|Double-blind Period (Core Phase)|Death|0|||
25340455|NCT00790400|50656715|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
25340456|NCT00790400|50656716|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
25340457|NCT00790400|50656715|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
25340458|NCT00790400|50656716|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
25340459|NCT00790400|50656715|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
25340460|NCT00790400|50656716|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
25340461|NCT00790400|50656715|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
25340462|NCT00790400|50656716|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
25340463|NCT00790400|50656715|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
25340464|NCT00790400|50656716|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
25340465|NCT00790400|50656715|FG000|Everolimus Period (Core or Extension)|Death|1|||
25340466|NCT00790400|50656716|FG001|Everolimus Period (Core or Extension)|Death|0|||
25340467|NCT00790400|50656715|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
25340468|NCT00790400|50656716|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
25340469|NCT00790400|50656715|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
25340470|NCT00790400|50656716|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
25340471|NCT00790400|50656715|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
25340472|NCT00790400|50656716|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
25340473|NCT00786032|50656725|FG000|Overall Study|Death|4|||
25340474|NCT00786032|50656725|FG000|Overall Study|Withdrawal by Subject|14|||
25340475|NCT00786032|50656725|FG000|Overall Study|Did not complete in the timeframe|6|||
25340476|NCT00785486|50656731|FG000|Midazolam Alone|Withdrawal by Subject|1|||
25340477|NCT00589979|50656754|FG000|Run-In Period|Adverse Event|5|||
25340478|NCT00589979|50656755|FG001|Run-In Period|Adverse Event|0|||
25340479|NCT00589979|50656756|FG002|Run-In Period|Adverse Event|0|||
25340480|NCT00589979|50656754|FG000|Run-In Period|Protocol Violation|3|||
25340481|NCT00589979|50656755|FG001|Run-In Period|Protocol Violation|0|||
25340482|NCT00589979|50656756|FG002|Run-In Period|Protocol Violation|0|||
25340483|NCT00589979|50656754|FG000|Run-In Period|Did not qualify for randomization|54|||
25340484|NCT00589979|50656755|FG001|Run-In Period|Did not qualify for randomization|0|||
25340485|NCT00589979|50656756|FG002|Run-In Period|Did not qualify for randomization|0|||
25340486|NCT00589979|50656754|FG000|Run-In Period|Withdrawal by Subject|10|||
25340487|NCT00589979|50656755|FG001|Run-In Period|Withdrawal by Subject|0|||
25340488|NCT00589979|50656756|FG002|Run-In Period|Withdrawal by Subject|0|||
25340489|NCT00589979|50656754|FG000|Run-In Period|Informed Consent Withdrawn|4|||
25340490|NCT00589979|50656755|FG001|Run-In Period|Informed Consent Withdrawn|0|||
25340491|NCT00589979|50656756|FG002|Run-In Period|Informed Consent Withdrawn|0|||
25340492|NCT00589979|50656754|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
25340493|NCT00589979|50656755|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
25340494|NCT00589979|50656756|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
25340495|NCT00589979|50656754|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
25340496|NCT00589979|50656755|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
25340497|NCT00589979|50656756|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
25340498|NCT00589979|50656754|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
25340499|NCT00589979|50656755|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
25340500|NCT00589979|50656756|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
25340501|NCT00589979|50656754|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
25340502|NCT00589979|50656755|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
25340503|NCT00589979|50656756|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
25340504|NCT00589979|50656754|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
25340505|NCT00589979|50656755|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
25340506|NCT00589979|50656756|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
25340507|NCT00589979|50656754|FG000|Double-Blind Treatment Period 2|Other|0|||
25340508|NCT00589979|50656755|FG001|Double-Blind Treatment Period 2|Other|0|||
25340509|NCT00589979|50656756|FG002|Double-Blind Treatment Period 2|Other|1|||
25340510|NCT00589979|50656754|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
25340511|NCT00589979|50656755|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
24905365|NCT00423085|49999549|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
24905366|NCT00423085|49999550|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
24905367|NCT00423085|49999551|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
24905368|NCT00423085|49999548|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
24905369|NCT00423085|49999549|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
24905370|NCT00423085|49999550|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
24977796|NCT03407482|50066272|FG000|Overall Study|Lost to Follow-up|1|||
24977797|NCT03407482|50066272|FG000|Overall Study|Non-Compliance With Study Drug|1|||
24977798|NCT03407482|50066272|FG000|Overall Study|Pregnancy|2|||
24977799|NCT03407482|50066272|FG000|Overall Study|Protocol Violation|1|||
24977800|NCT03407482|50066272|FG000|Overall Study|Study Terminated By Sponsor|106|||
24977801|NCT03407482|50066272|FG000|Overall Study|Withdrawal by Subject|6|||
24977802|NCT03407482|50066272|FG000|Overall Study|Data Entry Error|1|||
24977803|NCT00003782|50066279|FG000|Overall Study|No follow up data|30|||
24905371|NCT00423085|49999551|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
24905372|NCT00423085|49999548|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
24905373|NCT00423085|49999549|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
24977804|NCT00003782|50066280|FG001|Overall Study|No follow up data|31|||
24977805|NCT00003782|50066281|FG002|Overall Study|No follow up data|26|||
24977806|NCT03389308|50066289|FG000|Overall Study|Withdrawal by Subject|5|||
24977807|NCT03389308|50066289|FG000|Overall Study|Lost to Follow-up|3|||
24977808|NCT03389308|50066289|FG000|Overall Study|Adverse Event|2|||
25340512|NCT00589979|50656756|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
25340513|NCT00589979|50656754|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
25340514|NCT00589979|50656755|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
24905374|NCT00423085|49999550|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
24905375|NCT00423085|49999551|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
24905376|NCT00423085|49999548|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
24905377|NCT00423085|49999549|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
24905378|NCT00423085|49999550|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
24905379|NCT00423085|49999551|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
24905380|NCT00423085|49999548|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
24905381|NCT00423085|49999549|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
24905382|NCT00423085|49999550|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
24905383|NCT00423085|49999551|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
24905384|NCT00423085|49999548|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
24905385|NCT00423085|49999549|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
24905386|NCT00423085|49999550|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
24905387|NCT00423085|49999551|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
24905388|NCT00423085|49999548|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
24905389|NCT00423085|49999549|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
24905390|NCT00423085|49999550|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
24905391|NCT00423085|49999551|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
24905392|NCT00423085|49999548|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
24905393|NCT00423085|49999549|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
24905394|NCT00423085|49999550|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
24905395|NCT00423085|49999551|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
24905396|NCT00423085|49999548|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
24905397|NCT00423085|49999549|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
24905398|NCT00423085|49999550|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
24905399|NCT00423085|49999551|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
24905400|NCT00423085|49999548|FG000|52-Week Open-Label Extension Phase|Death|0|||
24905401|NCT00423085|49999549|FG001|52-Week Open-Label Extension Phase|Death|0|||
24905402|NCT00423085|49999550|FG002|52-Week Open-Label Extension Phase|Death|0|||
24905403|NCT00423085|49999551|FG003|52-Week Open-Label Extension Phase|Death|2|||
24905404|NCT00414661|49999565|FG000|Overall Study|Death|2|||
24905405|NCT00414661|49999566|FG001|Overall Study|Death|5|||
24905406|NCT00414661|49999567|FG002|Overall Study|Death|0|||
24977809|NCT03389308|50066289|FG000|Overall Study|Sponsor Request|2|||
25340515|NCT00589979|50656756|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
25340516|NCT00797732|50656770|FG000|Overall Study|Withdrawal by Subject|3|||
24977810|NCT03407170|50066293|FG000|Overall Study|Adverse Event|1|||
24977811|NCT03406858|50066297|FG000|Overall Study|Failure to receive treatment drug.|1|||
25340517|NCT00797732|50656771|FG001|Overall Study|Withdrawal by Subject|3|||
25340518|NCT00797732|50656772|FG002|Overall Study|Withdrawal by Subject|0|||
25340519|NCT00797732|50656770|FG000|Overall Study|Lost to Follow-up|1|||
24977812|NCT03406858|50066297|FG000|Overall Study|ineligible|1|||
25254851|NCT01193218|50570582|FG003|0-12 Weeks|Withdrawal by Subject|0|||
24905407|NCT00414661|49999568|FG003|Overall Study|Death|0|||
24905408|NCT00414661|49999565|FG000|Overall Study|Lost to Follow-up|1|||
24905409|NCT00414661|49999566|FG001|Overall Study|Lost to Follow-up|4|||
24905410|NCT00414661|49999567|FG002|Overall Study|Lost to Follow-up|0|||
24905411|NCT00414661|49999568|FG003|Overall Study|Lost to Follow-up|1|||
24905412|NCT00414661|49999565|FG000|Overall Study|Withdrawal by Subject|5|||
24905413|NCT00414661|49999566|FG001|Overall Study|Withdrawal by Subject|2|||
24905414|NCT00414661|49999567|FG002|Overall Study|Withdrawal by Subject|2|||
24905415|NCT00414661|49999568|FG003|Overall Study|Withdrawal by Subject|2|||
24905416|NCT00414661|49999565|FG000|Overall Study|Other|6|||
24905417|NCT00414661|49999566|FG001|Overall Study|Other|3|||
24905418|NCT00414661|49999567|FG002|Overall Study|Other|0|||
24905419|NCT00414661|49999568|FG003|Overall Study|Other|0|||
24905420|NCT00405067|49999581|FG000|Overall Study|Adverse Event|4|||
24905421|NCT00405067|49999582|FG001|Overall Study|Adverse Event|9|||
24905422|NCT00405067|49999583|FG002|Overall Study|Adverse Event|4|||
24905423|NCT00405067|49999581|FG000|Overall Study|Lost to Follow-up|0|||
24905424|NCT00405067|49999582|FG001|Overall Study|Lost to Follow-up|0|||
24905425|NCT00405067|49999583|FG002|Overall Study|Lost to Follow-up|1|||
24905426|NCT00708708|49999591|FG000|Overall Study|Another therapy instead of Enbrel|141|||
24905427|NCT00708708|49999591|FG000|Overall Study|Lost to Follow-up|52|||
24905428|NCT00708708|49999591|FG000|Overall Study|Withdrawal by Subject|51|||
24905429|NCT00708708|49999591|FG000|Overall Study|Intolerance|42|||
24905430|NCT00708708|49999591|FG000|Overall Study|Another therapy along with Enbrel|15|||
24905431|NCT00708708|49999591|FG000|Overall Study|Other unspecified|11|||
25340520|NCT00797732|50656771|FG001|Overall Study|Lost to Follow-up|0|||
25340521|NCT00797732|50656772|FG002|Overall Study|Lost to Follow-up|0|||
25340522|NCT00797732|50656770|FG000|Overall Study|Death|1|||
25340523|NCT00797732|50656771|FG001|Overall Study|Death|0|||
25340524|NCT00797732|50656772|FG002|Overall Study|Death|0|||
25340525|NCT00797732|50656770|FG000|Overall Study|Not meet inclusion criteria|0|||
24905432|NCT00708708|49999591|FG000|Overall Study|Good effectiveness|9|||
24905433|NCT00708708|49999591|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
24905434|NCT00708708|49999591|FG000|Overall Study|Administrative reasons|7|||
24905435|NCT00708708|49999591|FG000|Overall Study|Lack of effectiveness|4|||
24905436|NCT00708708|49999591|FG000|Overall Study|Lack of compliance|3|||
24905437|NCT00708708|49999591|FG000|Overall Study|Pregnancy|3|||
24905438|NCT00708708|49999591|FG000|Overall Study|Adverse Event|3|||
25340526|NCT00797732|50656771|FG001|Overall Study|Not meet inclusion criteria|0|||
25340527|NCT00797732|50656772|FG002|Overall Study|Not meet inclusion criteria|7|||
25340528|NCT00797732|50656770|FG000|Overall Study|Excluded due to time constraints|0|||
25340529|NCT00797732|50656771|FG001|Overall Study|Excluded due to time constraints|0|||
25340530|NCT00797732|50656772|FG002|Overall Study|Excluded due to time constraints|24|||
25340531|NCT00797732|50656770|FG000|Overall Study|Refused to Participate|0|||
25340532|NCT00797732|50656771|FG001|Overall Study|Refused to Participate|0|||
25340533|NCT00797732|50656772|FG002|Overall Study|Refused to Participate|123|||
25340534|NCT00790088|50656778|FG000|Overall Study|Protocol Violation|11|||
25340535|NCT00790088|50656778|FG000|Overall Study|Withdrawal by Subject|17|||
25340536|NCT00790088|50656778|FG000|Overall Study|Lost to Follow-up|7|||
25340537|NCT00790088|50656778|FG000|Overall Study|Physician Decision|4|||
25340538|NCT00736944|50656784|FG000|Induction|Death|1|||
25340539|NCT00736944|50656784|FG000|Definitive Treatment|Physician Decision|1|||
25340540|NCT00736476|50656793|FG000|Overall Study|Adverse Event|1|||
25340541|NCT00736476|50656794|FG001|Overall Study|Adverse Event|0|||
25340542|NCT00715299|50656806|FG000|Overall Study|Withdrawal by Subject|1|||
25340543|NCT00715299|50656806|FG000|Overall Study|Adverse Event|3|||
25340544|NCT00715299|50656806|FG000|Overall Study|failed the pre-screen exercise test|2|||
24905439|NCT00708708|49999591|FG000|Overall Study|Missing values|392|||
24905440|NCT00404755|49999598|FG000|Phase I (Bupropion)|Adverse Event|3|||
24905441|NCT00404755|49999598|FG000|Phase I (Bupropion)|Other|1|||
24905442|NCT00404755|49999598|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
24905443|NCT00614614|49999608|FG000|Primary Vaccination Phase|Adverse Event|6|||
24905444|NCT00614614|49999609|FG001|Primary Vaccination Phase|Adverse Event|0|||
24905445|NCT00614614|49999610|FG002|Primary Vaccination Phase|Adverse Event|0|||
24905446|NCT00614614|49999611|FG003|Primary Vaccination Phase|Adverse Event|0|||
24905447|NCT00614614|49999612|FG004|Primary Vaccination Phase|Adverse Event|0|||
24905448|NCT00614614|49999608|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
25340545|NCT00730236|50656810|FG000|Overall Study|Adverse Event|4|||
25340546|NCT00730236|50656810|FG000|Overall Study|Withdrawal by Subject|1|||
25340547|NCT00730236|50656810|FG000|Overall Study|Non-compliance|1|||
25340548|NCT00714285|50656818|FG000|Overall Study|Lost to Follow-up|0|||
24905449|NCT00614614|49999609|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
24905450|NCT00614614|49999610|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
24905451|NCT00614614|49999611|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
25340549|NCT00714285|50656819|FG001|Overall Study|Lost to Follow-up|2|||
25340550|NCT00714285|50656820|FG002|Overall Study|Lost to Follow-up|0|||
25340551|NCT00714285|50656821|FG003|Overall Study|Lost to Follow-up|1|||
24905452|NCT00614614|49999612|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
25340552|NCT00714285|50656818|FG000|Overall Study|Migrated/moved from study area|0|||
25340553|NCT00714285|50656819|FG001|Overall Study|Migrated/moved from study area|1|||
25340554|NCT00714285|50656820|FG002|Overall Study|Migrated/moved from study area|0|||
25340555|NCT00714285|50656821|FG003|Overall Study|Migrated/moved from study area|0|||
25340556|NCT00776984|50656835|FG000|Overall Study|Adverse Event|8|||
25340557|NCT00776984|50656836|FG001|Overall Study|Adverse Event|2|||
25340558|NCT00776984|50656835|FG000|Overall Study|Protocol Violation|4|||
24905453|NCT00614614|49999608|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
24905454|NCT00614614|49999609|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
24905455|NCT00614614|49999610|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
24905456|NCT00614614|49999611|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
24905457|NCT00614614|49999612|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
24905458|NCT00614614|49999608|FG000|Primary Vaccination Phase|Protocol Violation|9|||
24905459|NCT00614614|49999609|FG001|Primary Vaccination Phase|Protocol Violation|3|||
24905460|NCT00614614|49999610|FG002|Primary Vaccination Phase|Protocol Violation|0|||
24905461|NCT00614614|49999611|FG003|Primary Vaccination Phase|Protocol Violation|0|||
24905462|NCT00614614|49999612|FG004|Primary Vaccination Phase|Protocol Violation|0|||
24905463|NCT00614614|49999608|FG000|Primary Vaccination Phase|Other|4|||
24905464|NCT00614614|49999609|FG001|Primary Vaccination Phase|Other|0|||
24905465|NCT00614614|49999610|FG002|Primary Vaccination Phase|Other|0|||
24905466|NCT00614614|49999611|FG003|Primary Vaccination Phase|Other|0|||
24905467|NCT00614614|49999612|FG004|Primary Vaccination Phase|Other|0|||
24905468|NCT00614614|49999608|FG000|Booster Vaccination Phase|Adverse Event|0|||
24905469|NCT00614614|49999609|FG001|Booster Vaccination Phase|Adverse Event|0|||
24905470|NCT00614614|49999610|FG002|Booster Vaccination Phase|Adverse Event|1|||
24905471|NCT00614614|49999611|FG003|Booster Vaccination Phase|Adverse Event|1|||
24905472|NCT00614614|49999612|FG004|Booster Vaccination Phase|Adverse Event|0|||
25340559|NCT00776984|50656836|FG001|Overall Study|Protocol Violation|2|||
24905473|NCT00614614|49999608|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
24905474|NCT00614614|49999609|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
24905475|NCT00614614|49999610|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
24905476|NCT00614614|49999611|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
24905477|NCT00614614|49999612|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
24905478|NCT00614614|49999608|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
24905479|NCT00614614|49999609|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
24905480|NCT00614614|49999610|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
24905481|NCT00614614|49999611|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
24905482|NCT00614614|49999612|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
24905483|NCT00614614|49999608|FG000|Booster Vaccination Phase|Protocol Violation|0|||
24905484|NCT00614614|49999609|FG001|Booster Vaccination Phase|Protocol Violation|0|||
24905485|NCT00614614|49999610|FG002|Booster Vaccination Phase|Protocol Violation|2|||
24905486|NCT00614614|49999611|FG003|Booster Vaccination Phase|Protocol Violation|3|||
24905487|NCT00614614|49999612|FG004|Booster Vaccination Phase|Protocol Violation|0|||
24905488|NCT00614614|49999608|FG000|Booster Vaccination Phase|Other|0|||
24905489|NCT00614614|49999609|FG001|Booster Vaccination Phase|Other|1|||
24905490|NCT00614614|49999610|FG002|Booster Vaccination Phase|Other|3|||
24905491|NCT00614614|49999611|FG003|Booster Vaccination Phase|Other|2|||
24905492|NCT00614614|49999612|FG004|Booster Vaccination Phase|Other|1|||
24905493|NCT00713310|49999629|FG000|Overall Study|Adverse Event|5|||
24905494|NCT00713310|49999630|FG001|Overall Study|Adverse Event|2|||
24905495|NCT00713310|49999629|FG000|Overall Study|Lack of Efficacy|0|||
24905496|NCT00713310|49999630|FG001|Overall Study|Lack of Efficacy|2|||
24905497|NCT00713310|49999629|FG000|Overall Study|Withdrawal by Subject|0|||
24905498|NCT00713310|49999630|FG001|Overall Study|Withdrawal by Subject|2|||
24905499|NCT00422461|49999640|FG000|Overall Study|Adverse Event|1|||
24905500|NCT00422461|49999641|FG001|Overall Study|Adverse Event|2|||
24905501|NCT00422461|49999642|FG002|Overall Study|Adverse Event|1|||
24905502|NCT00422461|49999643|FG003|Overall Study|Adverse Event|1|||
24905503|NCT00422461|49999640|FG000|Overall Study|Other|0|||
24905504|NCT00422461|49999641|FG001|Overall Study|Other|0|||
24905505|NCT00422461|49999642|FG002|Overall Study|Other|0|||
24977813|NCT03406702|50066301|FG000|Overall Study|Missed Day 27 Dosing|1|||
24977814|NCT00003656|50066319|FG000|Overall Study|Adverse Event|0|||
24977815|NCT00003656|50066320|FG001|Overall Study|Adverse Event|1|||
24977816|NCT00003590|50066327|FG000|Overall Study|Ineligible Patient|1|||
25254852|NCT01193218|50570583|FG004|0-12 Weeks|Withdrawal by Subject|0|||
24905506|NCT00422461|49999643|FG003|Overall Study|Other|2|||
24905507|NCT00422461|49999640|FG000|Overall Study|Participants no longer willing to participate in study|1|||
24905508|NCT00422461|49999641|FG001|Overall Study|Participants no longer willing to participate in study|0|||
24905509|NCT00422461|49999642|FG002|Overall Study|Participants no longer willing to participate in study|0|||
24905510|NCT00422461|49999643|FG003|Overall Study|Participants no longer willing to participate in study|0|||
24905511|NCT00422461|49999640|FG000|Overall Study|Randomized but not treated|1|||
25340560|NCT00776984|50656835|FG000|Overall Study|Lost to Follow-up|2|||
24977817|NCT00003590|50066327|FG000|Overall Study|Adverse Event|7|||
25340561|NCT00776984|50656836|FG001|Overall Study|Lost to Follow-up|0|||
24905512|NCT00422461|49999641|FG001|Overall Study|Randomized but not treated|1|||
24905513|NCT00422461|49999642|FG002|Overall Study|Randomized but not treated|0|||
24905514|NCT00422461|49999643|FG003|Overall Study|Randomized but not treated|0|||
24905515|NCT00712920|49999656|FG000|Overall Study|Adverse Event|3|||
24905516|NCT00712920|49999657|FG001|Overall Study|Adverse Event|4|||
24905517|NCT00712920|49999658|FG002|Overall Study|Adverse Event|7|||
24905518|NCT00712920|49999656|FG000|Overall Study|Withdrawal by Subject|4|||
24905519|NCT00712920|49999657|FG001|Overall Study|Withdrawal by Subject|2|||
24905520|NCT00712920|49999658|FG002|Overall Study|Withdrawal by Subject|1|||
24905521|NCT00712920|49999656|FG000|Overall Study|Lost to Follow-up|1|||
24905522|NCT00712920|49999657|FG001|Overall Study|Lost to Follow-up|4|||
24905523|NCT00712920|49999658|FG002|Overall Study|Lost to Follow-up|0|||
24905524|NCT00712920|49999656|FG000|Overall Study|Lack of Efficacy|1|||
24905525|NCT00712920|49999657|FG001|Overall Study|Lack of Efficacy|0|||
24905526|NCT00712920|49999658|FG002|Overall Study|Lack of Efficacy|1|||
24905527|NCT00712920|49999656|FG000|Overall Study|Other|5|||
24905528|NCT00712920|49999657|FG001|Overall Study|Other|7|||
24905529|NCT00712920|49999658|FG002|Overall Study|Other|3|||
24905530|NCT00712920|49999656|FG000|Overall Study|Non-compliance|3|||
24905531|NCT00712920|49999657|FG001|Overall Study|Non-compliance|0|||
24905532|NCT00712920|49999658|FG002|Overall Study|Non-compliance|0|||
24905533|NCT00612586|49999677|FG000|Overall Study|Adverse Event|6|||
24905534|NCT00612586|49999678|FG001|Overall Study|Adverse Event|2|||
24905535|NCT00612586|49999677|FG000|Overall Study|Death|1|||
24905536|NCT00612586|49999678|FG001|Overall Study|Death|0|||
24905537|NCT00612586|49999677|FG000|Overall Study|Entry Criteria Not Met|0|||
24905538|NCT00612586|49999678|FG001|Overall Study|Entry Criteria Not Met|2|||
24905539|NCT00612586|49999677|FG000|Overall Study|Withdrawal by Subject|7|||
24905540|NCT00612586|49999678|FG001|Overall Study|Withdrawal by Subject|9|||
24905541|NCT00612586|49999677|FG000|Overall Study|Physician Decision|1|||
24905542|NCT00612586|49999678|FG001|Overall Study|Physician Decision|2|||
24905543|NCT00612586|49999677|FG000|Overall Study|Sponsor Decision|1|||
24905544|NCT00612586|49999678|FG001|Overall Study|Sponsor Decision|1|||
24905545|NCT00612586|49999677|FG000|Overall Study|Progressive Disease|26|||
24905546|NCT00612586|49999678|FG001|Overall Study|Progressive Disease|24|||
24905547|NCT00612586|49999677|FG000|Overall Study|Randomized and Not Treated|1|||
24905548|NCT00612586|49999678|FG001|Overall Study|Randomized and Not Treated|1|||
24905549|NCT00614380|49999689|FG000|Overall Study|Adverse Event|14|||
24905550|NCT00614380|49999690|FG001|Overall Study|Adverse Event|4|||
24905551|NCT00614380|49999691|FG002|Overall Study|Adverse Event|0|||
24905552|NCT00614380|49999692|FG003|Overall Study|Adverse Event|0|||
24905553|NCT00614380|49999689|FG000|Overall Study|Lost to Follow-up|6|||
24905554|NCT00614380|49999690|FG001|Overall Study|Lost to Follow-up|1|||
24905555|NCT00614380|49999691|FG002|Overall Study|Lost to Follow-up|0|||
24905556|NCT00614380|49999692|FG003|Overall Study|Lost to Follow-up|0|||
24905557|NCT00614380|49999689|FG000|Overall Study|Non compliant with the protocol|12|||
24905558|NCT00614380|49999690|FG001|Overall Study|Non compliant with the protocol|2|||
24905559|NCT00614380|49999691|FG002|Overall Study|Non compliant with the protocol|1|||
24905560|NCT00614380|49999692|FG003|Overall Study|Non compliant with the protocol|2|||
24905561|NCT00614380|49999689|FG000|Overall Study|Consent withdrawn|3|||
24905562|NCT00614380|49999690|FG001|Overall Study|Consent withdrawn|1|||
24905563|NCT00614380|49999691|FG002|Overall Study|Consent withdrawn|0|||
24905564|NCT00614380|49999692|FG003|Overall Study|Consent withdrawn|0|||
24905565|NCT00612508|49999709|FG000|Overall Study|Withdrawal by Subject|3|||
24905566|NCT00612508|49999710|FG001|Overall Study|Withdrawal by Subject|4|||
24905567|NCT00613834|49999720|FG000|Overall Study|Withdrawal by Subject|0|||
24905568|NCT00613834|49999721|FG001|Overall Study|Withdrawal by Subject|3|||
24905569|NCT00613366|49999735|FG000|Overall Study|Withdrawal by Subject|3|||
24905570|NCT00613366|49999736|FG001|Overall Study|Withdrawal by Subject|2|||
24905571|NCT00612352|49999744|FG000|Overall Study|Adverse Event|1|||
24905572|NCT00612352|49999745|FG001|Overall Study|Adverse Event|0|||
24905573|NCT00612352|49999744|FG000|Overall Study|Withdrawal by Subject|3|||
24905574|NCT00612352|49999745|FG001|Overall Study|Withdrawal by Subject|5|||
24905575|NCT00612352|49999744|FG000|Overall Study|moved out of state|1|||
24905576|NCT00612352|49999745|FG001|Overall Study|moved out of state|0|||
24905577|NCT00612352|49999744|FG000|Overall Study|didn't return calls/show up on test date|4|||
24905578|NCT00612352|49999745|FG001|Overall Study|didn't return calls/show up on test date|1|||
24905579|NCT00704730|49999753|FG000|Overall Study|Adverse Event|35|||
24905580|NCT00704730|49999754|FG001|Overall Study|Adverse Event|9|||
24905581|NCT00704730|49999753|FG000|Overall Study|Death|11|||
24905582|NCT00704730|49999754|FG001|Overall Study|Death|5|||
24905583|NCT00704730|49999753|FG000|Overall Study|Physician Decision|2|||
24905584|NCT00704730|49999754|FG001|Overall Study|Physician Decision|0|||
24905585|NCT00704730|49999753|FG000|Overall Study|Did not receive drug|5|||
24905586|NCT00704730|49999754|FG001|Overall Study|Did not receive drug|2|||
24905587|NCT00704730|49999753|FG000|Overall Study|Disease progression per PI|58|||
24905588|NCT00704730|49999754|FG001|Overall Study|Disease progression per PI|67|||
24905589|NCT00704730|49999753|FG000|Overall Study|data unavailable|1|||
24905590|NCT00704730|49999754|FG001|Overall Study|data unavailable|0|||
24905591|NCT00704730|49999753|FG000|Overall Study|Withdrawal by Subject|9|||
24905592|NCT00704730|49999754|FG001|Overall Study|Withdrawal by Subject|13|||
24905593|NCT00651261|49999763|FG000|Overall Study|Adverse Event|32|||
24905594|NCT00651261|49999764|FG001|Overall Study|Adverse Event|22|||
24905595|NCT00651261|49999763|FG000|Overall Study|Death|18|||
24905596|NCT00651261|49999764|FG001|Overall Study|Death|18|||
24905597|NCT00651261|49999763|FG000|Overall Study|Withdrawal by Subject|22|||
24905598|NCT00651261|49999764|FG001|Overall Study|Withdrawal by Subject|40|||
25340562|NCT00776984|50656835|FG000|Overall Study|Withdrawal by Subject|12|||
25340563|NCT00776984|50656836|FG001|Overall Study|Withdrawal by Subject|7|||
25340564|NCT00776984|50656835|FG000|Overall Study|Lack of Efficacy|0|||
25340565|NCT00776984|50656836|FG001|Overall Study|Lack of Efficacy|1|||
25340566|NCT00776984|50656835|FG000|Overall Study|Other|5|||
25340567|NCT00776984|50656836|FG001|Overall Study|Other|9|||
25340568|NCT00714051|50656844|FG000|Overall Study|Withdrawal by Subject|1|||
25340569|NCT00714051|50656845|FG001|Overall Study|Withdrawal by Subject|0|||
25340570|NCT00714051|50656844|FG000|Overall Study|Death|0|||
25340571|NCT00714051|50656845|FG001|Overall Study|Death|1|||
25340572|NCT00784784|50656853|FG000|Overall Study|Withdrawal by Subject|2|||
25340573|NCT00784784|50656854|FG001|Overall Study|Withdrawal by Subject|2|||
25340574|NCT00801983|50656862|FG000|Period 1|Lost to Follow-up|2|||
25340575|NCT00801983|50656863|FG001|Period 1|Lost to Follow-up|0|||
25340576|NCT00801983|50656862|FG000|Period 1|Withdrawal by Subject|2|||
25340577|NCT00801983|50656863|FG001|Period 1|Withdrawal by Subject|8|||
25340578|NCT00801983|50656862|FG000|Period 2|Withdrawal by Subject|2|||
24905599|NCT00651261|49999763|FG000|Overall Study|Induction failure|24|||
24905600|NCT00651261|49999764|FG001|Overall Study|Induction failure|35|||
24905601|NCT00651261|49999763|FG000|Overall Study|Disease progression|58|||
24905602|NCT00651261|49999764|FG001|Overall Study|Disease progression|58|||
24905603|NCT00651261|49999763|FG000|Overall Study|Alternative therapy|109|||
24905604|NCT00651261|49999764|FG001|Overall Study|Alternative therapy|107|||
24905605|NCT00651261|49999763|FG000|Overall Study|Other disease or participant decisions|23|||
24905606|NCT00651261|49999764|FG001|Overall Study|Other disease or participant decisions|23|||
24905607|NCT00651261|49999763|FG000|Overall Study|Never treated|5|||
24905608|NCT00651261|49999764|FG001|Overall Study|Never treated|3|||
24905609|NCT00651183|49999772|FG000|Overall Study|Lack of Efficacy|1|||
24905610|NCT00651183|49999773|FG001|Overall Study|Lack of Efficacy|0|||
24905611|NCT00651183|49999772|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
24905612|NCT00651183|49999773|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
24905613|NCT00651183|49999772|FG000|Overall Study|Tolerability insufficient|5|||
24905614|NCT00651183|49999773|FG001|Overall Study|Tolerability insufficient|2|||
24905615|NCT00651183|49999772|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
24905616|NCT00651183|49999773|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
24905617|NCT00651183|49999772|FG000|Overall Study|Withdrawal by Subject|6|||
24905618|NCT00651183|49999773|FG001|Overall Study|Withdrawal by Subject|3|||
24905619|NCT00651183|49999772|FG000|Overall Study|Lost to Follow-up|3|||
24905620|NCT00651183|49999773|FG001|Overall Study|Lost to Follow-up|1|||
24905621|NCT00651183|49999772|FG000|Overall Study|Other reasons|4|||
25254853|NCT01193218|50570584|FG005|0-12 Weeks|Withdrawal by Subject|0|||
25254854|NCT01193218|50570585|FG006|0-12 Weeks|Withdrawal by Subject|1|||
25254855|NCT01193218|50570586|FG007|0-12 Weeks|Withdrawal by Subject|0|||
25254856|NCT01193218|50570579|FG000|12-52 Weeks|Adverse Event|1|||
25254857|NCT01193218|50570580|FG001|12-52 Weeks|Adverse Event|0|||
25254858|NCT01193218|50570581|FG002|12-52 Weeks|Adverse Event|1|||
25254859|NCT01193218|50570582|FG003|12-52 Weeks|Adverse Event|2|||
25254860|NCT01193218|50570583|FG004|12-52 Weeks|Adverse Event|3|||
25254861|NCT01193218|50570584|FG005|12-52 Weeks|Adverse Event|3|||
25254862|NCT01193218|50570585|FG006|12-52 Weeks|Adverse Event|1|||
25254863|NCT01193218|50570586|FG007|12-52 Weeks|Adverse Event|2|||
25254864|NCT01193218|50570579|FG000|12-52 Weeks|Lack of Efficacy|0|||
25254865|NCT01193218|50570580|FG001|12-52 Weeks|Lack of Efficacy|0|||
25254866|NCT01193218|50570581|FG002|12-52 Weeks|Lack of Efficacy|0|||
25254867|NCT01193218|50570582|FG003|12-52 Weeks|Lack of Efficacy|0|||
25254868|NCT01193218|50570583|FG004|12-52 Weeks|Lack of Efficacy|0|||
25340579|NCT00801983|50656863|FG001|Period 2|Withdrawal by Subject|1|||
24905622|NCT00651183|49999773|FG001|Overall Study|Other reasons|2|||
24905623|NCT00651183|49999772|FG000|Overall Study|missing|1|||
24905624|NCT00651183|49999773|FG001|Overall Study|missing|0|||
24905625|NCT00699972|49999782|FG000|Overall Study|Adverse Event|7|||
25254869|NCT01193218|50570584|FG005|12-52 Weeks|Lack of Efficacy|0|||
25254870|NCT01193218|50570585|FG006|12-52 Weeks|Lack of Efficacy|1|||
25340580|NCT00587288|50656871|FG000|Overall Study|Adverse Event|0|||
25340581|NCT00587288|50656872|FG001|Overall Study|Adverse Event|1|||
24905626|NCT00699972|49999783|FG001|Overall Study|Adverse Event|9|||
24905627|NCT00699972|49999784|FG002|Overall Study|Adverse Event|24|||
25254871|NCT01193218|50570586|FG007|12-52 Weeks|Lack of Efficacy|0|||
25254872|NCT01193218|50570579|FG000|12-52 Weeks|Withdrawal by Subject|3|||
25254873|NCT01193218|50570580|FG001|12-52 Weeks|Withdrawal by Subject|0|||
25340582|NCT00587288|50656871|FG000|Overall Study|Lack of Efficacy|2|||
25340583|NCT00587288|50656872|FG001|Overall Study|Lack of Efficacy|8|||
24905628|NCT00699972|49999782|FG000|Overall Study|Lost to Follow-up|0|||
24905629|NCT00699972|49999783|FG001|Overall Study|Lost to Follow-up|2|||
24905630|NCT00699972|49999784|FG002|Overall Study|Lost to Follow-up|0|||
24905631|NCT00699972|49999782|FG000|Overall Study|Withdrawal by Subject|3|||
24905632|NCT00699972|49999783|FG001|Overall Study|Withdrawal by Subject|7|||
24905633|NCT00699972|49999784|FG002|Overall Study|Withdrawal by Subject|4|||
24905634|NCT00699972|49999782|FG000|Overall Study|Lack of Efficacy|2|||
24905635|NCT00699972|49999783|FG001|Overall Study|Lack of Efficacy|0|||
24905636|NCT00699972|49999784|FG002|Overall Study|Lack of Efficacy|2|||
24905637|NCT00699972|49999782|FG000|Overall Study|Administrative/Other|3|||
24905638|NCT00699972|49999783|FG001|Overall Study|Administrative/Other|1|||
24905639|NCT00699972|49999784|FG002|Overall Study|Administrative/Other|4|||
24905640|NCT00699972|49999782|FG000|Overall Study|Randomized, Not Treated|1|||
24905641|NCT00699972|49999783|FG001|Overall Study|Randomized, Not Treated|0|||
24905642|NCT00699972|49999784|FG002|Overall Study|Randomized, Not Treated|1|||
24905643|NCT00642759|49999792|FG000|Overall Study|Protocol Violation|1|||
24905644|NCT00611026|49999800|FG000|Randomized to Double-blind Treatment|Not treated|2|||
24905645|NCT00611026|49999801|FG001|Randomized to Double-blind Treatment|Not treated|1|||
24905646|NCT00611026|49999802|FG002|Randomized to Double-blind Treatment|Not treated|3|||
24905647|NCT00611026|49999800|FG000|Double-blind Treatment Period|Death|1|||
24905648|NCT00611026|49999801|FG001|Double-blind Treatment Period|Death|0|||
24905649|NCT00611026|49999802|FG002|Double-blind Treatment Period|Death|0|||
24905650|NCT00611026|49999800|FG000|Double-blind Treatment Period|Adverse Event|9|||
24905651|NCT00611026|49999801|FG001|Double-blind Treatment Period|Adverse Event|28|||
24905652|NCT00611026|49999802|FG002|Double-blind Treatment Period|Adverse Event|46|||
24905653|NCT00611026|49999800|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
24905654|NCT00611026|49999801|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
24905655|NCT00611026|49999802|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
24905656|NCT00611026|49999800|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
24905657|NCT00611026|49999801|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
24905658|NCT00611026|49999802|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
24905659|NCT00611026|49999800|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
24905660|NCT00611026|49999801|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
24905661|NCT00611026|49999802|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
24905662|NCT00611026|49999800|FG000|Double-blind Treatment Period|Other|13|||
24905663|NCT00611026|49999801|FG001|Double-blind Treatment Period|Other|20|||
24905664|NCT00611026|49999802|FG002|Double-blind Treatment Period|Other|18|||
24905665|NCT00646113|49999812|FG000|Overall Study|Lost to Follow-up|5|||
24905666|NCT00646113|49999812|FG000|Overall Study|Adverse Event|3|||
24905667|NCT00422383|49999821|FG000|Overall Study|Adverse Event|5|||
24905668|NCT00422383|49999822|FG001|Overall Study|Adverse Event|3|||
24905669|NCT00422383|49999823|FG002|Overall Study|Adverse Event|1|||
24905670|NCT00422383|49999824|FG003|Overall Study|Adverse Event|1|||
24905671|NCT00422383|49999825|FG004|Overall Study|Adverse Event|0|||
24905672|NCT00422383|49999821|FG000|Overall Study|Lack of Efficacy|4|||
24905673|NCT00422383|49999822|FG001|Overall Study|Lack of Efficacy|4|||
24905674|NCT00422383|49999823|FG002|Overall Study|Lack of Efficacy|2|||
24905675|NCT00422383|49999824|FG003|Overall Study|Lack of Efficacy|1|||
24905676|NCT00422383|49999825|FG004|Overall Study|Lack of Efficacy|1|||
24905677|NCT00422383|49999821|FG000|Overall Study|Lost to Follow-up|0|||
24905678|NCT00422383|49999822|FG001|Overall Study|Lost to Follow-up|1|||
24905679|NCT00422383|49999823|FG002|Overall Study|Lost to Follow-up|0|||
24905680|NCT00422383|49999824|FG003|Overall Study|Lost to Follow-up|0|||
24905681|NCT00422383|49999825|FG004|Overall Study|Lost to Follow-up|1|||
24905682|NCT00422383|49999821|FG000|Overall Study|Protocol Violation|1|||
24905683|NCT00422383|49999822|FG001|Overall Study|Protocol Violation|1|||
24905684|NCT00422383|49999823|FG002|Overall Study|Protocol Violation|1|||
24905685|NCT00422383|49999824|FG003|Overall Study|Protocol Violation|0|||
24905686|NCT00422383|49999825|FG004|Overall Study|Protocol Violation|0|||
24905687|NCT00422383|49999821|FG000|Overall Study|Withdrawal by Subject|5|||
24905688|NCT00422383|49999822|FG001|Overall Study|Withdrawal by Subject|5|||
24905689|NCT00422383|49999823|FG002|Overall Study|Withdrawal by Subject|0|||
24905690|NCT00422383|49999824|FG003|Overall Study|Withdrawal by Subject|0|||
25254874|NCT01193218|50570581|FG002|12-52 Weeks|Withdrawal by Subject|3|||
25254875|NCT01193218|50570582|FG003|12-52 Weeks|Withdrawal by Subject|0|||
24905691|NCT00422383|49999825|FG004|Overall Study|Withdrawal by Subject|1|||
24905692|NCT00612040|49999846|FG000|Overall Study|Adverse Event|0|||
24905693|NCT00612040|49999847|FG001|Overall Study|Adverse Event|2|||
24905694|NCT00612040|49999848|FG002|Overall Study|Adverse Event|1|||
24905695|NCT00612040|49999846|FG000|Overall Study|Protocol Violation|1|||
24905696|NCT00612040|49999847|FG001|Overall Study|Protocol Violation|2|||
24905697|NCT00612040|49999848|FG002|Overall Study|Protocol Violation|1|||
24905698|NCT00612040|49999846|FG000|Overall Study|Lack of Efficacy|2|||
25254876|NCT01193218|50570583|FG004|12-52 Weeks|Withdrawal by Subject|0|||
25254877|NCT01193218|50570584|FG005|12-52 Weeks|Withdrawal by Subject|2|||
24905699|NCT00612040|49999847|FG001|Overall Study|Lack of Efficacy|1|||
25254878|NCT01193218|50570585|FG006|12-52 Weeks|Withdrawal by Subject|1|||
24905700|NCT00612040|49999848|FG002|Overall Study|Lack of Efficacy|0|||
24905701|NCT00612040|49999846|FG000|Overall Study|Unclassified|2|||
24905702|NCT00612040|49999847|FG001|Overall Study|Unclassified|2|||
24905703|NCT00612040|49999848|FG002|Overall Study|Unclassified|5|||
24905704|NCT00422227|49999858|FG000|Overall Study|Adverse Event|3|||
24905705|NCT00422227|49999859|FG001|Overall Study|Adverse Event|8|||
24905706|NCT00422227|49999858|FG000|Overall Study|Lost to Follow-up|1|||
24905707|NCT00422227|49999859|FG001|Overall Study|Lost to Follow-up|3|||
24905708|NCT00422227|49999858|FG000|Overall Study|Withdrawal by Subject|0|||
24905709|NCT00422227|49999859|FG001|Overall Study|Withdrawal by Subject|4|||
24905710|NCT00421993|49999869|FG000|Overall Study|Withdrawal by Subject|22|||
24905711|NCT00421993|49999870|FG001|Overall Study|Withdrawal by Subject|23|||
24905712|NCT00421993|49999871|FG002|Overall Study|Withdrawal by Subject|23|||
24905713|NCT00421993|49999872|FG003|Overall Study|Withdrawal by Subject|24|||
24905714|NCT00421993|49999869|FG000|Overall Study|Lost to Follow-up|18|||
24905715|NCT00421993|49999870|FG001|Overall Study|Lost to Follow-up|19|||
24905716|NCT00421993|49999871|FG002|Overall Study|Lost to Follow-up|22|||
24905717|NCT00421993|49999872|FG003|Overall Study|Lost to Follow-up|20|||
24905718|NCT00421993|49999869|FG000|Overall Study|Adverse Event|11|||
24905719|NCT00421993|49999870|FG001|Overall Study|Adverse Event|1|||
24905720|NCT00421993|49999871|FG002|Overall Study|Adverse Event|6|||
24905721|NCT00421993|49999872|FG003|Overall Study|Adverse Event|4|||
24905722|NCT00421993|49999869|FG000|Overall Study|Protocol Violation|2|||
24905723|NCT00421993|49999870|FG001|Overall Study|Protocol Violation|2|||
24905724|NCT00421993|49999871|FG002|Overall Study|Protocol Violation|0|||
24905725|NCT00421993|49999872|FG003|Overall Study|Protocol Violation|1|||
24905726|NCT00421993|49999869|FG000|Overall Study|Lack of Efficacy|0|||
24905727|NCT00421993|49999870|FG001|Overall Study|Lack of Efficacy|3|||
24905728|NCT00421993|49999871|FG002|Overall Study|Lack of Efficacy|0|||
24905729|NCT00421993|49999872|FG003|Overall Study|Lack of Efficacy|5|||
24905730|NCT00421993|49999869|FG000|Overall Study|Pregnancy|0|||
24905731|NCT00421993|49999870|FG001|Overall Study|Pregnancy|1|||
24905732|NCT00421993|49999871|FG002|Overall Study|Pregnancy|1|||
24905733|NCT00421993|49999872|FG003|Overall Study|Pregnancy|2|||
24905734|NCT00421993|49999869|FG000|Overall Study|Subject transportation issues|0|||
24905735|NCT00421993|49999870|FG001|Overall Study|Subject transportation issues|0|||
24905736|NCT00421993|49999871|FG002|Overall Study|Subject transportation issues|0|||
24905737|NCT00421993|49999872|FG003|Overall Study|Subject transportation issues|1|||
24905738|NCT00413959|49999882|FG000|Overall Study|Pt had only one cycle.|1|||
24905739|NCT00645567|49999886|FG000|Overall Study|Adverse Event|1|||
24905740|NCT00611884|49999898|FG000|Overall Study|Adverse Event|1|||
24905741|NCT00611884|49999899|FG001|Overall Study|Adverse Event|0|||
24905742|NCT00611884|49999900|FG002|Overall Study|Adverse Event|0|||
24905743|NCT00611884|49999901|FG003|Overall Study|Adverse Event|1|||
24905744|NCT00611884|49999898|FG000|Overall Study|Non-Compliance|1|||
24905745|NCT00611884|49999899|FG001|Overall Study|Non-Compliance|4|||
25254879|NCT01193218|50570586|FG007|12-52 Weeks|Withdrawal by Subject|2|||
25254880|NCT01193218|50570579|FG000|12-52 Weeks|Other reason than above|1|||
25254881|NCT01193218|50570580|FG001|12-52 Weeks|Other reason than above|0|||
25254882|NCT01193218|50570581|FG002|12-52 Weeks|Other reason than above|0|||
25254883|NCT01193218|50570582|FG003|12-52 Weeks|Other reason than above|1|||
25254884|NCT01193218|50570583|FG004|12-52 Weeks|Other reason than above|1|||
25254885|NCT01193218|50570584|FG005|12-52 Weeks|Other reason than above|0|||
25254886|NCT01193218|50570585|FG006|12-52 Weeks|Other reason than above|0|||
25254887|NCT01193218|50570586|FG007|12-52 Weeks|Other reason than above|0|||
25254888|NCT01193101|50570606|FG000|Overall Study|Adverse Event|0|||
25254889|NCT01193101|50570607|FG001|Overall Study|Adverse Event|1|||
25340584|NCT00587288|50656871|FG000|Overall Study|Protocol Violation|1|||
25340585|NCT00587288|50656872|FG001|Overall Study|Protocol Violation|0|||
25340586|NCT00800735|50656880|FG000|Overall Study|Administrative/Other|2|||
25340587|NCT00800735|50656880|FG000|Overall Study|Insufficient Therapeutic Response|2|||
25340588|NCT00800735|50656880|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
25340589|NCT00800735|50656880|FG000|Overall Study|Withdrew Consent|3|||
25340590|NCT00730158|50656886|FG000|Overall Study|Withdrawal by Subject|1|||
25340591|NCT00730158|50656887|FG001|Overall Study|Withdrawal by Subject|1|||
25340592|NCT00784550|50656899|FG000|Overall Study|Adverse Event|12|||
24905746|NCT00611884|49999900|FG002|Overall Study|Non-Compliance|2|||
24905747|NCT00611884|49999901|FG003|Overall Study|Non-Compliance|2|||
24905748|NCT00611884|49999898|FG000|Overall Study|Lack of Efficacy|0|||
24905749|NCT00611884|49999899|FG001|Overall Study|Lack of Efficacy|1|||
24905750|NCT00611884|49999900|FG002|Overall Study|Lack of Efficacy|0|||
24905751|NCT00611884|49999901|FG003|Overall Study|Lack of Efficacy|0|||
24905752|NCT00611884|49999898|FG000|Overall Study|Unclassified|7|||
24905753|NCT00611884|49999899|FG001|Overall Study|Unclassified|4|||
24905754|NCT00611884|49999900|FG002|Overall Study|Unclassified|2|||
24905755|NCT00611884|49999901|FG003|Overall Study|Unclassified|3|||
24905756|NCT00420745|49999913|FG000|Overall Study|Adverse Event|2|||
25340593|NCT00784550|50656900|FG001|Overall Study|Adverse Event|10|||
24905757|NCT00420745|49999914|FG001|Overall Study|Adverse Event|2|||
24905758|NCT00420745|49999913|FG000|Overall Study|Lost to Follow-up|10|||
24905759|NCT00420745|49999914|FG001|Overall Study|Lost to Follow-up|2|||
24905760|NCT00420745|49999913|FG000|Overall Study|Protocol Violation|1|||
24905761|NCT00420745|49999914|FG001|Overall Study|Protocol Violation|0|||
24905762|NCT00420745|49999913|FG000|Overall Study|Physician Decision|1|||
24905763|NCT00420745|49999914|FG001|Overall Study|Physician Decision|1|||
24905764|NCT00420745|49999913|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
24905765|NCT00420745|49999914|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
24905766|NCT00420745|49999913|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
24905767|NCT00420745|49999914|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
24905768|NCT00611806|49999922|FG000|Overall Study|Withdrawal by Subject|8|||
24905769|NCT00611806|49999923|FG001|Overall Study|Withdrawal by Subject|2|||
24905770|NCT00611806|49999922|FG000|Overall Study|Adverse Event|2|||
24905771|NCT00611806|49999923|FG001|Overall Study|Adverse Event|1|||
24905772|NCT00611806|49999922|FG000|Overall Study|Lost to Follow-up|6|||
24905773|NCT00611806|49999923|FG001|Overall Study|Lost to Follow-up|0|||
24905774|NCT00413413|49999932|FG000|Single-Blind|Adverse Event|0|||
24905775|NCT00413413|49999933|FG001|Single-Blind|Adverse Event|9|||
24905776|NCT00413413|49999934|FG002|Single-Blind|Adverse Event|0|||
24905777|NCT00413413|49999932|FG000|Single-Blind|Lack of Efficacy|0|||
24905778|NCT00413413|49999933|FG001|Single-Blind|Lack of Efficacy|5|||
24905779|NCT00413413|49999934|FG002|Single-Blind|Lack of Efficacy|0|||
24905780|NCT00413413|49999932|FG000|Single-Blind|Subject no longer requires study drug|0|||
24905781|NCT00413413|49999933|FG001|Single-Blind|Subject no longer requires study drug|151|||
24905782|NCT00413413|49999934|FG002|Single-Blind|Subject no longer requires study drug|0|||
24905783|NCT00413413|49999932|FG000|Single-Blind|Protocol Violation|0|||
24905784|NCT00413413|49999933|FG001|Single-Blind|Protocol Violation|16|||
24905785|NCT00413413|49999934|FG002|Single-Blind|Protocol Violation|0|||
24905786|NCT00413413|49999932|FG000|Single-Blind|Withdrawal by Subject|0|||
25254890|NCT01193101|50570608|FG002|Overall Study|Adverse Event|1|||
25254891|NCT01193101|50570609|FG003|Overall Study|Adverse Event|3|||
25254892|NCT01193101|50570606|FG000|Overall Study|Lack of Efficacy|3|||
25254893|NCT01193101|50570607|FG001|Overall Study|Lack of Efficacy|1|||
25254894|NCT01193101|50570608|FG002|Overall Study|Lack of Efficacy|0|||
25254895|NCT01193101|50570609|FG003|Overall Study|Lack of Efficacy|8|||
25254896|NCT01193101|50570606|FG000|Overall Study|Withdrawal by Subject|2|||
25254897|NCT01193101|50570607|FG001|Overall Study|Withdrawal by Subject|4|||
25254898|NCT01193101|50570608|FG002|Overall Study|Withdrawal by Subject|1|||
25254899|NCT01193101|50570609|FG003|Overall Study|Withdrawal by Subject|1|||
25254900|NCT01193101|50570606|FG000|Overall Study|Administrative problems|0|||
25254901|NCT01193101|50570607|FG001|Overall Study|Administrative problems|0|||
25340594|NCT00784550|50656899|FG000|Overall Study|Lack of Efficacy|0|||
25340595|NCT00784550|50656900|FG001|Overall Study|Lack of Efficacy|1|||
25340596|NCT00784550|50656899|FG000|Overall Study|Protocol Violation|10|||
25340597|NCT00784550|50656900|FG001|Overall Study|Protocol Violation|10|||
25340598|NCT00784550|50656899|FG000|Overall Study|Lost to Follow-up|8|||
25340599|NCT00784550|50656900|FG001|Overall Study|Lost to Follow-up|5|||
25340600|NCT00784550|50656899|FG000|Overall Study|Physician Decision|2|||
25340601|NCT00784550|50656900|FG001|Overall Study|Physician Decision|3|||
25340602|NCT00784550|50656899|FG000|Overall Study|Withdrawal by Subject|4|||
25340603|NCT00784550|50656900|FG001|Overall Study|Withdrawal by Subject|13|||
25340604|NCT00729690|50656909|FG000|Overall Study|IT Catheter Malfunction|0|||
25340605|NCT00729690|50656910|FG001|Overall Study|IT Catheter Malfunction|2|||
25340606|NCT00729690|50656911|FG002|Overall Study|IT Catheter Malfunction|2|||
25340607|NCT00784238|50656919|FG000|Overall Study|Adverse Event|14|||
25340608|NCT00784238|50656919|FG000|Overall Study|Death|2|||
25340609|NCT00784238|50656919|FG000|Overall Study|Lack of Efficacy|33|||
25340610|NCT00784238|50656919|FG000|Overall Study|Lost to Follow-up|29|||
25340611|NCT00784238|50656919|FG000|Overall Study|Pregnancy|1|||
25340612|NCT00784238|50656919|FG000|Overall Study|Withdrawal by Subject|26|||
25340613|NCT00784238|50656919|FG000|Overall Study|Other|14|||
25340614|NCT00729612|50656926|FG000|Overall Study|Non evaluable for response|10|||
25340615|NCT00585546|50656930|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
25340616|NCT00585546|50656930|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
25340617|NCT00768248|50656936|FG000|Overall Study|Research coordinator didn't collect data|1|||
24905787|NCT00413413|49999933|FG001|Single-Blind|Withdrawal by Subject|27|||
25340618|NCT00768248|50656937|FG001|Overall Study|Research coordinator didn't collect data|1|||
25340619|NCT00775268|50656945|FG000|Baseline|Drug not synthesize dose|1|||
25340620|NCT00775268|50656946|FG001|Baseline|Drug not synthesize dose|0|||
25340621|NCT00775268|50656945|FG000|Baseline|Not treated-ineligible per CT|0|||
25340622|NCT00775268|50656946|FG001|Baseline|Not treated-ineligible per CT|1|||
25340623|NCT00775268|50656945|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
24905788|NCT00413413|49999934|FG002|Single-Blind|Withdrawal by Subject|0|||
25340624|NCT00775268|50656946|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
24905789|NCT00413413|49999932|FG000|Single-Blind|Lost to Follow-up|0|||
24905790|NCT00413413|49999933|FG001|Single-Blind|Lost to Follow-up|8|||
25254902|NCT01193101|50570608|FG002|Overall Study|Administrative problems|1|||
24905791|NCT00413413|49999934|FG002|Single-Blind|Lost to Follow-up|0|||
24905792|NCT00413413|49999932|FG000|Double-Blind|Adverse Event|6|||
24905793|NCT00413413|49999933|FG001|Double-Blind|Adverse Event|0|||
24905794|NCT00413413|49999934|FG002|Double-Blind|Adverse Event|5|||
24905795|NCT00413413|49999932|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
24905796|NCT00413413|49999933|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
24905797|NCT00413413|49999934|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
24905798|NCT00413413|49999932|FG000|Double-Blind|Protocol deviation|1|||
24905799|NCT00413413|49999933|FG001|Double-Blind|Protocol deviation|2|||
24905800|NCT00413413|49999934|FG002|Double-Blind|Protocol deviation|1|||
24905801|NCT00413413|49999932|FG000|Double-Blind|Subject withdrew consent|4|||
24905802|NCT00413413|49999933|FG001|Double-Blind|Subject withdrew consent|6|||
24905803|NCT00413413|49999934|FG002|Double-Blind|Subject withdrew consent|9|||
24905804|NCT00413413|49999932|FG000|Double-Blind|Lost to Follow-up|3|||
24905805|NCT00413413|49999933|FG001|Double-Blind|Lost to Follow-up|4|||
24905806|NCT00413413|49999934|FG002|Double-Blind|Lost to Follow-up|2|||
24905807|NCT00610714|49999944|FG000|Overall Study|Adverse Event|3|||
24905808|NCT00610714|49999945|FG001|Overall Study|Adverse Event|1|||
24905809|NCT00610714|49999944|FG000|Overall Study|Death|12|||
24905810|NCT00610714|49999945|FG001|Overall Study|Death|18|||
24905811|NCT00610714|49999944|FG000|Overall Study|Withdrawal by Subject|9|||
24905812|NCT00610714|49999945|FG001|Overall Study|Withdrawal by Subject|3|||
24905813|NCT00610714|49999944|FG000|Overall Study|Study completion at 120 PFS events|2|||
24905814|NCT00610714|49999945|FG001|Overall Study|Study completion at 120 PFS events|2|||
24905815|NCT00403585|49999951|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
24905816|NCT00403585|49999951|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
24905817|NCT00403585|49999951|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
24905818|NCT00645411|49999959|FG000|Overall Study|Adverse Event|0|||
24905819|NCT00645411|49999960|FG001|Overall Study|Adverse Event|0|||
24905820|NCT00645411|49999961|FG002|Overall Study|Adverse Event|0|||
24977818|NCT00003590|50066327|FG000|Overall Study|Withdrawal by Subject|1|||
24977819|NCT00003590|50066327|FG000|Overall Study|Lack of Efficacy|11|||
24977820|NCT00003590|50066327|FG000|Overall Study|Death|1|||
24977821|NCT00003590|50066327|FG000|Overall Study|Physician Decision|1|||
24977822|NCT03416374|50066333|FG000|Between Treatment Period I and II|Other|0|||
24977823|NCT03416374|50066334|FG001|Between Treatment Period I and II|Other|9|||
24977824|NCT03416374|50066333|FG000|Treatment Period II|Lack of Efficacy|3|||
24977825|NCT03416374|50066334|FG001|Treatment Period II|Lack of Efficacy|11|||
24977826|NCT03416374|50066333|FG000|Treatment Period II|Adverse Event|1|||
24977827|NCT03416374|50066334|FG001|Treatment Period II|Adverse Event|4|||
24977828|NCT03416374|50066333|FG000|Treatment Period II|Death|0|||
24977829|NCT03416374|50066334|FG001|Treatment Period II|Death|1|||
24905821|NCT00645411|49999962|FG003|Overall Study|Adverse Event|2|||
24977830|NCT03416374|50066333|FG000|Treatment Period II|Other|0|||
24977831|NCT03416374|50066334|FG001|Treatment Period II|Other|2|||
24977832|NCT03799952|50066345|FG000|Overall Study|Program was too easy, discontinued|1|||
25254903|NCT01193101|50570609|FG003|Overall Study|Administrative problems|0|||
25254904|NCT01193101|50570606|FG000|Overall Study|Abnormal test procedure results|0|||
24905822|NCT00645411|49999959|FG000|Overall Study|Withdrawal by Subject|2|||
25254905|NCT01193101|50570607|FG001|Overall Study|Abnormal test procedure results|1|||
25254906|NCT01193101|50570608|FG002|Overall Study|Abnormal test procedure results|0|||
25254907|NCT01193101|50570609|FG003|Overall Study|Abnormal test procedure results|0|||
25254908|NCT01192516|50570622|FG000|Overall Study|Lost to Follow-up|7|||
25254909|NCT01192516|50570623|FG001|Overall Study|Lost to Follow-up|10|||
25254910|NCT01192516|50570624|FG002|Overall Study|Lost to Follow-up|7|||
25254911|NCT01192516|50570622|FG000|Overall Study|Withdrawal by Subject|4|||
25254912|NCT01192516|50570623|FG001|Overall Study|Withdrawal by Subject|4|||
25254913|NCT01192516|50570624|FG002|Overall Study|Withdrawal by Subject|1|||
25340625|NCT00775268|50656945|FG000|After Completion|Participant missed scan appointment|1|||
24905823|NCT00645411|49999960|FG001|Overall Study|Withdrawal by Subject|1|||
24905824|NCT00645411|49999961|FG002|Overall Study|Withdrawal by Subject|19|||
24905825|NCT00645411|49999962|FG003|Overall Study|Withdrawal by Subject|21|||
24905826|NCT00645411|49999959|FG000|Overall Study|Lost to Follow-up|10|||
24977833|NCT03799952|50066346|FG001|Overall Study|Program was too easy, discontinued|0|||
24977834|NCT03799952|50066345|FG000|Overall Study|Lost to Follow-up|0|||
24977835|NCT03799952|50066346|FG001|Overall Study|Lost to Follow-up|2|||
24977836|NCT00077766|50066354|FG000|Overall Study|Adverse Event|1|||
24977837|NCT00077766|50066355|FG001|Overall Study|Adverse Event|1|||
24977838|NCT00077766|50066354|FG000|Overall Study|Withdrawal by Subject|4|||
24977839|NCT00077766|50066355|FG001|Overall Study|Withdrawal by Subject|3|||
24905827|NCT00645411|49999960|FG001|Overall Study|Lost to Follow-up|5|||
24977840|NCT00077766|50066354|FG000|Overall Study|Death|12|||
24977841|NCT00077766|50066355|FG001|Overall Study|Death|10|||
24905828|NCT00645411|49999961|FG002|Overall Study|Lost to Follow-up|124|||
24905829|NCT00645411|49999962|FG003|Overall Study|Lost to Follow-up|75|||
24977842|NCT00077766|50066354|FG000|Overall Study|Lost to Follow-up|2|||
24977843|NCT00077766|50066355|FG001|Overall Study|Lost to Follow-up|0|||
24905830|NCT00645411|49999959|FG000|Overall Study|Protocol Violation|1|||
24905831|NCT00645411|49999960|FG001|Overall Study|Protocol Violation|0|||
24905832|NCT00645411|49999961|FG002|Overall Study|Protocol Violation|1|||
24905833|NCT00645411|49999962|FG003|Overall Study|Protocol Violation|0|||
24905834|NCT00645411|49999959|FG000|Overall Study|Inappropriate enrollment|0|||
24905835|NCT00645411|49999960|FG001|Overall Study|Inappropriate enrollment|0|||
24905836|NCT00645411|49999961|FG002|Overall Study|Inappropriate enrollment|4|||
24905837|NCT00645411|49999962|FG003|Overall Study|Inappropriate enrollment|1|||
24905838|NCT00645411|49999959|FG000|Overall Study|Unable to classify|0|||
24905839|NCT00645411|49999960|FG001|Overall Study|Unable to classify|0|||
24905840|NCT00645411|49999961|FG002|Overall Study|Unable to classify|3|||
24905841|NCT00645411|49999962|FG003|Overall Study|Unable to classify|4|||
24905842|NCT00403273|49999981|FG000|Overall Study|Lost to Follow-up|3|||
24905843|NCT00403273|49999982|FG001|Overall Study|Lost to Follow-up|2|||
24905844|NCT00403273|49999981|FG000|Overall Study|Physician Decision|0|||
24905845|NCT00403273|49999982|FG001|Overall Study|Physician Decision|1|||
24905846|NCT00403273|49999981|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
24905847|NCT00403273|49999982|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
24905848|NCT00402727|50000005|FG000|Overall Study|Adverse Event|10|||
24905849|NCT00402727|50000006|FG001|Overall Study|Adverse Event|6|||
24905850|NCT00402727|50000005|FG000|Overall Study|Death|1|||
24905851|NCT00402727|50000006|FG001|Overall Study|Death|0|||
24905852|NCT00402727|50000005|FG000|Overall Study|Lack of Efficacy|1|||
24905853|NCT00402727|50000006|FG001|Overall Study|Lack of Efficacy|3|||
24905854|NCT00402727|50000005|FG000|Overall Study|Lost to Follow-up|24|||
24905855|NCT00402727|50000006|FG001|Overall Study|Lost to Follow-up|11|||
24905856|NCT00402727|50000005|FG000|Overall Study|Physician Decision|1|||
24905857|NCT00402727|50000006|FG001|Overall Study|Physician Decision|1|||
24905858|NCT00402727|50000005|FG000|Overall Study|Protocol Violation|0|||
24905859|NCT00402727|50000006|FG001|Overall Study|Protocol Violation|4|||
24905860|NCT00402727|50000005|FG000|Overall Study|Withdrawal by Subject|3|||
24905861|NCT00402727|50000006|FG001|Overall Study|Withdrawal by Subject|7|||
24905862|NCT00402727|50000005|FG000|Overall Study|supply problems|2|||
24905863|NCT00402727|50000006|FG001|Overall Study|supply problems|1|||
24905864|NCT00402727|50000005|FG000|Overall Study|non-compliance|0|||
24905865|NCT00402727|50000006|FG001|Overall Study|non-compliance|1|||
24905866|NCT00402649|50000012|FG000|Overall Study|Lost to Follow-up|1|||
24905867|NCT00402649|50000012|FG000|Overall Study|Withdrawal by Subject|1|||
24905868|NCT00402337|50000021|FG000|Overall Study|Adverse Event|0|||
24905869|NCT00402337|50000022|FG001|Overall Study|Adverse Event|2|||
24905870|NCT00402337|50000023|FG002|Overall Study|Adverse Event|2|||
24905871|NCT00402337|50000024|FG003|Overall Study|Adverse Event|3|||
24905872|NCT00402337|50000025|FG004|Overall Study|Adverse Event|2|||
24905873|NCT00402337|50000021|FG000|Overall Study|Noncompliance|0|||
24905874|NCT00402337|50000022|FG001|Overall Study|Noncompliance|0|||
24905875|NCT00402337|50000023|FG002|Overall Study|Noncompliance|0|||
24905876|NCT00402337|50000024|FG003|Overall Study|Noncompliance|0|||
24905877|NCT00402337|50000025|FG004|Overall Study|Noncompliance|2|||
24905878|NCT00402337|50000021|FG000|Overall Study|Withdrawal by Subject|5|||
24905879|NCT00402337|50000022|FG001|Overall Study|Withdrawal by Subject|3|||
24905880|NCT00402337|50000023|FG002|Overall Study|Withdrawal by Subject|1|||
24905881|NCT00402337|50000024|FG003|Overall Study|Withdrawal by Subject|6|||
24905882|NCT00402337|50000025|FG004|Overall Study|Withdrawal by Subject|4|||
24905883|NCT00402337|50000021|FG000|Overall Study|Lost to Follow-up|0|||
24905884|NCT00402337|50000022|FG001|Overall Study|Lost to Follow-up|0|||
24905885|NCT00402337|50000023|FG002|Overall Study|Lost to Follow-up|1|||
24905886|NCT00402337|50000024|FG003|Overall Study|Lost to Follow-up|2|||
24905887|NCT00402337|50000025|FG004|Overall Study|Lost to Follow-up|0|||
24905888|NCT00402337|50000021|FG000|Overall Study|Physician Decision|0|||
24905889|NCT00402337|50000022|FG001|Overall Study|Physician Decision|0|||
24905890|NCT00402337|50000023|FG002|Overall Study|Physician Decision|0|||
24905891|NCT00402337|50000024|FG003|Overall Study|Physician Decision|1|||
24905892|NCT00402337|50000025|FG004|Overall Study|Physician Decision|0|||
24905893|NCT00402337|50000021|FG000|Overall Study|Other Reason|0|||
24905894|NCT00402337|50000022|FG001|Overall Study|Other Reason|1|||
24905895|NCT00402337|50000023|FG002|Overall Study|Other Reason|0|||
24905896|NCT00402337|50000024|FG003|Overall Study|Other Reason|0|||
24905897|NCT00402337|50000025|FG004|Overall Study|Other Reason|0|||
24905898|NCT00650091|50000039|FG000|Amended Study Design|Withdrawal by Subject|12|||
24905899|NCT00650091|50000040|FG001|Amended Study Design|Withdrawal by Subject|11|||
24905900|NCT00650091|50000041|FG002|Amended Study Design|Withdrawal by Subject|0|||
24905901|NCT00650091|50000039|FG000|Amended Study Design|Physician Decision|5|||
24905902|NCT00650091|50000040|FG001|Amended Study Design|Physician Decision|0|||
24905903|NCT00650091|50000041|FG002|Amended Study Design|Physician Decision|0|||
24905904|NCT00650091|50000039|FG000|Amended Study Design|Adverse Event|1|||
24905905|NCT00650091|50000040|FG001|Amended Study Design|Adverse Event|4|||
24905906|NCT00650091|50000041|FG002|Amended Study Design|Adverse Event|0|||
25254914|NCT01192516|50570622|FG000|Overall Study|started new treatment|5|||
24905907|NCT00650091|50000039|FG000|Amended Study Design|Lung transplantation|4|||
24905908|NCT00650091|50000040|FG001|Amended Study Design|Lung transplantation|2|||
24905909|NCT00650091|50000041|FG002|Amended Study Design|Lung transplantation|0|||
24905910|NCT00650091|50000039|FG000|Amended Study Design|Other|1|||
24905911|NCT00650091|50000040|FG001|Amended Study Design|Other|3|||
24905912|NCT00650091|50000041|FG002|Amended Study Design|Other|0|||
24905913|NCT00642369|50000051|FG000|Overall Study|Adverse Event|2|||
24905914|NCT00642369|50000052|FG001|Overall Study|Adverse Event|3|||
24905915|NCT00642369|50000051|FG000|Overall Study|Withdrawal by Subject|1|||
24905916|NCT00642369|50000052|FG001|Overall Study|Withdrawal by Subject|0|||
24905917|NCT00642369|50000051|FG000|Overall Study|misdiagnosis|0|||
24905918|NCT00642369|50000052|FG001|Overall Study|misdiagnosis|1|||
24905919|NCT00642369|50000051|FG000|Overall Study|Lack of Efficacy|2|||
24905920|NCT00642369|50000052|FG001|Overall Study|Lack of Efficacy|2|||
24905921|NCT00645099|50000077|FG000|Overall Study|Lack of Efficacy|15|||
24905922|NCT00645099|50000078|FG001|Overall Study|Lack of Efficacy|6|||
25254915|NCT01192516|50570623|FG001|Overall Study|started new treatment|1|||
24905923|NCT00645099|50000077|FG000|Overall Study|Withdrawal by Subject|30|||
24905924|NCT00645099|50000078|FG001|Overall Study|Withdrawal by Subject|22|||
24905925|NCT00645099|50000077|FG000|Overall Study|Lost to Follow-up|6|||
24905926|NCT00645099|50000078|FG001|Overall Study|Lost to Follow-up|4|||
24905927|NCT00645099|50000077|FG000|Overall Study|Adverse Event|11|||
24905928|NCT00645099|50000078|FG001|Overall Study|Adverse Event|5|||
24905929|NCT00645099|50000077|FG000|Overall Study|Other|9|||
24905930|NCT00645099|50000078|FG001|Overall Study|Other|5|||
24905931|NCT00420511|50000086|FG000|Overall Study|Adverse Event|1|||
24905932|NCT00420511|50000087|FG001|Overall Study|Adverse Event|1|||
24905933|NCT00420511|50000086|FG000|Overall Study|Lost to Follow-up|1|||
24905934|NCT00420511|50000087|FG001|Overall Study|Lost to Follow-up|0|||
24905935|NCT00420199|50000097|FG000|Overall Study|Participant no longer met study criteria|1|||
24905936|NCT00420199|50000098|FG001|Overall Study|Participant no longer met study criteria|0|||
24905937|NCT00649389|50000113|FG000|Overall Study|Adverse Event|22|||
24905938|NCT00649389|50000114|FG001|Overall Study|Adverse Event|46|||
24905939|NCT00649389|50000115|FG002|Overall Study|Adverse Event|38|||
24905940|NCT00649389|50000116|FG003|Overall Study|Adverse Event|48|||
24905941|NCT00649389|50000113|FG000|Overall Study|Lost to Follow-up|15|||
24905942|NCT00649389|50000114|FG001|Overall Study|Lost to Follow-up|17|||
24905943|NCT00649389|50000115|FG002|Overall Study|Lost to Follow-up|21|||
24905944|NCT00649389|50000116|FG003|Overall Study|Lost to Follow-up|26|||
24905945|NCT00649389|50000113|FG000|Overall Study|Protocol Violation|11|||
24905946|NCT00649389|50000114|FG001|Overall Study|Protocol Violation|13|||
24905947|NCT00649389|50000115|FG002|Overall Study|Protocol Violation|9|||
24905948|NCT00649389|50000116|FG003|Overall Study|Protocol Violation|8|||
24905949|NCT00649389|50000113|FG000|Overall Study|Withdrawal by Subject|20|||
24905950|NCT00649389|50000114|FG001|Overall Study|Withdrawal by Subject|21|||
24905951|NCT00649389|50000115|FG002|Overall Study|Withdrawal by Subject|19|||
24905952|NCT00649389|50000116|FG003|Overall Study|Withdrawal by Subject|23|||
24905953|NCT00649389|50000113|FG000|Overall Study|Other|3|||
24977844|NCT00077766|50066354|FG000|Overall Study|Protocol Violation|1|||
24977845|NCT00077766|50066355|FG001|Overall Study|Protocol Violation|0|||
25254916|NCT01192516|50570624|FG002|Overall Study|started new treatment|0|||
25254917|NCT01192516|50570622|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
25254918|NCT01192516|50570623|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
25340626|NCT00775268|50656946|FG001|After Completion|Participant missed scan appointment|0|||
25340627|NCT00775190|50656965|FG000|Overall Study|Lost to Follow-up|2|||
25340628|NCT00775190|50656966|FG001|Overall Study|Lost to Follow-up|3|||
25340629|NCT00775190|50656965|FG000|Overall Study|Withdrawal by Subject|1|||
25340630|NCT00775190|50656966|FG001|Overall Study|Withdrawal by Subject|2|||
25340631|NCT00775190|50656965|FG000|Overall Study|Protocol Violation|1|||
24905954|NCT00649389|50000114|FG001|Overall Study|Other|9|||
25254919|NCT01192516|50570624|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
25254920|NCT01192399|50570636|FG000|Overall Study|Lack of Efficacy|2|||
25254921|NCT01176916|50570640|FG000|Overall Study|Adverse Event|61|||
25254922|NCT01176916|50570640|FG000|Overall Study|Death|1|||
25254923|NCT01176916|50570640|FG000|Overall Study|Lost to Follow-up|15|||
25254924|NCT01176916|50570640|FG000|Overall Study|Objective progression or relapse|17|||
25254925|NCT01176916|50570640|FG000|Overall Study|Protocol Violation|24|||
24905955|NCT00649389|50000115|FG002|Overall Study|Other|1|||
24905956|NCT00649389|50000116|FG003|Overall Study|Other|6|||
24905957|NCT00402103|50000128|FG000|Overall Study|Adverse Event|60|||
24905958|NCT00402103|50000129|FG001|Overall Study|Adverse Event|7|||
24905959|NCT00402103|50000128|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
24905960|NCT00402103|50000129|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
24905961|NCT00402103|50000128|FG000|Overall Study|Condition no longer requires study drug|2|||
24905962|NCT00402103|50000129|FG001|Overall Study|Condition no longer requires study drug|0|||
25340632|NCT00775190|50656966|FG001|Overall Study|Protocol Violation|0|||
24905963|NCT00402103|50000128|FG000|Overall Study|Protocol Deviation|8|||
24905964|NCT00402103|50000129|FG001|Overall Study|Protocol Deviation|0|||
24905965|NCT00402103|50000128|FG000|Overall Study|Patient withdrew consent|12|||
24905966|NCT00402103|50000129|FG001|Overall Study|Patient withdrew consent|1|||
24905967|NCT00402103|50000128|FG000|Overall Study|Lost to Follow-up|6|||
24905968|NCT00402103|50000129|FG001|Overall Study|Lost to Follow-up|3|||
24905969|NCT00402103|50000128|FG000|Overall Study|Administrative problems|2|||
25340633|NCT00479557|50656979|FG000|Overall Study|Death|0|||
24905970|NCT00402103|50000129|FG001|Overall Study|Administrative problems|0|||
24905971|NCT00641667|50000139|FG000|Overall Study|Withdrawal by Subject|1|||
25340634|NCT00479557|50656980|FG001|Overall Study|Death|0|||
25340635|NCT00479557|50656981|FG002|Overall Study|Death|0|||
25340636|NCT00479557|50656982|FG003|Overall Study|Death|0|||
25340637|NCT00479557|50656983|FG004|Overall Study|Death|0|||
25340638|NCT00479557|50656984|FG005|Overall Study|Death|1|||
25340639|NCT00479557|50656985|FG006|Overall Study|Death|0|||
25340640|NCT00479557|50656979|FG000|Overall Study|Lack of Efficacy|1|||
25340641|NCT00479557|50656980|FG001|Overall Study|Lack of Efficacy|0|||
24905972|NCT00641667|50000139|FG000|Overall Study|Adverse Event|1|||
24905973|NCT00641667|50000139|FG000|Overall Study|Physician Decision|1|||
25340642|NCT00479557|50656981|FG002|Overall Study|Lack of Efficacy|0|||
25340643|NCT00479557|50656982|FG003|Overall Study|Lack of Efficacy|0|||
25340644|NCT00479557|50656983|FG004|Overall Study|Lack of Efficacy|0|||
25340645|NCT00479557|50656984|FG005|Overall Study|Lack of Efficacy|0|||
25340646|NCT00479557|50656985|FG006|Overall Study|Lack of Efficacy|0|||
25340647|NCT00479557|50656979|FG000|Overall Study|Lost to Follow-up|0|||
25340648|NCT00479557|50656980|FG001|Overall Study|Lost to Follow-up|2|||
25340649|NCT00479557|50656981|FG002|Overall Study|Lost to Follow-up|0|||
25340650|NCT00479557|50656982|FG003|Overall Study|Lost to Follow-up|2|||
25340651|NCT00479557|50656983|FG004|Overall Study|Lost to Follow-up|0|||
25340652|NCT00479557|50656984|FG005|Overall Study|Lost to Follow-up|0|||
25340653|NCT00479557|50656985|FG006|Overall Study|Lost to Follow-up|0|||
24905974|NCT00641667|50000139|FG000|Overall Study|Worsening of underlying disease|3|||
24905975|NCT00704184|50000148|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
24905976|NCT00704184|50000149|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
24905977|NCT00704184|50000150|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
24905978|NCT00704184|50000151|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
24905979|NCT00704184|50000152|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
24905980|NCT00704184|50000148|FG000|Open-Label Treatment|Adverse Event|0|||
24905981|NCT00704184|50000149|FG001|Open-Label Treatment|Adverse Event|0|||
24905982|NCT00704184|50000150|FG002|Open-Label Treatment|Adverse Event|2|||
24905983|NCT00704184|50000151|FG003|Open-Label Treatment|Adverse Event|0|||
24905984|NCT00704184|50000152|FG004|Open-Label Treatment|Adverse Event|1|||
24905985|NCT00704184|50000148|FG000|Open-Label Treatment|Lack of Efficacy|0|||
24905986|NCT00704184|50000149|FG001|Open-Label Treatment|Lack of Efficacy|2|||
24905987|NCT00704184|50000150|FG002|Open-Label Treatment|Lack of Efficacy|2|||
24905988|NCT00704184|50000151|FG003|Open-Label Treatment|Lack of Efficacy|2|||
24905989|NCT00704184|50000152|FG004|Open-Label Treatment|Lack of Efficacy|1|||
24905990|NCT00704184|50000148|FG000|Open-Label Treatment|Physician Decision|0|||
24905991|NCT00704184|50000149|FG001|Open-Label Treatment|Physician Decision|0|||
24905992|NCT00704184|50000150|FG002|Open-Label Treatment|Physician Decision|0|||
24905993|NCT00704184|50000151|FG003|Open-Label Treatment|Physician Decision|0|||
24905994|NCT00704184|50000152|FG004|Open-Label Treatment|Physician Decision|1|||
24905995|NCT00704184|50000148|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
24905996|NCT00704184|50000149|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
24905997|NCT00704184|50000150|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
24905998|NCT00704184|50000151|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
24977846|NCT00077766|50066354|FG000|Overall Study|Kidney Transplantation|9|||
24977847|NCT00077766|50066355|FG001|Overall Study|Kidney Transplantation|5|||
24977848|NCT00077766|50066354|FG000|Overall Study|Transplantation|5|||
25078058|NCT03745651|50186223|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
25254926|NCT01176916|50570640|FG000|Overall Study|Withdrawal by Subject|37|||
25254927|NCT01176916|50570640|FG000|Overall Study|Other|6|||
25254928|NCT01176916|50570640|FG000|Overall Study|Withdrawal prior to Treatment|6|||
25254929|NCT01192204|50570646|FG000|Overall Study|could not keep recall appointments|1|||
25254930|NCT01192204|50570647|FG001|Overall Study|could not keep recall appointments|0|||
25254931|NCT01192126|50570654|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
25254932|NCT01192126|50570655|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
25254933|NCT01192126|50570654|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
25340654|NCT00479557|50656979|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
25340655|NCT00479557|50656980|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
24905999|NCT00704184|50000152|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
24906000|NCT00641043|50000166|FG000|Overall Study|Adverse Event|6|||
24906001|NCT00641043|50000167|FG001|Overall Study|Adverse Event|4|||
24906002|NCT00641043|50000166|FG000|Overall Study|Protocol Violation|2|||
24906003|NCT00641043|50000167|FG001|Overall Study|Protocol Violation|3|||
24977849|NCT00077766|50066355|FG001|Overall Study|Transplantation|1|||
25340656|NCT00479557|50656981|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
24977850|NCT00077766|50066354|FG000|Overall Study|Investigators Discretion|1|||
25340657|NCT00479557|50656982|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
24906004|NCT00641043|50000166|FG000|Overall Study|Lost to Follow-up|3|||
24906005|NCT00641043|50000167|FG001|Overall Study|Lost to Follow-up|2|||
24906006|NCT00641043|50000166|FG000|Overall Study|Withdrawal by Subject|4|||
24906007|NCT00641043|50000167|FG001|Overall Study|Withdrawal by Subject|4|||
25340658|NCT00479557|50656983|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
25340659|NCT00479557|50656984|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
25340660|NCT00479557|50656985|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
25340661|NCT00479557|50656979|FG000|Overall Study|AE not related to Study Drug|1|||
25340662|NCT00479557|50656980|FG001|Overall Study|AE not related to Study Drug|3|||
25340663|NCT00479557|50656981|FG002|Overall Study|AE not related to Study Drug|0|||
25340664|NCT00479557|50656982|FG003|Overall Study|AE not related to Study Drug|0|||
25340665|NCT00479557|50656983|FG004|Overall Study|AE not related to Study Drug|2|||
25340666|NCT00479557|50656984|FG005|Overall Study|AE not related to Study Drug|2|||
25340667|NCT00479557|50656985|FG006|Overall Study|AE not related to Study Drug|1|||
25340668|NCT00479557|50656979|FG000|Overall Study|Caregiver Request|2|||
25340669|NCT00479557|50656980|FG001|Overall Study|Caregiver Request|2|||
25340670|NCT00479557|50656981|FG002|Overall Study|Caregiver Request|2|||
25340671|NCT00479557|50656982|FG003|Overall Study|Caregiver Request|0|||
25340672|NCT00479557|50656983|FG004|Overall Study|Caregiver Request|1|||
25340673|NCT00479557|50656984|FG005|Overall Study|Caregiver Request|2|||
25340674|NCT00479557|50656985|FG006|Overall Study|Caregiver Request|0|||
25340675|NCT00479557|50656979|FG000|Overall Study|Investigator Request|0|||
25340676|NCT00479557|50656980|FG001|Overall Study|Investigator Request|0|||
25340677|NCT00479557|50656981|FG002|Overall Study|Investigator Request|1|||
25340678|NCT00479557|50656982|FG003|Overall Study|Investigator Request|0|||
25340679|NCT00479557|50656983|FG004|Overall Study|Investigator Request|0|||
25340680|NCT00479557|50656984|FG005|Overall Study|Investigator Request|0|||
25340681|NCT00479557|50656985|FG006|Overall Study|Investigator Request|0|||
25340682|NCT00479557|50656979|FG000|Overall Study|Subject Request|3|||
25340683|NCT00479557|50656980|FG001|Overall Study|Subject Request|0|||
25340684|NCT00479557|50656981|FG002|Overall Study|Subject Request|1|||
25340685|NCT00479557|50656982|FG003|Overall Study|Subject Request|1|||
25340686|NCT00479557|50656983|FG004|Overall Study|Subject Request|1|||
25340687|NCT00479557|50656984|FG005|Overall Study|Subject Request|4|||
25340688|NCT00479557|50656985|FG006|Overall Study|Subject Request|1|||
25340689|NCT00479557|50656979|FG000|Overall Study|Other|2|||
24906008|NCT00641043|50000166|FG000|Overall Study|Other incl. lack of efficacy|4|||
24906009|NCT00641043|50000167|FG001|Overall Study|Other incl. lack of efficacy|2|||
24906010|NCT00402025|50000176|FG000|Overall Study|Adverse Event|0|||
24906011|NCT00402025|50000177|FG001|Overall Study|Adverse Event|0|||
24906012|NCT00402025|50000178|FG002|Overall Study|Adverse Event|2|||
24906013|NCT00402025|50000176|FG000|Overall Study|Death|0|||
25340690|NCT00479557|50656980|FG001|Overall Study|Other|3|||
25340691|NCT00479557|50656981|FG002|Overall Study|Other|1|||
25340692|NCT00479557|50656982|FG003|Overall Study|Other|0|||
25340693|NCT00479557|50656983|FG004|Overall Study|Other|0|||
25340694|NCT00479557|50656984|FG005|Overall Study|Other|3|||
25340695|NCT00479557|50656985|FG006|Overall Study|Other|0|||
25340696|NCT00774800|50657007|FG000|Intervention 4|Withdrawal by Subject|1|||
25340697|NCT00439309|50657019|FG000|Follow-Up|Death|1|||
25340698|NCT00439309|50657020|FG001|Follow-Up|Death|0|||
25340699|NCT00439309|50657019|FG000|Follow-Up|Lost to Follow-up|2|||
25340700|NCT00439309|50657020|FG001|Follow-Up|Lost to Follow-up|0|||
25340701|NCT00439309|50657019|FG000|Follow-Up|Withdrawal by Subject|0|||
25340702|NCT00439309|50657020|FG001|Follow-Up|Withdrawal by Subject|1|||
25340703|NCT00439309|50657019|FG000|Follow-Up|Late response by subject|0|||
25340704|NCT00439309|50657020|FG001|Follow-Up|Late response by subject|1|||
25340705|NCT00479167|50657026|FG000|Overall Study|Withdrawal by Subject|1|||
24906014|NCT00402025|50000177|FG001|Overall Study|Death|1|||
24906015|NCT00402025|50000178|FG002|Overall Study|Death|5|||
24906016|NCT00402025|50000176|FG000|Overall Study|Disease Progression|1|||
24906017|NCT00402025|50000177|FG001|Overall Study|Disease Progression|1|||
25340706|NCT00725712|50657033|FG000|Overall Study|Withdrawal by Subject|2|||
25340707|NCT00725712|50657034|FG001|Overall Study|Withdrawal by Subject|1|||
25340708|NCT00725712|50657033|FG000|Overall Study|Protocol Violation|1|||
25340709|NCT00725712|50657034|FG001|Overall Study|Protocol Violation|0|||
25340710|NCT00725712|50657033|FG000|Overall Study|Progressive disease|37|||
25340711|NCT00725712|50657034|FG001|Overall Study|Progressive disease|16|||
25340712|NCT00725712|50657033|FG000|Overall Study|Clinical progression not based on RECIST|0|||
25340713|NCT00725712|50657034|FG001|Overall Study|Clinical progression not based on RECIST|3|||
25340714|NCT00725712|50657033|FG000|Overall Study|Adverse Event|5|||
24906018|NCT00402025|50000178|FG002|Overall Study|Disease Progression|2|||
25340715|NCT00725712|50657034|FG001|Overall Study|Adverse Event|5|||
25340716|NCT00725712|50657033|FG000|Overall Study|Death|2|||
25340717|NCT00725712|50657034|FG001|Overall Study|Death|0|||
24906019|NCT00402025|50000176|FG000|Overall Study|Physician Decision|1|||
24906020|NCT00402025|50000177|FG001|Overall Study|Physician Decision|1|||
24906021|NCT00402025|50000178|FG002|Overall Study|Physician Decision|0|||
25340718|NCT00725712|50657033|FG000|Overall Study|Other: Death|1|||
25340719|NCT00725712|50657034|FG001|Overall Study|Other: Death|0|||
24906022|NCT00402025|50000176|FG000|Overall Study|Participant Decision|0|||
24906023|NCT00402025|50000177|FG001|Overall Study|Participant Decision|0|||
24906024|NCT00402025|50000178|FG002|Overall Study|Participant Decision|1|||
24906025|NCT00609622|50000188|FG000|Overall Study|Adverse Event|14|||
24906026|NCT00609622|50000189|FG001|Overall Study|Adverse Event|10|||
24906027|NCT00609622|50000188|FG000|Overall Study|Withdrawal by Subject|4|||
24906028|NCT00609622|50000189|FG001|Overall Study|Withdrawal by Subject|20|||
24906029|NCT00609622|50000188|FG000|Overall Study|Death|1|||
24906030|NCT00609622|50000189|FG001|Overall Study|Death|4|||
24906031|NCT00609622|50000188|FG000|Overall Study|Protocol Violation|1|||
24906032|NCT00609622|50000189|FG001|Overall Study|Protocol Violation|1|||
24906033|NCT00609622|50000188|FG000|Overall Study|Objective progression or relapse|47|||
24906034|NCT00609622|50000189|FG001|Overall Study|Objective progression or relapse|41|||
24906035|NCT00609622|50000188|FG000|Overall Study|Study terminated by sponsor|16|||
24906036|NCT00609622|50000189|FG001|Overall Study|Study terminated by sponsor|3|||
24906037|NCT00609622|50000188|FG000|Overall Study|Other|7|||
24906038|NCT00609622|50000189|FG001|Overall Study|Other|14|||
24906039|NCT00609622|50000188|FG000|Overall Study|Global deterioration of health status|6|||
24906040|NCT00609622|50000189|FG001|Overall Study|Global deterioration of health status|2|||
24906041|NCT00699816|50000197|FG000|Overall Study|Protocol Violation|1|||
24906042|NCT00699816|50000198|FG001|Overall Study|Protocol Violation|3|||
24906043|NCT00699660|50000206|FG000|Overall Study|Lost to Follow-up|4|||
24906044|NCT00699660|50000207|FG001|Overall Study|Lost to Follow-up|2|||
24906045|NCT00699660|50000206|FG000|Overall Study|missing reports and recording failures|10|||
24906046|NCT00699660|50000207|FG001|Overall Study|missing reports and recording failures|6|||
24906047|NCT00627705|50000215|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
24906048|NCT00627705|50000216|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
24906049|NCT00627705|50000215|FG000|Overall Study|Adverse Event|1|||
24906050|NCT00627705|50000216|FG001|Overall Study|Adverse Event|0|||
24906051|NCT00627705|50000215|FG000|Overall Study|Withdrawal by Subject|0|||
24906052|NCT00627705|50000216|FG001|Overall Study|Withdrawal by Subject|2|||
24906053|NCT00627705|50000215|FG000|Overall Study|Lost to Follow-up|0|||
24906054|NCT00627705|50000216|FG001|Overall Study|Lost to Follow-up|1|||
24906055|NCT00610168|50000224|FG000|Overall Study|Withdrawal by Subject|2|||
24906056|NCT00610168|50000225|FG001|Overall Study|Withdrawal by Subject|0|||
24906057|NCT00644787|50000231|FG000|Period 1: Titration Phase|Adverse Event|11|||
24906058|NCT00644787|50000232|FG001|Period 1: Titration Phase|Adverse Event|0|||
24906059|NCT00644787|50000233|FG002|Period 1: Titration Phase|Adverse Event|0|||
24906060|NCT00644787|50000231|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
24906061|NCT00644787|50000232|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
24906062|NCT00644787|50000233|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
24906063|NCT00644787|50000231|FG000|Period 1: Titration Phase|Physician Decision|1|||
24906064|NCT00644787|50000232|FG001|Period 1: Titration Phase|Physician Decision|0|||
24906065|NCT00644787|50000233|FG002|Period 1: Titration Phase|Physician Decision|0|||
24906066|NCT00644787|50000231|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
24906067|NCT00644787|50000232|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
24906068|NCT00644787|50000233|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
24906069|NCT00644787|50000231|FG000|Period 1: Titration Phase|Worsening of complications|1|||
24906070|NCT00644787|50000232|FG001|Period 1: Titration Phase|Worsening of complications|0|||
24906071|NCT00644787|50000233|FG002|Period 1: Titration Phase|Worsening of complications|0|||
24906072|NCT00644787|50000231|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
24906073|NCT00644787|50000232|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
24906074|NCT00644787|50000233|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
24906075|NCT00644787|50000231|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
24906076|NCT00644787|50000232|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
25340720|NCT00725712|50657033|FG000|Overall Study|Hospitalized, unable to continue|0|||
25340721|NCT00725712|50657034|FG001|Overall Study|Hospitalized, unable to continue|1|||
25340722|NCT00729378|50657046|FG000|Baseline|Did not complete study measurements|72|||
25340723|NCT00729378|50657047|FG001|Baseline|Did not complete study measurements|33|||
25340724|NCT00729378|50657046|FG000|Baseline|Withdrawal by Subject|66|||
25340725|NCT00729378|50657047|FG001|Baseline|Withdrawal by Subject|59|||
24906077|NCT00644787|50000233|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
24906078|NCT00644787|50000231|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
24906079|NCT00644787|50000232|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
24906080|NCT00644787|50000233|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
24906081|NCT00644787|50000231|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
24906082|NCT00644787|50000232|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
24906083|NCT00644787|50000233|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
24906084|NCT00644787|50000231|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
24906085|NCT00644787|50000232|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
24906086|NCT00644787|50000233|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
24906087|NCT00644787|50000231|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
24906088|NCT00644787|50000232|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
24906089|NCT00644787|50000233|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
24906090|NCT00644787|50000231|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
24906091|NCT00644787|50000232|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
25340726|NCT00729378|50657046|FG000|12-months|Lost to Follow-up|100|||
25340727|NCT00729378|50657047|FG001|12-months|Lost to Follow-up|65|||
25340728|NCT00729378|50657046|FG000|24-months|Lost to Follow-up|72|||
25340729|NCT00729378|50657047|FG001|24-months|Lost to Follow-up|51|||
25340730|NCT00729378|50657046|FG000|36-months|Lost to Follow-up|15|||
25340731|NCT00729378|50657047|FG001|36-months|Lost to Follow-up|6|||
25340732|NCT00478933|50657056|FG000|Overall Study|Protocol Violation|22|||
25340733|NCT00478933|50657056|FG000|Overall Study|Informed consent not verified|3|||
25340734|NCT00478933|50657056|FG000|Overall Study|Inadequate data available|53|||
24906092|NCT00644787|50000233|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
24906093|NCT00699582|50000244|FG000|Overall Study|Adverse Event|4|||
24906094|NCT00699582|50000245|FG001|Overall Study|Adverse Event|11|||
24906095|NCT00699582|50000246|FG002|Overall Study|Adverse Event|23|||
24906096|NCT00699582|50000244|FG000|Overall Study|Withdrawal by Subject|6|||
24906097|NCT00699582|50000245|FG001|Overall Study|Withdrawal by Subject|7|||
24906098|NCT00699582|50000246|FG002|Overall Study|Withdrawal by Subject|4|||
24906099|NCT00699582|50000244|FG000|Overall Study|Lack of Efficacy|1|||
24906100|NCT00699582|50000245|FG001|Overall Study|Lack of Efficacy|0|||
24906101|NCT00699582|50000246|FG002|Overall Study|Lack of Efficacy|1|||
24906102|NCT00699582|50000244|FG000|Overall Study|Progressive Disease|1|||
24906103|NCT00699582|50000245|FG001|Overall Study|Progressive Disease|0|||
24906104|NCT00699582|50000246|FG002|Overall Study|Progressive Disease|0|||
24906105|NCT00699582|50000244|FG000|Overall Study|Administrative/Other|4|||
24906106|NCT00699582|50000245|FG001|Overall Study|Administrative/Other|3|||
24906107|NCT00699582|50000246|FG002|Overall Study|Administrative/Other|0|||
24906108|NCT00699582|50000244|FG000|Overall Study|Randomized, Not Treated|2|||
24906109|NCT00699582|50000245|FG001|Overall Study|Randomized, Not Treated|1|||
24906110|NCT00699582|50000246|FG002|Overall Study|Randomized, Not Treated|0|||
24906111|NCT00640341|50000257|FG000|Overall Study|Adverse Event|0|||
24906112|NCT00640341|50000258|FG001|Overall Study|Adverse Event|0|||
24906113|NCT00640341|50000259|FG002|Overall Study|Adverse Event|1|||
24906114|NCT00640341|50000257|FG000|Overall Study|Positive Slit Lamp Findings|0|||
24906115|NCT00640341|50000258|FG001|Overall Study|Positive Slit Lamp Findings|0|||
24906116|NCT00640341|50000259|FG002|Overall Study|Positive Slit Lamp Findings|1|||
24906117|NCT00640341|50000257|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
24906118|NCT00640341|50000258|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
24906119|NCT00640341|50000259|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
24906120|NCT00640341|50000257|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
24906121|NCT00640341|50000258|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
24906122|NCT00640341|50000259|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
24906123|NCT00640341|50000257|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
24906124|NCT00640341|50000258|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
24906125|NCT00640341|50000259|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
24906126|NCT00640341|50000257|FG000|Overall Study|Lost to Follow-up|2|||
24906127|NCT00640341|50000258|FG001|Overall Study|Lost to Follow-up|0|||
24906128|NCT00640341|50000259|FG002|Overall Study|Lost to Follow-up|0|||
24906129|NCT00640341|50000257|FG000|Overall Study|Withdrawal by Subject|4|||
24906130|NCT00640341|50000258|FG001|Overall Study|Withdrawal by Subject|0|||
24906131|NCT00640341|50000259|FG002|Overall Study|Withdrawal by Subject|1|||
24906132|NCT00640341|50000257|FG000|Overall Study|Unacceptable Lens Movement|1|||
24906133|NCT00640341|50000258|FG001|Overall Study|Unacceptable Lens Movement|0|||
24906134|NCT00640341|50000259|FG002|Overall Study|Unacceptable Lens Movement|0|||
24906135|NCT00640341|50000257|FG000|Overall Study|Poor fit/Uncomfortable|4|||
24906136|NCT00640341|50000258|FG001|Overall Study|Poor fit/Uncomfortable|0|||
24906137|NCT00640341|50000259|FG002|Overall Study|Poor fit/Uncomfortable|0|||
24906138|NCT00640341|50000257|FG000|Overall Study|Ineligable at Baseline|5|||
24906139|NCT00640341|50000258|FG001|Overall Study|Ineligable at Baseline|3|||
24906140|NCT00640341|50000259|FG002|Overall Study|Ineligable at Baseline|2|||
24906141|NCT00640341|50000257|FG000|Overall Study|Adverse event and positive slit lamp|1|||
24906142|NCT00640341|50000258|FG001|Overall Study|Adverse event and positive slit lamp|0|||
24906143|NCT00640341|50000259|FG002|Overall Study|Adverse event and positive slit lamp|0|||
24906144|NCT00699348|50000267|FG000|Overall Study|Death|6|||
24906145|NCT00699348|50000267|FG000|Overall Study|Adverse Event|15|||
25340735|NCT00725322|50657082|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
24906146|NCT00699348|50000267|FG000|Overall Study|Withdrawal by Subject|11|||
24906147|NCT00699348|50000267|FG000|Overall Study|Protocol Violation|10|||
24906148|NCT00699348|50000267|FG000|Overall Study|Lack of Efficacy|8|||
24906149|NCT00699348|50000267|FG000|Overall Study|Failure to return|1|||
24906150|NCT00699348|50000267|FG000|Overall Study|Blood transfusion|24|||
24906151|NCT00699348|50000267|FG000|Overall Study|Renal transplantation|10|||
24906152|NCT00699348|50000267|FG000|Overall Study|Other|5|||
24906153|NCT00643851|50000274|FG000|Overall Study|Death|0|||
24906154|NCT00643851|50000275|FG001|Overall Study|Death|1|||
24906155|NCT00643851|50000276|FG002|Overall Study|Death|0|||
24906156|NCT00643851|50000274|FG000|Overall Study|Lack of Efficacy|0|||
24906157|NCT00643851|50000275|FG001|Overall Study|Lack of Efficacy|1|||
24906158|NCT00643851|50000276|FG002|Overall Study|Lack of Efficacy|0|||
24906159|NCT00643851|50000274|FG000|Overall Study|Adverse Event|2|||
24906160|NCT00643851|50000275|FG001|Overall Study|Adverse Event|6|||
24906161|NCT00643851|50000276|FG002|Overall Study|Adverse Event|6|||
25340736|NCT00725322|50657083|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
25340737|NCT00725322|50657082|FG000|Washout (28 Days)|Protocol Violation|0|||
25340738|NCT00725322|50657083|FG001|Washout (28 Days)|Protocol Violation|1|||
25340739|NCT00725010|50657089|FG000|Overall Study|Toxicity|9|||
25340740|NCT00725010|50657089|FG000|Overall Study|Tumor Progression|7|||
25340741|NCT00725010|50657089|FG000|Overall Study|Withdrawal by Subject|2|||
25340742|NCT00725010|50657089|FG000|Overall Study|Death|1|||
25340743|NCT00725010|50657089|FG000|Overall Study|Lost to Follow-up|1|||
25340744|NCT00725010|50657089|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
24906162|NCT00643851|50000274|FG000|Overall Study|Lost to Follow-up|4|||
24906163|NCT00643851|50000275|FG001|Overall Study|Lost to Follow-up|6|||
24906164|NCT00643851|50000276|FG002|Overall Study|Lost to Follow-up|9|||
24906165|NCT00643851|50000274|FG000|Overall Study|Withdrawal by Subject|8|||
24906166|NCT00643851|50000275|FG001|Overall Study|Withdrawal by Subject|15|||
24906167|NCT00643851|50000276|FG002|Overall Study|Withdrawal by Subject|9|||
24906168|NCT00643851|50000274|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
24906169|NCT00643851|50000275|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
24906170|NCT00643851|50000276|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
24906171|NCT03667690|50000286|FG000|Overall Study|Adverse Event|0|||
24906172|NCT03667690|50000287|FG001|Overall Study|Adverse Event|3|||
24906173|NCT03667690|50000286|FG000|Overall Study|Death|22|||
24906174|NCT03667690|50000287|FG001|Overall Study|Death|21|||
25254934|NCT01192126|50570655|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
25254935|NCT01327482|50570661|FG000|Overall Study|Adverse Event|1|||
25254936|NCT01176565|50570667|FG000|Overall Study|Lost to Follow-up|12|||
25254937|NCT01176565|50570668|FG001|Overall Study|Lost to Follow-up|16|||
25254938|NCT01176565|50570667|FG000|Overall Study|Withdrawal by Subject|7|||
25340745|NCT00725010|50657089|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
25340746|NCT00725010|50657089|FG000|Overall Study|No further documentation|1|||
25254939|NCT01176565|50570668|FG001|Overall Study|Withdrawal by Subject|1|||
25254940|NCT01176565|50570667|FG000|Overall Study|Not Analyzed (any other reason)|1|||
25254941|NCT01176565|50570668|FG001|Overall Study|Not Analyzed (any other reason)|2|||
25254942|NCT01176292|50570676|FG000|Overall Study|Lost to Follow-up|2|||
25254943|NCT01176292|50570677|FG001|Overall Study|Lost to Follow-up|4|||
25254944|NCT01176292|50570676|FG000|Overall Study|Adverse Event|1|||
25254945|NCT01176292|50570677|FG001|Overall Study|Adverse Event|1|||
25254946|NCT01176292|50570676|FG000|Overall Study|Physician Decision|0|||
25254947|NCT01176292|50570677|FG001|Overall Study|Physician Decision|2|||
25254948|NCT01176292|50570676|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
25254949|NCT01176292|50570677|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
25254950|NCT01113541|50570683|FG000|Overall Study|Withdrawal by Subject|1|||
25254951|NCT01113541|50570683|FG000|Overall Study|Protocol Violation|1|||
25254952|NCT01113541|50570683|FG000|Overall Study|Study Terminated by Sponsor|7|||
25254953|NCT01113541|50570683|FG000|Overall Study|Adverse Event|4|||
25254954|NCT01113502|50570696|FG000|Overall Study|Withdrawal by Subject|1|||
25254955|NCT01113502|50570697|FG001|Overall Study|Withdrawal by Subject|0|||
25254956|NCT01113502|50570698|FG002|Overall Study|Withdrawal by Subject|1|||
25254957|NCT01113502|50570699|FG003|Overall Study|Withdrawal by Subject|1|||
25254958|NCT01113502|50570700|FG004|Overall Study|Withdrawal by Subject|0|||
25254959|NCT01113502|50570696|FG000|Overall Study|Adverse Event|0|||
25254960|NCT01113502|50570697|FG001|Overall Study|Adverse Event|0|||
25254961|NCT01113502|50570698|FG002|Overall Study|Adverse Event|3|||
25254962|NCT01113502|50570699|FG003|Overall Study|Adverse Event|2|||
24906175|NCT03667690|50000286|FG000|Overall Study|Lost to Follow-up|4|||
25078059|NCT03745651|50186224|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
24906176|NCT03667690|50000287|FG001|Overall Study|Lost to Follow-up|5|||
25254963|NCT01113502|50570700|FG004|Overall Study|Adverse Event|0|||
25254964|NCT01113463|50570713|FG000|Overall Study|Physician Decision|5|||
25340747|NCT00725010|50657089|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
24906177|NCT03667690|50000286|FG000|Overall Study|Withdrawal by Subject|7|||
24906178|NCT03667690|50000287|FG001|Overall Study|Withdrawal by Subject|8|||
24906179|NCT03667690|50000286|FG000|Overall Study|Subject could not return for additional investigational product|1|||
24977851|NCT00077766|50066355|FG001|Overall Study|Investigators Discretion|0|||
25340748|NCT00767000|50657100|FG000|54-week Study|Adverse Event|4|||
24906180|NCT03667690|50000287|FG001|Overall Study|Subject could not return for additional investigational product|0|||
24906181|NCT03667690|50000286|FG000|Overall Study|Subject discharged to hospice care|2|||
24906182|NCT03667690|50000287|FG001|Overall Study|Subject discharged to hospice care|0|||
24906183|NCT03667690|50000286|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
24906184|NCT03667690|50000287|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
24906185|NCT03667690|50000286|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
24906186|NCT03667690|50000287|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
24906187|NCT03667690|50000286|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
24906188|NCT03667690|50000287|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
24906189|NCT03667690|50000286|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
24906190|NCT03667690|50000287|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
24906191|NCT03667690|50000286|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
24906192|NCT03667690|50000287|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
24906193|NCT00627393|50000295|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
24906194|NCT00627393|50000296|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
24906195|NCT00627393|50000295|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
24906196|NCT00627393|50000296|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
24906197|NCT00627393|50000295|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
24906198|NCT00627393|50000296|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
24906199|NCT00627393|50000295|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
24906200|NCT00627393|50000296|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
24906201|NCT00577122|50000306|FG000|Overall Study|Adverse Event|0|||
24906202|NCT00577122|50000307|FG001|Overall Study|Adverse Event|2|||
24906203|NCT00577122|50000306|FG000|Overall Study|Progression, relapse during active trt|6|||
24906204|NCT00577122|50000307|FG001|Overall Study|Progression, relapse during active trt|8|||
24906205|NCT00577122|50000306|FG000|Overall Study|Prog, refract disease during active trt|8|||
24906206|NCT00577122|50000307|FG001|Overall Study|Prog, refract disease during active trt|5|||
24906207|NCT00577122|50000306|FG000|Overall Study|Alternative Therapy|0|||
24906208|NCT00577122|50000307|FG001|Overall Study|Alternative Therapy|1|||
24906209|NCT00696774|50000317|FG000|Period II|Adverse Event|0|||
24906210|NCT00696774|50000318|FG001|Period II|Adverse Event|0|||
24906211|NCT00696774|50000319|FG002|Period II|Adverse Event|15|||
24906212|NCT00696774|50000317|FG000|Period II|Lost to Follow-up|0|||
24906213|NCT00696774|50000318|FG001|Period II|Lost to Follow-up|0|||
24906214|NCT00696774|50000319|FG002|Period II|Lost to Follow-up|4|||
24906215|NCT00696774|50000317|FG000|Period II|Protocol Violation|0|||
24906216|NCT00696774|50000318|FG001|Period II|Protocol Violation|0|||
24906217|NCT00696774|50000319|FG002|Period II|Protocol Violation|11|||
24906218|NCT00696774|50000317|FG000|Period II|Withdrawal by Subject|0|||
24906219|NCT00696774|50000318|FG001|Period II|Withdrawal by Subject|0|||
24906220|NCT00696774|50000319|FG002|Period II|Withdrawal by Subject|4|||
24906221|NCT00696774|50000317|FG000|Period II|Sponsor Decision|0|||
24906222|NCT00696774|50000318|FG001|Period II|Sponsor Decision|0|||
24906223|NCT00696774|50000319|FG002|Period II|Sponsor Decision|0|||
24906224|NCT00696774|50000317|FG000|Period II|Lack of Efficacy|0|||
24906225|NCT00696774|50000318|FG001|Period II|Lack of Efficacy|0|||
24906226|NCT00696774|50000319|FG002|Period II|Lack of Efficacy|2|||
24906227|NCT00696774|50000317|FG000|Period III|Adverse Event|1|||
24906228|NCT00696774|50000318|FG001|Period III|Adverse Event|1|||
24906229|NCT00696774|50000319|FG002|Period III|Adverse Event|0|||
24906230|NCT00696774|50000317|FG000|Period III|Lost to Follow-up|2|||
24906231|NCT00696774|50000318|FG001|Period III|Lost to Follow-up|1|||
25078060|NCT03745651|50186225|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
25078061|NCT03745651|50186226|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
25254965|NCT01112917|50570717|FG000|Overall Study|Death|2|||
25254966|NCT01112917|50570718|FG001|Overall Study|Death|11|||
25254967|NCT01112917|50570717|FG000|Overall Study|Lost to Follow-up|1|||
25254968|NCT01112917|50570718|FG001|Overall Study|Lost to Follow-up|1|||
25254969|NCT01112917|50570717|FG000|Overall Study|Withdrawal by Subject|1|||
25254970|NCT01112917|50570718|FG001|Overall Study|Withdrawal by Subject|3|||
25254971|NCT01112917|50570717|FG000|Overall Study|Unable to Convert Filter|3|||
25254972|NCT01112917|50570718|FG001|Overall Study|Unable to Convert Filter|0|||
25254973|NCT01176058|50570724|FG000|Overall Study|Adverse Event|1|||
25254974|NCT01176058|50570725|FG001|Overall Study|Adverse Event|0|||
25254975|NCT01176058|50570724|FG000|Overall Study|Insufficient clinical response|2|||
25254976|NCT01176058|50570725|FG001|Overall Study|Insufficient clinical response|2|||
25254977|NCT01176058|50570724|FG000|Overall Study|Insufficient mycological response|0|||
25254978|NCT01176058|50570725|FG001|Overall Study|Insufficient mycological response|1|||
25254979|NCT01176058|50570724|FG000|Overall Study|Withdrawal by Subject|1|||
25254980|NCT01176058|50570725|FG001|Overall Study|Withdrawal by Subject|0|||
24906232|NCT00696774|50000319|FG002|Period III|Lost to Follow-up|0|||
24906233|NCT00696774|50000317|FG000|Period III|Protocol Violation|1|||
24906234|NCT00696774|50000318|FG001|Period III|Protocol Violation|1|||
24906235|NCT00696774|50000319|FG002|Period III|Protocol Violation|0|||
24906236|NCT00696774|50000317|FG000|Period III|Withdrawal by Subject|1|||
24906237|NCT00696774|50000318|FG001|Period III|Withdrawal by Subject|2|||
24906238|NCT00696774|50000319|FG002|Period III|Withdrawal by Subject|0|||
24906239|NCT00696774|50000317|FG000|Period III|Sponsor Decision|2|||
24906240|NCT00696774|50000318|FG001|Period III|Sponsor Decision|0|||
24906241|NCT00696774|50000319|FG002|Period III|Sponsor Decision|0|||
24906242|NCT00696774|50000317|FG000|Period III|Lack of Efficacy|0|||
24906243|NCT00696774|50000318|FG001|Period III|Lack of Efficacy|2|||
24906244|NCT00696774|50000319|FG002|Period III|Lack of Efficacy|0|||
24906245|NCT00608842|50000331|FG000|Overall Study|Participant's Request|0|||
24906246|NCT00608842|50000332|FG001|Overall Study|Participant's Request|1|||
24906247|NCT00608842|50000333|FG002|Overall Study|Participant's Request|2|||
24906248|NCT00608842|50000334|FG003|Overall Study|Participant's Request|1|||
24906249|NCT00608842|50000331|FG000|Overall Study|Lost to Follow-up|1|||
24977852|NCT00077766|50066354|FG000|Overall Study|Participant's decision|1|||
24977853|NCT00077766|50066355|FG001|Overall Study|Participant's decision|0|||
24977854|NCT00077766|50066354|FG000|Overall Study|Dialysis Discontinued|1|||
24977855|NCT00077766|50066355|FG001|Overall Study|Dialysis Discontinued|0|||
24977856|NCT00077766|50066354|FG000|Overall Study|Dialysis|0|||
24977857|NCT00077766|50066355|FG001|Overall Study|Dialysis|1|||
24977858|NCT00077766|50066354|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
24977859|NCT00077766|50066355|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
24977860|NCT00077766|50066354|FG000|Overall Study|Started Nocturnal Dialysis|0|||
24977861|NCT00077766|50066355|FG001|Overall Study|Started Nocturnal Dialysis|1|||
24977862|NCT00077766|50066354|FG000|Overall Study|Stop Dialysis|0|||
24977863|NCT00077766|50066355|FG001|Overall Study|Stop Dialysis|1|||
24977864|NCT00077766|50066354|FG000|Overall Study|Participants Vacation|2|||
24977865|NCT00077766|50066355|FG001|Overall Study|Participants Vacation|1|||
24977866|NCT03799718|50066362|FG000|Overall Study|Adverse Event|2|||
24977867|NCT03388138|50066368|FG000|Overall Study|Protocol Violation|1|||
24977868|NCT03388138|50066369|FG001|Overall Study|Protocol Violation|0|||
24977869|NCT02952898|50066378|FG000|Overall Study|Withdrawal by Subject|10|||
24977870|NCT02952898|50066379|FG001|Overall Study|Withdrawal by Subject|8|||
24977871|NCT02952898|50066380|FG002|Overall Study|Withdrawal by Subject|8|||
24977872|NCT02952898|50066378|FG000|Overall Study|Adverse Event|8|||
25340749|NCT00767000|50657101|FG001|54-week Study|Adverse Event|6|||
25340750|NCT00767000|50657102|FG002|54-week Study|Adverse Event|6|||
25340751|NCT00767000|50657103|FG003|54-week Study|Adverse Event|8|||
25340752|NCT00767000|50657104|FG004|54-week Study|Adverse Event|4|||
25340753|NCT00767000|50657100|FG000|54-week Study|Creaninine/creatinine clearance|2|||
25340754|NCT00767000|50657101|FG001|54-week Study|Creaninine/creatinine clearance|1|||
25340755|NCT00767000|50657102|FG002|54-week Study|Creaninine/creatinine clearance|2|||
25340756|NCT00767000|50657103|FG003|54-week Study|Creaninine/creatinine clearance|2|||
25340757|NCT00767000|50657104|FG004|54-week Study|Creaninine/creatinine clearance|4|||
25340758|NCT00767000|50657100|FG000|54-week Study|Hyperglycemia|0|||
25340759|NCT00767000|50657101|FG001|54-week Study|Hyperglycemia|0|||
25340760|NCT00767000|50657102|FG002|54-week Study|Hyperglycemia|1|||
25340761|NCT00767000|50657103|FG003|54-week Study|Hyperglycemia|0|||
25340762|NCT00767000|50657104|FG004|54-week Study|Hyperglycemia|1|||
25340763|NCT00767000|50657100|FG000|54-week Study|Hypoglycemia|0|||
25340764|NCT00767000|50657101|FG001|54-week Study|Hypoglycemia|1|||
25340765|NCT00767000|50657102|FG002|54-week Study|Hypoglycemia|0|||
25340766|NCT00767000|50657103|FG003|54-week Study|Hypoglycemia|0|||
25340767|NCT00767000|50657104|FG004|54-week Study|Hypoglycemia|0|||
25340768|NCT00767000|50657100|FG000|54-week Study|Interruption of study medication|0|||
25340769|NCT00767000|50657101|FG001|54-week Study|Interruption of study medication|0|||
25340770|NCT00767000|50657102|FG002|54-week Study|Interruption of study medication|1|||
25340771|NCT00767000|50657103|FG003|54-week Study|Interruption of study medication|0|||
24906250|NCT00608842|50000332|FG001|Overall Study|Lost to Follow-up|0|||
24906251|NCT00608842|50000333|FG002|Overall Study|Lost to Follow-up|0|||
24906252|NCT00608842|50000334|FG003|Overall Study|Lost to Follow-up|0|||
24977873|NCT02952898|50066379|FG001|Overall Study|Adverse Event|8|||
24977874|NCT02952898|50066380|FG002|Overall Study|Adverse Event|3|||
24977875|NCT02952898|50066378|FG000|Overall Study|Lost to Follow-up|3|||
24977876|NCT02952898|50066379|FG001|Overall Study|Lost to Follow-up|2|||
24977877|NCT02952898|50066380|FG002|Overall Study|Lost to Follow-up|2|||
24977878|NCT02952898|50066378|FG000|Overall Study|Non-compliance with study drug|1|||
24977879|NCT02952898|50066379|FG001|Overall Study|Non-compliance with study drug|1|||
24977880|NCT02952898|50066380|FG002|Overall Study|Non-compliance with study drug|2|||
25340772|NCT00767000|50657104|FG004|54-week Study|Interruption of study medication|0|||
25340773|NCT00767000|50657100|FG000|54-week Study|Lack of Efficacy|2|||
25340774|NCT00767000|50657101|FG001|54-week Study|Lack of Efficacy|0|||
25340775|NCT00767000|50657102|FG002|54-week Study|Lack of Efficacy|1|||
25340776|NCT00767000|50657103|FG003|54-week Study|Lack of Efficacy|0|||
25340777|NCT00767000|50657104|FG004|54-week Study|Lack of Efficacy|5|||
25340778|NCT00767000|50657100|FG000|54-week Study|Lost to Follow-up|4|||
25340779|NCT00767000|50657101|FG001|54-week Study|Lost to Follow-up|0|||
25340780|NCT00767000|50657102|FG002|54-week Study|Lost to Follow-up|1|||
25340781|NCT00767000|50657103|FG003|54-week Study|Lost to Follow-up|4|||
24906253|NCT00626925|50000346|FG000|Overall Study|Lost to Follow-up|1|||
24906254|NCT00626925|50000347|FG001|Overall Study|Lost to Follow-up|2|||
24906255|NCT00626925|50000346|FG000|Overall Study|relapse|1|||
24906256|NCT00626925|50000347|FG001|Overall Study|relapse|0|||
24906257|NCT00626925|50000346|FG000|Overall Study|Adverse effect|6|||
24906258|NCT00626925|50000347|FG001|Overall Study|Adverse effect|2|||
24906259|NCT00626925|50000346|FG000|Overall Study|Lack of Efficacy|1|||
24906260|NCT00626925|50000347|FG001|Overall Study|Lack of Efficacy|4|||
24906261|NCT00626925|50000346|FG000|Overall Study|Time constraints|3|||
24906262|NCT00626925|50000347|FG001|Overall Study|Time constraints|1|||
24906263|NCT00698646|50000370|FG000|Overall Study|Adverse Event|8|||
24906264|NCT00698646|50000371|FG001|Overall Study|Adverse Event|7|||
24906265|NCT00698646|50000372|FG002|Overall Study|Adverse Event|8|||
24906266|NCT00698646|50000370|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
24906267|NCT00698646|50000371|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
24906268|NCT00698646|50000372|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
24906269|NCT00698646|50000370|FG000|Overall Study|Protocol Deviation|6|||
24906270|NCT00698646|50000371|FG001|Overall Study|Protocol Deviation|2|||
24906271|NCT00698646|50000372|FG002|Overall Study|Protocol Deviation|3|||
24906272|NCT00698646|50000370|FG000|Overall Study|Withdrawal by Subject|10|||
24906273|NCT00698646|50000371|FG001|Overall Study|Withdrawal by Subject|11|||
24906274|NCT00698646|50000372|FG002|Overall Study|Withdrawal by Subject|8|||
24906275|NCT00698646|50000370|FG000|Overall Study|Lost to Follow-up|0|||
24906276|NCT00698646|50000371|FG001|Overall Study|Lost to Follow-up|0|||
24906277|NCT00698646|50000372|FG002|Overall Study|Lost to Follow-up|2|||
24906278|NCT00698646|50000370|FG000|Overall Study|Administrative problems|1|||
24906279|NCT00698646|50000371|FG001|Overall Study|Administrative problems|0|||
24906280|NCT00698646|50000372|FG002|Overall Study|Administrative problems|1|||
24906281|NCT00609466|50000383|FG000|Overall Study|Withdrawal by Subject|0|||
24977881|NCT00045734|50066388|FG000|Overall Study|Protocol Violation|1|||
24977882|NCT03387046|50066394|FG000|Overall Study|Adverse Event|1|||
24977883|NCT03387046|50066395|FG001|Overall Study|Adverse Event|1|||
24977884|NCT00045110|50066404|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
24977885|NCT00045110|50066405|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
24977886|NCT00045110|50066406|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
24977887|NCT00045110|50066404|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
24977888|NCT00045110|50066405|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
24977889|NCT00045110|50066406|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
24977890|NCT00045110|50066404|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
24977891|NCT00045110|50066405|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
24977892|NCT00045110|50066406|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
24977893|NCT03353740|50066423|FG000|Overall Study|Images for these participants not viable|52|||
24977894|NCT00003476|50066427|FG000|Overall Study|Not evaluable|1|||
25340782|NCT00767000|50657104|FG004|54-week Study|Lost to Follow-up|2|||
25340783|NCT00767000|50657100|FG000|54-week Study|Physician Decision|4|||
25340784|NCT00767000|50657101|FG001|54-week Study|Physician Decision|0|||
25340785|NCT00767000|50657102|FG002|54-week Study|Physician Decision|1|||
25340786|NCT00767000|50657103|FG003|54-week Study|Physician Decision|1|||
25340787|NCT00767000|50657104|FG004|54-week Study|Physician Decision|1|||
25340788|NCT00767000|50657100|FG000|54-week Study|Progressive disease|0|||
24906282|NCT00609466|50000384|FG001|Overall Study|Withdrawal by Subject|1|||
24906283|NCT00609466|50000385|FG002|Overall Study|Withdrawal by Subject|1|||
24906284|NCT00609466|50000383|FG000|Overall Study|Adverse Event|2|||
24906285|NCT00609466|50000384|FG001|Overall Study|Adverse Event|3|||
24906286|NCT00609466|50000385|FG002|Overall Study|Adverse Event|1|||
24906287|NCT00609466|50000383|FG000|Overall Study|Lack of Efficacy|0|||
24906288|NCT00609466|50000384|FG001|Overall Study|Lack of Efficacy|2|||
24906289|NCT00609466|50000385|FG002|Overall Study|Lack of Efficacy|2|||
24977895|NCT00003470|50066431|FG000|Overall Study|Not evaluable|6|||
24977896|NCT03386344|50066438|FG000|Overall Study|Adverse Event|6|||
25340789|NCT00767000|50657101|FG001|54-week Study|Progressive disease|0|||
25340790|NCT00767000|50657102|FG002|54-week Study|Progressive disease|1|||
25340791|NCT00767000|50657103|FG003|54-week Study|Progressive disease|0|||
24906290|NCT00608530|50000397|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
24906291|NCT00608530|50000398|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
24906292|NCT00608530|50000399|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
24906293|NCT00608530|50000400|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
24906294|NCT00608530|50000397|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
24906295|NCT00608530|50000398|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
25340792|NCT00767000|50657104|FG004|54-week Study|Progressive disease|0|||
25340793|NCT00767000|50657100|FG000|54-week Study|Protocol Violation|0|||
24906296|NCT00608530|50000399|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
24906297|NCT00608530|50000400|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
24906298|NCT00608530|50000397|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
24906299|NCT00608530|50000398|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
24906300|NCT00608530|50000399|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
24906301|NCT00608530|50000400|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
24906302|NCT00608530|50000397|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
24906303|NCT00608530|50000398|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
24906304|NCT00608530|50000399|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
24906305|NCT00608530|50000400|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
24906306|NCT00608530|50000397|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
24906307|NCT00608530|50000398|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
24906308|NCT00608530|50000399|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
24906309|NCT00608530|50000400|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
24906310|NCT00608530|50000397|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
24906311|NCT00608530|50000398|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
24906312|NCT00608530|50000399|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
24906313|NCT00608530|50000400|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
24906314|NCT00642993|50000417|FG000|Overall Study|Adverse Event|85|||
24906315|NCT00642993|50000418|FG001|Overall Study|Adverse Event|4|||
24906316|NCT00642993|50000417|FG000|Overall Study|Lost to Follow-up|8|||
24906317|NCT00642993|50000418|FG001|Overall Study|Lost to Follow-up|4|||
24906318|NCT00642993|50000417|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
24906319|NCT00642993|50000418|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
24906320|NCT00642993|50000417|FG000|Overall Study|Protocol Violation|1|||
24906321|NCT00642993|50000418|FG001|Overall Study|Protocol Violation|4|||
24906322|NCT00642993|50000417|FG000|Overall Study|Did not meet protocol eligibility|0|||
24906323|NCT00642993|50000418|FG001|Overall Study|Did not meet protocol eligibility|1|||
24906324|NCT00642993|50000417|FG000|Overall Study|Administrative|1|||
24906325|NCT00642993|50000418|FG001|Overall Study|Administrative|0|||
24906326|NCT00696696|50000424|FG000|Overall Study|Adverse Event|5|||
24906327|NCT00696696|50000424|FG000|Overall Study|Withdrawal by Subject|8|||
24906328|NCT00696696|50000424|FG000|Overall Study|Physician Decision|2|||
24906329|NCT00696696|50000424|FG000|Overall Study|Death|3|||
24906330|NCT00699192|50000431|FG000|Overall Study|Missing|1|||
24906331|NCT00699192|50000432|FG001|Overall Study|Missing|1|||
24906332|NCT00699192|50000433|FG002|Overall Study|Missing|1|||
24906333|NCT00699192|50000431|FG000|Overall Study|Adverse Event|9|||
24906334|NCT00699192|50000432|FG001|Overall Study|Adverse Event|4|||
24906335|NCT00699192|50000433|FG002|Overall Study|Adverse Event|3|||
24906336|NCT00699192|50000431|FG000|Overall Study|Abnormal test procedure result(s)|0|||
24906337|NCT00699192|50000432|FG001|Overall Study|Abnormal test procedure result(s)|0|||
24906338|NCT00699192|50000433|FG002|Overall Study|Abnormal test procedure result(s)|1|||
24906339|NCT00699192|50000431|FG000|Overall Study|Lack of Efficacy|0|||
24906340|NCT00699192|50000432|FG001|Overall Study|Lack of Efficacy|0|||
24906341|NCT00699192|50000433|FG002|Overall Study|Lack of Efficacy|1|||
24906342|NCT00699192|50000431|FG000|Overall Study|Withdrawal by Subject|3|||
24906343|NCT00699192|50000432|FG001|Overall Study|Withdrawal by Subject|2|||
24906344|NCT00699192|50000433|FG002|Overall Study|Withdrawal by Subject|4|||
24906345|NCT00699192|50000431|FG000|Overall Study|Administrative problems|1|||
24906346|NCT00699192|50000432|FG001|Overall Study|Administrative problems|3|||
24906347|NCT00699192|50000433|FG002|Overall Study|Administrative problems|1|||
24906348|NCT00699192|50000431|FG000|Overall Study|Protocol Violation|2|||
24906349|NCT00699192|50000432|FG001|Overall Study|Protocol Violation|2|||
24906350|NCT00699192|50000433|FG002|Overall Study|Protocol Violation|0|||
24906351|NCT00401245|50000449|FG000|Double Blind Titration Phase|Adverse Event|3|||
24906352|NCT00401245|50000450|FG001|Double Blind Titration Phase|Adverse Event|2|||
24906353|NCT00401245|50000451|FG002|Double Blind Titration Phase|Adverse Event|5|||
24906354|NCT00401245|50000452|FG003|Double Blind Titration Phase|Adverse Event|12|||
24906355|NCT00401245|50000453|FG004|Double Blind Titration Phase|Adverse Event|0|||
24906356|NCT00401245|50000454|FG005|Double Blind Titration Phase|Adverse Event|0|||
24906357|NCT00401245|50000455|FG006|Double Blind Titration Phase|Adverse Event|0|||
24906358|NCT00401245|50000456|FG007|Double Blind Titration Phase|Adverse Event|0|||
24906359|NCT00401245|50000449|FG000|Double Blind Titration Phase|Other|0|||
24977897|NCT03386344|50066439|FG001|Overall Study|Adverse Event|3|||
24977898|NCT03386344|50066440|FG002|Overall Study|Adverse Event|1|||
24977899|NCT03386344|50066438|FG000|Overall Study|Poor Compliance to Protocol|0|||
24977900|NCT03386344|50066439|FG001|Overall Study|Poor Compliance to Protocol|1|||
24906360|NCT00401245|50000450|FG001|Double Blind Titration Phase|Other|0|||
24906361|NCT00401245|50000451|FG002|Double Blind Titration Phase|Other|1|||
24906362|NCT00401245|50000452|FG003|Double Blind Titration Phase|Other|0|||
24906363|NCT00401245|50000453|FG004|Double Blind Titration Phase|Other|0|||
24906364|NCT00401245|50000454|FG005|Double Blind Titration Phase|Other|0|||
24906365|NCT00401245|50000455|FG006|Double Blind Titration Phase|Other|0|||
25340794|NCT00767000|50657101|FG001|54-week Study|Protocol Violation|0|||
25340795|NCT00767000|50657102|FG002|54-week Study|Protocol Violation|1|||
25340796|NCT00767000|50657103|FG003|54-week Study|Protocol Violation|2|||
25340797|NCT00767000|50657104|FG004|54-week Study|Protocol Violation|0|||
25340798|NCT00767000|50657100|FG000|54-week Study|Withdrawal by Subject|2|||
25340799|NCT00767000|50657101|FG001|54-week Study|Withdrawal by Subject|3|||
25340800|NCT00767000|50657102|FG002|54-week Study|Withdrawal by Subject|5|||
25340801|NCT00767000|50657103|FG003|54-week Study|Withdrawal by Subject|11|||
25340802|NCT00767000|50657104|FG004|54-week Study|Withdrawal by Subject|13|||
25340803|NCT00767000|50657100|FG000|54-week Study|Study terminated by sponsor|90|||
25340804|NCT00767000|50657101|FG001|54-week Study|Study terminated by sponsor|102|||
25340805|NCT00767000|50657102|FG002|54-week Study|Study terminated by sponsor|89|||
25340806|NCT00767000|50657103|FG003|54-week Study|Study terminated by sponsor|196|||
25340807|NCT00767000|50657104|FG004|54-week Study|Study terminated by sponsor|194|||
25340808|NCT00767000|50657100|FG000|54-week Study|Reason not reported|0|||
25340809|NCT00767000|50657101|FG001|54-week Study|Reason not reported|0|||
25340810|NCT00767000|50657102|FG002|54-week Study|Reason not reported|0|||
25340811|NCT00767000|50657103|FG003|54-week Study|Reason not reported|1|||
25340812|NCT00767000|50657104|FG004|54-week Study|Reason not reported|0|||
25340813|NCT00767000|50657100|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
25340814|NCT00767000|50657101|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
24906366|NCT00401245|50000456|FG007|Double Blind Titration Phase|Other|0|||
24906367|NCT00401245|50000449|FG000|Double Blind Titration Phase|Protocol Violation|0|||
24906368|NCT00401245|50000450|FG001|Double Blind Titration Phase|Protocol Violation|0|||
24906369|NCT00401245|50000451|FG002|Double Blind Titration Phase|Protocol Violation|0|||
24906370|NCT00401245|50000452|FG003|Double Blind Titration Phase|Protocol Violation|1|||
24906371|NCT00401245|50000453|FG004|Double Blind Titration Phase|Protocol Violation|0|||
24906372|NCT00401245|50000454|FG005|Double Blind Titration Phase|Protocol Violation|0|||
24906373|NCT00401245|50000455|FG006|Double Blind Titration Phase|Protocol Violation|0|||
24906374|NCT00401245|50000456|FG007|Double Blind Titration Phase|Protocol Violation|0|||
24906375|NCT00401245|50000449|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
24906376|NCT00401245|50000450|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
24906377|NCT00401245|50000451|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
24906378|NCT00401245|50000452|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
24906379|NCT00401245|50000453|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
24906380|NCT00401245|50000454|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
24906381|NCT00401245|50000455|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
24906382|NCT00401245|50000456|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
24906383|NCT00401245|50000449|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
24906384|NCT00401245|50000450|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
24906385|NCT00401245|50000451|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
24906386|NCT00401245|50000452|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
24906387|NCT00401245|50000453|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
24906388|NCT00401245|50000454|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
24906389|NCT00401245|50000455|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
24906390|NCT00401245|50000456|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
24906391|NCT00401245|50000449|FG000|Open Label Phase|Adverse Event|5|||
24906392|NCT00401245|50000450|FG001|Open Label Phase|Adverse Event|14|||
24906393|NCT00401245|50000451|FG002|Open Label Phase|Adverse Event|6|||
24906394|NCT00401245|50000452|FG003|Open Label Phase|Adverse Event|7|||
24906395|NCT00401245|50000453|FG004|Open Label Phase|Adverse Event|0|||
24906396|NCT00401245|50000454|FG005|Open Label Phase|Adverse Event|0|||
24906397|NCT00401245|50000455|FG006|Open Label Phase|Adverse Event|0|||
24906398|NCT00401245|50000456|FG007|Open Label Phase|Adverse Event|0|||
24906399|NCT00401245|50000449|FG000|Open Label Phase|Lost to Follow-up|5|||
24906400|NCT00401245|50000450|FG001|Open Label Phase|Lost to Follow-up|7|||
24906401|NCT00401245|50000451|FG002|Open Label Phase|Lost to Follow-up|5|||
24906402|NCT00401245|50000452|FG003|Open Label Phase|Lost to Follow-up|4|||
24906403|NCT00401245|50000453|FG004|Open Label Phase|Lost to Follow-up|0|||
24906404|NCT00401245|50000454|FG005|Open Label Phase|Lost to Follow-up|0|||
24906405|NCT00401245|50000455|FG006|Open Label Phase|Lost to Follow-up|0|||
24906406|NCT00401245|50000456|FG007|Open Label Phase|Lost to Follow-up|0|||
24906407|NCT00401245|50000449|FG000|Open Label Phase|Other|4|||
24906408|NCT00401245|50000450|FG001|Open Label Phase|Other|8|||
24906409|NCT00401245|50000451|FG002|Open Label Phase|Other|7|||
24906410|NCT00401245|50000452|FG003|Open Label Phase|Other|8|||
24906411|NCT00401245|50000453|FG004|Open Label Phase|Other|0|||
24906412|NCT00401245|50000454|FG005|Open Label Phase|Other|0|||
25340815|NCT00767000|50657102|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
25340816|NCT00767000|50657103|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
25340817|NCT00767000|50657104|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
24906413|NCT00401245|50000455|FG006|Open Label Phase|Other|0|||
24906414|NCT00401245|50000456|FG007|Open Label Phase|Other|0|||
24906415|NCT00401245|50000449|FG000|Open Label Phase|Protocol Violation|0|||
24906416|NCT00401245|50000450|FG001|Open Label Phase|Protocol Violation|1|||
24906417|NCT00401245|50000451|FG002|Open Label Phase|Protocol Violation|0|||
24906418|NCT00401245|50000452|FG003|Open Label Phase|Protocol Violation|1|||
24906419|NCT00401245|50000453|FG004|Open Label Phase|Protocol Violation|0|||
24906420|NCT00401245|50000454|FG005|Open Label Phase|Protocol Violation|0|||
24906421|NCT00401245|50000455|FG006|Open Label Phase|Protocol Violation|0|||
24906422|NCT00401245|50000456|FG007|Open Label Phase|Protocol Violation|0|||
24906423|NCT00401245|50000449|FG000|Open Label Phase|Withdrawal by Subject|3|||
24906424|NCT00401245|50000450|FG001|Open Label Phase|Withdrawal by Subject|3|||
24906425|NCT00401245|50000451|FG002|Open Label Phase|Withdrawal by Subject|2|||
24906426|NCT00401245|50000452|FG003|Open Label Phase|Withdrawal by Subject|1|||
24906427|NCT00401245|50000453|FG004|Open Label Phase|Withdrawal by Subject|0|||
24906428|NCT00401245|50000454|FG005|Open Label Phase|Withdrawal by Subject|0|||
24906429|NCT00401245|50000455|FG006|Open Label Phase|Withdrawal by Subject|0|||
24906430|NCT00401245|50000456|FG007|Open Label Phase|Withdrawal by Subject|0|||
24906431|NCT00401245|50000449|FG000|Open Label Phase|Lack of Efficacy|4|||
24906432|NCT00401245|50000450|FG001|Open Label Phase|Lack of Efficacy|2|||
24906433|NCT00401245|50000451|FG002|Open Label Phase|Lack of Efficacy|3|||
24906434|NCT00401245|50000452|FG003|Open Label Phase|Lack of Efficacy|0|||
24906435|NCT00401245|50000453|FG004|Open Label Phase|Lack of Efficacy|0|||
24906436|NCT00401245|50000454|FG005|Open Label Phase|Lack of Efficacy|0|||
24906437|NCT00401245|50000455|FG006|Open Label Phase|Lack of Efficacy|0|||
24906438|NCT00401245|50000456|FG007|Open Label Phase|Lack of Efficacy|0|||
24906439|NCT00401245|50000449|FG000|Double Blind Tapering Phase|Adverse Event|0|||
24906440|NCT00401245|50000450|FG001|Double Blind Tapering Phase|Adverse Event|0|||
24906441|NCT00401245|50000451|FG002|Double Blind Tapering Phase|Adverse Event|0|||
24906442|NCT00401245|50000452|FG003|Double Blind Tapering Phase|Adverse Event|0|||
25254981|NCT01175824|50570733|FG000|Overall Study|Adverse Event|2|||
24906443|NCT00401245|50000453|FG004|Double Blind Tapering Phase|Adverse Event|1|||
24906444|NCT00401245|50000454|FG005|Double Blind Tapering Phase|Adverse Event|1|||
24906445|NCT00401245|50000455|FG006|Double Blind Tapering Phase|Adverse Event|2|||
24906446|NCT00401245|50000456|FG007|Double Blind Tapering Phase|Adverse Event|4|||
24906447|NCT00401245|50000449|FG000|Double Blind Tapering Phase|Investigator request|0|||
24906448|NCT00401245|50000450|FG001|Double Blind Tapering Phase|Investigator request|0|||
24906449|NCT00401245|50000451|FG002|Double Blind Tapering Phase|Investigator request|0|||
24906450|NCT00401245|50000452|FG003|Double Blind Tapering Phase|Investigator request|0|||
24906451|NCT00401245|50000453|FG004|Double Blind Tapering Phase|Investigator request|0|||
24906452|NCT00401245|50000454|FG005|Double Blind Tapering Phase|Investigator request|0|||
24906453|NCT00401245|50000455|FG006|Double Blind Tapering Phase|Investigator request|0|||
24906454|NCT00401245|50000456|FG007|Double Blind Tapering Phase|Investigator request|1|||
24906455|NCT00401245|50000449|FG000|Double Blind Tapering Phase|Other|0|||
24906456|NCT00401245|50000450|FG001|Double Blind Tapering Phase|Other|0|||
24906457|NCT00401245|50000451|FG002|Double Blind Tapering Phase|Other|0|||
24906458|NCT00401245|50000452|FG003|Double Blind Tapering Phase|Other|0|||
24906459|NCT00401245|50000453|FG004|Double Blind Tapering Phase|Other|1|||
24906460|NCT00401245|50000454|FG005|Double Blind Tapering Phase|Other|0|||
24906461|NCT00401245|50000455|FG006|Double Blind Tapering Phase|Other|2|||
24906462|NCT00401245|50000456|FG007|Double Blind Tapering Phase|Other|2|||
24906463|NCT00401245|50000449|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
24906464|NCT00401245|50000450|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
24906465|NCT00401245|50000451|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
24906466|NCT00401245|50000452|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
24906467|NCT00401245|50000453|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
24906468|NCT00401245|50000454|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
24906469|NCT00401245|50000455|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
24906470|NCT00401245|50000456|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
24906471|NCT00401245|50000449|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
24906472|NCT00401245|50000450|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
24906473|NCT00401245|50000451|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
24906474|NCT00401245|50000452|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
24906475|NCT00401245|50000453|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
24906476|NCT00401245|50000454|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
24906477|NCT00401245|50000455|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
24906478|NCT00401245|50000456|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
24906479|NCT00696384|50000476|FG000|Open Label Phase|Adverse Event|27|||
24906480|NCT00696384|50000477|FG001|Open Label Phase|Adverse Event|0|||
24906481|NCT00696384|50000478|FG002|Open Label Phase|Adverse Event|0|||
24906482|NCT00696384|50000476|FG000|Open Label Phase|Protocol Violation|18|||
24906483|NCT00696384|50000477|FG001|Open Label Phase|Protocol Violation|0|||
24906484|NCT00696384|50000478|FG002|Open Label Phase|Protocol Violation|0|||
25254982|NCT01175824|50570734|FG001|Overall Study|Adverse Event|1|||
25254983|NCT01175824|50570733|FG000|Overall Study|Lack of Efficacy|2|||
24906485|NCT00696384|50000476|FG000|Open Label Phase|Lost to Follow-up|24|||
24906486|NCT00696384|50000477|FG001|Open Label Phase|Lost to Follow-up|0|||
24906487|NCT00696384|50000478|FG002|Open Label Phase|Lost to Follow-up|0|||
24906488|NCT00696384|50000476|FG000|Open Label Phase|Withdrawal by Subject|37|||
24906489|NCT00696384|50000477|FG001|Open Label Phase|Withdrawal by Subject|0|||
24906490|NCT00696384|50000478|FG002|Open Label Phase|Withdrawal by Subject|0|||
24906491|NCT00696384|50000476|FG000|Open Label Phase|Other|6|||
24906492|NCT00696384|50000477|FG001|Open Label Phase|Other|0|||
24906493|NCT00696384|50000478|FG002|Open Label Phase|Other|0|||
24906494|NCT00696384|50000476|FG000|Open Label Phase|Lack of Efficacy|3|||
24906495|NCT00696384|50000477|FG001|Open Label Phase|Lack of Efficacy|0|||
24906496|NCT00696384|50000478|FG002|Open Label Phase|Lack of Efficacy|0|||
24906497|NCT00696384|50000476|FG000|Open Label Phase|Physician Decision|4|||
24906498|NCT00696384|50000477|FG001|Open Label Phase|Physician Decision|0|||
24906499|NCT00696384|50000478|FG002|Open Label Phase|Physician Decision|0|||
24906500|NCT00696384|50000476|FG000|Double Blind Phase|Adverse Event|0|||
24906501|NCT00696384|50000477|FG001|Double Blind Phase|Adverse Event|2|||
24906502|NCT00696384|50000478|FG002|Double Blind Phase|Adverse Event|2|||
24906503|NCT00696384|50000476|FG000|Double Blind Phase|Lost to Follow-up|0|||
24906504|NCT00696384|50000477|FG001|Double Blind Phase|Lost to Follow-up|2|||
24906505|NCT00696384|50000478|FG002|Double Blind Phase|Lost to Follow-up|1|||
24906506|NCT00696384|50000476|FG000|Double Blind Phase|Withdrawal by Subject|0|||
24906507|NCT00696384|50000477|FG001|Double Blind Phase|Withdrawal by Subject|4|||
24906508|NCT00696384|50000478|FG002|Double Blind Phase|Withdrawal by Subject|3|||
24906509|NCT00696384|50000476|FG000|Double Blind Phase|Lack of Efficacy|0|||
24906510|NCT00696384|50000477|FG001|Double Blind Phase|Lack of Efficacy|1|||
25340818|NCT00724932|50657118|FG000|Overall Study|Lost to Follow-up|1|||
25340819|NCT00724932|50657119|FG001|Overall Study|Lost to Follow-up|0|||
25340820|NCT00724932|50657118|FG000|Overall Study|Not treated|4|||
25340821|NCT00724932|50657119|FG001|Overall Study|Not treated|3|||
24906511|NCT00696384|50000478|FG002|Double Blind Phase|Lack of Efficacy|0|||
24906512|NCT00696384|50000476|FG000|Double Blind Phase|Physician Decision|0|||
24906513|NCT00696384|50000477|FG001|Double Blind Phase|Physician Decision|2|||
24906514|NCT00696384|50000478|FG002|Double Blind Phase|Physician Decision|0|||
24906515|NCT00636675|50000489|FG000|Overall Study|Lost to Follow-up|121|||
24906516|NCT00636675|50000490|FG001|Overall Study|Lost to Follow-up|31|||
24906517|NCT00636675|50000489|FG000|Overall Study|Withdrawal by Subject|19|||
24906518|NCT00636675|50000490|FG001|Overall Study|Withdrawal by Subject|10|||
24906519|NCT00699998|50000500|FG000|Overall Study|Withdrawal by Subject|194|||
24906520|NCT00699998|50000501|FG001|Overall Study|Withdrawal by Subject|83|||
24906521|NCT00699998|50000502|FG002|Overall Study|Withdrawal by Subject|202|||
24906522|NCT00699998|50000503|FG003|Overall Study|Withdrawal by Subject|80|||
24906523|NCT00699998|50000500|FG000|Overall Study|Physician Decision|3|||
24906524|NCT00699998|50000501|FG001|Overall Study|Physician Decision|2|||
24906525|NCT00699998|50000502|FG002|Overall Study|Physician Decision|1|||
24906526|NCT00699998|50000503|FG003|Overall Study|Physician Decision|1|||
24906527|NCT00699998|50000500|FG000|Overall Study|Lost to Follow-up|2|||
24906528|NCT00699998|50000501|FG001|Overall Study|Lost to Follow-up|1|||
24906529|NCT00699998|50000502|FG002|Overall Study|Lost to Follow-up|3|||
24906530|NCT00699998|50000503|FG003|Overall Study|Lost to Follow-up|1|||
24906531|NCT00696072|50000520|FG000|Overall Study|continuing active treatment|10|||
24906532|NCT00696072|50000521|FG001|Overall Study|continuing active treatment|13|||
24906533|NCT00696072|50000520|FG000|Overall Study|Adverse Event|10|||
24906534|NCT00696072|50000521|FG001|Overall Study|Adverse Event|6|||
24906535|NCT00696072|50000520|FG000|Overall Study|Patient Request|3|||
24906536|NCT00696072|50000521|FG001|Overall Study|Patient Request|7|||
24906537|NCT00696072|50000520|FG000|Overall Study|Investigator Request|1|||
24906538|NCT00696072|50000521|FG001|Overall Study|Investigator Request|4|||
24906539|NCT00696072|50000520|FG000|Overall Study|Sponsor Request|0|||
24906540|NCT00696072|50000521|FG001|Overall Study|Sponsor Request|1|||
24906541|NCT00696072|50000520|FG000|Overall Study|Disease Progression|32|||
25340822|NCT00766532|50657127|FG000|Overall Study|Protocol Violation|2|||
24906542|NCT00696072|50000521|FG001|Overall Study|Disease Progression|30|||
24906543|NCT00696072|50000520|FG000|Overall Study|Non-specified|1|||
24906544|NCT00696072|50000521|FG001|Overall Study|Non-specified|2|||
25340823|NCT00774566|50657133|FG000|Overall Study|Protocol Violation|18|||
25340824|NCT00774566|50657134|FG001|Overall Study|Protocol Violation|15|||
24906545|NCT00634647|50000528|FG000|Overall Study|death on study|3|||
24906546|NCT00634647|50000528|FG000|Overall Study|refused further treatment|3|||
24906547|NCT00634647|50000528|FG000|Overall Study|declined to participate before treatment|1|||
24906548|NCT00576732|50000535|FG000|DOUBLE BLIND|Adverse Event|0|||
24906549|NCT00576732|50000536|FG001|DOUBLE BLIND|Adverse Event|0|||
24906550|NCT00576732|50000537|FG002|DOUBLE BLIND|Adverse Event|1|||
24906551|NCT00576732|50000538|FG003|DOUBLE BLIND|Adverse Event|0|||
24906552|NCT00576732|50000539|FG004|DOUBLE BLIND|Adverse Event|0|||
24906553|NCT00576732|50000540|FG005|DOUBLE BLIND|Adverse Event|0|||
24906554|NCT00576732|50000535|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
24906555|NCT00576732|50000536|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
25340825|NCT00766376|50657140|FG000|Overall Study|Withdrawal by Subject|27|||
24906556|NCT00576732|50000537|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
24906557|NCT00576732|50000538|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
24906558|NCT00576732|50000539|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
24906559|NCT00576732|50000540|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
24906560|NCT00576732|50000535|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
24906561|NCT00576732|50000536|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
24906562|NCT00576732|50000537|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
24906563|NCT00576732|50000538|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
24906564|NCT00576732|50000539|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
24906565|NCT00576732|50000540|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
24906566|NCT00576732|50000535|FG000|DOUBLE BLIND|OTHER|0|||
24906567|NCT00576732|50000536|FG001|DOUBLE BLIND|OTHER|2|||
24906568|NCT00576732|50000537|FG002|DOUBLE BLIND|OTHER|1|||
24906569|NCT00576732|50000538|FG003|DOUBLE BLIND|OTHER|0|||
24906570|NCT00576732|50000539|FG004|DOUBLE BLIND|OTHER|0|||
24906571|NCT00576732|50000540|FG005|DOUBLE BLIND|OTHER|0|||
24906572|NCT00576732|50000535|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
24906573|NCT00576732|50000536|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
24906574|NCT00576732|50000537|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
24906575|NCT00576732|50000538|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
24906576|NCT00576732|50000539|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
24906577|NCT00576732|50000540|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
24906578|NCT00576732|50000535|FG000|DOUBLE BLIND|Protocol Violation|1|||
24906579|NCT00576732|50000536|FG001|DOUBLE BLIND|Protocol Violation|0|||
24906580|NCT00576732|50000537|FG002|DOUBLE BLIND|Protocol Violation|0|||
24906581|NCT00576732|50000538|FG003|DOUBLE BLIND|Protocol Violation|0|||
24906582|NCT00576732|50000539|FG004|DOUBLE BLIND|Protocol Violation|0|||
24906583|NCT00576732|50000540|FG005|DOUBLE BLIND|Protocol Violation|0|||
24906584|NCT00576732|50000535|FG000|OPEN LABEL|Adverse Event|0|||
24906585|NCT00576732|50000536|FG001|OPEN LABEL|Adverse Event|0|||
24906586|NCT00576732|50000537|FG002|OPEN LABEL|Adverse Event|0|||
24906587|NCT00576732|50000538|FG003|OPEN LABEL|Adverse Event|4|||
24906588|NCT00576732|50000539|FG004|OPEN LABEL|Adverse Event|0|||
24906589|NCT00576732|50000540|FG005|OPEN LABEL|Adverse Event|1|||
24906590|NCT00576732|50000535|FG000|OPEN LABEL|Lost to Follow-up|0|||
24906591|NCT00576732|50000536|FG001|OPEN LABEL|Lost to Follow-up|0|||
24906592|NCT00576732|50000537|FG002|OPEN LABEL|Lost to Follow-up|0|||
24906593|NCT00576732|50000538|FG003|OPEN LABEL|Lost to Follow-up|2|||
24906594|NCT00576732|50000539|FG004|OPEN LABEL|Lost to Follow-up|1|||
24906595|NCT00576732|50000540|FG005|OPEN LABEL|Lost to Follow-up|1|||
24906596|NCT00576732|50000535|FG000|OPEN LABEL|Withdrawal by Subject|0|||
24906597|NCT00576732|50000536|FG001|OPEN LABEL|Withdrawal by Subject|0|||
24906598|NCT00576732|50000537|FG002|OPEN LABEL|Withdrawal by Subject|0|||
24906599|NCT00576732|50000538|FG003|OPEN LABEL|Withdrawal by Subject|1|||
24906600|NCT00576732|50000539|FG004|OPEN LABEL|Withdrawal by Subject|0|||
24906601|NCT00576732|50000540|FG005|OPEN LABEL|Withdrawal by Subject|1|||
24906602|NCT00576732|50000535|FG000|OPEN LABEL|OTHER|0|||
24906603|NCT00576732|50000536|FG001|OPEN LABEL|OTHER|0|||
24906604|NCT00576732|50000537|FG002|OPEN LABEL|OTHER|0|||
24906605|NCT00576732|50000538|FG003|OPEN LABEL|OTHER|0|||
24906606|NCT00576732|50000539|FG004|OPEN LABEL|OTHER|0|||
24906607|NCT00576732|50000540|FG005|OPEN LABEL|OTHER|2|||
24906608|NCT00576732|50000535|FG000|OPEN LABEL|Lack of Efficacy|0|||
24906609|NCT00576732|50000536|FG001|OPEN LABEL|Lack of Efficacy|0|||
24906610|NCT00576732|50000537|FG002|OPEN LABEL|Lack of Efficacy|0|||
24906611|NCT00576732|50000538|FG003|OPEN LABEL|Lack of Efficacy|2|||
24906612|NCT00576732|50000539|FG004|OPEN LABEL|Lack of Efficacy|2|||
24906613|NCT00576732|50000540|FG005|OPEN LABEL|Lack of Efficacy|3|||
24906614|NCT00576732|50000535|FG000|OPEN LABEL|Protocol Violation|0|||
24906615|NCT00576732|50000536|FG001|OPEN LABEL|Protocol Violation|0|||
24906616|NCT00576732|50000537|FG002|OPEN LABEL|Protocol Violation|0|||
24906617|NCT00576732|50000538|FG003|OPEN LABEL|Protocol Violation|2|||
24906618|NCT00576732|50000539|FG004|OPEN LABEL|Protocol Violation|1|||
24906619|NCT00576732|50000540|FG005|OPEN LABEL|Protocol Violation|0|||
24906620|NCT00697788|50000552|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
24906621|NCT00697788|50000553|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
24906622|NCT00697788|50000554|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
24906623|NCT00697788|50000555|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
24906624|NCT00697788|50000556|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
24906625|NCT00697788|50000557|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
24906626|NCT00697788|50000558|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
24906627|NCT00697788|50000559|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
24906628|NCT00697788|50000552|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
24906629|NCT00697788|50000553|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
24906630|NCT00697788|50000554|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
24906631|NCT00697788|50000555|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
24906632|NCT00697788|50000556|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
24906633|NCT00697788|50000557|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
24906634|NCT00697788|50000558|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
25340826|NCT00587054|50657144|FG000|Overall Study|Patient not treated|9|||
25340827|NCT00766142|50657148|FG000|Overall Study|Protocol Violation|4|||
25340828|NCT00724854|50657154|FG000|Overall Study|Lack of Efficacy|187|||
25340829|NCT00724854|50657155|FG001|Overall Study|Lack of Efficacy|13|||
25340830|NCT00724854|50657154|FG000|Overall Study|Lost to Follow-up|87|||
25340831|NCT00724854|50657155|FG001|Overall Study|Lost to Follow-up|10|||
25340832|NCT00724854|50657154|FG000|Overall Study|Adverse Event|62|||
25340833|NCT00724854|50657155|FG001|Overall Study|Adverse Event|4|||
25340834|NCT00724854|50657154|FG000|Overall Study|Other|42|||
25340835|NCT00724854|50657155|FG001|Overall Study|Other|3|||
25340836|NCT00724854|50657154|FG000|Overall Study|Death|11|||
25340837|NCT00724854|50657155|FG001|Overall Study|Death|0|||
25340838|NCT00724854|50657154|FG000|Overall Study|Change of treatment|7|||
24906635|NCT00697788|50000559|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
24906636|NCT00400153|50000589|FG000|Overall Study|AE due to study disease worsening|14|||
24906637|NCT00400153|50000590|FG001|Overall Study|AE due to study disease worsening|19|||
24906638|NCT00400153|50000591|FG002|Overall Study|AE due to study disease worsening|20|||
24906639|NCT00400153|50000589|FG000|Overall Study|AE due to other disease worsening|2|||
24906640|NCT00400153|50000590|FG001|Overall Study|AE due to other disease worsening|1|||
24906641|NCT00400153|50000591|FG002|Overall Study|AE due to other disease worsening|0|||
24906642|NCT00400153|50000589|FG000|Overall Study|AE due to other condition|3|||
24906643|NCT00400153|50000590|FG001|Overall Study|AE due to other condition|14|||
24906644|NCT00400153|50000591|FG002|Overall Study|AE due to other condition|15|||
24906645|NCT00400153|50000589|FG000|Overall Study|Protocol Violation|7|||
24906646|NCT00400153|50000590|FG001|Overall Study|Protocol Violation|4|||
24906647|NCT00400153|50000591|FG002|Overall Study|Protocol Violation|9|||
24906648|NCT00400153|50000589|FG000|Overall Study|Lost to Follow-up|2|||
24906649|NCT00400153|50000590|FG001|Overall Study|Lost to Follow-up|1|||
24906650|NCT00400153|50000591|FG002|Overall Study|Lost to Follow-up|4|||
24906651|NCT00400153|50000589|FG000|Overall Study|Withdrawal by Subject|12|||
24906652|NCT00400153|50000590|FG001|Overall Study|Withdrawal by Subject|11|||
24906653|NCT00400153|50000591|FG002|Overall Study|Withdrawal by Subject|10|||
24906654|NCT00400153|50000589|FG000|Overall Study|Other reasons - not mentioned above|8|||
24906655|NCT00400153|50000590|FG001|Overall Study|Other reasons - not mentioned above|5|||
24906656|NCT00400153|50000591|FG002|Overall Study|Other reasons - not mentioned above|3|||
24906657|NCT00631917|50000606|FG000|Overall Study|Adverse Event|34|||
24906658|NCT00631917|50000607|FG001|Overall Study|Adverse Event|45|||
24906659|NCT00631917|50000606|FG000|Overall Study|Abnormal laboratory value(s)|2|||
24906660|NCT00631917|50000607|FG001|Overall Study|Abnormal laboratory value(s)|1|||
24906661|NCT00631917|50000606|FG000|Overall Study|Abnormal test procedure result(s)|3|||
24906662|NCT00631917|50000607|FG001|Overall Study|Abnormal test procedure result(s)|2|||
24906663|NCT00631917|50000606|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
24906664|NCT00631917|50000607|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
24906665|NCT00631917|50000606|FG000|Overall Study|No longer required study drug|0|||
24906666|NCT00631917|50000607|FG001|Overall Study|No longer required study drug|1|||
24906667|NCT00631917|50000606|FG000|Overall Study|Protocol deviation|6|||
24906668|NCT00631917|50000607|FG001|Overall Study|Protocol deviation|5|||
24906669|NCT00631917|50000606|FG000|Overall Study|Subject withdrew consent|25|||
24906670|NCT00631917|50000607|FG001|Overall Study|Subject withdrew consent|33|||
24906671|NCT00631917|50000606|FG000|Overall Study|Lost to Follow-up|7|||
24906672|NCT00631917|50000607|FG001|Overall Study|Lost to Follow-up|7|||
24906673|NCT00631917|50000606|FG000|Overall Study|Administrative problems|2|||
24906674|NCT00631917|50000607|FG001|Overall Study|Administrative problems|0|||
24906675|NCT00631917|50000606|FG000|Overall Study|Death|1|||
24906676|NCT00631917|50000607|FG001|Overall Study|Death|0|||
24977901|NCT03386344|50066440|FG002|Overall Study|Poor Compliance to Protocol|0|||
24977902|NCT03386344|50066438|FG000|Overall Study|Study Terminated by Sponsor|101|||
24977903|NCT03386344|50066439|FG001|Overall Study|Study Terminated by Sponsor|102|||
24977904|NCT03386344|50066440|FG002|Overall Study|Study Terminated by Sponsor|106|||
24977905|NCT03386344|50066438|FG000|Overall Study|Lost to Follow-up|3|||
24977906|NCT03386344|50066439|FG001|Overall Study|Lost to Follow-up|2|||
24977907|NCT03386344|50066440|FG002|Overall Study|Lost to Follow-up|1|||
24977908|NCT03386344|50066438|FG000|Overall Study|At the Participant's own Request|7|||
24977909|NCT03386344|50066439|FG001|Overall Study|At the Participant's own Request|7|||
24977910|NCT03386344|50066440|FG002|Overall Study|At the Participant's own Request|8|||
24977911|NCT03386344|50066438|FG000|Overall Study|Reason not Specified|0|||
24977912|NCT03386344|50066439|FG001|Overall Study|Reason not Specified|1|||
24977913|NCT03386344|50066440|FG002|Overall Study|Reason not Specified|0|||
25078062|NCT03745651|50186227|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
25340839|NCT00724854|50657155|FG001|Overall Study|Change of treatment|0|||
25340840|NCT00724854|50657154|FG000|Overall Study|Withdrawal by Subject|5|||
24977914|NCT00399035|50066451|FG000|Overall Study|Death|289|||
24977915|NCT00399035|50066452|FG001|Overall Study|Death|141|||
24977916|NCT00399035|50066453|FG002|Overall Study|Death|234|||
24977917|NCT00399035|50066451|FG000|Overall Study|Lost to Follow-up|2|||
25340841|NCT00724854|50657155|FG001|Overall Study|Withdrawal by Subject|0|||
25340842|NCT00724854|50657154|FG000|Overall Study|Adverse event + lack of efficacy|2|||
25340843|NCT00724854|50657155|FG001|Overall Study|Adverse event + lack of efficacy|1|||
25340844|NCT00728988|50657164|FG000|Overall Study|Not Treated|2|||
25340845|NCT00728988|50657165|FG001|Overall Study|Not Treated|2|||
25340846|NCT00728988|50657164|FG000|Overall Study|Death|1|||
25340847|NCT00728988|50657165|FG001|Overall Study|Death|1|||
25340848|NCT00728988|50657164|FG000|Overall Study|Adverse Event|3|||
25340849|NCT00728988|50657165|FG001|Overall Study|Adverse Event|2|||
25340850|NCT00728988|50657164|FG000|Overall Study|Other|85|||
25340851|NCT00728988|50657165|FG001|Overall Study|Other|77|||
25340852|NCT00728988|50657164|FG000|Overall Study|Withdrawal by Subject|2|||
25340853|NCT00728988|50657165|FG001|Overall Study|Withdrawal by Subject|6|||
25340854|NCT00728754|50657174|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
25340855|NCT00728754|50657175|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
25340856|NCT00728754|50657174|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
25340857|NCT00728754|50657175|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
25340858|NCT00728754|50657174|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
25340859|NCT00728754|50657175|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
25340860|NCT00728130|50657181|FG000|Overall Study|Withdrawal by Subject|1|||
25340861|NCT00728130|50657181|FG000|Overall Study|Paperwork not completed in time|1|||
25340862|NCT00728130|50657181|FG000|Overall Study|Physician Decision|1|||
25340863|NCT00735696|50657185|FG000|Overall Study|Withdrawal by Subject|1|||
25340864|NCT00735696|50657185|FG000|Overall Study|Enrolled but never Treated|1|||
25340865|NCT00478231|50657189|FG000|Overall Study|Death|7|||
25340866|NCT00478231|50657189|FG000|Overall Study|Lack of Efficacy|47|||
25340867|NCT00478231|50657189|FG000|Overall Study|Lost to Follow-up|7|||
25340868|NCT00478231|50657189|FG000|Overall Study|Withdrawal by Subject|6|||
25340869|NCT00478231|50657189|FG000|Overall Study|Other|9|||
25340870|NCT00478231|50657189|FG000|Overall Study|Adverse Event|5|||
25340871|NCT00478231|50657189|FG000|Overall Study|Randomized, not treated|3|||
25340872|NCT00474175|50657196|FG000|Overall Study|Lack of Efficacy|0|||
25340873|NCT00474175|50657197|FG001|Overall Study|Lack of Efficacy|0|||
25340874|NCT00474175|50657198|FG002|Overall Study|Lack of Efficacy|1|||
25340875|NCT00474175|50657196|FG000|Overall Study|Withdrawal by Subject|0|||
25340876|NCT00474175|50657197|FG001|Overall Study|Withdrawal by Subject|1|||
25340877|NCT00474175|50657198|FG002|Overall Study|Withdrawal by Subject|1|||
25340878|NCT00474175|50657196|FG000|Overall Study|Ineligible|1|||
25340879|NCT00474175|50657197|FG001|Overall Study|Ineligible|3|||
25340880|NCT00474175|50657198|FG002|Overall Study|Ineligible|1|||
25340881|NCT00474175|50657196|FG000|Overall Study|Protocol Violation|0|||
25340882|NCT00474175|50657197|FG001|Overall Study|Protocol Violation|2|||
25340883|NCT00474175|50657198|FG002|Overall Study|Protocol Violation|1|||
25340884|NCT00474175|50657196|FG000|Overall Study|Administrative|0|||
25340885|NCT00474175|50657197|FG001|Overall Study|Administrative|1|||
25340886|NCT00474175|50657198|FG002|Overall Study|Administrative|0|||
25340887|NCT00443209|50657229|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
25340888|NCT00443209|50657230|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
25340889|NCT00443209|50657229|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
25340890|NCT00443209|50657230|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
25340891|NCT00443209|50657229|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
25340892|NCT00443209|50657230|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
25340893|NCT00443209|50657229|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
24977918|NCT00399035|50066452|FG001|Overall Study|Lost to Follow-up|1|||
24977919|NCT00399035|50066453|FG002|Overall Study|Lost to Follow-up|5|||
24977920|NCT00399035|50066451|FG000|Overall Study|Withdrawal by Subject|19|||
24977921|NCT00399035|50066452|FG001|Overall Study|Withdrawal by Subject|15|||
24977922|NCT00399035|50066453|FG002|Overall Study|Withdrawal by Subject|12|||
24977923|NCT00399035|50066451|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
24977924|NCT00399035|50066452|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
24977925|NCT00399035|50066453|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
24977926|NCT00399035|50066451|FG000|Overall Study|Severe non-compliance with protocol|2|||
24977927|NCT00399035|50066452|FG001|Overall Study|Severe non-compliance with protocol|1|||
24977928|NCT00399035|50066453|FG002|Overall Study|Severe non-compliance with protocol|0|||
24977929|NCT00073749|50066467|FG000|Overall Study|Disease Progression|2|||
24977930|NCT00073749|50066468|FG001|Overall Study|Disease Progression|0|||
24977931|NCT00073749|50066469|FG002|Overall Study|Disease Progression|3|||
25340894|NCT00443209|50657230|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
25340895|NCT00443209|50657229|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
25340896|NCT00443209|50657230|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
25340897|NCT00443209|50657229|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
25340898|NCT00443209|50657230|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
25340899|NCT00443209|50657229|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
25340900|NCT00443209|50657230|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
25340901|NCT00443209|50657229|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
24977932|NCT00073749|50066470|FG003|Overall Study|Disease Progression|2|||
24977933|NCT00073749|50066471|FG004|Overall Study|Disease Progression|3|||
24977934|NCT00073749|50066472|FG005|Overall Study|Disease Progression|1|||
24977935|NCT00073749|50066473|FG006|Overall Study|Disease Progression|3|||
24977936|NCT00073749|50066467|FG000|Overall Study|Death|0|||
24977937|NCT00073749|50066468|FG001|Overall Study|Death|1|||
24977938|NCT00073749|50066469|FG002|Overall Study|Death|1|||
24977939|NCT00073749|50066470|FG003|Overall Study|Death|0|||
24977940|NCT00073749|50066471|FG004|Overall Study|Death|0|||
24977941|NCT00073749|50066472|FG005|Overall Study|Death|0|||
24977942|NCT00073749|50066473|FG006|Overall Study|Death|29|||
24977943|NCT00073749|50066467|FG000|Overall Study|Adverse Event|0|||
24977944|NCT00073749|50066468|FG001|Overall Study|Adverse Event|3|||
24977945|NCT00073749|50066469|FG002|Overall Study|Adverse Event|6|||
24977946|NCT00073749|50066470|FG003|Overall Study|Adverse Event|4|||
24977947|NCT00073749|50066471|FG004|Overall Study|Adverse Event|2|||
24977948|NCT00073749|50066472|FG005|Overall Study|Adverse Event|1|||
24977949|NCT00073749|50066473|FG006|Overall Study|Adverse Event|0|||
24977950|NCT00073749|50066467|FG000|Overall Study|Physician Decision|0|||
24977951|NCT00073749|50066468|FG001|Overall Study|Physician Decision|0|||
24977952|NCT00073749|50066469|FG002|Overall Study|Physician Decision|1|||
24977953|NCT00073749|50066470|FG003|Overall Study|Physician Decision|0|||
24977954|NCT00073749|50066471|FG004|Overall Study|Physician Decision|0|||
24977955|NCT00073749|50066472|FG005|Overall Study|Physician Decision|2|||
24977956|NCT00073749|50066473|FG006|Overall Study|Physician Decision|0|||
24977957|NCT00073749|50066467|FG000|Overall Study|Withdrawal by Subject|0|||
24977958|NCT00073749|50066468|FG001|Overall Study|Withdrawal by Subject|1|||
24977959|NCT00073749|50066469|FG002|Overall Study|Withdrawal by Subject|0|||
24977960|NCT00073749|50066470|FG003|Overall Study|Withdrawal by Subject|0|||
24977961|NCT00073749|50066471|FG004|Overall Study|Withdrawal by Subject|1|||
24977962|NCT00073749|50066472|FG005|Overall Study|Withdrawal by Subject|0|||
24977963|NCT00073749|50066473|FG006|Overall Study|Withdrawal by Subject|2|||
24977964|NCT00073749|50066467|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
24977965|NCT00073749|50066468|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
24977966|NCT00073749|50066469|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
24977967|NCT00073749|50066470|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
24977968|NCT00073749|50066471|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
24977969|NCT00073749|50066472|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
24977970|NCT00073749|50066473|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
24977971|NCT00073749|50066467|FG000|Overall Study|Lost to Follow-up|0|||
24977972|NCT00073749|50066468|FG001|Overall Study|Lost to Follow-up|0|||
24977973|NCT00073749|50066469|FG002|Overall Study|Lost to Follow-up|0|||
24977974|NCT00073749|50066470|FG003|Overall Study|Lost to Follow-up|0|||
24977975|NCT00073749|50066471|FG004|Overall Study|Lost to Follow-up|0|||
24977976|NCT00073749|50066472|FG005|Overall Study|Lost to Follow-up|0|||
24977977|NCT00073749|50066473|FG006|Overall Study|Lost to Follow-up|2|||
24977978|NCT00073749|50066467|FG000|Overall Study|Other|0|||
24977979|NCT00073749|50066468|FG001|Overall Study|Other|0|||
24977980|NCT00073749|50066469|FG002|Overall Study|Other|0|||
24977981|NCT00073749|50066470|FG003|Overall Study|Other|0|||
24977982|NCT00073749|50066471|FG004|Overall Study|Other|0|||
24977983|NCT00073749|50066472|FG005|Overall Study|Other|2|||
24977984|NCT00073749|50066473|FG006|Overall Study|Other|0|||
24977985|NCT00398567|50066495|FG000|Overall Study|Disease Progression|3|||
24977986|NCT00398567|50066496|FG001|Overall Study|Disease Progression|4|||
24977987|NCT00398567|50066497|FG002|Overall Study|Disease Progression|27|||
24977988|NCT00398567|50066495|FG000|Overall Study|Withdrawal by Subject|1|||
24977989|NCT00398567|50066496|FG001|Overall Study|Withdrawal by Subject|0|||
24977990|NCT00398567|50066497|FG002|Overall Study|Withdrawal by Subject|4|||
24977991|NCT00398567|50066495|FG000|Overall Study|Adverse Event|0|||
24977992|NCT00398567|50066496|FG001|Overall Study|Adverse Event|0|||
24977993|NCT00398567|50066497|FG002|Overall Study|Adverse Event|2|||
24977994|NCT00398567|50066495|FG000|Overall Study|Protocol Violation|0|||
24977995|NCT00398567|50066496|FG001|Overall Study|Protocol Violation|0|||
24977996|NCT00398567|50066497|FG002|Overall Study|Protocol Violation|1|||
24977997|NCT05249569|50066503|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
24977998|NCT04779879|50066526|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
24977999|NCT04779879|50066527|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
25254984|NCT01175824|50570734|FG001|Overall Study|Lack of Efficacy|0|||
25254985|NCT01175824|50570733|FG000|Overall Study|Lost to Follow-up|0|||
24978000|NCT04779879|50066528|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
24978001|NCT04779879|50066529|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
24978002|NCT04779879|50066530|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
24978003|NCT04779879|50066531|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
24978004|NCT04779879|50066526|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
24978005|NCT04779879|50066527|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
24978006|NCT04779879|50066528|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
24978007|NCT04779879|50066529|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
24978008|NCT04779879|50066530|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
24978009|NCT04779879|50066531|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
24978010|NCT04779879|50066526|FG000|Part C: Up to Week 36|Death|0|||
24978011|NCT04779879|50066527|FG001|Part C: Up to Week 36|Death|0|||
24978012|NCT04779879|50066528|FG002|Part C: Up to Week 36|Death|0|||
24978013|NCT04779879|50066529|FG003|Part C: Up to Week 36|Death|0|||
24978014|NCT04779879|50066530|FG004|Part C: Up to Week 36|Death|0|||
24978015|NCT04779879|50066531|FG005|Part C: Up to Week 36|Death|1|||
24978016|NCT04779879|50066526|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
24978017|NCT04779879|50066527|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
24978018|NCT04779879|50066528|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
24978019|NCT04779879|50066529|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
24978020|NCT04779879|50066530|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
24978021|NCT04779879|50066531|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
24978022|NCT04535167|50066572|FG000|Treatment|Adverse Event|0|||
24978023|NCT04535167|50066573|FG001|Treatment|Adverse Event|0|||
24978024|NCT04535167|50066574|FG002|Treatment|Adverse Event|0|||
24978025|NCT04535167|50066575|FG003|Treatment|Adverse Event|0|||
24978026|NCT04535167|50066576|FG004|Treatment|Adverse Event|0|||
24978027|NCT04535167|50066577|FG005|Treatment|Adverse Event|0|||
24978028|NCT04535167|50066578|FG006|Treatment|Adverse Event|1|||
24978029|NCT04535167|50066572|FG000|Follow-Up|Death|0|||
24978030|NCT04535167|50066573|FG001|Follow-Up|Death|0|||
24978031|NCT04535167|50066574|FG002|Follow-Up|Death|0|||
24978032|NCT04535167|50066575|FG003|Follow-Up|Death|0|||
24978033|NCT04535167|50066576|FG004|Follow-Up|Death|0|||
24978034|NCT04535167|50066577|FG005|Follow-Up|Death|0|||
24978035|NCT04535167|50066578|FG006|Follow-Up|Death|1|||
24978036|NCT04535167|50066572|FG000|Follow-Up|Lost to Follow-up|0|||
24978037|NCT04535167|50066573|FG001|Follow-Up|Lost to Follow-up|0|||
24978038|NCT04535167|50066574|FG002|Follow-Up|Lost to Follow-up|0|||
24978039|NCT04535167|50066575|FG003|Follow-Up|Lost to Follow-up|1|||
24978040|NCT04535167|50066576|FG004|Follow-Up|Lost to Follow-up|0|||
24978041|NCT04535167|50066577|FG005|Follow-Up|Lost to Follow-up|0|||
24978042|NCT04535167|50066578|FG006|Follow-Up|Lost to Follow-up|0|||
24978043|NCT04223791|50066596|FG000|Overall Study|Lost to Follow-up|0|||
24978044|NCT04223791|50066597|FG001|Overall Study|Lost to Follow-up|4|||
24978045|NCT04223791|50066596|FG000|Overall Study|Physician Decision|5|||
24978046|NCT04223791|50066597|FG001|Overall Study|Physician Decision|1|||
24978047|NCT04223791|50066596|FG000|Overall Study|Protocol Violation|1|||
24978048|NCT04223791|50066597|FG001|Overall Study|Protocol Violation|1|||
24978049|NCT04223791|50066596|FG000|Overall Study|Withdrawal by Subject|10|||
24978050|NCT04223791|50066597|FG001|Overall Study|Withdrawal by Subject|12|||
24978051|NCT04223791|50066596|FG000|Overall Study|Pregnancy|1|||
24978052|NCT04223791|50066597|FG001|Overall Study|Pregnancy|1|||
24978053|NCT04223791|50066596|FG000|Overall Study|Ongoing in Study|305|||
24978054|NCT04223791|50066597|FG001|Overall Study|Ongoing in Study|302|||
24978055|NCT04115293|50066605|FG000|Overall Study|Adverse Event|0|||
24978056|NCT04115293|50066606|FG001|Overall Study|Adverse Event|2|||
24978057|NCT04115293|50066605|FG000|Overall Study|Withdrawal by Subject|2|||
24978058|NCT04115293|50066606|FG001|Overall Study|Withdrawal by Subject|1|||
24978059|NCT04115293|50066605|FG000|Overall Study|Physician Decision|1|||
24978060|NCT04115293|50066606|FG001|Overall Study|Physician Decision|0|||
24978061|NCT04115293|50066605|FG000|Overall Study|Death|1|||
24978062|NCT04115293|50066606|FG001|Overall Study|Death|1|||
24978063|NCT04035499|50066612|FG000|Overall Study|Death|2|||
24978064|NCT04035499|50066612|FG000|Overall Study|Withdrawal by Subject|1|||
24978065|NCT04031846|50066618|FG000|Overall Study|Lost to Follow-up|4|||
24978066|NCT04031846|50066619|FG001|Overall Study|Lost to Follow-up|4|||
24978067|NCT04031846|50066618|FG000|Overall Study|Physician Decision|0|||
24978068|NCT04031846|50066619|FG001|Overall Study|Physician Decision|1|||
24978069|NCT04031846|50066618|FG000|Overall Study|Protocol Violation|1|||
24978070|NCT04031846|50066619|FG001|Overall Study|Protocol Violation|1|||
24978071|NCT04031846|50066618|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
24978072|NCT04031846|50066619|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
24978073|NCT03915067|50066629|FG000|Overall Study|Adverse Event|0|||
24978074|NCT03915067|50066630|FG001|Overall Study|Adverse Event|0|||
24978075|NCT03915067|50066631|FG002|Overall Study|Adverse Event|1|||
24978076|NCT03915067|50066629|FG000|Overall Study|Withdrawal by Subject|4|||
24978077|NCT03915067|50066630|FG001|Overall Study|Withdrawal by Subject|3|||
24978078|NCT03915067|50066631|FG002|Overall Study|Withdrawal by Subject|0|||
24978079|NCT03915067|50066629|FG000|Overall Study|Lost to Follow-up|3|||
24978080|NCT03915067|50066630|FG001|Overall Study|Lost to Follow-up|2|||
24978081|NCT03915067|50066631|FG002|Overall Study|Lost to Follow-up|0|||
24978082|NCT03915067|50066629|FG000|Overall Study|Protocol Deviation|0|||
24978083|NCT03915067|50066630|FG001|Overall Study|Protocol Deviation|0|||
24978084|NCT03915067|50066631|FG002|Overall Study|Protocol Deviation|1|||
24978085|NCT03915067|50066629|FG000|Overall Study|Covid-19 Related Issues|2|||
24978086|NCT03915067|50066630|FG001|Overall Study|Covid-19 Related Issues|4|||
24978087|NCT03915067|50066631|FG002|Overall Study|Covid-19 Related Issues|4|||
24978088|NCT03915067|50066629|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
24978089|NCT03915067|50066630|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
24978090|NCT03915067|50066631|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
24978091|NCT03654404|50066639|FG000|Overall Study|Death|1|||
24978092|NCT03654404|50066639|FG000|Overall Study|Lost to Follow-up|2|||
24978093|NCT03654404|50066639|FG000|Overall Study|Withdrawal by Subject|5|||
24978094|NCT03602586|50066647|FG000|Overall Study|Withdrawal by Subject|3|||
24978095|NCT03447314|50066716|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
24978096|NCT03447314|50066717|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
24978097|NCT03447314|50066718|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
24978098|NCT03447314|50066719|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
24978099|NCT03447314|50066720|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
24978100|NCT03447314|50066721|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
24978101|NCT03447314|50066722|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
24978102|NCT03447314|50066723|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
24978103|NCT03447314|50066724|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
24978104|NCT03447314|50066725|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
24978105|NCT03447314|50066726|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
24978106|NCT03447314|50066727|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
24978107|NCT03447314|50066728|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
24978108|NCT03447314|50066729|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
24978109|NCT03447314|50066730|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
24978110|NCT03447314|50066731|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
24978111|NCT03447314|50066732|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
24978112|NCT03447314|50066733|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
24978113|NCT03447314|50066716|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
24978114|NCT03447314|50066717|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
24978115|NCT03447314|50066718|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
24978116|NCT03447314|50066719|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
25340902|NCT00443209|50657230|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
25340903|NCT00443209|50657229|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
25340904|NCT00443209|50657230|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
25340905|NCT00443209|50657229|FG000|Months 1 to 12 Treatment Period|Missing|2|||
25340906|NCT00443209|50657230|FG001|Months 1 to 12 Treatment Period|Missing|1|||
25340907|NCT00443209|50657229|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
25340908|NCT00443209|50657230|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
25340909|NCT00443209|50657229|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
25340910|NCT00443209|50657230|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
25340911|NCT00443209|50657229|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
25340912|NCT00443209|50657230|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
24978117|NCT03447314|50066720|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
24978118|NCT03447314|50066721|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
24978119|NCT03447314|50066722|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
24978120|NCT03447314|50066723|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
24978121|NCT03447314|50066724|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
24978122|NCT03447314|50066725|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
24978123|NCT03447314|50066726|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
24978124|NCT03447314|50066727|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
24978125|NCT03447314|50066728|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
24978126|NCT03447314|50066729|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
24978127|NCT03447314|50066730|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
24978128|NCT03447314|50066731|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
24978129|NCT03447314|50066732|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
24978130|NCT03447314|50066733|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
24978131|NCT03447314|50066716|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
25254986|NCT01175824|50570734|FG001|Overall Study|Lost to Follow-up|1|||
25254987|NCT01175824|50570733|FG000|Overall Study|Physician Decision|0|||
25254988|NCT01175824|50570734|FG001|Overall Study|Physician Decision|4|||
25254989|NCT01175824|50570733|FG000|Overall Study|Protocol Violation|2|||
25254990|NCT01175824|50570734|FG001|Overall Study|Protocol Violation|5|||
25254991|NCT01175824|50570733|FG000|Overall Study|Withdrawal by Subject|3|||
25254992|NCT01175824|50570734|FG001|Overall Study|Withdrawal by Subject|7|||
25254993|NCT01175824|50570733|FG000|Overall Study|Sponsor Decision|1|||
25254994|NCT01175824|50570734|FG001|Overall Study|Sponsor Decision|0|||
25254995|NCT01175824|50570733|FG000|Overall Study|Entry Criteria Not Met|6|||
25254996|NCT01175824|50570734|FG001|Overall Study|Entry Criteria Not Met|4|||
25254997|NCT01175707|50570742|FG000|Overall Study|Adverse Event|4|||
25340913|NCT00443209|50657229|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
24978132|NCT03447314|50066717|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
25254998|NCT01175707|50570743|FG001|Overall Study|Adverse Event|6|||
25340914|NCT00443209|50657230|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
24978133|NCT03447314|50066718|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
24978134|NCT03447314|50066719|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
24978135|NCT03447314|50066720|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
24978136|NCT03447314|50066721|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
24978137|NCT03447314|50066722|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
24978138|NCT03447314|50066723|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
25254999|NCT01112059|50570752|FG000|Overall Study|Withdrawal by Subject|1|||
25255000|NCT01112059|50570753|FG001|Overall Study|Withdrawal by Subject|0|||
25255001|NCT01175668|50570764|FG000|Overall Study|Withdrawal by Subject|2|||
25255002|NCT01175668|50570765|FG001|Overall Study|Withdrawal by Subject|0|||
25255003|NCT01111825|50570775|FG000|Overall Study|Withdrawal by Subject|0|||
25255004|NCT01111825|50570776|FG001|Overall Study|Withdrawal by Subject|0|||
25255005|NCT01111825|50570777|FG002|Overall Study|Withdrawal by Subject|1|||
25255006|NCT01111825|50570778|FG003|Overall Study|Withdrawal by Subject|0|||
25255007|NCT01111825|50570775|FG000|Overall Study|Lost to Follow-up|0|||
25255008|NCT01111825|50570776|FG001|Overall Study|Lost to Follow-up|0|||
25255009|NCT01111825|50570777|FG002|Overall Study|Lost to Follow-up|3|||
25255010|NCT01111825|50570778|FG003|Overall Study|Lost to Follow-up|1|||
25255011|NCT01111825|50570775|FG000|Overall Study|Adverse Event|2|||
25255012|NCT01111825|50570776|FG001|Overall Study|Adverse Event|1|||
25255013|NCT01111825|50570777|FG002|Overall Study|Adverse Event|4|||
25340915|NCT00443209|50657229|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
25340916|NCT00443209|50657230|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
25340917|NCT00443209|50657229|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
24978139|NCT03447314|50066724|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
24978140|NCT03447314|50066725|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
24978141|NCT03447314|50066726|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
24978142|NCT03447314|50066727|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
24978143|NCT03447314|50066728|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
24978144|NCT03447314|50066729|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
24978145|NCT03447314|50066730|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
24978146|NCT03447314|50066731|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
24978147|NCT03447314|50066732|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
24978148|NCT03447314|50066733|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
24978149|NCT03447314|50066716|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
24978150|NCT03447314|50066717|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
24978151|NCT03447314|50066718|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
25078063|NCT03745651|50186228|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
25078064|NCT03745651|50186229|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
25078065|NCT03745651|50186223|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
24978152|NCT03447314|50066719|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
24978153|NCT03447314|50066720|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
24978154|NCT03447314|50066721|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
24978155|NCT03447314|50066722|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
24978156|NCT03447314|50066723|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
25078066|NCT03745651|50186224|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
25078067|NCT03745651|50186225|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
25078068|NCT03745651|50186226|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
25078069|NCT03745651|50186227|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
25078070|NCT03745651|50186228|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
25078071|NCT03745651|50186229|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
25078072|NCT03745651|50186223|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
25078073|NCT03745651|50186224|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
25078074|NCT03745651|50186225|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
25078075|NCT03745651|50186226|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
25078076|NCT03745651|50186227|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
25078077|NCT03745651|50186228|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
25078078|NCT03745651|50186229|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
25255014|NCT01111825|50570778|FG003|Overall Study|Adverse Event|0|||
25255015|NCT01111825|50570775|FG000|Overall Study|Disease Progression|1|||
25255016|NCT01111825|50570776|FG001|Overall Study|Disease Progression|0|||
25255017|NCT01111825|50570777|FG002|Overall Study|Disease Progression|0|||
25255018|NCT01111825|50570778|FG003|Overall Study|Disease Progression|0|||
25255019|NCT01111825|50570775|FG000|Overall Study|Discontinuation by Sponsor|0|||
25255020|NCT01111825|50570776|FG001|Overall Study|Discontinuation by Sponsor|0|||
25255021|NCT01111825|50570777|FG002|Overall Study|Discontinuation by Sponsor|0|||
25255022|NCT01111825|50570778|FG003|Overall Study|Discontinuation by Sponsor|20|||
25255023|NCT01175590|50570790|FG000|Overall Study|Lost to Follow-up|1|||
25340918|NCT00443209|50657230|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
24978157|NCT03447314|50066724|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
24978158|NCT03447314|50066725|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
24978159|NCT03447314|50066726|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
24978160|NCT03447314|50066727|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
24978161|NCT03447314|50066728|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
24978162|NCT03447314|50066729|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
24978163|NCT03447314|50066730|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
24978164|NCT03447314|50066731|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
24978165|NCT03447314|50066732|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
24978166|NCT03447314|50066733|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
24978167|NCT03447314|50066716|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
24978168|NCT03447314|50066717|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
24978169|NCT03447314|50066718|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
24978170|NCT03447314|50066719|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
24978171|NCT03447314|50066720|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
24978172|NCT03447314|50066721|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
24978173|NCT03447314|50066722|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
24978174|NCT03447314|50066723|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
24978175|NCT03447314|50066724|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
24978176|NCT03447314|50066725|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
24978177|NCT03447314|50066726|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
24978178|NCT03447314|50066727|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
24978179|NCT03447314|50066728|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
24978180|NCT03447314|50066729|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
24978181|NCT03447314|50066730|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
24978182|NCT03447314|50066731|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
24978183|NCT03447314|50066732|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
24978184|NCT03447314|50066733|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
24978185|NCT03447314|50066716|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
24978186|NCT03447314|50066717|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
24978187|NCT03447314|50066718|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
24978188|NCT03447314|50066719|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
24978189|NCT03447314|50066720|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
24978190|NCT03447314|50066721|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
24978191|NCT03447314|50066722|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
24978192|NCT03447314|50066723|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
24978193|NCT03447314|50066724|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
24978194|NCT03447314|50066725|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
24978195|NCT03447314|50066726|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
24978196|NCT03447314|50066727|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
24978197|NCT03447314|50066728|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
24978198|NCT03447314|50066729|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
24978199|NCT03447314|50066730|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
24978200|NCT03447314|50066731|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
24978201|NCT03447314|50066732|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
24978202|NCT03447314|50066733|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
24978203|NCT03423121|50066776|FG000|Overall Study|Lost to Follow-up|2|||
24978204|NCT03423121|50066777|FG001|Overall Study|Lost to Follow-up|6|||
24978205|NCT03423121|50066776|FG000|Overall Study|Adverse Event|1|||
24978206|NCT03423121|50066777|FG001|Overall Study|Adverse Event|0|||
24978207|NCT03335475|50066785|FG000|Overall Study|Did not wear accelerometer|4|||
24978208|NCT03335475|50066786|FG001|Overall Study|Did not wear accelerometer|0|||
24978209|NCT03335475|50066785|FG000|Overall Study|Withdrawal by Subject|0|||
24978210|NCT03335475|50066786|FG001|Overall Study|Withdrawal by Subject|1|||
24978211|NCT03252756|50066794|FG000|Overall Study|Protocol Violation|2|||
24978212|NCT03252756|50066795|FG001|Overall Study|Protocol Violation|4|||
24978213|NCT03252756|50066794|FG000|Overall Study|COVID-19 Pandemic|1|||
24978214|NCT03252756|50066795|FG001|Overall Study|COVID-19 Pandemic|1|||
24978215|NCT03252756|50066794|FG000|Overall Study|Study Drug Expiration|0|||
24978216|NCT03252756|50066795|FG001|Overall Study|Study Drug Expiration|1|||
25340919|NCT00443209|50657229|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
24978217|NCT03164356|50066807|FG000|Overall Study|Lost to Follow-up|1|||
24978218|NCT03164356|50066808|FG001|Overall Study|Lost to Follow-up|1|||
24978219|NCT03164356|50066809|FG002|Overall Study|Lost to Follow-up|2|||
24978220|NCT03164356|50066810|FG003|Overall Study|Lost to Follow-up|1|||
24978221|NCT03164356|50066807|FG000|Overall Study|Physician Decision|0|||
24978222|NCT03164356|50066808|FG001|Overall Study|Physician Decision|0|||
24978223|NCT03164356|50066809|FG002|Overall Study|Physician Decision|3|||
24978224|NCT03164356|50066810|FG003|Overall Study|Physician Decision|0|||
24978225|NCT03164356|50066807|FG000|Overall Study|Protocol Violation|2|||
24978226|NCT03164356|50066808|FG001|Overall Study|Protocol Violation|1|||
24978227|NCT03164356|50066809|FG002|Overall Study|Protocol Violation|0|||
24978228|NCT03164356|50066810|FG003|Overall Study|Protocol Violation|0|||
24978229|NCT03164356|50066807|FG000|Overall Study|Withdrawal by Subject|1|||
24978230|NCT03164356|50066808|FG001|Overall Study|Withdrawal by Subject|0|||
24978231|NCT03164356|50066809|FG002|Overall Study|Withdrawal by Subject|0|||
24978232|NCT03164356|50066810|FG003|Overall Study|Withdrawal by Subject|0|||
24978233|NCT03164356|50066807|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
24978234|NCT03164356|50066808|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
24978235|NCT03164356|50066809|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
24978236|NCT03164356|50066810|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
24978237|NCT03164356|50066807|FG000|Overall Study|Subject Incarcerated|0|||
24978238|NCT03164356|50066808|FG001|Overall Study|Subject Incarcerated|1|||
24978239|NCT03164356|50066809|FG002|Overall Study|Subject Incarcerated|0|||
24978240|NCT03164356|50066810|FG003|Overall Study|Subject Incarcerated|0|||
24978241|NCT03164356|50066807|FG000|Overall Study|Prosthetist unable to participate|0|||
24978242|NCT03164356|50066808|FG001|Overall Study|Prosthetist unable to participate|2|||
24978243|NCT03164356|50066809|FG002|Overall Study|Prosthetist unable to participate|1|||
24978244|NCT03164356|50066810|FG003|Overall Study|Prosthetist unable to participate|0|||
24978245|NCT02677922|50066845|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
24978246|NCT02677922|50066846|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
24978247|NCT02677922|50066847|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
24978248|NCT02677922|50066848|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
24978249|NCT02677922|50066849|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
24978250|NCT02677922|50066850|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
24978251|NCT02677922|50066845|FG000|Treatment Period|Adverse Event|0|||
24978252|NCT02677922|50066846|FG001|Treatment Period|Adverse Event|0|||
24978253|NCT02677922|50066847|FG002|Treatment Period|Adverse Event|1|||
24978254|NCT02677922|50066848|FG003|Treatment Period|Adverse Event|3|||
24978255|NCT02677922|50066849|FG004|Treatment Period|Adverse Event|5|||
24978256|NCT02677922|50066850|FG005|Treatment Period|Adverse Event|2|||
24978257|NCT02677922|50066845|FG000|Treatment Period|Progressive Disease|1|||
24978258|NCT02677922|50066846|FG001|Treatment Period|Progressive Disease|1|||
24978259|NCT02677922|50066847|FG002|Treatment Period|Progressive Disease|0|||
24978260|NCT02677922|50066848|FG003|Treatment Period|Progressive Disease|0|||
24978261|NCT02677922|50066849|FG004|Treatment Period|Progressive Disease|8|||
24978262|NCT02677922|50066850|FG005|Treatment Period|Progressive Disease|7|||
24978263|NCT02677922|50066845|FG000|Treatment Period|Lack of Efficacy|0|||
24978264|NCT02677922|50066846|FG001|Treatment Period|Lack of Efficacy|0|||
25255024|NCT01175590|50570791|FG001|Overall Study|Lost to Follow-up|0|||
25255025|NCT01175590|50570790|FG000|Overall Study|Withdrawal by Subject|0|||
25255026|NCT01175590|50570791|FG001|Overall Study|Withdrawal by Subject|2|||
25255027|NCT01175590|50570790|FG000|Overall Study|Adverse Event|4|||
25255028|NCT01175590|50570791|FG001|Overall Study|Adverse Event|0|||
25255029|NCT01175590|50570790|FG000|Overall Study|Physician Decision|1|||
25255030|NCT01175590|50570791|FG001|Overall Study|Physician Decision|4|||
25255031|NCT01175590|50570790|FG000|Overall Study|Lack of Efficacy|1|||
25255032|NCT01175590|50570791|FG001|Overall Study|Lack of Efficacy|1|||
25255033|NCT01175590|50570790|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
25255034|NCT01175590|50570791|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
25255035|NCT01175590|50570790|FG000|Overall Study|Treated not as randomized|3|||
24978265|NCT02677922|50066847|FG002|Treatment Period|Lack of Efficacy|0|||
24978266|NCT02677922|50066848|FG003|Treatment Period|Lack of Efficacy|1|||
24978267|NCT02677922|50066849|FG004|Treatment Period|Lack of Efficacy|1|||
24978268|NCT02677922|50066850|FG005|Treatment Period|Lack of Efficacy|6|||
24978269|NCT02677922|50066845|FG000|Treatment Period|Withdrawal by Subject|0|||
24978270|NCT02677922|50066846|FG001|Treatment Period|Withdrawal by Subject|0|||
24978271|NCT02677922|50066847|FG002|Treatment Period|Withdrawal by Subject|1|||
24978272|NCT02677922|50066848|FG003|Treatment Period|Withdrawal by Subject|3|||
24978273|NCT02677922|50066849|FG004|Treatment Period|Withdrawal by Subject|5|||
24978274|NCT02677922|50066850|FG005|Treatment Period|Withdrawal by Subject|5|||
24978275|NCT02677922|50066845|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
24978276|NCT02677922|50066846|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
25255036|NCT01175590|50570791|FG001|Overall Study|Treated not as randomized|2|||
24978277|NCT02677922|50066847|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
24978278|NCT02677922|50066848|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
24978279|NCT02677922|50066849|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
24978280|NCT02677922|50066850|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
24978281|NCT02677922|50066845|FG000|Treatment Period|Disease Relapse|0|||
24978282|NCT02677922|50066846|FG001|Treatment Period|Disease Relapse|0|||
24978283|NCT02677922|50066847|FG002|Treatment Period|Disease Relapse|0|||
24978284|NCT02677922|50066848|FG003|Treatment Period|Disease Relapse|3|||
24978285|NCT02677922|50066849|FG004|Treatment Period|Disease Relapse|6|||
24978286|NCT02677922|50066850|FG005|Treatment Period|Disease Relapse|1|||
24978287|NCT02677922|50066845|FG000|Treatment Period|Allogeneic HSCT|1|||
24978288|NCT02677922|50066846|FG001|Treatment Period|Allogeneic HSCT|0|||
24978289|NCT02677922|50066847|FG002|Treatment Period|Allogeneic HSCT|0|||
24978290|NCT02677922|50066848|FG003|Treatment Period|Allogeneic HSCT|1|||
24978291|NCT02677922|50066849|FG004|Treatment Period|Allogeneic HSCT|4|||
24978292|NCT02677922|50066850|FG005|Treatment Period|Allogeneic HSCT|1|||
24978293|NCT02677922|50066845|FG000|Treatment Period|Other Reasons|0|||
24978294|NCT02677922|50066846|FG001|Treatment Period|Other Reasons|0|||
24978295|NCT02677922|50066847|FG002|Treatment Period|Other Reasons|0|||
24978296|NCT02677922|50066848|FG003|Treatment Period|Other Reasons|1|||
24978297|NCT02677922|50066849|FG004|Treatment Period|Other Reasons|3|||
24978298|NCT02677922|50066850|FG005|Treatment Period|Other Reasons|5|||
24978299|NCT02677922|50066845|FG000|Treatment Period|Death|0|||
24978300|NCT02677922|50066846|FG001|Treatment Period|Death|0|||
24978301|NCT02677922|50066847|FG002|Treatment Period|Death|0|||
24978302|NCT02677922|50066848|FG003|Treatment Period|Death|0|||
24978303|NCT02677922|50066849|FG004|Treatment Period|Death|12|||
24978304|NCT02677922|50066850|FG005|Treatment Period|Death|1|||
24978305|NCT02677922|50066845|FG000|Treatment Period|Non-compliance with Study Drug|0|||
24978306|NCT02677922|50066846|FG001|Treatment Period|Non-compliance with Study Drug|0|||
24978307|NCT02677922|50066847|FG002|Treatment Period|Non-compliance with Study Drug|0|||
24978308|NCT02677922|50066848|FG003|Treatment Period|Non-compliance with Study Drug|0|||
24978309|NCT02677922|50066849|FG004|Treatment Period|Non-compliance with Study Drug|1|||
24978310|NCT02677922|50066850|FG005|Treatment Period|Non-compliance with Study Drug|0|||
24978311|NCT02677922|50066845|FG000|Treatment Period|Physician Decision|0|||
24978312|NCT02677922|50066846|FG001|Treatment Period|Physician Decision|0|||
24978313|NCT02677922|50066847|FG002|Treatment Period|Physician Decision|0|||
24978314|NCT02677922|50066848|FG003|Treatment Period|Physician Decision|0|||
24978315|NCT02677922|50066849|FG004|Treatment Period|Physician Decision|0|||
24978316|NCT02677922|50066850|FG005|Treatment Period|Physician Decision|1|||
24978317|NCT02677922|50066845|FG000|Treatment Period|Symptomatic Deterioration|0|||
24978318|NCT02677922|50066846|FG001|Treatment Period|Symptomatic Deterioration|0|||
24978319|NCT02677922|50066847|FG002|Treatment Period|Symptomatic Deterioration|0|||
24978320|NCT02677922|50066848|FG003|Treatment Period|Symptomatic Deterioration|0|||
24978321|NCT02677922|50066849|FG004|Treatment Period|Symptomatic Deterioration|1|||
24978322|NCT02677922|50066850|FG005|Treatment Period|Symptomatic Deterioration|0|||
24978323|NCT02642042|50066865|FG000|Overall Study|Adverse Event|22|||
24978324|NCT02642042|50066865|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
24978325|NCT02642042|50066865|FG000|Overall Study|Progression/Relapse|28|||
24978326|NCT02642042|50066865|FG000|Overall Study|Death|1|||
24978327|NCT02642042|50066865|FG000|Overall Study|Not Protocol Specified|2|||
24978328|NCT02577406|50066871|FG000|Randomized Period|Death|1|||
24978329|NCT02577406|50066872|FG001|Randomized Period|Death|0|||
24978330|NCT02577406|50066871|FG000|Randomized Period|Other reasons|0|||
24978331|NCT02577406|50066872|FG001|Randomized Period|Other reasons|20|||
24978332|NCT02577406|50066871|FG000|Treatment Period|Transition to commercially available treatment|1|||
24978333|NCT02577406|50066872|FG001|Treatment Period|Transition to commercially available treatment|0|||
24978334|NCT02577406|50066871|FG000|Treatment Period|Progressive disease|47|||
24978335|NCT02577406|50066872|FG001|Treatment Period|Progressive disease|36|||
24978336|NCT02577406|50066871|FG000|Treatment Period|Death|36|||
24978337|NCT02577406|50066872|FG001|Treatment Period|Death|23|||
24978338|NCT02577406|50066871|FG000|Treatment Period|Other reasons|3|||
24978339|NCT02577406|50066872|FG001|Treatment Period|Other reasons|37|||
24978340|NCT02577406|50066871|FG000|Treatment Period|Withdrawal by Subject|10|||
24978341|NCT02577406|50066872|FG001|Treatment Period|Withdrawal by Subject|24|||
24978342|NCT02577406|50066871|FG000|Treatment Period|Adverse Event|17|||
24978343|NCT02577406|50066872|FG001|Treatment Period|Adverse Event|12|||
24978344|NCT02577406|50066871|FG000|Treatment Period|Disease relapse|27|||
24978345|NCT02577406|50066872|FG001|Treatment Period|Disease relapse|1|||
24978346|NCT02577406|50066871|FG000|Treatment Period|HSCT|6|||
24978347|NCT02577406|50066872|FG001|Treatment Period|HSCT|2|||
24978348|NCT02577406|50066871|FG000|Treatment Period|Lost to Follow-up|0|||
24978349|NCT02577406|50066872|FG001|Treatment Period|Lost to Follow-up|1|||
24978350|NCT02577406|50066871|FG000|Treatment Period|Protocol Violation|0|||
25078079|NCT03745651|50186223|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
24978351|NCT02577406|50066872|FG001|Treatment Period|Protocol Violation|1|||
25078080|NCT03745651|50186224|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
24978352|NCT02059265|50066891|FG000|Overall Study|Ineligible|4|||
24978353|NCT01925131|50066901|FG000|Overall Study|Death|0|||
24978354|NCT01925131|50066902|FG001|Overall Study|Death|0|||
24978355|NCT01925131|50066903|FG002|Overall Study|Death|1|||
24978356|NCT01925131|50066904|FG003|Overall Study|Death|0|||
24978357|NCT01925131|50066905|FG004|Overall Study|Death|0|||
24978358|NCT01925131|50066906|FG005|Overall Study|Death|0|||
24978359|NCT01925131|50066901|FG000|Overall Study|Progression/Relapse|1|||
24978360|NCT01925131|50066902|FG001|Overall Study|Progression/Relapse|1|||
24978361|NCT01925131|50066903|FG002|Overall Study|Progression/Relapse|4|||
24978362|NCT01925131|50066904|FG003|Overall Study|Progression/Relapse|0|||
24978363|NCT01925131|50066905|FG004|Overall Study|Progression/Relapse|0|||
24978364|NCT01925131|50066906|FG005|Overall Study|Progression/Relapse|1|||
24978365|NCT01925131|50066901|FG000|Overall Study|Patient Refusal|1|||
24978366|NCT01925131|50066902|FG001|Overall Study|Patient Refusal|0|||
24978367|NCT01925131|50066903|FG002|Overall Study|Patient Refusal|0|||
24978368|NCT01925131|50066904|FG003|Overall Study|Patient Refusal|0|||
24978369|NCT01925131|50066905|FG004|Overall Study|Patient Refusal|0|||
24978370|NCT01925131|50066906|FG005|Overall Study|Patient Refusal|0|||
24978371|NCT01925131|50066901|FG000|Overall Study|Adverse Event|0|||
24978372|NCT01925131|50066902|FG001|Overall Study|Adverse Event|0|||
24978373|NCT01925131|50066903|FG002|Overall Study|Adverse Event|2|||
24978374|NCT01925131|50066904|FG003|Overall Study|Adverse Event|0|||
24978375|NCT01925131|50066905|FG004|Overall Study|Adverse Event|1|||
24978376|NCT01925131|50066906|FG005|Overall Study|Adverse Event|3|||
24978377|NCT01925131|50066901|FG000|Overall Study|Other - Not Protocol Specified|3|||
24978378|NCT01925131|50066902|FG001|Overall Study|Other - Not Protocol Specified|1|||
24978379|NCT01925131|50066903|FG002|Overall Study|Other - Not Protocol Specified|2|||
24978380|NCT01925131|50066904|FG003|Overall Study|Other - Not Protocol Specified|5|||
24978381|NCT01925131|50066905|FG004|Overall Study|Other - Not Protocol Specified|10|||
24978382|NCT01925131|50066906|FG005|Overall Study|Other - Not Protocol Specified|6|||
24978383|NCT01809691|50066924|FG000|Overall Study|Currently on Treatment|192|||
24978384|NCT01809691|50066925|FG001|Overall Study|Currently on Treatment|100|||
24978385|NCT01809691|50066924|FG000|Overall Study|No Protocol Treatment|10|||
24978386|NCT01809691|50066925|FG001|Overall Study|No Protocol Treatment|11|||
24978387|NCT01809691|50066924|FG000|Overall Study|Adverse Event|80|||
24978388|NCT01809691|50066925|FG001|Overall Study|Adverse Event|21|||
24978389|NCT01809691|50066924|FG000|Overall Study|Disease Progression|226|||
24978390|NCT01809691|50066925|FG001|Overall Study|Disease Progression|372|||
24978391|NCT01809691|50066924|FG000|Overall Study|Death|26|||
24978392|NCT01809691|50066925|FG001|Overall Study|Death|13|||
24978393|NCT01809691|50066924|FG000|Overall Study|Participant Refusal|70|||
24978394|NCT01809691|50066925|FG001|Overall Study|Participant Refusal|72|||
24978395|NCT01809691|50066924|FG000|Overall Study|Other, Not Specified|34|||
24978396|NCT01809691|50066925|FG001|Overall Study|Other, Not Specified|52|||
24978397|NCT01708954|50066934|FG000|Step 1|Disease progression|26|||
24978398|NCT01708954|50066935|FG001|Step 1|Disease progression|17|||
24978399|NCT01708954|50066936|FG002|Step 1|Disease progression|14|||
24978400|NCT01708954|50066934|FG000|Step 1|Adverse Event|3|||
24978401|NCT01708954|50066935|FG001|Step 1|Adverse Event|11|||
24978402|NCT01708954|50066936|FG002|Step 1|Adverse Event|13|||
24978403|NCT01708954|50066934|FG000|Step 1|Death|3|||
24978404|NCT01708954|50066935|FG001|Step 1|Death|2|||
24978405|NCT01708954|50066936|FG002|Step 1|Death|3|||
24978406|NCT01708954|50066934|FG000|Step 1|Withdrawal by Subject|2|||
24978407|NCT01708954|50066935|FG001|Step 1|Withdrawal by Subject|5|||
25078081|NCT03745651|50186225|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
25340920|NCT00443209|50657230|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
25340921|NCT00439231|50657236|FG000|Overall Study|Lack of Efficacy|28|||
25340922|NCT00437983|50657242|FG000|Overall Study|Adverse Event|6|||
25340923|NCT00437983|50657243|FG001|Overall Study|Adverse Event|6|||
25340924|NCT00437983|50657242|FG000|Overall Study|Protocol Violation|2|||
25340925|NCT00437983|50657243|FG001|Overall Study|Protocol Violation|1|||
25340926|NCT00437983|50657242|FG000|Overall Study|Withdrawal by Subject|5|||
25340927|NCT00437983|50657243|FG001|Overall Study|Withdrawal by Subject|6|||
24978408|NCT01708954|50066936|FG002|Step 1|Withdrawal by Subject|3|||
25078082|NCT03745651|50186226|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
25078083|NCT03745651|50186227|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
24978409|NCT01708954|50066934|FG000|Step 1|Other complicating disease|0|||
24978410|NCT01708954|50066935|FG001|Step 1|Other complicating disease|2|||
25340928|NCT00783692|50657252|FG000|Induction Phase|Adverse Event|7|||
25340929|NCT00783692|50657253|FG001|Induction Phase|Adverse Event|9|||
24978411|NCT01708954|50066936|FG002|Step 1|Other complicating disease|0|||
24978412|NCT01708954|50066934|FG000|Step 1|Crossed over to Step 2|2|||
24978413|NCT01708954|50066935|FG001|Step 1|Crossed over to Step 2|0|||
24978414|NCT01708954|50066936|FG002|Step 1|Crossed over to Step 2|0|||
24978415|NCT01708954|50066934|FG000|Step 1|Symptomatic deterioration|1|||
24978416|NCT01708954|50066935|FG001|Step 1|Symptomatic deterioration|0|||
24978417|NCT01708954|50066936|FG002|Step 1|Symptomatic deterioration|1|||
25340930|NCT00783692|50657254|FG002|Induction Phase|Adverse Event|24|||
24978418|NCT01708954|50066934|FG000|Step 1|Off-treatment reason not submitted|1|||
24978419|NCT01708954|50066935|FG001|Step 1|Off-treatment reason not submitted|1|||
25340931|NCT00783692|50657255|FG003|Induction Phase|Adverse Event|0|||
25340932|NCT00783692|50657256|FG004|Induction Phase|Adverse Event|0|||
25340933|NCT00783692|50657257|FG005|Induction Phase|Adverse Event|0|||
25340934|NCT00783692|50657258|FG006|Induction Phase|Adverse Event|0|||
25340935|NCT00783692|50657252|FG000|Induction Phase|Protocol Violation|0|||
24978420|NCT01708954|50066936|FG002|Step 1|Off-treatment reason not submitted|1|||
24978421|NCT01708954|50066934|FG000|Step 1|Ineligible or never received treatment|4|||
24978422|NCT01708954|50066935|FG001|Step 1|Ineligible or never received treatment|2|||
24978423|NCT01708954|50066936|FG002|Step 1|Ineligible or never received treatment|8|||
24978424|NCT01708954|50066934|FG000|Step 2|Disease progression|9|||
24978425|NCT01708954|50066935|FG001|Step 2|Disease progression|4|||
24978426|NCT01708954|50066936|FG002|Step 2|Disease progression|0|||
24978427|NCT01708954|50066934|FG000|Step 2|Adverse Event|3|||
24978428|NCT01708954|50066935|FG001|Step 2|Adverse Event|2|||
24978429|NCT01708954|50066936|FG002|Step 2|Adverse Event|0|||
24978430|NCT01708954|50066934|FG000|Step 2|Withdrawal by Subject|1|||
24978431|NCT01708954|50066935|FG001|Step 2|Withdrawal by Subject|1|||
24978432|NCT01708954|50066936|FG002|Step 2|Withdrawal by Subject|0|||
24978433|NCT01708941|50066949|FG000|Overall Study|Adverse Event|4|||
24978434|NCT01708941|50066950|FG001|Overall Study|Adverse Event|6|||
24978435|NCT01708941|50066951|FG002|Overall Study|Adverse Event|1|||
24978436|NCT01708941|50066952|FG003|Overall Study|Adverse Event|0|||
24978437|NCT01708941|50066949|FG000|Overall Study|Death|1|||
24978438|NCT01708941|50066950|FG001|Overall Study|Death|1|||
24978439|NCT01708941|50066951|FG002|Overall Study|Death|2|||
24978440|NCT01708941|50066952|FG003|Overall Study|Death|14|||
24978441|NCT01708941|50066949|FG000|Overall Study|Withdrawal by Subject|1|||
24978442|NCT01708941|50066950|FG001|Overall Study|Withdrawal by Subject|0|||
24978443|NCT01708941|50066951|FG002|Overall Study|Withdrawal by Subject|3|||
24978444|NCT01708941|50066952|FG003|Overall Study|Withdrawal by Subject|4|||
24978445|NCT01708941|50066949|FG000|Overall Study|Disease progression|9|||
24978446|NCT01708941|50066950|FG001|Overall Study|Disease progression|10|||
24978447|NCT01708941|50066951|FG002|Overall Study|Disease progression|8|||
24978448|NCT01708941|50066952|FG003|Overall Study|Disease progression|0|||
24978449|NCT01708941|50066949|FG000|Overall Study|Alternative therapy|0|||
24978450|NCT01708941|50066950|FG001|Overall Study|Alternative therapy|0|||
24978451|NCT01708941|50066951|FG002|Overall Study|Alternative therapy|2|||
24978452|NCT01708941|50066952|FG003|Overall Study|Alternative therapy|0|||
24978453|NCT01708941|50066949|FG000|Overall Study|Ineligible and never started treatment|1|||
24978454|NCT01708941|50066950|FG001|Overall Study|Ineligible and never started treatment|0|||
24978455|NCT01708941|50066951|FG002|Overall Study|Ineligible and never started treatment|1|||
24978456|NCT01708941|50066952|FG003|Overall Study|Ineligible and never started treatment|0|||
24978457|NCT01708941|50066949|FG000|Overall Study|Never started treatment|2|||
24978458|NCT01708941|50066950|FG001|Overall Study|Never started treatment|1|||
24978459|NCT01708941|50066951|FG002|Overall Study|Never started treatment|0|||
24978460|NCT01708941|50066952|FG003|Overall Study|Never started treatment|0|||
24978461|NCT01708941|50066949|FG000|Overall Study|Ineligible|0|||
24978462|NCT01708941|50066950|FG001|Overall Study|Ineligible|0|||
24978463|NCT01708941|50066951|FG002|Overall Study|Ineligible|2|||
24978464|NCT01708941|50066952|FG003|Overall Study|Ineligible|0|||
24978465|NCT01698918|50066962|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
24978466|NCT01698918|50066962|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
25255037|NCT01175590|50570790|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
25255038|NCT01175590|50570791|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
25255039|NCT01175590|50570790|FG000|Overall Study|Protocol Violation|0|||
25255040|NCT01175590|50570791|FG001|Overall Study|Protocol Violation|1|||
25255041|NCT01175473|50570800|FG000|Overall Study|Adverse Event|2|||
25255042|NCT01175473|50570801|FG001|Overall Study|Adverse Event|2|||
25255043|NCT01111552|50570807|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
25255044|NCT01111552|50570808|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
25255045|NCT01111552|50570809|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
25255046|NCT01111552|50570810|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
25255047|NCT01111552|50570811|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
25255048|NCT01111552|50570807|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
25255049|NCT01111552|50570808|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
25340936|NCT00783692|50657253|FG001|Induction Phase|Protocol Violation|0|||
24978467|NCT01698918|50066962|FG000|First Line Treatment (Core+Extension)|Death|2|||
24978468|NCT01698918|50066962|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
24978469|NCT01698918|50066962|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
24978470|NCT01698918|50066962|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
24978471|NCT01698918|50066962|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
24978472|NCT01698918|50066962|FG000|Second Line Treatment (Core+Extension)|Death|1|||
25255050|NCT01111552|50570809|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
25340937|NCT00783692|50657254|FG002|Induction Phase|Protocol Violation|1|||
25340938|NCT00783692|50657255|FG003|Induction Phase|Protocol Violation|0|||
25340939|NCT00783692|50657256|FG004|Induction Phase|Protocol Violation|0|||
24978473|NCT01698918|50066962|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
24978474|NCT01698918|50066962|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
24978475|NCT01574274|50066977|FG000|Overall Study|Ineligible|0|||
24978476|NCT01574274|50066978|FG001|Overall Study|Ineligible|1|||
24978477|NCT01574274|50066977|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
25340940|NCT00783692|50657257|FG005|Induction Phase|Protocol Violation|0|||
25340941|NCT00783692|50657258|FG006|Induction Phase|Protocol Violation|0|||
25340942|NCT00783692|50657252|FG000|Induction Phase|Lack of Efficacy|1|||
25340943|NCT00783692|50657253|FG001|Induction Phase|Lack of Efficacy|3|||
25340944|NCT00783692|50657254|FG002|Induction Phase|Lack of Efficacy|28|||
25340945|NCT00783692|50657255|FG003|Induction Phase|Lack of Efficacy|0|||
25340946|NCT00783692|50657256|FG004|Induction Phase|Lack of Efficacy|0|||
25340947|NCT00783692|50657257|FG005|Induction Phase|Lack of Efficacy|0|||
25340948|NCT00783692|50657258|FG006|Induction Phase|Lack of Efficacy|0|||
25340949|NCT00783692|50657252|FG000|Induction Phase|Withdrawal by Subject|3|||
25340950|NCT00783692|50657253|FG001|Induction Phase|Withdrawal by Subject|9|||
25340951|NCT00783692|50657254|FG002|Induction Phase|Withdrawal by Subject|16|||
25340952|NCT00783692|50657255|FG003|Induction Phase|Withdrawal by Subject|0|||
25340953|NCT00783692|50657256|FG004|Induction Phase|Withdrawal by Subject|0|||
25340954|NCT00783692|50657257|FG005|Induction Phase|Withdrawal by Subject|0|||
25340955|NCT00783692|50657258|FG006|Induction Phase|Withdrawal by Subject|0|||
25340956|NCT00783692|50657252|FG000|Induction Phase|Lost to Follow-up|0|||
25340957|NCT00783692|50657253|FG001|Induction Phase|Lost to Follow-up|0|||
25340958|NCT00783692|50657254|FG002|Induction Phase|Lost to Follow-up|3|||
25340959|NCT00783692|50657255|FG003|Induction Phase|Lost to Follow-up|0|||
25340960|NCT00783692|50657256|FG004|Induction Phase|Lost to Follow-up|0|||
25340961|NCT00783692|50657257|FG005|Induction Phase|Lost to Follow-up|0|||
25340962|NCT00783692|50657258|FG006|Induction Phase|Lost to Follow-up|0|||
25340963|NCT00783692|50657252|FG000|Induction Phase|Other|0|||
25340964|NCT00783692|50657253|FG001|Induction Phase|Other|0|||
25340965|NCT00783692|50657254|FG002|Induction Phase|Other|2|||
25340966|NCT00783692|50657255|FG003|Induction Phase|Other|0|||
25340967|NCT00783692|50657256|FG004|Induction Phase|Other|0|||
25340968|NCT00783692|50657257|FG005|Induction Phase|Other|0|||
25340969|NCT00783692|50657258|FG006|Induction Phase|Other|0|||
25340970|NCT00783692|50657252|FG000|Maintenance Phase|Adverse Event|7|||
25340971|NCT00783692|50657253|FG001|Maintenance Phase|Adverse Event|0|||
25340972|NCT00783692|50657254|FG002|Maintenance Phase|Adverse Event|0|||
25340973|NCT00783692|50657255|FG003|Maintenance Phase|Adverse Event|15|||
25340974|NCT00783692|50657256|FG004|Maintenance Phase|Adverse Event|12|||
25340975|NCT00783692|50657257|FG005|Maintenance Phase|Adverse Event|9|||
25340976|NCT00783692|50657258|FG006|Maintenance Phase|Adverse Event|38|||
25340977|NCT00783692|50657252|FG000|Maintenance Phase|Protocol Violation|0|||
25340978|NCT00783692|50657253|FG001|Maintenance Phase|Protocol Violation|0|||
25340979|NCT00783692|50657254|FG002|Maintenance Phase|Protocol Violation|0|||
25340980|NCT00783692|50657255|FG003|Maintenance Phase|Protocol Violation|1|||
25340981|NCT00783692|50657256|FG004|Maintenance Phase|Protocol Violation|2|||
25340982|NCT00783692|50657257|FG005|Maintenance Phase|Protocol Violation|3|||
25340983|NCT00783692|50657258|FG006|Maintenance Phase|Protocol Violation|4|||
25340984|NCT00783692|50657252|FG000|Maintenance Phase|Lack of Efficacy|79|||
25340985|NCT00783692|50657253|FG001|Maintenance Phase|Lack of Efficacy|0|||
25340986|NCT00783692|50657254|FG002|Maintenance Phase|Lack of Efficacy|0|||
25340987|NCT00783692|50657255|FG003|Maintenance Phase|Lack of Efficacy|64|||
25340988|NCT00783692|50657256|FG004|Maintenance Phase|Lack of Efficacy|58|||
25340989|NCT00783692|50657257|FG005|Maintenance Phase|Lack of Efficacy|48|||
25340990|NCT00783692|50657258|FG006|Maintenance Phase|Lack of Efficacy|177|||
25340991|NCT00783692|50657252|FG000|Maintenance Phase|Withdrawal by Subject|7|||
25340992|NCT00783692|50657253|FG001|Maintenance Phase|Withdrawal by Subject|0|||
25340993|NCT00783692|50657254|FG002|Maintenance Phase|Withdrawal by Subject|0|||
25340994|NCT00783692|50657255|FG003|Maintenance Phase|Withdrawal by Subject|7|||
24978478|NCT01574274|50066978|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
25340995|NCT00783692|50657256|FG004|Maintenance Phase|Withdrawal by Subject|6|||
25340996|NCT00783692|50657257|FG005|Maintenance Phase|Withdrawal by Subject|9|||
25340997|NCT00783692|50657258|FG006|Maintenance Phase|Withdrawal by Subject|24|||
25340998|NCT00783692|50657252|FG000|Maintenance Phase|Lost to Follow-up|2|||
25340999|NCT00783692|50657253|FG001|Maintenance Phase|Lost to Follow-up|0|||
25341000|NCT00783692|50657254|FG002|Maintenance Phase|Lost to Follow-up|0|||
25341001|NCT00783692|50657255|FG003|Maintenance Phase|Lost to Follow-up|1|||
25341002|NCT00783692|50657256|FG004|Maintenance Phase|Lost to Follow-up|3|||
25341003|NCT00783692|50657257|FG005|Maintenance Phase|Lost to Follow-up|2|||
25341004|NCT00783692|50657258|FG006|Maintenance Phase|Lost to Follow-up|5|||
25341005|NCT00783692|50657252|FG000|Maintenance Phase|Other|0|||
25341006|NCT00783692|50657253|FG001|Maintenance Phase|Other|0|||
25341007|NCT00783692|50657254|FG002|Maintenance Phase|Other|0|||
25341008|NCT00783692|50657255|FG003|Maintenance Phase|Other|1|||
25341009|NCT00783692|50657256|FG004|Maintenance Phase|Other|0|||
25341010|NCT00783692|50657257|FG005|Maintenance Phase|Other|1|||
25341011|NCT00783692|50657258|FG006|Maintenance Phase|Other|1|||
25341012|NCT04992273|50657273|FG000|Overall Study|Lost to Follow-up|0|||
25341013|NCT04992273|50657274|FG001|Overall Study|Lost to Follow-up|1|||
25341014|NCT00783302|50657281|FG000|Overall Study|Lost to Follow-up|17|||
25341015|NCT00783302|50657281|FG000|Overall Study|Technical Problems|11|||
25341016|NCT00783302|50657281|FG000|Overall Study|Protocol Violation|3|||
25341017|NCT00783302|50657281|FG000|Overall Study|Physician Decision|1|||
25341018|NCT00783302|50657281|FG000|Overall Study|Withdrawal by Subject|3|||
25341019|NCT00783224|50657303|FG000|Overall Study|Adverse Event|0|||
25341020|NCT00783224|50657304|FG001|Overall Study|Adverse Event|0|||
24978479|NCT01574274|50066977|FG000|Overall Study|Ph+ B-ALL|3|||
24978480|NCT01574274|50066978|FG001|Overall Study|Ph+ B-ALL|4|||
24978481|NCT01574274|50066977|FG000|Overall Study|Induction Death|2|||
24978482|NCT01574274|50066978|FG001|Overall Study|Induction Death|0|||
24978483|NCT01574274|50066977|FG000|Overall Study|Induction Failure|4|||
24978484|NCT01574274|50066978|FG001|Overall Study|Induction Failure|1|||
24978485|NCT01574274|50066977|FG000|Overall Study|Adverse Event|16|||
24978486|NCT01574274|50066978|FG001|Overall Study|Adverse Event|13|||
24978487|NCT01574274|50066977|FG000|Overall Study|Remission Death|1|||
24978488|NCT01574274|50066978|FG001|Overall Study|Remission Death|0|||
24978489|NCT01574274|50066977|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
24978490|NCT01574274|50066978|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
24978491|NCT01574274|50066977|FG000|Overall Study|Other, unknown|3|||
24978492|NCT01574274|50066978|FG001|Overall Study|Other, unknown|2|||
24978493|NCT01275677|50066986|FG000|Overall Study|Not at risk for recurrence.|1|||
24978494|NCT01275677|50066987|FG001|Overall Study|Not at risk for recurrence.|1|||
24978495|NCT01275677|50066986|FG000|Overall Study|No follow-up|26|||
24978496|NCT01275677|50066987|FG001|Overall Study|No follow-up|37|||
24978497|NCT01275677|50066986|FG000|Overall Study|No clinical follow up.|1|||
24978498|NCT01275677|50066987|FG001|Overall Study|No clinical follow up.|4|||
24978499|NCT01208974|50066993|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
24978500|NCT01208974|50066994|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
24978501|NCT01208974|50066995|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
24978502|NCT01208974|50066996|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
24978503|NCT01208974|50066993|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
24978504|NCT01208974|50066994|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
24978505|NCT01208974|50066995|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
24978506|NCT01208974|50066996|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
24978507|NCT01208974|50066993|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
24978508|NCT01208974|50066994|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
24978509|NCT01208974|50066995|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
24978510|NCT01208974|50066996|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
24978511|NCT01169337|50067006|FG000|Overall Study|Lack of Efficacy|5|||
24978512|NCT01169337|50067007|FG001|Overall Study|Lack of Efficacy|7|||
25078084|NCT03745651|50186228|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
25078085|NCT03745651|50186229|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
25078086|NCT03745651|50186223|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
25078087|NCT03745651|50186224|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
25255051|NCT01111552|50570810|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
25255052|NCT01111552|50570811|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
25255053|NCT01111552|50570807|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
25255054|NCT01111552|50570808|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
25255055|NCT01111552|50570809|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
25255056|NCT01111552|50570810|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
24978513|NCT01169337|50067008|FG002|Overall Study|Lack of Efficacy|0|||
24978514|NCT01169337|50067006|FG000|Overall Study|Adverse Event|12|||
25255057|NCT01111552|50570811|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
25255058|NCT01111552|50570807|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
25255059|NCT01111552|50570808|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
25255060|NCT01111552|50570809|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
25255061|NCT01111552|50570810|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
25255062|NCT01111552|50570811|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
25255063|NCT01111552|50570807|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
25341021|NCT00783224|50657305|FG002|Overall Study|Adverse Event|1|||
25341022|NCT00783224|50657306|FG003|Overall Study|Adverse Event|0|||
25341023|NCT00783224|50657303|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
24978515|NCT01169337|50067007|FG001|Overall Study|Adverse Event|18|||
24978516|NCT01169337|50067008|FG002|Overall Study|Adverse Event|0|||
24978517|NCT01169337|50067006|FG000|Overall Study|Death|2|||
25341024|NCT00783224|50657304|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
24978518|NCT01169337|50067007|FG001|Overall Study|Death|0|||
24978519|NCT01169337|50067008|FG002|Overall Study|Death|0|||
24978520|NCT01169337|50067006|FG000|Overall Study|Withdrawal by Subject|11|||
24978521|NCT01169337|50067007|FG001|Overall Study|Withdrawal by Subject|11|||
24978522|NCT01169337|50067008|FG002|Overall Study|Withdrawal by Subject|6|||
24978523|NCT01169337|50067006|FG000|Overall Study|Noncompliance|2|||
24978524|NCT01169337|50067007|FG001|Overall Study|Noncompliance|0|||
24978525|NCT01169337|50067008|FG002|Overall Study|Noncompliance|0|||
24978526|NCT01169337|50067006|FG000|Overall Study|Other complicating disease|1|||
24978527|NCT01169337|50067007|FG001|Overall Study|Other complicating disease|1|||
24978528|NCT01169337|50067008|FG002|Overall Study|Other complicating disease|0|||
24978529|NCT01169337|50067006|FG000|Overall Study|Physician Decision|1|||
24978530|NCT01169337|50067007|FG001|Overall Study|Physician Decision|5|||
24978531|NCT01169337|50067008|FG002|Overall Study|Physician Decision|0|||
24978532|NCT01169337|50067006|FG000|Overall Study|Alternative therapy|0|||
24978533|NCT01169337|50067007|FG001|Overall Study|Alternative therapy|2|||
24978534|NCT01169337|50067008|FG002|Overall Study|Alternative therapy|0|||
24978535|NCT01169337|50067006|FG000|Overall Study|Changed hospital|0|||
24978536|NCT01169337|50067007|FG001|Overall Study|Changed hospital|1|||
24978537|NCT01169337|50067008|FG002|Overall Study|Changed hospital|0|||
24978538|NCT01169337|50067006|FG000|Overall Study|Never started treatment|0|||
24978539|NCT01169337|50067007|FG001|Overall Study|Never started treatment|2|||
24978540|NCT01169337|50067008|FG002|Overall Study|Never started treatment|0|||
24978541|NCT01169337|50067006|FG000|Overall Study|Reason not reported|1|||
24978542|NCT01169337|50067007|FG001|Overall Study|Reason not reported|0|||
24978543|NCT01169337|50067008|FG002|Overall Study|Reason not reported|0|||
24978544|NCT01169337|50067006|FG000|Overall Study|Continuing lenalidomide|9|||
24978545|NCT01169337|50067007|FG001|Overall Study|Continuing lenalidomide|43|||
24978546|NCT01169337|50067008|FG002|Overall Study|Continuing lenalidomide|0|||
24978547|NCT00840177|50067019|FG000|Overall Study|Adverse Event|5|||
24978548|NCT00840177|50067020|FG001|Overall Study|Adverse Event|1|||
24978549|NCT00840177|50067021|FG002|Overall Study|Adverse Event|1|||
24978550|NCT00840177|50067019|FG000|Overall Study|Refusal unrelated to adverse events|1|||
24978551|NCT00840177|50067020|FG001|Overall Study|Refusal unrelated to adverse events|0|||
24978552|NCT00840177|50067021|FG002|Overall Study|Refusal unrelated to adverse events|1|||
24978553|NCT00840177|50067019|FG000|Overall Study|Progression/relapse|2|||
24978554|NCT00840177|50067020|FG001|Overall Study|Progression/relapse|0|||
24978555|NCT00840177|50067021|FG002|Overall Study|Progression/relapse|0|||
24978556|NCT00840177|50067019|FG000|Overall Study|Death|4|||
24978557|NCT00840177|50067020|FG001|Overall Study|Death|5|||
24978558|NCT00840177|50067021|FG002|Overall Study|Death|5|||
24978559|NCT00840177|50067019|FG000|Overall Study|not protocol specified|6|||
24978560|NCT00840177|50067020|FG001|Overall Study|not protocol specified|3|||
24978561|NCT00840177|50067021|FG002|Overall Study|not protocol specified|0|||
24978562|NCT00840177|50067019|FG000|Overall Study|Ineligible|0|||
24978563|NCT00840177|50067020|FG001|Overall Study|Ineligible|0|||
24978564|NCT00840177|50067021|FG002|Overall Study|Ineligible|3|||
24978565|NCT00840177|50067019|FG000|Overall Study|Did not start treatment|0|||
24978566|NCT00840177|50067020|FG001|Overall Study|Did not start treatment|0|||
24978567|NCT00840177|50067021|FG002|Overall Study|Did not start treatment|1|||
24978568|NCT01347580|50067031|FG000|Overall Study|Withdrawal by Subject|13|||
24978569|NCT01347580|50067032|FG001|Overall Study|Withdrawal by Subject|23|||
24978570|NCT01347580|50067031|FG000|Overall Study|Death|30|||
24978571|NCT01347580|50067032|FG001|Overall Study|Death|19|||
24978572|NCT01347580|50067031|FG000|Overall Study|Protocol Violation|10|||
24978573|NCT01347580|50067032|FG001|Overall Study|Protocol Violation|7|||
24978574|NCT01347580|50067031|FG000|Overall Study|Lost to Follow-up|3|||
24978575|NCT01347580|50067032|FG001|Overall Study|Lost to Follow-up|1|||
24978576|NCT01347580|50067031|FG000|Overall Study|Had other reason|9|||
24978577|NCT01347580|50067032|FG001|Overall Study|Had other reason|6|||
24978578|NCT00398411|50067040|FG000|Overall Study|Death|0|||
24978579|NCT00398411|50067041|FG001|Overall Study|Death|1|||
24978580|NCT03352414|50067049|FG000|Overall Study|Ineligible by operative criteria|12|||
24978581|NCT03352414|50067050|FG001|Overall Study|Ineligible by operative criteria|10|||
24978582|NCT00364793|50067062|FG000|Overall Study|Adverse Event|2|||
24978583|NCT00364793|50067063|FG001|Overall Study|Adverse Event|0|||
24978584|NCT00364793|50067064|FG002|Overall Study|Adverse Event|0|||
24978585|NCT00364793|50067065|FG003|Overall Study|Adverse Event|0|||
24978586|NCT00364793|50067062|FG000|Overall Study|Death|1|||
24978587|NCT00364793|50067063|FG001|Overall Study|Death|0|||
24978588|NCT00364793|50067064|FG002|Overall Study|Death|1|||
24978589|NCT00364793|50067065|FG003|Overall Study|Death|0|||
24978590|NCT00364793|50067062|FG000|Overall Study|Lack of Efficacy|3|||
24978591|NCT00364793|50067063|FG001|Overall Study|Lack of Efficacy|3|||
24978592|NCT00364793|50067064|FG002|Overall Study|Lack of Efficacy|1|||
24978593|NCT00364793|50067065|FG003|Overall Study|Lack of Efficacy|1|||
24978594|NCT00364793|50067062|FG000|Overall Study|Lost to Follow-up|1|||
24978595|NCT00364793|50067063|FG001|Overall Study|Lost to Follow-up|0|||
24978596|NCT00364793|50067064|FG002|Overall Study|Lost to Follow-up|2|||
24978597|NCT00364793|50067065|FG003|Overall Study|Lost to Follow-up|0|||
24978598|NCT00364793|50067062|FG000|Overall Study|Poor or non-compliance|1|||
24978599|NCT00364793|50067063|FG001|Overall Study|Poor or non-compliance|1|||
24978600|NCT00364793|50067064|FG002|Overall Study|Poor or non-compliance|0|||
24978601|NCT00364793|50067065|FG003|Overall Study|Poor or non-compliance|1|||
24978602|NCT00364793|50067062|FG000|Overall Study|No longer meets criteria|0|||
25341025|NCT00783224|50657305|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
25341026|NCT00783224|50657306|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
25341027|NCT00783224|50657303|FG000|Overall Study|Inappropriate as a study subject|0|||
25341028|NCT00783224|50657304|FG001|Overall Study|Inappropriate as a study subject|0|||
25341029|NCT00783224|50657305|FG002|Overall Study|Inappropriate as a study subject|0|||
25341030|NCT00783224|50657306|FG003|Overall Study|Inappropriate as a study subject|1|||
25341031|NCT00782834|50657315|FG000|Treatment Phase|fibrous tumor not GIST|1|||
25341032|NCT00584805|50657319|FG000|Overall Study|No longer at risk of exposure|39|||
25341033|NCT00584805|50657319|FG000|Overall Study|Relocation|36|||
25341034|NCT00584805|50657319|FG000|Overall Study|Withdrawal by Subject|18|||
25341035|NCT00584805|50657319|FG000|Overall Study|Non-compliance|1|||
25341036|NCT00584805|50657319|FG000|Overall Study|Lost to follow up|3|||
25341037|NCT00584805|50657319|FG000|Overall Study|Screen failures|2|||
25341038|NCT00765674|50657329|FG000|Overall Study|Adverse Event|7|||
25341039|NCT00765674|50657330|FG001|Overall Study|Adverse Event|2|||
25341040|NCT00765674|50657331|FG002|Overall Study|Adverse Event|8|||
25341041|NCT00765674|50657332|FG003|Overall Study|Adverse Event|11|||
25341042|NCT00765674|50657329|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
25341043|NCT00765674|50657330|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
25341044|NCT00765674|50657331|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
25341045|NCT00765674|50657332|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
25341046|NCT00765674|50657329|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
25341047|NCT00765674|50657330|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
25341048|NCT00765674|50657331|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
25341049|NCT00765674|50657332|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
25341050|NCT00765674|50657329|FG000|Overall Study|Lack of Efficacy|2|||
25341051|NCT00765674|50657330|FG001|Overall Study|Lack of Efficacy|3|||
25341052|NCT00765674|50657331|FG002|Overall Study|Lack of Efficacy|1|||
25341053|NCT00765674|50657332|FG003|Overall Study|Lack of Efficacy|2|||
25341054|NCT00765674|50657329|FG000|Overall Study|Protocol Violation|2|||
25341055|NCT00765674|50657330|FG001|Overall Study|Protocol Violation|0|||
25341056|NCT00765674|50657331|FG002|Overall Study|Protocol Violation|1|||
25341057|NCT00765674|50657332|FG003|Overall Study|Protocol Violation|0|||
25341058|NCT00765674|50657329|FG000|Overall Study|Withdrawal by Subject|5|||
25341059|NCT00765674|50657330|FG001|Overall Study|Withdrawal by Subject|7|||
25341060|NCT00765674|50657331|FG002|Overall Study|Withdrawal by Subject|3|||
25341061|NCT00765674|50657332|FG003|Overall Study|Withdrawal by Subject|8|||
25341062|NCT00765674|50657329|FG000|Overall Study|Lost to Follow-up|4|||
25341063|NCT00765674|50657330|FG001|Overall Study|Lost to Follow-up|6|||
25341064|NCT00765674|50657331|FG002|Overall Study|Lost to Follow-up|2|||
25341065|NCT00765674|50657332|FG003|Overall Study|Lost to Follow-up|1|||
25341066|NCT00765674|50657329|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
25341067|NCT00765674|50657330|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
25341068|NCT00765674|50657331|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
25341069|NCT00765674|50657332|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
25341070|NCT00765362|50657342|FG000|Overall Study|Death|9|||
25341071|NCT00765362|50657342|FG000|Overall Study|Adverse Event|2|||
25341072|NCT00765362|50657342|FG000|Overall Study|Protocol Violation|18|||
25341073|NCT00765362|50657342|FG000|Overall Study|Withdrawal by Subject|13|||
25341074|NCT00765362|50657342|FG000|Overall Study|Lost to Follow-up|95|||
25341075|NCT00586898|50657346|FG000|Overall Study|Adverse Event|1|||
25341076|NCT00586898|50657346|FG000|Overall Study|Patiemt Non-compliance|1|||
25341077|NCT00586898|50657346|FG000|Overall Study|Evaluable for Toxicity Only|5|||
25341078|NCT04912245|50657350|FG000|Overall Study|Withdrawal by Subject|21|||
25341079|NCT04912245|50657351|FG001|Overall Study|Withdrawal by Subject|4|||
25341080|NCT04912245|50657350|FG000|Overall Study|Lost to Follow-up|5|||
25341081|NCT04912245|50657351|FG001|Overall Study|Lost to Follow-up|11|||
25341082|NCT00796991|50657358|FG000|Overall Study|Adverse Event|0|||
25341083|NCT00796991|50657359|FG001|Overall Study|Adverse Event|0|||
25341084|NCT00796991|50657360|FG002|Overall Study|Adverse Event|1|||
25341085|NCT00796991|50657358|FG000|Overall Study|Death|2|||
25341086|NCT00796991|50657359|FG001|Overall Study|Death|0|||
25341087|NCT00796991|50657360|FG002|Overall Study|Death|0|||
25341088|NCT00796991|50657358|FG000|Overall Study|Disease Progression|10|||
25341089|NCT00796991|50657359|FG001|Overall Study|Disease Progression|9|||
24978603|NCT00364793|50067063|FG001|Overall Study|No longer meets criteria|0|||
25341090|NCT00796991|50657360|FG002|Overall Study|Disease Progression|7|||
25341091|NCT00796991|50657358|FG000|Overall Study|Study Drug Toxicity|3|||
25341092|NCT00796991|50657359|FG001|Overall Study|Study Drug Toxicity|3|||
25341093|NCT00796991|50657360|FG002|Overall Study|Study Drug Toxicity|5|||
25341094|NCT00796991|50657358|FG000|Overall Study|Withdrawal by Subject|0|||
25341095|NCT00796991|50657359|FG001|Overall Study|Withdrawal by Subject|0|||
25341096|NCT00796991|50657360|FG002|Overall Study|Withdrawal by Subject|1|||
25341097|NCT00799487|50657371|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
25341098|NCT00799487|50657372|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
25341099|NCT00799487|50657373|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
25341100|NCT00799487|50657371|FG000|Dose Adjustment Period|Adverse Event|2|||
25341101|NCT00799487|50657372|FG001|Dose Adjustment Period|Adverse Event|0|||
25341102|NCT00799487|50657373|FG002|Dose Adjustment Period|Adverse Event|0|||
25341103|NCT00799487|50657371|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
25341104|NCT00799487|50657372|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
25341105|NCT00799487|50657373|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
25341106|NCT00799487|50657371|FG000|Dose Adjustment Period|Investigator Discretion|2|||
25341107|NCT00799487|50657372|FG001|Dose Adjustment Period|Investigator Discretion|0|||
25341108|NCT00799487|50657373|FG002|Dose Adjustment Period|Investigator Discretion|0|||
25341109|NCT00799487|50657371|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
25341110|NCT00799487|50657372|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
25341111|NCT00799487|50657373|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
25341112|NCT00799487|50657371|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
25341113|NCT00799487|50657372|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
25341114|NCT00799487|50657373|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
25341115|NCT00799487|50657371|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
25341116|NCT00799487|50657372|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
25341117|NCT00799487|50657373|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
25341118|NCT00799487|50657371|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
25341119|NCT00799487|50657372|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
25341120|NCT00799487|50657373|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
25341121|NCT00799487|50657371|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
25341122|NCT00799487|50657372|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
25341123|NCT00799487|50657373|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
25341124|NCT00799487|50657371|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
25341125|NCT00799487|50657372|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
25341126|NCT00799487|50657373|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
25341127|NCT00799487|50657371|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
25341128|NCT00799487|50657372|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
25341129|NCT00799487|50657373|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
25341130|NCT00799487|50657371|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
25341131|NCT00799487|50657372|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
25341132|NCT00799487|50657373|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
25341133|NCT00584727|50657384|FG000|First Intervention|Discontinuation|0|||
25341134|NCT00584727|50657385|FG001|First Intervention|Discontinuation|0|||
25341135|NCT00584727|50657386|FG002|First Intervention|Discontinuation|1|||
25341136|NCT00584727|50657387|FG003|First Intervention|Discontinuation|0|||
25341137|NCT00584727|50657388|FG004|First Intervention|Discontinuation|0|||
25341138|NCT00584727|50657389|FG005|First Intervention|Discontinuation|0|||
25341139|NCT00584727|50657384|FG000|Third Intervention|Protocol Violation|0|||
25341140|NCT00584727|50657385|FG001|Third Intervention|Protocol Violation|0|||
25341141|NCT00584727|50657386|FG002|Third Intervention|Protocol Violation|1|||
25341142|NCT00584727|50657387|FG003|Third Intervention|Protocol Violation|0|||
25341143|NCT00584727|50657388|FG004|Third Intervention|Protocol Violation|4|||
25341144|NCT00584727|50657389|FG005|Third Intervention|Protocol Violation|2|||
25341145|NCT00799409|50657403|FG000|Overall Study|Withdrawal by Subject|1|||
25341146|NCT00799409|50657404|FG001|Overall Study|Withdrawal by Subject|0|||
25341147|NCT00799409|50657405|FG002|Overall Study|Withdrawal by Subject|0|||
25341148|NCT00799409|50657403|FG000|Overall Study|Lost to Follow-up|1|||
25341149|NCT00799409|50657404|FG001|Overall Study|Lost to Follow-up|0|||
25341150|NCT00799409|50657405|FG002|Overall Study|Lost to Follow-up|0|||
25341151|NCT00799409|50657403|FG000|Overall Study|Optimal Dose Not Achieved|2|||
25341152|NCT00799409|50657404|FG001|Overall Study|Optimal Dose Not Achieved|0|||
25341153|NCT00799409|50657405|FG002|Overall Study|Optimal Dose Not Achieved|0|||
25341154|NCT00799409|50657403|FG000|Overall Study|Failure to follow study protocol)|1|||
25341155|NCT00799409|50657404|FG001|Overall Study|Failure to follow study protocol)|0|||
25341156|NCT00799409|50657405|FG002|Overall Study|Failure to follow study protocol)|0|||
25341157|NCT00799409|50657403|FG000|Overall Study|Did not attend lab school day 1|1|||
25341158|NCT00799409|50657404|FG001|Overall Study|Did not attend lab school day 1|0|||
25341159|NCT00799409|50657405|FG002|Overall Study|Did not attend lab school day 1|0|||
25341160|NCT00799409|50657403|FG000|Overall Study|medication compliance|1|||
25341161|NCT00799409|50657404|FG001|Overall Study|medication compliance|0|||
25341162|NCT00799409|50657405|FG002|Overall Study|medication compliance|0|||
25341163|NCT00782210|50657416|FG000|Overall Study|Adverse Event|21|||
25341164|NCT00782210|50657417|FG001|Overall Study|Adverse Event|17|||
25341165|NCT00782210|50657418|FG002|Overall Study|Adverse Event|16|||
25341166|NCT00782210|50657416|FG000|Overall Study|Lost to Follow-up|2|||
25341167|NCT00782210|50657417|FG001|Overall Study|Lost to Follow-up|1|||
25341168|NCT00782210|50657418|FG002|Overall Study|Lost to Follow-up|2|||
25341169|NCT00782210|50657416|FG000|Overall Study|Withdrawal by Subject|11|||
25341170|NCT00782210|50657417|FG001|Overall Study|Withdrawal by Subject|8|||
25341171|NCT00782210|50657418|FG002|Overall Study|Withdrawal by Subject|11|||
25341172|NCT00782210|50657416|FG000|Overall Study|Non compliance with protocol|0|||
25341173|NCT00782210|50657417|FG001|Overall Study|Non compliance with protocol|3|||
25341174|NCT00782210|50657418|FG002|Overall Study|Non compliance with protocol|2|||
25341175|NCT00782210|50657416|FG000|Overall Study|Lack of Efficacy|13|||
25341176|NCT00782210|50657417|FG001|Overall Study|Lack of Efficacy|4|||
25341177|NCT00782210|50657418|FG002|Overall Study|Lack of Efficacy|1|||
25341178|NCT00782210|50657416|FG000|Overall Study|Other reason not described above|3|||
25341179|NCT00782210|50657417|FG001|Overall Study|Other reason not described above|2|||
25341180|NCT00782210|50657418|FG002|Overall Study|Other reason not described above|3|||
25341181|NCT01558115|50657435|FG000|Overall Study|Withdrawal by Subject|3|||
25341182|NCT01558115|50657435|FG000|Overall Study|Study closed due to poor enrollment|4|||
25341183|NCT00764660|50657458|FG000|Overall Study|Adverse Event|6|||
25341184|NCT00764660|50657459|FG001|Overall Study|Adverse Event|3|||
25341185|NCT00764660|50657458|FG000|Overall Study|Lost to Follow-up|3|||
25341186|NCT00764660|50657459|FG001|Overall Study|Lost to Follow-up|4|||
25341187|NCT00764660|50657458|FG000|Overall Study|Withdrawal by Subject|7|||
25341188|NCT00764660|50657459|FG001|Overall Study|Withdrawal by Subject|3|||
25341189|NCT00764660|50657458|FG000|Overall Study|Noncompliance With Protocol|5|||
25341190|NCT00764660|50657459|FG001|Overall Study|Noncompliance With Protocol|1|||
25341191|NCT00764660|50657458|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
25341192|NCT00764660|50657459|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
25341193|NCT00584415|50657465|FG000|Overall Study|Adverse Event|7|||
25341194|NCT00764504|50657473|FG000|Overall Study|Death|12|||
25341195|NCT00764504|50657474|FG001|Overall Study|Death|6|||
25341196|NCT00764504|50657475|FG002|Overall Study|Death|13|||
25341197|NCT00764504|50657473|FG000|Overall Study|Revision of Device|12|||
25341198|NCT00764504|50657474|FG001|Overall Study|Revision of Device|23|||
25341199|NCT00764504|50657475|FG002|Overall Study|Revision of Device|14|||
25341200|NCT00764504|50657473|FG000|Overall Study|Physician Decision|1|||
25341201|NCT00764504|50657474|FG001|Overall Study|Physician Decision|0|||
25341202|NCT00764504|50657475|FG002|Overall Study|Physician Decision|0|||
25341203|NCT00764504|50657473|FG000|Overall Study|Withdrawal by Subject|1|||
25341204|NCT00764504|50657474|FG001|Overall Study|Withdrawal by Subject|7|||
25341205|NCT00764504|50657475|FG002|Overall Study|Withdrawal by Subject|4|||
25341206|NCT00764504|50657473|FG000|Overall Study|Lost to Follow-up|40|||
25341207|NCT00764504|50657474|FG001|Overall Study|Lost to Follow-up|34|||
25341208|NCT00764504|50657475|FG002|Overall Study|Lost to Follow-up|72|||
25341209|NCT00763958|50657485|FG000|Overall Study|did not meet final criteria|4|||
25341210|NCT00763958|50657486|FG001|Overall Study|did not meet final criteria|4|||
25341211|NCT00763958|50657485|FG000|Overall Study|Lost to Follow-up|10|||
25341212|NCT00763958|50657486|FG001|Overall Study|Lost to Follow-up|2|||
25341213|NCT00763958|50657485|FG000|Overall Study|Believed they were receiving placebo|0|||
25341214|NCT00763958|50657486|FG001|Overall Study|Believed they were receiving placebo|5|||
25341215|NCT00763256|50657495|FG000|Overall Study|Didn't return for appointments|7|||
25341216|NCT00763256|50657496|FG001|Overall Study|Didn't return for appointments|10|||
25341217|NCT00762788|50657508|FG000|Overall Study|Lost to Follow-up|26|||
25341218|NCT00762788|50657509|FG001|Overall Study|Lost to Follow-up|37|||
25341219|NCT00762788|50657510|FG002|Overall Study|Lost to Follow-up|21|||
25341220|NCT00762788|50657511|FG003|Overall Study|Lost to Follow-up|26|||
25341221|NCT00762788|50657512|FG004|Overall Study|Lost to Follow-up|13|||
25341222|NCT00762788|50657513|FG005|Overall Study|Lost to Follow-up|21|||
25341223|NCT00583947|50657529|FG000|Cross-over Period|Adverse Event|2|||
25341224|NCT00583947|50657530|FG001|Cross-over Period|Adverse Event|0|||
25341225|NCT00583947|50657529|FG000|Cross-over Period|Withdrawal by Subject|2|||
25341226|NCT00583947|50657530|FG001|Cross-over Period|Withdrawal by Subject|0|||
25341227|NCT00583947|50657529|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
25341228|NCT00583947|50657530|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
25341229|NCT00583947|50657529|FG000|Cross-over Period|Other|1|||
25341230|NCT00583947|50657530|FG001|Cross-over Period|Other|1|||
25341231|NCT00772928|50657540|FG000|Overall Study|Lost to Follow-up|9|||
25341232|NCT00772928|50657541|FG001|Overall Study|Lost to Follow-up|6|||
25341233|NCT00772928|50657540|FG000|Overall Study|Protocol Violation|10|||
25341234|NCT00772928|50657541|FG001|Overall Study|Protocol Violation|12|||
25341235|NCT00772928|50657540|FG000|Overall Study|Withdrawal by Subject|25|||
25341236|NCT00772928|50657541|FG001|Overall Study|Withdrawal by Subject|22|||
25341237|NCT00772928|50657540|FG000|Overall Study|Did not receive vaccine|0|||
25341238|NCT00772928|50657541|FG001|Overall Study|Did not receive vaccine|1|||
25341239|NCT00762476|50657549|FG000|Overall Study|Adverse Event|7|||
25341240|NCT00762476|50657550|FG001|Overall Study|Adverse Event|1|||
25341241|NCT00762476|50657549|FG000|Overall Study|Lost to Follow-up|2|||
25341242|NCT00762476|50657550|FG001|Overall Study|Lost to Follow-up|0|||
25341243|NCT00762476|50657549|FG000|Overall Study|Protocol Violation|5|||
25341244|NCT00762476|50657550|FG001|Overall Study|Protocol Violation|6|||
25341245|NCT00762476|50657549|FG000|Overall Study|Physician Decision|2|||
25341246|NCT00762476|50657550|FG001|Overall Study|Physician Decision|14|||
25341247|NCT00762476|50657549|FG000|Overall Study|Withdrawal by Subject|6|||
25341248|NCT00762476|50657550|FG001|Overall Study|Withdrawal by Subject|12|||
25341249|NCT00762476|50657549|FG000|Overall Study|antibiotic use|0|||
25341250|NCT00762476|50657550|FG001|Overall Study|antibiotic use|1|||
25341251|NCT00762476|50657549|FG000|Overall Study|non-compliance with study visits|0|||
25341252|NCT00762476|50657550|FG001|Overall Study|non-compliance with study visits|2|||
25341253|NCT00762476|50657549|FG000|Overall Study|Seasonal allergies|1|||
25341254|NCT00762476|50657550|FG001|Overall Study|Seasonal allergies|0|||
25341255|NCT00762164|50657559|FG000|Overall Study|Lost to Follow-up|1|||
25341256|NCT00762164|50657560|FG001|Overall Study|Lost to Follow-up|1|||
25341257|NCT00762164|50657559|FG000|Overall Study|Discontinued medication|2|||
24978604|NCT00364793|50067064|FG002|Overall Study|No longer meets criteria|0|||
24978605|NCT00364793|50067065|FG003|Overall Study|No longer meets criteria|1|||
24978606|NCT00364793|50067062|FG000|Overall Study|Withdrawal by Subject|0|||
24978607|NCT00364793|50067063|FG001|Overall Study|Withdrawal by Subject|1|||
24978608|NCT00364793|50067064|FG002|Overall Study|Withdrawal by Subject|0|||
24978609|NCT00364793|50067065|FG003|Overall Study|Withdrawal by Subject|0|||
24978610|NCT03351478|50067081|FG000|Overall Study|At the subject's own request|11|||
24978611|NCT03351478|50067082|FG001|Overall Study|At the subject's own request|12|||
24978612|NCT03351478|50067083|FG002|Overall Study|At the subject's own request|5|||
25078088|NCT03745651|50186225|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
25255064|NCT01111552|50570808|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
24978613|NCT03351478|50067081|FG000|Overall Study|Adverse Event|1|||
24978614|NCT03351478|50067082|FG001|Overall Study|Adverse Event|2|||
24978615|NCT03351478|50067083|FG002|Overall Study|Adverse Event|1|||
24978616|NCT03351478|50067081|FG000|Overall Study|Poor compliance to protocol|1|||
24978617|NCT03351478|50067082|FG001|Overall Study|Poor compliance to protocol|0|||
24978618|NCT03351478|50067083|FG002|Overall Study|Poor compliance to protocol|0|||
24978619|NCT03351478|50067081|FG000|Overall Study|Reason not Specified|1|||
25255065|NCT01111552|50570809|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
25255066|NCT01111552|50570810|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
25255067|NCT01111552|50570811|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
25255068|NCT01111552|50570807|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
25255069|NCT01111552|50570808|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
25255070|NCT01111552|50570809|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
25255071|NCT01111552|50570810|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
25255072|NCT01111552|50570811|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
25255073|NCT01111552|50570807|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
25255074|NCT01111552|50570808|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
25255075|NCT01111552|50570809|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
25255076|NCT01111552|50570810|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
25255077|NCT01111552|50570811|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
25255078|NCT01111552|50570807|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
25255079|NCT01111552|50570808|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
25255080|NCT01111552|50570809|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
25255081|NCT01111552|50570810|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
25255082|NCT01111552|50570811|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
25255083|NCT01111552|50570807|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
25255084|NCT01111552|50570808|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
25255085|NCT01111552|50570809|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
25255086|NCT01111552|50570810|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
25255087|NCT01111552|50570811|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
25255088|NCT01111552|50570807|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
25341258|NCT00762164|50657560|FG001|Overall Study|Discontinued medication|0|||
25341259|NCT00762164|50657559|FG000|Overall Study|Withdrawal by Subject|0|||
25341260|NCT00762164|50657560|FG001|Overall Study|Withdrawal by Subject|1|||
25341261|NCT00762086|50657568|FG000|Overall Study|Adverse Event|2|||
25341262|NCT00762086|50657569|FG001|Overall Study|Adverse Event|0|||
25341263|NCT00762086|50657568|FG000|Overall Study|Lost to Follow-up|0|||
25341264|NCT00762086|50657569|FG001|Overall Study|Lost to Follow-up|2|||
24978620|NCT03351478|50067082|FG001|Overall Study|Reason not Specified|3|||
24978621|NCT03351478|50067083|FG002|Overall Study|Reason not Specified|0|||
24978622|NCT03351478|50067081|FG000|Overall Study|Lost to Follow-up|0|||
24978623|NCT03351478|50067082|FG001|Overall Study|Lost to Follow-up|0|||
24978624|NCT03351478|50067083|FG002|Overall Study|Lost to Follow-up|1|||
25341265|NCT00762086|50657568|FG000|Overall Study|Non compliance|1|||
24978625|NCT00363545|50067093|FG000|Overall Study|Serious Adverse Event|0|||
24978626|NCT00363545|50067094|FG001|Overall Study|Serious Adverse Event|1|||
24978627|NCT00363545|50067093|FG000|Overall Study|Withdrawal by Subject|12|||
24978628|NCT00363545|50067094|FG001|Overall Study|Withdrawal by Subject|15|||
25341266|NCT00762086|50657569|FG001|Overall Study|Non compliance|0|||
25341267|NCT00762086|50657568|FG000|Overall Study|Withdrawal by Subject|2|||
25341268|NCT00762086|50657569|FG001|Overall Study|Withdrawal by Subject|2|||
25341269|NCT00762086|50657568|FG000|Overall Study|Ineligible to participate in the study|1|||
25341270|NCT00762086|50657569|FG001|Overall Study|Ineligible to participate in the study|0|||
25341271|NCT00761774|50657575|FG000|Overall Study|Adverse Event|17|||
25341272|NCT00761774|50657575|FG000|Overall Study|Lack of Efficacy|37|||
25341273|NCT00761774|50657575|FG000|Overall Study|Lost to Follow-up|2|||
25341274|NCT00761774|50657575|FG000|Overall Study|Withdrawal by Subject|9|||
25341275|NCT00761774|50657575|FG000|Overall Study|Non-compliance|4|||
25341276|NCT00761774|50657575|FG000|Overall Study|End of study|2|||
25341277|NCT00761774|50657575|FG000|Overall Study|Reclassification of seizures|1|||
25341278|NCT00761774|50657575|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
25341279|NCT00761774|50657575|FG000|Overall Study|Sponsor decision|1|||
25341280|NCT00761774|50657575|FG000|Overall Study|Investigator clinical judgement|1|||
25341281|NCT00761774|50657575|FG000|Overall Study|Patient moved out of study area|1|||
25341282|NCT00761774|50657575|FG000|Overall Study|Coordinator leaving site|1|||
25341283|NCT00761774|50657575|FG000|Overall Study|Subject IP non-compliance|1|||
25341284|NCT00761774|50657575|FG000|Overall Study|IP stopped by hospital physician|1|||
25341285|NCT00583791|50657581|FG000|Overall Study|Other|67|||
25341286|NCT00583791|50657581|FG000|Overall Study|Death|6|||
25341287|NCT00781274|50657585|FG000|Overall Study|Withdrawal by Subject|2|||
25341288|NCT00780416|50657591|FG000|Overall Study|Physician Decision|3|||
25341289|NCT00780416|50657592|FG001|Overall Study|Physician Decision|3|||
25341290|NCT00780416|50657591|FG000|Overall Study|Protocol Violation|1|||
25341291|NCT00780416|50657592|FG001|Overall Study|Protocol Violation|0|||
25341292|NCT00780416|50657591|FG000|Overall Study|Withdrawal by Subject|8|||
25341293|NCT00780416|50657592|FG001|Overall Study|Withdrawal by Subject|6|||
25341294|NCT00761462|50657600|FG000|Treatment|Subjects never received study medication|23|||
25341295|NCT00761462|50657601|FG001|Treatment|Subjects never received study medication|12|||
25341296|NCT00761462|50657600|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
25341297|NCT00761462|50657601|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
25341298|NCT00761462|50657600|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
25341299|NCT00761462|50657601|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
25341300|NCT00761462|50657600|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
25341301|NCT00761462|50657601|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
25341302|NCT00761306|50657607|FG000|Overall Study|Adverse Event|5|||
25341303|NCT00761306|50657607|FG000|Overall Study|Lack of Efficacy|4|||
25341304|NCT00761306|50657607|FG000|Overall Study|Protocol Violation|2|||
25341305|NCT00761306|50657607|FG000|Overall Study|Withdrawal of Consent|3|||
25341306|NCT00761306|50657607|FG000|Overall Study|Lost to Follow-up|1|||
25341307|NCT00761306|50657607|FG000|Overall Study|Administrative or Other Reasons|5|||
25341308|NCT00772538|50657613|FG000|Overall Study|Adverse Event|6|||
25341309|NCT00772538|50657614|FG001|Overall Study|Adverse Event|6|||
25341310|NCT00772538|50657613|FG000|Overall Study|Protocol Violation|3|||
25341311|NCT00772538|50657614|FG001|Overall Study|Protocol Violation|3|||
25341312|NCT00772538|50657613|FG000|Overall Study|Lost to Follow-up|1|||
25341313|NCT00772538|50657614|FG001|Overall Study|Lost to Follow-up|1|||
25341314|NCT00772538|50657613|FG000|Overall Study|Withdrawal by Subject|3|||
24978629|NCT00363545|50067093|FG000|Overall Study|Migrated/moved from study area|3|||
25255089|NCT01111552|50570808|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
25255090|NCT01111552|50570809|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
25255091|NCT01111552|50570810|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
25255092|NCT01111552|50570811|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
25255093|NCT01111552|50570807|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
25255094|NCT01111552|50570808|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
25255095|NCT01111552|50570809|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
25255096|NCT01111552|50570810|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
25255097|NCT01111552|50570811|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
25255098|NCT01111552|50570807|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
25255099|NCT01111552|50570808|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
25255100|NCT01111552|50570809|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
25255101|NCT01111552|50570810|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
25255102|NCT01111552|50570811|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
25255103|NCT01111552|50570807|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
25341315|NCT00772538|50657614|FG001|Overall Study|Withdrawal by Subject|8|||
25341316|NCT00772538|50657613|FG000|Overall Study|Lack of Efficacy|0|||
25341317|NCT00772538|50657614|FG001|Overall Study|Lack of Efficacy|1|||
25341318|NCT00772538|50657613|FG000|Overall Study|Other|7|||
25341319|NCT00772538|50657614|FG001|Overall Study|Other|7|||
25341320|NCT00761150|50657623|FG000|Open-label Period|Adverse Event|36|||
25341321|NCT00761150|50657624|FG001|Open-label Period|Adverse Event|0|||
25341322|NCT00761150|50657625|FG002|Open-label Period|Adverse Event|0|||
25341323|NCT00761150|50657623|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
25341324|NCT00761150|50657624|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
25341325|NCT00761150|50657625|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
25341326|NCT00761150|50657623|FG000|Open-label Period|Lost to Follow-up|7|||
25341327|NCT00761150|50657624|FG001|Open-label Period|Lost to Follow-up|0|||
25341328|NCT00761150|50657625|FG002|Open-label Period|Lost to Follow-up|0|||
25341329|NCT00761150|50657623|FG000|Open-label Period|Lack of Efficacy|4|||
25341330|NCT00761150|50657624|FG001|Open-label Period|Lack of Efficacy|0|||
25341331|NCT00761150|50657625|FG002|Open-label Period|Lack of Efficacy|0|||
25341332|NCT00761150|50657623|FG000|Open-label Period|Withdrawal by Subject|5|||
24978630|NCT00363545|50067094|FG001|Overall Study|Migrated/moved from study area|6|||
24978631|NCT00363545|50067093|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
24978632|NCT00363545|50067094|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
24978633|NCT00363545|50067093|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
24978634|NCT00363545|50067094|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
24978635|NCT00363545|50067093|FG000|Overall Study|Others|1|||
24978636|NCT00363545|50067094|FG001|Overall Study|Others|0|||
24978637|NCT03351244|50067103|FG000|Overall Study|Adverse Event|7|||
24978638|NCT03351244|50067104|FG001|Overall Study|Adverse Event|11|||
24978639|NCT03351244|50067105|FG002|Overall Study|Adverse Event|12|||
24978640|NCT03351244|50067103|FG000|Overall Study|Investigator's decision|0|||
24978641|NCT03351244|50067104|FG001|Overall Study|Investigator's decision|0|||
24978642|NCT03351244|50067105|FG002|Overall Study|Investigator's decision|2|||
24978643|NCT03351244|50067103|FG000|Overall Study|System error|0|||
24978644|NCT03351244|50067104|FG001|Overall Study|System error|0|||
24978645|NCT03351244|50067105|FG002|Overall Study|System error|2|||
24978646|NCT03351244|50067103|FG000|Overall Study|COVID-19 restrictions|3|||
24978647|NCT03351244|50067104|FG001|Overall Study|COVID-19 restrictions|0|||
24978648|NCT03351244|50067105|FG002|Overall Study|COVID-19 restrictions|1|||
24978649|NCT03351244|50067103|FG000|Overall Study|Non-compliance|2|||
24978650|NCT03351244|50067104|FG001|Overall Study|Non-compliance|5|||
24978651|NCT03351244|50067105|FG002|Overall Study|Non-compliance|0|||
24978652|NCT03351244|50067103|FG000|Overall Study|Withdrawal by Subject|11|||
24978653|NCT03351244|50067104|FG001|Overall Study|Withdrawal by Subject|16|||
24978654|NCT03351244|50067105|FG002|Overall Study|Withdrawal by Subject|13|||
24978655|NCT03351244|50067103|FG000|Overall Study|Lost to Follow-up|2|||
24978656|NCT03351244|50067104|FG001|Overall Study|Lost to Follow-up|6|||
24978657|NCT03351244|50067105|FG002|Overall Study|Lost to Follow-up|4|||
24978658|NCT03351244|50067103|FG000|Overall Study|Protocol Violation|2|||
24978659|NCT03351244|50067104|FG001|Overall Study|Protocol Violation|2|||
24978660|NCT03351244|50067105|FG002|Overall Study|Protocol Violation|0|||
24978661|NCT03386032|50067118|FG000|Overall Study|Lack of Efficacy|6|||
24978662|NCT03386032|50067119|FG001|Overall Study|Lack of Efficacy|2|||
24978663|NCT03386032|50067120|FG002|Overall Study|Lack of Efficacy|0|||
24978664|NCT03386032|50067118|FG000|Overall Study|Adverse Event|2|||
24978665|NCT03386032|50067119|FG001|Overall Study|Adverse Event|2|||
24978666|NCT03386032|50067120|FG002|Overall Study|Adverse Event|0|||
24978667|NCT03386032|50067118|FG000|Overall Study|Withdrawal by Subject|1|||
24978668|NCT03386032|50067119|FG001|Overall Study|Withdrawal by Subject|0|||
24978669|NCT03386032|50067120|FG002|Overall Study|Withdrawal by Subject|0|||
24978670|NCT03386032|50067118|FG000|Overall Study|Lost to Follow-up|9|||
24978671|NCT03386032|50067119|FG001|Overall Study|Lost to Follow-up|3|||
24978672|NCT03386032|50067120|FG002|Overall Study|Lost to Follow-up|0|||
24978673|NCT00077610|50067131|FG000|Overall Study|Adverse Event|9|||
24978674|NCT00077610|50067132|FG001|Overall Study|Adverse Event|7|||
24978675|NCT00077610|50067133|FG002|Overall Study|Adverse Event|1|||
24978676|NCT00077610|50067131|FG000|Overall Study|Lost to Follow-up|0|||
24978677|NCT00077610|50067132|FG001|Overall Study|Lost to Follow-up|1|||
24978678|NCT00077610|50067133|FG002|Overall Study|Lost to Follow-up|2|||
24978679|NCT00077610|50067131|FG000|Overall Study|Withdrawal by Subject|4|||
24978680|NCT00077610|50067132|FG001|Overall Study|Withdrawal by Subject|10|||
24978681|NCT00077610|50067133|FG002|Overall Study|Withdrawal by Subject|6|||
24978682|NCT00077610|50067131|FG000|Overall Study|Death|17|||
24978683|NCT00077610|50067132|FG001|Overall Study|Death|13|||
24978684|NCT00077610|50067133|FG002|Overall Study|Death|13|||
24978685|NCT00077610|50067131|FG000|Overall Study|Renal transplant|12|||
25078089|NCT03745651|50186226|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
25341333|NCT00761150|50657624|FG001|Open-label Period|Withdrawal by Subject|0|||
25341334|NCT00761150|50657625|FG002|Open-label Period|Withdrawal by Subject|0|||
24978686|NCT00077610|50067132|FG001|Overall Study|Renal transplant|15|||
24978687|NCT00077610|50067133|FG002|Overall Study|Renal transplant|11|||
24978688|NCT00077610|50067131|FG000|Overall Study|Withdrew from dialysis care|5|||
24978689|NCT00077610|50067132|FG001|Overall Study|Withdrew from dialysis care|0|||
24978690|NCT00077610|50067133|FG002|Overall Study|Withdrew from dialysis care|3|||
24978691|NCT00077610|50067131|FG000|Overall Study|Insufficient Therapeutic Response|1|||
25341335|NCT00761150|50657623|FG000|Open-label Period|Noncompliance|2|||
24978692|NCT00077610|50067132|FG001|Overall Study|Insufficient Therapeutic Response|0|||
24978693|NCT00077610|50067133|FG002|Overall Study|Insufficient Therapeutic Response|0|||
24978694|NCT00077610|50067131|FG000|Overall Study|Multiple blood transfusions|0|||
24978695|NCT00077610|50067132|FG001|Overall Study|Multiple blood transfusions|0|||
24978696|NCT00077610|50067133|FG002|Overall Study|Multiple blood transfusions|1|||
24978697|NCT00077610|50067131|FG000|Overall Study|Principal Investigator's decision|1|||
25255104|NCT01111552|50570808|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
25255105|NCT01111552|50570809|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
25255106|NCT01111552|50570810|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
25255107|NCT01111552|50570811|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
24978698|NCT00077610|50067132|FG001|Overall Study|Principal Investigator's decision|0|||
25341336|NCT00761150|50657624|FG001|Open-label Period|Noncompliance|0|||
24978699|NCT00077610|50067133|FG002|Overall Study|Principal Investigator's decision|1|||
24978700|NCT00077610|50067131|FG000|Overall Study|Worsening of health condition|1|||
24978701|NCT00077610|50067132|FG001|Overall Study|Worsening of health condition|1|||
24978702|NCT00077610|50067133|FG002|Overall Study|Worsening of health condition|0|||
24978703|NCT00077610|50067131|FG000|Overall Study|Given Epogen in hospital|1|||
24978704|NCT00077610|50067132|FG001|Overall Study|Given Epogen in hospital|0|||
24978705|NCT00077610|50067133|FG002|Overall Study|Given Epogen in hospital|0|||
24978706|NCT00077610|50067131|FG000|Overall Study|Transferred to other unit|0|||
24978707|NCT00077610|50067132|FG001|Overall Study|Transferred to other unit|0|||
24978708|NCT00077610|50067133|FG002|Overall Study|Transferred to other unit|1|||
24978709|NCT00077610|50067131|FG000|Overall Study|Transferred to nursing home|0|||
24978710|NCT00077610|50067132|FG001|Overall Study|Transferred to nursing home|0|||
24978711|NCT00077610|50067133|FG002|Overall Study|Transferred to nursing home|1|||
24978712|NCT00077610|50067131|FG000|Overall Study|Transfer to satellite unit|1|||
24978713|NCT00077610|50067132|FG001|Overall Study|Transfer to satellite unit|0|||
24978714|NCT00077610|50067133|FG002|Overall Study|Transfer to satellite unit|0|||
24978715|NCT00077610|50067131|FG000|Overall Study|Transfer to other center for surgery|1|||
24978716|NCT00077610|50067132|FG001|Overall Study|Transfer to other center for surgery|0|||
24978717|NCT00077610|50067133|FG002|Overall Study|Transfer to other center for surgery|0|||
24978718|NCT00077610|50067131|FG000|Overall Study|Change in dialysis modality|1|||
24978719|NCT00077610|50067132|FG001|Overall Study|Change in dialysis modality|0|||
24978720|NCT00077610|50067133|FG002|Overall Study|Change in dialysis modality|0|||
24978721|NCT00077610|50067131|FG000|Overall Study|Relocation|0|||
24978722|NCT00077610|50067132|FG001|Overall Study|Relocation|8|||
24978723|NCT00077610|50067133|FG002|Overall Study|Relocation|5|||
24978724|NCT00077610|50067131|FG000|Overall Study|Financial issues|0|||
24978725|NCT00077610|50067132|FG001|Overall Study|Financial issues|1|||
24978726|NCT00077610|50067133|FG002|Overall Study|Financial issues|0|||
24978727|NCT00077610|50067131|FG000|Overall Study|Sponsors decision to withdraw|0|||
24978728|NCT00077610|50067132|FG001|Overall Study|Sponsors decision to withdraw|0|||
24978729|NCT00077610|50067133|FG002|Overall Study|Sponsors decision to withdraw|1|||
24978730|NCT03385564|50067150|FG000|Overall Study|Adverse Event|0|||
24978731|NCT03385564|50067151|FG001|Overall Study|Adverse Event|0|||
24978732|NCT03385564|50067152|FG002|Overall Study|Adverse Event|3|||
24978733|NCT03385564|50067153|FG003|Overall Study|Adverse Event|3|||
24978734|NCT03385564|50067150|FG000|Overall Study|Other than listed|0|||
24978735|NCT03385564|50067151|FG001|Overall Study|Other than listed|0|||
24978736|NCT03385564|50067152|FG002|Overall Study|Other than listed|0|||
24978737|NCT03385564|50067153|FG003|Overall Study|Other than listed|5|||
24978738|NCT03385564|50067150|FG000|Overall Study|Withdrawal by Subject|0|||
24978739|NCT03385564|50067151|FG001|Overall Study|Withdrawal by Subject|1|||
24978740|NCT03385564|50067152|FG002|Overall Study|Withdrawal by Subject|1|||
24978741|NCT03385564|50067153|FG003|Overall Study|Withdrawal by Subject|0|||
24978742|NCT03385564|50067150|FG000|Overall Study|Lack of Efficacy|0|||
24978743|NCT03385564|50067151|FG001|Overall Study|Lack of Efficacy|0|||
24978744|NCT03385564|50067152|FG002|Overall Study|Lack of Efficacy|0|||
24978745|NCT03385564|50067153|FG003|Overall Study|Lack of Efficacy|1|||
24978746|NCT03385564|50067150|FG000|Overall Study|Death|0|||
24978747|NCT03385564|50067151|FG001|Overall Study|Death|0|||
24978748|NCT03385564|50067152|FG002|Overall Study|Death|1|||
24978749|NCT03385564|50067153|FG003|Overall Study|Death|0|||
24978750|NCT00066222|50067163|FG000|Overall Study|No protocol treatment received|1|||
25255108|NCT01111552|50570807|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
25255109|NCT01111552|50570808|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
25255110|NCT01111552|50570809|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
25255111|NCT01111552|50570810|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
25255112|NCT01111552|50570811|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
25255113|NCT01175083|50570827|FG000|Primary Epoch|Withdrawal by Subject|0|||
25255114|NCT01175083|50570828|FG001|Primary Epoch|Withdrawal by Subject|0|||
24978751|NCT00397943|50067172|FG000|Overall Study|Unspecified reasons|12|||
24978752|NCT00397943|50067173|FG001|Overall Study|Unspecified reasons|9|||
25255115|NCT01175083|50570829|FG002|Primary Epoch|Withdrawal by Subject|0|||
25341337|NCT00761150|50657625|FG002|Open-label Period|Noncompliance|0|||
24978753|NCT00397943|50067174|FG002|Overall Study|Unspecified reasons|0|||
24978754|NCT00397943|50067175|FG003|Overall Study|Unspecified reasons|0|||
24978755|NCT00397943|50067176|FG004|Overall Study|Unspecified reasons|0|||
24978756|NCT00066066|50067191|FG000|Overall Study|Lost to Follow-up|6|||
24978757|NCT00066066|50067192|FG001|Overall Study|Lost to Follow-up|4|||
24978758|NCT00066066|50067193|FG002|Overall Study|Lost to Follow-up|7|||
24978759|NCT00066066|50067194|FG003|Overall Study|Lost to Follow-up|4|||
24978760|NCT00066066|50067195|FG004|Overall Study|Lost to Follow-up|3|||
24978761|NCT00066066|50067196|FG005|Overall Study|Lost to Follow-up|5|||
24978762|NCT00363467|50067210|FG000|Overall Study|Physician Decision|1|||
24978763|NCT00397631|50067216|FG000|Overall Study|Adverse Event|5|||
24978764|NCT00397631|50067217|FG001|Overall Study|Adverse Event|6|||
24978765|NCT00397631|50067216|FG000|Overall Study|Lack of Efficacy|7|||
24978766|NCT00397631|50067217|FG001|Overall Study|Lack of Efficacy|10|||
24978767|NCT00397631|50067216|FG000|Overall Study|Lost to Follow-up|8|||
24978768|NCT00397631|50067217|FG001|Overall Study|Lost to Follow-up|9|||
24978769|NCT00397631|50067216|FG000|Overall Study|Physician Decision|2|||
24978770|NCT00397631|50067217|FG001|Overall Study|Physician Decision|0|||
24978771|NCT00397631|50067216|FG000|Overall Study|Protocol Violation|0|||
24978772|NCT00397631|50067217|FG001|Overall Study|Protocol Violation|1|||
24978773|NCT00397631|50067216|FG000|Overall Study|Withdrawal by Subject|7|||
24978774|NCT00397631|50067217|FG001|Overall Study|Withdrawal by Subject|14|||
24978775|NCT00397631|50067216|FG000|Overall Study|protocol discontinuation criteria|1|||
24978776|NCT00397631|50067217|FG001|Overall Study|protocol discontinuation criteria|4|||
24978777|NCT00077376|50067223|FG000|Overall Study|Adverse Event|8|||
24978778|NCT00077376|50067223|FG000|Overall Study|Withdrawal by Subject|2|||
24978779|NCT00077376|50067223|FG000|Overall Study|Death|1|||
24978780|NCT00077376|50067223|FG000|Overall Study|Physician Decision|1|||
24978781|NCT00077376|50067223|FG000|Overall Study|Alternative therapy|5|||
24978782|NCT00077376|50067223|FG000|Overall Study|Complicating disease|1|||
24978783|NCT00077376|50067223|FG000|Overall Study|Still on treatment|1|||
24978784|NCT00077376|50067223|FG000|Overall Study|Symptomatic deterioration|1|||
24978785|NCT00077376|50067223|FG000|Overall Study|Surgery|1|||
24978786|NCT00077376|50067223|FG000|Overall Study|Insurance ran out|1|||
24978787|NCT03406156|50067229|FG000|Overall Study|Death|6|||
24978788|NCT03406156|50067230|FG001|Overall Study|Death|2|||
24978789|NCT03406156|50067229|FG000|Overall Study|Withdrawal by Subject|0|||
24978790|NCT03406156|50067230|FG001|Overall Study|Withdrawal by Subject|2|||
24978791|NCT03406156|50067229|FG000|Overall Study|COVID-19 infection|1|||
24978792|NCT03406156|50067230|FG001|Overall Study|COVID-19 infection|0|||
24978793|NCT03406156|50067229|FG000|Overall Study|Non-compliance with study procedures|0|||
24978794|NCT03406156|50067230|FG001|Overall Study|Non-compliance with study procedures|1|||
24978795|NCT03406156|50067229|FG000|Overall Study|Other, not specified|0|||
24978796|NCT03406156|50067230|FG001|Overall Study|Other, not specified|1|||
24978797|NCT00363311|50067240|FG000|Overall Study|Adverse Event|6|||
24978798|NCT00363311|50067241|FG001|Overall Study|Adverse Event|4|||
24978799|NCT00363311|50067240|FG000|Overall Study|Lost to Follow-up|3|||
24978800|NCT00363311|50067241|FG001|Overall Study|Lost to Follow-up|0|||
24978801|NCT00363311|50067240|FG000|Overall Study|Protocol Violation|1|||
24978802|NCT00363311|50067241|FG001|Overall Study|Protocol Violation|2|||
24978803|NCT00363311|50067240|FG000|Overall Study|Withdrawal by Subject|12|||
24978804|NCT00363311|50067241|FG001|Overall Study|Withdrawal by Subject|6|||
24978805|NCT00363311|50067240|FG000|Overall Study|Physician Decision|1|||
24978806|NCT00363311|50067241|FG001|Overall Study|Physician Decision|1|||
24978807|NCT00363311|50067240|FG000|Overall Study|Sponsor Terminated Study|2|||
24978808|NCT00363311|50067241|FG001|Overall Study|Sponsor Terminated Study|2|||
24978809|NCT00363311|50067240|FG000|Overall Study|Disease Progression|46|||
24978810|NCT00363311|50067241|FG001|Overall Study|Disease Progression|26|||
24978811|NCT00363311|50067240|FG000|Overall Study|Non-Compliance|1|||
24978812|NCT00363311|50067241|FG001|Overall Study|Non-Compliance|1|||
24978813|NCT00363311|50067240|FG000|Overall Study|Participant Refused Biopsy|1|||
24978814|NCT00363311|50067241|FG001|Overall Study|Participant Refused Biopsy|0|||
24978815|NCT00363311|50067240|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
24978816|NCT00363311|50067241|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
24978817|NCT00363311|50067240|FG000|Overall Study|Participant Opted for Treatment|1|||
24978818|NCT00363311|50067241|FG001|Overall Study|Participant Opted for Treatment|0|||
24978819|NCT00363311|50067240|FG000|Overall Study|Participant Moved to Another Country|1|||
24978820|NCT00363311|50067241|FG001|Overall Study|Participant Moved to Another Country|0|||
24978821|NCT00363311|50067240|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
24978822|NCT00363311|50067241|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
24978823|NCT00363311|50067240|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
24978824|NCT00363311|50067241|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
24978825|NCT00363311|50067240|FG000|Overall Study|Participant Moved to Louisiana|0|||
24978826|NCT00363311|50067241|FG001|Overall Study|Participant Moved to Louisiana|1|||
24978827|NCT00362609|50067249|FG000|Overall Study|Withdrawal by Subject|0|||
24978828|NCT00362609|50067250|FG001|Overall Study|Withdrawal by Subject|1|||
24978829|NCT00362609|50067249|FG000|Overall Study|Protocol Violation|0|||
24978830|NCT00362609|50067250|FG001|Overall Study|Protocol Violation|1|||
24978831|NCT00362375|50067258|FG000|Overall Study|Lost to Follow-up|40|||
24978832|NCT00362375|50067259|FG001|Overall Study|Lost to Follow-up|35|||
24978833|NCT00362297|50067267|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
24978834|NCT00362297|50067268|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
24978835|NCT00065442|50067276|FG000|Overall Study|Lost to Follow-up|1|||
24978836|NCT00065442|50067277|FG001|Overall Study|Lost to Follow-up|1|||
24978837|NCT00065442|50067276|FG000|Overall Study|Death|121|||
24978838|NCT00065442|50067277|FG001|Overall Study|Death|210|||
24978839|NCT00065442|50067276|FG000|Overall Study|Withdrawal by Subject|3|||
24978840|NCT00065442|50067277|FG001|Overall Study|Withdrawal by Subject|9|||
24978841|NCT00090402|50067286|FG000|Overall Study|Death|1|||
24978842|NCT00090402|50067287|FG001|Overall Study|Death|1|||
24978843|NCT00090402|50067288|FG002|Overall Study|Death|0|||
24978844|NCT00090402|50067286|FG000|Overall Study|subject moved|0|||
24978845|NCT00090402|50067287|FG001|Overall Study|subject moved|1|||
24978846|NCT00090402|50067288|FG002|Overall Study|subject moved|0|||
24978847|NCT00090402|50067286|FG000|Overall Study|stopped taking study medication|1|||
24978848|NCT00090402|50067287|FG001|Overall Study|stopped taking study medication|0|||
24978849|NCT00090402|50067288|FG002|Overall Study|stopped taking study medication|1|||
24978850|NCT00361283|50067299|FG000|Overall Study|Lost to Follow-up|27|||
24978851|NCT00077064|50067305|FG000|Overall Study|Adverse Event|0|||
24978852|NCT00077064|50067306|FG001|Overall Study|Adverse Event|4|||
24978853|NCT00077064|50067305|FG000|Overall Study|Patient refusal|0|||
24978854|NCT00077064|50067306|FG001|Overall Study|Patient refusal|2|||
24978855|NCT00396383|50067313|FG000|Overall Study|Death|2|||
24978856|NCT00396383|50067313|FG000|Overall Study|Lost to Follow-up|1|||
24978857|NCT00395447|50067319|FG000|Overall Study|Death|37|||
24978858|NCT00395447|50067320|FG001|Overall Study|Death|32|||
24978859|NCT00395447|50067319|FG000|Overall Study|Lost to Follow-up|52|||
24978860|NCT00395447|50067320|FG001|Overall Study|Lost to Follow-up|43|||
24978861|NCT00395447|50067319|FG000|Overall Study|Withdrawal by Subject|24|||
24978862|NCT00395447|50067320|FG001|Overall Study|Withdrawal by Subject|19|||
24978863|NCT00395447|50067319|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
24978864|NCT00395447|50067320|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
24978865|NCT03404674|50067332|FG000|Overall Study|Inability to Attend Future Visits|0|||
24978866|NCT03404674|50067333|FG001|Overall Study|Inability to Attend Future Visits|1|||
24978867|NCT03404674|50067334|FG002|Overall Study|Inability to Attend Future Visits|1|||
24978868|NCT03404674|50067335|FG003|Overall Study|Inability to Attend Future Visits|0|||
24978869|NCT03404674|50067336|FG004|Overall Study|Inability to Attend Future Visits|0|||
24978870|NCT03404674|50067337|FG005|Overall Study|Inability to Attend Future Visits|0|||
24978871|NCT03404674|50067332|FG000|Overall Study|Behavioral Problems|0|||
24978872|NCT03404674|50067333|FG001|Overall Study|Behavioral Problems|0|||
24978873|NCT03404674|50067334|FG002|Overall Study|Behavioral Problems|1|||
24978874|NCT03404674|50067335|FG003|Overall Study|Behavioral Problems|0|||
25341338|NCT00761150|50657623|FG000|Open-label Period|Other|5|||
25341339|NCT00761150|50657624|FG001|Open-label Period|Other|0|||
25341340|NCT00761150|50657625|FG002|Open-label Period|Other|0|||
25341341|NCT00761150|50657623|FG000|Double-blind Period|Lack of Efficacy|0|||
25341342|NCT00761150|50657624|FG001|Double-blind Period|Lack of Efficacy|2|||
25341343|NCT00761150|50657625|FG002|Double-blind Period|Lack of Efficacy|19|||
24978875|NCT03404674|50067336|FG004|Overall Study|Behavioral Problems|0|||
24978876|NCT03404674|50067337|FG005|Overall Study|Behavioral Problems|0|||
24978877|NCT03404674|50067332|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
24978878|NCT03404674|50067333|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
24978879|NCT03404674|50067334|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
24978880|NCT03404674|50067335|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
24978881|NCT03404674|50067336|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
25341344|NCT00761150|50657623|FG000|Double-blind Period|Adverse Event|0|||
25341345|NCT00761150|50657624|FG001|Double-blind Period|Adverse Event|3|||
25341346|NCT00761150|50657625|FG002|Double-blind Period|Adverse Event|3|||
25341347|NCT00761150|50657623|FG000|Double-blind Period|Withdrawal by Subject|0|||
25341348|NCT00761150|50657624|FG001|Double-blind Period|Withdrawal by Subject|3|||
25341349|NCT00761150|50657625|FG002|Double-blind Period|Withdrawal by Subject|2|||
25341350|NCT00761150|50657623|FG000|Double-blind Period|Lost to Follow-up|0|||
25341351|NCT00761150|50657624|FG001|Double-blind Period|Lost to Follow-up|2|||
25341352|NCT00761150|50657625|FG002|Double-blind Period|Lost to Follow-up|1|||
25341353|NCT00761150|50657623|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
24978882|NCT03404674|50067337|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
24978883|NCT00064662|50067354|FG000|Overall Study|Death|1|||
24978884|NCT00064662|50067355|FG001|Overall Study|Death|1|||
25341354|NCT00761150|50657624|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
24978885|NCT00064662|50067354|FG000|Overall Study|Lost to Follow-up|57|||
24978886|NCT00064662|50067355|FG001|Overall Study|Lost to Follow-up|44|||
25341355|NCT00761150|50657625|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
25341356|NCT00761150|50657623|FG000|Double-blind Period|Noncompliance|0|||
25341357|NCT00761150|50657624|FG001|Double-blind Period|Noncompliance|1|||
25341358|NCT00761150|50657625|FG002|Double-blind Period|Noncompliance|0|||
24978887|NCT00064662|50067354|FG000|Overall Study|Withdrawal by Subject|14|||
24978888|NCT00064662|50067355|FG001|Overall Study|Withdrawal by Subject|14|||
24978889|NCT00064662|50067354|FG000|Overall Study|Administratively withdrawn|2|||
24978890|NCT00064662|50067355|FG001|Overall Study|Administratively withdrawn|2|||
24978891|NCT03404518|50067363|FG000|Overall Study|Lost to Follow-up|28|||
24978892|NCT03404518|50067364|FG001|Overall Study|Lost to Follow-up|30|||
24978893|NCT03404518|50067363|FG000|Overall Study|Protocol Violation|13|||
24978894|NCT03404518|50067364|FG001|Overall Study|Protocol Violation|6|||
24978895|NCT03404206|50067373|FG000|Overall Study|Withdrawal by Subject|1|||
24978896|NCT03404206|50067374|FG001|Overall Study|Withdrawal by Subject|1|||
24978897|NCT03404206|50067375|FG002|Overall Study|Withdrawal by Subject|0|||
24978898|NCT03404206|50067373|FG000|Overall Study|Lost to Follow-up|3|||
24978899|NCT03404206|50067374|FG001|Overall Study|Lost to Follow-up|1|||
24978900|NCT03404206|50067375|FG002|Overall Study|Lost to Follow-up|0|||
24978901|NCT03403426|50067383|FG000|Overall Study|Death|1|||
24978902|NCT03403426|50067383|FG000|Overall Study|Lost to Follow-up|2|||
24978903|NCT00394901|50067391|FG000|Baseline Phase|Protocol Violation|0|||
24978904|NCT00394901|50067392|FG001|Baseline Phase|Protocol Violation|0|||
24978905|NCT00394901|50067393|FG002|Baseline Phase|Protocol Violation|1|||
24978906|NCT00394901|50067394|FG003|Baseline Phase|Protocol Violation|0|||
24978907|NCT00394901|50067391|FG000|Double-blind Phase|Adverse Event|5|||
24978908|NCT00394901|50067392|FG001|Double-blind Phase|Adverse Event|7|||
24978909|NCT00394901|50067393|FG002|Double-blind Phase|Adverse Event|16|||
24978910|NCT00394901|50067394|FG003|Double-blind Phase|Adverse Event|20|||
24978911|NCT00394901|50067391|FG000|Double-blind Phase|Lack of Efficacy|6|||
24978912|NCT00394901|50067392|FG001|Double-blind Phase|Lack of Efficacy|4|||
24978913|NCT00394901|50067393|FG002|Double-blind Phase|Lack of Efficacy|1|||
24978914|NCT00394901|50067394|FG003|Double-blind Phase|Lack of Efficacy|3|||
24978915|NCT00394901|50067391|FG000|Double-blind Phase|Withdrawal by Subject|2|||
24978916|NCT00394901|50067392|FG001|Double-blind Phase|Withdrawal by Subject|0|||
24978917|NCT00394901|50067393|FG002|Double-blind Phase|Withdrawal by Subject|0|||
24978918|NCT00394901|50067394|FG003|Double-blind Phase|Withdrawal by Subject|0|||
24978919|NCT00394901|50067391|FG000|Double-blind Phase|Lost to Follow-up|0|||
24978920|NCT00394901|50067392|FG001|Double-blind Phase|Lost to Follow-up|0|||
24978921|NCT00394901|50067393|FG002|Double-blind Phase|Lost to Follow-up|0|||
24978922|NCT00394901|50067394|FG003|Double-blind Phase|Lost to Follow-up|1|||
24978923|NCT00394901|50067391|FG000|Double-blind Phase|Protocol Violation|0|||
24978924|NCT00394901|50067392|FG001|Double-blind Phase|Protocol Violation|0|||
24978925|NCT00394901|50067393|FG002|Double-blind Phase|Protocol Violation|0|||
24978926|NCT00394901|50067394|FG003|Double-blind Phase|Protocol Violation|1|||
24978927|NCT00394901|50067391|FG000|Double-blind Phase|Death|1|||
24978928|NCT00394901|50067392|FG001|Double-blind Phase|Death|0|||
24978929|NCT00394901|50067393|FG002|Double-blind Phase|Death|0|||
24978930|NCT00394901|50067394|FG003|Double-blind Phase|Death|0|||
24978931|NCT00394901|50067391|FG000|Double-blind Phase|Subject's Personal Reason|1|||
24978932|NCT00394901|50067392|FG001|Double-blind Phase|Subject's Personal Reason|0|||
24978933|NCT00394901|50067393|FG002|Double-blind Phase|Subject's Personal Reason|0|||
24978934|NCT00394901|50067394|FG003|Double-blind Phase|Subject's Personal Reason|1|||
24978935|NCT00394901|50067391|FG000|Double-blind Phase|Lack of Compliance|0|||
24978936|NCT00394901|50067392|FG001|Double-blind Phase|Lack of Compliance|3|||
24978937|NCT00394901|50067393|FG002|Double-blind Phase|Lack of Compliance|0|||
24978938|NCT00394901|50067394|FG003|Double-blind Phase|Lack of Compliance|0|||
25341359|NCT00761150|50657623|FG000|Double-blind Period|Other|0|||
25341360|NCT00761150|50657624|FG001|Double-blind Period|Other|3|||
25341361|NCT00761150|50657625|FG002|Double-blind Period|Other|3|||
25341362|NCT00760994|50657635|FG000|Overall Study|Lost to Follow-up|4|||
25341363|NCT00760994|50657636|FG001|Overall Study|Lost to Follow-up|4|||
25341364|NCT00760994|50657637|FG002|Overall Study|Lost to Follow-up|3|||
25341365|NCT00583557|50657647|FG000|Overall Study|Withdrawal by Subject|18|||
25341366|NCT00583557|50657647|FG000|Overall Study|Adverse Event|9|||
25341367|NCT00583557|50657647|FG000|Overall Study|Lack of Efficacy|31|||
25341368|NCT00583557|50657647|FG000|Overall Study|Lack of Compliance|5|||
25341369|NCT00583557|50657647|FG000|Overall Study|Other|5|||
24978939|NCT00394901|50067391|FG000|Double-blind Phase|Entry into another study was found|0|||
24978940|NCT00394901|50067392|FG001|Double-blind Phase|Entry into another study was found|0|||
24978941|NCT00394901|50067393|FG002|Double-blind Phase|Entry into another study was found|1|||
24978942|NCT00394901|50067394|FG003|Double-blind Phase|Entry into another study was found|0|||
24978943|NCT00394901|50067391|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
24978944|NCT00394901|50067392|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
25341370|NCT00583557|50657647|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
25341371|NCT00586820|50657653|FG000|Overall Study|Unsuccessful PCI|1|||
25341372|NCT00586820|50657654|FG001|Overall Study|Unsuccessful PCI|0|||
25341373|NCT00760838|50657662|FG000|Overall Study|Adverse Event|1|||
25341374|NCT00760838|50657663|FG001|Overall Study|Adverse Event|1|||
25341375|NCT00760838|50657662|FG000|Overall Study|Lack of Efficacy|1|||
25341376|NCT00760838|50657663|FG001|Overall Study|Lack of Efficacy|0|||
25341377|NCT00760838|50657662|FG000|Overall Study|Lost to Follow-up|2|||
25341378|NCT00760838|50657663|FG001|Overall Study|Lost to Follow-up|0|||
25341379|NCT00760838|50657662|FG000|Overall Study|Withdrawal by Subject|1|||
25341380|NCT00760838|50657663|FG001|Overall Study|Withdrawal by Subject|1|||
25341381|NCT00586664|50657672|FG000|Overall Study|Withdrawal by Subject|3|||
25341382|NCT00586664|50657673|FG001|Overall Study|Withdrawal by Subject|7|||
25341383|NCT00586664|50657674|FG002|Overall Study|Withdrawal by Subject|1|||
25341384|NCT00586664|50657672|FG000|Overall Study|Exclusion criteria met|2|||
25341385|NCT00586664|50657673|FG001|Overall Study|Exclusion criteria met|0|||
24978945|NCT00394901|50067393|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
24978946|NCT00394901|50067394|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
24978947|NCT03349060|50067410|FG000|Overall Study|Adverse Event|9|||
24978948|NCT03349060|50067411|FG001|Overall Study|Adverse Event|9|||
24978949|NCT03349060|50067412|FG002|Overall Study|Adverse Event|7|||
24978950|NCT03349060|50067410|FG000|Overall Study|Lack of Efficacy|1|||
24978951|NCT03349060|50067411|FG001|Overall Study|Lack of Efficacy|0|||
24978952|NCT03349060|50067412|FG002|Overall Study|Lack of Efficacy|2|||
24978953|NCT03349060|50067410|FG000|Overall Study|Lost to Follow-up|2|||
24978954|NCT03349060|50067411|FG001|Overall Study|Lost to Follow-up|1|||
24978955|NCT03349060|50067412|FG002|Overall Study|Lost to Follow-up|1|||
24978956|NCT03349060|50067410|FG000|Overall Study|Protocol Violation|2|||
24978957|NCT03349060|50067411|FG001|Overall Study|Protocol Violation|2|||
24978958|NCT03349060|50067412|FG002|Overall Study|Protocol Violation|1|||
24978959|NCT03349060|50067410|FG000|Overall Study|Withdrawal by Subject|5|||
24978960|NCT03349060|50067411|FG001|Overall Study|Withdrawal by Subject|3|||
24978961|NCT03349060|50067412|FG002|Overall Study|Withdrawal by Subject|4|||
24978962|NCT03349060|50067410|FG000|Overall Study|Medication error,no linked adverse event|0|||
24978963|NCT03349060|50067411|FG001|Overall Study|Medication error,no linked adverse event|0|||
24978964|NCT03349060|50067412|FG002|Overall Study|Medication error,no linked adverse event|1|||
24978965|NCT03349060|50067410|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
24978966|NCT03349060|50067411|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
24978967|NCT03349060|50067412|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
24978968|NCT03349060|50067410|FG000|Overall Study|Other|2|||
24978969|NCT03349060|50067411|FG001|Overall Study|Other|1|||
24978970|NCT03349060|50067412|FG002|Overall Study|Other|0|||
24978971|NCT03348904|50067423|FG000|Overall Study|Administrative reason by the sponsor|0|||
24978972|NCT03348904|50067424|FG001|Overall Study|Administrative reason by the sponsor|1|||
24978973|NCT03348904|50067425|FG002|Overall Study|Administrative reason by the sponsor|0|||
24978974|NCT00359021|50067435|FG000|Overall Study|Adverse Event|26|||
24978975|NCT00359021|50067436|FG001|Overall Study|Adverse Event|8|||
24978976|NCT00359021|50067435|FG000|Overall Study|Subject Non-Compliant|1|||
24978977|NCT00359021|50067436|FG001|Overall Study|Subject Non-Compliant|2|||
24978978|NCT00359021|50067435|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
24978979|NCT00359021|50067436|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
24978980|NCT00359021|50067435|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
24978981|NCT00359021|50067436|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
24978982|NCT00359021|50067435|FG000|Overall Study|Withdrawal by Subject|2|||
24978983|NCT00359021|50067436|FG001|Overall Study|Withdrawal by Subject|9|||
24978984|NCT00359021|50067435|FG000|Overall Study|Lost to Follow-up|1|||
24978985|NCT00359021|50067436|FG001|Overall Study|Lost to Follow-up|0|||
24978986|NCT00359021|50067435|FG000|Overall Study|Other|4|||
24978987|NCT00359021|50067436|FG001|Overall Study|Other|1|||
24978988|NCT00359021|50067435|FG000|Overall Study|Pregnancy|1|||
24978989|NCT00359021|50067436|FG001|Overall Study|Pregnancy|0|||
25341386|NCT00586664|50657674|FG002|Overall Study|Exclusion criteria met|0|||
25341387|NCT00437281|50657702|FG000|Overall Study|Adverse Event|0|||
25341388|NCT00437281|50657703|FG001|Overall Study|Adverse Event|0|||
25341389|NCT00437281|50657704|FG002|Overall Study|Adverse Event|0|||
25341390|NCT00437281|50657705|FG003|Overall Study|Adverse Event|1|||
25341391|NCT00437281|50657706|FG004|Overall Study|Adverse Event|0|||
25078090|NCT03745651|50186227|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
25341392|NCT00437281|50657707|FG005|Overall Study|Adverse Event|1|||
25341393|NCT00437281|50657708|FG006|Overall Study|Adverse Event|0|||
25341394|NCT00437281|50657709|FG007|Overall Study|Adverse Event|0|||
25341395|NCT00437281|50657710|FG008|Overall Study|Adverse Event|0|||
25341396|NCT00437281|50657711|FG009|Overall Study|Adverse Event|1|||
25341397|NCT00437281|50657712|FG010|Overall Study|Adverse Event|0|||
25341398|NCT00437281|50657713|FG011|Overall Study|Adverse Event|0|||
25341399|NCT00437281|50657714|FG012|Overall Study|Adverse Event|0|||
25341400|NCT00437281|50657715|FG013|Overall Study|Adverse Event|1|||
25341401|NCT00437281|50657716|FG014|Overall Study|Adverse Event|1|||
25341402|NCT00437281|50657717|FG015|Overall Study|Adverse Event|0|||
25341403|NCT00437281|50657718|FG016|Overall Study|Adverse Event|0|||
25341404|NCT00437281|50657719|FG017|Overall Study|Adverse Event|0|||
25341405|NCT00437281|50657720|FG018|Overall Study|Adverse Event|1|||
25341406|NCT00437281|50657721|FG019|Overall Study|Adverse Event|0|||
25341407|NCT00437281|50657702|FG000|Overall Study|Lost to Follow-up|0|||
25341408|NCT00437281|50657703|FG001|Overall Study|Lost to Follow-up|0|||
25341409|NCT00437281|50657704|FG002|Overall Study|Lost to Follow-up|0|||
25341410|NCT00437281|50657705|FG003|Overall Study|Lost to Follow-up|0|||
25341411|NCT00437281|50657706|FG004|Overall Study|Lost to Follow-up|0|||
25341412|NCT00437281|50657707|FG005|Overall Study|Lost to Follow-up|0|||
25341413|NCT00437281|50657708|FG006|Overall Study|Lost to Follow-up|0|||
25341414|NCT00437281|50657709|FG007|Overall Study|Lost to Follow-up|0|||
25341415|NCT00437281|50657710|FG008|Overall Study|Lost to Follow-up|0|||
25341416|NCT00437281|50657711|FG009|Overall Study|Lost to Follow-up|0|||
25341417|NCT00437281|50657712|FG010|Overall Study|Lost to Follow-up|0|||
25341418|NCT00437281|50657713|FG011|Overall Study|Lost to Follow-up|0|||
25341419|NCT00437281|50657714|FG012|Overall Study|Lost to Follow-up|0|||
25341420|NCT00437281|50657715|FG013|Overall Study|Lost to Follow-up|0|||
25341421|NCT00437281|50657716|FG014|Overall Study|Lost to Follow-up|0|||
25341422|NCT00437281|50657717|FG015|Overall Study|Lost to Follow-up|0|||
25341423|NCT00437281|50657718|FG016|Overall Study|Lost to Follow-up|0|||
25341424|NCT00437281|50657719|FG017|Overall Study|Lost to Follow-up|0|||
25341425|NCT00437281|50657720|FG018|Overall Study|Lost to Follow-up|0|||
25341426|NCT00437281|50657721|FG019|Overall Study|Lost to Follow-up|1|||
25341427|NCT00741039|50657795|FG000|Overall Study|Patient non-compliance|2|||
25341428|NCT00741039|50657796|FG001|Overall Study|Patient non-compliance|0|||
25341429|NCT00772382|50657802|FG000|Overall Study|Adverse Event|19|||
25341430|NCT00772382|50657802|FG000|Overall Study|Death|6|||
25341431|NCT00772382|50657802|FG000|Overall Study|Lack of Efficacy|4|||
25341432|NCT00772382|50657802|FG000|Overall Study|Physician Decision|5|||
25341433|NCT00772382|50657802|FG000|Overall Study|Protocol Violation|1|||
25341434|NCT00772382|50657802|FG000|Overall Study|Withdrawal by Subject|10|||
25341435|NCT00772382|50657802|FG000|Overall Study|Other Reasons|10|||
25341436|NCT00798707|50657809|FG000|Overall Study|Adverse Event|6|||
25341437|NCT00798707|50657810|FG001|Overall Study|Adverse Event|8|||
25341438|NCT00798707|50657811|FG002|Overall Study|Adverse Event|8|||
25341439|NCT00798707|50657809|FG000|Overall Study|Failed to return|2|||
25341440|NCT00798707|50657810|FG001|Overall Study|Failed to return|2|||
25341441|NCT00798707|50657811|FG002|Overall Study|Failed to return|0|||
25341442|NCT00798707|50657809|FG000|Overall Study|Investigator|0|||
25341443|NCT00798707|50657810|FG001|Overall Study|Investigator|1|||
25341444|NCT00798707|50657811|FG002|Overall Study|Investigator|2|||
25341445|NCT00798707|50657809|FG000|Overall Study|Lack of Efficacy|2|||
25341446|NCT00798707|50657810|FG001|Overall Study|Lack of Efficacy|2|||
25341447|NCT00798707|50657811|FG002|Overall Study|Lack of Efficacy|1|||
25341448|NCT00798707|50657809|FG000|Overall Study|Lost to Follow-up|5|||
25341449|NCT00798707|50657810|FG001|Overall Study|Lost to Follow-up|6|||
25341450|NCT00798707|50657811|FG002|Overall Study|Lost to Follow-up|6|||
25341451|NCT00798707|50657809|FG000|Overall Study|Other|0|||
25341452|NCT00798707|50657810|FG001|Overall Study|Other|1|||
25341453|NCT00798707|50657811|FG002|Overall Study|Other|0|||
25341454|NCT00798707|50657809|FG000|Overall Study|Protocol Violation|4|||
24979038|NCT00360269|50067460|FG000|Overall Study|Lost to Follow-up|7|||
24979039|NCT00360269|50067461|FG001|Overall Study|Lost to Follow-up|9|||
24979040|NCT00360269|50067460|FG000|Overall Study|Physician Decision|1|||
24979041|NCT00360269|50067461|FG001|Overall Study|Physician Decision|2|||
25078091|NCT03745651|50186228|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
25341455|NCT00798707|50657810|FG001|Overall Study|Protocol Violation|0|||
25341456|NCT00798707|50657811|FG002|Overall Study|Protocol Violation|2|||
24979042|NCT00360269|50067460|FG000|Overall Study|Adverse Event|1|||
24979043|NCT00360269|50067461|FG001|Overall Study|Adverse Event|0|||
24979044|NCT00360269|50067460|FG000|Overall Study|Withdrawal by Subject|1|||
24979045|NCT00360269|50067461|FG001|Overall Study|Withdrawal by Subject|1|||
24979046|NCT00076752|50067467|FG000|Overall Study|Death|2|||
24979047|NCT00076752|50067467|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
24979048|NCT03384940|50067475|FG000|Overall Study|Progressive disease|36|||
24979049|NCT03384940|50067476|FG001|Overall Study|Progressive disease|11|||
24979050|NCT03384940|50067477|FG002|Overall Study|Progressive disease|13|||
24979051|NCT03384940|50067475|FG000|Overall Study|Clinical progression|4|||
24979052|NCT03384940|50067476|FG001|Overall Study|Clinical progression|0|||
24979053|NCT03384940|50067477|FG002|Overall Study|Clinical progression|3|||
24979054|NCT03384940|50067475|FG000|Overall Study|Adverse Event|7|||
24979055|NCT03384940|50067476|FG001|Overall Study|Adverse Event|1|||
24979056|NCT03384940|50067477|FG002|Overall Study|Adverse Event|1|||
24979057|NCT03384940|50067475|FG000|Overall Study|Withdrawal by Subject|3|||
24979058|NCT03384940|50067476|FG001|Overall Study|Withdrawal by Subject|1|||
24979059|NCT03384940|50067477|FG002|Overall Study|Withdrawal by Subject|0|||
24979060|NCT03384940|50067475|FG000|Overall Study|Physician Decision|1|||
25341457|NCT00798707|50657809|FG000|Overall Study|Withdrawal by Subject|3|||
25341458|NCT00798707|50657810|FG001|Overall Study|Withdrawal by Subject|8|||
24979061|NCT03384940|50067476|FG001|Overall Study|Physician Decision|1|||
24979062|NCT03384940|50067477|FG002|Overall Study|Physician Decision|0|||
25341459|NCT00798707|50657811|FG002|Overall Study|Withdrawal by Subject|2|||
25341460|NCT00798707|50657809|FG000|Overall Study|Randomized not treated|4|||
24979063|NCT03384940|50067475|FG000|Overall Study|Death|2|||
24979064|NCT03384940|50067476|FG001|Overall Study|Death|1|||
24979065|NCT03384940|50067477|FG002|Overall Study|Death|0|||
24979066|NCT03384940|50067475|FG000|Overall Study|Other|0|||
24979067|NCT03384940|50067476|FG001|Overall Study|Other|0|||
24979068|NCT03384940|50067477|FG002|Overall Study|Other|1|||
24979069|NCT00075582|50067487|FG000|Overall Study|Adverse Event|3|||
24979070|NCT00075582|50067488|FG001|Overall Study|Adverse Event|1|||
24979071|NCT00075582|50067487|FG000|Overall Study|Lack of Efficacy|4|||
24979072|NCT00075582|50067488|FG001|Overall Study|Lack of Efficacy|8|||
24979073|NCT00075582|50067487|FG000|Overall Study|Physician Decision|5|||
25255116|NCT01175083|50570830|FG003|Primary Epoch|Withdrawal by Subject|0|||
25255117|NCT01175083|50570831|FG004|Primary Epoch|Withdrawal by Subject|0|||
25255118|NCT01175083|50570832|FG005|Primary Epoch|Withdrawal by Subject|2|||
25255119|NCT01175083|50570827|FG000|Primary Epoch|Lost to Follow-up|0|||
25255120|NCT01175083|50570828|FG001|Primary Epoch|Lost to Follow-up|0|||
25255121|NCT01175083|50570829|FG002|Primary Epoch|Lost to Follow-up|0|||
25255122|NCT01175083|50570830|FG003|Primary Epoch|Lost to Follow-up|0|||
25255123|NCT01175083|50570831|FG004|Primary Epoch|Lost to Follow-up|0|||
25255124|NCT01175083|50570832|FG005|Primary Epoch|Lost to Follow-up|1|||
25255125|NCT01175083|50570827|FG000|Booster Epoch|Death|0|||
25255126|NCT01175083|50570828|FG001|Booster Epoch|Death|0|||
25255127|NCT01175083|50570829|FG002|Booster Epoch|Death|1|||
25255128|NCT01175083|50570830|FG003|Booster Epoch|Death|0|||
25255129|NCT01175083|50570831|FG004|Booster Epoch|Death|0|||
25255130|NCT01175083|50570832|FG005|Booster Epoch|Death|0|||
25255131|NCT01175083|50570827|FG000|Booster Epoch|Withdrawal by Subject|0|||
25255132|NCT01175083|50570828|FG001|Booster Epoch|Withdrawal by Subject|0|||
25255133|NCT01175083|50570829|FG002|Booster Epoch|Withdrawal by Subject|0|||
25255134|NCT01175083|50570830|FG003|Booster Epoch|Withdrawal by Subject|1|||
25255135|NCT01175083|50570831|FG004|Booster Epoch|Withdrawal by Subject|0|||
25255136|NCT01175083|50570832|FG005|Booster Epoch|Withdrawal by Subject|0|||
25255137|NCT01174459|50570850|FG000|Overall Study|case report form (CRF) not collected|5|||
25255138|NCT01174342|50570854|FG000|Overall Study|Conversion to cesarean section|4|||
25255139|NCT01111474|50570858|FG000|Overall Study|Lost to Follow-up|12|||
25255140|NCT01174264|50570867|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
25255141|NCT01174264|50570868|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
25255142|NCT01174264|50570869|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
25255143|NCT01174264|50570867|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
25255144|NCT01174264|50570868|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
25255145|NCT01174264|50570869|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
25255146|NCT01174264|50570867|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
25255147|NCT01174264|50570868|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
25255148|NCT01174264|50570869|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
25255149|NCT01174186|50570879|FG000|Overall Study|Lost to Follow-up|0|||
24979074|NCT00075582|50067488|FG001|Overall Study|Physician Decision|8|||
24979075|NCT00075582|50067487|FG000|Overall Study|Withdrawal by Subject|2|||
24979076|NCT00075582|50067488|FG001|Overall Study|Withdrawal by Subject|2|||
24979077|NCT00075582|50067487|FG000|Overall Study|Ineligible for study|36|||
24979078|NCT00075582|50067488|FG001|Overall Study|Ineligible for study|16|||
24979079|NCT00063258|50067500|FG000|Overall Study|Physician Decision|2|||
24979080|NCT00063258|50067501|FG001|Overall Study|Physician Decision|0|||
24979081|NCT00063258|50067500|FG000|Overall Study|Lack of Efficacy|2|||
24979082|NCT00063258|50067501|FG001|Overall Study|Lack of Efficacy|0|||
24979083|NCT00088530|50067509|FG000|Overall Study|Progressive/Relapsed Disease|28|||
24979084|NCT00088530|50067510|FG001|Overall Study|Progressive/Relapsed Disease|39|||
24979085|NCT00088530|50067509|FG000|Overall Study|Adverse Event|15|||
24979086|NCT00088530|50067510|FG001|Overall Study|Adverse Event|9|||
24979087|NCT00088530|50067509|FG000|Overall Study|Withdrawal by Subject|2|||
24979088|NCT00088530|50067510|FG001|Overall Study|Withdrawal by Subject|5|||
25255150|NCT01174186|50570880|FG001|Overall Study|Lost to Follow-up|1|||
25255151|NCT01174186|50570879|FG000|Overall Study|Withdrawal by Subject|0|||
25255152|NCT01174186|50570880|FG001|Overall Study|Withdrawal by Subject|2|||
25255153|NCT01173718|50570886|FG000|Overall Study|Death|17|||
25255154|NCT01173718|50570886|FG000|Overall Study|Abandonment of study graft|27|||
25255155|NCT01111240|50570890|FG000|Overall Study|Adverse Event|190|||
24979089|NCT00088530|50067509|FG000|Overall Study|Lost to Follow-up|2|||
24979090|NCT00088530|50067510|FG001|Overall Study|Lost to Follow-up|0|||
24979091|NCT00088530|50067509|FG000|Overall Study|Physician Decision|2|||
24979092|NCT00088530|50067510|FG001|Overall Study|Physician Decision|0|||
24979093|NCT00088530|50067509|FG000|Overall Study|Sponsor decision|0|||
24979094|NCT00088530|50067510|FG001|Overall Study|Sponsor decision|1|||
24979095|NCT00088530|50067509|FG000|Overall Study|Patient never treated|1|||
25255156|NCT01111240|50570890|FG000|Overall Study|Lack of Efficacy|545|||
25255157|NCT01111240|50570890|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
25255158|NCT01111240|50570890|FG000|Overall Study|Other|312|||
25255159|NCT01111123|50570896|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
25255160|NCT01111123|50570897|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
24979096|NCT00088530|50067510|FG001|Overall Study|Patient never treated|0|||
24979097|NCT00359801|50067518|FG000|Overall Study|Lost to Follow-up|72|||
24979098|NCT00359801|50067519|FG001|Overall Study|Lost to Follow-up|58|||
24979099|NCT00359801|50067518|FG000|Overall Study|Withdrawal by Subject|143|||
24979100|NCT00359801|50067519|FG001|Overall Study|Withdrawal by Subject|96|||
24979101|NCT00359801|50067518|FG000|Overall Study|Other|66|||
24979102|NCT00359801|50067519|FG001|Overall Study|Other|46|||
24979103|NCT00359801|50067518|FG000|Overall Study|Final Status Unknown: missing data|7|||
24979104|NCT00359801|50067519|FG001|Overall Study|Final Status Unknown: missing data|4|||
24979105|NCT00359801|50067518|FG000|Overall Study|Sponsor Decision|17|||
24979106|NCT00359801|50067519|FG001|Overall Study|Sponsor Decision|16|||
24979107|NCT00045032|50067528|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
24979108|NCT00045032|50067529|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
24979109|NCT00045032|50067530|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
24979110|NCT00045032|50067528|FG000|Overall Study|Death|22|||
24979111|NCT00045032|50067529|FG001|Overall Study|Death|24|||
24979112|NCT00045032|50067530|FG002|Overall Study|Death|17|||
24979113|NCT00045032|50067528|FG000|Overall Study|Insufficient Therapeutic Response|542|||
24979114|NCT00045032|50067529|FG001|Overall Study|Insufficient Therapeutic Response|437|||
24979115|NCT00045032|50067530|FG002|Overall Study|Insufficient Therapeutic Response|445|||
24979116|NCT00045032|50067528|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
24979117|NCT00045032|50067529|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
24979118|NCT00045032|50067530|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
24979119|NCT00045032|50067528|FG000|Overall Study|Other Protocol Violation|2|||
24979120|NCT00045032|50067529|FG001|Overall Study|Other Protocol Violation|0|||
24979121|NCT00045032|50067530|FG002|Overall Study|Other Protocol Violation|1|||
24979122|NCT00045032|50067528|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
24979123|NCT00045032|50067529|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
24979124|NCT00045032|50067530|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
24979125|NCT00045032|50067528|FG000|Overall Study|Failure to Return|57|||
24979126|NCT00045032|50067529|FG001|Overall Study|Failure to Return|62|||
24979127|NCT00045032|50067530|FG002|Overall Study|Failure to Return|61|||
24979128|NCT00045032|50067528|FG000|Overall Study|Other|93|||
24979129|NCT00045032|50067529|FG001|Overall Study|Other|84|||
24979130|NCT00045032|50067530|FG002|Overall Study|Other|105|||
24979131|NCT00356915|50067543|FG000|Overall Study|Non compliance|1|||
24979132|NCT00356915|50067544|FG001|Overall Study|Non compliance|2|||
24979133|NCT00356915|50067545|FG002|Overall Study|Non compliance|1|||
24979134|NCT00356915|50067543|FG000|Overall Study|Protocol Violation|2|||
24979135|NCT00356915|50067544|FG001|Overall Study|Protocol Violation|3|||
24979136|NCT00356915|50067545|FG002|Overall Study|Protocol Violation|2|||
24979137|NCT00356915|50067543|FG000|Overall Study|Withdrawal by Subject|14|||
25255161|NCT01111123|50570896|FG000|Maintenance Phase|Lost to Follow-up|0|||
25255162|NCT01111123|50570897|FG001|Maintenance Phase|Lost to Follow-up|2|||
25255163|NCT01173679|50570905|FG000|Overall Study|Death|1|||
25255164|NCT01110382|50570912|FG000|Overall Study|Withdrawal by Subject|0|||
25255165|NCT01110382|50570913|FG001|Overall Study|Withdrawal by Subject|1|||
25255166|NCT01110382|50570912|FG000|Overall Study|Protocol Violation|0|||
24979138|NCT00356915|50067544|FG001|Overall Study|Withdrawal by Subject|14|||
24979139|NCT00356915|50067545|FG002|Overall Study|Withdrawal by Subject|10|||
24979140|NCT00356915|50067543|FG000|Overall Study|Lack of Efficacy|0|||
24979141|NCT00356915|50067544|FG001|Overall Study|Lack of Efficacy|0|||
24979142|NCT00356915|50067545|FG002|Overall Study|Lack of Efficacy|3|||
24979143|NCT00356915|50067543|FG000|Overall Study|Lost to Follow-up|27|||
24979144|NCT00356915|50067544|FG001|Overall Study|Lost to Follow-up|34|||
24979145|NCT00356915|50067545|FG002|Overall Study|Lost to Follow-up|14|||
24979146|NCT00356915|50067543|FG000|Overall Study|Administrative Decision|0|||
24979147|NCT00356915|50067544|FG001|Overall Study|Administrative Decision|0|||
24979148|NCT00356915|50067545|FG002|Overall Study|Administrative Decision|1|||
24979149|NCT00356915|50067543|FG000|Overall Study|Physician Decision|0|||
24979150|NCT00356915|50067544|FG001|Overall Study|Physician Decision|2|||
24979151|NCT00356915|50067545|FG002|Overall Study|Physician Decision|0|||
24979152|NCT00356915|50067543|FG000|Overall Study|Adverse Event|21|||
24979153|NCT00356915|50067544|FG001|Overall Study|Adverse Event|31|||
24979154|NCT00356915|50067545|FG002|Overall Study|Adverse Event|8|||
24979155|NCT00356915|50067543|FG000|Overall Study|Miscellaneous reasons|11|||
24979156|NCT00356915|50067544|FG001|Overall Study|Miscellaneous reasons|8|||
24979157|NCT00356915|50067545|FG002|Overall Study|Miscellaneous reasons|3|||
24979158|NCT00356759|50067561|FG000|Overall Study|Death|5|||
24979159|NCT00356759|50067562|FG001|Overall Study|Death|2|||
24979160|NCT00356759|50067561|FG000|Overall Study|Withdrawal by Subject|2|||
24979161|NCT00356759|50067562|FG001|Overall Study|Withdrawal by Subject|2|||
24979162|NCT00356759|50067561|FG000|Overall Study|Adverse Event|1|||
25255167|NCT01110382|50570913|FG001|Overall Study|Protocol Violation|1|||
25255168|NCT01173601|50570923|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
24979163|NCT00356759|50067562|FG001|Overall Study|Adverse Event|3|||
25255169|NCT01173601|50570924|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
25255170|NCT01173601|50570925|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
25255171|NCT01173601|50570926|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
25255172|NCT01173601|50570927|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
24979164|NCT00356759|50067561|FG000|Overall Study|Lost to Follow-up|1|||
24979165|NCT00356759|50067562|FG001|Overall Study|Lost to Follow-up|1|||
24979166|NCT00356759|50067561|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
24979167|NCT00356759|50067562|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
24979168|NCT03804710|50067570|FG000|Overall Study|Adverse Event|0|||
24979169|NCT03804710|50067571|FG001|Overall Study|Adverse Event|3|||
24979170|NCT03804710|50067570|FG000|Overall Study|Withdrawal by Subject|2|||
24979171|NCT03804710|50067571|FG001|Overall Study|Withdrawal by Subject|1|||
24979172|NCT03804710|50067570|FG000|Overall Study|Other|0|||
24979173|NCT03804710|50067571|FG001|Overall Study|Other|1|||
24979174|NCT00356603|50067583|FG000|Overall Study|Other|6|||
24979175|NCT00356603|50067584|FG001|Overall Study|Other|3|||
24979176|NCT00002558|50067594|FG000|Overall Study|Withdrawal by Subject|0|||
24979177|NCT00002558|50067595|FG001|Overall Study|Withdrawal by Subject|1|||
24979178|NCT00002540|50067603|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
24979179|NCT00002540|50067604|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
24979180|NCT00002540|50067603|FG000|Overall Study|Died Before Randomization|2|||
24979181|NCT00002540|50067604|FG001|Overall Study|Died Before Randomization|6|||
24979182|NCT00002540|50067603|FG000|Overall Study|Died Before ASU (Control)|202|||
24979183|NCT00002540|50067604|FG001|Overall Study|Died Before ASU (Control)|0|||
24979184|NCT00002540|50067603|FG000|Overall Study|Refused ASU (Control)|597|||
24979185|NCT00002540|50067604|FG001|Overall Study|Refused ASU (Control)|0|||
24979186|NCT00002540|50067603|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
24979187|NCT00002540|50067604|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
24979188|NCT00001880|50067610|FG000|Overall Study|Death|14|||
24979189|NCT00043550|50067617|FG000|Overall Study|Withdrawal by Subject|22|||
24979190|NCT00043550|50067618|FG001|Overall Study|Withdrawal by Subject|12|||
24979191|NCT00043550|50067619|FG002|Overall Study|Withdrawal by Subject|20|||
24979192|NCT00041756|50067632|FG000|Overall Study|Adverse Event|4|||
24979193|NCT00041756|50067633|FG001|Overall Study|Adverse Event|10|||
24979194|NCT00041756|50067634|FG002|Overall Study|Adverse Event|6|||
24979195|NCT00041756|50067635|FG003|Overall Study|Adverse Event|11|||
24979196|NCT00041756|50067636|FG004|Overall Study|Adverse Event|34|||
24979197|NCT00041756|50067632|FG000|Overall Study|Protocol Violation|1|||
24979198|NCT00041756|50067633|FG001|Overall Study|Protocol Violation|1|||
24979199|NCT00041756|50067634|FG002|Overall Study|Protocol Violation|2|||
24979200|NCT00041756|50067635|FG003|Overall Study|Protocol Violation|2|||
24979201|NCT00041756|50067636|FG004|Overall Study|Protocol Violation|1|||
24979202|NCT00041756|50067632|FG000|Overall Study|Withdrawal by Subject|3|||
24979203|NCT00041756|50067633|FG001|Overall Study|Withdrawal by Subject|3|||
24979204|NCT00041756|50067634|FG002|Overall Study|Withdrawal by Subject|4|||
24979205|NCT00041756|50067635|FG003|Overall Study|Withdrawal by Subject|2|||
24979206|NCT00041756|50067636|FG004|Overall Study|Withdrawal by Subject|3|||
24979207|NCT00041756|50067632|FG000|Overall Study|Lost to Follow-up|0|||
24979208|NCT00041756|50067633|FG001|Overall Study|Lost to Follow-up|1|||
24979209|NCT00041756|50067634|FG002|Overall Study|Lost to Follow-up|0|||
24979210|NCT00041756|50067635|FG003|Overall Study|Lost to Follow-up|1|||
24979211|NCT00041756|50067636|FG004|Overall Study|Lost to Follow-up|0|||
24979212|NCT00041756|50067632|FG000|Overall Study|Unable to meet protocol criteria|0|||
24979213|NCT00041756|50067633|FG001|Overall Study|Unable to meet protocol criteria|0|||
24979214|NCT00041756|50067634|FG002|Overall Study|Unable to meet protocol criteria|1|||
24979215|NCT00041756|50067635|FG003|Overall Study|Unable to meet protocol criteria|0|||
24979216|NCT00041756|50067636|FG004|Overall Study|Unable to meet protocol criteria|1|||
25341461|NCT00798707|50657810|FG001|Overall Study|Randomized not treated|5|||
24979217|NCT00041756|50067632|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
24979218|NCT00041756|50067633|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
24979219|NCT00041756|50067634|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
24979220|NCT00041756|50067635|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
25255173|NCT01173601|50570923|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
25255174|NCT01173601|50570924|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
25255175|NCT01173601|50570925|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
25255176|NCT01173601|50570926|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
25255177|NCT01173601|50570927|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
25255178|NCT01173601|50570923|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
25255179|NCT01173601|50570924|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
25255180|NCT01173601|50570925|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
25341462|NCT00798707|50657811|FG002|Overall Study|Randomized not treated|1|||
24979221|NCT00041756|50067636|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
24979222|NCT00041132|50067648|FG000|Overall Study|Adverse Event|19|||
24979223|NCT00041132|50067648|FG000|Overall Study|Death|1|||
24979224|NCT00041132|50067648|FG000|Overall Study|Not Eligible|7|||
24979225|NCT00041132|50067648|FG000|Overall Study|Withdrawal by Subject|1|||
24979226|NCT00041132|50067648|FG000|Overall Study|Physician Decision|2|||
24979227|NCT00040742|50067656|FG000|Overall Study|Death|0|||
24979228|NCT00040742|50067657|FG001|Overall Study|Death|0|||
24979229|NCT00040742|50067658|FG002|Overall Study|Death|1|||
24979230|NCT00040742|50067659|FG003|Overall Study|Death|0|||
24979231|NCT00040742|50067656|FG000|Overall Study|Adverse Event|15|||
24979232|NCT00040742|50067657|FG001|Overall Study|Adverse Event|16|||
24979233|NCT00040742|50067658|FG002|Overall Study|Adverse Event|21|||
24979234|NCT00040742|50067659|FG003|Overall Study|Adverse Event|9|||
25341463|NCT00760214|50657822|FG000|Overall Study|Adverse Event|8|||
25341464|NCT00760214|50657823|FG001|Overall Study|Adverse Event|9|||
25341465|NCT00760214|50657824|FG002|Overall Study|Adverse Event|12|||
25341466|NCT00760214|50657822|FG000|Overall Study|Protocol Violation|3|||
25341467|NCT00760214|50657823|FG001|Overall Study|Protocol Violation|0|||
25341468|NCT00760214|50657824|FG002|Overall Study|Protocol Violation|3|||
24979235|NCT00040742|50067656|FG000|Overall Study|Withdrawal by Subject|7|||
24979236|NCT00040742|50067657|FG001|Overall Study|Withdrawal by Subject|15|||
24979237|NCT00040742|50067658|FG002|Overall Study|Withdrawal by Subject|10|||
24979238|NCT00040742|50067659|FG003|Overall Study|Withdrawal by Subject|13|||
24979239|NCT00040742|50067656|FG000|Overall Study|Chemotoxicity|4|||
24979240|NCT00040742|50067657|FG001|Overall Study|Chemotoxicity|3|||
24979241|NCT00040742|50067658|FG002|Overall Study|Chemotoxicity|5|||
24979242|NCT00040742|50067659|FG003|Overall Study|Chemotoxicity|2|||
24979243|NCT00040742|50067656|FG000|Overall Study|Incomplete Forms|6|||
24979244|NCT00040742|50067657|FG001|Overall Study|Incomplete Forms|10|||
24979245|NCT00040742|50067658|FG002|Overall Study|Incomplete Forms|4|||
24979246|NCT00040742|50067659|FG003|Overall Study|Incomplete Forms|5|||
24979247|NCT00040742|50067656|FG000|Overall Study|Other medical|7|||
24979248|NCT00040742|50067657|FG001|Overall Study|Other medical|5|||
24979249|NCT00040742|50067658|FG002|Overall Study|Other medical|5|||
24979250|NCT00040742|50067659|FG003|Overall Study|Other medical|5|||
24979251|NCT00040664|50067669|FG000|Overall Study|Adverse Event|12|||
24979252|NCT00040664|50067670|FG001|Overall Study|Adverse Event|3|||
24979253|NCT00040664|50067671|FG002|Overall Study|Adverse Event|2|||
24979254|NCT00040664|50067672|FG003|Overall Study|Adverse Event|7|||
24979255|NCT00040664|50067669|FG000|Overall Study|Lack of Efficacy|9|||
24979256|NCT00040664|50067670|FG001|Overall Study|Lack of Efficacy|2|||
25341469|NCT00760214|50657822|FG000|Overall Study|Lost to Follow-up|0|||
25341470|NCT00760214|50657823|FG001|Overall Study|Lost to Follow-up|0|||
25341471|NCT00760214|50657824|FG002|Overall Study|Lost to Follow-up|1|||
25341472|NCT00760214|50657822|FG000|Overall Study|Withdrawal by Subject|12|||
25341473|NCT00760214|50657823|FG001|Overall Study|Withdrawal by Subject|14|||
25341474|NCT00760214|50657824|FG002|Overall Study|Withdrawal by Subject|13|||
25341475|NCT00760214|50657822|FG000|Overall Study|Lack of Efficacy|3|||
24979257|NCT00040664|50067671|FG002|Overall Study|Lack of Efficacy|3|||
24979258|NCT00040664|50067672|FG003|Overall Study|Lack of Efficacy|4|||
24979259|NCT00040664|50067669|FG000|Overall Study|Insufficient CD4 response|1|||
24979260|NCT00040664|50067670|FG001|Overall Study|Insufficient CD4 response|0|||
24979261|NCT00040664|50067671|FG002|Overall Study|Insufficient CD4 response|1|||
24979262|NCT00040664|50067672|FG003|Overall Study|Insufficient CD4 response|0|||
24979263|NCT00040664|50067669|FG000|Overall Study|Lost to Follow-up|4|||
24979264|NCT00040664|50067670|FG001|Overall Study|Lost to Follow-up|2|||
24979265|NCT00040664|50067671|FG002|Overall Study|Lost to Follow-up|0|||
24979266|NCT00040664|50067672|FG003|Overall Study|Lost to Follow-up|2|||
24979267|NCT00040664|50067669|FG000|Overall Study|Protocol Violation|2|||
24979268|NCT00040664|50067670|FG001|Overall Study|Protocol Violation|1|||
24979269|NCT00040664|50067671|FG002|Overall Study|Protocol Violation|0|||
24979270|NCT00040664|50067672|FG003|Overall Study|Protocol Violation|1|||
24979271|NCT00040664|50067669|FG000|Overall Study|Withdrawal by Subject|7|||
24979272|NCT00040664|50067670|FG001|Overall Study|Withdrawal by Subject|0|||
24979273|NCT00040664|50067671|FG002|Overall Study|Withdrawal by Subject|3|||
24979274|NCT00040664|50067672|FG003|Overall Study|Withdrawal by Subject|4|||
24979275|NCT00040664|50067669|FG000|Overall Study|Pregnancy|3|||
24979276|NCT00040664|50067670|FG001|Overall Study|Pregnancy|0|||
25255181|NCT01173601|50570926|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
25255182|NCT01173601|50570927|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
24979277|NCT00040664|50067671|FG002|Overall Study|Pregnancy|0|||
25255183|NCT01173601|50570923|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
25255184|NCT01173601|50570924|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
25255185|NCT01173601|50570925|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
25255186|NCT01173601|50570926|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
24979278|NCT00040664|50067672|FG003|Overall Study|Pregnancy|3|||
25255187|NCT01173601|50570927|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
25255188|NCT01173601|50570923|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
24979279|NCT00040664|50067669|FG000|Overall Study|Medication adherence/compliance problems|8|||
25341476|NCT00760214|50657823|FG001|Overall Study|Lack of Efficacy|2|||
25341477|NCT00760214|50657824|FG002|Overall Study|Lack of Efficacy|4|||
25341478|NCT00760214|50657822|FG000|Overall Study|Pregnancy|0|||
25341479|NCT00760214|50657823|FG001|Overall Study|Pregnancy|0|||
24979280|NCT00040664|50067670|FG001|Overall Study|Medication adherence/compliance problems|2|||
24979281|NCT00040664|50067671|FG002|Overall Study|Medication adherence/compliance problems|1|||
24979282|NCT00040664|50067672|FG003|Overall Study|Medication adherence/compliance problems|5|||
24979283|NCT00040664|50067669|FG000|Overall Study|Poor taste|2|||
24979284|NCT00040664|50067670|FG001|Overall Study|Poor taste|0|||
24979285|NCT00040664|50067671|FG002|Overall Study|Poor taste|2|||
24979286|NCT00040664|50067672|FG003|Overall Study|Poor taste|0|||
24979287|NCT00040664|50067669|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
24979288|NCT00040664|50067670|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
25341480|NCT00760214|50657824|FG002|Overall Study|Pregnancy|1|||
25341481|NCT00760214|50657822|FG000|Overall Study|Physician Decision|1|||
25341482|NCT00760214|50657823|FG001|Overall Study|Physician Decision|1|||
25341483|NCT00760214|50657824|FG002|Overall Study|Physician Decision|1|||
25341484|NCT00760214|50657822|FG000|Overall Study|Other|3|||
25341485|NCT00760214|50657823|FG001|Overall Study|Other|4|||
25341486|NCT00760214|50657824|FG002|Overall Study|Other|6|||
25341487|NCT00802841|50657834|FG000|Overall Study|Administrative problems|1|||
25341488|NCT00802841|50657835|FG001|Overall Study|Administrative problems|0|||
25341489|NCT00802841|50657834|FG000|Overall Study|Lost to Follow-up|2|||
25341490|NCT00802841|50657835|FG001|Overall Study|Lost to Follow-up|1|||
25341491|NCT00802841|50657834|FG000|Overall Study|Death|1|||
25341492|NCT00802841|50657835|FG001|Overall Study|Death|2|||
25341493|NCT00802841|50657834|FG000|Overall Study|Adverse Event|8|||
25341494|NCT00802841|50657835|FG001|Overall Study|Adverse Event|2|||
25341495|NCT00802841|50657834|FG000|Overall Study|Disease progression|7|||
25341496|NCT00802841|50657835|FG001|Overall Study|Disease progression|3|||
25341497|NCT00802841|50657834|FG000|Overall Study|Withdrawal by Subject|9|||
25341498|NCT00802841|50657835|FG001|Overall Study|Withdrawal by Subject|5|||
25341499|NCT00802841|50657834|FG000|Overall Study|Protocol deviation|2|||
25341500|NCT00802841|50657835|FG001|Overall Study|Protocol deviation|6|||
25341501|NCT00802841|50657834|FG000|Overall Study|Treatment duration completed|66|||
25341502|NCT00802841|50657835|FG001|Overall Study|Treatment duration completed|76|||
25341503|NCT00772148|50657845|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
25341504|NCT00772148|50657846|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
25341505|NCT00772148|50657845|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
25341506|NCT00772148|50657846|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
25341507|NCT00772148|50657845|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
25341508|NCT00772148|50657846|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
25341509|NCT00772148|50657845|FG000|Maintenance Phase (Week 52)|Death|2|||
25341510|NCT00772148|50657846|FG001|Maintenance Phase (Week 52)|Death|2|||
25341511|NCT00772148|50657845|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
25341512|NCT00772148|50657846|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
25341513|NCT00772148|50657845|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
25341514|NCT00772148|50657846|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
25341515|NCT00772148|50657845|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
25341516|NCT00772148|50657846|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
25341517|NCT00759902|50657854|FG000|Overall Study|Adverse Event|0|||
25341518|NCT00759902|50657855|FG001|Overall Study|Adverse Event|1|||
25341519|NCT00772070|50657863|FG000|Overall Study|Lost to Follow-up|0|||
25341520|NCT00772070|50657864|FG001|Overall Study|Lost to Follow-up|8|||
25341521|NCT00772070|50657863|FG000|Overall Study|Withdrawal by Subject|0|||
25341522|NCT00772070|50657864|FG001|Overall Study|Withdrawal by Subject|2|||
25341523|NCT00772070|50657863|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
24979289|NCT00040664|50067671|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
24979290|NCT00040664|50067672|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
24979291|NCT00040664|50067669|FG000|Overall Study|Change of formulation|2|||
24979292|NCT00040664|50067670|FG001|Overall Study|Change of formulation|2|||
24979293|NCT00040664|50067671|FG002|Overall Study|Change of formulation|0|||
24979294|NCT00040664|50067672|FG003|Overall Study|Change of formulation|0|||
24979295|NCT00040664|50067669|FG000|Overall Study|Non-viability of oral suspension|1|||
24979296|NCT00040664|50067670|FG001|Overall Study|Non-viability of oral suspension|0|||
24979297|NCT00040664|50067671|FG002|Overall Study|Non-viability of oral suspension|1|||
24979298|NCT00040664|50067672|FG003|Overall Study|Non-viability of oral suspension|0|||
24979299|NCT02952586|50067692|FG000|Lead-In Phase (7 Days)|Death|0|||
24979300|NCT02952586|50067693|FG001|Lead-In Phase (7 Days)|Death|1|||
24979301|NCT02952586|50067692|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
24979302|NCT02952586|50067693|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
24979303|NCT02952586|50067692|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
25341524|NCT00772070|50657864|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
25341525|NCT00796757|50657870|FG000|Overall Study|Withdrawal by Subject|14|||
25341526|NCT00796757|50657870|FG000|Overall Study|Death|61|||
25341527|NCT00796757|50657870|FG000|Overall Study|Protocol Violation|1|||
25341528|NCT00796757|50657870|FG000|Overall Study|Participant noncompliance|1|||
25341529|NCT00796757|50657870|FG000|Overall Study|Investigator's decision|2|||
25341530|NCT00796757|50657870|FG000|Overall Study|Other|7|||
25341531|NCT00759356|50657876|FG000|Overall Study|Adverse Event|0|||
25341532|NCT00759356|50657877|FG001|Overall Study|Adverse Event|1|||
25341533|NCT00759356|50657876|FG000|Overall Study|Withdrawal by Subject|0|||
25341534|NCT00759356|50657877|FG001|Overall Study|Withdrawal by Subject|2|||
25341535|NCT00759356|50657876|FG000|Overall Study|Subject was unable to return|1|||
25341536|NCT00759356|50657877|FG001|Overall Study|Subject was unable to return|0|||
25341537|NCT00721734|50657888|FG000|Overall Study|Progressive Disease|3|||
25341538|NCT00721734|50657889|FG001|Overall Study|Progressive Disease|10|||
25341539|NCT00721734|50657890|FG002|Overall Study|Progressive Disease|4|||
25341540|NCT00721734|50657891|FG003|Overall Study|Progressive Disease|5|||
25341541|NCT00721734|50657892|FG004|Overall Study|Progressive Disease|2|||
25341542|NCT00721734|50657888|FG000|Overall Study|Adverse Event|3|||
25341543|NCT00721734|50657889|FG001|Overall Study|Adverse Event|1|||
25341544|NCT00721734|50657890|FG002|Overall Study|Adverse Event|4|||
25341545|NCT00721734|50657891|FG003|Overall Study|Adverse Event|0|||
25341546|NCT00721734|50657892|FG004|Overall Study|Adverse Event|3|||
25341547|NCT00721734|50657888|FG000|Overall Study|Withdrawal by Subject|2|||
25341548|NCT00721734|50657889|FG001|Overall Study|Withdrawal by Subject|1|||
24979304|NCT02952586|50067693|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
24979305|NCT02952586|50067692|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
24979306|NCT02952586|50067693|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
24979307|NCT02952586|50067692|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
24979308|NCT02952586|50067693|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
24979309|NCT02952586|50067692|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
24979310|NCT02952586|50067693|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
24979311|NCT02952586|50067692|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
24979312|NCT02952586|50067693|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
24979313|NCT02952586|50067692|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
24979314|NCT02952586|50067693|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
24979315|NCT02952586|50067692|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
24979316|NCT02952586|50067693|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
24979317|NCT02952586|50067692|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
24979318|NCT02952586|50067693|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
24979319|NCT02952586|50067692|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
24979320|NCT02952586|50067693|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
24979321|NCT02952586|50067692|FG000|CRT for Cisplatin (63 Days)|Death|3|||
24979322|NCT02952586|50067693|FG001|CRT for Cisplatin (63 Days)|Death|8|||
24979323|NCT02952586|50067692|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
24979324|NCT02952586|50067693|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
24979325|NCT02952586|50067692|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
24979326|NCT02952586|50067693|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
24979327|NCT02952586|50067692|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
24979328|NCT02952586|50067693|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
24979329|NCT02952586|50067692|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
24979330|NCT02952586|50067693|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
24979331|NCT02952586|50067692|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
24979332|NCT02952586|50067693|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
24979333|NCT02952586|50067692|FG000|CRT for Cisplatin (63 Days)|Other|1|||
24979334|NCT02952586|50067693|FG001|CRT for Cisplatin (63 Days)|Other|1|||
24979335|NCT02952586|50067692|FG000|CRT for IMRT (63 Days)|Death|5|||
24979336|NCT02952586|50067693|FG001|CRT for IMRT (63 Days)|Death|8|||
24979337|NCT02952586|50067692|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
25341549|NCT00721734|50657890|FG002|Overall Study|Withdrawal by Subject|0|||
25341550|NCT00721734|50657891|FG003|Overall Study|Withdrawal by Subject|0|||
25341551|NCT00721734|50657892|FG004|Overall Study|Withdrawal by Subject|1|||
25341552|NCT00721734|50657888|FG000|Overall Study|Other|0|||
25341553|NCT00721734|50657889|FG001|Overall Study|Other|0|||
25341554|NCT00721734|50657890|FG002|Overall Study|Other|0|||
25341555|NCT00721734|50657891|FG003|Overall Study|Other|1|||
25341556|NCT00721734|50657892|FG004|Overall Study|Other|0|||
25341557|NCT00798317|50657906|FG000|Overall Study|Physician Decision|0|||
25341558|NCT00798317|50657907|FG001|Overall Study|Physician Decision|1|||
25341559|NCT00798317|50657906|FG000|Overall Study|Withdrawal by Subject|5|||
25341560|NCT00798317|50657907|FG001|Overall Study|Withdrawal by Subject|4|||
25341561|NCT00798317|50657906|FG000|Overall Study|Lost to Follow-up|2|||
25341562|NCT00798317|50657907|FG001|Overall Study|Lost to Follow-up|2|||
25341563|NCT00798317|50657906|FG000|Overall Study|Adverse Event|2|||
24979338|NCT02952586|50067693|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
25341564|NCT00798317|50657907|FG001|Overall Study|Adverse Event|0|||
25341565|NCT00798317|50657906|FG000|Overall Study|Death|1|||
25341566|NCT00798317|50657907|FG001|Overall Study|Death|0|||
25341567|NCT00779402|50657915|FG000|Treatment Phase 1|Disease Progression|1|||
25341568|NCT00779402|50657916|FG001|Treatment Phase 1|Disease Progression|0|||
25341569|NCT00779402|50657915|FG000|Treatment Phase 1|Adverse Event|2|||
25341570|NCT00779402|50657916|FG001|Treatment Phase 1|Adverse Event|0|||
24979339|NCT02952586|50067692|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
24979340|NCT02952586|50067693|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
24979341|NCT02952586|50067692|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
24979342|NCT02952586|50067693|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
24979343|NCT02952586|50067692|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
24979344|NCT02952586|50067693|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
24979345|NCT02952586|50067692|FG000|CRT for IMRT (63 Days)|Other|1|||
24979346|NCT02952586|50067693|FG001|CRT for IMRT (63 Days)|Other|0|||
24979347|NCT02952586|50067692|FG000|Maintenance Phase (12 Months)|Death|17|||
24979348|NCT02952586|50067693|FG001|Maintenance Phase (12 Months)|Death|11|||
24979349|NCT02952586|50067692|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
24979350|NCT02952586|50067693|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
24979351|NCT02952586|50067692|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
24979352|NCT02952586|50067693|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
24979353|NCT02952586|50067692|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
24979354|NCT02952586|50067693|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
24979355|NCT02952586|50067692|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
24979356|NCT02952586|50067693|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
24979357|NCT02952586|50067692|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
24979358|NCT02952586|50067693|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
24979359|NCT02952586|50067692|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
24979360|NCT02952586|50067693|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
24979361|NCT02952586|50067692|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
24979362|NCT02952586|50067693|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
24979363|NCT02952586|50067692|FG000|Maintenance Phase (12 Months)|Other|2|||
24979364|NCT02952586|50067693|FG001|Maintenance Phase (12 Months)|Other|1|||
24979365|NCT02952586|50067692|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
24979366|NCT02952586|50067693|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
24979367|NCT02952586|50067692|FG000|Follow-Up Phase (90 Days)|Death|12|||
24979368|NCT02952586|50067693|FG001|Follow-Up Phase (90 Days)|Death|10|||
24979369|NCT02952586|50067692|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
24979370|NCT02952586|50067693|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
24979371|NCT02952586|50067692|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
24979372|NCT02952586|50067693|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
24979373|NCT02952586|50067692|FG000|Follow-Up Phase (90 Days)|Other|7|||
24979374|NCT02952586|50067693|FG001|Follow-Up Phase (90 Days)|Other|5|||
24979375|NCT02952586|50067692|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
24979376|NCT02952586|50067693|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
24979377|NCT02952586|50067692|FG000|LT Follow-up (up to 45 Months)|Death|51|||
24979378|NCT02952586|50067693|FG001|LT Follow-up (up to 45 Months)|Death|31|||
24979379|NCT02952586|50067692|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
24979380|NCT02952586|50067693|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
24979381|NCT02952586|50067692|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
24979382|NCT02952586|50067693|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
24979383|NCT02952586|50067692|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
24979384|NCT02952586|50067693|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
24979385|NCT03384316|50067702|FG000|Overall Study|Screen failure|0|||
24979386|NCT03384316|50067703|FG001|Overall Study|Screen failure|1|||
24979387|NCT03403192|50067715|FG000|Overall Study|Lost to Follow-up|1|||
24979388|NCT03403192|50067716|FG001|Overall Study|Lost to Follow-up|2|||
24979389|NCT03403192|50067717|FG002|Overall Study|Lost to Follow-up|0|||
24979390|NCT03403192|50067718|FG003|Overall Study|Lost to Follow-up|0|||
24979391|NCT03403192|50067715|FG000|Overall Study|Unable to respond|0|||
24979392|NCT03403192|50067716|FG001|Overall Study|Unable to respond|1|||
24979393|NCT03403192|50067717|FG002|Overall Study|Unable to respond|0|||
24979394|NCT03403192|50067718|FG003|Overall Study|Unable to respond|0|||
24979395|NCT03403192|50067715|FG000|Overall Study|Incomplete|3|||
24979396|NCT03403192|50067716|FG001|Overall Study|Incomplete|1|||
24979397|NCT03403192|50067717|FG002|Overall Study|Incomplete|3|||
24979398|NCT03403192|50067718|FG003|Overall Study|Incomplete|6|||
24979399|NCT00356525|50067732|FG000|Overall Study|Progressive Disease|8|||
24979400|NCT00356525|50067733|FG001|Overall Study|Progressive Disease|5|||
24979401|NCT00356525|50067734|FG002|Overall Study|Progressive Disease|4|||
24979402|NCT00356525|50067735|FG003|Overall Study|Progressive Disease|2|||
24979403|NCT00356525|50067732|FG000|Overall Study|Adverse Event|1|||
24979404|NCT00356525|50067733|FG001|Overall Study|Adverse Event|3|||
24979405|NCT00356525|50067734|FG002|Overall Study|Adverse Event|1|||
24979406|NCT00356525|50067735|FG003|Overall Study|Adverse Event|1|||
24979407|NCT00356525|50067732|FG000|Overall Study|Lost to Follow-up|1|||
24979408|NCT00356525|50067733|FG001|Overall Study|Lost to Follow-up|0|||
24979409|NCT00356525|50067734|FG002|Overall Study|Lost to Follow-up|0|||
24979410|NCT00356525|50067735|FG003|Overall Study|Lost to Follow-up|0|||
24979411|NCT00356525|50067732|FG000|Overall Study|Physician Decision|2|||
24979412|NCT00356525|50067733|FG001|Overall Study|Physician Decision|2|||
24979413|NCT00356525|50067734|FG002|Overall Study|Physician Decision|2|||
24979414|NCT00356525|50067735|FG003|Overall Study|Physician Decision|1|||
24979415|NCT00356525|50067732|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
24979416|NCT00356525|50067733|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
24979417|NCT00356525|50067734|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
24979418|NCT00356525|50067735|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
24979419|NCT00356525|50067732|FG000|Overall Study|Withdrawal by Subject|1|||
24979420|NCT00356525|50067733|FG001|Overall Study|Withdrawal by Subject|1|||
24979421|NCT00356525|50067734|FG002|Overall Study|Withdrawal by Subject|0|||
24979422|NCT00356525|50067735|FG003|Overall Study|Withdrawal by Subject|3|||
24979423|NCT00356525|50067732|FG000|Overall Study|Death|0|||
24979424|NCT00356525|50067733|FG001|Overall Study|Death|0|||
24979425|NCT00356525|50067734|FG002|Overall Study|Death|0|||
24979426|NCT00356525|50067735|FG003|Overall Study|Death|1|||
24979427|NCT00356525|50067732|FG000|Overall Study|Sponsor Decision|0|||
24979428|NCT00356525|50067733|FG001|Overall Study|Sponsor Decision|0|||
24979429|NCT00356525|50067734|FG002|Overall Study|Sponsor Decision|0|||
24979430|NCT00356525|50067735|FG003|Overall Study|Sponsor Decision|1|||
24979431|NCT00356369|50067747|FG000|Active Phase|Withdrawal by Subject|2|||
24979432|NCT00356369|50067748|FG001|Active Phase|Withdrawal by Subject|1|||
24979433|NCT03383614|50067758|FG000|Overall Study|Withdrawal by Subject|0|||
24979434|NCT03383614|50067759|FG001|Overall Study|Withdrawal by Subject|1|||
24979435|NCT03383614|50067760|FG002|Overall Study|Withdrawal by Subject|0|||
24979436|NCT03383614|50067761|FG003|Overall Study|Withdrawal by Subject|0|||
24979437|NCT03403036|50067776|FG000|Overall Study|Lack of Efficacy|5|||
24979438|NCT00356135|50067783|FG000|Overall Study|Protocol Violation|1|||
24979439|NCT00356135|50067784|FG001|Overall Study|Protocol Violation|0|||
24979440|NCT00356135|50067785|FG002|Overall Study|Protocol Violation|0|||
24979441|NCT00356135|50067783|FG000|Overall Study|Adverse Event|1|||
24979442|NCT00356135|50067784|FG001|Overall Study|Adverse Event|0|||
24979443|NCT00356135|50067785|FG002|Overall Study|Adverse Event|0|||
24979444|NCT00356135|50067783|FG000|Overall Study|Lost to Follow-up|0|||
24979445|NCT00356135|50067784|FG001|Overall Study|Lost to Follow-up|0|||
24979446|NCT00356135|50067785|FG002|Overall Study|Lost to Follow-up|1|||
24979447|NCT00356135|50067783|FG000|Overall Study|Physician Decision|1|||
24979448|NCT00356135|50067784|FG001|Overall Study|Physician Decision|1|||
24979449|NCT00356135|50067785|FG002|Overall Study|Physician Decision|1|||
24979450|NCT00356135|50067783|FG000|Overall Study|Subject non-compliance|1|||
24979451|NCT00356135|50067784|FG001|Overall Study|Subject non-compliance|1|||
24979452|NCT00356135|50067785|FG002|Overall Study|Subject non-compliance|3|||
24979453|NCT03383146|50067797|FG000|Overall Study|Screen Failure|1|||
24979454|NCT03383146|50067798|FG001|Overall Study|Screen Failure|0|||
24979455|NCT03383146|50067797|FG000|Overall Study|Adverse Event|6|||
24979456|NCT03383146|50067798|FG001|Overall Study|Adverse Event|18|||
24979457|NCT03383146|50067797|FG000|Overall Study|Lack of Efficacy|0|||
24979458|NCT03383146|50067798|FG001|Overall Study|Lack of Efficacy|3|||
24979459|NCT03383146|50067797|FG000|Overall Study|Withdrawal by Subject|20|||
24979460|NCT03383146|50067798|FG001|Overall Study|Withdrawal by Subject|36|||
24979461|NCT03383146|50067797|FG000|Overall Study|Lost to Follow-up|5|||
24979462|NCT03383146|50067798|FG001|Overall Study|Lost to Follow-up|15|||
24979463|NCT03383146|50067797|FG000|Overall Study|Death|0|||
24979464|NCT03383146|50067798|FG001|Overall Study|Death|2|||
24979465|NCT03383146|50067797|FG000|Overall Study|Physician Decision|0|||
24979466|NCT03383146|50067798|FG001|Overall Study|Physician Decision|1|||
24979467|NCT03383146|50067797|FG000|Overall Study|Protocol Deviation|1|||
24979468|NCT03383146|50067798|FG001|Overall Study|Protocol Deviation|8|||
25341571|NCT00779402|50657915|FG000|Treatment Phase 1|Protocol Violation|1|||
25341572|NCT00779402|50657916|FG001|Treatment Phase 1|Protocol Violation|0|||
25341573|NCT00779402|50657915|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
25341574|NCT00779402|50657916|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
25341575|NCT00779402|50657915|FG000|Treatment Phase 1|Lost to Follow-up|0|||
25341576|NCT00779402|50657916|FG001|Treatment Phase 1|Lost to Follow-up|1|||
25341577|NCT00779402|50657915|FG000|Treatment Phase 1|Death|0|||
25341578|NCT00779402|50657916|FG001|Treatment Phase 1|Death|1|||
25341579|NCT00779402|50657915|FG000|Treatment Phase 1|Intercurrent Illness|1|||
25341580|NCT00779402|50657916|FG001|Treatment Phase 1|Intercurrent Illness|1|||
25341581|NCT00779402|50657915|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
25341582|NCT00779402|50657916|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
24979469|NCT03383146|50067797|FG000|Overall Study|Study Terminated by the Sponsor|48|||
24979470|NCT03383146|50067798|FG001|Overall Study|Study Terminated by the Sponsor|95|||
25341583|NCT00779402|50657915|FG000|Treatment Phase 1|Other|4|||
24979471|NCT03383146|50067797|FG000|Overall Study|Reason not Specified|4|||
24979472|NCT03383146|50067798|FG001|Overall Study|Reason not Specified|6|||
24979473|NCT03616964|50067808|FG000|Overall Study|Adverse Event|15|||
24979474|NCT03616964|50067809|FG001|Overall Study|Adverse Event|10|||
24979475|NCT03616964|50067810|FG002|Overall Study|Adverse Event|16|||
24979476|NCT03616964|50067808|FG000|Overall Study|Death|3|||
25341584|NCT00779402|50657916|FG001|Treatment Phase 1|Other|2|||
24979477|NCT03616964|50067809|FG001|Overall Study|Death|0|||
24979478|NCT03616964|50067810|FG002|Overall Study|Death|4|||
24979479|NCT03616964|50067808|FG000|Overall Study|Lack of Efficacy|4|||
24979480|NCT03616964|50067809|FG001|Overall Study|Lack of Efficacy|8|||
24979481|NCT03616964|50067810|FG002|Overall Study|Lack of Efficacy|8|||
24979482|NCT03616964|50067808|FG000|Overall Study|Lost to Follow-up|2|||
24979483|NCT03616964|50067809|FG001|Overall Study|Lost to Follow-up|1|||
24979484|NCT03616964|50067810|FG002|Overall Study|Lost to Follow-up|3|||
24979485|NCT03616964|50067808|FG000|Overall Study|Withdrawal by Subject|18|||
24979486|NCT03616964|50067809|FG001|Overall Study|Withdrawal by Subject|14|||
24979487|NCT03616964|50067810|FG002|Overall Study|Withdrawal by Subject|21|||
24979488|NCT03616964|50067808|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
24979489|NCT03616964|50067809|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
24979490|NCT03616964|50067810|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
24979491|NCT03616964|50067808|FG000|Overall Study|Sponsor's Decision|1|||
24979492|NCT03616964|50067809|FG001|Overall Study|Sponsor's Decision|0|||
24979493|NCT03616964|50067810|FG002|Overall Study|Sponsor's Decision|0|||
24979494|NCT03616964|50067808|FG000|Overall Study|Physician Decision|0|||
24979495|NCT03616964|50067809|FG001|Overall Study|Physician Decision|2|||
24979496|NCT03616964|50067810|FG002|Overall Study|Physician Decision|0|||
24979497|NCT03616964|50067808|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
24979498|NCT03616964|50067809|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
24979499|NCT03616964|50067810|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
24979500|NCT03616964|50067808|FG000|Overall Study|Protocol Violation|0|||
24979501|NCT03616964|50067809|FG001|Overall Study|Protocol Violation|1|||
24979502|NCT03616964|50067810|FG002|Overall Study|Protocol Violation|0|||
24979503|NCT03616964|50067808|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
24979504|NCT03616964|50067809|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
25341585|NCT00779402|50657915|FG000|Treatment Phase 1|Closure of Study|3|||
25341586|NCT00779402|50657916|FG001|Treatment Phase 1|Closure of Study|2|||
25341587|NCT00779402|50657915|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
25341588|NCT00779402|50657916|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
25341589|NCT00779402|50657915|FG000|Surveillance Phase|Protocol Violation|0|||
25341590|NCT00779402|50657916|FG001|Surveillance Phase|Protocol Violation|1|||
25341591|NCT00779402|50657915|FG000|Surveillance Phase|Patient refused to continue|22|||
25341592|NCT00779402|50657916|FG001|Surveillance Phase|Patient refused to continue|14|||
25341593|NCT00779402|50657915|FG000|Surveillance Phase|Lost to Follow-up|2|||
25341594|NCT00779402|50657916|FG001|Surveillance Phase|Lost to Follow-up|1|||
25341595|NCT00779402|50657915|FG000|Surveillance Phase|Death|0|||
25341596|NCT00779402|50657916|FG001|Surveillance Phase|Death|1|||
25341597|NCT00779402|50657915|FG000|Surveillance Phase|Intercurrent Illness|2|||
25341598|NCT00779402|50657916|FG001|Surveillance Phase|Intercurrent Illness|0|||
25341599|NCT00779402|50657915|FG000|Surveillance Phase|Other|5|||
25341600|NCT00779402|50657916|FG001|Surveillance Phase|Other|5|||
25341601|NCT00779402|50657915|FG000|Surveillance Phase|Withdrawal by Subject|4|||
25341602|NCT00779402|50657916|FG001|Surveillance Phase|Withdrawal by Subject|1|||
25341603|NCT00779402|50657915|FG000|Surveillance Phase|Closure of study|5|||
25341604|NCT00779402|50657916|FG001|Surveillance Phase|Closure of study|6|||
25341605|NCT00779402|50657915|FG000|Surveillance Phase|Completed Protocol Visits|3|||
25341606|NCT00779402|50657916|FG001|Surveillance Phase|Completed Protocol Visits|2|||
25341607|NCT00779402|50657915|FG000|Long-term Follow-up|Patient refused to continue|2|||
25341608|NCT00779402|50657916|FG001|Long-term Follow-up|Patient refused to continue|0|||
25341609|NCT00779402|50657915|FG000|Long-term Follow-up|Other|5|||
25341610|NCT00779402|50657916|FG001|Long-term Follow-up|Other|0|||
25341611|NCT00779402|50657915|FG000|Long-term Follow-up|Closure of Study|8|||
25341612|NCT00779402|50657916|FG001|Long-term Follow-up|Closure of Study|4|||
25341613|NCT00779402|50657915|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
25341614|NCT00779402|50657916|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
25341615|NCT00771914|50657926|FG000|Overall Study|Physician Decision|0|||
25341616|NCT00771914|50657927|FG001|Overall Study|Physician Decision|0|||
25341617|NCT00771914|50657928|FG002|Overall Study|Physician Decision|0|||
25341618|NCT00771914|50657929|FG003|Overall Study|Physician Decision|1|||
25341619|NCT00771914|50657926|FG000|Overall Study|Lost to Follow-up|0|||
25341620|NCT00771914|50657927|FG001|Overall Study|Lost to Follow-up|0|||
25341621|NCT00771914|50657928|FG002|Overall Study|Lost to Follow-up|0|||
25341622|NCT00771914|50657929|FG003|Overall Study|Lost to Follow-up|1|||
25341623|NCT00779324|50657941|FG000|Overall Study|Lost to Follow-up|2|||
25341624|NCT00779324|50657942|FG001|Overall Study|Lost to Follow-up|1|||
25341625|NCT00779324|50657941|FG000|Overall Study|Withdrawal by Subject|4|||
24979505|NCT03616964|50067810|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
24979506|NCT03616964|50067808|FG000|Overall Study|Randomized but Never Treated|1|||
24979507|NCT03616964|50067809|FG001|Overall Study|Randomized but Never Treated|1|||
25341626|NCT00779324|50657942|FG001|Overall Study|Withdrawal by Subject|2|||
25341627|NCT00779324|50657941|FG000|Overall Study|Missed visit|1|||
25341628|NCT00779324|50657942|FG001|Overall Study|Missed visit|1|||
25341629|NCT00779246|50657950|FG000|Overall Study|Missing sufficient data for analysis|33|||
25341630|NCT00779246|50657951|FG001|Overall Study|Missing sufficient data for analysis|53|||
25341631|NCT00771758|50657960|FG000|Overall Study|Adverse Event|2|||
25341632|NCT00771758|50657961|FG001|Overall Study|Adverse Event|8|||
25341633|NCT00771758|50657962|FG002|Overall Study|Adverse Event|1|||
25341634|NCT00771758|50657960|FG000|Overall Study|Lack of Efficacy|0|||
25341635|NCT00771758|50657961|FG001|Overall Study|Lack of Efficacy|2|||
25341636|NCT00771758|50657962|FG002|Overall Study|Lack of Efficacy|1|||
25341637|NCT00771758|50657960|FG000|Overall Study|Lost to Follow-up|1|||
25341638|NCT00771758|50657961|FG001|Overall Study|Lost to Follow-up|0|||
25341639|NCT00771758|50657962|FG002|Overall Study|Lost to Follow-up|0|||
25341640|NCT00771758|50657960|FG000|Overall Study|Protocol Violation|1|||
25341641|NCT00771758|50657961|FG001|Overall Study|Protocol Violation|0|||
25341642|NCT00771758|50657962|FG002|Overall Study|Protocol Violation|0|||
25341643|NCT00771758|50657960|FG000|Overall Study|Withdrawal by Subject|1|||
25341644|NCT00771758|50657961|FG001|Overall Study|Withdrawal by Subject|0|||
25341645|NCT00771758|50657962|FG002|Overall Study|Withdrawal by Subject|0|||
25341646|NCT00771758|50657960|FG000|Overall Study|Other|3|||
25341647|NCT00771758|50657961|FG001|Overall Study|Other|2|||
25341648|NCT00771758|50657962|FG002|Overall Study|Other|0|||
25341649|NCT00758498|50657990|FG000|Overall Study|Adverse Event|2|||
25341650|NCT00758498|50657991|FG001|Overall Study|Adverse Event|2|||
25341651|NCT00758498|50657992|FG002|Overall Study|Adverse Event|3|||
25341652|NCT00758498|50657990|FG000|Overall Study|Subject legally detained out of state|1|||
25341653|NCT00758498|50657991|FG001|Overall Study|Subject legally detained out of state|0|||
25341654|NCT00758498|50657992|FG002|Overall Study|Subject legally detained out of state|0|||
25341655|NCT00758498|50657990|FG000|Overall Study|Withdrawal by Subject|0|||
25341656|NCT00758498|50657991|FG001|Overall Study|Withdrawal by Subject|0|||
25341657|NCT00758498|50657992|FG002|Overall Study|Withdrawal by Subject|1|||
25341658|NCT00758498|50657990|FG000|Overall Study|Noncompliance to study procedures|0|||
25341659|NCT00758498|50657991|FG001|Overall Study|Noncompliance to study procedures|0|||
25341660|NCT00758498|50657992|FG002|Overall Study|Noncompliance to study procedures|1|||
25341661|NCT00798161|50658007|FG000|Overall Study|Adverse Event|3|||
25341662|NCT00798161|50658008|FG001|Overall Study|Adverse Event|4|||
25341663|NCT00798161|50658009|FG002|Overall Study|Adverse Event|6|||
25341664|NCT00798161|50658010|FG003|Overall Study|Adverse Event|6|||
25341665|NCT00798161|50658011|FG004|Overall Study|Adverse Event|5|||
25341666|NCT00798161|50658012|FG005|Overall Study|Adverse Event|2|||
25341667|NCT00798161|50658013|FG006|Overall Study|Adverse Event|4|||
25341668|NCT00798161|50658007|FG000|Overall Study|Protocol Violation|2|||
25341669|NCT00798161|50658008|FG001|Overall Study|Protocol Violation|1|||
25341670|NCT00798161|50658009|FG002|Overall Study|Protocol Violation|3|||
25341671|NCT00798161|50658010|FG003|Overall Study|Protocol Violation|3|||
25341672|NCT00798161|50658011|FG004|Overall Study|Protocol Violation|3|||
25341673|NCT00798161|50658012|FG005|Overall Study|Protocol Violation|2|||
25341674|NCT00798161|50658013|FG006|Overall Study|Protocol Violation|0|||
25341675|NCT00798161|50658007|FG000|Overall Study|Lost to Follow-up|1|||
25341676|NCT00798161|50658008|FG001|Overall Study|Lost to Follow-up|3|||
25341677|NCT00798161|50658009|FG002|Overall Study|Lost to Follow-up|4|||
25341678|NCT00798161|50658010|FG003|Overall Study|Lost to Follow-up|3|||
25341679|NCT00798161|50658011|FG004|Overall Study|Lost to Follow-up|4|||
25341680|NCT00798161|50658012|FG005|Overall Study|Lost to Follow-up|0|||
25341681|NCT00798161|50658013|FG006|Overall Study|Lost to Follow-up|0|||
25341682|NCT00798161|50658007|FG000|Overall Study|Withdrawal by Subject|5|||
25341683|NCT00798161|50658008|FG001|Overall Study|Withdrawal by Subject|4|||
25341684|NCT00798161|50658009|FG002|Overall Study|Withdrawal by Subject|5|||
25341685|NCT00798161|50658010|FG003|Overall Study|Withdrawal by Subject|4|||
25341686|NCT00798161|50658011|FG004|Overall Study|Withdrawal by Subject|2|||
25341687|NCT00798161|50658012|FG005|Overall Study|Withdrawal by Subject|3|||
25341688|NCT00798161|50658013|FG006|Overall Study|Withdrawal by Subject|1|||
25341689|NCT00798161|50658007|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
25341690|NCT00798161|50658008|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
25341691|NCT00798161|50658009|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
25341692|NCT00798161|50658010|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
25341693|NCT00798161|50658011|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
25341694|NCT00798161|50658012|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
25341695|NCT00798161|50658013|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
25341696|NCT00588341|50658029|FG000|Overall Study|Withdrawal by Subject|3|||
25341697|NCT00588341|50658029|FG000|Overall Study|Not treated due to metastatic disease|1|||
25341698|NCT00588341|50658029|FG000|Overall Study|Patient ineligible|1|||
25341699|NCT00802529|50658035|FG000|Overall Study|Lost to Follow-up|0|||
25341700|NCT00802529|50658036|FG001|Overall Study|Lost to Follow-up|1|||
25341701|NCT00758264|50658045|FG000|Active Phase|Withdrawal by Subject|0|||
25341702|NCT00758264|50658046|FG001|Active Phase|Withdrawal by Subject|0|||
25341703|NCT00758264|50658047|FG002|Active Phase|Withdrawal by Subject|1|||
25341704|NCT00758264|50658045|FG000|Active Phase|Lost to Follow-up|1|||
25341705|NCT00758264|50658046|FG001|Active Phase|Lost to Follow-up|0|||
25341706|NCT00758264|50658047|FG002|Active Phase|Lost to Follow-up|0|||
25341707|NCT00758264|50658045|FG000|Active Phase|Other|0|||
25341708|NCT00758264|50658046|FG001|Active Phase|Other|0|||
25341709|NCT00758264|50658047|FG002|Active Phase|Other|4|||
25341710|NCT00588731|50658057|FG000|Overall Study|Withdrawal by Subject|3|||
25341711|NCT00588731|50658058|FG001|Overall Study|Withdrawal by Subject|2|||
25341712|NCT00757172|50658064|FG000|Overall Study|Withdrawal by Subject|4|||
25341713|NCT00757172|50658064|FG000|Overall Study|Physician Decision|3|||
25341714|NCT00757172|50658064|FG000|Overall Study|Progression|4|||
25341715|NCT00797225|50658072|FG000|Weeks 1 to 12|Adverse Event|0|||
25341716|NCT00797225|50658073|FG001|Weeks 1 to 12|Adverse Event|0|||
25341717|NCT00797225|50658074|FG002|Weeks 1 to 12|Adverse Event|1|||
25341718|NCT00797225|50658075|FG003|Weeks 1 to 12|Adverse Event|0|||
25341719|NCT00797225|50658076|FG004|Weeks 1 to 12|Adverse Event|0|||
25341720|NCT00797225|50658077|FG005|Weeks 1 to 12|Adverse Event|0|||
25341721|NCT00797225|50658078|FG006|Weeks 1 to 12|Adverse Event|0|||
25341722|NCT00797225|50658079|FG007|Weeks 1 to 12|Adverse Event|0|||
24979508|NCT03616964|50067810|FG002|Overall Study|Randomized but Never Treated|1|||
24979509|NCT00350519|50067822|FG000|Overall Study|Death|0|||
24979510|NCT00350519|50067823|FG001|Overall Study|Death|1|||
24979511|NCT00350519|50067822|FG000|Overall Study|Physician Decision|0|||
24979512|NCT00350519|50067823|FG001|Overall Study|Physician Decision|1|||
24979513|NCT00350519|50067822|FG000|Overall Study|Protocol Violation|1|||
24979514|NCT00350519|50067823|FG001|Overall Study|Protocol Violation|2|||
24979515|NCT00350519|50067822|FG000|Overall Study|Withdrawal by Subject|3|||
24979516|NCT00350519|50067823|FG001|Overall Study|Withdrawal by Subject|2|||
24979517|NCT03382912|50067831|FG000|Overall Study|Physician Decision|0|||
24979518|NCT03382912|50067832|FG001|Overall Study|Physician Decision|1|||
24979519|NCT03382912|50067831|FG000|Overall Study|Sponsor Decision|6|||
24979520|NCT03382912|50067832|FG001|Overall Study|Sponsor Decision|6|||
24979521|NCT03382912|50067831|FG000|Overall Study|Withdrawal by Subject|0|||
24979522|NCT03382912|50067832|FG001|Overall Study|Withdrawal by Subject|5|||
24979523|NCT00350207|50067841|FG000|Overall Study|Adverse Event|5|||
24979524|NCT00350207|50067842|FG001|Overall Study|Adverse Event|2|||
24979525|NCT00350207|50067843|FG002|Overall Study|Adverse Event|2|||
24979526|NCT00350207|50067841|FG000|Overall Study|Lack of Efficacy|1|||
24979527|NCT00350207|50067842|FG001|Overall Study|Lack of Efficacy|0|||
24979528|NCT00350207|50067843|FG002|Overall Study|Lack of Efficacy|2|||
24979529|NCT00350207|50067841|FG000|Overall Study|Lost to Follow-up|1|||
25078092|NCT03745651|50186229|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
25255189|NCT01173601|50570924|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
25255190|NCT01173601|50570925|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
25255191|NCT01173601|50570926|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
25255192|NCT01173601|50570927|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
25255193|NCT01173601|50570923|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
25255194|NCT01173601|50570924|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
25255195|NCT01173601|50570925|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
25255196|NCT01173601|50570926|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
25255197|NCT01173601|50570927|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
25341723|NCT00797225|50658072|FG000|Weeks 1 to 12|Non-compliance|0|||
25341724|NCT00797225|50658073|FG001|Weeks 1 to 12|Non-compliance|1|||
25341725|NCT00797225|50658074|FG002|Weeks 1 to 12|Non-compliance|0|||
25341726|NCT00797225|50658075|FG003|Weeks 1 to 12|Non-compliance|0|||
25341727|NCT00797225|50658076|FG004|Weeks 1 to 12|Non-compliance|0|||
25341728|NCT00797225|50658077|FG005|Weeks 1 to 12|Non-compliance|0|||
25341729|NCT00797225|50658078|FG006|Weeks 1 to 12|Non-compliance|0|||
25341730|NCT00797225|50658079|FG007|Weeks 1 to 12|Non-compliance|0|||
25341731|NCT00797225|50658072|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
24979530|NCT00350207|50067842|FG001|Overall Study|Lost to Follow-up|0|||
24979531|NCT00350207|50067843|FG002|Overall Study|Lost to Follow-up|1|||
24979532|NCT00350207|50067841|FG000|Overall Study|Withdrawal by Subject|0|||
24979533|NCT00350207|50067842|FG001|Overall Study|Withdrawal by Subject|1|||
24979534|NCT00350207|50067843|FG002|Overall Study|Withdrawal by Subject|1|||
24979535|NCT00350207|50067841|FG000|Overall Study|Other|1|||
24979536|NCT00350207|50067842|FG001|Overall Study|Other|3|||
24979537|NCT00350207|50067843|FG002|Overall Study|Other|1|||
24979538|NCT00349973|50067853|FG000|Overall Study|Adverse Event|3|||
24979539|NCT00349973|50067854|FG001|Overall Study|Adverse Event|3|||
24979540|NCT00349973|50067853|FG000|Overall Study|Withdrawal by Subject|1|||
24979541|NCT00349973|50067854|FG001|Overall Study|Withdrawal by Subject|0|||
24979542|NCT03187262|50067860|FG000|Induction|Lack of Efficacy|2|||
24979543|NCT03187262|50067860|FG000|Induction|Progressive Disease|4|||
24979544|NCT03187262|50067860|FG000|Consolidation|Progressive Disease|5|||
24979545|NCT03381196|50067866|FG000|Overall Study|Withdrawal by Subject|7|||
24979546|NCT03381196|50067867|FG001|Overall Study|Withdrawal by Subject|7|||
24979547|NCT03381196|50067866|FG000|Overall Study|Other|0|||
24979548|NCT03381196|50067867|FG001|Overall Study|Other|1|||
24979549|NCT03381196|50067866|FG000|Overall Study|Lost to Follow-up|5|||
24979550|NCT03381196|50067867|FG001|Overall Study|Lost to Follow-up|4|||
25341732|NCT00797225|50658073|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
25341733|NCT00797225|50658074|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
25341734|NCT00797225|50658075|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
25341735|NCT00797225|50658076|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
25341736|NCT00797225|50658077|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
24979551|NCT03381196|50067866|FG000|Overall Study|Death|0|||
24979552|NCT03381196|50067867|FG001|Overall Study|Death|1|||
24979553|NCT03381196|50067866|FG000|Overall Study|Adverse Event|1|||
24979554|NCT03381196|50067867|FG001|Overall Study|Adverse Event|0|||
24979555|NCT03381196|50067866|FG000|Overall Study|Randomized, not treated|3|||
24979556|NCT03381196|50067867|FG001|Overall Study|Randomized, not treated|6|||
24979557|NCT02950558|50067875|FG000|Overall Study|Lost to Follow-up|2|||
24979558|NCT02950558|50067876|FG001|Overall Study|Lost to Follow-up|0|||
24979559|NCT03345472|50067883|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
24979560|NCT03345472|50067883|FG000|Implant to 3 Months|Physician Decision|1|||
24979561|NCT03345472|50067883|FG000|Implant to 3 Months|Adverse Event|1|||
24979562|NCT03345472|50067883|FG000|3 Months to 12 Months|Physician Decision|3|||
24979563|NCT03345472|50067883|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
24979564|NCT03345472|50067883|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
24979565|NCT03345472|50067883|FG000|3 Months to 12 Months|Adverse Event|1|||
24979566|NCT03345472|50067883|FG000|3 Months to 12 Months|Death|1|||
24979567|NCT00349349|50067890|FG000|Overall Study|Adverse Event|5|||
25078093|NCT03745651|50186223|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
25255198|NCT01173601|50570923|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
25255199|NCT01173601|50570924|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
25255200|NCT01173601|50570925|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
25255201|NCT01173601|50570926|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
25255202|NCT01173601|50570927|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
25255203|NCT01173601|50570923|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
25255204|NCT01173601|50570924|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
25255205|NCT01173601|50570925|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
25255206|NCT01173601|50570926|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
25255207|NCT01173601|50570927|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
25255208|NCT01173601|50570923|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
25255209|NCT01173601|50570924|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
25255210|NCT01173601|50570925|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
25255211|NCT01173601|50570926|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
25255212|NCT01173601|50570927|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
25255213|NCT01173601|50570923|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
25255214|NCT01173601|50570924|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
25255215|NCT01173601|50570925|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
25255216|NCT01173601|50570926|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
25255217|NCT01173601|50570927|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
25255218|NCT01173601|50570923|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
25255219|NCT01173601|50570924|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
25255220|NCT01173601|50570925|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
25255221|NCT01173601|50570926|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
25255222|NCT01173601|50570927|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
25255223|NCT01173601|50570923|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
25255224|NCT01173601|50570924|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
25255225|NCT01173601|50570925|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
25255226|NCT01173601|50570926|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
25255227|NCT01173601|50570927|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
25255228|NCT01173601|50570923|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
25341737|NCT00797225|50658078|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
25341738|NCT00797225|50658079|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
25341739|NCT00797225|50658072|FG000|Weeks 1 to 12|Sponsor Decision|1|||
25341740|NCT00797225|50658073|FG001|Weeks 1 to 12|Sponsor Decision|0|||
25341741|NCT00797225|50658074|FG002|Weeks 1 to 12|Sponsor Decision|0|||
25341742|NCT00797225|50658075|FG003|Weeks 1 to 12|Sponsor Decision|0|||
25341743|NCT00797225|50658076|FG004|Weeks 1 to 12|Sponsor Decision|0|||
25341744|NCT00797225|50658077|FG005|Weeks 1 to 12|Sponsor Decision|0|||
24979568|NCT00349349|50067891|FG001|Overall Study|Adverse Event|6|||
24979569|NCT00349349|50067892|FG002|Overall Study|Adverse Event|2|||
24979570|NCT00349349|50067890|FG000|Overall Study|Withdrawal by Subject|5|||
24979571|NCT00349349|50067891|FG001|Overall Study|Withdrawal by Subject|2|||
24979572|NCT00349349|50067892|FG002|Overall Study|Withdrawal by Subject|1|||
24979573|NCT00349349|50067890|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
24979574|NCT00349349|50067891|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
25341745|NCT00797225|50658078|FG006|Weeks 1 to 12|Sponsor Decision|0|||
25341746|NCT00797225|50658079|FG007|Weeks 1 to 12|Sponsor Decision|0|||
25341747|NCT00797225|50658072|FG000|Weeks 13 to 24|Non-compliance|0|||
25341748|NCT00797225|50658073|FG001|Weeks 13 to 24|Non-compliance|2|||
25341749|NCT00797225|50658074|FG002|Weeks 13 to 24|Non-compliance|0|||
25341750|NCT00797225|50658075|FG003|Weeks 13 to 24|Non-compliance|0|||
25341751|NCT00797225|50658076|FG004|Weeks 13 to 24|Non-compliance|0|||
25341752|NCT00797225|50658077|FG005|Weeks 13 to 24|Non-compliance|0|||
25341753|NCT00797225|50658078|FG006|Weeks 13 to 24|Non-compliance|0|||
25341754|NCT00797225|50658079|FG007|Weeks 13 to 24|Non-compliance|0|||
25341755|NCT00797225|50658072|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
25341756|NCT00797225|50658073|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
25341757|NCT00797225|50658074|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
25341758|NCT00797225|50658075|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
25341759|NCT00797225|50658076|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
25341760|NCT00797225|50658077|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
25341761|NCT00797225|50658078|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
25341762|NCT00797225|50658079|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
25341763|NCT00797225|50658072|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
25341764|NCT00797225|50658073|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
25341765|NCT00797225|50658074|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
25341766|NCT00797225|50658075|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
25341767|NCT00797225|50658076|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
25341768|NCT00797225|50658077|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
25341769|NCT00797225|50658078|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
25341770|NCT00797225|50658079|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
25341771|NCT00797225|50658072|FG000|Weeks 13 to 24|Adverse Event|0|||
25341772|NCT00797225|50658073|FG001|Weeks 13 to 24|Adverse Event|1|||
25341773|NCT00797225|50658074|FG002|Weeks 13 to 24|Adverse Event|0|||
24979575|NCT00349349|50067892|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
24979576|NCT00349349|50067890|FG000|Overall Study|Death|13|||
24979577|NCT00349349|50067891|FG001|Overall Study|Death|10|||
24979578|NCT00349349|50067892|FG002|Overall Study|Death|1|||
24979579|NCT00349349|50067890|FG000|Overall Study|Other Treatment Selected|2|||
24979580|NCT00349349|50067891|FG001|Overall Study|Other Treatment Selected|0|||
24979581|NCT00349349|50067892|FG002|Overall Study|Other Treatment Selected|0|||
24979582|NCT00349349|50067890|FG000|Overall Study|Participant Reduced General Condition|0|||
24979583|NCT00349349|50067891|FG001|Overall Study|Participant Reduced General Condition|1|||
24979584|NCT00349349|50067892|FG002|Overall Study|Participant Reduced General Condition|0|||
24979585|NCT00349349|50067890|FG000|Overall Study|Physician Decision|1|||
24979586|NCT00349349|50067891|FG001|Overall Study|Physician Decision|2|||
24979587|NCT00349349|50067892|FG002|Overall Study|Physician Decision|1|||
24979588|NCT00349349|50067890|FG000|Overall Study|No Response|0|||
24979589|NCT00349349|50067891|FG001|Overall Study|No Response|3|||
24979590|NCT00349349|50067892|FG002|Overall Study|No Response|0|||
24979591|NCT00349349|50067890|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
24979592|NCT00349349|50067891|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
24979593|NCT00349349|50067892|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
24979594|NCT02950480|50067904|FG000|Overall Study|Withdrawal by Subject|1|||
24979595|NCT02950480|50067905|FG001|Overall Study|Withdrawal by Subject|0|||
24979596|NCT00348881|50067913|FG000|Overall Study|Lost to Follow-up|12|||
24979597|NCT00348881|50067914|FG001|Overall Study|Lost to Follow-up|6|||
24979598|NCT00348881|50067913|FG000|Overall Study|Withdrawal by Subject|3|||
24979599|NCT00348881|50067914|FG001|Overall Study|Withdrawal by Subject|4|||
24979600|NCT00348881|50067913|FG000|Overall Study|Adverse Event|2|||
24979601|NCT00348881|50067914|FG001|Overall Study|Adverse Event|0|||
24979602|NCT00348881|50067913|FG000|Overall Study|Serious Adverse Event|0|||
24979603|NCT00348881|50067914|FG001|Overall Study|Serious Adverse Event|2|||
24979604|NCT03376516|50067924|FG000|Overall Study|Not treated|1|||
24979605|NCT03376516|50067924|FG000|Overall Study|Consent withdrawn|1|||
24979606|NCT03797144|50067950|FG000|Enrollment|Protocol Violation|4|||
24979607|NCT03797144|50067951|FG001|Enrollment|Protocol Violation|1|||
24979608|NCT03797144|50067950|FG000|Surgery|Protocol Violation|1|||
24979609|NCT03797144|50067951|FG001|Surgery|Protocol Violation|0|||
24979610|NCT03797144|50067950|FG000|3 Month|Early termination cut-off date|2|||
24979611|NCT03797144|50067951|FG001|3 Month|Early termination cut-off date|0|||
24979612|NCT03797144|50067950|FG000|12 Month|Early termination cut-off date|8|||
24979613|NCT03797144|50067951|FG001|12 Month|Early termination cut-off date|9|||
24979614|NCT03797144|50067950|FG000|24 Month|Early termination cut-off date|1|||
24979615|NCT03797144|50067951|FG001|24 Month|Early termination cut-off date|1|||
24979616|NCT00347009|50067958|FG000|Overall Study|Death|1|||
24979617|NCT00347009|50067958|FG000|Overall Study|Adverse Event|6|||
25341774|NCT00797225|50658075|FG003|Weeks 13 to 24|Adverse Event|0|||
25341775|NCT00797225|50658076|FG004|Weeks 13 to 24|Adverse Event|0|||
25341776|NCT00797225|50658077|FG005|Weeks 13 to 24|Adverse Event|0|||
25341777|NCT00797225|50658078|FG006|Weeks 13 to 24|Adverse Event|1|||
25341778|NCT00797225|50658079|FG007|Weeks 13 to 24|Adverse Event|0|||
25341779|NCT00797225|50658072|FG000|Weeks 13 to 24|Sponsor Decision|0|||
25341780|NCT00797225|50658073|FG001|Weeks 13 to 24|Sponsor Decision|0|||
25341781|NCT00797225|50658074|FG002|Weeks 13 to 24|Sponsor Decision|0|||
25341782|NCT00797225|50658075|FG003|Weeks 13 to 24|Sponsor Decision|0|||
24979618|NCT00347009|50067958|FG000|Overall Study|Withdrawal by Subject|3|||
24979619|NCT00347009|50067958|FG000|Overall Study|Physician Decision|5|||
24979620|NCT00347009|50067958|FG000|Overall Study|Lost to Follow-up|4|||
24979621|NCT00347009|50067958|FG000|Overall Study|Protocol Violation|2|||
24979622|NCT00347009|50067958|FG000|Overall Study|Adverse Laboratory Experience|1|||
24979623|NCT00347009|50067958|FG000|Overall Study|Insufficient Viral Suppression|3|||
24979624|NCT00347009|50067958|FG000|Overall Study|Increased ALT/HBV DNA|1|||
24979625|NCT00347009|50067958|FG000|Overall Study|Serious Adverse Event|1|||
24979626|NCT00346775|50067966|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
24979627|NCT00346775|50067967|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
24979628|NCT00346775|50067966|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
24979629|NCT00346775|50067967|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
24979630|NCT00346775|50067966|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
24979631|NCT00346775|50067967|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
24979632|NCT00346697|50067979|FG000|Overall Study|Lost to Follow-up|0|||
24979633|NCT00346697|50067980|FG001|Overall Study|Lost to Follow-up|1|||
24979634|NCT03400852|50067990|FG000|Blinded Treatment Period|Physician Decision|0|||
24979635|NCT03400852|50067991|FG001|Blinded Treatment Period|Physician Decision|1|||
24979636|NCT03400852|50067992|FG002|Blinded Treatment Period|Physician Decision|0|||
24979637|NCT03400852|50067990|FG000|Blinded Treatment Period|Adverse Event|1|||
24979638|NCT03400852|50067991|FG001|Blinded Treatment Period|Adverse Event|1|||
24979639|NCT03400852|50067992|FG002|Blinded Treatment Period|Adverse Event|0|||
24979640|NCT03400852|50067990|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
24979641|NCT03400852|50067991|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
24979642|NCT03400852|50067992|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
24979643|NCT03400852|50067990|FG000|Open Label Period|Physician Decision|0|||
24979644|NCT03400852|50067991|FG001|Open Label Period|Physician Decision|0|||
24979645|NCT03400852|50067992|FG002|Open Label Period|Physician Decision|1|||
24979646|NCT03400852|50067990|FG000|Open Label Period|Study terminated by sponsor|0|||
24979647|NCT03400852|50067991|FG001|Open Label Period|Study terminated by sponsor|0|||
24979648|NCT03400852|50067992|FG002|Open Label Period|Study terminated by sponsor|21|||
24979649|NCT03398356|50068003|FG000|Before Treatment|Lost to Follow-up|1|||
24979650|NCT03398356|50068004|FG001|Before Treatment|Lost to Follow-up|2|||
24979651|NCT03398356|50068005|FG002|Before Treatment|Lost to Follow-up|0|||
24979652|NCT03398356|50068003|FG000|Before Treatment|drug intolerance|2|||
24979653|NCT03398356|50068004|FG001|Before Treatment|drug intolerance|1|||
24979654|NCT03398356|50068005|FG002|Before Treatment|drug intolerance|0|||
24979655|NCT03398356|50068003|FG000|Before Treatment|Withdrawal by Subject|0|||
24979656|NCT03398356|50068004|FG001|Before Treatment|Withdrawal by Subject|5|||
24979657|NCT03398356|50068005|FG002|Before Treatment|Withdrawal by Subject|0|||
24979658|NCT03398356|50068003|FG000|Before Treatment|Physician Decision|0|||
24979659|NCT03398356|50068004|FG001|Before Treatment|Physician Decision|0|||
24979660|NCT03398356|50068005|FG002|Before Treatment|Physician Decision|11|||
24979661|NCT03398356|50068003|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
24979662|NCT03398356|50068004|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
24979663|NCT03398356|50068005|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
24979664|NCT00346151|50068013|FG000|Overall Study|Withdrawal by Subject|3|||
24979665|NCT00130286|50068021|FG000|Overall Study|Withdrawal by Subject|0|||
24979666|NCT00130286|50068022|FG001|Overall Study|Withdrawal by Subject|1|||
24979667|NCT00130286|50068023|FG002|Overall Study|Withdrawal by Subject|2|||
24979668|NCT00130286|50068024|FG003|Overall Study|Withdrawal by Subject|2|||
24979669|NCT00130286|50068021|FG000|Overall Study|Adverse Event|0|||
24979670|NCT00130286|50068022|FG001|Overall Study|Adverse Event|0|||
24979671|NCT00130286|50068023|FG002|Overall Study|Adverse Event|2|||
24979672|NCT00130286|50068024|FG003|Overall Study|Adverse Event|0|||
24979673|NCT00130286|50068021|FG000|Overall Study|Missing lab specimens|0|||
24979674|NCT00130286|50068022|FG001|Overall Study|Missing lab specimens|2|||
24979675|NCT00130286|50068023|FG002|Overall Study|Missing lab specimens|0|||
24979676|NCT00130286|50068024|FG003|Overall Study|Missing lab specimens|0|||
24979677|NCT00346073|50068036|FG000|Overall Study|Serious Adverse Event|2|||
24979678|NCT00346073|50068037|FG001|Overall Study|Serious Adverse Event|0|||
24979679|NCT00346073|50068036|FG000|Overall Study|Lost to Follow-up|39|||
24979680|NCT00346073|50068037|FG001|Overall Study|Lost to Follow-up|24|||
24979681|NCT03374488|50068045|FG000|Overall Study|Death|13|||
24979682|NCT03374488|50068046|FG001|Overall Study|Death|13|||
24979683|NCT03374488|50068045|FG000|Overall Study|Withdrawal by Subject|3|||
24979684|NCT03374488|50068046|FG001|Overall Study|Withdrawal by Subject|1|||
24979685|NCT03374488|50068045|FG000|Overall Study|Physician Decision|3|||
24979686|NCT03374488|50068046|FG001|Overall Study|Physician Decision|0|||
24979687|NCT00345683|50068055|FG000|Overall Study|Lost to Follow-up|19|||
24979688|NCT00345683|50068056|FG001|Overall Study|Lost to Follow-up|7|||
24979689|NCT00345683|50068055|FG000|Overall Study|Other|6|||
24979690|NCT00345683|50068056|FG001|Overall Study|Other|2|||
24979691|NCT03828383|50068064|FG000|Overall Study|Lost to Follow-up|3|||
24979692|NCT03828383|50068065|FG001|Overall Study|Lost to Follow-up|2|||
24979693|NCT03828383|50068064|FG000|Overall Study|Withdrawal by Subject|4|||
24979694|NCT03828383|50068065|FG001|Overall Study|Withdrawal by Subject|5|||
24979695|NCT00345605|50068071|FG000|Arm 1|Adverse Event|0|||
24979696|NCT00345605|50068072|FG001|Arm 1|Adverse Event|1|||
24979697|NCT00345605|50068071|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
24979698|NCT00345605|50068072|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
25341783|NCT00797225|50658076|FG004|Weeks 13 to 24|Sponsor Decision|0|||
24979699|NCT03394924|50068083|FG000|Overall Study|Adverse Event|0|||
24979700|NCT03394924|50068084|FG001|Overall Study|Adverse Event|5|||
24979701|NCT03394924|50068085|FG002|Overall Study|Adverse Event|0|||
24979702|NCT03394924|50068083|FG000|Overall Study|Withdrawal by Subject|2|||
24979703|NCT03394924|50068084|FG001|Overall Study|Withdrawal by Subject|0|||
24979704|NCT03394924|50068085|FG002|Overall Study|Withdrawal by Subject|0|||
24979705|NCT03394924|50068083|FG000|Overall Study|Lost to Follow-up|0|||
24979706|NCT03394924|50068084|FG001|Overall Study|Lost to Follow-up|1|||
24979707|NCT03394924|50068085|FG002|Overall Study|Lost to Follow-up|0|||
24979708|NCT03394924|50068083|FG000|Overall Study|Did not meet all inclusion criteria|1|||
24979709|NCT03394924|50068084|FG001|Overall Study|Did not meet all inclusion criteria|0|||
24979710|NCT03394924|50068085|FG002|Overall Study|Did not meet all inclusion criteria|0|||
24979711|NCT00345293|50068095|FG000|Overall Study|Unable to access line for sample|1|||
24979712|NCT00345293|50068096|FG001|Overall Study|Unable to access line for sample|0|||
24979713|NCT00345293|50068095|FG000|Overall Study|Withdrawal by Subject|1|||
24979714|NCT00345293|50068096|FG001|Overall Study|Withdrawal by Subject|0|||
24979715|NCT00355121|50068105|FG000|Overall Study|Did not receive study vaccine|1|||
24979716|NCT00355121|50068106|FG001|Overall Study|Did not receive study vaccine|0|||
24979717|NCT00355121|50068107|FG002|Overall Study|Did not receive study vaccine|1|||
24979718|NCT00355121|50068105|FG000|Overall Study|Adverse Event|0|||
24979719|NCT00355121|50068106|FG001|Overall Study|Adverse Event|1|||
24979720|NCT00355121|50068107|FG002|Overall Study|Adverse Event|0|||
24979721|NCT00355121|50068105|FG000|Overall Study|Protocol Violation|7|||
24979722|NCT00355121|50068106|FG001|Overall Study|Protocol Violation|9|||
24979723|NCT00355121|50068107|FG002|Overall Study|Protocol Violation|1|||
24979724|NCT00355121|50068105|FG000|Overall Study|Lost to Follow-up|4|||
24979725|NCT00355121|50068106|FG001|Overall Study|Lost to Follow-up|7|||
24979726|NCT00355121|50068107|FG002|Overall Study|Lost to Follow-up|1|||
24979727|NCT00355121|50068105|FG000|Overall Study|Withdrawal by Subject|9|||
24979728|NCT00355121|50068106|FG001|Overall Study|Withdrawal by Subject|10|||
24979729|NCT00355121|50068107|FG002|Overall Study|Withdrawal by Subject|2|||
24979730|NCT00355121|50068105|FG000|Overall Study|Serious adverse events|0|||
24979731|NCT00355121|50068106|FG001|Overall Study|Serious adverse events|2|||
24979732|NCT00355121|50068107|FG002|Overall Study|Serious adverse events|0|||
24979733|NCT00343889|50068120|FG000|Overall Study|Lost to Follow-up|2|||
24979734|NCT00343889|50068121|FG001|Overall Study|Lost to Follow-up|0|||
24979735|NCT00343889|50068120|FG000|Overall Study|Withdrawal by Subject|0|||
24979736|NCT00343889|50068121|FG001|Overall Study|Withdrawal by Subject|1|||
24979737|NCT00343889|50068120|FG000|Overall Study|Protocol Violation|1|||
24979738|NCT00343889|50068121|FG001|Overall Study|Protocol Violation|0|||
24979739|NCT00354341|50068129|FG000|Overall Study|Adverse Event|1|||
24979740|NCT00354341|50068130|FG001|Overall Study|Adverse Event|0|||
24979741|NCT00354341|50068129|FG000|Overall Study|Death|0|||
24979742|NCT00354341|50068130|FG001|Overall Study|Death|2|||
24979743|NCT00354341|50068129|FG000|Overall Study|Refused treatment|1|||
25255229|NCT01173601|50570924|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
25255230|NCT01173601|50570925|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
25255231|NCT01173601|50570926|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
25255232|NCT01173601|50570927|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
25255233|NCT01173601|50570923|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
25255234|NCT01173601|50570924|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
25255235|NCT01173601|50570925|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
25255236|NCT01173601|50570926|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
25341784|NCT00797225|50658077|FG005|Weeks 13 to 24|Sponsor Decision|0|||
25341785|NCT00797225|50658078|FG006|Weeks 13 to 24|Sponsor Decision|1|||
24979744|NCT00354341|50068130|FG001|Overall Study|Refused treatment|2|||
24979745|NCT00354341|50068129|FG000|Overall Study|Failure to return|0|||
24979746|NCT00354341|50068130|FG001|Overall Study|Failure to return|1|||
24979747|NCT00354341|50068129|FG000|Overall Study|Other|1|||
24979748|NCT00354341|50068130|FG001|Overall Study|Other|2|||
24979749|NCT00354107|50068136|FG000|Overall Study|Adverse Event|2|||
24979750|NCT00354107|50068136|FG000|Overall Study|Physician Decision|2|||
24979751|NCT00354107|50068136|FG000|Overall Study|Withdrawal by Subject|1|||
24979752|NCT00354029|50068142|FG000|Overall Study|Protocol Violation|4|||
24979753|NCT00354029|50068143|FG001|Overall Study|Protocol Violation|2|||
24979754|NCT00353873|50068151|FG000|Overall Study|Protocol Violation|1|||
24979755|NCT00353873|50068152|FG001|Overall Study|Protocol Violation|2|||
24979756|NCT00353873|50068151|FG000|Overall Study|Exacerbation|1|||
24979757|NCT00353873|50068152|FG001|Overall Study|Exacerbation|0|||
24979758|NCT00353873|50068151|FG000|Overall Study|Adverse Event|1|||
25341786|NCT00797225|50658079|FG007|Weeks 13 to 24|Sponsor Decision|0|||
25341787|NCT00778700|50658099|FG000|Overall Study|Adverse Event|6|||
25341788|NCT00778700|50658100|FG001|Overall Study|Adverse Event|1|||
25341789|NCT00778700|50658101|FG002|Overall Study|Adverse Event|3|||
25341790|NCT00778700|50658102|FG003|Overall Study|Adverse Event|5|||
25341791|NCT00778700|50658099|FG000|Overall Study|Protocol Violation|1|||
25341792|NCT00778700|50658100|FG001|Overall Study|Protocol Violation|1|||
25341793|NCT00778700|50658101|FG002|Overall Study|Protocol Violation|0|||
25341794|NCT00778700|50658102|FG003|Overall Study|Protocol Violation|0|||
25341795|NCT00778700|50658099|FG000|Overall Study|Subject Withdrew Consent|6|||
25341796|NCT00778700|50658100|FG001|Overall Study|Subject Withdrew Consent|4|||
25341797|NCT00778700|50658101|FG002|Overall Study|Subject Withdrew Consent|1|||
25341798|NCT00778700|50658102|FG003|Overall Study|Subject Withdrew Consent|4|||
24979759|NCT00353873|50068152|FG001|Overall Study|Adverse Event|0|||
24979760|NCT00353873|50068151|FG000|Overall Study|Physician Decision|2|||
24979761|NCT00353873|50068152|FG001|Overall Study|Physician Decision|0|||
24979762|NCT00353873|50068151|FG000|Overall Study|Withdrawal by Subject|1|||
24979763|NCT00353873|50068152|FG001|Overall Study|Withdrawal by Subject|1|||
24979764|NCT03796676|50068161|FG000|Overall Study|Adverse Event|2|||
24979765|NCT03796676|50068162|FG001|Overall Study|Adverse Event|1|||
25341799|NCT00778700|50658099|FG000|Overall Study|Lost to Follow-up|3|||
25341800|NCT00778700|50658100|FG001|Overall Study|Lost to Follow-up|1|||
25341801|NCT00778700|50658101|FG002|Overall Study|Lost to Follow-up|0|||
24979766|NCT03796676|50068163|FG002|Overall Study|Adverse Event|2|||
24979767|NCT03796676|50068161|FG000|Overall Study|Lost to Follow-up|2|||
24979768|NCT03796676|50068162|FG001|Overall Study|Lost to Follow-up|1|||
24979769|NCT03796676|50068163|FG002|Overall Study|Lost to Follow-up|0|||
24979770|NCT03796676|50068161|FG000|Overall Study|Protocol Violation|0|||
24979771|NCT03796676|50068162|FG001|Overall Study|Protocol Violation|0|||
24979772|NCT03796676|50068163|FG002|Overall Study|Protocol Violation|1|||
24979773|NCT03796676|50068161|FG000|Overall Study|Withdrawal by Subject|1|||
24979774|NCT03796676|50068162|FG001|Overall Study|Withdrawal by Subject|1|||
24979775|NCT03796676|50068163|FG002|Overall Study|Withdrawal by Subject|0|||
24979776|NCT03796676|50068161|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
24979777|NCT03796676|50068162|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
24979778|NCT03796676|50068163|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
24979779|NCT03342898|50068177|FG000|Overall Study|Adverse Event|3|||
24979780|NCT03342898|50068178|FG001|Overall Study|Adverse Event|1|||
24979781|NCT03342898|50068179|FG002|Overall Study|Adverse Event|0|||
24979782|NCT03342898|50068177|FG000|Overall Study|Lost to Follow-up|44|||
24979783|NCT03342898|50068178|FG001|Overall Study|Lost to Follow-up|40|||
24979784|NCT03342898|50068179|FG002|Overall Study|Lost to Follow-up|42|||
24979785|NCT03342898|50068177|FG000|Overall Study|Withdrawal of Consent|5|||
24979786|NCT03342898|50068178|FG001|Overall Study|Withdrawal of Consent|9|||
24979787|NCT03342898|50068179|FG002|Overall Study|Withdrawal of Consent|11|||
24979788|NCT03342898|50068177|FG000|Overall Study|Death|0|||
24979789|NCT03342898|50068178|FG001|Overall Study|Death|1|||
24979790|NCT03342898|50068179|FG002|Overall Study|Death|1|||
24979791|NCT03342898|50068177|FG000|Overall Study|Reason not Specified|2|||
24979792|NCT03342898|50068178|FG001|Overall Study|Reason not Specified|2|||
24979793|NCT03342898|50068179|FG002|Overall Study|Reason not Specified|0|||
24979794|NCT00339833|50068189|FG000|Overall Study|Withdrawal by Subject|1|||
24979795|NCT00339833|50068190|FG001|Overall Study|Withdrawal by Subject|2|||
24979796|NCT00339833|50068189|FG000|Overall Study|toothache|0|||
24979797|NCT00339833|50068190|FG001|Overall Study|toothache|1|||
24979798|NCT00339833|50068189|FG000|Overall Study|indigestion|0|||
24979799|NCT00339833|50068190|FG001|Overall Study|indigestion|1|||
24979800|NCT00339833|50068189|FG000|Overall Study|Chest pain|0|||
24979801|NCT00339833|50068190|FG001|Overall Study|Chest pain|1|||
24979802|NCT00339833|50068189|FG000|Overall Study|minor infection|0|||
24979803|NCT00339833|50068190|FG001|Overall Study|minor infection|1|||
24979804|NCT00339833|50068189|FG000|Overall Study|Poor venous access|2|||
24979805|NCT00339833|50068190|FG001|Overall Study|Poor venous access|2|||
24979806|NCT00339833|50068189|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
24979807|NCT00339833|50068190|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
24979808|NCT00339833|50068189|FG000|Overall Study|Error in data records|1|||
24979809|NCT00339833|50068190|FG001|Overall Study|Error in data records|0|||
24979810|NCT03793556|50068198|FG000|Overall Study|Withdrawal by Subject|12|||
25341802|NCT00778700|50658102|FG003|Overall Study|Lost to Follow-up|1|||
25341803|NCT00778700|50658099|FG000|Overall Study|Reason not Specified|2|||
25341804|NCT00778700|50658100|FG001|Overall Study|Reason not Specified|0|||
25341805|NCT00778700|50658101|FG002|Overall Study|Reason not Specified|1|||
25341806|NCT00778700|50658102|FG003|Overall Study|Reason not Specified|3|||
24979811|NCT03793556|50068199|FG001|Overall Study|Withdrawal by Subject|1|||
24979812|NCT03793556|50068198|FG000|Overall Study|Lost to Follow-up|1|||
24979813|NCT03793556|50068199|FG001|Overall Study|Lost to Follow-up|1|||
24979814|NCT03392194|50068210|FG000|Overall Study|Withdrawal by Subject|1|||
24979815|NCT03392194|50068211|FG001|Overall Study|Withdrawal by Subject|2|||
24979816|NCT03392194|50068210|FG000|Overall Study|Conflicts with personal schedule|1|||
24979817|NCT03392194|50068211|FG001|Overall Study|Conflicts with personal schedule|0|||
24979818|NCT03828617|50068221|FG000|Overall Study|Lost to Follow-up|22|||
24979819|NCT03828617|50068222|FG001|Overall Study|Lost to Follow-up|12|||
24979820|NCT03828617|50068223|FG002|Overall Study|Lost to Follow-up|23|||
24979821|NCT03828617|50068224|FG003|Overall Study|Lost to Follow-up|7|||
24979822|NCT03828617|50068221|FG000|Overall Study|No longer met eligibility criteria|0|||
24979823|NCT03828617|50068222|FG001|Overall Study|No longer met eligibility criteria|1|||
24979824|NCT03828617|50068223|FG002|Overall Study|No longer met eligibility criteria|1|||
24979825|NCT03828617|50068224|FG003|Overall Study|No longer met eligibility criteria|3|||
24979826|NCT03828617|50068221|FG000|Overall Study|Protocol Violation|0|||
24979827|NCT03828617|50068222|FG001|Overall Study|Protocol Violation|2|||
24979828|NCT03828617|50068223|FG002|Overall Study|Protocol Violation|0|||
24979829|NCT03828617|50068224|FG003|Overall Study|Protocol Violation|0|||
24979830|NCT03828617|50068221|FG000|Overall Study|Withdrawal by Subject|2|||
24979831|NCT03828617|50068222|FG001|Overall Study|Withdrawal by Subject|0|||
24979832|NCT03828617|50068223|FG002|Overall Study|Withdrawal by Subject|2|||
24979833|NCT03828617|50068224|FG003|Overall Study|Withdrawal by Subject|0|||
25255237|NCT01173601|50570927|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
25255238|NCT01173523|50570947|FG000|Overall Study|Clinical Progression|1|||
25255239|NCT01173523|50570948|FG001|Overall Study|Clinical Progression|1|||
25255240|NCT01173523|50570947|FG000|Overall Study|Progressive Disease|10|||
25255241|NCT01173523|50570948|FG001|Overall Study|Progressive Disease|8|||
25255242|NCT01173523|50570947|FG000|Overall Study|Other|2|||
24979834|NCT03391960|50068233|FG000|Overall Study|Protocol Violation|0|||
24979835|NCT03391960|50068234|FG001|Overall Study|Protocol Violation||||
24979836|NCT03390166|50068260|FG000|Overall Study|Death|0|||
24979837|NCT03390166|50068261|FG001|Overall Study|Death|1|||
24979838|NCT03390166|50068260|FG000|Overall Study|Lost to Follow-up|6|||
24979839|NCT03390166|50068261|FG001|Overall Study|Lost to Follow-up|4|||
24979840|NCT03390166|50068260|FG000|Overall Study|Physician Decision|2|||
24979841|NCT03390166|50068261|FG001|Overall Study|Physician Decision|1|||
24979842|NCT03390166|50068260|FG000|Overall Study|Move from study area|3|||
24979843|NCT03390166|50068261|FG001|Overall Study|Move from study area|2|||
24979844|NCT03390166|50068260|FG000|Overall Study|To militarycamp for conscript|1|||
24979845|NCT03390166|50068261|FG001|Overall Study|To militarycamp for conscript|0|||
24979846|NCT03390166|50068260|FG000|Overall Study|To drug therapy course|0|||
25341807|NCT00778700|50658099|FG000|Overall Study|Other|0|||
25341808|NCT00778700|50658100|FG001|Overall Study|Other|0|||
25341809|NCT00778700|50658101|FG002|Overall Study|Other|1|||
25341810|NCT00778700|50658102|FG003|Overall Study|Other|0|||
25341811|NCT00793403|50658116|FG000|Overall Study|Other|73|||
25341812|NCT00793325|50658120|FG000|Overall Study|Protocol Violation|18|||
25341813|NCT00793325|50658120|FG000|Overall Study|Lost to Follow-up|1|||
25341814|NCT00778622|50658146|FG000|Overall Study|Adverse Event|5|||
25078094|NCT03745651|50186224|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
25255243|NCT01173523|50570948|FG001|Overall Study|Other|3|||
25255244|NCT01173055|50570956|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
25255245|NCT01173055|50570957|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
25255246|NCT01173055|50570956|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
25255247|NCT01173055|50570957|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
25255248|NCT01172938|50570966|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
25255249|NCT01172938|50570967|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
25255250|NCT01172938|50570968|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
25255251|NCT01172938|50570969|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
25255252|NCT01172938|50570970|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
25255253|NCT01172938|50570971|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
25255254|NCT01172938|50570972|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
25255255|NCT01172938|50570973|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
25255256|NCT01172938|50570974|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
25255257|NCT01172938|50570966|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
25255258|NCT01172938|50570967|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
25255259|NCT01172938|50570968|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
25255260|NCT01172938|50570969|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
25255261|NCT01172938|50570970|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
25255262|NCT01172938|50570971|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
24979847|NCT03390166|50068261|FG001|Overall Study|To drug therapy course|1|||
24979848|NCT03390166|50068260|FG000|Overall Study|Move to work oversea|0|||
25078095|NCT03745651|50186225|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
25078096|NCT03745651|50186226|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
25255263|NCT01172938|50570972|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
25341815|NCT00778622|50658147|FG001|Overall Study|Adverse Event|4|||
25341816|NCT00778622|50658148|FG002|Overall Study|Adverse Event|7|||
25341817|NCT00778622|50658146|FG000|Overall Study|Withdrawal by Subject|4|||
25341818|NCT00778622|50658147|FG001|Overall Study|Withdrawal by Subject|5|||
25341819|NCT00778622|50658148|FG002|Overall Study|Withdrawal by Subject|5|||
25341820|NCT00778622|50658146|FG000|Overall Study|Lost to Follow-up|3|||
25341821|NCT00778622|50658147|FG001|Overall Study|Lost to Follow-up|3|||
25341822|NCT00778622|50658148|FG002|Overall Study|Lost to Follow-up|2|||
25341823|NCT00778622|50658146|FG000|Overall Study|Protocol Violation|0|||
25341824|NCT00778622|50658147|FG001|Overall Study|Protocol Violation|3|||
25341825|NCT00778622|50658148|FG002|Overall Study|Protocol Violation|0|||
24979849|NCT03390166|50068261|FG001|Overall Study|Move to work oversea|1|||
24979850|NCT03828539|50068269|FG000|Overall Study|Adverse Event|3|||
24979851|NCT03828539|50068270|FG001|Overall Study|Adverse Event|12|||
24979852|NCT03828539|50068269|FG000|Overall Study|Patient's/guardian's decision|3|||
24979853|NCT03828539|50068270|FG001|Overall Study|Patient's/guardian's decision|5|||
24979854|NCT03828539|50068269|FG000|Overall Study|Lost to Follow-up|4|||
24979855|NCT03828539|50068270|FG001|Overall Study|Lost to Follow-up|2|||
24979856|NCT03828539|50068269|FG000|Overall Study|Protocol Violation|3|||
24979857|NCT03828539|50068270|FG001|Overall Study|Protocol Violation|2|||
24979858|NCT03828539|50068269|FG000|Overall Study|Withdrawal of informed consent|2|||
24979859|NCT03828539|50068270|FG001|Overall Study|Withdrawal of informed consent|1|||
24979860|NCT03828539|50068269|FG000|Overall Study|New therapy for study indication|1|||
24979861|NCT03828539|50068270|FG001|Overall Study|New therapy for study indication|0|||
24979862|NCT03336502|50068278|FG000|Overall Study|Physician Decision|0|||
25255264|NCT01172938|50570973|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
25255265|NCT01172938|50570974|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
24979863|NCT03336502|50068279|FG001|Overall Study|Physician Decision|1|||
24979864|NCT03336502|50068278|FG000|Overall Study|Prohibited Drugs|1|||
24979865|NCT03336502|50068279|FG001|Overall Study|Prohibited Drugs|1|||
24979866|NCT03336502|50068278|FG000|Overall Study|Death|1|||
24979867|NCT03336502|50068279|FG001|Overall Study|Death|2|||
24979868|NCT03336502|50068278|FG000|Overall Study|Adverse Event|2|||
24979869|NCT03336502|50068279|FG001|Overall Study|Adverse Event|5|||
24979870|NCT00338741|50068287|FG000|Overall Study|Lost to Follow-up|2|||
24979871|NCT00338741|50068288|FG001|Overall Study|Lost to Follow-up|0|||
24979872|NCT03370510|50068296|FG000|Overall Study|COVID-19|2|||
24979873|NCT03370510|50068297|FG001|Overall Study|COVID-19|0|||
24979874|NCT00351611|50068305|FG000|Overall Study|Adverse Event|11|||
24979875|NCT00351611|50068306|FG001|Overall Study|Adverse Event|3|||
24979876|NCT00351611|50068305|FG000|Overall Study|Death|1|||
24979877|NCT00351611|50068306|FG001|Overall Study|Death|0|||
24979878|NCT00351611|50068305|FG000|Overall Study|Lost to Follow-up|1|||
24979879|NCT00351611|50068306|FG001|Overall Study|Lost to Follow-up|0|||
24979880|NCT00351611|50068305|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
24979881|NCT00351611|50068306|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
24979882|NCT00351611|50068305|FG000|Overall Study|Other|1|||
24979883|NCT00351611|50068306|FG001|Overall Study|Other|0|||
24979884|NCT00351611|50068305|FG000|Overall Study|Protocol Violation|0|||
24979885|NCT00351611|50068306|FG001|Overall Study|Protocol Violation|2|||
24979886|NCT00351533|50068314|FG000|Overall Study|Extubated before first BAL|1|||
24979887|NCT00351533|50068315|FG001|Overall Study|Extubated before first BAL|0|||
24979888|NCT00351533|50068314|FG000|Overall Study|Lost to Follow-up|1|||
24979889|NCT00351533|50068315|FG001|Overall Study|Lost to Follow-up|3|||
24979890|NCT00351533|50068314|FG000|Overall Study|Physician Decision|0|||
24979891|NCT00351533|50068315|FG001|Overall Study|Physician Decision|1|||
24979892|NCT00351533|50068314|FG000|Overall Study|Withdrawal by Subject|0|||
24979893|NCT00351533|50068315|FG001|Overall Study|Withdrawal by Subject|1|||
24979894|NCT00351377|50068321|FG000|Overall Study|Adverse Event|5|||
24979895|NCT00351377|50068321|FG000|Overall Study|Death|1|||
25255266|NCT01172938|50570966|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
25255267|NCT01172938|50570967|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
25255268|NCT01172938|50570968|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
25255269|NCT01172938|50570969|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
25255270|NCT01172938|50570970|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
25255271|NCT01172938|50570971|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
25255272|NCT01172938|50570972|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
25255273|NCT01172938|50570973|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
25255274|NCT01172938|50570974|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
25255275|NCT01172938|50570966|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
25341826|NCT00778622|50658146|FG000|Overall Study|Lack of Efficacy|2|||
24979896|NCT00351377|50068321|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
24979897|NCT00337727|50068327|FG000|Overall Study|Adverse Event|5|||
24979898|NCT00337727|50068328|FG001|Overall Study|Adverse Event|3|||
24979899|NCT00337727|50068327|FG000|Overall Study|Lost to Follow-up|5|||
24979900|NCT00337727|50068328|FG001|Overall Study|Lost to Follow-up|4|||
25341827|NCT00778622|50658147|FG001|Overall Study|Lack of Efficacy|0|||
24979901|NCT00337727|50068327|FG000|Overall Study|Physician Decision|1|||
24979902|NCT00337727|50068328|FG001|Overall Study|Physician Decision|0|||
24979903|NCT00337727|50068327|FG000|Overall Study|Protocol Violation|4|||
24979904|NCT00337727|50068328|FG001|Overall Study|Protocol Violation|0|||
24979905|NCT00337727|50068327|FG000|Overall Study|Withdrawal by Subject|3|||
24979906|NCT00337727|50068328|FG001|Overall Study|Withdrawal by Subject|5|||
24979907|NCT00324233|50068336|FG000|First Period|unable to insert catheter|1|||
24979908|NCT00324233|50068337|FG001|First Period|unable to insert catheter|0|||
24979909|NCT00324233|50068336|FG000|Second Period|unable to insert catheter|1|||
24979910|NCT00324233|50068337|FG001|Second Period|unable to insert catheter|1|||
24979911|NCT00324233|50068336|FG000|Second Period|Protocol Violation|4|||
24979912|NCT00324233|50068337|FG001|Second Period|Protocol Violation|6|||
25341828|NCT00778622|50658148|FG002|Overall Study|Lack of Efficacy|0|||
25341829|NCT00778622|50658146|FG000|Overall Study|immigration|1|||
25341830|NCT00778622|50658147|FG001|Overall Study|immigration|0|||
25341831|NCT00778622|50658148|FG002|Overall Study|immigration|0|||
25341832|NCT00778622|50658146|FG000|Overall Study|Other|1|||
25341833|NCT00778622|50658147|FG001|Overall Study|Other|0|||
25341834|NCT00778622|50658148|FG002|Overall Study|Other|1|||
25341835|NCT00777920|50658160|FG000|Overall Study|Adverse Event|39|||
25341836|NCT00777920|50658160|FG000|Overall Study|Withdrawal of Consent|4|||
25341837|NCT00777920|50658160|FG000|Overall Study|Lost to Follow-up|1|||
25341838|NCT00777920|50658160|FG000|Overall Study|Investigator's discretion|1|||
25341839|NCT00777920|50658160|FG000|Overall Study|Clinical status did not improve|1|||
25341840|NCT00777920|50658160|FG000|Overall Study|Other, not specified|4|||
25341841|NCT04236141|50658166|FG000|Overall Study|Death|18|||
25341842|NCT04236141|50658167|FG001|Overall Study|Death|10|||
25341843|NCT04236141|50658166|FG000|Overall Study|Withdrawal by Participant|1|||
24979929|NCT03335566|50068361|FG000|Overall Study|Adverse Event|0|||
24979930|NCT03335566|50068362|FG001|Overall Study|Adverse Event|1|||
24979931|NCT03335566|50068361|FG000|Overall Study|Lost to Follow-up|1|||
24979932|NCT03335566|50068362|FG001|Overall Study|Lost to Follow-up|0|||
24979933|NCT03335566|50068361|FG000|Overall Study|Technical Problems|1|||
24979934|NCT03335566|50068362|FG001|Overall Study|Technical Problems|0|||
24979935|NCT03335566|50068361|FG000|Overall Study|Protocol Violation|1|||
24979936|NCT03335566|50068362|FG001|Overall Study|Protocol Violation|0|||
24979937|NCT03335566|50068361|FG000|Overall Study|Other than specified above|1|||
24979938|NCT03335566|50068362|FG001|Overall Study|Other than specified above|2|||
24979939|NCT03369418|50068370|FG000|Overall Study|Withdrawal by Subject|3|||
24979940|NCT03369418|50068371|FG001|Overall Study|Withdrawal by Subject|3|||
24979941|NCT03334630|50068379|FG000|Overall Study|Withdrawal by Subject|7|||
24979942|NCT03334630|50068380|FG001|Overall Study|Withdrawal by Subject|7|||
24979943|NCT03334630|50068379|FG000|Overall Study|Lost to Follow-up|3|||
24979944|NCT03334630|50068380|FG001|Overall Study|Lost to Follow-up|1|||
24979945|NCT03334630|50068379|FG000|Overall Study|Adverse Event|0|||
24979946|NCT03334630|50068380|FG001|Overall Study|Adverse Event|1|||
24979947|NCT03334630|50068379|FG000|Overall Study|Physician Decision|1|||
24979948|NCT03334630|50068380|FG001|Overall Study|Physician Decision|1|||
24979949|NCT03334630|50068379|FG000|Overall Study|Enrollment closed|2|||
24979950|NCT03334630|50068380|FG001|Overall Study|Enrollment closed|1|||
24979951|NCT03334630|50068379|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
24979952|NCT03334630|50068380|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
25078097|NCT03745651|50186227|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
25078098|NCT03745651|50186228|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
25078099|NCT03745651|50186229|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
25078100|NCT03745651|50186223|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
25078101|NCT03745651|50186224|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
25078102|NCT03745651|50186225|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
25078103|NCT03745651|50186226|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
25078104|NCT03745651|50186227|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
25078105|NCT03745651|50186228|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
25078106|NCT03745651|50186229|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
25078107|NCT03745651|50186223|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
25078108|NCT03745651|50186224|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
25078109|NCT03745651|50186225|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
25078110|NCT03745651|50186226|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
24979953|NCT03334630|50068379|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
24979954|NCT03334630|50068380|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
24979955|NCT03368170|50068388|FG000|Overall Study|Adverse Event|2|||
24979956|NCT03368170|50068389|FG001|Overall Study|Adverse Event|1|||
24979957|NCT00324155|50068397|FG000|Enrolled and Randomized|No longer met study criteria|3|||
24979958|NCT00324155|50068398|FG001|Enrolled and Randomized|No longer met study criteria|0|||
24979959|NCT00324155|50068397|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
24979960|NCT00324155|50068398|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
25341844|NCT04236141|50658167|FG001|Overall Study|Withdrawal by Participant|0|||
24979961|NCT00324155|50068397|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
25341845|NCT04236141|50658166|FG000|Overall Study|Reason not Specified|1|||
24979962|NCT00324155|50068398|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
24979963|NCT00324155|50068397|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
24979964|NCT00324155|50068398|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
24979965|NCT00324155|50068397|FG000|Received Treatment in Induction Phase|Death|8|||
24979966|NCT00324155|50068398|FG001|Received Treatment in Induction Phase|Death|15|||
24979967|NCT00324155|50068397|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
24979968|NCT00324155|50068398|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
24979969|NCT00324155|50068397|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
24979970|NCT00324155|50068398|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
24979971|NCT00324155|50068397|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
25341846|NCT04236141|50658167|FG001|Overall Study|Reason not Specified|0|||
24979972|NCT00324155|50068398|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
24979973|NCT00324155|50068397|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
24979974|NCT00324155|50068398|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
24979975|NCT00324155|50068397|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
24979976|NCT00324155|50068398|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
24979977|NCT00324155|50068397|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
24979978|NCT00324155|50068398|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
24979979|NCT00324155|50068397|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
24979980|NCT00324155|50068398|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
24979981|NCT00324155|50068397|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
24979982|NCT00324155|50068398|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
24979983|NCT00324155|50068397|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
24979984|NCT00324155|50068398|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
24979985|NCT00324155|50068397|FG000|Follow-up Phase|On-going participants still on drug|11|||
24979986|NCT00324155|50068398|FG001|Follow-up Phase|On-going participants still on drug|6|||
24979987|NCT03334396|50068425|FG000|Overall Study|Adverse Event|1|||
24979988|NCT03334396|50068426|FG001|Overall Study|Adverse Event|0|||
24979989|NCT03334396|50068427|FG002|Overall Study|Adverse Event|1|||
24979990|NCT03334396|50068428|FG003|Overall Study|Adverse Event|0|||
24979991|NCT03334396|50068429|FG004|Overall Study|Adverse Event|0|||
24979992|NCT03334396|50068430|FG005|Overall Study|Adverse Event|0|||
24979993|NCT03334396|50068431|FG006|Overall Study|Adverse Event|0|||
24979994|NCT03334396|50068432|FG007|Overall Study|Adverse Event|0|||
24979995|NCT03334396|50068425|FG000|Overall Study|Lack of Efficacy|10|||
24979996|NCT03334396|50068426|FG001|Overall Study|Lack of Efficacy|4|||
24979997|NCT03334396|50068427|FG002|Overall Study|Lack of Efficacy|1|||
24979998|NCT03334396|50068428|FG003|Overall Study|Lack of Efficacy|3|||
24979999|NCT03334396|50068429|FG004|Overall Study|Lack of Efficacy|1|||
24980000|NCT03334396|50068430|FG005|Overall Study|Lack of Efficacy|0|||
24980001|NCT03334396|50068431|FG006|Overall Study|Lack of Efficacy|0|||
25341847|NCT04236141|50658166|FG000|Overall Study|Study terminated by Sponsor|8|||
25341848|NCT04236141|50658167|FG001|Overall Study|Study terminated by Sponsor|4|||
25341849|NCT00796445|50658175|FG000|Overall Study|Protocol Violation|5|||
25341850|NCT00796445|50658176|FG001|Overall Study|Protocol Violation|3|||
25341851|NCT00796445|50658175|FG000|Overall Study|Adverse event, serious fatal|10|||
25341852|NCT00796445|50658176|FG001|Overall Study|Adverse event, serious fatal|5|||
25341853|NCT00796445|50658175|FG000|Overall Study|Adverse event, non-fatal|4|||
25341854|NCT00796445|50658176|FG001|Overall Study|Adverse event, non-fatal|0|||
25341855|NCT00796445|50658175|FG000|Overall Study|Disease progression/recurrence|537|||
25341856|NCT00796445|50658176|FG001|Overall Study|Disease progression/recurrence|268|||
25341857|NCT00796445|50658175|FG000|Overall Study|Other|10|||
25341858|NCT00796445|50658176|FG001|Overall Study|Other|7|||
25341859|NCT00796445|50658175|FG000|Overall Study|Withdrawal by Subject|18|||
24980002|NCT03334396|50068432|FG007|Overall Study|Lack of Efficacy|1|||
24980003|NCT03334396|50068425|FG000|Overall Study|Lost to Follow-up|0|||
24980004|NCT03334396|50068426|FG001|Overall Study|Lost to Follow-up|0|||
24980005|NCT03334396|50068427|FG002|Overall Study|Lost to Follow-up|1|||
24980006|NCT03334396|50068428|FG003|Overall Study|Lost to Follow-up|0|||
24980007|NCT03334396|50068429|FG004|Overall Study|Lost to Follow-up|0|||
24980008|NCT03334396|50068430|FG005|Overall Study|Lost to Follow-up|0|||
24980009|NCT03334396|50068431|FG006|Overall Study|Lost to Follow-up|1|||
24980010|NCT03334396|50068432|FG007|Overall Study|Lost to Follow-up|0|||
24980011|NCT03334396|50068425|FG000|Overall Study|Physician Decision|1|||
24980012|NCT03334396|50068426|FG001|Overall Study|Physician Decision|0|||
24980013|NCT03334396|50068427|FG002|Overall Study|Physician Decision|0|||
24980014|NCT03334396|50068428|FG003|Overall Study|Physician Decision|0|||
24980015|NCT03334396|50068429|FG004|Overall Study|Physician Decision|0|||
24980016|NCT03334396|50068430|FG005|Overall Study|Physician Decision|0|||
24980017|NCT03334396|50068431|FG006|Overall Study|Physician Decision|0|||
25341860|NCT00796445|50658176|FG001|Overall Study|Withdrawal by Subject|9|||
24980018|NCT03334396|50068432|FG007|Overall Study|Physician Decision|0|||
24980019|NCT03334396|50068425|FG000|Overall Study|Withdrawal by Subject|10|||
24980020|NCT03334396|50068426|FG001|Overall Study|Withdrawal by Subject|5|||
24980021|NCT03334396|50068427|FG002|Overall Study|Withdrawal by Subject|7|||
24980022|NCT03334396|50068428|FG003|Overall Study|Withdrawal by Subject|2|||
24980023|NCT03334396|50068429|FG004|Overall Study|Withdrawal by Subject|2|||
24980024|NCT03334396|50068430|FG005|Overall Study|Withdrawal by Subject|1|||
24980025|NCT03334396|50068431|FG006|Overall Study|Withdrawal by Subject|2|||
24980026|NCT03334396|50068432|FG007|Overall Study|Withdrawal by Subject|0|||
24980027|NCT03334396|50068425|FG000|Overall Study|Pregnancy|0|||
24980028|NCT03334396|50068426|FG001|Overall Study|Pregnancy|1|||
24980029|NCT03334396|50068427|FG002|Overall Study|Pregnancy|0|||
24980030|NCT03334396|50068428|FG003|Overall Study|Pregnancy|0|||
24980031|NCT03334396|50068429|FG004|Overall Study|Pregnancy|0|||
24980032|NCT03334396|50068430|FG005|Overall Study|Pregnancy|0|||
24980033|NCT03334396|50068431|FG006|Overall Study|Pregnancy|0|||
24980034|NCT03334396|50068432|FG007|Overall Study|Pregnancy|0|||
24980035|NCT03334396|50068425|FG000|Overall Study|Ineligible|0|||
24980036|NCT03334396|50068426|FG001|Overall Study|Ineligible|1|||
24980037|NCT03334396|50068427|FG002|Overall Study|Ineligible|0|||
24980038|NCT03334396|50068428|FG003|Overall Study|Ineligible|0|||
24980039|NCT03334396|50068429|FG004|Overall Study|Ineligible|0|||
25341861|NCT00796445|50658175|FG000|Overall Study|Invalid Informed Consent Form|1|||
24980040|NCT03334396|50068430|FG005|Overall Study|Ineligible|0|||
24980041|NCT03334396|50068431|FG006|Overall Study|Ineligible|0|||
24980042|NCT03334396|50068432|FG007|Overall Study|Ineligible|0|||
24980043|NCT03334396|50068425|FG000|Overall Study|Started New Job|1|||
24980044|NCT03334396|50068426|FG001|Overall Study|Started New Job|0|||
24980045|NCT03334396|50068427|FG002|Overall Study|Started New Job|0|||
24980046|NCT03334396|50068428|FG003|Overall Study|Started New Job|0|||
24980047|NCT03334396|50068429|FG004|Overall Study|Started New Job|0|||
24980048|NCT03334396|50068430|FG005|Overall Study|Started New Job|0|||
24980049|NCT03334396|50068431|FG006|Overall Study|Started New Job|0|||
24980050|NCT03334396|50068432|FG007|Overall Study|Started New Job|0|||
24980051|NCT03338998|50068451|FG000|Treatment Period|Withdrawal by Subject|1|||
24980052|NCT03338998|50068452|FG001|Treatment Period|Withdrawal by Subject|1|||
24980053|NCT03338998|50068451|FG000|Treatment Period|Adverse Event|0|||
24980054|NCT03338998|50068452|FG001|Treatment Period|Adverse Event|2|||
24980055|NCT03338998|50068451|FG000|Treatment Period|Protocol deviation|1|||
24980056|NCT03338998|50068452|FG001|Treatment Period|Protocol deviation|0|||
24980057|NCT03338998|50068451|FG000|Treatment Period|Physician Decision|2|||
25078111|NCT03745651|50186227|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
25078112|NCT03745651|50186228|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
25078113|NCT03745651|50186229|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
25341862|NCT00796445|50658176|FG001|Overall Study|Invalid Informed Consent Form|0|||
25341863|NCT03939819|50658192|FG000|Overall Study|Death|2|||
25341864|NCT03939819|50658193|FG001|Overall Study|Death|0|||
25341865|NCT00756938|50658202|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
25341866|NCT00756938|50658203|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
25341867|NCT00756938|50658204|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
25341868|NCT00756938|50658205|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
25341869|NCT00756938|50658202|FG000|12-week Base Study|Protocol Violation|0|||
25341870|NCT00756938|50658203|FG001|12-week Base Study|Protocol Violation|0|||
25341871|NCT00756938|50658204|FG002|12-week Base Study|Protocol Violation|1|||
25341872|NCT00756938|50658205|FG003|12-week Base Study|Protocol Violation|0|||
25341873|NCT00756938|50658202|FG000|12-week Base Study|Lost to Follow-up|1|||
25341874|NCT00756938|50658203|FG001|12-week Base Study|Lost to Follow-up|0|||
25341875|NCT00756938|50658204|FG002|12-week Base Study|Lost to Follow-up|0|||
25341876|NCT00756938|50658205|FG003|12-week Base Study|Lost to Follow-up|0|||
24980058|NCT03338998|50068452|FG001|Treatment Period|Physician Decision|0|||
24980059|NCT03338998|50068451|FG000|Treatment Period|Subject failed swallow test|4|||
24980060|NCT03338998|50068452|FG001|Treatment Period|Subject failed swallow test|0|||
24980061|NCT03338998|50068451|FG000|Safety Follow-Up Period|Adverse Event|0|||
24980062|NCT03338998|50068452|FG001|Safety Follow-Up Period|Adverse Event|1|||
24980063|NCT03338998|50068451|FG000|Safety Follow-Up Period|Protocol deviation|1|||
24980064|NCT03338998|50068452|FG001|Safety Follow-Up Period|Protocol deviation|0|||
24980065|NCT03338998|50068451|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
24980066|NCT03338998|50068452|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
24980067|NCT03338296|50068461|FG000|Overall Study|Adverse Event|0|||
24980068|NCT03338296|50068462|FG001|Overall Study|Adverse Event|1|||
24980069|NCT03338296|50068461|FG000|Overall Study|Withdrawal by Subject|14|||
24980070|NCT03338296|50068462|FG001|Overall Study|Withdrawal by Subject|13|||
24980071|NCT03338296|50068461|FG000|Overall Study|Lost to Follow-up|10|||
24980072|NCT03338296|50068462|FG001|Overall Study|Lost to Follow-up|10|||
24980073|NCT03338296|50068461|FG000|Overall Study|Study Terminated by Sponsor|77|||
24980074|NCT03338296|50068462|FG001|Overall Study|Study Terminated by Sponsor|76|||
24980075|NCT03338296|50068461|FG000|Overall Study|Other|2|||
24980076|NCT03338296|50068462|FG001|Overall Study|Other|7|||
24980077|NCT03338296|50068461|FG000|Overall Study|Missing|0|||
24980078|NCT03338296|50068462|FG001|Overall Study|Missing|1|||
24980079|NCT03338062|50068470|FG000|Overall Study|Alternative Therapy|1|||
24980080|NCT03338062|50068471|FG001|Overall Study|Alternative Therapy|0|||
24980081|NCT03364192|50068478|FG000|Overall Study|Ineligible|10|||
24980082|NCT03364192|50068478|FG000|Overall Study|Withdrawal by Subject|5|||
24980083|NCT03364192|50068478|FG000|Overall Study|Lost to Follow-up|1|||
24980084|NCT03783962|50068485|FG000|Overall Study|Lost to Follow-up|3|||
24980085|NCT03783962|50068486|FG001|Overall Study|Lost to Follow-up|6|||
24980086|NCT03783962|50068485|FG000|Overall Study|Protocol Violation|0|||
24980087|NCT03783962|50068486|FG001|Overall Study|Protocol Violation|1|||
24980088|NCT03361228|50068494|FG000|Overall Study|Other|1|||
24980089|NCT03361228|50068495|FG001|Overall Study|Other|1|||
24980090|NCT03361228|50068494|FG000|Overall Study|Death|3|||
24980091|NCT03361228|50068495|FG001|Overall Study|Death|0|||
24980092|NCT03359590|50068501|FG000|First Intervention|Withdrawal by Subject|1|||
24980093|NCT03359590|50068502|FG001|First Intervention|Withdrawal by Subject|1|||
24980094|NCT03359590|50068501|FG000|First Intervention|Protocol Violation|0|||
24980095|NCT03359590|50068502|FG001|First Intervention|Protocol Violation|1|||
24980096|NCT05085964|50068510|FG000|Overall Study|Premature termination of study|21|||
24980097|NCT05085964|50068511|FG001|Overall Study|Premature termination of study|0|||
25255276|NCT01172938|50570967|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
25255277|NCT01172938|50570968|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
25255278|NCT01172938|50570969|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
25255279|NCT01172938|50570970|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
25255280|NCT01172938|50570971|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
25255281|NCT01172938|50570972|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
25255282|NCT01172938|50570973|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
25255283|NCT01172938|50570974|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
25255284|NCT01172938|50570966|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
25255285|NCT01172938|50570967|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
25255286|NCT01172938|50570968|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
25255287|NCT01172938|50570969|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
25255288|NCT01172938|50570970|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
25255289|NCT01172938|50570971|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
25255290|NCT01172938|50570972|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
25255291|NCT01172938|50570973|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
25255292|NCT01172938|50570974|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
25255293|NCT01172938|50570966|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
25255294|NCT01172938|50570967|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
25255295|NCT01172938|50570968|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
25255296|NCT01172938|50570969|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
25255297|NCT01172938|50570970|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
25255298|NCT01172938|50570971|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
25255299|NCT01172938|50570972|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
25255300|NCT01172938|50570973|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
25255301|NCT01172938|50570974|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
25255302|NCT01172938|50570966|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
25255303|NCT01172938|50570967|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
25255304|NCT01172938|50570968|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
24980098|NCT02891200|50068520|FG000|Overall Study|Lost to Follow-up|31|||
24980099|NCT02891200|50068521|FG001|Overall Study|Lost to Follow-up|36|||
24980100|NCT02891200|50068520|FG000|Overall Study|Death|10|||
24980101|NCT02891200|50068521|FG001|Overall Study|Death|9|||
24980102|NCT02891200|50068520|FG000|Overall Study|Withdrawal by Subject|1|||
24980103|NCT02891200|50068521|FG001|Overall Study|Withdrawal by Subject|4|||
24980104|NCT02946580|50068529|FG000|Overall Study|Withdrawal by Subject|1|||
24980105|NCT02946580|50068530|FG001|Overall Study|Withdrawal by Subject|2|||
24980106|NCT02946580|50068529|FG000|Overall Study|Adverse Event|0|||
24980107|NCT02946580|50068530|FG001|Overall Study|Adverse Event|2|||
24980108|NCT02946580|50068529|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
24980109|NCT02946580|50068530|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
24980110|NCT00323609|50068538|FG000|Overall Study|Death|16|||
24980111|NCT00323609|50068539|FG001|Overall Study|Death|21|||
24980112|NCT00323609|50068540|FG002|Overall Study|Death|0|||
24980113|NCT00323609|50068541|FG003|Overall Study|Death|0|||
24980114|NCT00323609|50068538|FG000|Overall Study|Lost to Follow-up|9|||
24980115|NCT00323609|50068539|FG001|Overall Study|Lost to Follow-up|10|||
24980116|NCT00323609|50068540|FG002|Overall Study|Lost to Follow-up|0|||
24980117|NCT00323609|50068541|FG003|Overall Study|Lost to Follow-up|0|||
24980118|NCT00323609|50068538|FG000|Overall Study|Physician Decision|2|||
24980119|NCT00323609|50068539|FG001|Overall Study|Physician Decision|0|||
24980120|NCT00323609|50068540|FG002|Overall Study|Physician Decision|0|||
24980121|NCT00323609|50068541|FG003|Overall Study|Physician Decision|1|||
24980122|NCT00323609|50068538|FG000|Overall Study|Withdrawal by Subject|11|||
24980123|NCT00323609|50068539|FG001|Overall Study|Withdrawal by Subject|23|||
24980124|NCT00323609|50068540|FG002|Overall Study|Withdrawal by Subject|4|||
24980125|NCT00323609|50068541|FG003|Overall Study|Withdrawal by Subject|4|||
24980126|NCT00323609|50068538|FG000|Overall Study|Other non-VCF-related medical condition|3|||
24980127|NCT00323609|50068539|FG001|Overall Study|Other non-VCF-related medical condition|2|||
24980128|NCT00323609|50068540|FG002|Overall Study|Other non-VCF-related medical condition|0|||
24980129|NCT00323609|50068541|FG003|Overall Study|Other non-VCF-related medical condition|0|||
24980130|NCT00323609|50068538|FG000|Overall Study|Sponsor discontinued trial|29|||
24980131|NCT00323609|50068539|FG001|Overall Study|Sponsor discontinued trial|29|||
24980132|NCT00323609|50068540|FG002|Overall Study|Sponsor discontinued trial|0|||
24980133|NCT00323609|50068541|FG003|Overall Study|Sponsor discontinued trial|0|||
24980134|NCT00323609|50068538|FG000|Overall Study|Unrelenting or severe back pain|1|||
24980135|NCT00323609|50068539|FG001|Overall Study|Unrelenting or severe back pain|1|||
24980136|NCT00323609|50068540|FG002|Overall Study|Unrelenting or severe back pain|0|||
24980137|NCT00323609|50068541|FG003|Overall Study|Unrelenting or severe back pain|0|||
24980138|NCT00323609|50068538|FG000|Overall Study|Logistical withdrawal|9|||
24980139|NCT00323609|50068539|FG001|Overall Study|Logistical withdrawal|5|||
24980140|NCT00323609|50068540|FG002|Overall Study|Logistical withdrawal|0|||
24980141|NCT00323609|50068541|FG003|Overall Study|Logistical withdrawal|1|||
24980142|NCT00323609|50068538|FG000|Overall Study|Other reason|11|||
24980143|NCT00323609|50068539|FG001|Overall Study|Other reason|8|||
24980144|NCT00323609|50068540|FG002|Overall Study|Other reason|4|||
24980145|NCT00323609|50068541|FG003|Overall Study|Other reason|9|||
24980146|NCT04598152|50068547|FG000|Overall Study|Lost to Follow-up|0|||
24980147|NCT04598152|50068548|FG001|Overall Study|Lost to Follow-up|1|||
24980148|NCT00323297|50068556|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
24980149|NCT00323297|50068557|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
24980150|NCT00323297|50068556|FG000|Part A (Double Blind Randomized)|Death|0|||
24980151|NCT00323297|50068557|FG001|Part A (Double Blind Randomized)|Death|1|||
24980152|NCT00323297|50068556|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
24980153|NCT00323297|50068557|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
24980154|NCT00323297|50068556|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
24980155|NCT00323297|50068557|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
24980156|NCT00323297|50068556|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
24980157|NCT00323297|50068557|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
24980158|NCT00323297|50068556|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
24980159|NCT00323297|50068557|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
24980160|NCT00323297|50068556|FG000|Part B (Open-label)|Death|0|||
24980161|NCT00323297|50068557|FG001|Part B (Open-label)|Death|1|||
24980162|NCT00323297|50068556|FG000|Part B (Open-label)|Reason unspecified|0|||
24980163|NCT00323297|50068557|FG001|Part B (Open-label)|Reason unspecified|1|||
24980164|NCT00323297|50068556|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
24980165|NCT00323297|50068557|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
24980166|NCT00323297|50068556|FG000|Part B (Open-label)|Lack of Efficacy|3|||
24980167|NCT00323297|50068557|FG001|Part B (Open-label)|Lack of Efficacy|1|||
24980168|NCT00323297|50068556|FG000|Part B (Open-label)|Adverse Event|5|||
24980169|NCT00323297|50068557|FG001|Part B (Open-label)|Adverse Event|5|||
24980170|NCT00323297|50068556|FG000|Part B (Open-label)|Protocol Violation|0|||
24980171|NCT00323297|50068557|FG001|Part B (Open-label)|Protocol Violation|1|||
24980172|NCT00323063|50068565|FG000|Overall Study|Adverse Event|1|||
24980173|NCT00323063|50068566|FG001|Overall Study|Adverse Event|0|||
24980174|NCT00323063|50068565|FG000|Overall Study|brain mets discovered prior to treatment|1|||
24980175|NCT00323063|50068566|FG001|Overall Study|brain mets discovered prior to treatment|0|||
24980176|NCT00322049|50068576|FG000|Overall Study|Moved out of area|0|||
24980177|NCT00322049|50068577|FG001|Overall Study|Moved out of area|0|||
24980178|NCT00322049|50068578|FG002|Overall Study|Moved out of area|0|||
24980179|NCT00322049|50068579|FG003|Overall Study|Moved out of area|1|||
24980180|NCT00322049|50068576|FG000|Overall Study|Infected with Dengue during study|0|||
24980181|NCT00322049|50068577|FG001|Overall Study|Infected with Dengue during study|1|||
24980182|NCT00322049|50068578|FG002|Overall Study|Infected with Dengue during study|0|||
24980183|NCT00322049|50068579|FG003|Overall Study|Infected with Dengue during study|0|||
24980184|NCT00321893|50068600|FG000|Overall Study|Non-Compliance/Refusal|16|||
24980185|NCT00321893|50068601|FG001|Overall Study|Non-Compliance/Refusal|10|||
24980186|NCT00321893|50068600|FG000|Overall Study|Lost to Follow-up|2|||
24980187|NCT00321893|50068601|FG001|Overall Study|Lost to Follow-up|1|||
24980188|NCT00321893|50068600|FG000|Overall Study|Adverse Event|6|||
24980189|NCT00321893|50068601|FG001|Overall Study|Adverse Event|3|||
24980190|NCT00371345|50068609|FG000|Overall Study|Disease Progression|21|||
24980191|NCT00371345|50068610|FG001|Overall Study|Disease Progression|35|||
25078114|NCT03745651|50186223|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
24980192|NCT00371345|50068609|FG000|Overall Study|Study Drug Toxicity|1|||
25255305|NCT01172938|50570969|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
24980193|NCT00371345|50068610|FG001|Overall Study|Study Drug Toxicity|7|||
24980194|NCT00371345|50068609|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
24980195|NCT00371345|50068610|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
24980196|NCT00371345|50068609|FG000|Overall Study|Participant Request|1|||
24980197|NCT00371345|50068610|FG001|Overall Study|Participant Request|1|||
24980198|NCT00371345|50068609|FG000|Overall Study|Participant Withdrew Consent|0|||
25255306|NCT01172938|50570970|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
25255307|NCT01172938|50570971|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
25255308|NCT01172938|50570972|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
25255309|NCT01172938|50570973|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
25255310|NCT01172938|50570974|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
25255311|NCT01172938|50570966|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
25341877|NCT00756938|50658202|FG000|Optional Extension|Lack of Efficacy|0|||
24980199|NCT00371345|50068610|FG001|Overall Study|Participant Withdrew Consent|1|||
24980200|NCT00321737|50068633|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
24980201|NCT00321737|50068634|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
24980202|NCT00321737|50068635|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
24980203|NCT00321737|50068633|FG000|Overall Study|Adverse Event|11|||
24980204|NCT00321737|50068634|FG001|Overall Study|Adverse Event|3|||
24980205|NCT00321737|50068635|FG002|Overall Study|Adverse Event|6|||
24980206|NCT00321737|50068633|FG000|Overall Study|Lost to Follow-up|5|||
24980207|NCT00321737|50068634|FG001|Overall Study|Lost to Follow-up|5|||
24980208|NCT00321737|50068635|FG002|Overall Study|Lost to Follow-up|6|||
24980209|NCT00321737|50068633|FG000|Overall Study|Withdrawal by Subject|19|||
24980210|NCT00321737|50068634|FG001|Overall Study|Withdrawal by Subject|12|||
24980211|NCT00321737|50068635|FG002|Overall Study|Withdrawal by Subject|17|||
24980212|NCT00321737|50068633|FG000|Overall Study|Protocol Violation|0|||
24980213|NCT00321737|50068634|FG001|Overall Study|Protocol Violation|0|||
24980214|NCT00321737|50068635|FG002|Overall Study|Protocol Violation|1|||
24980215|NCT00321737|50068633|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
24980216|NCT00321737|50068634|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
24980217|NCT00321737|50068635|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
24980218|NCT00321737|50068633|FG000|Overall Study|Possible Barrett's Esophagus|2|||
24980219|NCT00321737|50068634|FG001|Overall Study|Possible Barrett's Esophagus|1|||
24980220|NCT00321737|50068635|FG002|Overall Study|Possible Barrett's Esophagus|1|||
24980221|NCT00321737|50068633|FG000|Overall Study|Therapeutic Failure|6|||
24980222|NCT00321737|50068634|FG001|Overall Study|Therapeutic Failure|0|||
24980223|NCT00321737|50068635|FG002|Overall Study|Therapeutic Failure|2|||
24980224|NCT00321737|50068633|FG000|Overall Study|Pregnancy|0|||
24980225|NCT00321737|50068634|FG001|Overall Study|Pregnancy|2|||
24980226|NCT00321737|50068635|FG002|Overall Study|Pregnancy|0|||
24980227|NCT00321737|50068633|FG000|Overall Study|Noncompliance|2|||
24980228|NCT00321737|50068634|FG001|Overall Study|Noncompliance|0|||
24980229|NCT00321737|50068635|FG002|Overall Study|Noncompliance|0|||
24980230|NCT00321737|50068633|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
24980231|NCT00321737|50068634|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
24980232|NCT00321737|50068635|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
25341878|NCT00756938|50658203|FG001|Optional Extension|Lack of Efficacy|0|||
25341879|NCT00756938|50658204|FG002|Optional Extension|Lack of Efficacy|0|||
25341880|NCT00756938|50658205|FG003|Optional Extension|Lack of Efficacy|1|||
25341881|NCT00756938|50658202|FG000|Optional Extension|End of Study|0|||
25341882|NCT00756938|50658203|FG001|Optional Extension|End of Study|0|||
24980233|NCT00320801|50068645|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
24980234|NCT00320801|50068646|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
24980235|NCT00320801|50068647|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
24980236|NCT00320801|50068648|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
24980237|NCT00320801|50068645|FG000|Open-label Run-in Period|Adverse Event|33|||
24980238|NCT00320801|50068646|FG001|Open-label Run-in Period|Adverse Event|0|||
24980239|NCT00320801|50068647|FG002|Open-label Run-in Period|Adverse Event|0|||
24980240|NCT00320801|50068648|FG003|Open-label Run-in Period|Adverse Event|0|||
25255312|NCT01172938|50570967|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
24980241|NCT00320801|50068645|FG000|Open-label Run-in Period|Administrative|10|||
24980242|NCT00320801|50068646|FG001|Open-label Run-in Period|Administrative|0|||
25255313|NCT01172938|50570968|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
25255314|NCT01172938|50570969|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
25255315|NCT01172938|50570970|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
25341883|NCT00756938|50658204|FG002|Optional Extension|End of Study|0|||
25341884|NCT00756938|50658205|FG003|Optional Extension|End of Study|11|||
24980243|NCT00320801|50068647|FG002|Open-label Run-in Period|Administrative|0|||
24980244|NCT00320801|50068648|FG003|Open-label Run-in Period|Administrative|0|||
25255316|NCT01172938|50570971|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
24980245|NCT00320801|50068645|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
25255317|NCT01172938|50570972|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
25341885|NCT00756938|50658202|FG000|Optional Extension|Protocol-specific criteria met|0|||
24980246|NCT00320801|50068646|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
24980247|NCT00320801|50068647|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
24980248|NCT00320801|50068648|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
24980249|NCT00320801|50068645|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
24980250|NCT00320801|50068646|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
24980251|NCT00320801|50068647|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
24980252|NCT00320801|50068648|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
24980253|NCT00320801|50068645|FG000|Open-label Run-in Period|Did not qualify|1|||
24980254|NCT00320801|50068646|FG001|Open-label Run-in Period|Did not qualify|0|||
24980255|NCT00320801|50068647|FG002|Open-label Run-in Period|Did not qualify|0|||
24980256|NCT00320801|50068648|FG003|Open-label Run-in Period|Did not qualify|0|||
24980257|NCT00320801|50068645|FG000|Double-blind Phase|Withdrawal by Subject|0|||
24980258|NCT00320801|50068646|FG001|Double-blind Phase|Withdrawal by Subject|0|||
24980259|NCT00320801|50068647|FG002|Double-blind Phase|Withdrawal by Subject|1|||
24980260|NCT00320801|50068648|FG003|Double-blind Phase|Withdrawal by Subject|0|||
24980261|NCT00320801|50068645|FG000|Double-blind Phase|Adverse Event|0|||
24980262|NCT00320801|50068646|FG001|Double-blind Phase|Adverse Event|2|||
24980263|NCT00320801|50068647|FG002|Double-blind Phase|Adverse Event|8|||
24980264|NCT00320801|50068648|FG003|Double-blind Phase|Adverse Event|0|||
24980265|NCT00320801|50068645|FG000|Double-blind Phase|Administrative|0|||
24980266|NCT00320801|50068646|FG001|Double-blind Phase|Administrative|0|||
24980267|NCT00320801|50068647|FG002|Double-blind Phase|Administrative|4|||
24980268|NCT00320801|50068648|FG003|Double-blind Phase|Administrative|0|||
24980269|NCT00320801|50068645|FG000|Double-blind Phase|Lack of Efficacy|0|||
24980270|NCT00320801|50068646|FG001|Double-blind Phase|Lack of Efficacy|9|||
24980271|NCT00320801|50068647|FG002|Double-blind Phase|Lack of Efficacy|1|||
24980272|NCT00320801|50068648|FG003|Double-blind Phase|Lack of Efficacy|0|||
24980273|NCT00320801|50068645|FG000|Extension Phase|Withdrawal by Subject|0|||
24980274|NCT00320801|50068646|FG001|Extension Phase|Withdrawal by Subject|0|||
24980275|NCT00320801|50068647|FG002|Extension Phase|Withdrawal by Subject|0|||
24980276|NCT00320801|50068648|FG003|Extension Phase|Withdrawal by Subject|6|||
24980277|NCT00320801|50068645|FG000|Extension Phase|Adverse Event|0|||
24980278|NCT00320801|50068646|FG001|Extension Phase|Adverse Event|0|||
24980279|NCT00320801|50068647|FG002|Extension Phase|Adverse Event|0|||
24980280|NCT00320801|50068648|FG003|Extension Phase|Adverse Event|8|||
24980281|NCT00320801|50068645|FG000|Extension Phase|Administrative|0|||
24980282|NCT00320801|50068646|FG001|Extension Phase|Administrative|0|||
24980283|NCT00320801|50068647|FG002|Extension Phase|Administrative|0|||
24980284|NCT00320801|50068648|FG003|Extension Phase|Administrative|29|||
24980285|NCT00320801|50068645|FG000|Extension Phase|Lack of Efficacy|0|||
24980286|NCT00320801|50068646|FG001|Extension Phase|Lack of Efficacy|0|||
24980287|NCT00320801|50068647|FG002|Extension Phase|Lack of Efficacy|0|||
24980288|NCT00320801|50068648|FG003|Extension Phase|Lack of Efficacy|2|||
24980289|NCT00320801|50068645|FG000|Extension Phase|Lost to Follow-up|0|||
24980290|NCT00320801|50068646|FG001|Extension Phase|Lost to Follow-up|0|||
24980291|NCT00320801|50068647|FG002|Extension Phase|Lost to Follow-up|0|||
24980292|NCT00320801|50068648|FG003|Extension Phase|Lost to Follow-up|3|||
24980293|NCT00320489|50068660|FG000|Overall Study|Adverse Event|26|||
24980294|NCT00320489|50068661|FG001|Overall Study|Adverse Event|25|||
24980295|NCT00320489|50068660|FG000|Overall Study|Clinical Relapse|26|||
24980296|NCT00320489|50068661|FG001|Overall Study|Clinical Relapse|20|||
24980297|NCT00320489|50068660|FG000|Overall Study|Death|0|||
24980298|NCT00320489|50068661|FG001|Overall Study|Death|2|||
24980299|NCT00320489|50068660|FG000|Overall Study|Entry Criteria Exclusion|2|||
24980300|NCT00320489|50068661|FG001|Overall Study|Entry Criteria Exclusion|4|||
24980301|NCT00320489|50068660|FG000|Overall Study|Lack of Efficacy|16|||
24980302|NCT00320489|50068661|FG001|Overall Study|Lack of Efficacy|7|||
24980303|NCT00320489|50068660|FG000|Overall Study|Lost to Follow-up|21|||
24980304|NCT00320489|50068661|FG001|Overall Study|Lost to Follow-up|22|||
24980305|NCT00320489|50068660|FG000|Overall Study|Physician Decision|8|||
24980306|NCT00320489|50068661|FG001|Overall Study|Physician Decision|8|||
24980307|NCT00320489|50068660|FG000|Overall Study|Protocol Violation|4|||
24980308|NCT00320489|50068661|FG001|Overall Study|Protocol Violation|4|||
24980309|NCT00320489|50068660|FG000|Overall Study|Sponsor Decision|3|||
24980310|NCT00320489|50068661|FG001|Overall Study|Sponsor Decision|3|||
24980311|NCT00320489|50068660|FG000|Overall Study|Withdrawal by Subject|39|||
24980312|NCT00320489|50068661|FG001|Overall Study|Withdrawal by Subject|41|||
24980313|NCT03928028|50068670|FG000|Overall Study|Physician Decision|9|||
24980314|NCT03928028|50068671|FG001|Overall Study|Physician Decision|6|||
24980315|NCT03928028|50068672|FG002|Overall Study|Physician Decision|3|||
24980316|NCT03928028|50068670|FG000|Overall Study|Withdrawal by Subject|12|||
25341886|NCT00756938|50658203|FG001|Optional Extension|Protocol-specific criteria met|0|||
24980317|NCT03928028|50068671|FG001|Overall Study|Withdrawal by Subject|3|||
24980318|NCT03928028|50068672|FG002|Overall Study|Withdrawal by Subject|3|||
24980319|NCT00320411|50068680|FG000|Overall Study|No investigational product admin.|4|||
24980320|NCT00320255|50068690|FG000|Overall Study|Lack of Efficacy|1|||
24980321|NCT00320255|50068691|FG001|Overall Study|Lack of Efficacy|0|||
24980322|NCT00320255|50068692|FG002|Overall Study|Lack of Efficacy|0|||
24980323|NCT00320255|50068693|FG003|Overall Study|Lack of Efficacy|0|||
24980324|NCT00320255|50068694|FG004|Overall Study|Lack of Efficacy|0|||
24980325|NCT00320255|50068695|FG005|Overall Study|Lack of Efficacy|0|||
24980326|NCT00320255|50068690|FG000|Overall Study|Adverse Event|5|||
24980327|NCT00320255|50068691|FG001|Overall Study|Adverse Event|2|||
24980328|NCT00320255|50068692|FG002|Overall Study|Adverse Event|3|||
24980329|NCT00320255|50068693|FG003|Overall Study|Adverse Event|2|||
24980330|NCT00320255|50068694|FG004|Overall Study|Adverse Event|0|||
24980331|NCT00320255|50068695|FG005|Overall Study|Adverse Event|0|||
24980332|NCT00320255|50068690|FG000|Overall Study|Withdrawal by Subject|1|||
24980333|NCT00320255|50068691|FG001|Overall Study|Withdrawal by Subject|2|||
24980334|NCT00320255|50068692|FG002|Overall Study|Withdrawal by Subject|2|||
24980335|NCT00320255|50068693|FG003|Overall Study|Withdrawal by Subject|4|||
24980336|NCT00320255|50068694|FG004|Overall Study|Withdrawal by Subject|0|||
24980337|NCT00320255|50068695|FG005|Overall Study|Withdrawal by Subject|0|||
24980338|NCT00320255|50068690|FG000|Overall Study|Poor compliance/noncompliance|1|||
24980339|NCT00320255|50068691|FG001|Overall Study|Poor compliance/noncompliance|1|||
24980340|NCT00320255|50068692|FG002|Overall Study|Poor compliance/noncompliance|0|||
24980341|NCT00320255|50068693|FG003|Overall Study|Poor compliance/noncompliance|1|||
24980342|NCT00320255|50068694|FG004|Overall Study|Poor compliance/noncompliance|0|||
24980343|NCT00320255|50068695|FG005|Overall Study|Poor compliance/noncompliance|0|||
24980344|NCT00320255|50068690|FG000|Overall Study|No longer meets study criteria|0|||
24980345|NCT00320255|50068691|FG001|Overall Study|No longer meets study criteria|0|||
24980346|NCT00320255|50068692|FG002|Overall Study|No longer meets study criteria|0|||
24980347|NCT00320255|50068693|FG003|Overall Study|No longer meets study criteria|1|||
24980348|NCT00320255|50068694|FG004|Overall Study|No longer meets study criteria|0|||
24980349|NCT00320255|50068695|FG005|Overall Study|No longer meets study criteria|0|||
24980350|NCT00320255|50068690|FG000|Overall Study|Other|3|||
24980351|NCT00320255|50068691|FG001|Overall Study|Other|2|||
24980352|NCT00320255|50068692|FG002|Overall Study|Other|1|||
24980353|NCT00320255|50068693|FG003|Overall Study|Other|0|||
24980354|NCT00320255|50068694|FG004|Overall Study|Other|0|||
24980355|NCT00320255|50068695|FG005|Overall Study|Other|0|||
24980356|NCT00370331|50068712|FG000|Overall Study|Adverse Event|4|||
24980357|NCT00370331|50068713|FG001|Overall Study|Adverse Event|13|||
24980358|NCT00370331|50068712|FG000|Overall Study|Withdrawal by Subject|2|||
24980359|NCT00370331|50068713|FG001|Overall Study|Withdrawal by Subject|4|||
24980360|NCT00370331|50068712|FG000|Overall Study|Lost to Follow-up|0|||
24980361|NCT00370331|50068713|FG001|Overall Study|Lost to Follow-up|3|||
24980362|NCT00370331|50068712|FG000|Overall Study|Lack of Efficacy|0|||
24980363|NCT00370331|50068713|FG001|Overall Study|Lack of Efficacy|1|||
24980364|NCT00370331|50068712|FG000|Overall Study|Non-compliance|0|||
24980365|NCT00370331|50068713|FG001|Overall Study|Non-compliance|1|||
24980366|NCT00370331|50068712|FG000|Overall Study|Protocol Violation|1|||
24980367|NCT00370331|50068713|FG001|Overall Study|Protocol Violation|1|||
25341887|NCT00756938|50658204|FG002|Optional Extension|Protocol-specific criteria met|0|||
25341888|NCT00756938|50658205|FG003|Optional Extension|Protocol-specific criteria met|9|||
25341889|NCT00756938|50658202|FG000|Optional Extension|Physician Decision|0|||
25341890|NCT00756938|50658203|FG001|Optional Extension|Physician Decision|0|||
25341891|NCT00756938|50658204|FG002|Optional Extension|Physician Decision|0|||
25341892|NCT00756938|50658205|FG003|Optional Extension|Physician Decision|3|||
25341893|NCT00756938|50658202|FG000|Optional Extension|Lost to Follow-up|0|||
25341894|NCT00756938|50658203|FG001|Optional Extension|Lost to Follow-up|0|||
25341895|NCT00756938|50658204|FG002|Optional Extension|Lost to Follow-up|0|||
25341896|NCT00756938|50658205|FG003|Optional Extension|Lost to Follow-up|1|||
25341897|NCT00756938|50658202|FG000|Optional Extension|Protocol Violation|0|||
25341898|NCT00756938|50658203|FG001|Optional Extension|Protocol Violation|0|||
25341899|NCT00756938|50658204|FG002|Optional Extension|Protocol Violation|0|||
25341900|NCT00756938|50658205|FG003|Optional Extension|Protocol Violation|1|||
25078115|NCT03745651|50186224|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
25078116|NCT03745651|50186225|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
25078117|NCT03745651|50186226|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
25078118|NCT03745651|50186227|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
25078119|NCT03745651|50186228|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
25341901|NCT00756938|50658202|FG000|Optional Extension|Withdrawal by Subject|0|||
25341902|NCT00756938|50658203|FG001|Optional Extension|Withdrawal by Subject|0|||
25341903|NCT00756938|50658204|FG002|Optional Extension|Withdrawal by Subject|0|||
25341904|NCT00756938|50658205|FG003|Optional Extension|Withdrawal by Subject|10|||
25341905|NCT00756938|50658202|FG000|Optional Extension|Adverse Event|0|||
25341906|NCT00756938|50658203|FG001|Optional Extension|Adverse Event|0|||
24980388|NCT02962960|50068744|FG000|Overall Study|Withdrawal by Subject|1|||
24980389|NCT02962960|50068745|FG001|Overall Study|Withdrawal by Subject|1|||
24980390|NCT02962960|50068746|FG002|Overall Study|Withdrawal by Subject|0|||
24980391|NCT02962960|50068744|FG000|Overall Study|Adverse Event|1|||
24980392|NCT02962960|50068745|FG001|Overall Study|Adverse Event|1|||
24980393|NCT02962960|50068746|FG002|Overall Study|Adverse Event|0|||
24980394|NCT02962960|50068744|FG000|Overall Study|Protocol Violation|1|||
24980395|NCT02962960|50068745|FG001|Overall Study|Protocol Violation|0|||
24980396|NCT02962960|50068746|FG002|Overall Study|Protocol Violation|0|||
24980397|NCT00369941|50068758|FG000|Overall Study|Never Treated|1|||
24980398|NCT00369941|50068759|FG001|Overall Study|Never Treated|2|||
24980399|NCT00369941|50068758|FG000|Overall Study|Adverse Event|14|||
24980400|NCT00369941|50068759|FG001|Overall Study|Adverse Event|28|||
24980401|NCT00369941|50068758|FG000|Overall Study|Lack of Efficacy|6|||
24980402|NCT00369941|50068759|FG001|Overall Study|Lack of Efficacy|10|||
24980403|NCT00369941|50068758|FG000|Overall Study|Lost to Follow-up|12|||
24980404|NCT00369941|50068759|FG001|Overall Study|Lost to Follow-up|22|||
24980405|NCT00369941|50068758|FG000|Overall Study|Protocol Violation|5|||
24980406|NCT00369941|50068759|FG001|Overall Study|Protocol Violation|3|||
24980407|NCT00369941|50068758|FG000|Overall Study|Withdrawal by Subject|5|||
24980408|NCT00369941|50068759|FG001|Overall Study|Withdrawal by Subject|18|||
24980409|NCT00369941|50068758|FG000|Overall Study|Pregnancy|4|||
24980410|NCT00369941|50068759|FG001|Overall Study|Pregnancy|2|||
24980411|NCT00369941|50068758|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
24980412|NCT00369941|50068759|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
24980413|NCT00369941|50068758|FG000|Overall Study|Moved|11|||
25255318|NCT01172938|50570973|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
25255319|NCT01172938|50570974|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
25255320|NCT01172938|50570966|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
25255321|NCT01172938|50570967|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
25255322|NCT01172938|50570968|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
25255323|NCT01172938|50570969|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
25255324|NCT01172938|50570970|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
25255325|NCT01172938|50570971|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
25255326|NCT01172938|50570972|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
25255327|NCT01172938|50570973|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
25255328|NCT01172938|50570974|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
25255329|NCT01172938|50570966|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
25255330|NCT01172938|50570967|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
25255331|NCT01172938|50570968|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
25255332|NCT01172938|50570969|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
25255333|NCT01172938|50570970|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
25255334|NCT01172938|50570971|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
25255335|NCT01172938|50570972|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
25255336|NCT01172938|50570973|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
25255337|NCT01172938|50570974|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
25255338|NCT01172938|50570966|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
25255339|NCT01172938|50570967|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
25255340|NCT01172938|50570968|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
25255341|NCT01172938|50570969|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
25255342|NCT01172938|50570970|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
25255343|NCT01172938|50570971|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
25255344|NCT01172938|50570972|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
25255345|NCT01172938|50570973|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
25255346|NCT01172938|50570974|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
25255347|NCT01172938|50570966|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
24980414|NCT00369941|50068759|FG001|Overall Study|Moved|5|||
24980415|NCT00369941|50068758|FG000|Overall Study|Treatment with Prohibited Medication|3|||
24980416|NCT00369941|50068759|FG001|Overall Study|Treatment with Prohibited Medication|1|||
24980417|NCT00369941|50068758|FG000|Overall Study|Employment Interfered with Study Visits|1|||
24980418|NCT00369941|50068759|FG001|Overall Study|Employment Interfered with Study Visits|0|||
24980419|NCT00369941|50068758|FG000|Overall Study|Study Site Terminated|2|||
24980420|NCT00369941|50068759|FG001|Overall Study|Study Site Terminated|0|||
24980421|NCT00369941|50068758|FG000|Overall Study|Miscellaneous|3|||
24980422|NCT00369941|50068759|FG001|Overall Study|Miscellaneous|3|||
24980423|NCT00319553|50068768|FG000|Overall Study|Protocol Violation|1|||
24980424|NCT00319553|50068769|FG001|Overall Study|Protocol Violation|2|||
24980425|NCT00319553|50068768|FG000|Overall Study|Lost to Follow-up|2|||
24980426|NCT00319553|50068769|FG001|Overall Study|Lost to Follow-up|1|||
24980427|NCT00319553|50068768|FG000|Overall Study|Withdrawal by Subject|1|||
24980428|NCT00319553|50068769|FG001|Overall Study|Withdrawal by Subject|1|||
24980429|NCT00369785|50068777|FG000|Overall Study|Physician Decision|3|||
24980430|NCT00369785|50068778|FG001|Overall Study|Physician Decision|2|||
24980431|NCT00369785|50068777|FG000|Overall Study|Death|1|||
24980432|NCT00369785|50068778|FG001|Overall Study|Death|2|||
24980433|NCT00369785|50068777|FG000|Overall Study|Withdrawal by Subject|7|||
25341907|NCT00756938|50658204|FG002|Optional Extension|Adverse Event|0|||
25341908|NCT00756938|50658205|FG003|Optional Extension|Adverse Event|1|||
25341909|NCT00796367|50658226|FG000|Overall Study|Adverse Event|6|||
25341910|NCT00796367|50658227|FG001|Overall Study|Adverse Event|4|||
25341911|NCT00796367|50658228|FG002|Overall Study|Adverse Event|7|||
25341912|NCT00796367|50658226|FG000|Overall Study|Lost to Follow-up|5|||
25341913|NCT00796367|50658227|FG001|Overall Study|Lost to Follow-up|4|||
25341914|NCT00796367|50658228|FG002|Overall Study|Lost to Follow-up|21|||
25341915|NCT00796367|50658226|FG000|Overall Study|Withdrawal by Subject|9|||
24980434|NCT00369785|50068778|FG001|Overall Study|Withdrawal by Subject|6|||
24980435|NCT00369785|50068777|FG000|Overall Study|Toxicity|6|||
24980436|NCT00369785|50068778|FG001|Overall Study|Toxicity|4|||
24980437|NCT00369785|50068777|FG000|Overall Study|Never started|0|||
24980438|NCT00369785|50068778|FG001|Overall Study|Never started|2|||
24980439|NCT00369785|50068777|FG000|Overall Study|Progression|4|||
24980440|NCT00369785|50068778|FG001|Overall Study|Progression|4|||
24980441|NCT00369785|50068777|FG000|Overall Study|Multiple reasons|6|||
24980442|NCT00369785|50068778|FG001|Overall Study|Multiple reasons|5|||
24980443|NCT00369707|50068784|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
24980444|NCT00369707|50068784|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
24980445|NCT00369707|50068784|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
24980446|NCT00369707|50068784|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
24980447|NCT00369707|50068784|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
24980448|NCT00369707|50068784|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
24980449|NCT00369707|50068784|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
24980450|NCT00369707|50068784|FG000|Follow up for 2 Years After Treatment|Death|1|||
24980451|NCT00369707|50068784|FG000|Follow up for 2 Years After Treatment|Other|2|||
24980452|NCT02943460|50068791|FG000|Blinded Study Phase|Adverse Event|3|||
24980453|NCT02943460|50068792|FG001|Blinded Study Phase|Adverse Event|0|||
24980454|NCT02943460|50068793|FG002|Blinded Study Phase|Adverse Event|0|||
24980455|NCT02943460|50068791|FG000|Blinded Study Phase|Withdrew Consent|0|||
24980456|NCT02943460|50068792|FG001|Blinded Study Phase|Withdrew Consent|1|||
24980457|NCT02943460|50068793|FG002|Blinded Study Phase|Withdrew Consent|0|||
24980458|NCT02943460|50068791|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
24980459|NCT02943460|50068792|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
24980460|NCT02943460|50068793|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
24980461|NCT02943460|50068791|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
24980462|NCT02943460|50068792|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
24980463|NCT02943460|50068793|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
24980464|NCT02943460|50068791|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
24980465|NCT02943460|50068792|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
24980466|NCT02943460|50068793|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
24980467|NCT03768206|50068804|FG000|Overall Study|Lost to Follow-up|2|||
24980468|NCT03768206|50068805|FG001|Overall Study|Lost to Follow-up|1|||
24980469|NCT03768206|50068804|FG000|Overall Study|Withdrawal by Subject|0|||
24980470|NCT03768206|50068805|FG001|Overall Study|Withdrawal by Subject|1|||
24980471|NCT03767894|50068812|FG000|Overall Study|Withdrawal by Subject|1|||
24980472|NCT03766646|50068818|FG000|Overall Study|Withdrawal by Subject|1|||
24980473|NCT03766646|50068819|FG001|Overall Study|Withdrawal by Subject|0|||
24980474|NCT03766646|50068818|FG000|Overall Study|Protocol Violation|0|||
24980475|NCT03766646|50068819|FG001|Overall Study|Protocol Violation|3|||
24980476|NCT03765164|50068827|FG000|Pre-intervention|Withdrawal by Subject|5|||
24980477|NCT03765164|50068828|FG001|Pre-intervention|Withdrawal by Subject|6|||
24980478|NCT00369629|50068834|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
24980479|NCT00369629|50068835|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
24980480|NCT00369629|50068836|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
24980481|NCT00369629|50068837|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
24980482|NCT00369629|50068834|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
24980483|NCT00369629|50068835|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
24980484|NCT00369629|50068836|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
24980485|NCT00369629|50068837|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
24980486|NCT00369629|50068834|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
24980487|NCT00369629|50068835|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
24980488|NCT00369629|50068836|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
24980489|NCT00369629|50068837|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
24980490|NCT00369629|50068834|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
24980491|NCT00369629|50068835|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
24980492|NCT00369629|50068836|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
24980493|NCT00369629|50068837|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
24980494|NCT00369629|50068834|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
24980495|NCT00369629|50068835|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
25341916|NCT00796367|50658227|FG001|Overall Study|Withdrawal by Subject|11|||
24980496|NCT00369629|50068836|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
24980497|NCT00369629|50068837|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
24980498|NCT00369629|50068834|FG000|Completed 4 More Cycles|Progressive disease|2|||
24980499|NCT00369629|50068835|FG001|Completed 4 More Cycles|Progressive disease|1|||
24980500|NCT00369629|50068836|FG002|Completed 4 More Cycles|Progressive disease|2|||
24980501|NCT00369629|50068837|FG003|Completed 4 More Cycles|Progressive disease|0|||
24980502|NCT00369629|50068834|FG000|Follow up for 1 Year|Death|2|||
25255348|NCT01172938|50570967|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
25255349|NCT01172938|50570968|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
25255350|NCT01172938|50570969|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
25255351|NCT01172938|50570970|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
25255352|NCT01172938|50570971|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
25255353|NCT01172938|50570972|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
25255354|NCT01172938|50570973|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
25255355|NCT01172938|50570974|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
25255356|NCT01172938|50570966|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
25255357|NCT01172938|50570967|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
25255358|NCT01172938|50570968|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
25255359|NCT01172938|50570969|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
25255360|NCT01172938|50570970|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
25255361|NCT01172938|50570971|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
25255362|NCT01172938|50570972|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
25255363|NCT01172938|50570973|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
25255364|NCT01172938|50570974|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
25255365|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
25255366|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
25255367|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
25255368|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
25255369|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
25255370|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
25255371|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
25255372|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
25255373|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
25255374|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
25255375|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
25255376|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
25255377|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
25255378|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
25255379|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
25255380|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
25255381|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
25255382|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
25255383|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
25255384|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
25255385|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
25255386|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
25255387|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
25255388|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
25255389|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
25255390|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
25255391|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
25255392|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
25255393|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
25255394|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
25255395|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
25255396|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
25255397|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
25255398|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
25255399|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
25255400|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
25255401|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
24980503|NCT00369629|50068835|FG001|Follow up for 1 Year|Death|1|||
25255402|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
25255403|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
25255404|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
24980504|NCT00369629|50068836|FG002|Follow up for 1 Year|Death|1|||
24980505|NCT00369629|50068837|FG003|Follow up for 1 Year|Death|0|||
24980506|NCT00369629|50068834|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
24980507|NCT00369629|50068835|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
24980508|NCT00369629|50068836|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
24980509|NCT00369629|50068837|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
24980510|NCT00369629|50068834|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
24980511|NCT00369629|50068835|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
24980512|NCT00369629|50068836|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
24980513|NCT00369629|50068837|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
24980514|NCT02469064|50068849|FG000|Overall Study|Request not to receive intervention.|1|||
24980515|NCT02469064|50068850|FG001|Overall Study|Request not to receive intervention.|3|||
24980516|NCT02446912|50068859|FG000|Overall Study|Adverse Event|3|||
24980517|NCT02446912|50068860|FG001|Overall Study|Adverse Event|13|||
24980518|NCT02446912|50068861|FG002|Overall Study|Adverse Event|5|||
24980519|NCT02446912|50068859|FG000|Overall Study|Condition under investigation worsened|0|||
24980520|NCT02446912|50068860|FG001|Overall Study|Condition under investigation worsened|1|||
24980521|NCT02446912|50068861|FG002|Overall Study|Condition under investigation worsened|1|||
24980522|NCT02446912|50068859|FG000|Overall Study|Study-specific withdrawal criteria|1|||
24980523|NCT02446912|50068860|FG001|Overall Study|Study-specific withdrawal criteria|0|||
24980524|NCT02446912|50068861|FG002|Overall Study|Study-specific withdrawal criteria|0|||
24980525|NCT02446912|50068859|FG000|Overall Study|Lack of Efficacy|1|||
24980526|NCT02446912|50068860|FG001|Overall Study|Lack of Efficacy|4|||
24980527|NCT02446912|50068861|FG002|Overall Study|Lack of Efficacy|7|||
24980528|NCT02446912|50068859|FG000|Overall Study|Lost to Follow-up|0|||
24980529|NCT02446912|50068860|FG001|Overall Study|Lost to Follow-up|0|||
24980530|NCT02446912|50068861|FG002|Overall Study|Lost to Follow-up|2|||
24980531|NCT02446912|50068859|FG000|Overall Study|Severe non-compliance to protocol|1|||
24980532|NCT02446912|50068860|FG001|Overall Study|Severe non-compliance to protocol|0|||
24980533|NCT02446912|50068861|FG002|Overall Study|Severe non-compliance to protocol|1|||
24980534|NCT02446912|50068859|FG000|Overall Study|Withdrawal by Subject|10|||
24980535|NCT02446912|50068860|FG001|Overall Study|Withdrawal by Subject|15|||
24980536|NCT02446912|50068861|FG002|Overall Study|Withdrawal by Subject|15|||
24980537|NCT02446912|50068859|FG000|Overall Study|Miscellaneous|2|||
25341917|NCT00796367|50658228|FG002|Overall Study|Withdrawal by Subject|12|||
25341918|NCT00796367|50658226|FG000|Overall Study|Lack of Efficacy|2|||
25341919|NCT00796367|50658227|FG001|Overall Study|Lack of Efficacy|1|||
25341920|NCT00796367|50658228|FG002|Overall Study|Lack of Efficacy|0|||
25341921|NCT00796367|50658226|FG000|Overall Study|non compliance|3|||
25341922|NCT00796367|50658227|FG001|Overall Study|non compliance|1|||
25341923|NCT00796367|50658228|FG002|Overall Study|non compliance|1|||
25341924|NCT00796367|50658226|FG000|Overall Study|Pregnancy|1|||
25341925|NCT00796367|50658227|FG001|Overall Study|Pregnancy|0|||
25341926|NCT00796367|50658228|FG002|Overall Study|Pregnancy|1|||
25341927|NCT00796367|50658226|FG000|Overall Study|Requirement for restricted medication|2|||
25341928|NCT00796367|50658227|FG001|Overall Study|Requirement for restricted medication|0|||
25341929|NCT00796367|50658228|FG002|Overall Study|Requirement for restricted medication|2|||
25341930|NCT00796367|50658226|FG000|Overall Study|other|2|||
25341931|NCT00796367|50658227|FG001|Overall Study|other|4|||
25341932|NCT00796367|50658228|FG002|Overall Study|other|3|||
25341933|NCT00770588|50658238|FG000|Overall Study|Adverse Event|9|||
25341934|NCT00770588|50658239|FG001|Overall Study|Adverse Event|2|||
25341935|NCT00770588|50658238|FG000|Overall Study|Death caused by progression of disease|70|||
25341936|NCT00770588|50658239|FG001|Overall Study|Death caused by progression of disease|91|||
25341937|NCT00770588|50658238|FG000|Overall Study|Lost to Follow-up|1|||
24980538|NCT02446912|50068860|FG001|Overall Study|Miscellaneous|2|||
24980539|NCT02446912|50068861|FG002|Overall Study|Miscellaneous|4|||
24980540|NCT00736840|50068869|FG000|Overall Study|Lost to Follow-up|13|||
24980541|NCT00318461|50068878|FG000|Double-Blind, 6 Months|Adverse Event|11|||
24980542|NCT00318461|50068879|FG001|Double-Blind, 6 Months|Adverse Event|23|||
24980543|NCT00318461|50068880|FG002|Double-Blind, 6 Months|Adverse Event|29|||
24980544|NCT00318461|50068881|FG003|Double-Blind, 6 Months|Adverse Event|2|||
24980545|NCT00318461|50068882|FG004|Double-Blind, 6 Months|Adverse Event|8|||
24980546|NCT00318461|50068878|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
25341938|NCT00770588|50658239|FG001|Overall Study|Lost to Follow-up|1|||
25341939|NCT00770588|50658238|FG000|Overall Study|Withdrawal by Subject|1|||
25341940|NCT00770588|50658239|FG001|Overall Study|Withdrawal by Subject|1|||
25341941|NCT00777608|50658248|FG000|Overall Study|Lost to Follow-up|1|||
24980547|NCT00318461|50068879|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
24980548|NCT00318461|50068880|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
24980549|NCT00318461|50068881|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
24980550|NCT00318461|50068882|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
24980551|NCT00318461|50068878|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
24980552|NCT00318461|50068879|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
24980553|NCT00318461|50068880|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
24980554|NCT00318461|50068881|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
24980555|NCT00318461|50068882|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
24980556|NCT00318461|50068878|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
24980557|NCT00318461|50068879|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
24980558|NCT00318461|50068880|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
24980559|NCT00318461|50068881|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
24980560|NCT00318461|50068882|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
24980561|NCT00318461|50068878|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
24980562|NCT00318461|50068879|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
24980563|NCT00318461|50068880|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
24980564|NCT00318461|50068881|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
24980565|NCT00318461|50068882|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
24980566|NCT00318461|50068878|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
24980567|NCT00318461|50068879|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
24980568|NCT00318461|50068880|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
24980569|NCT00318461|50068881|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
24980570|NCT00318461|50068882|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
24980571|NCT00318461|50068878|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
24980572|NCT00318461|50068879|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
24980573|NCT00318461|50068880|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
24980574|NCT00318461|50068881|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
24980575|NCT00318461|50068882|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
24980576|NCT00318461|50068878|FG000|Double-Blind, 6 Months|Move|0|||
24980577|NCT00318461|50068879|FG001|Double-Blind, 6 Months|Move|1|||
24980578|NCT00318461|50068880|FG002|Double-Blind, 6 Months|Move|0|||
24980579|NCT00318461|50068881|FG003|Double-Blind, 6 Months|Move|0|||
24980580|NCT00318461|50068882|FG004|Double-Blind, 6 Months|Move|0|||
24980581|NCT00318461|50068878|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
24980582|NCT00318461|50068879|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
24980583|NCT00318461|50068880|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
24980584|NCT00318461|50068881|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
24980585|NCT00318461|50068882|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
24980586|NCT00318461|50068878|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
24980587|NCT00318461|50068879|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
24980588|NCT00318461|50068880|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
24980589|NCT00318461|50068881|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
24980590|NCT00318461|50068882|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
24980591|NCT00318461|50068878|FG000|Double-Blind, 6 Months|Work commitment|0|||
24980592|NCT00318461|50068879|FG001|Double-Blind, 6 Months|Work commitment|0|||
24980593|NCT00318461|50068880|FG002|Double-Blind, 6 Months|Work commitment|0|||
24980594|NCT00318461|50068881|FG003|Double-Blind, 6 Months|Work commitment|0|||
24980595|NCT00318461|50068882|FG004|Double-Blind, 6 Months|Work commitment|1|||
24980596|NCT00318461|50068878|FG000|Double-Blind, 6 Months|Investigator decision|0|||
24980597|NCT00318461|50068879|FG001|Double-Blind, 6 Months|Investigator decision|0|||
24980598|NCT00318461|50068880|FG002|Double-Blind, 6 Months|Investigator decision|0|||
24980599|NCT00318461|50068881|FG003|Double-Blind, 6 Months|Investigator decision|0|||
24980600|NCT00318461|50068882|FG004|Double-Blind, 6 Months|Investigator decision|1|||
24980601|NCT00318461|50068878|FG000|Double-Blind, 6 Months|Lack of time|1|||
24980602|NCT00318461|50068879|FG001|Double-Blind, 6 Months|Lack of time|0|||
24980603|NCT00318461|50068880|FG002|Double-Blind, 6 Months|Lack of time|0|||
24980604|NCT00318461|50068881|FG003|Double-Blind, 6 Months|Lack of time|0|||
24980605|NCT00318461|50068882|FG004|Double-Blind, 6 Months|Lack of time|0|||
24980606|NCT00318461|50068878|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
24980607|NCT00318461|50068879|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
24980608|NCT00318461|50068880|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
24980609|NCT00318461|50068881|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
24980610|NCT00318461|50068882|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
24980611|NCT00318461|50068878|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
24980612|NCT00318461|50068879|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
24980613|NCT00318461|50068880|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
25255405|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
25255406|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
25255407|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
25255408|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
24980614|NCT00318461|50068881|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
24980615|NCT00318461|50068882|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
24980616|NCT00318461|50068878|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
24980617|NCT00318461|50068879|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
24980618|NCT00318461|50068880|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
25255409|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
24980619|NCT00318461|50068881|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
24980620|NCT00318461|50068882|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
24980621|NCT00318461|50068878|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
24980622|NCT00318461|50068879|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
24980623|NCT00318461|50068880|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
24980624|NCT00318461|50068881|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
24980625|NCT00318461|50068882|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
24980626|NCT00318461|50068878|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
24980627|NCT00318461|50068879|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
24980628|NCT00318461|50068880|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
24980629|NCT00318461|50068881|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
24980630|NCT00318461|50068882|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
24980631|NCT00318461|50068878|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
24980632|NCT00318461|50068879|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
24980633|NCT00318461|50068880|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
24980634|NCT00318461|50068881|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
24980635|NCT00318461|50068882|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
24980636|NCT00318461|50068878|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
24980637|NCT00318461|50068879|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
24980638|NCT00318461|50068880|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
24980639|NCT00318461|50068881|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
24980640|NCT00318461|50068882|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
24980641|NCT00318461|50068878|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
24980642|NCT00318461|50068879|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
24980643|NCT00318461|50068880|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
24980644|NCT00318461|50068881|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
24980645|NCT00318461|50068882|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
24980646|NCT03764072|50068909|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
24980647|NCT03764072|50068910|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
24980648|NCT03764072|50068911|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
24980649|NCT03764072|50068912|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
24980650|NCT03764072|50068913|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
24980651|NCT03764072|50068914|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
24980652|NCT03764072|50068909|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
24980653|NCT03764072|50068910|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
24980654|NCT03764072|50068911|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
24980655|NCT03764072|50068912|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
24980656|NCT03764072|50068913|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
24980657|NCT03764072|50068914|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
24980658|NCT03764072|50068909|FG000|Overall Study|Lost to Follow-up|0|||
24980659|NCT03764072|50068910|FG001|Overall Study|Lost to Follow-up|0|||
24980660|NCT03764072|50068911|FG002|Overall Study|Lost to Follow-up|0|||
24980661|NCT03764072|50068912|FG003|Overall Study|Lost to Follow-up|0|||
24980662|NCT03764072|50068913|FG004|Overall Study|Lost to Follow-up|1|||
24980663|NCT03764072|50068914|FG005|Overall Study|Lost to Follow-up|0|||
24980664|NCT03333928|50068936|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
24980665|NCT03333928|50068937|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
24980666|NCT03333928|50068938|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
24980667|NCT03333928|50068936|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
24980668|NCT03333928|50068937|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
24980669|NCT03333928|50068938|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
24980670|NCT03333928|50068936|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
24980671|NCT03333928|50068937|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
24980672|NCT03333928|50068938|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
24980673|NCT03333928|50068936|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
24980674|NCT03333928|50068937|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
24980675|NCT03333928|50068938|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
24980676|NCT03333928|50068936|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
24980677|NCT03333928|50068937|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
24980678|NCT03333928|50068938|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
24980679|NCT03333928|50068936|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
24980680|NCT03333928|50068937|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
24980681|NCT03333928|50068938|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
25078120|NCT03745651|50186229|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
25078121|NCT02738879|50186247|FG000|Overall Study|Adverse Event|1|||
24980682|NCT03333928|50068936|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
24980683|NCT03333928|50068937|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
24980684|NCT03333928|50068938|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
24980685|NCT03333928|50068936|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
24980686|NCT03333928|50068937|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
24980687|NCT03333928|50068938|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
24980688|NCT02945410|50068960|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
24980689|NCT02945410|50068961|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
24980690|NCT02945410|50068962|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
24980691|NCT02945410|50068963|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
24980692|NCT02945410|50068964|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
24980693|NCT02945410|50068965|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
24980694|NCT02945410|50068960|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
24980695|NCT02945410|50068961|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
24980696|NCT02945410|50068962|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
24980697|NCT02945410|50068963|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
24980698|NCT02945410|50068964|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
24980699|NCT02945410|50068965|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
24980700|NCT02945410|50068960|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
24980701|NCT02945410|50068961|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
24980702|NCT02945410|50068962|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
24980703|NCT02945410|50068963|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
24980704|NCT02945410|50068964|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
24980705|NCT02945410|50068965|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
24980706|NCT02945254|50068975|FG000|Overall Study|Lost to Follow-up|1|||
24980707|NCT02945254|50068976|FG001|Overall Study|Lost to Follow-up|0|||
24980708|NCT02945254|50068975|FG000|Overall Study|Withdrawal by Subject|1|||
24980709|NCT02945254|50068976|FG001|Overall Study|Withdrawal by Subject|0|||
24980710|NCT02943070|50068998|FG000|Overall Study|Physician Decision|1|||
24980711|NCT02943070|50068998|FG000|Overall Study|Adverse Event|2|||
24980712|NCT02943070|50068998|FG000|Overall Study|Death|2|||
24980713|NCT02943070|50068998|FG000|Overall Study|Withdrawal by Subject|3|||
24980714|NCT02943070|50068998|FG000|Overall Study|Lost to Follow-up|4|||
24980715|NCT02943070|50068998|FG000|Overall Study|Retreatment or TURP|13|||
24980716|NCT02943070|50068998|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
24980717|NCT03332212|50069022|FG000|Overall Study|Not treated|0|||
24980718|NCT03332212|50069023|FG001|Overall Study|Not treated|1|||
24980719|NCT03332212|50069024|FG002|Overall Study|Not treated|0|||
24980720|NCT03332212|50069025|FG003|Overall Study|Not treated|0|||
25255410|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
25255411|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
25255412|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
25255413|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
25255414|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
25255415|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
25255416|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
25255417|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
25255418|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
25255419|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
25255420|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
25255421|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
25255422|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
25255423|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
25255424|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
25255425|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
25255426|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
25255427|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
25255428|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
25255429|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
25255430|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
25255431|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
25255432|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
25255433|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
25255434|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
25255435|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
25255436|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
25255437|NCT01172938|50570966|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
25255438|NCT01172938|50570967|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
25255439|NCT01172938|50570968|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
24980721|NCT03332212|50069022|FG000|Overall Study|Adverse Event|0|||
25255440|NCT01172938|50570969|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
24980722|NCT03332212|50069023|FG001|Overall Study|Adverse Event|0|||
24980723|NCT03332212|50069024|FG002|Overall Study|Adverse Event|0|||
24980724|NCT03332212|50069025|FG003|Overall Study|Adverse Event|1|||
24980725|NCT03332212|50069022|FG000|Overall Study|worsening of disease under study|1|||
24980726|NCT03332212|50069023|FG001|Overall Study|worsening of disease under study|1|||
24980727|NCT03332212|50069024|FG002|Overall Study|worsening of disease under study|0|||
24980728|NCT03332212|50069025|FG003|Overall Study|worsening of disease under study|0|||
24980729|NCT03331666|50069035|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
24980730|NCT03331666|50069036|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
24980731|NCT03331042|50069046|FG000|Overall Study|Protocol Violation|1|||
24980732|NCT03331042|50069047|FG001|Overall Study|Protocol Violation|0|||
24980733|NCT03331042|50069048|FG002|Overall Study|Protocol Violation|0|||
24980734|NCT03331042|50069049|FG003|Overall Study|Protocol Violation|0|||
24980735|NCT03331042|50069046|FG000|Overall Study|Physician Decision|0|||
24980736|NCT03331042|50069047|FG001|Overall Study|Physician Decision|0|||
25341942|NCT00777608|50658249|FG001|Overall Study|Lost to Follow-up|1|||
25341943|NCT00777608|50658248|FG000|Overall Study|Withdrawal by Subject|1|||
24980737|NCT03331042|50069048|FG002|Overall Study|Physician Decision|1|||
24980738|NCT03331042|50069049|FG003|Overall Study|Physician Decision|0|||
24980739|NCT03331042|50069046|FG000|Overall Study|Lost to Follow-up|0|||
24980740|NCT03331042|50069047|FG001|Overall Study|Lost to Follow-up|0|||
24980741|NCT03331042|50069048|FG002|Overall Study|Lost to Follow-up|0|||
24980742|NCT03331042|50069049|FG003|Overall Study|Lost to Follow-up|1|||
24980743|NCT03762668|50069067|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
24980744|NCT03762668|50069068|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
24980745|NCT03762200|50069074|FG000|Overall Study|Death|2|||
24980746|NCT03329404|50069080|FG000|Overall Study|The study was suspended.|1|||
24980747|NCT03329404|50069081|FG001|Overall Study|The study was suspended.|4|||
24980748|NCT03478930|50069089|FG000|Overall Study|Adverse Event|0|||
24980749|NCT03478930|50069090|FG001|Overall Study|Adverse Event|1|||
24980750|NCT03478930|50069089|FG000|Overall Study|Lack of Efficacy|3|||
24980751|NCT03478930|50069090|FG001|Overall Study|Lack of Efficacy|3|||
24980752|NCT03478930|50069089|FG000|Overall Study|Withdrawal by Subject|6|||
24980753|NCT03478930|50069090|FG001|Overall Study|Withdrawal by Subject|5|||
24980754|NCT03038438|50069096|FG000|Overall Study|Death|3|||
24980755|NCT03038438|50069096|FG000|Overall Study|Lost to Follow-up|8|||
24980756|NCT03038438|50069096|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
24980757|NCT03038438|50069096|FG000|Overall Study|Withdrawal by Subject|5|||
24980758|NCT03038438|50069096|FG000|Overall Study|No 36-Month Follow-Up|18|||
24980759|NCT03523000|50069100|FG000|Overall Study|Withdrawal by Subject|3|||
24980760|NCT03523000|50069101|FG001|Overall Study|Withdrawal by Subject|0|||
24980761|NCT03523000|50069100|FG000|Overall Study|Unsuccessful trial|2|||
24980762|NCT03523000|50069101|FG001|Overall Study|Unsuccessful trial|0|||
24980763|NCT03327220|50069112|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
24980764|NCT03327220|50069113|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
24980765|NCT03327220|50069112|FG000|Overall Study|Investigator Decision|2|||
24980766|NCT03327220|50069113|FG001|Overall Study|Investigator Decision|0|||
24980767|NCT03327220|50069112|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
24980768|NCT03327220|50069113|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
24980769|NCT03327220|50069112|FG000|Overall Study|Fungal infection|1|||
24980770|NCT03327220|50069113|FG001|Overall Study|Fungal infection|0|||
24980771|NCT03327220|50069112|FG000|Overall Study|Discharged to Rehabilitation|0|||
24980772|NCT03327220|50069113|FG001|Overall Study|Discharged to Rehabilitation|1|||
24980773|NCT03327220|50069112|FG000|Overall Study|Missing|1|||
24980774|NCT03327220|50069113|FG001|Overall Study|Missing|0|||
24980775|NCT00318149|50069125|FG000|Overall Study|Adverse Event|0|||
25341944|NCT00777608|50658249|FG001|Overall Study|Withdrawal by Subject|3|||
25341945|NCT00777608|50658248|FG000|Overall Study|Protocol Violation|1|||
25341946|NCT00777608|50658249|FG001|Overall Study|Protocol Violation|0|||
25341947|NCT00777608|50658248|FG000|Overall Study|Investigator Decision|1|||
25341948|NCT00777608|50658249|FG001|Overall Study|Investigator Decision|2|||
25341949|NCT00792935|50658257|FG000|Overall Study|Adverse Event|2|||
25341950|NCT00792935|50658258|FG001|Overall Study|Adverse Event|1|||
25341951|NCT00792935|50658257|FG000|Overall Study|Lost to Follow-up|0|||
25341952|NCT00792935|50658258|FG001|Overall Study|Lost to Follow-up|1|||
25341953|NCT00792935|50658257|FG000|Overall Study|Protocol Violation|2|||
25341954|NCT00792935|50658258|FG001|Overall Study|Protocol Violation|0|||
24980776|NCT00318149|50069126|FG001|Overall Study|Adverse Event|0|||
25341955|NCT00792935|50658257|FG000|Overall Study|Withdrawal by Subject|0|||
25341956|NCT00792935|50658258|FG001|Overall Study|Withdrawal by Subject|1|||
25341957|NCT00770510|50658264|FG000|Overall Study|Lost to Follow-up|2|||
24980777|NCT00318149|50069127|FG002|Overall Study|Adverse Event|0|||
24980778|NCT00318149|50069128|FG003|Overall Study|Adverse Event|0|||
24980779|NCT00318149|50069129|FG004|Overall Study|Adverse Event|0|||
24980780|NCT00318149|50069130|FG005|Overall Study|Adverse Event|2|||
24980781|NCT00317603|50069146|FG000|Overall Study|Progressive Disease|3|||
25341958|NCT00770510|50658264|FG000|Overall Study|Pregnancy|1|||
24980782|NCT03326518|50069153|FG000|Overall Study|Protocol Violation|1|||
24980783|NCT03326518|50069154|FG001|Overall Study|Protocol Violation|0|||
24980784|NCT03326518|50069155|FG002|Overall Study|Protocol Violation|0|||
24980785|NCT03326518|50069153|FG000|Overall Study|Withdrawal by Subject|1|||
24980786|NCT03326518|50069154|FG001|Overall Study|Withdrawal by Subject|0|||
24980787|NCT03326518|50069155|FG002|Overall Study|Withdrawal by Subject|0|||
24980788|NCT03326518|50069153|FG000|Overall Study|Lost to Follow-up|1|||
24980789|NCT03326518|50069154|FG001|Overall Study|Lost to Follow-up|0|||
24980790|NCT03326518|50069155|FG002|Overall Study|Lost to Follow-up|1|||
24980791|NCT00317369|50069166|FG000|Overall Study|Adverse Event|2|||
24980792|NCT00317369|50069167|FG001|Overall Study|Adverse Event|1|||
24980793|NCT00317369|50069168|FG002|Overall Study|Adverse Event|0|||
24980794|NCT00317369|50069166|FG000|Overall Study|Lack of Efficacy|0|||
24980795|NCT00317369|50069167|FG001|Overall Study|Lack of Efficacy|1|||
24980796|NCT00317369|50069168|FG002|Overall Study|Lack of Efficacy|1|||
24980797|NCT00317369|50069166|FG000|Overall Study|Withdrawal by Subject|0|||
24980798|NCT00317369|50069167|FG001|Overall Study|Withdrawal by Subject|0|||
24980799|NCT00317369|50069168|FG002|Overall Study|Withdrawal by Subject|1|||
24980800|NCT03325894|50069178|FG000|Overall Study|Adverse Event|2|||
24980801|NCT03325894|50069179|FG001|Overall Study|Adverse Event|3|||
24980802|NCT03325894|50069178|FG000|Overall Study|Protocol Violation|1|||
24980803|NCT03325894|50069179|FG001|Overall Study|Protocol Violation|2|||
24980804|NCT03325894|50069178|FG000|Overall Study|Withdrawal by Subject|10|||
24980805|NCT03325894|50069179|FG001|Overall Study|Withdrawal by Subject|6|||
24980806|NCT03325894|50069178|FG000|Overall Study|Lost to Follow-up|4|||
24980807|NCT03325894|50069179|FG001|Overall Study|Lost to Follow-up|9|||
24980808|NCT03325894|50069178|FG000|Overall Study|Lack of Efficacy|8|||
24980809|NCT03325894|50069179|FG001|Overall Study|Lack of Efficacy|14|||
24980810|NCT03325894|50069178|FG000|Overall Study|Study Terminated by Sponsor|38|||
24980811|NCT03325894|50069179|FG001|Overall Study|Study Terminated by Sponsor|43|||
24980812|NCT03325894|50069178|FG000|Overall Study|Other (Not received Treatment)|1|||
24980813|NCT03325894|50069179|FG001|Overall Study|Other (Not received Treatment)|0|||
24980814|NCT01239368|50069198|FG000|Overall Study|Principal investigator discretion|1|||
24980815|NCT01239368|50069199|FG001|Overall Study|Principal investigator discretion|0|||
24980816|NCT01239368|50069200|FG002|Overall Study|Principal investigator discretion|0|||
24980817|NCT01239368|50069201|FG003|Overall Study|Principal investigator discretion|0|||
24980818|NCT01239368|50069202|FG004|Overall Study|Principal investigator discretion|1|||
24980819|NCT01239368|50069203|FG005|Overall Study|Principal investigator discretion|2|||
24980820|NCT01239368|50069204|FG006|Overall Study|Principal investigator discretion|0|||
24980821|NCT01239368|50069205|FG007|Overall Study|Principal investigator discretion|0|||
24980822|NCT01239368|50069206|FG008|Overall Study|Principal investigator discretion|0|||
24980823|NCT01239368|50069207|FG009|Overall Study|Principal investigator discretion|1|||
24980824|NCT01239368|50069198|FG000|Overall Study|Disease progression on study|1|||
24980825|NCT01239368|50069199|FG001|Overall Study|Disease progression on study|1|||
24980826|NCT01239368|50069200|FG002|Overall Study|Disease progression on study|1|||
24980827|NCT01239368|50069201|FG003|Overall Study|Disease progression on study|1|||
24980828|NCT01239368|50069202|FG004|Overall Study|Disease progression on study|4|||
24980829|NCT01239368|50069203|FG005|Overall Study|Disease progression on study|2|||
24980830|NCT01239368|50069204|FG006|Overall Study|Disease progression on study|5|||
24980831|NCT01239368|50069205|FG007|Overall Study|Disease progression on study|0|||
25078122|NCT02738879|50186248|FG001|Overall Study|Adverse Event|1|||
24980832|NCT01239368|50069206|FG008|Overall Study|Disease progression on study|0|||
24980833|NCT01239368|50069207|FG009|Overall Study|Disease progression on study|2|||
24980834|NCT01239368|50069198|FG000|Overall Study|Refused further treatment|0|||
24980835|NCT01239368|50069199|FG001|Overall Study|Refused further treatment|0|||
24980836|NCT01239368|50069200|FG002|Overall Study|Refused further treatment|0|||
24980837|NCT01239368|50069201|FG003|Overall Study|Refused further treatment|0|||
24980838|NCT01239368|50069202|FG004|Overall Study|Refused further treatment|0|||
24980839|NCT01239368|50069203|FG005|Overall Study|Refused further treatment|0|||
24980840|NCT01239368|50069204|FG006|Overall Study|Refused further treatment|0|||
24980841|NCT01239368|50069205|FG007|Overall Study|Refused further treatment|0|||
24980842|NCT01239368|50069206|FG008|Overall Study|Refused further treatment|0|||
24980843|NCT01239368|50069207|FG009|Overall Study|Refused further treatment|1|||
24980844|NCT01239368|50069198|FG000|Overall Study|Death|0|||
24980845|NCT01239368|50069199|FG001|Overall Study|Death|0|||
24980846|NCT01239368|50069200|FG002|Overall Study|Death|0|||
24980847|NCT01239368|50069201|FG003|Overall Study|Death|0|||
24980848|NCT01239368|50069202|FG004|Overall Study|Death|0|||
24980849|NCT01239368|50069203|FG005|Overall Study|Death|0|||
24980850|NCT01239368|50069204|FG006|Overall Study|Death|1|||
24980851|NCT01239368|50069205|FG007|Overall Study|Death|0|||
24980852|NCT01239368|50069206|FG008|Overall Study|Death|0|||
25078123|NCT02738879|50186247|FG000|Overall Study|Death|0|||
25078124|NCT02738879|50186248|FG001|Overall Study|Death|2|||
24980853|NCT01239368|50069207|FG009|Overall Study|Death|0|||
24980854|NCT02903420|50069249|FG000|Overall Study|Death|3|||
24980855|NCT00369161|50069259|FG000|Overall Study|Adverse Event|15|||
24980856|NCT00369161|50069260|FG001|Overall Study|Adverse Event|13|||
24980857|NCT00369161|50069259|FG000|Overall Study|Abnormal laboratory value|0|||
24980858|NCT00369161|50069260|FG001|Overall Study|Abnormal laboratory value|1|||
24980859|NCT00369161|50069259|FG000|Overall Study|Lack of Efficacy|3|||
24980860|NCT00369161|50069260|FG001|Overall Study|Lack of Efficacy|1|||
24980861|NCT00369161|50069259|FG000|Overall Study|Protocol Violation|0|||
24980862|NCT00369161|50069260|FG001|Overall Study|Protocol Violation|2|||
24980863|NCT00369161|50069259|FG000|Overall Study|Withdrawal by Subject|2|||
24980864|NCT00369161|50069260|FG001|Overall Study|Withdrawal by Subject|3|||
24980865|NCT00369161|50069259|FG000|Overall Study|Death|1|||
24980866|NCT00369161|50069260|FG001|Overall Study|Death|2|||
25078125|NCT02738879|50186247|FG000|Overall Study|Lost to Follow-up|1|||
25078126|NCT02738879|50186248|FG001|Overall Study|Lost to Follow-up|5|||
25078127|NCT02738879|50186247|FG000|Overall Study|Protocol Violation|1|||
25078128|NCT02738879|50186248|FG001|Overall Study|Protocol Violation|3|||
25078129|NCT02738879|50186247|FG000|Overall Study|Physician Decision|3|||
25078130|NCT02738879|50186248|FG001|Overall Study|Physician Decision|4|||
25078131|NCT02738879|50186247|FG000|Overall Study|Pregnancy|0|||
25078132|NCT02738879|50186248|FG001|Overall Study|Pregnancy|1|||
25078133|NCT02738879|50186247|FG000|Overall Study|Screen Failure|1|||
25078134|NCT02738879|50186248|FG001|Overall Study|Screen Failure|2|||
25078135|NCT02738879|50186247|FG000|Overall Study|Site Discontinued Study Participation|1|||
25078136|NCT02738879|50186248|FG001|Overall Study|Site Discontinued Study Participation|0|||
25078137|NCT02738879|50186247|FG000|Overall Study|Withdrawal by Subject|5|||
25078138|NCT02738879|50186248|FG001|Overall Study|Withdrawal by Subject|7|||
25078139|NCT03502811|50186254|FG000|Overall Study|Death|157|||
25078140|NCT03502811|50186254|FG000|Overall Study|Withdrawal by Subject|105|||
25078141|NCT03502811|50186254|FG000|Overall Study|Lost to Follow-up|26|||
25078142|NCT03502811|50186254|FG000|Overall Study|No Visits (Missed)|31|||
25078143|NCT00515671|50186266|FG000|Overall Study|Lost to Follow-up|13|||
25078144|NCT00515671|50186267|FG001|Overall Study|Lost to Follow-up|10|||
25078145|NCT00515671|50186266|FG000|Overall Study|Withdrawal by Subject|3|||
25078146|NCT00515671|50186267|FG001|Overall Study|Withdrawal by Subject|5|||
25078147|NCT00515671|50186266|FG000|Overall Study|incarcerated|1|||
25078148|NCT00515671|50186267|FG001|Overall Study|incarcerated|2|||
25078149|NCT01677195|50186276|FG000|Overall Study|Lost to Follow-up|14|||
25078150|NCT01677195|50186277|FG001|Overall Study|Lost to Follow-up|22|||
25078151|NCT01677195|50186278|FG002|Overall Study|Lost to Follow-up|22|||
25078152|NCT01677195|50186276|FG000|Overall Study|Withdrawal by Subject|1|||
25078153|NCT01677195|50186277|FG001|Overall Study|Withdrawal by Subject|0|||
25078154|NCT01677195|50186278|FG002|Overall Study|Withdrawal by Subject|1|||
25078155|NCT01677195|50186276|FG000|Overall Study|Adverse Event|6|||
25078156|NCT01677195|50186277|FG001|Overall Study|Adverse Event|4|||
25078157|NCT01677195|50186278|FG002|Overall Study|Adverse Event|1|||
25078158|NCT01677195|50186276|FG000|Overall Study|Physician Decision|1|||
25078159|NCT01677195|50186277|FG001|Overall Study|Physician Decision|2|||
25078160|NCT01677195|50186278|FG002|Overall Study|Physician Decision|2|||
25078161|NCT01677195|50186276|FG000|Overall Study|Pregnancy|0|||
25078162|NCT01677195|50186277|FG001|Overall Study|Pregnancy|1|||
25078163|NCT01677195|50186278|FG002|Overall Study|Pregnancy|0|||
25078164|NCT01677195|50186276|FG000|Overall Study|Protocol Violation|7|||
25078165|NCT01677195|50186277|FG001|Overall Study|Protocol Violation|3|||
25078166|NCT01677195|50186278|FG002|Overall Study|Protocol Violation|4|||
25078167|NCT00928447|50186290|FG000|Overall Study|Withdrawal by Subject|1|||
25078168|NCT00928447|50186290|FG000|Overall Study|Investigator's decision|1|||
25078169|NCT02224846|50186296|FG000|Period 1 (Month 3)|Adverse Event|2|||
25078170|NCT02224846|50186297|FG001|Period 1 (Month 3)|Adverse Event|1|||
25078171|NCT02224846|50186296|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
25078172|NCT02224846|50186297|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
25078173|NCT02224846|50186296|FG000|Period 1 (Month 3)|Protocol Violation|4|||
25078174|NCT02224846|50186297|FG001|Period 1 (Month 3)|Protocol Violation|8|||
25078175|NCT02224846|50186296|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
25078176|NCT02224846|50186297|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
25078177|NCT02224846|50186296|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
25078178|NCT02224846|50186297|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
25078179|NCT02224846|50186296|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
25078180|NCT02224846|50186297|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
25078181|NCT02224846|50186296|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
25078182|NCT02224846|50186297|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
25078183|NCT02224846|50186296|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
25078184|NCT02224846|50186297|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
24980867|NCT00369161|50069259|FG000|Overall Study|Graft loss|4|||
24980868|NCT00369161|50069260|FG001|Overall Study|Graft loss|0|||
25078185|NCT02224846|50186296|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
25078186|NCT02224846|50186297|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
25078187|NCT02224846|50186296|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
25078188|NCT02224846|50186297|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
25078189|NCT02224846|50186296|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
24980869|NCT00369161|50069259|FG000|Overall Study|Administrative Problem|2|||
24980870|NCT00369161|50069260|FG001|Overall Study|Administrative Problem|2|||
24980871|NCT00337571|50069270|FG000|Overall Study|Lack of Efficacy|3|||
24980872|NCT00337571|50069271|FG001|Overall Study|Lack of Efficacy|0|||
24980873|NCT00337571|50069272|FG002|Overall Study|Lack of Efficacy|0|||
24980874|NCT00337571|50069273|FG003|Overall Study|Lack of Efficacy|0|||
24980875|NCT00337571|50069270|FG000|Overall Study|Adverse Event|4|||
24980876|NCT00337571|50069271|FG001|Overall Study|Adverse Event|5|||
24980877|NCT00337571|50069272|FG002|Overall Study|Adverse Event|8|||
24980878|NCT00337571|50069273|FG003|Overall Study|Adverse Event|4|||
24980879|NCT00337571|50069270|FG000|Overall Study|Withdrawal by Subject|2|||
24980880|NCT00337571|50069271|FG001|Overall Study|Withdrawal by Subject|2|||
24980881|NCT00337571|50069272|FG002|Overall Study|Withdrawal by Subject|1|||
24980882|NCT00337571|50069273|FG003|Overall Study|Withdrawal by Subject|0|||
24980883|NCT00337571|50069270|FG000|Overall Study|Lost to Follow-up|3|||
24980884|NCT00337571|50069271|FG001|Overall Study|Lost to Follow-up|1|||
24980885|NCT00337571|50069272|FG002|Overall Study|Lost to Follow-up|0|||
24980886|NCT00337571|50069273|FG003|Overall Study|Lost to Follow-up|1|||
24980887|NCT00337571|50069270|FG000|Overall Study|Poor/noncompliance|1|||
24980888|NCT00337571|50069271|FG001|Overall Study|Poor/noncompliance|1|||
24980889|NCT00337571|50069272|FG002|Overall Study|Poor/noncompliance|1|||
24980890|NCT00337571|50069273|FG003|Overall Study|Poor/noncompliance|1|||
24980891|NCT00337571|50069270|FG000|Overall Study|No longer met study criteria|1|||
24980892|NCT00337571|50069271|FG001|Overall Study|No longer met study criteria|0|||
24980893|NCT00337571|50069272|FG002|Overall Study|No longer met study criteria|0|||
24980894|NCT00337571|50069273|FG003|Overall Study|No longer met study criteria|0|||
24980895|NCT00337571|50069270|FG000|Overall Study|High Potassium level|0|||
24980896|NCT00337571|50069271|FG001|Overall Study|High Potassium level|0|||
24980897|NCT00337571|50069272|FG002|Overall Study|High Potassium level|0|||
24980898|NCT00337571|50069273|FG003|Overall Study|High Potassium level|1|||
24980899|NCT00368927|50069285|FG000|Overall Study|Lost to Follow-up|2|||
24980900|NCT00368927|50069286|FG001|Overall Study|Lost to Follow-up|0|||
24980901|NCT00368927|50069285|FG000|Overall Study|Adverse Event|1|||
24980902|NCT00368927|50069286|FG001|Overall Study|Adverse Event|1|||
24980903|NCT00368927|50069285|FG000|Overall Study|Withdrawal by Subject|1|||
24980904|NCT00368927|50069286|FG001|Overall Study|Withdrawal by Subject|2|||
24980905|NCT00368927|50069285|FG000|Overall Study|Physician Decision|1|||
24980906|NCT00368927|50069286|FG001|Overall Study|Physician Decision|0|||
24980907|NCT00316589|50069309|FG000|Overall Study|Withdrawal by Subject|0|||
24980908|NCT00316589|50069310|FG001|Overall Study|Withdrawal by Subject|5|||
24980909|NCT00316589|50069311|FG002|Overall Study|Withdrawal by Subject|0|||
24980910|NCT00316589|50069312|FG003|Overall Study|Withdrawal by Subject|1|||
24980911|NCT00316589|50069309|FG000|Overall Study|Subject unwilling/unable to comply|0|||
24980912|NCT00316589|50069310|FG001|Overall Study|Subject unwilling/unable to comply|6|||
24980913|NCT00316589|50069311|FG002|Overall Study|Subject unwilling/unable to comply|0|||
24980914|NCT00316589|50069312|FG003|Overall Study|Subject unwilling/unable to comply|2|||
24980915|NCT00316589|50069309|FG000|Overall Study|Adverse Event|1|||
24980916|NCT00316589|50069310|FG001|Overall Study|Adverse Event|0|||
24980917|NCT00316589|50069311|FG002|Overall Study|Adverse Event|0|||
24980918|NCT00316589|50069312|FG003|Overall Study|Adverse Event|1|||
24980919|NCT00316589|50069309|FG000|Overall Study|Physician Decision|0|||
24980920|NCT00316589|50069310|FG001|Overall Study|Physician Decision|1|||
25078190|NCT02224846|50186297|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
25078191|NCT02224846|50186296|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
25078192|NCT02224846|50186297|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
25078193|NCT02224846|50186296|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
25078194|NCT02224846|50186297|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
25078195|NCT02224846|50186296|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
25078196|NCT02224846|50186297|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
25078197|NCT02224846|50186296|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
25078198|NCT02224846|50186297|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
24980921|NCT00316589|50069311|FG002|Overall Study|Physician Decision|0|||
24980922|NCT00316589|50069312|FG003|Overall Study|Physician Decision|0|||
24980923|NCT00316589|50069309|FG000|Overall Study|Other reason|0|||
24980924|NCT00316589|50069310|FG001|Overall Study|Other reason|12|||
24980925|NCT00316589|50069311|FG002|Overall Study|Other reason|1|||
24980926|NCT00316589|50069312|FG003|Overall Study|Other reason|1|||
24980927|NCT00316277|50069326|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
24980928|NCT00316277|50069327|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
24980929|NCT00316277|50069326|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
24980930|NCT00316277|50069327|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
24980931|NCT00316277|50069326|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
24980932|NCT00316277|50069327|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
24980933|NCT00316277|50069326|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
24980934|NCT00316277|50069327|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
25078199|NCT02224846|50186296|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
24980935|NCT00316277|50069326|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
24980936|NCT00316277|50069327|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
24980937|NCT00368849|50069341|FG000|Overall Study|Withdrawal by Subject|0|||
25341959|NCT00770510|50658264|FG000|Overall Study|Withdrawal by Subject|2|||
25341960|NCT00770432|50658278|FG000|Overall Study|Other|4|||
25341961|NCT00770432|50658279|FG001|Overall Study|Other|6|||
25341962|NCT00770432|50658278|FG000|Overall Study|Non-compliance|0|||
25341963|NCT00770432|50658279|FG001|Overall Study|Non-compliance|1|||
25341964|NCT00792701|50658287|FG000|Overall Study|Adverse Event|0|||
25341965|NCT00792701|50658288|FG001|Overall Study|Adverse Event|22|||
25341966|NCT00792701|50658287|FG000|Overall Study|Ineligible|1|||
25341967|NCT00792701|50658288|FG001|Overall Study|Ineligible|3|||
25341968|NCT00792701|50658287|FG000|Overall Study|Withdrawal by Subject|1|||
25341969|NCT00792701|50658288|FG001|Overall Study|Withdrawal by Subject|19|||
25341970|NCT00792701|50658287|FG000|Overall Study|Not protocol specified|17|||
25341971|NCT00792701|50658288|FG001|Overall Study|Not protocol specified|0|||
24980938|NCT00368849|50069342|FG001|Overall Study|Withdrawal by Subject|1|||
24980939|NCT00368849|50069341|FG000|Overall Study|Physician Decision|0|||
24980940|NCT00368849|50069342|FG001|Overall Study|Physician Decision|1|||
24980941|NCT00316199|50069349|FG000|Overall Study|Adverse Event|2|||
24980942|NCT00316199|50069349|FG000|Overall Study|Death|8|||
24980943|NCT00316199|50069349|FG000|Overall Study|Lost to Follow-up|2|||
24980944|NCT00316121|50069355|FG000|Overall Study|Death|1|||
24980945|NCT00316121|50069356|FG001|Overall Study|Death|0|||
24980946|NCT00316121|50069355|FG000|Overall Study|Lost to Follow-up|14|||
24980947|NCT00316121|50069356|FG001|Overall Study|Lost to Follow-up|8|||
24980948|NCT00316121|50069355|FG000|Overall Study|Withdrawal by Subject|2|||
24980949|NCT00316121|50069356|FG001|Overall Study|Withdrawal by Subject|0|||
24980950|NCT00316121|50069355|FG000|Overall Study|Reason is missing|1|||
24980951|NCT00316121|50069356|FG001|Overall Study|Reason is missing|0|||
24980952|NCT00316121|50069355|FG000|Overall Study|Subject relocated|1|||
24980953|NCT00316121|50069356|FG001|Overall Study|Subject relocated|1|||
24980954|NCT00316121|50069355|FG000|Overall Study|Subject refused to return|1|||
24980955|NCT00316121|50069356|FG001|Overall Study|Subject refused to return|0|||
24980956|NCT00316121|50069355|FG000|Overall Study|Subject no show for visit x 3|1|||
24980957|NCT00316121|50069356|FG001|Overall Study|Subject no show for visit x 3|0|||
24980958|NCT00316121|50069355|FG000|Overall Study|Subject did not have 24 month visit|1|||
24980959|NCT00316121|50069356|FG001|Overall Study|Subject did not have 24 month visit|0|||
24980960|NCT00337103|50069375|FG000|Overall Study|Progressive Disease|414|||
24980961|NCT00337103|50069376|FG001|Overall Study|Progressive Disease|410|||
24980962|NCT00337103|50069375|FG000|Overall Study|Adverse Event|45|||
24980963|NCT00337103|50069376|FG001|Overall Study|Adverse Event|59|||
24980964|NCT00337103|50069375|FG000|Overall Study|Subject Choice|34|||
24980965|NCT00337103|50069376|FG001|Overall Study|Subject Choice|27|||
24980966|NCT00337103|50069375|FG000|Overall Study|Clinical Progression|27|||
24980967|NCT00337103|50069376|FG001|Overall Study|Clinical Progression|24|||
24980968|NCT00337103|50069375|FG000|Overall Study|Physician Decision|15|||
24980969|NCT00337103|50069376|FG001|Overall Study|Physician Decision|14|||
24980970|NCT00337103|50069375|FG000|Overall Study|Withdrawal by Subject|8|||
24980971|NCT00337103|50069376|FG001|Overall Study|Withdrawal by Subject|5|||
24980972|NCT00337103|50069375|FG000|Overall Study|Other|5|||
24980973|NCT00337103|50069376|FG001|Overall Study|Other|6|||
24980974|NCT00337103|50069375|FG000|Overall Study|Entry Criteria Not Met|4|||
24980975|NCT00337103|50069376|FG001|Overall Study|Entry Criteria Not Met|1|||
24980976|NCT00337103|50069375|FG000|Overall Study|Lost to Follow-up|1|||
24980977|NCT00337103|50069376|FG001|Overall Study|Lost to Follow-up|2|||
24980978|NCT00337103|50069375|FG000|Overall Study|Death|1|||
24980979|NCT00337103|50069376|FG001|Overall Study|Death|0|||
24980980|NCT00415532|50069385|FG000|Treatment Period|Adverse Event|2|||
25341972|NCT00777296|50658300|FG000|Overall Study|Adverse Event|0|||
25341973|NCT00777296|50658301|FG001|Overall Study|Adverse Event|1|||
24980981|NCT00415532|50069386|FG001|Treatment Period|Adverse Event|3|||
24980982|NCT00415532|50069385|FG000|Treatment Period|Death|2|||
24980983|NCT00415532|50069386|FG001|Treatment Period|Death|1|||
24980984|NCT00415532|50069385|FG000|Treatment Period|Lost to Follow-up|1|||
24980985|NCT00415532|50069386|FG001|Treatment Period|Lost to Follow-up|1|||
24980986|NCT00415532|50069385|FG000|Treatment Period|Protocol Violation|1|||
24980987|NCT00415532|50069386|FG001|Treatment Period|Protocol Violation|0|||
24980988|NCT00415532|50069385|FG000|Treatment Period|Withdrawal by Subject|6|||
24980989|NCT00415532|50069386|FG001|Treatment Period|Withdrawal by Subject|6|||
24980990|NCT00415532|50069385|FG000|Treatment Period|Other|2|||
24980991|NCT00415532|50069386|FG001|Treatment Period|Other|2|||
24980992|NCT00415532|50069385|FG000|Treatment Period|Ineligibility determined|1|||
24980993|NCT00415532|50069386|FG001|Treatment Period|Ineligibility determined|1|||
24980994|NCT00415532|50069385|FG000|Treatment Period|Noncompliance|1|||
24980995|NCT00415532|50069386|FG001|Treatment Period|Noncompliance|1|||
25341974|NCT00777296|50658302|FG002|Overall Study|Adverse Event|0|||
25341975|NCT00777296|50658303|FG003|Overall Study|Adverse Event|1|||
24980996|NCT00415532|50069385|FG000|Treatment Period|Requirement for alternative therapy|1|||
25341976|NCT00777296|50658300|FG000|Overall Study|Withdrawal by Subject|1|||
25341977|NCT00777296|50658301|FG001|Overall Study|Withdrawal by Subject|0|||
25341978|NCT00777296|50658302|FG002|Overall Study|Withdrawal by Subject|0|||
25341979|NCT00777296|50658303|FG003|Overall Study|Withdrawal by Subject|0|||
25341980|NCT00777296|50658300|FG000|Overall Study|CRF form not completed|0|||
25341981|NCT00777296|50658301|FG001|Overall Study|CRF form not completed|0|||
25341982|NCT00777296|50658302|FG002|Overall Study|CRF form not completed|2|||
25341983|NCT00777296|50658303|FG003|Overall Study|CRF form not completed|0|||
25341984|NCT00756470|50658325|FG000|Overall Study|Withdrawal by Subject|1|||
25341985|NCT00756470|50658325|FG000|Overall Study|Adverse Event|4|||
25255441|NCT01172938|50570970|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
25255442|NCT01172938|50570971|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
25255443|NCT01172938|50570972|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
25255444|NCT01172938|50570973|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
25255445|NCT01172938|50570974|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
25255446|NCT01172938|50570966|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
25255447|NCT01172938|50570967|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
25255448|NCT01172938|50570968|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
25255449|NCT01172938|50570969|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
25255450|NCT01172938|50570970|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
25255451|NCT01172938|50570971|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
25255452|NCT01172938|50570972|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
25255453|NCT01172938|50570973|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
25255454|NCT01172938|50570974|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
25255455|NCT01172938|50570966|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
25255456|NCT01172938|50570967|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
25255457|NCT01172938|50570968|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
25255458|NCT01172938|50570969|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
25255459|NCT01172938|50570970|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
25255460|NCT01172938|50570971|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
25255461|NCT01172938|50570972|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
25255462|NCT01172938|50570973|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
25255463|NCT01172938|50570974|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
25255464|NCT01172938|50570966|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
25255465|NCT01172938|50570967|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
25255466|NCT01172938|50570968|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
25255467|NCT01172938|50570969|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
25255468|NCT01172938|50570970|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
25255469|NCT01172938|50570971|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
25255470|NCT01172938|50570972|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
25255471|NCT01172938|50570973|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
25255472|NCT01172938|50570974|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
25255473|NCT01172938|50570966|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
25255474|NCT01172938|50570967|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
25255475|NCT01172938|50570968|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
25255476|NCT01172938|50570969|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
25255477|NCT01172938|50570970|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
25255478|NCT01172938|50570971|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
25255479|NCT01172938|50570972|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
25255480|NCT01172938|50570973|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
25255481|NCT01172938|50570974|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
25255482|NCT01172938|50570966|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
25255483|NCT01172938|50570967|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
25255484|NCT01172938|50570968|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
25255485|NCT01172938|50570969|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
25255486|NCT01172938|50570970|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
25255487|NCT01172938|50570971|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
25255488|NCT01172938|50570972|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
25255489|NCT01172938|50570973|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
25255490|NCT01172938|50570974|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
25255491|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
25341986|NCT00792623|50658329|FG000|Overall Study|Adverse Event|2|||
25341987|NCT00792623|50658329|FG000|Overall Study|Withdrawal by Subject|5|||
25255492|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
25255493|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
25255494|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
25341988|NCT00756314|50658336|FG000|Overall Study|Lost to Follow-up|2|||
24980997|NCT00415532|50069386|FG001|Treatment Period|Requirement for alternative therapy|0|||
24980998|NCT00415532|50069385|FG000|Safety Follow Up Period|Adverse Event|1|||
24980999|NCT00415532|50069386|FG001|Safety Follow Up Period|Adverse Event|3|||
24981000|NCT00415532|50069385|FG000|Safety Follow Up Period|Death|3|||
24981001|NCT00415532|50069386|FG001|Safety Follow Up Period|Death|0|||
24981002|NCT00415532|50069385|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
24981003|NCT00415532|50069386|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
24981004|NCT00415532|50069385|FG000|Safety Follow Up Period|Other|1|||
24981005|NCT00415532|50069386|FG001|Safety Follow Up Period|Other|4|||
24981006|NCT00415532|50069385|FG000|Safety Follow Up Period|Ineligibility determined|1|||
24981007|NCT00415532|50069386|FG001|Safety Follow Up Period|Ineligibility determined|1|||
24981008|NCT00415532|50069385|FG000|Safety Follow Up Period|Noncompliance|1|||
24981009|NCT00415532|50069386|FG001|Safety Follow Up Period|Noncompliance|0|||
24981010|NCT00415532|50069385|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
24981011|NCT00415532|50069386|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
24981012|NCT00315731|50069392|FG000|Overall Study|Lost to Follow-up|1|||
24981013|NCT00315731|50069392|FG000|Overall Study|Death|5|||
24981014|NCT00062868|50069419|FG000|Dose Level 1|Death|2|||
24981015|NCT00062868|50069420|FG001|Dose Level 1|Death|0|||
24981016|NCT00062868|50069421|FG002|Dose Level 1|Death|0|||
24981017|NCT00062868|50069422|FG003|Dose Level 1|Death|2|||
24981018|NCT00062868|50069423|FG004|Dose Level 1|Death|0|||
24981019|NCT00062868|50069424|FG005|Dose Level 1|Death|0|||
24981020|NCT00062868|50069425|FG006|Dose Level 1|Death|3|||
24981021|NCT00062868|50069426|FG007|Dose Level 1|Death|0|||
24981022|NCT00062868|50069427|FG008|Dose Level 1|Death|0|||
24981023|NCT00062868|50069428|FG009|Dose Level 1|Death|0|||
24981024|NCT00062868|50069429|FG010|Dose Level 1|Death|0|||
24981025|NCT00062868|50069430|FG011|Dose Level 1|Death|0|||
24981026|NCT00062868|50069431|FG012|Dose Level 1|Death|0|||
24981027|NCT00062868|50069432|FG013|Dose Level 1|Death|0|||
24981028|NCT00062868|50069433|FG014|Dose Level 1|Death|0|||
24981029|NCT00062868|50069434|FG015|Dose Level 1|Death|0|||
24981030|NCT00062868|50069435|FG016|Dose Level 1|Death|0|||
24981031|NCT00062868|50069436|FG017|Dose Level 1|Death|0|||
24981032|NCT00062868|50069437|FG018|Dose Level 1|Death|7|||
24981033|NCT00062868|50069438|FG019|Dose Level 1|Death|0|||
24981034|NCT00062868|50069439|FG020|Dose Level 1|Death|1|||
24981035|NCT00062868|50069419|FG000|Dose Level 1|Lost to Follow-up|0|||
24981036|NCT00062868|50069420|FG001|Dose Level 1|Lost to Follow-up|0|||
24981037|NCT00062868|50069421|FG002|Dose Level 1|Lost to Follow-up|0|||
24981038|NCT00062868|50069422|FG003|Dose Level 1|Lost to Follow-up|0|||
24981039|NCT00062868|50069423|FG004|Dose Level 1|Lost to Follow-up|0|||
24981040|NCT00062868|50069424|FG005|Dose Level 1|Lost to Follow-up|0|||
24981041|NCT00062868|50069425|FG006|Dose Level 1|Lost to Follow-up|0|||
24981042|NCT00062868|50069426|FG007|Dose Level 1|Lost to Follow-up|0|||
24981043|NCT00062868|50069427|FG008|Dose Level 1|Lost to Follow-up|0|||
24981044|NCT00062868|50069428|FG009|Dose Level 1|Lost to Follow-up|0|||
24981045|NCT00062868|50069429|FG010|Dose Level 1|Lost to Follow-up|0|||
24981046|NCT00062868|50069430|FG011|Dose Level 1|Lost to Follow-up|0|||
24981047|NCT00062868|50069431|FG012|Dose Level 1|Lost to Follow-up|1|||
24981048|NCT00062868|50069432|FG013|Dose Level 1|Lost to Follow-up|0|||
24981049|NCT00062868|50069433|FG014|Dose Level 1|Lost to Follow-up|0|||
24981050|NCT00062868|50069434|FG015|Dose Level 1|Lost to Follow-up|0|||
24981051|NCT00062868|50069435|FG016|Dose Level 1|Lost to Follow-up|0|||
24981052|NCT00062868|50069436|FG017|Dose Level 1|Lost to Follow-up|0|||
24981053|NCT00062868|50069437|FG018|Dose Level 1|Lost to Follow-up|2|||
24981054|NCT00062868|50069438|FG019|Dose Level 1|Lost to Follow-up|0|||
24981055|NCT00062868|50069439|FG020|Dose Level 1|Lost to Follow-up|1|||
24981056|NCT00062868|50069419|FG000|Dose Level 2|Death|0|||
24981057|NCT00062868|50069420|FG001|Dose Level 2|Death|3|||
24981058|NCT00062868|50069421|FG002|Dose Level 2|Death|0|||
24981059|NCT00062868|50069422|FG003|Dose Level 2|Death|0|||
24981060|NCT00062868|50069423|FG004|Dose Level 2|Death|2|||
24981061|NCT00062868|50069424|FG005|Dose Level 2|Death|0|||
24981062|NCT00062868|50069425|FG006|Dose Level 2|Death|0|||
24981063|NCT00062868|50069426|FG007|Dose Level 2|Death|0|||
24981064|NCT00062868|50069427|FG008|Dose Level 2|Death|0|||
24981065|NCT00062868|50069428|FG009|Dose Level 2|Death|0|||
24981066|NCT00062868|50069429|FG010|Dose Level 2|Death|1|||
24981067|NCT00062868|50069430|FG011|Dose Level 2|Death|0|||
24981068|NCT00062868|50069431|FG012|Dose Level 2|Death|0|||
24981069|NCT00062868|50069432|FG013|Dose Level 2|Death|0|||
24981070|NCT00062868|50069433|FG014|Dose Level 2|Death|0|||
24981071|NCT00062868|50069434|FG015|Dose Level 2|Death|0|||
24981072|NCT00062868|50069435|FG016|Dose Level 2|Death|2|||
24981073|NCT00062868|50069436|FG017|Dose Level 2|Death|0|||
24981074|NCT00062868|50069437|FG018|Dose Level 2|Death|0|||
24981075|NCT00062868|50069438|FG019|Dose Level 2|Death|0|||
24981076|NCT00062868|50069439|FG020|Dose Level 2|Death|0|||
24981077|NCT00062868|50069419|FG000|Dose Level 2|Lost to Follow-up|0|||
24981078|NCT00062868|50069420|FG001|Dose Level 2|Lost to Follow-up|0|||
24981079|NCT00062868|50069421|FG002|Dose Level 2|Lost to Follow-up|0|||
24981080|NCT00062868|50069422|FG003|Dose Level 2|Lost to Follow-up|0|||
24981081|NCT00062868|50069423|FG004|Dose Level 2|Lost to Follow-up|0|||
24981082|NCT00062868|50069424|FG005|Dose Level 2|Lost to Follow-up|0|||
24981083|NCT00062868|50069425|FG006|Dose Level 2|Lost to Follow-up|0|||
24981084|NCT00062868|50069426|FG007|Dose Level 2|Lost to Follow-up|0|||
24981085|NCT00062868|50069427|FG008|Dose Level 2|Lost to Follow-up|0|||
24981086|NCT00062868|50069428|FG009|Dose Level 2|Lost to Follow-up|0|||
24981087|NCT00062868|50069429|FG010|Dose Level 2|Lost to Follow-up|0|||
24981088|NCT00062868|50069430|FG011|Dose Level 2|Lost to Follow-up|0|||
24981089|NCT00062868|50069431|FG012|Dose Level 2|Lost to Follow-up|0|||
24981090|NCT00062868|50069432|FG013|Dose Level 2|Lost to Follow-up|1|||
24981091|NCT00062868|50069433|FG014|Dose Level 2|Lost to Follow-up|0|||
24981092|NCT00062868|50069434|FG015|Dose Level 2|Lost to Follow-up|0|||
24981093|NCT00062868|50069435|FG016|Dose Level 2|Lost to Follow-up|1|||
24981094|NCT00062868|50069436|FG017|Dose Level 2|Lost to Follow-up|0|||
24981095|NCT00062868|50069437|FG018|Dose Level 2|Lost to Follow-up|0|||
24981096|NCT00062868|50069438|FG019|Dose Level 2|Lost to Follow-up|0|||
24981097|NCT00062868|50069439|FG020|Dose Level 2|Lost to Follow-up|0|||
24981098|NCT00062868|50069419|FG000|Dose Level 3|Death|0|||
24981099|NCT00062868|50069420|FG001|Dose Level 3|Death|0|||
24981100|NCT00062868|50069421|FG002|Dose Level 3|Death|0|||
24981101|NCT00062868|50069422|FG003|Dose Level 3|Death|0|||
24981102|NCT00062868|50069423|FG004|Dose Level 3|Death|0|||
24981103|NCT00062868|50069424|FG005|Dose Level 3|Death|0|||
24981104|NCT00062868|50069425|FG006|Dose Level 3|Death|0|||
24981105|NCT00062868|50069426|FG007|Dose Level 3|Death|0|||
24981106|NCT00062868|50069427|FG008|Dose Level 3|Death|0|||
24981107|NCT00062868|50069428|FG009|Dose Level 3|Death|0|||
24981108|NCT00062868|50069429|FG010|Dose Level 3|Death|0|||
24981109|NCT00062868|50069430|FG011|Dose Level 3|Death|1|||
24981110|NCT00062868|50069431|FG012|Dose Level 3|Death|0|||
24981111|NCT00062868|50069432|FG013|Dose Level 3|Death|0|||
24981112|NCT00062868|50069433|FG014|Dose Level 3|Death|0|||
24981113|NCT00062868|50069434|FG015|Dose Level 3|Death|0|||
24981114|NCT00062868|50069435|FG016|Dose Level 3|Death|0|||
24981115|NCT00062868|50069436|FG017|Dose Level 3|Death|1|||
24981116|NCT00062868|50069437|FG018|Dose Level 3|Death|0|||
24981117|NCT00062868|50069438|FG019|Dose Level 3|Death|0|||
24981118|NCT00062868|50069439|FG020|Dose Level 3|Death|0|||
24981119|NCT00062868|50069419|FG000|Dose Level 3|Lost to Follow-up|0|||
24981120|NCT00062868|50069420|FG001|Dose Level 3|Lost to Follow-up|0|||
24981121|NCT00062868|50069421|FG002|Dose Level 3|Lost to Follow-up|0|||
24981122|NCT00062868|50069422|FG003|Dose Level 3|Lost to Follow-up|0|||
24981123|NCT00062868|50069423|FG004|Dose Level 3|Lost to Follow-up|0|||
24981124|NCT00062868|50069424|FG005|Dose Level 3|Lost to Follow-up|0|||
24981125|NCT00062868|50069425|FG006|Dose Level 3|Lost to Follow-up|0|||
24981126|NCT00062868|50069426|FG007|Dose Level 3|Lost to Follow-up|0|||
24981127|NCT00062868|50069427|FG008|Dose Level 3|Lost to Follow-up|0|||
24981128|NCT00062868|50069428|FG009|Dose Level 3|Lost to Follow-up|0|||
24981129|NCT00062868|50069429|FG010|Dose Level 3|Lost to Follow-up|0|||
24981130|NCT00062868|50069430|FG011|Dose Level 3|Lost to Follow-up|0|||
24981131|NCT00062868|50069431|FG012|Dose Level 3|Lost to Follow-up|0|||
24981132|NCT00062868|50069432|FG013|Dose Level 3|Lost to Follow-up|0|||
24981133|NCT00062868|50069433|FG014|Dose Level 3|Lost to Follow-up|1|||
24981134|NCT00062868|50069434|FG015|Dose Level 3|Lost to Follow-up|0|||
24981135|NCT00062868|50069435|FG016|Dose Level 3|Lost to Follow-up|0|||
24981136|NCT00062868|50069436|FG017|Dose Level 3|Lost to Follow-up|0|||
24981137|NCT00062868|50069437|FG018|Dose Level 3|Lost to Follow-up|0|||
24981138|NCT00062868|50069438|FG019|Dose Level 3|Lost to Follow-up|0|||
24981139|NCT00062868|50069439|FG020|Dose Level 3|Lost to Follow-up|0|||
24981140|NCT00062868|50069419|FG000|Dose Level 3|Withdrew|0|||
24981141|NCT00062868|50069420|FG001|Dose Level 3|Withdrew|0|||
24981142|NCT00062868|50069421|FG002|Dose Level 3|Withdrew|2|||
24981143|NCT00062868|50069422|FG003|Dose Level 3|Withdrew|0|||
24981144|NCT00062868|50069423|FG004|Dose Level 3|Withdrew|0|||
24981145|NCT00062868|50069424|FG005|Dose Level 3|Withdrew|0|||
24981146|NCT00062868|50069425|FG006|Dose Level 3|Withdrew|0|||
24981147|NCT00062868|50069426|FG007|Dose Level 3|Withdrew|0|||
24981148|NCT00062868|50069427|FG008|Dose Level 3|Withdrew|0|||
24981149|NCT00062868|50069428|FG009|Dose Level 3|Withdrew|0|||
24981150|NCT00062868|50069429|FG010|Dose Level 3|Withdrew|0|||
24981151|NCT00062868|50069430|FG011|Dose Level 3|Withdrew|0|||
24981152|NCT00062868|50069431|FG012|Dose Level 3|Withdrew|0|||
24981153|NCT00062868|50069432|FG013|Dose Level 3|Withdrew|0|||
24981154|NCT00062868|50069433|FG014|Dose Level 3|Withdrew|0|||
24981155|NCT00062868|50069434|FG015|Dose Level 3|Withdrew|0|||
24981156|NCT00062868|50069435|FG016|Dose Level 3|Withdrew|0|||
24981157|NCT00062868|50069436|FG017|Dose Level 3|Withdrew|0|||
24981158|NCT00062868|50069437|FG018|Dose Level 3|Withdrew|0|||
24981159|NCT00062868|50069438|FG019|Dose Level 3|Withdrew|0|||
24981160|NCT00062868|50069439|FG020|Dose Level 3|Withdrew|0|||
24981161|NCT00075504|50069485|FG000|Overall Study|Withdrawal by Subject|9|||
24981162|NCT00075504|50069486|FG001|Overall Study|Withdrawal by Subject|7|||
24981163|NCT00062166|50069492|FG000|Overall Study|Withdrawal by Subject|6|||
24981164|NCT00087438|50069497|FG000|Overall Study|Ineligible / No protocol treatment|4|||
24981165|NCT00321464|50069505|FG000|Overall Study|Death|169|||
24981166|NCT00321464|50069506|FG001|Overall Study|Death|174|||
24981167|NCT00321464|50069505|FG000|Overall Study|Disease progression|124|||
24981168|NCT00321464|50069506|FG001|Overall Study|Disease progression|124|||
24981169|NCT00321464|50069505|FG000|Overall Study|Withdrawal by Subject|117|||
24981170|NCT00321464|50069506|FG001|Overall Study|Withdrawal by Subject|118|||
24981171|NCT00321464|50069505|FG000|Overall Study|Participant request|57|||
24981172|NCT00321464|50069506|FG001|Overall Study|Participant request|61|||
24981173|NCT00321464|50069505|FG000|Overall Study|Adverse Event|43|||
24981174|NCT00321464|50069506|FG001|Overall Study|Adverse Event|28|||
24981175|NCT00321464|50069505|FG000|Overall Study|Physician Decision|15|||
24981176|NCT00321464|50069506|FG001|Overall Study|Physician Decision|14|||
24981177|NCT00321464|50069505|FG000|Overall Study|Noncompliance|4|||
24981178|NCT00321464|50069506|FG001|Overall Study|Noncompliance|10|||
24981179|NCT00321464|50069505|FG000|Overall Study|Lost to Follow-up|7|||
24981180|NCT00321464|50069506|FG001|Overall Study|Lost to Follow-up|8|||
24981181|NCT00321464|50069505|FG000|Overall Study|Protocol deviation|0|||
24981182|NCT00321464|50069506|FG001|Overall Study|Protocol deviation|2|||
24981183|NCT00321464|50069505|FG000|Overall Study|Ineligibility determined|2|||
24981184|NCT00321464|50069506|FG001|Overall Study|Ineligibility determined|1|||
24981185|NCT00321464|50069505|FG000|Overall Study|Other|21|||
24981186|NCT00321464|50069506|FG001|Overall Study|Other|18|||
24981187|NCT02889796|50069516|FG000|Overall Study|Withdrew Consent|18|||
24981188|NCT02889796|50069517|FG001|Overall Study|Withdrew Consent|29|||
24981189|NCT02889796|50069518|FG002|Overall Study|Withdrew Consent|20|||
24981190|NCT02889796|50069519|FG003|Overall Study|Withdrew Consent|1|||
24981191|NCT02889796|50069520|FG004|Overall Study|Withdrew Consent|2|||
24981192|NCT02889796|50069521|FG005|Overall Study|Withdrew Consent|35|||
24981193|NCT02889796|50069516|FG000|Overall Study|Investigator's Discretion|10|||
24981194|NCT02889796|50069517|FG001|Overall Study|Investigator's Discretion|9|||
24981195|NCT02889796|50069518|FG002|Overall Study|Investigator's Discretion|10|||
24981196|NCT02889796|50069519|FG003|Overall Study|Investigator's Discretion|3|||
24981197|NCT02889796|50069520|FG004|Overall Study|Investigator's Discretion|0|||
24981198|NCT02889796|50069521|FG005|Overall Study|Investigator's Discretion|15|||
24981199|NCT02889796|50069516|FG000|Overall Study|Adverse Event|17|||
24981200|NCT02889796|50069517|FG001|Overall Study|Adverse Event|8|||
24981201|NCT02889796|50069518|FG002|Overall Study|Adverse Event|8|||
24981202|NCT02889796|50069519|FG003|Overall Study|Adverse Event|4|||
24981203|NCT02889796|50069520|FG004|Overall Study|Adverse Event|1|||
24981204|NCT02889796|50069521|FG005|Overall Study|Adverse Event|7|||
24981205|NCT02889796|50069516|FG000|Overall Study|Lost to Follow-up|5|||
24981206|NCT02889796|50069517|FG001|Overall Study|Lost to Follow-up|7|||
24981207|NCT02889796|50069518|FG002|Overall Study|Lost to Follow-up|2|||
24981208|NCT02889796|50069519|FG003|Overall Study|Lost to Follow-up|0|||
24981209|NCT02889796|50069520|FG004|Overall Study|Lost to Follow-up|2|||
24981210|NCT02889796|50069521|FG005|Overall Study|Lost to Follow-up|6|||
24981211|NCT02889796|50069516|FG000|Overall Study|Protocol Violation|0|||
24981212|NCT02889796|50069517|FG001|Overall Study|Protocol Violation|1|||
24981213|NCT02889796|50069518|FG002|Overall Study|Protocol Violation|3|||
24981214|NCT02889796|50069519|FG003|Overall Study|Protocol Violation|0|||
24981215|NCT02889796|50069520|FG004|Overall Study|Protocol Violation|0|||
24981216|NCT02889796|50069521|FG005|Overall Study|Protocol Violation|4|||
24981217|NCT02889796|50069516|FG000|Overall Study|Non-compliance With Study Drug|0|||
24981218|NCT02889796|50069517|FG001|Overall Study|Non-compliance With Study Drug|2|||
24981219|NCT02889796|50069518|FG002|Overall Study|Non-compliance With Study Drug|0|||
24981220|NCT02889796|50069519|FG003|Overall Study|Non-compliance With Study Drug|0|||
24981221|NCT02889796|50069520|FG004|Overall Study|Non-compliance With Study Drug|1|||
24981222|NCT02889796|50069521|FG005|Overall Study|Non-compliance With Study Drug|2|||
24981223|NCT02889796|50069516|FG000|Overall Study|Death|1|||
24981224|NCT02889796|50069517|FG001|Overall Study|Death|1|||
24981225|NCT02889796|50069518|FG002|Overall Study|Death|0|||
24981226|NCT02889796|50069519|FG003|Overall Study|Death|1|||
24981227|NCT02889796|50069520|FG004|Overall Study|Death|0|||
24981228|NCT02889796|50069521|FG005|Overall Study|Death|1|||
24981229|NCT02889796|50069516|FG000|Overall Study|Pregnancy|0|||
24981230|NCT02889796|50069517|FG001|Overall Study|Pregnancy|1|||
24981231|NCT02889796|50069518|FG002|Overall Study|Pregnancy|1|||
24981232|NCT02889796|50069519|FG003|Overall Study|Pregnancy|0|||
24981233|NCT02889796|50069520|FG004|Overall Study|Pregnancy|0|||
24981234|NCT02889796|50069521|FG005|Overall Study|Pregnancy|0|||
24981235|NCT02889796|50069516|FG000|Overall Study|Randomized but not Dosed|2|||
24981236|NCT02889796|50069517|FG001|Overall Study|Randomized but not Dosed|0|||
24981237|NCT02889796|50069518|FG002|Overall Study|Randomized but not Dosed|0|||
24981238|NCT02889796|50069519|FG003|Overall Study|Randomized but not Dosed|0|||
24981239|NCT02889796|50069520|FG004|Overall Study|Randomized but not Dosed|0|||
24981240|NCT02889796|50069521|FG005|Overall Study|Randomized but not Dosed|2|||
24981241|NCT02889562|50069546|FG000|Overall Study|Physician Decision|0|||
24981242|NCT02889562|50069547|FG001|Overall Study|Physician Decision|1|||
24981243|NCT02889562|50069546|FG000|Overall Study|Withdrawal by Subject|0|||
24981244|NCT02889562|50069547|FG001|Overall Study|Withdrawal by Subject|1|||
24981245|NCT03323164|50069555|FG000|Overall Study|Poor quality imaging/scans|2|||
24981246|NCT03323164|50069556|FG001|Overall Study|Poor quality imaging/scans|2|||
24981247|NCT03323086|50069568|FG000|Overall Study|Lost to Follow-up|3|||
24981248|NCT03323086|50069569|FG001|Overall Study|Lost to Follow-up|2|||
24981249|NCT02888080|50069577|FG000|Overall Study|Subject / Guardian decision|1|||
24981250|NCT02888080|50069578|FG001|Overall Study|Subject / Guardian decision|3|||
24981251|NCT02888080|50069577|FG000|Overall Study|New Therapy for study indication|1|||
24981252|NCT02888080|50069578|FG001|Overall Study|New Therapy for study indication|0|||
24981253|NCT02888080|50069577|FG000|Overall Study|Lack of Efficacy|0|||
24981254|NCT02888080|50069578|FG001|Overall Study|Lack of Efficacy|1|||
24981255|NCT02888080|50069577|FG000|Overall Study|Adverse Event|0|||
24981256|NCT02888080|50069578|FG001|Overall Study|Adverse Event|1|||
24981257|NCT03322462|50069584|FG000|Overall Study|Technical difficulties|2|||
24981258|NCT03322462|50069584|FG000|Overall Study|Other|1|||
24981259|NCT00086580|50069592|FG000|Treatment Period|Disease progression|9|||
24981260|NCT00086580|50069593|FG001|Treatment Period|Disease progression|8|||
24981261|NCT00086580|50069592|FG000|Treatment Period|Unable to comply with protocol|3|||
24981262|NCT00086580|50069593|FG001|Treatment Period|Unable to comply with protocol|1|||
24981263|NCT00086580|50069592|FG000|Treatment Period|Withdrawal by Subject|7|||
24981264|NCT00086580|50069593|FG001|Treatment Period|Withdrawal by Subject|8|||
24981265|NCT00086580|50069592|FG000|Treatment Period|Physician Decision|13|||
24981266|NCT00086580|50069593|FG001|Treatment Period|Physician Decision|7|||
24981267|NCT00086580|50069592|FG000|Treatment Period|AE - not treatment related|7|||
24981268|NCT00086580|50069593|FG001|Treatment Period|AE - not treatment related|7|||
24981269|NCT00086580|50069592|FG000|Treatment Period|Toxicity - treatment related|15|||
24981270|NCT00086580|50069593|FG001|Treatment Period|Toxicity - treatment related|15|||
24981271|NCT00086580|50069592|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
24981272|NCT00086580|50069593|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
24981273|NCT00086580|50069592|FG000|Treatment Period|Death|5|||
24981274|NCT00086580|50069593|FG001|Treatment Period|Death|7|||
24981275|NCT00086580|50069592|FG000|Treatment Period|Other|5|||
24981276|NCT00086580|50069593|FG001|Treatment Period|Other|3|||
24981277|NCT00086580|50069592|FG000|Follow-up Period|Disease progression|72|||
24981278|NCT00086580|50069593|FG001|Follow-up Period|Disease progression|99|||
24981279|NCT00086580|50069592|FG000|Follow-up Period|Unable to comply with protocol|5|||
24981280|NCT00086580|50069593|FG001|Follow-up Period|Unable to comply with protocol|0|||
24981281|NCT00086580|50069592|FG000|Follow-up Period|Withdrawal by Subject|6|||
24981282|NCT00086580|50069593|FG001|Follow-up Period|Withdrawal by Subject|6|||
24981283|NCT00086580|50069592|FG000|Follow-up Period|Physician Decision|0|||
24981284|NCT00086580|50069593|FG001|Follow-up Period|Physician Decision|1|||
24981285|NCT00086580|50069592|FG000|Follow-up Period|AE - not related|1|||
24981286|NCT00086580|50069593|FG001|Follow-up Period|AE - not related|0|||
24981287|NCT00086580|50069592|FG000|Follow-up Period|Death|13|||
24981288|NCT00086580|50069593|FG001|Follow-up Period|Death|7|||
24981289|NCT00086580|50069592|FG000|Follow-up Period|Other|7|||
24981290|NCT00086580|50069593|FG001|Follow-up Period|Other|6|||
24981291|NCT00086580|50069592|FG000|Observation Period|Unable to comply with protocol|1|||
24981292|NCT00086580|50069593|FG001|Observation Period|Unable to comply with protocol|1|||
24981293|NCT00086580|50069592|FG000|Observation Period|Withdrawal by Subject|4|||
24981294|NCT00086580|50069593|FG001|Observation Period|Withdrawal by Subject|2|||
24981295|NCT00086580|50069592|FG000|Observation Period|Death|33|||
24981296|NCT00086580|50069593|FG001|Observation Period|Death|55|||
24981297|NCT00086580|50069592|FG000|Observation Period|Other|8|||
24981298|NCT00086580|50069593|FG001|Observation Period|Other|7|||
24981299|NCT00086502|50069601|FG000|Overall Study|Adverse Event|11|||
24981300|NCT00086502|50069602|FG001|Overall Study|Adverse Event|2|||
24981301|NCT00086502|50069601|FG000|Overall Study|Lack of Efficacy|0|||
24981302|NCT00086502|50069602|FG001|Overall Study|Lack of Efficacy|2|||
24981303|NCT00086502|50069601|FG000|Overall Study|Lost to Follow-up|3|||
24981304|NCT00086502|50069602|FG001|Overall Study|Lost to Follow-up|1|||
24981305|NCT00086502|50069601|FG000|Overall Study|Physician Decision|1|||
24981306|NCT00086502|50069602|FG001|Overall Study|Physician Decision|1|||
24981307|NCT00086502|50069601|FG000|Overall Study|Pregnancy|0|||
25255495|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
25255496|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
25255497|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
25255498|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
25255499|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
25255500|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
25255501|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
25255502|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
25341989|NCT00756314|50658337|FG001|Overall Study|Lost to Follow-up|59|||
24981308|NCT00086502|50069602|FG001|Overall Study|Pregnancy|1|||
24981309|NCT00086502|50069601|FG000|Overall Study|Protocol Violation|3|||
24981310|NCT00086502|50069602|FG001|Overall Study|Protocol Violation|3|||
24981311|NCT00086502|50069601|FG000|Overall Study|Withdrawal by Subject|5|||
24981312|NCT00086502|50069602|FG001|Overall Study|Withdrawal by Subject|6|||
24981313|NCT00086502|50069601|FG000|Overall Study|Patient Moved|1|||
24981314|NCT00086502|50069602|FG001|Overall Study|Patient Moved|1|||
24981315|NCT00086502|50069601|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
24981316|NCT00086502|50069602|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
24981317|NCT00086502|50069601|FG000|Overall Study|Patient Accidentally Unblinded|1|||
24981318|NCT00086502|50069602|FG001|Overall Study|Patient Accidentally Unblinded|0|||
24981319|NCT03826667|50069608|FG000|Overall Study|Protocol deviation|21|||
24981320|NCT03636542|50069620|FG000|Overall Study|Lost to Follow-up|1|||
24981321|NCT03636542|50069621|FG001|Overall Study|Lost to Follow-up|1|||
24981322|NCT03636542|50069620|FG000|Overall Study|Physician Decision|0|||
24981323|NCT03636542|50069621|FG001|Overall Study|Physician Decision|1|||
24981324|NCT03636542|50069620|FG000|Overall Study|Withdrawal by Subject|1|||
24981325|NCT03636542|50069621|FG001|Overall Study|Withdrawal by Subject|0|||
24981326|NCT03305770|50069629|FG000|Overall Study|Physician Decision - prior to dispense|0|||
24981327|NCT03305770|50069630|FG001|Overall Study|Physician Decision - prior to dispense|1|||
24981328|NCT03305770|50069629|FG000|Overall Study|Subject moved|1|||
24981329|NCT03305770|50069630|FG001|Overall Study|Subject moved|0|||
24981330|NCT00086190|50069641|FG000|Overall Study|Adverse Event|6|||
24981331|NCT00086190|50069642|FG001|Overall Study|Adverse Event|2|||
24981332|NCT00086190|50069643|FG002|Overall Study|Adverse Event|2|||
24981333|NCT00086190|50069641|FG000|Overall Study|Withdrawal by Subject|0|||
24981334|NCT00086190|50069642|FG001|Overall Study|Withdrawal by Subject|2|||
24981335|NCT00086190|50069643|FG002|Overall Study|Withdrawal by Subject|2|||
24981336|NCT00086190|50069641|FG000|Overall Study|Protocol Violation|1|||
24981337|NCT00086190|50069642|FG001|Overall Study|Protocol Violation|0|||
24981338|NCT00086190|50069643|FG002|Overall Study|Protocol Violation|0|||
24981339|NCT00086190|50069641|FG000|Overall Study|Moved|1|||
24981340|NCT00086190|50069642|FG001|Overall Study|Moved|0|||
24981341|NCT00086190|50069643|FG002|Overall Study|Moved|0|||
24981342|NCT00086190|50069641|FG000|Overall Study|Worsening depression|0|||
24981343|NCT00086190|50069642|FG001|Overall Study|Worsening depression|0|||
24981344|NCT00086190|50069643|FG002|Overall Study|Worsening depression|2|||
24981345|NCT03320824|50069653|FG000|Overall Study|Withdrawal by Subject|8|||
24981346|NCT03320824|50069654|FG001|Overall Study|Withdrawal by Subject|1|||
24981347|NCT03320824|50069653|FG000|Overall Study|Lost to Follow-up|10|||
24981348|NCT03320824|50069654|FG001|Overall Study|Lost to Follow-up|1|||
24981349|NCT03320824|50069653|FG000|Overall Study|moved out of state|0|||
24981350|NCT03320824|50069654|FG001|Overall Study|moved out of state|1|||
24981351|NCT03320824|50069653|FG000|Overall Study|could not complete final visit|0|||
24981352|NCT03320824|50069654|FG001|Overall Study|could not complete final visit|1|||
24981353|NCT03275350|50069666|FG000|Overall Study|Lost to Follow-up|4|||
24981354|NCT03275350|50069667|FG001|Overall Study|Lost to Follow-up|6|||
24981355|NCT03275350|50069666|FG000|Overall Study|Death|2|||
24981356|NCT03275350|50069667|FG001|Overall Study|Death|1|||
24981357|NCT03275350|50069666|FG000|Overall Study|Physician Decision|1|||
24981358|NCT03275350|50069667|FG001|Overall Study|Physician Decision|0|||
24981359|NCT03275350|50069666|FG000|Overall Study|Incarcerated|1|||
24981360|NCT03275350|50069667|FG001|Overall Study|Incarcerated|1|||
24981361|NCT03319732|50069674|FG000|Overall Study|Adverse Event|40|||
24981362|NCT03319732|50069674|FG000|Overall Study|Withdrawal by Subject|50|||
24981363|NCT03319732|50069674|FG000|Overall Study|MS relapse|10|||
24981364|NCT03319732|50069674|FG000|Overall Study|reason not specified|5|||
24981365|NCT03304522|50069681|FG000|Overall Study|Adverse Event|0|||
24981366|NCT03304522|50069682|FG001|Overall Study|Adverse Event|4|||
24981367|NCT03304522|50069681|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
24981368|NCT03304522|50069682|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
24981369|NCT03304522|50069681|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
24981370|NCT03304522|50069682|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
24981371|NCT03304522|50069681|FG000|Overall Study|Other|0|||
24981372|NCT03304522|50069682|FG001|Overall Study|Other|1|||
24981373|NCT03315286|50069690|FG000|Overall Study|Lost to Follow-up|0|||
24981374|NCT03315286|50069691|FG001|Overall Study|Lost to Follow-up|3|||
24981375|NCT03315286|50069690|FG000|Overall Study|Withdrawal by Subject|1|||
24981376|NCT03315286|50069691|FG001|Overall Study|Withdrawal by Subject|0|||
24981377|NCT03315286|50069690|FG000|Overall Study|Protocol Violation|0|||
24981378|NCT03315286|50069691|FG001|Overall Study|Protocol Violation|1|||
24981379|NCT03273946|50069697|FG000|Overall Study|Withdrawal by Subject|5|||
24981380|NCT03273946|50069697|FG000|Overall Study|Unwillingness of the guardian|1|||
24981381|NCT03273946|50069697|FG000|Overall Study|Participant refused to use the drug|2|||
24981382|NCT03273946|50069697|FG000|Overall Study|Participant relative refused to use drug|1|||
24981383|NCT00314951|50069703|FG000|Treatment|Didn't meet criteria for mITT population|16|||
24981384|NCT00314951|50069704|FG001|Treatment|Didn't meet criteria for mITT population|11|||
24981385|NCT00314951|50069703|FG000|Follow-up|mITT failure|44|||
24981386|NCT00314951|50069704|FG001|Follow-up|mITT failure|34|||
24981387|NCT00085644|50069712|FG000|Double-Blind Period|Adverse Event|5|||
24981388|NCT00085644|50069713|FG001|Double-Blind Period|Adverse Event|2|||
24981389|NCT00085644|50069714|FG002|Double-Blind Period|Adverse Event|0|||
24981390|NCT00085644|50069712|FG000|Double-Blind Period|Withdrawal by Subject|3|||
24981391|NCT00085644|50069713|FG001|Double-Blind Period|Withdrawal by Subject|0|||
24981392|NCT00085644|50069714|FG002|Double-Blind Period|Withdrawal by Subject|0|||
24981393|NCT00085644|50069712|FG000|Double-Blind Period|Lost to Follow-up|2|||
24981394|NCT00085644|50069713|FG001|Double-Blind Period|Lost to Follow-up|1|||
24981395|NCT00085644|50069714|FG002|Double-Blind Period|Lost to Follow-up|0|||
24981396|NCT00085644|50069712|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
24981397|NCT00085644|50069713|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
24981398|NCT00085644|50069714|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
24981399|NCT00085644|50069712|FG000|Double-Blind Period|Contemplating pregnancy|1|||
24981400|NCT00085644|50069713|FG001|Double-Blind Period|Contemplating pregnancy|0|||
24981401|NCT00085644|50069714|FG002|Double-Blind Period|Contemplating pregnancy|0|||
24981402|NCT00085644|50069712|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
24981403|NCT00085644|50069713|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
24981404|NCT00085644|50069714|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
24981405|NCT00085644|50069712|FG000|Open-Label Period|Adverse Event|0|||
24981406|NCT00085644|50069713|FG001|Open-Label Period|Adverse Event|0|||
24981407|NCT00085644|50069714|FG002|Open-Label Period|Adverse Event|38|||
24981408|NCT00085644|50069712|FG000|Open-Label Period|Withdrawal by Subject|0|||
24981409|NCT00085644|50069713|FG001|Open-Label Period|Withdrawal by Subject|0|||
24981410|NCT00085644|50069714|FG002|Open-Label Period|Withdrawal by Subject|29|||
24981411|NCT00085644|50069712|FG000|Open-Label Period|Lost to Follow-up|0|||
24981412|NCT00085644|50069713|FG001|Open-Label Period|Lost to Follow-up|0|||
24981413|NCT00085644|50069714|FG002|Open-Label Period|Lost to Follow-up|13|||
24981414|NCT00085644|50069712|FG000|Open-Label Period|Lack of Efficacy|0|||
24981415|NCT00085644|50069713|FG001|Open-Label Period|Lack of Efficacy|0|||
24981416|NCT00085644|50069714|FG002|Open-Label Period|Lack of Efficacy|15|||
24981417|NCT00085644|50069712|FG000|Open-Label Period|Pregnancy|0|||
24981418|NCT00085644|50069713|FG001|Open-Label Period|Pregnancy|0|||
24981419|NCT00085644|50069714|FG002|Open-Label Period|Pregnancy|3|||
24981420|NCT00085644|50069712|FG000|Open-Label Period|Contemplating pregnancy|0|||
24981421|NCT00085644|50069713|FG001|Open-Label Period|Contemplating pregnancy|0|||
24981422|NCT00085644|50069714|FG002|Open-Label Period|Contemplating pregnancy|3|||
24981423|NCT00085644|50069712|FG000|Open-Label Period|Protocol Violation|0|||
24981424|NCT00085644|50069713|FG001|Open-Label Period|Protocol Violation|0|||
24981425|NCT00085644|50069714|FG002|Open-Label Period|Protocol Violation|4|||
24981426|NCT00085644|50069712|FG000|Open-Label Period|Personal reason|0|||
24981427|NCT00085644|50069713|FG001|Open-Label Period|Personal reason|0|||
24981428|NCT00085644|50069714|FG002|Open-Label Period|Personal reason|4|||
24981429|NCT03315208|50069723|FG000|Overall Study|Lost to Follow-up|11|||
24981430|NCT03315208|50069724|FG001|Overall Study|Lost to Follow-up|6|||
24981431|NCT03315208|50069723|FG000|Overall Study|Withdrawal by Subject|2|||
24981432|NCT03315208|50069724|FG001|Overall Study|Withdrawal by Subject|0|||
24981433|NCT00314795|50069731|FG000|Overall Study|Adverse Event|8|||
24981434|NCT00314795|50069731|FG000|Overall Study|Death|4|||
24981435|NCT00314795|50069731|FG000|Overall Study|Reason not Specified|3|||
24981436|NCT00314795|50069731|FG000|Overall Study|Renal Transplant|3|||
24981437|NCT00314795|50069731|FG000|Overall Study|Participants Withdrew Consent|2|||
24981438|NCT00314327|50069735|FG000|Overall Study|Withdrawal by Subject|1|||
24981439|NCT00336479|50069743|FG000|Overall Study|Adverse Event|8|||
24981440|NCT00336479|50069744|FG001|Overall Study|Adverse Event|11|||
24981441|NCT00336479|50069745|FG002|Overall Study|Adverse Event|18|||
24981442|NCT00336479|50069746|FG003|Overall Study|Adverse Event|4|||
24981443|NCT00336479|50069743|FG000|Overall Study|Noncompliant|1|||
24981444|NCT00336479|50069744|FG001|Overall Study|Noncompliant|7|||
24981445|NCT00336479|50069745|FG002|Overall Study|Noncompliant|3|||
24981446|NCT00336479|50069746|FG003|Overall Study|Noncompliant|0|||
24981447|NCT00336479|50069743|FG000|Overall Study|Physician Decision|2|||
24981448|NCT00336479|50069744|FG001|Overall Study|Physician Decision|3|||
24981449|NCT00336479|50069745|FG002|Overall Study|Physician Decision|1|||
24981450|NCT00336479|50069746|FG003|Overall Study|Physician Decision|0|||
24981451|NCT00336479|50069743|FG000|Overall Study|Lost to Follow-up|3|||
24981452|NCT00336479|50069744|FG001|Overall Study|Lost to Follow-up|2|||
24981453|NCT00336479|50069745|FG002|Overall Study|Lost to Follow-up|0|||
24981454|NCT00336479|50069746|FG003|Overall Study|Lost to Follow-up|0|||
24981455|NCT00336479|50069743|FG000|Overall Study|Withdrawal by Subject|3|||
24981456|NCT00336479|50069744|FG001|Overall Study|Withdrawal by Subject|2|||
24981457|NCT00336479|50069745|FG002|Overall Study|Withdrawal by Subject|3|||
24981458|NCT00336479|50069746|FG003|Overall Study|Withdrawal by Subject|0|||
24981459|NCT00336479|50069743|FG000|Overall Study|Other|0|||
24981460|NCT00336479|50069744|FG001|Overall Study|Other|0|||
24981461|NCT00336479|50069745|FG002|Overall Study|Other|1|||
24981462|NCT00336479|50069746|FG003|Overall Study|Other|0|||
24981463|NCT00336479|50069743|FG000|Overall Study|Virologic Stopping Rule|20|||
24981464|NCT00336479|50069744|FG001|Overall Study|Virologic Stopping Rule|0|||
24981465|NCT00336479|50069745|FG002|Overall Study|Virologic Stopping Rule|0|||
24981466|NCT00336479|50069746|FG003|Overall Study|Virologic Stopping Rule|0|||
24981467|NCT00314249|50069759|FG000|Overall Study|Adverse Event|73|||
24981468|NCT00314249|50069760|FG001|Overall Study|Adverse Event|94|||
24981469|NCT00314249|50069759|FG000|Overall Study|Lack of Efficacy|33|||
24981470|NCT00314249|50069760|FG001|Overall Study|Lack of Efficacy|24|||
24981471|NCT00314249|50069759|FG000|Overall Study|Withdrawal by Subject|21|||
24981472|NCT00314249|50069760|FG001|Overall Study|Withdrawal by Subject|28|||
24981473|NCT00314249|50069759|FG000|Overall Study|Lost to Follow-up|15|||
24981474|NCT00314249|50069760|FG001|Overall Study|Lost to Follow-up|9|||
24981475|NCT00314249|50069759|FG000|Overall Study|Physician Decision|1|||
24981476|NCT00314249|50069760|FG001|Overall Study|Physician Decision|1|||
24981477|NCT00314249|50069759|FG000|Overall Study|Withdrawn for other reasons|4|||
24981478|NCT00314249|50069760|FG001|Overall Study|Withdrawn for other reasons|1|||
24981479|NCT00314249|50069759|FG000|Overall Study|Non-Compliant|5|||
24981480|NCT00314249|50069760|FG001|Overall Study|Non-Compliant|6|||
24981481|NCT03315130|50069769|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
24981482|NCT03315130|50069770|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
24981483|NCT03315130|50069771|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
24981484|NCT03315130|50069772|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
24981485|NCT03315130|50069769|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
24981486|NCT03315130|50069770|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
24981487|NCT03315130|50069771|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
24981488|NCT03315130|50069772|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
24981489|NCT03315130|50069769|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
24981490|NCT03315130|50069770|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
24981491|NCT03315130|50069771|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
24981492|NCT03315130|50069772|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
24981493|NCT03315130|50069769|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
24981494|NCT03315130|50069770|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
24981495|NCT03315130|50069771|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
24981496|NCT03315130|50069772|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
24981497|NCT03315130|50069769|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
24981498|NCT03315130|50069770|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
24981499|NCT03315130|50069771|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
24981500|NCT03315130|50069772|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
24981501|NCT03315130|50069769|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
24981502|NCT03315130|50069770|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
24981503|NCT03315130|50069771|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
24981504|NCT03315130|50069772|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
24981505|NCT03273166|50069792|FG000|Overall Study|Withdrawn prior to Completion|31|||
24981506|NCT03314662|50069800|FG000|Overall Study|Withdrawal by Subject|1|||
24981507|NCT03314662|50069801|FG001|Overall Study|Withdrawal by Subject|1|||
24981508|NCT03314662|50069802|FG002|Overall Study|Withdrawal by Subject|1|||
24981509|NCT03314662|50069800|FG000|Overall Study|Lost to Follow-up|5|||
24981510|NCT03314662|50069801|FG001|Overall Study|Lost to Follow-up|4|||
24981511|NCT03314662|50069802|FG002|Overall Study|Lost to Follow-up|4|||
24981512|NCT03314662|50069800|FG000|Overall Study|Death|2|||
24981513|NCT03314662|50069801|FG001|Overall Study|Death|0|||
24981514|NCT03314662|50069802|FG002|Overall Study|Death|0|||
24981515|NCT03271528|50069820|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
24981516|NCT03271528|50069821|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
24981517|NCT03271528|50069820|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
24981518|NCT03271528|50069821|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
24981519|NCT03271528|50069820|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
24981520|NCT03271528|50069821|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
24981521|NCT03271528|50069820|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
24981522|NCT03271528|50069821|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
24981523|NCT03271528|50069820|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
24981524|NCT03271528|50069821|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
24981525|NCT03271528|50069820|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
24981526|NCT03271528|50069821|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
24981527|NCT03271528|50069820|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
24981528|NCT03271528|50069821|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
25341990|NCT00727506|50658349|FG000|Overall Study|Adverse Event|0|||
24981529|NCT03301714|50069830|FG000|Overall Study|Lost to Follow-up|10|||
24981530|NCT03301714|50069831|FG001|Overall Study|Lost to Follow-up|4|||
24981531|NCT03301714|50069832|FG002|Overall Study|Lost to Follow-up|4|||
24981532|NCT03301714|50069830|FG000|Overall Study|Did not receive allocated intervention|0|||
24981533|NCT03301714|50069831|FG001|Overall Study|Did not receive allocated intervention|2|||
24981534|NCT03301714|50069832|FG002|Overall Study|Did not receive allocated intervention|3|||
24981535|NCT03299686|50069845|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
24981536|NCT03299686|50069846|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
24981537|NCT03299686|50069845|FG000|Treatment Epoch|Physician Decision|1|||
24981538|NCT03299686|50069846|FG001|Treatment Epoch|Physician Decision|0|||
24981539|NCT03299686|50069845|FG000|Treatment Epoch|Adverse Event|8|||
24981540|NCT03299686|50069846|FG001|Treatment Epoch|Adverse Event|4|||
24981541|NCT03299686|50069845|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
24981542|NCT03299686|50069846|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
24981543|NCT03462758|50069854|FG000|Overall Study|Chose no or other method of contraception|20|||
24981544|NCT03462758|50069855|FG001|Overall Study|Chose no or other method of contraception|23|||
24981545|NCT03462758|50069854|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
24981546|NCT03462758|50069855|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
24981547|NCT03462758|50069854|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
24981548|NCT03462758|50069855|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
24981549|NCT03462758|50069854|FG000|Overall Study|Medical contraindication|2|||
24981550|NCT03462758|50069855|FG001|Overall Study|Medical contraindication|2|||
24981551|NCT03462758|50069854|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
24981552|NCT03462758|50069855|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
24981553|NCT00075270|50069863|FG000|Overall Study|Withdrawal by Subject|28|||
24981554|NCT00075270|50069864|FG001|Overall Study|Withdrawal by Subject|21|||
24981555|NCT00075270|50069863|FG000|Overall Study|Lost to Follow-up|25|||
24981556|NCT00075270|50069864|FG001|Overall Study|Lost to Follow-up|28|||
24981557|NCT00075270|50069863|FG000|Overall Study|Protocol Violation|0|||
24981558|NCT00075270|50069864|FG001|Overall Study|Protocol Violation|2|||
24981559|NCT00075270|50069863|FG000|Overall Study|Death|198|||
24981560|NCT00075270|50069864|FG001|Overall Study|Death|215|||
24981561|NCT00075270|50069863|FG000|Overall Study|Other/Unknown|9|||
24981562|NCT00075270|50069864|FG001|Overall Study|Other/Unknown|5|||
24981563|NCT00075270|50069863|FG000|Overall Study|Missing|26|||
24981564|NCT00075270|50069864|FG001|Overall Study|Missing|13|||
24981565|NCT00074958|50069871|FG000|Overall Study|Adverse Event|1|||
24981566|NCT03298984|50069879|FG000|Overall Study|Physician Decision|1|||
24981567|NCT03298984|50069880|FG001|Overall Study|Physician Decision|0|||
24981568|NCT03298984|50069881|FG002|Overall Study|Physician Decision|0|||
24981569|NCT03298984|50069882|FG003|Overall Study|Physician Decision|6|||
24981570|NCT03298984|50069879|FG000|Overall Study|Lack of Efficacy|0|||
24981571|NCT03298984|50069880|FG001|Overall Study|Lack of Efficacy|1|||
24981572|NCT03298984|50069881|FG002|Overall Study|Lack of Efficacy|1|||
24981573|NCT03298984|50069882|FG003|Overall Study|Lack of Efficacy|4|||
24981574|NCT03298984|50069879|FG000|Overall Study|Relapsed disease (following remission)|0|||
24981575|NCT03298984|50069880|FG001|Overall Study|Relapsed disease (following remission)|0|||
24981576|NCT03298984|50069881|FG002|Overall Study|Relapsed disease (following remission)|1|||
24981577|NCT03298984|50069882|FG003|Overall Study|Relapsed disease (following remission)|1|||
24981578|NCT03298984|50069879|FG000|Overall Study|Adverse Event|0|||
24981579|NCT03298984|50069880|FG001|Overall Study|Adverse Event|0|||
24981580|NCT03298984|50069881|FG002|Overall Study|Adverse Event|0|||
24981581|NCT03298984|50069882|FG003|Overall Study|Adverse Event|1|||
24981582|NCT03298984|50069879|FG000|Overall Study|Death|0|||
24981583|NCT03298984|50069880|FG001|Overall Study|Death|0|||
24981584|NCT03298984|50069881|FG002|Overall Study|Death|0|||
24981585|NCT03298984|50069882|FG003|Overall Study|Death|2|||
24981586|NCT03298984|50069879|FG000|Overall Study|Insurance Company Decision|0|||
24981587|NCT03298984|50069880|FG001|Overall Study|Insurance Company Decision|0|||
24981588|NCT03298984|50069881|FG002|Overall Study|Insurance Company Decision|0|||
24981589|NCT03298984|50069882|FG003|Overall Study|Insurance Company Decision|1|||
24981590|NCT02940574|50069895|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
24981591|NCT02940574|50069896|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
24981592|NCT02940574|50069895|FG000|1-year Follow-up|Lost to Follow-up|3|||
24981593|NCT02940574|50069896|FG001|1-year Follow-up|Lost to Follow-up|4|||
24981594|NCT03606512|50069908|FG000|Overall Study|Lost to Follow-up|0|||
24981595|NCT03606512|50069909|FG001|Overall Study|Lost to Follow-up|1|||
24981596|NCT03606512|50069908|FG000|Overall Study|'moved from study area|0|||
24981597|NCT03606512|50069909|FG001|Overall Study|'moved from study area|1|||
24981598|NCT03760250|50069931|FG000|Overall Study|Withdrawal by Subject|1|||
24981599|NCT03760250|50069931|FG000|Overall Study|Physician Decision|1|||
24981600|NCT03757988|50069935|FG000|Overall Study|Withdrawal by Subject|1|||
24981601|NCT00313781|50069942|FG000|Before Crossover|Death|22|||
24981602|NCT00313781|50069943|FG001|Before Crossover|Death|8|||
24981603|NCT00313781|50069944|FG002|Before Crossover|Death|0|||
25078200|NCT02224846|50186297|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
25341991|NCT00727506|50658350|FG001|Overall Study|Adverse Event|0|||
24981604|NCT00313781|50069942|FG000|Before Crossover|Lost to Follow-up|0|||
24981605|NCT00313781|50069943|FG001|Before Crossover|Lost to Follow-up|3|||
24981606|NCT00313781|50069944|FG002|Before Crossover|Lost to Follow-up|0|||
24981607|NCT00313781|50069942|FG000|Before Crossover|Withdrawal by Subject|3|||
24981608|NCT00313781|50069943|FG001|Before Crossover|Withdrawal by Subject|1|||
24981609|NCT00313781|50069944|FG002|Before Crossover|Withdrawal by Subject|0|||
24981610|NCT00313781|50069942|FG000|Before Crossover|Other|45|||
24981611|NCT00313781|50069943|FG001|Before Crossover|Other|30|||
24981612|NCT00313781|50069944|FG002|Before Crossover|Other|0|||
24981613|NCT00313781|50069942|FG000|Before Crossover|Crossover|0|||
24981614|NCT00313781|50069943|FG001|Before Crossover|Crossover|37|||
24981615|NCT00313781|50069944|FG002|Before Crossover|Crossover|0|||
24981616|NCT00313781|50069942|FG000|Before Crossover|Randomized, not treated|5|||
24981617|NCT00313781|50069943|FG001|Before Crossover|Randomized, not treated|0|||
24981618|NCT00313781|50069944|FG002|Before Crossover|Randomized, not treated|0|||
24981619|NCT00313781|50069942|FG000|After Crossover|Death|0|||
24981620|NCT00313781|50069943|FG001|After Crossover|Death|0|||
24981621|NCT00313781|50069944|FG002|After Crossover|Death|6|||
24981622|NCT00313781|50069942|FG000|After Crossover|Withdrawal by Subject|0|||
24981623|NCT00313781|50069943|FG001|After Crossover|Withdrawal by Subject|0|||
24981624|NCT00313781|50069944|FG002|After Crossover|Withdrawal by Subject|3|||
24981625|NCT00313781|50069942|FG000|After Crossover|Other|0|||
24981626|NCT00313781|50069943|FG001|After Crossover|Other|0|||
24981627|NCT00313781|50069944|FG002|After Crossover|Other|18|||
24981628|NCT00368537|50069955|FG000|Randomization|No study drug dosed|13|||
24981629|NCT00368537|50069956|FG001|Randomization|No study drug dosed|6|||
24981630|NCT00368537|50069955|FG000|Baseline Participants|Lost to Follow-up|16|||
24981631|NCT00368537|50069956|FG001|Baseline Participants|Lost to Follow-up|17|||
24981632|NCT00368537|50069955|FG000|Baseline Participants|Withdrawal by Subject|6|||
24981633|NCT00368537|50069956|FG001|Baseline Participants|Withdrawal by Subject|4|||
24981634|NCT00368537|50069955|FG000|Baseline Participants|Death|1|||
24981635|NCT00368537|50069956|FG001|Baseline Participants|Death|2|||
24981636|NCT00368537|50069955|FG000|Baseline Participants|No susceptibility|1|||
24981637|NCT00368537|50069956|FG001|Baseline Participants|No susceptibility|0|||
24981638|NCT00368537|50069955|FG000|Baseline Participants|Patient uncompliant|0|||
24981639|NCT00368537|50069956|FG001|Baseline Participants|Patient uncompliant|1|||
24981640|NCT00313703|50069966|FG000|Overall Study|Lost to Follow-up|11|||
24981641|NCT00313703|50069967|FG001|Overall Study|Lost to Follow-up|2|||
24981642|NCT00313703|50069968|FG002|Overall Study|Lost to Follow-up|5|||
24981643|NCT00313703|50069969|FG003|Overall Study|Lost to Follow-up|12|||
24981644|NCT00313313|50069982|FG000|Overall Study|Lack of Efficacy|14|||
24981645|NCT00313313|50069983|FG001|Overall Study|Lack of Efficacy|9|||
24981646|NCT00313313|50069984|FG002|Overall Study|Lack of Efficacy|20|||
24981647|NCT00313313|50069982|FG000|Overall Study|Withdrawal of consent by subject|18|||
24981648|NCT00313313|50069983|FG001|Overall Study|Withdrawal of consent by subject|17|||
24981649|NCT00313313|50069984|FG002|Overall Study|Withdrawal of consent by subject|31|||
24981650|NCT00313313|50069982|FG000|Overall Study|Lost to Follow-up|10|||
24981651|NCT00313313|50069983|FG001|Overall Study|Lost to Follow-up|7|||
24981652|NCT00313313|50069984|FG002|Overall Study|Lost to Follow-up|9|||
24981653|NCT00313313|50069982|FG000|Overall Study|Adverse Event|15|||
24981654|NCT00313313|50069983|FG001|Overall Study|Adverse Event|16|||
24981655|NCT00313313|50069984|FG002|Overall Study|Adverse Event|12|||
24981656|NCT00313313|50069982|FG000|Overall Study|Physician Decision|2|||
24981657|NCT00313313|50069983|FG001|Overall Study|Physician Decision|6|||
24981658|NCT00313313|50069984|FG002|Overall Study|Physician Decision|4|||
24981659|NCT00313313|50069982|FG000|Overall Study|Poor/Noncompliance|3|||
24981660|NCT00313313|50069983|FG001|Overall Study|Poor/Noncompliance|6|||
24981661|NCT00313313|50069984|FG002|Overall Study|Poor/Noncompliance|2|||
24981662|NCT00313313|50069982|FG000|Overall Study|Pregnancy|1|||
24981663|NCT00313313|50069983|FG001|Overall Study|Pregnancy|2|||
24981664|NCT00313313|50069984|FG002|Overall Study|Pregnancy|0|||
24981665|NCT00313313|50069982|FG000|Overall Study|Death|0|||
24981666|NCT00313313|50069983|FG001|Overall Study|Death|0|||
24981667|NCT00313313|50069984|FG002|Overall Study|Death|2|||
24981668|NCT00313313|50069982|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
24981669|NCT00313313|50069983|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
24981670|NCT00313313|50069984|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
24981671|NCT00312845|50069994|FG000|Overall Study|Adverse Event|19|||
24981672|NCT00312845|50069995|FG001|Overall Study|Adverse Event|5|||
24981673|NCT00312845|50069994|FG000|Overall Study|Death|2|||
24981674|NCT00312845|50069995|FG001|Overall Study|Death|2|||
24981675|NCT00312845|50069994|FG000|Overall Study|Withdrawal by Subject|14|||
24981676|NCT00312845|50069995|FG001|Overall Study|Withdrawal by Subject|6|||
24981677|NCT00312845|50069994|FG000|Overall Study|Disease Progression|56|||
24981678|NCT00312845|50069995|FG001|Overall Study|Disease Progression|77|||
24981679|NCT00312845|50069994|FG000|Overall Study|Lost to Follow-up|2|||
24981680|NCT00312845|50069995|FG001|Overall Study|Lost to Follow-up|0|||
24981681|NCT00312845|50069994|FG000|Overall Study|Other|6|||
24981682|NCT00312845|50069995|FG001|Overall Study|Other|5|||
24981683|NCT00368069|50070003|FG000|Overall Study|Adverse Event|5|||
24981684|NCT00368069|50070004|FG001|Overall Study|Adverse Event|2|||
24981685|NCT00368069|50070003|FG000|Overall Study|Lack of Efficacy|0|||
24981686|NCT00368069|50070004|FG001|Overall Study|Lack of Efficacy|1|||
24981687|NCT00368069|50070003|FG000|Overall Study|Lost to Follow-up|1|||
24981688|NCT00368069|50070004|FG001|Overall Study|Lost to Follow-up|0|||
24981689|NCT00368069|50070003|FG000|Overall Study|Protocol Violation|0|||
24981690|NCT00368069|50070004|FG001|Overall Study|Protocol Violation|2|||
24981691|NCT00368069|50070003|FG000|Overall Study|Withdrawal of Consent|2|||
24981692|NCT00368069|50070004|FG001|Overall Study|Withdrawal of Consent|1|||
24981693|NCT00368069|50070003|FG000|Overall Study|no blood sampling possible|0|||
24981694|NCT00368069|50070004|FG001|Overall Study|no blood sampling possible|1|||
24981695|NCT00367991|50070012|FG000|Overall Study|Withdrawal by Subject|1|||
25255503|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
25255504|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
25255505|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
25255506|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
25255507|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
25255508|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
25255509|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
25255510|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
25255511|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
25255512|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
25255513|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
25255514|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
25255515|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
25255516|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
25255517|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
25255518|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
25255519|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
25255520|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
25255521|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
25255522|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
25255523|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
25255524|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
25255525|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
25255526|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
25255527|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
25255528|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
25255529|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
25255530|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
25255531|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
25255532|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
25255533|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
25255534|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
25255535|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
25255536|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
25255537|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
25255538|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
25255539|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
25255540|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
25255541|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
25255542|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
25255543|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
25255544|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
25255545|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
25255546|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
25255547|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
25255548|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
25255549|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
25255550|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
25255551|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
25255552|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
25255553|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
25255554|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
25255555|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
25255556|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
25341992|NCT00727506|50658351|FG002|Overall Study|Adverse Event|4|||
24981696|NCT00367991|50070013|FG001|Overall Study|Withdrawal by Subject|1|||
24981697|NCT00367991|50070012|FG000|Overall Study|Adverse Event|1|||
24981698|NCT00367991|50070013|FG001|Overall Study|Adverse Event|1|||
24981699|NCT00367835|50070021|FG000|Overall Study|Adverse Event|14|||
24981700|NCT00367835|50070022|FG001|Overall Study|Adverse Event|1|||
24981701|NCT00367835|50070021|FG000|Overall Study|Protocol Violation|1|||
24981702|NCT00367835|50070022|FG001|Overall Study|Protocol Violation|7|||
24981703|NCT00367835|50070021|FG000|Overall Study|Withdrawal by Subject|7|||
24981704|NCT00367835|50070022|FG001|Overall Study|Withdrawal by Subject|6|||
24981705|NCT00367835|50070021|FG000|Overall Study|Lost to Follow-up|1|||
24981706|NCT00367835|50070022|FG001|Overall Study|Lost to Follow-up|4|||
24981707|NCT00367835|50070021|FG000|Overall Study|Lack of Efficacy|3|||
24981708|NCT00367835|50070022|FG001|Overall Study|Lack of Efficacy|12|||
24981709|NCT00367835|50070021|FG000|Overall Study|Subject in juvenile detention center|1|||
24981710|NCT00367835|50070022|FG001|Overall Study|Subject in juvenile detention center|0|||
24981711|NCT00367835|50070021|FG000|Overall Study|refused blood collection|1|||
24981712|NCT00367835|50070022|FG001|Overall Study|refused blood collection|0|||
24981713|NCT00367835|50070021|FG000|Overall Study|Did not respond to calls|1|||
24981714|NCT00367835|50070022|FG001|Overall Study|Did not respond to calls|0|||
24981715|NCT00367835|50070021|FG000|Overall Study|History of lead poisoning|0|||
24981716|NCT00367835|50070022|FG001|Overall Study|History of lead poisoning|1|||
24981717|NCT03267940|50070034|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
24981718|NCT03267940|50070035|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
24981719|NCT03267940|50070036|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
24981720|NCT03267940|50070037|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
24981721|NCT03267940|50070038|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
24981722|NCT03267940|50070039|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
24981723|NCT03267940|50070034|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
24981724|NCT03267940|50070035|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
24981725|NCT03267940|50070036|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
24981726|NCT03267940|50070037|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
24981727|NCT03267940|50070038|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
24981728|NCT03267940|50070039|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
24981729|NCT03267940|50070034|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
24981730|NCT03267940|50070035|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
24981731|NCT03267940|50070036|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
24981732|NCT03267940|50070037|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
24981733|NCT03267940|50070038|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
24981734|NCT03267940|50070039|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
24981735|NCT03267940|50070034|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
24981736|NCT03267940|50070035|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
24981737|NCT03267940|50070036|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
24981738|NCT03267940|50070037|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
24981739|NCT03267940|50070038|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
24981740|NCT03267940|50070039|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
24981741|NCT03267940|50070034|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
24981742|NCT03267940|50070035|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
24981743|NCT03267940|50070036|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
24981744|NCT03267940|50070037|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
24981745|NCT03267940|50070038|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
24981746|NCT03267940|50070039|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
24981747|NCT03267940|50070034|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
24981748|NCT03267940|50070035|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
24981749|NCT03267940|50070036|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
24981750|NCT03267940|50070037|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
24981751|NCT03267940|50070038|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
24981752|NCT03267940|50070039|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
24981753|NCT03267940|50070034|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
24981754|NCT03267940|50070035|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
24981755|NCT03267940|50070036|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
24981756|NCT03267940|50070037|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
24981757|NCT03267940|50070038|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
24981758|NCT03267940|50070039|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
24981759|NCT03267940|50070034|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
24981760|NCT03267940|50070035|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
24981761|NCT03267940|50070036|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
24981762|NCT03267940|50070037|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
24981763|NCT03267940|50070038|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
25078201|NCT02224846|50186296|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
25078202|NCT02224846|50186297|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
24981764|NCT03267940|50070039|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
24981765|NCT03267940|50070034|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
24981766|NCT03267940|50070035|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
24981767|NCT03267940|50070036|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
24981768|NCT03267940|50070037|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
24981769|NCT03267940|50070038|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
24981770|NCT03267940|50070039|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
24981771|NCT03296566|50070059|FG000|Overall Study|Lost to Follow-up|19|||
24981772|NCT03296566|50070060|FG001|Overall Study|Lost to Follow-up|46|||
24981773|NCT03296566|50070059|FG000|Overall Study|Withdrawal by Subject|0|||
24981774|NCT03296566|50070060|FG001|Overall Study|Withdrawal by Subject|3|||
24981775|NCT03755882|50070066|FG000|Period 1|Protocol Violation|1|||
24981776|NCT03755882|50070067|FG001|Period 1|Protocol Violation|0|||
24981777|NCT03755882|50070066|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
24981778|NCT03755882|50070067|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
24981779|NCT00312377|50070075|FG000|Overall Study|Death|403|||
24981780|NCT00312377|50070076|FG001|Overall Study|Death|418|||
24981781|NCT00312377|50070075|FG000|Overall Study|Withdrawal by Subject|23|||
24981782|NCT00312377|50070076|FG001|Overall Study|Withdrawal by Subject|30|||
24981783|NCT00312377|50070075|FG000|Overall Study|Lost to Follow-up|9|||
24981784|NCT00312377|50070076|FG001|Overall Study|Lost to Follow-up|12|||
24981785|NCT00312377|50070075|FG000|Overall Study|Non-compliance|0|||
24981786|NCT00312377|50070076|FG001|Overall Study|Non-compliance|2|||
24981787|NCT00312377|50070075|FG000|Overall Study|Randomised but never received treatment|6|||
24981788|NCT00312377|50070076|FG001|Overall Study|Randomised but never received treatment|6|||
24981789|NCT00312377|50070075|FG000|Overall Study|Discontinue treatment survival follow up|202|||
24981790|NCT00312377|50070076|FG001|Overall Study|Discontinue treatment survival follow up|200|||
24981791|NCT00312377|50070075|FG000|Overall Study|Site ended participation in study|1|||
24981792|NCT00312377|50070076|FG001|Overall Study|Site ended participation in study|0|||
24981793|NCT03295318|50070085|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
24981794|NCT03295318|50070086|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
24981795|NCT03295318|50070087|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
24981796|NCT03295318|50070085|FG000|Overall Study|Death|1|||
24981797|NCT03295318|50070086|FG001|Overall Study|Death|1|||
24981798|NCT03295318|50070087|FG002|Overall Study|Death|1|||
24981799|NCT03295318|50070085|FG000|Overall Study|Protocol Violation|4|||
24981800|NCT03295318|50070086|FG001|Overall Study|Protocol Violation|3|||
24981801|NCT03295318|50070087|FG002|Overall Study|Protocol Violation|3|||
24981802|NCT03295318|50070085|FG000|Overall Study|Withdrawal by Subject|0|||
24981803|NCT03295318|50070086|FG001|Overall Study|Withdrawal by Subject|0|||
24981804|NCT03295318|50070087|FG002|Overall Study|Withdrawal by Subject|1|||
24981805|NCT03295318|50070085|FG000|Overall Study|Subject discontinued due to travel|0|||
24981806|NCT03295318|50070086|FG001|Overall Study|Subject discontinued due to travel|1|||
24981807|NCT03295318|50070087|FG002|Overall Study|Subject discontinued due to travel|0|||
24981808|NCT03311230|50070117|FG000|Overall Study|Withdrawal by Subject|1|||
24981809|NCT03311230|50070118|FG001|Overall Study|Withdrawal by Subject|4|||
24981810|NCT03311230|50070119|FG002|Overall Study|Withdrawal by Subject|2|||
24981811|NCT03311230|50070120|FG003|Overall Study|Withdrawal by Subject|7|||
24981812|NCT03311230|50070117|FG000|Overall Study|Unrelated injury|0|||
24981813|NCT03311230|50070118|FG001|Overall Study|Unrelated injury|1|||
24981814|NCT03311230|50070119|FG002|Overall Study|Unrelated injury|0|||
24981815|NCT03311230|50070120|FG003|Overall Study|Unrelated injury|0|||
24981816|NCT00312221|50070133|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
24981817|NCT00312221|50070134|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
24981818|NCT00312221|50070135|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
24981819|NCT00312221|50070136|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
24981820|NCT00312221|50070133|FG000|Open-label Run-in Period|Adverse Event|74|||
24981821|NCT00312221|50070134|FG001|Open-label Run-in Period|Adverse Event|0|||
24981822|NCT00312221|50070135|FG002|Open-label Run-in Period|Adverse Event|0|||
24981823|NCT00312221|50070136|FG003|Open-label Run-in Period|Adverse Event|0|||
24981824|NCT00312221|50070133|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
24981825|NCT00312221|50070134|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
24981826|NCT00312221|50070135|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
24981827|NCT00312221|50070136|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
24981828|NCT00312221|50070133|FG000|Open-label Run-in Period|Administrative|42|||
24981829|NCT00312221|50070134|FG001|Open-label Run-in Period|Administrative|0|||
24981830|NCT00312221|50070135|FG002|Open-label Run-in Period|Administrative|0|||
24981831|NCT00312221|50070136|FG003|Open-label Run-in Period|Administrative|0|||
24981832|NCT00312221|50070133|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
24981833|NCT00312221|50070134|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
24981834|NCT00312221|50070135|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
24981835|NCT00312221|50070136|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
24981836|NCT00312221|50070133|FG000|Open-label Run-in Period|Did not qualify|5|||
24981837|NCT00312221|50070134|FG001|Open-label Run-in Period|Did not qualify|0|||
24981838|NCT00312221|50070135|FG002|Open-label Run-in Period|Did not qualify|0|||
24981839|NCT00312221|50070136|FG003|Open-label Run-in Period|Did not qualify|0|||
24981840|NCT00312221|50070133|FG000|Double-blind Phase|Withdrawal by Subject|0|||
24981841|NCT00312221|50070134|FG001|Double-blind Phase|Withdrawal by Subject|6|||
24981842|NCT00312221|50070135|FG002|Double-blind Phase|Withdrawal by Subject|8|||
24981843|NCT00312221|50070136|FG003|Double-blind Phase|Withdrawal by Subject|7|||
24981844|NCT00312221|50070133|FG000|Double-blind Phase|Adverse Event|0|||
24981845|NCT00312221|50070134|FG001|Double-blind Phase|Adverse Event|10|||
24981846|NCT00312221|50070135|FG002|Double-blind Phase|Adverse Event|19|||
24981847|NCT00312221|50070136|FG003|Double-blind Phase|Adverse Event|18|||
24981848|NCT00312221|50070133|FG000|Double-blind Phase|Lost to Follow-up|0|||
24981849|NCT00312221|50070134|FG001|Double-blind Phase|Lost to Follow-up|0|||
24981850|NCT00312221|50070135|FG002|Double-blind Phase|Lost to Follow-up|2|||
24981851|NCT00312221|50070136|FG003|Double-blind Phase|Lost to Follow-up|2|||
24981852|NCT00312221|50070133|FG000|Double-blind Phase|Administrative|0|||
24981853|NCT00312221|50070134|FG001|Double-blind Phase|Administrative|26|||
24981854|NCT00312221|50070135|FG002|Double-blind Phase|Administrative|37|||
24981855|NCT00312221|50070136|FG003|Double-blind Phase|Administrative|33|||
24981856|NCT00312221|50070133|FG000|Double-blind Phase|Lack of Efficacy|0|||
24981857|NCT00312221|50070134|FG001|Double-blind Phase|Lack of Efficacy|17|||
24981858|NCT00312221|50070135|FG002|Double-blind Phase|Lack of Efficacy|6|||
24981859|NCT00312221|50070136|FG003|Double-blind Phase|Lack of Efficacy|10|||
24981860|NCT03294538|50070160|FG000|Overall Study|Adverse Event|0|||
24981861|NCT03294538|50070161|FG001|Overall Study|Adverse Event|1|||
24981862|NCT03294538|50070162|FG002|Overall Study|Adverse Event|1|||
24981863|NCT03294538|50070160|FG000|Overall Study|Lost to Follow-up|1|||
24981864|NCT03294538|50070161|FG001|Overall Study|Lost to Follow-up|0|||
24981865|NCT03294538|50070162|FG002|Overall Study|Lost to Follow-up|0|||
24981866|NCT03294538|50070160|FG000|Overall Study|Outside of Visit Window|4|||
24981867|NCT03294538|50070161|FG001|Overall Study|Outside of Visit Window|4|||
24981868|NCT03294538|50070162|FG002|Overall Study|Outside of Visit Window|1|||
24981869|NCT03265600|50070172|FG000|Overall Study|Lost to Follow-up|17|||
24981870|NCT03265600|50070173|FG001|Overall Study|Lost to Follow-up|5|||
24981871|NCT03265600|50070172|FG000|Overall Study|Withdrawal by Subject|4|||
24981872|NCT03265600|50070173|FG001|Overall Study|Withdrawal by Subject|2|||
24981873|NCT03265600|50070172|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
24981874|NCT03265600|50070173|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
24981875|NCT00335153|50070179|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
24981876|NCT00335153|50070179|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
24981877|NCT00335153|50070179|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
24981878|NCT00335153|50070179|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
24981879|NCT00335153|50070179|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
24981880|NCT00335153|50070179|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
24981881|NCT00335153|50070179|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
24981882|NCT00335153|50070179|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
24981883|NCT00335153|50070179|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
24981884|NCT00335153|50070179|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
24981885|NCT03265132|50070185|FG000|Overall Study|Adverse Event|0|||
24981886|NCT03265132|50070186|FG001|Overall Study|Adverse Event|1|||
24981887|NCT03265132|50070185|FG000|Overall Study|Lack of Efficacy|0|||
24981888|NCT03265132|50070186|FG001|Overall Study|Lack of Efficacy|2|||
24981889|NCT03265132|50070185|FG000|Overall Study|Progressive disease|0|||
24981890|NCT03265132|50070186|FG001|Overall Study|Progressive disease|2|||
24981891|NCT03265132|50070185|FG000|Overall Study|Withdrawal by Subject|0|||
24981892|NCT03265132|50070186|FG001|Overall Study|Withdrawal by Subject|1|||
24981893|NCT02939950|50070196|FG000|Overall Study|Lost to Follow-up|13|||
24981894|NCT02939950|50070197|FG001|Overall Study|Lost to Follow-up|16|||
24981895|NCT02939950|50070196|FG000|Overall Study|Positive slit lamp findings|0|||
24981896|NCT02939950|50070197|FG001|Overall Study|Positive slit lamp findings|1|||
24981897|NCT02939950|50070196|FG000|Overall Study|Chalazion upper lid|0|||
24981898|NCT02939950|50070197|FG001|Overall Study|Chalazion upper lid|1|||
24981899|NCT02939950|50070196|FG000|Overall Study|Lack of motivation|0|||
24981900|NCT02939950|50070197|FG001|Overall Study|Lack of motivation|2|||
24981901|NCT02939950|50070196|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
24981902|NCT02939950|50070197|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
24981903|NCT02939950|50070196|FG000|Overall Study|Military orders|1|||
24981904|NCT02939950|50070197|FG001|Overall Study|Military orders|0|||
24981905|NCT02939950|50070196|FG000|Overall Study|Participant Relocated|5|||
24981906|NCT02939950|50070197|FG001|Overall Study|Participant Relocated|3|||
24981907|NCT02939950|50070196|FG000|Overall Study|Study related symptoms|8|||
24981908|NCT02939950|50070197|FG001|Overall Study|Study related symptoms|8|||
24981909|NCT02939950|50070196|FG000|Overall Study|Unacceptable lens movement|2|||
24981910|NCT02939950|50070197|FG001|Overall Study|Unacceptable lens movement|0|||
24981911|NCT02939950|50070196|FG000|Overall Study|Protocol Violation|6|||
24981912|NCT02939950|50070197|FG001|Overall Study|Protocol Violation|3|||
24981913|NCT02939950|50070196|FG000|Overall Study|Physician Decision|2|||
24981914|NCT02939950|50070197|FG001|Overall Study|Physician Decision|0|||
24981915|NCT02939950|50070196|FG000|Overall Study|Pregnancy|6|||
24981916|NCT02939950|50070197|FG001|Overall Study|Pregnancy|7|||
24981917|NCT02939950|50070196|FG000|Overall Study|Withdrawal by Subject|12|||
24981918|NCT02939950|50070197|FG001|Overall Study|Withdrawal by Subject|28|||
24981919|NCT02939950|50070196|FG000|Overall Study|Adverse Event|7|||
24981920|NCT02939950|50070197|FG001|Overall Study|Adverse Event|3|||
24981921|NCT02939950|50070196|FG000|Overall Study|Randomized, not dispensed|1|||
24981922|NCT02939950|50070197|FG001|Overall Study|Randomized, not dispensed|0|||
24981923|NCT02939950|50070196|FG000|Overall Study|Ineligible at Baseline|2|||
24981924|NCT02939950|50070197|FG001|Overall Study|Ineligible at Baseline|8|||
24981925|NCT03753542|50070205|FG000|Overall Study|Lost to Follow-up|9|||
24981926|NCT03753542|50070206|FG001|Overall Study|Lost to Follow-up|14|||
24981927|NCT03292588|50070214|FG000|Overall Study|Death|1|||
24981928|NCT03292588|50070215|FG001|Overall Study|Death|0|||
24981929|NCT03292588|50070214|FG000|Overall Study|Lost to Follow-up|12|||
24981930|NCT03292588|50070215|FG001|Overall Study|Lost to Follow-up|16|||
24981931|NCT03292588|50070214|FG000|Overall Study|Physician Decision|0|||
24981932|NCT03292588|50070215|FG001|Overall Study|Physician Decision|1|||
24981933|NCT03292588|50070214|FG000|Overall Study|Withdrawal by Subject|4|||
24981934|NCT03292588|50070215|FG001|Overall Study|Withdrawal by Subject|4|||
24981935|NCT03292588|50070214|FG000|Overall Study|Move out of town|1|||
24981936|NCT03292588|50070215|FG001|Overall Study|Move out of town|0|||
24981937|NCT03292588|50070214|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
24981938|NCT03292588|50070215|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
24981939|NCT03752528|50070223|FG000|Part A|Lost to Follow-up|1|||
24981940|NCT03752528|50070223|FG000|Part A|Protocol Violation|1|||
24981941|NCT03752528|50070223|FG000|Part B|Protocol Violation|1|||
24981942|NCT03752528|50070223|FG000|Part B|Study terminated by sponsor|3|||
24981943|NCT00334295|50070230|FG000|Overall Study|Patients received fewer than 3 injection|5|||
24981944|NCT03292432|50070236|FG000|Overall Study|Lost to Follow-up|11|||
24981945|NCT03292432|50070237|FG001|Overall Study|Lost to Follow-up|8|||
24981946|NCT03292432|50070236|FG000|Overall Study|Death|2|||
24981947|NCT03292432|50070237|FG001|Overall Study|Death|1|||
25078203|NCT01632280|50186305|FG000|Overall Study|Withdrawal by Subject|1|||
25078204|NCT01632280|50186306|FG001|Overall Study|Withdrawal by Subject|0|||
25078205|NCT02224690|50186314|FG000|Overall Study|Adverse Event|8|||
25078206|NCT02224690|50186315|FG001|Overall Study|Adverse Event|1|||
25078207|NCT02224690|50186314|FG000|Overall Study|Met Withdrawal Criteria|4|||
25078208|NCT02224690|50186315|FG001|Overall Study|Met Withdrawal Criteria|0|||
25078209|NCT02224690|50186314|FG000|Overall Study|Use of G-tube|1|||
25078210|NCT02224690|50186315|FG001|Overall Study|Use of G-tube|0|||
25078211|NCT02224690|50186314|FG000|Overall Study|Did not meet eligibility criteria|1|||
25078212|NCT02224690|50186315|FG001|Overall Study|Did not meet eligibility criteria|0|||
25078213|NCT01634152|50186324|FG000|Overall Study|Adverse Event|2|||
25078214|NCT01634152|50186325|FG001|Overall Study|Adverse Event|0|||
25078215|NCT01634152|50186326|FG002|Overall Study|Adverse Event|2|||
25078216|NCT01634152|50186324|FG000|Overall Study|Consent withdrawn not due to AE|1|||
25078217|NCT01634152|50186325|FG001|Overall Study|Consent withdrawn not due to AE|0|||
25078218|NCT01634152|50186326|FG002|Overall Study|Consent withdrawn not due to AE|1|||
25078219|NCT01634152|50186324|FG000|Overall Study|Not treated|0|||
25078220|NCT01634152|50186325|FG001|Overall Study|Not treated|1|||
25078221|NCT01634152|50186326|FG002|Overall Study|Not treated|0|||
25078222|NCT01634152|50186324|FG000|Overall Study|Other reason not defined above|1|||
25078223|NCT01634152|50186325|FG001|Overall Study|Other reason not defined above|0|||
25078224|NCT01634152|50186326|FG002|Overall Study|Other reason not defined above|1|||
25078225|NCT03862807|50186334|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
25078226|NCT01378429|50186358|FG000|Overall Study|Noncompliance with study drug|1|||
25078227|NCT01378429|50186359|FG001|Overall Study|Noncompliance with study drug|0|||
25078228|NCT01599754|50186370|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
25078229|NCT01599754|50186371|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
25078230|NCT01599754|50186370|FG000|Overall Study|Participant noncompliance|4|||
25078231|NCT01599754|50186371|FG001|Overall Study|Participant noncompliance|4|||
25078232|NCT01599754|50186370|FG000|Overall Study|Lost to Follow-up|13|||
25078233|NCT01599754|50186371|FG001|Overall Study|Lost to Follow-up|6|||
25078234|NCT01599754|50186370|FG000|Overall Study|Death|31|||
25078235|NCT01599754|50186371|FG001|Overall Study|Death|33|||
25078236|NCT01599754|50186370|FG000|Overall Study|Adverse Event|3|||
25078237|NCT01599754|50186371|FG001|Overall Study|Adverse Event|2|||
25078238|NCT01599754|50186370|FG000|Overall Study|Investigator decision|1|||
25078239|NCT01599754|50186371|FG001|Overall Study|Investigator decision|3|||
25078240|NCT01599754|50186370|FG000|Overall Study|Withdrawal by Subject|24|||
25078241|NCT01599754|50186371|FG001|Overall Study|Withdrawal by Subject|25|||
24981948|NCT03292432|50070236|FG000|Overall Study|Withdrawal by Subject|1|||
24981949|NCT03292432|50070237|FG001|Overall Study|Withdrawal by Subject|2|||
24981950|NCT03292432|50070236|FG000|Overall Study|Site closed before any data collected|1|||
24981951|NCT03292432|50070237|FG001|Overall Study|Site closed before any data collected|0|||
24981952|NCT03291808|50070243|FG000|Overall Study|Lost to Follow-up|6|||
24981953|NCT03291808|50070243|FG000|Overall Study|Research burden|4|||
24981954|NCT03263806|50070249|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
24981955|NCT03263806|50070250|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
24981956|NCT03263806|50070249|FG000|Overall Study|Withdrawal by Subject|0|||
24981957|NCT03263806|50070250|FG001|Overall Study|Withdrawal by Subject|1|||
24981958|NCT03263806|50070249|FG000|Overall Study|Study Termination|5|||
24981959|NCT03263806|50070250|FG001|Overall Study|Study Termination|6|||
24981960|NCT03751280|50070258|FG000|Overall Study|Adverse Event|0|||
24981961|NCT03751280|50070259|FG001|Overall Study|Adverse Event|1|||
24981962|NCT03751280|50070258|FG000|Overall Study|Lost to Follow-up|3|||
24981963|NCT03751280|50070259|FG001|Overall Study|Lost to Follow-up|5|||
24981964|NCT03751280|50070258|FG000|Overall Study|Physician Decision|0|||
24981965|NCT03751280|50070259|FG001|Overall Study|Physician Decision|2|||
24981966|NCT03751280|50070258|FG000|Overall Study|Protocol Violation|0|||
24981967|NCT03751280|50070259|FG001|Overall Study|Protocol Violation|2|||
24981968|NCT03751280|50070258|FG000|Overall Study|Withdrawal by Subject|5|||
24981969|NCT03751280|50070259|FG001|Overall Study|Withdrawal by Subject|2|||
24981970|NCT00311363|50070269|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
24981971|NCT00311363|50070270|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
24981972|NCT00311363|50070271|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
24981973|NCT00311363|50070269|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
24981974|NCT00311363|50070270|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
24981975|NCT00311363|50070271|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
24981976|NCT00311363|50070269|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
24981977|NCT00311363|50070270|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
24981978|NCT00311363|50070271|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
24981979|NCT00311363|50070269|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
24981980|NCT00311363|50070270|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
24981981|NCT00311363|50070271|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
24981982|NCT00311363|50070269|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
24981983|NCT00311363|50070270|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
24981984|NCT00311363|50070271|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
24981985|NCT00311363|50070269|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
24981986|NCT00311363|50070270|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
24981987|NCT00311363|50070271|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
24981988|NCT00311363|50070269|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
24981989|NCT00311363|50070270|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
24981990|NCT00311363|50070271|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
25078242|NCT01599754|50186370|FG000|Overall Study|Study terminated by sponsor|282|||
25078243|NCT01599754|50186371|FG001|Overall Study|Study terminated by sponsor|285|||
25078244|NCT02138110|50186377|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
25078245|NCT02138110|50186377|FG000|Overall Scaffold Implantation|Death|3|||
25078246|NCT02223754|50186383|FG000|Period 1|Adverse Event|1|||
25078247|NCT02223754|50186384|FG001|Period 1|Adverse Event|0|||
25078248|NCT02223754|50186383|FG000|Period 1|Lost to Follow-up|0|||
25078249|NCT02223754|50186384|FG001|Period 1|Lost to Follow-up|1|||
25078250|NCT02223754|50186383|FG000|Period 1|Protocol Violation|2|||
25078251|NCT02223754|50186384|FG001|Period 1|Protocol Violation|4|||
25078252|NCT02223754|50186383|FG000|Period 1|Withdrawal by Subject|0|||
25078253|NCT02223754|50186384|FG001|Period 1|Withdrawal by Subject|4|||
25078254|NCT02223754|50186383|FG000|Period 1|Test Article No Longer Available|1|||
25078255|NCT02223754|50186384|FG001|Period 1|Test Article No Longer Available|5|||
25078256|NCT02223754|50186383|FG000|Period 1|Unsatisfactory Visual Response|0|||
25078257|NCT02223754|50186384|FG001|Period 1|Unsatisfactory Visual Response|1|||
25078258|NCT02223754|50186383|FG000|Period 2|Adverse Event|0|||
25078259|NCT02223754|50186384|FG001|Period 2|Adverse Event|1|||
25078260|NCT02223754|50186383|FG000|Period 2|Protocol Violation|1|||
25078261|NCT02223754|50186384|FG001|Period 2|Protocol Violation|0|||
25078262|NCT02223754|50186383|FG000|Period 2|Lens Discomfort|1|||
25078263|NCT02223754|50186384|FG001|Period 2|Lens Discomfort|1|||
25078264|NCT02223754|50186383|FG000|Period 2|Lost to Follow-up|1|||
25078265|NCT02223754|50186384|FG001|Period 2|Lost to Follow-up|0|||
25078266|NCT02223754|50186383|FG000|Period 2|Test Article No Longer Available|0|||
25078267|NCT02223754|50186384|FG001|Period 2|Test Article No Longer Available|1|||
25078268|NCT02223364|50186394|FG000|Overall Study|Protocol Violation|3|||
25078269|NCT02223364|50186395|FG001|Overall Study|Protocol Violation|0|||
25078270|NCT02223364|50186396|FG002|Overall Study|Protocol Violation|3|||
25078271|NCT02223364|50186394|FG000|Overall Study|subject expired before surgery|1|||
25078272|NCT02223364|50186395|FG001|Overall Study|subject expired before surgery|0|||
24981991|NCT00311363|50070269|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
25078273|NCT02223364|50186396|FG002|Overall Study|subject expired before surgery|0|||
24981992|NCT00311363|50070270|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
24981993|NCT00311363|50070271|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
24981994|NCT00311363|50070269|FG000|24-Week Single-Blind Treatment Period|Death|1|||
24981995|NCT00311363|50070270|FG001|24-Week Single-Blind Treatment Period|Death|0|||
24981996|NCT00311363|50070271|FG002|24-Week Single-Blind Treatment Period|Death|0|||
24981997|NCT00311363|50070269|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
25255557|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
25255558|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
25255559|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
24981998|NCT00311363|50070270|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
24981999|NCT00311363|50070271|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
24982000|NCT00311363|50070269|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
24982001|NCT00311363|50070270|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
24982002|NCT00311363|50070271|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
24982003|NCT00311363|50070269|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
24982004|NCT00311363|50070270|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
24982005|NCT00311363|50070271|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
24982006|NCT00311363|50070269|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
24982007|NCT00311363|50070270|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
24982008|NCT00311363|50070271|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
24982009|NCT00311363|50070269|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
24982010|NCT00311363|50070270|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
24982011|NCT00311363|50070271|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
24982012|NCT00311363|50070269|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
24982013|NCT00311363|50070270|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
24982014|NCT00311363|50070271|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
24982015|NCT00333983|50070284|FG000|Overall Study|Lost to Follow-up|2|||
24982016|NCT00333983|50070285|FG001|Overall Study|Lost to Follow-up|1|||
24982017|NCT00333983|50070286|FG002|Overall Study|Lost to Follow-up|0|||
25255560|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
25255561|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
25255562|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
25255563|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
25255564|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
25255565|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
25255566|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
25255567|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
25255568|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
25255569|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
25255570|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
25255571|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
25255572|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
25255573|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
25255574|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
25255575|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
25255576|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
25255577|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
25255578|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
25255579|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
25255580|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
25255581|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
25255582|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
25255583|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
25255584|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
25255585|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
25255586|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
25255587|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
25255588|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
25255589|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
25255590|NCT01172938|50570966|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
25255591|NCT01172938|50570967|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
25255592|NCT01172938|50570968|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
24982018|NCT00333983|50070284|FG000|Overall Study|Adverse Event|1|||
24982019|NCT00333983|50070285|FG001|Overall Study|Adverse Event|1|||
24982020|NCT00333983|50070286|FG002|Overall Study|Adverse Event|1|||
24982021|NCT00333983|50070284|FG000|Overall Study|Withdrawal by Subject|0|||
24982022|NCT00333983|50070285|FG001|Overall Study|Withdrawal by Subject|3|||
24982023|NCT00333983|50070286|FG002|Overall Study|Withdrawal by Subject|1|||
24982024|NCT03262012|50070298|FG000|Overall Study|Withdrawal by Subject|15|||
24982025|NCT03262012|50070299|FG001|Overall Study|Withdrawal by Subject|13|||
24982026|NCT03262012|50070300|FG002|Overall Study|Withdrawal by Subject|8|||
24982027|NCT03262012|50070301|FG003|Overall Study|Withdrawal by Subject|7|||
24982028|NCT03262012|50070298|FG000|Overall Study|Adverse Event|10|||
24982029|NCT03262012|50070299|FG001|Overall Study|Adverse Event|12|||
24982030|NCT03262012|50070300|FG002|Overall Study|Adverse Event|4|||
24982031|NCT03262012|50070301|FG003|Overall Study|Adverse Event|6|||
24982032|NCT03262012|50070298|FG000|Overall Study|Physician Decision|2|||
24982033|NCT03262012|50070299|FG001|Overall Study|Physician Decision|5|||
24982034|NCT03262012|50070300|FG002|Overall Study|Physician Decision|1|||
24982035|NCT03262012|50070301|FG003|Overall Study|Physician Decision|0|||
24982036|NCT03262012|50070298|FG000|Overall Study|Lack of Efficacy|0|||
24982037|NCT03262012|50070299|FG001|Overall Study|Lack of Efficacy|5|||
24982038|NCT03262012|50070300|FG002|Overall Study|Lack of Efficacy|1|||
24982039|NCT03262012|50070301|FG003|Overall Study|Lack of Efficacy|2|||
24982040|NCT03262012|50070298|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
24982041|NCT03262012|50070299|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
24982042|NCT03262012|50070300|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
24982043|NCT03262012|50070301|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
24982044|NCT03288142|50070313|FG000|Overall Study|Lost to Follow-up|22|||
24982045|NCT03288142|50070314|FG001|Overall Study|Lost to Follow-up|15|||
24982046|NCT00310817|50070326|FG000|Overall Study|AE or Death|3|||
24982047|NCT00310817|50070327|FG001|Overall Study|AE or Death|1|||
24982048|NCT00310817|50070328|FG002|Overall Study|AE or Death|0|||
24982049|NCT00310817|50070329|FG003|Overall Study|AE or Death|0|||
24982050|NCT00310817|50070326|FG000|Overall Study|Withdrawal by Subject|1|||
24982051|NCT00310817|50070327|FG001|Overall Study|Withdrawal by Subject|4|||
24982052|NCT00310817|50070328|FG002|Overall Study|Withdrawal by Subject|6|||
24982053|NCT00310817|50070329|FG003|Overall Study|Withdrawal by Subject|7|||
24982054|NCT00310817|50070326|FG000|Overall Study|Lost to Follow-up|2|||
24982055|NCT00310817|50070327|FG001|Overall Study|Lost to Follow-up|1|||
24982056|NCT00310817|50070328|FG002|Overall Study|Lost to Follow-up|0|||
24982057|NCT00310817|50070329|FG003|Overall Study|Lost to Follow-up|0|||
24982058|NCT00310817|50070326|FG000|Overall Study|Inappropriate Enrollment|1|||
24982059|NCT00310817|50070327|FG001|Overall Study|Inappropriate Enrollment|0|||
24982060|NCT00310817|50070328|FG002|Overall Study|Inappropriate Enrollment|1|||
24982061|NCT00310817|50070329|FG003|Overall Study|Inappropriate Enrollment|0|||
24982062|NCT00310817|50070326|FG000|Overall Study|Protocol Violation|1|||
24982063|NCT00310817|50070327|FG001|Overall Study|Protocol Violation|1|||
24982064|NCT00310817|50070328|FG002|Overall Study|Protocol Violation|1|||
24982065|NCT00310817|50070329|FG003|Overall Study|Protocol Violation|1|||
24982066|NCT00310817|50070326|FG000|Overall Study|Unable to classify|3|||
24982067|NCT00310817|50070327|FG001|Overall Study|Unable to classify|1|||
24982068|NCT00310817|50070328|FG002|Overall Study|Unable to classify|0|||
24982069|NCT00310817|50070329|FG003|Overall Study|Unable to classify|0|||
24982070|NCT02940886|50070374|FG000|Overall Study|Adverse Event|7|||
24982071|NCT02940886|50070375|FG001|Overall Study|Adverse Event|3|||
24982072|NCT02940886|50070374|FG000|Overall Study|Protocol Violation|0|||
24982073|NCT02940886|50070375|FG001|Overall Study|Protocol Violation|2|||
24982074|NCT02940886|50070374|FG000|Overall Study|Withdrawal by Subject|28|||
24982075|NCT02940886|50070375|FG001|Overall Study|Withdrawal by Subject|20|||
24982076|NCT02940886|50070374|FG000|Overall Study|Death|1|||
24982077|NCT02940886|50070375|FG001|Overall Study|Death|0|||
24982078|NCT02940886|50070374|FG000|Overall Study|Lack of Efficacy|1|||
24982079|NCT02940886|50070375|FG001|Overall Study|Lack of Efficacy|0|||
24982080|NCT02940886|50070374|FG000|Overall Study|Lost to Follow-up|49|||
24982081|NCT02940886|50070375|FG001|Overall Study|Lost to Follow-up|21|||
24982082|NCT02940886|50070374|FG000|Overall Study|Physician Decision|9|||
24982083|NCT02940886|50070375|FG001|Overall Study|Physician Decision|4|||
24982084|NCT02940886|50070374|FG000|Overall Study|Sponsor decision|0|||
24982085|NCT02940886|50070375|FG001|Overall Study|Sponsor decision|1|||
24982086|NCT02940886|50070374|FG000|Overall Study|No treatment|7|||
25078274|NCT02223364|50186394|FG000|Overall Study|Physician Decision|1|||
25078275|NCT02223364|50186395|FG001|Overall Study|Physician Decision|0|||
24982087|NCT02940886|50070375|FG001|Overall Study|No treatment|2|||
24982088|NCT02940886|50070374|FG000|Overall Study|Enrolment error|0|||
24982089|NCT02940886|50070375|FG001|Overall Study|Enrolment error|1|||
24982090|NCT03285958|50070385|FG000|Overall Study|Lost to Follow-up|1|||
24982091|NCT03285958|50070386|FG001|Overall Study|Lost to Follow-up|1|||
24982092|NCT03285958|50070385|FG000|Overall Study|Withdrawal by Subject|1|||
24982093|NCT03285958|50070386|FG001|Overall Study|Withdrawal by Subject|0|||
24982094|NCT03285958|50070385|FG000|Overall Study|Not able to attend required orientation|3|||
24982095|NCT03285958|50070386|FG001|Overall Study|Not able to attend required orientation|0|||
24982096|NCT03285646|50070395|FG000|Overall Study|Adverse Event|1|||
24982097|NCT03285646|50070396|FG001|Overall Study|Adverse Event|0|||
24982098|NCT03285646|50070395|FG000|Overall Study|Withdrawal by Subject|10|||
24982099|NCT03285646|50070396|FG001|Overall Study|Withdrawal by Subject|2|||
24982100|NCT03285646|50070395|FG000|Overall Study|Lost to Follow-up|2|||
24982101|NCT03285646|50070396|FG001|Overall Study|Lost to Follow-up|1|||
24982102|NCT03285646|50070395|FG000|Overall Study|Investigator/Sponsor Decision|0|||
24982103|NCT03285646|50070396|FG001|Overall Study|Investigator/Sponsor Decision|1|||
24982104|NCT03309202|50070407|FG000|Overall Study|Lost to Follow-up|1|||
24982105|NCT03309202|50070408|FG001|Overall Study|Lost to Follow-up|0|||
24982106|NCT03309202|50070409|FG002|Overall Study|Lost to Follow-up|0|||
24982107|NCT03309202|50070410|FG003|Overall Study|Lost to Follow-up|0|||
24982108|NCT00074490|50070425|FG000|Overall Study|Progressive malignancy|0|||
24982109|NCT00074490|50070426|FG001|Overall Study|Progressive malignancy|7|||
24982110|NCT00074490|50070427|FG002|Overall Study|Progressive malignancy|0|||
24982111|NCT00074490|50070428|FG003|Overall Study|Progressive malignancy|0|||
24982112|NCT00074490|50070429|FG004|Overall Study|Progressive malignancy|3|||
24982113|NCT00074490|50070430|FG005|Overall Study|Progressive malignancy|0|||
24982114|NCT03285490|50070445|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
24982115|NCT03285490|50070446|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
24982116|NCT03285490|50070445|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
24982117|NCT03285490|50070446|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
24982118|NCT02939716|50070453|FG000|Overall Study|scanner failure|0|||
24982119|NCT02939716|50070454|FG001|Overall Study|scanner failure|0|||
24982120|NCT02939716|50070455|FG002|Overall Study|scanner failure|0|||
24982121|NCT02939716|50070456|FG003|Overall Study|scanner failure|1|||
24982122|NCT02939716|50070457|FG004|Overall Study|scanner failure|1|||
24982123|NCT02939716|50070458|FG005|Overall Study|scanner failure|1|||
24982124|NCT00367133|50070487|FG000|2 Years|Death|20|||
24982125|NCT00367133|50070488|FG001|2 Years|Death|12|||
24982126|NCT00367133|50070489|FG002|2 Years|Death|12|||
24982127|NCT00367133|50070487|FG000|2 Years|Dropped|34|||
24982128|NCT00367133|50070488|FG001|2 Years|Dropped|19|||
24982129|NCT00367133|50070489|FG002|2 Years|Dropped|33|||
24982130|NCT00367133|50070487|FG000|2 Years|Missed visit|4|||
24982131|NCT00367133|50070488|FG001|2 Years|Missed visit|5|||
24982132|NCT00367133|50070489|FG002|2 Years|Missed visit|4|||
24982133|NCT00367055|50070499|FG000|Overall Study|Adverse Event|6|||
24982134|NCT00367055|50070500|FG001|Overall Study|Adverse Event|3|||
24982135|NCT00367055|50070499|FG000|Overall Study|Patient's Willing|3|||
24982136|NCT00367055|50070500|FG001|Overall Study|Patient's Willing|2|||
24982137|NCT00367055|50070499|FG000|Overall Study|Lack of Efficacy|1|||
24982138|NCT00367055|50070500|FG001|Overall Study|Lack of Efficacy|2|||
24982139|NCT00367055|50070499|FG000|Overall Study|Lost to Follow-up|1|||
24982140|NCT00367055|50070500|FG001|Overall Study|Lost to Follow-up|1|||
24982141|NCT00367055|50070499|FG000|Overall Study|Protocol Violation|0|||
24982142|NCT00367055|50070500|FG001|Overall Study|Protocol Violation|1|||
24982143|NCT00367055|50070499|FG000|Overall Study|Stopping Criterion Met|0|||
24982144|NCT00367055|50070500|FG001|Overall Study|Stopping Criterion Met|1|||
24982145|NCT00367055|50070499|FG000|Overall Study|Participant Living too Far from Hospital|0|||
24982146|NCT00367055|50070500|FG001|Overall Study|Participant Living too Far from Hospital|1|||
24982147|NCT00057330|50070508|FG000|Overall Study|Adverse Event|9|||
24982148|NCT00057330|50070509|FG001|Overall Study|Adverse Event|12|||
24982149|NCT00057330|50070508|FG000|Overall Study|Death|1|||
24982150|NCT00057330|50070509|FG001|Overall Study|Death|0|||
24982151|NCT00057330|50070508|FG000|Overall Study|Protocol Violation|1|||
24982152|NCT00057330|50070509|FG001|Overall Study|Protocol Violation|1|||
24982153|NCT00057330|50070508|FG000|Overall Study|Withdrawal by Subject|115|||
24982154|NCT00057330|50070509|FG001|Overall Study|Withdrawal by Subject|84|||
24982155|NCT00057330|50070508|FG000|Overall Study|Lost to Follow-up|745|||
24982156|NCT00057330|50070509|FG001|Overall Study|Lost to Follow-up|617|||
24982157|NCT00057330|50070508|FG000|Overall Study|Physician Decision|1|||
24982158|NCT00057330|50070509|FG001|Overall Study|Physician Decision|0|||
24982159|NCT00057330|50070508|FG000|Overall Study|Other|260|||
24982160|NCT00057330|50070509|FG001|Overall Study|Other|206|||
24982161|NCT03283696|50070517|FG000|Overall Study|Physician Decision|5|||
24982162|NCT03283696|50070518|FG001|Overall Study|Physician Decision|6|||
24982163|NCT03283696|50070517|FG000|Overall Study|Withdrawal by Subject|2|||
24982164|NCT03283696|50070518|FG001|Overall Study|Withdrawal by Subject|0|||
24982165|NCT02939560|50070524|FG000|Overall Study|Withdrawal by Subject|2|||
24982166|NCT02939560|50070524|FG000|Overall Study|Protocol Violation|1|||
24982167|NCT03748706|50070528|FG000|Overall Study|Lost to Follow-up|1|||
24982168|NCT00062010|50070532|FG000|Overall Study|Ineligible|3|||
24982169|NCT03747302|50070538|FG000|Overall Study|Withdrawal by Subject|1|||
24982170|NCT03747302|50070539|FG001|Overall Study|Withdrawal by Subject|2|||
24982171|NCT00056862|50070549|FG000|Overall Study|Protocol Violation|1|||
24982172|NCT00056862|50070550|FG001|Overall Study|Protocol Violation|0|||
24982173|NCT00056316|50070558|FG000|Overall Study|Withdrawal by Subject|2|||
25078276|NCT02223364|50186396|FG002|Overall Study|Physician Decision|0|||
24982174|NCT00056316|50070559|FG001|Overall Study|Withdrawal by Subject|2|||
24982175|NCT00056316|50070558|FG000|Overall Study|Death/NH placement of pt|1|||
24982176|NCT00056316|50070559|FG001|Overall Study|Death/NH placement of pt|1|||
24982177|NCT03308968|50070568|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
24982178|NCT03308968|50070569|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
24982179|NCT03308968|50070570|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
24982180|NCT03308968|50070568|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
24982181|NCT03308968|50070569|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
24982182|NCT03308968|50070570|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
24982183|NCT03308968|50070568|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
24982184|NCT03308968|50070569|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
24982185|NCT03308968|50070570|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
24982186|NCT03308968|50070568|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
24982187|NCT03308968|50070569|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
24982188|NCT03308968|50070570|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
24982189|NCT03308968|50070568|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
24982190|NCT03308968|50070569|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
24982191|NCT03308968|50070570|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
24982192|NCT03308968|50070568|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
24982193|NCT03308968|50070569|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
24982194|NCT03308968|50070570|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
24982195|NCT03308968|50070568|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
24982196|NCT03308968|50070569|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
24982197|NCT03308968|50070570|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
24982198|NCT03308968|50070568|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
24982199|NCT03308968|50070569|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
24982200|NCT03308968|50070570|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
25255593|NCT01172938|50570969|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
25255594|NCT01172938|50570970|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
25255595|NCT01172938|50570971|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
25255596|NCT01172938|50570972|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
25255597|NCT01172938|50570973|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
25255598|NCT01172938|50570974|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
25255599|NCT01109992|50570994|FG000|Overall Study|Withdrawal by Subject|0|||
25255600|NCT01109992|50570995|FG001|Overall Study|Withdrawal by Subject|1|||
25255601|NCT01109992|50570994|FG000|Overall Study|Movement during rest scan.|0|||
25255602|NCT01109992|50570995|FG001|Overall Study|Movement during rest scan.|1|||
25255603|NCT01109524|50571004|FG000|Overall Study|Disease Progression|29|||
25255604|NCT01109524|50571004|FG000|Overall Study|Study Drug toxicity|6|||
25255605|NCT01109524|50571004|FG000|Overall Study|Adverse Event|4|||
25255606|NCT01109524|50571004|FG000|Overall Study|Withdrawal by Subject|2|||
25255607|NCT01109524|50571004|FG000|Overall Study|Maximum clinical benefit|3|||
25255608|NCT01109524|50571004|FG000|Overall Study|Death|2|||
25255609|NCT01109524|50571004|FG000|Overall Study|No longer meets criteria|2|||
25255610|NCT01109524|50571004|FG000|Overall Study|Participant requested to end treatment|4|||
25255611|NCT01109524|50571004|FG000|Overall Study|Other|5|||
25255612|NCT01109173|50571019|FG000|Overall Study|Adverse Event|15|||
25255613|NCT01109173|50571020|FG001|Overall Study|Adverse Event|17|||
25255614|NCT01109173|50571021|FG002|Overall Study|Adverse Event|9|||
25255615|NCT01109173|50571022|FG003|Overall Study|Adverse Event|6|||
25255616|NCT01109173|50571019|FG000|Overall Study|Lost to Follow-up|0|||
25255617|NCT01109173|50571020|FG001|Overall Study|Lost to Follow-up|1|||
25255618|NCT01109173|50571021|FG002|Overall Study|Lost to Follow-up|0|||
25255619|NCT01109173|50571022|FG003|Overall Study|Lost to Follow-up|0|||
25255620|NCT01109173|50571019|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
25255621|NCT01109173|50571020|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
25255622|NCT01109173|50571021|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
25255623|NCT01109173|50571022|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
25255624|NCT01109173|50571019|FG000|Overall Study|Noncompliance|0|||
25255625|NCT01109173|50571020|FG001|Overall Study|Noncompliance|1|||
25255626|NCT01109173|50571021|FG002|Overall Study|Noncompliance|0|||
25255627|NCT01109173|50571022|FG003|Overall Study|Noncompliance|0|||
25255628|NCT01109173|50571019|FG000|Overall Study|Treatment Failure|25|||
25255629|NCT01109173|50571020|FG001|Overall Study|Treatment Failure|32|||
25255630|NCT01109173|50571021|FG002|Overall Study|Treatment Failure|69|||
25255631|NCT01109173|50571022|FG003|Overall Study|Treatment Failure|64|||
25255632|NCT01109173|50571019|FG000|Overall Study|Protocol Violation|4|||
24982201|NCT03308968|50070568|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
24982202|NCT03308968|50070569|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
24982203|NCT03308968|50070570|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
24982204|NCT03308968|50070568|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
24982205|NCT03308968|50070569|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
25078277|NCT01378975|50186406|FG000|Overall Study|Death|77|||
25255633|NCT01109173|50571020|FG001|Overall Study|Protocol Violation|5|||
25255634|NCT01109173|50571021|FG002|Overall Study|Protocol Violation|1|||
24982206|NCT03308968|50070570|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
24982207|NCT03308968|50070568|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
24982208|NCT03308968|50070569|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
24982209|NCT03308968|50070570|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
24982210|NCT03308968|50070568|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
24982211|NCT03308968|50070569|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
24982212|NCT03308968|50070570|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
24982213|NCT03308968|50070568|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
24982214|NCT03308968|50070569|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
24982215|NCT03308968|50070570|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
24982216|NCT03308968|50070568|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
24982217|NCT03308968|50070569|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
24982218|NCT03308968|50070570|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
24982219|NCT02940730|50070583|FG000|Intervention 2|Physician Decision|7|||
24982220|NCT02940730|50070584|FG001|Intervention 2|Physician Decision|0|||
24982221|NCT03741062|50070592|FG000|Overall Study|Protocol Violation|1|||
24982222|NCT03741062|50070593|FG001|Overall Study|Protocol Violation|0|||
24982223|NCT03281668|50070599|FG000|Overall Study|Physician Decision|1|||
24982224|NCT03281668|50070599|FG000|Overall Study|scheduling conflict, family circumstance|2|||
24982225|NCT03281668|50070599|FG000|Overall Study|Withdrawal by Subject|4|||
24982226|NCT03281668|50070599|FG000|Overall Study|Lost to Follow-up|1|||
24982227|NCT03307252|50070614|FG000|Part 2, Period 1|Treatment not received|0|||
24982228|NCT03307252|50070615|FG001|Part 2, Period 1|Treatment not received|0|||
24982229|NCT03307252|50070616|FG002|Part 2, Period 1|Treatment not received|0|||
24982230|NCT03307252|50070617|FG003|Part 2, Period 1|Treatment not received|0|||
24982231|NCT03307252|50070618|FG004|Part 2, Period 1|Treatment not received|0|||
24982232|NCT03307252|50070619|FG005|Part 2, Period 1|Treatment not received|1|||
24982233|NCT03307252|50070620|FG006|Part 2, Period 1|Treatment not received|0|||
24982234|NCT03307252|50070621|FG007|Part 2, Period 1|Treatment not received|0|||
24982235|NCT03307252|50070622|FG008|Part 2, Period 1|Treatment not received|0|||
24982236|NCT03307252|50070623|FG009|Part 2, Period 1|Treatment not received|0|||
24982237|NCT03307252|50070624|FG010|Part 2, Period 1|Treatment not received|0|||
24982238|NCT03307252|50070614|FG000|Part 2, Period 3|Other than listed|0|||
24982239|NCT03307252|50070615|FG001|Part 2, Period 3|Other than listed|0|||
24982240|NCT03307252|50070616|FG002|Part 2, Period 3|Other than listed|0|||
24982241|NCT03307252|50070617|FG003|Part 2, Period 3|Other than listed|0|||
24982242|NCT03307252|50070618|FG004|Part 2, Period 3|Other than listed|1|||
24982243|NCT03307252|50070619|FG005|Part 2, Period 3|Other than listed|0|||
24982244|NCT03307252|50070620|FG006|Part 2, Period 3|Other than listed|0|||
24982245|NCT03307252|50070621|FG007|Part 2, Period 3|Other than listed|0|||
24982246|NCT03307252|50070622|FG008|Part 2, Period 3|Other than listed|0|||
24982247|NCT03307252|50070623|FG009|Part 2, Period 3|Other than listed|0|||
24982248|NCT03307252|50070624|FG010|Part 2, Period 3|Other than listed|0|||
24982249|NCT03307252|50070614|FG000|Part 2, Period 4|Other than listed|0|||
24982250|NCT03307252|50070615|FG001|Part 2, Period 4|Other than listed|0|||
24982251|NCT03307252|50070616|FG002|Part 2, Period 4|Other than listed|0|||
24982252|NCT03307252|50070617|FG003|Part 2, Period 4|Other than listed|0|||
24982253|NCT03307252|50070618|FG004|Part 2, Period 4|Other than listed|0|||
24982254|NCT03307252|50070619|FG005|Part 2, Period 4|Other than listed|0|||
24982255|NCT03307252|50070620|FG006|Part 2, Period 4|Other than listed|1|||
24982256|NCT03307252|50070621|FG007|Part 2, Period 4|Other than listed|0|||
24982257|NCT03307252|50070622|FG008|Part 2, Period 4|Other than listed|0|||
24982258|NCT03307252|50070623|FG009|Part 2, Period 4|Other than listed|0|||
24982259|NCT03307252|50070624|FG010|Part 2, Period 4|Other than listed|0|||
24982260|NCT03307252|50070614|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
24982261|NCT03307252|50070615|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
24982262|NCT03307252|50070616|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
24982263|NCT03307252|50070617|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
24982264|NCT03307252|50070618|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
24982265|NCT03307252|50070619|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
24982266|NCT03307252|50070620|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
24982267|NCT03307252|50070621|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
24982268|NCT03307252|50070622|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
24982269|NCT03307252|50070623|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
24982270|NCT03307252|50070624|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
24982271|NCT03307174|50070642|FG000|Overall Study|Unplanned ICU Administrion|5|||
25078278|NCT01378975|50186407|FG001|Overall Study|Death|46|||
24982272|NCT03307174|50070643|FG001|Overall Study|Unplanned ICU Administrion|3|||
24982273|NCT03307174|50070642|FG000|Overall Study|Aborted Surgery|1|||
24982274|NCT03307174|50070643|FG001|Overall Study|Aborted Surgery|2|||
24982275|NCT03307174|50070642|FG000|Overall Study|Hypotension|6|||
24982276|NCT03307174|50070643|FG001|Overall Study|Hypotension|0|||
24982277|NCT03307174|50070642|FG000|Overall Study|Nonfunctional epidural|1|||
24982278|NCT03307174|50070643|FG001|Overall Study|Nonfunctional epidural|1|||
24982279|NCT03307174|50070642|FG000|Overall Study|Planned epidural removal|1|||
24982280|NCT03307174|50070643|FG001|Overall Study|Planned epidural removal|0|||
24982281|NCT03307174|50070642|FG000|Overall Study|Intrathecal catheter placement|0|||
24982282|NCT03307174|50070643|FG001|Overall Study|Intrathecal catheter placement|1|||
24982283|NCT03258814|50070651|FG000|Overall Study|Early Termination|4|||
24982284|NCT03258814|50070652|FG001|Overall Study|Early Termination|3|||
24982285|NCT03258814|50070653|FG002|Overall Study|Early Termination|10|||
24982286|NCT03257410|50070662|FG000|Overall Study|Adverse Event|2|||
24982287|NCT03257410|50070663|FG001|Overall Study|Adverse Event|3|||
24982288|NCT03257410|50070662|FG000|Overall Study|Protocol Violation|1|||
24982289|NCT03257410|50070663|FG001|Overall Study|Protocol Violation|2|||
24982290|NCT03257410|50070662|FG000|Overall Study|Lost to Follow-up|1|||
24982291|NCT03257410|50070663|FG001|Overall Study|Lost to Follow-up|0|||
24982292|NCT03257410|50070662|FG000|Overall Study|Withdrawal by Subject|1|||
24982293|NCT03257410|50070663|FG001|Overall Study|Withdrawal by Subject|2|||
24982294|NCT03257410|50070662|FG000|Overall Study|Physician Decision|1|||
24982295|NCT03257410|50070663|FG001|Overall Study|Physician Decision|1|||
24982296|NCT03257410|50070662|FG000|Overall Study|Renal transplantation|2|||
24982297|NCT03257410|50070663|FG001|Overall Study|Renal transplantation|0|||
24982298|NCT03257410|50070662|FG000|Overall Study|Switch to peritoneal dialysis|1|||
24982299|NCT03257410|50070663|FG001|Overall Study|Switch to peritoneal dialysis|0|||
24982300|NCT03257410|50070662|FG000|Overall Study|Death|3|||
24982301|NCT03257410|50070663|FG001|Overall Study|Death|2|||
24982302|NCT03257410|50070662|FG000|Overall Study|Change to another dialysis center|2|||
24982303|NCT03257410|50070663|FG001|Overall Study|Change to another dialysis center|2|||
24982304|NCT03257410|50070662|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
24982305|NCT03257410|50070663|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
24982306|NCT03257410|50070662|FG000|Overall Study|Miscellaneous|2|||
24982307|NCT03257410|50070663|FG001|Overall Study|Miscellaneous|2|||
24982308|NCT03257410|50070662|FG000|Overall Study|Other|0|||
24982309|NCT03257410|50070663|FG001|Overall Study|Other|1|||
24982310|NCT00056160|50070671|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
24982311|NCT00056160|50070672|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
24982312|NCT00056160|50070671|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
24982313|NCT00056160|50070672|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
24982314|NCT00056160|50070671|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
24982315|NCT00056160|50070672|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
24982316|NCT00056160|50070671|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
24982317|NCT00056160|50070672|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
24982318|NCT00056160|50070671|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
24982319|NCT00056160|50070672|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
24982320|NCT00056160|50070671|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
24982321|NCT00056160|50070672|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
24982322|NCT00056160|50070671|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
24982323|NCT00056160|50070672|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
24982324|NCT00056160|50070671|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
24982325|NCT00056160|50070672|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
24982326|NCT00056160|50070671|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
24982327|NCT00056160|50070672|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
24982328|NCT00056160|50070671|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
24982329|NCT00056160|50070672|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
24982330|NCT00056160|50070671|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
24982331|NCT00056160|50070672|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
24982332|NCT00056160|50070671|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
24982333|NCT00056160|50070672|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
24982334|NCT00056160|50070671|FG000|Final Follow-up|Transferred into expanded access study.|3|||
24982335|NCT00056160|50070672|FG001|Final Follow-up|Transferred into expanded access study.|0|||
24982336|NCT00056160|50070671|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
24982337|NCT00056160|50070672|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
24982338|NCT00056160|50070671|FG000|Final Follow-up|Adverse Event|1|||
24982339|NCT00056160|50070672|FG001|Final Follow-up|Adverse Event|0|||
24982340|NCT00061932|50070680|FG000|Overall Study|Withdrawal by Subject|13|||
24982341|NCT00061932|50070681|FG001|Overall Study|Withdrawal by Subject|4|||
24982342|NCT03280264|50070688|FG000|Overall Study|Adverse Event|1|||
24982343|NCT03280264|50070688|FG000|Overall Study|Physician Decision|1|||
24982344|NCT03280264|50070688|FG000|Overall Study|Withdrawal by Subject|1|||
24982345|NCT00060840|50070695|FG000|Overall Study|Change in surgical plan|2|||
24982346|NCT00060840|50070696|FG001|Overall Study|Change in surgical plan|6|||
24982347|NCT00060840|50070695|FG000|Overall Study|Death|0|||
25078279|NCT01378975|50186406|FG000|Overall Study|Investigator Request|1|||
24982348|NCT00060840|50070696|FG001|Overall Study|Death|1|||
24982349|NCT00060840|50070695|FG000|Overall Study|Withdrawal by Subject|0|||
24982350|NCT00060840|50070696|FG001|Overall Study|Withdrawal by Subject|1|||
24982351|NCT00060840|50070695|FG000|Overall Study|Subinvestigator unavailable|0|||
24982352|NCT00060840|50070696|FG001|Overall Study|Subinvestigator unavailable|1|||
24982353|NCT00060840|50070695|FG000|Overall Study|Physician Decision|1|||
24982354|NCT00060840|50070696|FG001|Overall Study|Physician Decision|0|||
24982355|NCT00060840|50070695|FG000|Overall Study|Other|1|||
24982356|NCT00060840|50070696|FG001|Overall Study|Other|0|||
24982357|NCT03280108|50070704|FG000|Overall Study|Lost to Follow-up|2|||
24982358|NCT03280108|50070705|FG001|Overall Study|Lost to Follow-up|0|||
24982359|NCT00059202|50070718|FG000|Overall Study|Withdrawal by Subject|5|||
24982360|NCT00059202|50070719|FG001|Overall Study|Withdrawal by Subject|9|||
24982361|NCT00059202|50070718|FG000|Overall Study|Protocol Violation|1|||
24982362|NCT00059202|50070719|FG001|Overall Study|Protocol Violation|3|||
24982363|NCT00059202|50070718|FG000|Overall Study|drug toxicity|0|||
24982364|NCT00059202|50070719|FG001|Overall Study|drug toxicity|3|||
24982365|NCT03278626|50070728|FG000|Overall Study|Death|2|||
24982366|NCT03278626|50070728|FG000|Overall Study|Toxicity|1|||
24982367|NCT03278626|50070728|FG000|Overall Study|Disease Progression|2|||
24982368|NCT03277846|50070734|FG000|Overall Study|Inpatient stay too brief|12|||
24982369|NCT03277846|50070735|FG001|Overall Study|Inpatient stay too brief|11|||
24982370|NCT00073008|50070743|FG000|Overall Study|Missing|6|||
24982371|NCT00073008|50070744|FG001|Overall Study|Missing|6|||
24982372|NCT00073008|50070743|FG000|Overall Study|Withdrawal by Subject|2|||
24982373|NCT00073008|50070744|FG001|Overall Study|Withdrawal by Subject|2|||
24982374|NCT00073008|50070743|FG000|Overall Study|Lost to Follow-up|1|||
24982375|NCT00073008|50070744|FG001|Overall Study|Lost to Follow-up|3|||
24982376|NCT00073008|50070743|FG000|Overall Study|Death|46|||
24982377|NCT00073008|50070744|FG001|Overall Study|Death|47|||
24982378|NCT00073008|50070743|FG000|Overall Study|"Other selected on Case Report Form"|7|||
24982379|NCT00073008|50070744|FG001|Overall Study|"Other selected on Case Report Form"|5|||
24982380|NCT00058422|50070750|FG000|Overall Study|Not treated|2|||
24982381|NCT00072384|50070754|FG000|Overall Study|Physician Decision|1|||
24982382|NCT00072384|50070754|FG000|Overall Study|Ineligible|8|||
24982383|NCT00054132|50070760|FG000|Overall Study|Not Treated|1|||
24982384|NCT00071760|50070765|FG000|Overall Study|Adverse Event|3|||
24982385|NCT00071760|50070765|FG000|Overall Study|Lost to Follow-up|4|||
24982386|NCT00071760|50070765|FG000|Overall Study|Protocol Violation|1|||
24982387|NCT00071760|50070765|FG000|Overall Study|Withdrawal by Subject|3|||
24982388|NCT00071760|50070765|FG000|Overall Study|Insufficient Viral Load Response|3|||
24982389|NCT00071760|50070765|FG000|Overall Study|Pulmonary Tuberculosis|1|||
24982390|NCT00071760|50070765|FG000|Overall Study|Unavailability of RTV|8|||
24982391|NCT00071760|50070765|FG000|Overall Study|Relocation|1|||
24982392|NCT00071760|50070765|FG000|Overall Study|Investigator's Recommendation (Rec.)|4|||
24982393|NCT00071760|50070765|FG000|Overall Study|Study Team Rec./Resistance|1|||
24982394|NCT00071760|50070765|FG000|Overall Study|Ongoing|25|||
25341993|NCT00727506|50658352|FG003|Overall Study|Adverse Event|4|||
25341994|NCT00727506|50658353|FG004|Overall Study|Adverse Event|1|||
24982397|NCT00057876|50070781|FG000|Overall Study|Adverse Event|8|||
24982398|NCT00057876|50070782|FG001|Overall Study|Adverse Event|8|||
24982399|NCT00057876|50070781|FG000|Overall Study|Death|2|||
24982400|NCT00057876|50070782|FG001|Overall Study|Death|1|||
24982401|NCT00057876|50070781|FG000|Overall Study|Withdrawal by Subject|5|||
24982402|NCT00057876|50070782|FG001|Overall Study|Withdrawal by Subject|6|||
24982403|NCT00057876|50070781|FG000|Overall Study|Lack of Efficacy|10|||
24982404|NCT00057876|50070782|FG001|Overall Study|Lack of Efficacy|8|||
24982405|NCT00057876|50070781|FG000|Overall Study|Ineligible|1|||
24982406|NCT00057876|50070782|FG001|Overall Study|Ineligible|2|||
24982407|NCT00057876|50070781|FG000|Overall Study|other reason|2|||
24982408|NCT00057876|50070782|FG001|Overall Study|other reason|2|||
24982409|NCT00057876|50070781|FG000|Overall Study|other complicating disease|1|||
24982410|NCT00057876|50070782|FG001|Overall Study|other complicating disease|0|||
24982411|NCT00053898|50070790|FG000|Overall Study|No follow-up data from any source|9|||
24982412|NCT00053898|50070791|FG001|Overall Study|No follow-up data from any source|12|||
24982413|NCT00053898|50070790|FG000|Overall Study|Follow-up from telephone contact only|5|||
24982414|NCT00053898|50070791|FG001|Overall Study|Follow-up from telephone contact only|1|||
24982415|NCT03256552|50070827|FG000|Overall Study|Protocol Violation|1|||
24982416|NCT03256552|50070827|FG000|Overall Study|Physician Decision|1|||
24982417|NCT03256552|50070827|FG000|Overall Study|Adverse Event|1|||
24982418|NCT03256552|50070827|FG000|Overall Study|Withdrawal by Subject|2|||
24982419|NCT00071058|50070837|FG000|Overall Study|brain tumor-removed from study|1|||
24982420|NCT00053352|50070844|FG000|Overall Study|Lost to Follow-up|0|||
24982421|NCT00053352|50070845|FG001|Overall Study|Lost to Follow-up|1|||
24982422|NCT00053352|50070844|FG000|Overall Study|Physician Decision|11|||
24982423|NCT00053352|50070845|FG001|Overall Study|Physician Decision|1|||
24982424|NCT00053352|50070844|FG000|Overall Study|Withdrawal by Subject|1|||
24982425|NCT00053352|50070845|FG001|Overall Study|Withdrawal by Subject|0|||
24982426|NCT00053352|50070844|FG000|Overall Study|Ineligible|8|||
24982427|NCT00053352|50070845|FG001|Overall Study|Ineligible|8|||
24982428|NCT00053352|50070844|FG000|Overall Study|Disease at new site|1|||
24982429|NCT00053352|50070845|FG001|Overall Study|Disease at new site|0|||
24982430|NCT03245398|50070854|FG000|Overall Study|Travelled to another island|1|||
24982431|NCT03245398|50070855|FG001|Overall Study|Travelled to another island|0|||
24982432|NCT03244618|50070865|FG000|Overall Study|Lost to Follow-up|3|||
24982433|NCT03244618|50070866|FG001|Overall Study|Lost to Follow-up|4|||
24982434|NCT03244618|50070865|FG000|Overall Study|Protocol Violation|4|||
24982435|NCT03244618|50070866|FG001|Overall Study|Protocol Violation|3|||
24982436|NCT03244618|50070865|FG000|Overall Study|Withdrawal by Subject|0|||
24982437|NCT03244618|50070866|FG001|Overall Study|Withdrawal by Subject|2|||
24982438|NCT00052962|50070874|FG000|Overall Study|Not evaluable|0|||
24982439|NCT00052962|50070875|FG001|Overall Study|Not evaluable|2|||
24982440|NCT00052962|50070874|FG000|Overall Study|Not randomized/not evaluable|1|||
24982441|NCT00052962|50070875|FG001|Overall Study|Not randomized/not evaluable|0|||
24982442|NCT00051636|50070883|FG000|Period 1 - Core|Adverse Event|2|||
24982443|NCT00051636|50070884|FG001|Period 1 - Core|Adverse Event|2|||
24982444|NCT00051636|50070883|FG000|Period 1 - Core|Protocol Violation|1|||
24982445|NCT00051636|50070884|FG001|Period 1 - Core|Protocol Violation|0|||
24982446|NCT00051636|50070883|FG000|Period 1 - Core|Withdrawal by Subject|1|||
24982447|NCT00051636|50070884|FG001|Period 1 - Core|Withdrawal by Subject|2|||
24982448|NCT00051636|50070883|FG000|Period 1 - Core|Lost to Follow-up|0|||
24982449|NCT00051636|50070884|FG001|Period 1 - Core|Lost to Follow-up|2|||
24982450|NCT00051636|50070883|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
24982451|NCT00051636|50070884|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
24982452|NCT00051636|50070883|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
24982453|NCT00051636|50070884|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
24982454|NCT00051636|50070883|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
24982455|NCT00051636|50070884|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
25078280|NCT01378975|50186407|FG001|Overall Study|Investigator Request|0|||
25255635|NCT01109173|50571022|FG003|Overall Study|Protocol Violation|2|||
25255636|NCT01109173|50571019|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
25255637|NCT01109173|50571020|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
25255638|NCT01109173|50571021|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
25255639|NCT01109173|50571022|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
25255640|NCT01109173|50571019|FG000|Overall Study|Not Specifiied|5|||
25255641|NCT01109173|50571020|FG001|Overall Study|Not Specifiied|4|||
25255642|NCT01109173|50571021|FG002|Overall Study|Not Specifiied|9|||
25255643|NCT01109173|50571022|FG003|Overall Study|Not Specifiied|14|||
25255644|NCT01172821|50571036|FG000|Overall Study|Adverse Event|5|||
25255645|NCT01172821|50571037|FG001|Overall Study|Adverse Event|2|||
25255646|NCT01172821|50571038|FG002|Overall Study|Adverse Event|2|||
25255647|NCT01172821|50571039|FG003|Overall Study|Adverse Event|7|||
25255648|NCT01172821|50571036|FG000|Overall Study|Protocol Violation|0|||
25255649|NCT01172821|50571037|FG001|Overall Study|Protocol Violation|2|||
25255650|NCT01172821|50571038|FG002|Overall Study|Protocol Violation|1|||
25255651|NCT01172821|50571039|FG003|Overall Study|Protocol Violation|2|||
25255652|NCT01172821|50571036|FG000|Overall Study|Lost to Follow-up|4|||
25255653|NCT01172821|50571037|FG001|Overall Study|Lost to Follow-up|1|||
25255654|NCT01172821|50571038|FG002|Overall Study|Lost to Follow-up|2|||
25255655|NCT01172821|50571039|FG003|Overall Study|Lost to Follow-up|2|||
25255656|NCT01172821|50571036|FG000|Overall Study|Withdrawal by Subject|2|||
25255657|NCT01172821|50571037|FG001|Overall Study|Withdrawal by Subject|3|||
25255658|NCT01172821|50571038|FG002|Overall Study|Withdrawal by Subject|3|||
25255659|NCT01172821|50571039|FG003|Overall Study|Withdrawal by Subject|3|||
25255660|NCT01172821|50571036|FG000|Overall Study|Other|3|||
25255661|NCT01172821|50571037|FG001|Overall Study|Other|4|||
25255662|NCT01172821|50571038|FG002|Overall Study|Other|5|||
25255663|NCT01172821|50571039|FG003|Overall Study|Other|3|||
25255664|NCT01172275|50571051|FG000|Overall Study|Lost to Follow-up|1|||
25255665|NCT01172275|50571052|FG001|Overall Study|Lost to Follow-up|0|||
25255666|NCT01172275|50571051|FG000|Overall Study|Protocol Violation|1|||
25255667|NCT01172275|50571052|FG001|Overall Study|Protocol Violation|0|||
25255668|NCT01108510|50571060|FG000|Overall Study|Randomized but Not Treated|5|||
25255669|NCT01108510|50571061|FG001|Overall Study|Randomized but Not Treated|1|||
25255670|NCT01108510|50571060|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
25255671|NCT01108510|50571061|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
25255672|NCT01108510|50571060|FG000|Overall Study|Adverse Event|26|||
25255673|NCT01108510|50571061|FG001|Overall Study|Adverse Event|19|||
24982456|NCT00051636|50070883|FG000|Period 2- Extended Observation Period|Death|4|||
24982457|NCT00051636|50070884|FG001|Period 2- Extended Observation Period|Death|5|||
24982458|NCT00051636|50070883|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
24982459|NCT00051636|50070884|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
25255674|NCT01108510|50571060|FG000|Overall Study|Lost to Follow-up|20|||
25255675|NCT01108510|50571061|FG001|Overall Study|Lost to Follow-up|17|||
24982460|NCT03255382|50070892|FG000|Overall Study|Adverse Event|3|||
24982461|NCT03255382|50070893|FG001|Overall Study|Adverse Event|0|||
24982462|NCT03255382|50070892|FG000|Overall Study|Lost to Follow-up|2|||
24982463|NCT03255382|50070893|FG001|Overall Study|Lost to Follow-up|0|||
24982464|NCT03255382|50070892|FG000|Overall Study|Withdrawal by Subject|2|||
24982465|NCT03255382|50070893|FG001|Overall Study|Withdrawal by Subject|0|||
24982466|NCT03255382|50070892|FG000|Overall Study|Other|6|||
24982467|NCT03255382|50070893|FG001|Overall Study|Other|0|||
24982468|NCT03254602|50070900|FG000|Overall Study|Lost to Follow-up|4|||
24982469|NCT00038142|50070906|FG000|Overall Study|Ineligible|1|||
24982470|NCT00038142|50070907|FG001|Overall Study|Ineligible|0|||
24982471|NCT00038142|50070906|FG000|Overall Study|Progressive Disease|11|||
24982472|NCT00038142|50070907|FG001|Overall Study|Progressive Disease|7|||
24982473|NCT00038142|50070906|FG000|Overall Study|Death|1|||
24982474|NCT00038142|50070907|FG001|Overall Study|Death|0|||
24982475|NCT00038142|50070906|FG000|Overall Study|Adverse Event|1|||
24982476|NCT00038142|50070907|FG001|Overall Study|Adverse Event|0|||
24982477|NCT00038142|50070906|FG000|Overall Study|Unknown Reason|8|||
24982478|NCT00038142|50070907|FG001|Overall Study|Unknown Reason|0|||
24982479|NCT00366899|50070915|FG000|Infant Series|Withdrawal by Subject|4|||
24982480|NCT00366899|50070916|FG001|Infant Series|Withdrawal by Subject|7|||
24982481|NCT00366899|50070915|FG000|Infant Series|Protocol Violation|2|||
24982482|NCT00366899|50070916|FG001|Infant Series|Protocol Violation|1|||
24982483|NCT00366899|50070915|FG000|Infant Series|Failed to return|1|||
24982484|NCT00366899|50070916|FG001|Infant Series|Failed to return|1|||
24982485|NCT00366899|50070915|FG000|Infant Series|Lost to Follow-up|0|||
24982486|NCT00366899|50070916|FG001|Infant Series|Lost to Follow-up|2|||
24982487|NCT00366899|50070915|FG000|Infant Series|Adverse Event|0|||
24982488|NCT00366899|50070916|FG001|Infant Series|Adverse Event|1|||
24982489|NCT00366899|50070915|FG000|Infant Series|Physician Decision|1|||
24982490|NCT00366899|50070916|FG001|Infant Series|Physician Decision|0|||
24982491|NCT00366899|50070915|FG000|Infant Series|Randomized but not consented|1|||
24982492|NCT00366899|50070916|FG001|Infant Series|Randomized but not consented|0|||
24982493|NCT00366899|50070915|FG000|After Infant Series|Lost to Follow-up|4|||
24982494|NCT00366899|50070916|FG001|After Infant Series|Lost to Follow-up|3|||
24982495|NCT00366899|50070915|FG000|After Infant Series|Withdrawal by Subject|1|||
24982496|NCT00366899|50070916|FG001|After Infant Series|Withdrawal by Subject|4|||
24982497|NCT00366899|50070915|FG000|After Infant Series|Adverse Event|1|||
24982498|NCT00366899|50070916|FG001|After Infant Series|Adverse Event|2|||
24982499|NCT00366899|50070915|FG000|After Infant Series|Protocol Violation|1|||
24982500|NCT00366899|50070916|FG001|After Infant Series|Protocol Violation|0|||
24982501|NCT00366899|50070915|FG000|Toddler Dose|Withdrawal by Subject|1|||
24982502|NCT00366899|50070916|FG001|Toddler Dose|Withdrawal by Subject|1|||
24982503|NCT00366899|50070915|FG000|Toddler Dose|Protocol Violation|1|||
24982504|NCT00366899|50070916|FG001|Toddler Dose|Protocol Violation|0|||
24982505|NCT03254134|50070950|FG000|Overall Study|Not eligible patients|599|||
24982506|NCT03254134|50070951|FG001|Overall Study|Not eligible patients|3630|||
24982507|NCT00037830|50070960|FG000|Overall Study|Adverse Event|2|||
24982508|NCT00037830|50070961|FG001|Overall Study|Adverse Event|0|||
24982509|NCT00037830|50070962|FG002|Overall Study|Adverse Event|0|||
24982510|NCT00037830|50070960|FG000|Overall Study|Withdrawal by Subject|4|||
24982511|NCT00037830|50070961|FG001|Overall Study|Withdrawal by Subject|5|||
24982512|NCT00037830|50070962|FG002|Overall Study|Withdrawal by Subject|1|||
24982513|NCT00037830|50070960|FG000|Overall Study|Protocol Violation|2|||
24982514|NCT00037830|50070961|FG001|Overall Study|Protocol Violation|2|||
24982515|NCT00037830|50070962|FG002|Overall Study|Protocol Violation|0|||
24982516|NCT00037830|50070960|FG000|Overall Study|Unrelated Medical Problem|2|||
24982517|NCT00037830|50070961|FG001|Overall Study|Unrelated Medical Problem|0|||
24982518|NCT00037830|50070962|FG002|Overall Study|Unrelated Medical Problem|0|||
24982519|NCT03242434|50070972|FG000|Overall Study|Death|0|||
24982520|NCT03242434|50070973|FG001|Overall Study|Death|2|||
24982521|NCT02939014|50070982|FG000|Overall Study|Lost to Follow-up|1|||
24982522|NCT02939014|50070983|FG001|Overall Study|Lost to Follow-up|0|||
24982523|NCT02939014|50070982|FG000|Overall Study|Death|4|||
24982524|NCT02939014|50070983|FG001|Overall Study|Death|3|||
24982525|NCT00051558|50070992|FG000|Overall Study|Adverse Event|30|||
24982526|NCT00051558|50070993|FG001|Overall Study|Adverse Event|18|||
24982527|NCT00051558|50070992|FG000|Overall Study|Withdrawal by Subject|29|||
24982528|NCT00051558|50070993|FG001|Overall Study|Withdrawal by Subject|42|||
24982529|NCT00051558|50070992|FG000|Overall Study|Death|9|||
24982530|NCT00051558|50070993|FG001|Overall Study|Death|15|||
24982531|NCT00051558|50070992|FG000|Overall Study|Lost to Follow-up|4|||
24982532|NCT00051558|50070993|FG001|Overall Study|Lost to Follow-up|13|||
24982533|NCT00051558|50070992|FG000|Overall Study|Protocol Violation|3|||
24982534|NCT00051558|50070993|FG001|Overall Study|Protocol Violation|4|||
24982535|NCT00051558|50070992|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
24982536|NCT00051558|50070993|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
24982537|NCT00051558|50070992|FG000|Overall Study|Sponsor Decision|6|||
24982538|NCT00051558|50070993|FG001|Overall Study|Sponsor Decision|1|||
24982539|NCT00051558|50070992|FG000|Overall Study|Other|2|||
24982540|NCT00051558|50070993|FG001|Overall Study|Other|1|||
24982541|NCT00051558|50070992|FG000|Overall Study|Significant Lab Value|2|||
24982542|NCT00051558|50070993|FG001|Overall Study|Significant Lab Value|0|||
24982543|NCT00051558|50070992|FG000|Overall Study|Physician Decision|5|||
24982544|NCT00051558|50070993|FG001|Overall Study|Physician Decision|0|||
24982545|NCT03251482|50071004|FG000|Overall Study|Withdrawal by Subject|0|||
24982546|NCT03251482|50071005|FG001|Overall Study|Withdrawal by Subject|1|||
25255676|NCT01108510|50571060|FG000|Overall Study|Withdrew Consent|21|||
25255677|NCT01108510|50571061|FG001|Overall Study|Withdrew Consent|15|||
25255678|NCT01108510|50571060|FG000|Overall Study|Investigator's Discretion|12|||
25255679|NCT01108510|50571061|FG001|Overall Study|Investigator's Discretion|10|||
25255680|NCT01108510|50571060|FG000|Overall Study|Participant Noncompliance|5|||
25255681|NCT01108510|50571061|FG001|Overall Study|Participant Noncompliance|7|||
25255682|NCT01108510|50571060|FG000|Overall Study|Lack of Efficacy|3|||
25255683|NCT01108510|50571061|FG001|Overall Study|Lack of Efficacy|0|||
25255684|NCT01108510|50571060|FG000|Overall Study|Pregnancy|0|||
25255685|NCT01108510|50571061|FG001|Overall Study|Pregnancy|3|||
25255686|NCT01108510|50571060|FG000|Overall Study|Death|1|||
25255687|NCT01108510|50571061|FG001|Overall Study|Death|1|||
25255688|NCT01108237|50571069|FG000|Overall Study|No alignment data|2|||
25255689|NCT01108237|50571070|FG001|Overall Study|No alignment data|17|||
25255690|NCT01108237|50571069|FG000|Overall Study|Did not meet criteria for analysis|7|||
25255691|NCT01108237|50571070|FG001|Overall Study|Did not meet criteria for analysis|0|||
25255692|NCT01340027|50571088|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
25255693|NCT01340027|50571089|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
25255694|NCT01340027|50571090|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
25255695|NCT01340027|50571091|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
25255696|NCT01340027|50571092|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
25255697|NCT01340027|50571093|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
25255698|NCT01340027|50571094|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
25255699|NCT01340027|50571095|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
25255700|NCT01340027|50571096|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
25255701|NCT01340027|50571097|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
25255702|NCT01340027|50571098|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
25255703|NCT01340027|50571099|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
25255704|NCT01340027|50571088|FG000|Overall Study|Adverse Event|0|||
25255705|NCT01340027|50571089|FG001|Overall Study|Adverse Event|1|||
25255706|NCT01340027|50571090|FG002|Overall Study|Adverse Event|2|||
25255707|NCT01340027|50571091|FG003|Overall Study|Adverse Event|0|||
25255708|NCT01340027|50571092|FG004|Overall Study|Adverse Event|1|||
25255709|NCT01340027|50571093|FG005|Overall Study|Adverse Event|2|||
25255710|NCT01340027|50571094|FG006|Overall Study|Adverse Event|2|||
25255711|NCT01340027|50571095|FG007|Overall Study|Adverse Event|1|||
25255712|NCT01340027|50571096|FG008|Overall Study|Adverse Event|4|||
25255713|NCT01340027|50571097|FG009|Overall Study|Adverse Event|1|||
25255714|NCT01340027|50571098|FG010|Overall Study|Adverse Event|1|||
25255715|NCT01340027|50571099|FG011|Overall Study|Adverse Event|3|||
25255716|NCT01340027|50571088|FG000|Overall Study|Lack of Efficacy|0|||
25255717|NCT01340027|50571089|FG001|Overall Study|Lack of Efficacy|0|||
25255718|NCT01340027|50571090|FG002|Overall Study|Lack of Efficacy|0|||
25255719|NCT01340027|50571091|FG003|Overall Study|Lack of Efficacy|0|||
25255720|NCT01340027|50571092|FG004|Overall Study|Lack of Efficacy|0|||
25255721|NCT01340027|50571093|FG005|Overall Study|Lack of Efficacy|0|||
25255722|NCT01340027|50571094|FG006|Overall Study|Lack of Efficacy|1|||
25255723|NCT01340027|50571095|FG007|Overall Study|Lack of Efficacy|1|||
25255724|NCT01340027|50571096|FG008|Overall Study|Lack of Efficacy|1|||
25255725|NCT01340027|50571097|FG009|Overall Study|Lack of Efficacy|0|||
25255726|NCT01340027|50571098|FG010|Overall Study|Lack of Efficacy|0|||
25255727|NCT01340027|50571099|FG011|Overall Study|Lack of Efficacy|0|||
25255728|NCT01340027|50571088|FG000|Overall Study|Lost to Follow-up|0|||
25255729|NCT01340027|50571089|FG001|Overall Study|Lost to Follow-up|1|||
25255730|NCT01340027|50571090|FG002|Overall Study|Lost to Follow-up|0|||
25255731|NCT01340027|50571091|FG003|Overall Study|Lost to Follow-up|0|||
25255732|NCT01340027|50571092|FG004|Overall Study|Lost to Follow-up|0|||
25255733|NCT01340027|50571093|FG005|Overall Study|Lost to Follow-up|0|||
25255734|NCT01340027|50571094|FG006|Overall Study|Lost to Follow-up|1|||
25255735|NCT01340027|50571095|FG007|Overall Study|Lost to Follow-up|0|||
25255736|NCT01340027|50571096|FG008|Overall Study|Lost to Follow-up|0|||
25255737|NCT01340027|50571097|FG009|Overall Study|Lost to Follow-up|1|||
25255738|NCT01340027|50571098|FG010|Overall Study|Lost to Follow-up|0|||
25255739|NCT01340027|50571099|FG011|Overall Study|Lost to Follow-up|0|||
25255740|NCT01340027|50571088|FG000|Overall Study|Protocol Violation|1|||
25255741|NCT01340027|50571089|FG001|Overall Study|Protocol Violation|2|||
25255742|NCT01340027|50571090|FG002|Overall Study|Protocol Violation|0|||
24982547|NCT03251482|50071006|FG002|Overall Study|Withdrawal by Subject|0|||
24982548|NCT03251482|50071007|FG003|Overall Study|Withdrawal by Subject|0|||
25255743|NCT01340027|50571091|FG003|Overall Study|Protocol Violation|0|||
25255744|NCT01340027|50571092|FG004|Overall Study|Protocol Violation|6|||
24982549|NCT03251482|50071008|FG004|Overall Study|Withdrawal by Subject|0|||
24982550|NCT03249454|50071020|FG000|Overall Study|Withdrawal by Subject|0|||
24982551|NCT03249454|50071021|FG001|Overall Study|Withdrawal by Subject|0|||
24982552|NCT03249454|50071022|FG002|Overall Study|Withdrawal by Subject|0|||
24982553|NCT03249454|50071023|FG003|Overall Study|Withdrawal by Subject|0|||
24982554|NCT03249454|50071024|FG004|Overall Study|Withdrawal by Subject|0|||
24982555|NCT03249454|50071025|FG005|Overall Study|Withdrawal by Subject|0|||
24982556|NCT03249454|50071026|FG006|Overall Study|Withdrawal by Subject|0|||
24982557|NCT03249454|50071027|FG007|Overall Study|Withdrawal by Subject|0|||
24982558|NCT03249454|50071028|FG008|Overall Study|Withdrawal by Subject|0|||
24982559|NCT03249454|50071029|FG009|Overall Study|Withdrawal by Subject|1|||
24982560|NCT03249454|50071030|FG010|Overall Study|Withdrawal by Subject|1|||
24982561|NCT03732248|50071043|FG000|Overall Study|Withdrawal by Subject|1|||
24982562|NCT03732248|50071044|FG001|Overall Study|Withdrawal by Subject|0|||
24982563|NCT00310037|50071052|FG000|Overall Study|Adverse Event|7|||
24982564|NCT00310037|50071053|FG001|Overall Study|Adverse Event|14|||
24982565|NCT00310037|50071052|FG000|Overall Study|Withdrawal by Subject|4|||
24982566|NCT00310037|50071053|FG001|Overall Study|Withdrawal by Subject|3|||
24982567|NCT00310037|50071052|FG000|Overall Study|Progression|6|||
24982568|NCT00310037|50071053|FG001|Overall Study|Progression|0|||
24982569|NCT00310037|50071052|FG000|Overall Study|Non-protocol treatment|1|||
24982570|NCT00310037|50071053|FG001|Overall Study|Non-protocol treatment|0|||
24982571|NCT00309959|50071059|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
24982572|NCT03238924|50071070|FG000|Overall Study|Withdrawal by Subject|2|||
24982573|NCT03238924|50071071|FG001|Overall Study|Withdrawal by Subject|2|||
24982574|NCT03247816|50071077|FG000|Overall Study|Adverse Event|12|||
24982575|NCT03247816|50071077|FG000|Overall Study|Physician Decision|3|||
24982576|NCT03247816|50071077|FG000|Overall Study|Lack of Efficacy|1|||
24982577|NCT03247816|50071077|FG000|Overall Study|Lost to Follow-up|10|||
24982578|NCT03247816|50071077|FG000|Overall Study|Missing Feraccru stop date|3|||
24982579|NCT00333359|50071095|FG000|Overall Study|Adverse Event|29|||
24982580|NCT00333359|50071096|FG001|Overall Study|Adverse Event|35|||
24982581|NCT00333359|50071095|FG000|Overall Study|Withdrawal by Subject|19|||
24982582|NCT00333359|50071096|FG001|Overall Study|Withdrawal by Subject|37|||
24982583|NCT00333359|50071095|FG000|Overall Study|Physician Decision|2|||
24982584|NCT00333359|50071096|FG001|Overall Study|Physician Decision|2|||
24982585|NCT00333359|50071095|FG000|Overall Study|Protocol Non-compliance|2|||
24982586|NCT00333359|50071096|FG001|Overall Study|Protocol Non-compliance|8|||
24982587|NCT00333359|50071095|FG000|Overall Study|Lost to Follow-up|15|||
24982588|NCT00333359|50071096|FG001|Overall Study|Lost to Follow-up|25|||
24982589|NCT00333359|50071095|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
24982590|NCT00333359|50071096|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
24982591|NCT00333359|50071095|FG000|Overall Study|Treatment Failure|3|||
24982592|NCT00333359|50071096|FG001|Overall Study|Treatment Failure|8|||
24982593|NCT00333359|50071095|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
24982594|NCT00333359|50071096|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
24982595|NCT03246724|50071108|FG000|Overall Study|Withdrawal by Subject|5|||
24982596|NCT03246724|50071109|FG001|Overall Study|Withdrawal by Subject|2|||
24982597|NCT03246724|50071110|FG002|Overall Study|Withdrawal by Subject|4|||
24982598|NCT03246724|50071111|FG003|Overall Study|Withdrawal by Subject|2|||
24982599|NCT03246724|50071108|FG000|Overall Study|Ineligible on day of surgery|7|||
24982600|NCT03246724|50071109|FG001|Overall Study|Ineligible on day of surgery|2|||
24982601|NCT03246724|50071110|FG002|Overall Study|Ineligible on day of surgery|0|||
24982602|NCT03246724|50071111|FG003|Overall Study|Ineligible on day of surgery|3|||
24982603|NCT03246724|50071108|FG000|Overall Study|Study completed before surgical date|2|||
24982604|NCT03246724|50071109|FG001|Overall Study|Study completed before surgical date|1|||
24982605|NCT03246724|50071110|FG002|Overall Study|Study completed before surgical date|8|||
24982606|NCT03246724|50071111|FG003|Overall Study|Study completed before surgical date|1|||
24982607|NCT03246724|50071108|FG000|Overall Study|Transferred to other arm|0|||
24982608|NCT03246724|50071109|FG001|Overall Study|Transferred to other arm|0|||
24982609|NCT03246724|50071110|FG002|Overall Study|Transferred to other arm|1|||
24982610|NCT03246724|50071111|FG003|Overall Study|Transferred to other arm|0|||
24982611|NCT03246724|50071108|FG000|Overall Study|Unable to obtain medication timely|0|||
24982612|NCT03246724|50071109|FG001|Overall Study|Unable to obtain medication timely|2|||
24982613|NCT03246724|50071110|FG002|Overall Study|Unable to obtain medication timely|2|||
24982614|NCT03246724|50071111|FG003|Overall Study|Unable to obtain medication timely|1|||
24982615|NCT03246724|50071108|FG000|Overall Study|Re-consented to participate|0|||
24982616|NCT03246724|50071109|FG001|Overall Study|Re-consented to participate|0|||
24982617|NCT03246724|50071110|FG002|Overall Study|Re-consented to participate|0|||
24982618|NCT03246724|50071111|FG003|Overall Study|Re-consented to participate|1|||
24982619|NCT03246646|50071123|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
24982620|NCT03246646|50071124|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
24982621|NCT03246646|50071123|FG000|Overall Study|Withdrawal by Subject|3|||
25078281|NCT01378975|50186406|FG000|Overall Study|Lost to Follow-up|4|||
24982622|NCT03246646|50071124|FG001|Overall Study|Withdrawal by Subject|0|||
24982623|NCT03246646|50071123|FG000|Overall Study|Lost to Follow-up|7|||
24982624|NCT03246646|50071124|FG001|Overall Study|Lost to Follow-up|0|||
24982625|NCT01347112|50071132|FG000|Overall Study|Withdrawal by Subject|1|||
24982626|NCT01347112|50071133|FG001|Overall Study|Withdrawal by Subject|7|||
24982627|NCT01347112|50071132|FG000|Overall Study|Lost to Follow-up|3|||
24982628|NCT01347112|50071133|FG001|Overall Study|Lost to Follow-up|5|||
24982629|NCT00308711|50071143|FG000|Overall Study|Withdrawal by Subject|1|||
24982630|NCT00308711|50071144|FG001|Overall Study|Withdrawal by Subject|0|||
24982631|NCT00308711|50071145|FG002|Overall Study|Withdrawal by Subject|1|||
24982632|NCT00308711|50071143|FG000|Overall Study|Protocol Violation|0|||
24982633|NCT00308711|50071144|FG001|Overall Study|Protocol Violation|1|||
24982634|NCT00308711|50071145|FG002|Overall Study|Protocol Violation|1|||
24982635|NCT00308711|50071143|FG000|Overall Study|Lost to Follow-up|0|||
24982636|NCT00308711|50071144|FG001|Overall Study|Lost to Follow-up|1|||
24982637|NCT00308711|50071145|FG002|Overall Study|Lost to Follow-up|0|||
24982638|NCT00308711|50071143|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
24982639|NCT00308711|50071144|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
24982640|NCT00308711|50071145|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
24982641|NCT00308711|50071143|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
24982642|NCT00308711|50071144|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
24982643|NCT00308711|50071145|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
24982644|NCT00308555|50071155|FG000|Overall Study|Withdrawal by Subject|1|||
24982645|NCT00308555|50071156|FG001|Overall Study|Withdrawal by Subject|0|||
24982646|NCT00308555|50071155|FG000|Overall Study|Physician Decision|2|||
24982647|NCT00308555|50071156|FG001|Overall Study|Physician Decision|0|||
24982648|NCT00050778|50071165|FG000|Overall Study|Adverse Event|13|||
24982649|NCT00050778|50071166|FG001|Overall Study|Adverse Event|3|||
24982650|NCT00050778|50071167|FG002|Overall Study|Adverse Event|2|||
24982651|NCT00050778|50071165|FG000|Overall Study|Death|0|||
24982652|NCT00050778|50071166|FG001|Overall Study|Death|1|||
24982653|NCT00050778|50071167|FG002|Overall Study|Death|1|||
24982654|NCT00050778|50071165|FG000|Overall Study|Lack of Efficacy|16|||
24982655|NCT00050778|50071166|FG001|Overall Study|Lack of Efficacy|2|||
24982656|NCT00050778|50071167|FG002|Overall Study|Lack of Efficacy|2|||
24982657|NCT00050778|50071165|FG000|Overall Study|Lost to Follow-up|0|||
24982658|NCT00050778|50071166|FG001|Overall Study|Lost to Follow-up|2|||
24982659|NCT00050778|50071167|FG002|Overall Study|Lost to Follow-up|4|||
24982660|NCT00050778|50071165|FG000|Overall Study|Physician Decision|3|||
24982661|NCT00050778|50071166|FG001|Overall Study|Physician Decision|0|||
24982662|NCT00050778|50071167|FG002|Overall Study|Physician Decision|2|||
24982663|NCT00050778|50071165|FG000|Overall Study|Protocol Violation|2|||
24982664|NCT00050778|50071166|FG001|Overall Study|Protocol Violation|0|||
24982665|NCT00050778|50071167|FG002|Overall Study|Protocol Violation|1|||
24982666|NCT00050778|50071165|FG000|Overall Study|Withdrawal by Subject|6|||
24982667|NCT00050778|50071166|FG001|Overall Study|Withdrawal by Subject|8|||
24982668|NCT00050778|50071167|FG002|Overall Study|Withdrawal by Subject|4|||
24982669|NCT00050778|50071165|FG000|Overall Study|Randomized but not treated|4|||
24982670|NCT00050778|50071166|FG001|Overall Study|Randomized but not treated|5|||
24982671|NCT00050778|50071167|FG002|Overall Study|Randomized but not treated|2|||
24982672|NCT00050778|50071165|FG000|Overall Study|Familial and personal reasons|1|||
24982673|NCT00050778|50071166|FG001|Overall Study|Familial and personal reasons|0|||
24982674|NCT00050778|50071167|FG002|Overall Study|Familial and personal reasons|0|||
24982675|NCT00050622|50071177|FG000|Overall Study|Adverse Event|1|||
25255745|NCT01340027|50571093|FG005|Overall Study|Protocol Violation|0|||
25341995|NCT00727506|50658354|FG005|Overall Study|Adverse Event|8|||
25341996|NCT00727506|50658349|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
25255746|NCT01340027|50571094|FG006|Overall Study|Protocol Violation|0|||
25255747|NCT01340027|50571095|FG007|Overall Study|Protocol Violation|1|||
25255748|NCT01340027|50571096|FG008|Overall Study|Protocol Violation|2|||
25255749|NCT01340027|50571097|FG009|Overall Study|Protocol Violation|2|||
25255750|NCT01340027|50571098|FG010|Overall Study|Protocol Violation|0|||
25255751|NCT01340027|50571099|FG011|Overall Study|Protocol Violation|0|||
25255752|NCT01340027|50571088|FG000|Overall Study|Withdrawal by Subject|4|||
25255753|NCT01340027|50571089|FG001|Overall Study|Withdrawal by Subject|3|||
25255754|NCT01340027|50571090|FG002|Overall Study|Withdrawal by Subject|1|||
25255755|NCT01340027|50571091|FG003|Overall Study|Withdrawal by Subject|3|||
25341997|NCT00727506|50658350|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
24982676|NCT00308087|50071203|FG000|Overall Study|Progressive Disease|19|||
24982677|NCT00308087|50071204|FG001|Overall Study|Progressive Disease|21|||
24982678|NCT00308087|50071203|FG000|Overall Study|Study Closure|11|||
24982679|NCT00308087|50071204|FG001|Overall Study|Study Closure|12|||
24982680|NCT00308087|50071203|FG000|Overall Study|Withdrawal by Subject|2|||
24982681|NCT00308087|50071204|FG001|Overall Study|Withdrawal by Subject|1|||
24982682|NCT00308087|50071203|FG000|Overall Study|Other|4|||
25255756|NCT01340027|50571092|FG004|Overall Study|Withdrawal by Subject|3|||
25255757|NCT01340027|50571093|FG005|Overall Study|Withdrawal by Subject|2|||
24982683|NCT00308087|50071204|FG001|Overall Study|Other|3|||
24982684|NCT00307931|50071210|FG000|Overall Study|Adverse Event|1|||
24982685|NCT02796170|50071216|FG000|Overall Study|Lost to Follow-up|3|||
24982686|NCT02796170|50071217|FG001|Overall Study|Lost to Follow-up|0|||
24982687|NCT00049842|50071225|FG000|Treatment Phase|Adverse Event|47|||
24982688|NCT00049842|50071226|FG001|Treatment Phase|Adverse Event|12|||
24982689|NCT00049842|50071225|FG000|Treatment Phase|Withdrawal by Subject|35|||
24982690|NCT00049842|50071226|FG001|Treatment Phase|Withdrawal by Subject|46|||
24982691|NCT00049842|50071225|FG000|Treatment Phase|Non-compliance with protocol|7|||
24982692|NCT00049842|50071226|FG001|Treatment Phase|Non-compliance with protocol|8|||
24982693|NCT00049842|50071225|FG000|Treatment Phase|Lost to Follow-up|4|||
24982694|NCT00049842|50071226|FG001|Treatment Phase|Lost to Follow-up|8|||
24982695|NCT00049842|50071225|FG000|Treatment Phase|Administrative|0|||
24982696|NCT00049842|50071226|FG001|Treatment Phase|Administrative|3|||
24982697|NCT00049842|50071225|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
24982698|NCT00049842|50071226|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
25255758|NCT01340027|50571094|FG006|Overall Study|Withdrawal by Subject|3|||
25255759|NCT01340027|50571095|FG007|Overall Study|Withdrawal by Subject|4|||
25255760|NCT01340027|50571096|FG008|Overall Study|Withdrawal by Subject|1|||
25255761|NCT01340027|50571097|FG009|Overall Study|Withdrawal by Subject|2|||
25255762|NCT01340027|50571098|FG010|Overall Study|Withdrawal by Subject|0|||
25255763|NCT01340027|50571099|FG011|Overall Study|Withdrawal by Subject|1|||
25255764|NCT01340027|50571088|FG000|Overall Study|Miscellaneous|0|||
25255765|NCT01340027|50571089|FG001|Overall Study|Miscellaneous|0|||
25255766|NCT01340027|50571090|FG002|Overall Study|Miscellaneous|0|||
25255767|NCT01340027|50571091|FG003|Overall Study|Miscellaneous|1|||
25255768|NCT01340027|50571092|FG004|Overall Study|Miscellaneous|0|||
25255769|NCT01340027|50571093|FG005|Overall Study|Miscellaneous|0|||
25255770|NCT01340027|50571094|FG006|Overall Study|Miscellaneous|0|||
25255771|NCT01340027|50571095|FG007|Overall Study|Miscellaneous|0|||
25255772|NCT01340027|50571096|FG008|Overall Study|Miscellaneous|0|||
25255773|NCT01340027|50571097|FG009|Overall Study|Miscellaneous|0|||
25255774|NCT01340027|50571098|FG010|Overall Study|Miscellaneous|1|||
25255775|NCT01340027|50571099|FG011|Overall Study|Miscellaneous|0|||
25255776|NCT01327053|50571127|FG000|Overall Study|Adverse Event|23|||
25255777|NCT01327053|50571128|FG001|Overall Study|Adverse Event|57|||
25255778|NCT01327053|50571127|FG000|Overall Study|Patient/guardian decision|11|||
25255779|NCT01327053|50571128|FG001|Overall Study|Patient/guardian decision|35|||
25255780|NCT01327053|50571127|FG000|Overall Study|Physician Decision|10|||
25255781|NCT01327053|50571128|FG001|Overall Study|Physician Decision|14|||
25255782|NCT01327053|50571127|FG000|Overall Study|Death|1|||
25255783|NCT01327053|50571128|FG001|Overall Study|Death|5|||
25255784|NCT01327053|50571127|FG000|Overall Study|Lost to Follow-up|2|||
25255785|NCT01327053|50571128|FG001|Overall Study|Lost to Follow-up|4|||
25255786|NCT01327053|50571127|FG000|Overall Study|Non-compliance with study treatment|0|||
25255787|NCT01327053|50571128|FG001|Overall Study|Non-compliance with study treatment|5|||
25255788|NCT01327053|50571127|FG000|Overall Study|Study terminated by Sponsor|1|||
25255789|NCT01327053|50571128|FG001|Overall Study|Study terminated by Sponsor|3|||
25255790|NCT01327053|50571127|FG000|Overall Study|Progressive disease|31|||
25255791|NCT01327053|50571128|FG001|Overall Study|Progressive disease|26|||
25255792|NCT01327053|50571127|FG000|Overall Study|Protocol Violation|0|||
25255793|NCT01327053|50571128|FG001|Overall Study|Protocol Violation|1|||
25255794|NCT01327053|50571127|FG000|Overall Study|Untreated|0|||
25255795|NCT01327053|50571128|FG001|Overall Study|Untreated|1|||
25255796|NCT01107925|50571142|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
25255797|NCT01107925|50571143|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
25255798|NCT01107925|50571144|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
25255799|NCT01107925|50571145|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
25255800|NCT01107925|50571146|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
25255801|NCT01107925|50571147|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
25255802|NCT01107925|50571142|FG000|Period 2|Withdrawal by Subject|0|||
25255803|NCT01107925|50571143|FG001|Period 2|Withdrawal by Subject|1|||
25255804|NCT01107925|50571144|FG002|Period 2|Withdrawal by Subject|0|||
25255805|NCT01107925|50571145|FG003|Period 2|Withdrawal by Subject|0|||
25255806|NCT01107925|50571146|FG004|Period 2|Withdrawal by Subject|0|||
25255807|NCT01107925|50571147|FG005|Period 2|Withdrawal by Subject|1|||
25255808|NCT01339832|50571175|FG000|Overall Study|Lost to Follow-up|3|||
25255809|NCT01339832|50571175|FG000|Overall Study|Death|11|||
25255810|NCT01339559|50571179|FG000|Overall Study|Adverse Event|92|||
25255811|NCT01339559|50571179|FG000|Overall Study|Death|5|||
25255812|NCT01339559|50571179|FG000|Overall Study|Lack of Efficacy|164|||
25255813|NCT01339559|50571179|FG000|Overall Study|Lost to Follow-up|22|||
25255814|NCT01339559|50571179|FG000|Overall Study|Subject choice|89|||
25255815|NCT01339559|50571179|FG000|Overall Study|Protocol Violation|15|||
25255816|NCT01339559|50571179|FG000|Overall Study|Study closure at site|1|||
24982699|NCT00049842|50071225|FG000|Follow-up Phase|Adverse Event|6|||
25255817|NCT01339559|50571179|FG000|Overall Study|Incarcerated|2|||
25255818|NCT01339559|50571179|FG000|Overall Study|Epilepsy surgery|1|||
24982700|NCT00049842|50071226|FG001|Follow-up Phase|Adverse Event|1|||
24982701|NCT00049842|50071225|FG000|Follow-up Phase|Other|1|||
24982702|NCT00049842|50071226|FG001|Follow-up Phase|Other|4|||
24982703|NCT00307151|50071236|FG000|Overall Study|Death|4|||
24982704|NCT00307151|50071237|FG001|Overall Study|Death|3|||
24982705|NCT00307151|50071238|FG002|Overall Study|Death|10|||
24982706|NCT00307151|50071239|FG003|Overall Study|Death|3|||
24982707|NCT00307151|50071236|FG000|Overall Study|Severe debilitation, unable to continue|1|||
24982708|NCT00307151|50071237|FG001|Overall Study|Severe debilitation, unable to continue|0|||
24982709|NCT00307151|50071238|FG002|Overall Study|Severe debilitation, unable to continue|0|||
24982710|NCT00307151|50071239|FG003|Overall Study|Severe debilitation, unable to continue|0|||
24982711|NCT00307151|50071236|FG000|Overall Study|Subject unable to get to clinic|1|||
24982712|NCT00307151|50071237|FG001|Overall Study|Subject unable to get to clinic|0|||
24982713|NCT00307151|50071238|FG002|Overall Study|Subject unable to get to clinic|6|||
24982714|NCT00307151|50071239|FG003|Overall Study|Subject unable to get to clinic|2|||
24982715|NCT00307151|50071236|FG000|Overall Study|Withdrew consent|0|||
24982716|NCT00307151|50071237|FG001|Overall Study|Withdrew consent|1|||
24982717|NCT00307151|50071238|FG002|Overall Study|Withdrew consent|1|||
24982718|NCT00307151|50071239|FG003|Overall Study|Withdrew consent|3|||
24982719|NCT00307151|50071236|FG000|Overall Study|Not willing to adhere to study reqs|2|||
24982720|NCT00307151|50071237|FG001|Overall Study|Not willing to adhere to study reqs|0|||
24982721|NCT00307151|50071238|FG002|Overall Study|Not willing to adhere to study reqs|2|||
24982722|NCT00307151|50071239|FG003|Overall Study|Not willing to adhere to study reqs|2|||
24982723|NCT00307151|50071236|FG000|Overall Study|Clinic unable to contact subject|3|||
24982724|NCT00307151|50071237|FG001|Overall Study|Clinic unable to contact subject|3|||
24982725|NCT00307151|50071238|FG002|Overall Study|Clinic unable to contact subject|1|||
24982726|NCT00307151|50071239|FG003|Overall Study|Clinic unable to contact subject|1|||
24982727|NCT02654132|50071251|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
24982728|NCT02654132|50071252|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
24982729|NCT02654132|50071251|FG000|Treatment Period|Disease progression|43|||
24982730|NCT02654132|50071252|FG001|Treatment Period|Disease progression|38|||
24982731|NCT02654132|50071251|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
24982732|NCT02654132|50071252|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
24982733|NCT02654132|50071251|FG000|Treatment Period|Other reasons|4|||
24982734|NCT02654132|50071252|FG001|Treatment Period|Other reasons|2|||
24982735|NCT02654132|50071251|FG000|Treatment Period|Study drug toxicity|2|||
24982736|NCT02654132|50071252|FG001|Treatment Period|Study drug toxicity|2|||
24982737|NCT02654132|50071251|FG000|Treatment Period|Withdrawal by Subject|2|||
24982738|NCT02654132|50071252|FG001|Treatment Period|Withdrawal by Subject|1|||
24982739|NCT02654132|50071251|FG000|Treatment Period|Maximum Clinical Benefit|0|||
24982740|NCT02654132|50071252|FG001|Treatment Period|Maximum Clinical Benefit|2|||
24982741|NCT02654132|50071251|FG000|Treatment Period|Participant request to discontinue|2|||
24982742|NCT02654132|50071252|FG001|Treatment Period|Participant request to discontinue|0|||
24982743|NCT02654132|50071251|FG000|Treatment Period|Administrative reasons by sponsor|0|||
24982744|NCT02654132|50071252|FG001|Treatment Period|Administrative reasons by sponsor|1|||
24982745|NCT02654132|50071251|FG000|Treatment Period|Death|1|||
24982746|NCT02654132|50071252|FG001|Treatment Period|Death|0|||
24982747|NCT03241342|50071261|FG000|Overall Study|Adverse Event|5|||
24982748|NCT03241342|50071262|FG001|Overall Study|Adverse Event|8|||
24982749|NCT03241342|50071263|FG002|Overall Study|Adverse Event|4|||
24982750|NCT03241342|50071261|FG000|Overall Study|Lack of Efficacy|0|||
24982751|NCT03241342|50071262|FG001|Overall Study|Lack of Efficacy|0|||
24982752|NCT03241342|50071263|FG002|Overall Study|Lack of Efficacy|1|||
24982753|NCT03241342|50071261|FG000|Overall Study|noncompliance with study drug|2|||
24982754|NCT03241342|50071262|FG001|Overall Study|noncompliance with study drug|1|||
24982755|NCT03241342|50071263|FG002|Overall Study|noncompliance with study drug|1|||
24982756|NCT03241342|50071261|FG000|Overall Study|sponsor decision|0|||
24982757|NCT03241342|50071262|FG001|Overall Study|sponsor decision|1|||
24982758|NCT03241342|50071263|FG002|Overall Study|sponsor decision|2|||
24982759|NCT03241342|50071261|FG000|Overall Study|not reported|15|||
24982760|NCT03241342|50071262|FG001|Overall Study|not reported|21|||
24982761|NCT03241342|50071263|FG002|Overall Study|not reported|19|||
24982762|NCT00306995|50071278|FG000|Study Part I|Withdrawal by Subject|0|||
24982763|NCT00306995|50071279|FG001|Study Part I|Withdrawal by Subject|0|||
24982764|NCT00306995|50071280|FG002|Study Part I|Withdrawal by Subject|0|||
25078282|NCT01378975|50186407|FG001|Overall Study|Lost to Follow-up|1|||
25078283|NCT01378975|50186406|FG000|Overall Study|Withdrew Consent|4|||
24982765|NCT00306995|50071281|FG003|Study Part I|Withdrawal by Subject|0|||
24982766|NCT00306995|50071282|FG004|Study Part I|Withdrawal by Subject|0|||
24982767|NCT00306995|50071283|FG005|Study Part I|Withdrawal by Subject|0|||
24982768|NCT00306995|50071284|FG006|Study Part I|Withdrawal by Subject|1|||
24982769|NCT00306995|50071278|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
24982770|NCT00306995|50071279|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
24982771|NCT00306995|50071280|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
25078284|NCT01378975|50186407|FG001|Overall Study|Withdrew Consent|3|||
24982772|NCT00306995|50071281|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
24982773|NCT00306995|50071282|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
24982774|NCT00306995|50071283|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
24982775|NCT00306995|50071284|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
24982776|NCT00121108|50071331|FG000|Overall Study|Lost to Follow-up|10|||
24982777|NCT00121108|50071332|FG001|Overall Study|Lost to Follow-up|22|||
24982778|NCT00121108|50071331|FG000|Overall Study|Withdrawal by Subject|106|||
24982779|NCT00121108|50071332|FG001|Overall Study|Withdrawal by Subject|195|||
24982780|NCT00121108|50071331|FG000|Overall Study|Death|5|||
24982781|NCT00121108|50071332|FG001|Overall Study|Death|8|||
24982782|NCT02387996|50071339|FG000|Overall Study|Disease Progression|167|||
24982783|NCT02387996|50071339|FG000|Overall Study|Study Drug Toxicity|31|||
24982784|NCT02387996|50071339|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
24982785|NCT02387996|50071339|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
24982786|NCT02387996|50071339|FG000|Overall Study|Subject Withdrew Consent|5|||
24982787|NCT02387996|50071339|FG000|Overall Study|Lost to Follow-up|1|||
24982788|NCT02387996|50071339|FG000|Overall Study|Poor/Non-Compliance|1|||
24982789|NCT02387996|50071339|FG000|Overall Study|Other Reasons|5|||
24982790|NCT02387996|50071339|FG000|Overall Study|Death|1|||
24982791|NCT03212326|50071343|FG000|Overall Study|Physician Decision|4|||
24982792|NCT03229486|50071349|FG000|Overall Study|Protocol Violation|0|||
24982793|NCT03229486|50071350|FG001|Overall Study|Protocol Violation|1|||
24982794|NCT01779050|50071358|FG000|Overall Study|Withdrawal by Subject|1|||
25078285|NCT02222896|50186414|FG000|Abdomen|Did not qualify|34|||
25078286|NCT02222896|50186415|FG001|Abdomen|Did not qualify|10|||
25078287|NCT02222896|50186416|FG002|Abdomen|Did not qualify|32|||
25078288|NCT02222896|50186414|FG000|Groin|Did not qualify|43|||
25078289|NCT02222896|50186415|FG001|Groin|Did not qualify|9|||
25078290|NCT02222896|50186416|FG002|Groin|Did not qualify|40|||
25078291|NCT02222818|50186429|FG000|Period 1|Eligibility criteria not met|0|||
25078292|NCT02222818|50186430|FG001|Period 1|Eligibility criteria not met|3|||
25078293|NCT01378195|50186441|FG000|Overall Study|Lost to Follow-up|29|||
25078294|NCT01378195|50186442|FG001|Overall Study|Lost to Follow-up|18|||
25078295|NCT01378117|50186451|FG000|Overall Study|withdrawal|2|||
25078296|NCT01378117|50186452|FG001|Overall Study|withdrawal|1|||
25078297|NCT01378117|50186453|FG002|Overall Study|withdrawal|2|||
25078298|NCT01378117|50186451|FG000|Overall Study|discharged before med given|2|||
25078299|NCT01378117|50186452|FG001|Overall Study|discharged before med given|0|||
25078300|NCT01378117|50186453|FG002|Overall Study|discharged before med given|1|||
25078301|NCT04254809|50186488|FG000|Overall Study|Lost to Follow-up|5|||
25078302|NCT04254809|50186489|FG001|Overall Study|Lost to Follow-up|10|||
25078303|NCT02736409|50186499|FG000|Overall Study|Withdrawal by Subject|4|||
25078304|NCT02736409|50186500|FG001|Overall Study|Withdrawal by Subject|2|||
25078305|NCT02736409|50186501|FG002|Overall Study|Withdrawal by Subject|17|||
25078306|NCT02736409|50186502|FG003|Overall Study|Withdrawal by Subject|3|||
25078307|NCT02736409|50186499|FG000|Overall Study|Non-Compliance with Study Drug|0|||
25078308|NCT02736409|50186500|FG001|Overall Study|Non-Compliance with Study Drug|0|||
25078309|NCT02736409|50186501|FG002|Overall Study|Non-Compliance with Study Drug|0|||
25078310|NCT02736409|50186502|FG003|Overall Study|Non-Compliance with Study Drug|1|||
25078311|NCT02736409|50186499|FG000|Overall Study|Adverse Event|0|||
25078312|NCT02736409|50186500|FG001|Overall Study|Adverse Event|1|||
25078313|NCT02736409|50186501|FG002|Overall Study|Adverse Event|5|||
25078314|NCT02736409|50186502|FG003|Overall Study|Adverse Event|4|||
25078315|NCT02736409|50186499|FG000|Overall Study|Other|0|||
25078316|NCT02736409|50186500|FG001|Overall Study|Other|0|||
24982795|NCT01779050|50071359|FG001|Overall Study|Withdrawal by Subject|0|||
24982796|NCT00306527|50071369|FG000|Overall Study|Lost to Follow-up|3|||
24982797|NCT00306527|50071370|FG001|Overall Study|Lost to Follow-up|4|||
24982798|NCT00306527|50071371|FG002|Overall Study|Lost to Follow-up|3|||
24982799|NCT00306527|50071372|FG003|Overall Study|Lost to Follow-up|0|||
24982800|NCT00306527|50071369|FG000|Overall Study|Withdrawal by Subject|2|||
24982801|NCT00306527|50071370|FG001|Overall Study|Withdrawal by Subject|3|||
24982802|NCT00306527|50071371|FG002|Overall Study|Withdrawal by Subject|0|||
24982803|NCT00306527|50071372|FG003|Overall Study|Withdrawal by Subject|3|||
24982804|NCT00306527|50071369|FG000|Overall Study|Adverse Event|0|||
24982805|NCT00306527|50071370|FG001|Overall Study|Adverse Event|0|||
24982806|NCT00306527|50071371|FG002|Overall Study|Adverse Event|1|||
24982807|NCT00306527|50071372|FG003|Overall Study|Adverse Event|1|||
24982808|NCT00306527|50071369|FG000|Overall Study|Death|1|||
24982809|NCT00306527|50071370|FG001|Overall Study|Death|0|||
24982810|NCT00306527|50071371|FG002|Overall Study|Death|1|||
24982811|NCT00306527|50071372|FG003|Overall Study|Death|2|||
24982812|NCT00306293|50071386|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
24982813|NCT00306293|50071387|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
25078317|NCT02736409|50186501|FG002|Overall Study|Other|1|||
25078318|NCT02736409|50186502|FG003|Overall Study|Other|1|||
25078319|NCT02736409|50186499|FG000|Overall Study|Pregnancy|0|||
25078320|NCT02736409|50186500|FG001|Overall Study|Pregnancy|0|||
25078321|NCT02736409|50186501|FG002|Overall Study|Pregnancy|1|||
25078322|NCT02736409|50186502|FG003|Overall Study|Pregnancy|0|||
24982814|NCT00306293|50071386|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
24982815|NCT00306293|50071387|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
24982816|NCT00306293|50071386|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
24982817|NCT00306293|50071387|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
24982818|NCT00306293|50071386|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
24982819|NCT00306293|50071387|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
24982820|NCT00306293|50071386|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
24982821|NCT00306293|50071387|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
24982822|NCT00306293|50071386|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
24982823|NCT00306293|50071387|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
24982824|NCT00306293|50071386|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
24982825|NCT00306293|50071387|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
24982826|NCT00306293|50071386|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
24982827|NCT00306293|50071387|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
24982828|NCT00294671|50071397|FG000|Overall Study|Lack of Efficacy|11|||
24982829|NCT00294671|50071398|FG001|Overall Study|Lack of Efficacy|23|||
24982830|NCT00294671|50071397|FG000|Overall Study|Liver transplant|7|||
24982831|NCT00294671|50071398|FG001|Overall Study|Liver transplant|9|||
24982832|NCT00294671|50071397|FG000|Overall Study|Drug related adverse event (AE)|4|||
24982833|NCT00294671|50071398|FG001|Overall Study|Drug related adverse event (AE)|2|||
24982834|NCT00294671|50071397|FG000|Overall Study|Non-drug related AE|3|||
24982835|NCT00294671|50071398|FG001|Overall Study|Non-drug related AE|2|||
24982836|NCT00294671|50071397|FG000|Overall Study|Lost to Follow-up|1|||
24982837|NCT00294671|50071398|FG001|Overall Study|Lost to Follow-up|3|||
24982838|NCT00294671|50071397|FG000|Overall Study|Non-compliance|1|||
24982839|NCT00294671|50071398|FG001|Overall Study|Non-compliance|0|||
24982840|NCT00294671|50071397|FG000|Overall Study|Death|0|||
24982841|NCT00294671|50071398|FG001|Overall Study|Death|1|||
24982842|NCT01495598|50071404|FG000|Overall Study|Death during follow up period|2|||
24982843|NCT01495598|50071404|FG000|Overall Study|Death on study|1|||
24982844|NCT01495598|50071404|FG000|Overall Study|Lost to Follow-up|3|||
24982845|NCT01495598|50071404|FG000|Overall Study|Physician Decision|8|||
24982846|NCT02937454|50071435|FG000|Overall Study|Adverse Event|0|||
24982847|NCT02937454|50071436|FG001|Overall Study|Adverse Event|1|||
24982848|NCT02937454|50071435|FG000|Overall Study|Death|98|||
24982849|NCT02937454|50071436|FG001|Overall Study|Death|95|||
24982850|NCT02937454|50071435|FG000|Overall Study|Lost to Follow-up|1|||
24982851|NCT02937454|50071436|FG001|Overall Study|Lost to Follow-up|1|||
24982852|NCT02937454|50071435|FG000|Overall Study|Physician Decision|0|||
24982853|NCT02937454|50071436|FG001|Overall Study|Physician Decision|1|||
24982854|NCT02937454|50071435|FG000|Overall Study|Protocol Violation|6|||
24982855|NCT02937454|50071436|FG001|Overall Study|Protocol Violation|10|||
24982856|NCT02937454|50071435|FG000|Overall Study|Withdrawal by Subject|27|||
24982857|NCT02937454|50071436|FG001|Overall Study|Withdrawal by Subject|15|||
24982858|NCT02937454|50071435|FG000|Overall Study|Other|8|||
24982859|NCT02937454|50071436|FG001|Overall Study|Other|5|||
24982860|NCT03211858|50071455|FG000|Overall Study|Adverse Event|8|||
24982861|NCT03211858|50071456|FG001|Overall Study|Adverse Event|6|||
24982862|NCT03211858|50071455|FG000|Overall Study|Lack of Efficacy|0|||
24982863|NCT03211858|50071456|FG001|Overall Study|Lack of Efficacy|4|||
24982864|NCT03211858|50071455|FG000|Overall Study|Poor compliance to protocol|6|||
24982865|NCT03211858|50071456|FG001|Overall Study|Poor compliance to protocol|2|||
24982866|NCT03211858|50071455|FG000|Overall Study|Non-serious Hypoglycemia|1|||
24982867|NCT03211858|50071456|FG001|Overall Study|Non-serious Hypoglycemia|0|||
24982868|NCT03211858|50071455|FG000|Overall Study|Other than specified above|22|||
24982869|NCT03211858|50071456|FG001|Overall Study|Other than specified above|21|||
24982870|NCT03211156|50071468|FG000|Overall Study|Withdrawal by Subject|0|||
24982871|NCT03211156|50071469|FG001|Overall Study|Withdrawal by Subject|2|||
24982872|NCT03211156|50071468|FG000|Overall Study|Lost to Follow-up|1|||
24982873|NCT03211156|50071469|FG001|Overall Study|Lost to Follow-up|1|||
24982874|NCT03211156|50071468|FG000|Overall Study|Adverse Event|1|||
24982875|NCT03211156|50071469|FG001|Overall Study|Adverse Event|0|||
24982876|NCT04472494|50071477|FG000|Pre-treatment|Other reasons|2|||
24982877|NCT04472494|50071478|FG001|Pre-treatment|Other reasons|0|||
24982878|NCT04472494|50071477|FG000|Treatment|Death|5|||
24982879|NCT04472494|50071478|FG001|Treatment|Death|2|||
24982880|NCT04472494|50071477|FG000|Treatment|Hospital discharge|1|||
24982881|NCT04472494|50071478|FG001|Treatment|Hospital discharge|1|||
24982882|NCT04419506|50071488|FG000|Overall Study|Adverse Event|0|||
24982883|NCT04419506|50071489|FG001|Overall Study|Adverse Event|10|||
24982884|NCT04419506|50071490|FG002|Overall Study|Adverse Event|0|||
24982885|NCT04419506|50071491|FG003|Overall Study|Adverse Event|3|||
24982886|NCT04419506|50071488|FG000|Overall Study|Withdrawal by Subject|0|||
24982887|NCT04419506|50071489|FG001|Overall Study|Withdrawal by Subject|0|||
24982888|NCT04419506|50071490|FG002|Overall Study|Withdrawal by Subject|0|||
24982889|NCT04419506|50071491|FG003|Overall Study|Withdrawal by Subject|1|||
24982890|NCT04419506|50071488|FG000|Overall Study|poor-compliance|0|||
24982891|NCT04419506|50071489|FG001|Overall Study|poor-compliance|0|||
24982892|NCT04419506|50071490|FG002|Overall Study|poor-compliance|0|||
24982893|NCT04419506|50071491|FG003|Overall Study|poor-compliance|1|||
24982894|NCT03236506|50071504|FG000|Overall Study|Death|1|||
24982895|NCT03236506|50071505|FG001|Overall Study|Death|1|||
24982896|NCT03236506|50071506|FG002|Overall Study|Death|1|||
24982897|NCT03236506|50071504|FG000|Overall Study|Withdrawal by Subject|3|||
24982898|NCT03236506|50071505|FG001|Overall Study|Withdrawal by Subject|3|||
24982899|NCT03236506|50071506|FG002|Overall Study|Withdrawal by Subject|4|||
24982900|NCT03236506|50071504|FG000|Overall Study|Did not initiate treatment|2|||
24982901|NCT03236506|50071505|FG001|Overall Study|Did not initiate treatment|1|||
24982902|NCT03236506|50071506|FG002|Overall Study|Did not initiate treatment|2|||
24982903|NCT03227692|50071525|FG000|Overall Study|Protocol Violation|1|||
24982904|NCT03227692|50071526|FG001|Overall Study|Protocol Violation|1|||
24982905|NCT03227692|50071525|FG000|Overall Study|Lost to Follow-up|4|||
24982906|NCT03227692|50071526|FG001|Overall Study|Lost to Follow-up|2|||
24982907|NCT03227692|50071525|FG000|Overall Study|Adverse Event|0|||
24982908|NCT03227692|50071526|FG001|Overall Study|Adverse Event|2|||
24982909|NCT03210220|50071534|FG000|Overall Study|Physician Decision|1|||
24982910|NCT03210220|50071535|FG001|Overall Study|Physician Decision|0|||
24982911|NCT03209518|50071541|FG000|Overall Study|Case Report Forms Uncollected|1|||
24982912|NCT03209518|50071541|FG000|Overall Study|Protocol Deviation|1|||
24982913|NCT03227224|50071549|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
24982914|NCT03227224|50071550|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
24982915|NCT03227224|50071551|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
24982916|NCT03227224|50071552|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
24982917|NCT03227224|50071549|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
24982918|NCT03227224|50071550|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
24982919|NCT03227224|50071551|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
24982920|NCT03227224|50071552|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
24982921|NCT03227224|50071549|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
24982922|NCT03227224|50071550|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
24982923|NCT03227224|50071551|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
24982924|NCT03227224|50071552|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
24982925|NCT03227224|50071549|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
24982926|NCT03227224|50071550|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
24982927|NCT03227224|50071551|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
24982928|NCT03227224|50071552|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
24982929|NCT03227224|50071549|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
24982930|NCT03227224|50071550|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
24982931|NCT03227224|50071551|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
24982932|NCT03227224|50071552|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
24982933|NCT03227224|50071549|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
24982934|NCT03227224|50071550|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
24982935|NCT03227224|50071551|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
24982936|NCT03227224|50071552|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
24982937|NCT03227224|50071549|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
24982938|NCT03227224|50071550|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
24982939|NCT03227224|50071551|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
24982940|NCT03227224|50071552|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
24982941|NCT03227224|50071549|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
24982942|NCT03227224|50071550|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
24982943|NCT03227224|50071551|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
24982944|NCT03227224|50071552|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
24982945|NCT03227224|50071549|FG000|Follow-up Phase (2 Weeks)|Other|4|||
24982946|NCT03227224|50071550|FG001|Follow-up Phase (2 Weeks)|Other|4|||
24982947|NCT03227224|50071551|FG002|Follow-up Phase (2 Weeks)|Other|6|||
24982948|NCT03227224|50071552|FG003|Follow-up Phase (2 Weeks)|Other|3|||
24982949|NCT03725852|50071571|FG000|Overall Study|Death|1|||
24982950|NCT03725852|50071572|FG001|Overall Study|Death|0|||
24982951|NCT03725852|50071571|FG000|Overall Study|Withdrawal by Subject|1|||
24982952|NCT03725852|50071572|FG001|Overall Study|Withdrawal by Subject|0|||
24982953|NCT03725852|50071571|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
24982954|NCT03725852|50071572|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
24982955|NCT00304031|50071581|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
24982956|NCT00304031|50071582|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
24982957|NCT00304031|50071583|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
25078323|NCT02736409|50186499|FG000|Overall Study|Lost to Follow-up|0|||
25078324|NCT02736409|50186500|FG001|Overall Study|Lost to Follow-up|0|||
25078325|NCT02736409|50186501|FG002|Overall Study|Lost to Follow-up|2|||
24982958|NCT00304031|50071581|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
24982959|NCT00304031|50071582|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
24982960|NCT00304031|50071583|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
24982961|NCT00304031|50071581|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
24982962|NCT00304031|50071582|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
24982963|NCT00304031|50071583|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
24982964|NCT00304031|50071581|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
24982965|NCT00304031|50071582|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
24982966|NCT00304031|50071583|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
24982967|NCT00304031|50071581|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
24982968|NCT00304031|50071582|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
24982969|NCT00304031|50071583|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
24982970|NCT00304031|50071581|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
24982971|NCT00304031|50071582|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
24982972|NCT00304031|50071583|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
24982973|NCT00304031|50071581|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
24982974|NCT00304031|50071582|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
24982975|NCT00304031|50071583|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
24982976|NCT00304031|50071581|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
24982977|NCT00304031|50071582|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
24982978|NCT00304031|50071583|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
24982979|NCT00304031|50071581|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
24982980|NCT00304031|50071582|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
24982981|NCT00304031|50071583|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
24982982|NCT00332189|50071598|FG000|Overall Study|Adverse Event|3|||
24982983|NCT00332189|50071598|FG000|Overall Study|Uncooperative/Noncompliant|3|||
24982984|NCT00332189|50071598|FG000|Overall Study|Withdrawal by Subject|9|||
24982985|NCT00332189|50071598|FG000|Overall Study|Lack of Efficacy|4|||
24982986|NCT00332189|50071598|FG000|Overall Study|Moved out of country|2|||
24982987|NCT00331799|50071603|FG000|Overall Study|Withdrawal by Subject|2|||
24982988|NCT00331799|50071603|FG000|Overall Study|Sedation|1|||
24982989|NCT00303719|50071609|FG000|Overall Study|Not evaluable, prior therapies|0|||
24982990|NCT00303719|50071610|FG001|Overall Study|Not evaluable, prior therapies|30|||
24982991|NCT00303719|50071609|FG000|Overall Study|Lost to Follow-up|0|||
24982992|NCT00303719|50071610|FG001|Overall Study|Lost to Follow-up|7|||
24982993|NCT00331409|50071617|FG000|Overall Study|Lack of Efficacy|4|||
24982994|NCT00303485|50071623|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
24982995|NCT00303485|50071624|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
24982996|NCT00303485|50071623|FG000|Overall Study|Failure to return|0|||
24982997|NCT00303485|50071624|FG001|Overall Study|Failure to return|1|||
24982998|NCT00303485|50071623|FG000|Overall Study|Withdrawal by Subject|1|||
24982999|NCT00303485|50071624|FG001|Overall Study|Withdrawal by Subject|0|||
24983000|NCT03235726|50071638|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
24983001|NCT03235726|50071639|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
24983002|NCT03235726|50071640|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
24983003|NCT03235726|50071641|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
24983004|NCT03235726|50071642|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
24983005|NCT03235726|50071643|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
24983006|NCT03235726|50071644|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
24983007|NCT03235726|50071645|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
24983008|NCT03235726|50071646|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
24983009|NCT03235726|50071647|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
24983010|NCT03235726|50071638|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
24983011|NCT03235726|50071639|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
24983012|NCT03235726|50071640|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
24983013|NCT03235726|50071641|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
24983014|NCT03235726|50071642|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
24983015|NCT03235726|50071643|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
24983016|NCT03235726|50071644|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
24983017|NCT03235726|50071645|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
24983018|NCT03235726|50071646|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
24983019|NCT03235726|50071647|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
24983020|NCT00303953|50071682|FG000|Overall Study|Ineligible|1|||
24983021|NCT00303953|50071682|FG000|Overall Study|Death|1|||
24983022|NCT00303953|50071682|FG000|Overall Study|Adverse Event|4|||
24983023|NCT00303953|50071682|FG000|Overall Study|Lack of Efficacy|12|||
24983024|NCT00303953|50071682|FG000|Overall Study|Physician Decision|1|||
24983025|NCT03723590|50071686|FG000|Overall Study|Withdrawal by Subject|3|||
24983026|NCT02935894|50071690|FG000|Overall Study|Subject dismissed|1|||
24983027|NCT03224182|50071696|FG000|Overall Study|Study Drug Not Instilled|6|||
24983028|NCT03224182|50071697|FG001|Overall Study|Study Drug Not Instilled|1|||
24983029|NCT03224182|50071696|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
24983030|NCT03224182|50071697|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
24983031|NCT03224182|50071696|FG000|Overall Study|Withdrew of Consent|4|||
24983032|NCT03224182|50071697|FG001|Overall Study|Withdrew of Consent|2|||
24983033|NCT03224182|50071696|FG000|Overall Study|Investigator Decision|3|||
24983034|NCT03224182|50071697|FG001|Overall Study|Investigator Decision|1|||
24983035|NCT03224182|50071696|FG000|Overall Study|Sponsor Decision|26|||
24983036|NCT03224182|50071697|FG001|Overall Study|Sponsor Decision|12|||
24983037|NCT03224182|50071696|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
24983038|NCT03224182|50071697|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
24983039|NCT03224182|50071696|FG000|Overall Study|Lost to Follow-up|1|||
24983040|NCT03224182|50071697|FG001|Overall Study|Lost to Follow-up|0|||
24983041|NCT03224182|50071696|FG000|Overall Study|Participant Had Recurrence|11|||
24983042|NCT03224182|50071697|FG001|Overall Study|Participant Had Recurrence|5|||
24983043|NCT03224182|50071696|FG000|Overall Study|Death|0|||
24983044|NCT03224182|50071697|FG001|Overall Study|Death|1|||
24983045|NCT03224182|50071696|FG000|Overall Study|Reason not Specified|3|||
24983046|NCT03224182|50071697|FG001|Overall Study|Reason not Specified|3|||
24983047|NCT03224182|50071696|FG000|Overall Study|Other|1|||
24983048|NCT03224182|50071697|FG001|Overall Study|Other|0|||
24983049|NCT02935192|50071705|FG000|Overall Study|Withdrawal by Subject|8|||
24983050|NCT02935192|50071706|FG001|Overall Study|Withdrawal by Subject|4|||
24983051|NCT03722264|50071712|FG000|Overall Study|Physician Decision|3|||
24983052|NCT03722030|50071720|FG000|Overall Study|Withdrawal by Subject|1|||
24983053|NCT03722030|50071721|FG001|Overall Study|Withdrawal by Subject|0|||
24983054|NCT03221842|50071728|FG000|Period 1 (Open-label)|Adverse Event|4|||
24983055|NCT03221842|50071729|FG001|Period 1 (Open-label)|Adverse Event|0|||
24983056|NCT03221842|50071728|FG000|Period 1 (Open-label)|Physician Decision|2|||
24983057|NCT03221842|50071729|FG001|Period 1 (Open-label)|Physician Decision|0|||
24983058|NCT03221842|50071728|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
24983059|NCT03221842|50071729|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
24983060|NCT03221842|50071728|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
24983061|NCT03221842|50071729|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
24983062|NCT03221842|50071728|FG000|Period 1 (Open-label)|Other|2|||
24983063|NCT03221842|50071729|FG001|Period 1 (Open-label)|Other|0|||
24983064|NCT03221842|50071728|FG000|Period 2 (Randomized, Blinded)|Death|0|||
24983065|NCT03221842|50071729|FG001|Period 2 (Randomized, Blinded)|Death|1|||
24983066|NCT03221842|50071728|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
24983067|NCT03221842|50071729|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
24983068|NCT03364738|50071739|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
24983069|NCT03364738|50071739|FG000|Overall Study|Withdrawal by Subject|1|||
24983070|NCT03364738|50071739|FG000|Overall Study|Adverse Event|1|||
24983071|NCT00303329|50071746|FG000|Overall Study|Adverse Event|7|||
24983072|NCT00303329|50071747|FG001|Overall Study|Adverse Event|14|||
24983073|NCT00303329|50071746|FG000|Overall Study|Abnormal Laboratory Values|0|||
24983074|NCT00303329|50071747|FG001|Overall Study|Abnormal Laboratory Values|1|||
24983075|NCT00303329|50071746|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
24983076|NCT00303329|50071747|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
24983077|NCT00303329|50071746|FG000|Overall Study|Condition no longer requires study drug|0|||
24983078|NCT00303329|50071747|FG001|Overall Study|Condition no longer requires study drug|8|||
24983079|NCT00303329|50071746|FG000|Overall Study|Protocol Violation|3|||
24983080|NCT00303329|50071747|FG001|Overall Study|Protocol Violation|0|||
24983081|NCT00303329|50071746|FG000|Overall Study|Withdrawal by Subject|9|||
24983082|NCT00303329|50071747|FG001|Overall Study|Withdrawal by Subject|15|||
24983083|NCT00303329|50071746|FG000|Overall Study|Lost to Follow-up|0|||
24983084|NCT00303329|50071747|FG001|Overall Study|Lost to Follow-up|1|||
24983085|NCT00303329|50071746|FG000|Overall Study|Administrative problems|1|||
24983086|NCT00303329|50071747|FG001|Overall Study|Administrative problems|0|||
24983087|NCT00303329|50071746|FG000|Overall Study|Death|2|||
24983088|NCT00303329|50071747|FG001|Overall Study|Death|12|||
24983089|NCT00303329|50071746|FG000|Overall Study|Stopped at end of core|3|||
24983090|NCT00303329|50071747|FG001|Overall Study|Stopped at end of core|9|||
24983091|NCT00303329|50071746|FG000|Overall Study|Stopped at end of extension 1|1|||
24983092|NCT00303329|50071747|FG001|Overall Study|Stopped at end of extension 1|0|||
24983093|NCT00329849|50071755|FG000|Overall Study|Withdrawal by Subject|6|||
24983094|NCT00329849|50071756|FG001|Overall Study|Withdrawal by Subject|4|||
24983095|NCT02934178|50071768|FG000|Received Vaccination 2|Death|0|||
24983096|NCT02934178|50071769|FG001|Received Vaccination 2|Death|1|||
24983097|NCT02934178|50071768|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
24983098|NCT02934178|50071769|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
24983099|NCT00329303|50071778|FG000|Overall Study|Lack of Efficacy|1|||
24983100|NCT00329303|50071779|FG001|Overall Study|Lack of Efficacy|0|||
24983101|NCT00329303|50071778|FG000|Overall Study|Decision of the sponsor|0|||
24983102|NCT00329303|50071779|FG001|Overall Study|Decision of the sponsor|1|||
24983103|NCT00329303|50071778|FG000|Overall Study|Patient no longer available|1|||
24983104|NCT00329303|50071779|FG001|Overall Study|Patient no longer available|0|||
24983105|NCT00329303|50071778|FG000|Overall Study|Patient relocated|0|||
24983106|NCT00329303|50071779|FG001|Overall Study|Patient relocated|1|||
24983107|NCT03216850|50071786|FG000|Overall Study|Pre-analytical error|6|||
24983108|NCT00302159|50071790|FG000|Overall Study|pt declined before treatment started|1|||
24983109|NCT00302159|50071790|FG000|Overall Study|pt started Avastin|1|||
24983110|NCT00302081|50071798|FG000|Overall Study|Adverse Event|6|||
24983111|NCT00302081|50071799|FG001|Overall Study|Adverse Event|5|||
24983112|NCT00302081|50071800|FG002|Overall Study|Adverse Event|4|||
24983113|NCT00302081|50071798|FG000|Overall Study|Lost to Follow-up|21|||
24983114|NCT00302081|50071799|FG001|Overall Study|Lost to Follow-up|18|||
24983115|NCT00302081|50071800|FG002|Overall Study|Lost to Follow-up|28|||
24983116|NCT00302081|50071798|FG000|Overall Study|Withdrawal by Subject|8|||
24983117|NCT00302081|50071799|FG001|Overall Study|Withdrawal by Subject|12|||
24983118|NCT00302081|50071800|FG002|Overall Study|Withdrawal by Subject|8|||
24983119|NCT00302081|50071798|FG000|Overall Study|Protocol Violation|5|||
24983120|NCT00302081|50071799|FG001|Overall Study|Protocol Violation|1|||
24983121|NCT00302081|50071800|FG002|Overall Study|Protocol Violation|2|||
24983122|NCT00302081|50071798|FG000|Overall Study|Lack of Efficacy|1|||
24983123|NCT00302081|50071799|FG001|Overall Study|Lack of Efficacy|0|||
24983124|NCT00302081|50071800|FG002|Overall Study|Lack of Efficacy|5|||
24983125|NCT00302081|50071798|FG000|Overall Study|Death|2|||
24983126|NCT00302081|50071799|FG001|Overall Study|Death|1|||
24983127|NCT00302081|50071800|FG002|Overall Study|Death|0|||
24983128|NCT00302081|50071798|FG000|Overall Study|Other|13|||
24983129|NCT00302081|50071799|FG001|Overall Study|Other|6|||
24983130|NCT00302081|50071800|FG002|Overall Study|Other|5|||
24983131|NCT00302003|50071808|FG000|Overall Study|Lack of Efficacy|62|||
24983132|NCT00302003|50071808|FG000|Overall Study|Lost to Follow-up|1|||
24983133|NCT00302003|50071808|FG000|Overall Study|Physician Decision|2|||
24983134|NCT00302003|50071808|FG000|Overall Study|Withdrawal by Subject|5|||
24983135|NCT00302003|50071808|FG000|Overall Study|Ineligible|9|||
24983136|NCT00302003|50071808|FG000|Overall Study|Protocol Violation|1|||
24983137|NCT00036270|50071814|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
24983138|NCT00036270|50071815|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
24983139|NCT00036270|50071814|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
24983140|NCT00036270|50071815|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
24983141|NCT00036270|50071814|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
24983142|NCT00036270|50071815|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
24983143|NCT00036270|50071814|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
24983144|NCT00036270|50071815|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
24983145|NCT00036270|50071814|FG000|Study Treatment to 5 Year Report|Other|277|||
24983146|NCT00036270|50071815|FG001|Study Treatment to 5 Year Report|Other|288|||
24983147|NCT00036270|50071814|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
24983148|NCT00036270|50071815|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
24983149|NCT00036270|50071814|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
24983150|NCT00036270|50071815|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
24983151|NCT00036270|50071814|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
24983152|NCT00036270|50071815|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
24983153|NCT00036270|50071814|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
24983154|NCT00036270|50071815|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
24983155|NCT00036270|50071814|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
24983156|NCT00036270|50071815|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
24983157|NCT00036270|50071814|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
24983158|NCT00036270|50071815|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
25341998|NCT00727506|50658351|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
25341999|NCT00727506|50658352|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
25342000|NCT00727506|50658353|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
25342001|NCT00727506|50658354|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
24983164|NCT00301067|50071825|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
24983165|NCT00301067|50071826|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
24983166|NCT00301067|50071827|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
24983167|NCT00301067|50071828|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
24983168|NCT00301067|50071825|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
24983169|NCT00301067|50071826|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
24983170|NCT00301067|50071827|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
24983171|NCT00301067|50071828|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
24983172|NCT00301067|50071825|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
24983173|NCT00301067|50071826|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
24983174|NCT00301067|50071827|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
24983175|NCT00301067|50071828|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
24983176|NCT00301067|50071825|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
24983177|NCT00301067|50071826|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
24983178|NCT00301067|50071827|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
24983179|NCT00301067|50071828|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
24983180|NCT00301067|50071825|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
24983181|NCT00301067|50071826|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
24983182|NCT00301067|50071827|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
24983183|NCT00301067|50071828|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
24983184|NCT00301067|50071825|FG000|Follow up Until Death|Alive at last data cut point|1|||
24983185|NCT00301067|50071826|FG001|Follow up Until Death|Alive at last data cut point|0|||
24983186|NCT00301067|50071827|FG002|Follow up Until Death|Alive at last data cut point|0|||
24983187|NCT00301067|50071828|FG003|Follow up Until Death|Alive at last data cut point|1|||
24983188|NCT00007020|50071839|FG000|Overall Study|Death|16|||
24983189|NCT00007020|50071839|FG000|Overall Study|Lost to Follow-up|13|||
24983190|NCT00007020|50071839|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
24983191|NCT00007020|50071839|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
24983192|NCT00007020|50071839|FG000|Overall Study|Pt cared for by outside physician|4|||
24983193|NCT00007020|50071839|FG000|Overall Study|No evidence of treatment|6|||
24983194|NCT00300755|50071848|FG000|Overall Study|Adverse Event|1|||
24983195|NCT00300755|50071849|FG001|Overall Study|Adverse Event|2|||
24983196|NCT00300755|50071850|FG002|Overall Study|Adverse Event|1|||
24983197|NCT00300755|50071848|FG000|Overall Study|Withdrawal by Subject|0|||
24983198|NCT00300755|50071849|FG001|Overall Study|Withdrawal by Subject|2|||
24983199|NCT00300755|50071850|FG002|Overall Study|Withdrawal by Subject|0|||
24983200|NCT00300755|50071848|FG000|Overall Study|Protocol Violation|0|||
24983201|NCT00300755|50071849|FG001|Overall Study|Protocol Violation|0|||
24983202|NCT00300755|50071850|FG002|Overall Study|Protocol Violation|1|||
24983203|NCT00033540|50071858|FG000|Overall Study|Adverse Event|14|||
24983204|NCT00033540|50071858|FG000|Overall Study|Death|1|||
24983205|NCT00033540|50071858|FG000|Overall Study|Progression|26|||
24983206|NCT00033540|50071858|FG000|Overall Study|Withdrawal by Subject|6|||
24983207|NCT00033540|50071858|FG000|Overall Study|Other|5|||
24983208|NCT00033540|50071858|FG000|Overall Study|Ineligible|3|||
24983209|NCT00033540|50071858|FG000|Overall Study|Never received treatment|2|||
24983210|NCT00300365|50071865|FG000|Overall Study|Lost to Follow-up|1|||
24983211|NCT00300365|50071866|FG001|Overall Study|Lost to Follow-up|0|||
24983212|NCT00300365|50071865|FG000|Overall Study|Physician Decision|2|||
24983213|NCT00300365|50071866|FG001|Overall Study|Physician Decision|0|||
24983214|NCT00300365|50071865|FG000|Overall Study|Withdrawal by Subject|1|||
24983215|NCT00300365|50071866|FG001|Overall Study|Withdrawal by Subject|0|||
24983216|NCT00300365|50071865|FG000|Overall Study|Adverse Event|0|||
24983217|NCT00300365|50071866|FG001|Overall Study|Adverse Event|2|||
24983218|NCT00048048|50071881|FG000|Core Treatment|Withdrawal by Subject|0|||
24983219|NCT00048048|50071882|FG001|Core Treatment|Withdrawal by Subject|0|||
24983220|NCT00048048|50071883|FG002|Core Treatment|Withdrawal by Subject|1|||
24983221|NCT00048048|50071884|FG003|Core Treatment|Withdrawal by Subject|0|||
24983222|NCT00048048|50071885|FG004|Core Treatment|Withdrawal by Subject|0|||
24983223|NCT00048048|50071886|FG005|Core Treatment|Withdrawal by Subject|0|||
24983224|NCT00048048|50071887|FG006|Core Treatment|Withdrawal by Subject|0|||
24983225|NCT00048048|50071888|FG007|Core Treatment|Withdrawal by Subject|0|||
24983226|NCT00048048|50071889|FG008|Core Treatment|Withdrawal by Subject|0|||
24983227|NCT00048048|50071890|FG009|Core Treatment|Withdrawal by Subject|0|||
24983228|NCT00048048|50071891|FG010|Core Treatment|Withdrawal by Subject|0|||
24983229|NCT00048048|50071892|FG011|Core Treatment|Withdrawal by Subject|0|||
24983230|NCT00048048|50071881|FG000|Core Treatment|Adverse Event|0|||
24983231|NCT00048048|50071882|FG001|Core Treatment|Adverse Event|0|||
24983232|NCT00048048|50071883|FG002|Core Treatment|Adverse Event|0|||
24983233|NCT00048048|50071884|FG003|Core Treatment|Adverse Event|0|||
24983234|NCT00048048|50071885|FG004|Core Treatment|Adverse Event|0|||
24983235|NCT00048048|50071886|FG005|Core Treatment|Adverse Event|0|||
24983236|NCT00048048|50071887|FG006|Core Treatment|Adverse Event|0|||
24983237|NCT00048048|50071888|FG007|Core Treatment|Adverse Event|1|||
24983238|NCT00048048|50071889|FG008|Core Treatment|Adverse Event|0|||
24983239|NCT00048048|50071890|FG009|Core Treatment|Adverse Event|0|||
24983240|NCT00048048|50071891|FG010|Core Treatment|Adverse Event|0|||
24983241|NCT00048048|50071892|FG011|Core Treatment|Adverse Event|0|||
24983242|NCT00048048|50071881|FG000|Extension Year 1|Early withdrawals|0|||
24983243|NCT00048048|50071882|FG001|Extension Year 1|Early withdrawals|0|||
24983244|NCT00048048|50071883|FG002|Extension Year 1|Early withdrawals|0|||
24983245|NCT00048048|50071884|FG003|Extension Year 1|Early withdrawals|0|||
24983246|NCT00048048|50071885|FG004|Extension Year 1|Early withdrawals|0|||
24983247|NCT00048048|50071886|FG005|Extension Year 1|Early withdrawals|0|||
24983248|NCT00048048|50071887|FG006|Extension Year 1|Early withdrawals|0|||
24983249|NCT00048048|50071888|FG007|Extension Year 1|Early withdrawals|0|||
24983250|NCT00048048|50071889|FG008|Extension Year 1|Early withdrawals|0|||
24983251|NCT00048048|50071890|FG009|Extension Year 1|Early withdrawals|2|||
24983252|NCT00048048|50071891|FG010|Extension Year 1|Early withdrawals|2|||
24983253|NCT00048048|50071892|FG011|Extension Year 1|Early withdrawals|4|||
24983254|NCT00048048|50071881|FG000|Extension Year 2|Early withdrawals|0|||
24983255|NCT00048048|50071882|FG001|Extension Year 2|Early withdrawals|0|||
24983256|NCT00048048|50071883|FG002|Extension Year 2|Early withdrawals|0|||
24983257|NCT00048048|50071884|FG003|Extension Year 2|Early withdrawals|0|||
24983258|NCT00048048|50071885|FG004|Extension Year 2|Early withdrawals|0|||
24983259|NCT00048048|50071886|FG005|Extension Year 2|Early withdrawals|0|||
24983260|NCT00048048|50071887|FG006|Extension Year 2|Early withdrawals|0|||
24983261|NCT00048048|50071888|FG007|Extension Year 2|Early withdrawals|0|||
24983262|NCT00048048|50071889|FG008|Extension Year 2|Early withdrawals|0|||
24983263|NCT00048048|50071890|FG009|Extension Year 2|Early withdrawals|0|||
24983264|NCT00048048|50071891|FG010|Extension Year 2|Early withdrawals|4|||
24983265|NCT00048048|50071892|FG011|Extension Year 2|Early withdrawals|2|||
24983266|NCT00300053|50071922|FG000|Overall Study|Patient/Caregiver Preference|2|||
24983267|NCT00300053|50071923|FG001|Overall Study|Patient/Caregiver Preference|2|||
24983268|NCT00300053|50071924|FG002|Overall Study|Patient/Caregiver Preference|3|||
24983269|NCT00300053|50071922|FG000|Overall Study|Death|0|||
24983270|NCT00300053|50071923|FG001|Overall Study|Death|0|||
24983271|NCT00300053|50071924|FG002|Overall Study|Death|3|||
24983272|NCT00300053|50071922|FG000|Overall Study|Lost to Follow-up|0|||
24983273|NCT00300053|50071923|FG001|Overall Study|Lost to Follow-up|1|||
24983274|NCT00300053|50071924|FG002|Overall Study|Lost to Follow-up|0|||
24983275|NCT00299975|50071936|FG000|Overall Study|Adverse Event|1|||
24983276|NCT00299975|50071937|FG001|Overall Study|Adverse Event|0|||
24983277|NCT00299975|50071938|FG002|Overall Study|Adverse Event|2|||
24983278|NCT00299975|50071936|FG000|Overall Study|Pregnancy|0|||
24983279|NCT00299975|50071937|FG001|Overall Study|Pregnancy|0|||
24983280|NCT00299975|50071938|FG002|Overall Study|Pregnancy|1|||
24983281|NCT00299975|50071936|FG000|Overall Study|Lack of Efficacy|1|||
24983282|NCT00299975|50071937|FG001|Overall Study|Lack of Efficacy|0|||
24983283|NCT00299975|50071938|FG002|Overall Study|Lack of Efficacy|1|||
24983284|NCT00299975|50071936|FG000|Overall Study|Lost to Follow-up|1|||
24983285|NCT00299975|50071937|FG001|Overall Study|Lost to Follow-up|0|||
24983286|NCT00299975|50071938|FG002|Overall Study|Lost to Follow-up|0|||
24983287|NCT00299975|50071936|FG000|Overall Study|Withdrawal by Subject|0|||
24983288|NCT00299975|50071937|FG001|Overall Study|Withdrawal by Subject|1|||
24983289|NCT00299975|50071938|FG002|Overall Study|Withdrawal by Subject|3|||
24983290|NCT00299975|50071936|FG000|Overall Study|Physician Decision|0|||
24983291|NCT00299975|50071937|FG001|Overall Study|Physician Decision|0|||
24983292|NCT00299975|50071938|FG002|Overall Study|Physician Decision|1|||
24983293|NCT00004980|50071948|FG000|Overall Study|Withdrawal by Subject|1|||
24983294|NCT00004980|50071949|FG001|Overall Study|Withdrawal by Subject|0|||
24983295|NCT00004980|50071948|FG000|Overall Study|memory difficulties|1|||
24983296|NCT00004980|50071949|FG001|Overall Study|memory difficulties|1|||
24983297|NCT00004980|50071948|FG000|Overall Study|Physician Decision|0|||
24983298|NCT00004980|50071949|FG001|Overall Study|Physician Decision|1|||
24983299|NCT00326963|50071955|FG000|Overall Study|Adverse Event|2|||
24983300|NCT00326963|50071955|FG000|Overall Study|Injection site reaction|1|||
24983301|NCT00326963|50071955|FG000|Overall Study|Death|1|||
24983302|NCT00326963|50071955|FG000|Overall Study|Failure to return|10|||
24983303|NCT00326963|50071955|FG000|Overall Study|Withdrawal by Subject|10|||
24983304|NCT00326963|50071955|FG000|Overall Study|Refused treatment / did not cooperate|5|||
24983305|NCT00326963|50071955|FG000|Overall Study|Violation of selection criteria at entry|2|||
24983306|NCT00326963|50071955|FG000|Overall Study|Other protocol violation|1|||
24983307|NCT00326963|50071955|FG000|Overall Study|Administrative / other|1|||
24983308|NCT00326885|50071960|FG000|Overall Study|Adverse Event|1|||
24983309|NCT00326885|50071960|FG000|Overall Study|Withdrawal by Subject|3|||
24983310|NCT00326885|50071960|FG000|Overall Study|Physician Decision|1|||
24983311|NCT00326885|50071960|FG000|Overall Study|Hospice withdrew consent|2|||
24983312|NCT00326495|50071965|FG000|Overall Study|Switched to alternative treatment|1|||
24983313|NCT00326495|50071965|FG000|Overall Study|Disease progression before treatment|1|||
24983314|NCT00326495|50071965|FG000|Overall Study|Refused further treatment|2|||
24983315|NCT00326495|50071965|FG000|Overall Study|Subject off study before assessment|1|||
24983316|NCT00326417|50071971|FG000|Overall Study|Withdrawal by Subject|0|||
24983317|NCT00326417|50071972|FG001|Overall Study|Withdrawal by Subject|0|||
25255819|NCT01339559|50571179|FG000|Overall Study|Pregnancy planned|2|||
24983318|NCT00326417|50071973|FG002|Overall Study|Withdrawal by Subject|1|||
24983319|NCT00326417|50071974|FG003|Overall Study|Withdrawal by Subject|0|||
24983320|NCT00326417|50071971|FG000|Overall Study|Arm Closed|7|||
24983321|NCT00326417|50071972|FG001|Overall Study|Arm Closed|0|||
24983322|NCT00326417|50071973|FG002|Overall Study|Arm Closed|0|||
24983323|NCT00326417|50071974|FG003|Overall Study|Arm Closed|3|||
24983324|NCT00326417|50071971|FG000|Overall Study|Death|7|||
25255820|NCT01339559|50571179|FG000|Overall Study|Left the country|1|||
24983325|NCT00326417|50071972|FG001|Overall Study|Death|0|||
24983326|NCT00326417|50071973|FG002|Overall Study|Death|0|||
24983327|NCT00326417|50071974|FG003|Overall Study|Death|0|||
24983328|NCT03825341|50071984|FG000|Overall Study|Withdrawal by Subject|0|||
24983329|NCT03825341|50071985|FG001|Overall Study|Withdrawal by Subject|1|||
24983330|NCT00297479|50071996|FG000|Overall Study|Lost to Follow-up|37|||
24983331|NCT00297479|50071997|FG001|Overall Study|Lost to Follow-up|54|||
24983332|NCT00297479|50071998|FG002|Overall Study|Lost to Follow-up|51|||
24983333|NCT00688870|50072008|FG000|Infant Series|Parent or legal guardian request|4|||
24983334|NCT00688870|50072009|FG001|Infant Series|Parent or legal guardian request|0|||
24983335|NCT00297167|50072019|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
24983336|NCT00297167|50072020|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
24983337|NCT00297167|50072021|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
24983338|NCT00297167|50072019|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
24983339|NCT00297167|50072020|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
24983340|NCT00297167|50072021|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
24983341|NCT03216226|50072030|FG000|Overall Study|Adverse Event|3|||
24983342|NCT03216226|50072031|FG001|Overall Study|Adverse Event|0|||
24983343|NCT03216226|50072030|FG000|Overall Study|Protocol Violation|1|||
24983344|NCT03216226|50072031|FG001|Overall Study|Protocol Violation|3|||
24983345|NCT03216226|50072030|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
24983346|NCT03216226|50072031|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
24983347|NCT03216226|50072030|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
24983348|NCT03216226|50072031|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
24983349|NCT03216226|50072030|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
24983350|NCT03216226|50072031|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
24983351|NCT03215758|50072039|FG000|Overall Study|Technical Problems|1|||
24983352|NCT03215758|50072040|FG001|Overall Study|Technical Problems|0|||
24983353|NCT03215758|50072039|FG000|Overall Study|Protocol deviation|0|||
24983354|NCT03215758|50072040|FG001|Overall Study|Protocol deviation|1|||
24983355|NCT03215758|50072039|FG000|Overall Study|Physician Decision|0|||
24983356|NCT03215758|50072040|FG001|Overall Study|Physician Decision|1|||
24983357|NCT03215758|50072039|FG000|Overall Study|Death|0|||
24983358|NCT03215758|50072040|FG001|Overall Study|Death|1|||
24983359|NCT03215758|50072039|FG000|Overall Study|Adverse Event|1|||
24983360|NCT03215758|50072040|FG001|Overall Study|Adverse Event|2|||
24983361|NCT03215758|50072039|FG000|Overall Study|Subject/Guardian Decision|3|||
24983362|NCT03215758|50072040|FG001|Overall Study|Subject/Guardian Decision|3|||
24983363|NCT00290771|50072048|FG000|Overall Study|Disease progression|95|||
24983364|NCT00290771|50072049|FG001|Overall Study|Disease progression|73|||
24983365|NCT00290771|50072048|FG000|Overall Study|Death|11|||
24983366|NCT00290771|50072049|FG001|Overall Study|Death|10|||
24983367|NCT00290771|50072048|FG000|Overall Study|Adverse Event|12|||
24983368|NCT00290771|50072049|FG001|Overall Study|Adverse Event|6|||
24983369|NCT00290771|50072048|FG000|Overall Study|Withdrawal by Subject|5|||
24983370|NCT00290771|50072049|FG001|Overall Study|Withdrawal by Subject|6|||
24983371|NCT00290771|50072048|FG000|Overall Study|Administrative problems|2|||
24983372|NCT00290771|50072049|FG001|Overall Study|Administrative problems|1|||
24983373|NCT00290771|50072048|FG000|Overall Study|Protocol Violation|2|||
24983374|NCT00290771|50072049|FG001|Overall Study|Protocol Violation|0|||
24983375|NCT00290771|50072048|FG000|Overall Study|Lost to Follow-up|0|||
24983376|NCT00290771|50072049|FG001|Overall Study|Lost to Follow-up|1|||
24983377|NCT00274625|50072058|FG000|Overall Study|Lost to Follow-up|46|||
24983378|NCT00274625|50072059|FG001|Overall Study|Lost to Follow-up|54|||
24983379|NCT00274625|50072058|FG000|Overall Study|Excluded from analysis|14|||
24983380|NCT00274625|50072059|FG001|Overall Study|Excluded from analysis|8|||
24983381|NCT00290693|50072065|FG000|Overall Study|Withdrawal by Subject|2|||
24983382|NCT03214666|50072076|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
24983383|NCT03214666|50072077|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
24983384|NCT03214666|50072078|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
24983385|NCT03214666|50072079|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
24983386|NCT03214666|50072080|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
24983387|NCT03214666|50072081|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
24983388|NCT00274469|50072098|FG000|Overall Study|Death|63|||
24983389|NCT00274469|50072099|FG001|Overall Study|Death|74|||
24983390|NCT00274469|50072098|FG000|Overall Study|Did not consent to OS follow-up|16|||
24983391|NCT00274469|50072099|FG001|Overall Study|Did not consent to OS follow-up|19|||
24983392|NCT03214588|50072108|FG000|Overall Study|Adverse Event|1|||
24983393|NCT03214588|50072109|FG001|Overall Study|Adverse Event|0|||
24983394|NCT03214588|50072110|FG002|Overall Study|Adverse Event|2|||
24983395|NCT03214588|50072108|FG000|Overall Study|Reason Not Specified|0|||
24983396|NCT03214588|50072109|FG001|Overall Study|Reason Not Specified|1|||
24983397|NCT03214588|50072110|FG002|Overall Study|Reason Not Specified|0|||
24983398|NCT03166618|50072120|FG000|Overall Study|Study was Terminated|0|||
24983399|NCT03166618|50072121|FG001|Overall Study|Study was Terminated|1|||
24983400|NCT03162796|50072138|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
24983401|NCT03162796|50072139|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
25078326|NCT02736409|50186502|FG003|Overall Study|Lost to Follow-up|1|||
25078327|NCT02736409|50186499|FG000|Overall Study|Physician Decision|0|||
25078328|NCT02736409|50186500|FG001|Overall Study|Physician Decision|0|||
25078329|NCT02736409|50186501|FG002|Overall Study|Physician Decision|0|||
25078330|NCT02736409|50186502|FG003|Overall Study|Physician Decision|2|||
25078331|NCT03099707|50186515|FG000|Overall Study|Withdrawal by Subject|0|||
25078332|NCT03099707|50186516|FG001|Overall Study|Withdrawal by Subject|3|||
25078333|NCT03099707|50186515|FG000|Overall Study|Lost to Follow-up|0|||
25078334|NCT03099707|50186516|FG001|Overall Study|Lost to Follow-up|1|||
25078335|NCT02906033|50186524|FG000|Baseline|Protocol Violation|37|||
25078336|NCT02906033|50186525|FG001|Baseline|Protocol Violation|33|||
25078337|NCT02906033|50186524|FG000|Follow-up|Lost to Follow-up|46|||
25078338|NCT02906033|50186525|FG001|Follow-up|Lost to Follow-up|62|||
25078339|NCT02221882|50186537|FG000|Overall Study|Withdrawal by Subject|0|||
25078340|NCT02221882|50186538|FG001|Overall Study|Withdrawal by Subject|0|||
25078341|NCT02221882|50186539|FG002|Overall Study|Withdrawal by Subject|4|||
25078342|NCT02221882|50186540|FG003|Overall Study|Withdrawal by Subject|2|||
25078343|NCT02221882|50186541|FG004|Overall Study|Withdrawal by Subject|2|||
25078344|NCT02221882|50186542|FG005|Overall Study|Withdrawal by Subject|2|||
25078345|NCT02221882|50186537|FG000|Overall Study|Death|0|||
25078346|NCT02221882|50186538|FG001|Overall Study|Death|1|||
25078347|NCT02221882|50186539|FG002|Overall Study|Death|0|||
25078348|NCT02221882|50186540|FG003|Overall Study|Death|0|||
25342002|NCT00727506|50658349|FG000|Overall Study|Progressive disease|4|||
25342003|NCT00727506|50658350|FG001|Overall Study|Progressive disease|7|||
25342004|NCT00727506|50658351|FG002|Overall Study|Progressive disease|9|||
25342005|NCT00727506|50658352|FG003|Overall Study|Progressive disease|28|||
25342006|NCT00727506|50658353|FG004|Overall Study|Progressive disease|38|||
25342007|NCT00727506|50658354|FG005|Overall Study|Progressive disease|28|||
25342008|NCT00727506|50658349|FG000|Overall Study|Refused to continue medication|0|||
25342009|NCT00727506|50658350|FG001|Overall Study|Refused to continue medication|1|||
25342010|NCT00727506|50658351|FG002|Overall Study|Refused to continue medication|2|||
25342011|NCT00727506|50658352|FG003|Overall Study|Refused to continue medication|3|||
25342012|NCT00727506|50658353|FG004|Overall Study|Refused to continue medication|1|||
25342013|NCT00727506|50658354|FG005|Overall Study|Refused to continue medication|2|||
25342014|NCT00727506|50658349|FG000|Overall Study|Other reason not described above|0|||
25342015|NCT00727506|50658350|FG001|Overall Study|Other reason not described above|0|||
25342016|NCT00727506|50658351|FG002|Overall Study|Other reason not described above|1|||
25342017|NCT00727506|50658352|FG003|Overall Study|Other reason not described above|4|||
25078349|NCT02221882|50186541|FG004|Overall Study|Death|0|||
25078350|NCT02221882|50186542|FG005|Overall Study|Death|0|||
25078351|NCT02837783|50186563|FG000|Overall Study|Adverse Event|1|||
25078352|NCT02837783|50186564|FG001|Overall Study|Adverse Event|0|||
25078353|NCT02837783|50186563|FG000|Overall Study|Other, Not Specified|1|||
25078354|NCT02837783|50186564|FG001|Overall Study|Other, Not Specified|2|||
25078355|NCT02221648|50186572|FG000|Overall Study|Withdrawal by Subject|3|||
25078356|NCT02221648|50186573|FG001|Overall Study|Withdrawal by Subject|3|||
25078357|NCT02220712|50186583|FG000|Overall Study|Adverse Event|1|||
25078358|NCT02220712|50186583|FG000|Overall Study|Withdrawal by Subject|2|||
25078359|NCT02220712|50186583|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
25078360|NCT02219932|50186593|FG000|Overall Study|Other|5|||
25078361|NCT02219932|50186594|FG001|Overall Study|Other|11|||
25078362|NCT02219932|50186593|FG000|Overall Study|Death|1|||
25078363|NCT02219932|50186594|FG001|Overall Study|Death|1|||
25078364|NCT02219932|50186593|FG000|Overall Study|Investigator Decision|0|||
25078365|NCT02219932|50186594|FG001|Overall Study|Investigator Decision|1|||
25078366|NCT02219932|50186593|FG000|Overall Study|Consent Withdrawn|11|||
25078367|NCT02219932|50186594|FG001|Overall Study|Consent Withdrawn|7|||
25078368|NCT02219932|50186593|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
25078369|NCT02219932|50186594|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
25078370|NCT02219932|50186593|FG000|Overall Study|Protocol Violation|10|||
25078371|NCT02219932|50186594|FG001|Overall Study|Protocol Violation|6|||
25078372|NCT02219932|50186593|FG000|Overall Study|Pregnancy|1|||
25078373|NCT02219932|50186594|FG001|Overall Study|Pregnancy|0|||
25078374|NCT02219932|50186593|FG000|Overall Study|Lost to Follow-up|4|||
25078375|NCT02219932|50186594|FG001|Overall Study|Lost to Follow-up|2|||
25342018|NCT00727506|50658353|FG004|Overall Study|Other reason not described above|1|||
25078376|NCT02219932|50186593|FG000|Overall Study|Adverse Event|23|||
25342019|NCT00727506|50658354|FG005|Overall Study|Other reason not described above|1|||
25078377|NCT02219932|50186594|FG001|Overall Study|Adverse Event|21|||
25078378|NCT02219464|50186602|FG000|Overall Study|Withdrawal by Subject|1|||
25078379|NCT02219464|50186603|FG001|Overall Study|Withdrawal by Subject|0|||
25078380|NCT02219464|50186602|FG000|Overall Study|case cancelled|1|||
25078381|NCT02219464|50186603|FG001|Overall Study|case cancelled|0|||
25078382|NCT02219464|50186602|FG000|Overall Study|catheter malfunction|1|||
24983402|NCT03162796|50072140|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
24983403|NCT03162796|50072138|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
24983404|NCT03162796|50072139|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
24983405|NCT03162796|50072140|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
24983406|NCT03162796|50072138|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
24983407|NCT03162796|50072139|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
24983408|NCT03162796|50072140|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
24983409|NCT03162796|50072138|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
24983410|NCT03162796|50072139|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
24983411|NCT03162796|50072140|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
24983412|NCT03162796|50072138|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
24983413|NCT03162796|50072139|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
24983414|NCT03162796|50072140|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
24983415|NCT03162796|50072138|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
24983416|NCT03162796|50072139|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
24983417|NCT03162796|50072140|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
24983418|NCT03162796|50072138|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
24983419|NCT03162796|50072139|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
24983420|NCT03162796|50072140|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
24983421|NCT03162796|50072138|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
24983422|NCT03162796|50072139|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
24983423|NCT03162796|50072140|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
24983424|NCT03162796|50072138|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
24983425|NCT03162796|50072139|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
24983426|NCT03162796|50072140|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
24983427|NCT03162796|50072138|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
24983428|NCT03162796|50072139|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
24983429|NCT03162796|50072140|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
24983430|NCT03162796|50072138|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
24983431|NCT03162796|50072139|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
24983432|NCT03162796|50072140|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
24983433|NCT03162328|50072153|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
24983434|NCT03162328|50072154|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
24983435|NCT03162328|50072155|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
24983436|NCT03162328|50072153|FG000|Screening Period|Withdrawal by Subject|1|||
24983437|NCT03162328|50072154|FG001|Screening Period|Withdrawal by Subject|0|||
24983438|NCT03162328|50072155|FG002|Screening Period|Withdrawal by Subject|0|||
24983439|NCT03162328|50072153|FG000|Study Period|Withdrawal by Subject|0|||
24983440|NCT03162328|50072154|FG001|Study Period|Withdrawal by Subject|0|||
24983441|NCT03162328|50072155|FG002|Study Period|Withdrawal by Subject|1|||
24983442|NCT00272987|50072169|FG000|Overall Study|Adverse Event|1|||
24983443|NCT00272987|50072170|FG001|Overall Study|Adverse Event|0|||
24983444|NCT00272987|50072171|FG002|Overall Study|Adverse Event|0|||
24983445|NCT00272987|50072169|FG000|Overall Study|Lost to Follow-up|3|||
24983446|NCT00272987|50072170|FG001|Overall Study|Lost to Follow-up|1|||
24983447|NCT00272987|50072171|FG002|Overall Study|Lost to Follow-up|1|||
24983448|NCT00272987|50072169|FG000|Overall Study|Withdrawal by Subject|1|||
24983449|NCT00272987|50072170|FG001|Overall Study|Withdrawal by Subject|0|||
24983450|NCT00272987|50072171|FG002|Overall Study|Withdrawal by Subject|3|||
24983451|NCT00272987|50072169|FG000|Overall Study|Sponsor Terminated study|0|||
24983452|NCT00272987|50072170|FG001|Overall Study|Sponsor Terminated study|1|||
24983453|NCT00272987|50072171|FG002|Overall Study|Sponsor Terminated study|1|||
24983454|NCT00272987|50072169|FG000|Overall Study|Disease progression|1|||
24983455|NCT00272987|50072170|FG001|Overall Study|Disease progression|1|||
24983456|NCT00272987|50072171|FG002|Overall Study|Disease progression|2|||
24983457|NCT00272987|50072169|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
24983458|NCT00272987|50072170|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
24983459|NCT00272987|50072171|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
24983460|NCT00272987|50072169|FG000|Overall Study|Death|1|||
24983461|NCT00272987|50072170|FG001|Overall Study|Death|0|||
24983462|NCT00272987|50072171|FG002|Overall Study|Death|0|||
24983463|NCT01730950|50072181|FG000|Overall Study|Protocol Violation|6|||
24983464|NCT01730950|50072182|FG001|Overall Study|Protocol Violation|6|||
24983465|NCT00271505|50072189|FG000|Overall Study|Screen Failure|3|||
24983466|NCT00271505|50072189|FG000|Overall Study|Adverse Event|1|||
24983467|NCT00271505|50072189|FG000|Overall Study|Death|1|||
24983468|NCT01642186|50072197|FG000|Overall Study|Death|0|||
24983469|NCT01642186|50072198|FG001|Overall Study|Death|2|||
24983470|NCT01642186|50072199|FG002|Overall Study|Death|2|||
24983471|NCT01642186|50072197|FG000|Overall Study|Lost to Follow-up|0|||
25255821|NCT01339559|50571179|FG000|Overall Study|Investigator decision|2|||
24983472|NCT01642186|50072198|FG001|Overall Study|Lost to Follow-up|0|||
24983473|NCT01642186|50072199|FG002|Overall Study|Lost to Follow-up|1|||
24983474|NCT00423514|50072209|FG000|Overall Study|Ineligible|1|||
24983475|NCT00423514|50072210|FG001|Overall Study|Ineligible|0|||
24983476|NCT00289991|50072218|FG000|Overall Study|Death|35|||
24983477|NCT00289991|50072219|FG001|Overall Study|Death|38|||
24983478|NCT00289991|50072218|FG000|Overall Study|Adverse Event|15|||
24983479|NCT00289991|50072219|FG001|Overall Study|Adverse Event|13|||
24983480|NCT00289991|50072218|FG000|Overall Study|Failure of prophylaxis|1|||
24983481|NCT00289991|50072219|FG001|Overall Study|Failure of prophylaxis|1|||
24983482|NCT00289991|50072218|FG000|Overall Study|Fungal breakthrough infection|0|||
24983483|NCT00289991|50072219|FG001|Overall Study|Fungal breakthrough infection|1|||
24983484|NCT00289991|50072218|FG000|Overall Study|Lost to Follow-up|0|||
24983485|NCT00289991|50072219|FG001|Overall Study|Lost to Follow-up|1|||
24983486|NCT00289991|50072218|FG000|Overall Study|Withdrawal by Subject|2|||
24983487|NCT00289991|50072219|FG001|Overall Study|Withdrawal by Subject|12|||
24983488|NCT00289991|50072218|FG000|Overall Study|Other|5|||
24983489|NCT00289991|50072219|FG001|Overall Study|Other|14|||
24983490|NCT00289913|50072230|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
24983491|NCT00289913|50072231|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
24983492|NCT00289913|50072232|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
24983493|NCT00289913|50072233|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
24983494|NCT00289913|50072234|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
24983495|NCT00289913|50072230|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
24983496|NCT00289913|50072231|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
24983497|NCT00289913|50072232|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
24983498|NCT00289913|50072233|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
24983499|NCT00289913|50072234|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
24983500|NCT00289913|50072230|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
24983501|NCT00289913|50072231|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
24983502|NCT00289913|50072232|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
24983503|NCT00289913|50072233|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
24983504|NCT00289913|50072234|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
24983505|NCT00289913|50072230|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
24983506|NCT00289913|50072231|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
24983507|NCT00289913|50072232|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
24983508|NCT00289913|50072233|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
24983509|NCT00289913|50072234|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
24983510|NCT00289913|50072230|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
24983511|NCT00289913|50072231|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
24983512|NCT00289913|50072232|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
24983513|NCT00289913|50072233|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
24983514|NCT00289913|50072234|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
24983515|NCT00289913|50072230|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
24983516|NCT00289913|50072231|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
24983517|NCT00289913|50072232|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
24983518|NCT00289913|50072233|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
24983519|NCT00289913|50072234|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
24983520|NCT00289913|50072230|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
24983521|NCT00289913|50072231|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
24983522|NCT00289913|50072232|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
24983523|NCT00289913|50072233|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
24983524|NCT00289913|50072234|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
24983525|NCT00289913|50072230|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
24983526|NCT00289913|50072231|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
24983527|NCT00289913|50072232|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
24983528|NCT00289913|50072233|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
24983529|NCT00289913|50072234|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
24983530|NCT00289913|50072230|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
24983531|NCT00289913|50072231|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
24983532|NCT00289913|50072232|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
24983533|NCT00289913|50072233|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
24983534|NCT00289913|50072234|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
24983535|NCT00289913|50072230|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
24983536|NCT00289913|50072231|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
24983537|NCT00289913|50072232|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
24983538|NCT00289913|50072233|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
24983539|NCT00289913|50072234|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
24983540|NCT00289913|50072230|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
24983541|NCT00289913|50072231|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
24983542|NCT00289913|50072232|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
24983543|NCT00289913|50072233|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
24983544|NCT00289913|50072234|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
24983545|NCT00289913|50072230|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
24983546|NCT00289913|50072231|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
24983547|NCT00289913|50072232|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
24983548|NCT00289913|50072233|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
24983549|NCT00289913|50072234|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
24983550|NCT00289913|50072230|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
24983551|NCT00289913|50072231|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
24983552|NCT00289913|50072232|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
24983553|NCT00289913|50072233|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
24983554|NCT00289913|50072234|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
24983555|NCT00289913|50072230|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
24983556|NCT00289913|50072231|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
24983557|NCT00289913|50072232|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
24983558|NCT00289913|50072233|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
24983559|NCT00289913|50072234|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
24983560|NCT00289913|50072230|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
24983561|NCT00289913|50072231|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
24983562|NCT00289913|50072232|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
24983563|NCT00289913|50072233|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
24983564|NCT00289913|50072234|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
24983565|NCT00289913|50072230|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
24983566|NCT00289913|50072231|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
24983567|NCT00289913|50072232|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
24983568|NCT00289913|50072233|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
24983569|NCT00289913|50072234|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
24983570|NCT00289913|50072230|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
24983571|NCT00289913|50072231|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
24983572|NCT00289913|50072232|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
24983573|NCT00289913|50072233|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
24983574|NCT00289913|50072234|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
24983575|NCT00289913|50072230|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
24983576|NCT00289913|50072231|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
24983577|NCT00289913|50072232|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
24983578|NCT00289913|50072233|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
24983579|NCT00289913|50072234|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
24983580|NCT00289913|50072230|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
24983581|NCT00289913|50072231|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
24983582|NCT00289913|50072232|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
24983583|NCT00289913|50072233|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
24983584|NCT00289913|50072234|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
24983585|NCT00289913|50072230|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
24983586|NCT00289913|50072231|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
24983587|NCT00289913|50072232|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
24983588|NCT00289913|50072233|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
24983589|NCT00289913|50072234|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
24983590|NCT00289913|50072230|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
25255822|NCT01339559|50571179|FG000|Overall Study|Patient didn't wish to continue|1|||
25255823|NCT01339559|50571179|FG000|Overall Study|PI decision|1|||
25255824|NCT00107900|50571190|FG000|Overall Study|Adverse Event|3|||
25255825|NCT00107900|50571191|FG001|Overall Study|Adverse Event|2|||
25255826|NCT00107900|50571192|FG002|Overall Study|Adverse Event|10|||
25255827|NCT00107900|50571193|FG003|Overall Study|Adverse Event|3|||
25255828|NCT00107900|50571194|FG004|Overall Study|Adverse Event|5|||
25255829|NCT00107900|50571195|FG005|Overall Study|Adverse Event|3|||
25255830|NCT00107900|50571190|FG000|Overall Study|Death|0|||
25255831|NCT00107900|50571191|FG001|Overall Study|Death|0|||
25255832|NCT00107900|50571192|FG002|Overall Study|Death|0|||
25255833|NCT00107900|50571193|FG003|Overall Study|Death|0|||
25255834|NCT00107900|50571194|FG004|Overall Study|Death|1|||
24983591|NCT00289913|50072231|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
24983592|NCT00289913|50072232|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
25078383|NCT02219464|50186603|FG001|Overall Study|catheter malfunction|0|||
25078384|NCT02219308|50186611|FG000|Overall Study|Withdrawal by Subject|1|||
25078385|NCT02219308|50186612|FG001|Overall Study|Withdrawal by Subject|2|||
25078386|NCT02218372|50186620|FG000|Overall Study|Adverse Event|1|||
25078387|NCT02218372|50186621|FG001|Overall Study|Adverse Event|1|||
25078388|NCT02218372|50186620|FG000|Overall Study|Miscellaneous|2|||
25078389|NCT02218372|50186621|FG001|Overall Study|Miscellaneous|1|||
25078390|NCT02218372|50186620|FG000|Overall Study|Randomized but did not receive treatment|2|||
25078391|NCT02218372|50186621|FG001|Overall Study|Randomized but did not receive treatment|3|||
25078392|NCT02218372|50186620|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
25078393|NCT02218372|50186621|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
25078394|NCT02218216|50186634|FG000|Overall Study|Study terminated before completed|6|||
25078395|NCT02218216|50186635|FG001|Overall Study|Study terminated before completed|0|||
25078396|NCT02218216|50186636|FG002|Overall Study|Study terminated before completed|0|||
25078397|NCT02217982|50186646|FG000|Overall Study|Trial discontinued|1|||
25078398|NCT02217982|50186647|FG001|Overall Study|Trial discontinued|0|||
25078399|NCT02217982|50186646|FG000|Overall Study|Adverse Event|0|||
25078400|NCT02217982|50186647|FG001|Overall Study|Adverse Event|1|||
25078401|NCT02254408|50186655|FG000|Overall Study|Randomized But Not Treated|1|||
25078402|NCT02254408|50186656|FG001|Overall Study|Randomized But Not Treated|3|||
25078403|NCT02254408|50186655|FG000|Overall Study|Adverse Event|1|||
25078404|NCT02254408|50186656|FG001|Overall Study|Adverse Event|0|||
25078405|NCT02254408|50186655|FG000|Overall Study|Death|2|||
25078406|NCT02254408|50186656|FG001|Overall Study|Death|3|||
25078407|NCT02254408|50186655|FG000|Overall Study|Investigator's Discretion|0|||
25078408|NCT02254408|50186656|FG001|Overall Study|Investigator's Discretion|1|||
25078409|NCT02254408|50186655|FG000|Overall Study|Withdrawal by Subject|3|||
25078410|NCT02254408|50186656|FG001|Overall Study|Withdrawal by Subject|3|||
25078411|NCT02254408|50186655|FG000|Overall Study|Lost to Follow-up|1|||
25078412|NCT02254408|50186656|FG001|Overall Study|Lost to Follow-up|0|||
25078413|NCT02207608|50186664|FG000|Overall Study|Adverse Event|1|||
25255835|NCT00107900|50571195|FG005|Overall Study|Death|0|||
25255836|NCT00107900|50571190|FG000|Overall Study|Lost to Follow-up|4|||
25255837|NCT00107900|50571191|FG001|Overall Study|Lost to Follow-up|1|||
25255838|NCT00107900|50571192|FG002|Overall Study|Lost to Follow-up|3|||
25342020|NCT00789815|50658376|FG000|Overall Study|Protocol Violation|6|||
25342021|NCT00789815|50658377|FG001|Overall Study|Protocol Violation|1|||
25342022|NCT00789815|50658376|FG000|Overall Study|Intubation due to massive bleeding|1|||
25342023|NCT00789815|50658377|FG001|Overall Study|Intubation due to massive bleeding|0|||
25342024|NCT00721578|50658383|FG000|Overall Study|Death|1|||
25342025|NCT00721578|50658384|FG001|Overall Study|Death|1|||
25342026|NCT00721578|50658383|FG000|Overall Study|Withdrawal by Subject|1|||
25342027|NCT00721578|50658384|FG001|Overall Study|Withdrawal by Subject|1|||
25342028|NCT00789737|50658392|FG000|Overall Study|Withdrawal by Subject|13|||
25342029|NCT00789737|50658393|FG001|Overall Study|Withdrawal by Subject|22|||
25342030|NCT00789737|50658392|FG000|Overall Study|Lost to Follow-up|10|||
25342031|NCT00789737|50658393|FG001|Overall Study|Lost to Follow-up|14|||
25342032|NCT00789737|50658392|FG000|Overall Study|Adverse Event|8|||
25342033|NCT00789737|50658393|FG001|Overall Study|Adverse Event|8|||
25342034|NCT00789737|50658392|FG000|Overall Study|Protocol Violation|3|||
25342035|NCT00789737|50658393|FG001|Overall Study|Protocol Violation|0|||
25078414|NCT02207608|50186665|FG001|Overall Study|Adverse Event|0|||
25078415|NCT03530995|50186673|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
25255839|NCT00107900|50571193|FG003|Overall Study|Lost to Follow-up|2|||
25255840|NCT00107900|50571194|FG004|Overall Study|Lost to Follow-up|5|||
25255841|NCT00107900|50571195|FG005|Overall Study|Lost to Follow-up|5|||
25255842|NCT00107900|50571190|FG000|Overall Study|Protocol Violation|1|||
25255843|NCT00107900|50571191|FG001|Overall Study|Protocol Violation|0|||
25255844|NCT00107900|50571192|FG002|Overall Study|Protocol Violation|5|||
25255845|NCT00107900|50571193|FG003|Overall Study|Protocol Violation|5|||
25255846|NCT00107900|50571194|FG004|Overall Study|Protocol Violation|7|||
25078416|NCT03530995|50186674|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
25255847|NCT00107900|50571195|FG005|Overall Study|Protocol Violation|0|||
25255848|NCT00107900|50571190|FG000|Overall Study|Withdrawal by Subject|1|||
25255849|NCT00107900|50571191|FG001|Overall Study|Withdrawal by Subject|0|||
25255850|NCT00107900|50571192|FG002|Overall Study|Withdrawal by Subject|5|||
25255851|NCT00107900|50571193|FG003|Overall Study|Withdrawal by Subject|0|||
25342036|NCT00789737|50658392|FG000|Overall Study|Lack of Efficacy|3|||
25342037|NCT00789737|50658393|FG001|Overall Study|Lack of Efficacy|0|||
24983593|NCT00289913|50072233|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
25078417|NCT03530995|50186673|FG000|Part 1 Period 3|Protocol Violation|1|||
25078418|NCT03530995|50186674|FG001|Part 1 Period 3|Protocol Violation|0|||
25078419|NCT03530995|50186673|FG000|Part 1 Period 4|Physician Decision|1|||
25255852|NCT00107900|50571194|FG004|Overall Study|Withdrawal by Subject|1|||
25255853|NCT00107900|50571195|FG005|Overall Study|Withdrawal by Subject|1|||
25078420|NCT03530995|50186674|FG001|Part 1 Period 4|Physician Decision|0|||
25078421|NCT03530995|50186673|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
25078422|NCT03530995|50186674|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
25078423|NCT02217436|50186698|FG000|Overall Study|Protocol Violation|1|||
25078424|NCT02217436|50186699|FG001|Overall Study|Protocol Violation|1|||
25078425|NCT02217436|50186698|FG000|Overall Study|Incomplete data|0|||
25078426|NCT02217436|50186699|FG001|Overall Study|Incomplete data|1|||
25078427|NCT02207530|50186705|FG000|Overall Study|Worsening condition under investigation|78|||
24983594|NCT00289913|50072234|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
24983595|NCT00289913|50072230|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
24983596|NCT00289913|50072231|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
24983597|NCT00289913|50072232|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
24983598|NCT00289913|50072233|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
25078428|NCT02207530|50186705|FG000|Overall Study|Patient decision to stop study treatment|5|||
25078429|NCT02207530|50186705|FG000|Overall Study|Adverse Event|8|||
25078430|NCT02207374|50186712|FG000|Overall Study|Withdrawal by Subject|5|||
25078431|NCT02207374|50186713|FG001|Overall Study|Withdrawal by Subject|9|||
25078432|NCT02207374|50186714|FG002|Overall Study|Withdrawal by Subject|4|||
25078433|NCT02207374|50186712|FG000|Overall Study|Death|1|||
25078434|NCT02207374|50186713|FG001|Overall Study|Death|0|||
25078435|NCT02207374|50186714|FG002|Overall Study|Death|1|||
25078436|NCT02207374|50186712|FG000|Overall Study|Missing follow-up information|0|||
25078437|NCT02207374|50186713|FG001|Overall Study|Missing follow-up information|1|||
25078438|NCT02207374|50186714|FG002|Overall Study|Missing follow-up information|1|||
25078439|NCT02217280|50186722|FG000|Overall Study|Withdrawal by Subject|2|||
25078440|NCT02217280|50186722|FG000|Overall Study|Post-consent sceen fail|2|||
25078441|NCT02786537|50186733|FG000|As Randomized|Adverse Event|0|||
25078442|NCT02786537|50186734|FG001|As Randomized|Adverse Event|11|||
25078443|NCT02786537|50186735|FG002|As Randomized|Adverse Event|0|||
25078444|NCT02786537|50186736|FG003|As Randomized|Adverse Event|4|||
25078445|NCT02786537|50186737|FG004|As Randomized|Adverse Event|6|||
25078446|NCT02786537|50186738|FG005|As Randomized|Adverse Event|2|||
25078447|NCT02786537|50186733|FG000|As Randomized|Lack of Efficacy|0|||
25078448|NCT02786537|50186734|FG001|As Randomized|Lack of Efficacy|0|||
25078449|NCT02786537|50186735|FG002|As Randomized|Lack of Efficacy|0|||
25078450|NCT02786537|50186736|FG003|As Randomized|Lack of Efficacy|1|||
25078451|NCT02786537|50186737|FG004|As Randomized|Lack of Efficacy|0|||
25078452|NCT02786537|50186738|FG005|As Randomized|Lack of Efficacy|0|||
25078453|NCT02786537|50186733|FG000|As Randomized|Withdrawal by Subject|1|||
25078454|NCT02786537|50186734|FG001|As Randomized|Withdrawal by Subject|2|||
25078455|NCT02786537|50186735|FG002|As Randomized|Withdrawal by Subject|0|||
25078456|NCT02786537|50186736|FG003|As Randomized|Withdrawal by Subject|1|||
25078457|NCT02786537|50186737|FG004|As Randomized|Withdrawal by Subject|1|||
25078458|NCT02786537|50186738|FG005|As Randomized|Withdrawal by Subject|0|||
25078459|NCT02786537|50186733|FG000|As Randomized|Death|0|||
25078460|NCT02786537|50186734|FG001|As Randomized|Death|2|||
25078461|NCT02786537|50186735|FG002|As Randomized|Death|0|||
25078462|NCT02786537|50186736|FG003|As Randomized|Death|3|||
25078463|NCT02786537|50186737|FG004|As Randomized|Death|1|||
25078464|NCT02786537|50186738|FG005|As Randomized|Death|0|||
25078465|NCT02786537|50186733|FG000|As Randomized|Non-compliance with study drug|1|||
25078466|NCT02786537|50186734|FG001|As Randomized|Non-compliance with study drug|11|||
25078467|NCT02786537|50186735|FG002|As Randomized|Non-compliance with study drug|0|||
25078468|NCT02786537|50186736|FG003|As Randomized|Non-compliance with study drug|1|||
25078469|NCT02786537|50186737|FG004|As Randomized|Non-compliance with study drug|0|||
25078470|NCT02786537|50186738|FG005|As Randomized|Non-compliance with study drug|1|||
25078471|NCT02786537|50186733|FG000|As Randomized|Lost to treatment follow-up|4|||
25078472|NCT02786537|50186734|FG001|As Randomized|Lost to treatment follow-up|32|||
25078473|NCT02786537|50186735|FG002|As Randomized|Lost to treatment follow-up|0|||
25078474|NCT02786537|50186736|FG003|As Randomized|Lost to treatment follow-up|24|||
25078475|NCT02786537|50186737|FG004|As Randomized|Lost to treatment follow-up|4|||
25078476|NCT02786537|50186738|FG005|As Randomized|Lost to treatment follow-up|4|||
25078477|NCT02786537|50186733|FG000|As Randomized|Incarceration|0|||
25078478|NCT02786537|50186734|FG001|As Randomized|Incarceration|1|||
25078479|NCT02786537|50186735|FG002|As Randomized|Incarceration|0|||
25078480|NCT02786537|50186736|FG003|As Randomized|Incarceration|0|||
25078481|NCT02786537|50186737|FG004|As Randomized|Incarceration|0|||
25255854|NCT00107900|50571190|FG000|Overall Study|Administrative Reasons|1|||
25255855|NCT00107900|50571191|FG001|Overall Study|Administrative Reasons|0|||
25078482|NCT02786537|50186738|FG005|As Randomized|Incarceration|0|||
25078483|NCT02786537|50186733|FG000|As Randomized|Opiate Dependency Relapse|0|||
25078484|NCT02786537|50186734|FG001|As Randomized|Opiate Dependency Relapse|1|||
25342038|NCT00789737|50658392|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
25078485|NCT02786537|50186735|FG002|As Randomized|Opiate Dependency Relapse|0|||
25078486|NCT02786537|50186736|FG003|As Randomized|Opiate Dependency Relapse|0|||
25078487|NCT02786537|50186737|FG004|As Randomized|Opiate Dependency Relapse|0|||
25078488|NCT02786537|50186738|FG005|As Randomized|Opiate Dependency Relapse|0|||
25078489|NCT02786537|50186733|FG000|As Randomized|HCV drugs stolen from pt|0|||
25078490|NCT02786537|50186734|FG001|As Randomized|HCV drugs stolen from pt|1|||
25078491|NCT02786537|50186735|FG002|As Randomized|HCV drugs stolen from pt|0|||
25078492|NCT02786537|50186736|FG003|As Randomized|HCV drugs stolen from pt|0|||
25078493|NCT02786537|50186737|FG004|As Randomized|HCV drugs stolen from pt|0|||
25078494|NCT02786537|50186738|FG005|As Randomized|HCV drugs stolen from pt|0|||
25078495|NCT02786537|50186733|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
25078496|NCT02786537|50186734|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
25078497|NCT02786537|50186735|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
25078498|NCT02786537|50186736|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
25078499|NCT02786537|50186737|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
25078500|NCT02786537|50186738|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
25078501|NCT02786537|50186733|FG000|As Randomized|Subject lost insurance|0|||
25078502|NCT02786537|50186734|FG001|As Randomized|Subject lost insurance|0|||
25078503|NCT02786537|50186735|FG002|As Randomized|Subject lost insurance|0|||
25078504|NCT02786537|50186736|FG003|As Randomized|Subject lost insurance|1|||
25078505|NCT02786537|50186737|FG004|As Randomized|Subject lost insurance|0|||
25078506|NCT02786537|50186738|FG005|As Randomized|Subject lost insurance|0|||
25078507|NCT02786537|50186733|FG000|As Treated|Adverse Event|0|||
25078508|NCT02786537|50186734|FG001|As Treated|Adverse Event|11|||
25078509|NCT02786537|50186735|FG002|As Treated|Adverse Event|0|||
25078510|NCT02786537|50186736|FG003|As Treated|Adverse Event|4|||
25078511|NCT02786537|50186737|FG004|As Treated|Adverse Event|6|||
25078512|NCT02786537|50186738|FG005|As Treated|Adverse Event|2|||
25078513|NCT02786537|50186733|FG000|As Treated|Death|0|||
25078514|NCT02786537|50186734|FG001|As Treated|Death|2|||
25078515|NCT02786537|50186735|FG002|As Treated|Death|0|||
25078516|NCT02786537|50186736|FG003|As Treated|Death|3|||
25078517|NCT02786537|50186737|FG004|As Treated|Death|1|||
25078518|NCT02786537|50186738|FG005|As Treated|Death|0|||
25078519|NCT02786537|50186733|FG000|As Treated|Lack of Efficacy|0|||
25078520|NCT02786537|50186734|FG001|As Treated|Lack of Efficacy|0|||
25078521|NCT02786537|50186735|FG002|As Treated|Lack of Efficacy|0|||
25078522|NCT02786537|50186736|FG003|As Treated|Lack of Efficacy|1|||
25078523|NCT02786537|50186737|FG004|As Treated|Lack of Efficacy|0|||
25078524|NCT02786537|50186738|FG005|As Treated|Lack of Efficacy|0|||
25078525|NCT02786537|50186733|FG000|As Treated|Lost to Follow-up|4|||
25078526|NCT02786537|50186734|FG001|As Treated|Lost to Follow-up|32|||
25078527|NCT02786537|50186735|FG002|As Treated|Lost to Follow-up|0|||
25078528|NCT02786537|50186736|FG003|As Treated|Lost to Follow-up|25|||
25078529|NCT02786537|50186737|FG004|As Treated|Lost to Follow-up|4|||
25078530|NCT02786537|50186738|FG005|As Treated|Lost to Follow-up|4|||
25078531|NCT02786537|50186733|FG000|As Treated|Non-compliance with study drug|1|||
25078532|NCT02786537|50186734|FG001|As Treated|Non-compliance with study drug|11|||
25078533|NCT02786537|50186735|FG002|As Treated|Non-compliance with study drug|0|||
25078534|NCT02786537|50186736|FG003|As Treated|Non-compliance with study drug|1|||
25078535|NCT02786537|50186737|FG004|As Treated|Non-compliance with study drug|0|||
25078536|NCT02786537|50186738|FG005|As Treated|Non-compliance with study drug|1|||
25078537|NCT02786537|50186733|FG000|As Treated|Lost insurance|0|||
25078538|NCT02786537|50186734|FG001|As Treated|Lost insurance|0|||
25078539|NCT02786537|50186735|FG002|As Treated|Lost insurance|0|||
25078540|NCT02786537|50186736|FG003|As Treated|Lost insurance|1|||
25078541|NCT02786537|50186737|FG004|As Treated|Lost insurance|0|||
25078542|NCT02786537|50186738|FG005|As Treated|Lost insurance|0|||
25078543|NCT02786537|50186733|FG000|As Treated|Withdrawal by Subject|1|||
25078544|NCT02786537|50186734|FG001|As Treated|Withdrawal by Subject|2|||
25078545|NCT02786537|50186735|FG002|As Treated|Withdrawal by Subject|0|||
25078546|NCT02786537|50186736|FG003|As Treated|Withdrawal by Subject|0|||
25078547|NCT02786537|50186737|FG004|As Treated|Withdrawal by Subject|1|||
25078548|NCT02786537|50186738|FG005|As Treated|Withdrawal by Subject|0|||
25078549|NCT02786537|50186733|FG000|As Treated|Incarceration|0|||
25078550|NCT02786537|50186734|FG001|As Treated|Incarceration|1|||
25078551|NCT02786537|50186735|FG002|As Treated|Incarceration|0|||
25078552|NCT02786537|50186736|FG003|As Treated|Incarceration|0|||
25078553|NCT02786537|50186737|FG004|As Treated|Incarceration|0|||
25078554|NCT02786537|50186738|FG005|As Treated|Incarceration|0|||
25078555|NCT02786537|50186733|FG000|As Treated|Opiate dependency relapse|0|||
25078556|NCT02786537|50186734|FG001|As Treated|Opiate dependency relapse|1|||
25078557|NCT02786537|50186735|FG002|As Treated|Opiate dependency relapse|0|||
24983599|NCT00289913|50072234|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
25078558|NCT02786537|50186736|FG003|As Treated|Opiate dependency relapse|0|||
25078559|NCT02786537|50186737|FG004|As Treated|Opiate dependency relapse|0|||
25078560|NCT02786537|50186738|FG005|As Treated|Opiate dependency relapse|0|||
25078561|NCT02786537|50186733|FG000|As Treated|Drugs stolen from patient|0|||
25078562|NCT02786537|50186734|FG001|As Treated|Drugs stolen from patient|1|||
25078563|NCT02786537|50186735|FG002|As Treated|Drugs stolen from patient|0|||
25078564|NCT02786537|50186736|FG003|As Treated|Drugs stolen from patient|0|||
25078565|NCT02786537|50186737|FG004|As Treated|Drugs stolen from patient|0|||
25078566|NCT02786537|50186738|FG005|As Treated|Drugs stolen from patient|0|||
25078567|NCT02786537|50186733|FG000|As Treated|Advised to stop tx after loss of meds|0|||
25078568|NCT02786537|50186734|FG001|As Treated|Advised to stop tx after loss of meds|1|||
25078569|NCT02786537|50186735|FG002|As Treated|Advised to stop tx after loss of meds|0|||
25078570|NCT02786537|50186736|FG003|As Treated|Advised to stop tx after loss of meds|0|||
25078571|NCT02786537|50186737|FG004|As Treated|Advised to stop tx after loss of meds|0|||
25078572|NCT02786537|50186738|FG005|As Treated|Advised to stop tx after loss of meds|0|||
25078573|NCT02216812|50186846|FG000|Overall Study|Lost to Follow-up|10|||
25078574|NCT02216812|50186847|FG001|Overall Study|Lost to Follow-up|5|||
25078575|NCT02252536|50186855|FG000|Overall Study|Lost to Follow-up|5|||
25078576|NCT02252536|50186856|FG001|Overall Study|Lost to Follow-up|3|||
25078577|NCT02206828|50186862|FG000|Overall Study|Lost to Follow-up|7|||
25078578|NCT01209767|50186889|FG000|Overall Study|Withdrawal by Subject|1|||
25078579|NCT01209767|50186889|FG000|Overall Study|Lost to Follow-up|3|||
25078580|NCT02252146|50186897|FG000|Overall Study|Lack of Efficacy|4|||
25078581|NCT02252146|50186897|FG000|Overall Study|Entered hospice care|1|||
25078582|NCT02252146|50186897|FG000|Overall Study|Inability to travel to study site|1|||
25078583|NCT02500589|50186903|FG000|Overall Study|Withdrawal by Subject|11|||
25078584|NCT02500589|50186904|FG001|Overall Study|Withdrawal by Subject|14|||
25078585|NCT02500589|50186903|FG000|Overall Study|Lost to Follow-up|10|||
25078586|NCT02500589|50186904|FG001|Overall Study|Lost to Follow-up|12|||
25078587|NCT02500589|50186903|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
25078588|NCT02500589|50186904|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
25078589|NCT02500589|50186903|FG000|Overall Study|Death|7|||
25078590|NCT02500589|50186904|FG001|Overall Study|Death|5|||
25078591|NCT02251990|50186916|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
25078592|NCT02251990|50186917|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
25078593|NCT02251990|50186916|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
25078594|NCT02251990|50186917|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
25078595|NCT02251990|50186916|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
25078596|NCT02251990|50186917|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
25078597|NCT02251990|50186916|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
25078598|NCT02251990|50186917|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
24983600|NCT00289913|50072230|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
24983601|NCT00289913|50072231|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
24983602|NCT00289913|50072232|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
24983603|NCT00289913|50072233|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
24983604|NCT00289913|50072234|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
24983605|NCT00289913|50072230|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
24983606|NCT00289913|50072231|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
24983607|NCT00289913|50072232|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
24983608|NCT00289913|50072233|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
24983609|NCT00289913|50072234|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
24983610|NCT00289913|50072230|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
24983611|NCT00289913|50072231|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
25078599|NCT02251990|50186916|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
25078600|NCT02251990|50186917|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
25078601|NCT02251990|50186916|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
25078602|NCT02251990|50186917|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
25078603|NCT02251912|50186926|FG000|Overall Study|Withdrawal by Subject|2|||
25078604|NCT02251912|50186927|FG001|Overall Study|Withdrawal by Subject|3|||
25078605|NCT02251912|50186926|FG000|Overall Study|Adverse Event|0|||
25078606|NCT02251912|50186927|FG001|Overall Study|Adverse Event|2|||
25078607|NCT02206048|50186942|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
25078608|NCT02205814|50186954|FG000|Overall Study|Lost to Follow-up|0|||
25078609|NCT02205814|50186955|FG001|Overall Study|Lost to Follow-up|0|||
25078610|NCT02205814|50186956|FG002|Overall Study|Lost to Follow-up|0|||
25078611|NCT02205814|50186957|FG003|Overall Study|Lost to Follow-up|1|||
25078612|NCT02205814|50186954|FG000|Overall Study|Lack of Efficacy|1|||
25078613|NCT02205814|50186955|FG001|Overall Study|Lack of Efficacy|0|||
25078614|NCT02205814|50186956|FG002|Overall Study|Lack of Efficacy|1|||
25078615|NCT02205814|50186957|FG003|Overall Study|Lack of Efficacy|1|||
25078616|NCT02205814|50186954|FG000|Overall Study|Physician Decision|0|||
25078617|NCT02205814|50186955|FG001|Overall Study|Physician Decision|0|||
25078618|NCT02205814|50186956|FG002|Overall Study|Physician Decision|1|||
24983612|NCT00289913|50072232|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
24983613|NCT00289913|50072233|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
25078619|NCT02205814|50186957|FG003|Overall Study|Physician Decision|0|||
25078620|NCT02205814|50186954|FG000|Overall Study|Protocol Violation|1|||
25078621|NCT02205814|50186955|FG001|Overall Study|Protocol Violation|0|||
25078622|NCT02205814|50186956|FG002|Overall Study|Protocol Violation|0|||
25078623|NCT02205814|50186957|FG003|Overall Study|Protocol Violation|1|||
25078624|NCT02205814|50186954|FG000|Overall Study|Withdrawal by Subject|0|||
25078625|NCT02205814|50186955|FG001|Overall Study|Withdrawal by Subject|1|||
25078626|NCT02205814|50186956|FG002|Overall Study|Withdrawal by Subject|2|||
25078627|NCT02205814|50186957|FG003|Overall Study|Withdrawal by Subject|1|||
25078628|NCT02205814|50186954|FG000|Overall Study|not compliant with study procedures|0|||
25078629|NCT02205814|50186955|FG001|Overall Study|not compliant with study procedures|0|||
25078630|NCT02205814|50186956|FG002|Overall Study|not compliant with study procedures|1|||
25078631|NCT02205814|50186957|FG003|Overall Study|not compliant with study procedures|0|||
25078632|NCT02662985|50186969|FG000|Treatment Period 1|Adverse Event|0|||
25078633|NCT02662985|50186970|FG001|Treatment Period 1|Adverse Event|2|||
25078634|NCT02662985|50186969|FG000|Treatment Period 1|Protocol Violation|0|||
25078635|NCT02662985|50186970|FG001|Treatment Period 1|Protocol Violation|1|||
25078636|NCT02662985|50186969|FG000|Treatment Period 1|Physician Decision|1|||
25078637|NCT02662985|50186970|FG001|Treatment Period 1|Physician Decision|0|||
25078638|NCT02662985|50186969|FG000|Treatment Period 1|Withdrawal by Subject|0|||
25078639|NCT02662985|50186970|FG001|Treatment Period 1|Withdrawal by Subject|1|||
25078640|NCT02662985|50186969|FG000|Treatment Period 2|Lack of Efficacy|0|||
25078641|NCT02662985|50186970|FG001|Treatment Period 2|Lack of Efficacy|1|||
25078642|NCT02662985|50186969|FG000|Treatment Period 2|Lost to Follow-up|1|||
25078643|NCT02662985|50186970|FG001|Treatment Period 2|Lost to Follow-up|0|||
25078644|NCT02662985|50186969|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
25078645|NCT02662985|50186970|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
25078646|NCT02662985|50186969|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
25078647|NCT02662985|50186970|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
25078648|NCT02662985|50186969|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
25078649|NCT02662985|50186970|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
25078650|NCT02662985|50186969|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
25078651|NCT02662985|50186970|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
25078652|NCT02662985|50186969|FG000|Treatment Period 3 (Extension Period)|Death|0|||
25078653|NCT02662985|50186970|FG001|Treatment Period 3 (Extension Period)|Death|1|||
25078654|NCT01631812|50186976|FG000|Overall Study|Adverse Event|25|||
25078655|NCT01631812|50186976|FG000|Overall Study|Lack of Efficacy|5|||
25078656|NCT01631812|50186976|FG000|Overall Study|Withdrawal by Subject|4|||
25078657|NCT01631812|50186976|FG000|Overall Study|Physician Decision|3|||
25078658|NCT02323295|50186982|FG000|Overall Study|Adverse Event|0|||
25078659|NCT02323295|50186983|FG001|Overall Study|Adverse Event|1|||
25078660|NCT02323295|50186982|FG000|Overall Study|Withdrawal by Subject|0|||
24983614|NCT00289913|50072234|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
24983615|NCT00289913|50072230|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
24983616|NCT00289913|50072231|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
24983617|NCT00289913|50072232|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
24983618|NCT00289913|50072233|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
24983619|NCT00289913|50072234|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
24983620|NCT00289913|50072230|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
24983621|NCT00289913|50072231|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
24983622|NCT00289913|50072232|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
24983623|NCT00289913|50072233|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
24983624|NCT00289913|50072234|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
24983625|NCT00289913|50072230|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
24983626|NCT00289913|50072231|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
24983627|NCT00289913|50072232|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
24983628|NCT00289913|50072233|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
24983629|NCT00289913|50072234|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
24983630|NCT00289913|50072230|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
24983631|NCT00289913|50072231|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
24983632|NCT00289913|50072232|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
24983633|NCT00289913|50072233|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
24983634|NCT00289913|50072234|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
24983635|NCT00289913|50072230|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
24983636|NCT00289913|50072231|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
24983637|NCT00289913|50072232|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
24983638|NCT00289913|50072233|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
24983639|NCT00289913|50072234|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
25078661|NCT02323295|50186983|FG001|Overall Study|Withdrawal by Subject|1|||
25078662|NCT02323295|50186982|FG000|Overall Study|Patient did not have surgery as planned.|0|||
25078663|NCT02323295|50186983|FG001|Overall Study|Patient did not have surgery as planned.|1|||
25078664|NCT02215954|50186992|FG000|Overall Study|Adverse Event|0|||
25342039|NCT00789737|50658393|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
25078665|NCT02215954|50186993|FG001|Overall Study|Adverse Event|0|||
25078666|NCT02215954|50186994|FG002|Overall Study|Adverse Event|1|||
25078667|NCT02215954|50186992|FG000|Overall Study|Withdrawal by Subject|0|||
25078668|NCT02215954|50186993|FG001|Overall Study|Withdrawal by Subject|0|||
25078669|NCT02215954|50186994|FG002|Overall Study|Withdrawal by Subject|2|||
25078670|NCT02215954|50186992|FG000|Overall Study|Not exposed|1|||
25078671|NCT02215954|50186993|FG001|Overall Study|Not exposed|1|||
25078672|NCT02215954|50186994|FG002|Overall Study|Not exposed|3|||
25078673|NCT01941719|50187005|FG000|Overall Study|Lost to Follow-up|20|||
25078674|NCT01941719|50187006|FG001|Overall Study|Lost to Follow-up|19|||
25078675|NCT02215252|50187016|FG000|Overall Study|Adverse Event|1|||
25078676|NCT02215252|50187017|FG001|Overall Study|Adverse Event|5|||
25078677|NCT02215252|50187018|FG002|Overall Study|Adverse Event|2|||
25078678|NCT02215252|50187016|FG000|Overall Study|Lost to Follow-up|0|||
25078679|NCT02215252|50187017|FG001|Overall Study|Lost to Follow-up|0|||
25078680|NCT02215252|50187018|FG002|Overall Study|Lost to Follow-up|1|||
25078681|NCT02215252|50187016|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
25078682|NCT02215252|50187017|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
25078683|NCT02215252|50187018|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
25078684|NCT02215252|50187016|FG000|Overall Study|Protocol Violation|0|||
25078685|NCT02215252|50187017|FG001|Overall Study|Protocol Violation|1|||
25078686|NCT02215252|50187018|FG002|Overall Study|Protocol Violation|0|||
25078687|NCT02215252|50187016|FG000|Overall Study|Withdrawal by Subject|1|||
25078688|NCT02215252|50187017|FG001|Overall Study|Withdrawal by Subject|0|||
25078689|NCT02215252|50187018|FG002|Overall Study|Withdrawal by Subject|0|||
25078690|NCT02215252|50187016|FG000|Overall Study|Other|0|||
25078691|NCT02215252|50187017|FG001|Overall Study|Other|1|||
25078692|NCT02215252|50187018|FG002|Overall Study|Other|1|||
25078693|NCT02204410|50187026|FG000|Overall Study|Lost to Follow-up|5|||
25078694|NCT02204410|50187026|FG000|Overall Study|Physician Decision|2|||
25078695|NCT02204410|50187026|FG000|Overall Study|Protocol Violation|1|||
25078696|NCT02204410|50187026|FG000|Overall Study|Withdrawal by Subject|3|||
25078697|NCT02250274|50187032|FG000|Overall Study|Insufficient blood draw amount|7|||
25078698|NCT02250274|50187033|FG001|Overall Study|Insufficient blood draw amount|6|||
25078699|NCT02213458|50187047|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
25078700|NCT02213458|50187048|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
25078701|NCT02213458|50187047|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
25078702|NCT02213458|50187048|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
25078703|NCT02213458|50187047|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
25078704|NCT02213458|50187048|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
25078705|NCT02213458|50187047|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
25078706|NCT02213458|50187048|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
25078707|NCT02213458|50187047|FG000|Overall Study|Refused re-consent|6|||
25078708|NCT02213458|50187048|FG001|Overall Study|Refused re-consent|0|||
25078709|NCT02213458|50187047|FG000|Overall Study|Lost to Follow-up|2|||
25078710|NCT02213458|50187048|FG001|Overall Study|Lost to Follow-up|2|||
25078711|NCT02213458|50187047|FG000|Overall Study|Withdrawal by Subject|26|||
25078712|NCT02213458|50187048|FG001|Overall Study|Withdrawal by Subject|8|||
25078713|NCT02213380|50187056|FG000|Underwent Randomization|Withdrawal by Subject|2|||
25078714|NCT02213380|50187057|FG001|Underwent Randomization|Withdrawal by Subject|0|||
25078715|NCT02213380|50187056|FG000|Underwent Randomization|Not treated|3|||
25078716|NCT02213380|50187057|FG001|Underwent Randomization|Not treated|3|||
25078717|NCT02213380|50187056|FG000|Per-protocol Analysis|Protocol Violation|32|||
25078718|NCT02213380|50187057|FG001|Per-protocol Analysis|Protocol Violation|36|||
25078719|NCT02202850|50187065|FG000|Overall Study|Other|2|||
25078720|NCT02202850|50187066|FG001|Overall Study|Other|2|||
25078721|NCT02202850|50187065|FG000|Overall Study|Enbrel treatment discontinued|15|||
25078722|NCT02202850|50187066|FG001|Overall Study|Enbrel treatment discontinued|3|||
25078723|NCT02202850|50187065|FG000|Overall Study|Lost to Follow-up|7|||
25078724|NCT02202850|50187066|FG001|Overall Study|Lost to Follow-up|1|||
25078725|NCT02212678|50187072|FG000|Overall Study|Adverse Event|1|||
25078726|NCT03104075|50187078|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
25078727|NCT03104075|50187079|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
25078728|NCT03038087|50187086|FG000|Overall Study|lost data|1|||
25078729|NCT02249182|50187097|FG000|Treatment Phase|Lost to Follow-up|4|||
25078730|NCT02249182|50187098|FG001|Treatment Phase|Lost to Follow-up|0|||
25078731|NCT02249182|50187099|FG002|Treatment Phase|Lost to Follow-up|0|||
25078732|NCT02249182|50187100|FG003|Treatment Phase|Lost to Follow-up|0|||
25078733|NCT02249182|50187101|FG004|Treatment Phase|Lost to Follow-up|0|||
25078734|NCT03641339|50187141|FG000|Overall Study|Physician Decision|1|||
24983640|NCT00289913|50072230|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
25078735|NCT03641339|50187142|FG001|Overall Study|Physician Decision|0|||
25078736|NCT03641339|50187143|FG002|Overall Study|Physician Decision|0|||
25078737|NCT03641339|50187144|FG003|Overall Study|Physician Decision|0|||
25078738|NCT03641339|50187145|FG004|Overall Study|Physician Decision|0|||
25078739|NCT03641339|50187146|FG005|Overall Study|Physician Decision|0|||
25078740|NCT03641339|50187141|FG000|Overall Study|Withdrawal by Subject|0|||
25078741|NCT03641339|50187142|FG001|Overall Study|Withdrawal by Subject|2|||
25078742|NCT03641339|50187143|FG002|Overall Study|Withdrawal by Subject|0|||
25078743|NCT03641339|50187144|FG003|Overall Study|Withdrawal by Subject|2|||
25078744|NCT03641339|50187145|FG004|Overall Study|Withdrawal by Subject|0|||
25078745|NCT03641339|50187146|FG005|Overall Study|Withdrawal by Subject|1|||
25078746|NCT02248480|50187162|FG000|Overall Study|Lack of Efficacy|4|||
25078747|NCT02248480|50187163|FG001|Overall Study|Lack of Efficacy|6|||
25078748|NCT02248480|50187162|FG000|Overall Study|Adverse Event|11|||
25078749|NCT02248480|50187163|FG001|Overall Study|Adverse Event|2|||
25078750|NCT02248480|50187162|FG000|Overall Study|Withdrawal by Subject|2|||
25078751|NCT02248480|50187163|FG001|Overall Study|Withdrawal by Subject|4|||
25078752|NCT02248480|50187162|FG000|Overall Study|Entry Criteria Not Met|0|||
25078753|NCT02248480|50187163|FG001|Overall Study|Entry Criteria Not Met|1|||
25078754|NCT02248480|50187162|FG000|Overall Study|Other:Physician Decision|0|||
25078755|NCT02248480|50187163|FG001|Overall Study|Other:Physician Decision|1|||
25078756|NCT01653158|50187170|FG000|Overall Study|Death|0|||
25078757|NCT01653158|50187171|FG001|Overall Study|Death|0|||
25078758|NCT01653158|50187172|FG002|Overall Study|Death|0|||
25078759|NCT01653158|50187173|FG003|Overall Study|Death|1|||
25078760|NCT01653158|50187174|FG004|Overall Study|Death|0|||
25078761|NCT01653158|50187175|FG005|Overall Study|Death|0|||
25078762|NCT01653158|50187176|FG006|Overall Study|Death|0|||
25078763|NCT01653158|50187177|FG007|Overall Study|Death|2|||
25078764|NCT01653158|50187170|FG000|Overall Study|Adverse Event|0|||
25078765|NCT01653158|50187171|FG001|Overall Study|Adverse Event|0|||
25078766|NCT01653158|50187172|FG002|Overall Study|Adverse Event|0|||
25078767|NCT01653158|50187173|FG003|Overall Study|Adverse Event|1|||
25078768|NCT01653158|50187174|FG004|Overall Study|Adverse Event|0|||
25078769|NCT01653158|50187175|FG005|Overall Study|Adverse Event|0|||
25078770|NCT01653158|50187176|FG006|Overall Study|Adverse Event|0|||
25078771|NCT01653158|50187177|FG007|Overall Study|Adverse Event|3|||
25078772|NCT01653158|50187170|FG000|Overall Study|Other|0|||
25078773|NCT01653158|50187171|FG001|Overall Study|Other|0|||
25078774|NCT01653158|50187172|FG002|Overall Study|Other|0|||
25078775|NCT01653158|50187173|FG003|Overall Study|Other|0|||
25078776|NCT01653158|50187174|FG004|Overall Study|Other|0|||
25078777|NCT01653158|50187175|FG005|Overall Study|Other|0|||
25078778|NCT01653158|50187176|FG006|Overall Study|Other|0|||
24983641|NCT00289913|50072231|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
24983642|NCT00289913|50072232|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
24983643|NCT00289913|50072233|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
24983644|NCT00289913|50072234|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
24983645|NCT00289289|50072252|FG000|Overall Study|Withdrawal by Subject|5|||
24983646|NCT00289289|50072253|FG001|Overall Study|Withdrawal by Subject|3|||
24983647|NCT00289289|50072254|FG002|Overall Study|Withdrawal by Subject|15|||
24983648|NCT00289289|50072252|FG000|Overall Study|Lost to Follow-up|1|||
24983649|NCT00289289|50072253|FG001|Overall Study|Lost to Follow-up|0|||
24983650|NCT00289289|50072254|FG002|Overall Study|Lost to Follow-up|1|||
24983651|NCT00289289|50072252|FG000|Overall Study|Death|4|||
24983652|NCT00289289|50072253|FG001|Overall Study|Death|2|||
24983653|NCT00289289|50072254|FG002|Overall Study|Death|5|||
24983654|NCT00289289|50072252|FG000|Overall Study|No implant attempted|0|||
24983655|NCT00289289|50072253|FG001|Overall Study|No implant attempted|0|||
24983656|NCT00289289|50072254|FG002|Overall Study|No implant attempted|1|||
24983657|NCT00289289|50072252|FG000|Overall Study|Physician Decision|1|||
24983658|NCT00289289|50072253|FG001|Overall Study|Physician Decision|0|||
24983659|NCT00289289|50072254|FG002|Overall Study|Physician Decision|6|||
24983660|NCT00289289|50072252|FG000|Overall Study|Non-study device implanted|2|||
24983661|NCT00289289|50072253|FG001|Overall Study|Non-study device implanted|1|||
24983662|NCT00289289|50072254|FG002|Overall Study|Non-study device implanted|3|||
24983663|NCT00289289|50072252|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
24983664|NCT00289289|50072253|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
24983665|NCT00289289|50072254|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
24983666|NCT00289289|50072252|FG000|Overall Study|Other Exit Reason|6|||
25078779|NCT01653158|50187177|FG007|Overall Study|Other|1|||
25078780|NCT01653158|50187170|FG000|Overall Study|Progressive disease|0|||
25078781|NCT01653158|50187171|FG001|Overall Study|Progressive disease|0|||
25078782|NCT01653158|50187172|FG002|Overall Study|Progressive disease|0|||
25078783|NCT01653158|50187173|FG003|Overall Study|Progressive disease|0|||
25078784|NCT01653158|50187174|FG004|Overall Study|Progressive disease|1|||
25078785|NCT01653158|50187175|FG005|Overall Study|Progressive disease|1|||
24983667|NCT00289289|50072253|FG001|Overall Study|Other Exit Reason|4|||
24983668|NCT00289289|50072254|FG002|Overall Study|Other Exit Reason|12|||
25078786|NCT01653158|50187176|FG006|Overall Study|Progressive disease|2|||
25078787|NCT01653158|50187177|FG007|Overall Study|Progressive disease|9|||
25078788|NCT01653158|50187170|FG000|Overall Study|Withdrawal by Subject|1|||
25078789|NCT01653158|50187171|FG001|Overall Study|Withdrawal by Subject|0|||
25078790|NCT01653158|50187172|FG002|Overall Study|Withdrawal by Subject|0|||
25078791|NCT01653158|50187173|FG003|Overall Study|Withdrawal by Subject|0|||
25078792|NCT01653158|50187174|FG004|Overall Study|Withdrawal by Subject|0|||
25078793|NCT01653158|50187175|FG005|Overall Study|Withdrawal by Subject|0|||
25078794|NCT01653158|50187176|FG006|Overall Study|Withdrawal by Subject|0|||
25078795|NCT01653158|50187177|FG007|Overall Study|Withdrawal by Subject|0|||
25078796|NCT02247466|50187202|FG000|Overall Study|Procedure changed to open surgery|0|||
25078797|NCT02247466|50187203|FG001|Overall Study|Procedure changed to open surgery|3|||
25078798|NCT03317795|50187211|FG000|Overall Study|IUD Expulsion|1|||
25078799|NCT03317795|50187212|FG001|Overall Study|IUD Expulsion|0|||
25078800|NCT03317795|50187211|FG000|Overall Study|Lost to Follow-up|1|||
25078801|NCT03317795|50187212|FG001|Overall Study|Lost to Follow-up|3|||
25078802|NCT03317795|50187211|FG000|Overall Study|Treatment change|0|||
25078803|NCT03317795|50187212|FG001|Overall Study|Treatment change|3|||
25078804|NCT03317795|50187211|FG000|Overall Study|Intolerance of medication|0|||
25078805|NCT03317795|50187212|FG001|Overall Study|Intolerance of medication|1|||
25078806|NCT02202616|50187218|FG000|Overall Study|Screen failed|24|||
25078807|NCT02202616|50187218|FG000|Overall Study|Adverse Event|32|||
25078808|NCT02202616|50187218|FG000|Overall Study|Protocol deviation|18|||
25078809|NCT02202616|50187218|FG000|Overall Study|Patient withdrew consent|12|||
25078810|NCT02202616|50187218|FG000|Overall Study|Lost to Follow-up|6|||
25078811|NCT02202616|50187218|FG000|Overall Study|Administrative problems|6|||
25078812|NCT02202616|50187218|FG000|Overall Study|Abnormal test procedure result|1|||
25078813|NCT02202616|50187218|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
25078814|NCT02455388|50187225|FG000|Overall Study|Protocol Violation|1|||
25078815|NCT02455388|50187226|FG001|Overall Study|Protocol Violation|0|||
25078816|NCT02455388|50187227|FG002|Overall Study|Protocol Violation|4|||
25078817|NCT02455388|50187225|FG000|Overall Study|Withdrawal by Subject|0|||
25078818|NCT02455388|50187226|FG001|Overall Study|Withdrawal by Subject|0|||
25078819|NCT02455388|50187227|FG002|Overall Study|Withdrawal by Subject|7|||
25078820|NCT02455076|50187240|FG000|Inpatient|Withdrawal by Subject|1|||
25078821|NCT02455076|50187241|FG001|Inpatient|Withdrawal by Subject|0|||
25078822|NCT02455076|50187242|FG002|Inpatient|Withdrawal by Subject|0|||
25078823|NCT02455076|50187243|FG003|Inpatient|Withdrawal by Subject|0|||
25078824|NCT02455076|50187244|FG004|Inpatient|Withdrawal by Subject|0|||
25078825|NCT02455076|50187240|FG000|Inpatient|Discharged <24 h after admission|0|||
25078826|NCT02455076|50187241|FG001|Inpatient|Discharged <24 h after admission|1|||
25078827|NCT02455076|50187242|FG002|Inpatient|Discharged <24 h after admission|0|||
25078828|NCT02455076|50187243|FG003|Inpatient|Discharged <24 h after admission|0|||
25078829|NCT02455076|50187244|FG004|Inpatient|Discharged <24 h after admission|0|||
25078830|NCT02455076|50187240|FG000|Inpatient|Adverse Event|3|||
25078831|NCT02455076|50187241|FG001|Inpatient|Adverse Event|0|||
25078832|NCT02455076|50187242|FG002|Inpatient|Adverse Event|0|||
25078833|NCT02455076|50187243|FG003|Inpatient|Adverse Event|0|||
25078834|NCT02455076|50187244|FG004|Inpatient|Adverse Event|0|||
25078835|NCT02455076|50187240|FG000|Outpatient|Adverse Event|0|||
25078836|NCT02455076|50187241|FG001|Outpatient|Adverse Event|0|||
25078837|NCT02455076|50187242|FG002|Outpatient|Adverse Event|0|||
25078838|NCT02455076|50187243|FG003|Outpatient|Adverse Event|5|||
25078839|NCT02455076|50187244|FG004|Outpatient|Adverse Event|0|||
25078840|NCT02455076|50187240|FG000|Outpatient|Lost to Follow-up|0|||
25078841|NCT02455076|50187241|FG001|Outpatient|Lost to Follow-up|0|||
25078842|NCT02455076|50187242|FG002|Outpatient|Lost to Follow-up|0|||
25078843|NCT02455076|50187243|FG003|Outpatient|Lost to Follow-up|1|||
25078844|NCT02455076|50187244|FG004|Outpatient|Lost to Follow-up|12|||
25078845|NCT02433080|50187258|FG000|Overall Study|Lost to Follow-up|1|||
25078846|NCT02433080|50187259|FG001|Overall Study|Lost to Follow-up|2|||
25078847|NCT02433080|50187258|FG000|Overall Study|Withdrawal by Subject|0|||
25078848|NCT02433080|50187259|FG001|Overall Study|Withdrawal by Subject|2|||
25078849|NCT03092219|50187268|FG000|Overall Study|Protocol Violation|7|||
25078850|NCT03092219|50187269|FG001|Overall Study|Protocol Violation|4|||
25078851|NCT02432846|50187284|FG000|Overall Study (4 Arms/Strata)|Death|3|||
25078852|NCT02432846|50187285|FG001|Overall Study (4 Arms/Strata)|Death|2|||
25078853|NCT02432846|50187286|FG002|Overall Study (4 Arms/Strata)|Death|4|||
25078854|NCT02432846|50187287|FG003|Overall Study (4 Arms/Strata)|Death|3|||
25078855|NCT02432846|50187288|FG004|Overall Study (4 Arms/Strata)|Death|0|||
25078856|NCT02432846|50187289|FG005|Overall Study (4 Arms/Strata)|Death|0|||
25078857|NCT02432846|50187284|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
25078858|NCT02432846|50187285|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
25078859|NCT02432846|50187286|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
25078860|NCT02432846|50187287|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
25078861|NCT02432846|50187288|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
25078862|NCT02432846|50187289|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
25078863|NCT02432846|50187284|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
25078864|NCT02432846|50187285|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
25078865|NCT02432846|50187286|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
25078866|NCT02432846|50187287|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
25078867|NCT02432846|50187288|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
25078868|NCT02432846|50187289|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
25078869|NCT02432846|50187284|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
25078870|NCT02432846|50187285|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
25078871|NCT02432846|50187286|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
25078872|NCT02432846|50187287|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
25078873|NCT02432846|50187288|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
25078874|NCT02432846|50187289|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
25078875|NCT02432846|50187284|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
25078876|NCT02432846|50187285|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
25078877|NCT02432846|50187286|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
25078878|NCT02432846|50187287|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
25078879|NCT02432846|50187288|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
25078880|NCT02432846|50187289|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
25078881|NCT02432846|50187284|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
25078882|NCT02432846|50187285|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
25078883|NCT02432846|50187286|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
25078884|NCT02432846|50187287|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
25078885|NCT02432846|50187288|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
25078886|NCT02432846|50187289|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
25078887|NCT02432846|50187284|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
25078888|NCT02432846|50187285|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
25078889|NCT02432846|50187286|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
25078890|NCT02432846|50187287|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
25078891|NCT02432846|50187288|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
25078892|NCT02432846|50187289|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
25078893|NCT02432846|50187284|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
25078894|NCT02432846|50187285|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
25078895|NCT02432846|50187286|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
25078896|NCT02432846|50187287|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
25078897|NCT02432846|50187288|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
25078898|NCT02432846|50187289|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
25078899|NCT02432846|50187284|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
25078900|NCT02432846|50187285|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
25078901|NCT02432846|50187286|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
25078902|NCT02432846|50187287|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
25078903|NCT02432846|50187288|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
25078904|NCT02432846|50187289|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
25078905|NCT02432846|50187284|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
25078906|NCT02432846|50187285|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
25078907|NCT02432846|50187286|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
25078908|NCT02432846|50187287|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
25078909|NCT02432846|50187288|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
25078910|NCT02432846|50187289|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
25078911|NCT02432846|50187284|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
25078912|NCT02432846|50187285|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
25078913|NCT02432846|50187286|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
25078914|NCT02432846|50187287|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
25078915|NCT02432846|50187288|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
25078916|NCT02432846|50187289|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
25078917|NCT02432846|50187284|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
25078918|NCT02432846|50187285|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
25078919|NCT02432846|50187286|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
25078920|NCT02432846|50187287|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
25078921|NCT02432846|50187288|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
25078922|NCT02432846|50187289|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
25078923|NCT02432846|50187284|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
25078924|NCT02432846|50187285|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
25078925|NCT02432846|50187286|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
25078926|NCT02432846|50187287|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
25078927|NCT02432846|50187288|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
25078928|NCT02432846|50187289|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
25078929|NCT02432846|50187284|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
25342040|NCT00789737|50658392|FG000|Overall Study|Other|11|||
25078930|NCT02432846|50187285|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
25078931|NCT02432846|50187286|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
25078932|NCT02432846|50187287|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
25078933|NCT02432846|50187288|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
25078934|NCT02432846|50187289|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
25078935|NCT02432144|50187302|FG000|Overall Study|Participant Non-Compliance|1|||
25078936|NCT02246998|50187310|FG000|Overall Study|Adverse Event|0|||
25078937|NCT02246998|50187311|FG001|Overall Study|Adverse Event|1|||
25078938|NCT02246998|50187312|FG002|Overall Study|Adverse Event|1|||
25078939|NCT02246998|50187313|FG003|Overall Study|Adverse Event|0|||
25078940|NCT02246998|50187310|FG000|Overall Study|Lost to Follow-up|1|||
25078941|NCT02246998|50187311|FG001|Overall Study|Lost to Follow-up|0|||
25078942|NCT02246998|50187312|FG002|Overall Study|Lost to Follow-up|0|||
25078943|NCT02246998|50187313|FG003|Overall Study|Lost to Follow-up|1|||
25078944|NCT02246998|50187310|FG000|Overall Study|Randomized but Never Dosed|1|||
25078945|NCT02246998|50187311|FG001|Overall Study|Randomized but Never Dosed|2|||
25078946|NCT02246998|50187312|FG002|Overall Study|Randomized but Never Dosed|2|||
25078947|NCT02246998|50187313|FG003|Overall Study|Randomized but Never Dosed|1|||
25078948|NCT02486588|50187332|FG000|Overall Study|Randomized in error- ineligible|738|||
25078949|NCT02486588|50187333|FG001|Overall Study|Randomized in error- ineligible|750|||
25078950|NCT02486588|50187334|FG002|Overall Study|Randomized in error- ineligible|755|||
25078951|NCT02486588|50187335|FG003|Overall Study|Randomized in error- ineligible|738|||
25078952|NCT02486588|50187336|FG004|Overall Study|Randomized in error- ineligible|746|||
25078953|NCT02486588|50187337|FG005|Overall Study|Randomized in error- ineligible|746|||
25078954|NCT00805961|50187356|FG000|Modality Therapy|Withdrawal by Subject|1|||
25078955|NCT00805961|50187356|FG000|Modality Therapy|Adverse Event|1|||
25078956|NCT00805961|50187356|FG000|Modality Therapy|Disease Progression|2|||
25078957|NCT00805961|50187356|FG000|Treatment-Free Interval|Adverse Event|3|||
25078958|NCT00805961|50187356|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
25078959|NCT00805961|50187356|FG000|Treatment-Free Interval|Physician Decision|1|||
25078960|NCT00805961|50187356|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
25078961|NCT00805961|50187356|FG000|Maintenance Treatment|Lack of Efficacy|13|||
25078962|NCT00805961|50187356|FG000|Maintenance Treatment|Intercurrent Illness|7|||
25078963|NCT00805961|50187356|FG000|Maintenance Treatment|Adverse Event|6|||
25078964|NCT00805961|50187356|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
25078965|NCT00805961|50187356|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
25078966|NCT00805961|50187356|FG000|Maintenance Treatment|Withdrawn Consent|1|||
25078967|NCT02202538|50187360|FG000|Overall Study|Withdrawal by Subject|5|||
25078968|NCT02202538|50187360|FG000|Overall Study|Did not meet all inclusion criteria|2|||
25078969|NCT02202538|50187360|FG000|Overall Study|Investigator Decision|1|||
25078970|NCT02454608|50187367|FG000|Double-Blind Period|Lack of Efficacy|0|||
25078971|NCT02454608|50187368|FG001|Double-Blind Period|Lack of Efficacy|2|||
25078972|NCT02454608|50187369|FG002|Double-Blind Period|Lack of Efficacy|0|||
25078973|NCT02454608|50187367|FG000|Open Label Period|Lost to Follow-up|0|||
25078974|NCT02454608|50187368|FG001|Open Label Period|Lost to Follow-up|0|||
25078975|NCT02454608|50187369|FG002|Open Label Period|Lost to Follow-up|11|||
25078976|NCT02454608|50187367|FG000|Open Label Period|Withdrawal by Subject|0|||
25078977|NCT02454608|50187368|FG001|Open Label Period|Withdrawal by Subject|0|||
25078978|NCT02454608|50187369|FG002|Open Label Period|Withdrawal by Subject|8|||
25078979|NCT02246764|50187380|FG000|Overall Study|Adverse Event|15|||
25078980|NCT02246764|50187381|FG001|Overall Study|Adverse Event|29|||
25078981|NCT02246764|50187382|FG002|Overall Study|Adverse Event|1|||
25078982|NCT02246764|50187380|FG000|Overall Study|Withdrawal by Subject|0|||
25078983|NCT02246764|50187381|FG001|Overall Study|Withdrawal by Subject|0|||
25078984|NCT02246764|50187382|FG002|Overall Study|Withdrawal by Subject|1|||
25078985|NCT02246764|50187380|FG000|Overall Study|Disallowed Concomitant Medication|1|||
25078986|NCT02246764|50187381|FG001|Overall Study|Disallowed Concomitant Medication|0|||
25078987|NCT02246764|50187382|FG002|Overall Study|Disallowed Concomitant Medication|0|||
25078988|NCT02246764|50187380|FG000|Overall Study|Physician Decision|0|||
25078989|NCT02246764|50187381|FG001|Overall Study|Physician Decision|2|||
25078990|NCT02246764|50187382|FG002|Overall Study|Physician Decision|1|||
25078991|NCT02246764|50187380|FG000|Overall Study|Protocol Violation|2|||
25078992|NCT02246764|50187381|FG001|Overall Study|Protocol Violation|1|||
25078993|NCT02246764|50187382|FG002|Overall Study|Protocol Violation|1|||
25078994|NCT02454530|50187392|FG000|Overall Study|Other|8|||
25078995|NCT02454530|50187393|FG001|Overall Study|Other|13|||
25078996|NCT02454530|50187392|FG000|Overall Study|Missing information|56|||
25078997|NCT02454530|50187393|FG001|Overall Study|Missing information|69|||
25078998|NCT02454530|50187392|FG000|Overall Study|Death|2|||
25078999|NCT02454530|50187393|FG001|Overall Study|Death|41|||
25079000|NCT02454530|50187392|FG000|Overall Study|Lost to Follow-up|4|||
25079001|NCT02454530|50187393|FG001|Overall Study|Lost to Follow-up|4|||
25079002|NCT02431676|50187403|FG000|Overall Study|no lab obtained|0|||
25079003|NCT02431676|50187404|FG001|Overall Study|no lab obtained|1|||
24983669|NCT00270257|50072263|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
25079004|NCT02431676|50187405|FG002|Overall Study|no lab obtained|2|||
25079005|NCT01654250|50187415|FG000|Overall Study|Lost to Follow-up|1|||
25079006|NCT01654250|50187416|FG001|Overall Study|Lost to Follow-up|0|||
25079007|NCT01652690|50187425|FG000|Overall Study|Withdrawal by Subject|16|||
25079008|NCT01652690|50187426|FG001|Overall Study|Withdrawal by Subject|4|||
25079009|NCT01652690|50187425|FG000|Overall Study|Other|8|||
25079010|NCT01652690|50187426|FG001|Overall Study|Other|9|||
25079011|NCT01652690|50187425|FG000|Overall Study|Lost to Follow-up|6|||
25079012|NCT01652690|50187426|FG001|Overall Study|Lost to Follow-up|6|||
25079013|NCT01652690|50187425|FG000|Overall Study|Death|5|||
25079014|NCT01652690|50187426|FG001|Overall Study|Death|2|||
25079015|NCT02429258|50187434|FG000|Overall Study|Withdrawal by Subject|2|||
25079016|NCT02429258|50187435|FG001|Overall Study|Withdrawal by Subject|0|||
25079017|NCT02429258|50187434|FG000|Overall Study|Protocol Violation|0|||
25079018|NCT02429258|50187435|FG001|Overall Study|Protocol Violation|1|||
25079019|NCT02201524|50187445|FG000|Overall Study|Adverse Event|0|||
25079020|NCT02201524|50187446|FG001|Overall Study|Adverse Event|2|||
25079021|NCT02201524|50187447|FG002|Overall Study|Adverse Event|1|||
25079022|NCT02201524|50187448|FG003|Overall Study|Adverse Event|0|||
25079023|NCT02201524|50187445|FG000|Overall Study|Insufficient clinical response|1|||
25079024|NCT02201524|50187446|FG001|Overall Study|Insufficient clinical response|0|||
25079025|NCT02201524|50187447|FG002|Overall Study|Insufficient clinical response|0|||
25079026|NCT02201524|50187448|FG003|Overall Study|Insufficient clinical response|0|||
25079027|NCT02201524|50187445|FG000|Overall Study|Lost to Follow-up|0|||
25079028|NCT02201524|50187446|FG001|Overall Study|Lost to Follow-up|0|||
25079029|NCT02201524|50187447|FG002|Overall Study|Lost to Follow-up|2|||
25079030|NCT02201524|50187448|FG003|Overall Study|Lost to Follow-up|0|||
25079031|NCT02201524|50187445|FG000|Overall Study|No longer meets eligibility criteria|0|||
25079032|NCT02201524|50187446|FG001|Overall Study|No longer meets eligibility criteria|0|||
25079033|NCT02201524|50187447|FG002|Overall Study|No longer meets eligibility criteria|0|||
25079034|NCT02201524|50187448|FG003|Overall Study|No longer meets eligibility criteria|2|||
25079035|NCT02201524|50187445|FG000|Overall Study|Protocol Violation|0|||
25079036|NCT02201524|50187446|FG001|Overall Study|Protocol Violation|0|||
25079037|NCT02201524|50187447|FG002|Overall Study|Protocol Violation|0|||
25079038|NCT02201524|50187448|FG003|Overall Study|Protocol Violation|1|||
25079039|NCT02201524|50187445|FG000|Overall Study|Withdrawal by Subject|0|||
25079040|NCT02201524|50187446|FG001|Overall Study|Withdrawal by Subject|0|||
25079041|NCT02201524|50187447|FG002|Overall Study|Withdrawal by Subject|1|||
25079042|NCT02201524|50187448|FG003|Overall Study|Withdrawal by Subject|1|||
25079043|NCT02201524|50187445|FG000|Overall Study|Other|1|||
25255856|NCT00107900|50571192|FG002|Overall Study|Administrative Reasons|2|||
25255857|NCT00107900|50571193|FG003|Overall Study|Administrative Reasons|2|||
25255858|NCT00107900|50571194|FG004|Overall Study|Administrative Reasons|2|||
25255859|NCT00107900|50571195|FG005|Overall Study|Administrative Reasons|0|||
25255860|NCT01339052|50571211|FG000|Overall Study|Disease progression|13|||
25255861|NCT01339052|50571212|FG001|Overall Study|Disease progression|46|||
25255862|NCT01339052|50571211|FG000|Overall Study|Adverse Event|1|||
25255863|NCT01339052|50571212|FG001|Overall Study|Adverse Event|1|||
25255864|NCT01339052|50571211|FG000|Overall Study|Withdrawal by Subject|0|||
25255865|NCT01339052|50571212|FG001|Overall Study|Withdrawal by Subject|3|||
25255866|NCT01339052|50571211|FG000|Overall Study|Physician Decision|1|||
25255867|NCT01339052|50571212|FG001|Overall Study|Physician Decision|0|||
25255868|NCT00107315|50571221|FG000|Overall Study|Disease Progression|9|||
25255869|NCT00107315|50571221|FG000|Overall Study|Adverse Event|4|||
25255870|NCT00107315|50571221|FG000|Overall Study|Withdrawal by Subject|2|||
25255871|NCT01335971|50571228|FG000|Overall Study|Withdrawal by Subject|1|||
25255872|NCT01335971|50571229|FG001|Overall Study|Withdrawal by Subject|0|||
25255873|NCT01335971|50571230|FG002|Overall Study|Withdrawal by Subject|0|||
25255874|NCT01335971|50571228|FG000|Overall Study|Did not complete bronchoscopy|1|||
25255875|NCT01335971|50571229|FG001|Overall Study|Did not complete bronchoscopy|1|||
25255876|NCT01335971|50571230|FG002|Overall Study|Did not complete bronchoscopy|1|||
25255877|NCT00107276|50571238|FG000|Overall Study|Progression|46|||
25255878|NCT00107276|50571238|FG000|Overall Study|Adverse Event|6|||
24983670|NCT00270257|50072264|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
24983671|NCT00269633|50072274|FG000|Overall Study|Withdrawal by Subject|1|||
24983672|NCT00269633|50072275|FG001|Overall Study|Withdrawal by Subject|0|||
25079044|NCT02201524|50187446|FG001|Overall Study|Other|1|||
25079045|NCT02201524|50187447|FG002|Overall Study|Other|0|||
25079046|NCT02201524|50187448|FG003|Overall Study|Other|0|||
25079047|NCT02453048|50187463|FG000|Overall Study|Only part of initial 6 mo. study|0|||
25079048|NCT02453048|50187464|FG001|Overall Study|Only part of initial 6 mo. study|0|||
25079049|NCT02453048|50187465|FG002|Overall Study|Only part of initial 6 mo. study|0|||
25079050|NCT02453048|50187466|FG003|Overall Study|Only part of initial 6 mo. study|0|||
25079051|NCT02453048|50187467|FG004|Overall Study|Only part of initial 6 mo. study|6|||
25079052|NCT02453048|50187463|FG000|Overall Study|Lost to Follow-up|0|||
25255879|NCT00107276|50571238|FG000|Overall Study|M.D. decision|2|||
25255880|NCT00107276|50571238|FG000|Overall Study|Patient refusal|1|||
25255881|NCT00107276|50571238|FG000|Overall Study|Death|1|||
25079053|NCT02453048|50187464|FG001|Overall Study|Lost to Follow-up|1|||
25079054|NCT02453048|50187465|FG002|Overall Study|Lost to Follow-up|2|||
25079055|NCT02453048|50187466|FG003|Overall Study|Lost to Follow-up|0|||
25079056|NCT02453048|50187467|FG004|Overall Study|Lost to Follow-up|0|||
25079057|NCT02137252|50187481|FG000|Overall Study|trial terminated early|2|||
25079058|NCT02137252|50187482|FG001|Overall Study|trial terminated early|1|||
25079059|NCT02201290|50187488|FG000|Overall Study|Withdrawal by Subject|2|||
25079060|NCT02201290|50187488|FG000|Overall Study|Lack of Efficacy|2|||
25079061|NCT02201290|50187488|FG000|Overall Study|Adverse Event|1|||
25079062|NCT02200510|50187494|FG000|Overall Study|Death|1|||
25079063|NCT02200510|50187495|FG001|Overall Study|Death|1|||
25079064|NCT02200510|50187494|FG000|Overall Study|Protocol Violation|0|||
25079065|NCT02200510|50187495|FG001|Overall Study|Protocol Violation|1|||
25079066|NCT02200510|50187494|FG000|Overall Study|Lost to Follow-up|7|||
25079067|NCT02200510|50187495|FG001|Overall Study|Lost to Follow-up|1|||
25079068|NCT02200510|50187494|FG000|Overall Study|potential COI - joined study team|1|||
25079069|NCT02200510|50187495|FG001|Overall Study|potential COI - joined study team|0|||
25079070|NCT02452892|50187505|FG000|Week 1 Initial Randommization|Adverse Event|1|||
25079071|NCT02452892|50187506|FG001|Week 1 Initial Randommization|Adverse Event|0|||
25079072|NCT02452892|50187507|FG002|Week 1 Initial Randommization|Adverse Event|0|||
25079073|NCT02452892|50187508|FG003|Week 1 Initial Randommization|Adverse Event|0|||
25079074|NCT02452892|50187505|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
25079075|NCT02452892|50187506|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
25079076|NCT02452892|50187507|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
25079077|NCT02452892|50187508|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
25079078|NCT02452892|50187505|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
25079079|NCT02452892|50187506|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
25079080|NCT02452892|50187507|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
25079081|NCT02452892|50187508|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
25079082|NCT02452892|50187505|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
25079083|NCT02452892|50187506|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
25079084|NCT02452892|50187507|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
25079085|NCT02452892|50187508|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
25079086|NCT02452892|50187505|FG000|Follow-up|Withdrawal by Subject|0|||
25079087|NCT02452892|50187506|FG001|Follow-up|Withdrawal by Subject|0|||
25079088|NCT02452892|50187507|FG002|Follow-up|Withdrawal by Subject|0|||
25079089|NCT02452892|50187508|FG003|Follow-up|Withdrawal by Subject|1|||
25079090|NCT02452892|50187505|FG000|Follow-up|Subject left town on Day 42|1|||
25079091|NCT02452892|50187506|FG001|Follow-up|Subject left town on Day 42|0|||
25079092|NCT02452892|50187507|FG002|Follow-up|Subject left town on Day 42|0|||
25079093|NCT02452892|50187508|FG003|Follow-up|Subject left town on Day 42|0|||
25079094|NCT02135848|50187523|FG000|Overall Study|Adverse Event|2|||
25079095|NCT02135848|50187524|FG001|Overall Study|Adverse Event|0|||
25079096|NCT02135848|50187523|FG000|Overall Study|Withdrawal by Subject|1|||
25079097|NCT02135848|50187524|FG001|Overall Study|Withdrawal by Subject|1|||
25079098|NCT02738333|50187544|FG000|Overall Study|Death|1|||
25079099|NCT02738333|50187545|FG001|Overall Study|Death|0|||
25079100|NCT02738333|50187546|FG002|Overall Study|Death|0|||
25079101|NCT02738333|50187544|FG000|Overall Study|Lost to Follow-up|1|||
25079102|NCT02738333|50187545|FG001|Overall Study|Lost to Follow-up|0|||
25079103|NCT02738333|50187546|FG002|Overall Study|Lost to Follow-up|0|||
25079104|NCT02135692|50187554|FG000|Overall Study|Adverse Event|3|||
25255882|NCT00107276|50571238|FG000|Overall Study|Ineligible|16|||
25255883|NCT01335698|50571248|FG000|Treatment Stage 1|Lack of Efficacy|3|||
25255884|NCT01335698|50571249|FG001|Treatment Stage 1|Lack of Efficacy|1|||
24983673|NCT00269477|50072285|FG000|Overall Study|Protocol Violation|5|||
24983674|NCT00269477|50072286|FG001|Overall Study|Protocol Violation|5|||
24983675|NCT00269477|50072287|FG002|Overall Study|Protocol Violation|1|||
24983676|NCT00269477|50072288|FG003|Overall Study|Protocol Violation|0|||
24983677|NCT00269477|50072285|FG000|Overall Study|Missed post-vaccination blood draw|0|||
24983678|NCT00269477|50072286|FG001|Overall Study|Missed post-vaccination blood draw|1|||
24983679|NCT00269477|50072287|FG002|Overall Study|Missed post-vaccination blood draw|0|||
24983680|NCT00269477|50072288|FG003|Overall Study|Missed post-vaccination blood draw|0|||
25079105|NCT02135692|50187554|FG000|Overall Study|Lack of Efficacy|2|||
25079106|NCT02135692|50187554|FG000|Overall Study|Protocol Violation|2|||
25079107|NCT02135692|50187554|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
25079108|NCT02135692|50187554|FG000|Overall Study|Product commercially available|159|||
25079109|NCT02135692|50187554|FG000|Overall Study|Study closed/terminated|153|||
25079110|NCT02135692|50187554|FG000|Overall Study|Lost to Follow-up|4|||
25079111|NCT02135692|50187554|FG000|Overall Study|Withdrawal by Subject|15|||
25079112|NCT02429414|50187560|FG000|Overall Study|Physician Decision|0|||
25079113|NCT02429414|50187561|FG001|Overall Study|Physician Decision|1|||
25079114|NCT02135614|50187569|FG000|Overall Study|Randomized but Not Treated|2|||
24983681|NCT00269399|50072300|FG000|Overall Study|Lack of Efficacy|27|||
25255885|NCT01335698|50571250|FG002|Treatment Stage 1|Lack of Efficacy|3|||
25079115|NCT02135614|50187570|FG001|Overall Study|Randomized but Not Treated|1|||
25079116|NCT02135614|50187569|FG000|Overall Study|Adverse Event|0|||
25079117|NCT02135614|50187570|FG001|Overall Study|Adverse Event|1|||
25079118|NCT02135614|50187569|FG000|Overall Study|Death|1|||
25079119|NCT02135614|50187570|FG001|Overall Study|Death|0|||
25079120|NCT02135614|50187569|FG000|Overall Study|Investigator's Discretion|0|||
25079121|NCT02135614|50187570|FG001|Overall Study|Investigator's Discretion|1|||
25079122|NCT02135614|50187569|FG000|Overall Study|Withdrew Consent|2|||
25079123|NCT02135614|50187570|FG001|Overall Study|Withdrew Consent|2|||
25079124|NCT02135614|50187569|FG000|Overall Study|Lost to Follow-up|3|||
25079125|NCT02135614|50187570|FG001|Overall Study|Lost to Follow-up|0|||
25079126|NCT02168842|50187578|FG000|Overall Study|Withdrawal by Subject|5|||
25079127|NCT02168842|50187579|FG001|Overall Study|Withdrawal by Subject|3|||
25079128|NCT02168842|50187578|FG000|Overall Study|Lost to Follow-up|0|||
25079129|NCT02168842|50187579|FG001|Overall Study|Lost to Follow-up|2|||
25079130|NCT02168842|50187578|FG000|Overall Study|Death|2|||
25079131|NCT02168842|50187579|FG001|Overall Study|Death|1|||
25079132|NCT02168842|50187578|FG000|Overall Study|Physician Decision|1|||
25079133|NCT02168842|50187579|FG001|Overall Study|Physician Decision|2|||
25079134|NCT02200042|50187589|FG000|Overall Study|Withdrawal by Subject|0|||
25079135|NCT02200042|50187590|FG001|Overall Study|Withdrawal by Subject|1|||
25079136|NCT02199028|50187598|FG000|Week 1|Adverse Event|1|||
25079137|NCT02199028|50187599|FG001|Week 1|Adverse Event|0|||
25079138|NCT02199028|50187598|FG000|Week 3|Adverse Event|1|||
25079139|NCT02199028|50187599|FG001|Week 3|Adverse Event|0|||
25079140|NCT03347123|50187608|FG000|Overall Study|Death|1|||
25079141|NCT03347123|50187609|FG001|Overall Study|Death|2|||
25079142|NCT03347123|50187610|FG002|Overall Study|Death|0|||
25079143|NCT03347123|50187611|FG003|Overall Study|Death|0|||
25079144|NCT03347123|50187612|FG004|Overall Study|Death|0|||
25079145|NCT03347123|50187613|FG005|Overall Study|Death|0|||
25079146|NCT03347123|50187614|FG006|Overall Study|Death|0|||
25079147|NCT03347123|50187608|FG000|Overall Study|Withdrawal by Subject|1|||
25079148|NCT03347123|50187609|FG001|Overall Study|Withdrawal by Subject|0|||
25079149|NCT03347123|50187610|FG002|Overall Study|Withdrawal by Subject|0|||
25079150|NCT03347123|50187611|FG003|Overall Study|Withdrawal by Subject|0|||
25079151|NCT03347123|50187612|FG004|Overall Study|Withdrawal by Subject|0|||
25079152|NCT03347123|50187613|FG005|Overall Study|Withdrawal by Subject|0|||
25079153|NCT03347123|50187614|FG006|Overall Study|Withdrawal by Subject|0|||
25079154|NCT03347123|50187608|FG000|Overall Study|Reason not Specified|3|||
25079155|NCT03347123|50187609|FG001|Overall Study|Reason not Specified|4|||
25079156|NCT03347123|50187610|FG002|Overall Study|Reason not Specified|0|||
25079157|NCT03347123|50187611|FG003|Overall Study|Reason not Specified|0|||
25079158|NCT03347123|50187612|FG004|Overall Study|Reason not Specified|0|||
25079159|NCT03347123|50187613|FG005|Overall Study|Reason not Specified|0|||
25079160|NCT03347123|50187614|FG006|Overall Study|Reason not Specified|0|||
25079161|NCT02198794|50187625|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
25079162|NCT02198794|50187626|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
25079163|NCT02198794|50187627|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
25079164|NCT02198794|50187628|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
25079165|NCT02198794|50187625|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
25079166|NCT02198794|50187626|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
25079167|NCT02198794|50187627|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
25079168|NCT02198794|50187628|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
25079169|NCT02198794|50187625|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
25079170|NCT02198794|50187626|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
25079171|NCT02198794|50187627|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
25079172|NCT02198794|50187628|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
25079173|NCT02198794|50187625|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
25079174|NCT02198794|50187626|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
25079175|NCT02198794|50187627|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
25079176|NCT02198794|50187628|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
25079177|NCT02198794|50187625|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
25079178|NCT02198794|50187626|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
25079179|NCT02198794|50187627|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
25079180|NCT02198794|50187628|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
25255886|NCT01335698|50571251|FG003|Treatment Stage 1|Lack of Efficacy|3|||
25079181|NCT02198794|50187625|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
25079182|NCT02198794|50187626|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
25079183|NCT02198794|50187627|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
25079184|NCT02198794|50187628|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
25079185|NCT02198794|50187625|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
25079186|NCT02198794|50187626|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
25079187|NCT02198794|50187627|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
25079188|NCT02198794|50187628|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
25079189|NCT02198794|50187625|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
25079190|NCT02198794|50187626|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
25079191|NCT02198794|50187627|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
25079192|NCT02198794|50187628|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
25079193|NCT02198794|50187625|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
25079194|NCT02198794|50187626|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
25079195|NCT02198794|50187627|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
25079196|NCT02198794|50187628|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
25079197|NCT02198794|50187625|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
25079198|NCT02198794|50187626|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
25079199|NCT02198794|50187627|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
25079200|NCT02198794|50187628|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
25079201|NCT02198794|50187625|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
25079202|NCT02198794|50187626|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
25079203|NCT02198794|50187627|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
25079204|NCT02198794|50187628|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
25079205|NCT02198794|50187625|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
25079206|NCT02198794|50187626|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
25079207|NCT02198794|50187627|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
25079208|NCT02198794|50187628|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
25079209|NCT02198794|50187625|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
25079210|NCT02198794|50187626|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
25079211|NCT02198794|50187627|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
25079212|NCT02198794|50187628|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
25079213|NCT02198794|50187625|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
25079214|NCT02198794|50187626|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
25079215|NCT02198794|50187627|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
25079216|NCT02198794|50187628|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
25079217|NCT02198794|50187625|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
25079218|NCT02198794|50187626|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
25079219|NCT02198794|50187627|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
25079220|NCT02198794|50187628|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
25079221|NCT02133664|50187639|FG000|Overall Study|Lost to Follow-up|2|||
25079222|NCT02133664|50187640|FG001|Overall Study|Lost to Follow-up|1|||
25079223|NCT02133664|50187639|FG000|Overall Study|Adverse Event|3|||
25079224|NCT02133664|50187640|FG001|Overall Study|Adverse Event|6|||
25079225|NCT02133508|50187646|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
25079226|NCT02133508|50187646|FG000|Overall Study|Death|12|||
25079227|NCT02133508|50187646|FG000|Overall Study|Lost to Follow-up|2|||
25079228|NCT02133352|50187650|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
25079229|NCT02167594|50187657|FG000|Overall Study|Withdrawal by Subject|2|||
25079230|NCT02167594|50187658|FG001|Overall Study|Withdrawal by Subject|0|||
25079231|NCT02167594|50187659|FG002|Overall Study|Withdrawal by Subject|0|||
25079232|NCT02167594|50187657|FG000|Overall Study|Death|0|||
25079233|NCT02167594|50187658|FG001|Overall Study|Death|1|||
25079234|NCT02167594|50187659|FG002|Overall Study|Death|0|||
25079235|NCT02555657|50187670|FG000|Overall Study|Death|274|||
25079236|NCT02555657|50187671|FG001|Overall Study|Death|262|||
25079237|NCT02555657|50187670|FG000|Overall Study|Physician Decision|0|||
25079238|NCT02555657|50187671|FG001|Overall Study|Physician Decision|1|||
25079239|NCT02555657|50187670|FG000|Overall Study|Sponsor Decision|27|||
25079240|NCT02555657|50187671|FG001|Overall Study|Sponsor Decision|15|||
25079241|NCT02555657|50187670|FG000|Overall Study|Withdrawal by Subject|11|||
25079242|NCT02555657|50187671|FG001|Overall Study|Withdrawal by Subject|32|||
25079243|NCT02195518|50187703|FG000|Overall Study|Adverse Event|1|||
25079244|NCT02195518|50187703|FG000|Overall Study|Protocol Violation|4|||
25079245|NCT02195518|50187703|FG000|Overall Study|Pregnancy|2|||
25079246|NCT02195518|50187703|FG000|Overall Study|Withdrawal by Subject|1|||
25079247|NCT02195518|50187703|FG000|Overall Study|Lost to Follow-up|1|||
24983682|NCT00269399|50072301|FG001|Overall Study|Lack of Efficacy|10|||
24983683|NCT00269399|50072300|FG000|Overall Study|Adverse Event|10|||
24983684|NCT00269399|50072301|FG001|Overall Study|Adverse Event|4|||
25079248|NCT02133742|50187724|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
25079249|NCT02133742|50187724|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
25079250|NCT02133742|50187724|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
25079251|NCT02133742|50187724|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
25079252|NCT02133742|50187724|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
25255887|NCT01335698|50571252|FG004|Treatment Stage 1|Lack of Efficacy|1|||
24983685|NCT00269399|50072300|FG000|Overall Study|Withdrawal by Subject|2|||
24983686|NCT00269399|50072301|FG001|Overall Study|Withdrawal by Subject|5|||
25079253|NCT03032705|50187732|FG000|Overall Study|Lost to Follow-up|16|||
25079254|NCT03032705|50187733|FG001|Overall Study|Lost to Follow-up|17|||
25079255|NCT03032705|50187732|FG000|Overall Study|did not quality|6|||
25079256|NCT03032705|50187733|FG001|Overall Study|did not quality|6|||
25079257|NCT04476251|50187739|FG000|Overall Study|Not treated|1|||
25079258|NCT03795233|50187745|FG000|Overall Study|Withdrawal by Subject|2|||
25079259|NCT03795233|50187746|FG001|Overall Study|Withdrawal by Subject|1|||
25079260|NCT03795233|50187745|FG000|Overall Study|Lost to Follow-up|1|||
25079261|NCT03795233|50187746|FG001|Overall Study|Lost to Follow-up|0|||
25079262|NCT03795233|50187745|FG000|Overall Study|Death|1|||
25079263|NCT03795233|50187746|FG001|Overall Study|Death|0|||
25079264|NCT03645863|50187755|FG000|Overall Study|Withdrawal by Subject|1|||
25079265|NCT03645863|50187756|FG001|Overall Study|Withdrawal by Subject|0|||
25079266|NCT03645863|50187757|FG002|Overall Study|Withdrawal by Subject|0|||
25079267|NCT03564119|50187767|FG000|Overall Study|Adverse Event|4|||
25079268|NCT03564119|50187768|FG001|Overall Study|Adverse Event|0|||
25079269|NCT03564119|50187767|FG000|Overall Study|Lost to Follow-up|1|||
25079270|NCT03564119|50187768|FG001|Overall Study|Lost to Follow-up|4|||
25079271|NCT03564119|50187767|FG000|Overall Study|Protocol Violation|1|||
25079272|NCT03564119|50187768|FG001|Overall Study|Protocol Violation|0|||
25079273|NCT03564119|50187767|FG000|Overall Study|Withdrawal by Subject|9|||
25079274|NCT03564119|50187768|FG001|Overall Study|Withdrawal by Subject|4|||
25079275|NCT03564119|50187767|FG000|Overall Study|Other Than Specified|0|||
25079276|NCT03564119|50187768|FG001|Overall Study|Other Than Specified|1|||
25079277|NCT04531241|50187774|FG000|Period 1|Withdrawal by Subject|2|||
25079278|NCT04531241|50187775|FG001|Period 1|Withdrawal by Subject|0|||
25079279|NCT04531241|50187774|FG000|Period 1|Dispesed incorrect lens power|1|||
25079280|NCT04531241|50187775|FG001|Period 1|Dispesed incorrect lens power|0|||
25079281|NCT04531241|50187774|FG000|Period 1|Protocol Violation|1|||
25079282|NCT04531241|50187775|FG001|Period 1|Protocol Violation|0|||
25079283|NCT04531241|50187774|FG000|Period 1|No longer eligible|0|||
25079284|NCT04531241|50187775|FG001|Period 1|No longer eligible|1|||
25079285|NCT04531241|50187774|FG000|Period 1|Lens Discomfort|0|||
25079286|NCT04531241|50187775|FG001|Period 1|Lens Discomfort|1|||
25079287|NCT04531241|50187774|FG000|Period 2|Covid-19 Related|1|||
25079288|NCT04531241|50187775|FG001|Period 2|Covid-19 Related|1|||
25079289|NCT03181529|50187783|FG000|Overall Study|Withdrawal by Subject|1|||
25079290|NCT03181529|50187784|FG001|Overall Study|Withdrawal by Subject|1|||
25079291|NCT03181529|50187783|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
25079292|NCT03181529|50187784|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
25079293|NCT03470441|50187798|FG000|Overall Study|Death|0|||
25079294|NCT03470441|50187799|FG001|Overall Study|Death|1|||
25079295|NCT03470441|50187800|FG002|Overall Study|Death|1|||
25079296|NCT03470441|50187801|FG003|Overall Study|Death|0|||
25079297|NCT03470441|50187798|FG000|Overall Study|Adverse Event|0|||
25079298|NCT03470441|50187799|FG001|Overall Study|Adverse Event|0|||
25079299|NCT03470441|50187800|FG002|Overall Study|Adverse Event|0|||
25079300|NCT03470441|50187801|FG003|Overall Study|Adverse Event|1|||
25079301|NCT03470441|50187798|FG000|Overall Study|Withdrawal by Subject|1|||
25079302|NCT03470441|50187799|FG001|Overall Study|Withdrawal by Subject|4|||
25079303|NCT03470441|50187800|FG002|Overall Study|Withdrawal by Subject|1|||
25079304|NCT03470441|50187801|FG003|Overall Study|Withdrawal by Subject|3|||
25079305|NCT03361865|50187813|FG000|Overall Study|Death|17|||
25079306|NCT03361865|50187814|FG001|Overall Study|Death|18|||
25079307|NCT03361865|50187813|FG000|Overall Study|Physician Decision|1|||
25079308|NCT03361865|50187814|FG001|Overall Study|Physician Decision|9|||
25079309|NCT03361865|50187813|FG000|Overall Study|Withdrawal by Subject|1|||
25079310|NCT03361865|50187814|FG001|Overall Study|Withdrawal by Subject|0|||
25079311|NCT02149121|50187828|FG000|Main Study Period|Lack of Efficacy|2|||
25079312|NCT02149121|50187829|FG001|Main Study Period|Lack of Efficacy|2|||
25079313|NCT02149121|50187830|FG002|Main Study Period|Lack of Efficacy|1|||
25079314|NCT02149121|50187831|FG003|Main Study Period|Lack of Efficacy|0|||
25079315|NCT02149121|50187832|FG004|Main Study Period|Lack of Efficacy|0|||
25079316|NCT02149121|50187833|FG005|Main Study Period|Lack of Efficacy|0|||
25079317|NCT02149121|50187834|FG006|Main Study Period|Lack of Efficacy|0|||
25255888|NCT01335698|50571248|FG000|Treatment Stage 1|Adverse Event|1|||
25255889|NCT01335698|50571249|FG001|Treatment Stage 1|Adverse Event|2|||
25255890|NCT01335698|50571250|FG002|Treatment Stage 1|Adverse Event|2|||
25079318|NCT02149121|50187828|FG000|Main Study Period|Withdrawal by Subject|9|||
25079319|NCT02149121|50187829|FG001|Main Study Period|Withdrawal by Subject|5|||
25079320|NCT02149121|50187830|FG002|Main Study Period|Withdrawal by Subject|1|||
25079321|NCT02149121|50187831|FG003|Main Study Period|Withdrawal by Subject|0|||
25079322|NCT02149121|50187832|FG004|Main Study Period|Withdrawal by Subject|0|||
25079323|NCT02149121|50187833|FG005|Main Study Period|Withdrawal by Subject|0|||
25079324|NCT02149121|50187834|FG006|Main Study Period|Withdrawal by Subject|0|||
25079325|NCT02149121|50187828|FG000|Main Study Period|Adverse Event|2|||
25079326|NCT02149121|50187829|FG001|Main Study Period|Adverse Event|5|||
25079327|NCT02149121|50187830|FG002|Main Study Period|Adverse Event|1|||
25079328|NCT02149121|50187831|FG003|Main Study Period|Adverse Event|0|||
25079329|NCT02149121|50187832|FG004|Main Study Period|Adverse Event|0|||
25079330|NCT02149121|50187833|FG005|Main Study Period|Adverse Event|0|||
25079331|NCT02149121|50187834|FG006|Main Study Period|Adverse Event|0|||
25079332|NCT02149121|50187828|FG000|Main Study Period|Protocol Violation|2|||
25079333|NCT02149121|50187829|FG001|Main Study Period|Protocol Violation|0|||
25079334|NCT02149121|50187830|FG002|Main Study Period|Protocol Violation|0|||
25079335|NCT02149121|50187831|FG003|Main Study Period|Protocol Violation|0|||
25079336|NCT02149121|50187832|FG004|Main Study Period|Protocol Violation|0|||
25079337|NCT02149121|50187833|FG005|Main Study Period|Protocol Violation|0|||
25079338|NCT02149121|50187834|FG006|Main Study Period|Protocol Violation|0|||
25079339|NCT02149121|50187828|FG000|Main Study Period|Lost to Follow-up|2|||
25079340|NCT02149121|50187829|FG001|Main Study Period|Lost to Follow-up|1|||
25079341|NCT02149121|50187830|FG002|Main Study Period|Lost to Follow-up|0|||
25079342|NCT02149121|50187831|FG003|Main Study Period|Lost to Follow-up|0|||
25079343|NCT02149121|50187832|FG004|Main Study Period|Lost to Follow-up|0|||
25079344|NCT02149121|50187833|FG005|Main Study Period|Lost to Follow-up|0|||
25079345|NCT02149121|50187834|FG006|Main Study Period|Lost to Follow-up|0|||
25079346|NCT02149121|50187828|FG000|Main Study Period|Death|1|||
25079347|NCT02149121|50187829|FG001|Main Study Period|Death|0|||
25079348|NCT02149121|50187830|FG002|Main Study Period|Death|0|||
25079349|NCT02149121|50187831|FG003|Main Study Period|Death|0|||
25079350|NCT02149121|50187832|FG004|Main Study Period|Death|0|||
25079351|NCT02149121|50187833|FG005|Main Study Period|Death|0|||
25079352|NCT02149121|50187834|FG006|Main Study Period|Death|0|||
25079353|NCT02149121|50187828|FG000|Main Study Period|Physician Decision|1|||
25079354|NCT02149121|50187829|FG001|Main Study Period|Physician Decision|0|||
25079355|NCT02149121|50187830|FG002|Main Study Period|Physician Decision|0|||
25079356|NCT02149121|50187831|FG003|Main Study Period|Physician Decision|0|||
25079357|NCT02149121|50187832|FG004|Main Study Period|Physician Decision|0|||
25079358|NCT02149121|50187833|FG005|Main Study Period|Physician Decision|0|||
25079359|NCT02149121|50187834|FG006|Main Study Period|Physician Decision|0|||
25079360|NCT02149121|50187828|FG000|Main Study Period|Developed any malignancy|0|||
25079361|NCT02149121|50187829|FG001|Main Study Period|Developed any malignancy|1|||
25255891|NCT01335698|50571251|FG003|Treatment Stage 1|Adverse Event|1|||
25255892|NCT01335698|50571252|FG004|Treatment Stage 1|Adverse Event|1|||
25255893|NCT01335698|50571248|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
25255894|NCT01335698|50571249|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
25255895|NCT01335698|50571250|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
25255896|NCT01335698|50571251|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
25255897|NCT01335698|50571252|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
25255898|NCT01335698|50571248|FG000|Treatment Stage 1|Lost to Follow-up|1|||
25255899|NCT01335698|50571249|FG001|Treatment Stage 1|Lost to Follow-up|1|||
25255900|NCT01335698|50571250|FG002|Treatment Stage 1|Lost to Follow-up|0|||
25255901|NCT01335698|50571251|FG003|Treatment Stage 1|Lost to Follow-up|0|||
25255902|NCT01335698|50571252|FG004|Treatment Stage 1|Lost to Follow-up|0|||
25255903|NCT01335698|50571248|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
25255904|NCT01335698|50571249|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
25255905|NCT01335698|50571250|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
25255906|NCT01335698|50571251|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
25255907|NCT01335698|50571252|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
25255908|NCT01335698|50571248|FG000|Treatment Stage 1|No longer meets study criteria|1|||
25255909|NCT01335698|50571249|FG001|Treatment Stage 1|No longer meets study criteria|1|||
25255910|NCT01335698|50571250|FG002|Treatment Stage 1|No longer meets study criteria|0|||
25255911|NCT01335698|50571251|FG003|Treatment Stage 1|No longer meets study criteria|1|||
25255912|NCT01335698|50571252|FG004|Treatment Stage 1|No longer meets study criteria|0|||
25255913|NCT01335698|50571248|FG000|Treatment Stage 1|Other|1|||
25255914|NCT01335698|50571249|FG001|Treatment Stage 1|Other|0|||
25255915|NCT01335698|50571250|FG002|Treatment Stage 1|Other|0|||
25255916|NCT01335698|50571251|FG003|Treatment Stage 1|Other|1|||
25255917|NCT01335698|50571252|FG004|Treatment Stage 1|Other|0|||
25079362|NCT02149121|50187830|FG002|Main Study Period|Developed any malignancy|1|||
25079363|NCT02149121|50187831|FG003|Main Study Period|Developed any malignancy|0|||
25079364|NCT02149121|50187832|FG004|Main Study Period|Developed any malignancy|0|||
25079365|NCT02149121|50187833|FG005|Main Study Period|Developed any malignancy|0|||
25255918|NCT01335698|50571248|FG000|Treatment Stage 2|Lack of Efficacy|2|||
25255919|NCT01335698|50571249|FG001|Treatment Stage 2|Lack of Efficacy|1|||
25255920|NCT01335698|50571250|FG002|Treatment Stage 2|Lack of Efficacy|3|||
25255921|NCT01335698|50571251|FG003|Treatment Stage 2|Lack of Efficacy|1|||
25255922|NCT01335698|50571252|FG004|Treatment Stage 2|Lack of Efficacy|0|||
25079366|NCT02149121|50187834|FG006|Main Study Period|Developed any malignancy|0|||
25079367|NCT02149121|50187828|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
25079368|NCT02149121|50187829|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
25079369|NCT02149121|50187830|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
25079370|NCT02149121|50187831|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
25255923|NCT01335698|50571248|FG000|Treatment Stage 2|Adverse Event|2|||
25255924|NCT01335698|50571249|FG001|Treatment Stage 2|Adverse Event|0|||
25255925|NCT01335698|50571250|FG002|Treatment Stage 2|Adverse Event|0|||
25255926|NCT01335698|50571251|FG003|Treatment Stage 2|Adverse Event|3|||
25255927|NCT01335698|50571252|FG004|Treatment Stage 2|Adverse Event|0|||
25255928|NCT01335698|50571248|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
25255929|NCT01335698|50571249|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
25255930|NCT01335698|50571250|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
25255931|NCT01335698|50571251|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
25255932|NCT01335698|50571252|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
25255933|NCT01335698|50571248|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
25255934|NCT01335698|50571249|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
25255935|NCT01335698|50571250|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
25255936|NCT01335698|50571251|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
25255937|NCT01335698|50571252|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
25255938|NCT01335698|50571248|FG000|Treatment Stage 2|Lost to Follow-up|1|||
25255939|NCT01335698|50571249|FG001|Treatment Stage 2|Lost to Follow-up|0|||
25255940|NCT01335698|50571250|FG002|Treatment Stage 2|Lost to Follow-up|0|||
25255941|NCT01335698|50571251|FG003|Treatment Stage 2|Lost to Follow-up|0|||
25255942|NCT01335698|50571252|FG004|Treatment Stage 2|Lost to Follow-up|0|||
25255943|NCT01335698|50571248|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
25255944|NCT01335698|50571249|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
25255945|NCT01335698|50571250|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
25255946|NCT01335698|50571251|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
25255947|NCT01335698|50571252|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
25255948|NCT01335698|50571248|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
25255949|NCT01335698|50571249|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
25255950|NCT01335698|50571250|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
25255951|NCT01335698|50571251|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
25255952|NCT01335698|50571252|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
25255953|NCT01335698|50571248|FG000|Treatment Stage 2|Switched to another formulation|1|||
25255954|NCT01335698|50571249|FG001|Treatment Stage 2|Switched to another formulation|1|||
25255955|NCT01335698|50571250|FG002|Treatment Stage 2|Switched to another formulation|0|||
25255956|NCT01335698|50571251|FG003|Treatment Stage 2|Switched to another formulation|0|||
25255957|NCT01335698|50571252|FG004|Treatment Stage 2|Switched to another formulation|0|||
25255958|NCT00107198|50571266|FG000|Overall Study|Lack of Efficacy|28|||
25255959|NCT00107198|50571266|FG000|Overall Study|Lost to Follow-up|12|||
25255960|NCT00107198|50571266|FG000|Overall Study|Protocol Violation|1|||
25255961|NCT00107198|50571266|FG000|Overall Study|Withdrawal by Subject|6|||
25255962|NCT00107198|50571266|FG000|Overall Study|Ineligible|5|||
25255963|NCT00107120|50571272|FG000|Overall Study|Adverse Event|4|||
25255964|NCT00107120|50571273|FG001|Overall Study|Adverse Event|1|||
25255965|NCT00107120|50571272|FG000|Overall Study|Lack of Efficacy|5|||
25255966|NCT00107120|50571273|FG001|Overall Study|Lack of Efficacy|5|||
25255967|NCT00107120|50571272|FG000|Overall Study|Protocol Violation|3|||
25255968|NCT00107120|50571273|FG001|Overall Study|Protocol Violation|0|||
25255969|NCT00107120|50571272|FG000|Overall Study|Withdrawal by Subject|8|||
25255970|NCT00107120|50571273|FG001|Overall Study|Withdrawal by Subject|9|||
25255971|NCT00107120|50571272|FG000|Overall Study|Lost to Follow-up|8|||
25255972|NCT00107120|50571273|FG001|Overall Study|Lost to Follow-up|6|||
25255973|NCT00107120|50571272|FG000|Overall Study|Pregnancy|0|||
25255974|NCT00107120|50571273|FG001|Overall Study|Pregnancy|1|||
25255975|NCT00107120|50571272|FG000|Overall Study|moving away from site|1|||
25255976|NCT00107120|50571273|FG001|Overall Study|moving away from site|1|||
25255977|NCT00107120|50571272|FG000|Overall Study|death of parent|0|||
25255978|NCT00107120|50571273|FG001|Overall Study|death of parent|1|||
25255979|NCT01335464|50571281|FG000|Overall Study|Adverse Event|15|||
25255980|NCT01335464|50571282|FG001|Overall Study|Adverse Event|25|||
25255981|NCT01335464|50571281|FG000|Overall Study|Non compliant with protocol|2|||
25255982|NCT01335464|50571282|FG001|Overall Study|Non compliant with protocol|0|||
25255983|NCT01335464|50571281|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
25255984|NCT01335464|50571282|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
25255985|NCT01335464|50571281|FG000|Overall Study|Not treated|2|||
25255986|NCT01335464|50571282|FG001|Overall Study|Not treated|0|||
25255987|NCT01335464|50571281|FG000|Overall Study|Reason other than those stated above|1|||
25255988|NCT01335464|50571282|FG001|Overall Study|Reason other than those stated above|1|||
25255989|NCT00107042|50571290|FG000|Overall Study|Lost to Follow-up|9|||
25255990|NCT00107042|50571291|FG001|Overall Study|Lost to Follow-up|7|||
25255991|NCT00107042|50571290|FG000|Overall Study|Withdrawal by Subject|6|||
25255992|NCT00107042|50571291|FG001|Overall Study|Withdrawal by Subject|1|||
25255993|NCT00107042|50571290|FG000|Overall Study|Moved out of area|5|||
25255994|NCT00107042|50571291|FG001|Overall Study|Moved out of area|3|||
25255995|NCT00107042|50571290|FG000|Overall Study|Pregnancy|1|||
25255996|NCT00107042|50571291|FG001|Overall Study|Pregnancy|1|||
25255997|NCT00107042|50571290|FG000|Overall Study|Inadvertent enrollment|0|||
25255998|NCT00107042|50571291|FG001|Overall Study|Inadvertent enrollment|1|||
25255999|NCT00107042|50571290|FG000|Overall Study|vaccinated outside window|1|||
25256000|NCT00107042|50571291|FG001|Overall Study|vaccinated outside window|1|||
25256001|NCT00107042|50571290|FG000|Overall Study|Disallowed medications|0|||
25256002|NCT00107042|50571291|FG001|Overall Study|Disallowed medications|2|||
25256003|NCT00106964|50571342|FG000|Overall Study|Lost to Follow-up|8|||
25256004|NCT00106964|50571343|FG001|Overall Study|Lost to Follow-up|6|||
24983687|NCT00269399|50072300|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
24983688|NCT00269399|50072301|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
24983689|NCT00269399|50072300|FG000|Overall Study|Other|0|||
24983690|NCT00269399|50072301|FG001|Overall Study|Other|4|||
24983691|NCT00269399|50072300|FG000|Overall Study|Development of exclusion criteria|0|||
24983692|NCT00269399|50072301|FG001|Overall Study|Development of exclusion criteria|1|||
24983693|NCT00269087|50072307|FG000|Overall Study|Adverse Event|20|||
24983694|NCT00269087|50072307|FG000|Overall Study|Withdrawal by Subject|1|||
24983695|NCT00269087|50072307|FG000|Overall Study|Exacerbation of COPD|13|||
24983696|NCT00289133|50072313|FG000|Overall Study|Non-study device implanted|12|||
24983697|NCT00289133|50072314|FG001|Overall Study|Non-study device implanted|0|||
24983698|NCT00289133|50072313|FG000|Overall Study|Protocol Violation|32|||
24983699|NCT00289133|50072314|FG001|Overall Study|Protocol Violation|38|||
24983700|NCT00289133|50072313|FG000|Overall Study|Withdrawal by Subject|9|||
24983701|NCT00289133|50072314|FG001|Overall Study|Withdrawal by Subject|10|||
24983702|NCT00289133|50072313|FG000|Overall Study|Death|5|||
24983703|NCT00289133|50072314|FG001|Overall Study|Death|10|||
24983704|NCT00289133|50072313|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
24983705|NCT00289133|50072314|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
24983706|NCT00289133|50072313|FG000|Overall Study|Physician Decision|41|||
24983707|NCT00289133|50072314|FG001|Overall Study|Physician Decision|45|||
24983708|NCT00289133|50072313|FG000|Overall Study|Revision|8|||
24983709|NCT00289133|50072314|FG001|Overall Study|Revision|6|||
24983710|NCT00289133|50072313|FG000|Overall Study|Lost to Follow-up|92|||
24983711|NCT00289133|50072314|FG001|Overall Study|Lost to Follow-up|115|||
24983712|NCT00288587|50072326|FG000|Overall Study|Death|4|||
24983713|NCT00288587|50072327|FG001|Overall Study|Death|4|||
24983714|NCT00288587|50072326|FG000|Overall Study|Transplant|0|||
24983715|NCT00288587|50072327|FG001|Overall Study|Transplant|3|||
24983716|NCT00288587|50072326|FG000|Overall Study|Adverse Event|0|||
24983717|NCT00288587|50072327|FG001|Overall Study|Adverse Event|1|||
24983718|NCT00288587|50072326|FG000|Overall Study|Physician Decision|0|||
24983719|NCT00288587|50072327|FG001|Overall Study|Physician Decision|2|||
24983720|NCT00288587|50072326|FG000|Overall Study|Severe Aortic Stenosis|1|||
24983721|NCT00288587|50072327|FG001|Overall Study|Severe Aortic Stenosis|0|||
24983722|NCT00268463|50072335|FG000|Overall Study|study terminated due to low accrual|10|||
24983723|NCT00268463|50072336|FG001|Overall Study|study terminated due to low accrual|12|||
24983724|NCT00288509|50072342|FG000|Treatment Cycle 1|Adverse Event|1|||
24983725|NCT00288509|50072342|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
24983726|NCT00288509|50072342|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
24983727|NCT00288509|50072342|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
24983728|NCT00288509|50072342|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
24983729|NCT00288509|50072342|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
24983730|NCT00288509|50072342|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
24983731|NCT00288509|50072342|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
24983732|NCT00288509|50072342|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
24983733|NCT00288509|50072342|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
24983734|NCT00288509|50072342|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
24983735|NCT00288509|50072342|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
24983736|NCT00288509|50072342|FG000|Treatment Cycle 4|Physician Decision|4|||
24983737|NCT00288509|50072342|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
24983738|NCT00266825|50072348|FG000|Completed Follow-Up|Lost to Follow-up|14|||
24983739|NCT00266825|50072349|FG001|Completed Follow-Up|Lost to Follow-up|19|||
24983740|NCT00266825|50072348|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
24983741|NCT00266825|50072349|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
24983742|NCT00265889|50072357|FG000|Overall Study|Physician Decision|1|||
24983743|NCT00265889|50072357|FG000|Overall Study|Protocol Violation|1|||
24983744|NCT00265889|50072357|FG000|Overall Study|Insurance denied the request|3|||
24983745|NCT02795182|50072365|FG000|Overall Study|Death|5|||
24983746|NCT02795182|50072366|FG001|Overall Study|Death|4|||
24983747|NCT02795182|50072367|FG002|Overall Study|Death|4|||
24983748|NCT02795182|50072368|FG003|Overall Study|Death|18|||
24983749|NCT02795182|50072365|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
24983750|NCT02795182|50072366|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
24983751|NCT02795182|50072367|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
24983752|NCT02795182|50072368|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
24983753|NCT02795182|50072365|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
24983754|NCT02795182|50072366|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
24983755|NCT02795182|50072367|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
25256005|NCT00106964|50571344|FG002|Overall Study|Lost to Follow-up|2|||
25256006|NCT00106964|50571342|FG000|Overall Study|Pregnancy|2|||
25256007|NCT00106964|50571343|FG001|Overall Study|Pregnancy|3|||
25256008|NCT00106964|50571344|FG002|Overall Study|Pregnancy|2|||
25256009|NCT00106964|50571342|FG000|Overall Study|Death|1|||
25256010|NCT00106964|50571343|FG001|Overall Study|Death|1|||
25256011|NCT00106964|50571344|FG002|Overall Study|Death|0|||
25256012|NCT00106964|50571342|FG000|Overall Study|Incarceration|0|||
25256013|NCT00106964|50571343|FG001|Overall Study|Incarceration|1|||
25256014|NCT00106964|50571344|FG002|Overall Study|Incarceration|0|||
25256015|NCT00106964|50571342|FG000|Overall Study|Site Funding Terminated|0|||
25256016|NCT00106964|50571343|FG001|Overall Study|Site Funding Terminated|1|||
25256017|NCT00106964|50571344|FG002|Overall Study|Site Funding Terminated|1|||
25256018|NCT00106964|50571342|FG000|Overall Study|Failure to adhere|2|||
25256019|NCT00106964|50571343|FG001|Overall Study|Failure to adhere|0|||
25256020|NCT00106964|50571344|FG002|Overall Study|Failure to adhere|0|||
25256021|NCT00106964|50571342|FG000|Overall Study|Did not meet eligibility criteria|0|||
25256022|NCT00106964|50571343|FG001|Overall Study|Did not meet eligibility criteria|2|||
25256023|NCT00106964|50571344|FG002|Overall Study|Did not meet eligibility criteria|2|||
25256024|NCT00106964|50571342|FG000|Overall Study|Required disallowed medication|0|||
25256025|NCT00106964|50571343|FG001|Overall Study|Required disallowed medication|1|||
25256026|NCT00106964|50571344|FG002|Overall Study|Required disallowed medication|0|||
25256027|NCT00106184|50571363|FG000|Overall Study|Withdrawal by Subject|3|||
25256028|NCT00106184|50571364|FG001|Overall Study|Withdrawal by Subject|2|||
25256029|NCT01334918|50571374|FG000|Overall Study|Did not receive study drug|6|||
25256030|NCT01334918|50571375|FG001|Overall Study|Did not receive study drug|0|||
25256031|NCT01334918|50571374|FG000|Overall Study|Adverse Event|2|||
25256032|NCT01334918|50571375|FG001|Overall Study|Adverse Event|0|||
25256033|NCT01334918|50571374|FG000|Overall Study|Withdrawal by Subject|0|||
25256034|NCT01334918|50571375|FG001|Overall Study|Withdrawal by Subject|1|||
25256035|NCT01332968|50571394|FG000|Induction Period|Adverse Event|23|||
25256036|NCT01332968|50571395|FG001|Induction Period|Adverse Event|26|||
25256037|NCT01332968|50571396|FG002|Induction Period|Adverse Event|0|||
25256038|NCT01332968|50571397|FG003|Induction Period|Adverse Event|0|||
25256039|NCT01332968|50571398|FG004|Induction Period|Adverse Event|0|||
25256040|NCT01332968|50571399|FG005|Induction Period|Adverse Event|0|||
25256041|NCT01332968|50571400|FG006|Induction Period|Adverse Event|0|||
25256042|NCT01332968|50571401|FG007|Induction Period|Adverse Event|0|||
25256043|NCT01332968|50571394|FG000|Induction Period|Death|1|||
25342041|NCT00789737|50658393|FG001|Overall Study|Other|7|||
25342042|NCT00792467|50658399|FG000|Overall Study|progression of disease|17|||
25342043|NCT00792467|50658399|FG000|Overall Study|Adverse Event|1|||
25342044|NCT00792467|50658399|FG000|Overall Study|patient request|1|||
25342045|NCT00792467|50658399|FG000|Overall Study|Lost to Follow-up|1|||
25342046|NCT00792467|50658399|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
25342047|NCT00792467|50658399|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
25342048|NCT00585468|50658404|FG000|First Intervention|Withdrawal by Subject|1|||
25342049|NCT00585468|50658405|FG001|First Intervention|Withdrawal by Subject|1|||
25342050|NCT00724152|50658418|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
25342051|NCT00724152|50658419|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
25342052|NCT00724152|50658420|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
25342053|NCT00724152|50658418|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
25342054|NCT00724152|50658419|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
25342055|NCT00724152|50658420|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
25342056|NCT00721110|50658434|FG000|Overall Study|Ultram use|1|||
25342057|NCT00721110|50658435|FG001|Overall Study|Ultram use|0|||
25342058|NCT00721110|50658436|FG002|Overall Study|Ultram use|0|||
25342059|NCT00721110|50658437|FG003|Overall Study|Ultram use|0|||
25342060|NCT00721110|50658434|FG000|Overall Study|vertical incision|0|||
25342061|NCT00721110|50658435|FG001|Overall Study|vertical incision|0|||
25342062|NCT00721110|50658436|FG002|Overall Study|vertical incision|1|||
25342063|NCT00721110|50658437|FG003|Overall Study|vertical incision|0|||
25342064|NCT00791999|50658451|FG000|Overall Study|Protocol planed withdrawal|14|||
25342065|NCT00791999|50658452|FG001|Overall Study|Protocol planed withdrawal|11|||
25342066|NCT00791999|50658453|FG002|Overall Study|Protocol planed withdrawal|11|||
25342067|NCT00791999|50658454|FG003|Overall Study|Protocol planed withdrawal|45|||
25342068|NCT00791999|50658451|FG000|Overall Study|Withdrawal by Subject|0|||
25342069|NCT00791999|50658452|FG001|Overall Study|Withdrawal by Subject|1|||
25342070|NCT00791999|50658453|FG002|Overall Study|Withdrawal by Subject|0|||
25256044|NCT01332968|50571395|FG001|Induction Period|Death|4|||
25342071|NCT00791999|50658454|FG003|Overall Study|Withdrawal by Subject|2|||
25342072|NCT00791999|50658451|FG000|Overall Study|Protocol Violation|3|||
25342073|NCT00791999|50658452|FG001|Overall Study|Protocol Violation|0|||
24983756|NCT02795182|50072368|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
25256045|NCT01332968|50571396|FG002|Induction Period|Death|0|||
25342074|NCT00791999|50658453|FG002|Overall Study|Protocol Violation|1|||
25256046|NCT01332968|50571397|FG003|Induction Period|Death|0|||
25256047|NCT01332968|50571398|FG004|Induction Period|Death|0|||
25256048|NCT01332968|50571399|FG005|Induction Period|Death|0|||
25256049|NCT01332968|50571400|FG006|Induction Period|Death|0|||
25256050|NCT01332968|50571401|FG007|Induction Period|Death|0|||
25256051|NCT01332968|50571394|FG000|Induction Period|Non-compliance|1|||
25256052|NCT01332968|50571395|FG001|Induction Period|Non-compliance|0|||
25256053|NCT01332968|50571396|FG002|Induction Period|Non-compliance|0|||
25256054|NCT01332968|50571397|FG003|Induction Period|Non-compliance|0|||
25256055|NCT01332968|50571398|FG004|Induction Period|Non-compliance|0|||
25256056|NCT01332968|50571399|FG005|Induction Period|Non-compliance|0|||
25256057|NCT01332968|50571400|FG006|Induction Period|Non-compliance|0|||
25256058|NCT01332968|50571401|FG007|Induction Period|Non-compliance|0|||
25256059|NCT01332968|50571394|FG000|Induction Period|Other|2|||
25256060|NCT01332968|50571395|FG001|Induction Period|Other|2|||
25256061|NCT01332968|50571396|FG002|Induction Period|Other|0|||
25256062|NCT01332968|50571397|FG003|Induction Period|Other|0|||
25256063|NCT01332968|50571398|FG004|Induction Period|Other|0|||
25256064|NCT01332968|50571399|FG005|Induction Period|Other|0|||
25256065|NCT01332968|50571400|FG006|Induction Period|Other|0|||
25256066|NCT01332968|50571401|FG007|Induction Period|Other|0|||
25256067|NCT01332968|50571394|FG000|Induction Period|Physician Decision|6|||
25256068|NCT01332968|50571395|FG001|Induction Period|Physician Decision|1|||
25256069|NCT01332968|50571396|FG002|Induction Period|Physician Decision|0|||
25256070|NCT01332968|50571397|FG003|Induction Period|Physician Decision|0|||
25256071|NCT01332968|50571398|FG004|Induction Period|Physician Decision|0|||
25256072|NCT01332968|50571399|FG005|Induction Period|Physician Decision|0|||
25256073|NCT01332968|50571400|FG006|Induction Period|Physician Decision|0|||
25256074|NCT01332968|50571401|FG007|Induction Period|Physician Decision|0|||
25256075|NCT01332968|50571394|FG000|Induction Period|Progressive Disease|15|||
25256076|NCT01332968|50571395|FG001|Induction Period|Progressive Disease|7|||
25256077|NCT01332968|50571396|FG002|Induction Period|Progressive Disease|0|||
25256078|NCT01332968|50571397|FG003|Induction Period|Progressive Disease|0|||
25256079|NCT01332968|50571398|FG004|Induction Period|Progressive Disease|0|||
25256080|NCT01332968|50571399|FG005|Induction Period|Progressive Disease|0|||
25256081|NCT01332968|50571400|FG006|Induction Period|Progressive Disease|0|||
25256082|NCT01332968|50571401|FG007|Induction Period|Progressive Disease|0|||
25256083|NCT01332968|50571394|FG000|Induction Period|Protocol Violation|3|||
25256084|NCT01332968|50571395|FG001|Induction Period|Protocol Violation|4|||
25256085|NCT01332968|50571396|FG002|Induction Period|Protocol Violation|0|||
25256086|NCT01332968|50571397|FG003|Induction Period|Protocol Violation|0|||
25256087|NCT01332968|50571398|FG004|Induction Period|Protocol Violation|0|||
25256088|NCT01332968|50571399|FG005|Induction Period|Protocol Violation|0|||
25256089|NCT01332968|50571400|FG006|Induction Period|Protocol Violation|0|||
25256090|NCT01332968|50571401|FG007|Induction Period|Protocol Violation|0|||
25256091|NCT01332968|50571394|FG000|Induction Period|Withdrawal by Subject|3|||
25256092|NCT01332968|50571395|FG001|Induction Period|Withdrawal by Subject|5|||
25256093|NCT01332968|50571396|FG002|Induction Period|Withdrawal by Subject|0|||
25256094|NCT01332968|50571397|FG003|Induction Period|Withdrawal by Subject|0|||
25256095|NCT01332968|50571398|FG004|Induction Period|Withdrawal by Subject|0|||
25256096|NCT01332968|50571399|FG005|Induction Period|Withdrawal by Subject|0|||
25256097|NCT01332968|50571400|FG006|Induction Period|Withdrawal by Subject|0|||
25256098|NCT01332968|50571401|FG007|Induction Period|Withdrawal by Subject|0|||
25256099|NCT01332968|50571394|FG000|Induction Period|Randomised but not treated|4|||
25256100|NCT01332968|50571395|FG001|Induction Period|Randomised but not treated|7|||
25256101|NCT01332968|50571396|FG002|Induction Period|Randomised but not treated|0|||
25256102|NCT01332968|50571397|FG003|Induction Period|Randomised but not treated|0|||
25256103|NCT01332968|50571398|FG004|Induction Period|Randomised but not treated|0|||
25256104|NCT01332968|50571399|FG005|Induction Period|Randomised but not treated|0|||
25256105|NCT01332968|50571400|FG006|Induction Period|Randomised but not treated|0|||
25256106|NCT01332968|50571401|FG007|Induction Period|Randomised but not treated|0|||
25256107|NCT01332968|50571394|FG000|Maintenance/Observation Period|Adverse Event|0|||
25256108|NCT01332968|50571395|FG001|Maintenance/Observation Period|Adverse Event|0|||
25256109|NCT01332968|50571396|FG002|Maintenance/Observation Period|Adverse Event|53|||
25256110|NCT01332968|50571397|FG003|Maintenance/Observation Period|Adverse Event|66|||
25256111|NCT01332968|50571398|FG004|Maintenance/Observation Period|Adverse Event|0|||
25256112|NCT01332968|50571399|FG005|Maintenance/Observation Period|Adverse Event|0|||
25256113|NCT01332968|50571400|FG006|Maintenance/Observation Period|Adverse Event|0|||
25256114|NCT01332968|50571401|FG007|Maintenance/Observation Period|Adverse Event|0|||
25256115|NCT01332968|50571394|FG000|Maintenance/Observation Period|Death|0|||
25256116|NCT01332968|50571395|FG001|Maintenance/Observation Period|Death|0|||
25256117|NCT01332968|50571396|FG002|Maintenance/Observation Period|Death|5|||
25256118|NCT01332968|50571397|FG003|Maintenance/Observation Period|Death|6|||
25256119|NCT01332968|50571398|FG004|Maintenance/Observation Period|Death|0|||
25256120|NCT01332968|50571399|FG005|Maintenance/Observation Period|Death|0|||
25256121|NCT01332968|50571400|FG006|Maintenance/Observation Period|Death|0|||
25256122|NCT01332968|50571401|FG007|Maintenance/Observation Period|Death|0|||
25256123|NCT01332968|50571394|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
25256124|NCT01332968|50571395|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
25256125|NCT01332968|50571396|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
25256126|NCT01332968|50571397|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
25256127|NCT01332968|50571398|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
25256128|NCT01332968|50571399|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
25256129|NCT01332968|50571400|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
25256130|NCT01332968|50571401|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
25256131|NCT01332968|50571394|FG000|Maintenance/Observation Period|Non-compliance|0|||
25256132|NCT01332968|50571395|FG001|Maintenance/Observation Period|Non-compliance|0|||
25256133|NCT01332968|50571396|FG002|Maintenance/Observation Period|Non-compliance|4|||
25256134|NCT01332968|50571397|FG003|Maintenance/Observation Period|Non-compliance|3|||
25256135|NCT01332968|50571398|FG004|Maintenance/Observation Period|Non-compliance|0|||
25256136|NCT01332968|50571399|FG005|Maintenance/Observation Period|Non-compliance|0|||
25256137|NCT01332968|50571400|FG006|Maintenance/Observation Period|Non-compliance|0|||
25256138|NCT01332968|50571401|FG007|Maintenance/Observation Period|Non-compliance|0|||
25256139|NCT01332968|50571394|FG000|Maintenance/Observation Period|Other|0|||
25256140|NCT01332968|50571395|FG001|Maintenance/Observation Period|Other|0|||
25256141|NCT01332968|50571396|FG002|Maintenance/Observation Period|Other|4|||
25256142|NCT01332968|50571397|FG003|Maintenance/Observation Period|Other|7|||
25256143|NCT01332968|50571398|FG004|Maintenance/Observation Period|Other|0|||
25256144|NCT01332968|50571399|FG005|Maintenance/Observation Period|Other|0|||
25256145|NCT01332968|50571400|FG006|Maintenance/Observation Period|Other|0|||
25256146|NCT01332968|50571401|FG007|Maintenance/Observation Period|Other|0|||
25256147|NCT01332968|50571394|FG000|Maintenance/Observation Period|Physician Decision|0|||
25256148|NCT01332968|50571395|FG001|Maintenance/Observation Period|Physician Decision|0|||
25256149|NCT01332968|50571396|FG002|Maintenance/Observation Period|Physician Decision|14|||
25256150|NCT01332968|50571397|FG003|Maintenance/Observation Period|Physician Decision|19|||
25256151|NCT01332968|50571398|FG004|Maintenance/Observation Period|Physician Decision|0|||
25256152|NCT01332968|50571399|FG005|Maintenance/Observation Period|Physician Decision|1|||
25256153|NCT01332968|50571400|FG006|Maintenance/Observation Period|Physician Decision|0|||
25256154|NCT01332968|50571401|FG007|Maintenance/Observation Period|Physician Decision|0|||
25256155|NCT01332968|50571394|FG000|Maintenance/Observation Period|Progressive Disease|0|||
25256156|NCT01332968|50571395|FG001|Maintenance/Observation Period|Progressive Disease|0|||
25256157|NCT01332968|50571396|FG002|Maintenance/Observation Period|Progressive Disease|72|||
25256158|NCT01332968|50571397|FG003|Maintenance/Observation Period|Progressive Disease|40|||
25256159|NCT01332968|50571398|FG004|Maintenance/Observation Period|Progressive Disease|0|||
25256160|NCT01332968|50571399|FG005|Maintenance/Observation Period|Progressive Disease|0|||
25256161|NCT01332968|50571400|FG006|Maintenance/Observation Period|Progressive Disease|0|||
25256162|NCT01332968|50571401|FG007|Maintenance/Observation Period|Progressive Disease|0|||
25256163|NCT01332968|50571394|FG000|Maintenance/Observation Period|Protocol Violation|0|||
25256164|NCT01332968|50571395|FG001|Maintenance/Observation Period|Protocol Violation|0|||
25256165|NCT01332968|50571396|FG002|Maintenance/Observation Period|Protocol Violation|1|||
25256166|NCT01332968|50571397|FG003|Maintenance/Observation Period|Protocol Violation|1|||
25256167|NCT01332968|50571398|FG004|Maintenance/Observation Period|Protocol Violation|0|||
25256168|NCT01332968|50571399|FG005|Maintenance/Observation Period|Protocol Violation|0|||
25256169|NCT01332968|50571400|FG006|Maintenance/Observation Period|Protocol Violation|0|||
25256170|NCT01332968|50571401|FG007|Maintenance/Observation Period|Protocol Violation|0|||
25256171|NCT01332968|50571394|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
25256172|NCT01332968|50571395|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
25256173|NCT01332968|50571396|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
25256174|NCT01332968|50571397|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
25256175|NCT01332968|50571398|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
25256176|NCT01332968|50571399|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
25256177|NCT01332968|50571400|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
25256178|NCT01332968|50571401|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
25256179|NCT01332968|50571394|FG000|Follow-Up Period|Adverse Event|0|||
25256180|NCT01332968|50571395|FG001|Follow-Up Period|Adverse Event|0|||
25256181|NCT01332968|50571396|FG002|Follow-Up Period|Adverse Event|0|||
25256182|NCT01332968|50571397|FG003|Follow-Up Period|Adverse Event|0|||
25256183|NCT01332968|50571398|FG004|Follow-Up Period|Adverse Event|0|||
25256184|NCT01332968|50571399|FG005|Follow-Up Period|Adverse Event|0|||
25256185|NCT01332968|50571400|FG006|Follow-Up Period|Adverse Event|0|||
25256186|NCT01332968|50571401|FG007|Follow-Up Period|Adverse Event|4|||
25256187|NCT01332968|50571394|FG000|Follow-Up Period|Death|0|||
25256188|NCT01332968|50571395|FG001|Follow-Up Period|Death|0|||
25256189|NCT01332968|50571396|FG002|Follow-Up Period|Death|0|||
24995120|NCT00047463|50085996|FG001|Overall Study|Withdrawal by Subject|3|||
25256190|NCT01332968|50571397|FG003|Follow-Up Period|Death|0|||
25256191|NCT01332968|50571398|FG004|Follow-Up Period|Death|0|||
25256192|NCT01332968|50571399|FG005|Follow-Up Period|Death|0|||
25256193|NCT01332968|50571400|FG006|Follow-Up Period|Death|27|||
25256194|NCT01332968|50571401|FG007|Follow-Up Period|Death|30|||
25256195|NCT01332968|50571394|FG000|Follow-Up Period|Lost to Follow-up|0|||
25256196|NCT01332968|50571395|FG001|Follow-Up Period|Lost to Follow-up|0|||
25256197|NCT01332968|50571396|FG002|Follow-Up Period|Lost to Follow-up|0|||
25256198|NCT01332968|50571397|FG003|Follow-Up Period|Lost to Follow-up|0|||
25256199|NCT01332968|50571398|FG004|Follow-Up Period|Lost to Follow-up|0|||
25256200|NCT01332968|50571399|FG005|Follow-Up Period|Lost to Follow-up|0|||
25256201|NCT01332968|50571400|FG006|Follow-Up Period|Lost to Follow-up|11|||
25256202|NCT01332968|50571401|FG007|Follow-Up Period|Lost to Follow-up|15|||
25256203|NCT01332968|50571394|FG000|Follow-Up Period|Non-compliance|0|||
25256204|NCT01332968|50571395|FG001|Follow-Up Period|Non-compliance|0|||
25256205|NCT01332968|50571396|FG002|Follow-Up Period|Non-compliance|0|||
25256206|NCT01332968|50571397|FG003|Follow-Up Period|Non-compliance|0|||
25256207|NCT01332968|50571398|FG004|Follow-Up Period|Non-compliance|0|||
25256208|NCT01332968|50571399|FG005|Follow-Up Period|Non-compliance|0|||
25256209|NCT01332968|50571400|FG006|Follow-Up Period|Non-compliance|4|||
25256210|NCT01332968|50571401|FG007|Follow-Up Period|Non-compliance|9|||
24983757|NCT02795182|50072365|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
24983758|NCT02795182|50072366|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
24983759|NCT02795182|50072367|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
24983760|NCT02795182|50072368|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
24983761|NCT02795182|50072365|FG000|Overall Study|Withdrawal by Subject|4|||
24983762|NCT02795182|50072366|FG001|Overall Study|Withdrawal by Subject|0|||
24983763|NCT02795182|50072367|FG002|Overall Study|Withdrawal by Subject|0|||
24983764|NCT02795182|50072368|FG003|Overall Study|Withdrawal by Subject|3|||
24983765|NCT02795182|50072365|FG000|Overall Study|Lost to Follow-up|0|||
24983766|NCT02795182|50072366|FG001|Overall Study|Lost to Follow-up|0|||
24983767|NCT02795182|50072367|FG002|Overall Study|Lost to Follow-up|1|||
24983768|NCT02795182|50072368|FG003|Overall Study|Lost to Follow-up|1|||
24983769|NCT02795182|50072365|FG000|Overall Study|Roll Over to Long Term Extension|3|||
24983770|NCT02795182|50072366|FG001|Overall Study|Roll Over to Long Term Extension|3|||
24983771|NCT02795182|50072367|FG002|Overall Study|Roll Over to Long Term Extension|2|||
24983772|NCT02795182|50072368|FG003|Overall Study|Roll Over to Long Term Extension|5|||
24983773|NCT02795182|50072365|FG000|Overall Study|Progressive Disease|0|||
24983774|NCT02795182|50072366|FG001|Overall Study|Progressive Disease|1|||
24983775|NCT02795182|50072367|FG002|Overall Study|Progressive Disease|0|||
24983776|NCT02795182|50072368|FG003|Overall Study|Progressive Disease|4|||
24983777|NCT02795182|50072365|FG000|Overall Study|Physician Decision|0|||
24983778|NCT02795182|50072366|FG001|Overall Study|Physician Decision|0|||
24983779|NCT02795182|50072367|FG002|Overall Study|Physician Decision|0|||
24983780|NCT02795182|50072368|FG003|Overall Study|Physician Decision|1|||
24983781|NCT03209362|50072387|FG000|Overall Study|Adverse Event|0|||
24983782|NCT03209362|50072388|FG001|Overall Study|Adverse Event|1|||
24983783|NCT03209362|50072387|FG000|Overall Study|Lost to Follow-up|0|||
24983784|NCT03209362|50072388|FG001|Overall Study|Lost to Follow-up|1|||
24983785|NCT03209362|50072387|FG000|Overall Study|Withdrawal by Subject|2|||
24983786|NCT03209362|50072388|FG001|Overall Study|Withdrawal by Subject|0|||
24983787|NCT03209362|50072387|FG000|Overall Study|Other|0|||
24983788|NCT03209362|50072388|FG001|Overall Study|Other|1|||
24983789|NCT02932462|50072396|FG000|Overall Study|Adverse Event|1|||
24983790|NCT02932462|50072397|FG001|Overall Study|Adverse Event|2|||
24983791|NCT02932462|50072396|FG000|Overall Study|Lost to Follow-up|4|||
24983792|NCT02932462|50072397|FG001|Overall Study|Lost to Follow-up|1|||
24983793|NCT02932462|50072396|FG000|Overall Study|Protocol Violation|0|||
24983794|NCT02932462|50072397|FG001|Overall Study|Protocol Violation|5|||
24983795|NCT02932462|50072396|FG000|Overall Study|Withdrawal by Subject|1|||
24983796|NCT02932462|50072397|FG001|Overall Study|Withdrawal by Subject|4|||
25256211|NCT01332968|50571394|FG000|Follow-Up Period|Other|0|||
25256212|NCT01332968|50571395|FG001|Follow-Up Period|Other|0|||
25256213|NCT01332968|50571396|FG002|Follow-Up Period|Other|0|||
25256214|NCT01332968|50571397|FG003|Follow-Up Period|Other|0|||
25256215|NCT01332968|50571398|FG004|Follow-Up Period|Other|0|||
25256216|NCT01332968|50571399|FG005|Follow-Up Period|Other|0|||
25256217|NCT01332968|50571400|FG006|Follow-Up Period|Other|18|||
25256218|NCT01332968|50571401|FG007|Follow-Up Period|Other|21|||
25256219|NCT01332968|50571394|FG000|Follow-Up Period|Physician Decision|0|||
25256220|NCT01332968|50571395|FG001|Follow-Up Period|Physician Decision|0|||
25256221|NCT01332968|50571396|FG002|Follow-Up Period|Physician Decision|0|||
25256222|NCT01332968|50571397|FG003|Follow-Up Period|Physician Decision|0|||
25256223|NCT01332968|50571398|FG004|Follow-Up Period|Physician Decision|0|||
25256224|NCT01332968|50571399|FG005|Follow-Up Period|Physician Decision|0|||
25256225|NCT01332968|50571400|FG006|Follow-Up Period|Physician Decision|12|||
25256226|NCT01332968|50571401|FG007|Follow-Up Period|Physician Decision|15|||
25256227|NCT01332968|50571394|FG000|Follow-Up Period|Progressive Disease|0|||
24983797|NCT02932462|50072396|FG000|Overall Study|Non-Compliance With Study Drug|0|||
24983798|NCT02932462|50072397|FG001|Overall Study|Non-Compliance With Study Drug|1|||
24983799|NCT02932462|50072396|FG000|Overall Study|Progressive Disease|1|||
24983800|NCT02932462|50072397|FG001|Overall Study|Progressive Disease|0|||
25256228|NCT01332968|50571395|FG001|Follow-Up Period|Progressive Disease|0|||
25256229|NCT01332968|50571396|FG002|Follow-Up Period|Progressive Disease|0|||
25256230|NCT01332968|50571397|FG003|Follow-Up Period|Progressive Disease|0|||
25256231|NCT01332968|50571398|FG004|Follow-Up Period|Progressive Disease|0|||
25256232|NCT01332968|50571399|FG005|Follow-Up Period|Progressive Disease|0|||
25256233|NCT01332968|50571400|FG006|Follow-Up Period|Progressive Disease|126|||
25256234|NCT01332968|50571401|FG007|Follow-Up Period|Progressive Disease|106|||
25256235|NCT01332968|50571394|FG000|Follow-Up Period|Protocol Violation|0|||
25256236|NCT01332968|50571395|FG001|Follow-Up Period|Protocol Violation|0|||
25256237|NCT01332968|50571396|FG002|Follow-Up Period|Protocol Violation|0|||
25256238|NCT01332968|50571397|FG003|Follow-Up Period|Protocol Violation|0|||
25256239|NCT01332968|50571398|FG004|Follow-Up Period|Protocol Violation|0|||
25256240|NCT01332968|50571399|FG005|Follow-Up Period|Protocol Violation|0|||
25256241|NCT01332968|50571400|FG006|Follow-Up Period|Protocol Violation|1|||
25256242|NCT01332968|50571401|FG007|Follow-Up Period|Protocol Violation|0|||
25256243|NCT01332968|50571394|FG000|Follow-Up Period|Withdrawal by Subject|0|||
25256244|NCT01332968|50571395|FG001|Follow-Up Period|Withdrawal by Subject|0|||
25256245|NCT01332968|50571396|FG002|Follow-Up Period|Withdrawal by Subject|0|||
25256246|NCT01332968|50571397|FG003|Follow-Up Period|Withdrawal by Subject|0|||
25256247|NCT01332968|50571398|FG004|Follow-Up Period|Withdrawal by Subject|0|||
25256248|NCT01332968|50571399|FG005|Follow-Up Period|Withdrawal by Subject|0|||
25256249|NCT01332968|50571400|FG006|Follow-Up Period|Withdrawal by Subject|29|||
25256250|NCT01332968|50571401|FG007|Follow-Up Period|Withdrawal by Subject|32|||
25256251|NCT01332968|50571394|FG000|Follow-Up Period|No reason provided|0|||
25256252|NCT01332968|50571395|FG001|Follow-Up Period|No reason provided|0|||
25256253|NCT01332968|50571396|FG002|Follow-Up Period|No reason provided|0|||
25256254|NCT01332968|50571397|FG003|Follow-Up Period|No reason provided|0|||
25256255|NCT01332968|50571398|FG004|Follow-Up Period|No reason provided|0|||
25256256|NCT01332968|50571399|FG005|Follow-Up Period|No reason provided|0|||
25256257|NCT01332968|50571400|FG006|Follow-Up Period|No reason provided|2|||
25256258|NCT01332968|50571401|FG007|Follow-Up Period|No reason provided|3|||
25256259|NCT01332851|50571411|FG000|Overall Study|Withdrawal by Subject|4|||
25256260|NCT01332851|50571412|FG001|Overall Study|Withdrawal by Subject|2|||
25256261|NCT01332851|50571411|FG000|Overall Study|Lost to Follow-up|7|||
25256262|NCT01332851|50571412|FG001|Overall Study|Lost to Follow-up|11|||
25256263|NCT01332305|50571427|FG000|Overall Study|Adverse Event|1|||
25256264|NCT01332305|50571428|FG001|Overall Study|Adverse Event|4|||
25256265|NCT01332305|50571429|FG002|Overall Study|Adverse Event|6|||
25256266|NCT01332305|50571430|FG003|Overall Study|Adverse Event|3|||
25256267|NCT01332305|50571431|FG004|Overall Study|Adverse Event|5|||
25256268|NCT01332305|50571427|FG000|Overall Study|Withdrawal by Subject|6|||
25256269|NCT01332305|50571428|FG001|Overall Study|Withdrawal by Subject|5|||
25256270|NCT01332305|50571429|FG002|Overall Study|Withdrawal by Subject|4|||
25256271|NCT01332305|50571430|FG003|Overall Study|Withdrawal by Subject|1|||
25256272|NCT01332305|50571431|FG004|Overall Study|Withdrawal by Subject|0|||
25256273|NCT01332305|50571427|FG000|Overall Study|Lost to Follow-up|0|||
25256274|NCT01332305|50571428|FG001|Overall Study|Lost to Follow-up|2|||
25256275|NCT01332305|50571429|FG002|Overall Study|Lost to Follow-up|3|||
25256276|NCT01332305|50571430|FG003|Overall Study|Lost to Follow-up|2|||
25256277|NCT01332305|50571431|FG004|Overall Study|Lost to Follow-up|3|||
25256278|NCT01332305|50571427|FG000|Overall Study|Protocol Violation|1|||
25256279|NCT01332305|50571428|FG001|Overall Study|Protocol Violation|2|||
25256280|NCT01332305|50571429|FG002|Overall Study|Protocol Violation|1|||
25256281|NCT01332305|50571430|FG003|Overall Study|Protocol Violation|0|||
25256282|NCT01332305|50571431|FG004|Overall Study|Protocol Violation|3|||
25256283|NCT01332305|50571427|FG000|Overall Study|Withdrawal by Sponsor|1|||
25256284|NCT01332305|50571428|FG001|Overall Study|Withdrawal by Sponsor|0|||
25256285|NCT01332305|50571429|FG002|Overall Study|Withdrawal by Sponsor|0|||
25256286|NCT01332305|50571430|FG003|Overall Study|Withdrawal by Sponsor|1|||
25256287|NCT01332305|50571431|FG004|Overall Study|Withdrawal by Sponsor|1|||
25256288|NCT01332305|50571427|FG000|Overall Study|Treatment Failure|1|||
25256289|NCT01332305|50571428|FG001|Overall Study|Treatment Failure|1|||
25256290|NCT01332305|50571429|FG002|Overall Study|Treatment Failure|0|||
25256291|NCT01332305|50571430|FG003|Overall Study|Treatment Failure|0|||
25256292|NCT01332305|50571431|FG004|Overall Study|Treatment Failure|0|||
24983801|NCT03206788|50072405|FG000|Overall Study|Withdrawal by Subject|0|||
25256293|NCT01332305|50571427|FG000|Overall Study|Physician Decision|0|||
25256294|NCT01332305|50571428|FG001|Overall Study|Physician Decision|0|||
25256295|NCT01332305|50571429|FG002|Overall Study|Physician Decision|0|||
25256296|NCT01332305|50571430|FG003|Overall Study|Physician Decision|1|||
25256297|NCT01332305|50571431|FG004|Overall Study|Physician Decision|0|||
25256298|NCT01332227|50571445|FG000|Overall Study|Adverse Event|4|||
25256299|NCT01332227|50571446|FG001|Overall Study|Adverse Event|1|||
25256300|NCT01332227|50571445|FG000|Overall Study|Withdrawal by Subject|5|||
25256301|NCT01332227|50571446|FG001|Overall Study|Withdrawal by Subject|1|||
25256302|NCT01332227|50571445|FG000|Overall Study|Lost to Follow-up|2|||
25256303|NCT01332227|50571446|FG001|Overall Study|Lost to Follow-up|0|||
25256304|NCT01332227|50571445|FG000|Overall Study|Lack of Efficacy|3|||
25256305|NCT01332227|50571446|FG001|Overall Study|Lack of Efficacy|1|||
25256306|NCT01332227|50571445|FG000|Overall Study|Poor compliance/noncompliance|1|||
25256307|NCT01332227|50571446|FG001|Overall Study|Poor compliance/noncompliance|1|||
25256308|NCT01332227|50571445|FG000|Overall Study|Patient moved from area|1|||
25256309|NCT01332227|50571446|FG001|Overall Study|Patient moved from area|0|||
25256310|NCT01332227|50571445|FG000|Overall Study|Patient began prohibited medication|0|||
25256311|NCT01332227|50571446|FG001|Overall Study|Patient began prohibited medication|1|||
25256312|NCT01332149|50571454|FG000|Overall Study|Adverse Event|11|||
25256313|NCT01332149|50571455|FG001|Overall Study|Adverse Event|9|||
25256314|NCT01332149|50571454|FG000|Overall Study|Other unspecified|5|||
25256315|NCT01332149|50571455|FG001|Overall Study|Other unspecified|7|||
25256316|NCT01332149|50571454|FG000|Overall Study|Protocol Violation|1|||
25256317|NCT01332149|50571455|FG001|Overall Study|Protocol Violation|3|||
25256318|NCT01332149|50571454|FG000|Overall Study|Withdrawal by Subject|4|||
25256319|NCT01332149|50571455|FG001|Overall Study|Withdrawal by Subject|5|||
25256320|NCT01332149|50571454|FG000|Overall Study|Lost to Follow-up|1|||
25256321|NCT01332149|50571455|FG001|Overall Study|Lost to Follow-up|1|||
25256322|NCT01332149|50571454|FG000|Overall Study|Insufficient clinical response|4|||
25256323|NCT01332149|50571455|FG001|Overall Study|Insufficient clinical response|7|||
25256324|NCT01332149|50571454|FG000|Overall Study|Did not meet entrance criteria|3|||
25256325|NCT01332149|50571455|FG001|Overall Study|Did not meet entrance criteria|4|||
25256326|NCT01332149|50571454|FG000|Overall Study|Randomized but not treated|1|||
25256327|NCT01332149|50571455|FG001|Overall Study|Randomized but not treated|2|||
25256328|NCT01330628|50571463|FG000|Overall Study|Death|2|||
25256329|NCT01330628|50571464|FG001|Overall Study|Death|3|||
25256330|NCT01330628|50571463|FG000|Overall Study|Lost to Follow-up|5|||
25256331|NCT01330628|50571464|FG001|Overall Study|Lost to Follow-up|6|||
25256332|NCT01330628|50571463|FG000|Overall Study|Adverse Event|44|||
25256333|NCT01330628|50571464|FG001|Overall Study|Adverse Event|25|||
25256334|NCT01330628|50571463|FG000|Overall Study|Withdrawn|18|||
25256335|NCT01330628|50571464|FG001|Overall Study|Withdrawn|6|||
25256336|NCT01330628|50571463|FG000|Overall Study|Didn't receive study treatment|1|||
25256337|NCT01330628|50571464|FG001|Overall Study|Didn't receive study treatment|0|||
25256338|NCT01330433|50571472|FG000|Overall Study|Death|1|||
25256339|NCT01330433|50571473|FG001|Overall Study|Death|3|||
25256340|NCT01330433|50571472|FG000|Overall Study|Lost to Follow-up|1|||
25256341|NCT01330433|50571473|FG001|Overall Study|Lost to Follow-up|0|||
25256342|NCT01330316|50571481|FG000|Overall Study|Adverse Event|2|||
25256343|NCT01330316|50571482|FG001|Overall Study|Adverse Event|2|||
25256344|NCT01330316|50571481|FG000|Overall Study|Lack of Efficacy|0|||
25256345|NCT01330316|50571482|FG001|Overall Study|Lack of Efficacy|10|||
25256346|NCT01330316|50571481|FG000|Overall Study|Lost to Follow-up|0|||
25256347|NCT01330316|50571482|FG001|Overall Study|Lost to Follow-up|1|||
25256348|NCT01330316|50571481|FG000|Overall Study|Withdrawal by Subject|0|||
25256349|NCT01330316|50571482|FG001|Overall Study|Withdrawal by Subject|1|||
25256350|NCT01330316|50571481|FG000|Overall Study|other than above|0|||
25256351|NCT01330316|50571482|FG001|Overall Study|other than above|1|||
25256352|NCT01326702|50571495|FG000|Overall Study|Other|1|||
25256353|NCT01326702|50571496|FG001|Overall Study|Other|0|||
25256354|NCT01326702|50571497|FG002|Overall Study|Other|0|||
25256355|NCT01326702|50571498|FG003|Overall Study|Other|0|||
25256356|NCT01326702|50571499|FG004|Overall Study|Other|0|||
25256357|NCT01326702|50571500|FG005|Overall Study|Other|1|||
25256358|NCT01326702|50571501|FG006|Overall Study|Other|0|||
25256359|NCT01326702|50571495|FG000|Overall Study|progressive disease|1|||
25256360|NCT01326702|50571496|FG001|Overall Study|progressive disease|1|||
25342075|NCT00791999|50658454|FG003|Overall Study|Protocol Violation|0|||
25342076|NCT00791999|50658451|FG000|Overall Study|Adverse Event|3|||
25342077|NCT00791999|50658452|FG001|Overall Study|Adverse Event|3|||
25342078|NCT00791999|50658453|FG002|Overall Study|Adverse Event|7|||
25342079|NCT00791999|50658454|FG003|Overall Study|Adverse Event|3|||
25342080|NCT00791999|50658451|FG000|Overall Study|Lack of Efficacy|0|||
25342081|NCT00791999|50658452|FG001|Overall Study|Lack of Efficacy|1|||
25342082|NCT00791999|50658453|FG002|Overall Study|Lack of Efficacy|0|||
25342083|NCT00791999|50658454|FG003|Overall Study|Lack of Efficacy|2|||
25342084|NCT00791999|50658451|FG000|Overall Study|Reason other than those above|1|||
25342085|NCT00791999|50658452|FG001|Overall Study|Reason other than those above|0|||
25342086|NCT00791999|50658453|FG002|Overall Study|Reason other than those above|1|||
25256361|NCT01326702|50571497|FG002|Overall Study|progressive disease|3|||
25342087|NCT00791999|50658454|FG003|Overall Study|Reason other than those above|0|||
25342088|NCT00585078|50658468|FG000|Overall Study|Withdrawal by Subject|4|||
25342089|NCT00585078|50658468|FG000|Overall Study|Poor performance status|1|||
25256362|NCT01326702|50571498|FG003|Overall Study|progressive disease|1|||
25256363|NCT01326702|50571499|FG004|Overall Study|progressive disease|3|||
25256364|NCT01326702|50571500|FG005|Overall Study|progressive disease|2|||
25256365|NCT01326702|50571501|FG006|Overall Study|progressive disease|3|||
25256366|NCT01326702|50571495|FG000|Overall Study|Death|0|||
25256367|NCT01326702|50571496|FG001|Overall Study|Death|1|||
25256368|NCT01326702|50571497|FG002|Overall Study|Death|0|||
25256369|NCT01326702|50571498|FG003|Overall Study|Death|0|||
25256370|NCT01326702|50571499|FG004|Overall Study|Death|0|||
25256371|NCT01326702|50571500|FG005|Overall Study|Death|0|||
25256372|NCT01326702|50571501|FG006|Overall Study|Death|0|||
25256373|NCT01326702|50571495|FG000|Overall Study|Adverse Event|0|||
25256374|NCT01326702|50571496|FG001|Overall Study|Adverse Event|0|||
25256375|NCT01326702|50571497|FG002|Overall Study|Adverse Event|1|||
25256376|NCT01326702|50571498|FG003|Overall Study|Adverse Event|1|||
25256377|NCT01326702|50571499|FG004|Overall Study|Adverse Event|0|||
25256378|NCT01326702|50571500|FG005|Overall Study|Adverse Event|3|||
25256379|NCT01326702|50571501|FG006|Overall Study|Adverse Event|1|||
25256380|NCT01326702|50571495|FG000|Overall Study|Withdrawal by Subject|0|||
25256381|NCT01326702|50571496|FG001|Overall Study|Withdrawal by Subject|0|||
24983802|NCT03206788|50072406|FG001|Overall Study|Withdrawal by Subject|1|||
24983803|NCT03206788|50072405|FG000|Overall Study|Adverse Event|0|||
24983804|NCT03206788|50072406|FG001|Overall Study|Adverse Event|1|||
25256382|NCT01326702|50571497|FG002|Overall Study|Withdrawal by Subject|1|||
25256383|NCT01326702|50571498|FG003|Overall Study|Withdrawal by Subject|0|||
25256384|NCT01326702|50571499|FG004|Overall Study|Withdrawal by Subject|1|||
25256385|NCT01326702|50571500|FG005|Overall Study|Withdrawal by Subject|1|||
25256386|NCT01326702|50571501|FG006|Overall Study|Withdrawal by Subject|3|||
25256387|NCT01326702|50571495|FG000|Overall Study|Not Treated|0|||
25256388|NCT01326702|50571496|FG001|Overall Study|Not Treated|0|||
25256389|NCT01326702|50571497|FG002|Overall Study|Not Treated|0|||
25256390|NCT01326702|50571498|FG003|Overall Study|Not Treated|1|||
25256391|NCT01326702|50571499|FG004|Overall Study|Not Treated|0|||
25256392|NCT01326702|50571500|FG005|Overall Study|Not Treated|1|||
25256393|NCT01326702|50571501|FG006|Overall Study|Not Treated|0|||
25256394|NCT01327703|50571520|FG000|Second Treatment Period|Adverse Event|1|||
25256395|NCT01327703|50571521|FG001|Second Treatment Period|Adverse Event|1|||
25256396|NCT01327703|50571520|FG000|Second Treatment Period|Protocol Violation|0|||
25256397|NCT01327703|50571521|FG001|Second Treatment Period|Protocol Violation|1|||
25256398|NCT01380080|50571532|FG000|Overall Study|Death|36|||
25256399|NCT01380080|50571533|FG001|Overall Study|Death|44|||
25256400|NCT01380080|50571532|FG000|Overall Study|Site is closing|28|||
25256401|NCT01380080|50571533|FG001|Overall Study|Site is closing|31|||
25256402|NCT01380080|50571532|FG000|Overall Study|Not able to get to clinic|7|||
25256403|NCT01380080|50571533|FG001|Overall Study|Not able to get to clinic|1|||
25256404|NCT01380080|50571532|FG000|Overall Study|Not willing to adhere to requirements|6|||
25256405|NCT01380080|50571533|FG001|Overall Study|Not willing to adhere to requirements|2|||
25256406|NCT01380080|50571532|FG000|Overall Study|Withdrawal by Subject|5|||
25256407|NCT01380080|50571533|FG001|Overall Study|Withdrawal by Subject|2|||
25256408|NCT01380080|50571532|FG000|Overall Study|Lost to Follow-up|3|||
25256409|NCT01380080|50571533|FG001|Overall Study|Lost to Follow-up|3|||
25256410|NCT01379768|50571542|FG000|Overall Study|Adverse Event|1|||
25256411|NCT01379768|50571543|FG001|Overall Study|Adverse Event|1|||
25256412|NCT01379768|50571544|FG002|Overall Study|Adverse Event|0|||
25256413|NCT01379768|50571542|FG000|Overall Study|Lost to Follow-up|2|||
25256414|NCT01379768|50571543|FG001|Overall Study|Lost to Follow-up|0|||
25256415|NCT01379768|50571544|FG002|Overall Study|Lost to Follow-up|0|||
25256416|NCT01379573|50571552|FG000|Overall Study|Lost to Follow-up|1|||
25256417|NCT01379573|50571552|FG000|Overall Study|Screen Failure|10|||
25256418|NCT01379534|50571558|FG000|Treatment Phase|Withdrawal by Subject|2|||
25256419|NCT01379534|50571559|FG001|Treatment Phase|Withdrawal by Subject|2|||
25256420|NCT01379534|50571558|FG000|Treatment Phase|Progressive disease|13|||
25256421|NCT01379534|50571559|FG001|Treatment Phase|Progressive disease|22|||
25256422|NCT01379534|50571558|FG000|Treatment Phase|Adverse Event|7|||
25256423|NCT01379534|50571559|FG001|Treatment Phase|Adverse Event|7|||
25256424|NCT01379534|50571558|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
25256425|NCT01379534|50571559|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
25256426|NCT01379534|50571558|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
25256427|NCT01379534|50571559|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
25256428|NCT01379534|50571558|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
25256429|NCT01379534|50571559|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
25256430|NCT01379534|50571558|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
25256431|NCT01379534|50571559|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
25256432|NCT01371851|50571567|FG000|Overall Study|Lost to Follow-up|5|||
25256433|NCT01371851|50571568|FG001|Overall Study|Lost to Follow-up|8|||
25256434|NCT01371851|50571567|FG000|Overall Study|was arrested and put in jail|0|||
25256435|NCT01371851|50571568|FG001|Overall Study|was arrested and put in jail|1|||
24983805|NCT03206788|50072405|FG000|Overall Study|Physician Decision|0|||
24983806|NCT03206788|50072406|FG001|Overall Study|Physician Decision|1|||
25256436|NCT01371851|50571567|FG000|Overall Study|non study related adverse event|1|||
25256437|NCT01371851|50571568|FG001|Overall Study|non study related adverse event|0|||
25256438|NCT01371851|50571567|FG000|Overall Study|Blood Pressure outside study parameters|2|||
25342090|NCT00585078|50658468|FG000|Overall Study|Disease Progression|24|||
25256439|NCT01371851|50571568|FG001|Overall Study|Blood Pressure outside study parameters|0|||
25256440|NCT01371734|50571577|FG000|Overall Study|Other|2|||
25256441|NCT01371734|50571578|FG001|Overall Study|Other|1|||
25256442|NCT01371734|50571579|FG002|Overall Study|Other|2|||
25256443|NCT01371734|50571577|FG000|Overall Study|Withdrawal by Subject|3|||
25256444|NCT01371734|50571578|FG001|Overall Study|Withdrawal by Subject|4|||
25256445|NCT01371734|50571579|FG002|Overall Study|Withdrawal by Subject|9|||
25256446|NCT01371734|50571577|FG000|Overall Study|Lost to Follow-up|5|||
25256447|NCT01371734|50571578|FG001|Overall Study|Lost to Follow-up|3|||
25256448|NCT01371734|50571579|FG002|Overall Study|Lost to Follow-up|1|||
25256449|NCT01371734|50571577|FG000|Overall Study|Protocol Violation|3|||
25256450|NCT01371734|50571578|FG001|Overall Study|Protocol Violation|1|||
25256451|NCT01371734|50571579|FG002|Overall Study|Protocol Violation|2|||
25256452|NCT01371734|50571577|FG000|Overall Study|Adverse Event|8|||
25256453|NCT01371734|50571578|FG001|Overall Study|Adverse Event|8|||
25256454|NCT01371734|50571579|FG002|Overall Study|Adverse Event|3|||
25256455|NCT01371734|50571577|FG000|Overall Study|Lack of Efficacy|2|||
25256456|NCT01371734|50571578|FG001|Overall Study|Lack of Efficacy|2|||
25256457|NCT01371734|50571579|FG002|Overall Study|Lack of Efficacy|0|||
25256458|NCT01365494|50571589|FG000|Overall Study|Adverse Event|1|||
25256459|NCT01365494|50571590|FG001|Overall Study|Adverse Event|0|||
25256460|NCT01365494|50571589|FG000|Overall Study|Withdrawal by Subject|0|||
25256461|NCT01365494|50571590|FG001|Overall Study|Withdrawal by Subject|1|||
25256462|NCT01365494|50571589|FG000|Overall Study|Lost to Follow-up|1|||
25256463|NCT01365494|50571590|FG001|Overall Study|Lost to Follow-up|2|||
25256464|NCT01357889|50571599|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
25256465|NCT01357889|50571600|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
25256466|NCT01357889|50571599|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
25256467|NCT01357889|50571600|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
25256468|NCT01357889|50571599|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
25256469|NCT01357889|50571600|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
25256470|NCT01357889|50571599|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
25256471|NCT01357889|50571600|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
25256472|NCT01357889|50571599|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
25256473|NCT01357889|50571600|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
25256474|NCT01357889|50571599|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
25256475|NCT01357889|50571600|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
25256476|NCT01357889|50571599|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
25256477|NCT01357889|50571600|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
25256478|NCT01357889|50571599|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
25256479|NCT01357889|50571600|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
25256480|NCT01357889|50571599|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
25256481|NCT01357889|50571600|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
25256482|NCT01357889|50571599|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
25256483|NCT01357889|50571600|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
25256484|NCT01357889|50571599|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
25256485|NCT01357889|50571600|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
25256486|NCT01357889|50571599|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
25256487|NCT01357889|50571600|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
25256488|NCT01357889|50571599|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
25256489|NCT01357889|50571600|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
25256490|NCT01357850|50571612|FG000|Overall Study|Lost to Follow-up|1|||
25256491|NCT01357850|50571613|FG001|Overall Study|Lost to Follow-up|0|||
25256492|NCT01357850|50571614|FG002|Overall Study|Lost to Follow-up|0|||
25256493|NCT01357850|50571615|FG003|Overall Study|Lost to Follow-up|0|||
25256494|NCT01357655|50571628|FG000|Overall Study|Administrative Reason by Sponsor|45|||
25256495|NCT01357655|50571629|FG001|Overall Study|Administrative Reason by Sponsor|0|||
25256496|NCT01357655|50571628|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
25256497|NCT01357655|50571629|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
25256498|NCT01357655|50571628|FG000|Overall Study|Disease Progression|1|||
25256499|NCT01357655|50571629|FG001|Overall Study|Disease Progression|0|||
25256500|NCT01357655|50571628|FG000|Overall Study|Lost to Follow-up|2|||
25256501|NCT01357655|50571629|FG001|Overall Study|Lost to Follow-up|0|||
25256502|NCT01357655|50571628|FG000|Overall Study|Maximum Clinical Benefit|2|||
25256503|NCT01357655|50571629|FG001|Overall Study|Maximum Clinical Benefit|0|||
25256504|NCT01357655|50571628|FG000|Overall Study|Reason Unspecified|1|||
25256505|NCT01357655|50571629|FG001|Overall Study|Reason Unspecified|0|||
25256506|NCT01357655|50571628|FG000|Overall Study|Study Drug Toxicity|11|||
25256507|NCT01357655|50571629|FG001|Overall Study|Study Drug Toxicity|0|||
25256508|NCT01357655|50571628|FG000|Overall Study|Subject Withdrew Consent|1|||
25256509|NCT01357655|50571629|FG001|Overall Study|Subject Withdrew Consent|0|||
25256510|NCT01357616|50571636|FG000|Overall Study|Adverse Event|1|||
25256511|NCT01357616|50571637|FG001|Overall Study|Adverse Event|1|||
25256512|NCT01357616|50571636|FG000|Overall Study|Lost to Follow-up|4|||
25256513|NCT01357616|50571637|FG001|Overall Study|Lost to Follow-up|3|||
25256514|NCT01357616|50571636|FG000|Overall Study|Protocol Violation|0|||
25256515|NCT01357616|50571637|FG001|Overall Study|Protocol Violation|2|||
25256516|NCT01357616|50571636|FG000|Overall Study|Inadequate Control of IOP|1|||
25256517|NCT01357616|50571637|FG001|Overall Study|Inadequate Control of IOP|2|||
25256518|NCT01357616|50571636|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
25256519|NCT01357616|50571637|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
25256520|NCT01357616|50571636|FG000|Overall Study|Withdrawal by Subject|1|||
25256521|NCT01357616|50571637|FG001|Overall Study|Withdrawal by Subject|0|||
25256522|NCT01357577|50571645|FG000|Overall Study|Lost to Follow-up|20|||
25256523|NCT01357577|50571646|FG001|Overall Study|Lost to Follow-up|16|||
25256524|NCT01357577|50571645|FG000|Overall Study|Withdrawal by Subject|16|||
25256525|NCT01357577|50571646|FG001|Overall Study|Withdrawal by Subject|8|||
25256526|NCT01357577|50571645|FG000|Overall Study|look at data in database?|1|||
25256527|NCT01357577|50571646|FG001|Overall Study|look at data in database?|2|||
25256528|NCT01351025|50571655|FG000|Week 0 - 20|Lost to Follow-up|2|||
25256529|NCT01351025|50571656|FG001|Week 0 - 20|Lost to Follow-up|1|||
25256530|NCT01351025|50571655|FG000|Week 0 - 20|Withdrawal by Subject|1|||
25256531|NCT01351025|50571656|FG001|Week 0 - 20|Withdrawal by Subject|0|||
25256532|NCT01351025|50571655|FG000|Week 24 - 44|Lost to Follow-up|0|||
25256533|NCT01351025|50571656|FG001|Week 24 - 44|Lost to Follow-up|2|||
25256534|NCT01351025|50571655|FG000|Week 24 - 44|Site closed|0|||
25256535|NCT01351025|50571656|FG001|Week 24 - 44|Site closed|1|||
25256536|NCT01351025|50571655|FG000|Week 24 - 44|unable to get to clinic|1|||
25256537|NCT01351025|50571656|FG001|Week 24 - 44|unable to get to clinic|1|||
25256538|NCT01349036|50571670|FG000|Overall Study|Disease progression|13|||
25256539|NCT01349036|50571671|FG001|Overall Study|Disease progression|22|||
25256540|NCT01349036|50571670|FG000|Overall Study|Other|1|||
25256541|NCT01349036|50571671|FG001|Overall Study|Other|0|||
25256542|NCT01349036|50571670|FG000|Overall Study|Withdrawal by Subject|0|||
25256543|NCT01349036|50571671|FG001|Overall Study|Withdrawal by Subject|2|||
25256544|NCT01348763|50571681|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
25256545|NCT01348763|50571681|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
25256546|NCT01346969|50571689|FG000|Overall Study|Withdrawal by Subject|0|||
25256547|NCT01346969|50571690|FG001|Overall Study|Withdrawal by Subject|0|||
25256548|NCT01346969|50571691|FG002|Overall Study|Withdrawal by Subject|1|||
25256549|NCT01346969|50571692|FG003|Overall Study|Withdrawal by Subject|0|||
25256550|NCT01346969|50571689|FG000|Overall Study|Lost to Follow-up|1|||
25256551|NCT01346969|50571690|FG001|Overall Study|Lost to Follow-up|0|||
25256552|NCT01346969|50571691|FG002|Overall Study|Lost to Follow-up|2|||
25256553|NCT01346969|50571692|FG003|Overall Study|Lost to Follow-up|0|||
25256554|NCT01346969|50571689|FG000|Overall Study|Physician Decision|0|||
25256555|NCT01346969|50571690|FG001|Overall Study|Physician Decision|0|||
25256556|NCT01346969|50571691|FG002|Overall Study|Physician Decision|0|||
25256557|NCT01346969|50571692|FG003|Overall Study|Physician Decision|1|||
25256558|NCT01346969|50571689|FG000|Overall Study|Randomized but not treated|1|||
25256559|NCT01346969|50571690|FG001|Overall Study|Randomized but not treated|0|||
25256560|NCT01346969|50571691|FG002|Overall Study|Randomized but not treated|0|||
25256561|NCT01346969|50571692|FG003|Overall Study|Randomized but not treated|0|||
25256562|NCT01346774|50571704|FG000|Overall Study|Did not take a single dose|6|||
25256563|NCT01346774|50571705|FG001|Overall Study|Did not take a single dose|4|||
25256564|NCT01346774|50571704|FG000|Overall Study|Lost to Follow-up|3|||
25256565|NCT01346774|50571705|FG001|Overall Study|Lost to Follow-up|4|||
25256566|NCT01346774|50571704|FG000|Overall Study|Withdrawal by Subject|1|||
25256567|NCT01346774|50571705|FG001|Overall Study|Withdrawal by Subject|4|||
25256568|NCT01346774|50571704|FG000|Overall Study|Protocol Violation|2|||
25256569|NCT01346774|50571705|FG001|Overall Study|Protocol Violation|3|||
25256570|NCT01346774|50571704|FG000|Overall Study|Adverse Event|1|||
25256571|NCT01346774|50571705|FG001|Overall Study|Adverse Event|2|||
24983807|NCT03205150|50072415|FG000|Overall Study|Protocol deviation|1|||
25256572|NCT01346696|50571711|FG000|Overall Study|Death|1|||
25256573|NCT01346540|50571717|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
25256574|NCT01346540|50571718|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
25256575|NCT01346540|50571717|FG000|Overall Study|Adverse Event|0|||
25256576|NCT01346540|50571718|FG001|Overall Study|Adverse Event|4|||
25256577|NCT01342913|50571727|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
25256578|NCT01342913|50571728|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
25256579|NCT01342913|50571729|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
25256580|NCT01342913|50571727|FG000|2-week Run-in Period|Physician Decision|6|||
25256581|NCT01342913|50571728|FG001|2-week Run-in Period|Physician Decision|0|||
25256582|NCT01342913|50571729|FG002|2-week Run-in Period|Physician Decision|0|||
25256583|NCT01342913|50571727|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
25256584|NCT01342913|50571728|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
25256585|NCT01342913|50571729|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
25256586|NCT01342913|50571727|FG000|2-week Run-in Period|Adverse Event|2|||
25256587|NCT01342913|50571728|FG001|2-week Run-in Period|Adverse Event|0|||
25256588|NCT01342913|50571729|FG002|2-week Run-in Period|Adverse Event|0|||
25256589|NCT01342913|50571727|FG000|2-week Run-in Period|Protocol Violation|5|||
25256590|NCT01342913|50571728|FG001|2-week Run-in Period|Protocol Violation|0|||
25256591|NCT01342913|50571729|FG002|2-week Run-in Period|Protocol Violation|0|||
25256592|NCT01342913|50571727|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
25256593|NCT01342913|50571728|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
25256594|NCT01342913|50571729|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
25256595|NCT01342913|50571727|FG000|Double-Blind Treatment Period|Adverse Event|0|||
25256596|NCT01342913|50571728|FG001|Double-Blind Treatment Period|Adverse Event|3|||
25256597|NCT01342913|50571729|FG002|Double-Blind Treatment Period|Adverse Event|6|||
25256598|NCT01342913|50571727|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
25256599|NCT01342913|50571728|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
25256600|NCT01342913|50571729|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
25256601|NCT01342913|50571727|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
25256602|NCT01342913|50571728|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
25256603|NCT01342913|50571729|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
25256604|NCT01342913|50571727|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
25256605|NCT01342913|50571728|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
25256606|NCT01342913|50571729|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
25256607|NCT01342913|50571727|FG000|Double-Blind Treatment Period|Physician Decision|0|||
25256608|NCT01342913|50571728|FG001|Double-Blind Treatment Period|Physician Decision|2|||
25256609|NCT01342913|50571729|FG002|Double-Blind Treatment Period|Physician Decision|0|||
25256610|NCT01342913|50571727|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
25256611|NCT01342913|50571728|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
25256612|NCT01342913|50571729|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
25256613|NCT01342796|50571737|FG000|Overall Study|Withdrawal by Subject|2|||
25256614|NCT01342796|50571738|FG001|Overall Study|Withdrawal by Subject|0|||
25256615|NCT01342796|50571737|FG000|Overall Study|Lost to Follow-up|0|||
25256616|NCT01342796|50571738|FG001|Overall Study|Lost to Follow-up|3|||
25256617|NCT01342796|50571737|FG000|Overall Study|Inappropriate enrollment|1|||
25256618|NCT01342796|50571738|FG001|Overall Study|Inappropriate enrollment|0|||
25256619|NCT01342640|50571744|FG000|Overall Study|Adverse Event|3|||
25256620|NCT01342640|50571744|FG000|Overall Study|Protocol Violation|16|||
25256621|NCT01342640|50571744|FG000|Overall Study|Lost to Follow-up|21|||
25256622|NCT01342640|50571744|FG000|Overall Study|Other|1|||
25256623|NCT01342484|50571751|FG000|Overall Study|Other Reasons|1|||
25256624|NCT01342484|50571752|FG001|Overall Study|Other Reasons|0|||
25256625|NCT01342484|50571753|FG002|Overall Study|Other Reasons|0|||
25256626|NCT01342484|50571751|FG000|Overall Study|Protocol Violation|0|||
25256627|NCT01342484|50571752|FG001|Overall Study|Protocol Violation|0|||
25256628|NCT01342484|50571753|FG002|Overall Study|Protocol Violation|1|||
25256629|NCT01342484|50571751|FG000|Overall Study|Withdrawal by Subject|1|||
25256630|NCT01342484|50571752|FG001|Overall Study|Withdrawal by Subject|0|||
25256631|NCT01342484|50571753|FG002|Overall Study|Withdrawal by Subject|0|||
25256632|NCT01342445|50571763|FG000|Overall Study|Experienced side effects|0|||
25256633|NCT01342445|50571764|FG001|Overall Study|Experienced side effects|2|||
25256634|NCT01342211|50571779|FG000|Overall Study|Lost to Follow-up|0|||
25256635|NCT01342211|50571780|FG001|Overall Study|Lost to Follow-up|0|||
25256636|NCT01342211|50571781|FG002|Overall Study|Lost to Follow-up|0|||
25256637|NCT01342211|50571782|FG003|Overall Study|Lost to Follow-up|1|||
25256638|NCT01342211|50571783|FG004|Overall Study|Lost to Follow-up|0|||
25256639|NCT01342211|50571779|FG000|Overall Study|Adverse Event|0|||
25256640|NCT01342211|50571780|FG001|Overall Study|Adverse Event|0|||
25256641|NCT01342211|50571781|FG002|Overall Study|Adverse Event|0|||
25256642|NCT01342211|50571782|FG003|Overall Study|Adverse Event|0|||
25256643|NCT01342211|50571783|FG004|Overall Study|Adverse Event|1|||
25256644|NCT01342211|50571779|FG000|Overall Study|Withdrawal by Subject|0|||
25256645|NCT01342211|50571780|FG001|Overall Study|Withdrawal by Subject|0|||
25256646|NCT01342211|50571781|FG002|Overall Study|Withdrawal by Subject|0|||
25256647|NCT01342211|50571782|FG003|Overall Study|Withdrawal by Subject|1|||
25256648|NCT01342211|50571783|FG004|Overall Study|Withdrawal by Subject|0|||
25256649|NCT01342211|50571779|FG000|Overall Study|Randomized, but not Treated|0|||
25256650|NCT01342211|50571780|FG001|Overall Study|Randomized, but not Treated|2|||
25256651|NCT01342211|50571781|FG002|Overall Study|Randomized, but not Treated|0|||
25256652|NCT01342211|50571782|FG003|Overall Study|Randomized, but not Treated|0|||
25342091|NCT00585078|50658468|FG000|Overall Study|Adverse Event|10|||
25256653|NCT01342211|50571783|FG004|Overall Study|Randomized, but not Treated|1|||
25256654|NCT01342094|50571801|FG000|Overall Study|Adverse Event|5|||
25256655|NCT01342094|50571802|FG001|Overall Study|Adverse Event|0|||
25256656|NCT01342094|50571801|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
25256657|NCT01342094|50571802|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
25256658|NCT01342094|50571801|FG000|Overall Study|Withdrawal by Subject|0|||
25256659|NCT01342094|50571802|FG001|Overall Study|Withdrawal by Subject|2|||
25256660|NCT01340768|50571810|FG000|Overall Study|Lost to Follow-up|10|||
25256661|NCT01340768|50571811|FG001|Overall Study|Lost to Follow-up|4|||
25256662|NCT01340768|50571810|FG000|Overall Study|Withdrawal by Subject|5|||
25256663|NCT01340768|50571811|FG001|Overall Study|Withdrawal by Subject|1|||
25256664|NCT01340768|50571810|FG000|Overall Study|Other|2|||
25256665|NCT01340768|50571811|FG001|Overall Study|Other|0|||
25256666|NCT01340651|50571817|FG000|Overall Study|Adverse Event|3|||
25256667|NCT01340651|50571817|FG000|Overall Study|Consent Withdrawn|2|||
25256668|NCT01340651|50571817|FG000|Overall Study|Commercial Supply per Sponsor|12|||
25256669|NCT01340495|50571823|FG000|Overall Study|Withdrawal by Subject|1|||
25256670|NCT01340300|50571831|FG000|Overall Study|Lost to Follow-up|3|||
25256671|NCT01340300|50571832|FG001|Overall Study|Lost to Follow-up|0|||
25256672|NCT01340300|50571833|FG002|Overall Study|Lost to Follow-up|5|||
25256673|NCT01340300|50571834|FG003|Overall Study|Lost to Follow-up|10|||
25256674|NCT01340300|50571831|FG000|Overall Study|Withdrawal by Subject|5|||
25256675|NCT01340300|50571832|FG001|Overall Study|Withdrawal by Subject|6|||
25256676|NCT01340300|50571833|FG002|Overall Study|Withdrawal by Subject|6|||
25256677|NCT01340300|50571834|FG003|Overall Study|Withdrawal by Subject|3|||
25256678|NCT01340300|50571831|FG000|Overall Study|Adverse Event|1|||
25256679|NCT01340300|50571832|FG001|Overall Study|Adverse Event|0|||
25256680|NCT01340300|50571833|FG002|Overall Study|Adverse Event|4|||
25256681|NCT01340300|50571834|FG003|Overall Study|Adverse Event|0|||
25256682|NCT01340300|50571831|FG000|Overall Study|Physician Decision|0|||
25256683|NCT01340300|50571832|FG001|Overall Study|Physician Decision|1|||
25256684|NCT01340300|50571833|FG002|Overall Study|Physician Decision|0|||
25256685|NCT01340300|50571834|FG003|Overall Study|Physician Decision|0|||
25256686|NCT01340300|50571831|FG000|Overall Study|Unrelated sickness|0|||
25256687|NCT01340300|50571832|FG001|Overall Study|Unrelated sickness|2|||
25256688|NCT01340300|50571833|FG002|Overall Study|Unrelated sickness|0|||
25256689|NCT01340300|50571834|FG003|Overall Study|Unrelated sickness|1|||
25256690|NCT01340066|50571846|FG000|Placebo Run in Period|Screen Failures|27|||
25256691|NCT01340066|50571847|FG001|Placebo Run in Period|Screen Failures|0|||
25256692|NCT01340066|50571848|FG002|Placebo Run in Period|Screen Failures|0|||
25256693|NCT01340066|50571846|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
25256694|NCT01340066|50571847|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
25256695|NCT01340066|50571848|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
25256696|NCT01340066|50571846|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
25256697|NCT01340066|50571847|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
25256698|NCT01340066|50571848|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
25256699|NCT01340066|50571846|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
25256700|NCT01340066|50571847|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
25256701|NCT01340066|50571848|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
25256702|NCT01107535|50571855|FG000|Overall Study|Death|5|||
25256703|NCT01326546|50571861|FG000|Overall Study|Lost to Follow-up|8|||
25256704|NCT01326546|50571862|FG001|Overall Study|Lost to Follow-up|7|||
25256705|NCT01326546|50571861|FG000|Overall Study|Protocol Violation|3|||
25256706|NCT01326546|50571862|FG001|Overall Study|Protocol Violation|4|||
25256707|NCT01326546|50571861|FG000|Overall Study|Pregnancy|0|||
25256708|NCT01326546|50571862|FG001|Overall Study|Pregnancy|1|||
25256709|NCT01326546|50571861|FG000|Overall Study|Adverse Event|1|||
25256710|NCT01326546|50571862|FG001|Overall Study|Adverse Event|0|||
25256711|NCT01326546|50571861|FG000|Overall Study|Withdrawal by Subject|5|||
25256712|NCT01326546|50571862|FG001|Overall Study|Withdrawal by Subject|1|||
25256713|NCT01325532|50571870|FG000|Overall Study|Withdrawal by Subject|2|||
25256714|NCT01325532|50571871|FG001|Overall Study|Withdrawal by Subject|0|||
25256715|NCT01171963|50571879|FG000|Overall Study|Adverse Event|10|||
25256716|NCT01171963|50571880|FG001|Overall Study|Adverse Event|15|||
25256717|NCT01171963|50571879|FG000|Overall Study|Lost to Follow-up|23|||
25256718|NCT01171963|50571880|FG001|Overall Study|Lost to Follow-up|24|||
25256719|NCT01171963|50571879|FG000|Overall Study|Other - diarrhoea|1|||
25256720|NCT01171963|50571880|FG001|Overall Study|Other - diarrhoea|0|||
25256721|NCT01171963|50571879|FG000|Overall Study|Withdrawal by Subject|114|||
25256722|NCT01171963|50571880|FG001|Overall Study|Withdrawal by Subject|129|||
25256723|NCT01171183|50571891|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
25256724|NCT01171183|50571892|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
25256725|NCT01171183|50571891|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
25256726|NCT01171183|50571892|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
25256727|NCT01171183|50571891|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
25256728|NCT01171183|50571892|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
25256729|NCT01171183|50571891|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
25342092|NCT00585078|50658468|FG000|Overall Study|Death|1|||
25342093|NCT00720876|50658472|FG000|Overall Study|found to be ineligible after starting tx|2|||
25256730|NCT01171183|50571892|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
25256731|NCT01171183|50571891|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
25256732|NCT01171183|50571892|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
25256733|NCT01171183|50571891|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
25256734|NCT01171183|50571892|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
25256735|NCT01170091|50571898|FG000|Overall Study|Missing efficacy evaluation|3|||
25342094|NCT00723840|50658476|FG000|Overall Study|Lost to Follow-up|2|||
25256736|NCT01170091|50571898|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
25256737|NCT01169779|50571904|FG000|Overall Study|Adverse Event|3|||
25256738|NCT01169779|50571905|FG001|Overall Study|Adverse Event|11|||
25256739|NCT01169779|50571904|FG000|Overall Study|Lack of Efficacy|1|||
25256740|NCT01169779|50571905|FG001|Overall Study|Lack of Efficacy|0|||
25256741|NCT01169779|50571904|FG000|Overall Study|Protocol Violation|1|||
25256742|NCT01169779|50571905|FG001|Overall Study|Protocol Violation|1|||
25256743|NCT01169779|50571904|FG000|Overall Study|Withdrawal by Subject|3|||
25256744|NCT01169779|50571905|FG001|Overall Study|Withdrawal by Subject|2|||
25256745|NCT01169779|50571904|FG000|Overall Study|Familial and personal reasons|3|||
25256746|NCT01169779|50571905|FG001|Overall Study|Familial and personal reasons|3|||
25256747|NCT01169701|50571913|FG000|Overall Study|Lost to Follow-up|1|||
25256748|NCT01169701|50571914|FG001|Overall Study|Lost to Follow-up|1|||
25256749|NCT01169701|50571913|FG000|Overall Study|Withdrawal by Subject|1|||
25256750|NCT01169701|50571914|FG001|Overall Study|Withdrawal by Subject|3|||
25256751|NCT01169701|50571913|FG000|Overall Study|Adverse Event|1|||
25256752|NCT01169701|50571914|FG001|Overall Study|Adverse Event|2|||
25256753|NCT01169701|50571913|FG000|Overall Study|Exclusion criteria|2|||
25256754|NCT01169701|50571914|FG001|Overall Study|Exclusion criteria|0|||
25256755|NCT01169701|50571913|FG000|Overall Study|Death|0|||
25256756|NCT01169701|50571914|FG001|Overall Study|Death|1|||
25256757|NCT01169701|50571913|FG000|Overall Study|Administrative problems|0|||
25256758|NCT01169701|50571914|FG001|Overall Study|Administrative problems|1|||
25256759|NCT01169701|50571913|FG000|Overall Study|Serious adverse event|0|||
25256760|NCT01169701|50571914|FG001|Overall Study|Serious adverse event|1|||
25256761|NCT01169701|50571913|FG000|Overall Study|Sponsor decision|0|||
25256762|NCT01169701|50571914|FG001|Overall Study|Sponsor decision|1|||
25256763|NCT01168999|50571924|FG000|Overall Study|Lost to Follow-up|2|||
25256764|NCT01168999|50571925|FG001|Overall Study|Lost to Follow-up|1|||
25256765|NCT01168999|50571926|FG002|Overall Study|Lost to Follow-up|0|||
25256766|NCT01168999|50571927|FG003|Overall Study|Lost to Follow-up|0|||
24983808|NCT03205150|50072416|FG001|Overall Study|Protocol deviation|3|||
24983809|NCT03205150|50072417|FG002|Overall Study|Protocol deviation|0|||
24983810|NCT03205150|50072415|FG000|Overall Study|Patient/guardian decision|0|||
24983811|NCT03205150|50072416|FG001|Overall Study|Patient/guardian decision|3|||
24983812|NCT03205150|50072417|FG002|Overall Study|Patient/guardian decision|0|||
24983813|NCT03205150|50072415|FG000|Overall Study|Adverse Event|1|||
24983814|NCT03205150|50072416|FG001|Overall Study|Adverse Event|1|||
24983815|NCT03205150|50072417|FG002|Overall Study|Adverse Event|1|||
24983816|NCT03205150|50072415|FG000|Overall Study|Lost to Follow-up|0|||
24983817|NCT03205150|50072416|FG001|Overall Study|Lost to Follow-up|0|||
24983818|NCT03205150|50072417|FG002|Overall Study|Lost to Follow-up|1|||
24983819|NCT02932306|50072428|FG000|Overall Study|Withdrawal by Subject|16|||
24983820|NCT02932306|50072429|FG001|Overall Study|Withdrawal by Subject|25|||
24983821|NCT02932306|50072428|FG000|Overall Study|Adverse Event|3|||
24983822|NCT02932306|50072429|FG001|Overall Study|Adverse Event|0|||
24983823|NCT02932306|50072428|FG000|Overall Study|Pregnancy|2|||
24983824|NCT02932306|50072429|FG001|Overall Study|Pregnancy|0|||
24983825|NCT02932306|50072428|FG000|Overall Study|Protocol Violation|1|||
24983826|NCT02932306|50072429|FG001|Overall Study|Protocol Violation|1|||
24983827|NCT02932306|50072428|FG000|Overall Study|Noncompliance with Study Drug|1|||
24983828|NCT02932306|50072429|FG001|Overall Study|Noncompliance with Study Drug|1|||
24983829|NCT02932306|50072428|FG000|Overall Study|Lost to Follow-up|36|||
24983830|NCT02932306|50072429|FG001|Overall Study|Lost to Follow-up|40|||
24983831|NCT02932306|50072428|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
24983832|NCT02932306|50072429|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
24983833|NCT02932306|50072428|FG000|Overall Study|Lack of Efficacy|0|||
24983834|NCT02932306|50072429|FG001|Overall Study|Lack of Efficacy|2|||
24983835|NCT02932306|50072428|FG000|Overall Study|Worsening condition|2|||
24983836|NCT02932306|50072429|FG001|Overall Study|Worsening condition|0|||
24983837|NCT02932306|50072428|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
24983838|NCT02932306|50072429|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
25342095|NCT00723840|50658476|FG000|Overall Study|Failure to return|18|||
25342096|NCT00723840|50658476|FG000|Overall Study|Withdrawal by Subject|55|||
24983839|NCT02932228|50072437|FG000|Overall Study|Death|8|||
24983840|NCT02932228|50072438|FG001|Overall Study|Death|23|||
24983841|NCT02932228|50072437|FG000|Overall Study|not eligible upon chart review|2|||
24983842|NCT02932228|50072438|FG001|Overall Study|not eligible upon chart review|5|||
24983843|NCT02931838|50072452|FG000|Overall Study|Reason not provided by investigator|1|||
25256767|NCT01167907|50571939|FG000|Overall Study|Protocol Violation|1|||
25256768|NCT01167907|50571940|FG001|Overall Study|Protocol Violation|0|||
25256769|NCT01167907|50571939|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
25256770|NCT01167907|50571940|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
25256771|NCT01166659|50571946|FG000|Overall Study|Subject Decision|8|||
25256772|NCT01166659|50571946|FG000|Overall Study|Investigator Decision|2|||
24983844|NCT02931838|50072453|FG001|Overall Study|Reason not provided by investigator|0|||
25256773|NCT01166659|50571946|FG000|Overall Study|Death|1|||
25256774|NCT01166659|50571946|FG000|Overall Study|Lost to Follow-up|1|||
25256775|NCT01166659|50571946|FG000|Overall Study|Study Closed at Site|1|||
25256776|NCT01115491|50571951|FG000|Overall Study|Death|22|||
25256777|NCT01115491|50571951|FG000|Overall Study|Adverse Event|3|||
25256778|NCT01115491|50571951|FG000|Overall Study|Lost to Follow-up|3|||
25256779|NCT01115491|50571951|FG000|Overall Study|Withdrawal by Subject|1|||
25256780|NCT01115491|50571951|FG000|Overall Study|Physician Decision|1|||
25256781|NCT01113931|50571957|FG000|Overall Study|Adverse Event|2|||
25256782|NCT01113931|50571958|FG001|Overall Study|Adverse Event|2|||
25256783|NCT01113931|50571957|FG000|Overall Study|Physician Decision|0|||
25256784|NCT01113931|50571958|FG001|Overall Study|Physician Decision|2|||
25256785|NCT01113931|50571957|FG000|Overall Study|Lost to Follow-up|12|||
25256786|NCT01113931|50571958|FG001|Overall Study|Lost to Follow-up|9|||
25256787|NCT01113931|50571957|FG000|Overall Study|Various|2|||
25256788|NCT01113931|50571958|FG001|Overall Study|Various|4|||
25256789|NCT01113931|50571957|FG000|Overall Study|Withdrawal by Subject|3|||
25256790|NCT01113931|50571958|FG001|Overall Study|Withdrawal by Subject|0|||
25256791|NCT01107379|50571964|FG000|Overall Study|Withdrawal by Subject|18|||
25256792|NCT01107379|50571964|FG000|Overall Study|Lost to Follow-up|3|||
25256793|NCT01106911|50571968|FG000|Overall Study|Physician Decision|2|||
25256794|NCT01106911|50571968|FG000|Overall Study|deemed ineligible after screening|3|||
25256795|NCT01106677|50571976|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
25256796|NCT01106677|50571977|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
25256797|NCT01106677|50571978|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
25256798|NCT01106677|50571979|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
25256799|NCT01106677|50571976|FG000|Core Period: Baseline to Week 26|Death|0|||
25256800|NCT01106677|50571977|FG001|Core Period: Baseline to Week 26|Death|0|||
25256801|NCT01106677|50571978|FG002|Core Period: Baseline to Week 26|Death|1|||
25256802|NCT01106677|50571979|FG003|Core Period: Baseline to Week 26|Death|0|||
25256803|NCT01106677|50571976|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
25256804|NCT01106677|50571977|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
25256805|NCT01106677|50571978|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
25256806|NCT01106677|50571979|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
25256807|NCT01106677|50571976|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
25256808|NCT01106677|50571977|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
25256809|NCT01106677|50571978|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
25256810|NCT01106677|50571979|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
25256811|NCT01106677|50571976|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
25256812|NCT01106677|50571977|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
25256813|NCT01106677|50571978|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
25256814|NCT01106677|50571979|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
25256815|NCT01106677|50571976|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
25256816|NCT01106677|50571977|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
25256817|NCT01106677|50571978|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
25256818|NCT01106677|50571979|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
25256819|NCT01106677|50571976|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
25256820|NCT01106677|50571977|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
25256821|NCT01106677|50571978|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
25256822|NCT01106677|50571979|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
25256823|NCT01106677|50571976|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
25256824|NCT01106677|50571977|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
25256825|NCT01106677|50571978|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
25256826|NCT01106677|50571979|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
25256827|NCT01106677|50571976|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
25256828|NCT01106677|50571977|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
25256829|NCT01106677|50571978|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
25256830|NCT01106677|50571979|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
25256831|NCT01106677|50571976|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
25256832|NCT01106677|50571977|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
25256833|NCT01106677|50571978|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
24983845|NCT02931838|50072454|FG002|Overall Study|Reason not provided by investigator|1|||
24983846|NCT02931838|50072455|FG003|Overall Study|Reason not provided by investigator|0|||
25256834|NCT01106677|50571979|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
25256835|NCT01106677|50571976|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
25256836|NCT01106677|50571977|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
25256837|NCT01106677|50571978|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
25256838|NCT01106677|50571979|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
25256839|NCT01106677|50571976|FG000|Core Period: Baseline to Week 26|Other|8|||
25256840|NCT01106677|50571977|FG001|Core Period: Baseline to Week 26|Other|14|||
25342097|NCT00723840|50658476|FG000|Overall Study|Serious Adverse Events|3|||
25256841|NCT01106677|50571978|FG002|Core Period: Baseline to Week 26|Other|8|||
25256842|NCT01106677|50571979|FG003|Core Period: Baseline to Week 26|Other|23|||
25256843|NCT01106677|50571976|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
25256844|NCT01106677|50571977|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
25256845|NCT01106677|50571978|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
25256846|NCT01106677|50571979|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
25256847|NCT01106677|50571976|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
25256848|NCT01106677|50571977|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
25256849|NCT01106677|50571978|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
25256850|NCT01106677|50571979|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
25256851|NCT01106677|50571976|FG000|Extension Period: Week 26 to Week 52|Death|0|||
25256852|NCT01106677|50571977|FG001|Extension Period: Week 26 to Week 52|Death|0|||
25256853|NCT01106677|50571978|FG002|Extension Period: Week 26 to Week 52|Death|0|||
25256854|NCT01106677|50571979|FG003|Extension Period: Week 26 to Week 52|Death|1|||
25256855|NCT01106677|50571976|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
25256856|NCT01106677|50571977|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
25256857|NCT01106677|50571978|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
25256858|NCT01106677|50571979|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
24983847|NCT02931838|50072456|FG004|Overall Study|Reason not provided by investigator|0|||
24983848|NCT02931838|50072457|FG005|Overall Study|Reason not provided by investigator|0|||
25256859|NCT01106677|50571976|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
25342098|NCT00723840|50658476|FG000|Overall Study|Other Medical Event|2|||
25342099|NCT00723840|50658476|FG000|Overall Study|Unspecified reason|2|||
25342100|NCT00789581|50658489|FG000|AC Therapy|Adverse Event|2|||
25342101|NCT00789581|50658490|FG001|AC Therapy|Adverse Event|3|||
25342102|NCT00789581|50658489|FG000|AC Therapy|Withdrawal by Subject|4|||
25342103|NCT00789581|50658490|FG001|AC Therapy|Withdrawal by Subject|7|||
25342104|NCT00789581|50658489|FG000|AC Therapy|Disease recurrence|3|||
25342105|NCT00789581|50658490|FG001|AC Therapy|Disease recurrence|1|||
25342106|NCT00789581|50658489|FG000|AC Therapy|Intercurrent Illness|1|||
25342107|NCT00789581|50658490|FG001|AC Therapy|Intercurrent Illness|0|||
25342108|NCT00789581|50658489|FG000|AC Therapy|Never Treated|1|||
25342109|NCT00789581|50658490|FG001|AC Therapy|Never Treated|4|||
25342110|NCT00789581|50658489|FG000|AC Therapy|Other|0|||
25342111|NCT00789581|50658490|FG001|AC Therapy|Other|2|||
25342112|NCT00789581|50658489|FG000|Adjuvant Therapy|Never treated|2|||
25342113|NCT00789581|50658490|FG001|Adjuvant Therapy|Never treated|2|||
25342114|NCT00789581|50658489|FG000|Adjuvant Therapy|Adverse Event|20|||
25342115|NCT00789581|50658490|FG001|Adjuvant Therapy|Adverse Event|44|||
25342116|NCT00789581|50658489|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
25342117|NCT00789581|50658490|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
25342118|NCT00789581|50658489|FG000|Adjuvant Therapy|Disease recurrence|2|||
25342119|NCT00789581|50658490|FG001|Adjuvant Therapy|Disease recurrence|1|||
25342120|NCT00789581|50658489|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
25342121|NCT00789581|50658490|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
25342122|NCT00789581|50658489|FG000|Adjuvant Therapy|Protocol Violation|1|||
25342123|NCT00789581|50658490|FG001|Adjuvant Therapy|Protocol Violation|1|||
25342124|NCT00789581|50658489|FG000|Adjuvant Therapy|Other|0|||
25342125|NCT00789581|50658490|FG001|Adjuvant Therapy|Other|1|||
25342126|NCT00717756|50658497|FG000|Overall Study|Withdrawal by Subject|1|||
25342127|NCT00717522|50658501|FG000|Overall Study|Disease Progression|5|||
25342128|NCT00717522|50658501|FG000|Overall Study|Adverse Event|1|||
25342129|NCT00717522|50658501|FG000|Overall Study|Death|1|||
24983849|NCT02931838|50072452|FG000|Overall Study|Poor/non-compliance|0|||
24983850|NCT02931838|50072453|FG001|Overall Study|Poor/non-compliance|0|||
24983851|NCT02931838|50072454|FG002|Overall Study|Poor/non-compliance|1|||
24983852|NCT02931838|50072455|FG003|Overall Study|Poor/non-compliance|0|||
24983853|NCT02931838|50072456|FG004|Overall Study|Poor/non-compliance|0|||
24983854|NCT02931838|50072457|FG005|Overall Study|Poor/non-compliance|0|||
24983855|NCT02931838|50072452|FG000|Overall Study|Lack of Efficacy|5|||
24983856|NCT02931838|50072453|FG001|Overall Study|Lack of Efficacy|4|||
24983857|NCT02931838|50072454|FG002|Overall Study|Lack of Efficacy|0|||
24983858|NCT02931838|50072455|FG003|Overall Study|Lack of Efficacy|0|||
24983859|NCT02931838|50072456|FG004|Overall Study|Lack of Efficacy|0|||
24983860|NCT02931838|50072457|FG005|Overall Study|Lack of Efficacy|1|||
25342130|NCT00791921|50658507|FG000|Overall Study|Protocol planed|24|||
25342131|NCT00791921|50658508|FG001|Overall Study|Protocol planed|88|||
25342132|NCT00791921|50658507|FG000|Overall Study|Withdrawal by Subject|1|||
24983861|NCT02931838|50072452|FG000|Overall Study|Lost to Follow-up|1|||
24983862|NCT02931838|50072453|FG001|Overall Study|Lost to Follow-up|0|||
24983863|NCT02931838|50072454|FG002|Overall Study|Lost to Follow-up|1|||
24983864|NCT02931838|50072455|FG003|Overall Study|Lost to Follow-up|1|||
25079371|NCT02149121|50187832|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
25342133|NCT00791921|50658508|FG001|Overall Study|Withdrawal by Subject|2|||
25342134|NCT00791921|50658507|FG000|Overall Study|Adverse Event|8|||
25342135|NCT00791921|50658508|FG001|Overall Study|Adverse Event|2|||
25342136|NCT00791921|50658507|FG000|Overall Study|Lack of Efficacy|0|||
25342137|NCT00791921|50658508|FG001|Overall Study|Lack of Efficacy|2|||
25342138|NCT00791921|50658507|FG000|Overall Study|Lack of study drug administration|1|||
25342139|NCT00791921|50658508|FG001|Overall Study|Lack of study drug administration|1|||
25342140|NCT00791921|50658507|FG000|Overall Study|Reason other than those above|0|||
25342141|NCT00791921|50658508|FG001|Overall Study|Reason other than those above|1|||
25342142|NCT00582933|50658514|FG000|Overall Study|Physician Decision|3|||
25342143|NCT00791765|50658520|FG000|Weeks 1 to 12|Adverse Event|0|||
25342144|NCT00791765|50658521|FG001|Weeks 1 to 12|Adverse Event|1|||
25342145|NCT00791765|50658520|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
25342146|NCT00791765|50658521|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
25342147|NCT00791765|50658520|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
25342148|NCT00791765|50658521|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
25342149|NCT00791765|50658520|FG000|Weeks 1 to 12|Physician Decision|1|||
25342150|NCT00791765|50658521|FG001|Weeks 1 to 12|Physician Decision|0|||
25342151|NCT00791765|50658520|FG000|Weeks 1 to 12|Disease progression|3|||
25342152|NCT00791765|50658521|FG001|Weeks 1 to 12|Disease progression|0|||
25342153|NCT00791765|50658520|FG000|Weeks 1 to 12|Ineligibility determined|0|||
25342154|NCT00791765|50658521|FG001|Weeks 1 to 12|Ineligibility determined|3|||
25342155|NCT00791765|50658520|FG000|Weeks 13 to 24|Protocol deviation|2|||
25342156|NCT00791765|50658521|FG001|Weeks 13 to 24|Protocol deviation|0|||
25342157|NCT00791765|50658520|FG000|Weeks 13 to 24|Adverse Event|0|||
25342158|NCT00791765|50658521|FG001|Weeks 13 to 24|Adverse Event|3|||
25342159|NCT00791765|50658520|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
25342160|NCT00791765|50658521|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
25342161|NCT00791765|50658520|FG000|Weeks 13 to 24|Disease progression|0|||
24983865|NCT02931838|50072456|FG004|Overall Study|Lost to Follow-up|2|||
24983866|NCT02931838|50072457|FG005|Overall Study|Lost to Follow-up|0|||
24983867|NCT02931838|50072452|FG000|Overall Study|Subject request to discontinue treatment|4|||
24983868|NCT02931838|50072453|FG001|Overall Study|Subject request to discontinue treatment|3|||
24983869|NCT02931838|50072454|FG002|Overall Study|Subject request to discontinue treatment|3|||
24983870|NCT02931838|50072455|FG003|Overall Study|Subject request to discontinue treatment|0|||
24983871|NCT02931838|50072456|FG004|Overall Study|Subject request to discontinue treatment|1|||
24983872|NCT02931838|50072457|FG005|Overall Study|Subject request to discontinue treatment|0|||
24983873|NCT02931838|50072452|FG000|Overall Study|Withdrawal by Subject|1|||
24983874|NCT02931838|50072453|FG001|Overall Study|Withdrawal by Subject|2|||
24983875|NCT02931838|50072454|FG002|Overall Study|Withdrawal by Subject|0|||
24983876|NCT02931838|50072455|FG003|Overall Study|Withdrawal by Subject|1|||
24983877|NCT02931838|50072456|FG004|Overall Study|Withdrawal by Subject|0|||
24983878|NCT02931838|50072457|FG005|Overall Study|Withdrawal by Subject|0|||
24983879|NCT02931838|50072452|FG000|Overall Study|Adverse Event|2|||
24983880|NCT02931838|50072453|FG001|Overall Study|Adverse Event|1|||
24983881|NCT02931838|50072454|FG002|Overall Study|Adverse Event|2|||
25342162|NCT00791765|50658521|FG001|Weeks 13 to 24|Disease progression|1|||
25342163|NCT00791765|50658520|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
24983882|NCT02931838|50072455|FG003|Overall Study|Adverse Event|1|||
24983883|NCT02931838|50072456|FG004|Overall Study|Adverse Event|3|||
24983884|NCT02931838|50072457|FG005|Overall Study|Adverse Event|1|||
24983885|NCT03201562|50072479|FG000|Overall Study|Physician Decision|0|||
24983886|NCT03201562|50072480|FG001|Overall Study|Physician Decision|0|||
24983887|NCT03201562|50072481|FG002|Overall Study|Physician Decision|1|||
24983888|NCT03201562|50072479|FG000|Overall Study|Adverse Event|0|||
24983889|NCT03201562|50072480|FG001|Overall Study|Adverse Event|0|||
24983890|NCT03201562|50072481|FG002|Overall Study|Adverse Event|1|||
24983891|NCT03201562|50072479|FG000|Overall Study|Lost to Follow-up|0|||
24983892|NCT03201562|50072480|FG001|Overall Study|Lost to Follow-up|1|||
24983893|NCT03201562|50072481|FG002|Overall Study|Lost to Follow-up|2|||
24983894|NCT03200860|50072491|FG000|Overall Study|Withdrawal by Subject|1|||
24983895|NCT03200860|50072492|FG001|Overall Study|Withdrawal by Subject|0|||
24983896|NCT03198754|50072500|FG000|Overall Study|Withdrawal by Subject|5|||
24983897|NCT03198754|50072501|FG001|Overall Study|Withdrawal by Subject|4|||
24983898|NCT03198754|50072500|FG000|Overall Study|Lost to Follow-up|4|||
24983899|NCT03198754|50072501|FG001|Overall Study|Lost to Follow-up|3|||
24983900|NCT03198754|50072500|FG000|Overall Study|Ineligible|2|||
24983901|NCT03198754|50072501|FG001|Overall Study|Ineligible|1|||
25342164|NCT00791765|50658521|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
25342165|NCT00791765|50658520|FG000|Weeks 13 to 24|Other|0|||
25342166|NCT00791765|50658521|FG001|Weeks 13 to 24|Other|1|||
25342167|NCT00789191|50658529|FG000|Overall Study|Adverse Event|2|||
25342168|NCT00789191|50658530|FG001|Overall Study|Adverse Event|4|||
25342169|NCT00789191|50658529|FG000|Overall Study|Lack of Efficacy|0|||
24983902|NCT03198520|50072507|FG000|Overall Study|Physician Decision|2|||
24983903|NCT03198520|50072507|FG000|Overall Study|Protocol Violation|2|||
25342170|NCT00789191|50658530|FG001|Overall Study|Lack of Efficacy|5|||
24983904|NCT03198520|50072507|FG000|Overall Study|Withdrawal by Subject|1|||
24983905|NCT03198520|50072507|FG000|Overall Study|Study Ended|1|||
24983906|NCT03194464|50072519|FG000|Overall Study|data not usable|2|||
24983907|NCT03192904|50072527|FG000|Overall Study|Physician Decision|3|||
24983908|NCT03192904|50072528|FG001|Overall Study|Physician Decision|1|||
25342171|NCT00789191|50658529|FG000|Overall Study|Protocol Violation|5|||
25342172|NCT00789191|50658530|FG001|Overall Study|Protocol Violation|3|||
25342173|NCT00789191|50658529|FG000|Overall Study|Withdrawal Criteria|2|||
25342174|NCT00789191|50658530|FG001|Overall Study|Withdrawal Criteria|4|||
25342175|NCT00789191|50658529|FG000|Overall Study|Unclassified|5|||
25342176|NCT00789191|50658530|FG001|Overall Study|Unclassified|3|||
25342177|NCT00789035|50658541|FG000|Overall Study|Adverse Event|0|||
25342178|NCT00789035|50658542|FG001|Overall Study|Adverse Event|2|||
25342179|NCT00789035|50658543|FG002|Overall Study|Adverse Event|0|||
25342180|NCT00789035|50658544|FG003|Overall Study|Adverse Event|1|||
25342181|NCT00789035|50658545|FG004|Overall Study|Adverse Event|3|||
25342182|NCT00789035|50658541|FG000|Overall Study|Lack of Efficacy|3|||
25342183|NCT00789035|50658542|FG001|Overall Study|Lack of Efficacy|0|||
25342184|NCT00789035|50658543|FG002|Overall Study|Lack of Efficacy|0|||
25342185|NCT00789035|50658544|FG003|Overall Study|Lack of Efficacy|0|||
25342186|NCT00789035|50658545|FG004|Overall Study|Lack of Efficacy|2|||
25342187|NCT00789035|50658541|FG000|Overall Study|Protocol Violation|1|||
25342188|NCT00789035|50658542|FG001|Overall Study|Protocol Violation|0|||
25342189|NCT00789035|50658543|FG002|Overall Study|Protocol Violation|0|||
25342190|NCT00789035|50658544|FG003|Overall Study|Protocol Violation|0|||
25342191|NCT00789035|50658545|FG004|Overall Study|Protocol Violation|0|||
25342192|NCT00789035|50658541|FG000|Overall Study|Withdrawal by Subject|0|||
25342193|NCT00789035|50658542|FG001|Overall Study|Withdrawal by Subject|2|||
25342194|NCT00789035|50658543|FG002|Overall Study|Withdrawal by Subject|0|||
25342195|NCT00789035|50658544|FG003|Overall Study|Withdrawal by Subject|0|||
25342196|NCT00789035|50658545|FG004|Overall Study|Withdrawal by Subject|0|||
25342197|NCT00789035|50658541|FG000|Overall Study|Other reason not defined above|2|||
25342198|NCT00789035|50658542|FG001|Overall Study|Other reason not defined above|3|||
25342199|NCT00789035|50658543|FG002|Overall Study|Other reason not defined above|1|||
25342200|NCT00789035|50658544|FG003|Overall Study|Other reason not defined above|0|||
25342201|NCT00789035|50658545|FG004|Overall Study|Other reason not defined above|1|||
25342202|NCT03326193|50658569|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
25342203|NCT03326193|50658569|FG000|Overall Study|Death|19|||
25342204|NCT03326193|50658569|FG000|Overall Study|Withdrawal by Subject|8|||
25342205|NCT00437203|50658592|FG000|Overall Study|Death|0|||
25342206|NCT00437203|50658593|FG001|Overall Study|Death|0|||
25342207|NCT00437203|50658594|FG002|Overall Study|Death|1|||
25342208|NCT00437203|50658595|FG003|Overall Study|Death|0|||
25342209|NCT00437203|50658596|FG004|Overall Study|Death|0|||
25342210|NCT00437203|50658597|FG005|Overall Study|Death|0|||
25342211|NCT00437203|50658598|FG006|Overall Study|Death|0|||
25342212|NCT00437203|50658599|FG007|Overall Study|Death|1|||
25342213|NCT00437203|50658600|FG008|Overall Study|Death|0|||
25342214|NCT00437203|50658601|FG009|Overall Study|Death|1|||
25342215|NCT00437203|50658592|FG000|Overall Study|Adverse Event|1|||
25342216|NCT00437203|50658593|FG001|Overall Study|Adverse Event|1|||
25342217|NCT00437203|50658594|FG002|Overall Study|Adverse Event|0|||
25342218|NCT00437203|50658595|FG003|Overall Study|Adverse Event|0|||
25342219|NCT00437203|50658596|FG004|Overall Study|Adverse Event|0|||
25342220|NCT00437203|50658597|FG005|Overall Study|Adverse Event|0|||
25342221|NCT00437203|50658598|FG006|Overall Study|Adverse Event|0|||
25342222|NCT00437203|50658599|FG007|Overall Study|Adverse Event|1|||
25342223|NCT00437203|50658600|FG008|Overall Study|Adverse Event|0|||
25342224|NCT00437203|50658601|FG009|Overall Study|Adverse Event|1|||
25342225|NCT00437203|50658592|FG000|Overall Study|Study terminated by sponsor|0|||
25342226|NCT00437203|50658593|FG001|Overall Study|Study terminated by sponsor|0|||
25342227|NCT00437203|50658594|FG002|Overall Study|Study terminated by sponsor|0|||
25342228|NCT00437203|50658595|FG003|Overall Study|Study terminated by sponsor|0|||
25342229|NCT00437203|50658596|FG004|Overall Study|Study terminated by sponsor|0|||
25342230|NCT00437203|50658597|FG005|Overall Study|Study terminated by sponsor|0|||
25342231|NCT00437203|50658598|FG006|Overall Study|Study terminated by sponsor|0|||
25342232|NCT00437203|50658599|FG007|Overall Study|Study terminated by sponsor|0|||
25342233|NCT00437203|50658600|FG008|Overall Study|Study terminated by sponsor|1|||
25342234|NCT00437203|50658601|FG009|Overall Study|Study terminated by sponsor|0|||
25342235|NCT00437203|50658592|FG000|Overall Study|Objective progression or relapse|5|||
25342236|NCT00437203|50658593|FG001|Overall Study|Objective progression or relapse|6|||
25342237|NCT00437203|50658594|FG002|Overall Study|Objective progression or relapse|2|||
25342238|NCT00437203|50658595|FG003|Overall Study|Objective progression or relapse|3|||
25342239|NCT00437203|50658596|FG004|Overall Study|Objective progression or relapse|3|||
25342240|NCT00437203|50658597|FG005|Overall Study|Objective progression or relapse|3|||
25342241|NCT00437203|50658598|FG006|Overall Study|Objective progression or relapse|6|||
25342242|NCT00437203|50658599|FG007|Overall Study|Objective progression or relapse|1|||
25342243|NCT00437203|50658600|FG008|Overall Study|Objective progression or relapse|2|||
25342244|NCT00437203|50658601|FG009|Overall Study|Objective progression or relapse|2|||
25342245|NCT00437203|50658592|FG000|Overall Study|Other|0|||
24983909|NCT03192904|50072527|FG000|Overall Study|Lost to Follow-up|0|||
25342246|NCT00437203|50658593|FG001|Overall Study|Other|1|||
25079372|NCT02149121|50187833|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
25342247|NCT00437203|50658594|FG002|Overall Study|Other|0|||
25342248|NCT00437203|50658595|FG003|Overall Study|Other|0|||
25342249|NCT00437203|50658596|FG004|Overall Study|Other|0|||
25342250|NCT00437203|50658597|FG005|Overall Study|Other|0|||
25342251|NCT00437203|50658598|FG006|Overall Study|Other|1|||
25342252|NCT00437203|50658599|FG007|Overall Study|Other|0|||
25342253|NCT00437203|50658600|FG008|Overall Study|Other|0|||
25342254|NCT00437203|50658601|FG009|Overall Study|Other|0|||
25342255|NCT00753272|50658634|FG000|Overall Study|Adverse Event|878|||
25342256|NCT00753272|50658635|FG001|Overall Study|Adverse Event|869|||
25342257|NCT00753272|50658634|FG000|Overall Study|Protocol Violation|28|||
25342258|NCT00753272|50658635|FG001|Overall Study|Protocol Violation|46|||
25342259|NCT00753272|50658634|FG000|Overall Study|Withdrawal by Subject|2481|||
25342260|NCT00753272|50658635|FG001|Overall Study|Withdrawal by Subject|2407|||
25342261|NCT00753272|50658634|FG000|Overall Study|Lost to Follow-up|491|||
25342262|NCT00753272|50658635|FG001|Overall Study|Lost to Follow-up|497|||
25342263|NCT00753272|50658634|FG000|Overall Study|Other|1104|||
25342264|NCT00753272|50658635|FG001|Overall Study|Other|1088|||
25342265|NCT00437125|50658644|FG000|Overall Study|Adverse Event|12|||
25342266|NCT00437125|50658644|FG000|Overall Study|Death|1|||
25342267|NCT00437125|50658644|FG000|Overall Study|Clinical Relapse|1|||
25342268|NCT00437125|50658644|FG000|Overall Study|Lack of Efficacy|1|||
25342269|NCT00437125|50658644|FG000|Overall Study|Lost to Follow-up|1|||
25342270|NCT00437125|50658644|FG000|Overall Study|Withdrawal by Subject|13|||
25342271|NCT00437125|50658644|FG000|Overall Study|Withdrawal by Caregiver|2|||
25342272|NCT00437125|50658644|FG000|Overall Study|Physician Decision|1|||
25342273|NCT00582309|50658660|FG000|Overall Study|Protocol Violation|0|||
25342274|NCT00582309|50658661|FG001|Overall Study|Protocol Violation|0|||
25342275|NCT00582309|50658662|FG002|Overall Study|Protocol Violation|2|||
25342276|NCT00443053|50658672|FG000|Overall Study|Adverse Event|2|||
25342277|NCT00443053|50658673|FG001|Overall Study|Adverse Event|1|||
25342278|NCT00443053|50658672|FG000|Overall Study|Withdrawal by Subject|9|||
25342279|NCT00443053|50658673|FG001|Overall Study|Withdrawal by Subject|18|||
25342280|NCT00443053|50658672|FG000|Overall Study|Lost to Follow-up|4|||
25342281|NCT00443053|50658673|FG001|Overall Study|Lost to Follow-up|5|||
25342282|NCT00443053|50658672|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
25342283|NCT00443053|50658673|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
25342284|NCT00443053|50658672|FG000|Overall Study|Noncompliance|2|||
25342285|NCT00443053|50658673|FG001|Overall Study|Noncompliance|1|||
25342286|NCT00443053|50658672|FG000|Overall Study|Other|3|||
25342287|NCT00443053|50658673|FG001|Overall Study|Other|4|||
25342288|NCT00443053|50658672|FG000|Overall Study|Physician Decision|0|||
25342289|NCT00443053|50658673|FG001|Overall Study|Physician Decision|4|||
25342290|NCT00720798|50658679|FG000|Overall Study|Adverse Event|304|||
25342291|NCT00720798|50658679|FG000|Overall Study|Death|39|||
25342292|NCT00720798|50658679|FG000|Overall Study|Insufficient Therapeutic Response|129|||
25342293|NCT00720798|50658679|FG000|Overall Study|Protocol Violation|4|||
25342294|NCT00720798|50658679|FG000|Overall Study|Refused Treatment|151|||
25342295|NCT00720798|50658679|FG000|Overall Study|Failure to Return|46|||
25342296|NCT00720798|50658679|FG000|Overall Study|Reason not Specified|83|||
25342297|NCT00756002|50658689|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
25342298|NCT00756002|50658690|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
25342299|NCT00756002|50658689|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
25342300|NCT00756002|50658690|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
25342301|NCT00756002|50658689|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
25342302|NCT00756002|50658690|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
25342303|NCT00756002|50658689|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
25342304|NCT00756002|50658690|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
25342305|NCT00756002|50658689|FG000|Double-Blind Treatment Period|Other|2|||
25256860|NCT01106677|50571977|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
25256861|NCT01106677|50571978|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
25256862|NCT01106677|50571979|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
25256863|NCT01106677|50571976|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
25256864|NCT01106677|50571977|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
25256865|NCT01106677|50571978|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
25256866|NCT01106677|50571979|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
25256867|NCT01106677|50571976|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
25256868|NCT01106677|50571977|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
25256869|NCT01106677|50571978|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
25256870|NCT01106677|50571979|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
25256871|NCT01106677|50571976|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
25256872|NCT01106677|50571977|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
25256873|NCT01106677|50571978|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
25342306|NCT00756002|50658690|FG001|Double-Blind Treatment Period|Other|2|||
25342307|NCT00717366|50658698|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
25342308|NCT00717366|50658699|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
25342309|NCT00717366|50658698|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
25342310|NCT00717366|50658699|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
25342311|NCT00717366|50658698|FG000|Core Study Period (20 Weeks)|Death|0|||
25342312|NCT00717366|50658699|FG001|Core Study Period (20 Weeks)|Death|1|||
25342313|NCT00717366|50658698|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
25342314|NCT00717366|50658699|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
25342315|NCT00717366|50658698|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
25342316|NCT00717366|50658699|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
25342317|NCT00717366|50658698|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
25342318|NCT00717366|50658699|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
25342319|NCT00717366|50658698|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
25342320|NCT00717366|50658699|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
25342321|NCT00723606|50658718|FG000|Overall Study|Adverse Event|2|||
25342322|NCT00723606|50658719|FG001|Overall Study|Adverse Event|5|||
25342323|NCT00723606|50658718|FG000|Overall Study|Other|2|||
25342324|NCT00723606|50658719|FG001|Overall Study|Other|0|||
25342325|NCT00723606|50658718|FG000|Overall Study|Withdrawal by Subject|0|||
25342326|NCT00723606|50658719|FG001|Overall Study|Withdrawal by Subject|2|||
25342327|NCT00442351|50658727|FG000|Overall Study|Administrative|6|||
25342328|NCT00442351|50658728|FG001|Overall Study|Administrative|5|||
25342329|NCT00442351|50658727|FG000|Overall Study|Did not meet protocol eligibility|1|||
25342330|NCT00442351|50658728|FG001|Overall Study|Did not meet protocol eligibility|0|||
25342331|NCT00442351|50658727|FG000|Overall Study|Other|0|||
25342332|NCT00442351|50658728|FG001|Overall Study|Other|1|||
25342333|NCT00436501|50658736|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
25342334|NCT00436501|50658737|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
25342335|NCT00436501|50658736|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
25342336|NCT00436501|50658737|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
25342337|NCT00755846|50658750|FG000|Overall Study|Adverse Event|0|||
25342338|NCT00755846|50658751|FG001|Overall Study|Adverse Event|0|||
25342339|NCT00755846|50658752|FG002|Overall Study|Adverse Event|0|||
25342340|NCT00755846|50658753|FG003|Overall Study|Adverse Event|1|||
25342341|NCT00755846|50658754|FG004|Overall Study|Adverse Event|3|||
25342342|NCT00755846|50658755|FG005|Overall Study|Adverse Event|2|||
25342343|NCT00755846|50658750|FG000|Overall Study|Protocol Violation|1|||
25342344|NCT00755846|50658751|FG001|Overall Study|Protocol Violation|1|||
25342345|NCT00755846|50658752|FG002|Overall Study|Protocol Violation|1|||
25342346|NCT00755846|50658753|FG003|Overall Study|Protocol Violation|1|||
25342347|NCT00755846|50658754|FG004|Overall Study|Protocol Violation|1|||
25342348|NCT00755846|50658755|FG005|Overall Study|Protocol Violation|1|||
25342349|NCT00755846|50658750|FG000|Overall Study|Lost to Follow-up|0|||
25342350|NCT00755846|50658751|FG001|Overall Study|Lost to Follow-up|2|||
25342351|NCT00755846|50658752|FG002|Overall Study|Lost to Follow-up|1|||
25342352|NCT00755846|50658753|FG003|Overall Study|Lost to Follow-up|0|||
25342353|NCT00755846|50658754|FG004|Overall Study|Lost to Follow-up|4|||
25342354|NCT00755846|50658755|FG005|Overall Study|Lost to Follow-up|2|||
25342355|NCT00755846|50658750|FG000|Overall Study|Withdrawal by Subject|2|||
25342356|NCT00755846|50658751|FG001|Overall Study|Withdrawal by Subject|3|||
25342357|NCT00755846|50658752|FG002|Overall Study|Withdrawal by Subject|5|||
25342358|NCT00755846|50658753|FG003|Overall Study|Withdrawal by Subject|2|||
25342359|NCT00755846|50658754|FG004|Overall Study|Withdrawal by Subject|0|||
25342360|NCT00755846|50658755|FG005|Overall Study|Withdrawal by Subject|1|||
25342361|NCT00755846|50658750|FG000|Overall Study|Hyperglycemic Rescue|21|||
25342362|NCT00755846|50658751|FG001|Overall Study|Hyperglycemic Rescue|7|||
25342363|NCT00755846|50658752|FG002|Overall Study|Hyperglycemic Rescue|5|||
25342364|NCT00755846|50658753|FG003|Overall Study|Hyperglycemic Rescue|8|||
25342365|NCT00755846|50658754|FG004|Overall Study|Hyperglycemic Rescue|8|||
25342366|NCT00755846|50658755|FG005|Overall Study|Hyperglycemic Rescue|7|||
25342367|NCT00755846|50658750|FG000|Overall Study|Physician Decision|1|||
25342368|NCT00755846|50658751|FG001|Overall Study|Physician Decision|3|||
25342369|NCT00755846|50658752|FG002|Overall Study|Physician Decision|0|||
25342370|NCT00755846|50658753|FG003|Overall Study|Physician Decision|1|||
25342371|NCT00755846|50658754|FG004|Overall Study|Physician Decision|0|||
25342372|NCT00755846|50658755|FG005|Overall Study|Physician Decision|1|||
25342373|NCT00755846|50658750|FG000|Overall Study|Administrative Error|0|||
25342374|NCT00755846|50658751|FG001|Overall Study|Administrative Error|1|||
25342375|NCT00755846|50658752|FG002|Overall Study|Administrative Error|0|||
25342376|NCT00755846|50658753|FG003|Overall Study|Administrative Error|0|||
24983910|NCT03192904|50072528|FG001|Overall Study|Lost to Follow-up|1|||
25342377|NCT00755846|50658754|FG004|Overall Study|Administrative Error|0|||
25342378|NCT00755846|50658755|FG005|Overall Study|Administrative Error|0|||
25342379|NCT00755846|50658750|FG000|Overall Study|Participant Non-compliance|0|||
24983911|NCT03268954|50072536|FG000|Overall Study|Ongoing|23|||
25342380|NCT00755846|50658751|FG001|Overall Study|Participant Non-compliance|0|||
24983912|NCT03268954|50072537|FG001|Overall Study|Ongoing|31|||
25342381|NCT00755846|50658752|FG002|Overall Study|Participant Non-compliance|0|||
25342382|NCT00755846|50658753|FG003|Overall Study|Participant Non-compliance|0|||
25342383|NCT00755846|50658754|FG004|Overall Study|Participant Non-compliance|1|||
25342384|NCT00755846|50658755|FG005|Overall Study|Participant Non-compliance|0|||
25342385|NCT03850093|50658772|FG000|Overall Study|Withdrawal by Subject|1|||
25342386|NCT03850093|50658773|FG001|Overall Study|Withdrawal by Subject|0|||
24983913|NCT03268954|50072536|FG000|Overall Study|Adverse Event|53|||
24983914|NCT03268954|50072537|FG001|Overall Study|Adverse Event|62|||
24983915|NCT03268954|50072536|FG000|Overall Study|Withdrawal by Subject|25|||
24983916|NCT03268954|50072537|FG001|Overall Study|Withdrawal by Subject|16|||
25342387|NCT03850093|50658774|FG002|Overall Study|Withdrawal by Subject|2|||
25342388|NCT00442117|50658784|FG000|Overall Study|Adverse Event|3|||
25342389|NCT00442117|50658785|FG001|Overall Study|Adverse Event|2|||
25342390|NCT00442117|50658784|FG000|Overall Study|Lack of Efficacy|2|||
25342391|NCT00442117|50658785|FG001|Overall Study|Lack of Efficacy|6|||
25342392|NCT00442117|50658784|FG000|Overall Study|Lost to Follow-up|1|||
25342393|NCT00442117|50658785|FG001|Overall Study|Lost to Follow-up|2|||
25342394|NCT00442117|50658784|FG000|Overall Study|Withdrawal by Subject|2|||
25342395|NCT00442117|50658785|FG001|Overall Study|Withdrawal by Subject|2|||
25342396|NCT00442117|50658784|FG000|Overall Study|Major Deviation|25|||
25342397|NCT00442117|50658785|FG001|Overall Study|Major Deviation|20|||
25342398|NCT00442117|50658784|FG000|Overall Study|Non compliance with protocol|3|||
25342399|NCT00442117|50658785|FG001|Overall Study|Non compliance with protocol|5|||
25342400|NCT00442117|50658784|FG000|Overall Study|Met Withdrawal Criteria|2|||
25342401|NCT00442117|50658785|FG001|Overall Study|Met Withdrawal Criteria|1|||
25342402|NCT00752726|50658793|FG000|Overall Study|Lost to Follow-up|2|||
25342403|NCT00752726|50658794|FG001|Overall Study|Lost to Follow-up|1|||
25342404|NCT00752726|50658793|FG000|Overall Study|Adverse Event|3|||
25342405|NCT00752726|50658794|FG001|Overall Study|Adverse Event|0|||
25342406|NCT00752726|50658793|FG000|Overall Study|Withdrawal by Subject|5|||
25342407|NCT00752726|50658794|FG001|Overall Study|Withdrawal by Subject|10|||
25342408|NCT00752726|50658793|FG000|Overall Study|Other Reason|1|||
25342409|NCT00752726|50658794|FG001|Overall Study|Other Reason|2|||
25342410|NCT00755222|50658802|FG000|Overall Study|Withdrawal by Subject|4|||
25342411|NCT00755222|50658803|FG001|Overall Study|Withdrawal by Subject|2|||
25342412|NCT00755222|50658802|FG000|Overall Study|Adverse Event|2|||
25342413|NCT00755222|50658803|FG001|Overall Study|Adverse Event|0|||
25342414|NCT00755222|50658802|FG000|Overall Study|Protocol Violation|2|||
24983917|NCT03268954|50072536|FG000|Overall Study|Progressive Disease|61|||
24983918|NCT03268954|50072537|FG001|Overall Study|Progressive Disease|48|||
24983919|NCT03268954|50072536|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
24983920|NCT03268954|50072537|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
24983921|NCT03268954|50072536|FG000|Overall Study|Reason not Specified|40|||
24983922|NCT03268954|50072537|FG001|Overall Study|Reason not Specified|40|||
24983923|NCT03188536|50072543|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
24983924|NCT03188536|50072543|FG000|Overall Study|Not participated/met inclusion criteria|1|||
24983925|NCT03187756|50072547|FG000|Overall Study|Termination of study|4|||
24983926|NCT03187132|50072553|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
24983927|NCT03187132|50072554|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
24983928|NCT03187132|50072553|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
24983929|NCT03187132|50072554|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
24983930|NCT03187132|50072553|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
24983931|NCT03187132|50072554|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
24983932|NCT03187132|50072553|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
24983933|NCT03187132|50072554|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
24983934|NCT03187132|50072553|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
24983935|NCT03187132|50072554|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
24983936|NCT03187132|50072553|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
24983937|NCT03187132|50072554|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
24983938|NCT03187132|50072553|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
24983939|NCT03187132|50072554|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
24983940|NCT03187132|50072553|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
24983941|NCT03187132|50072554|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
24983942|NCT03187132|50072553|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
24983943|NCT03187132|50072554|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
24983944|NCT03187132|50072553|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
24983945|NCT03187132|50072554|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
24983946|NCT03187132|50072553|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
24983947|NCT03187132|50072554|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
24983948|NCT03184558|50072560|FG000|Overall Study|Withdrawal by Subject|2|||
24983949|NCT03184558|50072560|FG000|Overall Study|Death|16|||
24983950|NCT03184558|50072560|FG000|Overall Study|Lost to Follow-up|2|||
24983951|NCT03184558|50072560|FG000|Overall Study|Other|9|||
25342415|NCT00755222|50658803|FG001|Overall Study|Protocol Violation|0|||
25342416|NCT00441727|50658812|FG000|Overall Study|Protocol Violation|19|||
25342417|NCT00441727|50658813|FG001|Overall Study|Protocol Violation|28|||
25342418|NCT00441727|50658814|FG002|Overall Study|Protocol Violation|32|||
25342419|NCT00441727|50658812|FG000|Overall Study|Adverse Event|26|||
25342420|NCT00441727|50658813|FG001|Overall Study|Adverse Event|33|||
25342421|NCT00441727|50658814|FG002|Overall Study|Adverse Event|28|||
25342422|NCT00441727|50658812|FG000|Overall Study|Lack of Efficacy|7|||
25342423|NCT00441727|50658813|FG001|Overall Study|Lack of Efficacy|8|||
25342424|NCT00441727|50658814|FG002|Overall Study|Lack of Efficacy|48|||
25342425|NCT00441727|50658812|FG000|Overall Study|Withdrawal by Subject|40|||
25342426|NCT00441727|50658813|FG001|Overall Study|Withdrawal by Subject|34|||
25342427|NCT00441727|50658814|FG002|Overall Study|Withdrawal by Subject|47|||
25342428|NCT00441727|50658812|FG000|Overall Study|Lost to Follow-up|5|||
25342429|NCT00441727|50658813|FG001|Overall Study|Lost to Follow-up|6|||
25342430|NCT00441727|50658814|FG002|Overall Study|Lost to Follow-up|5|||
25342431|NCT00441727|50658812|FG000|Overall Study|Safety Reasons|3|||
25342432|NCT00441727|50658813|FG001|Overall Study|Safety Reasons|1|||
25342433|NCT00441727|50658814|FG002|Overall Study|Safety Reasons|3|||
25342434|NCT00441727|50658812|FG000|Overall Study|Various reason specified|6|||
25342435|NCT00441727|50658813|FG001|Overall Study|Various reason specified|8|||
25342436|NCT00441727|50658814|FG002|Overall Study|Various reason specified|5|||
25342437|NCT00770120|50658836|FG000|Overall Study|Progression|31|||
25342438|NCT00770120|50658836|FG000|Overall Study|Adverse Event|11|||
25342439|NCT00770120|50658836|FG000|Overall Study|Not Protocol Specified|11|||
25342440|NCT00770120|50658836|FG000|Overall Study|Death|3|||
25342441|NCT00770120|50658836|FG000|Overall Study|Withdrawal by Subject|2|||
25342442|NCT00770120|50658836|FG000|Overall Study|Ineligible|1|||
25342443|NCT00770120|50658836|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
25342444|NCT00770120|50658836|FG000|Overall Study|Reason under Review|1|||
25342445|NCT00436345|50658843|FG000|Overall Study|ICU resident beyond follow-up period|3|||
25342446|NCT00436345|50658844|FG001|Overall Study|ICU resident beyond follow-up period|0|||
25342447|NCT00769184|50658851|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
25342448|NCT00769184|50658852|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
25342449|NCT00769184|50658851|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
25342450|NCT00769184|50658852|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
25342451|NCT00769184|50658851|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
25342452|NCT00769184|50658852|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
25342453|NCT00768560|50658866|FG000|Intervention Set 1|Adverse Event|0|||
25342454|NCT00768560|50658867|FG001|Intervention Set 1|Adverse Event|1|||
25342455|NCT00768560|50658868|FG002|Intervention Set 1|Adverse Event|0|||
25342456|NCT00768560|50658869|FG003|Intervention Set 1|Adverse Event|0|||
25342457|NCT00768560|50658870|FG004|Intervention Set 1|Adverse Event|0|||
25342458|NCT00768560|50658871|FG005|Intervention Set 1|Adverse Event|0|||
25342459|NCT00468559|50658881|FG000|Open-label Treatment Phase|Adverse Event|5|||
25342460|NCT00468559|50658882|FG001|Open-label Treatment Phase|Adverse Event|0|||
25342461|NCT00468559|50658883|FG002|Open-label Treatment Phase|Adverse Event|0|||
25342462|NCT00468559|50658881|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
25342463|NCT00468559|50658882|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
25342464|NCT00468559|50658883|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
25342465|NCT00468559|50658881|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
25342466|NCT00468559|50658882|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
25342467|NCT00468559|50658883|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
25342468|NCT00468559|50658881|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
25342469|NCT00468559|50658882|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
25342470|NCT00468559|50658883|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
25342471|NCT00468559|50658881|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
25342472|NCT00468559|50658882|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
25342473|NCT00468559|50658883|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
25342474|NCT00754442|50658893|FG000|Overall Study|Withdrawal by Subject|5|||
25342475|NCT00754442|50658894|FG001|Overall Study|Withdrawal by Subject|3|||
25342476|NCT00754052|50658903|FG000|Overall Study|Study terminated by Sponsor|5|||
25342477|NCT00754052|50658904|FG001|Overall Study|Study terminated by Sponsor|3|||
25342478|NCT00747812|50658912|FG000|Overall Study|Research Site Staff Relocation|5|||
25342479|NCT00747812|50658913|FG001|Overall Study|Research Site Staff Relocation|3|||
25342480|NCT02927067|50658921|FG000|Overall Study|Withdrawn Consent|20|||
25342481|NCT02927067|50658922|FG001|Overall Study|Withdrawn Consent|12|||
25342482|NCT02927067|50658921|FG000|Overall Study|Death|18|||
25342483|NCT02927067|50658922|FG001|Overall Study|Death|31|||
25342484|NCT02927067|50658921|FG000|Overall Study|Adverse Event|13|||
25342485|NCT02927067|50658922|FG001|Overall Study|Adverse Event|10|||
25342486|NCT02927067|50658921|FG000|Overall Study|Noncompliance|5|||
25342487|NCT02927067|50658922|FG001|Overall Study|Noncompliance|2|||
25342488|NCT02927067|50658921|FG000|Overall Study|Reason not Specified|4|||
25342489|NCT02927067|50658922|FG001|Overall Study|Reason not Specified|6|||
25342490|NCT01771107|50658932|FG000|Overall Study|Adverse Event|1|||
25342491|NCT01771107|50658933|FG001|Overall Study|Adverse Event|3|||
25342492|NCT01771107|50658932|FG000|Overall Study|Withdrawal by Subject|0|||
25342493|NCT01771107|50658933|FG001|Overall Study|Withdrawal by Subject|2|||
25342494|NCT01771107|50658932|FG000|Overall Study|Lost to Follow-up|0|||
25342495|NCT01771107|50658933|FG001|Overall Study|Lost to Follow-up|1|||
25342496|NCT01771107|50658932|FG000|Overall Study|participant moved|0|||
25342497|NCT01771107|50658933|FG001|Overall Study|participant moved|1|||
25342498|NCT01771107|50658932|FG000|Overall Study|Other|0|||
24983952|NCT03183778|50072564|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
24983953|NCT03182686|50072570|FG000|Overall Study|Lost to Follow-up|2|||
24983954|NCT03182686|50072571|FG001|Overall Study|Lost to Follow-up|0|||
24983955|NCT03182686|50072570|FG000|Overall Study|Adverse Event|2|||
24983956|NCT03182686|50072571|FG001|Overall Study|Adverse Event|0|||
24983957|NCT03182686|50072570|FG000|Overall Study|Withdrawal by Subject|3|||
24983958|NCT03182686|50072571|FG001|Overall Study|Withdrawal by Subject|0|||
24983959|NCT03181594|50072577|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
24983960|NCT03181594|50072577|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
24983961|NCT03181594|50072577|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
24983962|NCT03181594|50072577|FG000|Initial Study Protocol (12-month FU)|Death|1|||
24983963|NCT03181594|50072577|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
24983964|NCT03181594|50072577|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
24983965|NCT03180736|50072583|FG000|Overall Study|Adverse Event|3|||
24983966|NCT03180736|50072584|FG001|Overall Study|Adverse Event|4|||
24983967|NCT03180736|50072583|FG000|Overall Study|Death|10|||
24983968|NCT03180736|50072584|FG001|Overall Study|Death|7|||
24983969|NCT03180736|50072583|FG000|Overall Study|Withdrawal by Subject|5|||
24983970|NCT03180736|50072584|FG001|Overall Study|Withdrawal by Subject|12|||
24983971|NCT03180736|50072583|FG000|Overall Study|Lost to Follow-up|1|||
24983972|NCT03180736|50072584|FG001|Overall Study|Lost to Follow-up|0|||
24983973|NCT03180736|50072583|FG000|Overall Study|Lack of Efficacy|66|||
24983974|NCT03180736|50072584|FG001|Overall Study|Lack of Efficacy|87|||
24983975|NCT03180736|50072583|FG000|Overall Study|Physician Decision|4|||
24983976|NCT03180736|50072584|FG001|Overall Study|Physician Decision|7|||
24983977|NCT03180736|50072583|FG000|Overall Study|randomized but not treated|2|||
24983978|NCT03180736|50072584|FG001|Overall Study|randomized but not treated|3|||
24983979|NCT03178942|50072597|FG000|Overall Study|Withdrawal by Subject|2|||
24983980|NCT03178942|50072598|FG001|Overall Study|Withdrawal by Subject|0|||
24983981|NCT03178942|50072597|FG000|Overall Study|Lost to Follow-up|1|||
24983982|NCT03178942|50072598|FG001|Overall Study|Lost to Follow-up|2|||
24983983|NCT03175198|50072604|FG000|Overall Study|Adverse Event|480|||
24983984|NCT03175198|50072604|FG000|Overall Study|No actual visit|120|||
24983985|NCT03175198|50072604|FG000|Overall Study|Registration rule not followed|4|||
24983986|NCT03175198|50072604|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
24983987|NCT03175198|50072604|FG000|Overall Study|Other personal reason|509|||
24983988|NCT03175198|50072604|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
24983989|NCT03175198|50072604|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
24983990|NCT03175198|50072604|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
24983991|NCT03175198|50072604|FG000|Overall Study|To conduct invasive treatment of operation|53|||
24983992|NCT03175198|50072604|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
24983993|NCT03175120|50072610|FG000|Overall Study|Adverse Event|2|||
24983994|NCT03175120|50072611|FG001|Overall Study|Adverse Event|2|||
24983995|NCT03175120|50072610|FG000|Overall Study|Protocol Violation|5|||
24983996|NCT03175120|50072611|FG001|Overall Study|Protocol Violation|2|||
24983997|NCT03175120|50072610|FG000|Overall Study|Lost to Follow-up|1|||
24983998|NCT03175120|50072611|FG001|Overall Study|Lost to Follow-up|0|||
24983999|NCT03175120|50072610|FG000|Overall Study|Withdrawal by Subject|2|||
24984000|NCT03175120|50072611|FG001|Overall Study|Withdrawal by Subject|5|||
24984001|NCT03175120|50072610|FG000|Overall Study|Other|2|||
24984002|NCT03175120|50072611|FG001|Overall Study|Other|3|||
24984003|NCT03172702|50072617|FG000|Overall Study|Adverse Event|9|||
24984004|NCT03172702|50072617|FG000|Overall Study|Death|2|||
24984005|NCT03172702|50072617|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
24984006|NCT03172702|50072617|FG000|Overall Study|Withdrawal by Subject|5|||
24984007|NCT03172702|50072617|FG000|Overall Study|Other|2|||
24984008|NCT03167242|50072634|FG000|Overall Study|Patient/Guardian Decision|0|||
24984009|NCT03167242|50072635|FG001|Overall Study|Patient/Guardian Decision|1|||
24984010|NCT03167242|50072636|FG002|Overall Study|Patient/Guardian Decision|2|||
24984011|NCT03167242|50072637|FG003|Overall Study|Patient/Guardian Decision|1|||
24984012|NCT03167242|50072638|FG004|Overall Study|Patient/Guardian Decision|1|||
25342499|NCT01771107|50658933|FG001|Overall Study|Other|1|||
25342500|NCT01751685|50658943|FG000|6-mo Followup|Missed study visit|1|||
25342501|NCT01751685|50658944|FG001|6-mo Followup|Missed study visit|0|||
24984013|NCT03167242|50072639|FG005|Overall Study|Patient/Guardian Decision|1|||
24984014|NCT03167242|50072640|FG006|Overall Study|Patient/Guardian Decision|0|||
24984015|NCT03167242|50072641|FG007|Overall Study|Patient/Guardian Decision|0|||
24984016|NCT03167242|50072642|FG008|Overall Study|Patient/Guardian Decision|0|||
24984017|NCT03167242|50072643|FG009|Overall Study|Patient/Guardian Decision|0|||
24984018|NCT03167242|50072644|FG010|Overall Study|Patient/Guardian Decision|1|||
25342502|NCT01751685|50658943|FG000|6-mo Followup|Withdrawal by Subject|2|||
25342503|NCT01751685|50658944|FG001|6-mo Followup|Withdrawal by Subject|2|||
25342504|NCT01751685|50658943|FG000|6-mo Followup|Lost to Follow-up|0|||
25342505|NCT01751685|50658944|FG001|6-mo Followup|Lost to Follow-up|1|||
25342506|NCT01751685|50658943|FG000|12-mo Followup|Lost to Follow-up|5|||
25342507|NCT01751685|50658944|FG001|12-mo Followup|Lost to Follow-up|0|||
25342508|NCT00586508|50658952|FG000|Overall Study|Progressive disease|52|||
25342509|NCT00586508|50658953|FG001|Overall Study|Progressive disease|8|||
25342510|NCT00586508|50658952|FG000|Overall Study|Death|0|||
25342511|NCT00586508|50658953|FG001|Overall Study|Death|1|||
25342512|NCT00586508|50658952|FG000|Overall Study|Adverse Event|12|||
25342513|NCT00586508|50658953|FG001|Overall Study|Adverse Event|4|||
25342514|NCT00586508|50658952|FG000|Overall Study|Withdrawal by Subject|4|||
25342515|NCT00586508|50658953|FG001|Overall Study|Withdrawal by Subject|0|||
25342516|NCT00581919|50658959|FG000|Overall Study|Adverse Event|8|||
25342517|NCT00581919|50658959|FG000|Overall Study|Death|1|||
25342518|NCT00581919|50658959|FG000|Overall Study|Disease Progression|10|||
25342519|NCT00581919|50658959|FG000|Overall Study|Physician Decision|1|||
25342520|NCT00581919|50658959|FG000|Overall Study|Other Complicating Disease|1|||
25342521|NCT00581919|50658959|FG000|Overall Study|Started Non-Protocol Therapy|2|||
25342522|NCT00581919|50658959|FG000|Overall Study|Withdrawal by Subject|1|||
25342523|NCT00723528|50658967|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
25342524|NCT00723528|50658968|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
25342525|NCT00723528|50658969|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
25342526|NCT00723528|50658970|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
25342527|NCT00723528|50658971|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
25342528|NCT00723528|50658972|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
25342529|NCT00723528|50658973|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
25342530|NCT00723528|50658967|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
25342531|NCT00723528|50658968|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
25342532|NCT00723528|50658969|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
25342533|NCT00723528|50658970|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
25342534|NCT00723528|50658971|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
25342535|NCT00723528|50658972|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
25342536|NCT00723528|50658973|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
25256874|NCT01106677|50571979|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
25256875|NCT01106677|50571976|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
25256876|NCT01106677|50571977|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
25256877|NCT01106677|50571978|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
25256878|NCT01106677|50571979|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
25256879|NCT01106677|50571976|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
25256880|NCT01106677|50571977|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
25256881|NCT01106677|50571978|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
25256882|NCT01106677|50571979|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
25256883|NCT01106677|50571976|FG000|Extension Period: Week 26 to Week 52|Other|6|||
25256884|NCT01106677|50571977|FG001|Extension Period: Week 26 to Week 52|Other|5|||
25256885|NCT01106677|50571978|FG002|Extension Period: Week 26 to Week 52|Other|8|||
25256886|NCT01106677|50571979|FG003|Extension Period: Week 26 to Week 52|Other|5|||
25256887|NCT01106287|50572000|FG000|Overall Study|Adverse Event|1|||
25256888|NCT01106287|50572001|FG001|Overall Study|Adverse Event|0|||
25256889|NCT01106287|50572002|FG002|Overall Study|Adverse Event|0|||
25256890|NCT01106287|50572003|FG003|Overall Study|Adverse Event|0|||
25256891|NCT01104493|50572019|FG000|Overall Study|Lost to Follow-up|0|||
25256892|NCT01104493|50572020|FG001|Overall Study|Lost to Follow-up|2|||
25256893|NCT01104415|50572026|FG000|Core Phase|Consent withdrawn by subjects|1|||
25256894|NCT01104415|50572027|FG001|Core Phase|Consent withdrawn by subjects|0|||
25256895|NCT01104415|50572026|FG000|Extension Period|Progressive disease|0|||
25256896|NCT01104415|50572027|FG001|Extension Period|Progressive disease|4|||
25256897|NCT01104415|50572026|FG000|Extension Period|Death|0|||
25256898|NCT01104415|50572027|FG001|Extension Period|Death|1|||
25256899|NCT01104415|50572026|FG000|Extension Period|Physician Decision|0|||
25256900|NCT01104415|50572027|FG001|Extension Period|Physician Decision|1|||
25256901|NCT01104415|50572026|FG000|Extension Period|Transition to Study LX1606.302|0|||
25256902|NCT01104415|50572027|FG001|Extension Period|Transition to Study LX1606.302|4|||
25256903|NCT01104415|50572026|FG000|Extension Period|Heart surgery/feeling miserable|0|||
25256904|NCT01104415|50572027|FG001|Extension Period|Heart surgery/feeling miserable|1|||
25256905|NCT01099579|50572037|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
25256906|NCT01099579|50572038|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
25256907|NCT01099579|50572039|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
25256908|NCT01099579|50572037|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
25256909|NCT01099579|50572038|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
25342537|NCT00723528|50658967|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
25342538|NCT00723528|50658968|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
25342539|NCT00723528|50658969|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
25342540|NCT00723528|50658970|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
25342541|NCT00723528|50658971|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
25342542|NCT00723528|50658972|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
25342543|NCT00723528|50658973|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
25342544|NCT00723528|50658967|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
25342545|NCT00723528|50658968|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
25342546|NCT00723528|50658969|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
25342547|NCT00723528|50658970|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
25342548|NCT00723528|50658971|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
25342549|NCT00723528|50658972|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
25342550|NCT00723528|50658973|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
25342551|NCT00723528|50658967|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
25342552|NCT00723528|50658968|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
25342553|NCT00723528|50658969|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
25342554|NCT00723528|50658970|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
25342555|NCT00723528|50658971|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
25342556|NCT00723528|50658972|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
25342557|NCT00723528|50658973|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
25342558|NCT00723528|50658967|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
25342559|NCT00723528|50658968|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
25342560|NCT00723528|50658969|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
25342561|NCT00723528|50658970|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
25342562|NCT00723528|50658971|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
25342563|NCT00723528|50658972|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
25342564|NCT00723528|50658973|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
25342565|NCT00723528|50658967|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
25342566|NCT00723528|50658968|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
25342567|NCT00723528|50658969|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
25342568|NCT00723528|50658970|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
25342569|NCT00723528|50658971|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
25342570|NCT00723528|50658972|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
25342571|NCT00723528|50658973|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
25342572|NCT00723528|50658967|FG000|Period 2: After Controlled Period|Other|0|||
25342573|NCT00723528|50658968|FG001|Period 2: After Controlled Period|Other|0|||
25342574|NCT00723528|50658969|FG002|Period 2: After Controlled Period|Other|0|||
25342575|NCT00723528|50658970|FG003|Period 2: After Controlled Period|Other|0|||
25342576|NCT00723528|50658971|FG004|Period 2: After Controlled Period|Other|1|||
25342577|NCT00723528|50658972|FG005|Period 2: After Controlled Period|Other|4|||
25342578|NCT00723528|50658973|FG006|Period 2: After Controlled Period|Other|0|||
25256910|NCT01099579|50572039|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
25256911|NCT01099579|50572037|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
25256912|NCT01099579|50572038|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
25256913|NCT01099579|50572039|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
25256914|NCT01099579|50572037|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
25256915|NCT01099579|50572038|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
25256916|NCT01099579|50572039|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
25256917|NCT01099579|50572037|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
25256918|NCT01099579|50572038|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
25256919|NCT01099579|50572039|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
25256920|NCT01099579|50572037|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
25256921|NCT01099579|50572038|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
25256922|NCT01099579|50572039|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
25256923|NCT01099579|50572037|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
25256924|NCT01099579|50572038|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
25256925|NCT01099579|50572039|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
25256926|NCT01099579|50572037|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
25256927|NCT01099579|50572038|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
25256928|NCT01099579|50572039|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
25256929|NCT01099579|50572037|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
25256930|NCT01099579|50572038|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
25256931|NCT01099579|50572039|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
25256932|NCT01099579|50572037|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
25256933|NCT01099579|50572038|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
25342579|NCT00723528|50658967|FG000|Period 2: After Controlled Period|Adverse Event|0|||
25342580|NCT00723528|50658968|FG001|Period 2: After Controlled Period|Adverse Event|0|||
25342581|NCT00723528|50658969|FG002|Period 2: After Controlled Period|Adverse Event|0|||
25342582|NCT00723528|50658970|FG003|Period 2: After Controlled Period|Adverse Event|0|||
25342583|NCT00723528|50658971|FG004|Period 2: After Controlled Period|Adverse Event|1|||
25342584|NCT00723528|50658972|FG005|Period 2: After Controlled Period|Adverse Event|0|||
25342585|NCT00723528|50658973|FG006|Period 2: After Controlled Period|Adverse Event|1|||
25342586|NCT00723528|50658967|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
25342587|NCT00723528|50658968|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
25342588|NCT00723528|50658969|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
25342589|NCT00723528|50658970|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
25342590|NCT00723528|50658971|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
25342591|NCT00723528|50658972|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
25342592|NCT00723528|50658973|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
25342593|NCT00723528|50658967|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
25342594|NCT00723528|50658968|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
25342595|NCT00723528|50658969|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
25342596|NCT00723528|50658970|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
25342597|NCT00723528|50658971|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
25342598|NCT00723528|50658972|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
25342599|NCT00723528|50658973|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
25342600|NCT00751790|50658989|FG000|Overall Study|Lost to Follow-up|1|||
25342601|NCT00751790|50658989|FG000|Overall Study|Death|3|||
25342602|NCT00751790|50658989|FG000|Overall Study|Withdrawal by Subject|1|||
25342603|NCT00723450|50658995|FG000|Open-Label Phase|Adverse Event|26|||
25342604|NCT00723450|50658996|FG001|Open-Label Phase|Adverse Event|0|||
25342605|NCT00723450|50658997|FG002|Open-Label Phase|Adverse Event|0|||
25342606|NCT00723450|50658995|FG000|Open-Label Phase|Lack of Efficacy|18|||
25342607|NCT00723450|50658996|FG001|Open-Label Phase|Lack of Efficacy|0|||
25342608|NCT00723450|50658997|FG002|Open-Label Phase|Lack of Efficacy|0|||
25342609|NCT00723450|50658995|FG000|Open-Label Phase|Protocol Violation|35|||
25342610|NCT00723450|50658996|FG001|Open-Label Phase|Protocol Violation|0|||
25342611|NCT00723450|50658997|FG002|Open-Label Phase|Protocol Violation|0|||
25342612|NCT00723450|50658995|FG000|Open-Label Phase|Lost to Follow-up|7|||
25342613|NCT00723450|50658996|FG001|Open-Label Phase|Lost to Follow-up|0|||
25342614|NCT00723450|50658997|FG002|Open-Label Phase|Lost to Follow-up|0|||
25342615|NCT00723450|50658995|FG000|Open-Label Phase|Physician Decision|2|||
25342616|NCT00723450|50658996|FG001|Open-Label Phase|Physician Decision|0|||
25342617|NCT00723450|50658997|FG002|Open-Label Phase|Physician Decision|0|||
25342618|NCT00723450|50658995|FG000|Open-Label Phase|Withdrawal by Subject|37|||
25342619|NCT00723450|50658996|FG001|Open-Label Phase|Withdrawal by Subject|0|||
25342620|NCT00723450|50658997|FG002|Open-Label Phase|Withdrawal by Subject|0|||
25342621|NCT00723450|50658995|FG000|Randomized Phase|Adverse Event|0|||
25342622|NCT00723450|50658996|FG001|Randomized Phase|Adverse Event|26|||
25342623|NCT00723450|50658997|FG002|Randomized Phase|Adverse Event|17|||
25342624|NCT00723450|50658995|FG000|Randomized Phase|Lack of Efficacy|0|||
25342625|NCT00723450|50658996|FG001|Randomized Phase|Lack of Efficacy|11|||
25342626|NCT00723450|50658997|FG002|Randomized Phase|Lack of Efficacy|11|||
25342627|NCT00723450|50658995|FG000|Randomized Phase|Protocol Violation|0|||
25342628|NCT00723450|50658996|FG001|Randomized Phase|Protocol Violation|9|||
25342629|NCT00723450|50658997|FG002|Randomized Phase|Protocol Violation|13|||
25342630|NCT00723450|50658995|FG000|Randomized Phase|Lost to Follow-up|0|||
25342631|NCT00723450|50658996|FG001|Randomized Phase|Lost to Follow-up|2|||
25342632|NCT00723450|50658997|FG002|Randomized Phase|Lost to Follow-up|3|||
25342633|NCT00723450|50658995|FG000|Randomized Phase|Physician Decision|0|||
25342634|NCT00723450|50658996|FG001|Randomized Phase|Physician Decision|3|||
25342635|NCT00723450|50658997|FG002|Randomized Phase|Physician Decision|1|||
25342636|NCT00723450|50658995|FG000|Randomized Phase|Withdrawal by Subject|0|||
25342637|NCT00723450|50658996|FG001|Randomized Phase|Withdrawal by Subject|14|||
25342638|NCT00723450|50658997|FG002|Randomized Phase|Withdrawal by Subject|22|||
25342639|NCT00751400|50659006|FG000|Overall Study|Lost to Follow-up|10|||
25342640|NCT00585312|50659012|FG000|Overall Study|Adverse Event|3|||
25342641|NCT00585312|50659013|FG001|Overall Study|Adverse Event|0|||
25342642|NCT00585312|50659012|FG000|Overall Study|Lack of Efficacy|6|||
24984019|NCT03167242|50072645|FG011|Overall Study|Patient/Guardian Decision|0|||
25079373|NCT02149121|50187834|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
25342643|NCT00585312|50659013|FG001|Overall Study|Lack of Efficacy|11|||
25342644|NCT00585312|50659012|FG000|Overall Study|Lost to Follow-up|1|||
25342645|NCT00585312|50659013|FG001|Overall Study|Lost to Follow-up|1|||
25342646|NCT00585312|50659012|FG000|Overall Study|Reason not specified|2|||
25342647|NCT00585312|50659013|FG001|Overall Study|Reason not specified|0|||
25342648|NCT00585312|50659012|FG000|Overall Study|Withdrawal by Subject|5|||
25342649|NCT00585312|50659013|FG001|Overall Study|Withdrawal by Subject|1|||
25342650|NCT00585312|50659012|FG000|Overall Study|Study terminated by the sponsor|34|||
25342651|NCT00585312|50659013|FG001|Overall Study|Study terminated by the sponsor|31|||
25342652|NCT00753506|50659021|FG000|Overall Study|Withdrawal by Subject|4|||
25342653|NCT00753506|50659022|FG001|Overall Study|Withdrawal by Subject|1|||
25342654|NCT00753506|50659021|FG000|Overall Study|Lost to Follow-up|2|||
25342655|NCT00753506|50659022|FG001|Overall Study|Lost to Follow-up|0|||
25342656|NCT00753506|50659021|FG000|Overall Study|Other reason|1|||
25342657|NCT00753506|50659022|FG001|Overall Study|Other reason|1|||
25342658|NCT00720096|50659030|FG000|Overall Study|Withdrawal by Subject|0|||
25342659|NCT00720096|50659031|FG001|Overall Study|Withdrawal by Subject|2|||
25342660|NCT00723294|50659037|FG000|Overall Study|Lobular histology|2|||
25342661|NCT00723294|50659037|FG000|Overall Study|>25% intraductal component|1|||
25342662|NCT00723294|50659037|FG000|Overall Study|No MRI tumor enhancement|1|||
25342663|NCT00723294|50659037|FG000|Overall Study|1.0-Tesla MRI|1|||
25342664|NCT00723294|50659037|FG000|Overall Study|No cryoabalation|2|||
25342665|NCT00723294|50659037|FG000|Overall Study|Did not undergo surgery|1|||
25342666|NCT00723294|50659037|FG000|Overall Study|Treated prior to registration|1|||
25342667|NCT00723294|50659037|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
25342668|NCT00723294|50659037|FG000|Overall Study|Benign lesion|1|||
25342669|NCT00723294|50659037|FG000|Overall Study|Withdrawal by Subject|1|||
25342670|NCT00723294|50659037|FG000|Overall Study|No treatment due to probe failure|1|||
25342671|NCT00747344|50659043|FG000|Controlled Period|Adverse Event|3|||
25342672|NCT00747344|50659044|FG001|Controlled Period|Adverse Event|0|||
25342673|NCT00747344|50659045|FG002|Controlled Period|Adverse Event|0|||
25342674|NCT00747344|50659046|FG003|Controlled Period|Adverse Event|0|||
25342675|NCT00747344|50659043|FG000|Controlled Period|Lack of Efficacy|2|||
25342676|NCT00747344|50659044|FG001|Controlled Period|Lack of Efficacy|1|||
25342677|NCT00747344|50659045|FG002|Controlled Period|Lack of Efficacy|0|||
25342678|NCT00747344|50659046|FG003|Controlled Period|Lack of Efficacy|0|||
25342679|NCT00747344|50659043|FG000|Controlled Period|Other|0|||
25342680|NCT00747344|50659044|FG001|Controlled Period|Other|3|||
25342681|NCT00747344|50659045|FG002|Controlled Period|Other|0|||
25342682|NCT00747344|50659046|FG003|Controlled Period|Other|0|||
25342683|NCT00747344|50659043|FG000|After Controlled Period|Adverse Event|0|||
25342684|NCT00747344|50659044|FG001|After Controlled Period|Adverse Event|0|||
25342685|NCT00747344|50659045|FG002|After Controlled Period|Adverse Event|0|||
25342686|NCT00747344|50659046|FG003|After Controlled Period|Adverse Event|1|||
25342687|NCT00580983|50659054|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
25342688|NCT00753896|50659058|FG000|Overall Study|Adverse Event|4|||
25342689|NCT00753896|50659058|FG000|Overall Study|Death|1|||
25342690|NCT00753896|50659058|FG000|Overall Study|Lost to Follow-up|2|||
25342691|NCT00753896|50659058|FG000|Overall Study|Protocol Violation|1|||
25342692|NCT00753896|50659058|FG000|Overall Study|Withdrawal by Subject|4|||
25342693|NCT00753896|50659058|FG000|Overall Study|Entry Criteria Not Met|4|||
25342694|NCT00716976|50659064|FG000|Overall Study|Adverse Event|2|||
25342695|NCT00716976|50659065|FG001|Overall Study|Adverse Event|0|||
25342696|NCT00716976|50659064|FG000|Overall Study|Death|1|||
25342697|NCT00716976|50659065|FG001|Overall Study|Death|0|||
25342698|NCT00716976|50659064|FG000|Overall Study|Physician Decision|2|||
25342699|NCT00716976|50659065|FG001|Overall Study|Physician Decision|2|||
25342700|NCT00716976|50659064|FG000|Overall Study|Withdrawal by Subject|5|||
25342701|NCT00716976|50659065|FG001|Overall Study|Withdrawal by Subject|1|||
25342702|NCT00716976|50659064|FG000|Overall Study|Premature discontinuation cisplatin|5|||
25342703|NCT00716976|50659065|FG001|Overall Study|Premature discontinuation cisplatin|4|||
25342704|NCT00716976|50659064|FG000|Overall Study|Radiation during protocol|1|||
25342705|NCT00716976|50659065|FG001|Overall Study|Radiation during protocol|0|||
25342706|NCT00716976|50659064|FG000|Overall Study|Ineligibles|4|||
25342707|NCT00716976|50659065|FG001|Overall Study|Ineligibles|2|||
25342708|NCT00743444|50659073|FG000|First Intervention|Catheter placement problems|0|||
25342709|NCT00743444|50659074|FG001|First Intervention|Catheter placement problems|1|||
25342710|NCT00743444|50659073|FG000|Washout Period|Adverse Event|0|||
25342711|NCT00743444|50659074|FG001|Washout Period|Adverse Event|1|||
25342712|NCT00743366|50659080|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
25342713|NCT00743366|50659081|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
25342714|NCT00721968|50659089|FG000|Overall Study|Lost to Follow-up|2|||
25342715|NCT00721968|50659090|FG001|Overall Study|Lost to Follow-up|0|||
25342716|NCT00743288|50659096|FG000|Overall Study|Adverse Event|1|||
25342717|NCT00743288|50659097|FG001|Overall Study|Adverse Event|1|||
25342718|NCT00743288|50659098|FG002|Overall Study|Adverse Event|2|||
25342719|NCT00743288|50659099|FG003|Overall Study|Adverse Event|2|||
25342720|NCT00743288|50659100|FG004|Overall Study|Adverse Event|1|||
25342721|NCT00743288|50659101|FG005|Overall Study|Adverse Event|1|||
25342722|NCT00743288|50659102|FG006|Overall Study|Adverse Event|2|||
25342723|NCT00743288|50659096|FG000|Overall Study|Withdrawal by Subject|0|||
25342724|NCT00743288|50659097|FG001|Overall Study|Withdrawal by Subject|0|||
25342725|NCT00743288|50659098|FG002|Overall Study|Withdrawal by Subject|1|||
25342726|NCT00743288|50659099|FG003|Overall Study|Withdrawal by Subject|0|||
25342727|NCT00743288|50659100|FG004|Overall Study|Withdrawal by Subject|0|||
25342728|NCT00743288|50659101|FG005|Overall Study|Withdrawal by Subject|1|||
25342729|NCT00743288|50659102|FG006|Overall Study|Withdrawal by Subject|1|||
25342730|NCT00743288|50659096|FG000|Overall Study|Progressive disease (PD)|2|||
25342731|NCT00743288|50659097|FG001|Overall Study|Progressive disease (PD)|0|||
25342732|NCT00743288|50659098|FG002|Overall Study|Progressive disease (PD)|1|||
25342733|NCT00743288|50659099|FG003|Overall Study|Progressive disease (PD)|4|||
25342734|NCT00743288|50659100|FG004|Overall Study|Progressive disease (PD)|5|||
25342735|NCT00743288|50659101|FG005|Overall Study|Progressive disease (PD)|3|||
25342736|NCT00743288|50659102|FG006|Overall Study|Progressive disease (PD)|6|||
25342737|NCT00743288|50659096|FG000|Overall Study|Worsening of condition (Not PD)|0|||
25342738|NCT00743288|50659097|FG001|Overall Study|Worsening of condition (Not PD)|2|||
25342739|NCT00743288|50659098|FG002|Overall Study|Worsening of condition (Not PD)|1|||
25342740|NCT00743288|50659099|FG003|Overall Study|Worsening of condition (Not PD)|1|||
25342741|NCT00743288|50659100|FG004|Overall Study|Worsening of condition (Not PD)|0|||
25342742|NCT00743288|50659101|FG005|Overall Study|Worsening of condition (Not PD)|0|||
25342743|NCT00743288|50659102|FG006|Overall Study|Worsening of condition (Not PD)|0|||
25342744|NCT00750308|50659113|FG000|First Treatment|Adverse Event|0|||
25342745|NCT00750308|50659114|FG001|First Treatment|Adverse Event|1|||
25342746|NCT00750308|50659115|FG002|First Treatment|Adverse Event|0|||
25342747|NCT00750308|50659116|FG003|First Treatment|Adverse Event|0|||
25342748|NCT00750308|50659117|FG004|First Treatment|Adverse Event|0|||
25342749|NCT00750308|50659118|FG005|First Treatment|Adverse Event|0|||
25342750|NCT00750308|50659119|FG006|First Treatment|Adverse Event|0|||
25342751|NCT00750308|50659120|FG007|First Treatment|Adverse Event|0|||
25342752|NCT00750308|50659121|FG008|First Treatment|Adverse Event|0|||
25342753|NCT00750308|50659122|FG009|First Treatment|Adverse Event|0|||
25342754|NCT00750308|50659123|FG010|First Treatment|Adverse Event|1|||
25342755|NCT00750308|50659124|FG011|First Treatment|Adverse Event|1|||
25342756|NCT00750308|50659113|FG000|First Treatment|Withdrawal by Subject|0|||
25342757|NCT00750308|50659114|FG001|First Treatment|Withdrawal by Subject|0|||
25342758|NCT00750308|50659115|FG002|First Treatment|Withdrawal by Subject|0|||
25342759|NCT00750308|50659116|FG003|First Treatment|Withdrawal by Subject|1|||
25342760|NCT00750308|50659117|FG004|First Treatment|Withdrawal by Subject|0|||
25342761|NCT00750308|50659118|FG005|First Treatment|Withdrawal by Subject|0|||
25342762|NCT00750308|50659119|FG006|First Treatment|Withdrawal by Subject|0|||
25342763|NCT00750308|50659120|FG007|First Treatment|Withdrawal by Subject|1|||
25342764|NCT00750308|50659121|FG008|First Treatment|Withdrawal by Subject|0|||
25342765|NCT00750308|50659122|FG009|First Treatment|Withdrawal by Subject|0|||
25342766|NCT00750308|50659123|FG010|First Treatment|Withdrawal by Subject|0|||
25342767|NCT00750308|50659124|FG011|First Treatment|Withdrawal by Subject|0|||
25342768|NCT00750308|50659113|FG000|Second Treatment|Adverse Event|0|||
25342769|NCT00750308|50659114|FG001|Second Treatment|Adverse Event|0|||
25342770|NCT00750308|50659115|FG002|Second Treatment|Adverse Event|0|||
25342771|NCT00750308|50659116|FG003|Second Treatment|Adverse Event|0|||
25342772|NCT00750308|50659117|FG004|Second Treatment|Adverse Event|0|||
25342773|NCT00750308|50659118|FG005|Second Treatment|Adverse Event|1|||
25342774|NCT00750308|50659119|FG006|Second Treatment|Adverse Event|0|||
25342775|NCT00750308|50659120|FG007|Second Treatment|Adverse Event|0|||
25342776|NCT00750308|50659121|FG008|Second Treatment|Adverse Event|1|||
25342777|NCT00750308|50659122|FG009|Second Treatment|Adverse Event|0|||
25342778|NCT00750308|50659123|FG010|Second Treatment|Adverse Event|0|||
25342779|NCT00750308|50659124|FG011|Second Treatment|Adverse Event|0|||
25342780|NCT00750308|50659113|FG000|Second Treatment|Withdrawal by Subject|0|||
25342781|NCT00750308|50659114|FG001|Second Treatment|Withdrawal by Subject|0|||
25342782|NCT00750308|50659115|FG002|Second Treatment|Withdrawal by Subject|0|||
25342783|NCT00750308|50659116|FG003|Second Treatment|Withdrawal by Subject|0|||
25342784|NCT00750308|50659117|FG004|Second Treatment|Withdrawal by Subject|1|||
25342785|NCT00750308|50659118|FG005|Second Treatment|Withdrawal by Subject|0|||
25342786|NCT00750308|50659119|FG006|Second Treatment|Withdrawal by Subject|0|||
25342787|NCT00750308|50659120|FG007|Second Treatment|Withdrawal by Subject|0|||
25342788|NCT00750308|50659121|FG008|Second Treatment|Withdrawal by Subject|0|||
25342789|NCT00750308|50659122|FG009|Second Treatment|Withdrawal by Subject|0|||
25342790|NCT00750308|50659123|FG010|Second Treatment|Withdrawal by Subject|0|||
25342791|NCT00750308|50659124|FG011|Second Treatment|Withdrawal by Subject|0|||
25342792|NCT00750308|50659113|FG000|Third Treatment|Withdrawal by Subject|0|||
25342793|NCT00750308|50659114|FG001|Third Treatment|Withdrawal by Subject|1|||
25342794|NCT00750308|50659115|FG002|Third Treatment|Withdrawal by Subject|0|||
25342795|NCT00750308|50659116|FG003|Third Treatment|Withdrawal by Subject|0|||
25342796|NCT00750308|50659117|FG004|Third Treatment|Withdrawal by Subject|0|||
25342797|NCT00750308|50659118|FG005|Third Treatment|Withdrawal by Subject|0|||
25342798|NCT00750308|50659119|FG006|Third Treatment|Withdrawal by Subject|0|||
25342799|NCT00750308|50659120|FG007|Third Treatment|Withdrawal by Subject|0|||
25342800|NCT00750308|50659121|FG008|Third Treatment|Withdrawal by Subject|0|||
25342801|NCT00750308|50659122|FG009|Third Treatment|Withdrawal by Subject|0|||
25342802|NCT00750308|50659123|FG010|Third Treatment|Withdrawal by Subject|0|||
25342803|NCT00750308|50659124|FG011|Third Treatment|Withdrawal by Subject|0|||
25342804|NCT00750152|50659140|FG000|Overall Study|Adverse Event|2|||
25342805|NCT00750152|50659141|FG001|Overall Study|Adverse Event|1|||
25342806|NCT00750152|50659140|FG000|Overall Study|Lost to Follow-up|8|||
25342807|NCT00750152|50659141|FG001|Overall Study|Lost to Follow-up|13|||
25342808|NCT00750152|50659140|FG000|Overall Study|Withdrawal by Subject|3|||
25342809|NCT00750152|50659141|FG001|Overall Study|Withdrawal by Subject|3|||
25342810|NCT00750152|50659140|FG000|Overall Study|Physician Decision|1|||
25342811|NCT00750152|50659141|FG001|Overall Study|Physician Decision|1|||
25342812|NCT00750152|50659140|FG000|Overall Study|Non-compliance|0|||
25342813|NCT00750152|50659141|FG001|Overall Study|Non-compliance|1|||
25342814|NCT00750152|50659140|FG000|Overall Study|Termination by sponsor|1|||
25342815|NCT00750152|50659141|FG001|Overall Study|Termination by sponsor|0|||
25342816|NCT00750152|50659140|FG000|Overall Study|Other|7|||
25342817|NCT00750152|50659141|FG001|Overall Study|Other|8|||
25342818|NCT00749996|50659149|FG000|Overall Study|Lost to Follow-up|7|||
25342819|NCT00749996|50659150|FG001|Overall Study|Lost to Follow-up|4|||
25342820|NCT00749996|50659149|FG000|Overall Study|Withdrawal by Subject|5|||
25342821|NCT00749996|50659150|FG001|Overall Study|Withdrawal by Subject|4|||
25342822|NCT00749996|50659149|FG000|Overall Study|Protocol Violation|2|||
25342823|NCT00749996|50659150|FG001|Overall Study|Protocol Violation|3|||
25342824|NCT00749996|50659149|FG000|Overall Study|Physician Decision|2|||
25342825|NCT00749996|50659150|FG001|Overall Study|Physician Decision|0|||
25342826|NCT00749996|50659149|FG000|Overall Study|Pregnancy|0|||
25342827|NCT00749996|50659150|FG001|Overall Study|Pregnancy|2|||
25342828|NCT00749996|50659149|FG000|Overall Study|Adverse Event|1|||
25342829|NCT00749996|50659150|FG001|Overall Study|Adverse Event|0|||
25342830|NCT00749996|50659149|FG000|Overall Study|Death|1|||
25342831|NCT00749996|50659150|FG001|Overall Study|Death|0|||
25342832|NCT00749684|50659156|FG000|Overall Study|Death|1|||
25342833|NCT00749684|50659156|FG000|Overall Study|Adverse Event|27|||
25342834|NCT00749684|50659156|FG000|Overall Study|Participant's Wish|10|||
25342835|NCT00749684|50659156|FG000|Overall Study|Not Documented|1|||
25342836|NCT00749684|50659156|FG000|Overall Study|Progressive Desease|31|||
25342837|NCT00749684|50659156|FG000|Overall Study|Therapy according to protocol + AE|2|||
25342838|NCT00749684|50659156|FG000|Overall Study|AE+discontinuation on participants wish|1|||
25342839|NCT00749684|50659156|FG000|Overall Study|Missing|9|||
25342840|NCT00746798|50659164|FG000|Overall Study|Protocol Violation|0|||
25342841|NCT00746798|50659165|FG001|Overall Study|Protocol Violation|1|||
25342842|NCT00746798|50659166|FG002|Overall Study|Protocol Violation|0|||
25342843|NCT00746798|50659167|FG003|Overall Study|Protocol Violation|0|||
25342844|NCT00746798|50659164|FG000|Overall Study|Withdrawal by Subject|0|||
25342845|NCT00746798|50659165|FG001|Overall Study|Withdrawal by Subject|1|||
25342846|NCT00746798|50659166|FG002|Overall Study|Withdrawal by Subject|1|||
25342847|NCT00746798|50659167|FG003|Overall Study|Withdrawal by Subject|0|||
25342848|NCT00746798|50659164|FG000|Overall Study|Death|0|||
25342849|NCT00746798|50659165|FG001|Overall Study|Death|0|||
25342850|NCT00746798|50659166|FG002|Overall Study|Death|2|||
25342851|NCT00746798|50659167|FG003|Overall Study|Death|0|||
25342852|NCT00746798|50659164|FG000|Overall Study|Participant unable to return for visit|1|||
25342853|NCT00746798|50659165|FG001|Overall Study|Participant unable to return for visit|0|||
25342854|NCT00746798|50659166|FG002|Overall Study|Participant unable to return for visit|0|||
25342855|NCT00746798|50659167|FG003|Overall Study|Participant unable to return for visit|0|||
25342856|NCT00716274|50659180|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
25342857|NCT00716274|50659181|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
25342858|NCT00716274|50659182|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
25342859|NCT00716274|50659183|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
25342860|NCT00716274|50659184|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
25342861|NCT00716274|50659185|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
25342862|NCT00716274|50659180|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
25342863|NCT00716274|50659181|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
25342864|NCT00716274|50659182|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
25342865|NCT00716274|50659183|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
25342866|NCT00716274|50659184|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
25342867|NCT00716274|50659185|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
25342868|NCT00716274|50659180|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
25342869|NCT00716274|50659181|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
25342870|NCT00716274|50659182|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
25342871|NCT00716274|50659183|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
25342872|NCT00716274|50659184|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
25342873|NCT00716274|50659185|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
25342874|NCT00716274|50659180|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
25342875|NCT00716274|50659181|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
25342876|NCT00716274|50659182|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
25342877|NCT00716274|50659183|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
25342878|NCT00716274|50659184|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
25342879|NCT00716274|50659185|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
25342880|NCT00716274|50659180|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
25342881|NCT00716274|50659181|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
25342882|NCT00716274|50659182|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
25342883|NCT00716274|50659183|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
25342884|NCT00716274|50659184|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
25342885|NCT00716274|50659185|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
25342886|NCT00716274|50659180|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
25342887|NCT00716274|50659181|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
25342888|NCT00716274|50659182|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
25342889|NCT00716274|50659183|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
25342890|NCT00716274|50659184|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
25342891|NCT00716274|50659185|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
25342892|NCT00716274|50659180|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
25342893|NCT00716274|50659181|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
25342894|NCT00716274|50659182|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
25342895|NCT00716274|50659183|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
25342896|NCT00716274|50659184|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
25342897|NCT00716274|50659185|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
25342898|NCT00716274|50659180|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
25342899|NCT00716274|50659181|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
25342900|NCT00716274|50659182|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
25342901|NCT00716274|50659183|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
25342902|NCT00716274|50659184|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
25342903|NCT00716274|50659185|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
25342904|NCT00716274|50659180|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
25342905|NCT00716274|50659181|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
25342906|NCT00716274|50659182|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
25342907|NCT00716274|50659183|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
25342908|NCT00716274|50659184|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
25342909|NCT00716274|50659185|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
25342910|NCT00716274|50659180|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
25342911|NCT00716274|50659181|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
25342912|NCT00716274|50659182|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
25342913|NCT00716274|50659183|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
25342914|NCT00716274|50659184|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
25342915|NCT00716274|50659185|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
25342916|NCT00746564|50659202|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
25342917|NCT01298193|50659208|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
25342918|NCT01298193|50659208|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
25342919|NCT01298193|50659208|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
25342920|NCT01298193|50659208|FG000|Efficacy Phase (Second Cycle)|Death|1|||
25342921|NCT00719862|50659217|FG000|Overall Study|Adverse Event|1|||
25342922|NCT00719862|50659218|FG001|Overall Study|Adverse Event|2|||
25342923|NCT00719862|50659217|FG000|Overall Study|Lack of Efficacy|3|||
25342924|NCT00719862|50659218|FG001|Overall Study|Lack of Efficacy|0|||
25342925|NCT00719862|50659217|FG000|Overall Study|Non-Compliance|1|||
25342926|NCT00719862|50659218|FG001|Overall Study|Non-Compliance|0|||
25342927|NCT00719862|50659217|FG000|Overall Study|Withdrawal by Subject|1|||
25342928|NCT00719862|50659218|FG001|Overall Study|Withdrawal by Subject|0|||
25342929|NCT00719862|50659217|FG000|Overall Study|Lost to Follow-up|0|||
25342930|NCT00719862|50659218|FG001|Overall Study|Lost to Follow-up|1|||
25342931|NCT00719862|50659217|FG000|Overall Study|Other|2|||
25342932|NCT00719862|50659218|FG001|Overall Study|Other|3|||
25342933|NCT00742508|50659226|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
25342934|NCT00742508|50659227|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
25342935|NCT00742508|50659226|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
25342936|NCT00742508|50659227|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
25342937|NCT00742508|50659226|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
25342938|NCT00742508|50659227|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
25342939|NCT00742508|50659226|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
25342940|NCT00742508|50659227|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
25342941|NCT00742508|50659226|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
25342942|NCT00742508|50659227|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
25342943|NCT00719706|50659235|FG000|Overall Study|Adverse Event|5|||
25342944|NCT00719706|50659236|FG001|Overall Study|Adverse Event|4|||
25342945|NCT00719706|50659235|FG000|Overall Study|Withdrawal by Subject|1|||
25342946|NCT00719706|50659236|FG001|Overall Study|Withdrawal by Subject|2|||
24984020|NCT03167242|50072634|FG000|Overall Study|Lost to Follow-up|0|||
25342947|NCT00719706|50659235|FG000|Overall Study|Protocol Violation|3|||
25342948|NCT00719706|50659236|FG001|Overall Study|Protocol Violation|0|||
25342949|NCT00742274|50659244|FG000|Overall Study|Death|1|||
25342950|NCT00742274|50659245|FG001|Overall Study|Death|0|||
25342951|NCT00742274|50659244|FG000|Overall Study|Withdrawal by Subject|1|||
25342952|NCT00742274|50659245|FG001|Overall Study|Withdrawal by Subject|2|||
25342953|NCT00742274|50659244|FG000|Overall Study|Removed for medical reasons|1|||
25342954|NCT00742274|50659245|FG001|Overall Study|Removed for medical reasons|1|||
25342955|NCT00719472|50659251|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
25342956|NCT00719472|50659251|FG000|Enrolled in Study|Subject decision to withdraw|8|||
25342957|NCT00719472|50659251|FG000|Enrolled in Study|Various Reasons|17|||
25342958|NCT00719472|50659251|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
25342959|NCT00719472|50659251|FG000|Received Cycle 1 Treatment|Death|5|||
25342960|NCT00719472|50659251|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
25342961|NCT00719472|50659251|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
25342962|NCT00719472|50659251|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
25342963|NCT00719472|50659251|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
25342964|NCT00719472|50659251|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
25342965|NCT00719472|50659251|FG000|Received Cycle 2 Treatment|Death|6|||
25342966|NCT00719472|50659251|FG000|Received Cycle 2 Treatment|Disease progression|3|||
25342967|NCT00719472|50659251|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
25342968|NCT00719472|50659251|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
25342969|NCT00719472|50659251|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
25342970|NCT00719472|50659251|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
25342971|NCT00579501|50659255|FG000|Overall Study|Death|1|||
25342972|NCT00579501|50659255|FG000|Overall Study|End of neoadjuvant therapy|25|||
25342973|NCT00579501|50659255|FG000|Overall Study|toxicity|1|||
25342974|NCT00579501|50659255|FG000|Overall Study|Secondary lesion|1|||
25342975|NCT00579501|50659255|FG000|Overall Study|Radiation therapy before surgery|1|||
25342976|NCT00741338|50659261|FG000|Overall Study|Adverse Event|0|||
25342977|NCT00741338|50659262|FG001|Overall Study|Adverse Event|1|||
25342978|NCT00746330|50659272|FG000|Period 1|Abnormal test procedure result|0|||
25342979|NCT00746330|50659273|FG001|Period 1|Abnormal test procedure result|0|||
25342980|NCT00746330|50659274|FG002|Period 1|Abnormal test procedure result|1|||
25342981|NCT00746330|50659275|FG003|Period 1|Abnormal test procedure result|0|||
25342982|NCT00746252|50659288|FG000|Overall Study|weight gain >7.5 %|1|||
25342983|NCT00746252|50659289|FG001|Overall Study|weight gain >7.5 %|2|||
25342984|NCT00718770|50659295|FG000|Overall Study|Adverse Event|1|||
25342985|NCT00718770|50659295|FG000|Overall Study|Lack of Efficacy|1|||
25342986|NCT00718770|50659295|FG000|Overall Study|Lack of Efficacy|1|||
25342987|NCT00718770|50659295|FG000|Overall Study|Adverse Event|1|||
25342988|NCT00718770|50659295|FG000|Overall Study|Lack of Efficacy|1|||
25342989|NCT00718770|50659295|FG000|Overall Study|Adverse Event|1|||
25342990|NCT00718770|50659295|FG000|Overall Study|Lack of Efficacy|1|||
25342991|NCT00718770|50659295|FG000|Overall Study|Adverse Event|1|||
25342992|NCT00746096|50659301|FG000|Overall Study|Adverse Event|1|||
25342993|NCT00746096|50659302|FG001|Overall Study|Adverse Event|0|||
25342994|NCT00746096|50659301|FG000|Overall Study|Withdrawal by Subject|5|||
25342995|NCT00746096|50659302|FG001|Overall Study|Withdrawal by Subject|1|||
25342996|NCT00746096|50659301|FG000|Overall Study|Lost to Follow-up|2|||
25342997|NCT00746096|50659302|FG001|Overall Study|Lost to Follow-up|1|||
25342998|NCT00746096|50659301|FG000|Overall Study|Protocol Violation|1|||
25342999|NCT00746096|50659302|FG001|Overall Study|Protocol Violation|0|||
25343000|NCT00746096|50659301|FG000|Overall Study|No study drug treatment|1|||
25343001|NCT00746096|50659302|FG001|Overall Study|No study drug treatment|1|||
25343002|NCT00715026|50659308|FG000|Overall Study|Withdrawal by Subject|5|||
25343003|NCT00715026|50659308|FG000|Overall Study|Lost to Follow-up|3|||
25343004|NCT00715026|50659308|FG000|Overall Study|Protocol Violation|1|||
25343005|NCT00715026|50659308|FG000|Overall Study|Surgery done on non-study consented hip|1|||
25343006|NCT00714948|50659312|FG000|Overall Study|Adverse Event|2|||
25343007|NCT00714870|50659318|FG000|Overall Study|Lost to Follow-up|22|||
25343008|NCT00714870|50659319|FG001|Overall Study|Lost to Follow-up|5|||
25343009|NCT00714870|50659318|FG000|Overall Study|patient unable to come b/c back pain|1|||
25343010|NCT00714870|50659319|FG001|Overall Study|patient unable to come b/c back pain|0|||
25343011|NCT00714870|50659318|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
25343012|NCT00714870|50659319|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
25343013|NCT00714714|50659325|FG000|Overall Study|Adverse Event|1|||
25343014|NCT00441337|50659335|FG000|Overall Study|Disease Progression|6|||
25343015|NCT00441337|50659336|FG001|Overall Study|Disease Progression|6|||
25343016|NCT00441337|50659337|FG002|Overall Study|Disease Progression|4|||
25343017|NCT00441337|50659338|FG003|Overall Study|Disease Progression|18|||
25343018|NCT00441337|50659335|FG000|Overall Study|Lost to Follow-up|0|||
25343019|NCT00441337|50659336|FG001|Overall Study|Lost to Follow-up|0|||
25343020|NCT00441337|50659337|FG002|Overall Study|Lost to Follow-up|0|||
25343021|NCT00441337|50659338|FG003|Overall Study|Lost to Follow-up|1|||
24984021|NCT03167242|50072635|FG001|Overall Study|Lost to Follow-up|0|||
25343022|NCT00441337|50659335|FG000|Overall Study|Sponsor Decision|0|||
25343023|NCT00441337|50659336|FG001|Overall Study|Sponsor Decision|0|||
25343024|NCT00441337|50659337|FG002|Overall Study|Sponsor Decision|1|||
25343025|NCT00441337|50659338|FG003|Overall Study|Sponsor Decision|2|||
25343026|NCT00441337|50659335|FG000|Overall Study|Did not meet inclusion criteria|0|||
25343027|NCT00441337|50659336|FG001|Overall Study|Did not meet inclusion criteria|0|||
25343028|NCT00441337|50659337|FG002|Overall Study|Did not meet inclusion criteria|1|||
25343029|NCT00441337|50659338|FG003|Overall Study|Did not meet inclusion criteria|0|||
25343030|NCT00578877|50659358|FG000|Overall Study|Lost to Follow-up|8|||
25343031|NCT00578877|50659359|FG001|Overall Study|Lost to Follow-up|10|||
25343032|NCT00578877|50659358|FG000|Overall Study|early discontinue|61|||
25343033|NCT00578877|50659359|FG001|Overall Study|early discontinue|101|||
25343034|NCT00578877|50659358|FG000|Overall Study|did not provide follow-up data|12|||
25343035|NCT00578877|50659359|FG001|Overall Study|did not provide follow-up data|17|||
25343036|NCT00468481|50659367|FG000|Overall Study|Adverse Event|13|||
25343037|NCT00468481|50659368|FG001|Overall Study|Adverse Event|3|||
25343038|NCT00468481|50659367|FG000|Overall Study|Lost to Follow-up|25|||
25343039|NCT00468481|50659368|FG001|Overall Study|Lost to Follow-up|8|||
25343040|NCT00468481|50659367|FG000|Overall Study|Pregnancy|2|||
25343041|NCT00468481|50659368|FG001|Overall Study|Pregnancy|0|||
24984022|NCT03167242|50072636|FG002|Overall Study|Lost to Follow-up|1|||
24984023|NCT03167242|50072637|FG003|Overall Study|Lost to Follow-up|0|||
24984024|NCT03167242|50072638|FG004|Overall Study|Lost to Follow-up|0|||
25343042|NCT00468481|50659367|FG000|Overall Study|Protocol Violation|18|||
25343043|NCT00468481|50659368|FG001|Overall Study|Protocol Violation|8|||
25343044|NCT00468481|50659367|FG000|Overall Study|Withdrawal by Subject|12|||
25343045|NCT00468481|50659368|FG001|Overall Study|Withdrawal by Subject|3|||
25343046|NCT00468481|50659367|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
25343047|NCT00468481|50659368|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
25343048|NCT00468481|50659367|FG000|Overall Study|Prohibited Medication|1|||
25343049|NCT00468481|50659368|FG001|Overall Study|Prohibited Medication|1|||
25343050|NCT00468481|50659367|FG000|Overall Study|Egg Donor|1|||
25343051|NCT00468481|50659368|FG001|Overall Study|Egg Donor|0|||
25343052|NCT00468481|50659367|FG000|Overall Study|Moved out of area|4|||
25343053|NCT00468481|50659368|FG001|Overall Study|Moved out of area|1|||
25343054|NCT00468481|50659367|FG000|Overall Study|Non-Compliance|5|||
25343055|NCT00468481|50659368|FG001|Overall Study|Non-Compliance|0|||
25343056|NCT00468481|50659367|FG000|Overall Study|Other|6|||
25343057|NCT00468481|50659368|FG001|Overall Study|Other|0|||
25343058|NCT00714168|50659376|FG000|Overall Study|Pregnancy|5|||
25343059|NCT00714168|50659377|FG001|Overall Study|Pregnancy|4|||
25343060|NCT00714168|50659376|FG000|Overall Study|Lost to Follow-up|32|||
24984025|NCT03167242|50072639|FG005|Overall Study|Lost to Follow-up|1|||
24984026|NCT03167242|50072640|FG006|Overall Study|Lost to Follow-up|2|||
24984027|NCT03167242|50072641|FG007|Overall Study|Lost to Follow-up|1|||
24984028|NCT03167242|50072642|FG008|Overall Study|Lost to Follow-up|0|||
24984029|NCT03167242|50072643|FG009|Overall Study|Lost to Follow-up|0|||
24984030|NCT03167242|50072644|FG010|Overall Study|Lost to Follow-up|1|||
25343061|NCT00714168|50659377|FG001|Overall Study|Lost to Follow-up|50|||
25343062|NCT00714168|50659376|FG000|Overall Study|Relocation|4|||
25343063|NCT00714168|50659377|FG001|Overall Study|Relocation|3|||
25343064|NCT00714168|50659376|FG000|Overall Study|Non-study medical condition|3|||
25343065|NCT00714168|50659377|FG001|Overall Study|Non-study medical condition|2|||
24984031|NCT03167242|50072645|FG011|Overall Study|Lost to Follow-up|1|||
24984032|NCT03167242|50072634|FG000|Overall Study|Reason not provided|0|||
24984033|NCT03167242|50072635|FG001|Overall Study|Reason not provided|0|||
24984034|NCT03167242|50072636|FG002|Overall Study|Reason not provided|0|||
24984035|NCT03167242|50072637|FG003|Overall Study|Reason not provided|0|||
24984036|NCT03167242|50072638|FG004|Overall Study|Reason not provided|0|||
24984037|NCT03167242|50072639|FG005|Overall Study|Reason not provided|0|||
24984038|NCT03167242|50072640|FG006|Overall Study|Reason not provided|0|||
24984039|NCT03167242|50072641|FG007|Overall Study|Reason not provided|0|||
24984040|NCT03167242|50072642|FG008|Overall Study|Reason not provided|1|||
24984041|NCT03167242|50072643|FG009|Overall Study|Reason not provided|0|||
25343066|NCT00713700|50659383|FG000|Overall Study|Lost to Follow-up|3|||
25343067|NCT00713700|50659383|FG000|Overall Study|Withdrawal by Subject|1|||
25343068|NCT00468169|50659389|FG000|Overall Study|Withdrawal by Subject|1|||
25343069|NCT00468169|50659390|FG001|Overall Study|Withdrawal by Subject|0|||
25343070|NCT00435487|50659400|FG000|Overall Study|Death|3|||
25343071|NCT00435487|50659401|FG001|Overall Study|Death|4|||
25343072|NCT00435487|50659400|FG000|Overall Study|Adverse Event|0|||
25343073|NCT00435487|50659401|FG001|Overall Study|Adverse Event|3|||
24984042|NCT03167242|50072644|FG010|Overall Study|Reason not provided|0|||
24984043|NCT03167242|50072645|FG011|Overall Study|Reason not provided|0|||
24984044|NCT03286426|50072697|FG000|Overall Study|Physician Decision|3|||
24984045|NCT02882152|50072716|FG000|Overall Study|Lost to Follow-up|1|||
25343074|NCT00435487|50659400|FG000|Overall Study|Lost to Follow-up|2|||
24984046|NCT02882152|50072717|FG001|Overall Study|Lost to Follow-up|0|||
25343075|NCT00435487|50659401|FG001|Overall Study|Lost to Follow-up|2|||
25343076|NCT00435487|50659400|FG000|Overall Study|Other|5|||
25343077|NCT00435487|50659401|FG001|Overall Study|Other|2|||
25343078|NCT00435487|50659400|FG000|Overall Study|Withdrawal by Subject|2|||
25343079|NCT00435487|50659401|FG001|Overall Study|Withdrawal by Subject|1|||
25343080|NCT00435487|50659400|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
25343081|NCT00435487|50659401|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
25343082|NCT00435487|50659400|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
25343083|NCT00435487|50659401|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
25343084|NCT00579345|50659415|FG000|Overall Study|Withdrawal by Subject|2|||
25343085|NCT00579345|50659416|FG001|Overall Study|Withdrawal by Subject|0|||
25343086|NCT00579345|50659417|FG002|Overall Study|Withdrawal by Subject|0|||
25343087|NCT00579345|50659418|FG003|Overall Study|Withdrawal by Subject|0|||
25343088|NCT00579345|50659419|FG004|Overall Study|Withdrawal by Subject|0|||
25343089|NCT00579345|50659420|FG005|Overall Study|Withdrawal by Subject|0|||
25343090|NCT00579345|50659421|FG006|Overall Study|Withdrawal by Subject|0|||
25343091|NCT00579345|50659422|FG007|Overall Study|Withdrawal by Subject|1|||
25343092|NCT00579345|50659415|FG000|Overall Study|Lost to Follow-up|1|||
25343093|NCT00579345|50659416|FG001|Overall Study|Lost to Follow-up|0|||
25343094|NCT00579345|50659417|FG002|Overall Study|Lost to Follow-up|0|||
25343095|NCT00579345|50659418|FG003|Overall Study|Lost to Follow-up|0|||
25343096|NCT00579345|50659419|FG004|Overall Study|Lost to Follow-up|0|||
25343097|NCT00579345|50659420|FG005|Overall Study|Lost to Follow-up|0|||
25343098|NCT00579345|50659421|FG006|Overall Study|Lost to Follow-up|0|||
25343099|NCT00579345|50659422|FG007|Overall Study|Lost to Follow-up|0|||
25343100|NCT00579345|50659415|FG000|Overall Study|Adverse Event|0|||
25343101|NCT00579345|50659416|FG001|Overall Study|Adverse Event|0|||
25343102|NCT00579345|50659417|FG002|Overall Study|Adverse Event|1|||
25343103|NCT00579345|50659418|FG003|Overall Study|Adverse Event|0|||
25343104|NCT00579345|50659419|FG004|Overall Study|Adverse Event|0|||
25343105|NCT00579345|50659420|FG005|Overall Study|Adverse Event|0|||
25343106|NCT00579345|50659421|FG006|Overall Study|Adverse Event|0|||
25343107|NCT00579345|50659422|FG007|Overall Study|Adverse Event|0|||
25343108|NCT00579345|50659415|FG000|Overall Study|Protocol Violation|1|||
25343109|NCT00579345|50659416|FG001|Overall Study|Protocol Violation|0|||
25343110|NCT00579345|50659417|FG002|Overall Study|Protocol Violation|0|||
25343111|NCT00579345|50659418|FG003|Overall Study|Protocol Violation|0|||
25343112|NCT00579345|50659419|FG004|Overall Study|Protocol Violation|0|||
25343113|NCT00579345|50659420|FG005|Overall Study|Protocol Violation|0|||
25343114|NCT00579345|50659421|FG006|Overall Study|Protocol Violation|0|||
25343115|NCT00579345|50659422|FG007|Overall Study|Protocol Violation|1|||
25343116|NCT00579345|50659415|FG000|Overall Study|Death|1|||
25343117|NCT00579345|50659416|FG001|Overall Study|Death|1|||
25343118|NCT00579345|50659417|FG002|Overall Study|Death|1|||
25343119|NCT00579345|50659418|FG003|Overall Study|Death|1|||
25343120|NCT00579345|50659419|FG004|Overall Study|Death|0|||
25343121|NCT00579345|50659420|FG005|Overall Study|Death|0|||
25343122|NCT00579345|50659421|FG006|Overall Study|Death|0|||
25343123|NCT00579345|50659422|FG007|Overall Study|Death|0|||
25343124|NCT00795821|50659470|FG000|Acute Treatment Phase|Adverse Event|23|||
25343125|NCT00795821|50659471|FG001|Acute Treatment Phase|Adverse Event|4|||
25343126|NCT00795821|50659470|FG000|Acute Treatment Phase|Death|1|||
25343127|NCT00795821|50659471|FG001|Acute Treatment Phase|Death|0|||
25343128|NCT00795821|50659470|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
25343129|NCT00795821|50659471|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
25343130|NCT00795821|50659470|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
25343131|NCT00795821|50659471|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
25343132|NCT00795821|50659470|FG000|Acute Treatment Phase|Physician Decision|1|||
24984047|NCT00286091|50072725|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
24984048|NCT00286091|50072726|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
25343133|NCT00795821|50659471|FG001|Acute Treatment Phase|Physician Decision|1|||
25343134|NCT00795821|50659470|FG000|Acute Treatment Phase|Protocol Violation|1|||
25343135|NCT00795821|50659471|FG001|Acute Treatment Phase|Protocol Violation|2|||
25343136|NCT00795821|50659470|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
25343137|NCT00795821|50659471|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
25343138|NCT00795821|50659470|FG000|Long-term Extension Phase|Adverse Event|25|||
25343139|NCT00795821|50659471|FG001|Long-term Extension Phase|Adverse Event|32|||
25343140|NCT00795821|50659470|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
25343141|NCT00795821|50659471|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
25343142|NCT00795821|50659470|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
25343143|NCT00795821|50659471|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
25343144|NCT00795821|50659470|FG000|Long-term Extension Phase|Physician Decision|1|||
25343145|NCT00795821|50659471|FG001|Long-term Extension Phase|Physician Decision|2|||
25343146|NCT00795821|50659470|FG000|Long-term Extension Phase|Protocol Violation|3|||
25343147|NCT00795821|50659471|FG001|Long-term Extension Phase|Protocol Violation|5|||
25343148|NCT00795821|50659470|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
25343149|NCT00795821|50659471|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
25343150|NCT00795821|50659470|FG000|Taper Phase|Adverse Event|2|||
25343151|NCT00795821|50659471|FG001|Taper Phase|Adverse Event|0|||
25343152|NCT00795821|50659470|FG000|Taper Phase|Lost to Follow-up|1|||
25343153|NCT00795821|50659471|FG001|Taper Phase|Lost to Follow-up|0|||
25343154|NCT00795821|50659470|FG000|Taper Phase|Physician Decision|2|||
25343155|NCT00795821|50659471|FG001|Taper Phase|Physician Decision|0|||
25343156|NCT00795821|50659470|FG000|Taper Phase|Withdrawal by Subject|4|||
25343157|NCT00795821|50659471|FG001|Taper Phase|Withdrawal by Subject|0|||
25343158|NCT00578643|50659487|FG000|Overall Study|Death|1|||
25343159|NCT00578643|50659487|FG000|Overall Study|Lost to Follow-up|1|||
25343160|NCT00578565|50659491|FG000|Overall Study|Adverse Event|3|||
25343161|NCT00741260|50659503|FG000|Overall Study|Disease Progression|3|||
25343162|NCT00741260|50659504|FG001|Overall Study|Disease Progression|5|||
25343163|NCT00741260|50659505|FG002|Overall Study|Disease Progression|3|||
25343164|NCT00741260|50659506|FG003|Overall Study|Disease Progression|3|||
25343165|NCT00741260|50659507|FG004|Overall Study|Disease Progression|5|||
25343166|NCT00741260|50659508|FG005|Overall Study|Disease Progression|37|||
25343167|NCT00741260|50659509|FG006|Overall Study|Disease Progression|4|||
25343168|NCT00741260|50659503|FG000|Overall Study|Death|0|||
25343169|NCT00741260|50659504|FG001|Overall Study|Death|1|||
25343170|NCT00741260|50659505|FG002|Overall Study|Death|0|||
25343171|NCT00741260|50659506|FG003|Overall Study|Death|1|||
25343172|NCT00741260|50659507|FG004|Overall Study|Death|2|||
25343173|NCT00741260|50659508|FG005|Overall Study|Death|2|||
25343174|NCT00741260|50659509|FG006|Overall Study|Death|1|||
25343175|NCT00741260|50659503|FG000|Overall Study|Withdrawal by Subject|0|||
25343176|NCT00741260|50659504|FG001|Overall Study|Withdrawal by Subject|0|||
25343177|NCT00741260|50659505|FG002|Overall Study|Withdrawal by Subject|0|||
25343178|NCT00741260|50659506|FG003|Overall Study|Withdrawal by Subject|0|||
25343179|NCT00741260|50659507|FG004|Overall Study|Withdrawal by Subject|1|||
25343180|NCT00741260|50659508|FG005|Overall Study|Withdrawal by Subject|3|||
25343181|NCT00741260|50659509|FG006|Overall Study|Withdrawal by Subject|1|||
25343182|NCT00741260|50659503|FG000|Overall Study|Physician Decision|1|||
25343183|NCT00741260|50659504|FG001|Overall Study|Physician Decision|1|||
25343184|NCT00741260|50659505|FG002|Overall Study|Physician Decision|0|||
25343185|NCT00741260|50659506|FG003|Overall Study|Physician Decision|0|||
25343186|NCT00741260|50659507|FG004|Overall Study|Physician Decision|0|||
25343187|NCT00741260|50659508|FG005|Overall Study|Physician Decision|0|||
25343188|NCT00741260|50659509|FG006|Overall Study|Physician Decision|0|||
25343189|NCT00741260|50659503|FG000|Overall Study|Other|2|||
25343190|NCT00741260|50659504|FG001|Overall Study|Other|1|||
25343191|NCT00741260|50659505|FG002|Overall Study|Other|1|||
25343192|NCT00741260|50659506|FG003|Overall Study|Other|2|||
25343193|NCT00741260|50659507|FG004|Overall Study|Other|1|||
25343194|NCT00741260|50659508|FG005|Overall Study|Other|3|||
25343195|NCT00741260|50659509|FG006|Overall Study|Other|1|||
25343196|NCT00740870|50659530|FG000|Overall Study|Not Catheterized|4|||
25343197|NCT00740870|50659530|FG000|Overall Study|Further testing contraindicated implant|17|||
25343198|NCT00740792|50659541|FG000|Overall Study|Adverse Event|3|||
25343199|NCT00740792|50659542|FG001|Overall Study|Adverse Event|1|||
25343200|NCT00740792|50659543|FG002|Overall Study|Adverse Event|1|||
25343201|NCT00740792|50659544|FG003|Overall Study|Adverse Event|3|||
25343202|NCT00740792|50659541|FG000|Overall Study|Lack of Efficacy|1|||
25343203|NCT00740792|50659542|FG001|Overall Study|Lack of Efficacy|1|||
25343204|NCT00740792|50659543|FG002|Overall Study|Lack of Efficacy|0|||
25343205|NCT00740792|50659544|FG003|Overall Study|Lack of Efficacy|3|||
25343206|NCT00740792|50659541|FG000|Overall Study|Lost to Follow-up|2|||
25343207|NCT00740792|50659542|FG001|Overall Study|Lost to Follow-up|1|||
25343208|NCT00740792|50659543|FG002|Overall Study|Lost to Follow-up|0|||
25343209|NCT00740792|50659544|FG003|Overall Study|Lost to Follow-up|0|||
25343210|NCT00740792|50659541|FG000|Overall Study|Protocol Violation|0|||
25343211|NCT00740792|50659542|FG001|Overall Study|Protocol Violation|1|||
25343212|NCT00740792|50659543|FG002|Overall Study|Protocol Violation|0|||
25343213|NCT00740792|50659544|FG003|Overall Study|Protocol Violation|2|||
25256934|NCT01099579|50572039|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
25256935|NCT01103713|50572049|FG000|Overall Study|Lost to Follow-up|2|||
25256936|NCT01103713|50572049|FG000|Overall Study|Withdrawal by Subject|8|||
25256937|NCT01103713|50572049|FG000|Overall Study|Study terminated by sponsor|2|||
25256938|NCT01103713|50572049|FG000|Overall Study|Other|1|||
25256939|NCT01103479|50572059|FG000|Overall Study|Up to date with CRC screening|1|||
25256940|NCT01103479|50572060|FG001|Overall Study|Up to date with CRC screening|9|||
24984049|NCT00286091|50072725|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
24984050|NCT00286091|50072726|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
25256941|NCT01103479|50572061|FG002|Overall Study|Up to date with CRC screening|12|||
25343214|NCT00740792|50659541|FG000|Overall Study|Withdrawal by Subject|1|||
25256942|NCT01103479|50572059|FG000|Overall Study|Family history of CRC|1|||
25343215|NCT00740792|50659542|FG001|Overall Study|Withdrawal by Subject|1|||
25343216|NCT00740792|50659543|FG002|Overall Study|Withdrawal by Subject|0|||
25343217|NCT00740792|50659544|FG003|Overall Study|Withdrawal by Subject|0|||
25343218|NCT00740792|50659541|FG000|Overall Study|administrative|3|||
25343219|NCT00740792|50659542|FG001|Overall Study|administrative|3|||
25343220|NCT00740792|50659543|FG002|Overall Study|administrative|8|||
25343221|NCT00740792|50659544|FG003|Overall Study|administrative|2|||
25343222|NCT00740714|50659557|FG000|Overall Study|Withdrawal by Subject|17|||
25343223|NCT00740714|50659558|FG001|Overall Study|Withdrawal by Subject|19|||
25343224|NCT00740714|50659559|FG002|Overall Study|Withdrawal by Subject|29|||
25343225|NCT00788957|50659571|FG000|Part 1|Death|8|||
25343226|NCT00788957|50659572|FG001|Part 1|Death|0|||
25343227|NCT00788957|50659573|FG002|Part 1|Death|0|||
25343228|NCT00788957|50659574|FG003|Part 1|Death|0|||
25343229|NCT00788957|50659575|FG004|Part 1|Death|0|||
25343230|NCT00788957|50659576|FG005|Part 1|Death|0|||
25343231|NCT00788957|50659571|FG000|Part 1|Lost to Follow-up|1|||
25343232|NCT00788957|50659572|FG001|Part 1|Lost to Follow-up|0|||
25343233|NCT00788957|50659573|FG002|Part 1|Lost to Follow-up|0|||
25343234|NCT00788957|50659574|FG003|Part 1|Lost to Follow-up|0|||
25343235|NCT00788957|50659575|FG004|Part 1|Lost to Follow-up|0|||
25343236|NCT00788957|50659576|FG005|Part 1|Lost to Follow-up|0|||
25343237|NCT00788957|50659571|FG000|Part 2|Withdrawal by Subject|0|||
25343238|NCT00788957|50659572|FG001|Part 2|Withdrawal by Subject|9|||
25343239|NCT00788957|50659573|FG002|Part 2|Withdrawal by Subject|5|||
25343240|NCT00788957|50659574|FG003|Part 2|Withdrawal by Subject|3|||
25343241|NCT00788957|50659575|FG004|Part 2|Withdrawal by Subject|0|||
25343242|NCT00788957|50659576|FG005|Part 2|Withdrawal by Subject|0|||
25343243|NCT00788957|50659571|FG000|Part 2|Death|0|||
25343244|NCT00788957|50659572|FG001|Part 2|Death|32|||
25343245|NCT00788957|50659573|FG002|Part 2|Death|35|||
25343246|NCT00788957|50659574|FG003|Part 2|Death|37|||
25343247|NCT00788957|50659575|FG004|Part 2|Death|0|||
25343248|NCT00788957|50659576|FG005|Part 2|Death|0|||
25343249|NCT00788957|50659571|FG000|Part 2|Lost to Follow-up|0|||
25343250|NCT00788957|50659572|FG001|Part 2|Lost to Follow-up|0|||
25343251|NCT00788957|50659573|FG002|Part 2|Lost to Follow-up|3|||
25343252|NCT00788957|50659574|FG003|Part 2|Lost to Follow-up|0|||
25343253|NCT00788957|50659575|FG004|Part 2|Lost to Follow-up|0|||
25343254|NCT00788957|50659576|FG005|Part 2|Lost to Follow-up|0|||
25343255|NCT00788957|50659571|FG000|Part 2|On-study at time of data cut-off|0|||
25343256|NCT00788957|50659572|FG001|Part 2|On-study at time of data cut-off|1|||
25343257|NCT00788957|50659573|FG002|Part 2|On-study at time of data cut-off|1|||
25343258|NCT00788957|50659574|FG003|Part 2|On-study at time of data cut-off|1|||
25343259|NCT00788957|50659575|FG004|Part 2|On-study at time of data cut-off|0|||
25343260|NCT00788957|50659576|FG005|Part 2|On-study at time of data cut-off|0|||
25343261|NCT00788957|50659571|FG000|Part 3|Withdrawal by Subject|0|||
25343262|NCT00788957|50659572|FG001|Part 3|Withdrawal by Subject|0|||
25343263|NCT00788957|50659573|FG002|Part 3|Withdrawal by Subject|0|||
25343264|NCT00788957|50659574|FG003|Part 3|Withdrawal by Subject|0|||
25343265|NCT00788957|50659575|FG004|Part 3|Withdrawal by Subject|0|||
25343266|NCT00788957|50659576|FG005|Part 3|Withdrawal by Subject|2|||
25343267|NCT00788957|50659571|FG000|Part 3|Death|0|||
25343268|NCT00788957|50659572|FG001|Part 3|Death|0|||
25343269|NCT00788957|50659573|FG002|Part 3|Death|0|||
25343270|NCT00788957|50659574|FG003|Part 3|Death|0|||
25343271|NCT00788957|50659575|FG004|Part 3|Death|8|||
25343272|NCT00788957|50659576|FG005|Part 3|Death|9|||
25343273|NCT00788957|50659571|FG000|Part 3|On-study at time of data cut-off|0|||
25343274|NCT00788957|50659572|FG001|Part 3|On-study at time of data cut-off|0|||
24984051|NCT00286091|50072725|FG000|Double-blind Treatment Phase|Death|58|||
24984052|NCT00286091|50072726|FG001|Double-blind Treatment Phase|Death|65|||
24984053|NCT00286091|50072725|FG000|Double-blind Treatment Phase|Adverse Event|28|||
24984054|NCT00286091|50072726|FG001|Double-blind Treatment Phase|Adverse Event|40|||
24984055|NCT00286091|50072725|FG000|Double-blind Treatment Phase|Disease Progression|22|||
24984056|NCT00286091|50072726|FG001|Double-blind Treatment Phase|Disease Progression|35|||
24984057|NCT00286091|50072725|FG000|Double-blind Treatment Phase|Other|25|||
24984058|NCT00286091|50072726|FG001|Double-blind Treatment Phase|Other|33|||
25343275|NCT00788957|50659573|FG002|Part 3|On-study at time of data cut-off|0|||
25343276|NCT00788957|50659574|FG003|Part 3|On-study at time of data cut-off|0|||
25343277|NCT00788957|50659575|FG004|Part 3|On-study at time of data cut-off|1|||
24984059|NCT00286091|50072725|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
24984060|NCT00286091|50072726|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
24984061|NCT00286091|50072725|FG000|Double-blind Treatment Phase|Noncompliance|8|||
25343278|NCT00788957|50659576|FG005|Part 3|On-study at time of data cut-off|0|||
25343279|NCT00740636|50659595|FG000|Overall Study|Adverse Event|0|||
25343280|NCT00740636|50659596|FG001|Overall Study|Adverse Event|2|||
25343281|NCT00740636|50659595|FG000|Overall Study|Patient Ineligible|0|||
25343282|NCT00740636|50659596|FG001|Overall Study|Patient Ineligible|1|||
25343283|NCT00740636|50659595|FG000|Overall Study|Patient Not Treated|0|||
25343284|NCT00740636|50659596|FG001|Overall Study|Patient Not Treated|1|||
25343285|NCT00740636|50659595|FG000|Overall Study|Progressive Disease|1|||
25343286|NCT00740636|50659596|FG001|Overall Study|Progressive Disease|0|||
25343287|NCT00740636|50659595|FG000|Overall Study|Death|1|||
25343288|NCT00740636|50659596|FG001|Overall Study|Death|0|||
25343289|NCT00735254|50659606|FG000|Overall Study|Protocol Violation|1|||
25343290|NCT00735254|50659607|FG001|Overall Study|Protocol Violation|1|||
25343291|NCT00735254|50659608|FG002|Overall Study|Protocol Violation|1|||
25343292|NCT00735254|50659609|FG003|Overall Study|Protocol Violation|0|||
25343293|NCT00795509|50659619|FG000|Overall Study|Protocol Violation|31|||
25343294|NCT00787787|50659623|FG000|Overall Study|Lack of Efficacy|4|||
24984062|NCT00286091|50072726|FG001|Double-blind Treatment Phase|Noncompliance|8|||
24984063|NCT00286091|50072725|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
24984064|NCT00286091|50072726|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
24984065|NCT00286091|50072725|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
24984066|NCT00286091|50072726|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
24984067|NCT00286091|50072725|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
24984068|NCT00286091|50072726|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
24984069|NCT00286091|50072725|FG000|Open-label Treatment Phase|Physician Decision|24|||
24984070|NCT00286091|50072726|FG001|Open-label Treatment Phase|Physician Decision|21|||
24984071|NCT00286091|50072725|FG000|Open-label Treatment Phase|Adverse Event|5|||
24984072|NCT00286091|50072726|FG001|Open-label Treatment Phase|Adverse Event|16|||
24984073|NCT00286091|50072725|FG000|Open-label Treatment Phase|Other|11|||
24984074|NCT00286091|50072726|FG001|Open-label Treatment Phase|Other|11|||
24984075|NCT00286091|50072725|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
24984076|NCT00286091|50072726|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
24984077|NCT00286091|50072725|FG000|Open-label Treatment Phase|Death|10|||
24984078|NCT00286091|50072726|FG001|Open-label Treatment Phase|Death|7|||
24984079|NCT00286091|50072725|FG000|Open-label Treatment Phase|Disease Progression|9|||
24984080|NCT00286091|50072726|FG001|Open-label Treatment Phase|Disease Progression|3|||
24984081|NCT00286091|50072725|FG000|Open-label Treatment Phase|Noncompliance|3|||
24984082|NCT00286091|50072726|FG001|Open-label Treatment Phase|Noncompliance|1|||
24984083|NCT00286091|50072725|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
24984084|NCT00286091|50072726|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
24984085|NCT00286091|50072725|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
24984086|NCT00286091|50072726|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
24984087|NCT00286091|50072725|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
24984088|NCT00286091|50072726|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
25343295|NCT00787787|50659623|FG000|Overall Study|Adverse Event|3|||
25343296|NCT00787319|50659627|FG000|Overall Study|Lost to Follow-up|2|||
25343297|NCT00787319|50659627|FG000|Overall Study|Withdrawal by Subject|15|||
25343298|NCT00787319|50659627|FG000|Overall Study|Adverse Event|3|||
25343299|NCT00787319|50659627|FG000|Overall Study|Objective progression or relapse|30|||
25343300|NCT00787319|50659627|FG000|Overall Study|Lack of Efficacy|1|||
25343301|NCT00787319|50659627|FG000|Overall Study|Budget exhausted/exceeded|1|||
25343302|NCT00787319|50659627|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
25343303|NCT00787319|50659627|FG000|Overall Study|No health insurance reimbursement|2|||
25343304|NCT00787319|50659627|FG000|Overall Study|Stabilized disease findings|3|||
25343305|NCT00787319|50659627|FG000|Overall Study|Inactive disease|5|||
25343306|NCT00794963|50659633|FG000|Overall Study|Withdrawal by Subject|1|||
25343307|NCT00794963|50659634|FG001|Overall Study|Withdrawal by Subject|4|||
25343308|NCT00794573|50659642|FG000|Overall Study|Death|3|||
25343309|NCT00794573|50659643|FG001|Overall Study|Death|0|||
25343310|NCT00794573|50659642|FG000|Overall Study|Withdrawal by Subject|9|||
25343311|NCT00794573|50659643|FG001|Overall Study|Withdrawal by Subject|12|||
25343312|NCT00794573|50659642|FG000|Overall Study|Lost to Follow-up|26|||
25343313|NCT00794573|50659643|FG001|Overall Study|Lost to Follow-up|33|||
25343314|NCT00584844|50659649|FG000|Overall Study|Withdrawal by Subject|59|||
25343315|NCT00584844|50659649|FG000|Overall Study|Screen Failure|20|||
25343316|NCT00739934|50659657|FG000|Voriconazole IV|Adverse Event|6|||
25343317|NCT00739934|50659657|FG000|Voriconazole Oral|Other|3|||
25343318|NCT00739310|50659666|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
25343319|NCT00739310|50659666|FG000|Overall Study|Withdrawal by Subject|1|||
25343320|NCT00739310|50659666|FG000|Overall Study|Lost to Follow-up|2|||
25343321|NCT00734630|50659673|FG000|Overall Study|Lack of Efficacy|4|||
25343322|NCT00734630|50659674|FG001|Overall Study|Lack of Efficacy|4|||
25343323|NCT00734630|50659673|FG000|Overall Study|Withdrawal by Subject|7|||
24984089|NCT00285857|50072734|FG000|Overall Study|Withdrawal by Subject|2|||
24984090|NCT00285857|50072734|FG000|Overall Study|Inadequate initial breast cytology|1|||
24984091|NCT00285857|50072734|FG000|Overall Study|Adverse Event|1|||
24984092|NCT00284141|50072743|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
24984093|NCT00284141|50072743|FG000|Overall Study|Adverse Event|19|||
24984094|NCT00284141|50072743|FG000|Overall Study|Participant's request|9|||
24984095|NCT00284141|50072743|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
24984096|NCT00284141|50072743|FG000|Overall Study|Clinical deterioration / death|2|||
24984097|NCT00284141|50072743|FG000|Overall Study|General decline|1|||
24984098|NCT00284141|50072743|FG000|Overall Study|Pneumonia|1|||
25343324|NCT00734630|50659674|FG001|Overall Study|Withdrawal by Subject|9|||
25343325|NCT00734630|50659673|FG000|Overall Study|Lost to Follow-up|13|||
25343326|NCT00734630|50659674|FG001|Overall Study|Lost to Follow-up|7|||
25343327|NCT00734630|50659673|FG000|Overall Study|Protocol Violation|0|||
25343328|NCT00734630|50659674|FG001|Overall Study|Protocol Violation|3|||
25343329|NCT00734630|50659673|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
25343330|NCT00734630|50659674|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
25343331|NCT00734630|50659673|FG000|Overall Study|Adverse Event|3|||
25343332|NCT00734630|50659674|FG001|Overall Study|Adverse Event|6|||
25343333|NCT00734630|50659673|FG000|Overall Study|Randomized in Error|0|||
25343334|NCT00734630|50659674|FG001|Overall Study|Randomized in Error|1|||
25343335|NCT00734630|50659673|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
25343336|NCT00734630|50659674|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
25343337|NCT00734630|50659673|FG000|Overall Study|Poor Compliance|1|||
25343338|NCT00734630|50659674|FG001|Overall Study|Poor Compliance|1|||
25343339|NCT00584454|50659680|FG000|Overall Study|Adverse Event|1|||
25343340|NCT00584454|50659680|FG000|Overall Study|Relocation|1|||
25343341|NCT00584454|50659680|FG000|Overall Study|Clinical Hold|2|||
25343342|NCT00578175|50659687|FG000|Overall Study|Adverse Event|0|||
25343343|NCT00578175|50659688|FG001|Overall Study|Adverse Event|1|||
25343344|NCT00578175|50659689|FG002|Overall Study|Adverse Event|1|||
25343345|NCT00578175|50659687|FG000|Overall Study|Other reasons|70|||
25343346|NCT00578175|50659688|FG001|Overall Study|Other reasons|42|||
25343347|NCT00578175|50659689|FG002|Overall Study|Other reasons|23|||
25343348|NCT00435409|50659701|FG000|Overall Study|Protocol Violation|1|||
25343349|NCT00435409|50659702|FG001|Overall Study|Protocol Violation|2|||
25343350|NCT00435409|50659703|FG002|Overall Study|Protocol Violation|0|||
25343351|NCT00435409|50659701|FG000|Overall Study|Lost to Follow-up|1|||
25343352|NCT00435409|50659702|FG001|Overall Study|Lost to Follow-up|2|||
25343353|NCT00435409|50659703|FG002|Overall Study|Lost to Follow-up|0|||
25343354|NCT00435409|50659701|FG000|Overall Study|Death|8|||
25343355|NCT00435409|50659702|FG001|Overall Study|Death|6|||
25343356|NCT00435409|50659703|FG002|Overall Study|Death|6|||
25343357|NCT00435409|50659701|FG000|Overall Study|Objective progression or relapse|158|||
25343358|NCT00435409|50659702|FG001|Overall Study|Objective progression or relapse|93|||
25343359|NCT00435409|50659703|FG002|Overall Study|Objective progression or relapse|58|||
25343360|NCT00435409|50659701|FG000|Overall Study|Global deterioration of health status|0|||
25343361|NCT00435409|50659702|FG001|Overall Study|Global deterioration of health status|0|||
25343362|NCT00435409|50659703|FG002|Overall Study|Global deterioration of health status|4|||
25343363|NCT00435409|50659701|FG000|Overall Study|Withdrawal by Subject|8|||
25343364|NCT00435409|50659702|FG001|Overall Study|Withdrawal by Subject|7|||
25343365|NCT00435409|50659703|FG002|Overall Study|Withdrawal by Subject|1|||
25343366|NCT00435409|50659701|FG000|Overall Study|Other|45|||
25343367|NCT00435409|50659702|FG001|Overall Study|Other|30|||
25343368|NCT00435409|50659703|FG002|Overall Study|Other|1|||
25343369|NCT00435409|50659701|FG000|Overall Study|Adverse Event|0|||
25343370|NCT00435409|50659702|FG001|Overall Study|Adverse Event|0|||
25343371|NCT00435409|50659703|FG002|Overall Study|Adverse Event|8|||
25343372|NCT00435409|50659701|FG000|Overall Study|Sponsor decision|0|||
25343373|NCT00435409|50659702|FG001|Overall Study|Sponsor decision|3|||
25343374|NCT00435409|50659703|FG002|Overall Study|Sponsor decision|0|||
25343375|NCT00467857|50659720|FG000|Overall Study|Adverse Event|1|||
25343376|NCT00467857|50659721|FG001|Overall Study|Adverse Event|0|||
25343377|NCT00467857|50659720|FG000|Overall Study|Withdrew consent|2|||
25343378|NCT00467857|50659721|FG001|Overall Study|Withdrew consent|0|||
25343379|NCT00467857|50659720|FG000|Overall Study|Death|0|||
25343380|NCT00467857|50659721|FG001|Overall Study|Death|1|||
25343381|NCT00467857|50659720|FG000|Overall Study|Discharged from court service|0|||
25343382|NCT00467857|50659721|FG001|Overall Study|Discharged from court service|1|||
25343383|NCT00467857|50659720|FG000|Overall Study|Emergency care required|0|||
25343384|NCT00467857|50659721|FG001|Overall Study|Emergency care required|1|||
25343385|NCT00467857|50659720|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
25343386|NCT00467857|50659721|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
25343387|NCT00467857|50659720|FG000|Overall Study|Discontinuation reason missing|0|||
25343388|NCT00467857|50659721|FG001|Overall Study|Discontinuation reason missing|3|||
25343389|NCT00435019|50659729|FG000|Overall Study|Adverse Event|1|||
25343390|NCT00435019|50659730|FG001|Overall Study|Adverse Event|0|||
25343391|NCT00435019|50659729|FG000|Overall Study|Lack of Efficacy|1|||
25343392|NCT00435019|50659730|FG001|Overall Study|Lack of Efficacy|2|||
25343393|NCT00435019|50659729|FG000|Overall Study|Protocol Violation|3|||
25079374|NCT02149121|50187828|FG000|Main Study Period|Disease progression|0|||
25343394|NCT00435019|50659730|FG001|Overall Study|Protocol Violation|1|||
25343395|NCT00435019|50659729|FG000|Overall Study|Personal reasons for withdrawal|8|||
25343396|NCT00435019|50659730|FG001|Overall Study|Personal reasons for withdrawal|7|||
25343397|NCT00577863|50659738|FG000|Overall Study|Adverse Event|4|||
25343398|NCT00577863|50659739|FG001|Overall Study|Adverse Event|2|||
25343399|NCT00577863|50659738|FG000|Overall Study|Death|1|||
25343400|NCT00577863|50659739|FG001|Overall Study|Death|0|||
25343401|NCT00577863|50659738|FG000|Overall Study|Lost to Follow-up|2|||
25343402|NCT00577863|50659739|FG001|Overall Study|Lost to Follow-up|2|||
25343403|NCT00577863|50659738|FG000|Overall Study|Entry Criteria Exclusion|1|||
25343404|NCT00577863|50659739|FG001|Overall Study|Entry Criteria Exclusion|0|||
25343405|NCT00577863|50659738|FG000|Overall Study|Withdrawal by Subject|0|||
25343406|NCT00577863|50659739|FG001|Overall Study|Withdrawal by Subject|2|||
25343407|NCT00577863|50659738|FG000|Overall Study|Sponsor Decision|2|||
25343408|NCT00577863|50659739|FG001|Overall Study|Sponsor Decision|7|||
25343409|NCT00577863|50659738|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
25343410|NCT00577863|50659739|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
25343411|NCT00794417|50659749|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
25343412|NCT00794417|50659750|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
25343413|NCT00794417|50659751|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
25343414|NCT00794417|50659752|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
25343415|NCT00794417|50659749|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
25343416|NCT00794417|50659750|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
25343417|NCT00794417|50659751|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
25343418|NCT00794417|50659752|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
25343419|NCT00794417|50659749|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
25343420|NCT00794417|50659750|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
25343421|NCT00794417|50659751|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
25343422|NCT00794417|50659752|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
25343423|NCT00794417|50659749|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
25343424|NCT00794417|50659750|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
25343425|NCT00794417|50659751|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
25343426|NCT00794417|50659752|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
25343427|NCT00794417|50659749|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
25343428|NCT00794417|50659750|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
25343429|NCT00794417|50659751|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
25343430|NCT00794417|50659752|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
25343431|NCT00794417|50659749|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
25343432|NCT00794417|50659750|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
25343433|NCT00794417|50659751|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
25343434|NCT00794417|50659752|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
25343435|NCT00794339|50659764|FG000|Overall Study|Withdrawal by Subject|3|||
25343436|NCT00794339|50659764|FG000|Overall Study|Ineligible|4|||
25343437|NCT00794339|50659764|FG000|Overall Study|Tx prior to ATSM|3|||
25343438|NCT00794339|50659764|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
25343439|NCT00794339|50659764|FG000|Overall Study|Tx not per protocol|1|||
25343440|NCT00790907|50659788|FG000|Overall Study|Adverse Event|9|||
25343441|NCT00790907|50659789|FG001|Overall Study|Adverse Event|7|||
25343442|NCT00790907|50659790|FG002|Overall Study|Adverse Event|6|||
25343443|NCT00790907|50659788|FG000|Overall Study|Physician Decision|304|||
25343444|NCT00790907|50659789|FG001|Overall Study|Physician Decision|271|||
25343445|NCT00790907|50659790|FG002|Overall Study|Physician Decision|255|||
25343446|NCT00790907|50659788|FG000|Overall Study|Withdrawal by Subject|1|||
25343447|NCT00790907|50659789|FG001|Overall Study|Withdrawal by Subject|7|||
25343448|NCT00790907|50659790|FG002|Overall Study|Withdrawal by Subject|5|||
25343449|NCT00790907|50659788|FG000|Overall Study|Bleeding Event|11|||
25343450|NCT00790907|50659789|FG001|Overall Study|Bleeding Event|16|||
25343451|NCT00790907|50659790|FG002|Overall Study|Bleeding Event|21|||
25343452|NCT00790907|50659788|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
25343453|NCT00790907|50659789|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
25343454|NCT00790907|50659790|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
25343455|NCT00790907|50659788|FG000|Overall Study|Qualifying Condition Not Present|29|||
25343456|NCT00790907|50659789|FG001|Overall Study|Qualifying Condition Not Present|14|||
25343457|NCT00790907|50659790|FG002|Overall Study|Qualifying Condition Not Present|16|||
25343458|NCT00790907|50659788|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
25343459|NCT00790907|50659789|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
25343460|NCT00790907|50659790|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
25343461|NCT00790907|50659788|FG000|Overall Study|Did Not Receive Study Drug|10|||
25343462|NCT00790907|50659789|FG001|Overall Study|Did Not Receive Study Drug|0|||
25343463|NCT00790907|50659790|FG002|Overall Study|Did Not Receive Study Drug|0|||
25343464|NCT00793871|50659808|FG000|Overall Study|Death|50|||
25343465|NCT00793871|50659808|FG000|Overall Study|Lost to Follow-up|3|||
25343466|NCT00793871|50659808|FG000|Overall Study|Study terminated by the Sponsor|7|||
25343467|NCT00577707|50659816|FG000|Overall Study|Withdrawal by Subject|3|||
25343468|NCT00713349|50659820|FG000|Overall Study|Protocol Violation|1|||
25343469|NCT00712959|50659828|FG000|Overall Study|Protocol Violation|3|||
25343470|NCT00712959|50659829|FG001|Overall Study|Protocol Violation|1|||
25343471|NCT00712959|50659828|FG000|Overall Study|Lost to Follow-up|13|||
24984099|NCT00284141|50072743|FG000|Overall Study|Did not take study medication|2|||
24984100|NCT00284141|50072743|FG000|Overall Study|Ongoing treatment|2|||
25079375|NCT02149121|50187829|FG001|Main Study Period|Disease progression|1|||
25343472|NCT00712959|50659829|FG001|Overall Study|Lost to Follow-up|2|||
25343473|NCT00712959|50659828|FG000|Overall Study|Withdrawal by Subject|3|||
25343474|NCT00712959|50659829|FG001|Overall Study|Withdrawal by Subject|0|||
25343475|NCT00712725|50659843|FG000|Overall Study|Adverse Event|1|||
25343476|NCT00712725|50659844|FG001|Overall Study|Adverse Event|0|||
25343477|NCT00712725|50659845|FG002|Overall Study|Adverse Event|0|||
25343478|NCT00712725|50659846|FG003|Overall Study|Adverse Event|1|||
25343479|NCT00712725|50659847|FG004|Overall Study|Adverse Event|0|||
25343480|NCT00712725|50659848|FG005|Overall Study|Adverse Event|0|||
25343481|NCT00712725|50659849|FG006|Overall Study|Adverse Event|0|||
25343482|NCT00712725|50659850|FG007|Overall Study|Adverse Event|0|||
25343483|NCT00712725|50659843|FG000|Overall Study|Lost to Follow-up|3|||
25343484|NCT00712725|50659844|FG001|Overall Study|Lost to Follow-up|2|||
25343485|NCT00712725|50659845|FG002|Overall Study|Lost to Follow-up|1|||
25343486|NCT00712725|50659846|FG003|Overall Study|Lost to Follow-up|1|||
25343487|NCT00712725|50659847|FG004|Overall Study|Lost to Follow-up|2|||
25343488|NCT00712725|50659848|FG005|Overall Study|Lost to Follow-up|2|||
25343489|NCT00712725|50659849|FG006|Overall Study|Lost to Follow-up|3|||
25343490|NCT00712725|50659850|FG007|Overall Study|Lost to Follow-up|1|||
25343491|NCT00712725|50659843|FG000|Overall Study|Physician Decision|2|||
25343492|NCT00712725|50659844|FG001|Overall Study|Physician Decision|0|||
25343493|NCT00712725|50659845|FG002|Overall Study|Physician Decision|0|||
25343494|NCT00712725|50659846|FG003|Overall Study|Physician Decision|0|||
25343495|NCT00712725|50659847|FG004|Overall Study|Physician Decision|1|||
25343496|NCT00712725|50659848|FG005|Overall Study|Physician Decision|0|||
25343497|NCT00712725|50659849|FG006|Overall Study|Physician Decision|2|||
25343498|NCT00712725|50659850|FG007|Overall Study|Physician Decision|0|||
25343499|NCT00712725|50659843|FG000|Overall Study|Pregnancy|0|||
25343500|NCT00712725|50659844|FG001|Overall Study|Pregnancy|1|||
25343501|NCT00712725|50659845|FG002|Overall Study|Pregnancy|0|||
25343502|NCT00712725|50659846|FG003|Overall Study|Pregnancy|0|||
25343503|NCT00712725|50659847|FG004|Overall Study|Pregnancy|1|||
25343504|NCT00712725|50659848|FG005|Overall Study|Pregnancy|0|||
25343505|NCT00712725|50659849|FG006|Overall Study|Pregnancy|2|||
25343506|NCT00712725|50659850|FG007|Overall Study|Pregnancy|0|||
25343507|NCT00712725|50659843|FG000|Overall Study|Protocol Violation|2|||
25343508|NCT00712725|50659844|FG001|Overall Study|Protocol Violation|0|||
25343509|NCT00712725|50659845|FG002|Overall Study|Protocol Violation|1|||
25343510|NCT00712725|50659846|FG003|Overall Study|Protocol Violation|3|||
25343511|NCT00712725|50659847|FG004|Overall Study|Protocol Violation|2|||
25343512|NCT00712725|50659848|FG005|Overall Study|Protocol Violation|0|||
25343513|NCT00712725|50659849|FG006|Overall Study|Protocol Violation|1|||
25343514|NCT00712725|50659850|FG007|Overall Study|Protocol Violation|1|||
25343515|NCT00712725|50659843|FG000|Overall Study|Withdrawal by Subject|2|||
25343516|NCT00712725|50659844|FG001|Overall Study|Withdrawal by Subject|1|||
25343517|NCT00712725|50659845|FG002|Overall Study|Withdrawal by Subject|1|||
25343518|NCT00712725|50659846|FG003|Overall Study|Withdrawal by Subject|2|||
25343519|NCT00712725|50659847|FG004|Overall Study|Withdrawal by Subject|1|||
25343520|NCT00712725|50659848|FG005|Overall Study|Withdrawal by Subject|1|||
25343521|NCT00712725|50659849|FG006|Overall Study|Withdrawal by Subject|1|||
25343522|NCT00712725|50659850|FG007|Overall Study|Withdrawal by Subject|2|||
25343523|NCT00712725|50659843|FG000|Overall Study|Lack of Qualifying Event|16|||
25343524|NCT00712725|50659844|FG001|Overall Study|Lack of Qualifying Event|2|||
25343525|NCT00712725|50659845|FG002|Overall Study|Lack of Qualifying Event|6|||
25343526|NCT00712725|50659846|FG003|Overall Study|Lack of Qualifying Event|8|||
25343527|NCT00712725|50659847|FG004|Overall Study|Lack of Qualifying Event|11|||
25343528|NCT00712725|50659848|FG005|Overall Study|Lack of Qualifying Event|13|||
25343529|NCT00712725|50659849|FG006|Overall Study|Lack of Qualifying Event|11|||
25343530|NCT00712725|50659850|FG007|Overall Study|Lack of Qualifying Event|6|||
25343531|NCT00712725|50659843|FG000|Overall Study|Protocol Specified Criteria|3|||
25343532|NCT00712725|50659844|FG001|Overall Study|Protocol Specified Criteria|0|||
25343533|NCT00712725|50659845|FG002|Overall Study|Protocol Specified Criteria|1|||
25343534|NCT00712725|50659846|FG003|Overall Study|Protocol Specified Criteria|2|||
25343535|NCT00712725|50659847|FG004|Overall Study|Protocol Specified Criteria|1|||
24984101|NCT00265343|50072751|FG000|Overall Study|Adverse Event|10|||
24984102|NCT00265343|50072752|FG001|Overall Study|Adverse Event|7|||
24984103|NCT00265343|50072751|FG000|Overall Study|Withdrawal by Subject|3|||
24984104|NCT00265343|50072752|FG001|Overall Study|Withdrawal by Subject|9|||
24984105|NCT00265343|50072751|FG000|Overall Study|Other|8|||
25343536|NCT00712725|50659848|FG005|Overall Study|Protocol Specified Criteria|0|||
25343537|NCT00712725|50659849|FG006|Overall Study|Protocol Specified Criteria|2|||
24984106|NCT00265343|50072752|FG001|Overall Study|Other|3|||
25343538|NCT00712725|50659850|FG007|Overall Study|Protocol Specified Criteria|1|||
25343539|NCT00712335|50659873|FG000|Overall Study|Withdrawal by Subject|0|||
25343540|NCT00712335|50659874|FG001|Overall Study|Withdrawal by Subject|7|||
25343541|NCT00712335|50659875|FG002|Overall Study|Withdrawal by Subject|2|||
25343542|NCT00712335|50659876|FG003|Overall Study|Withdrawal by Subject|3|||
25343543|NCT00712335|50659877|FG004|Overall Study|Withdrawal by Subject|0|||
25343544|NCT00712335|50659873|FG000|Overall Study|Lost to Follow-up|2|||
25343545|NCT00712335|50659874|FG001|Overall Study|Lost to Follow-up|5|||
25343546|NCT00712335|50659875|FG002|Overall Study|Lost to Follow-up|0|||
25343547|NCT00712335|50659876|FG003|Overall Study|Lost to Follow-up|1|||
24984107|NCT00283595|50072760|FG000|Overall Study|Withdrawal by Subject|1|||
25343548|NCT00712335|50659877|FG004|Overall Study|Lost to Follow-up|0|||
25343549|NCT00712335|50659873|FG000|Overall Study|Protocol Violation|1|||
25343550|NCT00712335|50659874|FG001|Overall Study|Protocol Violation|2|||
25343551|NCT00712335|50659875|FG002|Overall Study|Protocol Violation|1|||
25343552|NCT00712335|50659876|FG003|Overall Study|Protocol Violation|0|||
25343553|NCT00712335|50659877|FG004|Overall Study|Protocol Violation|0|||
25343554|NCT00712335|50659873|FG000|Overall Study|Lack of Efficacy|0|||
25343555|NCT00712335|50659874|FG001|Overall Study|Lack of Efficacy|0|||
25343556|NCT00712335|50659875|FG002|Overall Study|Lack of Efficacy|1|||
25343557|NCT00712335|50659876|FG003|Overall Study|Lack of Efficacy|1|||
25343558|NCT00712335|50659877|FG004|Overall Study|Lack of Efficacy|0|||
25343559|NCT00712335|50659873|FG000|Overall Study|Other Reason|0|||
25343560|NCT00712335|50659874|FG001|Overall Study|Other Reason|3|||
25343561|NCT00712335|50659875|FG002|Overall Study|Other Reason|1|||
25343562|NCT00712335|50659876|FG003|Overall Study|Other Reason|0|||
25343563|NCT00712335|50659877|FG004|Overall Study|Other Reason|0|||
25343564|NCT00577629|50659889|FG000|Treatment Period|Death|1|||
25343565|NCT00577629|50659889|FG000|Long Term Follow-Up|Death|15|||
25343566|NCT00577629|50659889|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
25343567|NCT00577629|50659889|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
25343568|NCT00577629|50659889|FG000|Long Term Follow-Up|Physician Decision|1|||
25343569|NCT00710385|50659895|FG000|Overall Study|Did not qualify|1|||
25343570|NCT00710385|50659895|FG000|Overall Study|Withdrawal by Subject|1|||
25343571|NCT00710385|50659895|FG000|Overall Study|Undisclosed back pain|1|||
25343572|NCT00710385|50659895|FG000|Overall Study|Physician Decision|1|||
25343573|NCT00710385|50659895|FG000|Overall Study|Undisclosed excessive methadone use|1|||
25343574|NCT00701415|50659907|FG000|Overall Study|Adverse Event|0|||
25343575|NCT00701415|50659908|FG001|Overall Study|Adverse Event|1|||
25343576|NCT00701415|50659907|FG000|Overall Study|Social/family issues and needle phobia|1|||
25343577|NCT00701415|50659908|FG001|Overall Study|Social/family issues and needle phobia|0|||
25343578|NCT00700011|50659916|FG000|Overall Study|Death|0|||
25343579|NCT00700011|50659917|FG001|Overall Study|Death|1|||
25343580|NCT00707031|50659925|FG000|Overall Study|Adverse Event|45|||
25343581|NCT00707031|50659926|FG001|Overall Study|Adverse Event|45|||
25343582|NCT00707031|50659925|FG000|Overall Study|Lack of Efficacy|19|||
25343583|NCT00707031|50659926|FG001|Overall Study|Lack of Efficacy|6|||
25343584|NCT00707031|50659925|FG000|Overall Study|Lost to Follow-up|2|||
25343585|NCT00707031|50659926|FG001|Overall Study|Lost to Follow-up|1|||
25343586|NCT00707031|50659925|FG000|Overall Study|Protocol Violation|1|||
25343587|NCT00707031|50659926|FG001|Overall Study|Protocol Violation|0|||
25343588|NCT00707031|50659925|FG000|Overall Study|Withdrawal by Subject|7|||
25343589|NCT00707031|50659926|FG001|Overall Study|Withdrawal by Subject|8|||
25343590|NCT00707031|50659925|FG000|Overall Study|Poor Compliance to Protocol|7|||
25343591|NCT00707031|50659926|FG001|Overall Study|Poor Compliance to Protocol|13|||
25343592|NCT00707031|50659925|FG000|Overall Study|Familial or Personal Reasons|12|||
25343593|NCT00707031|50659926|FG001|Overall Study|Familial or Personal Reasons|15|||
25343594|NCT00707031|50659925|FG000|Overall Study|Serious Noncompliance|2|||
25343595|NCT00707031|50659926|FG001|Overall Study|Serious Noncompliance|3|||
25343596|NCT00707031|50659925|FG000|Overall Study|Sponsor Decision|9|||
25343597|NCT00707031|50659926|FG001|Overall Study|Sponsor Decision|8|||
25343598|NCT00711477|50659935|FG000|Overall Study|Adverse Event|3|||
25343599|NCT00711477|50659936|FG001|Overall Study|Adverse Event|1|||
25343600|NCT00711477|50659935|FG000|Overall Study|Lost to Follow-up|0|||
25343601|NCT00711477|50659936|FG001|Overall Study|Lost to Follow-up|1|||
25343602|NCT00711477|50659935|FG000|Overall Study|Noncompliance|0|||
25343603|NCT00711477|50659936|FG001|Overall Study|Noncompliance|1|||
25343604|NCT00699699|50659944|FG000|Overall Study|Adverse Event|36|||
25343605|NCT00699699|50659944|FG000|Overall Study|Individual different reasons|21|||
25343606|NCT00734474|50659957|FG000|Overall Study|Entry Criteria Not Met|0|||
25343607|NCT00734474|50659958|FG001|Overall Study|Entry Criteria Not Met|0|||
25343608|NCT00734474|50659959|FG002|Overall Study|Entry Criteria Not Met|5|||
25343609|NCT00734474|50659960|FG003|Overall Study|Entry Criteria Not Met|0|||
25343610|NCT00734474|50659961|FG004|Overall Study|Entry Criteria Not Met|3|||
25343611|NCT00734474|50659962|FG005|Overall Study|Entry Criteria Not Met|1|||
25343612|NCT00734474|50659963|FG006|Overall Study|Entry Criteria Not Met|0|||
25343613|NCT00734474|50659964|FG007|Overall Study|Entry Criteria Not Met|1|||
25343614|NCT00734474|50659965|FG008|Overall Study|Entry Criteria Not Met|1|||
25343615|NCT00734474|50659957|FG000|Overall Study|Lost to Follow-up|1|||
25343616|NCT00734474|50659958|FG001|Overall Study|Lost to Follow-up|0|||
25343617|NCT00734474|50659959|FG002|Overall Study|Lost to Follow-up|13|||
25343618|NCT00734474|50659960|FG003|Overall Study|Lost to Follow-up|0|||
25343619|NCT00734474|50659961|FG004|Overall Study|Lost to Follow-up|11|||
25343620|NCT00734474|50659962|FG005|Overall Study|Lost to Follow-up|1|||
25343621|NCT00734474|50659963|FG006|Overall Study|Lost to Follow-up|0|||
25343622|NCT00734474|50659964|FG007|Overall Study|Lost to Follow-up|9|||
25343623|NCT00734474|50659965|FG008|Overall Study|Lost to Follow-up|4|||
25343624|NCT00734474|50659957|FG000|Overall Study|Withdrawal by Subject|2|||
25343625|NCT00734474|50659958|FG001|Overall Study|Withdrawal by Subject|1|||
25343626|NCT00734474|50659959|FG002|Overall Study|Withdrawal by Subject|18|||
25343627|NCT00734474|50659960|FG003|Overall Study|Withdrawal by Subject|0|||
25343628|NCT00734474|50659961|FG004|Overall Study|Withdrawal by Subject|24|||
25343629|NCT00734474|50659962|FG005|Overall Study|Withdrawal by Subject|2|||
25343630|NCT00734474|50659963|FG006|Overall Study|Withdrawal by Subject|0|||
25343631|NCT00734474|50659964|FG007|Overall Study|Withdrawal by Subject|36|||
25343632|NCT00734474|50659965|FG008|Overall Study|Withdrawal by Subject|21|||
25343633|NCT00734474|50659957|FG000|Overall Study|Physician Decision|0|||
25343634|NCT00734474|50659958|FG001|Overall Study|Physician Decision|0|||
25343635|NCT00734474|50659959|FG002|Overall Study|Physician Decision|4|||
25343636|NCT00734474|50659960|FG003|Overall Study|Physician Decision|1|||
25343637|NCT00734474|50659961|FG004|Overall Study|Physician Decision|11|||
25343638|NCT00734474|50659962|FG005|Overall Study|Physician Decision|0|||
25343639|NCT00734474|50659963|FG006|Overall Study|Physician Decision|0|||
25343640|NCT00734474|50659964|FG007|Overall Study|Physician Decision|9|||
25343641|NCT00734474|50659965|FG008|Overall Study|Physician Decision|9|||
25343642|NCT00734474|50659957|FG000|Overall Study|Adverse Event|4|||
25343643|NCT00734474|50659958|FG001|Overall Study|Adverse Event|4|||
25343644|NCT00734474|50659959|FG002|Overall Study|Adverse Event|63|||
25343645|NCT00734474|50659960|FG003|Overall Study|Adverse Event|1|||
25343646|NCT00734474|50659961|FG004|Overall Study|Adverse Event|64|||
25343647|NCT00734474|50659962|FG005|Overall Study|Adverse Event|0|||
25343648|NCT00734474|50659963|FG006|Overall Study|Adverse Event|1|||
25343649|NCT00734474|50659964|FG007|Overall Study|Adverse Event|65|||
25343650|NCT00734474|50659965|FG008|Overall Study|Adverse Event|39|||
25343651|NCT00734474|50659957|FG000|Overall Study|Protocol Violation|0|||
25343652|NCT00734474|50659958|FG001|Overall Study|Protocol Violation|0|||
25343653|NCT00734474|50659959|FG002|Overall Study|Protocol Violation|4|||
25343654|NCT00734474|50659960|FG003|Overall Study|Protocol Violation|0|||
25343655|NCT00734474|50659961|FG004|Overall Study|Protocol Violation|3|||
25343656|NCT00734474|50659962|FG005|Overall Study|Protocol Violation|0|||
25343657|NCT00734474|50659963|FG006|Overall Study|Protocol Violation|0|||
25343658|NCT00734474|50659964|FG007|Overall Study|Protocol Violation|3|||
25343659|NCT00734474|50659965|FG008|Overall Study|Protocol Violation|1|||
25343660|NCT00734474|50659957|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
25343661|NCT00734474|50659958|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
25343662|NCT00734474|50659959|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
25343663|NCT00734474|50659960|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
25343664|NCT00734474|50659961|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
25343665|NCT00734474|50659962|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
25343666|NCT00734474|50659963|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
25343667|NCT00734474|50659964|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
25343668|NCT00734474|50659965|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
25343669|NCT00734474|50659957|FG000|Overall Study|Sponsor Decision|0|||
25343670|NCT00734474|50659958|FG001|Overall Study|Sponsor Decision|0|||
25343671|NCT00734474|50659959|FG002|Overall Study|Sponsor Decision|0|||
25343672|NCT00734474|50659960|FG003|Overall Study|Sponsor Decision|0|||
25343673|NCT00734474|50659961|FG004|Overall Study|Sponsor Decision|2|||
25343674|NCT00734474|50659962|FG005|Overall Study|Sponsor Decision|0|||
25343675|NCT00734474|50659963|FG006|Overall Study|Sponsor Decision|0|||
25343676|NCT00734474|50659964|FG007|Overall Study|Sponsor Decision|0|||
25343677|NCT00734474|50659965|FG008|Overall Study|Sponsor Decision|0|||
25343678|NCT00734474|50659957|FG000|Overall Study|Death|0|||
25343679|NCT00734474|50659958|FG001|Overall Study|Death|0|||
25343680|NCT00734474|50659959|FG002|Overall Study|Death|1|||
25343681|NCT00734474|50659960|FG003|Overall Study|Death|0|||
25343682|NCT00734474|50659961|FG004|Overall Study|Death|0|||
25343683|NCT00734474|50659962|FG005|Overall Study|Death|0|||
25343684|NCT00734474|50659963|FG006|Overall Study|Death|0|||
25343685|NCT00734474|50659964|FG007|Overall Study|Death|2|||
25343686|NCT00734474|50659965|FG008|Overall Study|Death|1|||
25343687|NCT00734474|50659957|FG000|Overall Study|Lack of Efficacy|0|||
25343688|NCT00734474|50659958|FG001|Overall Study|Lack of Efficacy|0|||
25343689|NCT00734474|50659959|FG002|Overall Study|Lack of Efficacy|4|||
25343690|NCT00734474|50659960|FG003|Overall Study|Lack of Efficacy|0|||
25343691|NCT00734474|50659961|FG004|Overall Study|Lack of Efficacy|0|||
25343692|NCT00734474|50659962|FG005|Overall Study|Lack of Efficacy|0|||
25343693|NCT00734474|50659963|FG006|Overall Study|Lack of Efficacy|0|||
25343694|NCT00734474|50659964|FG007|Overall Study|Lack of Efficacy|4|||
24984108|NCT00283595|50072761|FG001|Overall Study|Withdrawal by Subject|2|||
25343695|NCT00734474|50659965|FG008|Overall Study|Lack of Efficacy|6|||
24984109|NCT00265109|50072767|FG000|Overall Study|Withdrawal by Subject|5|||
25343696|NCT00583362|50659991|FG000|Overall Study|Adverse Event|44|||
25343697|NCT00583362|50659991|FG000|Overall Study|Lack of Efficacy|22|||
25343698|NCT00583362|50659991|FG000|Overall Study|Lost to Follow-up|4|||
25343699|NCT00583362|50659991|FG000|Overall Study|Non-compliance with study drug|28|||
25343700|NCT00583362|50659991|FG000|Overall Study|Pregnancy|7|||
25343701|NCT00583362|50659991|FG000|Overall Study|Miscommunication of visit window|5|||
25343702|NCT00583362|50659991|FG000|Overall Study|Current site closed|7|||
25343703|NCT00583362|50659991|FG000|Overall Study|Subject not dosed in LBSL99|1|||
25343704|NCT00583362|50659991|FG000|Overall Study|Subject moved out of the country/state|2|||
25343705|NCT00583362|50659991|FG000|Overall Study|Missed visits due to staff changes|1|||
25343706|NCT00583362|50659991|FG000|Overall Study|Misunderstanding of protocol|1|||
25343707|NCT00583362|50659991|FG000|Overall Study|Behavioral problems and non-compliance|1|||
25343708|NCT00583362|50659991|FG000|Overall Study|Sponsor request due to missed doses|1|||
25343709|NCT00583362|50659991|FG000|Overall Study|Physician Decision|19|||
25343710|NCT00583362|50659991|FG000|Overall Study|Protocol Violation|2|||
25343711|NCT00583362|50659991|FG000|Overall Study|Withdrawal by Subject|57|||
25343712|NCT00577473|50659997|FG000|Overall Study|Protocol Violation|1|||
25343713|NCT00577473|50659998|FG001|Overall Study|Protocol Violation|4|||
25343714|NCT00577473|50659997|FG000|Overall Study|Adverse Event|8|||
25343715|NCT00577473|50659998|FG001|Overall Study|Adverse Event|5|||
25343716|NCT00577473|50659997|FG000|Overall Study|Withdrawal by Subject|2|||
25343717|NCT00577473|50659998|FG001|Overall Study|Withdrawal by Subject|6|||
25343718|NCT00577473|50659997|FG000|Overall Study|Physician Decision|2|||
25343719|NCT00577473|50659998|FG001|Overall Study|Physician Decision|2|||
25343720|NCT00577473|50659997|FG000|Overall Study|Lack of Efficacy|8|||
25343721|NCT00577473|50659998|FG001|Overall Study|Lack of Efficacy|7|||
25343722|NCT00785291|50660007|FG000|Overall Study|Never began treatment|8|||
25343723|NCT00785291|50660008|FG001|Overall Study|Never began treatment|4|||
25343724|NCT00785291|50660009|FG002|Overall Study|Never began treatment|4|||
25343725|NCT00785291|50660007|FG000|Overall Study|Adverse Event|39|||
25343726|NCT00785291|50660008|FG001|Overall Study|Adverse Event|70|||
25343727|NCT00785291|50660009|FG002|Overall Study|Adverse Event|56|||
25343728|NCT00785291|50660007|FG000|Overall Study|Death|7|||
25343729|NCT00785291|50660008|FG001|Overall Study|Death|4|||
25343730|NCT00785291|50660009|FG002|Overall Study|Death|3|||
25343731|NCT00785291|50660007|FG000|Overall Study|Withdrawal by Subject|35|||
25343732|NCT00785291|50660008|FG001|Overall Study|Withdrawal by Subject|36|||
25343733|NCT00785291|50660009|FG002|Overall Study|Withdrawal by Subject|17|||
25343734|NCT00785291|50660007|FG000|Overall Study|Alternative Therapy|12|||
25343735|NCT00785291|50660008|FG001|Overall Study|Alternative Therapy|6|||
25343736|NCT00785291|50660009|FG002|Overall Study|Alternative Therapy|7|||
25343737|NCT00785291|50660007|FG000|Overall Study|Complicating illness|6|||
25343738|NCT00785291|50660008|FG001|Overall Study|Complicating illness|4|||
25343739|NCT00785291|50660009|FG002|Overall Study|Complicating illness|4|||
25343740|NCT00785291|50660007|FG000|Overall Study|Other Medical Reasons|29|||
25343741|NCT00785291|50660008|FG001|Overall Study|Other Medical Reasons|25|||
25343742|NCT00785291|50660009|FG002|Overall Study|Other Medical Reasons|15|||
25343743|NCT00705939|50660020|FG000|Overall Study|Protocol Violation|0|||
25343744|NCT00705939|50660021|FG001|Overall Study|Protocol Violation|0|||
25343745|NCT00705939|50660022|FG002|Overall Study|Protocol Violation|1|||
25343746|NCT00705939|50660020|FG000|Overall Study|Withdrawal by Subject|0|||
25343747|NCT00705939|50660021|FG001|Overall Study|Withdrawal by Subject|1|||
25343748|NCT00705939|50660022|FG002|Overall Study|Withdrawal by Subject|3|||
25343749|NCT00705939|50660020|FG000|Overall Study|Physician Decision|0|||
25343750|NCT00705939|50660021|FG001|Overall Study|Physician Decision|1|||
25343751|NCT00705939|50660022|FG002|Overall Study|Physician Decision|0|||
24984110|NCT00265109|50072767|FG000|Overall Study|Adverse Event|1|||
24984111|NCT03235024|50072774|FG000|Overall Study|Adverse Event|2|||
25079376|NCT02149121|50187830|FG002|Main Study Period|Disease progression|0|||
25079377|NCT02149121|50187831|FG003|Main Study Period|Disease progression|0|||
24984112|NCT03235024|50072775|FG001|Overall Study|Adverse Event|2|||
24984113|NCT03235024|50072774|FG000|Overall Study|Death|1|||
25256943|NCT01103479|50572060|FG001|Overall Study|Family history of CRC|0|||
24984114|NCT03235024|50072775|FG001|Overall Study|Death|0|||
25256944|NCT01103479|50572061|FG002|Overall Study|Family history of CRC|2|||
25256945|NCT01103479|50572059|FG000|Overall Study|Active cancer|1|||
25256946|NCT01103479|50572060|FG001|Overall Study|Active cancer|0|||
25256947|NCT01103479|50572061|FG002|Overall Study|Active cancer|0|||
25256948|NCT01103479|50572059|FG000|Overall Study|Saw non-study physician|2|||
25256949|NCT01103479|50572060|FG001|Overall Study|Saw non-study physician|0|||
25256950|NCT01103479|50572061|FG002|Overall Study|Saw non-study physician|0|||
25256951|NCT01103323|50572072|FG000|Without/Before Drug Switch|Adverse Event|50|||
25256952|NCT01103323|50572073|FG001|Without/Before Drug Switch|Adverse Event|7|||
25256953|NCT01103323|50572072|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
25256954|NCT01103323|50572073|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
25256955|NCT01103323|50572072|FG000|Without/Before Drug Switch|Protocol Violation|2|||
25256956|NCT01103323|50572073|FG001|Without/Before Drug Switch|Protocol Violation|0|||
25256957|NCT01103323|50572072|FG000|Without/Before Drug Switch|Physician Decision|2|||
25256958|NCT01103323|50572073|FG001|Without/Before Drug Switch|Physician Decision|0|||
24984115|NCT03235024|50072774|FG000|Overall Study|Lost to Follow-up|2|||
25256959|NCT01103323|50572072|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
25256960|NCT01103323|50572073|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
25256961|NCT01103323|50572072|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
24984116|NCT03235024|50072775|FG001|Overall Study|Lost to Follow-up|5|||
24984117|NCT03235024|50072774|FG000|Overall Study|Protocol Violation|1|||
24984118|NCT03235024|50072775|FG001|Overall Study|Protocol Violation|0|||
24984119|NCT03235024|50072774|FG000|Overall Study|Withdrawal by Subject|0|||
24984120|NCT03235024|50072775|FG001|Overall Study|Withdrawal by Subject|3|||
24984121|NCT03233308|50072781|FG000|Overall Study|Adverse Event|1|||
24984122|NCT03233308|50072781|FG000|Overall Study|Protocol Violation|1|||
24984123|NCT00283439|50072796|FG000|Overall Study|Adverse Event|0|||
24984124|NCT00283439|50072797|FG001|Overall Study|Adverse Event|0|||
24984125|NCT00283439|50072798|FG002|Overall Study|Adverse Event|0|||
24984126|NCT00283439|50072799|FG003|Overall Study|Adverse Event|1|||
24984127|NCT00283439|50072796|FG000|Overall Study|Death|0|||
24984128|NCT00283439|50072797|FG001|Overall Study|Death|0|||
24984129|NCT00283439|50072798|FG002|Overall Study|Death|1|||
24984130|NCT00283439|50072799|FG003|Overall Study|Death|0|||
24984131|NCT00283439|50072796|FG000|Overall Study|Disease progression|0|||
24984132|NCT00283439|50072797|FG001|Overall Study|Disease progression|1|||
24984133|NCT00283439|50072798|FG002|Overall Study|Disease progression|0|||
24984134|NCT00283439|50072799|FG003|Overall Study|Disease progression|0|||
24984135|NCT00283439|50072796|FG000|Overall Study|Requirement for alternative therapy|1|||
24984136|NCT00283439|50072797|FG001|Overall Study|Requirement for alternative therapy|2|||
24984137|NCT00283439|50072798|FG002|Overall Study|Requirement for alternative therapy|5|||
24984138|NCT00283439|50072799|FG003|Overall Study|Requirement for alternative therapy|2|||
24984139|NCT00283439|50072796|FG000|Overall Study|Stem cell transplant|6|||
24984140|NCT00283439|50072797|FG001|Overall Study|Stem cell transplant|6|||
24984141|NCT00283439|50072798|FG002|Overall Study|Stem cell transplant|4|||
24984142|NCT00283439|50072799|FG003|Overall Study|Stem cell transplant|3|||
24984143|NCT00283439|50072796|FG000|Overall Study|Treatment discontinued|0|||
24984144|NCT00283439|50072797|FG001|Overall Study|Treatment discontinued|2|||
24984145|NCT00283439|50072798|FG002|Overall Study|Treatment discontinued|1|||
24984146|NCT00283439|50072799|FG003|Overall Study|Treatment discontinued|3|||
24984147|NCT00283439|50072796|FG000|Overall Study|Other|1|||
24984148|NCT00283439|50072797|FG001|Overall Study|Other|0|||
24984149|NCT00283439|50072798|FG002|Overall Study|Other|0|||
24984150|NCT00283439|50072799|FG003|Overall Study|Other|0|||
24984151|NCT03233230|50072813|FG000|Overall Study|Adverse Event|6|||
24984152|NCT03233230|50072814|FG001|Overall Study|Adverse Event|3|||
24984153|NCT03233230|50072815|FG002|Overall Study|Adverse Event|6|||
24984154|NCT03233230|50072816|FG003|Overall Study|Adverse Event|3|||
24984155|NCT03233230|50072813|FG000|Overall Study|Protocol Violation|1|||
24984156|NCT03233230|50072814|FG001|Overall Study|Protocol Violation|2|||
24984157|NCT03233230|50072815|FG002|Overall Study|Protocol Violation|1|||
24984158|NCT03233230|50072816|FG003|Overall Study|Protocol Violation|1|||
24984159|NCT03233230|50072813|FG000|Overall Study|Lack of Efficacy|1|||
24984160|NCT03233230|50072814|FG001|Overall Study|Lack of Efficacy|0|||
24984161|NCT03233230|50072815|FG002|Overall Study|Lack of Efficacy|0|||
24984162|NCT03233230|50072816|FG003|Overall Study|Lack of Efficacy|0|||
24984163|NCT03233230|50072813|FG000|Overall Study|Other|5|||
24984164|NCT03233230|50072814|FG001|Overall Study|Other|5|||
24984165|NCT03233230|50072815|FG002|Overall Study|Other|5|||
24984166|NCT03233230|50072816|FG003|Overall Study|Other|3|||
24984167|NCT03233230|50072813|FG000|Overall Study|Withdrawal by Subject|2|||
24984168|NCT03233230|50072814|FG001|Overall Study|Withdrawal by Subject|2|||
24984169|NCT03233230|50072815|FG002|Overall Study|Withdrawal by Subject|0|||
24984170|NCT03233230|50072816|FG003|Overall Study|Withdrawal by Subject|1|||
24984171|NCT03233230|50072813|FG000|Overall Study|Lost to Follow-up|0|||
24984172|NCT03233230|50072814|FG001|Overall Study|Lost to Follow-up|3|||
24984173|NCT03233230|50072815|FG002|Overall Study|Lost to Follow-up|0|||
24984174|NCT03233230|50072816|FG003|Overall Study|Lost to Follow-up|0|||
24984175|NCT00283049|50072829|FG000|Overall Study|Adverse Event|6|||
24984176|NCT00283049|50072830|FG001|Overall Study|Adverse Event|1|||
24984177|NCT00283049|50072831|FG002|Overall Study|Adverse Event|4|||
24984178|NCT00283049|50072829|FG000|Overall Study|Protocol Violation|3|||
24984179|NCT00283049|50072830|FG001|Overall Study|Protocol Violation|0|||
24984180|NCT00283049|50072831|FG002|Overall Study|Protocol Violation|3|||
24984181|NCT00283049|50072829|FG000|Overall Study|Death|1|||
24984182|NCT00283049|50072830|FG001|Overall Study|Death|1|||
24984183|NCT00283049|50072831|FG002|Overall Study|Death|1|||
24984184|NCT00283049|50072829|FG000|Overall Study|Lack of Efficacy|0|||
24984185|NCT00283049|50072830|FG001|Overall Study|Lack of Efficacy|1|||
24984186|NCT00283049|50072831|FG002|Overall Study|Lack of Efficacy|1|||
24984187|NCT00283049|50072829|FG000|Overall Study|Lost to Follow-up|4|||
24984188|NCT00283049|50072830|FG001|Overall Study|Lost to Follow-up|2|||
24984189|NCT00283049|50072831|FG002|Overall Study|Lost to Follow-up|5|||
24984190|NCT00283049|50072829|FG000|Overall Study|Withdrawal by Subject|26|||
24984191|NCT00283049|50072830|FG001|Overall Study|Withdrawal by Subject|24|||
24984192|NCT00283049|50072831|FG002|Overall Study|Withdrawal by Subject|19|||
24984193|NCT00283049|50072829|FG000|Overall Study|Discontinuation of Study|18|||
24984194|NCT00283049|50072830|FG001|Overall Study|Discontinuation of Study|16|||
24984195|NCT00283049|50072831|FG002|Overall Study|Discontinuation of Study|20|||
24984196|NCT00283049|50072829|FG000|Overall Study|No longer requires study treatment|0|||
24984197|NCT00283049|50072830|FG001|Overall Study|No longer requires study treatment|0|||
24984198|NCT00283049|50072831|FG002|Overall Study|No longer requires study treatment|1|||
24984199|NCT00264875|50072839|FG000|Overall Study|Adverse Event|6|||
24984200|NCT00264875|50072839|FG000|Overall Study|Lost to Follow-up|6|||
24984201|NCT00264875|50072839|FG000|Overall Study|Protocol Violation|11|||
24984202|NCT00264875|50072839|FG000|Overall Study|Withdrawal by Subject|7|||
24984203|NCT03152110|50072843|FG000|Overall Study|Withdrawal by Subject|3|||
24984204|NCT03151408|50072850|FG000|Overall Study|Adverse Event|24|||
24984205|NCT03151408|50072851|FG001|Overall Study|Adverse Event|23|||
24984206|NCT03151408|50072850|FG000|Overall Study|Death|46|||
24984207|NCT03151408|50072851|FG001|Overall Study|Death|26|||
24984208|NCT03151408|50072850|FG000|Overall Study|Physician Decision|13|||
24984209|NCT03151408|50072851|FG001|Overall Study|Physician Decision|19|||
24984210|NCT03151408|50072850|FG000|Overall Study|Withdrawal by Subject|16|||
24984211|NCT03151408|50072851|FG001|Overall Study|Withdrawal by Subject|20|||
24984212|NCT03151408|50072850|FG000|Overall Study|Progressive disease|45|||
24984213|NCT03151408|50072851|FG001|Overall Study|Progressive disease|61|||
24984214|NCT03151408|50072850|FG000|Overall Study|non-compliance by patient|1|||
24984215|NCT03151408|50072851|FG001|Overall Study|non-compliance by patient|0|||
24984216|NCT03151408|50072850|FG000|Overall Study|other reasons|56|||
24984217|NCT03151408|50072851|FG001|Overall Study|other reasons|52|||
24984218|NCT03151408|50072850|FG000|Overall Study|randomized and not treated|2|||
24984219|NCT03151408|50072851|FG001|Overall Study|randomized and not treated|2|||
24984220|NCT00546754|50072859|FG000|Overall Study|Serious Adverse Event|1|||
24984221|NCT00546754|50072860|FG001|Overall Study|Serious Adverse Event|1|||
24984222|NCT00546754|50072859|FG000|Overall Study|Adverse Event|11|||
24984223|NCT00546754|50072860|FG001|Overall Study|Adverse Event|16|||
24984224|NCT00546754|50072859|FG000|Overall Study|Lack of Efficacy|1|||
24984225|NCT00546754|50072860|FG001|Overall Study|Lack of Efficacy|1|||
24984226|NCT00546754|50072859|FG000|Overall Study|Lost to Follow-up|9|||
24984227|NCT00546754|50072860|FG001|Overall Study|Lost to Follow-up|15|||
24984228|NCT00546754|50072859|FG000|Overall Study|Protocol Violation|3|||
24984229|NCT00546754|50072860|FG001|Overall Study|Protocol Violation|0|||
24984230|NCT00546754|50072859|FG000|Overall Study|Withdrawal by Subject|6|||
24984231|NCT00546754|50072860|FG001|Overall Study|Withdrawal by Subject|7|||
24984232|NCT00546754|50072859|FG000|Overall Study|Dyspnea|1|||
24984233|NCT00546754|50072860|FG001|Overall Study|Dyspnea|0|||
24984234|NCT00546754|50072859|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
24984235|NCT00546754|50072860|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
24984236|NCT00546754|50072859|FG000|Overall Study|Hip Replacement|1|||
24984237|NCT00546754|50072860|FG001|Overall Study|Hip Replacement|0|||
24984238|NCT00546754|50072859|FG000|Overall Study|Suicide|1|||
25256962|NCT01103323|50572073|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
25256963|NCT01103323|50572072|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
25256964|NCT01103323|50572073|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
25256965|NCT01103245|50572084|FG000|Overall Study|Withdrawal by Subject|1|||
25256966|NCT01103245|50572085|FG001|Overall Study|Withdrawal by Subject|0|||
25256967|NCT01103245|50572086|FG002|Overall Study|Withdrawal by Subject|3|||
25256968|NCT01103245|50572087|FG003|Overall Study|Withdrawal by Subject|0|||
25256969|NCT01103245|50572084|FG000|Overall Study|Inadequate IV access|1|||
25256970|NCT01103245|50572085|FG001|Overall Study|Inadequate IV access|0|||
25256971|NCT01103245|50572086|FG002|Overall Study|Inadequate IV access|0|||
25256972|NCT01103245|50572087|FG003|Overall Study|Inadequate IV access|0|||
25256973|NCT01103245|50572084|FG000|Overall Study|Adverse Event|0|||
25256974|NCT01103245|50572085|FG001|Overall Study|Adverse Event|2|||
25256975|NCT01103245|50572086|FG002|Overall Study|Adverse Event|1|||
25256976|NCT01103245|50572087|FG003|Overall Study|Adverse Event|0|||
25256977|NCT01103245|50572084|FG000|Overall Study|Physician Decision|1|||
25256978|NCT01103245|50572085|FG001|Overall Study|Physician Decision|0|||
25256979|NCT01103245|50572086|FG002|Overall Study|Physician Decision|0|||
25256980|NCT01103245|50572087|FG003|Overall Study|Physician Decision|0|||
25256981|NCT01099267|50572097|FG000|MDS-003 Study|Adverse Event|37|||
25256982|NCT01099267|50572097|FG000|MDS-003 Study|Lack of Efficacy|52|||
25256983|NCT01099267|50572097|FG000|MDS-003 Study|Withdrawal by Subject|8|||
25256984|NCT01099267|50572097|FG000|MDS-003 Study|Lost to Follow-up|1|||
25256985|NCT01099267|50572097|FG000|MDS-003 Study|Death|11|||
25256986|NCT01099267|50572097|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
25256987|NCT01099267|50572097|FG000|MDS-003 Study|Disease Progression|7|||
25256988|NCT01099267|50572097|FG000|MDS-003 Study|Investigator Decision|2|||
25256989|NCT01099267|50572097|FG000|MDS-003 Study|Non-Compliance|2|||
25256990|NCT01099267|50572097|FG000|MDS-003 Study|Loss of Response|1|||
24984239|NCT00546754|50072860|FG001|Overall Study|Suicide|0|||
24984240|NCT00546754|50072859|FG000|Overall Study|Missing Cooperation|1|||
25256991|NCT01099267|50572097|FG000|MDS-003 Study|Secondary Malign Disease|1|||
25256992|NCT01098487|50572101|FG000|Overall Study|Adverse Event|22|||
24984241|NCT00546754|50072860|FG001|Overall Study|Missing Cooperation|0|||
24984242|NCT00546754|50072859|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
24984243|NCT00546754|50072860|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
24984244|NCT00546754|50072859|FG000|Overall Study|Patient's Decision|0|||
24984245|NCT00546754|50072860|FG001|Overall Study|Patient's Decision|1|||
24984246|NCT00546754|50072859|FG000|Overall Study|Missing|14|||
24984247|NCT00546754|50072860|FG001|Overall Study|Missing|7|||
24984248|NCT00282347|50072868|FG000|Treatment Period|Death|2|||
24984249|NCT00282347|50072869|FG001|Treatment Period|Death|0|||
24984250|NCT00282347|50072868|FG000|Treatment Period|Lost to Follow-up|2|||
24984251|NCT00282347|50072869|FG001|Treatment Period|Lost to Follow-up|5|||
24984252|NCT00282347|50072868|FG000|Treatment Period|Withdrawal by Subject|1|||
24984253|NCT00282347|50072869|FG001|Treatment Period|Withdrawal by Subject|3|||
24984254|NCT00282347|50072868|FG000|Treatment Period|Physician Decision|0|||
24984255|NCT00282347|50072869|FG001|Treatment Period|Physician Decision|1|||
24984256|NCT00282347|50072868|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
24984257|NCT00282347|50072869|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
24984258|NCT00282347|50072868|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
24984259|NCT00282347|50072869|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
24984260|NCT00282347|50072868|FG000|Safety Follow-up Period|Physician Decision|1|||
24984261|NCT00282347|50072869|FG001|Safety Follow-up Period|Physician Decision|1|||
24984262|NCT00282347|50072868|FG000|Safety Follow-up Period|Protocol Deviation|0|||
24984263|NCT00282347|50072869|FG001|Safety Follow-up Period|Protocol Deviation|2|||
24984264|NCT00282347|50072868|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
24984265|NCT00282347|50072869|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
24984266|NCT00282347|50072868|FG000|B Cell Follow-up Period|Physician Decision|1|||
24984267|NCT00282347|50072869|FG001|B Cell Follow-up Period|Physician Decision|0|||
24984268|NCT00282347|50072868|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
24984269|NCT00282347|50072869|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
24984270|NCT00405964|50072879|FG000|Overall Study|Treatment Failure|17|||
24984271|NCT00405964|50072880|FG001|Overall Study|Treatment Failure|45|||
24984272|NCT00405964|50072879|FG000|Overall Study|Adverse Event|7|||
24984273|NCT00405964|50072880|FG001|Overall Study|Adverse Event|16|||
24984274|NCT00405964|50072879|FG000|Overall Study|Lost to Follow-up|5|||
24984275|NCT00405964|50072880|FG001|Overall Study|Lost to Follow-up|5|||
24984276|NCT00405964|50072879|FG000|Overall Study|Withdrawal by Subject|19|||
24984277|NCT00405964|50072880|FG001|Overall Study|Withdrawal by Subject|23|||
24984278|NCT00405964|50072879|FG000|Overall Study|Protocol Violation|11|||
24984279|NCT00405964|50072880|FG001|Overall Study|Protocol Violation|6|||
24984280|NCT00264797|50072888|FG000|Overall Study|Withdrawal by Subject|11|||
24984281|NCT00264797|50072889|FG001|Overall Study|Withdrawal by Subject|11|||
24984282|NCT00264797|50072888|FG000|Overall Study|Lost to Follow-up|9|||
24984283|NCT00264797|50072889|FG001|Overall Study|Lost to Follow-up|17|||
24984284|NCT00264797|50072888|FG000|Overall Study|Moved from area|3|||
24984285|NCT00264797|50072889|FG001|Overall Study|Moved from area|1|||
24984286|NCT00264797|50072888|FG000|Overall Study|Practical Problems|2|||
24984287|NCT00264797|50072889|FG001|Overall Study|Practical Problems|3|||
24984288|NCT00264797|50072888|FG000|Overall Study|Incarceration|4|||
24984289|NCT00264797|50072889|FG001|Overall Study|Incarceration|5|||
24984290|NCT00264797|50072888|FG000|Overall Study|Pressure/advice from Outsiders|1|||
24984291|NCT00264797|50072889|FG001|Overall Study|Pressure/advice from Outsiders|1|||
24984292|NCT00264797|50072888|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
24984293|NCT00264797|50072889|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
24984294|NCT00264797|50072888|FG000|Overall Study|Other|3|||
24984295|NCT00264797|50072889|FG001|Overall Study|Other|4|||
24984296|NCT03148756|50072897|FG000|Overall Study|Study Terminated|0|||
24984297|NCT03148756|50072898|FG001|Overall Study|Study Terminated|1|||
24984298|NCT00282113|50072907|FG000|Overall Study|Removed at parents request|1|||
24984299|NCT00282113|50072908|FG001|Overall Study|Removed at parents request|0|||
24984300|NCT00282113|50072909|FG002|Overall Study|Removed at parents request|0|||
24984301|NCT00281957|50072919|FG000|Overall Study|Adverse Event|7|||
24984302|NCT00281957|50072920|FG001|Overall Study|Adverse Event|2|||
24984303|NCT00281957|50072919|FG000|Overall Study|Death|1|||
24984304|NCT00281957|50072920|FG001|Overall Study|Death|0|||
24984305|NCT00281957|50072919|FG000|Overall Study|Progression/relapse|47|||
24984306|NCT00281957|50072920|FG001|Overall Study|Progression/relapse|35|||
24984307|NCT00281957|50072919|FG000|Overall Study|Not protocol specified|8|||
24984308|NCT00281957|50072920|FG001|Overall Study|Not protocol specified|1|||
24984309|NCT00281957|50072919|FG000|Overall Study|Not eligible|1|||
24984310|NCT00281957|50072920|FG001|Overall Study|Not eligible|2|||
24984311|NCT00281957|50072919|FG000|Overall Study|Did not start treatment|3|||
24984312|NCT00281957|50072920|FG001|Overall Study|Did not start treatment|1|||
24984313|NCT00281957|50072919|FG000|Overall Study|Refusal unrelated to adverse events|0|||
24984314|NCT00281957|50072920|FG001|Overall Study|Refusal unrelated to adverse events|1|||
24984315|NCT00281099|50072930|FG000|Overall Study|Death|46|||
24984316|NCT00281099|50072931|FG001|Overall Study|Death|57|||
24984317|NCT00281099|50072930|FG000|Overall Study|Lost to Follow-up|10|||
25079378|NCT02149121|50187832|FG004|Main Study Period|Disease progression|0|||
24984318|NCT00281099|50072931|FG001|Overall Study|Lost to Follow-up|19|||
25256993|NCT01098487|50572101|FG000|Overall Study|Lack of Efficacy|11|||
24984319|NCT00281099|50072930|FG000|Overall Study|Withdrawal by Subject|65|||
24984320|NCT00281099|50072931|FG001|Overall Study|Withdrawal by Subject|70|||
24984321|NCT00281099|50072930|FG000|Overall Study|Physician Decision|79|||
24984322|NCT00281099|50072931|FG001|Overall Study|Physician Decision|72|||
24984323|NCT00281099|50072930|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
24984324|NCT00281099|50072931|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
24984325|NCT00262925|50072938|FG000|Overall Study|Lack of Efficacy|3|||
24984326|NCT00262925|50072938|FG000|Overall Study|Adverse Event|4|||
24984327|NCT00262925|50072938|FG000|Overall Study|Death|2|||
24984328|NCT00262925|50072938|FG000|Overall Study|alternative therapy|1|||
24984329|NCT00262925|50072938|FG000|Overall Study|Other|1|||
24984330|NCT03720470|50072948|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
24984331|NCT03720470|50072949|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
24984332|NCT03720470|50072950|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
24984333|NCT03720470|50072951|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
24984334|NCT03720470|50072952|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
24984335|NCT03720470|50072953|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
24984336|NCT03720470|50072948|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
24984337|NCT03720470|50072949|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
24984338|NCT03720470|50072950|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
24984339|NCT03720470|50072951|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
24984340|NCT03720470|50072952|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
24984341|NCT03720470|50072953|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
24984342|NCT03720470|50072948|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
24984343|NCT03720470|50072949|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
24984344|NCT03720470|50072950|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
24984345|NCT03720470|50072951|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
24984346|NCT03720470|50072952|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
24984347|NCT03720470|50072953|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
24984348|NCT03720470|50072948|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
24984349|NCT03720470|50072949|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
24984350|NCT03720470|50072950|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
24984351|NCT03720470|50072951|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
24984352|NCT03720470|50072952|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
24984353|NCT03720470|50072953|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
24984354|NCT03720470|50072948|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
24984355|NCT03720470|50072949|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
24984356|NCT03720470|50072950|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
24984357|NCT03720470|50072951|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
24984358|NCT03720470|50072952|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
24984359|NCT03720470|50072953|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
24984360|NCT03720470|50072948|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
24984361|NCT03720470|50072949|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
24984362|NCT03720470|50072950|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
24984363|NCT03720470|50072951|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
24984364|NCT03720470|50072952|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
24984365|NCT03720470|50072953|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
24984366|NCT03720470|50072948|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
24984367|NCT03720470|50072949|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
24984368|NCT03720470|50072950|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
24984369|NCT03720470|50072951|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
24984370|NCT03720470|50072952|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
24984371|NCT03720470|50072953|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
24984372|NCT03720470|50072948|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
24984373|NCT03720470|50072949|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
24984374|NCT03720470|50072950|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
24984375|NCT03720470|50072951|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
24984376|NCT03720470|50072952|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
24984377|NCT03720470|50072953|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
24984378|NCT03720470|50072948|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
24984379|NCT03720470|50072949|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
24984380|NCT03720470|50072950|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
24984381|NCT03720470|50072951|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
24984382|NCT03720470|50072952|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
24984383|NCT03720470|50072953|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
24984384|NCT03720470|50072948|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
24984385|NCT03720470|50072949|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
24984386|NCT03720470|50072950|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
24984387|NCT03720470|50072951|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
24984388|NCT03720470|50072952|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
24984389|NCT03720470|50072953|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
24984390|NCT03720470|50072948|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
24984391|NCT03720470|50072949|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
24984392|NCT03720470|50072950|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
24984393|NCT03720470|50072951|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
24984394|NCT03720470|50072952|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
24984395|NCT03720470|50072953|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
24984396|NCT03720470|50072948|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
24984397|NCT03720470|50072949|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
24984398|NCT03720470|50072950|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
24984399|NCT03720470|50072951|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
24984400|NCT03720470|50072952|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
24984401|NCT03720470|50072953|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
24984402|NCT03720470|50072948|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
24984403|NCT03720470|50072949|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
24984404|NCT03720470|50072950|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
24984405|NCT03720470|50072951|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
24984406|NCT03720470|50072952|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
24984407|NCT03720470|50072953|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
24984408|NCT03720470|50072948|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
24984409|NCT03720470|50072949|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
24984410|NCT03720470|50072950|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
24984411|NCT03720470|50072951|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
24984412|NCT03720470|50072952|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
24984413|NCT03720470|50072953|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
24984414|NCT03720470|50072948|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
24984415|NCT03720470|50072949|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
24984416|NCT03720470|50072950|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
24984417|NCT03720470|50072951|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
24984418|NCT03720470|50072952|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
24984419|NCT03720470|50072953|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
24984420|NCT03720470|50072948|FG000|Treatment Period: Final 4 Weeks|Other|0|||
24984421|NCT03720470|50072949|FG001|Treatment Period: Final 4 Weeks|Other|1|||
24984422|NCT03720470|50072950|FG002|Treatment Period: Final 4 Weeks|Other|0|||
24984423|NCT03720470|50072951|FG003|Treatment Period: Final 4 Weeks|Other|2|||
24984424|NCT03720470|50072952|FG004|Treatment Period: Final 4 Weeks|Other|1|||
24984425|NCT03720470|50072953|FG005|Treatment Period: Final 4 Weeks|Other|0|||
24984426|NCT00262847|50072976|FG000|Overall Study|Disease Progression|309|||
24984427|NCT00262847|50072977|FG001|Overall Study|Disease Progression|274|||
24984428|NCT00262847|50072978|FG002|Overall Study|Disease Progression|195|||
24984429|NCT00262847|50072976|FG000|Overall Study|Patient Refusal|41|||
24984430|NCT00262847|50072977|FG001|Overall Study|Patient Refusal|52|||
24984431|NCT00262847|50072978|FG002|Overall Study|Patient Refusal|47|||
24984432|NCT00262847|50072976|FG000|Overall Study|Adverse Event|74|||
24984433|NCT00262847|50072977|FG001|Overall Study|Adverse Event|88|||
24984434|NCT00262847|50072978|FG002|Overall Study|Adverse Event|108|||
24984435|NCT00262847|50072976|FG000|Overall Study|Death|8|||
24984436|NCT00262847|50072977|FG001|Overall Study|Death|8|||
24984437|NCT00262847|50072978|FG002|Overall Study|Death|11|||
24984438|NCT00262847|50072976|FG000|Overall Study|Concomitant disease|3|||
24984439|NCT00262847|50072977|FG001|Overall Study|Concomitant disease|2|||
24984440|NCT00262847|50072978|FG002|Overall Study|Concomitant disease|4|||
24984441|NCT00262847|50072976|FG000|Overall Study|Other Reasons|79|||
24984442|NCT00262847|50072977|FG001|Overall Study|Other Reasons|88|||
24984443|NCT00262847|50072978|FG002|Overall Study|Other Reasons|27|||
24984444|NCT00262847|50072976|FG000|Overall Study|Did not receive study treatment|4|||
24984445|NCT00262847|50072977|FG001|Overall Study|Did not receive study treatment|1|||
24984446|NCT00262847|50072978|FG002|Overall Study|Did not receive study treatment|4|||
24984447|NCT00280397|50072989|FG000|Overall Study|Adverse Event|1|||
24984448|NCT00262301|50072998|FG000|Double-blind Phase|Lost to Follow-up|1|||
25079379|NCT02149121|50187833|FG005|Main Study Period|Disease progression|0|||
25079380|NCT02149121|50187834|FG006|Main Study Period|Disease progression|0|||
25079381|NCT02149121|50187828|FG000|Extension Study Period|Withdrawal by Subject|0|||
24984449|NCT00262301|50072999|FG001|Double-blind Phase|Lost to Follow-up|0|||
24984450|NCT00262301|50073000|FG002|Double-blind Phase|Lost to Follow-up|0|||
24984451|NCT00262301|50072998|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
24984452|NCT00262301|50072999|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
24984453|NCT00262301|50073000|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
24984454|NCT00279305|50073010|FG000|Overall Study|Pregnancy|1|||
24984455|NCT00279305|50073011|FG001|Overall Study|Pregnancy|0|||
24984456|NCT00279305|50073010|FG000|Overall Study|Withdrawal by Subject|2|||
24984457|NCT00279305|50073011|FG001|Overall Study|Withdrawal by Subject|0|||
24984458|NCT00279305|50073010|FG000|Overall Study|Dificulting establishing IV|1|||
24984459|NCT00279305|50073011|FG001|Overall Study|Dificulting establishing IV|0|||
24984460|NCT00279305|50073010|FG000|Overall Study|FDA Safety Alert|4|||
24984461|NCT00279305|50073011|FG001|Overall Study|FDA Safety Alert|1|||
24984462|NCT00278993|50073017|FG000|Overall Study|Adverse Event|24|||
24984463|NCT00278993|50073017|FG000|Overall Study|Withdrawal by Subject|5|||
24984464|NCT00278993|50073017|FG000|Overall Study|Progressive Disease|65|||
24984465|NCT00278993|50073017|FG000|Overall Study|Physician Decision|9|||
24984466|NCT00278993|50073017|FG000|Overall Study|Not Otherwise Specified|4|||
24984467|NCT00277355|50073023|FG000|Overall Study|Withdrawal by Subject|3|||
24984468|NCT00277355|50073024|FG001|Overall Study|Withdrawal by Subject|3|||
24984469|NCT00277355|50073023|FG000|Overall Study|Lost to Follow-up|2|||
24984470|NCT00277355|50073024|FG001|Overall Study|Lost to Follow-up|2|||
24984471|NCT00277355|50073023|FG000|Overall Study|Adverse Event|5|||
24984472|NCT00277355|50073024|FG001|Overall Study|Adverse Event|0|||
24984473|NCT00277355|50073023|FG000|Overall Study|Death|3|||
24984474|NCT00277355|50073024|FG001|Overall Study|Death|0|||
24984475|NCT00277355|50073023|FG000|Overall Study|Physician Decision|1|||
24984476|NCT00277355|50073024|FG001|Overall Study|Physician Decision|0|||
24984477|NCT00262223|50073033|FG000|Treatment Phase|Withdrawal by Subject|3|||
24984478|NCT00262223|50073034|FG001|Treatment Phase|Withdrawal by Subject|6|||
24984479|NCT00262223|50073033|FG000|Treatment Phase|Adverse Event|1|||
24984480|NCT00262223|50073034|FG001|Treatment Phase|Adverse Event|2|||
24984481|NCT00262223|50073033|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
24984482|NCT00262223|50073034|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
24984483|NCT00262223|50073033|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
24984484|NCT00262223|50073034|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
24984485|NCT00262223|50073033|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
24984486|NCT00262223|50073034|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
24984487|NCT00276419|50073043|FG000|First Intervention|Adverse Event|1|||
24984488|NCT00276419|50073044|FG001|First Intervention|Adverse Event|0|||
24984489|NCT00276419|50073043|FG000|First Intervention|Withdrawal by Subject|0|||
25256994|NCT01098487|50572101|FG000|Overall Study|Withdrawal by Subject|7|||
25256995|NCT01098487|50572101|FG000|Overall Study|Lost to Follow-up|3|||
25256996|NCT01098487|50572101|FG000|Overall Study|Physician Decision|1|||
25256997|NCT01098097|50572105|FG000|Overall Study|Adverse Event|17|||
25256998|NCT01098097|50572105|FG000|Overall Study|Lost to Follow-up|18|||
25256999|NCT01098097|50572105|FG000|Overall Study|Status unknown|16|||
25257000|NCT01098097|50572105|FG000|Overall Study|No reason reported|31|||
25257001|NCT01097863|50572112|FG000|Overall Study|Discomfort|1|||
25257002|NCT01097863|50572113|FG001|Overall Study|Discomfort|0|||
25257003|NCT01097863|50572114|FG002|Overall Study|Discomfort|1|||
25257004|NCT01097863|50572112|FG000|Overall Study|Did not return for final visit|0|||
25257005|NCT01097863|50572113|FG001|Overall Study|Did not return for final visit|0|||
25257006|NCT01097863|50572114|FG002|Overall Study|Did not return for final visit|1|||
25257007|NCT01326962|50572122|FG000|Overall Study|Adverse Event|1|||
25257008|NCT01326962|50572122|FG000|Overall Study|Withdrawal by Subject|1|||
25257009|NCT01326962|50572122|FG000|Overall Study|Lost to Follow-up|3|||
25257010|NCT01326962|50572122|FG000|Overall Study|Other|2|||
25257011|NCT01326728|50572128|FG000|Overall Study|Death|13|||
25257012|NCT01326728|50572129|FG001|Overall Study|Death|0|||
25257013|NCT01326728|50572128|FG000|Overall Study|Early closure of study|34|||
25257014|NCT01326728|50572129|FG001|Overall Study|Early closure of study|9|||
25257015|NCT01097707|50572139|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
25257016|NCT01097707|50572140|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
25257017|NCT01097707|50572141|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
25257018|NCT01097707|50572142|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
25257019|NCT01097707|50572143|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
25257020|NCT01097707|50572139|FG000|Overall Study|Adverse Event|4|||
25257021|NCT01097707|50572140|FG001|Overall Study|Adverse Event|2|||
25257022|NCT01097707|50572141|FG002|Overall Study|Adverse Event|3|||
25257023|NCT01097707|50572142|FG003|Overall Study|Adverse Event|1|||
25257024|NCT01097707|50572143|FG004|Overall Study|Adverse Event|3|||
25257025|NCT01097707|50572139|FG000|Overall Study|Entry Criteria Not Met|2|||
25257026|NCT01097707|50572140|FG001|Overall Study|Entry Criteria Not Met|1|||
25257027|NCT01097707|50572141|FG002|Overall Study|Entry Criteria Not Met|1|||
25079382|NCT02149121|50187829|FG001|Extension Study Period|Withdrawal by Subject|0|||
25079383|NCT02149121|50187830|FG002|Extension Study Period|Withdrawal by Subject|0|||
25257028|NCT01097707|50572142|FG003|Overall Study|Entry Criteria Not Met|0|||
25257029|NCT01097707|50572143|FG004|Overall Study|Entry Criteria Not Met|1|||
25257030|NCT01097707|50572139|FG000|Overall Study|Lack of Efficacy|1|||
25257031|NCT01097707|50572140|FG001|Overall Study|Lack of Efficacy|0|||
25257032|NCT01097707|50572141|FG002|Overall Study|Lack of Efficacy|0|||
25257033|NCT01097707|50572142|FG003|Overall Study|Lack of Efficacy|1|||
25257034|NCT01097707|50572143|FG004|Overall Study|Lack of Efficacy|0|||
25257035|NCT01097707|50572139|FG000|Overall Study|Lost to Follow-up|1|||
25257036|NCT01097707|50572140|FG001|Overall Study|Lost to Follow-up|1|||
25257037|NCT01097707|50572141|FG002|Overall Study|Lost to Follow-up|2|||
25257038|NCT01097707|50572142|FG003|Overall Study|Lost to Follow-up|0|||
25257039|NCT01097707|50572143|FG004|Overall Study|Lost to Follow-up|3|||
25257040|NCT01097707|50572139|FG000|Overall Study|Protocol Violation|2|||
25257041|NCT01097707|50572140|FG001|Overall Study|Protocol Violation|2|||
25257042|NCT01097707|50572141|FG002|Overall Study|Protocol Violation|3|||
25257043|NCT01097707|50572142|FG003|Overall Study|Protocol Violation|2|||
25257044|NCT01097707|50572143|FG004|Overall Study|Protocol Violation|2|||
25257045|NCT01097707|50572139|FG000|Overall Study|Sponsor Decision|31|||
25257046|NCT01097707|50572140|FG001|Overall Study|Sponsor Decision|31|||
25257047|NCT01097707|50572141|FG002|Overall Study|Sponsor Decision|34|||
25257048|NCT01097707|50572142|FG003|Overall Study|Sponsor Decision|35|||
25257049|NCT01097707|50572143|FG004|Overall Study|Sponsor Decision|36|||
25257050|NCT01097707|50572139|FG000|Overall Study|Withdrawal by Subject|3|||
25257051|NCT01097707|50572140|FG001|Overall Study|Withdrawal by Subject|6|||
25257052|NCT01097707|50572141|FG002|Overall Study|Withdrawal by Subject|1|||
25257053|NCT01097707|50572142|FG003|Overall Study|Withdrawal by Subject|4|||
25257054|NCT01097707|50572143|FG004|Overall Study|Withdrawal by Subject|3|||
25257055|NCT01097707|50572139|FG000|Overall Study|Reason unknown|0|||
25257056|NCT01097707|50572140|FG001|Overall Study|Reason unknown|0|||
25257057|NCT01097707|50572141|FG002|Overall Study|Reason unknown|0|||
25257058|NCT01097707|50572142|FG003|Overall Study|Reason unknown|0|||
25257059|NCT01097707|50572143|FG004|Overall Study|Reason unknown|1|||
25079384|NCT02149121|50187831|FG003|Extension Study Period|Withdrawal by Subject|1|||
25257060|NCT01326104|50572157|FG000|Overall Study|progressed prior to vaccine|0|||
25257061|NCT01326104|50572158|FG001|Overall Study|progressed prior to vaccine|2|||
25257062|NCT01326104|50572157|FG000|Overall Study|unable to make vaccine|0|||
25257063|NCT01326104|50572158|FG001|Overall Study|unable to make vaccine|2|||
25257064|NCT01326026|50572166|FG000|Overall Study|Adverse Event|4|||
25257065|NCT01326026|50572167|FG001|Overall Study|Adverse Event|3|||
25257066|NCT01326026|50572166|FG000|Overall Study|Withdrawal Criteria|5|||
25257067|NCT01326026|50572167|FG001|Overall Study|Withdrawal Criteria|7|||
25257068|NCT01326026|50572166|FG000|Overall Study|Other|3|||
25257069|NCT01326026|50572167|FG001|Overall Study|Other|3|||
25257070|NCT01097629|50572176|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
25257071|NCT01097629|50572177|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
24984490|NCT00276419|50073044|FG001|First Intervention|Withdrawal by Subject|2|||
24984491|NCT00262067|50073065|FG000|Overall Study|Death|190|||
24984492|NCT00262067|50073066|FG001|Overall Study|Death|89|||
24984493|NCT00262067|50073067|FG002|Overall Study|Death|186|||
24984494|NCT00262067|50073068|FG003|Overall Study|Death|99|||
24984495|NCT00262067|50073065|FG000|Overall Study|Lost to Follow-up|5|||
24984496|NCT00262067|50073066|FG001|Overall Study|Lost to Follow-up|4|||
24984497|NCT00262067|50073067|FG002|Overall Study|Lost to Follow-up|7|||
24984498|NCT00262067|50073068|FG003|Overall Study|Lost to Follow-up|5|||
24984499|NCT00262067|50073065|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
24984500|NCT00262067|50073066|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
24984501|NCT00262067|50073067|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
24984502|NCT00262067|50073068|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
24984503|NCT00262067|50073065|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
24984504|NCT00262067|50073066|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
24984505|NCT00262067|50073067|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
24984506|NCT00262067|50073068|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
24984507|NCT00275561|50073080|FG000|Overall Study|Withdrawal by Subject|0|||
24984508|NCT00275561|50073081|FG001|Overall Study|Withdrawal by Subject|1|||
24984509|NCT00275561|50073080|FG000|Overall Study|Travel|1|||
24984510|NCT00275561|50073081|FG001|Overall Study|Travel|1|||
24984511|NCT00275561|50073080|FG000|Overall Study|Scheduling|1|||
24984512|NCT00275561|50073081|FG001|Overall Study|Scheduling|2|||
24984513|NCT00275561|50073080|FG000|Overall Study|Family Issues|0|||
24984514|NCT00275561|50073081|FG001|Overall Study|Family Issues|2|||
24984515|NCT00274937|50073091|FG000|Overall Study|Physician Decision|10|||
24984516|NCT00274937|50073091|FG000|Overall Study|Withdrawal by Subject|6|||
24984517|NCT00274937|50073091|FG000|Overall Study|Progressive Disease|4|||
24984518|NCT00251693|50073098|FG000|Overall Study|Adverse Event|17|||
24984519|NCT00251693|50073099|FG001|Overall Study|Adverse Event|9|||
24984520|NCT00251693|50073100|FG002|Overall Study|Adverse Event|9|||
24984521|NCT00251693|50073098|FG000|Overall Study|Protocol Violation|2|||
24984522|NCT00251693|50073099|FG001|Overall Study|Protocol Violation|0|||
24984523|NCT00251693|50073100|FG002|Overall Study|Protocol Violation|2|||
24984524|NCT00251693|50073098|FG000|Overall Study|Lost to Follow-up|12|||
24984525|NCT00251693|50073099|FG001|Overall Study|Lost to Follow-up|7|||
24984526|NCT00251693|50073100|FG002|Overall Study|Lost to Follow-up|8|||
24984527|NCT00251693|50073098|FG000|Overall Study|Withdrawal by Subject|11|||
24984528|NCT00251693|50073099|FG001|Overall Study|Withdrawal by Subject|17|||
24984529|NCT00251693|50073100|FG002|Overall Study|Withdrawal by Subject|14|||
24984530|NCT00251693|50073098|FG000|Overall Study|Lack of Efficacy|0|||
24984531|NCT00251693|50073099|FG001|Overall Study|Lack of Efficacy|1|||
24984532|NCT00251693|50073100|FG002|Overall Study|Lack of Efficacy|0|||
24984533|NCT00251693|50073098|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
24984534|NCT00251693|50073099|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
24984535|NCT00251693|50073100|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
24984536|NCT00251693|50073098|FG000|Overall Study|Noncompliant|0|||
24984537|NCT00251693|50073099|FG001|Overall Study|Noncompliant|0|||
24984538|NCT00251693|50073100|FG002|Overall Study|Noncompliant|2|||
24984539|NCT00251693|50073098|FG000|Overall Study|Possible Barrett's esophagus|3|||
24984540|NCT00251693|50073099|FG001|Overall Study|Possible Barrett's esophagus|5|||
24984541|NCT00251693|50073100|FG002|Overall Study|Possible Barrett's esophagus|2|||
24984542|NCT00251693|50073098|FG000|Overall Study|Subject request/subject unavailable|1|||
24984543|NCT00251693|50073099|FG001|Overall Study|Subject request/subject unavailable|2|||
24984544|NCT00251693|50073100|FG002|Overall Study|Subject request/subject unavailable|0|||
24984545|NCT00251693|50073098|FG000|Overall Study|Abnormal laboratory findings|0|||
24984546|NCT00251693|50073099|FG001|Overall Study|Abnormal laboratory findings|0|||
24984547|NCT00251693|50073100|FG002|Overall Study|Abnormal laboratory findings|1|||
24984548|NCT00250835|50073108|FG000|Overall Study|Withdrawal by Subject|1|||
24984549|NCT03716024|50073118|FG000|Overall Study|Randomized, not Treated|7|||
24984550|NCT03716024|50073119|FG001|Overall Study|Randomized, not Treated|8|||
24984551|NCT03716024|50073118|FG000|Overall Study|Adverse Event|1|||
24984552|NCT03716024|50073119|FG001|Overall Study|Adverse Event|2|||
24984553|NCT03716024|50073118|FG000|Overall Study|Treatment Failure|1|||
24984554|NCT03716024|50073119|FG001|Overall Study|Treatment Failure|0|||
24984555|NCT03716024|50073118|FG000|Overall Study|Lost to Follow-up|2|||
24984556|NCT03716024|50073119|FG001|Overall Study|Lost to Follow-up|6|||
24984557|NCT03716024|50073118|FG000|Overall Study|Withdrawal by Subject|0|||
24984558|NCT03716024|50073119|FG001|Overall Study|Withdrawal by Subject|1|||
24984559|NCT03716024|50073118|FG000|Overall Study|Missing Reason|0|||
24984560|NCT03716024|50073119|FG001|Overall Study|Missing Reason|1|||
24984561|NCT00250679|50073128|FG000|Overall Study|Adverse Event|12|||
24984562|NCT00250679|50073129|FG001|Overall Study|Adverse Event|15|||
24984563|NCT00250679|50073130|FG002|Overall Study|Adverse Event|16|||
24984564|NCT00250679|50073128|FG000|Overall Study|Protocol Violation|2|||
24984565|NCT00250679|50073129|FG001|Overall Study|Protocol Violation|4|||
24984566|NCT00250679|50073130|FG002|Overall Study|Protocol Violation|3|||
24984567|NCT00250679|50073128|FG000|Overall Study|Withdrawal by Subject|15|||
24984568|NCT00250679|50073129|FG001|Overall Study|Withdrawal by Subject|18|||
24984569|NCT00250679|50073130|FG002|Overall Study|Withdrawal by Subject|15|||
24984570|NCT00250679|50073128|FG000|Overall Study|Lost to Follow-up|3|||
24984571|NCT00250679|50073129|FG001|Overall Study|Lost to Follow-up|4|||
24984572|NCT00250679|50073130|FG002|Overall Study|Lost to Follow-up|2|||
24984573|NCT00250679|50073128|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
24984574|NCT00250679|50073129|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
24984575|NCT00250679|50073130|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
24984576|NCT00250679|50073128|FG000|Overall Study|Lack of Efficacy|0|||
24984577|NCT00250679|50073129|FG001|Overall Study|Lack of Efficacy|1|||
24984578|NCT00250679|50073130|FG002|Overall Study|Lack of Efficacy|3|||
24984579|NCT00250679|50073128|FG000|Overall Study|Technical Holter issues|1|||
24984580|NCT00250679|50073129|FG001|Overall Study|Technical Holter issues|0|||
24984581|NCT00250679|50073130|FG002|Overall Study|Technical Holter issues|2|||
24984582|NCT00250679|50073128|FG000|Overall Study|Moved|1|||
24984583|NCT00250679|50073129|FG001|Overall Study|Moved|1|||
24984584|NCT00250679|50073130|FG002|Overall Study|Moved|0|||
24984585|NCT00250679|50073128|FG000|Overall Study|Non-compliance|1|||
24984586|NCT00250679|50073129|FG001|Overall Study|Non-compliance|1|||
24984587|NCT00250679|50073130|FG002|Overall Study|Non-compliance|0|||
24984588|NCT00250679|50073128|FG000|Overall Study|various single events: hip surgery,diary|3|||
24984589|NCT00250679|50073129|FG001|Overall Study|various single events: hip surgery,diary|1|||
24984590|NCT00250679|50073130|FG002|Overall Study|various single events: hip surgery,diary|1|||
24984591|NCT00261833|50073140|FG000|Overall Study|Death|1|||
24984592|NCT00261833|50073141|FG001|Overall Study|Death|3|||
24984593|NCT00261833|50073140|FG000|Overall Study|Adverse Event|1|||
24984594|NCT00261833|50073141|FG001|Overall Study|Adverse Event|4|||
24984595|NCT00261833|50073140|FG000|Overall Study|Withdrawal by Subject|5|||
24984596|NCT00261833|50073141|FG001|Overall Study|Withdrawal by Subject|7|||
24984597|NCT00261833|50073140|FG000|Overall Study|Protocol Violation|0|||
24984598|NCT00261833|50073141|FG001|Overall Study|Protocol Violation|1|||
24984599|NCT00261833|50073140|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
24984600|NCT00261833|50073141|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
24984601|NCT00261833|50073140|FG000|Overall Study|Lung transplantation|1|||
24984602|NCT00261833|50073141|FG001|Overall Study|Lung transplantation|1|||
24984603|NCT00261833|50073140|FG000|Overall Study|Missing reason|1|||
24984604|NCT00261833|50073141|FG001|Overall Study|Missing reason|0|||
24984605|NCT00261833|50073140|FG000|Overall Study|Not interested in being participant|0|||
24984606|NCT00261833|50073141|FG001|Overall Study|Not interested in being participant|1|||
24984607|NCT03713684|50073152|FG000|Overall Study|Adverse Event|1|||
24984608|NCT03713684|50073153|FG001|Overall Study|Adverse Event|3|||
24984609|NCT03713684|50073154|FG002|Overall Study|Adverse Event|1|||
24984610|NCT03713684|50073155|FG003|Overall Study|Adverse Event|0|||
24984611|NCT03713684|50073152|FG000|Overall Study|Poor compliance to protocol|2|||
24984612|NCT03713684|50073153|FG001|Overall Study|Poor compliance to protocol|1|||
24984613|NCT03713684|50073154|FG002|Overall Study|Poor compliance to protocol|0|||
24984614|NCT03713684|50073155|FG003|Overall Study|Poor compliance to protocol|1|||
24984615|NCT03713684|50073152|FG000|Overall Study|Withdrawal by Subject|14|||
24984616|NCT03713684|50073153|FG001|Overall Study|Withdrawal by Subject|6|||
24984617|NCT03713684|50073154|FG002|Overall Study|Withdrawal by Subject|14|||
24984618|NCT03713684|50073155|FG003|Overall Study|Withdrawal by Subject|16|||
24984619|NCT03713684|50073152|FG000|Overall Study|Other than specified|69|||
24984620|NCT03713684|50073153|FG001|Overall Study|Other than specified|77|||
24984621|NCT03713684|50073154|FG002|Overall Study|Other than specified|73|||
24984622|NCT03713684|50073155|FG003|Overall Study|Other than specified|70|||
24984623|NCT03711266|50073165|FG000|Overall Study|Lost to Follow-up|10|||
24984624|NCT03150862|50073177|FG000|Overall Study|Death|2|||
24984625|NCT03150862|50073178|FG001|Overall Study|Death|7|||
24984626|NCT03150862|50073179|FG002|Overall Study|Death|8|||
24984627|NCT03150862|50073180|FG003|Overall Study|Death|27|||
24984628|NCT03150862|50073181|FG004|Overall Study|Death|4|||
24984629|NCT03150862|50073182|FG005|Overall Study|Death|8|||
24984630|NCT03150862|50073183|FG006|Overall Study|Death|6|||
24984631|NCT03150862|50073184|FG007|Overall Study|Death|21|||
24984632|NCT03150862|50073177|FG000|Overall Study|Withdrawal by Subject|1|||
24984633|NCT03150862|50073178|FG001|Overall Study|Withdrawal by Subject|1|||
24984634|NCT03150862|50073179|FG002|Overall Study|Withdrawal by Subject|0|||
24984635|NCT03150862|50073180|FG003|Overall Study|Withdrawal by Subject|3|||
24984636|NCT03150862|50073181|FG004|Overall Study|Withdrawal by Subject|1|||
24984637|NCT03150862|50073182|FG005|Overall Study|Withdrawal by Subject|1|||
24984638|NCT03150862|50073183|FG006|Overall Study|Withdrawal by Subject|1|||
24984639|NCT03150862|50073184|FG007|Overall Study|Withdrawal by Subject|3|||
24984640|NCT03150862|50073177|FG000|Overall Study|Lost to Follow-up|0|||
24984641|NCT03150862|50073178|FG001|Overall Study|Lost to Follow-up|0|||
24984642|NCT03150862|50073179|FG002|Overall Study|Lost to Follow-up|1|||
24984643|NCT03150862|50073180|FG003|Overall Study|Lost to Follow-up|0|||
24984644|NCT03150862|50073181|FG004|Overall Study|Lost to Follow-up|0|||
24984645|NCT03150862|50073182|FG005|Overall Study|Lost to Follow-up|0|||
24984646|NCT03150862|50073183|FG006|Overall Study|Lost to Follow-up|0|||
24984647|NCT03150862|50073184|FG007|Overall Study|Lost to Follow-up|2|||
24984648|NCT03150862|50073177|FG000|Overall Study|Sponsor's decision|0|||
24984649|NCT03150862|50073178|FG001|Overall Study|Sponsor's decision|0|||
24984650|NCT03150862|50073179|FG002|Overall Study|Sponsor's decision|0|||
24984651|NCT03150862|50073180|FG003|Overall Study|Sponsor's decision|10|||
24984652|NCT03150862|50073181|FG004|Overall Study|Sponsor's decision|3|||
24984653|NCT03150862|50073182|FG005|Overall Study|Sponsor's decision|0|||
24984654|NCT03150862|50073183|FG006|Overall Study|Sponsor's decision|1|||
24984655|NCT03150862|50073184|FG007|Overall Study|Sponsor's decision|1|||
24984656|NCT03150862|50073177|FG000|Overall Study|Change in Methylation status|0|||
24984657|NCT03150862|50073178|FG001|Overall Study|Change in Methylation status|0|||
24984658|NCT03150862|50073179|FG002|Overall Study|Change in Methylation status|0|||
24984659|NCT03150862|50073180|FG003|Overall Study|Change in Methylation status|0|||
24984660|NCT03150862|50073181|FG004|Overall Study|Change in Methylation status|1|||
24984661|NCT03150862|50073182|FG005|Overall Study|Change in Methylation status|0|||
24984662|NCT03150862|50073183|FG006|Overall Study|Change in Methylation status|0|||
24984663|NCT03150862|50073184|FG007|Overall Study|Change in Methylation status|0|||
24984664|NCT03150862|50073177|FG000|Overall Study|Roll over in to Long Term Extension|0|||
24984665|NCT03150862|50073178|FG001|Overall Study|Roll over in to Long Term Extension|0|||
24984666|NCT03150862|50073179|FG002|Overall Study|Roll over in to Long Term Extension|0|||
24984667|NCT03150862|50073180|FG003|Overall Study|Roll over in to Long Term Extension|0|||
24984668|NCT03150862|50073181|FG004|Overall Study|Roll over in to Long Term Extension|0|||
24984669|NCT03150862|50073182|FG005|Overall Study|Roll over in to Long Term Extension|0|||
24984670|NCT03150862|50073183|FG006|Overall Study|Roll over in to Long Term Extension|0|||
24984671|NCT03150862|50073184|FG007|Overall Study|Roll over in to Long Term Extension|1|||
24984672|NCT03150862|50073177|FG000|Overall Study|Progressive Disease|0|||
24984673|NCT03150862|50073178|FG001|Overall Study|Progressive Disease|0|||
24984674|NCT03150862|50073179|FG002|Overall Study|Progressive Disease|0|||
24984675|NCT03150862|50073180|FG003|Overall Study|Progressive Disease|0|||
24984676|NCT03150862|50073181|FG004|Overall Study|Progressive Disease|0|||
24984677|NCT03150862|50073182|FG005|Overall Study|Progressive Disease|0|||
24984678|NCT03150862|50073183|FG006|Overall Study|Progressive Disease|0|||
24984679|NCT03150862|50073184|FG007|Overall Study|Progressive Disease|2|||
24984680|NCT00260429|50073213|FG000|Overall Study|failure to follow appointments|1|||
24984681|NCT00260429|50073214|FG001|Overall Study|failure to follow appointments|0|||
24984682|NCT00260429|50073213|FG000|Overall Study|scheduled hand surgery|1|||
24984683|NCT00260429|50073214|FG001|Overall Study|scheduled hand surgery|0|||
24984684|NCT00379288|50073224|FG000|Overall Study|Adverse Event|5|||
24984685|NCT00379288|50073225|FG001|Overall Study|Adverse Event|6|||
24984686|NCT00379288|50073226|FG002|Overall Study|Adverse Event|2|||
24984687|NCT00379288|50073227|FG003|Overall Study|Adverse Event|0|||
24984688|NCT00379288|50073224|FG000|Overall Study|Treatment Failure|0|||
24984689|NCT00379288|50073225|FG001|Overall Study|Treatment Failure|1|||
24984690|NCT00379288|50073226|FG002|Overall Study|Treatment Failure|0|||
24984691|NCT00379288|50073227|FG003|Overall Study|Treatment Failure|1|||
24984692|NCT00379288|50073224|FG000|Overall Study|Lost to Follow-up|3|||
24984693|NCT00379288|50073225|FG001|Overall Study|Lost to Follow-up|3|||
24984694|NCT00379288|50073226|FG002|Overall Study|Lost to Follow-up|2|||
24984695|NCT00379288|50073227|FG003|Overall Study|Lost to Follow-up|0|||
24984696|NCT00379288|50073224|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
24984697|NCT00379288|50073225|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
24984698|NCT00379288|50073226|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
24984699|NCT00379288|50073227|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
24984700|NCT00379288|50073224|FG000|Overall Study|Subject withdrew-related to study drug|1|||
24984701|NCT00379288|50073225|FG001|Overall Study|Subject withdrew-related to study drug|0|||
24984702|NCT00379288|50073226|FG002|Overall Study|Subject withdrew-related to study drug|0|||
24984703|NCT00379288|50073227|FG003|Overall Study|Subject withdrew-related to study drug|1|||
24984704|NCT00379288|50073224|FG000|Overall Study|Noncompliance with protocol|8|||
24984705|NCT00379288|50073225|FG001|Overall Study|Noncompliance with protocol|6|||
24984706|NCT00379288|50073226|FG002|Overall Study|Noncompliance with protocol|2|||
24984707|NCT00379288|50073227|FG003|Overall Study|Noncompliance with protocol|1|||
24984708|NCT00379288|50073224|FG000|Overall Study|Did not meet protocol eligibility|0|||
24984709|NCT00379288|50073225|FG001|Overall Study|Did not meet protocol eligibility|1|||
24984710|NCT00379288|50073226|FG002|Overall Study|Did not meet protocol eligibility|0|||
24984711|NCT00379288|50073227|FG003|Overall Study|Did not meet protocol eligibility|2|||
24984712|NCT00379288|50073224|FG000|Overall Study|Administrative|2|||
24984713|NCT00379288|50073225|FG001|Overall Study|Administrative|2|||
24984714|NCT00379288|50073226|FG002|Overall Study|Administrative|0|||
24984715|NCT00379288|50073227|FG003|Overall Study|Administrative|1|||
24984716|NCT00243503|50073237|FG000|Overall Study|Adverse Event|11|||
24984717|NCT00243503|50073237|FG000|Overall Study|Withdrawal by Subject|1|||
24984718|NCT00243503|50073237|FG000|Overall Study|Lack of Efficacy|44|||
24984719|NCT00243503|50073237|FG000|Overall Study|Death|1|||
24984720|NCT00243503|50073237|FG000|Overall Study|Other|1|||
24984721|NCT00239837|50073244|FG000|Overall Study|Lost to Follow-up|3|||
24984722|NCT00239837|50073245|FG001|Overall Study|Lost to Follow-up|7|||
24984723|NCT00259649|50073253|FG000|Overall Study|Lost to Follow-up|7|||
24984724|NCT00259649|50073253|FG000|Overall Study|irregular menses|3|||
24984725|NCT03712280|50073261|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
24984726|NCT03712280|50073262|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
24984727|NCT03712280|50073263|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
24984728|NCT03712280|50073264|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
24984729|NCT03712280|50073261|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
24984730|NCT03712280|50073262|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
24984731|NCT03712280|50073263|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
24984732|NCT03712280|50073264|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
24984733|NCT03712280|50073261|FG000|Overall Study|Adverse Event|0|||
24984734|NCT03712280|50073262|FG001|Overall Study|Adverse Event|0|||
24984735|NCT03712280|50073263|FG002|Overall Study|Adverse Event|1|||
24984736|NCT03712280|50073264|FG003|Overall Study|Adverse Event|0|||
24984737|NCT01345240|50073279|FG000|Overall Study|Adverse Event|3|||
24984738|NCT01345240|50073280|FG001|Overall Study|Adverse Event|5|||
24984739|NCT01345240|50073281|FG002|Overall Study|Adverse Event|4|||
24984740|NCT01345240|50073282|FG003|Overall Study|Adverse Event|2|||
24984741|NCT01345240|50073283|FG004|Overall Study|Adverse Event|1|||
24984742|NCT01345240|50073279|FG000|Overall Study|Lost to Follow-up|8|||
24984743|NCT01345240|50073280|FG001|Overall Study|Lost to Follow-up|9|||
24984744|NCT01345240|50073281|FG002|Overall Study|Lost to Follow-up|14|||
24984745|NCT01345240|50073282|FG003|Overall Study|Lost to Follow-up|7|||
24984746|NCT01345240|50073283|FG004|Overall Study|Lost to Follow-up|9|||
24984747|NCT03707912|50073315|FG000|Overall Study|Violation of inclusion criteria|1|||
24984748|NCT03707912|50073316|FG001|Overall Study|Violation of inclusion criteria|0|||
24984749|NCT02883244|50073324|FG000|Overall Study|Lost to Follow-up|0|||
24984750|NCT02883244|50073325|FG001|Overall Study|Lost to Follow-up|1|||
24984751|NCT02882854|50073333|FG000|Overall Study|Lost to Follow-up|1|||
24984752|NCT02882854|50073334|FG001|Overall Study|Lost to Follow-up|2|||
24984753|NCT02882854|50073333|FG000|Overall Study|Physician Decision|0|||
24984754|NCT02882854|50073334|FG001|Overall Study|Physician Decision|1|||
24984755|NCT03707522|50073344|FG000|Overall Study|Lost to Follow-up|24|||
24984756|NCT03707522|50073345|FG001|Overall Study|Lost to Follow-up|27|||
24984757|NCT03707522|50073346|FG002|Overall Study|Lost to Follow-up|41|||
24984758|NCT03707522|50073347|FG003|Overall Study|Lost to Follow-up|36|||
24984759|NCT03150082|50073357|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
24984760|NCT03150082|50073358|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
24984761|NCT03142750|50073386|FG000|Overall Study|Lost to Follow-up|4|||
24984762|NCT03142750|50073387|FG001|Overall Study|Lost to Follow-up|1|||
24984763|NCT03149848|50073397|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
24984764|NCT03149848|50073397|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
24984765|NCT03706040|50073407|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
24984766|NCT03706040|50073408|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
24984767|NCT03706040|50073409|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
24984768|NCT03706040|50073410|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
24984769|NCT03706040|50073411|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
24984770|NCT03706040|50073412|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
24984771|NCT03706040|50073413|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
24984772|NCT03706040|50073407|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
24984773|NCT03706040|50073408|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
24984774|NCT03706040|50073409|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
24984775|NCT03706040|50073410|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
24984776|NCT03706040|50073411|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
24984777|NCT03706040|50073412|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
24984778|NCT03706040|50073413|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
24984779|NCT03706040|50073407|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
24984780|NCT03706040|50073408|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
24984781|NCT03706040|50073409|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
24984782|NCT03706040|50073410|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
24984783|NCT03706040|50073411|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
24984784|NCT03706040|50073412|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
24984785|NCT03706040|50073413|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
24984786|NCT03706040|50073407|FG000|Period A (Week 0 to Week 16)|Other|2|||
24984787|NCT03706040|50073408|FG001|Period A (Week 0 to Week 16)|Other|0|||
24984788|NCT03706040|50073409|FG002|Period A (Week 0 to Week 16)|Other|2|||
24984789|NCT03706040|50073410|FG003|Period A (Week 0 to Week 16)|Other|0|||
24984790|NCT03706040|50073411|FG004|Period A (Week 0 to Week 16)|Other|0|||
24984791|NCT03706040|50073412|FG005|Period A (Week 0 to Week 16)|Other|0|||
24984792|NCT03706040|50073413|FG006|Period A (Week 0 to Week 16)|Other|0|||
24984793|NCT03706040|50073407|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
24984794|NCT03706040|50073408|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
24984795|NCT03706040|50073409|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
24984796|NCT03706040|50073410|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
24984797|NCT03706040|50073411|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
24984798|NCT03706040|50073412|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
24984799|NCT03706040|50073413|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
24984800|NCT03706040|50073407|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
24984801|NCT03706040|50073408|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
24984802|NCT03706040|50073409|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
24984803|NCT03706040|50073410|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
24984804|NCT03706040|50073411|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
24984805|NCT03706040|50073412|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
24984806|NCT03706040|50073413|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
24984807|NCT03706040|50073407|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
24984808|NCT03706040|50073408|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
24984809|NCT03706040|50073409|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
24984810|NCT03706040|50073410|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
24984811|NCT03706040|50073411|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
24984812|NCT03706040|50073412|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
24984813|NCT03706040|50073413|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
24984814|NCT03706040|50073407|FG000|Period B (Week 16 to Week 52)|Other|0|||
24984815|NCT03706040|50073408|FG001|Period B (Week 16 to Week 52)|Other|0|||
24984816|NCT03706040|50073409|FG002|Period B (Week 16 to Week 52)|Other|0|||
24984817|NCT03706040|50073410|FG003|Period B (Week 16 to Week 52)|Other|4|||
24984818|NCT03706040|50073411|FG004|Period B (Week 16 to Week 52)|Other|5|||
24984819|NCT03706040|50073412|FG005|Period B (Week 16 to Week 52)|Other|23|||
24984820|NCT03706040|50073413|FG006|Period B (Week 16 to Week 52)|Other|17|||
24984821|NCT03770000|50073434|FG000|Overall Study|Premature discontinuation due to PD|0|||
24984822|NCT03770000|50073435|FG001|Overall Study|Premature discontinuation due to PD|0|||
24984823|NCT03770000|50073436|FG002|Overall Study|Premature discontinuation due to PD|1|||
24984824|NCT03770000|50073437|FG003|Overall Study|Premature discontinuation due to PD|3|||
24984825|NCT03770000|50073438|FG004|Overall Study|Premature discontinuation due to PD|2|||
24984826|NCT03158272|50073457|FG000|Overall Study|Disease progression|3|||
24984827|NCT03158272|50073458|FG001|Overall Study|Disease progression|3|||
24984828|NCT03158272|50073459|FG002|Overall Study|Disease progression|4|||
24984829|NCT03158272|50073460|FG003|Overall Study|Disease progression|6|||
24984830|NCT03158272|50073457|FG000|Overall Study|Death|0|||
24984831|NCT03158272|50073458|FG001|Overall Study|Death|0|||
24984832|NCT03158272|50073459|FG002|Overall Study|Death|1|||
24984833|NCT03158272|50073460|FG003|Overall Study|Death|0|||
24984834|NCT03158272|50073457|FG000|Overall Study|Other reasons|0|||
24984835|NCT03158272|50073458|FG001|Overall Study|Other reasons|0|||
24984836|NCT03158272|50073459|FG002|Overall Study|Other reasons|1|||
24984837|NCT03158272|50073460|FG003|Overall Study|Other reasons|0|||
24984838|NCT03158272|50073457|FG000|Overall Study|Adverse event unrelated to the drug|0|||
24984839|NCT03158272|50073458|FG001|Overall Study|Adverse event unrelated to the drug|1|||
24984840|NCT03158272|50073459|FG002|Overall Study|Adverse event unrelated to the drug|0|||
24984841|NCT03158272|50073460|FG003|Overall Study|Adverse event unrelated to the drug|0|||
24984842|NCT03705494|50073474|FG000|Overall Study|Lost to Follow-up|2|||
24984843|NCT03705494|50073475|FG001|Overall Study|Lost to Follow-up|1|||
24984844|NCT03705494|50073474|FG000|Overall Study|Withdrawal by Subject|5|||
24984845|NCT03705494|50073475|FG001|Overall Study|Withdrawal by Subject|2|||
24984846|NCT01431508|50073481|FG000|Overall Study|Lack of Efficacy|1|||
24984847|NCT01431508|50073481|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
24984848|NCT00654628|50073485|FG000|6-week Active Treatment Period|Adverse Event|9|||
24984849|NCT00654628|50073485|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
24984850|NCT00654628|50073485|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
24984851|NCT00654628|50073485|FG000|6-week Active Treatment Period|Out of window period|1|||
24984852|NCT00654628|50073485|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
24984853|NCT00654628|50073485|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
24984854|NCT00536380|50073492|FG000|Overall Study|Adverse Event|0|||
24984855|NCT00536380|50073493|FG001|Overall Study|Adverse Event|2|||
24984856|NCT00536380|50073494|FG002|Overall Study|Adverse Event|2|||
24984857|NCT00536380|50073492|FG000|Overall Study|Lost to Follow-up|0|||
24984858|NCT00536380|50073493|FG001|Overall Study|Lost to Follow-up|0|||
24984859|NCT00536380|50073494|FG002|Overall Study|Lost to Follow-up|1|||
24984860|NCT00536380|50073492|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
24984861|NCT00536380|50073493|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
24984862|NCT00536380|50073494|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
24984863|NCT00536380|50073492|FG000|Overall Study|Withdrawal related to study drug|7|||
24984864|NCT00536380|50073493|FG001|Overall Study|Withdrawal related to study drug|5|||
24984865|NCT00536380|50073494|FG002|Overall Study|Withdrawal related to study drug|2|||
24984866|NCT00536380|50073492|FG000|Overall Study|Noncompliance with protocol|3|||
24984867|NCT00536380|50073493|FG001|Overall Study|Noncompliance with protocol|2|||
24984868|NCT00536380|50073494|FG002|Overall Study|Noncompliance with protocol|2|||
24984869|NCT00536380|50073492|FG000|Overall Study|Did not meet protocol eligibility|0|||
24984870|NCT00536380|50073493|FG001|Overall Study|Did not meet protocol eligibility|0|||
24984871|NCT00536380|50073494|FG002|Overall Study|Did not meet protocol eligibility|1|||
24984872|NCT00536380|50073492|FG000|Overall Study|Administrative|0|||
24984873|NCT00536380|50073493|FG001|Overall Study|Administrative|0|||
24984874|NCT00536380|50073494|FG002|Overall Study|Administrative|1|||
24984875|NCT00496834|50073504|FG000|Overall Study|Withdrawal by Subject|4|||
24984876|NCT00496834|50073505|FG001|Overall Study|Withdrawal by Subject|6|||
24984877|NCT00496834|50073504|FG000|Overall Study|Contraindicated medication administered|0|||
24984878|NCT00496834|50073505|FG001|Overall Study|Contraindicated medication administered|1|||
24984879|NCT00496834|50073504|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
24984880|NCT00496834|50073505|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
24984881|NCT00496834|50073504|FG000|Overall Study|Adverse Event|5|||
24984882|NCT00496834|50073505|FG001|Overall Study|Adverse Event|3|||
24984883|NCT00496834|50073504|FG000|Overall Study|IP administration violation|2|||
24984884|NCT00496834|50073505|FG001|Overall Study|IP administration violation|0|||
24984885|NCT00496834|50073504|FG000|Overall Study|Lost to Follow-up|2|||
24984886|NCT00496834|50073505|FG001|Overall Study|Lost to Follow-up|0|||
24984887|NCT00496834|50073504|FG000|Overall Study|Blood Pressure control failure|2|||
24984888|NCT00496834|50073505|FG001|Overall Study|Blood Pressure control failure|1|||
24984889|NCT05244122|50073513|FG000|Overall Study|Withdrawal by Subject|318|||
24984890|NCT00166504|50073534|FG000|Overall Study|Adverse Event|3|||
24984891|NCT00166504|50073535|FG001|Overall Study|Adverse Event|3|||
25079385|NCT02149121|50187832|FG004|Extension Study Period|Withdrawal by Subject|0|||
25079386|NCT02149121|50187833|FG005|Extension Study Period|Withdrawal by Subject|2|||
25079387|NCT02149121|50187834|FG006|Extension Study Period|Withdrawal by Subject|0|||
25079388|NCT01865617|50187886|FG000|Overall Study|Death|27|||
25079389|NCT01865617|50187887|FG001|Overall Study|Death|3|||
25079390|NCT01865617|50187888|FG002|Overall Study|Death|1|||
25079391|NCT01865617|50187889|FG003|Overall Study|Death|1|||
25079392|NCT01865617|50187890|FG004|Overall Study|Death|5|||
24984892|NCT00166504|50073534|FG000|Overall Study|Lost to Follow-up|1|||
24984893|NCT00166504|50073535|FG001|Overall Study|Lost to Follow-up|1|||
24984894|NCT00166504|50073534|FG000|Overall Study|Withdrawal by Subject|1|||
24984895|NCT00166504|50073535|FG001|Overall Study|Withdrawal by Subject|0|||
24984896|NCT03137992|50073541|FG000|Washout Period 1|Adverse Event|1|||
24984897|NCT03137992|50073542|FG001|Washout Period 1|Adverse Event|1|||
24984898|NCT03137992|50073543|FG002|Washout Period 1|Adverse Event|0|||
24984899|NCT03137992|50073544|FG003|Washout Period 1|Adverse Event|0|||
24984900|NCT03137992|50073545|FG004|Washout Period 1|Adverse Event|0|||
24984901|NCT03137992|50073546|FG005|Washout Period 1|Adverse Event|1|||
24984902|NCT03137992|50073541|FG000|Washout Period 1|Withdrawal by Subject|0|||
24984903|NCT03137992|50073542|FG001|Washout Period 1|Withdrawal by Subject|1|||
24984904|NCT03137992|50073543|FG002|Washout Period 1|Withdrawal by Subject|1|||
24984905|NCT03137992|50073544|FG003|Washout Period 1|Withdrawal by Subject|0|||
24984906|NCT03137992|50073545|FG004|Washout Period 1|Withdrawal by Subject|0|||
24984907|NCT03137992|50073546|FG005|Washout Period 1|Withdrawal by Subject|0|||
24984908|NCT03137992|50073541|FG000|Washout Period 1|Principal Investigator Discretion|0|||
24984909|NCT03137992|50073542|FG001|Washout Period 1|Principal Investigator Discretion|1|||
24984910|NCT03137992|50073543|FG002|Washout Period 1|Principal Investigator Discretion|0|||
24984911|NCT03137992|50073544|FG003|Washout Period 1|Principal Investigator Discretion|0|||
24984912|NCT03137992|50073545|FG004|Washout Period 1|Principal Investigator Discretion|0|||
25079393|NCT01865617|50187891|FG005|Overall Study|Death|1|||
25079394|NCT01865617|50187892|FG006|Overall Study|Death|11|||
25079395|NCT01865617|50187893|FG007|Overall Study|Death|1|||
25079396|NCT01865617|50187894|FG008|Overall Study|Death|11|||
24984913|NCT03137992|50073546|FG005|Washout Period 1|Principal Investigator Discretion|0|||
24984914|NCT03137992|50073541|FG000|Washout Period 1|COPD Exacerbation|1|||
24984915|NCT03137992|50073542|FG001|Washout Period 1|COPD Exacerbation|1|||
24984916|NCT03137992|50073543|FG002|Washout Period 1|COPD Exacerbation|1|||
24984917|NCT03137992|50073544|FG003|Washout Period 1|COPD Exacerbation|0|||
24984918|NCT03137992|50073545|FG004|Washout Period 1|COPD Exacerbation|1|||
24984919|NCT03137992|50073546|FG005|Washout Period 1|COPD Exacerbation|1|||
24984920|NCT03137992|50073541|FG000|Washout Period 1|Subject Noncompliance|1|||
24984921|NCT03137992|50073542|FG001|Washout Period 1|Subject Noncompliance|0|||
24984922|NCT03137992|50073543|FG002|Washout Period 1|Subject Noncompliance|0|||
24984923|NCT03137992|50073544|FG003|Washout Period 1|Subject Noncompliance|0|||
24984924|NCT03137992|50073545|FG004|Washout Period 1|Subject Noncompliance|1|||
24984925|NCT03137992|50073546|FG005|Washout Period 1|Subject Noncompliance|0|||
24984926|NCT03137992|50073541|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
24984927|NCT03137992|50073542|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
24984928|NCT03137992|50073543|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
24984929|NCT03137992|50073544|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
24984930|NCT03137992|50073545|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
24984931|NCT03137992|50073546|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
24984932|NCT03137992|50073541|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
24984933|NCT03137992|50073542|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
24984934|NCT03137992|50073543|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
24984935|NCT03137992|50073544|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
24984936|NCT03137992|50073545|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
24984937|NCT03137992|50073546|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
24984938|NCT03137992|50073541|FG000|Period 2 (Visit 3)|Adverse Event|0|||
24984939|NCT03137992|50073542|FG001|Period 2 (Visit 3)|Adverse Event|1|||
24984940|NCT03137992|50073543|FG002|Period 2 (Visit 3)|Adverse Event|0|||
24984941|NCT03137992|50073544|FG003|Period 2 (Visit 3)|Adverse Event|0|||
24984942|NCT03137992|50073545|FG004|Period 2 (Visit 3)|Adverse Event|0|||
24984943|NCT03137992|50073546|FG005|Period 2 (Visit 3)|Adverse Event|0|||
24984944|NCT03137992|50073541|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
24984945|NCT03137992|50073542|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
25079397|NCT01865617|50187895|FG009|Overall Study|Death|3|||
25079398|NCT01865617|50187896|FG010|Overall Study|Death|32|||
24984946|NCT03137992|50073543|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
24984947|NCT03137992|50073544|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
24984948|NCT03137992|50073545|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
24984949|NCT03137992|50073546|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
24984950|NCT03137992|50073541|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
24984951|NCT03137992|50073542|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
24984952|NCT03137992|50073543|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
24984953|NCT03137992|50073544|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
24984954|NCT03137992|50073545|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
24984955|NCT03137992|50073546|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
24984956|NCT03137992|50073541|FG000|Washout Period 2|COPD Exacerbation|1|||
24984957|NCT03137992|50073542|FG001|Washout Period 2|COPD Exacerbation|1|||
24984958|NCT03137992|50073543|FG002|Washout Period 2|COPD Exacerbation|0|||
24984959|NCT03137992|50073544|FG003|Washout Period 2|COPD Exacerbation|0|||
24984960|NCT03137992|50073545|FG004|Washout Period 2|COPD Exacerbation|1|||
24984961|NCT03137992|50073546|FG005|Washout Period 2|COPD Exacerbation|0|||
24984962|NCT03137992|50073541|FG000|Washout Period 2|Subject Non-compliance|0|||
24984963|NCT03137992|50073542|FG001|Washout Period 2|Subject Non-compliance|1|||
24984964|NCT03137992|50073543|FG002|Washout Period 2|Subject Non-compliance|0|||
24984965|NCT03137992|50073544|FG003|Washout Period 2|Subject Non-compliance|0|||
24984966|NCT03137992|50073545|FG004|Washout Period 2|Subject Non-compliance|0|||
24984967|NCT03137992|50073546|FG005|Washout Period 2|Subject Non-compliance|0|||
24984968|NCT03137992|50073541|FG000|Washout Period 2|Adverse Event|0|||
24984969|NCT03137992|50073542|FG001|Washout Period 2|Adverse Event|0|||
24984970|NCT03137992|50073543|FG002|Washout Period 2|Adverse Event|0|||
24984971|NCT03137992|50073544|FG003|Washout Period 2|Adverse Event|1|||
24984972|NCT03137992|50073545|FG004|Washout Period 2|Adverse Event|1|||
24984973|NCT03137992|50073546|FG005|Washout Period 2|Adverse Event|0|||
24984974|NCT03137992|50073541|FG000|Washout Period 2|Withdrawal by Subject|1|||
24984975|NCT03137992|50073542|FG001|Washout Period 2|Withdrawal by Subject|0|||
24984976|NCT03137992|50073543|FG002|Washout Period 2|Withdrawal by Subject|0|||
24984977|NCT03137992|50073544|FG003|Washout Period 2|Withdrawal by Subject|0|||
24984978|NCT03137992|50073545|FG004|Washout Period 2|Withdrawal by Subject|1|||
24984979|NCT03137992|50073546|FG005|Washout Period 2|Withdrawal by Subject|0|||
24984980|NCT03137992|50073541|FG000|Washout Period 2|Sponsor Decision|0|||
24984981|NCT03137992|50073542|FG001|Washout Period 2|Sponsor Decision|0|||
24984982|NCT03137992|50073543|FG002|Washout Period 2|Sponsor Decision|0|||
24984983|NCT03137992|50073544|FG003|Washout Period 2|Sponsor Decision|0|||
24984984|NCT03137992|50073545|FG004|Washout Period 2|Sponsor Decision|0|||
24984985|NCT03137992|50073546|FG005|Washout Period 2|Sponsor Decision|1|||
24984986|NCT03137992|50073541|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
24984987|NCT03137992|50073542|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
24984988|NCT03137992|50073543|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
24984989|NCT03137992|50073544|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
24984990|NCT03137992|50073545|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
24984991|NCT03137992|50073546|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
24984992|NCT03137992|50073541|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
24984993|NCT03137992|50073542|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
24984994|NCT03137992|50073543|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
24984995|NCT03137992|50073544|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
24984996|NCT03137992|50073545|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
24984997|NCT03137992|50073546|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
24984998|NCT03137992|50073541|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
24984999|NCT03137992|50073542|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
24985000|NCT03137992|50073543|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
24985001|NCT03137992|50073544|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
24985002|NCT03137992|50073545|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
24985003|NCT03137992|50073546|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
25079399|NCT01865617|50187897|FG011|Overall Study|Death|6|||
25079400|NCT01865617|50187898|FG012|Overall Study|Death|13|||
24985004|NCT03137992|50073541|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
24985005|NCT03137992|50073542|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
24985006|NCT03137992|50073543|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
24985007|NCT03137992|50073544|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
25079401|NCT01865617|50187886|FG000|Overall Study|Lost to Follow-up|2|||
24985008|NCT03137992|50073545|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
24985009|NCT03137992|50073546|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
24985010|NCT03137992|50073541|FG000|Part 2 (Open-label Extension)|Per study team|1|||
24985011|NCT03137992|50073542|FG001|Part 2 (Open-label Extension)|Per study team|0|||
24985012|NCT03137992|50073543|FG002|Part 2 (Open-label Extension)|Per study team|0|||
24985013|NCT03137992|50073544|FG003|Part 2 (Open-label Extension)|Per study team|0|||
24985014|NCT03137992|50073545|FG004|Part 2 (Open-label Extension)|Per study team|0|||
24985015|NCT03137992|50073546|FG005|Part 2 (Open-label Extension)|Per study team|0|||
24985016|NCT03137992|50073541|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
24985017|NCT03137992|50073542|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
24985018|NCT03137992|50073543|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
24985019|NCT03137992|50073544|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
24985020|NCT03137992|50073545|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
25079402|NCT01865617|50187887|FG001|Overall Study|Lost to Follow-up|0|||
25079403|NCT01865617|50187888|FG002|Overall Study|Lost to Follow-up|0|||
24985021|NCT03137992|50073546|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
24985022|NCT03704636|50073554|FG000|Overall Study|Inadequate Venous Flow|3|||
24985023|NCT05096312|50073569|FG000|Overall Study|Lost to Follow-up|2|||
24985024|NCT05096312|50073570|FG001|Overall Study|Lost to Follow-up|4|||
24985025|NCT05096312|50073569|FG000|Overall Study|Adverse Event|1|||
24985026|NCT05096312|50073570|FG001|Overall Study|Adverse Event|0|||
24985027|NCT04908488|50073578|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
24985028|NCT04908488|50073579|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
24985029|NCT04908488|50073578|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
24985030|NCT04908488|50073579|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
25257072|NCT01097629|50572178|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
25257073|NCT01097629|50572179|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
25257074|NCT01097629|50572180|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
25257075|NCT01097629|50572181|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
25257076|NCT01097629|50572182|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
25257077|NCT01097629|50572183|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
25257078|NCT01097629|50572176|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
25257079|NCT01097629|50572177|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
25257080|NCT01097629|50572178|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
25257081|NCT01097629|50572179|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
25257082|NCT01097629|50572180|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
25257083|NCT01097629|50572181|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
25257084|NCT01097629|50572182|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
25257085|NCT01097629|50572183|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
25257086|NCT01097629|50572176|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
25257087|NCT01097629|50572177|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
25257088|NCT01097629|50572178|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
24985031|NCT04876274|50073590|FG000|Overall Study|Lost to Follow-up|9|||
24985032|NCT04876274|50073591|FG001|Overall Study|Lost to Follow-up|12|||
24985033|NCT04865354|50073599|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
24985034|NCT04865354|50073600|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
24985035|NCT04865354|50073599|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
24985036|NCT04865354|50073600|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
24985037|NCT04865354|50073599|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
24985038|NCT04865354|50073600|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
24985039|NCT04860518|50073611|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
24985040|NCT04860518|50073612|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
24985041|NCT03110380|50073620|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
24985042|NCT03110380|50073621|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
24985043|NCT03110380|50073622|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
24985044|NCT03110380|50073623|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
24985045|NCT03110380|50073620|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
24985046|NCT03110380|50073621|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
24985047|NCT03110380|50073622|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
24985048|NCT03110380|50073623|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
24985049|NCT03110380|50073620|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
25257089|NCT01097629|50572179|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
25257090|NCT01097629|50572180|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
25079404|NCT01865617|50187889|FG003|Overall Study|Lost to Follow-up|0|||
25079405|NCT01865617|50187890|FG004|Overall Study|Lost to Follow-up|0|||
24985050|NCT03110380|50073621|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
24985051|NCT03110380|50073622|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
24985052|NCT03110380|50073623|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
24985053|NCT03110380|50073620|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
24985054|NCT03110380|50073621|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
24985055|NCT03110380|50073622|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
25079406|NCT01865617|50187891|FG005|Overall Study|Lost to Follow-up|0|||
25257091|NCT01097629|50572181|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
25257092|NCT01097629|50572182|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
25257093|NCT01097629|50572183|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
25257094|NCT01097629|50572176|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
25257095|NCT01097629|50572177|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
25257096|NCT01097629|50572178|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
25257097|NCT01097629|50572179|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
25257098|NCT01097629|50572180|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
25257099|NCT01097629|50572181|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
25257100|NCT01097629|50572182|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
25257101|NCT01097629|50572183|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
25257102|NCT01097629|50572176|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
25257103|NCT01097629|50572177|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
25257104|NCT01097629|50572178|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
25257105|NCT01097629|50572179|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
25257106|NCT01097629|50572180|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
25257107|NCT01097629|50572181|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
25257108|NCT01097629|50572182|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
25257109|NCT01097629|50572183|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
25257110|NCT01097629|50572176|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
25257111|NCT01097629|50572177|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
25257112|NCT01097629|50572178|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
25257113|NCT01097629|50572179|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
25257114|NCT01097629|50572180|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
25257115|NCT01097629|50572181|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
25257116|NCT01097629|50572182|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
25257117|NCT01097629|50572183|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
24985056|NCT03110380|50073623|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
24985057|NCT03110380|50073620|FG000|Double-Blind Treatment Phase|Death|2|||
24985058|NCT03110380|50073621|FG001|Double-Blind Treatment Phase|Death|1|||
24985059|NCT03110380|50073622|FG002|Double-Blind Treatment Phase|Death|0|||
24985060|NCT03110380|50073623|FG003|Double-Blind Treatment Phase|Death|0|||
24985061|NCT03110380|50073620|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
24985062|NCT03110380|50073621|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
24985063|NCT03110380|50073622|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
24985064|NCT03110380|50073623|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
24985065|NCT03110380|50073620|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
24985066|NCT03110380|50073621|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
24985067|NCT03110380|50073622|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
24985068|NCT03110380|50073623|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
24985069|NCT03110380|50073620|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
24985070|NCT03110380|50073621|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
25079407|NCT01865617|50187892|FG006|Overall Study|Lost to Follow-up|0|||
25257118|NCT01097629|50572176|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
25257119|NCT01097629|50572177|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
25257120|NCT01097629|50572178|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
25257121|NCT01097629|50572179|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
25257122|NCT01097629|50572180|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
25257123|NCT01097629|50572181|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
25257124|NCT01097629|50572182|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
25257125|NCT01097629|50572183|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
24985071|NCT03110380|50073622|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
24985072|NCT03110380|50073623|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
24985073|NCT03110380|50073620|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
24985074|NCT03110380|50073621|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
24985075|NCT03110380|50073622|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
24985076|NCT03110380|50073623|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
24985077|NCT03110380|50073620|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
24985078|NCT03110380|50073621|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
24985079|NCT03110380|50073622|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
24985080|NCT03110380|50073623|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
24985081|NCT03110380|50073620|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
24985082|NCT03110380|50073621|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
24985083|NCT03110380|50073622|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
24985084|NCT03110380|50073623|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
24985085|NCT04851314|50073633|FG000|Overall Study|Unable to complete research set-up procedures|0|||
24985086|NCT04851314|50073634|FG001|Overall Study|Unable to complete research set-up procedures|2|||
24985087|NCT04851314|50073633|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
25257126|NCT01097629|50572176|FG000|DB RO Phase|Withdrawal by Subject|0|||
24985088|NCT04851314|50073634|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
24985089|NCT04848662|50073642|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
24985090|NCT04848662|50073643|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
24985091|NCT03701516|50073649|FG000|Period 1|Lost to Follow-up|0|||
24985092|NCT03701516|50073650|FG001|Period 1|Lost to Follow-up|1|||
24985093|NCT03701516|50073649|FG000|Period 1|Adverse Event|0|||
24985094|NCT03701516|50073650|FG001|Period 1|Adverse Event|2|||
24985095|NCT03701516|50073649|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
24985096|NCT03701516|50073650|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
24985097|NCT03701516|50073649|FG000|Period 1|Non Compliance to Protocol|2|||
24985098|NCT03701516|50073650|FG001|Period 1|Non Compliance to Protocol|1|||
24985099|NCT03701516|50073649|FG000|Period 1|Withdrawal by Subject|0|||
24985100|NCT03701516|50073650|FG001|Period 1|Withdrawal by Subject|1|||
24985101|NCT03701516|50073649|FG000|Period 2|failed to meet all eligibility creiteria|1|||
24985102|NCT03701516|50073650|FG001|Period 2|failed to meet all eligibility creiteria|0|||
24985103|NCT03701516|50073649|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
24985104|NCT03701516|50073650|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
24985105|NCT03700892|50073658|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
24985106|NCT03700892|50073659|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
24985107|NCT03700892|50073660|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
24985108|NCT03700736|50073671|FG000|Overall Study|Pregnancy|1|||
25257127|NCT01097629|50572177|FG001|DB RO Phase|Withdrawal by Subject|0|||
25257128|NCT01097629|50572178|FG002|DB RO Phase|Withdrawal by Subject|0|||
25257129|NCT01097629|50572179|FG003|DB RO Phase|Withdrawal by Subject|0|||
25257130|NCT01097629|50572180|FG004|DB RO Phase|Withdrawal by Subject|0|||
25257131|NCT01097629|50572181|FG005|DB RO Phase|Withdrawal by Subject|0|||
25257132|NCT01097629|50572182|FG006|DB RO Phase|Withdrawal by Subject|0|||
25257133|NCT01097629|50572183|FG007|DB RO Phase|Withdrawal by Subject|1|||
25257134|NCT01097629|50572176|FG000|DB RO Phase|Protocol Violation|0|||
25257135|NCT01097629|50572177|FG001|DB RO Phase|Protocol Violation|0|||
25257136|NCT01097629|50572178|FG002|DB RO Phase|Protocol Violation|0|||
25257137|NCT01097629|50572179|FG003|DB RO Phase|Protocol Violation|1|||
25257138|NCT01097629|50572180|FG004|DB RO Phase|Protocol Violation|0|||
25257139|NCT01097629|50572181|FG005|DB RO Phase|Protocol Violation|1|||
25257140|NCT01097629|50572182|FG006|DB RO Phase|Protocol Violation|1|||
25257141|NCT01097629|50572183|FG007|DB RO Phase|Protocol Violation|0|||
25257142|NCT01097629|50572176|FG000|DB RO Phase|Lost to Follow-up|0|||
25257143|NCT01097629|50572177|FG001|DB RO Phase|Lost to Follow-up|0|||
25257144|NCT01097629|50572178|FG002|DB RO Phase|Lost to Follow-up|0|||
25257145|NCT01097629|50572179|FG003|DB RO Phase|Lost to Follow-up|0|||
25257146|NCT01097629|50572180|FG004|DB RO Phase|Lost to Follow-up|0|||
25257147|NCT01097629|50572181|FG005|DB RO Phase|Lost to Follow-up|0|||
25257148|NCT01097629|50572182|FG006|DB RO Phase|Lost to Follow-up|2|||
25257149|NCT01097629|50572183|FG007|DB RO Phase|Lost to Follow-up|0|||
24985109|NCT03700736|50073672|FG001|Overall Study|Pregnancy|1|||
24985110|NCT03700736|50073671|FG000|Overall Study|Withdrawal by Subject|2|||
24985111|NCT03700736|50073672|FG001|Overall Study|Withdrawal by Subject|6|||
25257150|NCT01324622|50572208|FG000|Overall Study|Lost to Follow-up|7|||
25257151|NCT01324622|50572209|FG001|Overall Study|Lost to Follow-up|7|||
25257152|NCT01324622|50572208|FG000|Overall Study|Death|1|||
25257153|NCT01324622|50572209|FG001|Overall Study|Death|0|||
24985112|NCT04737278|50073683|FG000|Overall Study|Lost to Follow-up|1|||
24985113|NCT04737278|50073684|FG001|Overall Study|Lost to Follow-up|1|||
24985114|NCT04737278|50073683|FG000|Overall Study|Withdrawal by Subject|1|||
24985115|NCT04737278|50073684|FG001|Overall Study|Withdrawal by Subject|0|||
24985116|NCT04737278|50073683|FG000|Overall Study|Protocol Violation|1|||
24985117|NCT04737278|50073684|FG001|Overall Study|Protocol Violation|1|||
24985118|NCT04737278|50073683|FG000|Overall Study|failure to complete questionnaire|1|||
24985119|NCT04737278|50073684|FG001|Overall Study|failure to complete questionnaire|1|||
24985120|NCT04725500|50073690|FG000|Screening|Screen Failure|26|||
24985121|NCT04725500|50073690|FG000|Screening|Withdrawal by Subject|1|||
24985122|NCT04725500|50073690|FG000|2 Week Take Home|Screen Fail|5|||
24985123|NCT04684394|50073696|FG000|Overall Study|Death|1|||
24985124|NCT04684394|50073697|FG001|Overall Study|Death|2|||
24985125|NCT04684394|50073696|FG000|Overall Study|Lost to Follow-up|1|||
24985126|NCT04684394|50073697|FG001|Overall Study|Lost to Follow-up|0|||
24985127|NCT04684394|50073696|FG000|Overall Study|Withdrawal by Subject|2|||
24985128|NCT04684394|50073697|FG001|Overall Study|Withdrawal by Subject|0|||
24985129|NCT04684394|50073696|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
24985130|NCT04684394|50073697|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
24985131|NCT04674644|50073703|FG000|Overall Study|with missing data|37|||
24985132|NCT04668950|50073710|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
24985133|NCT04668950|50073711|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
25257154|NCT01324622|50572208|FG000|Overall Study|Lack of Efficacy|1|||
25257155|NCT01324622|50572209|FG001|Overall Study|Lack of Efficacy|0|||
25257156|NCT01097005|50572216|FG000|Overall Study|Case Report Form not collected|18|||
25257157|NCT01097005|50572216|FG000|Overall Study|Subjects cannot visit the hospital|1|||
25257158|NCT01097005|50572216|FG000|Overall Study|Poor medication compliance|1|||
25257159|NCT01097005|50572216|FG000|Overall Study|No examination data available|244|||
25257160|NCT01097005|50572216|FG000|Overall Study|Deviation from exclusion criteria|37|||
25257161|NCT01097005|50572216|FG000|Overall Study|Adverse Event|14|||
25257162|NCT01097005|50572216|FG000|Overall Study|Discontinuance by complication|50|||
25257163|NCT01096849|50572225|FG000|Overall Study|Consent Withdrawn|1|||
25257164|NCT01096849|50572226|FG001|Overall Study|Consent Withdrawn|4|||
25257165|NCT01096849|50572227|FG002|Overall Study|Consent Withdrawn|2|||
24985134|NCT04668950|50073710|FG000|Overall Study|Could not confirm started study medication|15|||
24985135|NCT04668950|50073711|FG001|Overall Study|Could not confirm started study medication|15|||
24985136|NCT04668950|50073710|FG000|Overall Study|Could not confirm baseline status|6|||
24985137|NCT04668950|50073711|FG001|Overall Study|Could not confirm baseline status|2|||
25079408|NCT01865617|50187893|FG007|Overall Study|Lost to Follow-up|0|||
25257166|NCT01096849|50572225|FG000|Overall Study|Lack of Efficacy|0|||
25257167|NCT01096849|50572226|FG001|Overall Study|Lack of Efficacy|2|||
25257168|NCT01096849|50572227|FG002|Overall Study|Lack of Efficacy|0|||
25257169|NCT01096849|50572225|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
25257170|NCT01096849|50572226|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
25257171|NCT01096849|50572227|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
25257172|NCT01096849|50572225|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
25257173|NCT01096849|50572226|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
25257174|NCT01096849|50572227|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
25257175|NCT01096849|50572225|FG000|Overall Study|Administrative Reasons|0|||
25257176|NCT01096849|50572226|FG001|Overall Study|Administrative Reasons|1|||
25257177|NCT01096849|50572227|FG002|Overall Study|Administrative Reasons|2|||
24985138|NCT04668950|50073710|FG000|Overall Study|Drop out and did not start medication|15|||
24985139|NCT04668950|50073711|FG001|Overall Study|Drop out and did not start medication|17|||
24985140|NCT04668950|50073710|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
24985141|NCT04668950|50073711|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
24985142|NCT04668950|50073710|FG000|Overall Study|Other|2|||
24985143|NCT04668950|50073711|FG001|Overall Study|Other|4|||
24985144|NCT03078478|50073719|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
24985145|NCT03078478|50073720|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
24985146|NCT03078478|50073719|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
24985147|NCT03078478|50073720|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
24985148|NCT03078478|50073719|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
24985149|NCT03078478|50073720|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
24985150|NCT03078478|50073719|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
24985151|NCT03078478|50073720|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
24985152|NCT03078478|50073719|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
24985153|NCT03078478|50073720|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
24985154|NCT03078478|50073719|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
24985155|NCT03078478|50073720|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
24985156|NCT03078478|50073719|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
24985157|NCT03078478|50073720|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
24985158|NCT03078478|50073719|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
24985159|NCT03078478|50073720|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
24985160|NCT03539458|50073726|FG000|Overall Study|Death|1|||
24985161|NCT02879578|50073733|FG000|Overall Study|Adverse Event|1|||
24985162|NCT02879578|50073734|FG001|Overall Study|Adverse Event|2|||
24985163|NCT02879578|50073735|FG002|Overall Study|Adverse Event|14|||
24985164|NCT02879578|50073733|FG000|Overall Study|Protocol Violation|0|||
24985165|NCT02879578|50073734|FG001|Overall Study|Protocol Violation|1|||
24985166|NCT02879578|50073735|FG002|Overall Study|Protocol Violation|1|||
24985167|NCT02879578|50073733|FG000|Overall Study|Withdrawal by Subject|8|||
24985168|NCT02879578|50073734|FG001|Overall Study|Withdrawal by Subject|6|||
24985169|NCT02879578|50073735|FG002|Overall Study|Withdrawal by Subject|9|||
24985170|NCT02879578|50073733|FG000|Overall Study|Lost to Follow-up|1|||
24985171|NCT02879578|50073734|FG001|Overall Study|Lost to Follow-up|0|||
24985172|NCT02879578|50073735|FG002|Overall Study|Lost to Follow-up|4|||
24985173|NCT02879578|50073733|FG000|Overall Study|Physician Decision|0|||
24985174|NCT02879578|50073734|FG001|Overall Study|Physician Decision|0|||
24985175|NCT02879578|50073735|FG002|Overall Study|Physician Decision|4|||
24985176|NCT00045942|50073752|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
24985177|NCT00045942|50073753|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
24985178|NCT00045942|50073754|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
24985179|NCT00045942|50073755|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
24985180|NCT00045942|50073756|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
24985181|NCT00045942|50073757|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
24985182|NCT00045942|50073758|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
24985183|NCT00045942|50073759|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
24985184|NCT00045942|50073760|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
24985185|NCT00045942|50073752|FG000|PKC412A2104 (Core)|Adverse Event|5|||
24985186|NCT00045942|50073753|FG001|PKC412A2104 (Core)|Adverse Event|0|||
24985187|NCT00045942|50073754|FG002|PKC412A2104 (Core)|Adverse Event|0|||
24985188|NCT00045942|50073755|FG003|PKC412A2104 (Core)|Adverse Event|0|||
24985189|NCT00045942|50073756|FG004|PKC412A2104 (Core)|Adverse Event|0|||
24985190|NCT00045942|50073757|FG005|PKC412A2104 (Core)|Adverse Event|0|||
24985191|NCT00045942|50073758|FG006|PKC412A2104 (Core)|Adverse Event|0|||
24985192|NCT00045942|50073759|FG007|PKC412A2104 (Core)|Adverse Event|0|||
24985193|NCT00045942|50073760|FG008|PKC412A2104 (Core)|Adverse Event|0|||
24985194|NCT00045942|50073752|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
24985195|NCT00045942|50073753|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
24985196|NCT00045942|50073754|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
24985197|NCT00045942|50073755|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
24985198|NCT00045942|50073756|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
24985199|NCT00045942|50073757|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
24985200|NCT00045942|50073758|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
24985201|NCT00045942|50073759|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
24985202|NCT00045942|50073760|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
24985203|NCT00045942|50073752|FG000|PKC412A2104 (Core)|Death|1|||
24985204|NCT00045942|50073753|FG001|PKC412A2104 (Core)|Death|0|||
24985205|NCT00045942|50073754|FG002|PKC412A2104 (Core)|Death|0|||
24985206|NCT00045942|50073755|FG003|PKC412A2104 (Core)|Death|0|||
24985207|NCT00045942|50073756|FG004|PKC412A2104 (Core)|Death|0|||
24985208|NCT00045942|50073757|FG005|PKC412A2104 (Core)|Death|0|||
24985209|NCT00045942|50073758|FG006|PKC412A2104 (Core)|Death|0|||
24985210|NCT00045942|50073759|FG007|PKC412A2104 (Core)|Death|0|||
24985211|NCT00045942|50073760|FG008|PKC412A2104 (Core)|Death|0|||
24985212|NCT00045942|50073752|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
24985213|NCT00045942|50073753|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
24985214|NCT00045942|50073754|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
24985215|NCT00045942|50073755|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
24985216|NCT00045942|50073756|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
24985217|NCT00045942|50073757|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
24985218|NCT00045942|50073758|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
24985219|NCT00045942|50073759|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
24985220|NCT00045942|50073760|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
24985221|NCT00045942|50073752|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
24985222|NCT00045942|50073753|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
24985223|NCT00045942|50073754|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
24985224|NCT00045942|50073755|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
24985225|NCT00045942|50073756|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
24985226|NCT00045942|50073757|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
24985227|NCT00045942|50073758|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
24985228|NCT00045942|50073759|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
24985229|NCT00045942|50073760|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
24985230|NCT00045942|50073752|FG000|PKC412A2104E1|Lack of Efficacy|0|||
24985231|NCT00045942|50073753|FG001|PKC412A2104E1|Lack of Efficacy|11|||
24985232|NCT00045942|50073754|FG002|PKC412A2104E1|Lack of Efficacy|11|||
24985233|NCT00045942|50073755|FG003|PKC412A2104E1|Lack of Efficacy|23|||
24985234|NCT00045942|50073756|FG004|PKC412A2104E1|Lack of Efficacy|17|||
24985235|NCT00045942|50073757|FG005|PKC412A2104E1|Lack of Efficacy|0|||
24985236|NCT00045942|50073758|FG006|PKC412A2104E1|Lack of Efficacy|0|||
24985237|NCT00045942|50073759|FG007|PKC412A2104E1|Lack of Efficacy|0|||
24985238|NCT00045942|50073760|FG008|PKC412A2104E1|Lack of Efficacy|0|||
24985239|NCT00045942|50073752|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
24985240|NCT00045942|50073753|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
24985241|NCT00045942|50073754|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
24985242|NCT00045942|50073755|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
24985243|NCT00045942|50073756|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
24985244|NCT00045942|50073757|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
24985245|NCT00045942|50073758|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
24985246|NCT00045942|50073759|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
24985247|NCT00045942|50073760|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
24985248|NCT00045942|50073752|FG000|PKC412A2104E1|Adverse Event|0|||
24985249|NCT00045942|50073753|FG001|PKC412A2104E1|Adverse Event|1|||
24985250|NCT00045942|50073754|FG002|PKC412A2104E1|Adverse Event|1|||
24985251|NCT00045942|50073755|FG003|PKC412A2104E1|Adverse Event|3|||
24985252|NCT00045942|50073756|FG004|PKC412A2104E1|Adverse Event|6|||
24985253|NCT00045942|50073757|FG005|PKC412A2104E1|Adverse Event|0|||
24985254|NCT00045942|50073758|FG006|PKC412A2104E1|Adverse Event|0|||
24985255|NCT00045942|50073759|FG007|PKC412A2104E1|Adverse Event|0|||
25257178|NCT01096849|50572225|FG000|Overall Study|Lost to Follow-up|1|||
25257179|NCT01096849|50572226|FG001|Overall Study|Lost to Follow-up|3|||
25257180|NCT01096849|50572227|FG002|Overall Study|Lost to Follow-up|1|||
25257181|NCT01324388|50572238|FG000|Part 1 of Study|Adverse Event|2|||
25257182|NCT01324388|50572239|FG001|Part 1 of Study|Adverse Event|0|||
25257183|NCT01324388|50572240|FG002|Part 1 of Study|Adverse Event|0|||
25257184|NCT01324388|50572241|FG003|Part 1 of Study|Adverse Event|0|||
25257185|NCT01324388|50572238|FG000|Part 1 of Study|Protocol Violation|1|||
25257186|NCT01324388|50572239|FG001|Part 1 of Study|Protocol Violation|2|||
25257187|NCT01324388|50572240|FG002|Part 1 of Study|Protocol Violation|0|||
25257188|NCT01324388|50572241|FG003|Part 1 of Study|Protocol Violation|0|||
25257189|NCT01324388|50572238|FG000|Part 1 of Study|Physician Decision|1|||
25257190|NCT01324388|50572239|FG001|Part 1 of Study|Physician Decision|0|||
25257191|NCT01324388|50572240|FG002|Part 1 of Study|Physician Decision|0|||
25257192|NCT01324388|50572241|FG003|Part 1 of Study|Physician Decision|0|||
24985256|NCT00045942|50073760|FG008|PKC412A2104E1|Adverse Event|0|||
24985257|NCT00045942|50073752|FG000|PKC412A2104E1|Death|0|||
25257193|NCT01324388|50572238|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
24985258|NCT00045942|50073753|FG001|PKC412A2104E1|Death|4|||
24985259|NCT00045942|50073754|FG002|PKC412A2104E1|Death|1|||
24985260|NCT00045942|50073755|FG003|PKC412A2104E1|Death|1|||
24985261|NCT00045942|50073756|FG004|PKC412A2104E1|Death|1|||
24985262|NCT00045942|50073757|FG005|PKC412A2104E1|Death|0|||
24985263|NCT00045942|50073758|FG006|PKC412A2104E1|Death|0|||
24985264|NCT00045942|50073759|FG007|PKC412A2104E1|Death|0|||
24985265|NCT00045942|50073760|FG008|PKC412A2104E1|Death|0|||
24985266|NCT00045942|50073752|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
24985267|NCT00045942|50073753|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
24985268|NCT00045942|50073754|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
24985269|NCT00045942|50073755|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
24985270|NCT00045942|50073756|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
24985271|NCT00045942|50073757|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
24985272|NCT00045942|50073758|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
24985273|NCT00045942|50073759|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
24985274|NCT00045942|50073760|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
24985275|NCT00045942|50073752|FG000|PKC412A2104E2|Lost to Follow-up|0|||
24985276|NCT00045942|50073753|FG001|PKC412A2104E2|Lost to Follow-up|0|||
24985277|NCT00045942|50073754|FG002|PKC412A2104E2|Lost to Follow-up|0|||
24985278|NCT00045942|50073755|FG003|PKC412A2104E2|Lost to Follow-up|0|||
24985279|NCT00045942|50073756|FG004|PKC412A2104E2|Lost to Follow-up|0|||
24985280|NCT00045942|50073757|FG005|PKC412A2104E2|Lost to Follow-up|0|||
24985281|NCT00045942|50073758|FG006|PKC412A2104E2|Lost to Follow-up|0|||
24985282|NCT00045942|50073759|FG007|PKC412A2104E2|Lost to Follow-up|3|||
24985283|NCT00045942|50073760|FG008|PKC412A2104E2|Lost to Follow-up|0|||
24985284|NCT00045942|50073752|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
24985285|NCT00045942|50073753|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
24985286|NCT00045942|50073754|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
24985287|NCT00045942|50073755|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
24985288|NCT00045942|50073756|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
24985289|NCT00045942|50073757|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
24985290|NCT00045942|50073758|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
24985291|NCT00045942|50073759|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
24985292|NCT00045942|50073760|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
24985293|NCT00045942|50073752|FG000|PKC412A2104E2|Lack of Efficacy|0|||
24985294|NCT00045942|50073753|FG001|PKC412A2104E2|Lack of Efficacy|0|||
24985295|NCT00045942|50073754|FG002|PKC412A2104E2|Lack of Efficacy|0|||
24985296|NCT00045942|50073755|FG003|PKC412A2104E2|Lack of Efficacy|0|||
24985297|NCT00045942|50073756|FG004|PKC412A2104E2|Lack of Efficacy|0|||
24985298|NCT00045942|50073757|FG005|PKC412A2104E2|Lack of Efficacy|3|||
24985299|NCT00045942|50073758|FG006|PKC412A2104E2|Lack of Efficacy|2|||
24985300|NCT00045942|50073759|FG007|PKC412A2104E2|Lack of Efficacy|2|||
24985301|NCT00045942|50073760|FG008|PKC412A2104E2|Lack of Efficacy|6|||
24985302|NCT00045942|50073752|FG000|PKC412A2104E2|Adverse Event|0|||
24985303|NCT00045942|50073753|FG001|PKC412A2104E2|Adverse Event|0|||
24985304|NCT00045942|50073754|FG002|PKC412A2104E2|Adverse Event|0|||
24985305|NCT00045942|50073755|FG003|PKC412A2104E2|Adverse Event|0|||
24985306|NCT00045942|50073756|FG004|PKC412A2104E2|Adverse Event|0|||
24985307|NCT00045942|50073757|FG005|PKC412A2104E2|Adverse Event|4|||
24985308|NCT00045942|50073758|FG006|PKC412A2104E2|Adverse Event|3|||
24985309|NCT00045942|50073759|FG007|PKC412A2104E2|Adverse Event|1|||
24985310|NCT00045942|50073760|FG008|PKC412A2104E2|Adverse Event|0|||
24985311|NCT00045942|50073752|FG000|PKC412A2104E2|Death|0|||
24985312|NCT00045942|50073753|FG001|PKC412A2104E2|Death|0|||
24985313|NCT00045942|50073754|FG002|PKC412A2104E2|Death|0|||
24985314|NCT00045942|50073755|FG003|PKC412A2104E2|Death|0|||
24985315|NCT00045942|50073756|FG004|PKC412A2104E2|Death|0|||
24985316|NCT00045942|50073757|FG005|PKC412A2104E2|Death|1|||
24985317|NCT00045942|50073758|FG006|PKC412A2104E2|Death|2|||
25257194|NCT01324388|50572239|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
24985318|NCT00045942|50073759|FG007|PKC412A2104E2|Death|0|||
24985319|NCT00045942|50073760|FG008|PKC412A2104E2|Death|0|||
25257195|NCT01324388|50572240|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
24985320|NCT04386616|50073787|FG000|Overall Study|Death|22|||
24985321|NCT04386616|50073788|FG001|Overall Study|Death|22|||
24985322|NCT04386616|50073789|FG002|Overall Study|Death|21|||
24985323|NCT04386616|50073787|FG000|Overall Study|Lost to Follow-up|5|||
24985324|NCT04386616|50073788|FG001|Overall Study|Lost to Follow-up|8|||
24985325|NCT04386616|50073789|FG002|Overall Study|Lost to Follow-up|6|||
24985326|NCT04386616|50073787|FG000|Overall Study|Withdrawal by Subject|2|||
24985327|NCT04386616|50073788|FG001|Overall Study|Withdrawal by Subject|4|||
24985328|NCT04386616|50073789|FG002|Overall Study|Withdrawal by Subject|1|||
24985329|NCT04386616|50073787|FG000|Overall Study|Adverse Event|1|||
24985330|NCT04386616|50073788|FG001|Overall Study|Adverse Event|1|||
24985331|NCT04386616|50073789|FG002|Overall Study|Adverse Event|0|||
24985332|NCT00045708|50073809|FG000|Phase 1|early progressive disease|0|||
24985333|NCT00045708|50073810|FG001|Phase 1|early progressive disease|1|||
24985334|NCT00045708|50073811|FG002|Phase 1|early progressive disease|0|||
24985335|NCT00045630|50073828|FG000|Overall Study|Adverse Event|1|||
24985336|NCT00045630|50073828|FG000|Overall Study|Refusal unrelated to adverse event|1|||
24985337|NCT00045630|50073828|FG000|Overall Study|Progression/relapse|1|||
24985338|NCT00045630|50073828|FG000|Overall Study|Death|1|||
24985339|NCT00045630|50073828|FG000|Overall Study|Ineligible|2|||
24985340|NCT00003702|50073834|FG000|Overall Study|Ineligible cell types|2|||
24985341|NCT00003702|50073835|FG001|Overall Study|Ineligible cell types|2|||
24985342|NCT00003702|50073834|FG000|Overall Study|Did not meet criteria for persistence|8|||
24985343|NCT00003702|50073835|FG001|Overall Study|Did not meet criteria for persistence|5|||
24985344|NCT00003702|50073834|FG000|Overall Study|WHO score > 6|2|||
24985345|NCT00003702|50073835|FG001|Overall Study|WHO score > 6|1|||
24985346|NCT00003702|50073834|FG000|Overall Study|Inadequate documentation of disease|1|||
24985347|NCT00003702|50073835|FG001|Overall Study|Inadequate documentation of disease|3|||
24985348|NCT00031590|50073842|FG000|Overall Study|Adverse Event|1|||
24985349|NCT00031590|50073842|FG000|Overall Study|Withdrawal by parents|2|||
24985350|NCT00239681|50073849|FG000|Overall Study|Adverse Event|100|||
24985351|NCT00239681|50073850|FG001|Overall Study|Adverse Event|99|||
24985352|NCT00239681|50073849|FG000|Overall Study|Withdrawal by Subject|458|||
24985353|NCT00239681|50073850|FG001|Overall Study|Withdrawal by Subject|489|||
24985354|NCT00239681|50073849|FG000|Overall Study|Lost to Follow-up|28|||
24985355|NCT00239681|50073850|FG001|Overall Study|Lost to Follow-up|22|||
24985356|NCT00239681|50073849|FG000|Overall Study|Protocol Violation|4|||
24985357|NCT00239681|50073850|FG001|Overall Study|Protocol Violation|4|||
24985358|NCT00239681|50073849|FG000|Overall Study|Physician Decision|13|||
24985359|NCT00239681|50073850|FG001|Overall Study|Physician Decision|17|||
24985360|NCT00239681|50073849|FG000|Overall Study|No information chacked on CaseReportForm|90|||
24985361|NCT00239681|50073850|FG001|Overall Study|No information chacked on CaseReportForm|84|||
24985362|NCT02878330|50073858|FG000|Overall Study|Death|3|||
24985363|NCT02878330|50073859|FG001|Overall Study|Death|2|||
24985364|NCT02878330|50073858|FG000|Overall Study|Lost to Follow-up|11|||
24985365|NCT02878330|50073859|FG001|Overall Study|Lost to Follow-up|26|||
24985366|NCT02878330|50073858|FG000|Overall Study|Withdrawal by Subject|11|||
24985367|NCT02878330|50073859|FG001|Overall Study|Withdrawal by Subject|21|||
24985368|NCT02878330|50073858|FG000|Overall Study|Other|4|||
24985369|NCT02878330|50073859|FG001|Overall Study|Other|7|||
24985370|NCT00238433|50073866|FG000|Overall Study|Screen failure|1|||
24985371|NCT00238433|50073866|FG000|Overall Study|Lost to Follow-up|1|||
24985372|NCT00238433|50073866|FG000|Overall Study|Death|1|||
24985373|NCT00045162|50073873|FG000|Overall Study|Ineligible|12|||
24985374|NCT00045162|50073874|FG001|Overall Study|Ineligible|8|||
24985375|NCT00045162|50073873|FG000|Overall Study|Not treated|7|||
24985376|NCT00045162|50073874|FG001|Overall Study|Not treated|2|||
24985377|NCT00045162|50073873|FG000|Overall Study|Adverse Event|55|||
24985378|NCT00045162|50073874|FG001|Overall Study|Adverse Event|50|||
24985379|NCT00045162|50073873|FG000|Overall Study|Lack of Efficacy|32|||
24985380|NCT00045162|50073874|FG001|Overall Study|Lack of Efficacy|29|||
24985381|NCT00045162|50073873|FG000|Overall Study|Death|10|||
24985382|NCT00045162|50073874|FG001|Overall Study|Death|10|||
24985383|NCT00045162|50073873|FG000|Overall Study|Withdrawal by Subject|5|||
24985384|NCT00045162|50073874|FG001|Overall Study|Withdrawal by Subject|3|||
24985385|NCT00045162|50073873|FG000|Overall Study|Other|21|||
24985386|NCT00045162|50073874|FG001|Overall Study|Other|16|||
24985387|NCT02748616|50073880|FG000|Overall Study|Lost to Follow-up|1|||
24985388|NCT02748616|50073880|FG000|Overall Study|Withdrawal by Subject|2|||
24985389|NCT02748616|50073880|FG000|Overall Study|Physician Decision|2|||
24985390|NCT02748616|50073880|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
24985391|NCT00238121|50073886|FG000|Overall Study|Withdrawal by Subject|1|||
24985392|NCT00238121|50073887|FG001|Overall Study|Withdrawal by Subject|1|||
24985393|NCT00238121|50073886|FG000|Overall Study|Adverse Event|2|||
24985394|NCT00238121|50073887|FG001|Overall Study|Adverse Event|1|||
24985395|NCT03139552|50073892|FG000|Overall Study|unable to attend tasting due to schedule|3|||
24985396|NCT03804918|50073903|FG000|Overall Study|Participant did not use the app|1|||
24985397|NCT03139240|50073911|FG000|Overall Study|Lost to Follow-up|0|||
24985398|NCT03139240|50073912|FG001|Overall Study|Lost to Follow-up|1|||
24985399|NCT03139240|50073913|FG002|Overall Study|Lost to Follow-up|1|||
24985400|NCT03139240|50073914|FG003|Overall Study|Lost to Follow-up|0|||
24985401|NCT00237809|50073926|FG000|Overall Study|Lost to Follow-up|11|||
24985402|NCT00237809|50073927|FG001|Overall Study|Lost to Follow-up|10|||
24985403|NCT00237809|50073928|FG002|Overall Study|Lost to Follow-up|9|||
24985404|NCT00237809|50073929|FG003|Overall Study|Lost to Follow-up|9|||
24985405|NCT00003498|50073939|FG000|Overall Study|Not evaluable.|4|||
24985406|NCT00003492|50073943|FG000|Overall Study|Not evaluable|6|||
24985407|NCT03136198|50073949|FG000|Overall Study|Withdrawal by Subject|0|||
24985408|NCT03136198|50073950|FG001|Overall Study|Withdrawal by Subject|1|||
24985409|NCT00042666|50073956|FG000|Overall Study|Adverse Event|2|||
24985410|NCT00042666|50073956|FG000|Overall Study|Death|4|||
24985411|NCT00042666|50073956|FG000|Overall Study|Protocol Violation|1|||
24985412|NCT00042666|50073956|FG000|Overall Study|Participant/Physician Perception|1|||
24985413|NCT00042666|50073956|FG000|Overall Study|Progressive Disease|41|||
24985414|NCT00042666|50073956|FG000|Overall Study|Other|1|||
24985415|NCT00042666|50073956|FG000|Overall Study|Other|4|||
24985416|NCT00042432|50073963|FG000|Overall Study|Adverse Event|4|||
24985417|NCT00042432|50073964|FG001|Overall Study|Adverse Event|1|||
24985418|NCT00042432|50073963|FG000|Overall Study|Withdrawal by Subject|1|||
24985419|NCT00042432|50073964|FG001|Overall Study|Withdrawal by Subject|3|||
24985420|NCT00042432|50073963|FG000|Overall Study|Death|0|||
24985421|NCT00042432|50073964|FG001|Overall Study|Death|2|||
24985422|NCT00042432|50073963|FG000|Overall Study|Ineligibility determined|1|||
24985423|NCT00042432|50073964|FG001|Overall Study|Ineligibility determined|0|||
24985424|NCT00042432|50073963|FG000|Overall Study|Initiation of maintenance dialysis|1|||
24985425|NCT00042432|50073964|FG001|Overall Study|Initiation of maintenance dialysis|1|||
24985426|NCT00042432|50073963|FG000|Overall Study|Other|2|||
24985427|NCT00042432|50073964|FG001|Overall Study|Other|0|||
24985428|NCT00003474|50073970|FG000|Overall Study|Not Evaluable|14|||
24985429|NCT01542736|50073974|FG000|Overall Study|Death|1|||
24985430|NCT01346410|50073978|FG000|Overall Study|Death|1|||
24985431|NCT00003456|50073982|FG000|Overall Study|Not evaluable|8|||
24985432|NCT02719522|50073986|FG000|Overall Study|Implant Failure|4|||
24985433|NCT02719522|50073986|FG000|Overall Study|Death|2|||
24985434|NCT02719522|50073986|FG000|Overall Study|Lost to Follow-up|5|||
24985435|NCT00237185|50073992|FG000|Core|Adverse Event|3|||
24985436|NCT00237185|50073993|FG001|Core|Adverse Event|4|||
24985437|NCT00237185|50073992|FG000|Core|Abnormal laboratory value|0|||
24985438|NCT00237185|50073993|FG001|Core|Abnormal laboratory value|4|||
24985439|NCT00237185|50073992|FG000|Core|Abnormal test procedure results|1|||
24985440|NCT00237185|50073993|FG001|Core|Abnormal test procedure results|0|||
24985441|NCT00237185|50073992|FG000|Core|Lack of Efficacy|30|||
24985442|NCT00237185|50073993|FG001|Core|Lack of Efficacy|23|||
24985443|NCT00237185|50073992|FG000|Core|Protocol Violation|1|||
24985444|NCT00237185|50073993|FG001|Core|Protocol Violation|1|||
24985445|NCT00237185|50073992|FG000|Core|Withdrawal by Subject|4|||
24985446|NCT00237185|50073993|FG001|Core|Withdrawal by Subject|4|||
24985447|NCT00237185|50073992|FG000|Core|Administrative problems|0|||
24985448|NCT00237185|50073993|FG001|Core|Administrative problems|1|||
24985449|NCT00237185|50073992|FG000|Core|Death|4|||
24985450|NCT00237185|50073993|FG001|Core|Death|0|||
24985451|NCT00237185|50073992|FG000|Core|Determined ineligible post randomization|1|||
24985452|NCT00237185|50073993|FG001|Core|Determined ineligible post randomization|0|||
24985453|NCT00237185|50073992|FG000|Extension|Adverse Event|1|||
24985454|NCT00237185|50073993|FG001|Extension|Adverse Event|0|||
24985455|NCT00237185|50073992|FG000|Extension|Abnormal laboratory value|0|||
24985456|NCT00237185|50073993|FG001|Extension|Abnormal laboratory value|1|||
24985457|NCT00237185|50073992|FG000|Extension|Lack of Efficacy|9|||
24985458|NCT00237185|50073993|FG001|Extension|Lack of Efficacy|14|||
24985459|NCT00237185|50073992|FG000|Extension|Condition no longer required study drug|0|||
24985460|NCT00237185|50073993|FG001|Extension|Condition no longer required study drug|1|||
24985461|NCT00237185|50073992|FG000|Extension|Withdrawal by Subject|3|||
24985462|NCT00237185|50073993|FG001|Extension|Withdrawal by Subject|2|||
24985463|NCT00237185|50073992|FG000|Extension|Lost to Follow-up|1|||
24985464|NCT00237185|50073993|FG001|Extension|Lost to Follow-up|0|||
24985465|NCT00237185|50073992|FG000|Extension|Administrative problems|1|||
24985466|NCT00237185|50073993|FG001|Extension|Administrative problems|0|||
24985467|NCT00237185|50073992|FG000|Extension|Death|1|||
24985468|NCT00237185|50073993|FG001|Extension|Death|1|||
24985469|NCT00003222|50074001|FG000|Overall Study|Physician Decision|0|||
24985470|NCT00003222|50074002|FG001|Overall Study|Physician Decision|1|||
24985471|NCT02877082|50074008|FG000|Overall Study|Trial was closed early|5|||
25079409|NCT01865617|50187894|FG008|Overall Study|Lost to Follow-up|0|||
24985484|NCT02875834|50074028|FG000|Open-label Phase|Withdrawal by Subject|3|||
24985485|NCT02875834|50074029|FG001|Open-label Phase|Withdrawal by Subject|0|||
24985486|NCT02875834|50074030|FG002|Open-label Phase|Withdrawal by Subject|0|||
24985487|NCT02875834|50074031|FG003|Open-label Phase|Withdrawal by Subject|0|||
24985488|NCT02875834|50074028|FG000|Open-label Phase|(Not collected)|4|||
24985489|NCT02875834|50074029|FG001|Open-label Phase|(Not collected)|0|||
24985490|NCT02875834|50074030|FG002|Open-label Phase|(Not collected)|0|||
24985491|NCT02875834|50074031|FG003|Open-label Phase|(Not collected)|0|||
24985492|NCT02875834|50074028|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
24985493|NCT02875834|50074029|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
24985494|NCT02875834|50074030|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
24985495|NCT02875834|50074031|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
24985496|NCT02875834|50074028|FG000|Randomized Treatment Phase|Protocol Violation|0|||
24985497|NCT02875834|50074029|FG001|Randomized Treatment Phase|Protocol Violation|2|||
24985498|NCT02875834|50074030|FG002|Randomized Treatment Phase|Protocol Violation|0|||
24985499|NCT02875834|50074031|FG003|Randomized Treatment Phase|Protocol Violation|0|||
24985500|NCT02875834|50074028|FG000|Randomized Treatment Phase|(Not collected)|0|||
24985501|NCT02875834|50074029|FG001|Randomized Treatment Phase|(Not collected)|9|||
24985502|NCT02875834|50074030|FG002|Randomized Treatment Phase|(Not collected)|10|||
24985503|NCT02875834|50074031|FG003|Randomized Treatment Phase|(Not collected)|9|||
24985504|NCT02875366|50074043|FG000|Overall Study|Adverse Event|0|||
24985505|NCT02875366|50074044|FG001|Overall Study|Adverse Event|2|||
24985506|NCT02875366|50074043|FG000|Overall Study|Noncompliance|0|||
24985507|NCT02875366|50074044|FG001|Overall Study|Noncompliance|1|||
24985508|NCT00003102|50074053|FG000|Overall Study|Physician Decision|1|||
24985509|NCT00003102|50074054|FG001|Overall Study|Physician Decision|1|||
24985510|NCT00003102|50074055|FG002|Overall Study|Physician Decision|0|||
24985511|NCT00003102|50074053|FG000|Overall Study|Progressive Disease|0|||
24985512|NCT00003102|50074054|FG001|Overall Study|Progressive Disease|1|||
24985513|NCT00003102|50074055|FG002|Overall Study|Progressive Disease|0|||
24985514|NCT00003102|50074053|FG000|Overall Study|Adverse Event|0|||
24985515|NCT00003102|50074054|FG001|Overall Study|Adverse Event|1|||
24985516|NCT00003102|50074055|FG002|Overall Study|Adverse Event|1|||
24985517|NCT00003102|50074053|FG000|Overall Study|Death|0|||
24985518|NCT00003102|50074054|FG001|Overall Study|Death|0|||
24985519|NCT00003102|50074055|FG002|Overall Study|Death|1|||
24985520|NCT00002850|50074066|FG000|Overall Study|Death|4|||
24985521|NCT00002850|50074067|FG001|Overall Study|Death|1|||
24985522|NCT00002850|50074068|FG002|Overall Study|Death|3|||
24985523|NCT00002850|50074066|FG000|Overall Study|Protocol Violation|1|||
24985524|NCT00002850|50074067|FG001|Overall Study|Protocol Violation|0|||
24985525|NCT00002850|50074068|FG002|Overall Study|Protocol Violation|1|||
24985526|NCT00002850|50074066|FG000|Overall Study|Withdrawal by Subject|0|||
24985527|NCT00002850|50074067|FG001|Overall Study|Withdrawal by Subject|1|||
24985528|NCT00002850|50074068|FG002|Overall Study|Withdrawal by Subject|0|||
24985529|NCT00002766|50074078|FG000|Overall Study|Withdrawal by Subject|0|||
24985530|NCT00002766|50074079|FG001|Overall Study|Withdrawal by Subject|1|||
24985531|NCT00002766|50074078|FG000|Overall Study|Patient Not Treated|1|||
24985532|NCT00002766|50074079|FG001|Overall Study|Patient Not Treated|2|||
24985533|NCT00002766|50074078|FG000|Overall Study|Adverse Event|1|||
25079410|NCT01865617|50187895|FG009|Overall Study|Lost to Follow-up|0|||
25079411|NCT01865617|50187896|FG010|Overall Study|Lost to Follow-up|0|||
25079412|NCT01865617|50187897|FG011|Overall Study|Lost to Follow-up|0|||
25079413|NCT01865617|50187898|FG012|Overall Study|Lost to Follow-up|0|||
25079414|NCT01865617|50187886|FG000|Overall Study|Withdrawal by Subject|1|||
25079415|NCT01865617|50187887|FG001|Overall Study|Withdrawal by Subject|0|||
25079416|NCT01865617|50187888|FG002|Overall Study|Withdrawal by Subject|0|||
25079417|NCT01865617|50187889|FG003|Overall Study|Withdrawal by Subject|0|||
25079418|NCT01865617|50187890|FG004|Overall Study|Withdrawal by Subject|0|||
25079419|NCT01865617|50187891|FG005|Overall Study|Withdrawal by Subject|0|||
25079420|NCT01865617|50187892|FG006|Overall Study|Withdrawal by Subject|0|||
25079421|NCT01865617|50187893|FG007|Overall Study|Withdrawal by Subject|0|||
24985534|NCT00002766|50074079|FG001|Overall Study|Adverse Event|1|||
24985535|NCT00002766|50074078|FG000|Overall Study|Protocol Violation|1|||
24985536|NCT00002766|50074079|FG001|Overall Study|Protocol Violation|0|||
24985537|NCT02306122|50074092|FG000|Initial Physician Randomization|Physician Decision|0|||
24985538|NCT02306122|50074093|FG001|Initial Physician Randomization|Physician Decision|0|||
24985539|NCT02306122|50074094|FG002|Initial Physician Randomization|Physician Decision|0|||
24985540|NCT02306122|50074095|FG003|Initial Physician Randomization|Physician Decision|0|||
25079422|NCT01865617|50187894|FG008|Overall Study|Withdrawal by Subject|0|||
24985541|NCT02306122|50074096|FG004|Initial Physician Randomization|Physician Decision|0|||
25079423|NCT01865617|50187895|FG009|Overall Study|Withdrawal by Subject|0|||
24985542|NCT02306122|50074097|FG005|Initial Physician Randomization|Physician Decision|0|||
24985543|NCT02306122|50074098|FG006|Initial Physician Randomization|Physician Decision|0|||
24985544|NCT02306122|50074099|FG007|Initial Physician Randomization|Physician Decision|0|||
24985545|NCT02306122|50074100|FG008|Initial Physician Randomization|Physician Decision|1|||
24985546|NCT02306122|50074101|FG009|Initial Physician Randomization|Physician Decision|0|||
24985547|NCT02306122|50074102|FG010|Initial Physician Randomization|Physician Decision|0|||
24985548|NCT00001962|50074120|FG000|Overall Study|Lack of Efficacy|18|||
24985549|NCT00001962|50074120|FG000|Overall Study|Lack of Accrual|6|||
24985550|NCT00001962|50074120|FG000|Overall Study|Death|1|||
24985551|NCT00001962|50074120|FG000|Overall Study|Lost to Follow-up|2|||
24985552|NCT00001962|50074120|FG000|Overall Study|Adverse Event|1|||
24985553|NCT00028002|50074124|FG000|Overall Study|Withdrawal by Subject|3|||
24985554|NCT00028002|50074124|FG000|Overall Study|Ineligible|8|||
24985555|NCT00256997|50074131|FG000|Overall Study|Protocol Violation|1|||
24985556|NCT00256997|50074132|FG001|Overall Study|Protocol Violation|4|||
24985557|NCT00256997|50074131|FG000|Overall Study|Lack of Efficacy|1|||
24985558|NCT00256997|50074132|FG001|Overall Study|Lack of Efficacy|4|||
24985559|NCT00256997|50074131|FG000|Overall Study|Death|2|||
24985560|NCT00256997|50074132|FG001|Overall Study|Death|0|||
24985561|NCT00256997|50074131|FG000|Overall Study|Adverse Event|4|||
24985562|NCT00256997|50074132|FG001|Overall Study|Adverse Event|0|||
24985563|NCT00256997|50074131|FG000|Overall Study|Lost to Follow-up|3|||
24985564|NCT00256997|50074132|FG001|Overall Study|Lost to Follow-up|5|||
24985565|NCT00256997|50074131|FG000|Overall Study|Withdrawal by Subject|13|||
24985566|NCT00256997|50074132|FG001|Overall Study|Withdrawal by Subject|3|||
24985567|NCT00256997|50074131|FG000|Overall Study|Started but not treated|2|||
24985568|NCT00256997|50074132|FG001|Overall Study|Started but not treated|0|||
24985569|NCT00256997|50074131|FG000|Overall Study|Other|5|||
24985570|NCT00256997|50074132|FG001|Overall Study|Other|8|||
24985571|NCT00256997|50074131|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
24985572|NCT00256997|50074132|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
24985573|NCT00256997|50074131|FG000|Overall Study|Participant Non-compliant|3|||
24985574|NCT00256997|50074132|FG001|Overall Study|Participant Non-compliant|6|||
24985575|NCT00256997|50074131|FG000|Overall Study|Investigator Withdrew Participant|2|||
24985576|NCT00256997|50074132|FG001|Overall Study|Investigator Withdrew Participant|1|||
24985577|NCT00027846|50074142|FG000|Overall Study|Lost to Follow-up|0|||
24985578|NCT00027846|50074143|FG001|Overall Study|Lost to Follow-up|41|||
24985579|NCT00027846|50074144|FG002|Overall Study|Lost to Follow-up|9|||
24985580|NCT00027846|50074142|FG000|Overall Study|Withdrawal by Subject|0|||
24985581|NCT00027846|50074143|FG001|Overall Study|Withdrawal by Subject|14|||
24985582|NCT00027846|50074144|FG002|Overall Study|Withdrawal by Subject|7|||
24985583|NCT00027846|50074142|FG000|Overall Study|Ineligible for study|2|||
24985584|NCT00027846|50074143|FG001|Overall Study|Ineligible for study|6|||
24985585|NCT00027846|50074144|FG002|Overall Study|Ineligible for study|14|||
24985586|NCT00027846|50074142|FG000|Overall Study|Entry into another COG therapeutic study|0|||
24985587|NCT00027846|50074143|FG001|Overall Study|Entry into another COG therapeutic study|5|||
24985588|NCT00027846|50074144|FG002|Overall Study|Entry into another COG therapeutic study|2|||
24985589|NCT00027846|50074142|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
24985590|NCT00027846|50074143|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
24985591|NCT00027846|50074144|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
24985592|NCT00027378|50074156|FG000|Overall Study|Physician Decision|0|||
24985593|NCT00027378|50074157|FG001|Overall Study|Physician Decision|3|||
24985594|NCT00235391|50074169|FG000|Overall Study|Adverse Event|4|||
24985595|NCT00235391|50074170|FG001|Overall Study|Adverse Event|5|||
24985596|NCT00235391|50074171|FG002|Overall Study|Adverse Event|10|||
24985597|NCT00235391|50074172|FG003|Overall Study|Adverse Event|72|||
24985598|NCT00235391|50074173|FG004|Overall Study|Adverse Event|5|||
24985599|NCT00235391|50074174|FG005|Overall Study|Adverse Event|2|||
24985600|NCT00235391|50074169|FG000|Overall Study|Abnormal laboratory value(s)|3|||
24985601|NCT00235391|50074170|FG001|Overall Study|Abnormal laboratory value(s)|5|||
24985602|NCT00235391|50074171|FG002|Overall Study|Abnormal laboratory value(s)|4|||
24985603|NCT00235391|50074172|FG003|Overall Study|Abnormal laboratory value(s)|27|||
24985604|NCT00235391|50074173|FG004|Overall Study|Abnormal laboratory value(s)|1|||
24985605|NCT00235391|50074174|FG005|Overall Study|Abnormal laboratory value(s)|2|||
24985606|NCT00235391|50074169|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
24985607|NCT00235391|50074170|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
24985608|NCT00235391|50074171|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
24985609|NCT00235391|50074172|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
24985610|NCT00235391|50074173|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
24985611|NCT00235391|50074174|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
24985612|NCT00235391|50074169|FG000|Overall Study|Condition no longer requires treatment|3|||
24985613|NCT00235391|50074170|FG001|Overall Study|Condition no longer requires treatment|0|||
24985614|NCT00235391|50074171|FG002|Overall Study|Condition no longer requires treatment|0|||
24985615|NCT00235391|50074172|FG003|Overall Study|Condition no longer requires treatment|11|||
24985616|NCT00235391|50074173|FG004|Overall Study|Condition no longer requires treatment|1|||
24985617|NCT00235391|50074174|FG005|Overall Study|Condition no longer requires treatment|0|||
24985618|NCT00235391|50074169|FG000|Overall Study|Protocol deviation|0|||
24985619|NCT00235391|50074170|FG001|Overall Study|Protocol deviation|0|||
24985620|NCT00235391|50074171|FG002|Overall Study|Protocol deviation|1|||
24985621|NCT00235391|50074172|FG003|Overall Study|Protocol deviation|11|||
24985622|NCT00235391|50074173|FG004|Overall Study|Protocol deviation|0|||
24985623|NCT00235391|50074174|FG005|Overall Study|Protocol deviation|0|||
24985624|NCT00235391|50074169|FG000|Overall Study|Withdrawal by Subject|2|||
24985625|NCT00235391|50074170|FG001|Overall Study|Withdrawal by Subject|3|||
24985626|NCT00235391|50074171|FG002|Overall Study|Withdrawal by Subject|3|||
24985627|NCT00235391|50074172|FG003|Overall Study|Withdrawal by Subject|61|||
24985628|NCT00235391|50074173|FG004|Overall Study|Withdrawal by Subject|5|||
24985629|NCT00235391|50074174|FG005|Overall Study|Withdrawal by Subject|0|||
24985630|NCT00235391|50074169|FG000|Overall Study|Lost to Follow-up|0|||
24985631|NCT00235391|50074170|FG001|Overall Study|Lost to Follow-up|3|||
24985632|NCT00235391|50074171|FG002|Overall Study|Lost to Follow-up|3|||
24985633|NCT00235391|50074172|FG003|Overall Study|Lost to Follow-up|16|||
24985634|NCT00235391|50074173|FG004|Overall Study|Lost to Follow-up|0|||
24985635|NCT00235391|50074174|FG005|Overall Study|Lost to Follow-up|0|||
24985636|NCT00235391|50074169|FG000|Overall Study|Administrative problems|0|||
24985637|NCT00235391|50074170|FG001|Overall Study|Administrative problems|0|||
24985638|NCT00235391|50074171|FG002|Overall Study|Administrative problems|0|||
24985639|NCT00235391|50074172|FG003|Overall Study|Administrative problems|1|||
24985640|NCT00235391|50074173|FG004|Overall Study|Administrative problems|0|||
24985641|NCT00235391|50074174|FG005|Overall Study|Administrative problems|0|||
24985642|NCT00235391|50074169|FG000|Overall Study|Death|0|||
24985643|NCT00235391|50074170|FG001|Overall Study|Death|0|||
24985644|NCT00235391|50074171|FG002|Overall Study|Death|1|||
24985645|NCT00235391|50074172|FG003|Overall Study|Death|4|||
24985646|NCT00235391|50074173|FG004|Overall Study|Death|0|||
24985647|NCT00235391|50074174|FG005|Overall Study|Death|0|||
24985648|NCT00234533|50074218|FG000|Overall Study|Withdrawal by Subject|6|||
24985649|NCT00234533|50074218|FG000|Overall Study|Adverse Event|2|||
24985650|NCT00234533|50074218|FG000|Overall Study|Enrolled but not treated|3|||
24985651|NCT00026208|50074225|FG000|Overall Study|Complications of auto accident|1|||
24985652|NCT00026208|50074226|FG001|Overall Study|Complications of auto accident|0|||
24985653|NCT00025662|50074232|FG000|Overall Study|Withdrawal by Subject|2|||
24985654|NCT00025662|50074232|FG000|Overall Study|Technical failure of manipulation|1|||
24985655|NCT00025506|50074236|FG000|Overall Study|Ineligible: clerical error|1|||
24985656|NCT00025506|50074236|FG000|Overall Study|Ineligible: wrong cell type|5|||
24985657|NCT00025506|50074236|FG000|Overall Study|Ineligible: inadequate pathology|2|||
24985658|NCT00025506|50074236|FG000|Overall Study|Never Treated|2|||
24985659|NCT00024258|50074245|FG000|Overall Study|Withdrawal by Subject|1|||
24985660|NCT00024258|50074245|FG000|Overall Study|Disease Progression|8|||
24985661|NCT00023712|50074251|FG000|Overall Study|Not platinum sensitive|1|||
24985662|NCT00023712|50074252|FG001|Overall Study|Not platinum sensitive|0|||
24985663|NCT00023712|50074251|FG000|Overall Study|Never treated|1|||
24985664|NCT00023712|50074252|FG001|Overall Study|Never treated|1|||
24985665|NCT00023322|50074268|FG000|Overall Study|Lost to Follow-up|1|||
24985666|NCT04640168|50074274|FG000|Overall Study|Withdrawal by Subject|8|||
24985667|NCT04640168|50074275|FG001|Overall Study|Withdrawal by Subject|7|||
24985668|NCT04640168|50074274|FG000|Overall Study|Lost to Follow-up|1|||
24985669|NCT04640168|50074275|FG001|Overall Study|Lost to Follow-up|0|||
24985670|NCT04640168|50074274|FG000|Overall Study|Enrolled but not treated|12|||
24985671|NCT04640168|50074275|FG001|Overall Study|Enrolled but not treated|12|||
24985672|NCT00022698|50074283|FG000|Overall Study|Adverse Event|5|||
24985673|NCT00022698|50074284|FG001|Overall Study|Adverse Event|9|||
24985674|NCT00022698|50074283|FG000|Overall Study|Death|0|||
24985675|NCT00022698|50074284|FG001|Overall Study|Death|2|||
24985676|NCT00022698|50074283|FG000|Overall Study|Failure to return|0|||
24985677|NCT00022698|50074284|FG001|Overall Study|Failure to return|1|||
24985678|NCT00022698|50074283|FG000|Overall Study|Refused treatment|0|||
24985679|NCT00022698|50074284|FG001|Overall Study|Refused treatment|2|||
24985680|NCT00022698|50074283|FG000|Overall Study|Insufficient therapeutic response|2|||
24985681|NCT00022698|50074284|FG001|Overall Study|Insufficient therapeutic response|14|||
24985682|NCT00022698|50074283|FG000|Overall Study|Administrative /other|1|||
24985683|NCT00022698|50074284|FG001|Overall Study|Administrative /other|7|||
24985684|NCT04625972|50074294|FG000|Overall Study|Physician Decision|1|||
24985685|NCT04625972|50074295|FG001|Overall Study|Physician Decision|0|||
24985686|NCT04625972|50074294|FG000|Overall Study|Protocol Violation|0|||
24985687|NCT04625972|50074295|FG001|Overall Study|Protocol Violation|1|||
24985688|NCT04625972|50074294|FG000|Overall Study|Ongoing in Study|741|||
24985689|NCT04625972|50074295|FG001|Overall Study|Ongoing in Study|369|||
24985690|NCT04625972|50074294|FG000|Overall Study|Lost to Follow-up|2|||
24985691|NCT04625972|50074295|FG001|Overall Study|Lost to Follow-up|0|||
24985692|NCT04625972|50074294|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|5|||
24985693|NCT04625972|50074295|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|2|||
24985694|NCT04625972|50074294|FG000|Overall Study|Withdrawal by Subject|7|||
24985695|NCT04625972|50074295|FG001|Overall Study|Withdrawal by Subject|3|||
24985696|NCT00234065|50074303|FG000|Overall Study|Adverse Event|268|||
24985697|NCT00234065|50074304|FG001|Overall Study|Adverse Event|166|||
24985698|NCT00234065|50074303|FG000|Overall Study|Withdrawal by Subject|73|||
24985699|NCT00234065|50074304|FG001|Overall Study|Withdrawal by Subject|56|||
24985700|NCT00234065|50074303|FG000|Overall Study|Physician Decision|23|||
24985701|NCT00234065|50074304|FG001|Overall Study|Physician Decision|22|||
24985702|NCT00234065|50074303|FG000|Overall Study|Not Classified|111|||
24985703|NCT00234065|50074304|FG001|Overall Study|Not Classified|112|||
24985704|NCT00233987|50074310|FG000|Overall Study|Withdrawal by Subject|1|||
24985705|NCT00233987|50074310|FG000|Overall Study|Lack of Efficacy|2|||
24985706|NCT00233987|50074310|FG000|Overall Study|Reason Under Review|1|||
24985707|NCT00233987|50074310|FG000|Overall Study|Other - Not Protocol Specified|5|||
24985708|NCT00233987|50074310|FG000|Overall Study|Eligible but No Treatment Received|2|||
24985709|NCT00233987|50074310|FG000|Overall Study|Ineligible|4|||
24985710|NCT04623242|50074319|FG000|Overall Study|Withdrawal by Subject|7|||
24985711|NCT04623242|50074320|FG001|Overall Study|Withdrawal by Subject|12|||
24985712|NCT04623242|50074321|FG002|Overall Study|Withdrawal by Subject|5|||
24985713|NCT04623242|50074322|FG003|Overall Study|Withdrawal by Subject|7|||
24985714|NCT04623242|50074323|FG004|Overall Study|Withdrawal by Subject|0|||
24985715|NCT04623242|50074319|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
24985716|NCT04623242|50074320|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
24985717|NCT04623242|50074321|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
24985718|NCT04623242|50074322|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
24985719|NCT04623242|50074323|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
24985720|NCT04623242|50074319|FG000|Overall Study|Subject unblinded to mutation status|0|||
24985721|NCT04623242|50074320|FG001|Overall Study|Subject unblinded to mutation status|0|||
24985722|NCT04623242|50074321|FG002|Overall Study|Subject unblinded to mutation status|0|||
24985723|NCT04623242|50074322|FG003|Overall Study|Subject unblinded to mutation status|13|||
24985724|NCT04623242|50074323|FG004|Overall Study|Subject unblinded to mutation status|0|||
24985725|NCT00233363|50074340|FG000|Overall Study|Adverse Event|1|||
24985726|NCT00233363|50074341|FG001|Overall Study|Adverse Event|2|||
24985727|NCT00233363|50074340|FG000|Overall Study|Lack of Efficacy|0|||
24985728|NCT00233363|50074341|FG001|Overall Study|Lack of Efficacy|2|||
24985729|NCT00233363|50074340|FG000|Overall Study|Withdrawal by Subject|1|||
24985730|NCT00233363|50074341|FG001|Overall Study|Withdrawal by Subject|1|||
24985731|NCT00233363|50074340|FG000|Overall Study|Aggravation of complication|1|||
24985732|NCT00233363|50074341|FG001|Overall Study|Aggravation of complication|0|||
24985733|NCT01147666|50074362|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
24985734|NCT01147666|50074363|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
24985735|NCT01147666|50074364|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
24985736|NCT01147666|50074365|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
24985737|NCT01147666|50074366|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
24985738|NCT01147666|50074367|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
24985739|NCT01147666|50074368|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
24985740|NCT01147666|50074369|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
24985741|NCT01147666|50074370|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
24985742|NCT01147666|50074371|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
24985743|NCT01147666|50074372|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
24985744|NCT01147666|50074373|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
24985745|NCT01147666|50074374|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
24985746|NCT01147666|50074375|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
24985747|NCT01147666|50074376|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
24985748|NCT01147666|50074362|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
24985749|NCT01147666|50074363|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
24985750|NCT01147666|50074364|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
24985751|NCT01147666|50074365|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
24985752|NCT01147666|50074366|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
24985753|NCT01147666|50074367|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
24985754|NCT01147666|50074368|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
24985755|NCT01147666|50074369|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
24985756|NCT01147666|50074370|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
24985757|NCT01147666|50074371|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
24985758|NCT01147666|50074372|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
24985759|NCT01147666|50074373|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
24985760|NCT01147666|50074374|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
24985761|NCT01147666|50074375|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
24985762|NCT01147666|50074376|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
24985763|NCT01147666|50074362|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
24985764|NCT01147666|50074363|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
24985765|NCT01147666|50074364|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
24985766|NCT01147666|50074365|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
24985767|NCT01147666|50074366|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
24985768|NCT01147666|50074367|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
24985769|NCT01147666|50074368|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
24985770|NCT01147666|50074369|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
24985771|NCT01147666|50074370|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
24985772|NCT01147666|50074371|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
24985773|NCT01147666|50074372|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
24985774|NCT01147666|50074373|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
24985775|NCT01147666|50074374|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
24985776|NCT01147666|50074375|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
24985777|NCT01147666|50074376|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
24985778|NCT01147666|50074362|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
24985779|NCT01147666|50074363|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
24985780|NCT01147666|50074364|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
24985781|NCT01147666|50074365|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
24985782|NCT01147666|50074366|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
24985783|NCT01147666|50074367|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
24985784|NCT01147666|50074368|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
24985785|NCT01147666|50074369|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
24985786|NCT01147666|50074370|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
24985787|NCT01147666|50074371|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
24985788|NCT01147666|50074372|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
24985789|NCT01147666|50074373|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
24985790|NCT01147666|50074374|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
24985791|NCT01147666|50074375|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
24985792|NCT01147666|50074376|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
24985793|NCT01147666|50074362|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
24985794|NCT01147666|50074363|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
24985795|NCT01147666|50074364|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
24985796|NCT01147666|50074365|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
24985797|NCT01147666|50074366|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
24985798|NCT01147666|50074367|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
24985799|NCT01147666|50074368|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
24985800|NCT01147666|50074369|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
24985801|NCT01147666|50074370|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
24985802|NCT01147666|50074371|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
24985803|NCT01147666|50074372|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
24985804|NCT01147666|50074373|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
24985805|NCT01147666|50074374|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
24985806|NCT01147666|50074375|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
24985807|NCT01147666|50074376|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
24985808|NCT01147666|50074362|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
24985809|NCT01147666|50074363|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
24985810|NCT01147666|50074364|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
24985811|NCT01147666|50074365|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
24985812|NCT01147666|50074366|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
24985813|NCT01147666|50074367|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
24985814|NCT01147666|50074368|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
24985815|NCT01147666|50074369|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
24985816|NCT01147666|50074370|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
24985817|NCT01147666|50074371|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
24985818|NCT01147666|50074372|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
24985819|NCT01147666|50074373|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
24985820|NCT01147666|50074374|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
24985821|NCT01147666|50074375|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
24985822|NCT01147666|50074376|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
24985823|NCT01147666|50074362|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
24985824|NCT01147666|50074363|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
24985825|NCT01147666|50074364|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
24985826|NCT01147666|50074365|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
24985827|NCT01147666|50074366|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
24985828|NCT01147666|50074367|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
24985829|NCT01147666|50074368|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
24985830|NCT01147666|50074369|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
24985831|NCT01147666|50074370|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
24985832|NCT01147666|50074371|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
24985833|NCT01147666|50074372|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
24985834|NCT01147666|50074373|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
24985835|NCT01147666|50074374|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
24985836|NCT01147666|50074375|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
24985837|NCT01147666|50074376|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
24985838|NCT01147666|50074362|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
24985839|NCT01147666|50074363|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
24985840|NCT01147666|50074364|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
24985841|NCT01147666|50074365|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
24985842|NCT01147666|50074366|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
24985843|NCT01147666|50074367|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
24985844|NCT01147666|50074368|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
24985845|NCT01147666|50074369|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
24985846|NCT01147666|50074370|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
24985847|NCT01147666|50074371|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
24985848|NCT01147666|50074372|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
24985849|NCT01147666|50074373|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
24985850|NCT01147666|50074374|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
24985851|NCT01147666|50074375|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
24985852|NCT01147666|50074376|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
24985853|NCT01147666|50074362|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
24985854|NCT01147666|50074363|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
24985855|NCT01147666|50074364|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
24985856|NCT01147666|50074365|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
24985857|NCT01147666|50074366|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
24985858|NCT01147666|50074367|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
24985859|NCT01147666|50074368|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
24985860|NCT01147666|50074369|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
24985861|NCT01147666|50074370|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
24985862|NCT01147666|50074371|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
24985863|NCT01147666|50074372|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
24985864|NCT01147666|50074373|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
24985865|NCT01147666|50074374|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
24985866|NCT01147666|50074375|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
24985867|NCT01147666|50074376|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
24985868|NCT01147666|50074362|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
24985869|NCT01147666|50074363|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
24985870|NCT01147666|50074364|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
24985871|NCT01147666|50074365|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
24985872|NCT01147666|50074366|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
24985873|NCT01147666|50074367|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
24985874|NCT01147666|50074368|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
24985875|NCT01147666|50074369|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
24985876|NCT01147666|50074370|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
24985877|NCT01147666|50074371|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
24985878|NCT01147666|50074372|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
24985879|NCT01147666|50074373|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
24985880|NCT01147666|50074374|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
24985881|NCT01147666|50074375|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
24985882|NCT01147666|50074376|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
24985883|NCT01147666|50074362|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
24985884|NCT01147666|50074363|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
24985885|NCT01147666|50074364|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
24985886|NCT01147666|50074365|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
24985887|NCT01147666|50074366|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
24985888|NCT01147666|50074367|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
24985889|NCT01147666|50074368|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
24985890|NCT01147666|50074369|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
24985891|NCT01147666|50074370|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
24985892|NCT01147666|50074371|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
24985893|NCT01147666|50074372|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
24985894|NCT01147666|50074373|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
24985895|NCT01147666|50074374|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
24985896|NCT01147666|50074375|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
24985897|NCT01147666|50074376|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
24985898|NCT01147666|50074362|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
24985899|NCT01147666|50074363|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
24985900|NCT01147666|50074364|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
24985901|NCT01147666|50074365|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
24985902|NCT01147666|50074366|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
24985903|NCT01147666|50074367|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
24985904|NCT01147666|50074368|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
24985905|NCT01147666|50074369|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
24985906|NCT01147666|50074370|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
24985907|NCT01147666|50074371|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
24985908|NCT01147666|50074372|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
24985909|NCT01147666|50074373|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
24985910|NCT01147666|50074374|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
24985911|NCT01147666|50074375|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
24985912|NCT01147666|50074376|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
24985913|NCT01147666|50074362|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
24985914|NCT01147666|50074363|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
24985915|NCT01147666|50074364|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
24985916|NCT01147666|50074365|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
24985917|NCT01147666|50074366|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
24985918|NCT01147666|50074367|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
24985919|NCT01147666|50074368|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
24985920|NCT01147666|50074369|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
24985921|NCT01147666|50074370|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
24985922|NCT01147666|50074371|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
24985923|NCT01147666|50074372|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
24985924|NCT01147666|50074373|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
24985925|NCT01147666|50074374|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
24985926|NCT01147666|50074375|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
24985927|NCT01147666|50074376|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
24985928|NCT01147666|50074362|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
24985929|NCT01147666|50074363|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
24985930|NCT01147666|50074364|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
24985931|NCT01147666|50074365|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
24985932|NCT01147666|50074366|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
24985933|NCT01147666|50074367|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
24985934|NCT01147666|50074368|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
24985935|NCT01147666|50074369|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
24985936|NCT01147666|50074370|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
24985937|NCT01147666|50074371|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
24985938|NCT01147666|50074372|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
24985939|NCT01147666|50074373|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
24985940|NCT01147666|50074374|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
24985941|NCT01147666|50074375|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
24985942|NCT01147666|50074376|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
24985943|NCT00256295|50074438|FG000|Overall Study|Withdrawal by Subject|3|||
24985944|NCT00256295|50074438|FG000|Overall Study|Death|1|||
24985945|NCT02877004|50074445|FG000|Overall Study|Pregnancy|0|||
24985946|NCT02877004|50074446|FG001|Overall Study|Pregnancy|0|||
24985947|NCT02877004|50074447|FG002|Overall Study|Pregnancy|1|||
24985948|NCT04617860|50074477|FG000|Overall Study|Adverse Event|0|||
24985949|NCT04617860|50074478|FG001|Overall Study|Adverse Event|2|||
24985950|NCT04617860|50074479|FG002|Overall Study|Adverse Event|2|||
24985951|NCT04617860|50074477|FG000|Overall Study|Withdrawal by Subject|0|||
24985952|NCT04617860|50074478|FG001|Overall Study|Withdrawal by Subject|0|||
24985953|NCT04617860|50074479|FG002|Overall Study|Withdrawal by Subject|2|||
24985954|NCT04617860|50074477|FG000|Overall Study|Physician Decision|0|||
25079424|NCT01865617|50187896|FG010|Overall Study|Withdrawal by Subject|0|||
25079425|NCT01865617|50187897|FG011|Overall Study|Withdrawal by Subject|0|||
25079426|NCT01865617|50187898|FG012|Overall Study|Withdrawal by Subject|0|||
25079427|NCT01865617|50187886|FG000|Overall Study|Patient proceeded to new therapy|0|||
24985955|NCT04617860|50074478|FG001|Overall Study|Physician Decision|1|||
24985956|NCT04617860|50074479|FG002|Overall Study|Physician Decision|0|||
24985957|NCT04617860|50074477|FG000|Overall Study|Sponsor Decision|0|||
24985958|NCT04617860|50074478|FG001|Overall Study|Sponsor Decision|3|||
25079428|NCT01865617|50187887|FG001|Overall Study|Patient proceeded to new therapy|0|||
25079429|NCT01865617|50187888|FG002|Overall Study|Patient proceeded to new therapy|0|||
24985959|NCT04617860|50074479|FG002|Overall Study|Sponsor Decision|1|||
24985960|NCT04617860|50074477|FG000|Overall Study|Termination of Study by Sponsor|8|||
24985961|NCT04617860|50074478|FG001|Overall Study|Termination of Study by Sponsor|4|||
24985962|NCT04617860|50074479|FG002|Overall Study|Termination of Study by Sponsor|13|||
24985963|NCT04608500|50074491|FG000|Overall Study|Adverse Event|2|||
24985964|NCT04608500|50074492|FG001|Overall Study|Adverse Event|0|||
24985965|NCT04608500|50074491|FG000|Overall Study|Lost to Follow-up|15|||
24985966|NCT04608500|50074492|FG001|Overall Study|Lost to Follow-up|9|||
24985967|NCT04608500|50074491|FG000|Overall Study|Participant request|11|||
24985968|NCT04608500|50074492|FG001|Overall Study|Participant request|7|||
24985969|NCT04608500|50074491|FG000|Overall Study|Protocol Violation|1|||
24985970|NCT04608500|50074492|FG001|Overall Study|Protocol Violation|0|||
24985971|NCT04608500|50074491|FG000|Overall Study|Other|6|||
24985972|NCT04608500|50074492|FG001|Overall Study|Other|2|||
24985973|NCT04585646|50074498|FG000|First Intervention|Physician Decision|1|||
24985974|NCT04585646|50074499|FG001|First Intervention|Physician Decision|0|||
24985975|NCT04585646|50074498|FG000|First Intervention|Lost to Follow-up|0|||
24985976|NCT04585646|50074499|FG001|First Intervention|Lost to Follow-up|3|||
24985977|NCT04585646|50074498|FG000|First Intervention|Withdrawal by Subject|0|||
24985978|NCT04585646|50074499|FG001|First Intervention|Withdrawal by Subject|1|||
24985979|NCT04584788|50074515|FG000|Overall Study|Physician Decision|8|||
24985980|NCT04584788|50074515|FG000|Overall Study|Withdrawal by Subject|1|||
24985981|NCT04584788|50074515|FG000|Overall Study|Adverse Event|3|||
24985982|NCT04575038|50074521|FG000|Overall Study|Withdrawal by Subject|1|||
24985983|NCT04575038|50074522|FG001|Overall Study|Withdrawal by Subject|1|||
24985984|NCT03066622|50074530|FG000|Overall Study|Lost to Follow-up|24|||
24985985|NCT03066622|50074531|FG001|Overall Study|Lost to Follow-up|25|||
24985986|NCT03066622|50074530|FG000|Overall Study|Withdrawal by Subject|2|||
24985987|NCT03066622|50074531|FG001|Overall Study|Withdrawal by Subject|1|||
24985988|NCT04501952|50074563|FG000|Overall Study|Adverse Event|0|||
24985989|NCT04501952|50074564|FG001|Overall Study|Adverse Event|3|||
24985990|NCT04501952|50074563|FG000|Overall Study|Investigator's Discretion|0|||
24985991|NCT04501952|50074564|FG001|Overall Study|Investigator's Discretion|1|||
24985992|NCT04501952|50074563|FG000|Overall Study|Protocol Violation|1|||
24985993|NCT04501952|50074564|FG001|Overall Study|Protocol Violation|1|||
24985994|NCT04501952|50074563|FG000|Overall Study|Withdrew Consent|5|||
24985995|NCT04501952|50074564|FG001|Overall Study|Withdrew Consent|4|||
24985996|NCT04501952|50074563|FG000|Overall Study|Lost to Follow-up|7|||
24985997|NCT04501952|50074564|FG001|Overall Study|Lost to Follow-up|2|||
24985998|NCT04501952|50074563|FG000|Overall Study|Randomized and Never Treated|13|||
24985999|NCT04501952|50074564|FG001|Overall Study|Randomized and Never Treated|9|||
24986000|NCT02930122|50074582|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
24986001|NCT02930122|50074583|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
24986016|NCT03697460|50074603|FG000|Overall Study|Withdrawal by Subject|3|||
24986017|NCT00070018|50074607|FG000|Overall Study|Adverse Event|2|||
24986018|NCT00070018|50074607|FG000|Overall Study|Lack of Efficacy|1|||
24986019|NCT00070018|50074607|FG000|Overall Study|Withdrawal by Subject|1|||
24986020|NCT00231413|50074618|FG000|Overall Study|Non-serious AE|0|||
24986021|NCT00231413|50074619|FG001|Overall Study|Non-serious AE|0|||
24986022|NCT00231413|50074620|FG002|Overall Study|Non-serious AE|1|||
24986023|NCT00231413|50074621|FG003|Overall Study|Non-serious AE|0|||
24986024|NCT00231413|50074622|FG004|Overall Study|Non-serious AE|0|||
24986025|NCT00231413|50074623|FG005|Overall Study|Non-serious AE|0|||
24986026|NCT00231413|50074624|FG006|Overall Study|Non-serious AE|1|||
24986027|NCT00231413|50074618|FG000|Overall Study|Withdrawal by Subject|3|||
24986028|NCT00231413|50074619|FG001|Overall Study|Withdrawal by Subject|1|||
24986029|NCT00231413|50074620|FG002|Overall Study|Withdrawal by Subject|4|||
24986030|NCT00231413|50074621|FG003|Overall Study|Withdrawal by Subject|2|||
24986031|NCT00231413|50074622|FG004|Overall Study|Withdrawal by Subject|2|||
24986032|NCT00231413|50074623|FG005|Overall Study|Withdrawal by Subject|0|||
24986033|NCT00231413|50074624|FG006|Overall Study|Withdrawal by Subject|3|||
24986034|NCT00231413|50074618|FG000|Overall Study|Migrated/moved from study area|0|||
24986035|NCT00231413|50074619|FG001|Overall Study|Migrated/moved from study area|0|||
24986036|NCT00231413|50074620|FG002|Overall Study|Migrated/moved from study area|1|||
24986037|NCT00231413|50074621|FG003|Overall Study|Migrated/moved from study area|0|||
24986038|NCT00231413|50074622|FG004|Overall Study|Migrated/moved from study area|0|||
24986039|NCT00231413|50074623|FG005|Overall Study|Migrated/moved from study area|1|||
24986040|NCT00231413|50074624|FG006|Overall Study|Migrated/moved from study area|0|||
24986041|NCT00231413|50074618|FG000|Overall Study|Lost to Follow-up|4|||
24986042|NCT00231413|50074619|FG001|Overall Study|Lost to Follow-up|4|||
24986043|NCT00231413|50074620|FG002|Overall Study|Lost to Follow-up|1|||
24986044|NCT00231413|50074621|FG003|Overall Study|Lost to Follow-up|1|||
24986045|NCT00231413|50074622|FG004|Overall Study|Lost to Follow-up|1|||
24986046|NCT00231413|50074623|FG005|Overall Study|Lost to Follow-up|4|||
24986047|NCT00231413|50074624|FG006|Overall Study|Lost to Follow-up|0|||
24986048|NCT00231413|50074618|FG000|Overall Study|Pregnancy|1|||
24986049|NCT00231413|50074619|FG001|Overall Study|Pregnancy|0|||
24986050|NCT00231413|50074620|FG002|Overall Study|Pregnancy|0|||
24986051|NCT00231413|50074621|FG003|Overall Study|Pregnancy|0|||
24986052|NCT00231413|50074622|FG004|Overall Study|Pregnancy|0|||
24986053|NCT00231413|50074623|FG005|Overall Study|Pregnancy|0|||
24986054|NCT00231413|50074624|FG006|Overall Study|Pregnancy|0|||
24986055|NCT04494646|50074642|FG000|Overall Study|Adverse Event|0|||
24986056|NCT04494646|50074643|FG001|Overall Study|Adverse Event|1|||
24986057|NCT04494646|50074642|FG000|Overall Study|Withdrawal by Subject|0|||
24986058|NCT04494646|50074643|FG001|Overall Study|Withdrawal by Subject|1|||
24986059|NCT04529096|50074651|FG000|Overall Study|Adverse Event|6|||
24986060|NCT04529096|50074652|FG001|Overall Study|Adverse Event|1|||
24986061|NCT04529096|50074651|FG000|Overall Study|Lack of Efficacy|1|||
24986062|NCT04529096|50074652|FG001|Overall Study|Lack of Efficacy|0|||
24986063|NCT04529096|50074651|FG000|Overall Study|Lost to Follow-up|1|||
24986064|NCT04529096|50074652|FG001|Overall Study|Lost to Follow-up|1|||
24986065|NCT04529096|50074651|FG000|Overall Study|Non-Compliance With Study Drug|0|||
24986066|NCT04529096|50074652|FG001|Overall Study|Non-Compliance With Study Drug|1|||
24986067|NCT04529096|50074651|FG000|Overall Study|Physician Decision|1|||
24986068|NCT04529096|50074652|FG001|Overall Study|Physician Decision|3|||
24986069|NCT04529096|50074651|FG000|Overall Study|Withdrawal by Subject|5|||
24986070|NCT04529096|50074652|FG001|Overall Study|Withdrawal by Subject|0|||
24986071|NCT00231179|50074660|FG000|Overall Study|Lost to Follow-up|21|||
24986072|NCT00231179|50074661|FG001|Overall Study|Lost to Follow-up|21|||
24986073|NCT00231179|50074660|FG000|Overall Study|Withdrawal by Subject|3|||
24986074|NCT00231179|50074661|FG001|Overall Study|Withdrawal by Subject|3|||
24986075|NCT00229931|50074669|FG000|Overall Study|Death|1|||
24986076|NCT00229931|50074670|FG001|Overall Study|Death|0|||
24986077|NCT00229931|50074669|FG000|Overall Study|Lost to Follow-up|3|||
24986078|NCT00229931|50074670|FG001|Overall Study|Lost to Follow-up|2|||
24986079|NCT03135028|50074676|FG000|Overall Study|Death|6|||
24986080|NCT03135028|50074676|FG000|Overall Study|Study Terminated by Sponsor|2|||
24986081|NCT03135028|50074676|FG000|Overall Study|Withdrew Consent|1|||
24986082|NCT00228917|50074688|FG000|Overall Study|Migrated/moved from study area|0|||
24986083|NCT00228917|50074689|FG001|Overall Study|Migrated/moved from study area|0|||
24986084|NCT00228917|50074690|FG002|Overall Study|Migrated/moved from study area|0|||
24986085|NCT00228917|50074691|FG003|Overall Study|Migrated/moved from study area|0|||
24986086|NCT00228917|50074692|FG004|Overall Study|Migrated/moved from study area|0|||
24986087|NCT00228917|50074693|FG005|Overall Study|Migrated/moved from study area|2|||
24986088|NCT00228917|50074694|FG006|Overall Study|Migrated/moved from study area|0|||
24986089|NCT00228917|50074695|FG007|Overall Study|Migrated/moved from study area|0|||
24986090|NCT00227903|50074711|FG000|Overall Study|Withdrawal by Subject|2|||
24986091|NCT00227903|50074712|FG001|Overall Study|Withdrawal by Subject|5|||
24986092|NCT00227903|50074711|FG000|Overall Study|Subject moved out of area|1|||
24986093|NCT00227903|50074712|FG001|Overall Study|Subject moved out of area|2|||
24986094|NCT00227903|50074711|FG000|Overall Study|Lost to Follow-up|1|||
24986095|NCT00227903|50074712|FG001|Overall Study|Lost to Follow-up|3|||
24986096|NCT00227903|50074711|FG000|Overall Study|Miscarriage|1|||
24986097|NCT00227903|50074712|FG001|Overall Study|Miscarriage|0|||
24986098|NCT04411628|50074722|FG000|Overall Study|Withdrawal by Subject|1|||
24986099|NCT04411628|50074723|FG001|Overall Study|Withdrawal by Subject|1|||
24986100|NCT04411628|50074724|FG002|Overall Study|Withdrawal by Subject|2|||
24986101|NCT04411628|50074725|FG003|Overall Study|Withdrawal by Subject|0|||
24986102|NCT04411628|50074722|FG000|Overall Study|Lost to Follow-up|0|||
24986103|NCT04411628|50074723|FG001|Overall Study|Lost to Follow-up|1|||
24986104|NCT04411628|50074724|FG002|Overall Study|Lost to Follow-up|0|||
24986105|NCT04411628|50074725|FG003|Overall Study|Lost to Follow-up|0|||
24986106|NCT00227591|50074738|FG000|Overall Study|Withdrawal by Subject|1|||
24986107|NCT04512482|50074744|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
24986108|NCT04512482|50074745|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
24986109|NCT00226811|50074751|FG000|Overall Study|Death|8|||
24986110|NCT00226811|50074751|FG000|Overall Study|Adverse Event|11|||
24986111|NCT00226811|50074751|FG000|Overall Study|Lack of Efficacy|55|||
24986112|NCT00226811|50074751|FG000|Overall Study|Withdrawal by Subject|2|||
24986113|NCT02951052|50074757|FG000|Overall Study|Adverse Event|13|||
24986114|NCT02951052|50074758|FG001|Overall Study|Adverse Event|5|||
24986115|NCT02951052|50074757|FG000|Overall Study|Withdrawal by Subject|1|||
24986116|NCT02951052|50074758|FG001|Overall Study|Withdrawal by Subject|5|||
24986117|NCT02951052|50074757|FG000|Overall Study|Physician Decision|2|||
24986118|NCT02951052|50074758|FG001|Overall Study|Physician Decision|0|||
24986119|NCT02951052|50074757|FG000|Overall Study|Lost to Follow-up|1|||
24986120|NCT02951052|50074758|FG001|Overall Study|Lost to Follow-up|1|||
24986121|NCT02951052|50074757|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
24986122|NCT02951052|50074758|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
24986123|NCT02951052|50074757|FG000|Overall Study|Protocol Violation|5|||
24986124|NCT02951052|50074758|FG001|Overall Study|Protocol Violation|3|||
24986125|NCT02951052|50074757|FG000|Overall Study|Lack of Efficacy|3|||
24986126|NCT02951052|50074758|FG001|Overall Study|Lack of Efficacy|4|||
24986127|NCT02951052|50074757|FG000|Overall Study|Ongoing|1|||
24986128|NCT02951052|50074758|FG001|Overall Study|Ongoing|0|||
24986129|NCT00226655|50074768|FG000|Overall Study|Death|13|||
24986130|NCT00226655|50074768|FG000|Overall Study|Withdrawal by Subject|15|||
24986131|NCT00226655|50074768|FG000|Overall Study|Adverse Event|35|||
24986132|NCT00226655|50074768|FG000|Overall Study|Physician Decision|6|||
24986133|NCT00226655|50074768|FG000|Overall Study|Clinical deterioration|10|||
24986134|NCT03124108|50074784|FG000|Overall Study|Adverse Event|0|||
24986135|NCT03124108|50074785|FG001|Overall Study|Adverse Event|1|||
24986136|NCT03124108|50074786|FG002|Overall Study|Adverse Event|0|||
24986137|NCT04475588|50074798|FG000|Overall Study|Adverse Event|2|||
24986138|NCT04475588|50074799|FG001|Overall Study|Adverse Event|0|||
24986139|NCT04353596|50074808|FG000|Overall Study|Protocol Violation|4|||
24986140|NCT04353596|50074809|FG001|Overall Study|Protocol Violation|4|||
24986141|NCT04353596|50074808|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
24986142|NCT04353596|50074809|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
24986143|NCT04350788|50074817|FG000|Overall Study|Lost to Follow-up|6|||
24986144|NCT04350788|50074818|FG001|Overall Study|Lost to Follow-up|2|||
24986145|NCT04350788|50074817|FG000|Overall Study|Withdrawal by Subject|2|||
24986146|NCT04350788|50074818|FG001|Overall Study|Withdrawal by Subject|4|||
24986147|NCT04350788|50074817|FG000|Overall Study|Protocol Violation|4|||
24986148|NCT04350788|50074818|FG001|Overall Study|Protocol Violation|0|||
24986149|NCT03852316|50074829|FG000|Overall Study|Protocol Violation|1|||
24986150|NCT03852316|50074829|FG000|Overall Study|Withdrawal by Subject|2|||
24986151|NCT03852316|50074829|FG000|Overall Study|Enrolled but Device not Utilized|1|||
24986152|NCT04335812|50074835|FG000|Overall Study|Withdrawal by Subject|1|||
24986153|NCT04335812|50074836|FG001|Overall Study|Withdrawal by Subject|3|||
24986154|NCT04335812|50074835|FG000|Overall Study|Lost to Follow-up|12|||
24986155|NCT04335812|50074836|FG001|Overall Study|Lost to Follow-up|12|||
24986156|NCT04335812|50074835|FG000|Overall Study|Did not engage in the intervention|22|||
24986157|NCT04335812|50074836|FG001|Overall Study|Did not engage in the intervention|18|||
24986158|NCT03127384|50074842|FG000|Overall Study|Lost to Follow-up|4|||
24986159|NCT03127384|50074842|FG000|Overall Study|Subject request|2|||
24986160|NCT04398134|50074869|FG000|Overall Study|Adverse Event|0|||
24986161|NCT04398134|50074870|FG001|Overall Study|Adverse Event|0|||
24986162|NCT04398134|50074871|FG002|Overall Study|Adverse Event|1|||
24986163|NCT04398134|50074872|FG003|Overall Study|Adverse Event|0|||
24986164|NCT04398134|50074869|FG000|Overall Study|Withdrawal by Subject|2|||
24986165|NCT04398134|50074870|FG001|Overall Study|Withdrawal by Subject|0|||
24986166|NCT04398134|50074871|FG002|Overall Study|Withdrawal by Subject|0|||
24986167|NCT04398134|50074872|FG003|Overall Study|Withdrawal by Subject|1|||
24986168|NCT04398134|50074869|FG000|Overall Study|Study Terminated by Sponsor|30|||
24986169|NCT04398134|50074870|FG001|Overall Study|Study Terminated by Sponsor|11|||
24986170|NCT04398134|50074871|FG002|Overall Study|Study Terminated by Sponsor|32|||
24986171|NCT04398134|50074872|FG003|Overall Study|Study Terminated by Sponsor|11|||
24986172|NCT03122860|50074888|FG000|Overall Study|Discontinued Before Treatment|1|||
24986173|NCT03122860|50074889|FG001|Overall Study|Discontinued Before Treatment|1|||
24986174|NCT03122860|50074890|FG002|Overall Study|Discontinued Before Treatment|2|||
24986175|NCT03122860|50074891|FG003|Overall Study|Discontinued Before Treatment|0|||
24986176|NCT03122860|50074892|FG004|Overall Study|Discontinued Before Treatment|1|||
24986177|NCT03122860|50074893|FG005|Overall Study|Discontinued Before Treatment|0|||
24986178|NCT03122860|50074888|FG000|Overall Study|Adverse Event|1|||
24986179|NCT03122860|50074889|FG001|Overall Study|Adverse Event|0|||
24986180|NCT03122860|50074890|FG002|Overall Study|Adverse Event|1|||
24986181|NCT03122860|50074891|FG003|Overall Study|Adverse Event|1|||
24986182|NCT03122860|50074892|FG004|Overall Study|Adverse Event|0|||
24986183|NCT03122860|50074893|FG005|Overall Study|Adverse Event|0|||
24986184|NCT03122860|50074888|FG000|Overall Study|Lost to Follow-up|5|||
24986185|NCT03122860|50074889|FG001|Overall Study|Lost to Follow-up|2|||
24986186|NCT03122860|50074890|FG002|Overall Study|Lost to Follow-up|3|||
24986187|NCT03122860|50074891|FG003|Overall Study|Lost to Follow-up|3|||
24986188|NCT03122860|50074892|FG004|Overall Study|Lost to Follow-up|5|||
24986189|NCT03122860|50074893|FG005|Overall Study|Lost to Follow-up|4|||
24986190|NCT03122860|50074888|FG000|Overall Study|Subject Non-Compliance|0|||
24986191|NCT03122860|50074889|FG001|Overall Study|Subject Non-Compliance|0|||
24986192|NCT03122860|50074890|FG002|Overall Study|Subject Non-Compliance|1|||
24986193|NCT03122860|50074891|FG003|Overall Study|Subject Non-Compliance|0|||
24986194|NCT03122860|50074892|FG004|Overall Study|Subject Non-Compliance|0|||
24986195|NCT03122860|50074893|FG005|Overall Study|Subject Non-Compliance|0|||
24986196|NCT03122860|50074888|FG000|Overall Study|Withdrawal by Subject|3|||
24986197|NCT03122860|50074889|FG001|Overall Study|Withdrawal by Subject|2|||
24986198|NCT03122860|50074890|FG002|Overall Study|Withdrawal by Subject|5|||
24986199|NCT03122860|50074891|FG003|Overall Study|Withdrawal by Subject|7|||
24986200|NCT03122860|50074892|FG004|Overall Study|Withdrawal by Subject|9|||
24986201|NCT03122860|50074893|FG005|Overall Study|Withdrawal by Subject|8|||
24986202|NCT03798366|50074910|FG000|Overall Study|Lost to Follow-up|0|||
24986203|NCT03798366|50074911|FG001|Overall Study|Lost to Follow-up|1|||
24986204|NCT04327388|50074920|FG000|Overall Study|Adverse Event|17|||
24986205|NCT04327388|50074921|FG001|Overall Study|Adverse Event|18|||
24986206|NCT04327388|50074922|FG002|Overall Study|Adverse Event|9|||
24986207|NCT04327388|50074920|FG000|Overall Study|Other|1|||
24986208|NCT04327388|50074921|FG001|Overall Study|Other|2|||
24986209|NCT04327388|50074922|FG002|Overall Study|Other|0|||
24986210|NCT04327388|50074920|FG000|Overall Study|Randomized and not treated|2|||
24986211|NCT04327388|50074921|FG001|Overall Study|Randomized and not treated|0|||
24986212|NCT04327388|50074922|FG002|Overall Study|Randomized and not treated|2|||
24986213|NCT03796728|50074930|FG000|Overall Study|Lost to Follow-up|8|||
24986214|NCT03796728|50074930|FG000|Overall Study|Reason not Specified|16|||
24986215|NCT00352534|50074936|FG000|Initial Staging|Ineligible|8|||
24986216|NCT00352534|50074937|FG001|Initial Staging|Ineligible|9|||
24986217|NCT00352534|50074938|FG002|Initial Staging|Ineligible|0|||
24986218|NCT00352534|50074939|FG003|Initial Staging|Ineligible|0|||
24986219|NCT00352534|50074940|FG004|Initial Staging|Ineligible|0|||
24986220|NCT00352534|50074941|FG005|Initial Staging|Ineligible|0|||
24986221|NCT00352534|50074942|FG006|Initial Staging|Ineligible|0|||
24986222|NCT00352534|50074936|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
24986223|NCT00352534|50074937|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
24986224|NCT00352534|50074938|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
24986225|NCT00352534|50074939|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
24986226|NCT00352534|50074940|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
24986227|NCT00352534|50074941|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
24986228|NCT00352534|50074942|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
24986229|NCT00352534|50074936|FG000|Final Risk Group Assignment|Physician Decision|0|||
24986230|NCT00352534|50074937|FG001|Final Risk Group Assignment|Physician Decision|0|||
24986231|NCT00352534|50074938|FG002|Final Risk Group Assignment|Physician Decision|0|||
24986232|NCT00352534|50074939|FG003|Final Risk Group Assignment|Physician Decision|0|||
24986233|NCT00352534|50074940|FG004|Final Risk Group Assignment|Physician Decision|0|||
24986234|NCT00352534|50074941|FG005|Final Risk Group Assignment|Physician Decision|8|||
24986235|NCT00352534|50074942|FG006|Final Risk Group Assignment|Physician Decision|0|||
24986236|NCT00352534|50074936|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
24986237|NCT00352534|50074937|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
24986238|NCT00352534|50074938|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
24986239|NCT00352534|50074939|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
24986240|NCT00352534|50074940|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
24986241|NCT00352534|50074941|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
24986242|NCT00352534|50074942|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
24986243|NCT00352534|50074936|FG000|Final Risk Group Assignment|Ineligible|0|||
24986244|NCT00352534|50074937|FG001|Final Risk Group Assignment|Ineligible|0|||
24986245|NCT00352534|50074938|FG002|Final Risk Group Assignment|Ineligible|3|||
24986246|NCT00352534|50074939|FG003|Final Risk Group Assignment|Ineligible|1|||
24986247|NCT00352534|50074940|FG004|Final Risk Group Assignment|Ineligible|0|||
24986248|NCT00352534|50074941|FG005|Final Risk Group Assignment|Ineligible|13|||
24986249|NCT00352534|50074942|FG006|Final Risk Group Assignment|Ineligible|0|||
24986250|NCT00352534|50074936|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
24986251|NCT00352534|50074937|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
24986252|NCT00352534|50074938|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
24986253|NCT00352534|50074939|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
24986254|NCT00352534|50074940|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
24986255|NCT00352534|50074941|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
24986256|NCT00352534|50074942|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
24986257|NCT00352534|50074936|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
24986258|NCT00352534|50074937|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
24986259|NCT00352534|50074938|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
24986260|NCT00352534|50074939|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
24986261|NCT00352534|50074940|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
24986262|NCT00352534|50074941|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
24986263|NCT00352534|50074942|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
24986264|NCT00352534|50074936|FG000|Final Risk Group Assignment|Death|0|||
24986265|NCT00352534|50074937|FG001|Final Risk Group Assignment|Death|0|||
24986266|NCT00352534|50074938|FG002|Final Risk Group Assignment|Death|0|||
24986267|NCT00352534|50074939|FG003|Final Risk Group Assignment|Death|0|||
24986268|NCT00352534|50074940|FG004|Final Risk Group Assignment|Death|0|||
24986269|NCT00352534|50074941|FG005|Final Risk Group Assignment|Death|2|||
24986270|NCT00352534|50074942|FG006|Final Risk Group Assignment|Death|0|||
24986271|NCT04323800|50074954|FG000|Overall Study|Withdrawal by Subject|4|||
24986272|NCT04323800|50074955|FG001|Overall Study|Withdrawal by Subject|4|||
24986273|NCT04323800|50074954|FG000|Overall Study|Incomplete transfusion|1|||
24986274|NCT04323800|50074955|FG001|Overall Study|Incomplete transfusion|0|||
24986275|NCT04323800|50074954|FG000|Overall Study|Other|0|||
24986276|NCT04323800|50074955|FG001|Overall Study|Other|1|||
24986277|NCT04323800|50074954|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
24986278|NCT04323800|50074955|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
24986279|NCT04321460|50074963|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
24986280|NCT04321460|50074964|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
24986281|NCT03122548|50074970|FG000|Overall Study|Death|2|||
24986282|NCT03122548|50074970|FG000|Overall Study|Progression - subject went into hospice|1|||
24986283|NCT03122548|50074970|FG000|Overall Study|Study Terminated by Sponsor|2|||
24986284|NCT04459598|50074976|FG000|Overall Study|Adverse Event|1|||
24986285|NCT04459598|50074977|FG001|Overall Study|Adverse Event|1|||
24986286|NCT02929498|50074986|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
24986287|NCT02929498|50074987|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
24986288|NCT02929498|50074988|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
24986289|NCT02929498|50074986|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
24986290|NCT02929498|50074987|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
24986291|NCT02929498|50074988|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
24986292|NCT03792672|50074994|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
24986293|NCT03792672|50074995|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
24986294|NCT03792672|50074996|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
24986295|NCT03792672|50074997|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
24986296|NCT03792672|50074998|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
24986297|NCT03792672|50074999|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
24986298|NCT03792672|50074994|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
24986299|NCT03792672|50074995|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
24986300|NCT03792672|50074996|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
24986301|NCT03792672|50074997|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
24986302|NCT03792672|50074998|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
24986303|NCT03792672|50074999|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
24986304|NCT03792672|50074994|FG000|Treatment Period 4 (2 Days)|Other|1|||
24986305|NCT03792672|50074995|FG001|Treatment Period 4 (2 Days)|Other|0|||
24986306|NCT03792672|50074996|FG002|Treatment Period 4 (2 Days)|Other|0|||
24986307|NCT03792672|50074997|FG003|Treatment Period 4 (2 Days)|Other|0|||
24986308|NCT03792672|50074998|FG004|Treatment Period 4 (2 Days)|Other|0|||
24986309|NCT03792672|50074999|FG005|Treatment Period 4 (2 Days)|Other|0|||
24986310|NCT03120676|50075014|FG000|Overall Study|Not treated|1|||
24986311|NCT03120520|50075022|FG000|Overall Study|Lost to Follow-up|1|||
24986312|NCT03120520|50075023|FG001|Overall Study|Lost to Follow-up|1|||
24986313|NCT03120520|50075024|FG002|Overall Study|Lost to Follow-up|1|||
24986314|NCT03120520|50075025|FG003|Overall Study|Lost to Follow-up|1|||
24986315|NCT03120520|50075022|FG000|Overall Study|Withdrawal by Subject|3|||
24986316|NCT03120520|50075023|FG001|Overall Study|Withdrawal by Subject|2|||
24986317|NCT03120520|50075024|FG002|Overall Study|Withdrawal by Subject|3|||
24986318|NCT03120520|50075025|FG003|Overall Study|Withdrawal by Subject|2|||
24986319|NCT03120520|50075022|FG000|Overall Study|Other|0|||
24986320|NCT03120520|50075023|FG001|Overall Study|Other|1|||
24986321|NCT03120520|50075024|FG002|Overall Study|Other|0|||
24986322|NCT03120520|50075025|FG003|Overall Study|Other|0|||
24986323|NCT03787212|50075035|FG000|Period 1|Study Termination|2|||
24986324|NCT03787212|50075036|FG001|Period 1|Study Termination|2|||
24986325|NCT03125200|50075049|FG000|Overall Study|Study Termination|0|||
24986326|NCT03125200|50075050|FG001|Overall Study|Study Termination|0|||
24986327|NCT03125200|50075051|FG002|Overall Study|Study Termination|0|||
24986328|NCT03125200|50075052|FG003|Overall Study|Study Termination|1|||
24986329|NCT03125200|50075053|FG004|Overall Study|Study Termination|1|||
24986330|NCT03125200|50075054|FG005|Overall Study|Study Termination|2|||
24986331|NCT03125200|50075055|FG006|Overall Study|Study Termination|1|||
24986332|NCT03125200|50075049|FG000|Overall Study|Clinical Progression|0|||
24986333|NCT03125200|50075050|FG001|Overall Study|Clinical Progression|0|||
24986334|NCT03125200|50075051|FG002|Overall Study|Clinical Progression|0|||
24986335|NCT03125200|50075052|FG003|Overall Study|Clinical Progression|1|||
24986336|NCT03125200|50075053|FG004|Overall Study|Clinical Progression|0|||
24986337|NCT03125200|50075054|FG005|Overall Study|Clinical Progression|1|||
24986338|NCT03125200|50075055|FG006|Overall Study|Clinical Progression|0|||
24986339|NCT03125200|50075049|FG000|Overall Study|Progressive Disease|2|||
24986340|NCT03125200|50075050|FG001|Overall Study|Progressive Disease|1|||
24986341|NCT03125200|50075051|FG002|Overall Study|Progressive Disease|2|||
24986342|NCT03125200|50075052|FG003|Overall Study|Progressive Disease|1|||
24986343|NCT03125200|50075053|FG004|Overall Study|Progressive Disease|2|||
24986344|NCT03125200|50075054|FG005|Overall Study|Progressive Disease|0|||
24986345|NCT03125200|50075055|FG006|Overall Study|Progressive Disease|1|||
24986346|NCT03125200|50075049|FG000|Overall Study|Lack of Efficacy|0|||
24986347|NCT03125200|50075050|FG001|Overall Study|Lack of Efficacy|0|||
24986348|NCT03125200|50075051|FG002|Overall Study|Lack of Efficacy|0|||
24986349|NCT03125200|50075052|FG003|Overall Study|Lack of Efficacy|1|||
24986350|NCT03125200|50075053|FG004|Overall Study|Lack of Efficacy|0|||
24986351|NCT03125200|50075054|FG005|Overall Study|Lack of Efficacy|0|||
24986352|NCT03125200|50075055|FG006|Overall Study|Lack of Efficacy|0|||
24986353|NCT03125200|50075049|FG000|Overall Study|Toxicity|0|||
24986354|NCT03125200|50075050|FG001|Overall Study|Toxicity|0|||
24986355|NCT03125200|50075051|FG002|Overall Study|Toxicity|0|||
24986356|NCT03125200|50075052|FG003|Overall Study|Toxicity|1|||
24986357|NCT03125200|50075053|FG004|Overall Study|Toxicity|0|||
24986358|NCT03125200|50075054|FG005|Overall Study|Toxicity|0|||
24986359|NCT03125200|50075055|FG006|Overall Study|Toxicity|0|||
24986360|NCT03125200|50075049|FG000|Overall Study|Consent Withdrawn by Subject|0|||
24986361|NCT03125200|50075050|FG001|Overall Study|Consent Withdrawn by Subject|1|||
24986362|NCT03125200|50075051|FG002|Overall Study|Consent Withdrawn by Subject|0|||
24986363|NCT03125200|50075052|FG003|Overall Study|Consent Withdrawn by Subject|0|||
24986364|NCT03125200|50075053|FG004|Overall Study|Consent Withdrawn by Subject|1|||
24986365|NCT03125200|50075054|FG005|Overall Study|Consent Withdrawn by Subject|0|||
24986366|NCT03125200|50075055|FG006|Overall Study|Consent Withdrawn by Subject|1|||
24986367|NCT03132220|50075076|FG000|Overall Study|Lost to Follow-up|17|||
24986368|NCT03132220|50075077|FG001|Overall Study|Lost to Follow-up|8|||
24986369|NCT03132220|50075076|FG000|Overall Study|Withdrawal by Subject|1|||
24986370|NCT03132220|50075077|FG001|Overall Study|Withdrawal by Subject|4|||
24986371|NCT03119662|50075085|FG000|Overall Study|Withdrawal by Subject|0|||
24986372|NCT03119662|50075086|FG001|Overall Study|Withdrawal by Subject|1|||
24986373|NCT02728804|50075092|FG000|Overall Study|Ineligible|3|||
24986374|NCT02728804|50075092|FG000|Overall Study|Did not complete baseline questionnaire|9|||
24986375|NCT02728804|50075092|FG000|Overall Study|Death|99|||
24986376|NCT02699554|50075108|FG000|Overall Study|Lost to Follow-up|9|||
24986377|NCT03783780|50075122|FG000|Overall Study|Withdrawn prior to completion|1|||
24986378|NCT03783702|50075129|FG000|Overall Study|Lost to Follow-up|6|||
24986379|NCT03783702|50075130|FG001|Overall Study|Lost to Follow-up|8|||
24986380|NCT03783702|50075129|FG000|Overall Study|Protocol Violation|1|||
24986381|NCT03783702|50075130|FG001|Overall Study|Protocol Violation|3|||
24986382|NCT03575572|50075138|FG000|Overall Study|Withdrawal by Subject|2|||
24986383|NCT03575572|50075138|FG000|Overall Study|Physician Decision|2|||
24986384|NCT03116698|50075164|FG000|Overall Study|Adverse Event|1|||
24986385|NCT03116698|50075165|FG001|Overall Study|Adverse Event|1|||
24986386|NCT03116698|50075166|FG002|Overall Study|Adverse Event|1|||
24986387|NCT03116698|50075167|FG003|Overall Study|Adverse Event|0|||
24986388|NCT03116698|50075164|FG000|Overall Study|Withdrawal by Subject|1|||
24986389|NCT03116698|50075165|FG001|Overall Study|Withdrawal by Subject|4|||
24986390|NCT03116698|50075166|FG002|Overall Study|Withdrawal by Subject|5|||
24986391|NCT03116698|50075167|FG003|Overall Study|Withdrawal by Subject|2|||
24986392|NCT03116698|50075164|FG000|Overall Study|Lost to Follow-up|2|||
24986393|NCT03116698|50075165|FG001|Overall Study|Lost to Follow-up|0|||
24986394|NCT03116698|50075166|FG002|Overall Study|Lost to Follow-up|0|||
24986395|NCT03116698|50075167|FG003|Overall Study|Lost to Follow-up|0|||
24986396|NCT03116698|50075164|FG000|Overall Study|Physician Decision|1|||
24986397|NCT03116698|50075165|FG001|Overall Study|Physician Decision|1|||
24986398|NCT03116698|50075166|FG002|Overall Study|Physician Decision|0|||
24986399|NCT03116698|50075167|FG003|Overall Study|Physician Decision|0|||
24986400|NCT03116698|50075164|FG000|Overall Study|Protocol Violation|1|||
24986401|NCT03116698|50075165|FG001|Overall Study|Protocol Violation|0|||
24986402|NCT03116698|50075166|FG002|Overall Study|Protocol Violation|0|||
24986403|NCT03116698|50075167|FG003|Overall Study|Protocol Violation|0|||
24986404|NCT03116698|50075164|FG000|Overall Study|Death|0|||
24986405|NCT03116698|50075165|FG001|Overall Study|Death|0|||
24986406|NCT03116698|50075166|FG002|Overall Study|Death|2|||
24986407|NCT03116698|50075167|FG003|Overall Study|Death|0|||
24986408|NCT03116152|50075179|FG000|Overall Study|Disease Progression|49|||
24986409|NCT03116152|50075180|FG001|Overall Study|Disease Progression|47|||
24986410|NCT03116152|50075179|FG000|Overall Study|Death|5|||
24986411|NCT03116152|50075180|FG001|Overall Study|Death|2|||
24986412|NCT03116152|50075179|FG000|Overall Study|Adverse Event|21|||
24986413|NCT03116152|50075180|FG001|Overall Study|Adverse Event|7|||
24986414|NCT03116152|50075179|FG000|Overall Study|Protocol Violation|2|||
24986415|NCT03116152|50075180|FG001|Overall Study|Protocol Violation|2|||
24986416|NCT03116152|50075179|FG000|Overall Study|Withdrawal by Subject|0|||
24986417|NCT03116152|50075180|FG001|Overall Study|Withdrawal by Subject|1|||
24986418|NCT03116152|50075179|FG000|Overall Study|Physician Decision|3|||
24986419|NCT03116152|50075180|FG001|Overall Study|Physician Decision|2|||
24986420|NCT03116152|50075179|FG000|Overall Study|other|11|||
24986421|NCT03116152|50075180|FG001|Overall Study|other|34|||
24986422|NCT00226499|50075191|FG000|Overall Study|Adverse Event|10|||
24986423|NCT00226499|50075192|FG001|Overall Study|Adverse Event|6|||
24986424|NCT00226499|50075193|FG002|Overall Study|Adverse Event|3|||
24986425|NCT00226499|50075191|FG000|Overall Study|Others|1064|||
24986426|NCT00226499|50075192|FG001|Overall Study|Others|1066|||
24986427|NCT00226499|50075193|FG002|Overall Study|Others|356|||
24986428|NCT01400776|50075207|FG000|Overall Study|Adverse Event|7|||
24986429|NCT01400776|50075208|FG001|Overall Study|Adverse Event|2|||
24986430|NCT01400776|50075209|FG002|Overall Study|Adverse Event|9|||
24986431|NCT01400776|50075210|FG003|Overall Study|Adverse Event|2|||
24986432|NCT01400776|50075207|FG000|Overall Study|Lost to Follow-up|1|||
24986433|NCT01400776|50075208|FG001|Overall Study|Lost to Follow-up|0|||
24986434|NCT01400776|50075209|FG002|Overall Study|Lost to Follow-up|4|||
24986435|NCT01400776|50075210|FG003|Overall Study|Lost to Follow-up|1|||
24986436|NCT01400776|50075207|FG000|Overall Study|Withdrew Consent|4|||
24986437|NCT01400776|50075208|FG001|Overall Study|Withdrew Consent|2|||
24986438|NCT01400776|50075209|FG002|Overall Study|Withdrew Consent|6|||
24986439|NCT01400776|50075210|FG003|Overall Study|Withdrew Consent|1|||
24986440|NCT01400776|50075207|FG000|Overall Study|Protocol Deviation|6|||
24986441|NCT01400776|50075208|FG001|Overall Study|Protocol Deviation|1|||
24986442|NCT01400776|50075209|FG002|Overall Study|Protocol Deviation|5|||
24986443|NCT01400776|50075210|FG003|Overall Study|Protocol Deviation|2|||
24986444|NCT01400776|50075207|FG000|Overall Study|Reason not Specified|3|||
24986445|NCT01400776|50075208|FG001|Overall Study|Reason not Specified|0|||
24986446|NCT01400776|50075209|FG002|Overall Study|Reason not Specified|4|||
24986447|NCT01400776|50075210|FG003|Overall Study|Reason not Specified|3|||
24986448|NCT03131596|50075222|FG000|Overall Study|Protocol Violation|3|||
24986449|NCT03131596|50075223|FG001|Overall Study|Protocol Violation|3|||
24986450|NCT03131596|50075222|FG000|Overall Study|Lost to Follow-up|3|||
24986451|NCT03131596|50075223|FG001|Overall Study|Lost to Follow-up|0|||
24986452|NCT00255047|50075237|FG000|Overall Study|Serious Adverse Events|2|||
24986453|NCT00255047|50075238|FG001|Overall Study|Serious Adverse Events|1|||
24986454|NCT00255047|50075239|FG002|Overall Study|Serious Adverse Events|2|||
24986455|NCT00255047|50075240|FG003|Overall Study|Serious Adverse Events|1|||
24986456|NCT00255047|50075237|FG000|Overall Study|Adverse Event|0|||
24986457|NCT00255047|50075238|FG001|Overall Study|Adverse Event|3|||
24986458|NCT00255047|50075239|FG002|Overall Study|Adverse Event|2|||
24986459|NCT00255047|50075240|FG003|Overall Study|Adverse Event|1|||
24986460|NCT00255047|50075237|FG000|Overall Study|Protocol Violation|13|||
24986461|NCT00255047|50075238|FG001|Overall Study|Protocol Violation|13|||
24986462|NCT00255047|50075239|FG002|Overall Study|Protocol Violation|16|||
24986463|NCT00255047|50075240|FG003|Overall Study|Protocol Violation|20|||
24986464|NCT00255047|50075237|FG000|Overall Study|Lost to Follow-up|9|||
24986465|NCT00255047|50075238|FG001|Overall Study|Lost to Follow-up|8|||
24986466|NCT00255047|50075239|FG002|Overall Study|Lost to Follow-up|5|||
24986467|NCT00255047|50075240|FG003|Overall Study|Lost to Follow-up|6|||
24986468|NCT00255047|50075237|FG000|Overall Study|Withdrawal by Subject|24|||
24986469|NCT00255047|50075238|FG001|Overall Study|Withdrawal by Subject|23|||
24986470|NCT00255047|50075239|FG002|Overall Study|Withdrawal by Subject|25|||
24986471|NCT00255047|50075240|FG003|Overall Study|Withdrawal by Subject|18|||
24986472|NCT00225251|50075252|FG000|Overall Study|Withdrawal by Subject|1|||
24986473|NCT00225251|50075253|FG001|Overall Study|Withdrawal by Subject|1|||
24986474|NCT00254501|50075261|FG000|Overall Study|Lost to Follow-up|1|||
24986475|NCT00254501|50075262|FG001|Overall Study|Lost to Follow-up|1|||
24986476|NCT00253643|50075274|FG000|Overall Study|Withdrawal by Subject|0|||
24986477|NCT00253643|50075275|FG001|Overall Study|Withdrawal by Subject|0|||
24986478|NCT00253643|50075276|FG002|Overall Study|Withdrawal by Subject|1|||
24986479|NCT00253643|50075277|FG003|Overall Study|Withdrawal by Subject|1|||
24986480|NCT00253643|50075274|FG000|Overall Study|Non-Compliance|0|||
24986481|NCT00253643|50075275|FG001|Overall Study|Non-Compliance|0|||
24986482|NCT00253643|50075276|FG002|Overall Study|Non-Compliance|0|||
24986483|NCT00253643|50075277|FG003|Overall Study|Non-Compliance|2|||
24986484|NCT00221195|50075289|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
24986485|NCT00221195|50075290|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
24986486|NCT00221195|50075289|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
24986487|NCT00221195|50075290|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
24986488|NCT00221195|50075289|FG000|Washout Period (Months 7-9)|Death|0|||
24986489|NCT00221195|50075290|FG001|Washout Period (Months 7-9)|Death|1|||
24986490|NCT00221195|50075289|FG000|Therapy 2 (Months 10-15)|Death|1|||
24986491|NCT00221195|50075290|FG001|Therapy 2 (Months 10-15)|Death|0|||
24986492|NCT00221195|50075289|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
24986493|NCT00221195|50075290|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
24986494|NCT00220805|50075299|FG000|Overall Study|Adverse Event|1|||
24986495|NCT00220805|50075300|FG001|Overall Study|Adverse Event|3|||
24986496|NCT00220805|50075299|FG000|Overall Study|Withdrawal by Subject|3|||
24986497|NCT00220805|50075300|FG001|Overall Study|Withdrawal by Subject|0|||
24986498|NCT00220805|50075299|FG000|Overall Study|Lack of Efficacy|1|||
24986499|NCT00220805|50075300|FG001|Overall Study|Lack of Efficacy|0|||
24986500|NCT00220805|50075299|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
24986501|NCT00220805|50075300|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
24986502|NCT00220727|50075308|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
24986503|NCT00220727|50075309|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
24986504|NCT04495816|50075319|FG000|Overall Study|Lost to Follow-up|10|||
24986505|NCT04495816|50075320|FG001|Overall Study|Lost to Follow-up|4|||
24986506|NCT04495816|50075319|FG000|Overall Study|Withdrawal by Subject|3|||
24986507|NCT04495816|50075320|FG001|Overall Study|Withdrawal by Subject|5|||
24986508|NCT03971357|50075328|FG000|Overall Study|Lack of Efficacy|0|||
24986509|NCT03971357|50075329|FG001|Overall Study|Lack of Efficacy|1|||
24986510|NCT04310566|50075335|FG000|Period 1|Study Termination due to COVID-19|15|||
24986511|NCT04310566|50075336|FG001|Period 1|Study Termination due to COVID-19|17|||
24986512|NCT04310566|50075335|FG000|Period 1|Protocol Violation|0|||
24986513|NCT04310566|50075336|FG001|Period 1|Protocol Violation|1|||
24986514|NCT04310566|50075335|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
24986515|NCT04310566|50075336|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
24986516|NCT04310566|50075335|FG000|Period 1|Lost to Follow-up|1|||
24986517|NCT04310566|50075336|FG001|Period 1|Lost to Follow-up|0|||
24986518|NCT04310566|50075335|FG000|Period 1|Withdrawal by Subject|0|||
24986519|NCT04310566|50075336|FG001|Period 1|Withdrawal by Subject|1|||
24986520|NCT04310566|50075335|FG000|Period 2|Study Termination|7|||
24986521|NCT04310566|50075336|FG001|Period 2|Study Termination|5|||
24986522|NCT00252239|50075346|FG000|Overall Study|Withdrawal by Subject|1|||
24986523|NCT00252239|50075347|FG001|Overall Study|Withdrawal by Subject|0|||
24986524|NCT00252239|50075348|FG002|Overall Study|Withdrawal by Subject|0|||
24986525|NCT00252239|50075349|FG003|Overall Study|Withdrawal by Subject|1|||
24986526|NCT00252239|50075346|FG000|Overall Study|Lost to Follow-up|0|||
24986527|NCT00252239|50075347|FG001|Overall Study|Lost to Follow-up|0|||
24986528|NCT00252239|50075348|FG002|Overall Study|Lost to Follow-up|2|||
24986529|NCT00252239|50075349|FG003|Overall Study|Lost to Follow-up|0|||
24986530|NCT03103906|50075361|FG000|Overall Study|Adverse Event|2|||
24986531|NCT03103906|50075362|FG001|Overall Study|Adverse Event|3|||
24986532|NCT03103906|50075361|FG000|Overall Study|Other|2|||
24986533|NCT03103906|50075362|FG001|Overall Study|Other|0|||
24986534|NCT04799158|50075372|FG000|Run-In Period|Adverse Event|6|||
24986535|NCT04799158|50075373|FG001|Run-In Period|Adverse Event|0|||
24986536|NCT04799158|50075374|FG002|Run-In Period|Adverse Event|0|||
24986537|NCT04799158|50075375|FG003|Run-In Period|Adverse Event|0|||
24986538|NCT04799158|50075376|FG004|Run-In Period|Adverse Event|0|||
24986539|NCT04799158|50075372|FG000|Run-In Period|Lost to Follow-up|4|||
24986540|NCT04799158|50075373|FG001|Run-In Period|Lost to Follow-up|0|||
24986541|NCT04799158|50075374|FG002|Run-In Period|Lost to Follow-up|0|||
24986542|NCT04799158|50075375|FG003|Run-In Period|Lost to Follow-up|0|||
24986543|NCT04799158|50075376|FG004|Run-In Period|Lost to Follow-up|0|||
24986544|NCT04799158|50075372|FG000|Run-In Period|Significant Protocol Deviation|1|||
24986545|NCT04799158|50075373|FG001|Run-In Period|Significant Protocol Deviation|0|||
24986546|NCT04799158|50075374|FG002|Run-In Period|Significant Protocol Deviation|0|||
24986547|NCT04799158|50075375|FG003|Run-In Period|Significant Protocol Deviation|0|||
24986548|NCT04799158|50075376|FG004|Run-In Period|Significant Protocol Deviation|0|||
24986549|NCT04799158|50075372|FG000|Run-In Period|Withdrawal by Subject|11|||
24986550|NCT04799158|50075373|FG001|Run-In Period|Withdrawal by Subject|0|||
24986551|NCT04799158|50075374|FG002|Run-In Period|Withdrawal by Subject|0|||
24986552|NCT04799158|50075375|FG003|Run-In Period|Withdrawal by Subject|0|||
24986553|NCT04799158|50075376|FG004|Run-In Period|Withdrawal by Subject|0|||
24986554|NCT04799158|50075372|FG000|Run-In Period|Miscellaneous|3|||
24986555|NCT04799158|50075373|FG001|Run-In Period|Miscellaneous|0|||
24986556|NCT04799158|50075374|FG002|Run-In Period|Miscellaneous|0|||
24986557|NCT04799158|50075375|FG003|Run-In Period|Miscellaneous|0|||
25079430|NCT01865617|50187889|FG003|Overall Study|Patient proceeded to new therapy|0|||
25079431|NCT01865617|50187890|FG004|Overall Study|Patient proceeded to new therapy|2|||
24986558|NCT04799158|50075376|FG004|Run-In Period|Miscellaneous|0|||
24986559|NCT04799158|50075372|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
24986560|NCT04799158|50075373|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
24986561|NCT04799158|50075374|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
24986562|NCT04799158|50075375|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
24986563|NCT04799158|50075376|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
24986564|NCT04799158|50075372|FG000|On-Demand Treatment Period|Adverse Event|0|||
24986565|NCT04799158|50075373|FG001|On-Demand Treatment Period|Adverse Event|1|||
24986566|NCT04799158|50075374|FG002|On-Demand Treatment Period|Adverse Event|0|||
24986567|NCT04799158|50075375|FG003|On-Demand Treatment Period|Adverse Event|0|||
24986568|NCT04799158|50075376|FG004|On-Demand Treatment Period|Adverse Event|1|||
24986569|NCT04799158|50075372|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
24986570|NCT04799158|50075373|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
24986571|NCT04799158|50075374|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
24986572|NCT04799158|50075375|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
24986573|NCT04799158|50075376|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
24986574|NCT04799158|50075372|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
24986575|NCT04799158|50075373|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
24986576|NCT04799158|50075374|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
24986577|NCT04799158|50075375|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
24986578|NCT04799158|50075376|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
24986579|NCT04799158|50075372|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
24986580|NCT04799158|50075373|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
24986581|NCT04799158|50075374|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
24986582|NCT04799158|50075375|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
24986583|NCT04799158|50075376|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
24986584|NCT04799158|50075372|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
24986585|NCT04799158|50075373|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
24986586|NCT04799158|50075374|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
24986587|NCT04799158|50075375|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
24986588|NCT04799158|50075376|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
24986589|NCT04799158|50075372|FG000|On-Demand Treatment Period|Miscellaneous|0|||
24986590|NCT04799158|50075373|FG001|On-Demand Treatment Period|Miscellaneous|0|||
24986591|NCT04799158|50075374|FG002|On-Demand Treatment Period|Miscellaneous|0|||
24986592|NCT04799158|50075375|FG003|On-Demand Treatment Period|Miscellaneous|0|||
24986593|NCT04799158|50075376|FG004|On-Demand Treatment Period|Miscellaneous|1|||
24986594|NCT01319422|50075389|FG000|Overall Study|Withdrawal by Subject|1|||
24986595|NCT01319422|50075390|FG001|Overall Study|Withdrawal by Subject|0|||
24986596|NCT03102034|50075398|FG000|Overall Study|Withdrawal by Subject|1|||
24986597|NCT03102034|50075399|FG001|Overall Study|Withdrawal by Subject|0|||
24986598|NCT03774576|50075405|FG000|Period 2|Adverse Event|1|||
24986599|NCT02928952|50075416|FG000|Overall Study|Lost to Follow-up|5|||
24986600|NCT02928952|50075417|FG001|Overall Study|Lost to Follow-up|5|||
24986601|NCT02928952|50075416|FG000|Overall Study|Withdrawal by Subject|5|||
24986602|NCT02928952|50075417|FG001|Overall Study|Withdrawal by Subject|1|||
24986603|NCT02928952|50075416|FG000|Overall Study|Physician Decision|0|||
24986604|NCT02928952|50075417|FG001|Overall Study|Physician Decision|1|||
24986605|NCT03773796|50075423|FG000|Overall Study|Adverse Event|1|||
24986606|NCT03773796|50075423|FG000|Overall Study|Withdrawal by Subject|1|||
24986607|NCT03773796|50075423|FG000|Overall Study|Lack of Efficacy|1|||
24986608|NCT02927938|50075431|FG000|Overall Study|Death|0|||
24986609|NCT02927938|50075432|FG001|Overall Study|Death|1|||
24986610|NCT02927938|50075433|FG002|Overall Study|Death|0|||
24986611|NCT02927938|50075434|FG003|Overall Study|Death|4|||
24986612|NCT02927938|50075431|FG000|Overall Study|Early Study Termination|1|||
24986613|NCT02927938|50075432|FG001|Overall Study|Early Study Termination|5|||
24986614|NCT02927938|50075433|FG002|Overall Study|Early Study Termination|4|||
24986615|NCT02927938|50075434|FG003|Overall Study|Early Study Termination|3|||
24986616|NCT03765138|50075442|FG000|Overall Study|Lost to Follow-up|1|||
24986617|NCT03768726|50075449|FG000|Treatment Phase|Adverse Event|2|||
24986618|NCT03768726|50075450|FG001|Treatment Phase|Adverse Event|2|||
24986619|NCT03768726|50075449|FG000|Treatment Phase|Lost to Follow-up|1|||
24986620|NCT03768726|50075450|FG001|Treatment Phase|Lost to Follow-up|0|||
24986621|NCT03768726|50075449|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
24986622|NCT03768726|50075450|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
24986623|NCT03768726|50075449|FG000|Treatment Phase|Withdrawal by Subject|3|||
24986624|NCT03768726|50075450|FG001|Treatment Phase|Withdrawal by Subject|1|||
24986625|NCT03768726|50075449|FG000|Follow-Up|Adverse Event|2|||
24986626|NCT03768726|50075450|FG001|Follow-Up|Adverse Event|2|||
24986627|NCT03768726|50075449|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
24986628|NCT03768726|50075450|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
24986629|NCT03768726|50075449|FG000|Follow-Up|Withdrawal by Subject|2|||
24986630|NCT03768726|50075450|FG001|Follow-Up|Withdrawal by Subject|0|||
24986631|NCT03768726|50075449|FG000|Follow-Up|Other|1|||
24986632|NCT03768726|50075450|FG001|Follow-Up|Other|0|||
24986633|NCT03769896|50075458|FG000|Open-label Phase|Lack of Efficacy|5|||
24986634|NCT03769896|50075459|FG001|Open-label Phase|Lack of Efficacy|0|||
24986635|NCT03769896|50075458|FG000|Open-label Phase|Adverse Event|3|||
24986636|NCT03769896|50075459|FG001|Open-label Phase|Adverse Event|0|||
24986637|NCT03769896|50075458|FG000|Open-label Phase|Withdrawal by Subject|1|||
24986638|NCT03769896|50075459|FG001|Open-label Phase|Withdrawal by Subject|0|||
24986639|NCT05047601|50075469|FG000|Overall Study|Lost to Follow-up|9|||
24986640|NCT05047601|50075470|FG001|Overall Study|Lost to Follow-up|11|||
25079432|NCT01865617|50187891|FG005|Overall Study|Patient proceeded to new therapy|0|||
24986641|NCT05047601|50075471|FG002|Overall Study|Lost to Follow-up|7|||
24986642|NCT05047601|50075469|FG000|Overall Study|Withdrawal by Subject|25|||
24986643|NCT05047601|50075470|FG001|Overall Study|Withdrawal by Subject|36|||
24986644|NCT05047601|50075471|FG002|Overall Study|Withdrawal by Subject|23|||
24986645|NCT05047601|50075469|FG000|Overall Study|Other|10|||
24986646|NCT05047601|50075470|FG001|Overall Study|Other|6|||
24986647|NCT05047601|50075471|FG002|Overall Study|Other|5|||
24986648|NCT04658784|50075485|FG000|6-month Follow-up|Lost to Follow-up|2|||
24986649|NCT04658784|50075486|FG001|6-month Follow-up|Lost to Follow-up|5|||
24986650|NCT04606394|50075492|FG000|Overall Study|Withdrawal by Subject|3|||
24986651|NCT04606394|50075492|FG000|Overall Study|Exclusion criteria screen failure|12|||
24986652|NCT04585451|50075506|FG000|Overall Study|Withdrawal by Subject|26|||
24986653|NCT04585451|50075507|FG001|Overall Study|Withdrawal by Subject|0|||
24986654|NCT04325828|50075580|FG000|Overall Study|Ongoing|26|||
24986655|NCT04181788|50075606|FG000|TREATMENT|Adverse Event|0|||
24986656|NCT04181788|50075607|FG001|TREATMENT|Adverse Event|2|||
24986657|NCT04181788|50075608|FG002|TREATMENT|Adverse Event|1|||
24986658|NCT04181788|50075609|FG003|TREATMENT|Adverse Event|0|||
24986659|NCT04181788|50075610|FG004|TREATMENT|Adverse Event|1|||
24986660|NCT04181788|50075611|FG005|TREATMENT|Adverse Event|3|||
24986661|NCT04181788|50075606|FG000|TREATMENT|Death|0|||
24986662|NCT04181788|50075607|FG001|TREATMENT|Death|0|||
24986663|NCT04181788|50075608|FG002|TREATMENT|Death|0|||
24986664|NCT04181788|50075609|FG003|TREATMENT|Death|0|||
24986665|NCT04181788|50075610|FG004|TREATMENT|Death|8|||
24986666|NCT04181788|50075611|FG005|TREATMENT|Death|8|||
24986667|NCT04181788|50075606|FG000|TREATMENT|Physician Decision|0|||
24986668|NCT04181788|50075607|FG001|TREATMENT|Physician Decision|0|||
24986669|NCT04181788|50075608|FG002|TREATMENT|Physician Decision|0|||
24986670|NCT04181788|50075609|FG003|TREATMENT|Physician Decision|0|||
24986671|NCT04181788|50075610|FG004|TREATMENT|Physician Decision|0|||
24986672|NCT04181788|50075611|FG005|TREATMENT|Physician Decision|1|||
24986673|NCT04181788|50075606|FG000|TREATMENT|Progressive disease|3|||
24986674|NCT04181788|50075607|FG001|TREATMENT|Progressive disease|3|||
24986675|NCT04181788|50075608|FG002|TREATMENT|Progressive disease|5|||
24986676|NCT04181788|50075609|FG003|TREATMENT|Progressive disease|7|||
24986677|NCT04181788|50075610|FG004|TREATMENT|Progressive disease|20|||
24986678|NCT04181788|50075611|FG005|TREATMENT|Progressive disease|38|||
24986679|NCT04181788|50075606|FG000|TREATMENT|Global deterioration of health status|0|||
24986680|NCT04181788|50075607|FG001|TREATMENT|Global deterioration of health status|2|||
24986681|NCT04181788|50075608|FG002|TREATMENT|Global deterioration of health status|0|||
24986682|NCT04181788|50075609|FG003|TREATMENT|Global deterioration of health status|0|||
24986683|NCT04181788|50075610|FG004|TREATMENT|Global deterioration of health status|2|||
24986684|NCT04181788|50075611|FG005|TREATMENT|Global deterioration of health status|8|||
24986685|NCT04181788|50075606|FG000|TREATMENT|Withdrawal by Subject|1|||
24986686|NCT04181788|50075607|FG001|TREATMENT|Withdrawal by Subject|2|||
24986687|NCT04181788|50075608|FG002|TREATMENT|Withdrawal by Subject|0|||
24986688|NCT04181788|50075609|FG003|TREATMENT|Withdrawal by Subject|0|||
24986689|NCT04181788|50075610|FG004|TREATMENT|Withdrawal by Subject|3|||
24986690|NCT04181788|50075611|FG005|TREATMENT|Withdrawal by Subject|5|||
24986691|NCT04181788|50075606|FG000|TREATMENT|Other unspecified|0|||
24986692|NCT04181788|50075607|FG001|TREATMENT|Other unspecified|0|||
24986693|NCT04181788|50075608|FG002|TREATMENT|Other unspecified|0|||
24986694|NCT04181788|50075609|FG003|TREATMENT|Other unspecified|0|||
24986695|NCT04181788|50075610|FG004|TREATMENT|Other unspecified|0|||
24986696|NCT04181788|50075611|FG005|TREATMENT|Other unspecified|2|||
24986697|NCT04181788|50075606|FG000|TREATMENT|Ongoing|0|||
24986698|NCT04181788|50075607|FG001|TREATMENT|Ongoing|3|||
24986699|NCT04181788|50075608|FG002|TREATMENT|Ongoing|0|||
24986700|NCT04181788|50075609|FG003|TREATMENT|Ongoing|5|||
24986701|NCT04181788|50075610|FG004|TREATMENT|Ongoing|7|||
24986702|NCT04181788|50075611|FG005|TREATMENT|Ongoing|15|||
24986703|NCT04181788|50075606|FG000|FOLLOW-UP|Death|0|||
24986704|NCT04181788|50075607|FG001|FOLLOW-UP|Death|0|||
24986705|NCT04181788|50075608|FG002|FOLLOW-UP|Death|1|||
24986706|NCT04181788|50075609|FG003|FOLLOW-UP|Death|2|||
24986707|NCT04181788|50075610|FG004|FOLLOW-UP|Death|8|||
24986708|NCT04181788|50075611|FG005|FOLLOW-UP|Death|20|||
24986709|NCT04181788|50075606|FG000|FOLLOW-UP|Lost to Follow-up|0|||
24986710|NCT04181788|50075607|FG001|FOLLOW-UP|Lost to Follow-up|0|||
24986711|NCT04181788|50075608|FG002|FOLLOW-UP|Lost to Follow-up|0|||
24986712|NCT04181788|50075609|FG003|FOLLOW-UP|Lost to Follow-up|0|||
24986713|NCT04181788|50075610|FG004|FOLLOW-UP|Lost to Follow-up|0|||
24986714|NCT04181788|50075611|FG005|FOLLOW-UP|Lost to Follow-up|2|||
24986715|NCT04181788|50075606|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
24986716|NCT04181788|50075607|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
24986717|NCT04181788|50075608|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
24986718|NCT04181788|50075609|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
24986719|NCT04181788|50075610|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
24986720|NCT04181788|50075611|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
24986721|NCT04181788|50075606|FG000|FOLLOW-UP|Other unspecified|0|||
24986722|NCT04181788|50075607|FG001|FOLLOW-UP|Other unspecified|1|||
24986723|NCT04181788|50075608|FG002|FOLLOW-UP|Other unspecified|0|||
24986724|NCT04181788|50075609|FG003|FOLLOW-UP|Other unspecified|0|||
24986725|NCT04181788|50075610|FG004|FOLLOW-UP|Other unspecified|0|||
24986726|NCT04181788|50075611|FG005|FOLLOW-UP|Other unspecified|3|||
24986727|NCT04181788|50075606|FG000|FOLLOW-UP|Ongoing|0|||
24986728|NCT04181788|50075607|FG001|FOLLOW-UP|Ongoing|0|||
24986729|NCT04181788|50075608|FG002|FOLLOW-UP|Ongoing|1|||
24986730|NCT04181788|50075609|FG003|FOLLOW-UP|Ongoing|3|||
24986731|NCT04181788|50075610|FG004|FOLLOW-UP|Ongoing|2|||
24986732|NCT04181788|50075611|FG005|FOLLOW-UP|Ongoing|2|||
24986733|NCT04120194|50075634|FG000|Overall Study|Lost to Follow-up|11|||
24986734|NCT04120194|50075635|FG001|Overall Study|Lost to Follow-up|8|||
24986735|NCT04120194|50075634|FG000|Overall Study|Adverse Event|4|||
24986736|NCT04120194|50075635|FG001|Overall Study|Adverse Event|5|||
24986737|NCT04120194|50075634|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
24986738|NCT04120194|50075635|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
24986739|NCT04120194|50075634|FG000|Overall Study|Miscellaneous|4|||
24986740|NCT04120194|50075635|FG001|Overall Study|Miscellaneous|5|||
24986741|NCT04050670|50075641|FG000|Period 3|Physician Decision|0|||
24986742|NCT04050670|50075642|FG001|Period 3|Physician Decision|1|||
24986743|NCT04050670|50075643|FG002|Period 3|Physician Decision|0|||
24986744|NCT04016714|50075666|FG000|Overall Study|Death|1|||
24986745|NCT04016714|50075667|FG001|Overall Study|Death|0|||
24986746|NCT04016714|50075666|FG000|Overall Study|Lost to Follow-up|3|||
24986747|NCT04016714|50075667|FG001|Overall Study|Lost to Follow-up|1|||
24986748|NCT04016714|50075666|FG000|Overall Study|Physician Decision|3|||
24986749|NCT04016714|50075667|FG001|Overall Study|Physician Decision|3|||
24986750|NCT04016714|50075666|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
24986751|NCT04016714|50075667|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
24986752|NCT03997409|50075676|FG000|Overall Study|Protocol Violation|1|||
24986753|NCT03997409|50075677|FG001|Overall Study|Protocol Violation|1|||
24986754|NCT03997409|50075678|FG002|Overall Study|Protocol Violation|0|||
24986755|NCT03997409|50075676|FG000|Overall Study|Withdrawal by Subject|3|||
24986756|NCT03997409|50075677|FG001|Overall Study|Withdrawal by Subject|0|||
24986757|NCT03997409|50075678|FG002|Overall Study|Withdrawal by Subject|0|||
24986758|NCT03997409|50075676|FG000|Overall Study|Lost to Follow-up|0|||
24986759|NCT03997409|50075677|FG001|Overall Study|Lost to Follow-up|0|||
24986760|NCT03997409|50075678|FG002|Overall Study|Lost to Follow-up|1|||
24986761|NCT03946124|50075686|FG000|Overall Study|Withdrawal by Subject|19|||
24986762|NCT03812029|50075695|FG000|Overall Study|Protocol Violation|1|||
24986763|NCT03812029|50075696|FG001|Overall Study|Protocol Violation|0|||
24986764|NCT03812029|50075697|FG002|Overall Study|Protocol Violation|0|||
24986765|NCT03812029|50075698|FG003|Overall Study|Protocol Violation|1|||
24986766|NCT03812029|50075699|FG004|Overall Study|Protocol Violation|0|||
24986767|NCT03812029|50075695|FG000|Overall Study|Withdrawal by Subject|1|||
24986768|NCT03812029|50075696|FG001|Overall Study|Withdrawal by Subject|0|||
24986769|NCT03812029|50075697|FG002|Overall Study|Withdrawal by Subject|0|||
24986770|NCT03812029|50075698|FG003|Overall Study|Withdrawal by Subject|2|||
24986771|NCT03812029|50075699|FG004|Overall Study|Withdrawal by Subject|2|||
24986772|NCT03812029|50075695|FG000|Overall Study|Stopping rules|0|||
24986773|NCT03812029|50075696|FG001|Overall Study|Stopping rules|1|||
24986774|NCT03812029|50075697|FG002|Overall Study|Stopping rules|0|||
24986775|NCT03812029|50075698|FG003|Overall Study|Stopping rules|0|||
24986776|NCT03812029|50075699|FG004|Overall Study|Stopping rules|0|||
24986777|NCT03812029|50075695|FG000|Overall Study|Adverse Event|0|||
24986778|NCT03812029|50075696|FG001|Overall Study|Adverse Event|9|||
24986779|NCT03812029|50075697|FG002|Overall Study|Adverse Event|0|||
24986780|NCT03812029|50075698|FG003|Overall Study|Adverse Event|3|||
24986781|NCT03812029|50075699|FG004|Overall Study|Adverse Event|5|||
24986782|NCT03812029|50075695|FG000|Overall Study|Lost to Follow-up|0|||
24986783|NCT03812029|50075696|FG001|Overall Study|Lost to Follow-up|0|||
24986784|NCT03812029|50075697|FG002|Overall Study|Lost to Follow-up|0|||
24986785|NCT03812029|50075698|FG003|Overall Study|Lost to Follow-up|0|||
24986786|NCT03812029|50075699|FG004|Overall Study|Lost to Follow-up|3|||
24986787|NCT03747575|50075717|FG000|Overall Study|Withdrawal by Subject|6|||
24986788|NCT03747575|50075718|FG001|Overall Study|Withdrawal by Subject|3|||
24986789|NCT03747575|50075717|FG000|Overall Study|Lost to Follow-up|3|||
24986790|NCT03747575|50075718|FG001|Overall Study|Lost to Follow-up|3|||
24986791|NCT03747575|50075717|FG000|Overall Study|Adverse Event|0|||
24986792|NCT03747575|50075718|FG001|Overall Study|Adverse Event|1|||
24986793|NCT03657043|50075727|FG000|Overall Study|Withdrawal by Subject|1|||
24986794|NCT03657043|50075728|FG001|Overall Study|Withdrawal by Subject|1|||
24986795|NCT03657043|50075729|FG002|Overall Study|Withdrawal by Subject|0|||
25257196|NCT01324388|50572241|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
25257197|NCT01324388|50572238|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
25257198|NCT01324388|50572239|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
24986796|NCT03657043|50075730|FG003|Overall Study|Withdrawal by Subject|0|||
24986797|NCT03657043|50075731|FG004|Overall Study|Withdrawal by Subject|4|||
24986798|NCT03657043|50075727|FG000|Overall Study|Study closure by Sponsor|0|||
24986799|NCT03657043|50075728|FG001|Overall Study|Study closure by Sponsor|2|||
24986800|NCT03657043|50075729|FG002|Overall Study|Study closure by Sponsor|0|||
24986801|NCT03657043|50075730|FG003|Overall Study|Study closure by Sponsor|0|||
24986802|NCT03657043|50075731|FG004|Overall Study|Study closure by Sponsor|17|||
24986803|NCT03657043|50075727|FG000|Overall Study|Lost to Follow-up|0|||
24986804|NCT03657043|50075728|FG001|Overall Study|Lost to Follow-up|0|||
24986805|NCT03657043|50075729|FG002|Overall Study|Lost to Follow-up|0|||
24986806|NCT03657043|50075730|FG003|Overall Study|Lost to Follow-up|0|||
24986807|NCT03657043|50075731|FG004|Overall Study|Lost to Follow-up|4|||
24986808|NCT03657043|50075727|FG000|Overall Study|Death|6|||
24986809|NCT03657043|50075728|FG001|Overall Study|Death|5|||
24986810|NCT03657043|50075729|FG002|Overall Study|Death|0|||
24986811|NCT03657043|50075730|FG003|Overall Study|Death|0|||
24986812|NCT03657043|50075731|FG004|Overall Study|Death|53|||
24986813|NCT03657043|50075727|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
24986814|NCT03657043|50075728|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
24986815|NCT03657043|50075729|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
24986816|NCT03657043|50075730|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
24986817|NCT03657043|50075731|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
24986818|NCT03657043|50075727|FG000|Overall Study|Adverse Event|0|||
24986819|NCT03657043|50075728|FG001|Overall Study|Adverse Event|0|||
24986820|NCT03657043|50075729|FG002|Overall Study|Adverse Event|0|||
24986821|NCT03657043|50075730|FG003|Overall Study|Adverse Event|0|||
24986822|NCT03657043|50075731|FG004|Overall Study|Adverse Event|2|||
24986823|NCT03657043|50075727|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
24986824|NCT03657043|50075728|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
24986825|NCT03657043|50075729|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
24986826|NCT03657043|50075730|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
24986827|NCT03657043|50075731|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
24986828|NCT03657043|50075727|FG000|Overall Study|Withdrawal - declined follow-up|0|||
24986829|NCT03657043|50075728|FG001|Overall Study|Withdrawal - declined follow-up|0|||
24986830|NCT03657043|50075729|FG002|Overall Study|Withdrawal - declined follow-up|0|||
24986831|NCT03657043|50075730|FG003|Overall Study|Withdrawal - declined follow-up|0|||
24986832|NCT03657043|50075731|FG004|Overall Study|Withdrawal - declined follow-up|1|||
24986833|NCT03646669|50075741|FG000|Overall Study|Withdrawal by Subject|5|||
24986834|NCT03646669|50075742|FG001|Overall Study|Withdrawal by Subject|0|||
24986835|NCT03631706|50075750|FG000|Overall Study|Randomized, not treated|1|||
24986836|NCT03631706|50075751|FG001|Overall Study|Randomized, not treated|0|||
24986837|NCT03631706|50075750|FG000|Overall Study|Treatment ongoing|26|||
24986838|NCT03631706|50075751|FG001|Overall Study|Treatment ongoing|57|||
24986839|NCT03631706|50075750|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
24986840|NCT03631706|50075751|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
24986841|NCT03619876|50075759|FG000|Overall Study|Withdrawal by Subject|1|||
24986842|NCT03619876|50075760|FG001|Overall Study|Withdrawal by Subject|2|||
24986843|NCT03619876|50075759|FG000|Overall Study|Withdrawal due to incidental finding|0|||
24986844|NCT03619876|50075760|FG001|Overall Study|Withdrawal due to incidental finding|2|||
24986845|NCT03526861|50075782|FG000|Initial Treatment Period|Not dosed|1|||
24986846|NCT03526861|50075783|FG001|Initial Treatment Period|Not dosed|1|||
24986847|NCT03526861|50075784|FG002|Initial Treatment Period|Not dosed|1|||
24986848|NCT03526861|50075785|FG003|Initial Treatment Period|Not dosed|0|||
24986849|NCT03526861|50075786|FG004|Initial Treatment Period|Not dosed|0|||
24986850|NCT03526861|50075787|FG005|Initial Treatment Period|Not dosed|0|||
24986851|NCT03526861|50075788|FG006|Initial Treatment Period|Not dosed|0|||
24986852|NCT03526861|50075789|FG007|Initial Treatment Period|Not dosed|0|||
24986853|NCT03526861|50075790|FG008|Initial Treatment Period|Not dosed|0|||
24986854|NCT03526861|50075782|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
24986855|NCT03526861|50075783|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
24986856|NCT03526861|50075784|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
24986857|NCT03526861|50075785|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986858|NCT03526861|50075786|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986859|NCT03526861|50075787|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986860|NCT03526861|50075788|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986861|NCT03526861|50075789|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986862|NCT03526861|50075790|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986863|NCT03526861|50075782|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
24986864|NCT03526861|50075783|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
24986865|NCT03526861|50075784|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
25079433|NCT01865617|50187892|FG006|Overall Study|Patient proceeded to new therapy|0|||
25079434|NCT01865617|50187893|FG007|Overall Study|Patient proceeded to new therapy|0|||
25079435|NCT01865617|50187894|FG008|Overall Study|Patient proceeded to new therapy|0|||
24986866|NCT03526861|50075785|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
24986867|NCT03526861|50075786|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
24986868|NCT03526861|50075787|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
24986869|NCT03526861|50075788|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
24986870|NCT03526861|50075789|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
24986871|NCT03526861|50075790|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
24986872|NCT03526861|50075782|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
24986873|NCT03526861|50075783|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
24986874|NCT03526861|50075784|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
24986875|NCT03526861|50075785|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
24986876|NCT03526861|50075786|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
24986877|NCT03526861|50075787|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
24986878|NCT03526861|50075788|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
24986879|NCT03526861|50075789|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
24986880|NCT03526861|50075790|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
24986881|NCT03526861|50075782|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
24986882|NCT03526861|50075783|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
24986883|NCT03526861|50075784|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
24986884|NCT03526861|50075785|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
24986885|NCT03526861|50075786|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
24986886|NCT03526861|50075787|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
24986887|NCT03526861|50075788|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
24986888|NCT03526861|50075789|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
24986889|NCT03526861|50075790|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
24986890|NCT03526861|50075782|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986891|NCT03526861|50075783|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986892|NCT03526861|50075784|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986893|NCT03526861|50075785|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
24986894|NCT03526861|50075786|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986895|NCT03526861|50075787|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986896|NCT03526861|50075788|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986897|NCT03526861|50075789|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986898|NCT03526861|50075790|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986899|NCT03526861|50075782|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
24986900|NCT03526861|50075783|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
24986901|NCT03526861|50075784|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
24986902|NCT03526861|50075785|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
24986903|NCT03526861|50075786|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
24986904|NCT03526861|50075787|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
24986905|NCT03526861|50075788|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
24986906|NCT03526861|50075789|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
24986907|NCT03526861|50075790|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
24986908|NCT03526861|50075782|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
24986909|NCT03526861|50075783|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
24986910|NCT03526861|50075784|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
24986911|NCT03526861|50075785|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
24986912|NCT03526861|50075786|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
24986913|NCT03526861|50075787|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
24986914|NCT03526861|50075788|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
24986915|NCT03526861|50075789|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
24986916|NCT03526861|50075790|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
24986917|NCT03526861|50075782|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986918|NCT03526861|50075783|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986919|NCT03526861|50075784|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986920|NCT03526861|50075785|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986921|NCT03526861|50075786|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986922|NCT03526861|50075787|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986923|NCT03526861|50075788|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986924|NCT03526861|50075789|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
24986925|NCT03526861|50075790|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
24986926|NCT03515811|50075812|FG000|Overall Study|Lost to Follow-up|2|||
24986927|NCT03515811|50075813|FG001|Overall Study|Lost to Follow-up|1|||
24986928|NCT03515811|50075812|FG000|Overall Study|Protocol Violation|1|||
24986929|NCT03515811|50075813|FG001|Overall Study|Protocol Violation|1|||
24986930|NCT03515811|50075812|FG000|Overall Study|Death|1|||
24986931|NCT03515811|50075813|FG001|Overall Study|Death|1|||
24986932|NCT03515811|50075812|FG000|Overall Study|Withdrawal by Subject|0|||
24986933|NCT03515811|50075813|FG001|Overall Study|Withdrawal by Subject|2|||
24986934|NCT03515811|50075812|FG000|Overall Study|Technical Problems|1|||
24986935|NCT03515811|50075813|FG001|Overall Study|Technical Problems|0|||
24986936|NCT03515811|50075812|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
24986937|NCT03515811|50075813|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
24986938|NCT03515811|50075812|FG000|Overall Study|COVID-19|0|||
24986939|NCT03515811|50075813|FG001|Overall Study|COVID-19|1|||
24986940|NCT03510884|50075826|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
24986941|NCT03510884|50075827|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
24986942|NCT03510884|50075828|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
24986943|NCT03510884|50075829|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
24986944|NCT03510884|50075826|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
24986945|NCT03510884|50075827|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
24986946|NCT03510884|50075828|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
24986947|NCT03510884|50075829|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
24986948|NCT03510884|50075826|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
24986949|NCT03510884|50075827|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
24986950|NCT03510884|50075828|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
24986951|NCT03510884|50075829|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
24986952|NCT03510884|50075826|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
24986953|NCT03510884|50075827|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
24986954|NCT03510884|50075828|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
24986955|NCT03510884|50075829|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
24986956|NCT03510884|50075826|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
24986957|NCT03510884|50075827|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
24986958|NCT03510884|50075828|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
24986959|NCT03510884|50075829|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
24986960|NCT03510884|50075826|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
24986961|NCT03510884|50075827|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
24986962|NCT03510884|50075828|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
24986963|NCT03510884|50075829|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
24986964|NCT03510884|50075826|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
24986965|NCT03510884|50075827|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
24986966|NCT03510884|50075828|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
24986967|NCT03510884|50075829|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
24986968|NCT03510884|50075826|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
24986969|NCT03510884|50075827|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
24986970|NCT03510884|50075828|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
24986971|NCT03510884|50075829|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
24986972|NCT03510884|50075826|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
24986973|NCT03510884|50075827|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
24995121|NCT03015220|50086009|FG000|Overall Study|Withdrawal by Subject|3|||
24986974|NCT03510884|50075828|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
24986975|NCT03510884|50075829|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
24986976|NCT03510884|50075826|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
24986977|NCT03510884|50075827|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
24986978|NCT03510884|50075828|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
24986979|NCT03510884|50075829|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
24986980|NCT03492177|50075861|FG000|Overall Study|Adverse Event|1|||
24986981|NCT03492177|50075862|FG001|Overall Study|Adverse Event|0|||
24986982|NCT03492177|50075863|FG002|Overall Study|Adverse Event|0|||
24986983|NCT03492177|50075861|FG000|Overall Study|Death|3|||
24986984|NCT03492177|50075862|FG001|Overall Study|Death|0|||
24986985|NCT03492177|50075863|FG002|Overall Study|Death|3|||
24986986|NCT03492177|50075861|FG000|Overall Study|Lack of Efficacy|1|||
24986987|NCT03492177|50075862|FG001|Overall Study|Lack of Efficacy|2|||
24986988|NCT03492177|50075863|FG002|Overall Study|Lack of Efficacy|0|||
24986989|NCT03492177|50075861|FG000|Overall Study|Other|1|||
24986990|NCT03492177|50075862|FG001|Overall Study|Other|0|||
24986991|NCT03492177|50075863|FG002|Overall Study|Other|0|||
24986992|NCT03492177|50075861|FG000|Overall Study|Ongoing|16|||
24986993|NCT03492177|50075862|FG001|Overall Study|Ongoing|19|||
24986994|NCT03492177|50075863|FG002|Overall Study|Ongoing|17|||
24986995|NCT03488472|50075880|FG000|Overall Study|disease progression additional mets|1|||
24986996|NCT03456453|50075886|FG000|Overall Study|Withdrawal by Subject|2|||
24986997|NCT03456453|50075887|FG001|Overall Study|Withdrawal by Subject|0|||
24986998|NCT03456453|50075886|FG000|Overall Study|Not released to community|1|||
24986999|NCT03456453|50075887|FG001|Overall Study|Not released to community|5|||
24987000|NCT03456453|50075886|FG000|Overall Study|Lost to Follow-up|0|||
24987001|NCT03456453|50075887|FG001|Overall Study|Lost to Follow-up|2|||
24987002|NCT03455829|50075898|FG000|Overall Study|Death|2|||
24987003|NCT03455829|50075899|FG001|Overall Study|Death|3|||
24987004|NCT03455829|50075900|FG002|Overall Study|Death|2|||
24987005|NCT03455829|50075901|FG003|Overall Study|Death|4|||
24987006|NCT03455829|50075902|FG004|Overall Study|Death|2|||
24987007|NCT03455829|50075898|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
24987008|NCT03455829|50075899|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
24987009|NCT03455829|50075900|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
24987010|NCT03455829|50075901|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
24987011|NCT03455829|50075902|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
24987012|NCT03455829|50075898|FG000|Overall Study|Disease progression|0|||
24987013|NCT03455829|50075899|FG001|Overall Study|Disease progression|0|||
24987014|NCT03455829|50075900|FG002|Overall Study|Disease progression|0|||
24987015|NCT03455829|50075901|FG003|Overall Study|Disease progression|1|||
24987016|NCT03455829|50075902|FG004|Overall Study|Disease progression|1|||
24987017|NCT03441334|50075916|FG000|Overall Study|Withdrawal by Subject|1|||
24987018|NCT03441334|50075917|FG001|Overall Study|Withdrawal by Subject|0|||
24987019|NCT03429244|50075948|FG000|Overall Study|Withdrawal by Subject|2|||
24987020|NCT03429244|50075949|FG001|Overall Study|Withdrawal by Subject|1|||
24987021|NCT03429244|50075950|FG002|Overall Study|Withdrawal by Subject|1|||
24987022|NCT03412565|50075963|FG000|Overall Study|Other|0|||
24987023|NCT03412565|50075964|FG001|Overall Study|Other|0|||
24987024|NCT03412565|50075965|FG002|Overall Study|Other|0|||
24987025|NCT03412565|50075966|FG003|Overall Study|Other|3|||
24987026|NCT03412565|50075963|FG000|Overall Study|Withdrawal by Subject|0|||
24987027|NCT03412565|50075964|FG001|Overall Study|Withdrawal by Subject|0|||
24987028|NCT03412565|50075965|FG002|Overall Study|Withdrawal by Subject|1|||
24987029|NCT03412565|50075966|FG003|Overall Study|Withdrawal by Subject|5|||
24987030|NCT03412565|50075963|FG000|Overall Study|Physician Decision|0|||
24987031|NCT03412565|50075964|FG001|Overall Study|Physician Decision|1|||
24987032|NCT03412565|50075965|FG002|Overall Study|Physician Decision|0|||
24987033|NCT03412565|50075966|FG003|Overall Study|Physician Decision|1|||
24987034|NCT03412565|50075963|FG000|Overall Study|Death|1|||
24987035|NCT03412565|50075964|FG001|Overall Study|Death|2|||
24987036|NCT03412565|50075965|FG002|Overall Study|Death|2|||
24987037|NCT03412565|50075966|FG003|Overall Study|Death|4|||
24987038|NCT03412565|50075963|FG000|Overall Study|Still ongoing|0|||
24987039|NCT03412565|50075964|FG001|Overall Study|Still ongoing|62|||
24987040|NCT03412565|50075965|FG002|Overall Study|Still ongoing|59|||
24987041|NCT03412565|50075966|FG003|Overall Study|Still ongoing|41|||
24987042|NCT03370276|50075988|FG000|Overall Study|Death|0|||
24987043|NCT03370276|50075989|FG001|Overall Study|Death|2|||
24987044|NCT03370276|50075990|FG002|Overall Study|Death|5|||
24987045|NCT03277105|50076000|FG000|Overall Study|Death|77|||
24987046|NCT03277105|50076001|FG001|Overall Study|Death|73|||
24987047|NCT03277105|50076000|FG000|Overall Study|Lost to Follow-up|0|||
24987048|NCT03277105|50076001|FG001|Overall Study|Lost to Follow-up|3|||
24987049|NCT03277105|50076000|FG000|Overall Study|Withdrawal by Subject|10|||
24987050|NCT03277105|50076001|FG001|Overall Study|Withdrawal by Subject|9|||
24987051|NCT03277105|50076000|FG000|Overall Study|Other|1|||
24987052|NCT03277105|50076001|FG001|Overall Study|Other|3|||
24987053|NCT03277105|50076000|FG000|Overall Study|Ongoing|171|||
24987054|NCT03277105|50076001|FG001|Overall Study|Ongoing|175|||
24987055|NCT03250117|50076007|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
24987056|NCT03250117|50076008|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
24987057|NCT03250117|50076009|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
24987058|NCT03250117|50076010|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
24987059|NCT03230838|50076016|FG000|Overall Study|Withdrawal by Subject|3|||
24987060|NCT03230838|50076017|FG001|Overall Study|Withdrawal by Subject|0|||
24987061|NCT03230838|50076016|FG000|Overall Study|Temperature excursion|1|||
24987062|NCT03230838|50076017|FG001|Overall Study|Temperature excursion|0|||
24987063|NCT03217136|50076025|FG000|Overall Study|Lost to Follow-up|2|||
24987064|NCT03217136|50076026|FG001|Overall Study|Lost to Follow-up|1|||
24987065|NCT03217136|50076025|FG000|Overall Study|Site Randomized Participant in Error|0|||
24987066|NCT03217136|50076026|FG001|Overall Study|Site Randomized Participant in Error|1|||
24987067|NCT03217136|50076025|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
24987068|NCT03217136|50076026|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
24987069|NCT03217136|50076025|FG000|Overall Study|Dispensing Error|1|||
24987070|NCT03217136|50076026|FG001|Overall Study|Dispensing Error|0|||
24987071|NCT03217136|50076025|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
24987072|NCT03217136|50076026|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
24987073|NCT03213665|50076032|FG000|Overall Study|Adverse Event|1|||
24987074|NCT03213665|50076032|FG000|Overall Study|Physician Decision|2|||
24987075|NCT03213665|50076032|FG000|Overall Study|Withdrawal by Subject|3|||
24987076|NCT03213665|50076032|FG000|Overall Study|Progressive Disease|13|||
24987077|NCT03201965|50076039|FG000|Overall Study|Death|5|||
24987078|NCT03201965|50076040|FG001|Overall Study|Death|27|||
24987079|NCT03201965|50076041|FG002|Overall Study|Death|27|||
24987080|NCT03201965|50076039|FG000|Overall Study|Lost to Follow-up|0|||
24987081|NCT03201965|50076040|FG001|Overall Study|Lost to Follow-up|1|||
24987082|NCT03201965|50076041|FG002|Overall Study|Lost to Follow-up|0|||
24987083|NCT03201965|50076039|FG000|Overall Study|Withdrawal by Subject|3|||
24987084|NCT03201965|50076040|FG001|Overall Study|Withdrawal by Subject|13|||
24987085|NCT03201965|50076041|FG002|Overall Study|Withdrawal by Subject|4|||
24987086|NCT03201965|50076039|FG000|Overall Study|Ongoing|20|||
24987087|NCT03201965|50076040|FG001|Overall Study|Ongoing|152|||
24987088|NCT03201965|50076041|FG002|Overall Study|Ongoing|164|||
24987089|NCT03179761|50076050|FG000|Overall Study|Death|2|||
24987090|NCT03179761|50076051|FG001|Overall Study|Death|5|||
24987091|NCT03179761|50076050|FG000|Overall Study|Lost to Follow-up|2|||
24987092|NCT03179761|50076051|FG001|Overall Study|Lost to Follow-up|2|||
24987093|NCT03179761|50076050|FG000|Overall Study|Protocol Violation|1|||
24987094|NCT03179761|50076051|FG001|Overall Study|Protocol Violation|0|||
24987095|NCT03179761|50076050|FG000|Overall Study|Withdrawal by Subject|1|||
24987096|NCT03179761|50076051|FG001|Overall Study|Withdrawal by Subject|4|||
24987097|NCT03179761|50076050|FG000|Overall Study|Investigator Request|0|||
24987098|NCT03179761|50076051|FG001|Overall Study|Investigator Request|2|||
24987099|NCT03173248|50076059|FG000|Overall Study|Death|28|||
24987100|NCT03173248|50076060|FG001|Overall Study|Death|46|||
24987101|NCT03173248|50076059|FG000|Overall Study|Lost to Follow-up|0|||
24987102|NCT03173248|50076060|FG001|Overall Study|Lost to Follow-up|1|||
24987103|NCT03173248|50076059|FG000|Overall Study|Withdrawal by Subject|6|||
24987104|NCT03173248|50076060|FG001|Overall Study|Withdrawal by Subject|4|||
24987105|NCT03173248|50076059|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
24987106|NCT03173248|50076060|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
24987107|NCT03155841|50076068|FG000|Overall Study|Protocol Violation|3|||
24987108|NCT03155841|50076069|FG001|Overall Study|Protocol Violation|4|||
24987109|NCT03122886|50076077|FG000|Overall Study|Withdrawal by Subject|1|||
24987110|NCT03122886|50076078|FG001|Overall Study|Withdrawal by Subject|2|||
24987111|NCT03114891|50076088|FG000|First Treatment Round|Lost to Follow-up|0|||
24987112|NCT03114891|50076089|FG001|First Treatment Round|Lost to Follow-up|1|||
24987113|NCT03114891|50076090|FG002|First Treatment Round|Lost to Follow-up|1|||
24987114|NCT03114891|50076091|FG003|First Treatment Round|Lost to Follow-up|0|||
24987115|NCT03114891|50076088|FG000|First Treatment Round|Withdrawal by Subject|0|||
24987116|NCT03114891|50076089|FG001|First Treatment Round|Withdrawal by Subject|2|||
24987117|NCT03114891|50076090|FG002|First Treatment Round|Withdrawal by Subject|0|||
24987118|NCT03114891|50076091|FG003|First Treatment Round|Withdrawal by Subject|1|||
24987119|NCT03114891|50076088|FG000|3 Week Break|Lost to Follow-up|1|||
24987120|NCT03114891|50076089|FG001|3 Week Break|Lost to Follow-up|0|||
24987121|NCT03114891|50076090|FG002|3 Week Break|Lost to Follow-up|0|||
24987122|NCT03114891|50076091|FG003|3 Week Break|Lost to Follow-up|1|||
24987123|NCT03114891|50076088|FG000|3 Week Break|Withdrawal by Subject|0|||
24987124|NCT03114891|50076089|FG001|3 Week Break|Withdrawal by Subject|1|||
24987125|NCT03114891|50076090|FG002|3 Week Break|Withdrawal by Subject|0|||
24987126|NCT03114891|50076091|FG003|3 Week Break|Withdrawal by Subject|0|||
24987127|NCT03114891|50076088|FG000|Second Treatment Round|Lost to Follow-up|1|||
24987128|NCT03114891|50076089|FG001|Second Treatment Round|Lost to Follow-up|0|||
24987129|NCT03114891|50076090|FG002|Second Treatment Round|Lost to Follow-up|0|||
24987130|NCT03114891|50076091|FG003|Second Treatment Round|Lost to Follow-up|0|||
24987131|NCT03114891|50076088|FG000|Second Treatment Round|Physician Decision|1|||
24987132|NCT03114891|50076089|FG001|Second Treatment Round|Physician Decision|0|||
24987133|NCT03114891|50076090|FG002|Second Treatment Round|Physician Decision|0|||
24987134|NCT03114891|50076091|FG003|Second Treatment Round|Physician Decision|0|||
24987135|NCT03057847|50076133|FG000|Overall Study|Lost to Follow-up|16|||
24987136|NCT03056001|50076137|FG000|Overall Study|Death|24|||
24987137|NCT03056001|50076137|FG000|Overall Study|Still On Study (in follow up)|1|||
24987138|NCT02946463|50076165|FG000|Primary Evaluation Period|Physician Decision|0|||
24987139|NCT02946463|50076166|FG001|Primary Evaluation Period|Physician Decision|1|||
24987140|NCT02946463|50076165|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
24987141|NCT02946463|50076166|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
24987142|NCT02928224|50076176|FG000|Overall Study|Randomized, Not Treated|0|||
24987143|NCT02928224|50076177|FG001|Overall Study|Randomized, Not Treated|2|||
24987144|NCT02928224|50076178|FG002|Overall Study|Randomized, Not Treated|4|||
24987145|NCT02928224|50076179|FG003|Overall Study|Randomized, Not Treated|28|||
24987146|NCT02928224|50076176|FG000|Overall Study|Treatment Ongoing|6|||
24987147|NCT02928224|50076177|FG001|Overall Study|Treatment Ongoing|78|||
24987148|NCT02928224|50076178|FG002|Overall Study|Treatment Ongoing|78|||
24987149|NCT02928224|50076179|FG003|Overall Study|Treatment Ongoing|37|||
24987150|NCT02928224|50076176|FG000|Overall Study|Progressive Disease|23|||
24987151|NCT02928224|50076177|FG001|Overall Study|Progressive Disease|104|||
24987152|NCT02928224|50076178|FG002|Overall Study|Progressive Disease|101|||
24987153|NCT02928224|50076179|FG003|Overall Study|Progressive Disease|103|||
24987154|NCT02928224|50076176|FG000|Overall Study|Adverse Event|2|||
24987155|NCT02928224|50076177|FG001|Overall Study|Adverse Event|11|||
24987156|NCT02928224|50076178|FG002|Overall Study|Adverse Event|11|||
24987157|NCT02928224|50076179|FG003|Overall Study|Adverse Event|10|||
24987158|NCT02928224|50076176|FG000|Overall Study|Changes in Patient's Condition|3|||
24987159|NCT02928224|50076177|FG001|Overall Study|Changes in Patient's Condition|9|||
24987160|NCT02928224|50076178|FG002|Overall Study|Changes in Patient's Condition|9|||
24987161|NCT02928224|50076179|FG003|Overall Study|Changes in Patient's Condition|13|||
24987162|NCT02928224|50076176|FG000|Overall Study|Death|1|||
24987163|NCT02928224|50076177|FG001|Overall Study|Death|7|||
24987164|NCT02928224|50076178|FG002|Overall Study|Death|5|||
24987165|NCT02928224|50076179|FG003|Overall Study|Death|11|||
24987166|NCT02928224|50076176|FG000|Overall Study|Withdrawal by Subject|1|||
24987167|NCT02928224|50076177|FG001|Overall Study|Withdrawal by Subject|4|||
24987168|NCT02928224|50076178|FG002|Overall Study|Withdrawal by Subject|3|||
24987169|NCT02928224|50076179|FG003|Overall Study|Withdrawal by Subject|9|||
24987170|NCT02928224|50076176|FG000|Overall Study|Dose Interruptions>28|1|||
24987171|NCT02928224|50076177|FG001|Overall Study|Dose Interruptions>28|2|||
24987172|NCT02928224|50076178|FG002|Overall Study|Dose Interruptions>28|2|||
24987173|NCT02928224|50076179|FG003|Overall Study|Dose Interruptions>28|4|||
24987174|NCT02928224|50076176|FG000|Overall Study|Patient Decision to Discontinue Drug|0|||
24987175|NCT02928224|50076177|FG001|Overall Study|Patient Decision to Discontinue Drug|2|||
24987176|NCT02928224|50076178|FG002|Overall Study|Patient Decision to Discontinue Drug|2|||
24987177|NCT02928224|50076179|FG003|Overall Study|Patient Decision to Discontinue Drug|4|||
24987178|NCT02928224|50076176|FG000|Overall Study|Physician Decision|0|||
24987179|NCT02928224|50076177|FG001|Overall Study|Physician Decision|2|||
24987180|NCT02928224|50076178|FG002|Overall Study|Physician Decision|4|||
24987181|NCT02928224|50076179|FG003|Overall Study|Physician Decision|2|||
24987182|NCT02928224|50076176|FG000|Overall Study|not listed|0|||
24987183|NCT02928224|50076177|FG001|Overall Study|not listed|3|||
24987184|NCT02928224|50076178|FG002|Overall Study|not listed|1|||
24987185|NCT02928224|50076179|FG003|Overall Study|not listed|0|||
24987186|NCT02872116|50076220|FG000|Pre-Treatment|Disease Progression|0|||
24987187|NCT02872116|50076221|FG001|Pre-Treatment|Disease Progression|1|||
24987188|NCT02872116|50076222|FG002|Pre-Treatment|Disease Progression|0|||
24987189|NCT02872116|50076220|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
24987190|NCT02872116|50076221|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
24987191|NCT02872116|50076222|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
24987192|NCT02872116|50076220|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
24987193|NCT02872116|50076221|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
24987194|NCT02872116|50076222|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
24987195|NCT02872116|50076220|FG000|Pre-Treatment|Participant withdrew consent|2|||
24987196|NCT02872116|50076221|FG001|Pre-Treatment|Participant withdrew consent|20|||
24987197|NCT02872116|50076222|FG002|Pre-Treatment|Participant withdrew consent|3|||
24987198|NCT02872116|50076220|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
24987199|NCT02872116|50076221|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
24987200|NCT02872116|50076222|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
24987201|NCT02872116|50076220|FG000|Pre-Treatment|Other reasons|1|||
24987202|NCT02872116|50076221|FG001|Pre-Treatment|Other reasons|2|||
24987203|NCT02872116|50076222|FG002|Pre-Treatment|Other reasons|2|||
24987204|NCT02872116|50076220|FG000|Treatment|Death|122|||
24987205|NCT02872116|50076221|FG001|Treatment|Death|94|||
24987206|NCT02872116|50076222|FG002|Treatment|Death|68|||
24987207|NCT02872116|50076220|FG000|Treatment|Lost to Follow-up|5|||
24987208|NCT02872116|50076221|FG001|Treatment|Lost to Follow-up|7|||
24987209|NCT02872116|50076222|FG002|Treatment|Lost to Follow-up|3|||
24987210|NCT02872116|50076220|FG000|Treatment|Participant withdrew consent|20|||
24987211|NCT02872116|50076221|FG001|Treatment|Participant withdrew consent|40|||
24987212|NCT02872116|50076222|FG002|Treatment|Participant withdrew consent|8|||
24987213|NCT02872116|50076220|FG000|Treatment|Other reasons|12|||
24987214|NCT02872116|50076221|FG001|Treatment|Other reasons|12|||
24987215|NCT02872116|50076222|FG002|Treatment|Other reasons|5|||
24987216|NCT02860039|50076236|FG000|Overall Study|Death|4|||
24987217|NCT02860039|50076237|FG001|Overall Study|Death|0|||
24987218|NCT02860039|50076236|FG000|Overall Study|Lost to Follow-up|2|||
24987219|NCT02860039|50076237|FG001|Overall Study|Lost to Follow-up|2|||
24987220|NCT02860039|50076236|FG000|Overall Study|Protocol Violation|3|||
24987221|NCT02860039|50076237|FG001|Overall Study|Protocol Violation|1|||
24987222|NCT02860039|50076236|FG000|Overall Study|Withdrawal by Subject|1|||
24987223|NCT02860039|50076237|FG001|Overall Study|Withdrawal by Subject|0|||
24987224|NCT02860039|50076236|FG000|Overall Study|Not otherwise eligible|1|||
24987225|NCT02860039|50076237|FG001|Overall Study|Not otherwise eligible|1|||
24987226|NCT02854436|50076243|FG000|Overall Study|Adverse Event|1|||
24987227|NCT02854436|50076243|FG000|Overall Study|Death|208|||
24987228|NCT02854436|50076243|FG000|Overall Study|Lost to Follow-up|5|||
24987229|NCT02854436|50076243|FG000|Overall Study|Withdrawal by Subject|12|||
24987230|NCT02854436|50076243|FG000|Overall Study|Other|45|||
24987231|NCT02854436|50076243|FG000|Overall Study|Ongoing|18|||
24987232|NCT02761694|50076271|FG000|Overall Study|Lack of Efficacy|0|||
24987233|NCT02761694|50076272|FG001|Overall Study|Lack of Efficacy|0|||
24987234|NCT02761694|50076273|FG002|Overall Study|Lack of Efficacy|0|||
24987235|NCT02761694|50076274|FG003|Overall Study|Lack of Efficacy|0|||
24987236|NCT02761694|50076275|FG004|Overall Study|Lack of Efficacy|0|||
24987237|NCT02761694|50076276|FG005|Overall Study|Lack of Efficacy|0|||
24987238|NCT02761694|50076277|FG006|Overall Study|Lack of Efficacy|6|||
24987239|NCT02761694|50076278|FG007|Overall Study|Lack of Efficacy|0|||
24987240|NCT02761694|50076279|FG008|Overall Study|Lack of Efficacy|0|||
24987241|NCT02761694|50076280|FG009|Overall Study|Lack of Efficacy|1|||
24987242|NCT02761694|50076281|FG010|Overall Study|Lack of Efficacy|1|||
24987243|NCT02761694|50076282|FG011|Overall Study|Lack of Efficacy|4|||
24987244|NCT02761694|50076271|FG000|Overall Study|Death|0|||
24987245|NCT02761694|50076272|FG001|Overall Study|Death|0|||
24987246|NCT02761694|50076273|FG002|Overall Study|Death|0|||
24987247|NCT02761694|50076274|FG003|Overall Study|Death|0|||
24987248|NCT02761694|50076275|FG004|Overall Study|Death|0|||
24987249|NCT02761694|50076276|FG005|Overall Study|Death|0|||
24987250|NCT02761694|50076277|FG006|Overall Study|Death|2|||
24987251|NCT02761694|50076278|FG007|Overall Study|Death|0|||
24987252|NCT02761694|50076279|FG008|Overall Study|Death|2|||
24987253|NCT02761694|50076280|FG009|Overall Study|Death|2|||
24987254|NCT02761694|50076281|FG010|Overall Study|Death|1|||
24987255|NCT02761694|50076282|FG011|Overall Study|Death|0|||
24987256|NCT02761694|50076271|FG000|Overall Study|Physician Decision|0|||
24987257|NCT02761694|50076272|FG001|Overall Study|Physician Decision|0|||
24987258|NCT02761694|50076273|FG002|Overall Study|Physician Decision|0|||
24987259|NCT02761694|50076274|FG003|Overall Study|Physician Decision|0|||
24987260|NCT02761694|50076275|FG004|Overall Study|Physician Decision|0|||
24987261|NCT02761694|50076276|FG005|Overall Study|Physician Decision|0|||
24987262|NCT02761694|50076277|FG006|Overall Study|Physician Decision|1|||
24987263|NCT02761694|50076278|FG007|Overall Study|Physician Decision|0|||
24987264|NCT02761694|50076279|FG008|Overall Study|Physician Decision|0|||
24987265|NCT02761694|50076280|FG009|Overall Study|Physician Decision|0|||
24987266|NCT02761694|50076281|FG010|Overall Study|Physician Decision|0|||
24987267|NCT02761694|50076282|FG011|Overall Study|Physician Decision|0|||
24987268|NCT02761694|50076271|FG000|Overall Study|Withdrawal by Subject|0|||
24987269|NCT02761694|50076272|FG001|Overall Study|Withdrawal by Subject|0|||
24987270|NCT02761694|50076273|FG002|Overall Study|Withdrawal by Subject|0|||
24987271|NCT02761694|50076274|FG003|Overall Study|Withdrawal by Subject|1|||
24987272|NCT02761694|50076275|FG004|Overall Study|Withdrawal by Subject|0|||
24987273|NCT02761694|50076276|FG005|Overall Study|Withdrawal by Subject|0|||
24987274|NCT02761694|50076277|FG006|Overall Study|Withdrawal by Subject|4|||
24987275|NCT02761694|50076278|FG007|Overall Study|Withdrawal by Subject|0|||
24987276|NCT02761694|50076279|FG008|Overall Study|Withdrawal by Subject|2|||
24987277|NCT02761694|50076280|FG009|Overall Study|Withdrawal by Subject|1|||
24987278|NCT02761694|50076281|FG010|Overall Study|Withdrawal by Subject|0|||
24987279|NCT02761694|50076282|FG011|Overall Study|Withdrawal by Subject|0|||
24987280|NCT02761694|50076271|FG000|Overall Study|Lost to Follow-up|0|||
24987281|NCT02761694|50076272|FG001|Overall Study|Lost to Follow-up|0|||
24987282|NCT02761694|50076273|FG002|Overall Study|Lost to Follow-up|0|||
24987283|NCT02761694|50076274|FG003|Overall Study|Lost to Follow-up|0|||
24987284|NCT02761694|50076275|FG004|Overall Study|Lost to Follow-up|0|||
24987285|NCT02761694|50076276|FG005|Overall Study|Lost to Follow-up|0|||
24987286|NCT02761694|50076277|FG006|Overall Study|Lost to Follow-up|1|||
24987287|NCT02761694|50076278|FG007|Overall Study|Lost to Follow-up|0|||
24987288|NCT02761694|50076279|FG008|Overall Study|Lost to Follow-up|0|||
24987289|NCT02761694|50076280|FG009|Overall Study|Lost to Follow-up|0|||
24987290|NCT02761694|50076281|FG010|Overall Study|Lost to Follow-up|0|||
24987291|NCT02761694|50076282|FG011|Overall Study|Lost to Follow-up|1|||
24987292|NCT02761694|50076271|FG000|Overall Study|Adverse Event|0|||
24987293|NCT02761694|50076272|FG001|Overall Study|Adverse Event|0|||
24987294|NCT02761694|50076273|FG002|Overall Study|Adverse Event|0|||
24987295|NCT02761694|50076274|FG003|Overall Study|Adverse Event|0|||
24987296|NCT02761694|50076275|FG004|Overall Study|Adverse Event|0|||
24987297|NCT02761694|50076276|FG005|Overall Study|Adverse Event|0|||
24987298|NCT02761694|50076277|FG006|Overall Study|Adverse Event|1|||
24987299|NCT02761694|50076278|FG007|Overall Study|Adverse Event|0|||
24987300|NCT02761694|50076279|FG008|Overall Study|Adverse Event|1|||
24987301|NCT02761694|50076280|FG009|Overall Study|Adverse Event|0|||
24987302|NCT02761694|50076281|FG010|Overall Study|Adverse Event|0|||
24987303|NCT02761694|50076282|FG011|Overall Study|Adverse Event|1|||
24987304|NCT02761694|50076271|FG000|Overall Study|Other|4|||
24987305|NCT02761694|50076272|FG001|Overall Study|Other|4|||
24987306|NCT02761694|50076273|FG002|Overall Study|Other|1|||
24987307|NCT02761694|50076274|FG003|Overall Study|Other|2|||
24987308|NCT02761694|50076275|FG004|Overall Study|Other|3|||
24987309|NCT02761694|50076276|FG005|Overall Study|Other|3|||
24987310|NCT02761694|50076277|FG006|Overall Study|Other|18|||
24987311|NCT02761694|50076278|FG007|Overall Study|Other|8|||
24987312|NCT02761694|50076279|FG008|Overall Study|Other|0|||
24987313|NCT02761694|50076280|FG009|Overall Study|Other|1|||
24987314|NCT02761694|50076281|FG010|Overall Study|Other|1|||
24987315|NCT02761694|50076282|FG011|Overall Study|Other|0|||
24987316|NCT02726386|50076311|FG000|Overall Study|Adverse Event|17|||
24987317|NCT02726386|50076312|FG001|Overall Study|Adverse Event|20|||
24987318|NCT02726386|50076311|FG000|Overall Study|Withdrawal by Subject|14|||
24987319|NCT02726386|50076312|FG001|Overall Study|Withdrawal by Subject|28|||
24987320|NCT02726386|50076311|FG000|Overall Study|Other reasons|7|||
24987321|NCT02726386|50076312|FG001|Overall Study|Other reasons|8|||
24987322|NCT02574481|50076334|FG000|Overall Study|Withdrawal by Subject|29|||
24987323|NCT02574481|50076335|FG001|Overall Study|Withdrawal by Subject|15|||
24987324|NCT02574481|50076336|FG002|Overall Study|Withdrawal by Subject|4|||
24987325|NCT02574481|50076337|FG003|Overall Study|Withdrawal by Subject|1|||
24987326|NCT02574481|50076334|FG000|Overall Study|Adverse Event|5|||
24987327|NCT02574481|50076335|FG001|Overall Study|Adverse Event|1|||
24987328|NCT02574481|50076336|FG002|Overall Study|Adverse Event|1|||
24987329|NCT02574481|50076337|FG003|Overall Study|Adverse Event|0|||
24987330|NCT02574481|50076334|FG000|Overall Study|Visit Missed|15|||
24987331|NCT02574481|50076335|FG001|Overall Study|Visit Missed|7|||
24987332|NCT02574481|50076336|FG002|Overall Study|Visit Missed|5|||
24987333|NCT02574481|50076337|FG003|Overall Study|Visit Missed|0|||
24987334|NCT02574481|50076334|FG000|Overall Study|Other|7|||
24987335|NCT02574481|50076335|FG001|Overall Study|Other|2|||
24987336|NCT02574481|50076336|FG002|Overall Study|Other|0|||
24987337|NCT02574481|50076337|FG003|Overall Study|Other|0|||
24987338|NCT02574481|50076334|FG000|Overall Study|Death|48|||
24987339|NCT02574481|50076335|FG001|Overall Study|Death|26|||
24987340|NCT02574481|50076336|FG002|Overall Study|Death|12|||
24987341|NCT02574481|50076337|FG003|Overall Study|Death|4|||
24987342|NCT02574481|50076334|FG000|Overall Study|Physician Decision|5|||
24987343|NCT02574481|50076335|FG001|Overall Study|Physician Decision|2|||
24987344|NCT02574481|50076336|FG002|Overall Study|Physician Decision|0|||
24987345|NCT02574481|50076337|FG003|Overall Study|Physician Decision|0|||
24987346|NCT02574481|50076334|FG000|Overall Study|Lost to Follow-up|5|||
24987347|NCT02574481|50076335|FG001|Overall Study|Lost to Follow-up|1|||
24987348|NCT02574481|50076336|FG002|Overall Study|Lost to Follow-up|3|||
24987349|NCT02574481|50076337|FG003|Overall Study|Lost to Follow-up|0|||
24987350|NCT02489318|50076352|FG000|Randomized|Withdrawal by Subject|0|||
24987351|NCT02489318|50076353|FG001|Randomized|Withdrawal by Subject|1|||
24987352|NCT02489318|50076352|FG000|Treated|Adverse Event|19|||
24987353|NCT02489318|50076353|FG001|Treated|Adverse Event|62|||
24987354|NCT02489318|50076352|FG000|Treated|Death|13|||
24987355|NCT02489318|50076353|FG001|Treated|Death|11|||
24987356|NCT02489318|50076352|FG000|Treated|Physician Decision|4|||
24987357|NCT02489318|50076353|FG001|Treated|Physician Decision|6|||
24987358|NCT02489318|50076352|FG000|Treated|Protocol Violation|1|||
24987359|NCT02489318|50076353|FG001|Treated|Protocol Violation|2|||
24987360|NCT02489318|50076352|FG000|Treated|Withdrawal by Subject|37|||
24987361|NCT02489318|50076353|FG001|Treated|Withdrawal by Subject|36|||
24987362|NCT02489318|50076352|FG000|Treated|Other: Progressive Disease|245|||
24987363|NCT02489318|50076353|FG001|Treated|Other: Progressive Disease|138|||
24987364|NCT02489318|50076352|FG000|Treated|Other|0|||
24987365|NCT02489318|50076353|FG001|Treated|Other|2|||
24987366|NCT02489318|50076352|FG000|Treated|Ongoing|0|||
24987367|NCT02489318|50076353|FG001|Treated|Ongoing|267|||
24987368|NCT02438722|50076362|FG000|Overall Study|Adverse Event|12|||
24987369|NCT02438722|50076363|FG001|Overall Study|Adverse Event|9|||
24987370|NCT02438722|50076362|FG000|Overall Study|Refusal unrelated to AE|2|||
24987371|NCT02438722|50076363|FG001|Overall Study|Refusal unrelated to AE|5|||
24987372|NCT02438722|50076362|FG000|Overall Study|Disease progression/relapse|46|||
24987373|NCT02438722|50076363|FG001|Overall Study|Disease progression/relapse|51|||
24987374|NCT02438722|50076362|FG000|Overall Study|Death|0|||
24987375|NCT02438722|50076363|FG001|Overall Study|Death|3|||
24987376|NCT02438722|50076362|FG000|Overall Study|Physician Decision|2|||
24987377|NCT02438722|50076363|FG001|Overall Study|Physician Decision|2|||
24987378|NCT02438722|50076362|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
24987379|NCT02438722|50076363|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
24987380|NCT02438722|50076362|FG000|Overall Study|Withdrawal by Subject|0|||
24987381|NCT02438722|50076363|FG001|Overall Study|Withdrawal by Subject|1|||
24987382|NCT02438722|50076362|FG000|Overall Study|On protocol treatment|15|||
24987383|NCT02438722|50076363|FG001|Overall Study|On protocol treatment|14|||
24987384|NCT02438722|50076362|FG000|Overall Study|Did not receive protocol treatment|5|||
24987385|NCT02438722|50076363|FG001|Overall Study|Did not receive protocol treatment|0|||
24987386|NCT02426658|50076369|FG000|Overall Study|Withdrawal by Subject|1|||
24987387|NCT02426658|50076369|FG000|Overall Study|Patient expired before treatment|2|||
24987388|NCT02376829|50076384|FG000|Overall Study|Withdrawal by Subject|27|||
24987389|NCT02376829|50076385|FG001|Overall Study|Withdrawal by Subject|44|||
24987390|NCT02297438|50076394|FG000|Overall Study|Death|79|||
24987391|NCT02297438|50076395|FG001|Overall Study|Death|86|||
24987392|NCT02297438|50076394|FG000|Overall Study|Lost to Follow-up|9|||
24987393|NCT02297438|50076395|FG001|Overall Study|Lost to Follow-up|7|||
24987394|NCT02297438|50076394|FG000|Overall Study|Withdrawal by Subject|7|||
24987395|NCT02297438|50076395|FG001|Overall Study|Withdrawal by Subject|0|||
24987396|NCT02297438|50076394|FG000|Overall Study|Other|9|||
24987397|NCT02297438|50076395|FG001|Overall Study|Other|5|||
24987398|NCT02297438|50076394|FG000|Overall Study|Ongoing|65|||
24987399|NCT02297438|50076395|FG001|Overall Study|Ongoing|73|||
24987400|NCT02297139|50076403|FG000|Overall Study|Disease progression|0|||
24987401|NCT02297139|50076404|FG001|Overall Study|Disease progression|1|||
24987402|NCT02297139|50076403|FG000|Overall Study|Study drug toxicity|0|||
24987403|NCT02297139|50076404|FG001|Overall Study|Study drug toxicity|4|||
24987404|NCT02297139|50076403|FG000|Overall Study|Participant request to discontinue study treatment|0|||
24987405|NCT02297139|50076404|FG001|Overall Study|Participant request to discontinue study treatment|1|||
24987406|NCT02297139|50076403|FG000|Overall Study|Maximum clinical benefit|1|||
24987407|NCT02297139|50076404|FG001|Overall Study|Maximum clinical benefit|0|||
24987408|NCT02297139|50076403|FG000|Overall Study|Administrative reason by sponsor|0|||
24987409|NCT02297139|50076404|FG001|Overall Study|Administrative reason by sponsor|2|||
24987410|NCT02297139|50076403|FG000|Overall Study|Other reasons|0|||
24987411|NCT02297139|50076404|FG001|Overall Study|Other reasons|8|||
24987412|NCT02286089|50076414|FG000|Overall Study|Ongoing in Study|1|||
24987413|NCT02286089|50076415|FG001|Overall Study|Ongoing in Study|1|||
24987414|NCT02286089|50076416|FG002|Overall Study|Ongoing in Study|4|||
24987415|NCT02286089|50076417|FG003|Overall Study|Ongoing in Study|10|||
24987416|NCT02286089|50076414|FG000|Overall Study|Withdrawal by Subject|0|||
24987417|NCT02286089|50076415|FG001|Overall Study|Withdrawal by Subject|0|||
24987418|NCT02286089|50076416|FG002|Overall Study|Withdrawal by Subject|2|||
24987419|NCT02286089|50076417|FG003|Overall Study|Withdrawal by Subject|2|||
24987420|NCT02277444|50076427|FG000|Overall Study|Adverse Event|10|||
24987421|NCT02277444|50076427|FG000|Overall Study|Withdrawal by Subject|3|||
24987422|NCT02277444|50076427|FG000|Overall Study|Other|1|||
24987423|NCT02277444|50076427|FG000|Overall Study|Enrolled and not Treated|3|||
25257199|NCT01324388|50572240|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
24987424|NCT02277444|50076427|FG000|Overall Study|Ongoing|113|||
24987425|NCT02257736|50076433|FG000|Overall Study|Progressive disease|365|||
24987426|NCT02257736|50076434|FG001|Overall Study|Progressive disease|327|||
24987427|NCT02257736|50076433|FG000|Overall Study|Adverse Event|45|||
24987428|NCT02257736|50076434|FG001|Overall Study|Adverse Event|56|||
24987429|NCT02257736|50076433|FG000|Overall Study|Withdrawal by Subject|21|||
24987430|NCT02257736|50076434|FG001|Overall Study|Withdrawal by Subject|38|||
24987431|NCT02257736|50076433|FG000|Overall Study|Death|11|||
24987432|NCT02257736|50076434|FG001|Overall Study|Death|6|||
24987433|NCT02257736|50076433|FG000|Overall Study|Physician Decision|5|||
24987434|NCT02257736|50076434|FG001|Overall Study|Physician Decision|9|||
24987435|NCT02257736|50076433|FG000|Overall Study|Non-Compliance with study drug|1|||
24987436|NCT02257736|50076434|FG001|Overall Study|Non-Compliance with study drug|2|||
24987437|NCT02257736|50076433|FG000|Overall Study|Protocol Violation|1|||
24987438|NCT02257736|50076434|FG001|Overall Study|Protocol Violation|0|||
24987439|NCT02257736|50076433|FG000|Overall Study|Other|1|||
24987440|NCT02257736|50076434|FG001|Overall Study|Other|7|||
24987441|NCT02257736|50076433|FG000|Overall Study|Randomized, not treated|1|||
24987442|NCT02257736|50076434|FG001|Overall Study|Randomized, not treated|2|||
24987443|NCT02252172|50076442|FG000|Overall Study|Lost to Follow-up|3|||
24987444|NCT02252172|50076443|FG001|Overall Study|Lost to Follow-up|1|||
24987445|NCT02252172|50076442|FG000|Overall Study|Ongoing|276|||
24987446|NCT02252172|50076443|FG001|Overall Study|Ongoing|298|||
24987447|NCT02195479|50076451|FG000|Overall Study|Lost to Follow-up|3|||
24987448|NCT02195479|50076452|FG001|Overall Study|Lost to Follow-up|0|||
24987449|NCT02195479|50076451|FG000|Overall Study|Death|48|||
24987450|NCT02195479|50076452|FG001|Overall Study|Death|45|||
24987451|NCT02195479|50076451|FG000|Overall Study|Physician Decision|1|||
24987452|NCT02195479|50076452|FG001|Overall Study|Physician Decision|0|||
24987453|NCT02195479|50076451|FG000|Overall Study|Withdrawal by Subject|11|||
24987454|NCT02195479|50076452|FG001|Overall Study|Withdrawal by Subject|6|||
24987455|NCT02195479|50076451|FG000|Overall Study|Other|2|||
24987456|NCT02195479|50076452|FG001|Overall Study|Other|2|||
24987457|NCT02195479|50076451|FG000|Overall Study|Ongoing|291|||
24987458|NCT02195479|50076452|FG001|Overall Study|Ongoing|297|||
24987459|NCT02142959|50076461|FG000|Overall Study|Adverse Event|1|||
24987460|NCT02142959|50076462|FG001|Overall Study|Adverse Event|0|||
24987461|NCT02142959|50076463|FG002|Overall Study|Adverse Event|0|||
24987462|NCT02142959|50076461|FG000|Overall Study|Death|0|||
24987463|NCT02142959|50076462|FG001|Overall Study|Death|1|||
24987464|NCT02142959|50076463|FG002|Overall Study|Death|0|||
24987465|NCT02142959|50076461|FG000|Overall Study|Withdrawal by Subject|3|||
24987466|NCT02142959|50076462|FG001|Overall Study|Withdrawal by Subject|1|||
24987467|NCT02142959|50076463|FG002|Overall Study|Withdrawal by Subject|3|||
24987468|NCT02142959|50076461|FG000|Overall Study|Administrative Reasons|1|||
24987469|NCT02142959|50076462|FG001|Overall Study|Administrative Reasons|0|||
24987470|NCT02142959|50076463|FG002|Overall Study|Administrative Reasons|1|||
24987471|NCT02142959|50076461|FG000|Overall Study|Missing|0|||
24987472|NCT02142959|50076462|FG001|Overall Study|Missing|1|||
24987473|NCT02142959|50076463|FG002|Overall Study|Missing|0|||
24987474|NCT02142959|50076461|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
24987475|NCT02142959|50076462|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
24987476|NCT02142959|50076463|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
24987477|NCT02142959|50076461|FG000|Overall Study|Patient didn't complete end of study visit|0|||
24987478|NCT02142959|50076462|FG001|Overall Study|Patient didn't complete end of study visit|0|||
24987479|NCT02142959|50076463|FG002|Overall Study|Patient didn't complete end of study visit|1|||
24987480|NCT02100722|50076482|FG000|Overall Study|Withdrawal pre-procedure|4|||
24987481|NCT02100722|50076483|FG001|Overall Study|Withdrawal pre-procedure|9|||
24987482|NCT02100722|50076482|FG000|Overall Study|Withdrawal post-procedure|0|||
24987483|NCT02100722|50076483|FG001|Overall Study|Withdrawal post-procedure|3|||
24987484|NCT02100722|50076482|FG000|Overall Study|Lost to Follow-up|2|||
24987485|NCT02100722|50076483|FG001|Overall Study|Lost to Follow-up|2|||
24987486|NCT02100722|50076482|FG000|Overall Study|Continuing on study|751|||
24987487|NCT02100722|50076483|FG001|Overall Study|Continuing on study|729|||
24987488|NCT02076009|50076501|FG000|Overall Study|Death|44|||
24987489|NCT02076009|50076502|FG001|Overall Study|Death|30|||
24987490|NCT02076009|50076501|FG000|Overall Study|Withdrawal by Subject|9|||
24987491|NCT02076009|50076502|FG001|Overall Study|Withdrawal by Subject|3|||
24987492|NCT02076009|50076501|FG000|Overall Study|Lost to Follow-up|1|||
24987493|NCT02076009|50076502|FG001|Overall Study|Lost to Follow-up|1|||
24987494|NCT02076009|50076501|FG000|Overall Study|Progressive disease|1|||
24987495|NCT02076009|50076502|FG001|Overall Study|Progressive disease|0|||
24987496|NCT02076009|50076501|FG000|Overall Study|Ongoing|226|||
24987497|NCT02076009|50076502|FG001|Overall Study|Ongoing|249|||
24987498|NCT02076009|50076501|FG000|Overall Study|Subjects randomized but not treated|2|||
24987499|NCT02076009|50076502|FG001|Overall Study|Subjects randomized but not treated|3|||
24987500|NCT02043678|50076510|FG000|Overall Study|Never treated|11|||
24987501|NCT02043678|50076511|FG001|Overall Study|Never treated|9|||
24987502|NCT02043678|50076510|FG000|Overall Study|AE with clinical progressive disease(PD)|18|||
24987503|NCT02043678|50076511|FG001|Overall Study|AE with clinical progressive disease(PD)|18|||
24987504|NCT02043678|50076510|FG000|Overall Study|AE without clinical PD|51|||
24987505|NCT02043678|50076511|FG001|Overall Study|AE without clinical PD|34|||
24987506|NCT02043678|50076510|FG000|Overall Study|Lost to Follow-up|1|||
24987507|NCT02043678|50076511|FG001|Overall Study|Lost to Follow-up|1|||
24987508|NCT02043678|50076510|FG000|Overall Study|Other|19|||
24987509|NCT02043678|50076511|FG001|Overall Study|Other|16|||
24987510|NCT02043678|50076510|FG000|Overall Study|Clinical PD|108|||
24987511|NCT02043678|50076511|FG001|Overall Study|Clinical PD|138|||
24987512|NCT02043678|50076510|FG000|Overall Study|Radiological PD|91|||
25257200|NCT01324388|50572241|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
24987513|NCT02043678|50076511|FG001|Overall Study|Radiological PD|80|||
24987514|NCT02043678|50076510|FG000|Overall Study|Protocol-driven decision point|56|||
24987515|NCT02043678|50076511|FG001|Overall Study|Protocol-driven decision point|56|||
24987516|NCT02043678|50076510|FG000|Overall Study|Withdrawal by Subject|12|||
24987517|NCT02043678|50076511|FG001|Overall Study|Withdrawal by Subject|15|||
24987518|NCT02043678|50076510|FG000|Overall Study|Ongoing with treatment|34|||
24987519|NCT02043678|50076511|FG001|Overall Study|Ongoing with treatment|38|||
24987520|NCT02028988|50076517|FG000|Overall Study|Withdrawal by Subject|2|||
24987521|NCT02004236|50076524|FG000|Overall Study|Lack of Efficacy|0|||
24987522|NCT02004236|50076525|FG001|Overall Study|Lack of Efficacy|0|||
24987523|NCT02004236|50076526|FG002|Overall Study|Lack of Efficacy|16|||
24987524|NCT01974440|50076537|FG000|Overall Study|Lost to Follow-up|8|||
24987525|NCT01974440|50076538|FG001|Overall Study|Lost to Follow-up|7|||
24987526|NCT01974440|50076537|FG000|Overall Study|Withdrawal by Subject|20|||
24987527|NCT01974440|50076538|FG001|Overall Study|Withdrawal by Subject|19|||
24987528|NCT01974440|50076537|FG000|Overall Study|Ongoing|112|||
24987529|NCT01974440|50076538|FG001|Overall Study|Ongoing|116|||
24987530|NCT01959139|50076548|FG000|Phase II|Disease progression|0|||
24987531|NCT01959139|50076549|FG001|Phase II|Disease progression|0|||
24987532|NCT01959139|50076550|FG002|Phase II|Disease progression|26|||
24987533|NCT01959139|50076551|FG003|Phase II|Disease progression|34|||
24987534|NCT01959139|50076548|FG000|Phase II|Adverse Event|0|||
24987535|NCT01959139|50076549|FG001|Phase II|Adverse Event|0|||
24987536|NCT01959139|50076550|FG002|Phase II|Adverse Event|10|||
24987537|NCT01959139|50076551|FG003|Phase II|Adverse Event|11|||
24987538|NCT01959139|50076548|FG000|Phase II|Patient Refusal|0|||
24987539|NCT01959139|50076549|FG001|Phase II|Patient Refusal|0|||
24987540|NCT01959139|50076550|FG002|Phase II|Patient Refusal|5|||
24987541|NCT01959139|50076551|FG003|Phase II|Patient Refusal|4|||
24987542|NCT01959139|50076548|FG000|Phase II|Death|0|||
24987543|NCT01959139|50076549|FG001|Phase II|Death|0|||
24987544|NCT01959139|50076550|FG002|Phase II|Death|3|||
24987545|NCT01959139|50076551|FG003|Phase II|Death|1|||
24987546|NCT01959139|50076548|FG000|Phase II|Other/Unknown|0|||
24987547|NCT01959139|50076549|FG001|Phase II|Other/Unknown|0|||
24987548|NCT01959139|50076550|FG002|Phase II|Other/Unknown|8|||
24987549|NCT01959139|50076551|FG003|Phase II|Other/Unknown|5|||
24987550|NCT01959139|50076548|FG000|Phase II|On treatment|0|||
24987551|NCT01959139|50076549|FG001|Phase II|On treatment|0|||
24987552|NCT01959139|50076550|FG002|Phase II|On treatment|4|||
24987553|NCT01959139|50076551|FG003|Phase II|On treatment|0|||
24987554|NCT01946204|50076568|FG000|Overall Study|Death|38|||
24987555|NCT01946204|50076569|FG001|Overall Study|Death|59|||
24987556|NCT01946204|50076568|FG000|Overall Study|Withdrawal by Subject|37|||
24987557|NCT01946204|50076569|FG001|Overall Study|Withdrawal by Subject|50|||
24987558|NCT01946204|50076568|FG000|Overall Study|Lost to Follow-up|3|||
24987559|NCT01946204|50076569|FG001|Overall Study|Lost to Follow-up|7|||
24987560|NCT01946204|50076568|FG000|Overall Study|Ongoing|316|||
24987561|NCT01946204|50076569|FG001|Overall Study|Ongoing|687|||
24987562|NCT01946204|50076568|FG000|Overall Study|Other|7|||
24987563|NCT01946204|50076569|FG001|Overall Study|Other|3|||
24987564|NCT01784068|50076593|FG000|NTCS Phase|Adverse Event|5|||
24987565|NCT01784068|50076594|FG001|NTCS Phase|Adverse Event|0|||
24987566|NCT01784068|50076593|FG000|NTCS Phase|Physician Decision|2|||
24987567|NCT01784068|50076594|FG001|NTCS Phase|Physician Decision|0|||
24987568|NCT01784068|50076593|FG000|NTCS Phase|Patient/guardian decision|3|||
24987569|NCT01784068|50076594|FG001|NTCS Phase|Patient/guardian decision|0|||
24987570|NCT01784068|50076593|FG000|NTCS Phase|Death|2|||
24987571|NCT01784068|50076594|FG001|NTCS Phase|Death|0|||
24987572|NCT01784068|50076593|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
24987573|NCT01784068|50076594|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
24987574|NCT01784068|50076593|FG000|TFR Phase|Physician Decision|0|||
24987575|NCT01784068|50076594|FG001|TFR Phase|Physician Decision|1|||
24987576|NCT01784068|50076593|FG000|TFR Phase|Patient/guardian decision|0|||
24987577|NCT01784068|50076594|FG001|TFR Phase|Patient/guardian decision|3|||
24987578|NCT01784068|50076593|FG000|TFR Phase|Death|0|||
24987579|NCT01784068|50076594|FG001|TFR Phase|Death|1|||
24987580|NCT01784068|50076593|FG000|TFR Phase|Lack of Efficacy|0|||
24987581|NCT01784068|50076594|FG001|TFR Phase|Lack of Efficacy|88|||
24987582|NCT01776840|50076607|FG000|Overall Study|Lost to Follow-up|4|||
24987583|NCT01776840|50076608|FG001|Overall Study|Lost to Follow-up|4|||
24987584|NCT01776840|50076607|FG000|Overall Study|Withdrawal by Subject|42|||
24987585|NCT01776840|50076608|FG001|Overall Study|Withdrawal by Subject|22|||
24987586|NCT01776840|50076607|FG000|Overall Study|Ongoing|112|||
24987587|NCT01776840|50076608|FG001|Overall Study|Ongoing|129|||
24987588|NCT01642251|50076617|FG000|Overall Study|Progressive disease|0|||
24987589|NCT01642251|50076618|FG001|Overall Study|Progressive disease|0|||
24987590|NCT01642251|50076619|FG002|Overall Study|Progressive disease|3|||
24987591|NCT01642251|50076620|FG003|Overall Study|Progressive disease|3|||
24987592|NCT01642251|50076617|FG000|Overall Study|Adverse Event|0|||
24987593|NCT01642251|50076618|FG001|Overall Study|Adverse Event|0|||
24987594|NCT01642251|50076619|FG002|Overall Study|Adverse Event|5|||
24987595|NCT01642251|50076620|FG003|Overall Study|Adverse Event|4|||
24987596|NCT01642251|50076617|FG000|Overall Study|Death|0|||
24987597|NCT01642251|50076618|FG001|Overall Study|Death|0|||
24987598|NCT01642251|50076619|FG002|Overall Study|Death|1|||
24987599|NCT01642251|50076620|FG003|Overall Study|Death|3|||
24987600|NCT01642251|50076617|FG000|Overall Study|Withdrawal by Subject|0|||
24987601|NCT01642251|50076618|FG001|Overall Study|Withdrawal by Subject|0|||
24987602|NCT01642251|50076619|FG002|Overall Study|Withdrawal by Subject|1|||
24987603|NCT01642251|50076620|FG003|Overall Study|Withdrawal by Subject|3|||
24987604|NCT01642251|50076617|FG000|Overall Study|Alternative therapy|0|||
24987605|NCT01642251|50076618|FG001|Overall Study|Alternative therapy|0|||
24987606|NCT01642251|50076619|FG002|Overall Study|Alternative therapy|0|||
24987607|NCT01642251|50076620|FG003|Overall Study|Alternative therapy|2|||
24987608|NCT01642251|50076617|FG000|Overall Study|Other complicating disease|0|||
24987609|NCT01642251|50076618|FG001|Overall Study|Other complicating disease|0|||
24987610|NCT01642251|50076619|FG002|Overall Study|Other complicating disease|1|||
24987611|NCT01642251|50076620|FG003|Overall Study|Other complicating disease|0|||
24987612|NCT01642251|50076617|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
24987613|NCT01642251|50076618|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
24987614|NCT01642251|50076619|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
24987615|NCT01642251|50076620|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
24987616|NCT01615029|50076634|FG000|Overall Study|Adverse Event|0|||
24987617|NCT01615029|50076635|FG001|Overall Study|Adverse Event|0|||
24987618|NCT01615029|50076636|FG002|Overall Study|Adverse Event|0|||
24987619|NCT01615029|50076637|FG003|Overall Study|Adverse Event|0|||
24987620|NCT01615029|50076638|FG004|Overall Study|Adverse Event|1|||
24987621|NCT01615029|50076634|FG000|Overall Study|Death|0|||
24987622|NCT01615029|50076635|FG001|Overall Study|Death|0|||
24987623|NCT01615029|50076636|FG002|Overall Study|Death|0|||
24987624|NCT01615029|50076637|FG003|Overall Study|Death|0|||
24987625|NCT01615029|50076638|FG004|Overall Study|Death|1|||
24987626|NCT01615029|50076634|FG000|Overall Study|Lost to Follow-up|0|||
24987627|NCT01615029|50076635|FG001|Overall Study|Lost to Follow-up|0|||
24987628|NCT01615029|50076636|FG002|Overall Study|Lost to Follow-up|0|||
24987629|NCT01615029|50076637|FG003|Overall Study|Lost to Follow-up|0|||
24987630|NCT01615029|50076638|FG004|Overall Study|Lost to Follow-up|1|||
24987631|NCT01615029|50076634|FG000|Overall Study|Progressive disease|2|||
24987632|NCT01615029|50076635|FG001|Overall Study|Progressive disease|1|||
24987633|NCT01615029|50076636|FG002|Overall Study|Progressive disease|1|||
24987634|NCT01615029|50076637|FG003|Overall Study|Progressive disease|1|||
24987635|NCT01615029|50076638|FG004|Overall Study|Progressive disease|5|||
24987636|NCT01615029|50076634|FG000|Overall Study|Physician Decision|0|||
24987637|NCT01615029|50076635|FG001|Overall Study|Physician Decision|0|||
24987638|NCT01615029|50076636|FG002|Overall Study|Physician Decision|0|||
24987639|NCT01615029|50076637|FG003|Overall Study|Physician Decision|0|||
24987640|NCT01615029|50076638|FG004|Overall Study|Physician Decision|1|||
24987641|NCT01615029|50076634|FG000|Overall Study|Ongoing|1|||
24987642|NCT01615029|50076635|FG001|Overall Study|Ongoing|2|||
24987643|NCT01615029|50076636|FG002|Overall Study|Ongoing|3|||
24987644|NCT01615029|50076637|FG003|Overall Study|Ongoing|2|||
24987645|NCT01615029|50076638|FG004|Overall Study|Ongoing|23|||
24987646|NCT01606137|50076650|FG000|Overall Study|Adverse Event|85|||
24987647|NCT01606137|50076650|FG000|Overall Study|Withdrawal by Subject|74|||
24987648|NCT01606137|50076650|FG000|Overall Study|Lack of Efficacy|56|||
24987649|NCT01606137|50076650|FG000|Overall Study|Lost to Follow-up|15|||
24987650|NCT01606137|50076650|FG000|Overall Study|Protocol Violation|1|||
24987651|NCT01606137|50076650|FG000|Overall Study|Patient non-compliance|9|||
24987652|NCT01606137|50076650|FG000|Overall Study|Death|1|||
24987653|NCT01606137|50076650|FG000|Overall Study|Decreased/no pain|4|||
24987654|NCT01606137|50076650|FG000|Overall Study|Issues with driving|4|||
24987655|NCT01606137|50076650|FG000|Overall Study|multiple sclerosis less stable|1|||
24987656|NCT01606137|50076650|FG000|Overall Study|Increased bilirubin|1|||
24987657|NCT01606137|50076650|FG000|Overall Study|Spray causes nausea|1|||
24987658|NCT01606137|50076650|FG000|Overall Study|Not enough improvement|4|||
24987659|NCT01606137|50076650|FG000|Overall Study|Wanted to try another treatment|1|||
24987660|NCT01606137|50076650|FG000|Overall Study|Patient leaving country|1|||
24987661|NCT01606137|50076650|FG000|Overall Study|Personal reasons|1|||
24987662|NCT01606137|50076650|FG000|Overall Study|Unable to tolerate study med. taste|1|||
24987663|NCT01606137|50076650|FG000|Overall Study|Patient moving|1|||
24987664|NCT01606137|50076650|FG000|Overall Study|Unable to collect consistent data|1|||
24987665|NCT01532518|50076657|FG000|Overall Study|Withdrawal by Subject|0|||
24987666|NCT01532518|50076658|FG001|Overall Study|Withdrawal by Subject|0|||
24987667|NCT01532518|50076659|FG002|Overall Study|Withdrawal by Subject|1|||
24987678|NCT01314118|50076694|FG000|Overall Study|Adverse Event|9|||
24987679|NCT01314118|50076694|FG000|Overall Study|Progressive disease|27|||
24987680|NCT01314118|50076694|FG000|Overall Study|Physician Decision|11|||
24987681|NCT01314118|50076694|FG000|Overall Study|Death|4|||
24987682|NCT01314118|50076694|FG000|Overall Study|Protocol Violation|5|||
24987683|NCT01314118|50076694|FG000|Overall Study|Withdrawal by Subject|11|||
24987684|NCT01314118|50076694|FG000|Overall Study|Other|2|||
24987685|NCT01314118|50076694|FG000|Overall Study|Ongoing|62|||
24987686|NCT01171898|50076702|FG000|Overall Study|Death|0|||
24987687|NCT01171898|50076703|FG001|Overall Study|Death|0|||
24987688|NCT01171898|50076704|FG002|Overall Study|Death|2|||
24987689|NCT01171898|50076705|FG003|Overall Study|Death|0|||
24987690|NCT01171898|50076702|FG000|Overall Study|Lost to Follow-up|0|||
24987691|NCT01171898|50076703|FG001|Overall Study|Lost to Follow-up|1|||
24987692|NCT01171898|50076704|FG002|Overall Study|Lost to Follow-up|1|||
24987693|NCT01171898|50076705|FG003|Overall Study|Lost to Follow-up|1|||
24987694|NCT01171898|50076702|FG000|Overall Study|Withdrawal by Subject|1|||
24987695|NCT01171898|50076703|FG001|Overall Study|Withdrawal by Subject|4|||
24987696|NCT01171898|50076704|FG002|Overall Study|Withdrawal by Subject|6|||
24987697|NCT01171898|50076705|FG003|Overall Study|Withdrawal by Subject|3|||
24987698|NCT01171898|50076702|FG000|Overall Study|Terminated by Sponsor|1|||
24987699|NCT01171898|50076703|FG001|Overall Study|Terminated by Sponsor|0|||
24987700|NCT01171898|50076704|FG002|Overall Study|Terminated by Sponsor|0|||
24987701|NCT01171898|50076705|FG003|Overall Study|Terminated by Sponsor|0|||
24987702|NCT01171898|50076702|FG000|Overall Study|Ongoing|1|||
24987703|NCT01171898|50076703|FG001|Overall Study|Ongoing|9|||
24987704|NCT01171898|50076704|FG002|Overall Study|Ongoing|3|||
24987705|NCT01171898|50076705|FG003|Overall Study|Ongoing|0|||
24987706|NCT01171898|50076702|FG000|Overall Study|Other|1|||
24987707|NCT01171898|50076703|FG001|Overall Study|Other|5|||
24987708|NCT01171898|50076704|FG002|Overall Study|Other|0|||
24987709|NCT01171898|50076705|FG003|Overall Study|Other|2|||
24987710|NCT00980538|50076722|FG000|Overall Study|Lost to Follow-up|20|||
24987711|NCT00980538|50076722|FG000|Overall Study|Sponsor's Decision|4|||
24987712|NCT00980538|50076722|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
24987713|NCT00980538|50076722|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
24987714|NCT00980538|50076722|FG000|Overall Study|Switch to Commercially Available Medication|25|||
24987715|NCT00980538|50076722|FG000|Overall Study|Participant Non-Compliant|9|||
24987716|NCT00980538|50076722|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
24987717|NCT00980538|50076722|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
24987718|NCT00980538|50076722|FG000|Overall Study|Other|60|||
24987719|NCT00980538|50076722|FG000|Overall Study|Other|1|||
24987720|NCT00844285|50076729|FG000|Overall Study|Other|0|||
24987721|NCT00844285|50076730|FG001|Overall Study|Other|1|||
24987722|NCT00844285|50076731|FG002|Overall Study|Other|0|||
24987723|NCT00844285|50076729|FG000|Overall Study|Other than specified|95|||
24987724|NCT00844285|50076730|FG001|Overall Study|Other than specified|129|||
24987725|NCT00844285|50076731|FG002|Overall Study|Other than specified|12|||
24987726|NCT00844285|50076729|FG000|Overall Study|Site closure|256|||
24987727|NCT00844285|50076730|FG001|Overall Study|Site closure|450|||
24987728|NCT00844285|50076731|FG002|Overall Study|Site closure|50|||
24987729|NCT00844285|50076729|FG000|Overall Study|Follow-up < 8 years|16|||
24987730|NCT00844285|50076730|FG001|Overall Study|Follow-up < 8 years|23|||
24987731|NCT00844285|50076731|FG002|Overall Study|Follow-up < 8 years|4|||
24987732|NCT00844285|50076729|FG000|Overall Study|Protocol Violation|26|||
24987733|NCT00844285|50076730|FG001|Overall Study|Protocol Violation|28|||
24987734|NCT00844285|50076731|FG002|Overall Study|Protocol Violation|54|||
24987735|NCT00844285|50076729|FG000|Overall Study|Death|22|||
24987736|NCT00844285|50076730|FG001|Overall Study|Death|21|||
24987737|NCT00844285|50076731|FG002|Overall Study|Death|8|||
24987738|NCT00844285|50076729|FG000|Overall Study|Withdrew Consent|344|||
24987739|NCT00844285|50076730|FG001|Overall Study|Withdrew Consent|466|||
24987740|NCT00844285|50076731|FG002|Overall Study|Withdrew Consent|70|||
24987741|NCT00844285|50076729|FG000|Overall Study|Lost to Follow-up|330|||
24987742|NCT00844285|50076730|FG001|Overall Study|Lost to Follow-up|486|||
24987743|NCT00844285|50076731|FG002|Overall Study|Lost to Follow-up|74|||
24987744|NCT00711646|50076759|FG000|Overall Study|Adverse Event|6|||
24987745|NCT00711646|50076760|FG001|Overall Study|Adverse Event|1|||
24987746|NCT00711646|50076759|FG000|Overall Study|Withdrawal by Subject|4|||
24987747|NCT00711646|50076760|FG001|Overall Study|Withdrawal by Subject|0|||
24987748|NCT00711646|50076759|FG000|Overall Study|Protocol Violation|0|||
24987749|NCT00711646|50076760|FG001|Overall Study|Protocol Violation|1|||
24987750|NCT00711646|50076759|FG000|Overall Study|Lost to Follow-up|1|||
24987751|NCT00711646|50076760|FG001|Overall Study|Lost to Follow-up|0|||
24987752|NCT00711646|50076759|FG000|Overall Study|administrative decision|0|||
24987753|NCT00711646|50076760|FG001|Overall Study|administrative decision|1|||
24987754|NCT00711646|50076759|FG000|Overall Study|patient non-compliance|1|||
24987755|NCT00711646|50076760|FG001|Overall Study|patient non-compliance|0|||
24987756|NCT00640133|50076786|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
24987757|NCT00640133|50076787|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
24987758|NCT00640133|50076786|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
24987759|NCT00640133|50076787|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
24987760|NCT00640133|50076786|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
24987761|NCT00640133|50076787|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
24987762|NCT00379340|50076814|FG000|Overall Study|Death|0|||
24987763|NCT00379340|50076815|FG001|Overall Study|Death|0|||
24987764|NCT00379340|50076816|FG002|Overall Study|Death|0|||
24987765|NCT00379340|50076817|FG003|Overall Study|Death|2|||
24987766|NCT00379340|50076818|FG004|Overall Study|Death|0|||
24987767|NCT00379340|50076814|FG000|Overall Study|Lack of Efficacy|6|||
24987768|NCT00379340|50076815|FG001|Overall Study|Lack of Efficacy|1|||
24987769|NCT00379340|50076816|FG002|Overall Study|Lack of Efficacy|0|||
24987770|NCT00379340|50076817|FG003|Overall Study|Lack of Efficacy|4|||
24987771|NCT00379340|50076818|FG004|Overall Study|Lack of Efficacy|3|||
24987772|NCT00379340|50076814|FG000|Overall Study|Physician Decision|6|||
24987773|NCT00379340|50076815|FG001|Overall Study|Physician Decision|2|||
24987774|NCT00379340|50076816|FG002|Overall Study|Physician Decision|1|||
24987775|NCT00379340|50076817|FG003|Overall Study|Physician Decision|2|||
24987776|NCT00379340|50076818|FG004|Overall Study|Physician Decision|3|||
24987777|NCT00379340|50076814|FG000|Overall Study|Withdrawal by Subject|0|||
24987778|NCT00379340|50076815|FG001|Overall Study|Withdrawal by Subject|0|||
24987779|NCT00379340|50076816|FG002|Overall Study|Withdrawal by Subject|0|||
24987780|NCT00379340|50076817|FG003|Overall Study|Withdrawal by Subject|1|||
24987781|NCT00379340|50076818|FG004|Overall Study|Withdrawal by Subject|0|||
24987782|NCT00379340|50076814|FG000|Overall Study|Refusal of further protocol therapy|1|||
24987783|NCT00379340|50076815|FG001|Overall Study|Refusal of further protocol therapy|0|||
24987784|NCT00379340|50076816|FG002|Overall Study|Refusal of further protocol therapy|1|||
24987785|NCT00379340|50076817|FG003|Overall Study|Refusal of further protocol therapy|1|||
24987786|NCT00379340|50076818|FG004|Overall Study|Refusal of further protocol therapy|7|||
24987787|NCT00379340|50076814|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
24987788|NCT00379340|50076815|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
24987789|NCT00379340|50076816|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
24987790|NCT00379340|50076817|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
24987791|NCT00379340|50076818|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
24987792|NCT00379340|50076814|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
24987793|NCT00379340|50076815|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
24987794|NCT00379340|50076816|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
24987795|NCT00379340|50076817|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
24987796|NCT00379340|50076818|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
24987797|NCT00301808|50076831|FG000|Overall Study|Adverse Event|5|||
24987798|NCT00301808|50076831|FG000|Overall Study|Death|3|||
24987799|NCT00301808|50076831|FG000|Overall Study|Lack of Efficacy|4|||
24987800|NCT04979858|50076859|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
24987801|NCT04979858|50076860|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
24987802|NCT04030598|50076908|FG000|Overall Study|Voluntary Withdrawal|0|||
24987803|NCT04030598|50076909|FG001|Overall Study|Voluntary Withdrawal|1|||
24987804|NCT04030598|50076910|FG002|Overall Study|Voluntary Withdrawal|0|||
24987805|NCT03830164|50076930|FG000|Overall Study|Adverse Event|0|||
24987806|NCT03830164|50076931|FG001|Overall Study|Adverse Event|2|||
24987807|NCT03830164|50076932|FG002|Overall Study|Adverse Event|0|||
24987808|NCT03830164|50076930|FG000|Overall Study|Lack of Efficacy|1|||
24987809|NCT03830164|50076931|FG001|Overall Study|Lack of Efficacy|5|||
24987810|NCT03830164|50076932|FG002|Overall Study|Lack of Efficacy|0|||
24987811|NCT03830164|50076930|FG000|Overall Study|Lost to Follow-up|0|||
24987812|NCT03830164|50076931|FG001|Overall Study|Lost to Follow-up|1|||
24987813|NCT03830164|50076932|FG002|Overall Study|Lost to Follow-up|0|||
24987814|NCT03830164|50076930|FG000|Overall Study|Withdrawal by Subject|1|||
24987815|NCT03830164|50076931|FG001|Overall Study|Withdrawal by Subject|0|||
24987816|NCT03830164|50076932|FG002|Overall Study|Withdrawal by Subject|0|||
24987817|NCT03777436|50076942|FG000|Placebo-controlled Phase|Adverse Event|8|||
24987818|NCT03777436|50076943|FG001|Placebo-controlled Phase|Adverse Event|10|||
24987819|NCT03777436|50076944|FG002|Placebo-controlled Phase|Adverse Event|0|||
24987820|NCT03777436|50076942|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
24987821|NCT03777436|50076943|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
24987822|NCT03777436|50076944|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
24987823|NCT03777436|50076942|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
24987824|NCT03777436|50076943|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
24987825|NCT03777436|50076944|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
24987826|NCT03777436|50076942|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
24987827|NCT03777436|50076943|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
24987828|NCT03777436|50076944|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
25257201|NCT01102777|50572255|FG000|Overall Study|Death|2|||
24987829|NCT03777436|50076942|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
24987830|NCT03777436|50076943|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
24987831|NCT03777436|50076944|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
24987832|NCT03777436|50076942|FG000|Placebo-controlled Phase|Physician Decision|0|||
24987833|NCT03777436|50076943|FG001|Placebo-controlled Phase|Physician Decision|1|||
24987834|NCT03777436|50076944|FG002|Placebo-controlled Phase|Physician Decision|0|||
24987835|NCT03777436|50076942|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
24987836|NCT03777436|50076943|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
24987837|NCT03777436|50076944|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
24987838|NCT03777436|50076942|FG000|Apremilast Extension Phase|Adverse Event|0|||
24987839|NCT03777436|50076943|FG001|Apremilast Extension Phase|Adverse Event|0|||
24987840|NCT03777436|50076944|FG002|Apremilast Extension Phase|Adverse Event|6|||
24987841|NCT03777436|50076942|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
24987842|NCT03777436|50076943|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
24987843|NCT03777436|50076944|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
24987844|NCT03777436|50076942|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
24987845|NCT03777436|50076943|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
24987846|NCT03777436|50076944|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
24987847|NCT03777436|50076942|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
24987848|NCT03777436|50076943|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
24987849|NCT03777436|50076944|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
24987850|NCT03777436|50076942|FG000|Apremilast Extension Phase|Miscellaneous|0|||
24987851|NCT03777436|50076943|FG001|Apremilast Extension Phase|Miscellaneous|0|||
24987852|NCT03777436|50076944|FG002|Apremilast Extension Phase|Miscellaneous|1|||
24987853|NCT03156023|50076960|FG000|Overall Study|Withdrawal by Subject|1|||
24987854|NCT03156023|50076961|FG001|Overall Study|Withdrawal by Subject|0|||
24987855|NCT03156023|50076962|FG002|Overall Study|Withdrawal by Subject|2|||
24987856|NCT03156023|50076963|FG003|Overall Study|Withdrawal by Subject|1|||
24987857|NCT03156023|50076964|FG004|Overall Study|Withdrawal by Subject|1|||
24987858|NCT03156023|50076960|FG000|Overall Study|Lost to Follow-up|0|||
24987859|NCT03156023|50076961|FG001|Overall Study|Lost to Follow-up|0|||
24987860|NCT03156023|50076962|FG002|Overall Study|Lost to Follow-up|0|||
24987861|NCT03156023|50076963|FG003|Overall Study|Lost to Follow-up|0|||
24987862|NCT03156023|50076964|FG004|Overall Study|Lost to Follow-up|1|||
24987863|NCT03025880|50076982|FG000|Overall Study|Adverse Event|1|||
24987864|NCT03025880|50076983|FG001|Overall Study|Adverse Event|0|||
24987865|NCT03025880|50076982|FG000|Overall Study|Death|1|||
24987866|NCT03025880|50076983|FG001|Overall Study|Death|1|||
24987867|NCT03025880|50076982|FG000|Overall Study|Withdrawal by Subject|0|||
24987868|NCT03025880|50076983|FG001|Overall Study|Withdrawal by Subject|1|||
24987869|NCT03025880|50076982|FG000|Overall Study|Physician Decision|0|||
24987870|NCT03025880|50076983|FG001|Overall Study|Physician Decision|1|||
24987871|NCT03025880|50076982|FG000|Overall Study|Progressive Disease|12|||
24987872|NCT03025880|50076983|FG001|Overall Study|Progressive Disease|19|||
24987873|NCT02027376|50077000|FG000|Overall Study|Death|1|||
24987874|NCT02027376|50077001|FG001|Overall Study|Death|0|||
24987875|NCT02027376|50077002|FG002|Overall Study|Death|0|||
24987876|NCT01924533|50077014|FG000|Overall Study|Death|181|||
24987877|NCT01924533|50077015|FG001|Overall Study|Death|200|||
24987878|NCT01924533|50077014|FG000|Overall Study|Lost to Follow-up|0|||
24987879|NCT01924533|50077015|FG001|Overall Study|Lost to Follow-up|1|||
24987880|NCT01924533|50077014|FG000|Overall Study|Withdrawal by Subject|7|||
24987881|NCT01924533|50077015|FG001|Overall Study|Withdrawal by Subject|3|||
24987882|NCT01924533|50077014|FG000|Overall Study|Other Eligibility criteria|1|||
24987883|NCT01924533|50077015|FG001|Overall Study|Other Eligibility criteria|1|||
24987884|NCT01606436|50077021|FG000|Overall Study|Withdrawal by Subject|0|||
24987885|NCT01606436|50077022|FG001|Overall Study|Withdrawal by Subject|0|||
24987886|NCT01606436|50077023|FG002|Overall Study|Withdrawal by Subject|1|||
24987887|NCT01606436|50077024|FG003|Overall Study|Withdrawal by Subject|1|||
24987888|NCT01606436|50077025|FG004|Overall Study|Withdrawal by Subject|1|||
24987889|NCT01606436|50077026|FG005|Overall Study|Withdrawal by Subject|0|||
24987890|NCT01606436|50077021|FG000|Overall Study|Adverse Event|0|||
24987891|NCT01606436|50077022|FG001|Overall Study|Adverse Event|0|||
24987892|NCT01606436|50077023|FG002|Overall Study|Adverse Event|1|||
24987893|NCT01606436|50077024|FG003|Overall Study|Adverse Event|0|||
24987894|NCT01606436|50077025|FG004|Overall Study|Adverse Event|0|||
24987895|NCT01606436|50077026|FG005|Overall Study|Adverse Event|0|||
24987896|NCT01606436|50077021|FG000|Overall Study|Sponsor Decision|0|||
24987897|NCT01606436|50077022|FG001|Overall Study|Sponsor Decision|0|||
24987898|NCT01606436|50077023|FG002|Overall Study|Sponsor Decision|0|||
24987899|NCT01606436|50077024|FG003|Overall Study|Sponsor Decision|1|||
24987900|NCT01606436|50077025|FG004|Overall Study|Sponsor Decision|0|||
24987901|NCT01606436|50077026|FG005|Overall Study|Sponsor Decision|0|||
24987902|NCT00219557|50077037|FG000|Phase 1|Lack of Efficacy|3|||
24987903|NCT00219557|50077038|FG001|Phase 1|Lack of Efficacy|0|||
24987904|NCT00219557|50077039|FG002|Phase 1|Lack of Efficacy|0|||
25257202|NCT01102777|50572256|FG001|Overall Study|Death|6|||
24987905|NCT00219557|50077037|FG000|Phase 1|Adverse Event|2|||
24987906|NCT00219557|50077038|FG001|Phase 1|Adverse Event|0|||
24987907|NCT00219557|50077039|FG002|Phase 1|Adverse Event|0|||
24987908|NCT00219557|50077037|FG000|Phase 1|Withdrawal by Subject|1|||
24987909|NCT00219557|50077038|FG001|Phase 1|Withdrawal by Subject|0|||
25257203|NCT01102777|50572255|FG000|Overall Study|Lost to Follow-up|7|||
24987910|NCT00219557|50077039|FG002|Phase 1|Withdrawal by Subject|0|||
24987911|NCT00219557|50077037|FG000|Phase 1|Started chemotherapy at other institute|1|||
24987912|NCT00219557|50077038|FG001|Phase 1|Started chemotherapy at other institute|0|||
24987913|NCT00219557|50077039|FG002|Phase 1|Started chemotherapy at other institute|0|||
24987914|NCT00219557|50077037|FG000|Phase 2|Lack of Efficacy|0|||
24987915|NCT00219557|50077038|FG001|Phase 2|Lack of Efficacy|21|||
24987916|NCT00219557|50077039|FG002|Phase 2|Lack of Efficacy|15|||
24987917|NCT00219557|50077037|FG000|Phase 2|Adverse Event|0|||
24987918|NCT00219557|50077038|FG001|Phase 2|Adverse Event|22|||
24987919|NCT00219557|50077039|FG002|Phase 2|Adverse Event|2|||
24987920|NCT00219557|50077037|FG000|Phase 2|Death|0|||
24987921|NCT00219557|50077038|FG001|Phase 2|Death|8|||
24987922|NCT00219557|50077039|FG002|Phase 2|Death|2|||
24987923|NCT00219557|50077037|FG000|Phase 2|Other|0|||
24987924|NCT00219557|50077038|FG001|Phase 2|Other|8|||
24987925|NCT00219557|50077039|FG002|Phase 2|Other|6|||
24987926|NCT00219557|50077037|FG000|Phase 2|Withdrawal by Subject|0|||
24987927|NCT00219557|50077038|FG001|Phase 2|Withdrawal by Subject|9|||
24987928|NCT00219557|50077039|FG002|Phase 2|Withdrawal by Subject|5|||
24987929|NCT00219557|50077037|FG000|Phase 2|Treatment not received|0|||
24987930|NCT00219557|50077038|FG001|Phase 2|Treatment not received|1|||
24987931|NCT00219557|50077039|FG002|Phase 2|Treatment not received|3|||
24987932|NCT00251927|50077054|FG000|Overall Study|Adverse Event|3|||
24987933|NCT00251927|50077055|FG001|Overall Study|Adverse Event|15|||
24987934|NCT00251927|50077054|FG000|Overall Study|Lack of Efficacy|22|||
24987935|NCT00251927|50077055|FG001|Overall Study|Lack of Efficacy|16|||
24987936|NCT00251927|50077054|FG000|Overall Study|Lost to Follow-up|22|||
24987937|NCT00251927|50077055|FG001|Overall Study|Lost to Follow-up|8|||
24987938|NCT00251927|50077054|FG000|Overall Study|Protocol Violation|1|||
24987939|NCT00251927|50077055|FG001|Overall Study|Protocol Violation|2|||
24987940|NCT00251927|50077054|FG000|Overall Study|Pregnancy|2|||
24987941|NCT00251927|50077055|FG001|Overall Study|Pregnancy|0|||
24987942|NCT00251927|50077054|FG000|Overall Study|Withdrawal by Subject|40|||
24987943|NCT00251927|50077055|FG001|Overall Study|Withdrawal by Subject|25|||
24987944|NCT00251927|50077054|FG000|Overall Study|Study-specific discont. achieved|13|||
24987945|NCT00251927|50077055|FG001|Overall Study|Study-specific discont. achieved|2|||
24987946|NCT00251927|50077054|FG000|Overall Study|Study procedure non-compliance|5|||
24987947|NCT00251927|50077055|FG001|Overall Study|Study procedure non-compliance|6|||
24987948|NCT00165503|50077062|FG000|Overall Study|Death|1|||
24987949|NCT00165503|50077062|FG000|Overall Study|Lost to Follow-up|12|||
24987950|NCT00165503|50077062|FG000|Overall Study|Unresectable|3|||
24987951|NCT00162773|50077066|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
24987952|NCT00209339|50077070|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
24987953|NCT00209339|50077070|FG000|At 12 Months Follow-up|Death|1|||
24987954|NCT00209339|50077070|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
24987955|NCT00209339|50077070|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
24987956|NCT00209339|50077070|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
24987957|NCT00209339|50077070|FG000|At 24 Months Follow-up|Death|1|||
24987958|NCT00209339|50077070|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
24987959|NCT00209339|50077070|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
24987960|NCT00209339|50077070|FG000|At 4 Years Follow-up|Death|1|||
24987961|NCT00209339|50077070|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
24987962|NCT00209339|50077070|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
24987963|NCT00209339|50077070|FG000|At 5 Years Follow-up|Death|1|||
24987964|NCT03823391|50077076|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
24987965|NCT03823391|50077077|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
24987966|NCT03823391|50077076|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
24987967|NCT03823391|50077077|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
24987968|NCT00161213|50077085|FG000|Overall Study|Withdrawal by Subject|1|||
24987969|NCT00161213|50077085|FG000|Overall Study|Evaluable for toxicity but not response|1|||
24987970|NCT00209027|50077091|FG000|Overall Study|study terminated|10|||
24987971|NCT00209027|50077092|FG001|Overall Study|study terminated|0|||
24987972|NCT00208325|50077102|FG000|Overall Study|Death|18|||
24987973|NCT00208325|50077103|FG001|Overall Study|Death|19|||
24987974|NCT00208325|50077104|FG002|Overall Study|Death|7|||
25257204|NCT01102777|50572256|FG001|Overall Study|Lost to Follow-up|10|||
24987975|NCT00208325|50077105|FG003|Overall Study|Death|5|||
24987976|NCT00208325|50077102|FG000|Overall Study|Withdrawal by Subject|0|||
24987977|NCT00208325|50077103|FG001|Overall Study|Withdrawal by Subject|1|||
24987978|NCT00208325|50077104|FG002|Overall Study|Withdrawal by Subject|0|||
24987979|NCT00208325|50077105|FG003|Overall Study|Withdrawal by Subject|0|||
24987980|NCT00208325|50077102|FG000|Overall Study|Revision|4|||
24987981|NCT00208325|50077103|FG001|Overall Study|Revision|1|||
24987982|NCT00208325|50077104|FG002|Overall Study|Revision|0|||
24987983|NCT00208325|50077105|FG003|Overall Study|Revision|4|||
24987984|NCT00208325|50077102|FG000|Overall Study|Lost to Follow-up|1|||
24987985|NCT00208325|50077103|FG001|Overall Study|Lost to Follow-up|0|||
24987986|NCT00208325|50077104|FG002|Overall Study|Lost to Follow-up|2|||
24987987|NCT00208325|50077105|FG003|Overall Study|Lost to Follow-up|0|||
24987988|NCT00208325|50077102|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
24987989|NCT00208325|50077103|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
24987990|NCT00208325|50077104|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
24987991|NCT00208325|50077105|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
24987992|NCT00208325|50077102|FG000|Overall Study|Does not wish to Continue in Study|5|||
24987993|NCT00208325|50077103|FG001|Overall Study|Does not wish to Continue in Study|8|||
24987994|NCT00208325|50077104|FG002|Overall Study|Does not wish to Continue in Study|3|||
24987995|NCT00208325|50077105|FG003|Overall Study|Does not wish to Continue in Study|2|||
24987996|NCT00208325|50077102|FG000|Overall Study|Other|2|||
24987997|NCT00208325|50077103|FG001|Overall Study|Other|1|||
24987998|NCT00208325|50077104|FG002|Overall Study|Other|1|||
24987999|NCT00208325|50077105|FG003|Overall Study|Other|0|||
24988000|NCT00208325|50077102|FG000|Overall Study|Mis-Randomized|17|||
24988001|NCT00208325|50077103|FG001|Overall Study|Mis-Randomized|20|||
24988002|NCT00208325|50077104|FG002|Overall Study|Mis-Randomized|0|||
24988003|NCT00208325|50077105|FG003|Overall Study|Mis-Randomized|0|||
24988004|NCT00160667|50077118|FG000|Overall Study|Adverse Event|3|||
24988005|NCT00160667|50077119|FG001|Overall Study|Adverse Event|1|||
24988006|NCT00160667|50077120|FG002|Overall Study|Adverse Event|4|||
24988007|NCT00160667|50077118|FG000|Overall Study|Withdrawal by Subject|2|||
24988008|NCT00160667|50077119|FG001|Overall Study|Withdrawal by Subject|0|||
24988009|NCT00160667|50077120|FG002|Overall Study|Withdrawal by Subject|1|||
24988010|NCT00160667|50077118|FG000|Overall Study|Lack of Efficacy|0|||
24988011|NCT00160667|50077119|FG001|Overall Study|Lack of Efficacy|1|||
24988012|NCT00160667|50077120|FG002|Overall Study|Lack of Efficacy|0|||
24988013|NCT00160667|50077118|FG000|Overall Study|Protocol Violation|0|||
24988014|NCT00160667|50077119|FG001|Overall Study|Protocol Violation|1|||
24988015|NCT00160667|50077120|FG002|Overall Study|Protocol Violation|0|||
24988016|NCT00160667|50077118|FG000|Overall Study|Patient decision|0|||
24988017|NCT00160667|50077119|FG001|Overall Study|Patient decision|0|||
24988018|NCT00160667|50077120|FG002|Overall Study|Patient decision|1|||
24988019|NCT00206375|50077132|FG000|Overall Study|Lost to Follow-up|1|||
24988020|NCT00206375|50077133|FG001|Overall Study|Lost to Follow-up|0|||
24988021|NCT00206375|50077134|FG002|Overall Study|Lost to Follow-up|0|||
24988022|NCT00206375|50077132|FG000|Overall Study|Withdrawal by Subject|2|||
24988023|NCT00206375|50077133|FG001|Overall Study|Withdrawal by Subject|1|||
24988024|NCT00206375|50077134|FG002|Overall Study|Withdrawal by Subject|3|||
24988025|NCT00206375|50077132|FG000|Overall Study|Study terminated due to lack of funds|0|||
24988026|NCT00206375|50077133|FG001|Overall Study|Study terminated due to lack of funds|1|||
24988027|NCT00206375|50077134|FG002|Overall Study|Study terminated due to lack of funds|1|||
24988028|NCT00160199|50077144|FG000|Overall Study|Adverse Event|5|||
24988029|NCT00160199|50077145|FG001|Overall Study|Adverse Event|14|||
24988030|NCT00160199|50077144|FG000|Overall Study|Lack of Efficacy|0|||
24988031|NCT00160199|50077145|FG001|Overall Study|Lack of Efficacy|1|||
24988032|NCT00160199|50077144|FG000|Overall Study|Lost to Follow-up|7|||
24988033|NCT00160199|50077145|FG001|Overall Study|Lost to Follow-up|7|||
24988034|NCT00160199|50077144|FG000|Overall Study|Withdrawal by Subject|4|||
24988035|NCT00160199|50077145|FG001|Overall Study|Withdrawal by Subject|6|||
24988036|NCT00160199|50077144|FG000|Overall Study|Administrative|0|||
24988037|NCT00160199|50077145|FG001|Overall Study|Administrative|1|||
24988038|NCT00160199|50077144|FG000|Overall Study|Protocol Violation|8|||
24988039|NCT00160199|50077145|FG001|Overall Study|Protocol Violation|8|||
24988040|NCT00157157|50077151|FG000|Overall Study|Withdrawal by Subject|6|||
24988041|NCT00157157|50077151|FG000|Overall Study|Physician Decision|1|||
24988042|NCT00157157|50077151|FG000|Overall Study|Lost to Follow-up|1|||
24988043|NCT00157157|50077151|FG000|Overall Study|Enrolled in another study|1|||
24988044|NCT00157157|50077151|FG000|Overall Study|Met exclusion criteria|1|||
24988045|NCT00157157|50077151|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
24988046|NCT00203411|50077162|FG000|Follow-up|Progressive Disease|4|||
24988047|NCT00203021|50077169|FG000|Overall Study|Death|4|||
24988048|NCT00203021|50077170|FG001|Overall Study|Death|1|||
24988049|NCT00203021|50077169|FG000|Overall Study|Adverse Event|10|||
24988050|NCT00203021|50077170|FG001|Overall Study|Adverse Event|5|||
24988051|NCT00203021|50077169|FG000|Overall Study|Withdrawal by Subject|45|||
24988052|NCT00203021|50077170|FG001|Overall Study|Withdrawal by Subject|48|||
24988053|NCT00203021|50077169|FG000|Overall Study|Lost to Follow-up|9|||
24988054|NCT00203021|50077170|FG001|Overall Study|Lost to Follow-up|7|||
24988055|NCT00203021|50077169|FG000|Overall Study|Other than specified|11|||
24988056|NCT00203021|50077170|FG001|Overall Study|Other than specified|16|||
24988057|NCT00201851|50077179|FG000|Overall Study|Lost to Follow-up|2|||
24988058|NCT00201851|50077180|FG001|Overall Study|Lost to Follow-up|1|||
24988059|NCT00201851|50077181|FG002|Overall Study|Lost to Follow-up|0|||
24988060|NCT00201851|50077179|FG000|Overall Study|Ineligible post enrollment|6|||
24988061|NCT00201851|50077180|FG001|Overall Study|Ineligible post enrollment|1|||
24988062|NCT00201851|50077181|FG002|Overall Study|Ineligible post enrollment|1|||
24988063|NCT00200057|50077189|FG000|Overall Study|Lack of Efficacy|3|||
24988064|NCT00200057|50077189|FG000|Overall Study|Exited due to terminal illness of PI|2|||
24988065|NCT00200057|50077189|FG000|Overall Study|Withdrawal by Subject|1|||
24988066|NCT00200057|50077189|FG000|Overall Study|Change in medical condition|1|||
24988067|NCT00200057|50077189|FG000|Overall Study|Infection|1|||
24988068|NCT00200057|50077189|FG000|Overall Study|Death|1|||
24988069|NCT03129100|50077198|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
24988070|NCT03129100|50077199|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
24988071|NCT03129100|50077200|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
24988072|NCT03129100|50077201|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
24988073|NCT03129100|50077202|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
24988074|NCT03129100|50077203|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
24988075|NCT03129100|50077204|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
24988076|NCT03129100|50077205|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
24988077|NCT03129100|50077206|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
24988078|NCT03129100|50077207|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
24988079|NCT03129100|50077208|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
24988080|NCT03129100|50077209|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
24988081|NCT03129100|50077210|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
24988082|NCT03129100|50077211|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
24988083|NCT03129100|50077212|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
24988084|NCT03129100|50077213|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
24988085|NCT03129100|50077214|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
24988086|NCT03129100|50077215|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
24988087|NCT03129100|50077216|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
24988088|NCT03129100|50077217|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
24988089|NCT03129100|50077218|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
24988090|NCT03129100|50077219|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
24988091|NCT03129100|50077220|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
24988092|NCT03129100|50077221|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
24988093|NCT03129100|50077222|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
24988094|NCT03129100|50077223|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
24988095|NCT03129100|50077198|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
24988096|NCT03129100|50077199|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988097|NCT03129100|50077200|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988098|NCT03129100|50077201|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988099|NCT03129100|50077202|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988100|NCT03129100|50077203|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988101|NCT03129100|50077204|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988102|NCT03129100|50077205|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988103|NCT03129100|50077206|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988104|NCT03129100|50077207|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988105|NCT03129100|50077208|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988106|NCT03129100|50077209|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988107|NCT03129100|50077210|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988108|NCT03129100|50077211|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988109|NCT03129100|50077212|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988110|NCT03129100|50077213|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988111|NCT03129100|50077214|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988112|NCT03129100|50077215|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988113|NCT03129100|50077216|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988114|NCT03129100|50077217|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988115|NCT03129100|50077218|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988116|NCT03129100|50077219|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988117|NCT03129100|50077220|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988118|NCT03129100|50077221|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988119|NCT03129100|50077222|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988120|NCT03129100|50077223|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
24988121|NCT03129100|50077198|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
24988122|NCT03129100|50077199|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
24988123|NCT03129100|50077200|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988124|NCT03129100|50077201|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988125|NCT03129100|50077202|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988126|NCT03129100|50077203|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988127|NCT03129100|50077204|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988128|NCT03129100|50077205|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988129|NCT03129100|50077206|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988130|NCT03129100|50077207|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988131|NCT03129100|50077208|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988132|NCT03129100|50077209|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988133|NCT03129100|50077210|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988134|NCT03129100|50077211|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988135|NCT03129100|50077212|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988136|NCT03129100|50077213|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988137|NCT03129100|50077214|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988138|NCT03129100|50077215|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988139|NCT03129100|50077216|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988140|NCT03129100|50077217|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988141|NCT03129100|50077218|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988142|NCT03129100|50077219|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988143|NCT03129100|50077220|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988144|NCT03129100|50077221|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988145|NCT03129100|50077222|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988146|NCT03129100|50077223|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
24988147|NCT03129100|50077198|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
24988148|NCT03129100|50077199|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
24988149|NCT03129100|50077200|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988150|NCT03129100|50077201|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988151|NCT03129100|50077202|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988152|NCT03129100|50077203|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988153|NCT03129100|50077204|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988154|NCT03129100|50077205|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988155|NCT03129100|50077206|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988156|NCT03129100|50077207|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988157|NCT03129100|50077208|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988158|NCT03129100|50077209|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988159|NCT03129100|50077210|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988160|NCT03129100|50077211|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988161|NCT03129100|50077212|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988162|NCT03129100|50077213|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988163|NCT03129100|50077214|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988164|NCT03129100|50077215|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988165|NCT03129100|50077216|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988166|NCT03129100|50077217|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988167|NCT03129100|50077218|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988168|NCT03129100|50077219|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988169|NCT03129100|50077220|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988170|NCT03129100|50077221|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988171|NCT03129100|50077222|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988172|NCT03129100|50077223|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
24988173|NCT03129100|50077198|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988174|NCT03129100|50077199|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
24988175|NCT03129100|50077200|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988176|NCT03129100|50077201|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988177|NCT03129100|50077202|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988178|NCT03129100|50077203|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988179|NCT03129100|50077204|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988180|NCT03129100|50077205|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988181|NCT03129100|50077206|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988182|NCT03129100|50077207|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988183|NCT03129100|50077208|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988184|NCT03129100|50077209|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988185|NCT03129100|50077210|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988186|NCT03129100|50077211|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988187|NCT03129100|50077212|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988188|NCT03129100|50077213|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988189|NCT03129100|50077214|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988190|NCT03129100|50077215|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988191|NCT03129100|50077216|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988192|NCT03129100|50077217|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988193|NCT03129100|50077218|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988194|NCT03129100|50077219|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988195|NCT03129100|50077220|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988196|NCT03129100|50077221|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988197|NCT03129100|50077222|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988198|NCT03129100|50077223|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
24988199|NCT03129100|50077198|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988200|NCT03129100|50077199|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988201|NCT03129100|50077200|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
24988202|NCT03129100|50077201|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
24988203|NCT03129100|50077202|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988204|NCT03129100|50077203|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
24988205|NCT03129100|50077204|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
25079436|NCT01865617|50187895|FG009|Overall Study|Patient proceeded to new therapy|0|||
25257205|NCT01324310|50572263|FG000|Overall Study|Adverse Event|1|||
24988206|NCT03129100|50077205|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988207|NCT03129100|50077206|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988208|NCT03129100|50077207|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988209|NCT03129100|50077208|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988210|NCT03129100|50077209|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988211|NCT03129100|50077210|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988212|NCT03129100|50077211|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988213|NCT03129100|50077212|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988214|NCT03129100|50077213|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988215|NCT03129100|50077214|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988216|NCT03129100|50077215|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988217|NCT03129100|50077216|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988218|NCT03129100|50077217|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988219|NCT03129100|50077218|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988220|NCT03129100|50077219|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988221|NCT03129100|50077220|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988222|NCT03129100|50077221|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988223|NCT03129100|50077222|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988224|NCT03129100|50077223|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
24988225|NCT03129100|50077198|FG000|Period2 Extension Period (Group A and B)|Death|0|||
24988226|NCT03129100|50077199|FG001|Period2 Extension Period (Group A and B)|Death|0|||
24988227|NCT03129100|50077200|FG002|Period2 Extension Period (Group A and B)|Death|1|||
24988228|NCT03129100|50077201|FG003|Period2 Extension Period (Group A and B)|Death|0|||
24988229|NCT03129100|50077202|FG004|Period2 Extension Period (Group A and B)|Death|0|||
24988230|NCT03129100|50077203|FG005|Period2 Extension Period (Group A and B)|Death|0|||
24988231|NCT03129100|50077204|FG006|Period2 Extension Period (Group A and B)|Death|0|||
24988232|NCT03129100|50077205|FG007|Period2 Extension Period (Group A and B)|Death|0|||
24988233|NCT03129100|50077206|FG008|Period2 Extension Period (Group A and B)|Death|0|||
24988234|NCT03129100|50077207|FG009|Period2 Extension Period (Group A and B)|Death|0|||
24988235|NCT03129100|50077208|FG010|Period2 Extension Period (Group A and B)|Death|0|||
24988236|NCT03129100|50077209|FG011|Period2 Extension Period (Group A and B)|Death|0|||
24988237|NCT03129100|50077210|FG012|Period2 Extension Period (Group A and B)|Death|0|||
24988238|NCT03129100|50077211|FG013|Period2 Extension Period (Group A and B)|Death|0|||
24988239|NCT03129100|50077212|FG014|Period2 Extension Period (Group A and B)|Death|0|||
24988240|NCT03129100|50077213|FG015|Period2 Extension Period (Group A and B)|Death|0|||
24988241|NCT03129100|50077214|FG016|Period2 Extension Period (Group A and B)|Death|0|||
24988242|NCT03129100|50077215|FG017|Period2 Extension Period (Group A and B)|Death|0|||
24988243|NCT03129100|50077216|FG018|Period2 Extension Period (Group A and B)|Death|0|||
24988244|NCT03129100|50077217|FG019|Period2 Extension Period (Group A and B)|Death|0|||
24988245|NCT03129100|50077218|FG020|Period2 Extension Period (Group A and B)|Death|0|||
24988246|NCT03129100|50077219|FG021|Period2 Extension Period (Group A and B)|Death|0|||
24988247|NCT03129100|50077220|FG022|Period2 Extension Period (Group A and B)|Death|0|||
24988248|NCT03129100|50077221|FG023|Period2 Extension Period (Group A and B)|Death|0|||
24988249|NCT03129100|50077222|FG024|Period2 Extension Period (Group A and B)|Death|0|||
24988250|NCT03129100|50077223|FG025|Period2 Extension Period (Group A and B)|Death|0|||
24988251|NCT03129100|50077198|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988252|NCT03129100|50077199|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988253|NCT03129100|50077200|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
24988254|NCT03129100|50077201|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
24988255|NCT03129100|50077202|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
24988256|NCT03129100|50077203|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
24988257|NCT03129100|50077204|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
24988258|NCT03129100|50077205|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988259|NCT03129100|50077206|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988260|NCT03129100|50077207|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988261|NCT03129100|50077208|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988262|NCT03129100|50077209|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988263|NCT03129100|50077210|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988264|NCT03129100|50077211|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988265|NCT03129100|50077212|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988266|NCT03129100|50077213|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988267|NCT03129100|50077214|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988268|NCT03129100|50077215|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988269|NCT03129100|50077216|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988270|NCT03129100|50077217|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988271|NCT03129100|50077218|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988272|NCT03129100|50077219|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988273|NCT03129100|50077220|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988274|NCT03129100|50077221|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988275|NCT03129100|50077222|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988276|NCT03129100|50077223|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
24988277|NCT03129100|50077198|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988278|NCT03129100|50077199|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988279|NCT03129100|50077200|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
24988280|NCT03129100|50077201|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988281|NCT03129100|50077202|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988282|NCT03129100|50077203|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988283|NCT03129100|50077204|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988284|NCT03129100|50077205|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988285|NCT03129100|50077206|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988286|NCT03129100|50077207|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988287|NCT03129100|50077208|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988288|NCT03129100|50077209|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988289|NCT03129100|50077210|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988290|NCT03129100|50077211|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988291|NCT03129100|50077212|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988292|NCT03129100|50077213|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988293|NCT03129100|50077214|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988294|NCT03129100|50077215|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988295|NCT03129100|50077216|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988296|NCT03129100|50077217|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988297|NCT03129100|50077218|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988298|NCT03129100|50077219|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988299|NCT03129100|50077220|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988300|NCT03129100|50077221|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988301|NCT03129100|50077222|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988302|NCT03129100|50077223|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
24988303|NCT03129100|50077198|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988304|NCT03129100|50077199|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988305|NCT03129100|50077200|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
24988306|NCT03129100|50077201|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988307|NCT03129100|50077202|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988308|NCT03129100|50077203|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988309|NCT03129100|50077204|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988310|NCT03129100|50077205|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988311|NCT03129100|50077206|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988312|NCT03129100|50077207|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988313|NCT03129100|50077208|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988314|NCT03129100|50077209|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988315|NCT03129100|50077210|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988316|NCT03129100|50077211|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988317|NCT03129100|50077212|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988318|NCT03129100|50077213|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988319|NCT03129100|50077214|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988320|NCT03129100|50077215|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988321|NCT03129100|50077216|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988322|NCT03129100|50077217|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988323|NCT03129100|50077218|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988324|NCT03129100|50077219|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988325|NCT03129100|50077220|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988326|NCT03129100|50077221|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988327|NCT03129100|50077222|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988328|NCT03129100|50077223|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
24988329|NCT03129100|50077198|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988330|NCT03129100|50077199|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988331|NCT03129100|50077200|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
25257206|NCT01324310|50572263|FG000|Overall Study|Disease Progression|1|||
24988332|NCT03129100|50077201|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988333|NCT03129100|50077202|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988334|NCT03129100|50077203|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988335|NCT03129100|50077204|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988336|NCT03129100|50077205|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988337|NCT03129100|50077206|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988338|NCT03129100|50077207|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988339|NCT03129100|50077208|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988340|NCT03129100|50077209|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988341|NCT03129100|50077210|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988342|NCT03129100|50077211|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988343|NCT03129100|50077212|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988344|NCT03129100|50077213|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988345|NCT03129100|50077214|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988346|NCT03129100|50077215|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988347|NCT03129100|50077216|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988348|NCT03129100|50077217|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988349|NCT03129100|50077218|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988350|NCT03129100|50077219|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988351|NCT03129100|50077220|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988352|NCT03129100|50077221|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988353|NCT03129100|50077222|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988354|NCT03129100|50077223|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
24988355|NCT03129100|50077198|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988356|NCT03129100|50077199|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988357|NCT03129100|50077200|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988358|NCT03129100|50077201|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988359|NCT03129100|50077202|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
24988360|NCT03129100|50077203|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
24988361|NCT03129100|50077204|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
24988362|NCT03129100|50077205|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988363|NCT03129100|50077206|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988364|NCT03129100|50077207|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988365|NCT03129100|50077208|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988366|NCT03129100|50077209|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988367|NCT03129100|50077210|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988368|NCT03129100|50077211|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988369|NCT03129100|50077212|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988370|NCT03129100|50077213|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988371|NCT03129100|50077214|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988372|NCT03129100|50077215|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988373|NCT03129100|50077216|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988374|NCT03129100|50077217|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988375|NCT03129100|50077218|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988376|NCT03129100|50077219|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988377|NCT03129100|50077220|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988378|NCT03129100|50077221|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988379|NCT03129100|50077222|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988380|NCT03129100|50077223|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
24988381|NCT03129100|50077198|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988382|NCT03129100|50077199|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988383|NCT03129100|50077200|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988384|NCT03129100|50077201|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988385|NCT03129100|50077202|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988386|NCT03129100|50077203|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988387|NCT03129100|50077204|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988388|NCT03129100|50077205|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988389|NCT03129100|50077206|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988390|NCT03129100|50077207|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
24988391|NCT03129100|50077208|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988392|NCT03129100|50077209|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
25257207|NCT01102231|50572269|FG000|Overall Study|Protocol Violation|3|||
24988393|NCT03129100|50077210|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988394|NCT03129100|50077211|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988395|NCT03129100|50077212|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988396|NCT03129100|50077213|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988397|NCT03129100|50077214|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988398|NCT03129100|50077215|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988399|NCT03129100|50077216|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988400|NCT03129100|50077217|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988401|NCT03129100|50077218|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988402|NCT03129100|50077219|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988403|NCT03129100|50077220|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988404|NCT03129100|50077221|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988405|NCT03129100|50077222|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988406|NCT03129100|50077223|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
24988407|NCT03129100|50077198|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988408|NCT03129100|50077199|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988409|NCT03129100|50077200|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988410|NCT03129100|50077201|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988411|NCT03129100|50077202|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988412|NCT03129100|50077203|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988413|NCT03129100|50077204|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988414|NCT03129100|50077205|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988415|NCT03129100|50077206|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988416|NCT03129100|50077207|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988417|NCT03129100|50077208|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988418|NCT03129100|50077209|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
24988419|NCT03129100|50077210|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988420|NCT03129100|50077211|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988421|NCT03129100|50077212|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988422|NCT03129100|50077213|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988423|NCT03129100|50077214|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988424|NCT03129100|50077215|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988425|NCT03129100|50077216|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988426|NCT03129100|50077217|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988427|NCT03129100|50077218|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988428|NCT03129100|50077219|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988429|NCT03129100|50077220|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988430|NCT03129100|50077221|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988431|NCT03129100|50077222|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988432|NCT03129100|50077223|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
24988433|NCT03129100|50077198|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988434|NCT03129100|50077199|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988435|NCT03129100|50077200|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988436|NCT03129100|50077201|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988437|NCT03129100|50077202|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988438|NCT03129100|50077203|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988439|NCT03129100|50077204|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988440|NCT03129100|50077205|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988441|NCT03129100|50077206|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988442|NCT03129100|50077207|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988443|NCT03129100|50077208|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988444|NCT03129100|50077209|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
24988445|NCT03129100|50077210|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
24988446|NCT03129100|50077211|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
24988447|NCT03129100|50077212|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
24988448|NCT03129100|50077213|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988449|NCT03129100|50077214|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988450|NCT03129100|50077215|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988451|NCT03129100|50077216|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988452|NCT03129100|50077217|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988453|NCT03129100|50077218|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988454|NCT03129100|50077219|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988455|NCT03129100|50077220|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988456|NCT03129100|50077221|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988457|NCT03129100|50077222|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988458|NCT03129100|50077223|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
24988459|NCT03129100|50077198|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988460|NCT03129100|50077199|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988461|NCT03129100|50077200|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988462|NCT03129100|50077201|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988463|NCT03129100|50077202|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988464|NCT03129100|50077203|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988465|NCT03129100|50077204|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988466|NCT03129100|50077205|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988467|NCT03129100|50077206|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988468|NCT03129100|50077207|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988469|NCT03129100|50077208|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988470|NCT03129100|50077209|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
24988471|NCT03129100|50077210|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988472|NCT03129100|50077211|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
24988473|NCT03129100|50077212|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
24988474|NCT03129100|50077213|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988475|NCT03129100|50077214|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988476|NCT03129100|50077215|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988477|NCT03129100|50077216|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988478|NCT03129100|50077217|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988479|NCT03129100|50077218|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988480|NCT03129100|50077219|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988481|NCT03129100|50077220|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988482|NCT03129100|50077221|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988483|NCT03129100|50077222|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988484|NCT03129100|50077223|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
24988485|NCT03129100|50077198|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988486|NCT03129100|50077199|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988487|NCT03129100|50077200|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988488|NCT03129100|50077201|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988489|NCT03129100|50077202|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988490|NCT03129100|50077203|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988491|NCT03129100|50077204|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988492|NCT03129100|50077205|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988493|NCT03129100|50077206|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988494|NCT03129100|50077207|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988495|NCT03129100|50077208|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988496|NCT03129100|50077209|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988497|NCT03129100|50077210|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988498|NCT03129100|50077211|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988499|NCT03129100|50077212|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988500|NCT03129100|50077213|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
24988501|NCT03129100|50077214|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988502|NCT03129100|50077215|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988503|NCT03129100|50077216|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988504|NCT03129100|50077217|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988505|NCT03129100|50077218|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988506|NCT03129100|50077219|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988507|NCT03129100|50077220|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988508|NCT03129100|50077221|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988509|NCT03129100|50077222|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988510|NCT03129100|50077223|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
24988511|NCT03129100|50077198|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988512|NCT03129100|50077199|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988513|NCT03129100|50077200|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988514|NCT03129100|50077201|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988515|NCT03129100|50077202|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988516|NCT03129100|50077203|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988517|NCT03129100|50077204|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
25079437|NCT01865617|50187896|FG010|Overall Study|Patient proceeded to new therapy|0|||
24988518|NCT03129100|50077205|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988519|NCT03129100|50077206|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988520|NCT03129100|50077207|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988521|NCT03129100|50077208|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988522|NCT03129100|50077209|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988523|NCT03129100|50077210|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
24988524|NCT03129100|50077211|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988525|NCT03129100|50077212|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
24988526|NCT03129100|50077213|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
24988527|NCT03129100|50077214|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988528|NCT03129100|50077215|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988529|NCT03129100|50077216|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988530|NCT03129100|50077217|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988531|NCT03129100|50077218|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988532|NCT03129100|50077219|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988533|NCT03129100|50077220|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988534|NCT03129100|50077221|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988535|NCT03129100|50077222|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988536|NCT03129100|50077223|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
24988537|NCT03129100|50077198|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988538|NCT03129100|50077199|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988539|NCT03129100|50077200|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988540|NCT03129100|50077201|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988541|NCT03129100|50077202|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988542|NCT03129100|50077203|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988543|NCT03129100|50077204|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988544|NCT03129100|50077205|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988545|NCT03129100|50077206|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988546|NCT03129100|50077207|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988547|NCT03129100|50077208|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988548|NCT03129100|50077209|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988549|NCT03129100|50077210|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988550|NCT03129100|50077211|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988551|NCT03129100|50077212|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988552|NCT03129100|50077213|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988553|NCT03129100|50077214|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988554|NCT03129100|50077215|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
24988555|NCT03129100|50077216|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988556|NCT03129100|50077217|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
24988557|NCT03129100|50077218|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988558|NCT03129100|50077219|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988559|NCT03129100|50077220|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988560|NCT03129100|50077221|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988561|NCT03129100|50077222|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988562|NCT03129100|50077223|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
24988563|NCT03129100|50077198|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988564|NCT03129100|50077199|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988565|NCT03129100|50077200|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988566|NCT03129100|50077201|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988567|NCT03129100|50077202|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988568|NCT03129100|50077203|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988569|NCT03129100|50077204|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988570|NCT03129100|50077205|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988571|NCT03129100|50077206|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988572|NCT03129100|50077207|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988573|NCT03129100|50077208|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988574|NCT03129100|50077209|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988575|NCT03129100|50077210|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988576|NCT03129100|50077211|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988577|NCT03129100|50077212|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988578|NCT03129100|50077213|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988579|NCT03129100|50077214|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988580|NCT03129100|50077215|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988581|NCT03129100|50077216|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988582|NCT03129100|50077217|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988583|NCT03129100|50077218|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
24988584|NCT03129100|50077219|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988585|NCT03129100|50077220|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
25079438|NCT01865617|50187897|FG011|Overall Study|Patient proceeded to new therapy|0|||
24988586|NCT03129100|50077221|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988587|NCT03129100|50077222|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988588|NCT03129100|50077223|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
24988589|NCT03129100|50077198|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
24988590|NCT03129100|50077199|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
24988591|NCT03129100|50077200|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
24988592|NCT03129100|50077201|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
24988593|NCT03129100|50077202|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
24988594|NCT03129100|50077203|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
24988595|NCT03129100|50077204|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
24988596|NCT03129100|50077205|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
24988597|NCT03129100|50077206|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
24988598|NCT03129100|50077207|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
24988599|NCT03129100|50077208|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
24988600|NCT03129100|50077209|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
24988601|NCT03129100|50077210|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
24988602|NCT03129100|50077211|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
24988603|NCT03129100|50077212|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
24988604|NCT03129100|50077213|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
24988605|NCT03129100|50077214|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
24988606|NCT03129100|50077215|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
24988607|NCT03129100|50077216|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
24988608|NCT03129100|50077217|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
24988609|NCT03129100|50077218|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
24988610|NCT03129100|50077219|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
24988611|NCT03129100|50077220|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
24988612|NCT03129100|50077221|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
24988613|NCT03129100|50077222|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
24988614|NCT03129100|50077223|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
24988615|NCT03129100|50077198|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988616|NCT03129100|50077199|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988617|NCT03129100|50077200|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988618|NCT03129100|50077201|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988619|NCT03129100|50077202|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988620|NCT03129100|50077203|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988621|NCT03129100|50077204|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988622|NCT03129100|50077205|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988623|NCT03129100|50077206|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988624|NCT03129100|50077207|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988625|NCT03129100|50077208|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988626|NCT03129100|50077209|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988627|NCT03129100|50077210|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988628|NCT03129100|50077211|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988629|NCT03129100|50077212|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988630|NCT03129100|50077213|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988631|NCT03129100|50077214|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988632|NCT03129100|50077215|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988633|NCT03129100|50077216|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988634|NCT03129100|50077217|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988635|NCT03129100|50077218|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
24988636|NCT03129100|50077219|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988637|NCT03129100|50077220|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988638|NCT03129100|50077221|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988639|NCT03129100|50077222|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988640|NCT03129100|50077223|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
24988641|NCT03129100|50077198|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
24988642|NCT03129100|50077199|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
24988643|NCT03129100|50077200|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
24988644|NCT03129100|50077201|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
24988645|NCT03129100|50077202|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
24988646|NCT03129100|50077203|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
24988647|NCT03129100|50077204|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
24988648|NCT03129100|50077205|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
24988649|NCT03129100|50077206|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
24988650|NCT03129100|50077207|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
24988651|NCT03129100|50077208|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
24988652|NCT03129100|50077209|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
24988653|NCT03129100|50077210|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
24988654|NCT03129100|50077211|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
24988655|NCT03129100|50077212|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
24988656|NCT03129100|50077213|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
24988657|NCT03129100|50077214|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
24988658|NCT03129100|50077215|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
24988659|NCT03129100|50077216|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
24988660|NCT03129100|50077217|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
24988661|NCT03129100|50077218|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
24988662|NCT03129100|50077219|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
24988663|NCT03129100|50077220|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
24988664|NCT03129100|50077221|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
24988665|NCT03129100|50077222|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
24988666|NCT03129100|50077223|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
24988667|NCT03129100|50077198|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988668|NCT03129100|50077199|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988669|NCT03129100|50077200|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988670|NCT03129100|50077201|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988671|NCT03129100|50077202|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988672|NCT03129100|50077203|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988673|NCT03129100|50077204|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988674|NCT03129100|50077205|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988675|NCT03129100|50077206|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988676|NCT03129100|50077207|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988677|NCT03129100|50077208|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988678|NCT03129100|50077209|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988679|NCT03129100|50077210|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988680|NCT03129100|50077211|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988681|NCT03129100|50077212|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988682|NCT03129100|50077213|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988683|NCT03129100|50077214|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988684|NCT03129100|50077215|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988685|NCT03129100|50077216|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988686|NCT03129100|50077217|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988687|NCT03129100|50077218|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988688|NCT03129100|50077219|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988689|NCT03129100|50077220|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988690|NCT03129100|50077221|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
24988691|NCT03129100|50077222|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
24988692|NCT03129100|50077223|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
24988693|NCT03129100|50077198|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988694|NCT03129100|50077199|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988695|NCT03129100|50077200|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988696|NCT03129100|50077201|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988697|NCT03129100|50077202|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988698|NCT03129100|50077203|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988699|NCT03129100|50077204|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988700|NCT03129100|50077205|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988701|NCT03129100|50077206|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988702|NCT03129100|50077207|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988703|NCT03129100|50077208|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988704|NCT03129100|50077209|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988705|NCT03129100|50077210|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988706|NCT03129100|50077211|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988707|NCT03129100|50077212|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988708|NCT03129100|50077213|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988709|NCT03129100|50077214|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988710|NCT03129100|50077215|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988711|NCT03129100|50077216|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988712|NCT03129100|50077217|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988713|NCT03129100|50077218|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988714|NCT03129100|50077219|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988715|NCT03129100|50077220|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
24988716|NCT03129100|50077221|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
24988717|NCT03129100|50077222|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
24988718|NCT03129100|50077223|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
24988719|NCT03129100|50077198|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988720|NCT03129100|50077199|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988721|NCT03129100|50077200|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988722|NCT03129100|50077201|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988723|NCT03129100|50077202|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988724|NCT03129100|50077203|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988725|NCT03129100|50077204|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988726|NCT03129100|50077205|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988727|NCT03129100|50077206|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988728|NCT03129100|50077207|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988729|NCT03129100|50077208|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988730|NCT03129100|50077209|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988731|NCT03129100|50077210|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988732|NCT03129100|50077211|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988733|NCT03129100|50077212|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988734|NCT03129100|50077213|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988735|NCT03129100|50077214|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988736|NCT03129100|50077215|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988737|NCT03129100|50077216|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988738|NCT03129100|50077217|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988739|NCT03129100|50077218|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988740|NCT03129100|50077219|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988741|NCT03129100|50077220|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988742|NCT03129100|50077221|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988743|NCT03129100|50077222|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
24988744|NCT03129100|50077223|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
24988745|NCT03129100|50077198|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988746|NCT03129100|50077199|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988747|NCT03129100|50077200|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988748|NCT03129100|50077201|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988749|NCT03129100|50077202|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988750|NCT03129100|50077203|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988751|NCT03129100|50077204|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988752|NCT03129100|50077205|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988753|NCT03129100|50077206|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988754|NCT03129100|50077207|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988755|NCT03129100|50077208|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988756|NCT03129100|50077209|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988757|NCT03129100|50077210|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988758|NCT03129100|50077211|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988759|NCT03129100|50077212|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988760|NCT03129100|50077213|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988761|NCT03129100|50077214|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988762|NCT03129100|50077215|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988763|NCT03129100|50077216|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988764|NCT03129100|50077217|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988765|NCT03129100|50077218|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988766|NCT03129100|50077219|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988767|NCT03129100|50077220|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988768|NCT03129100|50077221|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988769|NCT03129100|50077222|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
24988770|NCT03129100|50077223|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
24988771|NCT03129100|50077198|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
24988772|NCT03129100|50077199|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
24988773|NCT03129100|50077200|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
24988774|NCT03129100|50077201|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
24988775|NCT03129100|50077202|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
24988776|NCT03129100|50077203|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
24988777|NCT03129100|50077204|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
24988778|NCT03129100|50077205|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
24988779|NCT03129100|50077206|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
24988780|NCT03129100|50077207|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
24988781|NCT03129100|50077208|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
24988782|NCT03129100|50077209|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
24988783|NCT03129100|50077210|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
24988784|NCT03129100|50077211|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
24988785|NCT03129100|50077212|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
24988786|NCT03129100|50077213|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
24988787|NCT03129100|50077214|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
24988788|NCT03129100|50077215|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
24988789|NCT03129100|50077216|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
24988790|NCT03129100|50077217|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
24988791|NCT03129100|50077218|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
24988792|NCT03129100|50077219|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
24988793|NCT03129100|50077220|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
24988794|NCT03129100|50077221|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
24988795|NCT03129100|50077222|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
24988796|NCT03129100|50077223|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
24988797|NCT03101020|50077262|FG000|Overall Study|Lack of time to participate|1|||
24988798|NCT03101020|50077263|FG001|Overall Study|Lack of time to participate|0|||
24988799|NCT03101020|50077262|FG000|Overall Study|Ran over by a car|0|||
24988800|NCT03101020|50077263|FG001|Overall Study|Ran over by a car|1|||
24988801|NCT03101020|50077262|FG000|Overall Study|Withdrawal by Subject|0|||
24988802|NCT03101020|50077263|FG001|Overall Study|Withdrawal by Subject|2|||
24988803|NCT03100942|50077273|FG000|Randomized Treatment Period|Withdrew Consent|4|||
24988804|NCT03100942|50077274|FG001|Randomized Treatment Period|Withdrew Consent|5|||
24988805|NCT03100942|50077275|FG002|Randomized Treatment Period|Withdrew Consent|3|||
24988806|NCT03100942|50077276|FG003|Randomized Treatment Period|Withdrew Consent|3|||
24988807|NCT03100942|50077277|FG004|Randomized Treatment Period|Withdrew Consent|0|||
24988808|NCT03100942|50077278|FG005|Randomized Treatment Period|Withdrew Consent|0|||
24988809|NCT03100942|50077279|FG006|Randomized Treatment Period|Withdrew Consent|0|||
24988810|NCT03100942|50077273|FG000|Randomized Treatment Period|Adverse Event|5|||
24988811|NCT03100942|50077274|FG001|Randomized Treatment Period|Adverse Event|2|||
24988812|NCT03100942|50077275|FG002|Randomized Treatment Period|Adverse Event|1|||
24988813|NCT03100942|50077276|FG003|Randomized Treatment Period|Adverse Event|0|||
24988814|NCT03100942|50077277|FG004|Randomized Treatment Period|Adverse Event|0|||
24988815|NCT03100942|50077278|FG005|Randomized Treatment Period|Adverse Event|0|||
24988816|NCT03100942|50077279|FG006|Randomized Treatment Period|Adverse Event|0|||
24988817|NCT03100942|50077273|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
24988818|NCT03100942|50077274|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
24988819|NCT03100942|50077275|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
24988820|NCT03100942|50077276|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
24988821|NCT03100942|50077277|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
24988822|NCT03100942|50077278|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
24988823|NCT03100942|50077279|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
24988824|NCT03100942|50077273|FG000|Randomized Treatment Period|Protocol Violation|0|||
24988825|NCT03100942|50077274|FG001|Randomized Treatment Period|Protocol Violation|1|||
24988826|NCT03100942|50077275|FG002|Randomized Treatment Period|Protocol Violation|1|||
24988827|NCT03100942|50077276|FG003|Randomized Treatment Period|Protocol Violation|1|||
24988828|NCT03100942|50077277|FG004|Randomized Treatment Period|Protocol Violation|0|||
24988829|NCT03100942|50077278|FG005|Randomized Treatment Period|Protocol Violation|0|||
24988830|NCT03100942|50077279|FG006|Randomized Treatment Period|Protocol Violation|0|||
24988831|NCT03100942|50077273|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
24988832|NCT03100942|50077274|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
24988833|NCT03100942|50077275|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
24988834|NCT03100942|50077276|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
24988835|NCT03100942|50077277|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
24988836|NCT03100942|50077278|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
24988837|NCT03100942|50077279|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
24988838|NCT03100942|50077273|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
24988839|NCT03100942|50077274|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
24988840|NCT03100942|50077275|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
24988841|NCT03100942|50077276|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
24988842|NCT03100942|50077277|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
24988843|NCT03100942|50077278|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
24988844|NCT03100942|50077279|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
24988845|NCT03100942|50077273|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
24988846|NCT03100942|50077274|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
24988847|NCT03100942|50077275|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
24988848|NCT03100942|50077276|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
24988849|NCT03100942|50077277|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
24988850|NCT03100942|50077278|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
24988851|NCT03100942|50077279|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
24988852|NCT03099694|50077294|FG000|Overall Study|Withdrawal by Subject|11|||
24988853|NCT03099694|50077295|FG001|Overall Study|Withdrawal by Subject|13|||
24988854|NCT03099694|50077294|FG000|Overall Study|Lost to Follow-up|9|||
24988855|NCT03099694|50077295|FG001|Overall Study|Lost to Follow-up|5|||
24988856|NCT03099538|50077302|FG000|Overall Study|Lack of Efficacy|3|||
24988857|NCT03099304|50077311|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
24988858|NCT03099304|50077312|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
24988859|NCT03099304|50077313|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
24988860|NCT03099304|50077314|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
24988861|NCT03099304|50077315|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
24988862|NCT03099304|50077316|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
24988863|NCT03099304|50077311|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
24988864|NCT03099304|50077312|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
24988865|NCT03099304|50077313|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
24988866|NCT03099304|50077314|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
24988867|NCT03099304|50077315|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
24988868|NCT03099304|50077316|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
24988869|NCT03099304|50077311|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
24988870|NCT03099304|50077312|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
24988871|NCT03099304|50077313|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
24988872|NCT03099304|50077314|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
24988873|NCT03099304|50077315|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
24988874|NCT03099304|50077316|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
24988875|NCT03099304|50077311|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
24988876|NCT03099304|50077312|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
24988877|NCT03099304|50077313|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
24988878|NCT03099304|50077314|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
24988879|NCT03099304|50077315|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
24988880|NCT03099304|50077316|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
24988881|NCT03099304|50077311|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
24988882|NCT03099304|50077312|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
24988883|NCT03099304|50077313|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
24988884|NCT03099304|50077314|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
24988885|NCT03099304|50077315|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
24988886|NCT03099304|50077316|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
24988887|NCT03099304|50077311|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
24988888|NCT03099304|50077312|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
24988889|NCT03099304|50077313|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
24988890|NCT03099304|50077314|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
24988891|NCT03099304|50077315|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
24988892|NCT03099304|50077316|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
24988893|NCT03099304|50077311|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
24988894|NCT03099304|50077312|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
24988895|NCT03099304|50077313|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
24988896|NCT03099304|50077314|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
24988897|NCT03099304|50077315|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
24988898|NCT03099304|50077316|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
24988899|NCT03099304|50077311|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
24988900|NCT03099304|50077312|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
24988901|NCT03099304|50077313|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
24988902|NCT03099304|50077314|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
24988903|NCT03099304|50077315|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
24988904|NCT03099304|50077316|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
24988905|NCT03099304|50077311|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
24988906|NCT03099304|50077312|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
24988907|NCT03099304|50077313|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
24988908|NCT03099304|50077314|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
24988909|NCT03099304|50077315|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
24988910|NCT03099304|50077316|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
24988911|NCT03099304|50077311|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
24988912|NCT03099304|50077312|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
24988913|NCT03099304|50077313|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
24988914|NCT03099304|50077314|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
24988915|NCT03099304|50077315|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
24988916|NCT03099304|50077316|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
24988917|NCT03099304|50077311|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
24988918|NCT03099304|50077312|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
24988919|NCT03099304|50077313|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
24988920|NCT03099304|50077314|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
24988921|NCT03099304|50077315|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
24988922|NCT03099304|50077316|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
24988923|NCT03099304|50077311|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
24988924|NCT03099304|50077312|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
24988925|NCT03099304|50077313|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
24988926|NCT03099304|50077314|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
24988927|NCT03099304|50077315|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
24988928|NCT03099304|50077316|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
24988929|NCT03099304|50077311|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
25257208|NCT01102231|50572269|FG000|Overall Study|Lack of Efficacy|2|||
25257209|NCT01102231|50572269|FG000|Overall Study|Death|2|||
24988930|NCT03099304|50077312|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
24988931|NCT03099304|50077313|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
24988932|NCT03099304|50077314|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
24988933|NCT03099304|50077315|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
24988934|NCT03099304|50077316|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
24988935|NCT03099304|50077311|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
24988936|NCT03099304|50077312|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
24988937|NCT03099304|50077313|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
24988938|NCT03099304|50077314|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
24988939|NCT03099304|50077315|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
24988940|NCT03099304|50077316|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
24988941|NCT03099304|50077311|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
24988942|NCT03099304|50077312|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
24988943|NCT03099304|50077313|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
24988944|NCT03099304|50077314|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
24988945|NCT03099304|50077315|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
24988946|NCT03099304|50077316|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
24988947|NCT03099304|50077311|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
24988948|NCT03099304|50077312|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
24988949|NCT03099304|50077313|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
24988950|NCT03099304|50077314|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
24988951|NCT03099304|50077315|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
24988952|NCT03099304|50077316|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
24988953|NCT03099304|50077311|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
24988954|NCT03099304|50077312|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
24988955|NCT03099304|50077313|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
24988956|NCT03099304|50077314|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
24988957|NCT03099304|50077315|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
24988958|NCT03099304|50077316|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
24988959|NCT03097588|50077343|FG000|Overall Study|Adverse Event|1|||
24988960|NCT01631214|50077349|FG000|Overall Study|Withdrawal by Subject|276|||
24988961|NCT01631214|50077350|FG001|Overall Study|Withdrawal by Subject|290|||
24988962|NCT01631214|50077349|FG000|Overall Study|Death|113|||
24988963|NCT01631214|50077350|FG001|Overall Study|Death|106|||
24988964|NCT01631214|50077349|FG000|Overall Study|Lost to Follow-up|54|||
24988965|NCT01631214|50077350|FG001|Overall Study|Lost to Follow-up|40|||
24988966|NCT01631214|50077349|FG000|Overall Study|Adverse Event|45|||
24988967|NCT01631214|50077350|FG001|Overall Study|Adverse Event|45|||
24988968|NCT01631214|50077349|FG000|Overall Study|Other|22|||
24988969|NCT01631214|50077350|FG001|Overall Study|Other|19|||
24988970|NCT01631214|50077349|FG000|Overall Study|Noncompliance|16|||
24988971|NCT01631214|50077350|FG001|Overall Study|Noncompliance|15|||
24988972|NCT01631214|50077349|FG000|Overall Study|Requirement for Alternative Therapy|8|||
24988973|NCT01631214|50077350|FG001|Overall Study|Requirement for Alternative Therapy|3|||
24988974|NCT01631214|50077349|FG000|Overall Study|Protocol Deviation|4|||
24988975|NCT01631214|50077350|FG001|Overall Study|Protocol Deviation|3|||
24988976|NCT01631214|50077349|FG000|Overall Study|Ineligibility determined|5|||
24988977|NCT01631214|50077350|FG001|Overall Study|Ineligibility determined|2|||
24988978|NCT01631214|50077349|FG000|Overall Study|Administrative Decision|1|||
24988979|NCT01631214|50077350|FG001|Overall Study|Administrative Decision|0|||
24988980|NCT03093454|50077360|FG000|Overall Study|Withdrawal by Subject|1|||
24988981|NCT03093454|50077361|FG001|Overall Study|Withdrawal by Subject|1|||
24988982|NCT03093454|50077360|FG000|Overall Study|Scheduling conflict|3|||
24988983|NCT03093454|50077361|FG001|Overall Study|Scheduling conflict|1|||
24988984|NCT03093454|50077360|FG000|Overall Study|Physician Decision|2|||
24988985|NCT03093454|50077361|FG001|Overall Study|Physician Decision|1|||
24988986|NCT00468130|50077382|FG000|Overall Study|Adverse Event|2|||
24988987|NCT00468130|50077383|FG001|Overall Study|Adverse Event|1|||
24988988|NCT00468130|50077382|FG000|Overall Study|Withdrawal by Subject|0|||
24988989|NCT00468130|50077383|FG001|Overall Study|Withdrawal by Subject|1|||
24988990|NCT00911820|50077393|FG000|Overall Study|RECIST progression|12|||
24988991|NCT00911820|50077394|FG001|Overall Study|RECIST progression|8|||
24988992|NCT00911820|50077393|FG000|Overall Study|Adverse Event|8|||
24988993|NCT00911820|50077394|FG001|Overall Study|Adverse Event|8|||
24988994|NCT00911820|50077393|FG000|Overall Study|Clinical Progression|7|||
24988995|NCT00911820|50077394|FG001|Overall Study|Clinical Progression|5|||
24988996|NCT00911820|50077393|FG000|Overall Study|Physician Decision|5|||
24988997|NCT00911820|50077394|FG001|Overall Study|Physician Decision|9|||
24988998|NCT00911820|50077393|FG000|Overall Study|Decline in Performance Status|4|||
24988999|NCT00911820|50077394|FG001|Overall Study|Decline in Performance Status|2|||
24989000|NCT00911820|50077393|FG000|Overall Study|Withdrawal by Subject|3|||
24989001|NCT00911820|50077394|FG001|Overall Study|Withdrawal by Subject|4|||
24989002|NCT00911820|50077393|FG000|Overall Study|Death|1|||
24989003|NCT00911820|50077394|FG001|Overall Study|Death|2|||
24989004|NCT00911820|50077393|FG000|Overall Study|Pursue surgery|1|||
24989005|NCT00911820|50077394|FG001|Overall Study|Pursue surgery|1|||
24989006|NCT00911820|50077393|FG000|Overall Study|Pursue Radiation|1|||
24989007|NCT00911820|50077394|FG001|Overall Study|Pursue Radiation|0|||
24989008|NCT00911820|50077393|FG000|Overall Study|Still on Therapy|2|||
24989009|NCT00911820|50077394|FG001|Overall Study|Still on Therapy|2|||
24989010|NCT00911820|50077393|FG000|Overall Study|Pathology Not Confirmed|1|||
24989011|NCT00911820|50077394|FG001|Overall Study|Pathology Not Confirmed|0|||
24989012|NCT00911820|50077393|FG000|Overall Study|Withdraw before Receive Treatment|0|||
24989013|NCT00911820|50077394|FG001|Overall Study|Withdraw before Receive Treatment|2|||
24989014|NCT00246324|50077409|FG000|Overall Study|Withdrawal by Subject|1|||
24989015|NCT02874742|50077416|FG000|Overall Study|Death|3|||
24989016|NCT02874742|50077417|FG001|Overall Study|Death|1|||
24989017|NCT02874742|50077418|FG002|Overall Study|Death|1|||
24989018|NCT02874742|50077416|FG000|Overall Study|Lost to Follow-up|2|||
24989019|NCT02874742|50077417|FG001|Overall Study|Lost to Follow-up|0|||
24989020|NCT02874742|50077418|FG002|Overall Study|Lost to Follow-up|0|||
24989021|NCT02874742|50077416|FG000|Overall Study|Withdrawal by Subject|8|||
24989022|NCT02874742|50077417|FG001|Overall Study|Withdrawal by Subject|4|||
24989023|NCT02874742|50077418|FG002|Overall Study|Withdrawal by Subject|0|||
24989024|NCT02874742|50077416|FG000|Overall Study|Other|3|||
24989025|NCT02874742|50077417|FG001|Overall Study|Other|1|||
24989026|NCT02874742|50077418|FG002|Overall Study|Other|0|||
24989027|NCT02874742|50077416|FG000|Overall Study|Ongoing|87|||
24989028|NCT02874742|50077417|FG001|Overall Study|Ongoing|98|||
24989029|NCT02874742|50077418|FG002|Overall Study|Ongoing|15|||
24989030|NCT04234984|50077428|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
24989031|NCT04234984|50077428|FG000|Follow-up at the Second Time Point|Death|1|||
24989032|NCT04234984|50077428|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
24989033|NCT03922750|50077442|FG000|Overall Study|Unclassified|0|||
24989034|NCT03922750|50077443|FG001|Overall Study|Unclassified|0|||
24989035|NCT03922750|50077444|FG002|Overall Study|Unclassified|1|||
24989036|NCT03922750|50077442|FG000|Overall Study|Adverse Event|0|||
24989037|NCT03922750|50077443|FG001|Overall Study|Adverse Event|1|||
24989038|NCT03922750|50077444|FG002|Overall Study|Adverse Event|0|||
24989039|NCT03617172|50077454|FG000|Overall Study|Lost to Follow-up|1|||
24989040|NCT03617172|50077455|FG001|Overall Study|Lost to Follow-up|0|||
24989041|NCT03760146|50077467|FG000|Overall Study|Adverse Event|11|||
24989042|NCT03760146|50077468|FG001|Overall Study|Adverse Event|8|||
24989043|NCT03760146|50077469|FG002|Overall Study|Adverse Event|0|||
24989044|NCT03760146|50077470|FG003|Overall Study|Adverse Event|0|||
24989045|NCT03760146|50077471|FG004|Overall Study|Adverse Event|0|||
24989046|NCT03760146|50077472|FG005|Overall Study|Adverse Event|0|||
24989047|NCT03760146|50077467|FG000|Overall Study|Death|1|||
24989048|NCT03760146|50077468|FG001|Overall Study|Death|0|||
24989049|NCT03760146|50077469|FG002|Overall Study|Death|0|||
24989050|NCT03760146|50077470|FG003|Overall Study|Death|0|||
24989051|NCT03760146|50077471|FG004|Overall Study|Death|0|||
24989052|NCT03760146|50077472|FG005|Overall Study|Death|0|||
24989053|NCT03760146|50077467|FG000|Overall Study|Lost to Follow-up|41|||
24989054|NCT03760146|50077468|FG001|Overall Study|Lost to Follow-up|28|||
24989055|NCT03760146|50077469|FG002|Overall Study|Lost to Follow-up|9|||
24989056|NCT03760146|50077470|FG003|Overall Study|Lost to Follow-up|2|||
24989057|NCT03760146|50077471|FG004|Overall Study|Lost to Follow-up|14|||
24989058|NCT03760146|50077472|FG005|Overall Study|Lost to Follow-up|8|||
24989059|NCT03760146|50077467|FG000|Overall Study|No longer met eligibility criteria|3|||
24989060|NCT03760146|50077468|FG001|Overall Study|No longer met eligibility criteria|9|||
24989061|NCT03760146|50077469|FG002|Overall Study|No longer met eligibility criteria|0|||
24989062|NCT03760146|50077470|FG003|Overall Study|No longer met eligibility criteria|0|||
24989063|NCT03760146|50077471|FG004|Overall Study|No longer met eligibility criteria|1|||
24989064|NCT03760146|50077472|FG005|Overall Study|No longer met eligibility criteria|0|||
24989065|NCT03760146|50077467|FG000|Overall Study|Protocol Violation|21|||
24989066|NCT03760146|50077468|FG001|Overall Study|Protocol Violation|13|||
24989067|NCT03760146|50077469|FG002|Overall Study|Protocol Violation|1|||
24989068|NCT03760146|50077470|FG003|Overall Study|Protocol Violation|0|||
24989069|NCT03760146|50077471|FG004|Overall Study|Protocol Violation|1|||
24989070|NCT03760146|50077472|FG005|Overall Study|Protocol Violation|0|||
24989071|NCT03760146|50077467|FG000|Overall Study|Withdrawal by Subject|19|||
24989072|NCT03760146|50077468|FG001|Overall Study|Withdrawal by Subject|20|||
24989073|NCT03760146|50077469|FG002|Overall Study|Withdrawal by Subject|1|||
24989074|NCT03760146|50077470|FG003|Overall Study|Withdrawal by Subject|0|||
24989075|NCT03760146|50077471|FG004|Overall Study|Withdrawal by Subject|1|||
24989076|NCT03760146|50077472|FG005|Overall Study|Withdrawal by Subject|0|||
24989077|NCT03759366|50077490|FG000|Primary Evaluation Period (26 Weeks)|Ongoing during the Primary Evaluation Period|1|||
24989078|NCT03759366|50077490|FG000|Extension Period (Up to 208 Weeks)|Ongoing during the Extension Period|10|||
24989079|NCT03760068|50077496|FG000|Overall Study|Withdrawal by Subject|7|||
24989080|NCT03760068|50077497|FG001|Overall Study|Withdrawal by Subject|8|||
24989081|NCT03760068|50077496|FG000|Overall Study|Adverse Event|1|||
24989082|NCT03760068|50077497|FG001|Overall Study|Adverse Event|2|||
24989083|NCT03760068|50077496|FG000|Overall Study|Administrative Decision by Sponsor|0|||
24989084|NCT03760068|50077497|FG001|Overall Study|Administrative Decision by Sponsor|2|||
24989085|NCT03760068|50077496|FG000|Overall Study|Physician Decision|1|||
24989086|NCT03760068|50077497|FG001|Overall Study|Physician Decision|2|||
24989087|NCT03760068|50077496|FG000|Overall Study|Lost to Follow-up|4|||
24989088|NCT03760068|50077497|FG001|Overall Study|Lost to Follow-up|9|||
24989089|NCT03760068|50077496|FG000|Overall Study|Subject Moved Out of State|1|||
24989090|NCT03760068|50077497|FG001|Overall Study|Subject Moved Out of State|0|||
24989091|NCT03759600|50077504|FG000|Overall Study|Ongoing at Data Cut-off|16|||
24989092|NCT03759600|50077504|FG000|Overall Study|Adverse Event|1|||
24989093|NCT03759600|50077504|FG000|Overall Study|Progressive Disease|3|||
24989094|NCT04724733|50077511|FG000|Overall Study|Lost to Follow-up|1|||
24989095|NCT04724733|50077512|FG001|Overall Study|Lost to Follow-up|1|||
24989096|NCT04724733|50077513|FG002|Overall Study|Lost to Follow-up|1|||
24989097|NCT04635839|50077523|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
24989098|NCT04635839|50077524|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
24989099|NCT04493502|50077532|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
24989100|NCT04493502|50077533|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
24989101|NCT04493502|50077532|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
24989102|NCT04493502|50077533|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
24989103|NCT04493502|50077532|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
24989104|NCT04493502|50077533|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
24989105|NCT04493502|50077532|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
24989106|NCT04493502|50077533|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
24989107|NCT04493502|50077532|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
24989108|NCT04493502|50077533|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
24989109|NCT04493502|50077532|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
24989110|NCT04493502|50077533|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
24989111|NCT04493502|50077532|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
24989112|NCT04493502|50077533|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
24989113|NCT04493502|50077532|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
24989114|NCT04493502|50077533|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
24989115|NCT04493502|50077532|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
24989116|NCT04493502|50077533|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
24989117|NCT04493502|50077532|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
24989118|NCT04493502|50077533|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
24989119|NCT04493502|50077532|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
24989120|NCT04493502|50077533|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
24989121|NCT04493502|50077532|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
24989122|NCT04493502|50077533|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
24989123|NCT04493502|50077532|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
24989124|NCT04493502|50077533|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
24989125|NCT04147858|50077544|FG000|Overall Study|Adverse Event|6|||
24989126|NCT04147858|50077545|FG001|Overall Study|Adverse Event|6|||
24989127|NCT04147858|50077546|FG002|Overall Study|Adverse Event|6|||
24989128|NCT04147858|50077544|FG000|Overall Study|Lack of Efficacy|3|||
24989129|NCT04147858|50077545|FG001|Overall Study|Lack of Efficacy|3|||
24989130|NCT04147858|50077546|FG002|Overall Study|Lack of Efficacy|1|||
24989131|NCT04147858|50077544|FG000|Overall Study|Lost to Follow-up|1|||
24989132|NCT04147858|50077545|FG001|Overall Study|Lost to Follow-up|6|||
24989133|NCT04147858|50077546|FG002|Overall Study|Lost to Follow-up|2|||
24989134|NCT04147858|50077544|FG000|Overall Study|Withdrawal by Subject|3|||
24989135|NCT04147858|50077545|FG001|Overall Study|Withdrawal by Subject|4|||
24989136|NCT04147858|50077546|FG002|Overall Study|Withdrawal by Subject|10|||
24989137|NCT04147858|50077544|FG000|Overall Study|Subject Noncompliance, Other|4|||
24989138|NCT04147858|50077545|FG001|Overall Study|Subject Noncompliance, Other|3|||
24989139|NCT04147858|50077546|FG002|Overall Study|Subject Noncompliance, Other|1|||
24989140|NCT04146896|50077556|FG000|Overall Study|Adverse Event|5|||
24989141|NCT04146896|50077557|FG001|Overall Study|Adverse Event|8|||
24989142|NCT04146896|50077556|FG000|Overall Study|Lack of Efficacy|3|||
24989143|NCT04146896|50077557|FG001|Overall Study|Lack of Efficacy|2|||
24989144|NCT04146896|50077556|FG000|Overall Study|Lost to Follow-up|0|||
24989145|NCT04146896|50077557|FG001|Overall Study|Lost to Follow-up|1|||
24989146|NCT04146896|50077556|FG000|Overall Study|Non-compliance|5|||
24989147|NCT04146896|50077557|FG001|Overall Study|Non-compliance|4|||
24989148|NCT04146896|50077556|FG000|Overall Study|Withdrawal by Subject|3|||
24989149|NCT04146896|50077557|FG001|Overall Study|Withdrawal by Subject|5|||
24989150|NCT04146896|50077556|FG000|Overall Study|Randomized in error|1|||
24989151|NCT04146896|50077557|FG001|Overall Study|Randomized in error|2|||
24989152|NCT04072887|50077569|FG000|Overall Study|Withdrawal by Subject|3|||
24989153|NCT04072887|50077570|FG001|Overall Study|Withdrawal by Subject|8|||
24989154|NCT04072887|50077571|FG002|Overall Study|Withdrawal by Subject|1|||
24989155|NCT04072887|50077572|FG003|Overall Study|Withdrawal by Subject|3|||
24989156|NCT04072887|50077573|FG004|Overall Study|Withdrawal by Subject|3|||
24989157|NCT04072887|50077574|FG005|Overall Study|Withdrawal by Subject|13|||
24989158|NCT04072887|50077569|FG000|Overall Study|Adverse Event|2|||
24989159|NCT04072887|50077570|FG001|Overall Study|Adverse Event|4|||
24989160|NCT04072887|50077571|FG002|Overall Study|Adverse Event|1|||
24989161|NCT04072887|50077572|FG003|Overall Study|Adverse Event|4|||
24989162|NCT04072887|50077573|FG004|Overall Study|Adverse Event|0|||
24989163|NCT04072887|50077574|FG005|Overall Study|Adverse Event|1|||
24989164|NCT04072887|50077569|FG000|Overall Study|Physician Decision|2|||
24989165|NCT04072887|50077570|FG001|Overall Study|Physician Decision|0|||
24989166|NCT04072887|50077571|FG002|Overall Study|Physician Decision|0|||
24989167|NCT04072887|50077572|FG003|Overall Study|Physician Decision|0|||
24989168|NCT04072887|50077573|FG004|Overall Study|Physician Decision|0|||
24989169|NCT04072887|50077574|FG005|Overall Study|Physician Decision|1|||
24989170|NCT04072887|50077569|FG000|Overall Study|Lost to Follow-up|1|||
24989171|NCT04072887|50077570|FG001|Overall Study|Lost to Follow-up|3|||
24989172|NCT04072887|50077571|FG002|Overall Study|Lost to Follow-up|0|||
24989173|NCT04072887|50077572|FG003|Overall Study|Lost to Follow-up|0|||
24989174|NCT04072887|50077573|FG004|Overall Study|Lost to Follow-up|0|||
24989175|NCT04072887|50077574|FG005|Overall Study|Lost to Follow-up|0|||
24989176|NCT04072887|50077569|FG000|Overall Study|Death|0|||
24989177|NCT04072887|50077570|FG001|Overall Study|Death|2|||
24989178|NCT04072887|50077571|FG002|Overall Study|Death|0|||
24989179|NCT04072887|50077572|FG003|Overall Study|Death|2|||
24989180|NCT04072887|50077573|FG004|Overall Study|Death|3|||
24989181|NCT04072887|50077574|FG005|Overall Study|Death|0|||
24989182|NCT03516812|50077667|FG000|Overall Study|Adverse Event|4|||
24989183|NCT03516812|50077667|FG000|Overall Study|Lack of Efficacy|2|||
24989184|NCT03282123|50077711|FG000|Overall Study|Withdrawal by Subject|5|||
24989185|NCT03122119|50077716|FG000|Overall Study|Did not meet eligibility critria|1|||
24989186|NCT02613169|50077722|FG000|Overall Study|Withdrawal by Subject|4|||
24989187|NCT02613169|50077723|FG001|Overall Study|Withdrawal by Subject|1|||
24989188|NCT02613169|50077722|FG000|Overall Study|Lost to Follow-up|0|||
24989189|NCT02613169|50077723|FG001|Overall Study|Lost to Follow-up|5|||
24989190|NCT02613169|50077722|FG000|Overall Study|HIV|0|||
24989191|NCT02613169|50077723|FG001|Overall Study|HIV|2|||
24989192|NCT02613169|50077722|FG000|Overall Study|No TB infection endpoint|14|||
24989193|NCT02613169|50077723|FG001|Overall Study|No TB infection endpoint|9|||
24989194|NCT02362464|50077729|FG000|Overall Study|Switched to alternative therapy|1|||
24989195|NCT02362464|50077729|FG000|Overall Study|Refused further treatment|1|||
24989196|NCT02362464|50077729|FG000|Overall Study|Physician Decision|4|||
24989197|NCT02352948|50077739|FG000|Overall Study|Death|47|||
24989198|NCT02352948|50077740|FG001|Overall Study|Death|48|||
24989199|NCT02352948|50077741|FG002|Overall Study|Death|114|||
24989200|NCT02352948|50077742|FG003|Overall Study|Death|74|||
24989201|NCT02352948|50077743|FG004|Overall Study|Death|77|||
24989202|NCT02352948|50077744|FG005|Overall Study|Death|44|||
24989203|NCT02352948|50077739|FG000|Overall Study|Lost to Follow-up|1|||
24989204|NCT02352948|50077740|FG001|Overall Study|Lost to Follow-up|0|||
24989205|NCT02352948|50077741|FG002|Overall Study|Lost to Follow-up|2|||
24989206|NCT02352948|50077742|FG003|Overall Study|Lost to Follow-up|1|||
24989207|NCT02352948|50077743|FG004|Overall Study|Lost to Follow-up|2|||
24989208|NCT02352948|50077744|FG005|Overall Study|Lost to Follow-up|1|||
24989209|NCT02352948|50077739|FG000|Overall Study|Withdrawal by Subject|1|||
24989210|NCT02352948|50077740|FG001|Overall Study|Withdrawal by Subject|10|||
24989211|NCT02352948|50077741|FG002|Overall Study|Withdrawal by Subject|11|||
24989212|NCT02352948|50077742|FG003|Overall Study|Withdrawal by Subject|23|||
24989213|NCT02352948|50077743|FG004|Overall Study|Withdrawal by Subject|9|||
24989214|NCT02352948|50077744|FG005|Overall Study|Withdrawal by Subject|4|||
24989215|NCT02352948|50077739|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
24989216|NCT02352948|50077740|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
24989217|NCT02352948|50077741|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
24989218|NCT02352948|50077742|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
24989219|NCT02352948|50077743|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
24989220|NCT02352948|50077744|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
24989221|NCT02352948|50077739|FG000|Overall Study|Other|0|||
24989222|NCT02352948|50077740|FG001|Overall Study|Other|0|||
24989223|NCT02352948|50077741|FG002|Overall Study|Other|2|||
24989224|NCT02352948|50077742|FG003|Overall Study|Other|0|||
24989225|NCT02352948|50077743|FG004|Overall Study|Other|0|||
24989226|NCT02352948|50077744|FG005|Overall Study|Other|0|||
24989227|NCT02008396|50077766|FG000|Overall Study|Protocol Violation|0|||
24989228|NCT02008396|50077767|FG001|Overall Study|Protocol Violation|1|||
24989229|NCT01974765|50077774|FG000|Overall Study|Withdrawal by Subject|1|||
24989230|NCT01974765|50077774|FG000|Overall Study|Death|1|||
24989231|NCT01974765|50077774|FG000|Overall Study|Adverse Event|2|||
24989232|NCT01802281|50077780|FG000|Overall Study|Death|1|||
24989233|NCT01802281|50077781|FG001|Overall Study|Death|2|||
24989234|NCT01802281|50077780|FG000|Overall Study|Withdrawal by Subject|2|||
24989235|NCT01802281|50077781|FG001|Overall Study|Withdrawal by Subject|1|||
24989236|NCT01802281|50077780|FG000|Overall Study|Ineligible|5|||
24989237|NCT01802281|50077781|FG001|Overall Study|Ineligible|3|||
24989238|NCT01725217|50077790|FG000|Overall Study|Withdrawal by Subject|1|||
24989239|NCT01725217|50077791|FG001|Overall Study|Withdrawal by Subject|0|||
24989240|NCT01725217|50077792|FG002|Overall Study|Withdrawal by Subject|0|||
24989241|NCT01592370|50077816|FG000|Overall Study|Disease Progression|62|||
24989242|NCT01592370|50077817|FG001|Overall Study|Disease Progression|16|||
24989243|NCT01592370|50077818|FG002|Overall Study|Disease Progression|52|||
24989244|NCT01592370|50077819|FG003|Overall Study|Disease Progression|3|||
24989245|NCT01592370|50077820|FG004|Overall Study|Disease Progression|3|||
24989246|NCT01592370|50077821|FG005|Overall Study|Disease Progression|31|||
24989247|NCT01592370|50077822|FG006|Overall Study|Disease Progression|14|||
24989248|NCT01592370|50077816|FG000|Overall Study|Study Drug Toxicity|14|||
24989249|NCT01592370|50077817|FG001|Overall Study|Study Drug Toxicity|3|||
24989250|NCT01592370|50077818|FG002|Overall Study|Study Drug Toxicity|0|||
24989251|NCT01592370|50077819|FG003|Overall Study|Study Drug Toxicity|0|||
24989252|NCT01592370|50077820|FG004|Overall Study|Study Drug Toxicity|0|||
24989253|NCT01592370|50077821|FG005|Overall Study|Study Drug Toxicity|0|||
24989254|NCT01592370|50077822|FG006|Overall Study|Study Drug Toxicity|1|||
24989255|NCT01592370|50077816|FG000|Overall Study|AE unrelated to study drug|4|||
24989256|NCT01592370|50077817|FG001|Overall Study|AE unrelated to study drug|3|||
24989257|NCT01592370|50077818|FG002|Overall Study|AE unrelated to study drug|0|||
24989258|NCT01592370|50077819|FG003|Overall Study|AE unrelated to study drug|0|||
24989259|NCT01592370|50077820|FG004|Overall Study|AE unrelated to study drug|0|||
24989260|NCT01592370|50077821|FG005|Overall Study|AE unrelated to study drug|0|||
24989261|NCT01592370|50077822|FG006|Overall Study|AE unrelated to study drug|1|||
24989262|NCT01592370|50077816|FG000|Overall Study|Request to discontinue study treatment|5|||
24989263|NCT01592370|50077817|FG001|Overall Study|Request to discontinue study treatment|0|||
24989264|NCT01592370|50077818|FG002|Overall Study|Request to discontinue study treatment|2|||
24989265|NCT01592370|50077819|FG003|Overall Study|Request to discontinue study treatment|0|||
24989266|NCT01592370|50077820|FG004|Overall Study|Request to discontinue study treatment|1|||
24989267|NCT01592370|50077821|FG005|Overall Study|Request to discontinue study treatment|2|||
24989268|NCT01592370|50077822|FG006|Overall Study|Request to discontinue study treatment|0|||
24989269|NCT01592370|50077816|FG000|Overall Study|Withdrew consent|1|||
24989270|NCT01592370|50077817|FG001|Overall Study|Withdrew consent|2|||
24989271|NCT01592370|50077818|FG002|Overall Study|Withdrew consent|1|||
24989272|NCT01592370|50077819|FG003|Overall Study|Withdrew consent|1|||
24989273|NCT01592370|50077820|FG004|Overall Study|Withdrew consent|0|||
24989274|NCT01592370|50077821|FG005|Overall Study|Withdrew consent|0|||
24989275|NCT01592370|50077822|FG006|Overall Study|Withdrew consent|0|||
24989276|NCT01592370|50077816|FG000|Overall Study|Maximum clinical benefit|11|||
24989277|NCT01592370|50077817|FG001|Overall Study|Maximum clinical benefit|1|||
24989278|NCT01592370|50077818|FG002|Overall Study|Maximum clinical benefit|7|||
24989279|NCT01592370|50077819|FG003|Overall Study|Maximum clinical benefit|1|||
24989280|NCT01592370|50077820|FG004|Overall Study|Maximum clinical benefit|0|||
24989281|NCT01592370|50077821|FG005|Overall Study|Maximum clinical benefit|0|||
24989282|NCT01592370|50077822|FG006|Overall Study|Maximum clinical benefit|0|||
24989283|NCT01592370|50077816|FG000|Overall Study|No longer meets study criteria|1|||
24989284|NCT01592370|50077817|FG001|Overall Study|No longer meets study criteria|0|||
24989285|NCT01592370|50077818|FG002|Overall Study|No longer meets study criteria|0|||
24989286|NCT01592370|50077819|FG003|Overall Study|No longer meets study criteria|0|||
24989287|NCT01592370|50077820|FG004|Overall Study|No longer meets study criteria|0|||
24989288|NCT01592370|50077821|FG005|Overall Study|No longer meets study criteria|0|||
24989289|NCT01592370|50077822|FG006|Overall Study|No longer meets study criteria|0|||
24989290|NCT01592370|50077816|FG000|Overall Study|Other Reasons|6|||
24989291|NCT01592370|50077817|FG001|Overall Study|Other Reasons|0|||
24989292|NCT01592370|50077818|FG002|Overall Study|Other Reasons|10|||
24989293|NCT01592370|50077819|FG003|Overall Study|Other Reasons|0|||
24989294|NCT01592370|50077820|FG004|Overall Study|Other Reasons|0|||
24989295|NCT01592370|50077821|FG005|Overall Study|Other Reasons|1|||
24989296|NCT01592370|50077822|FG006|Overall Study|Other Reasons|0|||
24989297|NCT01344057|50077851|FG000|Overall Study|Premature Withdrawal|1|||
24989298|NCT00886782|50077858|FG000|Overall Study|Disease progression|3|||
24989299|NCT00886782|50077859|FG001|Overall Study|Disease progression|3|||
24989300|NCT00886782|50077860|FG002|Overall Study|Disease progression|3|||
24989301|NCT00886782|50077858|FG000|Overall Study|Study drug toxicity|0|||
24989302|NCT00886782|50077859|FG001|Overall Study|Study drug toxicity|0|||
24989303|NCT00886782|50077860|FG002|Overall Study|Study drug toxicity|1|||
24989304|NCT00886782|50077858|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
24989305|NCT00886782|50077859|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
24989306|NCT00886782|50077860|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
24989307|NCT00583024|50077868|FG000|Overall Study|Lost to Follow-up|4|||
24989308|NCT03435640|50077883|FG000|Overall Study|Withdrawal by Subject|0|||
24989309|NCT03435640|50077884|FG001|Overall Study|Withdrawal by Subject|1|||
24989310|NCT03435640|50077885|FG002|Overall Study|Withdrawal by Subject|0|||
24989311|NCT03435640|50077886|FG003|Overall Study|Withdrawal by Subject|2|||
24989312|NCT03435640|50077887|FG004|Overall Study|Withdrawal by Subject|0|||
24989313|NCT03435640|50077888|FG005|Overall Study|Withdrawal by Subject|0|||
24989314|NCT03435640|50077889|FG006|Overall Study|Withdrawal by Subject|3|||
24989315|NCT03435640|50077890|FG007|Overall Study|Withdrawal by Subject|0|||
24989316|NCT03435640|50077891|FG008|Overall Study|Withdrawal by Subject|0|||
24989317|NCT03435640|50077892|FG009|Overall Study|Withdrawal by Subject|2|||
24989318|NCT03435640|50077893|FG010|Overall Study|Withdrawal by Subject|3|||
24989319|NCT03435640|50077883|FG000|Overall Study|Lost to Follow-up|0|||
24989320|NCT03435640|50077884|FG001|Overall Study|Lost to Follow-up|0|||
24989321|NCT03435640|50077885|FG002|Overall Study|Lost to Follow-up|1|||
24989322|NCT03435640|50077886|FG003|Overall Study|Lost to Follow-up|0|||
24989323|NCT03435640|50077887|FG004|Overall Study|Lost to Follow-up|0|||
24989324|NCT03435640|50077888|FG005|Overall Study|Lost to Follow-up|0|||
24989325|NCT03435640|50077889|FG006|Overall Study|Lost to Follow-up|0|||
24989326|NCT03435640|50077890|FG007|Overall Study|Lost to Follow-up|0|||
24989327|NCT03435640|50077891|FG008|Overall Study|Lost to Follow-up|0|||
24989328|NCT03435640|50077892|FG009|Overall Study|Lost to Follow-up|0|||
24989329|NCT03435640|50077893|FG010|Overall Study|Lost to Follow-up|0|||
24989330|NCT00655876|50077921|FG000|Overall Study|Protocol Violation|9|||
24989331|NCT00655876|50077922|FG001|Overall Study|Protocol Violation|7|||
24989332|NCT03092752|50077928|FG000|Overall Study|Aged <40 years|14209|||
24989333|NCT03092752|50077928|FG000|Overall Study|At least one claim with T2DM|61299|||
24989334|NCT03092752|50077928|FG000|Overall Study|Having no claim of study drugs|29282|||
24989335|NCT03092752|50077928|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
24989336|NCT03092752|50077928|FG000|Overall Study|<6 month history|245900|||
24989337|NCT03750552|50077951|FG000|Overall Study|Adverse Event|5|||
24989338|NCT03750552|50077952|FG001|Overall Study|Adverse Event|1|||
24989339|NCT03750552|50077951|FG000|Overall Study|Withdrawal by Subject|1|||
24989340|NCT03750552|50077952|FG001|Overall Study|Withdrawal by Subject|1|||
24989341|NCT03750552|50077951|FG000|Overall Study|Other|2|||
24989342|NCT03750552|50077952|FG001|Overall Study|Other|0|||
24989343|NCT03750240|50077959|FG000|Overall Study|Technical Difficulties|2|||
24989344|NCT00047008|50077965|FG000|Overall Study|Withdrawn consent|2|||
24989345|NCT00047008|50077966|FG001|Overall Study|Withdrawn consent|3|||
24989346|NCT00047008|50077965|FG000|Overall Study|Ineligible|9|||
24989347|NCT00047008|50077966|FG001|Overall Study|Ineligible|8|||
24989348|NCT03091738|50077972|FG000|Overall Study|Adverse Event|1|||
24989349|NCT03091738|50077972|FG000|Overall Study|Lost to Follow-up|1|||
24989350|NCT03193216|50077978|FG000|Overall Study|Lost to Follow-up|1|||
24989351|NCT03193216|50077979|FG001|Overall Study|Lost to Follow-up|0|||
24989352|NCT03193216|50077978|FG000|Overall Study|Withdrawal by Subject|5|||
24989353|NCT03193216|50077979|FG001|Overall Study|Withdrawal by Subject|0|||
24989354|NCT03193216|50077978|FG000|Overall Study|Physician Decision|4|||
24989355|NCT03193216|50077979|FG001|Overall Study|Physician Decision|0|||
24989356|NCT03091348|50077987|FG000|Overall Study|Lost to Follow-up|2|||
24989357|NCT03091348|50077988|FG001|Overall Study|Lost to Follow-up|1|||
24989358|NCT03751098|50077995|FG000|Overall Study|Withdrawal by Subject|0|||
24989359|NCT03751098|50077996|FG001|Overall Study|Withdrawal by Subject|1|||
24989360|NCT03751020|50078007|FG000|Overall Study|Withdrawal by Subject|2|||
24989361|NCT03751020|50078008|FG001|Overall Study|Withdrawal by Subject|0|||
24989362|NCT03751020|50078009|FG002|Overall Study|Withdrawal by Subject|0|||
24989363|NCT03751020|50078007|FG000|Overall Study|Lost to Follow-up|7|||
24989364|NCT03751020|50078008|FG001|Overall Study|Lost to Follow-up|4|||
24989365|NCT03751020|50078009|FG002|Overall Study|Lost to Follow-up|10|||
24989366|NCT03090100|50078019|FG000|Overall Study|Adverse Event|9|||
24989367|NCT03090100|50078020|FG001|Overall Study|Adverse Event|11|||
24989368|NCT03090100|50078019|FG000|Overall Study|Pregnancy|1|||
24989369|NCT03090100|50078020|FG001|Overall Study|Pregnancy|1|||
24989370|NCT03090100|50078019|FG000|Overall Study|Lack of Efficacy|2|||
24989371|NCT03090100|50078020|FG001|Overall Study|Lack of Efficacy|7|||
24989372|NCT03090100|50078019|FG000|Overall Study|Lost to Follow-up|2|||
24989373|NCT03090100|50078020|FG001|Overall Study|Lost to Follow-up|2|||
24989374|NCT03090100|50078019|FG000|Overall Study|Withdrawal by Subject|7|||
24989375|NCT03090100|50078020|FG001|Overall Study|Withdrawal by Subject|19|||
24989376|NCT03090100|50078019|FG000|Overall Study|Protocol Violation|2|||
24989377|NCT03090100|50078020|FG001|Overall Study|Protocol Violation|6|||
24989378|NCT03090100|50078019|FG000|Overall Study|Non-compliance|2|||
24989379|NCT03090100|50078020|FG001|Overall Study|Non-compliance|0|||
24989380|NCT03090100|50078019|FG000|Overall Study|Other|2|||
24989381|NCT03090100|50078020|FG001|Overall Study|Other|2|||
24989382|NCT03089944|50078026|FG000|Overall Study|Lost to Follow-up|8|||
24989383|NCT03089944|50078026|FG000|Overall Study|Withdrew Consent|2|||
24989384|NCT03089944|50078026|FG000|Overall Study|Adverse Event|1|||
24989385|NCT03089944|50078026|FG000|Overall Study|Other|1|||
24989386|NCT03739866|50078049|FG000|Overall Study|Lost to Follow-up|0|||
24989387|NCT03739866|50078050|FG001|Overall Study|Lost to Follow-up|0|||
24989388|NCT03739866|50078051|FG002|Overall Study|Lost to Follow-up|0|||
24989389|NCT03739866|50078052|FG003|Overall Study|Lost to Follow-up|1|||
24989390|NCT03739866|50078053|FG004|Overall Study|Lost to Follow-up|0|||
24989391|NCT03739866|50078054|FG005|Overall Study|Lost to Follow-up|0|||
24989392|NCT03739866|50078055|FG006|Overall Study|Lost to Follow-up|0|||
24989393|NCT03739866|50078056|FG007|Overall Study|Lost to Follow-up|0|||
24989394|NCT03739866|50078049|FG000|Overall Study|Enrolled but not treated|0|||
24989395|NCT03739866|50078050|FG001|Overall Study|Enrolled but not treated|0|||
24989396|NCT03739866|50078051|FG002|Overall Study|Enrolled but not treated|1|||
24989397|NCT03739866|50078052|FG003|Overall Study|Enrolled but not treated|0|||
24989398|NCT03739866|50078053|FG004|Overall Study|Enrolled but not treated|1|||
24989399|NCT03739866|50078054|FG005|Overall Study|Enrolled but not treated|0|||
24989400|NCT03739866|50078055|FG006|Overall Study|Enrolled but not treated|0|||
24989401|NCT03739866|50078056|FG007|Overall Study|Enrolled but not treated|0|||
24989402|NCT03739242|50078080|FG000|Overall Study|Withdrawal by Subject|1|||
24989403|NCT03739242|50078081|FG001|Overall Study|Withdrawal by Subject|1|||
24989404|NCT03739242|50078080|FG000|Overall Study|Protocol Violation|0|||
24989405|NCT03739242|50078081|FG001|Overall Study|Protocol Violation|1|||
24989406|NCT02849626|50078138|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
24989407|NCT02849626|50078139|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
24989408|NCT02849626|50078140|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
24989409|NCT02849626|50078141|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
24989410|NCT02849626|50078138|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
24989411|NCT02849626|50078139|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
24989412|NCT02849626|50078140|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
24989413|NCT02849626|50078141|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
24989414|NCT02849626|50078138|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
24989415|NCT02849626|50078139|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
24989416|NCT02849626|50078140|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
24989417|NCT02849626|50078141|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
24989418|NCT02849626|50078138|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
24989419|NCT02849626|50078139|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
24989420|NCT02849626|50078140|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
24989421|NCT02849626|50078141|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
24989422|NCT02849626|50078138|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
24989423|NCT02849626|50078139|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
24989424|NCT02849626|50078140|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
24989425|NCT02849626|50078141|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
24989426|NCT02849626|50078138|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
24989427|NCT02849626|50078139|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
24989428|NCT02849626|50078140|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
24989429|NCT02849626|50078141|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
24989430|NCT02849626|50078138|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
24989431|NCT02849626|50078139|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
24989432|NCT02849626|50078140|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
24989433|NCT02849626|50078141|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
24989434|NCT02849626|50078138|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
24989435|NCT02849626|50078139|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
24989436|NCT02849626|50078140|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
24989437|NCT02849626|50078141|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
24989438|NCT02849626|50078138|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
24989439|NCT02849626|50078139|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
24989440|NCT02849626|50078140|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
24989441|NCT02849626|50078141|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
24989442|NCT02849626|50078138|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
24989443|NCT02849626|50078139|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
24989444|NCT02849626|50078140|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
24989445|NCT02849626|50078141|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
24989446|NCT02849626|50078138|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
24989447|NCT02849626|50078139|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
24989448|NCT02849626|50078140|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
24989449|NCT02849626|50078141|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
24989450|NCT03735498|50078159|FG000|Overall Study|Withdrawal by Subject|5|||
24989451|NCT03735498|50078159|FG000|Overall Study|one participant only completed 5 of 6 sessions|1|||
24989452|NCT02659540|50078165|FG000|Overall Study|Adverse Event|3|||
24989453|NCT02659540|50078166|FG001|Overall Study|Adverse Event|2|||
24989454|NCT02659540|50078165|FG000|Overall Study|Death|1|||
25079439|NCT01865617|50187898|FG012|Overall Study|Patient proceeded to new therapy|0|||
24989455|NCT02659540|50078166|FG001|Overall Study|Death|0|||
24989456|NCT02659540|50078165|FG000|Overall Study|Progressive disease|2|||
24989457|NCT02659540|50078166|FG001|Overall Study|Progressive disease|6|||
24989458|NCT01097746|50078172|FG000|Overall Study|Adverse Event|4|||
24989459|NCT01097746|50078172|FG000|Overall Study|taken off study before any treatment given|1|||
24989460|NCT03733470|50078202|FG000|Overall Study|PI Decision|1|||
24989461|NCT03733470|50078203|FG001|Overall Study|PI Decision|1|||
24989462|NCT03732534|50078209|FG000|Overall Study|Study terminated by Sponsor|6|||
24989463|NCT03087058|50078215|FG000|Overall Study|Withdrawal by Subject|2|||
24989464|NCT03087058|50078216|FG001|Overall Study|Withdrawal by Subject|0|||
24989465|NCT03087058|50078217|FG002|Overall Study|Withdrawal by Subject|0|||
24989466|NCT03726996|50078224|FG000|Overall Study|Parent's decision|2|||
24989467|NCT03726996|50078224|FG000|Overall Study|Study early termination|2|||
24989468|NCT03882970|50078232|FG000|Overall Study|Adverse Event|5|||
24989469|NCT03882970|50078233|FG001|Overall Study|Adverse Event|7|||
24989470|NCT03882970|50078234|FG002|Overall Study|Adverse Event|3|||
24989471|NCT03882970|50078235|FG003|Overall Study|Adverse Event|1|||
24989472|NCT03882970|50078232|FG000|Overall Study|Death|1|||
24989473|NCT03882970|50078233|FG001|Overall Study|Death|2|||
24989474|NCT03882970|50078234|FG002|Overall Study|Death|1|||
24989475|NCT03882970|50078235|FG003|Overall Study|Death|1|||
24989476|NCT03882970|50078232|FG000|Overall Study|Lost to Follow-up|8|||
24989477|NCT03882970|50078233|FG001|Overall Study|Lost to Follow-up|9|||
24989478|NCT03882970|50078234|FG002|Overall Study|Lost to Follow-up|5|||
24989479|NCT03882970|50078235|FG003|Overall Study|Lost to Follow-up|5|||
24989480|NCT03882970|50078232|FG000|Overall Study|Physician Decision|0|||
24989481|NCT03882970|50078233|FG001|Overall Study|Physician Decision|2|||
24989482|NCT03882970|50078234|FG002|Overall Study|Physician Decision|2|||
24989483|NCT03882970|50078235|FG003|Overall Study|Physician Decision|2|||
24989484|NCT03882970|50078232|FG000|Overall Study|Protocol Violation|2|||
24989485|NCT03882970|50078233|FG001|Overall Study|Protocol Violation|0|||
24989486|NCT03882970|50078234|FG002|Overall Study|Protocol Violation|0|||
24989487|NCT03882970|50078235|FG003|Overall Study|Protocol Violation|0|||
24989488|NCT03882970|50078232|FG000|Overall Study|Withdrawal by Subject|8|||
24989489|NCT03882970|50078233|FG001|Overall Study|Withdrawal by Subject|17|||
24989490|NCT03882970|50078234|FG002|Overall Study|Withdrawal by Subject|7|||
24989491|NCT03882970|50078235|FG003|Overall Study|Withdrawal by Subject|22|||
24989492|NCT03882970|50078232|FG000|Overall Study|Personal Reason|2|||
24989493|NCT03882970|50078233|FG001|Overall Study|Personal Reason|3|||
24989494|NCT03882970|50078234|FG002|Overall Study|Personal Reason|1|||
24989495|NCT03882970|50078235|FG003|Overall Study|Personal Reason|3|||
24989496|NCT03730480|50078249|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
24989497|NCT03674112|50078256|FG000|Overall Study|Adverse Event|1|||
24989498|NCT03674112|50078257|FG001|Overall Study|Adverse Event|0|||
24989499|NCT03674112|50078256|FG000|Overall Study|Ongoing in the Study|79|||
24989500|NCT03674112|50078257|FG001|Overall Study|Ongoing in the Study|80|||
24989501|NCT03668808|50078283|FG000|First Intervention|Withdrawal by Subject|2|||
24989502|NCT03668808|50078284|FG001|First Intervention|Withdrawal by Subject|2|||
24989503|NCT03725982|50078294|FG000|First Intervention|Withdrawal by Subject|0|||
24989504|NCT03725982|50078295|FG001|First Intervention|Withdrawal by Subject|1|||
24989505|NCT03725982|50078294|FG000|First Intervention|Physician Decision|1|||
24989506|NCT03725982|50078295|FG001|First Intervention|Physician Decision|1|||
24989507|NCT02982954|50078311|FG000|Overall Study|Death|55|||
24989508|NCT02982954|50078312|FG001|Overall Study|Death|29|||
24989509|NCT02982954|50078313|FG002|Overall Study|Death|15|||
24989510|NCT02982954|50078314|FG003|Overall Study|Death|20|||
24989511|NCT02982954|50078311|FG000|Overall Study|Lost to Follow-up|2|||
24989512|NCT02982954|50078312|FG001|Overall Study|Lost to Follow-up|1|||
24989513|NCT02982954|50078313|FG002|Overall Study|Lost to Follow-up|0|||
24989514|NCT02982954|50078314|FG003|Overall Study|Lost to Follow-up|0|||
24989515|NCT02982954|50078311|FG000|Overall Study|Participant withdrew consent|7|||
24989516|NCT02982954|50078312|FG001|Overall Study|Participant withdrew consent|5|||
24989517|NCT02982954|50078313|FG002|Overall Study|Participant withdrew consent|1|||
24989518|NCT02982954|50078314|FG003|Overall Study|Participant withdrew consent|1|||
24989519|NCT02982954|50078311|FG000|Overall Study|Other reasons|42|||
24989520|NCT02982954|50078312|FG001|Overall Study|Other reasons|17|||
24989521|NCT02982954|50078313|FG002|Overall Study|Other reasons|12|||
24989522|NCT02982954|50078314|FG003|Overall Study|Other reasons|3|||
24989523|NCT02982954|50078311|FG000|Overall Study|Premature site closure|0|||
24989524|NCT02982954|50078312|FG001|Overall Study|Premature site closure|0|||
24989525|NCT02982954|50078313|FG002|Overall Study|Premature site closure|0|||
24989526|NCT02982954|50078314|FG003|Overall Study|Premature site closure|1|||
24989527|NCT03724968|50078326|FG000|Overall Study|Insurance issues|0|||
24989528|NCT03724968|50078327|FG001|Overall Study|Insurance issues|1|||
24989529|NCT03724968|50078326|FG000|Overall Study|Study closed|0|||
24989530|NCT03724968|50078327|FG001|Overall Study|Study closed|1|||
24989531|NCT03724812|50078333|FG000|Overall Study|Missed Visit|1|||
24989532|NCT03724812|50078333|FG000|Overall Study|Death|2|||
24989533|NCT03724812|50078333|FG000|Overall Study|Withdrawal by Subject|1|||
24989534|NCT03722784|50078340|FG000|Overall Study|Withdrawal by Subject|1|||
24989535|NCT03722784|50078341|FG001|Overall Study|Withdrawal by Subject|0|||
24989536|NCT03722784|50078340|FG000|Overall Study|Physician Decision|1|||
24989537|NCT03722784|50078341|FG001|Overall Study|Physician Decision|1|||
24989538|NCT03722784|50078340|FG000|Overall Study|Protocol Violation|0|||
24989539|NCT03722784|50078341|FG001|Overall Study|Protocol Violation|1|||
24989540|NCT03722238|50078350|FG000|Overall Study|Protocol Violation|1|||
24989541|NCT03722238|50078351|FG001|Overall Study|Protocol Violation|0|||
24989542|NCT03722238|50078350|FG000|Overall Study|Physician Decision|1|||
24989543|NCT03722238|50078351|FG001|Overall Study|Physician Decision|0|||
24989544|NCT03722238|50078350|FG000|Overall Study|Death|1|||
24989545|NCT03722238|50078351|FG001|Overall Study|Death|0|||
24989546|NCT03722238|50078350|FG000|Overall Study|Lost to Follow-up|6|||
24989547|NCT03722238|50078351|FG001|Overall Study|Lost to Follow-up|0|||
24989548|NCT03722238|50078350|FG000|Overall Study|Partial missing data|44|||
24989549|NCT03722238|50078351|FG001|Overall Study|Partial missing data|1|||
24989550|NCT03722238|50078350|FG000|Overall Study|Withdrawal by Subject|2|||
24989551|NCT03722238|50078351|FG001|Overall Study|Withdrawal by Subject|0|||
24989552|NCT03722238|50078350|FG000|Overall Study|Other|4|||
24989553|NCT03722238|50078351|FG001|Overall Study|Other|0|||
24989554|NCT03722238|50078350|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
24989555|NCT03722238|50078351|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
24989556|NCT03722238|50078350|FG000|Overall Study|Did not meet risk classification group criteria|90|||
24989557|NCT03722238|50078351|FG001|Overall Study|Did not meet risk classification group criteria|0|||
24989558|NCT03722238|50078350|FG000|Overall Study|Did not sign consent|17|||
24989559|NCT03722238|50078351|FG001|Overall Study|Did not sign consent|0|||
24989560|NCT03722238|50078350|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
24989561|NCT03722238|50078351|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
24989562|NCT03722238|50078350|FG000|Overall Study|Not willing to purchase study medication|142|||
24989563|NCT03722238|50078351|FG001|Overall Study|Not willing to purchase study medication|0|||
24989564|NCT03722238|50078350|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
24989565|NCT03722238|50078351|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
24989566|NCT02927080|50078367|FG000|Overall Study|Withdrawal by Subject|0|||
24989567|NCT02927080|50078368|FG001|Overall Study|Withdrawal by Subject|0|||
24989568|NCT02927080|50078369|FG002|Overall Study|Withdrawal by Subject|0|||
24989569|NCT02927080|50078370|FG003|Overall Study|Withdrawal by Subject|0|||
24989570|NCT02927080|50078371|FG004|Overall Study|Withdrawal by Subject|1|||
24989571|NCT02927080|50078372|FG005|Overall Study|Withdrawal by Subject|0|||
24989572|NCT02927080|50078373|FG006|Overall Study|Withdrawal by Subject|1|||
24989573|NCT02927080|50078374|FG007|Overall Study|Withdrawal by Subject|1|||
24989574|NCT02927080|50078375|FG008|Overall Study|Withdrawal by Subject|0|||
24989575|NCT02927080|50078376|FG009|Overall Study|Withdrawal by Subject|2|||
24989576|NCT02927080|50078367|FG000|Overall Study|Willingness to comply with protocol|0|||
24989577|NCT02927080|50078368|FG001|Overall Study|Willingness to comply with protocol|0|||
24989578|NCT02927080|50078369|FG002|Overall Study|Willingness to comply with protocol|0|||
24989579|NCT02927080|50078370|FG003|Overall Study|Willingness to comply with protocol|0|||
24989580|NCT02927080|50078371|FG004|Overall Study|Willingness to comply with protocol|0|||
24989581|NCT02927080|50078372|FG005|Overall Study|Willingness to comply with protocol|0|||
24989582|NCT02927080|50078373|FG006|Overall Study|Willingness to comply with protocol|0|||
24989583|NCT02927080|50078374|FG007|Overall Study|Willingness to comply with protocol|0|||
24989584|NCT02927080|50078375|FG008|Overall Study|Willingness to comply with protocol|0|||
24989585|NCT02927080|50078376|FG009|Overall Study|Willingness to comply with protocol|1|||
24989586|NCT02927080|50078367|FG000|Overall Study|Study terminated by Sponsor|0|||
24989587|NCT02927080|50078368|FG001|Overall Study|Study terminated by Sponsor|0|||
24989588|NCT02927080|50078369|FG002|Overall Study|Study terminated by Sponsor|0|||
24989589|NCT02927080|50078370|FG003|Overall Study|Study terminated by Sponsor|0|||
24989590|NCT02927080|50078371|FG004|Overall Study|Study terminated by Sponsor|0|||
24989591|NCT02927080|50078372|FG005|Overall Study|Study terminated by Sponsor|0|||
24989592|NCT02927080|50078373|FG006|Overall Study|Study terminated by Sponsor|6|||
24989593|NCT02927080|50078374|FG007|Overall Study|Study terminated by Sponsor|7|||
24989594|NCT02927080|50078375|FG008|Overall Study|Study terminated by Sponsor|2|||
24989595|NCT02927080|50078376|FG009|Overall Study|Study terminated by Sponsor|3|||
24989596|NCT02927080|50078367|FG000|Overall Study|Adverse Event|0|||
25079440|NCT01865617|50187886|FG000|Overall Study|Other|0|||
24989597|NCT02927080|50078368|FG001|Overall Study|Adverse Event|1|||
24989598|NCT02927080|50078369|FG002|Overall Study|Adverse Event|0|||
24989599|NCT02927080|50078370|FG003|Overall Study|Adverse Event|0|||
24989600|NCT02927080|50078371|FG004|Overall Study|Adverse Event|0|||
24989601|NCT02927080|50078372|FG005|Overall Study|Adverse Event|0|||
24989602|NCT02927080|50078373|FG006|Overall Study|Adverse Event|0|||
24989603|NCT02927080|50078374|FG007|Overall Study|Adverse Event|1|||
25079441|NCT01865617|50187887|FG001|Overall Study|Other|0|||
24989604|NCT02927080|50078375|FG008|Overall Study|Adverse Event|0|||
24989605|NCT02927080|50078376|FG009|Overall Study|Adverse Event|1|||
24989606|NCT02927080|50078367|FG000|Overall Study|Other|0|||
24989607|NCT02927080|50078368|FG001|Overall Study|Other|0|||
24989608|NCT02927080|50078369|FG002|Overall Study|Other|0|||
24989609|NCT02927080|50078370|FG003|Overall Study|Other|0|||
24989610|NCT02927080|50078371|FG004|Overall Study|Other|0|||
24989611|NCT02927080|50078372|FG005|Overall Study|Other|0|||
24989612|NCT02927080|50078373|FG006|Overall Study|Other|1|||
24989613|NCT02927080|50078374|FG007|Overall Study|Other|0|||
24989614|NCT02927080|50078375|FG008|Overall Study|Other|1|||
24989615|NCT02927080|50078376|FG009|Overall Study|Other|0|||
24989616|NCT02374476|50078423|FG000|VT Induced Ablation|Screening Failures|36|||
24989617|NCT02374476|50078424|FG001|VT Induced Ablation|Screening Failures|0|||
24989618|NCT02374476|50078425|FG002|VT Induced Ablation|Screening Failures|0|||
24989619|NCT02374476|50078423|FG000|Arm Assignment|Withdrawal by Subject|0|||
24989620|NCT02374476|50078424|FG001|Arm Assignment|Withdrawal by Subject|0|||
24989621|NCT02374476|50078425|FG002|Arm Assignment|Withdrawal by Subject|1|||
24989622|NCT02918292|50078432|FG000|Study Enrollment Prior to Transplant|Death|1|||
24989623|NCT02918292|50078432|FG000|Study Follow up After Transplant|Death|6|||
24989624|NCT03720210|50078436|FG000|Overall Study|Lost to Follow-up|1|||
24989625|NCT03719586|50078444|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
24989626|NCT03719586|50078445|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
24989627|NCT03719586|50078446|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
24989628|NCT03719586|50078447|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
24989629|NCT03353350|50078473|FG000|30-week Core Treatment Period|Protocol Violation|1|||
24989630|NCT03353350|50078474|FG001|30-week Core Treatment Period|Protocol Violation|1|||
24989631|NCT03353350|50078475|FG002|30-week Core Treatment Period|Protocol Violation|1|||
24989632|NCT03353350|50078476|FG003|30-week Core Treatment Period|Protocol Violation|0|||
24989633|NCT03353350|50078473|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
24989634|NCT03353350|50078474|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
24989635|NCT03353350|50078475|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
24989636|NCT03353350|50078476|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
24989637|NCT03353350|50078473|FG000|30-week Core Treatment Period|Adverse Event|0|||
24989638|NCT03353350|50078474|FG001|30-week Core Treatment Period|Adverse Event|4|||
24989639|NCT03353350|50078475|FG002|30-week Core Treatment Period|Adverse Event|2|||
24989640|NCT03353350|50078476|FG003|30-week Core Treatment Period|Adverse Event|3|||
24989641|NCT03353350|50078473|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
24989642|NCT03353350|50078474|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
24989643|NCT03353350|50078475|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
24989644|NCT03353350|50078476|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
24989645|NCT03353350|50078473|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
24989646|NCT03353350|50078474|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
24989647|NCT03353350|50078475|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
24989648|NCT03353350|50078476|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
24989649|NCT03353350|50078473|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
24989650|NCT03353350|50078474|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
24989651|NCT03353350|50078475|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
24989652|NCT03353350|50078476|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
24989653|NCT03353350|50078473|FG000|26-week Treatment Extension Period|Adverse Event|1|||
24989654|NCT03353350|50078474|FG001|26-week Treatment Extension Period|Adverse Event|0|||
24989655|NCT03353350|50078475|FG002|26-week Treatment Extension Period|Adverse Event|0|||
24989656|NCT03353350|50078476|FG003|26-week Treatment Extension Period|Adverse Event|1|||
24989657|NCT03353350|50078473|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
24989658|NCT03353350|50078474|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
24989659|NCT03353350|50078475|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
24989660|NCT03353350|50078476|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
24989661|NCT03032068|50078490|FG000|Overall Study|Adverse Event|1|||
24989662|NCT02674516|50078510|FG000|Overall Study|Lost to Follow-up|3|||
24989663|NCT02674516|50078511|FG001|Overall Study|Lost to Follow-up|0|||
24989664|NCT02674516|50078510|FG000|Overall Study|Protocol Violation|0|||
24989665|NCT02674516|50078511|FG001|Overall Study|Protocol Violation|4|||
24989666|NCT02674516|50078510|FG000|Overall Study|Knowledge of study hypothesis|1|||
24989667|NCT02674516|50078511|FG001|Overall Study|Knowledge of study hypothesis|0|||
24989668|NCT02463448|50078517|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
24989669|NCT02463448|50078517|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
24989670|NCT02463448|50078517|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
24989671|NCT02463448|50078517|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
24989672|NCT03794544|50078525|FG000|Overall Study|Withdrawal by Subject|1|||
24989673|NCT03794544|50078526|FG001|Overall Study|Withdrawal by Subject|1|||
24989674|NCT03794544|50078527|FG002|Overall Study|Withdrawal by Subject|0|||
24989675|NCT03794544|50078528|FG003|Overall Study|Withdrawal by Subject|0|||
24989676|NCT03794544|50078525|FG000|Overall Study|Death|0|||
24989677|NCT03794544|50078526|FG001|Overall Study|Death|0|||
24989678|NCT03794544|50078527|FG002|Overall Study|Death|0|||
24989679|NCT03794544|50078528|FG003|Overall Study|Death|1|||
24989680|NCT03794544|50078525|FG000|Overall Study|Lost to Follow-up|0|||
24989681|NCT03794544|50078526|FG001|Overall Study|Lost to Follow-up|1|||
24989682|NCT03794544|50078527|FG002|Overall Study|Lost to Follow-up|1|||
24989683|NCT03794544|50078528|FG003|Overall Study|Lost to Follow-up|0|||
24989684|NCT03794544|50078525|FG000|Overall Study|Other|0|||
24989685|NCT03794544|50078526|FG001|Overall Study|Other|1|||
24989686|NCT03794544|50078527|FG002|Overall Study|Other|0|||
24989687|NCT03794544|50078528|FG003|Overall Study|Other|0|||
24989688|NCT01804270|50078540|FG000|Overall Study|Withdrawal by Subject|1|||
24989689|NCT01804270|50078541|FG001|Overall Study|Withdrawal by Subject|1|||
24989690|NCT03107026|50078550|FG000|Overall Study|Adverse Event|2|||
24989691|NCT03107026|50078551|FG001|Overall Study|Adverse Event|14|||
24989692|NCT03107026|50078552|FG002|Overall Study|Adverse Event|23|||
24989693|NCT03107026|50078550|FG000|Overall Study|Lost to Follow-up|12|||
24989694|NCT03107026|50078551|FG001|Overall Study|Lost to Follow-up|12|||
24989695|NCT03107026|50078552|FG002|Overall Study|Lost to Follow-up|13|||
24989696|NCT03107026|50078550|FG000|Overall Study|Protocol Violation|1|||
24989697|NCT03107026|50078551|FG001|Overall Study|Protocol Violation|2|||
24989698|NCT03107026|50078552|FG002|Overall Study|Protocol Violation|0|||
24989699|NCT03107026|50078550|FG000|Overall Study|Pregnancy|1|||
24989700|NCT03107026|50078551|FG001|Overall Study|Pregnancy|0|||
24989701|NCT03107026|50078552|FG002|Overall Study|Pregnancy|0|||
24989702|NCT03107026|50078550|FG000|Overall Study|Withdrawal by Subject|13|||
24989703|NCT03107026|50078551|FG001|Overall Study|Withdrawal by Subject|5|||
24989704|NCT03107026|50078552|FG002|Overall Study|Withdrawal by Subject|17|||
24989705|NCT03107026|50078550|FG000|Overall Study|non compliance with study visits|1|||
24989706|NCT03107026|50078551|FG001|Overall Study|non compliance with study visits|2|||
24989707|NCT03107026|50078552|FG002|Overall Study|non compliance with study visits|0|||
24989708|NCT03107026|50078550|FG000|Overall Study|non-compliance with study drug|2|||
24989709|NCT03107026|50078551|FG001|Overall Study|non-compliance with study drug|2|||
24989710|NCT03107026|50078552|FG002|Overall Study|non-compliance with study drug|3|||
24989711|NCT03107026|50078550|FG000|Overall Study|Physician Decision|0|||
24989712|NCT03107026|50078551|FG001|Overall Study|Physician Decision|1|||
24989713|NCT03107026|50078552|FG002|Overall Study|Physician Decision|0|||
24989714|NCT03717480|50078560|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
24989715|NCT00005044|50078566|FG000|Overall Study|Protocol Violation|37|||
24989716|NCT00005044|50078567|FG001|Overall Study|Protocol Violation|46|||
24989717|NCT00005044|50078566|FG000|Overall Study|Withdrawal by Subject|1|||
24989718|NCT00005044|50078567|FG001|Overall Study|Withdrawal by Subject|5|||
24989719|NCT00005044|50078566|FG000|Overall Study|No protocol treatment|0|||
24989720|NCT00005044|50078567|FG001|Overall Study|No protocol treatment|1|||
24989721|NCT03084796|50078579|FG000|Overall Study|Adverse Event|4|||
24989722|NCT03084796|50078580|FG001|Overall Study|Adverse Event|5|||
24989723|NCT03084796|50078581|FG002|Overall Study|Adverse Event|6|||
24989724|NCT03084796|50078582|FG003|Overall Study|Adverse Event|2|||
24989725|NCT03084796|50078583|FG004|Overall Study|Adverse Event|3|||
24989726|NCT03084796|50078584|FG005|Overall Study|Adverse Event|5|||
24989727|NCT03084796|50078579|FG000|Overall Study|Withdrawal by Subject|3|||
24989728|NCT03084796|50078580|FG001|Overall Study|Withdrawal by Subject|5|||
24989729|NCT03084796|50078581|FG002|Overall Study|Withdrawal by Subject|2|||
24989730|NCT03084796|50078582|FG003|Overall Study|Withdrawal by Subject|1|||
24989731|NCT03084796|50078583|FG004|Overall Study|Withdrawal by Subject|3|||
24989732|NCT03084796|50078584|FG005|Overall Study|Withdrawal by Subject|0|||
24989733|NCT03084796|50078579|FG000|Overall Study|Protocol Violation|0|||
24989734|NCT03084796|50078580|FG001|Overall Study|Protocol Violation|0|||
24989735|NCT03084796|50078581|FG002|Overall Study|Protocol Violation|1|||
24989736|NCT03084796|50078582|FG003|Overall Study|Protocol Violation|0|||
24989737|NCT03084796|50078583|FG004|Overall Study|Protocol Violation|1|||
24989738|NCT03084796|50078584|FG005|Overall Study|Protocol Violation|1|||
24989739|NCT03084796|50078579|FG000|Overall Study|Lack of Efficacy|0|||
24989740|NCT03084796|50078580|FG001|Overall Study|Lack of Efficacy|0|||
24989741|NCT03084796|50078581|FG002|Overall Study|Lack of Efficacy|1|||
24989742|NCT03084796|50078582|FG003|Overall Study|Lack of Efficacy|0|||
24989743|NCT03084796|50078583|FG004|Overall Study|Lack of Efficacy|1|||
24989744|NCT03084796|50078584|FG005|Overall Study|Lack of Efficacy|0|||
24989745|NCT03084796|50078579|FG000|Overall Study|Lost to Follow-up|0|||
24989746|NCT03084796|50078580|FG001|Overall Study|Lost to Follow-up|0|||
24989747|NCT03084796|50078581|FG002|Overall Study|Lost to Follow-up|1|||
24989748|NCT03084796|50078582|FG003|Overall Study|Lost to Follow-up|1|||
24989749|NCT03084796|50078583|FG004|Overall Study|Lost to Follow-up|3|||
24989750|NCT03084796|50078584|FG005|Overall Study|Lost to Follow-up|1|||
24989751|NCT03084796|50078579|FG000|Overall Study|Randomization error|0|||
24989752|NCT03084796|50078580|FG001|Overall Study|Randomization error|0|||
24989753|NCT03084796|50078581|FG002|Overall Study|Randomization error|1|||
24989754|NCT03084796|50078582|FG003|Overall Study|Randomization error|0|||
24989755|NCT03084796|50078583|FG004|Overall Study|Randomization error|0|||
24989756|NCT03084796|50078584|FG005|Overall Study|Randomization error|0|||
24989757|NCT03717012|50078600|FG000|Overall Study|Due to trial termination|1|||
24989758|NCT03717012|50078601|FG001|Overall Study|Due to trial termination|2|||
24989759|NCT03717012|50078600|FG000|Overall Study|Protocol Violation|0|||
24989760|NCT03717012|50078601|FG001|Overall Study|Protocol Violation|2|||
24989761|NCT03717012|50078600|FG000|Overall Study|Adverse Event|0|||
24989762|NCT03717012|50078601|FG001|Overall Study|Adverse Event|1|||
24989763|NCT03717012|50078600|FG000|Overall Study|Lung transplant|0|||
24989764|NCT03717012|50078601|FG001|Overall Study|Lung transplant|1|||
24989765|NCT03078556|50078614|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
24989766|NCT03078556|50078615|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
24989767|NCT03078556|50078616|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
24989768|NCT03078556|50078617|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
24989769|NCT03078556|50078614|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
24989770|NCT03078556|50078615|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
24989771|NCT03078556|50078616|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
24989772|NCT03078556|50078617|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
24989773|NCT03078556|50078614|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
24989774|NCT03078556|50078615|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
24989775|NCT03078556|50078616|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
24989776|NCT03078556|50078617|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
24989777|NCT03078556|50078614|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
24989778|NCT03078556|50078615|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
24989779|NCT03078556|50078616|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
24989780|NCT03078556|50078617|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
24989781|NCT03714672|50078646|FG000|Overall Study|Adverse Event|0|||
24989782|NCT03714672|50078647|FG001|Overall Study|Adverse Event|0|||
24989783|NCT03714672|50078648|FG002|Overall Study|Adverse Event|3|||
24989784|NCT03714672|50078649|FG003|Overall Study|Adverse Event|0|||
24989785|NCT03714672|50078646|FG000|Overall Study|Physician Decision|0|||
24989786|NCT03714672|50078647|FG001|Overall Study|Physician Decision|1|||
24989787|NCT03714672|50078648|FG002|Overall Study|Physician Decision|0|||
24989788|NCT03714672|50078649|FG003|Overall Study|Physician Decision|0|||
24989789|NCT03714672|50078646|FG000|Overall Study|Other Reason|1|||
24989790|NCT03714672|50078647|FG001|Overall Study|Other Reason|2|||
24989791|NCT03714672|50078648|FG002|Overall Study|Other Reason|1|||
24989792|NCT03714672|50078649|FG003|Overall Study|Other Reason|1|||
24989793|NCT03714672|50078646|FG000|Overall Study|Lost to Follow-up|1|||
24989794|NCT03714672|50078647|FG001|Overall Study|Lost to Follow-up|1|||
24989795|NCT03714672|50078648|FG002|Overall Study|Lost to Follow-up|0|||
24989796|NCT03714672|50078649|FG003|Overall Study|Lost to Follow-up|0|||
24989797|NCT03083470|50078665|FG000|Overall Study|Lost to Follow-up|0|||
24989798|NCT03083470|50078666|FG001|Overall Study|Lost to Follow-up|0|||
24989799|NCT03083470|50078667|FG002|Overall Study|Lost to Follow-up|0|||
24989800|NCT03083470|50078668|FG003|Overall Study|Lost to Follow-up|0|||
24989801|NCT03083470|50078669|FG004|Overall Study|Lost to Follow-up|1|||
24989802|NCT03083470|50078665|FG000|Overall Study|Withdrawal by Subject|0|||
24989803|NCT03083470|50078666|FG001|Overall Study|Withdrawal by Subject|0|||
24989804|NCT03083470|50078667|FG002|Overall Study|Withdrawal by Subject|0|||
24989805|NCT03083470|50078668|FG003|Overall Study|Withdrawal by Subject|0|||
24989806|NCT03083470|50078669|FG004|Overall Study|Withdrawal by Subject|1|||
24989807|NCT05405244|50078681|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
24989808|NCT05405244|50078682|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
24989809|NCT05405244|50078681|FG000|Washout (2 Weeks)|Adverse Event|2|||
24989810|NCT05405244|50078682|FG001|Washout (2 Weeks)|Adverse Event|0|||
24989811|NCT05405244|50078681|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
24989812|NCT05405244|50078682|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
24989813|NCT03074500|50078695|FG000|Overall Study|Lost to Follow-up|1|||
24989814|NCT03074500|50078696|FG001|Overall Study|Lost to Follow-up|0|||
24989815|NCT03074500|50078697|FG002|Overall Study|Lost to Follow-up|0|||
24989816|NCT03074500|50078695|FG000|Overall Study|Lack of Efficacy|0|||
24989817|NCT03074500|50078696|FG001|Overall Study|Lack of Efficacy|1|||
24989818|NCT03074500|50078697|FG002|Overall Study|Lack of Efficacy|0|||
24989819|NCT03074500|50078695|FG000|Overall Study|Adverse Event|0|||
24989820|NCT03074500|50078696|FG001|Overall Study|Adverse Event|0|||
24989821|NCT03074500|50078697|FG002|Overall Study|Adverse Event|1|||
24989822|NCT03715530|50078710|FG000|Overall Study|Lost to Follow-up|3|||
24989823|NCT03715530|50078711|FG001|Overall Study|Lost to Follow-up|1|||
24989824|NCT03715530|50078712|FG002|Overall Study|Lost to Follow-up|2|||
24989825|NCT03077698|50078722|FG000|Progestin Monotherapy|Stable Disease|8|||
24989826|NCT03077698|50078723|FG001|Progestin Monotherapy|Stable Disease|0|||
24989827|NCT03077698|50078722|FG000|Progestin Monotherapy|Adverse Event|1|||
24989828|NCT03077698|50078723|FG001|Progestin Monotherapy|Adverse Event|0|||
24989829|NCT03077698|50078722|FG000|Progestin Monotherapy|Death|1|||
24989830|NCT03077698|50078723|FG001|Progestin Monotherapy|Death|0|||
24989831|NCT03077698|50078722|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
24989832|NCT03077698|50078723|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
24989833|NCT03077698|50078722|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
24989834|NCT03077698|50078723|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
24989835|NCT03077698|50078722|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
24989836|NCT03077698|50078723|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
24989837|NCT03077698|50078722|FG000|Safety Follow Up|Withdrawal by Subject|2|||
24989838|NCT03077698|50078723|FG001|Safety Follow Up|Withdrawal by Subject|1|||
24989839|NCT03077698|50078722|FG000|Safety Follow Up|Transfer of care to hospice|1|||
24989840|NCT03077698|50078723|FG001|Safety Follow Up|Transfer of care to hospice|0|||
24989841|NCT03079102|50078741|FG000|Overall Study|Physician Decision|0|||
24989842|NCT03079102|50078742|FG001|Overall Study|Physician Decision|1|||
24989843|NCT02434354|50078748|FG000|Overall Study|screen fail|3|||
24989844|NCT03076996|50078752|FG000|Overall Study|Withdrawal by Subject|2|||
24989845|NCT03076996|50078752|FG000|Overall Study|Lost to Follow-up|3|||
24989846|NCT03076996|50078752|FG000|Overall Study|Literacy precluded participation|1|||
24989847|NCT03078868|50078756|FG000|Overall Study|Physician Decision|3|||
24989848|NCT04524598|50078764|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
24989849|NCT04524598|50078765|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
24989850|NCT04524598|50078766|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
24989851|NCT04524598|50078767|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
24989852|NCT04524598|50078768|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
24989853|NCT04524598|50078764|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
24989854|NCT04524598|50078765|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
24989855|NCT04524598|50078766|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
24989856|NCT04524598|50078767|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
24989857|NCT04524598|50078768|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
24989858|NCT04524598|50078764|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
24989859|NCT04524598|50078765|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
24989860|NCT04524598|50078766|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
24989861|NCT04524598|50078767|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
24989862|NCT04524598|50078768|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
24989863|NCT04524598|50078764|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
24989864|NCT04524598|50078765|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
24989865|NCT04524598|50078766|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
24989866|NCT04524598|50078767|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
24989867|NCT04524598|50078768|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
24989868|NCT04524598|50078764|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
24989869|NCT04524598|50078765|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
24989870|NCT04524598|50078766|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
24989871|NCT04524598|50078767|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
24989872|NCT04524598|50078768|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
24989873|NCT04524598|50078764|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
24989874|NCT04524598|50078765|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
24989875|NCT04524598|50078766|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
24989876|NCT04524598|50078767|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
24989877|NCT04524598|50078768|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
24989878|NCT04524598|50078764|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
24989879|NCT04524598|50078765|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
24989880|NCT04524598|50078766|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
24989881|NCT04524598|50078767|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
24989882|NCT04524598|50078768|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
24989883|NCT03075904|50078782|FG000|Overall Study|Physician Decision|3|||
24989884|NCT03075904|50078782|FG000|Overall Study|Need for Medication not Permitted|1|||
24989885|NCT03073798|50078786|FG000|Overall Study|Adverse Event|1|||
24989886|NCT03073798|50078786|FG000|Overall Study|Withdrawal by Subject|1|||
24989887|NCT03075826|50078791|FG000|Overall Study|Withdrawal by Subject|1|||
24989888|NCT03075826|50078791|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
24989889|NCT02865850|50078806|FG000|Overall Study|Death|15|||
24989890|NCT02865850|50078807|FG001|Overall Study|Death|19|||
24989891|NCT02865850|50078806|FG000|Overall Study|Withdrawal by Subject|3|||
24989892|NCT02865850|50078807|FG001|Overall Study|Withdrawal by Subject|2|||
24989893|NCT02865850|50078806|FG000|Overall Study|Lost to Follow-up|3|||
24989894|NCT02865850|50078807|FG001|Overall Study|Lost to Follow-up|2|||
24989895|NCT03711162|50078816|FG000|Overall Study|Adverse Event|5|||
24989896|NCT03711162|50078817|FG001|Overall Study|Adverse Event|2|||
24989897|NCT03711162|50078818|FG002|Overall Study|Adverse Event|4|||
24989898|NCT03711162|50078816|FG000|Overall Study|Death|11|||
24989899|NCT03711162|50078817|FG001|Overall Study|Death|7|||
24989900|NCT03711162|50078818|FG002|Overall Study|Death|8|||
24989901|NCT03711162|50078816|FG000|Overall Study|Lost to Follow-up|1|||
24989902|NCT03711162|50078817|FG001|Overall Study|Lost to Follow-up|0|||
24989903|NCT03711162|50078818|FG002|Overall Study|Lost to Follow-up|1|||
24989904|NCT03711162|50078816|FG000|Overall Study|Study Terminated by Sponsor|139|||
24989905|NCT03711162|50078817|FG001|Overall Study|Study Terminated by Sponsor|152|||
24989906|NCT03711162|50078818|FG002|Overall Study|Study Terminated by Sponsor|146|||
24989907|NCT03711162|50078816|FG000|Overall Study|Withdrawal by Subject|17|||
24989908|NCT03711162|50078817|FG001|Overall Study|Withdrawal by Subject|10|||
24989909|NCT03711162|50078818|FG002|Overall Study|Withdrawal by Subject|10|||
24989910|NCT03711162|50078816|FG000|Overall Study|Miscellaneous|1|||
24989911|NCT03711162|50078817|FG001|Overall Study|Miscellaneous|2|||
24989912|NCT03711162|50078818|FG002|Overall Study|Miscellaneous|2|||
24989913|NCT03711162|50078816|FG000|Overall Study|Not Treated|1|||
24989914|NCT03711162|50078817|FG001|Overall Study|Not Treated|0|||
24989915|NCT03711162|50078818|FG002|Overall Study|Not Treated|1|||
24989916|NCT03711162|50078816|FG000|Overall Study|Physician Decision|0|||
24989917|NCT03711162|50078817|FG001|Overall Study|Physician Decision|2|||
24989918|NCT03711162|50078818|FG002|Overall Study|Physician Decision|0|||
24989919|NCT03711162|50078816|FG000|Overall Study|Lack of Efficacy|0|||
24989920|NCT03711162|50078817|FG001|Overall Study|Lack of Efficacy|0|||
24989921|NCT03711162|50078818|FG002|Overall Study|Lack of Efficacy|2|||
24989922|NCT03711162|50078816|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
24989923|NCT03711162|50078817|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
24989924|NCT03711162|50078818|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
24989925|NCT03072160|50078834|FG000|Overall Study|Adverse Event|3|||
24989926|NCT03072160|50078835|FG001|Overall Study|Adverse Event|1|||
24989927|NCT03072160|50078834|FG000|Overall Study|Refused further treatment|6|||
24989928|NCT03072160|50078835|FG001|Overall Study|Refused further treatment|1|||
24989929|NCT03072160|50078834|FG000|Overall Study|Physician Decision|1|||
24989930|NCT03072160|50078835|FG001|Overall Study|Physician Decision|0|||
24989931|NCT03072160|50078834|FG000|Overall Study|Disease progression on study|1|||
24989932|NCT03072160|50078835|FG001|Overall Study|Disease progression on study|1|||
24989933|NCT03072160|50078834|FG000|Overall Study|No contact|0|||
24989934|NCT03072160|50078835|FG001|Overall Study|No contact|1|||
24989935|NCT00407602|50078873|FG000|Overall Study|Death - unrelated to device|1|||
24989936|NCT00407602|50078873|FG000|Overall Study|Device explanted|5|||
24989937|NCT00407602|50078873|FG000|Overall Study|Withdrawal by Subject|1|||
24989938|NCT03057496|50078880|FG000|Overall Study|Withdrawal by Subject|8|||
24989939|NCT03057496|50078880|FG000|Overall Study|Lost to Follow-up|5|||
24989940|NCT03057496|50078880|FG000|Overall Study|Did not use device during home trial|3|||
24989941|NCT03057496|50078880|FG000|Overall Study|Device failure|2|||
24989942|NCT03708744|50078890|FG000|Overall Study|Withdrawal by Subject|0|||
24989943|NCT03708744|50078891|FG001|Overall Study|Withdrawal by Subject|0|||
24989944|NCT03708744|50078892|FG002|Overall Study|Withdrawal by Subject|1|||
24989945|NCT03708744|50078893|FG003|Overall Study|Withdrawal by Subject|0|||
24989946|NCT02574286|50078907|FG000|Overall Study|Adverse Event|3|||
24989947|NCT02574286|50078907|FG000|Overall Study|Withdrawal by Subject|2|||
24989948|NCT02083354|50078915|FG000|Overall Study|Withdrawal by Subject|9|||
24989949|NCT02083354|50078915|FG000|Overall Study|Lost to Follow-up|1|||
24989950|NCT02083354|50078915|FG000|Overall Study|Adverse Event|3|||
24989951|NCT02083354|50078915|FG000|Overall Study|Disease progression|46|||
24989952|NCT02083354|50078915|FG000|Overall Study|Study closed/terminated|5|||
24989953|NCT04230486|50078919|FG000|Overall Study|Screen Failure|1|||
24989954|NCT01399918|50078925|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
24989955|NCT00112840|50078932|FG000|Overall Study|Physician Decision|1|||
24989956|NCT00112840|50078933|FG001|Overall Study|Physician Decision|0|||
24989957|NCT00112840|50078934|FG002|Overall Study|Physician Decision|0|||
24989958|NCT00112840|50078932|FG000|Overall Study|Withdrawal by Subject|1|||
24989959|NCT00112840|50078933|FG001|Overall Study|Withdrawal by Subject|0|||
24989960|NCT00112840|50078934|FG002|Overall Study|Withdrawal by Subject|1|||
24989961|NCT00112840|50078932|FG000|Overall Study|Protocol Violation|0|||
24989962|NCT00112840|50078933|FG001|Overall Study|Protocol Violation|0|||
24989963|NCT00112840|50078934|FG002|Overall Study|Protocol Violation|5|||
24989964|NCT02197572|50078947|FG000|Overall Study|Progressive Disease|28|||
24989965|NCT02197572|50078947|FG000|Overall Study|Withdrawal by Subject|9|||
24989966|NCT02197572|50078947|FG000|Overall Study|Adverse Event|3|||
24989967|NCT02197572|50078947|FG000|Overall Study|Reason Not Specified|4|||
24989968|NCT03176784|50078955|FG000|Overall Study|Lost to Follow-up|77|||
24989969|NCT03176784|50078956|FG001|Overall Study|Lost to Follow-up|79|||
24989970|NCT03176784|50078957|FG002|Overall Study|Lost to Follow-up|79|||
24989971|NCT03176784|50078958|FG003|Overall Study|Lost to Follow-up|49|||
24989972|NCT03176784|50078955|FG000|Overall Study|Withdrawal by Subject|28|||
24989973|NCT03176784|50078956|FG001|Overall Study|Withdrawal by Subject|34|||
24989974|NCT03176784|50078957|FG002|Overall Study|Withdrawal by Subject|34|||
24989975|NCT03176784|50078958|FG003|Overall Study|Withdrawal by Subject|21|||
24989976|NCT03049852|50078971|FG000|Overall Study|Lost to Follow-up|0|||
24989977|NCT03049852|50078972|FG001|Overall Study|Lost to Follow-up|1|||
24989978|NCT03049852|50078973|FG002|Overall Study|Lost to Follow-up|0|||
24989979|NCT05091528|50078985|FG000|Overall Study|Study Termination by Sponsor|0|||
24989980|NCT05091528|50078986|FG001|Overall Study|Study Termination by Sponsor|1|||
24989981|NCT05091528|50078987|FG002|Overall Study|Study Termination by Sponsor|0|||
24989982|NCT05091528|50078988|FG003|Overall Study|Study Termination by Sponsor|1|||
24989983|NCT01317160|50078998|FG000|Overall Study|Incorrect inclusion|1|||
24989984|NCT01317160|50078999|FG001|Overall Study|Incorrect inclusion|1|||
24989985|NCT01317160|50078998|FG000|Overall Study|Lost to Follow-up|3|||
24989986|NCT01317160|50078999|FG001|Overall Study|Lost to Follow-up|3|||
24989987|NCT01317160|50078998|FG000|Overall Study|Withdrawal by Subject|0|||
24989988|NCT01317160|50078999|FG001|Overall Study|Withdrawal by Subject|2|||
24989989|NCT01317004|50079020|FG000|Overall Study|Withdrawal by Subject|1|||
24989990|NCT01317004|50079021|FG001|Overall Study|Withdrawal by Subject|4|||
24989991|NCT01317004|50079020|FG000|Overall Study|Protocol Violation|0|||
24989992|NCT01317004|50079021|FG001|Overall Study|Protocol Violation|2|||
24989993|NCT01317004|50079020|FG000|Overall Study|Adverse Event|3|||
24989994|NCT01317004|50079021|FG001|Overall Study|Adverse Event|3|||
24989995|NCT01343056|50079031|FG000|Overall Study|Lost to Follow-up|7|||
24989996|NCT01343056|50079032|FG001|Overall Study|Lost to Follow-up|5|||
24989997|NCT01343056|50079033|FG002|Overall Study|Lost to Follow-up|3|||
24989998|NCT01343056|50079034|FG003|Overall Study|Lost to Follow-up|9|||
24989999|NCT01316692|50079048|FG000|Overall Study|Adverse Event|5|||
24990000|NCT01316692|50079048|FG000|Overall Study|Disease Progression|7|||
24990001|NCT01316380|50079055|FG000|Overall Study|Adverse Event|0|||
24990002|NCT01316380|50079056|FG001|Overall Study|Adverse Event|2|||
24990003|NCT01316380|50079057|FG002|Overall Study|Adverse Event|1|||
24990004|NCT01316380|50079055|FG000|Overall Study|Protocol Violation|0|||
24990005|NCT01316380|50079056|FG001|Overall Study|Protocol Violation|0|||
24990006|NCT01316380|50079057|FG002|Overall Study|Protocol Violation|1|||
24990007|NCT01316380|50079055|FG000|Overall Study|Withdrawal by Subject|1|||
24990008|NCT01316380|50079056|FG001|Overall Study|Withdrawal by Subject|2|||
24990009|NCT01316380|50079057|FG002|Overall Study|Withdrawal by Subject|0|||
24990010|NCT01316380|50079055|FG000|Overall Study|Other|0|||
24990011|NCT01316380|50079056|FG001|Overall Study|Other|1|||
24990012|NCT01316380|50079057|FG002|Overall Study|Other|1|||
24990013|NCT01316380|50079055|FG000|Overall Study|Not treated|1|||
24990014|NCT01316380|50079056|FG001|Overall Study|Not treated|0|||
24990015|NCT01316380|50079057|FG002|Overall Study|Not treated|0|||
24990016|NCT01316224|50079065|FG000|Overall Study|Protocol Violation|3|||
24990017|NCT01316224|50079065|FG000|Overall Study|Adverse Event|3|||
24990018|NCT01316224|50079065|FG000|Overall Study|Lack of Efficacy|1|||
24990019|NCT01316224|50079065|FG000|Overall Study|Withdrawal by Subject|1|||
24990020|NCT01316224|50079065|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
24990021|NCT01316224|50079065|FG000|Overall Study|Other|1|||
24990022|NCT04315298|50079088|FG000|Overall Study|Withdrawal by Subject|0|||
24990023|NCT04315298|50079089|FG001|Overall Study|Withdrawal by Subject|0|||
24990024|NCT04315298|50079090|FG002|Overall Study|Withdrawal by Subject|0|||
24990025|NCT04315298|50079091|FG003|Overall Study|Withdrawal by Subject|2|||
24990026|NCT04315298|50079092|FG004|Overall Study|Withdrawal by Subject|2|||
24990027|NCT04315298|50079093|FG005|Overall Study|Withdrawal by Subject|2|||
24990028|NCT04315298|50079094|FG006|Overall Study|Withdrawal by Subject|0|||
24990029|NCT04315298|50079095|FG007|Overall Study|Withdrawal by Subject|1|||
24990030|NCT04315298|50079096|FG008|Overall Study|Withdrawal by Subject|1|||
24990031|NCT04315298|50079097|FG009|Overall Study|Withdrawal by Subject|1|||
24990032|NCT04315298|50079098|FG010|Overall Study|Withdrawal by Subject|0|||
24990033|NCT04315298|50079099|FG011|Overall Study|Withdrawal by Subject|0|||
24990034|NCT04315298|50079100|FG012|Overall Study|Withdrawal by Subject|0|||
24990035|NCT04315298|50079101|FG013|Overall Study|Withdrawal by Subject|0|||
24990036|NCT04315298|50079102|FG014|Overall Study|Withdrawal by Subject|0|||
24990037|NCT04315298|50079103|FG015|Overall Study|Withdrawal by Subject|0|||
24990038|NCT04315298|50079104|FG016|Overall Study|Withdrawal by Subject|0|||
24990039|NCT04315298|50079105|FG017|Overall Study|Withdrawal by Subject|0|||
24990040|NCT04315298|50079106|FG018|Overall Study|Withdrawal by Subject|0|||
24990041|NCT04315298|50079088|FG000|Overall Study|Physician Decision|0|||
24990042|NCT04315298|50079089|FG001|Overall Study|Physician Decision|0|||
24990043|NCT04315298|50079090|FG002|Overall Study|Physician Decision|0|||
24990044|NCT04315298|50079091|FG003|Overall Study|Physician Decision|0|||
24990045|NCT04315298|50079092|FG004|Overall Study|Physician Decision|1|||
24990046|NCT04315298|50079093|FG005|Overall Study|Physician Decision|0|||
24990047|NCT04315298|50079094|FG006|Overall Study|Physician Decision|0|||
24990048|NCT04315298|50079095|FG007|Overall Study|Physician Decision|0|||
24990049|NCT04315298|50079096|FG008|Overall Study|Physician Decision|0|||
24990050|NCT04315298|50079097|FG009|Overall Study|Physician Decision|0|||
24990051|NCT04315298|50079098|FG010|Overall Study|Physician Decision|0|||
24990052|NCT04315298|50079099|FG011|Overall Study|Physician Decision|0|||
24990053|NCT04315298|50079100|FG012|Overall Study|Physician Decision|0|||
24990054|NCT04315298|50079101|FG013|Overall Study|Physician Decision|0|||
24990055|NCT04315298|50079102|FG014|Overall Study|Physician Decision|0|||
24990056|NCT04315298|50079103|FG015|Overall Study|Physician Decision|0|||
24990057|NCT04315298|50079104|FG016|Overall Study|Physician Decision|0|||
24990058|NCT04315298|50079105|FG017|Overall Study|Physician Decision|0|||
24990059|NCT04315298|50079106|FG018|Overall Study|Physician Decision|0|||
24990060|NCT04315298|50079088|FG000|Overall Study|Lost to Follow-up|5|||
24990061|NCT04315298|50079089|FG001|Overall Study|Lost to Follow-up|10|||
24990062|NCT04315298|50079090|FG002|Overall Study|Lost to Follow-up|6|||
24990063|NCT04315298|50079091|FG003|Overall Study|Lost to Follow-up|8|||
24990064|NCT04315298|50079092|FG004|Overall Study|Lost to Follow-up|12|||
24990065|NCT04315298|50079093|FG005|Overall Study|Lost to Follow-up|13|||
24990066|NCT04315298|50079094|FG006|Overall Study|Lost to Follow-up|9|||
24990067|NCT04315298|50079095|FG007|Overall Study|Lost to Follow-up|16|||
24990068|NCT04315298|50079096|FG008|Overall Study|Lost to Follow-up|14|||
24990069|NCT04315298|50079097|FG009|Overall Study|Lost to Follow-up|0|||
24990070|NCT04315298|50079098|FG010|Overall Study|Lost to Follow-up|2|||
24990071|NCT04315298|50079099|FG011|Overall Study|Lost to Follow-up|1|||
24990072|NCT04315298|50079100|FG012|Overall Study|Lost to Follow-up|0|||
24990073|NCT04315298|50079101|FG013|Overall Study|Lost to Follow-up|0|||
24990074|NCT04315298|50079102|FG014|Overall Study|Lost to Follow-up|0|||
24990075|NCT04315298|50079103|FG015|Overall Study|Lost to Follow-up|2|||
24990076|NCT04315298|50079104|FG016|Overall Study|Lost to Follow-up|0|||
24990077|NCT04315298|50079105|FG017|Overall Study|Lost to Follow-up|0|||
24990078|NCT04315298|50079106|FG018|Overall Study|Lost to Follow-up|0|||
24990079|NCT04315298|50079088|FG000|Overall Study|Death|24|||
24990080|NCT04315298|50079089|FG001|Overall Study|Death|60|||
24990081|NCT04315298|50079090|FG002|Overall Study|Death|49|||
24990082|NCT04315298|50079091|FG003|Overall Study|Death|59|||
24990083|NCT04315298|50079092|FG004|Overall Study|Death|70|||
24990084|NCT04315298|50079093|FG005|Overall Study|Death|114|||
24990085|NCT04315298|50079094|FG006|Overall Study|Death|9|||
24990086|NCT04315298|50079095|FG007|Overall Study|Death|12|||
24990087|NCT04315298|50079096|FG008|Overall Study|Death|21|||
24990088|NCT04315298|50079097|FG009|Overall Study|Death|16|||
24990089|NCT04315298|50079098|FG010|Overall Study|Death|40|||
24990090|NCT04315298|50079099|FG011|Overall Study|Death|40|||
24990091|NCT04315298|50079100|FG012|Overall Study|Death|3|||
24990092|NCT04315298|50079101|FG013|Overall Study|Death|4|||
24990093|NCT04315298|50079102|FG014|Overall Study|Death|6|||
24990094|NCT04315298|50079103|FG015|Overall Study|Death|4|||
24990095|NCT04315298|50079104|FG016|Overall Study|Death|3|||
24990096|NCT04315298|50079105|FG017|Overall Study|Death|1|||
24990097|NCT04315298|50079106|FG018|Overall Study|Death|0|||
24990098|NCT04308668|50079175|FG000|Overall Study|Lost to Follow-up|32|||
24990099|NCT04308668|50079176|FG001|Overall Study|Lost to Follow-up|38|||
24990100|NCT04308668|50079175|FG000|Overall Study|Withdrawal by Subject|4|||
24990101|NCT04308668|50079176|FG001|Overall Study|Withdrawal by Subject|4|||
24990102|NCT04451330|50079184|FG000|Overall Study|Adverse Event|1|||
24990103|NCT04451330|50079185|FG001|Overall Study|Adverse Event|2|||
24990104|NCT04451330|50079184|FG000|Overall Study|Lost to Follow-up|5|||
24990105|NCT04451330|50079185|FG001|Overall Study|Lost to Follow-up|0|||
24990106|NCT04451330|50079184|FG000|Overall Study|Withdrawal by Subject|3|||
24990107|NCT04451330|50079185|FG001|Overall Study|Withdrawal by Subject|1|||
24990108|NCT04451330|50079184|FG000|Overall Study|Withdrawal by parent/guardian|1|||
24990109|NCT04451330|50079185|FG001|Overall Study|Withdrawal by parent/guardian|0|||
24990110|NCT04451330|50079184|FG000|Overall Study|Other than specified|0|||
24990111|NCT04451330|50079185|FG001|Overall Study|Other than specified|1|||
24990112|NCT02493426|50079191|FG000|Overall Study|Withdrawal by Subject|0|||
24990113|NCT02493426|50079192|FG001|Overall Study|Withdrawal by Subject|1|||
24990114|NCT04448756|50079201|FG000|Overall Study|Adverse Event|0|||
24990115|NCT04448756|50079202|FG001|Overall Study|Adverse Event|1|||
24990116|NCT04448756|50079203|FG002|Overall Study|Adverse Event|0|||
24990117|NCT04448756|50079201|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
24990118|NCT04448756|50079202|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
24990119|NCT04448756|50079203|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
24990120|NCT04448756|50079201|FG000|Overall Study|Withdrawal by Subject|0|||
25079442|NCT01865617|50187888|FG002|Overall Study|Other|0|||
25079443|NCT01865617|50187889|FG003|Overall Study|Other|0|||
25079444|NCT01865617|50187890|FG004|Overall Study|Other|0|||
24990121|NCT04448756|50079202|FG001|Overall Study|Withdrawal by Subject|3|||
24990122|NCT04448756|50079203|FG002|Overall Study|Withdrawal by Subject|1|||
24990123|NCT04448756|50079201|FG000|Overall Study|Death|2|||
24990124|NCT04448756|50079202|FG001|Overall Study|Death|1|||
24990125|NCT04448756|50079203|FG002|Overall Study|Death|0|||
24990126|NCT04274192|50079213|FG000|Overall Study|Protocol Violation|1|||
24990127|NCT04274192|50079214|FG001|Overall Study|Protocol Violation|0|||
24990128|NCT04387136|50079224|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
24990129|NCT04387136|50079225|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
24990130|NCT04252586|50079231|FG000|Overall Study|Withdrawal by parent/guardian|3|||
25079445|NCT01865617|50187891|FG005|Overall Study|Other|0|||
25079446|NCT01865617|50187892|FG006|Overall Study|Other|1|||
24990131|NCT04252586|50079231|FG000|Overall Study|Adverse Event|1|||
24990132|NCT04252586|50079231|FG000|Overall Study|Death|2|||
24990133|NCT04252586|50079231|FG000|Overall Study|Study terminated by sponsor|4|||
24990134|NCT04252586|50079231|FG000|Overall Study|Sponsor request|10|||
24990135|NCT04252586|50079231|FG000|Overall Study|Did not complete treatment period|1|||
24990136|NCT04247828|50079236|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
24990137|NCT04507776|50079240|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
24990138|NCT04386902|50079249|FG000|Overall Study|Withdrawal by Subject|5|||
24990139|NCT04386902|50079249|FG000|Overall Study|Technical problems in the recording|5|||
24990140|NCT04232540|50079255|FG000|Overall Study|Lost to Follow-up|1|||
24990141|NCT04232540|50079256|FG001|Overall Study|Lost to Follow-up|0|||
24990142|NCT04504032|50079264|FG000|Overall Study|Adverse Event|1|||
24990143|NCT04504032|50079265|FG001|Overall Study|Adverse Event|2|||
24990144|NCT04504032|50079264|FG000|Overall Study|Lost to Follow-up|6|||
24990145|NCT04504032|50079265|FG001|Overall Study|Lost to Follow-up|9|||
24990146|NCT04504032|50079264|FG000|Overall Study|Protocol Violation|2|||
24990147|NCT04504032|50079265|FG001|Overall Study|Protocol Violation|0|||
24990148|NCT04504032|50079264|FG000|Overall Study|Study terminated by sponsor|1|||
24990149|NCT04504032|50079265|FG001|Overall Study|Study terminated by sponsor|2|||
24990150|NCT04504032|50079264|FG000|Overall Study|Withdrawal by Subject|9|||
24990151|NCT04504032|50079265|FG001|Overall Study|Withdrawal by Subject|11|||
24990152|NCT04504032|50079264|FG000|Overall Study|Disease progression prior to dosing|15|||
24990153|NCT04504032|50079265|FG001|Overall Study|Disease progression prior to dosing|3|||
24990154|NCT04504032|50079264|FG000|Overall Study|Drug supply issues|1|||
24990155|NCT04504032|50079265|FG001|Overall Study|Drug supply issues|1|||
24990156|NCT04504032|50079264|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
24990157|NCT04504032|50079265|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
24990158|NCT04439240|50079271|FG000|Overall Study|Ineligible|2|||
24990159|NCT04439240|50079271|FG000|Overall Study|Never started treatment|2|||
24990160|NCT04439240|50079271|FG000|Overall Study|Adverse Event|12|||
24990161|NCT04439240|50079271|FG000|Overall Study|Death|2|||
24990162|NCT04439240|50079271|FG000|Overall Study|Disease progression|25|||
24990163|NCT04439240|50079271|FG000|Overall Study|Other diseases|2|||
24990164|NCT04439240|50079271|FG000|Overall Study|Withdrawal by Subject|3|||
24990165|NCT04439240|50079271|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
24990166|NCT04439240|50079271|FG000|Overall Study|Symptomatic decline|1|||
24990167|NCT04439240|50079271|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
24990168|NCT04439240|50079271|FG000|Overall Study|Clinical progression|1|||
24990169|NCT04605588|50079277|FG000|Overall Study|Withdrawal by Subject|1|||
24990170|NCT04605588|50079278|FG001|Overall Study|Withdrawal by Subject|0|||
24990171|NCT04885296|50079284|FG000|Period 1|Covid-19 Related|1|||
24990172|NCT04885296|50079285|FG001|Period 1|Covid-19 Related|0|||
24990173|NCT04885296|50079284|FG000|Period 1|Adverse Event|0|||
24990174|NCT04885296|50079285|FG001|Period 1|Adverse Event|1|||
24990175|NCT04885296|50079284|FG000|Period 1|Withdrawal by Subject|1|||
24990176|NCT04885296|50079285|FG001|Period 1|Withdrawal by Subject|1|||
24990177|NCT04885296|50079284|FG000|Period 1|Test Article No Longer Available|1|||
24990178|NCT04885296|50079285|FG001|Period 1|Test Article No Longer Available|0|||
24990179|NCT04885296|50079284|FG000|Period 1|Dispensed Study lens in Error|1|||
24990180|NCT04885296|50079285|FG001|Period 1|Dispensed Study lens in Error|0|||
24990181|NCT04885296|50079284|FG000|Period 1|Lost to Follow-up|1|||
24990182|NCT04885296|50079285|FG001|Period 1|Lost to Follow-up|0|||
24990183|NCT04885296|50079284|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
24990184|NCT04885296|50079285|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
24990185|NCT04602000|50079296|FG000|Overall Study|Withdrawal by Subject|3|||
24990186|NCT04602000|50079297|FG001|Overall Study|Withdrawal by Subject|6|||
24990187|NCT04602000|50079298|FG002|Overall Study|Withdrawal by Subject|3|||
24990188|NCT04602000|50079299|FG003|Overall Study|Withdrawal by Subject|27|||
24990189|NCT04602000|50079300|FG004|Overall Study|Withdrawal by Subject|39|||
24990190|NCT04602000|50079296|FG000|Overall Study|Physician Decision|1|||
24990191|NCT04602000|50079297|FG001|Overall Study|Physician Decision|0|||
24990192|NCT04602000|50079298|FG002|Overall Study|Physician Decision|0|||
24990193|NCT04602000|50079299|FG003|Overall Study|Physician Decision|2|||
24990194|NCT04602000|50079300|FG004|Overall Study|Physician Decision|2|||
24990195|NCT04602000|50079296|FG000|Overall Study|Death|0|||
24990196|NCT04602000|50079297|FG001|Overall Study|Death|1|||
24990197|NCT04602000|50079298|FG002|Overall Study|Death|0|||
24990198|NCT04602000|50079299|FG003|Overall Study|Death|1|||
24990199|NCT04602000|50079300|FG004|Overall Study|Death|2|||
24990200|NCT04602000|50079296|FG000|Overall Study|Lost to Follow-up|0|||
24990201|NCT04602000|50079297|FG001|Overall Study|Lost to Follow-up|0|||
24990202|NCT04602000|50079298|FG002|Overall Study|Lost to Follow-up|0|||
24990203|NCT04602000|50079299|FG003|Overall Study|Lost to Follow-up|3|||
24990204|NCT04602000|50079300|FG004|Overall Study|Lost to Follow-up|4|||
24990205|NCT04602000|50079296|FG000|Overall Study|Other|4|||
24990206|NCT04602000|50079297|FG001|Overall Study|Other|1|||
24990207|NCT04602000|50079298|FG002|Overall Study|Other|2|||
24990208|NCT04602000|50079299|FG003|Overall Study|Other|5|||
24990209|NCT04602000|50079300|FG004|Overall Study|Other|4|||
24990210|NCT04602000|50079296|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
24990211|NCT04602000|50079297|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
24990212|NCT04602000|50079298|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
24990213|NCT04602000|50079299|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
24990214|NCT04602000|50079300|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
24990215|NCT03041116|50079316|FG000|Double-blind|Death|0|||
24990216|NCT03041116|50079317|FG001|Double-blind|Death|2|||
24990217|NCT03041116|50079316|FG000|Double-blind|Withdrawal by Subject|0|||
24990218|NCT03041116|50079317|FG001|Double-blind|Withdrawal by Subject|4|||
24990219|NCT03041116|50079316|FG000|Open-label|Death|1|||
24990220|NCT03041116|50079317|FG001|Open-label|Death|0|||
24990221|NCT03041116|50079316|FG000|Open-label|Termination of the study by Sponsor|39|||
24990222|NCT03041116|50079317|FG001|Open-label|Termination of the study by Sponsor|37|||
24990223|NCT03041116|50079316|FG000|Open-label|Withdrawal by Subject|1|||
24990224|NCT03041116|50079317|FG001|Open-label|Withdrawal by Subject|0|||
24990225|NCT04860258|50079334|FG000|Overall Study|Withdrawal by Subject|0|||
24990226|NCT04860258|50079335|FG001|Overall Study|Withdrawal by Subject|0|||
24990227|NCT04860258|50079336|FG002|Overall Study|Withdrawal by Subject|4|||
24990228|NCT04860258|50079337|FG003|Overall Study|Withdrawal by Subject|1|||
24990229|NCT04860258|50079338|FG004|Overall Study|Withdrawal by Subject|4|||
24990230|NCT04860258|50079339|FG005|Overall Study|Withdrawal by Subject|1|||
24990231|NCT04860258|50079340|FG006|Overall Study|Withdrawal by Subject|0|||
24990232|NCT03041038|50079358|FG000|Overall Study|Withdrawal by Subject|4|||
24990233|NCT03041038|50079359|FG001|Overall Study|Withdrawal by Subject|0|||
24990234|NCT03041038|50079358|FG000|Overall Study|Lost to Follow-up|1|||
24990235|NCT03041038|50079359|FG001|Overall Study|Lost to Follow-up|1|||
24990236|NCT03041038|50079358|FG000|Overall Study|Protocol Violation|1|||
24990237|NCT03041038|50079359|FG001|Overall Study|Protocol Violation|1|||
24990238|NCT04382066|50079370|FG000|Overall Study|Adverse Event|1|||
24990239|NCT04382066|50079371|FG001|Overall Study|Adverse Event|0|||
24990240|NCT04382066|50079372|FG002|Overall Study|Adverse Event|0|||
24990241|NCT04382066|50079370|FG000|Overall Study|Death|1|||
24990242|NCT04382066|50079371|FG001|Overall Study|Death|0|||
24990243|NCT04382066|50079372|FG002|Overall Study|Death|1|||
24990244|NCT04435184|50079388|FG000|Overall Study|follow-up blood draws missing|3|||
24990245|NCT04435184|50079389|FG001|Overall Study|follow-up blood draws missing|5|||
24990246|NCT04432376|50079398|FG000|Double-blind Treatment Period|Adverse Event|2|||
24990247|NCT04432376|50079399|FG001|Double-blind Treatment Period|Adverse Event|6|||
24990248|NCT04432376|50079400|FG002|Double-blind Treatment Period|Adverse Event|0|||
24990249|NCT04432376|50079398|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
24990250|NCT04432376|50079399|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
24990251|NCT04432376|50079400|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
24990252|NCT04432376|50079398|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
24990253|NCT04432376|50079399|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
24990254|NCT04432376|50079400|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
24990255|NCT04432376|50079398|FG000|Double-blind Treatment Period|Protocol Violation|0|||
24990256|NCT04432376|50079399|FG001|Double-blind Treatment Period|Protocol Violation|1|||
24990257|NCT04432376|50079400|FG002|Double-blind Treatment Period|Protocol Violation|0|||
24990258|NCT04432376|50079398|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
24990259|NCT04432376|50079399|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
24990260|NCT04432376|50079400|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
24990261|NCT03693404|50079409|FG000|Overall Study|Withdrawal by Subject|1|||
24990262|NCT03693404|50079410|FG001|Overall Study|Withdrawal by Subject|0|||
24990263|NCT03693404|50079409|FG000|Overall Study|Lost to Follow-up|0|||
24990264|NCT03693404|50079410|FG001|Overall Study|Lost to Follow-up|5|||
24990265|NCT03693404|50079409|FG000|Overall Study|Excluded from Analysis|0|||
24990266|NCT03693404|50079410|FG001|Overall Study|Excluded from Analysis|1|||
24990267|NCT03696108|50079418|FG000|Overall Study|Physician Decision|1|||
24990268|NCT03696108|50079419|FG001|Overall Study|Physician Decision|0|||
24990269|NCT03696108|50079418|FG000|Overall Study|Withdrawal by Subject|3|||
24990270|NCT03696108|50079419|FG001|Overall Study|Withdrawal by Subject|6|||
24990271|NCT04218110|50079429|FG000|Overall Study|Withdrawal by Subject|0|||
24990272|NCT04218110|50079430|FG001|Overall Study|Withdrawal by Subject|0|||
24990273|NCT04218110|50079431|FG002|Overall Study|Withdrawal by Subject|0|||
24990274|NCT04218110|50079432|FG003|Overall Study|Withdrawal by Subject|1|||
24990275|NCT04214600|50079444|FG000|Overall Study|Lost to Follow-up|9|||
24990276|NCT04214600|50079445|FG001|Overall Study|Lost to Follow-up|14|||
25079447|NCT01865617|50187893|FG007|Overall Study|Other|0|||
24990277|NCT04210310|50079454|FG000|Overall Study|Lost to Follow-up|32|||
24990278|NCT04210310|50079455|FG001|Overall Study|Lost to Follow-up|1|||
24990279|NCT04209530|50079463|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
24995122|NCT03015220|50086010|FG001|Overall Study|Withdrawal by Subject|2|||
24990280|NCT04209530|50079464|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
24990281|NCT04209530|50079463|FG000|Overall Study|Withdrawal by Subject|0|||
24990282|NCT04209530|50079464|FG001|Overall Study|Withdrawal by Subject|1|||
24990283|NCT04349098|50079472|FG000|Overall Study|Death|16|||
24990284|NCT04349098|50079473|FG001|Overall Study|Death|8|||
24990285|NCT04349098|50079472|FG000|Overall Study|Lost to Follow-up|11|||
24990286|NCT04349098|50079473|FG001|Overall Study|Lost to Follow-up|8|||
24990287|NCT04349098|50079472|FG000|Overall Study|Withdrawal by Subject|8|||
24990288|NCT04349098|50079473|FG001|Overall Study|Withdrawal by Subject|5|||
24990289|NCT04349098|50079472|FG000|Overall Study|Other|3|||
24990290|NCT04349098|50079473|FG001|Overall Study|Other|5|||
24990291|NCT04208750|50079481|FG000|Overall Study|Lost to Follow-up|16|||
24990292|NCT04208750|50079482|FG001|Overall Study|Lost to Follow-up|15|||
24990293|NCT04381988|50079490|FG000|Overall Study|The study was terminated|4|||
24990294|NCT04381988|50079491|FG001|Overall Study|The study was terminated|0|||
24990295|NCT04333498|50079499|FG000|Overall Study|Lost to Follow-up|1|||
24990296|NCT04333498|50079500|FG001|Overall Study|Lost to Follow-up|0|||
24990297|NCT04333498|50079499|FG000|Overall Study|Lost to Follow-up|0|||
24990298|NCT04333498|50079500|FG001|Overall Study|Lost to Follow-up|1|||
24990299|NCT03355664|50079508|FG000|Overall Study|Adverse Event|1|||
24990300|NCT03355664|50079509|FG001|Overall Study|Adverse Event|2|||
24990301|NCT03355664|50079508|FG000|Overall Study|Lost to Follow-up|11|||
24990302|NCT03355664|50079509|FG001|Overall Study|Lost to Follow-up|7|||
24990303|NCT03355664|50079508|FG000|Overall Study|Protocol Violation|1|||
24990304|NCT03355664|50079509|FG001|Overall Study|Protocol Violation|2|||
24990305|NCT03355664|50079508|FG000|Overall Study|Withdrawal by Subject|2|||
24990306|NCT03355664|50079509|FG001|Overall Study|Withdrawal by Subject|1|||
24990307|NCT04170686|50079517|FG000|Screening|Physician Decision|12|||
24990308|NCT04170686|50079518|FG001|Screening|Physician Decision|13|||
24990309|NCT04170686|50079517|FG000|Randomization and Treatment|Lost to Follow-up|26|||
24990310|NCT04170686|50079518|FG001|Randomization and Treatment|Lost to Follow-up|15|||
24990311|NCT03695094|50079526|FG000|Overall Study|Adverse Event|1|||
24990312|NCT03695094|50079527|FG001|Overall Study|Adverse Event|1|||
24990313|NCT03695094|50079526|FG000|Overall Study|Withdrawal by Subject|1|||
24990314|NCT03695094|50079527|FG001|Overall Study|Withdrawal by Subject|0|||
24990315|NCT04497948|50079535|FG000|Overall Study|Death|2|||
24990316|NCT04495374|50079545|FG000|Overall Study|Protocol Violation|2|||
24990317|NCT04495374|50079546|FG001|Overall Study|Protocol Violation|1|||
24990318|NCT04794270|50079552|FG000|Period 1|Non Compliance|1|||
24990319|NCT04794270|50079553|FG001|Period 1|Non Compliance|0|||
24990320|NCT04794270|50079552|FG000|Period 1|Adverse Event|1|||
24990321|NCT04794270|50079553|FG001|Period 1|Adverse Event|0|||
24990322|NCT04794270|50079552|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
24990323|NCT04794270|50079553|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
24990324|NCT04567186|50079559|FG000|Period 1|COVID-19 related|1|||
24990325|NCT04567186|50079560|FG001|Period 1|COVID-19 related|0|||
24990326|NCT04567186|50079559|FG000|Period 1|Protocol Violation|0|||
24990327|NCT04567186|50079560|FG001|Period 1|Protocol Violation|1|||
24990328|NCT04567186|50079559|FG000|Period 1|Adverse Event|0|||
24990329|NCT04567186|50079560|FG001|Period 1|Adverse Event|2|||
24990330|NCT04567186|50079559|FG000|Period 2|COVID-19 Related|0|||
24990331|NCT04567186|50079560|FG001|Period 2|COVID-19 Related|1|||
24990332|NCT04567186|50079559|FG000|Period 2|Protocol Violation|0|||
24990333|NCT04567186|50079560|FG001|Period 2|Protocol Violation|1|||
24990334|NCT04567186|50079559|FG000|Period 2|Lost to Follow-up|0|||
24990335|NCT04567186|50079560|FG001|Period 2|Lost to Follow-up|1|||
24990336|NCT04567186|50079559|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
24990337|NCT04567186|50079560|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
24990338|NCT04168190|50079571|FG000|Overall Study|Lost to Follow-up|0|||
24990339|NCT04168190|50079572|FG001|Overall Study|Lost to Follow-up|1|||
24990340|NCT04168190|50079573|FG002|Overall Study|Lost to Follow-up|0|||
24990341|NCT04168190|50079574|FG003|Overall Study|Lost to Follow-up|7|||
24990342|NCT04168190|50079575|FG004|Overall Study|Lost to Follow-up|5|||
24990343|NCT04168190|50079571|FG000|Overall Study|Withdrawal by Subject|1|||
24990344|NCT04168190|50079572|FG001|Overall Study|Withdrawal by Subject|0|||
24990345|NCT04168190|50079573|FG002|Overall Study|Withdrawal by Subject|0|||
24990346|NCT04168190|50079574|FG003|Overall Study|Withdrawal by Subject|2|||
24990347|NCT04168190|50079575|FG004|Overall Study|Withdrawal by Subject|4|||
24990348|NCT04168190|50079571|FG000|Overall Study|Death|0|||
24990349|NCT04168190|50079572|FG001|Overall Study|Death|0|||
24990350|NCT04168190|50079573|FG002|Overall Study|Death|0|||
24990351|NCT04168190|50079574|FG003|Overall Study|Death|1|||
24990352|NCT04168190|50079575|FG004|Overall Study|Death|0|||
24990353|NCT04476108|50079589|FG000|Overall Study|Adverse Event|4|||
24990354|NCT04476108|50079590|FG001|Overall Study|Adverse Event|1|||
24990355|NCT04476108|50079589|FG000|Overall Study|Lost to Follow-up|1|||
24990356|NCT04476108|50079590|FG001|Overall Study|Lost to Follow-up|0|||
24990357|NCT04476108|50079589|FG000|Overall Study|Inadvertent Enrollment|1|||
24990358|NCT04476108|50079590|FG001|Overall Study|Inadvertent Enrollment|0|||
24990359|NCT04476108|50079589|FG000|Overall Study|Protocol Violation|1|||
24990360|NCT04476108|50079590|FG001|Overall Study|Protocol Violation|1|||
24990361|NCT04476108|50079589|FG000|Overall Study|Withdrawal by Subject|1|||
24990362|NCT04476108|50079590|FG001|Overall Study|Withdrawal by Subject|1|||
24990363|NCT03529942|50079596|FG000|Overall Study|Withdrawal by Subject|13|||
24990364|NCT03529942|50079596|FG000|Overall Study|Physician Decision|1|||
24990365|NCT03529942|50079596|FG000|Overall Study|Lost to Follow-up|7|||
24990366|NCT03529942|50079596|FG000|Overall Study|Needle inserted but no drug administered|1|||
24990367|NCT03529942|50079596|FG000|Overall Study|Personal reasons|1|||
24990368|NCT04732338|50079605|FG000|Overall Study|Lost to Follow-up|3|||
24990369|NCT04732338|50079606|FG001|Overall Study|Lost to Follow-up|3|||
24990370|NCT04194008|50079612|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
24990371|NCT04194008|50079612|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
24990372|NCT04194008|50079612|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
24990373|NCT04194008|50079612|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
24990374|NCT04194008|50079612|FG000|Treatment Phase With Nerivio|Missing data|4|||
24990375|NCT04194008|50079612|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
24990376|NCT04189952|50079625|FG000|Follow-up Period|Death|1|||
24990377|NCT04189952|50079625|FG000|Follow-up Period|Withdrawal by Subject|1|||
24990378|NCT04716426|50079631|FG000|Overall Study|Vaccination|1|||
24990379|NCT04716426|50079632|FG001|Overall Study|Vaccination|1|||
24990380|NCT04716426|50079631|FG000|Overall Study|Contamination|1|||
24990381|NCT04716426|50079632|FG001|Overall Study|Contamination|0|||
24990382|NCT03694548|50079640|FG000|Part A Survey|Protocol Violation|3|||
24990383|NCT03694548|50079641|FG001|Part A Survey|Protocol Violation|3|||
24990384|NCT03694548|50079642|FG002|Part A Survey|Protocol Violation|0|||
24990385|NCT03694548|50079640|FG000|Part B Yoga Program|Protocol Violation|0|||
24990386|NCT03694548|50079641|FG001|Part B Yoga Program|Protocol Violation|0|||
24990387|NCT03694548|50079642|FG002|Part B Yoga Program|Protocol Violation|3|||
24990388|NCT03694548|50079640|FG000|Part B Yoga Program|Did not attend intervention|0|||
24990389|NCT03694548|50079641|FG001|Part B Yoga Program|Did not attend intervention|0|||
24990390|NCT03694548|50079642|FG002|Part B Yoga Program|Did not attend intervention|8|||
24990391|NCT04166630|50079654|FG000|Overall Study|Withdrawal by Subject|0|||
24990392|NCT04166630|50079655|FG001|Overall Study|Withdrawal by Subject|1|||
24990393|NCT04164758|50079664|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
24990394|NCT04164758|50079665|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
24990395|NCT04164758|50079666|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
24990396|NCT04164758|50079664|FG000|Overall Study|Adverse Event|0|||
24990397|NCT04164758|50079665|FG001|Overall Study|Adverse Event|1|||
24990398|NCT04164758|50079666|FG002|Overall Study|Adverse Event|0|||
24990399|NCT04178720|50079676|FG000|Overall Study|Withdrawal by Subject|2|||
24990400|NCT04178720|50079677|FG001|Overall Study|Withdrawal by Subject|0|||
24990401|NCT04178720|50079676|FG000|Overall Study|Relocation|0|||
24990402|NCT04178720|50079677|FG001|Overall Study|Relocation|1|||
24990403|NCT04177862|50079688|FG000|Overall Study|Protocol Violation|2|||
24990404|NCT04177862|50079689|FG001|Overall Study|Protocol Violation|7|||
24990405|NCT04173572|50079698|FG000|Overall Study|Withdrawal by Subject|1|||
24990406|NCT04173572|50079699|FG001|Overall Study|Withdrawal by Subject|5|||
24990407|NCT04173572|50079698|FG000|Overall Study|Lost to Follow-up|3|||
24990408|NCT04173572|50079699|FG001|Overall Study|Lost to Follow-up|1|||
24990409|NCT04157738|50079707|FG000|Overall Study|Moved out of state|0|||
24990410|NCT04157738|50079708|FG001|Overall Study|Moved out of state|2|||
24990411|NCT04157738|50079707|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
24990412|NCT04157738|50079708|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
24990413|NCT04156646|50079716|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
24990414|NCT04156646|50079717|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
24990415|NCT04676412|50079728|FG000|Overall Study|Death|17|||
24990416|NCT04676412|50079729|FG001|Overall Study|Death|23|||
24990417|NCT04676412|50079728|FG000|Overall Study|Withdrawal by Subject|0|||
24990418|NCT04676412|50079729|FG001|Overall Study|Withdrawal by Subject|2|||
24990419|NCT04676412|50079728|FG000|Overall Study|Participants ongoing|32|||
24990420|NCT04676412|50079729|FG001|Overall Study|Participants ongoing|33|||
24990421|NCT04150250|50079737|FG000|Overall Study|Lost to Follow-up|0|||
24990422|NCT04150250|50079738|FG001|Overall Study|Lost to Follow-up|2|||
24990423|NCT04537806|50079746|FG000|Overall Study|Randomized but not treated|1|||
24990424|NCT04537806|50079747|FG001|Overall Study|Randomized but not treated|0|||
24990425|NCT04537806|50079746|FG000|Overall Study|Adverse Event|1|||
24990426|NCT04537806|50079747|FG001|Overall Study|Adverse Event|1|||
24990427|NCT04015232|50079755|FG000|Overall Study|Withdrawal by Subject|7|||
24990428|NCT04015232|50079756|FG001|Overall Study|Withdrawal by Subject|4|||
25257210|NCT01102231|50572269|FG000|Overall Study|Adverse Event|3|||
24990429|NCT04015232|50079755|FG000|Overall Study|Protocol Violation|1|||
24990430|NCT04015232|50079756|FG001|Overall Study|Protocol Violation|0|||
24990431|NCT04015232|50079755|FG000|Overall Study|Medical Grounds|3|||
24990432|NCT04015232|50079756|FG001|Overall Study|Medical Grounds|3|||
24990433|NCT04533204|50079768|FG000|Overall Study|Unable to understand training instructions|1|||
24990434|NCT04533204|50079769|FG001|Overall Study|Unable to understand training instructions|1|||
24990435|NCT04465422|50079777|FG000|Overall Study|Lost to Follow-up|0|||
24990436|NCT04465422|50079778|FG001|Overall Study|Lost to Follow-up|2|||
24990437|NCT04014062|50079788|FG000|Period I: Dosing|Medical Grounds|4|||
24990438|NCT04014062|50079789|FG001|Period I: Dosing|Medical Grounds|5|||
24990439|NCT04014062|50079788|FG000|Period I: Dosing|Withdrawal by Subject|3|||
24990440|NCT04014062|50079789|FG001|Period I: Dosing|Withdrawal by Subject|1|||
24990441|NCT04531098|50079803|FG000|Stage I|Adverse Event|0|||
24990442|NCT04531098|50079804|FG001|Stage I|Adverse Event|0|||
24990443|NCT04531098|50079805|FG002|Stage I|Adverse Event|3|||
24990444|NCT04531098|50079803|FG000|Stage I|Protocol Violation|0|||
24990445|NCT04531098|50079804|FG001|Stage I|Protocol Violation|0|||
24990446|NCT04531098|50079805|FG002|Stage I|Protocol Violation|5|||
24990447|NCT04531098|50079803|FG000|Stage I|Withdrawal by Subject|0|||
24990448|NCT04531098|50079804|FG001|Stage I|Withdrawal by Subject|5|||
24990449|NCT04531098|50079805|FG002|Stage I|Withdrawal by Subject|10|||
24990450|NCT04531098|50079803|FG000|Stage II|Adverse Event|1|||
24990451|NCT04531098|50079804|FG001|Stage II|Adverse Event|2|||
24990452|NCT04531098|50079805|FG002|Stage II|Adverse Event|0|||
24990453|NCT04531098|50079803|FG000|Stage II|Protocol Violation|1|||
24990454|NCT04531098|50079804|FG001|Stage II|Protocol Violation|2|||
24990455|NCT04531098|50079805|FG002|Stage II|Protocol Violation|0|||
24990456|NCT04531098|50079803|FG000|Stage II|Withdrawal by Subject|3|||
24990457|NCT04531098|50079804|FG001|Stage II|Withdrawal by Subject|1|||
24990458|NCT04531098|50079805|FG002|Stage II|Withdrawal by Subject|0|||
24990459|NCT04531098|50079803|FG000|Stage II|Moved from study area|8|||
24990460|NCT04531098|50079804|FG001|Stage II|Moved from study area|5|||
24990461|NCT04531098|50079805|FG002|Stage II|Moved from study area|0|||
24990462|NCT04144166|50079813|FG000|Overall Study|Discharged before study start|1|||
24990463|NCT04144166|50079813|FG000|Overall Study|Pregnancy|1|||
24990464|NCT04144166|50079813|FG000|Overall Study|Nail polish could not be removed from finger|1|||
24990465|NCT04142450|50079822|FG000|Overall Study|Screen Failure|1|||
24990466|NCT04142450|50079822|FG000|Overall Study|Lost to Follow-up|1|||
24990467|NCT04529850|50079826|FG000|Overall Study|Death|2|||
24990468|NCT04529850|50079826|FG000|Overall Study|Physician Decision|1|||
24990469|NCT04529850|50079826|FG000|Overall Study|Withdrawal by Subject|2|||
24990470|NCT04225676|50079830|FG000|Overall Study|Physician Decision|1|||
24990471|NCT04225676|50079830|FG000|Overall Study|Lack of Efficacy|1|||
24990472|NCT04225676|50079830|FG000|Overall Study|Study terminated by sponsor|3|||
24990473|NCT04142216|50079838|FG000|Overall Study|Hospitalization|0|||
24990474|NCT04142216|50079839|FG001|Overall Study|Hospitalization|2|||
24990475|NCT04142216|50079838|FG000|Overall Study|Death|3|||
24990476|NCT04142216|50079839|FG001|Overall Study|Death|1|||
24990477|NCT04142216|50079838|FG000|Overall Study|Referral to another hemodialysis unit|3|||
24990478|NCT04142216|50079839|FG001|Overall Study|Referral to another hemodialysis unit|2|||
24990479|NCT04142216|50079838|FG000|Overall Study|Use of clove|0|||
24990480|NCT04142216|50079839|FG001|Overall Study|Use of clove|1|||
24990481|NCT04140890|50079847|FG000|Overall Study|Withdrawal by Subject|0|||
24990482|NCT04140890|50079848|FG001|Overall Study|Withdrawal by Subject|1|||
24990483|NCT03700320|50079859|FG000|Overall Study|Adverse Event|5|||
24990484|NCT03700320|50079860|FG001|Overall Study|Adverse Event|31|||
24990485|NCT03700320|50079859|FG000|Overall Study|Lack of Efficacy|2|||
24990486|NCT03700320|50079860|FG001|Overall Study|Lack of Efficacy|5|||
24990487|NCT03700320|50079859|FG000|Overall Study|Withdrawal by Subject|29|||
24990488|NCT03700320|50079860|FG001|Overall Study|Withdrawal by Subject|75|||
24990489|NCT03700320|50079859|FG000|Overall Study|Lost to Follow-up|16|||
24990490|NCT03700320|50079860|FG001|Overall Study|Lost to Follow-up|23|||
24990491|NCT03700320|50079859|FG000|Overall Study|Pregnancy|2|||
24990492|NCT03700320|50079860|FG001|Overall Study|Pregnancy|4|||
24990493|NCT03700320|50079859|FG000|Overall Study|Protocol Deviation|7|||
24990494|NCT03700320|50079860|FG001|Overall Study|Protocol Deviation|31|||
24990495|NCT03700320|50079859|FG000|Overall Study|Non-compliance with Study Drug|1|||
24990496|NCT03700320|50079860|FG001|Overall Study|Non-compliance with Study Drug|3|||
24990497|NCT03700320|50079859|FG000|Overall Study|Reason not Specified|0|||
24990498|NCT03700320|50079860|FG001|Overall Study|Reason not Specified|1|||
24990499|NCT04139018|50079868|FG000|Overall Study|Screen fail|1|||
24990500|NCT04139018|50079869|FG001|Overall Study|Screen fail|0|||
24990501|NCT04139018|50079868|FG000|Overall Study|Withdrawal by Subject|2|||
24990502|NCT04139018|50079869|FG001|Overall Study|Withdrawal by Subject|0|||
24990503|NCT04139018|50079868|FG000|Overall Study|Lost to Follow-up|0|||
24990504|NCT04139018|50079869|FG001|Overall Study|Lost to Follow-up|1|||
24990505|NCT04456686|50079877|FG000|Overall Study|Adverse Event|2|||
25079448|NCT01865617|50187894|FG008|Overall Study|Other|0|||
24990506|NCT04456686|50079878|FG001|Overall Study|Adverse Event|1|||
24990507|NCT04456686|50079877|FG000|Overall Study|Lack of Efficacy|3|||
24990508|NCT04456686|50079878|FG001|Overall Study|Lack of Efficacy|1|||
24990509|NCT04456686|50079877|FG000|Overall Study|Withdrew consent|3|||
24990510|NCT04456686|50079878|FG001|Overall Study|Withdrew consent|1|||
24990511|NCT04456686|50079877|FG000|Overall Study|Physician Decision|2|||
24990512|NCT04456686|50079878|FG001|Overall Study|Physician Decision|2|||
24990513|NCT04456686|50079877|FG000|Overall Study|Withdrawal by Subject|5|||
24990514|NCT04456686|50079878|FG001|Overall Study|Withdrawal by Subject|1|||
24990515|NCT04456686|50079877|FG000|Overall Study|Protocol Violation|0|||
24990516|NCT04456686|50079878|FG001|Overall Study|Protocol Violation|1|||
24990517|NCT04527978|50079886|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
24990518|NCT04527978|50079887|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
24990519|NCT04136444|50079898|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
24990520|NCT04136444|50079899|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
24990521|NCT04425252|50079913|FG000|Overall Study|Withdrawal by Subject|2|||
24990522|NCT04425252|50079914|FG001|Overall Study|Withdrawal by Subject|1|||
24990523|NCT04425252|50079913|FG000|Overall Study|Lost to Follow-up|1|||
24990524|NCT04425252|50079914|FG001|Overall Study|Lost to Follow-up|0|||
24990525|NCT04425252|50079913|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
24990526|NCT04425252|50079914|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
24990527|NCT03696576|50079925|FG000|Overall Study|Soreness of throat after therapy|1|||
24990528|NCT03696576|50079926|FG001|Overall Study|Soreness of throat after therapy|1|||
24990529|NCT03696576|50079925|FG000|Overall Study|Lost to Follow-up|2|||
24990530|NCT03696576|50079926|FG001|Overall Study|Lost to Follow-up|4|||
24990531|NCT04003610|50079935|FG000|Overall Study|Lost to Follow-up|0|||
24990532|NCT04003610|50079936|FG001|Overall Study|Lost to Follow-up|1|||
24990533|NCT04003610|50079937|FG002|Overall Study|Lost to Follow-up|0|||
24990534|NCT04003610|50079935|FG000|Overall Study|Death|0|||
24990535|NCT04003610|50079936|FG001|Overall Study|Death|0|||
24990536|NCT04003610|50079937|FG002|Overall Study|Death|3|||
24990537|NCT04003610|50079935|FG000|Overall Study|Study Terminated by Sponsor|0|||
24990538|NCT04003610|50079936|FG001|Overall Study|Study Terminated by Sponsor|0|||
24990539|NCT04003610|50079937|FG002|Overall Study|Study Terminated by Sponsor|3|||
24990540|NCT03999554|50079951|FG000|Overall Study|Lost to Follow-up|4|||
24990541|NCT03999554|50079952|FG001|Overall Study|Lost to Follow-up|5|||
24990542|NCT03999554|50079953|FG002|Overall Study|Lost to Follow-up|4|||
24990543|NCT03999554|50079954|FG003|Overall Study|Lost to Follow-up|5|||
24990544|NCT03999554|50079955|FG004|Overall Study|Lost to Follow-up|8|||
24990545|NCT03999554|50079951|FG000|Overall Study|Protocol Violation|0|||
24990546|NCT03999554|50079952|FG001|Overall Study|Protocol Violation|0|||
24990547|NCT03999554|50079953|FG002|Overall Study|Protocol Violation|5|||
24990548|NCT03999554|50079954|FG003|Overall Study|Protocol Violation|0|||
24990549|NCT03999554|50079955|FG004|Overall Study|Protocol Violation|0|||
24990550|NCT03999554|50079951|FG000|Overall Study|Pregnancy|0|||
24990551|NCT03999554|50079952|FG001|Overall Study|Pregnancy|0|||
24990552|NCT03999554|50079953|FG002|Overall Study|Pregnancy|1|||
24990553|NCT03999554|50079954|FG003|Overall Study|Pregnancy|0|||
24990554|NCT03999554|50079955|FG004|Overall Study|Pregnancy|0|||
24990555|NCT03999554|50079951|FG000|Overall Study|Withdrawal by Subject|2|||
24990556|NCT03999554|50079952|FG001|Overall Study|Withdrawal by Subject|2|||
24990557|NCT03999554|50079953|FG002|Overall Study|Withdrawal by Subject|2|||
24990558|NCT03999554|50079954|FG003|Overall Study|Withdrawal by Subject|1|||
24990559|NCT03999554|50079955|FG004|Overall Study|Withdrawal by Subject|1|||
24990560|NCT03999554|50079951|FG000|Overall Study|failure to comply with protocol requirements|0|||
24990561|NCT03999554|50079952|FG001|Overall Study|failure to comply with protocol requirements|0|||
24990562|NCT03999554|50079953|FG002|Overall Study|failure to comply with protocol requirements|0|||
24990563|NCT03999554|50079954|FG003|Overall Study|failure to comply with protocol requirements|1|||
24990564|NCT03999554|50079955|FG004|Overall Study|failure to comply with protocol requirements|0|||
24990565|NCT04129346|50079970|FG000|Overall Study|Death|1|||
24990566|NCT04129346|50079971|FG001|Overall Study|Death|0|||
24990567|NCT04526574|50079979|FG000|Overall Study|Protocol Violation|3|||
24990568|NCT04526574|50079980|FG001|Overall Study|Protocol Violation|1|||
24990569|NCT04526574|50079979|FG000|Overall Study|Withdrawal by Subject|12|||
24990570|NCT04526574|50079980|FG001|Overall Study|Withdrawal by Subject|9|||
24990571|NCT04526574|50079979|FG000|Overall Study|Other|1|||
24990572|NCT04526574|50079980|FG001|Overall Study|Other|2|||
24990573|NCT04526574|50079979|FG000|Overall Study|Adverse Event|1|||
24990574|NCT04526574|50079980|FG001|Overall Study|Adverse Event|1|||
24990575|NCT04526574|50079979|FG000|Overall Study|Death|2|||
24990576|NCT04526574|50079980|FG001|Overall Study|Death|3|||
24990577|NCT04526574|50079979|FG000|Overall Study|Lost to Follow-up|9|||
24990578|NCT04526574|50079980|FG001|Overall Study|Lost to Follow-up|9|||
24990579|NCT04526574|50079979|FG000|Overall Study|No longer meets eligibility criteria|8|||
25079449|NCT01865617|50187895|FG009|Overall Study|Other|0|||
24990580|NCT04526574|50079980|FG001|Overall Study|No longer meets eligibility criteria|8|||
24990581|NCT03993392|50079990|FG000|Overall Study|Withdrawal by Subject|3|||
24990582|NCT03993392|50079990|FG000|Overall Study|Lost to Follow-up|2|||
24990583|NCT03993392|50079990|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
24990584|NCT04422990|50079997|FG000|Overall Study|Withdrawal by Subject|0|||
24990585|NCT04422990|50079998|FG001|Overall Study|Withdrawal by Subject|1|||
25079450|NCT01865617|50187896|FG010|Overall Study|Other|0|||
24990586|NCT04422990|50079997|FG000|Overall Study|Travel|3|||
24990587|NCT04422990|50079998|FG001|Overall Study|Travel|0|||
24990588|NCT04377308|50080009|FG000|Overall Study|Withdrawal by Subject|0|||
24990589|NCT04377308|50080010|FG001|Overall Study|Withdrawal by Subject|1|||
24990590|NCT04447404|50080018|FG000|Overall Study|Death|2|||
24990591|NCT04447404|50080019|FG001|Overall Study|Death|0|||
24990592|NCT03988166|50080025|FG000|Overall Study|Lost to Follow-up|2|||
24990593|NCT03988166|50080025|FG000|Overall Study|Death|1|||
24990594|NCT03988088|50080034|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
24990595|NCT03988088|50080035|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
24990596|NCT03988088|50080036|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
24990597|NCT03988088|50080037|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
24990598|NCT03988088|50080034|FG000|Open-Label Addendum|Lost to Follow-up|0|||
24990599|NCT03988088|50080035|FG001|Open-Label Addendum|Lost to Follow-up|0|||
24990600|NCT03988088|50080036|FG002|Open-Label Addendum|Lost to Follow-up|1|||
24990601|NCT03988088|50080037|FG003|Open-Label Addendum|Lost to Follow-up|0|||
24990602|NCT03987932|50080048|FG000|Overall Study|Lost to Follow-up|2|||
24990603|NCT03987932|50080049|FG001|Overall Study|Lost to Follow-up|1|||
24990604|NCT03987932|50080050|FG002|Overall Study|Lost to Follow-up|1|||
24990605|NCT03987932|50080048|FG000|Overall Study|Non-study related elective surgery|0|||
24990606|NCT03987932|50080049|FG001|Overall Study|Non-study related elective surgery|0|||
24990607|NCT03987932|50080050|FG002|Overall Study|Non-study related elective surgery|1|||
24990608|NCT03987620|50080060|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
24990609|NCT03987620|50080061|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
24990610|NCT03987620|50080060|FG000|Overall Study|Adverse Event|3|||
24990611|NCT03987620|50080061|FG001|Overall Study|Adverse Event|0|||
24990612|NCT03987620|50080060|FG000|Overall Study|Lost to Follow-up|1|||
24990613|NCT03987620|50080061|FG001|Overall Study|Lost to Follow-up|2|||
24990614|NCT03987620|50080060|FG000|Overall Study|Physician Decision|0|||
24990615|NCT03987620|50080061|FG001|Overall Study|Physician Decision|1|||
24990616|NCT03987620|50080060|FG000|Overall Study|Pregnancy|1|||
24990617|NCT03987620|50080061|FG001|Overall Study|Pregnancy|0|||
24990618|NCT03987620|50080060|FG000|Overall Study|Withdrawal by Subject|7|||
24990619|NCT03987620|50080061|FG001|Overall Study|Withdrawal by Subject|1|||
24990620|NCT03987620|50080060|FG000|Overall Study|Other|2|||
24990621|NCT03987620|50080061|FG001|Overall Study|Other|5|||
24990622|NCT03069352|50080069|FG000|Overall Study|Ongoing|12|||
24990623|NCT03069352|50080070|FG001|Overall Study|Ongoing|40|||
24990624|NCT04376060|50080076|FG000|Overall Study|Physician Decision|1|||
24990625|NCT04413552|50080090|FG000|Overall Study|Adverse Event|0|||
24990626|NCT04413552|50080091|FG001|Overall Study|Adverse Event|0|||
24990627|NCT04413552|50080092|FG002|Overall Study|Adverse Event|0|||
24990628|NCT04413552|50080093|FG003|Overall Study|Adverse Event|0|||
24990629|NCT04413552|50080094|FG004|Overall Study|Adverse Event|0|||
24990630|NCT04413552|50080095|FG005|Overall Study|Adverse Event|0|||
24990631|NCT04413552|50080096|FG006|Overall Study|Adverse Event|1|||
24990632|NCT04413552|50080097|FG007|Overall Study|Adverse Event|0|||
24990633|NCT04413552|50080098|FG008|Overall Study|Adverse Event|0|||
24990634|NCT04413552|50080099|FG009|Overall Study|Adverse Event|0|||
24990635|NCT03987074|50080130|FG000|Overall Study|Withdrew Consent|1|||
24990636|NCT03987074|50080131|FG001|Overall Study|Withdrew Consent|1|||
24990637|NCT03987074|50080132|FG002|Overall Study|Withdrew Consent|0|||
24990638|NCT03987074|50080133|FG003|Overall Study|Withdrew Consent|2|||
24990639|NCT03987074|50080134|FG004|Overall Study|Withdrew Consent|1|||
24990640|NCT03987074|50080130|FG000|Overall Study|Adverse Event|2|||
24990641|NCT03987074|50080131|FG001|Overall Study|Adverse Event|1|||
24990642|NCT03987074|50080132|FG002|Overall Study|Adverse Event|0|||
24990643|NCT03987074|50080133|FG003|Overall Study|Adverse Event|0|||
24990644|NCT03987074|50080134|FG004|Overall Study|Adverse Event|1|||
24990645|NCT03987074|50080130|FG000|Overall Study|Lost to Follow-up|0|||
24990646|NCT03987074|50080131|FG001|Overall Study|Lost to Follow-up|0|||
24990647|NCT03987074|50080132|FG002|Overall Study|Lost to Follow-up|1|||
24990648|NCT03987074|50080133|FG003|Overall Study|Lost to Follow-up|1|||
24990649|NCT03987074|50080134|FG004|Overall Study|Lost to Follow-up|0|||
24990650|NCT03987074|50080130|FG000|Overall Study|Investigator's Discretion|0|||
24990651|NCT03987074|50080131|FG001|Overall Study|Investigator's Discretion|0|||
24990652|NCT03987074|50080132|FG002|Overall Study|Investigator's Discretion|0|||
24990653|NCT03987074|50080133|FG003|Overall Study|Investigator's Discretion|1|||
24990654|NCT03987074|50080134|FG004|Overall Study|Investigator's Discretion|0|||
24990655|NCT04439214|50080146|FG000|Overall Study|Adverse Event|13|||
24990656|NCT04439214|50080146|FG000|Overall Study|Disease progression|16|||
24990657|NCT04439214|50080146|FG000|Overall Study|Death|1|||
24990658|NCT04439214|50080146|FG000|Overall Study|Withdrawal by Subject|2|||
24990659|NCT04439214|50080146|FG000|Overall Study|Declining health|1|||
24990660|NCT04439214|50080146|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
24990661|NCT04439214|50080146|FG000|Overall Study|Ineligible|5|||
24990662|NCT03696342|50080152|FG000|Overall Study|Lost to Follow-up|1|||
24990663|NCT03696342|50080153|FG001|Overall Study|Lost to Follow-up|0|||
24990664|NCT04411680|50080161|FG000|Treatment Period|Adverse Event|3|||
24990665|NCT04411680|50080162|FG001|Treatment Period|Adverse Event|0|||
24990666|NCT04411680|50080161|FG000|Treatment Period|Discharged from hospital|18|||
24990667|NCT04411680|50080162|FG001|Treatment Period|Discharged from hospital|7|||
24990668|NCT04411680|50080161|FG000|Treatment Period|Missed 1 or more doses|8|||
24990669|NCT04411680|50080162|FG001|Treatment Period|Missed 1 or more doses|0|||
24990670|NCT04411680|50080161|FG000|Treatment Period|Transferred to another hospital|0|||
24990671|NCT04411680|50080162|FG001|Treatment Period|Transferred to another hospital|1|||
24990672|NCT04411680|50080161|FG000|Follow up Period|Withdrawal by Subject|2|||
24990673|NCT04411680|50080162|FG001|Follow up Period|Withdrawal by Subject|0|||
24990674|NCT04411680|50080161|FG000|Follow up Period|Lost to Follow-up|5|||
24990675|NCT04411680|50080162|FG001|Follow up Period|Lost to Follow-up|6|||
24990676|NCT04411680|50080161|FG000|Follow up Period|Death|11|||
24990677|NCT04411680|50080162|FG001|Follow up Period|Death|8|||
24990678|NCT04410198|50080168|FG000|Overall Study|Death|10|||
24990679|NCT04410198|50080168|FG000|Overall Study|Withdrawal by Subject|7|||
24990680|NCT04410198|50080168|FG000|Overall Study|Transferred/Relocation|4|||
24990681|NCT04410198|50080168|FG000|Overall Study|Kidney Transplant|9|||
24990682|NCT04410198|50080168|FG000|Overall Study|Adverse Event|4|||
24990683|NCT04410198|50080168|FG000|Overall Study|Physician Decision|2|||
24990684|NCT04410198|50080168|FG000|Overall Study|Other than specified|1|||
24990685|NCT04161144|50080174|FG000|Overall Study|Withdrawal by Subject|0|||
24990686|NCT04161144|50080175|FG001|Overall Study|Withdrawal by Subject|1|||
24990687|NCT04161144|50080174|FG000|Overall Study|Protocol Violation|1|||
24990688|NCT04161144|50080175|FG001|Overall Study|Protocol Violation|0|||
24990689|NCT03984812|50080192|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
24990690|NCT03984812|50080193|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
24990691|NCT03984812|50080194|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
24990692|NCT03984812|50080195|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
24990693|NCT03984812|50080196|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
24990694|NCT03984812|50080197|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
24990695|NCT03984812|50080198|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
24990696|NCT03984812|50080199|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
24990697|NCT03984812|50080200|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
24990698|NCT03984812|50080201|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
24990699|NCT03984812|50080202|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
24990700|NCT04160988|50080229|FG000|Overall Study|poor image quality|28|||
24990701|NCT04153188|50080250|FG000|Overall Study|Lost to Follow-up|1|||
24990702|NCT04153188|50080251|FG001|Overall Study|Lost to Follow-up|1|||
24990703|NCT04153188|50080250|FG000|Overall Study|Withdrawal by Subject|2|||
24990704|NCT04153188|50080251|FG001|Overall Study|Withdrawal by Subject|0|||
24990705|NCT04153188|50080250|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
24990706|NCT04153188|50080251|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
24990707|NCT04113746|50080259|FG000|Overall Study|Lost to Follow-up|4|||
24990708|NCT04113746|50080260|FG001|Overall Study|Lost to Follow-up|4|||
24990709|NCT03611010|50080270|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
24990710|NCT03611010|50080271|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
24990711|NCT03611010|50080272|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
24990712|NCT03611010|50080273|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
24990713|NCT04357782|50080288|FG000|Overall Study|Discharged from hospital|1|||
24990714|NCT04357782|50080289|FG001|Overall Study|Discharged from hospital|0|||
24990715|NCT04357782|50080288|FG000|Overall Study|Death|0|||
24990716|NCT04357782|50080289|FG001|Overall Study|Death|2|||
24990717|NCT03980522|50080300|FG000|Treatment Period|Adverse Event|1|||
24990718|NCT03980522|50080301|FG001|Treatment Period|Adverse Event|0|||
24990719|NCT03980522|50080302|FG002|Treatment Period|Adverse Event|0|||
24990720|NCT03980522|50080303|FG003|Treatment Period|Adverse Event|0|||
24990721|NCT03980522|50080304|FG004|Treatment Period|Adverse Event|0|||
24990722|NCT04402866|50080322|FG000|Overall Study|Discontinued Prior to Treatment|0|||
24990723|NCT04402866|50080323|FG001|Overall Study|Discontinued Prior to Treatment|0|||
24990724|NCT04402866|50080324|FG002|Overall Study|Discontinued Prior to Treatment|0|||
24990725|NCT04402866|50080325|FG003|Overall Study|Discontinued Prior to Treatment|0|||
24990726|NCT04402866|50080326|FG004|Overall Study|Discontinued Prior to Treatment|2|||
24990727|NCT04402866|50080327|FG005|Overall Study|Discontinued Prior to Treatment|3|||
24990728|NCT04402866|50080322|FG000|Overall Study|Adverse Event|2|||
24990729|NCT04402866|50080323|FG001|Overall Study|Adverse Event|1|||
24990730|NCT04402866|50080324|FG002|Overall Study|Adverse Event|0|||
24990731|NCT04402866|50080325|FG003|Overall Study|Adverse Event|0|||
24990732|NCT04402866|50080326|FG004|Overall Study|Adverse Event|13|||
24990733|NCT04402866|50080327|FG005|Overall Study|Adverse Event|8|||
24990734|NCT04402866|50080322|FG000|Overall Study|Miscellaneous|0|||
24990735|NCT04402866|50080323|FG001|Overall Study|Miscellaneous|0|||
24990736|NCT04402866|50080324|FG002|Overall Study|Miscellaneous|1|||
24990737|NCT04402866|50080325|FG003|Overall Study|Miscellaneous|0|||
24990738|NCT04402866|50080326|FG004|Overall Study|Miscellaneous|0|||
24990739|NCT04402866|50080327|FG005|Overall Study|Miscellaneous|0|||
24990740|NCT04402866|50080322|FG000|Overall Study|Lost to Follow-up|0|||
24990741|NCT04402866|50080323|FG001|Overall Study|Lost to Follow-up|0|||
24990742|NCT04402866|50080324|FG002|Overall Study|Lost to Follow-up|0|||
24990743|NCT04402866|50080325|FG003|Overall Study|Lost to Follow-up|0|||
24990744|NCT04402866|50080326|FG004|Overall Study|Lost to Follow-up|0|||
24990745|NCT04402866|50080327|FG005|Overall Study|Lost to Follow-up|1|||
24990746|NCT04402866|50080322|FG000|Overall Study|Withdrawal by Subject|0|||
24990747|NCT04402866|50080323|FG001|Overall Study|Withdrawal by Subject|0|||
24990748|NCT04402866|50080324|FG002|Overall Study|Withdrawal by Subject|0|||
24990749|NCT04402866|50080325|FG003|Overall Study|Withdrawal by Subject|0|||
24990750|NCT04402866|50080326|FG004|Overall Study|Withdrawal by Subject|0|||
24990751|NCT04402866|50080327|FG005|Overall Study|Withdrawal by Subject|2|||
24990752|NCT04400682|50080339|FG000|Period 1|Withdrawal by Subject|1|||
24990753|NCT04400682|50080340|FG001|Period 1|Withdrawal by Subject|4|||
24990754|NCT03066778|50080348|FG000|Overall Study|Death|195|||
24990755|NCT03066778|50080349|FG001|Overall Study|Death|205|||
24990756|NCT03066778|50080348|FG000|Overall Study|Withdrawal by Subject|5|||
24990757|NCT03066778|50080349|FG001|Overall Study|Withdrawal by Subject|7|||
24990758|NCT04348656|50080358|FG000|Overall Study|Withdrawal by Subject|2|||
24990759|NCT04348656|50080359|FG001|Overall Study|Withdrawal by Subject|0|||
24990760|NCT04348656|50080358|FG000|Overall Study|Lost to Follow-up|11|||
24990761|NCT04348656|50080359|FG001|Overall Study|Lost to Follow-up|6|||
24990762|NCT04348500|50080374|FG000|Overall Study|Death|2|||
24990763|NCT04348500|50080375|FG001|Overall Study|Death|2|||
24990764|NCT04348500|50080374|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
24990765|NCT04348500|50080375|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
24990766|NCT04347954|50080384|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
24990767|NCT04347954|50080385|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
24990768|NCT04347954|50080386|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
24990769|NCT04347954|50080384|FG000|Overall Study|Lost to Follow-up|0|||
24990770|NCT04347954|50080385|FG001|Overall Study|Lost to Follow-up|1|||
24990771|NCT04347954|50080386|FG002|Overall Study|Lost to Follow-up|0|||
24990772|NCT03065530|50080398|FG000|Overall Study|Lack of Efficacy|1|||
24990773|NCT03065530|50080399|FG001|Overall Study|Lack of Efficacy|1|||
24990774|NCT03065530|50080400|FG002|Overall Study|Lack of Efficacy|0|||
24990775|NCT03065530|50080401|FG003|Overall Study|Lack of Efficacy|1|||
24990776|NCT03065530|50080398|FG000|Overall Study|Protocol Violation|1|||
24990777|NCT03065530|50080399|FG001|Overall Study|Protocol Violation|0|||
24990778|NCT03065530|50080400|FG002|Overall Study|Protocol Violation|1|||
24990779|NCT03065530|50080401|FG003|Overall Study|Protocol Violation|1|||
24990780|NCT03979820|50080423|FG000|Overall Study|Protocol Violation|1|||
24990781|NCT03979820|50080424|FG001|Overall Study|Protocol Violation|0|||
24990782|NCT03979820|50080425|FG002|Overall Study|Protocol Violation|0|||
24990783|NCT03979820|50080426|FG003|Overall Study|Protocol Violation|0|||
24990784|NCT03979820|50080423|FG000|Overall Study|Withdrawal by Subject|0|||
24990785|NCT03979820|50080424|FG001|Overall Study|Withdrawal by Subject|0|||
24990786|NCT03979820|50080425|FG002|Overall Study|Withdrawal by Subject|1|||
24990787|NCT03979820|50080426|FG003|Overall Study|Withdrawal by Subject|0|||
24990788|NCT03979820|50080423|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
24990789|NCT03979820|50080424|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
24990790|NCT03979820|50080425|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
24990791|NCT03979820|50080426|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
24990792|NCT03647488|50080443|FG000|Overall Study|Progressive disease|10|||
24990793|NCT03647488|50080444|FG001|Overall Study|Progressive disease|0|||
24990794|NCT03647488|50080445|FG002|Overall Study|Progressive disease|0|||
24990795|NCT03647488|50080443|FG000|Overall Study|Adverse Event|5|||
24990796|NCT03647488|50080444|FG001|Overall Study|Adverse Event|0|||
24990797|NCT03647488|50080445|FG002|Overall Study|Adverse Event|0|||
24990798|NCT03647488|50080443|FG000|Overall Study|Clinical progression|2|||
24990799|NCT03647488|50080444|FG001|Overall Study|Clinical progression|0|||
24990800|NCT03647488|50080445|FG002|Overall Study|Clinical progression|0|||
24990801|NCT03647488|50080443|FG000|Overall Study|Participant refused to take investigational product|1|||
24990802|NCT03647488|50080444|FG001|Overall Study|Participant refused to take investigational product|0|||
24990803|NCT03647488|50080445|FG002|Overall Study|Participant refused to take investigational product|0|||
24990804|NCT03693950|50080453|FG000|Overall Study|Withdrawal by Subject|1|||
24990805|NCT03693950|50080454|FG001|Overall Study|Withdrawal by Subject|0|||
24990806|NCT04110314|50080466|FG000|Overall Study|Did not meet inclusion criteria|35255|||
24990807|NCT04110314|50080467|FG001|Overall Study|Did not meet inclusion criteria|35104|||
24990808|NCT04110314|50080468|FG002|Overall Study|Did not meet inclusion criteria|35636|||
24990809|NCT04110314|50080469|FG003|Overall Study|Did not meet inclusion criteria|35135|||
24990810|NCT04110314|50080470|FG004|Overall Study|Did not meet inclusion criteria|35247|||
24990811|NCT04110314|50080471|FG005|Overall Study|Did not meet inclusion criteria|35727|||
24990812|NCT04109222|50080486|FG000|Overall Study|Adverse Event|1|||
24990813|NCT04109222|50080487|FG001|Overall Study|Adverse Event|0|||
24990814|NCT04109222|50080488|FG002|Overall Study|Adverse Event|0|||
24990815|NCT04098458|50080496|FG000|Overall Study|Death|1|||
24990816|NCT04098458|50080496|FG000|Overall Study|did not meet study inclusion criteria|3|||
24990817|NCT03447262|50080501|FG000|Overall Study|Adverse Event|7|||
24990818|NCT03447262|50080501|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
24990819|NCT03447262|50080501|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
24990820|NCT03447262|50080501|FG000|Overall Study|Death|2|||
24990821|NCT03447262|50080501|FG000|Overall Study|Study Termination by Sponsor|455|||
24990822|NCT03447262|50080501|FG000|Overall Study|Other|4|||
24990823|NCT04094870|50080510|FG000|Overall Study|Lost to Follow-up|1|||
24990824|NCT04094870|50080511|FG001|Overall Study|Lost to Follow-up|1|||
24990825|NCT04399356|50080526|FG000|Overall Study|Lost to Follow-up|1|||
24990826|NCT04399356|50080527|FG001|Overall Study|Lost to Follow-up|1|||
24990827|NCT04399356|50080526|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
24990828|NCT04399356|50080527|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
24990829|NCT04399356|50080526|FG000|Overall Study|Withdrawal by Subject|1|||
24990830|NCT04399356|50080527|FG001|Overall Study|Withdrawal by Subject|0|||
24990831|NCT03692676|50080537|FG000|Overall Study|exclude patients with prior use|4424|||
24990832|NCT03692676|50080538|FG001|Overall Study|exclude patients with prior use|24726|||
24990833|NCT03692676|50080539|FG002|Overall Study|exclude patients with prior use|0|||
24990834|NCT03692676|50080540|FG003|Overall Study|exclude patients with prior use|0|||
24990835|NCT03692676|50080537|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
24990836|NCT03692676|50080538|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
24990837|NCT03692676|50080539|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
24990838|NCT03692676|50080540|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
24990839|NCT03692676|50080537|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
24990840|NCT03692676|50080538|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
24990841|NCT03692676|50080539|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
24990842|NCT03692676|50080540|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
24990843|NCT03692676|50080537|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
24990844|NCT03692676|50080538|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
24990845|NCT03692676|50080539|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
24990846|NCT03692676|50080540|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
24990847|NCT03692676|50080537|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
24990848|NCT03692676|50080538|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
24990849|NCT03692676|50080539|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
24990850|NCT03692676|50080540|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
24990851|NCT03692676|50080537|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
24990852|NCT03692676|50080538|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
24990853|NCT03692676|50080539|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
24990854|NCT03692676|50080540|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
24990855|NCT03692676|50080537|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
24990856|NCT03692676|50080538|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
24990857|NCT03692676|50080539|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
24990858|NCT03692676|50080540|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
24990859|NCT03692676|50080537|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
24990860|NCT03692676|50080538|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
24990861|NCT03692676|50080539|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
24990862|NCT03692676|50080540|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
24990863|NCT03692676|50080537|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
24990864|NCT03692676|50080538|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
24990865|NCT03692676|50080539|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
24990866|NCT03692676|50080540|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
24990867|NCT03692676|50080537|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
24990868|NCT03692676|50080538|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
24990869|NCT03692676|50080539|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
24990870|NCT03692676|50080540|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
24990871|NCT03692676|50080537|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
24990872|NCT03692676|50080538|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
24995123|NCT03015220|50086011|FG002|Overall Study|Withdrawal by Subject|2|||
24990873|NCT03692676|50080539|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
24990874|NCT03692676|50080540|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
24990875|NCT03692676|50080537|FG000|Overall Study|Other|0|||
24990876|NCT03692676|50080538|FG001|Overall Study|Other|805|||
24990877|NCT03692676|50080539|FG002|Overall Study|Other|758|||
24990878|NCT03692676|50080540|FG003|Overall Study|Other|277|||
24990879|NCT03692676|50080537|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
24990880|NCT03692676|50080538|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
24990881|NCT03692676|50080539|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
24990882|NCT03692676|50080540|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
24990883|NCT03691428|50080552|FG000|Overall Study|Withdrawal by Subject|6|||
24990884|NCT03691428|50080553|FG001|Overall Study|Withdrawal by Subject|8|||
24990885|NCT04124952|50080559|FG000|Overall Study|Lost to Follow-up|1|||
24990886|NCT04122534|50080563|FG000|Overall Study|Lost to Follow-up|4|||
24990887|NCT04091360|50080573|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
24990888|NCT04091360|50080574|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
24990889|NCT04091360|50080575|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
24990890|NCT04091360|50080576|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
24990891|NCT04091360|50080577|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
24990892|NCT04091360|50080578|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
24990893|NCT04091360|50080579|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
24990894|NCT04091360|50080580|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
24990895|NCT04091360|50080581|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
24990896|NCT04091360|50080582|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
24990897|NCT04091360|50080573|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
24990898|NCT04091360|50080574|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
24990899|NCT04091360|50080575|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
24990900|NCT04091360|50080576|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
24990901|NCT04091360|50080577|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
24990902|NCT04091360|50080578|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
24990903|NCT04091360|50080579|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
24990904|NCT04091360|50080580|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
24990905|NCT04091360|50080581|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
24990906|NCT04091360|50080582|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
24990907|NCT04091360|50080573|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
24990908|NCT04091360|50080574|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
24990909|NCT04091360|50080575|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
24990910|NCT04091360|50080576|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
24990911|NCT04091360|50080577|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
24990912|NCT04091360|50080578|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
24990913|NCT04091360|50080579|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
24990914|NCT04091360|50080580|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
24990915|NCT04091360|50080581|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
24990916|NCT04091360|50080582|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
24990917|NCT04118166|50080604|FG000|Overall Study|Adverse Event|1|||
24990918|NCT04346628|50080611|FG000|Overall Study|Lost to Follow-up|4|||
24990919|NCT04346628|50080612|FG001|Overall Study|Lost to Follow-up|4|||
24990920|NCT04346628|50080611|FG000|Overall Study|Withdrew (had personal reasons)|2|||
24990921|NCT04346628|50080612|FG001|Overall Study|Withdrew (had personal reasons)|5|||
24990922|NCT04346628|50080611|FG000|Overall Study|Withdrew (medication intolerant)|0|||
24990923|NCT04346628|50080612|FG001|Overall Study|Withdrew (medication intolerant)|3|||
24990924|NCT04346628|50080611|FG000|Overall Study|Withdrew (declined intervention)|0|||
24990925|NCT04346628|50080612|FG001|Overall Study|Withdrew (declined intervention)|1|||
24990926|NCT03681470|50080618|FG000|Overall Study|Lack of Efficacy|3|||
24990927|NCT03681470|50080618|FG000|Overall Study|Lost to Follow-up|1|||
24990928|NCT03681470|50080618|FG000|Overall Study|Protocol Violation|3|||
24990929|NCT03681470|50080618|FG000|Overall Study|Withdrawal by Subject|1|||
24990930|NCT04343976|50080624|FG000|Overall Study|Withdrawal by Subject|0|||
24990931|NCT04343976|50080625|FG001|Overall Study|Withdrawal by Subject|1|||
24990932|NCT03322540|50080633|FG000|Overall Study|Death|21|||
24990933|NCT03322540|50080634|FG001|Overall Study|Death|28|||
24990934|NCT03322540|50080633|FG000|Overall Study|Lost to Follow-up|0|||
24990935|NCT03322540|50080634|FG001|Overall Study|Lost to Follow-up|1|||
24990936|NCT03322540|50080633|FG000|Overall Study|Physician Decision|7|||
24990937|NCT03322540|50080634|FG001|Overall Study|Physician Decision|6|||
24990938|NCT03322540|50080633|FG000|Overall Study|Withdrawal by Subject|3|||
24990939|NCT03322540|50080634|FG001|Overall Study|Withdrawal by Subject|1|||
24990940|NCT03322540|50080633|FG000|Overall Study|Study terminated by sponsor|0|||
24990941|NCT03322540|50080634|FG001|Overall Study|Study terminated by sponsor|1|||
24990942|NCT04339296|50080644|FG000|Overall Study|Refuse to participate after allocation|1|||
24990943|NCT04339296|50080645|FG001|Overall Study|Refuse to participate after allocation|1|||
24990944|NCT04339296|50080644|FG000|Overall Study|Withdrew after completion of baseline|2|||
24990945|NCT04339296|50080645|FG001|Overall Study|Withdrew after completion of baseline|1|||
24990946|NCT04339296|50080644|FG000|Overall Study|Lost to Follow-up|0|||
24990947|NCT04339296|50080645|FG001|Overall Study|Lost to Follow-up|4|||
24990948|NCT04339296|50080644|FG000|Overall Study|Discontinued intervention|5|||
24990949|NCT04339296|50080645|FG001|Overall Study|Discontinued intervention|3|||
24990950|NCT02025556|50080654|FG000|Overall Study|Adverse Event|0|||
24990951|NCT02025556|50080655|FG001|Overall Study|Adverse Event|4|||
24990952|NCT02025556|50080656|FG002|Overall Study|Adverse Event|2|||
24990953|NCT02025556|50080654|FG000|Overall Study|Lack of Efficacy|2|||
24990954|NCT02025556|50080655|FG001|Overall Study|Lack of Efficacy|1|||
24990955|NCT02025556|50080656|FG002|Overall Study|Lack of Efficacy|0|||
24990956|NCT02025556|50080654|FG000|Overall Study|Protocol Violation|2|||
24990957|NCT02025556|50080655|FG001|Overall Study|Protocol Violation|1|||
24990958|NCT02025556|50080656|FG002|Overall Study|Protocol Violation|0|||
24990959|NCT02025556|50080654|FG000|Overall Study|Withdrawal by Subject|0|||
24990960|NCT02025556|50080655|FG001|Overall Study|Withdrawal by Subject|3|||
24990961|NCT02025556|50080656|FG002|Overall Study|Withdrawal by Subject|6|||
24990962|NCT02025556|50080654|FG000|Overall Study|Lost to Follow-up|2|||
24990963|NCT02025556|50080655|FG001|Overall Study|Lost to Follow-up|4|||
24990964|NCT02025556|50080656|FG002|Overall Study|Lost to Follow-up|0|||
24990965|NCT02025556|50080654|FG000|Overall Study|Reason not reported|0|||
24990966|NCT02025556|50080655|FG001|Overall Study|Reason not reported|0|||
24990967|NCT02025556|50080656|FG002|Overall Study|Reason not reported|1|||
24990968|NCT04334460|50080666|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
24990969|NCT04334460|50080667|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
24990970|NCT04334460|50080666|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
24990971|NCT04334460|50080667|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
24990972|NCT04334148|50080676|FG000|Overall Study|positive nasal swab at baseline|0|||
24990973|NCT04334148|50080677|FG001|Overall Study|positive nasal swab at baseline|1|||
24990974|NCT04399122|50080685|FG000|Overall Study|Lost to Follow-up|2|||
24990975|NCT04399122|50080686|FG001|Overall Study|Lost to Follow-up|0|||
24990976|NCT04399122|50080685|FG000|Overall Study|Withdrawal by Subject|1|||
24990977|NCT04399122|50080686|FG001|Overall Study|Withdrawal by Subject|0|||
24990978|NCT04398732|50080707|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
24990979|NCT04398030|50080713|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
24990980|NCT04398030|50080714|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
24990981|NCT04398030|50080713|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
24990982|NCT04398030|50080714|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
24990983|NCT03064438|50080722|FG000|Overall Study|Lost to Follow-up|1|||
24990984|NCT03064438|50080723|FG001|Overall Study|Lost to Follow-up|0|||
24990985|NCT03064438|50080722|FG000|Overall Study|Withdrawal by Subject|0|||
24990986|NCT03064438|50080723|FG001|Overall Study|Withdrawal by Subject|1|||
24990987|NCT04327986|50080729|FG000|Overall Study|Physician Decision|2|||
24990988|NCT04327986|50080730|FG001|Overall Study|Physician Decision|0|||
24990989|NCT04327986|50080731|FG002|Overall Study|Physician Decision|0|||
24990990|NCT04327986|50080729|FG000|Overall Study|Death|1|||
24990991|NCT04327986|50080730|FG001|Overall Study|Death|0|||
24990992|NCT04327986|50080731|FG002|Overall Study|Death|0|||
24990993|NCT04322682|50080737|FG000|Overall Study|Withdrawal by Subject|33|||
24990994|NCT04322682|50080738|FG001|Overall Study|Withdrawal by Subject|47|||
24990995|NCT04322682|50080737|FG000|Overall Study|Death|5|||
24990996|NCT04322682|50080738|FG001|Overall Study|Death|9|||
24990997|NCT04322682|50080737|FG000|Overall Study|Lost to Follow-up|4|||
24990998|NCT04322682|50080738|FG001|Overall Study|Lost to Follow-up|8|||
24990999|NCT04322682|50080737|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
24991000|NCT04322682|50080738|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
24991001|NCT04322526|50080746|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
24991002|NCT04322526|50080747|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
24991003|NCT04322526|50080746|FG000|Washout (1 Week)|Lost to Follow-up|1|||
24991004|NCT04322526|50080747|FG001|Washout (1 Week)|Lost to Follow-up|2|||
24991005|NCT04115358|50080756|FG000|Overall Study|exfoliation|0|||
24991006|NCT04115358|50080757|FG001|Overall Study|exfoliation|0|||
24991007|NCT04115358|50080758|FG002|Overall Study|exfoliation|1|||
24991008|NCT04109118|50080767|FG000|Overall Study|Lost to Follow-up|3|||
24991009|NCT04105998|50080774|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
24991010|NCT04105998|50080775|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
24991011|NCT04397718|50080783|FG000|Overall Study|Death|7|||
24991012|NCT04397718|50080784|FG001|Overall Study|Death|11|||
24991013|NCT04397718|50080783|FG000|Overall Study|Lost to Follow-up|0|||
24991014|NCT04397718|50080784|FG001|Overall Study|Lost to Follow-up|4|||
24991015|NCT04105218|50080792|FG000|Overall Study|Withdrawal by Subject|3|||
24991016|NCT04105218|50080793|FG001|Overall Study|Withdrawal by Subject|2|||
24991017|NCT04105218|50080792|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
24991018|NCT04105218|50080793|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
24991019|NCT04105218|50080792|FG000|Overall Study|Failed screening tests|2|||
24991020|NCT04105218|50080793|FG001|Overall Study|Failed screening tests|1|||
24991021|NCT04317690|50080804|FG000|Overall Study|did not have complete information for primary outcome|0|||
24991022|NCT04317690|50080805|FG001|Overall Study|did not have complete information for primary outcome|4|||
24991023|NCT04317690|50080806|FG002|Overall Study|did not have complete information for primary outcome|0|||
24991024|NCT04317690|50080807|FG003|Overall Study|did not have complete information for primary outcome|2|||
24991025|NCT04317690|50080808|FG004|Overall Study|did not have complete information for primary outcome|0|||
24991026|NCT03721276|50080835|FG000|Overall Study|Lost to Follow-up|5|||
24991027|NCT03721276|50080836|FG001|Overall Study|Lost to Follow-up|3|||
24991028|NCT03721276|50080835|FG000|Overall Study|Adverse Event|0|||
24991029|NCT03721276|50080836|FG001|Overall Study|Adverse Event|1|||
24991030|NCT03269344|50080851|FG000|Overall Study|Protocol Violation|4|||
24991031|NCT03269344|50080852|FG001|Overall Study|Protocol Violation|3|||
24991032|NCT04389840|50080864|FG000|Overall Study|Adverse Event|0|||
24991033|NCT04389840|50080865|FG001|Overall Study|Adverse Event|0|||
24991034|NCT04389840|50080866|FG002|Overall Study|Adverse Event|0|||
24991035|NCT04389840|50080867|FG003|Overall Study|Adverse Event|1|||
24991036|NCT04389840|50080868|FG004|Overall Study|Adverse Event|0|||
24991037|NCT04389840|50080869|FG005|Overall Study|Adverse Event|0|||
24991038|NCT04389840|50080864|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
24991039|NCT04389840|50080865|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
24991040|NCT04389840|50080866|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
24991041|NCT04389840|50080867|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
24991042|NCT04389840|50080868|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
24991043|NCT04389840|50080869|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
24991044|NCT04389840|50080864|FG000|Overall Study|Death|0|||
24991045|NCT04389840|50080865|FG001|Overall Study|Death|1|||
24991046|NCT04389840|50080866|FG002|Overall Study|Death|0|||
24991047|NCT04389840|50080867|FG003|Overall Study|Death|0|||
24991048|NCT04389840|50080868|FG004|Overall Study|Death|0|||
24991049|NCT04389840|50080869|FG005|Overall Study|Death|0|||
24991050|NCT04307940|50080892|FG000|Overall Study|Adverse Event|1|||
24991051|NCT04307940|50080893|FG001|Overall Study|Adverse Event|0|||
24991052|NCT04307940|50080894|FG002|Overall Study|Adverse Event|0|||
24991053|NCT04307940|50080892|FG000|Overall Study|Withdrawal by Subject|2|||
24991054|NCT04307940|50080893|FG001|Overall Study|Withdrawal by Subject|3|||
24991055|NCT04307940|50080894|FG002|Overall Study|Withdrawal by Subject|1|||
24991056|NCT04307940|50080892|FG000|Overall Study|Lost to Follow-up|2|||
24991057|NCT04307940|50080893|FG001|Overall Study|Lost to Follow-up|0|||
24991058|NCT04307940|50080894|FG002|Overall Study|Lost to Follow-up|1|||
24991059|NCT02054104|50080904|FG000|Overall Study|Did not want to continue due to college classes|1|||
24991060|NCT02054104|50080905|FG001|Overall Study|Did not want to continue due to college classes|0|||
24991061|NCT02054104|50080904|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
24991062|NCT02054104|50080905|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
24991063|NCT02054104|50080904|FG000|Overall Study|No evidence of immunologic response|2|||
24991064|NCT02054104|50080905|FG001|Overall Study|No evidence of immunologic response|2|||
24991065|NCT02054104|50080904|FG000|Overall Study|Disease Progression On Study|4|||
24991066|NCT02054104|50080905|FG001|Overall Study|Disease Progression On Study|5|||
24991067|NCT02054104|50080904|FG000|Overall Study|Diagnosis of lymphoma|0|||
24991068|NCT02054104|50080905|FG001|Overall Study|Diagnosis of lymphoma|1|||
24991069|NCT02054104|50080904|FG000|Overall Study|Inconclusive response|0|||
24991070|NCT02054104|50080905|FG001|Overall Study|Inconclusive response|1|||
24991071|NCT04090242|50080913|FG000|Overall Study|Withdrawal by Subject|1|||
24991072|NCT04090242|50080914|FG001|Overall Study|Withdrawal by Subject|0|||
24991073|NCT04090164|50080923|FG000|Overall Study|incomplete data on file|245|||
24991074|NCT04090164|50080924|FG001|Overall Study|incomplete data on file|0|||
24991075|NCT04292730|50080953|FG000|Overall Study|Lost to Follow-up|8|||
24991076|NCT04292730|50080954|FG001|Overall Study|Lost to Follow-up|12|||
24991077|NCT04292730|50080955|FG002|Overall Study|Lost to Follow-up|12|||
24991078|NCT04292730|50080956|FG003|Overall Study|Lost to Follow-up|48|||
24991079|NCT04292730|50080953|FG000|Overall Study|Death|2|||
24991080|NCT04292730|50080954|FG001|Overall Study|Death|2|||
24991081|NCT04292730|50080955|FG002|Overall Study|Death|4|||
24991082|NCT04292730|50080956|FG003|Overall Study|Death|12|||
24991083|NCT04292730|50080953|FG000|Overall Study|Withdrew Consent|2|||
24991084|NCT04292730|50080954|FG001|Overall Study|Withdrew Consent|2|||
24991085|NCT04292730|50080955|FG002|Overall Study|Withdrew Consent|5|||
25079451|NCT01865617|50187897|FG011|Overall Study|Other|0|||
25079452|NCT01865617|50187898|FG012|Overall Study|Other|0|||
24991086|NCT04292730|50080956|FG003|Overall Study|Withdrew Consent|6|||
24991087|NCT04292730|50080953|FG000|Overall Study|Non-Compliance with Study Drug|0|||
24991088|NCT04292730|50080954|FG001|Overall Study|Non-Compliance with Study Drug|1|||
24991089|NCT04292730|50080955|FG002|Overall Study|Non-Compliance with Study Drug|0|||
24991090|NCT04292730|50080956|FG003|Overall Study|Non-Compliance with Study Drug|0|||
24991091|NCT04292730|50080953|FG000|Overall Study|Protocol Violation|0|||
24991092|NCT04292730|50080954|FG001|Overall Study|Protocol Violation|0|||
24991093|NCT04292730|50080955|FG002|Overall Study|Protocol Violation|1|||
24991094|NCT04292730|50080956|FG003|Overall Study|Protocol Violation|0|||
24991095|NCT04292730|50080953|FG000|Overall Study|Randomized but not Treated|8|||
24991096|NCT04292730|50080954|FG001|Overall Study|Randomized but not Treated|4|||
24991097|NCT04292730|50080955|FG002|Overall Study|Randomized but not Treated|0|||
24991098|NCT04292730|50080956|FG003|Overall Study|Randomized but not Treated|14|||
24991099|NCT02861014|50080965|FG000|Primary Analysis|Adverse Event|7|||
24991100|NCT02861014|50080965|FG000|Primary Analysis|Death|1|||
24991101|NCT02861014|50080965|FG000|Primary Analysis|Lack of Efficacy|3|||
24991102|NCT02861014|50080965|FG000|Primary Analysis|Physician Decision|2|||
24991103|NCT02861014|50080965|FG000|Primary Analysis|Pregnancy|4|||
24991104|NCT02861014|50080965|FG000|Primary Analysis|Protocol Violation|2|||
24991105|NCT02861014|50080965|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
24991106|NCT02861014|50080965|FG000|Primary Analysis|Withdrawal by Subject|14|||
24991107|NCT02861014|50080965|FG000|Primary Analysis|Commercial ocrelizumab|3|||
24991108|NCT02861014|50080965|FG000|Safety Follow-up|Adverse Event|1|||
24991109|NCT02861014|50080965|FG000|Safety Follow-up|Pregnancy|1|||
24991110|NCT02861014|50080965|FG000|Safety Follow-up|Withdrawal by Subject|9|||
24991111|NCT02861014|50080965|FG000|Safety Follow-up|Study terminated by sponsor|1|||
24991112|NCT02861014|50080965|FG000|Safety Follow-up|Physician Decision|1|||
24991113|NCT02861014|50080965|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
24991114|NCT02861014|50080965|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
24991115|NCT04382586|50080973|FG000|Overall Study|Death|3|||
24991116|NCT04382586|50080974|FG001|Overall Study|Death|4|||
24991117|NCT04382586|50080973|FG000|Overall Study|Lost to Follow-up|11|||
24991118|NCT04382586|50080974|FG001|Overall Study|Lost to Follow-up|8|||
24991119|NCT04382586|50080973|FG000|Overall Study|Withdrawal by Subject|3|||
24991120|NCT04382586|50080974|FG001|Overall Study|Withdrawal by Subject|1|||
24991121|NCT04382586|50080973|FG000|Overall Study|Physician Decision|0|||
24991122|NCT04382586|50080974|FG001|Overall Study|Physician Decision|3|||
24991123|NCT04275336|50080983|FG000|Overall Study|First venipuncture failed|4|||
24991124|NCT04275336|50080984|FG001|Overall Study|First venipuncture failed|6|||
24991125|NCT04275336|50080985|FG002|Overall Study|First venipuncture failed|5|||
24991126|NCT04275336|50080983|FG000|Overall Study|Unscheduled venipuncture|9|||
24991127|NCT04275336|50080984|FG001|Overall Study|Unscheduled venipuncture|13|||
24991128|NCT04275336|50080985|FG002|Overall Study|Unscheduled venipuncture|7|||
24991129|NCT04275336|50080983|FG000|Overall Study|Failed specimen of saliva|4|||
24991130|NCT04275336|50080984|FG001|Overall Study|Failed specimen of saliva|3|||
24991131|NCT04275336|50080985|FG002|Overall Study|Failed specimen of saliva|4|||
24991132|NCT04480710|50081000|FG000|Overall Study|Adverse Event|0|||
24991133|NCT04480710|50081001|FG001|Overall Study|Adverse Event|2|||
24991134|NCT04480710|50081002|FG002|Overall Study|Adverse Event|0|||
24991135|NCT04480710|50081003|FG003|Overall Study|Adverse Event|0|||
24991136|NCT04480710|50081000|FG000|Overall Study|Withdrawal by Subject|0|||
24991137|NCT04480710|50081001|FG001|Overall Study|Withdrawal by Subject|1|||
24991138|NCT04480710|50081002|FG002|Overall Study|Withdrawal by Subject|0|||
24991139|NCT04480710|50081003|FG003|Overall Study|Withdrawal by Subject|0|||
24991140|NCT04480710|50081000|FG000|Overall Study|Physician Decision|0|||
24991141|NCT04480710|50081001|FG001|Overall Study|Physician Decision|0|||
24991142|NCT04480710|50081002|FG002|Overall Study|Physician Decision|1|||
24991143|NCT04480710|50081003|FG003|Overall Study|Physician Decision|0|||
24991144|NCT04268316|50081022|FG000|Overall Study|Withdrawal by Subject|2|||
24991145|NCT04268316|50081023|FG001|Overall Study|Withdrawal by Subject|1|||
24991146|NCT04268316|50081024|FG002|Overall Study|Withdrawal by Subject|0|||
24991147|NCT01971970|50081034|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
24991148|NCT01971970|50081035|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
24991149|NCT01971970|50081034|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
24991150|NCT01971970|50081035|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
25079453|NCT02458313|50187931|FG000|Overall Study|Withdrawal by Subject|6|||
25079454|NCT02458313|50187932|FG001|Overall Study|Withdrawal by Subject|8|||
25257211|NCT01102231|50572269|FG000|Overall Study|Withdrawal by Subject|1|||
24991151|NCT01971970|50081034|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
24991152|NCT01971970|50081035|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
24991153|NCT01971970|50081034|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
24991154|NCT01971970|50081035|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
24991155|NCT01971970|50081034|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
24991156|NCT01971970|50081035|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
25079455|NCT02458313|50187931|FG000|Overall Study|Excluded for motion during MRI|1|||
24991157|NCT01971970|50081034|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
24991158|NCT01971970|50081035|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
24991159|NCT01971970|50081034|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
24991160|NCT01971970|50081035|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
24991161|NCT04079790|50081050|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
24991162|NCT04079790|50081051|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
24991163|NCT04079790|50081052|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
24991164|NCT04079790|50081053|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
24991165|NCT04079790|50081050|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
24991166|NCT04079790|50081051|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
24991167|NCT04079790|50081052|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
24991168|NCT04079790|50081053|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
24991169|NCT04079790|50081050|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
24991170|NCT04079790|50081051|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
24991171|NCT04079790|50081052|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
24991172|NCT04079790|50081053|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
24991173|NCT04259346|50081081|FG000|Overall Study|Lost to Follow-up|1|||
24991174|NCT04259346|50081082|FG001|Overall Study|Lost to Follow-up|3|||
24991175|NCT04259346|50081081|FG000|Overall Study|Protocol Violation|1|||
24991176|NCT04259346|50081082|FG001|Overall Study|Protocol Violation|0|||
24991177|NCT04259346|50081081|FG000|Overall Study|Withdrawal by Subject|1|||
24991178|NCT04259346|50081082|FG001|Overall Study|Withdrawal by Subject|0|||
24991179|NCT04259346|50081081|FG000|Overall Study|Adverse Event|1|||
24991180|NCT04259346|50081082|FG001|Overall Study|Adverse Event|1|||
24991181|NCT04230876|50081090|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
24991182|NCT04230876|50081091|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
24991183|NCT04228302|50081103|FG000|Overall Study|Adverse Event|0|||
24991184|NCT04228302|50081104|FG001|Overall Study|Adverse Event|0|||
24991185|NCT04228302|50081105|FG002|Overall Study|Adverse Event|0|||
24991186|NCT04228302|50081106|FG003|Overall Study|Adverse Event|0|||
24991187|NCT04228302|50081107|FG004|Overall Study|Adverse Event|1|||
24991188|NCT04228302|50081108|FG005|Overall Study|Adverse Event|0|||
24991189|NCT01348100|50081129|FG000|Overall Study|Subject Withdrew Consent|0|||
24991190|NCT01348100|50081130|FG001|Overall Study|Subject Withdrew Consent|0|||
24991191|NCT01348100|50081131|FG002|Overall Study|Subject Withdrew Consent|2|||
24991192|NCT01348100|50081132|FG003|Overall Study|Subject Withdrew Consent|0|||
24991193|NCT01348100|50081133|FG004|Overall Study|Subject Withdrew Consent|1|||
24991194|NCT01348100|50081134|FG005|Overall Study|Subject Withdrew Consent|0|||
24991195|NCT01348100|50081135|FG006|Overall Study|Subject Withdrew Consent|1|||
24991196|NCT01348100|50081129|FG000|Overall Study|Protocol Deviation|0|||
24991197|NCT01348100|50081130|FG001|Overall Study|Protocol Deviation|0|||
24991198|NCT01348100|50081131|FG002|Overall Study|Protocol Deviation|0|||
24991199|NCT01348100|50081132|FG003|Overall Study|Protocol Deviation|1|||
24991200|NCT01348100|50081133|FG004|Overall Study|Protocol Deviation|0|||
24991201|NCT01348100|50081134|FG005|Overall Study|Protocol Deviation|0|||
24991202|NCT01348100|50081135|FG006|Overall Study|Protocol Deviation|0|||
24991203|NCT01348100|50081129|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
24991204|NCT01348100|50081130|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
24991205|NCT01348100|50081131|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
24991206|NCT01348100|50081132|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
24991207|NCT01348100|50081133|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
24991208|NCT01348100|50081134|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
24991209|NCT01348100|50081135|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
24991210|NCT01348100|50081129|FG000|Overall Study|Lost to Follow-up|0|||
24991211|NCT01348100|50081130|FG001|Overall Study|Lost to Follow-up|0|||
24991212|NCT01348100|50081131|FG002|Overall Study|Lost to Follow-up|0|||
24991213|NCT01348100|50081132|FG003|Overall Study|Lost to Follow-up|0|||
24991214|NCT01348100|50081133|FG004|Overall Study|Lost to Follow-up|0|||
24991215|NCT01348100|50081134|FG005|Overall Study|Lost to Follow-up|0|||
24991216|NCT01348100|50081135|FG006|Overall Study|Lost to Follow-up|1|||
24991217|NCT01348100|50081129|FG000|Overall Study|Administrative Problems|0|||
24991218|NCT01348100|50081130|FG001|Overall Study|Administrative Problems|0|||
24991219|NCT01348100|50081131|FG002|Overall Study|Administrative Problems|0|||
24991220|NCT01348100|50081132|FG003|Overall Study|Administrative Problems|0|||
24991221|NCT01348100|50081133|FG004|Overall Study|Administrative Problems|0|||
24991222|NCT01348100|50081134|FG005|Overall Study|Administrative Problems|1|||
24991223|NCT01348100|50081135|FG006|Overall Study|Administrative Problems|1|||
24991224|NCT03676634|50081156|FG000|Overall Study|Red blood cell loss|1|||
24991225|NCT03676634|50081156|FG000|Overall Study|Out-of-limit pulse|2|||
24991226|NCT03675776|50081163|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
24991227|NCT03675776|50081164|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
24991228|NCT03675776|50081165|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
24991229|NCT03675776|50081163|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
24991230|NCT03675776|50081164|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
24991231|NCT03675776|50081165|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
24991232|NCT03673670|50081179|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
24991233|NCT03673670|50081180|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
24991234|NCT03673670|50081181|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
24991235|NCT03673670|50081182|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
24991236|NCT03673670|50081183|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
24991237|NCT03673670|50081184|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
24991238|NCT03673670|50081179|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
24991239|NCT03673670|50081180|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
24991240|NCT03673670|50081181|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
24991241|NCT03673670|50081182|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
24991242|NCT03673670|50081183|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
24991243|NCT03673670|50081184|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
24991244|NCT03673670|50081179|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
24991245|NCT03673670|50081180|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
24991246|NCT03673670|50081181|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
24991247|NCT03673670|50081182|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
24991248|NCT03673670|50081183|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
24991249|NCT03673670|50081184|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
24991250|NCT03673670|50081179|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
24991251|NCT03673670|50081180|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
24991252|NCT03673670|50081181|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
24991253|NCT03673670|50081182|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
24991254|NCT03673670|50081183|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
24991255|NCT03673670|50081184|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
24991256|NCT03673670|50081179|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
24991257|NCT03673670|50081180|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
24991258|NCT03673670|50081181|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
24991259|NCT03673670|50081182|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
24991260|NCT03673670|50081183|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
24991261|NCT03673670|50081184|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
24991262|NCT03673670|50081179|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
24991263|NCT03673670|50081180|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
24991264|NCT03673670|50081181|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
24991265|NCT03673670|50081182|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
24991266|NCT03673670|50081183|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
24991267|NCT03673670|50081184|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
24991268|NCT03673670|50081179|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
24991269|NCT03673670|50081180|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
24991270|NCT03673670|50081181|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
24991271|NCT03673670|50081182|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
24991272|NCT03673670|50081183|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
24991273|NCT03673670|50081184|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
25079456|NCT02458313|50187932|FG001|Overall Study|Excluded for motion during MRI|2|||
25079457|NCT01328431|50187949|FG000|Baseline|Protocol Violation|0|||
25079458|NCT01328431|50187950|FG001|Baseline|Protocol Violation|2|||
25079459|NCT01328431|50187949|FG000|1 Month (1M)|Lost to Follow-up|55|||
25079460|NCT01328431|50187950|FG001|1 Month (1M)|Lost to Follow-up|58|||
25079461|NCT01328431|50187949|FG000|3 Month (3M)|Death|2|||
25079462|NCT01328431|50187950|FG001|3 Month (3M)|Death|2|||
25079463|NCT01328431|50187949|FG000|3 Month (3M)|Lost to Follow-up|75|||
25079464|NCT01328431|50187950|FG001|3 Month (3M)|Lost to Follow-up|70|||
25079465|NCT01328431|50187949|FG000|12 Month (12M)|Death|2|||
25079466|NCT01328431|50187950|FG001|12 Month (12M)|Death|6|||
25079467|NCT01328431|50187949|FG000|12 Month (12M)|Lost to Follow-up|82|||
25079468|NCT01328431|50187950|FG001|12 Month (12M)|Lost to Follow-up|91|||
25079469|NCT00893789|50187960|FG000|Overall Study|Withdrawal by Subject|3|||
25079470|NCT00893789|50187961|FG001|Overall Study|Withdrawal by Subject|1|||
25079471|NCT00893789|50187962|FG002|Overall Study|Withdrawal by Subject|3|||
25079472|NCT00893789|50187963|FG003|Overall Study|Withdrawal by Subject|1|||
25079473|NCT00893789|50187960|FG000|Overall Study|Noncompliance With Study Drug|1|||
25079474|NCT00893789|50187961|FG001|Overall Study|Noncompliance With Study Drug|0|||
25079475|NCT00893789|50187962|FG002|Overall Study|Noncompliance With Study Drug|1|||
25079476|NCT00893789|50187963|FG003|Overall Study|Noncompliance With Study Drug|2|||
25079477|NCT00893789|50187960|FG000|Overall Study|Noncompliance With Study Procedures|1|||
25079478|NCT00893789|50187961|FG001|Overall Study|Noncompliance With Study Procedures|0|||
25079479|NCT00893789|50187962|FG002|Overall Study|Noncompliance With Study Procedures|0|||
25079480|NCT00893789|50187963|FG003|Overall Study|Noncompliance With Study Procedures|0|||
25079481|NCT00893789|50187960|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
25079482|NCT00893789|50187961|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
24991274|NCT04369742|50081203|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
24991275|NCT04369742|50081204|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
24991276|NCT04369742|50081203|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
24991277|NCT04369742|50081204|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
24991278|NCT04369430|50081212|FG000|Overall Study|Adverse Event|2|||
24991279|NCT04369430|50081213|FG001|Overall Study|Adverse Event|3|||
24991280|NCT04369430|50081212|FG000|Overall Study|Death|1|||
24991281|NCT04369430|50081213|FG001|Overall Study|Death|0|||
24991282|NCT04369430|50081212|FG000|Overall Study|Withdrawal by Subject|4|||
24991283|NCT04369430|50081213|FG001|Overall Study|Withdrawal by Subject|3|||
24991284|NCT04369430|50081212|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
24991285|NCT04369430|50081213|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
24991286|NCT04369430|50081212|FG000|Overall Study|Lost to Follow-up|0|||
24991287|NCT04369430|50081213|FG001|Overall Study|Lost to Follow-up|1|||
24991288|NCT04363736|50081221|FG000|Overall Study|Withdrawal by Subject|1|||
24991289|NCT04363736|50081222|FG001|Overall Study|Withdrawal by Subject|0|||
24991290|NCT04363736|50081221|FG000|Overall Study|Lost to Follow-up|10|||
24991291|NCT04363736|50081222|FG001|Overall Study|Lost to Follow-up|7|||
24991292|NCT04363736|50081221|FG000|Overall Study|Death|8|||
24991293|NCT04363736|50081222|FG001|Overall Study|Death|6|||
24991294|NCT04362176|50081230|FG000|Overall Study|Lost to Follow-up|5|||
24991295|NCT04362176|50081231|FG001|Overall Study|Lost to Follow-up|8|||
24991296|NCT04362176|50081230|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
24991297|NCT04362176|50081231|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
24991298|NCT04080752|50081239|FG000|Overall Study|Adverse Event|2|||
24991299|NCT04080752|50081240|FG001|Overall Study|Adverse Event|3|||
24991300|NCT04080752|50081239|FG000|Overall Study|Lack of Efficacy|1|||
24991301|NCT04080752|50081240|FG001|Overall Study|Lack of Efficacy|0|||
24991302|NCT04080752|50081239|FG000|Overall Study|Lost to Follow-up|1|||
24991303|NCT04080752|50081240|FG001|Overall Study|Lost to Follow-up|0|||
24991304|NCT04080752|50081239|FG000|Overall Study|Pregnancy|0|||
24991305|NCT04080752|50081240|FG001|Overall Study|Pregnancy|1|||
24991306|NCT04080752|50081239|FG000|Overall Study|Withdrawal by Subject|7|||
24991307|NCT04080752|50081240|FG001|Overall Study|Withdrawal by Subject|0|||
24991308|NCT04080752|50081239|FG000|Overall Study|Non-Compliance with Study Drug|0|||
24991309|NCT04080752|50081240|FG001|Overall Study|Non-Compliance with Study Drug|1|||
24991310|NCT04080752|50081239|FG000|Overall Study|Other|2|||
24991311|NCT04080752|50081240|FG001|Overall Study|Other|1|||
24991312|NCT04079816|50081247|FG000|Overall Study|Request of Subject|2|||
24991313|NCT04079816|50081247|FG000|Overall Study|Unable to draw samples|1|||
24991314|NCT04079114|50081251|FG000|Overall Study|Study prematuely terminated.|166|||
24991315|NCT03055936|50081259|FG000|Overall Study|Adverse Event|0|||
24991316|NCT03055936|50081260|FG001|Overall Study|Adverse Event|1|||
24991317|NCT03055936|50081261|FG002|Overall Study|Adverse Event|1|||
24991318|NCT03055936|50081262|FG003|Overall Study|Adverse Event|1|||
24991319|NCT03055936|50081259|FG000|Overall Study|Personal reason|2|||
24991320|NCT03055936|50081260|FG001|Overall Study|Personal reason|0|||
24991321|NCT03055936|50081261|FG002|Overall Study|Personal reason|1|||
24991322|NCT03055936|50081262|FG003|Overall Study|Personal reason|0|||
24991323|NCT03891524|50081304|FG000|Overall Study|Death|0|||
24991324|NCT03891524|50081305|FG001|Overall Study|Death|0|||
24991325|NCT03891524|50081306|FG002|Overall Study|Death|0|||
24991326|NCT03891524|50081307|FG003|Overall Study|Death|0|||
24991327|NCT03891524|50081308|FG004|Overall Study|Death|0|||
24991328|NCT03891524|50081309|FG005|Overall Study|Death|0|||
24991329|NCT03891524|50081310|FG006|Overall Study|Death|0|||
24991330|NCT03891524|50081311|FG007|Overall Study|Death|1|||
24991331|NCT03891524|50081304|FG000|Overall Study|Withdrawal by Subject|0|||
24991332|NCT03891524|50081305|FG001|Overall Study|Withdrawal by Subject|1|||
24991333|NCT03891524|50081306|FG002|Overall Study|Withdrawal by Subject|2|||
24991334|NCT03891524|50081307|FG003|Overall Study|Withdrawal by Subject|1|||
24991335|NCT03891524|50081308|FG004|Overall Study|Withdrawal by Subject|2|||
24991336|NCT03891524|50081309|FG005|Overall Study|Withdrawal by Subject|2|||
24991337|NCT03891524|50081310|FG006|Overall Study|Withdrawal by Subject|2|||
24991338|NCT03891524|50081311|FG007|Overall Study|Withdrawal by Subject|1|||
24991339|NCT03055624|50081346|FG000|Overall Study|Study closed|9|||
24991340|NCT01346176|50081353|FG000|Recruited|Protocol Violation|1|||
24991341|NCT01346176|50081354|FG001|Recruited|Protocol Violation|0|||
24991342|NCT01346176|50081355|FG002|Recruited|Protocol Violation|0|||
24991343|NCT01346176|50081353|FG000|Completed Advance Directive|Death|3|||
24991344|NCT01346176|50081354|FG001|Completed Advance Directive|Death|2|||
24991345|NCT01346176|50081355|FG002|Completed Advance Directive|Death|2|||
24991346|NCT01346176|50081353|FG000|Completed Advance Directive|Became Ineligible|3|||
24991347|NCT01346176|50081354|FG001|Completed Advance Directive|Became Ineligible|0|||
24991348|NCT01346176|50081355|FG002|Completed Advance Directive|Became Ineligible|1|||
24991349|NCT01346176|50081353|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
24991350|NCT01346176|50081354|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
24991351|NCT01346176|50081355|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
24991352|NCT01346176|50081353|FG000|Completed Satisfaction Survey|Death|3|||
24991353|NCT01346176|50081354|FG001|Completed Satisfaction Survey|Death|0|||
24991354|NCT01346176|50081355|FG002|Completed Satisfaction Survey|Death|2|||
24991355|NCT01346176|50081353|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
24991356|NCT01346176|50081354|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
24991357|NCT01346176|50081355|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
24991358|NCT04075604|50081366|FG000|Overall Study|Adverse Event|0|||
24991359|NCT04075604|50081367|FG001|Overall Study|Adverse Event|0|||
24991360|NCT04075604|50081368|FG002|Overall Study|Adverse Event|3|||
24991361|NCT04075604|50081366|FG000|Overall Study|Participant request to discontinue study treatment|0|||
24991362|NCT04075604|50081367|FG001|Overall Study|Participant request to discontinue study treatment|0|||
24991363|NCT04075604|50081368|FG002|Overall Study|Participant request to discontinue study treatment|1|||
24991364|NCT04075604|50081366|FG000|Overall Study|Participant withdrew consent|0|||
24991365|NCT04075604|50081367|FG001|Overall Study|Participant withdrew consent|0|||
24991366|NCT04075604|50081368|FG002|Overall Study|Participant withdrew consent|1|||
24991367|NCT04075604|50081366|FG000|Overall Study|Other reasons|1|||
24991368|NCT04075604|50081367|FG001|Overall Study|Other reasons|0|||
24991369|NCT04075604|50081368|FG002|Overall Study|Other reasons|0|||
24991370|NCT04075604|50081366|FG000|Overall Study|Disease progression|0|||
24991371|NCT04075604|50081367|FG001|Overall Study|Disease progression|1|||
24991372|NCT04075604|50081368|FG002|Overall Study|Disease progression|0|||
24991373|NCT04075604|50081366|FG000|Overall Study|Study drug toxicity|0|||
24991374|NCT04075604|50081367|FG001|Overall Study|Study drug toxicity|5|||
24991375|NCT04075604|50081368|FG002|Overall Study|Study drug toxicity|1|||
24991376|NCT03796208|50081387|FG000|Overall Study|Withdrawal by Subject|3|||
24991377|NCT03796208|50081388|FG001|Overall Study|Withdrawal by Subject|0|||
24991378|NCT03796208|50081387|FG000|Overall Study|Loss of pregnancy|1|||
24991379|NCT03796208|50081388|FG001|Overall Study|Loss of pregnancy|1|||
24991380|NCT03796208|50081387|FG000|Overall Study|Changed prenatal clinics|0|||
24991381|NCT03796208|50081388|FG001|Overall Study|Changed prenatal clinics|5|||
24991382|NCT03796208|50081387|FG000|Overall Study|Lost to Follow-up|20|||
24991383|NCT03796208|50081388|FG001|Overall Study|Lost to Follow-up|16|||
24991384|NCT01318876|50081394|FG000|Day 8 Survey|email address invalid|96|||
24991385|NCT01318876|50081394|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
24991386|NCT01318876|50081394|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
24991387|NCT03668600|50081398|FG000|Overall Study|Study Terminated by the Sponsor|157|||
24991388|NCT03668600|50081398|FG000|Overall Study|Protocol Violation|1|||
24991389|NCT03668600|50081398|FG000|Overall Study|Pregnancy|1|||
24991390|NCT03668600|50081398|FG000|Overall Study|Lost to Follow-up|7|||
24991391|NCT03668600|50081398|FG000|Overall Study|Withdrawal by Subject|56|||
24991392|NCT03668600|50081398|FG000|Overall Study|Lack of Efficacy|7|||
24991393|NCT03668600|50081398|FG000|Overall Study|Adverse Event|1|||
24991394|NCT04073186|50081402|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
24991395|NCT04073186|50081402|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
24991396|NCT04073186|50081402|FG000|First Wearing Cycle|Protocol Violation|1|||
24991397|NCT04073186|50081402|FG000|First Wearing Cycle|Lens Discomfort|2|||
24991398|NCT04073186|50081402|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
24991399|NCT04073186|50081402|FG000|Second Wearing Cycle|Adverse Event|1|||
24991400|NCT03054064|50081407|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
24991401|NCT03054064|50081407|FG000|Overall Study|Investigator Decision|2|||
24991402|NCT03054064|50081407|FG000|Overall Study|Bladder Issue|1|||
24991403|NCT03054064|50081407|FG000|Overall Study|High Blood Pressure|1|||
24991404|NCT03054064|50081407|FG000|Overall Study|Change in Status|1|||
24991405|NCT03053518|50081411|FG000|Overall Study|Withdrawal by Subject|3|||
24991406|NCT03053518|50081411|FG000|Overall Study|Lost to Follow-up|2|||
24991407|NCT03053518|50081411|FG000|Overall Study|Ineligible|5|||
24991408|NCT04015336|50081415|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
24991409|NCT04071158|50081438|FG000|Overall Study|Lost to Follow-up|1|||
24991410|NCT04071158|50081439|FG001|Overall Study|Lost to Follow-up|2|||
24991411|NCT04071158|50081440|FG002|Overall Study|Lost to Follow-up|3|||
24991412|NCT04071158|50081441|FG003|Overall Study|Lost to Follow-up|3|||
24991413|NCT04071158|50081442|FG004|Overall Study|Lost to Follow-up|5|||
24991414|NCT04071158|50081438|FG000|Overall Study|Randomized but not treated|2|||
24991415|NCT04071158|50081439|FG001|Overall Study|Randomized but not treated|2|||
24991416|NCT04071158|50081440|FG002|Overall Study|Randomized but not treated|0|||
24991417|NCT04071158|50081441|FG003|Overall Study|Randomized but not treated|0|||
24991418|NCT04071158|50081442|FG004|Overall Study|Randomized but not treated|0|||
24991419|NCT01317940|50081466|FG000|Overall Study|Death|1|||
24991420|NCT01317940|50081467|FG001|Overall Study|Death|0|||
24991421|NCT01317940|50081468|FG002|Overall Study|Death|1|||
24991422|NCT01317940|50081469|FG003|Overall Study|Death|0|||
24991423|NCT01317940|50081470|FG004|Overall Study|Death|0|||
24991424|NCT01317940|50081471|FG005|Overall Study|Death|0|||
24991425|NCT01317940|50081466|FG000|Overall Study|Lost to Follow-up|0|||
24991426|NCT01317940|50081467|FG001|Overall Study|Lost to Follow-up|0|||
24991427|NCT01317940|50081468|FG002|Overall Study|Lost to Follow-up|1|||
24991428|NCT01317940|50081469|FG003|Overall Study|Lost to Follow-up|1|||
24991429|NCT01317940|50081470|FG004|Overall Study|Lost to Follow-up|1|||
24991430|NCT01317940|50081471|FG005|Overall Study|Lost to Follow-up|0|||
24991431|NCT01317940|50081466|FG000|Overall Study|Change in therapy plan|0|||
24991432|NCT01317940|50081467|FG001|Overall Study|Change in therapy plan|0|||
24991433|NCT01317940|50081468|FG002|Overall Study|Change in therapy plan|3|||
24991434|NCT01317940|50081469|FG003|Overall Study|Change in therapy plan|0|||
24991435|NCT01317940|50081470|FG004|Overall Study|Change in therapy plan|0|||
24991436|NCT01317940|50081471|FG005|Overall Study|Change in therapy plan|0|||
24991437|NCT01345786|50081490|FG000|Overall Study|Adverse Event|0|||
24991438|NCT01345786|50081491|FG001|Overall Study|Adverse Event|1|||
24991439|NCT01345786|50081492|FG002|Overall Study|Adverse Event|3|||
24991440|NCT01345786|50081493|FG003|Overall Study|Adverse Event|1|||
24991441|NCT01345786|50081490|FG000|Overall Study|Subject withdrew consent|2|||
24991442|NCT01345786|50081491|FG001|Overall Study|Subject withdrew consent|2|||
24991443|NCT01345786|50081492|FG002|Overall Study|Subject withdrew consent|1|||
24991444|NCT01345786|50081493|FG003|Overall Study|Subject withdrew consent|0|||
24991445|NCT01345786|50081490|FG000|Overall Study|Noncompliance with protocol|1|||
24991446|NCT01345786|50081491|FG001|Overall Study|Noncompliance with protocol|0|||
24991447|NCT01345786|50081492|FG002|Overall Study|Noncompliance with protocol|1|||
24991448|NCT01345786|50081493|FG003|Overall Study|Noncompliance with protocol|0|||
24991449|NCT01345786|50081490|FG000|Overall Study|Administrative|3|||
24991450|NCT01345786|50081491|FG001|Overall Study|Administrative|5|||
24991451|NCT01345786|50081492|FG002|Overall Study|Administrative|0|||
24991452|NCT01345786|50081493|FG003|Overall Study|Administrative|0|||
24991453|NCT01345786|50081490|FG000|Overall Study|Lost to Follow-up|0|||
24991454|NCT01345786|50081491|FG001|Overall Study|Lost to Follow-up|0|||
24991455|NCT01345786|50081492|FG002|Overall Study|Lost to Follow-up|0|||
24991456|NCT01345786|50081493|FG003|Overall Study|Lost to Follow-up|2|||
24991457|NCT01317550|50081507|FG000|Overall Study|Withdrawal by Subject|1|||
24991458|NCT01317550|50081508|FG001|Overall Study|Withdrawal by Subject|0|||
24991459|NCT01317550|50081509|FG002|Overall Study|Withdrawal by Subject|0|||
24991460|NCT01317550|50081510|FG003|Overall Study|Withdrawal by Subject|0|||
24991461|NCT01317550|50081507|FG000|Overall Study|Lack of compliance study med|1|||
24991462|NCT01317550|50081508|FG001|Overall Study|Lack of compliance study med|0|||
24991463|NCT01317550|50081509|FG002|Overall Study|Lack of compliance study med|0|||
24991464|NCT01317550|50081510|FG003|Overall Study|Lack of compliance study med|0|||
24991465|NCT01317472|50081522|FG000|Overall Study|Withdrawal by Subject|1|||
24991466|NCT01317472|50081523|FG001|Overall Study|Withdrawal by Subject|0|||
24991467|NCT01317472|50081522|FG000|Overall Study|Unrelated hospitalization|1|||
24991468|NCT01317472|50081523|FG001|Overall Study|Unrelated hospitalization|0|||
24991469|NCT01345630|50081531|FG000|Overall Study|Adverse Event|22|||
24991470|NCT01345630|50081532|FG001|Overall Study|Adverse Event|23|||
24991471|NCT01345630|50081531|FG000|Overall Study|Lost to Follow-up|17|||
24991472|NCT01345630|50081532|FG001|Overall Study|Lost to Follow-up|16|||
24991473|NCT01345630|50081531|FG000|Overall Study|Protocol Violation|4|||
24991474|NCT01345630|50081532|FG001|Overall Study|Protocol Violation|1|||
24991475|NCT01345630|50081531|FG000|Overall Study|Medication error without associated AE|0|||
24991476|NCT01345630|50081532|FG001|Overall Study|Medication error without associated AE|1|||
24991477|NCT01345630|50081531|FG000|Overall Study|Study terminated by sponsor|254|||
24991478|NCT01345630|50081532|FG001|Overall Study|Study terminated by sponsor|285|||
24991479|NCT01345630|50081531|FG000|Overall Study|Other reasons|6|||
24991480|NCT01345630|50081532|FG001|Overall Study|Other reasons|8|||
24991481|NCT01345630|50081531|FG000|Overall Study|Withdrawn due to pregnancy|1|||
24991482|NCT01345630|50081532|FG001|Overall Study|Withdrawn due to pregnancy|2|||
24991483|NCT01345630|50081531|FG000|Overall Study|No longer willing to participate|9|||
24991484|NCT01345630|50081532|FG001|Overall Study|No longer willing to participate|12|||
24991485|NCT01345630|50081531|FG000|Overall Study|Insufficient clinical response|48|||
24991486|NCT01345630|50081532|FG001|Overall Study|Insufficient clinical response|11|||
24991487|NCT03693612|50081549|FG000|Overall Study|Lost to Follow-up|0|||
24991488|NCT03693612|50081550|FG001|Overall Study|Lost to Follow-up|0|||
24991489|NCT03693612|50081551|FG002|Overall Study|Lost to Follow-up|0|||
24991490|NCT03693612|50081552|FG003|Overall Study|Lost to Follow-up|0|||
24991491|NCT03693612|50081553|FG004|Overall Study|Lost to Follow-up|1|||
24991492|NCT03693612|50081554|FG005|Overall Study|Lost to Follow-up|0|||
24991493|NCT03693612|50081555|FG006|Overall Study|Lost to Follow-up|0|||
24991494|NCT03693612|50081549|FG000|Overall Study|Withdrawal by Subject|0|||
24991495|NCT03693612|50081550|FG001|Overall Study|Withdrawal by Subject|0|||
24991496|NCT03693612|50081551|FG002|Overall Study|Withdrawal by Subject|1|||
24991497|NCT03693612|50081552|FG003|Overall Study|Withdrawal by Subject|0|||
24991498|NCT03693612|50081553|FG004|Overall Study|Withdrawal by Subject|2|||
24991499|NCT03693612|50081554|FG005|Overall Study|Withdrawal by Subject|0|||
24991500|NCT03693612|50081555|FG006|Overall Study|Withdrawal by Subject|0|||
24991501|NCT03693612|50081549|FG000|Overall Study|Study Terminated by Sponsor|0|||
24991502|NCT03693612|50081550|FG001|Overall Study|Study Terminated by Sponsor|1|||
24991503|NCT03693612|50081551|FG002|Overall Study|Study Terminated by Sponsor|0|||
24991504|NCT03693612|50081552|FG003|Overall Study|Study Terminated by Sponsor|0|||
24991505|NCT03693612|50081553|FG004|Overall Study|Study Terminated by Sponsor|3|||
24991506|NCT03693612|50081554|FG005|Overall Study|Study Terminated by Sponsor|0|||
24991507|NCT03693612|50081555|FG006|Overall Study|Study Terminated by Sponsor|0|||
24991508|NCT03692910|50081571|FG000|Overall Study|Lost to Follow-up|4|||
24991509|NCT03692910|50081572|FG001|Overall Study|Lost to Follow-up|0|||
24991510|NCT03692910|50081573|FG002|Overall Study|Lost to Follow-up|0|||
24991511|NCT03692910|50081571|FG000|Overall Study|Withdrawal by Subject|2|||
24991512|NCT03692910|50081572|FG001|Overall Study|Withdrawal by Subject|0|||
24991513|NCT03692910|50081573|FG002|Overall Study|Withdrawal by Subject|0|||
24991514|NCT04223232|50081579|FG000|Overall Study|Withdrawal by Subject|1|||
24991515|NCT04206384|50081583|FG000|Overall Study|Withdrawal by Subject|8|||
24991516|NCT04206384|50081583|FG000|Overall Study|Adverse Event|2|||
24991517|NCT04051944|50081589|FG000|Overall Study|Study ending|1|||
24991518|NCT04051944|50081590|FG001|Overall Study|Study ending|1|||
24991519|NCT04051944|50081589|FG000|Overall Study|Early study termination by participant|1|||
24991520|NCT04051944|50081590|FG001|Overall Study|Early study termination by participant|0|||
24991521|NCT04051944|50081589|FG000|Overall Study|Withdrawal by Subject|2|||
24991522|NCT04051944|50081590|FG001|Overall Study|Withdrawal by Subject|2|||
24991523|NCT04051944|50081589|FG000|Overall Study|Lack of Efficacy|3|||
24991524|NCT04051944|50081590|FG001|Overall Study|Lack of Efficacy|0|||
24991525|NCT04051944|50081589|FG000|Overall Study|Adverse event, non- fatal|1|||
24991526|NCT04051944|50081590|FG001|Overall Study|Adverse event, non- fatal|1|||
24991527|NCT04050618|50081598|FG000|First Intervention|Withdrawal by Subject|2|||
24991528|NCT04050618|50081599|FG001|First Intervention|Withdrawal by Subject|0|||
24991529|NCT04050618|50081598|FG000|Second Intervention|Withdrawal by Subject|1|||
24991530|NCT04050618|50081599|FG001|Second Intervention|Withdrawal by Subject|0|||
24991531|NCT04067492|50081616|FG000|Overall Study|Lost to Follow-up|0|||
24991532|NCT04067492|50081617|FG001|Overall Study|Lost to Follow-up|0|||
24991533|NCT04067492|50081618|FG002|Overall Study|Lost to Follow-up|0|||
24991534|NCT04067492|50081619|FG003|Overall Study|Lost to Follow-up|0|||
24991535|NCT04067492|50081620|FG004|Overall Study|Lost to Follow-up|0|||
24991536|NCT04067492|50081621|FG005|Overall Study|Lost to Follow-up|1|||
24991537|NCT04067492|50081616|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
24991538|NCT04067492|50081617|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
24991539|NCT04067492|50081618|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
24991540|NCT04067492|50081619|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
24991541|NCT04067492|50081620|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
24991542|NCT04067492|50081621|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
24991543|NCT04067492|50081616|FG000|Overall Study|COVID-19 epidemiological situation|0|||
24991544|NCT04067492|50081617|FG001|Overall Study|COVID-19 epidemiological situation|0|||
24991545|NCT04067492|50081618|FG002|Overall Study|COVID-19 epidemiological situation|0|||
24991546|NCT04067492|50081619|FG003|Overall Study|COVID-19 epidemiological situation|1|||
24991547|NCT04067492|50081620|FG004|Overall Study|COVID-19 epidemiological situation|0|||
24991548|NCT04067492|50081621|FG005|Overall Study|COVID-19 epidemiological situation|0|||
24991549|NCT04046250|50081637|FG000|Overall Study|Death|0|||
24991550|NCT04046250|50081638|FG001|Overall Study|Death|1|||
24991551|NCT04046250|50081637|FG000|Overall Study|Withdrawal by Subject|3|||
24991552|NCT04046250|50081638|FG001|Overall Study|Withdrawal by Subject|3|||
24991553|NCT04375878|50081648|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
24991554|NCT04375878|50081649|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
24991555|NCT04375878|50081650|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
24991556|NCT04375878|50081651|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
24991557|NCT04375878|50081652|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
24991558|NCT04375878|50081653|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
24991559|NCT04375878|50081648|FG000|Crossover First and Second Interventions|Adverse Event|0|||
24991560|NCT04375878|50081649|FG001|Crossover First and Second Interventions|Adverse Event|0|||
24991561|NCT04375878|50081650|FG002|Crossover First and Second Interventions|Adverse Event|1|||
24991562|NCT04375878|50081651|FG003|Crossover First and Second Interventions|Adverse Event|0|||
24991563|NCT04375878|50081652|FG004|Crossover First and Second Interventions|Adverse Event|0|||
24991564|NCT04375878|50081653|FG005|Crossover First and Second Interventions|Adverse Event|0|||
24991565|NCT04375878|50081648|FG000|Extension Phase|Withdrawal by Subject|0|||
24991566|NCT04375878|50081649|FG001|Extension Phase|Withdrawal by Subject|0|||
24991567|NCT04375878|50081650|FG002|Extension Phase|Withdrawal by Subject|0|||
24991568|NCT04375878|50081651|FG003|Extension Phase|Withdrawal by Subject|0|||
24991569|NCT04375878|50081652|FG004|Extension Phase|Withdrawal by Subject|1|||
24991570|NCT04375878|50081653|FG005|Extension Phase|Withdrawal by Subject|0|||
24991571|NCT04189224|50081673|FG000|Period 2|Adverse Event|0|||
24991572|NCT04189224|50081674|FG001|Period 2|Adverse Event|1|||
24991573|NCT04186806|50081682|FG000|Period 1: 7 Days|Adverse Event|1|||
24991574|NCT04186806|50081683|FG001|Period 1: 7 Days|Adverse Event|0|||
24991575|NCT04041414|50081692|FG000|Overall Study|Lost to Follow-up|1|||
24991576|NCT04041414|50081693|FG001|Overall Study|Lost to Follow-up|2|||
24991577|NCT04370028|50081702|FG000|Overall Study|Withdrawal by Subject|695|||
24991578|NCT04370028|50081702|FG000|Overall Study|Protocol Violation|9|||
24991579|NCT04370028|50081702|FG000|Overall Study|Adverse Event|3|||
24991580|NCT04037748|50081715|FG000|Treatment Period 1|Withdrawal by Subject|3|||
24991581|NCT04037748|50081716|FG001|Treatment Period 1|Withdrawal by Subject|0|||
24991582|NCT04037748|50081715|FG000|Treatment Period 1|Adverse Event|1|||
24991583|NCT04037748|50081716|FG001|Treatment Period 1|Adverse Event|1|||
24991584|NCT04037748|50081715|FG000|Treatment Period 1|Protocol Violation|4|||
24991585|NCT04037748|50081716|FG001|Treatment Period 1|Protocol Violation|5|||
24991586|NCT04037748|50081715|FG000|Treatment Period 2|Adverse Event|0|||
24991587|NCT04037748|50081716|FG001|Treatment Period 2|Adverse Event|1|||
24991588|NCT04037748|50081715|FG000|Treatment Period 2|Protocol Violation|2|||
24991589|NCT04037748|50081716|FG001|Treatment Period 2|Protocol Violation|0|||
24991590|NCT04036110|50081725|FG000|Overall Study|Lost to Follow-up|3|||
24991591|NCT04036110|50081726|FG001|Overall Study|Lost to Follow-up|2|||
24991592|NCT04036110|50081727|FG002|Overall Study|Lost to Follow-up|1|||
24991593|NCT04036110|50081725|FG000|Overall Study|Study Suspended|4|||
24991594|NCT04036110|50081726|FG001|Overall Study|Study Suspended|5|||
24991595|NCT04036110|50081727|FG002|Overall Study|Study Suspended|1|||
24991596|NCT03053050|50081738|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
24991597|NCT03053050|50081739|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
24991598|NCT03053050|50081740|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
24991599|NCT03053050|50081741|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
24991600|NCT03053050|50081738|FG000|Randomized Phase|Withdrew Consent|16|||
24991601|NCT03053050|50081739|FG001|Randomized Phase|Withdrew Consent|8|||
24991602|NCT03053050|50081740|FG002|Randomized Phase|Withdrew Consent|9|||
24991603|NCT03053050|50081741|FG003|Randomized Phase|Withdrew Consent|0|||
24991604|NCT03053050|50081738|FG000|Randomized Phase|Investigator's Discretion|6|||
24991605|NCT03053050|50081739|FG001|Randomized Phase|Investigator's Discretion|6|||
24991606|NCT03053050|50081740|FG002|Randomized Phase|Investigator's Discretion|3|||
24991607|NCT03053050|50081741|FG003|Randomized Phase|Investigator's Discretion|0|||
24991608|NCT03053050|50081738|FG000|Randomized Phase|Lost to Follow-up|5|||
24991609|NCT03053050|50081739|FG001|Randomized Phase|Lost to Follow-up|1|||
24991610|NCT03053050|50081740|FG002|Randomized Phase|Lost to Follow-up|1|||
24991611|NCT03053050|50081741|FG003|Randomized Phase|Lost to Follow-up|0|||
24991612|NCT03053050|50081738|FG000|Randomized Phase|Adverse Event|0|||
24991613|NCT03053050|50081739|FG001|Randomized Phase|Adverse Event|1|||
24991614|NCT03053050|50081740|FG002|Randomized Phase|Adverse Event|0|||
24991615|NCT03053050|50081741|FG003|Randomized Phase|Adverse Event|0|||
24991616|NCT03053050|50081738|FG000|Randomized Phase|Randomized but Never Treated|2|||
24991617|NCT03053050|50081739|FG001|Randomized Phase|Randomized but Never Treated|2|||
24991618|NCT03053050|50081740|FG002|Randomized Phase|Randomized but Never Treated|2|||
24991619|NCT03053050|50081741|FG003|Randomized Phase|Randomized but Never Treated|0|||
24991620|NCT03053050|50081738|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
24991621|NCT03053050|50081739|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
24991622|NCT03053050|50081740|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
24991623|NCT03053050|50081741|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
24991624|NCT03053050|50081738|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
24991625|NCT03053050|50081739|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
24991626|NCT03053050|50081740|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
24991627|NCT03053050|50081741|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
24991628|NCT03053050|50081738|FG000|Open-label Phase|Withdrew Consent|0|||
24991629|NCT03053050|50081739|FG001|Open-label Phase|Withdrew Consent|0|||
24991630|NCT03053050|50081740|FG002|Open-label Phase|Withdrew Consent|0|||
24991631|NCT03053050|50081741|FG003|Open-label Phase|Withdrew Consent|6|||
24991632|NCT03053050|50081738|FG000|Open-label Phase|Investigator's Discretion|0|||
24991633|NCT03053050|50081739|FG001|Open-label Phase|Investigator's Discretion|0|||
24991634|NCT03053050|50081740|FG002|Open-label Phase|Investigator's Discretion|0|||
24991635|NCT03053050|50081741|FG003|Open-label Phase|Investigator's Discretion|4|||
24991636|NCT04369950|50081752|FG000|Overall Study|Protocol Violation|2|||
24991637|NCT04369950|50081753|FG001|Overall Study|Protocol Violation|2|||
24991638|NCT04035564|50081761|FG000|Overall Study|Protocol Violation|1|||
24991639|NCT04035564|50081762|FG001|Overall Study|Protocol Violation|2|||
24991640|NCT04035564|50081761|FG000|Overall Study|No laboratory available|2|||
24991641|NCT04035564|50081762|FG001|Overall Study|No laboratory available|2|||
24991642|NCT04035564|50081761|FG000|Overall Study|Guardian declined consent|1|||
24991643|NCT04035564|50081762|FG001|Overall Study|Guardian declined consent|2|||
25079483|NCT00893789|50187962|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
25079484|NCT00893789|50187963|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
24991644|NCT02955602|50081771|FG000|Overall Study|Adverse Event|0|||
24991645|NCT02955602|50081772|FG001|Overall Study|Adverse Event|3|||
24991646|NCT02955602|50081773|FG002|Overall Study|Adverse Event|0|||
24991647|NCT02955602|50081771|FG000|Overall Study|Withdrawal of informed consent|1|||
24991648|NCT02955602|50081772|FG001|Overall Study|Withdrawal of informed consent|3|||
24991649|NCT02955602|50081773|FG002|Overall Study|Withdrawal of informed consent|2|||
24991650|NCT02955602|50081771|FG000|Overall Study|Lost to Follow-up|0|||
24991651|NCT02955602|50081772|FG001|Overall Study|Lost to Follow-up|0|||
24991652|NCT02955602|50081773|FG002|Overall Study|Lost to Follow-up|1|||
24991653|NCT02955602|50081771|FG000|Overall Study|Other|0|||
24991654|NCT02955602|50081772|FG001|Overall Study|Other|1|||
24991655|NCT02955602|50081773|FG002|Overall Study|Other|3|||
24991656|NCT04179786|50081781|FG000|Overall Study|Withdrawal by Subject|8|||
24991657|NCT04175808|50081785|FG000|Part A|Miscellaneous|2|||
24991658|NCT04175808|50081786|FG001|Part A|Miscellaneous|0|||
24991659|NCT04175808|50081787|FG002|Part A|Miscellaneous|0|||
24991660|NCT04175808|50081788|FG003|Part A|Miscellaneous|0|||
24991661|NCT04175808|50081789|FG004|Part A|Miscellaneous|0|||
24991662|NCT04175808|50081790|FG005|Part A|Miscellaneous|0|||
24991663|NCT04175808|50081791|FG006|Part A|Miscellaneous|0|||
24991664|NCT04057196|50081807|FG000|Overall Study|Withdrawal by Subject|3|||
24991665|NCT04057196|50081807|FG000|Overall Study|Death|3|||
24991666|NCT04027686|50081813|FG000|Overall Study|Lost to Follow-up|2|||
24991667|NCT04027686|50081814|FG001|Overall Study|Lost to Follow-up|0|||
24991668|NCT04027686|50081813|FG000|Overall Study|Withdrawal by Subject|0|||
24991669|NCT04027686|50081814|FG001|Overall Study|Withdrawal by Subject|1|||
24991670|NCT03052426|50081827|FG000|Overall Study|Withdrawal by Subject|0|||
24991671|NCT03052426|50081828|FG001|Overall Study|Withdrawal by Subject|1|||
24991672|NCT03052426|50081829|FG002|Overall Study|Withdrawal by Subject|0|||
24991673|NCT03052426|50081827|FG000|Overall Study|Lost to Follow-up|2|||
24991674|NCT03052426|50081828|FG001|Overall Study|Lost to Follow-up|0|||
24991675|NCT03052426|50081829|FG002|Overall Study|Lost to Follow-up|1|||
24991676|NCT03688880|50081844|FG000|Overall Study|Withdrawal by Subject|0|||
24991677|NCT03688880|50081845|FG001|Overall Study|Withdrawal by Subject|2|||
24991678|NCT03688880|50081844|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
24991679|NCT03688880|50081845|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
24991680|NCT03688880|50081844|FG000|Overall Study|Lost to Follow-up|4|||
24991681|NCT03688880|50081845|FG001|Overall Study|Lost to Follow-up|7|||
24991682|NCT03688880|50081844|FG000|Overall Study|Adverse Event|0|||
24991683|NCT03688880|50081845|FG001|Overall Study|Adverse Event|2|||
24991684|NCT03688880|50081844|FG000|Overall Study|Device deficiencies|0|||
24991685|NCT03688880|50081845|FG001|Overall Study|Device deficiencies|2|||
24991686|NCT03688880|50081844|FG000|Overall Study|Other|10|||
24991687|NCT03688880|50081845|FG001|Overall Study|Other|16|||
24991688|NCT03051178|50081851|FG000|Overall Study|Withdrawal by Subject|5|||
24991689|NCT03051100|50081857|FG000|Overall Study|Withdrawal by Subject|1|||
24991690|NCT03051100|50081858|FG001|Overall Study|Withdrawal by Subject|0|||
24991691|NCT01343368|50081866|FG000|Overall Study|Death|1|||
24991692|NCT01343368|50081867|FG001|Overall Study|Death|0|||
24991693|NCT01343368|50081866|FG000|Overall Study|Lost to Follow-up|1|||
24991694|NCT01343368|50081867|FG001|Overall Study|Lost to Follow-up|0|||
24991695|NCT02955212|50081875|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
24991696|NCT02955212|50081876|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
24991697|NCT02955212|50081875|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
24991698|NCT02955212|50081876|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
24991699|NCT02955212|50081875|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
24991700|NCT02955212|50081876|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
24991701|NCT02955212|50081875|FG000|Period 1: Double-blind Treatment Period|Other|3|||
24991702|NCT02955212|50081876|FG001|Period 1: Double-blind Treatment Period|Other|2|||
24991703|NCT02955212|50081875|FG000|Period 2: Open-label Extension|Adverse Event|11|||
24991704|NCT02955212|50081876|FG001|Period 2: Open-label Extension|Adverse Event|7|||
24991705|NCT02955212|50081875|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
24991706|NCT02955212|50081876|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
24991707|NCT02955212|50081875|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
24991708|NCT02955212|50081876|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
24991709|NCT02955212|50081875|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
24991710|NCT02955212|50081876|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
24991711|NCT02955212|50081875|FG000|Period 2: Open-label Extension|Other|2|||
24991712|NCT02955212|50081876|FG001|Period 2: Open-label Extension|Other|4|||
24991713|NCT03050398|50081883|FG000|Overall Study|Study terminated by sponsor|8|||
24991714|NCT03662750|50081887|FG000|Overall Study|Withdrawal by Subject|1|||
24991715|NCT04052204|50081891|FG000|Overall Study|Death|1|||
24991716|NCT04052204|50081892|FG001|Overall Study|Death|0|||
24991717|NCT04052204|50081893|FG002|Overall Study|Death|0|||
24991718|NCT04052204|50081891|FG000|Overall Study|Progressive disease|1|||
24991719|NCT04052204|50081892|FG001|Overall Study|Progressive disease|0|||
24991720|NCT04052204|50081893|FG002|Overall Study|Progressive disease|0|||
24991721|NCT04052204|50081891|FG000|Overall Study|Other|1|||
24991722|NCT04052204|50081892|FG001|Overall Study|Other|0|||
24991723|NCT04052204|50081893|FG002|Overall Study|Other|0|||
24991724|NCT04050722|50081899|FG000|Overall Study|Withdrawal by Subject|1|||
24991725|NCT04050722|50081900|FG001|Overall Study|Withdrawal by Subject|0|||
24991726|NCT04049552|50081906|FG000|Overall Study|Lost to Follow-up|1|||
24991727|NCT03048058|50081914|FG000|Overall Study|Lost to Follow-up|4|||
24991728|NCT03048058|50081915|FG001|Overall Study|Lost to Follow-up|0|||
24991729|NCT03048058|50081914|FG000|Overall Study|Withdrawal by Subject|0|||
24991730|NCT03048058|50081915|FG001|Overall Study|Withdrawal by Subject|4|||
24991731|NCT03047980|50081921|FG000|Overall Study|Adverse Event|1|||
24991732|NCT04048382|50081927|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
24991733|NCT04048382|50081928|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
24991734|NCT04048382|50081927|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
24991735|NCT04048382|50081928|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
24991736|NCT04048382|50081927|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
24991737|NCT04048382|50081928|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
24991738|NCT04047446|50081936|FG000|Overall Study|Physician Decision|1|||
24991739|NCT04047446|50081937|FG001|Overall Study|Physician Decision|0|||
24991740|NCT03655106|50081945|FG000|Overall Study|Withdrawal by Subject|3|||
24991741|NCT03655106|50081946|FG001|Overall Study|Withdrawal by Subject|2|||
24991742|NCT03655106|50081945|FG000|Overall Study|Lost to Follow-up|2|||
24991743|NCT03655106|50081946|FG001|Overall Study|Lost to Follow-up|1|||
24991744|NCT03655106|50081945|FG000|Overall Study|Duplicate Enrollment|1|||
24991745|NCT03655106|50081946|FG001|Overall Study|Duplicate Enrollment|1|||
24991746|NCT03655106|50081945|FG000|Overall Study|Protocol Violation|3|||
24991747|NCT03655106|50081946|FG001|Overall Study|Protocol Violation|0|||
24991748|NCT03630302|50081952|FG000|Surgery|hardware issue prevented LFP recordings|1|||
24991749|NCT03630302|50081952|FG000|3 Month Visit|Adverse Event|2|||
24991750|NCT03630302|50081952|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
24991751|NCT04041440|50081958|FG000|Overall Study|Withdrawal by Subject|0|||
24991752|NCT04041440|50081959|FG001|Overall Study|Withdrawal by Subject|1|||
24991753|NCT04041440|50081958|FG000|Overall Study|Lost to Follow-up|0|||
24991754|NCT04041440|50081959|FG001|Overall Study|Lost to Follow-up|1|||
24991755|NCT03654560|50081968|FG000|Overall Study|Death|3|||
24991756|NCT03654560|50081969|FG001|Overall Study|Death|1|||
24991757|NCT03654560|50081968|FG000|Overall Study|Lost to Follow-up|1|||
24991758|NCT03654560|50081969|FG001|Overall Study|Lost to Follow-up|0|||
24991759|NCT03629054|50081977|FG000|Period 2 (4 Days)|Not treated|0|||
24991760|NCT03629054|50081978|FG001|Period 2 (4 Days)|Not treated|1|||
24991761|NCT03628898|50081984|FG000|Overall Study|Device deficiency|1|||
24991762|NCT03628508|50081988|FG000|Overall Study|Lost to Follow-up|1|||
24991763|NCT03045328|50081992|FG000|Overall Study|Withdrawal by Subject|2|||
24991764|NCT02154490|50081998|FG000|Overall Study|No tissue submitted|23|||
24991765|NCT02154490|50081998|FG000|Overall Study|No biomarker results|167|||
24991766|NCT02154490|50081998|FG000|Overall Study|Not assigned to a sub-study|270|||
24991767|NCT02154490|50081998|FG000|Overall Study|Did not register to a sub-study|749|||
24991768|NCT01286272|50082004|FG000|Overall Study|Ineligible after beginning treatment|1|||
24991769|NCT01286272|50082005|FG001|Overall Study|Ineligible after beginning treatment|3|||
24991770|NCT03627494|50082023|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
24991771|NCT03627494|50082024|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
24991772|NCT03627494|50082025|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
24991773|NCT03627494|50082026|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
24991774|NCT03627494|50082027|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
24991775|NCT03627494|50082028|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
24991776|NCT03627494|50082029|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
24991777|NCT03627494|50082030|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
24991778|NCT03627494|50082031|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
24991779|NCT03627494|50082032|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
24991780|NCT03627494|50082033|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
24991781|NCT03627494|50082034|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
24991782|NCT03627494|50082023|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
24991783|NCT03627494|50082024|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
24991784|NCT03627494|50082025|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
24991785|NCT03627494|50082026|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
24991786|NCT03627494|50082027|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
24991787|NCT03627494|50082028|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
24991788|NCT03627494|50082029|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
24991789|NCT03627494|50082030|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
24991790|NCT03627494|50082031|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
24991791|NCT03627494|50082032|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
24991792|NCT03627494|50082033|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
24991793|NCT03627494|50082034|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
24991794|NCT03627494|50082023|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
24991795|NCT03627494|50082024|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
24991796|NCT03627494|50082025|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
25079485|NCT00893789|50187960|FG000|Overall Study|Adverse Event|0|||
24991797|NCT03627494|50082026|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
24991798|NCT03627494|50082027|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
24991799|NCT03627494|50082028|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
24991800|NCT03627494|50082029|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
24991801|NCT03627494|50082030|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
24991802|NCT03627494|50082031|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
24991803|NCT03627494|50082032|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
24991804|NCT03627494|50082033|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
24991805|NCT03627494|50082034|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
24991806|NCT03627416|50082075|FG000|Overall Study|Adverse Event|0|||
24991807|NCT03627416|50082076|FG001|Overall Study|Adverse Event|1|||
24991808|NCT00972478|50082084|FG000|Overall Study|Adverse Event|3|||
24991809|NCT00972478|50082085|FG001|Overall Study|Adverse Event|16|||
24991810|NCT00972478|50082084|FG000|Overall Study|Withdrawal by Subject|1|||
24991811|NCT00972478|50082085|FG001|Overall Study|Withdrawal by Subject|8|||
24991812|NCT00972478|50082084|FG000|Overall Study|Progression/Relapse|0|||
24991813|NCT00972478|50082085|FG001|Overall Study|Progression/Relapse|2|||
24991814|NCT00972478|50082084|FG000|Overall Study|Death|0|||
24991815|NCT00972478|50082085|FG001|Overall Study|Death|2|||
24991816|NCT00972478|50082084|FG000|Overall Study|Not protocol specified|1|||
24991817|NCT00972478|50082085|FG001|Overall Study|Not protocol specified|1|||
24991818|NCT00972478|50082084|FG000|Overall Study|Ineligible|1|||
24991819|NCT00972478|50082085|FG001|Overall Study|Ineligible|7|||
24991820|NCT00972478|50082084|FG000|Overall Study|Not start protocol treatment|1|||
24991821|NCT00972478|50082085|FG001|Overall Study|Not start protocol treatment|2|||
24991822|NCT00097539|50082099|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
24991823|NCT00097539|50082100|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
24991824|NCT00097539|50082101|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
24991825|NCT00097539|50082102|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
24991826|NCT00097539|50082103|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
24991827|NCT00097539|50082104|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
24991828|NCT00097539|50082105|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
24991829|NCT00097539|50082099|FG000|Overall Study|Withdrawal by Subject|925|||
24991830|NCT00097539|50082100|FG001|Overall Study|Withdrawal by Subject|323|||
24991831|NCT00097539|50082101|FG002|Overall Study|Withdrawal by Subject|346|||
24991832|NCT00097539|50082102|FG003|Overall Study|Withdrawal by Subject|217|||
24991833|NCT00097539|50082103|FG004|Overall Study|Withdrawal by Subject|68|||
24991834|NCT00097539|50082104|FG005|Overall Study|Withdrawal by Subject|229|||
24991835|NCT00097539|50082105|FG006|Overall Study|Withdrawal by Subject|3|||
24991836|NCT00097539|50082099|FG000|Overall Study|Participant Non-compliant|2140|||
24991837|NCT00097539|50082100|FG001|Overall Study|Participant Non-compliant|567|||
24991838|NCT00097539|50082101|FG002|Overall Study|Participant Non-compliant|1067|||
24991839|NCT00097539|50082102|FG003|Overall Study|Participant Non-compliant|353|||
24991840|NCT00097539|50082103|FG004|Overall Study|Participant Non-compliant|136|||
24991841|NCT00097539|50082104|FG005|Overall Study|Participant Non-compliant|543|||
24991842|NCT00097539|50082105|FG006|Overall Study|Participant Non-compliant|18|||
24991843|NCT00097539|50082099|FG000|Overall Study|Lack of Efficacy|249|||
24991844|NCT00097539|50082100|FG001|Overall Study|Lack of Efficacy|122|||
24991845|NCT00097539|50082101|FG002|Overall Study|Lack of Efficacy|202|||
24991846|NCT00097539|50082102|FG003|Overall Study|Lack of Efficacy|105|||
24991847|NCT00097539|50082103|FG004|Overall Study|Lack of Efficacy|45|||
24991848|NCT00097539|50082104|FG005|Overall Study|Lack of Efficacy|228|||
24991849|NCT00097539|50082105|FG006|Overall Study|Lack of Efficacy|5|||
24991850|NCT00097539|50082099|FG000|Overall Study|Adverse Event|78|||
24991851|NCT00097539|50082100|FG001|Overall Study|Adverse Event|133|||
24991852|NCT00097539|50082101|FG002|Overall Study|Adverse Event|37|||
24991853|NCT00097539|50082102|FG003|Overall Study|Adverse Event|27|||
24991854|NCT00097539|50082103|FG004|Overall Study|Adverse Event|30|||
24991855|NCT00097539|50082104|FG005|Overall Study|Adverse Event|59|||
24991856|NCT00097539|50082105|FG006|Overall Study|Adverse Event|1|||
24991857|NCT00097539|50082099|FG000|Overall Study|Death|2|||
24991858|NCT00097539|50082100|FG001|Overall Study|Death|7|||
24991859|NCT00097539|50082101|FG002|Overall Study|Death|0|||
24991860|NCT00097539|50082102|FG003|Overall Study|Death|0|||
24991861|NCT00097539|50082103|FG004|Overall Study|Death|1|||
24991862|NCT00097539|50082104|FG005|Overall Study|Death|3|||
24991863|NCT00097539|50082105|FG006|Overall Study|Death|0|||
24991864|NCT00097539|50082099|FG000|Overall Study|Reasons Other Than Above|3602|||
24991865|NCT00097539|50082100|FG001|Overall Study|Reasons Other Than Above|1382|||
24991866|NCT00097539|50082101|FG002|Overall Study|Reasons Other Than Above|1757|||
24991867|NCT00097539|50082102|FG003|Overall Study|Reasons Other Than Above|692|||
24991868|NCT00097539|50082103|FG004|Overall Study|Reasons Other Than Above|361|||
24991869|NCT00097539|50082104|FG005|Overall Study|Reasons Other Than Above|1244|||
24991870|NCT00097539|50082105|FG006|Overall Study|Reasons Other Than Above|34|||
24991871|NCT00097539|50082099|FG000|Overall Study|Reason not Specified|111|||
24991872|NCT00097539|50082100|FG001|Overall Study|Reason not Specified|49|||
24991873|NCT00097539|50082101|FG002|Overall Study|Reason not Specified|53|||
24991874|NCT00097539|50082102|FG003|Overall Study|Reason not Specified|21|||
24991875|NCT00097539|50082103|FG004|Overall Study|Reason not Specified|11|||
24991876|NCT00097539|50082104|FG005|Overall Study|Reason not Specified|40|||
24991877|NCT00097539|50082105|FG006|Overall Study|Reason not Specified|2|||
24991878|NCT03925324|50082123|FG000|Overall Study|Death|1|||
24991879|NCT03925324|50082124|FG001|Overall Study|Death|1|||
24991880|NCT03042910|50082130|FG000|Overall Study|Adverse Event|1|||
24991881|NCT03042910|50082130|FG000|Overall Study|Disease Progression|2|||
24991882|NCT03042910|50082130|FG000|Overall Study|Withdrawal by Subject|3|||
24991883|NCT03042910|50082130|FG000|Overall Study|Enrolled but not treated|1|||
24991884|NCT03059446|50082134|FG000|Overall Study|Adverse Event|11|||
24991885|NCT03059446|50082134|FG000|Overall Study|Withdrawal of Consent|16|||
24991886|NCT03059446|50082134|FG000|Overall Study|Lost to Follow-up|3|||
24991887|NCT03059446|50082134|FG000|Overall Study|Protocol Violation|1|||
24991888|NCT03059446|50082134|FG000|Overall Study|Study Terminated by Sponsor|131|||
24991889|NCT03059446|50082134|FG000|Overall Study|Reason not Specified|5|||
24991890|NCT00090519|50082140|FG000|Overall Study|Adverse Event|5|||
24991891|NCT00090519|50082141|FG001|Overall Study|Adverse Event|4|||
24991892|NCT00090519|50082140|FG000|Overall Study|Death|9|||
24991893|NCT00090519|50082141|FG001|Overall Study|Death|9|||
24991894|NCT00090519|50082140|FG000|Overall Study|Lost to Follow-up|26|||
24991895|NCT00090519|50082141|FG001|Overall Study|Lost to Follow-up|29|||
24991896|NCT00090519|50082140|FG000|Overall Study|Withdrawal by Subject|28|||
24991897|NCT00090519|50082141|FG001|Overall Study|Withdrawal by Subject|29|||
24991898|NCT00090519|50082140|FG000|Overall Study|Physician Decision|2|||
24991899|NCT00090519|50082141|FG001|Overall Study|Physician Decision|3|||
24991900|NCT00090519|50082140|FG000|Overall Study|Sponsor Decision|3|||
24991901|NCT00090519|50082141|FG001|Overall Study|Sponsor Decision|1|||
24991902|NCT00096993|50082171|FG000|Overall Study|Death|1|||
24991903|NCT00096993|50082172|FG001|Overall Study|Death|0|||
24991904|NCT00096993|50082171|FG000|Overall Study|Disease progression|56|||
24991905|NCT00096993|50082172|FG001|Overall Study|Disease progression|53|||
24991906|NCT00096993|50082171|FG000|Overall Study|Adverse Event|2|||
24991907|NCT00096993|50082172|FG001|Overall Study|Adverse Event|8|||
24991908|NCT00096993|50082171|FG000|Overall Study|Subject's decision|3|||
24991909|NCT00096993|50082172|FG001|Overall Study|Subject's decision|1|||
24991910|NCT00096993|50082171|FG000|Overall Study|Physician Decision|2|||
24991911|NCT00096993|50082172|FG001|Overall Study|Physician Decision|1|||
24991912|NCT00096993|50082171|FG000|Overall Study|Non-compliance|0|||
24991913|NCT00096993|50082172|FG001|Overall Study|Non-compliance|1|||
24991914|NCT00096993|50082171|FG000|Overall Study|Other unspecified|1|||
24991915|NCT00096993|50082172|FG001|Overall Study|Other unspecified|1|||
24991916|NCT03040336|50082180|FG000|Overall Study|Death|1|||
24991917|NCT03040336|50082181|FG001|Overall Study|Death|0|||
24991918|NCT03040336|50082180|FG000|Overall Study|Withdrawal by Subject|2|||
24991919|NCT03040336|50082181|FG001|Overall Study|Withdrawal by Subject|3|||
24991920|NCT00072189|50082188|FG000|Overall Study|Withdrawal by Subject|1|||
24991921|NCT03040024|50082195|FG000|Overall Study|Adverse Event|0|||
24991922|NCT03040024|50082196|FG001|Overall Study|Adverse Event|1|||
24991923|NCT03040024|50082197|FG002|Overall Study|Adverse Event|0|||
24991924|NCT03040024|50082195|FG000|Overall Study|Death|0|||
24991925|NCT03040024|50082196|FG001|Overall Study|Death|1|||
24991926|NCT03040024|50082197|FG002|Overall Study|Death|0|||
24991927|NCT03040024|50082195|FG000|Overall Study|Physician Decision|0|||
24991928|NCT03040024|50082196|FG001|Overall Study|Physician Decision|0|||
24991929|NCT03040024|50082197|FG002|Overall Study|Physician Decision|1|||
24991930|NCT03039790|50082225|FG000|Overall Study|Lost to Follow-up|2|||
24991931|NCT03039790|50082226|FG001|Overall Study|Lost to Follow-up|0|||
24991932|NCT03039790|50082227|FG002|Overall Study|Lost to Follow-up|1|||
24991933|NCT03039790|50082228|FG003|Overall Study|Lost to Follow-up|1|||
24991934|NCT03039790|50082229|FG004|Overall Study|Lost to Follow-up|0|||
24991935|NCT03039790|50082230|FG005|Overall Study|Lost to Follow-up|1|||
24991936|NCT03039790|50082231|FG006|Overall Study|Lost to Follow-up|1|||
24991937|NCT03039790|50082232|FG007|Overall Study|Lost to Follow-up|1|||
24991938|NCT03039790|50082233|FG008|Overall Study|Lost to Follow-up|0|||
24991939|NCT03039790|50082234|FG009|Overall Study|Lost to Follow-up|1|||
24991940|NCT03039790|50082235|FG010|Overall Study|Lost to Follow-up|1|||
24991941|NCT03039790|50082236|FG011|Overall Study|Lost to Follow-up|0|||
24991942|NCT03039790|50082237|FG012|Overall Study|Lost to Follow-up|1|||
24991943|NCT03039790|50082238|FG013|Overall Study|Lost to Follow-up|0|||
24991944|NCT03039790|50082239|FG014|Overall Study|Lost to Follow-up|3|||
24991945|NCT03039790|50082240|FG015|Overall Study|Lost to Follow-up|1|||
24991946|NCT03039790|50082241|FG016|Overall Study|Lost to Follow-up|2|||
24991947|NCT03039790|50082242|FG017|Overall Study|Lost to Follow-up|2|||
24991948|NCT03039790|50082243|FG018|Overall Study|Lost to Follow-up|1|||
24991949|NCT03039790|50082244|FG019|Overall Study|Lost to Follow-up|3|||
24991950|NCT03039790|50082225|FG000|Overall Study|Withdrawal of Consent|1|||
24991951|NCT03039790|50082226|FG001|Overall Study|Withdrawal of Consent|0|||
24991952|NCT03039790|50082227|FG002|Overall Study|Withdrawal of Consent|0|||
24991953|NCT03039790|50082228|FG003|Overall Study|Withdrawal of Consent|1|||
24991954|NCT03039790|50082229|FG004|Overall Study|Withdrawal of Consent|0|||
24991955|NCT03039790|50082230|FG005|Overall Study|Withdrawal of Consent|0|||
24991956|NCT03039790|50082231|FG006|Overall Study|Withdrawal of Consent|0|||
24991957|NCT03039790|50082232|FG007|Overall Study|Withdrawal of Consent|0|||
24991958|NCT03039790|50082233|FG008|Overall Study|Withdrawal of Consent|0|||
24991959|NCT03039790|50082234|FG009|Overall Study|Withdrawal of Consent|1|||
24991960|NCT03039790|50082235|FG010|Overall Study|Withdrawal of Consent|0|||
24991961|NCT03039790|50082236|FG011|Overall Study|Withdrawal of Consent|0|||
24991962|NCT03039790|50082237|FG012|Overall Study|Withdrawal of Consent|2|||
24991963|NCT03039790|50082238|FG013|Overall Study|Withdrawal of Consent|0|||
24991964|NCT03039790|50082239|FG014|Overall Study|Withdrawal of Consent|1|||
24991965|NCT03039790|50082240|FG015|Overall Study|Withdrawal of Consent|5|||
24991966|NCT03039790|50082241|FG016|Overall Study|Withdrawal of Consent|3|||
24991967|NCT03039790|50082242|FG017|Overall Study|Withdrawal of Consent|0|||
24991968|NCT03039790|50082243|FG018|Overall Study|Withdrawal of Consent|2|||
24991969|NCT03039790|50082244|FG019|Overall Study|Withdrawal of Consent|5|||
24991970|NCT03039790|50082225|FG000|Overall Study|Death|0|||
24991971|NCT03039790|50082226|FG001|Overall Study|Death|0|||
24991972|NCT03039790|50082227|FG002|Overall Study|Death|0|||
24991973|NCT03039790|50082228|FG003|Overall Study|Death|0|||
24991974|NCT03039790|50082229|FG004|Overall Study|Death|0|||
24991975|NCT03039790|50082230|FG005|Overall Study|Death|0|||
24991976|NCT03039790|50082231|FG006|Overall Study|Death|0|||
24991977|NCT03039790|50082232|FG007|Overall Study|Death|0|||
24991978|NCT03039790|50082233|FG008|Overall Study|Death|0|||
24991979|NCT03039790|50082234|FG009|Overall Study|Death|0|||
24991980|NCT03039790|50082235|FG010|Overall Study|Death|0|||
24991981|NCT03039790|50082236|FG011|Overall Study|Death|0|||
24991982|NCT03039790|50082237|FG012|Overall Study|Death|0|||
24991983|NCT03039790|50082238|FG013|Overall Study|Death|0|||
24991984|NCT03039790|50082239|FG014|Overall Study|Death|0|||
24991985|NCT03039790|50082240|FG015|Overall Study|Death|1|||
24991986|NCT03039790|50082241|FG016|Overall Study|Death|3|||
24991987|NCT03039790|50082242|FG017|Overall Study|Death|0|||
24991988|NCT03039790|50082243|FG018|Overall Study|Death|2|||
24991989|NCT03039790|50082244|FG019|Overall Study|Death|0|||
24991990|NCT03039790|50082225|FG000|Overall Study|Reason, not Specified|1|||
24991991|NCT03039790|50082226|FG001|Overall Study|Reason, not Specified|0|||
24991992|NCT03039790|50082227|FG002|Overall Study|Reason, not Specified|0|||
24991993|NCT03039790|50082228|FG003|Overall Study|Reason, not Specified|0|||
24991994|NCT03039790|50082229|FG004|Overall Study|Reason, not Specified|0|||
24991995|NCT03039790|50082230|FG005|Overall Study|Reason, not Specified|0|||
24991996|NCT03039790|50082231|FG006|Overall Study|Reason, not Specified|0|||
24991997|NCT03039790|50082232|FG007|Overall Study|Reason, not Specified|0|||
24991998|NCT03039790|50082233|FG008|Overall Study|Reason, not Specified|0|||
24991999|NCT03039790|50082234|FG009|Overall Study|Reason, not Specified|0|||
24992000|NCT03039790|50082235|FG010|Overall Study|Reason, not Specified|0|||
24992001|NCT03039790|50082236|FG011|Overall Study|Reason, not Specified|0|||
24992002|NCT03039790|50082237|FG012|Overall Study|Reason, not Specified|0|||
24992003|NCT03039790|50082238|FG013|Overall Study|Reason, not Specified|0|||
24992004|NCT03039790|50082239|FG014|Overall Study|Reason, not Specified|0|||
24992005|NCT03039790|50082240|FG015|Overall Study|Reason, not Specified|0|||
24992006|NCT03039790|50082241|FG016|Overall Study|Reason, not Specified|2|||
24992007|NCT03039790|50082242|FG017|Overall Study|Reason, not Specified|0|||
24992008|NCT03039790|50082243|FG018|Overall Study|Reason, not Specified|1|||
24992009|NCT03039790|50082244|FG019|Overall Study|Reason, not Specified|0|||
24992010|NCT03038620|50082317|FG000|Overall Study|Lost to Follow-up|18|||
24992011|NCT03038620|50082318|FG001|Overall Study|Lost to Follow-up|23|||
24992012|NCT03038620|50082317|FG000|Overall Study|Withdrawal by Subject|0|||
24992013|NCT03038620|50082318|FG001|Overall Study|Withdrawal by Subject|15|||
24992014|NCT03038620|50082317|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
24992015|NCT03038620|50082318|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
24992016|NCT01350934|50082339|FG000|Base Study|Adverse Event|6|||
25079486|NCT00893789|50187961|FG001|Overall Study|Adverse Event|2|||
25079487|NCT00893789|50187962|FG002|Overall Study|Adverse Event|1|||
24992017|NCT01350934|50082340|FG001|Base Study|Adverse Event|0|||
24992018|NCT01350934|50082339|FG000|Base Study|Lost to Follow-up|1|||
24992019|NCT01350934|50082340|FG001|Base Study|Lost to Follow-up|0|||
24992020|NCT01350934|50082339|FG000|Base Study|Protocol Violation|1|||
24992021|NCT01350934|50082340|FG001|Base Study|Protocol Violation|1|||
24992022|NCT01350934|50082339|FG000|Base Study|Withdrawal by Subject|1|||
24992023|NCT01350934|50082340|FG001|Base Study|Withdrawal by Subject|2|||
24992024|NCT01350934|50082339|FG000|Base Study|Non-Compliance With Study Drug|2|||
24992025|NCT01350934|50082340|FG001|Base Study|Non-Compliance With Study Drug|0|||
24992026|NCT01350934|50082339|FG000|Extension Study|Adverse Event|2|||
24992027|NCT01350934|50082340|FG001|Extension Study|Adverse Event|1|||
24992028|NCT01350934|50082339|FG000|Extension Study|Lost to Follow-up|2|||
24992029|NCT01350934|50082340|FG001|Extension Study|Lost to Follow-up|0|||
24992030|NCT01350934|50082339|FG000|Extension Study|Protocol Violation|1|||
25079488|NCT00893789|50187963|FG003|Overall Study|Adverse Event|5|||
24992031|NCT01350934|50082340|FG001|Extension Study|Protocol Violation|1|||
24992032|NCT01350934|50082339|FG000|Extension Study|Lack of Efficacy|0|||
24992033|NCT01350934|50082340|FG001|Extension Study|Lack of Efficacy|1|||
24992034|NCT01350934|50082339|FG000|Extension Study|Withdrawal by Subject|0|||
24992035|NCT01350934|50082340|FG001|Extension Study|Withdrawal by Subject|1|||
24992036|NCT03622580|50082364|FG000|Overall Study|Death|16|||
24992037|NCT03622580|50082365|FG001|Overall Study|Death|21|||
24992038|NCT03622580|50082366|FG002|Overall Study|Death|13|||
24992039|NCT03622580|50082364|FG000|Overall Study|Adverse Event|6|||
24992040|NCT03622580|50082365|FG001|Overall Study|Adverse Event|6|||
24992041|NCT03622580|50082366|FG002|Overall Study|Adverse Event|5|||
24992042|NCT03622580|50082364|FG000|Overall Study|Withdrawal by Subject|12|||
24992043|NCT03622580|50082365|FG001|Overall Study|Withdrawal by Subject|7|||
24992044|NCT03622580|50082366|FG002|Overall Study|Withdrawal by Subject|19|||
24992045|NCT03622580|50082364|FG000|Overall Study|Lost to Follow-up|12|||
24992046|NCT03622580|50082365|FG001|Overall Study|Lost to Follow-up|9|||
24992047|NCT03622580|50082366|FG002|Overall Study|Lost to Follow-up|9|||
24992048|NCT03622580|50082364|FG000|Overall Study|Protocol Violation|1|||
24992049|NCT03622580|50082365|FG001|Overall Study|Protocol Violation|0|||
24992050|NCT03622580|50082366|FG002|Overall Study|Protocol Violation|1|||
24992051|NCT03622580|50082364|FG000|Overall Study|Physician Decision|3|||
24992052|NCT03622580|50082365|FG001|Overall Study|Physician Decision|0|||
24992053|NCT03622580|50082366|FG002|Overall Study|Physician Decision|1|||
24992054|NCT03622580|50082364|FG000|Overall Study|Pregnancy|0|||
24992055|NCT03622580|50082365|FG001|Overall Study|Pregnancy|1|||
24992056|NCT03622580|50082366|FG002|Overall Study|Pregnancy|0|||
24992057|NCT03622580|50082364|FG000|Overall Study|Lack of Efficacy|0|||
24992058|NCT03622580|50082365|FG001|Overall Study|Lack of Efficacy|0|||
24992059|NCT03622580|50082366|FG002|Overall Study|Lack of Efficacy|1|||
24992060|NCT03622580|50082364|FG000|Overall Study|Other|2|||
24992061|NCT03622580|50082365|FG001|Overall Study|Other|0|||
24992062|NCT03622580|50082366|FG002|Overall Study|Other|3|||
24992063|NCT00461032|50082377|FG000|Overall Study|Adverse Event|5|||
24992064|NCT00461032|50082378|FG001|Overall Study|Adverse Event|6|||
24992065|NCT00461032|50082377|FG000|Overall Study|Lack of Efficacy|5|||
24992066|NCT00461032|50082378|FG001|Overall Study|Lack of Efficacy|1|||
24992067|NCT00461032|50082377|FG000|Overall Study|Lost to Follow-up|7|||
24992068|NCT00461032|50082378|FG001|Overall Study|Lost to Follow-up|12|||
24992069|NCT00461032|50082377|FG000|Overall Study|Protocol Violation|4|||
24992070|NCT00461032|50082378|FG001|Overall Study|Protocol Violation|4|||
24992071|NCT00461032|50082377|FG000|Overall Study|Withdrawal by Subject|7|||
24992072|NCT00461032|50082378|FG001|Overall Study|Withdrawal by Subject|15|||
24992073|NCT00461032|50082377|FG000|Overall Study|Patient Moved or Relocated|2|||
24992074|NCT00461032|50082378|FG001|Overall Study|Patient Moved or Relocated|1|||
24992075|NCT00461032|50082377|FG000|Overall Study|Other|7|||
24992076|NCT00461032|50082378|FG001|Overall Study|Other|5|||
24992077|NCT00090142|50082384|FG000|Treatment Period I|Lost to Follow-up|1|||
24992078|NCT00090142|50082385|FG001|Treatment Period I|Lost to Follow-up|2|||
24992079|NCT00090142|50082384|FG000|Treatment Period I|Protocol Violation|2|||
24992080|NCT00090142|50082385|FG001|Treatment Period I|Protocol Violation|0|||
24992081|NCT00090142|50082384|FG000|Treatment Period I|Withdrawal by Subject|2|||
24992082|NCT00090142|50082385|FG001|Treatment Period I|Withdrawal by Subject|0|||
24992083|NCT00090142|50082384|FG000|Treatment Period I|Other|0|||
24992084|NCT00090142|50082385|FG001|Treatment Period I|Other|1|||
24992085|NCT00090142|50082384|FG000|Treatment Period II|Other|1|||
24992086|NCT00090142|50082385|FG001|Treatment Period II|Other|0|||
24992087|NCT03622112|50082402|FG000|Overall Study|Withdrawal by Subject|6|||
24992088|NCT03622112|50082403|FG001|Overall Study|Withdrawal by Subject|2|||
24992089|NCT03622112|50082404|FG002|Overall Study|Withdrawal by Subject|4|||
24992090|NCT03622112|50082405|FG003|Overall Study|Withdrawal by Subject|2|||
24992091|NCT03622112|50082406|FG004|Overall Study|Withdrawal by Subject|1|||
24992092|NCT03622112|50082407|FG005|Overall Study|Withdrawal by Subject|2|||
24992093|NCT03622112|50082408|FG006|Overall Study|Withdrawal by Subject|2|||
24992094|NCT03622112|50082402|FG000|Overall Study|Death|0|||
24992095|NCT03622112|50082403|FG001|Overall Study|Death|0|||
24992096|NCT03622112|50082404|FG002|Overall Study|Death|0|||
24992097|NCT03622112|50082405|FG003|Overall Study|Death|1|||
24992098|NCT03622112|50082406|FG004|Overall Study|Death|0|||
24992099|NCT03622112|50082407|FG005|Overall Study|Death|0|||
24992100|NCT03622112|50082408|FG006|Overall Study|Death|0|||
24992101|NCT03622112|50082402|FG000|Overall Study|Lost to Follow-up|1|||
24992102|NCT03622112|50082403|FG001|Overall Study|Lost to Follow-up|1|||
24992103|NCT03622112|50082404|FG002|Overall Study|Lost to Follow-up|0|||
24992104|NCT03622112|50082405|FG003|Overall Study|Lost to Follow-up|0|||
24992105|NCT03622112|50082406|FG004|Overall Study|Lost to Follow-up|0|||
24992106|NCT03622112|50082407|FG005|Overall Study|Lost to Follow-up|0|||
24992107|NCT03622112|50082408|FG006|Overall Study|Lost to Follow-up|0|||
24992108|NCT03622112|50082402|FG000|Overall Study|Study-specific withdrawal criteria|10|||
24992109|NCT03622112|50082403|FG001|Overall Study|Study-specific withdrawal criteria|8|||
24992110|NCT03622112|50082404|FG002|Overall Study|Study-specific withdrawal criteria|7|||
25079489|NCT00893789|50187960|FG000|Overall Study|Protocol Violation|0|||
24992111|NCT03622112|50082405|FG003|Overall Study|Study-specific withdrawal criteria|6|||
24992112|NCT03622112|50082406|FG004|Overall Study|Study-specific withdrawal criteria|4|||
24992113|NCT03622112|50082407|FG005|Overall Study|Study-specific withdrawal criteria|18|||
24992114|NCT03622112|50082408|FG006|Overall Study|Study-specific withdrawal criteria|4|||
24992115|NCT03622112|50082402|FG000|Overall Study|Protocol Violation|2|||
24992116|NCT03622112|50082403|FG001|Overall Study|Protocol Violation|0|||
24992117|NCT03622112|50082404|FG002|Overall Study|Protocol Violation|1|||
24992118|NCT03622112|50082405|FG003|Overall Study|Protocol Violation|1|||
24992119|NCT03622112|50082406|FG004|Overall Study|Protocol Violation|0|||
24992120|NCT03622112|50082407|FG005|Overall Study|Protocol Violation|0|||
24992121|NCT03622112|50082408|FG006|Overall Study|Protocol Violation|0|||
24992122|NCT03622112|50082402|FG000|Overall Study|Adverse Event|6|||
24992123|NCT03622112|50082403|FG001|Overall Study|Adverse Event|8|||
24992124|NCT03622112|50082404|FG002|Overall Study|Adverse Event|4|||
24992125|NCT03622112|50082405|FG003|Overall Study|Adverse Event|11|||
24992126|NCT03622112|50082406|FG004|Overall Study|Adverse Event|4|||
24992127|NCT03622112|50082407|FG005|Overall Study|Adverse Event|20|||
24992128|NCT03622112|50082408|FG006|Overall Study|Adverse Event|2|||
24992129|NCT03622112|50082402|FG000|Overall Study|Reason not specified|0|||
24992130|NCT03622112|50082403|FG001|Overall Study|Reason not specified|1|||
24992131|NCT03622112|50082404|FG002|Overall Study|Reason not specified|0|||
24992132|NCT03622112|50082405|FG003|Overall Study|Reason not specified|1|||
24992133|NCT03622112|50082406|FG004|Overall Study|Reason not specified|1|||
24992134|NCT03622112|50082407|FG005|Overall Study|Reason not specified|2|||
24992135|NCT03622112|50082408|FG006|Overall Study|Reason not specified|1|||
24992136|NCT04032158|50082426|FG000|Overall Study|Study Termination|2|||
24992137|NCT04032158|50082427|FG001|Overall Study|Study Termination|1|||
24992138|NCT03620708|50082436|FG000|Overall Study|Lost to Follow-up|1|||
24992139|NCT03620708|50082437|FG001|Overall Study|Lost to Follow-up|1|||
24992140|NCT03620708|50082438|FG002|Overall Study|Lost to Follow-up|2|||
24992141|NCT03620708|50082436|FG000|Overall Study|Withdrawal by Subject|0|||
24992142|NCT03620708|50082437|FG001|Overall Study|Withdrawal by Subject|0|||
24992143|NCT03620708|50082438|FG002|Overall Study|Withdrawal by Subject|1|||
24992144|NCT03654326|50082448|FG000|Overall Study|Withdrawal by Subject|5|||
24992145|NCT03654326|50082449|FG001|Overall Study|Withdrawal by Subject|3|||
24992146|NCT03654326|50082448|FG000|Overall Study|Physician Decision|0|||
24992147|NCT03654326|50082449|FG001|Overall Study|Physician Decision|1|||
24992148|NCT03654326|50082448|FG000|Overall Study|Unable to adhere to study schedule|0|||
24992149|NCT03654326|50082449|FG001|Overall Study|Unable to adhere to study schedule|1|||
24992150|NCT03654326|50082448|FG000|Overall Study|Lost to Follow-up|1|||
24992151|NCT03654326|50082449|FG001|Overall Study|Lost to Follow-up|1|||
24992152|NCT04025684|50082459|FG000|Overall Study|Withdrawal by Subject|1|||
24992153|NCT04025684|50082460|FG001|Overall Study|Withdrawal by Subject|1|||
24992154|NCT04025684|50082461|FG002|Overall Study|Withdrawal by Subject|0|||
24992155|NCT04025684|50082462|FG003|Overall Study|Withdrawal by Subject|0|||
24992156|NCT04025684|50082459|FG000|Overall Study|Multiple reasons|1|||
24992157|NCT04025684|50082460|FG001|Overall Study|Multiple reasons|3|||
24992158|NCT04025684|50082461|FG002|Overall Study|Multiple reasons|0|||
24992159|NCT04025684|50082462|FG003|Overall Study|Multiple reasons|1|||
24992160|NCT03617588|50082474|FG000|Overall Study|Withdrawal by Subject|1|||
24992161|NCT03617588|50082475|FG001|Overall Study|Withdrawal by Subject|0|||
24992162|NCT03616106|50082487|FG000|Overall Study|Removed by PI|6|||
24992163|NCT03616106|50082488|FG001|Overall Study|Removed by PI|0|||
24992164|NCT03616106|50082487|FG000|Overall Study|Withdrawal by Subject|1|||
24992165|NCT03616106|50082488|FG001|Overall Study|Withdrawal by Subject|1|||
24992166|NCT03616106|50082487|FG000|Overall Study|Lost to Follow-up|7|||
24992167|NCT03616106|50082488|FG001|Overall Study|Lost to Follow-up|0|||
24992168|NCT04019054|50082495|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
24992169|NCT04019054|50082496|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
24992170|NCT04019054|50082495|FG000|Overall Study|Withdrawal by Subject|3|||
24992171|NCT04019054|50082496|FG001|Overall Study|Withdrawal by Subject|1|||
24992172|NCT00071799|50082504|FG000|Overall Study|Adverse Event|19|||
24992173|NCT00071799|50082505|FG001|Overall Study|Adverse Event|10|||
24992174|NCT00071799|50082504|FG000|Overall Study|Protocol Violation|1|||
24992175|NCT00071799|50082505|FG001|Overall Study|Protocol Violation|7|||
24992176|NCT00071799|50082504|FG000|Overall Study|Lost to Follow-up|1|||
24992177|NCT00071799|50082505|FG001|Overall Study|Lost to Follow-up|1|||
24992178|NCT00071799|50082504|FG000|Overall Study|Withdrawal by Subject|15|||
24992179|NCT00071799|50082505|FG001|Overall Study|Withdrawal by Subject|37|||
24992180|NCT00071799|50082504|FG000|Overall Study|Physician Decision|0|||
24992181|NCT00071799|50082505|FG001|Overall Study|Physician Decision|2|||
24992182|NCT00071799|50082504|FG000|Overall Study|Lack of Efficacy|11|||
24992183|NCT00071799|50082505|FG001|Overall Study|Lack of Efficacy|18|||
24992184|NCT00071799|50082504|FG000|Overall Study|Disease Progression|23|||
24992185|NCT00071799|50082505|FG001|Overall Study|Disease Progression|20|||
24992186|NCT00071799|50082504|FG000|Overall Study|Different Central+Local Pathology Review|0|||
24992187|NCT00071799|50082505|FG001|Overall Study|Different Central+Local Pathology Review|1|||
24992188|NCT00071799|50082504|FG000|Overall Study|Not Documented|0|||
24992189|NCT00071799|50082505|FG001|Overall Study|Not Documented|2|||
24992190|NCT03615482|50082519|FG000|Overall Study|Death|1|||
24992191|NCT03615482|50082520|FG001|Overall Study|Death|0|||
24992192|NCT03615482|50082519|FG000|Overall Study|Lost to Follow-up|7|||
24992193|NCT03615482|50082520|FG001|Overall Study|Lost to Follow-up|7|||
24992194|NCT03615482|50082519|FG000|Overall Study|Physician Decision|2|||
24992195|NCT03615482|50082520|FG001|Overall Study|Physician Decision|3|||
24992196|NCT03615482|50082519|FG000|Overall Study|Withdrawal by Subject|7|||
24992197|NCT03615482|50082520|FG001|Overall Study|Withdrawal by Subject|7|||
24995124|NCT03015220|50086012|FG003|Overall Study|Withdrawal by Subject|2|||
24995125|NCT03015220|50086009|FG000|Overall Study|Lost to Follow-up|0|||
24995126|NCT03015220|50086010|FG001|Overall Study|Lost to Follow-up|0|||
24995127|NCT03015220|50086011|FG002|Overall Study|Lost to Follow-up|1|||
24995128|NCT03015220|50086012|FG003|Overall Study|Lost to Follow-up|0|||
24995129|NCT00022659|50086022|FG000|Overall Study|Ineligible: wrong primary|1|||
24995130|NCT00022659|50086022|FG000|Overall Study|Never treated|1|||
24995131|NCT03014674|50086033|FG000|Overall Study|Withdrawal by Subject|1|||
24995132|NCT03014674|50086034|FG001|Overall Study|Withdrawal by Subject|0|||
24995133|NCT03014674|50086035|FG002|Overall Study|Withdrawal by Subject|0|||
24995134|NCT03018106|50086045|FG000|Overall Study|Lost to Follow-up|0|||
24995135|NCT03018106|50086046|FG001|Overall Study|Lost to Follow-up|1|||
25079490|NCT00893789|50187961|FG001|Overall Study|Protocol Violation|1|||
25079491|NCT00893789|50187962|FG002|Overall Study|Protocol Violation|1|||
25079492|NCT00893789|50187963|FG003|Overall Study|Protocol Violation|4|||
25079493|NCT00893789|50187960|FG000|Overall Study|Lost to Follow-up|0|||
25079494|NCT00893789|50187961|FG001|Overall Study|Lost to Follow-up|0|||
25079495|NCT00893789|50187962|FG002|Overall Study|Lost to Follow-up|0|||
25079496|NCT00893789|50187963|FG003|Overall Study|Lost to Follow-up|1|||
25079497|NCT02164864|50187976|FG000|Overall Study|Trial disease worsening|7|||
25079498|NCT02164864|50187977|FG001|Overall Study|Trial disease worsening|5|||
25079499|NCT02164864|50187978|FG002|Overall Study|Trial disease worsening|1|||
25079500|NCT02164864|50187976|FG000|Overall Study|Other pre-existing disease worsening|6|||
25079501|NCT02164864|50187977|FG001|Overall Study|Other pre-existing disease worsening|4|||
25079502|NCT02164864|50187978|FG002|Overall Study|Other pre-existing disease worsening|9|||
25079503|NCT02164864|50187976|FG000|Overall Study|Other Adverse Event (AE)|52|||
25079504|NCT02164864|50187977|FG001|Overall Study|Other Adverse Event (AE)|32|||
25079505|NCT02164864|50187978|FG002|Overall Study|Other Adverse Event (AE)|49|||
25079506|NCT02164864|50187976|FG000|Overall Study|Protocol Violation|2|||
25079507|NCT02164864|50187977|FG001|Overall Study|Protocol Violation|4|||
25079508|NCT02164864|50187978|FG002|Overall Study|Protocol Violation|1|||
25079509|NCT02164864|50187976|FG000|Overall Study|Lost to Follow-up|4|||
25079510|NCT02164864|50187977|FG001|Overall Study|Lost to Follow-up|3|||
25079511|NCT02164864|50187978|FG002|Overall Study|Lost to Follow-up|2|||
25079512|NCT02164864|50187976|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
25079513|NCT02164864|50187977|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
25079514|NCT02164864|50187978|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
25079515|NCT02164864|50187976|FG000|Overall Study|Other than stated|3|||
25079516|NCT02164864|50187977|FG001|Overall Study|Other than stated|4|||
25079517|NCT02164864|50187978|FG002|Overall Study|Other than stated|14|||
25079518|NCT02419807|50187989|FG000|Overall Study|Withdrawal by Subject|4|||
25079519|NCT02419807|50187989|FG000|Overall Study|Physician Decision|1|||
25079520|NCT02419807|50187989|FG000|Overall Study|Protocol Violation|5|||
25079521|NCT03857867|50187993|FG000|Overall Study|Physician Decision|1|||
25079522|NCT01628926|50188001|FG000|Overall Study|Adverse Event|13|||
25079523|NCT01628926|50188002|FG001|Overall Study|Adverse Event|11|||
25079524|NCT01628926|50188003|FG002|Overall Study|Adverse Event|9|||
25079525|NCT01628926|50188001|FG000|Overall Study|Lack of Efficacy|2|||
25079526|NCT01628926|50188002|FG001|Overall Study|Lack of Efficacy|1|||
25079527|NCT01628926|50188003|FG002|Overall Study|Lack of Efficacy|5|||
25079528|NCT01628926|50188001|FG000|Overall Study|Withdrawal by Subject|6|||
25079529|NCT01628926|50188002|FG001|Overall Study|Withdrawal by Subject|4|||
25079530|NCT01628926|50188003|FG002|Overall Study|Withdrawal by Subject|2|||
25079531|NCT01628926|50188001|FG000|Overall Study|Protocol Violation|0|||
25079532|NCT01628926|50188002|FG001|Overall Study|Protocol Violation|1|||
25079533|NCT01628926|50188003|FG002|Overall Study|Protocol Violation|0|||
25079534|NCT01628926|50188001|FG000|Overall Study|Discontinuation criteria|3|||
25079535|NCT01628926|50188002|FG001|Overall Study|Discontinuation criteria|4|||
25079536|NCT01628926|50188003|FG002|Overall Study|Discontinuation criteria|0|||
25079537|NCT01628926|50188001|FG000|Overall Study|Physician Decision|2|||
25079538|NCT01628926|50188002|FG001|Overall Study|Physician Decision|2|||
25079539|NCT01628926|50188003|FG002|Overall Study|Physician Decision|1|||
25079540|NCT01628848|50188014|FG000|Overall Study|Adverse Event|9|||
25079541|NCT01628848|50188015|FG001|Overall Study|Adverse Event|7|||
25079542|NCT01628848|50188014|FG000|Overall Study|Lack of Efficacy|0|||
25079543|NCT01628848|50188015|FG001|Overall Study|Lack of Efficacy|4|||
25079544|NCT01628848|50188014|FG000|Overall Study|Withdrawal by Subject|0|||
25079545|NCT01628848|50188015|FG001|Overall Study|Withdrawal by Subject|2|||
24992198|NCT03688620|50082529|FG000|Overall Study|Other|0|||
24992199|NCT03688620|50082530|FG001|Overall Study|Other|0|||
24992200|NCT03688620|50082531|FG002|Overall Study|Other|1|||
24992201|NCT03688620|50082529|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
24992202|NCT03688620|50082530|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
24992203|NCT03688620|50082531|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
24992204|NCT03688620|50082529|FG000|Overall Study|Lost to Follow-up|16|||
24992205|NCT03688620|50082530|FG001|Overall Study|Lost to Follow-up|0|||
24992206|NCT03688620|50082531|FG002|Overall Study|Lost to Follow-up|1|||
24992207|NCT03688620|50082529|FG000|Overall Study|Withdrawal by Subject|0|||
24992208|NCT03688620|50082530|FG001|Overall Study|Withdrawal by Subject|0|||
24992209|NCT03688620|50082531|FG002|Overall Study|Withdrawal by Subject|6|||
24992210|NCT00090363|50082544|FG000|Overall Study|Lost to Follow-up|1|||
24992211|NCT00090363|50082545|FG001|Overall Study|Lost to Follow-up|2|||
24992212|NCT00090363|50082546|FG002|Overall Study|Lost to Follow-up|1|||
24992213|NCT00090363|50082544|FG000|Overall Study|Withdrawal by Subject|7|||
24992214|NCT00090363|50082545|FG001|Overall Study|Withdrawal by Subject|7|||
24992215|NCT00090363|50082546|FG002|Overall Study|Withdrawal by Subject|6|||
24992216|NCT00090363|50082544|FG000|Overall Study|Study-specific discontinuation criteria|75|||
24992217|NCT00090363|50082545|FG001|Overall Study|Study-specific discontinuation criteria|74|||
24992218|NCT00090363|50082546|FG002|Overall Study|Study-specific discontinuation criteria|62|||
24992219|NCT00090363|50082544|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
24992220|NCT00090363|50082545|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
24992221|NCT00090363|50082546|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
24992222|NCT00090363|50082544|FG000|Overall Study|Consent expired|7|||
24992223|NCT00090363|50082545|FG001|Overall Study|Consent expired|10|||
24992224|NCT00090363|50082546|FG002|Overall Study|Consent expired|9|||
24992225|NCT00090363|50082544|FG000|Overall Study|Reasons not specified|2|||
24992226|NCT00090363|50082545|FG001|Overall Study|Reasons not specified|1|||
24992227|NCT00090363|50082546|FG002|Overall Study|Reasons not specified|1|||
24992228|NCT00090363|50082544|FG000|Overall Study|Continuing on study off treatment|14|||
24992229|NCT00090363|50082545|FG001|Overall Study|Continuing on study off treatment|13|||
24992230|NCT00090363|50082546|FG002|Overall Study|Continuing on study off treatment|16|||
24992231|NCT03652610|50082556|FG000|Overall Study|Lost to Follow-up|1|||
24992232|NCT03652610|50082557|FG001|Overall Study|Lost to Follow-up|0|||
24992233|NCT03652610|50082556|FG000|Overall Study|Withdrawal by Subject|3|||
24992234|NCT03652610|50082557|FG001|Overall Study|Withdrawal by Subject|5|||
24992235|NCT03615404|50082563|FG000|Overall Study|Death|1|||
24992236|NCT03615404|50082563|FG000|Overall Study|vaccine did not pass quality assurance|1|||
24992237|NCT03614156|50082570|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
24992238|NCT03614156|50082571|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
24992239|NCT03614156|50082572|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
24992240|NCT03614156|50082573|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
24992241|NCT03614156|50082570|FG000|Open-Label Treatment Period|Adverse Event|7|||
24992242|NCT03614156|50082571|FG001|Open-Label Treatment Period|Adverse Event|0|||
24992243|NCT03614156|50082572|FG002|Open-Label Treatment Period|Adverse Event|0|||
24992244|NCT03614156|50082573|FG003|Open-Label Treatment Period|Adverse Event|0|||
24992245|NCT03614156|50082570|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
24992246|NCT03614156|50082571|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
24992247|NCT03614156|50082572|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
24992248|NCT03614156|50082573|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
24992249|NCT03614156|50082570|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
24992250|NCT03614156|50082571|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
24992251|NCT03614156|50082572|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
24992252|NCT03614156|50082573|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
24992253|NCT03614156|50082570|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
24992254|NCT03614156|50082571|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
24992255|NCT03614156|50082572|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
24992256|NCT03614156|50082573|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
24992257|NCT03614156|50082570|FG000|Open-Label Treatment Period|Protocol Violation|2|||
24992258|NCT03614156|50082571|FG001|Open-Label Treatment Period|Protocol Violation|0|||
24992259|NCT03614156|50082572|FG002|Open-Label Treatment Period|Protocol Violation|0|||
24992260|NCT03614156|50082573|FG003|Open-Label Treatment Period|Protocol Violation|0|||
24992261|NCT03614156|50082570|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
24992262|NCT03614156|50082571|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
24992263|NCT03614156|50082572|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
24992264|NCT03614156|50082573|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
24992265|NCT03614156|50082570|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
24992266|NCT03614156|50082571|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
24992267|NCT03614156|50082572|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
24992268|NCT03614156|50082573|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
25079546|NCT01628848|50188014|FG000|Overall Study|Physician Decision|3|||
24992269|NCT03614156|50082570|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
24992270|NCT03614156|50082571|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
24992271|NCT03614156|50082572|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
24992272|NCT03614156|50082573|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
24992273|NCT03614156|50082570|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
24992274|NCT03614156|50082571|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
24992275|NCT03614156|50082572|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
24992276|NCT03614156|50082573|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
24992277|NCT03614156|50082570|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
24992278|NCT03614156|50082571|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
24992279|NCT03614156|50082572|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
24992280|NCT03614156|50082573|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
24992281|NCT03614156|50082570|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
24992282|NCT03614156|50082571|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
24992283|NCT03614156|50082572|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
24992284|NCT03614156|50082573|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
24992285|NCT03614156|50082570|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
24992286|NCT03614156|50082571|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
24992287|NCT03614156|50082572|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
24992288|NCT03614156|50082573|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
24992289|NCT03614156|50082570|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
24992290|NCT03614156|50082571|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
24992291|NCT03614156|50082572|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
24992292|NCT03614156|50082573|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
24992293|NCT03614156|50082570|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
24992294|NCT03614156|50082571|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
24992295|NCT03614156|50082572|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
24992296|NCT03614156|50082573|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
24992297|NCT03614156|50082570|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
24992298|NCT03614156|50082571|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
24992299|NCT03614156|50082572|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
24992300|NCT03614156|50082573|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
24992301|NCT03614156|50082570|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
24992302|NCT03614156|50082571|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
24992303|NCT03614156|50082572|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
24992304|NCT03614156|50082573|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
24992305|NCT03614078|50082585|FG000|Overall Study|Withdrawal by Subject|2|||
24992306|NCT03614078|50082586|FG001|Overall Study|Withdrawal by Subject|2|||
24992307|NCT03614078|50082587|FG002|Overall Study|Withdrawal by Subject|3|||
24992308|NCT03614078|50082585|FG000|Overall Study|Participant Did Not Return for Visit|0|||
24992309|NCT03614078|50082586|FG001|Overall Study|Participant Did Not Return for Visit|1|||
24992310|NCT03614078|50082587|FG002|Overall Study|Participant Did Not Return for Visit|0|||
24992311|NCT03614078|50082585|FG000|Overall Study|High Neutrophils|0|||
24992312|NCT03614078|50082586|FG001|Overall Study|High Neutrophils|0|||
24992313|NCT03614078|50082587|FG002|Overall Study|High Neutrophils|2|||
24992314|NCT03614078|50082585|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
24992315|NCT03614078|50082586|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
24992316|NCT03614078|50082587|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
24992317|NCT03614078|50082585|FG000|Overall Study|Exacerbation of Psoriasis|0|||
24992318|NCT03614078|50082586|FG001|Overall Study|Exacerbation of Psoriasis|1|||
24992319|NCT03614078|50082587|FG002|Overall Study|Exacerbation of Psoriasis|0|||
24992320|NCT03614078|50082585|FG000|Overall Study|Adverse Event|0|||
24992321|NCT03614078|50082586|FG001|Overall Study|Adverse Event|2|||
24992322|NCT03614078|50082587|FG002|Overall Study|Adverse Event|0|||
24992323|NCT03614078|50082585|FG000|Overall Study|Dizziness and Rash|0|||
24992324|NCT03614078|50082586|FG001|Overall Study|Dizziness and Rash|1|||
24992325|NCT03614078|50082587|FG002|Overall Study|Dizziness and Rash|0|||
24992326|NCT03613454|50082597|FG000|Overall Study|Protocol Violation|1|||
24992327|NCT03613454|50082598|FG001|Overall Study|Protocol Violation|0|||
24992328|NCT03613454|50082597|FG000|Overall Study|Protocol Violation|0|||
24992329|NCT03613454|50082598|FG001|Overall Study|Protocol Violation|1|||
24992330|NCT03581786|50082606|FG000|Overall Study|Death|17|||
24992331|NCT03581786|50082607|FG001|Overall Study|Death|12|||
24992332|NCT03581786|50082606|FG000|Overall Study|Withdrawal by Subject|2|||
24992333|NCT03581786|50082607|FG001|Overall Study|Withdrawal by Subject|4|||
24992334|NCT03581786|50082606|FG000|Overall Study|Lost to Follow-up|1|||
24992335|NCT03581786|50082607|FG001|Overall Study|Lost to Follow-up|0|||
24992336|NCT03581786|50082606|FG000|Overall Study|reason other than specified above|0|||
24992337|NCT03581786|50082607|FG001|Overall Study|reason other than specified above|1|||
24992338|NCT03581786|50082606|FG000|Overall Study|Ongoing in the study|123|||
24992339|NCT03581786|50082607|FG001|Overall Study|Ongoing in the study|129|||
24992340|NCT03580382|50082615|FG000|Overall Study|Early Termination of Study|0|||
24992341|NCT03580382|50082616|FG001|Overall Study|Early Termination of Study|3|||
24992342|NCT03579290|50082621|FG000|Overall Study|Lost to Follow-up|9|||
24992343|NCT03611582|50082627|FG000|Overall Study|Adverse Event|26|||
24992344|NCT03611582|50082628|FG001|Overall Study|Adverse Event|6|||
24992345|NCT03611582|50082627|FG000|Overall Study|Protocol Violation|0|||
24992346|NCT03611582|50082628|FG001|Overall Study|Protocol Violation|1|||
24992347|NCT03611582|50082627|FG000|Overall Study|Pregnancy|1|||
24992348|NCT03611582|50082628|FG001|Overall Study|Pregnancy|2|||
24992349|NCT03611582|50082627|FG000|Overall Study|Lack of Efficacy|0|||
24992350|NCT03611582|50082628|FG001|Overall Study|Lack of Efficacy|1|||
24992351|NCT03611582|50082627|FG000|Overall Study|At the discretion of the investigator|1|||
24992352|NCT03611582|50082628|FG001|Overall Study|At the discretion of the investigator|0|||
24992353|NCT03611582|50082627|FG000|Overall Study|Safety concern as judged by the investigator|1|||
24992354|NCT03611582|50082628|FG001|Overall Study|Safety concern as judged by the investigator|2|||
24992355|NCT03611582|50082627|FG000|Overall Study|Withdrawal by Subject|4|||
24992356|NCT03611582|50082628|FG001|Overall Study|Withdrawal by Subject|3|||
24992357|NCT03611582|50082627|FG000|Overall Study|Lost to Follow-up|18|||
24992358|NCT03611582|50082628|FG001|Overall Study|Lost to Follow-up|7|||
24992359|NCT03611582|50082627|FG000|Overall Study|other|17|||
24992360|NCT03611582|50082628|FG001|Overall Study|other|16|||
24992361|NCT04015518|50082639|FG000|Overall Study|Adverse Event|6|||
24992362|NCT04015518|50082640|FG001|Overall Study|Adverse Event|1|||
24992363|NCT04015518|50082641|FG002|Overall Study|Adverse Event|1|||
24992364|NCT04015518|50082642|FG003|Overall Study|Adverse Event|3|||
24992365|NCT04015518|50082643|FG004|Overall Study|Adverse Event|3|||
24992366|NCT04015518|50082639|FG000|Overall Study|Lack of Efficacy|1|||
24992367|NCT04015518|50082640|FG001|Overall Study|Lack of Efficacy|0|||
24992368|NCT04015518|50082641|FG002|Overall Study|Lack of Efficacy|1|||
24992369|NCT04015518|50082642|FG003|Overall Study|Lack of Efficacy|0|||
24992370|NCT04015518|50082643|FG004|Overall Study|Lack of Efficacy|4|||
24992371|NCT04015518|50082639|FG000|Overall Study|Lost to Follow-up|0|||
24992372|NCT04015518|50082640|FG001|Overall Study|Lost to Follow-up|0|||
24992373|NCT04015518|50082641|FG002|Overall Study|Lost to Follow-up|0|||
24992374|NCT04015518|50082642|FG003|Overall Study|Lost to Follow-up|0|||
24992375|NCT04015518|50082643|FG004|Overall Study|Lost to Follow-up|1|||
24992376|NCT04015518|50082639|FG000|Overall Study|Withdrawal by Subject|0|||
24992377|NCT04015518|50082640|FG001|Overall Study|Withdrawal by Subject|1|||
24992378|NCT04015518|50082641|FG002|Overall Study|Withdrawal by Subject|0|||
24992379|NCT04015518|50082642|FG003|Overall Study|Withdrawal by Subject|1|||
24992380|NCT04015518|50082643|FG004|Overall Study|Withdrawal by Subject|1|||
24992381|NCT04015518|50082639|FG000|Overall Study|Patient did not come for consecutive visits|0|||
24992382|NCT04015518|50082640|FG001|Overall Study|Patient did not come for consecutive visits|1|||
24992383|NCT04015518|50082641|FG002|Overall Study|Patient did not come for consecutive visits|0|||
24992384|NCT04015518|50082642|FG003|Overall Study|Patient did not come for consecutive visits|0|||
24992385|NCT04015518|50082643|FG004|Overall Study|Patient did not come for consecutive visits|0|||
24992386|NCT04015518|50082639|FG000|Overall Study|not willing to travel due to Covid-19|0|||
24992387|NCT04015518|50082640|FG001|Overall Study|not willing to travel due to Covid-19|0|||
24992388|NCT04015518|50082641|FG002|Overall Study|not willing to travel due to Covid-19|1|||
24992389|NCT04015518|50082642|FG003|Overall Study|not willing to travel due to Covid-19|0|||
24992390|NCT04015518|50082643|FG004|Overall Study|not willing to travel due to Covid-19|0|||
24992391|NCT04015518|50082639|FG000|Overall Study|Patient wants to discontinue treatment|0|||
24992392|NCT04015518|50082640|FG001|Overall Study|Patient wants to discontinue treatment|0|||
24992393|NCT04015518|50082641|FG002|Overall Study|Patient wants to discontinue treatment|0|||
24992394|NCT04015518|50082642|FG003|Overall Study|Patient wants to discontinue treatment|1|||
24992395|NCT04015518|50082643|FG004|Overall Study|Patient wants to discontinue treatment|0|||
24992396|NCT04015518|50082639|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
24992397|NCT04015518|50082640|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
25079547|NCT01628848|50188015|FG001|Overall Study|Physician Decision|1|||
25079548|NCT02164318|50188025|FG000|Overall Study|Withdrawal by Subject|0|||
25079549|NCT02164318|50188026|FG001|Overall Study|Withdrawal by Subject|1|||
25079550|NCT02164318|50188027|FG002|Overall Study|Withdrawal by Subject|0|||
25079551|NCT02164318|50188028|FG003|Overall Study|Withdrawal by Subject|1|||
25079552|NCT03436199|50188041|FG000|Overall Study|Adverse Event|15|||
25079553|NCT03436199|50188042|FG001|Overall Study|Adverse Event|40|||
25079554|NCT03436199|50188043|FG002|Overall Study|Adverse Event|7|||
24992398|NCT04015518|50082641|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
24992399|NCT04015518|50082642|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
24992400|NCT04015518|50082643|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
24992401|NCT04015518|50082639|FG000|Overall Study|Pregnancy|0|||
24992402|NCT04015518|50082640|FG001|Overall Study|Pregnancy|0|||
24992403|NCT04015518|50082641|FG002|Overall Study|Pregnancy|0|||
24992404|NCT04015518|50082642|FG003|Overall Study|Pregnancy|0|||
25079555|NCT03436199|50188041|FG000|Overall Study|Withdrawal by Subject|4|||
24992405|NCT04015518|50082643|FG004|Overall Study|Pregnancy|1|||
24992406|NCT04015518|50082639|FG000|Overall Study|Personal reasons|1|||
24992407|NCT04015518|50082640|FG001|Overall Study|Personal reasons|0|||
24992408|NCT04015518|50082641|FG002|Overall Study|Personal reasons|0|||
24992409|NCT04015518|50082642|FG003|Overall Study|Personal reasons|0|||
24992410|NCT04015518|50082643|FG004|Overall Study|Personal reasons|1|||
24992411|NCT04015518|50082639|FG000|Overall Study|Withdrew consent|1|||
24992412|NCT04015518|50082640|FG001|Overall Study|Withdrew consent|0|||
24992413|NCT04015518|50082641|FG002|Overall Study|Withdrew consent|0|||
24992414|NCT04015518|50082642|FG003|Overall Study|Withdrew consent|0|||
24992415|NCT04015518|50082643|FG004|Overall Study|Withdrew consent|0|||
24992416|NCT04015518|50082639|FG000|Overall Study|Prostate carcinoma|1|||
24992417|NCT04015518|50082640|FG001|Overall Study|Prostate carcinoma|0|||
24992418|NCT04015518|50082641|FG002|Overall Study|Prostate carcinoma|0|||
24992419|NCT04015518|50082642|FG003|Overall Study|Prostate carcinoma|0|||
24992420|NCT04015518|50082643|FG004|Overall Study|Prostate carcinoma|0|||
24992421|NCT04015518|50082639|FG000|Overall Study|Could not keep appointments due to work|1|||
24992422|NCT04015518|50082640|FG001|Overall Study|Could not keep appointments due to work|0|||
24992423|NCT04015518|50082641|FG002|Overall Study|Could not keep appointments due to work|0|||
24992424|NCT04015518|50082642|FG003|Overall Study|Could not keep appointments due to work|0|||
24992425|NCT04015518|50082643|FG004|Overall Study|Could not keep appointments due to work|0|||
24992426|NCT03577730|50082660|FG000|Overall Study|Physician Decision|3|||
24992427|NCT03577730|50082661|FG001|Overall Study|Physician Decision|1|||
24992428|NCT03577730|50082660|FG000|Overall Study|Did not receive allocated intervention|1|||
24992429|NCT03577730|50082661|FG001|Overall Study|Did not receive allocated intervention|0|||
24992430|NCT03608774|50082669|FG000|Overall Study|Lost to Follow-up|5|||
24992431|NCT03608774|50082670|FG001|Overall Study|Lost to Follow-up|5|||
24992432|NCT03608774|50082669|FG000|Overall Study|Withdrawal by Subject|1|||
24992433|NCT03608774|50082670|FG001|Overall Study|Withdrawal by Subject|0|||
24992434|NCT03608774|50082669|FG000|Overall Study|Protocol Violation|1|||
24992435|NCT03608774|50082670|FG001|Overall Study|Protocol Violation|0|||
24992436|NCT03608774|50082669|FG000|Overall Study|Not eligible at enrollment|0|||
24992437|NCT03608774|50082670|FG001|Overall Study|Not eligible at enrollment|1|||
24992438|NCT03608774|50082669|FG000|Overall Study|Health related event|0|||
24992439|NCT03608774|50082670|FG001|Overall Study|Health related event|1|||
24992440|NCT04021524|50082678|FG000|Overall Study|Change in surgical intervention|0|||
24992441|NCT04021524|50082679|FG001|Overall Study|Change in surgical intervention|1|||
24992442|NCT03607682|50082685|FG000|Overall Study|Withdrawal by Subject|1|||
24992443|NCT03607682|50082685|FG000|Overall Study|Disease progression|1|||
24992444|NCT03606668|50082689|FG000|Overall Study|Screen Failure|1|||
24992445|NCT03606668|50082689|FG000|Overall Study|Lost to Follow-up|1|||
24992446|NCT03601052|50082693|FG000|Overall Study|Lost to Follow-up|2|||
24992447|NCT03600740|50082702|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
24992448|NCT03600428|50082708|FG000|Overall Study|Not eligible|0|||
24992449|NCT03600428|50082709|FG001|Overall Study|Not eligible|1|||
24992450|NCT03600428|50082708|FG000|Overall Study|Lost to Follow-up|5|||
24992451|NCT03600428|50082709|FG001|Overall Study|Lost to Follow-up|4|||
24992452|NCT03575702|50082717|FG000|Overall Study|Withdrawal by Subject|1|||
24992453|NCT03575702|50082718|FG001|Overall Study|Withdrawal by Subject|1|||
24992454|NCT03575702|50082717|FG000|Overall Study|Lost to Follow-up|1|||
24992455|NCT03575702|50082718|FG001|Overall Study|Lost to Follow-up|2|||
24992456|NCT03575702|50082717|FG000|Overall Study|Protocol Violation|0|||
25257212|NCT01102231|50572269|FG000|Overall Study|Did not received the treatment|4|||
25257213|NCT01094743|50572274|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
25257214|NCT01095835|50572282|FG000|Overall Study|Adverse Event|8|||
25257215|NCT01095835|50572283|FG001|Overall Study|Adverse Event|6|||
25257216|NCT01095835|50572284|FG002|Overall Study|Adverse Event|6|||
25257217|NCT01095835|50572282|FG000|Overall Study|Lack of Efficacy|0|||
25257218|NCT01095835|50572283|FG001|Overall Study|Lack of Efficacy|1|||
25257219|NCT01095835|50572284|FG002|Overall Study|Lack of Efficacy|0|||
25257220|NCT01095835|50572282|FG000|Overall Study|Physician Decision|0|||
25257221|NCT01095835|50572283|FG001|Overall Study|Physician Decision|0|||
25257222|NCT01095835|50572284|FG002|Overall Study|Physician Decision|1|||
25257223|NCT01095835|50572282|FG000|Overall Study|Withdrawal by Subject|1|||
25257224|NCT01095835|50572283|FG001|Overall Study|Withdrawal by Subject|3|||
25257225|NCT01095835|50572284|FG002|Overall Study|Withdrawal by Subject|0|||
24992457|NCT03575702|50082718|FG001|Overall Study|Protocol Violation|1|||
24992458|NCT03575702|50082717|FG000|Overall Study|Patient non compliance|4|||
24992459|NCT03575702|50082718|FG001|Overall Study|Patient non compliance|0|||
24992460|NCT03575468|50082726|FG000|Overall Study|Withdrawal by Subject|3|||
24992461|NCT03575468|50082727|FG001|Overall Study|Withdrawal by Subject|0|||
24992462|NCT03575468|50082726|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
24992463|NCT03575468|50082727|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
24992464|NCT03575468|50082726|FG000|Overall Study|Lost to Follow-up|13|||
25257226|NCT01095835|50572282|FG000|Overall Study|Non study compliance|0|||
24992465|NCT03575468|50082727|FG001|Overall Study|Lost to Follow-up|17|||
24992466|NCT03573908|50082735|FG000|Treatment Period|Adverse Event|4|||
24992467|NCT03573908|50082736|FG001|Treatment Period|Adverse Event|9|||
24992468|NCT03573908|50082737|FG002|Treatment Period|Adverse Event|0|||
24992469|NCT03573908|50082738|FG003|Treatment Period|Adverse Event|0|||
24992470|NCT03573908|50082739|FG004|Treatment Period|Adverse Event|0|||
24992471|NCT03573908|50082735|FG000|Treatment Period|Protocol Violation|1|||
24992472|NCT03573908|50082736|FG001|Treatment Period|Protocol Violation|0|||
24992473|NCT03573908|50082737|FG002|Treatment Period|Protocol Violation|0|||
24992474|NCT03573908|50082738|FG003|Treatment Period|Protocol Violation|0|||
24992475|NCT03573908|50082739|FG004|Treatment Period|Protocol Violation|0|||
24992476|NCT03573908|50082735|FG000|Treatment Period|Withdrawal by Subject|7|||
24992477|NCT03573908|50082736|FG001|Treatment Period|Withdrawal by Subject|5|||
24992478|NCT03573908|50082737|FG002|Treatment Period|Withdrawal by Subject|0|||
24992479|NCT03573908|50082738|FG003|Treatment Period|Withdrawal by Subject|0|||
24992480|NCT03573908|50082739|FG004|Treatment Period|Withdrawal by Subject|0|||
24992481|NCT03573908|50082735|FG000|Treatment Period|Lost to Follow-up|7|||
24992482|NCT03573908|50082736|FG001|Treatment Period|Lost to Follow-up|6|||
24992483|NCT03573908|50082737|FG002|Treatment Period|Lost to Follow-up|0|||
24992484|NCT03573908|50082738|FG003|Treatment Period|Lost to Follow-up|0|||
24992485|NCT03573908|50082739|FG004|Treatment Period|Lost to Follow-up|0|||
24992486|NCT03573908|50082735|FG000|Treatment Period|Pregnancy|1|||
24992487|NCT03573908|50082736|FG001|Treatment Period|Pregnancy|0|||
24992488|NCT03573908|50082737|FG002|Treatment Period|Pregnancy|0|||
24992489|NCT03573908|50082738|FG003|Treatment Period|Pregnancy|0|||
24992490|NCT03573908|50082739|FG004|Treatment Period|Pregnancy|0|||
24992491|NCT03573908|50082735|FG000|Treatment Period|Other, Not Specified|4|||
24992492|NCT03573908|50082736|FG001|Treatment Period|Other, Not Specified|6|||
24992493|NCT03573908|50082737|FG002|Treatment Period|Other, Not Specified|0|||
24992494|NCT03573908|50082738|FG003|Treatment Period|Other, Not Specified|0|||
24992495|NCT03573908|50082739|FG004|Treatment Period|Other, Not Specified|0|||
24992496|NCT03573908|50082735|FG000|Randomized Withdrawal Period|Adverse Event|0|||
24992497|NCT03573908|50082736|FG001|Randomized Withdrawal Period|Adverse Event|0|||
24992498|NCT03573908|50082737|FG002|Randomized Withdrawal Period|Adverse Event|3|||
24992499|NCT03573908|50082738|FG003|Randomized Withdrawal Period|Adverse Event|0|||
24992500|NCT03573908|50082739|FG004|Randomized Withdrawal Period|Adverse Event|0|||
24992501|NCT03573908|50082735|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
24992502|NCT03573908|50082736|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
24992503|NCT03573908|50082737|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
24992504|NCT03573908|50082738|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
24992505|NCT03573908|50082739|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
24992506|NCT03573908|50082735|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
24992507|NCT03573908|50082736|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
24992508|NCT03573908|50082737|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
24992509|NCT03573908|50082738|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
24992510|NCT03573908|50082739|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
24992511|NCT03573908|50082735|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
24992512|NCT03573908|50082736|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
24992513|NCT03573908|50082737|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
24992514|NCT03573908|50082738|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
24992515|NCT03573908|50082739|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
24992516|NCT03573830|50082750|FG000|Overall Study|Dropped without completing treatment|0|||
24992517|NCT03573830|50082751|FG001|Overall Study|Dropped without completing treatment|7|||
24992518|NCT03573830|50082750|FG000|Overall Study|Lost to Follow-up|4|||
24992519|NCT03573830|50082751|FG001|Overall Study|Lost to Follow-up|0|||
24992520|NCT03595904|50082758|FG000|Overall Study|Protocol Violation|3|||
24992521|NCT03595904|50082759|FG001|Overall Study|Protocol Violation|1|||
24992522|NCT03595904|50082758|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
24992523|NCT03595904|50082759|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
24992524|NCT03595904|50082758|FG000|Overall Study|Insurance complications|1|||
24992525|NCT03595904|50082759|FG001|Overall Study|Insurance complications|0|||
24992526|NCT03595904|50082758|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
24992527|NCT03595904|50082759|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
24992528|NCT03595280|50082768|FG000|Overall Study|Lost to Follow-up|6|||
24992529|NCT03595280|50082769|FG001|Overall Study|Lost to Follow-up|9|||
24992530|NCT03595280|50082770|FG002|Overall Study|Lost to Follow-up|15|||
24992531|NCT03593876|50082778|FG000|Overall Study|Withdrawal by Subject|1|||
24992532|NCT03593876|50082778|FG000|Overall Study|Discharged home before intervention completion|2|||
24992533|NCT00071487|50082786|FG000|52-Week Double-Blind Period|Adverse Event|5|||
24992534|NCT00071487|50082787|FG001|52-Week Double-Blind Period|Adverse Event|8|||
24992535|NCT00071487|50082788|FG002|52-Week Double-Blind Period|Adverse Event|4|||
24992536|NCT00071487|50082789|FG003|52-Week Double-Blind Period|Adverse Event|8|||
24992537|NCT00071487|50082786|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
24992538|NCT00071487|50082787|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
24992539|NCT00071487|50082788|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
24992540|NCT00071487|50082789|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
24992541|NCT00071487|50082786|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
24992542|NCT00071487|50082787|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
24992543|NCT00071487|50082788|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
24992544|NCT00071487|50082789|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
24992545|NCT00071487|50082786|FG000|52-Week Double-Blind Period|Physician Decision|1|||
24992546|NCT00071487|50082787|FG001|52-Week Double-Blind Period|Physician Decision|0|||
24992547|NCT00071487|50082788|FG002|52-Week Double-Blind Period|Physician Decision|0|||
24992548|NCT00071487|50082789|FG003|52-Week Double-Blind Period|Physician Decision|0|||
24992549|NCT00071487|50082786|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
24992550|NCT00071487|50082787|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
24992551|NCT00071487|50082788|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
24992552|NCT00071487|50082789|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
24992553|NCT00071487|50082786|FG000|52-Week Double-Blind Period|Pregnancy|0|||
24992554|NCT00071487|50082787|FG001|52-Week Double-Blind Period|Pregnancy|1|||
24992555|NCT00071487|50082788|FG002|52-Week Double-Blind Period|Pregnancy|0|||
24992556|NCT00071487|50082789|FG003|52-Week Double-Blind Period|Pregnancy|0|||
24992557|NCT00071487|50082786|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
24992558|NCT00071487|50082787|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
24992559|NCT00071487|50082788|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
24992560|NCT00071487|50082789|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
24992561|NCT00071487|50082786|FG000|52-Week Double-Blind Period|Death|0|||
24992562|NCT00071487|50082787|FG001|52-Week Double-Blind Period|Death|1|||
24992563|NCT00071487|50082788|FG002|52-Week Double-Blind Period|Death|0|||
24992564|NCT00071487|50082789|FG003|52-Week Double-Blind Period|Death|0|||
24992565|NCT00071487|50082786|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
24992566|NCT00071487|50082787|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
24992567|NCT00071487|50082788|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
24992568|NCT00071487|50082789|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
24992569|NCT00071487|50082786|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
24992570|NCT00071487|50082787|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
24992571|NCT00071487|50082788|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
24992572|NCT00071487|50082789|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
24992573|NCT00071487|50082786|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
24992574|NCT00071487|50082787|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
24992575|NCT00071487|50082788|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
24992576|NCT00071487|50082789|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
24992577|NCT00071487|50082786|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
24992578|NCT00071487|50082787|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
24992579|NCT00071487|50082788|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
24992580|NCT00071487|50082789|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
24992581|NCT00071487|50082786|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
24992582|NCT00071487|50082787|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
24992583|NCT00071487|50082788|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
24992584|NCT00071487|50082789|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
24992585|NCT00071487|50082786|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
24992586|NCT00071487|50082787|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
24992587|NCT00071487|50082788|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
24992588|NCT00071487|50082789|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
24992589|NCT00071487|50082786|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
24992590|NCT00071487|50082787|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
24992591|NCT00071487|50082788|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
24992592|NCT00071487|50082789|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
24992593|NCT03591146|50082806|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
24992594|NCT03591146|50082807|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
24992595|NCT03591146|50082808|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
24992596|NCT03591146|50082809|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
24992597|NCT03591146|50082810|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
24992598|NCT03591146|50082806|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
24992599|NCT03591146|50082807|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
24992600|NCT03591146|50082808|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
24992601|NCT03591146|50082809|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
24992602|NCT03591146|50082810|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
24992603|NCT03591146|50082806|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
24992604|NCT03591146|50082807|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
24992605|NCT03591146|50082808|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
24992606|NCT03591146|50082809|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
24992607|NCT03591146|50082810|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
24992608|NCT03591146|50082806|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
24992609|NCT03591146|50082807|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
24992610|NCT03591146|50082808|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
24992611|NCT03591146|50082809|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
24992612|NCT03591146|50082810|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
24992613|NCT00096447|50082822|FG000|Overall Study|Never treated|1|||
24992614|NCT03590366|50082833|FG000|Overall Study|Adverse Event|0|||
24992615|NCT03590366|50082834|FG001|Overall Study|Adverse Event|3|||
24992616|NCT03590366|50082833|FG000|Overall Study|Lost to Follow-up|3|||
24992617|NCT03590366|50082834|FG001|Overall Study|Lost to Follow-up|3|||
24992618|NCT03590366|50082833|FG000|Overall Study|Withdrawal by Subject|0|||
24992619|NCT03590366|50082834|FG001|Overall Study|Withdrawal by Subject|2|||
24992620|NCT03588572|50082842|FG000|Visitation 1|Lack of Efficacy|1|||
24992621|NCT03588572|50082843|FG001|Visitation 1|Lack of Efficacy|1|||
24992622|NCT03588572|50082842|FG000|Visitation 2|Lost to Follow-up|1|||
24992623|NCT03588572|50082843|FG001|Visitation 2|Lost to Follow-up|1|||
24992624|NCT03588572|50082842|FG000|Visitation 2|Lack of Efficacy|0|||
24992625|NCT03588572|50082843|FG001|Visitation 2|Lack of Efficacy|1|||
24992626|NCT03588572|50082842|FG000|Visitation 2|Withdrawal by Subject|1|||
24992627|NCT03588572|50082843|FG001|Visitation 2|Withdrawal by Subject|0|||
24992628|NCT03588572|50082842|FG000|Visitation 3|Lost to Follow-up|1|||
24992629|NCT03588572|50082843|FG001|Visitation 3|Lost to Follow-up|1|||
24992630|NCT03588572|50082842|FG000|Visitation 3|Physician Decision|1|||
24992631|NCT03588572|50082843|FG001|Visitation 3|Physician Decision|1|||
24992632|NCT03588572|50082842|FG000|Visitation 3|Withdrawal by Subject|1|||
24992633|NCT03588572|50082843|FG001|Visitation 3|Withdrawal by Subject|0|||
24992634|NCT00090285|50082851|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
24992635|NCT00090285|50082852|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
24992636|NCT00090285|50082853|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
24992637|NCT00090285|50082854|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
24992638|NCT00090285|50082855|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
24992639|NCT00090285|50082856|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
24992640|NCT00090285|50082851|FG000|Base Study Vaccination Period|Adverse Event|2|||
24992641|NCT00090285|50082852|FG001|Base Study Vaccination Period|Adverse Event|4|||
24992642|NCT00090285|50082853|FG002|Base Study Vaccination Period|Adverse Event|0|||
24992643|NCT00090285|50082854|FG003|Base Study Vaccination Period|Adverse Event|0|||
24992644|NCT00090285|50082855|FG004|Base Study Vaccination Period|Adverse Event|0|||
24992645|NCT00090285|50082856|FG005|Base Study Vaccination Period|Adverse Event|0|||
24992646|NCT00090285|50082851|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
24992647|NCT00090285|50082852|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
24992648|NCT00090285|50082853|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
24992649|NCT00090285|50082854|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
24992650|NCT00090285|50082855|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
24992651|NCT00090285|50082856|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
24992652|NCT00090285|50082851|FG000|Base Study Vaccination Period|Protocol Violation|2|||
24992653|NCT00090285|50082852|FG001|Base Study Vaccination Period|Protocol Violation|3|||
24992654|NCT00090285|50082853|FG002|Base Study Vaccination Period|Protocol Violation|0|||
24992655|NCT00090285|50082854|FG003|Base Study Vaccination Period|Protocol Violation|0|||
24992656|NCT00090285|50082855|FG004|Base Study Vaccination Period|Protocol Violation|0|||
24992657|NCT00090285|50082856|FG005|Base Study Vaccination Period|Protocol Violation|0|||
24992658|NCT00090285|50082851|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
24992659|NCT00090285|50082852|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
24992660|NCT00090285|50082853|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
24992661|NCT00090285|50082854|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
24992662|NCT00090285|50082855|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
24992663|NCT00090285|50082856|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
24992664|NCT00090285|50082851|FG000|Base Study Vaccination Period|Uncooperative|2|||
24992665|NCT00090285|50082852|FG001|Base Study Vaccination Period|Uncooperative|2|||
24992666|NCT00090285|50082853|FG002|Base Study Vaccination Period|Uncooperative|0|||
24992667|NCT00090285|50082854|FG003|Base Study Vaccination Period|Uncooperative|0|||
24992668|NCT00090285|50082855|FG004|Base Study Vaccination Period|Uncooperative|0|||
24992669|NCT00090285|50082856|FG005|Base Study Vaccination Period|Uncooperative|0|||
25079556|NCT03436199|50188042|FG001|Overall Study|Withdrawal by Subject|10|||
25079557|NCT03436199|50188043|FG002|Overall Study|Withdrawal by Subject|3|||
24992670|NCT00090285|50082851|FG000|Base Study Vaccination Period|Moved|20|||
24992671|NCT00090285|50082852|FG001|Base Study Vaccination Period|Moved|21|||
24992672|NCT00090285|50082853|FG002|Base Study Vaccination Period|Moved|0|||
24992673|NCT00090285|50082854|FG003|Base Study Vaccination Period|Moved|0|||
25079558|NCT03436199|50188041|FG000|Overall Study|Lost to Follow-up|1|||
24992674|NCT00090285|50082855|FG004|Base Study Vaccination Period|Moved|0|||
24992675|NCT00090285|50082856|FG005|Base Study Vaccination Period|Moved|0|||
24992676|NCT00090285|50082851|FG000|Base Study Vaccination Period|Site Terminated|1|||
24992677|NCT00090285|50082852|FG001|Base Study Vaccination Period|Site Terminated|0|||
24992678|NCT00090285|50082853|FG002|Base Study Vaccination Period|Site Terminated|0|||
24992679|NCT00090285|50082854|FG003|Base Study Vaccination Period|Site Terminated|0|||
24992680|NCT00090285|50082855|FG004|Base Study Vaccination Period|Site Terminated|0|||
24992681|NCT00090285|50082856|FG005|Base Study Vaccination Period|Site Terminated|0|||
24992682|NCT00090285|50082851|FG000|Base Study Vaccination Period|Other|2|||
24992683|NCT00090285|50082852|FG001|Base Study Vaccination Period|Other|2|||
24992684|NCT00090285|50082853|FG002|Base Study Vaccination Period|Other|0|||
24992685|NCT00090285|50082854|FG003|Base Study Vaccination Period|Other|0|||
24992686|NCT00090285|50082855|FG004|Base Study Vaccination Period|Other|0|||
24992687|NCT00090285|50082856|FG005|Base Study Vaccination Period|Other|0|||
24992688|NCT00090285|50082851|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
24992689|NCT00090285|50082852|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
24992690|NCT00090285|50082853|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
24992691|NCT00090285|50082854|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
24992692|NCT00090285|50082855|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
24992693|NCT00090285|50082856|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
24992694|NCT00090285|50082851|FG000|Base Study Vaccination Period|HIV positive|1|||
24992695|NCT00090285|50082852|FG001|Base Study Vaccination Period|HIV positive|1|||
24992696|NCT00090285|50082853|FG002|Base Study Vaccination Period|HIV positive|0|||
24992697|NCT00090285|50082854|FG003|Base Study Vaccination Period|HIV positive|0|||
24992698|NCT00090285|50082855|FG004|Base Study Vaccination Period|HIV positive|0|||
24992699|NCT00090285|50082856|FG005|Base Study Vaccination Period|HIV positive|0|||
24992700|NCT00090285|50082851|FG000|Base Study Follow-up Period|Adverse Event|3|||
24992701|NCT00090285|50082852|FG001|Base Study Follow-up Period|Adverse Event|10|||
24992702|NCT00090285|50082853|FG002|Base Study Follow-up Period|Adverse Event|0|||
24992703|NCT00090285|50082854|FG003|Base Study Follow-up Period|Adverse Event|0|||
24992704|NCT00090285|50082855|FG004|Base Study Follow-up Period|Adverse Event|0|||
24992705|NCT00090285|50082856|FG005|Base Study Follow-up Period|Adverse Event|0|||
24992706|NCT00090285|50082851|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
24992707|NCT00090285|50082852|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
24992708|NCT00090285|50082853|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
24992709|NCT00090285|50082854|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
24992710|NCT00090285|50082855|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
24992711|NCT00090285|50082856|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
24992712|NCT00090285|50082851|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
24992713|NCT00090285|50082852|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
24992714|NCT00090285|50082853|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
24992715|NCT00090285|50082854|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
24992716|NCT00090285|50082855|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
24992717|NCT00090285|50082856|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
24992718|NCT00090285|50082851|FG000|Base Study Follow-up Period|Moved|41|||
24992719|NCT00090285|50082852|FG001|Base Study Follow-up Period|Moved|36|||
24992720|NCT00090285|50082853|FG002|Base Study Follow-up Period|Moved|0|||
24992721|NCT00090285|50082854|FG003|Base Study Follow-up Period|Moved|0|||
24992722|NCT00090285|50082855|FG004|Base Study Follow-up Period|Moved|0|||
24992723|NCT00090285|50082856|FG005|Base Study Follow-up Period|Moved|0|||
24992724|NCT00090285|50082851|FG000|Base Study Follow-up Period|Other|2|||
24992725|NCT00090285|50082852|FG001|Base Study Follow-up Period|Other|0|||
24992726|NCT00090285|50082853|FG002|Base Study Follow-up Period|Other|0|||
24992727|NCT00090285|50082854|FG003|Base Study Follow-up Period|Other|0|||
24992728|NCT00090285|50082855|FG004|Base Study Follow-up Period|Other|0|||
24992729|NCT00090285|50082856|FG005|Base Study Follow-up Period|Other|0|||
24992730|NCT00090285|50082851|FG000|Base Study Follow-up Period|Protocol Violation|1|||
24992731|NCT00090285|50082852|FG001|Base Study Follow-up Period|Protocol Violation|0|||
24992732|NCT00090285|50082853|FG002|Base Study Follow-up Period|Protocol Violation|0|||
24992733|NCT00090285|50082854|FG003|Base Study Follow-up Period|Protocol Violation|0|||
24992734|NCT00090285|50082855|FG004|Base Study Follow-up Period|Protocol Violation|0|||
25257227|NCT01095835|50572283|FG001|Overall Study|Non study compliance|0|||
25257228|NCT01095835|50572284|FG002|Overall Study|Non study compliance|1|||
25257229|NCT01095835|50572282|FG000|Overall Study|Protocol Violation|1|||
25257230|NCT01095835|50572283|FG001|Overall Study|Protocol Violation|2|||
25257231|NCT01095835|50572284|FG002|Overall Study|Protocol Violation|0|||
25257232|NCT01324232|50572297|FG000|Overall Study|Protocol Violation|0|||
25257233|NCT01324232|50572298|FG001|Overall Study|Protocol Violation|0|||
24992735|NCT00090285|50082856|FG005|Base Study Follow-up Period|Protocol Violation|0|||
24992736|NCT00090285|50082851|FG000|Base Study Follow-up Period|Uncooperative|3|||
24992737|NCT00090285|50082852|FG001|Base Study Follow-up Period|Uncooperative|4|||
24992738|NCT00090285|50082853|FG002|Base Study Follow-up Period|Uncooperative|0|||
25257234|NCT01324232|50572299|FG002|Overall Study|Protocol Violation|0|||
25257235|NCT01324232|50572300|FG003|Overall Study|Protocol Violation|2|||
24992739|NCT00090285|50082854|FG003|Base Study Follow-up Period|Uncooperative|0|||
24992740|NCT00090285|50082855|FG004|Base Study Follow-up Period|Uncooperative|0|||
24992741|NCT00090285|50082856|FG005|Base Study Follow-up Period|Uncooperative|0|||
24992742|NCT00090285|50082851|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
24992743|NCT00090285|50082852|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
24992744|NCT00090285|50082853|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
24992745|NCT00090285|50082854|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
24992746|NCT00090285|50082855|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
24992747|NCT00090285|50082856|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
24992748|NCT00090285|50082851|FG000|Extension 1|Adverse Event|0|||
24992749|NCT00090285|50082852|FG001|Extension 1|Adverse Event|0|||
24992750|NCT00090285|50082853|FG002|Extension 1|Adverse Event|2|||
24992751|NCT00090285|50082854|FG003|Extension 1|Adverse Event|0|||
24992752|NCT00090285|50082855|FG004|Extension 1|Adverse Event|0|||
24992753|NCT00090285|50082856|FG005|Extension 1|Adverse Event|0|||
24992754|NCT00090285|50082851|FG000|Extension 1|Lost to Follow-up|0|||
24992755|NCT00090285|50082852|FG001|Extension 1|Lost to Follow-up|0|||
24992756|NCT00090285|50082853|FG002|Extension 1|Lost to Follow-up|35|||
24992757|NCT00090285|50082854|FG003|Extension 1|Lost to Follow-up|0|||
24992758|NCT00090285|50082855|FG004|Extension 1|Lost to Follow-up|0|||
24992759|NCT00090285|50082856|FG005|Extension 1|Lost to Follow-up|0|||
24992760|NCT00090285|50082851|FG000|Extension 1|Withdrawal by Subject|0|||
24992761|NCT00090285|50082852|FG001|Extension 1|Withdrawal by Subject|0|||
24992762|NCT00090285|50082853|FG002|Extension 1|Withdrawal by Subject|13|||
24992763|NCT00090285|50082854|FG003|Extension 1|Withdrawal by Subject|1|||
24992764|NCT00090285|50082855|FG004|Extension 1|Withdrawal by Subject|0|||
24992765|NCT00090285|50082856|FG005|Extension 1|Withdrawal by Subject|0|||
24992766|NCT00090285|50082851|FG000|Extension 1|Other|0|||
24992767|NCT00090285|50082852|FG001|Extension 1|Other|0|||
24992768|NCT00090285|50082853|FG002|Extension 1|Other|4|||
24992769|NCT00090285|50082854|FG003|Extension 1|Other|0|||
24992770|NCT00090285|50082855|FG004|Extension 1|Other|0|||
24992771|NCT00090285|50082856|FG005|Extension 1|Other|0|||
24992772|NCT00090285|50082851|FG000|Extension 1|Moved|0|||
24992773|NCT00090285|50082852|FG001|Extension 1|Moved|0|||
24992774|NCT00090285|50082853|FG002|Extension 1|Moved|3|||
24992775|NCT00090285|50082854|FG003|Extension 1|Moved|0|||
24992776|NCT00090285|50082855|FG004|Extension 1|Moved|0|||
24992777|NCT00090285|50082856|FG005|Extension 1|Moved|0|||
24992778|NCT00090285|50082851|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
24992779|NCT00090285|50082852|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
24992780|NCT00090285|50082853|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
24992781|NCT00090285|50082854|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
24992782|NCT00090285|50082855|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
24992783|NCT00090285|50082856|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
24992784|NCT00090285|50082851|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
24992785|NCT00090285|50082852|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
24992786|NCT00090285|50082853|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
24992787|NCT00090285|50082854|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
24992788|NCT00090285|50082855|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
24992789|NCT00090285|50082856|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
24992790|NCT00090285|50082851|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
24992791|NCT00090285|50082852|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
24992792|NCT00090285|50082853|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
24992793|NCT00090285|50082854|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
24992794|NCT00090285|50082855|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
24992795|NCT00090285|50082856|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
24992796|NCT00090285|50082851|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
24992797|NCT00090285|50082852|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
24992798|NCT00090285|50082853|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
24992799|NCT00090285|50082854|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
24992800|NCT00090285|50082855|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
24992801|NCT00090285|50082856|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
24992802|NCT00070941|50082874|FG000|Overall Study|Adverse Event|10|||
24992803|NCT00070941|50082875|FG001|Overall Study|Adverse Event|8|||
24992804|NCT00070941|50082876|FG002|Overall Study|Adverse Event|4|||
24992805|NCT00070707|50082886|FG000|Overall Study|Adverse Event|1|||
24992806|NCT00070707|50082887|FG001|Overall Study|Adverse Event|2|||
24992807|NCT00070707|50082886|FG000|Overall Study|Lack of Efficacy|4|||
24992808|NCT00070707|50082887|FG001|Overall Study|Lack of Efficacy|1|||
24992809|NCT00070707|50082886|FG000|Overall Study|Protocol Violation|8|||
24992810|NCT00070707|50082887|FG001|Overall Study|Protocol Violation|4|||
24992811|NCT00070707|50082886|FG000|Overall Study|Unrelated to Study Medication|1|||
24992812|NCT00070707|50082887|FG001|Overall Study|Unrelated to Study Medication|0|||
24992813|NCT03036124|50082895|FG000|Overall Study|Lost to Follow-up|0|||
24992814|NCT03036124|50082896|FG001|Overall Study|Lost to Follow-up|2|||
24992815|NCT03036124|50082895|FG000|Overall Study|Withdrawal by Subject|5|||
24992816|NCT03036124|50082896|FG001|Overall Study|Withdrawal by Subject|4|||
25079559|NCT03436199|50188042|FG001|Overall Study|Lost to Follow-up|0|||
24992817|NCT00070317|50082902|FG000|Overall Study|Inevaluable (Never Treated)|1|||
24992818|NCT00070317|50082902|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
24992819|NCT00070317|50082902|FG000|Overall Study|Ineligible required test not done|1|||
24992820|NCT00070317|50082902|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
24992821|NCT00070317|50082902|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
24992822|NCT03649412|50082908|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
24992823|NCT03649412|50082909|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
24992824|NCT03649412|50082908|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
24992825|NCT03649412|50082909|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
24992826|NCT03649412|50082908|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
24992827|NCT03649412|50082909|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
24992828|NCT03649412|50082908|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
24992829|NCT03649412|50082909|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
24992830|NCT03649412|50082908|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
24992831|NCT03649412|50082909|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
24992832|NCT03649412|50082908|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
24992833|NCT03649412|50082909|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
24992834|NCT03587636|50082954|FG000|Overall Study|Lost to Follow-up|2|||
24992835|NCT03587636|50082955|FG001|Overall Study|Lost to Follow-up|5|||
24992836|NCT03586544|50082973|FG000|First Intervention|Adverse Event|0|||
24992837|NCT03586544|50082974|FG001|First Intervention|Adverse Event|1|||
24992838|NCT03586544|50082973|FG000|Second Intervention|Withdrawal by Subject|0|||
24992839|NCT03586544|50082974|FG001|Second Intervention|Withdrawal by Subject|1|||
24992840|NCT03585296|50082980|FG000|Overall Study|Adverse Event|1|||
24992841|NCT03585296|50082980|FG000|Overall Study|Lost to Follow-up|2|||
24992842|NCT03585296|50082980|FG000|Overall Study|Withdrawal by Subject|2|||
24992843|NCT03589768|50082988|FG000|Overall Study|Death|1|||
24992844|NCT03589768|50082989|FG001|Overall Study|Death|0|||
24992845|NCT03589768|50082990|FG002|Overall Study|Death|8|||
24992846|NCT03589768|50082991|FG003|Overall Study|Death|3|||
24992847|NCT03589768|50082988|FG000|Overall Study|Withdrawal by Subject|2|||
24992848|NCT03589768|50082989|FG001|Overall Study|Withdrawal by Subject|0|||
24992849|NCT03589768|50082990|FG002|Overall Study|Withdrawal by Subject|0|||
24992850|NCT03589768|50082991|FG003|Overall Study|Withdrawal by Subject|0|||
24992851|NCT03589768|50082988|FG000|Overall Study|Protocol Violation|1|||
24992852|NCT03589768|50082989|FG001|Overall Study|Protocol Violation|0|||
24992853|NCT03589768|50082990|FG002|Overall Study|Protocol Violation|0|||
24992854|NCT03589768|50082991|FG003|Overall Study|Protocol Violation|0|||
24992855|NCT02892422|50083001|FG000|Overall Study|Enrolled not treated|4|||
24992856|NCT02892422|50083001|FG000|Overall Study|Adverse Event|38|||
24992857|NCT02892422|50083001|FG000|Overall Study|Lack of Efficacy|32|||
24992858|NCT02892422|50083001|FG000|Overall Study|Non-compliance with study drug|11|||
24992859|NCT02892422|50083001|FG000|Overall Study|Protocol Violation|4|||
24992860|NCT02892422|50083001|FG000|Overall Study|Withdrawal by Subject|56|||
24992861|NCT02892422|50083001|FG000|Overall Study|Lost to Follow-up|5|||
24992862|NCT02892422|50083001|FG000|Overall Study|sponsor information 16159A results|21|||
24992863|NCT02892422|50083001|FG000|Overall Study|withdrawal of consent|13|||
24992864|NCT02892422|50083001|FG000|Overall Study|exclusion criteria met|3|||
24992865|NCT02892422|50083001|FG000|Overall Study|moving elsewhere|4|||
24992866|NCT02892422|50083001|FG000|Overall Study|non-compliance|10|||
24992867|NCT02892422|50083001|FG000|Overall Study|patient legally incapable|1|||
24992868|NCT02892422|50083001|FG000|Overall Study|patient decision|7|||
24992869|NCT02892422|50083001|FG000|Overall Study|Investigator decision|1|||
24992870|NCT03571646|50083007|FG000|Overall Study|Adverse Event|1|||
24992871|NCT03571646|50083008|FG001|Overall Study|Adverse Event|0|||
24992872|NCT03571646|50083007|FG000|Overall Study|Withdrawal by Subject|1|||
24992873|NCT03571646|50083008|FG001|Overall Study|Withdrawal by Subject|1|||
24992874|NCT03645434|50083014|FG000|Period 1|Adverse Event|0|||
24992875|NCT03645434|50083015|FG001|Period 1|Adverse Event|0|||
24992876|NCT03645434|50083016|FG002|Period 1|Adverse Event|0|||
24992877|NCT03645434|50083017|FG003|Period 1|Adverse Event|1|||
24992878|NCT03645434|50083018|FG004|Period 1|Adverse Event|0|||
24992879|NCT03645434|50083019|FG005|Period 1|Adverse Event|0|||
24992880|NCT03645434|50083014|FG000|Period 1|COPD exacerbation|0|||
24992881|NCT03645434|50083015|FG001|Period 1|COPD exacerbation|0|||
24992882|NCT03645434|50083016|FG002|Period 1|COPD exacerbation|0|||
24992883|NCT03645434|50083017|FG003|Period 1|COPD exacerbation|0|||
24992884|NCT03645434|50083018|FG004|Period 1|COPD exacerbation|1|||
24992885|NCT03645434|50083019|FG005|Period 1|COPD exacerbation|0|||
24992886|NCT00089505|50083031|FG000|Overall Study|Death|4|||
24992887|NCT00089505|50083032|FG001|Overall Study|Death|1|||
24992888|NCT00089505|50083033|FG002|Overall Study|Death|5|||
24992889|NCT00089505|50083034|FG003|Overall Study|Death|8|||
24992890|NCT00089505|50083031|FG000|Overall Study|Withdrawal by Subject|3|||
24992891|NCT00089505|50083032|FG001|Overall Study|Withdrawal by Subject|0|||
24992892|NCT00089505|50083033|FG002|Overall Study|Withdrawal by Subject|6|||
24992893|NCT00089505|50083034|FG003|Overall Study|Withdrawal by Subject|6|||
24992894|NCT00089505|50083031|FG000|Overall Study|Lost to Follow-up|1|||
24992895|NCT00089505|50083032|FG001|Overall Study|Lost to Follow-up|1|||
24992896|NCT00089505|50083033|FG002|Overall Study|Lost to Follow-up|9|||
24992897|NCT00089505|50083034|FG003|Overall Study|Lost to Follow-up|7|||
24992898|NCT00089505|50083031|FG000|Overall Study|Physician Decision|1|||
24992899|NCT00089505|50083032|FG001|Overall Study|Physician Decision|0|||
24992900|NCT00089505|50083033|FG002|Overall Study|Physician Decision|0|||
24992901|NCT00089505|50083034|FG003|Overall Study|Physician Decision|0|||
24992902|NCT00089505|50083031|FG000|Overall Study|Protocol Violation|0|||
24992903|NCT00089505|50083032|FG001|Overall Study|Protocol Violation|0|||
24992904|NCT00089505|50083033|FG002|Overall Study|Protocol Violation|1|||
24992905|NCT00089505|50083034|FG003|Overall Study|Protocol Violation|0|||
24992906|NCT04009824|50083049|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
24992907|NCT04009824|50083050|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
24992908|NCT04009824|50083051|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
24992909|NCT04009824|50083052|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
24992910|NCT04009824|50083053|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
24992911|NCT03555890|50083069|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
24992912|NCT03555890|50083070|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
24992913|NCT03555890|50083071|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
24992914|NCT03555890|50083072|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
24992915|NCT03688074|50083084|FG000|Overall Study|Adverse Event|0|||
24992916|NCT03688074|50083085|FG001|Overall Study|Adverse Event|1|||
24992917|NCT03688074|50083084|FG000|Overall Study|Other|1|||
24992918|NCT03688074|50083085|FG001|Overall Study|Other|0|||
24992919|NCT03630120|50083095|FG000|Overall Study|Disease progression|0|||
24992920|NCT03630120|50083096|FG001|Overall Study|Disease progression|1|||
24992921|NCT03630120|50083097|FG002|Overall Study|Disease progression|1|||
24992922|NCT03630120|50083098|FG003|Overall Study|Disease progression|1|||
24992923|NCT03555266|50083110|FG000|Overall Study|Protocol Violation|6|||
24992924|NCT03555266|50083111|FG001|Overall Study|Protocol Violation|4|||
24992925|NCT03629886|50083119|FG000|Overall Study|Migrated / moved from the study area|0|||
24992926|NCT03629886|50083120|FG001|Overall Study|Migrated / moved from the study area|55|||
24992927|NCT03629886|50083119|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
24992928|NCT03629886|50083120|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
24992929|NCT03629886|50083119|FG000|Overall Study|Study vaccine not administrated|0|||
24992930|NCT03629886|50083120|FG001|Overall Study|Study vaccine not administrated|3|||
24992931|NCT03629886|50083119|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
24992932|NCT03629886|50083120|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
24992933|NCT03629886|50083119|FG000|Overall Study|Refused vaccination step of the study|0|||
24992934|NCT03629886|50083120|FG001|Overall Study|Refused vaccination step of the study|44|||
24992935|NCT03656874|50083129|FG000|Overall Study|Lost to Follow-up|3|||
24992936|NCT03656874|50083130|FG001|Overall Study|Lost to Follow-up|17|||
24992937|NCT03554486|50083138|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
24992938|NCT03554486|50083139|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
24992939|NCT03554486|50083140|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
24992940|NCT03554486|50083138|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
24992941|NCT03554486|50083139|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
24992942|NCT03554486|50083140|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
24992943|NCT03554486|50083138|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
24992944|NCT03554486|50083139|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
24992945|NCT03554486|50083140|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
24992946|NCT03554018|50083149|FG000|Overall Study|Lost to Follow-up|3|||
24992947|NCT03554018|50083150|FG001|Overall Study|Lost to Follow-up|7|||
24992948|NCT03571256|50083159|FG000|Overall Study|Adverse Event|3|||
24992949|NCT03571256|50083160|FG001|Overall Study|Adverse Event|0|||
24992950|NCT03571256|50083161|FG002|Overall Study|Adverse Event|1|||
24992951|NCT03571256|50083159|FG000|Overall Study|Withdrawal by Subject|3|||
24992952|NCT03571256|50083160|FG001|Overall Study|Withdrawal by Subject|1|||
24992953|NCT03571256|50083161|FG002|Overall Study|Withdrawal by Subject|1|||
24992954|NCT03571256|50083159|FG000|Overall Study|Other than specified|0|||
24992955|NCT03571256|50083160|FG001|Overall Study|Other than specified|1|||
24992956|NCT03571256|50083161|FG002|Overall Study|Other than specified|1|||
24992957|NCT03571256|50083159|FG000|Overall Study|Protocol Violation|0|||
24992958|NCT03571256|50083160|FG001|Overall Study|Protocol Violation|1|||
24992959|NCT03571256|50083161|FG002|Overall Study|Protocol Violation|1|||
24992960|NCT03570554|50083175|FG000|Overall Study|Non-compliance with study drug|0|||
24992961|NCT03570554|50083176|FG001|Overall Study|Non-compliance with study drug|0|||
24992962|NCT03570554|50083177|FG002|Overall Study|Non-compliance with study drug|1|||
24992963|NCT03570554|50083178|FG003|Overall Study|Non-compliance with study drug|0|||
24992964|NCT03570554|50083175|FG000|Overall Study|Adverse Event|0|||
24992965|NCT03570554|50083176|FG001|Overall Study|Adverse Event|0|||
24992966|NCT03570554|50083177|FG002|Overall Study|Adverse Event|0|||
24992967|NCT03570554|50083178|FG003|Overall Study|Adverse Event|1|||
24992968|NCT04004208|50083190|FG000|Overall Study|Withdrawal by parent/guardian|1|||
24992969|NCT04004208|50083191|FG001|Overall Study|Withdrawal by parent/guardian|1|||
24992970|NCT04004208|50083190|FG000|Overall Study|Death|3|||
24992971|NCT04004208|50083191|FG001|Overall Study|Death|0|||
24992972|NCT04004208|50083190|FG000|Overall Study|COVID-19 pandemic|1|||
24992973|NCT04004208|50083191|FG001|Overall Study|COVID-19 pandemic|0|||
24992974|NCT04004208|50083190|FG000|Overall Study|Physician Decision|1|||
24992975|NCT04004208|50083191|FG001|Overall Study|Physician Decision|0|||
24992976|NCT04004208|50083190|FG000|Overall Study|Adverse Event|1|||
24992977|NCT04004208|50083191|FG001|Overall Study|Adverse Event|1|||
24992978|NCT03643952|50083197|FG000|Overall Study|Lack of Efficacy|1|||
24992979|NCT03035032|50083209|FG000|Overall Study|Adverse Event|2|||
24992980|NCT03035032|50083209|FG000|Overall Study|Death|9|||
24992981|NCT03035032|50083209|FG000|Overall Study|Lost to Follow-up|1|||
24992982|NCT03035032|50083209|FG000|Overall Study|Progressive Disease|22|||
24992983|NCT03035032|50083209|FG000|Overall Study|Protocol Violation|2|||
24992984|NCT03035032|50083209|FG000|Overall Study|Withdrawal by Subject|2|||
24992985|NCT03035032|50083209|FG000|Overall Study|Physician Decision|5|||
24992986|NCT03629184|50083215|FG000|Overall Study|Withdrawal by Subject|2|||
24992987|NCT03629184|50083216|FG001|Overall Study|Withdrawal by Subject|1|||
24992988|NCT03629184|50083215|FG000|Overall Study|Physician Decision|1|||
24992989|NCT03629184|50083216|FG001|Overall Study|Physician Decision|0|||
24992990|NCT03549338|50083234|FG000|Overall Study|Progressive Disease|1|||
24992991|NCT03549338|50083235|FG001|Overall Study|Progressive Disease|0|||
24992992|NCT03549338|50083236|FG002|Overall Study|Progressive Disease|0|||
24992993|NCT03549338|50083234|FG000|Overall Study|Clinical Progression|0|||
24992994|NCT03549338|50083235|FG001|Overall Study|Clinical Progression|1|||
24992995|NCT03549338|50083236|FG002|Overall Study|Clinical Progression|0|||
24992996|NCT03629028|50083244|FG000|Overall Study|Lost to Follow-up|26|||
24992997|NCT03629028|50083245|FG001|Overall Study|Lost to Follow-up|23|||
24992998|NCT03629028|50083244|FG000|Overall Study|Pregnancy|4|||
24992999|NCT03629028|50083245|FG001|Overall Study|Pregnancy|2|||
24993000|NCT03629028|50083244|FG000|Overall Study|intolerance to examination|2|||
24993001|NCT03629028|50083245|FG001|Overall Study|intolerance to examination|0|||
24993002|NCT03549104|50083263|FG000|Overall Study|Physician Decision|2|||
24993003|NCT03549104|50083264|FG001|Overall Study|Physician Decision|0|||
24993004|NCT03549104|50083263|FG000|Overall Study|Withdrawal by Subject|5|||
24993005|NCT03549104|50083264|FG001|Overall Study|Withdrawal by Subject|2|||
24993006|NCT03549104|50083263|FG000|Overall Study|Covid shelter in place|1|||
24993007|NCT03549104|50083264|FG001|Overall Study|Covid shelter in place|2|||
24993008|NCT02892344|50083272|FG000|Overall Study|Protocol deviation|3|||
24993009|NCT02892344|50083273|FG001|Overall Study|Protocol deviation|4|||
24993010|NCT02892344|50083272|FG000|Overall Study|Adverse Event|1|||
24993011|NCT02892344|50083273|FG001|Overall Study|Adverse Event|8|||
24993012|NCT02892344|50083272|FG000|Overall Study|Lost to Follow-up|0|||
24993013|NCT02892344|50083273|FG001|Overall Study|Lost to Follow-up|1|||
24993014|NCT02892344|50083272|FG000|Overall Study|Non-compliance with study treatment|0|||
24993015|NCT02892344|50083273|FG001|Overall Study|Non-compliance with study treatment|1|||
24993016|NCT02892344|50083272|FG000|Overall Study|Physician Decision|0|||
24993017|NCT02892344|50083273|FG001|Overall Study|Physician Decision|2|||
24993018|NCT02892344|50083272|FG000|Overall Study|Subject/guardian decision|0|||
24993019|NCT02892344|50083273|FG001|Overall Study|Subject/guardian decision|4|||
24993020|NCT02892344|50083272|FG000|Overall Study|Technical problems|0|||
24993021|NCT02892344|50083273|FG001|Overall Study|Technical problems|1|||
24993022|NCT03567980|50083279|FG000|Overall Study|Adverse Event|1|||
24993023|NCT02894840|50083287|FG000|Overall Study|Lost to Follow-up|1|||
24993024|NCT02894840|50083288|FG001|Overall Study|Lost to Follow-up|0|||
24993025|NCT02894840|50083289|FG002|Overall Study|Lost to Follow-up|3|||
24993026|NCT02894840|50083290|FG003|Overall Study|Lost to Follow-up|0|||
24993027|NCT03358030|50083309|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
24993028|NCT03358030|50083310|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
24993029|NCT03358030|50083311|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
24993030|NCT03358030|50083312|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
24993031|NCT03358030|50083309|FG000|Overall Study|Ineligibility|0|||
24993032|NCT03358030|50083310|FG001|Overall Study|Ineligibility|0|||
24993033|NCT03358030|50083311|FG002|Overall Study|Ineligibility|0|||
24993034|NCT03358030|50083312|FG003|Overall Study|Ineligibility|2|||
25079560|NCT03436199|50188043|FG002|Overall Study|Lost to Follow-up|2|||
24993035|NCT03358030|50083309|FG000|Overall Study|Voluntary Withdrawal|1|||
24993036|NCT03358030|50083310|FG001|Overall Study|Voluntary Withdrawal|1|||
24993037|NCT03358030|50083311|FG002|Overall Study|Voluntary Withdrawal|3|||
24993038|NCT03358030|50083312|FG003|Overall Study|Voluntary Withdrawal|1|||
24993039|NCT03358030|50083309|FG000|Overall Study|Other|0|||
24993040|NCT03358030|50083310|FG001|Overall Study|Other|0|||
24993041|NCT03358030|50083311|FG002|Overall Study|Other|1|||
24993042|NCT03358030|50083312|FG003|Overall Study|Other|0|||
24993043|NCT03566810|50083326|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
24993044|NCT03566810|50083327|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
24993045|NCT03566810|50083328|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
24993046|NCT03566810|50083329|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
24993047|NCT03628716|50083352|FG000|Overall Study|Adverse Event|1|||
24993048|NCT03628716|50083353|FG001|Overall Study|Adverse Event|1|||
24993049|NCT03628716|50083352|FG000|Overall Study|Death|1|||
24993050|NCT03628716|50083353|FG001|Overall Study|Death|0|||
24993051|NCT03628716|50083352|FG000|Overall Study|Lack of Efficacy|15|||
24993052|NCT03628716|50083353|FG001|Overall Study|Lack of Efficacy|20|||
24993053|NCT03628716|50083352|FG000|Overall Study|Withdrawal by Subject|1|||
24993054|NCT03628716|50083353|FG001|Overall Study|Withdrawal by Subject|2|||
24993055|NCT03628716|50083352|FG000|Overall Study|Study Terminated by Sponsor|1|||
24993056|NCT03628716|50083353|FG001|Overall Study|Study Terminated by Sponsor|0|||
24993057|NCT04002960|50083361|FG000|Overall Study|Withdrawn prior to Completion|2|||
24993058|NCT04002648|50083367|FG000|Overall Study|Lost to Follow-up|2|||
24993059|NCT04002648|50083368|FG001|Overall Study|Lost to Follow-up|0|||
24993060|NCT00088413|50083389|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
24993061|NCT00088413|50083390|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
24993062|NCT00088413|50083391|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
24993063|NCT00088413|50083392|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
24993064|NCT00088413|50083389|FG000|Overall Study|Adverse Events/Side Effects|0|||
24993065|NCT00088413|50083390|FG001|Overall Study|Adverse Events/Side Effects|1|||
24993066|NCT00088413|50083391|FG002|Overall Study|Adverse Events/Side Effects|1|||
24993067|NCT00088413|50083392|FG003|Overall Study|Adverse Events/Side Effects|0|||
24993068|NCT00088413|50083389|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
24993069|NCT00088413|50083390|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
24993070|NCT00088413|50083391|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
24993071|NCT00088413|50083392|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
24993072|NCT00088413|50083389|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
24993073|NCT00088413|50083390|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
24993074|NCT00088413|50083391|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
24993075|NCT00088413|50083392|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
24993076|NCT00088413|50083389|FG000|Overall Study|Death|0|||
24993077|NCT00088413|50083390|FG001|Overall Study|Death|1|||
24993078|NCT00088413|50083391|FG002|Overall Study|Death|0|||
24993079|NCT00088413|50083392|FG003|Overall Study|Death|0|||
24993080|NCT00088413|50083389|FG000|Overall Study|Progressive disease|9|||
24993081|NCT00088413|50083390|FG001|Overall Study|Progressive disease|11|||
24993082|NCT00088413|50083391|FG002|Overall Study|Progressive disease|8|||
24993083|NCT00088413|50083392|FG003|Overall Study|Progressive disease|14|||
24993084|NCT00088413|50083389|FG000|Overall Study|Other|0|||
24993085|NCT00088413|50083390|FG001|Overall Study|Other|1|||
24993086|NCT00088413|50083391|FG002|Overall Study|Other|0|||
24993087|NCT00088413|50083392|FG003|Overall Study|Other|0|||
24993088|NCT00088413|50083389|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
24993089|NCT00088413|50083390|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
24993090|NCT00088413|50083391|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
24993091|NCT00088413|50083392|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
24993092|NCT03995784|50083404|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
24993093|NCT00086385|50083419|FG000|Overall Study|Death|2|||
24993094|NCT00086385|50083420|FG001|Overall Study|Death|2|||
24993095|NCT00086385|50083421|FG002|Overall Study|Death|1|||
24993096|NCT00086385|50083422|FG003|Overall Study|Death|1|||
24993097|NCT03993288|50083434|FG000|Overall Study|Lost to Follow-up|2|||
24993098|NCT03993288|50083435|FG001|Overall Study|Lost to Follow-up|1|||
24993099|NCT03993288|50083434|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
24993100|NCT03993288|50083435|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
24993101|NCT03993288|50083434|FG000|Overall Study|wrong randomization|0|||
24993102|NCT03993288|50083435|FG001|Overall Study|wrong randomization|1|||
24993103|NCT03993288|50083434|FG000|Overall Study|improper enrollment|0|||
24993104|NCT03993288|50083435|FG001|Overall Study|improper enrollment|1|||
24993105|NCT03993288|50083434|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
24993106|NCT03993288|50083435|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
24993107|NCT03993288|50083434|FG000|Overall Study|developed SAE|2|||
24993108|NCT03993288|50083435|FG001|Overall Study|developed SAE|0|||
24993109|NCT03993288|50083434|FG000|Overall Study|consent withdrawal|1|||
24993110|NCT03993288|50083435|FG001|Overall Study|consent withdrawal|0|||
24993111|NCT03993288|50083434|FG000|Overall Study|did not follow the treatment schedule|1|||
24993112|NCT03993288|50083435|FG001|Overall Study|did not follow the treatment schedule|0|||
24993113|NCT03993288|50083434|FG000|Overall Study|did not follow the treatment regimen|1|||
24993114|NCT03993288|50083435|FG001|Overall Study|did not follow the treatment regimen|0|||
24993115|NCT03993288|50083434|FG000|Overall Study|Adverse Event|1|||
24993116|NCT03993288|50083435|FG001|Overall Study|Adverse Event|0|||
24993117|NCT03993288|50083434|FG000|Overall Study|Withdrawal by Subject|1|||
24993118|NCT03993288|50083435|FG001|Overall Study|Withdrawal by Subject|1|||
24993119|NCT03991494|50083441|FG000|Overall Study|Progressive Disease|4|||
24993120|NCT00086307|50083450|FG000|Overall Study|Lack of Efficacy|1|||
24993121|NCT00086307|50083451|FG001|Overall Study|Lack of Efficacy|1|||
24993122|NCT00086307|50083452|FG002|Overall Study|Lack of Efficacy|2|||
24993123|NCT00086307|50083450|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
24993124|NCT00086307|50083451|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
24993125|NCT00086307|50083452|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
24993126|NCT00086307|50083450|FG000|Overall Study|Nausea and headaches|0|||
24993127|NCT00086307|50083451|FG001|Overall Study|Nausea and headaches|0|||
24993128|NCT00086307|50083452|FG002|Overall Study|Nausea and headaches|1|||
24993129|NCT00086307|50083450|FG000|Overall Study|Constipation and sleepiness|0|||
24993130|NCT00086307|50083451|FG001|Overall Study|Constipation and sleepiness|0|||
24993131|NCT00086307|50083452|FG002|Overall Study|Constipation and sleepiness|1|||
24993132|NCT00086307|50083450|FG000|Overall Study|Suicidal ideation|0|||
24993133|NCT00086307|50083451|FG001|Overall Study|Suicidal ideation|0|||
24993134|NCT00086307|50083452|FG002|Overall Study|Suicidal ideation|1|||
24993135|NCT00086307|50083450|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
24993136|NCT00086307|50083451|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
24993137|NCT00086307|50083452|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
24993138|NCT00086307|50083450|FG000|Overall Study|Withdrawal by Subject|0|||
24993139|NCT00086307|50083451|FG001|Overall Study|Withdrawal by Subject|0|||
24993140|NCT00086307|50083452|FG002|Overall Study|Withdrawal by Subject|2|||
24993141|NCT03624972|50083463|FG000|Overall Study|Lost to Follow-up|2|||
24993142|NCT03624972|50083464|FG001|Overall Study|Lost to Follow-up|0|||
24993143|NCT03624972|50083465|FG002|Overall Study|Lost to Follow-up|0|||
24993144|NCT03624972|50083463|FG000|Overall Study|Withdrawal by Subject|0|||
24993145|NCT03624972|50083464|FG001|Overall Study|Withdrawal by Subject|2|||
24993146|NCT03624972|50083465|FG002|Overall Study|Withdrawal by Subject|0|||
24993147|NCT03988842|50083474|FG000|Overall Study|Death|1|||
24993148|NCT02668822|50083481|FG000|Overall Study|Protocol Violation|2|||
24993149|NCT02668822|50083482|FG001|Overall Study|Protocol Violation|0|||
24993150|NCT02668822|50083481|FG000|Overall Study|Study Terminated by Sponsor|7|||
24993151|NCT02668822|50083482|FG001|Overall Study|Study Terminated by Sponsor|9|||
24993152|NCT02524288|50083488|FG000|Overall Study|Adverse Event|115|||
24993153|NCT02524288|50083488|FG000|Overall Study|Lost to Follow-up|216|||
24993154|NCT02524288|50083488|FG000|Overall Study|Non-Compliance With Protocol|32|||
24993155|NCT02524288|50083488|FG000|Overall Study|Non-Compliance With Study Drug|14|||
24993156|NCT02524288|50083488|FG000|Overall Study|Pregnancy Wish|6|||
24993157|NCT02524288|50083488|FG000|Overall Study|Protocol Violation|6|||
24993158|NCT02524288|50083488|FG000|Overall Study|Screen Failure|2|||
24993159|NCT02524288|50083488|FG000|Overall Study|Site Discontinued Study Participation|1|||
24993160|NCT02524288|50083488|FG000|Overall Study|Study Terminated By Sponsor|1417|||
24993161|NCT02524288|50083488|FG000|Overall Study|Subject Moved|32|||
24993162|NCT02524288|50083488|FG000|Overall Study|Withdrawal by Subject|76|||
24993163|NCT02524288|50083488|FG000|Overall Study|Pregnancy|22|||
24993164|NCT02524288|50083488|FG000|Overall Study|Physician Decision|2|||
24993165|NCT03624504|50083492|FG000|Overall Study|Unsuccessful Implant|1|||
24993166|NCT02954952|50083499|FG000|Overall Study|Withdrawal by Subject|1|||
24993167|NCT02954952|50083500|FG001|Overall Study|Withdrawal by Subject|0|||
24993168|NCT02954952|50083501|FG002|Overall Study|Withdrawal by Subject|0|||
24993169|NCT02954952|50083499|FG000|Overall Study|No data collected|0|||
24993170|NCT02954952|50083500|FG001|Overall Study|No data collected|1|||
24993171|NCT02954952|50083501|FG002|Overall Study|No data collected|0|||
24993172|NCT03547154|50083511|FG000|Overall Study|Disease Progression/Recurrence|6|||
24993173|NCT03547154|50083512|FG001|Overall Study|Disease Progression/Recurrence|14|||
24993174|NCT03547154|50083511|FG000|Overall Study|Adverse Event|26|||
24993175|NCT03547154|50083512|FG001|Overall Study|Adverse Event|31|||
24993176|NCT03547154|50083511|FG000|Overall Study|Protocol Violation|6|||
24993177|NCT03547154|50083512|FG001|Overall Study|Protocol Violation|1|||
24993178|NCT03547154|50083511|FG000|Overall Study|Physician Decision|4|||
24993179|NCT03547154|50083512|FG001|Overall Study|Physician Decision|3|||
24993180|NCT03547154|50083511|FG000|Overall Study|Insufficient Therapeutic Response|13|||
24993181|NCT03547154|50083512|FG001|Overall Study|Insufficient Therapeutic Response|10|||
24993182|NCT03547154|50083511|FG000|Overall Study|Withdrawal by Subject|10|||
24993183|NCT03547154|50083512|FG001|Overall Study|Withdrawal by Subject|6|||
24993184|NCT03547154|50083511|FG000|Overall Study|Not Selected|0|||
24993185|NCT03547154|50083512|FG001|Overall Study|Not Selected|1|||
24993186|NCT03547154|50083511|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
24993187|NCT03547154|50083512|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
24993188|NCT02275546|50083518|FG000|Treatment Period 2|Withdrawal by Subject|2|||
24993189|NCT02275546|50083519|FG001|Treatment Period 2|Withdrawal by Subject|1|||
24993190|NCT02275546|50083518|FG000|Treatment Period 2|Protocol Violation|0|||
24993191|NCT02275546|50083519|FG001|Treatment Period 2|Protocol Violation|1|||
24993192|NCT03624192|50083525|FG000|Overall Study|Lost to Follow-up|1|||
24993193|NCT03624192|50083526|FG001|Overall Study|Lost to Follow-up|1|||
24993194|NCT03034954|50083536|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
24993195|NCT03034954|50083537|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
24993196|NCT00057837|50083545|FG000|Overall Study|Progression/relapse|12|||
24993197|NCT00057837|50083546|FG001|Overall Study|Progression/relapse|14|||
24993198|NCT00057837|50083545|FG000|Overall Study|Adverse Event|2|||
24993199|NCT00057837|50083546|FG001|Overall Study|Adverse Event|12|||
24993200|NCT00057837|50083545|FG000|Overall Study|Death|5|||
24993201|NCT00057837|50083546|FG001|Overall Study|Death|4|||
24993202|NCT00057837|50083545|FG000|Overall Study|Withdrawal by Subject|5|||
24993203|NCT00057837|50083546|FG001|Overall Study|Withdrawal by Subject|3|||
24993204|NCT00057837|50083545|FG000|Overall Study|Alternative therapy|0|||
24993205|NCT00057837|50083546|FG001|Overall Study|Alternative therapy|1|||
24993206|NCT00057837|50083545|FG000|Overall Study|Other complicating disease|2|||
24993207|NCT00057837|50083546|FG001|Overall Study|Other complicating disease|1|||
24993208|NCT00057837|50083545|FG000|Overall Study|Physician Decision|1|||
24993209|NCT00057837|50083546|FG001|Overall Study|Physician Decision|0|||
24993210|NCT00057837|50083545|FG000|Overall Study|Ineligible|3|||
24993211|NCT00057837|50083546|FG001|Overall Study|Ineligible|3|||
24993212|NCT00057837|50083545|FG000|Overall Study|Never started treatment|1|||
24993213|NCT00057837|50083546|FG001|Overall Study|Never started treatment|1|||
24993214|NCT03546842|50083552|FG000|Overall Study|Protocol Violation|1|||
24993215|NCT03546842|50083552|FG000|Overall Study|Withdrawal by Subject|2|||
24993216|NCT03640052|50083556|FG000|Overall Study|Lost to Follow-up|0|||
24993217|NCT03640052|50083557|FG001|Overall Study|Lost to Follow-up|1|||
24993218|NCT03640052|50083558|FG002|Overall Study|Lost to Follow-up|0|||
24993219|NCT03640052|50083559|FG003|Overall Study|Lost to Follow-up|0|||
24993220|NCT03640052|50083560|FG004|Overall Study|Lost to Follow-up|0|||
24993221|NCT00068601|50083574|FG000|Overall Study|Ineligible|11|||
24993222|NCT00068601|50083575|FG001|Overall Study|Ineligible|13|||
24993223|NCT00068601|50083574|FG000|Overall Study|Not evaluable: withdrew consent|5|||
24993224|NCT00068601|50083575|FG001|Overall Study|Not evaluable: withdrew consent|4|||
24993225|NCT00068601|50083574|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
24993226|NCT00068601|50083575|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
24993227|NCT00068601|50083574|FG000|Overall Study|Death|11|||
24993228|NCT00068601|50083575|FG001|Overall Study|Death|3|||
24993229|NCT00068601|50083574|FG000|Overall Study|Lost to Follow-up|3|||
24993230|NCT00068601|50083575|FG001|Overall Study|Lost to Follow-up|2|||
24993231|NCT00068601|50083574|FG000|Overall Study|Missing primary outcome data|30|||
24993232|NCT00068601|50083575|FG001|Overall Study|Missing primary outcome data|34|||
24993233|NCT03638258|50083584|FG000|Overall Study|Adverse Event|1|||
24993234|NCT03638258|50083585|FG001|Overall Study|Adverse Event|0|||
24993235|NCT03638258|50083586|FG002|Overall Study|Adverse Event|2|||
24993236|NCT03638258|50083584|FG000|Overall Study|Lost to Follow-up|2|||
24993237|NCT03638258|50083585|FG001|Overall Study|Lost to Follow-up|4|||
24993238|NCT03638258|50083586|FG002|Overall Study|Lost to Follow-up|5|||
24993239|NCT03638258|50083584|FG000|Overall Study|Pregnancy|0|||
24993240|NCT03638258|50083585|FG001|Overall Study|Pregnancy|0|||
24993241|NCT03638258|50083586|FG002|Overall Study|Pregnancy|1|||
24993242|NCT03638258|50083584|FG000|Overall Study|Protocol Violation|0|||
24993243|NCT03638258|50083585|FG001|Overall Study|Protocol Violation|0|||
24993244|NCT03638258|50083586|FG002|Overall Study|Protocol Violation|1|||
24993245|NCT03638258|50083584|FG000|Overall Study|Withdrawal by Subject|4|||
24993246|NCT03638258|50083585|FG001|Overall Study|Withdrawal by Subject|5|||
24993247|NCT03638258|50083586|FG002|Overall Study|Withdrawal by Subject|12|||
24993248|NCT03638258|50083584|FG000|Overall Study|Lack of Efficacy|0|||
24993249|NCT03638258|50083585|FG001|Overall Study|Lack of Efficacy|0|||
25079561|NCT03436199|50188041|FG000|Overall Study|Protocol Violation|1|||
25079562|NCT03436199|50188042|FG001|Overall Study|Protocol Violation|1|||
24993250|NCT03638258|50083586|FG002|Overall Study|Lack of Efficacy|2|||
24993251|NCT01670656|50083600|FG000|Overall Study|Non-compliance with study drug|0|||
24993252|NCT01670656|50083601|FG001|Overall Study|Non-compliance with study drug|0|||
24993253|NCT01670656|50083602|FG002|Overall Study|Non-compliance with study drug|3|||
24993254|NCT01670656|50083603|FG003|Overall Study|Non-compliance with study drug|0|||
24993255|NCT01670656|50083604|FG004|Overall Study|Non-compliance with study drug|1|||
24993256|NCT01670656|50083600|FG000|Overall Study|Pregnancy|0|||
24993257|NCT01670656|50083601|FG001|Overall Study|Pregnancy|0|||
25079563|NCT03436199|50188043|FG002|Overall Study|Protocol Violation|0|||
24993258|NCT01670656|50083602|FG002|Overall Study|Pregnancy|0|||
24993259|NCT01670656|50083603|FG003|Overall Study|Pregnancy|0|||
24993260|NCT01670656|50083604|FG004|Overall Study|Pregnancy|1|||
24993261|NCT01670656|50083600|FG000|Overall Study|Withdrawal by Subject|1|||
24993262|NCT01670656|50083601|FG001|Overall Study|Withdrawal by Subject|1|||
24993263|NCT01670656|50083602|FG002|Overall Study|Withdrawal by Subject|0|||
24993264|NCT01670656|50083603|FG003|Overall Study|Withdrawal by Subject|0|||
24993265|NCT01670656|50083604|FG004|Overall Study|Withdrawal by Subject|0|||
24993266|NCT01670656|50083600|FG000|Overall Study|Non-compliance with protocol|0|||
24993267|NCT01670656|50083601|FG001|Overall Study|Non-compliance with protocol|3|||
25079564|NCT03436199|50188041|FG000|Overall Study|Physician Decision|0|||
24993268|NCT01670656|50083602|FG002|Overall Study|Non-compliance with protocol|1|||
24993269|NCT01670656|50083603|FG003|Overall Study|Non-compliance with protocol|1|||
24993270|NCT01670656|50083604|FG004|Overall Study|Non-compliance with protocol|2|||
24993271|NCT01670656|50083600|FG000|Overall Study|Adverse Event|2|||
24993272|NCT01670656|50083601|FG001|Overall Study|Adverse Event|2|||
24993273|NCT01670656|50083602|FG002|Overall Study|Adverse Event|2|||
24993274|NCT01670656|50083603|FG003|Overall Study|Adverse Event|3|||
24993275|NCT01670656|50083604|FG004|Overall Study|Adverse Event|3|||
24993276|NCT01670656|50083600|FG000|Overall Study|Subject withdrew consent|0|||
24993277|NCT01670656|50083601|FG001|Overall Study|Subject withdrew consent|1|||
24993278|NCT01670656|50083602|FG002|Overall Study|Subject withdrew consent|2|||
24993279|NCT01670656|50083603|FG003|Overall Study|Subject withdrew consent|1|||
24993280|NCT01670656|50083604|FG004|Overall Study|Subject withdrew consent|1|||
24993281|NCT01670656|50083600|FG000|Overall Study|Lost to Follow-up|0|||
24993282|NCT01670656|50083601|FG001|Overall Study|Lost to Follow-up|0|||
24993283|NCT01670656|50083602|FG002|Overall Study|Lost to Follow-up|0|||
24993284|NCT01670656|50083603|FG003|Overall Study|Lost to Follow-up|0|||
24993285|NCT01670656|50083604|FG004|Overall Study|Lost to Follow-up|3|||
24993286|NCT01670656|50083600|FG000|Overall Study|Subject moved|0|||
24993287|NCT01670656|50083601|FG001|Overall Study|Subject moved|0|||
24993288|NCT01670656|50083602|FG002|Overall Study|Subject moved|0|||
24993289|NCT01670656|50083603|FG003|Overall Study|Subject moved|1|||
24993290|NCT01670656|50083604|FG004|Overall Study|Subject moved|0|||
24993291|NCT03621696|50083620|FG000|Overall Study|Not eligible|0|||
24993292|NCT03621696|50083621|FG001|Overall Study|Not eligible|0|||
24993293|NCT03621696|50083622|FG002|Overall Study|Not eligible|0|||
24993294|NCT03621696|50083623|FG003|Overall Study|Not eligible|5|||
24993295|NCT03621696|50083620|FG000|Overall Study|Withdrawal by Subject|1|||
24993296|NCT03621696|50083621|FG001|Overall Study|Withdrawal by Subject|1|||
24993297|NCT03621696|50083622|FG002|Overall Study|Withdrawal by Subject|1|||
24993298|NCT03621696|50083623|FG003|Overall Study|Withdrawal by Subject|0|||
24993299|NCT03621696|50083620|FG000|Overall Study|Physician Decision|0|||
24993300|NCT03621696|50083621|FG001|Overall Study|Physician Decision|0|||
24993301|NCT03621696|50083622|FG002|Overall Study|Physician Decision|1|||
24993302|NCT03621696|50083623|FG003|Overall Study|Physician Decision|0|||
24993303|NCT00068445|50083633|FG000|Randomization|Cancel|1|||
24993304|NCT00068445|50083634|FG001|Randomization|Cancel|3|||
24993305|NCT00068445|50083633|FG000|Randomization|Ineligible|1|||
24993306|NCT00068445|50083634|FG001|Randomization|Ineligible|1|||
24993307|NCT00068445|50083633|FG000|Treatment|Refused Further Treatment|13|||
24993308|NCT00068445|50083634|FG001|Treatment|Refused Further Treatment|10|||
24993309|NCT00068445|50083633|FG000|Treatment|Adverse Event|7|||
24993310|NCT00068445|50083634|FG001|Treatment|Adverse Event|1|||
24993311|NCT00068445|50083633|FG000|Treatment|Other (Specifics not available)|9|||
24993312|NCT00068445|50083634|FG001|Treatment|Other (Specifics not available)|5|||
24993313|NCT03653208|50083649|FG000|Overall Study|Withdrawal by Subject|0|||
24993314|NCT03653208|50083650|FG001|Overall Study|Withdrawal by Subject|0|||
24993315|NCT03653208|50083651|FG002|Overall Study|Withdrawal by Subject|0|||
24993316|NCT03653208|50083652|FG003|Overall Study|Withdrawal by Subject|0|||
24993317|NCT03653208|50083653|FG004|Overall Study|Withdrawal by Subject|1|||
24993318|NCT03653208|50083654|FG005|Overall Study|Withdrawal by Subject|0|||
24993319|NCT03653208|50083655|FG006|Overall Study|Withdrawal by Subject|0|||
24993320|NCT03653208|50083656|FG007|Overall Study|Withdrawal by Subject|1|||
24993321|NCT03653208|50083657|FG008|Overall Study|Withdrawal by Subject|1|||
24993322|NCT03545984|50083679|FG000|Overall Study|CSF cases not present during rotation|11|||
24993323|NCT03545984|50083680|FG001|Overall Study|CSF cases not present during rotation|9|||
24993324|NCT03033784|50083688|FG000|Overall Study|Anxiety related to MRI scanner|0|||
24993325|NCT03033784|50083689|FG001|Overall Study|Anxiety related to MRI scanner|1|||
24993326|NCT03033784|50083690|FG002|Overall Study|Anxiety related to MRI scanner|0|||
24993327|NCT03033784|50083691|FG003|Overall Study|Anxiety related to MRI scanner|0|||
24993328|NCT03033784|50083692|FG004|Overall Study|Anxiety related to MRI scanner|0|||
24993329|NCT03033784|50083693|FG005|Overall Study|Anxiety related to MRI scanner|0|||
24993330|NCT03033784|50083694|FG006|Overall Study|Anxiety related to MRI scanner|0|||
24993331|NCT03033784|50083695|FG007|Overall Study|Anxiety related to MRI scanner|0|||
24993332|NCT03033784|50083696|FG008|Overall Study|Anxiety related to MRI scanner|0|||
24993333|NCT03033784|50083697|FG009|Overall Study|Anxiety related to MRI scanner|0|||
24993334|NCT03033784|50083698|FG010|Overall Study|Anxiety related to MRI scanner|0|||
24993335|NCT03033784|50083699|FG011|Overall Study|Anxiety related to MRI scanner|0|||
24993336|NCT03033784|50083700|FG012|Overall Study|Anxiety related to MRI scanner|0|||
24993337|NCT03033784|50083688|FG000|Overall Study|Withdrawal by Subject|0|||
24993338|NCT03033784|50083689|FG001|Overall Study|Withdrawal by Subject|0|||
24993339|NCT03033784|50083690|FG002|Overall Study|Withdrawal by Subject|0|||
24993340|NCT03033784|50083691|FG003|Overall Study|Withdrawal by Subject|0|||
24993341|NCT03033784|50083692|FG004|Overall Study|Withdrawal by Subject|0|||
24993342|NCT03033784|50083693|FG005|Overall Study|Withdrawal by Subject|0|||
24993343|NCT03033784|50083694|FG006|Overall Study|Withdrawal by Subject|0|||
24993344|NCT03033784|50083695|FG007|Overall Study|Withdrawal by Subject|0|||
24993345|NCT03033784|50083696|FG008|Overall Study|Withdrawal by Subject|0|||
24993346|NCT03033784|50083697|FG009|Overall Study|Withdrawal by Subject|0|||
24993347|NCT03033784|50083698|FG010|Overall Study|Withdrawal by Subject|0|||
24993348|NCT03033784|50083699|FG011|Overall Study|Withdrawal by Subject|0|||
24993349|NCT03033784|50083700|FG012|Overall Study|Withdrawal by Subject|2|||
24993350|NCT00038649|50083711|FG000|Overall Study|Adverse Event|9|||
24993351|NCT03544268|50083717|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
24993352|NCT03544268|50083718|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
24993353|NCT03652818|50083729|FG000|Overall Study|Adverse Event|1|||
24993354|NCT03652818|50083730|FG001|Overall Study|Adverse Event|0|||
24993355|NCT03652818|50083731|FG002|Overall Study|Adverse Event|0|||
24993356|NCT03652818|50083732|FG003|Overall Study|Adverse Event|0|||
24993357|NCT03652818|50083733|FG004|Overall Study|Adverse Event|0|||
24993358|NCT03652818|50083729|FG000|Overall Study|Physician Decision|1|||
24993359|NCT03652818|50083730|FG001|Overall Study|Physician Decision|0|||
24993360|NCT03652818|50083731|FG002|Overall Study|Physician Decision|0|||
24993361|NCT03652818|50083732|FG003|Overall Study|Physician Decision|0|||
24993362|NCT03652818|50083733|FG004|Overall Study|Physician Decision|0|||
24993363|NCT03652818|50083729|FG000|Overall Study|Lost to Follow-up|0|||
24993364|NCT03652818|50083730|FG001|Overall Study|Lost to Follow-up|1|||
24993365|NCT03652818|50083731|FG002|Overall Study|Lost to Follow-up|2|||
24993366|NCT03652818|50083732|FG003|Overall Study|Lost to Follow-up|1|||
24993367|NCT03652818|50083733|FG004|Overall Study|Lost to Follow-up|1|||
24993368|NCT03619902|50083745|FG000|Overall Study|Termination of Study by Investigator|1|||
24993369|NCT03619902|50083745|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
24993370|NCT00620464|50083751|FG000|Overall Study|Adverse Event|15|||
24993371|NCT00620464|50083752|FG001|Overall Study|Adverse Event|17|||
24993372|NCT00620464|50083751|FG000|Overall Study|Lost to Follow-up|1|||
24993373|NCT00620464|50083752|FG001|Overall Study|Lost to Follow-up|1|||
24993374|NCT00620464|50083751|FG000|Overall Study|Planning Pregnancy|1|||
24993375|NCT00620464|50083752|FG001|Overall Study|Planning Pregnancy|4|||
24993376|NCT00620464|50083751|FG000|Overall Study|Personal|2|||
24993377|NCT00620464|50083752|FG001|Overall Study|Personal|2|||
24993378|NCT00620464|50083751|FG000|Overall Study|Used prohibited medication|1|||
24993379|NCT00620464|50083752|FG001|Overall Study|Used prohibited medication|0|||
24993380|NCT03652662|50083760|FG000|Overall Study|Withdrawal by Subject|2|||
24993381|NCT03652662|50083761|FG001|Overall Study|Withdrawal by Subject|1|||
24993382|NCT03652662|50083760|FG000|Overall Study|Lost to Follow-up|1|||
24993383|NCT03652662|50083761|FG001|Overall Study|Lost to Follow-up|0|||
24993384|NCT03560258|50083770|FG000|Overall Study|Lost to Follow-up|3|||
24993385|NCT03560258|50083771|FG001|Overall Study|Lost to Follow-up|0|||
24993386|NCT03560258|50083772|FG002|Overall Study|Lost to Follow-up|0|||
24993387|NCT03560258|50083770|FG000|Overall Study|Protocol Violation|0|||
24993388|NCT03560258|50083771|FG001|Overall Study|Protocol Violation|1|||
24993389|NCT03560258|50083772|FG002|Overall Study|Protocol Violation|0|||
24993390|NCT03560258|50083770|FG000|Overall Study|Withdrawal by Subject|0|||
24993391|NCT03560258|50083771|FG001|Overall Study|Withdrawal by Subject|0|||
24993392|NCT03560258|50083772|FG002|Overall Study|Withdrawal by Subject|1|||
24993393|NCT02768662|50083780|FG000|Overall Study|Adverse Event|1|||
24993394|NCT02768662|50083780|FG000|Overall Study|Lost to Follow-up|4|||
24993395|NCT02768662|50083780|FG000|Overall Study|Withdrawal by Subject|3|||
24993396|NCT02768662|50083780|FG000|Overall Study|Study terminated by Sponsor|78|||
24993397|NCT03539432|50083786|FG000|Overall Study|Lost to Follow-up|0|||
24993398|NCT03539432|50083787|FG001|Overall Study|Lost to Follow-up|1|||
24993399|NCT03615924|50083795|FG000|Overall Study|Withdrawal by Subject|2|||
24993400|NCT03615924|50083796|FG001|Overall Study|Withdrawal by Subject|5|||
24993401|NCT03615924|50083795|FG000|Overall Study|Death|3|||
24993402|NCT03615924|50083796|FG001|Overall Study|Death|1|||
24993403|NCT03615924|50083795|FG000|Overall Study|Lost to Follow-up|1|||
24993404|NCT03615924|50083796|FG001|Overall Study|Lost to Follow-up|0|||
24993405|NCT03615924|50083795|FG000|Overall Study|Randomized in error|1|||
24993406|NCT03615924|50083796|FG001|Overall Study|Randomized in error|0|||
24993407|NCT03615924|50083795|FG000|Overall Study|Study termination by Sponsor|94|||
24993408|NCT03615924|50083796|FG001|Overall Study|Study termination by Sponsor|86|||
24993409|NCT03535844|50083804|FG000|Overall Study|Withdrawal by Subject|0|||
24993410|NCT03535844|50083805|FG001|Overall Study|Withdrawal by Subject|1|||
24993411|NCT03533114|50083822|FG000|Overall|Adverse Event|16|||
24993412|NCT03533114|50083823|FG001|Overall|Adverse Event|11|||
24993413|NCT03533114|50083822|FG000|Overall|Consent Withdrawal by Participant|7|||
24993414|NCT03533114|50083823|FG001|Overall|Consent Withdrawal by Participant|6|||
24993415|NCT03533114|50083822|FG000|Overall|Lack of Efficacy|5|||
24993416|NCT03533114|50083823|FG001|Overall|Lack of Efficacy|3|||
24993417|NCT03533114|50083822|FG000|Overall|Lost to Follow-up|1|||
24993418|NCT03533114|50083823|FG001|Overall|Lost to Follow-up|1|||
24993419|NCT03533114|50083822|FG000|Overall|Physician Decision|0|||
24993420|NCT03533114|50083823|FG001|Overall|Physician Decision|2|||
24993421|NCT03533114|50083822|FG000|Overall|Protocol deviation|1|||
24993422|NCT03533114|50083823|FG001|Overall|Protocol deviation|1|||
24993423|NCT03533114|50083822|FG000|Overall|Failure to meet randomization criteria|1|||
24993424|NCT03533114|50083823|FG001|Overall|Failure to meet randomization criteria|2|||
24993425|NCT03533114|50083822|FG000|Overall|Non-Compliance with study drug|0|||
24993426|NCT03533114|50083823|FG001|Overall|Non-Compliance with study drug|1|||
24993427|NCT03533114|50083822|FG000|Overall|Other|0|||
24993428|NCT03533114|50083823|FG001|Overall|Other|1|||
24993429|NCT03533114|50083822|FG000|Open Label Titration and Optimization|Adverse Event|11|||
24993430|NCT03533114|50083823|FG001|Open Label Titration and Optimization|Adverse Event|8|||
24993431|NCT03533114|50083822|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
24993432|NCT03533114|50083823|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
24993433|NCT03533114|50083822|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
24993434|NCT03533114|50083823|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
24993435|NCT03533114|50083822|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
24993436|NCT03533114|50083823|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
24993437|NCT03533114|50083822|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
24993438|NCT03533114|50083823|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
24993439|NCT03533114|50083822|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
24993440|NCT03533114|50083823|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
24993441|NCT03533114|50083822|FG000|Stable Dose|Adverse Event|0|||
24993442|NCT03533114|50083823|FG001|Stable Dose|Adverse Event|2|||
24993443|NCT03533114|50083822|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
24993444|NCT03533114|50083823|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
24993445|NCT03533114|50083822|FG000|Stable Dose|Lack of Efficacy|1|||
24993446|NCT03533114|50083823|FG001|Stable Dose|Lack of Efficacy|0|||
24993447|NCT03533114|50083822|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
24993448|NCT03533114|50083823|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
24993449|NCT03533114|50083822|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
24993450|NCT03533114|50083823|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
24993451|NCT03533114|50083822|FG000|Open-Label Safety Extension|Adverse Event|3|||
24993452|NCT03533114|50083823|FG001|Open-Label Safety Extension|Adverse Event|0|||
24993453|NCT03533114|50083822|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
24993454|NCT03533114|50083823|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
24993455|NCT03533114|50083822|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
24993456|NCT03533114|50083823|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
24993457|NCT03533114|50083822|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
24993458|NCT03533114|50083823|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
24993459|NCT03533114|50083822|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
24993460|NCT03533114|50083823|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
24993461|NCT03033394|50083831|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
24993462|NCT03033394|50083831|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
24993463|NCT03033394|50083831|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
24993464|NCT03033394|50083831|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
24993465|NCT03033394|50083831|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
24993466|NCT03981822|50083848|FG000|Overall Study|Lost to Follow-up|0|||
24993467|NCT03981822|50083849|FG001|Overall Study|Lost to Follow-up|1|||
24993468|NCT03981822|50083850|FG002|Overall Study|Lost to Follow-up|1|||
24993469|NCT03981822|50083851|FG003|Overall Study|Lost to Follow-up|0|||
24993470|NCT03981822|50083852|FG004|Overall Study|Lost to Follow-up|6|||
24993471|NCT03981822|50083853|FG005|Overall Study|Lost to Follow-up|4|||
24993472|NCT03981822|50083854|FG006|Overall Study|Lost to Follow-up|4|||
24993473|NCT03981822|50083855|FG007|Overall Study|Lost to Follow-up|2|||
24993474|NCT03981822|50083848|FG000|Overall Study|Withdrawal by Subject|0|||
24993475|NCT03981822|50083849|FG001|Overall Study|Withdrawal by Subject|1|||
24993476|NCT03981822|50083850|FG002|Overall Study|Withdrawal by Subject|0|||
24993477|NCT03981822|50083851|FG003|Overall Study|Withdrawal by Subject|0|||
24993478|NCT03981822|50083852|FG004|Overall Study|Withdrawal by Subject|0|||
24993479|NCT03981822|50083853|FG005|Overall Study|Withdrawal by Subject|1|||
24993480|NCT03981822|50083854|FG006|Overall Study|Withdrawal by Subject|0|||
24993481|NCT03981822|50083855|FG007|Overall Study|Withdrawal by Subject|2|||
24993482|NCT03981822|50083848|FG000|Overall Study|COVID-19 Related|0|||
24993483|NCT03981822|50083849|FG001|Overall Study|COVID-19 Related|0|||
24993484|NCT03981822|50083850|FG002|Overall Study|COVID-19 Related|0|||
25079565|NCT03436199|50188042|FG001|Overall Study|Physician Decision|1|||
25079566|NCT03436199|50188043|FG002|Overall Study|Physician Decision|0|||
25079567|NCT03436199|50188041|FG000|Overall Study|Could not return to clinic|1|||
25079568|NCT03436199|50188042|FG001|Overall Study|Could not return to clinic|0|||
25079569|NCT03436199|50188043|FG002|Overall Study|Could not return to clinic|0|||
25079570|NCT03436199|50188041|FG000|Overall Study|Withdrawn per physician|0|||
25079571|NCT03436199|50188042|FG001|Overall Study|Withdrawn per physician|1|||
24993485|NCT03981822|50083851|FG003|Overall Study|COVID-19 Related|0|||
25079572|NCT03436199|50188043|FG002|Overall Study|Withdrawn per physician|0|||
25079573|NCT02131636|50188053|FG000|Overall Study|Personal Reasons|4|||
25079574|NCT02131636|50188054|FG001|Overall Study|Personal Reasons|4|||
25079575|NCT02131636|50188053|FG000|Overall Study|Lost to Follow-up|4|||
25079576|NCT02131636|50188054|FG001|Overall Study|Lost to Follow-up|0|||
25079577|NCT02131636|50188053|FG000|Overall Study|Adverse Event|4|||
25079578|NCT02131636|50188054|FG001|Overall Study|Adverse Event|1|||
25079579|NCT02131324|50188062|FG000|Overall Study|Withdrawal by Subject|1|||
25079580|NCT02131324|50188063|FG001|Overall Study|Withdrawal by Subject|2|||
25079581|NCT02131324|50188062|FG000|Overall Study|Lost to Follow-up|1|||
25079582|NCT02131324|50188063|FG001|Overall Study|Lost to Follow-up|1|||
25079583|NCT02734693|50188072|FG000|Overall Study|Adverse Event|1|||
25079584|NCT02734693|50188073|FG001|Overall Study|Adverse Event|3|||
25079585|NCT02734693|50188074|FG002|Overall Study|Adverse Event|3|||
25079586|NCT02734693|50188072|FG000|Overall Study|Lack of Efficacy|1|||
25079587|NCT02734693|50188073|FG001|Overall Study|Lack of Efficacy|0|||
25079588|NCT02734693|50188074|FG002|Overall Study|Lack of Efficacy|0|||
25079589|NCT02734693|50188072|FG000|Overall Study|Lost to Follow-up|2|||
25079590|NCT02734693|50188073|FG001|Overall Study|Lost to Follow-up|0|||
25079591|NCT02734693|50188074|FG002|Overall Study|Lost to Follow-up|0|||
25079592|NCT02734693|50188072|FG000|Overall Study|Protocol Violation|1|||
25079593|NCT02734693|50188073|FG001|Overall Study|Protocol Violation|0|||
25079594|NCT02734693|50188074|FG002|Overall Study|Protocol Violation|0|||
25079595|NCT02734693|50188072|FG000|Overall Study|Withdrawal by Subject|1|||
25079596|NCT02734693|50188073|FG001|Overall Study|Withdrawal by Subject|0|||
25079597|NCT02734693|50188074|FG002|Overall Study|Withdrawal by Subject|0|||
25079598|NCT02193880|50188082|FG000|Overall Study|patients did not collect enough HPC|3|||
25079599|NCT01378325|50188088|FG000|Overall Study|Protocol Violation|0|||
25079600|NCT01378325|50188089|FG001|Overall Study|Protocol Violation|1|||
25079601|NCT01093573|50188098|FG000|Overall Study|Physician Decision|0|||
25079602|NCT01093573|50188099|FG001|Overall Study|Physician Decision|0|||
25079603|NCT01093573|50188100|FG002|Overall Study|Physician Decision|1|||
25079604|NCT01093573|50188098|FG000|Overall Study|Insurance Denied|0|||
25079605|NCT01093573|50188099|FG001|Overall Study|Insurance Denied|0|||
25079606|NCT01093573|50188100|FG002|Overall Study|Insurance Denied|1|||
25079607|NCT02733367|50188128|FG000|Overall Study|Withdrawal by Subject|6|||
25079608|NCT03688555|50188135|FG000|Treatment Period|Adverse Event|0|||
25079609|NCT03688555|50188136|FG001|Treatment Period|Adverse Event|0|||
25079610|NCT03688555|50188137|FG002|Treatment Period|Adverse Event|1|||
25079611|NCT03443869|50188146|FG000|Overall Study|Death|3|||
25079612|NCT03443869|50188147|FG001|Overall Study|Death|3|||
25079613|NCT03443869|50188146|FG000|Overall Study|Withdrawal by Subject|34|||
25079614|NCT03443869|50188147|FG001|Overall Study|Withdrawal by Subject|22|||
25079615|NCT03443869|50188146|FG000|Overall Study|Lost to Follow-up|1|||
25079616|NCT03443869|50188147|FG001|Overall Study|Lost to Follow-up|2|||
25079617|NCT03443869|50188146|FG000|Overall Study|Physician Decision|3|||
25079618|NCT03443869|50188147|FG001|Overall Study|Physician Decision|3|||
25079619|NCT03443869|50188146|FG000|Overall Study|Other|4|||
25079620|NCT03443869|50188147|FG001|Overall Study|Other|4|||
25079621|NCT01328951|50188188|FG000|Overall Study|Disease Progression|17|||
25079622|NCT01328951|50188189|FG001|Overall Study|Disease Progression|14|||
25079623|NCT01328951|50188188|FG000|Overall Study|Adverse Event|2|||
25079624|NCT01328951|50188189|FG001|Overall Study|Adverse Event|0|||
25079625|NCT01328951|50188188|FG000|Overall Study|Death|243|||
25079626|NCT01328951|50188189|FG001|Overall Study|Death|258|||
25079627|NCT01328951|50188188|FG000|Overall Study|Lost to Follow-up|6|||
25079628|NCT01328951|50188189|FG001|Overall Study|Lost to Follow-up|7|||
25257236|NCT01324232|50572297|FG000|Overall Study|Missing|0|||
24993486|NCT03981822|50083852|FG004|Overall Study|COVID-19 Related|2|||
24993487|NCT03981822|50083853|FG005|Overall Study|COVID-19 Related|1|||
24993488|NCT03981822|50083854|FG006|Overall Study|COVID-19 Related|2|||
24993489|NCT03981822|50083855|FG007|Overall Study|COVID-19 Related|1|||
24993490|NCT03980808|50083869|FG000|Overall Study|Lost to Follow-up|2|||
24993491|NCT03980808|50083870|FG001|Overall Study|Lost to Follow-up|2|||
24993492|NCT03650556|50083876|FG000|Overall Study|Death|2|||
24993493|NCT03650556|50083876|FG000|Overall Study|Withdrawal by Subject|20|||
24993494|NCT03650556|50083876|FG000|Overall Study|Physician Decision|2|||
24993495|NCT03650556|50083876|FG000|Overall Study|Lost to Follow-up|8|||
24993496|NCT03650556|50083876|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
24993497|NCT03650556|50083876|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
24993498|NCT03531632|50083884|FG000|Overall Study|Adverse Event|0|||
25079629|NCT01328951|50188188|FG000|Overall Study|Withdrawal by Subject|6|||
25079630|NCT01328951|50188189|FG001|Overall Study|Withdrawal by Subject|6|||
25079631|NCT01328951|50188188|FG000|Overall Study|Study Closed by the Sponsor|36|||
25079632|NCT01328951|50188189|FG001|Overall Study|Study Closed by the Sponsor|31|||
25079633|NCT01328951|50188188|FG000|Overall Study|Other|11|||
25079634|NCT01328951|50188189|FG001|Overall Study|Other|6|||
25079635|NCT02611817|50188202|FG000|Open-label Induction Phase|Reason not Specified|9|||
25079636|NCT02611817|50188203|FG001|Open-label Induction Phase|Reason not Specified|0|||
25257237|NCT01324232|50572298|FG001|Overall Study|Missing|0|||
25079637|NCT02611817|50188204|FG002|Open-label Induction Phase|Reason not Specified|0|||
25079638|NCT02611817|50188202|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
25079639|NCT02611817|50188203|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
25079640|NCT02611817|50188204|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
25079641|NCT02611817|50188202|FG000|Open-label Induction Phase|Pregnancy|1|||
25079642|NCT02611817|50188203|FG001|Open-label Induction Phase|Pregnancy|0|||
25079643|NCT02611817|50188204|FG002|Open-label Induction Phase|Pregnancy|0|||
25079644|NCT02611817|50188202|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
25079645|NCT02611817|50188203|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
25079646|NCT02611817|50188204|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
25079647|NCT02611817|50188202|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
25079648|NCT02611817|50188203|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
25079649|NCT02611817|50188204|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
25079650|NCT02611817|50188202|FG000|Open-label Induction Phase|Protocol Violation|5|||
25079651|NCT02611817|50188203|FG001|Open-label Induction Phase|Protocol Violation|0|||
25079652|NCT02611817|50188204|FG002|Open-label Induction Phase|Protocol Violation|0|||
25079653|NCT02611817|50188202|FG000|Open-label Induction Phase|Adverse Event|16|||
25079654|NCT02611817|50188203|FG001|Open-label Induction Phase|Adverse Event|0|||
25079655|NCT02611817|50188204|FG002|Open-label Induction Phase|Adverse Event|0|||
25079656|NCT02611817|50188202|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
25079657|NCT02611817|50188203|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
25079658|NCT02611817|50188204|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
25079659|NCT02611817|50188202|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
25079660|NCT02611817|50188203|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
25079661|NCT02611817|50188204|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
25079662|NCT02611817|50188202|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
25079663|NCT02611817|50188203|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
25079664|NCT02611817|50188204|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
25079665|NCT02611817|50188202|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
25079666|NCT02611817|50188203|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
25079667|NCT02611817|50188204|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
25079668|NCT02611817|50188202|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
25079669|NCT02611817|50188203|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
25079670|NCT02611817|50188204|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
25079671|NCT02611817|50188202|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
25079672|NCT02611817|50188203|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
25079673|NCT02611817|50188204|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
25079674|NCT02611817|50188202|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
25079675|NCT02611817|50188203|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
25079676|NCT02611817|50188204|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
25079677|NCT02735915|50188211|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
25079678|NCT02735915|50188211|FG000|Overall Study|Withdrawal following SAE|2|||
25079679|NCT02735915|50188211|FG000|Overall Study|Withdrawal by Subject|1|||
25079680|NCT02557139|50188220|FG000|Overall Study|Significant liver elevation|1|||
25079681|NCT02557139|50188221|FG001|Overall Study|Significant liver elevation|0|||
25079682|NCT02557139|50188222|FG002|Overall Study|Significant liver elevation|1|||
25079683|NCT02557139|50188220|FG000|Overall Study|Withdrawal by Subject|1|||
25079684|NCT02557139|50188221|FG001|Overall Study|Withdrawal by Subject|0|||
25079685|NCT02557139|50188222|FG002|Overall Study|Withdrawal by Subject|0|||
25079686|NCT02557139|50188220|FG000|Overall Study|Illness of prohibited medication|0|||
25079687|NCT02557139|50188221|FG001|Overall Study|Illness of prohibited medication|0|||
25079688|NCT02557139|50188222|FG002|Overall Study|Illness of prohibited medication|1|||
25079689|NCT01328717|50188239|FG000|Overall Study|Adverse Event|1|||
25079690|NCT01677741|50188251|FG000|Overall Study|Death|0|||
25079691|NCT01677741|50188252|FG001|Overall Study|Death|0|||
25079692|NCT01677741|50188253|FG002|Overall Study|Death|0|||
25079693|NCT01677741|50188254|FG003|Overall Study|Death|1|||
24993499|NCT03531632|50083885|FG001|Overall Study|Adverse Event|0|||
24993500|NCT03531632|50083886|FG002|Overall Study|Adverse Event|1|||
24993501|NCT03531632|50083884|FG000|Overall Study|Death|4|||
24993502|NCT03531632|50083885|FG001|Overall Study|Death|0|||
24993503|NCT03531632|50083886|FG002|Overall Study|Death|14|||
24993504|NCT03531632|50083884|FG000|Overall Study|Study Terminated|1|||
24993505|NCT03531632|50083885|FG001|Overall Study|Study Terminated|3|||
24993506|NCT03531632|50083886|FG002|Overall Study|Study Terminated|11|||
24993507|NCT03979638|50083897|FG000|Period 1|Physician Decision|1|||
24993508|NCT03979638|50083898|FG001|Period 1|Physician Decision|1|||
24993509|NCT03979638|50083897|FG000|Period 1|Withdrawal by Subject|4|||
24993510|NCT03979638|50083898|FG001|Period 1|Withdrawal by Subject|3|||
24993511|NCT03979638|50083897|FG000|Period 1|Study terminated by Sponsor|1|||
24993512|NCT03979638|50083898|FG001|Period 1|Study terminated by Sponsor|3|||
24993513|NCT03979638|50083897|FG000|Period 1|Protocol Violation|1|||
24993514|NCT03979638|50083898|FG001|Period 1|Protocol Violation|0|||
25079694|NCT01677741|50188255|FG004|Overall Study|Death|0|||
25079695|NCT01677741|50188256|FG005|Overall Study|Death|1|||
25079696|NCT01677741|50188257|FG006|Overall Study|Death|0|||
25079697|NCT01677741|50188258|FG007|Overall Study|Death|0|||
25079698|NCT01677741|50188251|FG000|Overall Study|Withdrawal by Subject|2|||
25079699|NCT01677741|50188252|FG001|Overall Study|Withdrawal by Subject|7|||
25079700|NCT01677741|50188253|FG002|Overall Study|Withdrawal by Subject|5|||
25079701|NCT01677741|50188254|FG003|Overall Study|Withdrawal by Subject|4|||
25079702|NCT01677741|50188255|FG004|Overall Study|Withdrawal by Subject|11|||
25079703|NCT01677741|50188256|FG005|Overall Study|Withdrawal by Subject|20|||
25079704|NCT01677741|50188257|FG006|Overall Study|Withdrawal by Subject|4|||
25079705|NCT01677741|50188258|FG007|Overall Study|Withdrawal by Subject|2|||
25079706|NCT01677741|50188251|FG000|Overall Study|Enrolled in a rollover study|0|||
25079707|NCT01677741|50188252|FG001|Overall Study|Enrolled in a rollover study|3|||
25079708|NCT01677741|50188253|FG002|Overall Study|Enrolled in a rollover study|2|||
25079709|NCT01677741|50188254|FG003|Overall Study|Enrolled in a rollover study|1|||
25079710|NCT01677741|50188255|FG004|Overall Study|Enrolled in a rollover study|6|||
25079711|NCT01677741|50188256|FG005|Overall Study|Enrolled in a rollover study|6|||
25079712|NCT01677741|50188257|FG006|Overall Study|Enrolled in a rollover study|7|||
25079713|NCT01677741|50188258|FG007|Overall Study|Enrolled in a rollover study|0|||
25079714|NCT01677741|50188251|FG000|Overall Study|Progressive disease|1|||
25079715|NCT01677741|50188252|FG001|Overall Study|Progressive disease|0|||
25079716|NCT01677741|50188253|FG002|Overall Study|Progressive disease|1|||
25079717|NCT01677741|50188254|FG003|Overall Study|Progressive disease|0|||
25079718|NCT01677741|50188255|FG004|Overall Study|Progressive disease|0|||
25079719|NCT01677741|50188256|FG005|Overall Study|Progressive disease|1|||
25079720|NCT01677741|50188257|FG006|Overall Study|Progressive disease|0|||
25079721|NCT01677741|50188258|FG007|Overall Study|Progressive disease|0|||
25079722|NCT01677507|50188310|FG000|Initial Assignment|Adverse Event|0|||
25079723|NCT01677507|50188311|FG001|Initial Assignment|Adverse Event|1|||
25079724|NCT01677507|50188310|FG000|Initial Assignment|Protocol Violation|0|||
25079725|NCT01677507|50188311|FG001|Initial Assignment|Protocol Violation|1|||
25079726|NCT01677507|50188310|FG000|Second Assigment|Withdrawal by Subject|2|||
25079727|NCT01677507|50188311|FG001|Second Assigment|Withdrawal by Subject|2|||
25079728|NCT01677507|50188310|FG000|Second Assigment|Adverse Event|1|||
25079729|NCT01677507|50188311|FG001|Second Assigment|Adverse Event|3|||
25079735|NCT02732951|50188340|FG000|Overall Study|Other than listed|1|||
25079736|NCT02732951|50188341|FG001|Overall Study|Other than listed|0|||
25079737|NCT02732951|50188340|FG000|Overall Study|Lost to Follow-up|0|||
25079738|NCT02732951|50188341|FG001|Overall Study|Lost to Follow-up|1|||
25079739|NCT02732951|50188340|FG000|Overall Study|Adverse Event|4|||
25079740|NCT02732951|50188341|FG001|Overall Study|Adverse Event|4|||
25079741|NCT02732951|50188340|FG000|Overall Study|Protocol Violation|0|||
25079742|NCT02732951|50188341|FG001|Overall Study|Protocol Violation|1|||
25079743|NCT01377233|50188352|FG000|Open-label|Adverse Event|1|||
25079744|NCT01377233|50188353|FG001|Open-label|Adverse Event|0|||
25079745|NCT01377233|50188354|FG002|Open-label|Adverse Event|0|||
25079746|NCT01377233|50188355|FG003|Open-label|Adverse Event|0|||
25079747|NCT01377233|50188356|FG004|Open-label|Adverse Event|0|||
25079748|NCT01377233|50188352|FG000|Open-label|Withdrawal by Subject|3|||
25079749|NCT01377233|50188353|FG001|Open-label|Withdrawal by Subject|0|||
25079750|NCT01377233|50188354|FG002|Open-label|Withdrawal by Subject|0|||
25079751|NCT01377233|50188355|FG003|Open-label|Withdrawal by Subject|0|||
25079752|NCT01377233|50188356|FG004|Open-label|Withdrawal by Subject|0|||
25079753|NCT01377233|50188352|FG000|Double-blind|Adverse Event|0|||
25079754|NCT01377233|50188353|FG001|Double-blind|Adverse Event|1|||
25079755|NCT01377233|50188354|FG002|Double-blind|Adverse Event|2|||
25079756|NCT01377233|50188355|FG003|Double-blind|Adverse Event|2|||
25079757|NCT01377233|50188356|FG004|Double-blind|Adverse Event|0|||
25079758|NCT01377233|50188352|FG000|Double-blind|Protocol Violation|0|||
25079759|NCT01377233|50188353|FG001|Double-blind|Protocol Violation|0|||
25079760|NCT01377233|50188354|FG002|Double-blind|Protocol Violation|0|||
25079761|NCT01377233|50188355|FG003|Double-blind|Protocol Violation|0|||
25079762|NCT01377233|50188356|FG004|Double-blind|Protocol Violation|1|||
25079763|NCT01377233|50188352|FG000|Double-blind|Withdrawal by Subject|0|||
25079764|NCT01377233|50188353|FG001|Double-blind|Withdrawal by Subject|0|||
25079765|NCT01377233|50188354|FG002|Double-blind|Withdrawal by Subject|0|||
25079766|NCT01377233|50188355|FG003|Double-blind|Withdrawal by Subject|1|||
25079767|NCT01377233|50188356|FG004|Double-blind|Withdrawal by Subject|0|||
25079768|NCT01377233|50188352|FG000|Double-blind|Administrative or other|0|||
25079769|NCT01377233|50188353|FG001|Double-blind|Administrative or other|0|||
25079770|NCT01377233|50188354|FG002|Double-blind|Administrative or other|0|||
25079771|NCT01377233|50188355|FG003|Double-blind|Administrative or other|1|||
25079772|NCT01377233|50188356|FG004|Double-blind|Administrative or other|1|||
25079773|NCT03248531|50188375|FG000|Overall Study|Adverse Event|0|||
25079774|NCT03248531|50188376|FG001|Overall Study|Adverse Event|0|||
25079775|NCT03248531|50188377|FG002|Overall Study|Adverse Event|1|||
25079776|NCT03248531|50188375|FG000|Overall Study|Lost to Follow-up|1|||
25079777|NCT03248531|50188376|FG001|Overall Study|Lost to Follow-up|0|||
25079778|NCT03248531|50188377|FG002|Overall Study|Lost to Follow-up|5|||
25079779|NCT03248531|50188375|FG000|Overall Study|Withdrawal by Subject|3|||
25079780|NCT03248531|50188376|FG001|Overall Study|Withdrawal by Subject|3|||
25079781|NCT03248531|50188377|FG002|Overall Study|Withdrawal by Subject|2|||
25079782|NCT03248531|50188375|FG000|Overall Study|Sponsor Request|0|||
25079783|NCT03248531|50188376|FG001|Overall Study|Sponsor Request|2|||
25079784|NCT03248531|50188377|FG002|Overall Study|Sponsor Request|0|||
25079785|NCT02656329|50188394|FG000|Overall Study|Lost to Follow-up|2|||
25079786|NCT02656329|50188395|FG001|Overall Study|Lost to Follow-up|3|||
25079787|NCT02656329|50188394|FG000|Overall Study|Withdrawal by Subject|7|||
25079788|NCT02656329|50188395|FG001|Overall Study|Withdrawal by Subject|6|||
25079789|NCT02656329|50188394|FG000|Overall Study|Study termination by Sponsor|150|||
25079790|NCT02656329|50188395|FG001|Overall Study|Study termination by Sponsor|142|||
25079791|NCT02656329|50188394|FG000|Overall Study|Other than specified above|5|||
25079792|NCT02656329|50188395|FG001|Overall Study|Other than specified above|6|||
25079793|NCT02712905|50188420|FG000|Monotherapy|Death|2|||
25079794|NCT02712905|50188421|FG001|Monotherapy|Death|5|||
25079795|NCT02712905|50188422|FG002|Monotherapy|Death|0|||
25079796|NCT02712905|50188423|FG003|Monotherapy|Death|3|||
25079797|NCT02712905|50188424|FG004|Monotherapy|Death|15|||
25079798|NCT02712905|50188425|FG005|Monotherapy|Death|1|||
25079799|NCT02712905|50188426|FG006|Monotherapy|Death|3|||
25079800|NCT02712905|50188427|FG007|Monotherapy|Death|3|||
25079801|NCT02712905|50188428|FG008|Monotherapy|Death|0|||
25079802|NCT02712905|50188429|FG009|Monotherapy|Death|27|||
25079803|NCT02712905|50188430|FG010|Monotherapy|Death|2|||
25079804|NCT02712905|50188431|FG011|Monotherapy|Death|5|||
25079805|NCT02712905|50188432|FG012|Monotherapy|Death|0|||
25079806|NCT02712905|50188433|FG013|Monotherapy|Death|0|||
25079807|NCT02712905|50188434|FG014|Monotherapy|Death|0|||
25079808|NCT02712905|50188435|FG015|Monotherapy|Death|0|||
25079809|NCT02712905|50188436|FG016|Monotherapy|Death|0|||
25079810|NCT02712905|50188437|FG017|Monotherapy|Death|0|||
25079811|NCT02712905|50188420|FG000|Monotherapy|Lost to Follow-up|0|||
25079812|NCT02712905|50188421|FG001|Monotherapy|Lost to Follow-up|1|||
25079813|NCT02712905|50188422|FG002|Monotherapy|Lost to Follow-up|0|||
25079814|NCT02712905|50188423|FG003|Monotherapy|Lost to Follow-up|1|||
25079815|NCT02712905|50188424|FG004|Monotherapy|Lost to Follow-up|0|||
25079816|NCT02712905|50188425|FG005|Monotherapy|Lost to Follow-up|0|||
25079817|NCT02712905|50188426|FG006|Monotherapy|Lost to Follow-up|0|||
25079818|NCT02712905|50188427|FG007|Monotherapy|Lost to Follow-up|0|||
25079819|NCT02712905|50188428|FG008|Monotherapy|Lost to Follow-up|0|||
25079820|NCT02712905|50188429|FG009|Monotherapy|Lost to Follow-up|2|||
25079821|NCT02712905|50188430|FG010|Monotherapy|Lost to Follow-up|0|||
25079822|NCT02712905|50188431|FG011|Monotherapy|Lost to Follow-up|0|||
25079823|NCT02712905|50188432|FG012|Monotherapy|Lost to Follow-up|0|||
25079824|NCT02712905|50188433|FG013|Monotherapy|Lost to Follow-up|0|||
25079825|NCT02712905|50188434|FG014|Monotherapy|Lost to Follow-up|0|||
25079826|NCT02712905|50188435|FG015|Monotherapy|Lost to Follow-up|0|||
25079827|NCT02712905|50188436|FG016|Monotherapy|Lost to Follow-up|0|||
25079828|NCT02712905|50188437|FG017|Monotherapy|Lost to Follow-up|0|||
25079829|NCT02712905|50188420|FG000|Monotherapy|Physician Decision|1|||
24993515|NCT03979638|50083897|FG000|Period 2|Study terminated by Sponsor|1|||
24993516|NCT03979638|50083898|FG001|Period 2|Study terminated by Sponsor|1|||
24993517|NCT03655054|50083913|FG000|Overall Study|Lost to Follow-up|1|||
24993518|NCT03615144|50083919|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
24993519|NCT03615144|50083920|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
24993520|NCT03682302|50083930|FG000|Overall Study|Lost to Follow-up|1|||
24993521|NCT03682302|50083931|FG001|Overall Study|Lost to Follow-up|2|||
24993522|NCT03682302|50083932|FG002|Overall Study|Lost to Follow-up|0|||
24993523|NCT03682302|50083933|FG003|Overall Study|Lost to Follow-up|1|||
24993524|NCT03682302|50083930|FG000|Overall Study|Study drug was not administered|0|||
24993525|NCT03682302|50083931|FG001|Overall Study|Study drug was not administered|0|||
24993526|NCT03682302|50083932|FG002|Overall Study|Study drug was not administered|1|||
24993527|NCT03682302|50083933|FG003|Overall Study|Study drug was not administered|1|||
24993528|NCT03522506|50083947|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
25079830|NCT02712905|50188421|FG001|Monotherapy|Physician Decision|0|||
25079831|NCT02712905|50188422|FG002|Monotherapy|Physician Decision|0|||
25079832|NCT02712905|50188423|FG003|Monotherapy|Physician Decision|1|||
25079833|NCT02712905|50188424|FG004|Monotherapy|Physician Decision|0|||
25079834|NCT02712905|50188425|FG005|Monotherapy|Physician Decision|0|||
25079835|NCT02712905|50188426|FG006|Monotherapy|Physician Decision|0|||
25079836|NCT02712905|50188427|FG007|Monotherapy|Physician Decision|0|||
25079837|NCT02712905|50188428|FG008|Monotherapy|Physician Decision|0|||
25079838|NCT02712905|50188429|FG009|Monotherapy|Physician Decision|1|||
25079839|NCT02712905|50188430|FG010|Monotherapy|Physician Decision|0|||
25079840|NCT02712905|50188431|FG011|Monotherapy|Physician Decision|0|||
25079841|NCT02712905|50188432|FG012|Monotherapy|Physician Decision|0|||
25079842|NCT02712905|50188433|FG013|Monotherapy|Physician Decision|0|||
25079843|NCT02712905|50188434|FG014|Monotherapy|Physician Decision|0|||
25079844|NCT02712905|50188435|FG015|Monotherapy|Physician Decision|0|||
25079845|NCT02712905|50188436|FG016|Monotherapy|Physician Decision|0|||
25079846|NCT02712905|50188437|FG017|Monotherapy|Physician Decision|0|||
25079847|NCT02712905|50188420|FG000|Monotherapy|Study Terminated by Sponsor|0|||
25079848|NCT02712905|50188421|FG001|Monotherapy|Study Terminated by Sponsor|0|||
25079849|NCT02712905|50188422|FG002|Monotherapy|Study Terminated by Sponsor|0|||
25079850|NCT02712905|50188423|FG003|Monotherapy|Study Terminated by Sponsor|0|||
25079851|NCT02712905|50188424|FG004|Monotherapy|Study Terminated by Sponsor|1|||
25079852|NCT02712905|50188425|FG005|Monotherapy|Study Terminated by Sponsor|0|||
25079853|NCT02712905|50188426|FG006|Monotherapy|Study Terminated by Sponsor|0|||
25079854|NCT02712905|50188427|FG007|Monotherapy|Study Terminated by Sponsor|0|||
25079855|NCT02712905|50188428|FG008|Monotherapy|Study Terminated by Sponsor|0|||
25079856|NCT02712905|50188429|FG009|Monotherapy|Study Terminated by Sponsor|2|||
25079857|NCT02712905|50188430|FG010|Monotherapy|Study Terminated by Sponsor|0|||
25079858|NCT02712905|50188431|FG011|Monotherapy|Study Terminated by Sponsor|0|||
25079859|NCT02712905|50188432|FG012|Monotherapy|Study Terminated by Sponsor|0|||
25079860|NCT02712905|50188433|FG013|Monotherapy|Study Terminated by Sponsor|0|||
25079861|NCT02712905|50188434|FG014|Monotherapy|Study Terminated by Sponsor|0|||
25079862|NCT02712905|50188435|FG015|Monotherapy|Study Terminated by Sponsor|0|||
25079863|NCT02712905|50188436|FG016|Monotherapy|Study Terminated by Sponsor|0|||
25079864|NCT02712905|50188437|FG017|Monotherapy|Study Terminated by Sponsor|0|||
25079865|NCT02712905|50188420|FG000|Monotherapy|Withdrawal by Subject|0|||
25079866|NCT02712905|50188421|FG001|Monotherapy|Withdrawal by Subject|0|||
25079867|NCT02712905|50188422|FG002|Monotherapy|Withdrawal by Subject|1|||
25079868|NCT02712905|50188423|FG003|Monotherapy|Withdrawal by Subject|0|||
25079869|NCT02712905|50188424|FG004|Monotherapy|Withdrawal by Subject|2|||
25079870|NCT02712905|50188425|FG005|Monotherapy|Withdrawal by Subject|0|||
25079871|NCT02712905|50188426|FG006|Monotherapy|Withdrawal by Subject|0|||
25079872|NCT02712905|50188427|FG007|Monotherapy|Withdrawal by Subject|0|||
25079873|NCT02712905|50188428|FG008|Monotherapy|Withdrawal by Subject|0|||
25079874|NCT02712905|50188429|FG009|Monotherapy|Withdrawal by Subject|4|||
25079875|NCT02712905|50188430|FG010|Monotherapy|Withdrawal by Subject|1|||
25079876|NCT02712905|50188431|FG011|Monotherapy|Withdrawal by Subject|2|||
25079877|NCT02712905|50188432|FG012|Monotherapy|Withdrawal by Subject|0|||
25079878|NCT02712905|50188433|FG013|Monotherapy|Withdrawal by Subject|0|||
25079879|NCT02712905|50188434|FG014|Monotherapy|Withdrawal by Subject|0|||
25079880|NCT02712905|50188435|FG015|Monotherapy|Withdrawal by Subject|0|||
25079881|NCT02712905|50188436|FG016|Monotherapy|Withdrawal by Subject|0|||
25079882|NCT02712905|50188437|FG017|Monotherapy|Withdrawal by Subject|0|||
25079883|NCT02712905|50188420|FG000|Monotherapy|Started New Cancer Drug|0|||
25079884|NCT02712905|50188421|FG001|Monotherapy|Started New Cancer Drug|0|||
25079885|NCT02712905|50188422|FG002|Monotherapy|Started New Cancer Drug|0|||
25079886|NCT02712905|50188423|FG003|Monotherapy|Started New Cancer Drug|0|||
25079887|NCT02712905|50188424|FG004|Monotherapy|Started New Cancer Drug|0|||
25079888|NCT02712905|50188425|FG005|Monotherapy|Started New Cancer Drug|1|||
25079889|NCT02712905|50188426|FG006|Monotherapy|Started New Cancer Drug|0|||
25079890|NCT02712905|50188427|FG007|Monotherapy|Started New Cancer Drug|0|||
25079891|NCT02712905|50188428|FG008|Monotherapy|Started New Cancer Drug|0|||
25079892|NCT02712905|50188429|FG009|Monotherapy|Started New Cancer Drug|0|||
25079893|NCT02712905|50188430|FG010|Monotherapy|Started New Cancer Drug|0|||
25079894|NCT02712905|50188431|FG011|Monotherapy|Started New Cancer Drug|0|||
25079895|NCT02712905|50188432|FG012|Monotherapy|Started New Cancer Drug|0|||
25079896|NCT02712905|50188433|FG013|Monotherapy|Started New Cancer Drug|0|||
25079897|NCT02712905|50188434|FG014|Monotherapy|Started New Cancer Drug|0|||
25079898|NCT02712905|50188435|FG015|Monotherapy|Started New Cancer Drug|0|||
25079899|NCT02712905|50188436|FG016|Monotherapy|Started New Cancer Drug|0|||
25079900|NCT02712905|50188437|FG017|Monotherapy|Started New Cancer Drug|0|||
25079901|NCT02712905|50188420|FG000|Monotherapy|Adverse Event|0|||
25079902|NCT02712905|50188421|FG001|Monotherapy|Adverse Event|0|||
25079903|NCT02712905|50188422|FG002|Monotherapy|Adverse Event|0|||
25079904|NCT02712905|50188423|FG003|Monotherapy|Adverse Event|0|||
25079905|NCT02712905|50188424|FG004|Monotherapy|Adverse Event|0|||
25079906|NCT02712905|50188425|FG005|Monotherapy|Adverse Event|0|||
25079907|NCT02712905|50188426|FG006|Monotherapy|Adverse Event|0|||
25079908|NCT02712905|50188427|FG007|Monotherapy|Adverse Event|0|||
25079909|NCT02712905|50188428|FG008|Monotherapy|Adverse Event|1|||
25079910|NCT02712905|50188429|FG009|Monotherapy|Adverse Event|0|||
25079911|NCT02712905|50188430|FG010|Monotherapy|Adverse Event|0|||
25079912|NCT02712905|50188431|FG011|Monotherapy|Adverse Event|0|||
25079913|NCT02712905|50188432|FG012|Monotherapy|Adverse Event|0|||
25079914|NCT02712905|50188433|FG013|Monotherapy|Adverse Event|0|||
25079915|NCT02712905|50188434|FG014|Monotherapy|Adverse Event|0|||
25079916|NCT02712905|50188435|FG015|Monotherapy|Adverse Event|0|||
25079917|NCT02712905|50188436|FG016|Monotherapy|Adverse Event|0|||
25079918|NCT02712905|50188437|FG017|Monotherapy|Adverse Event|0|||
25079919|NCT02712905|50188420|FG000|Combination Therapy|Death|0|||
25079920|NCT02712905|50188421|FG001|Combination Therapy|Death|0|||
25079921|NCT02712905|50188422|FG002|Combination Therapy|Death|0|||
25079922|NCT02712905|50188423|FG003|Combination Therapy|Death|0|||
25079923|NCT02712905|50188424|FG004|Combination Therapy|Death|0|||
25079924|NCT02712905|50188425|FG005|Combination Therapy|Death|0|||
25079925|NCT02712905|50188426|FG006|Combination Therapy|Death|0|||
25079926|NCT02712905|50188427|FG007|Combination Therapy|Death|0|||
25079927|NCT02712905|50188428|FG008|Combination Therapy|Death|0|||
25079928|NCT02712905|50188429|FG009|Combination Therapy|Death|0|||
25079929|NCT02712905|50188430|FG010|Combination Therapy|Death|0|||
25079930|NCT02712905|50188431|FG011|Combination Therapy|Death|0|||
25079931|NCT02712905|50188432|FG012|Combination Therapy|Death|5|||
25079932|NCT02712905|50188433|FG013|Combination Therapy|Death|6|||
25079933|NCT02712905|50188434|FG014|Combination Therapy|Death|1|||
25079934|NCT02712905|50188435|FG015|Combination Therapy|Death|3|||
25079935|NCT02712905|50188436|FG016|Combination Therapy|Death|1|||
25079936|NCT02712905|50188437|FG017|Combination Therapy|Death|3|||
25079937|NCT02712905|50188420|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
25079938|NCT02712905|50188421|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
25079939|NCT02712905|50188422|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
25079940|NCT02712905|50188423|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
25079941|NCT02712905|50188424|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
25079942|NCT02712905|50188425|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
25079943|NCT02712905|50188426|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
25079944|NCT02712905|50188427|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
25079945|NCT02712905|50188428|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
25079946|NCT02712905|50188429|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
25079947|NCT02712905|50188430|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
25079948|NCT02712905|50188431|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
25079949|NCT02712905|50188432|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
25079950|NCT02712905|50188433|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
25079951|NCT02712905|50188434|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
25079952|NCT02712905|50188435|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
25257238|NCT01324232|50572299|FG002|Overall Study|Missing|1|||
25257239|NCT01324232|50572300|FG003|Overall Study|Missing|0|||
25257240|NCT01324232|50572297|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
25257241|NCT01324232|50572298|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
25257242|NCT01324232|50572299|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
25257243|NCT01324232|50572300|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
25257244|NCT01324232|50572297|FG000|Overall Study|Lack of Efficacy|2|||
25257245|NCT01324232|50572298|FG001|Overall Study|Lack of Efficacy|1|||
24993529|NCT03522506|50083948|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
24993530|NCT03522506|50083949|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
24993531|NCT03522506|50083950|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
24993532|NCT03522506|50083947|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
24993533|NCT03522506|50083948|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
24993534|NCT03522506|50083949|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
24993535|NCT03522506|50083950|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
24993536|NCT02892734|50083981|FG000|Treatment on Study|Progressive Disease|2|||
24993537|NCT02892734|50083981|FG000|Follow up for 2 Years|Death|2|||
24993538|NCT02892734|50083981|FG000|Follow up for 2 Years|Study closed early|1|||
24993539|NCT00055497|50083989|FG000|Overall Study|Adverse Event|1|||
24993540|NCT00055497|50083990|FG001|Overall Study|Adverse Event|1|||
24993541|NCT00055497|50083991|FG002|Overall Study|Adverse Event|1|||
24993542|NCT00055497|50083992|FG003|Overall Study|Adverse Event|28|||
24993543|NCT00055497|50083989|FG000|Overall Study|Withdrawal by Subject|3|||
24993544|NCT00055497|50083990|FG001|Overall Study|Withdrawal by Subject|1|||
24993545|NCT00055497|50083991|FG002|Overall Study|Withdrawal by Subject|1|||
24993546|NCT00055497|50083992|FG003|Overall Study|Withdrawal by Subject|15|||
24993547|NCT00055497|50083989|FG000|Overall Study|Lost to Follow-up|0|||
24993548|NCT00055497|50083990|FG001|Overall Study|Lost to Follow-up|1|||
24993549|NCT00055497|50083991|FG002|Overall Study|Lost to Follow-up|0|||
24993550|NCT00055497|50083992|FG003|Overall Study|Lost to Follow-up|5|||
24993551|NCT00055497|50083989|FG000|Overall Study|Protocol Violation|0|||
24993552|NCT00055497|50083990|FG001|Overall Study|Protocol Violation|0|||
24993553|NCT00055497|50083991|FG002|Overall Study|Protocol Violation|0|||
24993554|NCT00055497|50083992|FG003|Overall Study|Protocol Violation|3|||
24993555|NCT00055497|50083989|FG000|Overall Study|Lack of Efficacy|1|||
24993556|NCT00055497|50083990|FG001|Overall Study|Lack of Efficacy|0|||
25079953|NCT02712905|50188436|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
25079954|NCT02712905|50188437|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
25079955|NCT02712905|50188420|FG000|Combination Therapy|Withdrawal by Subject|0|||
25257246|NCT01324232|50572299|FG002|Overall Study|Lack of Efficacy|2|||
25257247|NCT01324232|50572300|FG003|Overall Study|Lack of Efficacy|2|||
25257248|NCT01324232|50572297|FG000|Overall Study|Participant Refused Medication|0|||
25257249|NCT01324232|50572298|FG001|Overall Study|Participant Refused Medication|1|||
25257250|NCT01324232|50572299|FG002|Overall Study|Participant Refused Medication|0|||
25257251|NCT01324232|50572300|FG003|Overall Study|Participant Refused Medication|0|||
25257252|NCT01324232|50572297|FG000|Overall Study|Intercurrent illness|0|||
25257253|NCT01324232|50572298|FG001|Overall Study|Intercurrent illness|0|||
25257254|NCT01324232|50572299|FG002|Overall Study|Intercurrent illness|0|||
25257255|NCT01324232|50572300|FG003|Overall Study|Intercurrent illness|1|||
25257256|NCT01324232|50572297|FG000|Overall Study|Adverse Event|2|||
25257257|NCT01324232|50572298|FG001|Overall Study|Adverse Event|5|||
25257258|NCT01324232|50572299|FG002|Overall Study|Adverse Event|6|||
25257259|NCT01324232|50572300|FG003|Overall Study|Adverse Event|6|||
25257260|NCT01324232|50572297|FG000|Overall Study|Withdrawal by Subject|0|||
25257261|NCT01324232|50572298|FG001|Overall Study|Withdrawal by Subject|3|||
25257262|NCT01324232|50572299|FG002|Overall Study|Withdrawal by Subject|4|||
25257263|NCT01324232|50572300|FG003|Overall Study|Withdrawal by Subject|0|||
25257264|NCT01324232|50572297|FG000|Overall Study|Lost to Follow-up|1|||
25257265|NCT01324232|50572298|FG001|Overall Study|Lost to Follow-up|0|||
25257266|NCT01324232|50572299|FG002|Overall Study|Lost to Follow-up|0|||
25257267|NCT01324232|50572300|FG003|Overall Study|Lost to Follow-up|0|||
25257268|NCT01094119|50572317|FG000|Overall Study|Lack of Efficacy|2|||
25257269|NCT01094119|50572318|FG001|Overall Study|Lack of Efficacy|4|||
25257270|NCT01323920|50572324|FG000|Overall Study|Death|5|||
25257271|NCT01323920|50572324|FG000|Overall Study|Withdrawal by Subject|1|||
25257272|NCT01093885|50572328|FG000|Overall Study|Adverse Event|4|||
25257273|NCT01093885|50572328|FG000|Overall Study|Lost to Follow-up|1|||
25257274|NCT01101997|50572333|FG000|Overall Study|Withdrawal by Subject|2|||
25257275|NCT01324830|50572363|FG000|Overall Study|Progressive Disease|3|||
25257276|NCT01324830|50572364|FG001|Overall Study|Progressive Disease|2|||
25257277|NCT01324830|50572365|FG002|Overall Study|Progressive Disease|3|||
25257278|NCT01324830|50572366|FG003|Overall Study|Progressive Disease|3|||
25257279|NCT01324830|50572367|FG004|Overall Study|Progressive Disease|6|||
25257280|NCT01324830|50572368|FG005|Overall Study|Progressive Disease|6|||
25257281|NCT01324830|50572369|FG006|Overall Study|Progressive Disease|3|||
25257282|NCT01324830|50572370|FG007|Overall Study|Progressive Disease|3|||
25257283|NCT01324830|50572371|FG008|Overall Study|Progressive Disease|3|||
25257284|NCT01324830|50572372|FG009|Overall Study|Progressive Disease|6|||
25257285|NCT01324830|50572373|FG010|Overall Study|Progressive Disease|2|||
25257286|NCT01324830|50572374|FG011|Overall Study|Progressive Disease|1|||
25257287|NCT01324830|50572375|FG012|Overall Study|Progressive Disease|1|||
25257288|NCT01324830|50572376|FG013|Overall Study|Progressive Disease|1|||
25257289|NCT01324830|50572377|FG014|Overall Study|Progressive Disease|1|||
25257290|NCT01324830|50572378|FG015|Overall Study|Progressive Disease|3|||
25257291|NCT01324830|50572379|FG016|Overall Study|Progressive Disease|2|||
25257292|NCT01324830|50572380|FG017|Overall Study|Progressive Disease|3|||
25257293|NCT01324830|50572381|FG018|Overall Study|Progressive Disease|4|||
25257294|NCT01324830|50572363|FG000|Overall Study|Dose limiting toxicity|0|||
25257295|NCT01324830|50572364|FG001|Overall Study|Dose limiting toxicity|0|||
25257296|NCT01324830|50572365|FG002|Overall Study|Dose limiting toxicity|0|||
25257297|NCT01324830|50572366|FG003|Overall Study|Dose limiting toxicity|0|||
25257298|NCT01324830|50572367|FG004|Overall Study|Dose limiting toxicity|1|||
25257299|NCT01324830|50572368|FG005|Overall Study|Dose limiting toxicity|0|||
25257300|NCT01324830|50572369|FG006|Overall Study|Dose limiting toxicity|0|||
25257301|NCT01324830|50572370|FG007|Overall Study|Dose limiting toxicity|0|||
25257302|NCT01324830|50572371|FG008|Overall Study|Dose limiting toxicity|0|||
25257303|NCT01324830|50572372|FG009|Overall Study|Dose limiting toxicity|0|||
25257304|NCT01324830|50572373|FG010|Overall Study|Dose limiting toxicity|0|||
25257305|NCT01324830|50572374|FG011|Overall Study|Dose limiting toxicity|0|||
25257306|NCT01324830|50572375|FG012|Overall Study|Dose limiting toxicity|0|||
25257307|NCT01324830|50572376|FG013|Overall Study|Dose limiting toxicity|0|||
25257308|NCT01324830|50572377|FG014|Overall Study|Dose limiting toxicity|0|||
25257309|NCT01324830|50572378|FG015|Overall Study|Dose limiting toxicity|0|||
25257310|NCT01324830|50572379|FG016|Overall Study|Dose limiting toxicity|1|||
25257311|NCT01324830|50572380|FG017|Overall Study|Dose limiting toxicity|1|||
25257312|NCT01324830|50572381|FG018|Overall Study|Dose limiting toxicity|1|||
25257313|NCT01324830|50572363|FG000|Overall Study|Reason not mentioned above|0|||
25257314|NCT01324830|50572364|FG001|Overall Study|Reason not mentioned above|0|||
25257315|NCT01324830|50572365|FG002|Overall Study|Reason not mentioned above|0|||
25257316|NCT01324830|50572366|FG003|Overall Study|Reason not mentioned above|0|||
25257317|NCT01324830|50572367|FG004|Overall Study|Reason not mentioned above|0|||
25257318|NCT01324830|50572368|FG005|Overall Study|Reason not mentioned above|0|||
25257319|NCT01324830|50572369|FG006|Overall Study|Reason not mentioned above|0|||
25257320|NCT01324830|50572370|FG007|Overall Study|Reason not mentioned above|0|||
25257321|NCT01324830|50572371|FG008|Overall Study|Reason not mentioned above|0|||
25257322|NCT01324830|50572372|FG009|Overall Study|Reason not mentioned above|0|||
25257323|NCT01324830|50572373|FG010|Overall Study|Reason not mentioned above|0|||
25257324|NCT01324830|50572374|FG011|Overall Study|Reason not mentioned above|0|||
25257325|NCT01324830|50572375|FG012|Overall Study|Reason not mentioned above|0|||
25257326|NCT01324830|50572376|FG013|Overall Study|Reason not mentioned above|0|||
25257327|NCT01324830|50572377|FG014|Overall Study|Reason not mentioned above|0|||
25257328|NCT01324830|50572378|FG015|Overall Study|Reason not mentioned above|0|||
25257329|NCT01324830|50572379|FG016|Overall Study|Reason not mentioned above|0|||
25257330|NCT01324830|50572380|FG017|Overall Study|Reason not mentioned above|1|||
25257331|NCT01324830|50572381|FG018|Overall Study|Reason not mentioned above|0|||
25257332|NCT01324830|50572363|FG000|Overall Study|Adverse Event, serious fatal|0|||
25257333|NCT01324830|50572364|FG001|Overall Study|Adverse Event, serious fatal|1|||
25257334|NCT01324830|50572365|FG002|Overall Study|Adverse Event, serious fatal|0|||
25257335|NCT01324830|50572366|FG003|Overall Study|Adverse Event, serious fatal|0|||
25257336|NCT01324830|50572367|FG004|Overall Study|Adverse Event, serious fatal|0|||
25257337|NCT01324830|50572368|FG005|Overall Study|Adverse Event, serious fatal|0|||
25257338|NCT01324830|50572369|FG006|Overall Study|Adverse Event, serious fatal|0|||
25257339|NCT01324830|50572370|FG007|Overall Study|Adverse Event, serious fatal|0|||
25257340|NCT01324830|50572371|FG008|Overall Study|Adverse Event, serious fatal|0|||
25257341|NCT01324830|50572372|FG009|Overall Study|Adverse Event, serious fatal|0|||
25257342|NCT01324830|50572373|FG010|Overall Study|Adverse Event, serious fatal|0|||
25257343|NCT01324830|50572374|FG011|Overall Study|Adverse Event, serious fatal|0|||
25257344|NCT01324830|50572375|FG012|Overall Study|Adverse Event, serious fatal|0|||
25257345|NCT01324830|50572376|FG013|Overall Study|Adverse Event, serious fatal|0|||
25257346|NCT01324830|50572377|FG014|Overall Study|Adverse Event, serious fatal|0|||
25257347|NCT01324830|50572378|FG015|Overall Study|Adverse Event, serious fatal|0|||
25257348|NCT01324830|50572379|FG016|Overall Study|Adverse Event, serious fatal|0|||
25257349|NCT01324830|50572380|FG017|Overall Study|Adverse Event, serious fatal|0|||
25257350|NCT01324830|50572381|FG018|Overall Study|Adverse Event, serious fatal|0|||
25257351|NCT01324830|50572363|FG000|Overall Study|Adverse Event, non-fatal|0|||
25257352|NCT01324830|50572364|FG001|Overall Study|Adverse Event, non-fatal|0|||
25257353|NCT01324830|50572365|FG002|Overall Study|Adverse Event, non-fatal|0|||
25257354|NCT01324830|50572366|FG003|Overall Study|Adverse Event, non-fatal|0|||
25257355|NCT01324830|50572367|FG004|Overall Study|Adverse Event, non-fatal|0|||
25257356|NCT01324830|50572368|FG005|Overall Study|Adverse Event, non-fatal|0|||
25257357|NCT01324830|50572369|FG006|Overall Study|Adverse Event, non-fatal|0|||
25257358|NCT01324830|50572370|FG007|Overall Study|Adverse Event, non-fatal|0|||
25257359|NCT01324830|50572371|FG008|Overall Study|Adverse Event, non-fatal|2|||
25257360|NCT01324830|50572372|FG009|Overall Study|Adverse Event, non-fatal|0|||
25257361|NCT01324830|50572373|FG010|Overall Study|Adverse Event, non-fatal|1|||
25257362|NCT01324830|50572374|FG011|Overall Study|Adverse Event, non-fatal|0|||
25257363|NCT01324830|50572375|FG012|Overall Study|Adverse Event, non-fatal|0|||
25257364|NCT01324830|50572376|FG013|Overall Study|Adverse Event, non-fatal|0|||
25257365|NCT01324830|50572377|FG014|Overall Study|Adverse Event, non-fatal|0|||
25257366|NCT01324830|50572378|FG015|Overall Study|Adverse Event, non-fatal|0|||
25257367|NCT01324830|50572379|FG016|Overall Study|Adverse Event, non-fatal|0|||
25257368|NCT01324830|50572380|FG017|Overall Study|Adverse Event, non-fatal|1|||
25257369|NCT01324830|50572381|FG018|Overall Study|Adverse Event, non-fatal|0|||
25257370|NCT01324830|50572363|FG000|Overall Study|Withdrawal by Subject|0|||
25257371|NCT01324830|50572364|FG001|Overall Study|Withdrawal by Subject|0|||
25257372|NCT01324830|50572365|FG002|Overall Study|Withdrawal by Subject|0|||
25257373|NCT01324830|50572366|FG003|Overall Study|Withdrawal by Subject|0|||
25257374|NCT01324830|50572367|FG004|Overall Study|Withdrawal by Subject|0|||
25257375|NCT01324830|50572368|FG005|Overall Study|Withdrawal by Subject|1|||
25257376|NCT01324830|50572369|FG006|Overall Study|Withdrawal by Subject|0|||
25257377|NCT01324830|50572370|FG007|Overall Study|Withdrawal by Subject|0|||
25257378|NCT01324830|50572371|FG008|Overall Study|Withdrawal by Subject|0|||
25257379|NCT01324830|50572372|FG009|Overall Study|Withdrawal by Subject|0|||
25257380|NCT01324830|50572373|FG010|Overall Study|Withdrawal by Subject|1|||
25257381|NCT01324830|50572374|FG011|Overall Study|Withdrawal by Subject|0|||
25257382|NCT01324830|50572375|FG012|Overall Study|Withdrawal by Subject|0|||
25257383|NCT01324830|50572376|FG013|Overall Study|Withdrawal by Subject|0|||
25257384|NCT01324830|50572377|FG014|Overall Study|Withdrawal by Subject|0|||
25257385|NCT01324830|50572378|FG015|Overall Study|Withdrawal by Subject|0|||
25257386|NCT01324830|50572379|FG016|Overall Study|Withdrawal by Subject|0|||
25257387|NCT01324830|50572380|FG017|Overall Study|Withdrawal by Subject|0|||
25257388|NCT01324830|50572381|FG018|Overall Study|Withdrawal by Subject|1|||
25257389|NCT01324440|50572429|FG000|Overall Study|Subject moved|0|||
25257390|NCT01324440|50572430|FG001|Overall Study|Subject moved|1|||
25257391|NCT01325493|50572438|FG000|Overall Study|Protocol Violation|0|||
25257392|NCT01325493|50572439|FG001|Overall Study|Protocol Violation|1|||
24993557|NCT00055497|50083991|FG002|Overall Study|Lack of Efficacy|0|||
25257393|NCT01325493|50572438|FG000|Overall Study|loss of neuromonitoring signals|0|||
25257394|NCT01325493|50572439|FG001|Overall Study|loss of neuromonitoring signals|2|||
25257395|NCT01325493|50572438|FG000|Overall Study|Allergy|1|||
25257396|NCT01325493|50572439|FG001|Overall Study|Allergy|0|||
25257397|NCT01323972|50572449|FG000|Overall Study|Withdrawal by Subject|1|||
25257398|NCT01323972|50572450|FG001|Overall Study|Withdrawal by Subject|0|||
25257399|NCT01323972|50572451|FG002|Overall Study|Withdrawal by Subject|1|||
25257400|NCT01323972|50572452|FG003|Overall Study|Withdrawal by Subject|0|||
25257401|NCT01323972|50572449|FG000|Overall Study|Migrated/moved from study area|1|||
25257402|NCT01323972|50572450|FG001|Overall Study|Migrated/moved from study area|2|||
25257403|NCT01323972|50572451|FG002|Overall Study|Migrated/moved from study area|0|||
25257404|NCT01323972|50572452|FG003|Overall Study|Migrated/moved from study area|0|||
25257405|NCT01323972|50572449|FG000|Overall Study|Lost to Follow-up|0|||
25257406|NCT01323972|50572450|FG001|Overall Study|Lost to Follow-up|1|||
25257407|NCT01323972|50572451|FG002|Overall Study|Lost to Follow-up|1|||
25257408|NCT01323972|50572452|FG003|Overall Study|Lost to Follow-up|1|||
25257409|NCT01325337|50572469|FG000|Overall Study|Adverse Event|0|||
25257410|NCT01325337|50572470|FG001|Overall Study|Adverse Event|2|||
25257411|NCT01325337|50572471|FG002|Overall Study|Adverse Event|2|||
25257412|NCT01325337|50572472|FG003|Overall Study|Adverse Event|1|||
25257413|NCT01325337|50572473|FG004|Overall Study|Adverse Event|2|||
25257414|NCT01325337|50572469|FG000|Overall Study|Lost to Follow-up|2|||
25257415|NCT01325337|50572470|FG001|Overall Study|Lost to Follow-up|2|||
25257416|NCT01325337|50572471|FG002|Overall Study|Lost to Follow-up|2|||
25257417|NCT01325337|50572472|FG003|Overall Study|Lost to Follow-up|1|||
25257418|NCT01325337|50572473|FG004|Overall Study|Lost to Follow-up|2|||
25257419|NCT01325337|50572469|FG000|Overall Study|Personal Reasons|2|||
25257420|NCT01325337|50572470|FG001|Overall Study|Personal Reasons|5|||
25257421|NCT01325337|50572471|FG002|Overall Study|Personal Reasons|4|||
25257422|NCT01325337|50572472|FG003|Overall Study|Personal Reasons|8|||
25257423|NCT01325337|50572473|FG004|Overall Study|Personal Reasons|3|||
25257424|NCT01325337|50572469|FG000|Overall Study|Withdrawal by Subject|1|||
25257425|NCT01325337|50572470|FG001|Overall Study|Withdrawal by Subject|0|||
25257426|NCT01325337|50572471|FG002|Overall Study|Withdrawal by Subject|1|||
25257427|NCT01325337|50572472|FG003|Overall Study|Withdrawal by Subject|0|||
25257428|NCT01325337|50572473|FG004|Overall Study|Withdrawal by Subject|1|||
25257429|NCT01324947|50572485|FG000|Overall Study|Adverse Event|7|||
25257430|NCT01324947|50572485|FG000|Overall Study|Death|10|||
25257431|NCT01324947|50572485|FG000|Overall Study|Other|3|||
25257432|NCT01324947|50572485|FG000|Overall Study|Progressive Disease|50|||
25257433|NCT01324947|50572485|FG000|Overall Study|Withdrawal by Subject|3|||
25257434|NCT01324947|50572485|FG000|Overall Study|1 discontinued before starting drug|1|||
25257435|NCT01101841|50572493|FG000|Overall Study|Adverse Event|15|||
25257436|NCT01101841|50572494|FG001|Overall Study|Adverse Event|15|||
25257437|NCT01101841|50572493|FG000|Overall Study|Lost to Follow-up|9|||
25257438|NCT01101841|50572494|FG001|Overall Study|Lost to Follow-up|3|||
25257439|NCT01101841|50572493|FG000|Overall Study|Withdrawal by Subject|21|||
25257440|NCT01101841|50572494|FG001|Overall Study|Withdrawal by Subject|40|||
25257441|NCT01101841|50572493|FG000|Overall Study|Protocol Violation|1|||
25257442|NCT01101841|50572494|FG001|Overall Study|Protocol Violation|1|||
25257443|NCT01101841|50572493|FG000|Overall Study|Physician Decision|0|||
25257444|NCT01101841|50572494|FG001|Overall Study|Physician Decision|2|||
25257445|NCT01101841|50572493|FG000|Overall Study|Lack of Efficacy|0|||
25257446|NCT01101841|50572494|FG001|Overall Study|Lack of Efficacy|2|||
25257447|NCT01101841|50572493|FG000|Overall Study|Other|0|||
25257448|NCT01101841|50572494|FG001|Overall Study|Other|1|||
25257449|NCT01101841|50572493|FG000|Overall Study|Suicidality Tracking Scale|3|||
25257450|NCT01101841|50572494|FG001|Overall Study|Suicidality Tracking Scale|1|||
25257451|NCT01101841|50572493|FG000|Overall Study|Eligibility Criteria|1|||
25257452|NCT01101841|50572494|FG001|Overall Study|Eligibility Criteria|2|||
25257453|NCT01324401|50572503|FG000|Overall Study|Withdrawn before any treatment|0|||
25257454|NCT01324401|50572504|FG001|Overall Study|Withdrawn before any treatment|3|||
25257455|NCT01324401|50572503|FG000|Overall Study|Adverse Event|1|||
25257456|NCT01324401|50572504|FG001|Overall Study|Adverse Event|3|||
25257457|NCT01323660|50572510|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
25257458|NCT01323660|50572511|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
25257459|NCT01323660|50572512|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
25257460|NCT01323660|50572513|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
25257461|NCT01323660|50572514|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
25257462|NCT01323660|50572515|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
25257463|NCT01323660|50572510|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
25257464|NCT01323660|50572511|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
25257465|NCT01323660|50572512|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
25257466|NCT01323660|50572513|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
25257467|NCT01323660|50572514|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
25257468|NCT01323660|50572515|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
25257469|NCT01323660|50572510|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
25257470|NCT01323660|50572511|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
25257471|NCT01323660|50572512|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
25257472|NCT01323660|50572513|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
25257473|NCT01323660|50572514|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
25257474|NCT01323660|50572515|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
25257475|NCT01323660|50572510|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
25257476|NCT01323660|50572511|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
25257477|NCT01323660|50572512|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
25257478|NCT01323660|50572513|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
25257479|NCT01323660|50572514|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
25257480|NCT01323660|50572515|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
25257481|NCT01323660|50572510|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
25257482|NCT01323660|50572511|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
25257483|NCT01323660|50572512|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
25257484|NCT01323660|50572513|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
25257485|NCT01323660|50572514|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
25257486|NCT01323660|50572515|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
25257487|NCT01323660|50572510|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
25257488|NCT01323660|50572511|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
25257489|NCT01323660|50572512|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
25257490|NCT01323660|50572513|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
25257491|NCT01323660|50572514|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
25257492|NCT01323660|50572515|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
25257493|NCT01323660|50572510|FG000|Washout Period (14 Days)|Adverse Event|0|||
25257494|NCT01323660|50572511|FG001|Washout Period (14 Days)|Adverse Event|0|||
25257495|NCT01323660|50572512|FG002|Washout Period (14 Days)|Adverse Event|0|||
25257496|NCT01323660|50572513|FG003|Washout Period (14 Days)|Adverse Event|0|||
25257497|NCT01323660|50572514|FG004|Washout Period (14 Days)|Adverse Event|1|||
25257498|NCT01323660|50572515|FG005|Washout Period (14 Days)|Adverse Event|0|||
25257499|NCT01323660|50572510|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
25257500|NCT01323660|50572511|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
25257501|NCT01323660|50572512|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
25257502|NCT01323660|50572513|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
25257503|NCT01323660|50572514|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
25257504|NCT01323660|50572515|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
25257505|NCT01323660|50572510|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
25257506|NCT01323660|50572511|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
25257507|NCT01323660|50572512|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
25257508|NCT01323660|50572513|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
25257509|NCT01323660|50572514|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
25257510|NCT01323660|50572515|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
25257511|NCT01323660|50572510|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
25257512|NCT01323660|50572511|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
25257513|NCT01323660|50572512|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
25257514|NCT01323660|50572513|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
25257515|NCT01323660|50572514|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
25257516|NCT01323660|50572515|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
25257517|NCT01323660|50572510|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
25257518|NCT01323660|50572511|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
25079956|NCT02712905|50188421|FG001|Combination Therapy|Withdrawal by Subject|0|||
25079957|NCT02712905|50188422|FG002|Combination Therapy|Withdrawal by Subject|0|||
25079958|NCT02712905|50188423|FG003|Combination Therapy|Withdrawal by Subject|0|||
25079959|NCT02712905|50188424|FG004|Combination Therapy|Withdrawal by Subject|0|||
25079960|NCT02712905|50188425|FG005|Combination Therapy|Withdrawal by Subject|0|||
25079961|NCT02712905|50188426|FG006|Combination Therapy|Withdrawal by Subject|0|||
25079962|NCT02712905|50188427|FG007|Combination Therapy|Withdrawal by Subject|0|||
25079963|NCT02712905|50188428|FG008|Combination Therapy|Withdrawal by Subject|0|||
25079964|NCT02712905|50188429|FG009|Combination Therapy|Withdrawal by Subject|0|||
25079965|NCT02712905|50188430|FG010|Combination Therapy|Withdrawal by Subject|0|||
25079966|NCT02712905|50188431|FG011|Combination Therapy|Withdrawal by Subject|0|||
25079967|NCT02712905|50188432|FG012|Combination Therapy|Withdrawal by Subject|0|||
25079968|NCT02712905|50188433|FG013|Combination Therapy|Withdrawal by Subject|0|||
25079969|NCT02712905|50188434|FG014|Combination Therapy|Withdrawal by Subject|0|||
25079970|NCT02712905|50188435|FG015|Combination Therapy|Withdrawal by Subject|1|||
25079971|NCT02712905|50188436|FG016|Combination Therapy|Withdrawal by Subject|0|||
25079972|NCT02712905|50188437|FG017|Combination Therapy|Withdrawal by Subject|2|||
25079973|NCT02712905|50188420|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
25079974|NCT02712905|50188421|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
25079975|NCT02712905|50188422|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
25079976|NCT02712905|50188423|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
25079977|NCT02712905|50188424|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
25079978|NCT02712905|50188425|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
25079979|NCT02712905|50188426|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
25079980|NCT02712905|50188427|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
25079981|NCT02712905|50188428|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
25079982|NCT02712905|50188429|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
25079983|NCT02712905|50188430|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
25079984|NCT02712905|50188431|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
25079985|NCT02712905|50188432|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
25079986|NCT02712905|50188433|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
25079987|NCT02712905|50188434|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
25079988|NCT02712905|50188435|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
25079989|NCT02712905|50188436|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
25079990|NCT02712905|50188437|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
25079991|NCT03776357|50188475|FG000|Overall Study|Lost to Follow-up|3|||
25079992|NCT04520997|50188481|FG000|Overall Study|Lost to Follow-up|1|||
25079993|NCT04520997|50188482|FG001|Overall Study|Lost to Follow-up|1|||
25079994|NCT04520997|50188481|FG000|Overall Study|Withdrawal by Subject|1|||
25079995|NCT04520997|50188482|FG001|Overall Study|Withdrawal by Subject|0|||
25079996|NCT04520997|50188481|FG000|Overall Study|Not Treated|0|||
25079997|NCT04520997|50188482|FG001|Overall Study|Not Treated|1|||
25079998|NCT02734433|50188493|FG000|Overall Study|Disease progression|1|||
25079999|NCT02734433|50188494|FG001|Overall Study|Disease progression|5|||
25080000|NCT02734433|50188493|FG000|Overall Study|Clinical progression|0|||
25080001|NCT02734433|50188494|FG001|Overall Study|Clinical progression|1|||
25080002|NCT02734433|50188493|FG000|Overall Study|Withdrawal by Subject|1|||
25080003|NCT02734433|50188494|FG001|Overall Study|Withdrawal by Subject|2|||
25080004|NCT02452424|50188520|FG000|Overall Study|Death|2|||
25080005|NCT02452424|50188521|FG001|Overall Study|Death|2|||
25080006|NCT02452424|50188522|FG002|Overall Study|Death|2|||
25080007|NCT02452424|50188523|FG003|Overall Study|Death|6|||
25080008|NCT02452424|50188524|FG004|Overall Study|Death|2|||
25080009|NCT02452424|50188525|FG005|Overall Study|Death|0|||
25080010|NCT02452424|50188526|FG006|Overall Study|Death|5|||
25080011|NCT02452424|50188527|FG007|Overall Study|Death|1|||
25080012|NCT02452424|50188528|FG008|Overall Study|Death|3|||
25080013|NCT02452424|50188529|FG009|Overall Study|Death|1|||
25080014|NCT02452424|50188530|FG010|Overall Study|Death|0|||
25080015|NCT02452424|50188520|FG000|Overall Study|Lost to Follow-up|0|||
25080016|NCT02452424|50188521|FG001|Overall Study|Lost to Follow-up|1|||
25080017|NCT02452424|50188522|FG002|Overall Study|Lost to Follow-up|1|||
25080018|NCT02452424|50188523|FG003|Overall Study|Lost to Follow-up|0|||
25080019|NCT02452424|50188524|FG004|Overall Study|Lost to Follow-up|0|||
25080020|NCT02452424|50188525|FG005|Overall Study|Lost to Follow-up|0|||
25080021|NCT02452424|50188526|FG006|Overall Study|Lost to Follow-up|0|||
25080022|NCT02452424|50188527|FG007|Overall Study|Lost to Follow-up|0|||
25080023|NCT02452424|50188528|FG008|Overall Study|Lost to Follow-up|0|||
25080024|NCT02452424|50188529|FG009|Overall Study|Lost to Follow-up|0|||
25080025|NCT02452424|50188530|FG010|Overall Study|Lost to Follow-up|0|||
25080026|NCT02452424|50188520|FG000|Overall Study|Withdrawal by Subject|0|||
25080027|NCT02452424|50188521|FG001|Overall Study|Withdrawal by Subject|0|||
25080028|NCT02452424|50188522|FG002|Overall Study|Withdrawal by Subject|3|||
25080029|NCT02452424|50188523|FG003|Overall Study|Withdrawal by Subject|2|||
25080030|NCT02452424|50188524|FG004|Overall Study|Withdrawal by Subject|0|||
25080031|NCT02452424|50188525|FG005|Overall Study|Withdrawal by Subject|0|||
25080032|NCT02452424|50188526|FG006|Overall Study|Withdrawal by Subject|1|||
25080033|NCT02452424|50188527|FG007|Overall Study|Withdrawal by Subject|0|||
25080034|NCT02452424|50188528|FG008|Overall Study|Withdrawal by Subject|1|||
25080035|NCT02452424|50188529|FG009|Overall Study|Withdrawal by Subject|1|||
25080036|NCT02452424|50188530|FG010|Overall Study|Withdrawal by Subject|0|||
25080037|NCT02452424|50188520|FG000|Overall Study|Other|0|||
25080038|NCT02452424|50188521|FG001|Overall Study|Other|0|||
25080039|NCT02452424|50188522|FG002|Overall Study|Other|1|||
25080040|NCT02452424|50188523|FG003|Overall Study|Other|0|||
25080041|NCT02452424|50188524|FG004|Overall Study|Other|0|||
25080042|NCT02452424|50188525|FG005|Overall Study|Other|1|||
25080043|NCT02452424|50188526|FG006|Overall Study|Other|4|||
25080044|NCT02452424|50188527|FG007|Overall Study|Other|3|||
25080045|NCT02452424|50188528|FG008|Overall Study|Other|0|||
25080046|NCT02452424|50188529|FG009|Overall Study|Other|0|||
25080047|NCT02452424|50188530|FG010|Overall Study|Other|1|||
25080048|NCT02452424|50188520|FG000|Overall Study|Progressive disease (per RECIST)|0|||
25080049|NCT02452424|50188521|FG001|Overall Study|Progressive disease (per RECIST)|0|||
25080050|NCT02452424|50188522|FG002|Overall Study|Progressive disease (per RECIST)|0|||
25080051|NCT02452424|50188523|FG003|Overall Study|Progressive disease (per RECIST)|0|||
25080052|NCT02452424|50188524|FG004|Overall Study|Progressive disease (per RECIST)|0|||
25080053|NCT02452424|50188525|FG005|Overall Study|Progressive disease (per RECIST)|0|||
25080054|NCT02452424|50188526|FG006|Overall Study|Progressive disease (per RECIST)|0|||
25080055|NCT02452424|50188527|FG007|Overall Study|Progressive disease (per RECIST)|0|||
25080056|NCT02452424|50188528|FG008|Overall Study|Progressive disease (per RECIST)|2|||
25080057|NCT02452424|50188529|FG009|Overall Study|Progressive disease (per RECIST)|0|||
25080058|NCT02452424|50188530|FG010|Overall Study|Progressive disease (per RECIST)|0|||
25080059|NCT02452424|50188520|FG000|Overall Study|Adverse Event|0|||
25080060|NCT02452424|50188521|FG001|Overall Study|Adverse Event|0|||
25080061|NCT02452424|50188522|FG002|Overall Study|Adverse Event|0|||
25080062|NCT02452424|50188523|FG003|Overall Study|Adverse Event|0|||
25080063|NCT02452424|50188524|FG004|Overall Study|Adverse Event|0|||
25080064|NCT02452424|50188525|FG005|Overall Study|Adverse Event|0|||
25080065|NCT02452424|50188526|FG006|Overall Study|Adverse Event|0|||
25080066|NCT02452424|50188527|FG007|Overall Study|Adverse Event|0|||
25080067|NCT02452424|50188528|FG008|Overall Study|Adverse Event|0|||
25080068|NCT02452424|50188529|FG009|Overall Study|Adverse Event|0|||
25080069|NCT02452424|50188530|FG010|Overall Study|Adverse Event|1|||
25080070|NCT02419508|50188558|FG000|Overall Study|Adverse Event|9|||
25080071|NCT02419508|50188559|FG001|Overall Study|Adverse Event|3|||
25080072|NCT02419508|50188558|FG000|Overall Study|Withdrawal by Subject|1|||
25080073|NCT02419508|50188559|FG001|Overall Study|Withdrawal by Subject|0|||
25080074|NCT02419508|50188558|FG000|Overall Study|Other - Reason not specified|0|||
25080075|NCT02419508|50188559|FG001|Overall Study|Other - Reason not specified|1|||
25080076|NCT01328249|50188567|FG000|Overall Study|Adverse Event|3|||
25080077|NCT01328249|50188568|FG001|Overall Study|Adverse Event|0|||
25080078|NCT01328249|50188567|FG000|Overall Study|Disease progression|1|||
25080079|NCT01328249|50188568|FG001|Overall Study|Disease progression|0|||
25080080|NCT01328249|50188567|FG000|Overall Study|Withdrawal by Subject|1|||
25080081|NCT01328249|50188568|FG001|Overall Study|Withdrawal by Subject|1|||
25080082|NCT01328249|50188567|FG000|Overall Study|Moved before end of treatment visit|1|||
25080083|NCT01328249|50188568|FG001|Overall Study|Moved before end of treatment visit|0|||
25080084|NCT01328249|50188567|FG000|Overall Study|Subject choice|1|||
25080085|NCT01328249|50188568|FG001|Overall Study|Subject choice|1|||
25080086|NCT01328249|50188567|FG000|Overall Study|Protocol Violation|0|||
25080087|NCT01328249|50188568|FG001|Overall Study|Protocol Violation|1|||
25080088|NCT01651052|50188576|FG000|Overall Study|Death|21|||
25080089|NCT01651052|50188576|FG000|Overall Study|Explant|1|||
25080090|NCT01651052|50188576|FG000|Overall Study|Withdrawal by Subject|1|||
25080091|NCT01651052|50188576|FG000|Overall Study|Lost to Follow-up|3|||
25080092|NCT02388074|50188580|FG000|Overall Study|Lost in Transit|2|||
25080093|NCT02388074|50188580|FG000|Overall Study|Sample Not Returned|1|||
25080094|NCT01602549|50188586|FG000|Overall Study|Protocol Violation|0|||
25080095|NCT01602549|50188587|FG001|Overall Study|Protocol Violation|1|||
25080096|NCT01602549|50188586|FG000|Overall Study|Withdrawal by Subject|1|||
25080097|NCT01602549|50188587|FG001|Overall Study|Withdrawal by Subject|0|||
25080098|NCT02427464|50188597|FG000|Overall Study|Adverse Event|6|||
25080099|NCT02427464|50188598|FG001|Overall Study|Adverse Event|1|||
25080100|NCT02427464|50188597|FG000|Overall Study|Lost to Follow-up|16|||
25080101|NCT02427464|50188598|FG001|Overall Study|Lost to Follow-up|5|||
25080102|NCT02427464|50188597|FG000|Overall Study|Physician Decision|2|||
25080103|NCT02427464|50188598|FG001|Overall Study|Physician Decision|0|||
25080104|NCT02427464|50188597|FG000|Overall Study|Withdrawal by Subject|10|||
25080105|NCT02427464|50188598|FG001|Overall Study|Withdrawal by Subject|8|||
25080106|NCT02427464|50188597|FG000|Overall Study|Noncompliance|16|||
25080107|NCT02427464|50188598|FG001|Overall Study|Noncompliance|10|||
25080108|NCT02426918|50188607|FG000|Overall Study|Adverse Event|2|||
25080109|NCT02426918|50188608|FG001|Overall Study|Adverse Event|2|||
25080110|NCT02426918|50188609|FG002|Overall Study|Adverse Event|0|||
25080111|NCT02426918|50188607|FG000|Overall Study|Physician Decision|1|||
25080112|NCT02426918|50188608|FG001|Overall Study|Physician Decision|1|||
25080113|NCT02426918|50188609|FG002|Overall Study|Physician Decision|1|||
25080114|NCT02426918|50188607|FG000|Overall Study|Withdrawal by Subject|5|||
25080115|NCT02426918|50188608|FG001|Overall Study|Withdrawal by Subject|5|||
25080116|NCT02426918|50188609|FG002|Overall Study|Withdrawal by Subject|4|||
25080117|NCT02426918|50188607|FG000|Overall Study|Other|9|||
25080118|NCT02426918|50188608|FG001|Overall Study|Other|11|||
25080119|NCT02426918|50188609|FG002|Overall Study|Other|9|||
25080120|NCT02387840|50188623|FG000|Overall Study|Death|0|||
25080121|NCT02387840|50188624|FG001|Overall Study|Death|0|||
25080122|NCT02387840|50188625|FG002|Overall Study|Death|0|||
25080123|NCT02387840|50188626|FG003|Overall Study|Death|0|||
25080124|NCT02387840|50188627|FG004|Overall Study|Death|0|||
25080125|NCT02387840|50188628|FG005|Overall Study|Death|1|||
25080126|NCT02387762|50188650|FG000|Overall Study|Withdrawal by Subject|1|||
25080127|NCT02387762|50188651|FG001|Overall Study|Withdrawal by Subject|0|||
25080128|NCT02418182|50188659|FG000|Overall Study|Unable to re-consent|18|||
25080129|NCT02418182|50188660|FG001|Overall Study|Unable to re-consent|15|||
25080130|NCT02418182|50188659|FG000|Overall Study|Lost to Follow-up|0|||
25080131|NCT02418182|50188660|FG001|Overall Study|Lost to Follow-up|2|||
25080132|NCT02387372|50188681|FG000|Overall Study|Not Treated|1|||
25080133|NCT02387372|50188682|FG001|Overall Study|Not Treated|0|||
25080134|NCT02426138|50188698|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
25080135|NCT02426138|50188699|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
25080136|NCT02426684|50188712|FG000|Overall Study|Physician Decision|1|||
25080137|NCT02656173|50188718|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
25080138|NCT02656173|50188719|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
25080139|NCT02656173|50188718|FG000|Overall Study|Adverse Event|7|||
25080140|NCT02656173|50188719|FG001|Overall Study|Adverse Event|5|||
25080141|NCT02656173|50188718|FG000|Overall Study|Withdrawal by Subject|1|||
25080142|NCT02656173|50188719|FG001|Overall Study|Withdrawal by Subject|3|||
25080143|NCT02656173|50188718|FG000|Overall Study|Protocol Violation|0|||
25080144|NCT02656173|50188719|FG001|Overall Study|Protocol Violation|1|||
25080145|NCT02656173|50188718|FG000|Overall Study|Miscellaneous|2|||
25080146|NCT02656173|50188719|FG001|Overall Study|Miscellaneous|0|||
25080147|NCT02656017|50188729|FG000|Overall Study|Study burden|3|||
25080148|NCT02656017|50188730|FG001|Overall Study|Study burden|3|||
25080149|NCT02656017|50188729|FG000|Overall Study|Adverse Event|2|||
25080150|NCT02656017|50188730|FG001|Overall Study|Adverse Event|1|||
25080151|NCT02656017|50188729|FG000|Overall Study|Unable/unwilling to take study medication|2|||
25080152|NCT02656017|50188730|FG001|Overall Study|Unable/unwilling to take study medication|1|||
25080153|NCT02656017|50188729|FG000|Overall Study|Began Tolvaptan|1|||
25080154|NCT02656017|50188730|FG001|Overall Study|Began Tolvaptan|1|||
25080155|NCT02656017|50188729|FG000|Overall Study|Withdrawal by Subject|1|||
25080156|NCT02656017|50188730|FG001|Overall Study|Withdrawal by Subject|0|||
25080157|NCT02657343|50188742|FG000|Overall Study|Death|0|||
25080158|NCT02657343|50188743|FG001|Overall Study|Death|2|||
25080159|NCT02657343|50188744|FG002|Overall Study|Death|0|||
25080160|NCT02657343|50188745|FG003|Overall Study|Death|0|||
25080161|NCT02657343|50188746|FG004|Overall Study|Death|0|||
25080162|NCT02657343|50188747|FG005|Overall Study|Death|0|||
25080163|NCT02657343|50188742|FG000|Overall Study|Patient went to hospice|1|||
25080164|NCT02657343|50188743|FG001|Overall Study|Patient went to hospice|0|||
25080165|NCT02657343|50188744|FG002|Overall Study|Patient went to hospice|0|||
25080166|NCT02657343|50188745|FG003|Overall Study|Patient went to hospice|0|||
25080167|NCT02657343|50188746|FG004|Overall Study|Patient went to hospice|0|||
25080168|NCT02657343|50188747|FG005|Overall Study|Patient went to hospice|0|||
25080169|NCT02657343|50188742|FG000|Overall Study|Withdrawal by Subject|0|||
25080170|NCT02657343|50188743|FG001|Overall Study|Withdrawal by Subject|0|||
25080171|NCT02657343|50188744|FG002|Overall Study|Withdrawal by Subject|0|||
25080172|NCT02657343|50188745|FG003|Overall Study|Withdrawal by Subject|0|||
25080173|NCT02657343|50188746|FG004|Overall Study|Withdrawal by Subject|1|||
25080174|NCT02657343|50188747|FG005|Overall Study|Withdrawal by Subject|0|||
25080175|NCT02655237|50188763|FG000|Overall Study|Adverse Event|10|||
25080176|NCT02655237|50188764|FG001|Overall Study|Adverse Event|7|||
25080177|NCT02655237|50188763|FG000|Overall Study|Protocol Deviation|2|||
25080178|NCT02655237|50188764|FG001|Overall Study|Protocol Deviation|0|||
25080179|NCT02655237|50188763|FG000|Overall Study|Withdrawal by Participant|1|||
24993558|NCT00055497|50083992|FG003|Overall Study|Lack of Efficacy|27|||
24993559|NCT00055497|50083989|FG000|Overall Study|Administrative Reasons|0|||
24993560|NCT00055497|50083990|FG001|Overall Study|Administrative Reasons|0|||
24993561|NCT00055497|50083991|FG002|Overall Study|Administrative Reasons|0|||
24993562|NCT00055497|50083992|FG003|Overall Study|Administrative Reasons|1|||
24993563|NCT00055497|50083989|FG000|Overall Study|Other|0|||
24993564|NCT00055497|50083990|FG001|Overall Study|Other|0|||
24993565|NCT00055497|50083991|FG002|Overall Study|Other|0|||
24993566|NCT00055497|50083992|FG003|Overall Study|Other|11|||
24993567|NCT03520400|50084009|FG000|Overall Study|Physician Decision|15|||
24993568|NCT03520400|50084010|FG001|Overall Study|Physician Decision|7|||
24993569|NCT03615066|50084019|FG000|Main Study|Withdrew Consent|0|||
24993570|NCT03615066|50084020|FG001|Main Study|Withdrew Consent|1|||
24993571|NCT03615066|50084021|FG002|Main Study|Withdrew Consent|1|||
24993572|NCT03615066|50084019|FG000|Main Study|Lost to Follow-up|0|||
24993573|NCT03615066|50084020|FG001|Main Study|Lost to Follow-up|0|||
24993574|NCT03615066|50084021|FG002|Main Study|Lost to Follow-up|1|||
24993575|NCT03615066|50084019|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
24993576|NCT03615066|50084020|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
24993577|NCT03615066|50084021|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
24993578|NCT03615066|50084019|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
25080180|NCT02655237|50188764|FG001|Overall Study|Withdrawal by Participant|2|||
25080181|NCT02655237|50188763|FG000|Overall Study|Lack of Efficacy|0|||
25080182|NCT02655237|50188764|FG001|Overall Study|Lack of Efficacy|1|||
25080183|NCT02655237|50188763|FG000|Overall Study|Recovery Leading to Surgery|2|||
25080184|NCT02655237|50188764|FG001|Overall Study|Recovery Leading to Surgery|1|||
25080185|NCT02655237|50188763|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
25080186|NCT02655237|50188764|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
25080187|NCT02655237|50188763|FG000|Overall Study|Randomized but Not Treated|1|||
25080188|NCT02655237|50188764|FG001|Overall Study|Randomized but Not Treated|0|||
25080189|NCT02657031|50188772|FG000|Overall Study|Adverse Event|1|||
25080190|NCT02657031|50188773|FG001|Overall Study|Adverse Event|2|||
25080191|NCT04375397|50188801|FG000|Overall Study|Death|1|||
25080192|NCT04375397|50188802|FG001|Overall Study|Death|1|||
25080193|NCT04375397|50188801|FG000|Overall Study|Withdrew consent|2|||
25080194|NCT04375397|50188802|FG001|Overall Study|Withdrew consent|0|||
25080195|NCT04375397|50188801|FG000|Overall Study|Lost to Follow-up|6|||
25080196|NCT04375397|50188802|FG001|Overall Study|Lost to Follow-up|4|||
25080197|NCT04375397|50188801|FG000|Overall Study|Other, not specified|0|||
25080198|NCT04375397|50188802|FG001|Overall Study|Other, not specified|1|||
25080199|NCT02387216|50188810|FG000|Overall Study|Progressive disease|2|||
25080200|NCT02387216|50188811|FG001|Overall Study|Progressive disease|0|||
25080201|NCT02387216|50188810|FG000|Overall Study|Withdrawal by Subject|3|||
25080202|NCT02387216|50188811|FG001|Overall Study|Withdrawal by Subject|5|||
25080203|NCT02387216|50188810|FG000|Overall Study|Physician Decision|2|||
25080204|NCT02387216|50188811|FG001|Overall Study|Physician Decision|0|||
25080205|NCT02387216|50188810|FG000|Overall Study|Sponsor Decision|28|||
25080206|NCT02387216|50188811|FG001|Overall Study|Sponsor Decision|12|||
25080207|NCT02387216|50188810|FG000|Overall Study|Death|60|||
25080208|NCT02387216|50188811|FG001|Overall Study|Death|23|||
25080209|NCT02387216|50188810|FG000|Overall Study|Other|5|||
25080210|NCT02387216|50188811|FG001|Overall Study|Other|4|||
25080211|NCT02387216|50188810|FG000|Overall Study|Lost to Follow-up|0|||
25080212|NCT02387216|50188811|FG001|Overall Study|Lost to Follow-up|3|||
25080213|NCT02417246|50188819|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
25080214|NCT02417246|50188820|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
25080215|NCT02417246|50188819|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
25080216|NCT02417246|50188820|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
25080217|NCT02417246|50188819|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
25080218|NCT02417246|50188820|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
25080219|NCT02417246|50188819|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
25080220|NCT02417246|50188820|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
25080221|NCT02424734|50188831|FG000|Overall Study|Treatment stopped to be discharged home|2|||
25080222|NCT02424734|50188832|FG001|Overall Study|Treatment stopped to be discharged home|2|||
25080223|NCT02424734|50188833|FG002|Overall Study|Treatment stopped to be discharged home|0|||
25080224|NCT02424578|50188844|FG000|Overall Study|Withdrawal by Subject|0|||
25080225|NCT02424578|50188845|FG001|Overall Study|Withdrawal by Subject|1|||
25080226|NCT02416934|50188853|FG000|Overall Study|given steroids|1|||
25080227|NCT02416934|50188854|FG001|Overall Study|given steroids|2|||
25080228|NCT02416934|50188853|FG000|Overall Study|Lost to Follow-up|0|||
25080229|NCT02416934|50188854|FG001|Overall Study|Lost to Follow-up|2|||
25080230|NCT02416934|50188853|FG000|Overall Study|Withdrawal by Subject|1|||
25080231|NCT02416934|50188854|FG001|Overall Study|Withdrawal by Subject|0|||
25080232|NCT02416934|50188853|FG000|Overall Study|recruited during continuing renewal proc|0|||
25080233|NCT02416934|50188854|FG001|Overall Study|recruited during continuing renewal proc|1|||
25080234|NCT02416934|50188853|FG000|Overall Study|Protocol Violation|0|||
25080235|NCT02416934|50188854|FG001|Overall Study|Protocol Violation|1|||
25080236|NCT02416934|50188853|FG000|Overall Study|surgery started late|0|||
25080237|NCT02416934|50188854|FG001|Overall Study|surgery started late|1|||
25257519|NCT01323660|50572512|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
24993579|NCT03615066|50084020|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
24993580|NCT03615066|50084021|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
24993581|NCT03615066|50084019|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
24993582|NCT03615066|50084020|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
24993583|NCT03615066|50084021|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
24993584|NCT03527966|50084035|FG000|Overall Study|Lost to Follow-up|3|||
24993585|NCT03527966|50084036|FG001|Overall Study|Lost to Follow-up|0|||
24993586|NCT03808545|50084044|FG000|Overall Study|Withdrawal by Subject|1|||
24993587|NCT03808545|50084045|FG001|Overall Study|Withdrawal by Subject|1|||
24993588|NCT03807843|50084054|FG000|Overall Study|Lost to Follow-up|1|||
24993589|NCT03807843|50084055|FG001|Overall Study|Lost to Follow-up|0|||
24993590|NCT03519932|50084061|FG000|First Intervention|Adverse Event|1|||
25080238|NCT02416934|50188853|FG000|Overall Study|re-operation|1|||
25080239|NCT02416934|50188854|FG001|Overall Study|re-operation|0|||
25080240|NCT02819635|50188874|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
25080241|NCT02819635|50188875|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
25080242|NCT02819635|50188876|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
25080243|NCT02819635|50188877|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
25080244|NCT02819635|50188878|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
25080245|NCT02819635|50188879|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
25080246|NCT02819635|50188880|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
25080247|NCT02819635|50188881|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
25080248|NCT02819635|50188882|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
25080249|NCT02819635|50188883|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
25080250|NCT02819635|50188884|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
25080251|NCT02819635|50188885|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
25080252|NCT02819635|50188874|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
25080253|NCT02819635|50188875|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
25080254|NCT02819635|50188876|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
25080255|NCT02819635|50188877|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
25080256|NCT02819635|50188878|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
25080257|NCT02819635|50188879|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
25080258|NCT02819635|50188880|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
25080259|NCT02819635|50188881|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
25080260|NCT02819635|50188882|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
25080261|NCT02819635|50188883|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
25080262|NCT02819635|50188884|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
25080263|NCT02819635|50188885|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
25080264|NCT02819635|50188874|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
25080265|NCT02819635|50188875|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
25080266|NCT02819635|50188876|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
25080267|NCT02819635|50188877|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
25080268|NCT02819635|50188878|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
25080269|NCT02819635|50188879|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
25080270|NCT02819635|50188880|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
25080271|NCT02819635|50188881|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
25080272|NCT02819635|50188882|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
25080273|NCT02819635|50188883|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
25080274|NCT02819635|50188884|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
25080275|NCT02819635|50188885|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
25080276|NCT02819635|50188874|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
25080277|NCT02819635|50188875|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
25080278|NCT02819635|50188876|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
25080279|NCT02819635|50188877|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
25080280|NCT02819635|50188878|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
25080281|NCT02819635|50188879|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
25080282|NCT02819635|50188880|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
25080283|NCT02819635|50188881|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
25080284|NCT02819635|50188882|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
25080285|NCT02819635|50188883|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
25080286|NCT02819635|50188884|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
25080287|NCT02819635|50188885|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
25080288|NCT02819635|50188874|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
25080289|NCT02819635|50188875|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
25080290|NCT02819635|50188876|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
25080291|NCT02819635|50188877|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
25080292|NCT02819635|50188878|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
25080293|NCT02819635|50188879|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
25080294|NCT02819635|50188880|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
25080295|NCT02819635|50188881|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
25080296|NCT02819635|50188882|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
25080297|NCT02819635|50188883|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
25080298|NCT02819635|50188884|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
25080299|NCT02819635|50188885|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
25080300|NCT02819635|50188874|FG000|Substudy 2, Part 2|Adverse Event|0|||
25080301|NCT02819635|50188875|FG001|Substudy 2, Part 2|Adverse Event|0|||
25080302|NCT02819635|50188876|FG002|Substudy 2, Part 2|Adverse Event|0|||
25080303|NCT02819635|50188877|FG003|Substudy 2, Part 2|Adverse Event|0|||
25080304|NCT02819635|50188878|FG004|Substudy 2, Part 2|Adverse Event|0|||
25080305|NCT02819635|50188879|FG005|Substudy 2, Part 2|Adverse Event|4|||
25080306|NCT02819635|50188880|FG006|Substudy 2, Part 2|Adverse Event|0|||
25080307|NCT02819635|50188881|FG007|Substudy 2, Part 2|Adverse Event|0|||
25080308|NCT02819635|50188882|FG008|Substudy 2, Part 2|Adverse Event|0|||
25080309|NCT02819635|50188883|FG009|Substudy 2, Part 2|Adverse Event|0|||
25080310|NCT02819635|50188884|FG010|Substudy 2, Part 2|Adverse Event|0|||
25080311|NCT02819635|50188885|FG011|Substudy 2, Part 2|Adverse Event|0|||
25080312|NCT02819635|50188874|FG000|Substudy 2, Part 2|Withdrew consent|0|||
25080313|NCT02819635|50188875|FG001|Substudy 2, Part 2|Withdrew consent|0|||
25080314|NCT02819635|50188876|FG002|Substudy 2, Part 2|Withdrew consent|0|||
25080315|NCT02819635|50188877|FG003|Substudy 2, Part 2|Withdrew consent|0|||
25080316|NCT02819635|50188878|FG004|Substudy 2, Part 2|Withdrew consent|0|||
25080317|NCT02819635|50188879|FG005|Substudy 2, Part 2|Withdrew consent|3|||
25080318|NCT02819635|50188880|FG006|Substudy 2, Part 2|Withdrew consent|1|||
25080319|NCT02819635|50188881|FG007|Substudy 2, Part 2|Withdrew consent|0|||
25080320|NCT02819635|50188882|FG008|Substudy 2, Part 2|Withdrew consent|0|||
25080321|NCT02819635|50188883|FG009|Substudy 2, Part 2|Withdrew consent|0|||
25080322|NCT02819635|50188884|FG010|Substudy 2, Part 2|Withdrew consent|0|||
25080323|NCT02819635|50188885|FG011|Substudy 2, Part 2|Withdrew consent|0|||
25080324|NCT02819635|50188874|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
25080325|NCT02819635|50188875|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
25080326|NCT02819635|50188876|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
25080327|NCT02819635|50188877|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
25080328|NCT02819635|50188878|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
25080329|NCT02819635|50188879|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
25080330|NCT02819635|50188880|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
25080331|NCT02819635|50188881|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
25080332|NCT02819635|50188882|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
25080333|NCT02819635|50188883|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
25080334|NCT02819635|50188884|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
25080335|NCT02819635|50188885|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
25080336|NCT02819635|50188874|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
25080337|NCT02819635|50188875|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
25080338|NCT02819635|50188876|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
25080339|NCT02819635|50188877|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
25080340|NCT02819635|50188878|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
25080341|NCT02819635|50188879|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
25080342|NCT02819635|50188880|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
25080343|NCT02819635|50188881|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
25080344|NCT02819635|50188882|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
25080345|NCT02819635|50188883|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
25080346|NCT02819635|50188884|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
25080347|NCT02819635|50188885|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
25080348|NCT02819635|50188874|FG000|Substudy 2, Part 2|Other, not specified|0|||
25080349|NCT02819635|50188875|FG001|Substudy 2, Part 2|Other, not specified|0|||
25080350|NCT02819635|50188876|FG002|Substudy 2, Part 2|Other, not specified|0|||
25080351|NCT02819635|50188877|FG003|Substudy 2, Part 2|Other, not specified|0|||
25080352|NCT02819635|50188878|FG004|Substudy 2, Part 2|Other, not specified|0|||
25080353|NCT02819635|50188879|FG005|Substudy 2, Part 2|Other, not specified|4|||
25080354|NCT02819635|50188880|FG006|Substudy 2, Part 2|Other, not specified|8|||
25080355|NCT02819635|50188881|FG007|Substudy 2, Part 2|Other, not specified|0|||
25080356|NCT02819635|50188882|FG008|Substudy 2, Part 2|Other, not specified|0|||
25080357|NCT02819635|50188883|FG009|Substudy 2, Part 2|Other, not specified|0|||
25080358|NCT02819635|50188884|FG010|Substudy 2, Part 2|Other, not specified|0|||
25080359|NCT02819635|50188885|FG011|Substudy 2, Part 2|Other, not specified|0|||
25080360|NCT02819635|50188874|FG000|Substudy 3|Adverse Event|0|||
25080361|NCT02819635|50188875|FG001|Substudy 3|Adverse Event|0|||
25080362|NCT02819635|50188876|FG002|Substudy 3|Adverse Event|0|||
25080363|NCT02819635|50188877|FG003|Substudy 3|Adverse Event|0|||
25080364|NCT02819635|50188878|FG004|Substudy 3|Adverse Event|0|||
25080365|NCT02819635|50188879|FG005|Substudy 3|Adverse Event|0|||
25080366|NCT02819635|50188880|FG006|Substudy 3|Adverse Event|0|||
25080367|NCT02819635|50188881|FG007|Substudy 3|Adverse Event|0|||
25080368|NCT02819635|50188882|FG008|Substudy 3|Adverse Event|32|||
25080369|NCT02819635|50188883|FG009|Substudy 3|Adverse Event|3|||
25080370|NCT02819635|50188884|FG010|Substudy 3|Adverse Event|12|||
25080371|NCT02819635|50188885|FG011|Substudy 3|Adverse Event|18|||
25080372|NCT02819635|50188874|FG000|Substudy 3|Withdrew consent|0|||
25080373|NCT02819635|50188875|FG001|Substudy 3|Withdrew consent|0|||
25080374|NCT02819635|50188876|FG002|Substudy 3|Withdrew consent|0|||
25080375|NCT02819635|50188877|FG003|Substudy 3|Withdrew consent|0|||
25080376|NCT02819635|50188878|FG004|Substudy 3|Withdrew consent|0|||
25080377|NCT02819635|50188879|FG005|Substudy 3|Withdrew consent|0|||
25080378|NCT02819635|50188880|FG006|Substudy 3|Withdrew consent|0|||
25080379|NCT02819635|50188881|FG007|Substudy 3|Withdrew consent|0|||
25080380|NCT02819635|50188882|FG008|Substudy 3|Withdrew consent|11|||
25080381|NCT02819635|50188883|FG009|Substudy 3|Withdrew consent|1|||
25080382|NCT02819635|50188884|FG010|Substudy 3|Withdrew consent|4|||
25080383|NCT02819635|50188885|FG011|Substudy 3|Withdrew consent|9|||
25080384|NCT02819635|50188874|FG000|Substudy 3|Lost to Follow-up|0|||
25080385|NCT02819635|50188875|FG001|Substudy 3|Lost to Follow-up|0|||
25080386|NCT02819635|50188876|FG002|Substudy 3|Lost to Follow-up|0|||
25080387|NCT02819635|50188877|FG003|Substudy 3|Lost to Follow-up|0|||
25080388|NCT02819635|50188878|FG004|Substudy 3|Lost to Follow-up|0|||
25080389|NCT02819635|50188879|FG005|Substudy 3|Lost to Follow-up|0|||
25080390|NCT02819635|50188880|FG006|Substudy 3|Lost to Follow-up|0|||
25080391|NCT02819635|50188881|FG007|Substudy 3|Lost to Follow-up|0|||
25080392|NCT02819635|50188882|FG008|Substudy 3|Lost to Follow-up|1|||
25080393|NCT02819635|50188883|FG009|Substudy 3|Lost to Follow-up|0|||
25080394|NCT02819635|50188884|FG010|Substudy 3|Lost to Follow-up|1|||
25080395|NCT02819635|50188885|FG011|Substudy 3|Lost to Follow-up|1|||
25080396|NCT02819635|50188874|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
25080397|NCT02819635|50188875|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
25080398|NCT02819635|50188876|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
25080399|NCT02819635|50188877|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
25080400|NCT02819635|50188878|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
25080401|NCT02819635|50188879|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
25080402|NCT02819635|50188880|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
25080403|NCT02819635|50188881|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
25080404|NCT02819635|50188882|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
25080405|NCT02819635|50188883|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
25080406|NCT02819635|50188884|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
25080407|NCT02819635|50188885|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
25080408|NCT02819635|50188874|FG000|Substudy 3|Other, not specified|0|||
25080409|NCT02819635|50188875|FG001|Substudy 3|Other, not specified|0|||
25080410|NCT02819635|50188876|FG002|Substudy 3|Other, not specified|0|||
25080411|NCT02819635|50188877|FG003|Substudy 3|Other, not specified|0|||
25080412|NCT02819635|50188878|FG004|Substudy 3|Other, not specified|0|||
25080413|NCT02819635|50188879|FG005|Substudy 3|Other, not specified|0|||
25080414|NCT02819635|50188880|FG006|Substudy 3|Other, not specified|0|||
25080415|NCT02819635|50188881|FG007|Substudy 3|Other, not specified|0|||
25080416|NCT02819635|50188882|FG008|Substudy 3|Other, not specified|202|||
25080417|NCT02819635|50188883|FG009|Substudy 3|Other, not specified|5|||
25080418|NCT02819635|50188884|FG010|Substudy 3|Other, not specified|89|||
25080419|NCT02819635|50188885|FG011|Substudy 3|Other, not specified|39|||
25080420|NCT02424344|50188920|FG000|Overall Study|Lack of Efficacy|0|||
25080421|NCT02424344|50188921|FG001|Overall Study|Lack of Efficacy|1|||
25080422|NCT02424344|50188920|FG000|Overall Study|Withdrawal by Subject|2|||
25080423|NCT02424344|50188921|FG001|Overall Study|Withdrawal by Subject|1|||
25080424|NCT02424344|50188920|FG000|Overall Study|Lost to Follow-up|1|||
25080425|NCT02424344|50188921|FG001|Overall Study|Lost to Follow-up|0|||
25080426|NCT02424344|50188920|FG000|Overall Study|Adverse Event|4|||
25080427|NCT02424344|50188921|FG001|Overall Study|Adverse Event|8|||
25080428|NCT02423798|50188927|FG000|Overall Study|Withdrawal by Subject|3|||
25080429|NCT01651208|50188950|FG000|Overall Study|Lost to Follow-up|14|||
25080430|NCT01651208|50188951|FG001|Overall Study|Lost to Follow-up|16|||
25080431|NCT02383940|50188960|FG000|Overall Study|Adverse Event|1|||
25257520|NCT01323660|50572513|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
25257521|NCT01323660|50572514|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
25257522|NCT01323660|50572515|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
25257523|NCT01323660|50572510|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
25257524|NCT01323660|50572511|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
25257525|NCT01323660|50572512|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
25257526|NCT01323660|50572513|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
25257527|NCT01323660|50572514|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
25257528|NCT01323660|50572515|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
25257529|NCT01323660|50572510|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
25257530|NCT01323660|50572511|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
25257531|NCT01323660|50572512|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
25257532|NCT01323660|50572513|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
25257533|NCT01323660|50572514|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
25257534|NCT01323660|50572515|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
25257535|NCT01092637|50572531|FG000|Overall Study|Death|47|||
25257536|NCT01092637|50572532|FG001|Overall Study|Death|49|||
25257537|NCT01324323|50572539|FG000|Overall Study|Withdrawal by Subject|1|||
25257538|NCT01323582|50572553|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
25080432|NCT02383940|50188961|FG001|Overall Study|Adverse Event|0|||
25257539|NCT01323582|50572554|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
25257540|NCT01323582|50572553|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
25080433|NCT02383940|50188960|FG000|Overall Study|Lost to Follow-up|2|||
25080434|NCT02383940|50188961|FG001|Overall Study|Lost to Follow-up|2|||
25080435|NCT02383940|50188960|FG000|Overall Study|Physician Decision|2|||
25080436|NCT02383940|50188961|FG001|Overall Study|Physician Decision|0|||
25080437|NCT02383940|50188960|FG000|Overall Study|Withdrawal by Subject|1|||
25257541|NCT01323582|50572554|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
25257542|NCT01323582|50572553|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
25257543|NCT01323582|50572554|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
25257544|NCT01323621|50572564|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
25257545|NCT01323621|50572565|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
25257546|NCT01323621|50572566|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
25257547|NCT01323621|50572564|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
25257548|NCT01323621|50572565|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
25257549|NCT01323621|50572566|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
25257550|NCT01323621|50572564|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
25257551|NCT01323621|50572565|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
25257552|NCT01323621|50572566|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
25257553|NCT01323621|50572564|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
25257554|NCT01323621|50572565|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
25257555|NCT01323621|50572566|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
25257556|NCT01323621|50572564|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
25257557|NCT01323621|50572565|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
25257558|NCT01323621|50572566|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
25257559|NCT01323621|50572564|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
25257560|NCT01323621|50572565|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
25257561|NCT01323621|50572566|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
25257562|NCT01323621|50572564|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
25257563|NCT01323621|50572565|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
25257564|NCT01323621|50572566|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
25257565|NCT01323621|50572564|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
25257566|NCT01323621|50572565|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
25257567|NCT01323621|50572566|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
25257568|NCT01323621|50572564|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
25257569|NCT01323621|50572565|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
25257570|NCT01323621|50572566|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
25257571|NCT01323621|50572564|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
25257572|NCT01323621|50572565|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
25257573|NCT01323621|50572566|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
25257574|NCT01323621|50572564|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
25257575|NCT01323621|50572565|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
25257576|NCT01323621|50572566|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
25257577|NCT01323621|50572564|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
25257578|NCT01323621|50572565|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
25257579|NCT01323621|50572566|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
25257580|NCT01323192|50572574|FG000|Overall Study|Adverse Event|6|||
25257581|NCT01323192|50572575|FG001|Overall Study|Adverse Event|1|||
25257582|NCT01323192|50572574|FG000|Overall Study|Withdrawal by Subject|3|||
25257583|NCT01323192|50572575|FG001|Overall Study|Withdrawal by Subject|1|||
25257584|NCT01323192|50572574|FG000|Overall Study|Noncompliance with study medication|0|||
25257585|NCT01323192|50572575|FG001|Overall Study|Noncompliance with study medication|3|||
25257586|NCT01323192|50572574|FG000|Overall Study|Nonmedical reasons|0|||
25257587|NCT01323192|50572575|FG001|Overall Study|Nonmedical reasons|1|||
25257588|NCT01323387|50572581|FG000|Overall Study|Withdrawal by Subject|41|||
25257589|NCT01323387|50572581|FG000|Overall Study|Radiographic Data Unavailable|1|||
25257590|NCT01323387|50572581|FG000|Overall Study|Revision|14|||
25257591|NCT01323387|50572581|FG000|Overall Study|Protocol Violation|12|||
25257592|NCT01323387|50572581|FG000|Overall Study|Randomized but Never Treated|16|||
25257593|NCT01321749|50572589|FG000|Overall Study|Lost to Follow-up|4|||
25257594|NCT01321749|50572590|FG001|Overall Study|Lost to Follow-up|11|||
25257595|NCT01321749|50572589|FG000|Overall Study|Protocol Violation|4|||
25257596|NCT01321749|50572590|FG001|Overall Study|Protocol Violation|7|||
25257597|NCT01321749|50572589|FG000|Overall Study|Withdrawal by Subject|5|||
25257598|NCT01321749|50572590|FG001|Overall Study|Withdrawal by Subject|4|||
25257599|NCT01320735|50572596|FG000|Overall Study|Adverse Event|3|||
25257600|NCT01320735|50572596|FG000|Overall Study|Withdrawal by Subject|3|||
25257601|NCT01320735|50572596|FG000|Overall Study|Lost to Follow-up|13|||
25257602|NCT01320735|50572596|FG000|Overall Study|Administrative Reason|6|||
25257603|NCT01320735|50572596|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
25257604|NCT01320735|50572596|FG000|Overall Study|Protocol Violation|1|||
25257605|NCT01320735|50572596|FG000|Overall Study|Other|1|||
25257606|NCT01320735|50572596|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
25257607|NCT01320735|50572596|FG000|Overall Study|Investigator Unable to be Contacted|17|||
25257608|NCT01320033|50572603|FG000|Overall Study|Lack of Efficacy|0|||
24993591|NCT03519932|50084062|FG001|First Intervention|Adverse Event|3|||
25257609|NCT01320033|50572604|FG001|Overall Study|Lack of Efficacy|0|||
25257610|NCT01320033|50572605|FG002|Overall Study|Lack of Efficacy|1|||
25257611|NCT01320033|50572603|FG000|Overall Study|Adverse Event|9|||
25257612|NCT01320033|50572604|FG001|Overall Study|Adverse Event|7|||
25257613|NCT01320033|50572605|FG002|Overall Study|Adverse Event|8|||
25257614|NCT01320033|50572603|FG000|Overall Study|Withdrawal by Subject|22|||
25257615|NCT01320033|50572604|FG001|Overall Study|Withdrawal by Subject|23|||
25080438|NCT02383940|50188961|FG001|Overall Study|Withdrawal by Subject|1|||
25080439|NCT02383940|50188960|FG000|Overall Study|Randomized but not treated|2|||
25080440|NCT02383940|50188961|FG001|Overall Study|Randomized but not treated|0|||
25080441|NCT02383940|50188960|FG000|Overall Study|Other than specified above|1|||
25080442|NCT02383940|50188961|FG001|Overall Study|Other than specified above|0|||
25080443|NCT02383862|50188969|FG000|3 Month Follow up|Lost to Follow-up|23|||
25080444|NCT02383862|50188970|FG001|3 Month Follow up|Lost to Follow-up|21|||
25080445|NCT02383472|50188985|FG000|Overall Study|Withdrawal by Subject|1|||
25080446|NCT02383472|50188986|FG001|Overall Study|Withdrawal by Subject|1|||
25080447|NCT02234323|50188994|FG000|All Enrolled|Not Treated: Completed study in database|2|||
25257616|NCT01320033|50572605|FG002|Overall Study|Withdrawal by Subject|23|||
25257617|NCT01320033|50572603|FG000|Overall Study|Protocol Violation|3|||
25257618|NCT01320033|50572604|FG001|Overall Study|Protocol Violation|5|||
25257619|NCT01320033|50572605|FG002|Overall Study|Protocol Violation|3|||
25257620|NCT01320033|50572603|FG000|Overall Study|Lost to Follow-up|22|||
25257621|NCT01320033|50572604|FG001|Overall Study|Lost to Follow-up|26|||
25257622|NCT01320033|50572605|FG002|Overall Study|Lost to Follow-up|17|||
25257623|NCT01320033|50572603|FG000|Overall Study|Other|2|||
25257624|NCT01320033|50572604|FG001|Overall Study|Other|3|||
25257625|NCT01320033|50572605|FG002|Overall Study|Other|1|||
25257626|NCT01101061|50572619|FG000|Overall Study|Adverse Event|0|||
25257627|NCT01101061|50572620|FG001|Overall Study|Adverse Event|0|||
25257628|NCT01101061|50572621|FG002|Overall Study|Adverse Event|1|||
25257629|NCT01101061|50572622|FG003|Overall Study|Adverse Event|0|||
25257630|NCT01101061|50572623|FG004|Overall Study|Adverse Event|0|||
25257631|NCT01101061|50572624|FG005|Overall Study|Adverse Event|0|||
25257632|NCT01317615|50572642|FG000|Overall Study|Disease progression|25|||
25257633|NCT01317615|50572642|FG000|Overall Study|New cancer therapy|5|||
25257634|NCT01317615|50572642|FG000|Overall Study|Death|6|||
25257635|NCT01317615|50572642|FG000|Overall Study|Withdrawal by Subject|5|||
25257636|NCT01317615|50572642|FG000|Overall Study|Abnormal laboratory value(s)|1|||
25257637|NCT01317615|50572642|FG000|Overall Study|Adverse Event|7|||
25257638|NCT01078675|50572648|FG000|Overall Study|Withdrawal by Subject|7|||
25257639|NCT01078675|50572649|FG001|Overall Study|Withdrawal by Subject|3|||
25257640|NCT01078675|50572648|FG000|Overall Study|Protocol Violation|56|||
25257641|NCT01078675|50572649|FG001|Overall Study|Protocol Violation|0|||
25257642|NCT01078675|50572648|FG000|Overall Study|Provided in CRF for specific reasons|2|||
25257643|NCT01078675|50572649|FG001|Overall Study|Provided in CRF for specific reasons|3|||
25257644|NCT01078675|50572648|FG000|Overall Study|Adverse Event|3|||
25257645|NCT01078675|50572649|FG001|Overall Study|Adverse Event|0|||
25257646|NCT01100437|50572655|FG000|Titration/Stabilization|Adverse Event|0|||
25257647|NCT01100437|50572656|FG001|Titration/Stabilization|Adverse Event|0|||
25257648|NCT01100437|50572657|FG002|Titration/Stabilization|Adverse Event|4|||
25257649|NCT01100437|50572655|FG000|Titration/Stabilization|Non-compliance|0|||
25257650|NCT01100437|50572656|FG001|Titration/Stabilization|Non-compliance|0|||
25257651|NCT01100437|50572657|FG002|Titration/Stabilization|Non-compliance|1|||
25257652|NCT01100437|50572655|FG000|Titration/Stabilization|Sponsor canceled study|0|||
25257653|NCT01100437|50572656|FG001|Titration/Stabilization|Sponsor canceled study|0|||
25257654|NCT01100437|50572657|FG002|Titration/Stabilization|Sponsor canceled study|1|||
25257655|NCT01100437|50572655|FG000|Maintenance|Withdrawal by Subject|0|||
25257656|NCT01100437|50572656|FG001|Maintenance|Withdrawal by Subject|0|||
25257657|NCT01100437|50572657|FG002|Maintenance|Withdrawal by Subject|1|||
25257658|NCT01100437|50572655|FG000|Maintenance|Sponsor termination of study|0|||
25257659|NCT01100437|50572656|FG001|Maintenance|Sponsor termination of study|0|||
25257660|NCT01100437|50572657|FG002|Maintenance|Sponsor termination of study|1|||
25257661|NCT01322490|50572669|FG000|Treatment Period|Adverse Event|12|||
25257662|NCT01322490|50572670|FG001|Treatment Period|Adverse Event|18|||
25257663|NCT01322490|50572671|FG002|Treatment Period|Adverse Event|15|||
25257664|NCT01322490|50572669|FG000|Treatment Period|Death|5|||
25257665|NCT01322490|50572670|FG001|Treatment Period|Death|7|||
25257666|NCT01322490|50572671|FG002|Treatment Period|Death|3|||
25080448|NCT02234323|50188994|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
25257667|NCT01322490|50572669|FG000|Treatment Period|Lack of Efficacy|89|||
25257668|NCT01322490|50572670|FG001|Treatment Period|Lack of Efficacy|100|||
25080449|NCT02234323|50188994|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
25080450|NCT02234323|50188994|FG000|All Treated|Death|1|||
25080451|NCT02234323|50188994|FG000|All Treated|Physician Decision|5|||
25257669|NCT01322490|50572671|FG002|Treatment Period|Lack of Efficacy|112|||
25257670|NCT01322490|50572669|FG000|Treatment Period|Physician Decision|0|||
25257671|NCT01322490|50572670|FG001|Treatment Period|Physician Decision|2|||
25257672|NCT01322490|50572671|FG002|Treatment Period|Physician Decision|1|||
25257673|NCT01322490|50572669|FG000|Treatment Period|Protocol Violation|7|||
25257674|NCT01322490|50572670|FG001|Treatment Period|Protocol Violation|5|||
25257675|NCT01322490|50572671|FG002|Treatment Period|Protocol Violation|4|||
25257676|NCT01322490|50572669|FG000|Treatment Period|Withdrawal by Subject|14|||
25257677|NCT01322490|50572670|FG001|Treatment Period|Withdrawal by Subject|16|||
25257678|NCT01322490|50572671|FG002|Treatment Period|Withdrawal by Subject|11|||
25257679|NCT01322490|50572669|FG000|Treatment Period|Non-compliance with study drug|0|||
25257680|NCT01322490|50572670|FG001|Treatment Period|Non-compliance with study drug|0|||
25257681|NCT01322490|50572671|FG002|Treatment Period|Non-compliance with study drug|1|||
25257682|NCT01322490|50572669|FG000|Treatment Period|Other per report|2|||
25257683|NCT01322490|50572670|FG001|Treatment Period|Other per report|2|||
25257684|NCT01322490|50572671|FG002|Treatment Period|Other per report|1|||
25257685|NCT01322490|50572669|FG000|Treatment Period|Randomized but Not Treated|3|||
25257686|NCT01322490|50572670|FG001|Treatment Period|Randomized but Not Treated|3|||
25257687|NCT01322490|50572671|FG002|Treatment Period|Randomized but Not Treated|5|||
25257688|NCT01322490|50572669|FG000|Long Term Follow-up Period|Death|235|||
25257689|NCT01322490|50572670|FG001|Long Term Follow-up Period|Death|239|||
25257690|NCT01322490|50572671|FG002|Long Term Follow-up Period|Death|236|||
25257691|NCT01322490|50572669|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
25257692|NCT01322490|50572670|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
25257693|NCT01322490|50572671|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
25257694|NCT01322490|50572669|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
25257695|NCT01322490|50572670|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
25257696|NCT01322490|50572671|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
25257697|NCT01322490|50572669|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
25257698|NCT01322490|50572670|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
25257699|NCT01322490|50572671|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
25257700|NCT01322490|50572669|FG000|Long Term Follow-up Period|Other per report|3|||
25257701|NCT01322490|50572670|FG001|Long Term Follow-up Period|Other per report|2|||
25257702|NCT01322490|50572671|FG002|Long Term Follow-up Period|Other per report|2|||
25257703|NCT01322490|50572669|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
25257704|NCT01322490|50572670|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
25257705|NCT01322490|50572671|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
25257706|NCT01314261|50572683|FG000|Overall Study|Adverse Event|1|||
25257707|NCT01314261|50572684|FG001|Overall Study|Adverse Event|0|||
25257708|NCT01314261|50572685|FG002|Overall Study|Adverse Event|0|||
25257709|NCT01314261|50572686|FG003|Overall Study|Adverse Event|0|||
25257710|NCT01314261|50572683|FG000|Overall Study|Withdrawal by Subject|0|||
25257711|NCT01314261|50572684|FG001|Overall Study|Withdrawal by Subject|3|||
25257712|NCT01314261|50572685|FG002|Overall Study|Withdrawal by Subject|1|||
25257713|NCT01314261|50572686|FG003|Overall Study|Withdrawal by Subject|0|||
25257714|NCT01314261|50572683|FG000|Overall Study|Lost to Follow-up|1|||
25257715|NCT01314261|50572684|FG001|Overall Study|Lost to Follow-up|0|||
25257716|NCT01314261|50572685|FG002|Overall Study|Lost to Follow-up|2|||
25257717|NCT01314261|50572686|FG003|Overall Study|Lost to Follow-up|2|||
25257718|NCT01314261|50572683|FG000|Overall Study|Virologic Failure|0|||
25257719|NCT01314261|50572684|FG001|Overall Study|Virologic Failure|1|||
25080452|NCT02234323|50188994|FG000|All Treated|Lack of Efficacy|3|||
25080453|NCT02234323|50188994|FG000|All Treated|Exceeded lab value limit|2|||
25080454|NCT02234323|50188994|FG000|All Treated|Other|7|||
25080455|NCT02414828|50189004|FG000|Overall Study|Lost to Follow-up|0|||
25080456|NCT02414828|50189005|FG001|Overall Study|Lost to Follow-up|1|||
25257720|NCT01314261|50572685|FG002|Overall Study|Virologic Failure|0|||
25257721|NCT01314261|50572686|FG003|Overall Study|Virologic Failure|1|||
25257722|NCT01321710|50572699|FG000|Overall Study|Lost to Follow-up|4|||
25257723|NCT01321710|50572700|FG001|Overall Study|Lost to Follow-up|5|||
25257724|NCT01321710|50572701|FG002|Overall Study|Lost to Follow-up|0|||
25257725|NCT01321008|50572711|FG000|Overall Study|Early Study Termination|1|||
25257726|NCT01320150|50572717|FG000|Overall Study|Protocol Violation|15|||
25257727|NCT01320150|50572717|FG000|Overall Study|Withdrawal by Subject|5|||
25257728|NCT01320150|50572717|FG000|Overall Study|Death|2|||
25257729|NCT01320150|50572717|FG000|Overall Study|Lost to Follow-up|44|||
25257730|NCT01323530|50572728|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
25257731|NCT01323530|50572729|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
25257732|NCT01323530|50572730|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
25257733|NCT01323530|50572731|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
25257734|NCT01323530|50572732|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
25257735|NCT01323530|50572733|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
25257736|NCT01323530|50572734|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
25257737|NCT01323530|50572728|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
25257738|NCT01323530|50572729|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
25080457|NCT02414828|50189006|FG002|Overall Study|Lost to Follow-up|1|||
25257739|NCT01323530|50572730|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
25257740|NCT01323530|50572731|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
25080458|NCT02414828|50189007|FG003|Overall Study|Lost to Follow-up|2|||
25257741|NCT01323530|50572732|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
25257742|NCT01323530|50572733|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
25257743|NCT01323530|50572734|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
25257744|NCT01323530|50572728|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
25257745|NCT01323530|50572729|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
25257746|NCT01323530|50572730|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
25257747|NCT01323530|50572731|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
25257748|NCT01323530|50572732|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
25257749|NCT01323530|50572733|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
25257750|NCT01323530|50572734|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
25257751|NCT01323530|50572728|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
25257752|NCT01323530|50572729|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
25257753|NCT01323530|50572730|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
25257754|NCT01323530|50572731|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
25257755|NCT01323530|50572732|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
25257756|NCT01323530|50572733|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
25257757|NCT01323530|50572734|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
25257758|NCT01323530|50572728|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
25257759|NCT01323530|50572729|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
25257760|NCT01323530|50572730|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
25257761|NCT01323530|50572731|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
25257762|NCT01323530|50572732|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
25257763|NCT01323530|50572733|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
25257764|NCT01323530|50572734|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
25257765|NCT01323530|50572728|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
25257766|NCT01323530|50572729|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
25257767|NCT01323530|50572730|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
25257768|NCT01323530|50572731|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
25257769|NCT01323530|50572732|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
25257770|NCT01323530|50572733|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
25257771|NCT01323530|50572734|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
25257772|NCT01323530|50572728|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
25257773|NCT01323530|50572729|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
25257774|NCT01323530|50572730|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
25257775|NCT01323530|50572731|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
25257776|NCT01323530|50572732|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
25257777|NCT01323530|50572733|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
25257778|NCT01323530|50572734|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
25257779|NCT01323530|50572728|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
25257780|NCT01323530|50572729|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
25257781|NCT01323530|50572730|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
25257782|NCT01323530|50572731|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
25257783|NCT01323530|50572732|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
25257784|NCT01323530|50572733|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
25257785|NCT01323530|50572734|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
25257786|NCT01313637|50572755|FG000|Overall Study|Adverse Event|17|||
25257787|NCT01313637|50572756|FG001|Overall Study|Adverse Event|24|||
25257788|NCT01313637|50572757|FG002|Overall Study|Adverse Event|25|||
25257789|NCT01313637|50572758|FG003|Overall Study|Adverse Event|18|||
25257790|NCT01313637|50572755|FG000|Overall Study|Lack of Efficacy|44|||
25257791|NCT01313637|50572756|FG001|Overall Study|Lack of Efficacy|38|||
25257792|NCT01313637|50572757|FG002|Overall Study|Lack of Efficacy|37|||
25257793|NCT01313637|50572758|FG003|Overall Study|Lack of Efficacy|24|||
25257794|NCT01313637|50572755|FG000|Overall Study|Protocol Violation|4|||
25257795|NCT01313637|50572756|FG001|Overall Study|Protocol Violation|3|||
25257796|NCT01313637|50572757|FG002|Overall Study|Protocol Violation|11|||
25257797|NCT01313637|50572758|FG003|Overall Study|Protocol Violation|5|||
25257798|NCT01313637|50572755|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
25257799|NCT01313637|50572756|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
25257800|NCT01313637|50572757|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
25257801|NCT01313637|50572758|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
25257802|NCT01313637|50572755|FG000|Overall Study|Lost to Follow-up|0|||
25257803|NCT01313637|50572756|FG001|Overall Study|Lost to Follow-up|2|||
25257804|NCT01313637|50572757|FG002|Overall Study|Lost to Follow-up|1|||
25257805|NCT01313637|50572758|FG003|Overall Study|Lost to Follow-up|3|||
25257806|NCT01313637|50572755|FG000|Overall Study|Withdrawal by Subject|11|||
25257807|NCT01313637|50572756|FG001|Overall Study|Withdrawal by Subject|13|||
25257808|NCT01313637|50572757|FG002|Overall Study|Withdrawal by Subject|18|||
25257809|NCT01313637|50572758|FG003|Overall Study|Withdrawal by Subject|15|||
25257810|NCT01320722|50572773|FG000|Overall Study|Did not Receive Intervention|3|||
25257811|NCT01320722|50572774|FG001|Overall Study|Did not Receive Intervention|2|||
25257812|NCT01320722|50572775|FG002|Overall Study|Did not Receive Intervention|1|||
25257813|NCT01320722|50572776|FG003|Overall Study|Did not Receive Intervention|1|||
25257814|NCT01320722|50572777|FG004|Overall Study|Did not Receive Intervention|2|||
25257815|NCT01320722|50572773|FG000|Overall Study|Lost to Follow-up|0|||
25257816|NCT01320722|50572774|FG001|Overall Study|Lost to Follow-up|1|||
25257817|NCT01320722|50572775|FG002|Overall Study|Lost to Follow-up|0|||
25257818|NCT01320722|50572776|FG003|Overall Study|Lost to Follow-up|1|||
25257819|NCT01320722|50572777|FG004|Overall Study|Lost to Follow-up|3|||
25257820|NCT01320722|50572773|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
25257821|NCT01320722|50572774|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
25257822|NCT01320722|50572775|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
25257823|NCT01320722|50572776|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
25257824|NCT01320722|50572777|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
25257825|NCT01320722|50572773|FG000|Overall Study|Participant Developed a Rash|0|||
25257826|NCT01320722|50572774|FG001|Overall Study|Participant Developed a Rash|0|||
25257827|NCT01320722|50572775|FG002|Overall Study|Participant Developed a Rash|2|||
25257828|NCT01320722|50572776|FG003|Overall Study|Participant Developed a Rash|1|||
25257829|NCT01320722|50572777|FG004|Overall Study|Participant Developed a Rash|1|||
25257830|NCT01320722|50572773|FG000|Overall Study|Non-compliant with Medication|0|||
25257831|NCT01320722|50572774|FG001|Overall Study|Non-compliant with Medication|0|||
25257832|NCT01320722|50572775|FG002|Overall Study|Non-compliant with Medication|1|||
25257833|NCT01320722|50572776|FG003|Overall Study|Non-compliant with Medication|0|||
25257834|NCT01320722|50572777|FG004|Overall Study|Non-compliant with Medication|0|||
25257835|NCT01320722|50572773|FG000|Overall Study|Adverse Event|0|||
25257836|NCT01320722|50572774|FG001|Overall Study|Adverse Event|0|||
25257837|NCT01320722|50572775|FG002|Overall Study|Adverse Event|3|||
25257838|NCT01320722|50572776|FG003|Overall Study|Adverse Event|6|||
25257839|NCT01320722|50572777|FG004|Overall Study|Adverse Event|0|||
25257840|NCT01320722|50572773|FG000|Overall Study|Not Compliant with Study Procedures|0|||
25257841|NCT01320722|50572774|FG001|Overall Study|Not Compliant with Study Procedures|0|||
25257842|NCT01320722|50572775|FG002|Overall Study|Not Compliant with Study Procedures|0|||
25257843|NCT01320722|50572776|FG003|Overall Study|Not Compliant with Study Procedures|4|||
25257844|NCT01320722|50572777|FG004|Overall Study|Not Compliant with Study Procedures|0|||
25257845|NCT01320722|50572773|FG000|Overall Study|Pregnancy|0|||
25257846|NCT01320722|50572774|FG001|Overall Study|Pregnancy|0|||
25257847|NCT01320722|50572775|FG002|Overall Study|Pregnancy|0|||
25257848|NCT01320722|50572776|FG003|Overall Study|Pregnancy|1|||
25257849|NCT01320722|50572777|FG004|Overall Study|Pregnancy|0|||
25257850|NCT01320722|50572773|FG000|Overall Study|Started an Exclusionary Medication|0|||
25257851|NCT01320722|50572774|FG001|Overall Study|Started an Exclusionary Medication|0|||
25257852|NCT01320722|50572775|FG002|Overall Study|Started an Exclusionary Medication|0|||
25257853|NCT01320722|50572776|FG003|Overall Study|Started an Exclusionary Medication|0|||
25257854|NCT01320722|50572777|FG004|Overall Study|Started an Exclusionary Medication|1|||
25257855|NCT01320722|50572773|FG000|Overall Study|Withdrew due to Health Condition|0|||
25257856|NCT01320722|50572774|FG001|Overall Study|Withdrew due to Health Condition|0|||
25257857|NCT01320722|50572775|FG002|Overall Study|Withdrew due to Health Condition|0|||
25257858|NCT01320722|50572776|FG003|Overall Study|Withdrew due to Health Condition|0|||
25257859|NCT01320722|50572777|FG004|Overall Study|Withdrew due to Health Condition|1|||
25257860|NCT01313559|50572794|FG000|Overall Study|Withdrawal by Subject|1|||
25257861|NCT01313559|50572795|FG001|Overall Study|Withdrawal by Subject|2|||
25257862|NCT01313559|50572794|FG000|Overall Study|Disease progression|1|||
25257863|NCT01313559|50572795|FG001|Overall Study|Disease progression|0|||
25257864|NCT01313559|50572794|FG000|Overall Study|Rising PSA|2|||
25257865|NCT01313559|50572795|FG001|Overall Study|Rising PSA|0|||
25257866|NCT01312779|50572801|FG000|Overall Study|Withdrawal by Subject|2|||
25257867|NCT01312779|50572801|FG000|Overall Study|Death|3|||
25257868|NCT01312779|50572801|FG000|Overall Study|Not Implanted with Device|27|||
25257869|NCT01312467|50572814|FG000|Overall Study|Adverse Event|4|||
25257870|NCT01312467|50572814|FG000|Overall Study|Lost to Follow-up|1|||
25257871|NCT01312467|50572814|FG000|Overall Study|Withdrawal by Subject|2|||
25257872|NCT01312467|50572814|FG000|Overall Study|Deported to country of origin|1|||
25257873|NCT01312467|50572814|FG000|Overall Study|Another medical condition|1|||
25257874|NCT01312467|50572814|FG000|Overall Study|Ineligible|4|||
25257875|NCT01310127|50572821|FG000|Overall Study|Protocol Violation|1|||
25257876|NCT01310127|50572822|FG001|Overall Study|Protocol Violation|1|||
25257877|NCT01310127|50572821|FG000|Overall Study|advanced psc cataract outlier|1|||
25257878|NCT01310127|50572822|FG001|Overall Study|advanced psc cataract outlier|0|||
25257879|NCT01309893|50572828|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
25257880|NCT01309893|50572829|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
25257881|NCT01309893|50572828|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
25257882|NCT01309893|50572829|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
25257883|NCT01318902|50572839|FG000|Overall Study|Symptomatic Deterioration|0|||
25257884|NCT01318902|50572840|FG001|Overall Study|Symptomatic Deterioration|1|||
25257885|NCT01318902|50572841|FG002|Overall Study|Symptomatic Deterioration|1|||
25257886|NCT01318902|50572842|FG003|Overall Study|Symptomatic Deterioration|2|||
25257887|NCT01318902|50572839|FG000|Overall Study|Withdrawal by Patient|0|||
25257888|NCT01318902|50572840|FG001|Overall Study|Withdrawal by Patient|1|||
25257889|NCT01318902|50572841|FG002|Overall Study|Withdrawal by Patient|0|||
25257890|NCT01318902|50572842|FG003|Overall Study|Withdrawal by Patient|3|||
25257891|NCT01318902|50572839|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
25257892|NCT01318902|50572840|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
25257893|NCT01318902|50572841|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
25257894|NCT01318902|50572842|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
25257895|NCT01318902|50572839|FG000|Overall Study|Adverse Event|0|||
25257896|NCT01318902|50572840|FG001|Overall Study|Adverse Event|1|||
25257897|NCT01318902|50572841|FG002|Overall Study|Adverse Event|0|||
25257898|NCT01318902|50572842|FG003|Overall Study|Adverse Event|0|||
25257899|NCT01318902|50572839|FG000|Overall Study|Terminated by Sponsor|0|||
25257900|NCT01318902|50572840|FG001|Overall Study|Terminated by Sponsor|0|||
25257901|NCT01318902|50572841|FG002|Overall Study|Terminated by Sponsor|1|||
25257902|NCT01318902|50572842|FG003|Overall Study|Terminated by Sponsor|0|||
25257903|NCT01313858|50572857|FG000|Overall Study|Premature Treatment Termination|251|||
25257904|NCT01313858|50572858|FG001|Overall Study|Premature Treatment Termination|219|||
25257905|NCT01313858|50572859|FG002|Overall Study|Premature Treatment Termination|191|||
25257906|NCT01313858|50572857|FG000|Overall Study|Lost to Follow-up|35|||
25257907|NCT01313858|50572858|FG001|Overall Study|Lost to Follow-up|51|||
25257908|NCT01313858|50572859|FG002|Overall Study|Lost to Follow-up|47|||
25257909|NCT01090765|50572871|FG000|Overall Study|Patient withdrew consent|0|||
25257910|NCT01090765|50572872|FG001|Overall Study|Patient withdrew consent|0|||
25257911|NCT01090765|50572873|FG002|Overall Study|Patient withdrew consent|0|||
25257912|NCT01090765|50572874|FG003|Overall Study|Patient withdrew consent|0|||
25257913|NCT01090765|50572875|FG004|Overall Study|Patient withdrew consent|1|||
25257914|NCT01090765|50572876|FG005|Overall Study|Patient withdrew consent|1|||
25257915|NCT01090765|50572871|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
25257916|NCT01090765|50572872|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
25257917|NCT01090765|50572873|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
25257918|NCT01090765|50572874|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
25257919|NCT01090765|50572875|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
25257920|NCT01090765|50572876|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
25257921|NCT01090765|50572871|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
25257922|NCT01090765|50572872|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
25257923|NCT01090765|50572873|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
25257924|NCT01090765|50572874|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
25257925|NCT01090765|50572875|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
25257926|NCT01090765|50572876|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
25257927|NCT01313780|50572893|FG000|Overall Study|Lack of Efficacy|4|||
25257928|NCT01313780|50572894|FG001|Overall Study|Lack of Efficacy|2|||
25257929|NCT01313780|50572893|FG000|Overall Study|Adverse Event|6|||
25257930|NCT01313780|50572894|FG001|Overall Study|Adverse Event|11|||
25257931|NCT01313780|50572893|FG000|Overall Study|Withdrawal by Subject|2|||
25257932|NCT01313780|50572894|FG001|Overall Study|Withdrawal by Subject|8|||
25257933|NCT01313780|50572893|FG000|Overall Study|Protocol Violation|10|||
25257934|NCT01313780|50572894|FG001|Overall Study|Protocol Violation|4|||
25257935|NCT01313780|50572893|FG000|Overall Study|missing data|3|||
25257936|NCT01313780|50572894|FG001|Overall Study|missing data|3|||
25257937|NCT01090453|50572902|FG000|Overall Study|Withdrawal by Subject|1|||
25257938|NCT01090453|50572903|FG001|Overall Study|Withdrawal by Subject|2|||
25257939|NCT01090453|50572902|FG000|Overall Study|Lost to Follow-up|7|||
25257940|NCT01090453|50572903|FG001|Overall Study|Lost to Follow-up|7|||
25257941|NCT01090453|50572902|FG000|Overall Study|Non serious AEs|1|||
25257942|NCT01090453|50572903|FG001|Overall Study|Non serious AEs|0|||
25257943|NCT01090453|50572902|FG000|Overall Study|Protocol Violation|2|||
25257944|NCT01090453|50572903|FG001|Overall Study|Protocol Violation|0|||
25257945|NCT01090453|50572902|FG000|Overall Study|Other|2|||
25257946|NCT01090453|50572903|FG001|Overall Study|Other|4|||
25257947|NCT01090453|50572902|FG000|Overall Study|Eligibility Criteria|0|||
25257948|NCT01090453|50572903|FG001|Overall Study|Eligibility Criteria|1|||
25257949|NCT01171612|50572909|FG000|Overall Study|Lost to Follow-up|51|||
25257950|NCT01171534|50572918|FG000|Overall Study|Lost to Follow-up|0|||
25257951|NCT01171534|50572919|FG001|Overall Study|Lost to Follow-up|2|||
25257952|NCT01171534|50572918|FG000|Overall Study|screen failure|0|||
25257953|NCT01171534|50572919|FG001|Overall Study|screen failure|1|||
25257954|NCT01170598|50572925|FG000|Overall Study|Withdrawal by Subject|1|||
25257955|NCT01170598|50572925|FG000|Overall Study|Death|3|||
25257956|NCT01170598|50572925|FG000|Overall Study|Lost to Follow-up|1|||
25257957|NCT01170598|50572925|FG000|Overall Study|Refused|1|||
25257958|NCT01170364|50572931|FG000|Overall Study|Protocol Violation|4|||
25257959|NCT01170364|50572932|FG001|Overall Study|Protocol Violation|1|||
25257960|NCT01076179|50572938|FG000|Overall Study|Withdrawal by Subject|1|||
25257961|NCT01170208|50572946|FG000|Overall Study|Withdrawal by Subject|5|||
25257962|NCT01170208|50572947|FG001|Overall Study|Withdrawal by Subject|0|||
25257963|NCT01170208|50572948|FG002|Overall Study|Withdrawal by Subject|1|||
25257964|NCT01170208|50572946|FG000|Overall Study|Protocol Violation|1|||
25257965|NCT01170208|50572947|FG001|Overall Study|Protocol Violation|0|||
25257966|NCT01170208|50572948|FG002|Overall Study|Protocol Violation|1|||
25257967|NCT01313624|50572961|FG000|Double-Blind Phase|Adverse Event|27|||
25257968|NCT01313624|50572962|FG001|Double-Blind Phase|Adverse Event|4|||
25257969|NCT01313624|50572961|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
25257970|NCT01313624|50572962|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
25257971|NCT01313624|50572961|FG000|Double-Blind Phase|Lost to Follow-up|0|||
25257972|NCT01313624|50572962|FG001|Double-Blind Phase|Lost to Follow-up|2|||
25257973|NCT01313624|50572961|FG000|Double-Blind Phase|Physician Decision|1|||
25257974|NCT01313624|50572962|FG001|Double-Blind Phase|Physician Decision|0|||
25257975|NCT01313624|50572961|FG000|Double-Blind Phase|Lack of Efficacy|1|||
25257976|NCT01313624|50572962|FG001|Double-Blind Phase|Lack of Efficacy|0|||
25257977|NCT01313624|50572961|FG000|Open-Label Phase|Adverse Event|1|||
25257978|NCT01313624|50572962|FG001|Open-Label Phase|Adverse Event|10|||
25257979|NCT01313624|50572961|FG000|Open-Label Phase|Withdrawal by Subject|2|||
25257980|NCT01313624|50572962|FG001|Open-Label Phase|Withdrawal by Subject|2|||
25257981|NCT01313624|50572961|FG000|Open-Label Phase|Lost to Follow-up|1|||
25257982|NCT01313624|50572962|FG001|Open-Label Phase|Lost to Follow-up|1|||
25257983|NCT01169350|50572970|FG000|Overall Study|Physician Decision|3|||
25257984|NCT01169350|50572970|FG000|Overall Study|Lost to Follow-up|2|||
25257985|NCT01169038|50572974|FG000|Overall Study|Death|1|||
25257986|NCT01169038|50572974|FG000|Overall Study|Adverse Event|5|||
25257987|NCT01169038|50572974|FG000|Overall Study|Required antibiotic administration|1|||
25257988|NCT01167634|50572982|FG000|Overall Study|Lost to Follow-up|1|||
25257989|NCT01167634|50572983|FG001|Overall Study|Lost to Follow-up|3|||
25257990|NCT01167634|50572984|FG002|Overall Study|Lost to Follow-up|3|||
25257991|NCT01167634|50572985|FG003|Overall Study|Lost to Follow-up|4|||
25257992|NCT01167634|50572982|FG000|Overall Study|Withdrawal by Subject|1|||
25257993|NCT01167634|50572983|FG001|Overall Study|Withdrawal by Subject|1|||
25257994|NCT01167634|50572984|FG002|Overall Study|Withdrawal by Subject|0|||
25257995|NCT01167634|50572985|FG003|Overall Study|Withdrawal by Subject|0|||
25257996|NCT01166386|50572997|FG000|Overall Study|Withdrawal by Subject|3|||
25257997|NCT01166386|50572998|FG001|Overall Study|Withdrawal by Subject|5|||
25257998|NCT01114828|50573006|FG000|Overall Study|Adverse Event|1|||
25257999|NCT01114828|50573007|FG001|Overall Study|Adverse Event|1|||
25258000|NCT01114828|50573006|FG000|Overall Study|Lack of Efficacy|0|||
25258001|NCT01114828|50573007|FG001|Overall Study|Lack of Efficacy|2|||
25258002|NCT01114828|50573006|FG000|Overall Study|Protocol Violation|2|||
25258003|NCT01114828|50573007|FG001|Overall Study|Protocol Violation|0|||
25258004|NCT01114828|50573006|FG000|Overall Study|Withdrawal by Subject|0|||
25258005|NCT01114828|50573007|FG001|Overall Study|Withdrawal by Subject|1|||
25258006|NCT01313312|50573013|FG000|Overall Study|Adverse Event|5|||
25258007|NCT01313312|50573013|FG000|Overall Study|Withdrawal by Subject|18|||
25258008|NCT01313312|50573013|FG000|Overall Study|Lack of Efficacy|3|||
25258009|NCT01313312|50573013|FG000|Overall Study|Investigator Decision|1|||
25258010|NCT01313312|50573013|FG000|Overall Study|Observational Phase|1|||
25258011|NCT01313312|50573013|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
25258012|NCT01313312|50573013|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
25258013|NCT01114672|50573019|FG000|Overall Study|Death|0|||
25258014|NCT01114672|50573020|FG001|Overall Study|Death|1|||
25258015|NCT01114672|50573019|FG000|Overall Study|Withdrawal by Subject|2|||
25258016|NCT01114672|50573020|FG001|Overall Study|Withdrawal by Subject|1|||
25258017|NCT01114672|50573019|FG000|Overall Study|Lost to Follow-up|1|||
25258018|NCT01114672|50573020|FG001|Overall Study|Lost to Follow-up|0|||
25258019|NCT01114672|50573019|FG000|Overall Study|transplanted|1|||
25258020|NCT01114672|50573020|FG001|Overall Study|transplanted|0|||
25258021|NCT01114516|50573028|FG000|Overall Study|Lost to Follow-up|2|||
24993592|NCT03806127|50084075|FG000|Overall Study|Withdrawal by Subject|4|||
25258022|NCT01114516|50573029|FG001|Overall Study|Lost to Follow-up|1|||
25258023|NCT01114438|50573035|FG000|Overall Study|Adverse Event|10|||
25258024|NCT01114438|50573035|FG000|Overall Study|concomitant medication|1|||
24993593|NCT03806127|50084076|FG001|Overall Study|Withdrawal by Subject|5|||
25258025|NCT01114438|50573035|FG000|Overall Study|Physician Decision|1|||
25258026|NCT01114438|50573035|FG000|Overall Study|Withdrawal by Subject|2|||
25258027|NCT01313078|50573044|FG000|Overall Study|Death|1|||
25258028|NCT01313078|50573044|FG000|Overall Study|Discontinued study drug|1|||
25258029|NCT01313078|50573044|FG000|Overall Study|Withdrawal by Subject|1|||
25258030|NCT01114360|50573048|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
25258031|NCT01114360|50573049|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
25258032|NCT01310036|50573069|FG000|Overall Study|Administrative/other|10|||
25258033|NCT01310036|50573069|FG000|Overall Study|Withdrew Consent|11|||
25258034|NCT01310036|50573069|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
25258035|NCT01310036|50573069|FG000|Overall Study|Progression of Disease|164|||
25258036|NCT01310036|50573069|FG000|Overall Study|Death|1|||
25258037|NCT01310036|50573069|FG000|Overall Study|Adverse event or intercurrent illness|12|||
25258038|NCT01309100|50573073|FG000|Overall Study|Protocol Violation|1|||
25258039|NCT01309100|50573073|FG000|Overall Study|Positive Slit lamp finding|1|||
25258040|NCT01308788|50573082|FG000|2-year Treatment|medication change by treating physician|4|||
25258041|NCT01308788|50573083|FG001|2-year Treatment|medication change by treating physician|11|||
25258042|NCT01075321|50573089|FG000|Overall Study|Withdrawal by Subject|0|||
25258043|NCT01075321|50573090|FG001|Overall Study|Withdrawal by Subject|0|||
25258044|NCT01075321|50573091|FG002|Overall Study|Withdrawal by Subject|1|||
25258045|NCT01075321|50573092|FG003|Overall Study|Withdrawal by Subject|1|||
25258046|NCT01075321|50573089|FG000|Overall Study|Protocol Violation|0|||
25258047|NCT01075321|50573090|FG001|Overall Study|Protocol Violation|0|||
25258048|NCT01075321|50573091|FG002|Overall Study|Protocol Violation|1|||
25258049|NCT01075321|50573092|FG003|Overall Study|Protocol Violation|0|||
25258050|NCT01075321|50573089|FG000|Overall Study|Treatment Incomplete due to progression|1|||
25258051|NCT01075321|50573090|FG001|Overall Study|Treatment Incomplete due to progression|0|||
25258052|NCT01075321|50573091|FG002|Overall Study|Treatment Incomplete due to progression|0|||
25258053|NCT01075321|50573092|FG003|Overall Study|Treatment Incomplete due to progression|0|||
25258054|NCT01075321|50573089|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
25258055|NCT01075321|50573090|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
25258056|NCT01075321|50573091|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
25258057|NCT01075321|50573092|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
25258058|NCT01114204|50573106|FG000|Overall Study|Adverse Event|3|||
25258059|NCT01114204|50573107|FG001|Overall Study|Adverse Event|2|||
25258060|NCT01114204|50573106|FG000|Overall Study|Lost to Follow-up|1|||
25258061|NCT01114204|50573107|FG001|Overall Study|Lost to Follow-up|0|||
25258062|NCT01114204|50573106|FG000|Overall Study|Withdrawal by Subject|10|||
25258063|NCT01114204|50573107|FG001|Overall Study|Withdrawal by Subject|6|||
25258064|NCT01114204|50573106|FG000|Overall Study|Death|1|||
25258065|NCT01114204|50573107|FG001|Overall Study|Death|0|||
25258066|NCT01114204|50573106|FG000|Overall Study|Other-Personal reasons|2|||
25258067|NCT01114204|50573107|FG001|Overall Study|Other-Personal reasons|0|||
25258068|NCT01114204|50573106|FG000|Overall Study|Other-Medical monitor request|1|||
25258069|NCT01114204|50573107|FG001|Overall Study|Other-Medical monitor request|0|||
25258070|NCT01114204|50573106|FG000|Overall Study|Other-Participant request|2|||
25258071|NCT01114204|50573107|FG001|Overall Study|Other-Participant request|0|||
25258072|NCT01114204|50573106|FG000|Overall Study|Other-Protocol Violation|1|||
25258073|NCT01114204|50573107|FG001|Overall Study|Other-Protocol Violation|0|||
25258074|NCT01075243|50573116|FG000|Overall Study|Lost to Follow-up|5|||
25258075|NCT01075243|50573117|FG001|Overall Study|Lost to Follow-up|2|||
25258076|NCT01075243|50573118|FG002|Overall Study|Lost to Follow-up|0|||
25258077|NCT01075243|50573116|FG000|Overall Study|Withdrawal by Subject|1|||
25258078|NCT01075243|50573117|FG001|Overall Study|Withdrawal by Subject|1|||
25258079|NCT01075243|50573118|FG002|Overall Study|Withdrawal by Subject|0|||
25258080|NCT01308476|50573130|FG000|Overall Study|Lost to Follow-up|2|||
25258081|NCT01308476|50573131|FG001|Overall Study|Lost to Follow-up|2|||
25258082|NCT01308476|50573130|FG000|Overall Study|Other|1|||
25258083|NCT01308476|50573131|FG001|Overall Study|Other|0|||
25258084|NCT01078441|50573137|FG000|Overall Study|Withdrawal by Subject|1|||
25258085|NCT01308008|50573143|FG000|4 Weeks|Illness, disinterest, time|9|||
25258086|NCT01308008|50573144|FG001|4 Weeks|Illness, disinterest, time|2|||
25258087|NCT01113892|50573152|FG000|Overall Study|Lost to Follow-up|2|||
25258088|NCT01113892|50573153|FG001|Overall Study|Lost to Follow-up|2|||
25258089|NCT01113892|50573152|FG000|Overall Study|Withdrawal by Subject|1|||
25258090|NCT01113892|50573153|FG001|Overall Study|Withdrawal by Subject|1|||
25258091|NCT01113892|50573152|FG000|Overall Study|Death|2|||
25258092|NCT01113892|50573153|FG001|Overall Study|Death|4|||
25258093|NCT01113892|50573152|FG000|Overall Study|Graft no longer evaluable|9|||
25258094|NCT01113892|50573153|FG001|Overall Study|Graft no longer evaluable|9|||
25258095|NCT01090063|50573159|FG000|Screen|Screen Failed|4|||
25258096|NCT01090063|50573159|FG000|Treatment|Withdrawal by Subject|4|||
25258097|NCT01113580|50573175|FG000|Overall Study|Protocol Violation|1|||
25258098|NCT01113580|50573176|FG001|Overall Study|Protocol Violation|0|||
25258099|NCT01306214|50573185|FG000|Overall Study|Death|0|||
25258100|NCT01306214|50573186|FG001|Overall Study|Death|0|||
25258101|NCT01306214|50573187|FG002|Overall Study|Death|1|||
25258102|NCT01306214|50573185|FG000|Overall Study|Lost to Follow-up|3|||
25258103|NCT01306214|50573186|FG001|Overall Study|Lost to Follow-up|5|||
25258104|NCT01306214|50573187|FG002|Overall Study|Lost to Follow-up|4|||
25258105|NCT01306214|50573185|FG000|Overall Study|Withdrawal by Subject|24|||
25258106|NCT01306214|50573186|FG001|Overall Study|Withdrawal by Subject|22|||
25258107|NCT01306214|50573187|FG002|Overall Study|Withdrawal by Subject|16|||
25258108|NCT01306214|50573185|FG000|Overall Study|Not treated|1|||
25258109|NCT01306214|50573186|FG001|Overall Study|Not treated|1|||
25258110|NCT01306214|50573187|FG002|Overall Study|Not treated|1|||
25258111|NCT01077739|50573197|FG000|Overall Study|Premature withdrawal|1|||
25258112|NCT01077739|50573198|FG001|Overall Study|Premature withdrawal|3|||
25258113|NCT01077739|50573197|FG000|Overall Study|Withdrawal by Subject|1|||
25258114|NCT01077739|50573198|FG001|Overall Study|Withdrawal by Subject|0|||
25258115|NCT01077739|50573197|FG000|Overall Study|Death|0|||
25258116|NCT01077739|50573198|FG001|Overall Study|Death|3|||
25258117|NCT01077739|50573197|FG000|Overall Study|Unacceptable toxicity|1|||
25258118|NCT01077739|50573198|FG001|Overall Study|Unacceptable toxicity|2|||
25258119|NCT01077739|50573197|FG000|Overall Study|Other|2|||
25258120|NCT01077739|50573198|FG001|Overall Study|Other|2|||
25258121|NCT01306058|50573204|FG000|Overall Study|Death|1|||
25258122|NCT01306058|50573204|FG000|Overall Study|Enrolled but did not get treatment|1|||
25258123|NCT01305200|50573211|FG000|Overall Study|Physician Decision|4|||
25258124|NCT01305200|50573212|FG001|Overall Study|Physician Decision|6|||
25258125|NCT01305200|50573213|FG002|Overall Study|Physician Decision|1|||
25258126|NCT01305200|50573211|FG000|Overall Study|Withdrawal by Subject|24|||
25258127|NCT01305200|50573212|FG001|Overall Study|Withdrawal by Subject|21|||
25258128|NCT01305200|50573213|FG002|Overall Study|Withdrawal by Subject|1|||
25258129|NCT01305200|50573211|FG000|Overall Study|Ineligible|1|||
25258130|NCT01305200|50573212|FG001|Overall Study|Ineligible|2|||
25258131|NCT01305200|50573213|FG002|Overall Study|Ineligible|1|||
25258132|NCT01305200|50573211|FG000|Overall Study|Death|0|||
25258133|NCT01305200|50573212|FG001|Overall Study|Death|2|||
25258134|NCT01305200|50573213|FG002|Overall Study|Death|0|||
25258135|NCT01077271|50573223|FG000|Overall Study|Parental desire|8|||
25258136|NCT01077271|50573223|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
25258137|NCT01077271|50573223|FG000|Overall Study|Noncompliance|2|||
25258138|NCT01077271|50573223|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
25258139|NCT01077271|50573223|FG000|Overall Study|Changed doctors|2|||
25258140|NCT01077271|50573223|FG000|Overall Study|Parents thought too many injections|2|||
25258141|NCT01077271|50573223|FG000|Overall Study|End of RSV season nearly reached|1|||
25258142|NCT01077271|50573223|FG000|Overall Study|Mother unconvinced of the necessity|1|||
25258143|NCT01305044|50573237|FG000|Overall Study|Withdrawal by Subject|3|||
25258144|NCT01305044|50573238|FG001|Overall Study|Withdrawal by Subject|6|||
25258145|NCT01304498|50573246|FG000|Overall Study|Adverse Event|1|||
25258146|NCT01304498|50573247|FG001|Overall Study|Adverse Event|1|||
25258147|NCT01304498|50573246|FG000|Overall Study|Withdrawal by Subject|2|||
25258148|NCT01304498|50573247|FG001|Overall Study|Withdrawal by Subject|3|||
25258149|NCT01304498|50573246|FG000|Overall Study|Protocol Violation|1|||
25258150|NCT01304498|50573247|FG001|Overall Study|Protocol Violation|0|||
25258151|NCT01304498|50573246|FG000|Overall Study|Lost to Follow-up|2|||
25258152|NCT01304498|50573247|FG001|Overall Study|Lost to Follow-up|1|||
25258153|NCT01077193|50573253|FG000|Overall Study|Lost to Follow-up|1|||
25258154|NCT01077193|50573253|FG000|Overall Study|Withdrawal by Subject|2|||
25258155|NCT01077193|50573253|FG000|Overall Study|Lack of Efficacy|1|||
25258156|NCT01077193|50573253|FG000|Overall Study|Study Terminated by Sponsor|40|||
25258157|NCT01074931|50573257|FG000|Overall Study|Economic reasons|1|||
25258158|NCT01074931|50573257|FG000|Overall Study|Death|5|||
25258159|NCT01303172|50573267|FG000|Overall Study|Physician Decision|9|||
25258160|NCT01303172|50573268|FG001|Overall Study|Physician Decision|6|||
25258161|NCT01303172|50573267|FG000|Overall Study|Adverse Event|5|||
25258162|NCT01303172|50573268|FG001|Overall Study|Adverse Event|2|||
25258163|NCT01303172|50573267|FG000|Overall Study|Withdrawal by Subject|4|||
25258164|NCT01303172|50573268|FG001|Overall Study|Withdrawal by Subject|2|||
25258165|NCT01303172|50573267|FG000|Overall Study|Death|20|||
25258166|NCT01303172|50573268|FG001|Overall Study|Death|7|||
25258167|NCT01303172|50573267|FG000|Overall Study|Lack of Efficacy|25|||
25258168|NCT01303172|50573268|FG001|Overall Study|Lack of Efficacy|17|||
25258169|NCT01302938|50573277|FG000|Overall Study|Withdrawal by Subject|1|||
25258170|NCT01302938|50573278|FG001|Overall Study|Withdrawal by Subject|0|||
25258171|NCT01302938|50573277|FG000|Overall Study|Adverse Event|1|||
25258172|NCT01302938|50573278|FG001|Overall Study|Adverse Event|0|||
25258173|NCT01302548|50573287|FG000|Overall Study|Lost to Follow-up|2|||
25258174|NCT01302548|50573288|FG001|Overall Study|Lost to Follow-up|1|||
25258175|NCT01076959|50573294|FG000|Overall Study|Adverse Event|767|||
25258176|NCT01076959|50573294|FG000|Overall Study|Lack of Efficacy|849|||
25258177|NCT01076959|50573294|FG000|Overall Study|Non-compliance|274|||
25258178|NCT01076959|50573294|FG000|Overall Study|Lost to Follow-up|241|||
25258179|NCT01076959|50573294|FG000|Overall Study|Other|119|||
25258180|NCT01302392|50573313|FG000|Overall Study|Lost to Follow-up|1|||
25258181|NCT01302392|50573314|FG001|Overall Study|Lost to Follow-up|0|||
25258182|NCT01302392|50573313|FG000|Overall Study|Withdrawal by Subject|6|||
25258183|NCT01302392|50573314|FG001|Overall Study|Withdrawal by Subject|1|||
25258184|NCT01076647|50573322|FG000|Overall Study|Adverse Event|4|||
25258185|NCT01076647|50573323|FG001|Overall Study|Adverse Event|1|||
25258186|NCT01076647|50573322|FG000|Overall Study|Lack of Efficacy|0|||
25258187|NCT01076647|50573323|FG001|Overall Study|Lack of Efficacy|1|||
25258188|NCT01076647|50573322|FG000|Overall Study|Protocol Violation|7|||
25258189|NCT01076647|50573323|FG001|Overall Study|Protocol Violation|9|||
25258190|NCT01076647|50573322|FG000|Overall Study|Withdrawal criteria|2|||
25258191|NCT01076647|50573323|FG001|Overall Study|Withdrawal criteria|2|||
25258192|NCT01076647|50573322|FG000|Overall Study|Unclassified|12|||
25258193|NCT01076647|50573323|FG001|Overall Study|Unclassified|12|||
25258194|NCT01074307|50573331|FG000|Overall Study|No primary endpoint evaluation|14|||
25258195|NCT01074307|50573332|FG001|Overall Study|No primary endpoint evaluation|6|||
25258196|NCT01074307|50573331|FG000|Overall Study|Exclusion criterion|0|||
25258197|NCT01074307|50573332|FG001|Overall Study|Exclusion criterion|1|||
25258198|NCT01074307|50573331|FG000|Overall Study|Protocol Violation|8|||
25258199|NCT01074307|50573332|FG001|Overall Study|Protocol Violation|5|||
25258200|NCT01076335|50573338|FG000|Overall Study|Withdrawal by Subject|3|||
25258201|NCT01076335|50573338|FG000|Overall Study|Withdrawal without treatment|1|||
25258202|NCT01309737|50573345|FG000|Week 0 to 16|Death|1|||
25258203|NCT01309737|50573346|FG001|Week 0 to 16|Death|0|||
25258204|NCT01309737|50573347|FG002|Week 0 to 16|Death|1|||
25258205|NCT01309737|50573348|FG003|Week 0 to 16|Death|0|||
25258206|NCT01309737|50573349|FG004|Week 0 to 16|Death|0|||
25258207|NCT01309737|50573345|FG000|Week 0 to 16|Adverse Event|11|||
25258208|NCT01309737|50573346|FG001|Week 0 to 16|Adverse Event|10|||
25258209|NCT01309737|50573347|FG002|Week 0 to 16|Adverse Event|5|||
25258210|NCT01309737|50573348|FG003|Week 0 to 16|Adverse Event|0|||
25258211|NCT01309737|50573349|FG004|Week 0 to 16|Adverse Event|0|||
25258212|NCT01309737|50573345|FG000|Week 0 to 16|Lack of Efficacy|15|||
25258213|NCT01309737|50573346|FG001|Week 0 to 16|Lack of Efficacy|2|||
25258214|NCT01309737|50573347|FG002|Week 0 to 16|Lack of Efficacy|24|||
25258215|NCT01309737|50573348|FG003|Week 0 to 16|Lack of Efficacy|0|||
25258216|NCT01309737|50573349|FG004|Week 0 to 16|Lack of Efficacy|0|||
25258217|NCT01309737|50573345|FG000|Week 0 to 16|Lost to Follow-up|7|||
25258218|NCT01309737|50573346|FG001|Week 0 to 16|Lost to Follow-up|8|||
25258219|NCT01309737|50573347|FG002|Week 0 to 16|Lost to Follow-up|3|||
25258220|NCT01309737|50573348|FG003|Week 0 to 16|Lost to Follow-up|0|||
25258221|NCT01309737|50573349|FG004|Week 0 to 16|Lost to Follow-up|0|||
25258222|NCT01309737|50573345|FG000|Week 0 to 16|Withdrawal by Subject|7|||
25258223|NCT01309737|50573346|FG001|Week 0 to 16|Withdrawal by Subject|6|||
25258224|NCT01309737|50573347|FG002|Week 0 to 16|Withdrawal by Subject|7|||
25258225|NCT01309737|50573348|FG003|Week 0 to 16|Withdrawal by Subject|0|||
25258226|NCT01309737|50573349|FG004|Week 0 to 16|Withdrawal by Subject|0|||
25258227|NCT01309737|50573345|FG000|Week 0 to 16|Other|10|||
25258228|NCT01309737|50573346|FG001|Week 0 to 16|Other|14|||
25258229|NCT01309737|50573347|FG002|Week 0 to 16|Other|4|||
25258230|NCT01309737|50573348|FG003|Week 0 to 16|Other|0|||
25258231|NCT01309737|50573349|FG004|Week 0 to 16|Other|0|||
25258232|NCT01309737|50573345|FG000|Week 0 to 16|Randomized, but not treated|1|||
25258233|NCT01309737|50573346|FG001|Week 0 to 16|Randomized, but not treated|0|||
25258234|NCT01309737|50573347|FG002|Week 0 to 16|Randomized, but not treated|0|||
25258235|NCT01309737|50573348|FG003|Week 0 to 16|Randomized, but not treated|0|||
25258236|NCT01309737|50573349|FG004|Week 0 to 16|Randomized, but not treated|0|||
25258237|NCT01309737|50573345|FG000|Week 16 to 52|Death|0|||
25258238|NCT01309737|50573346|FG001|Week 16 to 52|Death|0|||
25258239|NCT01309737|50573347|FG002|Week 16 to 52|Death|0|||
25258240|NCT01309737|50573348|FG003|Week 16 to 52|Death|0|||
25258241|NCT01309737|50573349|FG004|Week 16 to 52|Death|1|||
25258242|NCT01309737|50573345|FG000|Week 16 to 52|Adverse Event|7|||
25258243|NCT01309737|50573346|FG001|Week 16 to 52|Adverse Event|7|||
25258244|NCT01309737|50573347|FG002|Week 16 to 52|Adverse Event|0|||
25258245|NCT01309737|50573348|FG003|Week 16 to 52|Adverse Event|6|||
25258246|NCT01309737|50573349|FG004|Week 16 to 52|Adverse Event|5|||
25258247|NCT01309737|50573345|FG000|Week 16 to 52|Lack of Efficacy|107|||
25258248|NCT01309737|50573346|FG001|Week 16 to 52|Lack of Efficacy|76|||
25258249|NCT01309737|50573347|FG002|Week 16 to 52|Lack of Efficacy|0|||
25258250|NCT01309737|50573348|FG003|Week 16 to 52|Lack of Efficacy|25|||
25258251|NCT01309737|50573349|FG004|Week 16 to 52|Lack of Efficacy|21|||
25258252|NCT01309737|50573345|FG000|Week 16 to 52|Lost to Follow-up|4|||
25258253|NCT01309737|50573346|FG001|Week 16 to 52|Lost to Follow-up|2|||
25258254|NCT01309737|50573347|FG002|Week 16 to 52|Lost to Follow-up|0|||
25258255|NCT01309737|50573348|FG003|Week 16 to 52|Lost to Follow-up|1|||
25258256|NCT01309737|50573349|FG004|Week 16 to 52|Lost to Follow-up|4|||
25258257|NCT01309737|50573345|FG000|Week 16 to 52|Withdrawal by Subject|5|||
25258258|NCT01309737|50573346|FG001|Week 16 to 52|Withdrawal by Subject|6|||
25258259|NCT01309737|50573347|FG002|Week 16 to 52|Withdrawal by Subject|0|||
25258260|NCT01309737|50573348|FG003|Week 16 to 52|Withdrawal by Subject|0|||
25258261|NCT01309737|50573349|FG004|Week 16 to 52|Withdrawal by Subject|2|||
25258262|NCT01309737|50573345|FG000|Week 16 to 52|Other|10|||
25258263|NCT01309737|50573346|FG001|Week 16 to 52|Other|12|||
25258264|NCT01309737|50573347|FG002|Week 16 to 52|Other|0|||
25258265|NCT01309737|50573348|FG003|Week 16 to 52|Other|2|||
25258266|NCT01309737|50573349|FG004|Week 16 to 52|Other|0|||
25258267|NCT01074229|50573375|FG000|Overall Study|Lost to Follow-up|1|||
25258268|NCT01074229|50573376|FG001|Overall Study|Lost to Follow-up|0|||
25258269|NCT01074229|50573377|FG002|Overall Study|Lost to Follow-up|0|||
25258270|NCT01074229|50573375|FG000|Overall Study|Change to open surgical procedure|1|||
25258271|NCT01074229|50573376|FG001|Overall Study|Change to open surgical procedure|3|||
25258272|NCT01074229|50573377|FG002|Overall Study|Change to open surgical procedure|4|||
25258273|NCT01106014|50573389|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
25258274|NCT01106014|50573390|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
25258275|NCT01106014|50573389|FG000|Overall Study|Adverse Event|78|||
25258276|NCT01106014|50573390|FG001|Overall Study|Adverse Event|42|||
25258277|NCT01106014|50573389|FG000|Overall Study|Withdrawal by Subject|43|||
25258278|NCT01106014|50573390|FG001|Overall Study|Withdrawal by Subject|37|||
25258279|NCT01106014|50573389|FG000|Overall Study|Administrative reason|7|||
25258280|NCT01106014|50573390|FG001|Overall Study|Administrative reason|6|||
25258281|NCT01106014|50573389|FG000|Overall Study|Lost to Follow-up|2|||
25258282|NCT01106014|50573390|FG001|Overall Study|Lost to Follow-up|3|||
25258283|NCT01073605|50573399|FG000|Overall Study|Ongoing at Cutoff Date|1|||
25258284|NCT01073605|50573400|FG001|Overall Study|Ongoing at Cutoff Date|1|||
25258285|NCT01073605|50573401|FG002|Overall Study|Ongoing at Cutoff Date|0|||
25258286|NCT01073605|50573399|FG000|Overall Study|Adverse Event|2|||
25258287|NCT01073605|50573400|FG001|Overall Study|Adverse Event|1|||
25258288|NCT01073605|50573401|FG002|Overall Study|Adverse Event|0|||
25258289|NCT01073605|50573399|FG000|Overall Study|Lost to Follow-up|3|||
25258290|NCT01073605|50573400|FG001|Overall Study|Lost to Follow-up|4|||
25258291|NCT01073605|50573401|FG002|Overall Study|Lost to Follow-up|9|||
25258292|NCT01073605|50573399|FG000|Overall Study|Other|25|||
25258293|NCT01073605|50573400|FG001|Overall Study|Other|21|||
25258294|NCT01073605|50573401|FG002|Overall Study|Other|29|||
25258295|NCT01073605|50573399|FG000|Overall Study|Withdrawal by Subject|31|||
25258296|NCT01073605|50573400|FG001|Overall Study|Withdrawal by Subject|39|||
25258297|NCT01073605|50573401|FG002|Overall Study|Withdrawal by Subject|22|||
25258298|NCT01073605|50573399|FG000|Overall Study|Randomized But Not Treated|0|||
25258299|NCT01073605|50573400|FG001|Overall Study|Randomized But Not Treated|1|||
25258300|NCT01073605|50573401|FG002|Overall Study|Randomized But Not Treated|1|||
25258301|NCT01073293|50573411|FG000|Overall Study|Lost to Follow-up|0|||
25258302|NCT01073293|50573412|FG001|Overall Study|Lost to Follow-up|1|||
25258303|NCT01073293|50573411|FG000|Overall Study|Withdrawal by Subject|5|||
25258304|NCT01073293|50573412|FG001|Overall Study|Withdrawal by Subject|10|||
25258305|NCT01105936|50573418|FG000|Period 1|Adverse Event|0|||
25258306|NCT01105936|50573419|FG001|Period 1|Adverse Event|0|||
25258307|NCT01105936|50573420|FG002|Period 1|Adverse Event|0|||
25258308|NCT01105936|50573421|FG003|Period 1|Adverse Event|1|||
25258309|NCT01105936|50573418|FG000|Period 2|Adverse Event|1|||
25258310|NCT01105936|50573419|FG001|Period 2|Adverse Event|0|||
25258311|NCT01105936|50573420|FG002|Period 2|Adverse Event|0|||
25258312|NCT01105936|50573421|FG003|Period 2|Adverse Event|0|||
25258313|NCT01105936|50573418|FG000|Period 3|Protocol Violation|0|||
25258314|NCT01105936|50573419|FG001|Period 3|Protocol Violation|2|||
25258315|NCT01105936|50573420|FG002|Period 3|Protocol Violation|0|||
25258316|NCT01105936|50573421|FG003|Period 3|Protocol Violation|0|||
25258317|NCT01309659|50573432|FG000|Overall Study|Protocol Violation|0|||
25258318|NCT01309659|50573433|FG001|Overall Study|Protocol Violation|1|||
25258319|NCT01104766|50573443|FG000|Overall Study|Did not meet inc/exc criteria|1|||
25258320|NCT01104766|50573444|FG001|Overall Study|Did not meet inc/exc criteria|0|||
25258321|NCT01104766|50573445|FG002|Overall Study|Did not meet inc/exc criteria|0|||
25258322|NCT01104766|50573446|FG003|Overall Study|Did not meet inc/exc criteria|0|||
25258323|NCT01104766|50573443|FG000|Overall Study|Adverse Event|17|||
25258324|NCT01104766|50573444|FG001|Overall Study|Adverse Event|15|||
25258325|NCT01104766|50573445|FG002|Overall Study|Adverse Event|20|||
25258326|NCT01104766|50573446|FG003|Overall Study|Adverse Event|14|||
25258327|NCT01104766|50573443|FG000|Overall Study|Lack of Efficacy|20|||
25258328|NCT01104766|50573444|FG001|Overall Study|Lack of Efficacy|15|||
25258329|NCT01104766|50573445|FG002|Overall Study|Lack of Efficacy|14|||
25258330|NCT01104766|50573446|FG003|Overall Study|Lack of Efficacy|8|||
25258331|NCT01104766|50573443|FG000|Overall Study|Protocol Violation|2|||
25258332|NCT01104766|50573444|FG001|Overall Study|Protocol Violation|0|||
25258333|NCT01104766|50573445|FG002|Overall Study|Protocol Violation|0|||
25258334|NCT01104766|50573446|FG003|Overall Study|Protocol Violation|0|||
25258335|NCT01104766|50573443|FG000|Overall Study|Withdrawal by Subject|17|||
25258336|NCT01104766|50573444|FG001|Overall Study|Withdrawal by Subject|19|||
25258337|NCT01104766|50573445|FG002|Overall Study|Withdrawal by Subject|25|||
25258338|NCT01104766|50573446|FG003|Overall Study|Withdrawal by Subject|15|||
25258339|NCT01104766|50573443|FG000|Overall Study|Lost to Follow-up|1|||
25258340|NCT01104766|50573444|FG001|Overall Study|Lost to Follow-up|2|||
25258341|NCT01104766|50573445|FG002|Overall Study|Lost to Follow-up|1|||
25258342|NCT01104766|50573446|FG003|Overall Study|Lost to Follow-up|1|||
25258343|NCT01104376|50573456|FG000|Overall Study|Withdrawal by Subject|15|||
25258344|NCT01104376|50573456|FG000|Overall Study|Consented but excluded after labs|13|||
25258345|NCT01072357|50573462|FG000|Overall Study|Lost to Follow-up|0|||
25258346|NCT01072357|50573463|FG001|Overall Study|Lost to Follow-up|1|||
25258347|NCT01072201|50573471|FG000|Overall Study|Lost to Follow-up|0|||
25258348|NCT01072201|50573472|FG001|Overall Study|Lost to Follow-up|1|||
25258349|NCT01103362|50573478|FG000|Overall Study|study terminated|596|||
25258350|NCT01103284|50573484|FG000|Overall Study|Death|2|||
25258351|NCT01103284|50573485|FG001|Overall Study|Death|0|||
25258352|NCT01103284|50573484|FG000|Overall Study|Lost to Follow-up|9|||
25258353|NCT01103284|50573485|FG001|Overall Study|Lost to Follow-up|10|||
25258354|NCT01103284|50573484|FG000|Overall Study|Pregnancy|3|||
25258355|NCT01103284|50573485|FG001|Overall Study|Pregnancy|1|||
25258356|NCT01103284|50573484|FG000|Overall Study|Protocol Violation|12|||
25258357|NCT01103284|50573485|FG001|Overall Study|Protocol Violation|5|||
25258358|NCT01103284|50573484|FG000|Overall Study|Adverse Event|0|||
25258359|NCT01103284|50573485|FG001|Overall Study|Adverse Event|5|||
25258360|NCT01103284|50573484|FG000|Overall Study|Withdrawal by Subject|14|||
25258361|NCT01103284|50573485|FG001|Overall Study|Withdrawal by Subject|18|||
25258362|NCT01103284|50573484|FG000|Overall Study|Dermal Hypersensitivity|0|||
25258363|NCT01103284|50573485|FG001|Overall Study|Dermal Hypersensitivity|1|||
25258364|NCT01103284|50573484|FG000|Overall Study|Termination by the Sponsor|0|||
25258365|NCT01103284|50573485|FG001|Overall Study|Termination by the Sponsor|1|||
25258366|NCT01103284|50573484|FG000|Overall Study|Not described|2|||
25258367|NCT01103284|50573485|FG001|Overall Study|Not described|1|||
25258368|NCT01103284|50573484|FG000|Overall Study|Missing CRF entries for study completion|0|||
25258369|NCT01103284|50573485|FG001|Overall Study|Missing CRF entries for study completion|2|||
25258370|NCT01070953|50573491|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
25258371|NCT01070953|50573491|FG000|Participants for Safety Evaluation|Off-label use|283|||
25258372|NCT01070953|50573491|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
25258373|NCT01070953|50573491|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
25258374|NCT01070953|50573491|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
25258375|NCT01070953|50573491|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
25258376|NCT01070953|50573491|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
25258377|NCT01070953|50573491|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
25258378|NCT01070953|50573491|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
25258379|NCT01070953|50573491|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
25258380|NCT01089361|50573503|FG000|Overall Study|Death|1|||
25258381|NCT01089361|50573504|FG001|Overall Study|Death|0|||
25258382|NCT01102972|50573514|FG000|Overall Study|Adverse Event|8|||
25258383|NCT01102972|50573515|FG001|Overall Study|Adverse Event|2|||
25258384|NCT01102972|50573514|FG000|Overall Study|Lack of Efficacy|2|||
25258385|NCT01102972|50573515|FG001|Overall Study|Lack of Efficacy|1|||
25258386|NCT01102972|50573514|FG000|Overall Study|Protocol Violation|1|||
25258387|NCT01102972|50573515|FG001|Overall Study|Protocol Violation|0|||
25258388|NCT01102972|50573514|FG000|Overall Study|Lost to Follow-up|10|||
25258389|NCT01102972|50573515|FG001|Overall Study|Lost to Follow-up|5|||
25258390|NCT01102972|50573514|FG000|Overall Study|Investigator Discretion|2|||
25258391|NCT01102972|50573515|FG001|Overall Study|Investigator Discretion|0|||
25258392|NCT01102972|50573514|FG000|Overall Study|Withdrawal by Subject|6|||
25258393|NCT01102972|50573515|FG001|Overall Study|Withdrawal by Subject|6|||
25258394|NCT01309269|50573521|FG000|Overall Study|Adverse Event|56|||
25258395|NCT01309269|50573521|FG000|Overall Study|Withdrawal by Subject|25|||
25258396|NCT01309269|50573521|FG000|Overall Study|Lack of Acceptance|15|||
25258397|NCT01309269|50573521|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
25258398|NCT01309269|50573521|FG000|Overall Study|Kidney Transplant|25|||
25258399|NCT01309269|50573521|FG000|Overall Study|Administrative Problems|141|||
25258400|NCT01309269|50573521|FG000|Overall Study|Other|256|||
25258401|NCT01309269|50573521|FG000|Overall Study|Other|1|||
25258402|NCT01309269|50573521|FG000|Overall Study|Study Completion Data Not Recorded|95|||
25258403|NCT01309269|50573521|FG000|Overall Study|Enrolled but not Treated|107|||
25258404|NCT01088503|50573528|FG000|Overall Study|Withdrawal by Subject|118|||
25258405|NCT01088503|50573529|FG001|Overall Study|Withdrawal by Subject|327|||
25258406|NCT01088503|50573530|FG002|Overall Study|Withdrawal by Subject|10|||
25258407|NCT01088503|50573528|FG000|Overall Study|Death|64|||
25258408|NCT01088503|50573529|FG001|Overall Study|Death|358|||
25258409|NCT01088503|50573530|FG002|Overall Study|Death|7|||
25258410|NCT01087489|50573536|FG000|Overall Study|enrolled in another VA study|0|||
25258411|NCT01087489|50573537|FG001|Overall Study|enrolled in another VA study|1|||
25258412|NCT01087489|50573536|FG000|Overall Study|Death|0|||
25258413|NCT01087489|50573537|FG001|Overall Study|Death|1|||
25258414|NCT01087489|50573536|FG000|Overall Study|unable to survey by telephone|0|||
25258415|NCT01087489|50573537|FG001|Overall Study|unable to survey by telephone|1|||
25258416|NCT01082965|50573545|FG000|Overall Study|Protocol Violation|0|||
25258417|NCT01082965|50573546|FG001|Overall Study|Protocol Violation|1|||
25258418|NCT01082965|50573545|FG000|Overall Study|Other|1|||
25258419|NCT01082965|50573546|FG001|Overall Study|Other|1|||
25258420|NCT01102426|50573554|FG000|Overall Study|Randomized but not treated|4|||
25258421|NCT01102426|50573555|FG001|Overall Study|Randomized but not treated|1|||
25258422|NCT01102426|50573554|FG000|Overall Study|Adverse Events (treatment-related)|15|||
25258423|NCT01102426|50573555|FG001|Overall Study|Adverse Events (treatment-related)|8|||
25258424|NCT01102426|50573554|FG000|Overall Study|Physician Decision|9|||
25258425|NCT01102426|50573555|FG001|Overall Study|Physician Decision|6|||
25258426|NCT01102426|50573554|FG000|Overall Study|Progressive Disease|85|||
25258427|NCT01102426|50573555|FG001|Overall Study|Progressive Disease|44|||
25258428|NCT01102426|50573554|FG000|Overall Study|Adverse Events (unrelated to|9|||
25258429|NCT01102426|50573555|FG001|Overall Study|Adverse Events (unrelated to|1|||
25258430|NCT01102426|50573554|FG000|Overall Study|Patient Refusal|24|||
25258431|NCT01102426|50573555|FG001|Overall Study|Patient Refusal|12|||
25258432|NCT01102426|50573554|FG000|Overall Study|Death (due to adverse events|0|||
25258433|NCT01102426|50573555|FG001|Overall Study|Death (due to adverse events|1|||
25258434|NCT01102426|50573554|FG000|Overall Study|Death (non-related to the study|19|||
25258435|NCT01102426|50573555|FG001|Overall Study|Death (non-related to the study|8|||
25258436|NCT01101334|50573563|FG000|Overall Study|Adverse Event|9|||
25258437|NCT01101334|50573564|FG001|Overall Study|Adverse Event|4|||
25258438|NCT01101334|50573563|FG000|Overall Study|Death|7|||
24993594|NCT03806127|50084075|FG000|Overall Study|Protocol Violation|3|||
24993595|NCT03806127|50084076|FG001|Overall Study|Protocol Violation|1|||
24993596|NCT03806127|50084075|FG000|Overall Study|Adverse Event|3|||
24993597|NCT03806127|50084076|FG001|Overall Study|Adverse Event|0|||
24993598|NCT03806127|50084075|FG000|Overall Study|Unable to Complete Procedures|0|||
24993599|NCT03806127|50084076|FG001|Overall Study|Unable to Complete Procedures|1|||
24993600|NCT03806127|50084075|FG000|Overall Study|Pregnancy|0|||
24993601|NCT03806127|50084076|FG001|Overall Study|Pregnancy|1|||
24993602|NCT03806127|50084075|FG000|Overall Study|Lost to Follow-up|5|||
24993603|NCT03806127|50084076|FG001|Overall Study|Lost to Follow-up|1|||
24993604|NCT03806127|50084075|FG000|Overall Study|Physician Decision|1|||
25258439|NCT01101334|50573564|FG001|Overall Study|Death|1|||
25258440|NCT01101334|50573563|FG000|Overall Study|Withdrawal by Subject|4|||
25258441|NCT01101334|50573564|FG001|Overall Study|Withdrawal by Subject|3|||
25258442|NCT01101334|50573563|FG000|Overall Study|Withdrawal by Sponsor|1|||
25258443|NCT01101334|50573564|FG001|Overall Study|Withdrawal by Sponsor|1|||
25258444|NCT01101334|50573563|FG000|Overall Study|Progressive Disease|22|||
25258445|NCT01101334|50573564|FG001|Overall Study|Progressive Disease|35|||
25258446|NCT01101334|50573563|FG000|Overall Study|Other|2|||
25258447|NCT01101334|50573564|FG001|Overall Study|Other|1|||
25258448|NCT01327547|50573572|FG000|Overall Study|Adverse Event|4|||
25258449|NCT01327547|50573573|FG001|Overall Study|Adverse Event|1|||
25258450|NCT01327547|50573572|FG000|Overall Study|Death|1|||
25258451|NCT01327547|50573573|FG001|Overall Study|Death|2|||
25258452|NCT01327547|50573572|FG000|Overall Study|Lost to Follow-up|6|||
25258453|NCT01327547|50573573|FG001|Overall Study|Lost to Follow-up|6|||
25258454|NCT01327547|50573572|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
25258455|NCT01327547|50573573|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
25258456|NCT01327547|50573572|FG000|Overall Study|Withdrawal by Subject|3|||
24993605|NCT03806127|50084076|FG001|Overall Study|Physician Decision|1|||
25258457|NCT01327547|50573573|FG001|Overall Study|Withdrawal by Subject|7|||
25258458|NCT01327547|50573572|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
25258459|NCT01327547|50573573|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
25258460|NCT01327547|50573572|FG000|Overall Study|Protocol Violation|1|||
25258461|NCT01327547|50573573|FG001|Overall Study|Protocol Violation|0|||
25258462|NCT01327547|50573572|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
25258463|NCT01327547|50573573|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
25258464|NCT01327547|50573572|FG000|Overall Study|Required prohibited medication|2|||
25258465|NCT01327547|50573573|FG001|Overall Study|Required prohibited medication|0|||
25258466|NCT01327547|50573572|FG000|Overall Study|Non-compliance with study procedures|1|||
25258467|NCT01327547|50573573|FG001|Overall Study|Non-compliance with study procedures|0|||
25258468|NCT01327547|50573572|FG000|Overall Study|By investigator in subject's interest|0|||
25258469|NCT01327547|50573573|FG001|Overall Study|By investigator in subject's interest|1|||
25258470|NCT01308567|50573595|FG000|Overall Study|Lost to Follow-up|2|||
25258471|NCT01308567|50573596|FG001|Overall Study|Lost to Follow-up|4|||
25258472|NCT01308567|50573597|FG002|Overall Study|Lost to Follow-up|4|||
25258473|NCT01307319|50573608|FG000|Overall Study|Adverse Event|2|||
25258474|NCT01307319|50573609|FG001|Overall Study|Adverse Event|2|||
25258475|NCT01307319|50573610|FG002|Overall Study|Adverse Event|1|||
25258476|NCT01307319|50573608|FG000|Overall Study|Lost to Follow-up|1|||
25258477|NCT01307319|50573609|FG001|Overall Study|Lost to Follow-up|0|||
25258478|NCT01307319|50573610|FG002|Overall Study|Lost to Follow-up|1|||
25258479|NCT01307319|50573608|FG000|Overall Study|Protocol Violation|1|||
25258480|NCT01307319|50573609|FG001|Overall Study|Protocol Violation|1|||
25258481|NCT01307319|50573610|FG002|Overall Study|Protocol Violation|0|||
25258482|NCT01307319|50573608|FG000|Overall Study|Withdrawal by Subject|0|||
25258483|NCT01307319|50573609|FG001|Overall Study|Withdrawal by Subject|1|||
25258484|NCT01307319|50573610|FG002|Overall Study|Withdrawal by Subject|2|||
25258485|NCT01307319|50573608|FG000|Overall Study|Other|0|||
25258486|NCT01307319|50573609|FG001|Overall Study|Other|4|||
25258487|NCT01307319|50573610|FG002|Overall Study|Other|3|||
25258488|NCT01080391|50573620|FG000|Overall Study|Randomized but not treated|7|||
25258489|NCT01080391|50573621|FG001|Overall Study|Randomized but not treated|4|||
25258490|NCT01070329|50573629|FG000|Overall Study|Adverse Event|13|||
25258491|NCT01070329|50573630|FG001|Overall Study|Adverse Event|10|||
25258492|NCT01070329|50573629|FG000|Overall Study|Lost to Follow-up|22|||
25258493|NCT01070329|50573630|FG001|Overall Study|Lost to Follow-up|12|||
25258494|NCT01070329|50573629|FG000|Overall Study|Withdrawal by Subject|9|||
25258495|NCT01070329|50573630|FG001|Overall Study|Withdrawal by Subject|11|||
25258496|NCT01070329|50573629|FG000|Overall Study|Protocol Violation|3|||
25258497|NCT01070329|50573630|FG001|Overall Study|Protocol Violation|8|||
25258498|NCT01070329|50573629|FG000|Overall Study|Lack of Efficacy|2|||
25258499|NCT01070329|50573630|FG001|Overall Study|Lack of Efficacy|6|||
25258500|NCT01070329|50573629|FG000|Overall Study|Physician Decision|2|||
25258501|NCT01070329|50573630|FG001|Overall Study|Physician Decision|1|||
25258502|NCT01070329|50573629|FG000|Overall Study|Entry Criteria Not Met|1|||
25258503|NCT01070329|50573630|FG001|Overall Study|Entry Criteria Not Met|0|||
25258504|NCT01070329|50573629|FG000|Overall Study|Sponsor Decision|0|||
25258505|NCT01070329|50573630|FG001|Overall Study|Sponsor Decision|1|||
25258506|NCT01069861|50573636|FG000|Overall Study|Death|1|||
25258507|NCT01069861|50573636|FG000|Overall Study|Adverse Event|1|||
25258508|NCT01069861|50573636|FG000|Overall Study|Did not meet entrance criteria|1|||
25258509|NCT01306929|50573640|FG000|Overall Study|Withdrawal by Subject|23|||
25258510|NCT01306929|50573640|FG000|Overall Study|Adverse Event|21|||
25258511|NCT01306929|50573640|FG000|Overall Study|Physician Decision|13|||
25258512|NCT01306929|50573640|FG000|Overall Study|Death|8|||
25258513|NCT01306929|50573640|FG000|Overall Study|Withdrawal by parent/guardian|5|||
25258514|NCT01306929|50573640|FG000|Overall Study|Protocol Violation|3|||
25258515|NCT01306929|50573640|FG000|Overall Study|Non-compliance with study drug|2|||
25258516|NCT01306929|50573640|FG000|Overall Study|Lost to Follow-up|2|||
25258517|NCT01306929|50573640|FG000|Overall Study|Various|17|||
25258518|NCT01064401|50573646|FG000|Overall Study|Adverse Event|47|||
25258519|NCT01064401|50573647|FG001|Overall Study|Adverse Event|56|||
25258520|NCT01064401|50573646|FG000|Overall Study|Lack of Efficacy|46|||
25258521|NCT01064401|50573647|FG001|Overall Study|Lack of Efficacy|23|||
25258522|NCT01064401|50573646|FG000|Overall Study|Lost to Follow-up|12|||
25258523|NCT01064401|50573647|FG001|Overall Study|Lost to Follow-up|9|||
25258524|NCT01064401|50573646|FG000|Overall Study|Consent Withdrawn|98|||
25258525|NCT01064401|50573647|FG001|Overall Study|Consent Withdrawn|80|||
25258526|NCT01064401|50573646|FG000|Overall Study|Investigator Decision|4|||
25258527|NCT01064401|50573647|FG001|Overall Study|Investigator Decision|6|||
25258528|NCT01064401|50573646|FG000|Overall Study|Death|4|||
25258529|NCT01064401|50573647|FG001|Overall Study|Death|0|||
25258530|NCT01064401|50573646|FG000|Overall Study|Pregnancy|4|||
25258531|NCT01064401|50573647|FG001|Overall Study|Pregnancy|7|||
25258532|NCT01064401|50573646|FG000|Overall Study|Noncompliance|7|||
25258533|NCT01064401|50573647|FG001|Overall Study|Noncompliance|8|||
25258534|NCT01064401|50573646|FG000|Overall Study|Site Closure|4|||
25258535|NCT01064401|50573647|FG001|Overall Study|Site Closure|5|||
25258536|NCT01064401|50573646|FG000|Overall Study|Other|2|||
25258537|NCT01064401|50573647|FG001|Overall Study|Other|1|||
25258538|NCT01306617|50573657|FG000|Overall Study|Adverse Event|1|||
25258539|NCT01306617|50573658|FG001|Overall Study|Adverse Event|0|||
25258540|NCT01306617|50573659|FG002|Overall Study|Adverse Event|0|||
25258541|NCT01306617|50573657|FG000|Overall Study|Virologic Failure|0|||
25258542|NCT01306617|50573658|FG001|Overall Study|Virologic Failure|0|||
25258543|NCT01306617|50573659|FG002|Overall Study|Virologic Failure|5|||
25258544|NCT01306617|50573657|FG000|Overall Study|Non-compliance|0|||
25258545|NCT01306617|50573658|FG001|Overall Study|Non-compliance|1|||
25258546|NCT01306617|50573659|FG002|Overall Study|Non-compliance|0|||
25258547|NCT01306305|50573669|FG000|Overall Study|Lost to Follow-up|1|||
25258548|NCT01306305|50573670|FG001|Overall Study|Lost to Follow-up|0|||
25258549|NCT01306305|50573669|FG000|Overall Study|Withdrew consent|1|||
25258550|NCT01306305|50573670|FG001|Overall Study|Withdrew consent|0|||
25258551|NCT01038427|50573679|FG000|Overall Study|Lost to follow up|1|||
25258552|NCT01038427|50573680|FG001|Overall Study|Lost to follow up|1|||
25258553|NCT01038427|50573681|FG002|Overall Study|Lost to follow up|0|||
25258554|NCT01038427|50573679|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
25258555|NCT01038427|50573680|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
25258556|NCT01038427|50573681|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
25258557|NCT01038427|50573679|FG000|Overall Study|Withdrew consent|0|||
25258558|NCT01038427|50573680|FG001|Overall Study|Withdrew consent|0|||
25258559|NCT01038427|50573681|FG002|Overall Study|Withdrew consent|1|||
25258560|NCT01038427|50573679|FG000|Overall Study|Adverse Event|2|||
25258561|NCT01038427|50573680|FG001|Overall Study|Adverse Event|2|||
25258562|NCT01038427|50573681|FG002|Overall Study|Adverse Event|1|||
25258563|NCT01038427|50573679|FG000|Overall Study|Enrolled in error|0|||
25258564|NCT01038427|50573680|FG001|Overall Study|Enrolled in error|1|||
25258565|NCT01038427|50573681|FG002|Overall Study|Enrolled in error|1|||
25258566|NCT01038427|50573679|FG000|Overall Study|Other|0|||
25258567|NCT01038427|50573680|FG001|Overall Study|Other|2|||
25258568|NCT01038427|50573681|FG002|Overall Study|Other|0|||
25258569|NCT01037413|50573689|FG000|Part A: Skin Testing|Adverse Event|1|||
25258570|NCT01037413|50573690|FG001|Part A: Skin Testing|Adverse Event|0|||
25258571|NCT01037413|50573689|FG000|Part A: Skin Testing|Protocol Violation|1|||
25258572|NCT01037413|50573690|FG001|Part A: Skin Testing|Protocol Violation|0|||
25258573|NCT01037413|50573689|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
25258574|NCT01037413|50573690|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
25258575|NCT01037413|50573689|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
25258576|NCT01037413|50573690|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
25258577|NCT01326845|50573705|FG000|Overall Study|Administrative Problems|5|||
25258578|NCT01326845|50573706|FG001|Overall Study|Administrative Problems|2|||
25258579|NCT01326845|50573705|FG000|Overall Study|Adverse Event|1|||
25258580|NCT01326845|50573706|FG001|Overall Study|Adverse Event|0|||
25258581|NCT01326845|50573705|FG000|Overall Study|Misisng|1|||
25258582|NCT01326845|50573706|FG001|Overall Study|Misisng|3|||
25258583|NCT01062763|50573714|FG000|Overall Study|Adverse Event|3|||
25258584|NCT01062763|50573715|FG001|Overall Study|Adverse Event|4|||
25258585|NCT01048099|50573721|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
25258586|NCT01048099|50573721|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
25258587|NCT01303965|50573729|FG000|Overall Study|Adverse Event|1|||
25258588|NCT01303965|50573730|FG001|Overall Study|Adverse Event|1|||
25258589|NCT01303965|50573729|FG000|Overall Study|Death|0|||
25258590|NCT01303965|50573730|FG001|Overall Study|Death|3|||
25258591|NCT01303965|50573729|FG000|Overall Study|Withdrawal by Subject|1|||
25258592|NCT01303965|50573730|FG001|Overall Study|Withdrawal by Subject|0|||
25258593|NCT01303965|50573729|FG000|Overall Study|Disease Progression|1|||
25258594|NCT01303965|50573730|FG001|Overall Study|Disease Progression|6|||
25258595|NCT01045993|50573740|FG000|Overall Study|Treated-later found eligibility not met|0|||
25258596|NCT01045993|50573741|FG001|Overall Study|Treated-later found eligibility not met|1|||
25258597|NCT01045993|50573742|FG002|Overall Study|Treated-later found eligibility not met|0|||
25258598|NCT01045993|50573743|FG003|Overall Study|Treated-later found eligibility not met|0|||
25258599|NCT01303419|50573753|FG000|Overall Study|Discontinuation of study|60|||
25258600|NCT01303419|50573753|FG000|Overall Study|Did not complete both imaging methods|5|||
25258601|NCT01303419|50573753|FG000|Overall Study|Did not meet all I/E after screening|31|||
25258602|NCT01326533|50573759|FG000|Overall Study|Lost to Follow-up|2|||
25258603|NCT01326533|50573760|FG001|Overall Study|Lost to Follow-up|0|||
25258604|NCT01326533|50573759|FG000|Overall Study|Withdrawal by Subject|1|||
25258605|NCT01326533|50573760|FG001|Overall Study|Withdrawal by Subject|0|||
25258606|NCT01326533|50573759|FG000|Overall Study|Adverse Event|1|||
25258607|NCT01326533|50573760|FG001|Overall Study|Adverse Event|0|||
25258608|NCT01045447|50573768|FG000|Overall Study|Adverse Event|0|||
25258609|NCT01045447|50573769|FG001|Overall Study|Adverse Event|1|||
25258610|NCT01045447|50573768|FG000|Overall Study|Lack of Efficacy|3|||
25258611|NCT01045447|50573769|FG001|Overall Study|Lack of Efficacy|1|||
25258612|NCT01045447|50573768|FG000|Overall Study|Protocol Violation|6|||
25258613|NCT01045447|50573769|FG001|Overall Study|Protocol Violation|3|||
25258614|NCT01045447|50573768|FG000|Overall Study|Withdrawal Criteria|10|||
25258615|NCT01045447|50573769|FG001|Overall Study|Withdrawal Criteria|10|||
25258616|NCT01045447|50573768|FG000|Overall Study|Unclassified|17|||
25258617|NCT01045447|50573769|FG001|Overall Study|Unclassified|13|||
25258618|NCT01301625|50573775|FG000|Overall Study|Death|5|||
25258619|NCT01301625|50573775|FG000|Overall Study|Not Due|21|||
25258620|NCT01301625|50573775|FG000|Overall Study|Expected|8|||
25258621|NCT01301625|50573775|FG000|Overall Study|Lost to Follow-up|1|||
25258622|NCT01301391|50573779|FG000|Overall Study|Death|13|||
25258623|NCT01301391|50573779|FG000|Overall Study|Lost to Follow-up|3|||
25258624|NCT01301391|50573779|FG000|Overall Study|Physician Decision|2|||
25258625|NCT01301391|50573779|FG000|Overall Study|Sponsor's decision|8|||
25258626|NCT01036321|50573785|FG000|Overall Study|Ineligible after randomization|0|||
25258627|NCT01036321|50573786|FG001|Overall Study|Ineligible after randomization|1|||
25258628|NCT01036321|50573785|FG000|Overall Study|Withdrawal by Subject|3|||
25258629|NCT01036321|50573786|FG001|Overall Study|Withdrawal by Subject|2|||
25258630|NCT01036321|50573785|FG000|Overall Study|Adverse Event|2|||
25258631|NCT01036321|50573786|FG001|Overall Study|Adverse Event|1|||
25258632|NCT01061359|50573792|FG000|Overall Study|Death|32|||
25258633|NCT01061359|50573792|FG000|Overall Study|Lost to Follow-up|1072|||
25258634|NCT01061359|50573792|FG000|Overall Study|Relapse|187|||
25258635|NCT01061359|50573792|FG000|Overall Study|Secondary neoplasm|11|||
25258636|NCT01301079|50573798|FG000|Overall Study|Lost to Follow-up|2|||
25258637|NCT01301079|50573799|FG001|Overall Study|Lost to Follow-up|2|||
25258638|NCT01036165|50573809|FG000|Overall Study|Adverse Event|6|||
25258639|NCT01036165|50573809|FG000|Overall Study|Lost to Follow-up|2|||
25258640|NCT01036165|50573809|FG000|Overall Study|Withdrawal by Subject|3|||
25258641|NCT01036165|50573809|FG000|Overall Study|Device Related Issues|3|||
25258642|NCT01036165|50573809|FG000|Overall Study|Problems finding proper area to inject|1|||
25258643|NCT01301001|50573813|FG000|First Intervention|Lost to Follow-up|4|||
25258644|NCT01301001|50573814|FG001|First Intervention|Lost to Follow-up|4|||
25258645|NCT01301001|50573813|FG000|First Intervention|Withdrawal by Subject|1|||
25258646|NCT01301001|50573814|FG001|First Intervention|Withdrawal by Subject|4|||
25258647|NCT01301001|50573813|FG000|First Intervention|Adverse Event|5|||
25258648|NCT01301001|50573814|FG001|First Intervention|Adverse Event|0|||
25258649|NCT01301001|50573813|FG000|First Intervention|Protocol Violation|0|||
25258650|NCT01301001|50573814|FG001|First Intervention|Protocol Violation|1|||
25258651|NCT01301001|50573813|FG000|Second Intervention|Adverse Event|2|||
25258652|NCT01301001|50573814|FG001|Second Intervention|Adverse Event|0|||
25258653|NCT01301001|50573813|FG000|Second Intervention|Withdrawal by Subject|2|||
25258654|NCT01301001|50573814|FG001|Second Intervention|Withdrawal by Subject|0|||
25258655|NCT01035463|50573823|FG000|Overall Study|Adverse Event|0|||
25258656|NCT01035463|50573824|FG001|Overall Study|Adverse Event|0|||
25258657|NCT01035463|50573825|FG002|Overall Study|Adverse Event|4|||
25258658|NCT01035463|50573826|FG003|Overall Study|Adverse Event|1|||
25258659|NCT01035463|50573827|FG004|Overall Study|Adverse Event|5|||
25258660|NCT01035463|50573828|FG005|Overall Study|Adverse Event|7|||
25258661|NCT01035463|50573823|FG000|Overall Study|Withdrawal by Subject|0|||
25258662|NCT01035463|50573824|FG001|Overall Study|Withdrawal by Subject|2|||
25258663|NCT01035463|50573825|FG002|Overall Study|Withdrawal by Subject|1|||
25258664|NCT01035463|50573826|FG003|Overall Study|Withdrawal by Subject|0|||
25258665|NCT01035463|50573827|FG004|Overall Study|Withdrawal by Subject|1|||
25258666|NCT01035463|50573828|FG005|Overall Study|Withdrawal by Subject|4|||
25258667|NCT01035463|50573823|FG000|Overall Study|Disease progression|0|||
25258668|NCT01035463|50573824|FG001|Overall Study|Disease progression|0|||
25258669|NCT01035463|50573825|FG002|Overall Study|Disease progression|0|||
25258670|NCT01035463|50573826|FG003|Overall Study|Disease progression|0|||
25258671|NCT01035463|50573827|FG004|Overall Study|Disease progression|0|||
25258672|NCT01035463|50573828|FG005|Overall Study|Disease progression|3|||
25258673|NCT01035463|50573823|FG000|Overall Study|Other Malignancy|0|||
25258674|NCT01035463|50573824|FG001|Overall Study|Other Malignancy|0|||
25258675|NCT01035463|50573825|FG002|Overall Study|Other Malignancy|0|||
25258676|NCT01035463|50573826|FG003|Overall Study|Other Malignancy|0|||
25258677|NCT01035463|50573827|FG004|Overall Study|Other Malignancy|0|||
25258678|NCT01035463|50573828|FG005|Overall Study|Other Malignancy|2|||
25258679|NCT01035463|50573823|FG000|Overall Study|Other|0|||
25258680|NCT01035463|50573824|FG001|Overall Study|Other|0|||
25258681|NCT01035463|50573825|FG002|Overall Study|Other|0|||
25258682|NCT01035463|50573826|FG003|Overall Study|Other|1|||
25258683|NCT01035463|50573827|FG004|Overall Study|Other|0|||
25258684|NCT01035463|50573828|FG005|Overall Study|Other|2|||
25258685|NCT01300923|50573835|FG000|Overall Study|Physician Decision|0|||
25258686|NCT01300923|50573836|FG001|Overall Study|Physician Decision|2|||
25258687|NCT01300767|50573841|FG000|Overall Study|Discomfort|2|||
25258688|NCT01300767|50573841|FG000|Overall Study|Biomicroscopy|1|||
25258689|NCT01300767|50573841|FG000|Overall Study|Unacceptable fit|1|||
25258690|NCT01300455|50573849|FG000|Washout|Withdrawal by Subject|1|||
25258691|NCT01300455|50573850|FG001|Washout|Withdrawal by Subject|0|||
25258692|NCT01107418|50573860|FG000|Overall Study|Disease Progression|45|||
25258693|NCT01107418|50573860|FG000|Overall Study|Adverse Event|3|||
25258694|NCT01107418|50573860|FG000|Overall Study|Withdrawal by Subject|1|||
25258695|NCT01107418|50573860|FG000|Overall Study|Study Closing|1|||
25258696|NCT01107418|50573860|FG000|Overall Study|Started Other Therapy|1|||
25258697|NCT01107418|50573860|FG000|Overall Study|Entered Extension Study|1|||
25258698|NCT01101178|50573875|FG000|Period 1|Withdrawal by Subject|1|||
25258699|NCT01101178|50573876|FG001|Period 1|Withdrawal by Subject|2|||
25258700|NCT01101178|50573875|FG000|Period 1|Positive drug screen|1|||
25258701|NCT01101178|50573876|FG001|Period 1|Positive drug screen|1|||
25258702|NCT01101178|50573875|FG000|Period 1|Adverse Event|2|||
25258703|NCT01101178|50573876|FG001|Period 1|Adverse Event|1|||
25258704|NCT01101178|50573875|FG000|Period 2|Withdrawal by Subject|0|||
25258705|NCT01101178|50573876|FG001|Period 2|Withdrawal by Subject|1|||
25258706|NCT01101022|50573885|FG000|Overall Study|Adverse Event|6|||
25258707|NCT01101022|50573886|FG001|Overall Study|Adverse Event|2|||
25258708|NCT01101022|50573885|FG000|Overall Study|Protocol Violation|4|||
25258709|NCT01101022|50573886|FG001|Overall Study|Protocol Violation|3|||
25258710|NCT01101022|50573885|FG000|Overall Study|Withdrawal by Subject|3|||
25258711|NCT01101022|50573886|FG001|Overall Study|Withdrawal by Subject|8|||
25258712|NCT01101022|50573885|FG000|Overall Study|Lost to Follow-up|1|||
25258713|NCT01101022|50573886|FG001|Overall Study|Lost to Follow-up|4|||
25258714|NCT01101022|50573885|FG000|Overall Study|Lack of Efficacy|0|||
25258715|NCT01101022|50573886|FG001|Overall Study|Lack of Efficacy|7|||
25258716|NCT01101022|50573885|FG000|Overall Study|Sponsor decision|1|||
25258717|NCT01101022|50573886|FG001|Overall Study|Sponsor decision|1|||
25258718|NCT01101022|50573885|FG000|Overall Study|Non-compliance|1|||
25258719|NCT01101022|50573886|FG001|Overall Study|Non-compliance|0|||
25258720|NCT01101022|50573885|FG000|Overall Study|Work schedule|1|||
25258721|NCT01101022|50573886|FG001|Overall Study|Work schedule|1|||
25258722|NCT01101022|50573885|FG000|Overall Study|Vacation|0|||
25258723|NCT01101022|50573886|FG001|Overall Study|Vacation|1|||
25258724|NCT01299909|50573895|FG000|Overall Study|Lost to Follow-up|22|||
25258725|NCT01299909|50573896|FG001|Overall Study|Lost to Follow-up|18|||
25258726|NCT01299909|50573897|FG002|Overall Study|Lost to Follow-up|17|||
25258727|NCT01298661|50573907|FG000|Overall Study|Withdrawal by Subject|2|||
25258728|NCT01298661|50573908|FG001|Overall Study|Withdrawal by Subject|0|||
25258729|NCT01298661|50573909|FG002|Overall Study|Withdrawal by Subject|2|||
25258730|NCT01100944|50573918|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
25258731|NCT01100944|50573919|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
25258732|NCT01100944|50573920|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
25258733|NCT01100944|50573918|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
25258734|NCT01100944|50573919|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
25258735|NCT01100944|50573920|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
25258736|NCT01100944|50573918|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
25258737|NCT01100944|50573919|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
25258738|NCT01100944|50573920|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
25258739|NCT01100944|50573918|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
25258740|NCT01100944|50573919|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
25258741|NCT01100944|50573920|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
25258742|NCT01100320|50573941|FG000|Period 1|Withdrawal by Subject|2|||
25258743|NCT01100320|50573942|FG001|Period 1|Withdrawal by Subject|4|||
25258744|NCT01100320|50573941|FG000|Period 1|Positive Drug Screen|1|||
25258745|NCT01100320|50573942|FG001|Period 1|Positive Drug Screen|1|||
25258746|NCT01100320|50573941|FG000|Period 1|Adverse Event|2|||
25258747|NCT01100320|50573942|FG001|Period 1|Adverse Event|2|||
25258748|NCT01100320|50573941|FG000|Period 2|Withdrawal by Subject|1|||
25258749|NCT01100320|50573942|FG001|Period 2|Withdrawal by Subject|1|||
25258750|NCT01100086|50573948|FG000|Period 1|Withdrawal by Subject|1|||
25258751|NCT01100086|50573949|FG001|Period 1|Withdrawal by Subject|0|||
25258752|NCT01297959|50573957|FG000|Overall Study|Adverse Event|0|||
25258753|NCT01297959|50573958|FG001|Overall Study|Adverse Event|1|||
25258754|NCT01297959|50573957|FG000|Overall Study|Protocol Violation|2|||
25258755|NCT01297959|50573958|FG001|Overall Study|Protocol Violation|1|||
25258756|NCT01297959|50573957|FG000|Overall Study|Withdrawal by Subject|5|||
25258757|NCT01297959|50573958|FG001|Overall Study|Withdrawal by Subject|4|||
25258758|NCT01297959|50573957|FG000|Overall Study|Physician Decision|0|||
25258759|NCT01297959|50573958|FG001|Overall Study|Physician Decision|1|||
25258760|NCT01297959|50573957|FG000|Overall Study|Unrelated medical illness / complication|0|||
25258761|NCT01297959|50573958|FG001|Overall Study|Unrelated medical illness / complication|2|||
25258762|NCT01297959|50573957|FG000|Overall Study|Other|13|||
25258763|NCT01297959|50573958|FG001|Overall Study|Other|7|||
25258764|NCT01035229|50573966|FG000|Overall Study|Adverse Event|61|||
25258765|NCT01035229|50573967|FG001|Overall Study|Adverse Event|14|||
25258766|NCT01035229|50573966|FG000|Overall Study|Withdrawal by Subject|20|||
25258767|NCT01035229|50573967|FG001|Overall Study|Withdrawal by Subject|7|||
25258768|NCT01035229|50573966|FG000|Overall Study|Lost to Follow-up|1|||
25258769|NCT01035229|50573967|FG001|Overall Study|Lost to Follow-up|0|||
25258770|NCT01035229|50573966|FG000|Overall Study|Administrative problems|1|||
25258771|NCT01035229|50573967|FG001|Overall Study|Administrative problems|1|||
25258772|NCT01035229|50573966|FG000|Overall Study|Death|13|||
25258773|NCT01035229|50573967|FG001|Overall Study|Death|5|||
25258774|NCT01035229|50573966|FG000|Overall Study|New cancer therapy|2|||
25258775|NCT01035229|50573967|FG001|Overall Study|New cancer therapy|0|||
25258776|NCT01035229|50573966|FG000|Overall Study|Protocol Violation|0|||
25258777|NCT01035229|50573967|FG001|Overall Study|Protocol Violation|2|||
25258778|NCT01035229|50573966|FG000|Overall Study|Sponsor's decision to end study|3|||
25258779|NCT01035229|50573967|FG001|Overall Study|Sponsor's decision to end study|3|||
25258780|NCT01035229|50573966|FG000|Overall Study|Disease Progression|261|||
25258781|NCT01035229|50573967|FG001|Overall Study|Disease Progression|152|||
25258782|NCT01106404|50573977|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
25258783|NCT01106404|50573978|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
25258784|NCT01106404|50573977|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
25258785|NCT01106404|50573978|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
25258786|NCT01106404|50573977|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
25258787|NCT01106404|50573978|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
25258788|NCT01106404|50573977|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
25258789|NCT01106404|50573978|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
25258790|NCT01059799|50573992|FG000|Overall Study|Adverse Event|2|||
25258791|NCT01059799|50573993|FG001|Overall Study|Adverse Event|3|||
25258792|NCT01059799|50573992|FG000|Overall Study|Lack of Efficacy|1|||
25258793|NCT01059799|50573993|FG001|Overall Study|Lack of Efficacy|0|||
25258794|NCT01059799|50573992|FG000|Overall Study|Protocol Violation|3|||
25258795|NCT01059799|50573993|FG001|Overall Study|Protocol Violation|2|||
25258796|NCT01059799|50573992|FG000|Overall Study|Withdrawal criteria|13|||
25258797|NCT01059799|50573993|FG001|Overall Study|Withdrawal criteria|2|||
25258798|NCT01059799|50573992|FG000|Overall Study|Other|12|||
25258799|NCT01059799|50573993|FG001|Overall Study|Other|3|||
25258800|NCT01106248|50573999|FG000|Overall Study|Adverse Event|1|||
25258801|NCT01106248|50573999|FG000|Overall Study|Administrative|2|||
25258802|NCT01059175|50574005|FG000|Overall Study|Death|17|||
25258803|NCT01059175|50574006|FG001|Overall Study|Death|17|||
25258804|NCT01059175|50574005|FG000|Overall Study|Adverse Event|4|||
25258805|NCT01059175|50574006|FG001|Overall Study|Adverse Event|2|||
25258806|NCT01059175|50574005|FG000|Overall Study|Lost to Follow-up|0|||
25258807|NCT01059175|50574006|FG001|Overall Study|Lost to Follow-up|1|||
25258808|NCT01297491|50574014|FG000|Overall Study|Adverse Event|11|||
25258809|NCT01297491|50574015|FG001|Overall Study|Adverse Event|6|||
25258810|NCT01297491|50574014|FG000|Overall Study|Physician Decision|3|||
25258811|NCT01297491|50574015|FG001|Overall Study|Physician Decision|2|||
25258812|NCT01297491|50574014|FG000|Overall Study|Progressive disease|11|||
25258813|NCT01297491|50574015|FG001|Overall Study|Progressive disease|20|||
25258814|NCT01297491|50574014|FG000|Overall Study|Patient/Guardian decision|3|||
25258815|NCT01297491|50574015|FG001|Overall Study|Patient/Guardian decision|4|||
25258816|NCT01297491|50574014|FG000|Overall Study|Death|2|||
25258817|NCT01297491|50574015|FG001|Overall Study|Death|1|||
25258818|NCT01106092|50574025|FG000|Overall Study|Withdrawal by Subject|0|||
25258819|NCT01106092|50574026|FG001|Overall Study|Withdrawal by Subject|0|||
25258820|NCT01106092|50574027|FG002|Overall Study|Withdrawal by Subject|0|||
25258821|NCT01106092|50574028|FG003|Overall Study|Withdrawal by Subject|1|||
25258822|NCT01097668|50574040|FG000|Overall Study|Withdrawal by Subject|1|||
25258823|NCT01097668|50574041|FG001|Overall Study|Withdrawal by Subject|2|||
25258824|NCT01097668|50574040|FG000|Overall Study|Lost to Follow-up|1|||
25258825|NCT01097668|50574041|FG001|Overall Study|Lost to Follow-up|0|||
25258826|NCT01325207|50574057|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
25258827|NCT01325207|50574058|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
25258828|NCT01325207|50574059|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
25258829|NCT01325207|50574060|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
25258830|NCT01325207|50574061|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
25258831|NCT01325207|50574062|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
25258832|NCT01325207|50574057|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
25258833|NCT01325207|50574058|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
25258834|NCT01325207|50574059|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
25258835|NCT01325207|50574060|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
25258836|NCT01325207|50574061|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
25258837|NCT01325207|50574062|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
25258838|NCT01325207|50574057|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
25258839|NCT01325207|50574058|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
25258840|NCT01325207|50574059|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
25258841|NCT01325207|50574060|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
25258842|NCT01325207|50574061|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
25258843|NCT01325207|50574062|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
25258844|NCT01325207|50574057|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
25258845|NCT01325207|50574058|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
25258846|NCT01325207|50574059|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
25258847|NCT01325207|50574060|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
25258848|NCT01325207|50574061|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
25258849|NCT01325207|50574062|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
25258850|NCT01325207|50574057|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
25258851|NCT01325207|50574058|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
25258852|NCT01325207|50574059|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
25258853|NCT01325207|50574060|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
25258854|NCT01325207|50574061|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
25258855|NCT01325207|50574062|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
25258856|NCT01325207|50574057|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
25258857|NCT01325207|50574058|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
25258858|NCT01325207|50574059|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
25258859|NCT01325207|50574060|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
25258860|NCT01325207|50574061|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
25258861|NCT01325207|50574062|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
25258862|NCT01325207|50574057|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
25258863|NCT01325207|50574058|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
25258864|NCT01325207|50574059|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
25258865|NCT01325207|50574060|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
25258866|NCT01325207|50574061|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
25258867|NCT01325207|50574062|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
25258868|NCT01324349|50574079|FG000|Overall Study|Death|1|||
25258869|NCT01324349|50574080|FG001|Overall Study|Death|1|||
25258870|NCT01324349|50574079|FG000|Overall Study|Withdrawal by Subject|0|||
25258871|NCT01324349|50574080|FG001|Overall Study|Withdrawal by Subject|1|||
25258872|NCT01095250|50574090|FG000|Overall Study|administrative reasons|8|||
25258873|NCT01095250|50574091|FG001|Overall Study|administrative reasons|10|||
25258874|NCT01095250|50574092|FG002|Overall Study|administrative reasons|7|||
25258875|NCT01095250|50574093|FG003|Overall Study|administrative reasons|5|||
25258876|NCT01095250|50574090|FG000|Overall Study|Withdrawal by Subject|0|||
25258877|NCT01095250|50574091|FG001|Overall Study|Withdrawal by Subject|0|||
25258878|NCT01095250|50574092|FG002|Overall Study|Withdrawal by Subject|1|||
25258879|NCT01095250|50574093|FG003|Overall Study|Withdrawal by Subject|0|||
25258880|NCT01324271|50574103|FG000|Overall Study|Lost to Follow-up|3|||
25258881|NCT01324271|50574104|FG001|Overall Study|Lost to Follow-up|0|||
25258882|NCT01324271|50574103|FG000|Overall Study|Physician Decision|1|||
25258883|NCT01324271|50574104|FG001|Overall Study|Physician Decision|0|||
25258884|NCT01095094|50574110|FG000|Overall Study|Withdrawal by Subject|1|||
25258885|NCT01095094|50574110|FG000|Overall Study|Death|1|||
25258886|NCT01095094|50574110|FG000|Overall Study|Physician Decision|1|||
25258887|NCT01323647|50574116|FG000|Overall Study|Migrated/moved from study area|2|||
25258888|NCT01323647|50574117|FG001|Overall Study|Migrated/moved from study area|0|||
25258889|NCT01323647|50574116|FG000|Overall Study|Withdrawal by Subject|5|||
25258890|NCT01323647|50574117|FG001|Overall Study|Withdrawal by Subject|0|||
25258891|NCT01323647|50574116|FG000|Overall Study|Lost to Follow-up|2|||
25258892|NCT01323647|50574117|FG001|Overall Study|Lost to Follow-up|0|||
25258893|NCT01094782|50574129|FG000|Overall Study|Withdrawal by Subject|5|||
25258894|NCT01094782|50574130|FG001|Overall Study|Withdrawal by Subject|5|||
25258895|NCT01094782|50574131|FG002|Overall Study|Withdrawal by Subject|1|||
25258896|NCT01094782|50574132|FG003|Overall Study|Withdrawal by Subject|5|||
25258897|NCT01094782|50574133|FG004|Overall Study|Withdrawal by Subject|5|||
25258898|NCT01094782|50574134|FG005|Overall Study|Withdrawal by Subject|0|||
25258899|NCT01094782|50574129|FG000|Overall Study|Lost to Follow-up|1|||
25258900|NCT01094782|50574130|FG001|Overall Study|Lost to Follow-up|0|||
25258901|NCT01094782|50574131|FG002|Overall Study|Lost to Follow-up|0|||
25258902|NCT01094782|50574132|FG003|Overall Study|Lost to Follow-up|2|||
25258903|NCT01094782|50574133|FG004|Overall Study|Lost to Follow-up|1|||
25258904|NCT01094782|50574134|FG005|Overall Study|Lost to Follow-up|4|||
25258905|NCT01094782|50574129|FG000|Overall Study|Positive Drug Screen|2|||
25258906|NCT01094782|50574130|FG001|Overall Study|Positive Drug Screen|2|||
25258907|NCT01094782|50574131|FG002|Overall Study|Positive Drug Screen|1|||
25258908|NCT01094782|50574132|FG003|Overall Study|Positive Drug Screen|1|||
25258909|NCT01094782|50574133|FG004|Overall Study|Positive Drug Screen|3|||
25258910|NCT01094782|50574134|FG005|Overall Study|Positive Drug Screen|2|||
25258911|NCT01094782|50574129|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
25258912|NCT01094782|50574130|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
25258913|NCT01094782|50574131|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
25258914|NCT01094782|50574132|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
25258915|NCT01094782|50574133|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
25258916|NCT01094782|50574134|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
25258917|NCT01094782|50574129|FG000|Overall Study|Unable to Complete Questionnaires|0|||
25258918|NCT01094782|50574130|FG001|Overall Study|Unable to Complete Questionnaires|1|||
25258919|NCT01094782|50574131|FG002|Overall Study|Unable to Complete Questionnaires|0|||
25258920|NCT01094782|50574132|FG003|Overall Study|Unable to Complete Questionnaires|0|||
25258921|NCT01094782|50574133|FG004|Overall Study|Unable to Complete Questionnaires|0|||
25258922|NCT01094782|50574134|FG005|Overall Study|Unable to Complete Questionnaires|0|||
25258923|NCT01094782|50574129|FG000|Overall Study|Healthy Subject Had Pain|0|||
25258924|NCT01094782|50574130|FG001|Overall Study|Healthy Subject Had Pain|1|||
25258925|NCT01094782|50574131|FG002|Overall Study|Healthy Subject Had Pain|0|||
25258926|NCT01094782|50574132|FG003|Overall Study|Healthy Subject Had Pain|0|||
25258927|NCT01094782|50574133|FG004|Overall Study|Healthy Subject Had Pain|0|||
25258928|NCT01094782|50574134|FG005|Overall Study|Healthy Subject Had Pain|0|||
25258929|NCT01094782|50574129|FG000|Overall Study|Hypertension|0|||
25258930|NCT01094782|50574130|FG001|Overall Study|Hypertension|0|||
25258931|NCT01094782|50574131|FG002|Overall Study|Hypertension|1|||
25258932|NCT01094782|50574132|FG003|Overall Study|Hypertension|0|||
25258933|NCT01094782|50574133|FG004|Overall Study|Hypertension|0|||
25258934|NCT01094782|50574134|FG005|Overall Study|Hypertension|0|||
25258935|NCT01094782|50574129|FG000|Overall Study|Wrong Pain Condition|0|||
25258936|NCT01094782|50574130|FG001|Overall Study|Wrong Pain Condition|0|||
25258937|NCT01094782|50574131|FG002|Overall Study|Wrong Pain Condition|0|||
25258938|NCT01094782|50574132|FG003|Overall Study|Wrong Pain Condition|2|||
25258939|NCT01094782|50574133|FG004|Overall Study|Wrong Pain Condition|1|||
25258940|NCT01094782|50574134|FG005|Overall Study|Wrong Pain Condition|1|||
25258941|NCT01094782|50574129|FG000|Overall Study|Recent Interventional Injection|0|||
25258942|NCT01094782|50574130|FG001|Overall Study|Recent Interventional Injection|0|||
25258943|NCT01094782|50574131|FG002|Overall Study|Recent Interventional Injection|0|||
25258944|NCT01094782|50574132|FG003|Overall Study|Recent Interventional Injection|0|||
25258945|NCT01094782|50574133|FG004|Overall Study|Recent Interventional Injection|0|||
25258946|NCT01094782|50574134|FG005|Overall Study|Recent Interventional Injection|1|||
25258947|NCT01094782|50574129|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
25258948|NCT01094782|50574130|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
25258949|NCT01094782|50574131|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
25258950|NCT01094782|50574132|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
25258951|NCT01094782|50574133|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
25258952|NCT01094782|50574134|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
25258953|NCT01094782|50574129|FG000|Overall Study|Noncompliance With Study Schedule|0|||
25258954|NCT01094782|50574130|FG001|Overall Study|Noncompliance With Study Schedule|0|||
25258955|NCT01094782|50574131|FG002|Overall Study|Noncompliance With Study Schedule|0|||
25258956|NCT01094782|50574132|FG003|Overall Study|Noncompliance With Study Schedule|1|||
25258957|NCT01094782|50574133|FG004|Overall Study|Noncompliance With Study Schedule|0|||
25258958|NCT01094782|50574134|FG005|Overall Study|Noncompliance With Study Schedule|0|||
25258959|NCT01097044|50574150|FG000|Overall Study|Withdrawal by Subject|4|||
25258960|NCT01097044|50574151|FG001|Overall Study|Withdrawal by Subject|4|||
25258961|NCT01097044|50574150|FG000|Overall Study|Lost to Follow-up|1|||
25258962|NCT01097044|50574151|FG001|Overall Study|Lost to Follow-up|0|||
25258963|NCT01097044|50574150|FG000|Overall Study|Withdrawal by Sponsor|0|||
25258964|NCT01097044|50574151|FG001|Overall Study|Withdrawal by Sponsor|1|||
25258965|NCT01322009|50574161|FG000|Overall Study|Death|0|||
25258966|NCT01322009|50574162|FG001|Overall Study|Death|1|||
25258967|NCT01322009|50574161|FG000|Overall Study|Adverse Event|0|||
25258968|NCT01322009|50574162|FG001|Overall Study|Adverse Event|1|||
25258969|NCT01322009|50574161|FG000|Overall Study|ng tube discontinued|0|||
25258970|NCT01322009|50574162|FG001|Overall Study|ng tube discontinued|1|||
25258971|NCT01321697|50574168|FG000|Overall Study|Study Terminated|7|||
25258972|NCT01320683|50574172|FG000|Overall Study|Positive antibody response|1|||
25258973|NCT01320293|50574176|FG000|Overall Study|Lack of Efficacy|1|||
25258974|NCT01320293|50574176|FG000|Overall Study|Adverse Event|1|||
25258975|NCT01318811|50574182|FG000|Overall Study|Physician Decision|1|||
25258976|NCT01318811|50574183|FG001|Overall Study|Physician Decision|1|||
25258977|NCT01318811|50574182|FG000|Overall Study|CRRT stopped for head CT|0|||
25258978|NCT01318811|50574183|FG001|Overall Study|CRRT stopped for head CT|1|||
25258979|NCT01318811|50574182|FG000|Overall Study|Death|0|||
25258980|NCT01318811|50574183|FG001|Overall Study|Death|1|||
25258981|NCT01318811|50574182|FG000|Overall Study|CRRT stopped for head MRI|0|||
25258982|NCT01318811|50574183|FG001|Overall Study|CRRT stopped for head MRI|1|||
25258983|NCT01093846|50574192|FG000|Overall Study|Adverse Event|0|||
25258984|NCT01093846|50574193|FG001|Overall Study|Adverse Event|0|||
25258985|NCT01093846|50574194|FG002|Overall Study|Adverse Event|1|||
25080459|NCT02413346|50189020|FG000|Overall Study|Adverse Event|6|||
25258986|NCT01093846|50574192|FG000|Overall Study|Lack of Efficacy|0|||
25258987|NCT01093846|50574193|FG001|Overall Study|Lack of Efficacy|0|||
25258988|NCT01093846|50574194|FG002|Overall Study|Lack of Efficacy|4|||
25258989|NCT01093846|50574192|FG000|Overall Study|Condition no longer required study drug|1|||
25258990|NCT01093846|50574193|FG001|Overall Study|Condition no longer required study drug|1|||
25258991|NCT01093846|50574194|FG002|Overall Study|Condition no longer required study drug|1|||
25258992|NCT01093846|50574192|FG000|Overall Study|Administrative Problems|18|||
25258993|NCT01093846|50574193|FG001|Overall Study|Administrative Problems|17|||
25258994|NCT01093846|50574194|FG002|Overall Study|Administrative Problems|15|||
25258995|NCT01315847|50574202|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
25258996|NCT01315847|50574203|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
25258997|NCT01315847|50574202|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
25258998|NCT01315847|50574203|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
25258999|NCT01093534|50574212|FG000|Overall Study|Adverse Event|2|||
25259000|NCT01093534|50574213|FG001|Overall Study|Adverse Event|5|||
25259001|NCT01093534|50574214|FG002|Overall Study|Adverse Event|2|||
25259002|NCT01093534|50574212|FG000|Overall Study|Lack of Efficacy|2|||
25259003|NCT01093534|50574213|FG001|Overall Study|Lack of Efficacy|1|||
25259004|NCT01093534|50574214|FG002|Overall Study|Lack of Efficacy|1|||
25259005|NCT01093534|50574212|FG000|Overall Study|Withdrawal by Subject|5|||
25259006|NCT01093534|50574213|FG001|Overall Study|Withdrawal by Subject|7|||
25259007|NCT01093534|50574214|FG002|Overall Study|Withdrawal by Subject|2|||
25259008|NCT01093534|50574212|FG000|Overall Study|Other|1|||
25259009|NCT01093534|50574213|FG001|Overall Study|Other|3|||
25259010|NCT01093534|50574214|FG002|Overall Study|Other|4|||
25259011|NCT01314911|50574225|FG000|Overall Study|Lost to Follow-up|3|||
25259012|NCT01314911|50574226|FG001|Overall Study|Lost to Follow-up|2|||
25259013|NCT01314911|50574225|FG000|Overall Study|Withdrawal by Subject|1|||
25259014|NCT01314911|50574226|FG001|Overall Study|Withdrawal by Subject|3|||
25259015|NCT01314911|50574225|FG000|Overall Study|Received Non-randomized Study Drug|0|||
25259016|NCT01314911|50574226|FG001|Overall Study|Received Non-randomized Study Drug|1|||
25259017|NCT01314911|50574225|FG000|Overall Study|Never Started Treatment|1|||
25259018|NCT01314911|50574226|FG001|Overall Study|Never Started Treatment|0|||
25259019|NCT01093222|50574232|FG000|Overall Study|Ineligible|6|||
25259020|NCT01093222|50574232|FG000|Overall Study|Adverse Event|7|||
25259021|NCT01093222|50574232|FG000|Overall Study|Progression/relapse|24|||
25259022|NCT01093222|50574232|FG000|Overall Study|Death|2|||
25259023|NCT01093222|50574232|FG000|Overall Study|Not protocol specified|1|||
25259024|NCT01313663|50574238|FG000|Overall Study|Study Closed/Terminated|2|||
25259025|NCT01313663|50574239|FG001|Overall Study|Study Closed/Terminated|4|||
25259026|NCT01313663|50574238|FG000|Overall Study|Lost to Follow-up|0|||
25259027|NCT01313663|50574239|FG001|Overall Study|Lost to Follow-up|1|||
25259028|NCT01313663|50574238|FG000|Overall Study|Physician Decision|0|||
25259029|NCT01313663|50574239|FG001|Overall Study|Physician Decision|2|||
25259030|NCT01313663|50574238|FG000|Overall Study|Withdrawal by Subject|2|||
25259031|NCT01313663|50574239|FG001|Overall Study|Withdrawal by Subject|1|||
25259032|NCT01092832|50574247|FG000|Overall Study|Other|1|||
25259033|NCT01092832|50574248|FG001|Overall Study|Other|0|||
25259034|NCT01313273|50574256|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
25259035|NCT01313273|50574257|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
25259036|NCT01313273|50574256|FG000|Overall Study|Withdrawal by Subject|1|||
25259037|NCT01313273|50574257|FG001|Overall Study|Withdrawal by Subject|0|||
25259038|NCT01313273|50574256|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
25259039|NCT01313273|50574257|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
25259040|NCT01091974|50574267|FG000|Overall Study|Did not start intervention|3|||
25259041|NCT01091974|50574268|FG001|Overall Study|Did not start intervention|1|||
25259042|NCT01091974|50574269|FG002|Overall Study|Did not start intervention|3|||
25259043|NCT01091974|50574270|FG003|Overall Study|Did not start intervention|1|||
25259044|NCT01091974|50574267|FG000|Overall Study|resumed sleep medication|0|||
25259045|NCT01091974|50574268|FG001|Overall Study|resumed sleep medication|0|||
25259046|NCT01091974|50574269|FG002|Overall Study|resumed sleep medication|1|||
25259047|NCT01091974|50574270|FG003|Overall Study|resumed sleep medication|2|||
25259048|NCT01091974|50574267|FG000|Overall Study|Withdrawal by Subject|1|||
25259049|NCT01091974|50574268|FG001|Overall Study|Withdrawal by Subject|3|||
25259050|NCT01091974|50574269|FG002|Overall Study|Withdrawal by Subject|2|||
25259051|NCT01091974|50574270|FG003|Overall Study|Withdrawal by Subject|2|||
25259052|NCT01091974|50574267|FG000|Overall Study|side-effects|1|||
25259053|NCT01091974|50574268|FG001|Overall Study|side-effects|1|||
25259054|NCT01091974|50574269|FG002|Overall Study|side-effects|0|||
25259055|NCT01091974|50574270|FG003|Overall Study|side-effects|2|||
25259056|NCT01313117|50574280|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
25259057|NCT01313117|50574280|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
25259058|NCT01313039|50574285|FG000|Overall Study|Physician Decision|1|||
25259059|NCT01313039|50574285|FG000|Overall Study|Adverse Event|1|||
25259060|NCT01091662|50574291|FG000|Overall Study|Adverse Event|1|||
25259061|NCT01091662|50574292|FG001|Overall Study|Adverse Event|9|||
25259062|NCT01091662|50574291|FG000|Overall Study|Physician Decision|1|||
25259063|NCT01091662|50574292|FG001|Overall Study|Physician Decision|1|||
25259064|NCT01091662|50574291|FG000|Overall Study|Withdrawal by Subject|7|||
25259065|NCT01091662|50574292|FG001|Overall Study|Withdrawal by Subject|6|||
25259066|NCT01091662|50574291|FG000|Overall Study|met exit criteria|7|||
25259067|NCT01091662|50574292|FG001|Overall Study|met exit criteria|13|||
25259068|NCT01091662|50574291|FG000|Overall Study|met exclusion criteria|1|||
25259069|NCT01091662|50574292|FG001|Overall Study|met exclusion criteria|0|||
25259070|NCT01091662|50574291|FG000|Overall Study|Lost to Follow-up|0|||
25259071|NCT01091662|50574292|FG001|Overall Study|Lost to Follow-up|1|||
25259072|NCT01091662|50574291|FG000|Overall Study|Pregnancy|0|||
25259073|NCT01091662|50574292|FG001|Overall Study|Pregnancy|1|||
25259074|NCT01091662|50574291|FG000|Overall Study|Protocol Violation|0|||
25259075|NCT01091662|50574292|FG001|Overall Study|Protocol Violation|2|||
25259076|NCT01091662|50574291|FG000|Overall Study|unable to swallow capsule|0|||
25259077|NCT01091662|50574292|FG001|Overall Study|unable to swallow capsule|1|||
25259078|NCT01312961|50574305|FG000|Overall Study|Adverse Event|3|||
25259079|NCT01312961|50574306|FG001|Overall Study|Adverse Event|3|||
25259080|NCT01312961|50574305|FG000|Overall Study|Lack of Efficacy|11|||
25259081|NCT01312961|50574306|FG001|Overall Study|Lack of Efficacy|1|||
25259082|NCT01312961|50574305|FG000|Overall Study|Poor compliance to protocol|1|||
25259083|NCT01312961|50574306|FG001|Overall Study|Poor compliance to protocol|0|||
25259084|NCT01312961|50574305|FG000|Overall Study|Other than specified above|2|||
25259085|NCT01312961|50574306|FG001|Overall Study|Other than specified above|3|||
25259086|NCT01311557|50574315|FG000|Overall Study|Serious adverse event|0|||
25259087|NCT01311557|50574316|FG001|Overall Study|Serious adverse event|1|||
25259088|NCT01311557|50574315|FG000|Overall Study|Protocol Violation|4|||
25259089|NCT01311557|50574316|FG001|Overall Study|Protocol Violation|2|||
25259090|NCT01311557|50574315|FG000|Overall Study|Lost to Follow-up|0|||
25259091|NCT01311557|50574316|FG001|Overall Study|Lost to Follow-up|1|||
25259092|NCT01311557|50574315|FG000|Overall Study|Withdrawal by Subject|1|||
25259093|NCT01311557|50574316|FG001|Overall Study|Withdrawal by Subject|2|||
25259094|NCT01310777|50574325|FG000|Overall Study|Adverse Event|23|||
25259095|NCT01310777|50574326|FG001|Overall Study|Adverse Event|1|||
25259096|NCT01310777|50574327|FG002|Overall Study|Adverse Event|15|||
25259097|NCT01310777|50574325|FG000|Overall Study|Lost to Follow-up|0|||
25259098|NCT01310777|50574326|FG001|Overall Study|Lost to Follow-up|4|||
25259099|NCT01310777|50574327|FG002|Overall Study|Lost to Follow-up|1|||
25259100|NCT01310777|50574325|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
25259101|NCT01310777|50574326|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
25259102|NCT01310777|50574327|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
25259103|NCT01310777|50574325|FG000|Overall Study|Inadequate Control of IOP|5|||
25259104|NCT01310777|50574326|FG001|Overall Study|Inadequate Control of IOP|7|||
25259105|NCT01310777|50574327|FG002|Overall Study|Inadequate Control of IOP|10|||
25259106|NCT01310777|50574325|FG000|Overall Study|Other|4|||
25259107|NCT01310777|50574326|FG001|Overall Study|Other|1|||
25259108|NCT01310777|50574327|FG002|Overall Study|Other|2|||
25259109|NCT01310699|50574337|FG000|Overall Study|Patients did not complete tandem.|4|||
25259110|NCT01310699|50574338|FG001|Overall Study|Patients did not complete tandem.|6|||
25259111|NCT01310075|50574348|FG000|Overall Study|Lost to Follow-up|1|||
25259112|NCT01310075|50574349|FG001|Overall Study|Lost to Follow-up|0|||
25259113|NCT01310075|50574348|FG000|Overall Study|Physician Decision|10|||
25259114|NCT01310075|50574349|FG001|Overall Study|Physician Decision|7|||
25259115|NCT01310075|50574348|FG000|Overall Study|Protocol Violation|2|||
25259116|NCT01310075|50574349|FG001|Overall Study|Protocol Violation|2|||
25259117|NCT01310075|50574348|FG000|Overall Study|Withdrawal by Subject|1|||
25259118|NCT01310075|50574349|FG001|Overall Study|Withdrawal by Subject|1|||
25259119|NCT01309997|50574357|FG000|Overall Study|Adverse Event|1|||
25259120|NCT01309997|50574358|FG001|Overall Study|Adverse Event|0|||
25259121|NCT01309997|50574357|FG000|Overall Study|Death|1|||
25259122|NCT01309997|50574358|FG001|Overall Study|Death|3|||
25259123|NCT01309997|50574357|FG000|Overall Study|Lack of Efficacy|2|||
25259124|NCT01309997|50574358|FG001|Overall Study|Lack of Efficacy|2|||
25259125|NCT01309997|50574357|FG000|Overall Study|Withdrawal by Subject|1|||
25259126|NCT01309997|50574358|FG001|Overall Study|Withdrawal by Subject|1|||
25259127|NCT01309919|50574377|FG000|Overall Study|Did not receive a postpartum IUD|17|||
25259128|NCT01309919|50574378|FG001|Overall Study|Did not receive a postpartum IUD|48|||
25259129|NCT01309841|50574387|FG000|Overall Study|Other|0|||
25259130|NCT01309841|50574388|FG001|Overall Study|Other|1|||
25259131|NCT01309841|50574389|FG002|Overall Study|Other|1|||
25259132|NCT01309841|50574387|FG000|Overall Study|Lost to Follow-up|7|||
25259133|NCT01309841|50574388|FG001|Overall Study|Lost to Follow-up|6|||
25259134|NCT01309841|50574389|FG002|Overall Study|Lost to Follow-up|4|||
25259135|NCT01309841|50574387|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
25259136|NCT01309841|50574388|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
25259137|NCT01309841|50574389|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
25259138|NCT01309841|50574387|FG000|Overall Study|Lack of Efficacy|0|||
25259139|NCT01309841|50574388|FG001|Overall Study|Lack of Efficacy|0|||
25259140|NCT01309841|50574389|FG002|Overall Study|Lack of Efficacy|2|||
25259141|NCT01309841|50574387|FG000|Overall Study|Adverse Event|9|||
25259142|NCT01309841|50574388|FG001|Overall Study|Adverse Event|22|||
25259143|NCT01309841|50574389|FG002|Overall Study|Adverse Event|11|||
25259144|NCT01309841|50574387|FG000|Overall Study|Death|1|||
25259145|NCT01309841|50574388|FG001|Overall Study|Death|0|||
25259146|NCT01309841|50574389|FG002|Overall Study|Death|0|||
25259147|NCT01309841|50574387|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
25259148|NCT01309841|50574388|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
25259149|NCT01309841|50574389|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
25259150|NCT01309841|50574387|FG000|Overall Study|Withdrawal by Subject|17|||
25259151|NCT01309841|50574388|FG001|Overall Study|Withdrawal by Subject|6|||
25259152|NCT01309841|50574389|FG002|Overall Study|Withdrawal by Subject|13|||
25259153|NCT01309841|50574387|FG000|Overall Study|Did Not Receive Treatment|2|||
25259154|NCT01309841|50574388|FG001|Overall Study|Did Not Receive Treatment|0|||
25259155|NCT01309841|50574389|FG002|Overall Study|Did Not Receive Treatment|1|||
25259156|NCT01309841|50574387|FG000|Overall Study|Severe non-compliance with protocol|0|||
25259157|NCT01309841|50574388|FG001|Overall Study|Severe non-compliance with protocol|5|||
25259158|NCT01309841|50574389|FG002|Overall Study|Severe non-compliance with protocol|2|||
25259159|NCT01308749|50574399|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
25259160|NCT01308749|50574400|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
25259161|NCT01308749|50574399|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
25259162|NCT01308749|50574400|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
25259163|NCT01308749|50574399|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
25259164|NCT01308749|50574400|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
25259165|NCT01307891|50574422|FG000|Overall Study|Progressive Disease|3|||
25259166|NCT01307891|50574423|FG001|Overall Study|Progressive Disease|1|||
25259167|NCT01307579|50574431|FG000|Overall Study|Death|3|||
25259168|NCT01307579|50574432|FG001|Overall Study|Death|6|||
25259169|NCT01307579|50574431|FG000|Overall Study|Physician Decision|26|||
25259170|NCT01307579|50574432|FG001|Overall Study|Physician Decision|29|||
25259171|NCT01307579|50574431|FG000|Overall Study|Withdrawal by Subject|7|||
25259172|NCT01307579|50574432|FG001|Overall Study|Withdrawal by Subject|3|||
25259173|NCT01307579|50574431|FG000|Overall Study|Institutional diagnosis of IFD|21|||
25259174|NCT01307579|50574432|FG001|Overall Study|Institutional diagnosis of IFD|36|||
25259175|NCT01307579|50574431|FG000|Overall Study|Begin conditioning for HSCT|42|||
25259176|NCT01307579|50574432|FG001|Overall Study|Begin conditioning for HSCT|44|||
25259177|NCT01307579|50574431|FG000|Overall Study|Refractory or relapsed AML|38|||
25259178|NCT01307579|50574432|FG001|Overall Study|Refractory or relapsed AML|23|||
25259179|NCT01307579|50574431|FG000|Overall Study|Ineligible|3|||
25259180|NCT01307579|50574432|FG001|Overall Study|Ineligible|4|||
25259181|NCT01057693|50574438|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
25259182|NCT01057693|50574439|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
25259183|NCT01057693|50574440|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
25259184|NCT01057693|50574438|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
25259185|NCT01057693|50574439|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
25259186|NCT01057693|50574440|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
25259187|NCT01057693|50574438|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
25259188|NCT01057693|50574439|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
25259189|NCT01057693|50574440|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
25259190|NCT01057693|50574438|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
25259191|NCT01057693|50574439|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
25259192|NCT01057693|50574440|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
25259193|NCT01057693|50574438|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
25259194|NCT01057693|50574439|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
25259195|NCT01057693|50574440|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
25259196|NCT01057693|50574438|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
25259197|NCT01057693|50574439|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
25259198|NCT01057693|50574440|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
25259199|NCT01057693|50574438|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
25259200|NCT01057693|50574439|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
25259201|NCT01057693|50574440|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
25259202|NCT01057693|50574438|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
25259203|NCT01057693|50574439|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
25259204|NCT01057693|50574440|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
25259205|NCT01057693|50574438|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
25259206|NCT01057693|50574439|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
25259207|NCT01057693|50574440|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
25259208|NCT01057693|50574438|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
25259209|NCT01057693|50574439|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
25259210|NCT01057693|50574440|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
25259211|NCT01057693|50574438|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
25259212|NCT01057693|50574439|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
25259213|NCT01057693|50574440|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
25259214|NCT01057693|50574438|FG000|Between Single-Blind and Double-Blind|Other|6|||
25259215|NCT01057693|50574439|FG001|Between Single-Blind and Double-Blind|Other|0|||
25259216|NCT01057693|50574440|FG002|Between Single-Blind and Double-Blind|Other|0|||
24993606|NCT03806127|50084075|FG000|Overall Study|Could Not Come Due to Covid|1|||
24993607|NCT03806127|50084076|FG001|Overall Study|Could Not Come Due to Covid|0|||
24993608|NCT03806127|50084075|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
24993609|NCT03806127|50084076|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
24993610|NCT03806127|50084075|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
24993611|NCT03806127|50084076|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
24993612|NCT03806127|50084075|FG000|Overall Study|Covid 19 Restrictions|2|||
24993613|NCT03806127|50084076|FG001|Overall Study|Covid 19 Restrictions|0|||
24993614|NCT03806127|50084075|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
24993615|NCT03806127|50084076|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
24993616|NCT03806127|50084075|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
24993617|NCT03806127|50084076|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
24993618|NCT02843074|50084082|FG000|Overall Study|Withdrawal by Subject|5|||
24993619|NCT02843074|50084082|FG000|Overall Study|Progressive disease|1|||
24993620|NCT02843074|50084082|FG000|Overall Study|Physician Decision|1|||
24993621|NCT02843074|50084082|FG000|Overall Study|Lost to Follow-up|1|||
24993622|NCT02843074|50084082|FG000|Overall Study|Death|9|||
25259217|NCT01057693|50574438|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
25259218|NCT01057693|50574439|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
25259219|NCT01057693|50574440|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
25259220|NCT01057693|50574438|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
25259221|NCT01057693|50574439|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
25259222|NCT01057693|50574440|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
25259223|NCT01057693|50574438|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
25259224|NCT01057693|50574439|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
25259225|NCT01057693|50574440|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
25080460|NCT02413346|50189021|FG001|Overall Study|Adverse Event|6|||
24993653|NCT03650400|50084113|FG000|Overall Study|Study terminated by sponsor|0|||
24993654|NCT03650400|50084114|FG001|Overall Study|Study terminated by sponsor|5|||
24993655|NCT00038103|50084122|FG000|Overall Study|Adverse Event|5|||
24993656|NCT00038103|50084123|FG001|Overall Study|Adverse Event|6|||
24993657|NCT00038103|50084122|FG000|Overall Study|Lack of Efficacy|48|||
24993658|NCT00038103|50084123|FG001|Overall Study|Lack of Efficacy|41|||
24993659|NCT00038103|50084122|FG000|Overall Study|Withdrawal by Subject|0|||
24993660|NCT00038103|50084123|FG001|Overall Study|Withdrawal by Subject|3|||
24993661|NCT00038103|50084122|FG000|Overall Study|Lost to Follow-up|0|||
24993662|NCT00038103|50084123|FG001|Overall Study|Lost to Follow-up|3|||
24993663|NCT00038103|50084122|FG000|Overall Study|Protocol Violation|0|||
24993664|NCT00038103|50084123|FG001|Overall Study|Protocol Violation|2|||
24993665|NCT00038103|50084122|FG000|Overall Study|Sponsor Decision|0|||
24993666|NCT00038103|50084123|FG001|Overall Study|Sponsor Decision|1|||
24993667|NCT00038103|50084122|FG000|Overall Study|Randomized/never treated|2|||
24993668|NCT00038103|50084123|FG001|Overall Study|Randomized/never treated|0|||
24993669|NCT03680742|50084129|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
24993670|NCT03678870|50084135|FG000|Overall Study|prescribed non- protocol medications|10|||
24993671|NCT03678870|50084136|FG001|Overall Study|prescribed non- protocol medications|6|||
24993672|NCT03678870|50084135|FG000|Overall Study|Lost to Follow-up|3|||
24993673|NCT03678870|50084136|FG001|Overall Study|Lost to Follow-up|2|||
24993674|NCT03805971|50084142|FG000|Overall Study|Withdrawal by Subject|1|||
24993675|NCT03805971|50084142|FG000|Overall Study|Protocol Violation|2|||
24993676|NCT03032380|50084149|FG000|Overall Study|Adverse Event|0|||
24993677|NCT03032380|50084150|FG001|Overall Study|Adverse Event|1|||
24993678|NCT03032380|50084149|FG000|Overall Study|Lack of Efficacy|1|||
24993679|NCT03032380|50084150|FG001|Overall Study|Lack of Efficacy|0|||
24993680|NCT03032380|50084149|FG000|Overall Study|Withdrawal by Subject|2|||
24993681|NCT03032380|50084150|FG001|Overall Study|Withdrawal by Subject|3|||
24993682|NCT03032380|50084149|FG000|Overall Study|Recovery|0|||
24993683|NCT03032380|50084150|FG001|Overall Study|Recovery|1|||
24993684|NCT03032380|50084149|FG000|Overall Study|Death|39|||
24993685|NCT03032380|50084150|FG001|Overall Study|Death|34|||
24993686|NCT03032380|50084149|FG000|Overall Study|Other - Miscellaneous|0|||
24993687|NCT03032380|50084150|FG001|Overall Study|Other - Miscellaneous|1|||
24993688|NCT03519854|50084174|FG000|Overall Study|Technical Error|0|||
24993689|NCT03519854|50084175|FG001|Overall Study|Technical Error|0|||
24993690|NCT03519854|50084176|FG002|Overall Study|Technical Error|1|||
24993691|NCT03519854|50084177|FG003|Overall Study|Technical Error|0|||
24993692|NCT03519854|50084178|FG004|Overall Study|Technical Error|0|||
24993693|NCT03519854|50084179|FG005|Overall Study|Technical Error|0|||
24993694|NCT03519854|50084180|FG006|Overall Study|Technical Error|0|||
24993695|NCT03519854|50084181|FG007|Overall Study|Technical Error|0|||
24993696|NCT03519854|50084182|FG008|Overall Study|Technical Error|0|||
24993697|NCT03519854|50084183|FG009|Overall Study|Technical Error|0|||
24993698|NCT03519854|50084184|FG010|Overall Study|Technical Error|0|||
24993699|NCT03519854|50084185|FG011|Overall Study|Technical Error|0|||
24993700|NCT03519854|50084186|FG012|Overall Study|Technical Error|0|||
24993701|NCT03519854|50084187|FG013|Overall Study|Technical Error|0|||
24993702|NCT03519854|50084188|FG014|Overall Study|Technical Error|0|||
24993703|NCT03519854|50084189|FG015|Overall Study|Technical Error|0|||
24993704|NCT03519854|50084190|FG016|Overall Study|Technical Error|0|||
24993705|NCT03519854|50084191|FG017|Overall Study|Technical Error|0|||
24993706|NCT03479216|50084231|FG000|Overall Study|Withdrawal by Subject|3|||
24993707|NCT03479216|50084232|FG001|Overall Study|Withdrawal by Subject|2|||
24993708|NCT03479216|50084231|FG000|Overall Study|Physician Decision|2|||
24993709|NCT03479216|50084232|FG001|Overall Study|Physician Decision|3|||
24993710|NCT03518840|50084238|FG000|Overall Study|Lost to Follow-up|6|||
24993711|NCT03436082|50084247|FG000|Overall Study|Did not undergo procedure|1|||
24993712|NCT03436082|50084248|FG001|Overall Study|Did not undergo procedure|0|||
24993713|NCT03677934|50084256|FG000|Overall Study|Adverse Event|1|||
24993714|NCT03677934|50084257|FG001|Overall Study|Adverse Event|1|||
24993715|NCT03677934|50084256|FG000|Overall Study|Death|8|||
24993716|NCT03677934|50084257|FG001|Overall Study|Death|4|||
24993717|NCT03677934|50084256|FG000|Overall Study|Lost to Follow-up|3|||
24993718|NCT03677934|50084257|FG001|Overall Study|Lost to Follow-up|0|||
24993719|NCT03677934|50084256|FG000|Overall Study|Non-Compliance With Study Drug|1|||
24993720|NCT03677934|50084257|FG001|Overall Study|Non-Compliance With Study Drug|0|||
24993721|NCT03677934|50084256|FG000|Overall Study|Physician Decision|0|||
24993722|NCT03677934|50084257|FG001|Overall Study|Physician Decision|1|||
24993723|NCT03677934|50084256|FG000|Overall Study|Withdrawal by Subject|1|||
24993724|NCT03677934|50084257|FG001|Overall Study|Withdrawal by Subject|7|||
24993725|NCT03435692|50084269|FG000|Overall Study|Lack of Efficacy|2|||
24993726|NCT03435692|50084270|FG001|Overall Study|Lack of Efficacy|2|||
24993727|NCT03435692|50084271|FG002|Overall Study|Lack of Efficacy|0|||
24993728|NCT03475316|50084285|FG000|6 Month Intervention|Adverse Event|2|||
24993729|NCT03475316|50084286|FG001|6 Month Intervention|Adverse Event|1|||
24993730|NCT03475316|50084285|FG000|6 Month Intervention|Withdrawal by Subject|2|||
24993731|NCT03475316|50084286|FG001|6 Month Intervention|Withdrawal by Subject|0|||
24993732|NCT03475316|50084285|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
24993733|NCT03475316|50084286|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
24993734|NCT03475316|50084285|FG000|9 Months|Study stopped due to COVID pandemic|3|||
24993735|NCT03475316|50084286|FG001|9 Months|Study stopped due to COVID pandemic|4|||
24993736|NCT03673956|50084296|FG000|Overall Study|Lost to Follow-up|1|||
24993737|NCT03673956|50084297|FG001|Overall Study|Lost to Follow-up|0|||
24993738|NCT03673956|50084298|FG002|Overall Study|Lost to Follow-up|0|||
24993739|NCT03673956|50084299|FG003|Overall Study|Lost to Follow-up|0|||
24993740|NCT03673956|50084296|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
24993741|NCT03673956|50084297|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
24993742|NCT03673956|50084298|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
24993743|NCT03673956|50084299|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
24993744|NCT03517436|50084309|FG000|Overall Study|Death|3|||
24993745|NCT03517436|50084309|FG000|Overall Study|Withdrawal by Subject|4|||
24993746|NCT03517436|50084309|FG000|Overall Study|Did not receive study valve.|1|||
24993747|NCT03673098|50084315|FG000|Overall Study|Lost to Follow-up|2|||
24993748|NCT03673098|50084316|FG001|Overall Study|Lost to Follow-up|3|||
24993749|NCT03673098|50084315|FG000|Overall Study|Withdrawal by Subject|6|||
24993750|NCT03673098|50084316|FG001|Overall Study|Withdrawal by Subject|1|||
24993751|NCT03673098|50084315|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
24993752|NCT03673098|50084316|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
24993753|NCT03435224|50084329|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
24993754|NCT03672396|50084333|FG000|Overall Study|Withdrawal by Subject|4|||
24993755|NCT03672396|50084333|FG000|Overall Study|Physician Decision|1|||
24993756|NCT03672396|50084333|FG000|Overall Study|Adverse Event|1|||
24993757|NCT03434834|50084337|FG000|Overall Study|unable to swallow OCT probe|16|||
24993758|NCT03605862|50084343|FG000|Overall Study|Withdrawal by Subject|12|||
24993759|NCT03605862|50084344|FG001|Overall Study|Withdrawal by Subject|9|||
24993760|NCT03605862|50084343|FG000|Overall Study|Adverse Event|2|||
24993761|NCT03605862|50084344|FG001|Overall Study|Adverse Event|1|||
24993762|NCT03605862|50084343|FG000|Overall Study|Physician Decision|3|||
24993763|NCT03605862|50084344|FG001|Overall Study|Physician Decision|1|||
25080461|NCT02413346|50189020|FG000|Overall Study|Withdrawal by Subject|30|||
25080462|NCT02413346|50189021|FG001|Overall Study|Withdrawal by Subject|40|||
25080463|NCT02413346|50189020|FG000|Overall Study|Lost to Follow-up|17|||
25080464|NCT02413346|50189021|FG001|Overall Study|Lost to Follow-up|21|||
25080465|NCT02413346|50189020|FG000|Overall Study|Protocol Violation|2|||
25080466|NCT02413346|50189021|FG001|Overall Study|Protocol Violation|0|||
25080467|NCT02413346|50189020|FG000|Overall Study|Other Miscellaneous Reasons|4|||
25080468|NCT02413346|50189021|FG001|Overall Study|Other Miscellaneous Reasons|3|||
25080469|NCT03390101|50189034|FG000|Weeks 0-12|Withdrawal by Subject|0|||
25080470|NCT03390101|50189035|FG001|Weeks 0-12|Withdrawal by Subject|1|||
25080471|NCT03390101|50189036|FG002|Weeks 0-12|Withdrawal by Subject|1|||
25080472|NCT03390101|50189034|FG000|Weeks 0-12|Lost to Follow-up|0|||
25080473|NCT03390101|50189035|FG001|Weeks 0-12|Lost to Follow-up|1|||
25080474|NCT03390101|50189036|FG002|Weeks 0-12|Lost to Follow-up|0|||
25080475|NCT03390101|50189034|FG000|Weeks 12-54|Withdrawal by Subject|0|||
25080476|NCT03390101|50189035|FG001|Weeks 12-54|Withdrawal by Subject|3|||
25080477|NCT03390101|50189036|FG002|Weeks 12-54|Withdrawal by Subject|1|||
25080478|NCT03390101|50189034|FG000|Weeks 12-54|Pregnancy|1|||
25080479|NCT03390101|50189035|FG001|Weeks 12-54|Pregnancy|0|||
25080480|NCT03390101|50189036|FG002|Weeks 12-54|Pregnancy|0|||
25080481|NCT03390101|50189034|FG000|Weeks 12-54|Adverse Event|2|||
25080482|NCT03390101|50189035|FG001|Weeks 12-54|Adverse Event|1|||
25080483|NCT03390101|50189036|FG002|Weeks 12-54|Adverse Event|1|||
25080484|NCT02732639|50189044|FG000|Overall Study|Lost to Follow-up|1|||
25080485|NCT02732561|50189050|FG000|Overall Study|Lost to Follow-up|1|||
25080486|NCT02732561|50189051|FG001|Overall Study|Lost to Follow-up|1|||
25080487|NCT02732561|50189050|FG000|Overall Study|Withdrawal by Subject|1|||
25080488|NCT02732561|50189051|FG001|Overall Study|Withdrawal by Subject|0|||
25080489|NCT02412878|50189059|FG000|Overall Study|Withdrawal by Subject|19|||
25080490|NCT02412878|50189060|FG001|Overall Study|Withdrawal by Subject|10|||
25080491|NCT02412878|50189059|FG000|Overall Study|Lost to Follow-up|2|||
25080492|NCT02412878|50189060|FG001|Overall Study|Lost to Follow-up|3|||
25080493|NCT02380742|50189068|FG000|Overall Study|Withdrawal by Subject|1|||
25080494|NCT02380742|50189069|FG001|Overall Study|Withdrawal by Subject|0|||
25080495|NCT02922725|50189078|FG000|Overall Study|Withdrawal by Subject|1|||
25080496|NCT02922725|50189079|FG001|Overall Study|Withdrawal by Subject|0|||
25080497|NCT02922725|50189080|FG002|Overall Study|Withdrawal by Subject|0|||
25080498|NCT02805257|50189089|FG000|Overall Study|Lost to Follow-up|7|||
25080499|NCT02805257|50189090|FG001|Overall Study|Lost to Follow-up|6|||
25080500|NCT02805257|50189089|FG000|Overall Study|Death|0|||
25080501|NCT02805257|50189090|FG001|Overall Study|Death|1|||
25080502|NCT04794803|50189098|FG000|Overall Study|Death|1|||
25080503|NCT04794803|50189099|FG001|Overall Study|Death|3|||
25080504|NCT04794803|50189098|FG000|Overall Study|Lost to Follow-up|2|||
25080505|NCT04794803|50189099|FG001|Overall Study|Lost to Follow-up|2|||
25080506|NCT04794803|50189098|FG000|Overall Study|Withdrawal by Subject|1|||
25080507|NCT04794803|50189099|FG001|Overall Study|Withdrawal by Subject|0|||
25080508|NCT04794803|50189098|FG000|Overall Study|Physician Decision|1|||
25080509|NCT04794803|50189099|FG001|Overall Study|Physician Decision|1|||
25080510|NCT04794803|50189098|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
25080511|NCT04794803|50189099|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
25080512|NCT04794803|50189098|FG000|Overall Study|Refused to continue the treatment|1|||
25080513|NCT04794803|50189099|FG001|Overall Study|Refused to continue the treatment|0|||
25080514|NCT04794803|50189098|FG000|Overall Study|Patient admitted to ICU|0|||
25080515|NCT04794803|50189099|FG001|Overall Study|Patient admitted to ICU|1|||
25080516|NCT01791595|50189112|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
25080517|NCT01791595|50189113|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
25080518|NCT01791595|50189114|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
25080519|NCT01791595|50189115|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
25080520|NCT01791595|50189116|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
25080521|NCT01791595|50189117|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
25080522|NCT01791595|50189118|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
25080523|NCT01791595|50189112|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
25080524|NCT01791595|50189113|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
25080525|NCT01791595|50189114|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
25080526|NCT01791595|50189115|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
25080527|NCT01791595|50189116|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
25080528|NCT01791595|50189117|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
25080529|NCT01791595|50189118|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
25080530|NCT01791595|50189112|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
25080531|NCT01791595|50189113|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
25080532|NCT01791595|50189114|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
25080533|NCT01791595|50189115|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
25080534|NCT01791595|50189116|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
25080535|NCT01791595|50189117|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
25080536|NCT01791595|50189118|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
25080537|NCT01791595|50189112|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
25080538|NCT01791595|50189113|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
25080539|NCT01791595|50189114|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
25080540|NCT01791595|50189115|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
25080541|NCT01791595|50189116|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
25080542|NCT01791595|50189117|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
25080543|NCT01791595|50189118|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
25080544|NCT01791595|50189112|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
25080545|NCT01791595|50189113|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
25080546|NCT01791595|50189114|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
25080547|NCT01791595|50189115|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
25080548|NCT01791595|50189116|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
25080549|NCT01791595|50189117|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
25080550|NCT01791595|50189118|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
25080551|NCT01791595|50189112|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
25080552|NCT01791595|50189113|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
25080553|NCT01791595|50189114|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
25080554|NCT01791595|50189115|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
25080555|NCT01791595|50189116|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
25080556|NCT01791595|50189117|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
25080557|NCT01791595|50189118|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
25080558|NCT01791595|50189112|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
25080559|NCT01791595|50189113|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
25080560|NCT01791595|50189114|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
25080561|NCT01791595|50189115|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
25080562|NCT01791595|50189116|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
25080563|NCT01791595|50189117|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
25080564|NCT01791595|50189118|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
25080565|NCT01791595|50189112|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
25080566|NCT01791595|50189113|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
25080567|NCT01791595|50189114|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
25080568|NCT01791595|50189115|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
25080569|NCT01791595|50189116|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
25080570|NCT01791595|50189117|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
25080571|NCT01791595|50189118|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
25080572|NCT01791595|50189112|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
25080573|NCT01791595|50189113|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
25080574|NCT01791595|50189114|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
25080575|NCT01791595|50189115|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
25080576|NCT01791595|50189116|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
25080577|NCT01791595|50189117|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
25080578|NCT01791595|50189118|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
25080579|NCT01791595|50189112|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
25080580|NCT01791595|50189113|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
25080581|NCT01791595|50189114|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
25080582|NCT01791595|50189115|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
25080583|NCT01791595|50189116|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
25080584|NCT01791595|50189117|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
25080585|NCT01791595|50189118|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
25080586|NCT01791595|50189112|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
25080587|NCT01791595|50189113|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
25080588|NCT01791595|50189114|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
25080589|NCT01791595|50189115|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
25080590|NCT01791595|50189116|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
25080591|NCT01791595|50189117|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
25080592|NCT01791595|50189118|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
25080593|NCT01791595|50189112|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
25080594|NCT01791595|50189113|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
25080595|NCT01791595|50189114|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
25080596|NCT01791595|50189115|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
25080597|NCT01791595|50189116|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
25080598|NCT01791595|50189117|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
25080599|NCT01791595|50189118|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
25080600|NCT01791595|50189112|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
25080601|NCT01791595|50189113|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
25080602|NCT01791595|50189114|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
25080603|NCT01791595|50189115|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
25080604|NCT01791595|50189116|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
25080605|NCT01791595|50189117|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
25080606|NCT01791595|50189118|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
25080607|NCT01791595|50189112|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
25080608|NCT01791595|50189113|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
25080609|NCT01791595|50189114|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
25080610|NCT01791595|50189115|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
25080611|NCT01791595|50189116|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
25080612|NCT01791595|50189117|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
25080613|NCT01791595|50189118|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
25080614|NCT01791595|50189112|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
25080615|NCT01791595|50189113|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
25080616|NCT01791595|50189114|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
25080617|NCT01791595|50189115|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
25080618|NCT01791595|50189116|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
25080619|NCT01791595|50189117|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
25080620|NCT01791595|50189118|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
25080621|NCT01791595|50189112|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
25080622|NCT01791595|50189113|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
25080623|NCT01791595|50189114|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
25080624|NCT01791595|50189115|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
25080625|NCT01791595|50189116|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
25080626|NCT01791595|50189117|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
25080627|NCT01791595|50189118|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
25080628|NCT01791595|50189112|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
25080629|NCT01791595|50189113|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
25080630|NCT01791595|50189114|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
25080631|NCT01791595|50189115|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
25080632|NCT01791595|50189116|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
25080633|NCT01791595|50189117|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
25080634|NCT01791595|50189118|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
25080635|NCT01791595|50189112|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
25080636|NCT01791595|50189113|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
25080637|NCT01791595|50189114|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
25080638|NCT01791595|50189115|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
25080639|NCT01791595|50189116|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
25080640|NCT01791595|50189117|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
25080641|NCT01791595|50189118|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
25080642|NCT01559363|50189171|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
25080643|NCT01559363|50189172|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
25080644|NCT01559363|50189173|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
25080645|NCT01559363|50189174|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
25080646|NCT01559363|50189175|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
25080647|NCT01559363|50189176|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
25080648|NCT01559363|50189171|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
25080649|NCT01559363|50189172|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
25080650|NCT01559363|50189173|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
25080651|NCT01559363|50189174|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
25080652|NCT01559363|50189175|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
25080653|NCT01559363|50189176|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
25080654|NCT01559363|50189171|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
25080655|NCT01559363|50189172|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
25080656|NCT01559363|50189173|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
25080657|NCT01559363|50189174|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
25080658|NCT01559363|50189175|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
25080659|NCT01559363|50189176|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
25080660|NCT01559363|50189171|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
25080661|NCT01559363|50189172|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
25080662|NCT01559363|50189173|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
25259226|NCT01057693|50574438|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
25080663|NCT01559363|50189174|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
25080664|NCT01559363|50189175|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
25080665|NCT01559363|50189176|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
25080666|NCT01559363|50189171|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
25080667|NCT01559363|50189172|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
25080668|NCT01559363|50189173|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
25080669|NCT01559363|50189174|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
25080670|NCT01559363|50189175|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
25080671|NCT01559363|50189176|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
25080672|NCT01559363|50189171|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
25080673|NCT01559363|50189172|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
25080674|NCT01559363|50189173|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
25080675|NCT01559363|50189174|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
25080676|NCT01559363|50189175|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
25080677|NCT01559363|50189176|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
25080678|NCT01559363|50189171|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
25080679|NCT01559363|50189172|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
25080680|NCT01559363|50189173|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
25080681|NCT01559363|50189174|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
25080682|NCT01559363|50189175|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
25080683|NCT01559363|50189176|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
25080684|NCT02732327|50189198|FG000|Overall Study|Protocol Violation|0|||
25080685|NCT02732327|50189199|FG001|Overall Study|Protocol Violation|1|||
25080686|NCT03179605|50189205|FG000|Overall Study|Withdrawal by Subject|1|||
25080687|NCT02412722|50189215|FG000|Overall Study|Adverse Event|0|||
25080688|NCT02412722|50189216|FG001|Overall Study|Adverse Event|2|||
25080689|NCT02412722|50189217|FG002|Overall Study|Adverse Event|0|||
25080690|NCT02412722|50189218|FG003|Overall Study|Adverse Event|3|||
25080691|NCT02412722|50189219|FG004|Overall Study|Adverse Event|0|||
25080692|NCT02412722|50189220|FG005|Overall Study|Adverse Event|3|||
25080693|NCT02412722|50189215|FG000|Overall Study|Progressive Disease|6|||
25080694|NCT02412722|50189216|FG001|Overall Study|Progressive Disease|4|||
25080695|NCT02412722|50189217|FG002|Overall Study|Progressive Disease|4|||
25080696|NCT02412722|50189218|FG003|Overall Study|Progressive Disease|9|||
25080697|NCT02412722|50189219|FG004|Overall Study|Progressive Disease|3|||
25080698|NCT02412722|50189220|FG005|Overall Study|Progressive Disease|3|||
25080699|NCT02412722|50189215|FG000|Overall Study|Withdrawal by Subject|2|||
25080700|NCT02412722|50189216|FG001|Overall Study|Withdrawal by Subject|0|||
25080701|NCT02412722|50189217|FG002|Overall Study|Withdrawal by Subject|1|||
25080702|NCT02412722|50189218|FG003|Overall Study|Withdrawal by Subject|2|||
25080703|NCT02412722|50189219|FG004|Overall Study|Withdrawal by Subject|1|||
25080704|NCT02412722|50189220|FG005|Overall Study|Withdrawal by Subject|1|||
25080705|NCT02412722|50189215|FG000|Overall Study|Lost to Follow-up|0|||
25080706|NCT02412722|50189216|FG001|Overall Study|Lost to Follow-up|0|||
25080707|NCT02412722|50189217|FG002|Overall Study|Lost to Follow-up|0|||
25080708|NCT02412722|50189218|FG003|Overall Study|Lost to Follow-up|0|||
25080709|NCT02412722|50189219|FG004|Overall Study|Lost to Follow-up|1|||
25080710|NCT02412722|50189220|FG005|Overall Study|Lost to Follow-up|0|||
25080711|NCT02412722|50189215|FG000|Overall Study|Received drug in run-in and discontinued|0|||
25080712|NCT02412722|50189216|FG001|Overall Study|Received drug in run-in and discontinued|2|||
25080713|NCT02412722|50189217|FG002|Overall Study|Received drug in run-in and discontinued|0|||
25080714|NCT02412722|50189218|FG003|Overall Study|Received drug in run-in and discontinued|0|||
25080715|NCT02412722|50189219|FG004|Overall Study|Received drug in run-in and discontinued|0|||
25080716|NCT02412722|50189220|FG005|Overall Study|Received drug in run-in and discontinued|0|||
25080717|NCT02412722|50189215|FG000|Overall Study|Reason not Specified|3|||
25080718|NCT02412722|50189216|FG001|Overall Study|Reason not Specified|0|||
25080719|NCT02412722|50189217|FG002|Overall Study|Reason not Specified|2|||
25080720|NCT02412722|50189218|FG003|Overall Study|Reason not Specified|1|||
25080721|NCT02412722|50189219|FG004|Overall Study|Reason not Specified|2|||
25080722|NCT02412722|50189220|FG005|Overall Study|Reason not Specified|6|||
25080723|NCT03074695|50189256|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
25080724|NCT03074695|50189257|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
25080725|NCT03074695|50189256|FG000|Overall Study|Research staff not available|1|||
25080726|NCT03074695|50189257|FG001|Overall Study|Research staff not available|2|||
25080727|NCT03074695|50189256|FG000|Overall Study|Did not receive neuraxial block|2|||
25080728|NCT03074695|50189257|FG001|Overall Study|Did not receive neuraxial block|2|||
25080729|NCT03469999|50189263|FG000|Overall Study|Lost to Follow-up|2|||
25080730|NCT02379728|50189270|FG000|Overall Study|Lost to Follow-up|1|||
25080731|NCT02379728|50189271|FG001|Overall Study|Lost to Follow-up|0|||
25080732|NCT02379728|50189272|FG002|Overall Study|Lost to Follow-up|3|||
25080733|NCT02379728|50189273|FG003|Overall Study|Lost to Follow-up|0|||
25080734|NCT02379728|50189270|FG000|Overall Study|Withdrawal by Subject|5|||
25080735|NCT02379728|50189271|FG001|Overall Study|Withdrawal by Subject|0|||
25080736|NCT02379728|50189272|FG002|Overall Study|Withdrawal by Subject|5|||
25080737|NCT02379728|50189273|FG003|Overall Study|Withdrawal by Subject|3|||
25080738|NCT02379728|50189270|FG000|Overall Study|Protocol Violation|0|||
25080739|NCT02379728|50189271|FG001|Overall Study|Protocol Violation|0|||
25080740|NCT02379728|50189272|FG002|Overall Study|Protocol Violation|2|||
25080741|NCT02379728|50189273|FG003|Overall Study|Protocol Violation|0|||
25080742|NCT03463993|50189284|FG000|Overall Study|Lost to Follow-up|7|||
25080743|NCT03463993|50189285|FG001|Overall Study|Lost to Follow-up|8|||
25080744|NCT03463993|50189284|FG000|Overall Study|Withdrawal by Subject|2|||
25080745|NCT03463993|50189285|FG001|Overall Study|Withdrawal by Subject|0|||
25080746|NCT03463993|50189284|FG000|Overall Study|Protocol Violation|4|||
25080747|NCT03463993|50189285|FG001|Overall Study|Protocol Violation|1|||
25080748|NCT03463993|50189284|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
25080749|NCT03463993|50189285|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
25080750|NCT03463993|50189284|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
25080751|NCT03463993|50189285|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
25080752|NCT02412488|50189300|FG000|Overall Study|Lost to Follow-up|10|||
25080753|NCT02412488|50189300|FG000|Overall Study|Withdrawal by Subject|5|||
25080754|NCT02412488|50189300|FG000|Overall Study|Physician Decision|1|||
25080755|NCT02412488|50189300|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
25080756|NCT02412488|50189300|FG000|Overall Study|Reveal LINQ explant|1|||
25080757|NCT02378480|50189306|FG000|Overall Study|Physician Decision|1|||
25080758|NCT02378480|50189307|FG001|Overall Study|Physician Decision|1|||
25080759|NCT02378480|50189306|FG000|Overall Study|Death|1|||
25080760|NCT02378480|50189307|FG001|Overall Study|Death|2|||
25080761|NCT02378480|50189306|FG000|Overall Study|Randomized, but Not Treated|6|||
25080762|NCT02378480|50189307|FG001|Overall Study|Randomized, but Not Treated|4|||
25080763|NCT02378480|50189306|FG000|Overall Study|Adverse Event|0|||
25080764|NCT02378480|50189307|FG001|Overall Study|Adverse Event|1|||
25080765|NCT02378480|50189306|FG000|Overall Study|Missed EOT/PTE Visit|1|||
25080766|NCT02378480|50189307|FG001|Overall Study|Missed EOT/PTE Visit|2|||
25080767|NCT02378480|50189306|FG000|Overall Study|Withdrawal by Subject|9|||
25080768|NCT02378480|50189307|FG001|Overall Study|Withdrawal by Subject|4|||
25080769|NCT02378480|50189306|FG000|Overall Study|Lost to Follow-up|10|||
25080770|NCT02378480|50189307|FG001|Overall Study|Lost to Follow-up|18|||
25080771|NCT02411396|50189313|FG000|Overall Study|Lost to Follow-up|31|||
25080772|NCT02411396|50189313|FG000|Overall Study|Death|10|||
25082670|NCT02714569|50191358|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
25082671|NCT02714569|50191359|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
25082672|NCT02714569|50191360|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
25082673|NCT02714569|50191361|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
25082674|NCT02714569|50191362|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
25082675|NCT02714569|50191363|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
25082676|NCT02714569|50191364|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
25082677|NCT02714569|50191365|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
25082678|NCT02714569|50191355|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
25082679|NCT02714569|50191356|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
25082680|NCT02714569|50191357|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
25082681|NCT02714569|50191358|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
25082682|NCT02714569|50191359|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
25082683|NCT02714569|50191360|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
25082684|NCT02714569|50191361|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
25082685|NCT02714569|50191362|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
25082686|NCT02714569|50191363|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
25082687|NCT02714569|50191364|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
25082688|NCT02714569|50191365|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
25082689|NCT02714569|50191355|FG000|Part A Third Intervention|Adverse Event|0|||
25082690|NCT02714569|50191356|FG001|Part A Third Intervention|Adverse Event|0|||
25082691|NCT02714569|50191357|FG002|Part A Third Intervention|Adverse Event|1|||
25082692|NCT02714569|50191358|FG003|Part A Third Intervention|Adverse Event|0|||
25082693|NCT02714569|50191359|FG004|Part A Third Intervention|Adverse Event|0|||
25082694|NCT02714569|50191360|FG005|Part A Third Intervention|Adverse Event|0|||
25082695|NCT02714569|50191361|FG006|Part A Third Intervention|Adverse Event|0|||
25082696|NCT02714569|50191362|FG007|Part A Third Intervention|Adverse Event|0|||
25082697|NCT02714569|50191363|FG008|Part A Third Intervention|Adverse Event|0|||
25082698|NCT02714569|50191364|FG009|Part A Third Intervention|Adverse Event|0|||
25082699|NCT02714569|50191365|FG010|Part A Third Intervention|Adverse Event|0|||
25082700|NCT02714569|50191355|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
25082701|NCT02714569|50191356|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
25082702|NCT02714569|50191357|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
25082703|NCT02714569|50191358|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
25080773|NCT02345252|50189334|FG000|Double-Blind Phase|Adverse Event|2|||
25080774|NCT02345252|50189335|FG001|Double-Blind Phase|Adverse Event|3|||
25080775|NCT02345252|50189334|FG000|Double-Blind Phase|Death|1|||
25080776|NCT02345252|50189335|FG001|Double-Blind Phase|Death|2|||
25080777|NCT02345252|50189334|FG000|Double-Blind Phase|Lack of Efficacy|1|||
25080778|NCT02345252|50189335|FG001|Double-Blind Phase|Lack of Efficacy|0|||
25080779|NCT02345252|50189334|FG000|Double-Blind Phase|Investigator's Discretion|4|||
25080780|NCT02345252|50189335|FG001|Double-Blind Phase|Investigator's Discretion|6|||
25080781|NCT02345252|50189334|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
25080782|NCT02345252|50189335|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
25080783|NCT02345252|50189334|FG000|Double-Blind Phase|Protocol Violation|2|||
25080784|NCT02345252|50189335|FG001|Double-Blind Phase|Protocol Violation|1|||
25080785|NCT02345252|50189334|FG000|Double-Blind Phase|Withdrew Consent|21|||
25080786|NCT02345252|50189335|FG001|Double-Blind Phase|Withdrew Consent|23|||
25080787|NCT02345252|50189334|FG000|Double-Blind Phase|Lost to Follow-up|8|||
25080788|NCT02345252|50189335|FG001|Double-Blind Phase|Lost to Follow-up|10|||
25080789|NCT02345252|50189334|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
25080790|NCT02345252|50189335|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
25080791|NCT01239797|50189345|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
25080792|NCT01239797|50189346|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
25080793|NCT01239797|50189345|FG000|Randomized Participants|Participant withdrew consent|1|||
25080794|NCT01239797|50189346|FG001|Randomized Participants|Participant withdrew consent|7|||
25080795|NCT01239797|50189345|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
25080796|NCT01239797|50189346|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
25080797|NCT01239797|50189345|FG000|Treated Participants|Disease progression|185|||
25080798|NCT01239797|50189346|FG001|Treated Participants|Disease progression|185|||
25080799|NCT01239797|50189345|FG000|Treated Participants|Study drug toxicity|39|||
25080800|NCT01239797|50189346|FG001|Treated Participants|Study drug toxicity|45|||
25080801|NCT01239797|50189345|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
25080802|NCT01239797|50189346|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
25080803|NCT01239797|50189345|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
25080804|NCT01239797|50189346|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
25080805|NCT01239797|50189345|FG000|Treated Participants|Administrative reason by sponsor|13|||
25080806|NCT01239797|50189346|FG001|Treated Participants|Administrative reason by sponsor|4|||
25080807|NCT01239797|50189345|FG000|Treated Participants|Other reasons|14|||
25080808|NCT01239797|50189346|FG001|Treated Participants|Other reasons|14|||
25080809|NCT01239797|50189345|FG000|Treated Participants|Participant withdrew consent|6|||
25080810|NCT01239797|50189346|FG001|Treated Participants|Participant withdrew consent|11|||
25080811|NCT01239797|50189345|FG000|Treated Participants|Death|1|||
25080812|NCT01239797|50189346|FG001|Treated Participants|Death|1|||
25080813|NCT01239797|50189345|FG000|Treated Participants|Participant no longer meets study criteria|1|||
25080814|NCT01239797|50189346|FG001|Treated Participants|Participant no longer meets study criteria|1|||
25080815|NCT01239797|50189345|FG000|Treated Participants|Poor/non-compliance|0|||
25080816|NCT01239797|50189346|FG001|Treated Participants|Poor/non-compliance|1|||
25080817|NCT02639065|50189352|FG000|Study Treatment|Disease Progression|11|||
25080818|NCT02639065|50189352|FG000|Study Treatment|Adverse Event|8|||
25080819|NCT02639065|50189352|FG000|Study Treatment|Withdrawal by Subject|1|||
25080820|NCT02639065|50189352|FG000|Follow up|Withdrawal by Subject|1|||
25080821|NCT02639065|50189352|FG000|Follow up|Symptomatic Deterioration|2|||
25080822|NCT02639065|50189352|FG000|Follow up|Death|2|||
25080823|NCT02639065|50189352|FG000|Follow up|Study Terminated|1|||
25080824|NCT02639065|50189352|FG000|Follow up|Disease Progression|3|||
25080825|NCT01236521|50189358|FG000|Overall Study|Withdrawal by Subject|12|||
25080826|NCT01236521|50189359|FG001|Overall Study|Withdrawal by Subject|17|||
25080827|NCT01236521|50189358|FG000|Overall Study|Death|2|||
25080828|NCT01236521|50189359|FG001|Overall Study|Death|1|||
25080829|NCT01236521|50189358|FG000|Overall Study|Lost to Follow-up|9|||
25080830|NCT01236521|50189359|FG001|Overall Study|Lost to Follow-up|7|||
25080831|NCT01092143|50189370|FG000|Overall Study|Adverse Event|10|||
25080832|NCT01092143|50189371|FG001|Overall Study|Adverse Event|5|||
25080833|NCT01092143|50189372|FG002|Overall Study|Adverse Event|1|||
25080834|NCT01092143|50189373|FG003|Overall Study|Adverse Event|4|||
25080835|NCT01092143|50189374|FG004|Overall Study|Adverse Event|3|||
25080836|NCT01092143|50189370|FG000|Overall Study|Lost to Follow-up|1|||
25080837|NCT01092143|50189371|FG001|Overall Study|Lost to Follow-up|0|||
25080838|NCT01092143|50189372|FG002|Overall Study|Lost to Follow-up|1|||
25080839|NCT01092143|50189373|FG003|Overall Study|Lost to Follow-up|0|||
25080840|NCT01092143|50189374|FG004|Overall Study|Lost to Follow-up|0|||
25080841|NCT01092143|50189370|FG000|Overall Study|Consent withdrawn|2|||
25080842|NCT01092143|50189371|FG001|Overall Study|Consent withdrawn|1|||
25080843|NCT01092143|50189372|FG002|Overall Study|Consent withdrawn|0|||
25080844|NCT01092143|50189373|FG003|Overall Study|Consent withdrawn|1|||
25259227|NCT01057693|50574439|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
25080845|NCT01092143|50189374|FG004|Overall Study|Consent withdrawn|3|||
25080846|NCT01092143|50189370|FG000|Overall Study|Not treated|0|||
25080847|NCT01092143|50189371|FG001|Overall Study|Not treated|0|||
25080848|NCT01092143|50189372|FG002|Overall Study|Not treated|1|||
25080849|NCT01092143|50189373|FG003|Overall Study|Not treated|0|||
25080850|NCT01092143|50189374|FG004|Overall Study|Not treated|0|||
25080851|NCT01092143|50189370|FG000|Overall Study|did not reversibility criteria|0|||
25080852|NCT01092143|50189371|FG001|Overall Study|did not reversibility criteria|0|||
25080853|NCT01092143|50189372|FG002|Overall Study|did not reversibility criteria|1|||
25080854|NCT01092143|50189373|FG003|Overall Study|did not reversibility criteria|0|||
25080855|NCT01092143|50189374|FG004|Overall Study|did not reversibility criteria|0|||
25080856|NCT01092143|50189370|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
25080857|NCT01092143|50189371|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
25080858|NCT01092143|50189372|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
25080859|NCT01092143|50189373|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
25080860|NCT01092143|50189374|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
25080861|NCT01092143|50189370|FG000|Overall Study|Ineligible patient|1|||
25080862|NCT01092143|50189371|FG001|Overall Study|Ineligible patient|0|||
25080863|NCT01092143|50189372|FG002|Overall Study|Ineligible patient|0|||
25080864|NCT01092143|50189373|FG003|Overall Study|Ineligible patient|0|||
25080865|NCT01092143|50189374|FG004|Overall Study|Ineligible patient|0|||
25080866|NCT01092143|50189370|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
25080867|NCT01092143|50189371|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
25080868|NCT01092143|50189372|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
25080869|NCT01092143|50189373|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
25080870|NCT01092143|50189374|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
25080871|NCT01092143|50189370|FG000|Overall Study|Patient travel|0|||
25080872|NCT01092143|50189371|FG001|Overall Study|Patient travel|0|||
25080873|NCT01092143|50189372|FG002|Overall Study|Patient travel|0|||
25080874|NCT01092143|50189373|FG003|Overall Study|Patient travel|0|||
25080875|NCT01092143|50189374|FG004|Overall Study|Patient travel|1|||
25080876|NCT01092143|50189370|FG000|Overall Study|Non compliance with study medication|0|||
25080877|NCT01092143|50189371|FG001|Overall Study|Non compliance with study medication|0|||
25080878|NCT01092143|50189372|FG002|Overall Study|Non compliance with study medication|0|||
25080879|NCT01092143|50189373|FG003|Overall Study|Non compliance with study medication|0|||
25080880|NCT01092143|50189374|FG004|Overall Study|Non compliance with study medication|1|||
25080881|NCT01092143|50189370|FG000|Overall Study|Randomized by mistake|0|||
25080882|NCT01092143|50189371|FG001|Overall Study|Randomized by mistake|0|||
25080883|NCT01092143|50189372|FG002|Overall Study|Randomized by mistake|0|||
25080884|NCT01092143|50189373|FG003|Overall Study|Randomized by mistake|1|||
25080885|NCT01092143|50189374|FG004|Overall Study|Randomized by mistake|0|||
25080886|NCT01092143|50189370|FG000|Overall Study|Pregnancy|0|||
25080887|NCT01092143|50189371|FG001|Overall Study|Pregnancy|0|||
25080888|NCT01092143|50189372|FG002|Overall Study|Pregnancy|0|||
25080889|NCT01092143|50189373|FG003|Overall Study|Pregnancy|1|||
25080890|NCT01092143|50189374|FG004|Overall Study|Pregnancy|0|||
25080891|NCT02377466|50189388|FG000|Overall Study|Other: Randomized and not treated|0|||
25080892|NCT02377466|50189389|FG001|Overall Study|Other: Randomized and not treated|2|||
25080893|NCT00950989|50189406|FG000|Overall Study|Death|0|||
25080894|NCT00950989|50189407|FG001|Overall Study|Death|0|||
25080895|NCT00950989|50189408|FG002|Overall Study|Death|1|||
25080896|NCT00950989|50189409|FG003|Overall Study|Death|0|||
25080897|NCT00950989|50189406|FG000|Overall Study|Administrative Decision|0|||
25080898|NCT00950989|50189407|FG001|Overall Study|Administrative Decision|1|||
25080899|NCT00950989|50189408|FG002|Overall Study|Administrative Decision|0|||
25080900|NCT00950989|50189409|FG003|Overall Study|Administrative Decision|0|||
25080901|NCT00950989|50189406|FG000|Overall Study|Disease Progression|0|||
25080902|NCT00950989|50189407|FG001|Overall Study|Disease Progression|0|||
25080903|NCT00950989|50189408|FG002|Overall Study|Disease Progression|1|||
25080904|NCT00950989|50189409|FG003|Overall Study|Disease Progression|0|||
25080905|NCT00950989|50189406|FG000|Overall Study|Withdrawal by Subject|2|||
25080906|NCT00950989|50189407|FG001|Overall Study|Withdrawal by Subject|1|||
25080907|NCT00950989|50189408|FG002|Overall Study|Withdrawal by Subject|0|||
25080908|NCT00950989|50189409|FG003|Overall Study|Withdrawal by Subject|0|||
25080909|NCT00950989|50189406|FG000|Overall Study|Adverse Event|2|||
25080910|NCT00950989|50189407|FG001|Overall Study|Adverse Event|1|||
25080911|NCT00950989|50189408|FG002|Overall Study|Adverse Event|1|||
25080912|NCT00950989|50189409|FG003|Overall Study|Adverse Event|0|||
25080913|NCT00593567|50189424|FG000|Overall Study|Adverse Event|2|||
25080914|NCT00593567|50189425|FG001|Overall Study|Adverse Event|0|||
25080915|NCT00593567|50189424|FG000|Overall Study|Physician Decision|2|||
25080916|NCT00593567|50189425|FG001|Overall Study|Physician Decision|0|||
25080917|NCT00593567|50189424|FG000|Overall Study|Protocol Violation|13|||
25080918|NCT00593567|50189425|FG001|Overall Study|Protocol Violation|7|||
25080919|NCT00593567|50189424|FG000|Overall Study|Lack of Efficacy|2|||
25080920|NCT00593567|50189425|FG001|Overall Study|Lack of Efficacy|1|||
25080921|NCT00593567|50189424|FG000|Overall Study|Withdrawal by Subject|1|||
25080922|NCT00593567|50189425|FG001|Overall Study|Withdrawal by Subject|2|||
25080923|NCT02411084|50189433|FG000|Overall Study|Lack of Efficacy|6|||
25080924|NCT02411084|50189434|FG001|Overall Study|Lack of Efficacy|3|||
25080925|NCT02411084|50189433|FG000|Overall Study|Death|5|||
25080926|NCT02411084|50189434|FG001|Overall Study|Death|4|||
25080927|NCT02411084|50189433|FG000|Overall Study|Adverse Event|2|||
25080928|NCT02411084|50189434|FG001|Overall Study|Adverse Event|1|||
25080929|NCT02411084|50189433|FG000|Overall Study|Other reasons|0|||
25080930|NCT02411084|50189434|FG001|Overall Study|Other reasons|5|||
25080931|NCT01602315|50189447|FG000|Overall Study|Protocol Violation|0|||
25080932|NCT01602315|50189448|FG001|Overall Study|Protocol Violation|0|||
25080933|NCT01602315|50189449|FG002|Overall Study|Protocol Violation|0|||
25080934|NCT01602315|50189450|FG003|Overall Study|Protocol Violation|0|||
25080935|NCT01602315|50189451|FG004|Overall Study|Protocol Violation|0|||
25080936|NCT01602315|50189452|FG005|Overall Study|Protocol Violation|1|||
25080937|NCT01602315|50189453|FG006|Overall Study|Protocol Violation|0|||
25080938|NCT01602315|50189447|FG000|Overall Study|Physician Decision|2|||
25080939|NCT01602315|50189448|FG001|Overall Study|Physician Decision|0|||
25080940|NCT01602315|50189449|FG002|Overall Study|Physician Decision|0|||
25080941|NCT01602315|50189450|FG003|Overall Study|Physician Decision|0|||
25080942|NCT01602315|50189451|FG004|Overall Study|Physician Decision|2|||
25080943|NCT01602315|50189452|FG005|Overall Study|Physician Decision|1|||
25080944|NCT01602315|50189453|FG006|Overall Study|Physician Decision|1|||
25080945|NCT01602315|50189447|FG000|Overall Study|Disease progression|6|||
25080946|NCT01602315|50189448|FG001|Overall Study|Disease progression|3|||
25080947|NCT01602315|50189449|FG002|Overall Study|Disease progression|10|||
25080948|NCT01602315|50189450|FG003|Overall Study|Disease progression|1|||
25080949|NCT01602315|50189451|FG004|Overall Study|Disease progression|41|||
25080950|NCT01602315|50189452|FG005|Overall Study|Disease progression|12|||
25080951|NCT01602315|50189453|FG006|Overall Study|Disease progression|15|||
25080952|NCT01602315|50189447|FG000|Overall Study|Death|1|||
25080953|NCT01602315|50189448|FG001|Overall Study|Death|1|||
25080954|NCT01602315|50189449|FG002|Overall Study|Death|1|||
25080955|NCT01602315|50189450|FG003|Overall Study|Death|1|||
25080956|NCT01602315|50189451|FG004|Overall Study|Death|7|||
25080957|NCT01602315|50189452|FG005|Overall Study|Death|2|||
25080958|NCT01602315|50189453|FG006|Overall Study|Death|2|||
25080959|NCT01602315|50189447|FG000|Overall Study|Withdrawal by Subject|2|||
25080960|NCT01602315|50189448|FG001|Overall Study|Withdrawal by Subject|0|||
25080961|NCT01602315|50189449|FG002|Overall Study|Withdrawal by Subject|2|||
25080962|NCT01602315|50189450|FG003|Overall Study|Withdrawal by Subject|0|||
25080963|NCT01602315|50189451|FG004|Overall Study|Withdrawal by Subject|6|||
25080964|NCT01602315|50189452|FG005|Overall Study|Withdrawal by Subject|0|||
25080965|NCT01602315|50189453|FG006|Overall Study|Withdrawal by Subject|1|||
25080966|NCT01602315|50189447|FG000|Overall Study|Adverse Event|5|||
25080967|NCT01602315|50189448|FG001|Overall Study|Adverse Event|1|||
25080968|NCT01602315|50189449|FG002|Overall Study|Adverse Event|5|||
25080969|NCT01602315|50189450|FG003|Overall Study|Adverse Event|4|||
25080970|NCT01602315|50189451|FG004|Overall Study|Adverse Event|15|||
25080971|NCT01602315|50189452|FG005|Overall Study|Adverse Event|3|||
25080972|NCT01602315|50189453|FG006|Overall Study|Adverse Event|9|||
25080973|NCT01602315|50189447|FG000|Overall Study|Subject/guardian decision|0|||
25080974|NCT01602315|50189448|FG001|Overall Study|Subject/guardian decision|0|||
25080975|NCT01602315|50189449|FG002|Overall Study|Subject/guardian decision|0|||
25080976|NCT01602315|50189450|FG003|Overall Study|Subject/guardian decision|0|||
25080977|NCT01602315|50189451|FG004|Overall Study|Subject/guardian decision|0|||
25080978|NCT01602315|50189452|FG005|Overall Study|Subject/guardian decision|0|||
25080979|NCT01602315|50189453|FG006|Overall Study|Subject/guardian decision|1|||
25080980|NCT01602315|50189447|FG000|Overall Study|Cross-over patients to combo treatment|0|||
25080981|NCT01602315|50189448|FG001|Overall Study|Cross-over patients to combo treatment|0|||
25080982|NCT01602315|50189449|FG002|Overall Study|Cross-over patients to combo treatment|0|||
25080983|NCT01602315|50189450|FG003|Overall Study|Cross-over patients to combo treatment|0|||
25080984|NCT01602315|50189451|FG004|Overall Study|Cross-over patients to combo treatment|0|||
25080985|NCT01602315|50189452|FG005|Overall Study|Cross-over patients to combo treatment|16|||
25080986|NCT01602315|50189453|FG006|Overall Study|Cross-over patients to combo treatment|0|||
25080987|NCT02344004|50189491|FG000|Overall Study|Adverse Event|11|||
25080988|NCT02344004|50189492|FG001|Overall Study|Adverse Event|1|||
25080989|NCT02344004|50189491|FG000|Overall Study|Death|9|||
25080990|NCT02344004|50189492|FG001|Overall Study|Death|7|||
25080991|NCT02344004|50189491|FG000|Overall Study|Physician Decision|4|||
25080992|NCT02344004|50189492|FG001|Overall Study|Physician Decision|1|||
25080993|NCT02344004|50189491|FG000|Overall Study|Withdrawal by Subject|22|||
25080994|NCT02344004|50189492|FG001|Overall Study|Withdrawal by Subject|5|||
25080995|NCT02344004|50189491|FG000|Overall Study|Rescue Medication|2|||
25080996|NCT02344004|50189492|FG001|Overall Study|Rescue Medication|0|||
25080997|NCT02344004|50189491|FG000|Overall Study|Other Not Specified|12|||
25080998|NCT02344004|50189492|FG001|Overall Study|Other Not Specified|0|||
25080999|NCT02344004|50189491|FG000|Overall Study|Protocol Violation|1|||
25081000|NCT02344004|50189492|FG001|Overall Study|Protocol Violation|0|||
25081001|NCT01328093|50189501|FG000|Double-Blind Phase|Adverse Event|78|||
25081002|NCT01328093|50189502|FG001|Double-Blind Phase|Adverse Event|15|||
25081003|NCT01328093|50189501|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
25081004|NCT01328093|50189502|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
25081005|NCT01328093|50189501|FG000|Double-Blind Phase|Lost to Follow-up|39|||
25081006|NCT01328093|50189502|FG001|Double-Blind Phase|Lost to Follow-up|14|||
25081007|NCT01328093|50189501|FG000|Double-Blind Phase|Protocol Violation|30|||
24993764|NCT03605862|50084343|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
24993765|NCT03605862|50084344|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
24993766|NCT03672006|50084353|FG000|Overall Study|exclusion criteria met|0|||
24993767|NCT03672006|50084354|FG001|Overall Study|exclusion criteria met|1|||
24993768|NCT03512288|50084364|FG000|Overall Study|Adverse Event|1|||
24993769|NCT03512288|50084365|FG001|Overall Study|Adverse Event|0|||
24993770|NCT03512288|50084364|FG000|Overall Study|Lost to Follow-up|12|||
24993771|NCT03512288|50084365|FG001|Overall Study|Lost to Follow-up|15|||
24993772|NCT03512288|50084364|FG000|Overall Study|Physician Decision|0|||
24993773|NCT03512288|50084365|FG001|Overall Study|Physician Decision|2|||
24993774|NCT03512288|50084364|FG000|Overall Study|Protocol Violation|6|||
24993775|NCT03512288|50084365|FG001|Overall Study|Protocol Violation|4|||
24993776|NCT03512288|50084364|FG000|Overall Study|Medication error without associated adverse event|1|||
24993777|NCT03512288|50084365|FG001|Overall Study|Medication error without associated adverse event|0|||
24993778|NCT03512288|50084364|FG000|Overall Study|No longer met eligibility criteria|5|||
24993779|NCT03512288|50084365|FG001|Overall Study|No longer met eligibility criteria|2|||
24993780|NCT03512288|50084364|FG000|Overall Study|Withdrawal by parent/guardian|14|||
24993781|NCT03512288|50084365|FG001|Overall Study|Withdrawal by parent/guardian|18|||
24993782|NCT03512288|50084364|FG000|Overall Study|Other|1|||
24993783|NCT03512288|50084365|FG001|Overall Study|Other|1|||
24993784|NCT03512288|50084364|FG000|Overall Study|Randomized but not treated|1|||
24993785|NCT03512288|50084365|FG001|Overall Study|Randomized but not treated|1|||
24993786|NCT03031678|50084371|FG000|Overall Study|Study closed prior to completion|1|||
24993787|NCT03669588|50084381|FG000|Overall Study|Adverse Event|1|||
24993788|NCT03669588|50084382|FG001|Overall Study|Adverse Event|0|||
24993789|NCT03669588|50084381|FG000|Overall Study|Physician Decision|0|||
24993790|NCT03669588|50084382|FG001|Overall Study|Physician Decision|1|||
24993791|NCT03669588|50084381|FG000|Overall Study|Protocol Violation|1|||
24993792|NCT03669588|50084382|FG001|Overall Study|Protocol Violation|0|||
24993793|NCT03669588|50084381|FG000|Overall Study|Sponsor Decision|1|||
24993794|NCT03669588|50084382|FG001|Overall Study|Sponsor Decision|1|||
24993795|NCT03669588|50084381|FG000|Overall Study|Withdrawal by Subject|1|||
24993796|NCT03669588|50084382|FG001|Overall Study|Withdrawal by Subject|4|||
24993797|NCT03669588|50084381|FG000|Overall Study|Rescue Therapy Needed|0|||
24993798|NCT03669588|50084382|FG001|Overall Study|Rescue Therapy Needed|1|||
24993799|NCT03646656|50084390|FG000|Overall Study|Lost to Follow-up|1|||
24993800|NCT03646656|50084391|FG001|Overall Study|Lost to Follow-up|0|||
24993801|NCT03646656|50084390|FG000|Overall Study|Withdrawal by Subject|2|||
24993802|NCT03646656|50084391|FG001|Overall Study|Withdrawal by Subject|0|||
24993803|NCT03598140|50084403|FG000|Overall Study|enrolled but didn't start|1|||
24993804|NCT03598140|50084404|FG001|Overall Study|enrolled but didn't start|0|||
24993805|NCT03644550|50084410|FG000|Overall Study|Withdrawal by Subject|3|||
24993806|NCT03644550|50084410|FG000|Overall Study|Progressive disease|15|||
24993807|NCT03511664|50084417|FG000|Overall Study|Treatment ongoing|49|||
24993808|NCT03511664|50084418|FG001|Overall Study|Treatment ongoing|5|||
24993809|NCT03511664|50084417|FG000|Overall Study|Entered long-term follow-up|140|||
24993810|NCT03511664|50084418|FG001|Overall Study|Entered long-term follow-up|50|||
24993811|NCT03511664|50084417|FG000|Overall Study|Withdrawal by Subject|29|||
24993812|NCT03511664|50084418|FG001|Overall Study|Withdrawal by Subject|53|||
24993813|NCT03511664|50084417|FG000|Overall Study|Lost to Follow-up|4|||
24993814|NCT03511664|50084418|FG001|Overall Study|Lost to Follow-up|4|||
24993815|NCT03511664|50084417|FG000|Overall Study|Physician Decision|0|||
24993816|NCT03511664|50084418|FG001|Overall Study|Physician Decision|1|||
24993817|NCT00054717|50084426|FG000|Overall Study|Randomized but not treated|2|||
24993818|NCT00054717|50084427|FG001|Overall Study|Randomized but not treated|8|||
24993819|NCT00054717|50084426|FG000|Overall Study|Adverse Event|70|||
24993820|NCT00054717|50084427|FG001|Overall Study|Adverse Event|22|||
24993821|NCT00054717|50084426|FG000|Overall Study|Protocol Violation|18|||
24993822|NCT00054717|50084427|FG001|Overall Study|Protocol Violation|19|||
24993823|NCT00054717|50084426|FG000|Overall Study|Lost to Follow-up|23|||
24993824|NCT00054717|50084427|FG001|Overall Study|Lost to Follow-up|13|||
24993825|NCT00054717|50084426|FG000|Overall Study|Withdrawal by Subject|32|||
24993826|NCT00054717|50084427|FG001|Overall Study|Withdrawal by Subject|20|||
24993827|NCT00054717|50084426|FG000|Overall Study|Other reason not defined above|117|||
24993828|NCT00054717|50084427|FG001|Overall Study|Other reason not defined above|217|||
24993829|NCT03430856|50084436|FG000|Overall Study|Adverse Event|0|||
24993830|NCT03430856|50084437|FG001|Overall Study|Adverse Event|1|||
24993831|NCT03430856|50084438|FG002|Overall Study|Adverse Event|0|||
24993832|NCT03430856|50084436|FG000|Overall Study|Rescue criteria|1|||
24993833|NCT03430856|50084437|FG001|Overall Study|Rescue criteria|1|||
24993834|NCT03430856|50084438|FG002|Overall Study|Rescue criteria|0|||
24993835|NCT03430856|50084436|FG000|Overall Study|Voluntary withdrawal of consent|1|||
24993836|NCT03430856|50084437|FG001|Overall Study|Voluntary withdrawal of consent|1|||
24993837|NCT03430856|50084438|FG002|Overall Study|Voluntary withdrawal of consent|1|||
24993838|NCT03731364|50084454|FG000|Overall Study|Adverse Event|0|||
24993839|NCT03731364|50084455|FG001|Overall Study|Adverse Event|0|||
24993840|NCT03731364|50084456|FG002|Overall Study|Adverse Event|1|||
24993841|NCT03731364|50084457|FG003|Overall Study|Adverse Event|2|||
24993842|NCT03731364|50084458|FG004|Overall Study|Adverse Event|1|||
24993843|NCT03510182|50084470|FG000|Overall Study|Withdrawal by Subject|2|||
24993844|NCT00066807|50084476|FG000|Overall Study|Study was terminated early|14|||
24993845|NCT00066807|50084477|FG001|Overall Study|Study was terminated early|15|||
25081008|NCT01328093|50189502|FG001|Double-Blind Phase|Protocol Violation|10|||
25081009|NCT01328093|50189501|FG000|Double-Blind Phase|Lack of Efficacy|55|||
25081010|NCT01328093|50189502|FG001|Double-Blind Phase|Lack of Efficacy|13|||
25081011|NCT01328093|50189501|FG000|Double-Blind Phase|Sponsor Decision|17|||
25081012|NCT01328093|50189502|FG001|Double-Blind Phase|Sponsor Decision|3|||
25081013|NCT01328093|50189501|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
25081014|NCT01328093|50189502|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
25081015|NCT01328093|50189501|FG000|Double-Blind Phase|Scheduling conflict|8|||
25081016|NCT01328093|50189502|FG001|Double-Blind Phase|Scheduling conflict|3|||
25081017|NCT01328093|50189501|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
25081018|NCT01328093|50189502|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
25081019|NCT01328093|50189501|FG000|Double-Blind Phase|Death|1|||
25081020|NCT01328093|50189502|FG001|Double-Blind Phase|Death|0|||
25081021|NCT01328093|50189501|FG000|Open-Label Phase|Sponsor Decision|98|||
25081022|NCT01328093|50189502|FG001|Open-Label Phase|Sponsor Decision|34|||
25081023|NCT01328093|50189501|FG000|Open-Label Phase|Protocol Violation|8|||
25081024|NCT01328093|50189502|FG001|Open-Label Phase|Protocol Violation|3|||
25081025|NCT01328093|50189501|FG000|Open-Label Phase|Lost to Follow-up|10|||
25081026|NCT01328093|50189502|FG001|Open-Label Phase|Lost to Follow-up|1|||
25081027|NCT01328093|50189501|FG000|Open-Label Phase|Adverse Event|10|||
25081028|NCT01328093|50189502|FG001|Open-Label Phase|Adverse Event|4|||
25081029|NCT01328093|50189501|FG000|Open-Label Phase|Lack of Efficacy|5|||
25081030|NCT01328093|50189502|FG001|Open-Label Phase|Lack of Efficacy|6|||
25081031|NCT01328093|50189501|FG000|Open-Label Phase|Withdrawal by Subject|4|||
25081032|NCT01328093|50189502|FG001|Open-Label Phase|Withdrawal by Subject|1|||
25081033|NCT01328093|50189501|FG000|Open-Label Phase|Scheduling conflict|2|||
25081034|NCT01328093|50189502|FG001|Open-Label Phase|Scheduling conflict|1|||
25081035|NCT01328093|50189501|FG000|Open-Label Phase|Subject is moving or has moved|2|||
25081036|NCT01328093|50189502|FG001|Open-Label Phase|Subject is moving or has moved|0|||
25081037|NCT01328093|50189501|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
25081038|NCT01328093|50189502|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
25081039|NCT02654145|50189509|FG000|Overall Study|Lack of Efficacy|1|||
25081040|NCT02654145|50189509|FG000|Overall Study|Protocol Violation|1|||
25081041|NCT02654145|50189509|FG000|Overall Study|Withdrawal by Subject|5|||
25081042|NCT01111565|50189513|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
25081043|NCT01111565|50189514|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
25081044|NCT01111565|50189515|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
25081045|NCT01111565|50189516|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
25081046|NCT01111565|50189517|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
25081047|NCT01111565|50189513|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
25081048|NCT01111565|50189514|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
25081049|NCT01111565|50189515|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
25081050|NCT01111565|50189516|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
25081051|NCT01111565|50189517|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
25081052|NCT01111565|50189513|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
25081053|NCT01111565|50189514|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
25081054|NCT01111565|50189515|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
25081055|NCT01111565|50189516|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
25081056|NCT01111565|50189517|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
25081057|NCT01111565|50189513|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
25081058|NCT01111565|50189514|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
25081059|NCT01111565|50189515|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
25081060|NCT01111565|50189516|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
25081061|NCT01111565|50189517|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
25081062|NCT01111565|50189513|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
25081063|NCT01111565|50189514|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
25081064|NCT01111565|50189515|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
25081065|NCT01111565|50189516|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
24993846|NCT03428750|50084485|FG000|Overall Study|Withdrawal by Subject|11|||
25081066|NCT01111565|50189517|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
25081067|NCT01111565|50189513|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
24993847|NCT03428750|50084486|FG001|Overall Study|Withdrawal by Subject|10|||
25081068|NCT01111565|50189514|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
25081069|NCT01111565|50189515|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
25081070|NCT01111565|50189516|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
25081071|NCT01111565|50189517|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
25081072|NCT01111565|50189513|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
25081073|NCT01111565|50189514|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
25081074|NCT01111565|50189515|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
25081075|NCT01111565|50189516|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
25081076|NCT01111565|50189517|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
25081077|NCT01111565|50189513|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
25081078|NCT01111565|50189514|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
25081079|NCT01111565|50189515|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
24993848|NCT03428750|50084485|FG000|Overall Study|Lost to Follow-up|3|||
24993849|NCT03428750|50084486|FG001|Overall Study|Lost to Follow-up|9|||
24993850|NCT03428750|50084485|FG000|Overall Study|Adverse Event|9|||
24993851|NCT03428750|50084486|FG001|Overall Study|Adverse Event|1|||
24993852|NCT03428750|50084485|FG000|Overall Study|Protocol Violation|1|||
24993853|NCT03428750|50084486|FG001|Overall Study|Protocol Violation|0|||
24993854|NCT03428750|50084485|FG000|Overall Study|Administrative|0|||
25081080|NCT01111565|50189516|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
25081081|NCT01111565|50189517|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
25081082|NCT01111565|50189513|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
25081083|NCT01111565|50189514|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
25081084|NCT01111565|50189515|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
25081085|NCT01111565|50189516|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
25081086|NCT01111565|50189517|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
25081087|NCT01111565|50189513|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
25081088|NCT01111565|50189514|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
25081089|NCT01111565|50189515|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
25081090|NCT01111565|50189516|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
25081091|NCT01111565|50189517|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
25081092|NCT01111565|50189513|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
25081093|NCT01111565|50189514|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
25081094|NCT01111565|50189515|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
25081095|NCT01111565|50189516|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
25081096|NCT01111565|50189517|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
25081097|NCT01111565|50189513|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
25081098|NCT01111565|50189514|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
25081099|NCT01111565|50189515|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
25259228|NCT01057693|50574440|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
25259229|NCT01057693|50574438|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
25259230|NCT01057693|50574439|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
25259231|NCT01057693|50574440|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
25259232|NCT01057693|50574438|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
25259233|NCT01057693|50574439|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
25259234|NCT01057693|50574440|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
25259235|NCT01057693|50574438|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
25259236|NCT01057693|50574439|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
25259237|NCT01057693|50574440|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
25259238|NCT01307501|50574448|FG000|Overall Study|Treatment Failure|1|||
25259239|NCT01307501|50574448|FG000|Overall Study|Death|20|||
25259240|NCT01307501|50574448|FG000|Overall Study|Lost to Follow-up|1|||
25259241|NCT01307501|50574448|FG000|Overall Study|Starting Hospice|1|||
25259242|NCT01034137|50574455|FG000|Overall Study|Adverse Event|9|||
25259243|NCT01034137|50574456|FG001|Overall Study|Adverse Event|10|||
25259244|NCT01034137|50574457|FG002|Overall Study|Adverse Event|8|||
25259245|NCT01034137|50574455|FG000|Overall Study|Withdrawal by Subject|4|||
25259246|NCT01034137|50574456|FG001|Overall Study|Withdrawal by Subject|3|||
25259247|NCT01034137|50574457|FG002|Overall Study|Withdrawal by Subject|3|||
25259248|NCT01034137|50574455|FG000|Overall Study|Lack of Efficacy|9|||
25259249|NCT01034137|50574456|FG001|Overall Study|Lack of Efficacy|4|||
25259250|NCT01034137|50574457|FG002|Overall Study|Lack of Efficacy|13|||
25259251|NCT01034137|50574455|FG000|Overall Study|Protocol Violation|2|||
24993855|NCT03428750|50084486|FG001|Overall Study|Administrative|1|||
24993856|NCT03666858|50084515|FG000|Cohort 1|Adverse Event|1|||
24993857|NCT03666858|50084516|FG001|Cohort 1|Adverse Event|0|||
24993858|NCT03666858|50084515|FG000|Cohort 2|Adverse Event|0|||
24993859|NCT03666858|50084516|FG001|Cohort 2|Adverse Event|1|||
24993860|NCT00054639|50084522|FG000|Overall Study|Lack of Efficacy|1|||
25259252|NCT01034137|50574456|FG001|Overall Study|Protocol Violation|2|||
25259253|NCT01034137|50574457|FG002|Overall Study|Protocol Violation|1|||
25259254|NCT01034137|50574455|FG000|Overall Study|Refused treatment or did not cooperate|2|||
25259255|NCT01034137|50574456|FG001|Overall Study|Refused treatment or did not cooperate|0|||
25259256|NCT01034137|50574457|FG002|Overall Study|Refused treatment or did not cooperate|1|||
25259257|NCT01034137|50574455|FG000|Overall Study|Administrative or other|2|||
25259258|NCT01034137|50574456|FG001|Overall Study|Administrative or other|3|||
25259259|NCT01034137|50574457|FG002|Overall Study|Administrative or other|4|||
25259260|NCT01056289|50574466|FG000|Open-label Phase|Adverse Event|29|||
25259261|NCT01056289|50574467|FG001|Open-label Phase|Adverse Event|0|||
25259262|NCT01056289|50574468|FG002|Open-label Phase|Adverse Event|0|||
25259263|NCT01056289|50574469|FG003|Open-label Phase|Adverse Event|0|||
25259264|NCT01056289|50574466|FG000|Open-label Phase|Lost to Follow-up|30|||
25259265|NCT01056289|50574467|FG001|Open-label Phase|Lost to Follow-up|0|||
25259266|NCT01056289|50574468|FG002|Open-label Phase|Lost to Follow-up|0|||
25259267|NCT01056289|50574469|FG003|Open-label Phase|Lost to Follow-up|0|||
25259268|NCT01056289|50574466|FG000|Open-label Phase|Other|9|||
25259269|NCT01056289|50574467|FG001|Open-label Phase|Other|0|||
25259270|NCT01056289|50574468|FG002|Open-label Phase|Other|0|||
25259271|NCT01056289|50574469|FG003|Open-label Phase|Other|0|||
25259272|NCT01056289|50574466|FG000|Open-label Phase|Protocol Violation|6|||
25259273|NCT01056289|50574467|FG001|Open-label Phase|Protocol Violation|0|||
25259274|NCT01056289|50574468|FG002|Open-label Phase|Protocol Violation|0|||
25259275|NCT01056289|50574469|FG003|Open-label Phase|Protocol Violation|0|||
25259276|NCT01056289|50574466|FG000|Open-label Phase|Withdrawal by Subject|26|||
25259277|NCT01056289|50574467|FG001|Open-label Phase|Withdrawal by Subject|0|||
25259278|NCT01056289|50574468|FG002|Open-label Phase|Withdrawal by Subject|0|||
25259279|NCT01056289|50574469|FG003|Open-label Phase|Withdrawal by Subject|0|||
25259280|NCT01056289|50574466|FG000|Open-label Phase|Lack of Efficacy|18|||
25259281|NCT01056289|50574467|FG001|Open-label Phase|Lack of Efficacy|0|||
25259282|NCT01056289|50574468|FG002|Open-label Phase|Lack of Efficacy|0|||
25259283|NCT01056289|50574469|FG003|Open-label Phase|Lack of Efficacy|0|||
25259284|NCT01056289|50574466|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
25259285|NCT01056289|50574467|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
25259286|NCT01056289|50574468|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
25259287|NCT01056289|50574469|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
25259288|NCT01056289|50574466|FG000|Double-blind Phase|Adverse Event|0|||
25259289|NCT01056289|50574467|FG001|Double-blind Phase|Adverse Event|1|||
25259290|NCT01056289|50574468|FG002|Double-blind Phase|Adverse Event|2|||
25259291|NCT01056289|50574469|FG003|Double-blind Phase|Adverse Event|1|||
25259292|NCT01056289|50574466|FG000|Double-blind Phase|Lost to Follow-up|0|||
25259293|NCT01056289|50574467|FG001|Double-blind Phase|Lost to Follow-up|2|||
25259294|NCT01056289|50574468|FG002|Double-blind Phase|Lost to Follow-up|2|||
25259295|NCT01056289|50574469|FG003|Double-blind Phase|Lost to Follow-up|2|||
25259296|NCT01056289|50574466|FG000|Double-blind Phase|Other|0|||
25259297|NCT01056289|50574467|FG001|Double-blind Phase|Other|0|||
25259298|NCT01056289|50574468|FG002|Double-blind Phase|Other|1|||
25259299|NCT01056289|50574469|FG003|Double-blind Phase|Other|2|||
25259300|NCT01056289|50574466|FG000|Double-blind Phase|Protocol Violation|0|||
25259301|NCT01056289|50574467|FG001|Double-blind Phase|Protocol Violation|0|||
25259302|NCT01056289|50574468|FG002|Double-blind Phase|Protocol Violation|1|||
25259303|NCT01056289|50574469|FG003|Double-blind Phase|Protocol Violation|1|||
25259304|NCT01056289|50574466|FG000|Double-blind Phase|Withdrawal by Subject|0|||
25259305|NCT01056289|50574467|FG001|Double-blind Phase|Withdrawal by Subject|0|||
25259306|NCT01056289|50574468|FG002|Double-blind Phase|Withdrawal by Subject|4|||
25259307|NCT01056289|50574469|FG003|Double-blind Phase|Withdrawal by Subject|2|||
25259308|NCT01056289|50574466|FG000|Double-blind Phase|Discontinuation symptom|0|||
25259309|NCT01056289|50574467|FG001|Double-blind Phase|Discontinuation symptom|1|||
25259310|NCT01056289|50574468|FG002|Double-blind Phase|Discontinuation symptom|2|||
25259311|NCT01056289|50574469|FG003|Double-blind Phase|Discontinuation symptom|2|||
25259312|NCT01056289|50574466|FG000|Double-blind Phase|Physician Decision|0|||
25259313|NCT01056289|50574467|FG001|Double-blind Phase|Physician Decision|0|||
25259314|NCT01056289|50574468|FG002|Double-blind Phase|Physician Decision|1|||
25259315|NCT01056289|50574469|FG003|Double-blind Phase|Physician Decision|0|||
25259316|NCT01039675|50574481|FG000|Overall Study|Adverse Event|0|||
25259317|NCT01039675|50574482|FG001|Overall Study|Adverse Event|2|||
25259318|NCT01039675|50574481|FG000|Overall Study|Lack of Efficacy|0|||
25259319|NCT01039675|50574482|FG001|Overall Study|Lack of Efficacy|2|||
25259320|NCT01039675|50574481|FG000|Overall Study|Withdrawal by Subject|0|||
25259321|NCT01039675|50574482|FG001|Overall Study|Withdrawal by Subject|1|||
25259322|NCT01039675|50574481|FG000|Overall Study|Lost to Follow-up|0|||
25259323|NCT01039675|50574482|FG001|Overall Study|Lost to Follow-up|1|||
25259324|NCT01039675|50574481|FG000|Overall Study|Physician Decision|0|||
25259325|NCT01039675|50574482|FG001|Overall Study|Physician Decision|1|||
25259326|NCT01033825|50574495|FG000|Overall Study|Withdrawal by Subject|2|||
25259327|NCT01033825|50574496|FG001|Overall Study|Withdrawal by Subject|3|||
25259328|NCT01033825|50574497|FG002|Overall Study|Withdrawal by Subject|2|||
25259329|NCT01033825|50574498|FG003|Overall Study|Withdrawal by Subject|1|||
25259330|NCT01033825|50574499|FG004|Overall Study|Withdrawal by Subject|1|||
25259331|NCT01033825|50574500|FG005|Overall Study|Withdrawal by Subject|0|||
25259332|NCT01033825|50574501|FG006|Overall Study|Withdrawal by Subject|0|||
25259333|NCT01033825|50574495|FG000|Overall Study|Adverse Event|0|||
25259334|NCT01033825|50574496|FG001|Overall Study|Adverse Event|0|||
25259335|NCT01033825|50574497|FG002|Overall Study|Adverse Event|0|||
25259336|NCT01033825|50574498|FG003|Overall Study|Adverse Event|1|||
25259337|NCT01033825|50574499|FG004|Overall Study|Adverse Event|0|||
25259338|NCT01033825|50574500|FG005|Overall Study|Adverse Event|0|||
25259339|NCT01033825|50574501|FG006|Overall Study|Adverse Event|0|||
25259340|NCT01033825|50574495|FG000|Overall Study|Protocol Violation|1|||
25259341|NCT01033825|50574496|FG001|Overall Study|Protocol Violation|0|||
25259342|NCT01033825|50574497|FG002|Overall Study|Protocol Violation|0|||
25259343|NCT01033825|50574498|FG003|Overall Study|Protocol Violation|0|||
25259344|NCT01033825|50574499|FG004|Overall Study|Protocol Violation|0|||
25259345|NCT01033825|50574500|FG005|Overall Study|Protocol Violation|0|||
25259346|NCT01033825|50574501|FG006|Overall Study|Protocol Violation|0|||
25259347|NCT01033825|50574495|FG000|Overall Study|Other|0|||
25259348|NCT01033825|50574496|FG001|Overall Study|Other|0|||
25259349|NCT01033825|50574497|FG002|Overall Study|Other|0|||
25259350|NCT01033825|50574498|FG003|Overall Study|Other|0|||
25259351|NCT01033825|50574499|FG004|Overall Study|Other|1|||
25259352|NCT01033825|50574500|FG005|Overall Study|Other|0|||
25259353|NCT01033825|50574501|FG006|Overall Study|Other|0|||
25259354|NCT01033747|50574521|FG000|Overall Study|Adverse Event|9|||
25259355|NCT01033747|50574522|FG001|Overall Study|Adverse Event|4|||
25259356|NCT01033747|50574521|FG000|Overall Study|Abnormal Laboratory Value|1|||
25259357|NCT01033747|50574522|FG001|Overall Study|Abnormal Laboratory Value|0|||
25259358|NCT01033747|50574521|FG000|Overall Study|Abnormal test procedure|0|||
25259359|NCT01033747|50574522|FG001|Overall Study|Abnormal test procedure|1|||
25259360|NCT01033747|50574521|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
25259361|NCT01033747|50574522|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
25259362|NCT01033747|50574521|FG000|Overall Study|Protocol Violation|1|||
25259363|NCT01033747|50574522|FG001|Overall Study|Protocol Violation|0|||
25259364|NCT01033747|50574521|FG000|Overall Study|Withdrawal by Subject|9|||
25259365|NCT01033747|50574522|FG001|Overall Study|Withdrawal by Subject|6|||
25259366|NCT01033747|50574521|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
25259367|NCT01033747|50574522|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
25259368|NCT01033747|50574521|FG000|Overall Study|Stopped at end of Extension 1|2|||
25259369|NCT01033747|50574522|FG001|Overall Study|Stopped at end of Extension 1|0|||
25259370|NCT01091428|50574532|FG000|Phase 1|Progressive Disease|24|||
25259371|NCT01091428|50574533|FG001|Phase 1|Progressive Disease|8|||
25259372|NCT01091428|50574534|FG002|Phase 1|Progressive Disease|0|||
25259373|NCT01091428|50574535|FG003|Phase 1|Progressive Disease|0|||
25259374|NCT01091428|50574532|FG000|Phase 1|Symptomatic Deterioration|3|||
25259375|NCT01091428|50574533|FG001|Phase 1|Symptomatic Deterioration|2|||
25259376|NCT01091428|50574534|FG002|Phase 1|Symptomatic Deterioration|0|||
25259377|NCT01091428|50574535|FG003|Phase 1|Symptomatic Deterioration|0|||
25259378|NCT01091428|50574532|FG000|Phase 1|Adverse Event|2|||
25259379|NCT01091428|50574533|FG001|Phase 1|Adverse Event|0|||
25259380|NCT01091428|50574534|FG002|Phase 1|Adverse Event|0|||
25259381|NCT01091428|50574535|FG003|Phase 1|Adverse Event|0|||
25259382|NCT01091428|50574532|FG000|Phase 1|Withdrawal by Subject|7|||
25259383|NCT01091428|50574533|FG001|Phase 1|Withdrawal by Subject|0|||
25259384|NCT01091428|50574534|FG002|Phase 1|Withdrawal by Subject|0|||
25259385|NCT01091428|50574535|FG003|Phase 1|Withdrawal by Subject|0|||
25259386|NCT01091428|50574532|FG000|Phase 1|Reason not specified|0|||
25259387|NCT01091428|50574533|FG001|Phase 1|Reason not specified|1|||
25259388|NCT01091428|50574534|FG002|Phase 1|Reason not specified|0|||
25259389|NCT01091428|50574535|FG003|Phase 1|Reason not specified|0|||
25259390|NCT01091428|50574532|FG000|Phase 1|Single-Patient IND|2|||
25259391|NCT01091428|50574533|FG001|Phase 1|Single-Patient IND|0|||
25259392|NCT01091428|50574534|FG002|Phase 1|Single-Patient IND|0|||
25259393|NCT01091428|50574535|FG003|Phase 1|Single-Patient IND|0|||
25259394|NCT01091428|50574532|FG000|Phase 2|Progressive Disease|0|||
25259395|NCT01091428|50574533|FG001|Phase 2|Progressive Disease|0|||
25259396|NCT01091428|50574534|FG002|Phase 2|Progressive Disease|44|||
25259397|NCT01091428|50574535|FG003|Phase 2|Progressive Disease|46|||
25259398|NCT01091428|50574532|FG000|Phase 2|Symptomatic Deterioration|0|||
25259399|NCT01091428|50574533|FG001|Phase 2|Symptomatic Deterioration|0|||
25259400|NCT01091428|50574534|FG002|Phase 2|Symptomatic Deterioration|1|||
25259401|NCT01091428|50574535|FG003|Phase 2|Symptomatic Deterioration|6|||
25259402|NCT01091428|50574532|FG000|Phase 2|Adverse Event|0|||
25259403|NCT01091428|50574533|FG001|Phase 2|Adverse Event|0|||
25259404|NCT01091428|50574534|FG002|Phase 2|Adverse Event|12|||
25259405|NCT01091428|50574535|FG003|Phase 2|Adverse Event|5|||
25259406|NCT01091428|50574532|FG000|Phase 2|Withdrawal by Subject|0|||
25259407|NCT01091428|50574533|FG001|Phase 2|Withdrawal by Subject|0|||
25259408|NCT01091428|50574534|FG002|Phase 2|Withdrawal by Subject|9|||
25259409|NCT01091428|50574535|FG003|Phase 2|Withdrawal by Subject|8|||
25259410|NCT01091428|50574532|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
25259411|NCT01091428|50574533|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
25259412|NCT01091428|50574534|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
25259413|NCT01091428|50574535|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
25259414|NCT01091428|50574532|FG000|Phase 2|Reason not specified|0|||
25259415|NCT01091428|50574533|FG001|Phase 2|Reason not specified|0|||
25259416|NCT01091428|50574534|FG002|Phase 2|Reason not specified|4|||
25259417|NCT01091428|50574535|FG003|Phase 2|Reason not specified|3|||
25259418|NCT01091428|50574532|FG000|Phase 2|Physician Decision|0|||
25259419|NCT01091428|50574533|FG001|Phase 2|Physician Decision|0|||
25259420|NCT01091428|50574534|FG002|Phase 2|Physician Decision|2|||
25259421|NCT01091428|50574535|FG003|Phase 2|Physician Decision|0|||
25259422|NCT01096342|50574554|FG000|Overall Study|Protocol Violation|1|||
25259423|NCT01039519|50574558|FG000|Treatment|Progressive disease|20|||
25259424|NCT01039519|50574558|FG000|Treatment|Treatment failure|2|||
25259425|NCT01039519|50574558|FG000|Treatment|Adverse Event|3|||
25259426|NCT01039519|50574558|FG000|Treatment|Physician Decision|2|||
25259427|NCT01039519|50574558|FG000|Survival Follow-up|Death|23|||
25259428|NCT01039519|50574558|FG000|Survival Follow-up|Sponsor decision|4|||
25259429|NCT01096186|50574562|FG000|Overall Study|Adverse Event|16|||
25259430|NCT01096186|50574562|FG000|Overall Study|Death|4|||
25259431|NCT01096186|50574562|FG000|Overall Study|Lack of Efficacy|4|||
25259432|NCT01096186|50574562|FG000|Overall Study|Lost to Follow-up|2|||
25259433|NCT01096186|50574562|FG000|Overall Study|Withdrawal by Subject|22|||
25259434|NCT01096186|50574562|FG000|Overall Study|Physician Decision|1|||
25259435|NCT01096186|50574562|FG000|Overall Study|Noncompliance with study drug|1|||
25259436|NCT01032889|50574569|FG000|Overall Study|Adverse Event|2|||
25259437|NCT01032889|50574570|FG001|Overall Study|Adverse Event|2|||
25259438|NCT01032889|50574571|FG002|Overall Study|Adverse Event|0|||
25259439|NCT01032889|50574569|FG000|Overall Study|Withdrawal of Consent|1|||
25259440|NCT01032889|50574570|FG001|Overall Study|Withdrawal of Consent|2|||
25259441|NCT01032889|50574571|FG002|Overall Study|Withdrawal of Consent|1|||
25259442|NCT01032889|50574569|FG000|Overall Study|Patient Request|0|||
25259443|NCT01032889|50574570|FG001|Overall Study|Patient Request|1|||
25259444|NCT01032889|50574571|FG002|Overall Study|Patient Request|0|||
25259445|NCT01032889|50574569|FG000|Overall Study|Lost to Follow-up|1|||
25259446|NCT01032889|50574570|FG001|Overall Study|Lost to Follow-up|1|||
25259447|NCT01032889|50574571|FG002|Overall Study|Lost to Follow-up|0|||
25259448|NCT01032889|50574569|FG000|Overall Study|Lack of Submental Fat|2|||
25259449|NCT01032889|50574570|FG001|Overall Study|Lack of Submental Fat|8|||
25259450|NCT01032889|50574571|FG002|Overall Study|Lack of Submental Fat|1|||
25259451|NCT01032889|50574569|FG000|Overall Study|Miscellaneous Reasons|2|||
25259452|NCT01032889|50574570|FG001|Overall Study|Miscellaneous Reasons|1|||
25259453|NCT01032889|50574571|FG002|Overall Study|Miscellaneous Reasons|1|||
25259454|NCT01049503|50574585|FG000|Overall Study|Lost to Follow-up|11|||
25259455|NCT01049503|50574586|FG001|Overall Study|Lost to Follow-up|12|||
25259456|NCT01049503|50574587|FG002|Overall Study|Lost to Follow-up|24|||
25259457|NCT01049503|50574588|FG003|Overall Study|Lost to Follow-up|26|||
25259458|NCT01049503|50574589|FG004|Overall Study|Lost to Follow-up|27|||
25259459|NCT01049503|50574590|FG005|Overall Study|Lost to Follow-up|8|||
25259460|NCT01029925|50574613|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
25259461|NCT01029925|50574613|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
25259462|NCT01029925|50574613|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
25259463|NCT01029691|50574620|FG000|Continued APAP to Delivery|Death|0|||
25259464|NCT01029691|50574621|FG001|Continued APAP to Delivery|Death|0|||
25259465|NCT01029691|50574622|FG002|Continued APAP to Delivery|Death|1|||
25259466|NCT01029535|50574631|FG000|Overall Study|Lost to Follow-up|24|||
25259467|NCT01029535|50574631|FG000|Overall Study|Protocol Violation|2|||
25259468|NCT01029535|50574631|FG000|Overall Study|Participant Withdrew Consent|2|||
25259469|NCT01029535|50574631|FG000|Overall Study|Adverse Event|1|||
25259470|NCT01029535|50574631|FG000|Overall Study|Use of Another Treatment|1|||
25259471|NCT01029535|50574631|FG000|Overall Study|Death|1|||
25259472|NCT01028053|50574636|FG000|Overall Study|Screen Failure|113|||
25259473|NCT01028053|50574636|FG000|Overall Study|Patient Request|11|||
25259474|NCT01028053|50574636|FG000|Overall Study|Protocol Violation|1|||
25259475|NCT01028053|50574636|FG000|Overall Study|Physician Decision|2|||
25259476|NCT01028053|50574636|FG000|Overall Study|Technical Problem|1|||
25259477|NCT01028053|50574636|FG000|Overall Study|Terminated by Sponsor|1|||
25259478|NCT01028053|50574636|FG000|Overall Study|Various reasons|4|||
25259479|NCT01023217|50574644|FG000|Overall Study|Withdrawal by Subject|1|||
25259480|NCT01023217|50574645|FG001|Overall Study|Withdrawal by Subject|0|||
25259481|NCT01095796|50574653|FG000|Overall Study|Randomized but Not Treated|5|||
25259482|NCT01095796|50574654|FG001|Overall Study|Randomized but Not Treated|2|||
25259483|NCT01095796|50574653|FG000|Overall Study|Adverse Event|9|||
25259484|NCT01095796|50574654|FG001|Overall Study|Adverse Event|19|||
25259485|NCT01095796|50574653|FG000|Overall Study|Death|3|||
25259486|NCT01095796|50574654|FG001|Overall Study|Death|2|||
25259487|NCT01095796|50574653|FG000|Overall Study|Pregnancy|2|||
25259488|NCT01095796|50574654|FG001|Overall Study|Pregnancy|0|||
25259489|NCT01095796|50574653|FG000|Overall Study|Lack of Efficacy|5|||
25259490|NCT01095796|50574654|FG001|Overall Study|Lack of Efficacy|3|||
25259491|NCT01095796|50574653|FG000|Overall Study|Investigator's Discretion|7|||
25259492|NCT01095796|50574654|FG001|Overall Study|Investigator's Discretion|2|||
25259493|NCT01095796|50574653|FG000|Overall Study|Withdrew Consent|16|||
25259494|NCT01095796|50574654|FG001|Overall Study|Withdrew Consent|22|||
25259495|NCT01095796|50574653|FG000|Overall Study|Lost to Follow-up|27|||
25259496|NCT01095796|50574654|FG001|Overall Study|Lost to Follow-up|29|||
25259497|NCT01095796|50574653|FG000|Overall Study|Participant Noncompliance|5|||
25259498|NCT01095796|50574654|FG001|Overall Study|Participant Noncompliance|10|||
25259499|NCT01095796|50574653|FG000|Overall Study|Protocol Violation|1|||
25259500|NCT01095796|50574654|FG001|Overall Study|Protocol Violation|0|||
25259501|NCT01095796|50574653|FG000|Overall Study|Participant Transferred to Another Study|215|||
25259502|NCT01095796|50574654|FG001|Overall Study|Participant Transferred to Another Study|200|||
25259503|NCT01023061|50574660|FG000|Overall Study|Withdrawal prior to treatment|2|||
25259504|NCT01027897|50574664|FG000|Overall Study|Protocol Violation|1|||
25259505|NCT01027897|50574664|FG000|Overall Study|Withdrawal by Subject|1|||
25259506|NCT01027351|50574674|FG000|Overall Study|Withdrawal by Subject|1|||
25259507|NCT01027351|50574675|FG001|Overall Study|Withdrawal by Subject|0|||
25259508|NCT01027351|50574676|FG002|Overall Study|Withdrawal by Subject|1|||
25259509|NCT01027351|50574677|FG003|Overall Study|Withdrawal by Subject|0|||
25259510|NCT01027351|50574678|FG004|Overall Study|Withdrawal by Subject|3|||
25259511|NCT01027351|50574679|FG005|Overall Study|Withdrawal by Subject|5|||
25259512|NCT01027351|50574674|FG000|Overall Study|Lost to Follow-up|1|||
25259513|NCT01027351|50574675|FG001|Overall Study|Lost to Follow-up|1|||
25259514|NCT01027351|50574676|FG002|Overall Study|Lost to Follow-up|0|||
25259515|NCT01027351|50574677|FG003|Overall Study|Lost to Follow-up|1|||
25259516|NCT01027351|50574678|FG004|Overall Study|Lost to Follow-up|6|||
25259517|NCT01027351|50574679|FG005|Overall Study|Lost to Follow-up|0|||
25259518|NCT01027351|50574674|FG000|Overall Study|Inappropriate enrollment|0|||
25259519|NCT01027351|50574675|FG001|Overall Study|Inappropriate enrollment|0|||
25259520|NCT01027351|50574676|FG002|Overall Study|Inappropriate enrollment|0|||
25259521|NCT01027351|50574677|FG003|Overall Study|Inappropriate enrollment|0|||
25259522|NCT01027351|50574678|FG004|Overall Study|Inappropriate enrollment|1|||
25259523|NCT01027351|50574679|FG005|Overall Study|Inappropriate enrollment|0|||
25259524|NCT01027351|50574674|FG000|Overall Study|Protocol Violation|1|||
25259525|NCT01027351|50574675|FG001|Overall Study|Protocol Violation|0|||
25259526|NCT01027351|50574676|FG002|Overall Study|Protocol Violation|0|||
25259527|NCT01027351|50574677|FG003|Overall Study|Protocol Violation|1|||
25259528|NCT01027351|50574678|FG004|Overall Study|Protocol Violation|1|||
25259529|NCT01027351|50574679|FG005|Overall Study|Protocol Violation|0|||
25259530|NCT01027273|50574702|FG000|Overall Study|Lost to Follow-up|57|||
25259531|NCT01027273|50574703|FG001|Overall Study|Lost to Follow-up|31|||
25259532|NCT01027273|50574702|FG000|Overall Study|Death|2|||
25259533|NCT01027273|50574703|FG001|Overall Study|Death|2|||
25259534|NCT01022203|50574711|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
25259535|NCT01022203|50574712|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
25259536|NCT01022203|50574711|FG000|Post Treatment Assessment|Physician Decision|2|||
25259537|NCT01022203|50574712|FG001|Post Treatment Assessment|Physician Decision|0|||
25259538|NCT01022203|50574711|FG000|Post Treatment Assessment|Adverse Event|0|||
25259539|NCT01022203|50574712|FG001|Post Treatment Assessment|Adverse Event|2|||
25259540|NCT01022203|50574711|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
25259541|NCT01022203|50574712|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
25259542|NCT01296711|50574729|FG000|Overall Study|Adverse Event|3|||
25259543|NCT01296711|50574730|FG001|Overall Study|Adverse Event|1|||
25259544|NCT01296711|50574731|FG002|Overall Study|Adverse Event|4|||
25259545|NCT01296711|50574732|FG003|Overall Study|Adverse Event|3|||
25259546|NCT01296711|50574733|FG004|Overall Study|Adverse Event|1|||
25259547|NCT01296711|50574734|FG005|Overall Study|Adverse Event|6|||
25259548|NCT01296711|50574735|FG006|Overall Study|Adverse Event|11|||
25259549|NCT01296711|50574736|FG007|Overall Study|Adverse Event|3|||
25259550|NCT01296711|50574729|FG000|Overall Study|Lack of Efficacy|1|||
25259551|NCT01296711|50574730|FG001|Overall Study|Lack of Efficacy|4|||
25259552|NCT01296711|50574731|FG002|Overall Study|Lack of Efficacy|1|||
25259553|NCT01296711|50574732|FG003|Overall Study|Lack of Efficacy|1|||
25259554|NCT01296711|50574733|FG004|Overall Study|Lack of Efficacy|1|||
25259555|NCT01296711|50574734|FG005|Overall Study|Lack of Efficacy|0|||
25259556|NCT01296711|50574735|FG006|Overall Study|Lack of Efficacy|2|||
25259557|NCT01296711|50574736|FG007|Overall Study|Lack of Efficacy|3|||
25259558|NCT01296711|50574729|FG000|Overall Study|Lost to Follow-up|0|||
25259559|NCT01296711|50574730|FG001|Overall Study|Lost to Follow-up|0|||
25259560|NCT01296711|50574731|FG002|Overall Study|Lost to Follow-up|1|||
25259561|NCT01296711|50574732|FG003|Overall Study|Lost to Follow-up|1|||
25259562|NCT01296711|50574733|FG004|Overall Study|Lost to Follow-up|2|||
25259563|NCT01296711|50574734|FG005|Overall Study|Lost to Follow-up|0|||
25259564|NCT01296711|50574735|FG006|Overall Study|Lost to Follow-up|4|||
25259565|NCT01296711|50574736|FG007|Overall Study|Lost to Follow-up|2|||
25259566|NCT01296711|50574729|FG000|Overall Study|Protocol Violation|0|||
25259567|NCT01296711|50574730|FG001|Overall Study|Protocol Violation|0|||
25259568|NCT01296711|50574731|FG002|Overall Study|Protocol Violation|0|||
25259569|NCT01296711|50574732|FG003|Overall Study|Protocol Violation|1|||
25259570|NCT01296711|50574733|FG004|Overall Study|Protocol Violation|1|||
25259571|NCT01296711|50574734|FG005|Overall Study|Protocol Violation|0|||
25259572|NCT01296711|50574735|FG006|Overall Study|Protocol Violation|0|||
25259573|NCT01296711|50574736|FG007|Overall Study|Protocol Violation|0|||
25259574|NCT01296711|50574729|FG000|Overall Study|Withdrawal by Subject|4|||
25259575|NCT01296711|50574730|FG001|Overall Study|Withdrawal by Subject|2|||
25259576|NCT01296711|50574731|FG002|Overall Study|Withdrawal by Subject|2|||
25259577|NCT01296711|50574732|FG003|Overall Study|Withdrawal by Subject|1|||
25259578|NCT01296711|50574733|FG004|Overall Study|Withdrawal by Subject|1|||
25259579|NCT01296711|50574734|FG005|Overall Study|Withdrawal by Subject|1|||
25259580|NCT01296711|50574735|FG006|Overall Study|Withdrawal by Subject|2|||
25259581|NCT01296711|50574736|FG007|Overall Study|Withdrawal by Subject|1|||
25259582|NCT01296711|50574729|FG000|Overall Study|Study termination|8|||
25259583|NCT01296711|50574730|FG001|Overall Study|Study termination|1|||
25259584|NCT01296711|50574731|FG002|Overall Study|Study termination|5|||
25259585|NCT01296711|50574732|FG003|Overall Study|Study termination|4|||
25259586|NCT01296711|50574733|FG004|Overall Study|Study termination|4|||
25259587|NCT01296711|50574734|FG005|Overall Study|Study termination|4|||
25259588|NCT01296711|50574735|FG006|Overall Study|Study termination|8|||
25259589|NCT01296711|50574736|FG007|Overall Study|Study termination|10|||
25259590|NCT01296711|50574729|FG000|Overall Study|Continued elevated liver enzymes|0|||
25259591|NCT01296711|50574730|FG001|Overall Study|Continued elevated liver enzymes|0|||
25259592|NCT01296711|50574731|FG002|Overall Study|Continued elevated liver enzymes|0|||
25259593|NCT01296711|50574732|FG003|Overall Study|Continued elevated liver enzymes|1|||
25259594|NCT01296711|50574733|FG004|Overall Study|Continued elevated liver enzymes|0|||
25259595|NCT01296711|50574734|FG005|Overall Study|Continued elevated liver enzymes|0|||
25259596|NCT01296711|50574735|FG006|Overall Study|Continued elevated liver enzymes|0|||
25259597|NCT01296711|50574736|FG007|Overall Study|Continued elevated liver enzymes|0|||
25259598|NCT01296711|50574729|FG000|Overall Study|Methotrexate discontinued|0|||
25259599|NCT01296711|50574730|FG001|Overall Study|Methotrexate discontinued|0|||
25259600|NCT01296711|50574731|FG002|Overall Study|Methotrexate discontinued|0|||
25259601|NCT01296711|50574732|FG003|Overall Study|Methotrexate discontinued|1|||
25259602|NCT01296711|50574733|FG004|Overall Study|Methotrexate discontinued|0|||
25259603|NCT01296711|50574734|FG005|Overall Study|Methotrexate discontinued|0|||
25259604|NCT01296711|50574735|FG006|Overall Study|Methotrexate discontinued|0|||
25259605|NCT01296711|50574736|FG007|Overall Study|Methotrexate discontinued|0|||
25259606|NCT01296711|50574729|FG000|Overall Study|Investigator discretion|0|||
25259607|NCT01296711|50574730|FG001|Overall Study|Investigator discretion|0|||
25259608|NCT01296711|50574731|FG002|Overall Study|Investigator discretion|0|||
25259609|NCT01296711|50574732|FG003|Overall Study|Investigator discretion|0|||
25259610|NCT01296711|50574733|FG004|Overall Study|Investigator discretion|0|||
25259611|NCT01296711|50574734|FG005|Overall Study|Investigator discretion|0|||
25259612|NCT01296711|50574735|FG006|Overall Study|Investigator discretion|1|||
25259613|NCT01296711|50574736|FG007|Overall Study|Investigator discretion|0|||
25259614|NCT01296711|50574729|FG000|Overall Study|Other|0|||
25259615|NCT01296711|50574730|FG001|Overall Study|Other|0|||
25259616|NCT01296711|50574731|FG002|Overall Study|Other|0|||
25259617|NCT01296711|50574732|FG003|Overall Study|Other|0|||
25259618|NCT01296711|50574733|FG004|Overall Study|Other|0|||
25259619|NCT01296711|50574734|FG005|Overall Study|Other|0|||
25259620|NCT01296711|50574735|FG006|Overall Study|Other|1|||
25259621|NCT01296711|50574736|FG007|Overall Study|Other|0|||
25259622|NCT01296711|50574729|FG000|Overall Study|Required restricted steroid injections|0|||
25259623|NCT01296711|50574730|FG001|Overall Study|Required restricted steroid injections|0|||
25259624|NCT01296711|50574731|FG002|Overall Study|Required restricted steroid injections|0|||
25259625|NCT01296711|50574732|FG003|Overall Study|Required restricted steroid injections|0|||
25259626|NCT01296711|50574733|FG004|Overall Study|Required restricted steroid injections|0|||
25259627|NCT01296711|50574734|FG005|Overall Study|Required restricted steroid injections|0|||
25259628|NCT01296711|50574735|FG006|Overall Study|Required restricted steroid injections|1|||
25259629|NCT01296711|50574736|FG007|Overall Study|Required restricted steroid injections|0|||
25259630|NCT01296711|50574729|FG000|Overall Study|Ongoing missed appointments|0|||
25259631|NCT01296711|50574730|FG001|Overall Study|Ongoing missed appointments|0|||
25259632|NCT01296711|50574731|FG002|Overall Study|Ongoing missed appointments|0|||
25259633|NCT01296711|50574732|FG003|Overall Study|Ongoing missed appointments|0|||
25259634|NCT01296711|50574733|FG004|Overall Study|Ongoing missed appointments|0|||
25259635|NCT01296711|50574734|FG005|Overall Study|Ongoing missed appointments|0|||
25259636|NCT01296711|50574735|FG006|Overall Study|Ongoing missed appointments|1|||
25259637|NCT01296711|50574736|FG007|Overall Study|Ongoing missed appointments|0|||
25259638|NCT01296711|50574729|FG000|Overall Study|Failure to comply with visits|0|||
25259639|NCT01296711|50574730|FG001|Overall Study|Failure to comply with visits|0|||
24993861|NCT00054639|50084522|FG000|Overall Study|Physician Decision|1|||
25259640|NCT01296711|50574731|FG002|Overall Study|Failure to comply with visits|0|||
25259641|NCT01296711|50574732|FG003|Overall Study|Failure to comply with visits|0|||
25259642|NCT01296711|50574733|FG004|Overall Study|Failure to comply with visits|0|||
25259643|NCT01296711|50574734|FG005|Overall Study|Failure to comply with visits|0|||
25259644|NCT01296711|50574735|FG006|Overall Study|Failure to comply with visits|0|||
25259645|NCT01296711|50574736|FG007|Overall Study|Failure to comply with visits|1|||
25259646|NCT01296711|50574729|FG000|Overall Study|Patient decision due to transport|0|||
25259647|NCT01296711|50574730|FG001|Overall Study|Patient decision due to transport|0|||
25259648|NCT01296711|50574731|FG002|Overall Study|Patient decision due to transport|0|||
25259649|NCT01296711|50574732|FG003|Overall Study|Patient decision due to transport|0|||
25259650|NCT01296711|50574733|FG004|Overall Study|Patient decision due to transport|0|||
25259651|NCT01296711|50574734|FG005|Overall Study|Patient decision due to transport|0|||
25259652|NCT01296711|50574735|FG006|Overall Study|Patient decision due to transport|0|||
25259653|NCT01296711|50574736|FG007|Overall Study|Patient decision due to transport|1|||
25259654|NCT01294917|50574754|FG000|Overall Study|Relocation|5|||
25259655|NCT01294917|50574754|FG000|Overall Study|Inconvenience|1|||
25259656|NCT01294683|50574762|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
25259657|NCT01294683|50574763|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
25259658|NCT01294683|50574762|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
25259659|NCT01294683|50574763|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
25259660|NCT01294683|50574762|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
25259661|NCT01294683|50574763|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
25259662|NCT01294683|50574762|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
25259663|NCT01294683|50574763|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
25259664|NCT01294683|50574762|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
25259665|NCT01294683|50574763|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
25259666|NCT01294683|50574762|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
25259667|NCT01294683|50574763|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
25259668|NCT01294683|50574762|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
25259669|NCT01294683|50574763|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
25259670|NCT01294683|50574762|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
25259671|NCT01294683|50574763|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
25259672|NCT01294683|50574762|FG000|Post Crossover (Period III)|Adverse Event|6|||
25259673|NCT01294683|50574763|FG001|Post Crossover (Period III)|Adverse Event|6|||
25259674|NCT01294683|50574762|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
25259675|NCT01294683|50574763|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
25259676|NCT01294683|50574762|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
25259677|NCT01294683|50574763|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
25259678|NCT01294683|50574762|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
25259679|NCT01294683|50574763|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
25259680|NCT01294449|50574777|FG000|Overall Study|Death|11|||
25259681|NCT01294449|50574778|FG001|Overall Study|Death|12|||
25259682|NCT01294449|50574777|FG000|Overall Study|Withdrawal by Subject|1|||
25259683|NCT01294449|50574778|FG001|Overall Study|Withdrawal by Subject|3|||
25259684|NCT01294371|50574784|FG000|Overall Study|Adverse Event|1|||
25259685|NCT01294371|50574784|FG000|Overall Study|Withdrawal by Subject|12|||
25259686|NCT01294371|50574784|FG000|Overall Study|Lost to Follow-up|6|||
25259687|NCT01294371|50574784|FG000|Overall Study|Administrative Reason|1|||
25259688|NCT01294371|50574784|FG000|Overall Study|Other|14|||
25259689|NCT01293123|50574793|FG000|Overall Study|Lost to Follow-up|0|||
25259690|NCT01293123|50574794|FG001|Overall Study|Lost to Follow-up|1|||
25259691|NCT01292187|50574802|FG000|Overall Study|Adverse Event|10|||
25259692|NCT01292187|50574803|FG001|Overall Study|Adverse Event|5|||
25259693|NCT01292187|50574802|FG000|Overall Study|Withdrawal by Subject|6|||
25259694|NCT01292187|50574803|FG001|Overall Study|Withdrawal by Subject|5|||
25259695|NCT01292187|50574802|FG000|Overall Study|All other reasons|1|||
25259696|NCT01292187|50574803|FG001|Overall Study|All other reasons|3|||
25259697|NCT01026493|50574818|FG000|Overall Study|Protocol Violation|0|||
25259698|NCT01026493|50574819|FG001|Overall Study|Protocol Violation|1|||
25259699|NCT01026493|50574820|FG002|Overall Study|Protocol Violation|0|||
25259700|NCT01026493|50574821|FG003|Overall Study|Protocol Violation|0|||
25259701|NCT01026493|50574822|FG004|Overall Study|Protocol Violation|2|||
25259702|NCT01026493|50574823|FG005|Overall Study|Protocol Violation|3|||
25259703|NCT01026493|50574824|FG006|Overall Study|Protocol Violation|4|||
25259704|NCT01026493|50574825|FG007|Overall Study|Protocol Violation|1|||
25259705|NCT01026103|50574843|FG000|Overall Study|Physician Decision|1|||
25259706|NCT01026103|50574843|FG000|Overall Study|did not receive study device bc of error|1|||
25259707|NCT01291173|50574851|FG000|Overall Study|Adverse Event|0|||
25259708|NCT01291173|50574852|FG001|Overall Study|Adverse Event|3|||
25259709|NCT01291173|50574853|FG002|Overall Study|Adverse Event|1|||
25259710|NCT01291173|50574854|FG003|Overall Study|Adverse Event|3|||
25259711|NCT01291173|50574851|FG000|Overall Study|Protocol Violation|7|||
25259712|NCT01291173|50574852|FG001|Overall Study|Protocol Violation|2|||
25259713|NCT01291173|50574853|FG002|Overall Study|Protocol Violation|2|||
25259714|NCT01291173|50574854|FG003|Overall Study|Protocol Violation|5|||
25259715|NCT01291173|50574851|FG000|Overall Study|Withdrawal by Subject|6|||
25259716|NCT01291173|50574852|FG001|Overall Study|Withdrawal by Subject|4|||
25259717|NCT01291173|50574853|FG002|Overall Study|Withdrawal by Subject|4|||
25259718|NCT01291173|50574854|FG003|Overall Study|Withdrawal by Subject|2|||
25259719|NCT01291173|50574851|FG000|Overall Study|Lost to Follow-up|4|||
25259720|NCT01291173|50574852|FG001|Overall Study|Lost to Follow-up|6|||
25259721|NCT01291173|50574853|FG002|Overall Study|Lost to Follow-up|3|||
25259722|NCT01291173|50574854|FG003|Overall Study|Lost to Follow-up|2|||
25259723|NCT01291173|50574851|FG000|Overall Study|Unable to meet visit schedule|0|||
25259724|NCT01291173|50574852|FG001|Overall Study|Unable to meet visit schedule|0|||
25259725|NCT01291173|50574853|FG002|Overall Study|Unable to meet visit schedule|1|||
25259726|NCT01291173|50574854|FG003|Overall Study|Unable to meet visit schedule|0|||
25259727|NCT01291173|50574851|FG000|Overall Study|Lack of compliance|0|||
25259728|NCT01291173|50574852|FG001|Overall Study|Lack of compliance|0|||
25259729|NCT01291173|50574853|FG002|Overall Study|Lack of compliance|0|||
25259730|NCT01291173|50574854|FG003|Overall Study|Lack of compliance|1|||
25259731|NCT01291173|50574851|FG000|Overall Study|Subject was unblinded|0|||
25259732|NCT01291173|50574852|FG001|Overall Study|Subject was unblinded|0|||
25259733|NCT01291173|50574853|FG002|Overall Study|Subject was unblinded|1|||
25259734|NCT01291173|50574854|FG003|Overall Study|Subject was unblinded|0|||
25259735|NCT01291173|50574851|FG000|Overall Study|Excluded therapy|0|||
25259736|NCT01291173|50574852|FG001|Overall Study|Excluded therapy|0|||
25259737|NCT01291173|50574853|FG002|Overall Study|Excluded therapy|1|||
25259738|NCT01291173|50574854|FG003|Overall Study|Excluded therapy|0|||
25259739|NCT01291017|50574864|FG000|Overall Study|Lost to Follow-up|2|||
25259740|NCT01291017|50574864|FG000|Overall Study|Withdrawal by Subject|3|||
25259741|NCT01290315|50574872|FG000|Overall Study|Adverse Event|0|||
25259742|NCT01290315|50574873|FG001|Overall Study|Adverse Event|0|||
25259743|NCT01290315|50574874|FG002|Overall Study|Adverse Event|0|||
25259744|NCT01290315|50574875|FG003|Overall Study|Adverse Event|3|||
25259745|NCT01290315|50574872|FG000|Overall Study|Selection criteria/compliance|2|||
25259746|NCT01290315|50574873|FG001|Overall Study|Selection criteria/compliance|1|||
25259747|NCT01290315|50574874|FG002|Overall Study|Selection criteria/compliance|0|||
25259748|NCT01290315|50574875|FG003|Overall Study|Selection criteria/compliance|2|||
25259749|NCT01290315|50574872|FG000|Overall Study|Lost to Follow-up|0|||
25259750|NCT01290315|50574873|FG001|Overall Study|Lost to Follow-up|1|||
25259751|NCT01290315|50574874|FG002|Overall Study|Lost to Follow-up|0|||
25259752|NCT01290315|50574875|FG003|Overall Study|Lost to Follow-up|0|||
25259753|NCT01290315|50574872|FG000|Overall Study|Withdrawal by Subject|1|||
25259754|NCT01290315|50574873|FG001|Overall Study|Withdrawal by Subject|1|||
25259755|NCT01290315|50574874|FG002|Overall Study|Withdrawal by Subject|0|||
25259756|NCT01290315|50574875|FG003|Overall Study|Withdrawal by Subject|0|||
25259757|NCT01289847|50574884|FG000|Overall Study|Patient could not comply with visits|1|||
25259758|NCT01079182|50574888|FG000|Overall Study|Lost to Follow-up|1634|||
25259759|NCT01079182|50574888|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
25259760|NCT01079182|50574888|FG000|Overall Study|Lack of Efficacy|514|||
25259761|NCT01079182|50574888|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
25259762|NCT01079182|50574888|FG000|Overall Study|Reasons not Evaluated|271|||
25259763|NCT01021813|50574894|FG000|DB Treatment Phase|Adverse Event|60|||
25259764|NCT01021813|50574895|FG001|DB Treatment Phase|Adverse Event|22|||
25259765|NCT01021813|50574896|FG002|DB Treatment Phase|Adverse Event|0|||
25259766|NCT01021813|50574897|FG003|DB Treatment Phase|Adverse Event|0|||
25259767|NCT01021813|50574898|FG004|DB Treatment Phase|Adverse Event|0|||
25259768|NCT01021813|50574894|FG000|DB Treatment Phase|Lack of Efficacy|44|||
25259769|NCT01021813|50574895|FG001|DB Treatment Phase|Lack of Efficacy|28|||
25259770|NCT01021813|50574896|FG002|DB Treatment Phase|Lack of Efficacy|0|||
25259771|NCT01021813|50574897|FG003|DB Treatment Phase|Lack of Efficacy|0|||
25259772|NCT01021813|50574898|FG004|DB Treatment Phase|Lack of Efficacy|0|||
25259773|NCT01021813|50574894|FG000|DB Treatment Phase|Lost to Follow-up|14|||
25259774|NCT01021813|50574895|FG001|DB Treatment Phase|Lost to Follow-up|12|||
25259775|NCT01021813|50574896|FG002|DB Treatment Phase|Lost to Follow-up|0|||
25259776|NCT01021813|50574897|FG003|DB Treatment Phase|Lost to Follow-up|0|||
25259777|NCT01021813|50574898|FG004|DB Treatment Phase|Lost to Follow-up|0|||
25259778|NCT01021813|50574894|FG000|DB Treatment Phase|Physician Decision|17|||
25259779|NCT01021813|50574895|FG001|DB Treatment Phase|Physician Decision|8|||
25259780|NCT01021813|50574896|FG002|DB Treatment Phase|Physician Decision|0|||
25259781|NCT01021813|50574897|FG003|DB Treatment Phase|Physician Decision|0|||
25259782|NCT01021813|50574898|FG004|DB Treatment Phase|Physician Decision|0|||
25259783|NCT01021813|50574894|FG000|DB Treatment Phase|Pregnancy|1|||
25259784|NCT01021813|50574895|FG001|DB Treatment Phase|Pregnancy|0|||
25259785|NCT01021813|50574896|FG002|DB Treatment Phase|Pregnancy|0|||
25259786|NCT01021813|50574897|FG003|DB Treatment Phase|Pregnancy|0|||
25259787|NCT01021813|50574898|FG004|DB Treatment Phase|Pregnancy|0|||
25259788|NCT01021813|50574894|FG000|DB Treatment Phase|Protocol Violation|4|||
25259789|NCT01021813|50574895|FG001|DB Treatment Phase|Protocol Violation|3|||
25259790|NCT01021813|50574896|FG002|DB Treatment Phase|Protocol Violation|0|||
25259791|NCT01021813|50574897|FG003|DB Treatment Phase|Protocol Violation|0|||
25259792|NCT01021813|50574898|FG004|DB Treatment Phase|Protocol Violation|0|||
25259793|NCT01021813|50574894|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
25259794|NCT01021813|50574895|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
25259795|NCT01021813|50574896|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
25259796|NCT01021813|50574897|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
25259797|NCT01021813|50574898|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
25259798|NCT01021813|50574894|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
25259799|NCT01021813|50574895|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
25259800|NCT01021813|50574896|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
25259801|NCT01021813|50574897|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
25259802|NCT01021813|50574898|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
25259803|NCT01021813|50574894|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
25259804|NCT01021813|50574895|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
25259805|NCT01021813|50574896|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
25259806|NCT01021813|50574897|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
25259807|NCT01021813|50574898|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
25259808|NCT01021813|50574894|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
25259809|NCT01021813|50574895|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
25259810|NCT01021813|50574896|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
25259811|NCT01021813|50574897|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
25259812|NCT01021813|50574898|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
25259813|NCT01021813|50574894|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
25082851|NCT02425891|50191624|FG000|Overall Study|Lost to Follow-up|4|||
25081100|NCT01111565|50189516|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
25081101|NCT01111565|50189517|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
25081102|NCT02343458|50189531|FG000|Overall Study|Adverse Event|15|||
25081103|NCT02343458|50189532|FG001|Overall Study|Adverse Event|14|||
25081104|NCT02343458|50189533|FG002|Overall Study|Adverse Event|15|||
25081105|NCT02343458|50189534|FG003|Overall Study|Adverse Event|3|||
25081106|NCT02343458|50189531|FG000|Overall Study|Lack of Efficacy|3|||
25081107|NCT02343458|50189532|FG001|Overall Study|Lack of Efficacy|8|||
25081108|NCT02343458|50189533|FG002|Overall Study|Lack of Efficacy|4|||
25081109|NCT02343458|50189534|FG003|Overall Study|Lack of Efficacy|8|||
25081110|NCT02343458|50189531|FG000|Overall Study|Withdrawal by Subject|18|||
25081111|NCT02343458|50189532|FG001|Overall Study|Withdrawal by Subject|17|||
25081112|NCT02343458|50189533|FG002|Overall Study|Withdrawal by Subject|23|||
25081113|NCT02343458|50189534|FG003|Overall Study|Withdrawal by Subject|14|||
25081114|NCT02343458|50189531|FG000|Overall Study|Physician Decision|1|||
25081115|NCT02343458|50189532|FG001|Overall Study|Physician Decision|4|||
25081116|NCT02343458|50189533|FG002|Overall Study|Physician Decision|2|||
25081117|NCT02343458|50189534|FG003|Overall Study|Physician Decision|2|||
25081118|NCT02343458|50189531|FG000|Overall Study|Lost to Follow-up|5|||
25081119|NCT02343458|50189532|FG001|Overall Study|Lost to Follow-up|5|||
25081120|NCT02343458|50189533|FG002|Overall Study|Lost to Follow-up|3|||
25081121|NCT02343458|50189534|FG003|Overall Study|Lost to Follow-up|1|||
25081122|NCT02343458|50189531|FG000|Overall Study|Protocol Violation|2|||
25081123|NCT02343458|50189532|FG001|Overall Study|Protocol Violation|5|||
25081124|NCT02343458|50189533|FG002|Overall Study|Protocol Violation|2|||
25081125|NCT02343458|50189534|FG003|Overall Study|Protocol Violation|2|||
25081126|NCT02343458|50189531|FG000|Overall Study|Protocol Specified Criteria|17|||
25081127|NCT02343458|50189532|FG001|Overall Study|Protocol Specified Criteria|13|||
25081128|NCT02343458|50189533|FG002|Overall Study|Protocol Specified Criteria|14|||
25081129|NCT02343458|50189534|FG003|Overall Study|Protocol Specified Criteria|8|||
25081130|NCT01328041|50189557|FG000|Overall Study|Adverse Event|7|||
25081131|NCT01328041|50189557|FG000|Overall Study|Lack of Efficacy|27|||
25081132|NCT01328041|50189557|FG000|Overall Study|Protocol Violation|7|||
25081133|NCT01328041|50189557|FG000|Overall Study|Lost to Follow-up|7|||
25081134|NCT01328041|50189557|FG000|Overall Study|Physician Decision|2|||
25081135|NCT01328041|50189557|FG000|Overall Study|Withdrawal by Subject|7|||
25081136|NCT02410772|50189564|FG000|Overall Study|Death|3|||
25081137|NCT02410772|50189565|FG001|Overall Study|Death|4|||
25081138|NCT02410772|50189566|FG002|Overall Study|Death|8|||
25081139|NCT02410772|50189564|FG000|Overall Study|Lost to Follow-up|31|||
25081140|NCT02410772|50189565|FG001|Overall Study|Lost to Follow-up|23|||
25081141|NCT02410772|50189566|FG002|Overall Study|Lost to Follow-up|22|||
25081142|NCT02410772|50189564|FG000|Overall Study|Pregnancy|8|||
25081143|NCT02410772|50189565|FG001|Overall Study|Pregnancy|4|||
25081144|NCT02410772|50189566|FG002|Overall Study|Pregnancy|5|||
25081145|NCT02410772|50189564|FG000|Overall Study|Protocol Violation|8|||
25081146|NCT02410772|50189565|FG001|Overall Study|Protocol Violation|8|||
25081147|NCT02410772|50189566|FG002|Overall Study|Protocol Violation|4|||
25081148|NCT02410772|50189564|FG000|Overall Study|Baseline Drug Resistance|49|||
25081149|NCT02410772|50189565|FG001|Overall Study|Baseline Drug Resistance|40|||
25081150|NCT02410772|50189566|FG002|Overall Study|Baseline Drug Resistance|51|||
25081151|NCT02410772|50189564|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
25081152|NCT02410772|50189565|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
25081153|NCT02410772|50189566|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
25081154|NCT02410772|50189564|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
25081155|NCT02410772|50189565|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
25081156|NCT02410772|50189566|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
25081157|NCT01648790|50189583|FG000|Treatment 3|Withdrawal by Subject|0|||
25081158|NCT01648790|50189584|FG001|Treatment 3|Withdrawal by Subject|0|||
25081159|NCT01648790|50189585|FG002|Treatment 3|Withdrawal by Subject|0|||
25081160|NCT01648790|50189586|FG003|Treatment 3|Withdrawal by Subject|1|||
25081161|NCT01648790|50189587|FG004|Treatment 3|Withdrawal by Subject|0|||
25081162|NCT01936857|50189610|FG000|Overall Study|Sent to prison or 06 center|11|||
25081163|NCT01936857|50189611|FG001|Overall Study|Sent to prison or 06 center|12|||
25081164|NCT01936857|50189610|FG000|Overall Study|Lost to Follow-up|10|||
25081165|NCT01936857|50189611|FG001|Overall Study|Lost to Follow-up|7|||
25081166|NCT01936857|50189610|FG000|Overall Study|Death|7|||
25081167|NCT01936857|50189611|FG001|Overall Study|Death|3|||
25081168|NCT01936857|50189610|FG000|Overall Study|Moved|2|||
25081169|NCT01936857|50189611|FG001|Overall Study|Moved|1|||
25081170|NCT01936857|50189610|FG000|Overall Study|Withdrawal by Subject|1|||
25081171|NCT01936857|50189611|FG001|Overall Study|Withdrawal by Subject|0|||
25081172|NCT01936857|50189610|FG000|Overall Study|Side effect of medication|1|||
25081173|NCT01936857|50189611|FG001|Overall Study|Side effect of medication|0|||
25081174|NCT01936857|50189610|FG000|Overall Study|Other|2|||
25081175|NCT01936857|50189611|FG001|Overall Study|Other|2|||
25081176|NCT01602224|50189620|FG000|Overall Study|Adverse Event|0|||
25081177|NCT01602224|50189621|FG001|Overall Study|Adverse Event|1|||
25081178|NCT01602224|50189622|FG002|Overall Study|Adverse Event|0|||
25081179|NCT01602224|50189620|FG000|Overall Study|Investigator Decison|1|||
25081180|NCT01602224|50189621|FG001|Overall Study|Investigator Decison|0|||
25081181|NCT01602224|50189622|FG002|Overall Study|Investigator Decison|0|||
25081182|NCT01602224|50189620|FG000|Overall Study|Lost to Follow-up|0|||
25081183|NCT01602224|50189621|FG001|Overall Study|Lost to Follow-up|0|||
25081184|NCT01602224|50189622|FG002|Overall Study|Lost to Follow-up|1|||
25081185|NCT01602224|50189620|FG000|Overall Study|Protocol Violation|0|||
25081186|NCT01602224|50189621|FG001|Overall Study|Protocol Violation|1|||
25081187|NCT01602224|50189622|FG002|Overall Study|Protocol Violation|0|||
25081188|NCT01602224|50189620|FG000|Overall Study|Sponsor Decision|2|||
25081189|NCT01602224|50189621|FG001|Overall Study|Sponsor Decision|3|||
25081190|NCT01602224|50189622|FG002|Overall Study|Sponsor Decision|2|||
25081191|NCT01602224|50189620|FG000|Overall Study|Withdrawal by Subject|5|||
25081192|NCT01602224|50189621|FG001|Overall Study|Withdrawal by Subject|3|||
25081193|NCT01602224|50189622|FG002|Overall Study|Withdrawal by Subject|3|||
25081194|NCT04498247|50189640|FG000|Overall Study|Lost to Follow-up|0|||
25081195|NCT04498247|50189641|FG001|Overall Study|Lost to Follow-up|0|||
25081196|NCT04498247|50189642|FG002|Overall Study|Lost to Follow-up|0|||
25081197|NCT04498247|50189643|FG003|Overall Study|Lost to Follow-up|1|||
25081198|NCT04498247|50189644|FG004|Overall Study|Lost to Follow-up|0|||
25081199|NCT04498247|50189645|FG005|Overall Study|Lost to Follow-up|0|||
25081200|NCT04498247|50189646|FG006|Overall Study|Lost to Follow-up|0|||
25081201|NCT04498247|50189647|FG007|Overall Study|Lost to Follow-up|0|||
25081202|NCT04498247|50189640|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
25081203|NCT04498247|50189641|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
25081204|NCT04498247|50189642|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
25081205|NCT04498247|50189643|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
25081206|NCT04498247|50189644|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
25081207|NCT04498247|50189645|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
25081208|NCT04498247|50189646|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
25081209|NCT04498247|50189647|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
25081210|NCT04498247|50189640|FG000|Overall Study|Withdrawal by Subject|0|||
25081211|NCT04498247|50189641|FG001|Overall Study|Withdrawal by Subject|8|||
25081212|NCT04498247|50189642|FG002|Overall Study|Withdrawal by Subject|0|||
25081213|NCT04498247|50189643|FG003|Overall Study|Withdrawal by Subject|7|||
25081214|NCT04498247|50189644|FG004|Overall Study|Withdrawal by Subject|0|||
25081215|NCT04498247|50189645|FG005|Overall Study|Withdrawal by Subject|0|||
25081216|NCT04498247|50189646|FG006|Overall Study|Withdrawal by Subject|1|||
25081217|NCT04498247|50189647|FG007|Overall Study|Withdrawal by Subject|0|||
25081218|NCT04498247|50189640|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
25081219|NCT04498247|50189641|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
25081220|NCT04498247|50189642|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
25081221|NCT04498247|50189643|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
25081222|NCT04498247|50189644|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
25081223|NCT04498247|50189645|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
25081224|NCT04498247|50189646|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
25081225|NCT04498247|50189647|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
25081226|NCT03887117|50189675|FG000|Overall Study|Discontinued prematurely|0|||
25081227|NCT03887117|50189676|FG001|Overall Study|Discontinued prematurely|1|||
25081228|NCT03887117|50189677|FG002|Overall Study|Discontinued prematurely|1|||
25081229|NCT03887117|50189678|FG003|Overall Study|Discontinued prematurely|2|||
25081230|NCT04038385|50189699|FG000|Overall Study|Completed baseline assessment only|7|||
25081231|NCT04038385|50189700|FG001|Overall Study|Completed baseline assessment only|4|||
25081232|NCT04038385|50189699|FG000|Overall Study|Moved out of area|4|||
25081233|NCT04038385|50189700|FG001|Overall Study|Moved out of area|2|||
25081234|NCT04038385|50189699|FG000|Overall Study|Discontinued study involvement|6|||
25081235|NCT04038385|50189700|FG001|Overall Study|Discontinued study involvement|1|||
25081236|NCT00783263|50189710|FG000|Overall Study|Adverse Event|3|||
25081237|NCT00783263|50189711|FG001|Overall Study|Adverse Event|0|||
25081238|NCT00783263|50189712|FG002|Overall Study|Adverse Event|2|||
25081239|NCT00783263|50189713|FG003|Overall Study|Adverse Event|1|||
25081240|NCT00783263|50189710|FG000|Overall Study|Lost to Follow-up|1|||
25081241|NCT00783263|50189711|FG001|Overall Study|Lost to Follow-up|1|||
25081242|NCT00783263|50189712|FG002|Overall Study|Lost to Follow-up|0|||
25081243|NCT00783263|50189713|FG003|Overall Study|Lost to Follow-up|0|||
24993862|NCT03428360|50084526|FG000|Overall Study|Informed consent withdrawn|5|||
24993863|NCT03428360|50084526|FG000|Overall Study|Withdrawal by Subject|4|||
24993864|NCT03428360|50084526|FG000|Overall Study|Lost to Follow-up|5|||
24993865|NCT03428360|50084526|FG000|Overall Study|Physician Decision|2|||
24993866|NCT03428360|50084526|FG000|Overall Study|Informed consent withdrawn|5|||
24993867|NCT03428360|50084526|FG000|Overall Study|Study terminated by sponsor|10|||
24993868|NCT03428360|50084526|FG000|Overall Study|Non-compliant with study|1|||
24993869|NCT03428360|50084526|FG000|Overall Study|Non-compliant with study drug|3|||
24993870|NCT03428360|50084526|FG000|Overall Study|Death|3|||
24993871|NCT03428360|50084526|FG000|Overall Study|Adverse Event|1|||
24993872|NCT03428360|50084526|FG000|Overall Study|Not on antiepileptic drug|1|||
24993873|NCT03427892|50084534|FG000|Overall Study|Lost to Follow-up|2|||
24993874|NCT03595332|50084540|FG000|Overall Study|Lost to Follow-up|16|||
24993875|NCT03595332|50084541|FG001|Overall Study|Lost to Follow-up|22|||
24993876|NCT03595332|50084540|FG000|Overall Study|Unable to retrieve ID from school|0|||
25081244|NCT00783263|50189710|FG000|Overall Study|Withdrawal by Subject|0|||
25081245|NCT00783263|50189711|FG001|Overall Study|Withdrawal by Subject|1|||
25081246|NCT00783263|50189712|FG002|Overall Study|Withdrawal by Subject|1|||
25081247|NCT00783263|50189713|FG003|Overall Study|Withdrawal by Subject|2|||
25081248|NCT03987919|50189740|FG000|Overall Study|Adverse Event|1|||
25081249|NCT03987919|50189741|FG001|Overall Study|Adverse Event|4|||
25081250|NCT03987919|50189742|FG002|Overall Study|Adverse Event|1|||
25081251|NCT03987919|50189743|FG003|Overall Study|Adverse Event|3|||
25081252|NCT03987919|50189740|FG000|Overall Study|Death|4|||
25081253|NCT03987919|50189741|FG001|Overall Study|Death|4|||
25081254|NCT03987919|50189742|FG002|Overall Study|Death|4|||
25081255|NCT03987919|50189743|FG003|Overall Study|Death|1|||
25081256|NCT03987919|50189740|FG000|Overall Study|Lost to Follow-up|5|||
25081257|NCT03987919|50189741|FG001|Overall Study|Lost to Follow-up|6|||
25081258|NCT03987919|50189742|FG002|Overall Study|Lost to Follow-up|8|||
25081259|NCT03987919|50189743|FG003|Overall Study|Lost to Follow-up|12|||
25081260|NCT03987919|50189740|FG000|Overall Study|Physician Decision|0|||
25081261|NCT03987919|50189741|FG001|Overall Study|Physician Decision|2|||
25081262|NCT03987919|50189742|FG002|Overall Study|Physician Decision|0|||
25081263|NCT03987919|50189743|FG003|Overall Study|Physician Decision|4|||
25081264|NCT03987919|50189740|FG000|Overall Study|Pregnancy|1|||
25081265|NCT03987919|50189741|FG001|Overall Study|Pregnancy|0|||
25081266|NCT03987919|50189742|FG002|Overall Study|Pregnancy|1|||
25081267|NCT03987919|50189743|FG003|Overall Study|Pregnancy|1|||
25081268|NCT03987919|50189740|FG000|Overall Study|Protocol Violation|0|||
25081269|NCT03987919|50189741|FG001|Overall Study|Protocol Violation|1|||
25081270|NCT03987919|50189742|FG002|Overall Study|Protocol Violation|0|||
25081271|NCT03987919|50189743|FG003|Overall Study|Protocol Violation|0|||
25081272|NCT03987919|50189740|FG000|Overall Study|Site terminated by Sponsor|0|||
25081273|NCT03987919|50189741|FG001|Overall Study|Site terminated by Sponsor|0|||
25081274|NCT03987919|50189742|FG002|Overall Study|Site terminated by Sponsor|0|||
25081275|NCT03987919|50189743|FG003|Overall Study|Site terminated by Sponsor|1|||
25081276|NCT03987919|50189740|FG000|Overall Study|Withdrawal by Subject|7|||
25081277|NCT03987919|50189741|FG001|Overall Study|Withdrawal by Subject|7|||
25081278|NCT03987919|50189742|FG002|Overall Study|Withdrawal by Subject|8|||
25081279|NCT03987919|50189743|FG003|Overall Study|Withdrawal by Subject|4|||
25081280|NCT03987919|50189740|FG000|Overall Study|Other - as reported by the investigator|1|||
25081281|NCT03987919|50189741|FG001|Overall Study|Other - as reported by the investigator|3|||
25081282|NCT03987919|50189742|FG002|Overall Study|Other - as reported by the investigator|2|||
25081283|NCT03987919|50189743|FG003|Overall Study|Other - as reported by the investigator|0|||
25081284|NCT00535405|50189763|FG000|Overall Study|Adverse Event|6|||
25081285|NCT00535405|50189764|FG001|Overall Study|Adverse Event|8|||
25081286|NCT00535405|50189765|FG002|Overall Study|Adverse Event|3|||
25259814|NCT01021813|50574895|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
25259815|NCT01021813|50574896|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
25259816|NCT01021813|50574897|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
25259817|NCT01021813|50574898|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
25259818|NCT01021813|50574894|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
25259819|NCT01021813|50574895|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
25259820|NCT01021813|50574896|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
25259821|NCT01021813|50574897|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
25081287|NCT00535405|50189766|FG003|Overall Study|Adverse Event|8|||
25081288|NCT00535405|50189767|FG004|Overall Study|Adverse Event|6|||
25081289|NCT00535405|50189763|FG000|Overall Study|Lost to Follow-up|1|||
25081290|NCT00535405|50189764|FG001|Overall Study|Lost to Follow-up|3|||
25081291|NCT00535405|50189765|FG002|Overall Study|Lost to Follow-up|3|||
25081292|NCT00535405|50189766|FG003|Overall Study|Lost to Follow-up|2|||
25081293|NCT00535405|50189767|FG004|Overall Study|Lost to Follow-up|1|||
25081294|NCT00535405|50189763|FG000|Overall Study|Physician Decision|3|||
25081295|NCT00535405|50189764|FG001|Overall Study|Physician Decision|2|||
25081296|NCT00535405|50189765|FG002|Overall Study|Physician Decision|0|||
25081297|NCT00535405|50189766|FG003|Overall Study|Physician Decision|1|||
25081298|NCT00535405|50189767|FG004|Overall Study|Physician Decision|1|||
25081299|NCT00535405|50189763|FG000|Overall Study|Protocol Violation|2|||
25081300|NCT00535405|50189764|FG001|Overall Study|Protocol Violation|2|||
25081301|NCT00535405|50189765|FG002|Overall Study|Protocol Violation|2|||
25081302|NCT00535405|50189766|FG003|Overall Study|Protocol Violation|1|||
25081303|NCT00535405|50189767|FG004|Overall Study|Protocol Violation|0|||
25081304|NCT00535405|50189763|FG000|Overall Study|Withdrawal by Subject|5|||
25081305|NCT00535405|50189764|FG001|Overall Study|Withdrawal by Subject|11|||
25081306|NCT00535405|50189765|FG002|Overall Study|Withdrawal by Subject|10|||
25081307|NCT00535405|50189766|FG003|Overall Study|Withdrawal by Subject|10|||
25081308|NCT00535405|50189767|FG004|Overall Study|Withdrawal by Subject|8|||
25081309|NCT00271817|50189782|FG000|Part 1|Adverse Event|68|||
25081310|NCT00271817|50189783|FG001|Part 1|Adverse Event|25|||
25081311|NCT00271817|50189784|FG002|Part 1|Adverse Event|156|||
25081312|NCT00271817|50189782|FG000|Part 1|Lost to Follow-up|6|||
25081313|NCT00271817|50189783|FG001|Part 1|Lost to Follow-up|8|||
25081314|NCT00271817|50189784|FG002|Part 1|Lost to Follow-up|24|||
25081315|NCT00271817|50189782|FG000|Part 1|Protocol Violation|5|||
25081316|NCT00271817|50189783|FG001|Part 1|Protocol Violation|4|||
25081317|NCT00271817|50189784|FG002|Part 1|Protocol Violation|7|||
25081318|NCT00271817|50189782|FG000|Part 1|Patient Moved|3|||
25081319|NCT00271817|50189783|FG001|Part 1|Patient Moved|1|||
25081320|NCT00271817|50189784|FG002|Part 1|Patient Moved|5|||
25081321|NCT00271817|50189782|FG000|Part 1|Withdrawal by Subject|23|||
25081322|NCT00271817|50189783|FG001|Part 1|Withdrawal by Subject|17|||
25081323|NCT00271817|50189784|FG002|Part 1|Withdrawal by Subject|45|||
25081324|NCT00271817|50189782|FG000|Part 1|LDL < 50 mg/dL|1|||
25081325|NCT00271817|50189783|FG001|Part 1|LDL < 50 mg/dL|4|||
25081326|NCT00271817|50189784|FG002|Part 1|LDL < 50 mg/dL|48|||
25081327|NCT00271817|50189782|FG000|Part 2|Adverse Event|0|||
25081328|NCT00271817|50189783|FG001|Part 2|Adverse Event|17|||
25081329|NCT00271817|50189784|FG002|Part 2|Adverse Event|33|||
25081330|NCT00271817|50189782|FG000|Part 2|Lack of Efficacy|0|||
25081331|NCT00271817|50189783|FG001|Part 2|Lack of Efficacy|1|||
25081332|NCT00271817|50189784|FG002|Part 2|Lack of Efficacy|6|||
25081333|NCT00271817|50189782|FG000|Part 2|Lost to Follow-up|0|||
25081334|NCT00271817|50189783|FG001|Part 2|Lost to Follow-up|6|||
25081335|NCT00271817|50189784|FG002|Part 2|Lost to Follow-up|18|||
25081336|NCT00271817|50189782|FG000|Part 2|Protocol Violation|0|||
25081337|NCT00271817|50189783|FG001|Part 2|Protocol Violation|3|||
25081338|NCT00271817|50189784|FG002|Part 2|Protocol Violation|5|||
25081339|NCT00271817|50189782|FG000|Part 2|Patient Moved|0|||
25081340|NCT00271817|50189783|FG001|Part 2|Patient Moved|0|||
25081341|NCT00271817|50189784|FG002|Part 2|Patient Moved|5|||
25081342|NCT00271817|50189782|FG000|Part 2|Withdrawal by Subject|0|||
25081343|NCT00271817|50189783|FG001|Part 2|Withdrawal by Subject|2|||
25081344|NCT00271817|50189784|FG002|Part 2|Withdrawal by Subject|13|||
25081345|NCT00271817|50189782|FG000|Part 2|LDL < 50 mg/dL|0|||
25081346|NCT00271817|50189783|FG001|Part 2|LDL < 50 mg/dL|3|||
25081347|NCT00271817|50189784|FG002|Part 2|LDL < 50 mg/dL|4|||
25081348|NCT02731157|50189796|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
25081349|NCT03268811|50189804|FG000|Overall Study|Adverse Event|0|||
25081350|NCT03268811|50189805|FG001|Overall Study|Adverse Event|1|||
25081351|NCT02732015|50189814|FG000|Overall Study|Lost to Follow-up|0|||
25081352|NCT02732015|50189815|FG001|Overall Study|Lost to Follow-up|1|||
25081353|NCT01441115|50189835|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
25081354|NCT02006147|50189846|FG000|Overall Study|Protocol Violation|1|||
25081355|NCT02006147|50189847|FG001|Overall Study|Protocol Violation|1|||
25081356|NCT02006147|50189848|FG002|Overall Study|Protocol Violation|0|||
25081357|NCT02006147|50189849|FG003|Overall Study|Protocol Violation|0|||
25081358|NCT02006147|50189846|FG000|Overall Study|Withdrawal by Subject|0|||
25081359|NCT02006147|50189847|FG001|Overall Study|Withdrawal by Subject|1|||
25081360|NCT02006147|50189848|FG002|Overall Study|Withdrawal by Subject|0|||
25081361|NCT02006147|50189849|FG003|Overall Study|Withdrawal by Subject|0|||
25081362|NCT02006147|50189846|FG000|Overall Study|Withdrawal by Sponsor|1|||
25081363|NCT02006147|50189847|FG001|Overall Study|Withdrawal by Sponsor|0|||
25081364|NCT02006147|50189848|FG002|Overall Study|Withdrawal by Sponsor|0|||
25081365|NCT02006147|50189849|FG003|Overall Study|Withdrawal by Sponsor|0|||
25081366|NCT02732119|50189860|FG000|Phase I|Adverse Event|1|||
25081367|NCT02732119|50189861|FG001|Phase I|Adverse Event|3|||
25081368|NCT02732119|50189862|FG002|Phase I|Adverse Event|1|||
25081369|NCT02732119|50189863|FG003|Phase I|Adverse Event|0|||
25081370|NCT02732119|50189864|FG004|Phase I|Adverse Event|0|||
25081371|NCT02732119|50189860|FG000|Phase I|Progressive disease|7|||
25081372|NCT02732119|50189861|FG001|Phase I|Progressive disease|3|||
25081373|NCT02732119|50189862|FG002|Phase I|Progressive disease|2|||
25081374|NCT02732119|50189863|FG003|Phase I|Progressive disease|0|||
25081375|NCT02732119|50189864|FG004|Phase I|Progressive disease|0|||
25081376|NCT02732119|50189860|FG000|Phase I|Protocol deviation|0|||
25081377|NCT02732119|50189861|FG001|Phase I|Protocol deviation|1|||
25081378|NCT02732119|50189862|FG002|Phase I|Protocol deviation|0|||
25081379|NCT02732119|50189863|FG003|Phase I|Protocol deviation|0|||
25081380|NCT02732119|50189864|FG004|Phase I|Protocol deviation|0|||
25081381|NCT02732119|50189860|FG000|Phase I|Physician Decision|0|||
25081382|NCT02732119|50189861|FG001|Phase I|Physician Decision|3|||
25081383|NCT02732119|50189862|FG002|Phase I|Physician Decision|4|||
25081384|NCT02732119|50189863|FG003|Phase I|Physician Decision|0|||
25081385|NCT02732119|50189864|FG004|Phase I|Physician Decision|0|||
25081386|NCT02732119|50189860|FG000|Phase II|Adverse Event|0|||
25081387|NCT02732119|50189861|FG001|Phase II|Adverse Event|0|||
25081388|NCT02732119|50189862|FG002|Phase II|Adverse Event|0|||
25081389|NCT02732119|50189863|FG003|Phase II|Adverse Event|3|||
25081390|NCT02732119|50189864|FG004|Phase II|Adverse Event|3|||
25081391|NCT02732119|50189860|FG000|Phase II|Death|0|||
25081392|NCT02732119|50189861|FG001|Phase II|Death|0|||
25081393|NCT02732119|50189862|FG002|Phase II|Death|0|||
25081394|NCT02732119|50189863|FG003|Phase II|Death|1|||
25081395|NCT02732119|50189864|FG004|Phase II|Death|0|||
25081396|NCT02732119|50189860|FG000|Phase II|Progressive dissease|0|||
25081397|NCT02732119|50189861|FG001|Phase II|Progressive dissease|0|||
25081398|NCT02732119|50189862|FG002|Phase II|Progressive dissease|0|||
25081399|NCT02732119|50189863|FG003|Phase II|Progressive dissease|30|||
25081400|NCT02732119|50189864|FG004|Phase II|Progressive dissease|23|||
25081401|NCT02732119|50189860|FG000|Phase II|Study terminated by sponsor|0|||
25081402|NCT02732119|50189861|FG001|Phase II|Study terminated by sponsor|0|||
25081403|NCT02732119|50189862|FG002|Phase II|Study terminated by sponsor|0|||
25081404|NCT02732119|50189863|FG003|Phase II|Study terminated by sponsor|2|||
25081405|NCT02732119|50189864|FG004|Phase II|Study terminated by sponsor|2|||
25081406|NCT02732119|50189860|FG000|Phase II|Other|0|||
25081407|NCT02732119|50189861|FG001|Phase II|Other|0|||
25081408|NCT02732119|50189862|FG002|Phase II|Other|0|||
25081409|NCT02732119|50189863|FG003|Phase II|Other|2|||
25081410|NCT02732119|50189864|FG004|Phase II|Other|0|||
25081411|NCT02732119|50189860|FG000|Phase II|Physician Decision|0|||
25081412|NCT02732119|50189861|FG001|Phase II|Physician Decision|0|||
25081413|NCT02732119|50189862|FG002|Phase II|Physician Decision|0|||
25081414|NCT02732119|50189863|FG003|Phase II|Physician Decision|8|||
25081415|NCT02732119|50189864|FG004|Phase II|Physician Decision|5|||
25081416|NCT03252925|50189887|FG000|Overall Study|Withdrawal by Subject|1|||
25081417|NCT03252925|50189888|FG001|Overall Study|Withdrawal by Subject|0|||
25081418|NCT03252925|50189887|FG000|Overall Study|Protocol Violation|6|||
25081419|NCT03252925|50189888|FG001|Overall Study|Protocol Violation|0|||
25081420|NCT03252925|50189887|FG000|Overall Study|Adverse Event|1|||
25081421|NCT03252925|50189888|FG001|Overall Study|Adverse Event|0|||
25081422|NCT03252925|50189887|FG000|Overall Study|Lost to Follow-up|6|||
25081423|NCT03252925|50189888|FG001|Overall Study|Lost to Follow-up|6|||
25081424|NCT01327885|50189896|FG000|Overall Study|Disease progression-according to RECIST|173|||
25081425|NCT01327885|50189897|FG001|Overall Study|Disease progression-according to RECIST|165|||
25081426|NCT01327885|50189896|FG000|Overall Study|Clinical progression|24|||
25081427|NCT01327885|50189897|FG001|Overall Study|Clinical progression|27|||
25081428|NCT01327885|50189896|FG000|Overall Study|Adverse Event|14|||
25081429|NCT01327885|50189897|FG001|Overall Study|Adverse Event|10|||
25081430|NCT01327885|50189896|FG000|Overall Study|Subject choice|5|||
25081431|NCT01327885|50189897|FG001|Overall Study|Subject choice|10|||
25081432|NCT01327885|50189896|FG000|Overall Study|Other|8|||
25081433|NCT01327885|50189897|FG001|Overall Study|Other|6|||
25081434|NCT01327885|50189896|FG000|Overall Study|Withdrawal of consent from study|3|||
25081435|NCT01327885|50189897|FG001|Overall Study|Withdrawal of consent from study|4|||
25081436|NCT01327885|50189896|FG000|Overall Study|Not treated|1|||
25081437|NCT01327885|50189897|FG001|Overall Study|Not treated|1|||
25081438|NCT01327885|50189896|FG000|Overall Study|Administrative decision|0|||
25081439|NCT01327885|50189897|FG001|Overall Study|Administrative decision|1|||
25081440|NCT03420781|50189915|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
25081441|NCT03420781|50189916|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
25081442|NCT03420781|50189917|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
25081443|NCT03420781|50189918|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
25081444|NCT03420781|50189919|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
25081445|NCT03420781|50189915|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
25081446|NCT03420781|50189916|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
25081447|NCT03420781|50189917|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
25081448|NCT03420781|50189918|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
25081449|NCT03420781|50189919|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
25081450|NCT03420781|50189915|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
25081451|NCT03420781|50189916|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
25081452|NCT03420781|50189917|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
25081453|NCT03420781|50189918|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
25081454|NCT03420781|50189919|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
25081455|NCT03420781|50189915|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
25081456|NCT03420781|50189916|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
25081457|NCT03420781|50189917|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
25081458|NCT03420781|50189918|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
25081459|NCT03420781|50189919|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
25081460|NCT03420781|50189915|FG000|Treatment Period (40 Weeks)|Death|2|||
25081461|NCT03420781|50189916|FG001|Treatment Period (40 Weeks)|Death|2|||
25081462|NCT03420781|50189917|FG002|Treatment Period (40 Weeks)|Death|0|||
25081463|NCT03420781|50189918|FG003|Treatment Period (40 Weeks)|Death|0|||
24993877|NCT03595332|50084541|FG001|Overall Study|Unable to retrieve ID from school|2|||
24993878|NCT03427268|50084550|FG000|Overall Study|Progressive disease|25|||
24993879|NCT03427268|50084550|FG000|Overall Study|Never treated|2|||
24993880|NCT03427268|50084550|FG000|Overall Study|Compassionate use|1|||
24993881|NCT03427268|50084550|FG000|Overall Study|Withdrawal by Subject|1|||
24993882|NCT03427268|50084550|FG000|Overall Study|Adverse Event|3|||
24993883|NCT03509948|50084554|FG000|Overall Study|Protocol Violation|0|||
24993884|NCT03509948|50084555|FG001|Overall Study|Protocol Violation|1|||
24993885|NCT03466658|50084561|FG000|Overall Study|Withdrawal by Subject|3|||
24993886|NCT03425396|50084572|FG000|Overall Study|Lost to Follow-up|2|||
24993887|NCT03425396|50084573|FG001|Overall Study|Lost to Follow-up|5|||
24993888|NCT03425396|50084574|FG002|Overall Study|Lost to Follow-up|2|||
24993889|NCT03425396|50084575|FG003|Overall Study|Lost to Follow-up|0|||
24993890|NCT03425396|50084576|FG004|Overall Study|Lost to Follow-up|0|||
24993891|NCT03425396|50084572|FG000|Overall Study|Withdrawal by Subject|0|||
24993892|NCT03425396|50084573|FG001|Overall Study|Withdrawal by Subject|1|||
24993893|NCT03425396|50084574|FG002|Overall Study|Withdrawal by Subject|0|||
24993894|NCT03425396|50084575|FG003|Overall Study|Withdrawal by Subject|1|||
24993895|NCT03425396|50084576|FG004|Overall Study|Withdrawal by Subject|0|||
24993896|NCT03425396|50084572|FG000|Overall Study|Other|0|||
24993897|NCT03425396|50084573|FG001|Overall Study|Other|1|||
24993898|NCT03425396|50084574|FG002|Overall Study|Other|1|||
24993899|NCT03425396|50084575|FG003|Overall Study|Other|0|||
24993900|NCT03425396|50084576|FG004|Overall Study|Other|1|||
25081464|NCT03420781|50189919|FG004|Treatment Period (40 Weeks)|Death|0|||
25081465|NCT03420781|50189915|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
25081466|NCT03420781|50189916|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
25081467|NCT03420781|50189917|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
25081468|NCT03420781|50189918|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
25081469|NCT03420781|50189919|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
25259822|NCT01021813|50574898|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
25259823|NCT01025635|50574917|FG000|Overall Study|Withdrawal by Subject|6|||
25259824|NCT01025635|50574918|FG001|Overall Study|Withdrawal by Subject|7|||
25259825|NCT01025635|50574917|FG000|Overall Study|Protocol Violation|4|||
25259826|NCT01025635|50574918|FG001|Overall Study|Protocol Violation|2|||
25259827|NCT01025635|50574917|FG000|Overall Study|Lack of Efficacy|0|||
25259828|NCT01025635|50574918|FG001|Overall Study|Lack of Efficacy|1|||
25259829|NCT01025635|50574917|FG000|Overall Study|Lost to Follow-up|9|||
25259830|NCT01025635|50574918|FG001|Overall Study|Lost to Follow-up|13|||
25259831|NCT01025635|50574917|FG000|Overall Study|Reason not known|4|||
25259832|NCT01025635|50574918|FG001|Overall Study|Reason not known|2|||
25259833|NCT01021423|50574926|FG000|Overall Study|Study terminated|4|||
25259834|NCT01021423|50574927|FG001|Overall Study|Study terminated|5|||
25259835|NCT01020877|50574935|FG000|Second Intervention|Withdrawal by Subject|1|||
25259836|NCT01020877|50574936|FG001|Second Intervention|Withdrawal by Subject|0|||
25259837|NCT01020799|50574945|FG000|Overall Study|Adverse Event|4|||
25259838|NCT01020799|50574946|FG001|Overall Study|Adverse Event|3|||
25259839|NCT01020799|50574947|FG002|Overall Study|Adverse Event|2|||
25081470|NCT03420781|50189915|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
25081471|NCT03420781|50189916|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
25081472|NCT03420781|50189917|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
25081473|NCT03420781|50189918|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
25081474|NCT03420781|50189919|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
25081475|NCT03420781|50189915|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
25081476|NCT03420781|50189916|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
25081477|NCT03420781|50189917|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
25081478|NCT03420781|50189918|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
25081479|NCT03420781|50189919|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
25081480|NCT03420781|50189915|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
25081481|NCT03420781|50189916|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
25081482|NCT03420781|50189917|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
25081483|NCT03420781|50189918|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
25081484|NCT03420781|50189919|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
25081485|NCT03420781|50189915|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
25081486|NCT03420781|50189916|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
25081487|NCT03420781|50189917|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
25081488|NCT03420781|50189918|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
25081489|NCT03420781|50189919|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
25081490|NCT03420781|50189915|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
25081491|NCT03420781|50189916|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
25081492|NCT03420781|50189917|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
25081493|NCT03420781|50189918|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
25081494|NCT03420781|50189919|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
25081495|NCT03420781|50189915|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
25081496|NCT03420781|50189916|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
25081497|NCT03420781|50189917|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
25081498|NCT03420781|50189918|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
25081499|NCT03420781|50189919|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
25081500|NCT03420781|50189915|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
25081501|NCT03420781|50189916|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
25081502|NCT03420781|50189917|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
25081503|NCT03420781|50189918|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
25081504|NCT03420781|50189919|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
25081505|NCT03269695|50189937|FG000|Overall Study|Adverse Event|2|||
25081506|NCT03269695|50189938|FG001|Overall Study|Adverse Event|1|||
25081507|NCT03269695|50189937|FG000|Overall Study|Lack of Efficacy|0|||
25081508|NCT03269695|50189938|FG001|Overall Study|Lack of Efficacy|1|||
25081509|NCT03269695|50189937|FG000|Overall Study|Withdrawal by Subject|0|||
24993929|NCT00066729|50084599|FG000|Overall Study|Lost to Follow-up|1|||
24993930|NCT00066729|50084599|FG000|Overall Study|Disease progression|1|||
24993931|NCT00032487|50084605|FG000|Overall Study|Withdrawal by Subject|67|||
24993932|NCT00032487|50084606|FG001|Overall Study|Withdrawal by Subject|43|||
24993933|NCT00032487|50084605|FG000|Overall Study|Adverse Event|3|||
24993934|NCT00032487|50084606|FG001|Overall Study|Adverse Event|7|||
24993935|NCT00032487|50084605|FG000|Overall Study|Lost to Follow-up|57|||
24993936|NCT00032487|50084606|FG001|Overall Study|Lost to Follow-up|58|||
24993937|NCT00032487|50084605|FG000|Overall Study|Had other reason|12|||
24993938|NCT00032487|50084606|FG001|Overall Study|Had other reason|12|||
24993939|NCT03641508|50084614|FG000|First Injection|Lost to Follow-up|2|||
24993940|NCT03641508|50084615|FG001|First Injection|Lost to Follow-up|0|||
24993941|NCT00066573|50084623|FG000|Overall Study|Did not received protocol treatment|28|||
24993942|NCT00066573|50084624|FG001|Overall Study|Did not received protocol treatment|28|||
24993943|NCT03465878|50084632|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
24993944|NCT03465878|50084633|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
24993945|NCT03465878|50084634|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
24993946|NCT03465878|50084635|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
24993947|NCT03465878|50084632|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
24993948|NCT03465878|50084633|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
24993949|NCT03465878|50084634|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
24993950|NCT03465878|50084635|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
24993951|NCT03465878|50084632|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
24993952|NCT03465878|50084633|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
24993953|NCT03465878|50084634|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
24993954|NCT03465878|50084635|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
24993955|NCT03637374|50084663|FG000|Overall Study|Death|2|||
24993956|NCT03637374|50084664|FG001|Overall Study|Death|0|||
24993957|NCT03421730|50084670|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
24993958|NCT03421730|50084671|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
24993959|NCT03421730|50084672|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
24993960|NCT03421730|50084673|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
24993961|NCT03421730|50084674|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
24993962|NCT03421730|50084675|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
24993963|NCT03421730|50084676|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
24993964|NCT03421730|50084677|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
24993965|NCT03421730|50084678|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
24993966|NCT03421730|50084679|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
24993967|NCT03421730|50084680|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
24993968|NCT03421730|50084681|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
24993969|NCT03421730|50084670|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
24993970|NCT03421730|50084671|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
24993971|NCT03421730|50084672|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
24993972|NCT03421730|50084673|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
24993973|NCT03421730|50084674|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
24993974|NCT03421730|50084675|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
24993975|NCT03421730|50084676|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
24993976|NCT03421730|50084677|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
24993977|NCT03421730|50084678|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
24993978|NCT03421730|50084679|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
24993979|NCT03421730|50084680|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
24993980|NCT03421730|50084681|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
24993981|NCT00054327|50084701|FG000|Overall Study|Engraftment failure|1|||
24993982|NCT00054327|50084702|FG001|Overall Study|Engraftment failure|0|||
24993983|NCT00054327|50084703|FG002|Overall Study|Engraftment failure|0|||
24993984|NCT00054327|50084704|FG003|Overall Study|Engraftment failure|0|||
24993985|NCT00054327|50084705|FG004|Overall Study|Engraftment failure|0|||
24993986|NCT00054327|50084706|FG005|Overall Study|Engraftment failure|0|||
24993987|NCT03503162|50084720|FG000|Overall Study|did not meet eligibility|1|||
24993988|NCT03029650|50084724|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
24993989|NCT03029650|50084725|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
24993990|NCT03029650|50084724|FG000|Washout (1 Week)|Physician Decision|0|||
24993991|NCT03029650|50084725|FG001|Washout (1 Week)|Physician Decision|1|||
24993992|NCT03462680|50084737|FG000|Overall Study|Withdrawal by Subject|3|||
24993993|NCT03462680|50084738|FG001|Overall Study|Withdrawal by Subject|5|||
24993994|NCT03636906|50084747|FG000|Overall Study|Adverse Event|0|||
24993995|NCT03636906|50084748|FG001|Overall Study|Adverse Event|0|||
24993996|NCT03636906|50084749|FG002|Overall Study|Adverse Event|1|||
24993997|NCT03636906|50084747|FG000|Overall Study|Lost to Follow-up|1|||
24993998|NCT03636906|50084748|FG001|Overall Study|Lost to Follow-up|0|||
24993999|NCT03636906|50084749|FG002|Overall Study|Lost to Follow-up|0|||
24994000|NCT03636906|50084747|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
24994001|NCT03636906|50084748|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
24994002|NCT03636906|50084749|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
24994003|NCT03636906|50084747|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
24994004|NCT03636906|50084748|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
24994005|NCT03636906|50084749|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
24994006|NCT03636906|50084747|FG000|Overall Study|Other|0|||
24994007|NCT03636906|50084748|FG001|Overall Study|Other|0|||
24994008|NCT03636906|50084749|FG002|Overall Study|Other|1|||
24994009|NCT03028870|50084767|FG000|Overall Study|Adverse Event|7|||
24994010|NCT03028870|50084768|FG001|Overall Study|Adverse Event|4|||
24994011|NCT03028870|50084769|FG002|Overall Study|Adverse Event|3|||
24994012|NCT03028870|50084770|FG003|Overall Study|Adverse Event|3|||
24994013|NCT03028870|50084767|FG000|Overall Study|Withdrawal by Subject|1|||
24994014|NCT03028870|50084768|FG001|Overall Study|Withdrawal by Subject|1|||
24994015|NCT03028870|50084769|FG002|Overall Study|Withdrawal by Subject|1|||
24994016|NCT03028870|50084770|FG003|Overall Study|Withdrawal by Subject|2|||
24994017|NCT03028870|50084767|FG000|Overall Study|Lost to Follow-up|1|||
24994018|NCT03028870|50084768|FG001|Overall Study|Lost to Follow-up|0|||
24994019|NCT03028870|50084769|FG002|Overall Study|Lost to Follow-up|0|||
24994020|NCT03028870|50084770|FG003|Overall Study|Lost to Follow-up|0|||
24994021|NCT03028870|50084767|FG000|Overall Study|Lack of Efficacy|3|||
24994022|NCT03028870|50084768|FG001|Overall Study|Lack of Efficacy|0|||
24994023|NCT03028870|50084769|FG002|Overall Study|Lack of Efficacy|0|||
24994024|NCT03028870|50084770|FG003|Overall Study|Lack of Efficacy|0|||
24994025|NCT03028870|50084767|FG000|Overall Study|Administrative|5|||
24994026|NCT03028870|50084768|FG001|Overall Study|Administrative|5|||
24994027|NCT03028870|50084769|FG002|Overall Study|Administrative|12|||
24994028|NCT03028870|50084770|FG003|Overall Study|Administrative|4|||
24994029|NCT03663582|50084780|FG000|Overall Study|Physician Decision|1|||
24994030|NCT03502616|50084786|FG000|Up to Week 16|Withdrawal by Subject|1|||
24994031|NCT03502616|50084787|FG001|Up to Week 16|Withdrawal by Subject|2|||
24994032|NCT03502616|50084786|FG000|Up to Week 16|Lost to Follow-up|0|||
24994033|NCT03502616|50084787|FG001|Up to Week 16|Lost to Follow-up|1|||
24994034|NCT03502616|50084786|FG000|Up to Week 16|Randomized, but not treated|1|||
24994035|NCT03502616|50084787|FG001|Up to Week 16|Randomized, but not treated|0|||
24994036|NCT03502616|50084786|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
24994037|NCT03502616|50084787|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
24994038|NCT03502616|50084786|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
24994039|NCT03502616|50084787|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
24994040|NCT03028012|50084808|FG000|Overall Study|Lost to Follow-up|2|||
24994041|NCT03028012|50084809|FG001|Overall Study|Lost to Follow-up|3|||
24994042|NCT03028012|50084810|FG002|Overall Study|Lost to Follow-up|3|||
24994043|NCT03635190|50084819|FG000|Overall Study|Lost to Follow-up|4|||
24994044|NCT03635190|50084819|FG000|Overall Study|Death|3|||
24994045|NCT03635190|50084819|FG000|Overall Study|Withdrawal by Subject|1|||
24994046|NCT03635190|50084819|FG000|Overall Study|Patient moved and did not return for follow up|1|||
24994047|NCT03634800|50084826|FG000|Overall Study|Adverse Event|1|||
24994048|NCT03634800|50084826|FG000|Overall Study|Disease Progression|4|||
25081510|NCT03269695|50189938|FG001|Overall Study|Withdrawal by Subject|1|||
25081511|NCT00462943|50189948|FG000|Overall Study|Failure to achieve a response|5|||
25081512|NCT00462943|50189949|FG001|Overall Study|Failure to achieve a response|5|||
25081513|NCT00462943|50189950|FG002|Overall Study|Failure to achieve a response|1|||
25081514|NCT00462943|50189948|FG000|Overall Study|Adverse Event|6|||
24994049|NCT03634800|50084826|FG000|Overall Study|Withdrawal by Subject|1|||
24994050|NCT03027466|50084834|FG000|Overall Study|Opting out of the app|1869|||
24994051|NCT03027466|50084835|FG001|Overall Study|Opting out of the app|1819|||
24994052|NCT03027466|50084836|FG002|Overall Study|Opting out of the app|1743|||
24994053|NCT03027466|50084837|FG003|Overall Study|Opting out of the app|1821|||
24994054|NCT03662334|50084849|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
24994055|NCT03662334|50084850|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
25081515|NCT00462943|50189949|FG001|Overall Study|Adverse Event|4|||
25081516|NCT00462943|50189950|FG002|Overall Study|Adverse Event|1|||
25081517|NCT00462943|50189948|FG000|Overall Study|Protocol Violation|1|||
25081518|NCT00462943|50189949|FG001|Overall Study|Protocol Violation|0|||
25081519|NCT00462943|50189950|FG002|Overall Study|Protocol Violation|0|||
25081520|NCT00462943|50189948|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
25081521|NCT00462943|50189949|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
24994056|NCT02955186|50084858|FG000|Overall Study|Withdrawal by Subject|6|||
24994057|NCT02955186|50084859|FG001|Overall Study|Withdrawal by Subject|2|||
24994058|NCT02955186|50084858|FG000|Overall Study|Protocol Violation|1|||
24994059|NCT02955186|50084859|FG001|Overall Study|Protocol Violation|0|||
24994060|NCT03502070|50084865|FG000|Overall Study|Withdrawal by Subject|1|||
24994061|NCT03502070|50084865|FG000|Overall Study|Screen Failure|1|||
24994062|NCT03586830|50084873|FG000|Overall Study|Site terminated by Sponsor|1|||
24994063|NCT03586830|50084874|FG001|Overall Study|Site terminated by Sponsor|4|||
24994064|NCT03586830|50084875|FG002|Overall Study|Site terminated by Sponsor|3|||
24994065|NCT03586830|50084876|FG003|Overall Study|Site terminated by Sponsor|3|||
24994066|NCT03586830|50084873|FG000|Overall Study|Lost to Follow-up|0|||
24994067|NCT03586830|50084874|FG001|Overall Study|Lost to Follow-up|2|||
24994068|NCT03586830|50084875|FG002|Overall Study|Lost to Follow-up|2|||
24994069|NCT03586830|50084876|FG003|Overall Study|Lost to Follow-up|1|||
24994070|NCT03586830|50084873|FG000|Overall Study|Withdrawal by Subject|1|||
24994071|NCT03586830|50084874|FG001|Overall Study|Withdrawal by Subject|0|||
24994072|NCT03586830|50084875|FG002|Overall Study|Withdrawal by Subject|3|||
24994073|NCT03586830|50084876|FG003|Overall Study|Withdrawal by Subject|1|||
24994074|NCT03026530|50084888|FG000|Overall Study|Lost to Follow-up|19|||
24994075|NCT03026530|50084889|FG001|Overall Study|Lost to Follow-up|24|||
24994076|NCT03026530|50084888|FG000|Overall Study|Protocol Violation|2|||
24994077|NCT03026530|50084889|FG001|Overall Study|Protocol Violation|5|||
24994078|NCT03418376|50084899|FG000|Overall Study|Musculoskeletal injury|1|||
24994079|NCT03418376|50084900|FG001|Overall Study|Musculoskeletal injury|2|||
24994080|NCT03418376|50084901|FG002|Overall Study|Musculoskeletal injury|1|||
24994081|NCT03418376|50084902|FG003|Overall Study|Musculoskeletal injury|0|||
24994082|NCT03418376|50084899|FG000|Overall Study|Personal reasons|0|||
24994083|NCT03418376|50084900|FG001|Overall Study|Personal reasons|2|||
24994084|NCT03418376|50084901|FG002|Overall Study|Personal reasons|2|||
24994085|NCT03418376|50084902|FG003|Overall Study|Personal reasons|1|||
24994086|NCT03418376|50084899|FG000|Overall Study|Exacerbation|0|||
25081522|NCT00462943|50189950|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
25081523|NCT00462943|50189948|FG000|Overall Study|Disease Progression|15|||
25081524|NCT00462943|50189949|FG001|Overall Study|Disease Progression|15|||
25081525|NCT00462943|50189950|FG002|Overall Study|Disease Progression|9|||
25081526|NCT00462943|50189948|FG000|Overall Study|Death|5|||
25081527|NCT00462943|50189949|FG001|Overall Study|Death|2|||
25081528|NCT00462943|50189950|FG002|Overall Study|Death|7|||
25081529|NCT00462943|50189948|FG000|Overall Study|Stem Cell Transplant|1|||
25081530|NCT00462943|50189949|FG001|Overall Study|Stem Cell Transplant|1|||
25081531|NCT00462943|50189950|FG002|Overall Study|Stem Cell Transplant|0|||
25081532|NCT00462943|50189948|FG000|Overall Study|Bone Marrow Transplant|1|||
25081533|NCT00462943|50189949|FG001|Overall Study|Bone Marrow Transplant|0|||
25081534|NCT00462943|50189950|FG002|Overall Study|Bone Marrow Transplant|0|||
25081535|NCT00462943|50189948|FG000|Overall Study|Required Lymphocyte Infusion|1|||
25081536|NCT00462943|50189949|FG001|Overall Study|Required Lymphocyte Infusion|0|||
25081537|NCT00462943|50189950|FG002|Overall Study|Required Lymphocyte Infusion|0|||
25081538|NCT00462943|50189948|FG000|Overall Study|Transplant - not specified|1|||
25081539|NCT00462943|50189949|FG001|Overall Study|Transplant - not specified|0|||
25081540|NCT00462943|50189950|FG002|Overall Study|Transplant - not specified|1|||
25081541|NCT00462943|50189948|FG000|Overall Study|Physician Decision|1|||
25081542|NCT00462943|50189949|FG001|Overall Study|Physician Decision|0|||
25081543|NCT00462943|50189950|FG002|Overall Study|Physician Decision|0|||
25081544|NCT00462943|50189948|FG000|Overall Study|Withdrawal by Subject|0|||
25081545|NCT00462943|50189949|FG001|Overall Study|Withdrawal by Subject|1|||
25081546|NCT00462943|50189950|FG002|Overall Study|Withdrawal by Subject|0|||
25081547|NCT02730793|50189974|FG000|Overall Study|Physician Decision|0|||
25081548|NCT02730793|50189975|FG001|Overall Study|Physician Decision|1|||
25081549|NCT02730793|50189974|FG000|Overall Study|Withdrawal by Subject|0|||
25081550|NCT02730793|50189975|FG001|Overall Study|Withdrawal by Subject|1|||
25081551|NCT02855125|50189983|FG000|Overall Study|Withdrawal by Subject|2|||
25081552|NCT02855125|50189984|FG001|Overall Study|Withdrawal by Subject|2|||
25081553|NCT02855125|50189983|FG000|Overall Study|Clinical Disease Progression|5|||
25081554|NCT02855125|50189984|FG001|Overall Study|Clinical Disease Progression|4|||
25081555|NCT02855125|50189983|FG000|Overall Study|Radiologic Disease Progression|36|||
25081556|NCT02855125|50189984|FG001|Overall Study|Radiologic Disease Progression|39|||
25081557|NCT02855125|50189983|FG000|Overall Study|Adverse Event|11|||
25081558|NCT02855125|50189984|FG001|Overall Study|Adverse Event|7|||
25081559|NCT02855125|50189983|FG000|Overall Study|Physician Decision|1|||
25081560|NCT02855125|50189984|FG001|Overall Study|Physician Decision|0|||
25081561|NCT02855125|50189983|FG000|Overall Study|On Treatment|9|||
25081562|NCT02855125|50189984|FG001|Overall Study|On Treatment|11|||
24994087|NCT03418376|50084900|FG001|Overall Study|Exacerbation|1|||
24994088|NCT03418376|50084901|FG002|Overall Study|Exacerbation|0|||
24994089|NCT03418376|50084902|FG003|Overall Study|Exacerbation|0|||
24994090|NCT03585504|50084914|FG000|Overall Study|Lost to Follow-up|26|||
24994091|NCT03585504|50084915|FG001|Overall Study|Lost to Follow-up|29|||
24994092|NCT03417830|50084923|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
24994093|NCT03417830|50084924|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
24994094|NCT03576768|50084935|FG000|Overall Study|Lost to Follow-up|3|||
24994095|NCT03576768|50084936|FG001|Overall Study|Lost to Follow-up|3|||
24994096|NCT03576768|50084937|FG002|Overall Study|Lost to Follow-up|0|||
24994097|NCT03576768|50084938|FG003|Overall Study|Lost to Follow-up|0|||
24994098|NCT03576066|50084950|FG000|Overall Study|Noncompliance with study drug|0|||
24994099|NCT03576066|50084951|FG001|Overall Study|Noncompliance with study drug|1|||
24994100|NCT03557034|50084963|FG000|Overall Study|Withdrawal by Subject|1|||
24994101|NCT03557034|50084964|FG001|Overall Study|Withdrawal by Subject|0|||
24994102|NCT03583554|50084970|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
24994103|NCT03583554|50084971|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
24994104|NCT03583554|50084972|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
24994105|NCT03948178|50084983|FG000|Overall Study|Protocol Violation|1|||
24994106|NCT03948178|50084983|FG000|Overall Study|Lost to Follow-up|2|||
24994107|NCT03948178|50084983|FG000|Overall Study|Withdrawal by Subject|2|||
24994108|NCT03948178|50084983|FG000|Overall Study|Reason not known|2|||
24994109|NCT03948178|50084983|FG000|Overall Study|Personal reason|14|||
24994110|NCT03948178|50084983|FG000|Overall Study|Disease progression|30|||
24994111|NCT03948178|50084983|FG000|Overall Study|Adverse Event|12|||
24994112|NCT03948178|50084983|FG000|Overall Study|Sponsor terminated study|164|||
24994113|NCT03520920|50084990|FG000|Overall Study|Death|13|||
24994114|NCT03520920|50084991|FG001|Overall Study|Death|1|||
24994115|NCT03520920|50084992|FG002|Overall Study|Death|0|||
24994116|NCT03520920|50084990|FG000|Overall Study|Withdrawal by Subject|2|||
24994117|NCT03520920|50084991|FG001|Overall Study|Withdrawal by Subject|1|||
24994118|NCT03520920|50084992|FG002|Overall Study|Withdrawal by Subject|0|||
24994119|NCT03520920|50084990|FG000|Overall Study|Study Terminated by the Sponsor|5|||
24994120|NCT03520920|50084991|FG001|Overall Study|Study Terminated by the Sponsor|14|||
24994121|NCT03520920|50084992|FG002|Overall Study|Study Terminated by the Sponsor|5|||
24994122|NCT02953340|50085008|FG000|Overall Study|Death|0|||
24994123|NCT02953340|50085009|FG001|Overall Study|Death|1|||
24994124|NCT02953340|50085008|FG000|Overall Study|Investigator Decision|3|||
24994125|NCT02953340|50085009|FG001|Overall Study|Investigator Decision|3|||
24994126|NCT02953340|50085008|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
24994127|NCT02953340|50085009|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
24994128|NCT02953340|50085008|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
24994129|NCT02953340|50085009|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
24994130|NCT02953340|50085008|FG000|Overall Study|Withdrawal by Subject|9|||
24994131|NCT02953340|50085009|FG001|Overall Study|Withdrawal by Subject|9|||
24994132|NCT02953340|50085008|FG000|Overall Study|Sponsor decision|0|||
24994133|NCT02953340|50085009|FG001|Overall Study|Sponsor decision|2|||
24994134|NCT02953340|50085008|FG000|Overall Study|Lost to Follow-up|3|||
24994135|NCT02953340|50085009|FG001|Overall Study|Lost to Follow-up|2|||
24994136|NCT02953340|50085008|FG000|Overall Study|Reason not specified|2|||
24994137|NCT02953340|50085009|FG001|Overall Study|Reason not specified|2|||
24994138|NCT03554772|50085025|FG000|Overall Study|Lost to Follow-up|0|||
24994139|NCT03554772|50085026|FG001|Overall Study|Lost to Follow-up|0|||
24994140|NCT03554772|50085027|FG002|Overall Study|Lost to Follow-up|0|||
24994141|NCT03554772|50085028|FG003|Overall Study|Lost to Follow-up|2|||
24994142|NCT03573804|50085038|FG000|Overall Study|claustrophobia or MRI table problems|10|||
24994143|NCT03417440|50085056|FG000|Overall Study|Lost to Follow-up|0|||
24994144|NCT03417440|50085057|FG001|Overall Study|Lost to Follow-up|1|||
24994145|NCT03417440|50085058|FG002|Overall Study|Lost to Follow-up|0|||
24994146|NCT03417440|50085059|FG003|Overall Study|Lost to Follow-up|0|||
24994147|NCT03417440|50085060|FG004|Overall Study|Lost to Follow-up|1|||
24994148|NCT03417440|50085061|FG005|Overall Study|Lost to Follow-up|0|||
24994149|NCT03417440|50085062|FG006|Overall Study|Lost to Follow-up|0|||
24994150|NCT03417440|50085063|FG007|Overall Study|Lost to Follow-up|0|||
24994151|NCT03417440|50085056|FG000|Overall Study|Withdrawal by Subject|2|||
24994152|NCT03417440|50085057|FG001|Overall Study|Withdrawal by Subject|0|||
24994153|NCT03417440|50085058|FG002|Overall Study|Withdrawal by Subject|2|||
24994154|NCT03417440|50085059|FG003|Overall Study|Withdrawal by Subject|1|||
24994155|NCT03417440|50085060|FG004|Overall Study|Withdrawal by Subject|1|||
24994156|NCT03417440|50085061|FG005|Overall Study|Withdrawal by Subject|0|||
24994157|NCT03417440|50085062|FG006|Overall Study|Withdrawal by Subject|0|||
24994158|NCT03417440|50085063|FG007|Overall Study|Withdrawal by Subject|1|||
24994159|NCT03458702|50085086|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
24994160|NCT03458702|50085087|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
24994161|NCT03458702|50085086|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
24994162|NCT03458702|50085087|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
24994163|NCT03454412|50085093|FG000|Baseline Assesment|Physician Decision|12|||
24994164|NCT03452540|50085097|FG000|Overall Study|Adverse Event|1|||
24994165|NCT03452540|50085097|FG000|Overall Study|Withdrawal by Subject|1|||
24994166|NCT03452540|50085097|FG000|Overall Study|Other SAE and AE|2|||
24994167|NCT03573336|50085104|FG000|Overall Study|Study terminated|2|||
24994168|NCT03573336|50085105|FG001|Overall Study|Study terminated|4|||
24994169|NCT03573336|50085106|FG002|Overall Study|Study terminated|2|||
24994170|NCT03500198|50085116|FG000|Overall Study|Lost to Follow-up|0|||
24994171|NCT03500198|50085117|FG001|Overall Study|Lost to Follow-up|1|||
24994172|NCT03553758|50085125|FG000|Overall Study|Lost to Follow-up|1|||
24994173|NCT03552198|50085135|FG000|Overall Study|Lost to Follow-up|42|||
24994174|NCT03552198|50085136|FG001|Overall Study|Lost to Follow-up|48|||
24994175|NCT03552198|50085137|FG002|Overall Study|Lost to Follow-up|15|||
24994176|NCT03552198|50085138|FG003|Overall Study|Lost to Follow-up|19|||
24994177|NCT03552198|50085135|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
24994178|NCT03552198|50085136|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
24994179|NCT03552198|50085137|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
24994180|NCT03552198|50085138|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
24994181|NCT03552198|50085135|FG000|Overall Study|Did not receive air alerts|1|||
24994182|NCT03552198|50085136|FG001|Overall Study|Did not receive air alerts|0|||
24994183|NCT03552198|50085137|FG002|Overall Study|Did not receive air alerts|0|||
24994184|NCT03552198|50085138|FG003|Overall Study|Did not receive air alerts|1|||
24994185|NCT02954354|50085151|FG000|Overall Study|Adverse Event|2|||
24994186|NCT02954354|50085152|FG001|Overall Study|Adverse Event|2|||
24994187|NCT02954354|50085153|FG002|Overall Study|Adverse Event|4|||
24994188|NCT02954354|50085151|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
24994189|NCT02954354|50085152|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
24994190|NCT02954354|50085153|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
24994191|NCT02954354|50085151|FG000|Overall Study|Lack of Efficacy|0|||
24994192|NCT02954354|50085152|FG001|Overall Study|Lack of Efficacy|2|||
24994193|NCT02954354|50085153|FG002|Overall Study|Lack of Efficacy|0|||
24994194|NCT02954354|50085151|FG000|Overall Study|Withdrawal by Subject|17|||
24994195|NCT02954354|50085152|FG001|Overall Study|Withdrawal by Subject|9|||
24994196|NCT02954354|50085153|FG002|Overall Study|Withdrawal by Subject|11|||
24994197|NCT02954354|50085151|FG000|Overall Study|Lost to Follow-up|12|||
24994198|NCT02954354|50085152|FG001|Overall Study|Lost to Follow-up|5|||
24994199|NCT02954354|50085153|FG002|Overall Study|Lost to Follow-up|0|||
24994200|NCT02954354|50085151|FG000|Overall Study|Miscellaneous|2|||
24994201|NCT02954354|50085152|FG001|Overall Study|Miscellaneous|2|||
24994202|NCT02954354|50085153|FG002|Overall Study|Miscellaneous|1|||
24994203|NCT03519516|50085165|FG000|Overall Study|Adverse Event|0|||
24994204|NCT03519516|50085166|FG001|Overall Study|Adverse Event|1|||
24994205|NCT03519204|50085174|FG000|Overall Study|Lost to Follow-up|3|||
24994206|NCT03519204|50085175|FG001|Overall Study|Lost to Follow-up|8|||
24994207|NCT03519204|50085174|FG000|Overall Study|Withdrawal by Subject|9|||
24994208|NCT03519204|50085175|FG001|Overall Study|Withdrawal by Subject|7|||
24994209|NCT03519204|50085174|FG000|Overall Study|Other Miscellaneous Reasons|1|||
24994210|NCT03519204|50085175|FG001|Overall Study|Other Miscellaneous Reasons|0|||
24994211|NCT03518658|50085187|FG000|Overall Study|Other|51|||
24994212|NCT03518658|50085188|FG001|Overall Study|Other|0|||
24994213|NCT03518112|50085196|FG000|Overall Study|Withdrawal by Subject|1|||
24994214|NCT03706456|50085200|FG000|Overall Study|Lack of Efficacy|1|||
24994215|NCT03706456|50085200|FG000|Overall Study|Ongoing|21|||
24994216|NCT03517566|50085209|FG000|Overall Study|Adverse Event|5|||
24994217|NCT03517566|50085210|FG001|Overall Study|Adverse Event|2|||
24994218|NCT03517566|50085211|FG002|Overall Study|Adverse Event|2|||
24994219|NCT03517566|50085212|FG003|Overall Study|Adverse Event|8|||
24994220|NCT03517566|50085213|FG004|Overall Study|Adverse Event|7|||
24994221|NCT03517566|50085209|FG000|Overall Study|Lack of Efficacy|3|||
24994222|NCT03517566|50085210|FG001|Overall Study|Lack of Efficacy|2|||
24994223|NCT03517566|50085211|FG002|Overall Study|Lack of Efficacy|1|||
24994224|NCT03517566|50085212|FG003|Overall Study|Lack of Efficacy|1|||
24994225|NCT03517566|50085213|FG004|Overall Study|Lack of Efficacy|4|||
24994226|NCT03517566|50085209|FG000|Overall Study|Lost to Follow-up|3|||
24994227|NCT03517566|50085210|FG001|Overall Study|Lost to Follow-up|1|||
24994228|NCT03517566|50085211|FG002|Overall Study|Lost to Follow-up|1|||
24994229|NCT03517566|50085212|FG003|Overall Study|Lost to Follow-up|1|||
24994230|NCT03517566|50085213|FG004|Overall Study|Lost to Follow-up|0|||
24994231|NCT03517566|50085209|FG000|Overall Study|Physician Decision|1|||
24994232|NCT03517566|50085210|FG001|Overall Study|Physician Decision|1|||
24994233|NCT03517566|50085211|FG002|Overall Study|Physician Decision|0|||
24994234|NCT03517566|50085212|FG003|Overall Study|Physician Decision|1|||
24994235|NCT03517566|50085213|FG004|Overall Study|Physician Decision|0|||
24994236|NCT03517566|50085209|FG000|Overall Study|Pregnancy|0|||
24994237|NCT03517566|50085210|FG001|Overall Study|Pregnancy|1|||
24994238|NCT03517566|50085211|FG002|Overall Study|Pregnancy|0|||
24994239|NCT03517566|50085212|FG003|Overall Study|Pregnancy|0|||
24994240|NCT03517566|50085213|FG004|Overall Study|Pregnancy|0|||
24994241|NCT03517566|50085209|FG000|Overall Study|Protocol Deviation|0|||
24994242|NCT03517566|50085210|FG001|Overall Study|Protocol Deviation|1|||
24994243|NCT03517566|50085211|FG002|Overall Study|Protocol Deviation|0|||
24994244|NCT03517566|50085212|FG003|Overall Study|Protocol Deviation|1|||
24994245|NCT03517566|50085213|FG004|Overall Study|Protocol Deviation|1|||
24994246|NCT03517566|50085209|FG000|Overall Study|Study terminated by Sponsor|11|||
24994247|NCT03517566|50085210|FG001|Overall Study|Study terminated by Sponsor|5|||
24994248|NCT03517566|50085211|FG002|Overall Study|Study terminated by Sponsor|6|||
24994249|NCT03517566|50085212|FG003|Overall Study|Study terminated by Sponsor|14|||
24994250|NCT03517566|50085213|FG004|Overall Study|Study terminated by Sponsor|12|||
24994251|NCT03517566|50085209|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
24994252|NCT03517566|50085210|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
24994253|NCT03517566|50085211|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
24994254|NCT03517566|50085212|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
24994255|NCT03517566|50085213|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
24994256|NCT03916744|50085229|FG000|Overall Study|Withdrawal by Subject|0|||
24994257|NCT03916744|50085230|FG001|Overall Study|Withdrawal by Subject|1|||
24994258|NCT03916744|50085231|FG002|Overall Study|Withdrawal by Subject|2|||
24994259|NCT03639610|50085246|FG000|Overall Study|Adverse Event|7|||
24994260|NCT03639610|50085247|FG001|Overall Study|Adverse Event|1|||
24994261|NCT03639610|50085248|FG002|Overall Study|Adverse Event|0|||
24994262|NCT03639610|50085246|FG000|Overall Study|Physician Decision|3|||
24994263|NCT03639610|50085247|FG001|Overall Study|Physician Decision|1|||
24994264|NCT03639610|50085248|FG002|Overall Study|Physician Decision|0|||
24994265|NCT03639610|50085246|FG000|Overall Study|Disease progression|8|||
24994266|NCT03639610|50085247|FG001|Overall Study|Disease progression|5|||
24994267|NCT03639610|50085248|FG002|Overall Study|Disease progression|3|||
24994268|NCT03639610|50085246|FG000|Overall Study|Study terminated by sponsor|2|||
24994269|NCT03639610|50085247|FG001|Overall Study|Study terminated by sponsor|1|||
24994270|NCT03639610|50085248|FG002|Overall Study|Study terminated by sponsor|1|||
24994271|NCT03639610|50085246|FG000|Overall Study|Patient request to stop treatment|1|||
24994272|NCT03639610|50085247|FG001|Overall Study|Patient request to stop treatment|2|||
24994273|NCT03639610|50085248|FG002|Overall Study|Patient request to stop treatment|0|||
24994274|NCT02954406|50085266|FG000|Overall Study|Adverse Event|0|||
24994275|NCT02954406|50085267|FG001|Overall Study|Adverse Event|1|||
24994276|NCT02954406|50085268|FG002|Overall Study|Adverse Event|0|||
24994277|NCT02954406|50085269|FG003|Overall Study|Adverse Event|0|||
24994278|NCT02954406|50085270|FG004|Overall Study|Adverse Event|1|||
24994279|NCT02954406|50085271|FG005|Overall Study|Adverse Event|0|||
24994280|NCT02954406|50085272|FG006|Overall Study|Adverse Event|0|||
24994281|NCT02954406|50085273|FG007|Overall Study|Adverse Event|0|||
24994282|NCT02954406|50085274|FG008|Overall Study|Adverse Event|1|||
24994283|NCT02954406|50085275|FG009|Overall Study|Adverse Event|1|||
24994284|NCT02954406|50085276|FG010|Overall Study|Adverse Event|0|||
24994285|NCT02954406|50085266|FG000|Overall Study|Progressive Disease|3|||
24994286|NCT02954406|50085267|FG001|Overall Study|Progressive Disease|4|||
24994287|NCT02954406|50085268|FG002|Overall Study|Progressive Disease|3|||
24994288|NCT02954406|50085269|FG003|Overall Study|Progressive Disease|4|||
24994289|NCT02954406|50085270|FG004|Overall Study|Progressive Disease|3|||
24994290|NCT02954406|50085271|FG005|Overall Study|Progressive Disease|3|||
24994291|NCT02954406|50085272|FG006|Overall Study|Progressive Disease|2|||
24994292|NCT02954406|50085273|FG007|Overall Study|Progressive Disease|2|||
24994293|NCT02954406|50085274|FG008|Overall Study|Progressive Disease|1|||
24994294|NCT02954406|50085275|FG009|Overall Study|Progressive Disease|1|||
24994295|NCT02954406|50085276|FG010|Overall Study|Progressive Disease|0|||
24994296|NCT02954406|50085266|FG000|Overall Study|Symptomatic Deterioration|0|||
24994297|NCT02954406|50085267|FG001|Overall Study|Symptomatic Deterioration|1|||
24994298|NCT02954406|50085268|FG002|Overall Study|Symptomatic Deterioration|0|||
24994299|NCT02954406|50085269|FG003|Overall Study|Symptomatic Deterioration|0|||
24994300|NCT02954406|50085270|FG004|Overall Study|Symptomatic Deterioration|0|||
24994301|NCT02954406|50085271|FG005|Overall Study|Symptomatic Deterioration|0|||
24994302|NCT02954406|50085272|FG006|Overall Study|Symptomatic Deterioration|0|||
24994303|NCT02954406|50085273|FG007|Overall Study|Symptomatic Deterioration|0|||
24994304|NCT02954406|50085274|FG008|Overall Study|Symptomatic Deterioration|0|||
24994305|NCT02954406|50085275|FG009|Overall Study|Symptomatic Deterioration|0|||
24994306|NCT02954406|50085276|FG010|Overall Study|Symptomatic Deterioration|0|||
24994307|NCT02954406|50085266|FG000|Overall Study|Death|0|||
24994308|NCT02954406|50085267|FG001|Overall Study|Death|0|||
24994309|NCT02954406|50085268|FG002|Overall Study|Death|0|||
24994310|NCT02954406|50085269|FG003|Overall Study|Death|0|||
24994311|NCT02954406|50085270|FG004|Overall Study|Death|1|||
24994312|NCT02954406|50085271|FG005|Overall Study|Death|0|||
24994313|NCT02954406|50085272|FG006|Overall Study|Death|0|||
24994314|NCT02954406|50085273|FG007|Overall Study|Death|0|||
24994315|NCT02954406|50085274|FG008|Overall Study|Death|1|||
24994316|NCT02954406|50085275|FG009|Overall Study|Death|1|||
24994317|NCT02954406|50085276|FG010|Overall Study|Death|0|||
24994318|NCT02954406|50085266|FG000|Overall Study|Reason Not Specified|0|||
24994319|NCT02954406|50085267|FG001|Overall Study|Reason Not Specified|0|||
24994320|NCT02954406|50085268|FG002|Overall Study|Reason Not Specified|3|||
24994321|NCT02954406|50085269|FG003|Overall Study|Reason Not Specified|2|||
24994322|NCT02954406|50085270|FG004|Overall Study|Reason Not Specified|2|||
24994323|NCT02954406|50085271|FG005|Overall Study|Reason Not Specified|0|||
24994324|NCT02954406|50085272|FG006|Overall Study|Reason Not Specified|1|||
24994325|NCT02954406|50085273|FG007|Overall Study|Reason Not Specified|0|||
24994326|NCT02954406|50085274|FG008|Overall Study|Reason Not Specified|1|||
24994327|NCT02954406|50085275|FG009|Overall Study|Reason Not Specified|0|||
24994328|NCT02954406|50085276|FG010|Overall Study|Reason Not Specified|0|||
24994329|NCT03514914|50085306|FG000|Overall Study|Death|3|||
24994330|NCT03514914|50085307|FG001|Overall Study|Death|3|||
24994331|NCT03514914|50085306|FG000|Overall Study|Lost to Follow-up|117|||
24994332|NCT03514914|50085307|FG001|Overall Study|Lost to Follow-up|89|||
24994333|NCT03513588|50085316|FG000|Overall Study|Lost to Follow-up|0|||
24994334|NCT03513588|50085317|FG001|Overall Study|Lost to Follow-up|1|||
24994335|NCT03513588|50085318|FG002|Overall Study|Lost to Follow-up|1|||
24994336|NCT03513588|50085316|FG000|Overall Study|Study dosing paused by sponsor|1|||
24994337|NCT03513588|50085317|FG001|Overall Study|Study dosing paused by sponsor|1|||
24994338|NCT03513588|50085318|FG002|Overall Study|Study dosing paused by sponsor|0|||
24994339|NCT03513588|50085316|FG000|Overall Study|Death|0|||
24994340|NCT03513588|50085317|FG001|Overall Study|Death|0|||
24994341|NCT03513588|50085318|FG002|Overall Study|Death|1|||
24994342|NCT03512028|50085330|FG000|Overall Study|Withdrawal by Subject|2|||
24994343|NCT03512028|50085331|FG001|Overall Study|Withdrawal by Subject|0|||
24994344|NCT03512028|50085330|FG000|Overall Study|Protocol Violation|2|||
24994345|NCT03512028|50085331|FG001|Overall Study|Protocol Violation|0|||
24994346|NCT03511326|50085337|FG000|Overall Study|Withdrawal by Subject|1|||
24994347|NCT03508830|50085343|FG000|Overall Study|Withdrawal by Subject|3|||
24994348|NCT03508830|50085344|FG001|Overall Study|Withdrawal by Subject|4|||
24994349|NCT03508830|50085343|FG000|Overall Study|Physician Decision|2|||
24994350|NCT03508830|50085344|FG001|Overall Study|Physician Decision|2|||
24994351|NCT03508050|50085352|FG000|Overall Study|Pleural adhesions|1|||
24994352|NCT03508050|50085353|FG001|Overall Study|Pleural adhesions|0|||
24994353|NCT03508050|50085352|FG000|Overall Study|Mucus plug|1|||
24994354|NCT03508050|50085353|FG001|Overall Study|Mucus plug|0|||
24994355|NCT03508050|50085352|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
24994356|NCT03508050|50085353|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
24994357|NCT03508050|50085352|FG000|Overall Study|Sustained desaturation|0|||
24994358|NCT03508050|50085353|FG001|Overall Study|Sustained desaturation|1|||
24994359|NCT03381274|50085365|FG000|Overall Study|Death|2|||
24994360|NCT03381274|50085366|FG001|Overall Study|Death|9|||
24994361|NCT03381274|50085367|FG002|Overall Study|Death|3|||
24994362|NCT03381274|50085368|FG003|Overall Study|Death|2|||
24994363|NCT03381274|50085369|FG004|Overall Study|Death|3|||
24994364|NCT03381274|50085365|FG000|Overall Study|Lost to Follow-up|0|||
24994365|NCT03381274|50085366|FG001|Overall Study|Lost to Follow-up|0|||
24994366|NCT03381274|50085367|FG002|Overall Study|Lost to Follow-up|0|||
24994367|NCT03381274|50085368|FG003|Overall Study|Lost to Follow-up|1|||
24994368|NCT03381274|50085369|FG004|Overall Study|Lost to Follow-up|0|||
24994369|NCT03381274|50085365|FG000|Overall Study|Withdrawal by Subject|2|||
24994370|NCT03381274|50085366|FG001|Overall Study|Withdrawal by Subject|1|||
24994371|NCT03381274|50085367|FG002|Overall Study|Withdrawal by Subject|3|||
24994372|NCT03381274|50085368|FG003|Overall Study|Withdrawal by Subject|1|||
24994373|NCT03381274|50085369|FG004|Overall Study|Withdrawal by Subject|0|||
24994374|NCT03381274|50085365|FG000|Overall Study|Other|1|||
24994375|NCT03381274|50085366|FG001|Overall Study|Other|11|||
24994376|NCT03381274|50085367|FG002|Overall Study|Other|0|||
24994377|NCT03381274|50085368|FG003|Overall Study|Other|2|||
24994378|NCT03381274|50085369|FG004|Overall Study|Other|2|||
24994379|NCT03569202|50085387|FG000|Part 3|Physician Decision|1|||
24994380|NCT03569202|50085388|FG001|Part 3|Physician Decision|0|||
24994381|NCT03569202|50085387|FG000|Part 3|Other|1|||
24994382|NCT03569202|50085388|FG001|Part 3|Other|1|||
24994383|NCT03568500|50085397|FG000|Overall Study|Lost to Follow-up|1|||
24994384|NCT03568500|50085398|FG001|Overall Study|Lost to Follow-up|1|||
24994385|NCT03568500|50085399|FG002|Overall Study|Lost to Follow-up|2|||
24994386|NCT03568500|50085397|FG000|Overall Study|Adverse Event|1|||
24994387|NCT03568500|50085398|FG001|Overall Study|Adverse Event|1|||
24994388|NCT03568500|50085399|FG002|Overall Study|Adverse Event|2|||
24994389|NCT03568500|50085397|FG000|Overall Study|Physician Decision|1|||
24994390|NCT03568500|50085398|FG001|Overall Study|Physician Decision|0|||
24994391|NCT03568500|50085399|FG002|Overall Study|Physician Decision|0|||
24994392|NCT03568500|50085397|FG000|Overall Study|Withdrawal by Subject|4|||
24994393|NCT03568500|50085398|FG001|Overall Study|Withdrawal by Subject|2|||
24994394|NCT03568500|50085399|FG002|Overall Study|Withdrawal by Subject|0|||
24994395|NCT03568500|50085397|FG000|Overall Study|Technical Problems|2|||
24994396|NCT03568500|50085398|FG001|Overall Study|Technical Problems|1|||
24994397|NCT03568500|50085399|FG002|Overall Study|Technical Problems|0|||
24994398|NCT03568500|50085397|FG000|Overall Study|Participant Noncompliance|1|||
24994399|NCT03568500|50085398|FG001|Overall Study|Participant Noncompliance|1|||
24994400|NCT03568500|50085399|FG002|Overall Study|Participant Noncompliance|0|||
24994401|NCT03504852|50085424|FG000|Overall Study|Withdrawal of informed consent|2|||
24994402|NCT03504852|50085425|FG001|Overall Study|Withdrawal of informed consent|1|||
24994403|NCT03504852|50085426|FG002|Overall Study|Withdrawal of informed consent|0|||
24994404|NCT03504852|50085424|FG000|Overall Study|Withdrawal by Subject|5|||
24994405|NCT03504852|50085425|FG001|Overall Study|Withdrawal by Subject|5|||
24994406|NCT03504852|50085426|FG002|Overall Study|Withdrawal by Subject|1|||
24994407|NCT03504852|50085424|FG000|Overall Study|Lost to Follow-up|4|||
24994408|NCT03504852|50085425|FG001|Overall Study|Lost to Follow-up|1|||
24994409|NCT03504852|50085426|FG002|Overall Study|Lost to Follow-up|0|||
24994410|NCT03504852|50085424|FG000|Overall Study|New therapy for study indication|1|||
24994411|NCT03504852|50085425|FG001|Overall Study|New therapy for study indication|0|||
24994412|NCT03504852|50085426|FG002|Overall Study|New therapy for study indication|0|||
24994413|NCT03504852|50085424|FG000|Overall Study|Lack of Efficacy|1|||
24994414|NCT03504852|50085425|FG001|Overall Study|Lack of Efficacy|2|||
24994415|NCT03504852|50085426|FG002|Overall Study|Lack of Efficacy|0|||
24994416|NCT03504852|50085424|FG000|Overall Study|Death|0|||
24994417|NCT03504852|50085425|FG001|Overall Study|Death|1|||
24994418|NCT03504852|50085426|FG002|Overall Study|Death|0|||
24994419|NCT03504852|50085424|FG000|Overall Study|Adverse Event|4|||
24994420|NCT03504852|50085425|FG001|Overall Study|Adverse Event|8|||
24994421|NCT03504852|50085426|FG002|Overall Study|Adverse Event|2|||
24994422|NCT03025828|50085436|FG000|Overall Study|Lost to Follow-up|1|||
24994423|NCT03546816|50085442|FG000|Overall Study|Adverse Event|5|||
24994424|NCT03546816|50085443|FG001|Overall Study|Adverse Event|3|||
24994425|NCT03546816|50085442|FG000|Overall Study|Lack of Efficacy|2|||
24994426|NCT03546816|50085443|FG001|Overall Study|Lack of Efficacy|4|||
24994427|NCT03546816|50085442|FG000|Overall Study|Pregnancy|1|||
24994428|NCT03546816|50085443|FG001|Overall Study|Pregnancy|0|||
24994429|NCT03546816|50085442|FG000|Overall Study|Physician Decision|2|||
24994430|NCT03546816|50085443|FG001|Overall Study|Physician Decision|0|||
24994431|NCT03546816|50085442|FG000|Overall Study|Withdrawal by Subject|8|||
24994432|NCT03546816|50085443|FG001|Overall Study|Withdrawal by Subject|10|||
24994433|NCT03546816|50085442|FG000|Overall Study|Lost to Follow-up|3|||
24994434|NCT03546816|50085443|FG001|Overall Study|Lost to Follow-up|2|||
24994435|NCT03024970|50085451|FG000|First Intervention|Adverse Event|1|||
24994436|NCT03024970|50085452|FG001|First Intervention|Adverse Event|0|||
24994437|NCT03024970|50085451|FG000|Second Intervention|Lost to Follow-up|1|||
24994438|NCT03024970|50085452|FG001|Second Intervention|Lost to Follow-up|0|||
24994439|NCT03500094|50085458|FG000|Overall Study|Withdrawal by Subject|1|||
24994440|NCT03500094|50085458|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
24994441|NCT03500094|50085458|FG000|Overall Study|Lost to Follow-up|1|||
24994442|NCT03566550|50085466|FG000|Overall Study|Withdrawal by Subject|0|||
24994443|NCT03566550|50085467|FG001|Overall Study|Withdrawal by Subject|1|||
24994444|NCT03566238|50085476|FG000|Overall Study|Adverse Event|0|||
24994445|NCT03566238|50085477|FG001|Overall Study|Adverse Event|1|||
24994446|NCT03566238|50085478|FG002|Overall Study|Adverse Event|0|||
24994447|NCT03566238|50085476|FG000|Overall Study|Lack of Efficacy|4|||
24994448|NCT03566238|50085477|FG001|Overall Study|Lack of Efficacy|2|||
24994449|NCT03566238|50085478|FG002|Overall Study|Lack of Efficacy|5|||
24994450|NCT03566238|50085476|FG000|Overall Study|Other|1|||
24994451|NCT03566238|50085477|FG001|Overall Study|Other|0|||
24994452|NCT03566238|50085478|FG002|Overall Study|Other|0|||
24994453|NCT02894502|50085489|FG000|Baseline|Withdrawal by Subject|24|||
24994454|NCT02894502|50085490|FG001|Baseline|Withdrawal by Subject|31|||
24994455|NCT02894502|50085491|FG002|Baseline|Withdrawal by Subject|36|||
24994456|NCT02894502|50085489|FG000|Baseline|Death|3|||
24994457|NCT02894502|50085490|FG001|Baseline|Death|1|||
24994458|NCT02894502|50085491|FG002|Baseline|Death|9|||
24994459|NCT02894502|50085489|FG000|First Follow up|Withdrawal by Subject|32|||
24994460|NCT02894502|50085490|FG001|First Follow up|Withdrawal by Subject|29|||
24994461|NCT02894502|50085491|FG002|First Follow up|Withdrawal by Subject|37|||
24994462|NCT02894502|50085489|FG000|First Follow up|Death|2|||
24994463|NCT02894502|50085490|FG001|First Follow up|Death|2|||
24994464|NCT02894502|50085491|FG002|First Follow up|Death|3|||
24994465|NCT02894502|50085489|FG000|Second Follow up|Withdrawal by Subject|13|||
24994466|NCT02894502|50085490|FG001|Second Follow up|Withdrawal by Subject|15|||
24994467|NCT02894502|50085491|FG002|Second Follow up|Withdrawal by Subject|13|||
24994468|NCT02894502|50085489|FG000|Second Follow up|Death|2|||
24994469|NCT02894502|50085490|FG001|Second Follow up|Death|3|||
24994470|NCT02894502|50085491|FG002|Second Follow up|Death|1|||
24994471|NCT02894502|50085489|FG000|Third Follow up|Withdrawal by Subject|5|||
24994472|NCT02894502|50085490|FG001|Third Follow up|Withdrawal by Subject|6|||
24994473|NCT02894502|50085491|FG002|Third Follow up|Withdrawal by Subject|3|||
24994474|NCT02894502|50085489|FG000|Third Follow up|Death|1|||
24994475|NCT02894502|50085490|FG001|Third Follow up|Death|1|||
24994476|NCT02894502|50085491|FG002|Third Follow up|Death|0|||
24994477|NCT03449030|50085512|FG000|Overall Study|Withdrawal by Subject|0|||
24994478|NCT03449030|50085513|FG001|Overall Study|Withdrawal by Subject|0|||
24994479|NCT03449030|50085514|FG002|Overall Study|Withdrawal by Subject|0|||
24994480|NCT03449030|50085515|FG003|Overall Study|Withdrawal by Subject|1|||
24994481|NCT03449030|50085516|FG004|Overall Study|Withdrawal by Subject|1|||
24994482|NCT03449030|50085517|FG005|Overall Study|Withdrawal by Subject|1|||
24994483|NCT03449030|50085518|FG006|Overall Study|Withdrawal by Subject|1|||
24994484|NCT03449030|50085519|FG007|Overall Study|Withdrawal by Subject|2|||
24994485|NCT03449030|50085520|FG008|Overall Study|Withdrawal by Subject|0|||
24994486|NCT03449030|50085521|FG009|Overall Study|Withdrawal by Subject|0|||
24994487|NCT03449030|50085512|FG000|Overall Study|Symptomatic Deterioration|0|||
24994488|NCT03449030|50085513|FG001|Overall Study|Symptomatic Deterioration|1|||
24994489|NCT03449030|50085514|FG002|Overall Study|Symptomatic Deterioration|0|||
24994490|NCT03449030|50085515|FG003|Overall Study|Symptomatic Deterioration|0|||
24994491|NCT03449030|50085516|FG004|Overall Study|Symptomatic Deterioration|0|||
24994492|NCT03449030|50085517|FG005|Overall Study|Symptomatic Deterioration|1|||
24994493|NCT03449030|50085518|FG006|Overall Study|Symptomatic Deterioration|1|||
24994494|NCT03449030|50085519|FG007|Overall Study|Symptomatic Deterioration|0|||
24994495|NCT03449030|50085520|FG008|Overall Study|Symptomatic Deterioration|2|||
24994496|NCT03449030|50085521|FG009|Overall Study|Symptomatic Deterioration|0|||
24994497|NCT03449030|50085512|FG000|Overall Study|Progressive Disease|1|||
24994498|NCT03449030|50085513|FG001|Overall Study|Progressive Disease|0|||
24994499|NCT03449030|50085514|FG002|Overall Study|Progressive Disease|1|||
24994500|NCT03449030|50085515|FG003|Overall Study|Progressive Disease|4|||
24994501|NCT03449030|50085516|FG004|Overall Study|Progressive Disease|5|||
24994502|NCT03449030|50085517|FG005|Overall Study|Progressive Disease|3|||
24994503|NCT03449030|50085518|FG006|Overall Study|Progressive Disease|0|||
24994504|NCT03449030|50085519|FG007|Overall Study|Progressive Disease|1|||
24994505|NCT03449030|50085520|FG008|Overall Study|Progressive Disease|1|||
24994506|NCT03449030|50085521|FG009|Overall Study|Progressive Disease|1|||
24994507|NCT03449030|50085512|FG000|Overall Study|Adverse Event|0|||
24994508|NCT03449030|50085513|FG001|Overall Study|Adverse Event|0|||
24994509|NCT03449030|50085514|FG002|Overall Study|Adverse Event|0|||
24994510|NCT03449030|50085515|FG003|Overall Study|Adverse Event|0|||
24994511|NCT03449030|50085516|FG004|Overall Study|Adverse Event|0|||
24994512|NCT03449030|50085517|FG005|Overall Study|Adverse Event|2|||
24994513|NCT03449030|50085518|FG006|Overall Study|Adverse Event|0|||
24994514|NCT03449030|50085519|FG007|Overall Study|Adverse Event|0|||
24994515|NCT03449030|50085520|FG008|Overall Study|Adverse Event|0|||
24994516|NCT03449030|50085521|FG009|Overall Study|Adverse Event|0|||
24994517|NCT03449030|50085512|FG000|Overall Study|Death|0|||
24994518|NCT03449030|50085513|FG001|Overall Study|Death|0|||
24994519|NCT03449030|50085514|FG002|Overall Study|Death|0|||
24994520|NCT03449030|50085515|FG003|Overall Study|Death|0|||
24994521|NCT03449030|50085516|FG004|Overall Study|Death|1|||
24994522|NCT03449030|50085517|FG005|Overall Study|Death|0|||
24994523|NCT03449030|50085518|FG006|Overall Study|Death|0|||
24994524|NCT03449030|50085519|FG007|Overall Study|Death|0|||
24994525|NCT03449030|50085520|FG008|Overall Study|Death|0|||
24994526|NCT03449030|50085521|FG009|Overall Study|Death|0|||
24994527|NCT03448406|50085546|FG000|Overall Study|Noncompliance of scheduled visits|1|||
24994528|NCT03448406|50085547|FG001|Overall Study|Noncompliance of scheduled visits|2|||
24994529|NCT03448406|50085546|FG000|Overall Study|Withdrawal by Subject|1|||
24994530|NCT03448406|50085547|FG001|Overall Study|Withdrawal by Subject|2|||
24994531|NCT03448406|50085546|FG000|Overall Study|Protocol Violation|1|||
24994532|NCT03448406|50085547|FG001|Overall Study|Protocol Violation|0|||
24994533|NCT03448406|50085546|FG000|Overall Study|Adverse Event|8|||
24994534|NCT03448406|50085547|FG001|Overall Study|Adverse Event|9|||
24994535|NCT03499028|50085555|FG000|Overall Study|Lost to Follow-up|12|||
24994536|NCT03499028|50085556|FG001|Overall Study|Lost to Follow-up|9|||
24994537|NCT03499028|50085555|FG000|Overall Study|Withdrawal by Subject|5|||
24994538|NCT03499028|50085556|FG001|Overall Study|Withdrawal by Subject|8|||
24994539|NCT03499028|50085555|FG000|Overall Study|Unplanned SNF discharge|5|||
24994540|NCT03499028|50085556|FG001|Overall Study|Unplanned SNF discharge|8|||
24994541|NCT03498560|50085564|FG000|Overall Study|Found Ineligible|2|||
24994542|NCT03498560|50085564|FG000|Overall Study|Withdrawal by Subject|14|||
24994543|NCT03498560|50085564|FG000|Overall Study|Lost to Follow-up|4|||
24994544|NCT03498560|50085564|FG000|Overall Study|Death|1|||
24994545|NCT00064701|50085572|FG000|One Year Post-transplant|Did not receive study drug|7|||
24994546|NCT00064701|50085573|FG001|One Year Post-transplant|Did not receive study drug|12|||
24994547|NCT00064701|50085574|FG002|One Year Post-transplant|Did not receive study drug|11|||
24994548|NCT00064701|50085572|FG000|One Year Post-transplant|Adverse Event|23|||
24994549|NCT00064701|50085573|FG001|One Year Post-transplant|Adverse Event|19|||
24994550|NCT00064701|50085574|FG002|One Year Post-transplant|Adverse Event|37|||
24994551|NCT00064701|50085572|FG000|One Year Post-transplant|Rejection|0|||
24994552|NCT00064701|50085573|FG001|One Year Post-transplant|Rejection|1|||
24994553|NCT00064701|50085574|FG002|One Year Post-transplant|Rejection|16|||
24994554|NCT00064701|50085572|FG000|One Year Post-transplant|Non-compliance|4|||
24994555|NCT00064701|50085573|FG001|One Year Post-transplant|Non-compliance|2|||
24994556|NCT00064701|50085574|FG002|One Year Post-transplant|Non-compliance|5|||
24994557|NCT00064701|50085572|FG000|One Year Post-transplant|Graft Failure|3|||
24994558|NCT00064701|50085573|FG001|One Year Post-transplant|Graft Failure|2|||
24994559|NCT00064701|50085574|FG002|One Year Post-transplant|Graft Failure|1|||
24994560|NCT00064701|50085572|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
24994561|NCT00064701|50085573|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
24994562|NCT00064701|50085574|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
24994563|NCT00064701|50085572|FG000|One Year Post-transplant|Lost to Follow-up|1|||
24994564|NCT00064701|50085573|FG001|One Year Post-transplant|Lost to Follow-up|0|||
24994565|NCT00064701|50085574|FG002|One Year Post-transplant|Lost to Follow-up|0|||
24994566|NCT00064701|50085572|FG000|One Year Post-transplant|Converted to rapamycin|1|||
24994567|NCT00064701|50085573|FG001|One Year Post-transplant|Converted to rapamycin|0|||
24994568|NCT00064701|50085574|FG002|One Year Post-transplant|Converted to rapamycin|0|||
24994569|NCT00064701|50085572|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
24994570|NCT00064701|50085573|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
24994571|NCT00064701|50085574|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
24994572|NCT00064701|50085572|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
24994573|NCT00064701|50085573|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
24994574|NCT00064701|50085574|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
24994575|NCT00064701|50085572|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
24994576|NCT00064701|50085573|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
24994577|NCT00064701|50085574|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
24994578|NCT00064701|50085572|FG000|One Year Post-transplant|Poor absorption|0|||
24994579|NCT00064701|50085573|FG001|One Year Post-transplant|Poor absorption|1|||
24994580|NCT00064701|50085574|FG002|One Year Post-transplant|Poor absorption|0|||
24994581|NCT00064701|50085572|FG000|One Year Post-transplant|Pancreas transplant|0|||
24994582|NCT00064701|50085573|FG001|One Year Post-transplant|Pancreas transplant|0|||
24994583|NCT00064701|50085574|FG002|One Year Post-transplant|Pancreas transplant|1|||
24994584|NCT00064701|50085572|FG000|Clinical Continuation Phase|Adverse Event|12|||
24994585|NCT00064701|50085573|FG001|Clinical Continuation Phase|Adverse Event|21|||
24994586|NCT00064701|50085574|FG002|Clinical Continuation Phase|Adverse Event|14|||
24994587|NCT00064701|50085572|FG000|Clinical Continuation Phase|Non-compliance|8|||
24994588|NCT00064701|50085573|FG001|Clinical Continuation Phase|Non-compliance|6|||
24994589|NCT00064701|50085574|FG002|Clinical Continuation Phase|Non-compliance|7|||
24994590|NCT00064701|50085572|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
24994591|NCT00064701|50085573|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
24994592|NCT00064701|50085574|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
24994593|NCT00064701|50085572|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
24994594|NCT00064701|50085573|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
24994595|NCT00064701|50085574|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
24994596|NCT00064701|50085572|FG000|Clinical Continuation Phase|Graft Failure|5|||
24994597|NCT00064701|50085573|FG001|Clinical Continuation Phase|Graft Failure|5|||
24994598|NCT00064701|50085574|FG002|Clinical Continuation Phase|Graft Failure|2|||
24994599|NCT00064701|50085572|FG000|Clinical Continuation Phase|Rejection|1|||
24994600|NCT00064701|50085573|FG001|Clinical Continuation Phase|Rejection|2|||
24994601|NCT00064701|50085574|FG002|Clinical Continuation Phase|Rejection|2|||
24994602|NCT00064701|50085572|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
24994603|NCT00064701|50085573|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
24994604|NCT00064701|50085574|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
24994605|NCT00064701|50085572|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
24994606|NCT00064701|50085573|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
24994607|NCT00064701|50085574|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
24994608|NCT00064701|50085572|FG000|Clinical Continuation Phase|Physician Decision|1|||
24994609|NCT00064701|50085573|FG001|Clinical Continuation Phase|Physician Decision|3|||
24994610|NCT00064701|50085574|FG002|Clinical Continuation Phase|Physician Decision|0|||
24994611|NCT00064701|50085572|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
24994612|NCT00064701|50085573|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
24994613|NCT00064701|50085574|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
24994614|NCT00064701|50085572|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
24994615|NCT00064701|50085573|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
24994616|NCT00064701|50085574|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
24994617|NCT00064701|50085572|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
24994618|NCT00064701|50085573|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
24994619|NCT00064701|50085574|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
24994620|NCT00064701|50085572|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
24994621|NCT00064701|50085573|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
24994622|NCT00064701|50085574|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
24994623|NCT00064701|50085572|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
24994624|NCT00064701|50085573|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
24994625|NCT00064701|50085574|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
24994626|NCT00064701|50085572|FG000|Clinical Continuation Phase|Patient opted out|0|||
24994627|NCT00064701|50085573|FG001|Clinical Continuation Phase|Patient opted out|0|||
24994628|NCT00064701|50085574|FG002|Clinical Continuation Phase|Patient opted out|1|||
24994629|NCT00064077|50085586|FG000|Overall Study|Improper prior treatment|1|||
24994630|NCT00064077|50085587|FG001|Overall Study|Improper prior treatment|0|||
24994631|NCT00064077|50085588|FG002|Overall Study|Improper prior treatment|0|||
24994632|NCT00064077|50085589|FG003|Overall Study|Improper prior treatment|0|||
24994633|NCT00064077|50085586|FG000|Overall Study|Poor risk|2|||
24994634|NCT00064077|50085587|FG001|Overall Study|Poor risk|0|||
24994635|NCT00064077|50085588|FG002|Overall Study|Poor risk|1|||
24994636|NCT00064077|50085589|FG003|Overall Study|Poor risk|1|||
24994637|NCT00064077|50085586|FG000|Overall Study|Pathology|10|||
24994638|NCT00064077|50085587|FG001|Overall Study|Pathology|7|||
24994639|NCT00064077|50085588|FG002|Overall Study|Pathology|3|||
24994640|NCT00064077|50085589|FG003|Overall Study|Pathology|4|||
24994641|NCT00064077|50085586|FG000|Overall Study|No surgery|0|||
24994642|NCT00064077|50085587|FG001|Overall Study|No surgery|0|||
24994643|NCT00064077|50085588|FG002|Overall Study|No surgery|1|||
24994644|NCT00064077|50085589|FG003|Overall Study|No surgery|0|||
24994645|NCT00064077|50085586|FG000|Overall Study|No tumor|0|||
24994646|NCT00064077|50085587|FG001|Overall Study|No tumor|0|||
24994647|NCT00064077|50085588|FG002|Overall Study|No tumor|1|||
24994648|NCT00064077|50085589|FG003|Overall Study|No tumor|0|||
24994649|NCT00064077|50085586|FG000|Overall Study|Other reasons|2|||
24994650|NCT00064077|50085587|FG001|Overall Study|Other reasons|2|||
24994651|NCT00064077|50085588|FG002|Overall Study|Other reasons|1|||
24994652|NCT00064077|50085589|FG003|Overall Study|Other reasons|2|||
24994653|NCT00063999|50085601|FG000|Overall Study|Withdrawal by Subject|1|||
24994654|NCT00063999|50085602|FG001|Overall Study|Withdrawal by Subject|0|||
24994655|NCT00063999|50085601|FG000|Overall Study|Ineligible|44|||
24994656|NCT00063999|50085602|FG001|Overall Study|Ineligible|24|||
24994657|NCT03131440|50085647|FG000|Overall Study|Withdrawal by Subject|1|||
24994658|NCT03131440|50085648|FG001|Overall Study|Withdrawal by Subject|3|||
24994659|NCT03131440|50085649|FG002|Overall Study|Withdrawal by Subject|0|||
24994660|NCT03131440|50085650|FG003|Overall Study|Withdrawal by Subject|0|||
24994661|NCT03131440|50085651|FG004|Overall Study|Withdrawal by Subject|1|||
24994662|NCT03131440|50085652|FG005|Overall Study|Withdrawal by Subject|0|||
24994663|NCT03131440|50085653|FG006|Overall Study|Withdrawal by Subject|0|||
24994664|NCT03131440|50085654|FG007|Overall Study|Withdrawal by Subject|1|||
24994665|NCT03131440|50085655|FG008|Overall Study|Withdrawal by Subject|1|||
24994666|NCT03131440|50085656|FG009|Overall Study|Withdrawal by Subject|1|||
24994667|NCT03131440|50085657|FG010|Overall Study|Withdrawal by Subject|0|||
24994668|NCT03131440|50085658|FG011|Overall Study|Withdrawal by Subject|1|||
24994669|NCT03131440|50085659|FG012|Overall Study|Withdrawal by Subject|1|||
24994670|NCT03131440|50085660|FG013|Overall Study|Withdrawal by Subject|0|||
24994671|NCT03131440|50085661|FG014|Overall Study|Withdrawal by Subject|1|||
24994672|NCT03131440|50085662|FG015|Overall Study|Withdrawal by Subject|0|||
24994673|NCT03131440|50085663|FG016|Overall Study|Withdrawal by Subject|0|||
24994674|NCT03131440|50085664|FG017|Overall Study|Withdrawal by Subject|0|||
24994675|NCT03131440|50085665|FG018|Overall Study|Withdrawal by Subject|1|||
24994676|NCT03131440|50085666|FG019|Overall Study|Withdrawal by Subject|0|||
24994677|NCT03131440|50085667|FG020|Overall Study|Withdrawal by Subject|1|||
24994678|NCT03131440|50085668|FG021|Overall Study|Withdrawal by Subject|1|||
24994679|NCT03131440|50085669|FG022|Overall Study|Withdrawal by Subject|1|||
24994680|NCT03131440|50085670|FG023|Overall Study|Withdrawal by Subject|0|||
24994681|NCT03131440|50085671|FG024|Overall Study|Withdrawal by Subject|0|||
24994682|NCT03131440|50085672|FG025|Overall Study|Withdrawal by Subject|0|||
24994683|NCT03131440|50085673|FG026|Overall Study|Withdrawal by Subject|0|||
24994684|NCT03131440|50085674|FG027|Overall Study|Withdrawal by Subject|0|||
24994685|NCT03131440|50085675|FG028|Overall Study|Withdrawal by Subject|0|||
24994686|NCT03131440|50085676|FG029|Overall Study|Withdrawal by Subject|0|||
24994687|NCT03131440|50085677|FG030|Overall Study|Withdrawal by Subject|1|||
24994688|NCT03131440|50085678|FG031|Overall Study|Withdrawal by Subject|0|||
24994689|NCT03131440|50085647|FG000|Overall Study|Lost to Follow-up|0|||
24994690|NCT03131440|50085648|FG001|Overall Study|Lost to Follow-up|0|||
24994691|NCT03131440|50085649|FG002|Overall Study|Lost to Follow-up|0|||
24994692|NCT03131440|50085650|FG003|Overall Study|Lost to Follow-up|0|||
24994693|NCT03131440|50085651|FG004|Overall Study|Lost to Follow-up|0|||
24994694|NCT03131440|50085652|FG005|Overall Study|Lost to Follow-up|1|||
24994695|NCT03131440|50085653|FG006|Overall Study|Lost to Follow-up|0|||
24994696|NCT03131440|50085654|FG007|Overall Study|Lost to Follow-up|0|||
24994697|NCT03131440|50085655|FG008|Overall Study|Lost to Follow-up|0|||
24994698|NCT03131440|50085656|FG009|Overall Study|Lost to Follow-up|0|||
24994699|NCT03131440|50085657|FG010|Overall Study|Lost to Follow-up|0|||
24994700|NCT03131440|50085658|FG011|Overall Study|Lost to Follow-up|0|||
24994701|NCT03131440|50085659|FG012|Overall Study|Lost to Follow-up|0|||
24994702|NCT03131440|50085660|FG013|Overall Study|Lost to Follow-up|0|||
24994703|NCT03131440|50085661|FG014|Overall Study|Lost to Follow-up|0|||
24994704|NCT03131440|50085662|FG015|Overall Study|Lost to Follow-up|0|||
24994705|NCT03131440|50085663|FG016|Overall Study|Lost to Follow-up|0|||
24994706|NCT03131440|50085664|FG017|Overall Study|Lost to Follow-up|0|||
24994707|NCT03131440|50085665|FG018|Overall Study|Lost to Follow-up|0|||
24994708|NCT03131440|50085666|FG019|Overall Study|Lost to Follow-up|2|||
24994709|NCT03131440|50085667|FG020|Overall Study|Lost to Follow-up|1|||
24994710|NCT03131440|50085668|FG021|Overall Study|Lost to Follow-up|0|||
24994711|NCT03131440|50085669|FG022|Overall Study|Lost to Follow-up|1|||
24994712|NCT03131440|50085670|FG023|Overall Study|Lost to Follow-up|0|||
24994713|NCT03131440|50085671|FG024|Overall Study|Lost to Follow-up|1|||
24994714|NCT03131440|50085672|FG025|Overall Study|Lost to Follow-up|0|||
24994715|NCT03131440|50085673|FG026|Overall Study|Lost to Follow-up|0|||
24994716|NCT03131440|50085674|FG027|Overall Study|Lost to Follow-up|2|||
24994717|NCT03131440|50085675|FG028|Overall Study|Lost to Follow-up|0|||
24994718|NCT03131440|50085676|FG029|Overall Study|Lost to Follow-up|2|||
24994719|NCT03131440|50085677|FG030|Overall Study|Lost to Follow-up|0|||
24994720|NCT03131440|50085678|FG031|Overall Study|Lost to Follow-up|0|||
24994721|NCT03131440|50085647|FG000|Overall Study|Death|0|||
24994722|NCT03131440|50085648|FG001|Overall Study|Death|0|||
24994723|NCT03131440|50085649|FG002|Overall Study|Death|0|||
24994724|NCT03131440|50085650|FG003|Overall Study|Death|0|||
24994725|NCT03131440|50085651|FG004|Overall Study|Death|0|||
24994726|NCT03131440|50085652|FG005|Overall Study|Death|0|||
24994727|NCT03131440|50085653|FG006|Overall Study|Death|0|||
24994728|NCT03131440|50085654|FG007|Overall Study|Death|0|||
24994729|NCT03131440|50085655|FG008|Overall Study|Death|0|||
24994730|NCT03131440|50085656|FG009|Overall Study|Death|0|||
24994731|NCT03131440|50085657|FG010|Overall Study|Death|0|||
24994732|NCT03131440|50085658|FG011|Overall Study|Death|0|||
24994733|NCT03131440|50085659|FG012|Overall Study|Death|0|||
24994734|NCT03131440|50085660|FG013|Overall Study|Death|0|||
24994735|NCT03131440|50085661|FG014|Overall Study|Death|0|||
24994736|NCT03131440|50085662|FG015|Overall Study|Death|0|||
24994737|NCT03131440|50085663|FG016|Overall Study|Death|0|||
24994738|NCT03131440|50085664|FG017|Overall Study|Death|0|||
24994739|NCT03131440|50085665|FG018|Overall Study|Death|0|||
24994740|NCT03131440|50085666|FG019|Overall Study|Death|0|||
24994741|NCT03131440|50085667|FG020|Overall Study|Death|0|||
24994742|NCT03131440|50085668|FG021|Overall Study|Death|0|||
24994743|NCT03131440|50085669|FG022|Overall Study|Death|0|||
24994744|NCT03131440|50085670|FG023|Overall Study|Death|0|||
24994745|NCT03131440|50085671|FG024|Overall Study|Death|0|||
24994746|NCT03131440|50085672|FG025|Overall Study|Death|1|||
24994747|NCT03131440|50085673|FG026|Overall Study|Death|0|||
24994748|NCT03131440|50085674|FG027|Overall Study|Death|0|||
24994749|NCT03131440|50085675|FG028|Overall Study|Death|0|||
24994750|NCT03131440|50085676|FG029|Overall Study|Death|0|||
24994751|NCT03131440|50085677|FG030|Overall Study|Death|0|||
24994752|NCT03131440|50085678|FG031|Overall Study|Death|0|||
24994753|NCT02915302|50085723|FG000|Overall Study|Adverse Event|3|||
24994754|NCT02915302|50085724|FG001|Overall Study|Adverse Event|0|||
24994755|NCT02915302|50085723|FG000|Overall Study|Protocol Violation|20|||
24994756|NCT02915302|50085724|FG001|Overall Study|Protocol Violation|27|||
24994757|NCT02915302|50085723|FG000|Overall Study|Lost to Follow-up|19|||
24994758|NCT02915302|50085724|FG001|Overall Study|Lost to Follow-up|22|||
24994759|NCT02915302|50085723|FG000|Overall Study|Withdrawal by Subject|22|||
24994760|NCT02915302|50085724|FG001|Overall Study|Withdrawal by Subject|29|||
24994761|NCT02915302|50085723|FG000|Overall Study|Other|1|||
24994762|NCT02915302|50085724|FG001|Overall Study|Other|0|||
24994763|NCT03023878|50085730|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
24994764|NCT03023878|50085730|FG000|Pre-Study Run-In Period|Death|1|||
24994765|NCT03023878|50085730|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
24994766|NCT03023878|50085730|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
24994767|NCT03023878|50085730|FG000|Treatment Period|Disease Progression|1|||
24994768|NCT03023878|50085730|FG000|Treatment Period|Withdrawal by Subject|1|||
24994769|NCT03023878|50085730|FG000|Treatment Period|Adverse Event|1|||
24994770|NCT03023878|50085730|FG000|Long Term Follow-Up Period|Death|2|||
24994771|NCT03022630|50085736|FG000|Overall Study|Death|9|||
24994772|NCT03022630|50085737|FG001|Overall Study|Death|7|||
24994773|NCT03022630|50085736|FG000|Overall Study|Withdrawal by Subject|0|||
24994774|NCT03022630|50085737|FG001|Overall Study|Withdrawal by Subject|5|||
24994775|NCT03023722|50085748|FG000|Overall Study|No follow-up assessment|4|||
24994776|NCT03022084|50085754|FG000|Overall Study|Lost to Follow-up|2|||
24994777|NCT03022084|50085755|FG001|Overall Study|Lost to Follow-up|3|||
24994778|NCT03021304|50085761|FG000|Overall Study|Lack of Efficacy|1|||
25081563|NCT02855125|50189983|FG000|Overall Study|Randomized but not treated|0|||
24994779|NCT01979536|50085767|FG000|Overall Study|Physician Decision|2|||
24994780|NCT01979536|50085768|FG001|Overall Study|Physician Decision|3|||
24994781|NCT01979536|50085767|FG000|Overall Study|Withdrawal by Subject|0|||
24994782|NCT01979536|50085768|FG001|Overall Study|Withdrawal by Subject|1|||
24994783|NCT01979536|50085767|FG000|Overall Study|Refusal|0|||
25081564|NCT02855125|50189984|FG001|Overall Study|Randomized but not treated|1|||
25081565|NCT02730871|50190007|FG000|Overall Study|Adverse Event|6|||
25081566|NCT02730871|50190008|FG001|Overall Study|Adverse Event|0|||
25081567|NCT03376789|50190016|FG000|Overall Study|Withdrawal by Subject|3|||
25081568|NCT03376789|50190017|FG001|Overall Study|Withdrawal by Subject|5|||
25081569|NCT03376789|50190016|FG000|Overall Study|Protocol Violation|0|||
25081570|NCT03376789|50190017|FG001|Overall Study|Protocol Violation|1|||
25081571|NCT03376789|50190016|FG000|Overall Study|Adverse Event|0|||
25081572|NCT03376789|50190017|FG001|Overall Study|Adverse Event|1|||
25081573|NCT03376789|50190016|FG000|Overall Study|Lost to Follow-up|1|||
25081574|NCT03376789|50190017|FG001|Overall Study|Lost to Follow-up|1|||
25081575|NCT03376789|50190016|FG000|Overall Study|Per sponsor due to noncompliance|1|||
25081576|NCT03376789|50190017|FG001|Overall Study|Per sponsor due to noncompliance|0|||
25081577|NCT03376789|50190016|FG000|Overall Study|Subject off study medication|0|||
25081578|NCT03376789|50190017|FG001|Overall Study|Subject off study medication|1|||
25081579|NCT04032093|50190033|FG000|Overall Study|Lost to Follow-up|7|||
25081580|NCT04032093|50190034|FG001|Overall Study|Lost to Follow-up|7|||
25081581|NCT04032093|50190035|FG002|Overall Study|Lost to Follow-up|6|||
25081582|NCT04032093|50190036|FG003|Overall Study|Lost to Follow-up|10|||
25081583|NCT04032093|50190037|FG004|Overall Study|Lost to Follow-up|13|||
25081584|NCT04032093|50190038|FG005|Overall Study|Lost to Follow-up|7|||
25081585|NCT04032093|50190039|FG006|Overall Study|Lost to Follow-up|7|||
25081586|NCT04032093|50190040|FG007|Overall Study|Lost to Follow-up|5|||
25081587|NCT04032093|50190041|FG008|Overall Study|Lost to Follow-up|9|||
25081588|NCT04032093|50190042|FG009|Overall Study|Lost to Follow-up|12|||
25081589|NCT04032093|50190033|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
25081590|NCT04032093|50190034|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
25081591|NCT04032093|50190035|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
25081592|NCT04032093|50190036|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
25081593|NCT04032093|50190037|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
25081594|NCT04032093|50190038|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
25081595|NCT04032093|50190039|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
25081596|NCT04032093|50190040|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
25081597|NCT04032093|50190041|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
25081598|NCT04032093|50190042|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
25081599|NCT04032093|50190033|FG000|Overall Study|Other|1|||
25081600|NCT04032093|50190034|FG001|Overall Study|Other|0|||
25081601|NCT04032093|50190035|FG002|Overall Study|Other|0|||
25081602|NCT04032093|50190036|FG003|Overall Study|Other|1|||
25081603|NCT04032093|50190037|FG004|Overall Study|Other|1|||
25081604|NCT04032093|50190038|FG005|Overall Study|Other|0|||
25081605|NCT04032093|50190039|FG006|Overall Study|Other|0|||
25081606|NCT04032093|50190040|FG007|Overall Study|Other|0|||
25081607|NCT04032093|50190041|FG008|Overall Study|Other|0|||
25081608|NCT04032093|50190042|FG009|Overall Study|Other|1|||
25081609|NCT04032093|50190033|FG000|Overall Study|Withdrawal by Subject|1|||
25081610|NCT04032093|50190034|FG001|Overall Study|Withdrawal by Subject|3|||
25081611|NCT04032093|50190035|FG002|Overall Study|Withdrawal by Subject|2|||
25081612|NCT04032093|50190036|FG003|Overall Study|Withdrawal by Subject|2|||
25081613|NCT04032093|50190037|FG004|Overall Study|Withdrawal by Subject|3|||
25081614|NCT04032093|50190038|FG005|Overall Study|Withdrawal by Subject|0|||
25081615|NCT04032093|50190039|FG006|Overall Study|Withdrawal by Subject|0|||
25081616|NCT04032093|50190040|FG007|Overall Study|Withdrawal by Subject|0|||
25081617|NCT04032093|50190041|FG008|Overall Study|Withdrawal by Subject|0|||
25081618|NCT04032093|50190042|FG009|Overall Study|Withdrawal by Subject|0|||
25081619|NCT04032093|50190033|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
25081620|NCT04032093|50190034|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
25081621|NCT04032093|50190035|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
25081622|NCT04032093|50190036|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
25081623|NCT04032093|50190037|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
25081624|NCT04032093|50190038|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
25081625|NCT04032093|50190039|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
25081626|NCT04032093|50190040|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
25081627|NCT04032093|50190041|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
25081628|NCT04032093|50190042|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
25081629|NCT04032093|50190033|FG000|Overall Study|Adverse Event|0|||
25081630|NCT04032093|50190034|FG001|Overall Study|Adverse Event|0|||
25081631|NCT04032093|50190035|FG002|Overall Study|Adverse Event|0|||
25081632|NCT04032093|50190036|FG003|Overall Study|Adverse Event|0|||
25081633|NCT04032093|50190037|FG004|Overall Study|Adverse Event|0|||
25081634|NCT04032093|50190038|FG005|Overall Study|Adverse Event|0|||
25081635|NCT04032093|50190039|FG006|Overall Study|Adverse Event|0|||
25081636|NCT04032093|50190040|FG007|Overall Study|Adverse Event|0|||
25081637|NCT04032093|50190041|FG008|Overall Study|Adverse Event|0|||
25081638|NCT04032093|50190042|FG009|Overall Study|Adverse Event|1|||
25081639|NCT04032093|50190033|FG000|Overall Study|Physician Decision|0|||
25081640|NCT04032093|50190034|FG001|Overall Study|Physician Decision|0|||
25081641|NCT04032093|50190035|FG002|Overall Study|Physician Decision|0|||
25081642|NCT04032093|50190036|FG003|Overall Study|Physician Decision|0|||
25081643|NCT04032093|50190037|FG004|Overall Study|Physician Decision|0|||
25081644|NCT04032093|50190038|FG005|Overall Study|Physician Decision|1|||
25081645|NCT04032093|50190039|FG006|Overall Study|Physician Decision|0|||
25081646|NCT04032093|50190040|FG007|Overall Study|Physician Decision|0|||
25081647|NCT04032093|50190041|FG008|Overall Study|Physician Decision|0|||
25081648|NCT04032093|50190042|FG009|Overall Study|Physician Decision|0|||
25081649|NCT01675167|50190066|FG000|Open-label Titration Phase|Adverse Event|81|||
25081650|NCT01675167|50190067|FG001|Open-label Titration Phase|Adverse Event|0|||
25081651|NCT01675167|50190068|FG002|Open-label Titration Phase|Adverse Event|0|||
25081652|NCT01675167|50190066|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
25081653|NCT01675167|50190067|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
25081654|NCT01675167|50190068|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
25081655|NCT01675167|50190066|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
25081656|NCT01675167|50190067|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
25081657|NCT01675167|50190068|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
25081658|NCT01675167|50190066|FG000|Open-label Titration Phase|Protocol Violation|43|||
25081659|NCT01675167|50190067|FG001|Open-label Titration Phase|Protocol Violation|0|||
25081660|NCT01675167|50190068|FG002|Open-label Titration Phase|Protocol Violation|0|||
25081661|NCT01675167|50190066|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
25081662|NCT01675167|50190067|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
25081663|NCT01675167|50190068|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
25081664|NCT01675167|50190066|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
25081665|NCT01675167|50190067|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
25081666|NCT01675167|50190068|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
25081667|NCT01675167|50190066|FG000|Open-label Titration Phase|Other|55|||
25081668|NCT01675167|50190067|FG001|Open-label Titration Phase|Other|0|||
25081669|NCT01675167|50190068|FG002|Open-label Titration Phase|Other|0|||
25081670|NCT01675167|50190066|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
25081671|NCT01675167|50190067|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
25081672|NCT01675167|50190068|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
25081673|NCT01675167|50190066|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
25081674|NCT01675167|50190067|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
25081675|NCT01675167|50190068|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
25081676|NCT01675167|50190066|FG000|Double-blind Treatment Phase|Adverse Event|0|||
25081677|NCT01675167|50190067|FG001|Double-blind Treatment Phase|Adverse Event|5|||
25081678|NCT01675167|50190068|FG002|Double-blind Treatment Phase|Adverse Event|13|||
25081679|NCT01675167|50190066|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
25081680|NCT01675167|50190067|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
25081681|NCT01675167|50190068|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
25081682|NCT01675167|50190066|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
25081683|NCT01675167|50190067|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
25081684|NCT01675167|50190068|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
25081685|NCT01675167|50190066|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
25081686|NCT01675167|50190067|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
25081687|NCT01675167|50190068|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
25081688|NCT01675167|50190066|FG000|Double-blind Treatment Phase|Other|0|||
25081689|NCT01675167|50190067|FG001|Double-blind Treatment Phase|Other|7|||
25081690|NCT01675167|50190068|FG002|Double-blind Treatment Phase|Other|5|||
25081691|NCT01675011|50190078|FG000|Overall Study|Trial terminated by Sponsor|3|||
25081692|NCT01675011|50190079|FG001|Overall Study|Trial terminated by Sponsor|1|||
25081693|NCT02649231|50190116|FG000|Overall Study|Adverse Event|0|||
25081694|NCT02649231|50190117|FG001|Overall Study|Adverse Event|0|||
25081695|NCT02649231|50190118|FG002|Overall Study|Adverse Event|0|||
25081696|NCT02649231|50190119|FG003|Overall Study|Adverse Event|1|||
25081697|NCT02649231|50190116|FG000|Overall Study|Lost to Follow-up|2|||
25081698|NCT02649231|50190117|FG001|Overall Study|Lost to Follow-up|1|||
25081699|NCT02649231|50190118|FG002|Overall Study|Lost to Follow-up|1|||
25081700|NCT02649231|50190119|FG003|Overall Study|Lost to Follow-up|0|||
25081701|NCT02649231|50190116|FG000|Overall Study|Withdrawal by Subject|0|||
25081702|NCT02649231|50190117|FG001|Overall Study|Withdrawal by Subject|1|||
25081703|NCT02649231|50190118|FG002|Overall Study|Withdrawal by Subject|0|||
25081704|NCT02649231|50190119|FG003|Overall Study|Withdrawal by Subject|1|||
25081705|NCT02649231|50190116|FG000|Overall Study|Protocol Violation|2|||
25081706|NCT02649231|50190117|FG001|Overall Study|Protocol Violation|1|||
25081707|NCT02649231|50190118|FG002|Overall Study|Protocol Violation|1|||
25081708|NCT02649231|50190119|FG003|Overall Study|Protocol Violation|0|||
25081709|NCT01376245|50190133|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
25081710|NCT01376245|50190134|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
25081711|NCT01376245|50190135|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
25081712|NCT01376245|50190136|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
25081713|NCT01376245|50190137|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
25081714|NCT01376245|50190133|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
25081715|NCT01376245|50190134|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
25081716|NCT01376245|50190135|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
25081717|NCT01376245|50190136|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
25081718|NCT01376245|50190137|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
25081719|NCT01376245|50190133|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
25081720|NCT01376245|50190134|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
25081721|NCT01376245|50190135|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
25081722|NCT01376245|50190136|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
25081723|NCT01376245|50190137|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
25081724|NCT01376245|50190133|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
25081725|NCT01376245|50190134|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
25081726|NCT01376245|50190135|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
25081727|NCT01376245|50190136|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
25081728|NCT01376245|50190137|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
25081729|NCT01376245|50190133|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
25081730|NCT01376245|50190134|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
25081731|NCT01376245|50190135|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
25081732|NCT01376245|50190136|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
25081733|NCT01376245|50190137|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
25081734|NCT01376245|50190133|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
25081735|NCT01376245|50190134|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
25081736|NCT01376245|50190135|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
25081737|NCT01376245|50190136|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
25081738|NCT01376245|50190137|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
25081739|NCT01376245|50190133|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
25081740|NCT01376245|50190134|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
25081741|NCT01376245|50190135|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
25081742|NCT01376245|50190136|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
25081743|NCT01376245|50190137|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
25081744|NCT01376245|50190133|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
25081745|NCT01376245|50190134|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
25081746|NCT01376245|50190135|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
25081747|NCT01376245|50190136|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
25081748|NCT01376245|50190137|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
25081749|NCT01376245|50190133|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
25081750|NCT01376245|50190134|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
25081751|NCT01376245|50190135|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
25081752|NCT01376245|50190136|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
25081753|NCT01376245|50190137|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
25081754|NCT01376245|50190133|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
25081755|NCT01376245|50190134|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
25081756|NCT01376245|50190135|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
25081757|NCT01376245|50190136|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
25081758|NCT01376245|50190137|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
25081759|NCT01376245|50190133|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
25081760|NCT01376245|50190134|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
25081761|NCT01376245|50190135|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
25081762|NCT01376245|50190136|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
25081763|NCT01376245|50190137|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
25081764|NCT01376245|50190133|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
25081765|NCT01376245|50190134|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
25081766|NCT01376245|50190135|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
25081767|NCT01376245|50190136|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
25081768|NCT01376245|50190137|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
25081769|NCT01674621|50190152|FG000|Overall Study|Adverse Event|3|||
25081770|NCT01674621|50190153|FG001|Overall Study|Adverse Event|2|||
25081771|NCT01674621|50190154|FG002|Overall Study|Adverse Event|5|||
25081772|NCT01674621|50190155|FG003|Overall Study|Adverse Event|5|||
25081773|NCT01674621|50190156|FG004|Overall Study|Adverse Event|1|||
25081774|NCT01674621|50190152|FG000|Overall Study|Inability to Complete Study Procedures|0|||
25081775|NCT01674621|50190153|FG001|Overall Study|Inability to Complete Study Procedures|0|||
25081776|NCT01674621|50190154|FG002|Overall Study|Inability to Complete Study Procedures|0|||
25081777|NCT01674621|50190155|FG003|Overall Study|Inability to Complete Study Procedures|0|||
25081778|NCT01674621|50190156|FG004|Overall Study|Inability to Complete Study Procedures|2|||
25081779|NCT01674621|50190152|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
25081780|NCT01674621|50190153|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
25081781|NCT01674621|50190154|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
25081782|NCT01674621|50190155|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
25081783|NCT01674621|50190156|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
25081784|NCT01674621|50190152|FG000|Overall Study|Withdrawal by Subject|2|||
25081785|NCT01674621|50190153|FG001|Overall Study|Withdrawal by Subject|5|||
25081786|NCT01674621|50190154|FG002|Overall Study|Withdrawal by Subject|2|||
25081787|NCT01674621|50190155|FG003|Overall Study|Withdrawal by Subject|0|||
25081788|NCT01674621|50190156|FG004|Overall Study|Withdrawal by Subject|1|||
25081789|NCT01674621|50190152|FG000|Overall Study|Other than specified|0|||
25081790|NCT01674621|50190153|FG001|Overall Study|Other than specified|1|||
25081791|NCT01674621|50190154|FG002|Overall Study|Other than specified|0|||
25081792|NCT01674621|50190155|FG003|Overall Study|Other than specified|0|||
25081793|NCT01674621|50190156|FG004|Overall Study|Other than specified|2|||
25081794|NCT02730169|50190173|FG000|Overall Study|Protocol Violation|1|||
25081795|NCT02730169|50190174|FG001|Overall Study|Protocol Violation|0|||
25081796|NCT02730169|50190175|FG002|Overall Study|Protocol Violation|0|||
25081797|NCT02730169|50190176|FG003|Overall Study|Protocol Violation|1|||
25081798|NCT02730169|50190173|FG000|Overall Study|Adverse Event|2|||
25081799|NCT02730169|50190174|FG001|Overall Study|Adverse Event|3|||
25081800|NCT02730169|50190175|FG002|Overall Study|Adverse Event|3|||
25081801|NCT02730169|50190176|FG003|Overall Study|Adverse Event|0|||
25081802|NCT02730169|50190173|FG000|Overall Study|Adverse Event of Special Interest|0|||
25081803|NCT02730169|50190174|FG001|Overall Study|Adverse Event of Special Interest|1|||
25081804|NCT02730169|50190175|FG002|Overall Study|Adverse Event of Special Interest|2|||
25081805|NCT02730169|50190176|FG003|Overall Study|Adverse Event of Special Interest|0|||
25081806|NCT02730169|50190173|FG000|Overall Study|Withdrawal by Subject|6|||
25081807|NCT02730169|50190174|FG001|Overall Study|Withdrawal by Subject|11|||
25081808|NCT02730169|50190175|FG002|Overall Study|Withdrawal by Subject|6|||
25081809|NCT02730169|50190176|FG003|Overall Study|Withdrawal by Subject|8|||
25081810|NCT02730169|50190173|FG000|Overall Study|Lost to Follow-up|5|||
25081811|NCT02730169|50190174|FG001|Overall Study|Lost to Follow-up|6|||
25081812|NCT02730169|50190175|FG002|Overall Study|Lost to Follow-up|5|||
25081813|NCT02730169|50190176|FG003|Overall Study|Lost to Follow-up|6|||
25081814|NCT02730169|50190173|FG000|Overall Study|Other|0|||
25081815|NCT02730169|50190174|FG001|Overall Study|Other|0|||
25081816|NCT02730169|50190175|FG002|Overall Study|Other|1|||
25081817|NCT02730169|50190176|FG003|Overall Study|Other|1|||
25081818|NCT02648217|50190188|FG000|Overall Study|Adverse Event|0|||
25081819|NCT02648217|50190189|FG001|Overall Study|Adverse Event|1|||
25081820|NCT02648217|50190188|FG000|Overall Study|Lost to Follow-up|1|||
25081821|NCT02648217|50190189|FG001|Overall Study|Lost to Follow-up|1|||
25081822|NCT02648217|50190188|FG000|Overall Study|Withdrawal by Subject|4|||
25081823|NCT02648217|50190189|FG001|Overall Study|Withdrawal by Subject|3|||
25081824|NCT02648217|50190188|FG000|Overall Study|Unclassified|5|||
25081825|NCT02648217|50190189|FG001|Overall Study|Unclassified|0|||
25081826|NCT00709735|50190197|FG000|Overall Study|Lost to Follow-up|1|||
25081827|NCT00709735|50190198|FG001|Overall Study|Lost to Follow-up|1|||
25081828|NCT00709735|50190197|FG000|Overall Study|Relapse into Opioid Abuse|0|||
25081829|NCT00709735|50190198|FG001|Overall Study|Relapse into Opioid Abuse|1|||
25081830|NCT00709735|50190197|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
25081831|NCT00709735|50190198|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
25081832|NCT02647905|50190204|FG000|Overall Study|Lost to Follow-up|1|||
25081833|NCT02647905|50190204|FG000|Overall Study|Withdrawal by Subject|2|||
25081834|NCT04185909|50190217|FG000|Overall Study|Lost to Follow-up|1|||
25081835|NCT04076943|50190221|FG000|Overall Study|Withdrawal by Subject|12|||
25081836|NCT04076943|50190221|FG000|Overall Study|Adverse Event|1|||
25081837|NCT04076943|50190221|FG000|Overall Study|Progressive Disease|2|||
25081838|NCT04076943|50190221|FG000|Overall Study|Death|13|||
25081839|NCT04076943|50190221|FG000|Overall Study|Other than specified|6|||
25081840|NCT00708643|50190227|FG000|Overall Study|Adverse Event|0|||
25081841|NCT00708643|50190228|FG001|Overall Study|Adverse Event|1|||
25081842|NCT01285557|50190291|FG000|Overall Study|Death|173|||
25081843|NCT01285557|50190292|FG001|Overall Study|Death|90|||
25081844|NCT01285557|50190291|FG000|Overall Study|Lost to Follow-up|6|||
25081845|NCT01285557|50190292|FG001|Overall Study|Lost to Follow-up|2|||
25081846|NCT01285557|50190291|FG000|Overall Study|Withdrew Consent|6|||
25081847|NCT01285557|50190292|FG001|Overall Study|Withdrew Consent|1|||
25081848|NCT01285557|50190291|FG000|Overall Study|Sponsor Study Termination|23|||
25081849|NCT01285557|50190292|FG001|Overall Study|Sponsor Study Termination|13|||
25081850|NCT01285557|50190291|FG000|Overall Study|Randomized but not treated|1|||
25081851|NCT01285557|50190292|FG001|Overall Study|Randomized but not treated|1|||
25081852|NCT01285557|50190291|FG000|Overall Study|Study follow-up ongoing|28|||
25081853|NCT01285557|50190292|FG001|Overall Study|Study follow-up ongoing|14|||
25081854|NCT01285557|50190291|FG000|Overall Study|Sponsor Decision|2|||
25081855|NCT01285557|50190292|FG001|Overall Study|Sponsor Decision|1|||
25081856|NCT01376167|50190354|FG000|Overall Study|Lost to Follow-up|2|||
25081857|NCT01376167|50190355|FG001|Overall Study|Lost to Follow-up|4|||
25081858|NCT01376167|50190356|FG002|Overall Study|Lost to Follow-up|2|||
25081859|NCT01376167|50190354|FG000|Overall Study|Physician Decision|1|||
25081860|NCT01376167|50190355|FG001|Overall Study|Physician Decision|1|||
25081861|NCT01376167|50190356|FG002|Overall Study|Physician Decision|0|||
25081862|NCT01376167|50190354|FG000|Overall Study|Withdrawal by Subject|1|||
25081863|NCT01376167|50190355|FG001|Overall Study|Withdrawal by Subject|5|||
25081864|NCT01376167|50190356|FG002|Overall Study|Withdrawal by Subject|4|||
25081865|NCT02647281|50190376|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
25081866|NCT02647281|50190377|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
25081867|NCT02647281|50190378|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
25081868|NCT02647281|50190379|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
25081869|NCT02647281|50190380|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
25081870|NCT02647281|50190381|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
25081871|NCT02647281|50190382|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
25081872|NCT02647281|50190383|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
25081873|NCT02647281|50190384|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
25081874|NCT02729545|50190415|FG000|Overall Study|Pregnancy|1|||
25081875|NCT02729545|50190416|FG001|Overall Study|Pregnancy|1|||
25081876|NCT02729545|50190415|FG000|Overall Study|Lost to Follow-up|0|||
25081877|NCT02729545|50190416|FG001|Overall Study|Lost to Follow-up|1|||
25081878|NCT02729545|50190415|FG000|Overall Study|Withdrawal by Subject|2|||
25081879|NCT02729545|50190416|FG001|Overall Study|Withdrawal by Subject|3|||
25081880|NCT01376089|50190424|FG000|Overall Study|Patient received no contrast media|3|||
25081881|NCT01376089|50190425|FG001|Overall Study|Patient received no contrast media|4|||
25081882|NCT00706849|50190437|FG000|Treatment Period|Adverse Event|0|||
25081883|NCT00706849|50190438|FG001|Treatment Period|Adverse Event|9|||
25081884|NCT00706849|50190437|FG000|Treatment Period|Other|0|||
25081885|NCT00706849|50190438|FG001|Treatment Period|Other|1|||
25081886|NCT00706849|50190437|FG000|Follow-up Period|Withdrawal by Subject|0|||
25081887|NCT00706849|50190438|FG001|Follow-up Period|Withdrawal by Subject|2|||
25081888|NCT00706849|50190437|FG000|Follow-up Period|Protocol non-compliance|0|||
25081889|NCT00706849|50190438|FG001|Follow-up Period|Protocol non-compliance|1|||
25081890|NCT00707161|50190444|FG000|Overall Study|Physician Decision|6|||
25081891|NCT02130466|50190462|FG000|Overall Study|Death|4|||
25081892|NCT02130466|50190463|FG001|Overall Study|Death|1|||
25081893|NCT02130466|50190464|FG002|Overall Study|Death|1|||
25081894|NCT02130466|50190465|FG003|Overall Study|Death|3|||
25081895|NCT02130466|50190466|FG004|Overall Study|Death|2|||
25081896|NCT02130466|50190467|FG005|Overall Study|Death|30|||
25081897|NCT02130466|50190468|FG006|Overall Study|Death|45|||
25081898|NCT02130466|50190469|FG007|Overall Study|Death|2|||
25081899|NCT02130466|50190470|FG008|Overall Study|Death|3|||
25081900|NCT02130466|50190471|FG009|Overall Study|Death|4|||
25081901|NCT02130466|50190472|FG010|Overall Study|Death|5|||
25081902|NCT02130466|50190473|FG011|Overall Study|Death|3|||
25081903|NCT02130466|50190474|FG012|Overall Study|Death|11|||
25081904|NCT02130466|50190475|FG013|Overall Study|Death|7|||
25081905|NCT02130466|50190462|FG000|Overall Study|Lost to Follow-up|1|||
25081906|NCT02130466|50190463|FG001|Overall Study|Lost to Follow-up|0|||
25081907|NCT02130466|50190464|FG002|Overall Study|Lost to Follow-up|0|||
25081908|NCT02130466|50190465|FG003|Overall Study|Lost to Follow-up|0|||
25081909|NCT02130466|50190466|FG004|Overall Study|Lost to Follow-up|0|||
25081910|NCT02130466|50190467|FG005|Overall Study|Lost to Follow-up|1|||
25081911|NCT02130466|50190468|FG006|Overall Study|Lost to Follow-up|0|||
25081912|NCT02130466|50190469|FG007|Overall Study|Lost to Follow-up|0|||
25081913|NCT02130466|50190470|FG008|Overall Study|Lost to Follow-up|0|||
25081914|NCT02130466|50190471|FG009|Overall Study|Lost to Follow-up|0|||
25081915|NCT02130466|50190472|FG010|Overall Study|Lost to Follow-up|0|||
25081916|NCT02130466|50190473|FG011|Overall Study|Lost to Follow-up|0|||
25081917|NCT02130466|50190474|FG012|Overall Study|Lost to Follow-up|1|||
25081918|NCT02130466|50190475|FG013|Overall Study|Lost to Follow-up|0|||
25081919|NCT02130466|50190462|FG000|Overall Study|Physician Decision|0|||
25081920|NCT02130466|50190463|FG001|Overall Study|Physician Decision|0|||
25081921|NCT02130466|50190464|FG002|Overall Study|Physician Decision|0|||
25081922|NCT02130466|50190465|FG003|Overall Study|Physician Decision|0|||
25081923|NCT02130466|50190466|FG004|Overall Study|Physician Decision|0|||
25081924|NCT02130466|50190467|FG005|Overall Study|Physician Decision|1|||
25081925|NCT02130466|50190468|FG006|Overall Study|Physician Decision|1|||
25081926|NCT02130466|50190469|FG007|Overall Study|Physician Decision|0|||
25081927|NCT02130466|50190470|FG008|Overall Study|Physician Decision|0|||
25081928|NCT02130466|50190471|FG009|Overall Study|Physician Decision|0|||
25081929|NCT02130466|50190472|FG010|Overall Study|Physician Decision|0|||
25081930|NCT02130466|50190473|FG011|Overall Study|Physician Decision|0|||
25081931|NCT02130466|50190474|FG012|Overall Study|Physician Decision|0|||
25081932|NCT02130466|50190475|FG013|Overall Study|Physician Decision|0|||
25081933|NCT02130466|50190462|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
25081934|NCT02130466|50190463|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
25081935|NCT02130466|50190464|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
25081936|NCT02130466|50190465|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
25081937|NCT02130466|50190466|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
25081938|NCT02130466|50190467|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
25081939|NCT02130466|50190468|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
25081940|NCT02130466|50190469|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
25081941|NCT02130466|50190470|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
25081942|NCT02130466|50190471|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
25081943|NCT02130466|50190472|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
25081944|NCT02130466|50190473|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
25081945|NCT02130466|50190474|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
25081946|NCT02130466|50190475|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
25081947|NCT02130466|50190462|FG000|Overall Study|Withdrawal by Subject|1|||
25081948|NCT02130466|50190463|FG001|Overall Study|Withdrawal by Subject|0|||
25081949|NCT02130466|50190464|FG002|Overall Study|Withdrawal by Subject|0|||
25081950|NCT02130466|50190465|FG003|Overall Study|Withdrawal by Subject|0|||
25081951|NCT02130466|50190466|FG004|Overall Study|Withdrawal by Subject|0|||
25081952|NCT02130466|50190467|FG005|Overall Study|Withdrawal by Subject|1|||
25081953|NCT02130466|50190468|FG006|Overall Study|Withdrawal by Subject|0|||
25081954|NCT02130466|50190469|FG007|Overall Study|Withdrawal by Subject|0|||
25081955|NCT02130466|50190470|FG008|Overall Study|Withdrawal by Subject|1|||
25081956|NCT02130466|50190471|FG009|Overall Study|Withdrawal by Subject|0|||
25081957|NCT02130466|50190472|FG010|Overall Study|Withdrawal by Subject|0|||
25081958|NCT02130466|50190473|FG011|Overall Study|Withdrawal by Subject|0|||
25081959|NCT02130466|50190474|FG012|Overall Study|Withdrawal by Subject|0|||
25081960|NCT02130466|50190475|FG013|Overall Study|Withdrawal by Subject|0|||
25081961|NCT02163538|50190524|FG000|Overall Study|Protocol Violation|1|||
25081962|NCT02163538|50190525|FG001|Overall Study|Protocol Violation|0|||
25081963|NCT02163538|50190524|FG000|Overall Study|Physician Decision|0|||
25081964|NCT02163538|50190525|FG001|Overall Study|Physician Decision|1|||
25081965|NCT02163226|50190533|FG000|Overall Study|Death|2|||
25081966|NCT02163226|50190534|FG001|Overall Study|Death|1|||
25081967|NCT02163226|50190533|FG000|Overall Study|Withdrawal by Subject|5|||
25081968|NCT02163226|50190534|FG001|Overall Study|Withdrawal by Subject|2|||
25081969|NCT02163226|50190533|FG000|Overall Study|Returned home, local radiotherapy|3|||
25081970|NCT02163226|50190534|FG001|Overall Study|Returned home, local radiotherapy|0|||
25081971|NCT02163226|50190533|FG000|Overall Study|Repeat imaging showed no disease|2|||
25081972|NCT02163226|50190534|FG001|Overall Study|Repeat imaging showed no disease|0|||
25081973|NCT02163226|50190533|FG000|Overall Study|Incomplete radiotherapy|3|||
25081974|NCT02163226|50190534|FG001|Overall Study|Incomplete radiotherapy|0|||
25081975|NCT02163226|50190533|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
25081976|NCT02163226|50190534|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
25081977|NCT02163226|50190533|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
25081978|NCT02163226|50190534|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
25081979|NCT02163226|50190533|FG000|Overall Study|ineligible|0|||
25081980|NCT02163226|50190534|FG001|Overall Study|ineligible|3|||
25081981|NCT02193178|50190540|FG000|Overall Study|Lost to Follow-up|1|||
25081982|NCT02193178|50190540|FG000|Overall Study|Dry eyes|1|||
25081983|NCT02129608|50190561|FG000|Overall Study|Lost to Follow-up|0|||
25081984|NCT02129608|50190562|FG001|Overall Study|Lost to Follow-up|1|||
25081985|NCT02129608|50190563|FG002|Overall Study|Lost to Follow-up|1|||
25081986|NCT02129608|50190561|FG000|Overall Study|Withdrawal by Subject|0|||
25081987|NCT02129608|50190562|FG001|Overall Study|Withdrawal by Subject|0|||
25081988|NCT02129608|50190563|FG002|Overall Study|Withdrawal by Subject|2|||
25081989|NCT01631188|50190571|FG000|Overall Study|Physician Decision|75|||
25081990|NCT02129062|50190575|FG000|Overall Study|Death|1|||
25081991|NCT02129062|50190575|FG000|Overall Study|Disease Progression|2|||
25081992|NCT02162758|50190581|FG000|Overall Study|Study termination|0|||
25081993|NCT02162758|50190582|FG001|Overall Study|Study termination|1|||
25081994|NCT02192164|50190588|FG000|Overall Study|Other|8|||
25081995|NCT02192164|50190588|FG000|Overall Study|Withdrawal by Subject|1|||
25081996|NCT02192164|50190588|FG000|Overall Study|Physician Decision|4|||
25081997|NCT02192164|50190588|FG000|Overall Study|Did not meet the exclusion criteria|1|||
25081998|NCT02191618|50190595|FG000|Overall Study|Withdrawal by Subject|3|||
25081999|NCT02191618|50190595|FG000|Overall Study|Missed Visit|4|||
25082000|NCT02646891|50190609|FG000|Overall Study|Adverse Event|0|||
25082001|NCT02646891|50190610|FG001|Overall Study|Adverse Event|1|||
25082002|NCT02646891|50190611|FG002|Overall Study|Adverse Event|0|||
25082003|NCT02646891|50190612|FG003|Overall Study|Adverse Event|0|||
25082004|NCT02646891|50190613|FG004|Overall Study|Adverse Event|0|||
25082005|NCT02646891|50190614|FG005|Overall Study|Adverse Event|0|||
25082006|NCT02646891|50190615|FG006|Overall Study|Adverse Event|0|||
25082007|NCT02646891|50190616|FG007|Overall Study|Adverse Event|0|||
25082008|NCT02646891|50190617|FG008|Overall Study|Adverse Event|0|||
25082009|NCT02646891|50190618|FG009|Overall Study|Adverse Event|0|||
25082010|NCT02646891|50190609|FG000|Overall Study|Lost to Follow-up|0|||
25082011|NCT02646891|50190610|FG001|Overall Study|Lost to Follow-up|0|||
25082012|NCT02646891|50190611|FG002|Overall Study|Lost to Follow-up|0|||
25082013|NCT02646891|50190612|FG003|Overall Study|Lost to Follow-up|0|||
25082014|NCT02646891|50190613|FG004|Overall Study|Lost to Follow-up|0|||
25082015|NCT02646891|50190614|FG005|Overall Study|Lost to Follow-up|0|||
25082016|NCT02646891|50190615|FG006|Overall Study|Lost to Follow-up|2|||
25082017|NCT02646891|50190616|FG007|Overall Study|Lost to Follow-up|2|||
25082018|NCT02646891|50190617|FG008|Overall Study|Lost to Follow-up|2|||
25082019|NCT02646891|50190618|FG009|Overall Study|Lost to Follow-up|2|||
25082020|NCT02646891|50190609|FG000|Overall Study|Protocol Violation|0|||
25082021|NCT02646891|50190610|FG001|Overall Study|Protocol Violation|0|||
25082022|NCT02646891|50190611|FG002|Overall Study|Protocol Violation|0|||
24994784|NCT01979536|50085768|FG001|Overall Study|Refusal|1|||
24994785|NCT01979536|50085767|FG000|Overall Study|Relapse|0|||
24994786|NCT01979536|50085768|FG001|Overall Study|Relapse|1|||
24994787|NCT01979536|50085767|FG000|Overall Study|Study terminated by Sponsor|0|||
24994788|NCT01979536|50085768|FG001|Overall Study|Study terminated by Sponsor|1|||
24994789|NCT01979536|50085767|FG000|Overall Study|Did not start treatment|0|||
24994790|NCT01979536|50085768|FG001|Overall Study|Did not start treatment|1|||
24994791|NCT03496298|50085785|FG000|Overall Study|Adverse Event|49|||
24994792|NCT03496298|50085786|FG001|Overall Study|Adverse Event|68|||
24994793|NCT03496298|50085787|FG002|Overall Study|Adverse Event|79|||
24994794|NCT03496298|50085785|FG000|Overall Study|Study terminated by Sponsor|1050|||
24994795|NCT03496298|50085786|FG001|Overall Study|Study terminated by Sponsor|1063|||
24994796|NCT03496298|50085787|FG002|Overall Study|Study terminated by Sponsor|1071|||
24994797|NCT03496298|50085785|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
24994798|NCT03496298|50085786|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
24994799|NCT03496298|50085787|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
24994800|NCT03496298|50085785|FG000|Overall Study|Withdrawal by Subject|176|||
24994801|NCT03496298|50085786|FG001|Overall Study|Withdrawal by Subject|154|||
24994802|NCT03496298|50085787|FG002|Overall Study|Withdrawal by Subject|151|||
24994803|NCT03496298|50085785|FG000|Overall Study|Other|29|||
24994804|NCT03496298|50085786|FG001|Overall Study|Other|20|||
24994805|NCT03496298|50085787|FG002|Overall Study|Other|23|||
24994806|NCT03496298|50085785|FG000|Overall Study|Randomized and not treated|1|||
24994807|NCT03496298|50085786|FG001|Overall Study|Randomized and not treated|1|||
24994808|NCT03496298|50085787|FG002|Overall Study|Randomized and not treated|1|||
24994809|NCT02914522|50085800|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
24994810|NCT02914522|50085801|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
24994811|NCT02914522|50085802|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
24994812|NCT02914522|50085803|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
24994813|NCT02914522|50085804|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
24994814|NCT02914522|50085805|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
24994815|NCT02914522|50085806|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
24994816|NCT02914522|50085807|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
24994817|NCT02914522|50085808|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
24994818|NCT02914522|50085809|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
24994819|NCT02914522|50085810|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
24994820|NCT02914522|50085800|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
24994821|NCT02914522|50085801|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
24994822|NCT02914522|50085802|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
24994823|NCT02914522|50085803|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
24994824|NCT02914522|50085804|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
24994825|NCT02914522|50085805|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
24994826|NCT02914522|50085806|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
24994827|NCT02914522|50085807|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
24994828|NCT02914522|50085808|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
24994829|NCT02914522|50085809|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
24994830|NCT02914522|50085810|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
24994831|NCT02914522|50085800|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
24994832|NCT02914522|50085801|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
24994833|NCT02914522|50085802|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
25082023|NCT02646891|50190612|FG003|Overall Study|Protocol Violation|0|||
25082024|NCT02646891|50190613|FG004|Overall Study|Protocol Violation|0|||
25082025|NCT02646891|50190614|FG005|Overall Study|Protocol Violation|0|||
25082026|NCT02646891|50190615|FG006|Overall Study|Protocol Violation|1|||
25082027|NCT02646891|50190616|FG007|Overall Study|Protocol Violation|1|||
24994834|NCT02914522|50085803|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
24994835|NCT02914522|50085804|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
24994836|NCT02914522|50085805|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
24994837|NCT02914522|50085806|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
24994838|NCT02914522|50085807|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
24994839|NCT02914522|50085808|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
24994840|NCT02914522|50085809|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
24994841|NCT02914522|50085810|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
24994842|NCT02914522|50085800|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
24994843|NCT02914522|50085801|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
24994844|NCT02914522|50085802|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
24994845|NCT02914522|50085803|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
24994846|NCT02914522|50085804|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
24994847|NCT02914522|50085805|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
24994848|NCT02914522|50085806|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
25082028|NCT02646891|50190617|FG008|Overall Study|Protocol Violation|0|||
25082029|NCT02646891|50190618|FG009|Overall Study|Protocol Violation|0|||
25082030|NCT02646891|50190609|FG000|Overall Study|Withdrawal by Subject|2|||
25082031|NCT02646891|50190610|FG001|Overall Study|Withdrawal by Subject|0|||
25082032|NCT02646891|50190611|FG002|Overall Study|Withdrawal by Subject|1|||
25082033|NCT02646891|50190612|FG003|Overall Study|Withdrawal by Subject|0|||
25082034|NCT02646891|50190613|FG004|Overall Study|Withdrawal by Subject|0|||
25082035|NCT02646891|50190614|FG005|Overall Study|Withdrawal by Subject|0|||
25082036|NCT02646891|50190615|FG006|Overall Study|Withdrawal by Subject|5|||
25082037|NCT02646891|50190616|FG007|Overall Study|Withdrawal by Subject|9|||
25082038|NCT02646891|50190617|FG008|Overall Study|Withdrawal by Subject|7|||
25082039|NCT02646891|50190618|FG009|Overall Study|Withdrawal by Subject|3|||
25082040|NCT02646891|50190609|FG000|Overall Study|Death|0|||
25082041|NCT02646891|50190610|FG001|Overall Study|Death|0|||
25082042|NCT02646891|50190611|FG002|Overall Study|Death|0|||
25082043|NCT02646891|50190612|FG003|Overall Study|Death|0|||
25082044|NCT02646891|50190613|FG004|Overall Study|Death|0|||
25082045|NCT02646891|50190614|FG005|Overall Study|Death|0|||
25082046|NCT02646891|50190615|FG006|Overall Study|Death|1|||
25082047|NCT02646891|50190616|FG007|Overall Study|Death|1|||
25082048|NCT02646891|50190617|FG008|Overall Study|Death|1|||
25082049|NCT02646891|50190618|FG009|Overall Study|Death|0|||
25082050|NCT02646423|50190658|FG000|Overall Study|Adverse Event|5|||
25082051|NCT02646423|50190659|FG001|Overall Study|Adverse Event|7|||
25082052|NCT02646423|50190658|FG000|Overall Study|Ineligible|2|||
25082053|NCT02646423|50190659|FG001|Overall Study|Ineligible|1|||
25082054|NCT02647359|50190685|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
25082055|NCT02647359|50190686|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
25082056|NCT02647359|50190685|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
25082057|NCT02647359|50190686|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
25082058|NCT02647359|50190685|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
25082059|NCT02647359|50190686|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
25082060|NCT02647359|50190685|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
25082061|NCT02647359|50190686|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
25082062|NCT02647359|50190685|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
25082063|NCT02647359|50190686|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
25082064|NCT02647359|50190685|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
25082065|NCT02647359|50190686|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
25082066|NCT02645409|50190698|FG000|Overall Study|Withdrawal by Subject|3|||
25082067|NCT02645409|50190699|FG001|Overall Study|Withdrawal by Subject|0|||
25082068|NCT02645409|50190698|FG000|Overall Study|Physician Decision|1|||
25082069|NCT02645409|50190699|FG001|Overall Study|Physician Decision|0|||
25082070|NCT01597479|50190706|FG000|Overall Study|Protocol Violation|1|||
25082071|NCT01597479|50190707|FG001|Overall Study|Protocol Violation|0|||
25082072|NCT01597479|50190706|FG000|Overall Study|Lost to Follow-up|1|||
25082073|NCT01597479|50190707|FG001|Overall Study|Lost to Follow-up|0|||
25082074|NCT04248465|50190716|FG000|Randomized-Controlled Period|Death|12|||
25082075|NCT04248465|50190717|FG001|Randomized-Controlled Period|Death|5|||
25082076|NCT04248465|50190716|FG000|Randomized-Controlled Period|Adverse Event|2|||
25082077|NCT04248465|50190717|FG001|Randomized-Controlled Period|Adverse Event|0|||
25082078|NCT04248465|50190716|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
25082079|NCT04248465|50190717|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
25082080|NCT04248465|50190716|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
25082081|NCT04248465|50190717|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
25259840|NCT01020799|50574945|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
25082082|NCT04248465|50190716|FG000|Randomized-Controlled Period|Physician Decision|1|||
25082083|NCT04248465|50190717|FG001|Randomized-Controlled Period|Physician Decision|1|||
25082084|NCT04248465|50190716|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
25082085|NCT04248465|50190717|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
25082086|NCT04248465|50190716|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
25082087|NCT04248465|50190717|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
25082088|NCT04248465|50190716|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
25082089|NCT04248465|50190717|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
25082090|NCT02643693|50190725|FG000|Overall Study|Physician Decision|0|||
25082091|NCT02643693|50190726|FG001|Overall Study|Physician Decision|1|||
25082092|NCT02643693|50190727|FG002|Overall Study|Physician Decision|0|||
25082093|NCT02643693|50190728|FG003|Overall Study|Physician Decision|0|||
25082094|NCT02643693|50190729|FG004|Overall Study|Physician Decision|0|||
25082095|NCT02643693|50190730|FG005|Overall Study|Physician Decision|0|||
25082096|NCT02643693|50190725|FG000|Overall Study|Withdrawal by Subject|0|||
25082097|NCT02643693|50190726|FG001|Overall Study|Withdrawal by Subject|1|||
25082098|NCT02643693|50190727|FG002|Overall Study|Withdrawal by Subject|0|||
25082099|NCT02643693|50190728|FG003|Overall Study|Withdrawal by Subject|0|||
25082100|NCT02643693|50190729|FG004|Overall Study|Withdrawal by Subject|0|||
24994849|NCT02914522|50085807|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
24994850|NCT02914522|50085808|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
24994851|NCT02914522|50085809|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
24994852|NCT02914522|50085810|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
24994853|NCT02914522|50085800|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
24994854|NCT02914522|50085801|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
24994855|NCT02914522|50085802|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
24994856|NCT02914522|50085803|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
24994857|NCT02914522|50085804|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
24994858|NCT02914522|50085805|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
24994859|NCT02914522|50085806|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
24994860|NCT02914522|50085807|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
24994861|NCT02914522|50085808|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
24994862|NCT02914522|50085809|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
24994863|NCT02914522|50085810|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
24994864|NCT02914522|50085800|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
24994865|NCT02914522|50085801|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
24994866|NCT02914522|50085802|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
24994867|NCT02914522|50085803|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
24994868|NCT02914522|50085804|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
24994869|NCT02914522|50085805|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
24994870|NCT02914522|50085806|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
24994871|NCT02914522|50085807|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
24994872|NCT02914522|50085808|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
24994873|NCT02914522|50085809|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
24994874|NCT02914522|50085810|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
24994875|NCT02914522|50085800|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
24994876|NCT02914522|50085801|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
24994877|NCT02914522|50085802|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
24994878|NCT02914522|50085803|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
24994879|NCT02914522|50085804|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
24994880|NCT02914522|50085805|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
24994881|NCT02914522|50085806|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
24994882|NCT02914522|50085807|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
24994883|NCT02914522|50085808|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
24994884|NCT02914522|50085809|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
24994885|NCT02914522|50085810|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
24994886|NCT02914522|50085800|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
24994887|NCT02914522|50085801|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
24994888|NCT02914522|50085802|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
24994889|NCT02914522|50085803|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
24994890|NCT02914522|50085804|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
24994891|NCT02914522|50085805|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
24994892|NCT02914522|50085806|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
24994893|NCT02914522|50085807|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
24994894|NCT02914522|50085808|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
24994895|NCT02914522|50085809|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
24994896|NCT02914522|50085810|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
24994897|NCT02914522|50085800|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
24994898|NCT02914522|50085801|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
24994899|NCT02914522|50085802|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
24994900|NCT02914522|50085803|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
24994901|NCT02914522|50085804|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
24994902|NCT02914522|50085805|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
24994903|NCT02914522|50085806|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
24994904|NCT02914522|50085807|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
24994905|NCT02914522|50085808|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
24994906|NCT02914522|50085809|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
24994907|NCT02914522|50085810|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
24994908|NCT02914522|50085800|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
24994909|NCT02914522|50085801|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
24994910|NCT02914522|50085802|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
24994911|NCT02914522|50085803|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
24994912|NCT02914522|50085804|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
24994913|NCT02914522|50085805|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
24994914|NCT02914522|50085806|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
24994915|NCT02914522|50085807|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
24994916|NCT02914522|50085808|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
24994917|NCT02914522|50085809|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
24994918|NCT02914522|50085810|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
24994919|NCT02914522|50085800|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
24994920|NCT02914522|50085801|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
24994921|NCT02914522|50085802|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
24994922|NCT02914522|50085803|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
24994923|NCT02914522|50085804|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
24994924|NCT02914522|50085805|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
24994925|NCT02914522|50085806|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
24994926|NCT02914522|50085807|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
24994927|NCT02914522|50085808|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
24994928|NCT02914522|50085809|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
24994929|NCT02914522|50085810|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
24994930|NCT02914522|50085800|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
24994931|NCT02914522|50085801|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
24994932|NCT02914522|50085802|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
24994933|NCT02914522|50085803|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
24994934|NCT02914522|50085804|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
24994935|NCT02914522|50085805|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
24994936|NCT02914522|50085806|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
24994937|NCT02914522|50085807|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
24994938|NCT02914522|50085808|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
24994939|NCT02914522|50085809|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
24994940|NCT02914522|50085810|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
24994941|NCT02914522|50085800|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
24994942|NCT02914522|50085801|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
24994943|NCT02914522|50085802|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
24994944|NCT02914522|50085803|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
24994945|NCT02914522|50085804|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
24994946|NCT02914522|50085805|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
24994947|NCT02914522|50085806|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
24994948|NCT02914522|50085807|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
24994949|NCT02914522|50085808|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
24994950|NCT02914522|50085809|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
24994951|NCT02914522|50085810|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
24994952|NCT02914522|50085800|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
24994953|NCT02914522|50085801|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
24994954|NCT02914522|50085802|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
24994955|NCT02914522|50085803|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
24994956|NCT02914522|50085804|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
24994957|NCT02914522|50085805|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
24994958|NCT02914522|50085806|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
24994959|NCT02914522|50085807|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
24994960|NCT02914522|50085808|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
24994961|NCT02914522|50085809|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
25082101|NCT02643693|50190730|FG005|Overall Study|Withdrawal by Subject|0|||
25082102|NCT02643693|50190725|FG000|Overall Study|Protocol Adherence Issues|2|||
25082103|NCT02643693|50190726|FG001|Overall Study|Protocol Adherence Issues|0|||
25082104|NCT02643693|50190727|FG002|Overall Study|Protocol Adherence Issues|1|||
25082105|NCT02643693|50190728|FG003|Overall Study|Protocol Adherence Issues|0|||
25082106|NCT02643693|50190729|FG004|Overall Study|Protocol Adherence Issues|0|||
25082107|NCT02643693|50190730|FG005|Overall Study|Protocol Adherence Issues|1|||
25082108|NCT02726113|50190740|FG000|Total Enrollment|Physician Decision|0|||
25082109|NCT02726113|50190741|FG001|Total Enrollment|Physician Decision|1|||
25082110|NCT02726113|50190740|FG000|Total Enrollment|Protocol Violation|1|||
25082111|NCT02726113|50190741|FG001|Total Enrollment|Protocol Violation|0|||
25082112|NCT02726113|50190740|FG000|Total Enrollment|Withdrawal by Subject|2|||
25082113|NCT02726113|50190741|FG001|Total Enrollment|Withdrawal by Subject|1|||
25082114|NCT02726113|50190740|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
25082115|NCT02726113|50190741|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
25082116|NCT02726113|50190740|FG000|Genomic Analysis|Protocol Violation|1|||
25082117|NCT02726113|50190741|FG001|Genomic Analysis|Protocol Violation|0|||
25082118|NCT02726113|50190740|FG000|Genomic Analysis|Withdrawal by Subject|2|||
25082119|NCT02726113|50190741|FG001|Genomic Analysis|Withdrawal by Subject|1|||
25082120|NCT02726113|50190740|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
25082121|NCT02726113|50190741|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
25082122|NCT01361919|50190759|FG000|Overall Study|technical issues|10|||
25082123|NCT01361919|50190760|FG001|Overall Study|technical issues|12|||
25082124|NCT01361919|50190761|FG002|Overall Study|technical issues|10|||
25082125|NCT02642679|50190769|FG000|Overall Study|Withdrawal by Subject|1|||
25082126|NCT02642679|50190769|FG000|Overall Study|Physician Decision|1|||
25082127|NCT02642679|50190769|FG000|Overall Study|Physician Decision|1|||
25082128|NCT00705523|50190775|FG000|Overall Study|Lost to Follow-up|2|||
25082129|NCT00705523|50190776|FG001|Overall Study|Lost to Follow-up|3|||
25082130|NCT02725411|50190785|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
25082131|NCT02725411|50190786|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
25082132|NCT02725411|50190787|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
25082133|NCT02725411|50190785|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
25082134|NCT02725411|50190786|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
25082135|NCT02725411|50190787|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
25082136|NCT02725411|50190785|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
25082137|NCT02725411|50190786|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
25082138|NCT02725411|50190787|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
25082139|NCT02725411|50190785|FG000|Treatment Period (56 Weeks)|Other|1|||
25082140|NCT02725411|50190786|FG001|Treatment Period (56 Weeks)|Other|4|||
25082141|NCT02725411|50190787|FG002|Treatment Period (56 Weeks)|Other|5|||
25082142|NCT02725411|50190785|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
25082143|NCT02725411|50190786|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
25082144|NCT02725411|50190787|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
25082145|NCT02725411|50190785|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
25082146|NCT02725411|50190786|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
25082147|NCT02725411|50190787|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
25082148|NCT02725411|50190785|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
25082149|NCT02725411|50190786|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
25082150|NCT02725411|50190787|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
25082151|NCT02725411|50190785|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
25082152|NCT02725411|50190786|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
25082153|NCT02725411|50190787|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
25082154|NCT02725411|50190785|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
25082155|NCT02725411|50190786|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
25082156|NCT02725411|50190787|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
25082157|NCT02725411|50190785|FG000|Follow-up Period (24 Weeks)|Other|1|||
25082158|NCT02725411|50190786|FG001|Follow-up Period (24 Weeks)|Other|4|||
25082159|NCT02725411|50190787|FG002|Follow-up Period (24 Weeks)|Other|2|||
25082160|NCT02725411|50190785|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
25082161|NCT02725411|50190786|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
25082162|NCT02725411|50190787|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
25082163|NCT02190604|50190823|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082164|NCT02190604|50190824|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082165|NCT02190604|50190825|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082166|NCT02190604|50190826|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082167|NCT02190604|50190827|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082168|NCT02190604|50190828|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082169|NCT02190604|50190829|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082170|NCT02190604|50190830|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082171|NCT02190604|50190831|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082172|NCT02190604|50190832|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082173|NCT02190604|50190833|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082174|NCT02190604|50190834|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082175|NCT02190604|50190835|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082176|NCT02190604|50190836|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082177|NCT02190604|50190837|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
25082178|NCT02190604|50190838|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082179|NCT02190604|50190839|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082180|NCT02190604|50190840|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082181|NCT02190604|50190841|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
25082182|NCT02190604|50190823|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082183|NCT02190604|50190824|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082184|NCT02190604|50190825|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082185|NCT02190604|50190826|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082186|NCT02190604|50190827|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082187|NCT02190604|50190828|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082188|NCT02190604|50190829|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082189|NCT02190604|50190830|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082190|NCT02190604|50190831|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082191|NCT02190604|50190832|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082192|NCT02190604|50190833|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082193|NCT02190604|50190834|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082194|NCT02190604|50190835|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082195|NCT02190604|50190836|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
25082196|NCT02190604|50190837|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082197|NCT02190604|50190838|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082198|NCT02190604|50190839|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082199|NCT02190604|50190840|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082200|NCT02190604|50190841|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
25082201|NCT02127970|50190900|FG000|Overall Study|Adverse Event|2|||
25082202|NCT02127970|50190901|FG001|Overall Study|Adverse Event|1|||
25082203|NCT02127970|50190900|FG000|Overall Study|Death|1|||
25082204|NCT02127970|50190901|FG001|Overall Study|Death|1|||
25082205|NCT02127970|50190900|FG000|Overall Study|Lost to Follow-up|14|||
25082206|NCT02127970|50190901|FG001|Overall Study|Lost to Follow-up|14|||
25082207|NCT02127970|50190900|FG000|Overall Study|Reason not Specified|4|||
25082208|NCT02127970|50190901|FG001|Overall Study|Reason not Specified|7|||
25082209|NCT02127970|50190900|FG000|Overall Study|Pregnancy|0|||
25082210|NCT02127970|50190901|FG001|Overall Study|Pregnancy|1|||
25082211|NCT02127970|50190900|FG000|Overall Study|Subject Withdrew Consent|5|||
25082212|NCT02127970|50190901|FG001|Overall Study|Subject Withdrew Consent|3|||
25082213|NCT03549871|50190909|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
25082214|NCT03549871|50190910|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
25082215|NCT03549871|50190909|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
25082216|NCT03549871|50190910|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
25082217|NCT03549871|50190909|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
25082218|NCT03549871|50190910|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
25082219|NCT03549871|50190909|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
25082220|NCT03549871|50190910|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
25082221|NCT03549871|50190909|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
25082222|NCT03549871|50190910|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
25082223|NCT03549871|50190909|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
25082224|NCT03549871|50190910|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
25082225|NCT03549871|50190909|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
25082226|NCT03549871|50190910|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
25082227|NCT03549871|50190909|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
25082228|NCT03549871|50190910|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
25082229|NCT03549871|50190909|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
25082230|NCT03549871|50190910|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
25082231|NCT03549871|50190909|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
25082232|NCT03549871|50190910|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
25082233|NCT03549871|50190909|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
25082234|NCT03549871|50190910|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
25082235|NCT00705367|50190933|FG000|Long-term Extension Period|Adverse Event|2|||
25082236|NCT00705367|50190934|FG001|Long-term Extension Period|Adverse Event|0|||
25082237|NCT00705367|50190933|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
25082238|NCT00705367|50190934|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
25082239|NCT00705367|50190933|FG000|Long-term Extension Period|Lack of Efficacy|1|||
25082240|NCT00705367|50190934|FG001|Long-term Extension Period|Lack of Efficacy|0|||
25082241|NCT00705367|50190933|FG000|Long-term Extension Period|No longer met study criteria|1|||
25082242|NCT00705367|50190934|FG001|Long-term Extension Period|No longer met study criteria|0|||
25082243|NCT00705367|50190933|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
25082244|NCT00705367|50190934|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
25082245|NCT02864251|50190945|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
25082246|NCT02864251|50190946|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
25082247|NCT02864251|50190947|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
25082248|NCT02864251|50190945|FG000|Pre-Treatment|Withdrawal by Participant|0|||
25082249|NCT02864251|50190946|FG001|Pre-Treatment|Withdrawal by Participant|0|||
25082250|NCT02864251|50190947|FG002|Pre-Treatment|Withdrawal by Participant|4|||
25082251|NCT02864251|50190945|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
25082252|NCT02864251|50190946|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
25082253|NCT02864251|50190947|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
25082254|NCT02864251|50190945|FG000|Pre-Treatment|Other Reasons|0|||
25082255|NCT02864251|50190946|FG001|Pre-Treatment|Other Reasons|1|||
25082256|NCT02864251|50190947|FG002|Pre-Treatment|Other Reasons|1|||
25082257|NCT02864251|50190945|FG000|Treatment|Disease Progression|109|||
25082258|NCT02864251|50190946|FG001|Treatment|Disease Progression|52|||
25082259|NCT02864251|50190947|FG002|Treatment|Disease Progression|100|||
25082260|NCT02864251|50190945|FG000|Treatment|Study Drug Toxicity|9|||
25082261|NCT02864251|50190946|FG001|Treatment|Study Drug Toxicity|4|||
25082262|NCT02864251|50190947|FG002|Treatment|Study Drug Toxicity|10|||
25082263|NCT02864251|50190945|FG000|Treatment|Death|0|||
25082264|NCT02864251|50190946|FG001|Treatment|Death|2|||
25082265|NCT02864251|50190947|FG002|Treatment|Death|3|||
25082266|NCT02864251|50190945|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
25082267|NCT02864251|50190946|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
25082268|NCT02864251|50190947|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
25082269|NCT02864251|50190945|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
25082270|NCT02864251|50190946|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
25082271|NCT02864251|50190947|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
25082272|NCT02864251|50190945|FG000|Treatment|Withdrawal by Participant|8|||
25082273|NCT02864251|50190946|FG001|Treatment|Withdrawal by Participant|5|||
25082274|NCT02864251|50190947|FG002|Treatment|Withdrawal by Participant|13|||
25082275|NCT02864251|50190945|FG000|Treatment|Maximum Clinical Benefit|1|||
25082276|NCT02864251|50190946|FG001|Treatment|Maximum Clinical Benefit|0|||
25082277|NCT02864251|50190947|FG002|Treatment|Maximum Clinical Benefit|1|||
25082278|NCT02864251|50190945|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
25082279|NCT02864251|50190946|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
25082280|NCT02864251|50190947|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
25082281|NCT02864251|50190945|FG000|Treatment|Other Reasons|0|||
25082282|NCT02864251|50190946|FG001|Treatment|Other Reasons|1|||
25082283|NCT02864251|50190947|FG002|Treatment|Other Reasons|3|||
25082284|NCT02864251|50190945|FG000|Treatment|Not Reported|1|||
25082285|NCT02864251|50190946|FG001|Treatment|Not Reported|0|||
25082286|NCT02864251|50190947|FG002|Treatment|Not Reported|0|||
25082287|NCT02864251|50190945|FG000|Treatment|Ongoing Treatment|1|||
25082288|NCT02864251|50190946|FG001|Treatment|Ongoing Treatment|0|||
25082289|NCT02864251|50190947|FG002|Treatment|Ongoing Treatment|2|||
25082290|NCT00705289|50190955|FG000|Overall Study|Subject or treating physician's choice|131|||
25082291|NCT02038777|50190984|FG000|Overall Study|Death|0|||
25082292|NCT02038777|50190985|FG001|Overall Study|Death|2|||
25082293|NCT02038777|50190986|FG002|Overall Study|Death|0|||
25082294|NCT02038777|50190987|FG003|Overall Study|Death|1|||
25082295|NCT02038777|50190988|FG004|Overall Study|Death|2|||
25082296|NCT02038777|50190989|FG005|Overall Study|Death|4|||
25082297|NCT02038777|50190990|FG006|Overall Study|Death|0|||
25082298|NCT02038777|50190991|FG007|Overall Study|Death|10|||
25082299|NCT02038777|50190984|FG000|Overall Study|Lost to Follow-up|0|||
25082300|NCT02038777|50190985|FG001|Overall Study|Lost to Follow-up|0|||
25082301|NCT02038777|50190986|FG002|Overall Study|Lost to Follow-up|0|||
25082302|NCT02038777|50190987|FG003|Overall Study|Lost to Follow-up|1|||
25082303|NCT02038777|50190988|FG004|Overall Study|Lost to Follow-up|0|||
25082304|NCT02038777|50190989|FG005|Overall Study|Lost to Follow-up|0|||
25082305|NCT02038777|50190990|FG006|Overall Study|Lost to Follow-up|0|||
25082306|NCT02038777|50190991|FG007|Overall Study|Lost to Follow-up|0|||
25082307|NCT02038777|50190984|FG000|Overall Study|Other|0|||
25082308|NCT02038777|50190985|FG001|Overall Study|Other|1|||
25082309|NCT02038777|50190986|FG002|Overall Study|Other|0|||
25082310|NCT02038777|50190987|FG003|Overall Study|Other|2|||
25082311|NCT02038777|50190988|FG004|Overall Study|Other|1|||
25082312|NCT02038777|50190989|FG005|Overall Study|Other|0|||
25082313|NCT02038777|50190990|FG006|Overall Study|Other|0|||
25082314|NCT02038777|50190991|FG007|Overall Study|Other|0|||
25082315|NCT02038777|50190984|FG000|Overall Study|Randomized but not treated|0|||
25082316|NCT02038777|50190985|FG001|Overall Study|Randomized but not treated|1|||
25082317|NCT02038777|50190986|FG002|Overall Study|Randomized but not treated|0|||
25082318|NCT02038777|50190987|FG003|Overall Study|Randomized but not treated|0|||
25082319|NCT02038777|50190988|FG004|Overall Study|Randomized but not treated|0|||
25082320|NCT02038777|50190989|FG005|Overall Study|Randomized but not treated|0|||
25082321|NCT02038777|50190990|FG006|Overall Study|Randomized but not treated|0|||
25082322|NCT02038777|50190991|FG007|Overall Study|Randomized but not treated|0|||
25082323|NCT02038777|50190984|FG000|Overall Study|Started Chemotherapy|1|||
25082324|NCT02038777|50190985|FG001|Overall Study|Started Chemotherapy|0|||
25082325|NCT02038777|50190986|FG002|Overall Study|Started Chemotherapy|3|||
25082326|NCT02038777|50190987|FG003|Overall Study|Started Chemotherapy|0|||
25082327|NCT02038777|50190988|FG004|Overall Study|Started Chemotherapy|0|||
25259841|NCT01020799|50574946|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
25082328|NCT02038777|50190989|FG005|Overall Study|Started Chemotherapy|0|||
25082329|NCT02038777|50190990|FG006|Overall Study|Started Chemotherapy|0|||
25082330|NCT02038777|50190991|FG007|Overall Study|Started Chemotherapy|0|||
25082331|NCT00703963|50191010|FG000|Overall Study|Withdrawal by Subject|7|||
25082332|NCT00703963|50191011|FG001|Overall Study|Withdrawal by Subject|13|||
25082333|NCT00703963|50191010|FG000|Overall Study|Physician Decision|0|||
25082334|NCT00703963|50191011|FG001|Overall Study|Physician Decision|1|||
25082335|NCT02721355|50191019|FG000|Overall Study|Lost to Follow-up|6|||
25082336|NCT02721355|50191020|FG001|Overall Study|Lost to Follow-up|1|||
25082337|NCT02733991|50191028|FG000|Overall Study|Adverse Event|1|||
25082338|NCT02733991|50191029|FG001|Overall Study|Adverse Event|0|||
25082339|NCT02733991|50191028|FG000|Overall Study|Withdrawal by Subject|0|||
25082340|NCT02733991|50191029|FG001|Overall Study|Withdrawal by Subject|5|||
25082341|NCT00702949|50191038|FG000|Overall Study|Refusal|3|||
25082342|NCT00702949|50191039|FG001|Overall Study|Refusal|2|||
25082343|NCT00702949|50191040|FG002|Overall Study|Refusal|2|||
25082344|NCT00702949|50191038|FG000|Overall Study|Adverse Event|1|||
25082345|NCT00702949|50191039|FG001|Overall Study|Adverse Event|6|||
25082346|NCT00702949|50191040|FG002|Overall Study|Adverse Event|3|||
25082347|NCT00702949|50191038|FG000|Overall Study|Other Medical Reason/unknown|1|||
25082348|NCT00702949|50191039|FG001|Overall Study|Other Medical Reason/unknown|1|||
25082349|NCT00702949|50191040|FG002|Overall Study|Other Medical Reason/unknown|3|||
25082350|NCT00702715|50191052|FG000|Overall Study|Lost to Follow-up|1|||
25082351|NCT00702715|50191053|FG001|Overall Study|Lost to Follow-up|0|||
25082352|NCT00702403|50191059|FG000|From Consent to Engraftment|Progressive leukemia|6|||
25082353|NCT00702403|50191059|FG000|From Consent to Engraftment|Critically ill|2|||
25082354|NCT00702403|50191059|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
25082355|NCT00702403|50191059|FG000|From Consent to Engraftment|Myocardial infarction|1|||
25082356|NCT00702403|50191059|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
25082357|NCT00702403|50191059|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
25082358|NCT00702403|50191059|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
25082359|NCT00702403|50191059|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
25082360|NCT00702403|50191059|FG000|From Engraftment to Study Completion|Non-compliance|2|||
25082361|NCT00702403|50191059|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
25082362|NCT00702403|50191059|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
25082363|NCT00702403|50191059|FG000|From Engraftment to Study Completion|Suicide|1|||
25082364|NCT00702403|50191059|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
25082365|NCT00702403|50191059|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
25082366|NCT00702403|50191059|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
25082367|NCT00702325|50191068|FG000|Overall Study|Adverse Event|1|||
25082368|NCT00702325|50191069|FG001|Overall Study|Adverse Event|0|||
25082369|NCT00702325|50191068|FG000|Overall Study|Withdrawal by Subject|7|||
25082370|NCT00702325|50191069|FG001|Overall Study|Withdrawal by Subject|7|||
25082371|NCT00702325|50191068|FG000|Overall Study|Lost to Follow-up|3|||
25082372|NCT00702325|50191069|FG001|Overall Study|Lost to Follow-up|4|||
25082373|NCT00702325|50191068|FG000|Overall Study|Incorrect enrollment|5|||
25082374|NCT00702325|50191069|FG001|Overall Study|Incorrect enrollment|7|||
25082375|NCT00702325|50191068|FG000|Overall Study|Developed study discontinuation criteria|18|||
25082376|NCT00702325|50191069|FG001|Overall Study|Developed study discontinuation criteria|28|||
25082377|NCT00702325|50191068|FG000|Overall Study|Severe noncompliance to protocol|3|||
25082378|NCT00702325|50191069|FG001|Overall Study|Severe noncompliance to protocol|3|||
25082379|NCT00702325|50191068|FG000|Overall Study|Termination due to lab results|1|||
25082380|NCT00702325|50191069|FG001|Overall Study|Termination due to lab results|0|||
25082381|NCT00702325|50191068|FG000|Overall Study|Didn't follow study medication dosage|0|||
25082382|NCT00702325|50191069|FG001|Overall Study|Didn't follow study medication dosage|2|||
25082383|NCT00702325|50191068|FG000|Overall Study|Withdrew consent|0|||
25082384|NCT00702325|50191069|FG001|Overall Study|Withdrew consent|1|||
25082385|NCT00702325|50191068|FG000|Overall Study|Incorrectly Discontinued|0|||
25082386|NCT00702325|50191069|FG001|Overall Study|Incorrectly Discontinued|1|||
25082387|NCT02719171|50191080|FG000|Overall Study|Adverse Event|1|||
25082388|NCT02719171|50191081|FG001|Overall Study|Adverse Event|2|||
25082389|NCT02719171|50191082|FG002|Overall Study|Adverse Event|0|||
25082390|NCT02719171|50191083|FG003|Overall Study|Adverse Event|0|||
25082391|NCT02719171|50191084|FG004|Overall Study|Adverse Event|2|||
25082392|NCT02719171|50191080|FG000|Overall Study|Lost to Follow-up|0|||
25082393|NCT02719171|50191081|FG001|Overall Study|Lost to Follow-up|0|||
25082394|NCT02719171|50191082|FG002|Overall Study|Lost to Follow-up|1|||
25082395|NCT02719171|50191083|FG003|Overall Study|Lost to Follow-up|0|||
25082396|NCT02719171|50191084|FG004|Overall Study|Lost to Follow-up|0|||
25082397|NCT02719171|50191080|FG000|Overall Study|Subject Withdrawal|0|||
25082398|NCT02719171|50191081|FG001|Overall Study|Subject Withdrawal|2|||
25082399|NCT02719171|50191082|FG002|Overall Study|Subject Withdrawal|2|||
25082400|NCT02719171|50191083|FG003|Overall Study|Subject Withdrawal|1|||
25082401|NCT02719171|50191084|FG004|Overall Study|Subject Withdrawal|0|||
25082402|NCT02719171|50191080|FG000|Overall Study|Other|0|||
25082403|NCT02719171|50191081|FG001|Overall Study|Other|0|||
25082404|NCT02719171|50191082|FG002|Overall Study|Other|0|||
25082405|NCT02719171|50191083|FG003|Overall Study|Other|1|||
25082406|NCT02719171|50191084|FG004|Overall Study|Other|0|||
25082407|NCT02718625|50191101|FG000|Overall Study|Adverse Event|0|||
25082408|NCT02718625|50191102|FG001|Overall Study|Adverse Event|1|||
25082409|NCT02718625|50191101|FG000|Overall Study|Termination of Study by Sponsor|0|||
25082852|NCT02425891|50191625|FG001|Overall Study|Lost to Follow-up|6|||
25082410|NCT02718625|50191102|FG001|Overall Study|Termination of Study by Sponsor|1|||
25082411|NCT02716987|50191114|FG000|Overall Study|Ligand synthesis failure|0|||
25082412|NCT02716987|50191115|FG001|Overall Study|Ligand synthesis failure|0|||
25082413|NCT02716987|50191116|FG002|Overall Study|Ligand synthesis failure|1|||
25082414|NCT02716987|50191117|FG003|Overall Study|Ligand synthesis failure|0|||
25082415|NCT02716987|50191118|FG004|Overall Study|Ligand synthesis failure|0|||
25082416|NCT02716987|50191119|FG005|Overall Study|Ligand synthesis failure|0|||
25082417|NCT02716987|50191114|FG000|Overall Study|Withdrawal by Subject|0|||
25082418|NCT02716987|50191115|FG001|Overall Study|Withdrawal by Subject|0|||
25082419|NCT02716987|50191116|FG002|Overall Study|Withdrawal by Subject|0|||
25082420|NCT02716987|50191117|FG003|Overall Study|Withdrawal by Subject|0|||
25082421|NCT02716987|50191118|FG004|Overall Study|Withdrawal by Subject|1|||
25082422|NCT02716987|50191119|FG005|Overall Study|Withdrawal by Subject|1|||
25082423|NCT00701779|50191144|FG000|Overall Study|Adverse Event|6|||
25082424|NCT00701779|50191144|FG000|Overall Study|Lost to Follow-up|1|||
25082425|NCT00701779|50191144|FG000|Overall Study|Withdrawal by Subject|2|||
25082426|NCT03707977|50191167|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
25082427|NCT03707977|50191168|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
25082428|NCT03707977|50191169|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
25082429|NCT03707977|50191167|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
25082430|NCT03707977|50191168|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
25082431|NCT03707977|50191169|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
25082432|NCT03332095|50191185|FG000|Overall Study|Lost to Follow-up|1|||
25082433|NCT03332095|50191186|FG001|Overall Study|Lost to Follow-up|0|||
25082434|NCT03332095|50191185|FG000|Overall Study|Pregnancy|0|||
25082435|NCT03332095|50191186|FG001|Overall Study|Pregnancy|1|||
25082436|NCT02764489|50191193|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
25082437|NCT02764489|50191194|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
25082438|NCT02764489|50191193|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
25082439|NCT02764489|50191194|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
25082440|NCT02764489|50191193|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
25082441|NCT02764489|50191194|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
25082442|NCT02764489|50191193|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
25082443|NCT02764489|50191194|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
25082444|NCT02001623|50191219|FG000|Overall Study|Disease Progression|2|||
25082445|NCT02001623|50191220|FG001|Overall Study|Disease Progression|2|||
25082446|NCT02001623|50191221|FG002|Overall Study|Disease Progression|3|||
25082447|NCT02001623|50191222|FG003|Overall Study|Disease Progression|2|||
25082448|NCT02001623|50191223|FG004|Overall Study|Disease Progression|3|||
25082449|NCT02001623|50191224|FG005|Overall Study|Disease Progression|2|||
25082450|NCT02001623|50191225|FG006|Overall Study|Disease Progression|3|||
25082451|NCT02001623|50191226|FG007|Overall Study|Disease Progression|3|||
25082452|NCT02001623|50191227|FG008|Overall Study|Disease Progression|7|||
25082453|NCT02001623|50191228|FG009|Overall Study|Disease Progression|40|||
25082454|NCT02001623|50191229|FG010|Overall Study|Disease Progression|5|||
25082455|NCT02001623|50191230|FG011|Overall Study|Disease Progression|9|||
25082456|NCT02001623|50191231|FG012|Overall Study|Disease Progression|9|||
25082457|NCT02001623|50191232|FG013|Overall Study|Disease Progression|20|||
25082458|NCT02001623|50191233|FG014|Overall Study|Disease Progression|9|||
25082459|NCT02001623|50191219|FG000|Overall Study|Physician Decision|0|||
25082460|NCT02001623|50191220|FG001|Overall Study|Physician Decision|0|||
25082461|NCT02001623|50191221|FG002|Overall Study|Physician Decision|0|||
25082462|NCT02001623|50191222|FG003|Overall Study|Physician Decision|0|||
25082463|NCT02001623|50191223|FG004|Overall Study|Physician Decision|0|||
25082464|NCT02001623|50191224|FG005|Overall Study|Physician Decision|0|||
25082465|NCT02001623|50191225|FG006|Overall Study|Physician Decision|0|||
25082466|NCT02001623|50191226|FG007|Overall Study|Physician Decision|0|||
25082467|NCT02001623|50191227|FG008|Overall Study|Physician Decision|3|||
25082468|NCT02001623|50191228|FG009|Overall Study|Physician Decision|2|||
25082469|NCT02001623|50191229|FG010|Overall Study|Physician Decision|3|||
25082470|NCT02001623|50191230|FG011|Overall Study|Physician Decision|3|||
25082471|NCT02001623|50191231|FG012|Overall Study|Physician Decision|1|||
25082472|NCT02001623|50191232|FG013|Overall Study|Physician Decision|2|||
25082473|NCT02001623|50191233|FG014|Overall Study|Physician Decision|1|||
25082474|NCT02001623|50191219|FG000|Overall Study|Death|0|||
25082475|NCT02001623|50191220|FG001|Overall Study|Death|1|||
25082476|NCT02001623|50191221|FG002|Overall Study|Death|0|||
25082477|NCT02001623|50191222|FG003|Overall Study|Death|0|||
25082478|NCT02001623|50191223|FG004|Overall Study|Death|0|||
25082479|NCT02001623|50191224|FG005|Overall Study|Death|0|||
25082480|NCT02001623|50191225|FG006|Overall Study|Death|0|||
25082481|NCT02001623|50191226|FG007|Overall Study|Death|0|||
25082482|NCT02001623|50191227|FG008|Overall Study|Death|0|||
25082483|NCT02001623|50191228|FG009|Overall Study|Death|0|||
25082484|NCT02001623|50191229|FG010|Overall Study|Death|0|||
25082485|NCT02001623|50191230|FG011|Overall Study|Death|0|||
25082486|NCT02001623|50191231|FG012|Overall Study|Death|0|||
25082487|NCT02001623|50191232|FG013|Overall Study|Death|0|||
25082488|NCT02001623|50191233|FG014|Overall Study|Death|0|||
25082489|NCT02001623|50191219|FG000|Overall Study|Adverse Event|0|||
25082490|NCT02001623|50191220|FG001|Overall Study|Adverse Event|0|||
25082491|NCT02001623|50191221|FG002|Overall Study|Adverse Event|0|||
25082492|NCT02001623|50191222|FG003|Overall Study|Adverse Event|0|||
25082493|NCT02001623|50191223|FG004|Overall Study|Adverse Event|0|||
25082494|NCT02001623|50191224|FG005|Overall Study|Adverse Event|1|||
25082495|NCT02001623|50191225|FG006|Overall Study|Adverse Event|0|||
25082496|NCT02001623|50191226|FG007|Overall Study|Adverse Event|3|||
25082497|NCT02001623|50191227|FG008|Overall Study|Adverse Event|4|||
25082498|NCT02001623|50191228|FG009|Overall Study|Adverse Event|6|||
25082499|NCT02001623|50191229|FG010|Overall Study|Adverse Event|4|||
25082500|NCT02001623|50191230|FG011|Overall Study|Adverse Event|0|||
25082501|NCT02001623|50191231|FG012|Overall Study|Adverse Event|3|||
25082502|NCT02001623|50191232|FG013|Overall Study|Adverse Event|5|||
25082503|NCT02001623|50191233|FG014|Overall Study|Adverse Event|6|||
25082504|NCT02001623|50191219|FG000|Overall Study|Other - Miscellaneous|0|||
25082505|NCT02001623|50191220|FG001|Overall Study|Other - Miscellaneous|0|||
25082506|NCT02001623|50191221|FG002|Overall Study|Other - Miscellaneous|0|||
25082507|NCT02001623|50191222|FG003|Overall Study|Other - Miscellaneous|0|||
25082508|NCT02001623|50191223|FG004|Overall Study|Other - Miscellaneous|0|||
25082509|NCT02001623|50191224|FG005|Overall Study|Other - Miscellaneous|0|||
25082510|NCT02001623|50191225|FG006|Overall Study|Other - Miscellaneous|0|||
25082511|NCT02001623|50191226|FG007|Overall Study|Other - Miscellaneous|0|||
25082512|NCT02001623|50191227|FG008|Overall Study|Other - Miscellaneous|0|||
25082513|NCT02001623|50191228|FG009|Overall Study|Other - Miscellaneous|1|||
25082514|NCT02001623|50191229|FG010|Overall Study|Other - Miscellaneous|0|||
25259842|NCT01020799|50574947|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
25259843|NCT01020799|50574945|FG000|Overall Study|Protocol Violation|3|||
25259844|NCT01020799|50574946|FG001|Overall Study|Protocol Violation|2|||
25259845|NCT01020799|50574947|FG002|Overall Study|Protocol Violation|0|||
25259846|NCT01020799|50574945|FG000|Overall Study|Withdrawal by Subject|2|||
25259847|NCT01020799|50574946|FG001|Overall Study|Withdrawal by Subject|2|||
25259848|NCT01020799|50574947|FG002|Overall Study|Withdrawal by Subject|3|||
25259849|NCT01020799|50574945|FG000|Overall Study|Lost to Follow-up|6|||
25259850|NCT01020799|50574946|FG001|Overall Study|Lost to Follow-up|4|||
25259851|NCT01020799|50574947|FG002|Overall Study|Lost to Follow-up|2|||
25259852|NCT01288989|50574960|FG000|Overall Study|Death|0|||
25259853|NCT01288989|50574961|FG001|Overall Study|Death|0|||
25259854|NCT01288989|50574962|FG002|Overall Study|Death|0|||
25259855|NCT01288989|50574963|FG003|Overall Study|Death|1|||
25259856|NCT01288989|50574964|FG004|Overall Study|Death|0|||
25259857|NCT01288989|50574960|FG000|Overall Study|Dose limiting toxicity|1|||
25259858|NCT01288989|50574961|FG001|Overall Study|Dose limiting toxicity|0|||
25259859|NCT01288989|50574962|FG002|Overall Study|Dose limiting toxicity|0|||
25259860|NCT01288989|50574963|FG003|Overall Study|Dose limiting toxicity|0|||
25259861|NCT01288989|50574964|FG004|Overall Study|Dose limiting toxicity|0|||
25259862|NCT01288989|50574960|FG000|Overall Study|Adverse Event|0|||
25259863|NCT01288989|50574961|FG001|Overall Study|Adverse Event|0|||
25259864|NCT01288989|50574962|FG002|Overall Study|Adverse Event|0|||
25259865|NCT01288989|50574963|FG003|Overall Study|Adverse Event|0|||
25259866|NCT01288989|50574964|FG004|Overall Study|Adverse Event|2|||
25259867|NCT01288989|50574960|FG000|Overall Study|Physician Decision|0|||
25259868|NCT01288989|50574961|FG001|Overall Study|Physician Decision|0|||
25259869|NCT01288989|50574962|FG002|Overall Study|Physician Decision|0|||
25259870|NCT01288989|50574963|FG003|Overall Study|Physician Decision|0|||
25259871|NCT01288989|50574964|FG004|Overall Study|Physician Decision|1|||
25259872|NCT01288989|50574960|FG000|Overall Study|Withdrawal by Subject|0|||
25259873|NCT01288989|50574961|FG001|Overall Study|Withdrawal by Subject|0|||
25259874|NCT01288989|50574962|FG002|Overall Study|Withdrawal by Subject|0|||
25259875|NCT01288989|50574963|FG003|Overall Study|Withdrawal by Subject|0|||
25259876|NCT01288989|50574964|FG004|Overall Study|Withdrawal by Subject|3|||
25259877|NCT01020487|50574985|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
25259878|NCT01020487|50574986|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
25259879|NCT01020487|50574987|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
25259880|NCT01020487|50574985|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
25259881|NCT01020487|50574986|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
25259882|NCT01020487|50574987|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
25259883|NCT01020487|50574985|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
25259884|NCT01020487|50574986|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
25259885|NCT01020487|50574987|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
25259886|NCT01020487|50574985|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
25259887|NCT01020487|50574986|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
25082515|NCT02001623|50191230|FG011|Overall Study|Other - Miscellaneous|0|||
25082516|NCT02001623|50191231|FG012|Overall Study|Other - Miscellaneous|0|||
25082853|NCT02425891|50191624|FG000|Overall Study|Non-Compliance|1|||
25082854|NCT02425891|50191625|FG001|Overall Study|Non-Compliance|1|||
24994962|NCT02914522|50085810|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
24994963|NCT02914522|50085800|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
24994964|NCT02914522|50085801|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
24994965|NCT02914522|50085802|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
24994966|NCT02914522|50085803|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
24994967|NCT02914522|50085804|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
24994968|NCT02914522|50085805|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
24994969|NCT02914522|50085806|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
24994970|NCT02914522|50085807|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
24994971|NCT02914522|50085808|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
24994972|NCT02914522|50085809|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
24994973|NCT02914522|50085810|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
24994974|NCT02914522|50085800|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
24994975|NCT02914522|50085801|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
24994976|NCT02914522|50085802|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
24994977|NCT02914522|50085803|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
24994978|NCT02914522|50085804|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
24994979|NCT02914522|50085805|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
24994980|NCT02914522|50085806|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
24994981|NCT02914522|50085807|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
24994982|NCT02914522|50085808|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
24994983|NCT02914522|50085809|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
24994984|NCT02914522|50085810|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
24994985|NCT02924428|50085839|FG000|Overall Study|Adverse Event|1|||
24994986|NCT02924428|50085840|FG001|Overall Study|Adverse Event|0|||
24994987|NCT02924428|50085839|FG000|Overall Study|Physician Decision|1|||
24994988|NCT02924428|50085840|FG001|Overall Study|Physician Decision|0|||
24994989|NCT02924428|50085839|FG000|Overall Study|Lost to Follow-up|2|||
24994990|NCT02924428|50085840|FG001|Overall Study|Lost to Follow-up|4|||
24994991|NCT02924428|50085839|FG000|Overall Study|Pregnancy|0|||
24994992|NCT02924428|50085840|FG001|Overall Study|Pregnancy|1|||
24994993|NCT00062751|50085851|FG000|Overall Study|Disease progression|24|||
24994994|NCT00062751|50085852|FG001|Overall Study|Disease progression|17|||
24994995|NCT00062751|50085853|FG002|Overall Study|Disease progression|24|||
24994996|NCT00062751|50085854|FG003|Overall Study|Disease progression|2|||
24994997|NCT00062751|50085855|FG004|Overall Study|Disease progression|2|||
24994998|NCT00062751|50085851|FG000|Overall Study|Adverse Event|4|||
24994999|NCT00062751|50085852|FG001|Overall Study|Adverse Event|7|||
24995000|NCT00062751|50085853|FG002|Overall Study|Adverse Event|2|||
24995001|NCT00062751|50085854|FG003|Overall Study|Adverse Event|2|||
24995002|NCT00062751|50085855|FG004|Overall Study|Adverse Event|2|||
24995003|NCT00062751|50085851|FG000|Overall Study|Other|2|||
24995004|NCT00062751|50085852|FG001|Overall Study|Other|3|||
24995005|NCT00062751|50085853|FG002|Overall Study|Other|1|||
24995006|NCT00062751|50085854|FG003|Overall Study|Other|0|||
24995007|NCT00062751|50085855|FG004|Overall Study|Other|1|||
24995008|NCT00062751|50085851|FG000|Overall Study|Withdrawal by Subject|1|||
24995009|NCT00062751|50085852|FG001|Overall Study|Withdrawal by Subject|2|||
24995010|NCT00062751|50085853|FG002|Overall Study|Withdrawal by Subject|2|||
24995011|NCT00062751|50085854|FG003|Overall Study|Withdrawal by Subject|1|||
24995012|NCT00062751|50085855|FG004|Overall Study|Withdrawal by Subject|0|||
24995013|NCT00062751|50085851|FG000|Overall Study|Symptomatic deterioration|1|||
24995014|NCT00062751|50085852|FG001|Overall Study|Symptomatic deterioration|1|||
24995015|NCT00062751|50085853|FG002|Overall Study|Symptomatic deterioration|0|||
24995016|NCT00062751|50085854|FG003|Overall Study|Symptomatic deterioration|0|||
24995017|NCT00062751|50085855|FG004|Overall Study|Symptomatic deterioration|1|||
24995018|NCT00062751|50085851|FG000|Overall Study|Death|1|||
24995019|NCT00062751|50085852|FG001|Overall Study|Death|0|||
24995020|NCT00062751|50085853|FG002|Overall Study|Death|1|||
24995021|NCT00062751|50085854|FG003|Overall Study|Death|0|||
24995022|NCT00062751|50085855|FG004|Overall Study|Death|0|||
24995023|NCT00062439|50085872|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
24995024|NCT00062439|50085872|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
24995025|NCT00062439|50085872|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
24995026|NCT00062439|50085872|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
24995027|NCT00062439|50085872|FG000|Post Chemoradiation Assessment|Death|1|||
24995028|NCT00062439|50085872|FG000|Post Chemoradiation Assessment|Disease progression|2|||
24995029|NCT00062439|50085872|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
24995030|NCT00062439|50085872|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
24995031|NCT00062439|50085872|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
24995032|NCT00062439|50085872|FG000|Surgery|Physician Decision|4|||
24995033|NCT00062439|50085872|FG000|Surgery|Death|1|||
24995034|NCT00062439|50085872|FG000|Surgery|Adverse Event|2|||
24995035|NCT00062439|50085872|FG000|Consolidation Chemotherapy|Adverse Event|2|||
24995036|NCT00051363|50085883|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
24995037|NCT00051363|50085884|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
24995038|NCT00051363|50085883|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
24995039|NCT00051363|50085884|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
24995040|NCT00051363|50085883|FG000|Overall Study|Death|2|||
24995041|NCT00051363|50085884|FG001|Overall Study|Death|2|||
24995042|NCT00051363|50085883|FG000|Overall Study|Excluded Pre-Randomization|2|||
24995043|NCT00051363|50085884|FG001|Overall Study|Excluded Pre-Randomization|5|||
24995044|NCT00031551|50085892|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
24995045|NCT00031551|50085893|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
24995046|NCT00049257|50085903|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
24995047|NCT00049257|50085903|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
24995048|NCT00049257|50085903|FG000|Carboplatin, Paclitaxel|Death|2|||
24995049|NCT00049257|50085903|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
24995050|NCT03020992|50085907|FG000|Overall Study|Adverse Event|5|||
24995051|NCT03020992|50085907|FG000|Overall Study|Withdrawal by Subject|1|||
24995052|NCT03020914|50085914|FG000|Overall Study|Surgery Cancelled|1|||
24995053|NCT03020914|50085915|FG001|Overall Study|Surgery Cancelled|0|||
24995054|NCT03018340|50085923|FG000|Overall Study|Adverse Event|1|||
24995055|NCT03018340|50085924|FG001|Overall Study|Adverse Event|2|||
24995056|NCT03018340|50085923|FG000|Overall Study|Withdrawal by Subject|0|||
24995057|NCT03018340|50085924|FG001|Overall Study|Withdrawal by Subject|8|||
24995058|NCT03018340|50085923|FG000|Overall Study|Lack of Efficacy|0|||
24995059|NCT03018340|50085924|FG001|Overall Study|Lack of Efficacy|1|||
24995060|NCT03018340|50085923|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
24995061|NCT03018340|50085924|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
24995062|NCT03018340|50085923|FG000|Overall Study|Lost to Follow-up|1|||
24995063|NCT03018340|50085924|FG001|Overall Study|Lost to Follow-up|7|||
24995064|NCT03018340|50085923|FG000|Overall Study|Protocol Violation|3|||
24995065|NCT03018340|50085924|FG001|Overall Study|Protocol Violation|7|||
24995066|NCT03018340|50085923|FG000|Overall Study|Not further specified|0|||
24995067|NCT03018340|50085924|FG001|Overall Study|Not further specified|1|||
24995068|NCT03016078|50085934|FG000|Overall Study|Protocol Violation|1|||
24995069|NCT03016078|50085934|FG000|Overall Study|Protocol Violation|1|||
24995070|NCT00048165|50085940|FG000|Completed 6 Months Study|Administration/Other|8|||
24995071|NCT00048165|50085941|FG001|Completed 6 Months Study|Administration/Other|8|||
24995072|NCT00048165|50085940|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
24995073|NCT00048165|50085941|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
24995074|NCT00048165|50085940|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
24995075|NCT00048165|50085941|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
24995076|NCT00048165|50085940|FG000|Completed 6 Months Study|Death|12|||
24995077|NCT00048165|50085941|FG001|Completed 6 Months Study|Death|6|||
24995078|NCT00048165|50085940|FG000|Completed 6 Months Study|Insufficient therapy|1|||
24995079|NCT00048165|50085941|FG001|Completed 6 Months Study|Insufficient therapy|4|||
24995080|NCT00048165|50085940|FG000|Completed 6 Months Study|Other violation|4|||
24995081|NCT00048165|50085941|FG001|Completed 6 Months Study|Other violation|6|||
24995082|NCT00048165|50085940|FG000|Completed 6 Months Study|Refused treatment|5|||
24995083|NCT00048165|50085941|FG001|Completed 6 Months Study|Refused treatment|5|||
24995084|NCT00048165|50085940|FG000|Completed 6 Months Study|Violation criteria|0|||
24995085|NCT00048165|50085941|FG001|Completed 6 Months Study|Violation criteria|2|||
24995086|NCT00048165|50085940|FG000|Completed 6 Months Study|Did not receive study drug|6|||
25082517|NCT02001623|50191232|FG013|Overall Study|Other - Miscellaneous|1|||
25082518|NCT02001623|50191233|FG014|Overall Study|Other - Miscellaneous|0|||
25082519|NCT02001623|50191219|FG000|Overall Study|Withdrawal by Subject|1|||
25082520|NCT02001623|50191220|FG001|Overall Study|Withdrawal by Subject|0|||
25082521|NCT02001623|50191221|FG002|Overall Study|Withdrawal by Subject|0|||
25082522|NCT02001623|50191222|FG003|Overall Study|Withdrawal by Subject|0|||
25082523|NCT02001623|50191223|FG004|Overall Study|Withdrawal by Subject|0|||
25082524|NCT02001623|50191224|FG005|Overall Study|Withdrawal by Subject|0|||
25082525|NCT02001623|50191225|FG006|Overall Study|Withdrawal by Subject|0|||
25082526|NCT02001623|50191226|FG007|Overall Study|Withdrawal by Subject|0|||
25082527|NCT02001623|50191227|FG008|Overall Study|Withdrawal by Subject|1|||
25082528|NCT02001623|50191228|FG009|Overall Study|Withdrawal by Subject|3|||
25082529|NCT02001623|50191229|FG010|Overall Study|Withdrawal by Subject|2|||
25082530|NCT02001623|50191230|FG011|Overall Study|Withdrawal by Subject|2|||
25082531|NCT02001623|50191231|FG012|Overall Study|Withdrawal by Subject|1|||
25082532|NCT02001623|50191232|FG013|Overall Study|Withdrawal by Subject|5|||
25082533|NCT02001623|50191233|FG014|Overall Study|Withdrawal by Subject|2|||
25082534|NCT02001623|50191219|FG000|Overall Study|Lost to Follow-up|0|||
25082535|NCT02001623|50191220|FG001|Overall Study|Lost to Follow-up|0|||
25082536|NCT02001623|50191221|FG002|Overall Study|Lost to Follow-up|0|||
25171891|NCT01755767|50309518|FG003|Overall Study|Clinical Disease Progression|20|||
25171892|NCT01755767|50309515|FG000|Overall Study|Radiographic Disease Progression|9|||
25171893|NCT01755767|50309516|FG001|Overall Study|Radiographic Disease Progression|4|||
25171894|NCT01755767|50309517|FG002|Overall Study|Radiographic Disease Progression|44|||
25171895|NCT01755767|50309518|FG003|Overall Study|Radiographic Disease Progression|27|||
25171896|NCT01755767|50309515|FG000|Overall Study|Adverse Event|6|||
25171897|NCT01755767|50309516|FG001|Overall Study|Adverse Event|0|||
25171898|NCT01755767|50309517|FG002|Overall Study|Adverse Event|28|||
25171899|NCT01755767|50309518|FG003|Overall Study|Adverse Event|11|||
25171900|NCT01755767|50309515|FG000|Overall Study|Death|1|||
25171901|NCT01755767|50309516|FG001|Overall Study|Death|2|||
25171902|NCT01755767|50309517|FG002|Overall Study|Death|15|||
25171903|NCT01755767|50309518|FG003|Overall Study|Death|4|||
25171904|NCT01755767|50309515|FG000|Overall Study|Subject Decision|0|||
25171905|NCT01755767|50309516|FG001|Overall Study|Subject Decision|0|||
25171906|NCT01755767|50309517|FG002|Overall Study|Subject Decision|10|||
25171907|NCT01755767|50309518|FG003|Overall Study|Subject Decision|3|||
25171908|NCT01755767|50309515|FG000|Overall Study|Withdrawal by Subject|0|||
25171909|NCT01755767|50309516|FG001|Overall Study|Withdrawal by Subject|0|||
25171910|NCT01755767|50309517|FG002|Overall Study|Withdrawal by Subject|2|||
25171911|NCT01755767|50309518|FG003|Overall Study|Withdrawal by Subject|1|||
25171912|NCT01755767|50309515|FG000|Overall Study|Other|0|||
25171913|NCT01755767|50309516|FG001|Overall Study|Other|0|||
25171914|NCT01755767|50309517|FG002|Overall Study|Other|2|||
25171915|NCT01755767|50309518|FG003|Overall Study|Other|3|||
25171916|NCT01755767|50309515|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
25171917|NCT01755767|50309516|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
25171918|NCT01755767|50309517|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
25171919|NCT01755767|50309518|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
25171920|NCT01730339|50309614|FG000|Overall Study|Withdrawal by Subject|3|||
25171921|NCT01730339|50309615|FG001|Overall Study|Withdrawal by Subject|2|||
25171922|NCT01730339|50309614|FG000|Overall Study|Lost to Follow-up|1|||
25171923|NCT01730339|50309615|FG001|Overall Study|Lost to Follow-up|1|||
25171924|NCT01730339|50309614|FG000|Overall Study|Un-specified|1|||
25171925|NCT01730339|50309615|FG001|Overall Study|Un-specified|0|||
25171926|NCT01754753|50309672|FG000|Overall Study|Study close|43|||
25171927|NCT01754753|50309673|FG001|Overall Study|Study close|44|||
25171928|NCT01754753|50309672|FG000|Overall Study|Lost to Follow-up|9|||
25171929|NCT01754753|50309673|FG001|Overall Study|Lost to Follow-up|5|||
25171930|NCT01729871|50309681|FG000|Overall Study|Adverse Event|7|||
25171931|NCT01729871|50309682|FG001|Overall Study|Adverse Event|7|||
25171932|NCT01729871|50309681|FG000|Overall Study|Death|0|||
25171933|NCT01729871|50309682|FG001|Overall Study|Death|1|||
25171934|NCT01729871|50309681|FG000|Overall Study|Lack of Efficacy|0|||
25171935|NCT01729871|50309682|FG001|Overall Study|Lack of Efficacy|1|||
25171936|NCT01729871|50309681|FG000|Overall Study|Physician Decision|0|||
25171937|NCT01729871|50309682|FG001|Overall Study|Physician Decision|2|||
25171938|NCT01729871|50309681|FG000|Overall Study|Protocol Violation|1|||
25171939|NCT01729871|50309682|FG001|Overall Study|Protocol Violation|0|||
25171940|NCT01729871|50309681|FG000|Overall Study|Withdrawal by Subject|0|||
25171941|NCT01729871|50309682|FG001|Overall Study|Withdrawal by Subject|3|||
25171942|NCT01729871|50309681|FG000|Overall Study|Other|4|||
25171943|NCT01729871|50309682|FG001|Overall Study|Other|9|||
25171944|NCT01729559|50309690|FG000|Overall Study|Protocol Violation|31|||
25171945|NCT01729559|50309691|FG001|Overall Study|Protocol Violation|28|||
25082537|NCT02001623|50191222|FG003|Overall Study|Lost to Follow-up|0|||
25082538|NCT02001623|50191223|FG004|Overall Study|Lost to Follow-up|0|||
25082539|NCT02001623|50191224|FG005|Overall Study|Lost to Follow-up|0|||
25171946|NCT01728779|50309710|FG000|Overall Study|Withdrawal by Subject|1|||
25171947|NCT01728623|50309721|FG000|Overall Study|Disease progression|26|||
25171948|NCT01728623|50309721|FG000|Overall Study|Adverse Event|1|||
25171949|NCT01728623|50309721|FG000|Overall Study|Withdrawal by Subject|1|||
25171950|NCT01754129|50309728|FG000|Overall Study|Death|13|||
25171951|NCT01754129|50309728|FG000|Overall Study|Duodopa discontinuation|9|||
25171952|NCT01754129|50309728|FG000|Overall Study|Lost to Follow-up|7|||
25171953|NCT01754129|50309728|FG000|Overall Study|Withdrew consent|1|||
25171954|NCT01754129|50309728|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
25171955|NCT01728077|50309741|FG000|Overall Study|Lack of Efficacy|3|||
25171956|NCT01728077|50309742|FG001|Overall Study|Lack of Efficacy|1|||
25171957|NCT01728077|50309741|FG000|Overall Study|Lost to Follow-up|1|||
25171958|NCT01728077|50309742|FG001|Overall Study|Lost to Follow-up|0|||
25171959|NCT01728077|50309741|FG000|Overall Study|Subject choice|2|||
25171960|NCT01728077|50309742|FG001|Overall Study|Subject choice|3|||
25171961|NCT01728077|50309741|FG000|Overall Study|Death|0|||
25171962|NCT01728077|50309742|FG001|Overall Study|Death|1|||
25171963|NCT01728077|50309741|FG000|Overall Study|Patient moving|1|||
25171964|NCT01728077|50309742|FG001|Overall Study|Patient moving|0|||
25171965|NCT01728077|50309741|FG000|Overall Study|Non compliance|1|||
25171966|NCT01728077|50309742|FG001|Overall Study|Non compliance|0|||
25171967|NCT01606007|50309761|FG000|Overall Study|Reason 'Other' in the protocol|0|||
25171968|NCT01606007|50309762|FG001|Overall Study|Reason 'Other' in the protocol|1|||
25171969|NCT01606007|50309763|FG002|Overall Study|Reason 'Other' in the protocol|1|||
25171970|NCT01606007|50309761|FG000|Overall Study|Pregnancy|0|||
25171971|NCT01606007|50309762|FG001|Overall Study|Pregnancy|1|||
25171972|NCT01606007|50309763|FG002|Overall Study|Pregnancy|1|||
25171973|NCT01606007|50309761|FG000|Overall Study|Withdrawal by Subject|8|||
25171974|NCT01606007|50309762|FG001|Overall Study|Withdrawal by Subject|6|||
25171975|NCT01606007|50309763|FG002|Overall Study|Withdrawal by Subject|1|||
25171976|NCT01606007|50309761|FG000|Overall Study|Adverse Event|0|||
25171977|NCT01606007|50309762|FG001|Overall Study|Adverse Event|1|||
25171978|NCT01606007|50309763|FG002|Overall Study|Adverse Event|1|||
25171979|NCT01606007|50309761|FG000|Overall Study|discontinue study treatment|0|||
25171980|NCT01606007|50309762|FG001|Overall Study|discontinue study treatment|2|||
25171981|NCT01606007|50309763|FG002|Overall Study|discontinue study treatment|1|||
25171982|NCT01606007|50309761|FG000|Overall Study|Lost to Follow-up|6|||
25171983|NCT01606007|50309762|FG001|Overall Study|Lost to Follow-up|8|||
25171984|NCT01606007|50309763|FG002|Overall Study|Lost to Follow-up|5|||
25171985|NCT01606007|50309761|FG000|Overall Study|Poor/Non-compliance|1|||
25171986|NCT01606007|50309762|FG001|Overall Study|Poor/Non-compliance|0|||
25171987|NCT01606007|50309763|FG002|Overall Study|Poor/Non-compliance|0|||
25171988|NCT01753193|50309842|FG000|Overall Study|Withdrawal by Subject|23|||
25171989|NCT01753193|50309842|FG000|Overall Study|Lost to Follow-up|6|||
25171990|NCT01753193|50309842|FG000|Overall Study|Death|1|||
25171991|NCT01753193|50309842|FG000|Overall Study|Other|16|||
25171992|NCT01727297|50309889|FG000|Overall Study|Death|13|||
25171993|NCT01727297|50309890|FG001|Overall Study|Death|0|||
25171994|NCT01727297|50309889|FG000|Overall Study|Protocol Violation|1|||
25171995|NCT01727297|50309890|FG001|Overall Study|Protocol Violation|10|||
25171996|NCT01727297|50309889|FG000|Overall Study|Adverse Event|3|||
25171997|NCT01727297|50309890|FG001|Overall Study|Adverse Event|1|||
25171998|NCT01727297|50309889|FG000|Overall Study|Lost to Follow-up|11|||
25171999|NCT01727297|50309890|FG001|Overall Study|Lost to Follow-up|0|||
25172000|NCT01727297|50309889|FG000|Overall Study|Withdrawal by Subject|26|||
25172001|NCT01727297|50309890|FG001|Overall Study|Withdrawal by Subject|27|||
25172002|NCT01727297|50309889|FG000|Overall Study|Physician Decision|19|||
25172003|NCT01727297|50309890|FG001|Overall Study|Physician Decision|5|||
25172004|NCT01727297|50309889|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
25172005|NCT01727297|50309890|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
25172006|NCT01753115|50309906|FG000|Overall Study|Lost to Follow-up|3|||
25172007|NCT01753115|50309907|FG001|Overall Study|Lost to Follow-up|6|||
25172008|NCT01753115|50309908|FG002|Overall Study|Lost to Follow-up|8|||
25172009|NCT01753115|50309906|FG000|Overall Study|Withdrawal by Subject|6|||
25172010|NCT01753115|50309907|FG001|Overall Study|Withdrawal by Subject|5|||
25172011|NCT01753115|50309908|FG002|Overall Study|Withdrawal by Subject|6|||
25172012|NCT01753115|50309906|FG000|Overall Study|Subject non-compliant|3|||
25172013|NCT01753115|50309907|FG001|Overall Study|Subject non-compliant|3|||
25172014|NCT01753115|50309908|FG002|Overall Study|Subject non-compliant|0|||
25172015|NCT01753115|50309906|FG000|Overall Study|Used excluded drug|0|||
25172016|NCT01753115|50309907|FG001|Overall Study|Used excluded drug|1|||
25172017|NCT01753115|50309908|FG002|Overall Study|Used excluded drug|0|||
25172018|NCT01727141|50309929|FG000|Overall Study|Physician Decision|0|||
25172019|NCT01727141|50309930|FG001|Overall Study|Physician Decision|1|||
25172020|NCT01727141|50309931|FG002|Overall Study|Physician Decision|0|||
25172021|NCT01727141|50309932|FG003|Overall Study|Physician Decision|2|||
25172022|NCT01727141|50309929|FG000|Overall Study|Lost to Follow-up|0|||
25172023|NCT01727141|50309930|FG001|Overall Study|Lost to Follow-up|2|||
25172024|NCT01727141|50309931|FG002|Overall Study|Lost to Follow-up|0|||
25172025|NCT01727141|50309932|FG003|Overall Study|Lost to Follow-up|0|||
25172026|NCT01727141|50309929|FG000|Overall Study|Death|0|||
25172027|NCT01727141|50309930|FG001|Overall Study|Death|1|||
25172028|NCT01727141|50309931|FG002|Overall Study|Death|1|||
25172029|NCT01727141|50309932|FG003|Overall Study|Death|1|||
25172030|NCT01727141|50309929|FG000|Overall Study|Protocol deviation|1|||
25172031|NCT01727141|50309930|FG001|Overall Study|Protocol deviation|1|||
25172032|NCT01727141|50309931|FG002|Overall Study|Protocol deviation|0|||
25172033|NCT01727141|50309932|FG003|Overall Study|Protocol deviation|1|||
25172034|NCT01727141|50309929|FG000|Overall Study|Withdrawal by Subject|4|||
25172035|NCT01727141|50309930|FG001|Overall Study|Withdrawal by Subject|4|||
25172036|NCT01727141|50309931|FG002|Overall Study|Withdrawal by Subject|2|||
25172037|NCT01727141|50309932|FG003|Overall Study|Withdrawal by Subject|11|||
25259888|NCT01020487|50574987|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
25259889|NCT01020487|50574985|FG000|Part 2 Open-label Period|Adverse Event|0|||
25259890|NCT01020487|50574986|FG001|Part 2 Open-label Period|Adverse Event|4|||
25259891|NCT01020487|50574987|FG002|Part 2 Open-label Period|Adverse Event|1|||
25259892|NCT01024855|50574997|FG000|Overall Study|Inclusion/exclusion criteria|1|||
25259893|NCT01014013|50575004|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
25259894|NCT01014013|50575005|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
25259895|NCT01014013|50575004|FG000|Overall Study|Clinical adverse experience|4|||
25259896|NCT01014013|50575005|FG001|Overall Study|Clinical adverse experience|2|||
25259897|NCT01014013|50575004|FG000|Overall Study|Laboratory adverse experience|1|||
25259898|NCT01014013|50575005|FG001|Overall Study|Laboratory adverse experience|1|||
25259899|NCT01014013|50575004|FG000|Overall Study|Protocol Violation|1|||
25259900|NCT01014013|50575005|FG001|Overall Study|Protocol Violation|3|||
25259901|NCT01014013|50575004|FG000|Overall Study|Withdrawal by Subject|7|||
25259902|NCT01014013|50575005|FG001|Overall Study|Withdrawal by Subject|4|||
25259903|NCT01014013|50575004|FG000|Overall Study|Clinical/microbiologic failure|1|||
25259904|NCT01014013|50575005|FG001|Overall Study|Clinical/microbiologic failure|2|||
25259905|NCT01014013|50575004|FG000|Overall Study|Pathogen culture = no growth|26|||
25259906|NCT01014013|50575005|FG001|Overall Study|Pathogen culture = no growth|34|||
25259907|NCT01014013|50575004|FG000|Overall Study|Negative urine culture|2|||
25259908|NCT01014013|50575005|FG001|Overall Study|Negative urine culture|0|||
25259909|NCT01014013|50575004|FG000|Overall Study|Pathogen resistant|7|||
25259910|NCT01014013|50575005|FG001|Overall Study|Pathogen resistant|4|||
25259911|NCT01014013|50575004|FG000|Overall Study|Physician Decision|0|||
25259912|NCT01014013|50575005|FG001|Overall Study|Physician Decision|1|||
25259913|NCT01014013|50575004|FG000|Overall Study|Another antibiotic therapy required|0|||
25259914|NCT01014013|50575005|FG001|Overall Study|Another antibiotic therapy required|1|||
25259915|NCT01014013|50575004|FG000|Overall Study|Appendectomy|1|||
25259916|NCT01014013|50575005|FG001|Overall Study|Appendectomy|0|||
25259917|NCT01014013|50575004|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
25259918|NCT01014013|50575005|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
25259919|NCT01013701|50575013|FG000|Overall Study|study prematurely terminated|7|||
25259920|NCT01020019|50575020|FG000|Overall Study|Lost to Follow-up|21|||
25259921|NCT01020019|50575021|FG001|Overall Study|Lost to Follow-up|18|||
25259922|NCT01020019|50575020|FG000|Overall Study|Adverse Event|1|||
25259923|NCT01020019|50575021|FG001|Overall Study|Adverse Event|5|||
25259924|NCT01020019|50575020|FG000|Overall Study|not interested in treatment|4|||
25259925|NCT01020019|50575021|FG001|Overall Study|not interested in treatment|4|||
25259926|NCT01020019|50575020|FG000|Overall Study|moving|0|||
25259927|NCT01020019|50575021|FG001|Overall Study|moving|2|||
25259928|NCT01024465|50575027|FG000|Overall Study|Adverse Event|2|||
25259929|NCT01024465|50575027|FG000|Overall Study|Physician Decision|1|||
25259930|NCT01024387|50575031|FG000|Overall Study|Radiographic Progression|29|||
25259931|NCT01024387|50575031|FG000|Overall Study|Symptomatic Progression|10|||
25259932|NCT01024387|50575031|FG000|Overall Study|Physician Decision|5|||
25259933|NCT01024387|50575031|FG000|Overall Study|Withdrawal by Subject|5|||
25259934|NCT01024387|50575031|FG000|Overall Study|Death|2|||
25259935|NCT01024387|50575031|FG000|Overall Study|Prolonged Treatment Delay|1|||
25259936|NCT01024387|50575031|FG000|Overall Study|Adverse Event|3|||
25259937|NCT01024387|50575031|FG000|Overall Study|Other|5|||
25259938|NCT01019317|50575035|FG000|Overall Study|Not Eligible|4|||
25259939|NCT01024309|50575041|FG000|Overall Study|Physician Decision|4|||
25259940|NCT01024309|50575042|FG001|Overall Study|Physician Decision|0|||
25259941|NCT01024309|50575041|FG000|Overall Study|Withdrawal by Subject|4|||
25259942|NCT01024309|50575042|FG001|Overall Study|Withdrawal by Subject|4|||
25259943|NCT01090492|50575056|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
25259944|NCT01090492|50575057|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
25259945|NCT01090492|50575058|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
25259946|NCT01090492|50575059|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
25259947|NCT01090492|50575060|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
25259948|NCT01090492|50575061|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
25259949|NCT01090492|50575062|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
25259950|NCT01090492|50575063|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
25259951|NCT01090492|50575056|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
25259952|NCT01090492|50575057|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
25259953|NCT01090492|50575058|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
25259954|NCT01090492|50575059|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
25259955|NCT01090492|50575060|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
25259956|NCT01090492|50575061|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
25259957|NCT01090492|50575062|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
25259958|NCT01090492|50575063|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
25259959|NCT01090492|50575056|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
25259960|NCT01090492|50575057|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
25259961|NCT01090492|50575058|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
25259962|NCT01090492|50575059|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
25259963|NCT01090492|50575060|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
25259964|NCT01090492|50575061|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
25259965|NCT01090492|50575062|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
25259966|NCT01090492|50575063|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
25259967|NCT01090492|50575056|FG000|First Intervention Period (4 Weeks)|Other|0|||
25259968|NCT01090492|50575057|FG001|First Intervention Period (4 Weeks)|Other|0|||
25259969|NCT01090492|50575058|FG002|First Intervention Period (4 Weeks)|Other|1|||
25259970|NCT01090492|50575059|FG003|First Intervention Period (4 Weeks)|Other|1|||
25259971|NCT01090492|50575060|FG004|First Intervention Period (4 Weeks)|Other|2|||
25259972|NCT01090492|50575061|FG005|First Intervention Period (4 Weeks)|Other|0|||
25259973|NCT01090492|50575062|FG006|First Intervention Period (4 Weeks)|Other|0|||
25259974|NCT01090492|50575063|FG007|First Intervention Period (4 Weeks)|Other|0|||
25259975|NCT01090492|50575056|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
25259976|NCT01090492|50575057|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
25259977|NCT01090492|50575058|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
25259978|NCT01090492|50575059|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
25259979|NCT01090492|50575060|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
25259980|NCT01090492|50575061|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
25259981|NCT01090492|50575062|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
25259982|NCT01090492|50575063|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
25259983|NCT01090492|50575056|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
25259984|NCT01090492|50575057|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
25259985|NCT01090492|50575058|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
25259986|NCT01090492|50575059|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
25259987|NCT01090492|50575060|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
25259988|NCT01090492|50575061|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
25259989|NCT01090492|50575062|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
25259990|NCT01090492|50575063|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
25259991|NCT01090492|50575056|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
25259992|NCT01090492|50575057|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
25259993|NCT01090492|50575058|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
25259994|NCT01090492|50575059|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
25259995|NCT01090492|50575060|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
25259996|NCT01090492|50575061|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
25259997|NCT01090492|50575062|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
25259998|NCT01090492|50575063|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
25259999|NCT01090492|50575056|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
25260000|NCT01090492|50575057|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
25260001|NCT01090492|50575058|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
25260002|NCT01090492|50575059|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
25260003|NCT01090492|50575060|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
25260004|NCT01090492|50575061|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
25260005|NCT01090492|50575062|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
25260006|NCT01090492|50575063|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
25260007|NCT01090492|50575056|FG000|Second Intervention Period (4 Weeks)|Other|0|||
25260008|NCT01090492|50575057|FG001|Second Intervention Period (4 Weeks)|Other|1|||
25260009|NCT01090492|50575058|FG002|Second Intervention Period (4 Weeks)|Other|1|||
25260010|NCT01090492|50575059|FG003|Second Intervention Period (4 Weeks)|Other|0|||
25260011|NCT01090492|50575060|FG004|Second Intervention Period (4 Weeks)|Other|0|||
25260012|NCT01090492|50575061|FG005|Second Intervention Period (4 Weeks)|Other|0|||
25260013|NCT01090492|50575062|FG006|Second Intervention Period (4 Weeks)|Other|0|||
25260014|NCT01090492|50575063|FG007|Second Intervention Period (4 Weeks)|Other|0|||
25260015|NCT01090492|50575056|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
25260016|NCT01090492|50575057|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
25260017|NCT01090492|50575058|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
25260018|NCT01090492|50575059|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
25260019|NCT01090492|50575060|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
25260020|NCT01090492|50575061|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
25260021|NCT01090492|50575062|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
25260022|NCT01090492|50575063|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
25260023|NCT01090492|50575056|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
25260024|NCT01090492|50575057|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
25260025|NCT01090492|50575058|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
25260026|NCT01090492|50575059|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
25260027|NCT01090492|50575060|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
25260028|NCT01090492|50575061|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
25260029|NCT01090492|50575062|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
25260030|NCT01090492|50575063|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
25260031|NCT01288911|50575084|FG000|Double-blind Period|Death|11|||
25260032|NCT01288911|50575085|FG001|Double-blind Period|Death|7|||
25260033|NCT01288911|50575084|FG000|Double-blind Period|Lost to Follow-up|0|||
25260034|NCT01288911|50575085|FG001|Double-blind Period|Lost to Follow-up|2|||
25260035|NCT01288911|50575084|FG000|Double-blind Period|Progressive Disease|75|||
25260036|NCT01288911|50575085|FG001|Double-blind Period|Progressive Disease|103|||
25260037|NCT01288911|50575084|FG000|Double-blind Period|Protocol Violation|1|||
25260038|NCT01288911|50575085|FG001|Double-blind Period|Protocol Violation|0|||
25260039|NCT01288911|50575084|FG000|Double-blind Period|Withdrawal by Subject|25|||
25260040|NCT01288911|50575085|FG001|Double-blind Period|Withdrawal by Subject|26|||
25260041|NCT01288911|50575084|FG000|Double-blind Period|Miscellaneous Reason|29|||
25260042|NCT01288911|50575085|FG001|Double-blind Period|Miscellaneous Reason|42|||
25260043|NCT01288911|50575084|FG000|Double-blind Period|Randomized but never received study drug|1|||
25260044|NCT01288911|50575085|FG001|Double-blind Period|Randomized but never received study drug|2|||
25260045|NCT01288911|50575084|FG000|Open-label Period (All Enzalutamide)|Death|0|||
25260046|NCT01288911|50575085|FG001|Open-label Period (All Enzalutamide)|Death|1|||
25260047|NCT01288911|50575084|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
25260048|NCT01288911|50575085|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
25260049|NCT01288911|50575084|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
25260050|NCT01288911|50575085|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
25260051|NCT01288911|50575084|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
25260052|NCT01288911|50575085|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
25260053|NCT01288911|50575084|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
25260054|NCT01288911|50575085|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
25260055|NCT01288911|50575084|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
25260056|NCT01288911|50575085|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
25260057|NCT01288443|50575100|FG000|Overall Study|Adverse Event|0|||
25260058|NCT01288443|50575101|FG001|Overall Study|Adverse Event|0|||
25260059|NCT01288443|50575102|FG002|Overall Study|Adverse Event|1|||
25260060|NCT01288443|50575103|FG003|Overall Study|Adverse Event|1|||
25260061|NCT01288443|50575104|FG004|Overall Study|Adverse Event|3|||
25260062|NCT01288443|50575105|FG005|Overall Study|Adverse Event|1|||
25260063|NCT01288443|50575100|FG000|Overall Study|Poor compliance to protocol|0|||
25260064|NCT01288443|50575101|FG001|Overall Study|Poor compliance to protocol|0|||
25260065|NCT01288443|50575102|FG002|Overall Study|Poor compliance to protocol|0|||
25260066|NCT01288443|50575103|FG003|Overall Study|Poor compliance to protocol|0|||
25260067|NCT01288443|50575104|FG004|Overall Study|Poor compliance to protocol|0|||
25260068|NCT01288443|50575105|FG005|Overall Study|Poor compliance to protocol|1|||
25260069|NCT01288443|50575100|FG000|Overall Study|Participant Moved|0|||
25260070|NCT01288443|50575101|FG001|Overall Study|Participant Moved|0|||
25260071|NCT01288443|50575102|FG002|Overall Study|Participant Moved|0|||
25260072|NCT01288443|50575103|FG003|Overall Study|Participant Moved|1|||
25260073|NCT01288443|50575104|FG004|Overall Study|Participant Moved|2|||
25260074|NCT01288443|50575105|FG005|Overall Study|Participant Moved|1|||
25260075|NCT01288443|50575100|FG000|Overall Study|Consent withdrawn by Participant|0|||
25260076|NCT01288443|50575101|FG001|Overall Study|Consent withdrawn by Participant|0|||
25260077|NCT01288443|50575102|FG002|Overall Study|Consent withdrawn by Participant|0|||
25260078|NCT01288443|50575103|FG003|Overall Study|Consent withdrawn by Participant|0|||
25260079|NCT01288443|50575104|FG004|Overall Study|Consent withdrawn by Participant|0|||
25260080|NCT01288443|50575105|FG005|Overall Study|Consent withdrawn by Participant|1|||
25260081|NCT01288443|50575100|FG000|Overall Study|Lost to Follow-up|0|||
25260082|NCT01288443|50575101|FG001|Overall Study|Lost to Follow-up|1|||
25260083|NCT01288443|50575102|FG002|Overall Study|Lost to Follow-up|0|||
25260084|NCT01288443|50575103|FG003|Overall Study|Lost to Follow-up|0|||
25260085|NCT01288443|50575104|FG004|Overall Study|Lost to Follow-up|0|||
25260086|NCT01288443|50575105|FG005|Overall Study|Lost to Follow-up|0|||
25260087|NCT01288443|50575100|FG000|Overall Study|Study drug auto-injector administration|0|||
25260088|NCT01288443|50575101|FG001|Overall Study|Study drug auto-injector administration|0|||
25260089|NCT01288443|50575102|FG002|Overall Study|Study drug auto-injector administration|0|||
25260090|NCT01288443|50575103|FG003|Overall Study|Study drug auto-injector administration|0|||
25260091|NCT01288443|50575104|FG004|Overall Study|Study drug auto-injector administration|1|||
25260092|NCT01288443|50575105|FG005|Overall Study|Study drug auto-injector administration|1|||
25260093|NCT01288443|50575100|FG000|Overall Study|Other than above|0|||
25260094|NCT01288443|50575101|FG001|Overall Study|Other than above|0|||
25260095|NCT01288443|50575102|FG002|Overall Study|Other than above|0|||
25260096|NCT01288443|50575103|FG003|Overall Study|Other than above|2|||
25260097|NCT01288443|50575104|FG004|Overall Study|Other than above|1|||
25260098|NCT01288443|50575105|FG005|Overall Study|Other than above|0|||
25260099|NCT01288287|50575119|FG000|Overall Study|Lost to Follow-up|8|||
25260100|NCT01288287|50575119|FG000|Overall Study|Withdrawal by Subject|4|||
25260101|NCT01288287|50575119|FG000|Overall Study|Lack of Efficacy|13|||
25260102|NCT01288287|50575119|FG000|Overall Study|Other Reason|13|||
25260103|NCT01288287|50575119|FG000|Overall Study|Unknown Reason|1|||
25260104|NCT01288287|50575119|FG000|Overall Study|Unknown Status|7|||
25260105|NCT01288209|50575126|FG000|Overall Study|Withdrawal by Subject|1|||
25260106|NCT01288209|50575127|FG001|Overall Study|Withdrawal by Subject|3|||
25260107|NCT01288209|50575126|FG000|Overall Study|Other|1|||
25260108|NCT01288209|50575127|FG001|Overall Study|Other|0|||
25260109|NCT01288053|50575133|FG000|Overall Study|Death|1|||
25260110|NCT01287195|50575137|FG000|Overall Study|Withdrawal by Subject|2|||
25260111|NCT01287117|50575145|FG000|Overall Study|Adverse Event|2|||
25260112|NCT01287117|50575146|FG001|Overall Study|Adverse Event|1|||
25260113|NCT01287117|50575147|FG002|Overall Study|Adverse Event|1|||
25260114|NCT01287117|50575148|FG003|Overall Study|Adverse Event|1|||
25260115|NCT01287117|50575145|FG000|Overall Study|Lost to Follow-up|1|||
25260116|NCT01287117|50575146|FG001|Overall Study|Lost to Follow-up|1|||
25260117|NCT01287117|50575147|FG002|Overall Study|Lost to Follow-up|0|||
25260118|NCT01287117|50575148|FG003|Overall Study|Lost to Follow-up|0|||
25260119|NCT01287117|50575145|FG000|Overall Study|Physician Decision|0|||
25260120|NCT01287117|50575146|FG001|Overall Study|Physician Decision|1|||
25260121|NCT01287117|50575147|FG002|Overall Study|Physician Decision|1|||
25260122|NCT01287117|50575148|FG003|Overall Study|Physician Decision|1|||
25260123|NCT01287117|50575145|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
25260124|NCT01287117|50575146|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
25260125|NCT01287117|50575147|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
25260126|NCT01287117|50575148|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
25260127|NCT01287117|50575145|FG000|Overall Study|Disease Progression|10|||
25260128|NCT01287117|50575146|FG001|Overall Study|Disease Progression|5|||
25260129|NCT01287117|50575147|FG002|Overall Study|Disease Progression|6|||
25260130|NCT01287117|50575148|FG003|Overall Study|Disease Progression|5|||
25260131|NCT01287039|50575160|FG000|Overall Study|Noncompliance with study procedures|0|||
25260132|NCT01287039|50575161|FG001|Overall Study|Noncompliance with study procedures|1|||
25260133|NCT01287039|50575160|FG000|Overall Study|Change of location/residence|0|||
25260134|NCT01287039|50575161|FG001|Overall Study|Change of location/residence|3|||
25260135|NCT01287039|50575160|FG000|Overall Study|Elective surgery|0|||
25260136|NCT01287039|50575161|FG001|Overall Study|Elective surgery|1|||
25260137|NCT01287039|50575160|FG000|Overall Study|Protocol Violation|2|||
25260138|NCT01287039|50575161|FG001|Overall Study|Protocol Violation|3|||
25260139|NCT01287039|50575160|FG000|Overall Study|Excluded medication taken|1|||
25260140|NCT01287039|50575161|FG001|Overall Study|Excluded medication taken|0|||
25260141|NCT01287039|50575160|FG000|Overall Study|Noncompliance with study medication|0|||
25260142|NCT01287039|50575161|FG001|Overall Study|Noncompliance with study medication|1|||
25260143|NCT01287039|50575160|FG000|Overall Study|Problem with travel|0|||
25260144|NCT01287039|50575161|FG001|Overall Study|Problem with travel|1|||
25260145|NCT01287039|50575160|FG000|Overall Study|Death|1|||
25260146|NCT01287039|50575161|FG001|Overall Study|Death|0|||
25260147|NCT01287039|50575160|FG000|Overall Study|Change of residence|1|||
25260148|NCT01287039|50575161|FG001|Overall Study|Change of residence|0|||
25260149|NCT01287039|50575160|FG000|Overall Study|Adverse Event|7|||
25260150|NCT01287039|50575161|FG001|Overall Study|Adverse Event|4|||
25260151|NCT01287039|50575160|FG000|Overall Study|Withdrawal by Subject|14|||
25260152|NCT01287039|50575161|FG001|Overall Study|Withdrawal by Subject|11|||
25260153|NCT01287039|50575160|FG000|Overall Study|Lost to Follow-up|3|||
25260154|NCT01287039|50575161|FG001|Overall Study|Lost to Follow-up|2|||
25260155|NCT01285401|50575169|FG000|Overall Study|Prematurely withdrawn from the study|17|||
25260156|NCT01285401|50575170|FG001|Overall Study|Prematurely withdrawn from the study|29|||
25260157|NCT01285323|50575178|FG000|Overall Study|Adverse Event|9|||
25260158|NCT01285323|50575179|FG001|Overall Study|Adverse Event|8|||
25260159|NCT01285323|50575178|FG000|Overall Study|Lack of Efficacy|4|||
25260160|NCT01285323|50575179|FG001|Overall Study|Lack of Efficacy|2|||
25260161|NCT01285323|50575178|FG000|Overall Study|Withdrawal by Subject|15|||
25260162|NCT01285323|50575179|FG001|Overall Study|Withdrawal by Subject|11|||
25260163|NCT01285323|50575178|FG000|Overall Study|Protocol Violation|1|||
25260164|NCT01285323|50575179|FG001|Overall Study|Protocol Violation|2|||
25260165|NCT01285323|50575178|FG000|Overall Study|Non-compliance with study procedures|2|||
25260166|NCT01285323|50575179|FG001|Overall Study|Non-compliance with study procedures|3|||
25260167|NCT01285323|50575178|FG000|Overall Study|Lost to Follow-up|1|||
25260168|NCT01285323|50575179|FG001|Overall Study|Lost to Follow-up|1|||
25260169|NCT01285323|50575178|FG000|Overall Study|Other|1|||
25260170|NCT01285323|50575179|FG001|Overall Study|Other|3|||
25260171|NCT01284621|50575185|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
25260172|NCT01284621|50575186|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
25260173|NCT01284621|50575187|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
25260174|NCT01284621|50575188|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
25260175|NCT01284621|50575189|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
25260176|NCT01284621|50575190|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
25260177|NCT01283139|50575204|FG000|Overall Study|Lost to Follow-up|5|||
25260178|NCT01283139|50575205|FG001|Overall Study|Lost to Follow-up|2|||
25260179|NCT01283139|50575206|FG002|Overall Study|Lost to Follow-up|3|||
25260180|NCT01283139|50575207|FG003|Overall Study|Lost to Follow-up|1|||
25260181|NCT01283139|50575204|FG000|Overall Study|Withdrawal by Subject|8|||
25260182|NCT01283139|50575205|FG001|Overall Study|Withdrawal by Subject|8|||
25260183|NCT01283139|50575206|FG002|Overall Study|Withdrawal by Subject|6|||
25260184|NCT01283139|50575207|FG003|Overall Study|Withdrawal by Subject|8|||
25260185|NCT01283139|50575204|FG000|Overall Study|Death|2|||
25260186|NCT01283139|50575205|FG001|Overall Study|Death|0|||
25260187|NCT01283139|50575206|FG002|Overall Study|Death|2|||
25260188|NCT01283139|50575207|FG003|Overall Study|Death|2|||
25260189|NCT01283139|50575204|FG000|Overall Study|Lack of Efficacy|1|||
25260190|NCT01283139|50575205|FG001|Overall Study|Lack of Efficacy|2|||
25260191|NCT01283139|50575206|FG002|Overall Study|Lack of Efficacy|2|||
25260192|NCT01283139|50575207|FG003|Overall Study|Lack of Efficacy|1|||
25260193|NCT01283139|50575204|FG000|Overall Study|Early termination due to AE/SAE|1|||
25260194|NCT01283139|50575205|FG001|Overall Study|Early termination due to AE/SAE|1|||
25260195|NCT01283139|50575206|FG002|Overall Study|Early termination due to AE/SAE|0|||
25260196|NCT01283139|50575207|FG003|Overall Study|Early termination due to AE/SAE|0|||
25260197|NCT01283139|50575204|FG000|Overall Study|Participant's refusal to continue|0|||
25260198|NCT01283139|50575205|FG001|Overall Study|Participant's refusal to continue|3|||
25260199|NCT01283139|50575206|FG002|Overall Study|Participant's refusal to continue|1|||
25260200|NCT01283139|50575207|FG003|Overall Study|Participant's refusal to continue|1|||
25260201|NCT01283139|50575204|FG000|Overall Study|Pregnancy|0|||
25260202|NCT01283139|50575205|FG001|Overall Study|Pregnancy|1|||
25260203|NCT01283139|50575206|FG002|Overall Study|Pregnancy|1|||
25260204|NCT01283139|50575207|FG003|Overall Study|Pregnancy|0|||
25260205|NCT01283139|50575204|FG000|Overall Study|Missed follow-up visit|0|||
25260206|NCT01283139|50575205|FG001|Overall Study|Missed follow-up visit|1|||
25260207|NCT01283139|50575206|FG002|Overall Study|Missed follow-up visit|2|||
25260208|NCT01283139|50575207|FG003|Overall Study|Missed follow-up visit|2|||
25260209|NCT01283139|50575204|FG000|Overall Study|Participant randomized in error|0|||
25260210|NCT01283139|50575205|FG001|Overall Study|Participant randomized in error|0|||
25260211|NCT01283139|50575206|FG002|Overall Study|Participant randomized in error|1|||
25260212|NCT01283139|50575207|FG003|Overall Study|Participant randomized in error|0|||
25260213|NCT01282203|50575217|FG000|Overall Study|Adverse Event|1|||
25260214|NCT01281969|50575226|FG000|Overall Study|not randomized didn't meet criteria|0|||
25260215|NCT01281969|50575227|FG001|Overall Study|not randomized didn't meet criteria|0|||
25260216|NCT01281969|50575228|FG002|Overall Study|not randomized didn't meet criteria|7|||
25260217|NCT01281969|50575226|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
25260218|NCT01281969|50575227|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
25260219|NCT01281969|50575228|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
25260220|NCT01281969|50575226|FG000|Overall Study|not randomized, child consent not given|0|||
25260221|NCT01281969|50575227|FG001|Overall Study|not randomized, child consent not given|0|||
25260222|NCT01281969|50575228|FG002|Overall Study|not randomized, child consent not given|2|||
25260223|NCT01281813|50575239|FG000|Overall Study|Adverse Event|0|||
25260224|NCT01281813|50575240|FG001|Overall Study|Adverse Event|0|||
25260225|NCT01281813|50575241|FG002|Overall Study|Adverse Event|10|||
25260226|NCT01281813|50575239|FG000|Overall Study|Lost to Follow-up|0|||
25260227|NCT01281813|50575240|FG001|Overall Study|Lost to Follow-up|0|||
25260228|NCT01281813|50575241|FG002|Overall Study|Lost to Follow-up|31|||
25260229|NCT01281813|50575239|FG000|Overall Study|Withdrawal by Subject|0|||
25260230|NCT01281813|50575240|FG001|Overall Study|Withdrawal by Subject|0|||
25260231|NCT01281813|50575241|FG002|Overall Study|Withdrawal by Subject|13|||
25260232|NCT01281813|50575239|FG000|Overall Study|Subject Non-Compliant|0|||
25260233|NCT01281813|50575240|FG001|Overall Study|Subject Non-Compliant|0|||
25260234|NCT01281813|50575241|FG002|Overall Study|Subject Non-Compliant|6|||
25260235|NCT01281813|50575239|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
25260236|NCT01281813|50575240|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
25260237|NCT01281813|50575241|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
25260238|NCT01281813|50575239|FG000|Overall Study|Sponsor's Decision|4|||
25260239|NCT01281813|50575240|FG001|Overall Study|Sponsor's Decision|3|||
25260240|NCT01281813|50575241|FG002|Overall Study|Sponsor's Decision|7|||
25260241|NCT01281813|50575239|FG000|Overall Study|Switched to Commercially Available Medication|0|||
25260242|NCT01281813|50575240|FG001|Overall Study|Switched to Commercially Available Medication|0|||
25260243|NCT01281813|50575241|FG002|Overall Study|Switched to Commercially Available Medication|26|||
25260244|NCT01281813|50575239|FG000|Overall Study|Other|0|||
25260245|NCT01281813|50575240|FG001|Overall Study|Other|1|||
25260246|NCT01281813|50575241|FG002|Overall Study|Other|39|||
25260247|NCT01090414|50575253|FG000|Study 101-99|Progressive Disease|28|||
25260248|NCT01090414|50575254|FG001|Study 101-99|Progressive Disease|48|||
25260249|NCT01090414|50575255|FG002|Study 101-99|Progressive Disease|10|||
25260250|NCT01090414|50575256|FG003|Study 101-99|Progressive Disease|4|||
25260251|NCT01090414|50575253|FG000|Study 101-99|Adverse Event|10|||
25260252|NCT01090414|50575254|FG001|Study 101-99|Adverse Event|28|||
25260253|NCT01090414|50575255|FG002|Study 101-99|Adverse Event|18|||
25260254|NCT01090414|50575256|FG003|Study 101-99|Adverse Event|0|||
25260255|NCT01090414|50575253|FG000|Study 101-99|Investigator Request|1|||
25260256|NCT01090414|50575254|FG001|Study 101-99|Investigator Request|11|||
25260257|NCT01090414|50575255|FG002|Study 101-99|Investigator Request|4|||
25260258|NCT01090414|50575256|FG003|Study 101-99|Investigator Request|0|||
25260259|NCT01090414|50575253|FG000|Study 101-99|Death|3|||
25260260|NCT01090414|50575254|FG001|Study 101-99|Death|8|||
25260261|NCT01090414|50575255|FG002|Study 101-99|Death|1|||
25260262|NCT01090414|50575256|FG003|Study 101-99|Death|0|||
25260263|NCT01090414|50575253|FG000|Study 101-99|Sponsor Discontinued Study|0|||
25260264|NCT01090414|50575254|FG001|Study 101-99|Sponsor Discontinued Study|7|||
25260265|NCT01090414|50575255|FG002|Study 101-99|Sponsor Discontinued Study|5|||
25260266|NCT01090414|50575256|FG003|Study 101-99|Sponsor Discontinued Study|0|||
25260267|NCT01090414|50575253|FG000|Study 101-99|Other (Unknown Reasons)|3|||
25260268|NCT01090414|50575254|FG001|Study 101-99|Other (Unknown Reasons)|3|||
25260269|NCT01090414|50575255|FG002|Study 101-99|Other (Unknown Reasons)|0|||
25260270|NCT01090414|50575256|FG003|Study 101-99|Other (Unknown Reasons)|0|||
25260271|NCT01090414|50575253|FG000|Study 101-99|Withdrew Consent|0|||
25260272|NCT01090414|50575254|FG001|Study 101-99|Withdrew Consent|2|||
25260273|NCT01090414|50575255|FG002|Study 101-99|Withdrew Consent|3|||
25260274|NCT01090414|50575256|FG003|Study 101-99|Withdrew Consent|1|||
25260275|NCT01090414|50575253|FG000|Study 101-99|Participant Request|3|||
25260276|NCT01090414|50575254|FG001|Study 101-99|Participant Request|1|||
25260277|NCT01090414|50575255|FG002|Study 101-99|Participant Request|0|||
25260278|NCT01090414|50575256|FG003|Study 101-99|Participant Request|0|||
25260279|NCT01090102|50575280|FG000|First 12 Weeks|Withdrawal by Subject|1|||
25260280|NCT01090102|50575281|FG001|First 12 Weeks|Withdrawal by Subject|1|||
25260281|NCT01090102|50575280|FG000|First 12 Weeks|Adverse Event|2|||
25260282|NCT01090102|50575281|FG001|First 12 Weeks|Adverse Event|0|||
25260283|NCT01090102|50575280|FG000|First 12 Weeks|Death|1|||
25260284|NCT01090102|50575281|FG001|First 12 Weeks|Death|1|||
25260285|NCT01090102|50575280|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
25260286|NCT01090102|50575281|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
25260287|NCT01287897|50575291|FG000|Overall Study|Adverse Event|5|||
25260288|NCT01287897|50575292|FG001|Overall Study|Adverse Event|3|||
25260289|NCT01287897|50575293|FG002|Overall Study|Adverse Event|6|||
25260290|NCT01287897|50575294|FG003|Overall Study|Adverse Event|4|||
25260291|NCT01287897|50575291|FG000|Overall Study|Lack of Efficacy|2|||
25260292|NCT01287897|50575292|FG001|Overall Study|Lack of Efficacy|0|||
25260293|NCT01287897|50575293|FG002|Overall Study|Lack of Efficacy|0|||
25260294|NCT01287897|50575294|FG003|Overall Study|Lack of Efficacy|0|||
25260295|NCT01287897|50575291|FG000|Overall Study|Protocol Violation|1|||
25260296|NCT01287897|50575292|FG001|Overall Study|Protocol Violation|1|||
25260297|NCT01287897|50575293|FG002|Overall Study|Protocol Violation|0|||
25260298|NCT01287897|50575294|FG003|Overall Study|Protocol Violation|1|||
25260299|NCT01287897|50575291|FG000|Overall Study|Lost to Follow-up|0|||
25260300|NCT01287897|50575292|FG001|Overall Study|Lost to Follow-up|0|||
25260301|NCT01287897|50575293|FG002|Overall Study|Lost to Follow-up|2|||
25260302|NCT01287897|50575294|FG003|Overall Study|Lost to Follow-up|0|||
25260303|NCT01287897|50575291|FG000|Overall Study|Withdrawal by Subject|1|||
25260304|NCT01287897|50575292|FG001|Overall Study|Withdrawal by Subject|5|||
25260305|NCT01287897|50575293|FG002|Overall Study|Withdrawal by Subject|3|||
25260306|NCT01287897|50575294|FG003|Overall Study|Withdrawal by Subject|2|||
25260307|NCT01287897|50575291|FG000|Overall Study|Not consented properly|0|||
25260308|NCT01287897|50575292|FG001|Overall Study|Not consented properly|1|||
25260309|NCT01287897|50575293|FG002|Overall Study|Not consented properly|0|||
25260310|NCT01287897|50575294|FG003|Overall Study|Not consented properly|0|||
25260311|NCT01287897|50575291|FG000|Overall Study|Not meeting entrance criteria|1|||
25260312|NCT01287897|50575292|FG001|Overall Study|Not meeting entrance criteria|1|||
25260313|NCT01287897|50575293|FG002|Overall Study|Not meeting entrance criteria|0|||
25260314|NCT01287897|50575294|FG003|Overall Study|Not meeting entrance criteria|0|||
25260315|NCT01287897|50575291|FG000|Overall Study|Other|1|||
25260316|NCT01287897|50575292|FG001|Overall Study|Other|0|||
25260317|NCT01287897|50575293|FG002|Overall Study|Other|1|||
25260318|NCT01287897|50575294|FG003|Overall Study|Other|0|||
25260319|NCT01090024|50575308|FG000|Period 1|Met exclusion criteria|0|||
25260320|NCT01090024|50575309|FG001|Period 1|Met exclusion criteria|0|||
25260321|NCT01090024|50575310|FG002|Period 1|Met exclusion criteria|0|||
25260322|NCT01090024|50575311|FG003|Period 1|Met exclusion criteria|0|||
25260323|NCT01090024|50575312|FG004|Period 1|Met exclusion criteria|0|||
25082540|NCT02001623|50191225|FG006|Overall Study|Lost to Follow-up|0|||
25260324|NCT01090024|50575313|FG005|Period 1|Met exclusion criteria|0|||
25260325|NCT01090024|50575314|FG006|Period 1|Met exclusion criteria|0|||
25260326|NCT01090024|50575315|FG007|Period 1|Met exclusion criteria|0|||
25260327|NCT01090024|50575316|FG008|Period 1|Met exclusion criteria|0|||
25260328|NCT01090024|50575317|FG009|Period 1|Met exclusion criteria|0|||
25260329|NCT01090024|50575318|FG010|Period 1|Met exclusion criteria|0|||
25260330|NCT01090024|50575319|FG011|Period 1|Met exclusion criteria|0|||
25260331|NCT01090024|50575320|FG012|Period 1|Met exclusion criteria|0|||
25260332|NCT01090024|50575321|FG013|Period 1|Met exclusion criteria|0|||
25260333|NCT01090024|50575322|FG014|Period 1|Met exclusion criteria|1|||
25260334|NCT01090024|50575323|FG015|Period 1|Met exclusion criteria|0|||
25260335|NCT01090024|50575324|FG016|Period 1|Met exclusion criteria|0|||
25260336|NCT01090024|50575325|FG017|Period 1|Met exclusion criteria|0|||
25260337|NCT01090024|50575308|FG000|Period 1|Adverse Event|0|||
25260338|NCT01090024|50575309|FG001|Period 1|Adverse Event|0|||
25260339|NCT01090024|50575310|FG002|Period 1|Adverse Event|0|||
25260340|NCT01090024|50575311|FG003|Period 1|Adverse Event|0|||
25260341|NCT01090024|50575312|FG004|Period 1|Adverse Event|0|||
25260342|NCT01090024|50575313|FG005|Period 1|Adverse Event|0|||
25260343|NCT01090024|50575314|FG006|Period 1|Adverse Event|0|||
25260344|NCT01090024|50575315|FG007|Period 1|Adverse Event|0|||
25260345|NCT01090024|50575316|FG008|Period 1|Adverse Event|0|||
25260346|NCT01090024|50575317|FG009|Period 1|Adverse Event|1|||
25260347|NCT01090024|50575318|FG010|Period 1|Adverse Event|0|||
25260348|NCT01090024|50575319|FG011|Period 1|Adverse Event|1|||
25260349|NCT01090024|50575320|FG012|Period 1|Adverse Event|0|||
25260350|NCT01090024|50575321|FG013|Period 1|Adverse Event|0|||
25260351|NCT01090024|50575322|FG014|Period 1|Adverse Event|0|||
25260352|NCT01090024|50575323|FG015|Period 1|Adverse Event|0|||
25260353|NCT01090024|50575324|FG016|Period 1|Adverse Event|0|||
25260354|NCT01090024|50575325|FG017|Period 1|Adverse Event|1|||
25260355|NCT01090024|50575308|FG000|Period 1|Withdrawal by Subject|0|||
25260356|NCT01090024|50575309|FG001|Period 1|Withdrawal by Subject|0|||
25260357|NCT01090024|50575310|FG002|Period 1|Withdrawal by Subject|0|||
25260358|NCT01090024|50575311|FG003|Period 1|Withdrawal by Subject|1|||
25260359|NCT01090024|50575312|FG004|Period 1|Withdrawal by Subject|0|||
25260360|NCT01090024|50575313|FG005|Period 1|Withdrawal by Subject|0|||
25260361|NCT01090024|50575314|FG006|Period 1|Withdrawal by Subject|0|||
25260362|NCT01090024|50575315|FG007|Period 1|Withdrawal by Subject|0|||
25260363|NCT01090024|50575316|FG008|Period 1|Withdrawal by Subject|0|||
25260364|NCT01090024|50575317|FG009|Period 1|Withdrawal by Subject|0|||
25260365|NCT01090024|50575318|FG010|Period 1|Withdrawal by Subject|0|||
25260366|NCT01090024|50575319|FG011|Period 1|Withdrawal by Subject|0|||
25260367|NCT01090024|50575320|FG012|Period 1|Withdrawal by Subject|0|||
25260368|NCT01090024|50575321|FG013|Period 1|Withdrawal by Subject|0|||
25260369|NCT01090024|50575322|FG014|Period 1|Withdrawal by Subject|0|||
25260370|NCT01090024|50575323|FG015|Period 1|Withdrawal by Subject|0|||
25260371|NCT01090024|50575324|FG016|Period 1|Withdrawal by Subject|0|||
25260372|NCT01090024|50575325|FG017|Period 1|Withdrawal by Subject|0|||
25260373|NCT01090024|50575308|FG000|Period 1|Lost to Follow-up|0|||
25260374|NCT01090024|50575309|FG001|Period 1|Lost to Follow-up|1|||
25260375|NCT01090024|50575310|FG002|Period 1|Lost to Follow-up|0|||
25260376|NCT01090024|50575311|FG003|Period 1|Lost to Follow-up|0|||
25260377|NCT01090024|50575312|FG004|Period 1|Lost to Follow-up|0|||
25260378|NCT01090024|50575313|FG005|Period 1|Lost to Follow-up|0|||
25260379|NCT01090024|50575314|FG006|Period 1|Lost to Follow-up|0|||
25260380|NCT01090024|50575315|FG007|Period 1|Lost to Follow-up|0|||
25260381|NCT01090024|50575316|FG008|Period 1|Lost to Follow-up|0|||
24995087|NCT00048165|50085941|FG001|Completed 6 Months Study|Did not receive study drug|6|||
24995088|NCT00048165|50085940|FG000|Completed 12 Months Study|Administration/Other|0|||
24995089|NCT00048165|50085941|FG001|Completed 12 Months Study|Administration/Other|2|||
24995090|NCT00048165|50085940|FG000|Completed 12 Months Study|Death|2|||
24995091|NCT00048165|50085941|FG001|Completed 12 Months Study|Death|1|||
24995092|NCT00048165|50085940|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
24995093|NCT00048165|50085941|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
24995094|NCT00059787|50085949|FG000|Overall Study|Adverse Event|13|||
24995095|NCT00059787|50085949|FG000|Overall Study|disease progression|2|||
24995096|NCT00059787|50085949|FG000|Overall Study|ineligible|1|||
24995097|NCT00059787|50085949|FG000|Overall Study|Other|4|||
24995098|NCT00058539|50085954|FG000|Overall Study|Disease progression|24|||
24995099|NCT00058539|50085954|FG000|Overall Study|Adverse Event|3|||
24995100|NCT00058539|50085954|FG000|Overall Study|Withdrawal by Subject|5|||
24995101|NCT00058539|50085954|FG000|Overall Study|Physician Decision|9|||
24995102|NCT00058539|50085954|FG000|Overall Study|Death|1|||
24995103|NCT03015532|50085966|FG000|Overall Study|Adverse Event|0|||
24995104|NCT03015532|50085967|FG001|Overall Study|Adverse Event|0|||
24995105|NCT03015532|50085968|FG002|Overall Study|Adverse Event|0|||
24995106|NCT03015532|50085969|FG003|Overall Study|Adverse Event|0|||
24995107|NCT03015532|50085970|FG004|Overall Study|Adverse Event|0|||
25260382|NCT01090024|50575317|FG009|Period 1|Lost to Follow-up|0|||
25260383|NCT01090024|50575318|FG010|Period 1|Lost to Follow-up|0|||
25260384|NCT01090024|50575319|FG011|Period 1|Lost to Follow-up|0|||
25260385|NCT01090024|50575320|FG012|Period 1|Lost to Follow-up|0|||
25260386|NCT01090024|50575321|FG013|Period 1|Lost to Follow-up|0|||
25082541|NCT02001623|50191226|FG007|Overall Study|Lost to Follow-up|0|||
25082542|NCT02001623|50191227|FG008|Overall Study|Lost to Follow-up|0|||
25082543|NCT02001623|50191228|FG009|Overall Study|Lost to Follow-up|1|||
25082544|NCT02001623|50191229|FG010|Overall Study|Lost to Follow-up|0|||
25082545|NCT02001623|50191230|FG011|Overall Study|Lost to Follow-up|0|||
25082546|NCT02001623|50191231|FG012|Overall Study|Lost to Follow-up|0|||
25082547|NCT02001623|50191232|FG013|Overall Study|Lost to Follow-up|0|||
25082548|NCT02001623|50191233|FG014|Overall Study|Lost to Follow-up|0|||
25082549|NCT02001623|50191219|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
25082550|NCT02001623|50191220|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
25082551|NCT02001623|50191221|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
25082552|NCT02001623|50191222|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
25082553|NCT02001623|50191223|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
25082554|NCT02001623|50191224|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
25082555|NCT02001623|50191225|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
25082556|NCT02001623|50191226|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
25082557|NCT02001623|50191227|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
25082558|NCT02001623|50191228|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
25082559|NCT02001623|50191229|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
25082560|NCT02001623|50191230|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
25082561|NCT02001623|50191231|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
25082562|NCT02001623|50191232|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
25082563|NCT02001623|50191233|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
25082564|NCT02001623|50191219|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
25082565|NCT02001623|50191220|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
25082566|NCT02001623|50191221|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
25082567|NCT02001623|50191222|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
25082568|NCT02001623|50191223|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
25082569|NCT02001623|50191224|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
25082570|NCT02001623|50191225|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
25082571|NCT02001623|50191226|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
25082572|NCT02001623|50191227|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
25082573|NCT02001623|50191228|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
25082574|NCT02001623|50191229|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
25082575|NCT02001623|50191230|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
25082576|NCT02001623|50191231|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
25082577|NCT02001623|50191232|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
25082578|NCT02001623|50191233|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
25082579|NCT02713867|50191284|FG000|Randomization|Other Reason|2|||
25082580|NCT02713867|50191285|FG001|Randomization|Other Reason|1|||
25082581|NCT02713867|50191284|FG000|Randomization|Participant Withdrew consent|0|||
25082582|NCT02713867|50191285|FG001|Randomization|Participant Withdrew consent|2|||
25082583|NCT02713867|50191284|FG000|Treatment Period|Other Reasons|22|||
25082584|NCT02713867|50191285|FG001|Treatment Period|Other Reasons|28|||
25082585|NCT02713867|50191284|FG000|Treatment Period|Administrative reason by sponsor|21|||
25082586|NCT02713867|50191285|FG001|Treatment Period|Administrative reason by sponsor|16|||
25082587|NCT02713867|50191284|FG000|Treatment Period|No longer meets study criteria|2|||
25082588|NCT02713867|50191285|FG001|Treatment Period|No longer meets study criteria|1|||
25082589|NCT02713867|50191284|FG000|Treatment Period|Poor/Non Compliance|1|||
25082590|NCT02713867|50191285|FG001|Treatment Period|Poor/Non Compliance|0|||
25082591|NCT02713867|50191284|FG000|Treatment Period|Maximum Clinical Benefit|5|||
25082592|NCT02713867|50191285|FG001|Treatment Period|Maximum Clinical Benefit|6|||
25082593|NCT02713867|50191284|FG000|Treatment Period|Withdrew consent|3|||
25082594|NCT02713867|50191285|FG001|Treatment Period|Withdrew consent|6|||
25082595|NCT02713867|50191284|FG000|Treatment Period|Requested to Discontinue|8|||
25082596|NCT02713867|50191285|FG001|Treatment Period|Requested to Discontinue|8|||
25082597|NCT02713867|50191284|FG000|Treatment Period|AE unrelated to Study Drug|11|||
25082598|NCT02713867|50191285|FG001|Treatment Period|AE unrelated to Study Drug|10|||
25082599|NCT02713867|50191284|FG000|Treatment Period|Death|7|||
25082600|NCT02713867|50191285|FG001|Treatment Period|Death|3|||
25082601|NCT02713867|50191284|FG000|Treatment Period|Study Drug Toxicity|16|||
25082602|NCT02713867|50191285|FG001|Treatment Period|Study Drug Toxicity|19|||
25082603|NCT02713867|50191284|FG000|Treatment Period|Disease Progression|82|||
25082604|NCT02713867|50191285|FG001|Treatment Period|Disease Progression|83|||
25082605|NCT01854775|50191294|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
25082606|NCT01854775|50191295|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
25082607|NCT01854775|50191296|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
25082608|NCT01854775|50191294|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
25082609|NCT01854775|50191295|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
25082610|NCT01854775|50191296|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
25082611|NCT01854775|50191294|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
25082612|NCT01854775|50191295|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
25082613|NCT01854775|50191296|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
25082614|NCT01854775|50191294|FG000|Extension Phase|Pregnancy|3|||
25082615|NCT01854775|50191295|FG001|Extension Phase|Pregnancy|0|||
25082616|NCT01854775|50191296|FG002|Extension Phase|Pregnancy|0|||
25082617|NCT01854775|50191294|FG000|Extension Phase|Investigator's Discretion|1|||
25082618|NCT01854775|50191295|FG001|Extension Phase|Investigator's Discretion|0|||
25082619|NCT01854775|50191296|FG002|Extension Phase|Investigator's Discretion|0|||
25082620|NCT01854775|50191294|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
25082621|NCT01854775|50191295|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
25082622|NCT01854775|50191296|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
25082623|NCT01854775|50191294|FG000|Extension Phase|Lost to Follow-up|2|||
25082624|NCT01854775|50191295|FG001|Extension Phase|Lost to Follow-up|0|||
25082625|NCT01854775|50191296|FG002|Extension Phase|Lost to Follow-up|0|||
25082626|NCT01854775|50191294|FG000|Extension Phase|Still on Study|32|||
25082627|NCT01854775|50191295|FG001|Extension Phase|Still on Study|47|||
25082628|NCT01854775|50191296|FG002|Extension Phase|Still on Study|18|||
25082629|NCT02730455|50191307|FG000|Overall Study|Death|5|||
25082630|NCT02730455|50191308|FG001|Overall Study|Death|6|||
25082631|NCT02730455|50191309|FG002|Overall Study|Death|4|||
25082632|NCT02730455|50191307|FG000|Overall Study|Consent withdrawn|2|||
25082633|NCT02730455|50191308|FG001|Overall Study|Consent withdrawn|4|||
25082634|NCT02730455|50191309|FG002|Overall Study|Consent withdrawn|1|||
25082635|NCT02730455|50191307|FG000|Overall Study|Lost to Follow-up|3|||
25082636|NCT02730455|50191308|FG001|Overall Study|Lost to Follow-up|1|||
25082637|NCT02730455|50191309|FG002|Overall Study|Lost to Follow-up|4|||
25082638|NCT02730455|50191307|FG000|Overall Study|Other|1|||
25082639|NCT02730455|50191308|FG001|Overall Study|Other|1|||
25082640|NCT02730455|50191309|FG002|Overall Study|Other|2|||
25082641|NCT02730455|50191307|FG000|Overall Study|Other|2|||
25082642|NCT02730455|50191308|FG001|Overall Study|Other|2|||
25082643|NCT02730455|50191309|FG002|Overall Study|Other|0|||
25082644|NCT04440449|50191319|FG000|Overall Study|Lost to Follow-up|2|||
25082645|NCT04440449|50191320|FG001|Overall Study|Lost to Follow-up|0|||
25082646|NCT00701311|50191327|FG000|Overall Study|Lack of Efficacy|3|||
25082647|NCT00701311|50191327|FG000|Overall Study|Adverse Event|3|||
25082648|NCT00701311|50191327|FG000|Overall Study|Withdrawal by Subject|2|||
25082649|NCT02730377|50191337|FG000|Overall Study|Other|5|||
25082650|NCT02730377|50191338|FG001|Overall Study|Other|4|||
25082651|NCT02730377|50191337|FG000|Overall Study|Death|1|||
25082652|NCT02730377|50191338|FG001|Overall Study|Death|8|||
25082653|NCT02730377|50191337|FG000|Overall Study|Inadequate glycaemic control|368|||
25082654|NCT02730377|50191338|FG001|Overall Study|Inadequate glycaemic control|473|||
25082655|NCT02730377|50191337|FG000|Overall Study|Adverse Event|79|||
25082656|NCT02730377|50191338|FG001|Overall Study|Adverse Event|41|||
25082657|NCT02730377|50191337|FG000|Overall Study|Protocol Violation|23|||
25082658|NCT02730377|50191338|FG001|Overall Study|Protocol Violation|30|||
25082659|NCT02730377|50191337|FG000|Overall Study|Lack of Efficacy|4|||
25082660|NCT02730377|50191338|FG001|Overall Study|Lack of Efficacy|13|||
25082661|NCT02730377|50191337|FG000|Overall Study|Pregnancy|0|||
25082662|NCT02730377|50191338|FG001|Overall Study|Pregnancy|1|||
25082663|NCT02730377|50191337|FG000|Overall Study|Withdrawal by Subject|45|||
25260387|NCT01090024|50575322|FG014|Period 1|Lost to Follow-up|0|||
25260388|NCT01090024|50575323|FG015|Period 1|Lost to Follow-up|0|||
25260389|NCT01090024|50575324|FG016|Period 1|Lost to Follow-up|0|||
25260390|NCT01090024|50575325|FG017|Period 1|Lost to Follow-up|0|||
25260391|NCT01090024|50575308|FG000|Period 2|Lost to Follow-up|0|||
25260392|NCT01090024|50575309|FG001|Period 2|Lost to Follow-up|0|||
25260393|NCT01090024|50575310|FG002|Period 2|Lost to Follow-up|0|||
25260394|NCT01090024|50575311|FG003|Period 2|Lost to Follow-up|1|||
25260395|NCT01090024|50575312|FG004|Period 2|Lost to Follow-up|0|||
25260396|NCT01090024|50575313|FG005|Period 2|Lost to Follow-up|0|||
25260397|NCT01090024|50575314|FG006|Period 2|Lost to Follow-up|0|||
25260398|NCT01090024|50575315|FG007|Period 2|Lost to Follow-up|0|||
25260399|NCT01090024|50575316|FG008|Period 2|Lost to Follow-up|0|||
25260400|NCT01090024|50575317|FG009|Period 2|Lost to Follow-up|0|||
25260401|NCT01090024|50575318|FG010|Period 2|Lost to Follow-up|0|||
25260402|NCT01090024|50575319|FG011|Period 2|Lost to Follow-up|0|||
25260403|NCT01090024|50575320|FG012|Period 2|Lost to Follow-up|0|||
25260404|NCT01090024|50575321|FG013|Period 2|Lost to Follow-up|0|||
25260405|NCT01090024|50575322|FG014|Period 2|Lost to Follow-up|0|||
25260406|NCT01090024|50575323|FG015|Period 2|Lost to Follow-up|0|||
25260407|NCT01090024|50575324|FG016|Period 2|Lost to Follow-up|0|||
25260408|NCT01090024|50575325|FG017|Period 2|Lost to Follow-up|0|||
25260409|NCT01090024|50575308|FG000|Period 2|Adverse Event|1|||
25260410|NCT01090024|50575309|FG001|Period 2|Adverse Event|0|||
25260411|NCT01090024|50575310|FG002|Period 2|Adverse Event|0|||
25260412|NCT01090024|50575311|FG003|Period 2|Adverse Event|0|||
25260413|NCT01090024|50575312|FG004|Period 2|Adverse Event|0|||
25260414|NCT01090024|50575313|FG005|Period 2|Adverse Event|0|||
25082664|NCT02730377|50191338|FG001|Overall Study|Withdrawal by Subject|42|||
25082665|NCT02730377|50191337|FG000|Overall Study|Lost to Follow-up|25|||
25082666|NCT02730377|50191338|FG001|Overall Study|Lost to Follow-up|21|||
25260415|NCT01090024|50575314|FG006|Period 2|Adverse Event|0|||
25260416|NCT01090024|50575315|FG007|Period 2|Adverse Event|0|||
25260417|NCT01090024|50575316|FG008|Period 2|Adverse Event|0|||
25260418|NCT01090024|50575317|FG009|Period 2|Adverse Event|0|||
25260419|NCT01090024|50575318|FG010|Period 2|Adverse Event|0|||
25260420|NCT01090024|50575319|FG011|Period 2|Adverse Event|0|||
25260421|NCT01090024|50575320|FG012|Period 2|Adverse Event|0|||
25260422|NCT01090024|50575321|FG013|Period 2|Adverse Event|0|||
25260423|NCT01090024|50575322|FG014|Period 2|Adverse Event|0|||
25260424|NCT01090024|50575323|FG015|Period 2|Adverse Event|0|||
25260425|NCT01090024|50575324|FG016|Period 2|Adverse Event|0|||
25260426|NCT01090024|50575325|FG017|Period 2|Adverse Event|0|||
25260427|NCT01090024|50575308|FG000|Period 3|Withdrawal by Subject|0|||
25260428|NCT01090024|50575309|FG001|Period 3|Withdrawal by Subject|0|||
25260429|NCT01090024|50575310|FG002|Period 3|Withdrawal by Subject|0|||
25260430|NCT01090024|50575311|FG003|Period 3|Withdrawal by Subject|0|||
25260431|NCT01090024|50575312|FG004|Period 3|Withdrawal by Subject|0|||
25260432|NCT01090024|50575313|FG005|Period 3|Withdrawal by Subject|0|||
25260433|NCT01090024|50575314|FG006|Period 3|Withdrawal by Subject|0|||
25260434|NCT01090024|50575315|FG007|Period 3|Withdrawal by Subject|0|||
25260435|NCT01090024|50575316|FG008|Period 3|Withdrawal by Subject|0|||
25260436|NCT01090024|50575317|FG009|Period 3|Withdrawal by Subject|0|||
25260437|NCT01090024|50575318|FG010|Period 3|Withdrawal by Subject|0|||
25260438|NCT01090024|50575319|FG011|Period 3|Withdrawal by Subject|0|||
25260439|NCT01090024|50575320|FG012|Period 3|Withdrawal by Subject|0|||
25260440|NCT01090024|50575321|FG013|Period 3|Withdrawal by Subject|0|||
25260441|NCT01090024|50575322|FG014|Period 3|Withdrawal by Subject|0|||
25260442|NCT01090024|50575323|FG015|Period 3|Withdrawal by Subject|1|||
25260443|NCT01090024|50575324|FG016|Period 3|Withdrawal by Subject|0|||
25260444|NCT01090024|50575325|FG017|Period 3|Withdrawal by Subject|0|||
25260445|NCT01090024|50575308|FG000|Period 3|Protocol Violation|0|||
25260446|NCT01090024|50575309|FG001|Period 3|Protocol Violation|0|||
25260447|NCT01090024|50575310|FG002|Period 3|Protocol Violation|0|||
25260448|NCT01090024|50575311|FG003|Period 3|Protocol Violation|0|||
25260449|NCT01090024|50575312|FG004|Period 3|Protocol Violation|0|||
25260450|NCT01090024|50575313|FG005|Period 3|Protocol Violation|0|||
25260451|NCT01090024|50575314|FG006|Period 3|Protocol Violation|0|||
25260452|NCT01090024|50575315|FG007|Period 3|Protocol Violation|0|||
25260453|NCT01090024|50575316|FG008|Period 3|Protocol Violation|1|||
25260454|NCT01090024|50575317|FG009|Period 3|Protocol Violation|0|||
25260455|NCT01090024|50575318|FG010|Period 3|Protocol Violation|0|||
25260456|NCT01090024|50575319|FG011|Period 3|Protocol Violation|0|||
25260457|NCT01090024|50575320|FG012|Period 3|Protocol Violation|0|||
25260458|NCT01090024|50575321|FG013|Period 3|Protocol Violation|0|||
25260459|NCT01090024|50575322|FG014|Period 3|Protocol Violation|0|||
25260460|NCT01090024|50575323|FG015|Period 3|Protocol Violation|0|||
25260461|NCT01090024|50575324|FG016|Period 3|Protocol Violation|0|||
25260462|NCT01090024|50575325|FG017|Period 3|Protocol Violation|0|||
25260463|NCT01090024|50575308|FG000|Period 3|Adverse Event|0|||
25260464|NCT01090024|50575309|FG001|Period 3|Adverse Event|0|||
25260465|NCT01090024|50575310|FG002|Period 3|Adverse Event|0|||
25260466|NCT01090024|50575311|FG003|Period 3|Adverse Event|0|||
25260467|NCT01090024|50575312|FG004|Period 3|Adverse Event|0|||
25260468|NCT01090024|50575313|FG005|Period 3|Adverse Event|1|||
25260469|NCT01090024|50575314|FG006|Period 3|Adverse Event|0|||
25260470|NCT01090024|50575315|FG007|Period 3|Adverse Event|0|||
25260471|NCT01090024|50575316|FG008|Period 3|Adverse Event|0|||
25260472|NCT01090024|50575317|FG009|Period 3|Adverse Event|0|||
25260473|NCT01090024|50575318|FG010|Period 3|Adverse Event|0|||
25260474|NCT01090024|50575319|FG011|Period 3|Adverse Event|0|||
25260475|NCT01090024|50575320|FG012|Period 3|Adverse Event|0|||
25260476|NCT01090024|50575321|FG013|Period 3|Adverse Event|0|||
25260477|NCT01090024|50575322|FG014|Period 3|Adverse Event|0|||
25260478|NCT01090024|50575323|FG015|Period 3|Adverse Event|0|||
25260479|NCT01090024|50575324|FG016|Period 3|Adverse Event|0|||
25260480|NCT01090024|50575325|FG017|Period 3|Adverse Event|0|||
25260481|NCT04868890|50575337|FG000|Overall Study|Death|2|||
25260482|NCT04868890|50575338|FG001|Overall Study|Death|1|||
25260483|NCT04868890|50575337|FG000|Overall Study|Withdrawal by Subject|1|||
25260484|NCT04868890|50575338|FG001|Overall Study|Withdrawal by Subject|5|||
25260485|NCT01281189|50575346|FG000|Overall Study|Adverse Event|7|||
25260486|NCT01281189|50575347|FG001|Overall Study|Adverse Event|9|||
25260487|NCT01281189|50575346|FG000|Overall Study|Lost to Follow-up|6|||
25260488|NCT01281189|50575347|FG001|Overall Study|Lost to Follow-up|4|||
25260489|NCT01281189|50575346|FG000|Overall Study|Withdrawal by Subject|21|||
25260490|NCT01281189|50575347|FG001|Overall Study|Withdrawal by Subject|24|||
25260491|NCT01281189|50575346|FG000|Overall Study|Physician Decision|2|||
25260492|NCT01281189|50575347|FG001|Overall Study|Physician Decision|3|||
25260493|NCT01281189|50575346|FG000|Overall Study|Death|103|||
25260494|NCT01281189|50575347|FG001|Overall Study|Death|91|||
25260495|NCT01281189|50575346|FG000|Overall Study|Other|8|||
25260496|NCT01281189|50575347|FG001|Overall Study|Other|12|||
25260497|NCT01280955|50575353|FG000|Overall Study|Death|2|||
25260498|NCT01280955|50575353|FG000|Overall Study|Withdrawal by Subject|1|||
25260499|NCT01280721|50575359|FG000|Overall Study|Adverse Event|4|||
25260500|NCT01280721|50575359|FG000|Overall Study|Physician Decision|3|||
25260501|NCT01280721|50575359|FG000|Overall Study|Withdrawal by Subject|6|||
25260502|NCT01280721|50575359|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
25260503|NCT01280721|50575359|FG000|Overall Study|No tolerability for the lowest dose|2|||
25260504|NCT01087762|50575377|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
25260505|NCT01087762|50575378|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
25260506|NCT01087762|50575379|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
25260507|NCT01087762|50575380|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
25260508|NCT01087762|50575381|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
25260509|NCT01087762|50575377|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
25260510|NCT01087762|50575378|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
25260511|NCT01087762|50575379|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
25260512|NCT01087762|50575380|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
25260513|NCT01087762|50575381|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
25260514|NCT01087762|50575377|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
25260515|NCT01087762|50575378|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
25260516|NCT01087762|50575379|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
25260517|NCT01087762|50575380|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
25260518|NCT01087762|50575381|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
25260519|NCT01087762|50575377|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
25260520|NCT01087762|50575378|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
25260521|NCT01087762|50575379|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
25260522|NCT01087762|50575380|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
25260523|NCT01087762|50575381|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
25260524|NCT01087762|50575377|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
25260525|NCT01087762|50575378|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
25260526|NCT01087762|50575379|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
25260527|NCT01087762|50575380|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
25260528|NCT01087762|50575381|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
25260529|NCT01087762|50575377|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
25260530|NCT01087762|50575378|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
25260531|NCT01087762|50575379|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
25260532|NCT01087762|50575380|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
25260533|NCT01087762|50575381|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
25260534|NCT01087762|50575377|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
25260535|NCT01087762|50575378|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
25260536|NCT01087762|50575379|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
25260537|NCT01087762|50575380|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
25260538|NCT01087762|50575381|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
25260539|NCT01087762|50575377|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
25260540|NCT01087762|50575378|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
25260541|NCT01087762|50575379|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
25260542|NCT01087762|50575380|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
25260543|NCT01087762|50575381|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
25260544|NCT01087762|50575377|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
25260545|NCT01087762|50575378|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
25260546|NCT01087762|50575379|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
25260547|NCT01087762|50575380|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
25260548|NCT01087762|50575381|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
25260549|NCT01087762|50575377|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
25260550|NCT01087762|50575378|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
25260551|NCT01087762|50575379|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
25260552|NCT01087762|50575380|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
25260553|NCT01087762|50575381|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
25260554|NCT01087762|50575377|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
25260555|NCT01087762|50575378|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
25260556|NCT01087762|50575379|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
25260557|NCT01087762|50575380|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
25260558|NCT01087762|50575381|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
25260559|NCT01087762|50575377|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
25260560|NCT01087762|50575378|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
25260561|NCT01087762|50575379|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
25260562|NCT01087762|50575380|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
25260563|NCT01087762|50575381|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
25260564|NCT01087762|50575377|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
25260565|NCT01087762|50575378|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
25260566|NCT01087762|50575379|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
25260567|NCT01087762|50575380|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
25260568|NCT01087762|50575381|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
25260569|NCT01078168|50575393|FG000|Overall Study|Physician Decision|0|||
25260570|NCT01078168|50575394|FG001|Overall Study|Physician Decision|1|||
25260571|NCT01086358|50575400|FG000|First Intervention|Lost to Follow-up|9|||
25260572|NCT01086358|50575401|FG001|First Intervention|Lost to Follow-up|4|||
25260573|NCT01086358|50575400|FG000|First Intervention|Withdrawal by Subject|0|||
25260574|NCT01086358|50575401|FG001|First Intervention|Withdrawal by Subject|1|||
25260575|NCT01086358|50575400|FG000|Second Intervention|Lost to Follow-up|4|||
25260576|NCT01086358|50575401|FG001|Second Intervention|Lost to Follow-up|4|||
25260577|NCT01277601|50575411|FG000|Overall Study|Adverse Event|5|||
25260578|NCT01277601|50575412|FG001|Overall Study|Adverse Event|3|||
25260579|NCT01277601|50575413|FG002|Overall Study|Adverse Event|0|||
25260580|NCT01277601|50575414|FG003|Overall Study|Adverse Event|7|||
25260581|NCT01277601|50575411|FG000|Overall Study|Withdrawal by Subject|18|||
25260582|NCT01277601|50575412|FG001|Overall Study|Withdrawal by Subject|21|||
25260583|NCT01277601|50575413|FG002|Overall Study|Withdrawal by Subject|8|||
25260584|NCT01277601|50575414|FG003|Overall Study|Withdrawal by Subject|17|||
25260585|NCT01277601|50575411|FG000|Overall Study|Lost to Follow-up|7|||
25260586|NCT01277601|50575412|FG001|Overall Study|Lost to Follow-up|9|||
25260587|NCT01277601|50575413|FG002|Overall Study|Lost to Follow-up|4|||
25260588|NCT01277601|50575414|FG003|Overall Study|Lost to Follow-up|2|||
25260589|NCT01277601|50575411|FG000|Overall Study|Physician Decision|3|||
25260590|NCT01277601|50575412|FG001|Overall Study|Physician Decision|5|||
25260591|NCT01277601|50575413|FG002|Overall Study|Physician Decision|1|||
25260592|NCT01277601|50575414|FG003|Overall Study|Physician Decision|6|||
25260593|NCT01277601|50575411|FG000|Overall Study|Pregnancy|2|||
25260594|NCT01277601|50575412|FG001|Overall Study|Pregnancy|2|||
25260595|NCT01277601|50575413|FG002|Overall Study|Pregnancy|4|||
25260596|NCT01277601|50575414|FG003|Overall Study|Pregnancy|1|||
25260597|NCT01277601|50575411|FG000|Overall Study|Noncompliance with Study Drug|1|||
25260598|NCT01277601|50575412|FG001|Overall Study|Noncompliance with Study Drug|3|||
25260599|NCT01277601|50575413|FG002|Overall Study|Noncompliance with Study Drug|2|||
25260600|NCT01277601|50575414|FG003|Overall Study|Noncompliance with Study Drug|0|||
25260601|NCT01277601|50575411|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
25260602|NCT01277601|50575412|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
25260603|NCT01277601|50575413|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
25260604|NCT01277601|50575414|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
25260605|NCT01277601|50575411|FG000|Overall Study|Protocol Violation|0|||
25260606|NCT01277601|50575412|FG001|Overall Study|Protocol Violation|2|||
25260607|NCT01277601|50575413|FG002|Overall Study|Protocol Violation|5|||
25260608|NCT01277601|50575414|FG003|Overall Study|Protocol Violation|0|||
25260609|NCT01277601|50575411|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
25260610|NCT01277601|50575412|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
25260611|NCT01277601|50575413|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
25260612|NCT01277601|50575414|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
25260613|NCT01277523|50575444|FG000|Overall Study|Adverse Event|1|||
25260614|NCT01277523|50575445|FG001|Overall Study|Adverse Event|0|||
25260615|NCT01277523|50575446|FG002|Overall Study|Adverse Event|0|||
25260616|NCT01277523|50575444|FG000|Overall Study|Protocol Violation|2|||
25260617|NCT01277523|50575445|FG001|Overall Study|Protocol Violation|0|||
25260618|NCT01277523|50575446|FG002|Overall Study|Protocol Violation|0|||
25260619|NCT01277523|50575444|FG000|Overall Study|Other Reason not Defined|0|||
25260620|NCT01277523|50575445|FG001|Overall Study|Other Reason not Defined|1|||
25260621|NCT01277523|50575446|FG002|Overall Study|Other Reason not Defined|0|||
25260622|NCT01081834|50575459|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
25260623|NCT01081834|50575460|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
25260624|NCT01081834|50575461|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
25260625|NCT01081834|50575462|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
25260626|NCT01081834|50575463|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
25260627|NCT01081834|50575459|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
25260628|NCT01081834|50575460|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
25260629|NCT01081834|50575461|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
25260630|NCT01081834|50575462|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
25260631|NCT01081834|50575463|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
25260632|NCT01081834|50575459|FG000|Core Period: Baseline to Week 26|Death|1|||
25260633|NCT01081834|50575460|FG001|Core Period: Baseline to Week 26|Death|0|||
25260634|NCT01081834|50575461|FG002|Core Period: Baseline to Week 26|Death|0|||
25260635|NCT01081834|50575462|FG003|Core Period: Baseline to Week 26|Death|0|||
25260636|NCT01081834|50575463|FG004|Core Period: Baseline to Week 26|Death|0|||
25260637|NCT01081834|50575459|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
25260638|NCT01081834|50575460|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
25260639|NCT01081834|50575461|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
25260640|NCT01081834|50575462|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
25260641|NCT01081834|50575463|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
25260642|NCT01081834|50575459|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
25260643|NCT01081834|50575460|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
25260644|NCT01081834|50575461|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
25260645|NCT01081834|50575462|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
25260646|NCT01081834|50575463|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
25260647|NCT01081834|50575459|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
25260648|NCT01081834|50575460|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
25260649|NCT01081834|50575461|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
25260650|NCT01081834|50575462|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
25260651|NCT01081834|50575463|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
25260652|NCT01081834|50575459|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
25260653|NCT01081834|50575460|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
25260654|NCT01081834|50575461|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
25260655|NCT01081834|50575462|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
25260656|NCT01081834|50575463|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
25260657|NCT01081834|50575459|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
25260658|NCT01081834|50575460|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
25260659|NCT01081834|50575461|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
25260660|NCT01081834|50575462|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
25260661|NCT01081834|50575463|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
25260662|NCT01081834|50575459|FG000|Core Period: Baseline to Week 26|Other|4|||
25260663|NCT01081834|50575460|FG001|Core Period: Baseline to Week 26|Other|4|||
25260664|NCT01081834|50575461|FG002|Core Period: Baseline to Week 26|Other|3|||
25260665|NCT01081834|50575462|FG003|Core Period: Baseline to Week 26|Other|1|||
25260666|NCT01081834|50575463|FG004|Core Period: Baseline to Week 26|Other|0|||
25260667|NCT01081834|50575459|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
25260668|NCT01081834|50575460|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
25260669|NCT01081834|50575461|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
25260670|NCT01081834|50575462|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
25260671|NCT01081834|50575463|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
25260672|NCT01081834|50575459|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
25260673|NCT01081834|50575460|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
25260674|NCT01081834|50575461|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
25260675|NCT01081834|50575462|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
25260676|NCT01081834|50575463|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
25260677|NCT01081834|50575459|FG000|Extension Period: Week 26 to Week 52|Death|1|||
25260678|NCT01081834|50575460|FG001|Extension Period: Week 26 to Week 52|Death|0|||
25260679|NCT01081834|50575461|FG002|Extension Period: Week 26 to Week 52|Death|0|||
25260680|NCT01081834|50575462|FG003|Extension Period: Week 26 to Week 52|Death|0|||
25260681|NCT01081834|50575463|FG004|Extension Period: Week 26 to Week 52|Death|0|||
25260682|NCT01081834|50575459|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
25260683|NCT01081834|50575460|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
25260684|NCT01081834|50575461|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
25260685|NCT01081834|50575462|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
25260686|NCT01081834|50575463|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
25260687|NCT01081834|50575459|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
25260688|NCT01081834|50575460|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
25260689|NCT01081834|50575461|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
25260690|NCT01081834|50575462|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
25260691|NCT01081834|50575463|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
25260692|NCT01081834|50575459|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
25260693|NCT01081834|50575460|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
25260694|NCT01081834|50575461|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
25260695|NCT01081834|50575462|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
25260696|NCT01081834|50575463|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
25260697|NCT01081834|50575459|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
25260698|NCT01081834|50575460|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
25260699|NCT01081834|50575461|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
25260700|NCT01081834|50575462|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
25260701|NCT01081834|50575463|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
25260702|NCT01081834|50575459|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
25260703|NCT01081834|50575460|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
25260704|NCT01081834|50575461|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
25260705|NCT01081834|50575462|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
25260706|NCT01081834|50575463|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
25260707|NCT01081834|50575459|FG000|Extension Period: Week 26 to Week 52|Other|4|||
25260708|NCT01081834|50575460|FG001|Extension Period: Week 26 to Week 52|Other|5|||
25260709|NCT01081834|50575461|FG002|Extension Period: Week 26 to Week 52|Other|4|||
25260710|NCT01081834|50575462|FG003|Extension Period: Week 26 to Week 52|Other|0|||
25260711|NCT01081834|50575463|FG004|Extension Period: Week 26 to Week 52|Other|0|||
25260712|NCT01081834|50575459|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
25260713|NCT01081834|50575460|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
25260714|NCT01081834|50575461|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
25260715|NCT01081834|50575462|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
25260716|NCT01081834|50575463|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
25260717|NCT01081834|50575459|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
25260718|NCT01081834|50575460|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
25260719|NCT01081834|50575461|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
25260720|NCT01081834|50575462|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
25260721|NCT01081834|50575463|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
25260722|NCT01276509|50575486|FG000|Overall Study|Adverse Event|9|||
25260723|NCT01276509|50575487|FG001|Overall Study|Adverse Event|8|||
25260724|NCT01276509|50575488|FG002|Overall Study|Adverse Event|4|||
25260725|NCT01276509|50575489|FG003|Overall Study|Adverse Event|3|||
25260726|NCT01276509|50575486|FG000|Overall Study|Lack of Efficacy|2|||
25260727|NCT01276509|50575487|FG001|Overall Study|Lack of Efficacy|1|||
25260728|NCT01276509|50575488|FG002|Overall Study|Lack of Efficacy|1|||
25260729|NCT01276509|50575489|FG003|Overall Study|Lack of Efficacy|2|||
25260730|NCT01276509|50575486|FG000|Overall Study|Pregnancy|1|||
25260731|NCT01276509|50575487|FG001|Overall Study|Pregnancy|0|||
25260732|NCT01276509|50575488|FG002|Overall Study|Pregnancy|0|||
25260733|NCT01276509|50575489|FG003|Overall Study|Pregnancy|0|||
25260734|NCT01276509|50575486|FG000|Overall Study|Withdrawal by Subject|1|||
25260735|NCT01276509|50575487|FG001|Overall Study|Withdrawal by Subject|2|||
25260736|NCT01276509|50575488|FG002|Overall Study|Withdrawal by Subject|0|||
25260737|NCT01276509|50575489|FG003|Overall Study|Withdrawal by Subject|0|||
25260738|NCT01276509|50575486|FG000|Overall Study|Other|0|||
25260739|NCT01276509|50575487|FG001|Overall Study|Other|1|||
25260740|NCT01276509|50575488|FG002|Overall Study|Other|0|||
25260741|NCT01276509|50575489|FG003|Overall Study|Other|0|||
25260742|NCT01079962|50575501|FG000|Overall Study|Adverse Event|2|||
25260743|NCT01079962|50575502|FG001|Overall Study|Adverse Event|2|||
25260744|NCT01079962|50575501|FG000|Overall Study|Withdrawal by Subject|5|||
25260745|NCT01079962|50575502|FG001|Overall Study|Withdrawal by Subject|7|||
25260746|NCT01079962|50575501|FG000|Overall Study|Protocol Violation|2|||
25260747|NCT01079962|50575502|FG001|Overall Study|Protocol Violation|2|||
25260748|NCT01079962|50575501|FG000|Overall Study|No blood pressure (BP) control|3|||
25260749|NCT01079962|50575502|FG001|Overall Study|No blood pressure (BP) control|0|||
25260750|NCT01079962|50575501|FG000|Overall Study|Inclusion/exclusion criteria|1|||
25260751|NCT01079962|50575502|FG001|Overall Study|Inclusion/exclusion criteria|3|||
25260752|NCT01079962|50575501|FG000|Overall Study|Participant not returning for next visit|1|||
25260753|NCT01079962|50575502|FG001|Overall Study|Participant not returning for next visit|0|||
25260754|NCT01079962|50575501|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
25260755|NCT01079962|50575502|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
25260756|NCT01274637|50575510|FG000|Overall Study|Withdrawal by Subject|0|||
25260757|NCT01274637|50575511|FG001|Overall Study|Withdrawal by Subject|1|||
25260758|NCT01274637|50575510|FG000|Overall Study|Lost to Follow-up|0|||
25260759|NCT01274637|50575511|FG001|Overall Study|Lost to Follow-up|1|||
25260760|NCT01079806|50575519|FG000|Day 1 to Week 96|Adverse Event|0|||
25260761|NCT01079806|50575520|FG001|Day 1 to Week 96|Adverse Event|3|||
25260762|NCT01079806|50575519|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
25260763|NCT01079806|50575520|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
25260764|NCT01079806|50575519|FG000|Day 1 to Week 96|Pregnancy|0|||
25260765|NCT01079806|50575520|FG001|Day 1 to Week 96|Pregnancy|1|||
25260766|NCT01079806|50575519|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
25260767|NCT01079806|50575520|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
25260768|NCT01079806|50575519|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
25260769|NCT01079806|50575520|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
25260770|NCT01079806|50575519|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
25260771|NCT01079806|50575520|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
25260772|NCT01079806|50575519|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
25260773|NCT01079806|50575520|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
25260774|NCT01079806|50575519|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
25260775|NCT01079806|50575520|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
25260776|NCT01079806|50575519|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
25260777|NCT01079806|50575520|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
25260778|NCT01079806|50575519|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
25260779|NCT01079806|50575520|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
25260780|NCT01078090|50575528|FG000|Overall Study|Lost to Follow-up|2363|||
25260781|NCT01078090|50575528|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
25260782|NCT01078090|50575528|FG000|Overall Study|Lack of Efficacy|1193|||
25260783|NCT01078090|50575528|FG000|Overall Study|ADR and lack of efficacy|61|||
25260784|NCT01078090|50575528|FG000|Overall Study|Other|523|||
25260785|NCT01077622|50575546|FG000|Overall Study|Physician Decision|2|||
25260786|NCT01077622|50575546|FG000|Overall Study|Withdrawal by Subject|1|||
25260787|NCT01313676|50575554|FG000|Overall Study|Adverse Event|395|||
25260788|NCT01313676|50575555|FG001|Overall Study|Adverse Event|365|||
25260789|NCT01313676|50575556|FG002|Overall Study|Adverse Event|372|||
25260790|NCT01313676|50575557|FG003|Overall Study|Adverse Event|333|||
25260791|NCT01313676|50575554|FG000|Overall Study|Lack of Efficacy|98|||
25260792|NCT01313676|50575555|FG001|Overall Study|Lack of Efficacy|90|||
25260793|NCT01313676|50575556|FG002|Overall Study|Lack of Efficacy|65|||
25260794|NCT01313676|50575557|FG003|Overall Study|Lack of Efficacy|46|||
25260795|NCT01313676|50575554|FG000|Overall Study|Protocol Violation|37|||
25260796|NCT01313676|50575555|FG001|Overall Study|Protocol Violation|44|||
25260797|NCT01313676|50575556|FG002|Overall Study|Protocol Violation|46|||
25260798|NCT01313676|50575557|FG003|Overall Study|Protocol Violation|44|||
25260799|NCT01313676|50575554|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
25260800|NCT01313676|50575555|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
25260801|NCT01313676|50575556|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
25260802|NCT01313676|50575557|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
25260803|NCT01313676|50575554|FG000|Overall Study|Study Closed/terminated|7|||
25260804|NCT01313676|50575555|FG001|Overall Study|Study Closed/terminated|6|||
25260805|NCT01313676|50575556|FG002|Overall Study|Study Closed/terminated|9|||
25260806|NCT01313676|50575557|FG003|Overall Study|Study Closed/terminated|9|||
25260807|NCT01313676|50575554|FG000|Overall Study|Lost to Follow-up|0|||
25260808|NCT01313676|50575555|FG001|Overall Study|Lost to Follow-up|0|||
25260809|NCT01313676|50575556|FG002|Overall Study|Lost to Follow-up|1|||
25260810|NCT01313676|50575557|FG003|Overall Study|Lost to Follow-up|0|||
25260811|NCT01313676|50575554|FG000|Overall Study|Physician Decision|53|||
25260812|NCT01313676|50575555|FG001|Overall Study|Physician Decision|64|||
25260813|NCT01313676|50575556|FG002|Overall Study|Physician Decision|62|||
25260814|NCT01313676|50575557|FG003|Overall Study|Physician Decision|48|||
25260815|NCT01313676|50575554|FG000|Overall Study|Decision by Participant or Proxy|643|||
25260816|NCT01313676|50575555|FG001|Overall Study|Decision by Participant or Proxy|527|||
25260817|NCT01313676|50575556|FG002|Overall Study|Decision by Participant or Proxy|515|||
25260818|NCT01313676|50575557|FG003|Overall Study|Decision by Participant or Proxy|492|||
25260819|NCT01313676|50575554|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
25260820|NCT01313676|50575555|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
25260821|NCT01313676|50575556|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
25260822|NCT01313676|50575557|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
25260823|NCT01313676|50575554|FG000|Overall Study|Investigator Site Closed|12|||
25260824|NCT01313676|50575555|FG001|Overall Study|Investigator Site Closed|11|||
25260825|NCT01313676|50575556|FG002|Overall Study|Investigator Site Closed|15|||
25260826|NCT01313676|50575557|FG003|Overall Study|Investigator Site Closed|10|||
25260827|NCT01313676|50575554|FG000|Overall Study|Missing|1|||
25260828|NCT01313676|50575555|FG001|Overall Study|Missing|1|||
25260829|NCT01313676|50575556|FG002|Overall Study|Missing|1|||
25260830|NCT01313676|50575557|FG003|Overall Study|Missing|0|||
25260831|NCT01313286|50575568|FG000|Period 1|Withdrawal by Subject|2|||
25260832|NCT01313286|50575569|FG001|Period 1|Withdrawal by Subject|0|||
25260833|NCT01313208|50575577|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
25260834|NCT01313208|50575578|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
25260835|NCT01313208|50575577|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
25260836|NCT01313208|50575578|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
25260837|NCT01313208|50575577|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
25260838|NCT01313208|50575578|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
25260839|NCT01313208|50575577|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
25260840|NCT01313208|50575578|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
25260841|NCT01313208|50575577|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
25260842|NCT01313208|50575578|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
25260843|NCT01313208|50575577|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
25260844|NCT01313208|50575578|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
25260845|NCT01313208|50575577|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
25260846|NCT01313208|50575578|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
25260847|NCT01313208|50575577|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
25260848|NCT01313208|50575578|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
25260849|NCT01313208|50575577|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
25260850|NCT01313208|50575578|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
25260851|NCT01312428|50575588|FG000|Overall Study|Study Termination|3|||
25260852|NCT01312428|50575589|FG001|Overall Study|Study Termination|4|||
25260853|NCT01075984|50575602|FG000|Treatment Phase|Adverse Event|0|||
25260854|NCT01075984|50575603|FG001|Treatment Phase|Adverse Event|1|||
25260855|NCT01075984|50575604|FG002|Treatment Phase|Adverse Event|3|||
25260856|NCT01075984|50575605|FG003|Treatment Phase|Adverse Event|7|||
25260857|NCT01075984|50575606|FG004|Treatment Phase|Adverse Event|35|||
25260858|NCT01075984|50575602|FG000|Treatment Phase|Protocol Violation|0|||
25260859|NCT01075984|50575603|FG001|Treatment Phase|Protocol Violation|0|||
25260860|NCT01075984|50575604|FG002|Treatment Phase|Protocol Violation|1|||
25260861|NCT01075984|50575605|FG003|Treatment Phase|Protocol Violation|0|||
25260862|NCT01075984|50575606|FG004|Treatment Phase|Protocol Violation|3|||
25260863|NCT01075984|50575602|FG000|Treatment Phase|Withdrawal by Subject|0|||
25260864|NCT01075984|50575603|FG001|Treatment Phase|Withdrawal by Subject|0|||
25260865|NCT01075984|50575604|FG002|Treatment Phase|Withdrawal by Subject|2|||
25260866|NCT01075984|50575605|FG003|Treatment Phase|Withdrawal by Subject|0|||
25260867|NCT01075984|50575606|FG004|Treatment Phase|Withdrawal by Subject|15|||
25260868|NCT01075984|50575602|FG000|Treatment Phase|Treatment Failure|0|||
25260869|NCT01075984|50575603|FG001|Treatment Phase|Treatment Failure|0|||
25260870|NCT01075984|50575604|FG002|Treatment Phase|Treatment Failure|1|||
25260871|NCT01075984|50575605|FG003|Treatment Phase|Treatment Failure|0|||
25260872|NCT01075984|50575606|FG004|Treatment Phase|Treatment Failure|5|||
25260873|NCT01075984|50575602|FG000|Treatment Phase|Progression of disease|0|||
25260874|NCT01075984|50575603|FG001|Treatment Phase|Progression of disease|0|||
25260875|NCT01075984|50575604|FG002|Treatment Phase|Progression of disease|0|||
25260876|NCT01075984|50575605|FG003|Treatment Phase|Progression of disease|0|||
25260877|NCT01075984|50575606|FG004|Treatment Phase|Progression of disease|2|||
25260878|NCT01075984|50575602|FG000|Follow-up Phase|Protocol Violation|0|||
25260879|NCT01075984|50575603|FG001|Follow-up Phase|Protocol Violation|0|||
25260880|NCT01075984|50575604|FG002|Follow-up Phase|Protocol Violation|1|||
25260881|NCT01075984|50575605|FG003|Follow-up Phase|Protocol Violation|0|||
25260882|NCT01075984|50575606|FG004|Follow-up Phase|Protocol Violation|3|||
25260883|NCT01075984|50575602|FG000|Follow-up Phase|Adverse Event|0|||
25260884|NCT01075984|50575603|FG001|Follow-up Phase|Adverse Event|0|||
25260885|NCT01075984|50575604|FG002|Follow-up Phase|Adverse Event|0|||
25260886|NCT01075984|50575605|FG003|Follow-up Phase|Adverse Event|2|||
25260887|NCT01075984|50575606|FG004|Follow-up Phase|Adverse Event|27|||
25260888|NCT01075984|50575602|FG000|Follow-up Phase|Administrative|0|||
25260889|NCT01075984|50575603|FG001|Follow-up Phase|Administrative|0|||
25260890|NCT01075984|50575604|FG002|Follow-up Phase|Administrative|0|||
25260891|NCT01075984|50575605|FG003|Follow-up Phase|Administrative|0|||
25260892|NCT01075984|50575606|FG004|Follow-up Phase|Administrative|1|||
25260893|NCT01075984|50575602|FG000|Follow-up Phase|Withdrawal by Subject|0|||
25260894|NCT01075984|50575603|FG001|Follow-up Phase|Withdrawal by Subject|0|||
25260895|NCT01075984|50575604|FG002|Follow-up Phase|Withdrawal by Subject|0|||
25260896|NCT01075984|50575605|FG003|Follow-up Phase|Withdrawal by Subject|0|||
25260897|NCT01075984|50575606|FG004|Follow-up Phase|Withdrawal by Subject|10|||
25260898|NCT01075984|50575602|FG000|Follow-up Phase|Progression of disease|0|||
25260899|NCT01075984|50575603|FG001|Follow-up Phase|Progression of disease|0|||
25260900|NCT01075984|50575604|FG002|Follow-up Phase|Progression of disease|0|||
25260901|NCT01075984|50575605|FG003|Follow-up Phase|Progression of disease|0|||
25260902|NCT01075984|50575606|FG004|Follow-up Phase|Progression of disease|2|||
25260903|NCT01075984|50575602|FG000|Follow-up Phase|Treatment failure|0|||
25260904|NCT01075984|50575603|FG001|Follow-up Phase|Treatment failure|0|||
25260905|NCT01075984|50575604|FG002|Follow-up Phase|Treatment failure|0|||
25260906|NCT01075984|50575605|FG003|Follow-up Phase|Treatment failure|0|||
25260907|NCT01075984|50575606|FG004|Follow-up Phase|Treatment failure|4|||
25260908|NCT01024231|50575625|FG000|Overall Study|Other Reasons|1|||
25260909|NCT01024231|50575626|FG001|Overall Study|Other Reasons|2|||
25260910|NCT01024231|50575627|FG002|Overall Study|Other Reasons|0|||
25260911|NCT01024231|50575628|FG003|Overall Study|Other Reasons|0|||
25260912|NCT01024231|50575629|FG004|Overall Study|Other Reasons|2|||
25260913|NCT01024231|50575630|FG005|Overall Study|Other Reasons|0|||
25260914|NCT01024231|50575631|FG006|Overall Study|Other Reasons|1|||
25260915|NCT01024231|50575625|FG000|Overall Study|Maximum Clinical Benefit|1|||
25260916|NCT01024231|50575626|FG001|Overall Study|Maximum Clinical Benefit|2|||
25260917|NCT01024231|50575627|FG002|Overall Study|Maximum Clinical Benefit|0|||
25260918|NCT01024231|50575628|FG003|Overall Study|Maximum Clinical Benefit|1|||
25260919|NCT01024231|50575629|FG004|Overall Study|Maximum Clinical Benefit|1|||
25260920|NCT01024231|50575630|FG005|Overall Study|Maximum Clinical Benefit|0|||
25260921|NCT01024231|50575631|FG006|Overall Study|Maximum Clinical Benefit|0|||
25260922|NCT01024231|50575625|FG000|Overall Study|Disease Progression|3|||
25260923|NCT01024231|50575626|FG001|Overall Study|Disease Progression|1|||
25260924|NCT01024231|50575627|FG002|Overall Study|Disease Progression|3|||
25260925|NCT01024231|50575628|FG003|Overall Study|Disease Progression|0|||
25260926|NCT01024231|50575629|FG004|Overall Study|Disease Progression|4|||
25260927|NCT01024231|50575630|FG005|Overall Study|Disease Progression|11|||
25260928|NCT01024231|50575631|FG006|Overall Study|Disease Progression|6|||
25260929|NCT01024231|50575625|FG000|Overall Study|AE unrelated to Study Drug|0|||
25260930|NCT01024231|50575626|FG001|Overall Study|AE unrelated to Study Drug|1|||
25260931|NCT01024231|50575627|FG002|Overall Study|AE unrelated to Study Drug|0|||
25260932|NCT01024231|50575628|FG003|Overall Study|AE unrelated to Study Drug|0|||
25260933|NCT01024231|50575629|FG004|Overall Study|AE unrelated to Study Drug|0|||
25260934|NCT01024231|50575630|FG005|Overall Study|AE unrelated to Study Drug|0|||
25260935|NCT01024231|50575631|FG006|Overall Study|AE unrelated to Study Drug|0|||
25260936|NCT01024231|50575625|FG000|Overall Study|No longer meets criteria|0|||
25260937|NCT01024231|50575626|FG001|Overall Study|No longer meets criteria|0|||
25260938|NCT01024231|50575627|FG002|Overall Study|No longer meets criteria|0|||
25260939|NCT01024231|50575628|FG003|Overall Study|No longer meets criteria|0|||
25260940|NCT01024231|50575629|FG004|Overall Study|No longer meets criteria|1|||
25260941|NCT01024231|50575630|FG005|Overall Study|No longer meets criteria|0|||
25260942|NCT01024231|50575631|FG006|Overall Study|No longer meets criteria|1|||
25260943|NCT01024231|50575625|FG000|Overall Study|Study Drug Toxicity|1|||
25260944|NCT01024231|50575626|FG001|Overall Study|Study Drug Toxicity|6|||
25260945|NCT01024231|50575627|FG002|Overall Study|Study Drug Toxicity|6|||
25260946|NCT01024231|50575628|FG003|Overall Study|Study Drug Toxicity|4|||
25260947|NCT01024231|50575629|FG004|Overall Study|Study Drug Toxicity|2|||
25260948|NCT01024231|50575630|FG005|Overall Study|Study Drug Toxicity|0|||
25260949|NCT01024231|50575631|FG006|Overall Study|Study Drug Toxicity|7|||
25260950|NCT01024231|50575625|FG000|Overall Study|Death|6|||
25260951|NCT01024231|50575626|FG001|Overall Study|Death|2|||
25260952|NCT01024231|50575627|FG002|Overall Study|Death|1|||
25260953|NCT01024231|50575628|FG003|Overall Study|Death|0|||
25260954|NCT01024231|50575629|FG004|Overall Study|Death|4|||
25260955|NCT01024231|50575630|FG005|Overall Study|Death|3|||
25260956|NCT01024231|50575631|FG006|Overall Study|Death|5|||
25260957|NCT01024231|50575625|FG000|Overall Study|Lost to Follow-up|0|||
25260958|NCT01024231|50575626|FG001|Overall Study|Lost to Follow-up|0|||
25260959|NCT01024231|50575627|FG002|Overall Study|Lost to Follow-up|0|||
25260960|NCT01024231|50575628|FG003|Overall Study|Lost to Follow-up|0|||
25260961|NCT01024231|50575629|FG004|Overall Study|Lost to Follow-up|0|||
25260962|NCT01024231|50575630|FG005|Overall Study|Lost to Follow-up|0|||
25260963|NCT01024231|50575631|FG006|Overall Study|Lost to Follow-up|1|||
25260964|NCT01024231|50575625|FG000|Overall Study|Withdrew Consent|0|||
25260965|NCT01024231|50575626|FG001|Overall Study|Withdrew Consent|1|||
25260966|NCT01024231|50575627|FG002|Overall Study|Withdrew Consent|0|||
25260967|NCT01024231|50575628|FG003|Overall Study|Withdrew Consent|0|||
25260968|NCT01024231|50575629|FG004|Overall Study|Withdrew Consent|0|||
25260969|NCT01024231|50575630|FG005|Overall Study|Withdrew Consent|0|||
25260970|NCT01024231|50575631|FG006|Overall Study|Withdrew Consent|0|||
25260971|NCT01024231|50575625|FG000|Overall Study|Continuing on Treatment|0|||
25260972|NCT01024231|50575626|FG001|Overall Study|Continuing on Treatment|0|||
25260973|NCT01024231|50575627|FG002|Overall Study|Continuing on Treatment|0|||
25260974|NCT01024231|50575628|FG003|Overall Study|Continuing on Treatment|0|||
25260975|NCT01024231|50575629|FG004|Overall Study|Continuing on Treatment|3|||
25260976|NCT01024231|50575630|FG005|Overall Study|Continuing on Treatment|2|||
25260977|NCT01024231|50575631|FG006|Overall Study|Continuing on Treatment|0|||
25260978|NCT01077544|50575654|FG000|Overall Study|New Cancer Therapy|3|||
25260979|NCT01077544|50575655|FG001|Overall Study|New Cancer Therapy|3|||
25260980|NCT01077544|50575654|FG000|Overall Study|Adverse Event|0|||
25260981|NCT01077544|50575655|FG001|Overall Study|Adverse Event|1|||
25260982|NCT01077544|50575654|FG000|Overall Study|Disease Progression|0|||
25260983|NCT01077544|50575655|FG001|Overall Study|Disease Progression|1|||
25260984|NCT01075516|50575663|FG000|Overall Study|Death|5|||
25260985|NCT01075516|50575664|FG001|Overall Study|Death|9|||
25260986|NCT01075516|50575663|FG000|Overall Study|Lost to Follow-up|10|||
25260987|NCT01075516|50575664|FG001|Overall Study|Lost to Follow-up|2|||
25260988|NCT01075516|50575663|FG000|Overall Study|Withdrawal by Subject|3|||
25260989|NCT01075516|50575664|FG001|Overall Study|Withdrawal by Subject|5|||
25260990|NCT01012999|50575670|FG000|Overall Study|Protocol Violation|1|||
25260991|NCT01017601|50575676|FG000|Overall Study|Disease Progression|12|||
25260992|NCT01017601|50575677|FG001|Overall Study|Disease Progression|12|||
25260993|NCT01017601|50575676|FG000|Overall Study|Withdrawal by Subject|0|||
25260994|NCT01017601|50575677|FG001|Overall Study|Withdrawal by Subject|1|||
25260995|NCT01016977|50575685|FG000|Overall Study|Lost to Follow-up|1|||
25260996|NCT01016977|50575686|FG001|Overall Study|Lost to Follow-up|0|||
25260997|NCT01016977|50575685|FG000|Overall Study|Withdrawal by Subject|2|||
25260998|NCT01016977|50575686|FG001|Overall Study|Withdrawal by Subject|2|||
25260999|NCT01012765|50575695|FG000|Treatment Period 1|Adverse Event|1|||
25261000|NCT01012765|50575696|FG001|Treatment Period 1|Adverse Event|0|||
25261001|NCT01012765|50575697|FG002|Treatment Period 1|Adverse Event|1|||
25261002|NCT01012765|50575698|FG003|Treatment Period 1|Adverse Event|0|||
25261003|NCT01012765|50575699|FG004|Treatment Period 1|Adverse Event|0|||
25261004|NCT01012765|50575700|FG005|Treatment Period 1|Adverse Event|0|||
25261005|NCT01012765|50575695|FG000|Treatment Period 1|Withdrawal by Subject|2|||
25261006|NCT01012765|50575696|FG001|Treatment Period 1|Withdrawal by Subject|0|||
25261007|NCT01012765|50575697|FG002|Treatment Period 1|Withdrawal by Subject|0|||
25261008|NCT01012765|50575698|FG003|Treatment Period 1|Withdrawal by Subject|0|||
25261009|NCT01012765|50575699|FG004|Treatment Period 1|Withdrawal by Subject|0|||
25261010|NCT01012765|50575700|FG005|Treatment Period 1|Withdrawal by Subject|0|||
25261011|NCT01012765|50575695|FG000|Treatment Period 1|Administrative problems|0|||
25261012|NCT01012765|50575696|FG001|Treatment Period 1|Administrative problems|0|||
25261013|NCT01012765|50575697|FG002|Treatment Period 1|Administrative problems|1|||
25261014|NCT01012765|50575698|FG003|Treatment Period 1|Administrative problems|1|||
25261015|NCT01012765|50575699|FG004|Treatment Period 1|Administrative problems|1|||
25261016|NCT01012765|50575700|FG005|Treatment Period 1|Administrative problems|0|||
25261017|NCT01012765|50575695|FG000|Treatment Period 1|Protocol Violation|0|||
25261018|NCT01012765|50575696|FG001|Treatment Period 1|Protocol Violation|0|||
25261019|NCT01012765|50575697|FG002|Treatment Period 1|Protocol Violation|0|||
25261020|NCT01012765|50575698|FG003|Treatment Period 1|Protocol Violation|2|||
25261021|NCT01012765|50575699|FG004|Treatment Period 1|Protocol Violation|1|||
25261022|NCT01012765|50575700|FG005|Treatment Period 1|Protocol Violation|0|||
25261023|NCT01012765|50575695|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
25261024|NCT01012765|50575696|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
25261025|NCT01012765|50575697|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
25261026|NCT01012765|50575698|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
25261027|NCT01012765|50575699|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
25261028|NCT01012765|50575700|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
25261029|NCT01012765|50575695|FG000|Treatment Period 2|Withdrawal by Subject|1|||
25261030|NCT01012765|50575696|FG001|Treatment Period 2|Withdrawal by Subject|0|||
25261031|NCT01012765|50575697|FG002|Treatment Period 2|Withdrawal by Subject|1|||
25261032|NCT01012765|50575698|FG003|Treatment Period 2|Withdrawal by Subject|0|||
25261033|NCT01012765|50575699|FG004|Treatment Period 2|Withdrawal by Subject|1|||
25261034|NCT01012765|50575700|FG005|Treatment Period 2|Withdrawal by Subject|0|||
25261035|NCT01012765|50575695|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
25261036|NCT01012765|50575696|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
25261037|NCT01012765|50575697|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
25261038|NCT01012765|50575698|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
25261039|NCT01012765|50575699|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
25261040|NCT01012765|50575700|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
25261041|NCT01012765|50575695|FG000|Treatment Period 2|Adverse Event|0|||
25261042|NCT01012765|50575696|FG001|Treatment Period 2|Adverse Event|1|||
25261043|NCT01012765|50575697|FG002|Treatment Period 2|Adverse Event|1|||
25261044|NCT01012765|50575698|FG003|Treatment Period 2|Adverse Event|0|||
25261045|NCT01012765|50575699|FG004|Treatment Period 2|Adverse Event|0|||
25261046|NCT01012765|50575700|FG005|Treatment Period 2|Adverse Event|0|||
25261047|NCT01012765|50575695|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
25261048|NCT01012765|50575696|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
25261049|NCT01012765|50575697|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
25261050|NCT01012765|50575698|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
25261051|NCT01012765|50575699|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
25261052|NCT01012765|50575700|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
25261053|NCT01010503|50575708|FG000|Overall Study|Adverse Event|1|||
25261054|NCT01010503|50575708|FG000|Overall Study|Death|1|||
25261055|NCT01009645|50575716|FG000|Overall Study|Lost to Follow-up|2|||
25261056|NCT01009645|50575717|FG001|Overall Study|Lost to Follow-up|8|||
25261057|NCT01009645|50575718|FG002|Overall Study|Lost to Follow-up|4|||
25261058|NCT01009645|50575719|FG003|Overall Study|Lost to Follow-up|5|||
25261059|NCT01006291|50575732|FG000|Overall Study|Adverse Event|2|||
25261060|NCT01006291|50575733|FG001|Overall Study|Adverse Event|1|||
25261061|NCT01006291|50575734|FG002|Overall Study|Adverse Event|2|||
25261062|NCT01006291|50575732|FG000|Overall Study|Lack of Efficacy|2|||
25261063|NCT01006291|50575733|FG001|Overall Study|Lack of Efficacy|2|||
25261064|NCT01006291|50575734|FG002|Overall Study|Lack of Efficacy|1|||
25261065|NCT01006291|50575732|FG000|Overall Study|Protocol Violation|3|||
25261066|NCT01006291|50575733|FG001|Overall Study|Protocol Violation|3|||
25261067|NCT01006291|50575734|FG002|Overall Study|Protocol Violation|3|||
25261068|NCT01006291|50575732|FG000|Overall Study|Withdrawal criteria|5|||
25261069|NCT01006291|50575733|FG001|Overall Study|Withdrawal criteria|4|||
25261070|NCT01006291|50575734|FG002|Overall Study|Withdrawal criteria|4|||
25261071|NCT01006291|50575732|FG000|Overall Study|Other|14|||
25261072|NCT01006291|50575733|FG001|Overall Study|Other|14|||
25261073|NCT01006291|50575734|FG002|Overall Study|Other|17|||
25261074|NCT01006135|50575742|FG000|Overall Study|Adverse Event|22|||
25261075|NCT01006135|50575742|FG000|Overall Study|Protocol Violation|14|||
25261076|NCT01006135|50575742|FG000|Overall Study|Lost to Follow-up|32|||
25261077|NCT01006135|50575742|FG000|Overall Study|Other|72|||
25261078|NCT01012609|50575748|FG000|Overall Study|Withdrawal by Subject|1|||
25261079|NCT01012609|50575749|FG001|Overall Study|Withdrawal by Subject|1|||
25261080|NCT01012219|50575756|FG000|Period 1|Withdrawal by Subject|1|||
25261081|NCT01012219|50575756|FG000|Period 2|Withdrawal by Subject|1|||
25261082|NCT01011907|50575765|FG000|Overall Study|Withdrawal by Subject|13|||
25082704|NCT02714569|50191359|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
25082705|NCT02714569|50191360|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
25082706|NCT02714569|50191361|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
25082707|NCT02714569|50191362|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
25082708|NCT02714569|50191363|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
25082709|NCT02714569|50191364|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
25082710|NCT02714569|50191365|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
25082711|NCT02714569|50191355|FG000|Part B (Overall)|Lost to Follow-up|0|||
25082712|NCT02714569|50191356|FG001|Part B (Overall)|Lost to Follow-up|0|||
25082713|NCT02714569|50191357|FG002|Part B (Overall)|Lost to Follow-up|0|||
25082714|NCT02714569|50191358|FG003|Part B (Overall)|Lost to Follow-up|0|||
25082715|NCT02714569|50191359|FG004|Part B (Overall)|Lost to Follow-up|0|||
25082716|NCT02714569|50191360|FG005|Part B (Overall)|Lost to Follow-up|0|||
25082717|NCT02714569|50191361|FG006|Part B (Overall)|Lost to Follow-up|1|||
25082718|NCT02714569|50191362|FG007|Part B (Overall)|Lost to Follow-up|0|||
25082719|NCT02714569|50191363|FG008|Part B (Overall)|Lost to Follow-up|0|||
25082720|NCT02714569|50191364|FG009|Part B (Overall)|Lost to Follow-up|0|||
25082721|NCT02714569|50191365|FG010|Part B (Overall)|Lost to Follow-up|0|||
25082722|NCT02714569|50191355|FG000|Part B (Overall)|Withdrawal by Subject|0|||
25082723|NCT02714569|50191356|FG001|Part B (Overall)|Withdrawal by Subject|0|||
25082724|NCT02714569|50191357|FG002|Part B (Overall)|Withdrawal by Subject|0|||
25082725|NCT02714569|50191358|FG003|Part B (Overall)|Withdrawal by Subject|0|||
25082726|NCT02714569|50191359|FG004|Part B (Overall)|Withdrawal by Subject|0|||
25082727|NCT02714569|50191360|FG005|Part B (Overall)|Withdrawal by Subject|0|||
25082728|NCT02714569|50191361|FG006|Part B (Overall)|Withdrawal by Subject|0|||
25082729|NCT02714569|50191362|FG007|Part B (Overall)|Withdrawal by Subject|1|||
25082730|NCT02714569|50191363|FG008|Part B (Overall)|Withdrawal by Subject|0|||
25082731|NCT02714569|50191364|FG009|Part B (Overall)|Withdrawal by Subject|1|||
25082732|NCT02714569|50191365|FG010|Part B (Overall)|Withdrawal by Subject|0|||
25082733|NCT02714569|50191355|FG000|Part B (Overall)|Adverse Event|0|||
25082734|NCT02714569|50191356|FG001|Part B (Overall)|Adverse Event|0|||
25082735|NCT02714569|50191357|FG002|Part B (Overall)|Adverse Event|0|||
25082736|NCT02714569|50191358|FG003|Part B (Overall)|Adverse Event|0|||
25082737|NCT02714569|50191359|FG004|Part B (Overall)|Adverse Event|0|||
25082738|NCT02714569|50191360|FG005|Part B (Overall)|Adverse Event|0|||
25082739|NCT02714569|50191361|FG006|Part B (Overall)|Adverse Event|0|||
25082740|NCT02714569|50191362|FG007|Part B (Overall)|Adverse Event|0|||
25082741|NCT02714569|50191363|FG008|Part B (Overall)|Adverse Event|0|||
25082742|NCT02714569|50191364|FG009|Part B (Overall)|Adverse Event|1|||
25082743|NCT02714569|50191365|FG010|Part B (Overall)|Adverse Event|0|||
25082744|NCT02713789|50191428|FG000|Overall Study|Lost to Follow-up|0|||
25082745|NCT02713789|50191429|FG001|Overall Study|Lost to Follow-up|1|||
25082746|NCT02713789|50191430|FG002|Overall Study|Lost to Follow-up|1|||
25082747|NCT04086121|50191438|FG000|Overall Study|Other than listed|8|||
25082748|NCT04086121|50191438|FG000|Overall Study|Withdrawal by Subject|3|||
25082749|NCT04086121|50191438|FG000|Overall Study|Lost to Follow-up|2|||
25082750|NCT04086121|50191438|FG000|Overall Study|Adverse Event|1|||
25082751|NCT02729909|50191445|FG000|Overall Study|Lost to Follow-up|0|||
25082752|NCT02729909|50191446|FG001|Overall Study|Lost to Follow-up|1|||
25082753|NCT02729909|50191445|FG000|Overall Study|Lack of Efficacy|0|||
25082754|NCT02729909|50191446|FG001|Overall Study|Lack of Efficacy|2|||
25082755|NCT02729909|50191445|FG000|Overall Study|Significant Protocol Deviation|0|||
25082756|NCT02729909|50191446|FG001|Overall Study|Significant Protocol Deviation|2|||
25082757|NCT02729909|50191445|FG000|Overall Study|Voluntary Withdrawal|1|||
25082758|NCT02729909|50191446|FG001|Overall Study|Voluntary Withdrawal|0|||
25082759|NCT02713243|50191454|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
25082760|NCT02713243|50191455|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
25082761|NCT02713243|50191454|FG000|Overall Study|Administrative problems|0|||
25082762|NCT02713243|50191455|FG001|Overall Study|Administrative problems|1|||
25082763|NCT02713243|50191454|FG000|Overall Study|Protocol deviation|0|||
25082764|NCT02713243|50191455|FG001|Overall Study|Protocol deviation|1|||
25082765|NCT03434041|50191463|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
25082766|NCT03434041|50191464|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
25082767|NCT03434041|50191463|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
25082768|NCT03434041|50191464|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
25082769|NCT03434041|50191463|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
25082770|NCT03434041|50191464|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
25082771|NCT03434041|50191463|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
25082772|NCT03434041|50191464|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
25082773|NCT03434041|50191463|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
25082774|NCT03434041|50191464|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
25082775|NCT03434041|50191463|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
25082776|NCT03434041|50191464|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
25082777|NCT03434041|50191463|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
25082778|NCT03434041|50191464|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
25082779|NCT03434041|50191463|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
25082780|NCT03434041|50191464|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
25082781|NCT03434041|50191463|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
25082782|NCT03434041|50191464|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
25082783|NCT03434041|50191463|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
25082784|NCT03434041|50191464|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
25082785|NCT03434041|50191463|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
25082786|NCT03434041|50191464|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
25082787|NCT00708461|50191479|FG000|Overall Study|Lost to Follow-up|18|||
25082788|NCT00708461|50191480|FG001|Overall Study|Lost to Follow-up|11|||
25082789|NCT00708461|50191479|FG000|Overall Study|Withdrawal by Subject|8|||
25082790|NCT00708461|50191480|FG001|Overall Study|Withdrawal by Subject|9|||
25082791|NCT00708461|50191479|FG000|Overall Study|left workforce|115|||
25082792|NCT00708461|50191480|FG001|Overall Study|left workforce|180|||
25082793|NCT00700999|50191488|FG000|Overall Study|Lost to Follow-up|7|||
25082794|NCT00700999|50191489|FG001|Overall Study|Lost to Follow-up|7|||
25082795|NCT00700999|50191488|FG000|Overall Study|Excluded - did not meet study criteria|0|||
25082796|NCT00700999|50191489|FG001|Overall Study|Excluded - did not meet study criteria|1|||
25082797|NCT00700999|50191488|FG000|Overall Study|Withdrawal by Subject|8|||
25082798|NCT00700999|50191489|FG001|Overall Study|Withdrawal by Subject|1|||
25082799|NCT02729831|50191499|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
25082800|NCT02729831|50191500|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
25082801|NCT02729831|50191501|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
25082802|NCT02729831|50191502|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
25082803|NCT02729831|50191499|FG000|1 Week Post-visit|Lost to Follow-up|43|||
25082804|NCT02729831|50191500|FG001|1 Week Post-visit|Lost to Follow-up|40|||
25082805|NCT02729831|50191501|FG002|1 Week Post-visit|Lost to Follow-up|38|||
25082806|NCT02729831|50191502|FG003|1 Week Post-visit|Lost to Follow-up|36|||
25082807|NCT02729831|50191499|FG000|6 Month Follow-up|Lost to Follow-up|54|||
25082808|NCT02729831|50191500|FG001|6 Month Follow-up|Lost to Follow-up|51|||
25082809|NCT02729831|50191501|FG002|6 Month Follow-up|Lost to Follow-up|48|||
25082810|NCT02729831|50191502|FG003|6 Month Follow-up|Lost to Follow-up|42|||
25082811|NCT02729831|50191499|FG000|6 Month Follow-up|Death|1|||
25082812|NCT02729831|50191500|FG001|6 Month Follow-up|Death|3|||
25082813|NCT02729831|50191501|FG002|6 Month Follow-up|Death|0|||
25082814|NCT02729831|50191502|FG003|6 Month Follow-up|Death|1|||
25082815|NCT02729753|50191514|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
25082816|NCT02729753|50191515|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
25082817|NCT00709319|50191524|FG000|Overall Study|Death|4|||
25082818|NCT00709319|50191524|FG000|Overall Study|Withdrawal by Subject|2|||
25082819|NCT02729051|50191569|FG000|Overall Study|Adverse Event|21|||
25082820|NCT02729051|50191570|FG001|Overall Study|Adverse Event|11|||
25082821|NCT02729051|50191569|FG000|Overall Study|Lack of Efficacy|1|||
25082822|NCT02729051|50191570|FG001|Overall Study|Lack of Efficacy|1|||
25082823|NCT02729051|50191569|FG000|Overall Study|Lost to Follow-up|1|||
25082824|NCT02729051|50191570|FG001|Overall Study|Lost to Follow-up|2|||
25082825|NCT02729051|50191569|FG000|Overall Study|Physician Decision|1|||
25082826|NCT02729051|50191570|FG001|Overall Study|Physician Decision|1|||
25082827|NCT02729051|50191569|FG000|Overall Study|Withdrawal by Subject|6|||
25082828|NCT02729051|50191570|FG001|Overall Study|Withdrawal by Subject|17|||
25082829|NCT00707993|50191578|FG000|Overall Study|Adverse Event|16|||
25082830|NCT00707993|50191579|FG001|Overall Study|Adverse Event|20|||
25082831|NCT00707993|50191578|FG000|Overall Study|Protocol Violation|4|||
25082832|NCT00707993|50191579|FG001|Overall Study|Protocol Violation|7|||
25082833|NCT00707993|50191578|FG000|Overall Study|Lost to Follow-up|0|||
25082834|NCT00707993|50191579|FG001|Overall Study|Lost to Follow-up|4|||
25082835|NCT00707993|50191578|FG000|Overall Study|Withdrawal by Subject|12|||
25082836|NCT00707993|50191579|FG001|Overall Study|Withdrawal by Subject|16|||
25082837|NCT00707993|50191578|FG000|Overall Study|Hyperglycemic Rescue|55|||
25082838|NCT00707993|50191579|FG001|Overall Study|Hyperglycemic Rescue|47|||
25082839|NCT00707993|50191578|FG000|Overall Study|Other|2|||
25082840|NCT00707993|50191579|FG001|Overall Study|Other|0|||
25082841|NCT00708227|50191589|FG000|Overall Study|Physician Decision|0|||
25082842|NCT00708227|50191590|FG001|Overall Study|Physician Decision|3|||
25082843|NCT00708227|50191591|FG002|Overall Study|Physician Decision|1|||
25082844|NCT00708227|50191592|FG003|Overall Study|Physician Decision|2|||
25082845|NCT00708227|50191589|FG000|Overall Study|Withdrawal by Subject|1|||
25082846|NCT00708227|50191590|FG001|Overall Study|Withdrawal by Subject|2|||
25082847|NCT00708227|50191591|FG002|Overall Study|Withdrawal by Subject|0|||
25082848|NCT00708227|50191592|FG003|Overall Study|Withdrawal by Subject|1|||
25082849|NCT02425891|50191624|FG000|Overall Study|Death|333|||
25082850|NCT02425891|50191625|FG001|Overall Study|Death|314|||
25082855|NCT02425891|50191624|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
25082856|NCT02425891|50191625|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
25082857|NCT02425891|50191624|FG000|Overall Study|Physician Decision|0|||
25082858|NCT02425891|50191625|FG001|Overall Study|Physician Decision|1|||
25082859|NCT02425891|50191624|FG000|Overall Study|Protocol Violation|1|||
25082860|NCT02425891|50191625|FG001|Overall Study|Protocol Violation|1|||
25082861|NCT02425891|50191624|FG000|Overall Study|Study Terminated By Sponsor|85|||
25082862|NCT02425891|50191625|FG001|Overall Study|Study Terminated By Sponsor|95|||
25082863|NCT02425891|50191624|FG000|Overall Study|Withdrawal by Subject|27|||
25082864|NCT02425891|50191625|FG001|Overall Study|Withdrawal by Subject|32|||
25082865|NCT03241225|50191635|FG000|Overall Study|Lost to Follow-up|2|||
25082866|NCT03241225|50191636|FG001|Overall Study|Lost to Follow-up|1|||
25082867|NCT03241225|50191635|FG000|Overall Study|Protocol Violation|4|||
25082868|NCT03241225|50191636|FG001|Overall Study|Protocol Violation|1|||
25082869|NCT03241225|50191635|FG000|Overall Study|Withdrawal by Subject|1|||
25082870|NCT03241225|50191636|FG001|Overall Study|Withdrawal by Subject|0|||
25082871|NCT01597245|50191646|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
25082872|NCT01597245|50191647|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
25082873|NCT01597245|50191648|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
25082874|NCT01597245|50191649|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
25082875|NCT01597245|50191650|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
25082876|NCT01597245|50191651|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
25082877|NCT01597245|50191652|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
25082878|NCT01597245|50191653|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
25082879|NCT01597245|50191654|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
25082880|NCT01597245|50191655|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
25082881|NCT01597245|50191656|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
25082882|NCT01597245|50191657|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
25082883|NCT01597245|50191658|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
25082884|NCT01597245|50191659|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
25082885|NCT01597245|50191660|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
25082886|NCT01597245|50191661|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
25082887|NCT01597245|50191662|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
25082888|NCT01597245|50191663|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
25082889|NCT01597245|50191664|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
25082890|NCT01597245|50191665|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
25082891|NCT01597245|50191666|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
25082892|NCT01597245|50191646|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
25082893|NCT01597245|50191647|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
25082894|NCT01597245|50191648|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
25082895|NCT01597245|50191649|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
25082896|NCT01597245|50191650|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
25082897|NCT01597245|50191651|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
25082898|NCT01597245|50191652|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
25082899|NCT01597245|50191653|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
25082900|NCT01597245|50191654|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
25082901|NCT01597245|50191655|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
25082902|NCT01597245|50191656|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
25082903|NCT01597245|50191657|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
25082904|NCT01597245|50191658|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
25082905|NCT01597245|50191659|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
25082906|NCT01597245|50191660|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
25082907|NCT01597245|50191661|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
25082908|NCT01597245|50191662|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
25082909|NCT01597245|50191663|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
25082910|NCT01597245|50191664|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
25082911|NCT01597245|50191665|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
25082912|NCT01597245|50191666|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
25082913|NCT01597245|50191646|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
25082914|NCT01597245|50191647|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
25082915|NCT01597245|50191648|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
25082916|NCT01597245|50191649|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
25082917|NCT01597245|50191650|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
25082918|NCT01597245|50191651|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
25082919|NCT01597245|50191652|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
25082920|NCT01597245|50191653|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
25082921|NCT01597245|50191654|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
25082922|NCT01597245|50191655|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
25082923|NCT01597245|50191656|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
25082924|NCT01597245|50191657|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
25082925|NCT01597245|50191658|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
25082926|NCT01597245|50191659|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
25082927|NCT01597245|50191660|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
25082928|NCT01597245|50191661|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
25082929|NCT01597245|50191662|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
25082930|NCT01597245|50191663|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
25082931|NCT01597245|50191664|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
25082932|NCT01597245|50191665|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
25082933|NCT01597245|50191666|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
25082934|NCT01597245|50191646|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
25082935|NCT01597245|50191647|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
25082936|NCT01597245|50191648|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
25082937|NCT01597245|50191649|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082938|NCT01597245|50191650|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082939|NCT01597245|50191651|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082940|NCT01597245|50191652|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082941|NCT01597245|50191653|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082942|NCT01597245|50191654|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082943|NCT01597245|50191655|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082944|NCT01597245|50191656|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082945|NCT01597245|50191657|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082946|NCT01597245|50191658|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082947|NCT01597245|50191659|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082948|NCT01597245|50191660|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082949|NCT01597245|50191661|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082950|NCT01597245|50191662|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082951|NCT01597245|50191663|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082952|NCT01597245|50191664|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082953|NCT01597245|50191665|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082954|NCT01597245|50191666|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
25082955|NCT01597245|50191646|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
25082956|NCT01597245|50191647|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082957|NCT01597245|50191648|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082958|NCT01597245|50191649|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
25082959|NCT01597245|50191650|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082960|NCT01597245|50191651|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082961|NCT01597245|50191652|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082962|NCT01597245|50191653|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082963|NCT01597245|50191654|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082964|NCT01597245|50191655|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082965|NCT01597245|50191656|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082966|NCT01597245|50191657|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082967|NCT01597245|50191658|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082968|NCT01597245|50191659|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082969|NCT01597245|50191660|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082970|NCT01597245|50191661|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082971|NCT01597245|50191662|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082972|NCT01597245|50191663|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082973|NCT01597245|50191664|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082974|NCT01597245|50191665|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082975|NCT01597245|50191666|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
25082976|NCT01597245|50191646|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
25082977|NCT01597245|50191647|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
25082978|NCT01597245|50191648|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
25082979|NCT01597245|50191649|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082980|NCT01597245|50191650|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082981|NCT01597245|50191651|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082982|NCT01597245|50191652|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082983|NCT01597245|50191653|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082984|NCT01597245|50191654|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082985|NCT01597245|50191655|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082986|NCT01597245|50191656|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082987|NCT01597245|50191657|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082988|NCT01597245|50191658|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082989|NCT01597245|50191659|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082990|NCT01597245|50191660|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082991|NCT01597245|50191661|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082992|NCT01597245|50191662|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082993|NCT01597245|50191663|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082994|NCT01597245|50191664|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082995|NCT01597245|50191665|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082996|NCT01597245|50191666|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
25082997|NCT01597245|50191646|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25082998|NCT01597245|50191647|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25082999|NCT01597245|50191648|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25083000|NCT01597245|50191649|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25083001|NCT01597245|50191650|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25083002|NCT01597245|50191651|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
25083003|NCT01597245|50191652|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
25083004|NCT01597245|50191653|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25083005|NCT01597245|50191654|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25083006|NCT01597245|50191655|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25083007|NCT01597245|50191656|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25083008|NCT01597245|50191657|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25083009|NCT01597245|50191658|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25083010|NCT01597245|50191659|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25083011|NCT01597245|50191660|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25083012|NCT01597245|50191661|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25083013|NCT01597245|50191662|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25083014|NCT01597245|50191663|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25083015|NCT01597245|50191664|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25083016|NCT01597245|50191665|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25083017|NCT01597245|50191666|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
25083018|NCT01597245|50191646|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
25083019|NCT01597245|50191647|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
25083020|NCT01597245|50191648|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
25083021|NCT01597245|50191649|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
25083022|NCT01597245|50191650|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
25083023|NCT01597245|50191651|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
25083024|NCT01597245|50191652|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
25083025|NCT01597245|50191653|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
25083026|NCT01597245|50191654|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
25083027|NCT01597245|50191655|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
25083028|NCT01597245|50191656|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
25083029|NCT01597245|50191657|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
25083030|NCT01597245|50191658|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
25083031|NCT01597245|50191659|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
25083032|NCT01597245|50191660|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
25083033|NCT01597245|50191661|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
25083034|NCT01597245|50191662|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
25083035|NCT01597245|50191663|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
25083036|NCT01597245|50191664|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
25083037|NCT01597245|50191665|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
25083038|NCT01597245|50191666|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
25083039|NCT01597245|50191646|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
25083040|NCT01597245|50191647|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
25083041|NCT01597245|50191648|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
25083042|NCT01597245|50191649|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
25083043|NCT01597245|50191650|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
25083044|NCT01597245|50191651|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
25083045|NCT01597245|50191652|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
25083046|NCT01597245|50191653|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
25083047|NCT01597245|50191654|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
25083048|NCT01597245|50191655|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
25083049|NCT01597245|50191656|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
25083050|NCT01597245|50191657|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
25083051|NCT01597245|50191658|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
25083052|NCT01597245|50191659|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
25083053|NCT01597245|50191660|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
25083054|NCT01597245|50191661|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
25083055|NCT01597245|50191662|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
25083056|NCT01597245|50191663|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
25083057|NCT01597245|50191664|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
25083058|NCT01597245|50191665|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
25083059|NCT01597245|50191666|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
25083060|NCT01597245|50191646|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
25083061|NCT01597245|50191647|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
25083062|NCT01597245|50191648|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
25083063|NCT01597245|50191649|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
25083064|NCT01597245|50191650|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
25083065|NCT01597245|50191651|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
25083066|NCT01597245|50191652|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
25083067|NCT01597245|50191653|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
25083068|NCT01597245|50191654|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
25083069|NCT01597245|50191655|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
25083070|NCT01597245|50191656|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
25083071|NCT01597245|50191657|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
25083072|NCT01597245|50191658|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
25083073|NCT01597245|50191659|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
25083074|NCT01597245|50191660|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
25083075|NCT01597245|50191661|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
25083076|NCT01597245|50191662|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
25083077|NCT01597245|50191663|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
25083078|NCT01597245|50191664|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
25083079|NCT01597245|50191665|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
25083080|NCT01597245|50191666|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
25083081|NCT01597245|50191646|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
25083082|NCT01597245|50191647|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
25083083|NCT01597245|50191648|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
25083084|NCT01597245|50191649|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
25083085|NCT01597245|50191650|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
25083086|NCT01597245|50191651|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
25083087|NCT01597245|50191652|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
25083088|NCT01597245|50191653|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
25083089|NCT01597245|50191654|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
25083090|NCT01597245|50191655|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
25083091|NCT01597245|50191656|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
25083092|NCT01597245|50191657|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
25083093|NCT01597245|50191658|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
25083094|NCT01597245|50191659|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
25083095|NCT01597245|50191660|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
25083096|NCT01597245|50191661|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
25083097|NCT01597245|50191662|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
25083098|NCT01597245|50191663|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
25083099|NCT01597245|50191664|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
25083100|NCT01597245|50191665|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
25083101|NCT01597245|50191666|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
25083102|NCT01597245|50191646|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
25083103|NCT01597245|50191647|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
25083104|NCT01597245|50191648|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
25083105|NCT01597245|50191649|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
25083106|NCT01597245|50191650|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
25083107|NCT01597245|50191651|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
25083108|NCT01597245|50191652|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
25083109|NCT01597245|50191653|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
25083110|NCT01597245|50191654|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
25083111|NCT01597245|50191655|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
25083112|NCT01597245|50191656|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
25083113|NCT01597245|50191657|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
25083114|NCT01597245|50191658|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
25083115|NCT01597245|50191659|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
25083116|NCT01597245|50191660|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
25083117|NCT01597245|50191661|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
25083118|NCT01597245|50191662|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
25083119|NCT01597245|50191663|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
25083120|NCT01597245|50191664|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
25083121|NCT01597245|50191665|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
25083122|NCT01597245|50191666|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
25083123|NCT01597245|50191646|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
25083124|NCT01597245|50191647|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
25083125|NCT01597245|50191648|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
25083126|NCT01597245|50191649|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
25083127|NCT01597245|50191650|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
25083128|NCT01597245|50191651|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
25083129|NCT01597245|50191652|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
25083130|NCT01597245|50191653|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
25083131|NCT01597245|50191654|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
25083132|NCT01597245|50191655|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
25083133|NCT01597245|50191656|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
25083134|NCT01597245|50191657|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
25083135|NCT01597245|50191658|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
25083136|NCT01597245|50191659|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
25083137|NCT01597245|50191660|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
25083138|NCT01597245|50191661|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
25083139|NCT01597245|50191662|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
25083140|NCT01597245|50191663|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
25083141|NCT01597245|50191664|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
25083142|NCT01597245|50191665|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
25083143|NCT01597245|50191666|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
25083144|NCT01597245|50191646|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
25083145|NCT01597245|50191647|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
25083146|NCT01597245|50191648|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
25083147|NCT01597245|50191649|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
25083148|NCT01597245|50191650|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
25083149|NCT01597245|50191651|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
25083150|NCT01597245|50191652|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
25083151|NCT01597245|50191653|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
25083152|NCT01597245|50191654|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
25083153|NCT01597245|50191655|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
25083154|NCT01597245|50191656|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
25083155|NCT01597245|50191657|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
25083156|NCT01597245|50191658|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
25083157|NCT01597245|50191659|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
25083158|NCT01597245|50191660|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
25083159|NCT01597245|50191661|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
25083160|NCT01597245|50191662|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
25083161|NCT01597245|50191663|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
25083162|NCT01597245|50191664|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
25083163|NCT01597245|50191665|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
25083164|NCT01597245|50191666|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
25083165|NCT01597245|50191646|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083166|NCT01597245|50191647|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083167|NCT01597245|50191648|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083168|NCT01597245|50191649|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083169|NCT01597245|50191650|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083170|NCT01597245|50191651|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083171|NCT01597245|50191652|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083172|NCT01597245|50191653|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083173|NCT01597245|50191654|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083174|NCT01597245|50191655|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083175|NCT01597245|50191656|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
25083176|NCT01597245|50191657|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083177|NCT01597245|50191658|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083178|NCT01597245|50191659|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083179|NCT01597245|50191660|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083180|NCT01597245|50191661|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083181|NCT01597245|50191662|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083182|NCT01597245|50191663|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083183|NCT01597245|50191664|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083184|NCT01597245|50191665|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083185|NCT01597245|50191666|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
25083186|NCT01597245|50191646|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083187|NCT01597245|50191647|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083188|NCT01597245|50191648|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083189|NCT01597245|50191649|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083190|NCT01597245|50191650|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083191|NCT01597245|50191651|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083192|NCT01597245|50191652|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083193|NCT01597245|50191653|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083194|NCT01597245|50191654|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083195|NCT01597245|50191655|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083196|NCT01597245|50191656|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083197|NCT01597245|50191657|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083198|NCT01597245|50191658|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083199|NCT01597245|50191659|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
25083200|NCT01597245|50191660|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
25083201|NCT01597245|50191661|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
25083202|NCT01597245|50191662|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083203|NCT01597245|50191663|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083204|NCT01597245|50191664|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083205|NCT01597245|50191665|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083206|NCT01597245|50191666|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
25083207|NCT01597245|50191646|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083208|NCT01597245|50191647|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083209|NCT01597245|50191648|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083210|NCT01597245|50191649|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083211|NCT01597245|50191650|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083212|NCT01597245|50191651|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083213|NCT01597245|50191652|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083214|NCT01597245|50191653|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083215|NCT01597245|50191654|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083216|NCT01597245|50191655|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083217|NCT01597245|50191656|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083218|NCT01597245|50191657|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083219|NCT01597245|50191658|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083220|NCT01597245|50191659|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
25083221|NCT01597245|50191660|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
25083222|NCT01597245|50191661|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
25083223|NCT01597245|50191662|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083224|NCT01597245|50191663|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083225|NCT01597245|50191664|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083226|NCT01597245|50191665|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083227|NCT01597245|50191666|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
25083228|NCT01597245|50191646|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083229|NCT01597245|50191647|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083230|NCT01597245|50191648|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083231|NCT01597245|50191649|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083232|NCT01597245|50191650|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083233|NCT01597245|50191651|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083234|NCT01597245|50191652|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083235|NCT01597245|50191653|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083236|NCT01597245|50191654|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083237|NCT01597245|50191655|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083238|NCT01597245|50191656|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083239|NCT01597245|50191657|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083240|NCT01597245|50191658|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083241|NCT01597245|50191659|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083242|NCT01597245|50191660|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
25083243|NCT01597245|50191661|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
25083244|NCT01597245|50191662|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083245|NCT01597245|50191663|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083246|NCT01597245|50191664|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083247|NCT01597245|50191665|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083248|NCT01597245|50191666|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
25083249|NCT01597245|50191646|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083250|NCT01597245|50191647|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083251|NCT01597245|50191648|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083252|NCT01597245|50191649|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083253|NCT01597245|50191650|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083254|NCT01597245|50191651|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083255|NCT01597245|50191652|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083256|NCT01597245|50191653|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083257|NCT01597245|50191654|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083258|NCT01597245|50191655|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083259|NCT01597245|50191656|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083260|NCT01597245|50191657|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083261|NCT01597245|50191658|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083262|NCT01597245|50191659|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083263|NCT01597245|50191660|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
25083264|NCT01597245|50191661|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
25083265|NCT01597245|50191662|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083266|NCT01597245|50191663|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083267|NCT01597245|50191664|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083268|NCT01597245|50191665|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083269|NCT01597245|50191666|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
25083270|NCT01597245|50191646|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083271|NCT01597245|50191647|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083272|NCT01597245|50191648|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083273|NCT01597245|50191649|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083274|NCT01597245|50191650|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083275|NCT01597245|50191651|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083276|NCT01597245|50191652|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083277|NCT01597245|50191653|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083278|NCT01597245|50191654|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083279|NCT01597245|50191655|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083280|NCT01597245|50191656|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083281|NCT01597245|50191657|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083282|NCT01597245|50191658|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083283|NCT01597245|50191659|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
25083284|NCT01597245|50191660|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
25083285|NCT01597245|50191661|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
25083286|NCT01597245|50191662|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083287|NCT01597245|50191663|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083288|NCT01597245|50191664|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083289|NCT01597245|50191665|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083290|NCT01597245|50191666|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
25083291|NCT01597245|50191646|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083292|NCT01597245|50191647|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083293|NCT01597245|50191648|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083294|NCT01597245|50191649|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083295|NCT01597245|50191650|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083296|NCT01597245|50191651|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083297|NCT01597245|50191652|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083298|NCT01597245|50191653|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083299|NCT01597245|50191654|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083300|NCT01597245|50191655|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083301|NCT01597245|50191656|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083302|NCT01597245|50191657|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083303|NCT01597245|50191658|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083304|NCT01597245|50191659|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083305|NCT01597245|50191660|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
25083306|NCT01597245|50191661|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
25083307|NCT01597245|50191662|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083308|NCT01597245|50191663|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083309|NCT01597245|50191664|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083310|NCT01597245|50191665|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083311|NCT01597245|50191666|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
25083312|NCT01597245|50191646|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083313|NCT01597245|50191647|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083314|NCT01597245|50191648|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083315|NCT01597245|50191649|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083316|NCT01597245|50191650|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083317|NCT01597245|50191651|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083318|NCT01597245|50191652|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083319|NCT01597245|50191653|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083320|NCT01597245|50191654|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083321|NCT01597245|50191655|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083322|NCT01597245|50191656|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083323|NCT01597245|50191657|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083324|NCT01597245|50191658|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083325|NCT01597245|50191659|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083326|NCT01597245|50191660|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
25083327|NCT01597245|50191661|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
25083328|NCT01597245|50191662|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083329|NCT01597245|50191663|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083330|NCT01597245|50191664|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083331|NCT01597245|50191665|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083332|NCT01597245|50191666|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
25083333|NCT01597245|50191646|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083334|NCT01597245|50191647|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083335|NCT01597245|50191648|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083336|NCT01597245|50191649|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083337|NCT01597245|50191650|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083338|NCT01597245|50191651|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083339|NCT01597245|50191652|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083340|NCT01597245|50191653|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083341|NCT01597245|50191654|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083342|NCT01597245|50191655|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083343|NCT01597245|50191656|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083344|NCT01597245|50191657|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083345|NCT01597245|50191658|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083346|NCT01597245|50191659|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083347|NCT01597245|50191660|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
25083348|NCT01597245|50191661|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
25083349|NCT01597245|50191662|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083350|NCT01597245|50191663|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083351|NCT01597245|50191664|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083352|NCT01597245|50191665|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083353|NCT01597245|50191666|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
25083354|NCT01597245|50191646|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083355|NCT01597245|50191647|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083356|NCT01597245|50191648|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083357|NCT01597245|50191649|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083358|NCT01597245|50191650|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083359|NCT01597245|50191651|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083360|NCT01597245|50191652|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083361|NCT01597245|50191653|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083362|NCT01597245|50191654|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083363|NCT01597245|50191655|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083364|NCT01597245|50191656|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083365|NCT01597245|50191657|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083366|NCT01597245|50191658|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083367|NCT01597245|50191659|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083368|NCT01597245|50191660|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
25083369|NCT01597245|50191661|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
25083370|NCT01597245|50191662|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083371|NCT01597245|50191663|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083372|NCT01597245|50191664|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083373|NCT01597245|50191665|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083374|NCT01597245|50191666|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
25083375|NCT01597245|50191646|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083376|NCT01597245|50191647|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083377|NCT01597245|50191648|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083378|NCT01597245|50191649|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083379|NCT01597245|50191650|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083380|NCT01597245|50191651|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083381|NCT01597245|50191652|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083382|NCT01597245|50191653|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083383|NCT01597245|50191654|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083384|NCT01597245|50191655|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083385|NCT01597245|50191656|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083386|NCT01597245|50191657|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083387|NCT01597245|50191658|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083388|NCT01597245|50191659|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
25083389|NCT01597245|50191660|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083390|NCT01597245|50191661|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083391|NCT01597245|50191662|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083392|NCT01597245|50191663|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083393|NCT01597245|50191664|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083394|NCT01597245|50191665|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083395|NCT01597245|50191666|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
25083396|NCT01597245|50191646|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
25083397|NCT01597245|50191647|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
25083398|NCT01597245|50191648|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
25083399|NCT01597245|50191649|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
25083400|NCT01597245|50191650|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
25083401|NCT01597245|50191651|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
25083402|NCT01597245|50191652|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
25083403|NCT01597245|50191653|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
25083404|NCT01597245|50191654|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
25083405|NCT01597245|50191655|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
25083406|NCT01597245|50191656|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
25083407|NCT01597245|50191657|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
25083408|NCT01597245|50191658|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
25083409|NCT01597245|50191659|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
25083410|NCT01597245|50191660|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
25083411|NCT01597245|50191661|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
25083412|NCT01597245|50191662|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
25083413|NCT01597245|50191663|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
25083414|NCT01597245|50191664|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
25083415|NCT01597245|50191665|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
25083416|NCT01597245|50191666|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
25083417|NCT01597245|50191646|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
25083418|NCT01597245|50191647|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
25083419|NCT01597245|50191648|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
25083420|NCT01597245|50191649|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
25083421|NCT01597245|50191650|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
25083422|NCT01597245|50191651|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
25083423|NCT01597245|50191652|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
25083424|NCT01597245|50191653|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
25083425|NCT01597245|50191654|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
25083426|NCT01597245|50191655|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
25083427|NCT01597245|50191656|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
25083428|NCT01597245|50191657|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
25083429|NCT01597245|50191658|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
25083430|NCT01597245|50191659|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
25083431|NCT01597245|50191660|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
25083432|NCT01597245|50191661|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
25083433|NCT01597245|50191662|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
25083434|NCT01597245|50191663|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
25083435|NCT01597245|50191664|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
25083436|NCT01597245|50191665|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
25083437|NCT01597245|50191666|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
25083438|NCT01597245|50191646|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083439|NCT01597245|50191647|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083440|NCT01597245|50191648|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083441|NCT01597245|50191649|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083442|NCT01597245|50191650|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083443|NCT01597245|50191651|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083444|NCT01597245|50191652|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083445|NCT01597245|50191653|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083446|NCT01597245|50191654|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083447|NCT01597245|50191655|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083448|NCT01597245|50191656|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083449|NCT01597245|50191657|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083450|NCT01597245|50191658|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083451|NCT01597245|50191659|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083452|NCT01597245|50191660|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083453|NCT01597245|50191661|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083454|NCT01597245|50191662|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
25083455|NCT01597245|50191663|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083456|NCT01597245|50191664|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
25083457|NCT01597245|50191665|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
25083458|NCT01597245|50191666|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
25083459|NCT01597245|50191646|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083460|NCT01597245|50191647|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083461|NCT01597245|50191648|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083462|NCT01597245|50191649|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083463|NCT01597245|50191650|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083464|NCT01597245|50191651|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083465|NCT01597245|50191652|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083466|NCT01597245|50191653|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083467|NCT01597245|50191654|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083468|NCT01597245|50191655|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083469|NCT01597245|50191656|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083470|NCT01597245|50191657|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083471|NCT01597245|50191658|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083472|NCT01597245|50191659|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083473|NCT01597245|50191660|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083474|NCT01597245|50191661|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083475|NCT01597245|50191662|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083476|NCT01597245|50191663|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
25083477|NCT01597245|50191664|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
25083478|NCT01597245|50191665|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
25083479|NCT01597245|50191666|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
25083480|NCT01597245|50191646|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083481|NCT01597245|50191647|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083482|NCT01597245|50191648|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083483|NCT01597245|50191649|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083484|NCT01597245|50191650|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083485|NCT01597245|50191651|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083486|NCT01597245|50191652|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083487|NCT01597245|50191653|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083488|NCT01597245|50191654|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083489|NCT01597245|50191655|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083490|NCT01597245|50191656|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083491|NCT01597245|50191657|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083492|NCT01597245|50191658|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083493|NCT01597245|50191659|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083494|NCT01597245|50191660|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083495|NCT01597245|50191661|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083496|NCT01597245|50191662|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
25083497|NCT01597245|50191663|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083498|NCT01597245|50191664|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
25083499|NCT01597245|50191665|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
25083500|NCT01597245|50191666|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
25083501|NCT01597245|50191646|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083502|NCT01597245|50191647|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083503|NCT01597245|50191648|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083504|NCT01597245|50191649|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083505|NCT01597245|50191650|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083506|NCT01597245|50191651|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083507|NCT01597245|50191652|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083508|NCT01597245|50191653|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083509|NCT01597245|50191654|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083510|NCT01597245|50191655|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083511|NCT01597245|50191656|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083512|NCT01597245|50191657|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083513|NCT01597245|50191658|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083514|NCT01597245|50191659|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083515|NCT01597245|50191660|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083516|NCT01597245|50191661|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083517|NCT01597245|50191662|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
25083518|NCT01597245|50191663|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083519|NCT01597245|50191664|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
25083520|NCT01597245|50191665|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
25083521|NCT01597245|50191666|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
25083522|NCT01597245|50191646|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083523|NCT01597245|50191647|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083524|NCT01597245|50191648|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083525|NCT01597245|50191649|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083526|NCT01597245|50191650|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083527|NCT01597245|50191651|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083528|NCT01597245|50191652|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083529|NCT01597245|50191653|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083530|NCT01597245|50191654|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083531|NCT01597245|50191655|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083532|NCT01597245|50191656|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083533|NCT01597245|50191657|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083534|NCT01597245|50191658|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083535|NCT01597245|50191659|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083536|NCT01597245|50191660|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083537|NCT01597245|50191661|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083538|NCT01597245|50191662|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
25083539|NCT01597245|50191663|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083540|NCT01597245|50191664|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083541|NCT01597245|50191665|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
25083542|NCT01597245|50191666|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
25083543|NCT01597245|50191646|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083544|NCT01597245|50191647|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083545|NCT01597245|50191648|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083546|NCT01597245|50191649|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083547|NCT01597245|50191650|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083548|NCT01597245|50191651|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083549|NCT01597245|50191652|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083550|NCT01597245|50191653|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083551|NCT01597245|50191654|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083552|NCT01597245|50191655|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083553|NCT01597245|50191656|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083554|NCT01597245|50191657|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083555|NCT01597245|50191658|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083556|NCT01597245|50191659|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083557|NCT01597245|50191660|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083558|NCT01597245|50191661|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083559|NCT01597245|50191662|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
25083560|NCT01597245|50191663|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083561|NCT01597245|50191664|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083562|NCT01597245|50191665|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
25083563|NCT01597245|50191666|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
25083564|NCT01597245|50191646|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083565|NCT01597245|50191647|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083566|NCT01597245|50191648|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083567|NCT01597245|50191649|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083568|NCT01597245|50191650|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083569|NCT01597245|50191651|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083570|NCT01597245|50191652|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083571|NCT01597245|50191653|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083572|NCT01597245|50191654|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083573|NCT01597245|50191655|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083574|NCT01597245|50191656|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083575|NCT01597245|50191657|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083576|NCT01597245|50191658|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083577|NCT01597245|50191659|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083578|NCT01597245|50191660|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083579|NCT01597245|50191661|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083580|NCT01597245|50191662|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083581|NCT01597245|50191663|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083582|NCT01597245|50191664|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083583|NCT01597245|50191665|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
25083584|NCT01597245|50191666|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
25083585|NCT00707057|50191701|FG000|Overall Study|Withdrawal by Subject|8|||
25083586|NCT00707057|50191702|FG001|Overall Study|Withdrawal by Subject|3|||
25083587|NCT00707057|50191701|FG000|Overall Study|Dosed incorrectly|0|||
25083588|NCT00707057|50191702|FG001|Overall Study|Dosed incorrectly|1|||
25083589|NCT02639247|50191710|FG000|Overall Study|Lost to Follow-up|2|||
25083590|NCT02639247|50191711|FG001|Overall Study|Lost to Follow-up|1|||
25083591|NCT02639247|50191710|FG000|Overall Study|Death|2|||
25083592|NCT02639247|50191711|FG001|Overall Study|Death|0|||
25083593|NCT02639247|50191710|FG000|Overall Study|Withdrew Consent|0|||
25083594|NCT02639247|50191711|FG001|Overall Study|Withdrew Consent|1|||
25083595|NCT02639247|50191710|FG000|Overall Study|Protocol Violation|1|||
25083596|NCT02639247|50191711|FG001|Overall Study|Protocol Violation|0|||
25083597|NCT00706901|50191720|FG000|Overall Study|Lost to Follow-up|2|||
25083598|NCT00706901|50191721|FG001|Overall Study|Lost to Follow-up|3|||
25083599|NCT00706901|50191722|FG002|Overall Study|Lost to Follow-up|2|||
25083600|NCT00706901|50191720|FG000|Overall Study|Withdrawal by Subject|4|||
25083601|NCT00706901|50191721|FG001|Overall Study|Withdrawal by Subject|2|||
25083602|NCT00706901|50191722|FG002|Overall Study|Withdrawal by Subject|5|||
25083603|NCT00706901|50191720|FG000|Overall Study|In Jail|1|||
25083604|NCT00706901|50191721|FG001|Overall Study|In Jail|0|||
25083605|NCT00706901|50191722|FG002|Overall Study|In Jail|1|||
25083606|NCT00706901|50191720|FG000|Overall Study|Death|1|||
25083607|NCT00706901|50191721|FG001|Overall Study|Death|0|||
25083608|NCT00706901|50191722|FG002|Overall Study|Death|0|||
25083609|NCT01673373|50191731|FG000|Overall Study|Death|2|||
25083610|NCT01236547|50191740|FG000|Overall Study|Protocol Violation|0|||
25083611|NCT01236547|50191741|FG001|Overall Study|Protocol Violation|1|||
25083612|NCT01236547|50191742|FG002|Overall Study|Protocol Violation|1|||
25083613|NCT01236547|50191743|FG003|Overall Study|Protocol Violation|6|||
25083614|NCT01236547|50191744|FG004|Overall Study|Protocol Violation|12|||
25083615|NCT02167945|50191757|FG000|Overall Study|Adverse Event|16|||
25083616|NCT02167945|50191757|FG000|Overall Study|Withdrew Consent|42|||
25083617|NCT02167945|50191757|FG000|Overall Study|Lost to Follow-up|122|||
25083618|NCT02167945|50191757|FG000|Overall Study|COVID-19 logistical restrictions|6|||
25083619|NCT02167945|50191757|FG000|Overall Study|Other, not specified|63|||
25083620|NCT01991977|50191769|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
25083621|NCT01991977|50191769|FG000|Overall Study|Withdrew after start of treatment|5|||
25083622|NCT01375075|50191779|FG000|Overall Study|Adverse Event|0|||
25083623|NCT01375075|50191780|FG001|Overall Study|Adverse Event|0|||
25083624|NCT01375075|50191781|FG002|Overall Study|Adverse Event|3|||
25083625|NCT01375075|50191782|FG003|Overall Study|Adverse Event|1|||
25083626|NCT01375075|50191783|FG004|Overall Study|Adverse Event|0|||
25083627|NCT01375075|50191784|FG005|Overall Study|Adverse Event|1|||
25083628|NCT01375075|50191779|FG000|Overall Study|Entry Criterion Not Met|1|||
25083629|NCT01375075|50191780|FG001|Overall Study|Entry Criterion Not Met|0|||
25083630|NCT01375075|50191781|FG002|Overall Study|Entry Criterion Not Met|0|||
25083631|NCT01375075|50191782|FG003|Overall Study|Entry Criterion Not Met|0|||
25083632|NCT01375075|50191783|FG004|Overall Study|Entry Criterion Not Met|0|||
25083633|NCT01375075|50191784|FG005|Overall Study|Entry Criterion Not Met|1|||
25083634|NCT01375075|50191779|FG000|Overall Study|Withdrawal by Subject|0|||
25083635|NCT01375075|50191780|FG001|Overall Study|Withdrawal by Subject|1|||
25083636|NCT01375075|50191781|FG002|Overall Study|Withdrawal by Subject|0|||
25083637|NCT01375075|50191782|FG003|Overall Study|Withdrawal by Subject|0|||
25083638|NCT01375075|50191783|FG004|Overall Study|Withdrawal by Subject|0|||
25083639|NCT01375075|50191784|FG005|Overall Study|Withdrawal by Subject|1|||
25083640|NCT00706433|50191806|FG000|Overall Study|Lost to Follow-up|3|||
25083641|NCT00706433|50191807|FG001|Overall Study|Lost to Follow-up|1|||
25083642|NCT00706433|50191808|FG002|Overall Study|Lost to Follow-up|6|||
25083643|NCT00706433|50191809|FG003|Overall Study|Lost to Follow-up|0|||
25083644|NCT00706433|50191806|FG000|Overall Study|Withdrawal by Subject|1|||
25083645|NCT00706433|50191807|FG001|Overall Study|Withdrawal by Subject|2|||
25083646|NCT00706433|50191808|FG002|Overall Study|Withdrawal by Subject|3|||
25083647|NCT00706433|50191809|FG003|Overall Study|Withdrawal by Subject|1|||
25083648|NCT00706433|50191806|FG000|Overall Study|Adverse Event|0|||
25083649|NCT00706433|50191807|FG001|Overall Study|Adverse Event|0|||
25083650|NCT00706433|50191808|FG002|Overall Study|Adverse Event|1|||
25083651|NCT00706433|50191809|FG003|Overall Study|Adverse Event|0|||
25083652|NCT00706433|50191806|FG000|Overall Study|Protocol Violation|1|||
25083653|NCT00706433|50191807|FG001|Overall Study|Protocol Violation|0|||
25083654|NCT00706433|50191808|FG002|Overall Study|Protocol Violation|0|||
25083655|NCT00706433|50191809|FG003|Overall Study|Protocol Violation|0|||
25083656|NCT00706433|50191806|FG000|Overall Study|new job|0|||
25083657|NCT00706433|50191807|FG001|Overall Study|new job|0|||
25083658|NCT00706433|50191808|FG002|Overall Study|new job|0|||
25083659|NCT00706433|50191809|FG003|Overall Study|new job|1|||
25261083|NCT01011907|50575766|FG001|Overall Study|Withdrawal by Subject|11|||
25261084|NCT01011907|50575765|FG000|Overall Study|Adverse Event|1|||
25261085|NCT01011907|50575766|FG001|Overall Study|Adverse Event|4|||
25261086|NCT01011673|50575774|FG000|Randomized|Secondary headache|2|||
25261087|NCT01011673|50575775|FG001|Randomized|Secondary headache|1|||
25261088|NCT01011673|50575774|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
25261089|NCT01011673|50575775|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
